Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" A4GALT "A14GALT, Gb3S, P(k), P1" ENSG00000128274 "Alpha 1,4-galactosyltransferase (P blood group)" Q9NPC4 22 42692112-42721298 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 69.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "NK-cell: 1.4;plasmacytoid DC: 3.4" "Group enriched" "Detected in many" 13 "dendritic cells: 3.4;NK-cells: 1.4" "Cell line enhanced" "Detected in many" "ASC diff: 21.9;ASC TERT1: 17.9;RPTEC TERT1: 14.8;TIME: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001141 Uncertain Mitochondria NA NA Mitochondria "HPA001141: AB_1078139" "unprognostic (2.59e-2)" "prognostic favorable (2.48e-4)" "unprognostic (2.24e-2)" "unprognostic (4.54e-3)" "unprognostic (7.41e-2)" "unprognostic (1.53e-1)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.30e-1)" "unprognostic (1.28e-1)" "unprognostic (4.82e-3)" "unprognostic (4.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.96e-1)" "unprognostic (8.72e-2)" "unprognostic (3.46e-2)" "unprognostic (2.74e-1)" 22.7 5.9 3.5 8.2 3.7 3.8 15.3 1.4 3.8 21.2 12.0 2.3 32.6 4.8 13.0 16.9 15.0 11.7 11.0 26.8 2.3 1.3 30.0 4.4 14.0 6.4 2.9 3.0 11.8 3.4 1.4 7.7 12.6 2.9 15.4 2.1 9.9 15.4 39.8 12.5 8.7 7.0 18.6 5.3 11.4 11.3 6.7 2.4 1.3 10.7 13.0 10.1 16.1 25.6 0.1 3.4 0.0 0.0 1.4 0.0 0.0 0.6 7.4 0.0 0.0 21.9 17.9 11.2 2.9 3.2 0.6 1.1 2.3 1.2 7.2 5.2 5.2 3.8 0.7 7.1 3.5 0.1 0.0 1.4 0.1 11.8 0.2 6.6 0.0 0.5 10.5 1.0 3.1 0.5 1.0 2.6 0.0 0.0 0.0 2.8 10.1 0.0 0.0 0.9 0.5 1.8 0.0 1.7 0.7 14.8 12.7 0.1 0.0 9.1 0.2 0.0 1.4 5.8 0.8 15.7 0.0 1.4 13.4 3.8 1.5 6.8 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.4 0.0 0.0 3.5 3.7 1.4 3.8 2.3 1.3 2.9 3.0 2.9 2.4 0.0 0.3 1.4 28.5 8.1 0.0 14.6 2.5 2.7 9.1 17.4 0.0 36.7 11.6 18.0 0.4 40.9 0.0 23.3 1.0 26.1 24.9 31.4 1.1 0.2 4.8 0.0 0.0 22.1 1.8 1.5 42.8 5.4 6.8 52.3 0.0 0.5 3.7 0.0 28.3 45.6 0.4 38.8 39.6 0.4 0.4 7.8 7.9 1.0 0.0 69.8 AATK "AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77" ENSG00000181409 "Apoptosis associated tyrosine kinase" Q6ZMQ8 17 81117295-81166077 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.3;intestine: 28.7" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 29.8;Alveolar cells type 2: 23.6;Bipolar cells: 43.5;Horizontal cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "neutrophil: 3.6" "Lineage enriched" "Detected in single" 21 "granulocytes: 3.6" "Group enriched" "Detected in some" 6 "CACO-2: 30.3;SH-SY5Y: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009073 Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA009073: AB_1078076" "unprognostic (3.47e-3)" "unprognostic (3.01e-2)" "unprognostic (1.12e-1)" "unprognostic (1.95e-4)" "unprognostic (1.96e-1)" "unprognostic (1.94e-1)" "unprognostic (7.29e-2)" "unprognostic (9.85e-2)" "unprognostic (6.09e-2)" "unprognostic (4.27e-2)" "unprognostic (2.88e-3)" "unprognostic (2.48e-1)" "unprognostic (4.28e-6)" "unprognostic (1.58e-3)" "unprognostic (1.21e-1)" "unprognostic (1.39e-1)" "unprognostic (4.57e-2)" 2.8 4.7 14.3 3.2 16.6 3.7 0.9 19.0 29.0 1.2 3.3 16.5 0.0 28.7 1.0 1.1 1.7 1.2 2.7 2.3 23.6 13.9 1.2 1.2 9.7 1.5 20.1 13.6 1.0 17.9 3.6 6.4 2.6 11.0 2.4 1.1 4.1 5.6 3.6 1.1 1.9 20.3 1.3 35.3 5.9 4.5 1.3 9.8 0.0 1.3 0.0 1.0 1.3 1.1 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.2 0.3 2.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 30.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 1.2 1.4 1.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 3.2 0.0 0.1 0.5 0.3 0.1 1.3 2.5 0.2 0.0 0.0 2.9 10.4 0.2 0.0 1.5 0.1 0.3 0.8 1.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 14.3 16.6 19.0 22.3 23.6 13.9 20.1 13.6 11.0 9.8 29.8 23.6 0.0 0.8 0.2 43.5 2.2 2.5 0.0 0.0 0.0 3.9 0.0 0.0 0.6 0.0 1.1 6.9 0.0 1.6 0.1 0.4 1.0 5.8 0.0 2.0 20.6 1.7 0.6 4.1 0.0 1.4 0.6 5.0 0.0 4.5 8.3 1.3 4.5 2.5 0.8 4.1 0.0 0.8 0.5 0.2 0.3 1.9 0.7 7.2 0.1 ABCB11 "ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP" ENSG00000073734 "ATP binding cassette subfamily B member 11" O95342 2 168922938-169031322 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport Translocase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "liver: 47.4" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 38.7;Alveolar cells type 2: 58.1;Club cells: 35.2;granulocytes: 22.1;Hepatocytes: 17.9" "Cancer enriched" "Detected in single" 87 "liver cancer: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.0;NB-4: 1.7;PC-3: 1.0;THP-1: 2.6;TIME: 1.8;U-2197: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA019035 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA019035: AB_1844429" "unprognostic (7.78e-2)" "unprognostic (3.92e-1)" "unprognostic (8.31e-2)" "unprognostic (2.56e-1)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "unprognostic (1.00e-2)" "unprognostic (9.71e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (5.64e-3)" "unprognostic (3.71e-1)" "unprognostic (5.26e-6)" "unprognostic (7.12e-2)" "unprognostic (1.82e-1)" "unprognostic (1.94e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.8 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 38.7 58.1 0.0 0.0 0.0 0.0 0.3 0.0 16.0 35.2 0.0 0.0 0.0 0.0 0.1 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.1 17.9 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 ABCB6 "EST45597, MTABC3, umat" ENSG00000115657 "ATP binding cassette subfamily B member 6 (Langereis blood group)" Q9NP58 2 219209766-219219017 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Dyskeratosis congenita, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 4.0;Club cells: 2.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046723, HPA058011" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol" NA NA 22000 "Golgi apparatus" "Nucleoplasm, Plasma membrane, Mitochondria, Cytosol" "HPA046723: AB_10960288, HPA058011: AB_2683578" "unprognostic (8.04e-2)" "unprognostic (3.22e-2)" "unprognostic (4.53e-3)" "unprognostic (3.19e-2)" "unprognostic (2.55e-1)" "unprognostic (9.11e-2)" "prognostic unfavorable (9.45e-7)" "unprognostic (2.26e-1)" "unprognostic (3.62e-2)" "unprognostic (1.53e-1)" "unprognostic (1.18e-4)" "unprognostic (3.02e-3)" "prognostic unfavorable (1.52e-7)" "unprognostic (1.51e-1)" "unprognostic (9.55e-2)" "unprognostic (7.75e-2)" "unprognostic (2.30e-1)" 10.1 8.4 8.2 3.9 13.5 10.2 9.2 7.6 9.1 6.9 7.6 5.4 8.3 8.1 7.1 10.1 9.0 8.4 8.5 9.5 5.6 8.2 6.9 16.2 7.2 4.9 9.8 7.6 13.1 7.1 8.0 6.0 3.7 9.2 9.2 4.2 6.0 5.6 11.3 24.0 5.5 8.0 9.5 9.2 3.2 6.8 19.5 7.7 0.8 9.9 11.3 4.7 14.8 6.0 2.8 5.6 1.3 1.1 1.2 3.2 2.4 0.1 9.9 2.0 12.5 14.0 5.0 12.3 3.7 3.4 4.1 4.1 15.2 2.1 0.1 19.1 3.6 2.2 21.4 0.2 1.5 1.3 6.3 2.2 15.5 10.9 27.9 16.9 0.0 5.2 7.3 1.8 2.7 0.0 6.1 7.1 2.1 13.1 1.9 2.7 5.1 1.0 0.1 3.1 23.0 4.1 5.2 6.3 0.6 2.2 0.2 7.4 7.9 7.7 18.3 8.1 8.0 5.5 0.3 3.2 5.5 0.2 7.4 4.3 5.0 4.0 0.0 6.2 0.1 7.3 1.3 1.1 0.0 1.7 0.9 0.5 2.8 1.3 0.7 0.9 2.3 3.2 2.1 0.0 1.2 0.8 5.6 1.1 2.4 8.2 13.5 7.6 9.1 5.6 8.2 9.8 7.6 9.2 7.7 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 4.0 2.3 0.0 0.0 0.2 0.0 0.6 1.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.7 0.0 0.2 0.9 0.2 0.3 0.2 0.0 0.0 0.0 ABCC6 "ARA, EST349056, MLP1, MRP6, PXE, URG7" ENSG00000091262 "ATP binding cassette subfamily C member 6" O95255 16 16148928-16223522 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 27.4" "Cell type enhanced" "Detected in many" 14 "Distal tubular cells: 38.1;Hepatocytes: 56.7;Proximal tubular cells: 117.8" "Cancer enhanced" "Detected in many" "liver cancer: 16.7" "Cell type enriched" "Detected in some" 5 "classical monocyte: 7.3" "Lineage enriched" "Detected in many" 5 "monocytes: 7.3" "Cell line enriched" "Detected in some" 8 "Hep G2: 38.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA038105 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA038105: AB_2675835" "unprognostic (1.32e-1)" "unprognostic (1.11e-1)" "unprognostic (5.98e-2)" "unprognostic (3.15e-2)" "unprognostic (1.59e-1)" "unprognostic (3.09e-1)" "prognostic favorable (3.82e-4)" "unprognostic (6.54e-3)" "unprognostic (3.64e-1)" "unprognostic (9.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.65e-1)" "unprognostic (1.12e-3)" "unprognostic (3.42e-1)" "unprognostic (2.00e-1)" "unprognostic (4.91e-2)" "unprognostic (1.41e-1)" 2.3 1.4 0.2 0.0 0.2 0.0 1.1 0.0 0.0 0.1 1.5 7.0 0.0 0.0 0.0 0.3 1.2 0.8 0.1 0.1 9.0 27.4 2.8 0.0 0.2 0.1 6.7 0.5 0.1 0.0 0.7 1.2 6.7 0.2 1.7 0.0 3.7 0.0 0.2 0.1 2.2 0.0 2.2 0.0 0.0 0.0 0.2 0.9 1.3 7.3 0.6 0.1 1.2 0.0 0.9 0.4 0.0 0.0 0.5 1.1 0.0 0.2 0.6 0.9 3.8 1.5 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.4 1.1 0.1 38.6 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.2 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.6 0.1 0.5 0.1 0.2 4.9 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 7.3 0.3 0.0 1.0 0.0 0.0 0.1 0.0 0.9 0.2 0.1 0.1 1.3 0.6 0.1 0.1 0.0 1.2 26.8 26.9 3.6 0.7 0.1 0.3 2.4 20.4 18.7 9.1 8.7 0.0 0.0 38.1 1.6 0.2 0.6 19.1 0.0 7.1 0.0 1.0 1.6 1.1 56.7 1.1 0.0 2.9 1.8 4.1 0.4 1.4 1.5 1.7 1.0 13.4 1.3 2.9 3.5 5.3 117.8 0.7 0.0 0.5 0.1 0.2 0.6 0.0 0.0 13.3 0.4 ABCF2 "ABC28, EST133090, HUSSY-18, M-ABC1" ENSG00000285292 "ATP binding cassette subfamily F member 2" Q9UG63 7 151207837-151227166 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 41.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA020091, HPA021815, HPA030388" Approved Uncertain Cytosol NA NA Cytosol "HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558" 7.9 4.3 4.4 6.5 6.4 2.4 6.1 4.2 10.8 5.5 5.4 5.4 4.0 3.6 5.7 3.3 6.1 5.8 4.3 4.5 4.1 6.2 5.2 5.8 6.1 5.0 8.3 4.0 6.0 10.8 2.7 4.1 5.7 4.1 5.2 4.4 2.9 5.8 20.3 5.6 3.1 6.0 3.1 5.9 3.3 7.2 5.6 5.2 4.9 5.5 6.8 4.8 3.3 8.5 11.3 8.7 9.8 10.0 24.2 13.4 12.7 11.8 9.0 18.8 10.4 12.2 5.0 18.2 10.0 8.7 11.4 9.3 10.3 19.5 13.8 16.7 18.9 10.0 14.3 14.3 18.4 7.8 4.2 12.1 9.5 5.6 18.9 24.3 4.7 11.5 9.9 20.7 17.8 8.5 15.0 9.6 26.5 8.9 15.5 9.7 26.4 0.9 8.2 16.5 9.5 8.7 10.1 20.3 4.0 10.3 3.5 9.7 20.2 10.9 8.0 8.1 5.9 10.3 14.1 8.4 2.4 12.9 20.6 12.4 13.1 22.8 16.0 19.5 7.7 8.7 9.8 2.3 10.3 7.1 24.2 8.5 14.4 12.6 11.3 8.4 12.7 12.0 0.7 10.0 5.5 6.8 12.7 13.4 0.0 0.3 9.0 17.6 24.2 17.5 0.0 7.6 0.0 0.0 0.0 7.9 0.0 0.0 0.0 37.1 11.3 15.3 0.0 0.0 0.0 1.0 10.7 10.3 11.4 0.0 9.5 6.4 10.4 10.5 41.5 9.8 4.6 18.6 0.0 8.0 12.9 0.0 20.1 13.8 0.0 11.9 12.9 17.6 22.3 8.4 22.0 0.0 14.9 12.2 13.9 ABHD12B "BEM46L3, C14orf29" ENSG00000131969 "Abhydrolase domain containing 12B" Q7Z5M8 14 50872160-50904970 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.0;retina: 10.0;skin 1: 21.6" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 136.7" "Cancer enriched" "Detected in many" 5 "testis cancer: 7.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 2.3;neutrophil: 5.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;Hep G2: 1.4;NB-4: 2.4;NTERA-2: 1.6;RH-30: 2.0;SH-SY5Y: 1.3;SuSa: 2.9;T-47d: 1.3;THP-1: 1.9" "Region enriched" "Detected in single" 5 "thalamus: 2.3" "Low region specificity" "Detected in many" HPA002873 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA002873: AB_2220573" "unprognostic (6.61e-2)" "unprognostic (3.49e-2)" "unprognostic (2.92e-3)" "unprognostic (1.99e-3)" "unprognostic (4.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.62e-2)" "unprognostic (2.09e-1)" "unprognostic (4.31e-2)" "unprognostic (6.27e-2)" "unprognostic (3.30e-1)" "unprognostic (3.35e-1)" "unprognostic (1.70e-3)" "unprognostic (3.16e-2)" "unprognostic (9.62e-2)" "unprognostic (3.18e-3)" "unprognostic (1.68e-1)" 1.1 0.2 2.4 0.4 10.0 2.4 2.8 0.3 5.2 0.2 1.5 5.4 0.3 0.2 0.8 0.4 0.7 2.0 0.4 0.5 1.4 1.2 0.6 0.2 0.8 0.4 2.2 2.7 0.3 1.1 1.3 0.3 0.4 2.2 0.3 2.4 10.0 0.2 0.2 0.2 21.6 0.3 0.2 0.7 0.2 0.2 1.2 3.9 0.0 0.4 0.0 0.3 0.2 0.2 0.0 0.1 5.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.4 0.5 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.9 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.9 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 2.4 10.0 0.3 5.2 1.4 1.2 2.2 2.7 2.2 3.9 0.0 0.0 0.0 0.0 0.3 3.3 1.4 0.0 14.7 0.0 1.8 2.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.8 1.1 0.0 0.0 0.0 0.9 136.7 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.2 0.2 1.3 0.2 0.0 1.6 0.1 ABHD14A-ACY1 ENSG00000114786 "ABHD14A-ACY1 readthrough" 3 51974706-51989183 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 3.7;Club cells: 3.4;Collecting duct cells: 5.2;Distal tubular cells: 3.3;Proximal tubular cells: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 3.4;HUVEC TERT2: 4.2;SH-SY5Y: 3.4" "HPA036174, HPA036175, HPA038153" Approved Uncertain Vesicles NA NA Vesicles "HPA036174: AB_2674988, HPA036175: AB_2674989, HPA038153: AB_2675868" "unprognostic (8.40e-2)" "unprognostic (1.37e-1)" "unprognostic (4.90e-2)" "unprognostic (7.22e-3)" "unprognostic (3.83e-2)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (1.35e-1)" "unprognostic (6.23e-2)" "unprognostic (2.71e-1)" "unprognostic (1.10e-1)" "unprognostic (1.29e-2)" "unprognostic (9.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (7.11e-4)" 2.7 2.9 3.5 2.6 8.2 2.0 2.3 8.3 15.1 3.7 3.5 3.2 1.9 4.8 2.5 3.2 2.0 3.3 3.5 4.8 3.2 4.1 5.8 8.4 3.0 1.9 2.7 7.2 2.7 4.6 1.4 3.7 1.7 5.6 2.8 1.6 8.2 4.1 2.2 8.0 2.0 10.5 2.0 3.9 3.3 2.6 2.2 1.3 0.9 4.7 1.8 2.8 2.3 2.7 2.4 5.2 1.2 4.0 4.7 4.1 2.7 0.0 0.0 0.3 0.5 2.0 1.1 0.2 0.0 2.0 0.4 0.4 2.0 3.4 0.8 0.1 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.1 0.0 0.0 0.0 2.6 1.0 0.0 0.0 0.5 4.2 1.1 2.1 0.0 0.0 0.0 2.0 1.5 1.3 1.0 1.8 0.5 0.0 0.2 0.0 0.0 0.4 3.4 0.0 2.4 0.0 0.0 0.9 0.0 0.0 1.0 0.0 2.1 0.0 0.0 0.0 2.0 1.6 0.0 0.0 0.2 1.7 1.2 4.1 4.0 2.4 2.4 2.3 4.1 5.2 1.7 2.1 2.7 0.0 4.7 2.0 2.4 2.5 2.7 3.5 8.2 8.3 15.1 3.2 4.1 2.7 7.2 5.6 1.3 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 5.2 0.0 0.0 3.3 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 1.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ABHD5 "CGI-58, NCIE2" ENSG00000011198 "Abhydrolase domain containing 5" Q8WTS1 3 43690108-43734371 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Cataract, Deafness, Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 70.3" "Cell type enhanced" "Detected in many" 7 "Syncytiotrophoblasts: 171.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 26.1;classical monocyte: 7.6;neutrophil: 21.0" "Group enriched" "Detected in many" 5 "granulocytes: 26.1;monocytes: 7.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020685, HPA035851, HPA035852" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073" "unprognostic (2.58e-1)" "unprognostic (2.73e-1)" "prognostic favorable (8.89e-4)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (2.26e-1)" "unprognostic (6.13e-2)" "unprognostic (2.40e-2)" "unprognostic (5.33e-2)" "unprognostic (3.50e-3)" "unprognostic (2.56e-2)" "unprognostic (4.13e-3)" "prognostic favorable (9.17e-5)" "unprognostic (2.48e-1)" "unprognostic (8.87e-2)" "unprognostic (4.18e-2)" "unprognostic (4.18e-2)" 26.5 10.5 5.2 7.4 12.2 32.2 70.3 8.5 10.3 7.6 10.2 10.5 5.9 7.4 4.6 4.0 22.7 3.7 10.4 9.8 7.4 4.5 10.1 18.4 14.1 8.7 18.5 4.6 4.2 12.8 9.1 8.6 20.2 14.9 5.8 6.7 4.4 21.1 7.4 10.4 24.8 15.1 8.1 19.0 7.0 8.9 8.1 12.5 3.3 13.2 9.9 6.7 11.2 16.0 1.7 3.6 26.1 7.6 0.9 2.4 2.5 8.5 3.0 3.6 3.8 15.2 5.8 7.5 34.9 13.9 9.6 7.2 4.7 3.0 7.1 4.8 10.9 8.5 2.8 5.7 8.5 9.8 25.8 5.5 18.2 11.6 3.2 7.6 4.1 5.9 6.4 29.5 16.1 13.8 8.4 16.0 4.8 10.8 5.4 21.3 4.6 2.9 2.9 9.7 6.8 9.8 1.3 10.4 4.1 12.4 17.0 4.4 6.0 15.3 8.3 3.6 4.0 8.9 3.5 8.8 8.5 6.7 15.7 15.1 4.9 13.6 3.4 9.0 7.5 6.6 26.1 7.6 4.4 1.2 3.7 1.0 1.7 0.9 1.4 3.6 1.2 0.8 1.3 21.0 0.9 2.7 0.9 2.4 2.5 5.2 12.2 8.5 10.3 7.4 4.5 18.5 4.6 14.9 12.5 23.8 43.8 8.5 23.5 35.4 11.3 9.7 15.3 17.4 25.0 26.2 25.5 13.3 28.2 49.4 13.5 16.9 64.4 23.3 53.5 21.2 16.2 21.6 16.1 11.3 16.6 3.2 34.9 14.7 26.6 12.9 4.9 30.4 6.8 16.2 17.1 12.4 61.4 24.6 5.3 31.4 14.7 0.0 26.8 35.6 43.9 35.8 171.7 15.8 18.2 41.1 ABHD6 ENSG00000163686 "Abhydrolase domain containing 6" Q9BV23 3 58237506-58295693 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.4" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 53.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017283, HPA073225" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA017283: AB_1844452, HPA073225: AB_2686583" "unprognostic (4.20e-2)" "unprognostic (7.92e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.35e-2)" "unprognostic (1.16e-2)" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (1.15e-2)" "unprognostic (9.54e-2)" "unprognostic (1.11e-3)" "unprognostic (1.34e-2)" "unprognostic (1.94e-1)" "prognostic favorable (1.11e-11)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (2.72e-1)" "unprognostic (6.31e-2)" 8.3 10.0 11.6 4.6 14.0 1.0 5.8 17.7 22.5 3.7 8.1 30.0 10.3 26.3 4.7 10.8 4.8 6.9 4.4 4.1 19.0 9.2 24.3 43.4 6.3 5.2 18.6 12.2 4.1 2.4 4.8 15.2 4.8 19.0 4.4 8.1 10.5 3.0 12.9 3.1 17.2 33.5 6.8 24.0 22.8 9.0 3.1 14.3 2.0 6.6 2.1 5.4 4.6 4.1 3.9 7.0 2.1 9.3 0.7 2.6 1.1 2.0 7.7 1.1 5.0 14.5 2.6 13.4 5.4 4.8 5.7 7.7 4.0 2.8 3.9 0.5 2.9 17.6 6.0 5.2 2.4 5.1 6.6 2.6 3.3 5.2 5.5 4.9 1.0 17.6 2.5 11.1 5.2 2.5 6.7 3.2 6.5 3.9 9.0 4.6 1.5 6.7 0.4 3.7 16.7 17.0 2.5 2.3 8.7 8.7 2.8 6.7 2.7 5.9 3.3 11.1 2.3 2.2 2.7 3.4 4.1 4.5 10.1 6.4 2.6 7.6 0.1 10.5 9.9 5.6 0.0 2.8 2.1 2.1 9.3 2.0 3.9 1.2 2.6 4.6 3.0 1.2 1.5 0.0 0.7 6.2 7.0 1.4 1.1 11.6 14.0 17.7 22.5 19.0 9.2 18.6 12.2 19.0 14.3 0.0 2.6 8.8 2.6 7.7 13.8 4.8 0.0 17.4 5.7 3.5 3.9 2.2 1.7 2.9 0.8 7.8 13.6 0.0 1.6 0.4 2.1 1.3 10.5 53.3 8.1 14.3 0.0 26.4 14.6 0.4 6.4 9.6 3.3 14.4 2.2 10.8 1.6 0.0 7.8 15.4 3.0 0.0 3.5 0.5 2.3 21.5 0.5 3.2 4.5 2.0 ABLIM2 KIAA1808 ENSG00000163995 "Actin binding LIM protein family member 2" Q6H8Q1 4 7965310-8158832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0;skeletal muscle: 71.8" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 11.1;Intestinal endocrine cells: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.0" "Lineage enriched" "Detected in single" 4 "T-cells: 3.0" "Group enriched" "Detected in some" 5 "SCLC-21H: 13.2;SiHa: 5.8;U-2197: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035808 Uncertain Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA035808: AB_10601962" "unprognostic (7.57e-2)" "unprognostic (3.24e-3)" "unprognostic (7.78e-2)" "unprognostic (3.33e-1)" "unprognostic (2.86e-2)" "unprognostic (6.09e-2)" "unprognostic (1.49e-2)" "unprognostic (5.54e-2)" "unprognostic (1.46e-1)" "unprognostic (5.01e-3)" "unprognostic (2.04e-2)" "unprognostic (3.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.32e-2)" "unprognostic (5.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.45e-2)" 4.0 3.8 8.2 1.9 19.1 0.8 2.1 4.0 26.0 1.4 2.1 2.3 0.0 1.1 1.2 1.3 10.5 1.4 1.7 5.7 3.4 5.1 2.5 1.2 1.8 1.4 2.8 7.6 1.1 3.3 2.4 6.1 1.2 9.9 1.8 2.1 1.3 2.6 1.2 71.8 3.8 1.8 2.1 1.8 14.8 1.8 1.5 4.0 0.0 2.4 1.9 2.3 1.5 1.7 0.7 0.5 0.0 0.2 0.0 3.0 0.2 1.0 0.0 0.2 1.5 0.4 0.1 0.4 0.0 0.0 0.1 0.0 0.0 1.3 2.9 0.3 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.7 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.6 1.9 0.1 0.0 1.2 2.7 0.9 0.1 1.0 0.6 0.2 0.0 13.2 1.0 5.8 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.4 20.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.0 0.1 3.0 0.0 2.5 0.0 0.5 0.7 1.2 0.9 0.0 0.0 0.2 0.0 1.2 0.2 8.2 19.1 4.0 26.0 3.4 5.1 2.8 7.6 9.9 4.0 0.0 1.4 0.0 0.1 2.3 5.1 3.6 0.0 2.7 0.0 3.5 0.0 0.0 0.0 3.0 1.7 2.7 7.5 0.0 3.8 0.5 0.4 0.3 2.3 0.4 0.1 11.1 10.3 1.3 0.3 4.2 0.0 0.0 0.0 0.0 3.0 2.7 3.4 4.5 3.5 0.3 2.9 6.5 4.2 0.0 1.5 5.5 0.0 0.0 5.2 0.1 ABTB1 "BPOZ, Btb3, BTBD21, EF1ABP" ENSG00000114626 "Ankyrin repeat and BTB domain containing 1" Q969K4 3 127672935-127680920 "Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 107.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 107.3" "Lineage enriched" "Detected in all" 12 "granulocytes: 107.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035022, HPA035023" Uncertain Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA035022: AB_10669998, HPA035023: AB_10602104" "unprognostic (6.76e-2)" "unprognostic (9.18e-3)" "unprognostic (2.11e-2)" "unprognostic (6.34e-2)" "unprognostic (6.51e-2)" "unprognostic (2.00e-3)" "unprognostic (4.43e-2)" "unprognostic (2.12e-2)" "unprognostic (9.81e-2)" "unprognostic (4.48e-3)" "unprognostic (4.55e-3)" "unprognostic (2.86e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.88e-1)" "unprognostic (1.81e-2)" "unprognostic (3.98e-2)" "unprognostic (7.92e-3)" 20.4 13.7 11.7 17.7 20.1 42.3 14.2 43.4 27.2 15.4 14.3 13.8 12.9 12.3 15.6 10.9 9.6 13.1 17.6 20.4 10.9 8.2 11.4 8.3 15.5 22.1 9.7 15.8 15.8 11.2 7.8 15.3 12.0 11.4 13.5 4.9 12.4 15.2 14.5 25.1 11.6 13.0 13.3 7.5 41.4 11.7 5.9 12.5 17.8 10.2 9.1 10.4 14.6 17.4 2.9 3.8 107.3 8.6 3.2 5.8 5.1 3.1 7.6 0.7 1.5 7.2 6.9 5.8 5.0 8.7 3.5 4.8 0.2 6.7 1.4 9.0 3.8 4.3 1.4 0.0 3.8 0.8 14.7 2.1 2.3 13.5 1.8 5.8 0.3 7.1 8.6 4.1 3.5 0.9 11.3 3.6 5.9 0.1 10.3 3.7 5.0 3.5 9.9 0.6 3.6 8.4 2.2 4.2 9.8 5.2 2.0 7.0 4.7 3.6 4.4 18.2 1.9 1.1 2.6 6.6 3.6 3.1 6.5 1.6 8.4 2.7 0.4 8.5 2.9 5.7 4.5 8.6 20.5 2.4 6.2 2.3 2.5 2.6 2.3 3.8 2.9 2.2 1.9 107.3 3.2 5.4 2.4 5.8 5.1 11.7 20.1 43.4 27.2 10.9 8.2 9.7 15.8 11.4 12.5 17.9 18.3 15.2 14.1 10.4 9.9 6.2 10.2 4.0 2.3 7.0 17.7 6.5 13.3 12.2 0.4 13.5 12.4 0.0 15.1 20.9 14.5 11.3 14.9 8.5 19.9 3.2 23.0 23.4 52.6 1.9 31.4 20.7 10.1 45.9 16.6 16.2 19.1 23.0 21.2 17.0 30.1 64.7 31.9 0.7 6.8 8.2 13.3 46.5 11.2 8.4 AC004593.3 ENSG00000285162 "Beta-chimaerin isoform 3 " 7 29122340-29514667 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 6.3;brain: 16.3" "Group enriched" "Detected in some" 11 "Collecting duct cells: 1.8;Early spermatids: 1.0;granulocytes: 1.1;Hepatocytes: 2.4;Late spermatids: 1.1" "Group enriched" "Detected in some" 34 "classical monocyte: 6.2;intermediate monocyte: 5.1;myeloid DC: 6.3;non-classical monocyte: 2.5" "Group enriched" "Detected in many" 59 "dendritic cells: 6.3;monocytes: 6.2" "Cell line enhanced" "Detected in some" "EFO-21: 2.7;GAMG: 3.3;HaCaT: 3.5;HEL: 2.5;U-266/84: 4.1" HPA019026 Uncertain "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA019026: " 0.1 0.3 0.1 0.2 0.1 0.2 0.1 16.3 0.1 0.1 0.2 0.1 0.1 2.6 0.4 0.1 0.1 0.0 0.4 1.2 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.5 0.7 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.0 0.1 0.1 0.5 1.9 2.9 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.0 6.3 0.1 6.2 0.0 0.0 2.2 0.0 0.2 0.7 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.3 1.5 0.0 2.7 0.0 3.3 3.5 0.1 0.0 0.0 0.1 1.2 2.5 0.8 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 1.2 0.0 1.6 1.3 0.7 0.0 0.2 0.0 0.3 0.6 0.2 0.1 0.8 1.2 0.9 1.6 0.4 0.1 0.7 0.6 0.0 0.0 0.1 0.3 4.1 0.0 0.0 0.0 1.7 0.0 6.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.1 0.0 2.5 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004754.1 ENSG00000269881 16 249547-269943 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "intestine: 15.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 2.4;ASC TERT1: 2.4;EFO-21: 5.1;HHSteC: 2.5;hTERT-RPE1: 2.9" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA011651: , HPA071871: AB_2732188" "unprognostic (1.22e-1)" "unprognostic (2.09e-2)" "unprognostic (2.26e-1)" "unprognostic (1.75e-2)" "unprognostic (5.40e-2)" "unprognostic (2.56e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (3.37e-2)" "unprognostic (5.06e-2)" "unprognostic (5.24e-3)" "unprognostic (4.66e-2)" "unprognostic (7.84e-2)" "unprognostic (1.10e-1)" "unprognostic (1.32e-1)" "unprognostic (1.69e-1)" "unprognostic (2.95e-2)" 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.3 0.6 0.6 0.2 15.3 0.3 0.3 0.1 0.2 0.0 0.9 0.4 1.4 0.3 0.1 0.0 0.0 0.7 0.1 1.7 0.0 0.2 0.0 0.2 0.0 0.0 0.3 1.0 0.1 7.4 0.2 0.7 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.8 0.4 1.8 2.4 2.4 0.5 0.0 1.2 0.0 0.1 0.3 0.1 0.0 5.1 1.1 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 2.5 0.0 0.0 1.0 0.0 0.2 1.0 2.9 0.7 0.1 0.0 0.3 0.0 2.1 0.0 0.2 1.2 0.6 0.0 1.3 0.0 0.0 0.9 0.0 0.3 1.0 0.0 0.0 0.4 0.2 1.0 0.6 0.0 0.4 0.0 1.0 0.0 0.1 0.2 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.8 0.0 0.5 1.5 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC008403.1 ENSG00000268465 19 48465837-48472431 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.7;intestine: 3.6;testis: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 2.9;LHCN-M2: 3.6;NB-4: 3.8;U-698: 5.0" HPA060662 Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA060662: AB_2732652" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.5 0.1 3.6 0.0 2.7 0.0 0.1 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.3 0.1 1.6 0.0 0.2 0.1 0.5 4.7 0.1 0.0 0.0 0.0 1.0 0.5 0.7 0.4 0.0 1.0 0.0 0.0 0.0 0.0 2.9 2.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.6 2.3 1.3 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 1.9 0.3 0.0 3.6 0.0 0.0 3.8 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.2 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.9 1.9 0.0 0.0 0.9 0.9 5.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.3 0.2 1.0 0.3 0.4 0.3 0.0 0.6 0.1 0.0 0.0 0.4 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008758.5 ENSG00000268870 19 12391949-12441082 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 7.6;RT4: 6.1" "HPA003150, HPA018683" Uncertain Uncertain "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA003150: AB_1080725, HPA018683: AB_2669920" 2.1 1.3 1.3 4.3 1.4 1.4 3.3 6.5 2.3 3.3 3.6 0.2 10.8 1.2 2.7 1.4 1.7 0.8 1.5 1.1 1.4 0.7 4.9 3.0 1.7 3.1 1.5 0.7 1.4 2.3 0.3 1.3 3.0 1.8 2.9 2.5 0.1 3.5 6.2 1.9 1.8 4.0 1.0 2.3 1.6 1.3 1.6 1.4 8.4 2.0 1.1 1.2 3.4 4.4 2.5 1.6 0.6 0.4 1.1 2.6 1.2 1.6 0.0 1.1 2.4 0.2 0.0 3.7 1.2 0.0 0.3 0.0 1.5 0.1 1.1 3.7 1.0 1.0 0.0 0.0 0.9 0.0 0.0 0.7 3.6 0.0 2.3 0.0 2.0 3.9 0.0 1.6 1.9 0.0 0.0 1.4 1.7 1.5 0.0 0.0 0.2 1.8 0.6 1.9 3.5 0.0 0.9 7.6 0.0 0.0 6.1 0.0 1.1 0.1 0.7 0.0 2.9 3.5 2.6 0.6 0.4 0.4 3.0 0.3 0.0 1.0 2.0 0.8 0.2 1.1 0.0 0.4 0.6 1.7 0.2 2.6 2.5 2.2 1.9 1.6 1.7 2.5 0.1 0.3 1.1 0.1 0.3 2.2 1.2 1.3 1.4 6.5 2.3 1.4 0.7 1.5 0.7 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008770.2 ENSG00000267179 19 11925075-11979290 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.1;HHSteC: 2.8;PC-3: 1.8;U-266/70: 2.6;U-937: 2.0" HPA047845 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (2.46e-3)" "unprognostic (9.75e-5)" "unprognostic (1.14e-2)" "unprognostic (1.80e-1)" "unprognostic (2.37e-2)" "unprognostic (2.38e-3)" "unprognostic (1.26e-1)" "unprognostic (1.58e-3)" "unprognostic (4.30e-2)" "unprognostic (3.97e-2)" "unprognostic (4.82e-3)" "unprognostic (2.69e-2)" "unprognostic (5.04e-3)" "unprognostic (2.24e-2)" "unprognostic (9.29e-2)" "unprognostic (1.67e-1)" "unprognostic (8.13e-2)" 3.8 4.6 2.3 7.9 2.7 2.1 7.7 3.0 3.3 2.5 3.4 1.2 4.4 1.4 3.7 4.0 2.4 1.8 4.5 2.1 2.3 2.0 2.8 2.9 4.4 4.9 2.3 1.0 3.6 8.5 1.4 3.9 2.9 1.8 2.8 2.7 1.8 5.3 3.5 2.3 3.6 2.2 4.7 2.0 2.7 2.4 5.9 2.3 3.0 2.3 1.6 4.0 3.2 4.3 1.5 1.5 1.4 1.3 1.1 1.9 0.8 0.6 0.0 0.7 0.0 0.0 0.8 0.0 1.3 2.1 0.9 1.0 0.0 0.4 0.8 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.7 0.8 0.0 0.0 0.5 0.2 1.8 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.6 2.6 1.2 1.7 0.4 2.0 0.0 0.0 0.5 1.4 0.7 0.6 1.9 0.7 1.1 0.6 1.5 1.5 0.3 0.6 1.0 1.1 1.3 0.6 0.2 0.8 2.3 2.7 3.0 2.5 2.3 2.0 2.3 1.0 1.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008878.3 ENSG00000268861 19 7382834-7472477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 7.7;bone marrow: 7.1;lymphoid tissue: 8.6" "Cell type enhanced" "Detected in single" 40 "Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 18.3;HL-60: 8.3;MOLT-4: 11.7;REH: 9.6;THP-1: 13.8;U-698: 10.9;U-937: 8.6" "HPA042689, HPA071867" Supported Uncertain Cytosol NA NA Cytosol "HPA042689: AB_10794385, HPA071867: AB_2686466" "unprognostic (1.46e-1)" "unprognostic (2.47e-2)" "unprognostic (2.97e-1)" "unprognostic (1.20e-2)" "unprognostic (3.92e-2)" "unprognostic (2.45e-4)" 0.0 1.2 4.3 7.1 0.0 0.0 0.0 0.5 0.0 0.9 0.1 1.5 0.0 2.1 0.0 0.2 0.0 1.0 8.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 2.3 4.9 0.0 0.0 0.7 4.8 2.4 7.4 1.4 7.7 3.3 0.1 4.2 1.4 0.0 0.2 0.5 0.0 1.3 0.3 0.0 0.0 1.1 0.0 0.3 0.0 0.0 18.3 0.0 4.5 0.0 0.0 2.5 0.0 5.8 0.0 0.0 0.2 0.0 0.0 0.4 8.3 7.3 2.8 0.1 0.1 2.2 0.0 1.0 4.7 0.0 0.0 3.7 0.0 11.7 3.0 0.0 0.9 0.0 9.6 0.1 3.7 0.2 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 13.8 0.0 0.1 0.3 0.2 0.0 0.1 0.0 10.9 0.3 8.6 0.0 0.9 1.7 7.7 2.7 1.9 1.5 7.4 3.6 1.8 1.1 6.7 4.2 1.4 4.3 0.1 3.3 1.4 1.7 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008982.1 ENSG00000268083 19 38817471-38840178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "NB-4: 25.7" "Low region specificity" "Detected in all" "HPA002907, HPA051748" Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA002907: AB_1847964, HPA051748: AB_2681588" "unprognostic (1.36e-2)" 1.7 1.0 0.5 0.4 1.0 4.3 0.7 0.8 3.3 0.5 3.1 0.2 0.2 2.2 1.4 3.5 1.1 0.5 0.3 4.9 0.5 0.6 1.6 6.3 5.0 5.3 0.8 0.2 1.3 1.3 0.0 0.5 0.8 0.8 1.3 0.2 0.2 0.6 0.5 5.8 1.0 1.8 0.2 0.8 2.6 1.1 3.2 0.7 2.5 1.0 2.4 0.2 0.7 1.0 1.9 5.9 2.4 2.5 2.5 3.6 2.2 1.4 0.0 0.2 0.3 0.1 0.1 1.6 0.4 0.0 0.5 0.1 0.7 0.1 0.2 1.3 0.1 0.1 0.8 0.0 0.0 0.1 1.3 0.4 0.9 0.0 0.0 0.1 0.4 0.9 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.5 0.4 0.0 1.0 1.1 25.7 1.9 0.0 0.0 1.5 0.7 0.6 0.3 0.3 0.6 3.6 0.0 0.0 4.6 0.0 0.4 5.9 0.0 0.1 2.6 1.8 2.3 1.1 0.9 2.0 0.1 0.7 0.1 1.6 2.5 2.4 2.5 2.0 3.6 1.6 2.5 2.7 2.4 1.9 2.3 2.9 0.2 2.5 1.1 5.9 3.4 2.2 0.5 1.0 0.8 3.3 0.5 0.6 0.8 0.2 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010319.2 ENSG00000269035 19 17436611-17460804 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 32 "retina: 41.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.3;HHSteC: 1.0;THP-1: 1.2" HPA041580 Approved Uncertain "Nuclear membrane" NA NA "Nuclear membrane" "HPA041580: AB_10795700" 0.9 0.2 0.4 0.1 0.5 0.1 0.3 0.1 0.5 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.3 0.5 0.4 0.1 0.1 0.3 0.1 0.2 0.0 0.7 0.1 0.1 0.3 0.1 1.2 0.1 0.1 41.6 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.1 0.5 0.5 0.4 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010487.3 ENSG00000283088 19 52880663-52962768 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 22.4" HPA062474 Uncertain "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "HPA062474: AB_2732685" 2.4 0.1 1.7 3.3 3.5 1.1 2.9 1.6 2.6 4.5 2.5 1.5 5.7 2.2 4.7 4.4 3.5 4.1 4.3 2.2 1.7 4.1 0.3 2.8 2.3 4.6 0.8 5.6 1.6 9.7 5.3 4.9 2.3 7.3 3.0 1.5 2.9 4.3 1.1 0.0 2.9 3.3 3.9 4.9 1.9 1.9 3.8 9.1 4.5 2.1 2.6 6.2 4.1 1.0 2.2 2.8 2.2 4.6 2.6 1.4 2.0 0.0 3.7 3.9 0.2 0.0 2.2 2.0 1.7 1.9 3.2 1.3 0.5 2.4 1.5 1.2 1.9 0.3 0.0 0.8 1.2 0.0 0.5 1.5 3.4 0.0 2.1 0.0 1.8 0.7 0.0 2.1 0.8 1.7 2.3 0.9 1.9 0.0 2.3 0.0 2.5 0.0 3.9 0.0 2.3 2.0 2.5 1.5 0.3 22.4 1.8 4.7 0.0 0.7 0.0 6.1 2.2 0.1 1.3 1.0 1.8 0.2 1.9 1.5 6.5 1.6 0.0 0.0 2.2 2.8 0.7 0.8 1.9 1.6 2.0 0.5 1.4 1.1 1.8 1.0 2.6 0.8 0.3 4.6 2.2 2.2 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011455.2 ENSG00000269547 19 38915404-38949855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.6;ovary: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.7;A549: 5.2;AN3-CA: 2.8;T-47d: 4.4;U-251 MG: 6.4" "HPA052730, HPA056957" Uncertain Uncertain Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA052730: AB_2681929, HPA056957: AB_2683286" "unprognostic (6.10e-2)" "unprognostic (3.79e-2)" 1.3 2.6 0.3 1.7 0.3 0.0 0.1 0.4 1.1 0.3 0.1 0.0 1.2 0.5 0.1 0.4 0.8 1.1 0.1 0.1 1.6 1.1 0.2 0.0 0.2 3.0 0.6 0.0 0.1 0.5 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.3 0.1 0.1 0.5 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 5.2 0.0 2.8 0.9 0.0 0.5 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.3 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.5 0.3 1.2 0.5 0.5 0.0 1.2 0.3 2.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.4 0.2 0.0 1.4 1.4 0.0 6.4 0.0 0.6 0.0 2.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC012184.2 ENSG00000260537 16 70299194-70372582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 27 "Ciliated cells: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 22.6;U-698: 22.3" "HPA046380, HPA066668" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA046380: AB_2679645, HPA066668: " 12.9 11.6 2.6 10.2 4.7 10.4 7.2 12.9 6.3 4.8 7.4 5.6 5.2 9.8 5.7 5.2 9.8 4.2 7.1 10.8 2.9 2.7 7.2 14.6 6.6 8.8 3.6 3.7 4.5 13.7 0.8 7.1 4.3 4.9 4.7 7.5 7.7 8.7 5.8 23.5 15.9 7.0 6.0 3.2 7.0 7.3 2.6 4.5 6.8 8.0 6.6 13.3 13.4 5.2 8.8 14.7 12.3 16.0 12.0 17.9 11.1 1.4 4.9 4.2 9.8 0.0 4.7 8.2 4.6 5.5 7.9 8.4 9.0 12.6 8.3 5.8 4.7 1.5 5.0 0.0 3.4 6.2 2.5 6.2 5.4 4.1 0.6 5.1 8.2 4.4 3.0 0.8 8.2 0.0 2.0 5.6 2.3 3.1 2.2 3.3 3.7 0.1 0.0 5.1 0.7 1.1 22.6 1.7 15.2 2.5 6.3 5.3 5.1 11.7 2.1 2.3 1.3 4.3 2.0 5.2 5.4 5.6 2.2 2.9 7.7 5.1 22.3 0.7 5.2 9.7 12.3 13.0 9.2 13.5 16.0 11.2 8.8 11.9 13.2 14.7 8.3 10.2 9.9 1.8 12.0 11.5 3.0 17.9 11.1 2.6 4.7 12.9 6.3 2.9 2.7 3.6 3.7 4.9 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC024592.3 ENSG00000267740 19 5866171-5903787 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.9;Ciliated cells: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA072209 Uncertain Mitochondria NA NA Mitochondria "HPA072209: AB_2686495" "unprognostic (2.12e-2)" "unprognostic (2.24e-1)" "unprognostic (3.38e-1)" 8.8 15.0 8.4 8.8 8.5 11.1 10.9 8.0 17.4 10.6 9.8 5.0 8.9 10.8 9.9 7.8 12.7 6.7 9.6 24.1 7.8 9.9 8.5 14.4 8.0 11.5 9.6 10.0 8.2 16.3 3.2 7.1 6.6 7.5 7.0 3.9 7.5 12.3 8.8 22.7 12.3 10.0 9.9 8.6 7.4 7.3 5.6 5.3 7.9 8.0 16.6 7.0 12.7 8.2 7.2 10.4 6.4 8.5 5.5 7.5 12.1 5.1 6.9 2.2 5.8 4.2 0.8 1.9 3.4 4.9 6.6 4.7 2.5 4.4 4.2 3.4 2.7 3.1 3.6 1.3 4.1 1.3 1.8 2.1 1.1 3.1 5.6 2.8 1.9 2.3 1.8 7.0 5.1 2.4 2.0 2.2 6.1 1.8 5.6 1.0 4.2 6.9 1.5 3.2 2.2 3.3 6.5 2.2 5.4 3.2 1.6 3.5 4.9 2.6 3.5 3.4 1.0 2.1 6.3 4.2 1.3 3.2 8.0 6.6 5.3 5.6 2.1 4.2 6.7 2.9 6.4 8.5 4.0 6.0 7.1 5.3 7.2 6.3 5.8 8.6 6.7 7.3 5.8 4.8 5.5 6.3 10.4 7.5 12.1 8.4 8.5 8.0 17.4 7.8 9.9 9.6 10.0 7.5 5.3 3.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC068631.2 ENSG00000283149 3 186581995-186597103 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA010814 Uncertain Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA010814: AB_1078691" 1.9 1.3 3.1 6.3 2.7 1.2 0.0 4.7 2.9 1.3 8.3 0.7 0.1 1.9 0.4 1.3 5.3 0.5 1.5 0.2 2.8 0.0 1.6 0.0 2.3 0.6 0.5 0.0 0.0 1.5 0.3 2.1 1.7 0.2 2.9 1.2 0.0 9.0 17.4 9.7 8.7 10.7 11.9 6.6 12.7 10.1 12.9 16.1 10.9 5.1 4.2 24.0 6.7 9.9 6.8 35.5 6.2 8.0 29.8 16.1 15.7 9.5 13.0 9.1 13.0 6.5 0.2 8.0 18.2 37.2 13.0 15.6 5.5 5.7 5.5 11.6 20.7 8.0 6.3 3.9 4.5 31.8 4.4 28.0 8.0 5.3 4.0 32.0 0.0 5.3 12.9 11.3 10.3 23.0 1.0 1.9 10.7 22.9 7.3 15.2 15.6 20.2 3.4 6.7 8.0 5.9 22.5 13.5 27.2 22.8 10.1 12.5 13.9 7.6 6.7 9.7 11.9 8.7 8.5 9.0 7.5 10.1 10.5 5.5 4.9 9.5 1.8 10.7 7.2 17.4 8.8 6.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC091057.5 ENSG00000284906 "Rho GTPase-activating protein 11B " Q3KRB8 15 30624548-30685606 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 7.1;lymphoid tissue: 14.4;testis: 5.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA064479 Uncertain Uncertain Vesicles NA Yes Vesicles "HPA064479: AB_2685272" 0.2 0.1 0.8 10.3 1.8 7.1 0.5 0.7 0.9 0.1 5.1 0.6 0.0 1.1 0.8 0.2 1.8 0.2 0.3 0.2 1.0 0.0 0.1 0.9 2.8 0.1 0.0 0.1 0.0 0.0 0.4 0.7 0.6 0.0 1.2 0.3 0.1 0.1 0.4 0.9 1.5 0.8 1.9 1.4 1.0 5.8 2.1 14.4 0.0 1.4 5.7 0.5 0.0 1.0 1.0 1.6 0.3 0.0 0.8 0.0 4.4 2.9 5.0 2.5 0.1 0.6 2.8 4.6 1.9 3.2 3.7 3.0 3.7 2.8 1.8 1.9 3.6 4.0 2.6 1.6 2.8 6.1 3.1 7.4 10.0 1.3 0.0 4.7 5.3 0.2 0.2 2.1 1.6 1.1 2.2 6.6 4.4 8.7 2.2 2.1 3.6 4.0 1.5 2.2 1.5 5.1 5.1 1.3 0.9 2.8 2.4 2.2 5.4 2.0 1.0 1.4 2.5 2.4 2.5 5.0 4.2 2.4 3.9 3.0 3.2 6.1 1.7 5.4 4.0 1.6 0.3 0.2 0.4 0.0 0.0 0.6 0.8 0.6 0.1 1.0 0.1 0.1 0.1 0.0 0.1 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092143.1 ENSG00000198211 16 89919165-89936092 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SK-MEL-30: 19.0" "CAB011512, HPA043640, HPA046280" Uncertain Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB011512: AB_444319, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.90e-4)" "unprognostic (6.87e-2)" 0.4 0.2 0.2 0.1 0.8 0.3 0.1 0.4 0.7 1.0 0.5 0.6 0.0 0.1 1.2 0.9 1.0 0.7 1.5 1.8 0.2 0.4 0.1 1.3 0.4 0.1 0.9 0.4 4.0 0.2 0.1 0.7 1.4 2.0 2.6 0.1 0.3 0.1 0.1 0.6 5.1 0.4 0.5 2.8 0.6 0.1 10.9 0.2 0.0 0.3 0.0 0.1 1.0 5.1 0.1 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.1 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.3 0.2 0.8 0.4 0.7 0.2 0.4 0.9 0.4 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC093155.3 ENSG00000267561 1 86993009-87169204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 10.8" "Cell type enriched" "Detected in some" 4 "granulocytes: 4.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 4.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.6" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.0;HEL: 13.2;HMC-1: 16.8;THP-1: 11.4" "HPA043069, HPA043603" Approved Uncertain Mitochondria NA NA Mitochondria "HPA043069: AB_10964127, HPA043603: AB_10963432" "unprognostic (4.41e-1)" "unprognostic (3.13e-2)" "unprognostic (2.05e-1)" "unprognostic (1.85e-2)" "unprognostic (3.17e-1)" "unprognostic (2.57e-1)" "unprognostic (4.51e-2)" "unprognostic (5.19e-3)" "unprognostic (3.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.14e-1)" "unprognostic (2.54e-1)" 10.8 3.2 0.6 0.9 0.8 0.0 3.7 0.8 0.6 2.1 1.3 0.6 0.8 0.5 1.1 0.5 2.1 4.1 0.6 0.6 0.8 4.3 2.5 0.3 0.7 3.7 0.6 0.0 0.5 2.7 0.6 1.2 0.9 0.7 1.6 0.6 1.0 2.0 0.8 0.8 0.7 2.4 0.6 0.0 2.2 0.6 0.1 0.9 4.6 0.1 0.4 0.2 0.1 0.0 0.1 0.8 2.0 2.4 9.0 0.2 0.0 0.1 0.0 0.3 0.6 0.8 0.0 0.2 0.0 0.2 0.2 0.3 0.1 0.4 0.1 0.5 13.2 0.4 0.1 0.1 0.3 16.8 1.5 0.3 0.2 0.0 0.0 0.1 0.2 0.1 0.3 0.2 0.0 0.2 0.2 0.3 1.1 0.0 0.2 0.3 0.0 0.4 0.4 0.1 0.4 0.3 0.0 0.4 0.9 0.2 11.4 0.0 0.3 0.7 0.1 1.3 0.9 3.5 0.0 0.6 0.0 0.4 2.0 0.1 4.6 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.1 0.0 0.4 0.0 0.9 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC093668.1 ENSG00000270249 7 102541501-102592444 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 6.9" "Cell type enriched" "Detected in single" 12 "Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.7;hTERT-RPE1: 3.4;Karpas-707: 4.0" HPA046970 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" 0.4 0.7 0.6 0.8 0.6 0.7 0.4 3.1 1.1 1.0 1.0 2.5 0.9 2.5 0.4 0.6 0.0 0.3 0.6 0.5 1.4 0.1 0.7 0.5 0.3 0.7 1.2 6.9 2.9 0.4 0.5 0.6 1.1 0.2 5.4 1.7 1.4 0.0 0.3 1.3 1.1 0.2 0.3 0.1 0.4 0.7 4.0 3.5 1.3 1.0 0.7 5.3 1.2 0.1 0.0 1.0 0.2 0.2 3.7 0.5 1.1 0.7 0.6 0.0 0.0 2.1 2.3 0.7 1.6 0.4 0.8 0.0 0.0 0.0 0.7 0.0 1.3 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.4 0.0 1.2 0.0 4.0 0.0 0.4 2.6 1.3 0.5 2.3 1.0 1.4 0.0 0.5 0.3 0.8 1.5 1.2 0.0 0.0 0.2 1.7 0.5 0.0 0.0 0.0 0.1 0.3 0.0 1.8 1.5 0.4 0.4 1.0 0.0 0.0 0.7 0.4 2.9 0.9 4.1 4.0 3.8 2.9 1.7 3.1 5.3 3.0 1.3 0.7 1.0 3.5 5.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC104662.2 ENSG00000281028 4 25160663-25277306 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA004099 Uncertain Uncertain Cytosol NA NA Cytosol "HPA004099: AB_1855353" "unprognostic (3.59e-2)" 1.7 2.3 6.7 5.5 11.1 6.7 3.7 9.7 9.3 2.0 4.1 4.3 5.0 7.8 1.7 2.5 5.4 3.5 1.6 1.5 7.3 2.8 10.1 4.0 4.4 10.0 2.4 1.5 1.8 2.9 14.9 2.8 7.1 1.1 5.4 2.1 4.5 2.5 1.8 0.0 6.0 2.6 11.3 2.5 3.6 9.2 10.6 6.1 5.3 1.6 5.3 3.1 4.8 2.1 2.0 7.5 1.9 1.4 4.3 0.9 5.3 3.7 4.4 2.4 3.2 6.1 4.1 8.9 9.1 11.4 12.2 4.0 7.5 13.5 2.1 11.4 10.7 2.9 9.3 3.8 6.9 5.8 2.6 6.3 9.1 3.8 0.6 12.4 3.6 3.1 0.7 4.5 4.6 2.2 3.9 6.0 4.2 15.7 3.5 6.1 10.8 0.9 3.6 6.7 2.4 6.3 12.0 5.9 2.7 9.8 5.0 1.0 3.6 1.3 2.6 4.4 2.9 1.7 7.4 6.3 1.8 2.9 5.2 10.6 12.0 19.1 5.4 6.5 4.6 7.5 1.9 6.2 2.4 1.8 1.6 2.1 2.4 2.3 1.4 1.9 1.8 2.1 3.2 1.4 1.3 2.0 4.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC126755.2 ENSG00000233024 "Nuclear pore complex-interacting protein family member A5 isoform 2 " 16 18358086-18379331 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.5" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.7;Ciliated cells: 10.7;granulocytes: 10.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 4.7" "Group enriched" "Detected in many" 6 "B-cells: 4.7;T-cells: 1.8" "Low cell line specificity" "Detected in all" HPA053611 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (9.10e-2)" "unprognostic (6.00e-3)" "unprognostic (1.66e-1)" "unprognostic (5.77e-2)" "unprognostic (8.31e-2)" "unprognostic (6.34e-2)" "unprognostic (6.34e-2)" "unprognostic (6.76e-2)" "unprognostic (1.30e-3)" "unprognostic (5.87e-2)" "unprognostic (5.79e-3)" "unprognostic (1.60e-2)" "unprognostic (1.25e-5)" "unprognostic (1.96e-1)" "unprognostic (1.90e-2)" "unprognostic (5.38e-2)" "unprognostic (6.45e-3)" 4.1 5.4 5.2 3.3 5.5 3.3 6.0 46.5 10.1 5.4 6.9 3.4 9.5 10.0 4.7 6.3 4.4 3.3 6.4 6.4 3.5 4.6 5.4 4.2 3.3 11.5 6.6 14.3 27.8 2.8 5.4 6.3 3.7 7.0 17.5 9.8 4.5 7.6 2.8 4.9 4.0 4.6 6.5 3.6 4.6 3.8 4.7 0.5 0.5 0.5 0.3 1.8 0.5 7.0 4.7 26.0 21.2 22.3 20.8 6.1 27.2 9.9 13.4 20.0 4.6 4.2 9.8 10.6 23.9 7.9 12.8 8.0 7.3 16.4 8.3 7.7 26.2 22.7 22.6 22.7 12.4 60.1 21.3 33.3 16.8 22.6 28.3 6.5 12.2 6.0 19.7 13.4 10.8 20.3 27.2 11.0 7.0 5.9 29.2 6.4 9.8 13.3 13.4 7.4 11.6 17.1 10.8 14.6 10.4 9.9 14.9 12.4 18.1 8.0 15.2 8.3 14.9 11.6 15.0 8.1 17.3 9.3 0.0 0.5 0.5 1.8 0.1 0.6 4.7 1.2 0.9 0.2 1.1 1.0 0.4 0.0 0.3 0.3 0.5 0.4 0.5 3.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 10.7 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC133551.1 ENSG00000274175 Unmapped 17234-19833 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 30 "epididymis: 11.7;testis: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.8;EFO-21: 2.1;HEL: 1.6;HMC-1: 1.3;K-562: 2.2;RPMI-8226: 1.4;U-2 OS: 1.8;U-266/84: 3.6" "HPA047832, HPA060916" Uncertain "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.2 1.8 0.0 0.0 0.3 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135068.3 ENSG00000279408 15 21651844-21652968 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.0;testis: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-2 OS: 3.7" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC171558.1 ENSG00000274792 Unmapped 386278-387620 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "testis: 1.6" "Group enriched" "Detected in some" 5 "Early spermatids: 4.8;Late spermatids: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "NTERA-2: 1.1;U-2 OS: 1.1" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 ACACA "ACAC, ACC, ACC1" ENSG00000278540 "Acetyl-CoA carboxylase alpha" Q13085 17 37084988-37406818 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Allosteric enzyme, Ligase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013715, HPA036650, HPA063018" Approved Supported "Nucleoli fibrillar center,Actin filaments,Cytosol" NA NA Cytosol "Nucleoli fibrillar center, Actin filaments" "CAB013715: , HPA036650: AB_2675228, HPA063018: AB_2684922" "unprognostic (1.96e-2)" "unprognostic (1.07e-2)" "unprognostic (3.04e-2)" "unprognostic (1.10e-1)" "unprognostic (4.86e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.24e-5)" "unprognostic (8.81e-2)" "unprognostic (6.56e-2)" "unprognostic (2.38e-3)" "unprognostic (3.38e-1)" "unprognostic (2.24e-1)" "unprognostic (6.72e-2)" "unprognostic (1.18e-1)" "unprognostic (4.89e-1)" "unprognostic (4.49e-2)" "unprognostic (2.03e-2)" 10.7 4.8 5.6 2.5 7.7 3.0 18.5 6.0 11.5 5.3 4.2 6.9 12.7 3.8 4.5 11.7 9.2 3.8 3.6 2.3 4.9 3.0 5.8 7.3 3.5 6.3 4.6 4.3 2.3 13.6 7.9 2.6 6.1 12.2 5.1 4.8 4.6 14.4 11.3 5.4 2.5 7.8 4.2 2.3 3.9 5.5 5.7 2.0 4.2 4.5 5.0 4.3 4.6 4.4 3.2 1.3 4.1 2.0 3.9 2.0 14.9 3.1 18.2 19.1 25.4 25.1 6.3 6.6 9.4 6.9 12.6 12.1 2.6 2.0 5.4 10.7 18.3 15.4 3.3 22.6 10.9 5.9 9.9 11.9 7.9 12.3 4.0 6.4 2.4 20.2 13.2 18.4 13.7 8.7 12.2 10.7 28.3 1.4 1.0 12.6 6.8 9.8 13.8 9.4 9.9 10.5 11.4 2.7 16.4 16.9 20.6 8.1 11.9 5.6 5.3 16.5 11.2 7.4 10.8 5.9 9.4 8.2 1.6 4.0 4.7 18.6 5.4 5.4 8.1 1.1 2.8 0.3 2.3 4.1 2.1 2.7 2.5 2.7 3.2 4.4 3.9 2.7 1.3 2.0 2.7 2.4 3.2 2.0 29.8 40.1 3.7 15.6 10.3 15.4 6.5 2.5 8.1 12.5 10.4 25.5 14.2 8.3 5.9 46.0 7.5 4.8 23.3 7.2 5.4 7.5 20.3 6.9 8.1 5.0 22.3 8.6 4.3 2.1 39.8 9.2 4.2 10.1 3.6 7.2 19.9 6.5 5.8 14.9 5.0 10.7 6.5 4.8 7.9 17.9 13.9 13.6 4.3 8.7 18.2 ACADVL "ACAD6, LCACD, VLCAD" ENSG00000072778 "Acyl-CoA dehydrogenase very long chain" P49748 17 7217125-7225273 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019006, HPA020595" Enhanced Supported Nucleoplasm,Nucleoli,Mitochondria NA NA 19000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA019006: AB_1844478, HPA020595: AB_1844479" "unprognostic (4.81e-2)" "unprognostic (2.86e-1)" "unprognostic (2.21e-2)" "unprognostic (1.09e-2)" "unprognostic (6.63e-3)" "unprognostic (1.51e-1)" "unprognostic (1.89e-2)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favorable (6.87e-4)" "unprognostic (3.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-1)" "unprognostic (4.01e-1)" "unprognostic (2.84e-3)" 32.7 69.2 22.8 18.2 21.1 15.1 24.1 19.8 18.4 21.1 44.0 16.5 26.7 51.7 17.4 19.7 31.5 14.2 24.4 118.2 20.2 12.2 35.2 90.0 17.3 9.8 18.5 16.8 15.5 67.8 31.5 32.3 40.2 20.9 22.1 24.2 20.0 27.4 29.0 132.3 20.3 51.2 25.0 15.7 21.9 28.7 11.5 18.6 14.6 29.6 36.9 21.2 22.4 31.8 8.3 32.0 37.9 29.0 11.6 14.9 20.0 33.5 32.1 13.2 18.1 57.0 21.0 25.0 24.7 34.4 28.1 17.5 12.9 30.3 18.0 20.6 51.7 10.1 25.9 8.8 27.0 24.9 56.9 9.1 9.6 22.8 19.7 27.4 9.1 25.0 23.3 24.7 23.5 37.1 43.6 25.3 22.1 12.3 21.9 45.1 12.7 9.4 11.0 6.2 35.2 12.7 13.2 14.6 42.6 62.6 30.6 3.5 8.7 34.8 44.3 20.2 12.9 20.3 14.0 25.1 24.9 18.7 12.6 24.1 20.6 9.6 0.9 45.9 16.1 18.1 6.8 29.0 37.9 13.5 18.0 12.4 8.3 10.9 14.9 32.0 7.6 8.3 10.2 6.3 11.6 12.0 26.0 9.7 20.0 22.8 21.1 19.8 18.4 20.2 12.2 18.5 16.8 20.9 18.6 56.6 73.4 64.0 249.7 77.5 39.6 397.7 150.3 17.4 43.3 191.9 58.9 369.3 157.5 241.9 107.0 71.4 453.8 23.3 66.5 164.5 100.7 311.9 89.7 297.9 171.6 31.8 172.2 51.5 68.0 184.1 115.3 93.1 77.6 423.8 144.6 37.1 129.2 196.4 124.8 276.8 38.8 103.5 102.3 100.5 34.7 76.5 554.7 68.2 215.2 275.4 ACIN1 "ACINUS, fSAP152, KIAA0670" ENSG00000100813 "Apoptotic chromatin condensation inducer 1" Q9UKV3 14 23058564-23095614 "Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000657 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA000657: AB_1078091" "unprognostic (2.54e-3)" "unprognostic (1.99e-1)" "unprognostic (1.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.89e-3)" "prognostic unfavorable (4.88e-5)" "unprognostic (1.49e-3)" "unprognostic (9.70e-2)" "unprognostic (4.11e-2)" "unprognostic (1.00e-2)" "unprognostic (6.64e-3)" "unprognostic (1.35e-3)" "unprognostic (4.34e-2)" "unprognostic (2.78e-2)" "unprognostic (2.28e-2)" "unprognostic (7.33e-2)" 32.4 44.4 34.6 46.6 36.2 57.6 32.5 45.7 41.8 36.6 30.1 39.1 35.2 28.5 52.9 32.2 39.3 34.6 33.3 29.7 33.1 28.3 34.9 35.5 28.8 41.1 34.4 27.7 43.9 34.5 51.1 48.3 37.0 33.7 35.4 34.6 31.5 33.0 38.3 43.8 38.1 35.1 40.1 35.0 52.9 34.0 34.5 40.6 44.2 38.5 27.1 45.9 30.5 47.8 6.9 6.8 13.4 4.9 9.7 5.5 2.7 23.7 24.5 38.7 31.3 24.2 19.5 38.9 26.5 18.7 32.1 26.2 32.4 27.9 44.1 15.7 21.9 21.1 26.2 53.4 30.3 33.0 31.0 23.7 38.8 25.9 44.6 13.9 42.0 34.5 22.8 18.7 32.8 27.7 26.3 28.0 32.9 35.7 17.7 24.1 29.7 47.6 41.5 43.5 26.4 23.4 43.2 30.1 23.5 26.6 42.0 25.8 19.0 35.2 23.0 20.9 29.4 18.9 34.0 28.6 22.0 22.0 20.8 24.4 18.8 21.1 45.7 19.5 31.9 23.8 4.1 4.9 5.6 5.5 4.5 4.4 4.4 3.7 4.2 4.1 6.9 5.1 4.6 13.4 9.7 3.7 6.8 3.8 2.7 34.6 36.2 45.7 41.8 33.1 28.3 34.4 27.7 33.7 40.6 65.5 108.5 33.5 28.5 33.2 38.0 57.7 30.6 109.7 78.5 33.2 25.5 48.1 14.9 45.8 27.6 44.3 40.8 46.7 42.7 55.4 35.5 30.5 120.8 24.7 40.9 14.3 55.9 32.5 26.9 5.0 42.6 35.7 25.3 52.3 37.3 25.9 52.1 42.1 36.0 14.1 42.2 6.5 39.6 35.1 34.6 40.7 57.9 36.3 40.7 34.1 ACKR4 "CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1" ENSG00000129048 "Atypical chemokine receptor 4" Q9NPB9 3 132597237-132618967 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 35.6;salivary gland: 29.0" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 35.7;monocytes: 11.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "basophil: 1.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.8" "Cell line enriched" "Detected in some" 6 "BJ hTERT+: 88.7" "Group enriched" "Detected in some" 7 "cerebellum: 5.3;pons and medulla: 1.6" "Low region specificity" "Detected in all" HPA054926 Approved Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" "HPA054926: " "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (2.62e-2)" "unprognostic (8.27e-2)" "unprognostic (5.17e-2)" "unprognostic (4.55e-3)" "unprognostic (8.93e-2)" "unprognostic (2.26e-1)" "unprognostic (4.85e-2)" "unprognostic (4.20e-3)" "unprognostic (1.03e-3)" "unprognostic (2.69e-3)" "unprognostic (1.95e-1)" "unprognostic (2.01e-1)" "unprognostic (1.86e-1)" "unprognostic (1.18e-1)" "unprognostic (1.22e-1)" 13.9 1.9 0.3 2.9 0.4 0.5 10.9 0.4 0.4 3.7 8.7 0.2 4.5 16.2 5.6 7.1 5.7 2.6 9.8 7.1 0.6 0.6 6.6 2.0 10.0 2.7 0.6 0.2 2.1 3.0 0.0 8.2 0.7 0.6 5.2 1.2 1.3 29.0 2.0 3.1 10.7 35.6 5.0 0.4 1.5 10.5 3.4 0.1 0.8 1.8 12.8 1.5 8.2 4.5 0.2 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.4 3.4 0.0 14.5 88.7 0.9 2.5 0.0 0.1 1.0 0.0 9.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.4 0.6 0.6 0.6 0.2 0.6 0.1 35.7 1.4 0.0 0.4 5.8 1.8 0.7 0.0 1.4 2.3 5.2 5.9 0.2 0.0 0.2 2.1 5.1 1.3 0.0 10.8 0.0 4.1 0.4 0.0 0.0 0.4 1.6 0.0 9.8 0.8 0.0 2.0 0.0 1.7 11.8 0.0 1.1 6.6 0.0 2.5 2.4 3.1 0.0 1.9 0.1 0.0 5.6 0.2 0.0 0.6 1.0 ACP5 "HPAP, TRAP" ENSG00000102575 "Acid phosphatase 5, tartrate resistant" P13686 19 11574660-11579008 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 117.9;lung: 151.9" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 439.8;Ito cells: 434.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 51.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 14.6;BJ hTERT+: 9.8;K-562: 10.3;RPMI-8226: 13.9;SK-MEL-30: 41.4;U-138 MG: 38.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002584, HPA057655, HPA059463" Enhanced Uncertain Cytosol "Intracellular and membrane" NA NA 3700000 Cytosol "CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028" "unprognostic (4.27e-2)" "unprognostic (2.05e-2)" "unprognostic (2.93e-1)" "unprognostic (8.60e-3)" "unprognostic (2.96e-1)" "unprognostic (1.95e-2)" "unprognostic (5.21e-2)" "unprognostic (5.17e-3)" "unprognostic (5.13e-2)" "unprognostic (3.80e-1)" "unprognostic (3.66e-3)" "unprognostic (9.09e-2)" "unprognostic (1.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" 117.9 2.8 0.9 21.1 1.1 1.4 7.7 0.7 1.0 11.9 10.2 1.2 2.1 7.7 7.7 6.5 12.1 3.5 9.1 6.8 0.9 0.4 28.0 16.3 151.9 30.8 1.0 1.0 13.2 8.7 0.2 1.6 9.2 1.2 6.4 8.7 19.1 8.6 2.8 3.0 10.4 15.6 3.3 1.9 20.7 15.0 3.5 0.7 9.2 2.2 8.2 18.4 11.4 10.1 51.4 13.9 16.8 9.4 2.6 16.0 8.1 3.3 0.4 0.0 0.0 0.2 0.0 14.6 0.4 9.8 0.0 0.0 0.0 0.1 0.5 0.6 2.9 2.4 0.1 0.0 1.5 0.0 3.7 0.3 0.1 0.0 1.8 0.6 0.0 0.2 0.0 1.1 0.1 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.7 0.3 0.5 0.3 0.1 0.3 0.1 0.7 13.9 0.0 0.1 0.2 0.3 0.0 0.0 41.4 0.4 0.0 0.1 0.3 38.9 0.4 0.7 0.1 0.2 1.8 0.2 8.0 0.0 1.2 0.0 9.4 16.8 4.1 9.1 2.1 51.4 6.4 4.7 1.7 23.5 8.3 4.7 2.6 2.6 8.7 13.9 16.0 8.1 0.9 1.1 0.7 1.0 0.9 0.4 1.0 1.0 1.2 0.7 8.9 8.5 68.7 8.2 9.2 6.0 1.1 22.9 2.7 2.3 7.0 17.7 29.7 8.3 1.6 0.1 2.9 5.9 0.0 9.9 23.7 12.1 16.2 65.4 6.4 439.8 1.6 2.9 434.6 101.6 0.0 1.7 100.7 13.5 131.7 4.5 43.7 4.7 21.0 11.3 91.3 31.7 0.0 3.2 0.0 0.1 9.7 21.9 25.4 8.3 4.3 ACSF2 "ACSMW, FLJ20920" ENSG00000167107 "Acyl-CoA synthetase family member 2" Q96CM8 17 50426158-50474845 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 60.0" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 70.1;Proximal tubular cells: 99.5;Syncytiotrophoblasts: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 37.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024693 Enhanced Uncertain Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules, Cytosol" "HPA024693: AB_2671654" "unprognostic (1.40e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (1.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.48e-2)" "unprognostic (1.14e-2)" "unprognostic (6.49e-2)" "unprognostic (7.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (2.45e-2)" "prognostic favorable (2.41e-4)" 13.2 37.6 4.8 7.7 4.4 1.1 16.3 2.0 4.0 8.4 19.1 4.0 30.3 9.2 3.5 15.4 6.7 4.3 7.2 12.9 5.6 2.0 60.0 15.0 9.0 3.7 3.7 2.8 9.4 3.4 2.6 1.7 14.1 3.9 12.4 7.4 7.6 10.1 33.3 28.4 9.7 22.4 4.5 3.5 4.5 8.0 4.5 3.6 3.5 30.6 6.6 5.9 13.0 7.6 7.8 13.8 11.9 6.2 1.2 4.3 2.1 9.6 3.1 2.6 6.2 27.5 5.0 15.3 2.3 3.4 5.0 9.9 12.3 18.5 6.0 5.1 2.8 4.6 5.8 1.8 11.4 6.0 7.5 4.4 10.3 1.5 21.8 4.6 1.3 9.6 22.2 17.5 6.4 0.8 18.0 6.8 7.9 1.2 3.4 5.4 11.6 3.1 4.1 0.4 18.2 4.6 7.8 1.9 15.2 1.6 37.7 8.5 4.6 4.5 6.9 4.7 5.5 6.0 8.8 5.1 9.2 2.9 1.3 0.7 6.1 1.2 3.1 3.8 6.5 0.5 0.0 2.5 11.9 1.8 6.2 1.6 7.8 1.3 1.8 13.8 1.9 0.6 0.8 0.4 1.2 5.4 5.2 4.3 2.1 4.8 4.4 2.0 4.0 5.6 2.0 3.7 2.8 3.9 3.6 26.8 22.4 2.4 22.9 5.4 0.0 17.3 10.2 12.0 17.0 3.5 0.0 70.1 10.0 10.9 0.2 5.2 47.0 0.0 3.9 9.5 5.9 3.5 21.9 34.1 19.9 0.0 9.8 4.3 8.8 1.3 24.7 11.5 3.3 15.4 19.9 6.6 4.5 35.1 13.4 99.5 0.2 0.0 3.9 0.0 2.7 6.0 67.7 5.7 18.3 10.6 ACSL1 "ACS1, FACL1, FACL2, LACS, LACS1, LACS2" ENSG00000151726 "Acyl-CoA synthetase long chain family member 1" P33121 4 184755595-184826818 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 105.0;liver: 190.9" "Group enriched" "Detected in many" 4 "Early spermatids: 359.4;Hepatocytes: 1018.8;Late spermatids: 335.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "neutrophil: 80.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 80.2" "Cell line enhanced" "Detected in many" "ASC diff: 151.2;ASC TERT1: 36.7;HSkMC: 80.3;RPTEC TERT1: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011316, HPA011964" Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA011316: AB_1844536, HPA011964: AB_1844537" "unprognostic (1.10e-2)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.21e-2)" "unprognostic (1.82e-3)" "unprognostic (2.75e-2)" "unprognostic (1.79e-1)" "unprognostic (5.89e-2)" "unprognostic (9.83e-2)" "unprognostic (3.15e-1)" "prognostic favorable (1.25e-5)" "unprognostic (2.77e-1)" "unprognostic (4.38e-2)" "unprognostic (6.25e-3)" "unprognostic (3.13e-2)" 105.0 6.7 4.2 14.1 13.5 46.0 54.4 3.2 9.6 7.2 12.2 16.4 5.5 4.9 5.7 12.7 8.8 6.4 5.7 24.3 6.4 4.1 32.8 190.9 20.7 18.9 24.0 3.8 4.2 7.3 5.9 8.7 4.4 11.6 14.2 2.6 9.1 17.9 4.8 89.1 20.4 4.5 6.4 18.2 16.9 6.5 6.4 15.9 2.1 8.3 10.1 5.8 7.6 11.0 0.5 2.2 80.2 8.9 0.7 0.7 2.9 6.1 1.9 1.2 3.1 151.2 36.7 1.0 3.4 1.7 2.0 1.4 0.4 1.7 2.5 0.3 4.0 4.9 3.8 5.4 2.2 1.7 12.4 1.9 1.8 1.7 5.0 24.3 4.9 4.6 80.3 18.6 1.7 8.7 3.6 2.6 0.4 0.8 7.8 9.8 3.2 0.3 6.8 0.2 4.1 2.7 0.9 1.0 3.2 47.8 17.5 4.6 4.3 3.1 9.4 10.5 0.5 3.4 5.0 2.8 1.8 2.1 4.3 1.0 3.0 1.5 1.1 5.8 6.9 2.8 2.3 8.9 2.8 0.5 5.2 0.5 0.5 0.4 0.2 2.2 0.5 0.4 0.3 80.2 0.7 3.6 0.4 0.7 2.9 4.2 13.5 3.2 9.6 6.4 4.1 24.0 3.8 11.6 15.9 23.8 107.2 14.5 16.5 18.7 5.8 89.7 28.1 13.4 21.6 29.6 17.7 8.6 79.6 3.9 359.4 5.6 2.6 0.0 11.0 1.9 9.1 56.1 23.1 1018.8 39.4 3.2 0.0 19.0 136.2 335.5 17.8 64.1 30.4 24.4 4.2 3.3 9.0 0.9 15.6 75.0 10.3 12.9 12.0 8.1 16.7 35.9 2.9 10.0 1.7 21.4 ACSM5 FLJ20581 ENSG00000183549 "Acyl-CoA synthetase medium chain family member 5" Q6NUN0 16 20409534-20441336 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 94.6" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 179.6" "Group enriched" "Detected in some" 7 "liver cancer: 20.5;renal cancer: 9.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.8;intermediate monocyte: 1.9;myeloid DC: 3.2;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 8 "dendritic cells: 3.2;monocytes: 2.8" "Group enriched" "Detected in some" 5 "ASC diff: 5.8;ASC TERT1: 12.6;HSkMC: 15.0;U-87 MG: 9.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA041435 Uncertain Uncertain Vesicles NA NA Vesicles "HPA041435: AB_10961121" "unprognostic (1.01e-1)" "unprognostic (1.61e-3)" "unprognostic (3.73e-2)" "unprognostic (1.98e-2)" "unprognostic (1.03e-1)" "unprognostic (1.59e-2)" "unprognostic (1.84e-2)" "unprognostic (4.64e-3)" "unprognostic (1.64e-1)" "unprognostic (2.01e-2)" "unprognostic (2.15e-2)" "unprognostic (2.33e-1)" "unprognostic (5.11e-3)" "unprognostic (2.09e-2)" "unprognostic (3.85e-2)" "unprognostic (2.78e-2)" "unprognostic (1.57e-1)" 11.1 1.1 1.9 0.7 2.1 0.4 3.2 1.3 1.6 1.0 1.0 2.9 0.0 0.5 0.3 2.8 0.5 0.6 1.0 0.9 3.0 1.9 8.9 94.6 0.9 1.6 2.9 2.1 0.4 1.4 0.4 0.1 0.7 2.0 0.4 0.6 0.5 0.5 0.5 4.4 0.6 0.6 0.5 2.9 1.7 0.9 1.0 3.0 0.1 1.7 0.6 0.4 0.5 0.7 0.3 3.2 0.3 2.8 0.0 0.3 0.5 0.0 0.0 0.1 0.1 5.8 12.6 0.0 0.1 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.2 0.0 15.0 0.0 0.8 0.1 0.3 0.0 0.0 0.1 0.6 1.7 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 9.2 0.1 0.0 0.3 2.8 0.1 0.1 1.9 0.1 0.1 0.3 0.2 3.2 0.3 0.2 0.3 0.1 0.0 1.3 0.1 0.0 0.5 1.9 2.1 1.3 1.6 3.0 1.9 2.9 2.1 2.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.7 0.3 0.0 179.6 3.3 0.0 0.0 6.7 8.8 0.2 8.6 1.2 0.0 1.8 0.0 1.1 0.0 0.0 5.6 31.5 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.1 ACSS2 "ACAS2, AceCS, ACS, ACSA, dJ1161H23.1" ENSG00000131069 "Acyl-CoA synthetase short chain family member 2" Q9NR19 20 34872146-34927962 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.4" "Cell type enhanced" "Detected in all" 5 "Enterocytes: 98.3;Mucus-secreting cells: 80.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Group enriched" "Detected in many" 5 "dendritic cells: 12.6;granulocytes: 17.0;monocytes: 11.6" "Cell line enhanced" "Detected in many" "RPMI-8226: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004141 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA004141: AB_1078094" "unprognostic (1.97e-2)" "unprognostic (1.33e-1)" "unprognostic (1.70e-1)" "unprognostic (2.25e-2)" "unprognostic (1.84e-2)" "unprognostic (1.86e-1)" "unprognostic (1.42e-1)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "unprognostic (3.92e-2)" "unprognostic (1.66e-1)" "unprognostic (1.42e-2)" "prognostic favorable (2.04e-4)" "unprognostic (2.72e-1)" "unprognostic (2.32e-1)" "unprognostic (3.08e-1)" "unprognostic (2.54e-1)" 30.3 12.6 2.8 9.2 7.0 1.9 12.4 5.6 7.0 6.8 21.0 10.6 8.3 21.4 6.6 7.0 8.1 4.5 7.7 24.8 2.9 2.5 11.2 15.7 11.7 3.2 6.8 3.2 5.1 3.2 4.7 2.5 4.6 5.5 3.4 10.4 3.5 9.8 6.8 63.4 6.8 24.1 3.0 6.1 2.7 13.4 3.1 7.1 1.1 3.9 7.3 3.0 6.5 6.1 0.7 12.6 17.0 11.6 0.3 3.0 4.7 11.9 1.6 1.2 1.6 8.5 9.0 12.4 7.1 5.5 2.0 3.5 4.3 6.6 0.0 8.1 3.1 7.7 9.0 2.9 17.9 1.5 0.1 2.8 16.6 0.8 2.0 6.2 1.6 9.1 6.1 3.9 2.9 2.8 2.9 3.1 1.2 10.5 1.3 2.7 1.4 0.5 7.3 0.8 3.6 20.3 4.4 7.8 26.2 6.8 1.2 1.1 5.4 8.7 6.4 6.9 3.4 3.1 3.6 11.7 2.4 3.3 4.3 2.3 11.3 8.2 3.8 6.7 2.6 1.9 17.0 11.6 3.0 0.6 7.2 0.5 0.4 1.6 0.7 12.6 0.7 3.0 1.5 6.5 0.3 3.4 2.1 1.1 4.7 2.8 7.0 5.6 7.0 2.9 2.5 6.8 3.2 5.5 7.1 11.9 40.9 3.0 8.5 6.9 6.0 70.4 25.5 5.3 13.6 10.4 5.9 13.6 10.0 16.5 7.2 13.2 98.3 23.3 29.5 8.5 8.9 8.8 9.2 44.8 14.7 7.9 7.5 10.4 17.2 6.0 10.6 13.8 13.5 19.8 80.6 8.8 18.1 60.0 4.2 51.2 3.4 12.9 9.9 11.6 7.3 9.5 17.5 5.0 60.0 8.9 ACTN2 ENSG00000077522 "Actinin alpha 2" P35609 1 236686454-236764631 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Actin-binding "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 141.3;skeletal muscle: 320.9;tongue: 75.4" "Cell type enriched" "Detected in some" 88 "Cardiomyocytes: 1655.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 3.1;HSkMC: 12.2;hTEC/SVTERT24-B: 7.6;WM-115: 2.4" "Region enhanced" "Detected in many" "basal ganglia: 59.7" "Low region specificity" "Detected in many" "HPA006035, HPA008315" Enhanced Uncertain "Actin filaments" NA NA 69000000 "Actin filaments" "HPA006035: AB_1078095, HPA008315: AB_1844543" "unprognostic (1.75e-1)" "unprognostic (1.50e-1)" "unprognostic (2.41e-2)" "unprognostic (1.69e-3)" "unprognostic (2.91e-1)" "unprognostic (4.32e-3)" "unprognostic (7.85e-2)" "unprognostic (2.97e-3)" "unprognostic (2.17e-2)" "unprognostic (2.80e-1)" "unprognostic (2.97e-1)" "unprognostic (2.66e-1)" "unprognostic (2.71e-11)" "unprognostic (1.30e-2)" "unprognostic (1.10e-2)" "unprognostic (4.98e-2)" "unprognostic (1.22e-1)" 3.5 0.6 1.6 0.6 10.7 0.6 0.7 0.3 2.5 0.6 0.6 5.1 0.0 0.6 0.7 4.4 3.7 0.7 0.7 141.3 2.5 1.4 0.6 0.6 0.9 0.6 4.7 1.4 0.7 0.7 0.6 0.1 0.6 2.7 2.8 0.6 0.0 4.9 0.6 320.9 0.6 0.7 1.5 3.9 0.6 0.7 0.9 4.3 0.0 3.5 75.4 4.8 0.9 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.1 3.1 0.0 0.0 0.1 0.0 0.0 0.7 12.2 0.0 7.6 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.7 0.5 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 10.7 0.3 2.5 2.5 1.4 4.7 1.4 2.7 4.3 0.0 1.1 0.0 0.3 0.2 0.7 1655.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.6 0.0 0.7 0.3 0.0 0.0 0.1 0.0 0.0 1.3 0.0 18.7 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.6 1.1 0.0 1.4 1.9 2.0 0.1 0.0 0.0 0.0 0.1 ACTN3 ENSG00000248746 "Actinin alpha 3 (gene/pseudogene)" Q08043 11 66546395-66563329 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "skeletal muscle: 185.5" "Group enriched" "Detected in some" 5 "Early spermatids: 4.7;Late spermatids: 11.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 11 "HDLM-2: 17.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA006035 Uncertain Uncertain "Actin filaments" NA NA 29000000 "Actin filaments" "HPA006035: AB_1078095" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (6.16e-2)" "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (3.35e-4)" "unprognostic (1.40e-3)" "unprognostic (5.37e-3)" "unprognostic (5.09e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.66e-2)" "unprognostic (6.71e-9)" "unprognostic (2.06e-1)" "unprognostic (6.98e-2)" "unprognostic (5.16e-2)" "unprognostic (2.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 185.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 7.7 1.9 0.1 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.2 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 11.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 ACVR1 "ACVR1A, ACVRLK2, ALK2, SKR1" ENSG00000115170 "Activin A receptor type 1" Q04771 2 157736444-157875862 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007505, HPA046514" Approved Uncertain Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA007505: AB_1844752, HPA046514: AB_2732526" "unprognostic (6.99e-2)" "unprognostic (3.32e-2)" "unprognostic (3.02e-1)" "unprognostic (1.19e-2)" "unprognostic (2.73e-1)" "unprognostic (6.09e-2)" "unprognostic (3.66e-3)" "unprognostic (1.08e-1)" "unprognostic (3.99e-1)" "unprognostic (3.20e-1)" "unprognostic (2.65e-2)" "unprognostic (4.29e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-3)" "unprognostic (3.17e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (5.17e-4)" 18.9 9.2 18.0 10.0 12.7 1.6 38.7 15.3 12.2 25.2 14.4 7.4 8.4 8.9 24.8 26.8 11.0 16.6 20.5 18.8 18.7 8.6 21.7 18.9 22.5 15.1 10.4 7.9 18.5 12.3 11.3 17.0 14.2 12.3 16.8 10.5 14.3 18.1 13.6 15.6 12.8 11.5 29.2 12.3 9.2 11.8 8.8 10.9 7.5 34.0 14.6 6.9 16.1 32.5 1.4 2.4 3.8 2.6 1.9 10.0 1.6 2.1 4.3 5.0 6.5 25.4 26.5 7.0 15.4 25.6 12.4 13.2 3.4 4.8 0.0 7.1 16.6 12.0 6.0 3.6 8.3 13.3 14.7 3.1 8.7 2.5 4.9 20.1 0.6 10.4 33.2 15.8 25.3 32.3 16.2 13.4 2.4 3.2 2.4 15.5 3.8 0.1 0.2 7.5 3.0 7.8 1.4 6.7 1.8 16.0 8.1 4.4 5.5 5.9 3.4 21.1 8.2 1.8 2.3 19.3 18.8 6.2 9.2 5.8 1.6 1.2 0.1 19.3 0.5 20.2 3.8 2.6 0.2 1.1 1.7 1.2 1.4 7.8 2.5 1.8 0.8 3.1 1.5 0.8 1.9 2.3 2.4 10.0 1.6 18.0 12.7 15.3 12.2 18.7 8.6 10.4 7.9 12.3 10.9 8.9 7.0 0.8 6.8 8.8 7.5 9.2 12.7 6.7 9.1 7.0 0.0 7.0 5.0 8.4 0.5 13.5 3.1 0.0 15.5 4.4 11.6 8.9 4.7 12.1 6.5 3.2 4.1 17.2 11.6 1.1 18.7 7.7 3.3 3.6 5.2 6.1 14.7 3.5 14.9 15.3 1.5 12.9 15.5 0.5 2.5 6.6 8.8 1.0 3.5 7.6 ACVR2B ActR-IIB ENSG00000114739 "Activin A receptor type 2B" Q13705 3 38453851-38493142 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 16.4;NTERA-2: 20.3;SuSa: 12.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007398, CAB025115, HPA040384" Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" No No Cytosol "Nucleoplasm, Nuclear bodies" "CAB025115: , HPA007398: AB_2667822, HPA040384: AB_2732484" "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "unprognostic (3.47e-1)" "unprognostic (8.73e-2)" "unprognostic (9.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.32e-2)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (1.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (1.64e-1)" "unprognostic (1.98e-1)" "unprognostic (1.83e-1)" "unprognostic (4.75e-1)" 2.8 7.4 5.5 4.6 7.9 1.1 5.5 13.2 7.5 5.2 3.4 7.2 4.5 2.8 4.7 5.1 2.5 5.6 3.3 3.9 5.9 5.4 5.3 5.4 6.9 2.2 5.9 5.4 8.3 6.1 11.3 5.1 16.0 6.5 3.9 3.6 5.0 4.6 4.2 15.9 2.4 2.8 4.6 4.7 3.1 4.0 9.1 9.1 12.8 4.8 1.7 2.2 4.2 10.3 0.3 0.3 0.5 0.2 0.5 1.6 0.3 0.8 1.4 16.4 1.4 0.6 0.4 8.8 0.3 0.5 0.3 0.7 2.3 1.1 0.1 1.2 0.3 0.5 1.0 6.3 1.0 0.9 2.4 4.1 4.2 2.5 3.5 0.8 2.9 1.6 0.7 0.9 0.5 1.8 1.0 1.1 6.2 6.9 1.4 0.3 1.3 5.1 1.9 20.3 0.8 0.7 1.7 5.5 1.0 1.0 1.9 3.8 6.7 0.4 2.5 2.2 12.2 1.3 3.9 0.9 0.5 2.7 0.4 1.4 3.9 5.4 0.9 0.6 2.5 1.1 0.5 0.1 0.1 0.4 0.2 0.6 0.2 1.0 0.5 0.0 0.3 1.6 1.5 0.3 0.5 0.2 0.3 0.7 0.3 5.5 7.9 13.2 7.0 5.9 5.4 5.9 5.4 6.5 9.1 6.0 6.7 0.5 3.6 3.5 20.7 11.6 5.1 6.7 4.5 0.0 21.6 6.7 0.0 3.2 9.1 6.1 2.9 0.0 3.3 5.8 3.1 3.2 1.1 7.5 2.2 20.6 6.9 4.9 2.1 12.6 10.9 3.2 6.8 0.0 3.2 9.6 3.8 2.5 7.4 2.8 25.5 0.0 5.6 8.1 19.0 3.4 5.1 2.5 4.7 3.3 ADAM10 "CD156c, HsT18717, kuz, MADM" ENSG00000137845 "ADAM metallopeptidase domain 10" O14672 15 58588807-58749978 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 77.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001709, HPA050670" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 8200000 "Plasma membrane" "Nucleoplasm, Vesicles" "CAB001709: , HPA050670: " "unprognostic (1.43e-1)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (5.04e-2)" "unprognostic (3.09e-1)" "unprognostic (2.70e-3)" "unprognostic (7.48e-2)" "prognostic unfavorable (8.46e-5)" "unprognostic (3.99e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (6.69e-2)" "unprognostic (2.57e-2)" "unprognostic (2.57e-3)" "unprognostic (9.14e-2)" "unprognostic (2.09e-2)" "unprognostic (1.60e-2)" 25.9 11.1 15.5 17.1 17.7 15.6 20.0 25.2 17.6 18.6 20.1 15.7 12.7 13.9 19.9 11.8 17.1 13.8 18.0 18.8 17.6 13.7 20.8 14.8 25.0 26.1 23.1 12.4 13.9 13.1 10.9 11.6 36.1 14.5 23.6 16.7 14.6 12.4 19.1 8.9 15.4 15.6 12.8 30.4 40.4 18.4 8.5 18.9 38.5 27.3 9.2 14.9 30.0 19.1 6.2 12.7 26.9 23.7 9.8 12.2 12.8 12.1 27.4 7.5 8.1 9.6 13.9 18.9 10.4 31.0 7.7 10.7 12.6 16.1 5.6 32.2 9.3 13.5 24.8 4.5 11.0 10.2 8.4 5.8 9.6 10.0 11.7 10.7 6.8 27.7 12.1 8.1 5.4 7.9 11.2 14.9 12.2 6.0 15.3 13.5 4.5 22.4 7.7 10.2 4.0 3.9 9.3 24.5 14.4 17.9 32.7 8.1 5.3 11.3 13.2 18.0 17.1 7.8 13.6 10.5 10.1 11.3 77.5 10.0 8.6 18.5 6.1 14.1 13.1 17.6 12.9 18.8 10.4 8.1 21.5 12.2 5.3 8.0 7.1 12.7 6.2 8.4 7.0 26.9 9.8 23.7 5.8 10.3 12.8 15.5 17.7 25.2 16.9 17.6 13.7 23.1 12.4 14.5 18.9 77.4 49.8 30.6 25.8 23.7 20.2 29.7 30.6 30.8 35.2 76.8 25.5 27.4 1.7 45.7 21.6 61.6 39.3 0.0 27.7 46.7 28.8 75.5 27.9 30.4 56.9 42.9 34.7 76.1 87.0 16.2 16.7 64.0 43.9 13.6 45.8 27.0 37.3 43.2 15.9 20.3 32.7 12.9 28.3 13.6 16.2 19.4 22.2 43.6 33.7 59.6 ADAM15 MDC15 ENSG00000143537 "ADAM metallopeptidase domain 15" Q13444 1 155050566-155062775 "Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion, Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 139.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 17.2;intermediate monocyte: 12.0;myeloid DC: 28.7" "Group enriched" "Detected in many" 5 "dendritic cells: 28.7;monocytes: 17.2" "Cell line enhanced" "Detected in many" "PC-3: 64.1;RPMI-8226: 67.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011633, HPA072878" Uncertain Uncertain Vesicles NA NA 13000 Vesicles "HPA011633: AB_1844574, HPA072878: " "unprognostic (6.35e-3)" "unprognostic (1.51e-1)" "unprognostic (1.60e-1)" "unprognostic (7.60e-2)" "prognostic unfavorable (5.83e-5)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (2.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (5.64e-9)" "unprognostic (3.35e-2)" "unprognostic (6.20e-2)" "unprognostic (2.04e-2)" "unprognostic (7.40e-2)" 32.7 8.3 7.3 13.3 8.9 19.3 47.9 7.8 13.9 19.9 21.2 22.2 11.9 10.7 20.4 16.2 36.0 19.3 30.3 42.3 8.0 7.7 12.4 12.8 29.2 23.3 10.8 8.3 15.7 17.5 18.9 6.9 25.5 13.9 17.8 15.9 15.4 20.4 12.1 13.6 45.8 20.3 25.6 13.6 16.0 19.6 8.3 7.4 2.7 14.6 41.5 19.7 13.4 26.5 1.1 28.7 0.7 17.2 0.7 4.5 8.1 20.8 6.7 1.3 29.8 11.0 9.2 12.9 9.2 11.8 11.8 8.0 4.8 12.0 5.8 41.7 12.1 5.2 26.2 6.7 28.4 3.1 2.6 8.7 1.4 13.2 4.7 19.2 11.8 1.5 9.8 30.1 11.9 17.2 16.3 53.4 1.8 2.2 24.4 8.7 11.3 0.1 8.7 4.2 36.4 64.1 1.8 4.0 67.6 8.6 5.5 4.1 8.8 20.2 25.5 7.9 2.2 37.7 7.3 39.3 11.6 4.9 11.5 10.2 2.7 2.1 2.5 8.4 9.0 12.6 0.0 17.2 0.3 4.5 12.0 3.1 1.0 2.3 2.6 28.7 1.1 1.0 1.2 0.7 0.7 2.8 2.3 3.8 8.1 7.3 8.9 7.8 13.9 8.0 7.7 10.8 8.3 13.9 7.4 3.0 7.0 6.0 22.9 43.5 8.9 9.2 33.1 4.0 5.7 8.7 27.5 9.0 0.0 34.2 1.5 86.7 58.2 0.0 22.4 139.2 17.1 43.0 1.1 17.4 29.2 6.4 12.2 51.0 57.4 1.0 16.1 18.9 13.5 3.6 62.3 8.0 30.5 51.8 17.0 2.2 15.6 12.9 16.1 0.9 6.1 49.9 14.9 5.0 53.8 32.0 ADAM33 "C20orf153, dJ964F7.1, DKFZp434K0521" ENSG00000149451 "ADAM metallopeptidase domain 33" Q9BZ11 20 3667965-3682246 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 55.7;smooth muscle: 58.0" "Cell type enhanced" "Detected in some" 12 "Fibroblasts: 23.2;Leydig cells: 21.0;Peritubular cells: 9.6;Smooth muscle cells: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "ASC diff: 31.3;ASC TERT1: 40.6;BJ: 13.8;BJ hTERT+: 23.7;fHDF/TERT166: 14.1;U-2197: 18.9" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low region specificity" "Detected in all" "HPA067152, HPA071758" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA067152: AB_2685791, HPA071758: " "unprognostic (1.10e-1)" "unprognostic (3.02e-2)" "unprognostic (2.24e-2)" "unprognostic (3.35e-3)" "unprognostic (4.39e-3)" "unprognostic (7.43e-4)" "unprognostic (7.14e-3)" "unprognostic (1.67e-1)" "unprognostic (1.78e-3)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (3.56e-1)" "unprognostic (2.75e-11)" "unprognostic (1.05e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-5)" "unprognostic (3.10e-3)" 10.0 1.5 4.6 9.2 2.6 0.0 20.2 2.8 2.7 55.7 29.5 2.2 20.9 4.7 44.3 12.3 17.0 16.9 17.5 5.3 5.0 0.9 0.9 0.5 3.6 2.2 4.9 3.0 11.8 1.6 0.0 1.6 5.4 7.0 22.8 5.5 3.7 4.2 27.1 3.5 4.8 9.1 58.0 3.3 1.9 9.9 5.4 3.5 0.1 4.0 10.1 2.0 24.9 36.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.3 40.6 0.1 13.8 23.7 4.1 8.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 6.9 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.1 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.6 2.6 2.8 2.7 5.0 0.9 4.9 3.0 7.0 3.5 0.0 0.0 0.0 0.1 4.8 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.2 23.2 0.2 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 21.0 0.6 3.3 0.0 0.0 3.3 0.0 0.0 9.6 0.0 0.0 6.5 15.1 0.6 0.5 2.8 0.5 0.0 0.0 0.0 ADAMTSL3 "KIAA1233, punctin-2" ENSG00000156218 "ADAMTS like 3" P82987 15 83654086-84039842 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 131.0;Alveolar cells type 2: 92.7;Ciliated cells: 103.1;Club cells: 111.5;granulocytes: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 12.3;hTERT-RPE1: 3.7;RPTEC TERT1: 14.3;TIME: 13.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA034773, HPA034774" Uncertain Uncertain Vesicles "Secreted in other tissues" NA NA 110000 Vesicles "HPA034773: AB_10601965, HPA034774: AB_2674326" "unprognostic (2.20e-1)" "unprognostic (1.37e-1)" "unprognostic (2.98e-2)" "unprognostic (1.07e-2)" "unprognostic (1.56e-1)" "unprognostic (9.89e-2)" "unprognostic (4.07e-2)" "unprognostic (3.27e-1)" "unprognostic (9.18e-3)" "unprognostic (5.92e-2)" "unprognostic (9.97e-2)" "unprognostic (3.85e-1)" "unprognostic (8.59e-3)" "unprognostic (5.00e-3)" "unprognostic (4.62e-1)" "unprognostic (8.64e-2)" "unprognostic (3.95e-5)" 6.9 5.0 1.5 6.2 2.9 0.0 5.3 2.8 2.8 8.7 14.3 4.4 1.8 1.5 12.0 3.7 5.4 5.6 4.7 15.9 3.1 1.3 3.8 12.1 10.6 1.5 5.1 2.9 2.0 12.9 1.1 2.6 12.0 7.2 8.1 3.7 19.9 4.7 8.7 2.6 2.2 3.1 26.8 3.6 2.0 7.5 2.9 4.2 0.2 4.6 2.2 0.5 8.0 13.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.9 0.0 14.3 0.0 0.0 0.0 0.2 0.2 0.0 1.4 0.0 0.0 13.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.9 2.8 2.8 3.1 1.3 5.1 2.9 7.2 4.2 131.0 92.7 0.0 4.4 6.3 0.1 6.1 0.0 103.1 111.5 1.8 0.0 0.1 0.0 0.4 12.0 3.6 0.0 0.0 1.9 0.1 1.6 1.8 58.1 8.6 0.2 6.4 0.0 1.3 0.6 13.4 45.8 0.6 0.0 0.0 0.0 0.0 1.5 0.0 15.9 0.6 0.2 25.8 0.5 1.8 1.3 1.0 0.1 0.0 0.0 1.7 ADCK1 FLJ39600 ENSG00000063761 "AarF domain containing kinase 1" Q86TW2 14 77800083-77935012 "Enzymes, Predicted secreted proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051012, HPA055014" Uncertain Uncertain Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA051012: AB_2681310, HPA055014: AB_2682672" "unprognostic (6.36e-2)" "unprognostic (7.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.76e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.70e-4)" "prognostic favorable (4.11e-5)" "unprognostic (2.33e-1)" "unprognostic (1.64e-1)" "unprognostic (4.57e-3)" "unprognostic (1.38e-1)" "prognostic favorable (5.82e-6)" "unprognostic (6.30e-3)" "unprognostic (2.06e-1)" "unprognostic (9.57e-2)" "unprognostic (4.06e-1)" 7.2 11.0 11.0 7.0 15.2 7.4 6.9 6.8 20.5 5.6 10.3 19.0 7.7 11.2 7.7 10.3 7.7 7.1 9.1 11.1 12.4 10.4 8.8 10.5 6.2 6.0 13.5 9.4 6.6 9.8 11.3 11.3 7.8 15.0 8.2 10.3 13.8 10.6 8.9 13.7 8.5 8.5 10.5 10.6 9.7 7.5 5.5 11.5 10.8 9.1 7.8 7.5 6.9 5.0 4.0 8.9 1.4 7.2 3.4 5.3 3.1 3.3 5.4 3.3 10.8 8.1 4.6 4.3 3.4 5.7 3.1 3.8 3.0 8.0 7.3 5.5 6.0 5.7 6.4 17.8 5.4 2.0 4.2 5.6 1.9 3.4 4.9 8.3 2.8 4.1 5.8 10.1 1.2 3.9 3.2 4.4 6.4 7.0 4.5 4.0 16.8 3.4 5.6 6.4 12.3 6.4 5.6 0.5 5.8 4.4 8.5 7.2 4.0 6.6 9.3 4.0 5.1 13.3 6.2 3.9 2.9 2.3 5.9 3.1 4.6 5.0 4.2 4.4 4.9 3.8 1.4 4.7 1.3 5.3 7.2 3.5 1.7 2.2 3.1 8.9 4.0 2.5 4.6 0.4 3.4 2.8 7.0 3.7 3.1 11.0 15.2 6.8 20.5 12.4 10.4 13.5 9.4 15.0 11.5 0.0 3.0 0.8 1.8 0.8 5.0 4.8 0.0 1.4 1.2 0.0 19.6 6.8 3.3 3.6 1.2 1.2 2.1 0.0 4.3 3.6 2.0 1.3 1.1 5.8 8.2 7.9 1.7 1.8 5.1 0.4 1.4 5.4 0.0 1.0 3.6 3.2 3.0 0.0 1.8 3.3 8.8 0.0 1.9 1.7 9.7 1.3 4.5 1.8 4.9 0.9 ADCK2 MGC20727 ENSG00000133597 "AarF domain containing kinase 2" Q7Z695 7 140673153-140696261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036036 Approved Uncertain Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA036036: AB_10672078" "unprognostic (2.76e-1)" "unprognostic (1.79e-1)" "unprognostic (5.72e-2)" "unprognostic (5.30e-2)" "unprognostic (4.03e-3)" "unprognostic (1.52e-1)" "unprognostic (3.05e-2)" "unprognostic (7.48e-2)" "unprognostic (2.61e-1)" "unprognostic (7.10e-3)" "unprognostic (6.81e-3)" "unprognostic (9.36e-3)" "prognostic favorable (9.75e-5)" "unprognostic (1.89e-2)" "unprognostic (2.00e-1)" "unprognostic (4.13e-1)" "unprognostic (2.13e-1)" 12.3 10.6 15.3 11.3 16.6 8.8 13.4 15.4 27.0 12.3 15.1 26.3 13.2 8.8 10.3 11.4 18.0 20.0 10.3 10.2 16.6 18.2 12.3 12.5 12.8 15.6 19.5 13.1 14.5 22.8 21.4 12.7 19.9 18.2 14.4 13.2 10.7 16.8 14.0 12.5 25.8 13.0 10.9 24.0 13.6 13.0 7.6 13.3 20.6 25.1 9.9 16.2 13.4 18.9 8.2 12.0 3.2 5.0 5.1 7.3 2.2 16.0 11.6 2.7 12.7 10.0 11.4 16.5 8.3 10.2 8.7 5.8 10.5 11.4 21.6 12.6 5.8 20.4 13.3 13.9 9.5 2.6 15.9 14.2 4.5 4.5 5.1 13.9 3.0 11.3 9.5 29.1 5.0 6.9 9.0 7.5 15.4 7.9 10.6 3.1 20.0 22.5 7.5 4.0 12.8 12.6 17.8 0.1 10.4 4.7 16.1 10.8 7.6 11.4 16.7 11.4 5.5 14.8 6.1 7.9 10.9 3.8 18.1 16.0 7.4 11.2 15.8 16.1 12.1 12.9 0.0 3.7 3.2 5.4 5.0 4.9 8.2 4.8 5.3 5.7 4.2 7.3 4.7 0.1 5.1 3.0 12.0 6.0 2.2 15.3 16.6 15.4 27.0 16.6 18.2 19.5 13.1 18.2 13.3 8.9 5.1 8.2 18.5 11.0 11.4 5.8 5.1 2.7 1.2 8.7 0.0 25.4 5.0 5.3 16.9 9.0 8.5 0.0 6.4 18.4 7.1 15.5 11.5 8.6 27.9 11.1 16.1 6.7 7.9 12.5 3.1 11.8 3.3 7.2 13.8 11.6 5.9 14.4 12.7 4.8 4.8 0.0 6.9 5.9 3.1 12.2 28.3 7.7 11.3 16.1 ADD2 ADDB ENSG00000075340 "Adducin 2" P35612 2 70607618-70768225 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "bone marrow: 53.6;brain: 35.0" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 28.5;Erythroid cells: 70.0;Horizontal cells: 131.9" "Cancer enhanced" "Detected in many" "testis cancer: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 4.7;non-classical monocyte: 4.4" "Group enriched" "Detected in many" 20 "B-cells: 4.7;monocytes: 4.4;T-cells: 1.9" "Cell line enhanced" "Detected in many" "HAP1: 14.3;JURKAT: 13.9;K-562: 18.7;NTERA-2: 36.9;RPMI-8226: 17.6;SCLC-21H: 18.4;U-251 MG: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009796, HPA034509, HPA034510" Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 66000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009796: AB_2223572, HPA034509: AB_2674201, HPA034510: AB_2674202" "unprognostic (3.58e-2)" "unprognostic (2.68e-4)" "unprognostic (3.83e-2)" "unprognostic (3.01e-4)" "unprognostic (1.94e-1)" "unprognostic (2.25e-3)" "unprognostic (1.35e-1)" "unprognostic (3.26e-1)" "unprognostic (3.49e-1)" "unprognostic (1.48e-1)" "unprognostic (1.20e-2)" "unprognostic (8.93e-2)" "unprognostic (4.47e-7)" "unprognostic (2.81e-4)" "unprognostic (1.77e-1)" "unprognostic (1.71e-3)" "unprognostic (1.31e-3)" 1.9 2.6 14.0 2.6 17.9 53.6 1.5 29.7 35.0 1.3 1.3 1.2 0.0 1.0 1.3 1.2 2.3 1.4 1.2 1.5 14.1 10.7 0.9 0.9 1.8 3.1 6.0 19.7 1.0 2.1 1.3 2.8 1.6 14.0 1.3 1.2 1.7 1.1 1.1 1.6 1.2 1.2 1.9 6.0 1.9 1.1 2.9 2.7 0.0 2.3 0.0 2.9 1.5 0.5 4.7 0.1 0.1 4.4 0.0 1.9 0.6 7.1 8.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.1 5.3 0.0 14.3 0.0 0.0 0.0 8.4 0.7 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 3.4 0.0 13.9 18.7 0.0 0.0 0.0 0.1 0.6 36.9 0.0 0.2 0.0 0.2 17.6 2.4 0.0 18.4 8.3 9.1 0.0 0.0 4.2 0.0 4.4 0.3 0.0 0.4 0.0 19.4 6.0 7.0 0.0 0.3 2.9 3.3 0.1 0.1 0.0 0.0 2.4 0.1 4.7 0.0 0.0 0.1 4.0 1.9 1.0 0.1 0.0 4.4 0.0 0.0 0.6 14.0 17.9 29.7 35.0 14.1 10.7 6.0 19.7 14.0 2.7 0.0 0.3 3.4 0.1 0.1 19.8 2.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 28.5 2.9 0.0 70.0 0.9 0.2 1.0 0.7 0.0 0.0 0.2 131.9 0.0 1.3 0.3 24.0 0.9 0.0 1.7 1.0 0.0 0.5 0.5 0.0 0.7 0.0 9.4 0.0 0.0 0.7 3.2 0.1 0.2 0.0 0.0 0.6 ADGB "C6orf103, CAPN16, dJ408K24.1, FLJ23121" ENSG00000118492 Androglobin Q8N7X0 6 146598965-146815462 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.9;epididymis: 13.1;testis: 30.6" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 121.8;Early spermatids: 236.9;Late spermatids: 53.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 6.6;pons and medulla: 20.9" "Cell type enriched" "Detected in single" 10 "myeloid DC: 2.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 2.6" "Cell line enriched" "Detected in single" 25 "HDLM-2: 17.9" "Low region specificity" "Detected in all" "HPA036340, HPA036341" Enhanced Uncertain Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA036340: AB_2675071, HPA036341: AB_10672241" "unprognostic (4.15e-3)" "unprognostic (1.23e-2)" "unprognostic (9.30e-3)" "unprognostic (1.09e-1)" "unprognostic (2.07e-2)" "unprognostic (3.11e-2)" "unprognostic (5.05e-1)" "unprognostic (2.34e-1)" "unprognostic (4.83e-3)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (1.77e-2)" "unprognostic (3.66e-2)" "unprognostic (2.68e-1)" 0.1 0.1 1.6 0.1 6.6 0.1 0.2 0.0 0.2 1.0 0.5 5.1 0.0 0.1 0.4 13.1 0.2 9.8 0.1 0.1 2.2 2.7 0.2 0.2 4.8 0.2 0.0 0.0 4.3 0.1 0.3 0.8 0.2 20.9 0.2 0.4 0.0 0.1 0.3 0.1 0.3 0.1 0.1 0.4 0.1 0.2 30.6 1.2 0.0 0.2 0.1 0.2 0.1 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 6.6 0.0 0.1 2.2 2.7 0.0 0.0 20.9 1.2 3.0 1.0 0.0 0.0 0.0 0.0 0.8 0.0 121.8 14.8 0.0 3.9 0.0 0.0 0.0 236.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 53.2 2.6 1.2 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 19.2 3.0 0.0 0.0 0.0 0.0 0.0 ADGRD1 "DKFZp434B1272, GPR133, PGR25" ENSG00000111452 "Adhesion G protein-coupled receptor D1" Q6QNK2 12 130953907-131141469 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 66.1" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 29.1;Cardiomyocytes: 39.1;Fibroblasts: 20.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 4.1;intermediate monocyte: 4.9;myeloid DC: 2.4;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 4.9" "Cell line enhanced" "Detected in some" "BJ: 5.1;fHDF/TERT166: 5.8;HeLa: 10.5;HHSteC: 6.7;HMC-1: 14.5;U-2 OS: 7.1" "Region enhanced" "Detected in some" "basal ganglia: 5.3" "Low region specificity" "Detected in all" "HPA042395, HPA076279" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA 600000 "Plasma membrane" Nucleoplasm "HPA042395: AB_10796906, HPA076279: " "unprognostic (3.21e-1)" "unprognostic (1.49e-4)" "unprognostic (1.32e-2)" "unprognostic (1.63e-1)" "unprognostic (4.40e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (9.27e-4)" "unprognostic (2.55e-3)" "unprognostic (1.63e-2)" "unprognostic (6.94e-2)" "unprognostic (1.11e-2)" "unprognostic (3.98e-2)" "unprognostic (4.79e-5)" "unprognostic (1.31e-3)" "unprognostic (4.58e-1)" "unprognostic (2.15e-2)" "unprognostic (1.77e-3)" 12.7 2.1 2.0 3.2 3.1 0.5 8.9 1.1 3.9 11.2 5.5 2.2 3.9 2.2 13.3 14.0 6.8 8.8 45.6 34.8 1.9 1.5 1.6 5.2 18.6 0.6 4.2 2.2 12.5 11.8 0.3 3.5 26.6 2.4 13.3 2.4 13.0 1.6 2.3 11.6 3.8 6.4 66.1 6.4 1.9 10.2 3.8 2.6 0.0 6.3 7.1 2.1 29.5 30.8 0.2 2.4 0.0 4.9 0.5 0.0 1.2 0.0 0.7 0.0 2.6 0.1 0.0 0.1 5.1 0.0 0.0 0.4 0.0 0.0 0.3 0.0 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.5 0.0 6.7 0.0 14.5 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.9 0.0 0.1 0.2 2.2 0.5 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.3 0.0 0.4 0.0 0.5 7.1 1.9 0.1 0.1 1.8 0.9 0.1 0.0 0.0 0.0 4.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.5 3.6 0.0 0.0 1.2 2.0 3.1 1.1 3.9 1.9 1.5 4.2 2.2 2.4 2.6 20.8 29.1 0.0 0.0 0.0 0.0 39.1 0.0 4.0 9.1 1.8 0.0 0.9 0.0 0.0 14.7 1.0 0.0 0.0 0.3 0.6 20.1 0.1 1.1 2.6 2.3 0.0 0.0 3.1 2.4 14.7 12.7 0.7 0.0 1.8 0.0 0.0 0.5 0.0 14.9 0.0 0.7 6.5 0.9 2.6 5.7 0.0 0.8 0.0 0.0 0.3 ADGRE2 "CD312, EMR2" ENSG00000127507 "Adhesion G protein-coupled receptor E2" Q9UHX3 19 14732393-14778541 "CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Cell adhesion, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.7;lymphoid tissue: 38.9" "Cell type enhanced" "Detected in many" 15 "granulocytes: 44.2;Kupffer cells: 60.1;Macrophages: 39.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 19.6;eosinophil: 24.2;intermediate monocyte: 15.7;neutrophil: 19.1;non-classical monocyte: 28.7" "Group enriched" "Detected in many" 8 "granulocytes: 24.2;monocytes: 28.7" "Cell line enhanced" "Detected in some" "HEL: 10.3;HMC-1: 16.6;NB-4: 10.1;RPMI-8226: 7.3;U-937: 13.2" HPA055200 Uncertain Vesicles,Cytosol NA NA Vesicles Cytosol "HPA055200: " "unprognostic (2.46e-2)" "unprognostic (3.58e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (9.10e-2)" "unprognostic (3.58e-2)" "unprognostic (2.77e-2)" "unprognostic (3.88e-2)" "unprognostic (4.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.32e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.35e-6)" "unprognostic (1.46e-1)" "unprognostic (2.45e-3)" "unprognostic (2.50e-1)" "unprognostic (1.01e-1)" 6.3 3.1 1.7 22.9 1.9 7.2 4.4 1.0 1.3 14.9 8.1 2.5 0.9 2.4 12.0 1.0 1.9 2.3 3.3 7.3 2.0 1.8 3.4 4.3 15.6 37.4 2.2 0.0 5.3 3.5 0.7 1.6 10.9 2.4 3.8 2.5 3.2 2.4 3.9 3.5 3.0 3.0 2.0 3.1 38.9 2.0 2.2 1.4 2.8 3.4 5.2 2.8 7.5 2.1 0.1 3.1 24.2 28.7 1.2 0.0 1.8 0.2 1.0 0.1 0.2 0.1 0.3 1.1 0.8 1.1 0.0 0.0 0.2 0.2 0.2 0.1 0.7 2.1 1.7 0.3 0.1 0.0 0.2 0.2 10.3 3.3 0.2 0.5 3.8 16.6 0.8 1.5 3.7 0.6 0.1 0.1 0.9 2.4 0.4 1.2 0.5 1.3 10.1 0.4 0.7 0.2 0.1 1.4 7.3 0.0 0.3 0.1 0.2 2.1 1.8 0.4 0.2 0.3 4.8 0.3 0.3 0.3 0.2 0.1 0.2 0.1 0.2 1.0 13.2 0.6 19.6 4.4 24.2 0.0 15.7 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 19.1 1.2 28.7 0.6 0.0 1.8 1.7 1.9 1.0 1.3 2.0 1.8 2.2 0.0 2.4 1.4 3.0 10.6 5.4 4.4 0.0 0.7 0.6 0.0 4.0 4.5 0.0 0.0 0.1 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.3 0.3 1.7 44.2 0.4 13.5 0.0 1.2 1.3 60.1 2.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.2 0.3 0.0 0.3 0.7 0.0 3.0 ADGRF4 "FLJ38076, GPR115, PGR18" ENSG00000153294 "Adhesion G protein-coupled receptor F4" Q8IZF3 6 47685864-47722021 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8" "Cell type enhanced" "Detected in some" 14 "Extravillous trophoblasts: 9.6;Pancreatic endocrine cells: 12.3;Syncytiotrophoblasts: 6.1;Urothelial cells: 16.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 8.7;HBEC3-KT: 13.8;hTCEpi: 21.5;OE19: 12.0;U-87 MG: 18.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA007131, HPA007158" Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA007131: AB_2667756, HPA007158: AB_1849254" "unprognostic (1.40e-2)" "unprognostic (7.06e-3)" "unprognostic (2.11e-1)" "unprognostic (4.68e-2)" "unprognostic (3.79e-2)" "unprognostic (3.77e-2)" "unprognostic (2.04e-3)" "unprognostic (2.64e-1)" "unprognostic (3.47e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (2.86e-1)" "unprognostic (1.66e-8)" "unprognostic (1.62e-3)" "unprognostic (2.01e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" 0.0 0.5 0.0 0.1 0.1 0.0 1.9 0.3 0.0 7.0 1.0 0.1 0.0 0.0 1.0 0.0 15.8 0.9 0.5 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 23.9 0.2 1.9 1.2 0.0 1.8 0.0 0.4 30.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 17.8 14.0 2.3 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.0 0.0 0.0 0.0 0.6 0.0 3.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.5 8.7 0.0 13.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.5 0.2 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.0 0.8 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.2 1.2 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.3 0.0 3.3 0.2 0.0 0.0 0.0 3.0 9.6 0.1 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.1 0.0 0.0 16.0 ADH4 ADH-2 ENSG00000198099 "Alcohol dehydrogenase 4 (class II), pi polypeptide" P08319 4 99123657-99157792 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 345.2" "Cell type enriched" "Detected in some" 34 "Hepatocytes: 802.6" "Cancer enriched" "Detected in some" 60 "liver cancer: 230.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "Hep G2: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA020525 Enhanced Uncertain Nucleoplasm,Cytosol NA NA 5300000 "Nucleoplasm, Cytosol" "HPA020525: AB_1844609" "unprognostic (2.75e-1)" "unprognostic (1.69e-2)" "unprognostic (1.85e-2)" "unprognostic (5.54e-3)" "unprognostic (2.14e-2)" "unprognostic (1.33e-2)" "prognostic favorable (7.08e-6)" "unprognostic (1.49e-1)" "unprognostic (1.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.88e-1)" "unprognostic (2.34e-2)" "unprognostic (7.16e-3)" "unprognostic (2.20e-1)" "unprognostic (5.89e-3)" 0.3 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.2 3.6 0.0 0.1 11.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.2 345.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.4 0.1 4.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.1 0.1 0.5 1.2 0.7 2.8 0.5 0.4 0.9 0.1 0.3 0.3 0.2 0.3 0.5 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.2 0.5 0.3 0.0 0.2 0.3 0.0 0.2 0.4 0.3 0.1 0.6 0.8 22.4 0.1 1.8 0.5 0.3 0.0 0.2 0.2 0.2 0.1 0.2 0.4 1.0 0.1 0.3 0.3 0.6 0.4 0.0 0.2 0.2 1.8 0.5 0.2 0.4 0.2 0.3 2.0 0.3 0.0 0.3 0.5 0.0 0.4 0.5 0.2 0.5 0.1 0.6 0.4 0.7 0.1 0.7 0.1 2.8 0.4 0.5 0.9 0.5 0.8 0.4 0.5 0.5 0.1 1.2 0.8 0.8 1.0 0.4 0.5 0.7 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 15.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 21.9 0.0 0.0 23.3 0.5 0.0 0.0 0.0 0.0 802.6 0.0 0.0 0.0 13.5 20.9 2.6 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 ADK AK ENSG00000156110 "Adenosine kinase" P55263 10 74151185-74709303 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Purine salvage" "Kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 71.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032876, HPA038391, HPA038409, HPA075222" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 320000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB032876: AB_2242229, HPA038391: AB_2675990, HPA038409: AB_10675798, HPA075222: " "unprognostic (1.55e-3)" "unprognostic (1.09e-1)" "unprognostic (1.88e-1)" "unprognostic (2.62e-2)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.93e-4)" "prognostic favorable (9.91e-4)" "unprognostic (2.64e-1)" "unprognostic (2.88e-1)" "unprognostic (1.55e-1)" "unprognostic (8.15e-3)" "unprognostic (2.51e-1)" "unprognostic (1.89e-3)" "unprognostic (2.03e-1)" "unprognostic (2.88e-2)" "unprognostic (4.97e-3)" "unprognostic (2.95e-2)" 13.8 10.7 11.8 13.6 25.4 12.1 14.5 11.2 11.8 9.5 9.3 9.0 9.6 8.8 6.6 10.6 29.4 8.9 6.3 15.7 9.8 11.1 19.0 71.9 15.1 17.9 12.3 9.3 5.2 12.6 15.1 23.5 43.2 11.6 8.7 10.8 8.5 13.1 11.4 18.1 20.8 6.4 8.3 13.2 11.3 7.4 11.9 10.3 13.4 20.8 24.1 21.9 12.6 14.7 49.3 23.0 5.4 21.6 6.5 15.7 9.8 38.1 8.6 9.1 12.2 9.2 14.2 21.0 33.2 26.3 25.7 28.9 24.1 39.8 20.0 8.3 13.3 12.1 34.9 10.7 35.3 41.2 13.4 12.3 12.7 14.1 25.9 10.5 20.3 5.2 13.0 23.3 18.7 46.6 19.0 22.3 9.3 10.1 6.5 19.3 21.3 23.9 27.5 2.6 17.8 60.9 23.1 15.8 17.2 28.1 21.0 7.2 8.5 14.6 56.7 11.0 8.5 37.7 15.4 19.1 8.5 15.7 22.7 27.3 9.4 10.6 22.6 16.1 29.3 5.2 1.3 10.1 1.4 4.5 18.0 10.0 29.7 9.5 8.2 23.0 49.3 7.9 6.5 5.4 6.5 21.6 16.7 15.7 9.8 11.8 25.4 11.2 11.8 9.8 11.1 12.3 9.3 11.6 10.3 77.4 57.2 37.1 62.9 83.7 14.5 53.3 35.7 34.8 76.2 29.6 53.0 120.6 77.9 60.0 55.9 14.7 5.9 0.0 58.9 113.1 27.2 33.9 19.8 112.8 36.3 11.1 10.4 14.7 21.4 22.9 15.5 40.6 45.5 31.5 11.5 10.0 45.7 14.0 11.3 48.3 27.9 6.5 32.8 13.3 12.2 84.8 89.7 20.3 19.9 57.0 ADORA2B ENSG00000170425 "Adenosine A2b receptor" P29275 17 15944917-15975746 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 65.4;Suprabasal keratinocytes: 56.2;Urothelial cells: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.8;myeloid DC: 8.4" "Group enriched" "Detected in many" 86 "dendritic cells: 8.4;granulocytes: 12.8;monocytes: 4.5" "Cell line enhanced" "Detected in many" "GAMG: 50.2;HMC-1: 50.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073747 Uncertain Cytosol NA NA Cytosol "HPA073747: " "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (4.68e-1)" "unprognostic (7.88e-3)" "unprognostic (2.64e-4)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (1.50e-2)" "unprognostic (2.18e-3)" "unprognostic (1.38e-1)" "unprognostic (1.66e-9)" "unprognostic (2.07e-1)" "unprognostic (3.49e-1)" "unprognostic (1.50e-2)" "unprognostic (2.84e-1)" 1.5 1.5 7.6 4.5 9.1 1.6 1.8 7.3 8.7 2.9 15.3 2.4 0.0 0.8 1.7 1.5 11.1 2.2 3.8 1.2 6.6 3.0 0.6 0.7 4.1 1.0 1.9 5.4 0.6 2.8 0.4 1.9 9.0 5.2 1.7 12.8 10.5 1.9 0.7 0.7 10.4 1.6 2.8 3.9 0.7 2.6 0.7 2.6 0.1 0.6 4.4 4.5 6.8 5.6 0.0 8.4 12.8 4.5 0.0 0.0 1.5 10.0 5.5 0.1 0.2 1.8 3.5 0.2 1.9 8.7 5.7 7.1 2.6 10.5 1.3 2.4 1.7 50.2 15.8 2.4 14.5 7.6 2.8 5.5 9.7 1.8 3.8 7.1 0.0 50.7 2.0 6.2 8.1 18.9 9.8 2.8 1.5 0.4 0.0 5.6 2.6 0.6 1.9 0.6 21.6 7.8 0.0 0.1 0.0 5.8 2.7 0.2 0.3 4.3 1.0 2.6 4.3 0.0 1.5 2.4 2.0 5.4 5.6 9.0 0.8 0.0 0.0 8.1 0.0 2.8 12.8 4.0 2.6 0.0 4.5 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.4 0.0 2.3 0.1 0.0 1.5 7.6 9.1 7.3 8.7 6.6 3.0 1.9 5.4 5.2 2.6 3.0 3.4 0.0 12.7 65.4 0.0 1.2 2.5 8.1 7.9 0.0 0.0 10.1 0.0 6.2 0.3 0.6 4.9 0.0 0.8 2.8 6.1 11.9 0.0 0.0 4.6 0.0 2.4 0.0 2.7 0.0 0.0 5.1 6.8 0.0 1.4 7.4 0.8 4.8 0.0 0.0 0.5 0.0 1.9 0.5 1.2 56.2 5.1 0.0 3.7 26.7 ADRA1A "ADRA1C, ADRA1L1" ENSG00000120907 "Adrenoceptor alpha 1A" P35348 8 26748150-26867273 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.1" "Group enriched" "Detected in some" 15 "Early spermatids: 50.8;Hepatocytes: 14.0;Late spermatids: 20.6" "Cancer enhanced" "Detected in some" "liver cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 1.3;HAP1: 1.7;JURKAT: 2.0;NTERA-2: 2.3;U-2 OS: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029678, HPA029679, HPA076693" Approved Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA029678: AB_10602108, HPA029679: AB_2673143, HPA076693: " "unprognostic (1.27e-1)" "unprognostic (1.68e-2)" "unprognostic (1.99e-1)" "unprognostic (3.57e-1)" "unprognostic (5.04e-4)" "unprognostic (1.97e-1)" "unprognostic (9.55e-2)" "unprognostic (3.08e-1)" "unprognostic (1.58e-2)" "unprognostic (7.47e-2)" "unprognostic (1.71e-2)" "unprognostic (6.06e-3)" "unprognostic (7.41e-2)" "unprognostic (1.52e-2)" "unprognostic (1.30e-1)" 14.5 0.7 7.1 1.1 3.9 0.3 3.4 6.2 4.9 0.9 1.5 5.9 4.9 1.0 1.8 2.0 0.9 0.6 0.5 10.1 11.6 2.0 0.8 45.1 3.9 1.4 4.7 4.7 1.0 0.5 0.3 0.6 0.3 3.8 10.2 0.7 0.6 4.6 11.2 0.6 0.9 1.3 2.4 1.9 7.0 1.2 0.5 4.2 0.0 0.6 0.1 0.6 0.6 0.7 0.3 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 7.1 3.9 6.2 4.9 11.6 2.0 4.7 4.7 3.8 4.2 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 1.3 0.0 20.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ADRB2 "ADRB2R, ADRBR, B2AR, BAR" ENSG00000169252 "Adrenoceptor beta 2" P07550 5 148825245-148828687 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.6" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 104.2;Basal keratinocytes: 344.2;granulocytes: 116.5;Suprabasal keratinocytes: 214.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 24.5;hTERT-HME1: 25.4;PC-3: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003431, HPA075322" Uncertain Uncertain Cytosol NA NA Cytosol "HPA003431: AB_1845333, HPA075322: " "unprognostic (2.28e-2)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (9.35e-3)" "unprognostic (5.54e-2)" "unprognostic (2.34e-1)" "unprognostic (9.85e-2)" "unprognostic (3.17e-2)" "unprognostic (2.23e-1)" "prognostic favorable (3.15e-9)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.49e-1)" "unprognostic (7.65e-2)" 11.7 0.2 0.7 0.9 0.4 4.6 13.8 0.0 0.3 6.1 0.9 0.3 0.9 0.2 6.4 1.4 1.1 2.8 0.7 0.3 0.2 6.0 8.5 1.1 0.9 0.0 0.0 0.5 0.0 4.0 3.8 0.7 3.3 0.1 4.4 15.9 1.3 1.2 1.0 3.7 2.9 0.0 0.5 2.0 2.3 5.4 4.8 6.1 14.0 10.8 7.3 34.6 9.6 7.6 0.0 0.0 0.0 0.3 0.0 0.0 1.5 4.4 2.0 2.3 0.0 3.3 0.0 2.1 0.4 7.4 6.8 0.0 9.2 2.3 0.0 0.2 0.0 1.6 0.0 0.2 0.0 3.8 0.0 24.5 0.6 25.4 1.7 0.9 0.0 0.0 2.9 5.3 0.0 0.0 4.2 0.1 0.0 10.5 2.2 1.4 4.3 1.1 1.9 0.0 0.0 1.8 0.2 0.6 0.9 0.0 2.3 4.1 0.0 1.8 2.5 1.1 0.7 0.0 0.1 0.0 5.0 0.8 3.5 4.7 14.0 34.6 7.8 25.7 4.8 8.2 20.9 5.3 3.0 1.4 12.9 7.6 7.3 10.8 6.1 0.4 9.6 104.2 33.5 11.1 31.2 344.2 0.2 12.4 0.0 8.1 33.0 0.0 0.0 0.3 0.0 1.4 0.2 17.5 0.0 0.0 0.2 0.2 6.1 16.2 116.5 11.9 14.7 0.0 2.9 6.7 12.7 0.4 0.0 16.5 28.7 1.0 1.4 3.5 5.3 0.0 0.0 0.0 4.8 0.0 3.6 0.0 0.0 214.5 0.5 35.5 0.8 48.5 ADSS ENSG00000035687 "Adenylosuccinate synthase" P30520 1 244408494-244452134 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024400 Supported Supported "Plasma membrane,Cytosol" NA NA 620000 Cytosol "Plasma membrane" "HPA024400: AB_1844623" "unprognostic (4.24e-3)" "unprognostic (2.63e-1)" "unprognostic (3.95e-2)" "unprognostic (8.68e-2)" "unprognostic (6.91e-2)" "unprognostic (2.04e-1)" "unprognostic (1.62e-2)" "unprognostic (2.58e-1)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" "unprognostic (1.44e-2)" "unprognostic (3.10e-1)" "unprognostic (1.35e-1)" "unprognostic (7.62e-2)" "unprognostic (1.86e-1)" "unprognostic (2.04e-1)" "unprognostic (1.18e-2)" 19.4 17.8 23.2 23.8 31.2 29.2 26.3 18.3 26.3 20.9 20.9 35.9 27.1 21.1 18.9 23.3 27.7 18.3 15.8 9.8 24.9 23.4 25.1 19.3 19.2 21.2 42.5 16.6 20.9 21.2 26.6 17.7 21.0 34.9 19.8 22.7 13.1 25.0 21.7 11.0 26.5 23.2 22.9 29.3 24.9 24.7 48.9 36.7 26.7 26.3 17.9 24.8 26.5 21.8 10.9 13.6 24.6 21.3 15.5 16.0 11.9 25.7 14.2 12.4 10.9 14.6 20.9 22.9 26.0 21.9 18.7 14.2 18.7 24.9 23.0 17.3 20.0 8.0 19.5 13.5 17.0 21.0 17.0 24.0 15.3 14.2 14.1 17.5 36.2 19.8 14.3 20.6 17.4 17.6 21.8 66.6 12.7 26.5 17.1 18.5 6.1 23.2 24.3 33.0 24.6 15.7 21.5 11.8 24.8 31.0 16.0 16.9 14.8 22.1 20.6 26.0 13.8 14.3 19.3 29.1 17.3 9.5 20.0 27.0 20.8 27.2 17.4 14.3 42.5 25.5 24.6 15.8 13.0 15.0 20.5 16.0 10.9 13.7 12.8 13.6 8.6 11.8 13.3 11.9 15.5 21.3 5.5 14.7 11.9 23.2 31.2 18.3 26.3 24.9 23.4 42.5 16.6 34.9 36.7 44.7 30.5 40.0 44.7 90.9 12.4 5.8 35.7 127.2 85.3 57.6 5.9 47.0 74.6 41.2 102.9 33.7 30.0 0.0 44.0 83.0 35.8 40.9 28.9 29.6 33.8 9.5 17.3 37.4 38.1 103.8 17.5 51.2 40.5 37.9 29.4 34.0 38.5 21.0 15.9 57.5 7.2 12.9 34.0 104.8 68.7 86.1 45.2 60.6 38.1 62.8 ADTRP "AIG1L, C6orf105, dJ413H6.1" ENSG00000111863 "Androgen dependent TFPI regulating protein" Q96IZ2 6 11712054-11807046 "Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 109.7;Enterocytes: 113.2;Late spermatids: 127.1;Paneth cells: 73.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "pons and medulla: 12.4" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 10.5;T-reg: 9.8" "Lineage enriched" "Detected in many" 7 "T-cells: 10.5" "Cell line enhanced" "Detected in some" "hTERT-HME1: 10.5;HUVEC TERT2: 35.9;RPMI-8226: 13.5;TIME: 19.4;U-138 MG: 12.9;U-266/84: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA048113 Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA048113: AB_2680268" "unprognostic (6.82e-3)" "unprognostic (1.41e-1)" "unprognostic (1.58e-1)" "unprognostic (8.14e-3)" "unprognostic (3.04e-3)" "unprognostic (1.41e-2)" "unprognostic (4.00e-2)" "unprognostic (1.77e-1)" "unprognostic (1.85e-2)" "unprognostic (2.72e-1)" "unprognostic (5.41e-3)" "unprognostic (2.90e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (2.61e-2)" "unprognostic (1.40e-1)" "unprognostic (1.95e-2)" "unprognostic (1.26e-1)" 0.8 0.4 0.6 10.6 0.8 0.0 0.9 0.3 2.1 0.4 21.8 1.5 48.3 22.4 0.4 4.0 0.9 0.5 0.3 0.5 1.2 0.4 3.8 1.0 3.9 2.0 0.4 1.1 0.4 0.6 0.8 0.3 0.3 12.4 1.7 16.2 38.0 0.7 48.0 0.4 12.7 61.2 0.5 0.4 1.0 11.4 14.1 0.1 0.8 0.7 0.6 3.2 2.7 0.5 0.2 0.2 1.4 0.3 0.1 10.5 1.5 1.7 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.3 0.5 0.3 1.6 0.8 0.0 0.7 0.3 1.1 0.7 0.0 4.8 0.6 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 8.9 3.6 10.5 7.5 35.9 0.2 8.6 0.0 1.2 0.0 0.0 0.2 0.1 0.0 2.5 0.0 0.1 13.5 0.7 0.1 0.0 0.1 0.6 0.0 0.3 1.3 0.0 0.3 19.4 12.9 0.9 0.3 1.0 0.5 15.2 0.0 2.7 0.5 0.1 1.4 0.1 0.0 0.0 0.3 2.3 0.2 2.8 0.2 0.1 0.1 10.5 0.8 0.2 0.1 0.2 0.2 9.8 1.5 0.6 0.8 0.3 2.1 1.2 0.4 0.4 1.1 12.4 0.1 0.0 1.4 1.5 0.2 4.5 0.0 0.0 0.0 0.0 3.4 5.2 0.0 0.1 44.7 0.7 109.7 0.1 113.2 23.3 2.2 0.1 1.0 0.5 5.7 0.0 8.9 0.0 5.2 0.0 0.3 127.1 1.7 1.3 1.7 47.7 36.6 0.0 5.0 73.7 0.7 0.0 0.0 0.0 1.0 1.5 0.8 5.0 0.1 5.7 46.8 0.4 AEN "FLJ12484, FLJ12562, ISG20L1" ENSG00000181026 "Apoptosis enhancing nuclease" Q8WTP8 15 88621296-88632282 "Predicted intracellular proteins" "Apoptosis, DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048599 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Nucleoplasm, Nucleoli" "Nuclear membrane" "HPA048599: AB_2756313" "unprognostic (8.64e-2)" "unprognostic (1.94e-1)" "unprognostic (2.16e-2)" "prognostic favorable (1.72e-4)" "unprognostic (1.52e-2)" "unprognostic (4.40e-2)" "unprognostic (4.08e-2)" "unprognostic (9.42e-2)" "unprognostic (4.28e-2)" "unprognostic (1.17e-2)" "unprognostic (9.00e-2)" "unprognostic (7.88e-2)" "unprognostic (8.58e-3)" "unprognostic (3.39e-2)" "unprognostic (2.73e-1)" "unprognostic (8.71e-2)" "unprognostic (6.10e-2)" 9.4 10.4 6.5 10.2 7.2 14.8 11.2 2.8 5.0 8.0 7.8 4.9 13.4 5.0 9.3 10.2 8.9 7.0 23.0 8.2 4.7 8.5 7.9 17.4 9.1 15.4 13.1 3.1 11.2 18.8 6.7 21.3 11.0 7.8 11.6 9.1 4.3 14.5 9.1 18.8 5.9 8.0 10.6 9.3 14.2 11.1 14.3 4.6 14.0 16.6 10.9 13.7 12.5 5.4 9.3 4.1 0.6 3.6 3.0 15.0 7.6 4.9 22.1 13.8 11.8 6.1 7.4 29.3 17.7 16.2 13.6 16.8 18.1 9.7 21.3 5.7 9.6 12.3 7.1 50.8 14.3 11.5 5.2 20.0 11.4 8.9 29.9 15.1 9.4 11.5 9.1 12.7 17.0 14.0 4.9 11.4 7.1 17.9 12.1 16.6 11.5 11.6 7.9 33.3 10.3 12.8 15.3 9.8 15.7 5.7 10.7 10.9 10.0 7.1 8.2 13.6 33.0 6.8 10.9 10.3 13.9 19.4 5.6 23.8 23.5 15.7 18.2 12.8 10.6 27.2 0.0 1.8 0.6 5.3 3.1 10.0 9.3 9.1 6.9 4.1 9.3 10.0 8.8 0.4 3.0 3.6 2.4 15.0 7.6 6.5 7.2 2.8 5.0 4.7 8.5 13.1 3.1 7.8 4.6 6.0 7.2 11.2 18.2 16.6 0.4 3.4 10.2 2.7 12.5 1.8 0.0 3.4 3.3 12.4 19.8 4.4 2.9 0.0 6.4 13.5 6.7 23.7 2.3 5.0 4.1 1.6 8.6 1.8 5.9 39.3 4.0 5.1 13.5 20.8 5.8 2.3 9.5 5.8 2.5 5.0 0.8 12.9 17.0 6.3 15.0 24.7 5.1 7.2 6.0 24.5 AFAP1L2 "Em:AC005383.4, FLJ14564, KIAA1914, XB130" ENSG00000169129 "Actin filament associated protein 1 like 2" Q8N4X5 10 114294824-114404756 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 47.9" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 38.4;Sertoli cells: 19.4;Smooth muscle cells: 17.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 39.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 4.0;T-cells: 4.0" "Cell line enhanced" "Detected in some" "A-431: 26.4;CAPAN-2: 28.5;EFO-21: 21.2;HaCaT: 36.3;RPMI-8226: 18.6;RPTEC TERT1: 22.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "cerebellum: 169.5;olfactory region: 48.1" HPA037843 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA037843: AB_10669990" "unprognostic (2.31e-3)" "unprognostic (1.30e-1)" "unprognostic (2.02e-1)" "unprognostic (5.06e-3)" "unprognostic (4.14e-2)" "unprognostic (9.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (3.76e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.55e-5)" "unprognostic (1.11e-1)" "unprognostic (3.88e-2)" "unprognostic (1.72e-1)" "unprognostic (1.86e-1)" 4.5 1.7 9.0 5.9 6.3 0.3 7.1 24.7 8.8 12.9 7.1 5.3 30.5 2.4 22.3 9.7 5.9 13.8 3.6 2.9 7.8 7.1 9.1 1.2 3.2 2.4 8.0 6.7 9.3 8.2 35.1 1.8 10.6 5.5 7.9 3.2 8.1 4.2 28.4 1.8 5.7 4.0 11.1 5.7 39.9 4.1 1.5 6.5 3.4 47.9 7.5 4.3 3.7 14.0 4.0 0.3 0.4 0.0 0.8 4.0 1.4 26.4 3.9 3.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 28.5 0.0 21.2 0.2 0.4 36.3 0.1 9.9 0.0 0.5 0.0 0.0 0.2 0.0 1.1 0.0 1.0 0.0 10.8 3.0 2.7 0.1 0.1 1.0 0.0 0.0 0.0 1.1 0.6 0.0 0.2 0.7 0.2 0.3 0.3 18.6 22.4 0.2 0.1 0.1 0.8 0.6 1.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 2.6 3.8 2.7 2.8 0.0 4.0 0.9 2.2 0.4 0.8 0.0 0.3 4.0 1.4 9.0 6.3 24.7 8.5 7.8 7.1 8.0 6.7 5.5 6.5 0.0 0.0 0.5 8.2 11.0 0.8 1.2 0.0 0.0 2.3 38.4 0.0 0.6 0.0 0.6 1.0 9.5 2.5 0.0 12.8 0.9 5.8 3.2 0.0 0.0 0.4 1.6 0.0 4.9 0.0 2.1 2.8 0.0 5.0 1.0 1.3 2.8 14.6 1.7 1.8 0.3 0.5 19.4 17.6 0.0 0.8 5.9 0.2 3.2 1.7 3.0 AGMO "FLJ16237, TMEM195" ENSG00000187546 "Alkylglycerol monooxygenase" Q6ZNB7 7 15200318-15562015 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 41.9;liver: 57.9" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 79.7" "Cancer enriched" "Detected in many" 5 "liver cancer: 15.7" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "basophil: 3.6;neutrophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.6" "Cell line enhanced" "Detected in some" "HSkMC: 4.1;Karpas-707: 8.7;NTERA-2: 3.9;SCLC-21H: 3.7;TIME: 4.4;WM-115: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA057900 Uncertain Vesicles NA NA Vesicles "HPA057900: " "unprognostic (2.82e-1)" "unprognostic (9.28e-2)" "unprognostic (5.60e-3)" "unprognostic (1.44e-4)" "unprognostic (7.52e-2)" "unprognostic (1.07e-2)" "unprognostic (3.61e-2)" "unprognostic (6.56e-2)" "unprognostic (3.31e-1)" "unprognostic (3.35e-1)" "unprognostic (4.18e-3)" "unprognostic (3.24e-1)" "unprognostic (1.64e-1)" "unprognostic (2.04e-2)" "unprognostic (3.45e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" 6.8 0.2 0.8 1.0 1.2 0.1 3.7 0.3 0.5 0.3 16.5 1.1 0.1 4.6 0.3 7.3 0.3 0.3 4.7 0.9 0.7 0.6 5.3 57.9 0.4 0.5 1.1 0.8 0.3 0.3 0.0 0.7 0.4 0.7 0.4 0.3 0.0 0.4 0.1 0.5 0.5 41.9 0.1 1.1 0.3 0.3 1.8 2.0 0.0 0.7 0.1 0.1 1.0 0.4 0.2 0.1 3.6 0.1 0.6 0.1 0.0 0.0 2.5 0.1 2.2 0.2 3.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 1.3 0.0 0.7 3.7 0.0 0.0 0.0 0.0 2.9 0.0 0.0 4.4 1.5 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 17.2 3.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 3.1 0.6 0.0 0.1 0.0 0.0 0.8 1.2 0.3 0.4 0.7 0.6 1.1 0.8 0.7 2.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 15.3 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.7 0.1 2.6 0.0 0.0 0.1 0.7 0.0 0.0 79.7 0.1 0.0 1.7 1.3 1.3 0.9 0.0 0.1 3.3 0.0 0.1 0.0 0.6 0.0 0.0 15.2 0.0 6.5 0.2 0.4 2.5 0.0 0.1 0.0 0.6 0.0 AGTR1 "AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R" ENSG00000144891 "Angiotensin II receptor type 1" P30556 3 148697784-148743008 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 29.6;placenta: 44.9" "Group enriched" "Detected in many" 5 "Leydig cells: 134.3;Sertoli cells: 142.3" "Group enriched" "Detected in many" 8 "breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 64.4;ASC TERT1: 9.0;BJ hTERT+ SV40 Large T+: 12.3;HBF TERT88: 19.4;HSkMC: 11.7" "Low region specificity" "Detected in many" HPA003596 Enhanced Uncertain Vesicles NA NA Vesicles "HPA003596: AB_1845163" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.48e-4)" "unprognostic (5.28e-3)" "unprognostic (1.55e-1)" "unprognostic (3.46e-1)" "unprognostic (1.28e-2)" "unprognostic (3.26e-2)" "unprognostic (3.08e-2)" "unprognostic (9.25e-3)" "unprognostic (4.11e-2)" "unprognostic (4.79e-2)" "unprognostic (3.21e-3)" "unprognostic (1.46e-1)" "unprognostic (2.54e-1)" "unprognostic (5.41e-3)" 18.8 11.6 0.0 0.1 0.0 0.0 10.8 0.0 0.0 0.8 5.5 0.0 0.6 0.5 0.5 2.2 1.6 3.1 0.0 0.1 5.7 29.6 2.6 0.0 0.9 0.8 0.6 0.6 0.8 44.9 1.3 1.0 1.0 1.0 2.9 4.4 0.7 1.1 0.0 2.3 1.7 0.2 4.1 0.0 4.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 64.4 9.0 0.0 0.0 1.3 12.3 7.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 1.1 0.6 0.3 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 3.1 0.0 5.7 5.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.2 0.0 0.0 6.6 0.2 13.7 1.2 0.0 26.8 0.6 0.0 22.7 29.4 0.8 0.2 134.3 0.0 1.7 0.0 0.0 4.5 0.8 0.0 7.1 0.0 0.0 142.3 15.5 0.0 0.4 1.5 0.2 0.0 0.0 0.0 AHI1 "FLJ20069, JBTS3, ORF1" ENSG00000135541 "Abelson helper integration site 1" Q8N157 6 135283532-135497776 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation" "Developmental protein" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 54.2" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 1056.4;Rod photoreceptor cells: 1624.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031698, HPA046684" Approved Uncertain Centrosome NA NA Centrosome "HPA031698: AB_2673997, HPA046684: AB_2679752" "unprognostic (4.00e-2)" "unprognostic (2.86e-1)" "unprognostic (8.13e-2)" "unprognostic (1.02e-1)" "unprognostic (3.17e-2)" "unprognostic (2.18e-2)" "unprognostic (2.70e-3)" "unprognostic (2.11e-1)" "unprognostic (2.11e-1)" "unprognostic (4.58e-2)" "prognostic favorable (7.51e-5)" "unprognostic (2.81e-2)" "prognostic unfavorable (4.07e-9)" "unprognostic (2.49e-2)" "unprognostic (1.88e-1)" "unprognostic (3.36e-2)" "unprognostic (6.19e-3)" 6.7 16.2 16.8 6.4 16.5 5.9 12.5 35.3 26.5 11.7 8.7 4.2 13.2 4.9 14.4 32.1 7.8 9.0 9.0 7.6 15.9 19.9 8.4 6.8 8.1 6.0 11.4 19.6 13.9 11.6 11.5 54.2 8.3 18.2 16.3 13.1 10.0 8.2 15.9 6.7 6.1 5.7 11.1 18.5 4.3 10.7 29.2 13.1 3.3 11.6 5.0 6.3 8.9 12.0 10.6 16.6 4.8 1.7 3.8 4.2 0.5 5.2 7.2 8.5 10.9 13.9 15.1 3.8 9.7 12.2 9.8 15.1 2.8 5.6 8.2 4.8 9.3 9.8 4.0 6.3 3.0 14.6 6.5 8.5 3.0 20.3 5.3 5.9 15.2 3.3 7.0 5.0 15.2 8.3 15.2 8.0 10.2 13.5 0.5 13.2 5.6 14.4 3.4 5.1 4.0 4.4 7.3 3.4 2.7 4.9 5.3 14.8 7.9 12.9 4.8 5.8 6.6 3.8 6.9 7.6 8.5 10.5 14.5 7.6 10.7 9.8 3.8 12.0 2.2 10.1 4.8 1.7 0.6 4.2 0.5 2.6 8.2 4.0 4.2 2.6 10.6 3.2 4.1 0.1 3.8 0.5 16.6 2.4 0.5 16.8 16.5 35.3 26.5 15.9 19.9 11.4 19.6 18.2 13.1 35.7 87.4 13.4 33.8 25.4 293.7 22.6 7.6 89.7 51.2 55.8 1056.4 21.3 11.6 24.5 265.7 46.0 7.7 0.0 38.6 16.0 36.7 32.6 56.6 15.8 12.0 311.4 97.8 16.5 4.7 272.8 62.7 18.8 30.4 11.8 34.2 96.6 20.6 37.4 61.2 9.7 1624.0 51.8 41.2 126.9 110.1 19.7 23.9 12.8 31.5 21.8 AIF1 "AIF-1, Em:AF129756.17, IBA1, IRT-1" ENSG00000204472 "Allograft inflammatory factor 1" P55008 6 31615184-31617021 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 119.2;lymphoid tissue: 99.3" "Group enriched" "Detected in many" 19 "Hofbauer cells: 1482.8;Kupffer cells: 1886.5;Macrophages: 1383.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 23 "classical monocyte: 67.4;intermediate monocyte: 104.8;myeloid DC: 35.9;neutrophil: 51.7;non-classical monocyte: 119.2" "Group enriched" "Detected in many" 33 "dendritic cells: 35.9;granulocytes: 51.7;monocytes: 119.2" "Cell line enhanced" "Detected in some" "HEL: 25.8;HMC-1: 37.2;JURKAT: 15.1;NB-4: 59.1;THP-1: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049234, HPA062949" Enhanced Uncertain Cytosol NA NA Cytosol "HPA049234: AB_2680685, HPA062949: AB_2732694" "unprognostic (3.20e-2)" "unprognostic (7.21e-3)" "unprognostic (6.11e-2)" "unprognostic (2.33e-2)" "unprognostic (2.46e-1)" "unprognostic (1.13e-1)" "unprognostic (6.98e-2)" "unprognostic (4.83e-2)" "unprognostic (2.72e-2)" "unprognostic (7.56e-2)" "unprognostic (1.41e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.29e-1)" "unprognostic (1.02e-2)" "unprognostic (9.59e-2)" "unprognostic (4.89e-2)" 13.5 9.5 13.0 27.7 23.8 39.8 7.8 1.8 10.0 5.2 8.0 17.0 0.1 6.1 3.2 8.3 3.6 5.6 9.8 5.8 10.2 10.2 15.4 12.6 19.9 40.5 16.9 3.1 4.9 3.4 2.0 4.9 17.0 12.8 6.1 9.7 4.6 5.7 4.3 3.5 2.9 10.8 11.1 28.5 99.3 4.8 2.6 16.2 71.7 3.6 1.7 9.8 11.2 3.5 0.7 35.9 51.7 119.2 0.3 2.1 59.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 0.0 0.0 1.7 37.2 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.1 0.0 0.0 0.0 0.2 59.1 0.1 0.0 0.0 9.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.3 0.0 0.5 67.4 3.2 0.2 104.8 0.2 0.7 0.3 0.3 35.9 0.1 2.1 1.7 51.7 0.3 119.2 3.3 0.1 59.6 13.0 23.8 1.8 10.0 10.2 10.2 16.9 3.1 12.8 16.2 23.8 84.5 70.4 0.6 28.8 0.0 5.5 25.5 18.7 35.2 40.1 0.0 9.9 0.0 0.0 1.1 13.5 0.4 0.0 0.4 10.9 24.2 0.3 64.9 8.9 1482.8 0.0 1.2 43.0 1886.5 1.5 6.9 1383.0 37.1 40.5 0.0 0.0 0.1 5.8 0.7 3.1 0.0 51.8 17.6 0.3 1.5 24.7 19.0 27.4 0.4 0.0 AIPL1 LCA4 ENSG00000129221 "Aryl hydrocarbon receptor interacting protein like 1" Q9NZN9 17 6393693-6435199 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "retina: 123.7" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 388.8;Rod photoreceptor cells: 1307.2" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 4.1;OE19: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA026578 Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026578: AB_2671905" "unprognostic (2.42e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-2)" "unprognostic (1.68e-3)" "unprognostic (3.24e-1)" "unprognostic (1.13e-3)" "unprognostic (3.76e-1)" "unprognostic (5.35e-2)" 0.1 0.1 1.4 0.4 0.3 2.9 0.1 0.5 0.8 0.2 0.1 0.1 0.1 0.0 0.1 0.3 1.1 0.0 0.3 0.1 0.6 0.5 0.1 0.1 0.2 0.1 0.5 0.1 0.2 0.1 0.0 0.8 0.1 0.1 0.1 0.0 123.7 2.3 0.1 0.1 2.4 0.1 0.1 0.1 1.0 0.2 3.3 0.1 0.2 0.4 0.1 0.2 0.1 0.1 1.0 1.1 2.2 0.7 1.1 0.6 0.0 0.1 1.5 0.5 0.1 0.1 0.0 0.4 0.0 0.3 0.1 0.5 0.1 0.1 0.3 0.1 0.0 0.1 4.1 0.1 0.2 0.2 0.2 0.3 0.4 1.7 0.4 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.4 0.2 0.1 0.8 7.6 1.3 0.1 0.0 0.0 0.1 1.0 0.2 0.2 0.9 0.3 0.0 0.3 0.2 0.0 0.0 0.3 0.2 0.4 0.3 0.3 0.1 0.1 0.6 0.5 0.2 0.9 0.7 0.6 0.6 0.3 0.3 0.6 0.3 0.1 0.3 1.0 0.3 0.4 2.2 1.1 0.5 1.1 0.4 0.0 1.4 0.3 0.5 0.5 0.6 0.5 0.5 0.1 0.1 0.1 3.0 0.6 0.0 1.0 0.7 109.4 0.6 0.0 0.0 2.3 0.0 388.8 0.1 0.0 0.0 7.5 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 62.0 0.0 2.5 0.0 1.0 0.0 0.3 1.7 0.0 0.0 135.1 0.1 0.0 0.4 0.0 1307.2 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.0 2.0 AKAP11 "AKAP220, DKFZp781I12161, FLJ11304, KIAA0629, PPP1R44, PRKA11" ENSG00000023516 "A-kinase anchoring protein 11" Q9UKA4 13 42272153-42323267 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039089 Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Nucleoli, Plasma membrane, Cytosol" "HPA039089: AB_10674279" "unprognostic (6.43e-2)" "prognostic unfavorable (9.26e-4)" "unprognostic (4.91e-1)" "unprognostic (6.89e-2)" "unprognostic (1.92e-1)" "unprognostic (7.34e-2)" "unprognostic (1.16e-1)" "unprognostic (1.83e-1)" "unprognostic (7.91e-2)" "unprognostic (2.15e-3)" "unprognostic (3.02e-2)" "unprognostic (1.35e-1)" "unprognostic (7.49e-3)" "unprognostic (7.44e-2)" "unprognostic (1.49e-1)" "unprognostic (6.02e-2)" "unprognostic (1.10e-1)" 11.2 13.6 21.7 10.0 42.3 3.0 11.0 19.9 30.7 17.1 9.1 9.0 5.9 6.9 13.0 15.2 10.2 10.2 9.7 10.4 18.3 17.9 12.9 9.9 10.2 13.4 16.4 22.8 14.6 6.4 11.6 14.5 7.2 20.3 11.1 10.1 6.7 7.6 12.4 5.7 9.1 8.1 13.4 21.4 11.7 9.5 18.1 16.0 5.6 13.3 4.6 12.6 10.4 9.4 3.0 1.6 4.2 1.4 4.8 2.7 0.7 9.4 9.7 11.9 7.0 15.6 19.2 5.2 12.8 10.7 7.8 7.3 10.6 7.9 19.5 5.0 14.3 8.2 11.3 10.3 10.7 14.9 20.7 4.8 5.5 6.7 5.2 12.3 13.6 13.5 14.0 11.1 15.8 13.9 11.4 11.3 9.8 18.0 7.9 15.6 7.1 7.9 4.4 7.0 13.9 4.5 6.6 8.4 9.4 7.7 7.0 5.1 7.4 9.8 6.5 4.5 5.7 5.6 7.4 15.7 13.2 6.9 19.8 9.6 3.0 3.8 10.1 16.8 7.0 9.2 4.2 0.9 1.2 1.7 1.1 2.1 2.7 2.4 1.6 1.0 3.0 2.1 2.1 0.3 4.8 1.4 1.6 2.7 0.7 21.7 42.3 19.9 24.6 18.3 17.9 16.4 22.8 20.3 16.0 23.8 23.3 15.9 13.0 10.9 54.0 42.5 15.3 30.8 40.9 27.9 35.3 3.6 1.7 10.1 7.6 19.9 8.4 23.3 8.1 3.1 16.4 11.4 33.5 19.7 10.7 39.7 20.2 27.6 23.5 9.4 20.1 21.2 8.5 11.8 14.2 66.5 10.8 15.8 31.5 17.7 36.7 19.4 17.9 31.7 33.9 14.8 2.1 15.9 11.2 11.3 AL049629.2 ENSG00000284969 "CD59 glycoprotein " 11 33698261-33722467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "placenta: 65.2" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 5.3;Ductal cells: 8.2;Exocrine glandular cells: 12.5;Pancreatic endocrine cells: 27.1" "Group enriched" "Detected in some" 6 "memory CD8 T-cell: 1.6;T-reg: 2.5" "Lineage enriched" "Detected in single" 8 "T-cells: 2.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 19.4;HUVEC TERT2: 24.9;TIME: 30.6;U-2197: 26.0" HPA026494 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA026494: AB_1846321" 3.2 0.4 0.3 2.8 0.5 1.2 2.2 0.4 2.6 0.7 0.5 0.1 0.9 1.5 1.3 2.3 1.5 0.3 2.6 2.4 1.6 2.0 0.6 1.9 2.0 0.9 1.0 0.4 1.3 0.1 0.2 65.2 0.9 0.4 0.4 0.5 3.1 1.3 3.9 0.0 0.1 1.4 0.7 0.4 3.6 1.0 0.5 0.2 1.0 1.4 1.4 0.8 2.9 0.0 0.3 0.0 0.0 0.0 2.5 0.2 0.5 1.5 0.1 1.0 1.6 3.8 0.0 8.4 3.8 1.1 1.0 0.0 4.3 0.0 0.9 5.7 0.5 1.0 0.1 19.4 1.8 0.8 0.1 0.1 3.3 0.4 0.4 0.2 0.5 1.4 1.3 0.5 6.9 0.9 24.9 0.1 0.2 3.3 7.1 0.4 0.7 0.3 0.2 0.6 11.4 0.2 0.7 0.5 2.2 0.9 0.0 0.1 0.9 1.5 2.8 0.1 0.4 0.0 30.6 3.2 1.2 26.0 3.2 1.7 1.5 0.1 7.4 0.0 7.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 5.3 3.4 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL121900.2 ENSG00000284776 20 18567453-18744216 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9;Ciliated cells: 5.3" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBF TERT88: 22.9" HPA040981 Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA040981: AB_10673268" 4.0 5.7 4.0 4.4 5.8 5.8 6.0 4.5 14.1 3.6 6.2 2.0 6.0 5.2 7.4 5.9 4.5 5.4 5.4 7.8 4.4 15.4 6.3 4.7 6.9 4.5 5.4 7.7 16.1 8.3 5.3 4.4 7.6 4.6 6.4 3.1 8.8 8.2 12.2 1.1 5.5 5.9 4.3 5.8 0.9 6.8 5.4 3.6 5.1 9.9 6.8 5.7 6.4 4.9 6.9 2.9 4.8 3.9 5.9 1.7 3.7 1.8 7.9 3.9 2.6 9.1 0.5 2.4 6.5 6.2 0.7 0.9 5.6 0.5 1.9 7.8 3.5 3.5 4.9 15.1 22.9 0.9 0.3 5.1 2.0 2.0 3.1 10.0 6.0 0.0 14.4 4.5 7.4 3.6 8.0 1.5 0.9 7.9 5.3 2.8 1.7 0.8 2.1 3.2 0.0 0.3 4.1 5.5 4.9 4.7 7.8 2.0 0.2 6.4 3.1 6.6 5.0 6.5 0.0 8.5 0.4 7.1 5.3 1.7 8.5 1.5 5.1 1.6 5.6 2.9 3.2 2.7 4.8 4.8 5.9 4.9 5.4 3.6 6.9 2.9 1.7 3.4 1.9 3.9 2.8 1.2 4.5 1.7 8.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL139300.1 ENSG00000256500 14 103562962-103685924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 37.2" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 1.4;granulocytes: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044617, HPA052450" Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044617: AB_2679024, HPA052450: AB_2681838" "unprognostic (1.56e-1)" 10.2 7.5 16.6 7.8 20.3 2.8 15.5 21.9 25.1 5.9 4.8 3.2 5.1 2.0 5.5 4.6 5.8 3.9 4.2 20.0 17.2 17.2 5.3 5.6 4.2 7.7 17.3 6.2 5.0 15.8 9.9 5.8 4.2 5.2 5.0 2.9 2.7 7.7 6.3 37.2 2.0 4.2 8.5 22.6 2.9 2.8 18.5 4.0 2.2 7.8 9.2 5.4 6.6 6.9 4.2 4.9 4.2 5.1 2.3 4.4 1.3 6.3 12.0 13.2 1.2 7.3 9.0 5.8 18.5 14.3 20.9 13.2 7.3 9.7 16.2 12.1 13.4 14.1 6.3 8.8 10.6 13.3 5.4 1.0 6.2 6.3 6.8 9.7 8.5 3.7 7.0 2.9 10.0 11.4 11.8 11.9 10.7 8.3 4.2 15.0 12.1 13.3 3.1 9.1 14.3 15.1 5.9 10.4 8.7 10.7 7.4 17.3 10.6 11.0 4.6 10.3 5.5 10.2 4.9 8.4 9.2 7.3 14.7 8.7 5.4 6.3 18.5 15.5 3.5 8.3 0.7 3.2 4.2 2.8 4.3 2.9 1.9 3.4 4.1 1.9 4.2 4.4 1.9 2.8 2.3 5.1 4.9 4.2 1.3 16.6 20.3 21.9 25.1 17.2 17.2 17.3 6.2 5.2 4.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL162417.1 ENSG00000285245 9 133098121-133163914 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 6.8;HUVEC TERT2: 2.1;K-562: 1.5;REH: 2.4;TIME: 2.3;U-937: 1.5" HPA025961 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA025961: AB_2671795" 2.4 1.8 2.0 5.1 1.5 3.4 6.0 2.6 2.4 1.6 1.5 1.8 1.0 3.2 2.0 1.5 1.9 0.9 2.0 2.0 2.1 1.2 0.9 2.9 8.2 1.2 0.9 6.5 4.6 0.8 0.9 7.9 2.9 2.7 1.1 6.5 2.2 2.6 1.3 1.3 1.0 3.7 2.2 3.0 1.4 0.9 1.5 0.0 2.6 0.4 4.1 2.0 3.0 0.0 0.0 0.0 0.2 0.0 0.1 1.6 0.0 0.6 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 2.1 0.1 1.5 0.5 0.0 0.0 0.6 0.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL355315.1 ENSG00000249967 10 97584374-97673910 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 22.2;liver: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Lineage enhanced" "Detected in single" "NK-cells: 1.0" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;EFO-21: 3.4;GAMG: 2.8;HBEC3-KT: 2.6;hTERT-RPE1: 5.1" HPA076857 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA076857: AB_2686817" 2.4 1.1 1.9 0.3 2.3 0.3 1.0 4.6 3.3 1.9 0.9 5.5 0.6 0.3 1.1 2.5 0.8 2.7 2.3 4.9 2.6 1.0 22.2 15.1 0.8 0.3 6.4 3.3 0.8 2.4 5.7 0.9 0.6 4.8 0.8 0.3 2.1 0.8 3.9 2.2 0.9 0.8 0.8 5.5 0.9 0.9 0.9 4.6 0.0 0.8 2.5 0.4 1.0 0.9 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.5 3.2 0.0 1.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 3.4 0.5 2.8 1.7 0.0 2.6 1.8 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.0 0.6 0.0 1.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.9 2.3 4.6 2.3 2.6 1.0 6.4 3.3 4.8 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL669918.1 ENSG00000250264 6 32813767-32838822 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 17.2;HDLM-2: 11.4;HEL: 12.4" HPA001312 Approved Approved "Nuclear speckles,Endoplasmic reticulum" NA NA "Nuclear speckles, Endoplasmic reticulum" "HPA001312: AB_1080206" "unprognostic (6.13e-2)" "unprognostic (8.76e-3)" "unprognostic (4.62e-1)" "unprognostic (9.88e-2)" "unprognostic (1.99e-1)" "unprognostic (3.39e-2)" "unprognostic (1.72e-1)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.49e-1)" "unprognostic (8.73e-2)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (1.33e-1)" 6.5 3.6 2.8 25.5 3.1 3.8 3.6 3.1 3.3 4.8 7.7 3.5 1.0 5.7 4.6 2.5 4.8 3.6 5.7 3.5 2.1 2.6 5.3 10.0 8.5 12.6 3.2 2.8 4.7 2.1 1.7 5.0 2.4 3.6 3.8 3.1 3.6 7.0 1.4 2.5 3.3 15.1 2.7 2.8 18.1 12.3 2.5 3.1 14.0 7.5 3.2 10.6 3.8 3.9 8.6 5.5 8.1 4.8 2.3 4.6 5.1 2.1 3.2 0.0 0.7 1.6 1.7 0.5 0.6 0.3 0.0 0.6 0.0 3.3 17.2 2.0 0.2 0.2 7.8 1.6 1.7 0.6 11.4 0.2 12.4 2.1 0.3 0.5 0.0 0.5 0.0 0.9 0.5 0.2 0.0 0.0 1.9 3.1 2.9 0.2 0.6 1.4 0.9 0.2 0.0 2.9 6.0 0.6 5.5 0.0 0.0 0.3 0.3 0.5 5.3 1.4 0.0 5.1 1.3 0.0 1.3 1.9 0.4 0.7 1.4 2.8 7.6 0.7 3.6 0.4 1.6 3.1 6.1 3.5 3.2 3.4 8.0 2.8 3.9 5.5 8.6 2.1 4.6 8.1 2.3 4.8 5.2 4.2 5.1 2.8 3.1 3.1 3.3 2.1 2.6 3.2 2.8 3.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALDH1B1 "ALDH5, ALDHX" ENSG00000137124 "Aldehyde dehydrogenase 1 family member B1" P30837 9 38392664-38398661 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 113.9" "Group enriched" "Detected in many" 5 "Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 55.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021037, HPA077080" Enhanced Supported Nucleoplasm,Vesicles,Mitochondria,Cytosol NA NA 210000 Mitochondria "Nucleoplasm, Vesicles, Cytosol" "HPA021037: AB_1844724, HPA077080: " "unprognostic (4.16e-1)" "unprognostic (1.98e-2)" "unprognostic (5.84e-2)" "unprognostic (1.55e-3)" "unprognostic (2.47e-2)" "unprognostic (4.48e-3)" "unprognostic (2.84e-3)" "unprognostic (2.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (2.09e-1)" "unprognostic (1.00e-1)" "prognostic favorable (2.05e-4)" "unprognostic (1.04e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.89e-2)" 7.4 4.9 2.1 16.8 2.1 0.6 5.4 1.1 5.4 5.8 25.4 1.7 6.1 7.0 27.3 10.7 21.6 16.7 30.8 11.6 3.1 2.0 18.0 55.2 3.5 5.9 2.4 2.0 12.2 14.6 1.4 1.4 1.6 3.0 22.7 11.5 5.2 5.9 18.2 19.4 3.0 11.2 113.9 2.7 2.8 15.8 7.8 1.7 1.6 6.3 7.0 2.0 54.5 8.3 5.9 9.4 1.2 10.5 7.5 10.2 5.1 21.5 20.1 6.2 9.9 8.8 10.5 5.0 10.3 5.2 8.7 9.0 13.4 4.2 13.6 6.2 14.5 13.2 3.0 20.4 21.9 8.7 15.2 8.8 6.7 14.8 39.8 6.4 10.7 7.6 12.5 4.8 7.1 6.2 17.9 8.3 3.3 19.4 13.4 13.2 8.2 0.0 4.3 18.4 55.5 9.0 4.4 37.6 10.4 7.8 9.7 13.6 6.3 7.9 5.2 6.0 6.8 4.9 8.4 5.6 10.1 16.7 8.4 12.9 2.0 3.9 5.4 5.2 11.0 6.8 0.2 4.2 0.2 7.3 9.1 10.2 5.9 7.0 6.6 9.4 3.1 5.8 6.8 1.2 7.5 10.5 1.3 4.8 5.1 2.1 2.1 1.1 5.4 3.1 2.0 2.4 2.0 3.0 1.7 8.9 1.7 3.6 3.8 0.9 1.3 5.6 117.2 0.0 3.4 15.7 2.0 1.3 14.9 60.1 0.5 3.8 7.0 0.0 5.9 40.0 6.2 2.9 9.2 113.4 6.5 0.0 15.0 9.8 3.8 1.3 6.1 4.0 0.0 7.2 16.9 1.3 14.2 3.5 6.3 118.8 0.3 0.0 9.5 0.3 0.6 0.9 1.5 2.9 68.9 2.6 ALG1L2 ENSG00000251287 "ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like 2" C9J202 3 130081831-130113227 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 4.0;lymphoid tissue: 3.5" "Cell type enhanced" "Detected in some" 5 "Basal glandular cells: 4.9;Cone photoreceptor cells: 3.9;Horizontal cells: 4.8;Muller glia cells: 4.8" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "plasmacytoid DC: 4.0" "Lineage enriched" "Detected in single" 4 "dendritic cells: 4.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.6;HDLM-2: 1.9;HEL: 1.8;Karpas-707: 1.4;REH: 2.9" HPA060392 Uncertain Uncertain "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA060392: AB_2684273" "unprognostic (1.05e-1)" "unprognostic (5.13e-2)" "unprognostic (5.44e-3)" "unprognostic (8.15e-2)" "unprognostic (2.98e-2)" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "unprognostic (4.38e-1)" "unprognostic (3.91e-1)" "prognostic favorable (7.75e-4)" "unprognostic (4.58e-2)" "unprognostic (4.17e-2)" "unprognostic (5.93e-4)" "unprognostic (1.24e-1)" "unprognostic (2.19e-1)" "unprognostic (2.35e-2)" "unprognostic (4.28e-3)" 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 3.5 0.3 0.0 0.0 0.0 0.1 0.7 4.0 0.0 0.3 0.0 0.9 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 1.4 0.0 0.0 0.0 0.5 0.1 0.9 0.0 2.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.4 0.6 0.3 0.3 0.4 0.1 0.0 0.0 0.0 4.0 0.9 0.1 0.0 1.6 0.8 4.9 0.0 1.9 0.2 0.0 1.4 1.2 1.8 3.9 0.2 1.7 0.0 0.4 0.0 0.9 0.0 0.0 0.2 0.6 1.8 0.0 0.2 0.2 4.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.6 4.8 0.0 0.0 2.5 0.3 3.0 0.0 0.1 0.5 0.1 0.0 0.0 0.5 0.6 1.4 ALKBH1 "ABH, alkB, ALKBH, hABH" ENSG00000100601 "AlkB homolog 1, histone H2A dioxygenase" Q13686 14 77672404-77708020 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, RNA repair, Translation regulation" "Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044087, HPA060061" Approved Supported "Nucleoplasm,Endoplasmic reticulum" "Intracellular and membrane" NA NA Nucleoplasm "Endoplasmic reticulum" "HPA044087: AB_2678803, HPA060061: " "unprognostic (1.92e-2)" "unprognostic (8.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.37e-3)" "unprognostic (3.41e-2)" "unprognostic (5.03e-2)" "unprognostic (3.74e-3)" "unprognostic (7.45e-3)" "unprognostic (2.68e-2)" "unprognostic (3.95e-2)" "unprognostic (5.05e-3)" "unprognostic (2.16e-2)" "prognostic favorable (1.80e-4)" "unprognostic (1.65e-3)" "unprognostic (1.46e-1)" "unprognostic (2.63e-1)" "unprognostic (2.44e-2)" 8.2 8.5 6.2 6.7 8.6 2.7 9.7 9.6 8.8 9.7 9.1 8.2 4.5 6.5 7.0 5.9 7.1 8.0 5.8 11.1 5.4 5.7 7.9 9.4 5.9 8.3 6.5 3.7 8.3 7.9 8.4 11.2 10.2 6.4 9.3 9.1 9.9 7.2 8.7 16.5 8.2 6.7 7.8 5.5 8.3 7.8 9.9 6.6 12.7 8.8 6.5 10.3 8.5 9.4 5.4 4.9 11.4 5.7 5.2 5.3 3.2 5.3 8.0 6.5 4.4 7.0 7.7 8.2 5.6 7.3 12.4 14.0 8.1 3.3 8.3 3.2 5.1 5.8 4.9 14.2 6.1 14.7 5.6 5.6 4.4 4.7 6.8 9.9 4.6 2.9 6.5 10.1 7.3 11.6 5.5 10.1 6.5 6.8 4.8 6.6 8.5 6.2 6.0 7.2 8.1 10.3 6.2 6.6 5.5 7.1 4.8 8.4 6.3 4.6 4.8 6.1 5.6 11.8 4.8 4.6 5.2 5.3 5.7 4.5 6.0 9.5 8.1 3.5 6.7 5.1 11.4 5.0 2.2 5.0 5.7 4.3 5.4 4.7 5.0 4.9 4.9 5.0 3.9 1.4 5.2 3.8 2.6 5.3 3.2 6.2 8.6 9.6 8.8 5.4 5.7 6.5 3.7 6.4 6.6 0.0 4.6 3.7 4.9 7.4 4.0 6.5 0.0 5.3 3.4 1.8 2.0 8.9 8.3 5.3 3.3 4.1 4.2 0.0 6.1 6.7 6.0 3.8 9.2 3.0 6.5 0.0 2.4 3.1 4.6 3.1 6.1 5.6 5.0 5.4 4.6 7.3 5.7 0.0 4.9 5.1 4.9 6.5 5.2 15.8 14.9 4.6 10.2 4.4 4.2 3.0 ALKBH5 "FLJ20308, OFOXD1" ENSG00000091542 "AlkB homolog 5, RNA demethylase" Q6P6C2 17 18183078-18209954 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 130.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007196 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA007196: AB_1850461" "unprognostic (1.07e-1)" "unprognostic (1.51e-1)" "unprognostic (2.23e-2)" "unprognostic (1.48e-2)" "unprognostic (1.80e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (2.64e-1)" "unprognostic (1.34e-1)" "unprognostic (1.94e-2)" "prognostic favorable (3.75e-4)" "unprognostic (6.54e-2)" "unprognostic (3.99e-2)" "unprognostic (2.88e-2)" "unprognostic (3.22e-2)" "unprognostic (4.68e-3)" "prognostic unfavorable (5.69e-4)" 18.0 19.5 17.1 14.6 21.9 19.1 26.2 23.4 25.3 18.2 21.8 20.1 18.8 15.1 22.1 12.1 17.3 30.5 18.7 45.8 16.5 18.9 16.0 24.2 14.7 16.9 19.0 16.9 20.9 25.0 22.7 20.2 14.8 15.4 19.4 8.9 19.9 23.7 21.1 130.4 12.7 16.9 20.4 15.3 18.8 16.2 29.7 17.6 26.8 23.5 19.5 13.7 26.8 44.8 11.5 8.9 17.6 10.6 7.6 17.0 5.7 33.1 32.0 13.0 23.4 19.1 13.3 11.3 16.0 19.8 26.3 24.5 36.1 8.8 21.0 23.7 17.6 13.9 21.9 19.6 16.9 13.6 23.9 26.7 15.4 18.2 20.1 17.8 11.1 20.7 12.7 11.5 19.7 11.7 16.7 15.2 16.4 16.7 9.6 14.6 24.6 23.9 12.4 11.0 13.9 16.4 21.7 25.7 36.8 7.7 11.4 13.4 17.7 20.0 13.9 18.2 42.7 14.0 9.6 15.4 25.4 17.7 37.2 31.3 11.2 8.5 12.7 46.1 18.2 16.6 4.3 7.2 17.6 15.1 7.4 14.0 7.9 13.6 17.0 8.9 11.5 10.9 11.0 4.6 7.6 10.6 6.6 7.9 5.7 17.1 21.9 23.4 25.3 16.5 18.9 19.0 16.9 15.4 17.6 32.8 25.7 39.8 24.5 57.5 79.0 78.7 25.5 28.1 18.2 26.2 37.3 28.1 71.3 24.0 48.1 37.6 35.4 46.7 27.3 36.7 47.3 36.0 41.4 52.9 29.7 112.8 58.5 27.6 39.9 29.1 38.0 25.6 47.2 17.2 41.8 72.5 28.5 42.4 48.8 81.8 52.8 19.4 44.3 106.7 98.2 48.9 26.3 48.4 31.6 21.6 ALOX12 12S-LOX ENSG00000108839 "Arachidonate 12-lipoxygenase, 12S type" P18054 17 6996065-7010736 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Hydrolase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 1.8;Suprabasal keratinocytes: 1.0;Urothelial cells: 1.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "A-431: 17.5;HEL: 28.0" "Region enriched" "Detected in single" 5 "olfactory region: 5.4" "HPA010691, CAB019287, HPA064819" Enhanced Supported "Nuclear speckles,Vesicles,Cytosol" NA NA 5800000 Cytosol "Nuclear speckles, Vesicles" "CAB019287: , HPA010691: AB_1844756, HPA064819: " "unprognostic (3.61e-3)" "unprognostic (6.93e-2)" "unprognostic (7.17e-5)" "unprognostic (9.43e-2)" "unprognostic (6.06e-2)" "unprognostic (2.25e-3)" "unprognostic (2.45e-1)" "unprognostic (3.16e-1)" "unprognostic (3.02e-2)" "unprognostic (1.59e-2)" "unprognostic (3.96e-5)" "unprognostic (4.01e-3)" "unprognostic (2.25e-2)" "unprognostic (1.56e-1)" "unprognostic (2.87e-1)" "unprognostic (5.90e-2)" "unprognostic (3.47e-2)" 0.3 0.6 0.3 1.5 0.4 2.0 0.3 0.3 1.0 28.6 0.4 0.3 0.3 0.7 3.4 0.5 28.4 0.4 1.6 0.8 0.3 0.1 0.3 0.3 0.5 1.9 0.5 0.3 0.4 0.8 0.0 0.3 0.7 0.4 0.3 0.0 0.4 8.1 0.3 0.5 12.8 0.8 0.3 0.3 1.5 0.3 0.6 0.3 0.3 0.8 22.7 9.5 1.2 42.7 1.1 1.3 4.8 0.9 0.7 0.8 14.3 17.5 2.9 1.3 1.0 0.0 0.0 1.2 1.1 0.0 0.0 0.0 2.6 0.6 0.9 0.6 0.0 1.0 2.2 0.0 0.1 0.0 1.9 2.3 28.0 3.9 1.9 0.1 0.2 4.6 0.0 0.0 0.0 0.0 1.7 0.0 1.9 1.8 1.0 0.0 0.2 0.3 0.6 0.9 0.1 0.6 1.0 0.6 0.4 0.0 2.2 0.1 0.6 0.5 0.6 0.2 1.8 1.0 0.7 3.2 1.5 0.9 1.5 0.7 0.5 0.2 0.5 0.9 2.1 0.7 1.8 0.9 1.7 0.7 0.5 0.5 1.1 0.5 0.8 0.7 0.7 0.2 0.4 4.8 0.7 0.4 1.3 0.3 14.3 0.3 0.4 0.3 0.6 0.3 0.1 0.5 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 1.7 ALX1 CART1 ENSG00000180318 "ALX homeobox 1" Q15699 12 85280107-85301784 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 13.9" "Cell type enriched" "Detected in some" 6 "Melanocytes: 30.4" "Cancer enriched" "Detected in some" 10 "melanoma: 16.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 6.9;HEK 293: 15.4;HUVEC TERT2: 11.3;SK-MEL-30: 18.7;THP-1: 12.2;WM-115: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001598, HPA018905" Uncertain Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Nuclear bodies" "Nucleoplasm, Golgi apparatus" "HPA001598: AB_1078400, HPA018905: AB_1844783" "unprognostic (4.92e-3)" "unprognostic (8.09e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-1)" "unprognostic (6.24e-2)" "unprognostic (2.05e-2)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (3.57e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-5)" "unprognostic (8.97e-2)" "unprognostic (1.43e-1)" 1.9 0.0 0.1 0.0 0.2 0.0 4.8 0.0 0.2 5.4 0.1 0.0 0.8 0.0 5.4 8.5 0.1 4.7 0.0 0.1 0.2 0.2 8.3 0.0 0.1 0.0 0.2 0.0 3.6 0.1 0.0 1.6 0.1 0.0 1.6 0.0 13.9 3.8 2.0 0.4 3.3 0.1 1.1 0.0 0.0 0.1 1.5 0.0 0.0 0.2 4.0 0.0 2.4 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.5 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.5 0.0 6.9 0.3 0.0 0.0 15.4 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 6.3 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 1.8 4.0 0.0 0.0 18.7 2.9 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.3 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 AMBP "EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI" ENSG00000106927 "Alpha-1-microglobulin/bikunin precursor" P02760 9 114060127-114078472 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "liver: 592.2" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 9824.4" "Cancer enriched" "Detected in many" 115 "liver cancer: 2620.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 154 "Hep G2: 168.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001497, CAB069436, HPA075585" Approved Approved "Golgi apparatus,Vesicles,Cytosol" "Secreted to blood" NA NA 71000000000 Vesicles "Golgi apparatus, Cytosol" "CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: " "unprognostic (6.92e-2)" "unprognostic (3.61e-1)" "unprognostic (4.95e-3)" "prognostic favorable (1.20e-4)" "unprognostic (9.79e-2)" "unprognostic (2.90e-1)" "unprognostic (1.04e-3)" "unprognostic (7.59e-2)" "unprognostic (2.83e-2)" "unprognostic (2.04e-1)" "unprognostic (2.14e-1)" "unprognostic (7.84e-2)" "unprognostic (4.36e-2)" "unprognostic (2.89e-3)" "unprognostic (4.66e-2)" "unprognostic (2.97e-3)" "unprognostic (9.45e-3)" 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 7.8 0.1 0.0 0.0 1.7 592.2 0.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.1 168.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.0 0.0 0.8 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 42.0 0.6 1.3 0.0 0.0 2035.7 0.0 1.2 1.8 0.0 0.0 3.3 105.1 19.2 0.0 0.4 256.9 25.3 0.3 0.1 0.4 0.0 9824.4 0.7 0.0 2.4 175.6 182.3 40.5 0.6 0.0 0.0 6.4 0.9 0.0 22.8 1.1 0.0 9.9 0.0 0.0 0.0 0.2 0.1 0.4 1.1 3.8 1.0 0.3 AMMECR1 ENSG00000101935 "Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1" Q9Y4X0 X 110194186-110440233 "Disease related genes, Predicted intracellular proteins" "Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 70.0;Rod photoreceptor cells: 93.5;Syncytiotrophoblasts: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000590, HPA051762" Uncertain Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA000590: AB_2666037, HPA051762: AB_2681596" "unprognostic (7.77e-2)" "unprognostic (1.93e-1)" "unprognostic (2.06e-1)" "unprognostic (5.17e-2)" "unprognostic (1.25e-1)" "unprognostic (6.87e-2)" "unprognostic (1.66e-3)" "unprognostic (6.55e-2)" "unprognostic (5.98e-2)" "prognostic favorable (6.62e-5)" "unprognostic (3.61e-2)" "unprognostic (3.96e-2)" "unprognostic (2.43e-3)" "unprognostic (3.33e-1)" "unprognostic (1.02e-1)" "prognostic favorable (8.44e-4)" "unprognostic (7.82e-2)" 7.2 6.6 2.4 10.1 4.5 17.0 5.3 2.9 6.5 6.3 6.2 3.9 5.0 4.6 5.3 6.0 15.9 6.3 6.5 3.0 3.1 2.9 7.5 8.5 5.9 5.8 2.6 3.2 12.4 7.4 5.0 9.5 22.7 6.6 4.3 6.1 9.7 6.5 7.0 3.2 14.2 7.8 4.5 2.4 9.7 5.8 4.0 2.3 12.5 6.0 11.1 11.3 6.8 8.9 4.3 2.9 1.5 4.8 1.2 6.7 1.9 11.3 5.6 4.1 2.0 4.7 7.0 4.5 7.9 7.1 6.5 9.6 8.9 8.3 6.7 3.8 10.4 5.2 5.4 13.1 8.9 6.7 4.7 5.9 9.3 12.9 1.8 11.9 7.4 3.9 3.9 15.9 7.4 13.3 3.5 5.1 3.3 25.9 20.2 4.9 9.5 3.5 2.6 18.9 9.7 11.0 7.7 4.4 11.9 11.0 9.6 6.6 3.2 13.3 13.1 11.1 5.2 3.2 7.4 2.3 4.5 2.8 13.3 7.1 4.2 4.7 10.8 6.9 15.5 15.0 1.3 1.9 1.5 3.4 1.3 4.6 3.3 6.7 5.4 2.9 4.3 4.6 3.9 1.3 1.2 4.8 1.3 4.6 1.9 2.4 4.5 2.9 6.5 3.1 2.9 2.6 3.2 6.6 2.3 0.0 9.8 8.2 3.8 8.5 29.6 3.8 5.1 5.3 3.4 3.5 49.1 19.3 19.9 8.0 0.4 4.2 7.9 70.0 10.4 9.3 11.3 5.9 2.3 6.0 6.1 1.6 14.5 25.2 7.8 0.8 11.8 4.0 3.3 7.2 10.2 5.8 9.8 0.0 16.3 8.2 93.5 12.9 4.7 1.8 6.9 23.3 72.3 10.0 9.9 11.5 AMOT KIAA1071 ENSG00000126016 Angiomotin Q4VCS5 X 112774503-112840815 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 40.0;epididymis: 102.0" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 27.9;Cytotrophoblasts: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 15.6;HAP1: 16.7;OE19: 13.4;SuSa: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067290, HPA067853" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA067290: AB_2685819, HPA067853: AB_2732773" "unprognostic (1.08e-2)" "unprognostic (5.51e-2)" "unprognostic (2.38e-2)" "unprognostic (3.36e-1)" "unprognostic (3.20e-1)" "unprognostic (8.95e-2)" "unprognostic (3.82e-2)" "prognostic favorable (3.94e-4)" "unprognostic (4.46e-2)" "unprognostic (3.79e-1)" "unprognostic (2.17e-1)" "unprognostic (5.60e-2)" "prognostic favorable (4.21e-9)" "unprognostic (9.54e-2)" "unprognostic (2.59e-2)" "unprognostic (4.50e-2)" "unprognostic (6.44e-2)" 3.7 2.3 18.4 2.0 17.9 1.3 5.5 3.0 14.0 8.1 3.5 13.9 40.0 3.1 4.7 102.0 3.8 9.7 3.1 3.7 15.4 10.9 8.2 2.5 3.0 1.6 14.4 10.3 5.4 2.7 8.4 7.0 14.9 18.0 5.6 4.3 1.2 6.9 27.6 25.2 2.7 3.6 3.5 15.7 2.1 3.3 2.7 13.5 0.1 3.8 9.3 1.8 3.2 4.3 0.5 0.2 0.0 0.6 1.9 1.5 0.2 2.7 0.0 15.6 0.6 0.3 0.3 5.7 0.5 0.0 0.0 0.0 6.5 0.5 0.3 3.2 2.4 0.0 5.6 16.7 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.0 3.5 0.4 3.2 0.1 0.3 0.0 0.0 0.3 0.2 4.2 0.2 6.9 13.4 0.1 5.4 4.8 0.1 7.2 7.1 0.0 5.3 0.0 0.0 6.0 24.5 0.5 0.1 0.1 1.9 4.6 0.0 6.2 0.4 0.0 0.0 0.7 0.0 4.0 0.0 0.0 0.0 1.1 0.4 1.5 0.5 0.7 1.0 0.2 0.2 0.7 0.6 0.0 1.9 0.6 0.2 1.0 0.2 18.4 17.9 3.0 14.0 15.4 10.9 14.4 10.3 18.0 13.5 3.0 1.3 0.0 2.1 1.5 1.0 1.2 0.0 8.1 6.8 27.9 0.0 35.2 1.7 3.4 0.1 3.0 4.6 0.0 1.8 2.6 3.8 8.2 0.0 3.6 5.2 0.0 15.2 3.7 1.5 0.0 6.4 0.6 3.3 2.8 9.2 4.5 2.2 3.5 6.0 14.4 0.4 6.5 3.1 0.5 2.1 1.0 13.3 0.0 6.3 2.2 ANG "RAA1, RNASE5" ENSG00000214274 Angiogenin P03950 14 20684177-20698971 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Stress response" "Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 371.4" "Cell type enriched" "Detected in many" 21 "Hepatocytes: 4646.2" "Cancer enriched" "Detected in all" 17 "liver cancer: 279.2" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "classical monocyte: 18.1;myeloid DC: 10.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Hep G2: 52.5;OE19: 40.2" "Low region specificity" "Detected in many" HPA055896 Approved "Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments" "Secreted to blood" Yes No 308000000 230000000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "Actin filaments" "HPA055896: " "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.77e-2)" "prognostic favorable (6.85e-4)" "unprognostic (5.71e-3)" "unprognostic (6.99e-2)" "prognostic favorable (7.83e-5)" "unprognostic (1.16e-1)" "unprognostic (3.20e-3)" "unprognostic (9.19e-3)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (6.65e-2)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (2.00e-1)" "unprognostic (3.09e-1)" 17.0 0.9 0.7 2.6 0.7 0.7 16.4 0.5 0.7 14.4 9.0 0.7 6.6 3.5 10.7 10.3 8.0 3.8 13.3 3.8 0.8 0.7 10.6 371.4 6.9 2.3 1.0 0.1 17.7 9.0 1.3 1.1 1.9 0.8 17.5 6.5 5.5 20.2 7.7 3.5 4.0 7.4 9.7 1.5 1.5 7.9 7.1 0.4 0.0 4.2 5.5 3.6 14.3 15.0 4.5 10.4 0.3 18.1 0.0 0.9 4.8 1.3 3.4 0.8 0.0 8.6 10.3 0.1 1.4 3.0 0.4 1.4 2.0 1.8 0.1 0.4 4.2 2.9 1.3 0.9 1.0 0.4 5.8 1.3 0.3 1.9 52.5 1.8 1.3 0.1 8.3 0.8 0.5 1.8 4.3 2.0 1.5 0.0 9.6 1.2 0.2 0.2 0.4 0.2 40.2 3.8 0.2 1.3 3.9 0.8 1.0 0.0 0.1 1.5 0.6 2.3 1.9 1.4 0.2 1.7 0.5 1.0 0.5 0.2 2.0 1.6 0.2 1.1 0.6 1.6 0.0 18.1 0.0 0.3 2.1 0.2 4.5 0.9 0.8 10.4 2.4 0.2 0.2 0.3 0.0 0.1 1.6 0.4 4.8 0.7 0.7 0.5 0.6 0.8 0.7 1.0 0.1 0.8 0.4 26.8 12.4 18.0 36.0 24.2 0.0 0.6 219.1 60.2 18.2 10.4 0.0 1.5 10.0 27.6 0.7 12.2 37.1 23.3 27.7 3.3 31.0 52.1 0.0 4646.2 15.9 0.0 68.2 70.0 110.5 1.1 65.9 16.0 21.9 1.0 138.3 9.1 26.8 17.3 22.6 45.5 0.6 12.9 18.6 0.7 1.0 45.8 7.8 12.1 44.2 29.8 ANKRD23 "DARP, FLJ32449, MARP3" ENSG00000163126 "Ankyrin repeat domain 23" Q86SG2 2 96824526-96857934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 184.5" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "Karpas-707: 29.7" "Not detected" "Not detected" HPA036201 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "HPA036201: AB_10673347" "unprognostic (2.48e-1)" "unprognostic (7.83e-4)" "unprognostic (4.93e-4)" "unprognostic (1.21e-2)" "unprognostic (4.28e-1)" "unprognostic (3.28e-1)" "unprognostic (3.27e-2)" "unprognostic (6.66e-2)" "unprognostic (2.46e-2)" "unprognostic (3.59e-2)" "unprognostic (1.81e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-6)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.54e-1)" "unprognostic (2.70e-4)" 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.1 2.6 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 0.1 0.1 0.7 0.0 0.1 2.2 0.1 184.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 12.2 0.9 0.1 0.1 0.4 0.2 0.5 0.0 0.9 1.2 0.4 0.3 0.5 0.3 0.6 0.0 0.2 0.8 0.2 0.0 0.2 0.1 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.2 0.2 0.1 0.8 0.7 0.4 0.4 0.1 0.1 0.6 1.4 0.2 0.3 0.4 0.0 0.1 0.1 1.1 0.6 29.7 0.2 0.7 0.3 0.6 0.3 0.1 0.2 1.0 0.0 3.7 0.1 0.7 1.1 0.1 0.2 0.5 0.0 0.1 0.8 0.0 0.2 0.3 0.5 0.5 0.0 1.3 0.5 0.2 0.3 0.8 0.3 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.9 0.0 0.2 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.4 0.0 0.6 0.7 2.1 2.5 0.0 10.7 2.3 0.0 2.0 0.3 0.0 0.3 3.0 0.6 0.4 0.0 0.9 0.1 0.9 0.4 1.1 1.0 0.2 1.6 0.0 2.5 0.8 1.5 1.4 0.0 0.0 0.0 1.1 1.8 0.1 0.0 2.8 0.0 3.6 0.0 1.9 1.0 0.4 1.1 0.2 0.0 0.6 0.1 ANKRD24 KIAA1981 ENSG00000089847 "Ankyrin repeat domain 24" Q8TF21 19 4183354-4224814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Cell type enriched" "Detected in some" 4 "Extravillous trophoblasts: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 9 "B-cells: 1.3" "Cell line enhanced" "Detected in some" "Karpas-707: 5.6;U-266/70: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041534, HPA048498" Uncertain Uncertain Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA041534: AB_2677537, HPA048498: AB_2680420" "unprognostic (3.70e-2)" "unprognostic (3.96e-3)" "unprognostic (5.23e-9)" "unprognostic (7.03e-2)" "unprognostic (5.01e-2)" "unprognostic (2.31e-1)" "prognostic favorable (9.13e-5)" "unprognostic (1.53e-1)" "unprognostic (3.52e-2)" "unprognostic (3.41e-2)" "unprognostic (1.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.27e-2)" "unprognostic (7.63e-2)" "unprognostic (1.61e-1)" "unprognostic (2.43e-2)" "unprognostic (1.73e-4)" 1.4 2.1 6.0 0.8 8.5 1.1 1.2 1.4 22.1 1.0 1.1 0.8 0.1 1.9 1.0 2.1 0.5 1.4 1.3 0.6 5.1 4.4 1.8 5.5 1.1 1.0 4.1 9.4 1.4 3.3 2.4 3.8 1.9 2.3 4.3 0.9 1.0 1.7 1.7 2.5 1.1 1.5 0.7 2.3 1.5 1.6 7.3 1.8 0.1 1.9 0.1 0.6 0.6 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 3.2 0.3 3.4 0.2 0.1 0.0 0.0 0.1 0.1 0.1 2.0 0.4 0.2 0.2 0.1 0.5 0.0 2.4 0.3 0.1 0.1 0.1 1.8 0.1 0.3 1.8 0.1 0.3 0.8 0.5 0.1 2.0 0.1 5.6 0.0 0.7 0.0 0.1 2.5 0.7 0.7 0.4 0.0 0.4 0.0 0.2 0.9 0.2 0.1 0.1 0.3 0.6 0.7 0.4 0.0 0.1 1.2 0.9 0.0 18.9 1.6 0.1 0.8 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.0 8.5 1.4 22.1 5.1 4.4 4.1 9.4 2.3 1.8 0.0 3.4 0.0 0.2 0.0 0.8 0.8 2.5 0.0 2.3 0.0 3.9 0.2 0.0 0.1 0.5 0.0 0.3 0.0 0.0 17.7 0.0 0.2 0.0 1.0 0.3 0.0 3.5 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.7 1.1 0.0 0.9 0.0 0.2 0.0 ANKRD30A NY-BR-1 ENSG00000148513 "Ankyrin repeat domain 30A" Q9BXX3 10 37125788-37384111 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 38 "breast: 31.7;testis: 17.8" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 12.3;Late spermatids: 4.8;Spermatocytes: 23.6" "Cancer enriched" "Detected in single" 37 "breast cancer: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "A549: 3.9;U-266/70: 15.6" HPA071849 Uncertain Nucleoli NA NA Nucleoli "HPA071849: " "unprognostic (2.79e-1)" "unprognostic (2.81e-1)" "unprognostic (1.01e-7)" "unprognostic (1.41e-1)" "unprognostic (5.93e-1)" 0.6 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 23.6 1.7 0.0 0.2 0.0 0.0 0.0 ANKRD30B NY-BR-1.1 ENSG00000180777 "Ankyrin repeat domain 30B" Q9BXX2 18 14728272-14852738 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 17 "testis: 42.2" "Group enriched" "Detected in some" 8 "Early spermatids: 10.7;Late spermatids: 11.2;Spermatocytes: 17.0" "Cancer enhanced" "Detected in single" "breast cancer: 2.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 31.8" "HPA060455, HPA071849" Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA060455: AB_2684282, HPA071849: " "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" "unprognostic (1.65e-1)" "unprognostic (1.86e-1)" "unprognostic (9.74e-2)" "unprognostic (2.84e-1)" "unprognostic (1.55e-9)" "unprognostic (1.38e-2)" "unprognostic (1.53e-1)" "unprognostic (7.98e-2)" 0.3 0.2 1.2 0.1 2.5 0.1 2.3 0.0 1.8 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.9 0.1 0.1 0.1 0.1 0.4 1.2 0.1 0.6 0.1 0.0 0.1 1.0 0.1 0.2 2.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 42.2 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.8 2.6 0.1 31.8 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.5 0.0 1.8 0.9 0.9 0.4 1.2 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.0 10.7 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.8 11.2 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.4 0.3 0.5 0.0 0.6 0.1 ANO1 "DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A" ENSG00000131620 "Anoctamin 1" Q5XXA6 11 70078302-70189528 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Developmental protein, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 56.2;Hepatocytes: 117.3;Late spermatids: 50.1;Sertoli cells: 45.3;Smooth muscle cells: 42.3;Suprabasal keratinocytes: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 32.9;CAPAN-2: 50.5;HaCaT: 61.6;OE19: 43.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA032148, HPA057356" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA032148: AB_2674180, HPA057356: AB_2732610" "unprognostic (2.73e-1)" "unprognostic (7.91e-2)" "unprognostic (3.66e-2)" "prognostic favorable (4.58e-6)" "unprognostic (1.90e-1)" "prognostic unfavorable (7.28e-5)" "unprognostic (1.16e-3)" "prognostic unfavorable (2.40e-4)" "unprognostic (2.13e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.21e-1)" "prognostic unfavorable (4.09e-6)" "unprognostic (1.56e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.81e-1)" 6.9 0.4 1.1 2.1 1.1 0.0 17.2 1.6 1.4 9.7 5.3 1.1 142.4 0.2 14.2 38.5 3.6 11.7 10.6 6.9 1.1 0.2 2.6 24.4 4.4 1.5 1.0 1.0 3.9 4.5 0.5 2.0 6.2 1.5 7.2 1.7 1.7 122.9 93.6 3.4 19.1 1.8 5.7 1.0 1.1 9.5 7.6 0.9 1.1 8.9 8.1 3.8 4.5 5.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 32.9 1.3 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 50.5 0.0 0.6 0.0 0.0 61.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 43.3 4.8 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 10.5 0.2 0.3 3.9 0.1 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 1.6 1.4 1.1 0.2 1.0 1.0 1.5 0.9 0.0 0.0 0.0 18.1 15.8 0.0 2.8 25.5 0.0 1.2 0.0 0.0 1.1 0.0 2.9 56.2 2.2 0.0 0.0 0.0 0.6 3.5 9.1 4.6 117.3 0.2 0.0 0.0 4.9 1.6 50.1 1.7 0.9 5.0 0.0 11.4 1.0 0.6 0.0 1.4 0.4 0.3 45.3 42.3 1.4 1.5 40.8 3.4 0.0 0.2 17.8 ANO10 "FLJ10375, MGC47890, SCAR10, TMEM16K" ENSG00000160746 "Anoctamin 10" Q9NW15 3 43354859-43691594 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 104.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 22.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016624, HPA051569" Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA016624: , HPA051569: AB_2681537" "unprognostic (1.51e-3)" "unprognostic (1.38e-2)" "prognostic favorable (6.70e-4)" "prognostic favorable (1.11e-4)" "unprognostic (4.23e-1)" "unprognostic (2.69e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (7.99e-3)" "unprognostic (1.03e-2)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "prognostic favorable (6.41e-6)" "unprognostic (9.83e-3)" "unprognostic (1.22e-1)" "unprognostic (5.19e-3)" "unprognostic (5.71e-2)" 21.6 12.7 11.8 12.6 13.2 20.6 22.0 18.2 14.1 17.5 27.4 14.3 13.2 42.0 17.9 12.4 19.8 10.4 16.7 10.5 12.3 15.2 22.2 10.5 13.6 10.7 17.3 12.3 12.7 14.4 18.6 14.4 17.5 19.4 10.7 24.4 18.6 23.1 19.5 11.3 24.6 52.9 19.9 23.6 9.4 11.1 9.1 8.8 5.5 17.7 15.8 13.9 13.7 17.0 2.0 8.5 22.4 12.5 6.3 4.6 4.3 9.0 7.2 8.0 8.4 32.6 17.6 9.8 26.5 44.2 13.6 17.3 4.8 8.4 1.0 8.5 34.9 13.4 4.9 6.3 14.5 16.5 10.0 4.5 11.8 9.7 5.2 14.3 2.1 9.6 16.3 11.6 16.7 22.8 24.9 31.7 5.7 8.8 7.7 30.0 6.4 2.3 1.5 9.6 7.0 8.4 1.8 5.7 3.1 26.7 9.5 2.0 5.9 10.5 8.6 6.1 14.8 18.4 4.3 25.8 20.7 7.7 21.7 12.1 5.0 6.5 0.3 18.9 4.5 13.6 4.4 12.5 0.9 4.6 7.1 2.7 1.9 3.2 3.1 8.5 2.0 2.8 4.3 22.4 6.3 7.7 1.5 3.5 4.3 11.8 13.2 18.2 14.1 12.3 15.2 17.3 12.3 19.4 8.8 6.0 2.7 2.2 5.2 4.9 7.1 4.5 10.2 4.0 7.9 14.0 0.0 12.0 104.5 19.0 2.7 14.0 47.9 23.3 15.4 15.5 7.8 5.5 2.3 6.8 10.4 9.5 9.2 19.0 9.2 3.1 5.2 8.2 13.5 1.8 19.1 20.3 11.8 16.5 9.6 14.9 3.6 6.5 12.3 14.7 22.6 5.4 14.3 3.9 24.3 4.6 ANO2 "C12orf3, TMEM16B" ENSG00000047617 "Anoctamin 2" Q9NQ90 12 5531869-5946232 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "placenta: 46.9;retina: 30.6;testis: 13.4" "Group enriched" "Detected in many" 12 "Cone photoreceptor cells: 76.6;Early spermatids: 58.6;Late spermatids: 219.4;Rod photoreceptor cells: 168.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "basophil: 5.1" "Lineage enriched" "Detected in single" 51 "granulocytes: 5.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.6;HUVEC TERT2: 8.5;U-2 OS: 22.5" "Region enriched" "Detected in some" 4 "basal ganglia: 20.0" "HPA036276, HPA057499" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA036276: AB_10670713, HPA057499: AB_2732613" "unprognostic (6.32e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-1)" "unprognostic (1.25e-2)" "unprognostic (1.55e-1)" "unprognostic (4.05e-3)" "unprognostic (2.86e-1)" "unprognostic (2.62e-1)" "unprognostic (1.11e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-3)" "unprognostic (3.78e-3)" "unprognostic (1.04e-2)" "unprognostic (1.10e-2)" "unprognostic (9.93e-2)" "unprognostic (2.27e-1)" "unprognostic (2.17e-1)" 5.8 0.1 1.0 1.3 2.3 0.0 4.3 1.2 1.3 3.3 1.0 1.6 0.9 0.8 1.8 2.1 0.9 1.9 1.5 3.9 1.9 0.9 1.2 0.9 4.7 0.9 1.6 2.0 0.9 0.9 1.4 0.9 46.9 1.2 1.4 0.7 30.6 0.9 1.6 2.3 0.6 0.9 2.1 1.1 1.9 1.0 13.4 0.9 0.9 1.6 1.3 0.9 1.3 2.3 0.0 0.0 5.1 0.0 0.0 0.0 0.2 2.2 0.0 4.0 0.0 0.0 0.2 1.9 0.0 8.6 0.4 0.9 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.0 0.1 0.6 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.5 0.0 0.0 1.7 0.0 0.8 0.0 0.0 4.1 2.0 0.0 1.7 0.0 0.9 0.1 0.1 0.0 0.0 2.1 1.4 0.0 3.7 1.2 0.0 0.2 0.0 22.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 1.0 2.3 1.2 1.3 1.9 0.9 1.6 2.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 7.4 1.1 0.0 0.0 0.0 0.0 76.6 1.1 0.0 0.0 58.6 3.6 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.2 9.5 0.0 1.8 0.0 219.4 0.3 0.0 0.0 0.0 0.0 10.6 0.0 0.0 1.4 0.0 168.7 0.0 0.4 1.5 1.3 0.1 2.1 0.0 0.0 0.0 ANO6 "DKFZp313M0720, TMEM16F" ENSG00000177119 "Anoctamin 6" Q4KMQ2 12 45215987-45440404 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Lipid transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 81.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038958 Approved Approved "Plasma membrane,Cytosol" NA NA 1500000 "Plasma membrane, Cytosol" "HPA038958: AB_10672835" "prognostic unfavorable (7.56e-5)" "prognostic unfavorable (3.82e-4)" "unprognostic (2.16e-1)" "unprognostic (1.75e-2)" "unprognostic (1.29e-1)" "unprognostic (9.82e-3)" "unprognostic (7.43e-2)" "unprognostic (3.01e-3)" "unprognostic (7.55e-2)" "unprognostic (2.84e-3)" "unprognostic (1.41e-3)" "unprognostic (3.02e-1)" "unprognostic (2.68e-2)" "unprognostic (1.26e-3)" "unprognostic (1.26e-1)" "unprognostic (4.20e-2)" "unprognostic (1.28e-1)" 40.7 15.3 6.4 17.3 7.0 3.8 42.8 2.5 7.3 22.2 29.7 6.1 34.8 16.5 33.2 16.0 21.2 18.5 20.2 20.7 6.7 5.4 21.6 25.4 25.6 11.7 7.6 4.2 27.4 12.7 20.1 7.1 23.3 8.8 21.6 6.9 14.2 16.8 39.3 40.3 10.0 41.3 42.8 14.6 12.5 13.5 10.4 5.8 21.6 11.2 14.7 9.6 37.6 38.1 2.1 7.1 4.4 9.3 3.1 4.0 5.0 13.6 15.7 8.8 12.0 40.6 21.1 33.7 19.2 24.2 13.3 12.3 23.6 20.7 7.1 18.0 30.0 11.8 18.1 8.0 10.6 15.5 10.4 5.7 8.2 6.4 19.9 12.9 12.7 6.6 17.6 10.6 11.1 16.4 31.7 17.4 14.9 6.2 11.5 14.1 3.6 13.5 4.1 9.8 0.0 5.9 7.8 11.5 7.8 12.2 21.7 4.0 13.7 20.1 12.5 9.2 23.9 14.7 20.1 23.8 14.2 9.1 14.3 9.7 6.1 7.0 8.6 12.8 40.8 11.3 4.4 7.7 1.9 3.3 9.3 3.4 2.1 3.2 2.8 7.1 1.7 2.9 2.0 0.9 3.1 8.6 3.6 4.0 5.0 6.4 7.0 2.5 7.3 6.7 5.4 7.6 4.2 8.8 5.8 56.6 10.2 3.7 20.1 27.1 0.4 20.3 30.6 6.7 13.6 17.4 0.0 29.4 3.3 35.0 1.0 34.4 4.9 0.0 32.0 21.1 32.3 17.2 12.7 81.6 17.8 0.0 8.1 54.0 49.8 1.3 47.5 21.3 16.9 8.2 11.4 9.8 55.0 10.2 38.2 18.0 0.2 38.8 31.6 2.4 4.2 19.3 20.6 6.4 10.7 25.1 ANO9 "PIG5, TMEM16J, TP53I5" ENSG00000185101 "Anoctamin 9" A1A5B4 11 417933-442011 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 69.4" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 72.1;Mucus-secreting cells: 39.0;Paneth cells: 37.1;Undifferentiated cells: 37.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 26.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 41 "B-cells: 2.2;NK-cells: 3.9;T-cells: 7.9" "Cell line enhanced" "Detected in some" "BEWO: 7.0;CAPAN-2: 21.2;HaCaT: 12.3;RPMI-8226: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039948, HPA040112" Approved Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA039948: AB_2676765, HPA040112: " "unprognostic (3.62e-3)" "unprognostic (2.83e-2)" "unprognostic (4.68e-2)" "unprognostic (1.62e-1)" "unprognostic (1.41e-2)" "unprognostic (8.93e-2)" "unprognostic (6.98e-2)" "unprognostic (8.94e-3)" "unprognostic (1.39e-1)" "unprognostic (2.28e-3)" "unprognostic (1.54e-1)" "unprognostic (7.94e-2)" "unprognostic (1.91e-2)" "unprognostic (1.18e-2)" "unprognostic (2.08e-1)" "unprognostic (3.92e-1)" "prognostic favorable (8.81e-4)" 0.7 0.1 0.1 17.4 0.2 0.9 1.4 0.1 0.2 1.4 32.1 0.1 1.3 21.5 0.8 4.7 6.8 1.2 6.2 0.4 0.2 0.1 4.8 0.4 5.8 6.3 0.4 0.1 0.5 5.6 0.0 1.6 0.7 0.3 2.6 5.4 0.6 6.2 0.6 0.1 14.4 69.4 0.5 0.5 4.8 4.4 0.4 0.1 11.3 2.2 6.1 17.2 3.4 2.7 2.2 0.1 0.0 0.0 3.9 7.9 1.5 2.0 0.3 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 1.9 21.2 1.5 1.1 0.0 0.0 12.3 0.0 5.0 0.0 1.7 0.0 0.0 0.3 2.9 0.0 0.3 0.0 0.0 3.4 0.0 0.8 0.0 0.0 3.2 0.1 1.3 0.0 2.4 0.4 0.1 0.0 4.4 0.0 0.1 0.0 14.8 3.2 3.0 0.9 0.1 0.2 5.2 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 5.6 2.2 6.8 3.2 0.1 1.0 3.9 2.9 0.0 3.9 0.0 0.0 7.9 1.5 0.1 0.2 0.1 0.2 0.2 0.1 0.4 0.1 0.3 0.1 0.0 8.9 12.7 4.0 4.6 0.0 2.2 5.1 0.0 3.4 3.5 0.0 0.1 0.0 9.2 0.5 0.0 72.1 0.0 5.6 2.6 0.5 2.7 0.0 0.0 0.3 0.0 14.9 0.6 0.0 0.0 0.0 0.2 3.3 1.8 39.0 0.0 8.6 37.1 0.0 2.6 0.0 0.0 1.0 0.1 0.0 5.5 0.1 10.1 37.3 3.9 ANTXR1 "ATR, FLJ10601, FLJ21776, TEM8" ENSG00000169604 "Anthrax toxin receptor 1" Q9H6X2 2 69013178-69249327 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor Hypotrichosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 44.0;Fibroblasts: 78.7;Peritubular cells: 63.6;Smooth muscle cells: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 73.4;RH-30: 39.8;TIME: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054785 Uncertain Vesicles "Intracellular and membrane" NA NA 4100000 Vesicles "HPA054785: " "unprognostic (1.44e-1)" "prognostic unfavorable (5.76e-4)" "unprognostic (8.49e-2)" "unprognostic (4.77e-2)" "unprognostic (3.61e-1)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (4.15e-3)" "unprognostic (9.05e-3)" "unprognostic (1.15e-1)" "unprognostic (3.48e-3)" "unprognostic (2.26e-3)" "unprognostic (9.84e-2)" "prognostic unfavorable (1.22e-5)" "unprognostic (2.09e-2)" 27.5 25.8 10.0 10.1 14.9 0.1 21.1 11.0 9.6 33.4 14.2 23.6 8.5 4.9 35.7 13.5 14.0 20.7 51.5 18.8 17.0 10.1 6.1 3.1 20.1 4.4 19.4 6.5 45.5 3.1 30.5 10.4 32.3 23.6 21.7 8.8 37.2 13.8 23.0 12.4 17.9 8.9 30.4 21.4 11.7 7.4 6.6 16.7 2.6 17.5 10.4 6.7 29.1 24.5 0.0 0.1 0.1 0.0 0.2 0.4 0.0 6.9 8.7 7.7 4.8 35.8 17.5 0.1 11.4 23.2 12.1 9.7 0.0 0.6 0.0 6.7 30.0 7.3 6.6 5.3 6.8 11.4 0.0 4.3 1.8 19.4 2.2 15.8 1.5 1.0 28.4 2.7 12.0 7.5 30.3 3.3 4.0 1.1 0.0 73.4 3.1 4.2 0.1 7.3 0.0 5.7 0.0 39.8 0.1 3.0 6.1 4.4 19.6 22.1 0.1 7.8 4.5 2.3 0.4 49.9 15.4 12.9 15.4 12.0 0.0 0.0 0.0 7.9 1.3 6.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 10.0 14.9 11.0 9.0 17.0 10.1 19.4 6.5 23.6 16.7 6.0 21.2 0.0 16.2 44.0 0.7 5.1 0.0 5.3 7.9 0.0 0.0 0.7 0.0 1.2 30.7 2.9 0.0 0.0 2.3 0.7 78.7 8.7 1.1 0.0 3.4 0.0 0.0 4.9 0.3 28.8 39.4 2.7 23.6 1.0 0.0 12.0 1.2 0.0 63.6 0.0 0.4 19.4 53.6 5.4 2.0 20.6 1.1 0.0 0.0 8.1 AOAH ENSG00000136250 "Acyloxyacyl hydrolase" P28039 7 36512949-36724549 "Enzymes, Predicted secreted proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.6;lymphoid tissue: 57.4" "Cell type enhanced" "Detected in many" 17 "Hofbauer cells: 31.1;Kupffer cells: 110.3;Macrophages: 54.2;T-cells: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 54.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 4.1;NB-4: 21.3;THP-1: 16.3;U-937: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA021666, HPA026716" Approved Uncertain Vesicles "Secreted to blood" NA NA Vesicles "HPA021666: AB_2670799, HPA026716: AB_2671960" "unprognostic (3.55e-2)" "unprognostic (4.03e-3)" "unprognostic (4.45e-2)" "unprognostic (3.58e-1)" "unprognostic (6.06e-2)" "unprognostic (4.78e-2)" "unprognostic (2.40e-1)" "unprognostic (3.14e-3)" "unprognostic (5.42e-2)" "unprognostic (6.02e-2)" "unprognostic (3.36e-2)" "unprognostic (1.05e-1)" "unprognostic (1.46e-3)" "unprognostic (1.75e-1)" "unprognostic (1.92e-3)" "unprognostic (2.38e-1)" "unprognostic (1.35e-1)" 8.4 3.4 5.2 17.2 4.9 19.3 2.8 1.9 3.6 3.1 5.3 7.4 0.2 4.9 3.9 7.2 2.5 3.1 8.4 3.4 4.8 3.8 3.1 6.8 9.4 23.2 6.9 2.0 2.1 2.3 0.6 2.4 5.7 5.8 3.8 7.3 3.8 4.5 1.4 1.5 1.6 7.6 4.7 12.6 57.4 3.3 1.4 6.8 14.0 2.9 0.4 10.9 7.2 2.8 0.3 34.8 18.7 54.6 19.2 8.8 31.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.5 0.0 0.0 0.0 2.9 0.0 0.3 0.1 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.5 21.3 0.1 0.0 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 7.1 0.0 0.3 54.6 17.6 8.8 47.9 1.8 0.3 0.4 6.1 34.8 0.0 1.0 7.8 18.7 19.2 20.2 0.5 0.1 31.0 5.2 4.9 1.9 3.6 4.8 3.8 6.9 2.0 5.8 6.8 0.0 14.0 8.8 0.0 0.7 0.0 0.4 0.0 1.4 4.5 0.0 0.0 0.2 1.7 0.2 0.4 0.5 5.8 0.0 0.0 0.2 0.5 0.1 4.7 0.6 31.1 0.0 14.9 3.1 110.3 0.4 0.0 54.2 0.0 19.0 0.4 3.2 0.0 1.5 0.4 0.3 0.2 0.0 0.9 0.0 0.0 0.3 0.1 51.7 0.5 0.1 AP000646.1 ENSG00000285509 11 121024125-121113108 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 2.0;parathyroid gland: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 4.0" "HPA038593, HPA038594" Uncertain Uncertain Cytosol NA NA Cytosol "HPA038593: AB_10669647, HPA038594: AB_2676103" 0.0 0.0 0.2 0.0 0.0 0.8 0.6 0.1 0.0 0.5 0.0 0.2 0.0 0.5 0.6 0.8 0.2 0.5 0.0 0.8 2.0 2.5 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.2 0.3 0.3 0.8 1.7 0.4 0.3 0.4 0.2 1.9 2.4 2.3 0.3 1.1 1.2 0.6 0.7 0.8 1.0 0.0 0.8 0.5 2.5 0.1 0.4 4.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.0 1.1 1.0 0.0 1.0 0.6 1.6 0.0 0.0 0.2 0.1 0.3 0.0 1.4 0.2 2.5 0.7 0.2 0.7 2.2 3.0 0.8 0.1 0.0 2.5 1.4 0.2 0.0 2.0 0.2 0.5 0.9 0.2 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP000812.5 ENSG00000284922 "Leucine-rich repeat-containing protein 51 " 11 72080777-72110782 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "fallopian tube: 26.0;testis: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 6.0;HBEC3-KT: 5.9;MCF7: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA039949 Approved Uncertain Microtubules NA NA Microtubules "HPA039949: AB_10960708" 0.7 0.6 2.7 0.6 5.0 0.8 1.1 0.1 3.3 0.6 0.7 5.7 0.9 0.6 1.9 3.1 0.6 26.0 0.6 0.7 2.4 2.1 0.9 1.7 0.6 1.7 3.3 3.3 0.6 2.5 3.7 0.6 4.6 1.0 0.9 2.1 0.6 1.0 0.9 0.6 0.9 1.0 0.8 0.9 0.6 24.2 2.6 0.7 3.7 0.0 0.8 1.1 0.0 0.1 0.0 0.6 0.0 0.0 0.9 0.0 0.5 0.2 0.0 0.5 1.3 0.8 0.4 1.1 1.1 0.8 2.4 0.0 0.5 0.1 0.2 6.0 1.2 1.3 0.8 5.9 1.0 2.4 1.1 0.8 0.4 0.2 0.2 0.0 0.0 1.7 0.0 2.7 0.9 0.4 0.2 1.4 0.1 0.0 0.9 6.6 0.1 0.0 0.3 2.1 0.0 1.5 1.2 0.6 2.1 1.0 0.8 0.0 0.9 0.9 0.1 0.0 2.4 0.4 0.0 0.4 0.3 0.4 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP002748.4 ENSG00000256349 11 66509079-66533613 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 3.4" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "NTERA-2: 16.3;THP-1: 4.1" HPA058283 Uncertain Uncertain Midbody NA NA Midbody "HPA058283: AB_2683667" 0.2 0.9 0.0 0.0 0.6 0.0 0.3 0.7 0.2 0.5 0.3 0.0 1.0 0.0 0.1 0.3 0.5 0.0 0.7 0.3 0.7 1.0 0.3 1.4 0.2 0.3 3.4 0.0 0.2 0.1 0.3 0.1 0.4 0.2 0.9 0.0 0.3 0.7 0.3 0.5 0.4 0.0 0.5 0.4 0.7 0.1 0.0 0.7 0.0 1.2 0.6 0.8 1.0 0.9 0.0 0.6 0.0 0.0 0.0 0.5 0.5 0.5 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.7 0.0 0.3 1.2 0.0 0.0 0.3 1.7 0.2 0.0 1.8 0.2 0.8 0.0 0.6 0.2 0.5 16.3 0.9 0.0 0.9 0.0 0.0 0.3 0.8 0.3 0.0 0.3 0.4 0.6 0.2 1.4 4.1 0.0 0.7 0.1 0.0 0.1 0.0 0.2 0.7 0.0 0.2 0.4 0.0 0.2 0.0 0.2 1.2 0.7 0.0 0.3 0.5 0.7 0.0 0.3 0.0 0.0 0.6 0.3 0.5 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APBB3 FE65L2 ENSG00000113108 "Amyloid beta precursor protein binding family B member 3" O95704 5 140558268-140564781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.6" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 48.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005571, HPA076196" Approved Approved "Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" "HPA005571: AB_1844912, HPA076196: " "unprognostic (7.63e-2)" "unprognostic (4.58e-2)" "unprognostic (1.13e-2)" "unprognostic (1.36e-2)" "unprognostic (1.29e-1)" "unprognostic (1.40e-3)" "unprognostic (1.44e-1)" "unprognostic (5.06e-2)" "unprognostic (7.22e-2)" "unprognostic (1.98e-1)" "prognostic favorable (6.79e-4)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.06e-6)" "unprognostic (1.06e-1)" "unprognostic (4.59e-1)" "unprognostic (9.38e-2)" "unprognostic (4.67e-2)" 4.2 5.6 7.5 4.3 9.2 3.3 3.4 26.6 23.8 4.5 4.3 8.2 5.7 2.0 4.7 6.3 4.2 6.0 7.8 8.2 9.7 13.1 3.3 3.4 3.2 2.6 7.9 7.3 4.3 3.5 8.2 11.0 5.7 10.9 5.9 3.6 8.7 8.8 7.4 2.5 3.4 2.8 4.1 4.2 4.7 4.4 11.8 5.5 2.0 6.7 3.3 3.4 3.8 2.3 1.4 1.8 7.7 3.6 0.7 1.4 1.1 0.6 0.7 0.5 2.9 0.0 1.2 5.8 1.4 1.7 2.1 3.9 1.9 1.7 2.4 3.3 2.5 1.3 1.1 0.0 2.2 0.6 2.3 1.2 0.9 5.2 0.1 3.5 0.8 1.0 7.6 0.9 1.8 1.4 0.5 1.5 5.6 0.4 6.6 2.2 1.4 0.3 1.8 1.2 0.7 3.6 0.4 0.7 1.4 1.8 1.5 9.0 4.5 3.8 1.3 5.1 0.3 4.0 3.9 1.1 0.4 1.0 0.0 0.2 2.5 1.9 0.3 0.9 0.6 0.8 7.7 1.4 0.0 1.4 3.6 0.9 0.5 1.0 1.3 1.0 1.4 0.6 1.3 3.3 0.7 0.6 1.8 1.0 1.1 7.5 9.2 26.6 17.4 9.7 13.1 7.9 7.3 10.9 5.5 3.0 9.4 3.4 2.8 2.5 22.6 1.9 12.7 1.4 6.8 5.2 0.0 9.5 5.0 3.3 48.3 5.8 5.0 0.0 1.4 10.2 4.1 2.9 10.4 14.3 11.9 17.5 5.2 7.4 29.1 31.3 5.2 10.2 6.8 4.6 3.6 12.4 2.3 3.2 4.6 3.1 15.7 0.0 3.1 8.4 6.0 2.5 9.8 4.4 2.8 2.4 APCDD1L FLJ90166 ENSG00000198768 "APC down-regulated 1 like" Q8NCL9 20 58459101-58515131 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "salivary gland: 39.2;smooth muscle: 10.9" "Cell type enhanced" "Detected in single" 29 "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 43.4;hTEC/SVTERT24-B: 15.4;HUVEC TERT2: 15.6;TIME: 30.5;U-87 MG: 19.2" "Not detected" "Not detected" HPA067015 Uncertain Uncertain Mitochondria No No Mitochondria "HPA067015: AB_2685764" "unprognostic (2.61e-1)" "unprognostic (8.26e-3)" "unprognostic (4.63e-3)" "unprognostic (1.35e-5)" "unprognostic (4.09e-3)" "unprognostic (9.73e-3)" "unprognostic (1.31e-3)" "unprognostic (1.06e-4)" "unprognostic (7.63e-4)" "unprognostic (2.14e-2)" "unprognostic (7.62e-3)" "unprognostic (2.16e-1)" "unprognostic (6.55e-13)" "unprognostic (5.01e-3)" "unprognostic (3.21e-1)" "unprognostic (2.24e-2)" "unprognostic (1.81e-3)" 0.5 0.6 0.2 0.6 0.2 0.0 5.2 0.6 0.1 3.3 1.2 0.1 0.0 0.1 2.4 0.2 0.8 0.0 2.1 5.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 0.0 0.1 3.6 0.7 3.2 39.2 1.7 0.6 0.9 0.8 10.9 0.3 0.0 0.6 0.1 0.0 0.0 0.1 1.0 0.6 6.1 5.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 9.2 0.0 0.9 0.7 0.0 2.8 0.0 0.0 43.4 0.2 0.4 0.0 1.4 1.4 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 1.3 0.0 15.4 0.2 3.1 15.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.5 6.5 0.4 0.0 8.5 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOBEC3A "ARP3, PHRBN" ENSG00000128383 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3A" P31941 22 38952741-38992778 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 113.5;bone marrow: 42.7;lymphoid tissue: 31.5" "Cell type enriched" "Detected in many" 5 "Urothelial cells: 223.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 15.8" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "intermediate monocyte: 113.5" "Lineage enriched" "Detected in many" 7 "monocytes: 113.5" "Cell line enhanced" "Detected in some" "Karpas-707: 3.5" "HPA043237, HPA056980, HPA066719" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: AB_2685711" "unprognostic (6.45e-3)" "unprognostic (1.44e-2)" "unprognostic (1.12e-1)" "unprognostic (5.21e-3)" "unprognostic (1.31e-1)" "unprognostic (2.72e-2)" "unprognostic (1.91e-1)" "unprognostic (1.91e-1)" "unprognostic (3.52e-1)" "unprognostic (2.59e-3)" "unprognostic (9.01e-3)" "unprognostic (2.00e-1)" "unprognostic (1.13e-2)" "unprognostic (1.76e-1)" "unprognostic (4.98e-2)" "unprognostic (3.41e-1)" "unprognostic (1.91e-1)" 4.3 0.2 0.3 11.0 0.4 42.7 0.5 0.2 0.7 1.7 0.8 0.2 0.0 0.6 1.3 1.4 7.2 3.3 3.4 0.9 0.2 0.3 0.7 1.3 16.0 15.8 1.9 0.5 0.7 0.7 0.1 0.3 4.9 0.7 0.3 0.2 2.0 5.9 0.0 1.2 0.3 0.8 0.8 1.7 31.5 0.8 0.4 0.2 1.4 0.7 22.3 29.0 2.7 6.4 0.2 1.2 15.3 113.5 0.1 0.1 15.2 0.7 0.3 0.5 2.5 0.2 0.4 1.1 0.3 0.0 0.0 0.1 0.2 1.6 0.6 1.7 0.2 0.3 2.1 0.6 0.4 0.0 0.8 0.2 0.2 1.7 0.2 0.2 0.3 1.1 0.2 0.9 0.3 0.2 0.3 0.1 0.5 0.3 3.5 0.1 1.3 0.5 0.5 1.1 0.5 0.2 0.9 0.5 0.7 0.6 1.3 1.2 0.6 0.4 1.4 0.2 0.3 1.1 0.1 1.5 1.1 0.9 0.4 0.4 0.5 0.8 1.0 1.4 2.5 1.2 3.5 26.8 0.9 0.0 113.5 0.1 0.2 0.0 0.0 1.2 0.1 0.0 0.0 15.3 0.1 31.1 0.1 0.1 15.2 0.3 0.4 0.2 0.7 0.2 0.3 1.9 0.5 0.7 0.2 26.8 47.2 0.0 9.0 1.1 0.5 0.0 0.0 14.7 33.0 1.8 3.9 0.2 0.0 0.0 0.5 0.1 4.3 23.3 0.2 0.2 0.5 4.8 24.4 0.0 15.6 0.0 0.0 0.6 18.0 0.0 0.3 11.3 15.1 0.0 0.0 0.8 0.8 0.0 0.4 0.0 0.8 0.0 0.9 0.1 0.5 5.9 0.2 1.0 0.0 223.8 APOBEC3F "ARP8, BK150C2.4.MRNA, KA6" ENSG00000128394 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3F" Q8IUX4 22 39040604-39053910 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 17.7" HPA073637 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA073637: " "unprognostic (1.38e-3)" "unprognostic (1.28e-3)" "unprognostic (4.63e-2)" "unprognostic (1.63e-2)" "unprognostic (6.16e-2)" "unprognostic (3.51e-2)" "unprognostic (3.90e-2)" "unprognostic (1.42e-1)" "unprognostic (6.03e-2)" "unprognostic (1.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.88e-1)" "unprognostic (2.06e-3)" "unprognostic (9.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.49e-1)" "prognostic favorable (8.28e-4)" 6.9 9.0 1.9 7.9 2.3 2.5 3.1 0.7 2.0 9.6 5.4 3.9 14.5 3.1 8.2 5.6 5.6 8.1 3.1 6.7 2.4 1.7 5.9 4.5 5.4 13.1 1.8 1.2 14.1 5.5 3.9 4.9 1.7 2.6 6.4 2.4 6.6 6.4 16.3 3.2 1.6 5.0 3.9 3.6 14.3 4.3 11.9 1.9 7.3 4.2 2.5 15.9 5.4 4.5 23.2 4.3 5.9 9.1 9.3 6.9 4.7 4.4 3.5 1.4 5.5 4.1 6.1 2.0 3.4 6.3 8.1 12.9 3.0 8.0 10.6 3.6 7.1 6.7 5.6 1.3 5.3 3.2 10.0 4.4 14.3 0.0 1.5 8.1 1.5 6.0 8.0 2.3 4.1 1.4 4.4 7.4 2.8 1.0 17.7 4.0 3.2 3.2 1.9 0.6 0.0 0.5 5.3 0.5 2.3 6.7 5.9 0.7 1.1 4.1 1.1 2.2 3.3 4.2 1.2 1.9 1.7 4.7 0.2 1.5 3.1 1.6 0.5 4.9 1.4 2.6 1.4 3.3 5.9 6.1 6.6 6.9 16.4 4.0 6.2 4.3 23.2 2.5 3.9 1.5 9.3 9.1 3.7 5.4 4.7 1.9 2.3 0.7 2.0 2.4 1.7 1.8 1.2 2.6 1.9 0.0 0.3 5.2 4.0 0.8 0.0 4.4 10.2 2.7 0.0 0.0 0.0 1.4 1.7 7.1 2.1 1.5 0.5 0.0 3.5 1.2 2.2 3.4 2.3 0.9 5.0 0.0 1.2 4.3 2.1 3.3 4.6 1.9 5.0 6.4 2.1 2.0 4.6 2.8 6.0 2.8 0.3 0.0 1.9 0.3 0.2 0.6 1.4 5.3 1.5 6.2 APOBEC3G "bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019" ENSG00000239713 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3G" Q9HC16 22 39077005-39087743 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 64.4" "Cell type enhanced" "Detected in many" 10 "B-cells: 66.5;monocytes: 92.8;T-cells: 124.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 14.8;Daudi: 20.0;HDLM-2: 16.7;Karpas-707: 23.0" "HPA001812, HPA073637" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001812: AB_1078175, HPA073637: " "prognostic favorable (4.78e-4)" "prognostic favorable (4.70e-4)" "unprognostic (8.18e-3)" "prognostic favorable (6.03e-5)" "unprognostic (2.37e-1)" "unprognostic (3.43e-1)" "unprognostic (7.77e-2)" "unprognostic (2.33e-1)" "unprognostic (4.23e-1)" "unprognostic (4.13e-3)" "unprognostic (9.13e-3)" "unprognostic (1.81e-1)" "prognostic unfavorable (8.66e-13)" "unprognostic (3.41e-2)" "unprognostic (5.83e-2)" "unprognostic (2.91e-2)" "prognostic favorable (6.30e-4)" 6.0 6.1 1.9 8.0 2.2 4.8 3.8 1.4 1.8 6.4 4.2 2.8 8.0 1.7 6.1 4.3 3.7 8.8 7.2 4.6 2.4 1.7 4.1 4.1 5.1 16.0 2.5 1.3 12.4 0.9 2.0 3.4 3.4 2.5 5.0 3.3 4.8 3.8 28.0 3.3 1.2 5.6 3.6 3.1 18.9 3.5 15.6 1.4 6.5 3.8 2.6 15.2 7.4 6.0 16.1 8.6 5.9 17.5 35.5 64.4 39.1 1.9 0.0 0.0 0.0 2.5 4.9 0.1 0.4 8.2 9.6 14.8 0.7 11.9 20.0 0.2 3.4 6.1 0.0 0.1 0.6 2.8 16.7 0.0 10.3 0.0 0.1 11.1 3.4 4.9 7.4 0.2 5.2 1.1 0.0 1.3 0.6 0.9 23.0 1.4 0.0 3.8 3.4 0.3 0.0 0.7 7.7 0.0 12.7 0.0 8.8 0.0 0.0 0.2 0.0 1.1 0.9 0.0 6.5 0.0 1.5 0.1 0.0 0.0 0.0 1.9 0.2 1.7 3.1 2.5 4.0 6.8 4.5 64.4 15.1 37.7 16.1 20.2 49.8 8.6 11.6 6.9 30.3 5.9 35.5 17.5 5.5 15.8 39.1 1.9 2.2 1.4 1.8 2.4 1.7 2.5 1.3 2.5 1.4 3.0 12.8 66.5 12.9 1.5 0.2 2.2 2.5 8.1 12.5 0.0 2.0 2.9 5.0 8.7 39.3 8.7 0.0 23.3 2.1 1.2 7.7 7.9 11.6 0.8 27.1 0.0 5.8 10.4 18.7 11.7 17.5 15.2 6.8 92.8 1.7 7.8 2.3 1.5 8.5 1.0 1.0 19.4 8.0 0.7 1.1 1.1 0.8 124.6 1.1 18.5 APPL1 APPL ENSG00000157500 "Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1" Q9UKG1 3 57227737-57273468 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "naive B-cell: 20.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011138, HPA073477" Approved Uncertain "Mitotic spindle,Centrosome" Yes No 28000 "Mitotic spindle, Centrosome" "HPA011138: AB_1844959, HPA073477: AB_2797272" "unprognostic (1.39e-1)" "unprognostic (3.45e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (3.68e-2)" "unprognostic (2.31e-3)" "unprognostic (1.30e-3)" "unprognostic (1.81e-2)" "unprognostic (1.05e-1)" "unprognostic (8.36e-2)" "unprognostic (9.05e-3)" "unprognostic (5.55e-2)" "prognostic favorable (7.26e-5)" "unprognostic (3.99e-2)" "unprognostic (8.76e-2)" "unprognostic (1.12e-2)" "unprognostic (1.55e-1)" 18.3 14.0 20.9 15.3 17.9 13.7 22.5 25.2 23.7 18.5 15.7 12.8 16.8 12.6 19.2 14.5 21.0 16.0 13.2 23.7 15.8 15.4 17.0 14.3 15.3 24.3 15.4 18.8 24.0 38.2 28.4 20.4 14.1 18.8 15.7 14.4 11.0 18.0 22.2 40.5 19.9 14.5 20.5 16.7 15.0 16.3 10.5 15.7 20.9 20.0 15.2 18.9 17.7 20.8 20.7 12.0 2.5 3.9 4.7 3.5 1.7 14.9 6.5 6.4 23.2 11.0 15.5 13.5 7.9 4.9 8.0 9.2 7.6 9.0 24.3 3.3 12.2 12.6 3.0 17.1 13.7 13.8 18.3 7.6 13.7 10.4 8.0 11.9 30.4 10.1 11.4 12.5 10.2 11.1 16.1 12.7 15.3 4.6 15.3 9.0 5.1 23.9 7.5 10.0 10.6 11.2 0.8 26.0 13.0 14.1 8.4 6.5 13.8 10.9 16.4 10.4 9.0 8.0 19.8 12.0 13.3 9.4 19.3 15.3 14.1 20.6 17.1 14.4 14.7 8.6 1.6 3.9 2.5 2.6 3.0 3.5 11.3 2.8 2.4 7.2 20.7 2.6 1.9 1.0 4.7 2.5 12.0 1.1 1.7 20.9 17.9 25.2 23.7 15.8 15.4 15.4 18.8 18.8 15.7 47.6 39.2 44.5 41.0 47.1 39.5 88.3 45.9 20.1 55.7 40.1 29.5 40.0 49.7 52.3 22.7 58.0 26.9 0.0 52.6 38.3 45.7 34.4 22.0 37.6 46.6 49.3 43.8 35.6 50.8 15.5 67.6 54.0 18.6 85.6 35.9 55.2 46.8 11.5 71.5 43.7 52.2 51.8 38.7 40.0 39.4 60.9 23.5 30.5 44.7 23.4 APRT ENSG00000198931 "Adenine phosphoribosyltransferase" P07741 16 88809339-88811944 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026681 Approved Approved Nucleoplasm,Cytosol NA NA 1200000 "Nucleoplasm, Cytosol" "HPA026681: AB_1844964" "unprognostic (5.87e-2)" "unprognostic (5.10e-2)" "unprognostic (1.98e-1)" "unprognostic (3.67e-2)" "unprognostic (1.78e-1)" "unprognostic (2.50e-3)" "unprognostic (1.72e-3)" "unprognostic (6.90e-2)" "unprognostic (1.71e-1)" "unprognostic (1.82e-1)" "unprognostic (6.78e-2)" "unprognostic (8.74e-2)" "unprognostic (9.58e-3)" "unprognostic (1.14e-1)" "unprognostic (2.51e-1)" "unprognostic (4.75e-2)" "unprognostic (1.48e-2)" 22.9 37.1 10.9 33.6 13.2 32.9 31.6 10.1 15.3 22.7 31.1 10.7 33.6 27.1 19.9 28.3 50.7 21.0 30.4 22.5 9.1 8.2 27.7 60.4 30.6 94.2 14.8 10.7 17.9 58.2 19.4 15.6 19.3 11.0 25.1 15.1 13.9 48.2 37.4 26.2 49.8 24.3 18.4 12.1 30.4 27.5 16.0 12.2 37.9 29.5 49.7 35.8 18.5 32.8 65.4 92.1 24.2 70.2 58.2 83.7 104.7 25.6 37.7 7.4 33.3 9.1 18.1 39.4 19.4 17.3 22.9 8.9 38.8 31.2 23.9 38.1 11.0 10.9 27.5 12.1 31.9 4.6 16.8 72.1 20.3 17.8 40.5 28.8 13.9 16.7 19.3 34.6 18.3 23.2 10.6 28.6 40.7 42.7 17.9 11.6 94.5 39.2 41.1 28.5 26.7 49.4 42.3 11.5 56.5 25.3 17.5 36.8 22.6 37.0 21.7 20.9 7.2 71.5 27.7 18.5 20.7 18.1 16.7 19.1 35.2 29.5 65.7 30.5 37.0 18.3 8.5 70.2 24.2 63.0 57.7 83.7 63.2 81.9 67.5 71.6 65.4 75.9 64.3 4.3 58.2 37.1 92.1 66.1 104.7 10.9 13.2 10.1 15.3 9.1 8.2 14.8 10.7 11.0 12.2 107.2 125.0 285.8 232.8 283.3 20.2 39.3 252.3 87.0 112.6 87.2 5.9 238.4 344.8 378.2 9.5 147.6 262.7 70.0 383.2 347.1 184.5 203.2 130.3 282.7 315.2 14.3 202.5 130.8 259.2 24.9 222.1 260.5 281.7 449.1 262.5 57.6 343.1 185.9 127.3 427.1 16.1 38.8 137.7 8.1 99.7 432.5 144.4 269.7 340.7 292.1 AQP3 GIL ENSG00000165272 "Aquaporin 3 (Gill blood group)" Q92482 9 33441154-33447633 "Blood group antigen proteins, Plasma proteins, Predicted membrane proteins" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4" "Group enriched" "Detected in many" 6 "Basal glandular cells: 608.6;Basal keratinocytes: 1708.5;Collecting duct cells: 1526.7;Glandular cells: 959.6;Suprabasal keratinocytes: 2172.4;Urothelial cells: 2008.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "hippocampal formation: 2.1;pons and medulla: 6.7" "Group enriched" "Detected in many" 6 "MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1" "Lineage enriched" "Detected in many" 16 "T-cells: 42.1" "Cell line enhanced" "Detected in many" "HaCaT: 28.1;HeLa: 51.2;JURKAT: 28.8;RT4: 47.6;SK-BR-3: 32.9;U-266/70: 34.1;U-266/84: 44.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014924 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA014924: AB_2669120" "unprognostic (4.29e-2)" "prognostic favorable (5.31e-4)" "unprognostic (1.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.84e-2)" "unprognostic (1.11e-2)" "unprognostic (9.95e-2)" "unprognostic (1.64e-1)" "unprognostic (3.46e-1)" "unprognostic (9.06e-2)" "unprognostic (4.87e-2)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (1.16e-2)" "unprognostic (2.59e-1)" "unprognostic (3.73e-2)" "unprognostic (4.51e-2)" 1.3 0.4 0.4 2.7 0.2 1.9 5.2 0.9 0.3 29.7 26.7 0.1 1.7 9.9 5.5 3.2 179.6 3.3 2.0 6.0 2.1 0.4 23.9 44.0 16.5 5.7 0.5 0.3 3.6 5.7 0.0 0.7 5.3 6.7 15.5 1.2 0.4 194.2 5.5 0.9 65.2 33.2 5.1 0.3 17.2 3.9 1.2 0.0 70.6 0.6 132.4 156.1 37.6 60.2 2.6 2.4 0.5 0.1 0.5 42.1 10.3 0.1 8.4 0.4 0.0 15.6 2.8 0.2 0.0 0.2 0.2 0.2 4.4 2.6 0.1 2.0 0.0 0.1 28.1 1.3 0.1 0.0 13.4 1.3 0.9 51.2 0.4 0.0 0.2 0.3 0.4 1.4 0.1 0.0 0.0 0.1 28.8 14.3 13.0 1.5 6.2 12.8 5.0 1.1 19.2 0.1 0.2 21.3 2.3 0.2 47.6 0.4 1.1 7.1 32.9 0.0 1.9 0.2 2.2 0.2 0.0 0.2 0.0 0.0 34.1 44.2 3.2 0.1 0.0 0.0 0.3 0.1 0.0 4.5 0.0 41.1 2.6 39.2 12.0 0.0 0.5 22.7 10.8 0.5 0.5 0.1 2.4 42.1 10.3 0.4 0.2 0.9 0.3 2.1 0.4 0.5 0.3 6.7 0.0 35.7 265.4 2.2 608.6 1708.5 1.4 2.1 104.4 136.5 215.0 1526.7 2.0 0.6 0.0 27.2 1.3 40.5 4.2 93.5 41.7 1.3 46.3 959.6 19.7 111.7 2.2 0.0 7.9 16.0 3.8 0.0 30.8 32.1 150.1 1.0 63.7 0.3 32.0 2.9 1.1 28.8 0.4 0.0 42.2 0.0 1.0 2172.4 42.0 43.3 3.5 2008.6 ARFGAP1 "ARF1GAP, bA261N11.3, FLJ10767" ENSG00000101199 "ADP ribosylation factor GTPase activating protein 1" Q8N6T3 20 63272785-63289793 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051019, HPA056273" Approved Supported "Nuclear membrane,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "Nuclear membrane" "HPA051019: AB_2681313, HPA056273: AB_2683084" "unprognostic (1.81e-1)" "unprognostic (4.64e-2)" "unprognostic (1.27e-1)" "unprognostic (3.93e-1)" "unprognostic (1.38e-1)" "unprognostic (1.24e-1)" "unprognostic (1.57e-3)" "unprognostic (7.76e-2)" "unprognostic (8.86e-3)" "unprognostic (8.62e-2)" "prognostic favorable (4.57e-4)" "unprognostic (3.23e-2)" "prognostic unfavorable (3.48e-7)" "unprognostic (1.16e-1)" "unprognostic (7.59e-2)" "unprognostic (4.34e-2)" "unprognostic (2.86e-1)" 12.3 13.8 17.8 16.7 21.8 12.4 10.4 29.2 28.9 16.0 16.6 27.1 15.3 14.8 17.3 17.9 13.4 16.0 20.0 14.3 17.5 17.2 13.7 14.8 13.1 16.6 26.0 19.9 16.7 32.8 13.7 40.9 17.9 19.2 16.2 11.7 20.1 21.3 18.1 10.4 21.9 15.7 14.8 15.9 17.2 21.1 19.9 22.7 11.2 15.0 10.3 15.5 16.0 11.9 7.4 8.2 8.3 12.6 6.6 9.9 7.0 11.2 21.4 9.3 11.1 11.2 12.7 18.3 16.5 13.6 33.6 16.9 50.9 12.6 8.6 15.1 19.8 15.3 15.6 8.5 26.6 10.4 5.6 9.4 6.6 20.7 42.9 17.2 9.9 13.9 10.9 17.2 16.2 9.1 11.9 11.8 9.1 12.0 10.0 9.0 18.5 17.9 9.4 12.4 11.9 18.5 10.1 13.5 8.3 8.3 13.8 10.0 11.0 19.7 21.1 20.6 7.9 15.5 12.8 15.3 20.5 27.9 12.4 13.0 10.2 6.6 9.3 20.8 7.0 12.7 6.9 7.6 8.3 8.8 10.5 9.9 4.8 4.8 8.0 8.2 7.4 4.9 4.6 3.6 6.6 12.6 6.2 5.9 7.0 17.8 21.8 29.2 28.9 17.5 17.2 26.0 19.9 19.2 22.7 20.8 30.7 9.0 5.8 9.0 25.4 10.6 10.2 14.7 13.6 12.2 31.4 9.8 8.3 10.5 10.4 9.5 21.3 23.3 13.4 20.9 14.6 11.1 16.1 19.2 13.1 20.6 23.5 17.8 17.2 16.3 11.5 10.5 11.8 10.8 27.0 11.5 20.5 12.7 9.2 10.2 19.1 6.5 9.2 9.5 7.0 7.4 12.7 10.7 15.8 5.8 ARGLU1 FLJ10154 ENSG00000134884 "Arginine and glutamate rich 1" Q9NWB6 13 106541673-106568164 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 91.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034962, HPA056792" Supported Enhanced Nucleoplasm,Mitochondria,Cytosol No No Nucleoplasm "Mitochondria, Cytosol" "HPA034962: AB_10611676, HPA056792: AB_2683236" "unprognostic (1.66e-2)" "unprognostic (3.10e-2)" "unprognostic (2.24e-1)" "unprognostic (2.82e-1)" "unprognostic (3.97e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (3.21e-2)" "unprognostic (9.00e-2)" "unprognostic (1.52e-1)" "prognostic favorable (3.92e-5)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (2.91e-3)" "unprognostic (2.65e-1)" "unprognostic (2.87e-1)" "prognostic favorable (7.34e-5)" 43.5 31.8 59.1 46.5 63.6 67.5 46.1 82.1 72.8 37.9 41.7 44.9 33.5 35.2 62.2 50.9 38.1 50.2 55.0 40.4 55.7 20.6 30.5 24.4 65.3 75.7 62.5 44.5 65.2 34.1 24.0 61.1 48.3 44.0 38.9 48.6 35.5 46.8 48.2 34.1 53.0 54.3 43.3 51.8 50.4 42.8 25.9 67.2 40.2 45.5 22.0 61.0 44.0 44.9 23.7 23.2 34.7 18.0 16.5 18.6 10.9 26.6 14.8 67.4 15.1 10.7 18.6 15.0 29.7 9.0 10.0 15.2 30.2 38.8 32.4 10.2 11.6 11.7 30.2 14.2 12.2 18.8 42.1 15.1 37.2 91.5 15.5 9.5 60.0 24.8 16.6 16.1 9.1 12.3 25.0 12.7 22.5 13.4 25.2 12.8 9.4 23.7 31.9 17.8 19.6 5.6 40.9 16.9 15.4 11.2 31.1 17.6 25.3 14.0 22.5 6.7 27.9 17.7 31.1 23.0 13.4 13.4 14.9 16.6 28.3 23.3 38.8 27.7 38.5 15.3 34.7 18.0 16.7 18.6 14.6 17.2 20.7 13.8 11.6 14.4 23.7 15.8 13.8 30.3 16.5 13.4 23.2 15.5 10.9 59.1 63.6 82.1 72.8 55.7 20.6 62.5 44.5 44.0 67.2 131.0 200.7 147.3 175.2 232.4 221.8 78.3 101.9 224.9 215.0 108.2 127.6 118.5 84.6 100.9 28.5 282.9 157.6 93.5 97.9 120.4 173.1 219.9 158.9 69.6 87.5 287.6 180.1 188.4 85.6 18.1 236.2 133.0 121.4 162.3 134.2 304.1 112.4 133.3 204.7 39.4 283.1 213.4 189.5 194.6 112.8 229.2 154.9 147.4 126.3 268.6 ARHGAP11B ENSG00000285077 "Rho GTPase activating protein 11B" Q3KRB8 15 30624494-30638805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 2.6;intestine: 2.7;stomach 1: 1.9" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 93.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 17.9" HPA064479 Uncertain Uncertain Vesicles NA NA Vesicles "HPA064479: AB_2685272" 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.1 1.1 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 0.0 1.0 0.0 2.7 0.0 0.0 0.0 0.3 0.1 0.0 0.3 1.9 0.4 0.0 0.9 0.3 1.0 0.8 0.0 0.0 0.0 1.3 0.0 2.9 0.4 0.0 1.8 0.6 0.6 1.6 0.2 1.0 1.3 0.5 4.6 3.1 0.0 1.4 1.0 1.8 5.3 4.2 0.1 2.5 4.1 0.4 0.0 17.9 1.4 0.4 0.9 0.2 0.4 0.1 0.5 1.1 0.9 1.5 0.0 1.3 7.8 3.9 0.2 2.4 0.6 0.9 1.4 0.3 0.9 1.8 1.2 1.3 4.6 2.7 1.0 1.1 1.3 0.6 0.7 1.5 3.3 1.3 4.8 2.7 0.1 3.0 3.0 2.1 1.4 1.1 3.7 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.3 0.9 0.8 1.0 0.3 0.6 0.0 0.0 0.0 0.3 0.2 0.0 0.0 1.0 11.2 1.0 1.8 3.4 0.7 0.0 1.4 0.0 1.8 5.9 0.0 0.0 0.4 20.2 0.5 1.7 93.5 0.5 0.0 0.9 0.9 1.1 0.8 0.0 3.2 0.0 4.3 5.7 12.8 2.0 2.9 0.0 3.6 4.0 13.2 0.4 3.4 1.1 0.3 2.4 0.0 1.0 13.6 10.0 1.3 0.0 5.3 2.9 0.9 ARHGAP15 BM046 ENSG00000075884 "Rho GTPase activating protein 15" Q53QZ3 2 143091362-143768352 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 52.0;bone marrow: 33.5;lymphoid tissue: 94.4" "Cell type enhanced" "Detected in many" 8 "B-cells: 62.8;Early spermatids: 89.3;granulocytes: 83.5;T-cells: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 18.2;HEL: 25.4;HL-60: 35.8;MOLT-4: 23.7;NB-4: 27.8;THP-1: 37.8;U-698: 28.4;U-937: 19.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA032125 Uncertain "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA032125: AB_10671370" "unprognostic (1.59e-2)" "unprognostic (2.40e-3)" "unprognostic (8.63e-2)" "unprognostic (2.19e-2)" "unprognostic (2.99e-1)" "unprognostic (6.62e-3)" "unprognostic (6.14e-2)" "unprognostic (2.18e-3)" "unprognostic (1.32e-2)" "unprognostic (3.58e-2)" "unprognostic (2.13e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (6.95e-5)" "unprognostic (4.40e-2)" "unprognostic (2.12e-2)" "unprognostic (4.58e-2)" "unprognostic (6.94e-2)" 5.5 2.7 3.6 36.6 4.6 33.5 3.7 0.6 2.9 2.4 4.3 1.5 2.1 2.7 2.1 4.3 3.6 2.4 4.9 5.0 3.8 2.1 4.5 4.8 9.1 36.9 7.8 1.7 1.5 1.2 0.4 1.3 1.6 4.6 3.9 3.3 1.0 8.1 2.2 1.1 1.7 12.2 1.6 11.3 51.8 3.0 3.5 5.9 94.4 4.2 2.2 21.7 6.0 3.9 25.2 14.5 52.0 9.6 28.7 46.0 23.2 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 25.4 0.1 0.0 0.0 35.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.1 1.2 0.0 0.0 23.7 27.8 0.1 0.0 0.0 13.3 0.1 6.7 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 1.2 37.8 0.1 0.1 0.9 0.0 0.0 0.3 0.1 28.4 0.2 19.0 1.1 38.6 8.6 34.9 26.6 8.8 42.3 25.2 46.0 33.3 14.5 22.5 33.9 28.4 52.0 28.7 9.6 14.4 36.5 23.2 3.6 4.6 0.6 2.9 3.8 2.1 7.8 1.7 4.6 5.9 0.0 14.8 62.8 0.0 4.9 0.0 2.0 0.0 4.0 4.5 0.0 0.0 0.1 0.0 0.0 89.3 2.6 0.0 0.0 0.0 0.3 11.5 0.2 83.5 0.4 19.7 1.6 0.0 6.7 31.4 5.3 13.8 38.9 8.5 19.8 0.0 0.2 0.0 0.0 3.2 0.3 0.2 45.3 28.6 7.1 1.0 4.0 0.2 90.6 0.0 0.1 ARHGAP17 "FLJ10308, FLJ13219, NADRIN, RICH1, WBP15" ENSG00000140750 "Rho GTPase activating protein 17" Q68EM7 16 24919385-25015666 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041703 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041703: AB_10794304" "unprognostic (1.79e-1)" "unprognostic (8.98e-2)" "unprognostic (8.11e-2)" "prognostic favorable (3.59e-4)" "unprognostic (4.42e-2)" "unprognostic (3.49e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (3.02e-2)" "unprognostic (6.62e-2)" "unprognostic (8.81e-3)" "unprognostic (4.99e-2)" "unprognostic (3.45e-2)" "unprognostic (1.38e-2)" "unprognostic (1.94e-1)" "unprognostic (3.91e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.76e-4)" 25.0 23.2 12.3 22.5 21.7 10.1 20.6 12.2 15.8 15.1 15.8 22.9 6.8 14.3 21.4 12.4 19.1 16.8 15.4 18.9 13.4 5.4 15.0 12.6 17.8 28.7 28.0 8.7 15.1 14.0 17.0 20.5 62.6 16.3 13.7 16.0 19.3 16.4 10.9 22.0 19.2 25.5 15.1 19.6 40.8 16.5 18.6 24.8 16.9 17.1 12.4 29.6 13.4 16.8 25.7 24.6 8.0 17.2 5.7 7.2 6.8 20.5 11.8 15.8 16.7 16.3 17.2 17.8 14.6 13.9 15.5 15.0 18.3 8.2 9.6 9.7 25.6 14.5 5.8 15.7 9.2 16.3 14.9 21.7 8.5 28.0 30.0 18.6 11.1 7.9 21.9 5.5 16.5 11.9 10.9 25.5 8.4 10.4 0.0 16.9 14.4 10.3 13.9 19.0 5.6 10.8 48.5 13.4 3.7 18.7 4.5 11.0 11.5 14.4 14.7 5.5 13.3 8.1 28.1 34.9 11.6 9.4 25.8 11.0 9.9 12.3 5.6 14.1 16.4 10.1 3.5 9.0 8.0 6.3 17.2 5.7 25.7 5.6 6.4 13.9 24.0 6.4 6.2 4.7 5.7 14.0 24.6 7.2 6.8 12.3 21.7 12.2 15.8 13.4 5.4 28.0 8.7 16.3 24.8 8.9 11.2 6.4 5.7 12.9 5.5 22.7 12.7 6.7 7.9 5.2 9.8 9.2 3.3 11.9 4.5 28.4 31.3 0.0 13.8 16.2 9.9 8.7 6.9 5.8 23.1 9.5 20.2 28.3 25.4 7.3 12.4 15.9 15.1 6.4 22.2 6.1 15.0 28.3 11.0 3.8 7.2 25.8 24.7 4.4 14.9 21.0 13.2 13.6 15.3 11.3 ARHGAP32 "GC-GAP, GRIT, KIAA0712, MGC1892, RICS" ENSG00000134909 "Rho GTPase activating protein 32" A7KAX9 11 128965060-129279324 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.9" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 115.8;Muller glia cells: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 21.2;SK-BR-3: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038382, HPA038389, HPA061505" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA038382: AB_2675984, HPA038389: AB_10670972, HPA061505: AB_2684544" "unprognostic (1.17e-1)" "unprognostic (3.58e-2)" "unprognostic (2.54e-2)" "unprognostic (1.82e-1)" "unprognostic (3.89e-2)" "unprognostic (5.64e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-2)" "unprognostic (7.32e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (6.64e-4)" "unprognostic (1.47e-1)" "unprognostic (6.17e-3)" "unprognostic (1.17e-1)" "unprognostic (4.01e-1)" "unprognostic (5.80e-2)" "unprognostic (1.64e-2)" 4.0 5.9 22.1 3.4 32.8 1.7 9.4 4.7 46.9 8.2 12.3 5.1 1.5 18.4 7.3 8.4 21.9 12.2 6.8 3.8 9.9 6.8 6.5 4.5 5.2 1.5 6.4 21.7 10.2 13.3 14.9 5.3 7.5 5.4 6.0 14.3 4.5 13.4 4.1 6.2 16.0 19.0 5.5 4.3 2.6 10.8 9.2 8.4 5.8 3.6 12.8 12.9 8.0 13.1 1.3 1.6 0.7 2.1 3.0 1.2 0.6 6.4 3.4 10.8 0.0 3.5 3.6 7.8 2.4 3.4 1.5 1.9 7.9 13.4 0.0 3.7 4.7 7.8 14.7 4.9 6.1 3.0 0.0 1.7 0.1 1.7 2.9 1.7 0.0 0.0 3.4 8.0 1.5 9.1 3.4 1.9 5.5 0.3 0.1 2.7 5.0 5.3 0.1 2.9 19.4 3.7 13.1 3.2 1.3 1.7 21.2 10.7 4.3 3.7 23.1 4.4 4.3 12.0 2.0 3.5 5.5 2.9 3.2 4.7 0.1 0.0 0.0 2.4 14.7 3.4 0.0 0.4 0.0 0.3 2.1 1.2 0.0 0.4 0.6 1.0 1.3 0.8 0.2 0.7 3.0 0.7 1.6 0.4 0.6 22.1 32.8 4.7 46.9 9.9 6.8 6.4 21.7 5.4 8.4 6.0 12.6 0.5 10.9 16.3 25.3 3.9 12.7 41.5 28.4 10.4 115.8 17.3 1.7 6.9 12.7 4.9 46.1 0.0 23.7 3.3 11.9 19.8 1.1 13.6 5.4 17.5 39.1 6.2 4.6 10.4 6.4 3.4 15.1 0.0 61.0 120.0 20.3 45.6 12.4 8.6 31.5 19.4 5.9 8.6 5.6 27.1 23.8 1.3 46.4 48.2 ARHGAP35 "GRF-1, GRLF1, KIAA1722, P190A, p190ARhoGAP, p190RhoGAP" ENSG00000160007 "Rho GTPase activating protein 35" Q9NRY4 19 46918676-47005077 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, GTPase activation, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 167.2;Late spermatids: 476.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037311, HPA055184, HPA056470" Approved Supported "Nuclear bodies,Aggresome" NA NA "Nuclear bodies" Aggresome "CAB037311: AB_477435, HPA055184: AB_2682730, HPA056470: AB_2683142" "unprognostic (5.47e-3)" "unprognostic (1.38e-1)" "unprognostic (1.80e-1)" "unprognostic (2.40e-2)" "unprognostic (2.01e-2)" "unprognostic (7.78e-3)" "unprognostic (9.82e-3)" "unprognostic (4.41e-2)" "unprognostic (2.71e-1)" "unprognostic (2.73e-2)" "unprognostic (3.25e-2)" "unprognostic (1.92e-1)" "prognostic favorable (5.55e-8)" "unprognostic (2.78e-1)" "unprognostic (1.45e-1)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" 4.0 3.1 11.9 1.9 9.0 0.8 5.4 6.1 11.7 4.5 4.4 3.9 3.9 3.3 5.3 4.3 2.6 8.7 10.7 9.9 6.7 7.7 4.8 2.1 8.4 6.2 4.2 17.3 4.4 2.0 4.4 3.9 4.8 5.6 9.0 3.4 5.1 4.2 4.6 2.2 3.1 13.8 7.0 2.4 4.5 2.2 1.1 1.4 0.9 1.2 1.0 3.1 1.1 20.4 23.3 15.7 13.9 14.4 12.0 2.6 11.1 16.0 11.4 13.1 12.4 7.4 11.0 7.9 45.6 17.1 12.5 14.4 14.4 15.7 7.6 6.0 14.8 16.3 9.6 13.5 8.8 12.6 12.1 14.5 12.8 13.7 15.9 10.1 7.4 9.9 4.0 13.0 12.0 8.4 13.8 8.2 14.8 8.6 9.5 10.8 3.4 9.5 40.9 15.8 15.0 20.6 19.4 8.2 10.2 18.3 10.7 12.7 10.0 8.0 10.8 13.1 4.1 7.6 9.0 22.4 9.1 24.3 0.9 1.0 0.9 2.8 0.8 2.9 0.8 2.6 3.1 1.3 1.1 1.0 1.2 0.4 1.0 1.2 1.4 0.8 1.1 41.7 35.5 3.4 12.2 13.5 31.7 53.1 25.5 8.1 19.4 24.4 23.6 3.0 6.6 11.9 167.2 19.4 41.2 0.0 17.3 0.8 13.4 22.5 9.2 80.5 12.7 65.2 30.0 28.8 14.0 476.8 21.6 7.8 20.3 15.4 22.1 28.0 16.4 17.5 24.1 18.4 23.1 19.4 17.5 42.7 22.0 14.4 1.4 13.1 23.8 11.6 ARHGAP4 "C1, KIAA0131, p115, RhoGAP4, SrGAP4" ENSG00000089820 "Rho GTPase activating protein 4" P98171 X 153907367-153934999 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 44.8;lymphoid tissue: 48.4" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 71.1;Kupffer cells: 73.8;Macrophages: 43.6;T-cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 26.2;Karpas-707: 26.9;MOLT-4: 25.3;RPMI-8226: 49.8;THP-1: 24.3;U-698: 23.2;U-937: 21.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001012, HPA001083" Enhanced Approved "Nucleoplasm,Focal adhesion sites" NA NA "Focal adhesion sites" Nucleoplasm "HPA001012: AB_1078201, HPA001083: AB_1078199" "unprognostic (3.54e-2)" "prognostic favorable (3.94e-5)" "prognostic unfavorable (1.97e-5)" "unprognostic (5.79e-2)" "unprognostic (9.42e-2)" "prognostic favorable (3.31e-4)" "unprognostic (5.72e-3)" "unprognostic (1.39e-1)" "unprognostic (3.27e-1)" "unprognostic (1.37e-1)" "unprognostic (7.81e-3)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (8.47e-3)" "unprognostic (2.01e-1)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" 7.0 4.8 5.3 24.3 5.8 44.8 5.0 4.5 3.2 3.1 6.5 5.2 2.1 6.0 3.9 7.0 4.4 5.2 6.5 4.2 4.5 3.2 7.4 4.9 13.4 29.1 5.2 0.9 2.6 2.3 0.9 3.5 9.0 4.8 4.2 3.0 5.7 7.5 1.8 1.6 1.8 18.0 3.9 5.9 48.4 4.9 3.6 4.2 43.2 4.2 1.6 29.0 7.1 3.6 10.8 17.7 18.7 30.5 8.5 15.7 12.6 0.4 0.1 0.2 1.7 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.1 12.5 26.2 1.6 0.0 0.2 0.2 1.3 0.0 0.0 7.1 1.0 10.2 0.1 0.5 1.1 18.6 17.3 0.0 0.1 0.0 0.1 0.1 2.6 6.6 0.0 26.9 0.1 1.3 25.3 0.3 0.8 0.1 0.0 12.0 3.5 49.8 0.1 0.2 2.4 3.6 0.2 0.6 0.2 0.3 5.9 24.3 0.5 0.1 0.3 0.2 0.1 16.3 13.9 23.2 0.2 21.7 0.0 5.1 14.1 18.7 15.7 23.1 10.9 10.8 11.2 12.4 14.1 10.4 10.1 10.1 12.0 8.5 30.5 17.7 12.6 12.6 5.3 5.8 4.5 3.2 4.5 3.2 5.2 0.9 4.8 4.2 8.9 33.9 40.2 0.5 3.1 9.8 30.4 2.5 13.4 4.5 17.4 3.9 1.7 5.0 0.7 0.1 10.6 3.9 0.0 0.6 1.2 2.1 0.4 33.5 0.5 71.1 3.2 4.6 4.3 73.8 0.0 0.9 43.6 10.1 12.6 2.1 1.3 0.1 0.0 0.0 0.6 4.4 0.0 0.9 0.5 4.9 1.5 1.1 48.4 3.9 0.4 ARHGDIG RHOGDI-3 ENSG00000242173 "Rho GDP dissociation inhibitor gamma" Q99819 16 268727-283010 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 60.4;intestine: 31.7;pancreas: 45.3" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 3.3;Exocrine glandular cells: 9.9;Pancreatic endocrine cells: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 5.2;HEK 293: 18.8;MCF7: 24.2;SCLC-21H: 8.5;SH-SY5Y: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078260 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA078260: AB_2732375" "unprognostic (1.11e-2)" "unprognostic (5.69e-2)" "unprognostic (7.98e-2)" "unprognostic (2.66e-2)" "unprognostic (9.04e-2)" "unprognostic (2.13e-2)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-1)" "unprognostic (1.44e-2)" "unprognostic (3.18e-1)" "unprognostic (2.94e-1)" "unprognostic (5.86e-6)" "unprognostic (2.81e-2)" "unprognostic (4.34e-1)" "unprognostic (2.15e-1)" "unprognostic (6.32e-2)" 3.7 3.1 37.3 1.8 15.6 1.0 1.1 43.3 60.4 1.0 1.8 3.7 0.0 31.7 1.1 2.3 1.1 1.0 0.9 3.6 29.0 27.4 1.0 0.9 1.0 1.0 21.2 21.4 1.0 45.3 0.9 1.7 2.4 12.7 1.1 1.2 0.6 1.3 1.3 2.0 0.9 12.0 1.3 8.6 1.0 9.3 2.0 2.0 0.0 0.9 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.1 2.0 0.0 0.6 0.1 0.3 0.0 0.3 0.0 0.3 0.1 0.0 0.7 0.4 0.0 0.1 5.2 0.0 0.0 0.0 18.8 0.0 0.3 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.9 0.2 0.0 1.2 0.2 0.0 24.2 0.0 0.3 2.6 1.3 0.0 0.0 0.0 0.4 0.0 0.0 8.5 10.5 0.1 0.1 0.0 0.3 1.8 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 37.3 15.6 43.3 43.8 29.0 27.4 21.2 21.4 12.7 2.0 0.0 0.0 0.0 0.0 0.3 3.3 0.8 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 0.4 0.0 1.3 0.0 9.9 0.2 0.4 0.0 0.0 0.0 0.4 0.0 1.2 1.3 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.9 6.4 0.3 0.0 0.0 2.7 0.0 0.2 0.2 2.5 0.0 0.3 0.0 0.9 0.0 ARHGEF40 "FLJ10357, solo" ENSG00000165801 "Rho guanine nucleotide exchange factor 40" Q8TER5 14 21070270-21090240 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 58.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 2.8;neutrophil: 9.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.2" "Cell line enhanced" "Detected in many" "AF22: 17.4;ASC TERT1: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030745, HPA030746, HPA030757" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA030745: , HPA030746: AB_10599613, HPA030757: AB_10600203" "unprognostic (6.30e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-1)" "unprognostic (5.91e-2)" "unprognostic (2.55e-1)" "unprognostic (8.16e-3)" "unprognostic (1.27e-2)" "unprognostic (9.84e-3)" "unprognostic (1.33e-1)" "unprognostic (8.80e-2)" "unprognostic (1.64e-2)" "unprognostic (2.53e-1)" "unprognostic (6.01e-3)" "unprognostic (1.14e-2)" "unprognostic (1.38e-2)" "unprognostic (2.33e-1)" "unprognostic (8.95e-2)" 15.7 32.9 9.3 7.4 9.2 1.7 12.4 16.5 8.2 16.2 8.2 11.4 30.9 3.5 13.6 12.6 5.9 9.3 20.2 7.8 10.2 4.6 7.2 16.9 9.3 4.2 12.6 4.5 15.7 16.6 17.7 6.6 6.3 9.1 9.8 6.3 10.3 20.1 30.0 6.5 4.9 5.2 11.2 10.5 19.5 6.4 4.7 10.8 1.3 11.0 4.9 2.5 8.6 9.6 0.0 1.0 9.2 1.3 0.1 0.0 0.5 1.6 1.5 17.4 3.1 14.8 22.3 0.6 5.8 15.7 6.8 5.3 0.7 4.1 0.0 0.9 11.5 6.9 2.5 1.5 2.0 2.6 3.2 0.6 2.3 1.7 4.7 2.0 1.5 8.6 9.0 1.4 5.9 1.8 13.4 0.0 0.0 0.7 0.7 5.5 0.2 0.0 4.8 3.9 0.3 0.3 0.5 11.5 0.7 4.4 2.1 0.4 6.0 3.2 0.3 4.7 3.6 1.5 5.1 2.8 14.1 9.2 6.2 2.7 1.4 0.0 0.0 4.8 2.1 3.8 0.0 1.3 2.8 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 9.2 0.1 0.0 0.0 0.0 0.5 9.3 9.2 16.5 8.2 10.2 4.6 12.6 4.5 9.1 10.8 6.0 5.3 0.9 6.7 4.2 8.1 10.6 58.6 0.0 2.3 14.0 0.0 0.9 16.6 18.1 0.8 9.0 1.7 0.0 8.9 0.7 16.6 2.0 36.9 26.9 12.7 4.8 7.5 6.7 26.9 2.0 22.5 16.1 21.9 3.6 8.7 33.2 12.1 0.0 22.6 6.0 6.8 25.8 24.2 2.6 2.5 3.9 1.0 1.9 20.0 4.9 ARID2 "BAF200, DKFZp686G052, FLJ30619, KIAA1557" ENSG00000189079 "AT-rich interaction domain 2" Q68CP9 12 45729665-45908040 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 522.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063044 Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA063044: AB_2684929" "unprognostic (8.41e-2)" "unprognostic (1.03e-1)" "unprognostic (4.02e-2)" "unprognostic (3.94e-2)" "unprognostic (4.15e-2)" "prognostic favorable (5.75e-4)" "unprognostic (1.26e-2)" "unprognostic (9.71e-2)" "unprognostic (9.04e-2)" "unprognostic (5.57e-2)" "unprognostic (1.34e-1)" "unprognostic (2.47e-1)" "unprognostic (1.12e-2)" "unprognostic (9.21e-2)" "unprognostic (3.02e-1)" "unprognostic (2.00e-1)" "unprognostic (6.53e-2)" 9.0 7.9 7.1 14.6 7.2 14.0 11.8 15.7 8.8 10.2 11.4 8.2 17.9 6.4 12.2 10.7 11.5 8.8 10.6 8.2 7.4 5.8 8.7 6.9 10.2 13.0 9.6 3.8 12.2 10.7 18.4 15.1 10.3 7.5 9.9 8.1 10.1 9.7 20.6 8.6 13.5 12.6 12.5 7.3 10.2 9.0 30.9 11.0 33.3 11.5 8.2 11.2 10.0 10.0 2.1 5.3 10.5 4.9 3.1 4.4 1.3 5.4 7.8 14.0 6.1 6.0 4.2 7.6 3.8 5.4 5.3 5.0 11.1 5.6 10.5 7.1 5.2 3.9 6.6 11.3 6.5 7.7 4.6 5.4 13.9 8.6 5.4 4.1 10.9 6.4 3.4 4.9 6.7 10.8 7.5 5.4 15.9 11.7 10.9 4.7 7.1 15.6 7.8 8.4 0.0 4.2 12.1 10.0 10.1 5.1 9.1 7.6 9.7 6.2 7.2 6.0 8.4 11.0 21.9 6.4 5.7 6.9 3.8 4.9 7.3 6.1 29.4 4.4 28.8 4.0 10.5 1.7 4.2 4.1 2.2 4.3 1.7 3.7 4.4 2.4 2.1 3.6 3.3 2.4 3.1 4.9 5.3 3.1 1.3 7.1 7.2 15.7 8.8 7.4 5.8 9.6 3.8 7.5 11.0 26.8 27.9 10.2 11.5 30.0 49.0 12.6 5.1 9.4 12.5 27.9 64.8 11.9 6.6 11.2 522.0 21.5 15.0 0.0 8.7 8.9 17.5 17.9 20.9 13.1 9.9 30.2 20.2 16.5 27.5 122.6 23.0 20.0 13.5 12.6 19.9 19.7 15.6 24.6 21.2 6.9 67.9 25.8 22.7 61.7 16.5 36.1 19.6 24.5 16.0 16.5 ARID4B "BCAA, BRCAA1, RBP1L1, SAP180" ENSG00000054267 "AT-rich interaction domain 4B" Q4LE39 1 235131634-235328219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027205, HPA027333" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoplasm "HPA027205: , HPA027333: AB_1845013" "unprognostic (2.62e-1)" "unprognostic (2.38e-1)" "unprognostic (1.67e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-3)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.30e-2)" "unprognostic (1.03e-1)" "unprognostic (5.69e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (1.42e-2)" "unprognostic (1.25e-1)" "unprognostic (3.52e-2)" "unprognostic (8.84e-3)" 15.3 13.8 14.9 19.0 22.5 34.1 15.9 32.8 17.6 19.7 13.4 19.2 18.2 9.1 18.7 18.1 12.0 15.0 15.2 10.6 15.2 14.5 13.1 14.0 15.5 22.3 26.9 13.9 21.8 16.8 23.8 25.7 14.7 20.3 17.9 10.7 12.0 16.7 17.0 12.3 12.3 14.2 14.6 19.8 19.8 14.7 19.5 23.4 33.7 20.2 8.2 18.9 18.2 18.6 17.1 11.7 35.9 11.8 16.6 17.0 6.0 12.2 9.2 16.2 12.5 11.9 12.5 13.3 14.0 12.3 9.7 9.5 9.5 13.1 14.4 16.3 10.5 6.9 10.9 13.1 5.9 14.1 18.5 14.2 11.6 11.1 7.9 9.1 12.4 17.1 8.4 8.0 11.9 10.2 12.7 13.1 9.2 15.0 20.7 9.1 5.5 18.5 11.3 14.8 8.8 6.1 6.9 11.5 12.0 10.6 10.3 13.2 18.3 17.8 14.8 13.8 4.9 15.6 20.1 18.0 12.0 9.1 14.6 13.6 20.2 16.0 14.4 8.2 9.1 16.0 24.6 7.1 19.5 16.1 7.6 14.7 15.6 17.0 13.7 6.8 17.1 16.9 14.4 35.9 16.6 11.8 11.7 13.6 6.0 14.9 22.5 32.8 17.6 15.2 14.5 26.9 13.9 20.3 23.4 95.3 99.9 54.7 68.9 110.4 111.2 62.2 35.7 91.0 101.2 29.6 113.9 55.7 16.6 62.0 329.6 108.9 41.9 46.7 41.8 58.1 114.7 81.5 105.3 23.1 39.4 106.5 86.4 65.7 52.4 349.2 93.7 99.4 79.2 108.2 45.8 77.7 57.3 49.9 72.9 15.0 150.5 45.3 129.6 212.6 167.8 93.1 131.0 129.6 39.6 111.5 ARIH1 "ARI, HARI, HHARI, UBCH7BP" ENSG00000166233 "Ariadne RBR E3 ubiquitin protein ligase 1" Q9Y4X5 15 72474326-72602985 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003295, HPA073245" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA003295: AB_1845017, HPA073245: AB_2686587" "unprognostic (3.31e-2)" "unprognostic (1.92e-1)" "unprognostic (2.25e-1)" "unprognostic (3.18e-2)" "unprognostic (8.21e-2)" "unprognostic (5.45e-2)" "unprognostic (1.73e-1)" "unprognostic (9.43e-2)" "unprognostic (7.92e-2)" "unprognostic (1.37e-1)" "unprognostic (4.96e-2)" "unprognostic (9.19e-2)" "unprognostic (1.78e-1)" "unprognostic (2.93e-1)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (5.70e-2)" 15.3 15.6 11.4 17.4 15.5 24.6 13.3 20.4 21.5 15.8 14.5 10.4 14.0 17.0 21.1 11.2 14.2 12.3 14.4 19.7 10.5 10.5 10.9 10.5 13.7 9.3 10.1 15.0 17.3 13.5 12.9 14.0 15.4 12.6 14.0 7.6 13.0 13.2 13.1 68.3 16.3 13.5 15.8 10.7 11.4 12.5 55.2 10.0 16.9 11.7 13.0 12.7 18.4 20.4 1.9 1.1 4.6 1.5 2.1 2.5 0.3 9.4 9.9 9.8 5.7 5.1 3.6 11.5 10.6 3.9 4.8 3.3 10.0 8.1 9.2 16.0 4.5 17.0 13.5 10.0 5.5 2.7 16.4 6.9 7.0 12.2 6.6 3.6 10.4 8.1 4.2 1.9 5.3 6.9 4.6 3.5 6.8 7.3 11.0 4.7 6.1 10.0 4.0 10.6 3.4 3.6 11.4 11.9 5.2 2.7 15.8 9.2 10.5 13.8 6.2 16.3 13.5 5.0 12.0 9.1 8.0 11.1 30.7 14.8 11.6 23.2 10.8 5.3 9.5 8.4 4.6 1.0 2.2 1.7 1.5 1.5 0.7 1.3 1.1 0.7 1.9 1.6 1.5 3.4 2.1 0.7 1.1 2.5 0.3 11.4 15.5 20.4 14.0 10.5 10.5 10.1 15.0 12.6 10.0 17.9 30.7 20.4 42.7 58.8 62.5 41.5 20.4 29.4 30.7 17.4 86.4 15.9 3.3 17.2 84.9 33.4 23.6 0.0 16.2 16.9 29.1 45.9 43.7 24.7 16.7 58.8 44.6 41.1 23.7 41.4 26.4 21.3 15.1 10.0 22.7 24.7 20.6 20.1 25.8 12.2 60.6 19.4 46.1 40.7 29.7 52.2 34.1 30.5 20.9 52.0 ARL14EP "ARF7EP, C11orf46, FLJ38968" ENSG00000152219 "ADP ribosylation factor like GTPase 14 effector protein" Q8N8R7 11 30323051-30338227 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039634, HPA048127" Approved Supported "Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol" NA NA "Vesicles, Focal adhesion sites, Cytosol" Nucleoplasm "HPA039634: AB_2676606, HPA048127: AB_2680277" "prognostic favorable (2.50e-5)" "unprognostic (8.93e-2)" "unprognostic (6.19e-3)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (5.26e-4)" "unprognostic (2.50e-2)" "unprognostic (6.50e-3)" "unprognostic (5.76e-2)" "unprognostic (8.86e-2)" "unprognostic (1.04e-1)" "unprognostic (8.57e-3)" "unprognostic (1.60e-1)" "unprognostic (3.47e-1)" "unprognostic (4.50e-2)" "prognostic favorable (7.49e-4)" 13.9 21.5 24.5 12.9 29.1 6.3 18.7 22.7 23.4 17.0 14.5 8.0 22.4 8.7 18.1 22.7 11.1 15.8 12.4 20.5 17.7 15.5 16.5 17.6 10.3 23.5 15.5 20.5 20.1 15.0 33.4 28.6 10.6 15.1 19.0 10.3 9.0 17.0 19.9 28.0 11.6 12.5 18.3 16.0 18.2 14.4 14.5 15.0 11.6 23.3 13.9 19.1 16.1 15.1 17.6 12.7 5.5 9.6 24.4 28.7 11.2 5.8 8.5 9.5 8.3 15.6 17.0 4.8 11.5 14.5 10.4 11.6 4.7 2.2 23.8 7.9 8.2 11.6 9.9 13.8 9.7 14.8 18.9 17.1 7.2 6.7 8.2 24.6 12.8 8.3 17.6 19.6 4.9 18.7 15.2 11.4 9.9 11.3 13.0 18.1 5.6 11.6 10.6 11.0 13.1 11.9 10.2 23.2 9.7 13.9 8.1 10.9 11.6 8.9 12.0 14.1 8.9 12.7 7.3 10.0 12.0 6.4 23.5 10.9 20.4 11.6 15.5 11.4 8.0 11.4 5.5 9.6 3.0 12.1 9.4 28.7 17.6 14.8 13.4 12.7 14.0 13.7 13.1 1.7 24.4 7.0 9.1 9.5 11.2 24.5 29.1 22.7 23.4 17.7 15.5 15.5 20.5 15.1 15.0 26.8 28.1 30.5 38.1 11.0 32.2 57.0 17.8 34.8 20.5 24.4 13.7 14.7 64.6 23.3 99.1 24.8 6.3 0.0 19.6 10.7 22.3 27.7 26.6 24.2 22.8 30.2 13.9 12.9 24.3 44.0 25.3 30.9 25.3 43.3 10.0 34.4 19.0 9.7 23.7 27.2 28.6 12.9 24.1 60.6 33.2 9.7 9.3 28.9 10.4 24.4 ARL6IP4 "SFRS20, SR-25, SRp25, SRrp37" ENSG00000182196 "ADP ribosylation factor like GTPase 6 interacting protein 4" Q66PJ3 12 122980060-122982913 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA052098 Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA052098: AB_2681724" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" "unprognostic (8.42e-3)" "unprognostic (1.86e-1)" "unprognostic (4.23e-2)" "unprognostic (2.04e-3)" "unprognostic (6.48e-4)" "unprognostic (1.06e-2)" "unprognostic (1.38e-1)" "unprognostic (8.62e-2)" "unprognostic (3.03e-5)" "unprognostic (4.01e-2)" "unprognostic (8.41e-8)" "unprognostic (6.84e-2)" "unprognostic (2.16e-1)" "unprognostic (1.43e-2)" "prognostic favorable (1.08e-4)" 42.1 59.6 63.3 35.7 46.8 55.3 40.3 36.9 55.9 36.7 43.0 32.2 38.9 43.7 33.8 30.7 38.9 42.9 40.1 57.0 42.8 40.9 45.2 59.1 33.9 51.6 45.2 38.3 50.0 94.4 30.0 34.7 29.7 35.1 38.9 24.7 39.7 59.7 41.2 131.1 30.7 44.9 64.3 36.1 38.1 41.6 35.2 27.7 35.5 39.1 43.4 39.9 39.5 39.9 54.4 72.4 58.1 81.5 46.5 59.6 61.3 49.0 53.6 35.3 23.6 24.8 32.9 27.7 28.3 34.1 42.6 32.4 26.4 20.9 46.9 35.6 35.8 19.9 26.0 28.1 45.9 19.0 41.5 29.3 77.9 47.5 51.8 47.8 42.4 34.4 34.0 37.1 32.7 43.1 46.8 46.8 37.9 34.5 22.8 34.0 57.9 49.3 77.2 27.7 29.7 34.0 37.6 38.8 55.4 36.8 41.9 34.3 41.1 26.7 44.8 65.1 16.1 58.7 55.3 41.8 24.7 45.0 23.5 35.2 49.0 23.6 53.4 35.6 49.8 30.8 32.9 58.4 58.1 47.4 72.2 51.0 54.4 57.0 52.5 72.4 50.6 55.1 49.4 16.1 46.5 81.5 49.3 59.6 61.3 63.3 46.8 36.9 55.9 42.8 40.9 45.2 38.3 35.1 27.7 86.4 116.6 229.3 258.2 181.7 102.3 0.0 173.3 87.0 80.8 200.7 41.2 248.7 437.7 251.9 151.9 255.7 444.9 46.7 552.1 221.9 252.2 285.2 160.8 400.6 340.2 92.2 214.5 213.6 390.7 256.2 206.0 341.0 357.7 480.7 268.3 146.1 343.4 291.0 170.1 721.8 106.3 174.6 249.2 209.1 156.8 177.7 200.9 256.7 288.4 330.8 ARMC8 "DKFZP434A043, GID5, HSPC056, VID28" ENSG00000114098 "Armadillo repeat containing 8" Q8IUR7 3 138187248-138298389 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036996, HPA044869" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA036996: AB_10672786, HPA044869: AB_2679123" "unprognostic (2.04e-1)" "unprognostic (1.60e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (3.51e-2)" "unprognostic (2.39e-2)" "prognostic unfavorable (8.90e-5)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (7.48e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (3.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.06e-2)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" 19.4 13.5 16.9 14.3 21.9 43.5 14.5 52.6 26.4 17.1 14.4 16.8 9.4 9.9 15.2 10.8 18.0 13.7 13.0 14.4 16.9 20.9 16.6 13.8 13.9 16.3 17.6 16.1 14.3 11.9 20.5 26.1 16.3 26.3 14.5 15.9 12.5 11.9 15.8 34.6 11.8 13.1 20.6 18.7 16.7 14.2 14.7 19.1 21.3 18.2 12.1 18.4 16.9 12.9 25.6 25.4 40.1 23.8 25.3 26.5 19.3 20.4 10.0 13.2 10.7 16.7 14.8 17.8 15.9 15.4 21.8 21.4 15.7 10.9 19.4 16.4 13.6 25.6 10.8 17.0 15.5 27.0 13.0 12.0 34.5 6.6 10.6 21.2 26.7 38.7 22.0 9.9 14.0 20.2 11.9 17.0 17.0 12.8 11.0 27.0 18.0 18.7 12.6 18.3 15.5 8.8 14.7 21.3 15.4 14.3 19.1 15.4 11.2 22.8 7.9 13.2 18.0 15.7 14.1 18.4 11.7 9.5 15.4 11.6 21.2 16.2 29.7 10.5 12.8 11.5 32.3 22.1 40.1 22.8 23.8 26.0 25.6 21.0 24.0 25.4 22.0 24.6 24.4 15.6 25.3 23.5 11.2 26.5 19.3 16.9 21.9 52.6 26.4 16.9 20.9 17.6 16.1 26.3 19.1 26.8 13.1 26.2 26.3 27.5 36.5 20.9 20.4 10.7 29.6 12.2 31.4 25.9 10.0 17.4 5.7 22.2 15.9 70.0 12.8 23.2 20.3 19.7 33.6 21.2 20.1 41.3 22.5 23.4 25.0 5.8 28.1 27.7 18.6 15.4 15.1 24.5 11.5 20.4 20.8 23.7 42.0 12.9 28.9 44.1 30.6 24.8 28.5 26.1 16.1 24.0 ARNTL "bHLHe5, BMAL1, JAP3, MOP3, PASD3" ENSG00000133794 "Aryl hydrocarbon receptor nuclear translocator like" O00327 11 13276652-13387266 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045962, HPA050938" Supported Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Nucleoplasm Vesicles "CAB045962: AB_11124144, HPA050938: AB_2681282" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (9.00e-2)" "unprognostic (1.77e-1)" "unprognostic (3.72e-1)" "unprognostic (3.76e-2)" "unprognostic (8.92e-2)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "unprognostic (7.80e-2)" "unprognostic (1.34e-2)" "unprognostic (2.10e-1)" "unprognostic (2.77e-2)" "unprognostic (3.11e-2)" "unprognostic (7.08e-2)" 12.3 28.5 13.4 10.3 13.3 13.4 18.2 24.4 25.2 16.4 10.3 5.7 10.6 11.8 10.4 6.5 9.3 9.7 9.4 8.1 11.5 7.5 11.1 17.3 12.1 15.0 6.7 13.1 21.1 9.8 6.1 17.8 9.2 9.3 7.5 8.9 8.6 11.2 8.2 19.2 27.2 10.9 11.7 9.6 10.4 9.6 16.2 9.3 29.2 17.6 0.7 12.2 8.1 17.0 2.8 6.1 20.0 7.8 9.8 19.7 7.3 6.9 6.7 6.2 4.2 11.9 7.7 4.9 7.0 7.5 6.8 8.1 3.4 10.1 0.1 2.2 5.2 9.9 2.7 4.8 8.4 5.9 11.8 5.1 3.2 5.5 1.7 21.3 1.4 13.2 9.6 22.0 2.5 18.4 5.0 4.9 13.6 1.9 12.4 6.9 3.7 3.3 0.7 1.7 6.0 3.7 4.2 7.8 3.4 6.7 1.6 1.3 12.0 5.8 2.0 6.7 7.0 4.5 5.9 9.5 7.2 5.6 17.0 4.0 3.6 9.5 0.0 7.1 3.7 6.2 4.4 6.7 13.7 14.3 6.9 19.7 2.4 13.4 12.9 6.1 2.8 7.8 9.1 20.0 9.8 7.8 1.1 8.5 7.3 13.4 13.3 24.4 25.2 11.5 7.5 6.7 13.1 9.3 9.3 23.8 16.0 4.2 11.8 27.4 25.4 7.2 10.2 4.0 13.6 1.8 15.7 13.7 14.9 6.0 1.2 6.3 10.2 0.0 5.8 1.7 9.3 5.8 2.3 18.7 7.2 28.6 1.2 12.9 15.1 2.5 11.8 10.5 3.3 9.0 4.7 16.9 5.7 5.9 18.7 7.8 29.1 12.9 8.2 4.1 3.8 28.2 5.3 18.1 3.4 12.1 ARPC3 "ARC21, p21-Arc" ENSG00000111229 "Actin related protein 2/3 complex subunit 3" O15145 12 110434825-110450422 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006550 Approved Uncertain Nucleoplasm NA NA 38000000 Nucleoplasm "HPA006550: AB_1854869" "unprognostic (1.83e-1)" "unprognostic (4.21e-3)" "unprognostic (4.15e-1)" "unprognostic (4.26e-3)" "unprognostic (2.89e-1)" "unprognostic (1.11e-3)" "unprognostic (1.10e-2)" "unprognostic (6.71e-2)" "unprognostic (2.89e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (9.96e-2)" "prognostic unfavorable (2.22e-11)" "unprognostic (3.00e-1)" "unprognostic (5.83e-2)" "unprognostic (2.05e-2)" "unprognostic (1.79e-3)" 47.9 50.5 47.4 65.2 50.0 123.1 65.3 21.3 61.0 40.2 58.9 29.4 31.4 47.2 35.9 56.9 88.1 32.4 49.4 39.7 44.6 39.1 64.3 54.0 86.0 143.3 41.1 38.0 27.6 51.5 23.8 41.9 58.4 34.4 34.4 63.9 23.1 51.2 37.6 23.9 35.5 52.2 40.1 49.6 93.9 47.8 29.3 35.0 65.7 38.6 49.8 99.3 61.6 47.2 59.7 83.9 136.8 111.0 33.9 50.9 102.9 48.8 39.2 35.1 21.9 36.5 69.6 46.4 55.6 60.8 66.7 65.6 42.1 39.1 70.9 41.6 61.1 41.2 38.3 37.8 57.0 72.8 40.9 46.1 61.3 17.4 40.7 59.9 60.5 96.3 48.8 61.9 42.2 39.2 83.7 82.9 49.1 38.8 19.4 82.2 38.6 72.2 149.3 34.1 57.1 47.3 56.4 20.3 60.1 115.7 62.7 39.1 39.0 37.4 52.7 46.2 53.7 85.2 102.4 69.8 40.2 22.6 35.4 38.0 38.5 55.4 99.6 52.7 61.4 47.3 89.4 83.8 134.8 32.1 97.9 29.0 59.7 32.9 35.7 83.9 52.2 24.8 32.1 136.8 33.9 111.0 53.8 50.9 102.9 47.4 50.0 21.3 61.0 44.6 39.1 41.1 38.0 34.4 35.0 175.7 264.9 449.7 241.0 141.6 37.6 43.7 229.3 270.4 177.5 254.7 11.8 446.1 490.7 567.2 84.2 191.2 402.9 140.2 470.4 667.1 173.4 288.5 473.1 161.8 1260.7 50.9 263.3 228.9 810.9 28.3 159.6 1039.3 227.7 769.2 436.5 125.5 569.7 627.8 148.2 609.1 28.3 245.8 164.8 185.1 179.4 150.3 603.5 401.3 343.1 512.2 ARSA ENSG00000100299 "Arylsulfatase A" P15289 22 50622754-50628173 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 87.0;Late spermatids: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005554, CAB025183" Enhanced Uncertain "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 4500000 "Golgi apparatus" Cytosol "CAB025183: , HPA005554: AB_1078220" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (4.07e-2)" "prognostic favorable (2.96e-5)" "unprognostic (4.66e-2)" "unprognostic (4.40e-1)" "unprognostic (1.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.61e-2)" "unprognostic (2.16e-1)" "unprognostic (4.47e-2)" "unprognostic (2.76e-1)" "unprognostic (9.90e-2)" "unprognostic (1.41e-2)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" "unprognostic (7.73e-3)" 19.0 15.2 14.0 15.2 15.7 16.6 15.2 11.9 17.9 12.0 20.3 21.4 26.4 30.2 13.3 21.4 15.6 18.5 23.3 18.8 13.4 8.8 17.5 24.1 15.7 16.8 19.1 10.3 9.3 45.4 13.1 20.4 18.5 17.3 15.8 8.8 14.0 36.8 21.9 6.3 11.1 23.4 8.7 13.2 25.6 23.6 27.2 17.9 10.6 18.7 7.5 16.5 14.8 13.3 5.6 15.7 30.1 19.8 3.9 8.9 7.7 4.1 5.8 2.8 5.4 20.9 11.4 7.0 6.7 8.2 2.9 5.0 1.6 6.4 2.8 4.1 11.0 5.4 6.4 0.6 6.2 0.4 1.2 4.4 1.6 6.5 5.8 14.5 2.4 17.1 13.5 12.1 4.8 3.1 9.9 6.6 5.8 1.7 39.3 5.9 4.7 2.2 2.8 0.8 4.3 5.8 2.0 0.2 12.9 4.9 6.4 1.3 4.3 9.5 8.5 4.8 2.6 3.8 3.0 11.6 2.1 8.0 7.5 1.9 9.3 0.8 2.1 6.1 2.2 6.9 4.3 13.7 17.1 8.9 16.0 7.9 5.6 6.5 7.3 11.2 5.6 3.9 5.3 30.1 3.9 19.8 15.7 8.5 7.7 14.0 15.7 11.9 17.9 13.4 8.8 19.1 10.3 17.3 17.9 6.0 11.7 17.5 11.1 4.1 4.9 6.5 30.6 13.4 4.5 12.2 3.9 10.2 1.7 28.6 51.1 7.9 87.0 23.3 18.7 18.1 13.0 12.6 5.8 27.6 33.4 6.4 35.3 9.2 28.5 100.4 10.0 17.4 16.9 37.9 23.2 9.3 25.7 35.9 5.6 20.6 6.2 0.0 4.7 43.1 3.1 4.8 11.1 10.5 19.0 14.9 ARSF ENSG00000062096 "Arylsulfatase F" P54793 X 3041471-3112726 "Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.3;kidney: 11.5;skin 1: 8.3" "Cell type enhanced" "Detected in some" 31 "Distal tubular cells: 1.7;Proximal tubular cells: 4.6" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.0;U-266/70: 1.1" HPA000549 Uncertain Cytosol "Secreted in other tissues" NA NA Cytosol "HPA000549: AB_1845055" "unprognostic (2.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.87e-1)" "unprognostic (5.41e-3)" "unprognostic (3.83e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (9.72e-2)" "unprognostic (4.70e-1)" "unprognostic (6.33e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (3.59e-1)" "unprognostic (1.23e-1)" "unprognostic (9.76e-2)" "unprognostic (1.48e-1)" 0.0 4.6 2.7 0.0 5.3 0.0 0.1 0.0 1.9 0.4 0.0 0.0 0.0 2.5 3.1 0.0 0.0 0.0 1.3 0.5 11.5 1.7 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.6 1.5 0.3 0.2 1.9 0.3 0.8 0.3 0.0 0.2 0.4 0.5 0.7 0.0 0.2 2.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.2 0.3 0.0 0.0 0.3 0.4 0.0 0.4 0.2 0.3 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.3 0.0 0.1 0.5 0.1 0.1 1.1 0.1 0.1 0.8 0.4 0.3 1.9 0.3 0.4 0.2 0.3 0.3 0.1 0.3 0.2 0.0 0.3 0.3 0.3 1.2 0.8 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 ARV1 ENSG00000173409 "ARV1 homolog, fatty acid homeostasis modulator" Q9H2C2 1 230978981-231000595 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 92.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035709 Approved Uncertain Vesicles NA NA Vesicles "HPA035709: AB_2674744" "unprognostic (2.32e-1)" "unprognostic (4.69e-2)" "prognostic favorable (1.33e-4)" "unprognostic (3.29e-1)" "unprognostic (1.42e-1)" "unprognostic (9.95e-2)" "unprognostic (5.66e-2)" "prognostic favorable (3.27e-5)" "unprognostic (1.37e-1)" "unprognostic (1.12e-2)" "unprognostic (9.57e-2)" "unprognostic (9.82e-2)" "unprognostic (2.31e-1)" "unprognostic (4.82e-1)" "unprognostic (5.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.12e-3)" 8.2 16.3 22.0 10.1 31.0 10.0 16.1 17.1 24.3 11.0 20.0 16.5 13.9 13.8 8.1 20.6 13.6 12.3 17.0 24.2 23.8 21.8 21.0 20.9 12.5 11.0 22.7 17.7 9.8 14.9 18.4 25.8 9.4 22.0 14.0 21.6 15.4 16.9 13.4 15.7 14.6 15.6 10.7 27.1 10.5 13.7 24.6 18.2 11.0 18.4 16.8 11.9 12.7 9.3 15.3 13.9 7.3 17.7 12.5 14.0 8.3 20.0 21.8 10.9 13.0 15.9 13.9 10.2 9.4 17.5 17.4 20.1 8.0 15.7 5.8 11.8 10.9 10.7 16.5 20.5 12.8 20.7 14.7 28.8 17.9 15.8 10.8 16.2 26.3 14.6 15.0 13.5 9.4 10.9 11.3 11.6 18.0 26.3 15.9 11.4 7.0 10.7 8.0 14.0 21.2 14.8 12.7 16.2 16.4 23.2 16.5 11.4 17.3 11.3 13.4 27.8 2.7 24.0 23.5 6.4 6.9 4.4 12.6 22.6 24.6 21.6 14.4 18.9 23.0 18.8 6.4 7.6 7.3 9.8 10.8 13.3 15.3 11.0 11.7 9.1 10.1 13.8 12.7 1.9 12.5 17.7 13.9 14.0 8.3 22.0 31.0 17.1 24.3 23.8 21.8 22.7 17.7 22.0 18.2 14.9 24.8 20.9 19.1 11.4 19.4 26.9 7.6 17.4 18.2 27.9 2.0 32.5 51.4 20.9 26.0 11.9 11.7 46.7 35.3 12.7 17.5 14.6 16.2 17.9 21.8 36.5 7.5 12.3 11.5 14.7 8.6 14.3 23.6 9.0 15.0 28.4 17.4 10.5 15.6 24.2 13.2 0.0 14.4 92.9 16.8 13.2 13.0 7.9 27.4 16.2 ASAP3 "CENTB6, DDEFL1, FLJ20199, UPLC1" ENSG00000088280 "ArfGAP with SH3 domain, ankyrin repeat and PH domain 3" Q8TDY4 1 23428563-23484568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.6" "Lineage enhanced" "Detected in single" "monocytes: 1.6" "Cell line enhanced" "Detected in many" "ASC diff: 19.6;ASC TERT1: 18.6;HSkMC: 23.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020537, HPA020546" Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA020537: AB_2670467, HPA020546: AB_2670470" "unprognostic (2.51e-1)" "unprognostic (2.70e-2)" "unprognostic (4.35e-3)" "prognostic unfavorable (5.56e-4)" "unprognostic (3.87e-1)" "unprognostic (2.24e-2)" "unprognostic (1.19e-3)" "prognostic favorable (2.80e-4)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.30e-4)" "unprognostic (2.24e-1)" "unprognostic (1.18e-1)" "prognostic favorable (5.12e-5)" "unprognostic (3.39e-3)" "unprognostic (3.92e-2)" "unprognostic (2.02e-2)" "unprognostic (7.27e-2)" 10.6 15.5 8.7 5.9 9.9 0.7 15.2 2.6 8.3 11.0 8.9 6.6 13.5 2.4 7.9 7.7 12.9 8.7 7.8 20.7 6.9 5.1 10.7 7.4 7.9 2.3 9.2 6.1 29.6 13.7 13.7 7.4 12.4 16.3 12.0 6.8 8.2 14.6 25.5 24.2 32.5 3.7 9.9 15.4 1.9 8.9 9.4 6.7 0.2 12.0 12.0 6.2 7.0 17.7 0.1 0.0 0.0 1.6 0.0 0.4 0.4 1.0 1.0 10.6 6.9 19.6 18.6 13.1 1.9 2.3 3.0 3.8 0.7 0.0 5.4 2.2 3.7 1.7 5.0 7.3 1.7 1.7 0.2 0.9 0.3 2.8 6.8 10.6 0.0 0.5 23.7 2.7 4.7 4.3 8.9 2.3 0.8 3.6 0.0 1.8 2.2 0.7 0.0 1.8 2.9 2.5 2.8 1.1 0.0 2.0 2.1 0.4 3.6 8.3 2.1 2.1 5.5 7.9 0.0 0.8 1.2 3.2 3.6 0.1 2.3 2.3 0.6 0.5 0.0 0.7 0.0 0.2 0.0 0.0 0.7 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.4 8.7 9.9 2.6 8.3 6.9 5.1 9.2 6.1 16.3 6.7 8.9 7.0 0.0 1.7 1.8 1.0 11.6 0.0 2.7 2.3 3.5 0.0 1.6 3.3 4.0 3.5 3.1 2.1 0.0 5.2 32.0 6.7 3.3 1.1 3.4 1.6 0.0 1.2 3.7 0.0 5.6 11.5 0.4 0.0 0.0 7.0 7.5 4.0 0.0 12.7 4.9 0.5 0.0 1.9 6.0 8.1 3.8 1.1 0.0 3.7 1.1 ASPN "FLJ20129, PLAP-1, SLRR1C" ENSG00000106819 Asporin Q9BXN1 9 92456205-92482506 "Disease related genes, Plasma proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 62.1" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 59.6;Fibroblasts: 60.7;Ito cells: 22.7;Sertoli cells: 38.8;Smooth muscle cells: 29.5;Suprabasal keratinocytes: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 14.7;BJ hTERT+: 5.0;HHSteC: 21.0;HSkMC: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007894, HPA008435, HPA024230" Approved Uncertain Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 33000 Nucleoplasm Cytosol "HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113" "unprognostic (2.40e-1)" "unprognostic (1.02e-2)" "unprognostic (8.13e-3)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (1.01e-2)" "unprognostic (9.50e-3)" "unprognostic (1.17e-1)" "unprognostic (2.74e-3)" "unprognostic (6.38e-2)" "unprognostic (3.70e-2)" "unprognostic (4.70e-2)" "prognostic unfavorable (1.64e-7)" "unprognostic (1.42e-3)" "unprognostic (3.04e-2)" "unprognostic (6.27e-3)" "unprognostic (2.48e-2)" 13.4 2.2 0.5 5.2 1.7 0.0 4.8 0.4 0.7 40.2 14.6 0.6 8.1 2.8 62.1 26.7 15.3 9.9 26.4 31.6 0.6 0.6 3.5 21.9 10.3 0.7 0.9 1.4 7.8 4.7 0.8 1.9 3.7 1.0 12.2 3.6 1.6 2.0 3.6 10.8 3.7 19.7 37.1 0.8 0.8 8.8 6.7 0.4 1.5 7.1 27.7 2.2 24.2 3.8 0.4 0.2 1.9 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.3 14.7 0.0 2.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 4.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.2 0.1 0.7 0.2 0.0 0.0 0.5 1.7 0.4 0.7 0.6 0.6 0.9 1.4 1.0 0.4 0.0 1.4 0.0 0.0 59.6 0.5 3.6 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.0 0.3 5.8 0.0 0.0 0.0 0.0 60.7 0.0 1.1 0.4 0.2 0.0 0.0 22.7 0.0 0.2 5.5 0.5 13.5 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.6 38.8 29.5 0.0 0.0 23.6 0.0 0.0 0.0 0.0 ASPSCR1 "ASPL, ASPS, TUG, UBXD9, UBXN9" ENSG00000169696 "ASPSCR1, UBX domain containing tether for SLC2A4" Q9BZE9 17 81976807-82017406 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 151.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "Hep G2: 82.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026749 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA026749: AB_1845114" "unprognostic (5.01e-2)" "unprognostic (1.19e-3)" "unprognostic (7.61e-2)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "prognostic favorable (8.55e-4)" "unprognostic (2.02e-1)" "unprognostic (2.07e-2)" "unprognostic (3.43e-1)" "unprognostic (1.71e-3)" "prognostic favorable (2.67e-4)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (3.16e-2)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "unprognostic (1.01e-2)" 10.3 12.6 14.3 12.6 14.5 16.8 10.6 16.5 20.8 9.9 12.9 16.7 11.8 17.5 10.1 15.8 11.9 9.3 15.1 11.5 13.1 12.6 15.8 31.9 14.1 14.8 18.9 12.9 8.8 17.8 17.0 19.7 21.8 14.8 13.2 7.1 14.4 22.6 9.9 25.1 15.5 14.4 9.1 12.6 13.2 13.0 16.9 14.6 9.8 16.4 12.9 13.0 9.7 8.3 8.1 14.6 15.7 11.3 7.2 10.5 5.2 5.1 9.0 3.5 5.1 2.2 2.8 15.3 4.9 3.7 5.9 5.8 5.2 5.9 5.2 5.0 3.5 4.5 2.5 3.8 3.7 1.8 3.6 11.5 5.8 7.3 82.6 7.3 5.1 8.5 3.2 4.0 2.9 2.1 3.1 5.6 4.4 5.8 7.5 3.3 17.3 4.7 11.1 4.4 9.5 6.6 5.2 5.1 10.6 5.7 4.7 9.4 9.6 3.9 12.6 9.0 4.2 7.5 12.2 4.6 10.1 7.0 7.4 6.1 5.4 3.2 5.8 5.4 5.2 6.0 15.7 11.3 8.0 6.7 7.6 4.0 7.9 10.5 9.0 14.6 8.1 8.0 6.0 2.9 7.2 9.3 9.1 4.9 5.2 14.3 14.5 16.5 20.8 13.1 12.6 18.9 12.9 14.8 14.6 8.9 46.0 18.6 20.7 11.8 21.4 11.4 17.8 10.7 9.1 14.0 39.3 64.7 33.2 21.2 40.2 16.0 26.7 0.0 22.9 151.3 16.6 19.3 20.8 45.6 39.1 47.7 24.0 15.4 16.6 63.2 10.9 17.1 18.6 18.0 24.4 56.7 16.2 20.1 16.6 44.0 32.8 12.9 15.3 43.6 48.7 12.5 49.7 23.6 23.8 19.7 ATG2A KIAA0404 ENSG00000110046 "Autophagy related 2A" Q2TAZ0 11 64894546-64917248 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 16.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 16.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038715 Uncertain Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Vesicles Nucleoplasm "HPA038715: AB_10673474" "unprognostic (3.05e-2)" "unprognostic (2.33e-1)" "unprognostic (7.55e-2)" "unprognostic (1.18e-1)" "unprognostic (3.42e-1)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.37e-1)" "unprognostic (2.68e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-2)" "prognostic favorable (4.79e-5)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (3.37e-1)" "unprognostic (1.15e-1)" 8.4 8.3 6.0 8.4 10.4 63.7 7.1 12.2 14.3 7.2 9.2 11.6 8.2 10.0 9.5 5.5 6.1 7.7 8.9 6.4 7.0 6.4 9.0 33.2 9.3 7.7 7.5 7.5 11.8 11.7 7.6 8.7 8.9 9.0 8.5 4.3 12.1 9.3 8.4 12.4 15.9 11.4 9.7 6.7 11.1 9.2 8.0 8.2 13.2 8.4 7.8 9.4 7.9 6.2 1.0 2.3 16.5 2.0 1.5 2.6 0.9 9.9 9.7 3.6 9.6 4.7 3.3 9.5 5.5 8.3 7.6 5.6 8.6 7.9 7.2 11.7 4.8 9.8 8.6 3.6 6.6 2.0 6.7 12.4 6.4 14.5 7.7 6.7 5.0 14.9 9.1 5.8 9.6 5.1 4.4 6.3 7.3 12.1 5.9 3.3 16.2 6.0 17.0 4.1 2.8 10.8 6.7 5.6 10.4 4.1 8.6 13.1 5.1 8.1 11.8 10.2 2.8 11.4 6.4 8.0 7.2 7.1 14.2 4.2 11.5 4.0 5.1 10.6 4.0 4.5 2.8 2.0 2.0 2.6 1.9 2.2 0.8 1.7 2.2 1.3 1.0 1.4 2.5 16.5 1.5 1.5 2.3 0.9 0.9 6.0 10.4 12.2 14.3 7.0 6.4 7.5 7.5 9.0 8.2 8.9 14.4 11.8 7.7 25.6 17.0 5.6 2.5 10.7 10.3 8.7 31.4 11.2 1.7 8.3 1.7 9.0 26.4 0.0 8.9 4.7 14.6 10.6 9.2 17.5 9.7 12.7 34.4 8.6 14.6 2.5 11.8 16.9 28.7 10.8 12.8 10.3 12.5 16.1 9.6 5.2 25.4 12.9 10.7 6.2 5.5 33.5 56.0 39.2 15.6 13.5 ATP5MF "ATP5J2, ATP5JL" ENSG00000241468 "ATP synthase membrane subunit f" P56134 7 99448475-99466331 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 700.3;Distal tubular cells: 1212.0;Hofbauer cells: 681.7;monocytes: 591.5;Proximal tubular cells: 993.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067267, HPA070412" Approved Supported "Nuclear membrane,Mitochondria" NA NA 1400000 Mitochondria "Nuclear membrane" "HPA067267: AB_2685815, HPA070412: AB_2686266" "unprognostic (2.43e-2)" "unprognostic (1.42e-1)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (4.55e-3)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (6.19e-2)" "unprognostic (2.31e-3)" "unprognostic (2.58e-1)" "unprognostic (3.65e-2)" "unprognostic (6.88e-3)" "unprognostic (9.24e-2)" "unprognostic (4.90e-2)" "unprognostic (2.52e-1)" "unprognostic (5.78e-2)" 42.4 49.0 68.0 36.6 52.0 46.4 42.8 37.3 58.8 30.7 62.7 19.0 39.9 62.9 21.2 41.2 57.4 24.8 36.6 94.5 53.9 49.8 59.6 93.5 30.0 35.5 54.6 43.6 20.7 63.6 16.3 36.7 33.4 36.3 35.0 47.3 30.9 57.1 45.2 178.8 27.8 61.5 24.6 33.0 35.6 43.4 58.3 25.5 52.9 37.9 98.0 37.6 27.8 30.2 68.3 129.7 117.2 104.1 58.3 84.0 140.0 86.7 76.6 64.6 104.3 50.9 51.7 40.9 57.6 44.9 61.9 67.1 81.3 80.2 81.4 60.8 35.7 105.4 53.5 71.4 66.0 66.2 58.6 91.7 55.1 122.5 104.8 38.4 93.9 63.1 58.9 63.7 53.8 57.0 54.2 58.9 70.6 111.7 89.7 64.8 203.9 140.4 163.0 91.9 174.2 90.2 62.9 53.9 139.1 130.5 96.5 62.1 68.5 75.4 186.6 54.5 100.7 47.0 121.9 49.9 54.5 87.2 90.0 84.0 51.4 118.1 169.8 63.1 91.9 83.7 90.0 104.0 117.2 54.2 104.1 51.7 68.3 63.5 61.0 129.7 56.9 55.8 59.5 49.7 58.3 79.2 102.7 84.0 140.0 68.0 52.0 37.3 58.8 53.9 49.8 54.6 43.6 36.3 25.5 20.8 44.7 0.0 0.0 0.0 0.0 0.0 0.0 93.7 67.1 366.4 0.0 700.3 1212.0 418.8 0.0 0.0 0.0 0.0 501.7 525.7 0.0 0.0 59.3 0.0 681.7 0.0 0.0 0.0 0.0 0.0 0.0 46.9 0.0 591.5 0.0 0.0 502.5 0.0 0.0 993.9 0.0 0.0 0.0 0.0 0.0 0.0 364.9 0.0 0.0 0.0 ATP5MGL "ATP5K2, ATP5L2, dJ222E13.5" ENSG00000249222 "ATP synthase membrane subunit g like" Q7Z4Y8 22 42639803-42640601 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.9;bone marrow: 4.5" "Cell type enhanced" "Detected in some" 10 "Cytotrophoblasts: 9.5;Distal tubular cells: 5.0;Extravillous trophoblasts: 7.3;Hofbauer cells: 9.6;Syncytiotrophoblasts: 8.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RT4: 2.5" HPA044629 Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA044629: AB_2679028" "unprognostic (4.53e-2)" "unprognostic (3.46e-2)" "unprognostic (1.20e-2)" "unprognostic (5.67e-2)" "unprognostic (3.01e-2)" "unprognostic (3.36e-2)" "unprognostic (1.31e-2)" "unprognostic (1.70e-2)" "unprognostic (6.74e-2)" "unprognostic (4.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-1)" "unprognostic (4.17e-1)" "unprognostic (5.12e-2)" "unprognostic (1.85e-3)" 0.4 0.7 0.4 0.0 0.4 4.5 0.3 0.6 0.5 0.0 0.2 0.4 0.4 2.4 0.3 0.4 0.4 1.2 0.3 0.4 0.4 0.7 0.2 1.0 0.3 0.5 0.4 0.0 0.4 0.0 0.3 0.0 0.9 0.1 0.7 3.1 0.5 0.0 0.3 0.4 1.0 0.3 0.5 0.1 0.5 0.2 1.2 1.0 3.9 1.2 0.6 1.0 1.1 0.2 0.0 0.4 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.3 1.7 0.3 1.0 0.2 0.6 0.3 0.2 0.0 0.0 0.8 0.6 1.2 0.0 2.0 0.7 0.0 0.0 1.2 0.0 0.0 1.0 0.5 0.5 0.8 0.0 0.0 1.4 0.0 0.5 0.8 1.7 1.6 0.1 0.0 0.2 0.0 0.6 0.0 2.5 0.2 0.1 0.0 0.7 0.2 0.4 0.2 0.0 0.0 1.2 0.8 0.9 0.6 0.6 1.2 0.1 0.3 0.7 1.0 2.3 1.2 0.7 0.6 0.6 0.5 1.2 0.9 0.6 0.5 1.2 1.0 0.7 3.9 0.6 0.7 1.0 0.7 1.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.8 0.0 9.5 5.0 0.4 0.0 0.0 0.0 0.0 1.0 7.3 0.0 0.0 2.3 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 ATP6V0A1 "a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1" ENSG00000033627 "ATPase H+ transporting V0 subunit a1" Q93050 17 42458844-42522611 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.2;parathyroid gland: 65.6" "Cell type enhanced" "Detected in all" 8 "Cone photoreceptor cells: 276.9;Rod photoreceptor cells: 349.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022144 Enhanced Approved "Nuclear speckles,Golgi apparatus,Vesicles,Cytosol" NA NA 21000 "Golgi apparatus, Vesicles" "Nuclear speckles, Cytosol" "HPA022144: AB_1845189" "unprognostic (3.93e-2)" "unprognostic (2.02e-1)" "unprognostic (4.35e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-2)" "unprognostic (8.69e-2)" "unprognostic (1.84e-2)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.05e-4)" "unprognostic (3.25e-1)" "prognostic favorable (1.28e-4)" "unprognostic (3.07e-1)" "unprognostic (3.68e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (6.90e-4)" 9.4 15.6 19.3 9.3 46.1 9.9 9.1 55.8 66.2 8.0 11.6 25.8 5.1 17.9 11.4 11.1 9.6 9.7 12.2 9.9 23.8 32.8 20.3 11.3 12.7 6.6 23.6 24.8 11.4 9.3 65.6 23.6 11.2 43.3 9.9 11.3 19.7 8.2 10.7 28.9 14.7 12.4 11.7 23.7 11.1 8.8 9.8 13.1 5.2 16.3 6.7 7.8 6.7 6.9 6.3 9.1 14.2 10.5 0.1 2.8 4.2 6.6 13.8 8.5 15.2 14.2 12.4 4.9 4.7 8.8 10.1 13.3 8.8 15.0 1.2 8.7 9.7 13.9 14.5 13.0 8.0 11.8 10.3 13.6 10.7 10.4 6.9 8.8 4.6 19.6 9.1 11.6 16.2 6.9 12.6 7.1 5.0 38.9 42.3 15.0 5.7 1.8 4.1 5.4 8.8 0.1 0.1 8.8 18.6 11.7 5.3 23.4 12.4 7.3 6.7 14.0 11.5 16.3 7.0 4.2 8.6 0.3 12.6 5.6 17.2 23.4 2.5 11.5 0.1 10.0 12.1 10.5 8.0 0.8 3.4 1.2 3.5 0.6 0.1 9.1 6.3 1.0 0.8 14.2 0.1 2.4 4.7 2.8 4.2 19.3 46.1 55.8 65.9 23.8 32.8 23.6 24.8 43.3 13.1 17.9 46.6 27.3 45.1 17.5 158.7 19.5 30.6 6.7 14.8 14.0 276.9 26.4 10.0 14.7 2.4 19.2 44.6 46.7 15.8 13.4 33.9 38.7 23.1 33.6 46.0 90.6 81.5 19.6 33.1 3.1 16.1 25.8 38.8 3.6 23.1 51.9 17.6 38.6 22.3 28.4 349.7 6.5 48.9 38.7 18.5 17.7 83.5 4.4 19.5 10.7 ATP6V0A4 "a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2" ENSG00000105929 "ATPase H+ transporting V0 subunit a4" Q9HBG4 7 138706294-138799560 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 40.6;salivary gland: 55.4" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 15.7;Cytotrophoblasts: 11.7;Distal tubular cells: 26.6;Melanocytes: 6.8" "Cancer enriched" "Detected in many" 8 "renal cancer: 25.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SK-BR-3: 35.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA018029, HPA064555" Enhanced Uncertain Cytosol NA NA Cytosol "HPA018029: AB_1845190, HPA064555: AB_2685284" "unprognostic (1.99e-2)" "unprognostic (8.60e-3)" "unprognostic (1.12e-2)" "unprognostic (3.10e-2)" "unprognostic (1.43e-1)" "unprognostic (6.53e-2)" "unprognostic (4.63e-2)" "unprognostic (4.28e-1)" "unprognostic (1.35e-1)" "unprognostic (9.79e-3)" "unprognostic (1.73e-1)" "prognostic favorable (1.32e-6)" "unprognostic (4.35e-1)" "unprognostic (1.56e-1)" "unprognostic (1.02e-1)" "unprognostic (1.10e-2)" 0.1 0.0 0.5 0.0 0.3 0.0 2.2 0.1 0.4 1.7 0.0 0.3 3.1 0.0 0.3 0.5 2.7 0.0 0.0 0.0 0.4 0.3 40.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.6 0.2 1.0 0.2 0.5 0.0 0.3 55.4 1.2 0.0 6.5 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 1.8 7.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.4 1.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 3.1 1.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 3.0 0.1 0.0 0.0 0.0 35.9 1.2 2.0 0.1 0.0 0.1 0.4 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.1 0.4 0.4 0.3 0.3 0.0 0.2 0.1 0.0 0.6 0.0 0.8 0.0 0.0 0.3 0.0 1.4 1.2 15.7 2.0 11.7 26.6 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.3 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 4.2 0.0 0.0 1.1 ATP6V1C2 "ATP6C2, VMA5" ENSG00000143882 "ATPase H+ transporting V1 subunit C2" Q8NEY4 2 10721649-10785110 "Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 49.3;placenta: 39.0;retina: 54.4;salivary gland: 41.8" "Cell type enhanced" "Detected in some" 19 "Cytotrophoblasts: 101.4;Distal tubular cells: 38.1;Intestinal endocrine cells: 39.9;Syncytiotrophoblasts: 141.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "BEWO: 40.6;SK-BR-3: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA034734, HPA067305" Approved Uncertain Mitochondria NA NA Mitochondria "HPA034734: AB_2674305, HPA067305: AB_2732763" "unprognostic (2.29e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (6.55e-3)" "unprognostic (2.69e-2)" "unprognostic (2.20e-2)" "unprognostic (7.03e-3)" "unprognostic (8.53e-2)" "unprognostic (1.29e-1)" "unprognostic (2.11e-2)" "unprognostic (6.77e-2)" "unprognostic (2.73e-2)" "prognostic unfavorable (1.12e-11)" "unprognostic (6.17e-2)" "unprognostic (3.30e-1)" "unprognostic (2.37e-1)" "unprognostic (8.27e-2)" 1.4 0.9 0.4 0.4 0.5 1.1 2.4 0.5 0.8 21.2 0.8 0.6 49.3 0.1 2.1 30.5 6.9 0.8 0.8 0.7 0.8 0.3 13.2 2.0 0.8 0.5 0.4 0.4 0.9 1.1 0.1 8.9 39.0 0.5 1.8 0.7 54.4 41.8 15.1 0.4 36.7 0.7 0.4 0.6 1.3 0.6 0.8 0.4 0.9 1.4 6.0 3.5 0.5 7.2 1.1 0.8 0.6 1.7 0.9 2.2 1.1 0.3 0.4 1.3 1.5 0.0 0.0 40.6 0.6 0.0 0.0 0.0 0.8 1.0 1.0 0.8 0.0 0.6 0.6 0.6 0.0 0.0 0.5 1.5 0.5 0.6 1.4 0.0 0.9 0.6 0.0 0.1 0.0 0.0 1.0 0.0 0.3 0.4 2.0 0.0 1.2 0.3 1.5 1.0 0.6 0.4 0.8 0.7 3.3 0.0 0.9 1.1 1.3 0.3 14.5 0.4 5.5 1.4 2.1 0.2 0.5 1.0 0.6 0.5 3.5 1.0 0.6 0.6 0.8 0.4 0.3 0.8 0.6 2.2 1.7 1.3 1.1 1.0 1.7 0.5 0.9 1.0 0.5 0.0 0.9 0.8 0.8 0.9 1.1 0.4 0.5 0.5 0.8 0.8 0.3 0.4 0.4 0.5 0.4 0.0 1.6 0.0 4.2 0.3 0.0 1.0 0.0 2.7 2.3 7.0 0.0 101.4 38.1 0.0 0.6 0.1 0.0 0.0 0.2 23.0 0.5 0.6 2.3 0.0 12.0 0.0 39.9 0.0 0.3 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.4 2.0 141.4 0.0 0.6 0.3 ATP8A2 "ATPIB, ML-1" ENSG00000132932 "ATPase phospholipid transporting 8A2" Q9NTI2 13 25372071-26025851 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 34.9;pituitary gland: 37.0;testis: 10.4" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 90.3;Early spermatids: 29.4;Rod photoreceptor cells: 86.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3;naive CD8 T-cell: 3.3" "Lineage enriched" "Detected in single" 12 "T-cells: 3.3" "Group enriched" "Detected in some" 4 "HMC-1: 21.6;JURKAT: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039926, HPA040033" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA039926: AB_10794205, HPA040033: AB_2676809" "unprognostic (3.79e-2)" "unprognostic (4.28e-2)" "unprognostic (3.32e-2)" "unprognostic (1.95e-4)" "unprognostic (3.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.31e-2)" "unprognostic (2.97e-3)" "unprognostic (2.77e-1)" "unprognostic (3.66e-1)" "unprognostic (4.96e-4)" "unprognostic (1.24e-1)" "unprognostic (1.18e-2)" "unprognostic (4.20e-5)" "unprognostic (9.10e-2)" "unprognostic (2.95e-1)" "unprognostic (7.22e-2)" 1.1 4.9 11.2 1.4 11.4 0.8 2.2 34.9 30.2 1.1 1.3 1.3 0.0 1.4 2.1 4.8 0.9 0.9 1.0 1.0 9.4 11.8 1.3 0.8 2.3 1.9 6.7 10.4 1.2 1.9 0.9 37.0 1.2 19.8 1.1 1.3 3.1 1.0 1.0 1.3 0.9 1.5 1.0 3.5 1.3 1.8 10.4 1.4 0.0 1.0 0.0 1.2 1.2 0.3 0.0 0.0 0.2 0.0 0.2 3.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.0 0.0 0.0 0.6 1.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 21.6 0.2 0.0 0.0 0.0 0.6 0.5 9.6 0.0 0.0 1.7 0.3 3.7 0.0 2.0 0.0 0.7 0.0 2.7 1.0 0.2 0.1 3.3 0.0 0.1 0.3 0.1 0.4 0.0 0.4 0.2 0.1 1.1 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.8 0.6 0.0 0.0 2.3 3.3 0.2 0.2 0.0 0.0 0.7 0.6 11.2 11.4 34.9 18.4 9.4 11.8 6.7 10.4 19.8 1.4 0.0 9.8 0.9 0.1 0.9 20.0 2.2 2.5 0.0 0.0 0.0 90.3 1.2 0.0 0.3 29.4 1.5 0.0 0.0 0.0 0.3 0.4 0.2 4.7 0.0 2.4 20.6 0.0 0.0 0.0 24.5 0.9 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.1 0.6 86.2 12.9 0.0 12.9 9.9 0.4 0.9 0.5 0.0 0.0 ATP8B1 "ATPIC, BRIC, FIC1, PFIC, PFIC1" ENSG00000081923 "ATPase phospholipid transporting 8B1" O43520 18 57646426-57803101 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hearing, Lipid transport, Transport" Translocase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 198.4;Mucus-secreting cells: 179.9;Undifferentiated cells: 138.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.5;HBF TERT88: 24.7;RT4: 58.5" "Low region specificity" "Detected in many" "HPA018673, HPA018674" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA018673: AB_1845207, HPA018674: AB_1845208" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "prognostic favorable (2.60e-4)" "unprognostic (8.81e-2)" "unprognostic (1.32e-3)" "unprognostic (2.06e-1)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (9.62e-3)" "unprognostic (1.97e-1)" "unprognostic (3.30e-3)" "unprognostic (4.55e-3)" "prognostic favorable (6.35e-4)" "unprognostic (1.88e-1)" "unprognostic (2.22e-1)" "unprognostic (3.25e-1)" "unprognostic (8.60e-3)" 3.8 2.3 0.0 1.8 0.0 0.0 3.4 0.0 0.3 4.5 21.3 8.9 2.4 0.8 6.7 2.6 4.8 1.8 0.2 0.0 2.1 3.0 3.6 0.0 0.1 0.7 10.7 2.7 1.1 1.3 6.0 19.3 5.8 2.8 0.4 3.6 11.1 2.0 0.2 1.2 13.3 0.0 5.7 0.2 12.8 5.4 6.0 2.0 4.7 2.1 0.7 1.3 0.3 10.2 3.5 0.1 0.1 3.6 6.6 5.0 19.9 19.4 21.0 13.1 2.6 8.9 0.7 6.0 27.5 8.3 15.2 0.1 4.2 24.7 0.2 0.4 0.1 0.9 0.9 1.1 0.2 0.1 1.0 3.8 6.3 11.1 15.5 11.0 0.2 0.1 0.4 12.1 4.9 0.2 0.2 0.2 11.0 1.0 0.1 0.1 0.2 2.9 58.5 0.4 0.3 0.4 12.3 0.1 0.5 3.8 0.6 12.6 17.1 0.6 2.7 4.6 0.2 0.1 0.2 0.4 0.2 0.9 0.8 2.1 0.5 1.3 0.9 1.0 2.7 1.0 0.7 0.5 6.0 0.9 1.0 4.7 0.7 1.2 2.0 0.4 0.3 17.9 18.2 4.5 44.8 6.9 0.7 4.0 33.1 40.2 48.9 38.4 0.0 17.1 0.0 20.8 2.0 26.8 198.4 0.0 45.9 1.9 5.1 74.4 4.6 16.8 2.3 6.4 65.7 30.1 3.8 0.0 0.3 1.3 6.8 1.0 179.9 0.2 33.7 74.8 0.0 0.1 1.1 12.9 17.6 0.3 1.2 14.3 9.2 1.5 138.5 100.6 ATP8B4 "ATPIM, KIAA1939" ENSG00000104043 "ATPase phospholipid transporting 8B4 (putative)" Q8TF62 15 49858238-50182817 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2" "Group enriched" "Detected in many" 4 "Early spermatids: 23.4;granulocytes: 19.6;Hofbauer cells: 12.9;Kupffer cells: 29.9;Late spermatids: 19.9;Macrophages: 17.3;T-cells: 8.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 6.9;NK-cell: 10.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 19.1;NB-4: 7.3;THP-1: 12.3;U-937: 38.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040254 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA040254: AB_10673028" "unprognostic (6.45e-3)" "unprognostic (3.83e-2)" "unprognostic (5.39e-2)" "unprognostic (2.96e-3)" "unprognostic (3.25e-1)" "unprognostic (6.51e-3)" "unprognostic (1.03e-1)" "unprognostic (4.87e-3)" "unprognostic (1.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.20e-2)" "unprognostic (1.53e-1)" "unprognostic (2.08e-1)" 2.3 1.2 1.6 1.5 2.1 28.1 1.0 0.6 0.9 26.0 1.5 1.7 1.6 0.4 18.2 3.5 0.6 9.5 3.1 0.8 2.5 0.9 1.0 1.2 3.2 0.7 2.7 0.1 3.9 0.4 0.2 1.1 2.9 2.1 0.7 1.2 0.8 0.9 0.6 0.4 0.5 1.1 2.7 3.1 2.3 0.6 0.9 4.6 0.8 0.5 0.8 2.1 1.3 1.5 0.0 2.2 6.9 1.7 10.6 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 5.2 0.0 3.0 0.6 0.0 0.0 5.3 19.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.4 38.5 0.0 6.9 1.7 2.4 0.5 0.8 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.8 10.6 0.3 0.0 0.0 0.8 1.6 2.1 0.6 0.9 2.5 0.9 2.7 0.1 2.1 4.6 0.0 3.4 1.3 0.1 1.3 0.2 1.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 23.4 0.5 0.4 0.0 0.0 1.6 3.3 0.5 19.6 2.8 12.9 0.0 0.0 1.8 29.9 19.9 1.7 17.3 1.7 1.0 0.3 0.5 0.0 0.0 0.7 0.8 0.0 0.0 4.3 0.4 0.6 0.3 2.4 8.6 0.0 0.1 ATR "FRP1, MEC1, SCKL, SCKL1" ENSG00000175054 "ATR serine/threonine kinase" Q13535 3 142449235-142578826 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 35.3;Spermatocytes: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054320 Supported "Nucleoplasm,Golgi apparatus" No No Nucleoplasm "Golgi apparatus" "HPA054320: AB_2682448" "unprognostic (1.47e-1)" "unprognostic (8.90e-2)" "unprognostic (2.90e-1)" "unprognostic (4.23e-2)" "unprognostic (2.25e-2)" "unprognostic (6.42e-2)" "prognostic unfavorable (8.39e-5)" "unprognostic (3.44e-1)" "unprognostic (1.67e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.94e-1)" "unprognostic (5.61e-2)" "unprognostic (1.06e-1)" "unprognostic (3.55e-1)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" 10.5 24.3 7.7 11.4 15.9 10.1 14.8 11.3 14.6 10.1 8.5 10.0 10.4 6.0 14.7 16.8 9.4 12.1 9.3 8.8 9.8 7.1 9.6 12.0 10.3 16.0 10.0 8.1 12.3 13.6 18.0 22.5 8.8 12.5 11.0 11.2 9.5 12.5 10.8 7.7 11.2 10.9 9.8 8.8 14.2 9.0 15.3 9.7 19.0 13.8 7.7 15.1 10.9 10.6 5.8 2.8 2.2 4.0 6.7 6.0 0.8 22.7 11.2 7.5 8.5 10.7 11.8 8.9 12.6 7.1 9.4 9.7 5.2 7.3 18.6 13.0 8.9 12.3 14.8 11.0 11.6 14.2 5.9 7.2 10.2 8.5 5.1 4.7 17.1 5.7 9.2 6.4 8.9 10.6 6.4 9.7 9.7 7.1 8.4 9.6 10.0 12.9 7.1 7.2 14.9 8.0 10.7 10.9 13.5 9.5 10.6 5.3 5.4 23.2 8.4 8.2 7.1 12.2 6.9 12.5 9.6 4.8 12.4 13.5 11.0 6.5 17.3 12.5 6.7 7.6 0.7 2.7 2.2 4.4 4.0 6.0 3.1 3.2 4.2 2.8 5.8 4.1 4.0 1.7 6.7 2.5 2.5 2.4 0.8 7.7 15.9 11.3 14.6 9.8 7.1 10.0 8.1 12.5 9.7 6.0 8.8 13.4 6.5 3.5 14.7 7.1 7.6 18.7 6.8 3.5 35.3 6.6 0.0 5.3 12.0 7.1 2.1 0.0 4.3 3.3 4.8 6.7 1.1 6.0 5.7 7.9 7.5 8.6 9.1 6.9 6.1 6.9 10.1 4.6 5.4 4.8 6.2 0.0 6.7 4.1 23.4 0.0 6.4 42.3 15.8 4.0 4.2 5.1 7.0 5.2 AURKA "AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7" ENSG00000087586 "Aurora kinase A" O14965 20 56369389-56392337 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 32.3;testis: 41.1" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 70.0;Extravillous trophoblasts: 59.5;granulocytes: 55.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001454, HPA002636" Enhanced Approved Nucleoplasm,Centrosome,Cytosol Yes Yes "Nucleoplasm, Centrosome, Cytosol" "CAB001454: AB_563420, HPA002636: AB_1845217" "unprognostic (7.73e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (9.40e-5)" "unprognostic (1.92e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (4.69e-3)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.47e-8)" "unprognostic (1.67e-1)" "unprognostic (6.83e-2)" "unprognostic (9.00e-2)" "unprognostic (5.14e-2)" 3.7 2.3 1.5 12.7 1.3 8.3 3.0 1.3 1.8 1.4 6.7 1.3 0.8 7.3 1.8 1.2 7.7 1.1 3.7 4.1 1.1 1.1 2.4 5.1 2.9 12.3 1.6 0.9 8.3 1.4 0.3 0.7 6.1 1.5 1.0 8.3 1.5 2.7 0.5 6.9 2.1 7.2 2.7 1.3 7.4 4.3 41.1 1.1 32.3 1.2 5.9 13.3 2.4 2.4 3.9 5.2 6.0 8.7 2.0 6.6 2.6 33.0 24.4 16.3 11.5 0.9 2.1 20.7 27.1 12.7 65.7 27.7 68.2 23.2 10.8 18.7 11.1 34.1 26.7 29.0 18.2 70.0 9.8 11.1 19.3 25.0 42.5 0.5 25.8 27.2 1.0 1.9 22.7 20.4 5.2 15.3 17.7 21.9 8.6 27.9 33.7 15.4 20.0 14.9 27.1 25.1 11.7 31.5 12.0 10.5 8.7 14.1 7.6 37.9 43.6 18.2 15.6 25.8 16.1 8.8 28.6 28.3 15.8 38.2 12.1 14.0 18.8 15.4 15.0 23.6 0.2 5.3 6.0 1.9 8.7 2.9 3.9 3.3 1.9 5.2 1.4 1.5 1.5 3.7 2.0 4.8 1.2 6.6 2.6 1.5 1.3 1.3 1.8 1.1 1.1 1.6 0.9 1.5 1.1 0.0 3.2 4.5 1.1 1.0 1.0 3.4 2.5 1.4 2.3 3.5 2.0 9.8 1.7 3.9 16.9 1.6 5.3 70.0 4.2 59.5 3.8 0.7 55.2 2.4 14.8 1.6 5.8 3.1 2.4 9.5 1.4 5.5 0.0 18.0 5.7 3.5 3.6 3.5 0.4 1.9 2.5 6.5 2.1 16.2 31.6 1.0 6.9 4.9 9.8 1.4 AXIN2 "DKFZp781B0869, MGC126582" ENSG00000168646 "Axin 2" Q9Y2T1 17 65528563-65561647 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 87.1" "Cancer enhanced" "Detected in all" "colorectal cancer: 33.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 11.8;CACO-2: 22.1;Hep G2: 32.9;OE19: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012283, CAB017783" Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB012283: AB_2290204, CAB017783: " "unprognostic (1.31e-2)" "unprognostic (1.29e-1)" "unprognostic (1.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.48e-1)" "unprognostic (9.81e-2)" "unprognostic (1.12e-2)" "unprognostic (1.82e-1)" "unprognostic (4.57e-2)" "unprognostic (8.84e-3)" "prognostic favorable (6.58e-4)" "unprognostic (1.98e-1)" "unprognostic (1.42e-1)" "unprognostic (3.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.74e-1)" "unprognostic (1.25e-1)" 7.4 10.1 9.0 7.0 8.9 0.9 5.2 8.2 13.1 16.5 12.2 8.7 10.5 7.2 29.0 7.7 6.5 18.6 6.9 7.3 7.9 5.7 3.5 2.5 15.2 3.4 5.3 10.3 14.7 3.9 3.2 5.8 18.2 10.6 14.8 15.2 7.8 4.6 9.8 12.4 14.9 7.5 18.0 4.8 6.9 14.6 6.8 9.0 27.6 11.3 3.6 3.8 11.8 8.7 4.1 0.0 4.4 0.0 1.9 5.1 0.8 0.0 5.9 11.8 0.2 4.3 1.8 5.2 0.1 0.5 0.4 0.7 22.1 2.1 0.4 0.7 3.4 0.4 0.1 2.4 0.0 0.8 1.0 1.3 0.0 1.0 32.9 0.4 0.0 0.0 1.0 0.9 0.9 0.2 0.7 1.0 2.2 0.0 0.5 0.6 0.1 5.7 0.0 2.3 36.5 0.2 4.1 0.6 0.0 1.1 0.1 3.7 2.4 0.2 0.1 2.0 9.1 0.4 0.1 2.6 2.3 4.3 3.3 0.7 0.0 1.2 1.5 1.1 0.2 1.1 4.4 0.0 0.0 0.3 0.0 0.8 1.0 2.3 0.4 0.0 4.1 5.1 0.8 0.0 1.9 0.0 0.0 0.0 0.8 9.0 8.9 8.2 13.1 7.9 5.7 5.3 10.3 10.6 9.0 0.0 7.0 0.0 1.2 10.0 3.8 8.1 2.5 1.4 10.3 0.0 3.9 14.3 0.0 1.0 27.8 3.8 2.8 0.0 0.7 87.1 17.5 4.1 0.0 1.9 3.3 1.6 5.2 1.3 0.0 11.2 6.1 0.3 16.9 1.8 18.7 3.5 0.7 3.5 10.3 0.6 1.9 12.9 5.9 5.4 12.6 4.8 11.9 0.0 16.8 1.1 AXL "ARK, JTK11, Tyro7, UFO" ENSG00000167601 "AXL receptor tyrosine kinase" P30530 19 41219203-41261766 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Differentiation, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Oncogene, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Kupffer cells: 104.4;Sertoli cells: 207.0;Smooth muscle cells: 341.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 8.8;plasmacytoid DC: 18.3" "Group enriched" "Detected in many" 14 "dendritic cells: 18.3;NK-cells: 8.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 67.0;U-251 MG: 71.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032501, HPA037422, HPA037423, HPA075217" Uncertain Supported "Vesicles,Plasma membrane,Actin filaments" NA Yes 12100000 61000000 "Plasma membrane" "Vesicles, Actin filaments" "CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: AB_2675470, HPA075217: " "unprognostic (2.20e-1)" "unprognostic (2.02e-1)" "unprognostic (6.79e-3)" "unprognostic (1.01e-1)" "unprognostic (1.40e-1)" "unprognostic (8.49e-3)" "unprognostic (2.42e-1)" "unprognostic (1.74e-1)" "unprognostic (3.15e-2)" "unprognostic (2.82e-2)" "unprognostic (9.57e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.53e-7)" "unprognostic (1.16e-3)" "unprognostic (1.52e-2)" "unprognostic (5.56e-2)" "unprognostic (4.83e-3)" 38.0 15.4 10.6 11.7 12.7 1.3 27.1 6.3 12.1 26.2 26.8 13.4 8.1 9.1 28.0 19.4 21.8 17.4 17.8 18.5 11.5 6.1 7.8 13.0 20.0 7.6 10.6 9.3 20.9 5.1 9.6 5.6 26.6 10.1 19.5 10.2 16.8 7.8 20.4 14.1 13.8 12.8 29.4 10.7 27.3 16.2 22.4 10.4 3.4 12.0 8.4 5.8 35.6 18.3 0.1 18.3 0.9 0.2 8.8 0.3 0.2 53.3 21.4 1.3 0.1 4.8 4.9 0.0 42.3 38.1 62.2 38.6 1.1 25.1 0.0 17.2 67.0 32.5 4.5 0.0 28.5 53.6 0.0 0.0 0.0 14.2 0.8 17.6 0.0 0.0 3.7 0.5 36.6 56.9 35.3 23.0 0.0 2.0 0.0 38.5 0.0 0.0 0.0 0.5 0.1 10.3 0.0 22.7 0.0 27.8 0.0 0.0 0.0 10.9 0.0 0.2 8.2 0.1 0.9 47.2 44.1 30.1 42.1 71.7 0.0 0.1 0.1 29.4 0.0 32.8 0.9 0.2 0.1 0.1 0.2 0.2 0.1 0.3 0.1 4.2 0.1 0.2 0.2 0.3 8.8 0.1 18.3 0.2 0.2 10.6 12.7 6.3 12.1 11.5 6.1 10.6 9.3 10.1 10.4 8.9 2.2 0.5 72.4 37.1 0.0 4.2 0.0 4.0 5.7 5.2 0.0 2.3 0.0 4.0 8.6 2.9 0.0 0.0 0.2 1.7 91.1 28.0 0.0 0.0 26.7 1.6 0.0 13.5 104.4 2.7 57.0 49.8 25.3 4.6 0.0 28.7 8.9 0.0 75.0 0.0 1.1 207.0 341.9 0.5 2.1 25.5 9.6 2.5 0.0 26.4 AZGP1 "ZA2G, ZAG" ENSG00000160862 "Alpha-2-glycoprotein 1, zinc-binding" P25311 7 99966720-99976157 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 158.8;salivary gland: 270.5" "Group enriched" "Detected in many" 6 "Glandular cells: 2272.6;Hepatocytes: 3981.0" "Group enriched" "Detected in many" 12 "breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 16.8;Karpas-707: 9.6;OE19: 49.6;RPMI-8226: 38.9;T-47d: 13.0" "Region enriched" "Detected in single" 4 "olfactory region: 0.9" "HPA012582, HPA012876, CAB016087, CAB032276" Enhanced Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 55200000000 160000000000 Vesicles Nucleoplasm "CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: " "unprognostic (8.14e-2)" "unprognostic (1.50e-1)" "unprognostic (3.41e-1)" "unprognostic (5.42e-3)" "unprognostic (4.98e-2)" "unprognostic (5.74e-3)" "prognostic favorable (2.90e-4)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (2.35e-2)" "unprognostic (1.79e-1)" "prognostic favorable (1.53e-4)" "unprognostic (2.18e-1)" "unprognostic (2.08e-2)" "unprognostic (9.80e-2)" "unprognostic (3.51e-3)" 6.4 0.0 1.1 1.3 1.7 0.0 64.1 1.1 1.4 1.1 1.4 1.5 0.9 1.4 0.9 1.2 1.3 0.0 2.2 9.0 1.2 0.4 18.0 158.8 3.0 0.9 2.7 1.2 1.0 55.3 0.0 0.9 1.0 1.3 62.4 0.0 1.6 270.5 2.5 1.0 11.5 1.5 0.9 1.1 0.9 14.4 1.2 1.7 0.9 1.0 3.0 3.2 1.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.2 4.3 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 1.6 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 1.4 0.0 49.6 0.0 0.0 0.5 38.9 0.0 0.0 0.0 0.6 0.2 7.9 3.8 0.0 13.0 0.0 0.0 0.1 0.0 0.6 0.3 0.6 0.2 0.1 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 1.7 1.1 1.4 1.2 0.4 2.7 1.2 1.3 1.7 20.8 187.7 32.0 321.8 3.8 0.0 94.8 420.4 5.3 50.0 5.2 2.0 0.0 39.7 11.0 1.3 0.4 8.5 46.7 221.1 0.0 0.2 2272.6 3.5 3981.0 0.0 0.0 11.9 58.3 79.1 3.1 0.9 0.3 59.1 3.6 5.4 22.6 173.5 5.8 0.0 512.3 0.2 0.0 1.1 4.3 0.4 8.4 0.0 15.2 6.3 497.4 B4GALNT4 "FLJ25045, NGalNAc-T1" ENSG00000182272 "Beta-1,4-N-acetyl-galactosaminyltransferase 4" Q76KP1 11 369796-382116 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.1;ovary: 18.6" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 17.5;Cardiomyocytes: 11.2;Horizontal cells: 31.8;Muller glia cells: 40.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.2;NTERA-2: 18.0;SCLC-21H: 22.4;SH-SY5Y: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043276, HPA053126" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA No "Nucleoplasm, Cytosol" Vesicles "HPA043276: , HPA053126: AB_2682049" "unprognostic (6.11e-2)" "unprognostic (7.82e-2)" "unprognostic (1.79e-1)" "unprognostic (6.92e-3)" "unprognostic (5.36e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.69e-3)" "unprognostic (4.99e-3)" "unprognostic (1.52e-10)" "unprognostic (9.01e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-4)" "unprognostic (1.25e-1)" 1.6 2.5 20.6 2.8 16.7 1.2 3.5 26.5 35.1 5.9 2.0 8.6 0.8 2.4 8.6 2.4 1.8 8.7 2.1 1.4 17.6 16.8 1.2 1.1 1.3 1.6 11.5 14.9 18.6 1.8 6.3 6.1 1.1 13.0 3.8 1.6 2.3 4.0 3.7 1.1 3.8 2.9 3.1 8.3 1.5 1.5 1.8 11.0 0.0 1.1 0.0 1.7 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.6 20.2 11.5 0.0 0.0 4.7 3.6 0.9 1.6 0.5 2.0 0.0 0.0 2.7 0.4 3.2 0.7 2.7 4.8 0.5 0.0 6.8 0.0 6.4 6.2 0.2 0.0 4.9 0.4 2.9 0.1 2.2 7.3 0.2 1.0 6.1 0.0 0.0 5.9 0.2 0.0 18.0 0.3 7.9 0.0 0.0 2.6 0.2 0.0 22.4 27.3 1.3 1.0 0.2 2.2 7.9 0.0 4.9 1.1 6.4 1.9 0.2 0.0 0.9 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.6 16.7 26.5 21.2 17.6 16.8 11.5 14.9 13.0 11.0 0.0 0.0 0.0 1.3 0.7 17.5 11.2 0.0 0.0 0.0 1.8 3.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.2 31.8 1.7 0.0 0.0 0.0 2.8 0.0 3.3 0.0 0.0 40.9 0.3 0.0 1.1 0.0 8.1 0.0 0.2 0.0 0.2 0.3 0.2 0.0 0.0 0.4 B4GALT3 beta4Gal-T3 ENSG00000158850 "Beta-1,4-galactosyltransferase 3" O60512 1 161171310-161177968 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 95.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 74.9" "Low region specificity" "Detected in all" HPA010793 Approved Supported "Golgi apparatus,Cytosol" NA NA 74000 "Golgi apparatus" Cytosol "HPA010793: AB_1078256" "unprognostic (5.67e-3)" "unprognostic (7.68e-3)" "unprognostic (1.20e-2)" "unprognostic (8.15e-3)" "unprognostic (3.91e-1)" "unprognostic (1.10e-2)" "prognostic unfavorable (5.87e-5)" "unprognostic (3.11e-2)" "unprognostic (3.13e-1)" "unprognostic (4.64e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-1)" "prognostic unfavorable (7.12e-7)" "unprognostic (1.86e-1)" "unprognostic (1.56e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-1)" 20.7 18.7 16.5 17.2 22.1 17.3 33.4 20.1 23.2 15.0 19.0 12.4 22.2 18.4 13.6 21.0 20.4 17.2 17.5 17.2 13.4 14.7 22.5 21.7 20.8 21.6 16.4 13.4 25.4 37.5 15.8 29.1 41.0 16.6 18.5 19.3 14.8 33.0 27.8 19.5 20.2 15.1 11.7 14.1 26.6 21.5 28.4 16.4 14.8 28.2 10.7 21.4 20.6 22.9 16.7 22.6 7.1 12.6 15.1 25.5 11.9 9.9 6.6 9.8 12.9 14.6 7.5 15.7 5.7 10.2 11.8 10.9 13.0 20.4 9.2 16.3 6.4 11.3 10.2 10.3 6.3 7.0 9.6 12.6 5.3 4.4 10.4 10.5 10.3 14.8 10.4 9.4 10.9 11.9 14.2 13.4 12.1 17.0 20.8 9.6 10.3 6.7 9.9 12.3 20.1 14.1 8.2 5.5 22.7 10.1 6.2 14.0 16.6 5.7 15.1 11.9 13.9 15.1 18.9 5.6 5.9 10.7 6.7 16.6 74.9 40.4 12.3 8.8 8.9 9.4 5.1 8.9 7.1 17.6 10.1 15.7 16.7 16.7 16.8 10.8 13.5 16.4 15.4 5.9 15.1 12.6 22.6 25.5 11.9 16.5 22.1 20.1 23.2 13.4 14.7 16.4 13.4 16.6 16.4 17.9 18.3 36.5 26.3 34.2 12.6 9.5 7.6 10.7 6.8 24.4 2.0 38.4 5.0 25.4 7.0 20.2 14.7 0.0 19.9 75.2 19.5 33.5 9.2 11.6 25.2 25.4 27.6 26.4 16.8 4.0 8.9 13.8 21.9 6.4 22.4 7.4 28.1 14.4 6.7 17.3 6.3 25.8 34.6 9.8 42.9 36.6 95.5 34.6 21.7 45.5 BAAT BAT ENSG00000136881 "Bile acid-CoA:amino acid N-acyltransferase" Q14032 9 101360417-101383519 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Hydrolase, Serine esterase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 128.4" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 745.7" "Cancer enriched" "Detected in many" 42 "liver cancer: 181.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.1;CACO-2: 3.4;Hep G2: 2.4;OE19: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021251, HPA021330" Enhanced Uncertain Vesicles NA NA 470000 Vesicles "HPA021251: AB_1845247, HPA021330: AB_2670674" "unprognostic (2.53e-2)" "unprognostic (1.81e-1)" "unprognostic (9.97e-2)" "unprognostic (9.33e-2)" "unprognostic (7.75e-3)" "unprognostic (4.68e-2)" "prognostic favorable (4.97e-4)" "unprognostic (2.14e-2)" "unprognostic (6.19e-2)" "unprognostic (4.43e-4)" "unprognostic (3.65e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (4.24e-7)" "unprognostic (1.74e-1)" "unprognostic (2.12e-1)" "unprognostic (2.17e-2)" "unprognostic (1.75e-1)" 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 22.8 0.0 0.1 0.1 0.2 128.4 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.7 0.1 0.1 6.1 0.4 0.3 0.0 0.0 0.0 0.3 0.1 0.1 0.3 3.4 0.1 0.6 0.2 0.0 0.3 0.3 0.1 0.2 0.5 0.3 0.1 0.5 0.2 2.4 0.0 0.9 0.3 0.0 1.0 0.1 0.0 0.1 0.0 0.8 0.7 0.4 0.5 0.1 0.2 0.3 1.0 2.6 0.7 0.2 1.1 0.2 0.6 0.2 0.3 0.4 0.4 0.2 0.5 0.2 0.0 0.2 0.1 0.6 0.6 0.2 0.4 0.4 0.6 0.5 0.5 0.2 0.6 0.3 0.2 0.0 0.7 0.1 0.1 0.5 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.8 0.4 89.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 745.7 0.0 0.0 0.0 11.1 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 BARD1 ENSG00000138376 "BRCA1 associated RING domain 1" Q99728 2 214725646-214809711 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 54.9;Basal keratinocytes: 60.9;Spermatogonia: 54.9;Suprabasal keratinocytes: 65.1;Urothelial cells: 57.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB034106, HPA035354, HPA044864" Enhanced Supported "Nuclear speckles,Cytoplasmic bodies" No No "Nuclear speckles" "Cytoplasmic bodies" "CAB034106: AB_2061237, HPA035354: AB_2674585, HPA044864: AB_2679119" "unprognostic (4.85e-2)" "unprognostic (1.87e-2)" "unprognostic (1.74e-2)" "unprognostic (8.37e-3)" "unprognostic (2.57e-2)" "unprognostic (1.03e-2)" "unprognostic (6.25e-4)" "unprognostic (1.99e-1)" "unprognostic (2.16e-2)" "unprognostic (3.92e-3)" "unprognostic (2.80e-2)" "unprognostic (7.41e-2)" "unprognostic (1.94e-8)" "unprognostic (3.94e-2)" "unprognostic (2.28e-1)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" 4.4 1.9 3.2 11.8 4.8 16.1 4.9 1.2 5.8 7.3 5.4 5.4 3.6 3.7 6.8 5.0 10.0 4.1 3.9 3.6 3.4 2.8 2.2 2.1 5.3 8.2 5.1 1.9 5.8 3.7 3.6 6.3 3.8 4.5 5.7 6.1 1.9 4.7 6.5 12.4 16.3 4.5 7.5 5.3 4.7 3.8 9.5 3.9 25.8 4.0 8.0 9.9 8.3 7.8 9.7 6.6 6.0 3.4 6.1 16.0 2.0 7.8 4.3 11.9 6.1 1.6 2.0 8.2 9.6 5.6 9.4 10.9 5.5 7.8 8.5 4.6 3.9 5.8 8.6 8.5 5.6 13.5 6.7 4.4 8.4 8.0 5.8 0.6 9.4 8.5 2.7 0.8 8.3 4.6 3.2 3.2 9.4 4.7 23.9 9.1 6.5 16.8 9.8 9.4 4.9 2.2 14.5 12.0 7.7 2.8 6.6 3.7 6.0 8.8 10.1 3.5 7.1 10.3 9.4 2.7 12.2 8.6 7.1 8.6 7.2 8.0 17.2 4.9 7.2 8.1 2.9 1.7 6.0 4.8 3.4 3.1 8.9 5.3 5.2 3.0 9.7 2.5 3.6 0.5 6.1 2.9 6.6 16.0 2.0 3.2 4.8 1.2 5.8 3.4 2.8 5.1 1.9 4.5 3.9 6.0 2.1 9.5 54.9 60.9 3.3 12.5 15.3 12.0 9.1 8.7 0.0 9.4 3.3 6.8 8.1 7.5 3.4 23.3 6.0 13.6 7.7 21.0 15.0 3.6 10.6 1.6 1.2 12.3 8.8 3.6 5.8 8.8 3.3 17.2 11.3 3.3 5.6 5.8 9.6 0.6 6.8 19.4 15.5 19.7 54.9 65.1 4.2 8.6 11.0 57.3 BARX2 ENSG00000043039 "BARX homeobox 2" Q9UMQ3 11 129375940-129452279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 99.1;Suprabasal keratinocytes: 72.1;Urothelial cells: 102.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB033311, HPA064966, HPA068414" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984" "unprognostic (4.25e-2)" "unprognostic (2.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.22e-5)" "unprognostic (3.85e-2)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (1.43e-3)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.15e-1)" "unprognostic (8.39e-2)" "unprognostic (3.48e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.06e-4)" 0.1 0.0 0.3 1.6 0.5 0.0 6.0 0.6 0.9 8.7 4.4 1.4 0.3 7.1 0.6 1.8 49.8 6.8 5.0 0.1 0.5 0.4 1.9 0.1 0.5 0.1 0.7 0.2 1.0 6.9 0.0 0.6 1.5 4.1 1.5 1.9 0.0 78.3 0.7 1.0 11.2 7.9 0.0 1.6 0.0 2.6 1.2 0.2 0.4 0.5 40.7 36.4 0.2 22.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.4 7.8 0.0 1.9 0.0 60.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.7 0.0 1.5 0.0 2.3 0.0 0.0 0.0 7.7 0.3 0.0 0.0 14.7 0.0 0.1 0.1 0.0 0.0 7.4 0.0 0.1 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.6 0.9 0.5 0.4 0.7 0.2 4.1 0.2 0.0 1.4 0.0 99.1 38.2 0.4 0.4 2.5 6.7 6.8 0.0 0.0 10.6 6.6 18.2 6.5 0.3 27.5 0.0 0.6 6.4 2.3 15.2 0.0 0.0 1.6 0.0 1.7 0.0 0.0 1.3 0.0 0.8 10.1 0.0 12.2 0.8 5.0 22.1 0.4 1.4 0.2 0.0 0.7 0.0 1.1 72.1 3.5 0.0 15.8 102.1 BATF3 "JDP1, JUNDM1, SNFT" ENSG00000123685 "Basic leucine zipper ATF-like transcription factor 3" Q9NR55 1 212686418-212699985 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.8" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 36.2;Macrophages: 24.9;monocytes: 98.2;Smooth muscle cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 18.0;myeloid DC: 16.5;non-classical monocyte: 26.8" "Group enriched" "Detected in many" 36 "dendritic cells: 16.5;monocytes: 26.8" "Cell line enriched" "Detected in some" 12 "HDLM-2: 93.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA075858 Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA075858: " "unprognostic (3.87e-2)" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (6.85e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (3.84e-2)" "unprognostic (6.59e-2)" "unprognostic (3.08e-1)" "unprognostic (6.47e-2)" "unprognostic (1.28e-2)" "unprognostic (1.75e-1)" "unprognostic (6.43e-10)" "unprognostic (9.88e-2)" "unprognostic (5.19e-2)" "unprognostic (3.90e-1)" "unprognostic (7.08e-2)" 10.4 1.3 6.7 6.3 9.4 5.4 3.5 0.4 5.2 2.0 2.4 3.3 0.2 1.4 1.8 0.4 1.8 2.6 3.8 4.1 5.5 2.1 2.6 2.3 7.2 8.7 9.5 2.8 3.1 3.2 1.2 1.3 4.6 4.3 2.3 1.6 0.5 2.2 1.2 1.5 1.1 4.3 3.7 4.7 9.5 3.2 1.1 7.1 5.0 2.1 2.6 4.9 3.0 6.0 0.2 16.5 0.6 26.8 0.3 0.4 2.4 0.3 0.9 0.1 0.0 0.0 0.6 0.7 0.5 1.1 1.1 1.2 0.0 0.3 0.0 0.2 0.0 1.8 0.0 1.1 0.2 0.8 93.1 2.2 0.0 0.3 0.0 0.2 4.2 0.6 0.1 0.0 2.2 0.3 0.1 0.0 7.7 0.1 1.1 0.2 0.0 3.2 1.7 0.4 0.0 1.5 0.6 0.4 0.0 1.0 0.0 0.2 0.1 0.3 0.0 0.0 0.4 0.0 3.0 0.0 0.5 2.1 0.1 2.4 0.1 0.2 0.5 1.5 3.8 1.1 0.0 4.1 0.0 0.0 18.0 0.0 0.2 0.0 0.0 16.5 0.0 0.0 0.0 0.6 0.3 26.8 0.0 0.4 2.4 6.7 9.4 0.4 5.2 5.5 2.1 9.5 2.8 4.3 7.1 3.0 1.1 0.5 2.2 5.0 0.1 0.3 0.0 4.0 2.3 0.0 0.0 0.8 0.0 0.7 0.3 5.8 0.0 0.0 0.3 36.2 8.5 6.6 4.7 0.2 4.6 0.0 0.0 6.2 10.5 0.8 0.9 24.9 1.7 98.2 0.0 0.2 1.3 0.0 0.0 0.5 0.4 0.0 25.8 1.1 4.3 2.5 3.8 1.0 0.0 0.9 BAZ1A "ACF1, hACF1, WALp1, WCRF180" ENSG00000198604 "Bromodomain adjacent to zinc finger domain 1A" Q9NRL2 14 34752731-34875647 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 380.8;Early spermatids: 560.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 22.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 22.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA002730 Supported Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA002730: AB_1078269" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (2.76e-2)" "unprognostic (1.84e-2)" "unprognostic (4.24e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (4.11e-2)" "unprognostic (3.99e-3)" "unprognostic (1.01e-2)" "unprognostic (2.24e-3)" "unprognostic (9.02e-2)" "prognostic unfavorable (1.31e-7)" "unprognostic (2.44e-1)" "unprognostic (7.83e-2)" "unprognostic (2.90e-2)" "unprognostic (4.37e-2)" 15.2 5.3 3.8 23.8 4.6 39.3 9.8 1.6 3.1 9.3 14.0 3.0 9.9 6.0 6.8 5.8 14.8 7.6 8.3 9.4 3.7 2.6 7.5 11.7 23.7 21.9 8.2 1.1 11.7 6.7 6.2 6.6 13.4 5.1 10.1 8.0 3.3 10.7 8.2 9.0 14.4 17.6 7.0 6.6 34.7 7.6 17.4 5.3 33.2 8.4 15.1 19.4 14.7 18.6 3.6 3.0 22.0 4.7 2.0 2.9 1.0 16.6 8.9 14.9 11.4 6.5 7.6 18.5 13.5 7.4 12.7 12.8 8.7 12.1 33.4 10.7 9.6 7.0 17.4 25.4 8.8 22.2 12.0 10.9 21.7 8.1 24.2 7.7 35.8 26.3 7.0 9.1 13.7 18.4 5.1 18.4 15.2 20.0 8.6 10.6 19.0 34.0 11.2 7.2 13.2 12.5 26.1 15.5 9.3 7.9 16.2 19.0 15.6 18.4 25.3 7.3 5.3 12.9 24.9 16.1 11.8 8.7 12.6 13.6 4.8 4.7 28.6 3.8 16.8 13.4 3.9 4.3 5.1 2.6 4.5 1.9 3.3 2.7 2.9 2.4 3.6 2.7 2.2 22.0 2.0 4.7 3.0 2.8 1.0 3.8 4.6 1.6 3.1 3.7 2.6 8.2 1.1 5.1 5.3 56.6 74.6 62.4 190.4 380.8 2.3 11.6 25.5 73.6 58.0 15.7 2.0 59.9 0.0 79.3 560.7 61.8 66.5 23.3 65.2 94.9 81.7 165.1 101.3 28.0 79.6 0.0 29.2 25.8 88.6 290.9 37.4 126.2 69.2 144.3 45.8 2.8 92.7 70.2 12.7 10.3 2.0 6.5 117.4 223.9 39.1 340.5 164.7 97.6 50.3 278.3 BBOX1 "BBH, BBOX, G-BBH, gamma-BBH" ENSG00000129151 "Gamma-butyrobetaine hydroxylase 1" O75936 11 27040725-27127809 "Enzymes, Predicted intracellular proteins" "Carnitine biosynthesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 139.4;liver: 39.3" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 1023.7" "Group enriched" "Detected in many" 6 "glioma: 23.7;renal cancer: 59.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTCEpi: 16.2;RPTEC TERT1: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007600, HPA027823" Enhanced Approved Uncertain "Vesicles,Actin filaments" NA NA 25000 Vesicles "Actin filaments" "HPA007600: AB_1845284, HPA027823: AB_10602394" "unprognostic (9.96e-3)" "unprognostic (1.80e-2)" "unprognostic (8.17e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (7.03e-2)" "unprognostic (6.66e-2)" "unprognostic (7.05e-3)" "unprognostic (1.13e-2)" "unprognostic (3.03e-1)" "unprognostic (6.89e-2)" "unprognostic (2.03e-2)" "unprognostic (1.60e-1)" "prognostic favorable (1.45e-5)" "unprognostic (1.71e-2)" "unprognostic (2.70e-1)" "unprognostic (3.22e-1)" "unprognostic (1.73e-3)" 0.9 0.5 9.2 0.5 7.1 0.5 8.2 3.9 7.5 1.5 0.6 4.9 0.1 0.5 0.6 3.6 5.7 3.8 3.6 0.5 7.9 6.3 139.4 39.3 0.6 0.6 10.9 4.3 0.5 0.8 0.5 8.3 1.3 9.2 0.7 0.5 0.0 2.2 2.0 0.6 16.4 0.5 0.5 7.1 0.5 0.6 0.6 5.8 0.0 8.9 1.6 0.7 0.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.0 16.2 0.0 0.0 3.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.5 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 7.1 3.9 7.5 7.9 6.3 10.9 4.3 9.2 5.8 0.0 1.1 0.0 5.5 7.2 0.0 0.0 17.8 6.7 2.3 43.6 0.0 0.1 189.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 25.4 0.0 0.0 0.0 0.6 1.2 1.1 0.0 0.0 1.7 0.0 0.0 11.3 0.1 0.0 0.4 1023.7 0.3 0.0 0.4 0.0 0.1 31.2 0.2 0.0 0.0 2.2 BBS1 FLJ23590 ENSG00000174483 "Bardet-Biedl syndrome 1" Q8NFJ9 11 66510606-66533627 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Olfaction, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 14.7;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 11.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA058283 Uncertain Uncertain Midbody NA NA Midbody "HPA058283: AB_2683667" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (1.56e-1)" "unprognostic (1.08e-3)" "unprognostic (1.40e-2)" "unprognostic (6.68e-2)" "unprognostic (1.72e-2)" "unprognostic (2.76e-1)" "unprognostic (1.19e-3)" "unprognostic (2.61e-2)" "unprognostic (6.05e-2)" "unprognostic (3.04e-1)" "unprognostic (2.20e-1)" "unprognostic (2.38e-1)" "unprognostic (4.87e-4)" 9.0 14.1 17.3 6.1 24.7 3.4 12.4 23.0 32.7 21.3 13.7 15.5 16.5 7.3 21.9 19.9 10.0 30.2 14.5 10.5 13.9 15.8 26.2 7.7 11.5 5.4 11.4 20.4 30.4 14.3 44.6 21.4 9.2 14.8 17.6 8.5 22.7 17.2 25.0 6.5 9.5 7.7 15.8 8.4 6.4 12.2 11.0 9.5 8.0 28.8 6.2 7.7 14.7 9.7 4.7 2.3 2.0 5.0 5.3 5.2 3.1 4.1 4.2 10.0 3.9 18.9 13.4 4.4 3.4 6.9 5.3 4.4 6.9 7.3 0.5 7.4 8.6 4.1 7.6 7.4 7.6 5.0 3.7 4.5 1.7 5.3 3.9 8.8 3.1 1.0 13.4 7.2 7.0 5.3 13.2 6.9 6.1 3.8 2.7 5.6 3.6 2.7 3.3 6.0 12.6 7.9 6.9 6.5 5.1 14.4 5.2 10.1 6.8 5.7 6.4 13.1 5.3 13.3 1.5 6.6 3.8 4.3 4.4 1.1 2.4 1.1 1.0 12.7 0.9 4.2 0.0 3.0 0.5 4.0 3.2 5.2 4.7 5.1 4.2 2.3 2.4 3.8 4.8 2.0 5.3 5.0 1.1 1.6 3.1 17.3 24.7 23.0 32.7 13.9 15.8 11.4 20.4 14.8 9.5 0.0 2.1 0.0 1.1 0.5 4.2 0.4 0.0 14.7 1.2 0.0 7.9 1.3 0.0 0.6 3.9 0.6 0.1 0.0 0.3 0.6 1.1 0.9 0.0 0.0 0.5 0.0 1.2 0.6 1.6 0.6 0.9 0.3 0.0 1.0 0.4 1.2 0.4 0.0 1.4 1.3 11.5 0.0 0.5 4.9 2.5 0.9 0.8 0.0 0.8 1.0 BCKDHB ENSG00000083123 "Branched chain keto acid dehydrogenase E1 subunit beta" P21953 6 80106647-80346270 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.6" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 56.4;Hepatocytes: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031580, HPA031956" Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" Yes No Mitochondria Nucleoli "HPA031580: AB_10696054, HPA031956: " "unprognostic (4.23e-1)" "unprognostic (1.61e-1)" "unprognostic (9.50e-3)" "unprognostic (9.37e-3)" "unprognostic (1.66e-1)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (2.30e-2)" "unprognostic (1.94e-1)" "unprognostic (7.32e-3)" "unprognostic (2.67e-1)" "unprognostic (4.65e-2)" "prognostic favorable (5.54e-9)" "unprognostic (2.67e-1)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (1.49e-2)" 13.9 12.0 9.9 9.0 12.2 5.8 18.1 9.5 14.3 10.2 17.3 22.7 9.4 9.1 11.6 7.7 10.2 10.9 7.4 14.7 11.9 7.6 24.7 58.6 6.4 8.1 11.3 11.2 13.9 12.1 13.7 15.5 5.5 14.1 13.1 16.5 11.7 30.5 10.3 8.2 8.6 11.8 11.5 16.7 5.3 15.0 10.0 12.4 11.2 12.5 7.9 7.7 14.0 8.2 9.1 10.3 2.6 4.3 13.4 15.7 5.2 7.0 2.6 10.0 13.4 10.2 8.9 8.0 5.0 10.4 8.3 11.4 4.3 9.7 20.0 5.4 12.0 9.7 7.1 5.5 6.6 11.6 24.8 8.2 9.9 6.9 5.8 11.3 14.0 4.5 8.5 6.8 5.7 7.1 7.4 9.8 15.6 8.3 17.9 18.5 3.9 5.1 8.2 7.4 15.4 3.4 13.0 31.1 17.1 22.9 10.8 6.7 9.5 8.5 7.1 5.0 11.5 9.1 10.8 4.2 5.0 3.4 4.5 6.7 12.8 12.5 6.6 6.1 10.5 7.4 2.6 3.4 0.8 8.5 4.0 11.1 9.1 7.2 7.2 6.6 9.1 9.6 10.0 0.7 13.4 4.3 10.3 15.7 5.2 9.9 12.2 9.5 14.3 11.9 7.6 11.3 11.2 14.1 12.4 8.9 15.2 6.7 10.1 7.6 7.0 26.0 10.2 16.0 14.8 5.2 2.0 15.7 23.2 6.8 56.4 9.0 12.4 0.0 9.0 6.6 13.0 8.6 16.1 55.0 10.2 3.2 11.5 11.1 9.8 4.1 8.1 6.1 15.1 10.0 28.8 14.6 4.5 11.5 8.1 25.2 8.2 6.5 8.9 7.7 4.8 10.8 8.7 8.9 15.3 9.8 BCL2L14 "BCL-G, BCLG" ENSG00000121380 "BCL2 like 14" Q9BZR8 12 12049844-12211084 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 40.1;testis: 29.8" "Group enriched" "Detected in many" 11 "Early spermatids: 317.4;Late spermatids: 661.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.0" "Lineage enhanced" "Detected in single" "T-cells: 3.0" "Group enriched" "Detected in some" 4 "CAPAN-2: 5.1;NTERA-2: 3.9;OE19: 5.0;RT4: 4.7;SuSa: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040665, HPA059846" Enhanced Uncertain Cytosol NA NA Cytosol "HPA040665: AB_10964282, HPA059846: " "unprognostic (3.65e-4)" "unprognostic (4.95e-3)" "unprognostic (1.68e-2)" "unprognostic (2.02e-3)" "unprognostic (2.69e-1)" "unprognostic (2.70e-4)" "unprognostic (1.10e-1)" "unprognostic (2.43e-1)" "unprognostic (3.24e-2)" "unprognostic (4.59e-5)" "unprognostic (1.06e-2)" "unprognostic (1.06e-2)" "unprognostic (5.79e-6)" "unprognostic (3.83e-2)" "unprognostic (3.37e-2)" "unprognostic (2.82e-2)" "unprognostic (1.73e-8)" 0.1 0.1 0.1 5.3 0.2 0.0 0.3 0.1 0.1 0.3 17.6 0.1 0.1 11.5 0.1 0.4 0.4 0.2 7.7 0.1 0.1 0.1 0.3 0.3 1.3 1.6 0.1 0.1 0.4 11.2 0.0 0.1 0.1 0.1 1.6 13.3 0.1 0.8 0.1 0.1 0.1 40.1 0.1 0.1 0.9 7.8 29.8 0.1 4.1 0.1 0.3 1.2 2.5 0.2 0.9 0.0 0.1 0.2 0.0 3.0 0.3 0.2 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.9 5.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.9 5.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.1 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.7 0.9 1.4 0.7 0.0 0.0 1.0 0.3 0.1 0.0 0.0 0.0 3.0 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 2.9 0.0 2.6 0.3 0.3 0.4 2.5 2.7 4.5 1.8 0.0 0.1 0.0 0.3 317.4 0.3 31.5 0.0 6.6 0.0 0.4 3.1 0.0 0.0 0.2 0.0 6.4 0.0 0.0 661.8 5.2 0.0 0.0 6.4 42.7 0.0 3.3 17.5 3.5 0.0 0.7 6.5 0.0 5.2 2.7 0.4 0.1 0.0 26.4 7.8 BCL2L2 "BCL-W, KIAA0271, PPP1R51" ENSG00000129473 "BCL2 like 2" Q92843 14 23298790-23311759 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB040539, HPA048740" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB040539: , HPA048740: " "unprognostic (8.23e-3)" "unprognostic (9.85e-2)" "unprognostic (1.71e-2)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (1.64e-1)" "unprognostic (3.47e-3)" "unprognostic (1.53e-2)" "unprognostic (1.78e-1)" "unprognostic (2.91e-3)" "unprognostic (1.50e-3)" "unprognostic (2.60e-1)" "prognostic favorable (1.99e-6)" "unprognostic (2.44e-1)" "unprognostic (2.00e-1)" "unprognostic (6.60e-2)" "unprognostic (5.38e-2)" 29.9 22.8 38.2 15.6 33.6 7.4 25.1 27.3 44.8 13.7 32.3 27.4 21.9 19.4 19.0 20.6 32.8 16.6 17.6 23.8 36.2 32.9 22.3 9.0 18.6 8.6 43.3 39.5 17.5 30.6 34.1 16.5 15.1 32.8 31.8 20.4 15.0 36.5 31.9 10.6 29.2 19.0 34.8 40.9 11.3 22.3 14.9 28.1 1.2 25.6 11.8 10.1 23.0 23.2 1.3 1.8 0.6 1.8 0.1 0.3 1.3 11.8 12.8 11.6 8.5 22.4 19.6 10.6 21.5 13.2 10.7 11.8 7.8 18.9 7.7 7.7 11.8 13.6 22.1 7.2 13.5 13.5 3.9 6.8 8.5 17.1 15.4 14.0 9.2 15.1 15.1 26.6 8.0 13.0 13.7 9.0 1.4 8.3 7.6 12.7 8.9 0.7 6.2 4.5 16.4 25.0 5.5 14.3 3.5 9.4 20.3 15.4 9.2 9.7 15.5 17.5 7.5 9.8 7.4 17.5 19.1 12.0 12.9 11.0 9.8 5.8 1.1 12.1 7.6 21.6 0.0 1.8 0.4 0.3 1.8 0.2 1.3 0.0 0.2 1.8 1.0 0.3 0.0 0.6 0.1 1.0 0.9 0.1 1.3 38.2 33.6 27.3 44.8 36.2 32.9 43.3 39.5 32.8 28.1 8.9 13.3 0.5 6.8 7.7 17.1 25.0 2.5 9.4 12.5 5.2 23.6 4.4 11.6 7.4 17.7 9.0 10.1 0.0 15.7 3.4 6.7 14.5 5.7 6.4 4.9 19.1 17.9 9.8 7.3 3.3 10.3 4.0 6.8 4.6 15.5 6.8 18.7 10.5 20.1 7.5 12.0 6.5 16.0 0.0 0.2 9.7 4.7 1.8 9.7 15.2 BCL2L2-PABPN1 ENSG00000258643 "BCL2L2-PABPN1 readthrough" Q92843 14 23306835-23325369 "Cancer-related genes, Predicted intracellular proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 34 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.8;Ciliated cells: 8.1;Club cells: 2.3;granulocytes: 2.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 21.5;BJ hTERT+ SV40 Large T+ RasG12V: 23.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000637, HPA048740" Approved Uncertain "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA000637: AB_1079553, HPA048740: " "unprognostic (1.32e-2)" "unprognostic (8.74e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-3)" "unprognostic (9.82e-3)" "unprognostic (2.85e-2)" "unprognostic (1.05e-6)" "unprognostic (4.39e-2)" "unprognostic (1.67e-1)" "unprognostic (1.84e-3)" "unprognostic (7.61e-2)" "unprognostic (3.47e-2)" "unprognostic (1.72e-7)" "unprognostic (3.13e-2)" "unprognostic (8.77e-2)" "unprognostic (3.46e-3)" "unprognostic (4.95e-2)" 11.4 5.3 14.2 5.8 17.7 12.0 17.7 16.4 24.2 17.9 21.0 14.4 11.4 4.5 13.7 6.9 14.4 16.1 16.0 11.2 17.8 9.5 7.1 6.9 10.3 6.4 13.1 21.2 8.0 21.4 29.1 11.4 18.0 17.5 16.3 5.6 7.5 22.1 37.7 7.0 14.5 7.7 18.6 20.2 9.7 13.0 15.0 14.8 0.0 14.4 5.7 5.4 16.6 12.1 1.9 1.1 2.1 4.4 3.5 0.3 1.1 5.1 6.6 4.2 3.4 0.3 9.6 3.3 1.4 13.8 21.5 23.4 5.4 16.8 1.7 1.2 7.2 5.2 7.3 4.8 6.6 5.6 3.5 5.3 0.4 0.9 8.7 2.9 1.8 10.4 8.7 12.2 7.9 1.5 1.7 5.1 0.1 1.6 5.1 6.5 7.9 0.2 1.1 5.3 1.0 4.2 3.2 0.1 1.1 3.7 2.1 7.0 2.8 2.1 7.1 1.9 0.7 3.8 2.8 1.9 5.6 4.4 5.5 3.6 2.8 2.6 0.5 2.3 3.8 8.6 2.1 4.4 0.3 0.2 1.6 0.2 1.4 0.0 0.0 0.6 1.9 0.3 0.1 0.8 3.5 2.6 1.1 0.0 1.1 14.2 17.7 16.4 24.2 17.8 9.5 13.1 21.2 17.5 14.8 3.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 8.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 BCO1 "BCDO, BCDO1, BCMO, BCMO1, FLJ10730" ENSG00000135697 "Beta-carotene oxygenase 1" Q9HAY6 16 81238448-81291142 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "intestine: 28.1;retina: 62.0" "Cell type enhanced" "Detected in some" 13 "Mucus-secreting cells: 7.2;Paneth cells: 2.5;Proximal tubular cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 12.8;EFO-21: 9.7;HAP1: 3.7;NTERA-2: 5.2;RPTEC TERT1: 9.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA043811 Uncertain "Actin filaments,Centriolar satellite" NA NA "Actin filaments, Centriolar satellite" "HPA043811: AB_10962487" "unprognostic (2.78e-1)" "unprognostic (3.88e-3)" "unprognostic (2.61e-1)" "unprognostic (3.32e-1)" "unprognostic (4.05e-2)" "unprognostic (8.01e-4)" "unprognostic (1.65e-1)" "unprognostic (2.99e-2)" "unprognostic (1.58e-3)" "unprognostic (7.26e-2)" "unprognostic (2.97e-2)" "unprognostic (1.08e-3)" "unprognostic (1.46e-1)" "unprognostic (1.90e-2)" "unprognostic (2.48e-1)" "unprognostic (5.07e-2)" "unprognostic (1.09e-1)" 0.1 0.0 1.3 0.2 1.4 0.0 0.2 0.2 1.6 0.3 28.1 0.3 1.4 11.0 0.7 0.5 0.7 0.6 1.4 0.1 1.7 1.9 4.2 2.5 0.3 0.1 0.8 0.1 2.0 0.4 0.0 1.9 0.1 5.9 1.3 3.6 62.0 1.3 2.8 0.6 0.3 16.9 0.4 0.4 0.1 2.3 0.2 0.3 0.3 0.2 0.5 0.1 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 2.6 0.0 9.7 0.0 0.4 0.1 3.7 0.0 0.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 5.2 0.8 0.0 0.0 0.0 0.0 9.8 0.3 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.4 0.2 1.6 1.7 1.9 0.8 0.1 5.9 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.2 0.6 0.0 0.0 1.4 0.0 0.0 0.0 7.2 0.0 0.4 2.5 1.1 5.5 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 1.7 0.6 BCORL1 "CXorf10, FLJ11362" ENSG00000085185 "BCL6 corepressor like 1" Q5H9F3 X 129981107-130058083 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Syncytiotrophoblasts: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 20.4;HAP1: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031775, HPA031777, HPA068568" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA031775: AB_10602332, HPA031777: AB_10671578, HPA068568: AB_2686007" "unprognostic (8.07e-2)" "unprognostic (2.78e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (2.20e-5)" "unprognostic (4.58e-1)" "unprognostic (1.68e-3)" "unprognostic (1.96e-3)" "unprognostic (5.56e-3)" "unprognostic (2.39e-1)" "unprognostic (8.02e-2)" "unprognostic (4.46e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.00e-4)" "unprognostic (9.18e-2)" "unprognostic (2.60e-2)" "unprognostic (3.09e-1)" "unprognostic (1.41e-2)" 7.5 7.9 7.7 5.2 9.1 9.8 9.1 19.8 10.5 8.7 8.3 10.7 8.1 5.4 9.2 5.4 5.8 9.3 4.2 6.9 8.4 4.5 7.5 4.7 6.7 5.3 7.6 5.9 11.4 8.9 13.4 15.0 28.9 7.5 8.1 4.5 6.0 6.5 8.4 6.0 6.5 6.0 8.8 5.3 7.7 6.6 26.1 8.1 6.8 10.3 2.2 5.1 6.7 8.5 1.2 1.6 3.5 1.3 0.8 1.3 0.7 2.2 5.5 12.9 20.4 7.6 5.5 3.6 3.0 3.5 3.9 4.5 6.6 1.4 1.0 6.7 6.0 3.7 1.3 30.8 1.2 3.7 2.2 4.5 10.6 2.7 2.2 3.8 2.6 3.1 3.4 2.5 7.7 0.4 5.8 4.7 3.5 5.1 10.8 2.5 1.3 3.9 8.0 3.5 1.8 3.9 8.3 5.2 1.4 2.2 0.3 2.1 7.3 1.6 0.4 2.0 7.2 4.5 4.0 3.9 3.2 4.1 3.8 2.9 3.5 6.3 1.6 2.1 5.4 1.5 0.1 1.3 2.8 1.3 0.2 1.0 1.2 0.9 0.8 1.6 1.0 0.6 0.7 3.5 0.8 0.5 0.7 0.2 0.7 7.7 9.1 19.8 10.5 8.4 4.5 7.6 5.9 7.5 8.1 0.0 3.2 0.0 2.3 10.5 1.8 6.4 5.1 2.7 1.2 7.0 0.0 10.7 0.0 3.2 0.4 7.1 2.7 0.0 0.9 4.2 5.8 2.9 6.9 3.0 2.8 7.9 11.5 3.1 2.6 1.0 4.4 1.8 6.8 1.0 1.7 3.1 2.3 0.0 3.5 2.2 1.0 6.5 4.5 3.5 5.3 10.0 78.1 1.5 2.8 2.5 BDKRB2 BK-2 ENSG00000168398 "Bradykinin receptor B2" P30411 14 96204679-96244166 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 15.3;Ciliated cells: 13.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebellum: 13.5;pons and medulla: 5.7" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 22.8;BJ hTERT+: 41.8;U-87 MG: 18.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003551, HPA050841" Approved Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus, Vesicles" "HPA003551: , HPA050841: AB_2681254" "unprognostic (1.03e-1)" "unprognostic (7.90e-2)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (8.79e-3)" "unprognostic (2.68e-2)" "unprognostic (1.93e-1)" "unprognostic (4.66e-2)" "unprognostic (1.94e-1)" "unprognostic (2.84e-2)" "unprognostic (3.19e-1)" "unprognostic (1.72e-1)" "unprognostic (3.32e-3)" "unprognostic (3.11e-2)" "unprognostic (9.40e-2)" "unprognostic (9.90e-2)" "unprognostic (1.49e-2)" 9.0 1.2 1.5 3.7 1.0 0.0 4.7 13.5 1.1 12.2 9.0 1.3 4.4 5.6 8.5 12.7 14.9 5.1 21.1 4.3 0.8 0.7 12.1 0.7 2.2 0.4 0.9 0.3 4.7 6.8 0.9 1.1 2.9 5.7 6.9 9.2 0.9 3.1 11.3 2.7 4.0 10.3 11.3 1.3 0.4 4.2 3.2 0.0 0.6 3.6 13.9 4.4 16.7 13.5 0.0 0.9 0.0 0.0 0.0 1.2 0.0 0.7 2.7 0.0 4.9 7.4 22.8 0.0 2.4 41.8 1.4 1.7 0.1 4.6 0.0 0.1 3.8 1.6 6.5 0.0 1.0 1.2 0.5 0.0 0.0 0.5 0.0 3.6 0.0 0.0 6.9 3.3 4.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 8.8 0.0 0.0 1.0 0.0 1.4 0.0 1.5 0.5 0.8 6.9 0.0 1.0 0.4 0.0 0.0 0.1 0.1 1.4 0.0 0.1 0.0 0.0 18.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.5 1.0 13.5 1.1 0.8 0.7 0.9 0.3 5.7 0.0 3.0 1.9 0.0 0.5 8.1 0.0 0.5 15.3 13.4 9.1 8.7 0.0 0.5 6.6 10.2 0.0 4.2 8.9 0.0 3.5 1.9 6.1 0.8 0.0 0.0 0.2 0.0 6.8 3.1 0.0 0.0 0.9 0.6 5.0 0.0 5.0 0.0 4.5 4.5 1.1 0.0 0.0 0.0 2.0 0.0 0.0 5.1 3.3 0.0 0.7 2.4 BEAN1 SCA31 ENSG00000166546 "Brain expressed associated with NEDD4 1" Q3B7T3 16 66427297-66493529 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell type enhanced" "Detected in some" 9 "Cytotrophoblasts: 4.8;Early spermatids: 8.4;Extravillous trophoblasts: 8.9;Late spermatids: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.9;neutrophil: 5.2;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 7 "dendritic cells: 2.4;granulocytes: 5.2" "Cell line enhanced" "Detected in some" "AN3-CA: 9.7;BEWO: 4.9;RPTEC TERT1: 8.6;U-87 MG: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053851 Uncertain Uncertain Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA053851: AB_2682280" "unprognostic (1.92e-1)" "unprognostic (5.79e-4)" "unprognostic (3.83e-2)" "unprognostic (3.38e-3)" "unprognostic (1.01e-1)" "unprognostic (4.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.13e-1)" "unprognostic (4.89e-1)" "unprognostic (1.59e-1)" "unprognostic (2.13e-3)" "unprognostic (4.18e-2)" "unprognostic (3.38e-2)" "unprognostic (1.63e-1)" "unprognostic (3.10e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-2)" 1.2 1.2 2.9 1.1 2.5 2.9 1.2 6.9 9.6 1.2 0.7 0.1 0.0 0.6 1.2 1.9 1.8 1.9 1.4 3.0 4.6 4.1 0.9 1.1 1.4 0.9 2.3 3.2 1.4 1.9 0.1 0.4 4.5 11.6 1.0 0.9 5.0 1.9 0.4 3.6 3.2 0.8 0.8 1.7 1.2 1.2 3.1 0.2 0.0 1.9 3.1 0.9 1.0 1.0 0.3 2.4 5.2 0.5 0.4 0.2 0.1 0.8 1.0 1.0 9.7 0.3 0.1 4.9 0.3 0.0 0.1 0.1 0.0 1.0 0.1 0.6 0.3 0.6 0.2 0.1 0.1 0.3 0.0 0.7 0.0 0.2 0.7 0.7 0.1 0.0 0.7 1.9 0.6 0.3 1.4 0.0 0.2 0.1 0.3 0.2 0.5 0.0 0.4 0.3 0.1 0.6 0.1 0.2 0.5 8.6 0.6 0.1 0.2 0.2 0.2 1.4 0.7 0.2 0.1 0.3 0.4 2.7 0.1 0.4 0.5 0.1 0.1 5.6 0.2 1.4 0.4 0.5 1.9 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.2 0.1 5.2 0.4 0.2 2.4 0.1 0.1 2.9 2.5 6.9 9.6 4.6 4.1 2.3 3.2 11.6 0.2 0.0 0.0 0.0 0.2 0.1 0.4 1.2 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.2 8.4 0.3 0.0 0.0 0.0 8.9 0.6 1.0 0.0 0.0 0.9 0.0 0.0 1.3 0.0 8.0 0.3 0.0 3.3 0.0 0.0 0.0 1.0 0.0 2.1 0.0 0.9 0.0 0.5 2.9 0.3 0.1 2.4 0.0 0.0 0.3 BEX2 DJ79P11.1 ENSG00000133134 "Brain expressed X-linked 2" Q9BXY8 X 103309346-103311046 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 79.2;epididymis: 67.1" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 354.8;Muller glia cells: 185.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 18.0;NK-cells: 21.3;T-cells: 26.8" "Cell line enhanced" "Detected in many" "GAMG: 18.6;hTCEpi: 31.0;NTERA-2: 29.9;SCLC-21H: 44.0;SH-SY5Y: 20.0" "HPA045384, HPA078630" Uncertain Uncertain Cytosol NA NA Cytosol "HPA045384: AB_2679305, HPA078630: " "unprognostic (7.56e-2)" "unprognostic (7.08e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (8.54e-7)" "unprognostic (3.21e-1)" "unprognostic (1.65e-1)" "unprognostic (4.27e-2)" "prognostic favorable (1.52e-4)" "unprognostic (7.36e-3)" "unprognostic (6.82e-2)" "unprognostic (8.22e-3)" "unprognostic (6.63e-2)" "prognostic favorable (3.05e-13)" "unprognostic (4.14e-3)" "unprognostic (6.80e-2)" "unprognostic (1.40e-1)" "unprognostic (2.38e-3)" 1.7 39.6 49.1 4.1 62.6 6.8 10.9 44.9 79.2 5.8 4.7 11.5 3.0 2.7 14.7 67.1 3.0 8.9 4.8 7.3 53.4 57.6 26.4 1.4 6.6 7.3 32.5 40.3 29.0 13.5 29.6 40.1 5.0 29.6 12.4 4.1 11.5 11.1 12.8 2.5 4.2 4.2 5.7 18.7 7.9 6.5 13.2 13.6 3.1 52.8 1.3 9.2 3.7 2.2 18.0 3.5 4.0 0.1 21.3 26.8 7.1 0.0 0.8 3.8 0.0 0.0 0.0 14.8 0.1 2.0 2.6 3.7 2.6 1.2 0.0 10.4 0.0 18.6 0.6 0.0 3.0 2.2 0.0 8.0 0.4 0.4 0.1 15.2 0.0 8.2 0.9 31.0 1.2 9.5 5.8 0.1 10.7 5.3 0.2 0.3 1.3 6.2 0.0 29.9 0.0 2.6 0.0 0.0 0.0 1.2 1.1 44.0 20.0 2.0 0.4 6.6 3.7 3.6 0.0 0.0 0.0 3.0 0.1 0.6 10.1 6.4 0.0 5.0 0.0 0.4 4.0 0.1 0.3 8.5 0.1 11.8 18.0 16.8 9.8 0.5 15.0 26.8 19.2 0.5 21.3 0.0 3.5 11.3 7.1 49.1 62.6 44.9 60.5 53.4 57.6 32.5 40.3 29.6 13.6 14.9 49.0 36.6 86.3 28.0 178.0 20.2 56.0 13.4 63.7 108.2 41.2 66.0 354.8 40.3 13.3 11.7 2.0 0.0 36.9 9.9 3.3 54.5 12.7 0.8 6.1 114.4 96.4 1.8 0.0 48.7 14.7 4.7 25.3 1.8 25.1 185.5 28.0 7.0 20.8 145.1 106.4 6.5 4.5 14.0 6.0 23.3 53.3 21.7 17.2 43.8 BFSP2 "CP47, CP49, LIFL-L, phakinin" ENSG00000170819 "Beaded filament structural protein 2" Q13515 3 133399995-133475222 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "blood: 12.7" "Group enriched" "Detected in some" 4 "B-cells: 10.7;Melanocytes: 5.0" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 7 "T-reg: 12.7" "Lineage enriched" "Detected in single" 48 "T-cells: 12.7" "Group enriched" "Detected in some" 7 "Daudi: 5.7;U-698: 6.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA038464, HPA062959" Enhanced Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038464: AB_10672746, HPA062959: AB_2684912" "unprognostic (1.58e-3)" "unprognostic (7.47e-4)" "unprognostic (1.04e-2)" "unprognostic (2.32e-1)" "unprognostic (9.59e-2)" "unprognostic (4.04e-5)" "unprognostic (8.13e-2)" "unprognostic (5.57e-2)" "unprognostic (6.71e-2)" "unprognostic (1.91e-3)" "unprognostic (1.74e-2)" "unprognostic (4.70e-2)" "unprognostic (1.68e-5)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "unprognostic (8.23e-2)" "unprognostic (2.21e-2)" 0.0 0.0 0.1 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.1 0.2 0.0 0.0 12.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.8 6.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 1.7 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.9 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 BICD2 KIAA0699 ENSG00000185963 "BICD cargo adaptor 2" Q8TD16 9 92711363-92764812 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 65.5;Suprabasal keratinocytes: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023013, HPA024452" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA023013: AB_1845352, HPA024452: AB_1845353" "unprognostic (9.99e-3)" "unprognostic (1.98e-1)" "unprognostic (7.84e-3)" "unprognostic (2.81e-2)" "unprognostic (4.33e-2)" "unprognostic (2.86e-1)" "unprognostic (2.37e-2)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (6.54e-3)" "unprognostic (8.12e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.39e-4)" "unprognostic (1.25e-1)" "unprognostic (2.26e-1)" "unprognostic (3.95e-1)" "unprognostic (1.39e-2)" 10.4 7.8 13.9 8.9 12.5 7.2 7.1 13.2 13.1 13.1 9.9 7.7 7.9 3.2 9.7 4.5 27.2 7.2 6.7 15.6 11.8 5.8 7.5 5.2 9.1 9.3 13.4 9.8 8.4 7.2 21.7 3.8 9.8 11.9 7.4 3.7 6.6 9.1 10.0 13.9 40.3 5.9 9.7 9.2 11.3 5.9 5.9 11.0 8.5 6.2 16.3 18.2 10.6 17.2 3.3 5.2 10.5 7.5 1.5 2.4 2.0 14.3 11.9 8.9 9.1 17.3 12.0 12.6 14.0 10.1 8.0 6.3 7.0 6.5 16.2 9.1 15.5 10.2 45.2 9.9 22.2 9.1 7.7 10.8 8.5 11.6 9.6 10.3 11.8 13.9 12.2 31.1 13.3 10.2 9.5 11.8 7.0 8.4 12.6 17.4 9.4 11.2 7.4 6.1 10.6 14.7 12.3 19.3 8.6 12.8 12.1 6.2 9.6 9.8 9.1 6.3 9.3 3.7 5.5 15.8 14.8 9.9 24.9 15.1 10.5 7.6 14.4 12.5 7.3 12.9 2.2 4.4 5.6 1.8 5.2 1.8 2.7 2.0 2.4 5.2 3.3 1.9 1.7 10.5 1.5 7.5 4.5 1.2 2.0 13.9 12.5 13.2 13.1 11.8 5.8 13.4 9.8 11.9 11.0 26.8 10.1 12.4 12.7 65.5 12.3 46.2 7.6 14.7 19.4 7.0 5.9 7.4 3.3 8.5 5.1 13.5 1.0 0.0 4.3 5.5 22.3 7.8 23.1 6.7 12.6 14.3 10.4 17.8 32.0 5.0 19.5 24.3 15.1 9.0 2.2 3.9 7.5 3.1 31.5 5.8 5.5 19.4 19.8 7.9 8.4 114.4 6.1 10.2 2.3 15.8 BLK MGC10442 ENSG00000136573 "BLK proto-oncogene, Src family tyrosine kinase" P51451 8 11486894-11564604 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "blood: 47.8;intestine: 23.5;lymphoid tissue: 39.8" "Cell type enriched" "Detected in some" 52 "B-cells: 93.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 47.8;naive B-cell: 33.9" "Lineage enriched" "Detected in many" 5 "B-cells: 47.8" "Cell line enhanced" "Detected in some" "Daudi: 44.0;REH: 11.9;RPMI-8226: 14.5;U-698: 21.5;U-87 MG: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB005093, HPA069571" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB005093: AB_2274756, HPA069571: AB_2732137" "unprognostic (6.50e-5)" "unprognostic (4.22e-3)" "unprognostic (5.64e-2)" "unprognostic (1.42e-1)" "unprognostic (3.45e-1)" "unprognostic (5.98e-6)" "unprognostic (1.59e-2)" "unprognostic (8.94e-4)" "unprognostic (1.02e-3)" "unprognostic (9.83e-3)" "unprognostic (1.22e-2)" "unprognostic (4.66e-2)" "unprognostic (9.05e-6)" "unprognostic (5.62e-2)" "unprognostic (5.43e-2)" "unprognostic (2.19e-1)" "unprognostic (1.16e-1)" 0.5 0.2 0.1 32.3 0.1 1.7 0.2 0.1 0.1 0.1 1.2 0.0 0.0 0.3 0.1 0.0 1.9 0.2 0.4 0.3 0.1 0.1 1.3 0.5 0.6 27.6 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.3 2.4 0.0 0.1 0.1 23.5 0.0 0.1 31.9 1.4 0.2 0.0 3.9 0.7 0.4 39.8 2.5 0.4 47.8 4.3 0.1 0.0 0.0 9.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.9 0.0 14.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.3 3.8 21.5 9.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 9.8 47.8 0.3 1.1 0.0 33.9 0.2 0.1 0.1 0.0 0.0 4.3 0.4 1.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 93.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BLM "BS, RECQ2, RECQL3" ENSG00000197299 "Bloom syndrome RecQ like helicase" P54132 15 90717327-90816165 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 36.7" "Cell type enhanced" "Detected in many" 6 "B-cells: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005689 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005689: AB_1845372" "unprognostic (2.77e-1)" "unprognostic (3.82e-3)" "unprognostic (4.03e-2)" "unprognostic (2.98e-2)" "unprognostic (4.75e-2)" "unprognostic (9.89e-2)" "unprognostic (6.12e-5)" "unprognostic (2.82e-2)" "unprognostic (4.55e-3)" "unprognostic (5.24e-3)" "unprognostic (1.80e-3)" "unprognostic (9.12e-2)" "unprognostic (1.55e-15)" "unprognostic (6.53e-3)" "unprognostic (6.55e-2)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" 1.8 0.4 3.1 11.4 1.5 5.5 0.6 4.7 2.6 0.7 1.9 0.9 0.5 1.4 1.2 1.1 2.9 0.4 1.3 1.0 2.3 2.4 0.9 0.5 2.0 7.7 2.8 0.2 0.9 0.4 0.0 1.2 3.6 0.5 0.7 2.5 0.7 7.8 0.0 1.7 0.6 2.8 0.5 1.9 6.7 1.4 4.9 0.5 36.7 0.6 3.1 9.3 1.4 0.7 7.4 1.2 4.3 1.6 4.6 5.0 1.6 5.5 7.8 8.8 5.1 0.0 0.4 5.5 4.1 1.2 4.7 5.1 6.9 3.9 14.2 2.6 1.1 5.9 9.2 13.5 3.7 6.1 8.6 10.0 14.9 8.5 2.2 0.0 14.3 7.4 0.0 0.0 4.7 2.4 0.6 3.3 7.7 12.8 4.4 4.9 3.4 10.7 7.8 9.3 12.1 1.7 10.9 16.5 5.5 1.1 9.9 6.5 6.1 3.3 4.5 2.6 8.6 3.1 11.7 1.8 3.4 6.3 3.5 8.8 3.3 13.2 14.8 1.9 10.1 5.9 2.5 1.0 4.3 3.1 1.2 4.8 7.4 2.8 3.8 1.2 4.3 2.0 2.2 0.8 4.6 1.6 1.2 5.0 1.6 3.1 1.5 4.7 1.7 2.3 2.4 2.8 0.2 0.5 0.5 3.0 12.8 18.6 0.5 0.2 2.9 8.4 0.0 9.4 6.8 0.0 2.0 1.8 1.7 0.9 2.0 0.7 0.0 0.0 0.6 6.5 1.5 0.6 12.7 0.5 4.8 0.0 0.0 2.5 9.7 1.6 0.0 3.8 0.0 1.0 1.2 1.2 0.8 0.0 0.4 0.0 6.5 0.0 0.4 12.0 11.8 0.5 0.8 8.7 2.3 0.3 BMPR2 "BMPR-II, BMPR3, BRK-3, PPH1, T-ALK" ENSG00000204217 "Bone morphogenetic protein receptor type 2" Q13873 2 202376936-202567751 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017385, HPA049014" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA017385: AB_1845397, HPA049014: AB_2680599" "unprognostic (2.17e-1)" "unprognostic (9.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.55e-1)" "unprognostic (4.30e-2)" "unprognostic (1.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.13e-2)" "unprognostic (1.97e-1)" "unprognostic (1.29e-2)" "unprognostic (1.21e-3)" "unprognostic (9.20e-2)" "unprognostic (1.18e-1)" "unprognostic (3.40e-1)" 18.1 15.0 12.1 9.8 14.2 1.1 10.2 9.5 17.1 15.7 11.7 8.2 6.5 5.5 12.9 10.2 10.6 10.3 13.2 14.6 10.8 13.5 10.7 11.5 24.9 4.4 10.4 14.5 12.0 7.0 15.5 6.1 21.7 10.8 11.0 7.7 11.4 7.1 9.1 10.6 7.2 8.1 15.3 7.5 8.9 7.2 12.9 3.8 3.9 11.6 5.2 5.4 11.1 8.9 1.6 2.6 0.9 2.7 1.1 3.6 0.9 5.7 5.4 5.6 8.8 14.0 13.6 10.8 12.0 12.1 10.5 10.5 4.7 8.7 2.0 14.0 24.2 9.0 10.9 7.3 9.3 16.5 6.0 5.0 6.1 5.8 7.3 9.7 1.7 4.8 9.9 8.8 7.7 10.3 16.2 30.2 2.5 3.9 10.0 12.9 10.8 1.4 1.6 3.1 2.8 5.0 3.9 11.0 3.0 8.9 12.3 5.7 5.7 12.8 7.6 14.1 14.3 5.9 4.0 33.3 21.4 11.4 7.3 7.2 1.4 1.7 0.6 5.1 3.9 6.2 0.5 2.0 0.9 3.4 1.8 2.5 1.5 1.3 2.2 2.3 1.6 2.7 1.4 0.6 1.1 2.7 2.6 3.6 0.9 12.1 14.2 9.5 17.1 10.8 13.5 10.4 14.5 10.8 3.8 98.3 38.9 17.1 16.1 29.8 51.7 46.4 12.7 21.4 39.8 19.2 76.6 14.0 1.7 27.3 2.4 119.4 12.7 0.0 24.7 19.4 40.9 19.9 23.1 15.5 16.2 33.4 24.1 109.2 20.0 2.3 31.4 17.4 40.5 15.4 16.3 38.7 36.3 20.9 40.3 10.7 29.9 64.7 45.7 17.7 11.1 31.5 16.7 13.8 13.4 22.7 BNIP3 Nip3 ENSG00000176171 "BCL2 interacting protein 3" Q12983 10 131966455-131982013 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 122.7" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 391.8;Proximal tubular cells: 579.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 72.0;hTERT-RPE1: 56.2;U-87 MG: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003015, CAB011676" Supported Uncertain Cytosol NA NA Cytosol "CAB011676: , HPA003015: AB_1078290" "unprognostic (1.01e-3)" "unprognostic (1.42e-3)" "unprognostic (1.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.58e-2)" "unprognostic (1.62e-3)" "unprognostic (6.57e-3)" "unprognostic (1.12e-1)" "unprognostic (2.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (4.55e-4)" "unprognostic (2.37e-3)" "unprognostic (1.04e-1)" "unprognostic (3.29e-2)" "unprognostic (2.98e-1)" 19.3 12.0 18.3 4.0 18.6 3.0 8.7 13.5 28.3 7.7 4.6 13.0 5.1 4.0 6.0 11.4 8.1 6.0 7.9 43.3 16.9 14.6 27.6 53.4 6.7 4.6 16.5 14.2 19.3 122.7 6.0 7.3 13.0 22.6 18.2 2.9 5.2 19.2 6.6 48.0 9.0 4.5 6.0 13.3 4.9 6.4 6.0 11.1 3.3 10.8 6.2 4.0 9.2 7.3 6.1 3.0 5.1 3.5 2.2 23.4 8.9 72.0 5.8 4.2 11.7 11.2 11.9 21.6 17.6 16.3 13.3 38.0 1.2 1.6 0.1 28.6 10.1 15.5 4.4 8.8 25.0 50.1 3.8 6.7 2.5 3.7 16.7 15.0 3.3 2.0 8.2 6.3 12.9 13.1 56.2 9.2 4.5 6.6 0.2 21.7 5.7 1.6 18.4 3.5 0.5 17.5 4.0 2.1 6.1 14.5 1.2 5.5 12.9 3.6 7.4 10.0 18.6 4.5 4.6 10.5 18.8 6.3 7.0 13.9 12.3 10.5 10.0 68.2 0.1 3.2 2.2 3.5 5.1 9.8 2.3 10.4 5.7 13.9 10.3 3.0 6.1 23.4 15.4 0.9 2.2 3.1 2.3 13.2 8.9 18.3 18.6 13.5 28.3 16.9 14.6 16.5 14.2 22.6 11.1 44.7 40.9 23.1 75.3 26.6 87.6 141.4 101.9 89.7 48.9 80.3 37.3 149.9 255.4 174.2 61.9 44.2 3.5 0.0 75.7 295.7 56.6 118.1 0.0 391.8 65.8 314.6 77.8 54.6 21.8 85.4 65.0 16.1 32.1 39.7 6.7 125.3 189.3 1.9 97.2 579.1 50.2 38.8 23.8 33.5 100.7 11.4 206.9 25.4 4.8 42.9 BOC CDON2 ENSG00000144857 "BOC cell adhesion associated, oncogene regulated" Q9BWV1 3 113211003-113287459 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 18.8;Leydig cells: 78.6;Peritubular cells: 44.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 8 "B-cells: 1.3" "Cell line enhanced" "Detected in many" "AN3-CA: 31.2;ASC diff: 46.2;BJ hTERT+: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025806 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Intracellular and membrane" NA No 4500000 "Nuclear bodies, Plasma membrane" Nucleoplasm "CAB025806: " "unprognostic (6.89e-3)" "unprognostic (1.34e-2)" "unprognostic (2.62e-3)" "unprognostic (1.03e-2)" "unprognostic (5.03e-3)" "prognostic favorable (4.89e-4)" "unprognostic (8.66e-5)" "unprognostic (1.10e-1)" "unprognostic (1.19e-2)" "unprognostic (4.78e-3)" "unprognostic (3.42e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-3)" "unprognostic (4.94e-3)" "unprognostic (1.11e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.18e-5)" 19.4 4.8 5.3 10.4 8.1 0.4 21.6 4.2 6.0 26.6 23.8 5.4 10.6 3.9 25.8 25.3 19.6 33.2 14.5 20.3 13.3 2.9 4.7 1.0 3.6 3.6 5.5 2.2 26.1 12.0 1.9 12.5 1.9 26.2 21.2 3.9 45.6 17.9 17.4 4.6 25.7 9.6 35.2 36.7 3.5 11.8 9.2 7.6 1.2 13.4 12.9 4.9 28.4 25.0 1.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 2.9 11.0 31.2 46.2 2.4 0.3 5.0 16.5 1.2 1.1 0.0 0.0 0.0 3.1 8.4 0.7 0.0 2.2 1.0 0.4 0.0 1.3 0.0 1.0 0.0 0.2 0.1 0.1 8.0 0.7 0.7 0.1 10.3 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.5 2.8 0.0 2.7 0.0 4.9 0.0 0.3 0.0 3.3 4.7 0.0 0.2 0.1 3.4 1.3 0.1 0.0 1.8 2.9 0.0 1.6 0.0 0.0 0.0 3.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 5.3 8.1 4.2 6.0 13.3 2.9 5.5 2.2 26.2 7.6 0.0 0.3 0.0 2.3 18.8 0.4 0.8 0.0 0.0 1.2 5.2 0.0 4.4 0.0 0.0 1.3 3.3 0.0 0.0 0.0 4.0 12.4 2.8 0.0 0.0 0.7 0.0 1.7 2.5 0.0 1.1 78.6 0.9 10.1 0.0 0.0 14.1 0.5 0.0 44.9 0.0 0.5 0.0 8.3 1.1 3.0 9.7 1.6 0.0 0.0 0.3 BOLA2 "BOLA2A, My016" ENSG00000183336 "BolA family member 2" Q9H3K6 16 29443056-29454964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.6" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 2: 2.4;Ciliated cells: 1.4;Club cells: 2.3;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045380, HPA046696" Supported Uncertain Nucleoplasm NA NA 180000 Nucleoplasm "HPA045380: AB_2679301, HPA046696: AB_2679757" 2.3 3.6 3.6 9.0 3.6 9.5 2.2 1.3 2.0 1.4 5.6 13.5 1.6 0.0 4.6 1.2 1.5 3.1 3.3 2.7 3.2 3.5 2.7 6.6 3.4 0.6 7.2 0.7 3.6 2.9 1.8 0.8 7.1 1.2 4.6 2.5 10.7 0.5 3.6 6.0 7.2 5.5 1.8 1.2 2.3 2.3 25.6 21.4 15.8 20.7 10.4 20.1 18.1 14.2 23.4 3.9 8.4 1.5 2.2 12.4 4.7 2.3 4.5 5.9 10.7 12.9 5.2 14.8 1.4 7.2 8.3 1.9 7.8 0.3 14.6 35.6 11.8 8.9 23.5 3.8 7.7 12.8 1.9 4.4 9.2 2.6 0.9 5.0 17.2 5.3 12.3 2.5 28.7 9.7 13.3 10.7 7.6 21.8 18.0 5.8 25.8 3.8 5.8 10.0 11.1 2.6 23.2 4.4 0.8 7.5 5.5 5.0 9.2 5.8 10.2 9.9 22.6 12.0 9.4 10.4 10.8 9.9 8.2 19.3 15.8 16.5 20.7 16.0 25.6 15.6 16.7 14.8 20.6 11.9 13.7 3.7 10.4 17.4 21.4 20.1 18.1 0.0 2.4 0.0 0.2 0.1 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.2 0.0 0.4 0.5 0.0 0.5 0.0 0.7 0.1 0.0 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.2 0.0 0.2 0.3 BOLA2B ENSG00000169627 "BolA family member 2B" Q9H3K6 16 30192934-30194306 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 47.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 89.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 80.0;Hep G2: 72.9;MCF7: 69.2" "HPA045380, HPA046696" Supported Uncertain Nucleoplasm NA NA 180000 Nucleoplasm "HPA045380: AB_2679301, HPA046696: AB_2679757" "unprognostic (2.49e-1)" "unprognostic (4.60e-3)" "unprognostic (8.49e-2)" "unprognostic (3.02e-3)" "unprognostic (9.80e-4)" "unprognostic (1.22e-1)" "unprognostic (3.75e-2)" "unprognostic (1.25e-1)" "unprognostic (3.08e-2)" "unprognostic (2.24e-2)" "unprognostic (1.26e-1)" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (2.94e-1)" "unprognostic (5.29e-1)" "unprognostic (2.21e-2)" "unprognostic (4.91e-3)" 5.3 6.2 10.0 8.5 8.3 17.6 4.5 6.7 8.8 5.1 13.8 6.1 3.9 14.7 5.8 5.6 9.7 3.3 6.7 11.9 8.2 6.1 7.4 5.4 4.9 15.6 8.9 3.9 5.2 8.3 1.8 6.5 5.5 4.7 4.1 8.5 5.0 7.9 3.9 5.9 7.4 11.2 4.2 8.5 10.8 9.2 7.8 5.6 9.2 3.9 7.7 13.7 7.8 24.9 47.7 32.4 24.8 33.5 25.6 33.6 26.2 15.2 49.2 4.8 11.7 1.6 1.9 15.7 3.7 2.3 3.5 4.9 29.3 15.9 4.6 18.2 1.0 6.3 8.3 2.7 7.1 0.6 14.3 80.0 9.9 28.1 72.9 3.5 6.3 13.1 1.1 4.7 6.0 2.4 1.2 6.1 14.7 6.5 15.5 3.1 69.2 17.8 18.6 14.5 7.0 51.6 15.6 7.1 34.0 4.6 24.8 14.7 14.6 2.0 21.3 4.9 1.5 9.6 9.2 4.8 8.1 6.5 14.0 14.0 26.0 16.1 16.2 11.7 16.9 12.0 14.3 25.5 24.8 28.6 33.5 29.7 47.7 30.3 31.7 21.4 38.1 22.2 31.8 4.3 25.6 29.2 32.4 33.6 26.2 10.0 8.3 6.7 8.8 8.2 6.1 8.9 3.9 4.7 5.6 14.9 16.3 3.7 2.1 5.6 0.8 89.6 33.1 42.8 39.8 22.7 2.0 6.5 39.7 11.7 27.2 8.0 36.6 0.0 21.1 4.3 5.6 3.1 27.9 18.1 10.1 1.6 27.7 15.4 27.7 21.6 2.3 10.1 6.8 13.6 24.2 4.1 21.3 25.4 1.4 21.3 2.0 6.5 5.1 4.3 6.8 9.8 3.2 17.5 23.3 3.3 BOLL BOULE ENSG00000152430 "Boule homolog, RNA binding protein" Q8N9W6 2 197726879-197786762 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 83.6" "Cell type enhanced" "Detected in some" 25 "Early spermatids: 119.5;Late spermatids: 97.5;Spermatocytes: 256.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "T-reg: 4.7" "Lineage enriched" "Detected in single" 12 "T-cells: 4.7" "Cell line enhanced" "Detected in some" "MCF7: 1.6;U-266/70: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018678, HPA048813" Enhanced Supported "Nucleoli fibrillar center,Plasma membrane,Midbody ring,Cytosol" NA NA Cytosol "Nucleoli fibrillar center, Plasma membrane, Midbody ring" "HPA018678: AB_1845411, HPA048813: AB_2680529" "unprognostic (3.55e-2)" "unprognostic (1.69e-1)" "unprognostic (6.05e-2)" "unprognostic (3.08e-2)" "unprognostic (7.93e-2)" "unprognostic (3.20e-1)" "unprognostic (3.73e-1)" "unprognostic (1.77e-1)" "unprognostic (2.80e-1)" "unprognostic (3.08e-1)" "unprognostic (9.49e-2)" "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 83.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.1 4.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.5 0.3 0.6 0.6 0.0 0.0 0.7 0.4 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.5 0.0 1.6 0.0 0.2 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.2 0.2 3.5 0.6 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 119.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.5 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.4 256.1 39.8 0.0 0.0 0.0 0.0 0.0 BORCS5 "LOH12CR1, LOH1CR12" ENSG00000165714 "BLOC-1 related complex subunit 5" Q969J3 12 12357079-12469694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039509, HPA043627" Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA039509: AB_2676550, HPA043627: AB_2678588" "unprognostic (1.82e-1)" "unprognostic (2.87e-1)" "unprognostic (2.81e-1)" "unprognostic (2.41e-1)" "unprognostic (8.00e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (6.78e-2)" "unprognostic (6.16e-2)" "unprognostic (2.79e-2)" "unprognostic (6.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-3)" "unprognostic (1.50e-2)" "unprognostic (2.14e-1)" "unprognostic (1.72e-1)" "unprognostic (9.51e-2)" 8.9 11.9 13.6 8.3 19.4 17.7 13.7 10.8 20.8 9.5 8.6 20.4 4.8 5.9 8.4 19.7 11.1 7.5 8.4 10.9 12.9 14.9 8.6 11.5 9.1 9.4 16.1 18.2 8.1 13.5 14.5 9.9 8.8 16.6 9.1 7.9 10.0 7.7 7.3 10.7 10.7 6.7 10.1 16.0 8.7 8.9 11.3 15.0 9.0 8.5 4.4 12.2 8.8 8.9 8.3 7.8 9.7 10.5 12.9 14.4 6.7 4.2 4.4 3.3 3.3 7.6 10.2 3.9 3.9 4.6 4.7 5.8 11.0 4.4 5.3 2.3 6.1 3.4 3.2 5.6 5.5 5.2 15.2 5.0 3.0 4.4 6.2 7.3 3.0 4.4 5.8 4.0 6.4 7.5 7.5 5.5 7.0 4.1 7.5 6.0 9.0 4.5 3.2 10.1 4.5 2.8 3.8 4.7 5.7 5.9 2.8 4.1 4.7 4.2 3.4 8.3 11.6 2.6 3.5 4.6 3.1 7.3 4.0 3.6 3.8 3.4 12.1 6.7 4.9 5.3 2.5 6.5 9.7 11.3 10.5 13.3 8.3 12.8 12.3 7.8 6.5 8.7 8.8 7.1 12.9 6.7 5.3 14.4 6.7 13.6 19.4 10.8 20.8 12.9 14.9 16.1 18.2 16.6 15.0 8.9 2.9 6.2 10.4 0.0 14.8 0.0 10.2 5.3 4.5 7.0 11.8 7.5 8.3 8.3 4.2 2.9 3.4 0.0 10.9 10.2 3.1 7.6 2.3 4.7 13.1 12.7 4.7 5.5 10.0 3.1 4.9 8.3 0.0 25.2 4.6 14.1 8.2 2.6 6.7 8.6 15.7 25.8 0.0 11.9 5.1 0.0 12.1 12.5 4.7 7.6 BRD8 "p120, SMAP" ENSG00000112983 "Bromodomain containing 8" Q9H0E9 5 138139766-138178986 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Spermatocytes: 193.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001841 Supported Supported Nucleoplasm,Mitochondria NA Yes Nucleoplasm Mitochondria "HPA001841: AB_1845438" "unprognostic (1.25e-1)" "unprognostic (1.20e-1)" "unprognostic (2.81e-3)" "unprognostic (2.31e-2)" "unprognostic (9.01e-2)" "unprognostic (3.56e-2)" "prognostic unfavorable (1.09e-6)" "unprognostic (1.73e-1)" "unprognostic (7.01e-2)" "unprognostic (6.06e-2)" "unprognostic (1.51e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (7.80e-4)" "unprognostic (4.29e-1)" "unprognostic (1.28e-1)" "unprognostic (2.22e-1)" "unprognostic (2.07e-2)" 11.9 14.1 21.0 10.4 22.1 14.0 18.2 28.9 24.8 17.1 15.7 21.1 14.4 11.1 20.0 31.2 13.8 18.9 12.0 11.6 16.5 16.6 15.5 14.2 14.0 13.5 18.5 16.8 24.9 17.8 19.8 37.0 17.7 22.1 17.2 18.4 15.4 14.7 18.5 15.3 16.8 12.8 18.7 16.6 16.4 14.3 54.6 20.7 25.5 20.5 7.7 15.3 14.3 14.0 9.7 10.6 17.8 9.6 20.7 15.3 8.3 11.4 15.0 26.5 42.4 19.3 18.2 24.0 17.8 19.8 25.9 27.3 22.5 25.8 11.5 17.9 16.5 26.6 13.5 27.9 17.2 28.0 20.1 20.7 15.6 35.7 15.2 10.8 9.4 16.5 13.5 11.4 20.5 18.7 20.9 16.4 21.6 13.9 14.9 17.2 12.8 19.1 15.1 11.9 13.3 7.8 18.7 21.9 14.0 17.4 16.9 23.5 11.8 21.3 9.3 16.2 37.5 16.0 17.5 10.2 12.8 14.9 8.8 15.4 13.3 14.7 15.9 9.8 14.0 11.8 12.7 9.6 11.9 14.1 6.9 14.8 9.7 12.0 12.4 10.6 9.6 15.3 15.1 17.8 20.7 7.1 7.4 11.0 8.3 21.0 22.1 28.9 24.8 16.5 16.6 18.5 16.8 22.1 20.7 23.8 28.1 13.4 8.4 6.2 29.9 31.6 12.7 40.2 37.5 26.2 35.3 22.4 16.6 14.7 69.4 21.5 13.6 23.3 10.8 10.9 16.2 15.0 22.1 15.1 10.3 28.6 30.0 11.6 14.2 29.1 29.1 15.4 23.6 36.1 19.4 28.9 14.4 14.4 22.6 9.2 33.8 25.8 10.3 193.0 44.5 6.0 21.2 15.2 18.3 6.7 BRINP1 "DBC1, DBCCR1, FAM5A" ENSG00000078725 "BMP/retinoic acid inducible neural specific 1" O60477 9 119153458-119369467 "Predicted intracellular proteins, Transporters" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 47.0" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 7.5;Cone photoreceptor cells: 23.6;Ito cells: 4.9;Proximal tubular cells: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 9.2;NTERA-2: 17.6;SCLC-21H: 7.8;SH-SY5Y: 3.4;SuSa: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038828 Approved Uncertain Microtubules "Intracellular and membrane" NA NA Microtubules "HPA038828: AB_10670909" "unprognostic (8.60e-5)" "unprognostic (2.31e-2)" "unprognostic (1.24e-1)" "unprognostic (5.09e-5)" "unprognostic (1.12e-1)" "unprognostic (1.14e-2)" "unprognostic (1.37e-1)" "unprognostic (2.98e-1)" "unprognostic (1.76e-1)" "unprognostic (1.02e-1)" "unprognostic (2.28e-4)" "unprognostic (1.51e-2)" "unprognostic (5.06e-3)" "unprognostic (1.39e-3)" "unprognostic (1.56e-1)" "unprognostic (7.59e-2)" "unprognostic (1.41e-1)" 1.0 5.6 17.7 1.0 16.5 0.9 3.8 19.7 47.0 1.4 1.1 5.1 0.0 1.1 1.2 7.2 1.2 1.0 2.7 2.8 16.0 12.4 3.0 1.7 1.1 0.9 7.4 10.7 1.0 0.9 1.0 1.0 0.9 5.8 2.9 1.0 0.2 1.7 7.6 1.2 0.9 1.7 1.0 9.7 1.3 1.0 1.5 5.1 0.0 1.3 0.0 0.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 17.6 0.0 0.0 0.0 1.8 0.0 0.1 0.0 7.8 3.4 0.0 0.0 0.0 6.5 0.7 0.0 0.0 1.2 1.9 0.0 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 16.5 19.7 32.2 16.0 12.4 7.4 10.7 5.8 5.1 0.0 0.0 0.0 0.4 0.0 7.5 0.6 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.6 2.4 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.4 8.8 2.3 0.0 0.3 0.7 0.7 0.0 0.0 0.0 0.0 0.1 BRPF1 BR140 ENSG00000156983 "Bromodomain and PHD finger containing 1" P55201 3 9731729-9748018 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003359 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003359: AB_1078217" "unprognostic (4.18e-2)" "unprognostic (2.21e-2)" "unprognostic (6.47e-2)" "unprognostic (9.10e-2)" "unprognostic (3.42e-1)" "unprognostic (2.33e-2)" "prognostic unfavorable (3.20e-5)" "unprognostic (3.00e-1)" "unprognostic (3.72e-1)" "unprognostic (3.26e-3)" "unprognostic (4.27e-2)" "prognostic unfavorable (5.28e-4)" "unprognostic (1.51e-3)" "unprognostic (4.86e-2)" "unprognostic (3.55e-1)" "unprognostic (6.87e-2)" "unprognostic (9.67e-3)" 10.5 7.7 6.2 10.4 8.1 29.2 10.7 16.5 13.1 10.7 9.5 10.4 5.0 6.8 14.4 8.9 10.7 12.9 10.7 7.0 5.4 4.2 8.2 5.3 10.7 12.3 8.3 7.0 12.5 9.2 11.3 9.5 9.9 7.5 9.0 6.3 9.6 12.1 8.5 11.1 14.2 10.5 8.3 5.1 12.2 9.2 23.7 11.4 24.3 12.0 7.8 11.4 11.5 9.4 1.2 3.5 2.3 1.8 9.3 4.2 1.3 5.4 8.5 8.4 4.1 5.3 4.5 43.2 6.7 4.5 7.9 5.9 7.5 4.6 9.4 3.1 6.7 7.8 4.6 8.5 6.8 5.7 9.9 9.1 12.1 16.9 5.0 6.2 17.1 11.3 5.7 5.7 11.7 7.0 4.4 6.1 9.8 12.8 9.5 4.9 13.1 10.7 14.1 10.7 4.0 8.0 14.4 5.9 6.5 4.2 8.6 5.0 7.8 7.3 5.2 6.2 5.5 5.3 16.7 7.7 9.4 8.0 8.0 12.4 7.7 8.6 17.4 7.3 14.1 8.0 2.2 1.8 2.3 2.7 1.6 4.2 1.1 2.1 2.5 1.5 1.2 2.5 2.9 1.3 9.3 1.5 3.5 1.3 1.3 6.2 8.1 16.5 13.1 5.4 4.2 8.3 7.0 7.5 11.4 14.9 10.6 4.5 4.7 12.6 4.4 3.5 0.0 4.0 7.9 7.0 5.9 3.6 0.0 3.6 1.6 7.5 4.4 0.0 4.7 4.6 4.1 4.4 8.1 2.4 5.5 7.9 9.8 8.6 4.8 0.4 6.1 5.2 1.7 1.0 5.0 4.5 4.3 2.9 5.6 1.8 3.8 6.5 4.7 15.8 11.7 16.2 3.1 7.5 5.8 5.5 BSPRY FLJ20150 ENSG00000119411 "B-box and SPRY domain containing" Q5W0U4 9 113349541-113371233 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 67.7;salivary gland: 68.2" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 59.2;Exocrine glandular cells: 58.0;Pancreatic endocrine cells: 56.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "basal ganglia: 20.8" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 8.0" "Lineage enriched" "Detected in single" 20 "dendritic cells: 8.0" "Cell line enhanced" "Detected in some" "A-431: 18.1;CAPAN-2: 11.6;MCF7: 27.0;OE19: 31.4;RPMI-8226: 14.1;SK-BR-3: 13.6;T-47d: 13.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042889, HPA077485" Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042889: AB_10795515, HPA077485: " "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "unprognostic (1.18e-1)" "unprognostic (2.20e-3)" "unprognostic (1.68e-1)" "unprognostic (2.10e-3)" "unprognostic (4.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (2.28e-1)" "unprognostic (1.95e-2)" "prognostic favorable (4.56e-14)" "unprognostic (1.15e-3)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (1.70e-1)" 0.2 1.6 1.0 4.6 20.8 2.1 6.1 4.1 1.4 2.9 5.4 0.4 7.9 3.6 1.0 6.4 14.2 1.9 8.5 1.4 0.6 0.7 9.3 0.4 4.1 0.6 0.7 1.3 0.3 37.8 67.7 10.1 1.7 0.6 2.4 4.5 2.7 68.2 4.8 0.1 12.4 6.8 0.4 0.3 0.3 10.4 2.1 1.8 1.2 28.2 10.7 5.4 1.5 3.2 0.0 8.0 0.0 0.0 0.0 0.4 0.1 18.1 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 3.8 11.6 0.0 0.2 0.0 0.0 1.6 0.1 0.0 0.0 2.0 1.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 9.4 0.1 0.0 0.0 27.0 0.3 0.0 0.4 31.4 0.0 0.4 0.0 14.1 1.8 3.9 6.2 0.0 0.0 13.6 0.0 0.8 13.7 1.9 0.0 0.0 0.0 0.0 0.0 4.4 5.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.0 0.0 0.1 1.0 20.8 4.1 1.4 0.6 0.7 0.7 1.3 0.6 1.8 6.0 5.8 2.4 1.7 0.9 0.6 1.6 15.3 2.7 4.5 26.2 5.9 8.1 33.2 59.2 0.1 0.1 12.9 0.0 58.0 0.7 0.4 15.4 3.5 0.8 1.2 0.0 19.7 0.0 0.0 0.2 0.0 0.1 10.1 1.8 19.3 0.3 56.5 14.0 0.0 15.3 9.1 0.0 0.0 0.5 2.3 12.4 5.6 0.5 24.3 13.9 BTAF1 "MOT1, TAF-172, TAF(II)170, TAF172, TAFII170" ENSG00000095564 "B-TFIID TATA-box binding protein associated factor 1" O14981 10 91923769-92030325 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070682 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA070682: AB_2686294" "unprognostic (2.41e-1)" "unprognostic (1.29e-1)" "unprognostic (5.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-1)" "prognostic favorable (5.07e-4)" "unprognostic (2.72e-1)" "unprognostic (9.28e-2)" "unprognostic (1.16e-1)" "unprognostic (7.34e-2)" "unprognostic (9.70e-3)" "unprognostic (4.27e-2)" "prognostic unfavorable (4.04e-5)" "unprognostic (6.45e-2)" "unprognostic (1.10e-1)" "unprognostic (4.79e-2)" "unprognostic (1.98e-1)" 21.8 13.7 15.1 20.2 23.1 26.7 20.8 19.9 21.6 20.8 19.7 18.3 17.4 15.9 24.3 22.0 19.4 26.2 15.5 15.9 16.0 7.0 13.8 15.5 20.1 29.3 22.2 13.4 30.4 19.7 21.1 22.3 13.8 16.5 18.2 16.4 18.1 21.0 18.3 15.8 48.6 23.4 22.1 22.4 22.4 19.6 21.2 23.8 29.0 19.5 10.8 25.8 24.3 21.2 6.9 9.6 6.8 6.3 4.4 5.3 2.6 16.8 8.2 19.4 23.5 10.3 16.3 9.7 9.9 11.8 9.8 14.7 11.3 10.3 18.2 6.4 9.7 6.1 18.3 13.0 8.8 14.8 12.4 14.0 12.9 19.3 11.8 10.6 19.3 13.5 11.5 11.4 14.9 21.8 21.2 9.4 15.6 10.5 21.0 10.0 7.3 14.9 12.3 8.8 4.9 6.5 12.1 12.1 8.4 9.2 10.4 7.5 8.8 9.5 4.8 12.2 13.4 9.8 12.9 10.1 8.9 7.1 11.9 14.0 24.4 11.2 15.0 13.9 17.9 2.3 6.8 5.5 2.9 5.3 3.7 4.6 5.1 3.9 3.6 4.0 6.9 4.9 3.7 3.9 4.4 6.3 9.6 3.1 2.6 15.1 23.1 19.9 21.6 16.0 7.0 22.2 13.4 16.5 23.8 17.9 26.9 9.3 10.2 19.3 24.2 12.6 2.5 30.8 17.0 19.2 43.2 5.5 1.7 5.6 6.5 12.7 7.3 0.0 5.7 8.6 10.8 12.3 23.1 7.8 6.3 17.5 15.5 8.0 8.9 3.6 10.9 15.4 5.0 7.2 6.4 12.8 5.8 5.8 11.0 2.2 37.4 6.5 18.6 18.7 8.5 26.1 12.2 13.8 7.8 14.0 BTBD1 ENSG00000064726 "BTB domain containing 1" Q9H0C5 15 83016422-83067354 "Predicted intracellular proteins" "Differentiation, Myogenesis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.2" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 78.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024263, HPA067671" Enhanced Supported "Nucleoplasm,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Nucleoplasm "HPA024263: , HPA067671: AB_2685882" "unprognostic (1.63e-1)" "unprognostic (4.61e-2)" "unprognostic (1.35e-1)" "unprognostic (5.54e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (4.80e-2)" "unprognostic (1.65e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-1)" "unprognostic (2.73e-1)" "unprognostic (1.07e-1)" "prognostic favorable (6.21e-7)" "unprognostic (8.94e-3)" "unprognostic (8.27e-2)" "unprognostic (7.71e-2)" "unprognostic (1.89e-2)" 11.6 9.4 17.6 7.9 17.3 10.4 10.0 11.9 22.5 9.2 11.0 13.8 4.7 10.8 8.5 9.8 10.4 10.9 9.8 35.0 17.0 14.3 13.0 11.3 8.1 11.1 17.0 11.5 8.5 6.1 12.8 10.0 8.0 18.0 10.6 12.3 6.9 8.7 8.7 96.2 6.6 10.6 9.3 18.2 9.2 7.9 18.4 11.5 10.5 12.7 21.3 11.0 9.8 7.4 4.6 8.8 9.3 6.7 3.9 7.2 2.1 15.4 14.9 13.2 12.9 20.8 35.9 6.9 22.5 30.8 19.5 21.7 9.4 16.1 31.1 28.0 25.2 16.2 19.6 28.8 18.0 23.1 24.8 23.5 26.4 22.3 13.4 24.5 24.9 29.5 29.2 16.3 13.2 19.8 25.3 28.6 12.2 23.4 17.5 41.0 8.1 18.9 13.0 18.4 13.6 16.5 19.3 33.5 15.4 19.6 36.8 23.1 16.6 26.1 21.7 36.9 18.8 16.3 21.0 28.7 22.1 16.5 30.4 31.1 18.0 27.7 30.3 23.9 42.3 15.3 2.2 4.9 9.3 5.5 5.4 4.9 4.5 5.2 7.2 8.8 4.6 5.9 5.8 2.9 3.9 6.7 3.8 4.8 2.1 17.6 17.3 11.9 22.5 17.0 14.3 17.0 11.5 18.0 11.5 14.9 4.3 16.8 11.9 13.5 8.9 78.3 7.6 30.8 21.6 10.4 5.9 7.1 14.9 12.7 24.1 14.7 14.8 23.3 9.1 11.1 13.3 10.4 17.3 9.2 16.1 11.1 22.3 14.7 23.0 20.5 8.1 19.5 11.8 19.0 11.5 7.3 12.1 17.3 10.6 12.1 7.8 6.5 13.2 44.2 14.9 10.7 6.8 15.8 16.5 15.9 BTBD16 "C10orf87, Em:AC061711.1, FLJ25359" ENSG00000138152 "BTB domain containing 16" Q32M84 10 122271306-122338162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skin 1: 9.1;testis: 27.6;urinary bladder: 17.9" "Group enriched" "Detected in some" 19 "Early spermatids: 100.4;Late spermatids: 53.9" "Cancer enriched" "Detected in many" 14 "urothelial cancer: 18.4" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 29 "T-reg: 2.8" "Lineage enriched" "Detected in single" 29 "T-cells: 2.8" "Cell line enriched" "Detected in some" 8 "RT4: 27.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA040529, HPA057638" Uncertain Uncertain Nucleoli,Cytosol Yes NA Nucleoli Cytosol "HPA040529: AB_2677022, HPA057638: " "unprognostic (1.41e-4)" "unprognostic (1.33e-1)" "unprognostic (5.97e-2)" "unprognostic (5.98e-3)" "unprognostic (2.08e-1)" "unprognostic (2.09e-3)" "unprognostic (2.88e-1)" "unprognostic (4.54e-2)" "unprognostic (1.76e-1)" "unprognostic (6.85e-2)" "unprognostic (2.48e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (9.12e-2)" "unprognostic (9.44e-3)" 0.3 0.0 0.6 0.3 0.5 0.0 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.6 0.3 0.3 0.2 0.3 0.3 0.9 0.4 0.3 4.4 0.3 0.3 1.2 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.4 0.3 0.3 9.1 0.3 0.3 2.3 0.3 0.0 27.6 0.3 0.3 0.3 0.3 0.3 17.9 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 1.3 27.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.6 0.5 0.3 0.3 0.9 0.4 1.2 0.3 0.3 0.3 0.0 0.0 0.0 0.2 2.5 0.0 0.2 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.9 100.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 53.9 0.6 0.0 0.0 0.0 0.0 0.0 1.3 2.9 0.4 0.8 0.0 0.0 0.2 3.7 0.9 2.8 0.1 0.0 0.0 0.8 BTBD19 ENSG00000222009 "BTB domain containing 19" C9JJ37 1 44808482-44815585 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "neutrophil: 2.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 2.3" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 7.0;HUVEC TERT2: 6.4;TIME: 14.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042633, HPA076404" Uncertain Uncertain Cytosol NA NA Cytosol "HPA042633: AB_2678091, HPA076404: AB_2686796" "unprognostic (4.69e-2)" "unprognostic (8.74e-3)" "unprognostic (1.82e-3)" "unprognostic (1.20e-4)" "unprognostic (5.32e-2)" "unprognostic (3.80e-2)" "unprognostic (1.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.70e-1)" "unprognostic (1.53e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.18e-8)" "unprognostic (2.20e-3)" "unprognostic (2.78e-2)" "unprognostic (8.29e-2)" "unprognostic (1.70e-1)" 6.7 8.7 3.5 3.6 1.9 2.7 4.9 0.6 2.8 13.5 2.0 2.4 6.2 1.6 13.9 21.4 2.1 6.4 4.2 3.8 1.3 1.4 4.2 2.2 4.1 1.8 1.4 4.0 8.4 1.5 3.2 11.9 7.9 6.3 5.6 1.8 7.6 1.7 8.3 1.8 1.2 2.2 5.6 1.9 2.3 2.2 3.5 0.6 0.1 6.0 2.0 1.4 2.1 4.3 0.0 0.2 2.3 0.1 0.0 0.2 0.0 0.1 1.1 1.0 1.1 2.3 2.6 0.7 2.1 1.3 1.0 2.0 0.0 0.8 0.1 1.0 3.7 0.5 0.3 0.0 1.1 0.4 0.9 0.2 2.0 0.3 1.1 2.3 0.0 1.6 3.9 0.1 3.7 0.7 7.0 6.4 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.7 0.0 0.0 0.0 0.3 0.1 1.2 1.3 0.0 0.0 14.9 3.8 3.0 1.8 1.6 0.5 0.1 0.0 2.3 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 3.5 1.9 0.6 2.8 1.3 1.4 1.4 4.0 6.3 0.6 3.0 3.4 0.0 1.6 1.8 0.0 1.0 2.5 1.4 4.5 1.8 0.0 0.2 0.0 0.9 0.4 3.5 2.1 0.0 0.5 0.2 3.8 0.9 2.3 2.8 2.7 0.0 0.0 3.7 6.0 0.0 2.8 4.6 3.3 0.0 1.3 1.5 0.8 0.8 1.1 2.7 0.0 0.0 4.6 0.7 0.2 1.9 1.0 0.0 0.7 1.3 BTN3A1 "BT3.1, BTF5, BTN3.1, CD277" ENSG00000026950 "Butyrophilin subfamily 3 member A1" O00481 6 26402237-26415216 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "granulocytes: 24.4;T-cells: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA012565 Approved Uncertain Vesicles NA NA Vesicles "HPA012565: AB_1845494" "unprognostic (2.82e-2)" "unprognostic (6.43e-2)" "unprognostic (1.45e-3)" "unprognostic (4.72e-3)" "unprognostic (1.41e-2)" "unprognostic (1.42e-1)" "unprognostic (3.10e-2)" "unprognostic (9.31e-2)" "unprognostic (9.81e-2)" "unprognostic (8.60e-3)" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "prognostic unfavorable (4.15e-5)" "unprognostic (2.45e-1)" "unprognostic (5.02e-2)" "unprognostic (3.26e-2)" "prognostic favorable (4.81e-4)" 11.3 14.3 6.7 33.5 5.4 10.3 10.2 10.7 5.9 18.5 14.9 10.0 10.1 11.5 22.3 14.1 13.1 9.6 16.5 9.0 5.3 6.1 9.7 11.4 29.9 24.1 7.1 5.4 15.5 9.4 5.6 11.2 8.5 7.8 17.9 12.1 12.3 16.7 10.0 4.8 9.7 20.6 10.2 9.0 45.2 12.5 4.9 6.7 16.5 8.5 9.8 32.9 11.6 12.9 9.8 4.4 17.4 5.9 18.4 23.4 12.1 3.7 3.2 4.7 4.8 13.6 14.5 0.5 3.0 12.0 6.9 20.3 0.1 8.1 9.7 10.6 5.5 10.8 2.5 1.5 4.8 4.0 9.5 3.3 5.1 3.9 2.2 6.1 4.7 4.7 7.8 2.7 6.0 2.7 10.5 9.7 15.7 1.2 12.7 2.8 0.3 8.5 2.9 0.5 1.6 1.0 11.8 2.1 22.0 4.2 4.7 2.5 5.0 1.7 3.6 6.8 0.7 3.3 1.9 2.4 5.3 1.3 1.5 2.9 21.7 22.1 3.5 8.1 10.6 4.0 17.4 5.3 13.5 23.4 5.7 20.9 9.8 14.6 21.7 4.4 5.3 12.7 16.8 11.9 18.4 5.9 2.1 16.9 12.1 6.7 5.4 10.7 5.9 5.3 6.1 7.1 5.4 7.8 6.7 14.9 6.2 15.4 3.5 3.8 4.3 3.5 7.6 5.3 11.4 5.2 0.0 4.5 0.0 5.4 0.1 11.3 9.1 0.0 2.9 3.6 6.6 5.3 24.4 3.4 6.9 0.0 4.6 10.4 11.8 0.4 3.4 8.3 1.7 2.8 14.6 2.9 2.4 7.0 2.5 1.2 0.4 0.0 3.3 0.0 0.1 2.9 1.3 37.4 6.8 4.2 BUB1 "BUB1A, BUB1L, hBUB1" ENSG00000169679 "BUB1 mitotic checkpoint serine/threonine kinase" O43683 2 110637698-110678114 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 56.5;testis: 30.9" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "T-reg: 6.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 68.1" "Not detected" "Not detected" HPA006123 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA006123: AB_1845498" "unprognostic (7.74e-2)" "unprognostic (3.45e-2)" "unprognostic (9.72e-3)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.61e-1)" "unprognostic (5.62e-3)" "prognostic unfavorable (1.03e-5)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.26e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (2.37e-5)" "unprognostic (1.76e-1)" "unprognostic (0.00e+0)" "unprognostic (2.45e-2)" "unprognostic (3.64e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" 1.1 0.9 0.5 15.8 1.0 8.9 0.6 0.3 1.0 1.2 2.8 0.4 0.0 2.4 0.7 2.3 5.8 0.5 1.0 1.1 0.5 0.5 0.9 0.8 2.1 11.6 0.6 0.2 1.0 0.7 0.0 0.4 2.4 0.5 0.7 4.3 0.4 1.4 0.0 0.5 1.8 3.1 1.4 1.3 7.9 1.8 30.9 0.1 56.5 0.6 5.7 12.1 2.5 2.0 1.8 2.4 3.0 0.2 1.4 6.1 1.1 30.3 8.9 23.4 14.7 1.0 1.7 12.4 15.8 10.4 27.5 20.8 18.7 17.5 20.6 9.8 9.1 25.8 13.3 29.9 11.5 34.2 16.3 14.6 68.1 9.5 14.9 0.2 19.6 19.3 0.4 0.7 21.2 10.5 3.9 16.1 23.1 29.8 43.0 22.5 10.0 32.8 16.4 22.6 10.8 16.9 21.8 20.0 31.4 5.6 9.6 15.7 6.8 11.2 9.6 8.5 14.9 7.5 16.6 6.6 12.5 20.5 9.4 21.9 22.5 21.1 25.3 8.5 15.2 22.0 3.0 0.0 0.7 0.6 0.2 0.9 1.8 2.5 1.0 0.8 1.4 1.6 1.5 0.0 1.4 0.1 2.4 6.1 1.1 0.5 1.0 0.3 1.0 0.5 0.5 0.6 0.2 0.5 0.1 0.0 1.0 7.8 0.2 0.5 0.0 0.8 0.0 1.4 2.3 0.0 0.0 1.3 0.0 0.2 8.3 0.0 0.0 0.0 0.0 8.1 0.3 0.2 0.0 0.2 6.6 0.0 0.0 1.3 1.3 4.7 0.3 1.7 0.0 1.0 0.9 0.0 0.1 0.0 0.4 0.0 0.0 6.5 0.0 68.0 14.1 0.4 0.6 2.5 2.0 0.9 C11orf24 DM4E3 ENSG00000171067 "Chromosome 11 open reading frame 24" Q96F05 11 68261335-68272001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 65.7" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 99.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 63.4" "HPA012411, HPA012748" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus" Vesicles "HPA012411: , HPA012748: AB_1845526" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "prognostic unfavorable (7.38e-4)" "unprognostic (2.31e-2)" "unprognostic (7.91e-2)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.56e-1)" "unprognostic (2.68e-2)" "unprognostic (4.99e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.60e-9)" "unprognostic (2.18e-2)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (8.67e-3)" 12.9 9.3 6.6 12.9 10.6 2.7 14.7 6.7 13.7 14.1 32.6 23.3 8.4 35.2 21.8 12.3 8.6 12.2 19.2 19.1 9.1 6.5 10.0 44.3 12.6 14.4 10.3 8.1 14.1 17.5 5.8 8.1 12.6 14.5 12.2 11.8 14.7 22.1 12.6 6.9 8.9 65.7 21.5 13.8 11.3 13.5 7.8 10.3 3.4 9.2 11.4 18.8 14.6 10.5 23.7 16.4 9.3 11.0 5.5 9.2 6.9 12.5 13.0 7.7 15.0 18.7 19.0 9.0 30.3 19.7 15.3 15.8 27.4 7.8 5.7 9.4 37.6 13.9 14.2 11.4 13.6 9.9 6.2 6.7 6.0 13.2 18.3 15.1 5.1 20.3 15.7 10.2 23.2 9.5 9.2 6.1 3.0 10.5 9.4 12.9 15.6 1.2 7.4 12.9 20.4 15.8 2.3 13.2 29.3 6.9 6.0 5.1 9.5 9.9 7.9 63.4 6.7 7.4 4.3 6.7 24.1 14.9 30.3 13.3 11.6 11.3 5.3 19.3 4.0 23.1 9.3 7.2 7.5 9.2 11.0 6.2 17.3 5.3 5.7 12.0 23.7 5.0 5.3 1.1 5.5 8.1 16.4 4.8 6.9 6.6 10.6 6.7 13.7 9.1 6.5 10.3 8.1 14.5 10.3 8.9 2.2 11.5 8.0 12.5 3.7 8.5 12.7 10.7 4.5 8.7 2.0 12.7 1.7 14.5 2.8 6.4 37.3 0.0 27.1 24.7 18.1 10.2 43.9 99.7 14.5 0.0 4.6 9.2 12.1 5.6 13.0 12.4 27.0 21.6 33.5 6.6 21.8 12.4 15.2 8.8 2.9 12.9 17.9 12.7 20.6 9.8 8.8 4.9 12.8 7.9 C16orf71 "DKFZp686H2240, FLJ43261" ENSG00000166246 "Chromosome 16 open reading frame 71" Q8IYS4 16 4734272-4749396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "fallopian tube: 14.1;testis: 48.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 18.7;Early spermatids: 20.4;Late spermatids: 45.3;Spermatocytes: 48.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 7.6;U-2197: 8.3" HPA049468 Enhanced Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA049468: AB_2680779" "unprognostic (1.24e-2)" "unprognostic (8.87e-2)" "unprognostic (2.39e-1)" "prognostic favorable (7.49e-4)" "unprognostic (7.06e-2)" "unprognostic (2.17e-2)" "unprognostic (5.36e-3)" "unprognostic (2.21e-2)" "unprognostic (1.69e-1)" "unprognostic (2.15e-2)" "unprognostic (6.79e-3)" "unprognostic (1.13e-1)" "unprognostic (8.56e-3)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (2.54e-5)" "unprognostic (1.65e-1)" 0.3 0.5 0.7 0.3 1.9 0.0 0.3 1.0 1.0 0.9 0.3 2.4 0.6 0.2 0.6 2.5 0.4 14.1 0.8 0.3 1.1 1.0 1.0 1.1 1.7 0.1 0.7 0.5 1.2 0.4 0.8 1.7 0.1 3.6 0.5 0.1 0.4 1.3 1.1 0.4 0.2 0.3 0.4 0.5 0.2 0.3 48.9 0.7 0.2 1.1 0.0 0.4 0.3 0.5 1.4 4.1 0.0 1.1 0.0 0.7 0.4 0.6 3.3 0.7 1.9 4.4 1.9 1.4 1.8 1.6 1.5 1.9 1.5 1.4 0.1 1.8 2.7 4.4 1.5 1.7 1.7 0.3 0.7 1.1 0.4 2.4 0.1 1.4 1.4 0.6 0.5 0.4 5.8 1.6 1.1 0.8 1.3 1.1 0.9 1.5 7.6 0.4 1.2 1.0 2.1 1.6 0.5 0.8 2.2 4.0 0.7 4.9 1.8 1.8 1.5 0.6 1.3 6.7 0.4 0.6 1.2 1.4 8.3 0.9 3.3 2.6 0.8 0.7 0.4 1.3 0.0 0.7 0.0 0.2 0.2 0.0 0.0 0.7 0.1 0.9 1.4 0.4 0.5 0.0 0.0 1.1 4.1 0.0 0.4 0.7 1.9 1.0 1.0 1.1 1.0 0.7 0.5 3.6 0.7 0.0 0.6 0.0 0.2 0.0 0.8 0.8 0.0 18.7 5.7 0.0 3.9 0.2 0.0 0.5 20.4 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 45.3 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 1.3 1.7 0.0 0.0 48.1 6.6 0.0 0.1 0.0 0.0 0.0 C17orf49 "BAP18, HEPIS, MGC49942" ENSG00000258315 "Chromosome 17 open reading frame 49" Q8IXM2 17 7014495-7017525 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "monocytes: 100.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022961, HPA024457" Supported Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (1.48e-2)" "unprognostic (1.67e-3)" "unprognostic (9.09e-2)" "unprognostic (5.15e-2)" "unprognostic (4.54e-1)" "unprognostic (3.27e-2)" "unprognostic (2.38e-1)" "unprognostic (7.62e-2)" "unprognostic (2.27e-2)" "unprognostic (4.06e-2)" "unprognostic (2.25e-2)" "unprognostic (1.49e-2)" "unprognostic (1.06e-9)" "unprognostic (5.68e-2)" "unprognostic (1.74e-1)" "unprognostic (1.41e-2)" "unprognostic (4.62e-2)" 28.3 21.9 32.7 30.7 29.1 55.4 25.8 24.9 32.1 21.4 20.7 20.9 13.9 18.5 19.1 29.9 29.7 27.2 25.6 25.6 28.4 24.5 23.3 34.3 30.4 45.2 25.9 21.1 19.0 25.1 20.8 20.9 29.7 19.7 20.4 23.2 22.5 22.7 16.8 32.7 30.2 19.2 18.4 23.1 44.6 18.4 21.8 17.9 60.4 31.4 30.7 53.7 25.7 18.8 52.3 78.9 48.8 49.8 82.3 48.3 40.4 18.3 24.5 38.8 30.0 27.7 39.4 13.3 10.0 16.4 20.1 16.5 12.0 15.2 17.7 27.7 23.9 6.5 15.3 9.6 19.4 15.4 61.7 25.6 15.9 7.8 23.1 20.8 10.1 21.3 24.7 26.2 15.0 30.4 14.5 31.4 14.4 5.8 50.6 24.5 21.0 16.6 33.9 12.9 21.1 14.4 10.4 11.4 25.6 22.7 12.3 10.6 30.1 17.6 9.1 17.7 14.6 11.5 13.1 17.1 11.7 14.5 19.7 25.4 18.2 10.3 5.9 18.3 15.1 16.7 48.8 37.6 34.4 47.0 49.8 29.8 52.3 48.3 47.0 57.6 50.6 32.3 35.7 34.3 82.3 37.1 78.9 47.9 40.4 32.7 29.1 24.9 32.1 28.4 24.5 25.9 21.1 19.7 17.9 3.0 10.1 19.8 5.3 9.3 1.0 0.4 0.0 4.0 7.9 1.8 0.0 9.5 14.9 15.3 0.1 9.3 5.6 0.0 20.0 13.6 6.9 2.7 17.4 1.5 9.7 0.0 29.4 8.0 8.7 1.0 3.7 18.0 23.6 100.0 10.0 2.0 18.7 13.6 1.4 3.7 3.9 6.5 15.5 4.6 18.8 10.3 8.7 20.8 16.0 4.6 C19orf38 HIDE1 ENSG00000214212 "Chromosome 19 open reading frame 38" A8MVS5 19 10836575-10869790 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 58.7;bone marrow: 54.4" "Cell type enhanced" "Detected in many" 18 "Kupffer cells: 101.9;Macrophages: 32.6;monocytes: 24.4;Spermatocytes: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 19 "classical monocyte: 44.3;eosinophil: 26.1;intermediate monocyte: 48.7;myeloid DC: 26.2;neutrophil: 37.3;non-classical monocyte: 58.7" "Group enriched" "Detected in many" 19 "dendritic cells: 26.2;granulocytes: 37.3;monocytes: 58.7" "Cell line enriched" "Detected in some" 4 "U-937: 32.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012150, HPA055027" Uncertain "Golgi apparatus,Plasma membrane,Cytosol" No NA Cytosol "Golgi apparatus, Plasma membrane" "HPA012150: AB_10603448, HPA055027: " "unprognostic (6.65e-3)" "prognostic favorable (2.43e-4)" "unprognostic (6.44e-4)" "unprognostic (6.98e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-3)" "unprognostic (3.56e-1)" "unprognostic (8.27e-2)" "unprognostic (5.60e-2)" "unprognostic (6.02e-2)" "unprognostic (9.74e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.75e-7)" "unprognostic (2.31e-1)" "unprognostic (4.00e-2)" "unprognostic (1.03e-2)" "unprognostic (2.11e-2)" 2.7 1.2 2.1 6.9 4.0 54.4 1.8 0.7 3.1 2.0 1.3 4.8 0.0 1.3 0.9 4.0 0.9 2.6 2.1 5.6 2.4 2.1 1.4 2.3 12.8 19.6 4.2 0.6 1.6 1.3 0.3 1.0 1.9 3.8 1.6 1.0 1.5 1.0 0.8 2.3 0.6 1.7 2.3 6.3 22.3 1.2 15.0 3.7 4.1 0.7 0.5 2.0 2.8 3.5 2.1 26.2 37.3 58.7 1.2 0.8 20.7 1.5 0.0 0.1 0.3 1.5 0.8 0.1 0.2 0.0 0.3 0.6 0.1 0.2 3.8 0.3 0.0 0.1 0.1 0.2 0.2 0.2 1.7 0.4 0.2 0.0 0.0 1.1 2.5 0.4 4.1 0.4 0.7 0.2 0.1 0.1 0.4 0.2 8.1 0.1 1.4 0.1 5.9 0.3 0.2 0.3 2.8 0.0 1.9 0.0 0.1 0.2 0.1 0.8 0.0 0.6 0.1 0.1 5.6 0.0 0.0 0.0 0.7 0.0 4.9 2.3 1.1 0.0 32.8 0.0 1.2 44.3 26.1 0.1 48.7 0.2 2.1 0.1 0.1 26.2 1.2 0.8 0.2 37.3 1.2 58.7 0.5 0.3 20.7 2.1 4.0 0.7 3.1 2.4 2.1 4.2 0.6 3.8 3.7 0.0 2.6 12.3 0.3 0.7 0.0 0.6 0.0 2.7 1.2 1.8 2.0 0.8 0.0 0.0 2.7 0.0 0.0 0.0 1.1 0.6 1.1 0.4 2.3 0.9 21.2 0.0 0.0 0.0 101.9 5.3 0.9 32.6 1.7 24.4 0.5 2.3 0.2 3.5 0.7 0.4 1.0 6.5 0.1 27.0 15.8 0.6 0.6 0.8 0.3 0.6 C19orf70 "MIC13, P117, QIL1" ENSG00000174917 "Chromosome 19 open reading frame 70" Q5XKP0 19 5678421-5680896 "Predicted intracellular proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 13 "Late spermatids: 2933.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042672 Approved Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA042672: AB_10794531" "unprognostic (9.54e-2)" "unprognostic (4.90e-3)" "unprognostic (3.04e-1)" "unprognostic (3.21e-3)" "unprognostic (1.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.65e-1)" "unprognostic (2.53e-3)" "unprognostic (2.14e-2)" "unprognostic (9.32e-2)" "unprognostic (2.50e-2)" "unprognostic (1.57e-1)" "prognostic favorable (7.60e-5)" "unprognostic (1.08e-1)" "unprognostic (5.94e-2)" "unprognostic (2.27e-1)" "unprognostic (5.47e-2)" 20.2 23.6 32.9 14.5 28.4 13.2 16.0 11.0 29.8 13.0 22.2 13.5 17.8 25.4 12.2 26.8 22.7 16.7 24.0 70.2 27.2 26.5 30.5 38.4 12.7 21.1 32.1 21.1 13.5 24.2 13.2 15.6 12.4 16.9 16.6 11.7 13.6 28.7 22.7 79.1 17.6 20.7 14.7 20.9 14.1 18.2 33.4 12.3 11.6 20.3 45.0 12.6 15.4 11.8 43.6 48.2 11.6 42.2 27.4 39.5 40.7 24.2 20.1 7.0 13.4 16.5 17.1 9.1 16.1 15.3 18.6 15.4 16.0 12.7 10.6 26.2 14.0 9.9 18.1 3.6 22.8 5.3 17.4 38.4 10.3 14.0 17.8 23.3 14.1 13.0 20.0 20.6 10.0 13.9 11.7 13.3 16.3 15.9 33.1 14.0 21.9 21.3 16.8 7.4 17.8 64.4 11.7 8.5 38.7 20.3 15.3 16.4 20.9 4.9 31.8 22.5 4.7 19.4 17.4 13.5 18.3 7.8 33.4 22.7 50.0 33.1 8.4 27.3 22.6 18.5 8.9 35.5 11.6 33.6 42.2 39.5 43.6 38.6 37.2 41.2 35.6 38.1 35.9 5.6 27.4 35.6 48.2 30.9 40.7 32.9 28.4 11.0 29.8 27.2 26.5 32.1 21.1 16.9 12.3 65.5 61.7 101.3 135.8 87.3 47.7 288.5 122.3 167.3 76.2 150.1 25.5 132.2 623.4 178.9 798.0 106.8 325.2 46.7 265.1 165.3 137.3 120.3 92.3 251.0 214.9 17.5 154.8 98.8 146.2 2933.3 115.3 157.0 163.6 263.3 176.9 49.5 211.4 214.0 112.8 383.4 42.2 109.9 170.0 106.7 73.5 109.3 105.3 94.8 219.4 109.5 C1orf141 ENSG00000203963 "Chromosome 1 open reading frame 141" Q5JVX7 1 67092165-67231853 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 14.9;fallopian tube: 12.8;testis: 18.7" "Group enriched" "Detected in some" 4 "Ciliated cells: 84.3;Early spermatids: 83.3;Late spermatids: 78.9;Muller glia cells: 34.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "pons and medulla: 14.9" "Group enriched" "Detected in some" 5 "basophil: 2.5;neutrophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.5" "Cell line enriched" "Detected in single" 37 "HEL: 18.1" "Low region specificity" "Detected in all" HPA035316 Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA035316: AB_10600886" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (1.01e-1)" "unprognostic (2.20e-2)" 0.0 0.0 1.1 0.0 2.6 0.0 0.0 0.1 1.3 0.3 0.1 1.9 0.0 0.0 0.1 1.1 0.0 12.8 0.2 0.0 2.6 1.8 0.1 0.1 2.0 0.1 0.3 0.7 1.8 0.0 0.0 1.0 0.0 14.9 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.2 18.7 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 2.5 0.1 0.4 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 18.1 0.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.4 0.0 0.1 0.0 0.5 1.1 2.6 0.1 1.3 2.6 1.8 0.3 0.7 14.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 84.3 15.9 0.0 0.0 0.0 0.0 0.0 83.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 78.9 1.7 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.7 0.0 1.3 0.0 0.0 6.0 0.7 0.0 0.1 0.0 0.0 0.0 C1orf158 MGC35194 ENSG00000157330 "Chromosome 1 open reading frame 158" Q8N1D5 1 12746215-12763699 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 23.5;testis: 74.6" "Group enriched" "Detected in some" 13 "Ciliated cells: 105.7;Early spermatids: 148.7;Late spermatids: 65.2" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5" "Region enhanced" "Detected in many" "pons and medulla: 9.3" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA028396 Uncertain Cytosol NA NA Cytosol "HPA028396: AB_10603451" "unprognostic (1.11e-2)" "unprognostic (4.94e-3)" "unprognostic (4.62e-1)" "unprognostic (8.00e-2)" "unprognostic (4.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.45e-1)" "unprognostic (3.51e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-2)" 0.0 0.0 0.7 0.0 2.4 0.3 0.0 0.0 0.2 0.9 0.0 6.2 0.0 0.0 0.4 4.2 0.1 23.5 0.1 0.0 1.0 1.4 0.0 0.0 2.8 0.1 0.2 0.1 4.8 0.1 0.0 0.4 0.1 9.3 0.0 0.0 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.2 0.1 0.1 74.6 0.9 0.0 0.5 0.0 0.1 0.0 0.0 0.9 0.6 2.3 0.6 1.1 0.8 0.1 0.5 1.3 1.1 0.7 0.6 0.0 1.0 0.1 0.3 0.2 0.2 1.3 0.7 1.1 0.3 0.3 0.4 0.4 0.1 0.1 0.2 0.2 0.7 1.1 1.9 0.5 0.0 0.9 1.0 0.1 0.7 0.3 0.1 0.4 0.1 0.5 0.9 1.4 0.3 0.5 0.2 0.7 1.5 0.3 0.5 0.6 0.3 0.9 0.1 0.5 1.9 0.8 0.5 0.6 0.3 1.4 0.7 0.2 0.5 0.5 0.8 0.4 0.8 0.6 0.5 1.2 1.0 1.1 0.5 1.6 0.6 0.5 0.7 0.5 0.6 0.5 0.5 0.5 0.1 0.9 0.8 0.7 2.3 1.1 0.6 0.6 0.4 0.1 0.7 2.4 0.0 0.2 1.0 1.4 0.2 0.1 9.3 0.9 3.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 105.7 7.9 0.0 0.0 0.0 0.0 0.0 148.7 0.0 0.0 0.0 0.0 0.5 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 65.2 1.7 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 6.5 0.0 7.9 1.3 0.0 0.0 0.0 0.0 0.1 C1orf194 ENSG00000179902 "Chromosome 1 open reading frame 194" Q5T5A4 1 109105951-109113857 "Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 36.5;fallopian tube: 60.2;testis: 77.6" "Group enriched" "Detected in some" 10 "Ciliated cells: 776.3;Early spermatids: 1757.0;Late spermatids: 2679.4" "Group enriched" "Detected in many" 6 "endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8" "Region enriched" "Detected in many" 5 "pons and medulla: 36.5" "Cell type enriched" "Detected in some" 5 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 5.3" "Cell line enhanced" "Detected in some" "AF22: 4.5;RPTEC TERT1: 1.1;SCLC-21H: 6.3;U-87 MG: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031144, HPA049684" Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA031144: AB_10602109, HPA049684: AB_2680849" "unprognostic (9.91e-3)" "unprognostic (7.60e-3)" "unprognostic (2.28e-2)" "prognostic favorable (1.36e-4)" "unprognostic (3.03e-1)" "unprognostic (1.14e-2)" "unprognostic (4.53e-1)" "unprognostic (3.91e-3)" "unprognostic (5.27e-2)" "unprognostic (9.21e-3)" "unprognostic (3.98e-3)" "unprognostic (1.52e-1)" "unprognostic (6.08e-6)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (5.94e-3)" "unprognostic (3.27e-3)" 0.3 0.4 1.5 0.3 6.8 0.3 0.4 0.3 2.6 1.8 0.3 12.3 0.0 0.4 1.0 11.1 0.4 60.2 0.3 0.3 3.0 1.6 0.3 0.3 7.5 0.4 0.5 1.8 10.3 0.7 0.4 2.7 0.3 36.5 0.4 0.4 0.0 0.3 0.3 0.3 0.3 0.4 0.4 0.7 0.3 0.5 77.6 2.3 0.0 0.5 0.0 0.3 0.5 0.2 0.2 0.0 5.3 0.0 0.0 0.3 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 6.3 0.3 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 6.8 0.3 2.6 3.0 1.6 0.5 1.8 36.5 2.3 0.0 2.6 0.0 0.2 0.0 0.6 2.0 0.0 776.3 56.9 0.0 0.0 0.0 0.0 0.0 1757.0 0.0 0.0 0.0 0.2 0.0 0.2 1.6 3.5 0.0 0.1 0.0 0.0 0.0 0.0 2679.4 19.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 17.7 0.0 0.0 6.5 0.0 176.3 13.0 0.1 0.0 0.0 0.0 0.0 C1orf210 "MGC52423, TEMP" ENSG00000253313 "Chromosome 1 open reading frame 210" Q8IVY1 1 43281883-43285617 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.0" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 105.5;Paneth cells: 49.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "basophil: 5.4" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "A-431: 7.4;BEWO: 8.3;CACO-2: 7.8;CAPAN-2: 25.2;OE19: 20.3;SK-BR-3: 8.8;T-47d: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA013788 Uncertain Uncertain "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA013788: AB_1845637" "unprognostic (1.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.06e-2)" "unprognostic (1.98e-1)" "unprognostic (3.54e-2)" "unprognostic (2.74e-1)" "unprognostic (2.01e-2)" "prognostic favorable (0.00e+0)" "unprognostic (7.57e-3)" "unprognostic (3.94e-1)" "unprognostic (1.00e-1)" "unprognostic (1.61e-2)" 0.3 0.1 0.3 6.5 0.3 0.0 7.4 0.3 0.3 3.9 28.6 0.4 7.4 20.6 1.0 10.9 11.2 2.6 20.7 0.3 0.3 0.1 25.2 3.3 13.5 0.3 0.3 0.3 1.0 29.8 3.0 9.6 6.1 0.4 4.4 14.4 0.4 25.8 7.2 0.3 10.6 64.0 0.5 0.3 0.3 14.6 1.1 0.3 1.0 32.1 7.8 7.7 3.4 5.2 0.1 0.3 5.4 0.3 0.4 0.2 0.0 7.4 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.0 0.0 7.8 25.2 0.0 0.1 0.0 0.0 5.7 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.1 0.0 20.3 0.0 0.0 0.0 0.2 0.6 4.8 3.0 0.2 0.0 8.8 0.0 1.4 9.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.3 0.4 0.3 0.2 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.4 0.3 20.8 10.7 0.8 5.9 1.0 0.0 0.0 22.9 4.0 4.5 21.0 0.0 11.1 24.9 17.9 0.1 0.0 105.5 0.0 29.5 2.9 0.2 10.4 0.0 0.9 0.6 0.0 32.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 34.2 0.0 16.3 49.1 0.0 39.3 0.0 0.0 0.2 0.1 0.0 2.3 3.9 0.0 31.2 7.8 C1orf228 "MGC33556, NCRNA00082, p40" ENSG00000198520 "Chromosome 1 open reading frame 228" Q6PIY5 1 44674692-44725591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.0;testis: 17.9" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 46.8;Early spermatids: 45.0;granulocytes: 81.7;Late spermatids: 39.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 8.6;MOLT-4: 7.1;NB-4: 10.1;U-937: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034769 Uncertain Uncertain Cytosol NA NA Cytosol "HPA034769: AB_10670979" "unprognostic (2.01e-5)" "unprognostic (4.28e-3)" "unprognostic (7.27e-2)" "prognostic favorable (8.64e-4)" "unprognostic (9.23e-2)" "unprognostic (7.43e-3)" "unprognostic (3.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.49e-2)" "unprognostic (9.34e-3)" "unprognostic (1.22e-2)" "unprognostic (9.38e-2)" "unprognostic (1.25e-10)" "unprognostic (1.99e-4)" "unprognostic (1.50e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-3)" 0.9 2.2 6.3 0.7 11.2 4.3 1.5 3.2 6.8 1.7 1.0 5.6 3.9 0.7 3.1 6.8 1.3 14.0 1.5 0.6 6.5 2.4 1.4 7.0 2.0 1.5 1.4 7.5 4.5 1.4 3.0 5.4 0.8 7.7 1.8 0.9 3.3 1.6 1.4 0.5 1.7 0.8 0.9 2.4 0.8 1.4 17.9 5.4 0.2 1.3 0.0 1.0 0.8 0.8 1.4 6.2 10.4 2.7 0.5 2.3 1.8 0.2 0.3 2.0 0.1 0.7 2.6 0.5 0.0 0.3 0.5 0.3 0.5 4.3 0.3 0.3 0.9 1.0 0.5 0.0 0.0 0.0 1.1 0.2 1.0 2.6 0.6 0.2 8.6 5.1 2.0 0.3 0.8 0.0 1.5 0.2 0.3 0.1 0.8 0.2 0.1 7.1 10.1 0.1 0.6 0.1 3.7 0.2 2.4 0.9 0.0 1.4 0.9 0.0 1.4 1.1 1.4 0.4 4.5 0.0 0.3 0.3 0.4 0.0 0.3 0.3 0.2 0.3 13.7 0.4 10.4 2.7 7.5 0.3 0.8 0.1 0.7 1.5 1.0 1.3 1.4 2.2 2.3 1.2 0.5 0.1 6.2 0.1 1.8 6.3 11.2 3.2 6.8 6.5 2.4 1.4 7.5 7.7 5.4 6.0 5.0 14.5 0.4 0.7 1.1 0.0 0.0 46.8 9.1 0.0 11.8 0.3 0.0 0.0 45.0 0.0 0.3 0.0 0.0 0.1 0.7 0.4 81.7 3.2 10.7 1.6 9.8 0.0 15.0 39.8 0.3 6.1 0.0 0.0 0.6 6.1 0.0 0.0 0.7 0.0 4.3 6.5 0.3 2.3 14.3 0.6 0.1 1.0 0.6 0.1 C1R ENSG00000159403 "Complement C1r" P00736 12 7080209-7092607 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 370.2" "Group enriched" "Detected in many" 5 "Fibroblasts: 462.9;Hepatocytes: 1385.8;Leydig cells: 1057.9;Peritubular cells: 364.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 2.0;gdT-cell: 1.6;MAIT T-cell: 2.0;memory CD4 T-cell: 1.4;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.8;naive CD8 T-cell: 2.9;neutrophil: 2.5;NK-cell: 3.2;T-reg: 1.4" "Group enriched" "Detected in many" 6 "granulocytes: 2.5;NK-cells: 3.2;T-cells: 3.4" "Cell line enhanced" "Detected in many" "ASC diff: 181.7;ASC TERT1: 92.7;BJ hTERT+: 80.0;BJ hTERT+ SV40 Large T+ RasG12V: 49.3;HSkMC: 107.4" "Low region specificity" "Detected in all" "HPA001251, HPA001551" Uncertain Uncertain Nucleoplasm,Cytosol "Secreted to blood" NA NA 14000000000 "Nucleoplasm, Cytosol" "HPA001251: AB_2666252, HPA001551: AB_10754818" "unprognostic (1.55e-2)" "unprognostic (8.97e-2)" "unprognostic (3.46e-2)" "unprognostic (1.92e-1)" "unprognostic (1.47e-2)" "unprognostic (2.66e-2)" "unprognostic (1.94e-2)" "unprognostic (2.05e-1)" "unprognostic (2.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.21e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (1.94e-14)" "unprognostic (3.54e-2)" "unprognostic (2.25e-2)" "unprognostic (6.13e-2)" "unprognostic (2.59e-2)" 45.8 17.4 2.6 18.1 3.8 0.0 82.0 1.4 2.8 36.7 24.5 2.4 11.2 5.0 27.2 66.8 38.1 33.3 46.7 49.5 1.9 1.8 27.5 370.2 25.3 46.8 3.5 2.0 103.5 11.4 1.4 6.3 10.3 4.6 47.8 15.3 17.7 12.8 13.2 16.0 10.7 14.4 53.2 6.2 35.1 19.8 39.3 1.9 2.3 30.6 20.7 15.1 46.8 83.8 0.4 0.0 2.5 0.4 3.2 3.4 0.8 0.1 1.5 0.1 1.3 181.7 92.7 0.1 20.4 80.0 24.2 49.3 0.2 0.3 0.0 0.6 15.9 1.6 0.3 1.7 0.8 3.4 1.9 0.1 0.0 0.6 0.6 34.9 0.1 0.2 107.4 0.5 11.0 0.8 18.4 0.4 0.1 0.0 2.5 3.1 0.0 0.9 0.1 0.8 0.0 0.1 1.1 0.5 0.1 0.1 0.9 0.0 0.3 14.7 0.4 0.4 0.2 0.0 0.0 0.0 5.8 0.9 26.7 0.1 0.1 0.4 0.0 8.3 0.1 0.8 0.0 0.4 2.0 1.6 0.1 2.0 0.0 1.4 3.4 0.0 0.4 2.8 2.9 2.5 3.2 0.0 0.0 1.4 0.8 2.6 3.8 1.4 2.8 1.9 1.8 3.5 2.0 4.6 1.9 20.8 84.7 28.4 53.6 48.5 0.2 14.6 168.2 6.7 34.2 17.4 2.0 2.9 3.3 164.2 3.5 51.3 0.3 23.3 39.1 4.8 462.9 14.1 9.3 1385.8 10.3 0.0 0.0 128.9 25.4 9.4 1057.9 10.1 50.6 2.8 0.6 15.1 74.1 0.6 364.9 5.0 0.9 168.1 97.8 5.7 4.1 35.0 4.3 13.1 0.7 9.8 C21orf2 "A2, LRRC76, YF5" ENSG00000160226 "Chromosome 21 open reading frame 2" O43822 21 44328944-44339402 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, DNA damage" "Ciliopathy, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 196.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030283, HPA030284, CAB034126, CAB034128" Supported Supported Vesicles,Mitochondria,Cytosol NA NA Mitochondria "Vesicles, Cytosol" "CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700" "unprognostic (1.84e-1)" "unprognostic (1.56e-1)" "unprognostic (3.14e-2)" "unprognostic (1.29e-2)" "unprognostic (2.11e-3)" "unprognostic (1.36e-1)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (9.73e-2)" "unprognostic (2.77e-1)" "prognostic favorable (1.32e-4)" "unprognostic (1.49e-1)" "prognostic favorable (4.08e-4)" "unprognostic (2.98e-1)" "unprognostic (2.79e-1)" "unprognostic (1.32e-2)" "unprognostic (1.06e-1)" 18.8 13.4 19.8 11.3 21.6 19.7 9.2 10.3 23.4 13.8 14.7 18.2 14.3 13.4 12.6 19.1 6.9 14.7 13.2 11.3 19.5 16.6 18.0 11.6 12.8 12.4 16.4 19.1 15.2 14.5 7.4 17.6 12.4 13.2 12.3 3.9 14.3 16.1 17.2 21.0 22.3 15.4 5.8 12.6 16.1 21.1 16.7 11.2 10.9 16.4 8.1 13.0 8.1 7.0 10.8 21.7 1.2 8.5 12.1 9.7 4.9 8.0 3.4 3.2 4.2 2.1 1.4 12.9 4.2 2.5 1.7 0.9 6.1 2.4 5.8 8.4 1.4 3.4 3.8 0.6 0.8 0.4 8.8 8.4 6.0 2.7 7.1 2.8 6.5 6.5 2.0 1.5 0.7 1.5 2.9 1.0 4.4 7.3 10.0 1.0 9.9 7.1 15.9 8.1 4.1 5.2 18.1 4.2 12.9 1.9 11.8 8.6 7.9 5.8 1.4 6.9 2.0 6.2 14.3 4.7 3.6 4.7 3.9 3.1 16.3 8.6 4.0 8.9 13.1 6.5 1.2 7.1 1.0 7.1 8.5 8.5 10.8 7.3 9.7 7.3 8.6 8.5 8.2 0.9 12.1 6.2 21.7 4.0 4.9 19.8 21.6 10.3 22.4 19.5 16.6 16.4 19.1 13.2 11.2 3.0 16.5 25.0 18.4 14.4 43.7 2.2 35.7 32.1 9.1 12.2 35.3 25.4 66.3 24.9 73.3 10.0 27.6 0.0 51.4 12.3 38.1 21.2 19.5 18.1 31.3 35.0 31.6 9.2 14.5 196.9 24.5 17.6 40.5 31.5 29.6 34.1 20.6 31.1 29.7 36.0 24.8 12.9 18.9 40.3 10.9 13.6 27.3 20.8 31.8 18.6 C22orf31 "bK747E2.1, HS747E2A" ENSG00000100249 "Chromosome 22 open reading frame 31" O95567 22 29058672-29061844 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.4;testis: 12.7" "Group enriched" "Detected in some" 15 "Early spermatids: 55.4;Late spermatids: 34.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "OE19: 1.4" "Not detected" "Not detected" "HPA000604, HPA068522" Uncertain Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA000604: AB_1079086, HPA068522: " 0.0 0.4 0.9 0.0 3.4 0.0 0.4 0.4 0.9 0.5 0.3 0.2 0.4 1.6 0.5 0.5 0.0 0.0 1.0 0.2 0.2 0.0 0.2 0.0 0.8 1.1 0.0 0.2 0.4 0.0 0.2 0.3 0.5 0.0 0.1 0.6 0.4 0.1 0.0 0.0 0.6 12.7 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.2 0.0 0.8 0.0 0.9 0.8 0.0 0.0 0.4 0.6 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 55.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 0.9 0.0 1.7 0.0 0.0 3.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.7 0.6 0.0 0.0 0.0 0.0 C2CD5 "CDP138, KIAA0528" ENSG00000111731 "C2 calcium dependent domain containing 5" Q86YS7 12 22448583-22544546 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 49.1;Early spermatids: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046194 Approved Supported "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA046194: AB_10965327" "unprognostic (2.59e-1)" "unprognostic (1.84e-1)" "unprognostic (1.23e-2)" "unprognostic (1.17e-1)" "unprognostic (1.82e-1)" "unprognostic (1.97e-3)" "unprognostic (1.08e-3)" "unprognostic (1.17e-2)" "unprognostic (8.47e-2)" "unprognostic (1.71e-1)" "unprognostic (2.69e-2)" "unprognostic (2.50e-2)" "unprognostic (1.51e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (2.05e-1)" "unprognostic (1.87e-3)" 10.2 11.2 18.9 16.3 26.6 11.8 13.6 48.5 30.7 13.1 18.5 10.0 10.0 17.8 15.6 12.3 10.4 15.8 15.4 8.8 14.6 16.5 15.7 7.8 11.2 13.8 13.5 22.8 17.4 12.3 23.3 26.2 9.3 26.9 10.3 20.0 13.3 12.7 10.0 8.0 11.7 14.8 12.7 10.8 15.0 19.2 12.9 12.9 18.7 15.5 4.9 14.3 11.7 11.8 7.3 6.1 15.3 14.1 12.8 8.0 4.3 8.5 8.4 18.8 10.2 12.5 16.6 12.0 9.4 10.2 17.7 21.1 9.3 11.4 9.7 4.2 8.8 9.8 7.6 12.0 7.7 24.7 15.7 12.5 12.0 9.2 8.3 11.5 16.1 14.5 9.5 5.6 11.3 20.0 16.8 12.7 13.5 7.8 6.3 11.4 9.1 15.2 24.8 37.5 16.7 6.4 13.3 20.9 13.1 10.5 7.0 8.7 7.6 8.5 8.4 8.9 29.1 11.1 10.8 11.0 10.6 8.6 9.5 9.9 5.1 3.9 15.6 6.6 12.3 7.8 15.3 6.1 2.9 5.5 13.5 7.2 7.3 8.0 5.4 6.1 5.0 7.2 5.7 6.2 12.8 14.1 3.5 8.0 4.3 18.9 26.6 48.5 30.7 14.6 16.5 13.5 22.8 26.9 12.9 8.9 15.8 5.2 3.6 6.2 28.7 13.9 15.3 22.7 25.0 5.2 49.1 3.1 5.0 3.0 54.5 7.1 12.3 0.0 4.0 1.7 6.8 5.4 17.3 7.4 7.1 17.5 15.5 20.3 28.5 14.0 8.1 12.0 6.8 1.8 19.2 6.7 2.8 10.5 7.4 5.1 45.1 6.5 6.1 10.3 6.1 4.8 2.2 7.0 15.3 3.9 C2orf66 UNQ6411 ENSG00000187944 "Chromosome 2 open reading frame 66" Q6UXQ4 2 196805002-196810276 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "adipose tissue: 7.0;pituitary gland: 6.4" "Cell type enriched" "Detected in some" 12 "Early spermatids: 27.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 9.4;RT4: 3.5;TIME: 3.9" HPA020869 Uncertain Uncertain Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA020869: AB_1851545" "unprognostic (1.19e-1)" "unprognostic (4.85e-2)" "unprognostic (6.95e-2)" "unprognostic (1.19e-1)" "unprognostic (3.48e-2)" "unprognostic (1.61e-2)" "unprognostic (6.80e-3)" "unprognostic (3.05e-2)" "unprognostic (1.95e-1)" "unprognostic (4.10e-3)" "unprognostic (4.54e-4)" "unprognostic (1.98e-1)" "unprognostic (1.75e-5)" "unprognostic (1.84e-1)" "unprognostic (2.30e-1)" "unprognostic (1.38e-2)" "unprognostic (1.86e-2)" 7.0 4.0 0.4 0.2 0.7 0.2 1.0 0.1 0.4 0.0 0.2 0.0 0.1 1.2 0.1 1.1 0.4 0.7 0.4 2.8 0.3 0.0 0.2 0.0 0.7 0.3 0.6 0.0 6.4 0.1 0.3 0.4 0.0 0.2 0.0 2.8 0.3 0.1 0.0 0.2 0.0 2.6 0.1 0.2 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.4 1.1 0.5 0.3 0.0 0.5 0.2 0.2 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 1.1 0.2 0.3 0.6 9.4 1.0 0.1 0.0 0.1 0.8 0.7 1.4 0.2 0.2 0.2 0.8 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.2 3.5 0.4 0.2 0.0 0.1 0.1 0.4 0.0 0.0 3.9 0.3 0.3 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 C3orf20 DKFZP434N1817 ENSG00000131379 "Chromosome 3 open reading frame 20" Q8ND61 3 14675099-14773034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 30.9" "Group enriched" "Detected in some" 27 "Early spermatids: 16.4;Late spermatids: 27.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "Daudi: 5.7;HEL: 12.2;U-698: 9.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA039584 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039584: AB_10795152" "unprognostic (1.23e-1)" "unprognostic (2.82e-1)" "unprognostic (5.88e-3)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.76e-3)" "unprognostic (1.81e-1)" "unprognostic (7.82e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (9.08e-2)" "unprognostic (4.74e-2)" "unprognostic (3.24e-1)" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-4)" 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 30.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 5.7 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 12.2 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 2.0 0.0 0.5 0.8 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 1.2 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 C4orf47 LOC441054 ENSG00000205129 "Chromosome 4 open reading frame 47" A7E2U8 4 185426249-185449826 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8;fallopian tube: 20.3;testis: 20.6" "Group enriched" "Detected in many" 7 "Ciliated cells: 125.8;Early spermatids: 125.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 4 "granulocytes: 4.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.1;hTERT-RPE1: 8.3;U-87 MG: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043662, HPA063485" Enhanced Uncertain Vesicles NA NA Vesicles "HPA043662: AB_10964715, HPA063485: " "unprognostic (3.38e-2)" "unprognostic (2.66e-1)" "unprognostic (5.78e-3)" "unprognostic (2.84e-3)" "unprognostic (3.61e-3)" "unprognostic (1.31e-1)" "unprognostic (5.82e-5)" "unprognostic (3.72e-2)" "unprognostic (4.62e-2)" "unprognostic (2.84e-1)" "unprognostic (1.25e-1)" "unprognostic (8.71e-3)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.05e-1)" "unprognostic (3.64e-2)" "unprognostic (9.88e-3)" "unprognostic (1.50e-1)" 0.9 0.5 4.4 0.7 13.3 0.8 3.7 1.7 4.0 1.8 0.7 3.6 0.8 0.6 2.2 12.3 0.7 20.3 1.8 1.2 3.8 3.8 2.4 1.0 3.3 0.5 2.4 2.9 3.0 1.3 1.0 7.1 0.7 20.8 1.2 0.7 2.1 1.0 1.4 0.6 1.9 0.7 1.0 4.7 0.8 0.5 20.6 5.5 0.0 7.3 0.0 0.6 1.0 0.6 0.1 0.7 4.1 0.6 0.9 0.6 0.2 3.9 0.0 0.4 2.1 0.8 4.1 1.2 0.1 0.3 0.3 0.5 0.6 2.4 0.1 0.8 0.1 0.4 0.3 0.5 0.6 0.9 0.8 0.7 0.0 0.1 0.6 1.0 0.0 0.3 0.9 0.9 1.0 0.4 8.3 0.0 0.9 0.5 0.2 3.0 0.5 0.0 0.0 0.5 0.0 1.5 0.1 0.0 0.3 1.1 0.1 2.2 1.0 0.7 0.1 2.4 0.8 0.2 0.6 1.2 0.6 0.3 0.0 0.1 1.7 0.0 0.0 10.0 0.0 0.2 0.0 0.6 0.6 0.2 0.1 0.4 0.0 0.6 0.6 0.2 0.1 0.1 0.2 4.1 0.9 0.2 0.7 0.0 0.2 4.4 13.3 1.7 4.0 3.8 3.8 2.4 2.9 20.8 5.5 3.0 1.0 0.0 0.5 0.6 0.6 0.5 0.0 125.8 17.0 3.5 9.8 0.1 1.7 1.2 125.8 0.6 0.0 0.0 0.5 1.2 0.8 1.2 0.0 0.0 0.2 1.6 0.0 1.3 0.3 7.5 0.6 0.4 1.7 0.0 0.0 1.6 1.4 0.0 0.7 3.2 14.2 0.0 1.0 3.5 4.3 0.5 0.2 0.0 0.0 0.3 C6orf118 "bA85G2.1, MGC23884" ENSG00000112539 "Chromosome 6 open reading frame 118" Q5T5N4 6 165279664-165309607 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 14.5;fallopian tube: 23.9;pituitary gland: 10.4;testis: 9.6" "Group enriched" "Detected in some" 7 "Ciliated cells: 329.2;Early spermatids: 104.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 7.4;SCLC-21H: 4.3" "Low region specificity" "Detected in many" "HPA029787, HPA029789" Approved Uncertain Mitochondria NA NA Mitochondria "HPA029787: AB_10599999, HPA029789: AB_10601002" "unprognostic (2.84e-1)" "unprognostic (3.09e-4)" "unprognostic (2.70e-2)" "unprognostic (7.99e-2)" "unprognostic (5.34e-2)" "unprognostic (1.41e-1)" "unprognostic (2.50e-1)" "unprognostic (4.27e-2)" "unprognostic (4.89e-2)" "unprognostic (8.18e-9)" "unprognostic (3.22e-3)" "unprognostic (3.03e-2)" "unprognostic (6.55e-3)" "unprognostic (4.50e-1)" 0.3 0.3 4.4 0.3 11.4 0.3 0.3 0.1 0.8 1.5 0.3 7.5 0.1 0.3 1.0 7.2 0.3 23.9 0.3 0.3 4.3 2.7 0.3 0.3 4.7 0.3 0.3 1.0 3.4 0.3 0.3 10.4 0.3 14.5 0.3 0.3 0.0 0.3 0.4 0.3 0.3 0.3 0.3 0.8 0.3 0.3 9.6 3.9 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 7.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.2 0.0 0.2 0.0 4.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 11.4 0.1 0.8 4.3 2.7 0.3 1.0 14.5 3.9 0.0 1.0 0.0 0.1 0.0 0.0 0.3 0.0 329.2 22.7 0.0 0.0 0.0 0.0 0.0 104.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 1.0 0.9 0.0 0.0 0.0 0.0 0.1 C6orf163 ENSG00000203872 "Chromosome 6 open reading frame 163" Q5TEZ5 6 87344849-87365463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 20.2" "Group enriched" "Detected in some" 26 "Early spermatids: 164.9;Late spermatids: 171.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 4 "basal ganglia: 1.4" "Low region specificity" "Detected in all" "HPA044797, HPA052927" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA044797: AB_10962365, HPA052927: AB_2681990" "unprognostic (4.98e-2)" "unprognostic (6.42e-2)" "unprognostic (1.65e-1)" "unprognostic (2.33e-2)" "unprognostic (4.18e-2)" "unprognostic (3.49e-2)" "unprognostic (7.55e-3)" "unprognostic (3.96e-3)" "unprognostic (1.37e-1)" "unprognostic (1.95e-2)" "unprognostic (5.60e-4)" "unprognostic (6.66e-2)" "unprognostic (3.77e-3)" "unprognostic (1.46e-1)" "unprognostic (1.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.42e-2)" 0.7 0.8 0.5 0.5 4.3 3.2 1.3 0.7 1.0 0.8 0.8 1.5 0.5 0.0 1.4 3.0 0.5 2.3 0.5 1.0 0.9 0.4 0.6 0.9 1.7 0.9 0.5 0.5 3.3 1.1 1.7 1.8 0.5 4.6 1.2 1.2 0.5 1.2 0.5 1.5 2.4 1.1 0.5 0.5 1.7 0.8 20.2 1.2 0.5 1.1 0.5 0.8 0.6 0.6 1.4 0.7 3.4 0.9 1.2 1.8 0.4 0.2 0.6 3.0 4.5 0.5 3.3 3.6 0.0 0.0 0.6 1.0 1.3 0.9 1.8 0.5 0.4 1.9 0.8 1.2 2.6 0.0 1.6 1.8 2.3 1.0 1.0 0.0 1.1 0.6 1.6 1.5 0.8 0.8 1.3 0.5 1.9 3.5 1.6 0.4 0.7 0.3 1.5 0.7 0.1 0.2 4.0 1.0 0.1 1.9 2.9 2.3 1.2 0.3 0.5 1.2 3.2 0.6 1.3 1.0 1.8 1.4 0.9 1.4 0.5 0.8 0.3 0.2 2.1 1.1 0.5 0.7 0.3 1.8 0.4 0.9 1.3 1.8 1.2 0.7 1.4 1.7 1.8 3.4 1.2 0.9 0.4 1.0 0.4 0.5 4.3 0.7 1.0 0.9 0.4 0.5 0.5 4.6 1.2 0.0 0.3 0.0 0.3 0.3 0.6 1.7 2.5 1.4 0.0 0.0 0.0 0.4 0.0 0.1 164.9 0.0 0.2 0.0 0.0 0.3 0.4 0.4 0.0 0.2 0.2 0.0 0.0 0.0 1.2 171.0 2.3 0.0 1.7 0.0 0.3 0.0 0.1 0.0 1.8 0.4 0.5 6.5 0.4 2.1 1.6 0.1 0.7 0.0 0.2 0.3 C7orf31 ENSG00000153790 "Chromosome 7 open reading frame 31" Q8N865 7 25134697-25180356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 60.9" "Group enriched" "Detected in many" 17 "Early spermatids: 399.0;Late spermatids: 665.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 18.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA020346 Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA020346: AB_1845758" "unprognostic (3.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (6.90e-3)" "prognostic unfavorable (1.81e-4)" "unprognostic (1.19e-1)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (2.90e-1)" "unprognostic (1.06e-1)" "unprognostic (3.12e-3)" "unprognostic (8.26e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.15e-2)" 2.4 6.2 1.5 4.8 3.1 1.3 2.3 4.0 1.6 3.3 5.1 2.9 2.0 3.3 3.3 2.9 2.4 2.6 3.7 3.1 1.9 1.5 2.6 1.2 2.8 7.0 2.0 2.2 4.6 1.8 4.3 2.1 1.1 2.3 3.2 3.6 4.1 6.0 2.3 0.9 1.8 3.9 2.4 2.9 3.7 3.4 60.9 2.4 5.9 4.6 0.9 3.3 3.5 5.1 3.0 5.9 2.3 1.3 2.8 2.8 0.9 2.8 2.0 4.5 5.2 1.8 1.0 2.5 1.2 4.9 3.7 5.6 3.9 2.7 7.2 1.9 2.2 14.6 1.1 5.0 1.4 4.0 3.4 4.9 3.4 0.2 5.2 4.3 5.5 8.3 3.1 3.9 3.0 0.7 2.6 0.7 6.2 5.1 4.0 0.9 0.0 5.6 7.0 1.8 6.6 1.8 7.0 5.2 1.1 2.5 3.6 1.3 3.8 1.2 4.9 4.6 6.6 0.8 9.2 1.0 2.3 6.2 0.0 1.8 18.0 5.7 10.3 0.7 5.3 10.6 1.4 1.3 2.3 1.7 0.6 2.3 3.0 1.1 1.5 1.7 2.1 2.8 2.2 0.1 2.8 0.8 5.9 2.8 0.9 1.5 3.1 4.0 1.6 1.9 1.5 2.0 2.2 2.3 2.4 0.0 5.3 2.9 2.3 1.0 0.9 1.0 2.5 5.3 0.0 0.0 0.0 2.8 3.3 1.0 399.0 2.2 2.5 0.0 3.4 2.1 2.5 0.9 0.0 1.0 2.4 0.0 4.1 1.8 5.0 665.4 6.6 2.9 3.3 4.6 2.8 7.7 3.2 6.5 4.9 0.6 0.5 0.0 2.1 31.4 12.4 0.5 1.9 4.3 6.0 0.9 C8orf33 FLJ20989 ENSG00000182307 "Chromosome 8 open reading frame 33" Q9H7E9 8 145052378-145056030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024812, HPA026104" Approved Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA024812: AB_10599490, HPA026104: AB_10600875" "prognostic unfavorable (2.77e-4)" "unprognostic (6.51e-3)" "unprognostic (1.85e-1)" "unprognostic (5.06e-2)" "unprognostic (1.12e-1)" "unprognostic (9.56e-3)" "prognostic unfavorable (8.95e-4)" "unprognostic (4.75e-2)" "unprognostic (3.51e-1)" "unprognostic (2.45e-2)" "unprognostic (5.17e-2)" "unprognostic (2.71e-1)" "unprognostic (1.05e-1)" "unprognostic (5.29e-2)" "unprognostic (1.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.37e-1)" 14.3 41.8 14.4 8.8 13.5 5.5 23.2 10.7 17.3 25.3 19.3 13.4 11.3 11.3 11.9 15.0 12.1 14.4 13.1 15.0 15.3 12.1 15.5 11.8 9.4 12.4 14.3 12.0 24.3 13.5 32.4 8.5 12.9 18.1 13.9 24.9 11.9 12.5 24.4 21.7 11.5 7.6 9.5 21.8 9.3 10.2 9.3 13.5 9.1 16.6 10.5 8.5 10.1 9.4 8.7 13.7 4.9 12.0 17.9 13.0 11.3 8.3 8.6 3.0 1.4 17.7 6.2 5.8 5.8 12.1 11.2 8.1 1.7 0.7 9.8 19.3 6.8 1.6 2.8 12.2 12.9 8.1 4.4 22.1 12.8 5.2 2.7 16.8 6.6 2.8 13.3 21.8 6.2 11.5 5.5 8.7 12.5 24.2 2.1 5.3 12.1 13.8 3.7 7.2 7.3 22.8 8.6 3.8 11.6 7.5 2.9 7.0 10.7 16.5 1.8 7.5 5.3 1.9 2.6 4.5 2.9 8.6 4.3 7.4 7.0 4.8 20.7 9.5 15.3 5.0 0.3 10.0 4.9 10.3 12.0 13.0 8.7 10.9 11.5 13.7 8.6 12.9 10.3 0.6 17.9 9.4 12.6 7.8 11.3 14.4 13.5 10.7 17.3 15.3 12.1 14.3 12.0 18.1 13.5 26.8 22.7 32.8 25.8 39.4 43.0 15.7 50.9 28.1 38.7 24.4 29.5 32.9 53.0 60.8 2.6 44.6 31.5 0.0 56.0 33.0 30.5 21.9 20.8 57.2 25.9 47.7 33.9 37.4 16.7 3.7 35.1 22.8 15.1 28.9 32.5 47.3 45.2 34.5 36.4 31.4 50.3 25.8 34.4 22.4 38.2 37.5 20.8 24.2 44.8 23.5 C8orf74 ENSG00000171060 "Chromosome 8 open reading frame 74" Q6P047 8 10672637-10700593 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 30.2" "Group enriched" "Detected in some" 103 "Early spermatids: 154.4;Late spermatids: 281.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "A549: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA027986 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA027986: AB_10600762" "unprognostic (4.24e-2)" "unprognostic (5.62e-2)" "unprognostic (4.68e-2)" "unprognostic (5.54e-2)" "unprognostic (2.37e-2)" "unprognostic (1.56e-4)" "unprognostic (6.82e-2)" "unprognostic (2.20e-2)" 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.6 0.6 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 1.4 0.0 0.1 0.0 0.2 0.1 30.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.5 0.1 0.0 0.6 1.4 0.5 0.9 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.8 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.1 0.3 0.0 0.5 0.5 0.3 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.8 0.8 0.3 0.3 0.0 0.2 0.1 0.3 0.3 0.0 0.3 0.1 0.2 0.3 0.4 0.5 0.1 0.5 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 154.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 281.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.0 C8orf76 FLJ14825 ENSG00000189376 "Chromosome 8 open reading frame 76" Q96K31 8 123219957-123241398 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 128.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 59.8" HPA023708 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023708: AB_1845785" "prognostic unfavorable (9.95e-4)" "unprognostic (1.61e-1)" "unprognostic (9.71e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (4.47e-3)" "unprognostic (1.48e-2)" "unprognostic (2.49e-2)" "unprognostic (1.43e-1)" "unprognostic (3.50e-1)" "unprognostic (7.80e-2)" "prognostic unfavorable (5.95e-11)" "unprognostic (1.54e-2)" "unprognostic (1.94e-1)" "unprognostic (3.26e-1)" "unprognostic (2.71e-2)" 11.9 15.4 13.5 11.4 21.8 13.8 14.5 18.5 15.2 12.0 13.5 11.5 27.0 11.8 9.2 16.1 16.4 9.5 11.2 11.1 11.5 11.8 10.1 19.3 10.2 15.9 11.8 10.6 9.8 12.3 8.5 24.0 15.5 10.9 11.5 15.8 12.5 13.9 23.7 16.9 10.0 12.5 10.8 9.4 15.9 10.4 7.4 14.4 18.8 13.9 9.9 18.3 10.3 10.7 12.7 17.2 24.4 18.9 13.4 18.6 11.0 8.5 7.9 7.4 5.2 7.2 6.7 5.0 8.1 7.9 9.5 9.6 7.2 6.3 5.9 8.9 7.7 7.1 6.6 8.4 4.4 10.8 9.3 12.0 6.9 3.6 10.1 13.1 3.6 5.7 4.9 8.6 8.5 7.1 5.7 8.4 9.3 9.8 4.6 7.8 25.0 10.5 8.2 6.0 20.9 13.8 5.6 3.8 6.7 8.1 7.1 9.7 9.1 8.1 59.8 8.5 7.9 7.3 8.8 4.6 5.4 10.4 5.8 6.6 6.1 6.7 6.3 5.8 8.2 5.8 15.9 16.7 24.4 13.3 18.9 13.9 11.2 14.5 16.8 17.2 12.7 13.9 13.7 9.8 13.4 15.3 14.9 18.6 11.0 13.5 21.8 18.5 15.2 11.5 11.8 11.8 10.6 10.9 14.4 11.9 1.3 15.7 15.3 11.9 7.9 4.8 5.1 14.7 5.7 1.8 9.8 23.3 5.0 14.4 2.3 5.8 16.8 0.0 10.4 25.8 12.4 15.5 21.9 9.8 20.4 128.7 23.7 8.0 17.1 3.0 11.8 16.5 13.5 19.0 12.8 10.2 13.7 14.4 7.1 7.9 7.1 19.4 4.5 13.1 19.3 10.0 33.6 13.8 14.0 34.2 C9orf129 bA165J3.3 ENSG00000204352 "Chromosome 9 open reading frame 129" Q5T035 9 93318199-93346414 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in many" 4 "brain: 12.7;testis: 4.3" "Group enriched" "Detected in some" 41 "Early spermatids: 17.5;Late spermatids: 49.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "NTERA-2: 7.0" HPA071515 Uncertain Mitochondria NA NA Mitochondria "HPA071515: " "unprognostic (1.12e-1)" "unprognostic (2.46e-2)" "unprognostic (1.23e-1)" "unprognostic (9.47e-2)" "unprognostic (1.25e-1)" "unprognostic (1.84e-1)" "unprognostic (4.58e-2)" "unprognostic (1.35e-1)" "unprognostic (3.45e-1)" 0.7 0.6 5.9 1.3 7.2 0.7 0.7 4.7 12.7 1.4 0.8 0.7 0.0 1.1 0.9 2.0 1.0 1.3 0.6 0.9 4.3 5.7 0.6 0.7 0.7 0.7 3.2 9.3 0.6 1.1 0.6 0.6 0.8 4.3 1.0 0.8 0.6 0.6 1.2 1.3 0.6 0.8 1.0 2.1 1.0 1.1 4.3 1.1 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 7.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 7.2 4.7 12.7 4.3 5.7 3.2 9.3 4.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 CABLES2 "C20orf150, dJ908M14.2, ik3-2" ENSG00000149679 "Cdk5 and Abl enzyme substrate 2" Q9BTV7 20 62388632-62407285 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.9" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 33.1;Late spermatids: 16.4;Spermatocytes: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052138 Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Nuclear bodies" "Nucleoplasm, Cell Junctions" "HPA052138: AB_2681743" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (5.26e-5)" "unprognostic (1.45e-2)" "unprognostic (1.51e-1)" "unprognostic (2.71e-2)" "unprognostic (5.07e-2)" "unprognostic (5.37e-3)" "unprognostic (6.05e-2)" "unprognostic (1.40e-3)" "unprognostic (3.09e-2)" "prognostic unfavorable (1.24e-6)" "unprognostic (1.99e-2)" "unprognostic (3.87e-1)" "unprognostic (1.67e-1)" "unprognostic (2.94e-2)" 2.3 3.3 5.9 5.6 5.6 8.3 2.8 15.1 10.2 3.4 4.4 3.6 1.3 3.6 3.7 3.6 3.7 4.7 3.0 10.5 4.3 5.5 2.6 3.6 2.9 5.7 4.9 5.3 4.3 3.7 4.1 5.8 4.3 7.2 4.1 4.1 3.1 3.6 4.2 5.4 5.2 4.9 4.3 3.5 4.1 3.8 34.9 5.4 5.1 5.7 2.6 5.2 4.1 3.2 1.4 1.1 1.0 1.1 1.5 4.1 0.5 9.3 7.0 12.2 12.4 1.9 2.7 1.7 5.3 5.3 14.9 6.9 25.4 5.4 9.4 4.6 3.4 20.4 6.0 7.4 3.5 5.8 4.2 4.1 11.0 3.7 6.1 3.4 4.4 5.7 1.7 4.0 4.3 1.6 2.6 3.4 12.3 2.8 8.3 3.3 11.5 11.6 3.5 4.0 9.4 8.1 16.1 10.3 4.1 2.2 6.2 6.6 10.2 7.8 10.4 2.1 4.8 7.0 6.8 3.5 13.8 4.2 18.1 5.5 8.0 6.5 11.2 12.4 5.1 7.2 0.0 0.9 0.2 2.7 1.1 1.5 1.4 1.9 2.1 1.1 1.1 1.0 1.2 1.0 1.5 1.1 0.9 4.1 0.5 5.9 5.6 15.1 10.2 4.3 5.5 4.9 5.3 7.2 5.4 3.0 1.7 2.2 0.5 0.8 6.4 6.7 0.0 0.0 3.4 0.0 3.9 0.9 1.7 1.7 33.1 1.5 1.5 0.0 2.0 0.5 2.1 0.9 0.0 1.5 1.7 12.7 3.4 1.8 2.4 16.4 1.7 1.5 0.0 0.0 3.3 1.6 1.9 2.9 3.2 0.7 2.9 0.0 0.9 16.7 7.3 1.8 1.9 0.0 2.5 0.5 CACHD1 "KIAA1573, VWCD1" ENSG00000158966 "Cache domain containing 1" 1 64470792-64693058 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 37.5;Club cells: 18.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 11 "naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Cell line enhanced" "Detected in many" "AF22: 21.4;NTERA-2: 29.3;SuSa: 19.1;U-2197: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017202 Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA017202: AB_1852423" "unprognostic (2.92e-2)" "unprognostic (2.91e-1)" "unprognostic (1.29e-2)" "unprognostic (1.02e-1)" "unprognostic (3.75e-1)" "unprognostic (1.01e-1)" "unprognostic (4.82e-2)" "unprognostic (4.32e-2)" "unprognostic (6.77e-2)" "unprognostic (1.33e-1)" "unprognostic (8.16e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-3)" "unprognostic (2.67e-2)" "unprognostic (3.89e-1)" "unprognostic (3.65e-1)" "unprognostic (2.13e-1)" 5.4 7.6 6.5 0.5 8.4 0.0 4.7 1.2 4.3 7.3 0.8 0.2 6.1 5.2 1.6 8.5 2.1 1.2 3.5 4.2 3.3 0.4 4.7 0.4 2.3 14.2 3.7 5.5 4.5 5.5 4.0 1.0 4.4 4.3 0.8 3.0 0.9 5.3 0.6 1.7 3.3 0.5 2.4 0.2 2.1 4.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.8 21.4 3.1 8.5 3.0 0.0 3.0 3.9 5.1 4.9 12.4 0.1 0.0 8.8 4.8 3.7 1.5 11.9 2.5 5.2 2.3 6.4 4.4 1.3 0.0 0.0 1.9 0.0 2.6 1.7 0.6 3.2 2.9 2.7 3.0 0.0 0.0 0.0 0.3 0.3 0.0 29.3 0.1 2.2 2.3 2.1 0.0 0.0 0.6 0.5 11.2 6.5 0.0 2.6 19.1 0.8 0.2 1.9 0.5 3.8 15.0 2.6 0.0 0.0 0.0 0.4 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 37.5 0.0 6.1 15.3 12.7 1.4 0.0 13.4 18.2 3.5 0.0 0.0 0.0 2.0 7.7 11.8 0.0 0.0 2.5 0.1 4.1 1.2 2.3 0.9 0.2 0.0 0.0 3.1 0.3 2.3 13.3 1.8 1.7 0.0 0.0 5.2 1.3 0.0 2.8 3.1 1.1 6.5 5.7 0.4 0.4 12.9 0.0 0.0 0.1 4.8 CACNA1A "APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6" ENSG00000141837 "Calcium voltage-gated channel subunit alpha1 A" O00555 19 13206442-13633025 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 77.9" "Group enriched" "Detected in many" 8 "Bipolar cells: 68.3;Horizontal cells: 235.2;Intestinal endocrine cells: 205.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 4 "cerebellum: 77.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "SCLC-21H: 31.2;U-87 MG: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064258, HPA068138, HPA071902" Enhanced Supported Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA064258: AB_2685229, HPA068138: , HPA071902: " "unprognostic (1.09e-1)" "unprognostic (3.73e-3)" "unprognostic (2.27e-1)" "unprognostic (2.78e-4)" "unprognostic (4.00e-2)" "unprognostic (2.29e-3)" "unprognostic (5.47e-2)" "unprognostic (3.13e-1)" "unprognostic (2.86e-1)" "unprognostic (1.14e-2)" "prognostic favorable (4.32e-4)" "unprognostic (5.31e-3)" "unprognostic (5.03e-6)" "unprognostic (6.29e-2)" "unprognostic (1.59e-1)" "unprognostic (2.61e-2)" "unprognostic (6.25e-2)" 2.2 5.3 7.6 1.0 12.2 0.7 0.9 77.9 19.7 0.8 1.5 1.8 0.0 3.9 1.2 2.8 0.7 2.2 0.8 1.1 5.7 5.1 0.7 0.5 0.7 1.3 3.9 7.3 1.1 3.0 0.7 1.5 0.6 7.2 0.8 1.7 1.2 0.9 0.8 1.3 0.7 2.8 0.9 3.3 1.3 7.7 1.9 2.8 0.0 0.7 0.0 1.0 0.8 0.3 2.8 0.8 1.9 1.1 0.8 0.8 0.4 0.0 0.1 0.0 3.9 0.1 0.3 0.0 1.6 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.1 3.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 2.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.0 0.1 0.9 0.0 0.2 0.4 0.0 0.1 0.0 0.1 31.2 0.0 0.0 0.0 0.2 0.1 0.0 1.2 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.0 17.6 0.0 0.4 1.9 0.4 0.7 0.5 0.5 0.8 2.8 0.5 0.3 0.4 1.7 0.6 0.7 1.6 0.8 1.1 0.8 0.6 0.4 7.6 12.2 77.9 17.4 5.7 5.1 3.9 7.3 7.2 2.8 6.0 2.7 1.3 1.4 0.6 68.3 2.2 0.0 6.7 2.3 1.8 15.7 0.0 0.0 0.6 22.1 4.2 0.0 0.0 0.3 0.1 2.1 0.8 1.1 0.0 0.5 235.2 205.4 1.8 1.3 17.9 1.1 2.1 0.0 1.0 1.1 2.9 1.9 0.0 0.4 2.0 6.2 0.0 4.2 4.1 5.1 0.1 0.2 4.3 0.8 0.9 CACNA2D3 HSA272268 ENSG00000157445 "Calcium voltage-gated channel auxiliary subunit alpha2delta 3" Q8IZS8 3 54122547-55074557 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;skeletal muscle: 19.5" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 28.9;Early spermatids: 77.9;Late spermatids: 41.2;Syncytiotrophoblasts: 56.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.2;HAP1: 2.8;HeLa: 14.0" "Low region specificity" "Detected in all" HPA030849 Uncertain Nucleoplasm NA NA 49000 Nucleoplasm "HPA030849: " "unprognostic (6.92e-2)" "unprognostic (1.35e-2)" "unprognostic (1.89e-1)" "unprognostic (4.34e-5)" "unprognostic (5.53e-3)" "unprognostic (2.64e-3)" "unprognostic (3.24e-1)" "unprognostic (1.17e-2)" "unprognostic (5.84e-3)" "unprognostic (7.22e-3)" "unprognostic (1.14e-2)" "unprognostic (2.43e-1)" "unprognostic (2.00e-1)" "unprognostic (1.47e-3)" "unprognostic (2.19e-1)" "unprognostic (3.62e-2)" "unprognostic (6.95e-2)" 1.5 10.3 6.4 1.3 21.9 1.0 1.5 2.4 23.2 1.5 2.0 1.4 0.2 1.4 1.4 4.0 2.1 2.1 1.6 5.1 8.9 8.0 3.8 1.1 2.2 2.2 4.8 12.8 6.7 1.2 1.1 2.4 2.1 9.0 3.4 1.7 2.4 1.9 4.4 19.5 1.2 1.7 2.4 1.7 1.6 1.9 3.9 4.2 0.0 2.1 3.6 2.1 1.0 2.1 0.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 1.7 0.2 14.0 0.0 0.8 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.2 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 6.4 21.9 2.4 16.1 8.9 8.0 4.8 12.8 9.0 4.2 0.0 0.0 0.0 0.3 0.2 9.8 28.9 0.0 1.4 1.2 0.0 7.9 8.4 6.6 0.0 77.9 0.1 0.0 0.0 0.6 2.3 2.4 0.2 0.0 0.0 5.4 0.0 0.0 0.6 7.9 41.2 2.6 10.3 0.0 0.0 0.0 4.3 0.8 0.0 1.4 0.1 1.3 6.5 1.9 5.0 2.2 0.1 56.9 0.0 0.0 0.4 CACTIN "C19orf29, cactin, fSAPc, NY-REN-24" ENSG00000105298 "Cactin, spliceosome C complex subunit" Q8WUQ7 19 3610641-3626815 "Predicted intracellular proteins" "Immunity, Innate immunity, mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042504, HPA042548" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA042504: AB_10797501, HPA042548: AB_10794760" "unprognostic (1.18e-1)" "unprognostic (7.90e-3)" "unprognostic (1.09e-1)" "prognostic favorable (3.69e-5)" "unprognostic (5.93e-2)" "unprognostic (2.87e-3)" "unprognostic (3.38e-2)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "unprognostic (1.38e-2)" "unprognostic (1.17e-2)" "unprognostic (7.22e-3)" "unprognostic (3.88e-2)" "unprognostic (4.98e-3)" "unprognostic (5.78e-2)" "unprognostic (3.08e-2)" "unprognostic (5.55e-3)" 16.1 14.4 18.3 19.4 17.8 19.8 16.2 19.2 19.9 11.8 12.4 13.1 12.3 14.5 14.2 9.6 11.9 13.0 13.0 10.3 14.2 10.9 11.9 14.8 11.7 16.5 14.3 9.9 21.4 14.9 8.9 11.1 11.3 13.4 13.4 8.5 10.3 15.5 12.8 28.6 22.0 16.2 12.2 9.8 23.0 15.7 14.4 15.0 13.9 12.6 11.9 12.7 11.3 18.5 2.1 4.3 0.8 2.9 0.9 3.7 1.3 14.5 8.4 7.1 12.1 5.2 5.2 10.8 10.5 4.2 6.3 7.0 8.3 6.6 12.2 9.0 6.5 7.4 13.6 7.4 8.7 3.8 12.3 9.8 7.6 11.5 9.9 7.3 10.2 11.1 5.0 8.5 5.8 4.1 3.8 9.0 10.7 16.8 13.7 3.3 8.8 18.3 8.9 15.2 8.9 9.9 19.4 9.2 11.5 5.8 7.4 9.8 13.7 11.7 8.3 8.4 4.0 6.6 11.8 11.6 8.5 10.7 18.5 18.2 21.0 14.0 13.5 10.5 16.5 11.4 0.0 1.2 0.0 3.7 2.9 1.3 2.0 1.8 1.7 1.0 2.1 2.0 2.5 0.8 0.9 0.4 4.3 1.4 1.3 18.3 17.8 19.2 19.1 14.2 10.9 14.3 9.9 13.4 15.0 0.0 2.4 4.2 3.8 5.4 4.8 2.8 10.2 0.0 1.2 1.8 2.0 3.0 0.0 4.6 2.1 3.0 4.6 0.0 4.2 4.4 3.7 4.6 4.6 4.3 4.4 0.0 1.2 3.1 4.1 3.6 5.5 2.8 1.7 9.0 5.6 5.6 4.8 3.5 5.3 2.8 5.6 0.0 4.5 9.1 9.1 6.9 2.7 3.5 5.2 3.5 CADPS2 CAPS2 ENSG00000081803 "Calcium dependent secretion activator 2" Q86UW7 7 122318425-122886759 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 105.4" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 31.6;Collecting duct cells: 38.4;Muller glia cells: 28.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 105.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 20.3;Karpas-707: 26.5;OE19: 29.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 325.7" HPA056398 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA056398: AB_2683117" "unprognostic (1.93e-1)" "unprognostic (5.05e-2)" "unprognostic (1.91e-1)" "unprognostic (3.67e-3)" "unprognostic (8.69e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (1.33e-1)" "unprognostic (4.07e-1)" "unprognostic (4.33e-2)" "unprognostic (3.93e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.01e-7)" "unprognostic (9.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.71e-2)" "unprognostic (3.45e-2)" 5.1 11.2 5.1 1.9 7.1 0.0 9.5 105.4 21.1 16.5 5.3 1.4 13.3 6.1 16.3 16.4 5.7 5.7 8.0 4.6 6.8 8.8 20.3 6.2 9.0 1.3 14.0 9.3 5.2 13.2 15.4 17.7 2.7 7.0 10.4 5.4 4.7 23.0 11.5 2.6 2.4 4.7 11.2 4.1 3.3 9.8 1.9 1.4 0.4 9.4 2.4 1.6 4.4 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 2.4 2.5 0.1 0.2 6.3 1.4 6.4 0.0 5.9 0.0 0.0 2.9 0.2 0.0 0.2 0.8 0.6 0.0 5.2 2.0 0.0 11.4 8.2 0.0 0.1 2.6 1.1 1.0 0.8 5.7 20.3 0.0 0.0 26.5 0.1 13.9 0.0 0.0 5.9 29.0 10.0 0.0 0.0 10.5 0.3 6.6 10.3 0.0 0.2 11.5 0.5 1.6 4.4 0.0 5.8 2.2 1.5 0.0 4.1 7.9 0.3 0.0 8.7 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 7.1 105.4 21.1 6.8 8.8 14.0 9.3 7.0 1.4 8.9 31.6 0.0 7.7 1.9 0.0 10.1 5.1 8.1 17.0 38.4 0.0 0.2 14.9 4.7 5.5 19.6 4.5 0.0 9.4 0.3 3.8 16.7 1.1 10.2 0.3 3.2 4.6 16.0 2.7 5.3 8.9 1.1 3.3 0.0 11.6 28.4 6.6 2.9 9.6 6.9 1.3 0.0 5.1 0.5 2.5 1.3 0.2 0.0 7.6 7.4 CALN1 CABP8 ENSG00000183166 "Calneuron 1" Q9BXU9 7 71779491-72447151 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.0;brain: 48.5;lymphoid tissue: 20.0" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 4.8;Early spermatids: 5.1;Spermatocytes: 6.9;Spermatogonia: 11.4;Suprabasal keratinocytes: 8.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "Karpas-707: 31.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036278, HPA036708" Approved Uncertain "Vesicles,Plasma membrane" No No Vesicles "Plasma membrane" "HPA036278: AB_10673125, HPA036708: " "unprognostic (6.38e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-1)" "unprognostic (1.32e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-2)" "unprognostic (3.67e-4)" "unprognostic (3.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.57e-2)" "unprognostic (1.41e-1)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (7.72e-4)" "unprognostic (2.99e-1)" 0.8 16.0 10.8 0.8 17.7 1.5 1.0 48.5 39.1 2.3 0.9 5.1 0.0 0.9 1.4 0.8 0.8 1.0 1.3 0.8 9.5 4.4 0.8 1.0 0.9 0.8 6.8 7.3 1.0 1.9 0.8 0.3 0.8 18.6 1.0 0.9 0.0 0.8 2.4 0.9 4.2 0.8 0.9 8.4 0.8 0.8 11.3 3.3 20.0 0.9 0.0 0.8 0.9 1.9 0.3 1.3 0.6 0.4 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 31.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 4.8 0.0 0.5 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 5.0 4.8 0.0 0.2 0.0 0.0 0.6 0.4 0.3 0.2 0.1 0.1 0.2 0.2 0.2 1.3 0.3 0.2 0.2 0.5 0.3 0.1 0.4 0.1 0.1 10.8 17.7 48.5 11.6 9.5 4.4 6.8 7.3 18.6 3.3 0.0 0.0 0.0 0.2 2.1 0.1 4.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 1.8 0.3 3.2 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.7 0.0 0.6 0.0 0.0 6.9 11.4 8.5 0.1 0.0 0.0 0.1 CAMK2B "CAM2, CAMK2, CAMKB" ENSG00000058404 "Calcium/calmodulin dependent protein kinase II beta" Q13554 7 44217150-44334577 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7" "Cell type enriched" "Detected in many" 11 "Bipolar cells: 838.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006849, HPA026307, HPA051783, HPA051785, HPA053973" Enhanced Supported Supported "Plasma membrane,Cell Junctions,Cytosol" NA NA 680000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (1.88e-3)" "unprognostic (4.49e-2)" "unprognostic (3.55e-3)" "unprognostic (1.36e-2)" "unprognostic (5.25e-2)" "unprognostic (2.90e-2)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (2.71e-1)" "unprognostic (1.17e-2)" "unprognostic (1.60e-2)" "unprognostic (5.23e-7)" "unprognostic (7.04e-2)" "unprognostic (2.34e-1)" "unprognostic (3.15e-2)" "unprognostic (3.95e-2)" 1.4 8.1 20.6 1.4 46.7 1.2 2.0 60.1 81.9 1.2 1.4 4.0 0.7 1.7 1.3 18.8 2.0 1.8 1.2 39.2 36.5 18.0 1.7 3.5 1.2 1.8 10.3 21.3 1.1 3.3 5.6 9.9 1.1 13.4 3.0 1.4 2.7 1.8 2.2 70.7 1.8 1.6 1.2 4.1 1.3 2.4 2.3 4.8 0.0 7.7 2.4 2.0 1.1 0.0 1.3 1.0 3.2 1.2 3.2 1.2 0.8 0.0 0.3 0.2 0.3 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.9 0.2 0.1 0.1 0.2 0.8 0.0 1.1 2.4 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 5.3 0.0 0.2 0.1 0.0 2.4 0.1 0.9 0.1 0.0 0.0 42.0 2.2 0.2 0.0 0.0 0.1 1.9 0.2 0.2 0.2 0.4 0.2 0.0 0.5 0.4 0.1 0.2 0.0 0.2 3.2 0.7 1.0 0.8 0.9 1.2 1.1 1.0 0.5 0.5 1.3 1.2 1.1 2.0 3.2 1.2 1.0 0.9 0.8 20.6 46.7 60.1 42.4 36.5 18.0 10.3 21.3 13.4 4.8 0.0 0.0 0.0 27.8 1.0 838.1 74.9 2.5 0.0 0.0 0.0 43.2 0.0 8.3 0.0 0.8 0.6 0.0 0.0 0.0 0.1 0.4 2.6 4.6 4.4 0.2 57.2 39.0 0.0 1.2 2.1 1.7 0.0 1.7 0.0 0.0 14.1 0.1 0.0 0.0 0.8 46.7 0.0 0.9 0.0 1.7 0.4 0.2 0.0 0.0 0.7 CAMSAP3 "KIAA1543, Nezha, PPP1R80" ENSG00000076826 "Calmodulin regulated spectrin associated protein family member 3" Q9P1Y5 19 7595902-7618304 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 33.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 20.1;Hep G2: 11.4;SK-BR-3: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043830, HPA062149" Enhanced Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA043830: AB_10795879, HPA062149: AB_2684698" "unprognostic (3.83e-2)" "unprognostic (1.18e-1)" "unprognostic (8.67e-2)" "unprognostic (7.90e-3)" "unprognostic (3.66e-1)" "unprognostic (3.87e-3)" "unprognostic (7.00e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (1.64e-1)" "unprognostic (2.30e-2)" "unprognostic (1.41e-1)" "prognostic favorable (7.55e-7)" "unprognostic (2.16e-2)" "unprognostic (3.88e-2)" "unprognostic (3.72e-2)" "unprognostic (1.59e-3)" 0.8 2.8 8.0 1.9 9.2 0.9 4.1 12.0 15.5 4.5 11.4 0.8 13.5 20.9 1.5 8.0 14.7 4.8 7.6 0.9 5.2 4.8 9.7 14.2 4.5 1.1 2.6 6.5 1.0 15.7 4.2 6.2 3.6 7.0 6.7 4.1 8.8 22.1 16.0 1.1 33.9 17.7 1.0 1.0 1.1 14.5 9.1 1.1 0.9 9.6 2.5 5.7 4.1 6.9 0.0 0.1 0.0 0.0 0.0 0.6 0.0 8.4 1.4 0.2 0.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 20.1 4.5 2.3 3.6 0.0 0.9 7.5 3.3 2.2 0.0 1.5 7.7 0.0 0.3 11.4 0.0 0.0 3.5 0.0 4.3 0.0 0.3 0.3 0.0 3.4 0.7 0.0 0.0 9.6 0.1 0.1 5.2 6.2 3.7 0.5 0.0 2.8 1.5 4.5 6.5 6.9 1.0 9.8 0.0 1.3 8.2 1.3 0.0 0.0 1.6 0.0 0.3 4.0 0.7 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 8.0 9.2 12.0 15.5 5.2 4.8 2.6 6.5 7.0 1.1 8.9 19.2 0.0 2.4 8.8 22.3 0.8 17.8 0.0 4.5 8.7 0.0 0.4 3.3 5.2 4.4 0.6 31.9 0.0 10.2 0.6 0.3 9.0 5.7 20.3 0.2 9.5 12.6 0.6 1.3 2.7 1.4 0.4 0.0 0.0 18.0 1.3 11.5 21.0 0.0 11.3 12.8 0.0 0.7 0.5 1.7 16.6 0.5 0.9 14.0 4.3 CAMTA2 KIAA0909 ENSG00000108509 "Calmodulin binding transcription activator 2" O94983 17 4967992-4987652 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027835, HPA051147" Supported "Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol" NA NA Nucleoplasm "Vesicles, Actin filaments, Mitochondria, Cytosol" "HPA027835: , HPA051147: AB_2681362" "unprognostic (2.82e-1)" "unprognostic (3.06e-1)" "unprognostic (1.11e-2)" "unprognostic (1.01e-3)" "unprognostic (1.10e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (4.71e-2)" "unprognostic (2.78e-2)" "unprognostic (7.08e-2)" "prognostic favorable (6.00e-8)" "unprognostic (3.42e-2)" "unprognostic (9.02e-2)" "unprognostic (3.73e-2)" "unprognostic (1.20e-1)" "unprognostic (4.56e-2)" "unprognostic (1.19e-1)" 9.8 6.4 27.0 9.2 25.2 6.4 5.4 63.6 44.9 6.2 8.0 6.4 3.8 7.3 6.2 3.1 8.4 6.8 6.1 8.0 33.8 17.4 5.5 4.2 8.8 6.2 11.7 19.1 6.7 11.7 14.8 21.3 5.1 18.5 6.8 8.0 5.5 8.7 9.1 20.1 8.6 9.0 10.5 6.5 8.7 8.0 9.0 8.8 2.7 6.5 2.9 6.5 6.5 4.7 1.3 2.2 5.7 8.1 1.1 2.7 2.1 8.0 14.4 2.7 3.8 18.1 12.6 5.6 7.8 8.7 7.4 6.6 3.6 2.2 9.5 7.6 12.2 6.3 8.2 10.2 12.2 4.2 13.3 13.2 6.0 7.8 4.0 10.4 3.5 25.8 8.7 15.3 7.0 11.0 9.0 12.3 7.4 9.7 8.7 6.9 5.3 6.2 2.2 0.4 9.6 6.0 5.4 3.0 3.7 8.4 8.5 3.7 3.2 4.9 9.0 2.4 4.8 7.9 3.5 16.3 5.9 3.5 6.2 12.7 4.4 4.7 3.4 14.4 7.0 5.7 1.0 2.2 1.8 2.7 3.0 2.1 1.3 1.2 2.5 1.4 0.9 1.8 2.0 5.7 1.1 8.1 2.2 1.1 2.1 27.0 25.2 63.6 44.9 33.8 17.4 11.7 19.1 18.5 8.8 3.0 13.7 8.3 3.5 6.2 12.1 5.9 15.3 5.3 3.4 10.4 9.8 5.2 1.7 6.8 29.0 6.9 16.3 0.0 9.8 6.8 6.8 5.5 12.7 11.9 7.7 33.4 10.9 14.1 9.2 39.5 9.5 8.0 3.3 8.2 13.1 4.3 9.1 12.4 8.9 10.5 9.6 12.9 12.3 5.2 7.6 9.2 10.4 10.2 9.5 3.4 CAPN6 "CalpM, CANPX, CAPNX" ENSG00000077274 "Calpain 6" Q9Y6Q1 X 111245103-111270523 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 62.9;placenta: 173.5" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 165.5;Syncytiotrophoblasts: 117.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 25.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 1.2;plasmacytoid DC: 2.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HDLM-2: 10.1;NTERA-2: 15.8;SuSa: 14.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA040259 Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA040259: " "unprognostic (1.27e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-2)" "unprognostic (5.77e-3)" "unprognostic (2.07e-1)" "unprognostic (9.93e-2)" "unprognostic (8.39e-3)" "unprognostic (1.06e-1)" "unprognostic (2.08e-1)" "unprognostic (9.45e-3)" "unprognostic (5.12e-1)" "unprognostic (6.25e-2)" "unprognostic (7.67e-2)" "unprognostic (6.50e-2)" "unprognostic (5.02e-3)" "unprognostic (2.66e-1)" "unprognostic (6.30e-2)" 1.7 0.0 0.2 1.7 0.2 0.0 6.0 0.3 0.3 3.9 4.2 0.2 23.4 0.2 18.2 62.9 2.4 2.9 2.6 0.4 0.2 0.0 5.1 0.4 0.3 1.1 0.2 0.4 1.9 4.1 0.0 0.2 173.5 0.3 3.6 2.2 2.1 5.6 21.7 1.7 1.0 1.3 2.0 0.3 1.0 7.2 2.8 0.2 0.5 1.7 4.7 2.9 1.4 2.6 0.1 2.0 0.8 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 15.8 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.3 0.4 0.3 0.0 14.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.2 0.2 0.3 0.3 0.2 0.0 0.2 0.4 0.3 0.2 0.0 0.0 0.0 1.0 0.1 0.0 0.3 10.2 0.0 0.0 7.0 0.0 35.2 3.3 5.0 0.0 0.0 0.0 0.0 0.6 165.5 2.6 0.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 2.7 0.0 20.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 117.5 0.0 0.0 0.3 CARD16 "COP, COP1, PSEUDO-ICE" ENSG00000204397 "Caspase recruitment domain family member 16" Q5EG05 11 105041326-105101431 "Predicted intracellular proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 126.3;lymphoid tissue: 52.1" "Cell type enhanced" "Detected in many" 8 "Kupffer cells: 242.8;Macrophages: 269.3;monocytes: 172.3;Paneth cells: 336.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 38.8;HHSteC: 68.1;HUVEC TERT2: 31.2;TIME: 28.5" "HPA053981, HPA062805" Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA053981: AB_2682332, HPA062805: AB_2684871" "unprognostic (2.25e-3)" "unprognostic (6.56e-2)" "unprognostic (1.49e-1)" "unprognostic (8.12e-2)" "unprognostic (4.45e-3)" "unprognostic (1.76e-1)" "unprognostic (4.71e-1)" "unprognostic (8.68e-2)" "unprognostic (1.56e-1)" "unprognostic (1.17e-2)" "unprognostic (5.12e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.93e-7)" "unprognostic (2.81e-1)" "unprognostic (6.68e-2)" "unprognostic (1.82e-1)" "unprognostic (1.19e-1)" 11.4 4.0 3.8 21.9 6.8 20.9 8.1 2.3 4.3 5.5 13.3 1.7 4.2 16.3 4.4 4.9 9.0 5.4 11.1 6.4 4.7 2.6 8.1 7.3 30.2 14.5 6.4 3.0 7.6 7.2 0.0 3.2 28.5 6.2 8.2 11.8 4.1 5.8 4.4 4.1 5.6 20.2 5.6 9.2 52.1 7.5 2.1 6.2 6.2 5.5 7.4 11.5 10.9 12.8 23.4 57.8 126.3 110.3 19.4 47.9 68.9 0.3 0.0 0.0 38.8 1.0 5.3 0.2 0.8 2.7 0.1 0.7 0.3 0.0 4.0 5.4 2.3 5.8 2.7 0.3 5.6 0.0 16.5 0.0 0.8 0.7 0.4 68.1 5.3 0.0 9.6 2.9 3.9 2.7 0.4 31.2 0.2 0.0 0.0 0.0 0.0 1.8 4.6 0.0 0.0 0.1 4.4 0.1 5.1 0.1 2.5 0.0 0.0 6.1 0.8 19.4 1.4 0.8 12.8 28.5 2.7 0.3 1.7 0.1 0.0 0.8 0.0 3.1 17.9 0.6 44.0 85.3 61.6 26.4 110.3 25.1 23.4 24.1 25.3 57.8 17.9 14.3 21.8 126.3 19.4 97.2 6.7 47.9 68.9 3.8 6.8 2.3 4.3 4.7 2.6 6.4 3.0 6.2 6.2 26.8 49.5 67.7 15.9 23.8 0.0 8.7 28.1 18.7 42.1 14.0 0.0 7.7 1.7 5.9 0.2 66.1 70.9 0.0 19.4 3.1 27.9 3.8 59.9 2.1 81.0 0.0 15.7 50.3 242.8 0.7 19.0 269.3 13.5 172.3 70.7 0.0 7.0 336.9 17.0 0.4 0.0 6.5 9.9 0.1 0.6 13.7 10.9 108.6 47.2 28.3 CASP1 "ICE, IL1BC" ENSG00000137752 "Caspase 1" P29466 11 105025443-105035250 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 64.2;lymphoid tissue: 40.7" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 83.5;Kupffer cells: 119.3;Macrophages: 125.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 38.4;HBEC3-KT: 18.2;HHSteC: 20.6;U-937: 45.4" "Region enhanced" "Detected in many" "olfactory region: 22.8" "Low region specificity" "Detected in all" "CAB002685, HPA003056" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB002685: , HPA003056: AB_1846037" "unprognostic (1.21e-3)" "unprognostic (3.02e-1)" "unprognostic (9.47e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (5.24e-2)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (6.67e-2)" "unprognostic (2.75e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (9.03e-2)" "unprognostic (2.30e-2)" "unprognostic (3.18e-1)" "unprognostic (5.19e-2)" 7.4 3.9 6.6 15.1 17.0 8.2 6.9 3.5 7.0 4.1 12.8 2.2 2.9 34.0 3.0 4.2 10.6 4.3 7.3 4.9 9.3 3.0 6.4 5.8 20.5 16.2 16.7 2.6 4.4 3.4 0.2 3.7 8.7 13.3 6.1 13.9 3.7 7.0 3.2 1.6 9.9 37.2 5.2 17.4 40.7 5.6 1.5 11.0 4.1 3.7 5.6 9.0 9.7 13.2 7.3 39.6 40.5 64.2 11.1 34.3 31.2 0.4 0.1 0.0 1.8 2.0 4.3 0.3 1.9 38.4 4.8 13.5 0.0 0.2 6.2 0.8 2.2 8.9 2.7 0.0 18.2 1.1 4.0 0.0 0.3 0.2 0.4 20.6 7.2 0.0 7.3 12.9 3.9 10.6 12.6 2.1 0.1 0.0 0.0 1.1 0.0 0.2 10.1 0.0 0.0 0.1 6.0 0.1 4.9 0.1 3.0 0.1 0.1 5.7 0.4 8.4 0.0 0.4 16.7 2.4 4.4 0.2 0.4 0.5 0.0 1.7 0.0 2.8 45.4 0.9 12.3 42.8 23.2 25.4 64.2 34.3 7.3 18.1 22.0 39.6 6.0 9.9 16.4 40.5 11.1 64.0 1.4 22.2 31.2 6.6 17.0 3.5 7.0 9.3 3.0 16.7 2.6 13.3 11.0 17.9 35.4 32.0 33.0 23.1 0.0 2.6 12.7 12.0 11.4 10.4 0.0 1.3 1.7 15.7 0.0 24.1 33.9 0.0 11.7 1.0 13.1 5.7 15.1 1.7 83.5 0.0 5.8 17.8 119.3 0.2 3.1 125.6 5.0 34.3 32.1 0.0 4.7 49.2 3.2 1.0 0.1 0.0 5.4 0.0 0.0 19.4 0.9 48.4 29.9 41.4 CASP3 "apopain, CPP32, CPP32B, Yama" ENSG00000164305 "Caspase 3" P42574 4 184627696-184649509 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 76.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "basophil: 76.7;eosinophil: 62.8" "Lineage enriched" "Detected in all" 7 "granulocytes: 76.7" "Cell line enhanced" "Detected in all" "Karpas-707: 74.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000091, HPA002643, CAB008381" Enhanced Approved Nucleoplasm,Mitochondria NA NA 310000 Mitochondria Nucleoplasm "CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048" "unprognostic (1.38e-1)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "prognostic favorable (2.24e-4)" "unprognostic (2.29e-3)" "unprognostic (3.58e-2)" "unprognostic (9.57e-3)" "unprognostic (5.86e-2)" "unprognostic (3.56e-2)" "unprognostic (1.12e-2)" "unprognostic (1.70e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.41e-2)" "unprognostic (5.74e-3)" "unprognostic (1.30e-1)" "unprognostic (4.05e-3)" 20.7 11.6 10.8 16.9 10.5 16.7 10.0 22.3 9.2 10.4 25.4 12.8 12.5 32.3 13.9 11.5 22.8 8.9 12.0 8.8 10.0 8.8 10.6 18.7 12.4 23.6 10.2 8.5 8.3 10.0 4.6 13.6 29.4 9.7 8.8 20.9 8.2 13.0 10.0 12.6 9.5 49.7 9.3 12.6 26.5 18.7 6.4 10.9 44.7 7.8 13.5 24.3 16.2 11.0 4.2 5.2 76.7 10.6 9.2 9.9 7.0 8.3 4.7 18.7 8.9 11.6 15.5 10.8 25.3 19.2 17.8 10.3 8.5 7.1 11.7 4.0 12.3 8.4 7.2 14.8 9.0 20.3 30.0 8.1 18.7 3.7 19.7 13.9 15.2 17.8 21.1 11.0 11.3 9.1 12.8 22.0 12.1 15.4 74.2 18.3 3.6 24.0 14.2 18.5 9.3 5.9 17.4 8.8 11.3 15.3 13.8 10.7 11.7 10.9 10.0 14.2 19.4 5.4 9.9 14.9 8.1 7.5 6.0 11.7 34.5 32.3 8.0 9.9 10.6 11.5 76.7 4.2 62.8 5.5 6.8 5.7 4.2 5.1 7.8 5.2 3.1 3.9 5.8 5.8 9.2 10.6 4.1 9.9 7.0 10.8 10.5 22.3 9.2 10.0 8.8 10.2 8.5 9.7 10.9 17.9 12.0 18.6 18.8 43.3 17.6 14.1 5.1 25.4 20.5 12.2 0.0 41.4 11.6 16.0 7.6 23.3 28.6 0.0 20.9 27.1 16.9 14.4 17.3 12.9 20.5 12.7 17.3 20.9 25.1 3.2 6.9 17.5 28.7 55.9 34.1 13.8 20.4 19.9 7.1 6.5 10.2 12.9 14.4 7.5 14.2 25.0 43.0 36.2 21.5 31.5 CATSPERB "C14orf161, FLJ14298" ENSG00000133962 "Cation channel sperm associated auxiliary subunit beta" Q9H7T0 14 91580696-91780707 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 15.1" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 11.1;Exocrine glandular cells: 9.3;Pancreatic endocrine cells: 11.1" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.8;OE19: 4.0;U-937: 3.7" "Not detected" "Not detected" HPA035134 Uncertain Uncertain Vesicles NA NA Vesicles "HPA035134: AB_10671510" "unprognostic (2.69e-2)" "unprognostic (1.95e-1)" "unprognostic (1.16e-3)" "unprognostic (1.93e-1)" "unprognostic (7.04e-3)" "unprognostic (2.72e-5)" "unprognostic (1.81e-1)" "unprognostic (5.01e-3)" "unprognostic (1.81e-3)" "unprognostic (3.52e-3)" "unprognostic (2.30e-2)" "unprognostic (4.34e-1)" "unprognostic (8.99e-3)" "unprognostic (6.85e-2)" "unprognostic (8.31e-2)" "unprognostic (8.88e-2)" "unprognostic (2.71e-3)" 0.6 0.1 0.0 0.6 0.0 0.0 1.4 0.0 0.2 0.4 0.9 0.3 0.4 0.4 0.6 0.7 1.2 0.6 0.0 0.0 0.3 0.2 0.9 1.1 0.0 0.2 15.1 1.0 0.3 0.0 0.9 0.7 3.7 0.0 1.7 4.2 1.2 0.1 0.0 0.8 2.0 2.0 0.9 0.6 0.5 0.3 0.4 0.2 1.1 0.2 0.7 1.6 0.4 0.6 0.0 0.7 1.6 0.0 0.0 1.8 0.2 0.3 0.0 0.0 2.3 3.8 1.1 0.9 0.0 0.1 0.6 0.0 0.5 0.7 1.4 2.0 0.4 1.2 2.2 0.0 1.6 0.8 0.6 0.7 0.4 0.5 1.5 0.0 1.0 0.5 0.2 0.4 2.2 0.6 0.7 0.2 4.0 0.5 0.3 0.0 0.0 0.4 0.9 1.6 0.1 0.0 0.8 1.5 1.7 0.4 2.1 0.9 0.2 0.2 0.0 0.3 0.9 0.8 0.3 0.2 3.7 1.0 1.1 0.2 0.6 1.1 0.0 1.5 0.4 1.6 1.0 0.0 0.2 1.1 1.4 0.4 0.7 0.2 0.2 0.0 0.4 3.0 1.0 0.0 0.2 0.1 0.0 0.1 0.0 1.4 2.3 0.0 0.0 0.0 0.0 1.6 11.1 0.0 0.3 0.0 9.3 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 1.0 2.1 0.0 11.1 0.9 0.0 0.5 0.0 0.0 0.0 0.9 0.2 0.0 0.2 0.0 0.4 0.3 CBR3 SDR21C2 ENSG00000159231 "Carbonyl reductase 3" O75828 21 36134912-36146566 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 68.2" "Group enriched" "Detected in many" 4 "Basal glandular cells: 23.4;Basal keratinocytes: 63.1;Glandular cells: 36.1;Leydig cells: 62.7;Melanocytes: 62.4;monocytes: 36.1;Peritubular cells: 71.1;Smooth muscle cells: 20.3;Suprabasal keratinocytes: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 11.9;NK-cells: 4.9;T-cells: 17.9" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 43.6" "Low region specificity" "Detected in all" HPA018434 Uncertain Approved Nucleoplasm,Cytosol Yes NA "Nucleoplasm, Cytosol" "HPA018434: AB_1846110" "unprognostic (3.64e-3)" "unprognostic (2.32e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.22e-2)" "unprognostic (6.12e-2)" "unprognostic (2.98e-2)" "unprognostic (3.75e-1)" "unprognostic (9.10e-2)" "prognostic unfavorable (5.95e-6)" "unprognostic (3.13e-1)" "unprognostic (1.80e-1)" "unprognostic (3.99e-3)" "unprognostic (1.94e-1)" 9.2 1.5 5.4 3.0 13.9 0.9 12.2 3.1 4.7 8.6 3.8 1.4 4.1 2.4 5.5 8.8 27.6 4.1 4.9 4.9 3.6 2.9 1.6 0.4 3.5 3.4 3.8 6.1 9.3 1.2 0.3 1.2 2.2 2.5 7.2 2.9 3.3 21.8 4.2 2.4 16.3 2.6 10.5 2.3 1.5 2.7 4.3 2.7 0.9 2.3 68.2 14.1 7.1 8.0 11.9 1.2 0.4 0.5 4.9 17.9 6.2 12.2 3.5 1.5 3.1 12.0 18.6 2.4 13.4 15.9 15.4 12.3 0.1 2.6 0.0 3.9 13.7 5.4 5.7 2.0 2.7 6.2 16.7 6.4 0.5 3.7 0.1 1.0 0.0 0.0 2.6 0.3 10.7 1.4 7.4 9.3 1.4 0.0 0.1 4.5 9.2 1.1 5.4 1.2 3.8 15.5 2.6 2.9 23.9 5.1 5.2 0.8 1.1 10.2 12.5 19.5 0.8 3.7 1.4 6.4 10.0 0.8 11.2 12.9 0.6 0.2 0.0 10.4 0.3 17.9 0.0 0.3 0.0 1.2 0.2 1.5 11.9 13.0 4.0 1.2 10.6 17.9 12.3 0.4 4.9 0.5 0.3 5.1 6.2 5.4 13.9 3.1 4.7 3.6 2.9 3.8 6.1 2.5 2.7 0.0 2.7 0.0 23.4 63.1 0.2 0.2 5.1 5.3 11.4 0.0 0.0 0.9 8.3 3.3 0.5 11.3 1.1 0.0 0.6 0.2 7.7 36.1 5.7 0.0 7.4 0.0 0.0 8.6 3.7 1.1 62.7 5.6 62.4 36.1 8.9 1.4 2.1 1.1 71.1 0.0 0.4 0.0 20.3 0.4 0.2 40.8 0.2 1.3 2.9 11.5 CCDC106 HSU79303 ENSG00000173581 "Coiled-coil domain containing 106" Q9BWC9 19 55641062-55653161 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 11.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 39.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041925, HPA043219" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041925: AB_2677750, HPA043219: AB_2678368" "unprognostic (5.74e-3)" "unprognostic (1.34e-1)" "unprognostic (1.71e-1)" "unprognostic (5.16e-2)" "unprognostic (9.19e-2)" "unprognostic (2.82e-1)" "unprognostic (8.11e-2)" "unprognostic (1.21e-2)" "unprognostic (4.88e-2)" "unprognostic (8.74e-2)" "prognostic favorable (2.23e-6)" "unprognostic (2.28e-1)" "prognostic favorable (7.54e-11)" "unprognostic (5.03e-2)" "unprognostic (7.88e-2)" "unprognostic (3.26e-1)" "unprognostic (8.69e-2)" 15.9 18.7 31.6 8.7 43.9 4.4 14.5 27.2 29.8 13.9 10.4 14.3 10.5 7.2 13.2 11.2 13.0 12.5 14.2 18.0 32.3 21.2 23.5 19.2 10.4 14.8 20.3 14.4 20.9 13.8 19.2 17.5 8.8 15.2 14.7 5.2 12.4 18.0 19.6 34.1 9.3 8.3 20.0 15.1 15.6 13.0 15.9 10.8 13.7 18.0 6.5 14.1 16.9 10.0 11.1 9.0 0.0 2.4 0.6 3.4 1.5 3.9 15.5 6.8 11.9 4.9 4.7 0.9 3.4 6.0 11.9 10.0 3.3 6.1 11.5 2.7 6.3 0.3 3.4 11.5 7.4 3.4 0.6 39.5 12.2 10.4 5.9 14.7 0.8 7.0 7.5 0.9 2.8 0.6 8.3 3.7 7.5 8.9 7.4 5.8 1.0 7.3 4.8 3.2 0.4 8.6 11.5 3.5 7.9 12.3 0.3 7.5 14.0 2.7 19.4 6.7 4.2 8.4 7.9 4.1 3.7 3.8 0.3 2.5 4.4 1.5 14.9 9.9 3.9 0.2 0.0 2.4 0.0 0.5 1.6 1.5 7.8 0.5 0.7 3.0 11.1 3.4 2.0 0.0 0.6 0.1 9.0 0.3 1.5 31.6 43.9 27.2 29.4 32.3 21.2 20.3 14.4 15.2 10.8 0.0 2.2 8.3 7.6 2.3 21.3 19.5 12.7 0.0 1.2 19.2 3.9 11.2 34.9 16.1 3.0 11.3 5.5 0.0 6.3 12.7 8.9 4.6 9.2 14.9 14.5 35.0 4.7 5.5 7.8 1.5 13.0 7.1 3.3 18.0 7.0 18.8 9.0 5.8 17.7 41.5 7.1 12.9 7.2 5.9 19.6 3.1 7.3 3.8 4.7 2.0 CCDC120 JM11 ENSG00000147144 "Coiled-coil domain containing 120" Q96HB5 X 49053572-49069857 "Cancer-related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 14.4;BEWO: 20.7;HaCaT: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000561 Uncertain Mitochondria NA NA Mitochondria "HPA000561: AB_2244190" "unprognostic (1.65e-1)" "unprognostic (1.79e-1)" "unprognostic (1.19e-1)" "unprognostic (7.59e-3)" "unprognostic (1.80e-3)" "unprognostic (1.08e-2)" "unprognostic (2.59e-3)" "unprognostic (1.23e-1)" "unprognostic (1.04e-1)" "unprognostic (1.72e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (4.85e-2)" "unprognostic (2.64e-2)" "unprognostic (3.82e-3)" "unprognostic (4.54e-3)" "unprognostic (2.34e-3)" 3.3 3.1 5.8 3.1 4.7 2.9 5.0 17.3 5.8 8.4 6.8 1.6 10.4 12.0 5.5 9.9 27.6 5.1 4.1 2.1 4.0 1.6 7.0 4.8 4.4 2.6 1.5 3.3 6.5 7.0 6.1 12.2 13.3 4.0 6.0 3.3 4.7 11.4 10.2 1.5 26.1 12.5 2.5 1.8 3.8 7.7 5.8 1.5 6.0 5.6 8.8 15.1 7.4 12.2 2.5 2.2 3.9 0.8 1.6 1.5 0.4 14.4 1.9 3.2 0.1 0.0 0.0 20.7 0.5 0.7 1.1 1.7 4.8 6.2 0.6 2.3 0.8 2.4 13.9 2.4 8.2 0.1 3.7 4.6 1.3 3.3 1.6 1.1 0.0 2.4 1.8 6.6 1.3 0.4 2.2 1.8 3.8 2.0 0.2 0.0 12.1 5.0 0.4 3.7 6.8 0.1 4.5 2.4 1.3 6.3 7.8 4.4 3.4 2.6 5.2 1.5 4.6 12.6 1.9 0.8 0.1 3.8 0.1 0.1 4.7 3.2 0.1 0.1 0.0 0.6 2.9 0.8 1.5 1.4 0.2 0.9 0.8 1.5 1.3 0.3 2.5 1.5 1.4 3.9 1.6 0.4 2.2 0.5 0.4 5.8 4.7 17.3 5.8 4.0 1.6 1.5 3.3 4.0 1.5 6.0 1.9 0.8 3.2 4.5 5.8 1.2 2.5 2.7 2.3 12.2 3.9 10.2 0.0 4.7 0.1 2.9 6.2 0.0 5.7 2.6 1.5 5.1 0.0 1.9 1.9 9.5 5.8 3.7 2.7 0.0 2.0 0.0 0.0 0.0 5.5 2.3 9.7 6.2 1.1 2.4 6.1 0.0 0.8 1.1 0.7 8.2 14.1 1.0 3.9 7.6 CCDC125 KENAE ENSG00000183323 "Coiled-coil domain containing 125" Q86Z20 5 69280175-69332809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 87.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 5.8;eosinophil: 13.0;neutrophil: 10.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.0" "Cell line enhanced" "Detected in many" "T-47d: 19.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA041878 Approved Uncertain "Nucleoplasm,Nuclear membrane,Intermediate filaments" NA NA "Nuclear membrane, Intermediate filaments" Nucleoplasm "HPA041878: AB_10796787" "prognostic unfavorable (8.06e-4)" "unprognostic (1.01e-1)" "unprognostic (2.35e-2)" "prognostic favorable (4.40e-4)" "unprognostic (1.05e-1)" "unprognostic (1.91e-2)" "unprognostic (8.21e-2)" "unprognostic (3.08e-2)" "unprognostic (4.06e-2)" "unprognostic (5.07e-2)" "unprognostic (2.52e-2)" "unprognostic (1.91e-2)" "unprognostic (2.05e-2)" "unprognostic (5.40e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "prognostic favorable (2.51e-4)" 4.3 6.1 4.9 6.1 5.6 13.6 10.0 4.9 4.7 4.1 7.9 5.8 7.8 6.7 5.9 4.0 6.6 5.5 10.0 3.0 4.8 4.9 5.0 17.6 5.8 6.2 6.4 4.9 4.8 14.9 4.2 10.4 5.5 6.7 10.1 7.9 3.6 15.9 12.3 2.8 5.3 10.6 4.5 4.7 5.2 8.3 3.4 4.1 3.1 5.5 4.7 5.5 7.3 5.6 0.9 1.5 13.0 2.3 1.1 1.1 0.8 2.1 3.6 0.7 10.1 1.2 0.7 13.0 1.3 1.9 0.9 0.5 3.2 10.9 3.9 7.6 1.4 0.8 2.8 7.4 3.8 0.8 13.6 5.9 2.5 5.8 6.1 3.1 2.6 1.4 4.2 1.9 4.2 1.3 2.1 1.4 4.7 7.2 1.7 0.7 8.7 3.4 4.3 0.1 2.8 2.3 5.0 0.0 5.3 5.0 2.5 4.2 2.7 2.6 5.9 1.9 0.1 19.4 2.8 1.7 0.8 1.5 2.5 2.0 7.9 12.1 1.5 2.6 14.5 0.4 5.8 1.1 13.0 1.1 0.9 0.9 0.9 1.0 0.8 1.5 0.9 0.9 0.5 10.9 1.1 2.3 1.2 0.7 0.8 4.9 5.6 4.9 4.7 4.8 4.9 6.4 4.9 6.7 4.1 23.8 14.8 4.2 3.6 0.9 4.4 5.5 5.1 87.0 19.4 1.8 2.0 26.8 5.0 10.6 0.8 2.9 9.3 0.0 10.4 6.6 1.3 8.6 15.1 15.3 5.4 3.2 1.2 1.8 4.5 1.5 2.0 3.9 1.7 8.2 12.3 5.4 7.8 13.5 2.1 6.9 7.4 0.0 1.4 1.4 2.3 0.9 10.4 3.1 7.4 4.6 CCDC129 FLJ38344 ENSG00000180347 "Coiled-coil domain containing 129" Q6ZRS4 7 31514071-31658720 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 17.2;salivary gland: 10.9" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 8.2;Intestinal endocrine cells: 1.7;Late spermatids: 5.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebellum: 7.9;midbrain: 5.0;pons and medulla: 17.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 1.6;CACO-2: 1.3;RH-30: 2.1;T-47d: 2.7;U-2 OS: 5.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA024103 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA024103: AB_1846132" "unprognostic (1.11e-2)" "unprognostic (1.39e-1)" "unprognostic (1.57e-1)" "unprognostic (1.78e-5)" "unprognostic (9.72e-3)" "unprognostic (1.78e-1)" "unprognostic (3.89e-2)" "unprognostic (6.42e-3)" "unprognostic (1.01e-1)" "unprognostic (5.77e-2)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.99e-1)" "unprognostic (1.53e-1)" 0.1 0.0 0.1 0.6 2.0 0.1 3.3 7.9 0.3 3.7 0.9 1.2 0.0 2.1 1.1 0.2 0.1 0.1 0.1 0.0 0.4 1.4 0.1 0.0 0.4 0.0 5.0 0.0 0.0 0.2 0.0 0.4 0.9 17.2 0.1 0.2 0.0 10.9 0.0 0.0 4.5 0.9 1.1 0.2 0.0 0.8 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.8 1.1 0.0 0.1 1.0 0.1 0.0 0.0 1.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.5 0.8 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.1 2.1 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.2 2.7 0.0 0.0 0.0 5.6 0.2 0.3 0.2 0.1 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.7 0.2 0.1 0.1 0.8 1.0 0.4 1.1 0.1 0.0 0.8 0.0 0.1 0.1 2.0 7.9 0.3 0.4 1.4 5.0 0.0 17.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 5.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 CCDC148 MGC125588 ENSG00000153237 "Coiled-coil domain containing 148" Q8NFR7 2 158171081-158456753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 5.9;testis: 6.5" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 40.2;Cone photoreceptor cells: 53.0;Early spermatids: 22.4;Rod photoreceptor cells: 29.6" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 9 "basophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.1;HBF TERT88: 4.3;hTEC/SVTERT24-B: 2.8;RPTEC TERT1: 3.3;SCLC-21H: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042626 Uncertain Uncertain "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA042626: AB_10806244" "unprognostic (1.88e-1)" "unprognostic (5.90e-2)" "unprognostic (3.31e-2)" "unprognostic (1.94e-4)" "unprognostic (3.29e-1)" "unprognostic (7.65e-2)" "unprognostic (1.23e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (7.98e-2)" "unprognostic (1.84e-1)" "unprognostic (1.18e-1)" "unprognostic (1.42e-2)" "unprognostic (5.77e-2)" "unprognostic (3.35e-2)" "prognostic favorable (2.54e-4)" "unprognostic (6.57e-3)" 0.1 0.5 0.6 0.0 0.8 0.0 1.8 1.9 0.3 1.4 0.0 0.0 0.6 2.4 0.0 3.3 0.4 0.0 0.7 0.8 4.3 0.1 0.6 0.0 0.5 1.3 0.1 5.9 1.9 0.0 0.4 0.0 1.0 0.7 0.0 0.2 0.0 0.0 1.0 0.0 0.0 6.5 1.8 0.0 0.1 0.3 0.0 0.0 1.9 0.0 0.0 0.2 0.0 1.3 0.0 0.8 1.0 0.0 0.0 0.1 0.9 0.0 1.1 2.3 1.1 6.1 0.1 0.1 0.9 0.4 0.5 0.0 0.3 4.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.4 0.0 0.2 0.0 0.1 0.5 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 3.3 0.4 4.2 0.2 0.3 0.4 0.5 1.3 2.4 0.3 0.0 0.4 0.5 0.1 0.2 0.6 0.7 0.0 1.0 0.0 0.4 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.2 0.0 9.1 2.0 0.0 40.2 3.4 7.0 53.0 0.0 11.6 5.6 22.4 0.2 0.0 0.0 1.6 0.0 0.5 0.8 0.0 1.0 0.1 4.8 0.0 1.8 0.0 3.8 0.9 0.0 0.0 1.0 0.0 5.2 3.4 0.0 1.8 4.8 29.6 6.5 0.3 7.5 1.5 0.4 0.0 0.0 0.0 1.6 CCDC153 LOC283152 ENSG00000248712 "Coiled-coil domain containing 153" Q494R4 11 119189638-119196769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 15.1;fallopian tube: 15.8;pituitary gland: 20.0" "Cell type enriched" "Detected in many" 7 "Ciliated cells: 151.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 15.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.1" "Cell line enhanced" "Detected in many" "T-47d: 13.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041497 Uncertain Uncertain Cytosol NA NA Cytosol "HPA041497: AB_10794378" "unprognostic (4.66e-2)" "unprognostic (1.86e-2)" "unprognostic (3.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.53e-1)" "unprognostic (3.22e-2)" "unprognostic (6.87e-2)" "unprognostic (2.23e-3)" "unprognostic (5.19e-2)" "unprognostic (9.43e-3)" "unprognostic (1.36e-1)" "unprognostic (2.36e-1)" "unprognostic (2.92e-3)" "unprognostic (1.15e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-3)" "unprognostic (1.98e-3)" 1.4 1.1 2.2 0.6 4.8 3.8 0.8 0.5 0.9 1.4 0.6 2.0 0.5 0.5 1.1 5.3 1.5 15.8 3.1 2.0 2.6 3.9 1.5 0.6 5.2 0.5 0.5 0.5 1.7 0.5 3.3 20.0 1.3 9.8 0.5 0.6 0.5 0.7 1.6 0.5 1.4 0.8 0.7 1.2 0.8 1.6 2.8 2.4 0.5 1.1 0.5 0.9 0.7 0.5 0.4 1.6 15.1 2.4 0.3 0.6 0.7 2.2 3.0 1.8 1.8 0.3 0.3 4.4 1.3 1.5 0.6 0.7 4.9 7.7 1.5 6.4 0.3 2.2 1.6 0.4 1.5 0.1 3.0 2.5 7.2 2.2 3.3 1.1 2.3 0.9 0.7 1.0 1.6 0.4 2.4 1.5 1.6 2.1 2.9 0.1 8.9 1.5 2.2 0.9 3.2 5.2 2.0 2.5 1.4 0.5 2.2 2.4 1.2 3.0 1.5 1.7 1.2 13.1 2.7 3.0 3.3 2.6 2.0 2.7 1.2 1.8 1.2 1.5 1.3 4.0 0.4 2.4 3.8 0.3 1.5 0.2 0.4 0.2 0.4 1.6 0.4 0.6 0.5 15.1 0.3 1.5 1.6 0.4 0.7 2.2 4.8 0.5 0.9 2.6 3.9 0.5 0.5 9.8 2.4 0.0 6.7 0.0 1.3 2.5 0.0 0.2 0.0 151.3 20.5 7.0 0.0 3.5 0.0 0.8 2.5 1.5 3.3 0.0 1.8 2.9 1.3 0.9 0.0 1.3 3.1 0.0 1.7 3.1 3.5 4.8 0.3 3.4 3.3 5.4 2.7 0.9 1.0 7.0 2.5 2.9 1.9 6.5 6.2 6.6 3.4 1.9 2.7 0.0 1.8 2.0 CCDC169-SOHLH2 C13orf38-SOHLH2 ENSG00000250709 "CCDC169-SOHLH2 readthrough" 13 36168794-36297842 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 42.2" "Cell type enhanced" "Detected in single" 35 "Late spermatids: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.4;HEL: 2.3;HL-60: 6.2;LHCN-M2: 2.4;NB-4: 3.5;SuSa: 2.3;U-937: 5.0" HPA029182 Uncertain Vesicles NA NA Vesicles "HPA029182: AB_10602409" "unprognostic (5.56e-2)" "unprognostic (3.93e-1)" "unprognostic (3.60e-2)" "unprognostic (4.66e-1)" "unprognostic (2.17e-1)" "unprognostic (1.84e-2)" "unprognostic (6.12e-2)" "unprognostic (3.43e-2)" 0.4 0.5 0.5 0.2 1.8 0.2 0.4 0.4 1.4 0.5 0.8 0.3 4.9 0.2 1.0 2.0 0.3 0.4 0.3 1.1 0.5 0.6 0.7 0.3 0.3 0.2 0.5 1.3 0.4 0.4 0.3 0.3 3.3 1.1 0.6 0.3 0.5 0.4 9.1 0.5 0.3 0.4 3.0 1.0 0.3 0.6 42.2 0.0 0.0 0.4 0.0 0.2 1.6 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 3.4 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.3 6.2 0.0 0.1 0.0 0.8 0.0 0.3 0.8 0.0 0.1 0.0 2.4 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 1.7 0.0 0.1 0.0 2.3 0.1 1.1 0.6 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.1 5.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.4 1.4 0.5 0.6 0.5 1.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC198 "C14orf105, FLJ10650" ENSG00000100557 "Coiled-coil domain containing 198" Q9NVL8 14 57469301-57493867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 25.8;kidney: 75.8;pancreas: 21.8" "Group enriched" "Detected in some" 5 "Collecting duct cells: 54.1;Distal tubular cells: 58.0;Proximal tubular cells: 165.1" "Cancer enhanced" "Detected in many" "renal cancer: 25.1" "Region enhanced" "Detected in single" "pons and medulla: 1.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "A549: 9.3;RPTEC TERT1: 27.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029202 Uncertain Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA029202: AB_10600754" "unprognostic (1.45e-1)" "unprognostic (3.65e-1)" "unprognostic (2.38e-1)" "unprognostic (6.67e-2)" "prognostic unfavorable (5.61e-4)" "unprognostic (1.21e-1)" "unprognostic (5.45e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.92e-4)" "unprognostic (6.07e-2)" "unprognostic (2.77e-1)" "unprognostic (1.61e-3)" 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.6 0.1 0.6 0.1 0.0 1.6 0.7 0.4 25.8 0.1 15.3 17.7 0.1 0.1 0.2 75.8 17.7 0.1 0.0 0.1 0.0 6.1 21.8 0.0 0.1 0.1 1.5 0.1 0.0 0.0 0.1 0.8 0.1 0.4 0.1 0.0 0.3 0.1 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.3 0.1 2.7 1.9 4.5 0.9 3.4 5.0 3.6 0.0 9.3 0.0 0.3 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.9 0.9 0.4 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.3 0.3 0.1 0.2 0.1 0.2 0.1 0.0 0.2 27.7 0.4 0.3 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.3 0.7 0.5 0.1 0.1 0.3 0.4 0.3 1.4 0.3 0.2 3.1 0.9 0.6 2.1 0.4 2.6 2.1 4.2 3.0 0.2 2.7 3.5 5.0 4.5 3.4 0.6 1.9 5.0 3.6 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.0 1.5 0.0 3.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.1 0.0 0.0 58.0 18.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 165.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC74A FLJ40345 ENSG00000163040 "Coiled-coil domain containing 74A" Q96AQ1 2 131527675-131533666 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.1;testis: 41.2" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 107.1;Early spermatids: 339.1;Late spermatids: 203.8;Spermatocytes: 157.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 3.3" "Lineage enhanced" "Detected in single" "dendritic cells: 3.3" "Cell line enhanced" "Detected in many" "NTERA-2: 19.3;SCLC-21H: 15.9" HPA060727 Uncertain Vesicles NA NA Vesicles "HPA060727: " "prognostic favorable (5.11e-4)" "unprognostic (2.89e-3)" "unprognostic (6.49e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (1.91e-1)" "unprognostic (1.36e-2)" "unprognostic (2.18e-3)" "unprognostic (1.71e-1)" "unprognostic (2.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (1.70e-7)" "unprognostic (7.28e-3)" "prognostic favorable (4.92e-4)" "unprognostic (5.96e-2)" "unprognostic (3.53e-2)" 1.3 12.8 5.8 2.7 6.5 0.2 6.8 1.1 4.4 5.6 1.9 3.2 4.7 0.9 7.1 7.1 1.9 26.1 5.1 2.2 5.1 6.8 3.0 0.5 3.0 0.9 2.2 4.1 7.1 1.5 13.3 14.1 0.9 13.6 5.2 1.3 2.4 1.8 5.1 0.9 3.5 0.8 5.9 3.0 1.0 1.0 41.2 1.9 2.2 2.6 0.9 1.2 4.5 2.7 0.0 3.3 0.0 0.1 0.0 0.8 0.2 0.0 3.9 4.0 0.2 5.8 14.1 0.3 3.4 5.6 3.1 2.3 0.1 6.0 1.5 2.1 5.2 5.3 3.0 1.7 1.0 1.3 3.9 7.5 0.0 3.8 0.1 0.7 0.1 0.3 4.6 0.4 3.1 0.0 6.2 1.2 8.5 2.2 4.4 2.8 2.4 8.5 2.3 19.3 1.5 2.6 4.1 0.0 1.8 7.9 0.0 15.9 11.5 0.4 0.6 0.6 1.6 5.5 0.8 1.3 0.9 3.0 12.2 2.5 0.9 0.7 0.5 13.1 0.4 5.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.4 3.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 5.8 6.5 1.1 4.4 5.1 6.8 2.2 4.1 13.6 1.9 0.0 0.3 0.0 8.2 4.5 0.4 0.4 2.5 107.1 11.4 7.0 0.0 0.3 6.6 6.5 339.1 0.5 0.0 0.0 0.6 0.3 12.3 7.9 0.0 0.0 0.3 0.0 7.5 1.8 0.0 203.8 34.2 1.8 1.7 0.0 0.3 7.7 2.1 0.0 64.3 2.4 0.9 0.0 3.1 157.3 16.4 5.3 0.2 0.0 1.5 4.8 CCDC74B DKFZp434E2321 ENSG00000152076 "Coiled-coil domain containing 74B" Q96LY2 2 130139287-130145134 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 12.4;testis: 22.7" "Cell type enhanced" "Detected in many" 21 "Ciliated cells: 66.9;Early spermatids: 268.8;Late spermatids: 93.0;Spermatocytes: 141.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 10.6;SH-SY5Y: 15.1" HPA060727 Uncertain Vesicles NA NA Vesicles "HPA060727: " "prognostic favorable (4.46e-4)" "unprognostic (4.75e-3)" "unprognostic (2.67e-1)" "unprognostic (2.76e-3)" "unprognostic (2.81e-1)" "unprognostic (1.73e-1)" "unprognostic (8.69e-3)" "unprognostic (9.43e-2)" "unprognostic (2.99e-1)" "unprognostic (2.10e-1)" "unprognostic (6.43e-3)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (2.43e-2)" "unprognostic (1.48e-4)" "unprognostic (8.31e-3)" "unprognostic (9.94e-3)" 0.0 1.4 2.8 0.1 2.4 0.0 0.4 0.0 2.2 8.3 0.1 0.0 3.5 0.6 0.1 12.4 1.1 0.1 3.0 4.0 1.0 0.0 1.0 0.1 0.9 2.1 0.2 7.5 7.7 0.0 2.7 0.0 0.2 2.5 0.0 0.1 0.0 1.0 1.4 0.0 0.0 22.7 3.7 0.0 0.4 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.9 2.9 0.1 2.7 5.8 0.6 2.2 1.2 0.3 0.5 0.8 0.7 0.1 3.6 2.0 3.4 1.0 0.2 0.3 0.4 2.0 5.5 0.0 6.9 0.1 0.3 0.1 0.2 1.2 0.0 0.9 0.0 3.6 0.2 1.4 0.1 1.7 0.8 2.0 0.0 0.0 5.9 0.5 6.0 4.5 0.0 3.2 1.7 0.0 10.6 15.1 1.6 0.1 0.3 0.7 6.0 0.7 0.4 1.1 5.0 6.1 0.5 0.1 0.2 0.0 6.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.0 0.3 0.0 2.0 0.5 0.4 0.4 2.5 66.9 3.4 5.2 0.0 0.1 3.3 1.1 268.8 0.1 0.0 0.0 0.2 0.7 2.4 3.9 0.0 0.0 0.3 3.2 10.9 0.0 0.0 93.0 9.5 0.2 0.0 0.0 0.0 3.5 0.0 0.0 11.7 0.3 0.0 0.0 2.1 141.1 14.6 1.0 0.1 0.0 0.0 0.3 CCDC83 "CT148, FLJ42119, MGC34732" ENSG00000150676 "Coiled-coil domain containing 83" Q8IWF9 11 85855101-85920021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 27.7" "Group enriched" "Detected in some" 11 "Early spermatids: 142.1;Late spermatids: 149.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "MCF7: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039707, HPA039882" Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA039707: AB_10795259, HPA039882: AB_10795410" "unprognostic (1.14e-1)" "unprognostic (4.09e-1)" "unprognostic (1.49e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-6)" "unprognostic (3.52e-1)" "unprognostic (2.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.8 0.8 0.3 0.6 0.0 0.1 0.0 0.5 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.2 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.7 0.3 0.3 0.2 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.3 7.9 0.1 0.4 0.0 1.3 0.0 0.1 0.0 0.1 0.6 0.3 0.1 0.1 0.1 0.5 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.2 0.1 0.4 0.8 0.6 0.3 0.6 0.4 0.4 0.3 0.3 0.3 0.3 0.4 0.3 0.5 1.8 0.3 0.8 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 142.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.4 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 13.1 1.3 0.0 0.0 0.0 0.0 0.0 CCDC85C ENSG00000205476 "Coiled-coil domain containing 85C" A6NKD9 14 99500180-99604026 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058346, HPA061922" Uncertain Approved "Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Cell Junctions" Yes No "Nucleoli rim, Cell Junctions" "Nucleoplasm, Nuclear bodies, Mitotic chromosome" "HPA058346: AB_2683686, HPA061922: " "unprognostic (7.17e-2)" "unprognostic (2.23e-2)" "unprognostic (3.64e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (5.70e-2)" "unprognostic (2.61e-1)" "unprognostic (1.68e-3)" "unprognostic (4.80e-2)" "unprognostic (1.45e-2)" "unprognostic (8.75e-2)" "unprognostic (3.30e-1)" "unprognostic (1.68e-3)" "prognostic favorable (2.60e-5)" "unprognostic (4.14e-2)" "unprognostic (1.95e-1)" "unprognostic (8.74e-3)" "unprognostic (9.81e-3)" 3.5 12.0 13.9 3.3 15.5 7.2 6.1 45.2 11.8 11.3 15.3 11.7 16.6 15.4 8.7 12.6 24.0 10.0 13.9 11.4 11.6 7.6 7.8 32.3 6.7 1.9 10.3 5.9 6.9 15.3 10.4 10.0 7.1 9.1 15.8 9.5 19.9 20.8 14.8 15.2 13.6 27.0 15.4 8.4 3.0 10.5 8.1 8.1 2.7 9.5 9.3 8.7 13.7 17.9 0.3 0.1 0.7 0.0 0.4 2.0 0.6 17.5 16.1 20.0 12.0 0.2 0.0 18.6 5.9 6.1 12.0 7.0 19.5 18.7 0.1 23.7 6.7 3.3 23.7 14.7 14.3 7.5 28.8 8.7 0.9 16.0 13.1 1.6 0.2 1.9 0.0 7.6 3.4 9.9 7.1 3.7 10.5 4.2 2.7 1.4 29.4 7.8 2.4 7.3 20.3 16.8 11.7 8.4 3.9 8.5 7.0 9.9 12.5 15.2 8.1 3.7 8.0 17.7 3.6 8.4 2.3 20.0 8.5 5.9 4.2 5.5 0.1 0.4 1.5 1.6 0.7 0.0 0.0 0.6 0.0 0.8 0.2 1.9 1.3 0.0 0.3 2.0 1.1 0.6 0.4 0.0 0.1 2.0 0.6 13.9 15.5 45.2 11.8 11.6 7.6 10.3 5.9 9.1 8.1 20.8 6.4 0.9 7.8 7.8 31.0 2.2 7.6 2.7 9.1 1.8 58.9 5.4 0.0 7.3 2.3 4.2 14.2 0.0 8.1 3.5 2.3 8.5 5.8 15.3 1.6 1.6 9.2 6.2 1.2 0.9 0.6 0.6 8.5 0.0 9.6 28.9 11.9 14.0 0.7 5.1 47.8 0.0 2.3 0.9 1.6 12.3 4.1 0.7 10.9 10.3 CD101 "IGSF2, V7" ENSG00000134256 "CD101 molecule" Q93033 1 117001750-117036476 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.7;lung: 17.5" "Cell type enhanced" "Detected in some" 9 "Kupffer cells: 6.2;Macrophages: 7.2;Sertoli cells: 6.5;T-cells: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 33.7" "Group enriched" "Detected in many" 17 "dendritic cells: 12.2;granulocytes: 33.7;monocytes: 17.4" "Cell line enriched" "Detected in some" 9 "HMC-1: 25.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA049527, HPA057763" Approved Uncertain Mitochondria NA NA 42000 Mitochondria "HPA049527: , HPA057763: AB_2683519" "unprognostic (1.25e-1)" "unprognostic (7.95e-3)" "unprognostic (5.40e-3)" "unprognostic (4.10e-3)" "unprognostic (2.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.03e-2)" "unprognostic (3.58e-3)" "unprognostic (3.57e-2)" "unprognostic (7.29e-3)" "unprognostic (3.15e-1)" "unprognostic (4.54e-2)" "unprognostic (7.15e-6)" "unprognostic (7.00e-2)" "unprognostic (8.07e-2)" "unprognostic (5.05e-2)" "unprognostic (5.28e-2)" 0.9 1.7 0.8 11.3 1.1 5.7 0.8 0.2 1.1 1.3 5.0 0.6 1.2 4.6 1.7 0.4 1.8 1.5 1.4 2.6 1.1 0.5 1.3 0.8 17.5 4.0 1.3 0.2 1.0 2.3 0.0 0.8 0.5 1.1 1.6 3.2 0.7 2.1 1.3 0.5 1.8 10.9 1.6 2.0 7.8 1.8 0.9 1.2 6.4 0.9 2.4 7.4 2.4 1.8 0.1 12.2 33.7 17.4 0.0 1.2 2.5 0.4 0.0 0.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 1.2 1.9 0.1 0.0 0.0 1.1 0.1 0.8 0.0 0.0 0.1 25.3 0.3 1.3 0.0 0.1 0.2 0.2 0.5 0.1 0.6 0.1 1.5 0.0 2.9 0.8 0.0 0.0 0.0 0.5 0.0 0.6 0.7 0.4 0.6 0.4 0.5 0.3 0.6 0.9 0.6 0.5 0.1 0.4 0.5 0.2 0.2 0.1 0.0 0.7 1.9 1.5 0.0 7.6 33.7 0.1 10.0 0.7 0.1 0.2 1.2 12.2 0.0 0.3 1.2 0.3 0.0 17.4 0.0 1.1 2.5 0.8 1.1 0.2 1.1 1.1 0.5 1.3 0.2 1.1 1.2 0.0 1.4 0.5 0.1 1.1 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.5 0.0 0.2 0.1 1.1 0.4 0.7 0.0 1.7 0.0 6.2 1.3 0.3 7.2 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 6.5 0.2 0.0 0.0 1.4 0.0 4.6 0.1 0.1 CD207 "CLEC4K, Langerin" ENSG00000116031 "CD207 molecule" Q9UJ71 2 70830214-70835822 "CD markers, Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.5;skin 1: 42.3" "Cell type enhanced" "Detected in some" 14 "Basal keratinocytes: 3.5;Macrophages: 1.5;Melanocytes: 5.0;monocytes: 2.8;Suprabasal keratinocytes: 4.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "myeloid DC: 4.0" "Lineage enriched" "Detected in single" 18 "dendritic cells: 4.0" "Cell line enriched" "Detected in some" 4 "AN3-CA: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002222, HPA011216" Enhanced Uncertain Cytosol No NA Cytosol "CAB002222: AB_563850, HPA011216: AB_1078453" "unprognostic (1.45e-2)" "unprognostic (8.28e-3)" "unprognostic (9.34e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "unprognostic (2.23e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-3)" "unprognostic (1.05e-1)" "unprognostic (4.86e-2)" "unprognostic (3.45e-1)" "unprognostic (1.63e-1)" "unprognostic (7.92e-4)" "unprognostic (2.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (2.46e-2)" 0.5 0.1 0.1 1.8 0.1 0.0 1.4 0.1 0.1 2.4 1.7 0.1 0.1 1.6 1.1 0.4 9.7 0.3 2.9 0.3 0.1 0.1 0.2 0.9 3.7 0.2 0.1 0.1 0.2 0.2 0.0 1.1 0.1 0.1 1.0 1.1 0.4 1.2 0.2 0.1 42.3 2.6 0.1 0.1 1.5 0.4 0.4 0.1 3.3 0.2 11.3 16.5 0.3 1.9 0.0 4.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 14.1 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 1.9 0.0 0.0 0.0 0.3 2.5 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 CD226 "DNAM-1, DNAM1, PTA1, TLiSA1" ENSG00000150637 "CD226 molecule" Q15762 18 69831158-69961803 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.9;parathyroid gland: 82.5" "Cell type enhanced" "Detected in many" 10 "granulocytes: 12.8;Kupffer cells: 11.2;monocytes: 21.6;T-cells: 25.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 19.4;MAIT T-cell: 7.3;memory CD4 T-cell: 16.1;memory CD8 T-cell: 11.8;naive CD4 T-cell: 9.0;naive CD8 T-cell: 9.7;NK-cell: 14.0;T-reg: 5.5" "Group enriched" "Detected in many" 11 "NK-cells: 14.0;T-cells: 19.4" "Group enriched" "Detected in some" 6 "HEL: 45.3;HMC-1: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA015715, HPA015865" Supported Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" NA No 27000000 "Plasma membrane" "Nucleoplasm, Centriolar satellite" "HPA015715: AB_1846278, HPA015865: " "unprognostic (1.42e-4)" "unprognostic (1.30e-3)" "unprognostic (9.01e-3)" "unprognostic (3.49e-5)" "unprognostic (4.15e-1)" "unprognostic (9.52e-4)" "unprognostic (3.68e-3)" "unprognostic (2.93e-2)" "unprognostic (3.43e-1)" "unprognostic (3.31e-3)" "unprognostic (8.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (2.20e-1)" "unprognostic (3.91e-2)" "unprognostic (2.27e-1)" "unprognostic (3.58e-2)" 1.2 0.6 1.0 7.5 2.0 1.7 0.8 0.7 0.9 1.5 2.9 0.3 0.1 1.1 1.0 1.4 0.8 0.8 1.4 0.9 1.9 1.3 1.3 3.1 5.2 14.0 1.7 0.0 1.0 0.6 82.5 2.4 0.6 1.3 0.9 1.2 2.4 5.4 0.6 1.1 0.4 6.0 1.3 4.2 31.9 1.4 1.8 0.5 6.4 1.8 2.6 10.1 2.0 1.6 0.4 1.5 0.9 0.6 14.0 19.4 6.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 2.4 0.0 45.3 0.1 0.0 0.0 0.3 20.2 0.0 0.5 0.1 0.3 0.0 0.0 0.4 0.1 4.7 0.2 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.1 5.5 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.5 19.4 0.4 7.3 0.4 16.1 11.8 1.5 0.1 9.0 9.7 0.9 14.0 0.6 0.1 5.5 6.6 1.0 2.0 0.7 0.9 1.9 1.3 1.7 0.0 1.3 0.5 3.0 5.1 0.8 0.3 0.0 2.4 1.6 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 6.6 0.1 0.0 0.0 0.3 0.0 0.4 0.2 12.8 0.5 1.4 0.0 0.0 2.5 11.2 7.5 0.9 7.8 0.0 21.6 0.0 1.4 0.2 0.0 0.7 0.0 3.7 0.0 0.3 0.3 0.5 0.4 0.0 25.4 0.0 0.1 CD274 "B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1" ENSG00000120217 "CD274 molecule" Q9NZQ7 9 5450503-5470566 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 23.9;placenta: 56.0" "Cell type enhanced" "Detected in many" 14 "granulocytes: 26.7;monocytes: 73.9;Syncytiotrophoblasts: 37.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.4" "Group enriched" "Detected in many" 6 "granulocytes: 8.4;T-cells: 2.4" "Cell line enhanced" "Detected in many" "HDLM-2: 34.2;HHSteC: 22.8;U-251 MG: 37.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003528, CAB076385" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" Nucleoplasm "CAB076385: AB_2687655, HPA003528: " "prognostic favorable (8.89e-4)" "unprognostic (4.54e-2)" "prognostic favorable (1.64e-5)" "unprognostic (1.27e-2)" "unprognostic (2.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.61e-2)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (5.67e-4)" "unprognostic (7.39e-3)" "unprognostic (1.69e-2)" "unprognostic (1.24e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-2)" "unprognostic (2.67e-1)" "unprognostic (9.02e-2)" 3.4 2.1 1.7 10.8 3.2 1.4 2.2 2.5 3.3 2.0 2.3 2.5 2.8 2.6 1.7 2.4 3.0 1.9 4.3 9.5 1.4 3.7 3.0 3.6 23.9 6.4 2.3 0.7 1.7 2.7 3.8 7.4 56.0 3.2 2.9 2.2 3.3 1.7 1.6 4.3 1.3 2.7 2.3 2.4 12.8 1.9 1.2 1.0 11.6 3.7 2.1 5.8 3.1 1.9 0.9 0.0 8.4 0.1 0.4 2.4 0.7 5.9 0.1 0.0 0.2 0.0 0.0 0.0 11.9 10.1 3.0 4.2 0.0 1.9 0.0 0.2 0.3 1.5 0.2 0.0 5.2 9.9 34.2 0.0 3.4 0.1 0.0 22.8 0.0 0.0 0.2 0.0 6.3 9.3 3.1 5.9 0.3 0.0 1.1 9.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 0.3 0.6 0.1 0.0 0.1 0.1 0.9 0.7 0.9 0.0 0.1 10.9 6.5 2.0 0.2 37.9 0.2 0.1 0.1 2.1 0.1 0.0 8.4 0.1 0.3 1.2 0.1 2.1 0.9 2.4 1.8 0.0 0.2 1.3 0.7 5.7 0.4 0.0 0.0 1.1 0.7 1.7 3.2 2.5 3.3 1.4 3.7 2.3 0.7 3.2 1.0 11.9 10.7 0.5 1.2 4.0 1.4 6.5 0.0 4.0 3.4 0.0 0.0 4.9 0.0 6.4 0.2 6.3 0.8 0.0 3.7 20.2 1.9 0.9 26.7 1.0 4.9 0.0 0.0 10.4 1.9 0.0 0.3 7.7 3.3 73.9 0.1 0.6 12.0 0.0 0.4 0.4 0.1 0.0 0.9 0.5 0.7 2.3 37.2 1.3 0.2 2.2 CD300C "CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR" ENSG00000167850 "CD300c molecule" Q08708 17 74541108-74546143 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 46.8" "Group enriched" "Detected in some" 12 "granulocytes: 15.0;Hofbauer cells: 29.5;Kupffer cells: 28.1;Macrophages: 33.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 28.6;intermediate monocyte: 46.8;myeloid DC: 32.5;non-classical monocyte: 46.4" "Group enriched" "Detected in many" 5 "dendritic cells: 32.5;monocytes: 46.8" "Cell line enhanced" "Detected in some" "HEL: 5.3;HMC-1: 26.2;THP-1: 4.9;U-937: 12.4" "HPA014523, HPA060349" Approved Uncertain "Golgi apparatus,Vesicles,Mitochondria" NA NA "Golgi apparatus" "Vesicles, Mitochondria" "HPA014523: AB_1846293, HPA060349: " "unprognostic (1.55e-2)" "unprognostic (2.60e-1)" "unprognostic (9.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.21e-1)" "unprognostic (3.47e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.68e-2)" "unprognostic (7.51e-2)" "unprognostic (6.51e-2)" "unprognostic (1.50e-2)" "unprognostic (1.37e-3)" "unprognostic (6.27e-2)" "prognostic unfavorable (8.53e-5)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" 9.8 2.8 3.6 9.0 4.6 10.9 1.8 0.4 2.9 1.2 1.7 2.9 0.0 1.5 1.4 1.9 1.0 1.9 2.8 3.4 2.0 1.7 1.9 2.1 11.2 12.3 5.3 1.3 1.1 1.3 0.5 1.2 3.8 3.9 1.9 1.8 1.8 1.8 0.7 1.1 0.9 2.3 4.1 7.1 14.2 1.6 0.9 2.7 0.1 1.6 0.1 1.4 3.5 1.1 0.4 32.5 8.4 46.8 8.6 0.1 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 2.4 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 12.4 0.0 8.4 28.6 1.4 0.1 46.8 0.1 0.4 0.0 0.0 32.5 0.3 0.0 0.0 1.0 8.6 46.4 2.1 0.0 10.7 3.6 4.6 0.4 2.9 2.0 1.7 5.3 1.3 3.9 2.7 0.0 2.2 0.0 0.0 0.3 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 15.0 0.0 29.5 0.0 0.0 0.0 28.1 0.0 0.0 33.8 1.7 1.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 CD33 "FLJ00391, p67, SIGLEC-3, SIGLEC3" ENSG00000105383 "CD33 molecule" P20138 19 51225064-51243860 "CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.3;lymphoid tissue: 45.4" "Group enriched" "Detected in many" 7 "granulocytes: 73.9;Hofbauer cells: 67.4;Kupffer cells: 119.1;Macrophages: 56.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 37.6;intermediate monocyte: 27.3;myeloid DC: 49.3;non-classical monocyte: 12.6" "Group enriched" "Detected in many" 9 "dendritic cells: 49.3;monocytes: 37.6" "Cell line enhanced" "Detected in some" "HEL: 28.5;HL-60: 37.9;HMC-1: 28.4;NB-4: 18.1;RPMI-8226: 20.5;THP-1: 22.2;U-937: 28.0" "CAB011442, HPA035832, HPA064807" Approved Approved "Nucleoplasm,Plasma membrane" NA NA 1400000 "Nucleoplasm, Plasma membrane" "CAB011442: , HPA035832: AB_2674808, HPA064807: AB_2685356" "unprognostic (1.18e-2)" "unprognostic (1.45e-2)" "unprognostic (2.80e-2)" "unprognostic (7.14e-2)" "unprognostic (3.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.59e-1)" "unprognostic (5.90e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-1)" "unprognostic (2.53e-1)" "unprognostic (6.28e-2)" "unprognostic (6.88e-4)" "unprognostic (7.79e-2)" "unprognostic (3.35e-2)" "unprognostic (6.49e-2)" "unprognostic (1.67e-1)" 10.2 4.3 3.6 8.4 6.0 23.0 6.5 0.8 3.5 2.6 2.7 4.4 0.3 2.5 2.3 5.2 1.7 3.9 5.3 7.5 3.1 2.5 4.1 6.4 11.6 45.4 6.4 1.8 1.9 1.9 0.5 1.7 5.4 5.2 2.6 3.4 2.6 2.9 2.1 1.2 2.5 4.0 5.6 9.9 31.6 2.8 1.5 5.8 2.5 1.7 0.2 2.7 4.7 2.3 0.1 49.3 4.6 37.6 3.3 0.2 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 28.5 0.1 0.0 0.0 37.9 28.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 7.2 0.0 0.0 0.0 18.1 0.0 0.0 8.7 0.0 1.5 20.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.2 0.2 4.9 0.4 0.6 0.0 0.1 2.4 0.0 3.3 28.0 0.1 3.3 37.6 2.3 0.0 27.3 0.1 0.0 0.0 0.1 49.3 0.1 0.0 0.0 4.6 3.3 12.6 1.4 0.2 14.7 3.6 6.0 0.8 3.5 3.1 2.5 6.4 1.8 5.2 5.8 0.0 10.7 1.4 0.5 1.5 0.1 0.6 0.0 1.4 1.2 0.0 0.0 0.7 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.4 1.5 0.3 73.9 0.8 67.4 0.0 0.0 8.6 119.1 1.3 0.3 56.4 1.7 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.7 0.5 0.9 0.7 1.7 0.0 0.3 CD3D T3D ENSG00000167286 "CD3d molecule" P04234 11 118338954-118342744 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 108.7;lymphoid tissue: 181.4" "Cell type enriched" "Detected in many" 12 "T-cells: 532.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 53 "gdT-cell: 105.6;MAIT T-cell: 68.6;memory CD4 T-cell: 88.1;memory CD8 T-cell: 97.6;naive CD4 T-cell: 78.8;naive CD8 T-cell: 98.6;T-reg: 108.7" "Lineage enriched" "Detected in many" 63 "T-cells: 108.7" "Cell line enhanced" "Detected in some" "JURKAT: 69.9;MOLT-4: 149.5;NB-4: 27.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB013055, HPA071778" Enhanced Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB013055: , HPA071778: " "prognostic favorable (3.00e-4)" "prognostic favorable (8.46e-5)" "unprognostic (1.05e-2)" "prognostic favorable (1.73e-7)" "unprognostic (6.00e-2)" "prognostic favorable (1.70e-4)" "unprognostic (3.82e-1)" "unprognostic (2.40e-2)" "unprognostic (2.24e-3)" "unprognostic (1.01e-2)" "unprognostic (5.69e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (9.00e-2)" "unprognostic (2.02e-1)" "unprognostic (3.66e-2)" "prognostic favorable (6.16e-4)" 2.6 0.8 0.5 17.4 0.7 4.8 1.7 0.5 0.7 1.3 4.1 0.7 0.8 4.1 1.2 1.6 3.2 1.9 2.9 1.0 0.7 0.4 2.6 1.9 6.1 40.8 0.9 0.5 1.0 1.2 0.0 0.7 0.8 0.7 2.2 4.3 1.1 9.0 0.8 0.7 1.3 19.3 1.0 1.5 28.6 4.4 0.8 0.5 181.4 2.7 2.8 32.6 5.7 2.4 0.5 0.3 1.7 0.3 0.2 108.7 64.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.9 5.7 0.0 0.0 0.0 149.5 27.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.2 105.6 0.2 68.6 0.5 88.1 97.6 0.3 0.2 78.8 98.6 1.7 0.2 0.3 0.3 108.7 64.9 0.5 0.7 0.5 0.7 0.7 0.4 0.9 0.5 0.7 0.5 6.0 45.4 3.0 0.3 13.6 0.0 2.5 0.0 2.7 4.5 3.5 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 5.1 0.1 11.6 2.0 0.6 0.0 1.2 9.8 7.6 0.4 0.0 6.1 11.8 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 5.6 0.0 0.0 10.3 0.2 532.0 0.3 0.0 CD48 "BCM1, BLAST, hCD48, mCD48, SLAMF2" ENSG00000117091 "CD48 molecule" P09326 1 160678746-160711851 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.3;lymphoid tissue: 86.3" "Group enriched" "Detected in many" 5 "B-cells: 233.4;granulocytes: 88.9;Hofbauer cells: 87.6;Kupffer cells: 195.5;Macrophages: 131.8;T-cells: 297.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 38.9;HMC-1: 43.5;U-266/70: 92.1;U-266/84: 61.5" "CAB002497, HPA055146" Enhanced Supported "Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 2600000 "Plasma membrane" "Nucleoli fibrillar center, Cytosol" "CAB002497: AB_563586, HPA055146: AB_2682716" "prognostic favorable (3.91e-4)" "unprognostic (1.72e-3)" "prognostic favorable (4.17e-4)" "unprognostic (1.58e-3)" "unprognostic (2.36e-1)" "unprognostic (1.71e-3)" "unprognostic (2.09e-2)" "unprognostic (2.19e-2)" "unprognostic (1.92e-1)" "unprognostic (3.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.36e-4)" "unprognostic (3.21e-1)" "unprognostic (4.69e-2)" "unprognostic (9.38e-2)" "unprognostic (8.51e-2)" 5.5 1.4 1.0 44.6 0.9 23.1 2.8 0.6 0.7 3.2 5.0 0.5 1.1 3.2 1.9 2.5 7.3 2.1 4.8 1.8 1.0 1.0 3.6 3.1 15.4 86.3 1.6 0.3 2.3 1.5 0.0 1.3 2.2 0.8 2.8 5.7 2.4 13.9 1.5 1.3 1.2 21.2 1.7 3.8 66.6 5.0 1.3 0.2 50.8 2.9 3.6 58.0 8.6 2.6 34.6 53.6 35.8 74.1 24.9 57.9 81.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 4.6 43.5 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 14.2 0.0 0.0 13.5 6.7 0.0 0.0 0.0 0.8 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.1 61.5 15.8 0.0 11.7 0.0 28.2 52.2 35.8 42.4 74.1 57.9 34.6 48.3 48.8 53.6 27.9 49.7 52.5 13.4 24.9 73.5 9.4 36.4 81.3 1.0 0.9 0.6 0.7 1.0 1.0 1.6 0.3 0.8 0.2 0.0 14.8 233.4 0.5 4.8 0.0 0.8 5.1 4.0 2.3 3.5 0.0 0.7 1.7 0.1 0.0 0.7 0.0 23.3 0.2 0.7 3.1 0.2 88.9 1.8 87.6 0.0 1.2 8.6 195.5 0.4 1.7 131.8 37.1 8.2 0.0 0.0 0.1 0.0 0.4 1.5 0.0 0.0 0.7 0.4 0.1 2.6 0.3 297.5 0.0 0.3 CD59 "16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20" ENSG00000085063 "CD59 molecule (CD59 blood group)" P13987 11 33703010-33736491 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 285.5" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 1502.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 217.5;U-2197: 180.1" "CAB001448, HPA026494" Supported Uncertain "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 98000000 "Golgi apparatus, Vesicles" "CAB001448: AB_563604, HPA026494: AB_1846321" "unprognostic (2.07e-2)" "prognostic unfavorable (3.81e-5)" "unprognostic (7.40e-2)" "unprognostic (1.14e-2)" "unprognostic (2.11e-2)" "prognostic unfavorable (3.10e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (4.47e-2)" "unprognostic (2.98e-1)" "prognostic unfavorable (2.92e-5)" "unprognostic (1.66e-2)" "prognostic favorable (1.39e-10)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.31e-1)" "unprognostic (1.03e-2)" "unprognostic (3.09e-1)" 96.7 41.0 36.7 26.3 44.3 23.8 76.0 25.9 32.7 44.8 36.9 24.0 57.9 16.5 45.4 132.8 68.4 53.2 67.6 90.5 35.6 38.4 100.0 61.0 86.4 39.8 39.7 25.8 39.3 52.3 60.6 48.0 285.5 68.7 47.4 37.7 51.4 114.8 62.6 70.6 43.4 25.0 52.4 32.9 26.2 54.7 28.1 23.1 16.1 85.9 57.7 40.0 51.2 63.4 13.5 20.5 42.8 4.8 17.7 60.4 11.1 16.8 15.8 4.7 13.8 109.9 86.2 2.7 96.0 107.2 24.1 28.2 7.3 50.7 1.3 17.2 103.4 28.7 19.0 8.6 95.8 33.8 26.8 13.1 1.7 56.0 11.0 30.0 10.1 5.8 40.0 24.2 20.4 98.3 66.8 146.8 5.9 11.8 39.0 151.5 15.4 4.7 4.2 2.6 31.1 82.5 1.8 14.6 13.5 72.7 28.8 3.2 4.4 33.4 15.5 17.6 13.9 11.8 1.0 217.5 55.4 13.3 180.1 33.3 17.3 33.8 1.6 47.6 0.0 96.2 30.5 4.8 42.8 11.3 1.6 14.4 13.5 24.0 12.7 20.5 10.6 15.7 9.3 28.4 17.7 0.9 10.5 60.4 11.1 36.7 44.3 25.9 32.7 35.6 38.4 39.7 25.8 68.7 23.1 253.1 215.4 44.4 795.7 254.1 47.4 262.5 430.6 580.9 208.1 230.3 31.4 513.5 139.3 1251.4 102.0 802.4 90.2 140.2 547.4 330.2 284.0 787.9 136.2 175.7 400.2 44.5 160.2 566.0 129.7 49.4 219.8 141.1 1204.5 272.3 85.9 184.1 823.9 122.8 192.3 162.3 45.0 271.7 576.8 86.8 27.6 248.5 699.7 62.8 98.2 1502.4 CD70 "CD27L, CD27LG, TNFSF7" ENSG00000125726 "CD70 molecule" P32970 19 6583183-6604103 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Cytokine "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.3;lymphoid tissue: 12.7" "Cell type enriched" "Detected in some" 23 "monocytes: 417.4" "Cancer enhanced" "Detected in many" "renal cancer: 24.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 13.9;T-reg: 23.3" "Group enriched" "Detected in many" 38 "B-cells: 13.9;T-cells: 23.3" "Cell line enhanced" "Detected in many" "SiHa: 36.8;THP-1: 30.2;U-251 MG: 44.7;U-266/70: 79.5;U-266/84: 57.5" HPA046582 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA046582: " "unprognostic (8.71e-2)" "unprognostic (9.91e-2)" "unprognostic (1.61e-1)" "unprognostic (2.33e-4)" "unprognostic (1.73e-2)" "unprognostic (1.51e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (2.57e-2)" "unprognostic (1.40e-1)" "unprognostic (2.27e-1)" "unprognostic (2.08e-1)" 5.3 0.2 0.2 9.3 0.2 1.4 2.2 0.9 0.9 1.4 4.1 0.2 0.1 1.0 0.4 1.8 4.0 0.7 0.8 0.4 0.2 0.2 1.7 0.4 1.9 6.1 0.4 0.1 0.3 0.4 0.0 0.3 0.3 0.2 0.9 3.1 0.2 3.1 1.2 1.2 3.3 5.2 0.7 0.5 11.8 1.7 1.9 0.1 3.2 0.8 1.8 12.7 3.1 1.1 13.9 0.1 0.2 0.0 0.4 23.3 0.9 0.2 7.5 0.0 14.8 0.3 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 14.2 0.8 0.0 16.3 10.4 9.1 0.7 0.0 0.0 0.3 0.0 11.2 0.0 0.0 0.0 0.4 0.1 0.0 8.7 6.2 2.4 0.0 0.0 0.2 0.4 0.2 0.0 0.2 17.8 0.1 0.0 13.7 3.8 0.0 3.0 4.8 0.0 0.0 0.0 36.8 0.0 0.1 0.0 0.1 30.2 0.2 0.1 6.6 0.0 44.7 79.5 57.5 25.6 8.2 4.5 2.8 0.2 0.0 0.0 1.9 0.0 4.8 13.9 3.2 5.0 0.0 4.0 0.4 1.3 0.1 0.4 0.0 0.1 23.3 0.9 0.2 0.2 0.9 0.9 0.2 0.2 0.4 0.1 0.2 0.1 0.0 0.0 18.2 0.1 5.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.1 1.1 0.0 0.3 0.0 1.7 1.3 0.0 0.0 0.0 1.7 3.3 417.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.2 4.6 0.0 10.2 0.0 0.0 CD79B "B29, IGB" ENSG00000007312 "CD79b molecule" P40259 17 63928740-63932354 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 138.8;lymphoid tissue: 56.6" "Cell type enriched" "Detected in many" 8 "B-cells: 486.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 100.6;naive B-cell: 138.8" "Lineage enriched" "Detected in many" 6 "B-cells: 138.8" "Cell line enhanced" "Detected in some" "Daudi: 117.7;REH: 38.7;U-698: 161.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009178, CAB009751, HPA044107" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: " "unprognostic (3.90e-3)" "unprognostic (1.61e-3)" "unprognostic (5.21e-2)" "unprognostic (3.45e-3)" "unprognostic (4.22e-3)" "prognostic favorable (2.35e-4)" "unprognostic (1.82e-1)" "unprognostic (9.25e-3)" "unprognostic (3.89e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-1)" "unprognostic (2.87e-2)" "unprognostic (2.50e-3)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (4.28e-2)" "unprognostic (2.75e-1)" 1.7 0.7 0.4 50.6 0.4 11.1 1.2 0.3 0.4 0.6 1.7 0.3 0.3 0.7 0.6 0.5 2.6 0.6 1.4 3.4 0.4 0.2 2.3 1.7 1.3 56.6 0.4 0.3 0.6 1.6 0.0 9.0 0.5 0.3 1.0 1.3 0.8 8.9 0.9 1.2 0.9 22.4 0.5 0.4 56.0 1.8 0.6 0.3 3.7 1.4 1.7 46.6 4.5 0.9 138.8 4.2 0.5 25.0 3.4 9.2 9.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 38.7 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.8 0.1 0.0 0.4 0.0 0.0 5.9 5.7 161.1 0.0 0.2 0.0 0.5 1.1 0.0 4.2 16.5 4.8 100.6 5.4 2.8 4.2 138.8 3.7 2.2 0.5 3.4 25.0 0.6 9.2 9.0 0.4 0.4 0.3 0.4 0.4 0.2 0.4 0.3 0.3 0.3 0.0 2.2 486.9 0.3 3.9 0.0 0.8 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 7.1 0.0 23.3 0.0 0.4 4.3 0.3 15.0 0.5 4.7 0.0 1.2 62.0 14.1 1.1 1.1 3.5 20.3 1.0 0.0 0.0 0.0 0.0 1.8 0.8 0.0 0.0 3.3 0.7 0.1 2.8 0.3 34.6 0.0 0.1 CDC25B ENSG00000101224 "Cell division cycle 25B" P30305 20 3786772-3806121 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 4.5;NK-cells: 9.3;T-cells: 15.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038892, HPA038893, HPA075215" Enhanced Uncertain "Vesicles,Mitotic spindle" Yes Yes Vesicles "Mitotic spindle" "HPA038892: AB_2676258, HPA038893: AB_2676259, HPA075215: " "unprognostic (4.69e-2)" "unprognostic (5.74e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (4.76e-4)" "unprognostic (1.13e-1)" "unprognostic (4.23e-1)" "prognostic unfavorable (1.19e-4)" "unprognostic (1.31e-2)" "unprognostic (4.92e-2)" "unprognostic (2.74e-1)" "unprognostic (1.67e-1)" "unprognostic (6.03e-2)" "prognostic unfavorable (2.94e-13)" "unprognostic (1.15e-1)" "unprognostic (2.38e-1)" "unprognostic (3.94e-1)" "unprognostic (9.46e-2)" 12.1 8.7 15.1 27.7 23.3 26.0 28.8 49.6 21.1 13.0 14.7 12.8 4.6 14.9 17.0 10.3 11.7 13.0 18.6 7.5 15.7 12.5 13.3 11.0 33.0 42.8 21.9 12.5 17.3 5.7 7.5 21.0 30.3 13.8 11.0 12.0 7.7 7.4 10.2 6.2 19.8 16.8 14.8 14.7 24.5 14.1 6.3 22.3 33.3 18.7 20.8 31.6 15.3 16.3 4.5 1.3 1.5 1.8 9.3 15.5 5.9 29.0 62.7 8.4 13.9 10.3 10.1 4.2 14.4 21.6 24.1 18.0 10.9 42.1 20.3 6.2 14.7 59.6 42.5 11.3 23.9 11.4 7.8 12.2 10.9 20.1 13.1 41.2 8.4 5.6 9.9 19.2 22.3 26.4 8.2 13.3 10.2 7.0 53.5 14.2 23.3 26.3 12.3 6.2 19.9 26.8 13.8 23.8 14.5 16.4 2.7 6.0 13.1 34.1 32.6 16.7 7.5 11.0 4.4 11.0 12.9 15.7 23.4 19.0 13.1 20.6 8.2 6.6 8.3 12.4 1.5 1.4 0.0 13.6 1.8 12.7 3.5 13.6 13.7 1.3 4.5 11.4 13.2 0.1 9.3 0.9 0.7 15.5 5.9 15.1 23.3 49.6 21.1 15.7 12.5 21.9 12.5 13.8 22.3 8.9 23.7 9.0 5.5 10.0 13.9 6.8 7.6 0.0 3.4 7.0 2.0 5.3 0.0 7.8 0.5 24.0 3.8 23.3 4.2 14.2 13.6 4.7 1.1 11.6 24.4 3.2 7.5 12.9 11.6 1.0 6.6 10.6 16.9 5.4 7.9 8.3 10.4 2.9 8.5 9.4 2.4 0.0 11.3 1.0 11.5 9.8 3.0 25.4 3.5 3.4 CDC42EP1 "Borg5, CEP1, MSE55" ENSG00000128283 "CDC42 effector protein 1" Q00587 22 37560447-37569405 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 199.1;Exocrine glandular cells: 194.9;Pancreatic endocrine cells: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 9.4;intermediate monocyte: 2.9;myeloid DC: 3.5" "Group enriched" "Detected in many" 10 "dendritic cells: 3.5;monocytes: 9.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006379, HPA076536" Approved Supported "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA006379: AB_1078486, HPA076536: " "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (2.44e-1)" "unprognostic (3.79e-3)" "unprognostic (5.82e-2)" "unprognostic (4.06e-2)" "unprognostic (4.38e-2)" "unprognostic (5.57e-2)" "unprognostic (9.45e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.86e-2)" "unprognostic (2.85e-2)" "unprognostic (3.85e-2)" "unprognostic (3.81e-2)" "unprognostic (1.09e-3)" 19.1 26.2 12.1 10.6 29.4 1.9 21.9 2.9 27.3 17.2 13.0 68.7 7.2 19.7 21.0 6.2 25.0 20.4 31.9 12.2 18.3 10.1 14.6 57.4 18.6 6.9 41.4 13.1 31.7 80.8 7.4 5.7 24.9 28.7 11.5 9.9 12.0 36.5 16.9 7.2 22.4 13.8 13.2 34.5 9.7 69.5 8.8 34.2 0.4 9.7 14.2 14.2 10.3 19.2 0.6 3.5 0.4 9.4 0.6 0.3 3.5 30.5 8.9 3.9 17.3 6.2 10.6 18.8 17.6 10.4 20.3 14.1 21.8 4.0 0.0 6.2 20.3 6.5 23.9 4.5 8.8 6.8 3.8 15.3 0.1 8.6 13.1 44.4 0.0 0.1 19.7 13.4 16.7 16.0 16.4 15.1 0.0 19.1 0.1 8.3 10.5 0.0 0.1 3.4 23.9 20.1 0.1 7.0 0.6 7.1 0.4 0.1 0.7 12.9 28.7 27.5 5.6 12.8 2.7 23.0 42.7 25.5 20.5 24.3 0.0 0.1 0.0 16.9 0.1 34.4 0.4 9.4 0.0 0.2 2.9 0.2 0.0 0.1 0.1 3.5 0.6 0.1 0.3 0.3 0.6 0.2 0.4 0.0 3.5 12.1 29.4 2.9 27.3 18.3 10.1 41.4 13.1 28.7 34.2 6.0 24.5 3.4 55.6 41.7 0.0 1.6 91.7 1.4 12.5 12.2 0.0 83.5 1.7 199.1 3.2 31.5 19.5 0.0 194.9 83.2 32.7 99.5 2.3 31.4 11.9 1.6 11.1 61.4 2.9 1.2 36.5 3.9 20.3 10.0 60.1 9.5 199.6 49.1 33.2 4.4 0.0 38.8 53.1 2.4 0.2 45.5 93.8 2.6 57.5 135.8 CDC73 "C1orf28, FIHP, HRPT1, HRPT2, parafibromin" ENSG00000134371 "Cell division cycle 73" Q6P1J9 1 193121997-193253901 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002326, CAB016359, HPA069324" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016359: AB_628102, HPA002326: , HPA069324: " "unprognostic (4.41e-2)" "unprognostic (6.22e-2)" "unprognostic (1.90e-2)" "unprognostic (5.30e-2)" "unprognostic (2.88e-3)" "unprognostic (3.53e-2)" "unprognostic (2.48e-3)" "unprognostic (5.74e-2)" "unprognostic (1.25e-1)" "unprognostic (1.40e-1)" "unprognostic (7.23e-3)" "unprognostic (2.17e-1)" "unprognostic (5.44e-3)" "unprognostic (3.47e-1)" "unprognostic (2.49e-1)" "unprognostic (6.73e-3)" "unprognostic (2.98e-3)" 23.4 20.0 18.1 16.8 22.9 21.0 20.1 25.6 22.6 20.4 20.1 14.5 16.3 12.0 26.8 15.2 20.6 14.9 16.4 21.4 18.4 15.0 18.8 17.1 17.2 16.6 19.7 15.9 23.3 14.5 27.1 24.8 17.3 19.4 26.9 16.2 13.6 17.3 19.0 44.5 15.0 14.5 25.6 23.9 16.0 15.7 16.3 22.1 20.6 27.1 14.1 15.8 26.8 35.0 6.6 6.7 10.2 7.0 9.0 12.5 5.2 13.4 12.1 16.0 10.3 15.0 14.6 12.3 14.5 14.1 17.6 15.4 8.3 16.0 17.5 10.3 17.8 9.7 13.2 14.5 13.7 21.5 11.1 6.9 12.7 10.9 8.0 14.1 17.2 12.7 11.9 13.3 16.5 15.8 15.6 14.9 10.0 19.2 14.2 23.5 12.4 14.1 8.5 15.4 19.8 4.5 12.6 9.7 16.7 20.6 9.4 4.8 13.2 18.1 22.4 20.7 18.6 19.2 12.5 16.6 17.1 4.0 14.5 14.8 13.3 9.9 14.4 10.3 10.6 29.9 6.6 7.0 10.2 9.3 6.8 12.5 6.6 9.2 9.2 6.7 5.4 8.4 8.7 7.4 9.0 5.7 4.9 9.3 5.2 18.1 22.9 25.6 22.6 18.4 15.0 19.7 15.9 19.4 22.1 32.8 20.1 34.3 31.1 33.1 31.2 36.4 20.4 20.1 19.4 31.4 33.4 21.8 28.2 29.4 11.9 30.1 16.2 23.3 28.5 34.0 29.2 33.5 39.4 14.3 28.0 20.6 10.9 22.1 25.9 6.1 31.1 38.8 27.0 47.7 15.3 33.5 28.2 13.1 33.9 26.4 36.3 25.8 57.1 56.5 32.0 30.6 31.8 29.8 16.1 23.2 CDH12 "Br-cadherin, CDHB" ENSG00000154162 "Cadherin 12" P55289 5 21750673-22853622 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;cervix, uterine: 9.3;pituitary gland: 8.6" "Group enriched" "Detected in some" 12 "Bipolar cells: 17.4;Horizontal cells: 19.1;Rod photoreceptor cells: 55.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.5;PC-3: 5.3;SCLC-21H: 7.6;U-2 OS: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029325 Uncertain Uncertain Vesicles NA NA Vesicles "HPA029325: AB_2672998" "unprognostic (2.38e-1)" "unprognostic (3.21e-1)" "unprognostic (4.95e-2)" "unprognostic (8.61e-2)" "unprognostic (3.31e-2)" "unprognostic (3.91e-1)" "unprognostic (2.72e-1)" "unprognostic (3.26e-2)" "unprognostic (1.34e-1)" "unprognostic (3.51e-2)" "unprognostic (3.25e-4)" "unprognostic (7.35e-2)" "unprognostic (3.48e-2)" "unprognostic (5.19e-2)" 0.5 5.2 5.8 0.3 17.7 0.4 1.7 2.0 13.8 9.3 0.5 0.0 0.0 0.5 1.3 1.0 0.4 6.7 0.3 0.5 6.3 3.4 0.7 0.5 0.8 0.3 1.4 4.8 0.5 0.5 0.6 8.6 0.7 4.2 0.5 0.6 1.4 3.1 0.9 0.5 2.5 0.4 0.9 2.5 0.3 0.4 2.9 0.5 0.0 0.4 0.0 0.5 1.5 0.2 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.3 0.0 1.1 0.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 5.3 0.2 0.0 0.1 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.0 5.8 17.7 2.0 13.8 6.3 3.4 1.4 4.8 4.2 0.5 0.0 0.0 0.0 0.0 0.1 17.4 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 55.7 0.0 0.0 2.2 1.2 0.0 0.1 0.0 0.0 0.0 CDH17 "cadherin, HPT-1" ENSG00000079112 "Cadherin 17" Q12864 8 94127171-94217303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 184.4" "Group enriched" "Detected in some" 51 "Enterocytes: 404.8;Intestinal endocrine cells: 104.0;Mucus-secreting cells: 149.4;Paneth cells: 316.3;Undifferentiated cells: 191.5" "Group enriched" "Detected in many" 6 "colorectal cancer: 156.4;stomach cancer: 54.9" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 5 "neutrophil: 12.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.1" "Cell line enhanced" "Detected in some" "CACO-2: 21.9;OE19: 94.0;U-266/70: 36.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023614, HPA023616, CAB025143, HPA026556" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA 3400000 "Cell Junctions" Nucleoplasm "CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897" "unprognostic (2.08e-1)" "unprognostic (5.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (3.02e-1)" "unprognostic (3.06e-2)" "unprognostic (5.60e-2)" "unprognostic (3.38e-3)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (5.47e-2)" "unprognostic (3.74e-2)" "unprognostic (2.36e-1)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "unprognostic (7.33e-2)" "unprognostic (1.46e-2)" 0.3 0.2 0.2 17.6 0.3 0.3 0.3 0.2 0.2 0.3 88.9 0.2 0.2 54.5 0.4 0.3 0.4 0.4 7.0 0.6 0.2 0.3 0.3 0.3 0.3 0.5 0.2 0.2 0.3 0.4 0.0 0.3 0.2 0.2 0.4 44.0 0.2 0.3 0.2 0.3 0.2 184.4 1.4 0.2 0.6 0.3 0.3 0.2 0.3 0.2 0.2 0.5 0.4 0.3 1.5 0.8 12.1 1.0 1.4 0.6 0.1 0.0 4.0 0.2 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 21.9 1.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.3 0.1 0.3 0.1 94.0 0.1 0.2 0.0 0.7 0.1 0.0 0.4 0.2 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.3 0.1 36.3 0.0 0.1 0.1 0.1 0.2 2.5 1.0 1.2 0.5 0.8 0.3 0.6 0.5 0.4 0.8 1.5 0.5 0.6 12.1 1.4 0.5 0.7 0.5 0.1 0.2 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 404.8 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 104.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 149.4 0.0 0.0 316.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 191.5 0.0 CDH26 VR20 ENSG00000124215 "Cadherin 26" Q8IXH8 20 59958427-60034011 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.1;prostate: 15.3" "Cell type enhanced" "Detected in some" 19 "Ciliated cells: 45.5;Club cells: 18.2;Glandular cells: 12.1;Syncytiotrophoblasts: 12.5" "Group enriched" "Detected in some" 6 "cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;eosinophil: 1.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "RT4: 34.7" "Low region specificity" "Detected in single" "HPA015722, HPA047578" Uncertain Supported "Plasma membrane,Microtubules" NA NA "Plasma membrane" Microtubules "HPA015722: AB_2077659, HPA047578: AB_2680091" "unprognostic (2.42e-1)" "prognostic favorable (7.62e-4)" "unprognostic (4.71e-4)" "unprognostic (8.17e-2)" "unprognostic (9.40e-2)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "prognostic favorable (3.75e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (3.26e-4)" "unprognostic (8.24e-3)" "unprognostic (9.96e-7)" "unprognostic (1.85e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (1.04e-1)" 0.8 0.5 0.8 0.7 1.2 1.3 0.8 2.0 1.1 3.8 0.7 0.7 0.7 0.5 1.3 0.7 3.8 2.5 0.7 0.7 1.2 1.0 0.7 0.7 2.9 0.7 1.3 0.7 2.0 0.7 0.7 1.9 0.7 1.4 15.3 0.4 1.4 2.8 0.7 1.0 0.4 0.7 0.7 1.6 0.7 1.9 0.7 0.7 4.2 0.7 0.7 16.1 6.2 1.3 0.0 0.9 1.6 1.4 0.0 0.2 0.4 0.0 0.5 0.1 0.0 0.4 0.2 0.3 0.1 0.0 0.1 0.0 0.6 0.6 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 5.3 0.0 0.1 0.0 0.2 0.2 0.1 1.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.2 0.2 0.4 0.4 0.0 0.1 0.0 0.0 0.6 0.0 34.7 0.7 0.1 0.3 0.2 0.1 0.4 0.2 0.4 0.1 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.8 0.0 0.0 1.4 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.8 1.2 2.0 1.1 1.2 1.0 1.3 0.7 1.4 0.7 6.0 6.7 0.0 0.9 0.1 0.7 0.6 0.0 45.5 18.2 0.0 0.0 1.4 0.0 0.0 2.7 2.1 0.0 0.0 0.0 0.0 0.2 12.1 1.1 0.0 0.5 0.0 0.0 0.0 1.5 1.1 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.2 0.0 12.5 0.0 0.0 6.7 CDH9 ENSG00000113100 "Cadherin 9" Q9ULB4 5 26880600-27121150 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 46.8" "Cell type enhanced" "Detected in single" 37 "Proximal tubular cells: 3.3" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "amygdala: 46.8;basal ganglia: 24.6;cerebral cortex: 23.7;hippocampal formation: 15.9;olfactory region: 15.6" "Cell type enhanced" "Detected in some" "neutrophil: 8.3" "Group enriched" "Detected in many" 5 "B-cells: 4.1;granulocytes: 8.3" "Cell line enhanced" "Detected in some" "K-562: 9.4;NTERA-2: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007167 Approved Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA007167: AB_1078489" "unprognostic (1.49e-1)" "unprognostic (2.27e-4)" 0.7 0.5 46.8 1.0 24.6 2.8 0.7 0.5 23.7 0.5 0.8 0.0 0.0 0.6 0.9 1.2 0.7 0.5 0.7 0.5 15.9 3.5 10.5 0.5 0.6 1.6 1.2 15.6 0.6 1.1 1.0 0.5 0.8 1.5 1.0 1.2 0.0 0.5 0.1 0.5 1.9 1.5 0.8 0.6 0.8 0.9 3.7 2.6 0.0 1.9 0.0 1.7 0.5 0.5 4.1 0.9 8.3 1.1 0.1 0.8 1.1 2.5 0.9 0.5 0.8 0.4 0.0 1.6 0.0 0.9 0.3 0.7 0.0 0.9 1.3 0.3 0.3 0.2 0.3 0.1 0.6 0.0 0.1 0.3 0.5 0.7 2.5 0.0 0.0 1.6 0.6 0.7 0.0 0.0 0.0 0.2 0.8 9.4 2.3 0.0 1.5 0.8 0.5 13.9 0.2 0.5 0.3 0.3 0.4 0.5 0.5 3.1 0.3 0.0 0.4 0.5 2.7 0.5 0.9 1.7 0.1 0.8 0.8 0.3 2.8 1.0 4.4 1.0 1.0 0.8 1.3 0.2 0.4 0.2 0.7 0.6 4.1 0.4 0.2 0.1 2.5 0.3 0.5 8.3 0.1 1.1 0.9 0.8 1.1 46.8 24.6 0.5 23.7 15.9 3.5 1.2 15.6 1.5 2.6 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDK10 PISSLRE ENSG00000185324 "Cyclin dependent kinase 10" Q15131 16 89680737-89696364 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007451, HPA059634, HPA067060" Uncertain Supported "Nucleoplasm,Midbody,Midbody ring" Yes Yes Nucleoplasm "Midbody, Midbody ring" "HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (3.74e-3)" "unprognostic (9.87e-2)" "unprognostic (1.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.53e-1)" "unprognostic (9.06e-2)" "unprognostic (2.99e-1)" "unprognostic (2.13e-1)" "prognostic favorable (2.69e-4)" "unprognostic (2.58e-2)" "unprognostic (2.93e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (6.88e-2)" "prognostic favorable (3.63e-4)" 12.3 19.9 16.8 16.4 23.8 17.3 10.1 14.8 21.9 11.1 18.3 8.1 16.4 23.4 12.1 21.7 14.4 14.4 19.4 8.7 15.3 12.6 22.2 33.9 11.8 14.0 13.3 19.4 11.3 22.2 21.6 27.7 13.6 15.8 13.6 12.6 8.1 17.2 8.9 17.5 14.1 20.7 9.0 10.7 15.9 19.0 8.7 13.6 8.0 27.1 10.1 12.1 10.8 14.5 7.8 14.5 3.4 15.3 15.2 13.3 8.8 14.7 9.6 7.7 3.1 3.2 6.1 8.1 12.2 6.9 8.7 2.9 7.4 11.2 13.1 6.2 10.5 5.4 10.3 3.3 17.0 5.5 2.9 8.1 5.1 10.8 0.8 13.4 8.3 9.4 7.5 5.7 5.5 8.3 5.8 15.1 8.7 13.4 1.8 9.9 19.2 10.0 23.8 15.8 16.0 7.3 14.6 10.5 18.4 15.6 11.7 7.6 16.5 15.3 7.1 3.6 9.1 16.7 13.2 13.4 5.9 15.3 6.1 8.3 6.6 3.6 4.0 9.0 14.3 8.4 3.2 11.7 3.4 12.9 15.3 10.9 6.8 11.4 8.9 14.5 7.8 13.3 10.9 1.5 15.2 11.2 10.0 8.8 8.8 16.8 23.8 14.8 21.9 15.3 12.6 13.3 19.4 15.8 13.6 11.9 28.2 16.7 22.2 13.7 17.3 4.8 45.9 18.7 9.1 26.2 23.6 25.3 36.5 23.6 5.0 17.5 42.9 0.0 11.0 16.4 18.6 26.1 9.2 37.6 16.3 17.5 65.1 19.6 16.7 5.4 22.2 13.0 18.6 14.4 38.5 10.3 14.2 35.1 11.7 45.1 33.8 6.5 11.3 23.1 29.8 13.6 23.3 17.5 50.1 18.6 CDK13 "CDC2L, CDC2L5, CHED, KIAA1791" ENSG00000065883 "Cyclin dependent kinase 13" Q14004 7 39949646-40099580 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059241 Uncertain Supported "Nuclear speckles,Golgi apparatus,Cytosol" NA NA "Nuclear speckles" "Golgi apparatus, Cytosol" "HPA059241: AB_2683956" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (2.67e-1)" "unprognostic (2.72e-1)" "unprognostic (1.83e-1)" "unprognostic (1.02e-1)" "unprognostic (4.18e-3)" "unprognostic (3.42e-2)" "unprognostic (8.09e-2)" "unprognostic (1.13e-2)" "unprognostic (3.77e-2)" "unprognostic (8.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.21e-1)" "unprognostic (3.33e-2)" "unprognostic (3.53e-1)" "unprognostic (3.53e-2)" 16.9 15.3 16.0 29.0 14.5 26.7 20.4 23.3 18.2 16.6 18.3 16.4 14.2 11.3 20.3 17.7 20.9 18.1 20.2 13.6 14.3 11.3 14.7 17.5 19.6 21.9 16.5 15.1 24.2 15.3 26.3 15.3 14.8 12.0 15.5 15.5 14.9 17.6 14.5 19.4 16.7 16.3 16.4 11.5 17.4 14.5 20.2 15.7 31.2 23.1 14.6 21.5 18.5 23.6 14.0 3.9 7.9 3.4 5.0 5.0 1.4 15.7 9.4 16.4 15.6 14.8 14.5 11.3 12.6 13.7 11.6 14.6 9.8 10.9 28.6 7.4 13.2 20.4 19.2 13.4 11.1 17.1 14.0 9.9 12.7 11.5 8.8 14.2 19.3 13.9 8.5 14.9 13.2 17.7 13.3 13.6 13.3 21.4 19.8 12.0 8.1 15.3 13.7 23.7 11.1 11.0 17.0 10.9 11.5 10.9 16.0 11.7 17.0 16.0 34.7 11.4 22.2 14.2 24.1 16.1 16.0 15.3 10.3 17.1 16.4 13.8 23.6 11.7 17.5 20.4 7.9 2.7 4.4 5.0 2.2 3.4 7.6 4.8 3.7 1.5 14.0 4.9 4.9 7.6 5.0 3.4 3.9 4.3 1.4 16.0 14.5 23.3 18.2 14.3 11.3 16.5 15.1 12.0 15.7 41.7 63.7 28.9 17.1 19.1 42.3 25.6 30.6 34.8 47.8 29.6 66.8 11.5 6.6 19.1 10.7 22.5 15.9 0.0 13.4 7.5 19.4 16.3 16.2 20.7 11.6 35.0 18.0 20.3 23.2 7.0 24.2 18.3 13.5 15.4 17.7 26.6 24.2 10.5 16.6 11.1 68.4 6.5 15.6 31.4 31.5 22.8 10.2 22.5 18.8 21.7 CDK16 "FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1" ENSG00000102225 "Cyclin dependent kinase 16" Q00536 X 47217860-47229997 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 91.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000974, HPA001366, CAB016535" Approved Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Microtubules, Cytosol" "Plasma membrane" "CAB016535: AB_785112, HPA000974: AB_2666162, HPA001366: AB_1079584" "unprognostic (2.37e-3)" "unprognostic (6.93e-2)" "unprognostic (2.96e-2)" "unprognostic (1.16e-3)" "unprognostic (8.80e-2)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.02e-6)" "unprognostic (2.85e-1)" "unprognostic (5.59e-2)" "unprognostic (7.62e-3)" "unprognostic (1.20e-1)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (1.59e-2)" "unprognostic (1.83e-1)" "unprognostic (3.89e-3)" "unprognostic (2.55e-1)" 22.0 20.1 32.3 13.9 25.0 26.6 17.6 51.5 49.0 17.2 19.3 15.5 17.0 16.4 14.8 12.8 23.8 18.8 14.1 47.3 29.2 18.0 19.9 12.7 14.0 10.8 22.0 21.1 16.7 18.6 22.8 14.9 18.6 28.5 12.7 14.7 13.7 20.1 16.1 91.2 17.0 15.3 18.2 14.8 12.0 14.7 28.7 12.1 10.4 20.9 36.3 12.6 12.9 12.1 8.5 13.5 8.5 10.7 6.3 7.7 5.7 40.6 31.2 30.0 44.3 22.0 18.9 30.0 19.4 23.9 29.5 22.0 35.1 19.8 9.8 12.4 34.7 54.7 23.1 31.9 41.3 19.9 11.7 50.6 10.6 43.9 27.3 28.6 11.1 24.9 23.6 26.4 41.8 50.5 24.7 26.4 10.3 15.7 16.7 25.8 35.4 9.7 25.6 23.5 15.4 33.8 10.3 23.7 17.1 22.2 32.3 25.4 19.2 52.6 40.7 20.0 36.5 36.3 13.7 26.5 19.8 32.4 30.1 23.1 13.2 12.8 9.5 17.4 52.0 22.1 3.1 8.8 8.5 4.8 10.7 6.2 3.8 6.2 7.7 11.6 8.5 5.6 5.8 4.2 6.3 9.6 13.5 6.0 5.7 32.3 25.0 51.5 49.0 29.2 18.0 22.0 21.1 28.5 12.1 0.0 6.7 15.3 27.9 28.8 24.3 37.2 15.3 4.0 4.5 29.6 3.9 23.1 46.4 30.2 25.1 15.7 50.5 0.0 32.2 31.3 23.1 37.6 5.7 14.8 21.7 28.6 26.9 20.3 19.6 46.6 15.8 10.3 32.1 12.6 30.7 16.0 41.5 33.6 12.4 28.2 12.9 0.0 19.8 18.1 16.8 30.4 21.7 10.2 41.6 53.3 CDK5R1 "Nck5a, p35, p35nck5a" ENSG00000176749 "Cyclin dependent kinase 5 regulatory subunit 1" Q15078 17 32486619-32491256 "Predicted intracellular proteins" "Biological rhythms" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 58.8" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 43.2;Early spermatids: 15.1;Late spermatids: 13.7;Muller glia cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 32.2;SK-MEL-30: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000252 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA000252: AB_2665953" "unprognostic (1.08e-1)" "unprognostic (9.13e-2)" "unprognostic (1.79e-2)" "unprognostic (3.65e-1)" "unprognostic (1.97e-1)" "unprognostic (8.09e-2)" "unprognostic (2.74e-5)" "unprognostic (1.81e-2)" "unprognostic (3.32e-1)" "unprognostic (2.18e-1)" "unprognostic (5.90e-2)" "unprognostic (5.60e-1)" "unprognostic (6.98e-2)" "unprognostic (1.60e-1)" "unprognostic (7.92e-2)" "unprognostic (8.81e-2)" "unprognostic (1.03e-1)" 1.6 3.3 21.9 6.4 21.1 4.9 1.8 26.0 58.8 1.2 1.6 3.6 0.0 2.0 1.6 1.0 5.5 1.5 1.6 1.6 21.4 17.3 1.5 1.3 1.4 11.5 7.6 24.5 3.2 2.0 1.3 3.0 1.4 7.8 1.4 1.5 0.9 1.2 1.3 1.8 2.2 2.0 1.3 4.1 7.7 2.2 5.2 3.2 1.2 1.1 0.3 12.3 1.7 1.1 0.6 1.8 2.9 0.9 0.7 4.2 1.5 2.0 1.2 5.3 1.7 0.6 1.0 0.6 1.2 0.7 1.5 2.0 3.1 0.5 1.0 1.2 1.1 1.3 1.0 2.0 1.3 2.1 0.4 4.0 0.3 0.5 1.2 0.2 0.6 1.1 0.6 3.2 1.6 1.3 0.6 1.1 3.7 2.0 1.2 3.3 0.8 1.8 0.8 3.4 0.7 1.1 1.5 3.2 3.7 0.7 0.9 32.2 8.7 1.2 0.7 23.1 0.8 1.3 2.4 1.1 2.2 3.3 0.8 3.3 0.6 0.8 1.0 1.9 3.0 5.2 0.0 0.9 1.2 2.3 0.8 1.8 0.6 3.1 1.3 0.2 0.5 4.2 2.6 2.9 0.7 0.4 1.8 0.4 1.5 21.9 21.1 26.0 37.3 21.4 17.3 7.6 24.5 7.8 3.2 0.0 1.0 1.4 0.4 1.3 10.4 2.8 0.0 0.0 0.0 0.0 43.2 0.5 0.0 0.1 15.1 0.6 0.2 0.0 0.5 0.3 0.4 0.9 0.0 0.8 0.8 1.6 0.0 1.3 3.8 13.7 0.0 0.4 3.3 0.0 0.8 17.0 1.1 0.2 0.7 1.2 5.6 0.0 1.4 3.2 5.7 1.1 0.9 4.4 0.9 0.3 CDK7 "CAK, CAK1, CDKN7, MO15, STK1" ENSG00000134058 "Cyclin dependent kinase 7" P50613 5 69234795-69277430 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 97.9;Extravillous trophoblasts: 285.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004364, HPA007932, HPA008453" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Plasma membrane, Cytosol" "CAB004364: AB_627243, HPA007932: AB_1078492, HPA008453: " "unprognostic (3.12e-2)" "unprognostic (1.23e-1)" "unprognostic (4.87e-2)" "unprognostic (4.53e-2)" "unprognostic (3.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.49e-3)" "unprognostic (1.64e-2)" "unprognostic (7.77e-3)" "unprognostic (1.81e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (3.40e-2)" "prognostic unfavorable (9.42e-7)" "unprognostic (2.61e-1)" "unprognostic (2.38e-1)" "unprognostic (3.86e-2)" "unprognostic (1.55e-2)" 7.9 12.9 10.9 6.2 15.2 44.1 14.0 10.8 14.7 9.4 12.7 6.0 6.3 15.8 9.4 8.6 23.4 18.5 16.5 8.1 11.5 9.3 13.8 10.6 10.1 8.8 7.6 9.7 7.7 9.1 3.3 16.2 22.9 11.2 11.2 14.8 6.6 13.2 6.5 15.9 15.4 9.8 12.1 9.2 7.9 13.9 29.0 7.8 12.1 20.0 15.6 15.5 10.7 11.7 15.6 15.0 22.4 11.3 12.4 15.3 7.8 3.6 7.7 1.8 0.5 2.4 11.6 14.7 6.4 7.7 10.7 17.4 16.6 1.9 2.8 10.1 1.7 12.4 2.5 1.4 2.8 5.8 1.3 7.0 0.4 8.1 7.9 0.4 6.7 3.2 14.3 13.8 9.0 2.8 9.4 13.5 15.6 10.3 4.5 4.9 0.7 4.0 14.7 1.7 3.7 7.4 6.6 0.4 1.1 1.6 1.0 0.6 6.5 1.5 5.8 3.4 6.4 11.6 0.6 2.6 0.0 3.2 0.9 5.1 4.8 8.4 3.7 0.8 4.0 0.8 7.3 10.9 22.4 8.6 11.3 14.8 12.4 12.9 15.3 15.0 15.6 11.1 13.2 10.0 12.4 8.0 11.2 12.8 7.8 10.9 15.2 10.8 12.7 11.5 9.3 7.6 9.7 11.2 7.8 14.9 10.4 2.4 16.5 51.3 6.3 8.9 5.1 48.2 10.3 5.2 11.8 97.9 13.3 21.5 6.2 11.3 9.2 0.0 19.0 285.4 10.2 19.9 15.1 6.6 21.2 1.6 2.9 6.7 8.2 3.6 6.9 10.2 6.8 9.0 11.4 9.0 22.5 14.0 6.7 20.7 8.2 25.8 12.2 25.4 15.8 36.6 54.0 9.6 11.8 28.6 CDK9 "C-2k, CDC2L4, PITALRE, TAK" ENSG00000136807 "Cyclin dependent kinase 9" P50750 9 127785679-127790787 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004216, HPA006738" Supported Approved "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "CAB004216: AB_627245, HPA006738: AB_1078493" "unprognostic (3.60e-1)" "unprognostic (1.71e-1)" "unprognostic (5.44e-3)" "unprognostic (1.04e-3)" "unprognostic (1.93e-1)" "unprognostic (3.97e-2)" "unprognostic (2.07e-1)" "unprognostic (5.84e-2)" "unprognostic (2.66e-1)" "unprognostic (8.36e-2)" "unprognostic (1.24e-3)" "unprognostic (3.11e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (1.37e-1)" "unprognostic (1.00e-1)" "unprognostic (3.52e-2)" "unprognostic (8.78e-3)" 26.2 27.0 22.8 18.9 22.4 33.9 17.4 31.0 26.8 23.1 21.9 22.9 24.7 16.6 22.5 20.1 22.7 29.1 21.5 22.9 26.3 23.4 18.5 48.7 23.3 26.6 23.4 18.8 43.7 29.1 15.5 28.4 19.8 20.6 20.7 10.8 18.7 20.6 21.6 14.6 26.6 21.4 21.0 17.9 29.0 17.7 22.3 16.1 29.3 25.8 18.3 24.2 17.0 17.6 6.0 8.9 5.1 6.4 18.6 9.9 2.9 9.0 16.4 10.3 11.3 11.7 9.2 13.5 9.3 13.7 9.7 8.8 12.2 10.2 15.9 10.9 10.5 13.4 18.3 6.8 15.2 3.7 14.2 8.1 14.8 17.8 10.0 17.1 14.3 23.8 16.1 18.6 10.3 11.6 12.6 20.0 14.2 12.8 21.3 8.7 23.8 15.6 21.6 22.8 13.7 17.6 45.2 8.8 22.7 14.1 10.1 10.2 12.2 14.0 14.8 8.3 8.4 18.6 13.6 22.9 11.7 13.2 10.0 9.0 38.9 29.9 14.2 10.9 9.8 10.6 3.7 3.4 4.9 9.9 4.5 9.9 3.5 5.6 7.9 4.4 6.0 6.3 7.7 5.1 18.6 6.4 8.9 3.8 2.9 22.8 22.4 31.0 26.8 26.3 23.4 23.4 18.8 20.6 16.1 11.9 14.3 20.4 20.9 21.4 13.1 12.9 15.3 18.7 7.9 10.4 2.0 18.7 13.3 26.6 3.2 26.7 12.9 0.0 32.7 18.8 16.4 18.5 24.3 23.6 20.6 23.8 18.5 31.9 17.0 4.3 18.1 18.9 15.1 64.9 11.8 16.2 30.5 11.8 29.4 12.7 7.5 0.0 22.7 7.5 24.0 19.3 42.9 23.5 13.1 23.1 CDKL3 NKIAMRE ENSG00000006837 "Cyclin dependent kinase like 3" Q8IVW4 5 134286350-134371047 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.4" "Group enriched" "Detected in many" 8 "Early spermatids: 261.7;Late spermatids: 219.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA027751 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA027751: AB_10601256" "unprognostic (4.70e-2)" "unprognostic (2.15e-2)" "unprognostic (2.35e-1)" "unprognostic (1.48e-1)" "unprognostic (1.43e-1)" "unprognostic (3.98e-2)" "unprognostic (3.43e-3)" "unprognostic (5.93e-2)" "unprognostic (2.12e-3)" "unprognostic (1.49e-1)" "unprognostic (8.47e-4)" "unprognostic (2.82e-1)" "unprognostic (9.85e-4)" "unprognostic (8.33e-2)" "unprognostic (4.88e-2)" "unprognostic (7.10e-3)" "unprognostic (3.43e-3)" 2.5 2.7 7.0 2.2 7.1 1.6 2.5 7.0 8.5 2.6 2.4 5.9 5.5 2.3 3.9 5.3 2.6 3.7 2.6 6.6 6.1 6.5 4.5 2.8 2.2 2.5 8.0 4.3 3.0 2.4 3.2 6.5 2.2 8.6 2.8 2.6 3.9 2.0 3.2 7.5 2.7 2.5 4.6 8.4 2.7 2.2 33.4 9.3 1.3 3.9 2.1 3.0 2.8 2.2 1.5 2.7 1.0 1.1 1.4 4.0 1.3 1.0 2.1 3.1 2.2 5.4 4.6 1.3 2.9 2.6 1.3 3.2 1.9 1.5 2.7 1.8 1.8 6.0 0.9 2.6 1.8 2.6 2.9 2.0 1.4 2.3 3.3 3.3 0.6 0.9 2.2 4.7 3.9 1.2 2.2 1.3 6.5 1.5 1.2 3.5 1.1 2.1 8.0 2.1 0.6 1.0 3.4 1.3 0.8 1.7 0.9 4.8 1.4 2.1 0.5 3.5 3.7 1.8 1.6 0.9 2.6 0.6 3.5 1.0 3.3 4.4 5.2 4.0 2.1 2.0 0.0 0.9 1.0 0.9 1.1 4.0 1.5 1.4 2.5 2.7 1.0 3.8 3.8 0.2 1.4 0.4 1.6 2.3 1.3 7.0 7.1 7.0 8.5 6.1 6.5 8.0 4.3 8.6 9.3 0.0 3.0 0.0 5.7 9.6 12.7 1.6 0.0 5.3 3.4 5.2 3.9 2.4 8.3 2.6 261.7 3.6 0.5 0.0 4.4 1.6 6.9 4.0 3.5 1.8 3.1 6.4 2.9 3.1 0.6 219.5 4.6 4.0 10.1 2.8 0.7 10.0 1.5 0.9 8.5 6.1 9.6 0.0 5.6 30.5 13.2 9.7 3.8 3.2 1.1 3.3 CENPJ "BM032, CPAP, LAP, LIP1, MCPH6, Sas-4, SASS4, SCKL4" ENSG00000151849 "Centromere protein J" Q9HC77 13 24882284-24922889 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Dwarfism, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 115.8;Spermatocytes: 61.7;Spermatogonia: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060426 Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA "Nucleoplasm, Plasma membrane, Centrosome" "HPA060426: AB_2684278" "unprognostic (2.69e-1)" "unprognostic (3.17e-1)" "unprognostic (2.68e-1)" "unprognostic (1.01e-2)" "unprognostic (9.39e-2)" "unprognostic (1.17e-2)" "unprognostic (2.15e-5)" "unprognostic (7.41e-2)" "unprognostic (1.50e-2)" "unprognostic (9.83e-2)" "unprognostic (2.44e-1)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (7.36e-2)" "unprognostic (5.51e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-1)" 5.0 3.5 6.6 6.7 11.9 10.2 6.2 18.4 6.4 10.3 7.6 5.0 7.2 7.5 8.8 4.8 6.6 6.0 3.3 4.2 5.4 4.4 3.9 2.9 4.9 8.5 9.7 3.8 8.1 3.2 2.1 4.6 7.6 7.2 6.3 8.8 2.4 4.6 12.0 3.6 7.6 9.0 9.1 11.6 7.4 4.6 24.3 10.1 14.6 20.8 5.7 7.8 7.9 7.8 4.3 2.4 3.8 1.3 2.2 2.1 0.7 5.3 5.2 17.7 16.5 2.5 3.6 10.0 12.5 5.7 7.8 7.3 6.7 9.5 9.7 3.7 4.5 5.6 13.0 13.3 7.0 12.0 8.9 6.6 35.2 12.3 5.6 1.2 16.1 11.6 2.2 2.0 6.8 3.8 3.6 5.9 9.3 9.9 18.1 8.1 5.1 11.0 22.0 10.0 14.2 4.0 12.3 12.3 5.0 3.1 6.0 9.0 8.4 6.3 6.8 5.1 16.3 3.4 11.0 5.5 9.2 6.3 12.7 8.2 5.0 9.1 10.5 4.3 11.8 14.2 1.9 0.8 3.8 2.1 1.3 0.9 4.3 1.4 1.6 0.9 4.1 1.8 0.9 0.4 2.2 0.9 2.4 1.5 0.7 6.6 11.9 18.4 6.4 5.4 4.4 9.7 3.8 7.2 10.1 3.0 8.0 3.0 3.6 1.8 7.2 5.3 0.0 9.4 14.8 3.5 3.9 5.6 0.0 1.5 115.8 5.3 5.2 0.0 2.6 11.2 2.7 2.0 4.7 1.5 3.7 3.2 0.0 1.3 2.4 17.0 6.1 4.6 0.0 9.0 2.5 2.6 1.7 6.2 5.3 0.8 2.0 6.5 7.2 61.7 32.4 1.1 2.4 6.9 3.3 1.4 CEP126 KIAA1377 ENSG00000110318 "Centrosomal protein 126" Q9P2H0 11 101915015-102001058 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 47.3" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 254.3;Horizontal cells: 96.9;Spermatocytes: 115.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 10.0;EFO-21: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038381, HPA038399" Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA038381: AB_10669780, HPA038399: AB_10670157" "unprognostic (7.61e-2)" "unprognostic (6.75e-2)" "unprognostic (9.07e-2)" "unprognostic (1.02e-2)" "unprognostic (9.31e-2)" "unprognostic (8.87e-2)" "unprognostic (1.55e-4)" "unprognostic (1.52e-2)" "unprognostic (5.77e-2)" "unprognostic (9.55e-2)" "unprognostic (7.72e-3)" "unprognostic (8.87e-2)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.30e-2)" "unprognostic (3.41e-1)" "unprognostic (9.61e-2)" "unprognostic (6.99e-3)" 7.6 11.1 9.0 2.4 20.2 2.4 8.3 16.8 14.8 7.9 4.2 5.0 4.2 2.0 9.1 6.7 5.3 17.5 4.9 4.5 9.6 8.3 3.8 1.4 6.1 3.3 7.5 10.2 11.4 5.0 6.4 47.3 2.6 12.4 6.6 4.8 3.2 3.2 7.6 2.3 8.5 2.7 7.3 9.2 3.1 4.0 19.2 8.9 0.5 7.4 1.5 2.5 3.9 9.7 2.5 4.8 1.4 0.5 3.3 2.0 0.5 0.9 2.2 1.1 1.3 10.0 5.5 0.5 2.1 1.8 1.0 0.9 0.6 3.0 1.3 9.5 1.9 4.4 0.9 1.3 2.4 0.9 3.1 1.5 0.3 3.7 1.2 1.1 0.2 0.3 1.9 4.7 1.3 2.8 5.1 3.0 1.3 0.3 0.4 2.5 1.1 1.1 0.3 0.8 1.1 1.7 0.2 1.1 0.2 2.0 1.2 2.7 4.2 1.3 1.9 0.3 2.0 3.7 0.4 1.7 3.3 1.9 1.0 2.2 2.2 1.2 0.2 3.2 0.3 1.3 0.7 0.5 1.0 2.0 0.1 0.9 1.8 1.2 1.6 0.4 2.5 1.7 1.7 1.4 3.3 0.2 4.8 0.3 0.5 9.0 20.2 16.8 14.8 9.6 8.3 7.5 10.2 12.4 8.9 8.9 7.0 0.5 4.6 0.0 17.6 7.5 5.1 254.3 43.3 17.4 43.2 1.2 3.3 2.0 13.5 3.0 0.0 0.0 0.3 0.7 3.5 2.8 0.0 0.0 0.3 96.9 64.4 3.1 0.0 6.9 49.8 1.4 0.0 0.0 10.3 26.8 1.0 0.0 48.1 4.4 47.8 6.5 1.6 115.1 25.4 0.0 0.1 7.0 1.3 2.0 CEP135 "CEP4, FLJ13621, KIAA0635" ENSG00000174799 "Centrosomal protein 135" Q66GS9 4 55948871-56033363 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 27.1" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 56.2;monocytes: 85.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073950 Uncertain "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA073950: " "unprognostic (2.75e-1)" "unprognostic (2.71e-2)" "unprognostic (2.48e-2)" "unprognostic (1.06e-2)" "unprognostic (3.63e-1)" "unprognostic (3.42e-2)" "unprognostic (4.65e-3)" "unprognostic (4.78e-3)" "unprognostic (1.83e-3)" "unprognostic (9.89e-3)" "unprognostic (9.50e-2)" "unprognostic (2.27e-1)" "unprognostic (6.02e-9)" "unprognostic (7.55e-2)" "unprognostic (5.54e-2)" "unprognostic (1.95e-1)" "prognostic favorable (6.11e-5)" 5.5 3.0 2.9 13.8 6.0 12.8 5.2 5.1 5.3 8.5 4.6 3.1 7.5 4.3 12.8 4.5 4.7 7.4 4.5 3.4 5.3 3.4 5.7 2.9 7.0 13.0 5.8 3.9 9.6 4.5 4.1 6.9 8.1 4.5 4.4 4.6 2.5 3.7 5.9 2.3 5.4 6.2 7.1 5.5 11.1 3.6 9.3 4.6 27.1 5.0 4.5 10.1 4.8 5.6 9.2 8.7 11.9 4.4 7.1 7.5 2.0 6.9 3.8 10.7 10.0 2.2 4.3 4.6 6.9 4.9 6.4 7.5 4.3 7.3 18.9 5.3 3.1 5.1 3.3 11.1 4.3 12.1 5.1 7.1 6.6 5.7 3.8 2.4 11.9 10.4 3.3 3.4 8.0 5.8 2.9 5.3 9.7 12.1 9.1 6.5 4.2 16.6 7.4 6.7 3.5 4.2 12.1 5.1 3.9 4.6 5.2 7.7 8.1 6.2 4.2 5.1 6.7 5.7 7.7 5.2 8.7 14.2 10.3 12.1 5.0 3.5 12.9 4.4 9.4 10.6 11.9 3.4 4.2 4.7 4.1 4.3 4.6 6.0 4.5 2.1 9.2 7.5 4.8 7.0 7.1 4.4 8.7 3.7 2.0 2.9 6.0 5.1 5.3 5.3 3.4 5.8 3.9 4.5 4.6 6.0 14.3 15.9 7.2 8.0 12.6 7.3 2.5 22.7 14.8 7.0 9.8 15.3 3.3 7.8 56.2 15.3 3.9 23.3 4.7 11.7 5.9 4.3 13.9 1.8 9.0 25.4 5.2 12.3 9.2 11.4 5.5 17.8 5.0 85.6 4.3 4.7 11.0 5.7 7.8 9.0 21.0 6.5 6.6 53.2 43.8 5.8 8.0 16.0 5.2 5.5 CEP83 "CCDC41, NPHP18, NY-REN-58" ENSG00000173588 "Centrosomal protein 83" 12 94306449-94459988 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 88.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038161 Approved Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA038161: AB_10674547" "unprognostic (4.98e-2)" "unprognostic (1.64e-2)" "unprognostic (7.22e-2)" "unprognostic (1.75e-2)" "unprognostic (4.76e-3)" "unprognostic (3.59e-2)" "unprognostic (5.44e-3)" "unprognostic (1.70e-1)" "unprognostic (2.24e-2)" "unprognostic (1.92e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (4.98e-4)" "prognostic unfavorable (5.00e-10)" "unprognostic (1.29e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "unprognostic (1.95e-2)" 6.8 9.8 10.1 11.3 10.5 8.4 9.7 11.8 10.1 8.7 7.4 7.6 7.0 5.5 12.3 12.7 6.7 16.2 6.1 19.0 9.0 6.6 8.2 6.3 7.1 7.7 6.2 7.7 11.0 12.2 9.3 12.1 6.3 8.9 6.8 10.3 7.8 10.0 8.5 7.3 6.3 5.4 11.0 6.3 6.9 6.3 22.3 7.3 10.6 9.7 9.4 8.0 6.7 9.2 7.6 8.5 1.9 3.5 5.7 6.6 2.0 5.7 6.4 10.9 10.3 4.8 6.5 9.4 10.1 3.3 7.3 7.6 7.9 4.8 15.0 2.2 3.0 4.7 8.1 13.1 7.7 11.4 8.6 9.5 8.8 6.7 8.0 4.8 14.4 6.1 4.2 6.5 6.1 18.8 4.4 6.9 12.2 11.3 6.1 7.6 5.7 9.8 24.0 12.5 9.8 11.9 13.5 10.3 15.0 6.7 7.2 11.4 4.7 8.5 10.1 6.9 10.2 6.8 9.1 4.0 8.7 5.4 4.3 7.9 8.1 9.0 13.6 3.6 15.3 8.2 0.6 3.5 1.9 5.8 3.5 5.2 6.6 5.8 4.4 7.7 7.6 6.1 5.4 1.4 5.7 1.5 8.5 6.6 2.0 10.1 10.5 11.8 10.1 9.0 6.6 6.2 7.7 8.9 7.3 14.9 12.5 10.7 13.1 0.0 11.9 22.3 0.0 88.3 21.6 3.5 13.7 5.5 1.7 4.2 27.1 6.5 3.8 0.0 2.9 8.9 4.9 7.3 25.5 4.9 5.0 4.8 14.3 1.8 4.0 10.1 10.0 5.1 0.0 19.8 8.2 4.3 2.8 3.5 6.0 3.7 10.0 0.0 6.4 39.4 22.0 0.0 2.7 5.1 10.3 10.2 CEP85 "CCDC21, DKFZP434L0117" ENSG00000130695 "Centrosomal protein 85" Q6P2H3 1 26234153-26279038 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 87.8" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 26.8;Spermatocytes: 43.5;Spermatogonia: 37.7;Syncytiotrophoblasts: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 15.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028252 Approved Approved "Nucleoli,Golgi apparatus,Centrosome,Cytosol" NA NA "Nucleoli, Golgi apparatus" "Centrosome, Cytosol" "HPA028252: AB_1846142" "unprognostic (1.08e-1)" "unprognostic (2.59e-2)" "unprognostic (1.74e-2)" "unprognostic (4.16e-2)" "unprognostic (2.66e-1)" "unprognostic (5.30e-3)" "prognostic unfavorable (4.39e-6)" "unprognostic (3.72e-2)" "unprognostic (5.30e-2)" "unprognostic (8.24e-2)" "unprognostic (9.18e-2)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (7.33e-3)" "unprognostic (5.41e-2)" "unprognostic (1.02e-2)" "unprognostic (2.60e-2)" 2.1 2.7 4.8 3.8 11.0 12.4 3.1 7.7 8.8 2.4 3.7 15.5 4.6 3.5 2.6 3.3 5.6 2.7 2.6 19.4 5.5 4.0 3.8 3.7 3.2 5.3 20.4 4.9 2.4 3.3 4.4 4.7 3.6 7.8 3.0 4.5 4.0 3.5 2.5 87.8 8.4 3.3 2.9 10.4 4.3 3.7 26.8 13.5 12.1 5.4 5.5 6.6 3.0 3.8 2.4 3.8 15.6 5.0 2.1 3.4 2.8 13.5 6.7 10.8 11.5 3.0 2.8 21.3 6.9 3.2 9.5 10.2 8.6 12.7 12.9 9.4 2.8 5.2 12.0 12.1 5.7 9.6 9.4 10.5 18.2 13.2 9.1 3.1 16.6 20.2 1.4 5.7 8.0 5.8 4.5 4.2 17.5 24.5 18.0 7.0 4.9 15.9 20.2 10.5 6.7 11.2 16.3 12.6 12.0 4.8 2.1 18.4 8.5 9.7 8.1 8.0 6.2 7.4 11.9 4.9 7.8 13.0 9.1 10.6 14.2 20.7 16.1 4.8 29.3 14.7 3.4 4.6 15.6 3.0 4.4 2.5 2.4 2.0 2.3 3.8 1.3 1.8 3.4 0.5 2.1 5.0 1.3 3.2 2.8 4.8 11.0 7.7 8.8 5.5 4.0 20.4 4.9 7.8 13.5 0.0 2.1 0.0 4.2 6.2 9.6 26.8 2.5 1.4 4.5 5.2 11.8 2.0 6.6 1.7 0.8 1.8 3.9 0.0 1.1 3.6 2.1 2.2 2.3 2.5 4.3 0.0 1.7 1.8 5.2 2.3 1.4 4.0 1.7 4.6 3.1 1.3 2.1 3.4 0.4 0.8 10.1 0.0 1.0 43.5 37.7 5.4 34.9 3.5 4.7 3.2 CEP89 "CCDC123, FLJ14640" ENSG00000121289 "Centrosomal protein 89" Q96ST8 19 32875925-32971991 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039382, HPA040056" Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "HPA039382: AB_2676479, HPA040056: AB_10671048" "unprognostic (4.23e-2)" "unprognostic (7.50e-3)" "unprognostic (1.97e-1)" "unprognostic (1.53e-3)" "unprognostic (1.30e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.78e-5)" "unprognostic (1.12e-1)" "unprognostic (4.55e-2)" "unprognostic (3.04e-2)" "unprognostic (1.80e-2)" "unprognostic (4.00e-2)" "unprognostic (1.74e-1)" "unprognostic (4.48e-2)" "unprognostic (6.53e-2)" "unprognostic (3.03e-1)" "unprognostic (2.47e-2)" 10.1 9.5 8.5 8.3 12.1 6.8 11.6 16.4 14.4 12.9 10.5 12.5 9.7 6.4 17.0 11.3 10.1 14.8 8.3 8.8 8.1 6.4 9.8 5.6 9.4 8.9 7.9 8.4 17.1 9.0 11.3 20.2 8.8 9.1 15.0 7.4 10.2 10.3 10.2 10.5 10.7 7.4 11.4 6.6 7.7 8.1 8.4 8.4 10.1 11.8 5.0 7.6 10.2 11.4 7.7 5.1 12.7 6.1 2.8 6.9 2.1 13.4 18.5 12.9 11.0 7.0 8.2 7.4 10.9 7.3 19.3 14.8 6.6 8.4 5.6 5.9 11.1 10.9 7.8 12.6 8.8 13.4 14.5 7.7 4.3 12.9 6.4 5.6 5.9 4.3 9.8 12.2 18.2 11.9 7.9 14.4 7.7 6.5 8.2 8.9 10.2 6.7 4.6 5.5 7.5 6.0 7.5 7.0 4.8 8.8 7.6 18.2 13.4 11.1 7.7 6.3 8.2 5.9 4.9 9.2 14.0 12.4 11.9 11.0 4.1 6.3 5.0 12.0 5.6 10.5 12.7 4.4 2.1 4.0 6.1 6.9 4.7 4.2 3.4 2.4 7.7 4.1 4.7 5.3 2.8 3.0 5.1 4.4 2.1 8.5 12.1 16.4 14.4 8.1 6.4 7.9 8.4 9.1 8.4 26.8 13.6 12.6 9.2 4.5 15.3 15.3 12.7 62.9 25.0 19.2 17.7 8.4 10.0 16.5 11.6 11.7 6.4 23.3 14.2 9.1 9.9 6.2 16.2 5.3 10.2 19.1 9.4 14.1 5.7 5.9 15.0 9.9 5.0 12.6 9.6 10.1 12.8 2.9 12.0 12.2 38.5 0.0 11.3 21.5 13.2 4.0 3.5 7.1 7.7 4.3 CERS6 LASS6 ENSG00000172292 "Ceramide synthase 6" Q6ZMG9 2 168455862-168775137 "Predicted membrane proteins" "Inflammatory response, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 9.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044683, HPA063527" Approved Uncertain Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA044683: AB_10965059, HPA063527: AB_2685030" "unprognostic (2.17e-2)" "unprognostic (1.87e-1)" "unprognostic (3.92e-3)" "prognostic unfavorable (7.31e-4)" "unprognostic (3.24e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (1.28e-1)" "unprognostic (1.11e-2)" "unprognostic (9.80e-2)" "unprognostic (1.64e-2)" "unprognostic (2.93e-2)" "unprognostic (2.38e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-2)" "unprognostic (2.41e-1)" "unprognostic (4.80e-2)" 12.3 13.5 17.7 12.2 17.5 9.6 14.2 28.0 23.2 12.3 24.4 6.5 19.8 22.4 17.4 17.0 12.7 9.8 9.7 26.9 14.5 15.9 12.1 11.7 9.4 12.5 11.0 15.9 15.6 7.3 15.8 14.6 8.3 9.2 12.2 27.1 13.4 6.9 17.1 9.4 20.0 28.3 11.0 8.5 6.9 21.0 11.0 8.1 25.1 24.1 7.4 7.5 11.8 30.5 0.8 9.0 0.7 1.7 1.1 1.7 0.5 5.9 5.3 9.5 10.9 23.6 17.6 0.0 6.0 6.1 6.4 8.7 8.4 13.2 0.0 8.7 5.4 9.1 11.3 12.2 13.9 10.8 0.0 8.4 10.9 5.7 6.0 20.7 22.9 5.3 19.5 40.1 13.5 10.6 6.4 3.2 16.3 5.8 0.0 13.3 6.5 20.1 6.4 8.8 12.8 7.8 15.6 18.0 10.3 6.1 17.9 13.2 15.9 5.8 15.0 3.1 8.2 13.3 13.1 1.8 16.5 6.9 4.5 10.3 0.1 0.0 0.0 10.8 12.2 11.0 0.7 1.7 0.0 0.3 1.2 0.6 0.2 0.6 0.3 1.3 0.8 1.7 1.3 0.2 1.1 1.0 9.0 0.0 0.5 17.7 17.5 28.0 23.2 14.5 15.9 11.0 15.9 9.2 8.1 6.0 10.1 10.9 40.4 96.7 20.6 40.6 30.6 25.4 18.2 10.4 0.0 0.5 0.0 12.6 4.2 12.7 42.8 0.0 20.1 0.8 10.8 29.9 10.3 41.4 21.3 35.0 99.7 14.7 43.8 2.7 18.4 31.6 10.1 96.4 94.8 31.2 14.0 35.1 37.4 8.4 2.3 64.7 18.6 3.9 3.0 81.1 0.5 8.6 107.7 39.9 CFDP1 "BCNT, CENP-29, CP27, p97, SWC5, Yeti" ENSG00000153774 "Craniofacial development protein 1" Q9UEE9 16 75293698-75433485 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Enterocytes: 441.3;Paneth cells: 557.6;Proximal tubular cells: 451.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041316, HPA048242" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA041316: AB_10794371, HPA048242: AB_2680327" "unprognostic (1.45e-1)" "unprognostic (8.64e-2)" "unprognostic (1.13e-1)" "unprognostic (4.88e-1)" "unprognostic (3.97e-2)" "prognostic unfavorable (9.63e-5)" "unprognostic (5.81e-3)" "unprognostic (2.17e-1)" "unprognostic (1.26e-2)" "unprognostic (2.61e-2)" "unprognostic (1.42e-1)" "unprognostic (7.37e-2)" "unprognostic (2.85e-2)" "unprognostic (6.54e-2)" "unprognostic (1.36e-1)" "unprognostic (4.92e-3)" "unprognostic (1.25e-1)" 21.3 33.0 38.3 23.3 32.9 18.7 28.5 31.8 35.4 35.6 24.3 19.5 24.6 18.9 37.4 40.9 21.3 36.1 18.8 19.2 33.7 40.5 40.2 26.6 20.6 16.9 33.6 28.4 54.5 26.9 20.9 53.0 38.5 32.7 28.4 25.8 21.1 23.8 25.6 25.9 20.8 22.2 33.8 38.6 18.0 19.1 38.5 29.7 27.2 28.7 12.6 21.4 26.0 41.1 20.1 28.2 33.7 27.6 15.1 37.8 15.0 16.5 12.3 42.1 15.5 38.3 42.8 12.6 16.6 19.4 22.0 32.0 21.1 22.7 15.9 24.7 20.4 24.7 18.6 32.2 26.4 44.3 6.9 15.3 16.6 11.9 45.1 26.4 17.4 14.5 26.6 22.7 26.6 32.5 38.6 23.9 29.7 23.1 7.4 24.6 37.7 25.6 38.6 20.5 28.1 6.5 46.4 17.3 27.5 24.5 9.1 25.2 21.3 27.8 5.8 22.8 37.9 24.1 31.0 14.2 15.8 17.1 16.6 10.5 14.5 22.6 59.8 15.9 23.2 13.9 28.7 27.3 33.7 19.4 27.6 27.3 19.8 26.7 21.3 28.2 20.1 24.5 23.1 22.4 15.1 25.0 28.1 37.8 15.0 38.3 32.9 31.8 35.4 33.7 40.5 33.6 28.4 32.7 29.7 35.7 47.3 55.9 92.1 51.4 87.2 29.5 86.6 139.2 73.9 109.9 110.0 100.8 167.5 63.8 109.9 72.1 441.3 70.0 82.6 93.0 53.5 100.2 27.7 133.3 67.3 58.8 79.0 55.9 48.2 54.7 115.9 50.3 32.1 44.1 151.7 51.5 79.7 557.6 105.7 451.1 103.9 97.0 53.6 273.8 142.2 57.3 129.5 38.3 90.4 107.8 CGNL1 "FLJ14957, JACOP, KIAA1749, PCING" ENSG00000128849 "Cingulin like 1" Q0VF96 15 57375967-57550727 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.8" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 81.1;Hepatocytes: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 29.4;SuSa: 22.4;TIME: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013500, HPA056911, HPA069214" Enhanced Supported "Nuclear bodies,Cell Junctions" No No "Cell Junctions" "Nuclear bodies" "CAB013500: , HPA056911: AB_2683274, HPA069214: AB_2686102" "unprognostic (1.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.52e-2)" "prognostic favorable (3.55e-4)" "unprognostic (3.22e-1)" "unprognostic (1.51e-3)" "prognostic favorable (5.58e-4)" "unprognostic (4.32e-2)" "unprognostic (2.34e-1)" "unprognostic (4.86e-2)" "unprognostic (4.05e-2)" "unprognostic (1.91e-2)" "prognostic favorable (1.37e-6)" "unprognostic (2.26e-2)" "unprognostic (3.39e-1)" "unprognostic (1.88e-3)" "unprognostic (1.18e-2)" 3.1 8.7 10.8 1.7 9.8 0.6 14.6 3.2 12.2 25.7 2.0 7.3 8.9 1.4 14.9 4.9 7.7 7.0 2.7 13.6 11.2 7.8 54.8 26.2 15.3 1.3 8.3 5.9 8.1 13.6 12.5 2.9 20.8 10.9 27.6 2.3 11.1 32.0 12.7 1.0 7.4 1.7 10.6 5.3 0.8 9.0 5.2 9.7 1.3 15.0 4.2 8.0 10.0 14.6 0.5 0.2 1.1 0.1 0.3 0.2 0.0 0.0 0.7 7.4 0.0 0.0 0.0 0.1 0.1 1.6 0.6 1.4 4.6 0.0 0.0 6.5 0.9 1.1 0.0 3.5 0.0 1.0 0.0 0.5 0.0 0.0 3.1 0.1 0.0 0.0 0.2 0.2 0.7 0.0 2.5 29.4 0.3 0.0 0.0 1.1 1.3 0.0 0.1 3.6 2.0 0.3 0.0 3.7 0.1 2.5 0.0 0.1 0.4 0.0 2.8 0.0 22.4 0.3 0.3 18.0 0.0 1.9 0.0 1.0 0.0 0.0 0.0 0.1 3.3 0.0 0.9 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.2 0.2 1.1 0.3 0.0 0.2 0.1 0.0 10.8 9.8 3.2 12.2 11.2 7.8 8.3 5.9 10.9 9.7 47.6 81.1 0.0 10.9 4.0 0.4 19.4 17.8 2.7 18.2 21.0 0.0 0.8 34.9 6.9 2.5 13.5 0.2 23.3 11.6 0.7 19.3 30.4 1.1 49.7 0.3 0.0 12.6 22.1 1.0 11.5 18.4 2.4 6.8 1.0 3.2 37.1 5.1 0.0 26.2 32.9 1.3 0.0 2.8 0.5 0.4 2.0 1.1 0.5 2.9 7.6 CGRRF1 "CGR19, RNF197" ENSG00000100532 "Cell growth regulator with ring finger domain 1" Q99675 14 54509812-54539309 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 105.4;Spermatocytes: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002930 Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA002930: AB_1078507" "unprognostic (1.81e-1)" "unprognostic (3.76e-1)" "unprognostic (5.61e-2)" "unprognostic (4.38e-1)" "unprognostic (1.01e-1)" "unprognostic (3.21e-1)" "prognostic unfavorable (6.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.58e-2)" "unprognostic (2.63e-1)" "unprognostic (7.29e-2)" "unprognostic (2.64e-3)" "prognostic favorable (2.57e-8)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (1.48e-1)" "unprognostic (1.74e-1)" 13.3 12.8 18.3 5.7 19.2 10.2 17.3 21.9 18.9 12.7 11.4 16.2 12.7 8.0 14.3 20.1 8.4 12.6 8.3 12.7 15.2 15.4 20.8 10.3 9.9 10.9 16.6 14.6 11.4 19.5 11.2 16.5 10.0 20.1 14.7 9.9 9.8 9.7 16.3 20.7 5.0 9.6 12.4 18.2 8.8 10.2 24.9 16.7 3.0 18.0 6.3 7.2 12.6 9.2 11.9 6.4 31.3 10.7 12.4 13.7 11.7 8.5 7.6 8.0 7.2 13.8 8.6 6.0 8.3 7.5 12.1 11.9 7.0 9.5 4.6 10.5 6.8 13.3 7.5 8.5 7.0 14.3 9.7 7.2 6.5 1.9 8.8 17.2 3.8 3.8 8.5 13.6 9.0 14.8 7.6 8.4 7.8 2.6 5.8 10.9 15.0 3.8 5.8 5.3 7.7 12.0 8.6 9.7 2.8 9.3 11.1 5.7 4.8 6.6 3.5 12.5 7.4 9.4 3.3 7.2 14.9 12.7 6.3 6.9 4.3 5.0 6.7 9.2 4.6 9.9 31.3 7.9 13.4 12.3 9.0 12.3 11.1 13.4 13.5 6.4 11.9 13.7 12.6 8.0 12.4 10.7 5.6 13.5 11.7 18.3 19.2 21.9 18.9 15.2 15.4 16.6 14.6 20.1 16.7 8.9 7.8 12.4 17.2 6.8 17.8 18.5 5.1 18.7 10.3 15.7 9.8 12.5 19.9 19.5 105.4 17.7 12.0 0.0 14.8 9.3 18.6 18.7 28.8 8.6 15.2 11.1 10.3 20.3 11.0 31.0 15.5 13.6 15.1 12.6 8.7 22.4 14.4 12.7 21.2 21.9 12.0 19.4 26.2 79.4 35.5 3.0 10.1 19.2 11.3 11.8 CHAF1A "CAF-1, CAF1, CAF1B, CAF1P150, MGC71229, P150" ENSG00000167670 "Chromatin assembly factor 1 subunit A" Q13111 19 4402662-4445018 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, DNA replication" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Erythroid cells: 46.7;Spermatocytes: 48.8;Spermatogonia: 120.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.2" "Group enriched" "Detected in many" 4 "dendritic cells: 15.2;granulocytes: 4.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015186 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB015186: AB_628065" "unprognostic (1.91e-1)" "prognostic favorable (8.22e-5)" "unprognostic (2.49e-1)" "unprognostic (4.71e-2)" "unprognostic (2.06e-1)" "unprognostic (1.89e-3)" "unprognostic (5.30e-3)" "unprognostic (8.78e-2)" "unprognostic (2.06e-2)" "unprognostic (2.12e-2)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.54e-2)" "prognostic favorable (4.15e-6)" "unprognostic (1.71e-1)" "unprognostic (2.11e-3)" "unprognostic (4.03e-2)" 5.3 5.3 6.3 14.6 7.3 28.2 5.3 12.6 8.8 4.7 7.2 4.9 8.6 6.9 4.7 5.1 11.5 4.7 5.2 4.0 6.1 3.9 3.0 4.5 4.6 13.3 5.5 5.6 4.6 4.4 3.3 4.3 7.5 5.4 6.5 7.2 4.1 7.8 8.1 12.2 11.3 7.0 6.8 4.8 8.2 5.6 20.4 4.9 27.8 3.3 9.8 11.5 6.7 5.9 1.7 15.2 4.3 2.4 1.0 0.8 0.9 21.4 14.7 24.5 15.4 2.4 3.0 12.6 20.4 8.4 17.3 19.6 17.8 7.7 33.1 8.5 6.5 9.8 16.9 20.9 13.9 20.5 19.0 22.9 20.6 21.9 14.0 1.2 23.8 16.8 1.7 2.9 14.2 6.1 3.2 8.1 18.5 24.8 30.0 10.6 12.4 38.4 13.3 27.3 11.0 12.2 28.6 19.4 18.9 4.5 25.6 17.4 13.5 14.0 9.9 8.1 16.1 8.7 17.8 5.8 14.3 12.5 24.2 24.7 15.1 22.3 31.8 12.0 30.7 16.8 2.9 2.3 4.3 0.5 2.4 0.4 1.7 0.6 0.1 2.0 0.8 0.6 0.4 1.2 1.0 0.4 15.2 0.8 0.9 6.3 7.3 12.6 8.8 6.1 3.9 5.5 5.6 5.4 4.9 0.0 4.6 11.2 5.5 8.7 12.5 5.0 2.5 5.3 2.3 5.2 2.0 15.4 1.7 5.7 5.6 3.3 3.8 46.7 5.9 33.8 3.7 3.9 2.3 3.9 10.3 1.6 1.7 2.5 2.8 5.3 2.8 8.7 1.7 12.6 6.2 5.0 5.1 0.0 3.5 2.1 8.4 32.3 3.4 48.8 120.2 13.0 12.2 5.7 10.0 4.1 CHEK2 "bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53" ENSG00000183765 "Checkpoint kinase 2" O96017 22 28687743-28742422 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3;Spermatogonia: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001878, CAB002030" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "CAB002030: AB_563660, HPA001878: AB_1078514" "unprognostic (1.54e-1)" "unprognostic (2.20e-1)" "unprognostic (5.83e-2)" "unprognostic (2.93e-2)" "unprognostic (2.42e-1)" "unprognostic (3.83e-2)" "unprognostic (1.49e-3)" "unprognostic (5.08e-3)" "unprognostic (3.33e-3)" "unprognostic (9.62e-3)" "unprognostic (1.28e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (7.80e-9)" "unprognostic (2.38e-2)" "unprognostic (1.78e-1)" "unprognostic (7.27e-2)" "unprognostic (6.79e-3)" 5.6 8.3 2.5 13.0 7.0 13.7 5.6 0.7 5.6 6.6 9.8 2.5 4.8 6.8 4.8 10.9 10.0 4.3 6.0 6.0 4.1 2.3 5.3 6.5 7.9 10.1 6.7 1.6 12.9 6.7 1.2 4.2 10.1 5.1 8.3 10.6 8.7 7.0 5.8 2.2 6.3 8.5 5.4 5.0 9.8 5.8 9.7 3.6 13.1 7.5 4.8 13.7 6.2 6.7 11.8 8.7 6.5 8.4 2.9 4.4 3.7 14.9 4.8 13.7 17.0 3.9 19.5 8.8 7.4 8.7 9.8 14.4 12.1 10.2 17.7 6.3 5.2 10.6 14.4 20.8 13.6 11.5 12.6 16.0 23.3 9.2 20.2 3.8 14.7 17.1 8.2 6.3 12.6 11.2 6.0 10.8 14.2 14.0 15.5 9.2 21.0 11.8 23.7 19.3 18.5 12.2 25.6 9.4 20.6 6.1 6.2 8.1 4.6 8.3 14.7 8.2 10.6 10.1 13.6 3.7 7.9 9.5 6.9 3.9 9.4 16.5 34.6 7.5 15.5 10.0 6.5 3.7 1.2 1.1 8.4 2.3 11.8 2.2 2.1 8.7 8.4 4.4 2.8 0.3 2.9 4.1 7.0 2.8 3.7 2.5 7.0 0.7 5.6 4.1 2.3 6.7 1.6 5.1 3.6 8.9 4.5 7.5 4.5 5.7 1.0 1.0 0.0 2.7 4.5 1.8 0.0 10.5 0.0 1.7 4.7 2.2 2.0 23.3 1.2 11.7 8.9 2.3 3.5 0.9 8.4 0.0 1.2 3.1 2.1 0.5 5.8 6.6 1.7 2.8 4.7 0.6 1.3 3.5 4.2 3.2 1.2 0.0 2.8 2.5 20.2 1.9 2.9 4.3 7.9 3.4 CHFR "FLJ10796, RNF196" ENSG00000072609 "Checkpoint with forkhead and ring finger domains" Q96EP1 12 132822187-132956304 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 88.4;Rod photoreceptor cells: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045768, HPA073826" Approved Uncertain "Nuclear bodies,Microtubules" NA NA "Nuclear bodies, Microtubules" "HPA045768: , HPA073826: AB_2732242" "unprognostic (1.46e-1)" "unprognostic (2.11e-2)" "unprognostic (1.41e-1)" "unprognostic (3.86e-2)" "unprognostic (2.08e-1)" "unprognostic (2.14e-3)" "unprognostic (6.56e-4)" "unprognostic (1.94e-2)" "unprognostic (2.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.00e-2)" "unprognostic (3.98e-3)" "prognostic unfavorable (4.21e-9)" "unprognostic (5.03e-1)" "unprognostic (8.46e-2)" "unprognostic (6.71e-2)" "unprognostic (1.11e-2)" 13.7 11.4 14.1 19.0 15.0 25.8 12.5 20.0 16.9 12.1 15.2 16.5 13.4 19.0 15.6 16.7 21.6 12.6 14.3 13.7 12.5 9.8 12.8 13.4 17.0 21.7 15.1 12.6 9.6 16.8 9.6 20.6 22.9 13.0 14.3 12.8 15.5 13.9 14.7 21.0 16.7 18.7 17.8 15.1 24.9 16.8 19.2 14.2 22.3 13.5 12.7 18.4 18.6 14.2 6.6 12.1 19.7 17.0 12.3 12.5 10.1 4.4 11.0 9.3 0.8 8.2 10.8 17.3 9.2 7.7 9.8 10.3 8.6 3.8 0.1 8.9 10.7 7.3 7.3 1.1 9.4 5.7 0.6 9.8 14.7 7.5 8.7 17.8 0.6 25.5 14.6 8.5 9.0 6.7 7.1 12.0 1.5 6.2 0.0 6.8 15.0 10.6 11.4 11.1 7.9 8.7 1.4 1.3 4.4 6.5 21.2 9.1 11.6 7.6 7.9 7.1 11.3 14.0 15.1 13.5 0.6 2.2 5.1 3.4 16.1 0.0 2.2 0.0 3.0 8.9 17.6 14.2 19.7 10.8 16.9 10.0 6.6 8.7 11.6 12.1 4.5 8.3 9.1 18.9 12.3 17.0 6.6 12.5 10.1 14.1 15.0 20.0 16.9 12.5 9.8 15.1 12.6 13.0 14.2 11.9 21.6 16.1 4.3 5.5 20.3 8.9 0.0 10.7 19.4 7.0 88.4 10.0 8.3 9.1 51.1 11.3 10.7 0.0 11.9 12.8 7.7 8.7 62.6 7.3 17.2 20.6 20.3 13.5 18.0 58.8 6.9 15.9 10.1 25.2 8.8 8.1 13.4 10.5 8.1 3.4 107.7 19.4 7.3 13.4 19.2 8.4 19.8 21.8 7.3 13.3 CHID1 "FLJ42707, MGC3234" ENSG00000177830 "Chitinase domain containing 1" Q9BWS9 11 867860-915058 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 289.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039374 Uncertain Uncertain "Nucleoplasm,Intermediate filaments" "Intracellular and membrane" No No 1700000 "Nucleoplasm, Intermediate filaments" "HPA039374: AB_10673609" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (8.96e-2)" "prognostic favorable (6.76e-4)" "unprognostic (4.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.97e-2)" "unprognostic (3.62e-2)" "unprognostic (7.88e-2)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (5.21e-2)" "unprognostic (1.74e-3)" "unprognostic (1.15e-1)" "unprognostic (7.53e-2)" "unprognostic (3.29e-2)" "unprognostic (2.89e-2)" 18.2 26.6 19.3 17.8 22.2 16.5 19.7 13.4 25.2 20.4 18.3 14.1 23.3 12.9 18.1 40.1 18.5 27.8 25.9 22.0 16.0 19.3 21.0 47.5 14.2 19.6 17.1 17.8 26.1 63.0 20.1 26.8 27.8 13.7 19.5 12.8 21.0 36.8 23.0 14.5 12.8 14.3 22.4 16.5 29.7 16.8 36.4 12.9 10.9 20.3 21.9 13.8 15.6 15.7 20.5 33.6 8.3 23.1 18.4 17.9 18.8 19.5 19.1 14.6 35.5 56.3 30.0 24.6 21.9 26.1 21.6 21.1 20.9 57.8 16.1 20.6 32.1 21.5 38.8 14.4 25.6 15.9 14.0 35.6 11.5 7.1 19.1 26.0 26.6 10.3 29.0 16.3 14.6 21.3 35.8 18.1 20.5 20.9 41.3 14.9 13.8 14.9 35.0 12.9 37.1 29.1 12.9 14.0 29.0 15.8 5.7 27.9 23.0 23.9 33.7 20.4 15.2 13.6 41.0 17.6 24.7 10.8 6.9 17.7 24.4 20.5 9.7 27.6 23.4 19.2 7.6 23.1 8.3 16.9 20.4 17.9 20.5 16.4 17.6 33.6 15.1 17.4 17.4 3.0 18.4 19.2 31.4 14.1 18.8 19.3 22.2 13.4 25.2 16.0 19.3 17.1 17.8 13.7 12.9 38.7 36.7 23.1 47.9 20.3 39.9 20.1 48.4 30.8 23.9 50.6 17.7 97.8 61.3 53.7 96.5 24.8 30.3 23.3 50.7 67.4 51.5 73.1 28.8 71.4 70.9 28.6 51.2 53.4 51.8 289.6 58.1 27.5 52.3 34.3 40.4 59.1 39.0 45.6 54.8 66.6 40.6 51.8 30.3 108.0 122.6 20.5 76.5 17.5 64.8 43.7 CHM "DXS540, REP-1, TCD" ENSG00000188419 "CHM, Rab escort protein 1" P24386 X 85861180-86047562 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "GTPase activation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003231, CAB016171" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016171: AB_2229397, HPA003231: AB_1078518" "unprognostic (6.50e-3)" "unprognostic (1.80e-1)" "unprognostic (1.67e-1)" "unprognostic (1.74e-2)" "unprognostic (2.82e-1)" "unprognostic (4.40e-1)" "unprognostic (6.20e-3)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.20e-1)" "unprognostic (1.49e-1)" "unprognostic (1.97e-3)" "unprognostic (4.18e-2)" "unprognostic (6.15e-2)" "unprognostic (2.44e-1)" "unprognostic (7.60e-3)" 12.6 18.8 13.9 9.7 23.2 3.2 11.2 17.8 22.9 14.3 9.3 9.0 8.3 6.6 14.5 7.1 9.7 15.9 10.4 9.9 12.6 11.0 17.7 10.9 9.9 9.2 9.3 12.1 11.8 8.3 20.2 31.9 13.2 17.9 11.3 9.3 7.5 10.4 10.8 16.3 8.1 8.0 12.5 12.1 10.8 10.2 6.6 11.9 14.6 15.6 8.4 8.7 12.1 10.4 7.4 4.6 6.2 7.1 4.9 6.0 3.9 9.0 6.0 6.1 4.1 10.1 10.7 3.9 10.7 9.0 7.5 8.3 4.8 8.4 3.1 13.9 7.7 26.3 5.2 13.3 6.0 12.9 6.2 6.4 1.8 8.7 4.9 8.0 7.6 13.6 8.1 5.7 12.1 15.4 8.3 12.8 5.2 6.4 10.7 11.6 2.6 4.7 2.8 9.2 6.3 9.8 5.0 11.0 4.7 7.0 5.3 5.5 8.4 12.9 4.5 10.1 8.9 3.3 3.7 9.1 9.6 6.8 33.3 5.3 4.0 14.7 4.4 10.3 6.5 8.3 6.2 5.8 4.0 5.5 7.1 5.0 6.6 4.4 5.6 4.6 7.4 5.8 6.0 3.2 4.9 5.6 4.6 5.5 3.9 13.9 23.2 17.8 22.9 12.6 11.0 9.3 12.1 17.9 11.9 3.0 8.3 7.5 14.7 6.2 34.6 10.2 17.8 20.1 12.5 15.7 7.9 8.1 16.6 13.3 0.6 14.3 7.3 0.0 10.7 8.0 11.8 18.5 16.1 11.3 13.6 22.3 18.0 14.7 19.4 0.9 14.4 13.8 5.0 11.8 10.6 28.5 13.0 8.6 11.7 27.6 21.2 45.3 13.7 2.9 10.7 6.5 15.3 13.6 8.8 12.6 CHMP2A "BC-2, CHMP2, VPS2, VPS2A" ENSG00000130724 "Charged multivesicular body protein 2A" O43633 19 58551566-58555124 "Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041153, HPA042031" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 49000 Cytosol "Nucleoplasm, Plasma membrane" "HPA041153: AB_10964358, HPA042031: AB_10961727" "unprognostic (1.80e-1)" "unprognostic (4.70e-2)" "unprognostic (7.29e-2)" "unprognostic (1.44e-3)" "unprognostic (6.60e-2)" "unprognostic (2.54e-1)" "unprognostic (3.86e-2)" "unprognostic (2.60e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-2)" "unprognostic (2.69e-1)" "unprognostic (1.45e-1)" "unprognostic (2.98e-1)" "unprognostic (2.21e-1)" "unprognostic (3.09e-2)" "unprognostic (4.23e-2)" "unprognostic (2.71e-2)" 40.7 59.6 52.5 37.3 56.7 55.1 41.2 36.3 44.8 39.0 53.2 37.8 50.4 43.5 36.9 61.7 57.4 41.9 60.4 80.6 45.0 40.1 64.8 66.5 36.4 55.8 48.2 38.7 36.9 59.8 46.9 39.1 79.2 38.5 35.2 49.2 33.0 62.4 64.8 75.7 54.9 72.0 42.4 48.5 43.4 45.2 29.4 35.1 34.0 49.8 53.9 44.4 42.5 34.0 17.5 30.5 117.2 34.7 17.0 29.4 24.9 18.0 48.6 15.7 14.4 24.3 30.5 19.4 16.7 34.7 8.9 9.7 14.3 26.9 4.8 24.7 27.9 25.8 14.7 12.9 31.9 7.6 16.1 106.0 11.8 35.6 21.9 47.1 19.5 18.5 35.3 45.3 13.9 44.7 30.4 25.8 22.8 14.0 23.1 26.9 30.5 24.7 18.1 6.5 50.0 37.3 10.7 13.5 36.2 38.8 41.0 18.5 31.4 27.2 36.4 20.0 10.3 27.9 20.0 29.0 45.6 6.6 13.2 19.3 58.9 64.4 15.7 32.1 23.2 29.9 33.5 34.7 46.6 20.2 31.7 17.0 17.5 22.3 22.7 30.5 15.8 15.7 17.7 117.2 17.0 31.6 27.8 29.4 24.9 52.5 56.7 36.3 44.8 45.0 40.1 48.2 38.7 38.5 35.1 92.3 99.1 97.2 231.9 147.1 67.2 100.3 152.8 155.2 81.9 157.1 15.7 253.5 374.7 261.4 89.0 137.1 466.3 70.0 457.0 242.2 112.6 224.1 116.8 190.9 235.9 49.3 149.1 122.8 143.9 66.0 134.3 151.3 204.1 239.9 215.7 135.6 375.5 326.1 125.2 436.3 71.4 84.1 139.8 101.7 97.9 173.4 384.7 105.5 183.9 310.0 CHODL "C21orf68, FLJ12627, MT75, PRED12" ENSG00000154645 Chondrolectin Q9H9P2 21 17901263-18267373 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 59.6" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 3.5;Early spermatids: 2.2;Late spermatids: 3.1;Leydig cells: 2.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 6.8;hypothalamus: 8.2;pons and medulla: 8.6" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 4.9" "Lineage enriched" "Detected in single" 8 "T-cells: 4.9" "Cell line enhanced" "Detected in some" "U-266/70: 4.1;U-266/84: 10.0;U-87 MG: 11.6" "Group enriched" "Detected in many" 4 "basal ganglia: 4.1;hypothalamus: 14.3;pons and medulla: 11.4" "Region enriched" "Detected in all" 6 "olfactory region: 208.8" "HPA017282, HPA057559" Enhanced Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA017282: AB_1846687, HPA057559: " "unprognostic (3.91e-1)" "unprognostic (3.18e-2)" "unprognostic (2.37e-2)" "prognostic unfavorable (1.18e-6)" "unprognostic (6.74e-2)" "unprognostic (6.82e-2)" "unprognostic (1.06e-3)" "unprognostic (6.79e-2)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.87e-1)" "unprognostic (4.83e-2)" "unprognostic (1.02e-1)" 2.3 1.9 0.8 2.1 6.8 0.0 1.1 0.5 0.8 0.3 2.3 0.5 4.0 1.5 0.7 1.1 1.4 0.5 0.8 3.4 1.3 8.2 4.7 0.0 0.3 0.3 1.4 0.8 0.5 0.0 0.5 2.1 1.7 8.6 8.2 3.4 1.4 0.6 1.8 1.3 2.1 0.9 0.4 2.2 12.3 0.7 59.6 1.1 0.1 0.9 4.3 1.1 1.1 1.1 0.4 0.6 0.0 0.1 0.4 4.9 0.3 0.0 0.0 1.0 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.1 0.0 2.5 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.1 0.0 0.6 0.1 2.1 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.3 0.0 1.1 0.9 1.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 4.1 10.0 0.3 11.6 0.0 0.1 0.0 0.0 0.0 0.7 0.0 4.9 0.4 0.3 0.8 0.1 0.2 0.0 1.1 0.0 0.4 0.1 0.6 1.0 0.3 0.8 6.8 0.5 0.8 1.3 8.2 1.4 0.8 8.6 1.1 0.0 0.0 0.0 0.6 3.5 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.2 2.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 2.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.2 1.1 1.7 1.9 0.5 1.0 0.0 0.3 CHRM4 ENSG00000180720 "Cholinergic receptor muscarinic 4" P08173 11 46385098-46386608 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.7;intestine: 8.0;lymphoid tissue: 17.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 5.0;SCLC-21H: 14.5;U-2 OS: 4.2" "Group enriched" "Detected in many" 6 "amygdala: 26.8;basal ganglia: 65.9;cerebral cortex: 30.5;hippocampal formation: 26.4;olfactory region: 36.4" "Group enriched" "Detected in many" 7 "amygdala: 5.5;basal ganglia: 15.3;cerebral cortex: 8.6;hippocampal formation: 7.6;olfactory region: 20.1" "CAB022444, HPA072083" Enhanced Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "CAB022444: , HPA072083: " "unprognostic (7.11e-2)" "unprognostic (3.79e-1)" "unprognostic (5.31e-2)" "unprognostic (7.38e-2)" "unprognostic (8.63e-3)" "unprognostic (1.38e-1)" "unprognostic (6.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (2.96e-3)" "unprognostic (4.08e-3)" "unprognostic (5.02e-2)" "unprognostic (3.83e-2)" "unprognostic (3.64e-1)" "unprognostic (1.71e-1)" "unprognostic (3.56e-1)" "unprognostic (5.08e-2)" 0.0 0.5 1.1 0.2 11.7 1.6 0.0 0.0 6.0 0.0 0.6 3.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.2 8.0 0.1 0.0 17.2 0.8 4.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.3 0.1 0.2 0.0 3.0 0.0 0.1 0.2 0.1 1.5 0.2 0.3 0.3 0.0 2.6 0.1 1.8 0.1 0.0 2.2 0.3 0.5 0.2 0.0 0.2 0.5 0.6 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.6 0.2 0.0 1.1 0.2 0.2 0.6 0.1 0.2 0.0 5.0 0.0 0.0 0.1 14.5 0.4 0.4 0.1 0.1 0.3 0.1 2.4 0.0 0.4 4.2 0.0 0.1 0.8 0.6 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHTF18 "C16orf41, C321D2.4, CHL12, Ctf18" ENSG00000127586 "Chromosome transmission fidelity factor 18" Q8WVB6 16 788046-800737 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 20.9;Extravillous trophoblasts: 16.6;Spermatogonia: 23.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 28.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040976, HPA056209" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040976: AB_2677232, HPA056209: AB_2683066" "unprognostic (3.83e-2)" "unprognostic (4.97e-2)" "unprognostic (4.25e-2)" "unprognostic (9.35e-2)" "unprognostic (4.59e-2)" "unprognostic (3.02e-3)" "unprognostic (1.80e-3)" "unprognostic (3.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.19e-1)" "unprognostic (4.00e-2)" "unprognostic (1.44e-2)" "prognostic unfavorable (1.43e-8)" "unprognostic (2.07e-2)" "unprognostic (1.55e-1)" "unprognostic (9.89e-2)" "prognostic favorable (2.78e-4)" 2.4 3.1 8.3 6.7 5.6 16.8 3.1 11.1 4.7 5.0 5.3 4.1 4.1 6.1 4.1 2.8 5.1 3.2 2.4 1.7 2.7 2.3 2.6 2.0 2.9 4.4 4.4 4.6 5.2 3.1 0.7 2.4 4.1 3.5 3.2 1.7 4.0 4.0 2.6 2.4 8.3 7.2 1.8 2.3 5.9 6.7 11.3 4.3 15.5 3.1 3.8 7.3 2.9 3.6 1.0 1.4 4.6 3.0 2.1 2.4 0.7 8.0 3.9 3.2 2.6 0.3 0.2 28.4 5.1 1.4 2.6 1.8 7.0 6.2 9.1 5.3 0.8 1.3 9.0 0.7 3.9 0.0 5.1 11.6 4.0 4.6 3.6 0.0 2.5 7.9 0.1 0.5 2.5 1.3 0.3 2.2 9.5 6.0 3.0 0.6 15.5 9.7 9.3 4.2 1.8 4.8 17.5 8.2 11.8 0.8 2.3 4.2 5.4 3.7 8.2 2.7 0.4 6.0 6.0 1.4 3.8 14.0 6.9 6.8 7.2 2.4 5.1 1.2 3.6 6.6 4.6 0.6 0.0 2.4 3.0 1.5 0.4 1.1 1.9 1.4 1.0 1.3 0.3 0.3 2.1 1.6 0.8 1.4 0.7 8.3 5.6 11.1 4.7 2.7 2.3 4.4 4.6 3.5 4.3 3.0 3.4 3.7 3.2 4.7 20.9 3.6 0.0 2.7 3.4 1.8 2.0 10.9 1.7 2.4 1.0 1.8 0.9 0.0 3.3 16.6 3.3 1.0 4.6 1.8 5.4 6.4 6.3 2.5 2.1 1.1 1.7 2.9 0.0 0.0 3.3 2.8 1.6 0.0 1.4 0.7 6.7 0.0 3.3 13.3 23.5 1.8 7.2 2.5 3.3 1.4 CKAP4 "CLIMP-63, ERGIC-63, P63" ENSG00000136026 "Cytoskeleton associated protein 4" Q07065 12 106237877-106304279 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Mucus-secreting cells: 162.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 34.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 34.6" "Cell line enhanced" "Detected in many" "BJ: 74.6;BJ hTERT+: 94.1;fHDF/TERT166: 112.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000278, HPA000792, HPA001225" Enhanced Uncertain "Nuclear speckles,Cytosol,Cytoplasmic bodies" NA NA 11000 "Nuclear speckles, Cytosol" "Cytoplasmic bodies" "HPA000278: AB_1078527, HPA000792: AB_1078526, HPA001225: AB_2666241" "unprognostic (5.25e-2)" "unprognostic (1.47e-1)" "unprognostic (1.91e-1)" "unprognostic (7.13e-2)" "unprognostic (2.44e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (6.61e-5)" "prognostic unfavorable (5.61e-4)" "unprognostic (5.02e-2)" "unprognostic (9.66e-3)" "unprognostic (1.95e-1)" "unprognostic (6.23e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.20e-3)" "unprognostic (6.97e-2)" "unprognostic (1.29e-2)" "unprognostic (3.66e-2)" 13.0 23.8 7.1 15.3 4.9 39.5 27.2 6.9 8.4 42.3 19.2 6.5 24.8 8.1 23.7 35.2 47.3 17.2 26.6 32.9 5.7 8.0 18.3 42.1 22.2 28.5 6.3 5.4 28.6 55.2 12.7 12.0 30.6 6.8 23.9 20.5 13.2 34.4 28.0 11.1 20.8 10.7 20.4 5.8 16.7 23.0 10.3 4.2 4.0 18.6 30.0 27.8 25.8 21.4 4.2 2.3 34.6 7.5 0.1 1.0 2.4 11.4 14.4 17.5 18.9 34.1 30.4 10.1 74.6 94.1 36.5 42.0 6.1 2.6 0.7 13.6 112.3 12.4 20.8 12.7 11.3 26.3 0.4 7.4 0.0 8.3 11.9 25.4 0.1 0.2 29.1 15.5 30.9 22.4 46.3 42.6 0.8 0.0 1.5 34.6 3.8 0.5 0.4 10.1 6.0 17.5 5.3 12.6 0.9 11.1 10.3 5.7 6.4 13.2 9.0 7.1 16.4 10.1 5.2 36.3 28.8 15.9 11.9 21.0 4.0 0.0 8.1 20.7 1.4 25.1 34.6 7.5 8.7 0.5 2.7 0.7 4.2 0.7 0.4 2.3 1.6 1.0 0.9 12.7 0.1 4.1 0.0 0.2 2.4 7.1 4.9 6.9 8.4 5.7 8.0 6.3 5.4 6.8 4.2 20.8 24.5 3.0 33.7 48.7 12.8 42.1 43.3 5.3 21.6 22.7 9.8 24.4 5.0 32.4 0.9 24.8 13.4 0.0 75.4 79.1 87.2 68.6 19.5 49.1 19.2 44.5 39.7 49.7 37.3 1.1 63.3 14.9 32.1 6.4 162.0 23.7 51.4 5.8 57.7 9.1 18.4 12.9 46.7 2.5 12.2 62.9 22.1 3.2 60.8 36.8 CKAP5 "ch-TOG, KIAA0097, TOG, TOGp" ENSG00000175216 "Cytoskeleton associated protein 5" Q14008 11 46743048-46846308 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 89.5;Spermatocytes: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039377, HPA040375" Supported Approved "Nucleoli,Nucleoli rim,Plasma membrane,Centrosome" NA Yes 460000 "Plasma membrane, Centrosome" "Nucleoli, Nucleoli rim" "HPA039377: AB_10805477, HPA040375: AB_10794739" "unprognostic (8.00e-2)" "unprognostic (7.35e-2)" "unprognostic (2.35e-1)" "unprognostic (4.12e-2)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (6.09e-2)" "unprognostic (1.12e-2)" "unprognostic (2.21e-2)" "unprognostic (4.30e-3)" "unprognostic (3.77e-2)" "unprognostic (2.03e-1)" "unprognostic (2.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (4.69e-2)" 13.7 25.5 20.6 11.5 25.7 18.6 12.5 34.6 32.9 11.3 14.6 16.5 7.3 10.2 13.7 10.4 11.7 9.5 10.1 16.6 19.2 19.3 9.7 37.7 8.5 14.1 18.8 21.1 23.8 7.9 20.0 20.8 13.8 33.0 13.5 15.0 9.1 8.7 12.0 26.3 10.7 9.9 16.1 22.5 8.8 12.9 25.4 22.2 28.6 8.0 10.8 14.7 12.6 9.7 8.6 8.4 6.0 8.7 11.7 10.0 3.6 26.4 25.6 55.0 23.5 13.0 20.5 12.8 30.4 18.5 28.9 30.8 20.8 9.0 28.9 10.7 20.4 31.0 30.1 39.4 17.2 36.4 26.0 30.1 48.2 20.5 20.0 9.7 36.7 20.2 10.4 9.2 16.2 35.2 15.1 21.8 25.4 34.0 27.1 23.9 18.2 31.2 9.5 29.5 19.7 20.6 33.1 58.5 25.3 9.3 16.3 25.6 21.8 41.3 14.8 15.1 25.4 27.3 10.0 18.7 28.1 24.9 47.7 44.8 15.4 33.2 41.6 17.6 17.4 27.5 5.4 5.7 6.0 9.0 8.7 8.8 8.6 6.7 10.0 8.4 8.0 8.2 8.5 0.9 11.7 7.8 5.4 7.5 3.6 20.6 25.7 34.6 31.2 19.2 19.3 18.8 21.1 33.0 22.2 23.8 20.5 16.4 7.9 7.6 18.2 57.6 10.2 33.5 21.6 8.7 35.3 13.2 8.3 10.6 89.5 13.5 8.1 0.0 6.6 12.2 13.2 11.2 35.9 6.2 16.0 12.7 11.6 14.1 12.9 37.9 18.1 13.5 6.8 16.2 14.1 14.9 12.6 12.4 27.3 8.7 24.2 19.4 6.6 81.4 60.7 10.2 9.6 9.6 14.9 7.8 CLCN5 "ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN" ENSG00000171365 "Chloride voltage-gated channel 5" P51795 X 49922615-50099235 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 46.1" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 6.6" "Group enriched" "Detected in many" 8 "dendritic cells: 6.6;monocytes: 1.8" "Cell line enhanced" "Detected in many" "CACO-2: 25.4;RH-30: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000401, HPA003213" Uncertain Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane" Cytosol "HPA000401: AB_1078531, HPA003213: AB_2666843" "unprognostic (3.33e-2)" "unprognostic (6.15e-2)" "unprognostic (3.13e-1)" "unprognostic (1.57e-1)" "unprognostic (7.59e-2)" "unprognostic (1.27e-1)" "unprognostic (1.54e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-1)" "unprognostic (5.21e-2)" "prognostic favorable (5.20e-4)" "unprognostic (3.59e-2)" "prognostic favorable (2.05e-8)" "unprognostic (7.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" 4.4 4.1 2.5 2.4 2.9 2.1 3.4 9.4 3.4 2.3 3.1 2.6 4.7 5.0 9.8 26.7 3.7 4.6 7.6 2.2 3.1 2.8 46.1 15.8 4.7 3.0 2.6 2.5 10.8 6.7 2.6 8.3 7.3 5.9 2.7 3.7 7.6 4.0 3.5 5.6 6.2 6.4 3.8 4.3 3.0 4.0 5.9 2.3 1.2 3.6 4.0 2.3 2.4 3.1 0.2 6.6 0.5 1.8 0.3 0.4 0.5 1.8 2.8 2.2 3.3 8.4 5.3 4.7 1.5 0.8 1.0 1.2 25.4 1.7 1.8 0.8 1.7 5.6 1.5 6.8 0.8 1.6 0.7 4.6 1.8 1.4 6.6 4.0 2.3 3.4 3.1 1.1 2.6 3.8 0.8 3.6 2.4 2.7 2.7 2.9 1.8 0.8 0.7 3.2 4.2 1.4 1.1 39.3 2.8 3.8 2.9 3.8 2.7 2.2 2.2 3.1 8.7 1.9 1.1 1.8 1.0 2.1 7.8 0.9 2.3 6.9 4.1 1.7 3.8 5.1 0.1 1.8 0.0 0.2 1.5 0.3 0.2 0.4 0.4 3.8 0.2 0.1 0.1 0.5 0.3 0.3 6.6 0.0 0.5 2.5 2.9 9.4 3.4 3.1 2.8 2.6 2.5 5.9 2.3 8.9 5.9 1.5 1.6 6.4 19.5 1.6 5.1 5.3 0.0 12.2 2.0 5.2 10.0 3.7 1.1 3.8 10.9 0.0 2.9 2.2 5.7 3.1 2.3 21.7 8.9 7.9 0.0 0.6 9.5 0.0 4.9 8.9 3.3 5.4 5.7 2.8 5.8 6.2 12.4 32.4 4.3 0.0 3.3 1.0 0.7 8.3 4.2 0.0 6.4 4.6 CLDN14 DFNB29 ENSG00000159261 "Claudin 14" O95500 21 36460621-36576569 "Disease related genes, Predicted membrane proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 7.4;liver: 25.0" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 7.6;Distal tubular cells: 16.6;Ductal cells: 10.3;Exocrine glandular cells: 7.3;Hepatocytes: 19.8;Pancreatic endocrine cells: 13.1" "Cancer enriched" "Detected in many" 6 "liver cancer: 7.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 2.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.1" "Cell line enriched" "Detected in some" 14 "HDLM-2: 70.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA054707 Uncertain Vesicles NA NA Vesicles "HPA054707: " "unprognostic (1.14e-1)" "unprognostic (2.21e-1)" "unprognostic (3.74e-2)" "unprognostic (9.43e-2)" "unprognostic (8.20e-3)" "unprognostic (5.54e-2)" "prognostic favorable (1.53e-4)" "unprognostic (3.50e-4)" "unprognostic (2.28e-1)" "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (4.87e-1)" "unprognostic (7.44e-4)" "unprognostic (2.77e-2)" "unprognostic (7.65e-2)" "unprognostic (2.45e-2)" "unprognostic (9.71e-2)" 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.1 0.3 0.0 7.4 25.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 1.8 0.1 0.2 0.1 0.0 0.2 0.0 0.3 0.2 0.4 0.0 0.5 1.4 0.1 0.1 0.0 0.0 0.2 0.0 0.6 0.2 0.0 0.2 0.2 2.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 70.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.8 5.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.3 1.4 0.0 0.2 0.1 1.9 3.7 0.0 0.3 0.1 0.0 0.7 0.2 2.1 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.2 0.2 0.2 1.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 1.0 0.3 0.0 0.8 7.6 0.0 0.0 1.8 0.0 0.1 16.6 10.3 0.4 0.0 0.0 0.0 7.3 0.9 0.0 0.7 0.0 19.8 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 3.3 1.0 0.0 0.0 13.1 0.0 0.4 0.0 0.0 0.0 0.2 0.5 0.0 0.3 0.7 0.0 0.0 1.4 CLEC2A "INPE5792, KACL, PILAR, UNQ5792" ENSG00000188393 "C-type lectin domain family 2 member A" Q6UVW9 12 9898673-9932381 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 37.0" "Group enriched" "Detected in some" 199 "Basal keratinocytes: 16.7;Suprabasal keratinocytes: 32.4" "Cancer enhanced" "Detected in some" "cervical cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 13.5;U-937: 33.7" "HPA048530, HPA072407" Approved Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA048530: AB_2680429, HPA072407: AB_2686518" "unprognostic (3.10e-1)" "unprognostic (5.29e-2)" "unprognostic (2.23e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.3 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.1 CLEC2D "CLAX, LLT1, OCIL" ENSG00000069493 "C-type lectin domain family 2 member D" Q9UHP7 12 9664969-9699555 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 45.6;lymphoid tissue: 47.5" "Group enriched" "Detected in many" 5 "B-cells: 129.2;Early spermatids: 83.6;monocytes: 115.4;T-cells: 223.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "gdT-cell: 37.8;MAIT T-cell: 23.0;memory B-cell: 15.9;memory CD4 T-cell: 37.3;memory CD8 T-cell: 41.3;naive B-cell: 24.6;naive CD4 T-cell: 39.4;naive CD8 T-cell: 45.6;T-reg: 31.5" "Group enriched" "Detected in many" 11 "B-cells: 24.6;T-cells: 45.6" "Group enriched" "Detected in many" 4 "Daudi: 27.8;HDLM-2: 21.7;Karpas-707: 13.2;U-698: 42.8" "HPA017649, HPA047584" Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA017649: AB_1846912, HPA047584: " "unprognostic (1.09e-3)" "prognostic favorable (1.37e-4)" "unprognostic (1.16e-1)" "unprognostic (4.27e-2)" "unprognostic (1.29e-1)" "unprognostic (2.77e-4)" "unprognostic (4.34e-2)" "unprognostic (1.72e-3)" "unprognostic (1.24e-2)" "unprognostic (1.92e-1)" "unprognostic (6.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (5.85e-11)" "unprognostic (1.17e-1)" "unprognostic (2.70e-1)" "unprognostic (3.44e-1)" "prognostic favorable (1.68e-7)" 3.8 1.0 1.1 47.5 1.1 7.8 3.7 0.8 1.0 2.9 6.0 0.6 1.4 1.7 3.0 7.0 3.6 3.2 3.0 3.3 1.2 1.1 2.6 1.3 10.4 28.3 1.7 1.2 4.0 1.5 0.2 1.3 1.7 1.1 4.5 2.1 2.5 9.8 3.2 1.2 2.4 11.2 3.2 2.5 21.3 2.7 5.7 1.0 44.7 2.8 2.7 29.4 8.2 2.5 24.6 0.4 1.1 0.4 3.1 45.6 19.2 0.5 1.0 1.5 0.1 0.2 0.6 1.7 0.7 1.0 0.3 0.9 0.8 0.9 27.8 0.1 0.7 0.4 0.3 0.5 0.1 0.5 21.7 0.4 0.8 0.7 1.2 2.5 0.7 0.7 1.0 0.7 0.2 0.9 3.4 0.0 0.5 0.2 13.2 0.6 1.8 0.3 2.4 1.4 0.1 0.2 6.0 0.6 0.8 1.4 1.5 0.3 0.5 0.4 1.2 1.2 2.9 0.2 0.7 0.2 0.5 0.7 0.4 0.5 1.8 0.4 42.8 1.2 1.3 0.8 1.1 0.4 0.2 37.8 0.2 23.0 15.9 37.3 41.3 0.4 24.6 39.4 45.6 1.1 3.1 0.2 0.3 31.5 19.2 1.1 1.1 0.8 1.0 1.2 1.1 1.7 1.2 1.1 1.0 6.0 26.8 129.2 29.8 3.7 0.6 6.9 2.5 10.7 11.4 1.8 3.9 9.1 6.6 2.1 83.6 9.8 0.4 0.0 1.7 5.4 7.0 13.2 18.6 2.1 8.0 4.8 0.0 12.3 20.8 15.6 7.8 18.9 1.7 115.4 2.5 3.7 2.3 2.0 9.2 1.9 2.1 19.4 6.6 4.7 5.1 4.3 4.0 223.7 3.0 25.3 CLEC4E "CLECSF9, mincle" ENSG00000166523 "C-type lectin domain family 4 member E" Q9ULY5 12 8533305-8540963 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.7;bone marrow: 37.7;lymphoid tissue: 41.2" "Group enriched" "Detected in some" 8 "Kupffer cells: 144.8;Macrophages: 65.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "classical monocyte: 22.8;neutrophil: 81.7" "Group enriched" "Detected in many" 17 "granulocytes: 81.7;monocytes: 22.8" "Group enriched" "Detected in some" 4 "NB-4: 5.8;RPTEC TERT1: 16.3" "Not detected" "Not detected" HPA004935 Uncertain Uncertain Cytosol NA NA Cytosol "HPA004935: AB_2667299" "unprognostic (3.05e-2)" "unprognostic (2.01e-2)" "unprognostic (8.91e-2)" "unprognostic (3.76e-1)" "unprognostic (1.76e-1)" "unprognostic (9.71e-3)" "unprognostic (1.77e-1)" "unprognostic (1.24e-1)" "unprognostic (9.29e-2)" "unprognostic (1.83e-1)" "unprognostic (1.16e-1)" "unprognostic (2.11e-2)" "unprognostic (7.65e-3)" "unprognostic (1.62e-1)" "unprognostic (1.51e-1)" "unprognostic (8.44e-2)" "unprognostic (2.29e-1)" 8.4 3.0 1.1 20.9 2.4 37.7 17.5 1.2 2.2 3.4 1.4 0.0 1.1 0.1 1.2 1.6 1.7 4.2 6.7 5.9 1.3 1.2 6.2 3.5 25.6 41.2 2.8 0.6 1.0 3.3 0.0 1.7 1.7 9.0 1.6 0.5 1.1 1.2 0.6 2.7 0.7 1.9 3.2 5.3 34.2 1.8 3.3 0.8 0.7 12.8 0.9 1.1 2.2 2.2 0.0 2.9 81.7 22.8 0.0 0.0 4.5 0.1 0.6 0.4 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.1 2.0 0.1 0.2 2.6 0.0 0.2 0.1 0.2 0.2 0.0 0.3 0.3 0.3 0.0 0.7 0.1 0.0 1.7 0.1 0.6 0.7 0.1 0.2 0.1 0.0 0.1 0.0 5.8 0.5 0.0 0.1 0.1 0.2 0.1 16.3 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.0 0.5 1.3 0.6 0.1 1.1 0.1 0.2 0.1 0.1 1.6 0.5 0.1 0.0 22.8 0.0 0.0 3.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 81.7 0.0 0.1 0.1 0.0 4.5 1.1 2.4 1.2 2.2 1.3 1.2 2.8 0.6 9.0 0.8 0.0 6.6 1.4 0.0 0.0 0.0 0.3 7.6 1.4 3.4 1.8 0.0 0.0 0.0 4.5 0.3 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 5.8 0.0 0.0 11.6 144.8 1.1 0.9 65.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 12.9 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 CLECL1 DCAL1 ENSG00000184293 "C-type lectin like 1" Q8IZS7 12 9715860-9733299 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 9 "blood: 42.4;intestine: 11.5;lymphoid tissue: 20.6" "Group enriched" "Detected in some" 4 "B-cells: 69.2;Hofbauer cells: 21.8;Kupffer cells: 84.7;Macrophages: 31.4;monocytes: 69.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 42.4" "Lineage enriched" "Detected in many" 5 "B-cells: 42.4" "Group enriched" "Detected in some" 5 "HEL: 16.0;Karpas-707: 22.2;U-698: 56.8;U-937: 31.2" HPA063928 Supported "Plasma membrane,Centriolar satellite" NA NA "Plasma membrane, Centriolar satellite" "HPA063928: " "unprognostic (2.18e-2)" "unprognostic (2.35e-3)" "unprognostic (2.20e-3)" "unprognostic (1.90e-3)" "unprognostic (3.66e-1)" "unprognostic (1.90e-3)" "unprognostic (2.83e-1)" "unprognostic (7.55e-4)" "unprognostic (5.10e-2)" "unprognostic (2.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (3.91e-5)" "unprognostic (3.31e-1)" "unprognostic (2.45e-1)" "unprognostic (6.10e-2)" "unprognostic (7.39e-2)" 2.7 1.0 0.8 9.8 1.1 0.9 1.1 0.3 0.9 0.6 1.7 1.3 0.1 1.6 0.7 1.3 2.6 0.9 1.5 2.7 1.0 0.9 1.6 1.4 1.9 15.5 1.3 0.7 0.5 1.7 0.0 0.9 0.5 0.9 0.8 2.8 0.8 1.5 0.1 0.5 0.5 11.5 0.9 2.5 20.5 2.6 0.6 0.3 2.2 0.9 0.5 20.6 2.8 2.4 42.4 8.6 0.7 4.6 0.0 3.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 56.8 0.0 31.2 0.0 0.7 2.6 0.1 1.7 4.6 0.0 42.4 1.4 3.5 6.1 14.5 0.0 0.5 0.1 0.0 4.6 8.6 0.1 2.1 0.8 1.1 0.3 0.9 1.0 0.9 1.3 0.7 0.9 0.3 0.0 0.0 69.2 0.1 1.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.4 0.0 4.7 0.2 21.8 0.0 0.0 0.6 84.7 1.1 0.3 31.4 11.8 69.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.5 0.2 0.0 0.0 1.6 0.2 12.5 0.0 0.1 CLIC2 XAP121 ENSG00000155962 "Chloride intracellular channel 2" O15247 X 155276211-155334657 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 62.3;vagina: 66.1" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 83.4;Alveolar cells type 2: 48.6;Endothelial cells: 49.6;Kupffer cells: 47.8;monocytes: 118.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 9.5;myeloid DC: 24.5;non-classical monocyte: 6.5" "Group enriched" "Detected in many" 14 "dendritic cells: 24.5;monocytes: 9.5" "Group enriched" "Detected in some" 5 "HDLM-2: 37.3;K-562: 20.2;Karpas-707: 18.6;RPMI-8226: 31.8" "Low region specificity" "Detected in all" "HPA047381, HPA060101" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 290000 "Plasma membrane, Cytosol" Nucleoplasm "HPA047381: AB_2680022, HPA060101: AB_2684204" "unprognostic (3.27e-2)" "unprognostic (5.21e-3)" "unprognostic (9.70e-2)" "unprognostic (7.25e-2)" "unprognostic (9.71e-2)" "unprognostic (3.78e-2)" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.95e-1)" "unprognostic (1.74e-1)" "unprognostic (1.97e-1)" "unprognostic (3.31e-1)" "prognostic unfavorable (1.74e-5)" "unprognostic (1.97e-2)" "unprognostic (2.97e-2)" "unprognostic (6.63e-2)" "unprognostic (1.54e-1)" 26.5 3.7 3.8 7.5 6.1 3.4 24.1 2.6 4.8 15.5 6.8 0.6 3.3 4.0 11.3 10.5 10.4 6.5 9.8 9.4 3.7 3.4 5.4 6.3 31.0 15.6 7.5 1.4 12.5 2.6 2.0 7.8 4.5 6.8 9.1 6.9 3.0 5.4 3.2 10.3 5.2 7.3 10.2 5.2 32.1 4.7 5.6 4.3 6.9 62.3 8.7 12.4 14.0 66.1 0.0 24.5 0.6 9.5 1.1 0.1 1.0 0.2 0.0 0.4 0.3 0.3 2.1 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 37.3 0.2 5.2 0.1 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.2 0.0 0.2 20.2 18.6 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 31.8 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.7 0.6 0.7 0.3 1.2 1.6 0.0 0.9 1.1 0.6 0.0 1.8 0.1 0.0 9.5 0.1 0.0 0.0 0.1 24.5 0.0 0.0 0.0 0.6 1.1 6.5 2.5 0.0 1.0 3.8 6.1 2.6 4.8 3.7 3.4 7.5 1.4 6.8 4.3 83.4 48.6 0.8 0.7 11.7 1.1 2.8 0.0 2.7 10.3 0.0 0.0 0.0 0.0 0.0 0.1 49.6 0.0 23.3 0.2 0.1 22.3 0.4 3.5 1.0 4.8 0.0 1.2 19.0 47.8 0.4 12.7 29.8 16.9 118.2 0.0 0.0 0.1 0.0 8.9 0.2 0.3 6.5 4.8 0.0 0.0 12.0 0.0 2.2 0.0 1.4 CLINT1 "CLINT, ENTH, EPNR, KIAA0171" ENSG00000113282 "Clathrin interactor 1" Q14677 5 157785743-157859175 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 260.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 95.0;eosinophil: 27.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 95.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043280, HPA056947" Supported Supported Nucleoplasm,Vesicles NA NA 340000 Vesicles Nucleoplasm "HPA043280: AB_10793944, HPA056947: AB_2683283" "unprognostic (1.92e-2)" "unprognostic (6.93e-2)" "prognostic favorable (2.95e-4)" "unprognostic (7.23e-2)" "unprognostic (1.55e-1)" "unprognostic (2.79e-1)" "unprognostic (2.53e-1)" "unprognostic (8.13e-2)" "unprognostic (1.05e-1)" "unprognostic (3.19e-2)" "unprognostic (4.89e-3)" "unprognostic (1.04e-1)" "prognostic favorable (8.88e-5)" "unprognostic (1.91e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (6.77e-4)" "unprognostic (3.56e-1)" 22.0 23.3 12.6 27.1 18.8 38.1 18.8 13.6 14.7 22.0 27.9 10.0 43.8 28.8 19.1 30.3 56.4 17.1 40.3 23.4 14.0 12.7 40.8 48.6 22.3 19.2 11.7 11.7 20.1 25.3 47.9 25.9 30.1 14.3 21.5 23.7 11.3 39.9 47.1 38.7 26.0 34.6 30.9 13.0 19.0 29.4 12.1 13.0 23.6 30.3 23.3 32.8 37.1 33.8 7.8 9.9 95.0 7.8 8.8 12.7 7.5 22.7 33.0 23.5 21.8 32.8 27.7 33.8 32.2 33.4 31.9 45.0 46.0 36.1 43.0 36.9 30.6 41.3 34.5 31.9 37.2 45.5 20.3 25.7 28.6 29.7 22.9 33.5 39.1 38.9 20.5 28.0 35.7 40.3 19.9 29.7 25.3 24.5 24.0 25.5 20.1 30.7 21.8 24.6 22.4 34.2 27.6 35.3 36.3 31.9 41.1 20.7 22.6 23.2 40.3 31.7 31.1 27.7 27.7 29.9 27.9 20.7 25.3 31.5 28.0 26.6 55.2 22.5 44.8 24.4 95.0 7.4 27.6 7.4 7.8 12.7 7.8 7.1 7.3 9.9 7.0 6.2 6.6 2.8 8.8 7.8 7.8 10.1 7.5 12.6 18.8 13.6 14.7 14.0 12.7 11.7 11.7 14.3 13.0 56.6 99.2 47.4 59.4 50.7 20.8 83.7 107.0 167.3 144.5 64.6 7.9 38.0 81.2 70.0 3.2 43.5 56.7 46.7 56.4 59.6 50.0 79.2 80.0 72.7 26.7 11.1 52.4 21.5 38.0 2.9 43.7 46.0 33.7 103.6 70.8 23.6 54.4 66.6 26.9 71.1 17.5 38.8 32.4 38.1 40.0 68.4 57.1 39.6 82.7 260.7 CLK3 clk3 ENSG00000179335 "CDC like kinase 3" P49761 15 74598500-74645414 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046817 Approved Supported "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA046817: AB_10964124" "unprognostic (4.10e-2)" "unprognostic (8.43e-2)" "prognostic unfavorable (2.05e-6)" "unprognostic (1.91e-3)" "unprognostic (7.91e-2)" "unprognostic (5.76e-2)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" "unprognostic (1.95e-1)" "unprognostic (2.54e-1)" "unprognostic (8.14e-3)" "prognostic unfavorable (5.92e-4)" "unprognostic (1.35e-2)" "unprognostic (2.24e-1)" "unprognostic (9.73e-2)" "unprognostic (2.48e-1)" "unprognostic (2.25e-2)" 20.9 17.2 15.7 24.7 22.5 62.7 31.1 23.4 18.8 24.9 24.6 23.1 16.4 18.6 24.1 17.7 25.3 17.3 21.2 16.4 17.8 13.5 17.2 16.0 19.6 21.9 29.3 14.5 23.7 21.8 19.0 19.9 27.9 16.7 20.6 14.4 19.9 24.8 20.9 28.4 24.1 20.7 19.8 19.2 23.8 19.6 31.5 23.3 28.8 21.0 12.0 23.7 23.2 19.8 38.9 36.0 60.7 46.0 43.6 43.4 39.7 22.3 14.2 18.8 10.5 24.2 18.6 14.9 15.3 24.2 21.9 26.9 19.3 14.8 20.4 11.4 13.6 30.6 15.8 35.0 14.7 14.3 29.0 19.2 25.0 21.1 13.3 38.5 6.7 19.4 23.2 29.4 28.8 24.0 26.8 24.0 20.8 12.2 14.9 12.7 15.8 19.9 22.7 12.0 22.2 10.1 16.1 9.0 13.4 17.1 16.3 10.6 12.5 12.2 13.6 13.5 15.1 12.9 13.5 11.0 13.0 10.0 8.1 20.0 24.5 19.6 16.8 11.4 33.1 16.4 32.9 34.4 45.0 38.5 37.4 37.4 37.7 41.1 39.7 31.9 38.9 42.1 40.1 60.7 43.6 46.0 36.0 43.4 39.7 15.7 22.5 23.4 18.8 17.8 13.5 29.3 14.5 16.7 23.3 6.0 35.5 20.9 38.8 40.0 34.9 14.9 20.4 17.4 18.2 12.2 53.0 22.9 26.6 29.6 59.6 28.3 37.1 23.3 21.0 31.4 22.7 32.5 20.8 10.9 24.3 27.0 28.2 17.2 24.0 14.8 25.6 28.5 27.0 32.5 24.6 17.7 28.8 28.1 19.1 14.2 42.2 12.9 24.4 37.1 17.5 36.6 49.0 39.2 22.6 53.1 CLN6 "FLJ20561, HsT18960, nclf" ENSG00000128973 "CLN6, transmembrane ER protein" Q9NWW5 15 68206992-68257211 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 161.8;Hofbauer cells: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066046, HPA066759" Approved Approved "Nucleoli,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" "Nucleoli, Vesicles" "HPA066046: AB_2685604, HPA066759: " "unprognostic (1.01e-1)" "unprognostic (1.54e-3)" "unprognostic (7.01e-2)" "unprognostic (3.58e-2)" "unprognostic (2.71e-2)" "unprognostic (3.08e-1)" "unprognostic (2.24e-2)" "unprognostic (5.07e-2)" "unprognostic (2.40e-2)" "unprognostic (2.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.85e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-1)" "unprognostic (6.78e-2)" 21.2 17.8 11.6 16.5 11.8 29.8 13.9 14.9 20.7 14.4 20.2 13.2 11.6 17.1 11.7 14.3 16.7 12.0 17.1 10.4 11.7 10.8 22.0 29.5 18.8 27.0 11.1 12.2 12.4 19.7 11.7 11.5 18.6 14.3 13.4 18.0 28.6 16.0 17.9 16.3 17.0 18.5 12.4 11.6 26.5 15.7 13.8 9.7 27.7 14.5 18.2 21.7 11.0 10.9 2.9 4.6 9.4 13.4 1.8 4.1 2.7 11.5 28.8 7.5 10.6 4.7 3.8 18.2 11.0 5.3 13.6 11.2 22.2 18.8 18.0 5.5 6.5 10.1 21.5 21.6 10.7 5.4 11.9 26.4 25.9 21.1 16.5 9.6 29.1 18.5 6.7 3.6 10.9 7.5 2.8 9.0 10.3 17.0 36.5 10.4 31.6 13.2 20.9 18.1 20.5 12.3 12.9 23.1 24.5 11.3 30.2 15.5 6.4 12.4 19.4 10.6 5.9 10.4 29.1 5.9 15.3 18.2 11.3 38.9 26.7 29.0 14.7 9.6 35.4 14.8 0.0 7.3 0.4 2.8 11.5 3.8 2.9 2.1 4.1 4.6 2.3 2.7 1.2 9.4 1.8 13.4 3.8 1.9 2.7 11.6 11.8 14.9 20.7 11.7 10.8 11.1 12.2 14.3 9.7 8.9 5.8 12.7 17.8 17.9 161.8 19.9 0.0 0.0 4.5 5.2 15.7 29.2 0.0 3.1 0.2 12.9 13.6 23.3 1.6 44.9 15.2 12.6 9.2 17.7 76.0 20.6 14.6 14.1 18.0 1.3 8.3 11.9 18.6 7.2 15.3 16.9 3.1 20.9 7.8 1.3 31.0 6.5 8.0 0.9 16.8 12.3 18.2 10.9 30.5 14.5 CLNK MIST ENSG00000109684 "Cytokine dependent hematopoietic cell linker" Q7Z7G1 4 10486395-10684865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 10.9;lymphoid tissue: 10.8" "Cell type enhanced" "Detected in some" 9 "Distal tubular cells: 11.6;granulocytes: 11.5" "Cancer enriched" "Detected in single" 13 "renal cancer: 3.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HDLM-2: 9.2;U-937: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035671, HPA035672" Uncertain Uncertain Vesicles NA NA Vesicles "HPA035671: AB_10669673, HPA035672: AB_10669775" "unprognostic (2.47e-3)" "unprognostic (4.74e-4)" "unprognostic (1.99e-4)" "unprognostic (2.24e-3)" "unprognostic (1.17e-1)" "unprognostic (2.23e-6)" "unprognostic (2.05e-2)" "unprognostic (5.37e-4)" "unprognostic (9.87e-2)" "unprognostic (3.75e-2)" "unprognostic (2.55e-1)" "unprognostic (7.74e-3)" "unprognostic (1.55e-1)" "unprognostic (6.05e-3)" "unprognostic (6.65e-3)" "unprognostic (1.45e-1)" "unprognostic (2.99e-2)" 0.4 0.5 0.3 5.7 0.3 0.5 0.7 0.4 0.3 1.9 1.8 0.1 0.1 0.7 0.8 1.7 2.0 0.4 1.4 0.3 0.3 0.3 10.9 1.2 3.2 5.0 0.3 0.1 0.5 0.7 0.0 3.2 1.5 0.5 0.5 0.4 1.6 2.5 0.1 0.3 1.2 2.3 1.7 0.3 6.3 1.6 1.1 0.1 8.4 0.5 1.5 10.8 0.4 0.4 3.4 5.5 1.6 0.4 4.3 3.6 0.5 0.1 0.6 0.5 0.3 0.8 0.2 0.6 0.4 0.0 0.1 0.2 0.0 0.4 0.3 0.1 0.4 0.1 0.4 0.0 0.0 0.1 9.2 0.4 0.4 0.5 0.1 0.1 0.3 0.3 0.4 0.1 0.0 0.3 0.2 0.1 0.2 0.1 0.7 0.0 0.0 0.0 0.4 0.2 0.4 0.2 0.2 0.1 1.1 0.1 0.6 0.8 0.1 0.3 0.5 0.3 0.3 0.3 0.0 1.0 0.2 0.3 0.6 0.3 0.5 0.1 0.4 0.5 4.8 0.2 1.0 0.4 0.6 0.7 0.3 0.3 3.4 1.2 0.4 5.5 2.9 0.5 0.5 1.6 4.3 0.2 1.4 3.6 0.5 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.1 0.5 0.1 3.0 4.8 0.8 0.8 0.7 1.1 0.6 0.0 0.0 1.2 0.0 2.0 0.3 11.6 0.0 4.9 0.3 0.0 0.0 0.0 1.6 0.4 0.4 11.5 0.2 0.2 0.0 0.0 0.6 0.3 3.1 0.3 1.3 1.7 0.0 0.0 0.2 0.2 0.0 2.1 0.0 0.8 0.0 0.4 1.1 0.5 0.4 0.1 2.5 0.0 0.6 CLSTN2 "CDHR13, CS2, CSTN2, FLJ39113" ENSG00000158258 "Calsyntenin 2" Q9H4D0 3 139935185-140577397 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;ovary: 59.4" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 17.1;Late spermatids: 10.8;Leydig cells: 25.9" "Cancer enriched" "Detected in many" 7 "breast cancer: 15.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 21.0;SCLC-21H: 9.3;SuSa: 28.6;THP-1: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031342, HPA061800" Approved Uncertain "Vesicles,Cytokinetic bridge" Yes No 9100 Vesicles "Cytokinetic bridge" "HPA031342: AB_10602800, HPA061800: AB_2684615" "unprognostic (7.58e-2)" "unprognostic (2.64e-2)" "unprognostic (8.02e-2)" "unprognostic (1.51e-3)" "unprognostic (5.52e-3)" "unprognostic (8.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (5.58e-1)" "unprognostic (6.25e-2)" "unprognostic (2.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-2)" "unprognostic (3.16e-2)" "unprognostic (7.63e-5)" "unprognostic (7.22e-5)" 14.2 5.0 4.9 1.0 9.8 0.8 8.5 1.5 19.7 4.1 1.8 2.4 0.3 1.2 5.2 1.8 1.6 3.6 2.6 5.9 15.4 4.0 4.5 1.5 1.7 2.8 4.1 14.3 59.4 2.0 1.5 1.3 1.5 23.7 5.4 1.4 3.0 1.6 1.8 1.9 2.1 1.5 6.6 1.4 0.8 1.4 1.9 0.5 0.0 2.9 0.5 1.0 1.9 4.7 0.3 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 3.3 0.0 1.4 0.4 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 1.3 0.0 0.0 0.0 28.6 1.4 5.8 0.0 0.7 0.3 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 4.9 9.8 1.5 19.7 15.4 4.0 4.1 14.3 23.7 0.5 0.0 0.0 0.0 0.2 0.5 0.7 5.3 0.0 5.3 1.2 3.5 0.0 0.2 1.7 0.0 17.1 0.7 0.0 0.0 0.2 0.0 1.6 5.3 0.0 0.0 0.1 0.0 0.0 3.1 0.8 10.8 25.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 7.9 3.7 0.0 6.1 0.7 0.7 0.0 0.0 0.0 0.0 0.1 CMAS ENSG00000111726 "Cytidine monophosphate N-acetylneuraminic acid synthetase" Q8NFW8 12 22046174-22065674 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Syncytiotrophoblasts: 445.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039905 Supported Uncertain Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA039905: AB_10795237" "unprognostic (5.54e-2)" "unprognostic (4.10e-2)" "unprognostic (4.25e-1)" "unprognostic (5.39e-3)" "unprognostic (1.94e-2)" "unprognostic (3.99e-2)" "unprognostic (2.30e-2)" "unprognostic (4.17e-3)" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.44e-1)" "unprognostic (7.53e-2)" "prognostic unfavorable (7.19e-4)" "unprognostic (2.27e-1)" "unprognostic (1.91e-2)" "unprognostic (3.65e-1)" "unprognostic (2.03e-1)" 8.1 28.2 28.1 9.6 31.6 17.6 14.9 16.3 39.3 12.1 34.3 14.5 17.1 29.4 12.8 32.0 33.2 10.0 11.0 18.1 28.8 33.4 12.8 31.9 7.9 9.8 33.9 27.3 11.9 18.6 14.6 14.3 20.2 34.3 17.0 33.1 10.2 14.8 12.9 18.2 12.9 32.9 13.3 18.0 8.5 12.9 30.2 14.8 6.4 10.9 11.9 12.4 11.8 17.2 12.2 19.5 19.4 18.9 22.8 19.9 15.0 19.4 15.8 19.4 9.2 15.3 19.1 28.2 13.6 15.0 14.8 15.7 35.3 22.6 17.3 13.4 11.6 27.3 15.9 11.4 18.9 20.0 22.8 14.4 52.1 12.8 17.7 14.3 13.7 27.7 12.8 18.0 18.8 28.1 20.2 19.6 18.8 32.7 8.8 26.2 25.6 15.8 32.0 46.8 21.8 21.9 11.2 20.3 16.4 17.6 21.4 7.8 13.7 10.7 19.0 15.3 40.7 26.1 18.9 14.2 16.7 13.8 14.7 24.9 6.1 7.8 23.0 27.2 10.8 16.8 10.3 17.9 19.4 13.7 18.9 17.8 12.2 18.6 18.1 19.5 12.1 16.8 17.4 1.8 22.8 16.5 12.3 19.9 15.0 28.1 31.6 16.3 39.3 28.8 33.4 33.9 27.3 34.3 14.8 11.9 13.7 19.0 62.8 26.0 35.2 62.1 28.1 46.8 28.4 22.7 3.9 144.0 64.6 44.6 10.3 38.6 126.2 116.8 73.5 117.3 40.1 92.3 22.0 56.7 56.8 33.4 40.0 38.6 32.1 12.9 23.6 27.0 42.2 49.5 94.4 20.7 65.2 133.3 26.2 64.8 17.4 19.4 37.0 79.6 93.5 38.9 445.4 22.3 85.9 97.2 CMPK2 "NDK, TYKi, UMP-CMPK2" ENSG00000134326 "Cytidine/uridine monophosphate kinase 2" Q5EBM0 2 6840570-6866635 "Enzymes, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 12.9;HEL: 20.1;MOLT-4: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041430 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA041430: AB_10796674" "unprognostic (2.37e-1)" "unprognostic (6.07e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (4.71e-4)" "unprognostic (1.82e-1)" "unprognostic (5.08e-2)" "unprognostic (3.80e-2)" "unprognostic (8.93e-2)" "unprognostic (6.63e-2)" "unprognostic (4.54e-3)" "unprognostic (7.39e-3)" "unprognostic (1.43e-1)" "unprognostic (1.09e-3)" "unprognostic (1.28e-1)" "unprognostic (1.77e-2)" "unprognostic (7.69e-2)" "unprognostic (4.32e-2)" 8.8 3.8 3.0 6.8 8.1 14.5 4.2 0.9 5.0 2.7 4.2 4.0 1.3 5.0 2.5 6.4 1.8 2.3 3.4 3.7 3.3 3.9 4.0 3.1 17.9 13.4 3.2 5.7 1.3 3.7 2.9 3.0 4.7 3.6 2.1 2.2 4.7 20.8 4.3 3.0 1.2 6.1 3.1 3.8 7.9 7.4 9.2 0.4 8.8 3.1 1.6 2.6 2.7 1.6 1.4 1.9 7.8 6.4 0.9 0.7 1.2 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.2 14.2 12.9 0.0 1.4 3.1 0.8 0.0 3.7 0.2 0.0 0.0 0.0 0.3 0.2 20.1 0.0 0.0 0.0 0.7 1.4 0.0 0.0 0.1 0.0 0.0 0.0 2.0 4.9 0.1 0.0 0.1 11.0 3.7 0.3 0.0 1.1 3.5 0.0 0.0 0.0 0.4 0.3 0.5 0.2 0.0 1.7 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 3.3 0.4 0.0 0.0 3.7 0.9 5.5 2.8 7.8 0.7 6.4 0.4 1.4 0.5 0.4 1.9 0.2 0.5 0.5 1.8 0.9 3.2 0.1 0.6 1.2 3.0 8.1 0.9 5.0 3.3 3.9 3.2 5.7 3.6 0.4 3.0 6.9 2.7 0.8 0.3 1.6 1.4 0.0 4.0 0.0 1.8 0.0 2.0 1.7 2.4 2.5 4.7 5.3 70.0 5.8 2.4 1.9 0.7 2.3 1.3 15.9 0.0 6.9 7.4 6.7 1.1 1.4 5.1 0.0 5.4 1.7 4.6 4.1 1.9 5.3 0.6 0.2 0.0 2.0 0.1 4.1 0.4 0.7 4.3 0.9 1.6 CNIH1 "CNIH, CNIL, TGAM77" ENSG00000100528 "Cornichon family AMPA receptor auxiliary protein 1" O95406 14 54423560-54441431 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002544 Approved Uncertain Vesicles NA NA Vesicles "HPA002544: AB_2081856" "unprognostic (1.06e-1)" "unprognostic (1.18e-3)" "unprognostic (7.09e-2)" "unprognostic (5.06e-2)" "unprognostic (1.50e-1)" "unprognostic (8.93e-3)" "unprognostic (1.47e-1)" "unprognostic (2.71e-3)" "unprognostic (4.78e-2)" "unprognostic (4.62e-1)" "unprognostic (1.38e-2)" "unprognostic (1.79e-1)" "unprognostic (4.12e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-1)" "unprognostic (1.71e-2)" "prognostic unfavorable (8.95e-4)" 32.2 32.3 24.3 19.9 24.9 11.7 27.7 20.6 28.0 23.5 31.0 18.9 22.5 35.8 25.4 20.3 28.7 25.2 27.5 31.0 21.6 22.9 29.4 83.6 26.1 36.2 23.5 18.9 22.0 26.3 12.3 31.2 21.0 20.5 26.9 35.8 23.2 20.5 23.2 25.1 14.3 32.1 46.2 25.5 17.1 20.7 16.7 16.2 26.3 24.1 27.3 27.8 40.6 20.0 23.6 31.7 7.6 31.2 15.6 30.7 31.6 41.6 25.5 21.5 24.1 58.1 74.4 20.0 50.7 65.1 44.0 50.5 15.1 58.8 52.6 33.8 38.4 26.9 41.8 38.8 36.9 55.0 20.1 22.7 20.1 16.4 27.4 58.4 24.3 17.0 60.5 46.1 40.9 58.0 45.2 41.2 21.8 19.6 17.9 48.9 23.0 26.9 18.5 15.8 48.4 51.8 20.7 36.1 17.5 49.7 31.2 18.0 20.0 29.6 23.8 56.1 20.8 36.6 26.5 26.4 37.0 36.9 31.0 30.5 11.2 24.2 25.5 44.9 20.9 32.7 1.9 31.2 3.8 12.9 23.7 21.5 23.6 22.8 18.4 31.7 18.9 30.7 20.5 7.6 15.6 18.2 17.8 23.2 31.6 24.3 24.9 20.6 28.0 21.6 22.9 23.5 18.9 20.5 16.2 32.8 55.8 74.2 72.9 93.9 41.9 74.4 43.3 65.6 43.3 43.6 19.6 81.2 76.3 83.7 21.1 62.1 85.5 46.7 54.2 106.7 92.0 77.1 194.9 125.6 106.1 63.5 100.2 65.1 100.9 13.8 55.5 72.8 79.2 77.5 75.5 42.1 62.6 89.2 61.9 125.2 36.3 45.3 68.4 49.2 77.8 96.1 59.3 59.7 96.4 71.6 CNNM4 "ACDP4, KIAA1592" ENSG00000158158 "Cyclin and CBS domain divalent metal cation transport mediator 4" Q6P4Q7 2 96760902-96811891 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Biomineralization, Ion transport, Sensory transduction, Transport, Vision" "Amelogenesis imperfecta, Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 106.0;Enterocytes: 53.8;Rod photoreceptor cells: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-BR-3: 29.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017732 Enhanced Uncertain "Plasma membrane,Actin filaments" NA NA "Actin filaments" "Plasma membrane" "HPA017732: AB_1847395" "unprognostic (1.98e-3)" "unprognostic (8.95e-3)" "unprognostic (1.11e-1)" "prognostic unfavorable (9.14e-4)" "unprognostic (3.42e-2)" "unprognostic (5.28e-2)" "unprognostic (1.54e-3)" "unprognostic (3.36e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.75e-4)" "unprognostic (4.75e-3)" "unprognostic (3.72e-1)" "unprognostic (8.14e-2)" "unprognostic (3.13e-1)" "unprognostic (3.44e-2)" "unprognostic (1.15e-2)" "unprognostic (1.06e-1)" 3.7 4.0 4.8 17.0 9.6 4.5 7.4 24.1 11.1 6.8 31.2 11.3 8.3 6.3 10.4 5.2 7.7 10.8 7.3 11.5 5.4 5.0 5.9 4.9 8.1 4.3 6.0 6.6 6.1 11.4 9.0 10.6 17.1 5.5 7.4 33.5 13.9 10.8 11.3 21.3 7.4 11.1 5.7 5.2 6.1 12.6 11.8 6.1 4.6 9.7 6.1 9.3 6.5 7.4 3.7 2.2 2.8 2.3 0.8 3.2 1.1 6.9 4.6 3.7 6.8 3.9 2.6 10.2 3.0 4.3 4.5 6.1 8.3 7.5 5.0 8.8 3.1 6.2 9.0 9.5 5.2 4.2 10.1 7.5 4.0 3.1 4.5 5.4 1.9 4.0 2.5 6.5 7.2 4.4 3.0 2.4 5.1 2.0 14.4 2.3 9.8 4.0 2.8 4.9 12.9 6.3 6.0 1.7 5.8 4.5 5.4 17.4 5.2 5.8 29.6 4.3 10.8 14.4 3.3 2.2 2.6 5.9 5.7 3.4 5.0 4.0 2.6 3.8 3.8 4.6 2.8 1.6 0.5 3.2 1.8 1.1 3.7 1.7 1.7 2.2 2.1 1.1 2.1 0.7 0.8 2.3 1.7 0.8 1.1 4.8 9.6 24.1 11.1 5.4 5.0 6.0 6.6 5.5 6.1 35.7 7.7 4.7 3.8 5.0 38.8 11.8 7.6 5.3 14.8 7.0 106.0 4.7 0.0 2.6 4.1 2.9 53.8 0.0 3.6 1.4 2.8 3.4 1.1 3.0 3.0 31.8 9.7 3.1 5.4 1.0 0.9 2.4 0.0 0.0 26.3 7.7 3.8 20.9 1.1 1.2 46.8 0.0 4.7 5.5 2.0 3.6 5.6 2.9 21.7 4.9 CNR1 "CANN6, CB-R, CB1, CB1A, CB1K5, CNR" ENSG00000118432 "Cannabinoid receptor 1" P21554 6 88139864-88166359 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5" "Cell type enriched" "Detected in some" 14 "Sertoli cells: 97.0" "Cancer enriched" "Detected in many" 13 "glioma: 12.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 2.9;naive B-cell: 2.1" "Lineage enriched" "Detected in single" 6 "B-cells: 2.9" "Group enriched" "Detected in some" 7 "ASC diff: 40.3;HSkMC: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042256, HPA069945" Enhanced Supported Supported "Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Actin filaments" "HPA042256: AB_2677917, HPA069945: " "unprognostic (1.28e-1)" "unprognostic (7.04e-2)" "unprognostic (4.61e-2)" "unprognostic (4.08e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-3)" "unprognostic (1.37e-1)" "unprognostic (2.07e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-2)" "unprognostic (2.74e-2)" "unprognostic (2.68e-1)" "unprognostic (1.70e-1)" "unprognostic (5.59e-3)" "unprognostic (2.68e-3)" "unprognostic (5.88e-2)" "unprognostic (7.00e-2)" 19.4 6.4 18.0 5.2 15.8 1.5 14.9 13.8 30.5 3.9 5.5 0.8 0.8 2.3 3.1 4.7 3.7 5.5 3.6 1.4 17.6 7.7 0.9 0.7 6.4 6.5 2.3 14.7 4.1 1.8 1.3 18.3 5.2 4.2 1.5 5.1 0.0 4.3 4.0 1.7 2.4 4.2 5.8 3.2 2.3 2.3 2.7 2.8 0.0 2.6 0.0 9.9 2.7 3.1 2.9 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 40.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.9 1.4 0.0 2.6 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 3.3 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.7 3.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 18.0 15.8 13.8 21.4 17.6 7.7 2.3 14.7 4.2 2.8 0.0 7.2 2.7 0.4 0.6 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 97.0 2.3 0.0 0.1 0.1 0.1 0.0 0.0 0.7 CNTLN "bA340N12.1, C9orf101, C9orf39, FLJ20276" ENSG00000044459 Centlein Q9NXG0 9 17134982-17503923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 58.9;Spermatogonia: 51.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.9" "Lineage enriched" "Detected in many" 4 "monocytes: 6.9" "Cell line enhanced" "Detected in many" "HEL: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007201, HPA036728, HPA036729" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA007201: AB_2667775, HPA036728: AB_10670847, HPA036729: AB_10670240" "unprognostic (1.97e-2)" "unprognostic (2.81e-3)" "unprognostic (1.81e-1)" "unprognostic (2.48e-1)" "unprognostic (1.55e-1)" "unprognostic (1.60e-1)" "unprognostic (7.71e-2)" "unprognostic (1.68e-1)" "unprognostic (7.71e-3)" "unprognostic (5.07e-3)" "unprognostic (1.06e-1)" "unprognostic (6.65e-2)" "unprognostic (2.47e-1)" "unprognostic (5.38e-2)" "unprognostic (3.35e-2)" "unprognostic (1.37e-1)" "unprognostic (5.80e-2)" 13.2 5.6 4.3 5.2 5.1 12.5 7.4 15.5 4.5 16.6 8.6 4.2 6.7 2.2 22.6 6.0 6.0 8.0 7.4 4.9 4.2 3.8 5.0 20.0 5.4 4.8 4.9 2.6 15.2 3.6 10.0 13.2 6.1 6.3 9.8 4.0 7.0 3.8 6.3 5.9 3.5 4.4 11.9 8.1 8.6 4.4 8.2 6.8 4.4 5.5 5.8 2.8 11.7 13.5 0.3 1.5 0.8 6.9 1.2 0.2 0.5 5.9 4.1 9.0 5.1 4.5 10.5 0.3 7.0 4.7 5.2 7.2 0.3 2.0 4.3 1.1 4.8 5.7 0.3 10.4 2.9 8.2 0.2 3.7 25.5 8.7 1.5 4.9 3.5 5.6 6.6 1.5 4.4 4.3 4.9 7.4 1.6 0.9 1.0 8.3 0.5 2.8 5.6 7.0 1.0 7.7 4.2 8.3 2.1 3.0 1.5 5.7 5.9 8.5 0.2 2.2 3.7 1.7 8.9 5.4 7.2 2.8 7.8 6.0 3.6 4.3 0.1 3.4 4.4 3.2 0.6 2.7 0.1 0.1 3.3 0.0 0.3 0.2 0.1 1.5 0.3 0.1 0.1 0.8 1.2 6.9 1.5 0.2 0.5 4.3 5.1 15.5 4.5 4.2 3.8 4.9 2.6 6.3 6.8 6.0 14.5 0.8 12.1 7.8 9.1 10.6 5.1 2.7 2.3 8.7 0.0 1.5 5.0 7.5 13.2 20.3 1.3 23.3 10.4 4.0 13.6 3.2 7.0 35.9 15.7 19.1 2.4 19.6 34.5 6.5 42.3 18.3 8.5 26.2 2.6 25.0 4.2 0.0 29.0 6.3 8.4 12.9 15.0 58.9 51.1 4.8 0.8 3.2 3.0 3.5 CNTROB "LIP8, PP1221" ENSG00000170037 "Centrobin, centriole duplication and spindle assembly protein" Q8N137 17 7932101-7949918 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 51.2" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023319, HPA023320, HPA023321, HPA023325" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892" "unprognostic (5.73e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-1)" "unprognostic (5.26e-2)" "unprognostic (4.21e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (9.88e-4)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.07e-1)" "unprognostic (3.47e-3)" "unprognostic (1.48e-2)" "unprognostic (8.63e-2)" "unprognostic (4.47e-2)" "unprognostic (1.54e-1)" "unprognostic (4.79e-1)" "unprognostic (2.16e-2)" 9.0 7.4 7.5 9.2 10.1 18.4 9.3 11.2 12.7 13.0 10.9 9.8 9.9 6.8 21.3 12.6 11.0 10.4 9.0 7.1 9.5 8.0 9.2 8.7 15.0 8.4 9.3 9.9 11.4 11.0 16.5 9.6 9.9 9.9 9.9 12.5 10.3 9.6 8.6 6.8 16.9 9.1 16.3 7.0 9.9 8.4 51.2 6.4 16.0 10.4 6.2 11.2 9.3 10.0 2.1 7.6 9.4 3.4 3.4 3.5 2.6 22.3 14.7 21.9 12.1 9.3 12.8 7.1 19.5 18.3 27.3 20.9 12.4 8.3 23.0 10.3 17.0 12.2 18.0 17.0 13.6 30.6 22.6 13.3 15.2 24.0 9.8 13.7 14.1 23.6 11.7 10.1 19.2 19.4 13.2 16.8 23.1 11.0 11.3 18.9 7.2 21.4 13.6 4.9 8.1 11.5 22.8 15.1 8.6 12.6 6.9 7.2 12.9 15.8 8.1 6.2 12.2 11.0 9.0 13.7 15.3 13.0 20.6 26.8 17.3 11.6 15.9 13.1 18.1 21.7 9.4 2.5 1.0 2.9 3.4 2.6 2.1 2.2 3.5 1.7 1.5 1.4 2.4 0.4 3.4 1.4 7.6 2.9 2.6 7.5 10.1 11.2 12.7 9.5 8.0 9.3 9.9 9.9 6.4 6.0 15.8 4.5 6.8 7.0 5.8 3.0 5.1 4.0 7.9 12.2 7.9 3.3 1.7 4.4 2.1 5.8 3.6 0.0 6.0 3.6 5.0 5.0 18.4 3.4 5.7 3.2 2.9 5.5 5.9 3.4 4.9 7.2 3.3 0.0 5.6 5.3 5.0 3.5 7.4 2.6 6.5 0.0 3.5 40.6 8.3 7.5 2.1 4.9 7.3 4.1 COG5 "GOLTC1, GTC90" ENSG00000164597 "Component of oligomeric golgi complex 5" Q9UP83 7 107201555-107564514 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020300, HPA041583" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA020300: AB_2081406, HPA041583: AB_2677564" "unprognostic (3.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (9.72e-4)" "unprognostic (2.41e-1)" "unprognostic (3.11e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (3.40e-3)" "unprognostic (1.94e-1)" "unprognostic (2.06e-1)" "unprognostic (3.91e-3)" "unprognostic (8.73e-2)" "unprognostic (3.90e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (1.15e-1)" 17.2 15.8 15.2 13.7 14.9 16.5 13.9 16.1 17.7 24.8 12.1 15.0 18.3 8.8 28.4 14.0 16.4 10.9 20.3 25.7 13.3 10.3 12.7 8.9 12.9 9.5 14.7 12.5 16.7 18.9 40.3 28.4 14.4 13.4 25.6 14.1 10.5 34.0 20.6 16.5 15.8 12.5 23.8 17.5 10.8 13.1 12.6 15.3 14.0 26.3 11.5 17.3 13.9 21.4 9.8 8.6 10.1 12.9 7.0 12.3 8.9 16.2 7.5 6.8 2.6 2.0 1.8 6.7 12.0 14.3 6.4 10.2 4.8 7.5 2.3 4.6 11.8 14.7 8.4 2.8 2.1 9.3 11.3 2.1 1.8 3.1 8.0 1.5 4.6 10.7 6.1 1.1 12.5 14.0 12.2 18.4 4.6 5.2 8.9 12.3 8.0 4.8 0.0 0.9 16.0 8.1 2.1 3.0 4.2 5.5 7.8 1.5 10.1 4.1 12.4 13.1 8.5 1.2 3.0 20.9 3.9 6.6 19.9 7.0 2.9 6.7 5.0 10.5 6.4 19.0 9.9 10.8 10.1 9.6 12.5 12.3 9.8 12.0 10.3 8.6 8.2 10.2 10.1 5.1 7.0 12.9 5.5 9.5 8.9 15.2 14.9 16.1 17.7 13.3 10.3 14.7 12.5 13.4 15.3 3.0 13.3 7.0 10.2 10.9 20.8 22.6 5.1 12.0 12.5 14.0 31.4 8.8 1.7 9.2 12.8 11.7 13.0 0.0 9.5 6.7 12.2 18.0 3.5 4.9 10.2 11.1 9.9 7.4 11.0 17.5 10.9 12.3 11.8 10.8 14.9 7.8 8.4 10.5 11.7 5.4 17.5 25.8 6.2 14.0 13.2 11.7 8.8 13.8 12.5 12.3 COL16A1 ENSG00000084636 "Collagen type XVI alpha 1 chain" Q07092 1 31652247-31704319 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Fibroblasts: 46.4;Leydig cells: 40.6;Muller glia cells: 43.8;Peritubular cells: 85.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 38.8;ASC TERT1: 30.0;BJ hTERT+: 32.9;fHDF/TERT166: 30.0;HSkMC: 28.4;U-2197: 27.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027237 Uncertain "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 530000 Cytosol "Plasma membrane" "HPA027237: AB_10600699" "unprognostic (2.25e-2)" "unprognostic (9.88e-2)" "unprognostic (5.64e-2)" "unprognostic (8.43e-2)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.00e-1)" "unprognostic (3.99e-2)" "unprognostic (2.04e-1)" "unprognostic (4.48e-3)" "unprognostic (1.66e-3)" "unprognostic (1.44e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (4.00e-9)" "unprognostic (9.62e-2)" "unprognostic (6.13e-2)" "unprognostic (4.60e-2)" "unprognostic (2.15e-2)" 18.0 7.3 7.0 12.7 9.0 0.2 10.8 2.8 8.2 63.1 17.3 10.2 12.5 6.1 31.0 15.2 9.3 8.3 15.9 9.1 9.6 6.2 3.4 1.0 7.2 3.1 9.9 10.2 62.6 2.6 1.3 7.3 8.2 8.8 29.3 4.6 12.5 15.3 38.1 4.2 26.9 8.6 45.2 15.7 3.9 10.5 10.0 10.3 1.5 11.8 7.9 5.0 26.1 28.3 0.2 0.0 0.7 0.1 0.1 0.4 0.0 0.0 0.5 0.0 0.0 38.8 30.0 4.1 17.8 32.9 4.3 4.5 0.1 3.1 0.0 0.5 30.0 0.6 13.9 0.0 18.3 1.0 0.0 0.0 0.0 2.0 6.0 12.9 0.0 0.1 28.4 12.6 12.3 6.7 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.4 0.7 2.1 0.3 2.6 0.1 0.3 0.0 0.0 16.0 16.0 27.5 0.3 0.0 0.0 0.0 10.9 0.0 1.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.7 0.1 0.1 0.0 0.0 0.0 7.0 9.0 2.8 7.1 9.6 6.2 9.9 10.2 8.8 10.3 8.9 3.8 0.0 13.1 27.2 2.6 7.0 0.0 8.1 4.5 17.4 2.0 1.4 0.0 4.5 10.5 2.2 4.5 0.0 0.6 3.1 46.4 3.8 6.9 0.0 1.1 0.0 26.6 6.7 0.8 17.8 40.6 1.5 13.5 0.0 14.2 43.8 1.2 2.5 85.9 0.8 1.9 0.0 25.8 8.8 1.8 18.4 1.8 0.0 4.5 10.6 COL8A2 "FECD, FECD1, PPCD, PPCD2" ENSG00000171812 "Collagen type VIII alpha 2 chain" P25067 1 36095236-36125220 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 39.4" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 9.8;Fibroblasts: 13.4;Hofbauer cells: 6.5;Melanocytes: 6.8;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "classical monocyte: 1.0;intermediate monocyte: 1.2;myeloid DC: 2.8;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 15 "dendritic cells: 2.8;monocytes: 1.2" "Cell line enhanced" "Detected in some" "BJ: 5.6;fHDF/TERT166: 4.1;HHSteC: 14.2;hTERT-RPE1: 18.1;THP-1: 4.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA049788 Uncertain Uncertain "Golgi apparatus" "Secreted to extracellular matrix" NA NA "Golgi apparatus" "HPA049788: AB_2680882" "unprognostic (9.98e-2)" "unprognostic (3.26e-2)" "unprognostic (2.51e-2)" "unprognostic (8.41e-3)" "unprognostic (8.76e-2)" "prognostic favorable (9.44e-4)" "unprognostic (1.15e-1)" "unprognostic (1.75e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (7.26e-4)" "unprognostic (3.50e-2)" "unprognostic (3.01e-1)" "prognostic unfavorable (9.35e-5)" "unprognostic (1.08e-2)" "unprognostic (6.77e-2)" "unprognostic (2.24e-2)" "unprognostic (1.16e-3)" 4.4 1.2 1.7 8.1 3.4 0.3 7.2 6.0 1.3 9.6 4.8 4.5 1.0 1.4 5.2 3.1 6.4 3.4 6.3 11.1 1.7 1.4 1.1 0.4 4.8 2.9 3.8 0.9 4.2 1.8 0.1 3.7 13.7 7.6 5.5 2.1 39.4 6.5 13.4 1.4 4.6 1.8 16.3 4.8 7.5 9.6 1.9 2.5 1.9 7.7 4.7 3.5 10.1 5.5 0.0 2.8 0.1 1.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 1.0 0.1 5.6 1.6 1.5 0.9 0.2 0.1 0.0 0.8 4.1 0.0 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.1 14.2 0.0 0.0 1.7 0.1 0.7 0.0 18.1 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.5 0.5 0.5 0.0 0.2 0.4 0.0 4.5 0.1 2.3 0.3 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.1 0.0 0.2 2.4 0.0 0.2 1.7 3.4 6.0 1.3 1.7 1.4 3.8 0.9 7.6 2.5 0.0 2.6 0.0 1.6 1.9 0.0 9.8 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.3 0.0 0.7 0.0 0.0 0.2 0.2 13.4 0.7 2.3 0.0 6.5 0.0 0.0 0.6 1.9 0.0 2.8 5.1 6.8 0.0 0.0 0.3 0.4 0.0 5.6 0.0 0.0 6.5 2.3 0.0 0.1 1.1 0.7 0.0 0.0 0.4 COMMD4 FLJ20452 ENSG00000140365 "COMM domain containing 4" Q9H0A8 15 75335891-75343224 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 188.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039935, HPA066957" Uncertain Supported "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA039935: , HPA066957: AB_2685754" "unprognostic (7.77e-2)" "unprognostic (3.07e-3)" "unprognostic (1.03e-1)" "unprognostic (6.57e-3)" "unprognostic (1.32e-1)" "unprognostic (1.89e-1)" "unprognostic (1.49e-1)" "unprognostic (2.60e-1)" "unprognostic (9.11e-2)" "unprognostic (1.78e-3)" "unprognostic (2.01e-1)" "unprognostic (2.65e-1)" "unprognostic (1.39e-3)" "unprognostic (2.51e-1)" "unprognostic (2.27e-1)" "unprognostic (1.96e-1)" "unprognostic (5.07e-2)" 15.9 35.2 16.1 20.7 17.5 20.4 16.2 12.6 23.1 14.4 19.5 21.7 22.2 21.9 20.7 26.2 17.7 15.7 30.1 16.6 13.9 12.9 25.1 28.1 24.3 17.4 15.6 15.4 13.7 15.2 14.9 16.2 23.7 14.1 15.2 15.9 20.9 30.8 16.6 13.2 15.2 20.1 16.7 16.6 19.3 18.3 32.7 14.7 30.4 20.3 27.4 17.3 16.4 14.5 17.3 26.0 14.6 22.3 26.9 33.4 13.8 33.0 51.4 23.6 30.6 10.4 14.9 23.2 25.7 23.9 44.2 44.8 29.6 44.3 21.2 24.3 19.3 43.2 34.8 45.0 26.8 22.3 15.5 57.6 25.1 41.3 32.6 18.4 19.5 24.7 16.7 14.3 28.6 5.5 12.5 21.9 22.7 25.8 30.8 34.0 39.2 16.8 21.7 33.2 17.2 30.2 29.8 38.3 27.8 22.5 29.3 19.0 27.9 33.3 25.2 39.2 18.6 38.7 34.9 20.3 31.3 29.8 31.5 45.0 22.0 50.3 24.2 34.5 40.5 30.1 10.8 17.3 14.6 33.4 22.3 20.8 17.3 20.9 24.6 19.0 15.8 12.6 19.7 3.6 26.9 18.7 26.0 30.9 13.8 16.1 17.5 12.6 23.1 13.9 12.9 15.6 15.4 14.1 14.7 26.8 47.9 31.3 40.5 24.0 37.8 16.8 45.9 40.2 38.7 33.2 29.5 61.9 49.7 56.4 6.7 33.7 52.0 93.5 68.4 86.4 38.0 26.7 40.5 35.8 108.1 15.9 29.3 41.1 37.2 14.5 45.5 42.5 35.4 27.9 48.2 66.0 63.1 63.1 32.2 74.2 42.9 45.3 32.0 188.6 61.8 26.8 42.4 34.6 54.0 32.5 COQ5 MGC4767 ENSG00000110871 "Coenzyme Q5, methyltransferase" Q5HYK3 12 120503274-120534434 "Enzymes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049487 Approved Uncertain Nucleoli,Mitochondria NA NA Nucleoli Mitochondria "HPA049487: AB_2680789" "unprognostic (1.46e-1)" "unprognostic (1.99e-2)" "unprognostic (1.32e-1)" "unprognostic (6.30e-3)" "unprognostic (2.00e-1)" "unprognostic (1.66e-1)" "unprognostic (1.88e-1)" "unprognostic (1.60e-1)" "unprognostic (2.01e-2)" "unprognostic (6.20e-2)" "unprognostic (1.62e-1)" "unprognostic (8.37e-2)" "unprognostic (3.79e-2)" "unprognostic (2.02e-1)" "unprognostic (7.73e-2)" "unprognostic (2.00e-2)" "unprognostic (3.88e-2)" 14.6 21.7 15.8 16.1 16.7 7.0 29.5 15.6 21.3 12.5 16.4 13.5 21.8 15.7 12.6 16.4 14.0 15.5 13.5 31.9 14.8 13.1 26.0 39.8 17.6 19.1 17.5 15.4 15.1 28.6 14.2 13.4 18.6 19.4 12.7 17.1 11.6 17.9 17.8 58.4 11.1 13.2 14.0 18.5 14.6 12.4 16.9 15.0 17.2 17.7 30.4 15.2 10.1 17.0 21.3 27.4 9.7 19.6 25.1 28.2 22.4 15.9 25.6 23.1 6.6 30.5 23.5 15.9 19.5 12.8 20.0 12.7 10.2 13.5 16.1 23.1 20.4 14.2 17.3 20.5 21.7 20.6 20.1 12.1 21.4 15.7 16.9 24.9 23.3 13.5 22.5 23.5 18.6 22.0 31.3 17.5 31.1 21.0 11.8 23.1 20.9 13.4 26.8 20.3 11.5 19.9 25.0 23.4 23.3 25.7 12.2 17.5 14.1 14.1 7.2 26.5 25.2 36.3 19.3 17.5 13.9 15.9 10.2 12.9 25.5 21.5 18.3 15.8 22.2 16.6 9.4 19.6 9.7 18.8 19.2 18.2 21.1 20.4 19.9 27.4 21.3 28.2 22.3 2.1 25.1 17.9 18.0 24.4 22.4 15.8 16.7 15.6 21.3 14.8 13.1 17.5 15.4 19.4 15.0 11.9 10.9 16.3 10.7 6.9 11.5 26.2 15.3 16.0 7.9 14.0 13.7 60.9 39.7 25.5 42.0 11.7 17.2 23.3 17.3 38.3 14.1 8.4 17.3 37.2 40.3 4.8 14.5 16.0 15.6 14.5 15.3 13.1 21.9 36.1 14.6 11.8 12.3 23.2 17.7 52.6 14.4 6.5 10.3 13.7 15.4 7.9 48.7 17.5 29.2 7.5 CORIN "ATC2, CRN, Lrp4, PRSC, TMPRSS10" ENSG00000145244 "Corin, serine peptidase" Q9Y5Q5 4 47593998-47838106 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 11.6;heart muscle: 39.5" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 50.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "pons and medulla: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "ASC TERT1: 32.6" "Region enhanced" "Detected in some" "basal ganglia: 2.7" "Low region specificity" "Detected in single" HPA070941 Approved "Nuclear bodies,Plasma membrane,Actin filaments" "Intracellular and membrane" Yes No "Plasma membrane" "Nuclear bodies, Actin filaments" "HPA070941: AB_2686324" "unprognostic (1.05e-1)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (2.10e-1)" "unprognostic (3.18e-1)" "unprognostic (3.58e-4)" "unprognostic (3.19e-1)" "unprognostic (3.67e-2)" "unprognostic (8.22e-2)" "unprognostic (9.78e-2)" "unprognostic (6.53e-2)" "unprognostic (1.18e-1)" "unprognostic (2.86e-2)" "unprognostic (5.18e-2)" "unprognostic (7.22e-2)" "unprognostic (1.33e-2)" 0.3 0.1 0.3 0.0 0.1 0.0 0.8 0.1 0.1 3.1 0.1 0.1 2.6 0.0 3.4 11.6 0.7 1.2 4.5 39.5 0.0 0.2 2.0 0.0 1.3 0.0 0.2 0.0 0.6 0.1 0.0 1.5 0.6 1.6 1.7 0.0 0.4 0.3 4.6 0.2 5.3 0.4 0.5 0.0 3.5 0.3 3.7 0.0 0.2 0.1 1.7 0.4 0.8 3.2 0.2 0.0 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.2 7.5 32.6 0.0 1.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.0 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.2 0.2 0.0 1.6 0.0 0.0 6.9 0.0 0.2 3.4 0.8 50.9 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 9.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.8 4.4 0.0 5.0 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.1 0.0 4.2 3.0 4.6 2.4 0.0 0.0 0.0 0.2 CORO7-PAM16 ENSG00000103426 "CORO7-PAM16 readthrough" 16 4340251-4420494 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Ciliated cells: 1.4;Club cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;HDLM-2: 2.4;THP-1: 1.9;TIME: 1.5" "HPA041657, HPA053586, HPA062721" Uncertain Approved Nucleoplasm,Microtubules,Mitochondria NA NA "Nucleoplasm, Mitochondria" Microtubules "HPA041657: AB_10796351, HPA053586: AB_2682201, HPA062721: AB_2684849" "unprognostic (2.95e-2)" "unprognostic (2.46e-1)" "unprognostic (1.44e-1)" "unprognostic (2.46e-1)" "unprognostic (2.11e-1)" "unprognostic (1.24e-2)" "unprognostic (2.11e-4)" "unprognostic (4.39e-2)" "unprognostic (9.83e-3)" "unprognostic (1.20e-1)" "unprognostic (8.75e-3)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.79e-2)" "unprognostic (2.59e-2)" "unprognostic (2.19e-1)" "unprognostic (3.85e-1)" 2.4 3.4 5.4 5.2 7.4 6.7 2.0 3.0 6.0 2.0 2.5 10.0 0.6 3.2 2.2 2.4 2.2 2.9 3.1 2.2 4.8 4.1 2.0 2.9 3.4 11.2 10.9 3.2 2.0 2.0 2.0 1.7 2.4 4.1 2.2 2.0 1.1 2.0 3.0 2.4 3.1 2.5 2.2 10.1 4.5 2.5 4.3 9.9 4.7 2.0 1.2 4.1 2.8 1.8 0.4 0.6 2.7 1.3 0.5 0.8 1.3 0.0 0.0 0.0 0.4 0.0 0.3 0.8 0.2 0.4 0.0 0.0 1.7 0.3 0.0 0.2 0.0 0.3 0.9 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.7 0.0 0.5 0.0 0.2 1.4 0.2 0.7 0.7 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.2 0.0 1.9 1.5 0.0 0.0 0.6 0.1 0.6 1.2 0.1 0.0 0.1 0.0 0.0 1.3 0.9 0.8 0.7 0.7 0.3 0.4 0.3 0.6 0.4 0.3 0.3 2.7 0.5 0.4 0.3 0.3 1.3 5.4 7.4 3.0 6.0 4.8 4.1 10.9 3.2 4.1 9.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COX10 ENSG00000006695 "COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor" Q12887 17 14069496-14208677 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heme biosynthesis" Transferase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 34.9" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 89.2;Late spermatids: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032005, HPA032006" Supported Supported Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoli, Cytosol" "HPA032005: AB_10603560, HPA032006: AB_10670554" "unprognostic (6.17e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.40e-2)" "unprognostic (6.27e-3)" "unprognostic (1.07e-1)" "unprognostic (9.46e-3)" "unprognostic (6.46e-2)" "prognostic favorable (4.32e-6)" "prognostic favorable (8.73e-4)" "unprognostic (8.82e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-2)" 5.5 6.9 5.3 5.7 6.5 7.0 5.4 6.5 7.2 4.4 11.8 4.1 2.9 9.7 5.1 3.6 9.4 4.8 3.5 18.9 5.8 3.8 10.0 9.3 5.2 8.4 4.5 2.8 4.9 9.6 7.2 6.4 6.6 5.7 5.2 10.1 5.5 6.7 4.8 34.9 6.0 10.9 7.2 4.0 4.6 7.7 15.5 4.9 5.9 5.2 9.6 7.4 7.2 5.8 11.9 13.6 4.0 14.1 8.8 17.5 9.8 7.3 14.1 5.9 8.4 5.9 5.4 13.3 8.9 6.2 16.3 11.3 12.3 5.4 17.3 7.1 9.0 5.6 14.1 11.9 11.5 13.1 9.3 12.0 10.3 11.3 13.6 10.3 10.6 9.7 7.7 14.5 10.2 13.0 6.5 8.6 12.3 13.9 5.9 7.2 9.1 9.0 7.0 8.9 27.6 7.3 7.6 19.9 12.2 10.2 13.8 4.4 7.4 9.2 12.3 11.0 29.1 6.9 6.0 7.0 7.1 6.0 7.2 11.2 7.2 10.1 7.8 10.7 11.0 8.8 3.0 10.6 4.0 9.9 14.1 10.4 11.9 11.6 10.3 13.6 8.2 12.6 11.9 1.2 8.8 11.9 4.6 17.5 9.8 5.3 6.5 6.5 7.2 5.8 3.8 4.5 2.8 5.7 4.9 0.0 14.3 5.2 7.2 8.7 8.0 89.2 7.6 5.3 4.5 10.4 9.8 16.5 34.9 8.0 33.1 4.9 19.0 0.0 7.5 14.8 5.1 7.4 4.7 8.9 9.4 0.0 12.1 4.9 3.8 61.2 2.0 5.4 5.0 4.6 14.2 2.8 8.6 11.0 6.3 11.4 11.6 0.0 5.1 14.6 15.9 9.2 13.5 5.3 15.1 11.8 CPAMD8 "K-CAP, KIAA1283, VIP" ENSG00000160111 "C3 and PZP like, alpha-2-macroglobulin domain containing 8" Q8IZJ3 19 16892947-17026815 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 19.3;retina: 23.7;seminal vesicle: 30.5" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 21.4;Collecting duct cells: 26.2;Glandular cells: 18.0;Leydig cells: 29.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "classical monocyte: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "BEWO: 14.7;EFO-21: 9.5;T-47d: 25.8" "Not detected" "Not detected" "HPA031327, HPA031328, HPA031329, HPA031330" Uncertain Uncertain "Focal adhesion sites" "Secreted to blood" NA NA 180000 "Focal adhesion sites" "HPA031327: AB_2673829, HPA031328: AB_2673830, HPA031329: , HPA031330: AB_10603788" "unprognostic (4.71e-3)" "unprognostic (1.07e-2)" "unprognostic (4.20e-2)" "unprognostic (2.76e-2)" "unprognostic (4.32e-2)" "unprognostic (4.06e-3)" "unprognostic (7.85e-2)" "unprognostic (9.30e-2)" "unprognostic (1.58e-1)" "unprognostic (2.71e-2)" "unprognostic (1.62e-1)" "unprognostic (4.24e-2)" "unprognostic (8.69e-2)" "unprognostic (1.01e-3)" "unprognostic (2.08e-1)" "unprognostic (8.45e-2)" "unprognostic (1.80e-2)" 3.1 1.3 1.0 0.4 2.3 0.2 3.6 0.6 2.3 5.3 0.4 2.9 6.5 0.2 1.5 8.2 0.6 0.6 0.4 7.0 1.2 1.3 8.9 0.5 11.5 1.5 4.9 0.4 0.6 0.4 3.5 2.0 3.1 5.1 19.3 0.0 23.7 1.1 30.5 1.7 0.4 0.4 0.4 5.6 1.1 0.1 0.9 2.8 0.9 11.6 1.4 0.4 1.2 1.4 0.2 0.0 0.6 1.5 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 14.7 0.0 0.1 0.0 0.0 0.0 0.0 0.3 9.5 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 2.2 0.5 0.0 0.0 1.4 0.0 0.1 0.4 2.0 0.0 0.0 0.0 0.4 0.0 0.1 25.8 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 2.3 0.6 2.3 1.2 1.3 4.9 0.4 5.1 2.8 20.8 21.4 0.0 10.1 0.8 0.4 4.8 2.5 1.4 12.5 26.2 0.0 6.4 0.0 0.6 1.5 8.6 0.0 0.0 0.0 5.0 2.4 18.0 2.3 0.0 2.6 0.0 0.0 12.9 6.6 3.6 29.1 1.5 0.0 0.0 0.4 0.0 0.9 0.8 6.0 0.0 0.0 0.0 2.8 5.4 1.0 0.5 5.0 0.0 0.0 3.4 CPLX1 CPX-I ENSG00000168993 "Complexin 1" O14810 4 784957-826198 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 98.8" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 30.5;Horizontal cells: 17.5;Intestinal endocrine cells: 20.6;Rod photoreceptor cells: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071191, HPA074390" Supported Uncertain Vesicles NA NA Vesicles "HPA071191: , HPA074390: " "unprognostic (9.21e-3)" "prognostic unfavorable (4.20e-4)" "unprognostic (3.45e-2)" "unprognostic (4.68e-2)" "unprognostic (1.16e-2)" "unprognostic (1.02e-1)" "unprognostic (3.14e-2)" "unprognostic (2.26e-2)" "unprognostic (9.52e-3)" "unprognostic (2.01e-2)" "prognostic favorable (5.05e-4)" "unprognostic (1.10e-3)" "unprognostic (3.32e-1)" "unprognostic (2.05e-2)" "unprognostic (1.12e-1)" "unprognostic (1.34e-1)" "unprognostic (7.77e-2)" 7.8 6.5 13.1 2.9 40.7 1.5 2.4 26.3 98.8 2.2 2.5 3.9 0.0 2.8 4.2 1.5 1.6 2.3 1.9 3.0 16.9 7.6 2.4 2.4 2.8 2.4 16.3 18.3 2.4 3.0 3.4 1.7 1.8 52.8 4.4 1.7 3.8 4.4 2.5 4.5 3.0 2.8 2.0 5.4 5.6 3.2 4.9 4.2 0.0 1.8 0.0 1.6 1.7 1.7 0.2 2.3 0.1 0.0 0.0 0.8 0.0 2.7 0.2 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 8.2 0.9 2.0 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.9 0.2 0.0 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.1 0.0 1.2 1.1 0.0 1.3 2.2 1.3 0.0 0.0 0.8 0.0 0.2 43.0 6.0 0.2 2.8 0.0 0.1 4.3 0.1 0.0 0.0 0.3 0.0 0.0 0.1 2.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 13.1 40.7 26.3 98.8 16.9 7.6 16.3 18.3 52.8 4.2 0.0 0.0 0.0 3.4 0.9 30.5 3.0 0.0 0.0 3.4 0.0 3.9 0.0 1.7 0.4 1.2 10.8 0.5 0.0 0.7 2.6 0.7 2.0 0.0 3.8 0.2 17.5 20.6 8.0 0.3 1.9 1.7 0.0 1.7 0.0 1.7 13.7 0.7 2.9 0.0 0.8 15.0 0.0 1.4 4.7 8.2 1.0 0.8 1.0 1.5 1.1 CPLX2 "CPX-2, DKFZp547D155" ENSG00000145920 "Complexin 2" Q6PUV4 5 175796310-175884020 "Predicted intracellular proteins" "Differentiation, Exocytosis, Mast cell degranulation, Neurogenesis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 95.3;epididymis: 80.1" "Cell type enhanced" "Detected in some" 29 "Horizontal cells: 90.6;Intestinal endocrine cells: 35.2;Late spermatids: 18.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Group enriched" "Detected in some" 22 "A549: 106.1;Hep G2: 64.0;SCLC-21H: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071191, HPA074390" Supported Uncertain Vesicles NA NA Vesicles "HPA071191: , HPA074390: " "unprognostic (1.36e-1)" "unprognostic (1.12e-1)" "unprognostic (2.81e-1)" "unprognostic (8.98e-2)" "unprognostic (1.23e-2)" "unprognostic (5.73e-2)" "unprognostic (5.16e-2)" "unprognostic (2.49e-3)" "unprognostic (6.22e-2)" "unprognostic (1.20e-2)" "unprognostic (2.06e-1)" "unprognostic (1.90e-5)" "unprognostic (6.88e-2)" "unprognostic (2.20e-1)" "unprognostic (7.32e-2)" "unprognostic (6.87e-2)" 1.7 23.3 72.6 2.0 32.7 1.4 1.3 79.0 95.3 1.3 2.6 2.6 0.3 2.7 1.3 80.1 1.4 1.4 1.4 1.3 68.3 16.3 1.4 1.3 2.1 1.3 37.2 26.3 1.3 7.9 1.3 11.3 1.3 17.9 1.4 2.2 0.2 1.3 1.4 1.3 1.4 2.5 1.6 4.0 1.3 5.1 3.1 3.7 0.0 1.4 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 106.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.1 0.0 0.0 45.2 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 72.6 32.7 79.0 66.6 68.3 16.3 37.2 26.3 17.9 3.7 0.0 0.0 0.0 0.0 0.0 3.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.6 35.2 0.0 0.0 18.1 0.9 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 3.8 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 CPM ENSG00000135678 "Carboxypeptidase M" P14384 12 68842197-68971570 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 56.1" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 333.5;Sertoli cells: 750.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 15.5;myeloid DC: 11.9" "Group enriched" "Detected in many" 5 "dendritic cells: 11.9;monocytes: 15.5" "Cell line enhanced" "Detected in many" "ASC diff: 29.5;ASC TERT1: 21.0;HSkMC: 37.8;SiHa: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002657, HPA077243" Enhanced Uncertain Vesicles NA NA 5000000 Vesicles "HPA002657: AB_1078398, HPA077243: " "unprognostic (1.74e-1)" "unprognostic (3.11e-1)" "unprognostic (2.88e-3)" "prognostic favorable (1.00e-4)" "unprognostic (4.58e-2)" "unprognostic (8.61e-2)" "unprognostic (1.57e-2)" "unprognostic (2.01e-1)" "unprognostic (8.42e-2)" "unprognostic (1.40e-1)" "unprognostic (1.35e-1)" "unprognostic (1.42e-1)" "unprognostic (1.47e-3)" "unprognostic (8.58e-2)" "unprognostic (6.85e-2)" "unprognostic (2.59e-2)" "unprognostic (1.06e-1)" 56.1 6.6 3.8 5.4 7.0 1.1 37.2 1.2 4.9 6.5 12.9 13.2 0.9 1.6 10.7 6.1 4.1 6.4 6.5 2.9 5.3 3.0 22.1 11.6 24.1 13.0 10.9 4.3 7.5 7.8 3.2 1.0 27.9 5.5 6.2 10.8 2.7 3.2 1.7 8.2 13.0 3.7 2.5 6.7 11.4 5.9 5.8 9.3 1.1 5.1 3.5 4.5 4.4 4.4 2.8 11.9 1.3 15.5 0.3 1.3 4.7 0.0 1.5 0.0 0.0 29.5 21.0 0.3 3.9 0.4 0.7 0.9 1.2 1.6 0.2 3.9 0.5 1.7 0.0 0.5 1.0 1.7 0.0 1.0 0.0 6.4 0.1 0.1 0.4 0.7 37.8 0.2 0.4 0.8 3.5 0.0 0.1 0.0 0.0 3.0 0.6 0.0 0.2 0.6 0.0 2.1 1.2 0.2 0.0 2.9 2.3 0.1 0.0 27.7 4.3 3.3 2.3 0.4 10.3 0.1 0.5 3.2 0.2 0.0 0.1 0.1 5.1 1.7 5.2 2.3 0.3 15.5 0.1 0.1 10.2 0.0 1.4 1.2 0.0 11.9 2.8 0.7 0.1 1.3 0.3 4.7 0.8 1.3 4.7 3.8 7.0 1.2 4.9 5.3 3.0 10.9 4.3 5.5 9.3 333.5 253.0 5.4 2.5 11.0 2.5 1.6 147.7 26.8 114.9 48.8 0.0 22.1 24.9 48.5 13.5 7.1 69.0 0.0 179.6 47.4 3.8 40.7 105.6 33.4 132.7 0.0 10.4 90.2 236.7 12.1 97.2 57.6 10.1 10.8 28.4 65.4 68.6 50.7 74.3 67.7 4.3 750.3 107.2 0.5 1.9 8.7 144.2 7.9 29.3 2.4 CPSF4 "CPSF30, NAR" ENSG00000160917 "Cleavage and polyadenylation specific factor 4" O95639 7 99438922-99457371 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049094, HPA066470" Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA049094: AB_2680626, HPA066470: AB_2685672" "unprognostic (4.03e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "unprognostic (1.90e-2)" "unprognostic (2.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (5.84e-2)" "unprognostic (2.28e-2)" "unprognostic (3.15e-1)" "unprognostic (3.73e-3)" "unprognostic (3.36e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "unprognostic (4.23e-2)" 15.2 11.6 19.3 11.8 19.0 15.7 11.8 20.9 25.6 9.3 9.8 19.8 13.1 12.4 11.1 11.4 13.6 11.2 10.3 10.0 21.5 16.0 10.0 11.7 9.3 20.3 16.8 17.4 13.4 25.4 7.3 12.7 15.1 21.9 11.6 10.2 9.9 17.3 12.2 21.2 18.4 9.6 10.5 20.3 13.9 11.5 38.4 14.6 8.7 11.0 10.7 17.8 10.5 10.4 10.2 6.4 3.1 4.1 5.0 9.7 3.9 14.8 13.1 22.3 17.7 9.1 10.5 26.4 9.8 12.4 15.4 20.3 21.4 20.1 21.5 13.4 9.7 19.5 13.0 15.4 15.5 14.8 15.6 16.4 10.2 15.0 20.7 47.9 18.4 13.1 19.0 13.4 16.2 24.8 11.6 14.1 15.7 26.4 25.5 14.5 36.8 37.8 33.8 20.3 20.2 18.5 15.3 15.0 25.4 9.6 14.1 17.7 20.5 11.4 23.7 23.3 24.8 9.9 19.7 7.7 14.5 20.1 24.8 18.8 23.8 25.1 31.2 11.1 18.3 17.1 1.4 4.1 3.1 4.4 3.3 5.8 10.2 6.7 7.9 5.2 8.5 8.5 7.6 1.6 5.0 2.6 6.4 9.7 3.9 19.3 19.0 20.9 25.6 21.5 16.0 16.8 17.4 21.9 14.6 6.0 9.9 6.7 14.2 7.8 3.8 8.6 7.6 1.4 6.8 1.8 9.8 47.0 13.3 12.3 2.7 9.2 7.0 0.0 14.8 28.0 9.5 12.1 12.7 7.6 18.7 6.4 7.5 4.9 8.1 4.2 25.3 10.5 8.5 21.6 10.0 6.9 12.9 3.5 16.3 14.0 6.0 19.4 19.5 14.7 22.0 8.2 38.0 10.1 11.9 12.7 CPT2 "CPT1, CPTASE" ENSG00000157184 "Carnitine palmitoyltransferase 2" P23786 1 53196429-53214197 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.0" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 64.6;Hepatocytes: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028201, HPA028202, HPA028214" Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoplasm, Mitochondria" Nucleoli "HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958" "unprognostic (2.43e-1)" "unprognostic (2.27e-1)" "prognostic favorable (5.27e-4)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (9.34e-2)" "unprognostic (6.48e-2)" "unprognostic (1.75e-2)" "unprognostic (2.86e-1)" "unprognostic (1.67e-1)" "unprognostic (3.00e-2)" "unprognostic (8.97e-2)" "prognostic favorable (1.46e-12)" "unprognostic (4.00e-2)" "unprognostic (2.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.95e-2)" 7.5 15.5 5.3 6.8 6.1 2.3 6.5 4.0 7.2 5.1 15.4 9.4 10.7 16.6 5.1 7.6 10.5 5.4 11.3 21.4 4.3 4.5 19.8 69.0 6.9 8.3 5.7 3.7 5.3 15.9 10.7 11.5 18.1 6.4 6.0 15.6 13.8 11.8 12.2 13.6 6.0 18.9 5.5 5.2 10.3 10.1 11.2 4.7 9.7 8.3 7.2 10.3 8.0 4.9 5.9 12.4 10.0 13.1 4.8 8.0 6.5 7.7 3.2 7.5 7.3 6.5 3.8 8.5 4.8 4.9 6.9 6.4 1.6 6.5 13.2 7.3 2.2 7.8 7.7 14.0 11.0 5.9 7.3 8.2 7.5 4.3 1.3 9.5 7.1 7.3 8.2 9.4 5.0 4.2 7.7 4.7 11.7 9.6 4.7 4.2 4.5 5.5 5.8 14.0 14.4 8.6 6.4 7.2 13.9 8.6 7.2 11.2 7.6 9.6 12.2 18.1 18.1 14.2 15.2 4.5 3.9 3.1 6.8 3.9 14.5 8.9 8.1 5.0 8.2 5.7 4.1 8.4 10.0 5.1 12.6 6.2 4.5 4.9 5.9 12.4 5.9 8.0 5.5 5.1 4.8 13.1 6.4 7.0 6.5 5.3 6.1 4.0 7.2 4.3 4.5 5.7 3.7 6.4 4.7 11.9 20.8 8.9 5.1 1.5 3.1 12.4 15.3 4.0 3.4 10.4 13.7 64.6 21.6 10.7 1.1 3.6 39.8 0.0 9.3 16.0 2.8 4.8 2.3 80.0 23.6 14.3 13.9 6.7 13.5 2.1 6.4 8.2 6.8 26.2 26.9 10.5 9.8 21.0 4.9 28.3 9.9 6.5 3.2 29.8 16.3 2.3 45.7 7.1 25.3 4.6 CRB1 "LCA8, RP12" ENSG00000134376 "Crumbs 1, cell polarity complex component" P82279 1 197268204-197478455 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 155.1;Muller glia cells: 100.9;Rod photoreceptor cells: 136.0" "Cancer enriched" "Detected in single" 12 "glioma: 2.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "basophil: 9.4" "Lineage enriched" "Detected in single" 22 "granulocytes: 9.4" "Cell line enriched" "Detected in some" 8 "HeLa: 17.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA061250, HPA063127" Approved Uncertain Vesicles "Intracellular and membrane" NA NA Vesicles "HPA061250: AB_2684458, HPA063127: AB_2684944" "unprognostic (1.96e-1)" "unprognostic (5.38e-3)" "unprognostic (2.92e-3)" "unprognostic (1.50e-2)" "unprognostic (5.13e-1)" "unprognostic (3.28e-2)" "unprognostic (2.38e-1)" "unprognostic (2.49e-2)" "unprognostic (1.05e-1)" "unprognostic (1.48e-3)" "unprognostic (2.59e-1)" "unprognostic (2.01e-3)" "unprognostic (1.78e-3)" "unprognostic (1.56e-1)" "unprognostic (3.36e-2)" "unprognostic (2.96e-1)" 1.1 1.1 11.9 0.9 11.0 1.8 1.2 31.4 20.4 0.9 0.9 10.4 0.0 0.9 0.8 1.2 1.1 2.0 1.0 1.2 11.4 6.2 1.1 0.9 1.0 1.0 4.0 8.9 2.6 1.7 0.7 1.9 0.9 14.1 1.0 0.9 9.0 0.8 0.9 2.4 0.9 0.9 0.8 8.7 0.9 1.5 7.3 9.6 0.0 1.3 0.0 0.8 0.9 0.1 0.1 0.0 9.4 0.0 0.1 0.4 0.0 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 17.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.3 0.1 0.0 0.0 0.0 0.0 11.9 11.0 31.4 10.5 11.4 6.2 4.0 8.9 14.1 9.6 0.0 0.0 0.0 0.2 0.2 12.7 1.2 0.0 0.0 0.0 0.0 155.1 0.0 0.0 0.0 1.4 0.0 0.0 23.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.0 100.9 0.0 0.0 0.4 0.0 136.0 0.0 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 CRLF3 "CREME9, CYTOR4" ENSG00000176390 "Cytokine receptor like factor 3" Q8IUI8 17 30769388-30824776 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 43.6" "Cell type enhanced" "Detected in many" 4 "T-cells: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007596 Enhanced Approved "Plasma membrane,Cytosol" NA NA 830000 "Plasma membrane, Cytosol" "HPA007596: AB_1847241" "unprognostic (1.02e-1)" "unprognostic (9.79e-2)" "unprognostic (7.12e-2)" "unprognostic (9.65e-2)" "unprognostic (2.28e-1)" "unprognostic (1.55e-1)" "unprognostic (2.52e-2)" "unprognostic (9.22e-2)" "unprognostic (1.00e-2)" "unprognostic (3.10e-2)" "unprognostic (5.81e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.31e-7)" "unprognostic (3.35e-1)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (6.51e-2)" 8.7 4.8 8.8 22.7 8.3 16.7 7.3 12.4 9.4 6.9 7.0 5.9 3.9 5.5 6.3 3.6 15.4 6.1 7.0 5.8 7.5 6.6 5.3 5.4 9.7 28.6 6.6 9.3 5.8 5.5 5.1 6.9 12.3 7.3 6.6 7.4 4.4 7.5 3.9 3.8 10.7 11.3 6.1 8.7 22.0 5.9 9.6 6.7 26.7 5.7 4.5 27.8 10.3 9.3 15.9 13.9 43.6 21.8 12.9 35.7 25.2 6.2 6.9 4.3 9.0 7.9 6.2 6.5 5.9 5.8 11.5 12.1 9.2 4.3 20.9 8.9 7.3 11.2 11.0 7.3 4.9 13.9 9.8 13.4 8.8 6.1 6.0 4.4 11.5 6.5 3.7 6.9 9.3 7.9 4.5 11.2 18.8 22.1 22.2 7.2 3.8 25.5 12.7 8.6 10.5 4.6 11.3 14.0 12.3 7.6 5.3 3.1 7.3 6.3 9.5 6.5 9.5 7.2 5.8 5.9 6.7 8.3 10.8 14.4 9.3 7.7 14.0 6.4 9.5 7.4 15.5 18.8 43.6 13.0 19.2 13.7 15.9 18.3 14.6 13.9 14.9 35.7 26.4 38.3 12.9 21.8 7.2 20.1 25.2 8.8 8.3 12.4 9.4 7.5 6.6 6.6 9.3 7.3 6.7 0.0 8.4 28.2 5.7 20.0 17.5 3.7 2.5 9.4 3.4 7.0 13.7 16.5 5.0 4.9 13.2 9.0 6.3 0.0 4.6 15.0 7.1 4.7 22.0 3.0 15.6 6.4 3.5 6.2 19.7 16.0 6.1 21.7 5.0 16.2 2.9 3.5 6.7 3.5 3.9 3.7 22.3 12.9 8.2 10.9 22.3 24.3 38.3 45.7 3.5 7.0 CRYGA "CRY-g-A, CRYG1, CRYG5" ENSG00000168582 "Crystallin gamma A" P11844 2 208160740-208163576 "Predicted intracellular proteins" "Eye lens protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-138 MG: 1.3" "Not detected" "Not detected" HPA043386 Supported Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043386: " "unprognostic (1.49e-1)" 0.1 0.0 1.0 0.1 1.8 0.0 0.1 0.1 1.5 0.1 0.1 0.1 0.1 0.0 0.6 0.1 0.1 0.0 0.1 0.1 0.9 1.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 0.1 1.5 0.9 1.1 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYGS CRYG8 ENSG00000213139 "Crystallin gamma S" P22914 3 186538441-186546702 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 15.1;cervix, uterine: 21.8" "Cell type enhanced" "Detected in some" 5 "Rod photoreceptor cells: 3.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035103, HPA063539" Supported Uncertain Cytosol NA NA Cytosol "HPA035103: AB_10696367, HPA063539: " "unprognostic (5.52e-4)" "unprognostic (1.29e-3)" "unprognostic (1.44e-2)" "unprognostic (5.45e-2)" "unprognostic (4.90e-2)" "unprognostic (5.85e-2)" "unprognostic (4.79e-2)" "unprognostic (1.73e-2)" "unprognostic (4.76e-2)" "unprognostic (1.12e-1)" "unprognostic (5.84e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.72e-9)" "unprognostic (1.10e-1)" "unprognostic (9.53e-2)" "unprognostic (3.67e-1)" "prognostic favorable (2.73e-4)" 1.6 1.9 3.6 1.8 2.7 4.0 3.4 15.1 3.3 21.8 1.8 3.5 1.6 1.7 2.7 3.8 1.6 1.3 1.6 1.6 4.1 4.1 2.2 1.8 2.6 4.2 4.2 1.6 2.2 1.8 1.9 1.6 1.6 3.0 1.6 3.7 5.8 1.8 2.9 1.6 3.0 1.8 2.3 3.2 3.6 2.4 1.8 1.6 6.0 1.6 3.2 3.3 1.6 1.6 0.3 0.6 0.2 0.2 0.0 2.1 0.1 1.0 2.0 3.7 3.1 3.6 5.6 0.5 0.5 1.2 1.3 2.5 0.4 1.5 3.8 4.1 2.7 1.6 3.2 1.7 2.8 5.5 3.2 4.9 5.0 1.4 1.9 1.4 2.9 3.4 5.9 3.8 1.2 2.1 5.4 4.2 4.2 1.0 2.2 3.0 1.2 2.6 1.5 0.2 1.7 1.6 4.3 0.8 1.8 1.5 2.3 1.7 1.6 2.6 2.5 1.0 3.0 2.0 1.7 4.5 1.4 1.1 1.6 2.7 4.6 2.3 5.3 1.9 1.9 2.7 0.0 0.2 0.0 1.4 0.0 2.1 0.3 1.9 0.8 0.4 0.1 0.2 0.4 0.2 0.0 0.0 0.6 0.2 0.1 3.6 2.7 15.1 3.3 4.1 4.1 4.2 1.6 3.0 1.6 0.0 1.7 0.5 0.2 0.2 1.0 2.2 2.5 0.0 1.2 0.0 2.0 0.1 0.0 0.4 0.1 0.7 0.4 0.0 0.2 0.1 0.5 0.2 1.1 1.1 0.3 1.6 0.0 1.8 0.0 1.0 0.3 1.6 0.0 0.0 0.9 0.5 0.3 0.0 0.7 0.0 3.0 0.0 0.6 1.4 0.7 0.1 0.2 1.3 1.0 0.1 CSF1 "M-CSF, MCSF, MGC31930" ENSG00000184371 "Colony stimulating factor 1" P09603 1 109910242-109930992 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Immunity, Inflammatory response, Innate immunity" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 47.6;granulocytes: 111.9;Ito cells: 54.0;Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "basophil: 7.0;eosinophil: 16.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 16.5" "Cell line enhanced" "Detected in many" "ASC diff: 46.5;ASC TERT1: 29.2;BJ hTERT+: 30.6;GAMG: 29.0;HHSteC: 70.7;HSkMC: 45.2;hTERT-RPE1: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA076624 Supported "Nuclear bodies,Plasma membrane" "Secreted to blood" NA NA 270000 17000000 "Plasma membrane" "Nuclear bodies" "HPA076624: AB_2686810" "unprognostic (2.35e-3)" "unprognostic (2.14e-1)" "unprognostic (7.36e-2)" "unprognostic (4.19e-1)" "unprognostic (3.60e-1)" "unprognostic (1.64e-2)" "prognostic unfavorable (4.25e-5)" "unprognostic (1.04e-1)" "unprognostic (1.75e-2)" "unprognostic (2.18e-1)" "unprognostic (1.72e-1)" "unprognostic (5.10e-2)" "prognostic unfavorable (1.00e-11)" "unprognostic (2.03e-1)" "unprognostic (1.88e-2)" "unprognostic (4.01e-1)" "unprognostic (3.16e-2)" 38.1 21.4 11.5 14.6 16.7 10.1 36.5 4.3 14.6 13.8 12.8 28.2 3.6 8.5 12.0 10.1 11.3 15.7 20.6 16.0 11.4 5.8 10.7 10.3 23.5 16.9 24.3 5.4 16.9 11.3 6.7 5.2 26.0 19.2 16.3 11.0 12.2 12.4 11.6 12.7 10.4 12.7 16.0 21.9 25.8 11.9 7.5 20.3 2.9 12.4 7.8 11.0 20.6 29.2 0.0 0.0 16.5 0.0 0.0 1.0 0.1 1.5 5.7 2.9 1.1 46.5 29.2 1.0 6.6 30.6 5.3 4.9 0.2 0.8 0.0 8.4 16.3 29.0 1.2 1.2 2.2 2.0 18.5 0.9 2.0 3.3 1.9 70.7 0.0 2.6 45.2 0.6 11.6 7.0 32.5 1.0 0.5 0.4 1.1 6.3 0.1 0.0 0.3 0.9 0.4 0.5 0.2 1.5 0.1 2.1 1.5 0.1 0.3 1.9 0.5 2.3 3.7 0.4 0.2 3.5 5.5 1.9 24.4 3.7 0.5 0.2 0.0 14.0 0.0 20.6 7.0 0.0 16.5 0.2 0.0 0.5 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.1 11.5 16.7 4.3 14.6 11.4 5.8 24.3 5.4 19.2 20.3 8.9 47.6 2.4 5.4 6.5 0.2 2.4 22.9 0.0 5.7 3.5 0.0 0.5 0.0 23.8 0.3 19.0 0.6 0.0 2.0 0.4 28.2 4.8 111.9 2.5 9.2 0.0 7.5 54.0 3.5 0.0 23.3 11.7 10.1 2.8 0.8 1.9 8.1 0.9 8.1 1.1 0.1 58.2 25.9 0.6 0.6 4.8 0.7 8.5 0.6 1.8 CSNK1A1L MGC33182 ENSG00000180138 "Casein kinase 1 alpha 1 like" Q8N752 13 37103259-37105664 "Enzymes, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 10.5;testis: 9.0" "Group enriched" "Detected in some" 8 "Early spermatids: 23.1;Late spermatids: 19.5;Spermatocytes: 11.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 40 "neutrophil: 10.5" "Lineage enriched" "Detected in single" 42 "granulocytes: 10.5" "Not detected" "Not detected" HPA051334 Uncertain Cytosol NA NA Cytosol "HPA051334: AB_2681446" "unprognostic (1.23e-2)" "unprognostic (1.59e-1)" "unprognostic (3.19e-2)" "unprognostic (3.54e-2)" "unprognostic (2.40e-2)" "unprognostic (5.40e-2)" "unprognostic (8.90e-2)" "unprognostic (3.47e-1)" "unprognostic (1.47e-3)" "unprognostic (4.50e-1)" "unprognostic (2.02e-1)" "unprognostic (2.28e-3)" "unprognostic (3.45e-1)" "unprognostic (2.38e-1)" 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.0 0.0 0.0 0.0 0.0 0.1 0.2 10.5 0.2 0.1 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.6 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 10.5 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.0 1.5 1.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 23.1 0.5 0.0 0.0 0.0 0.1 0.4 0.9 0.0 0.0 0.1 0.0 0.0 1.8 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.4 1.1 2.4 0.2 0.0 0.0 1.0 CSRNP3 "FAM130A2, FLJ32093, PPP1R73, TAIP-2" ENSG00000178662 "Cysteine and serine rich nuclear protein 3" Q8WYN3 2 165469647-165689407 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.7;pituitary gland: 21.1" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 49.8;Cone photoreceptor cells: 66.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.9;PC-3: 3.1;SCLC-21H: 9.5;SH-SY5Y: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017905 Approved Uncertain "Nucleoplasm,Nucleoli rim" NA NA "Nucleoli rim" Nucleoplasm "HPA017905: AB_1857757" "unprognostic (2.85e-1)" "unprognostic (1.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.11e-1)" "unprognostic (1.27e-1)" "unprognostic (3.61e-1)" "unprognostic (8.87e-2)" "unprognostic (1.02e-2)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (4.87e-2)" "unprognostic (1.01e-1)" "unprognostic (1.82e-3)" "unprognostic (7.41e-2)" "unprognostic (5.36e-2)" "unprognostic (3.17e-1)" "unprognostic (1.08e-2)" 2.1 5.5 9.3 1.4 24.9 0.7 6.7 8.8 31.7 5.7 2.0 3.2 0.4 2.1 6.3 2.3 2.0 2.5 2.5 3.4 9.3 10.2 3.7 1.8 1.4 1.1 5.3 13.2 7.8 8.0 6.0 21.1 1.1 7.8 3.9 2.5 4.0 4.9 5.1 0.9 2.1 1.7 5.7 2.9 2.1 2.0 1.9 4.8 0.0 5.3 0.0 1.0 1.9 2.5 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.6 0.0 0.4 0.2 0.6 0.0 0.3 0.0 0.9 0.6 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 3.1 0.0 0.1 0.8 0.7 0.0 9.5 7.7 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.8 0.3 0.0 0.3 0.6 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.3 24.9 8.8 31.7 9.3 10.2 5.3 13.2 7.8 4.8 3.0 3.2 0.0 2.6 4.6 49.8 6.7 10.2 0.0 1.2 10.4 66.8 0.3 3.3 1.8 2.5 2.9 0.5 0.0 2.1 0.1 4.7 0.3 0.0 2.9 2.0 11.1 7.5 1.3 0.3 1.3 6.9 0.0 6.8 0.0 2.6 18.3 1.0 1.9 7.8 5.0 17.9 6.5 14.6 0.7 0.7 4.0 0.2 0.0 2.9 1.4 CTBS CTB ENSG00000117151 Chitobiase Q01459 1 84549606-84574480 "Plasma proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in single" 6 "basal ganglia: 7.6" "CAB017043, HPA023594, HPA048810" Approved Uncertain Cytosol "Intracellular and membrane" NA NA 380000000 Cytosol "CAB017043: , HPA023594: AB_1847311, HPA048810: " "unprognostic (7.76e-2)" "unprognostic (1.28e-2)" "unprognostic (1.11e-1)" "unprognostic (1.36e-1)" "unprognostic (9.36e-2)" "unprognostic (3.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.76e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (9.23e-2)" "unprognostic (1.27e-1)" "unprognostic (2.94e-2)" "unprognostic (7.08e-2)" "unprognostic (4.89e-2)" "unprognostic (3.12e-1)" "unprognostic (4.04e-2)" 6.4 6.9 4.0 8.8 4.4 9.7 15.3 4.4 3.5 5.3 5.8 3.3 8.1 3.7 6.2 16.4 4.8 5.2 8.0 13.1 4.5 4.4 10.4 22.3 15.6 28.1 5.8 2.3 5.1 15.0 6.5 10.4 6.9 8.1 8.1 5.1 4.7 18.5 12.5 4.3 8.4 7.2 6.7 10.0 12.6 6.1 3.5 4.4 5.5 5.9 4.9 5.1 5.5 5.2 0.8 0.4 3.2 1.6 0.7 0.6 0.2 1.8 0.6 0.4 0.4 5.6 6.7 1.4 1.3 4.5 0.6 1.7 0.2 2.2 2.4 0.5 2.8 0.7 0.8 0.1 1.7 1.9 2.2 0.6 1.5 0.3 0.3 3.4 1.6 0.8 4.9 3.3 1.6 2.5 4.0 1.9 1.0 1.4 4.4 1.3 0.1 1.0 1.8 0.4 0.4 0.6 0.5 0.7 1.6 4.0 0.9 0.3 0.8 0.5 1.8 2.1 1.1 1.0 1.7 2.9 2.3 0.2 3.1 1.4 1.3 0.4 0.7 1.6 2.2 1.6 1.8 0.8 1.5 0.2 0.9 0.4 0.5 0.4 0.3 0.4 0.8 0.3 0.6 3.2 0.7 1.6 0.4 0.4 0.2 4.0 4.4 4.4 3.5 4.5 4.4 5.8 2.3 8.1 4.4 8.9 16.0 29.6 25.9 27.0 5.8 5.1 30.6 26.8 20.5 22.7 39.3 20.5 36.5 15.7 2.6 28.2 17.1 0.0 16.9 19.2 19.6 41.9 43.8 58.7 42.5 3.2 22.2 45.4 70.4 3.0 19.5 43.1 6.8 23.4 21.5 19.9 17.2 21.0 23.0 38.3 40.1 12.9 14.4 7.5 9.8 21.7 21.4 17.5 16.9 25.3 CTC1 "AAF132, C17orf68, FLJ22170" ENSG00000178971 "CST telomere replication complex component 1" Q2NKJ3 17 8224821-8248095 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052436 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA052436: " "unprognostic (6.47e-2)" "unprognostic (1.06e-2)" "unprognostic (6.16e-3)" "unprognostic (2.81e-3)" "unprognostic (1.33e-1)" "unprognostic (2.20e-3)" "unprognostic (3.96e-1)" "unprognostic (2.07e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "prognostic favorable (6.49e-5)" "unprognostic (2.89e-3)" "unprognostic (3.24e-1)" "unprognostic (5.76e-2)" "unprognostic (1.47e-1)" "unprognostic (1.77e-2)" "unprognostic (1.66e-2)" 9.9 10.0 9.9 15.2 12.2 18.0 12.2 28.5 15.3 10.3 11.3 12.4 8.7 8.9 15.6 12.7 8.2 10.5 10.7 7.0 6.8 7.5 11.8 14.4 13.8 24.1 9.7 7.4 14.5 14.5 12.2 18.5 7.9 9.2 11.2 12.2 11.5 11.0 12.2 5.0 15.5 15.7 13.4 7.4 25.0 9.9 8.8 10.6 32.9 12.5 4.0 23.0 9.1 10.6 6.1 4.6 5.1 2.4 2.7 6.3 2.0 2.5 5.6 5.2 4.9 16.4 3.9 6.5 3.0 3.2 4.3 2.9 4.3 7.6 9.2 3.0 5.1 3.1 8.6 6.1 4.4 2.7 6.7 5.9 4.5 5.4 5.5 2.8 1.4 14.2 3.9 4.9 5.6 7.7 8.5 7.6 13.4 4.3 3.1 3.0 3.3 15.6 6.2 4.3 8.3 1.4 7.4 2.0 5.9 10.9 5.9 4.6 5.3 5.8 7.6 5.0 10.2 4.6 4.3 10.0 1.4 3.2 3.2 3.4 6.5 3.8 6.1 2.6 5.5 3.9 3.6 1.6 2.4 4.7 1.9 4.4 5.0 4.5 4.1 1.5 6.1 6.3 5.8 5.1 2.7 2.4 4.6 3.5 2.0 9.9 12.2 28.5 15.3 6.8 7.5 9.7 7.4 9.2 10.6 0.0 12.0 11.5 2.6 1.6 5.9 3.9 5.1 2.7 3.4 5.2 35.3 5.2 1.7 3.0 2.7 3.1 3.3 0.0 3.3 3.5 2.5 3.2 5.8 8.1 3.3 1.6 6.4 3.7 9.7 4.3 4.0 3.2 0.0 6.4 5.5 2.3 4.5 5.3 2.1 1.5 17.7 0.0 2.8 4.3 4.4 1.8 9.3 7.0 3.2 3.3 CTSF "CATSF, CLN13" ENSG00000174080 "Cathepsin F" Q9UBX1 11 66563463-66568841 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 256.1;Muller glia cells: 186.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "NK-cells: 7.5;T-cells: 9.7" "Cell line enhanced" "Detected in many" "HSkMC: 28.4;SK-MEL-30: 52.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002141, HPA031431" Approved Uncertain "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 3600000 Cytosol "Vesicles, Plasma membrane" "CAB002141: AB_563471, HPA031431: " "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (7.22e-3)" "unprognostic (2.25e-2)" "unprognostic (6.72e-2)" "unprognostic (2.67e-2)" "unprognostic (2.76e-2)" "unprognostic (3.69e-1)" "unprognostic (4.14e-1)" "unprognostic (1.69e-2)" "unprognostic (9.12e-2)" "prognostic favorable (8.92e-7)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (3.89e-1)" "unprognostic (2.42e-1)" 28.1 29.4 24.7 8.0 29.0 1.8 31.1 38.4 47.1 37.3 23.8 32.6 25.2 5.8 38.1 29.8 12.9 34.3 37.3 34.5 25.3 20.5 29.8 45.4 17.3 8.5 28.0 26.0 68.2 23.1 42.6 15.9 20.2 25.4 32.3 8.1 35.0 35.5 37.8 35.8 19.7 9.4 34.6 22.4 10.4 17.8 37.1 30.1 0.8 18.6 14.2 6.3 22.2 21.5 2.1 1.1 0.5 0.7 7.5 9.7 2.4 0.1 9.3 5.0 13.0 21.5 8.7 3.6 6.6 16.7 6.8 4.8 0.0 8.3 0.0 11.1 14.4 0.3 0.9 8.6 2.8 3.6 2.2 0.0 0.3 3.8 0.0 12.0 0.1 5.1 28.4 9.7 1.5 1.1 20.3 4.3 2.7 2.9 1.5 8.5 1.9 0.1 1.1 0.6 5.0 3.4 0.0 1.9 1.6 6.1 0.2 6.0 6.5 17.5 2.0 52.8 0.5 13.3 0.8 2.8 2.8 2.7 3.2 0.7 8.9 0.1 0.0 6.6 0.1 4.1 0.0 0.7 0.4 6.5 0.7 7.0 2.0 5.6 7.3 0.8 2.1 9.7 5.5 0.5 7.5 0.3 1.1 1.7 2.4 24.7 29.0 38.4 47.1 25.3 20.5 28.0 26.0 25.4 30.1 11.9 14.1 3.4 58.6 35.3 99.1 43.9 35.7 2.7 5.7 34.9 39.3 22.1 13.3 8.5 123.6 24.1 0.0 0.0 6.6 8.1 75.7 48.4 9.2 51.3 13.1 127.1 11.5 49.7 15.8 256.1 134.9 9.9 148.5 2.8 3.1 186.2 8.9 1.9 114.5 30.7 63.2 77.6 43.8 164.4 36.6 22.1 19.8 19.2 3.0 26.5 CWC22 "EIF4GL, fSAPb, KIAA1604, NCM" ENSG00000163510 "CWC22 spliceosome associated protein homolog" Q9HCG8 2 179944876-180007113 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036748 Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA036748: AB_10669913" "unprognostic (1.90e-1)" "unprognostic (7.10e-2)" "unprognostic (7.30e-2)" "unprognostic (6.14e-2)" "unprognostic (4.96e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (7.42e-4)" "unprognostic (3.15e-1)" "unprognostic (1.31e-2)" "unprognostic (3.30e-2)" "unprognostic (3.84e-2)" "unprognostic (4.80e-2)" "prognostic unfavorable (7.76e-5)" "unprognostic (1.74e-1)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (9.44e-3)" 20.4 14.2 15.8 17.3 16.8 18.1 19.2 33.5 24.6 21.1 17.0 10.5 13.5 12.4 21.5 14.3 18.4 17.6 15.5 14.8 17.5 11.9 17.2 20.7 14.7 21.3 14.4 19.6 25.4 14.7 21.8 25.0 17.8 17.0 20.4 15.2 9.1 15.4 14.7 20.2 15.9 17.4 23.6 19.0 20.5 15.4 10.9 16.3 26.5 20.7 17.6 21.7 21.8 23.8 12.4 9.9 26.4 11.9 10.9 16.4 8.2 9.6 6.0 16.8 11.2 12.2 14.5 12.8 12.8 15.1 15.8 15.4 13.5 12.2 19.0 11.5 9.2 13.8 10.6 15.9 11.9 23.9 16.7 14.0 25.4 7.8 18.4 12.0 35.3 14.2 9.5 14.5 19.8 26.9 10.3 11.7 13.2 27.6 11.7 10.3 9.7 18.4 18.4 25.8 11.6 9.7 17.0 20.8 14.2 10.9 12.2 11.5 15.6 10.5 8.4 14.6 18.8 6.3 22.4 10.0 13.5 11.5 8.8 13.2 10.3 10.8 23.2 12.1 14.3 13.5 26.4 9.5 21.5 12.3 11.9 12.4 12.4 13.3 14.5 9.9 11.3 16.4 12.8 15.9 10.9 8.9 6.3 11.3 8.2 15.8 16.8 33.5 24.6 17.5 11.9 14.4 19.6 17.0 16.3 17.9 26.0 19.8 23.6 16.9 14.6 25.2 22.9 52.2 35.2 10.4 23.6 15.7 8.3 21.1 1.2 21.7 10.5 0.0 16.6 14.4 15.9 13.2 26.5 12.4 12.1 12.7 15.0 15.4 19.7 1.5 21.6 21.4 3.3 21.6 15.8 16.3 16.2 16.7 17.3 14.4 16.9 45.3 13.2 25.1 21.5 16.3 20.7 17.5 13.5 15.4 CXXC4 IDAX ENSG00000168772 "CXXC finger protein 4" 4 104468312-104494901 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.4;pituitary gland: 17.2" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 41.0;Cone photoreceptor cells: 29.5;Horizontal cells: 42.9;Intestinal endocrine cells: 98.1;Rod photoreceptor cells: 25.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.9;memory CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 20 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "AF22: 7.2;AN3-CA: 10.0;Karpas-707: 9.3;RPMI-8226: 5.4;SCLC-21H: 12.5;U-266/70: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036600, HPA036925" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA036600: AB_10673659, HPA036925: " "unprognostic (1.37e-2)" "unprognostic (1.12e-1)" "unprognostic (5.75e-2)" "unprognostic (5.86e-2)" "unprognostic (9.07e-3)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "unprognostic (9.69e-3)" "unprognostic (2.75e-1)" "unprognostic (2.45e-1)" "prognostic favorable (2.19e-4)" "unprognostic (1.82e-1)" "unprognostic (4.52e-3)" "unprognostic (5.69e-2)" "unprognostic (1.37e-1)" "unprognostic (2.38e-1)" "unprognostic (4.42e-3)" 2.2 4.3 10.3 0.9 12.0 0.6 4.3 17.5 19.4 2.4 2.5 7.4 0.8 5.4 1.9 5.3 1.0 6.7 1.5 5.3 9.9 14.4 1.7 2.7 2.3 0.7 7.9 9.9 5.6 5.8 3.2 17.2 1.4 10.2 2.1 2.9 7.9 7.5 2.1 1.3 0.8 5.5 1.8 5.3 1.4 4.3 4.9 13.3 0.0 7.1 0.1 0.7 1.6 1.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 7.2 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.6 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 9.3 0.0 0.0 2.7 0.0 2.6 0.1 0.1 0.0 0.0 5.4 0.0 0.1 12.5 2.3 0.0 0.6 0.0 3.1 0.3 0.0 0.0 0.0 1.7 0.0 0.1 10.2 2.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.8 0.0 0.1 1.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 10.3 12.0 17.5 19.4 9.9 14.4 7.9 9.9 10.2 13.3 0.0 5.4 0.0 0.8 0.2 41.0 12.8 0.0 14.7 2.3 0.0 29.5 0.1 0.0 0.1 0.2 1.6 0.9 0.0 2.9 0.0 0.4 0.5 0.0 2.4 0.1 42.9 98.1 1.3 0.3 0.4 0.3 0.0 1.7 0.0 4.3 13.3 2.1 0.0 10.3 0.7 25.3 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.8 0.4 CYB561A3 CYBASC3 ENSG00000162144 "Cytochrome b561 family member A3" Q8NBI2 11 61348745-61362299 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 113.7;blood: 98.8" "Cell type enhanced" "Detected in many" 10 "Melanocytes: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "memory B-cell: 40.5;naive B-cell: 50.1;plasmacytoid DC: 98.8" "Group enriched" "Detected in all" 10 "B-cells: 50.1;dendritic cells: 98.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045674, HPA052548" Approved Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA045674: , HPA052548: AB_2681866" "unprognostic (2.61e-1)" "unprognostic (8.78e-2)" "unprognostic (4.16e-1)" "unprognostic (3.62e-2)" "unprognostic (1.37e-1)" "unprognostic (9.41e-3)" "unprognostic (7.41e-3)" "unprognostic (2.48e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.83e-1)" "unprognostic (3.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.80e-3)" 10.0 113.7 4.0 22.5 6.4 7.1 7.5 4.7 6.9 6.6 10.9 10.9 14.4 6.1 10.9 9.9 8.8 11.0 11.0 5.7 5.1 4.1 9.7 30.6 12.4 21.7 8.3 3.5 14.5 17.9 9.0 6.6 21.0 6.8 9.2 9.6 10.7 10.9 8.1 10.2 24.8 15.8 7.6 5.6 24.0 8.5 8.0 7.0 16.8 10.0 8.4 33.3 10.7 7.3 50.1 98.8 3.8 7.4 3.3 3.8 8.7 18.2 30.8 4.9 14.2 23.4 15.5 4.2 9.2 14.0 11.1 11.1 8.3 20.4 35.5 16.6 16.2 9.0 25.5 4.7 25.6 6.8 23.7 10.5 6.1 20.8 5.6 11.0 8.4 15.9 21.8 36.2 24.1 11.1 9.2 16.5 16.1 20.0 21.3 18.6 19.6 15.8 3.6 9.2 16.3 17.7 19.2 4.8 26.5 12.8 18.1 6.1 10.1 18.8 27.1 21.2 3.4 22.0 9.8 10.9 13.1 6.8 12.7 13.2 13.3 17.6 19.9 18.0 14.7 16.4 1.6 7.4 3.8 3.8 6.0 3.4 40.5 2.7 3.4 7.4 50.1 2.8 3.0 2.5 3.3 6.4 98.8 2.6 8.7 4.0 6.4 4.7 6.9 5.1 4.1 8.3 3.5 6.8 7.0 6.0 28.1 119.0 16.1 25.1 15.4 1.4 7.6 29.4 25.0 12.2 29.5 43.5 10.0 22.6 55.7 11.9 46.6 0.0 34.2 35.0 17.5 17.4 8.1 18.7 49.1 17.5 18.5 11.6 20.3 10.6 19.2 29.8 303.7 77.5 27.1 16.9 21.9 38.6 19.4 12.9 51.6 12.9 12.3 5.4 11.1 21.0 33.1 21.8 26.6 12.9 CYP19A1 "ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM" ENSG00000137869 "Cytochrome P450 family 19 subfamily A member 1" P11511 15 51208057-51338610 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 49 "placenta: 440.1" "Cell type enriched" "Detected in some" 36 "Syncytiotrophoblasts: 1678.9" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 8 "basal ganglia: 5.9" "Cell type enriched" "Detected in single" 17 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 45.7;HDLM-2: 7.9;HSkMC: 15.3;SuSa: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000355, HPA051194" Enhanced Uncertain Mitochondria NA NA Mitochondria "CAB000355: , HPA051194: AB_2681381" "unprognostic (9.41e-2)" "unprognostic (7.44e-2)" "unprognostic (9.52e-5)" "unprognostic (6.81e-2)" "unprognostic (2.72e-1)" "unprognostic (4.25e-4)" "unprognostic (5.18e-5)" "unprognostic (1.54e-3)" "unprognostic (2.38e-2)" "unprognostic (2.52e-1)" "unprognostic (1.97e-1)" "unprognostic (5.37e-2)" "unprognostic (1.54e-5)" "unprognostic (2.52e-3)" "unprognostic (2.11e-1)" "unprognostic (1.40e-2)" "unprognostic (1.11e-1)" 9.0 4.6 0.2 0.2 5.9 0.1 2.1 0.2 0.3 0.9 0.3 0.3 0.2 0.4 0.2 0.3 0.3 0.2 0.3 1.3 0.2 0.7 0.3 0.2 0.6 0.2 0.2 0.2 4.4 0.6 0.1 0.2 440.1 0.2 0.5 0.1 0.2 0.9 1.4 0.8 2.3 0.2 0.7 0.5 0.5 0.1 3.0 0.2 0.3 3.0 0.2 0.2 1.2 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 45.7 2.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.3 0.1 3.7 0.3 0.0 0.0 15.3 0.0 0.1 1.9 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 8.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.4 0.6 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 5.9 0.2 0.3 0.2 0.7 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 6.9 1.4 0.0 0.0 0.0 13.4 0.0 0.0 0.0 1.6 4.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 6.5 0.3 7.7 0.2 0.0 1678.9 0.0 0.0 0.0 CYP1B1 "CP1B, GLC3A" ENSG00000138061 "Cytochrome P450 family 1 subfamily B member 1" Q16678 2 38066973-38109902 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Disease mutation, Glaucoma, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.0;lung: 39.2" "Cell type enhanced" "Detected in many" 11 "Glandular cells: 345.6;Leydig cells: 147.9;Peritubular cells: 160.5;Urothelial cells: 295.9" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "classical monocyte: 45.0" "Lineage enriched" "Detected in many" 22 "monocytes: 45.0" "Cell line enhanced" "Detected in many" "ASC diff: 24.6;ASC TERT1: 26.4;HSkMC: 105.7;hTERT-RPE1: 24.4;SiHa: 49.2;U-87 MG: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB011705, HPA026863" Approved Uncertain Mitochondria NA NA Mitochondria "CAB011705: AB_731810, HPA026863: AB_10600900" "unprognostic (7.25e-3)" "unprognostic (2.28e-1)" "unprognostic (1.24e-3)" "unprognostic (2.27e-1)" "unprognostic (2.04e-2)" "unprognostic (1.68e-1)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (9.69e-2)" "unprognostic (4.20e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (4.39e-6)" "unprognostic (1.87e-3)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "prognostic unfavorable (2.76e-4)" 9.1 3.1 0.5 9.4 1.2 0.0 11.4 1.0 1.2 11.4 2.1 0.7 4.5 0.0 12.8 5.9 3.5 15.0 6.9 17.5 1.2 8.8 3.5 39.2 26.3 3.1 1.0 6.1 3.6 0.0 1.3 0.8 3.3 10.7 0.0 19.3 0.0 13.0 4.8 0.5 1.4 10.6 5.1 15.7 0.3 3.9 0.5 5.1 2.5 1.1 4.2 6.9 2.1 0.0 0.4 2.0 45.0 0.0 0.0 16.2 1.2 13.2 0.4 0.0 24.6 26.4 0.0 0.1 0.8 0.2 2.3 0.0 5.5 0.0 3.6 3.2 0.5 10.8 0.0 0.7 0.4 1.0 0.7 0.0 4.0 0.0 6.8 0.0 0.0 105.7 10.3 5.7 0.2 24.4 0.0 0.0 0.1 0.0 0.1 5.2 0.0 4.0 1.4 1.8 2.5 0.0 0.0 0.0 2.5 0.1 0.1 0.4 49.2 7.2 0.0 1.4 9.1 1.9 0.0 0.2 0.0 20.2 0.0 0.0 0.0 0.0 26.8 0.0 2.2 0.4 45.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.0 5.5 0.2 0.0 16.2 17.9 50.6 0.5 98.2 15.8 0.9 2.7 0.0 12.0 35.2 43.6 0.0 0.4 13.3 5.0 11.7 36.8 0.0 0.0 0.5 0.7 41.1 345.6 3.5 9.7 12.6 0.0 1.7 5.5 116.2 8.6 147.9 28.1 16.9 39.7 0.3 0.5 0.4 0.0 160.5 0.8 0.3 19.4 20.8 1.0 1.8 12.4 0.2 0.0 0.8 295.9 CYP20A1 CYP-M ENSG00000119004 "Cytochrome P450 family 20 subfamily A member 1" Q6UW02 2 203238940-203305611 "Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055872, HPA058461" Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions,Actin filaments" No No "Plasma membrane, Cell Junctions, Actin filaments" Nucleoplasm "HPA055872: AB_2682951, HPA058461: AB_2683725" "unprognostic (4.72e-2)" "unprognostic (2.06e-2)" "unprognostic (1.20e-2)" "unprognostic (2.14e-2)" "unprognostic (1.42e-1)" "unprognostic (3.06e-2)" "unprognostic (5.21e-2)" "unprognostic (2.58e-2)" "unprognostic (4.21e-2)" "unprognostic (2.62e-2)" "unprognostic (4.53e-2)" "unprognostic (4.42e-2)" "unprognostic (7.64e-3)" "unprognostic (9.39e-2)" "unprognostic (2.18e-1)" "unprognostic (1.23e-2)" "unprognostic (1.95e-3)" 11.1 14.9 5.0 9.1 6.4 2.8 7.6 6.8 6.1 9.3 8.6 8.6 9.2 6.0 10.8 7.1 8.0 8.0 9.1 7.0 4.5 4.8 13.5 12.5 8.4 7.8 8.1 2.1 13.4 17.3 9.1 13.6 9.4 6.5 9.0 7.8 10.9 9.8 8.8 5.3 6.3 10.5 9.0 6.5 10.1 8.8 10.8 8.1 13.8 16.9 4.3 9.1 7.7 9.7 13.0 13.6 6.8 11.3 8.8 15.5 9.1 5.2 4.9 2.5 4.9 14.6 3.1 5.2 8.9 4.5 3.8 3.9 14.1 7.6 3.8 7.3 5.6 6.4 5.8 3.2 4.0 5.3 5.1 3.8 8.2 3.1 6.4 11.3 9.0 5.2 6.9 3.1 6.1 6.4 2.8 7.5 7.0 12.7 13.1 6.9 7.1 7.5 4.7 9.7 3.8 10.9 5.1 5.7 7.4 4.5 10.4 3.7 5.1 0.3 4.6 7.3 4.6 2.8 4.9 8.5 12.3 4.8 6.1 5.6 8.9 9.7 4.6 7.6 3.6 5.7 5.2 10.4 6.8 14.4 11.3 15.5 11.1 14.9 12.7 7.8 13.0 12.5 9.2 2.2 8.8 10.5 13.6 13.4 9.1 5.0 6.4 6.8 6.1 4.5 4.8 8.1 2.1 6.5 8.1 14.9 28.6 32.8 34.8 11.0 38.9 22.7 35.7 28.1 43.3 15.7 55.0 28.0 10.0 15.4 79.1 37.9 32.7 23.3 17.9 19.0 33.8 32.0 27.8 42.9 33.5 47.7 43.6 74.3 32.1 14.0 113.9 25.8 6.8 21.6 29.9 37.0 13.8 28.1 78.8 22.1 69.0 64.7 26.8 43.2 28.1 11.7 34.1 33.1 28.6 27.5 CYP2B6 "CPB6, CYP2B, CYPIIB6" ENSG00000197408 "Cytochrome P450 family 2 subfamily B member 6" P20813 19 40991250-41018398 "Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "liver: 137.3" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 326.3" "Cancer enhanced" "Detected in many" "liver cancer: 28.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;OE19: 4.9" "Not detected" "Not detected" "CAB033866, HPA048124, HPA062973" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914" "unprognostic (1.86e-1)" "unprognostic (1.23e-2)" "unprognostic (1.13e-2)" "unprognostic (6.13e-2)" "unprognostic (4.59e-2)" "unprognostic (4.63e-2)" "unprognostic (4.41e-2)" "unprognostic (1.73e-1)" "unprognostic (5.78e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (9.43e-2)" "unprognostic (5.44e-1)" 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.0 3.0 137.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 1.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.9 1.8 3.1 0.8 0.7 0.9 0.1 0.4 0.4 0.5 0.4 0.1 0.0 0.4 0.2 0.3 0.0 0.1 1.5 0.0 0.3 0.3 0.2 0.1 7.0 0.4 0.1 0.1 0.3 0.6 0.4 0.7 0.4 0.4 0.4 0.4 0.0 0.4 0.3 0.1 0.3 0.5 0.7 0.4 0.1 0.2 0.1 0.8 1.8 0.6 4.9 0.4 0.2 0.5 0.4 1.7 0.1 0.9 0.2 0.3 0.1 0.5 0.3 0.7 1.1 0.8 0.6 0.3 0.7 0.5 0.3 0.7 0.9 0.2 1.1 0.3 3.1 0.8 0.4 0.4 0.5 0.4 0.6 0.6 0.4 0.1 1.9 0.5 0.8 2.7 0.7 0.3 1.8 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.2 2.5 1.4 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.9 46.7 0.2 0.0 0.0 0.1 0.0 326.3 0.0 0.0 0.0 10.4 11.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 7.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.2 0.6 CYP2U1 SPG49 ENSG00000155016 "Cytochrome P450 family 2 subfamily U member 1" Q7Z449 4 107931369-107953457 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 122.7" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 18.6;Peritubular cells: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041622, HPA046754, HPA064827" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362" "unprognostic (3.54e-1)" "unprognostic (2.45e-1)" "unprognostic (3.08e-1)" "unprognostic (2.84e-1)" "unprognostic (5.16e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (1.20e-3)" "unprognostic (3.19e-1)" "unprognostic (8.97e-3)" "unprognostic (5.41e-3)" "unprognostic (3.02e-1)" "prognostic favorable (2.75e-5)" "prognostic unfavorable (6.97e-4)" "unprognostic (1.19e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.6 7.9 7.7 4.4 9.1 0.4 7.3 11.3 9.2 7.8 7.3 7.0 4.1 4.0 9.5 4.6 6.3 9.8 6.6 8.8 7.1 7.9 6.4 6.8 6.6 6.7 8.3 5.2 12.0 2.6 10.3 8.1 2.7 7.8 12.4 4.7 8.6 4.5 11.0 4.3 3.1 6.0 12.3 7.0 8.5 4.6 3.9 7.4 122.7 4.7 3.5 5.4 7.3 5.3 2.6 2.7 0.7 5.9 1.6 1.7 0.4 2.5 1.2 3.4 6.3 18.8 9.0 0.5 10.8 16.3 6.6 10.5 0.0 1.7 6.9 0.8 6.4 5.2 0.1 5.3 4.0 10.4 1.9 1.6 1.4 2.4 0.3 7.5 2.0 0.0 10.1 3.4 3.1 2.1 13.5 2.5 7.8 0.1 3.3 5.5 1.8 7.4 0.0 3.5 0.2 3.0 4.2 4.1 0.0 2.1 4.3 6.7 5.0 2.7 4.7 11.5 3.0 2.3 1.0 6.8 4.3 0.5 6.1 4.3 14.0 13.2 2.2 3.5 0.0 4.8 0.0 0.3 0.7 1.2 1.1 0.9 2.0 0.9 1.0 2.2 2.6 1.7 1.3 0.0 1.6 5.9 2.7 0.0 0.4 7.7 9.1 11.3 6.9 7.1 7.9 8.3 5.2 7.8 7.4 3.0 3.8 3.2 3.2 1.0 4.3 3.4 2.5 13.4 3.4 8.7 3.9 0.4 0.0 0.9 9.6 5.8 2.6 0.0 1.7 0.3 5.1 1.7 4.6 6.8 1.9 1.6 2.9 6.7 6.1 6.1 16.4 4.6 18.6 3.6 1.1 9.9 0.4 0.0 16.6 2.4 3.3 0.0 5.2 0.9 4.3 1.3 0.2 1.3 1.6 0.7 CYP3A4 CYP3A3 ENSG00000160868 "Cytochrome P450 family 3 subfamily A member 4" P08684 7 99756960-99784265 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 45 "intestine: 145.3;liver: 464.6" "Cell type enriched" "Detected in some" 45 "Hepatocytes: 2276.5" "Cancer enriched" "Detected in some" 240 "liver cancer: 351.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.2;NB-4: 4.5;RPMI-8226: 6.7;SCLC-21H: 2.6;SH-SY5Y: 5.0" "CAB033671, HPA072245, HPA075539" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "CAB033671: AB_782375, HPA072245: , HPA075539: " "unprognostic (4.55e-2)" "unprognostic (8.95e-2)" "unprognostic (8.08e-2)" "unprognostic (1.63e-1)" "unprognostic (5.89e-2)" "unprognostic (5.37e-2)" "unprognostic (7.07e-3)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" "unprognostic (4.92e-2)" "unprognostic (3.78e-2)" "unprognostic (6.42e-2)" "unprognostic (1.89e-8)" "unprognostic (2.59e-1)" "unprognostic (1.75e-2)" "unprognostic (9.79e-2)" "unprognostic (6.82e-2)" 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 145.3 0.1 0.1 56.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 464.6 0.1 0.1 0.1 0.1 0.1 6.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 126.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.6 0.2 0.6 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.0 1.9 0.4 0.0 1.2 0.0 0.4 0.0 0.0 0.1 0.5 0.0 0.5 0.0 0.1 4.5 0.3 0.0 0.0 0.0 2.2 6.7 0.0 0.5 2.6 5.0 0.5 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 1.4 0.0 0.7 0.1 0.7 0.1 0.7 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.6 0.6 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 4.3 1.0 0.3 0.0 0.3 40.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 2.6 46.7 0.8 0.0 0.0 0.5 0.0 2276.5 0.0 0.0 0.0 39.3 50.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.4 0.9 CYP3A43 ENSG00000021461 "Cytochrome P450 family 3 subfamily A member 43" Q9HB55 7 99828013-99866102 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 32.5" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 6.3;granulocytes: 2.3;Hepatocytes: 6.8;Late spermatids: 2.5" "Cancer enriched" "Detected in single" 18 "liver cancer: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "HPA066463, HPA072245, HPA075539" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA066463: AB_2685670, HPA072245: , HPA075539: " "unprognostic (1.20e-3)" "unprognostic (4.74e-2)" "unprognostic (3.64e-3)" "unprognostic (7.24e-2)" "unprognostic (2.52e-1)" "prognostic favorable (3.41e-4)" "unprognostic (1.68e-2)" "unprognostic (1.44e-1)" "unprognostic (2.38e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-2)" "unprognostic (1.23e-2)" "unprognostic (6.46e-2)" "unprognostic (5.90e-2)" "unprognostic (3.10e-1)" "unprognostic (6.37e-4)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.9 0.1 0.0 0.1 0.1 0.1 0.0 0.2 32.5 0.1 0.1 0.1 0.1 0.1 8.0 0.0 2.2 0.1 0.1 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.5 1.6 0.6 0.3 0.6 0.2 0.1 0.0 0.9 0.3 1.1 0.2 0.2 0.0 0.2 0.2 0.2 1.2 0.7 1.5 0.3 0.3 0.1 1.3 0.2 0.0 0.7 0.2 0.5 0.9 1.5 1.3 0.3 0.9 1.3 0.0 0.7 0.0 0.0 0.6 0.5 0.1 1.0 1.0 0.0 0.0 0.0 0.6 0.4 0.3 0.0 0.9 0.0 0.2 0.8 1.6 0.5 0.4 0.6 1.7 0.0 0.7 0.5 0.0 1.6 0.5 0.2 1.1 0.7 1.1 1.2 0.1 0.8 0.4 0.2 1.5 0.6 0.4 0.6 0.2 0.3 0.3 0.3 0.2 0.1 0.6 0.5 0.5 1.6 0.3 0.2 0.5 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.2 0.0 0.0 0.0 0.0 0.0 0.5 2.3 6.8 0.1 1.6 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.9 0.2 0.3 0.0 0.0 0.0 0.0 CYP3A5 "CP35, P450PCN3, PCN3" ENSG00000106258 "Cytochrome P450 family 3 subfamily A member 5" P20815 7 99648194-99680026 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 72.9;liver: 73.4;stomach 1: 21.3" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 346.5;Enterocytes: 640.5;Hepatocytes: 330.1;Urothelial cells: 352.8" "Cancer enhanced" "Detected in many" "liver cancer: 38.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 8.3;CAPAN-2: 5.6;Hep G2: 5.7;OE19: 23.6" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " "unprognostic (2.13e-1)" "unprognostic (4.36e-2)" "unprognostic (4.04e-2)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "unprognostic (2.73e-1)" "prognostic favorable (3.72e-5)" "unprognostic (1.37e-3)" "unprognostic (1.21e-2)" "unprognostic (7.29e-3)" "unprognostic (3.85e-1)" "unprognostic (4.05e-2)" "unprognostic (1.46e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" "unprognostic (2.39e-4)" "unprognostic (6.58e-3)" 1.0 3.3 0.4 2.0 0.5 0.0 1.3 0.6 0.6 1.9 32.6 0.6 1.0 30.3 0.7 0.5 5.2 0.5 8.2 0.4 0.4 0.0 6.8 73.4 2.4 0.8 0.4 0.4 0.6 12.1 0.0 1.8 0.6 0.8 4.9 5.1 0.4 0.6 1.3 0.4 4.3 72.9 0.6 0.5 0.4 21.3 0.7 0.4 0.5 0.4 2.2 4.0 3.0 2.7 0.0 0.2 0.1 0.6 0.0 0.7 0.2 0.0 2.1 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 8.3 5.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.3 0.2 23.6 0.0 0.1 0.0 0.6 0.5 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.4 0.5 0.6 0.6 0.4 0.0 0.4 0.4 0.8 0.4 11.9 11.3 11.2 107.3 41.0 13.1 1.0 346.5 14.7 12.5 3.5 11.8 1.3 0.0 58.0 1.7 2.5 640.5 46.7 44.6 1.0 3.8 166.5 9.3 330.1 0.6 7.9 52.5 9.8 8.3 0.0 2.3 4.6 3.3 7.2 117.1 6.0 69.5 210.5 2.5 4.2 20.2 0.0 3.5 6.8 4.2 51.6 1.3 12.9 85.2 352.8 CYP3A7 "CP37, P450-HFLA" ENSG00000160870 "Cytochrome P450 family 3 subfamily A member 7" P24462 7 99684957-99735196 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 82.6" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 135.0" "Cancer enriched" "Detected in some" 43 "liver cancer: 38.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 1.9;BJ hTERT+: 3.3;Hep G2: 6.4;HHSteC: 3.7;RT4: 1.9" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " "unprognostic (8.10e-3)" "unprognostic (1.45e-1)" "unprognostic (3.12e-1)" "unprognostic (5.47e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (4.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.34e-2)" "unprognostic (8.28e-2)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-11)" "unprognostic (2.02e-2)" "unprognostic (5.87e-2)" "unprognostic (2.97e-1)" "unprognostic (1.34e-3)" 0.1 0.4 0.1 0.1 0.0 0.0 2.6 0.1 0.1 0.0 0.7 0.0 0.0 0.1 0.3 0.1 0.2 0.0 3.9 0.0 0.1 0.0 2.8 82.6 0.6 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.9 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.4 3.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 135.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 18.4 0.1 0.0 0.0 4.9 3.7 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 CYP3A7-CYP3A51P ENSG00000282301 "CYP3A7-CYP3A51P readthrough" P24462 7 99685226-99735093 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 73.9" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 7.6" "Cell type enhanced" "Detected in single" "eosinophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.3;U-87 MG: 2.6" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.1 73.9 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 1.1 0.0 0.0 0.5 0.0 0.3 0.5 1.6 0.5 0.2 4.3 0.0 0.6 0.2 0.0 0.0 0.0 1.3 0.1 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.9 1.4 1.9 0.0 0.0 0.5 0.3 0.4 0.4 0.0 0.4 0.5 0.0 0.8 0.5 1.1 0.1 0.2 1.2 0.5 0.2 0.5 0.2 0.1 0.4 1.5 0.0 0.0 0.4 0.2 0.0 0.5 0.6 0.6 0.0 0.1 0.4 0.3 0.5 0.5 0.6 0.9 0.7 0.1 2.6 0.7 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYTH1 "B2-1, cytohesin-1, D17S811E, PSCD1" ENSG00000108669 "Cytohesin 1" Q15438 17 78674048-78782297 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 139.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047498 Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA047498: " "unprognostic (3.82e-3)" "unprognostic (5.49e-2)" "unprognostic (1.34e-2)" "unprognostic (8.17e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.48e-4)" "unprognostic (6.60e-2)" "unprognostic (3.47e-2)" "unprognostic (3.26e-1)" "unprognostic (9.69e-2)" "unprognostic (4.94e-2)" "unprognostic (1.56e-2)" "unprognostic (1.22e-1)" "unprognostic (2.21e-2)" "unprognostic (4.14e-2)" "unprognostic (1.27e-1)" "unprognostic (1.10e-1)" 17.4 12.4 20.7 28.5 36.0 34.4 12.0 17.7 27.5 10.1 17.4 64.1 5.0 13.2 7.7 6.5 25.9 10.2 15.5 10.3 21.5 16.0 11.5 16.0 25.7 42.3 44.4 27.4 5.9 16.0 7.5 8.4 15.8 32.1 15.2 19.9 10.1 17.3 5.3 17.5 15.9 21.4 10.0 31.2 31.8 24.8 7.9 45.2 19.3 15.2 9.2 50.1 14.4 12.1 24.7 19.1 45.9 20.0 21.8 39.4 31.3 9.1 6.4 6.4 5.5 4.4 5.7 6.2 4.3 3.8 5.3 6.3 4.0 10.3 6.8 4.4 5.7 9.1 8.1 3.1 11.3 4.3 14.3 8.7 2.7 8.1 7.4 3.2 5.6 27.6 2.7 9.3 6.0 6.3 3.6 17.1 23.0 4.5 26.4 6.3 4.7 36.3 5.0 1.6 14.9 5.7 9.6 7.1 23.9 5.8 6.4 3.7 13.6 7.6 14.8 6.0 6.8 7.2 6.7 8.1 4.2 6.2 6.7 4.4 30.7 14.1 25.0 3.1 5.7 4.4 45.9 16.2 31.4 39.4 20.0 28.6 24.7 32.8 31.8 13.7 23.0 36.5 30.7 33.8 21.8 17.6 19.1 24.5 31.3 20.7 36.0 17.7 27.5 21.5 16.0 44.4 27.4 32.1 45.2 56.6 46.2 41.5 26.5 36.6 62.3 16.6 17.8 33.5 31.8 5.2 104.1 2.4 6.6 10.4 23.5 51.6 24.0 0.0 16.1 7.5 15.4 34.8 33.7 24.6 41.7 41.3 26.6 30.7 66.6 33.2 4.0 73.5 35.4 139.7 45.7 16.5 31.3 24.9 4.9 5.8 74.3 6.5 11.7 14.1 15.3 30.1 6.1 71.7 15.2 45.7 CYTH3 "ARNO3, cytohesin-3, GRP1, PSCD3" ENSG00000008256 "Cytohesin 3" O43739 7 6161776-6272644 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.6" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 38.8" "Cancer enhanced" "Detected in all" "melanoma: 47.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.9" "Group enriched" "Detected in many" 5 "dendritic cells: 1.8;NK-cells: 3.3;T-cells: 5.9" "Cell line enhanced" "Detected in many" "WM-115: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013979 Uncertain Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA013979: AB_1855799" "unprognostic (6.58e-2)" "unprognostic (1.37e-2)" "unprognostic (1.65e-2)" "unprognostic (5.75e-3)" "unprognostic (1.27e-3)" "unprognostic (1.27e-2)" "unprognostic (2.32e-2)" "unprognostic (2.63e-1)" "unprognostic (8.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (1.73e-2)" "unprognostic (2.20e-1)" "unprognostic (4.41e-2)" "prognostic unfavorable (2.63e-5)" 24.0 9.1 10.9 6.6 14.4 6.1 22.0 14.2 17.6 10.4 16.4 7.0 5.7 15.1 13.0 8.1 13.4 12.6 13.9 21.1 11.4 7.2 8.8 3.0 14.0 5.4 9.4 10.7 11.0 6.6 9.4 7.1 66.6 9.4 6.8 6.7 17.8 8.6 8.7 12.3 15.6 18.5 15.2 8.5 7.5 9.2 26.0 6.5 2.9 20.4 10.8 5.0 7.7 16.5 0.6 1.8 0.7 0.4 3.3 5.9 0.4 21.6 5.5 5.2 3.6 24.5 29.0 7.4 12.8 11.2 12.7 12.1 8.4 10.8 2.9 7.8 25.8 16.4 20.4 3.6 9.3 8.5 0.2 5.1 0.8 6.5 1.0 11.6 0.9 1.4 20.5 4.2 6.7 9.8 5.7 2.2 4.3 3.4 0.4 9.2 3.5 0.7 3.8 3.6 2.9 7.4 3.8 14.0 1.6 9.8 2.6 3.4 6.5 7.9 27.8 22.5 4.7 1.7 6.1 8.0 8.7 23.2 9.4 7.8 1.0 0.3 3.0 2.8 2.3 35.5 0.7 0.4 0.0 2.2 0.2 5.9 0.3 1.0 2.4 0.4 0.6 0.1 1.5 0.3 3.3 0.4 1.8 0.8 0.4 10.9 14.4 14.2 17.6 11.4 7.2 9.4 10.7 9.4 6.5 14.9 8.0 2.4 1.7 13.5 4.8 16.5 2.5 2.7 3.4 3.5 7.9 12.6 5.0 3.3 9.9 14.7 7.5 0.0 2.4 7.4 14.4 3.0 12.7 1.5 9.9 14.3 2.9 16.0 2.7 12.1 15.3 4.6 30.4 1.0 5.8 8.8 6.4 5.3 12.4 1.0 1.8 38.8 24.0 19.5 10.5 9.9 12.7 5.0 6.9 1.6 CYTH4 "CYT4, cytohesin-4, PSCD4" ENSG00000100055 "Cytohesin 4" Q9UIA0 22 37282027-37315345 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 52.3;lymphoid tissue: 53.9" "Cell type enhanced" "Detected in some" 11 "granulocytes: 55.4;Hofbauer cells: 64.0;Kupffer cells: 57.8;Macrophages: 83.4;T-cells: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 12.1;HMC-1: 50.8;THP-1: 33.3;U-266/70: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004065, HPA071573" Approved Supported "Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol" NA NA "Plasma membrane" "Cytokinetic bridge, Centriolar satellite, Cytosol" "HPA004065: , HPA071573: AB_2686418" "unprognostic (4.30e-3)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" "unprognostic (9.28e-3)" "unprognostic (9.25e-2)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (5.84e-2)" "unprognostic (3.30e-3)" "unprognostic (1.23e-1)" "unprognostic (3.31e-2)" "unprognostic (8.42e-2)" "prognostic unfavorable (2.41e-8)" "unprognostic (3.70e-2)" "unprognostic (1.92e-2)" "unprognostic (5.56e-2)" "unprognostic (2.07e-1)" 13.6 6.6 7.0 32.0 9.2 24.2 7.6 1.5 4.2 2.9 5.0 7.0 0.9 4.1 3.9 6.5 3.2 5.5 8.3 9.2 4.7 3.7 5.1 4.5 14.8 27.4 10.3 2.6 2.5 3.1 1.1 3.7 13.5 6.9 4.0 4.8 4.6 10.3 2.1 2.1 3.0 13.2 6.0 9.9 53.9 5.4 2.3 7.5 12.9 3.6 2.9 22.9 12.0 3.2 8.0 27.2 52.3 31.4 11.4 15.1 16.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.1 0.0 0.8 0.0 0.0 0.2 0.0 1.8 0.0 3.5 0.0 0.0 0.0 12.1 50.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.1 4.5 0.0 0.0 0.3 0.4 0.1 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.1 0.0 0.0 0.0 0.0 10.3 1.3 1.6 6.9 4.1 0.1 3.7 15.6 21.6 15.1 26.4 10.6 7.8 8.3 11.9 12.4 8.0 8.0 10.6 52.3 11.4 31.4 27.2 7.5 16.1 7.0 9.2 1.5 4.2 4.7 3.7 10.3 2.6 6.9 7.5 3.0 12.5 18.1 0.7 2.2 0.0 1.6 0.0 0.0 3.4 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.6 2.1 0.3 55.4 0.8 64.0 0.0 0.0 2.5 57.8 0.0 0.6 83.4 6.8 1.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.1 1.9 0.8 48.9 0.0 0.6 DBF4B "ASKL1, chifb, DRF1, FLJ13087, ZDBF1B" ENSG00000161692 "DBF4 zinc finger B" Q8NFT6 17 44708608-44752264 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 27.8;Horizontal cells: 28.6;Spermatocytes: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA048465 Uncertain Supported Nucleoplasm,Vesicles NA Yes Nucleoplasm Vesicles "HPA048465: AB_2680405" "unprognostic (2.44e-1)" "unprognostic (1.26e-1)" "unprognostic (6.37e-2)" "unprognostic (2.15e-3)" "unprognostic (1.62e-1)" "unprognostic (6.13e-2)" "unprognostic (1.53e-4)" "unprognostic (7.61e-2)" "unprognostic (1.54e-2)" "unprognostic (4.08e-2)" "unprognostic (8.43e-3)" "unprognostic (1.83e-1)" "unprognostic (4.23e-6)" "unprognostic (1.50e-1)" "unprognostic (3.36e-1)" "unprognostic (2.57e-1)" "unprognostic (1.39e-1)" 2.6 2.0 8.0 5.8 6.1 5.6 3.4 7.1 9.4 3.6 4.1 5.3 3.3 2.4 6.4 11.4 3.5 5.9 4.3 2.0 6.7 3.7 3.1 1.6 3.0 4.7 6.7 4.7 5.9 2.3 2.6 4.5 3.3 6.2 5.4 4.1 6.4 3.3 4.8 5.4 6.5 3.7 5.3 4.7 4.4 3.2 10.9 6.4 6.9 6.8 2.5 5.2 4.2 3.2 1.5 0.9 1.8 1.6 0.0 2.2 0.5 3.9 8.3 6.2 4.5 0.6 1.2 5.4 4.2 1.8 8.9 8.8 3.5 3.4 5.8 2.3 1.5 8.0 3.8 5.4 1.7 10.3 9.6 8.6 7.4 6.3 4.6 0.3 4.9 6.4 0.5 0.6 4.9 1.6 2.0 4.4 9.9 9.3 6.1 4.8 4.1 7.3 3.0 2.7 8.2 4.4 6.5 7.2 2.5 2.1 2.4 3.5 3.7 4.0 1.3 3.3 7.0 4.2 3.3 1.9 3.1 5.9 3.9 7.6 2.8 3.6 7.6 2.3 4.4 4.8 0.0 0.9 1.8 0.3 1.6 0.2 1.5 0.2 0.3 0.9 0.4 0.0 2.2 0.0 0.0 1.3 0.7 0.6 0.5 8.0 6.1 7.1 9.4 6.7 3.7 6.7 4.7 6.2 6.4 0.0 1.4 7.5 2.4 0.6 27.8 1.0 0.0 2.7 3.4 5.2 11.8 3.2 0.0 0.2 8.1 2.2 0.0 0.0 0.7 1.1 1.3 2.2 3.5 0.2 1.2 28.6 4.1 1.3 1.6 5.5 1.1 2.2 5.0 1.0 0.5 11.7 0.3 0.0 2.8 0.3 16.1 0.0 0.9 36.9 11.3 0.1 1.1 1.0 0.6 2.0 DCAF12L1 "KIAA1892L, WDR40B" ENSG00000198889 "DDB1 and CUL4 associated factor 12 like 1" Q5VU92 X 126549383-126552851 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 22.6;testis: 30.9" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 15.4;Late spermatids: 30.6;Spermatogonia: 12.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "EFO-21: 17.6;U-2 OS: 9.8" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (2.62e-5)" "unprognostic (2.88e-1)" "unprognostic (1.19e-1)" "unprognostic (3.40e-1)" "unprognostic (1.39e-3)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (1.74e-1)" 0.2 0.1 0.2 0.0 0.1 0.0 0.7 0.1 0.1 0.5 0.1 0.0 6.2 0.0 0.6 22.6 0.1 4.3 4.3 0.1 0.1 0.4 3.3 0.1 0.1 0.0 0.1 0.0 1.5 0.1 0.0 0.6 0.0 0.3 1.0 0.0 0.5 0.1 3.9 0.1 0.1 0.1 2.5 0.1 1.5 1.6 30.9 0.0 0.3 0.9 0.2 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.8 0.0 0.0 0.0 3.4 12.5 0.0 0.0 0.0 0.0 0.0 DCAF12L2 WDR40C ENSG00000198354 "DDB1 and CUL4 associated factor 12 like 2" Q5VW00 X 126163499-126166097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 15.7;epididymis: 53.6;testis: 15.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HAP1: 5.9;NTERA-2: 4.9;U-2 OS: 8.1" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (1.16e-4)" "unprognostic (8.83e-3)" "unprognostic (2.93e-1)" "unprognostic (2.52e-2)" "unprognostic (2.72e-1)" "unprognostic (3.02e-1)" "unprognostic (3.34e-3)" "unprognostic (1.16e-1)" "unprognostic (8.47e-4)" "unprognostic (1.56e-2)" "unprognostic (4.05e-2)" "unprognostic (3.86e-2)" "unprognostic (2.51e-1)" 1.1 1.2 1.1 0.1 1.9 0.1 2.3 0.5 2.1 1.9 0.9 0.0 15.7 0.1 2.4 53.6 0.5 3.0 0.2 0.4 1.0 3.9 0.4 0.1 0.2 0.2 1.0 1.7 1.9 0.2 2.4 1.3 0.1 1.3 2.0 0.2 0.2 0.6 5.6 0.4 0.5 0.5 2.0 0.8 0.2 0.7 15.8 0.1 0.0 0.4 0.0 0.3 2.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 0.5 2.1 1.0 3.9 1.0 1.7 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCTN3 DCTN-22 ENSG00000137100 "Dynactin subunit 3" O75935 9 34613545-34620523 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044905 Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA044905: AB_10960996" "unprognostic (3.38e-1)" "unprognostic (4.13e-2)" "unprognostic (3.47e-1)" "unprognostic (6.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.92e-3)" "unprognostic (9.88e-2)" "unprognostic (4.41e-2)" "prognostic favorable (2.10e-5)" "unprognostic (1.26e-3)" "unprognostic (4.24e-3)" "prognostic favorable (5.76e-11)" "unprognostic (3.06e-1)" "unprognostic (2.25e-1)" "unprognostic (3.22e-1)" "unprognostic (4.43e-2)" 26.4 32.5 42.4 16.2 49.1 46.5 30.4 33.7 58.3 25.7 23.3 20.7 22.2 21.4 24.6 25.5 33.7 31.7 23.1 42.8 36.3 37.4 32.8 32.4 21.1 21.9 35.8 48.4 32.6 33.7 29.8 36.3 23.0 37.4 27.4 20.6 27.5 32.4 28.6 69.1 37.9 18.3 28.0 26.2 19.4 23.7 16.2 22.0 42.6 32.4 37.1 29.2 22.5 24.9 28.5 44.6 62.3 45.9 29.9 56.0 46.8 34.2 28.8 26.8 28.0 23.8 33.3 11.0 29.3 27.4 40.9 32.2 18.4 12.9 15.8 18.4 38.5 14.3 13.7 24.3 30.7 26.2 49.5 30.5 10.5 51.0 15.8 25.8 27.6 32.1 29.3 26.6 28.2 18.5 20.0 26.9 29.8 12.5 32.8 35.6 28.2 34.7 74.5 8.1 14.4 46.5 17.5 14.5 21.7 19.7 12.2 8.9 22.9 21.7 20.0 11.2 8.2 26.8 31.7 24.4 25.8 20.9 29.2 28.4 22.2 28.7 10.5 40.5 16.1 52.4 62.3 44.0 59.3 35.2 44.2 32.0 28.5 37.8 37.2 44.0 28.3 29.9 35.7 38.4 29.9 45.9 44.6 56.0 46.8 42.4 49.1 33.7 58.3 36.3 37.4 35.8 48.4 37.4 22.0 29.8 31.8 49.9 82.5 90.2 76.0 72.8 63.7 57.6 43.3 76.8 23.6 100.4 175.8 103.7 8.3 78.7 68.5 210.2 135.3 93.0 101.4 62.7 86.5 74.9 115.9 69.9 71.7 73.1 79.5 15.7 95.8 80.9 141.7 86.6 53.8 145.8 101.0 66.0 115.2 170.3 63.4 58.2 101.0 73.5 71.3 124.6 83.4 96.6 55.1 72.9 DCXR "DCR, KIDCR, SDR20C1" ENSG00000169738 "Dicarbonyl and L-xylulose reductase" Q7Z4W1 17 82035136-82037732 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Xylose metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 293.8" "Group enriched" "Detected in all" 5 "Distal tubular cells: 688.1;Hepatocytes: 2593.4;Proximal tubular cells: 1817.7" "Cancer enhanced" "Detected in all" "liver cancer: 305.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 65.1;MCF7: 80.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023371, HPA023863" Enhanced Uncertain Nucleoli,Microtubules NA NA 2700000 "Nucleoli, Microtubules" "HPA023371: AB_1847530, HPA023863: AB_1847531" "unprognostic (3.33e-2)" "unprognostic (1.67e-3)" "unprognostic (3.75e-1)" "unprognostic (1.16e-2)" "unprognostic (1.19e-1)" "unprognostic (8.43e-2)" "unprognostic (4.54e-3)" "unprognostic (1.86e-2)" "unprognostic (3.05e-1)" "unprognostic (2.56e-2)" "prognostic favorable (4.70e-4)" "unprognostic (1.72e-1)" "prognostic favorable (2.13e-4)" "unprognostic (1.81e-1)" "unprognostic (1.36e-1)" "unprognostic (2.64e-1)" "unprognostic (1.10e-2)" 12.7 6.1 12.8 4.3 12.1 5.7 12.2 9.0 15.1 9.9 9.5 8.4 18.1 7.8 4.4 62.7 11.7 6.1 4.8 11.8 9.8 9.7 50.8 293.8 10.5 5.3 14.4 7.3 8.1 13.0 6.7 7.2 9.0 13.4 22.3 5.4 7.8 19.3 14.0 22.5 8.6 6.8 3.6 8.4 4.4 14.9 8.7 9.7 8.3 15.6 12.6 9.1 7.5 6.4 32.8 52.7 25.3 33.1 35.2 43.7 35.8 8.9 12.4 5.7 10.3 23.1 5.8 15.2 4.6 6.0 12.7 8.7 21.8 3.9 18.6 9.0 6.4 1.6 10.6 10.4 9.3 4.4 3.9 26.8 17.8 9.3 65.1 24.7 13.7 21.9 8.4 11.5 4.0 14.6 2.7 7.1 11.1 20.2 13.6 6.7 80.0 11.4 32.8 6.6 40.3 13.1 10.5 7.7 24.2 9.4 12.8 16.0 9.4 6.5 55.1 8.0 3.6 41.3 13.5 3.6 6.7 8.4 9.1 8.6 13.9 10.2 8.8 5.8 15.0 4.9 13.9 33.1 25.3 24.7 30.6 23.6 28.6 30.8 23.6 52.7 32.8 43.7 31.9 16.5 35.2 28.0 42.5 33.1 35.8 12.8 12.1 9.0 15.1 9.8 9.7 14.4 7.3 13.4 9.7 47.6 155.8 118.2 185.0 52.0 15.8 102.4 124.9 20.1 28.4 169.3 17.7 343.4 688.1 41.9 5.1 35.2 135.9 23.3 37.0 376.5 68.0 203.5 64.5 2593.4 145.3 20.6 52.6 88.4 114.9 15.1 65.6 57.1 170.4 47.7 117.0 81.8 32.4 105.2 44.6 1817.7 18.5 19.4 66.5 6.6 48.3 64.0 286.5 126.9 129.4 155.9 DDIT4L "REDD2, Rtp801L" ENSG00000145358 "DNA damage inducible transcript 4 like" Q96D03 4 100185870-100190782 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 106.4" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 21.0;Distal tubular cells: 18.3;Extravillous trophoblasts: 14.7;Sertoli cells: 19.4;Smooth muscle cells: 16.0" "Cancer enhanced" "Detected in many" "testis cancer: 19.3" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 7 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 12.9;BJ: 18.8;fHDF/TERT166: 10.2;HSkMC: 9.8;hTERT-RPE1: 21.5;RPTEC TERT1: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050903 Uncertain "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA050903: " "unprognostic (2.21e-1)" "unprognostic (1.92e-1)" "unprognostic (1.34e-1)" "prognostic favorable (5.77e-4)" "unprognostic (1.66e-3)" "unprognostic (5.92e-2)" "unprognostic (2.72e-2)" "unprognostic (3.12e-1)" "unprognostic (3.21e-1)" "unprognostic (7.18e-2)" "unprognostic (2.59e-1)" "unprognostic (1.41e-1)" "unprognostic (4.47e-2)" "unprognostic (4.82e-3)" "unprognostic (2.09e-2)" "unprognostic (7.53e-5)" "unprognostic (4.99e-3)" 1.4 0.5 1.5 0.3 6.3 0.3 0.6 2.0 1.6 7.9 0.6 1.7 0.0 0.2 0.9 3.0 2.6 0.9 0.3 3.5 2.1 0.7 6.2 0.2 0.4 0.3 1.5 1.6 2.8 0.2 0.3 1.2 1.3 2.7 3.8 0.5 5.2 6.3 2.6 106.4 0.4 0.3 0.8 2.4 0.5 0.2 1.1 1.7 0.0 0.6 18.6 1.2 0.5 0.9 0.2 0.0 0.0 0.2 0.0 2.0 0.2 0.0 1.4 5.5 0.0 2.5 12.9 0.8 18.8 1.6 0.3 0.1 0.1 0.5 0.0 0.4 10.2 0.4 0.0 3.9 0.3 0.3 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 9.8 0.1 0.2 1.0 21.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 6.2 0.0 0.0 0.3 0.0 0.0 13.4 0.0 0.0 0.0 0.3 0.7 2.5 1.4 0.0 0.0 0.1 0.0 0.0 0.0 1.4 2.5 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.1 2.0 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 1.0 0.2 1.5 6.3 2.0 1.6 2.1 0.7 1.5 1.6 2.7 1.7 0.0 0.0 0.0 0.1 2.4 0.0 4.7 0.0 0.0 0.0 21.0 0.0 1.7 18.3 0.1 0.6 1.5 0.0 0.0 0.0 14.7 5.0 0.8 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 6.8 0.0 0.0 8.3 0.5 0.0 2.1 1.3 0.0 19.4 16.0 0.7 0.1 1.3 3.3 0.0 0.0 0.1 DDRGK1 "C20orf116, dJ1187M17.3, UFBP1" ENSG00000198171 "DDRGK domain containing 1" Q96HY6 20 3190350-3204685 "Predicted intracellular proteins" "Ubl conjugation pathway" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013373, HPA013705" Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoli "HPA013373: AB_2091955, HPA013705: AB_2668872" "unprognostic (2.99e-1)" "unprognostic (1.55e-1)" "unprognostic (3.42e-2)" "unprognostic (1.60e-1)" "unprognostic (6.54e-3)" "unprognostic (2.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.63e-1)" "unprognostic (4.10e-3)" "unprognostic (8.16e-2)" "unprognostic (5.44e-3)" "unprognostic (7.29e-2)" "prognostic favorable (2.01e-5)" "unprognostic (6.80e-3)" "unprognostic (1.43e-2)" "unprognostic (2.48e-2)" "unprognostic (6.90e-2)" 29.5 47.3 28.5 18.6 45.7 17.8 20.5 33.4 38.2 22.1 23.9 29.8 23.7 35.3 21.5 17.8 21.1 21.0 24.3 17.7 27.0 21.8 28.5 54.0 27.0 17.5 47.9 22.9 23.9 43.6 37.5 17.7 31.3 30.9 27.3 16.6 20.6 48.5 29.3 29.5 22.2 31.9 17.1 36.8 20.2 31.5 14.7 39.3 12.6 34.0 14.2 16.2 20.8 29.4 15.1 32.0 24.4 20.2 12.3 21.0 12.9 29.9 37.8 9.4 17.4 21.3 8.1 13.5 19.1 9.2 11.8 13.0 29.7 21.9 18.0 15.7 10.6 22.8 33.7 9.6 28.6 4.4 12.2 18.0 15.2 12.6 51.5 29.2 17.1 16.5 12.7 28.1 22.6 16.2 13.1 10.8 13.0 21.1 21.7 7.5 16.4 11.7 32.0 11.6 20.6 17.5 15.5 8.3 27.3 19.2 28.3 20.8 12.8 19.6 55.7 17.8 5.9 23.6 10.5 16.2 19.1 8.5 13.4 29.1 16.2 18.2 7.6 5.3 14.5 11.1 11.7 20.2 24.4 19.6 13.3 19.5 15.1 20.9 21.0 20.5 15.1 18.7 18.2 5.4 12.3 12.1 32.0 18.6 12.9 28.5 45.7 33.4 38.2 27.0 21.8 47.9 22.9 30.9 39.3 41.7 48.8 26.8 54.1 23.4 43.2 27.9 104.4 44.2 40.9 66.3 60.9 110.7 16.6 129.1 42.5 50.1 133.4 0.0 154.4 53.3 42.9 64.4 27.6 109.1 106.6 49.3 51.3 39.3 55.8 12.9 51.8 50.8 37.1 61.3 57.4 61.1 136.8 122.8 64.7 61.9 91.7 64.7 41.2 35.6 20.7 33.9 122.1 30.5 77.9 57.1 DDX19A "DDX19L, FLJ11126" ENSG00000168872 "DEAD-box helicase 19A" Q9NUU7 16 70346829-70373383 "Enzymes, Predicted intracellular proteins, Transporters" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045252, HPA066668" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045252: AB_10961128, HPA066668: " "unprognostic (3.11e-2)" "unprognostic (1.93e-1)" "unprognostic (9.07e-2)" "unprognostic (3.95e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (2.38e-4)" "prognostic unfavorable (8.05e-5)" "unprognostic (1.45e-1)" "unprognostic (1.59e-1)" "unprognostic (1.67e-1)" "unprognostic (1.30e-1)" "unprognostic (5.87e-2)" "unprognostic (1.24e-1)" "unprognostic (2.01e-2)" "unprognostic (1.49e-1)" "unprognostic (3.01e-2)" "unprognostic (6.68e-3)" 18.4 20.6 14.5 15.5 19.7 9.8 18.1 16.6 19.6 16.9 19.2 19.2 17.8 9.3 22.0 14.2 19.2 17.1 16.1 22.1 18.6 13.5 16.6 24.8 14.4 18.0 17.1 15.5 21.6 22.5 31.7 17.4 21.8 15.1 15.4 14.4 14.2 14.4 21.1 51.5 15.8 13.5 25.9 15.4 14.1 17.2 9.7 13.7 17.1 19.7 14.4 18.4 19.5 15.5 8.1 14.2 7.9 11.4 8.2 10.3 8.8 13.2 15.0 15.8 16.0 23.8 16.2 15.1 16.9 17.4 26.8 20.9 22.5 9.9 22.2 16.1 17.8 12.7 15.2 28.3 16.8 22.2 7.4 15.4 11.6 12.3 27.6 21.5 20.2 9.7 19.9 12.1 24.4 19.2 13.2 17.0 16.2 27.9 5.8 16.0 19.0 22.4 16.8 25.5 15.8 9.2 27.8 10.6 30.4 16.2 8.2 13.0 17.5 43.3 9.5 12.7 17.1 17.4 12.9 11.5 18.7 14.8 11.8 16.0 16.4 24.6 48.9 12.6 18.5 18.3 7.9 11.4 5.8 10.2 10.7 9.4 7.7 8.9 10.0 14.2 8.1 9.9 10.3 0.7 8.2 9.6 7.3 7.5 8.8 14.5 19.7 16.6 19.6 18.6 13.5 17.1 15.5 15.1 13.7 14.9 20.2 21.7 15.7 8.9 31.9 16.2 28.1 13.4 22.7 10.4 31.4 18.9 8.3 11.1 1.4 13.8 6.6 23.3 12.1 13.1 12.8 16.7 17.3 15.3 12.3 22.3 13.8 14.7 14.5 1.3 24.2 11.8 10.1 17.2 8.8 18.0 11.6 8.6 11.7 10.6 31.0 25.8 15.5 12.2 16.4 8.9 14.4 12.9 11.3 15.9 DDX19B "DBP5, DDX19" ENSG00000157349 "DEAD-box helicase 19B" Q9UMR2 16 70289663-70335283 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 170.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037229, CAB037284, HPA046380, HPA066668" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB037229: AB_1840791, CAB037284: AB_1840792, HPA046380: AB_2679645, HPA066668: " "unprognostic (2.91e-2)" "unprognostic (5.37e-2)" "unprognostic (6.48e-2)" "unprognostic (3.55e-2)" "unprognostic (3.98e-2)" "unprognostic (4.05e-2)" "unprognostic (2.93e-2)" "unprognostic (1.98e-2)" "unprognostic (1.40e-1)" "unprognostic (1.05e-1)" "unprognostic (6.33e-2)" "unprognostic (4.07e-1)" "unprognostic (7.95e-2)" "unprognostic (2.19e-1)" "unprognostic (3.50e-1)" "unprognostic (1.04e-1)" "unprognostic (6.32e-2)" 22.2 18.6 8.8 16.6 12.7 19.4 20.1 30.4 16.3 13.1 16.7 14.6 13.8 14.4 15.0 13.9 16.0 13.2 15.2 15.0 8.3 8.3 15.9 33.9 16.6 15.3 10.5 10.7 14.6 21.6 20.3 17.9 12.0 13.2 13.8 18.2 19.3 16.8 15.2 24.8 26.9 16.6 15.7 10.1 17.8 18.5 64.3 12.3 17.4 18.0 16.9 20.8 16.2 13.9 21.1 21.1 27.0 28.6 22.1 35.4 22.5 2.0 12.4 17.7 16.0 9.8 13.1 15.3 10.0 14.2 22.0 23.0 26.4 15.3 16.2 9.5 12.6 8.9 12.2 0.1 5.7 22.8 6.7 11.3 9.6 8.1 21.6 21.1 20.5 9.3 16.1 11.3 16.7 12.7 9.1 16.8 5.0 9.7 7.0 13.4 14.2 0.0 29.7 11.1 7.7 5.2 28.4 9.6 23.4 13.1 11.5 11.6 15.3 23.6 5.4 12.7 8.1 12.1 18.2 10.2 10.4 9.3 8.6 9.2 15.1 7.8 37.7 3.4 16.8 13.4 27.0 22.1 19.0 23.2 28.6 22.3 21.1 20.9 25.3 21.1 19.0 19.0 18.0 4.1 22.1 17.7 6.5 35.4 22.5 8.8 12.7 30.4 16.3 8.3 8.3 10.5 10.7 13.2 12.3 11.9 17.9 27.3 15.3 8.4 17.8 6.6 12.7 29.4 20.5 10.4 11.8 16.5 26.6 35.6 170.5 17.5 27.5 0.0 57.8 18.6 16.1 14.9 10.5 12.4 25.9 9.5 21.1 11.6 14.6 32.4 19.2 19.7 3.3 43.3 14.6 16.0 37.9 34.5 14.9 17.4 15.7 12.9 12.3 78.8 7.4 9.2 26.4 25.5 20.3 15.7 DECR1 "DECR, SDR18C1" ENSG00000104325 "2,4-dienoyl-CoA reductase 1" Q16698 8 90001405-90052092 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 120.2" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 338.2;Proximal tubular cells: 333.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "SK-BR-3: 132.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023160, HPA023162, HPA023238" Enhanced Supported Mitochondria,Cytosol No No 740000 Mitochondria Cytosol "HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587" "prognostic unfavorable (1.49e-4)" "unprognostic (5.76e-3)" "unprognostic (8.37e-3)" "unprognostic (6.13e-3)" "unprognostic (2.01e-1)" "unprognostic (4.45e-2)" "unprognostic (1.68e-2)" "unprognostic (8.23e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (9.12e-2)" "unprognostic (1.42e-1)" "prognostic favorable (1.79e-7)" "unprognostic (1.40e-1)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "prognostic favorable (6.06e-4)" 26.9 45.7 13.2 18.1 17.6 9.2 15.6 10.3 14.5 13.0 29.0 10.4 11.8 32.4 11.9 13.7 16.2 8.5 12.6 70.0 15.4 9.0 44.8 120.2 12.9 14.0 12.5 12.8 12.7 14.4 22.2 16.8 5.8 13.6 11.0 22.9 9.5 15.7 9.9 37.9 12.5 42.7 11.5 11.9 20.1 12.7 17.0 14.5 20.3 15.0 32.1 15.3 11.6 10.6 23.4 52.3 37.2 42.8 19.8 31.3 27.8 10.5 6.0 17.8 20.1 12.5 20.3 3.8 9.3 16.1 6.1 9.5 2.4 10.5 8.1 7.4 11.1 5.5 8.0 6.6 9.4 10.2 12.2 0.7 19.3 5.4 9.6 15.6 4.2 4.0 16.0 7.3 4.8 8.1 15.1 18.0 12.9 20.1 16.0 29.0 12.1 12.0 6.2 1.1 22.4 18.2 10.2 4.7 14.4 29.8 26.6 0.8 6.7 14.0 132.5 11.1 0.5 17.0 10.9 16.3 10.3 4.9 13.5 5.5 8.1 6.1 9.5 9.8 9.6 13.1 15.0 31.5 10.2 21.4 42.8 22.6 23.4 20.1 21.8 52.3 19.2 21.3 21.0 37.2 19.8 37.2 20.4 31.3 27.8 13.2 17.6 10.3 14.5 15.4 9.0 12.5 12.8 13.6 14.5 71.5 50.7 52.5 52.8 36.7 12.7 229.8 79.0 71.0 51.2 68.0 2.0 44.0 338.2 106.7 118.9 49.7 161.9 0.0 82.2 42.9 47.8 37.6 48.5 196.2 104.2 30.2 100.6 52.2 85.9 33.7 79.1 96.9 81.0 80.2 84.9 41.0 80.5 101.7 48.4 333.3 6.5 71.1 40.1 118.4 23.4 35.9 34.3 71.9 118.0 55.4 DENND2D "FLJ22457, RP5-1180E21.2" ENSG00000162777 "DENN domain containing 2D" Q9H6A0 1 111187174-111204535 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 51.0;lymphoid tissue: 67.6" "Cell type enhanced" "Detected in many" 8 "T-cells: 105.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 44.8;MAIT T-cell: 38.2;memory CD4 T-cell: 32.5;memory CD8 T-cell: 45.6;naive CD4 T-cell: 51.0;naive CD8 T-cell: 48.4;NK-cell: 45.1;T-reg: 13.7" "Group enriched" "Detected in all" 6 "NK-cells: 45.1;T-cells: 51.0" "Cell line enhanced" "Detected in many" "HDLM-2: 21.0;MOLT-4: 52.9;SK-BR-3: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043630, HPA048642" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043630: AB_2678589, HPA048642: AB_2680474" "unprognostic (1.72e-3)" "prognostic favorable (1.67e-4)" "unprognostic (2.60e-2)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic favorable (2.70e-4)" "unprognostic (5.09e-2)" "unprognostic (8.10e-2)" "unprognostic (1.35e-1)" "unprognostic (4.66e-3)" "unprognostic (3.09e-2)" "unprognostic (1.02e-1)" "unprognostic (9.61e-2)" "unprognostic (3.80e-3)" "unprognostic (5.45e-2)" "unprognostic (2.75e-2)" "prognostic favorable (8.66e-5)" 8.9 11.1 0.9 42.9 2.6 3.5 6.5 0.8 1.6 4.9 10.4 1.4 4.9 6.4 2.4 5.9 19.5 6.4 9.9 2.5 1.0 1.0 11.4 9.3 11.5 42.0 2.6 0.8 3.0 7.5 8.8 8.0 20.2 1.9 9.2 6.9 3.7 21.1 4.7 1.3 7.9 13.8 1.3 3.2 33.8 9.0 5.1 1.8 39.2 8.0 7.0 67.6 15.7 8.2 8.2 3.2 3.5 3.5 45.1 51.0 29.6 10.4 0.4 0.0 0.0 2.6 1.0 0.1 0.6 0.0 1.1 0.2 3.1 5.1 11.1 3.7 1.6 0.0 3.3 0.0 0.5 1.1 21.0 0.0 3.3 0.7 0.0 3.9 0.0 3.4 3.1 2.3 0.3 0.0 3.5 0.1 4.2 0.0 3.5 0.3 8.9 52.9 0.3 0.0 13.2 1.4 1.3 0.0 16.1 3.7 11.3 3.7 0.0 3.7 34.3 1.2 0.0 10.1 10.5 0.0 0.0 0.0 0.0 0.0 3.2 1.3 8.3 0.0 9.3 0.0 0.8 3.5 2.3 44.8 2.5 38.2 7.2 32.5 45.6 3.2 8.2 51.0 48.4 3.5 45.1 1.8 2.4 13.7 29.6 0.9 2.6 0.8 1.6 1.0 1.0 2.6 0.8 1.9 1.8 6.0 15.6 29.2 15.0 4.4 0.0 0.9 7.6 18.7 18.2 19.2 0.0 1.2 16.6 23.6 26.8 2.9 16.1 0.0 14.1 2.1 4.1 21.1 17.3 4.9 46.9 0.0 5.8 9.2 28.5 38.6 1.1 9.9 6.8 1.0 23.6 0.0 13.8 14.0 0.4 21.0 0.5 0.0 0.7 13.0 0.7 3.4 9.6 105.1 20.4 26.5 DENND6B "AFI1B, FAM116B, MGC33692" ENSG00000205593 "DENN domain containing 6B" Q8NEG7 22 50309030-50327060 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 24.7" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 8.3;RPMI-8226: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018934, HPA021653, HPA029570" Uncertain Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA018934: AB_1848365, HPA021653: AB_1848366, HPA029570: AB_10602131" "unprognostic (2.50e-2)" "unprognostic (2.55e-2)" "prognostic unfavorable (1.41e-4)" "prognostic favorable (5.93e-5)" "unprognostic (9.39e-2)" "unprognostic (3.17e-1)" "unprognostic (1.89e-3)" "unprognostic (1.16e-1)" "unprognostic (5.10e-2)" "unprognostic (4.50e-2)" "unprognostic (1.19e-2)" "unprognostic (1.18e-1)" "unprognostic (8.92e-2)" "unprognostic (1.10e-1)" "unprognostic (4.15e-1)" "unprognostic (1.56e-1)" "unprognostic (1.31e-2)" 2.7 5.5 11.6 4.3 17.0 2.0 3.2 21.1 22.8 5.7 2.8 7.5 5.5 2.5 5.2 5.3 3.4 24.7 6.2 2.3 8.4 10.2 5.7 1.3 7.3 5.2 4.9 14.4 4.3 6.4 6.8 15.1 2.3 10.4 4.7 2.3 4.1 5.9 7.4 1.1 5.0 3.0 3.6 3.2 4.4 4.2 9.0 4.5 0.0 6.0 1.0 3.5 4.4 2.7 0.7 1.8 0.5 3.9 1.0 0.7 0.9 0.6 2.3 5.0 5.4 1.2 4.8 0.0 1.0 2.4 0.6 0.4 0.1 3.5 8.3 2.1 2.3 0.3 4.2 0.1 0.1 0.2 2.0 1.2 1.4 4.0 0.2 1.1 0.2 3.7 4.1 5.3 0.1 0.7 4.9 1.0 0.1 1.8 1.5 1.2 3.6 0.0 0.8 0.3 2.5 0.2 1.2 0.0 12.0 6.2 2.0 2.1 4.0 2.7 3.4 0.4 0.2 5.5 1.2 1.1 0.9 0.8 0.8 0.1 1.3 0.3 1.2 2.2 0.9 1.0 0.5 2.6 0.1 0.4 3.2 0.6 0.6 0.6 0.7 1.8 0.7 0.6 0.7 0.5 1.0 3.9 1.4 0.6 0.9 11.6 17.0 21.1 22.8 8.4 10.2 4.9 14.4 10.4 4.5 3.0 2.6 18.2 2.8 1.0 4.9 1.1 7.6 30.8 7.9 5.2 21.6 0.2 3.3 4.8 20.6 3.4 4.9 23.3 1.6 0.6 4.0 3.3 5.7 0.8 12.8 1.6 9.8 3.7 21.8 47.0 2.3 13.7 5.0 26.2 3.4 6.4 2.6 2.3 2.5 14.1 15.4 0.0 1.2 23.6 17.9 0.5 0.8 7.2 3.3 2.3 DERL3 "C22orf14, derlin-3, FLJ43842, IZP6, MGC71803" ENSG00000099958 "Derlin 3" Q96Q80 22 23834503-23839128 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.7;pancreas: 80.8" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 88.6;Late spermatids: 121.3;Melanocytes: 212.6;Spermatocytes: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "plasmacytoid DC: 77.7" "Lineage enriched" "Detected in many" 9 "dendritic cells: 77.7" "Cell line enhanced" "Detected in some" "Karpas-707: 33.9;RPMI-8226: 19.9;U-266/70: 36.4;U-698: 8.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB037234, HPA049306" Approved Uncertain Vesicles NA NA Vesicles "CAB037234: AB_1840802, HPA049306: " "unprognostic (2.01e-3)" "prognostic favorable (8.70e-5)" "unprognostic (9.72e-3)" "unprognostic (7.47e-2)" "unprognostic (9.77e-3)" "prognostic favorable (8.01e-4)" "unprognostic (2.23e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (4.74e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (7.76e-13)" "unprognostic (1.53e-2)" "unprognostic (4.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.95e-1)" 1.3 1.8 1.2 27.3 2.1 4.1 2.8 1.7 1.6 3.7 21.5 1.1 20.2 18.7 1.9 2.9 4.1 3.4 5.7 3.9 1.2 1.9 2.9 4.7 7.2 25.5 1.3 1.2 1.1 80.8 0.6 4.0 7.9 2.4 1.6 6.9 1.9 44.8 29.3 1.3 0.4 14.9 0.3 1.0 28.5 21.8 12.6 1.6 1.0 9.5 3.4 36.1 15.5 1.2 8.4 77.7 0.1 0.0 0.0 0.1 1.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.1 3.5 0.6 0.0 0.6 0.0 0.3 0.6 0.0 0.7 1.8 0.1 2.0 0.0 0.4 3.8 0.9 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.5 33.9 0.0 0.0 0.5 2.0 0.5 1.4 0.1 2.6 0.0 19.9 0.7 0.1 0.3 0.0 0.1 0.0 0.2 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.0 36.4 4.4 8.6 0.4 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 8.4 0.0 0.0 0.0 6.1 0.0 0.0 0.1 0.0 0.0 77.7 0.0 1.3 1.2 2.1 1.7 1.6 1.2 1.9 1.3 1.2 2.4 1.6 0.0 1.4 39.4 1.5 1.5 1.1 2.8 2.5 14.7 3.4 0.0 2.0 0.7 0.0 0.3 88.6 0.5 1.3 0.0 5.0 4.3 1.1 2.3 2.3 3.2 2.9 0.0 1.7 6.7 2.4 121.3 2.3 1.7 212.6 0.0 4.0 0.8 1.6 0.0 3.9 0.3 0.5 0.0 1.2 55.6 36.8 1.8 12.9 5.7 4.3 0.9 DGCR8 "C22orf12, DGCRK6, Gy1, pasha" ENSG00000128191 "DGCR8, microprocessor complex subunit" Q8WYQ5 22 20080232-20111877 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 46.8;Rod photoreceptor cells: 59.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 41.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076916, HPA079351" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA076916: , HPA079351: " "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (1.97e-1)" "unprognostic (1.81e-1)" "unprognostic (8.34e-2)" "unprognostic (2.75e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.34e-1)" "unprognostic (5.72e-3)" "unprognostic (2.83e-1)" "unprognostic (1.09e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.02e-2)" "unprognostic (4.20e-1)" "unprognostic (4.68e-2)" "unprognostic (2.26e-2)" 7.9 7.8 9.9 10.3 10.1 10.1 9.4 29.8 14.1 9.7 10.3 11.8 13.4 7.6 14.5 8.1 11.7 11.5 10.5 7.8 10.0 6.9 7.9 7.9 8.1 8.9 10.6 9.7 13.9 15.2 11.6 16.8 17.9 10.4 9.5 7.9 11.3 10.5 10.3 19.9 11.3 10.1 12.6 7.4 10.3 10.0 22.4 10.9 11.1 9.8 11.9 9.0 11.5 12.6 1.7 3.3 1.2 6.8 3.2 4.6 2.7 12.1 8.6 11.2 6.6 4.4 7.2 14.3 11.7 7.0 7.9 5.6 9.2 6.2 10.8 6.5 10.9 5.3 11.7 10.2 9.7 6.9 10.6 15.1 11.8 9.1 7.5 11.7 21.7 9.8 5.7 12.2 8.3 6.1 7.3 6.9 6.6 41.6 7.9 9.2 7.8 13.0 6.4 10.9 8.8 6.5 15.6 11.9 3.7 4.8 11.4 12.5 8.0 10.7 6.3 6.8 7.0 6.0 9.3 10.3 11.6 9.7 7.2 11.8 4.4 6.0 10.9 8.6 9.9 11.2 0.0 2.1 1.2 4.5 1.9 3.5 1.7 2.2 4.6 2.9 1.5 2.3 2.6 0.4 3.2 6.8 3.3 2.7 2.7 9.9 10.1 29.8 14.1 10.0 6.9 10.6 9.7 10.4 10.9 6.0 9.3 8.0 4.5 8.5 34.3 2.5 5.1 6.7 6.8 5.2 37.3 11.0 0.0 5.6 46.8 6.7 6.3 0.0 8.7 9.5 5.6 7.7 3.5 11.3 4.6 41.3 7.0 8.6 7.0 31.3 17.0 3.8 5.0 6.4 9.2 15.8 8.6 6.0 9.9 2.8 59.4 6.5 4.7 16.9 13.0 8.2 11.3 6.9 8.2 4.7 DGKE "DAGK6, DGK" ENSG00000153933 "Diacylglycerol kinase epsilon" P52429 17 56834099-56869567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Bipolar cells: 167.4;Cone photoreceptor cells: 178.7;Rod photoreceptor cells: 165.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 43.5;MOLT-4: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017167 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017167: AB_1847638" "unprognostic (1.19e-2)" "unprognostic (2.11e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.92e-5)" "unprognostic (4.20e-2)" "unprognostic (4.87e-2)" "unprognostic (3.37e-1)" "unprognostic (4.27e-2)" "unprognostic (1.19e-3)" "unprognostic (4.75e-2)" "unprognostic (6.07e-3)" "unprognostic (2.68e-1)" "unprognostic (2.55e-2)" "unprognostic (1.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.26e-1)" "unprognostic (3.69e-3)" 7.8 4.9 7.8 8.3 17.7 5.5 5.2 21.3 18.6 9.5 7.4 4.4 5.6 5.4 13.3 8.9 5.0 8.2 9.4 4.9 7.4 9.2 4.2 4.9 8.1 9.3 5.6 10.0 7.3 6.5 9.5 14.5 5.5 9.9 8.9 7.0 17.4 4.3 7.3 2.4 3.4 7.1 9.3 6.8 12.7 6.4 12.5 5.4 14.5 8.3 2.5 8.6 6.5 15.3 2.4 2.4 1.2 0.8 1.9 4.5 0.8 1.7 1.6 1.5 0.1 0.3 0.5 0.7 2.9 2.3 2.0 2.3 3.8 2.1 2.5 3.6 1.5 1.0 2.1 3.6 1.6 4.1 8.0 4.7 3.2 4.0 2.5 1.7 6.2 4.5 0.9 2.0 2.1 4.2 1.8 2.7 7.4 2.6 43.5 2.4 2.5 14.5 3.5 1.1 2.2 4.9 4.5 6.3 5.9 2.0 3.8 2.4 1.6 2.3 1.2 0.1 1.0 2.7 3.0 2.4 0.5 2.7 0.8 0.4 5.7 11.7 1.7 1.7 3.6 0.1 0.3 0.5 0.0 2.7 0.4 2.0 2.4 1.9 2.3 0.6 0.9 1.9 2.5 1.2 1.9 0.8 2.4 4.5 0.8 7.8 17.7 21.3 18.6 7.4 9.2 5.6 10.0 9.9 5.4 3.0 5.9 2.2 10.2 7.9 167.4 5.5 15.3 1.4 4.5 15.7 178.7 3.2 0.0 6.5 13.1 23.3 3.4 0.0 4.0 2.2 4.3 13.9 0.0 3.8 1.9 7.9 10.9 32.5 5.6 7.4 4.0 4.1 3.3 2.8 7.1 13.8 4.9 5.5 4.9 0.0 165.4 6.5 10.3 25.4 18.5 5.8 2.9 13.8 4.6 8.8 DHDDS "DS, FLJ13102, HDS, RP59" ENSG00000117682 "Dehydrodolichyl diphosphate synthase subunit" Q86SQ9 1 26432282-26471294 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism" Transferase "Disease mutation, Epilepsy, Mental retardation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 241.5;Rod photoreceptor cells: 101.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026721, HPA026727" Uncertain Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA026721: AB_1847643, HPA026727: AB_1847644" "unprognostic (1.11e-2)" "unprognostic (5.43e-2)" "unprognostic (5.12e-2)" "unprognostic (9.81e-2)" "unprognostic (6.71e-2)" "unprognostic (7.23e-2)" "unprognostic (1.32e-3)" "unprognostic (3.81e-3)" "unprognostic (2.40e-1)" "unprognostic (5.42e-2)" "unprognostic (4.51e-2)" "unprognostic (3.40e-2)" "prognostic favorable (4.08e-7)" "unprognostic (9.42e-2)" "unprognostic (2.85e-1)" "unprognostic (2.22e-1)" "unprognostic (2.95e-1)" 31.8 14.4 11.2 10.8 15.9 6.4 15.0 45.9 18.8 10.4 23.1 12.5 8.3 12.2 15.4 21.9 18.9 9.2 10.9 14.8 9.7 10.7 16.2 15.3 9.5 10.3 12.1 15.8 9.8 14.7 23.2 15.5 13.1 20.6 9.6 23.9 22.0 56.9 9.1 10.3 13.1 12.2 11.3 7.6 10.5 14.2 12.9 8.9 9.7 12.1 11.1 16.9 10.6 9.8 11.1 11.2 11.8 19.5 8.1 11.6 8.2 14.9 12.2 8.1 11.1 16.8 14.1 14.0 25.6 16.0 19.8 19.8 18.8 16.5 16.9 15.7 23.9 14.5 10.9 10.9 20.0 19.0 10.3 5.8 16.8 30.3 13.8 15.8 18.3 24.8 19.3 11.9 27.3 15.4 13.3 24.9 11.1 12.0 18.6 18.1 10.2 9.3 7.7 12.8 21.0 16.4 11.2 14.4 14.4 10.7 14.1 11.4 9.1 17.2 19.0 11.3 11.7 14.3 10.3 31.7 13.8 13.4 25.9 14.6 22.7 30.4 18.2 21.7 23.0 13.4 6.5 13.4 7.1 11.6 19.5 8.4 11.1 7.7 7.5 11.2 9.3 6.5 9.0 11.8 8.1 18.0 9.1 7.3 8.2 11.2 15.9 45.9 18.8 9.7 10.7 12.1 15.8 20.6 8.9 8.9 5.6 17.5 7.9 4.0 31.4 13.7 12.7 8.1 10.3 14.0 241.5 15.5 10.0 17.0 55.9 9.0 44.5 0.0 12.6 19.4 8.2 11.0 18.5 11.5 21.3 14.3 20.1 11.1 7.3 16.4 9.8 9.7 10.1 48.7 32.2 15.3 14.8 42.1 7.1 20.3 101.1 0.0 10.3 9.3 13.5 4.4 21.3 10.0 14.0 11.1 DHRSX "DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6" ENSG00000169084 "Dehydrogenase/reductase X-linked" Q8N5I4 X 2219516-2502805 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA003035, HPA075955" Approved Uncertain "Mitotic spindle,Cytosol" "Secreted to blood" NA NA Cytosol "Mitotic spindle" "HPA003035: AB_1080631, HPA075955: " "unprognostic (7.77e-2)" "unprognostic (1.06e-1)" "unprognostic (3.95e-2)" "unprognostic (4.65e-3)" "unprognostic (8.87e-2)" "unprognostic (1.78e-1)" "unprognostic (1.29e-1)" "unprognostic (4.59e-3)" "unprognostic (1.08e-1)" "unprognostic (1.21e-1)" "unprognostic (1.08e-2)" "unprognostic (1.17e-1)" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (1.57e-1)" "unprognostic (2.11e-1)" "unprognostic (3.69e-2)" 7.3 9.5 21.5 3.1 26.7 2.9 55.7 21.5 25.3 32.1 7.3 1.2 1.2 4.6 25.1 6.4 3.2 7.5 6.7 37.8 23.7 3.4 34.6 18.9 5.8 3.2 21.8 16.9 25.0 15.2 5.5 24.2 32.7 28.3 7.7 6.5 1.2 10.8 5.7 6.3 4.9 6.5 5.3 26.5 5.9 8.6 3.4 23.6 1.2 8.1 1.2 2.7 6.1 27.4 12.2 18.3 30.0 21.1 8.7 9.1 10.0 4.5 20.9 14.1 6.5 17.6 11.1 10.6 10.4 17.7 8.0 10.8 15.6 9.9 7.3 13.4 12.3 18.7 2.2 9.7 8.4 5.7 13.4 15.1 7.0 11.0 11.6 20.3 3.8 5.7 13.6 10.4 6.9 6.9 13.6 6.3 8.1 7.7 3.6 12.8 5.2 13.9 5.3 3.4 6.1 5.8 5.4 7.4 2.0 8.6 11.2 13.4 13.4 9.9 11.8 7.7 9.0 5.1 6.0 8.5 8.8 2.1 4.9 6.1 4.2 0.0 18.8 5.8 5.0 3.9 6.5 21.1 17.1 8.4 15.7 8.9 12.2 7.6 7.0 18.3 10.6 7.2 6.0 30.0 8.7 9.5 14.8 9.1 10.0 21.5 26.7 21.5 25.3 23.7 3.4 21.8 16.9 28.3 23.6 17.9 9.4 13.4 20.7 9.4 8.8 20.9 25.5 6.7 5.7 24.4 9.8 36.6 11.6 44.5 0.4 12.8 31.3 0.0 70.9 36.4 20.8 43.3 18.4 46.5 34.3 3.2 18.5 11.6 15.9 1.8 22.5 27.2 11.8 47.7 19.0 8.0 61.5 28.1 23.7 35.4 5.9 19.4 14.4 9.7 17.2 5.6 89.7 13.4 22.6 17.1 DHX34 "DDX34, KIAA0134" ENSG00000134815 "DExH-box helicase 34" Q14147 19 47349281-47382704 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 48.6;Spermatocytes: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 13.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042159, HPA043558" Uncertain Uncertain "Nucleoplasm,Intermediate filaments" NA NA "Nucleoplasm, Intermediate filaments" "HPA042159: AB_10963066, HPA043558: AB_10961262" "unprognostic (1.26e-1)" "unprognostic (5.17e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (1.08e-1)" "unprognostic (3.06e-3)" "prognostic unfavorable (8.63e-6)" "unprognostic (9.14e-2)" "unprognostic (4.74e-2)" "unprognostic (5.11e-2)" "unprognostic (4.76e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (3.16e-6)" "unprognostic (7.38e-2)" "unprognostic (1.59e-1)" "unprognostic (2.72e-1)" "unprognostic (7.21e-3)" 6.8 6.9 12.6 11.0 11.5 20.3 6.6 18.7 13.3 8.2 5.9 9.1 8.9 7.7 10.4 5.3 8.3 9.0 5.7 6.0 11.2 6.4 7.2 10.9 8.9 7.9 12.3 8.4 13.3 12.9 7.8 14.2 7.8 11.4 8.9 4.6 8.5 9.9 8.3 7.8 11.8 7.0 6.6 10.5 13.5 6.7 21.8 12.5 5.6 9.6 4.6 9.6 7.3 11.2 1.5 1.9 13.5 2.2 0.8 1.8 1.1 7.2 19.1 4.7 9.2 4.1 2.8 9.0 5.8 1.9 6.0 5.4 12.2 7.2 11.2 5.9 3.2 6.5 10.7 6.5 7.6 3.1 9.3 17.7 11.7 10.4 9.2 4.6 9.0 5.0 3.6 6.2 10.1 5.7 3.9 4.0 5.1 19.4 4.9 4.0 8.6 8.9 22.6 9.8 9.5 11.5 9.9 3.7 6.7 3.2 9.8 8.4 5.2 7.1 7.1 4.7 5.6 6.4 5.8 4.5 7.0 9.1 4.4 10.2 7.4 10.2 10.4 5.6 6.6 8.2 1.0 2.0 0.8 1.3 2.2 1.2 1.2 1.0 1.8 1.9 1.5 1.6 0.7 13.5 0.8 1.7 1.5 0.6 1.1 12.6 11.5 18.7 13.3 11.2 6.4 12.3 8.4 11.4 12.5 6.0 7.2 2.2 5.1 6.6 7.7 2.8 0.0 6.7 3.4 7.0 2.0 4.2 0.0 4.3 20.8 3.1 3.4 0.0 2.8 4.7 3.0 5.1 3.5 4.4 6.7 0.0 3.5 3.1 5.9 48.6 4.9 10.4 1.7 3.6 3.9 1.5 3.1 2.9 4.6 1.4 5.1 6.5 3.6 24.5 11.7 6.4 4.2 3.2 4.3 5.2 DIAPH2 "DIA, DIA2, POF, POF2" ENSG00000147202 "Diaphanous related formin 2" O60879 X 96684663-97604997 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Oogenesis" "Developmental protein" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 117.7;Syncytiotrophoblasts: 99.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005647, CAB015461, CAB068183, CAB068184" Enhanced Supported "Nucleoli,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" Nucleoli "CAB015461: AB_831223, CAB068183: AB_2665693, CAB068184: AB_2665694, HPA005647: AB_1078657" "unprognostic (5.75e-2)" "unprognostic (4.13e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (2.16e-5)" "unprognostic (1.58e-1)" "unprognostic (6.48e-2)" "unprognostic (4.06e-1)" "unprognostic (1.07e-2)" "unprognostic (2.41e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (2.12e-4)" "unprognostic (3.39e-2)" "prognostic unfavorable (3.90e-4)" "unprognostic (6.44e-2)" "unprognostic (3.11e-2)" "unprognostic (6.99e-3)" "unprognostic (6.08e-3)" 25.3 5.7 8.2 16.5 13.6 19.9 12.0 1.6 4.6 17.8 18.5 2.9 15.1 5.5 10.7 9.1 16.3 10.4 12.6 13.0 6.6 3.0 6.1 15.7 16.8 6.9 4.1 4.4 14.2 6.6 8.7 5.5 37.2 7.1 16.0 11.4 4.7 9.4 17.2 19.9 9.3 12.0 18.5 7.3 9.8 9.9 12.3 5.1 9.4 7.5 12.0 4.9 19.8 26.9 2.7 4.3 5.7 5.8 1.4 2.8 1.0 0.0 4.0 1.9 3.9 11.1 18.5 0.0 7.0 7.4 3.8 8.0 3.3 7.6 11.3 5.6 6.0 7.2 0.0 10.4 1.1 4.9 0.3 5.9 0.0 4.9 3.6 9.3 14.6 5.2 9.3 3.7 5.0 15.8 5.1 7.3 8.5 0.0 9.4 7.0 3.2 5.5 6.0 15.4 0.0 5.9 0.0 10.5 0.0 2.1 6.0 0.0 4.0 0.0 2.0 5.6 12.5 1.7 8.0 9.1 8.1 3.7 6.7 4.5 0.1 0.0 9.5 6.8 14.9 4.7 0.0 5.8 5.7 2.3 5.4 1.8 2.7 2.4 2.8 4.3 2.4 1.6 1.5 0.6 1.4 4.5 4.1 1.3 1.0 8.2 13.6 1.6 4.6 6.6 3.0 4.1 4.4 7.1 5.1 29.8 42.7 10.6 4.8 9.6 5.7 19.0 7.6 42.8 18.2 19.2 0.0 41.5 6.6 16.9 60.0 25.2 23.6 0.0 20.1 14.6 25.5 6.7 7.0 23.1 17.8 0.0 23.6 8.0 30.6 117.7 41.7 21.4 8.5 6.4 27.6 12.5 26.4 35.1 19.1 6.1 14.0 25.8 18.6 4.9 12.2 15.9 99.0 12.5 28.1 4.8 DIMT1 "DIMT1L, HSA9761" ENSG00000086189 "DIM1 dimethyladenosine transferase 1 homolog" Q9UNQ2 5 62387254-62403939 "Enzymes, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042944 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA042944: AB_2678234" "unprognostic (1.58e-1)" "unprognostic (2.27e-1)" "unprognostic (6.02e-3)" "unprognostic (7.16e-2)" "unprognostic (8.95e-3)" "unprognostic (1.73e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (8.88e-2)" "unprognostic (1.18e-2)" "unprognostic (1.62e-1)" "unprognostic (5.31e-2)" "unprognostic (3.70e-1)" "prognostic unfavorable (8.90e-12)" "unprognostic (8.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.49e-1)" "unprognostic (5.15e-2)" 16.7 14.0 18.9 16.7 17.0 10.6 18.9 11.5 23.5 18.6 11.8 12.4 11.8 11.0 16.2 11.9 20.1 14.2 15.3 19.7 19.1 17.0 11.9 16.3 11.7 22.5 18.8 8.5 17.8 28.4 8.9 13.4 16.7 12.3 18.8 9.5 10.0 16.1 18.3 17.9 12.2 11.9 24.6 20.2 22.1 10.2 10.7 9.8 16.3 19.0 19.0 19.2 21.7 13.2 7.9 7.7 5.0 5.6 7.0 13.2 6.1 14.6 8.8 16.1 21.0 11.9 15.8 16.0 18.7 7.1 14.5 15.4 14.2 15.6 30.1 17.2 13.9 15.7 11.4 10.8 11.1 18.4 21.3 18.9 20.6 11.5 11.8 14.3 16.9 15.9 13.7 9.0 14.1 13.8 14.4 12.6 19.8 20.9 13.9 14.8 14.7 24.9 26.1 15.5 6.5 18.5 16.1 16.2 41.5 13.1 13.5 18.0 15.8 16.0 15.0 16.0 12.0 12.1 15.9 13.9 10.0 10.4 14.2 25.6 18.4 19.1 27.1 15.2 30.5 14.8 5.0 3.1 2.3 7.7 5.6 11.7 7.9 10.4 9.3 5.0 6.6 13.2 11.0 0.8 7.0 4.3 7.7 9.3 6.1 18.9 17.0 11.5 14.7 19.1 17.0 18.8 8.5 12.3 9.8 3.0 7.4 18.2 65.3 45.2 5.5 27.9 22.9 13.4 21.6 14.0 9.8 38.5 18.3 24.9 5.1 26.8 3.6 0.0 19.6 38.1 27.3 43.1 12.7 10.9 28.5 0.0 4.6 16.5 16.1 3.6 26.7 17.5 27.0 21.6 11.7 6.0 17.2 2.9 19.1 22.7 4.1 6.5 49.9 12.6 21.1 33.1 29.9 25.4 15.7 57.8 DISP3 "KIAA1337, PTCHD2" ENSG00000204624 "Dispatched RND transporter family member 3" Q9P2K9 1 11479166-11537584 "Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;testis: 7.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.9;NTERA-2: 3.4;SCLC-21H: 3.2;SH-SY5Y: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054579 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA054579: AB_2682529" "unprognostic (4.93e-2)" "unprognostic (2.23e-2)" "unprognostic (1.61e-1)" "unprognostic (9.55e-3)" "unprognostic (1.80e-1)" "unprognostic (2.73e-1)" "unprognostic (6.12e-2)" "unprognostic (7.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.08e-1)" "unprognostic (4.34e-3)" "unprognostic (4.86e-2)" "unprognostic (3.80e-2)" "unprognostic (3.88e-1)" "unprognostic (7.06e-2)" "unprognostic (1.79e-4)" "unprognostic (1.34e-1)" 0.9 1.9 7.3 1.1 10.0 0.9 0.9 4.1 17.4 0.9 1.0 9.0 0.0 1.3 1.1 0.9 0.8 1.0 0.8 0.8 7.3 5.7 0.9 0.8 0.9 1.2 4.0 6.5 0.9 1.6 0.8 4.2 0.8 5.1 1.6 0.9 5.4 0.9 0.8 0.8 0.8 1.3 1.0 2.1 1.1 1.2 7.5 6.8 0.0 0.9 0.0 1.0 0.9 0.1 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 7.9 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 3.4 0.0 0.0 0.8 0.0 2.0 0.0 0.2 3.2 11.0 2.4 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 10.0 4.1 12.9 7.3 5.7 4.0 6.5 5.1 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DKK3 "REIC, RIG" ENSG00000050165 "Dickkopf WNT signaling pathway inhibitor 3" Q9UBP4 11 11963106-12009769 "Plasma proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "brain: 94.7;heart muscle: 297.4" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 489.8;Muller glia cells: 1823.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 8.9;memory CD8 T-cell: 5.5;naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 90 "T-cells: 8.9" "Cell line enhanced" "Detected in many" "BJ: 60.1;BJ hTERT+: 93.0;fHDF/TERT166: 87.0;hTERT-RPE1: 54.3;TIME: 49.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011868, CAB024949" Approved Supported "Nuclear bodies,Vesicles,Cytosol" "Secreted in other tissues" No No 15000000 Vesicles "Nuclear bodies, Cytosol" "CAB024949: , HPA011868: AB_1847716" "unprognostic (4.24e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (7.84e-2)" "unprognostic (3.06e-3)" "unprognostic (6.58e-3)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-3)" "unprognostic (5.28e-2)" "unprognostic (4.51e-2)" "unprognostic (3.87e-2)" "prognostic unfavorable (6.31e-5)" "unprognostic (7.41e-3)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.02e-3)" 4.8 21.7 44.9 3.5 94.7 1.3 6.8 32.5 60.3 25.8 7.3 12.1 4.1 4.9 7.8 5.6 8.8 4.9 17.9 297.4 49.6 23.5 5.1 2.7 17.8 3.1 19.1 45.8 10.8 5.7 10.9 6.6 7.5 24.7 16.8 4.6 10.7 9.1 22.3 2.7 8.3 7.3 12.0 32.9 9.0 7.0 8.9 25.5 0.0 4.7 2.5 2.6 10.5 7.8 0.0 0.0 0.0 0.0 0.0 8.9 0.6 0.2 1.8 2.6 0.0 2.2 4.4 0.0 60.1 93.0 26.6 30.3 1.3 0.4 0.0 6.6 87.0 14.2 9.2 0.2 25.9 10.2 0.0 0.0 0.0 0.2 0.0 17.0 0.0 0.0 6.7 8.7 9.0 22.3 54.3 28.2 0.0 0.0 0.0 36.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 9.2 0.0 0.0 7.8 0.2 0.0 0.0 7.3 0.0 0.0 49.9 15.8 12.4 1.6 15.5 0.0 0.0 0.0 2.6 0.0 14.8 0.0 0.0 0.0 0.8 0.0 8.9 0.0 0.8 5.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 44.9 94.7 32.5 46.5 49.6 23.5 19.1 45.8 24.7 25.5 3.0 4.8 0.0 55.5 40.5 22.0 489.8 0.0 4.0 20.5 0.0 11.8 0.4 0.0 0.6 98.7 37.6 0.0 0.0 0.2 0.6 30.9 9.6 1.1 0.0 15.3 12.7 1.7 47.3 1.0 66.1 19.0 2.3 60.8 0.0 0.0 1823.0 1.0 0.0 54.1 0.0 52.9 187.5 74.5 0.5 1.3 12.9 0.7 4.9 0.1 2.6 DLG1 "dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97" ENSG00000075711 "Discs large MAGUK scaffold protein 1" Q12959 3 197042560-197299300 "Predicted intracellular proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016307, HPA069593" Supported Uncertain "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "CAB016307: AB_2092015, HPA069593: " "unprognostic (2.04e-2)" "unprognostic (1.37e-1)" "unprognostic (7.79e-2)" "unprognostic (4.56e-3)" "unprognostic (3.54e-2)" "unprognostic (8.56e-2)" "unprognostic (8.90e-3)" "unprognostic (2.97e-1)" "unprognostic (5.98e-2)" "unprognostic (2.33e-1)" "unprognostic (2.41e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-3)" "unprognostic (3.56e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (3.07e-1)" 12.3 12.6 30.0 10.2 34.5 9.6 14.2 42.1 37.7 19.9 17.8 32.3 17.0 16.1 15.4 8.8 30.2 12.7 12.9 13.8 26.9 19.2 21.0 18.6 12.9 10.6 32.9 27.3 18.7 11.9 28.2 19.8 15.1 29.1 12.1 20.2 10.4 16.5 14.7 18.7 13.7 18.4 15.3 32.2 8.8 16.7 11.1 39.4 14.7 34.6 13.9 14.8 13.8 15.7 3.7 2.9 2.9 1.0 1.4 3.9 1.5 45.1 7.1 14.2 25.8 11.7 11.0 14.5 16.1 14.8 16.2 19.1 20.9 19.5 13.1 46.3 16.0 32.9 29.7 13.0 25.1 31.3 3.5 8.6 11.5 11.0 15.2 11.7 11.4 11.5 9.9 13.7 14.9 32.7 54.8 20.3 10.9 9.3 16.1 39.0 17.5 17.0 4.4 11.1 25.5 13.8 9.1 17.2 9.5 16.9 19.1 7.0 11.8 25.3 16.8 18.4 16.5 38.4 8.8 19.3 44.0 11.6 12.1 27.2 25.4 18.3 17.1 16.2 17.5 13.8 0.0 0.9 2.9 1.5 1.0 3.9 3.7 2.9 2.7 2.2 2.0 3.0 3.1 1.1 1.4 0.4 2.9 2.9 1.5 30.0 34.5 42.1 37.7 26.9 19.2 32.9 27.3 29.1 39.4 23.8 18.8 19.3 47.6 47.4 27.5 25.2 22.9 28.1 18.2 47.1 90.3 41.8 5.0 19.0 10.7 25.6 44.1 0.0 17.6 17.3 28.1 48.9 11.5 47.8 12.9 35.0 27.7 28.3 20.6 14.9 26.4 15.8 35.4 9.0 32.3 90.6 23.3 43.2 24.1 15.4 91.0 12.9 20.8 28.6 35.1 61.9 20.9 24.5 33.3 110.2 DLL1 ENSG00000198719 "Delta like canonical Notch ligand 1" O00548 6 170282206-170306565 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Autism spectrum disorder, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.9" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 59.4;Intestinal endocrine cells: 49.7;Mucus-secreting cells: 76.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "NK-cell: 7.3" "Lineage enriched" "Detected in single" 8 "NK-cells: 7.3" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;HBEC3-KT: 10.8;NB-4: 17.8;THP-1: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078298 Uncertain Nucleoplasm NA NA 210000 Nucleoplasm "HPA078298: " "unprognostic (1.03e-1)" "unprognostic (9.22e-2)" "unprognostic (2.17e-3)" "unprognostic (1.95e-1)" "unprognostic (2.89e-2)" "unprognostic (6.35e-2)" "unprognostic (1.63e-2)" "unprognostic (1.89e-1)" "unprognostic (9.22e-2)" "unprognostic (1.14e-2)" "unprognostic (1.39e-2)" "unprognostic (2.64e-2)" "unprognostic (5.23e-3)" "unprognostic (3.50e-1)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (1.66e-1)" 8.9 5.7 4.1 5.5 9.0 3.2 8.6 2.5 13.8 7.4 10.3 18.5 2.6 8.1 6.0 3.0 11.1 5.7 11.4 7.2 5.2 4.0 5.8 13.5 6.8 5.6 5.5 5.2 2.5 13.8 2.2 3.1 5.0 10.0 14.5 5.2 14.3 8.9 7.1 3.8 14.3 13.1 3.9 4.6 36.9 5.9 1.6 7.3 0.9 6.1 5.3 6.3 4.5 11.0 0.0 0.0 0.1 0.9 7.3 0.5 0.2 0.9 0.1 4.3 2.7 0.3 0.2 2.3 0.2 0.6 0.3 0.5 1.1 0.1 0.0 0.2 0.1 0.7 7.0 2.7 10.8 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 3.1 0.1 2.0 0.0 1.1 0.2 1.1 0.1 0.0 0.0 0.4 3.0 0.0 17.8 0.6 0.4 0.0 0.8 4.3 0.1 0.0 1.3 1.9 0.1 0.3 0.0 0.0 1.6 0.7 14.7 0.5 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.8 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.3 0.1 7.3 0.9 0.0 0.0 0.2 4.1 9.0 2.5 11.2 5.2 4.0 5.5 5.2 10.0 7.3 0.0 0.3 0.0 15.5 59.4 0.7 4.6 0.0 10.7 10.3 1.8 21.6 2.4 0.0 0.3 0.3 18.9 1.6 0.0 1.5 5.2 8.9 3.8 5.7 0.0 1.0 0.0 49.7 20.9 3.9 1.2 0.3 2.5 6.8 0.0 76.5 1.0 0.9 2.9 1.1 0.0 0.6 12.9 9.0 0.5 1.9 11.2 3.1 0.0 2.6 0.9 DNAJA3 "hTid-1, TID1" ENSG00000103423 "DnaJ heat shock protein family (Hsp40) member A3" Q96EY1 16 4425805-4456775 "Predicted intracellular proteins" Apoptosis Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016095, HPA040875, HPA044229" Approved Supported Vesicles,Mitochondria NA NA Mitochondria Vesicles "CAB016095: AB_668801, HPA040875: AB_2677183, HPA044229: AB_2678865" "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (2.86e-3)" "unprognostic (2.91e-2)" "unprognostic (4.17e-1)" "unprognostic (5.18e-2)" "unprognostic (1.60e-1)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (3.16e-3)" "unprognostic (1.55e-1)" "unprognostic (3.27e-2)" "prognostic favorable (1.79e-4)" "unprognostic (4.17e-2)" "unprognostic (1.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.92e-1)" 10.8 26.6 10.7 11.3 15.5 6.2 13.0 15.3 20.8 10.0 14.0 13.9 11.1 17.3 11.3 8.7 15.6 12.6 12.5 28.8 13.9 12.6 19.0 44.8 9.1 13.4 13.0 13.0 13.2 18.1 21.6 12.1 13.7 14.2 11.5 13.4 10.6 14.4 13.4 46.7 12.8 13.2 11.4 12.6 11.4 12.8 15.1 11.1 13.6 16.1 16.2 13.3 13.4 11.2 10.4 6.5 2.2 7.0 7.8 11.9 7.9 9.0 18.1 6.3 12.0 7.9 7.0 11.8 11.9 9.0 16.6 13.7 15.0 12.8 17.8 11.1 7.7 11.8 13.7 20.6 14.1 9.7 12.2 17.8 9.0 15.6 14.5 19.7 15.8 8.7 8.5 16.9 14.7 24.5 8.4 8.0 14.0 23.4 14.7 9.4 20.7 14.7 11.4 13.8 16.8 16.7 18.4 10.1 33.3 12.4 9.7 15.6 6.7 13.0 29.9 19.7 5.7 17.1 13.3 7.4 12.4 8.4 29.9 14.9 15.2 20.4 24.3 6.6 15.3 14.6 0.7 4.6 2.2 9.5 7.0 11.0 10.4 9.1 8.9 6.5 8.9 11.9 9.2 0.5 7.8 5.2 4.6 7.4 7.9 10.7 15.5 15.3 20.8 13.9 12.6 13.0 13.0 14.2 11.1 11.9 7.2 17.9 16.3 14.0 22.0 30.7 10.2 8.1 12.5 24.4 9.8 35.8 38.1 17.3 52.4 10.5 15.3 0.0 10.6 24.7 13.3 14.9 12.7 36.1 14.4 22.3 16.8 6.7 10.1 12.7 17.8 10.0 20.3 14.4 15.8 19.5 13.0 14.0 20.8 21.4 20.5 12.9 11.8 35.4 34.5 14.8 23.8 15.2 28.5 13.5 DNASE1L2 DNAS1L2 ENSG00000167968 "Deoxyribonuclease 1 like 2" Q92874 16 2235816-2238711 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 11.7;skin 1: 20.6" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 1.1;Horizontal cells: 1.6;Rod photoreceptor cells: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "eosinophil: 1.4;neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044714 Uncertain Mitochondria "Secreted in other tissues" NA NA Mitochondria "HPA044714: AB_10962870" "unprognostic (9.88e-2)" "unprognostic (1.11e-3)" "unprognostic (6.80e-4)" "unprognostic (4.29e-2)" "unprognostic (2.35e-1)" "unprognostic (1.55e-1)" "unprognostic (2.72e-2)" "unprognostic (2.50e-1)" "unprognostic (2.72e-1)" "unprognostic (1.86e-1)" "unprognostic (2.96e-3)" "unprognostic (2.17e-2)" "unprognostic (4.67e-4)" "unprognostic (1.40e-4)" "unprognostic (3.51e-1)" "unprognostic (2.28e-1)" "unprognostic (2.94e-4)" 0.6 1.3 1.3 0.6 2.1 0.8 2.1 8.8 2.8 0.6 0.6 0.6 0.6 0.8 1.2 3.5 0.6 0.4 0.6 0.6 1.6 2.1 0.9 1.6 0.6 0.6 1.5 0.6 0.7 1.9 0.2 2.1 1.3 1.3 0.8 0.2 0.6 11.7 0.6 0.7 20.6 0.8 0.6 1.3 1.0 0.9 1.9 0.6 2.4 2.7 7.1 3.4 0.6 0.6 0.0 0.0 1.6 0.0 0.0 0.2 0.0 1.9 4.0 1.7 1.8 1.4 0.8 6.9 0.6 0.5 1.6 0.8 4.4 4.1 2.6 2.1 0.2 0.5 0.6 0.6 0.2 0.2 5.1 3.8 1.1 6.2 1.0 0.2 1.2 4.2 0.9 1.4 1.2 0.3 1.6 0.3 3.0 3.5 3.9 0.6 4.5 3.6 7.5 1.7 0.5 2.7 6.7 2.0 3.5 0.9 0.9 3.5 1.8 0.9 1.5 2.8 0.4 6.1 2.7 0.2 3.4 4.4 1.9 1.4 9.5 4.5 2.4 1.1 2.5 1.7 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.3 2.1 8.8 2.8 1.6 2.1 1.5 0.6 1.3 0.6 0.0 1.1 0.0 0.0 0.1 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.6 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 DND1 "MGC34750, RBMS4" ENSG00000256453 "DND microRNA-mediated repression inhibitor 1" Q8IYX4 5 140670794-140673586 "Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.2;testis: 12.0" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 44.0;Horizontal cells: 19.1;Spermatogonia: 26.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 6 "T-cells: 1.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059723 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA059723: " 0.5 0.2 1.7 0.4 0.8 0.4 0.7 3.2 0.4 0.6 0.6 0.4 0.4 0.3 0.4 0.5 0.4 0.7 0.4 0.4 0.4 0.4 0.4 0.8 0.5 0.4 0.4 0.4 0.4 0.4 1.0 1.1 0.4 0.4 0.6 0.9 0.4 0.4 0.6 0.4 0.3 0.4 0.5 0.5 0.7 0.4 12.0 0.4 0.4 0.4 0.4 1.4 0.4 0.4 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.5 0.5 0.8 0.6 0.9 0.4 2.1 0.2 0.9 3.5 3.2 1.0 0.7 0.8 0.3 0.6 0.4 0.8 2.2 1.1 1.4 0.7 2.0 0.3 1.4 0.3 1.4 0.5 1.0 0.7 3.4 2.9 1.8 0.4 1.2 1.1 0.7 0.1 1.2 0.2 0.2 2.6 0.6 0.0 2.2 2.1 0.5 0.4 1.8 0.4 1.4 1.2 0.2 0.1 0.8 0.7 0.3 0.5 0.0 0.8 1.6 0.6 0.1 4.0 1.1 0.4 0.0 0.5 0.8 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.8 3.2 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.0 1.4 1.3 0.8 0.5 10.3 0.0 0.0 0.0 1.2 3.5 3.9 0.2 0.0 0.2 44.0 0.7 0.4 0.0 0.3 0.3 0.7 1.6 0.0 0.9 0.5 19.1 1.2 0.0 1.0 5.6 0.6 1.1 0.0 0.0 0.1 3.9 0.2 0.0 0.4 0.0 3.8 0.0 0.3 6.9 26.2 0.9 0.2 3.2 0.6 1.2 DOC2A ENSG00000149927 "Double C2 domain alpha" Q14183 16 30005509-30023270 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.0;testis: 12.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 72.3;Early spermatids: 196.5;Late spermatids: 146.0" "Cancer enhanced" "Detected in many" "renal cancer: 5.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 9.8;SCLC-21H: 26.6;U-937: 12.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 13.5;cerebral cortex: 30.8;hippocampal formation: 24.4" HPA065676 Uncertain "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Cell Junctions" "Nucleoplasm, Nucleoli" "HPA065676: AB_2685528" "unprognostic (1.46e-3)" "unprognostic (3.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.31e-1)" "unprognostic (4.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.66e-2)" "unprognostic (9.14e-2)" "unprognostic (3.90e-2)" "unprognostic (2.89e-2)" "unprognostic (1.28e-3)" "unprognostic (5.13e-2)" "unprognostic (8.29e-3)" "unprognostic (1.71e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" "unprognostic (2.61e-1)" 1.2 2.7 18.5 1.0 17.5 3.9 2.3 24.0 49.0 1.3 3.1 0.9 0.3 1.7 1.6 2.4 1.1 3.3 1.8 1.0 15.3 8.3 1.6 1.4 3.5 1.4 2.8 27.4 5.7 1.0 1.3 3.2 1.2 13.1 2.5 2.4 0.0 1.6 1.4 1.1 2.0 2.3 1.8 4.2 3.1 1.7 12.6 1.8 0.0 1.6 0.0 1.2 1.4 0.6 0.6 1.1 1.0 0.4 0.2 0.5 0.3 0.7 1.5 1.1 0.8 0.3 0.0 9.8 0.4 0.7 0.5 0.3 4.0 2.7 0.0 0.9 0.4 1.4 0.2 5.0 2.0 0.2 0.1 0.5 0.8 0.5 0.3 0.7 0.9 2.9 1.2 0.8 0.1 1.1 5.0 0.0 3.3 0.3 0.0 0.0 7.8 2.1 3.6 1.5 3.1 4.2 8.0 0.1 0.4 0.5 0.8 26.6 2.1 0.6 2.8 0.2 2.4 2.7 1.7 0.8 0.3 1.5 0.3 0.3 0.5 0.1 0.1 0.3 12.8 0.3 0.8 0.4 0.0 0.0 0.3 0.1 0.5 0.1 0.3 1.1 0.6 0.5 0.5 1.0 0.2 0.0 0.0 0.1 0.3 18.5 17.5 24.0 36.2 15.3 8.3 2.8 27.4 13.1 1.8 0.0 5.8 0.5 3.1 0.6 1.2 0.6 2.5 72.3 12.5 1.8 21.6 0.3 1.7 0.0 196.5 0.7 0.9 0.0 0.0 0.9 0.7 1.8 0.0 0.0 0.4 0.0 1.2 1.8 1.3 146.0 0.6 1.3 1.7 0.0 2.2 3.1 0.0 0.0 1.8 0.0 1.8 0.0 0.3 1.7 4.1 0.6 0.1 0.0 4.1 0.7 DOCK4 "FLJ34238, KIAA0716" ENSG00000128512 "Dedicator of cytokinesis 4" Q8N1I0 7 111726110-112206411 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 44.7;Horizontal cells: 89.0;Ito cells: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.4" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 19.2;HUVEC TERT2: 36.4;TIME: 31.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071516 Approved "Nucleoli,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nucleoli, Plasma membrane" "Golgi apparatus, Cytosol" "HPA071516: AB_2686407" "unprognostic (1.37e-1)" "unprognostic (4.18e-1)" "unprognostic (1.53e-1)" "unprognostic (2.48e-2)" "unprognostic (7.10e-2)" "unprognostic (2.03e-2)" "unprognostic (9.10e-2)" "unprognostic (2.18e-2)" "unprognostic (3.03e-2)" "unprognostic (5.78e-2)" "unprognostic (7.06e-2)" "unprognostic (3.66e-1)" "unprognostic (5.71e-2)" "unprognostic (1.89e-2)" "unprognostic (9.48e-2)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" 10.7 6.5 16.5 10.0 28.2 2.3 6.8 11.7 28.2 9.1 4.4 21.0 2.0 2.8 7.9 4.4 4.4 8.7 7.9 6.9 22.2 10.1 7.3 13.9 25.5 3.7 18.2 12.4 14.2 5.0 4.7 4.0 10.8 12.2 6.5 4.9 1.7 4.4 3.9 6.7 3.5 3.2 10.7 20.3 3.2 3.1 3.5 21.8 0.0 5.8 2.7 3.6 5.7 5.2 0.2 0.3 6.4 1.2 0.1 0.1 0.2 0.0 1.7 4.1 3.3 3.4 5.0 2.3 0.4 4.5 0.8 1.3 0.0 0.0 0.3 3.4 1.0 0.9 0.2 0.6 3.9 3.5 1.2 6.7 0.1 2.8 5.7 2.4 0.5 0.2 2.6 0.4 19.2 9.9 1.2 36.4 1.6 0.0 10.3 1.7 0.4 0.8 0.2 2.2 0.5 7.0 0.2 3.0 1.6 2.8 0.1 0.9 3.2 2.5 2.1 2.5 3.8 0.3 0.1 31.4 3.2 1.5 6.1 1.3 0.4 0.1 0.3 0.3 0.8 7.1 0.2 0.7 0.1 0.0 1.2 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 6.4 0.1 0.2 0.3 0.0 0.2 16.5 28.2 11.7 18.2 22.2 10.1 18.2 12.4 12.2 21.8 44.7 5.0 0.5 3.6 4.6 26.2 11.6 2.5 12.0 21.6 3.5 21.6 0.2 0.0 1.4 2.4 32.2 0.7 0.0 0.3 0.2 6.0 9.4 2.3 14.9 13.6 89.0 10.5 40.5 15.6 1.1 5.2 17.3 8.5 8.2 0.7 4.4 1.0 9.9 7.8 1.1 10.3 12.9 3.3 0.7 1.7 2.4 0.0 0.0 0.8 1.6 DPEP1 ENSG00000015413 "Dipeptidase 1" P16444 16 89613308-89638456 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Lipid metabolism" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "intestine: 161.7;kidney: 52.2;pancreas: 100.5" "Cell type enhanced" "Detected in many" 26 "Leydig cells: 268.4;Peritubular cells: 1144.5;Proximal tubular cells: 391.6" "Cancer enriched" "Detected in many" 8 "colorectal cancer: 107.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 5.2;Hep G2: 20.3;HHSteC: 9.2;U-937: 28.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009426, HPA012783" Enhanced Approved "Nucleoplasm,Cell Junctions" "Intracellular and membrane" NA NA 270000 "Nucleoplasm, Cell Junctions" "HPA009426: AB_1847842, HPA012783: AB_1847843" "unprognostic (3.31e-2)" "unprognostic (3.86e-1)" "unprognostic (1.37e-1)" "unprognostic (1.95e-2)" "unprognostic (1.91e-2)" "unprognostic (4.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-1)" "unprognostic (3.45e-2)" "unprognostic (5.18e-1)" "unprognostic (8.68e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.84e-4)" "unprognostic (6.12e-3)" "unprognostic (1.92e-1)" "unprognostic (5.23e-2)" "unprognostic (3.93e-2)" 0.1 0.4 0.1 0.9 0.1 0.0 0.1 0.1 0.1 1.5 53.6 0.1 0.4 16.1 0.2 3.4 0.3 0.1 0.9 0.1 0.1 0.1 52.2 0.1 0.3 0.9 0.1 0.1 0.2 100.5 0.0 0.2 0.1 0.2 0.1 0.0 0.2 0.3 0.4 0.1 0.4 161.7 0.1 0.1 0.9 0.2 9.8 0.1 0.2 0.1 0.1 0.5 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 1.1 0.1 2.8 0.0 0.0 0.0 0.0 5.2 0.1 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.4 0.0 0.0 20.3 9.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.6 0.7 2.1 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.1 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 3.0 2.6 14.9 0.0 0.5 3.3 0.3 0.0 0.0 1.2 22.7 0.0 0.1 48.0 0.3 10.3 0.1 4.2 0.0 171.7 0.3 4.5 0.0 1.1 0.0 0.5 0.0 8.5 1.8 0.0 29.1 268.4 1.7 5.0 1.8 1.9 0.0 43.8 11.5 1144.5 391.6 0.1 6.5 0.3 15.6 2.9 0.3 0.3 0.5 1.2 0.0 DPH1 "DPH2L, DPH2L1, OVCA1" ENSG00000108963 "Diphthamide biosynthesis 1" Q9BZG8 17 2030110-2043430 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 2: 8.6;Club cells: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069750, HPA073864" Approved Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA069750: AB_2686188, HPA073864: " "unprognostic (5.54e-2)" "unprognostic (1.99e-1)" "unprognostic (1.62e-1)" "unprognostic (1.86e-2)" "unprognostic (1.50e-2)" "unprognostic (1.46e-1)" "unprognostic (2.21e-1)" "unprognostic (1.10e-1)" "unprognostic (3.93e-2)" "unprognostic (2.30e-1)" "prognostic favorable (1.78e-5)" "unprognostic (2.74e-3)" "unprognostic (2.10e-2)" "unprognostic (1.03e-1)" "unprognostic (3.40e-1)" "unprognostic (7.30e-2)" "unprognostic (1.41e-1)" 16.6 22.9 17.6 19.0 22.7 10.3 17.0 38.6 26.5 17.8 17.1 17.2 21.1 17.0 22.2 17.0 17.9 29.0 22.6 20.2 14.1 13.1 21.4 32.7 15.7 22.7 17.0 21.6 25.2 29.4 28.4 42.9 17.3 15.4 26.1 13.3 21.3 25.7 23.9 33.3 29.0 17.3 18.9 11.4 17.8 18.4 19.5 19.9 17.5 21.0 25.8 19.0 17.2 16.0 11.3 9.3 0.7 6.8 5.6 12.0 5.5 9.1 16.1 4.4 10.7 13.8 10.1 12.2 12.1 18.2 20.6 13.4 15.4 7.5 17.9 15.7 35.8 7.9 7.3 14.8 13.6 11.2 4.6 33.9 4.1 7.6 9.2 13.1 5.2 6.8 15.1 13.9 16.5 13.4 14.7 9.3 10.4 14.0 7.4 8.1 12.1 9.1 3.4 4.1 11.2 16.5 10.6 3.1 13.9 9.2 5.7 8.3 9.7 10.9 12.5 12.1 4.3 18.1 4.3 6.4 14.4 6.6 17.7 10.9 7.3 5.0 4.4 14.2 7.1 5.0 0.0 4.6 0.7 9.5 6.8 10.4 11.3 7.8 8.6 9.3 9.5 12.0 8.7 0.3 5.6 4.6 6.7 10.4 5.5 17.6 22.7 38.6 26.5 14.1 13.1 17.0 21.6 15.4 19.9 3.0 8.6 0.0 0.8 0.3 1.9 1.3 0.0 2.7 4.5 0.0 2.0 1.2 0.0 0.4 0.9 0.6 0.4 0.0 0.5 0.7 1.3 0.5 2.3 0.0 0.5 1.6 0.0 0.6 0.0 1.0 0.6 1.0 0.0 0.0 0.3 1.0 0.0 0.0 0.4 0.4 3.0 0.0 1.2 0.7 0.3 0.3 1.1 0.7 0.4 0.6 DROSHA "Etohi2, HSA242976, RN3, RNASE3L, RNASEN" ENSG00000113360 "Drosha ribonuclease III" Q9NRR4 5 31400497-31532196 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, RNA-mediated gene silencing" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031150 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031150: AB_2673761" "unprognostic (8.37e-3)" "unprognostic (1.81e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (6.79e-4)" "unprognostic (5.40e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (1.39e-4)" "unprognostic (3.11e-1)" "unprognostic (4.08e-2)" "unprognostic (9.08e-2)" "unprognostic (1.86e-1)" "unprognostic (5.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (6.94e-2)" "unprognostic (2.32e-2)" 15.7 16.8 18.4 17.7 32.1 12.2 16.1 33.7 33.7 17.4 16.3 19.1 12.2 15.9 22.3 25.8 16.0 18.2 14.1 15.2 16.6 15.1 15.3 11.7 13.9 17.8 13.6 16.4 26.7 17.8 23.9 38.9 17.0 18.9 17.2 19.2 23.7 17.5 19.2 23.6 16.0 17.5 16.9 19.4 16.8 16.0 12.8 16.4 25.6 21.9 13.4 19.8 18.2 16.2 4.7 6.4 3.3 4.8 4.8 6.4 3.1 12.4 15.7 17.4 23.6 9.3 11.4 25.1 16.5 8.1 15.4 11.5 16.5 16.2 14.0 19.0 12.1 17.9 10.9 21.4 12.5 17.2 13.1 15.1 17.2 51.6 11.9 8.4 19.2 51.4 8.9 8.8 17.2 8.3 11.8 13.1 15.0 21.8 6.6 13.4 12.4 18.5 14.4 16.4 10.1 12.6 16.8 33.3 10.1 8.7 14.2 9.1 12.0 41.9 17.2 10.1 16.2 15.8 11.1 11.4 14.9 17.3 13.3 15.6 12.1 19.8 15.4 10.3 21.7 14.2 1.8 2.4 3.3 5.2 2.6 5.5 4.2 5.4 6.0 5.2 4.7 6.4 4.4 0.8 4.8 4.8 6.4 5.1 3.1 18.4 32.1 33.7 33.7 16.6 15.1 13.6 16.4 18.9 16.4 11.9 14.7 3.0 4.6 3.2 18.2 21.0 7.6 20.1 15.9 5.2 0.0 6.6 3.3 7.2 2.5 6.2 7.3 0.0 7.0 6.4 7.4 5.0 9.2 5.1 6.7 6.4 10.9 9.2 7.8 4.3 10.0 3.2 1.7 9.0 10.1 10.5 7.8 8.6 12.4 4.2 16.8 6.5 4.7 5.8 8.4 3.0 4.1 5.7 10.0 5.1 DSN1 "C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13" ENSG00000149636 "DSN1 homolog, MIS12 kinetochore complex component" Q9H410 20 36751791-36773818 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 90.5;Spermatogonia: 91.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002813, HPA030627" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol" Yes Yes Nucleoplasm "Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol" "HPA002813: AB_1078343, HPA030627: AB_2732460" "unprognostic (3.60e-2)" "prognostic favorable (4.49e-4)" "unprognostic (5.22e-3)" "unprognostic (1.13e-3)" "unprognostic (2.00e-1)" "unprognostic (4.64e-2)" "prognostic unfavorable (4.16e-5)" "unprognostic (3.93e-1)" "unprognostic (9.35e-2)" "unprognostic (5.51e-2)" "unprognostic (2.98e-2)" "unprognostic (7.66e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.92e-2)" "unprognostic (2.53e-1)" "unprognostic (2.58e-2)" "unprognostic (2.84e-1)" 6.7 10.4 5.6 15.6 7.4 11.6 8.2 5.4 7.2 5.1 8.6 4.1 9.5 6.3 9.5 12.0 9.1 5.0 8.1 6.2 5.1 4.7 5.8 8.6 6.1 11.0 4.8 3.9 5.3 5.4 3.6 7.6 12.9 5.1 6.5 10.3 10.1 9.7 8.1 4.6 7.3 8.8 5.9 4.1 11.6 7.0 27.2 4.1 21.2 6.3 11.4 13.8 5.8 5.5 10.9 25.4 21.7 5.9 5.6 6.5 3.7 13.0 11.8 13.9 11.1 5.5 7.2 9.2 16.0 13.6 24.6 27.7 20.5 17.0 15.1 10.7 8.7 27.2 17.2 13.0 12.6 23.5 6.6 8.3 29.4 11.3 13.7 1.2 16.8 13.0 2.7 3.6 17.0 5.4 4.0 12.0 16.4 11.4 12.5 16.1 9.3 21.5 13.0 6.5 23.6 20.9 16.9 42.4 10.0 6.2 7.8 14.3 6.5 19.9 20.5 9.7 10.8 20.9 11.3 6.2 22.5 13.7 22.0 17.2 10.5 14.1 17.1 18.9 15.2 16.0 21.7 3.6 7.5 4.4 5.9 4.9 8.8 4.8 5.8 3.9 10.9 5.9 5.5 6.5 5.6 5.0 25.4 6.5 3.7 5.6 7.4 5.4 7.2 5.1 4.7 4.8 3.9 5.1 4.1 6.0 4.1 9.3 10.2 4.4 8.0 4.1 2.5 10.7 10.3 5.2 27.5 42.7 6.6 5.2 6.3 5.8 6.4 0.0 5.6 29.3 7.5 7.5 3.5 4.5 12.6 6.4 2.4 9.8 3.7 5.8 8.1 6.1 1.7 8.2 9.0 4.8 4.7 5.7 7.1 2.9 15.8 0.0 7.2 90.5 91.3 6.4 39.7 6.4 10.5 10.8 DSTYK "DustyPK, KIAA0472, RIP5, RIPK5" ENSG00000133059 "Dual serine/threonine and tyrosine protein kinase" Q6XUX3 1 205142505-205211566 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Horizontal cells: 84.2;Melanocytes: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044140 Approved Uncertain "Nuclear speckles,Intermediate filaments,Cytosol" NA NA "Nuclear speckles, Intermediate filaments" Cytosol "HPA044140: AB_10965031" "unprognostic (1.42e-2)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (1.02e-3)" "unprognostic (1.39e-1)" "unprognostic (2.66e-1)" "unprognostic (1.43e-2)" "unprognostic (9.01e-2)" "unprognostic (1.81e-1)" "unprognostic (1.06e-1)" "unprognostic (2.25e-3)" "unprognostic (1.20e-1)" "unprognostic (3.26e-2)" "unprognostic (7.80e-2)" "unprognostic (1.93e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (8.73e-5)" 6.4 9.2 13.8 4.4 13.3 19.6 8.2 20.4 16.4 8.4 6.5 6.8 4.2 3.3 10.5 7.4 6.7 9.2 5.4 5.7 10.7 9.0 9.3 2.5 7.3 5.4 8.1 11.8 14.0 5.9 22.0 11.0 7.1 12.2 7.2 4.6 9.2 6.2 8.8 14.6 14.0 4.8 8.8 11.0 7.0 5.3 11.5 9.2 7.1 8.4 3.6 5.3 7.6 6.4 3.5 3.1 9.8 3.5 4.8 5.1 1.6 6.9 4.5 4.9 5.9 7.1 12.0 3.4 8.7 8.7 9.1 6.2 2.0 3.8 5.1 2.6 14.6 5.0 4.9 5.3 5.6 9.3 2.4 5.7 9.3 6.0 2.2 6.4 2.6 5.0 7.0 8.5 9.3 8.9 10.9 6.6 3.7 12.0 3.5 7.2 4.7 2.0 2.3 5.2 1.3 5.4 1.8 8.8 4.5 6.1 4.4 2.7 5.3 7.4 7.7 24.3 5.9 5.6 3.4 6.6 5.7 5.7 8.6 5.7 3.6 2.5 3.0 6.6 3.6 20.3 9.8 3.5 6.0 4.6 2.5 4.3 2.7 3.4 3.8 3.1 3.5 5.1 3.7 5.1 4.8 1.8 2.3 2.0 1.6 13.8 13.3 20.4 16.4 10.7 9.0 8.1 11.8 12.2 9.2 26.8 13.3 11.1 5.8 13.3 46.4 9.5 12.7 29.4 17.0 15.7 31.4 5.9 5.0 10.9 8.6 14.9 3.2 23.3 7.8 4.9 18.1 8.2 23.1 7.4 7.8 84.2 12.2 24.5 20.2 17.3 15.3 13.1 86.0 10.0 5.8 50.7 8.5 3.5 17.0 6.2 34.9 25.8 12.0 20.0 12.7 12.2 2.2 14.9 7.6 5.6 DTD1 "bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68" ENSG00000125821 "D-tyrosyl-tRNA deacylase 1" Q8TEA8 20 18587893-18766644 "Enzymes, Predicted intracellular proteins" "DNA replication" "DNA-binding, Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 137.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA040981 Uncertain Uncertain Nucleoli,Cytosol NA NA 180000 "Nucleoli, Cytosol" "HPA040981: AB_10673268" "unprognostic (3.32e-1)" "unprognostic (1.05e-1)" "unprognostic (1.82e-1)" "unprognostic (5.94e-2)" "unprognostic (1.83e-1)" "unprognostic (2.90e-1)" "unprognostic (1.27e-3)" "unprognostic (9.67e-2)" "unprognostic (1.72e-1)" "unprognostic (1.81e-1)" "unprognostic (6.84e-2)" "unprognostic (1.32e-1)" "unprognostic (9.09e-3)" "unprognostic (2.42e-1)" "unprognostic (8.44e-2)" "unprognostic (2.59e-2)" "unprognostic (8.53e-2)" 14.9 17.7 25.2 13.6 26.5 13.6 19.7 22.4 35.4 13.5 13.7 22.2 10.5 10.6 14.4 17.2 18.8 14.5 11.1 16.7 24.7 29.5 20.1 9.4 13.7 15.5 25.2 30.4 19.1 19.7 20.3 23.7 12.7 27.3 13.6 16.0 17.1 17.6 12.4 22.5 17.6 9.8 15.0 30.9 12.7 16.3 20.6 14.4 4.8 29.5 24.9 17.4 13.4 12.6 20.9 27.5 29.9 20.6 16.4 22.5 12.6 18.7 21.1 20.8 20.4 8.9 16.6 11.6 16.6 15.4 13.2 14.5 13.8 14.7 0.0 11.4 15.4 18.5 10.6 16.6 35.2 13.9 9.1 11.9 20.9 4.8 22.9 28.2 16.2 11.3 13.1 28.3 14.9 55.0 11.3 22.4 3.6 13.0 24.4 19.2 27.5 3.4 29.5 19.3 14.2 46.5 0.0 31.0 15.8 20.1 10.1 28.5 21.5 8.9 24.7 42.8 9.5 14.0 10.1 22.1 17.5 9.5 22.3 22.4 19.6 19.4 10.4 12.0 19.0 14.5 29.9 14.5 10.4 22.2 20.6 22.2 20.9 21.7 22.5 27.5 17.8 16.0 16.7 17.1 16.4 20.5 6.4 16.1 12.6 25.2 26.5 22.4 35.4 24.7 29.5 25.2 30.4 27.3 14.4 32.8 20.0 24.2 32.6 20.9 39.1 17.3 30.6 25.4 17.0 40.1 2.0 25.2 36.5 64.2 24.1 30.8 7.3 0.0 76.4 30.7 25.8 26.4 41.5 10.4 41.2 41.3 22.3 24.5 20.4 17.6 16.7 29.6 40.5 48.7 19.7 48.4 68.4 24.6 18.4 51.2 30.2 0.0 17.5 60.6 137.5 31.1 10.4 30.5 24.3 23.6 DTL "CDT2, DCAF2, L2DTL, RAMP" ENSG00000143476 "Denticleless E3 ubiquitin protein ligase homolog" Q9NZJ0 1 212035553-212107400 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 17.8;Erythroid cells: 23.3;Extravillous trophoblasts: 13.2;Spermatocytes: 35.9;Spermatogonia: 19.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD8 T-cell: 1.5;T-reg: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028016, HPA032023, HPA032031" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119" "unprognostic (7.61e-2)" "unprognostic (1.01e-3)" "unprognostic (2.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (8.96e-3)" "unprognostic (2.45e-3)" "unprognostic (8.83e-3)" "unprognostic (2.52e-3)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.71e-9)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (1.96e-2)" "unprognostic (2.82e-1)" 1.3 0.7 0.4 5.4 0.6 10.8 1.3 0.4 0.5 1.2 2.8 0.3 0.1 1.7 1.0 0.6 4.0 0.4 1.5 0.6 0.4 0.4 0.8 1.0 1.6 4.4 0.4 0.1 0.6 0.5 0.6 0.7 5.4 0.2 0.6 4.2 0.2 1.1 0.1 0.4 1.6 3.3 1.4 0.4 4.6 1.1 37.2 0.1 41.2 0.9 5.7 7.5 0.9 1.6 0.7 0.3 0.0 0.4 0.6 5.2 0.7 12.6 10.8 18.5 9.2 1.1 2.3 9.1 15.9 9.9 15.1 22.5 6.7 11.2 9.6 6.0 6.1 9.7 9.9 24.4 13.4 21.8 11.6 11.7 15.3 14.3 8.1 0.0 20.1 9.6 1.0 0.4 24.4 13.0 2.7 6.9 17.0 18.2 19.6 17.4 5.1 26.8 9.2 21.4 9.6 12.5 21.3 32.7 18.5 4.3 8.8 11.6 18.2 15.1 14.5 6.5 19.7 12.4 9.2 3.7 15.1 11.3 15.6 17.9 7.2 11.2 22.2 7.6 13.3 14.6 0.0 0.0 0.0 0.6 0.4 0.0 0.7 0.8 1.5 0.3 0.1 0.0 0.3 0.0 0.6 0.0 0.0 5.2 0.7 0.4 0.6 0.4 0.5 0.4 0.4 0.4 0.1 0.2 0.1 0.0 0.0 7.8 0.4 2.1 0.0 6.1 2.5 0.0 1.2 0.0 0.0 7.5 0.0 0.2 17.8 1.8 0.5 23.3 0.0 13.2 1.2 0.2 0.0 0.0 3.9 0.0 0.0 1.3 0.3 7.9 1.1 1.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 35.9 19.1 1.5 1.3 1.9 2.9 0.0 DTNA "D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3" ENSG00000134769 "Dystrobrevin alpha" Q9Y4J8 18 34493290-34891844 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 106.3;heart muscle: 82.8;skeletal muscle: 90.2" "Cell type enhanced" "Detected in many" 18 "Cardiomyocytes: 121.0;Muller glia cells: 42.7" "Cancer enriched" "Detected in many" 9 "glioma: 28.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;T-cells: 6.7" "Cell line enhanced" "Detected in many" "MCF7: 17.7;NTERA-2: 19.8;SCLC-21H: 27.8;U-87 MG: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015196, HPA071177" Enhanced Approved "Nucleoplasm,Cell Junctions,Intermediate filaments" NA NA "Cell Junctions, Intermediate filaments" Nucleoplasm "CAB015196: AB_2261797, HPA071177: " "unprognostic (1.57e-1)" "unprognostic (4.57e-2)" "unprognostic (3.13e-3)" "unprognostic (7.82e-6)" "unprognostic (5.03e-1)" "unprognostic (2.43e-3)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (1.23e-1)" "unprognostic (6.27e-2)" "unprognostic (1.35e-4)" "unprognostic (6.89e-2)" "prognostic favorable (2.64e-7)" "unprognostic (6.08e-3)" "unprognostic (3.93e-2)" "unprognostic (1.12e-1)" "unprognostic (7.27e-5)" 9.3 5.3 51.5 4.0 47.6 1.6 7.3 37.7 69.1 4.5 5.4 38.7 0.9 3.4 4.3 13.9 13.9 7.6 7.1 82.8 42.3 46.5 2.7 2.5 4.8 2.3 44.7 21.0 5.4 12.3 1.4 6.1 3.6 51.0 14.6 5.6 3.4 5.7 15.9 90.2 1.8 3.9 15.2 106.3 3.9 3.6 4.7 39.5 0.0 9.3 6.5 2.4 12.8 1.7 1.4 7.0 0.4 1.3 1.0 6.7 1.7 0.3 0.1 7.6 0.0 4.9 13.6 1.2 2.0 7.4 0.3 0.9 1.7 0.0 0.0 4.5 0.8 7.0 0.6 0.9 3.9 0.7 0.0 5.3 0.0 0.4 3.5 3.9 0.1 0.1 10.3 0.8 6.4 2.2 7.3 3.3 0.0 1.1 1.0 2.1 17.7 0.1 0.0 19.8 0.3 4.0 0.0 3.7 12.1 0.3 0.1 27.8 3.2 0.0 0.7 2.0 12.5 10.9 2.6 0.1 8.8 4.8 0.1 2.7 0.6 0.9 0.4 28.4 0.0 3.8 0.4 1.3 0.0 1.4 0.0 1.9 1.4 2.7 1.9 7.0 1.1 2.8 2.0 0.1 1.0 0.0 0.2 6.7 1.7 51.5 47.6 37.7 35.7 42.3 46.5 44.7 21.0 51.0 39.5 0.0 1.4 0.0 0.0 1.3 10.2 121.0 22.9 4.0 1.2 0.0 5.9 0.0 5.0 9.9 3.1 0.7 0.0 0.0 21.8 0.1 2.8 0.9 0.0 0.0 7.1 1.6 0.0 0.0 4.1 1.9 5.5 8.8 5.0 0.0 0.0 42.7 12.5 0.0 0.4 1.5 4.2 12.9 22.8 0.5 1.5 0.9 0.0 0.0 0.0 0.1 DUSP28 "DUSP26, VHP" ENSG00000188542 "Dual specificity phosphatase 28" Q4G0W2 2 240560054-240564014 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047456, CAB069448" Uncertain Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB069448: , HPA047456: AB_10961145" "unprognostic (1.88e-2)" "unprognostic (9.29e-2)" "unprognostic (4.86e-2)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (1.07e-2)" "unprognostic (1.09e-2)" "unprognostic (7.56e-3)" "unprognostic (4.13e-3)" "unprognostic (3.71e-2)" "prognostic favorable (1.84e-4)" "unprognostic (9.85e-2)" "unprognostic (1.80e-3)" "unprognostic (6.99e-2)" "unprognostic (2.52e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-3)" 1.8 2.8 2.7 3.0 3.4 7.9 3.5 6.3 3.7 3.1 2.6 3.3 6.5 2.9 2.6 5.0 3.5 3.1 4.4 16.3 2.8 2.7 3.2 3.4 2.5 6.1 3.5 2.4 2.6 10.2 2.6 5.0 3.2 2.8 4.3 2.8 2.7 3.7 2.4 21.2 4.9 4.2 4.3 2.2 5.9 4.2 8.2 2.3 2.6 4.4 13.4 4.2 2.8 4.5 3.8 3.3 10.7 2.1 2.7 3.3 2.0 1.7 1.6 2.2 2.6 1.4 0.8 2.4 1.9 1.2 1.5 1.1 1.0 4.5 2.7 1.0 1.2 2.3 5.1 1.7 0.7 1.6 3.4 6.4 3.9 3.4 2.5 1.0 2.5 6.7 1.7 1.8 1.0 1.3 2.9 0.7 3.9 2.7 3.3 1.3 1.9 3.1 4.0 1.4 2.6 1.4 3.8 4.8 3.6 1.1 2.9 4.9 2.7 1.8 1.9 2.2 1.4 2.4 4.4 1.7 3.5 2.9 2.2 1.7 13.2 3.8 4.4 2.2 1.9 2.8 10.7 2.1 0.7 2.7 1.4 3.0 2.1 2.8 2.8 1.2 3.8 3.3 3.0 3.6 2.7 1.5 3.3 2.2 2.0 2.7 3.4 6.3 3.6 2.8 2.7 3.5 2.4 2.8 2.3 0.0 5.0 5.1 6.9 3.3 6.3 12.9 12.7 6.7 1.2 12.2 3.9 6.4 13.3 4.1 27.6 3.1 11.8 0.0 5.1 4.0 4.1 8.4 6.9 6.6 10.0 7.9 8.1 2.5 10.3 29.8 2.8 7.0 6.8 8.2 8.1 7.4 3.9 11.8 1.4 11.2 6.6 6.5 5.6 41.1 17.6 4.6 5.8 12.5 10.1 6.8 DUX4 ENSG00000260596 "Double homeobox 4" Q9UBX2 4 190173774-190185942 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.4" "Group enriched" "Detected in some" 21 "Early spermatids: 4.1;Late spermatids: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.5;U-2 OS: 3.7;U-266/70: 8.0;U-266/84: 10.4;U-698: 2.4" HPA058451 Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Golgi apparatus, Cytosol" "HPA058451: AB_2683722" 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.5 0.3 0.0 1.1 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 2.5 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 3.7 0.7 0.0 8.0 10.4 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DYNC2H1 "DHC1b, DHC2, DNCH2, DYH1B, hdhc11" ENSG00000187240 "Dynein cytoplasmic 2 heavy chain 1" Q8NCM8 11 103109431-103479863 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Motor protein" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 35.7" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 167.3;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 86.1;Spermatocytes: 64.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.9" "Group enriched" "Detected in many" 5 "NK-cells: 2.9;T-cells: 2.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.0" "Low region specificity" "Detected in all" "HPA039015, HPA039016" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA039015: AB_2676309, HPA039016: AB_10673410" "unprognostic (3.11e-1)" "unprognostic (2.60e-1)" "unprognostic (1.28e-2)" "unprognostic (1.54e-1)" "unprognostic (7.11e-2)" "unprognostic (2.08e-1)" "unprognostic (4.14e-3)" "unprognostic (2.07e-2)" "unprognostic (2.05e-1)" "unprognostic (4.10e-2)" "unprognostic (2.87e-2)" "unprognostic (7.13e-2)" "prognostic favorable (8.49e-5)" "unprognostic (3.75e-3)" "unprognostic (1.62e-1)" "unprognostic (3.88e-2)" "unprognostic (4.11e-3)" 7.3 5.7 6.3 3.8 8.9 1.4 8.4 13.2 9.3 11.5 4.8 5.5 11.0 4.1 11.3 9.6 3.9 14.6 7.8 3.7 7.1 7.1 8.5 2.6 10.2 2.6 4.8 7.9 11.4 5.1 24.2 35.7 3.9 11.2 7.6 2.6 6.2 4.5 10.7 1.6 5.7 3.4 7.8 5.1 4.8 4.2 14.3 5.2 1.1 10.7 3.0 2.4 6.1 6.6 0.5 0.4 0.4 0.2 2.9 2.2 0.0 1.0 2.2 5.7 2.8 8.0 18.0 0.3 3.2 5.2 5.4 5.8 1.2 1.1 0.0 4.5 6.2 2.5 4.3 4.4 6.0 4.3 0.0 4.1 0.8 3.7 0.1 7.7 1.7 1.0 11.2 2.3 12.1 13.9 8.4 2.1 1.1 0.1 0.0 6.9 4.1 0.5 0.4 1.5 0.0 6.1 0.0 4.7 0.1 5.8 0.7 4.1 2.9 5.1 1.4 2.4 1.4 5.3 1.1 5.1 6.5 2.6 6.1 2.1 0.0 0.0 0.0 1.9 5.2 1.9 0.4 0.2 0.0 0.9 0.1 2.2 0.5 0.7 1.1 0.4 0.3 0.8 1.1 0.0 2.9 0.1 0.2 0.0 0.0 6.3 8.9 13.2 9.3 7.1 7.1 4.8 7.9 11.2 5.2 0.0 12.5 0.0 11.5 6.0 22.2 9.4 2.5 167.3 23.9 26.2 106.0 0.3 1.7 5.6 13.4 9.0 0.0 0.0 3.1 0.4 14.8 5.9 3.5 0.8 2.0 30.2 16.6 6.7 1.5 6.5 19.2 3.8 8.5 0.0 0.8 17.7 6.8 1.1 17.3 14.8 86.1 19.4 11.3 64.2 10.4 4.8 0.5 2.5 0.9 5.7 DYNLL2 "Dlc2, DNCL1B, MGC17810, RSPH22" ENSG00000264364 "Dynein light chain LC8-type 2" Q96FJ2 17 58083415-58095536 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 366.0;Late spermatids: 723.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: AB_2676771" "unprognostic (7.22e-2)" "unprognostic (7.76e-2)" "unprognostic (3.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.93e-1)" "unprognostic (3.72e-2)" "unprognostic (6.78e-2)" "unprognostic (2.91e-2)" "unprognostic (1.68e-1)" "unprognostic (1.10e-2)" "prognostic favorable (5.26e-4)" "unprognostic (1.24e-1)" "prognostic favorable (1.12e-12)" "unprognostic (2.87e-2)" "unprognostic (1.28e-1)" "unprognostic (1.31e-1)" "unprognostic (7.02e-2)" 15.4 28.3 38.6 11.1 55.2 9.9 11.6 41.1 41.1 12.9 14.5 22.6 16.3 16.2 12.0 15.6 11.9 13.5 13.3 43.8 32.2 40.2 28.1 23.1 11.8 9.4 48.3 28.7 14.4 11.8 36.2 15.0 19.7 40.6 20.6 13.7 15.5 19.2 18.8 64.8 12.6 15.6 14.3 32.5 11.2 12.7 19.0 27.2 7.6 22.0 15.1 11.8 9.9 16.4 1.5 0.8 3.5 3.0 1.5 3.1 0.8 20.7 14.1 29.1 13.2 18.1 10.0 46.3 21.0 8.4 10.2 8.0 31.3 10.1 18.6 23.9 13.0 12.2 11.2 13.4 16.6 17.6 18.3 9.7 20.1 8.3 18.3 14.4 21.5 12.5 10.0 11.4 11.8 9.4 10.7 6.7 15.8 20.0 11.3 9.8 31.4 24.3 8.9 20.0 13.7 14.5 22.5 17.1 7.7 8.8 22.7 19.9 15.9 18.8 7.6 16.0 15.7 22.5 10.1 12.2 20.1 25.3 13.3 15.4 21.2 25.7 22.7 10.3 17.3 14.0 3.5 1.1 2.0 2.6 0.6 2.9 1.3 2.1 2.3 0.5 1.5 2.2 3.1 1.7 1.5 3.0 0.8 1.4 0.8 38.6 55.2 41.1 41.1 32.2 40.2 48.3 28.7 40.6 27.2 11.9 49.9 27.4 30.9 43.6 58.8 158.5 38.2 14.7 29.6 57.6 37.3 88.3 26.6 31.4 366.0 29.3 47.1 23.3 27.0 62.0 29.2 30.1 22.0 85.9 36.0 66.7 64.5 22.1 21.7 723.4 27.3 23.1 62.4 27.1 52.5 69.7 32.5 40.3 25.1 66.7 36.2 25.8 38.5 40.0 41.2 40.3 50.2 19.2 44.1 28.3 DYRK3 "hYAK3-2, RED, REDK" ENSG00000143479 "Dual specificity tyrosine phosphorylation regulated kinase 3" O43781 1 206635536-206684419 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.2" "Cell type enriched" "Detected in many" 6 "Early spermatids: 160.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in single" 15 "dendritic cells: 6.1" "Cell line enhanced" "Detected in many" "hTERT-HME1: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA075041 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA075041: AB_2686730" "unprognostic (6.51e-2)" "unprognostic (1.24e-2)" "unprognostic (3.36e-2)" "unprognostic (2.03e-1)" "unprognostic (2.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.20e-4)" "unprognostic (2.69e-1)" "unprognostic (3.91e-1)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (9.41e-7)" "unprognostic (2.38e-1)" "unprognostic (2.04e-1)" "unprognostic (1.99e-2)" "unprognostic (7.62e-3)" 7.1 2.7 4.2 4.2 3.5 6.2 7.7 1.3 2.7 5.6 2.7 2.6 3.7 1.2 7.6 5.1 2.7 6.2 12.8 16.3 6.0 3.4 3.4 7.4 5.0 1.6 2.6 2.0 7.6 5.2 2.8 11.2 1.2 4.6 4.5 1.5 4.1 5.5 3.0 2.1 2.0 2.1 7.5 2.7 1.8 3.7 38.2 3.1 5.1 11.9 3.0 1.7 5.4 7.6 0.0 6.1 0.0 0.1 0.0 0.3 0.0 2.5 3.5 0.8 4.9 8.7 7.8 0.1 8.2 18.1 7.5 9.7 0.2 1.3 3.7 1.2 9.6 13.2 0.7 4.2 6.6 8.0 0.0 2.8 5.4 4.4 0.8 13.8 3.7 3.5 5.5 4.3 12.9 35.7 7.7 5.8 5.7 10.4 0.7 11.5 0.9 8.2 2.1 6.9 0.2 6.5 20.4 2.6 0.0 2.4 0.1 5.0 3.7 7.3 0.3 10.0 1.0 0.9 0.9 4.3 15.7 5.9 7.6 6.8 2.9 1.1 4.4 9.3 4.1 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 4.2 3.5 1.3 2.7 6.0 3.4 2.6 2.0 4.6 3.1 3.0 5.1 0.5 10.3 5.8 0.1 10.3 2.5 13.4 5.7 1.8 9.8 0.0 0.0 3.0 160.9 4.2 0.0 0.0 1.9 0.1 7.3 3.2 0.0 1.1 0.9 0.0 2.4 2.5 1.5 27.7 3.7 1.9 8.5 1.8 0.3 3.0 1.4 0.0 1.8 1.0 7.4 6.5 10.3 17.6 3.4 3.1 0.3 0.0 0.2 3.5 DZIP1L "DZIP2, FLJ32844" ENSG00000158163 "DAZ interacting zinc finger protein 1 like" Q8IYY4 3 138061990-138115818 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 93.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "classical monocyte: 1.8;eosinophil: 1.7;intermediate monocyte: 1.3;myeloid DC: 1.5" "Group enriched" "Detected in many" 17 "dendritic cells: 1.5;granulocytes: 1.7;monocytes: 1.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030404 Approved Supported "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA030404: AB_10601548" "unprognostic (3.65e-2)" "unprognostic (8.37e-2)" "unprognostic (2.87e-2)" "unprognostic (3.71e-2)" "unprognostic (8.22e-2)" "unprognostic (6.50e-2)" "unprognostic (6.47e-4)" "unprognostic (1.54e-1)" "unprognostic (3.21e-2)" "unprognostic (3.13e-1)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (1.51e-2)" "unprognostic (2.35e-3)" "unprognostic (2.72e-1)" "unprognostic (9.98e-2)" "unprognostic (2.77e-2)" 5.3 2.0 2.2 6.1 2.5 10.9 5.5 12.1 3.3 17.4 5.1 5.3 3.1 2.9 14.8 6.5 4.3 15.2 7.9 3.8 2.4 2.1 5.1 1.2 6.4 2.0 2.6 1.6 12.4 8.3 6.2 5.6 2.7 6.1 9.3 2.1 10.9 2.5 5.0 1.7 10.4 2.3 11.3 3.4 3.1 10.0 4.2 3.4 0.1 4.2 4.2 2.5 8.0 17.8 0.0 1.5 1.7 1.8 0.0 0.0 0.4 5.2 3.1 6.2 5.2 4.0 5.3 1.4 8.6 5.2 5.1 6.5 2.1 0.4 0.0 4.4 7.9 7.1 1.7 4.5 2.0 2.5 1.1 4.4 2.3 6.4 0.3 3.2 1.7 4.0 5.6 2.1 5.6 2.7 5.2 2.8 1.4 1.7 0.0 6.9 0.3 0.0 0.7 7.5 0.0 1.1 0.0 7.2 0.0 2.3 8.4 2.2 4.9 8.8 0.0 4.4 3.6 2.3 3.6 2.1 12.7 5.8 6.1 4.4 0.0 0.0 0.1 5.0 2.5 4.9 0.0 1.8 1.7 0.0 1.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 2.2 2.5 12.1 3.3 2.4 2.1 2.6 1.6 6.1 3.4 3.0 1.3 0.0 0.6 3.2 6.5 2.7 2.5 93.7 11.4 1.8 7.9 0.0 5.0 3.1 15.6 1.8 0.0 0.0 1.1 0.1 3.5 0.5 0.0 0.0 1.4 3.2 0.0 0.0 1.0 1.0 5.8 2.7 0.0 1.0 0.0 2.3 3.7 0.0 3.9 0.5 17.8 0.0 4.7 0.4 1.5 3.8 0.0 0.0 0.0 0.1 EDEM1 "EDEM, KIAA0212" ENSG00000134109 "ER degradation enhancing alpha-mannosidase like protein 1" Q92611 3 5187646-5219957 "Plasma proteins, Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 57.5;lymphoid tissue: 89.4" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 96.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 48.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029565 Uncertain Enhanced "Endoplasmic reticulum,Aggresome" NA NA "Endoplasmic reticulum" Aggresome "HPA029565: AB_10602032" "unprognostic (3.03e-1)" "unprognostic (3.02e-2)" "unprognostic (3.57e-3)" "unprognostic (4.30e-3)" "unprognostic (1.37e-1)" "unprognostic (2.60e-2)" "unprognostic (6.29e-2)" "unprognostic (2.09e-2)" "unprognostic (1.39e-1)" "unprognostic (6.49e-2)" "unprognostic (5.72e-3)" "unprognostic (1.51e-1)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "unprognostic (2.34e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" 6.5 7.6 5.3 13.1 6.7 26.3 7.0 4.8 6.3 6.7 7.6 4.5 5.1 5.9 8.4 6.4 10.5 7.0 6.2 4.8 4.3 3.1 6.6 57.5 14.2 16.9 3.9 5.0 8.6 20.3 10.2 6.5 14.2 4.2 6.6 7.6 5.5 9.7 5.7 3.7 10.1 11.8 5.4 3.7 15.4 7.8 7.8 4.0 89.4 7.8 5.5 23.5 8.8 8.1 9.9 10.3 4.3 5.8 2.9 8.9 2.8 4.7 4.8 3.0 3.0 4.0 9.0 9.7 7.8 10.6 5.4 7.1 2.2 6.3 25.5 4.2 7.7 11.8 3.7 3.3 10.7 8.3 48.9 1.9 8.7 4.5 4.9 18.8 10.2 25.5 8.1 13.1 11.5 12.7 7.3 10.7 33.3 2.2 35.3 6.6 2.8 20.5 3.9 1.5 2.2 3.6 29.9 5.4 23.4 6.2 10.0 0.4 4.0 5.6 8.1 11.5 2.8 4.1 32.9 10.4 10.4 7.3 8.8 8.9 20.8 12.6 43.9 17.3 9.9 8.6 3.5 3.8 4.0 5.8 5.0 8.4 9.9 8.8 6.5 4.6 6.8 7.9 6.2 4.3 2.9 5.8 10.3 8.9 2.8 5.3 6.7 4.8 6.3 4.3 3.1 3.9 5.0 4.2 4.0 56.6 96.8 35.0 6.3 18.3 4.1 2.8 17.8 6.7 20.5 15.7 9.8 8.0 0.0 6.0 9.1 11.3 14.8 0.0 10.5 26.0 8.7 10.9 23.1 65.7 15.8 1.6 8.1 14.7 33.3 37.6 7.8 35.8 15.1 47.7 22.7 3.5 14.0 0.0 8.5 7.0 3.5 0.0 12.2 6.7 2.0 23.8 34.2 21.4 10.1 16.1 EDN1 ET1 ENSG00000078401 "Endothelin 1" P05305 6 12290363-12297194 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 804.7;Ductal cells: 273.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.9" "Lineage enriched" "Detected in many" 6 "monocytes: 7.9" "Cell line enhanced" "Detected in many" "EFO-21: 109.7;HUVEC TERT2: 72.7;T-47d: 22.4;TIME: 53.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031976, CAB032500, CAB037291" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted to blood" NA Yes 9740 "Nucleoli, Golgi apparatus" Nucleoplasm "CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "unprognostic (9.72e-2)" "unprognostic (3.40e-1)" "unprognostic (1.91e-1)" "unprognostic (6.24e-2)" "unprognostic (2.94e-3)" "unprognostic (1.42e-1)" "unprognostic (8.92e-2)" "unprognostic (4.19e-2)" "unprognostic (3.17e-1)" "unprognostic (8.02e-3)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (1.34e-1)" "unprognostic (3.47e-1)" 35.7 1.5 8.4 6.2 30.8 3.6 19.2 3.2 22.0 8.2 9.2 4.2 1.1 9.0 7.2 15.3 10.8 8.6 11.9 5.2 19.0 6.2 5.7 2.8 25.1 6.7 10.9 5.5 4.3 8.2 1.6 1.0 16.0 25.1 5.4 12.9 6.9 9.7 8.5 25.6 8.2 6.7 9.7 13.5 10.2 6.8 4.8 5.6 0.2 2.9 3.8 2.1 5.3 4.1 0.2 0.2 1.2 7.9 0.0 0.2 0.0 1.6 9.2 0.1 0.0 0.0 0.0 0.0 2.9 2.6 2.4 2.0 11.9 1.4 0.0 109.7 1.1 1.5 0.8 0.0 1.7 1.8 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 1.0 0.4 0.3 0.7 72.7 0.0 0.0 0.0 9.2 0.2 0.0 0.0 0.1 1.6 0.1 0.0 0.8 0.0 5.8 1.5 0.1 0.0 0.3 8.7 0.0 20.3 22.4 0.1 53.8 6.2 4.9 0.1 3.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 7.9 0.1 0.0 0.0 8.4 30.8 3.2 22.0 19.0 6.2 10.9 5.5 25.1 5.6 160.8 31.6 0.8 804.7 168.7 0.0 2.0 5.1 0.0 46.6 36.6 0.0 1.4 3.3 273.4 11.4 170.8 145.3 0.0 195.7 0.6 8.2 167.4 1.1 0.8 1.7 1.6 15.0 109.2 6.3 10.0 5.2 3.6 8.5 19.0 12.9 0.2 217.0 147.3 0.4 5.7 0.0 6.5 6.2 1.1 0.4 56.3 0.7 5.7 34.9 116.8 EDNRA ENSG00000151617 "Endothelin receptor type A" P25101 4 147480917-147544954 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 62.6;seminal vesicle: 52.3" "Cell type enhanced" "Detected in some" 14 "Leydig cells: 40.6;Peritubular cells: 64.0;Sertoli cells: 51.8;Smooth muscle cells: 84.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 7.3;ASC TERT1: 14.5;HHSteC: 7.4;LHCN-M2: 17.2;SH-SY5Y: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013774, CAB018957" Uncertain Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB018957: AB_2039838, HPA013774: AB_1847994" "unprognostic (3.08e-2)" "unprognostic (6.28e-2)" "unprognostic (1.78e-1)" "unprognostic (3.42e-1)" "unprognostic (1.07e-2)" "unprognostic (1.39e-1)" "unprognostic (3.20e-2)" "unprognostic (7.20e-2)" "unprognostic (2.75e-3)" "unprognostic (1.47e-2)" "unprognostic (1.34e-3)" "unprognostic (2.88e-1)" "prognostic unfavorable (1.50e-7)" "prognostic unfavorable (3.93e-4)" "unprognostic (6.20e-3)" "unprognostic (3.11e-2)" "unprognostic (2.53e-3)" 7.6 2.6 1.3 1.4 1.8 0.0 7.2 0.6 2.4 62.6 2.6 1.0 21.7 1.5 37.3 14.2 4.7 13.3 7.3 15.1 1.3 1.3 3.1 1.4 12.7 2.0 1.8 1.0 23.5 0.9 1.9 2.2 5.9 2.7 21.5 1.5 10.3 4.1 52.3 4.8 3.2 1.8 19.4 1.6 11.5 4.4 9.1 1.4 2.9 5.0 6.0 2.6 14.7 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 4.2 0.0 7.3 14.5 0.0 2.2 2.9 0.4 0.1 0.2 0.0 0.0 0.0 0.7 0.5 0.0 0.3 0.6 0.2 0.0 1.5 0.0 2.5 0.0 7.4 0.0 0.0 5.6 0.5 0.4 0.0 2.7 0.0 0.0 0.0 1.1 17.2 0.2 0.0 0.1 1.2 0.0 0.9 0.0 0.7 0.1 1.1 0.8 0.0 13.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.9 0.6 0.0 0.0 1.1 0.3 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.8 0.6 2.4 1.3 1.3 1.8 1.0 2.7 1.4 3.0 4.0 0.0 0.6 2.7 0.0 17.1 0.0 0.0 7.9 0.0 0.0 0.2 0.0 0.0 2.0 2.7 0.0 0.0 0.0 0.1 11.8 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.1 40.6 0.3 3.3 0.0 0.0 0.0 0.2 0.0 64.0 0.0 0.0 51.8 84.6 0.6 0.6 2.4 0.1 0.0 0.0 0.2 EDNRB "ETB, HSCR, HSCR2" ENSG00000136160 "Endothelin receptor type B" P24530 13 77895481-77975529 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Albinism, Deafness, Disease mutation, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 67.5" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 97.7;Ito cells: 106.8;Melanocytes: 104.6;Muller glia cells: 142.7;Sertoli cells: 213.4;Smooth muscle cells: 110.2" "Group enriched" "Detected in all" 7 "glioma: 41.1;melanoma: 127.7;renal cancer: 28.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "classical monocyte: 2.0;intermediate monocyte: 2.1" "Lineage enriched" "Detected in single" 21 "monocytes: 2.1" "Cell line enhanced" "Detected in some" "AF22: 25.2;ASC diff: 19.2;SK-MEL-30: 23.1;U-266/70: 15.1;WM-115: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017842, HPA027546" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "CAB017842: , HPA027546: AB_2672327" "unprognostic (7.75e-2)" "unprognostic (6.73e-2)" "unprognostic (1.41e-3)" "unprognostic (2.59e-2)" "unprognostic (8.37e-2)" "unprognostic (2.45e-3)" "unprognostic (4.17e-3)" "unprognostic (5.43e-2)" "unprognostic (1.02e-1)" "unprognostic (1.38e-2)" "unprognostic (3.40e-2)" "unprognostic (3.01e-2)" "prognostic favorable (7.20e-5)" "unprognostic (1.59e-2)" "unprognostic (3.86e-2)" "unprognostic (4.58e-2)" "unprognostic (6.77e-3)" 25.4 23.2 22.2 10.3 29.8 0.8 23.1 10.3 30.7 8.1 7.2 13.6 2.3 10.9 7.7 3.6 4.9 6.0 8.5 23.7 16.7 16.4 22.3 26.5 28.4 15.6 24.2 8.1 4.9 6.4 7.7 6.3 67.5 33.2 14.9 7.7 51.0 13.4 4.4 6.7 5.1 11.9 7.4 33.4 16.0 5.8 3.1 12.4 0.0 17.6 2.0 2.9 10.9 8.2 0.0 0.0 0.0 2.1 0.0 0.0 0.4 2.0 0.0 25.2 0.0 19.2 0.7 0.3 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 23.1 3.4 0.0 0.1 0.1 0.2 0.0 0.0 0.1 15.1 8.5 0.0 0.4 0.0 48.1 0.0 2.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22.2 29.8 10.3 11.9 16.7 16.4 24.2 8.1 33.2 12.4 11.9 38.2 0.0 1.0 13.2 3.2 7.3 0.0 2.7 4.5 0.0 5.9 14.3 0.0 0.0 2.4 97.7 0.0 0.0 0.0 10.2 27.8 2.5 5.8 0.5 10.9 0.0 0.0 106.8 21.3 1.8 73.9 9.2 104.6 0.0 0.0 142.7 0.1 0.0 2.5 0.0 3.4 213.4 110.2 0.3 1.4 6.4 4.8 0.0 0.0 1.4 EEF1AKMT3 "DKFZP586D0919, FAM119B, METTL21B" ENSG00000123427 "EEF1A lysine methyltransferase 3" Q96AZ1 12 57771492-57782541 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 39.7" "Cell type enhanced" "Detected in some" 10 "Exocrine glandular cells: 10.8;Hofbauer cells: 6.6;monocytes: 15.4;Proximal tubular cells: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 7 "RH-30: 59.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043020, HPA045492" Uncertain Approved "Nucleoplasm,Mitotic chromosome,Centrosome" NA NA Centrosome "Nucleoplasm, Mitotic chromosome" "HPA043020: AB_2678274, HPA045492: " "unprognostic (2.00e-1)" "unprognostic (6.52e-2)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (1.06e-1)" "unprognostic (7.34e-3)" "unprognostic (7.52e-3)" "unprognostic (1.66e-1)" "unprognostic (2.32e-1)" "unprognostic (1.54e-3)" "unprognostic (5.77e-2)" "unprognostic (1.33e-1)" "unprognostic (1.34e-2)" "unprognostic (1.23e-1)" 9.3 6.1 3.1 3.8 3.0 1.6 10.1 3.7 3.8 8.9 5.4 2.5 8.7 2.8 10.1 8.1 6.4 7.2 8.3 3.9 2.5 1.6 10.8 6.1 7.2 5.5 2.1 2.7 10.7 34.4 6.0 3.6 4.5 3.5 7.7 3.7 6.1 39.7 14.6 2.8 6.2 3.3 7.0 2.9 3.8 6.0 4.3 1.4 1.5 8.4 5.1 6.2 7.7 6.9 0.7 3.9 1.2 5.4 1.8 10.6 2.6 1.9 3.5 1.8 2.2 5.3 5.0 1.5 2.2 4.4 3.7 3.7 2.1 3.3 1.1 2.5 3.0 2.6 1.9 1.4 1.3 3.7 1.2 2.1 5.6 1.9 3.5 4.7 1.4 2.4 5.3 3.5 3.8 4.0 6.0 3.9 5.2 3.3 8.9 2.2 1.5 1.6 3.9 1.3 1.4 3.2 3.3 59.3 3.8 2.5 2.2 1.7 2.4 3.9 2.8 2.4 1.7 4.7 3.7 3.7 5.5 3.1 2.2 2.3 1.9 0.8 1.5 4.2 6.0 3.7 0.5 3.9 0.1 2.5 1.5 10.6 0.7 4.9 2.9 3.9 0.7 2.5 1.9 1.2 1.8 5.4 2.0 3.0 2.6 3.1 3.0 3.7 3.8 2.5 1.6 2.1 2.7 3.5 1.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 1.8 0.0 2.7 5.0 4.7 0.0 0.0 0.0 0.0 10.8 4.0 0.0 0.0 2.3 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 15.4 0.0 0.0 6.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 EEF1AKMT4 ENSG00000284753 "EEF1A lysine methyltransferase 4" O60344 3 184249650-184259585 "Predicted intracellular proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 29.5" "Group enriched" "Detected in some" 4 "Club cells: 5.7;Collecting duct cells: 7.0;Distal tubular cells: 13.3;Ductal cells: 14.2;Exocrine glandular cells: 13.1;Pancreatic endocrine cells: 10.0;Proximal tubular cells: 17.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 2.1 1.7 0.2 3.3 0.8 1.8 1.9 0.3 0.5 1.3 4.2 0.0 2.5 2.5 0.6 0.5 4.1 0.4 1.4 2.4 0.4 4.2 29.5 2.3 2.5 0.2 0.0 1.7 8.3 1.0 3.1 8.4 0.8 1.6 2.3 0.8 5.7 2.7 5.4 2.4 4.3 1.1 0.1 3.7 1.6 13.0 0.6 4.8 6.9 4.5 3.7 1.3 1.6 4.9 10.1 1.2 12.0 3.4 7.6 5.6 13.1 6.9 1.6 4.4 2.4 1.6 10.1 1.5 2.9 2.3 2.2 12.9 2.0 15.6 10.3 1.7 12.2 4.9 7.4 7.5 1.3 6.1 8.7 4.1 4.4 8.2 2.9 10.8 3.5 2.0 9.1 2.6 4.5 1.0 1.9 5.2 7.4 14.5 1.1 20.6 4.4 13.1 3.3 17.2 13.1 9.2 2.2 12.6 2.7 3.2 8.0 2.7 3.0 23.7 5.8 2.4 19.9 5.0 1.4 2.6 3.5 6.1 7.6 8.7 17.5 15.4 2.1 17.9 2.7 0.0 12.0 1.2 4.3 9.7 4.8 4.9 4.6 4.2 10.1 3.2 3.3 5.2 0.2 3.4 6.2 9.0 7.6 5.6 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 5.7 7.0 0.0 0.0 13.3 14.2 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.8 0.0 0.0 10.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EEF1AKMT4-ECE2 ENSG00000284917 "EEF1AKMT4-ECE2 readthrough" O60344 3 184249695-184293031 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 22.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "REH: 5.1" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 1.2 6.6 0.0 2.1 0.1 0.3 0.3 0.0 1.5 0.6 2.9 0.0 1.5 0.9 0.3 0.3 2.8 0.5 0.6 2.1 0.0 2.8 22.6 1.3 1.5 0.0 0.0 0.9 6.0 1.5 2.0 6.1 0.2 1.4 0.6 0.2 4.0 1.6 3.8 0.3 2.9 0.4 0.0 2.4 0.3 9.7 0.0 3.3 4.9 3.1 2.5 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EEF2KMT "EFM3, FAM86A, MGC19636, SB153" ENSG00000118894 "Eukaryotic elongation factor 2 lysine methyltransferase" Q96G04 16 5084304-5097808 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 8 "Early spermatids: 172.8;Late spermatids: 268.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 41.8" HPA041610 Approved Uncertain Vesicles NA NA Vesicles "HPA041610: AB_2677581" "unprognostic (4.50e-2)" "unprognostic (1.53e-1)" "unprognostic (8.89e-3)" "unprognostic (3.95e-2)" "unprognostic (2.01e-2)" "unprognostic (7.70e-2)" "prognostic unfavorable (8.85e-4)" "unprognostic (3.53e-1)" "unprognostic (1.37e-1)" "unprognostic (4.03e-2)" "unprognostic (9.73e-2)" "unprognostic (1.53e-1)" "unprognostic (5.24e-3)" "unprognostic (1.82e-1)" "unprognostic (2.07e-1)" "unprognostic (2.75e-2)" "prognostic unfavorable (2.35e-4)" 4.8 6.1 4.8 4.3 15.5 0.8 11.6 4.4 7.5 5.6 4.6 4.4 2.2 6.7 6.5 4.4 5.4 5.7 3.6 5.7 5.8 4.5 4.9 8.0 8.6 3.9 4.2 4.3 5.8 13.9 10.4 5.0 2.9 7.5 4.4 4.8 2.6 5.9 6.2 7.0 4.5 3.5 7.1 3.8 4.7 4.9 27.0 4.8 3.8 6.1 5.2 4.3 5.3 3.8 9.4 7.0 6.5 11.0 7.0 13.7 5.1 2.5 6.3 3.9 6.7 4.8 3.9 5.0 4.7 3.4 6.0 3.7 4.8 6.6 6.8 3.0 6.0 6.4 4.4 7.3 7.3 4.4 7.6 5.3 3.0 3.5 7.9 6.0 7.0 4.7 4.4 5.5 6.9 12.3 2.2 5.9 8.6 5.3 6.5 5.0 16.6 2.7 4.0 6.5 14.3 3.2 6.7 4.4 41.8 6.5 3.0 4.7 3.6 6.1 8.6 3.5 3.3 5.4 2.5 2.6 8.2 5.2 24.2 4.7 4.4 4.8 4.7 2.3 4.9 7.1 6.5 5.6 0.4 7.6 10.1 12.5 9.4 7.9 8.8 7.0 7.2 5.6 9.9 0.8 7.0 11.0 1.9 13.7 5.1 4.8 15.5 4.4 7.5 5.8 4.5 4.2 4.3 7.5 4.8 3.0 3.0 5.7 6.9 0.0 2.4 0.8 2.5 13.4 4.5 5.2 0.0 5.2 26.6 15.0 172.8 5.8 2.1 0.0 16.0 10.5 5.7 7.0 1.1 10.4 13.2 6.4 3.5 4.9 1.6 268.3 7.2 2.7 0.0 6.4 5.4 4.8 13.6 0.0 3.5 15.3 2.5 0.0 0.3 5.0 17.3 0.0 3.4 4.4 6.9 6.3 EFCAB6 "dJ185D5.1, DJBP, FLJ23588, HSCBCIP1, KIAA1672" ENSG00000186976 "EF-hand calcium binding domain 6" Q5THR3 22 43528744-43812337 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.2;testis: 32.2" "Group enriched" "Detected in many" 13 "Early spermatids: 263.3;Late spermatids: 334.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 5.6;RPTEC TERT1: 3.8" "Low region specificity" "Detected in some" HPA003098 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA003098: AB_1079087" "unprognostic (1.85e-1)" "unprognostic (8.85e-3)" "unprognostic (4.45e-2)" "unprognostic (1.04e-5)" "unprognostic (1.00e-1)" "unprognostic (4.25e-2)" "unprognostic (4.96e-2)" "unprognostic (8.82e-3)" "unprognostic (2.02e-1)" "unprognostic (1.54e-1)" "unprognostic (1.91e-3)" "unprognostic (3.66e-2)" "unprognostic (1.71e-3)" "unprognostic (4.54e-1)" "unprognostic (1.82e-1)" "unprognostic (1.65e-3)" "unprognostic (1.33e-2)" 1.2 1.8 3.3 0.8 4.8 0.6 2.1 1.2 4.7 2.2 1.3 3.0 8.9 1.0 2.3 9.3 1.2 11.5 2.2 1.3 2.3 2.6 2.7 1.1 2.6 0.8 1.4 2.4 4.0 2.3 5.2 17.2 0.8 5.7 1.9 0.9 5.2 1.7 4.8 1.0 1.2 0.9 1.3 1.3 0.8 1.8 32.2 1.3 0.0 5.0 0.5 0.8 1.3 1.2 0.3 0.0 0.0 1.3 0.0 0.6 0.1 0.3 0.8 1.2 1.7 1.5 5.6 0.0 1.3 1.0 0.3 0.6 0.0 0.3 0.0 0.8 0.6 2.3 1.6 0.0 0.4 1.2 0.0 0.4 0.0 0.0 0.0 3.3 0.1 0.0 1.9 2.0 1.4 0.4 1.3 0.4 0.5 0.1 0.1 0.9 3.5 0.1 0.3 1.5 1.0 0.5 0.1 0.0 0.1 3.8 0.7 2.3 0.9 3.3 0.1 1.8 1.0 0.6 0.0 0.4 1.0 0.3 1.3 0.3 0.2 0.2 0.0 2.3 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.2 0.0 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 3.3 4.8 1.2 4.7 2.3 2.6 1.4 2.4 5.7 1.3 3.0 2.6 0.0 0.8 0.2 4.0 1.4 0.0 22.7 3.4 0.0 5.9 0.0 0.0 0.5 263.3 0.0 0.0 0.0 0.6 0.1 0.3 0.5 1.1 0.0 0.2 6.4 0.0 0.6 0.0 334.9 2.8 0.0 0.0 1.0 0.4 2.0 1.1 0.0 1.4 1.0 12.9 6.5 1.0 23.2 4.7 0.1 0.1 0.0 0.2 0.1 EFR3B "FLJ37871, KIAA0953" ENSG00000084710 "EFR3 homolog B" Q9Y2G0 2 25042130-25159137 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;retina: 21.1;skeletal muscle: 25.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 26.8;Cone photoreceptor cells: 21.6;Early spermatids: 15.3;Late spermatids: 37.7;Muller glia cells: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "AN3-CA: 9.0;BEWO: 10.6;SH-SY5Y: 9.4;SK-BR-3: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038089, HPA071831" Uncertain Supported "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA038089: AB_10672618, HPA071831: " "unprognostic (9.31e-2)" "unprognostic (3.92e-1)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.44e-2)" "unprognostic (1.24e-3)" "unprognostic (3.82e-1)" "unprognostic (3.42e-1)" "unprognostic (1.32e-2)" "unprognostic (4.49e-6)" "unprognostic (4.83e-2)" "unprognostic (4.43e-2)" "unprognostic (1.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" 1.9 3.2 13.1 1.7 22.9 1.3 1.3 15.5 30.5 1.4 1.7 9.4 0.0 1.4 1.8 8.4 1.3 1.8 1.5 6.9 11.4 8.7 1.4 1.1 4.4 1.3 8.7 13.5 1.4 1.3 2.4 4.1 3.2 29.9 1.5 1.8 21.1 1.1 2.0 25.1 1.7 1.3 2.6 7.8 4.3 2.2 3.5 9.0 0.0 4.5 0.2 1.1 1.4 0.7 1.0 0.6 4.4 0.5 1.0 0.7 0.1 0.1 7.1 8.4 9.0 0.5 0.1 10.6 0.9 0.2 0.4 0.1 5.7 0.3 0.1 0.5 1.2 2.9 0.5 6.6 0.0 0.1 1.3 1.6 1.4 0.3 0.5 0.0 0.1 0.7 0.1 0.0 2.0 0.1 0.6 0.2 0.2 0.1 0.4 0.2 0.8 0.2 0.4 1.7 0.1 5.7 0.6 8.0 0.2 0.1 0.2 3.5 9.4 1.0 15.8 5.1 4.9 0.8 0.1 0.5 0.5 2.4 3.6 1.7 0.6 0.7 0.1 6.5 0.1 1.7 4.4 0.4 1.1 0.7 0.3 0.5 0.6 0.4 0.6 0.3 1.0 0.4 0.7 1.7 1.0 0.5 0.6 0.2 0.1 13.1 22.9 15.5 22.7 11.4 8.7 8.7 13.5 29.9 9.0 26.8 0.6 0.0 0.6 0.0 8.6 7.4 0.0 0.0 0.0 8.7 21.6 0.0 0.0 0.2 15.3 2.0 0.4 0.0 0.7 0.1 1.0 0.7 0.0 0.0 0.8 4.8 3.5 3.7 0.0 37.7 1.1 0.0 0.0 0.0 0.0 20.0 0.5 0.0 2.5 0.1 10.3 0.0 1.4 2.1 1.9 0.1 0.1 0.0 0.3 0.4 EFS "CASS3, EFS1, EFS2, HEFS, SIN" ENSG00000100842 "Embryonal Fyn-associated substrate" O43281 14 23356402-23365752 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 18.7;Syncytiotrophoblasts: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 28.2;AN3-CA: 15.4;BEWO: 23.7;SH-SY5Y: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001581, HPA001790" Approved Uncertain Nucleoplasm,Cytosol No NA Nucleoplasm Cytosol "HPA001581: AB_2666367, HPA001790: " "unprognostic (9.58e-3)" "unprognostic (1.10e-2)" "unprognostic (3.68e-2)" "unprognostic (1.78e-1)" "unprognostic (6.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.00e-1)" "unprognostic (3.85e-2)" "unprognostic (7.36e-2)" "unprognostic (2.15e-1)" "unprognostic (2.75e-1)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.09e-5)" "unprognostic (3.44e-3)" "unprognostic (1.73e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" 12.0 10.2 11.7 4.4 15.7 0.6 13.1 9.4 21.2 17.9 8.5 29.4 8.0 2.8 17.0 9.8 18.3 10.0 6.7 5.5 14.3 8.3 3.2 1.2 5.7 2.8 14.9 8.2 23.7 1.5 25.0 3.2 33.1 15.6 17.9 3.1 8.3 15.6 18.6 3.8 42.3 3.9 13.0 25.7 4.5 4.7 4.4 16.0 0.4 6.8 15.5 10.0 11.8 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 28.2 15.4 7.1 8.2 23.7 2.1 4.3 0.7 0.3 0.0 0.0 0.0 0.0 11.6 0.1 10.8 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 4.6 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 9.0 0.0 0.0 9.0 3.1 27.0 6.0 0.9 0.0 3.6 6.7 0.0 0.0 3.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 15.7 9.4 11.8 14.3 8.3 14.9 8.2 15.6 16.0 0.0 4.1 0.0 7.2 10.3 2.7 0.6 0.0 1.4 4.5 0.0 5.9 8.0 1.7 0.0 0.7 1.4 0.0 0.0 0.0 12.8 13.0 6.3 0.0 0.0 1.3 0.0 0.0 3.1 0.0 0.4 18.7 0.0 6.8 0.0 0.0 8.0 0.0 0.0 13.1 0.1 8.1 6.5 5.1 0.5 0.4 11.7 15.1 0.0 0.0 4.7 EGR3 PILOT ENSG00000179388 "Early growth response 3" Q06889 8 22687659-22693302 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.0" "Group enriched" "Detected in many" 4 "granulocytes: 102.0;Intestinal endocrine cells: 272.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 11.5;basal ganglia: 33.6;cerebral cortex: 35.0;hippocampal formation: 13.7;olfactory region: 12.8" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.6;HMC-1: 7.5;MCF7: 24.5;SK-MEL-30: 16.4" "Group enriched" "Detected in many" 10 "amygdala: 26.1;basal ganglia: 40.1;cerebral cortex: 47.9;hippocampal formation: 32.4;olfactory region: 18.2" "Group enriched" "Detected in many" 9 "amygdala: 29.0;basal ganglia: 68.2;cerebral cortex: 57.2;hippocampal formation: 56.6;olfactory region: 75.0" "HPA006206, CAB009373" Uncertain Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB009373: AB_2097202, HPA006206: AB_10602491" "prognostic favorable (1.83e-4)" "unprognostic (1.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "unprognostic (4.07e-2)" "unprognostic (1.00e-1)" "unprognostic (6.44e-2)" "prognostic favorable (4.78e-4)" "unprognostic (3.48e-2)" "unprognostic (5.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.11e-2)" "unprognostic (4.72e-2)" "unprognostic (2.35e-2)" "unprognostic (1.07e-2)" 20.7 17.7 11.5 12.3 33.6 5.6 7.1 0.8 35.0 7.4 3.3 11.1 0.2 0.9 3.8 1.0 4.0 14.6 20.6 8.5 13.7 2.0 3.0 2.0 4.1 7.3 1.9 12.8 10.6 2.9 12.8 5.0 1.2 3.6 10.3 2.2 2.6 2.3 4.0 1.6 28.4 3.6 8.3 1.6 2.8 5.3 4.1 2.1 5.5 5.8 1.3 5.8 12.3 2.5 0.8 0.0 2.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 1.5 4.6 0.1 0.4 0.5 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.3 0.3 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.5 0.4 0.2 0.2 0.0 0.6 0.1 0.1 0.2 0.1 0.0 24.5 0.0 0.2 0.1 1.7 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.1 0.4 0.0 16.4 0.2 1.1 0.0 0.0 0.2 0.1 0.2 0.3 0.3 0.0 0.0 0.7 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 11.5 33.6 0.8 35.0 13.7 2.0 1.9 12.8 3.6 2.1 6.0 18.6 7.5 26.7 20.5 1.6 35.5 0.0 2.7 3.4 0.0 0.0 1.2 0.0 2.5 19.0 17.5 0.9 0.0 3.9 1.1 23.9 18.9 102.0 0.4 3.7 0.0 272.8 20.9 12.3 6.2 2.8 11.0 20.3 0.0 12.8 3.0 2.6 2.9 0.4 0.0 1.1 0.0 23.7 0.0 0.2 43.7 8.1 0.0 4.3 3.1 EIF1AD "haponin, MGC11102" ENSG00000175376 "Eukaryotic translation initiation factor 1A domain containing" Q8N9N8 11 65996545-66002176 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054991, HPA058735" Uncertain Approved "Nucleoplasm,Vesicles,Intermediate filaments" NA NA "Nucleoplasm, Vesicles" "Intermediate filaments" "HPA054991: AB_2682664, HPA058735: AB_2683802" "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (3.59e-5)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavorable (8.63e-5)" "unprognostic (1.86e-2)" "unprognostic (1.17e-1)" "unprognostic (8.76e-2)" "unprognostic (1.36e-3)" "unprognostic (2.31e-1)" "unprognostic (1.59e-3)" "unprognostic (7.63e-3)" "unprognostic (1.40e-1)" "unprognostic (1.28e-3)" "unprognostic (3.96e-1)" 16.8 18.4 15.5 17.9 18.8 38.7 16.3 21.8 23.7 16.0 15.3 15.4 19.9 15.0 18.3 16.4 22.1 16.0 15.3 15.6 15.1 16.1 15.2 18.5 16.2 21.1 18.8 11.1 21.5 23.7 22.0 24.0 25.5 17.7 15.8 14.8 17.5 17.8 16.2 27.1 23.4 17.6 14.9 18.2 22.2 16.6 22.3 19.9 21.2 16.0 18.1 27.0 15.5 23.8 14.8 16.1 28.2 15.5 11.6 14.7 9.4 22.4 19.7 16.6 16.5 13.3 13.9 15.6 16.5 16.3 21.2 18.0 18.9 21.7 17.1 29.0 18.9 18.1 15.6 19.7 22.0 19.7 15.8 10.2 24.2 22.6 20.4 16.6 22.1 19.0 11.6 19.3 31.7 21.7 14.5 14.1 18.2 36.0 25.0 30.0 30.0 20.4 24.6 12.4 10.4 21.5 22.5 16.8 33.5 11.9 14.1 12.2 15.0 18.6 25.4 19.3 13.7 24.8 13.7 16.8 27.6 18.7 22.5 15.9 30.6 36.0 35.9 20.1 15.5 18.3 28.2 15.5 10.0 14.7 12.7 11.3 14.8 12.6 10.7 16.1 14.5 12.0 11.0 10.6 11.6 15.3 9.7 11.3 9.4 15.5 18.8 21.8 23.7 15.1 16.1 18.8 11.1 17.7 19.9 3.0 4.8 11.2 10.4 33.5 6.9 13.4 12.7 6.7 2.3 5.2 13.7 14.0 13.3 11.8 12.0 12.7 10.2 0.0 11.3 20.1 11.8 10.7 12.7 13.6 22.0 11.1 2.4 14.7 8.2 11.4 11.2 19.8 11.8 15.4 10.7 6.0 20.7 14.4 5.3 12.8 18.0 6.5 18.9 25.6 21.3 42.8 21.2 17.5 8.0 11.2 EIF2D LGTN ENSG00000143486 "Eukaryotic translation initiation factor 2D" P41214 1 206571292-206612463 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028220 Approved Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA028220: AB_10602022" "unprognostic (1.67e-2)" "unprognostic (2.44e-1)" "unprognostic (3.68e-2)" "unprognostic (6.46e-3)" "unprognostic (4.09e-3)" "unprognostic (2.39e-1)" "unprognostic (2.20e-3)" "unprognostic (6.60e-2)" "unprognostic (1.45e-1)" "unprognostic (3.93e-1)" "unprognostic (1.49e-1)" "unprognostic (3.64e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (3.54e-1)" "unprognostic (1.97e-1)" "unprognostic (8.32e-2)" "unprognostic (2.13e-2)" 19.4 22.3 12.3 14.6 17.0 15.7 25.0 16.7 14.5 23.6 22.2 19.4 23.7 12.1 24.5 21.1 22.3 25.2 19.0 15.2 13.5 9.0 19.6 20.0 15.4 19.9 19.7 10.0 36.2 38.1 19.7 17.3 15.2 14.9 22.8 18.9 18.1 26.9 18.3 27.7 19.2 15.2 22.6 14.5 16.0 21.9 13.1 18.5 29.3 29.3 20.0 21.7 21.0 21.1 19.2 16.6 5.6 13.1 16.4 21.3 10.5 20.3 12.6 10.3 8.9 30.5 40.2 12.5 11.5 23.9 20.9 20.6 10.2 17.8 34.6 8.9 23.5 6.7 14.5 16.7 26.1 18.6 11.3 21.5 12.1 15.1 19.3 33.6 21.9 12.5 36.5 34.8 16.6 33.1 26.7 26.5 25.4 28.1 16.3 18.2 16.0 19.6 10.2 8.4 15.3 19.3 15.9 22.1 38.1 21.2 7.6 9.7 8.9 10.1 27.2 24.5 16.1 20.8 17.3 18.5 11.6 11.6 5.3 15.3 14.9 8.3 24.2 15.6 14.9 8.6 5.6 10.3 1.6 11.8 9.2 15.9 19.2 16.4 14.5 16.6 15.5 21.3 15.3 0.2 16.4 13.1 8.8 14.5 10.5 12.3 17.0 16.7 14.5 13.5 9.0 19.7 10.0 14.9 18.5 14.9 13.7 22.9 30.1 12.8 10.6 8.4 2.5 18.7 18.2 10.4 3.9 33.5 21.6 16.0 30.3 18.0 8.1 0.0 17.2 21.7 17.7 20.5 17.3 7.9 19.3 3.2 4.7 20.3 12.6 10.3 26.7 12.8 16.9 25.2 12.2 9.4 16.1 11.5 25.8 24.5 13.6 19.4 17.6 23.3 9.3 20.3 21.4 20.8 31.5 23.6 ELL "C19orf17, ELL1, Men, PPP1R68" ENSG00000105656 "Elongation factor for RNA polymerase II" P55199 19 18442663-18522127 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 301.9;Late spermatids: 183.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004202, HPA046076" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA004202: , HPA046076: AB_2679526" "unprognostic (9.49e-2)" "unprognostic (1.38e-1)" "unprognostic (3.26e-3)" "unprognostic (2.07e-1)" "unprognostic (1.64e-1)" "unprognostic (2.10e-1)" "unprognostic (8.26e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-1)" "unprognostic (3.00e-2)" "unprognostic (6.28e-3)" "unprognostic (2.38e-2)" "unprognostic (1.57e-1)" "unprognostic (2.07e-1)" "unprognostic (5.12e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" 19.9 7.7 5.1 13.4 9.9 38.4 10.8 17.0 9.7 11.9 13.5 7.7 8.6 10.4 12.6 9.5 9.3 9.1 10.9 9.5 5.8 4.4 9.8 11.6 14.2 10.7 6.2 3.5 12.7 14.6 6.2 10.5 27.0 6.3 10.4 4.4 9.1 10.6 9.0 20.3 13.3 10.9 10.0 5.1 15.9 9.3 31.7 7.7 11.0 7.8 7.2 13.6 18.5 13.2 3.1 8.6 17.2 5.6 2.1 7.9 3.3 8.9 4.4 2.3 4.9 2.5 3.2 17.0 7.1 6.3 5.4 5.2 5.0 7.1 11.3 8.8 4.7 3.7 6.3 3.4 7.8 2.7 9.2 8.0 6.8 4.4 4.3 3.8 7.4 8.7 6.5 6.7 7.0 5.5 4.2 3.8 6.2 9.4 15.6 2.8 7.6 8.7 8.1 7.7 5.4 12.6 7.5 3.7 11.9 3.8 6.3 4.2 4.6 5.2 9.0 7.7 3.1 4.5 9.3 6.3 6.3 4.9 8.6 6.6 25.5 16.0 8.4 8.3 12.6 8.9 0.3 5.6 3.8 4.7 4.1 7.9 3.1 2.9 4.2 4.7 2.3 1.9 2.9 17.2 2.1 2.1 8.6 3.0 3.3 5.1 9.9 17.0 9.7 5.8 4.4 6.2 3.5 6.3 7.7 6.0 6.7 6.0 22.3 24.8 4.1 4.0 10.2 6.7 3.4 3.5 3.9 37.4 10.0 7.0 301.9 11.7 10.5 0.0 7.0 14.6 16.0 13.8 10.5 13.4 16.6 1.6 18.9 8.6 11.5 183.8 6.1 13.8 6.8 11.8 9.0 4.2 8.8 2.9 2.8 5.7 3.5 19.4 28.8 19.0 21.8 26.6 57.4 11.4 6.4 18.6 ELMOD1 DKFZp547C176 ENSG00000110675 "ELMO domain containing 1" Q8N336 11 107591091-107666779 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 51.1;pituitary gland: 20.8;skin 1: 34.7" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 30.4;Cone photoreceptor cells: 15.7;Horizontal cells: 35.0;Late spermatids: 14.0;Rod photoreceptor cells: 17.8" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 11.9;RH-30: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038435, HPA066479" Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038435: AB_10795575, HPA066479: " "unprognostic (2.74e-1)" "unprognostic (1.72e-4)" "unprognostic (2.58e-2)" "unprognostic (9.13e-2)" "unprognostic (3.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.34e-1)" "unprognostic (6.59e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (6.29e-2)" "unprognostic (9.44e-2)" "unprognostic (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (3.15e-1)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" 1.5 4.2 10.7 1.5 41.1 1.3 4.1 12.8 51.1 1.5 1.4 1.7 0.0 1.4 1.6 1.3 1.2 3.6 1.2 4.8 13.8 14.3 4.7 1.3 1.6 1.3 8.7 15.2 1.2 1.2 1.2 20.8 1.2 14.8 2.1 1.3 1.4 1.3 1.2 2.8 34.7 1.3 1.4 6.6 1.2 1.2 2.9 3.9 0.0 1.3 0.0 1.2 1.1 0.1 0.9 0.7 2.4 0.9 1.8 0.5 0.2 0.0 0.0 4.5 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.2 3.5 0.4 2.2 0.3 0.4 0.0 1.8 0.1 0.0 0.1 1.2 0.1 0.0 0.4 0.1 0.0 0.0 0.1 11.9 1.5 0.0 0.1 0.8 0.1 0.0 0.1 0.5 0.0 1.8 0.0 27.1 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.3 0.0 0.7 0.1 0.0 0.0 3.6 0.0 2.1 1.6 0.9 0.6 0.4 0.6 0.4 0.5 0.5 0.2 0.2 0.9 0.4 0.5 2.4 1.8 0.6 0.7 0.4 0.2 10.7 41.1 12.8 26.9 13.8 14.3 8.7 15.2 14.8 3.9 0.0 3.8 0.0 0.4 0.0 30.4 3.6 0.0 8.1 2.3 0.0 15.7 0.1 0.0 0.0 8.5 0.7 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.8 0.1 35.0 0.0 0.6 0.3 14.0 0.3 1.4 0.0 0.0 0.0 6.5 0.0 0.0 0.4 3.6 17.8 0.0 0.5 0.9 0.4 2.8 0.0 0.0 0.0 0.3 ELMOD3 "DFNB88, FLJ21977, RBED1, RBM29" ENSG00000115459 "ELMO domain containing 3" Q96FG2 2 85354394-85391752 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012126 Approved Uncertain Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA012126: AB_1848130" "unprognostic (1.90e-1)" "unprognostic (9.80e-3)" "unprognostic (1.42e-3)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (1.60e-2)" "unprognostic (1.35e-2)" "unprognostic (1.52e-2)" "unprognostic (4.62e-2)" "unprognostic (5.63e-2)" "prognostic favorable (6.16e-6)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.09e-6)" "unprognostic (5.71e-2)" "unprognostic (1.53e-1)" "unprognostic (9.51e-2)" "prognostic favorable (2.85e-5)" 18.5 14.5 11.0 10.5 17.4 4.9 15.0 15.4 14.7 13.4 12.0 18.4 18.6 9.5 12.7 11.6 8.7 13.8 11.5 9.2 13.2 8.6 10.7 14.4 8.4 9.0 20.2 8.8 12.0 11.4 14.4 15.6 11.7 14.2 13.7 9.7 13.0 11.6 14.5 18.8 9.7 10.6 13.4 11.1 11.1 12.1 12.3 17.4 7.6 13.0 6.8 10.2 11.9 10.7 4.5 4.5 10.8 6.6 6.1 7.6 3.9 4.0 5.2 6.0 8.8 18.7 8.4 3.5 7.5 5.8 11.2 10.3 4.3 2.1 3.1 5.8 6.0 13.7 4.3 8.3 10.3 10.2 11.0 5.8 5.4 2.9 3.0 9.8 4.1 7.2 8.6 9.1 10.6 12.2 9.4 7.9 6.4 5.5 3.7 10.3 3.1 6.0 2.4 2.8 8.4 5.5 4.3 12.2 2.9 5.1 2.5 5.6 2.9 4.6 6.4 6.9 7.1 3.5 3.1 4.4 8.0 4.3 6.9 6.8 4.6 8.2 4.2 8.0 4.8 8.1 9.1 3.9 10.8 7.6 2.6 4.0 4.5 4.9 3.0 4.5 4.1 4.2 7.3 3.5 6.1 6.6 1.2 7.3 3.9 11.0 17.4 15.4 14.7 13.2 8.6 20.2 8.8 14.2 17.4 6.0 5.9 13.7 8.8 4.1 26.2 4.8 12.7 6.7 13.6 10.4 27.5 11.6 6.6 7.1 3.8 7.2 17.8 0.0 7.9 4.9 8.7 10.2 9.2 7.3 7.6 28.6 8.1 9.2 9.2 3.6 17.8 11.0 16.9 12.6 8.9 19.7 7.8 14.0 22.3 4.8 29.2 19.4 6.6 13.0 10.1 5.6 10.4 13.8 11.9 7.1 ELOA "SIII, TCEB3, TCEB3A" ENSG00000011007 "Elongin A" Q14241 1 23743155-23762059 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 68.1;monocytes: 61.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005910 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA005910: AB_1080227" "unprognostic (6.90e-2)" "unprognostic (5.99e-3)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.99e-1)" "unprognostic (3.93e-2)" "prognostic unfavorable (1.44e-5)" "unprognostic (1.72e-1)" "unprognostic (8.84e-3)" "unprognostic (6.00e-2)" "unprognostic (4.94e-2)" "unprognostic (2.14e-2)" "unprognostic (2.95e-3)" "unprognostic (2.90e-1)" "unprognostic (4.27e-2)" "unprognostic (4.80e-2)" "unprognostic (4.14e-2)" 25.6 13.7 10.0 14.2 16.1 22.9 16.3 16.0 17.2 13.7 12.2 15.2 15.1 9.8 15.0 9.0 23.6 13.3 15.7 12.9 9.9 9.8 18.1 41.7 20.3 24.1 10.3 12.5 16.0 41.5 19.1 17.1 19.6 12.7 13.6 13.5 13.0 18.6 13.4 26.0 18.3 14.1 14.0 10.9 20.5 24.6 14.4 10.0 19.3 18.4 22.4 21.8 15.6 14.5 20.7 18.8 18.3 20.9 11.0 14.8 13.2 20.3 11.4 16.5 14.1 19.5 12.2 10.4 21.1 19.1 31.5 27.6 13.9 17.9 10.7 26.0 21.4 17.7 19.6 33.8 22.2 35.3 30.6 16.7 24.1 17.8 16.2 17.3 25.2 14.6 12.9 18.0 34.3 26.3 11.7 18.8 17.7 35.6 18.6 25.1 15.4 13.0 10.3 19.1 22.9 17.3 19.6 21.0 20.3 14.8 13.9 31.5 17.7 19.2 19.4 23.4 19.2 14.0 9.3 19.9 24.8 21.9 43.9 24.8 19.3 21.5 23.6 21.7 25.2 24.7 18.3 19.8 15.4 14.8 20.9 14.6 20.7 12.4 13.3 18.8 16.6 10.2 13.4 5.5 11.0 18.4 15.5 14.0 13.2 10.0 16.1 16.0 17.2 9.9 9.8 10.3 12.5 12.7 10.0 26.8 68.1 0.0 0.0 0.0 0.0 0.0 0.0 30.8 33.0 17.4 0.0 23.2 5.0 34.1 0.0 0.0 0.0 0.0 28.4 28.4 0.0 0.0 12.8 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 61.3 0.0 0.0 32.3 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 ELOA3C ENSG00000275553 "Elongin A3 family member C" 18 46968695-46969912 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049178, HPA050086, HPA053158" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EME1 "FLJ31364, MMS4L, SLX2A" ENSG00000154920 "Essential meiotic structure-specific endonuclease 1" Q96AY2 17 50373220-50381483 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 15.3;epididymis: 10.6;testis: 21.9" "Cell type enhanced" "Detected in some" 13 "Extravillous trophoblasts: 4.0;Spermatocytes: 10.5;Spermatogonia: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 29 "basophil: 15.3" "Lineage enriched" "Detected in single" 29 "granulocytes: 15.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016127, HPA052188" Supported Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "CAB016127: AB_2278026, HPA052188: " "unprognostic (3.81e-1)" "unprognostic (7.72e-2)" "unprognostic (6.49e-2)" "unprognostic (2.45e-3)" "unprognostic (2.74e-1)" "unprognostic (1.94e-2)" "unprognostic (9.94e-5)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.02e-2)" "unprognostic (4.37e-3)" "unprognostic (2.83e-3)" "unprognostic (0.00e+0)" "unprognostic (9.82e-2)" "unprognostic (1.26e-1)" "unprognostic (3.71e-1)" "unprognostic (3.41e-1)" 1.0 0.9 1.6 2.5 2.0 6.0 0.8 0.8 1.8 1.3 1.9 3.0 0.0 1.1 0.9 10.6 2.6 0.7 1.6 0.7 0.9 0.6 0.7 0.8 1.1 3.3 1.4 0.9 1.3 0.6 0.2 0.5 2.4 1.5 0.7 2.0 1.0 1.6 0.1 1.4 1.5 2.1 0.8 1.9 2.2 1.1 21.9 2.8 5.7 0.5 0.9 3.9 1.0 1.2 0.1 0.5 15.3 0.0 0.0 0.1 0.2 7.4 11.0 14.7 7.7 0.7 1.5 10.6 7.8 3.0 10.9 10.1 17.3 6.1 6.0 10.4 3.1 6.8 5.9 13.6 6.2 15.6 11.7 10.7 14.3 12.7 8.0 0.0 5.8 4.7 0.3 0.4 12.6 5.2 1.4 2.5 17.3 8.6 14.4 6.4 8.2 13.3 7.5 8.5 7.7 7.6 13.8 28.5 8.3 2.4 3.0 5.7 11.4 4.8 2.6 4.5 12.3 9.4 6.7 1.7 14.2 8.5 9.3 10.7 9.0 9.1 5.8 4.5 6.6 8.7 15.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.2 1.6 2.0 0.8 1.8 0.9 0.6 1.4 0.9 1.5 2.8 0.0 1.4 0.0 0.2 0.1 1.5 0.4 0.0 1.4 1.2 0.0 0.0 1.9 0.0 0.2 0.4 0.0 0.0 0.0 0.0 4.0 0.5 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.6 0.7 0.0 1.8 0.4 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.4 10.5 8.0 0.1 0.9 0.0 0.6 0.1 ENC1 "ENC-1, KLHL37, NRPB, PIG10, TP53I10" ENSG00000171617 "Ectodermal-neural cortex 1" O14682 5 74627406-74641424 "Cancer-related genes, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 106.8" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 54.5;Ito cells: 49.7;Pancreatic endocrine cells: 54.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 7 "amygdala: 39.7;basal ganglia: 42.7;cerebral cortex: 86.4;hippocampal formation: 44.1;olfactory region: 43.9" "Group enriched" "Detected in many" 6 "classical monocyte: 5.4;eosinophil: 3.4;gdT-cell: 2.3;intermediate monocyte: 4.8;memory CD8 T-cell: 3.0;myeloid DC: 2.4;naive CD8 T-cell: 2.5;neutrophil: 1.4;NK-cell: 2.8;non-classical monocyte: 1.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078061 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA078061: " "prognostic unfavorable (3.88e-4)" "unprognostic (4.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.00e-3)" "unprognostic (1.05e-1)" "unprognostic (2.22e-3)" "unprognostic (1.36e-1)" "unprognostic (9.74e-2)" "unprognostic (1.24e-1)" "unprognostic (2.59e-1)" "unprognostic (4.98e-2)" "unprognostic (8.08e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (9.69e-2)" "unprognostic (3.08e-1)" "unprognostic (2.88e-1)" "unprognostic (5.65e-2)" 2.2 1.1 39.7 4.7 42.7 5.4 1.8 1.3 106.8 4.2 5.2 2.4 2.1 6.4 2.9 1.6 2.5 1.3 7.5 3.2 44.1 7.7 2.2 6.4 4.8 2.2 4.6 43.9 6.0 12.3 1.0 2.4 4.2 4.9 4.3 8.1 0.8 5.4 7.4 1.7 1.7 8.1 3.0 2.3 4.0 9.8 4.5 1.5 0.5 1.3 0.3 2.0 6.5 1.3 0.4 2.4 3.4 5.4 2.8 3.0 1.4 11.8 14.7 14.6 6.9 6.3 1.5 31.5 7.9 9.0 9.1 6.7 23.6 19.9 0.0 9.9 6.8 14.9 9.6 0.2 15.3 19.8 0.2 1.1 13.0 2.8 10.3 0.6 1.2 0.1 2.4 1.0 24.1 2.3 31.0 7.4 3.0 2.8 7.6 23.7 2.8 1.2 1.7 15.3 10.9 13.2 1.4 9.6 1.2 4.9 9.0 19.7 8.0 1.3 6.5 0.7 18.8 3.1 1.6 17.6 15.4 25.8 9.1 25.5 0.1 0.0 0.2 17.8 1.1 23.5 0.0 5.4 3.4 2.3 4.8 0.0 0.1 0.5 3.0 2.4 0.4 0.2 2.5 1.4 2.8 1.3 0.0 0.0 1.4 39.7 42.7 1.3 86.4 44.1 7.7 4.6 43.9 4.9 1.5 0.0 13.4 5.7 13.3 2.3 0.4 1.1 17.8 5.3 7.9 10.4 2.0 12.1 3.3 54.5 16.1 6.0 12.3 0.0 27.4 3.5 12.2 16.4 20.8 16.3 21.6 0.0 14.9 49.7 10.4 13.6 34.8 5.3 0.0 1.8 18.9 0.5 54.2 10.5 31.5 3.3 1.1 6.5 8.2 0.6 0.4 1.0 2.2 4.4 26.4 13.6 ENTPD1 "ATPDase, CD39, NTPDase-1, SPG64" ENSG00000138185 "Ectonucleoside triphosphate diphosphohydrolase 1" P49961 10 95711779-95869695 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Hydrolase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 59.4" "Cell type enhanced" "Detected in many" 8 "B-cells: 45.3;Endothelial cells: 46.6;Kupffer cells: 77.1;Macrophages: 80.4;monocytes: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 37.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HDLM-2: 57.3;Karpas-707: 47.1" "CAB002494, HPA014067" Enhanced Uncertain Microtubules NA NA Microtubules "CAB002494: AB_563557, HPA014067: AB_1848178" "unprognostic (1.14e-1)" "unprognostic (1.01e-2)" "unprognostic (3.11e-1)" "unprognostic (5.67e-2)" "unprognostic (9.68e-3)" "unprognostic (3.45e-3)" "unprognostic (6.31e-2)" "unprognostic (5.26e-3)" "unprognostic (2.73e-1)" "unprognostic (1.28e-2)" "unprognostic (6.40e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (5.33e-5)" "unprognostic (9.79e-2)" "unprognostic (2.30e-1)" "prognostic favorable (7.89e-4)" "unprognostic (5.09e-2)" 10.4 7.5 7.4 16.2 8.4 15.6 8.8 7.6 6.9 18.9 12.7 13.1 8.7 5.8 59.4 12.8 13.2 15.6 22.2 6.8 7.4 7.4 6.2 3.9 14.8 14.5 8.5 4.9 10.3 2.8 3.0 4.3 24.0 9.9 14.7 9.1 10.8 6.7 12.7 3.3 5.5 12.2 37.2 17.9 25.3 7.5 5.4 7.2 3.5 13.4 12.5 21.1 25.2 12.4 6.0 11.8 37.4 15.2 0.5 5.1 4.6 0.1 0.3 0.9 0.8 0.0 0.0 0.5 0.5 0.4 0.0 0.0 0.5 0.1 1.0 0.6 0.0 1.4 0.3 0.0 0.0 0.0 57.3 0.7 0.6 0.4 0.7 0.0 1.5 0.2 0.0 0.0 0.2 0.0 0.3 7.5 0.3 0.6 47.1 0.0 0.6 0.4 1.5 0.6 0.6 0.2 2.4 0.4 0.7 0.5 0.2 0.7 1.1 0.3 1.1 0.8 0.6 0.5 1.6 0.8 0.4 0.2 0.6 0.6 6.7 0.9 0.0 0.6 3.1 0.2 0.1 15.2 37.4 0.1 10.7 0.3 6.0 0.6 0.3 11.8 4.6 0.1 0.1 26.7 0.5 2.4 0.7 5.1 4.6 7.4 8.4 7.6 6.9 7.4 7.4 8.5 4.9 9.9 7.2 0.0 1.4 45.3 0.3 7.9 1.4 8.5 0.0 1.4 1.2 1.8 2.0 0.4 1.7 0.0 5.9 46.6 0.0 0.0 1.8 1.7 8.7 0.4 3.5 0.0 23.2 0.0 0.0 11.6 77.1 6.1 0.6 80.4 15.1 46.9 0.0 0.7 0.2 0.2 2.8 0.3 0.7 6.5 32.0 6.2 4.3 9.8 13.2 14.6 0.4 0.2 EPB42 "MGC116735, MGC116737, PA" ENSG00000166947 "Erythrocyte membrane protein band 4.2" P16452 15 43197227-43221125 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape, Erythrocyte maturation" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 54.8;placenta: 16.1" "Cell type enriched" "Detected in many" 15 "Erythroid cells: 186.9" "Not detected" "Not detected" "Region enriched" "Detected in some" 4 "cerebellum: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 92 "HEL: 43.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040261 Supported Uncertain Nucleoplasm,Cytosol NA NA 7500000 "Nucleoplasm, Cytosol" "HPA040261: AB_10673441" "unprognostic (8.45e-2)" "unprognostic (4.66e-1)" "unprognostic (4.15e-1)" "unprognostic (1.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.99e-1)" "unprognostic (1.54e-1)" "unprognostic (1.59e-3)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" "unprognostic (5.27e-3)" "unprognostic (1.31e-1)" "unprognostic (1.48e-5)" "unprognostic (1.70e-2)" "unprognostic (1.20e-1)" "unprognostic (5.88e-2)" "unprognostic (3.47e-3)" 7.5 0.4 0.4 0.4 0.9 54.8 1.3 4.3 1.0 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.4 0.5 0.6 1.9 0.4 0.9 0.5 0.9 5.5 0.3 0.5 0.3 0.8 0.3 0.3 0.3 16.1 0.7 0.5 0.3 0.3 0.3 0.3 1.3 1.1 1.0 0.3 0.3 5.3 0.5 2.4 0.3 0.5 1.2 0.3 0.5 1.6 4.5 0.0 0.3 0.2 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 4.2 0.4 0.9 4.3 1.0 0.4 0.9 0.5 0.3 0.7 0.3 0.0 0.0 0.5 1.2 1.6 3.7 0.3 2.5 0.0 0.0 0.0 5.9 3.3 0.0 0.0 7.7 0.6 1.1 186.9 0.0 1.9 1.7 1.0 4.6 0.5 1.0 6.4 0.0 1.3 0.3 8.0 2.6 0.8 1.7 0.0 0.8 2.8 0.0 1.7 0.7 0.0 7.8 6.5 1.2 12.1 3.8 2.5 5.6 4.4 0.6 1.6 EPC1 Epl1 ENSG00000120616 "Enhancer of polycomb homolog 1" Q9H2F5 10 32267751-32378798 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028931 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA028931: " "unprognostic (6.94e-2)" "unprognostic (3.03e-2)" "unprognostic (9.93e-2)" "unprognostic (9.43e-2)" "unprognostic (5.73e-2)" "prognostic favorable (6.40e-4)" "unprognostic (1.80e-2)" "unprognostic (3.83e-3)" "unprognostic (7.43e-2)" "unprognostic (5.55e-2)" "prognostic favorable (6.02e-4)" "unprognostic (4.40e-2)" "unprognostic (1.59e-3)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-3)" 17.3 10.0 13.2 19.9 14.3 35.0 19.4 45.3 16.3 20.1 18.0 15.6 13.6 10.6 21.4 15.1 11.7 17.3 12.4 13.5 13.0 10.5 12.3 13.9 13.7 20.5 14.1 10.1 25.4 19.9 20.4 35.7 12.5 12.6 17.2 16.1 15.8 15.1 14.7 22.0 16.8 15.5 21.5 14.3 18.9 13.2 10.2 17.8 41.2 17.9 14.4 19.9 19.1 17.8 12.7 11.1 16.1 6.1 6.6 9.1 3.1 8.0 8.3 17.1 14.4 8.1 11.6 6.7 9.4 5.7 10.3 10.1 5.7 9.6 14.7 6.3 9.5 5.0 7.7 9.0 7.4 7.6 12.1 8.5 12.7 7.0 7.0 8.9 8.6 14.5 9.7 12.4 6.8 5.0 11.9 9.4 9.9 10.6 18.4 9.8 7.9 15.9 6.2 3.8 8.0 3.2 18.0 13.9 7.0 8.4 7.6 13.1 13.5 8.3 6.2 12.6 9.3 6.0 14.3 9.7 7.4 10.6 5.1 7.6 7.9 6.0 15.5 7.2 13.8 6.8 14.6 6.1 10.9 8.6 4.0 9.1 10.7 8.6 7.8 3.9 12.7 8.9 8.1 16.1 6.6 5.8 11.1 8.7 3.1 13.2 14.3 45.3 16.3 13.0 10.5 14.1 10.1 12.6 17.8 38.7 44.0 77.3 86.8 25.3 99.6 29.1 45.9 42.8 43.3 38.4 64.8 30.6 8.3 43.7 7.1 51.7 46.2 23.3 38.1 32.8 45.2 61.4 82.1 31.6 31.0 108.1 94.6 41.1 43.7 8.9 87.8 51.5 38.8 56.9 46.9 54.5 39.7 45.2 64.0 15.9 84.6 97.0 49.1 82.2 32.8 21.8 38.6 107.8 41.2 54.7 EPHB6 HEP ENSG00000106123 "EPH receptor B6" 7 142855061-142871094 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.1;lymphoid tissue: 26.7;skin 1: 32.1" "Cell type enhanced" "Detected in many" 16 "Muller glia cells: 270.3;Sertoli cells: 103.5;Suprabasal keratinocytes: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "MOLT-4: 18.2;RT4: 34.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035784 Uncertain "Nuclear speckles" "Intracellular and membrane" NA NA "Nuclear speckles" "HPA035784: AB_2674781" "unprognostic (1.90e-2)" "prognostic favorable (1.80e-4)" "unprognostic (7.08e-3)" "unprognostic (2.95e-2)" "prognostic unfavorable (4.10e-4)" "unprognostic (2.53e-3)" "unprognostic (3.15e-2)" "unprognostic (4.39e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.06e-3)" "unprognostic (3.18e-1)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (4.93e-2)" "unprognostic (3.16e-1)" "prognostic favorable (4.68e-5)" 3.3 1.7 7.4 3.0 30.1 3.3 2.6 3.1 29.3 9.0 1.5 0.8 3.4 0.9 3.0 4.5 7.5 6.4 2.8 1.4 5.4 4.2 1.7 1.3 2.4 3.6 3.3 14.4 3.9 7.8 0.8 1.1 2.9 1.7 6.8 0.9 1.5 4.7 8.1 1.8 32.1 1.6 2.0 1.4 2.6 3.3 3.8 3.6 26.7 6.6 2.5 3.3 5.1 6.5 4.1 0.9 1.0 1.3 0.0 3.1 1.4 0.1 0.0 0.0 0.4 2.0 1.0 0.0 0.2 0.4 0.1 0.0 0.6 1.3 0.0 0.0 0.1 0.0 4.5 0.2 0.0 0.0 1.0 0.1 0.3 0.0 0.2 0.6 4.3 0.2 0.3 0.0 1.2 0.0 0.0 0.2 3.0 0.6 0.0 0.0 0.0 18.2 3.3 3.1 0.7 1.3 0.4 0.0 0.0 0.0 34.6 0.0 0.0 1.2 0.9 0.0 0.4 2.9 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 1.3 0.5 0.1 1.0 0.6 4.1 2.5 1.4 0.9 1.0 3.1 1.5 1.0 0.0 0.4 0.1 1.9 1.4 7.4 30.1 3.1 29.3 5.4 4.2 3.3 14.4 1.7 3.6 3.0 1.7 4.5 25.1 48.3 4.3 2.0 38.2 6.7 10.3 7.0 2.0 0.2 5.0 25.0 0.7 1.4 0.0 0.0 5.7 0.0 12.3 11.7 0.0 1.8 4.3 0.0 1.7 1.3 11.5 4.0 27.9 5.3 11.8 0.0 0.0 270.3 19.6 0.0 9.2 0.4 5.0 103.5 18.4 0.2 8.3 103.5 0.2 8.3 0.0 23.4 EPOR ENSG00000187266 "Erythropoietin receptor" P19235 19 11377205-11384342 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted membrane proteins" Receptor "Cancer-related genes, Congenital erythrocytosis, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0;Ito cells: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA077654 Supported "Nuclear speckles,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA077654: " "unprognostic (9.13e-2)" "unprognostic (7.14e-2)" "unprognostic (1.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (1.11e-1)" "unprognostic (3.70e-1)" "unprognostic (1.50e-2)" "unprognostic (5.60e-2)" "unprognostic (9.00e-2)" "prognostic favorable (3.17e-5)" "unprognostic (6.37e-3)" "unprognostic (1.59e-2)" "unprognostic (2.08e-1)" "unprognostic (2.00e-1)" "unprognostic (7.48e-2)" "unprognostic (1.01e-3)" 5.5 8.6 2.1 1.1 2.9 14.7 2.6 1.3 1.7 3.9 3.3 2.8 13.3 1.0 3.6 11.6 2.4 3.2 1.8 11.2 1.9 1.4 12.1 8.4 8.5 6.9 1.9 1.6 1.9 9.2 28.1 5.2 12.7 2.3 3.1 1.4 3.3 8.7 18.3 2.0 1.1 1.7 1.5 4.0 8.0 3.7 2.2 1.0 1.6 21.5 1.0 1.5 1.9 2.1 2.6 2.5 12.2 7.7 0.9 4.8 2.9 3.5 1.2 3.5 4.1 5.4 3.4 2.1 2.2 6.8 3.6 4.6 1.2 1.3 2.4 3.9 4.0 5.0 0.9 2.7 1.4 4.2 2.0 1.6 13.1 1.1 2.0 3.8 2.7 5.5 2.5 0.5 4.8 3.3 8.4 8.3 5.1 11.6 11.7 4.0 3.1 2.5 3.3 1.9 1.9 9.4 6.7 6.0 5.3 3.3 1.8 1.4 11.0 1.4 2.0 6.1 3.9 3.6 4.7 3.4 1.9 2.7 6.5 2.0 6.0 4.3 2.6 10.5 2.7 2.0 8.1 4.2 3.3 2.1 5.1 4.5 2.6 4.2 3.1 2.5 1.6 4.8 2.8 12.2 0.9 7.7 0.1 3.7 2.9 2.1 2.9 1.3 1.7 1.9 1.4 1.9 1.6 2.3 1.0 17.9 16.8 5.3 3.5 2.1 2.5 5.1 7.6 2.7 4.5 19.2 0.0 1.8 3.3 2.0 0.7 6.5 0.3 70.0 2.9 11.5 7.6 2.4 26.5 1.9 32.5 1.6 8.1 78.5 15.6 0.0 2.6 3.1 8.5 1.0 2.3 11.1 3.8 0.0 3.9 0.8 2.2 19.4 20.8 3.3 6.4 0.9 2.5 8.7 1.4 1.1 ERBB3 "HER3, LCCS2" ENSG00000065361 "Erb-b2 receptor tyrosine kinase 3" P21860 12 56076799-56103505 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 180.9;Enterocytes: 163.1;Paneth cells: 165.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.3" "Cell line enhanced" "Detected in many" "Hep G2: 30.9;MCF7: 20.2;OE19: 31.8;RT4: 24.2;SK-BR-3: 28.4;SK-MEL-30: 37.9;T-47d: 31.5;WM-115: 40.2" "Low region specificity" "Detected in many" "CAB025331, HPA045396" Uncertain Supported "Plasma membrane,Actin filaments" "Secreted - unknown location" NA NA 420000 "Plasma membrane" "Actin filaments" "CAB025331: , HPA045396: AB_2679312" "unprognostic (2.97e-1)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" "unprognostic (8.97e-2)" "unprognostic (1.63e-1)" "unprognostic (1.07e-3)" "unprognostic (2.31e-3)" "unprognostic (2.66e-2)" "unprognostic (9.89e-2)" "unprognostic (4.30e-2)" "unprognostic (4.76e-3)" "unprognostic (5.77e-2)" "unprognostic (1.06e-2)" "unprognostic (4.56e-2)" "unprognostic (1.57e-1)" "unprognostic (6.72e-3)" "unprognostic (2.07e-2)" 1.1 1.4 11.6 12.6 16.5 0.6 26.8 2.0 16.7 6.8 40.5 40.3 12.0 37.7 2.8 7.5 29.4 5.7 22.9 3.4 18.6 9.0 16.5 33.9 13.4 0.5 23.5 9.3 0.9 21.5 11.4 1.0 15.4 14.9 16.8 29.7 5.5 36.8 22.3 1.1 30.7 41.3 3.2 27.4 0.5 32.9 1.2 23.8 0.0 4.5 7.4 8.5 11.8 14.4 0.9 0.7 5.3 0.6 1.2 1.2 0.2 10.0 0.6 0.8 0.3 0.0 0.0 16.4 0.8 1.9 1.1 1.1 5.5 18.2 0.0 0.2 0.2 0.1 8.6 1.2 1.9 0.6 0.2 0.8 0.0 0.3 30.9 0.0 0.0 0.1 0.4 2.5 0.2 0.0 0.2 0.0 0.1 0.7 0.3 0.1 20.2 0.1 0.3 2.8 31.8 0.4 0.1 1.9 0.5 2.1 24.2 0.9 0.3 0.7 28.4 37.9 2.7 31.5 0.1 0.0 0.1 1.1 0.6 0.1 0.2 0.1 0.1 0.1 0.0 40.2 5.3 0.4 0.8 0.9 0.4 0.4 0.4 0.7 0.3 0.3 0.9 0.6 1.2 3.3 1.2 0.6 0.7 0.8 0.2 11.6 16.5 2.0 16.7 18.6 9.0 23.5 9.3 14.9 23.8 110.2 61.2 1.3 13.0 16.3 1.5 1.4 180.9 21.4 61.4 33.2 2.0 44.4 1.7 41.9 0.9 2.2 163.1 0.0 77.1 73.6 2.7 83.4 1.1 83.9 5.5 0.0 89.5 6.7 1.9 0.0 1.4 1.7 52.3 2.8 134.3 11.3 75.9 165.5 0.0 31.8 1.1 6.5 1.7 2.4 2.3 32.2 84.1 1.5 124.3 62.5 ERCC4 "FANCQ, RAD1, XPF" ENSG00000175595 "ERCC excision repair 4, endonuclease catalytic subunit" Q92889 16 13920157-13952345 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cockayne syndrome, Disease mutation, Dwarfism, Fanconi anemia, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 121.2;Late spermatids: 71.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000156, HPA045828" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "CAB000156: , HPA045828: AB_2679463" "unprognostic (2.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.12e-3)" "unprognostic (9.41e-2)" "unprognostic (3.35e-1)" "unprognostic (1.40e-2)" "unprognostic (1.64e-2)" "unprognostic (2.26e-1)" "unprognostic (3.59e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (8.49e-2)" "unprognostic (5.26e-2)" "unprognostic (1.67e-1)" "unprognostic (1.15e-1)" "unprognostic (6.30e-2)" "unprognostic (5.88e-4)" 8.4 12.7 8.6 7.0 11.3 5.3 6.4 8.9 9.7 8.1 6.7 9.9 6.0 4.1 8.5 6.8 6.7 8.5 6.8 7.8 7.2 7.1 6.9 7.2 6.9 6.8 10.5 8.8 9.9 7.6 13.3 13.0 5.9 9.6 8.3 5.4 7.1 6.4 7.0 31.3 6.9 5.7 8.5 10.3 7.7 6.6 14.2 8.9 13.7 9.7 5.6 6.4 9.1 7.8 8.4 7.9 8.3 6.8 8.9 7.4 2.6 5.4 7.0 6.4 9.2 10.7 10.1 5.0 7.2 7.7 6.5 8.3 2.4 5.4 9.1 10.4 6.3 5.7 6.9 9.5 4.9 10.1 12.3 5.6 4.5 7.8 6.0 9.8 6.1 5.1 7.6 6.9 8.6 7.3 6.3 8.6 5.5 7.0 10.7 9.1 4.5 8.0 4.1 4.7 2.8 3.7 9.2 13.0 11.2 4.0 3.7 5.3 6.3 8.8 7.2 6.7 5.4 9.1 4.6 9.7 9.6 7.1 8.6 6.3 9.5 11.2 6.3 9.2 7.3 9.8 8.3 6.2 5.4 6.8 6.8 7.4 6.2 6.4 5.1 5.5 8.4 6.4 6.9 7.2 8.9 5.7 7.9 5.8 2.6 8.6 11.3 8.9 9.7 7.2 7.1 10.5 8.8 9.6 8.9 17.9 15.7 9.7 6.8 4.2 0.0 7.9 12.7 18.7 5.7 5.2 0.0 13.6 8.3 10.4 121.2 9.5 2.8 0.0 7.3 5.9 9.9 7.6 1.1 15.7 10.5 0.0 9.2 16.0 11.3 71.5 13.8 10.6 10.1 11.8 5.3 0.0 8.2 0.0 19.8 9.3 0.0 25.8 5.9 46.6 16.7 4.8 10.3 16.0 6.1 4.0 ERCC6L "FLJ20105, PICH, RAD26L" ENSG00000186871 "ERCC excision repair 6 like, spindle assembly checkpoint helicase" Q2NKX8 X 72204657-72239047 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.1" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 2.5;Extravillous trophoblasts: 1.5;Spermatocytes: 1.7;Spermatogonia: 2.0" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "NK-cell: 5.3" "Lineage enriched" "Detected in many" 5 "NK-cells: 5.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA050492 Approved Uncertain Nucleoplasm,Centrosome,Cytosol No No Centrosome "Nucleoplasm, Cytosol" "HPA050492: AB_2681145" "prognostic unfavorable (1.80e-4)" "unprognostic (2.93e-1)" "unprognostic (1.95e-2)" "unprognostic (5.76e-3)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (9.23e-6)" "unprognostic (8.63e-3)" "unprognostic (1.57e-2)" "unprognostic (1.99e-2)" "unprognostic (3.68e-5)" "unprognostic (4.61e-2)" "unprognostic (0.00e+0)" "unprognostic (2.97e-3)" "unprognostic (9.56e-2)" "unprognostic (1.17e-1)" "unprognostic (6.41e-2)" 0.4 0.5 0.2 3.1 0.2 6.0 3.0 0.9 0.8 1.5 2.2 0.2 0.2 1.5 0.9 0.8 4.6 0.6 1.0 0.2 0.2 0.3 0.5 0.5 0.8 4.7 0.7 0.2 1.2 0.5 0.0 0.6 0.9 0.9 0.7 2.5 0.2 1.1 0.2 2.6 1.3 2.1 0.5 1.3 4.0 1.5 2.0 0.2 13.1 0.5 2.8 5.6 0.7 1.6 0.5 0.3 0.5 0.2 5.3 1.1 0.4 11.0 9.7 8.9 5.6 0.6 1.1 4.9 11.9 5.5 10.4 11.0 7.9 6.9 17.9 4.5 4.2 14.1 9.2 16.8 8.8 18.6 10.2 12.2 6.2 3.4 4.6 0.0 12.0 8.7 0.1 0.5 14.5 2.7 1.7 5.8 9.1 8.1 4.4 10.6 8.7 11.4 7.0 16.2 10.8 15.0 9.6 16.0 3.2 2.6 6.9 7.4 5.3 8.8 5.9 2.2 7.6 4.5 2.7 3.5 7.1 11.4 13.3 7.7 3.5 5.3 15.5 5.0 8.3 7.0 0.0 0.2 0.5 0.1 0.1 0.6 0.2 0.5 0.1 0.1 0.5 0.4 1.1 0.3 5.3 0.2 0.3 1.1 0.4 0.2 0.2 0.9 0.8 0.2 0.3 0.7 0.2 0.9 0.2 0.0 0.0 0.8 0.2 0.2 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.0 0.1 0.3 0.0 0.1 0.1 ERP29 "C12orf8, ERp28, ERp29, ERp31, PDI-DB, PDIA9" ENSG00000089248 "Endoplasmic reticulum protein 29" P30040 12 112013316-112023451 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039363, HPA039456" Enhanced Uncertain Nucleoplasm,Microtubules "Intracellular and membrane" NA NA 4900000 Microtubules Nucleoplasm "HPA039363: AB_10673422, HPA039456: AB_10672963" "unprognostic (2.70e-2)" "unprognostic (1.16e-1)" "unprognostic (1.96e-1)" "prognostic favorable (7.43e-5)" "unprognostic (1.13e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" "unprognostic (1.21e-1)" "unprognostic (5.10e-3)" "unprognostic (2.58e-1)" "unprognostic (3.21e-1)" "unprognostic (2.74e-3)" "unprognostic (3.34e-1)" "unprognostic (1.76e-1)" "unprognostic (6.26e-2)" 19.1 37.1 20.2 32.4 19.8 55.1 39.7 29.5 30.8 23.3 45.8 16.8 66.5 32.0 23.1 38.3 30.6 24.6 39.0 24.2 18.6 24.9 34.9 67.5 33.8 61.2 22.5 19.7 28.5 111.2 33.3 35.9 46.1 23.4 30.9 29.6 23.2 61.5 58.8 13.0 37.0 35.6 27.2 21.4 41.6 39.5 31.7 16.3 35.8 53.8 28.3 37.6 24.4 30.9 49.2 83.9 60.6 43.3 14.8 37.7 46.6 20.3 19.9 14.6 28.4 55.4 22.2 31.2 20.0 24.6 16.3 21.0 30.9 23.7 21.8 15.7 34.8 17.3 25.4 27.2 25.9 13.3 18.6 15.2 24.7 22.6 34.7 37.5 60.3 24.2 31.6 34.0 26.3 30.7 43.4 22.6 23.4 28.1 40.7 12.3 23.6 19.7 109.7 23.8 72.3 15.0 16.4 17.8 70.1 33.4 31.4 13.3 17.9 24.9 20.7 60.1 28.9 25.9 83.2 16.8 13.8 21.4 13.1 14.8 45.2 51.8 18.4 23.3 38.1 10.7 14.8 43.3 60.6 25.5 32.0 27.6 47.9 33.8 31.6 41.9 49.2 37.7 30.7 8.7 14.8 29.0 83.9 31.5 46.6 20.2 19.8 29.5 30.8 18.6 24.9 22.5 19.7 23.4 16.3 77.4 153.2 311.9 160.1 125.5 118.0 81.5 201.2 108.4 83.0 176.2 104.1 416.0 79.6 181.9 5.0 100.2 238.7 46.7 186.3 318.9 107.4 199.9 87.6 289.4 332.4 76.3 189.9 117.9 288.1 11.5 119.3 206.5 160.3 143.3 207.8 130.1 146.6 273.5 100.4 213.5 151.3 51.8 107.2 40.1 200.2 140.8 369.3 228.4 248.2 181.2 ESD ENSG00000139684 "Esterase D" P10768 13 46771256-46797232 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039700 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 16000000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039700: AB_10697553" "unprognostic (3.05e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (7.66e-2)" "unprognostic (1.75e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.73e-2)" "unprognostic (3.31e-1)" "unprognostic (1.01e-1)" "unprognostic (2.12e-2)" "unprognostic (1.49e-2)" "unprognostic (1.08e-1)" "unprognostic (2.91e-2)" "unprognostic (2.71e-2)" "unprognostic (2.18e-1)" "unprognostic (6.44e-2)" "unprognostic (1.37e-3)" 58.5 30.9 32.0 28.6 29.8 24.2 44.5 23.7 32.0 54.4 37.3 29.0 34.2 31.8 53.2 50.4 54.1 40.6 30.3 45.6 30.7 29.3 58.8 82.2 28.2 31.4 31.7 32.1 61.3 24.9 27.5 47.5 26.4 28.6 55.2 41.7 32.5 31.5 45.2 47.4 29.7 38.4 50.8 37.4 31.1 32.1 32.4 26.7 65.5 78.9 50.9 31.7 62.5 36.9 30.1 48.7 15.1 37.1 29.8 35.7 26.4 22.1 12.9 39.1 26.9 45.9 75.9 10.5 31.9 46.3 44.5 34.7 21.8 27.2 25.2 9.6 38.2 33.3 22.7 43.0 37.7 57.0 28.8 44.7 32.6 13.0 33.5 37.6 63.6 14.0 51.8 35.0 28.7 38.7 53.7 41.7 43.5 31.8 6.8 73.6 21.7 56.4 42.3 10.1 28.7 24.5 44.9 23.0 17.0 63.1 9.0 19.4 22.0 14.2 12.1 25.6 28.1 23.2 36.5 27.8 16.4 19.4 31.5 29.4 4.6 9.9 21.8 35.4 36.5 21.9 7.7 37.1 15.1 15.0 31.5 24.6 30.1 30.0 23.0 40.8 25.3 35.7 27.9 4.3 29.8 28.0 48.7 24.9 26.4 32.0 29.8 23.7 32.0 30.7 29.3 31.7 32.1 28.6 26.7 50.6 42.5 68.7 203.4 119.1 47.0 89.2 124.9 77.6 61.4 146.5 39.3 134.7 305.1 153.5 36.2 95.8 72.1 46.7 90.4 115.2 195.1 96.4 94.6 148.9 197.0 20.6 104.5 112.3 138.2 18.5 247.9 128.5 156.9 100.0 108.9 147.8 82.8 115.8 198.7 400.9 62.5 148.8 210.1 67.4 44.1 113.0 62.2 82.2 173.0 130.7 ESYT2 "CHR2SYT, FAM62B, KIAA1228" ENSG00000117868 "Extended synaptotagmin 2" A0FGR8 7 158730995-158830253 "Plasma proteins, Predicted membrane proteins, Transporters" "Endocytosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002132 Approved Uncertain Cytosol NA NA 130000 Cytosol "HPA002132: AB_1078807" "unprognostic (2.30e-1)" "unprognostic (1.06e-2)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (5.72e-2)" "unprognostic (5.43e-2)" "unprognostic (9.01e-2)" "unprognostic (9.94e-2)" "unprognostic (1.72e-1)" "unprognostic (8.71e-3)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.13e-1)" "unprognostic (7.54e-2)" "unprognostic (6.70e-2)" "unprognostic (4.58e-2)" "unprognostic (3.70e-3)" "prognostic unfavorable (2.81e-5)" 33.3 25.6 15.3 16.2 23.5 19.6 27.3 21.7 26.3 26.7 27.9 17.8 21.6 15.8 31.2 31.0 32.5 28.3 31.1 28.4 16.1 17.5 20.6 16.7 26.1 18.0 15.6 16.7 41.6 23.2 29.7 22.0 35.2 20.6 21.1 22.6 23.4 26.7 31.4 34.5 24.5 22.5 37.8 14.9 13.2 19.4 13.3 12.1 29.0 30.5 24.3 23.2 30.5 27.6 1.4 3.6 2.0 2.3 6.6 8.5 2.9 29.6 17.8 5.7 6.0 19.2 22.3 19.0 14.0 14.3 11.2 12.6 9.9 39.0 9.1 16.2 25.1 23.1 14.8 8.2 14.7 10.8 9.4 8.4 7.5 14.2 10.5 19.6 26.9 17.2 16.1 18.3 12.6 16.9 22.5 13.2 24.8 16.1 30.8 18.2 24.9 27.9 19.5 9.1 20.0 17.2 23.8 11.0 11.2 19.0 12.7 16.7 9.2 44.6 36.1 20.3 13.9 13.1 29.5 20.4 12.4 6.5 54.7 17.8 21.1 5.4 8.9 30.7 28.0 36.5 2.0 1.9 1.5 8.5 2.3 4.7 1.4 7.1 6.0 3.6 1.0 6.7 7.9 1.2 6.6 1.5 2.4 5.8 2.9 15.3 23.5 21.7 26.3 16.1 17.5 15.6 16.7 20.6 12.1 35.7 32.5 9.0 10.9 41.0 15.1 25.8 22.9 36.1 33.0 45.4 15.7 24.1 3.3 13.5 11.2 41.4 27.1 23.3 17.1 22.4 41.1 18.3 11.6 17.4 18.3 12.7 20.3 25.2 23.8 3.0 32.5 22.6 49.0 10.8 29.5 15.2 24.1 5.8 51.2 8.2 10.6 32.3 52.8 10.9 10.0 45.2 34.1 25.9 22.5 21.4 ETAA1 ETAA16 ENSG00000143971 "ETAA1, ATR kinase activator" Q9NY74 2 67397319-67412089 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035048, HPA035049" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035048: AB_10670300, HPA035049: AB_2674430" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (5.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.30e-1)" "unprognostic (3.39e-2)" "unprognostic (6.47e-2)" "unprognostic (5.53e-2)" "unprognostic (1.12e-2)" "unprognostic (8.33e-2)" "unprognostic (9.89e-2)" "unprognostic (1.87e-1)" "unprognostic (8.52e-3)" "unprognostic (9.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.01e-2)" "unprognostic (1.14e-2)" 9.3 23.4 6.4 11.0 11.3 6.6 14.7 14.0 10.6 15.4 11.7 6.3 9.4 7.2 14.6 13.9 12.0 13.9 15.7 9.4 8.7 5.5 17.5 11.1 11.3 14.8 9.7 10.4 15.6 16.2 14.2 13.9 8.8 10.7 11.6 9.2 6.1 12.4 13.7 11.4 12.4 11.1 10.6 8.5 11.8 10.5 11.3 10.3 19.2 15.9 9.7 9.8 11.6 12.7 7.5 4.4 3.4 5.2 4.2 7.4 3.1 9.1 7.0 12.0 10.8 9.4 13.0 9.8 9.8 13.0 10.4 10.1 5.6 11.1 17.1 5.4 8.0 14.7 11.2 10.1 11.8 15.0 10.0 8.1 9.5 17.0 8.2 8.9 9.4 9.0 10.2 16.9 7.7 12.1 16.6 16.5 14.0 7.7 7.4 14.3 4.1 13.9 10.4 12.2 14.7 7.7 10.1 19.1 7.9 12.7 6.0 10.1 20.1 9.9 9.1 9.3 12.3 7.9 4.6 11.4 14.2 10.9 6.7 11.4 8.3 7.4 13.8 13.2 10.0 10.7 3.4 2.5 2.0 5.5 4.1 6.0 7.5 5.1 3.2 3.1 7.0 7.0 6.2 0.2 4.2 5.2 4.4 7.4 3.1 6.4 11.3 14.0 10.6 8.7 5.5 9.7 10.4 10.7 10.3 20.8 16.0 0.0 6.9 2.2 4.8 8.5 17.8 22.7 10.3 12.2 0.0 5.7 10.0 15.6 0.3 3.1 4.2 0.0 15.9 5.0 7.6 6.2 5.8 8.2 4.1 4.8 10.3 7.4 5.1 1.5 11.2 6.7 1.7 9.0 6.1 5.2 16.4 3.5 12.4 10.0 4.3 0.0 3.1 11.4 7.8 2.3 1.7 5.0 6.0 4.7 ETS2 ENSG00000157557 "ETS proto-oncogene 2, transcription factor" P15036 21 38805307-38824955 "Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 580.2;Suprabasal keratinocytes: 425.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 16.5;granulocytes: 18.5;monocytes: 14.9" "Cell line enhanced" "Detected in many" "HEL: 60.5;hTCEpi: 55.4;hTERT-HME1: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003176 Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA003176: AB_2666824" "unprognostic (2.06e-1)" "unprognostic (5.91e-2)" "unprognostic (9.16e-3)" "unprognostic (5.33e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.88e-3)" "unprognostic (7.36e-2)" "unprognostic (8.99e-3)" "unprognostic (3.66e-2)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-2)" "unprognostic (2.12e-1)" "unprognostic (1.89e-1)" "unprognostic (8.10e-2)" "unprognostic (7.10e-2)" 33.6 10.4 25.8 29.6 12.8 44.7 28.5 5.5 36.5 28.4 38.1 7.3 13.7 39.7 27.0 20.3 30.1 21.8 42.6 42.9 16.2 10.8 21.2 75.5 58.3 56.9 13.8 18.2 23.6 11.7 20.0 19.7 23.2 14.2 31.4 50.6 12.9 17.6 17.4 64.2 72.4 59.0 43.3 13.6 68.7 25.8 8.3 11.0 7.2 21.5 28.4 13.7 40.8 35.5 0.2 16.5 18.5 14.9 0.1 2.5 3.6 23.4 5.0 3.5 1.1 4.0 13.6 9.4 5.5 32.0 7.3 9.7 4.4 6.7 5.1 2.7 4.9 10.7 7.0 5.9 14.7 14.0 4.7 2.3 60.5 30.4 11.0 41.2 3.7 5.9 8.0 55.4 10.3 45.2 4.7 5.8 3.4 6.2 0.0 3.2 3.4 11.2 4.0 11.3 7.8 3.3 36.8 2.2 4.7 10.3 15.2 2.7 3.6 15.6 6.4 1.2 1.3 0.3 6.9 6.2 17.6 2.5 11.2 12.0 0.1 0.0 5.1 4.2 12.5 14.6 10.1 9.2 3.3 1.7 12.3 2.0 0.2 1.6 2.5 16.5 0.2 1.6 1.6 18.5 0.1 14.9 4.0 0.1 3.6 25.8 12.8 5.5 36.5 16.2 10.8 13.8 18.2 14.2 11.0 47.6 133.7 24.2 580.2 379.6 2.1 25.0 45.9 141.8 183.1 48.8 0.0 42.0 10.0 60.7 3.0 196.3 148.0 23.3 94.2 94.1 55.2 133.5 49.7 211.1 50.3 0.0 88.0 256.6 144.5 1.7 16.7 174.6 64.1 29.7 182.6 1.0 94.1 98.2 23.3 27.9 1.1 51.8 93.5 0.6 2.9 425.2 148.5 18.1 194.6 292.4 EXD2 "C14orf114, EXDL2, FLJ10738" ENSG00000081177 "Exonuclease 3'-5' domain containing 2" Q9NVH0 14 69191511-69244020 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002906, HPA005848" Uncertain Approved "Intermediate filaments,Mitochondria" NA NA Mitochondria "Intermediate filaments" "HPA002906: AB_1078767, HPA005848: AB_1078768" "unprognostic (3.36e-2)" "unprognostic (1.61e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (9.91e-2)" "unprognostic (8.03e-2)" "unprognostic (2.46e-1)" "unprognostic (4.64e-2)" "unprognostic (8.97e-2)" "prognostic favorable (2.08e-9)" "unprognostic (1.16e-1)" "unprognostic (3.06e-2)" "unprognostic (8.75e-2)" "unprognostic (2.14e-2)" 8.1 7.7 14.3 5.0 19.0 2.3 10.6 20.4 20.1 15.8 8.8 21.7 10.2 7.2 14.4 13.6 10.7 14.5 8.6 8.9 13.8 12.0 11.5 6.0 9.0 4.0 13.7 13.3 12.4 24.9 21.9 13.2 8.0 13.9 11.4 10.0 9.6 17.0 12.1 10.3 7.0 6.8 11.0 20.7 5.8 8.7 20.0 12.6 5.0 12.4 5.2 5.9 10.5 7.9 4.1 7.4 10.9 3.4 3.6 6.0 3.1 19.1 9.0 7.0 10.3 4.3 5.2 8.9 9.6 8.1 9.0 11.9 7.6 13.6 0.0 7.1 10.0 5.5 10.9 7.7 9.7 10.2 4.8 9.2 5.6 3.4 4.5 16.9 4.1 5.4 10.5 16.1 9.1 6.0 5.5 12.6 4.9 3.5 7.4 8.5 9.7 2.3 6.3 7.6 10.3 9.1 0.0 6.7 6.7 13.2 7.1 13.7 12.2 7.2 15.0 7.0 7.9 20.1 3.6 10.0 8.4 6.0 6.7 4.9 5.7 7.6 0.0 0.0 4.5 6.2 10.9 3.4 2.9 3.3 1.9 6.0 4.1 3.5 3.3 7.4 2.4 4.2 6.0 0.4 3.6 1.7 5.8 2.4 3.1 14.3 19.0 20.4 20.1 13.8 12.0 13.7 13.3 13.9 12.6 11.9 7.5 3.2 4.2 2.9 9.4 10.3 5.1 9.4 9.1 0.0 7.9 7.1 5.0 10.0 2.4 4.4 3.2 0.0 7.6 3.8 4.6 4.8 1.1 4.7 5.6 9.5 5.8 10.4 5.9 1.8 5.8 1.8 3.3 9.0 8.7 6.8 9.0 7.0 11.3 4.8 8.7 0.0 3.9 31.0 8.7 3.8 2.4 0.5 6.9 3.0 EXOC4 "KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p" ENSG00000131558 "Exocyst complex component 4" Q96A65 7 133253073-134066589 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Rod photoreceptor cells: 229.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031443, HPA031444" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA031443: AB_10602496, HPA031444: AB_2673886" "unprognostic (1.70e-1)" "unprognostic (1.62e-2)" "unprognostic (2.05e-1)" "unprognostic (5.09e-2)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (8.63e-2)" "unprognostic (2.33e-1)" "unprognostic (4.40e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (6.19e-4)" "unprognostic (9.78e-3)" "prognostic favorable (6.85e-5)" "unprognostic (5.91e-2)" "unprognostic (2.18e-1)" "unprognostic (3.37e-1)" "unprognostic (3.35e-2)" 21.2 23.7 18.5 17.7 22.3 10.5 19.4 25.7 24.4 20.8 17.0 19.7 22.2 11.2 25.8 20.6 21.5 24.2 16.8 16.5 14.7 15.4 15.6 15.2 16.5 12.6 14.2 19.3 27.7 26.5 28.5 31.2 16.4 22.0 16.9 18.8 19.3 20.5 18.8 50.7 24.4 13.7 20.8 18.7 17.9 16.3 17.2 17.3 34.7 22.9 18.3 22.1 26.3 20.6 8.3 16.3 8.1 12.7 18.4 12.4 10.4 17.8 14.7 20.4 20.1 23.9 25.0 7.1 13.1 21.9 11.9 15.7 8.5 25.2 13.4 9.5 24.6 17.5 11.4 10.9 17.9 19.8 20.4 13.1 10.8 15.5 8.9 26.3 14.2 11.8 24.3 22.4 17.0 31.5 26.4 20.3 17.8 15.5 13.4 22.1 11.7 25.8 15.7 15.3 21.5 13.8 11.5 18.1 24.1 19.2 16.0 15.9 25.1 19.7 18.2 21.1 24.0 12.0 13.4 22.0 13.3 7.0 14.0 14.3 21.3 13.0 13.0 39.3 16.7 20.2 8.1 12.0 6.9 11.8 12.7 10.5 8.3 12.3 12.4 16.3 8.0 10.1 10.4 4.0 18.4 10.5 7.3 12.4 10.4 18.5 22.3 25.7 24.4 14.7 15.4 14.2 19.3 22.0 17.3 20.8 21.1 11.9 14.2 16.8 35.3 24.9 7.6 18.7 15.9 14.0 88.4 13.6 3.3 12.9 23.1 21.5 15.8 0.0 15.7 13.8 11.9 17.0 8.1 14.4 15.6 47.7 16.7 24.5 30.4 20.6 16.1 18.0 13.5 12.6 21.4 20.6 13.9 17.5 17.7 13.3 229.7 12.9 10.8 18.1 12.6 14.9 9.4 20.8 18.4 16.9 EXOSC4 "FLJ20591, hRrp41p, p12A, RRP41, RRP41A, Rrp41p, SKI6, Ski6p" ENSG00000178896 "Exosome component 4" Q9NPD3 8 144078626-144080647 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 251.1;Late spermatids: 557.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 91.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024792, HPA065103" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "HPA024792: AB_1848325, HPA065103: " "unprognostic (2.32e-1)" "unprognostic (1.55e-2)" "unprognostic (3.06e-1)" "unprognostic (3.53e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-2)" "unprognostic (6.58e-3)" "unprognostic (1.26e-1)" "unprognostic (8.36e-2)" "prognostic favorable (2.23e-4)" "unprognostic (4.32e-2)" "unprognostic (1.41e-1)" "unprognostic (2.30e-2)" "unprognostic (5.18e-2)" "unprognostic (1.23e-1)" "unprognostic (2.71e-1)" "unprognostic (5.11e-2)" 12.3 16.7 12.8 11.4 17.6 13.8 8.9 13.9 20.6 8.1 12.0 10.5 13.6 15.8 9.8 10.4 14.5 10.0 9.3 16.5 11.4 11.2 14.9 21.5 8.7 11.4 11.5 13.0 10.3 15.0 8.0 10.2 11.5 12.0 12.1 6.5 11.6 28.0 14.7 12.1 12.7 11.1 6.7 9.3 13.4 13.9 45.0 9.7 14.8 10.8 10.4 11.1 8.7 7.8 24.7 38.2 19.0 31.8 17.1 16.1 18.8 10.3 22.9 4.1 9.8 3.5 2.7 11.2 8.2 3.4 6.4 6.5 16.0 7.3 6.3 12.0 3.4 4.6 8.6 7.5 8.9 1.9 8.3 25.5 9.0 17.1 17.7 5.9 6.7 10.8 3.8 9.2 7.4 5.9 2.5 3.3 6.9 14.1 4.3 5.2 37.9 10.4 13.3 10.6 11.0 91.9 4.6 6.7 16.3 6.1 10.6 12.9 17.0 10.2 13.2 18.8 2.2 15.0 10.2 3.2 6.6 14.5 15.8 13.8 11.4 13.6 7.9 9.5 10.8 10.3 19.0 31.8 12.5 15.9 29.4 16.1 22.0 12.4 15.4 29.8 24.7 15.9 15.4 9.2 17.1 16.1 38.2 13.7 18.8 12.8 17.6 13.9 20.6 11.4 11.2 11.5 13.0 12.0 9.7 8.9 24.2 15.2 27.4 83.9 8.8 18.2 20.4 18.7 12.5 26.2 7.9 39.9 104.5 49.6 251.1 24.8 32.9 0.0 40.1 34.1 31.5 24.7 13.9 52.3 40.4 6.4 24.9 20.9 31.4 557.6 17.3 24.1 33.7 54.1 29.8 14.1 51.1 45.6 19.8 81.3 6.8 12.9 40.6 52.4 33.8 76.9 40.3 13.8 40.1 33.2 FA2H "FAAH, FAXDC1, FLJ25287, SPG35" ENSG00000103089 "Fatty acid 2-hydroxylase" Q7L5A8 16 74712955-74774831 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Oxidoreductase "Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.2;stomach 1: 45.5" "Cell type enhanced" "Detected in many" 20 "Mucus-secreting cells: 34.0;Paneth cells: 56.1;Urothelial cells: 163.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 24 "memory B-cell: 3.0" "Lineage enriched" "Detected in single" 24 "B-cells: 3.0" "Cell line enhanced" "Detected in some" "A549: 16.0;HAP1: 20.7;JURKAT: 38.1;OE19: 25.5;SK-BR-3: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056614, HPA077840" Approved Uncertain "Nuclear membrane" NA NA "Nuclear membrane" "HPA056614: AB_2683191, HPA077840: AB_2686858" "unprognostic (1.33e-1)" "unprognostic (4.97e-2)" "unprognostic (9.19e-2)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.85e-2)" "unprognostic (1.48e-2)" "unprognostic (2.47e-2)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.74e-4)" "unprognostic (6.01e-2)" "prognostic favorable (5.01e-6)" "unprognostic (1.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.83e-2)" "unprognostic (2.11e-3)" 0.7 0.7 11.8 3.4 27.7 0.7 2.6 2.8 25.3 2.0 16.2 62.4 0.0 8.1 0.7 2.2 3.7 1.8 14.3 0.7 22.3 11.0 3.7 0.7 1.5 0.9 40.5 16.5 0.6 6.8 7.1 0.8 1.0 28.5 1.9 15.4 0.0 8.4 1.0 0.6 3.5 11.3 1.4 78.2 0.8 45.5 2.4 44.6 2.6 2.0 0.0 4.7 3.8 1.2 3.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 16.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 8.7 8.9 0.0 0.0 0.0 0.9 1.5 20.7 0.2 0.0 0.0 0.6 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 38.1 0.0 0.0 0.0 6.3 0.3 0.0 0.4 25.5 1.0 0.0 0.0 0.7 10.1 6.5 2.8 0.0 0.0 12.3 0.0 0.5 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.8 27.7 2.8 16.1 22.3 11.0 40.5 16.5 28.5 44.6 0.0 2.2 0.0 4.2 0.5 0.0 0.3 10.2 4.0 2.3 0.0 0.0 0.2 6.6 11.5 6.3 0.0 25.4 0.0 12.9 0.1 0.0 20.7 0.0 0.0 0.1 0.0 6.4 0.0 0.0 2.7 0.0 0.0 3.3 0.0 34.0 0.0 26.4 56.1 0.4 0.0 0.0 0.0 0.1 0.5 2.1 0.6 0.1 0.0 16.8 163.9 FAAP100 "C17orf70, FLJ22175" ENSG00000185504 "Fanconi anemia core complex associated protein 100" Q0VG06 17 81539885-81553961 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023954, HPA024626, HPA026532" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023954: AB_1845601, HPA024626: AB_1845602, HPA026532: AB_1845603" "unprognostic (5.25e-2)" "unprognostic (5.40e-2)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (2.91e-1)" "unprognostic (1.85e-2)" "unprognostic (4.87e-3)" "unprognostic (1.30e-1)" "unprognostic (1.16e-1)" "unprognostic (3.49e-2)" "unprognostic (1.05e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (1.00e-7)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "unprognostic (9.85e-2)" "unprognostic (4.24e-1)" 11.4 10.0 7.7 21.1 8.6 9.8 13.4 33.2 10.9 9.0 12.2 13.4 9.6 13.0 11.1 13.6 11.7 11.0 22.6 9.0 6.9 7.1 11.7 19.3 9.6 20.0 8.4 7.6 12.7 20.1 9.7 14.1 9.6 6.9 12.5 5.5 12.8 15.9 11.9 9.4 16.8 14.0 14.0 7.0 23.8 11.1 11.3 5.9 16.7 15.1 14.5 15.5 9.9 9.2 6.1 6.5 2.3 6.1 4.7 5.3 3.6 7.7 14.1 6.4 17.9 7.6 8.0 9.8 7.9 3.7 9.4 5.8 9.1 9.4 13.8 6.4 10.0 9.4 10.0 3.2 9.4 2.2 3.9 10.3 9.4 14.0 12.4 7.9 10.1 11.1 9.6 7.1 6.9 8.0 12.1 17.9 14.4 13.6 11.2 4.7 14.8 15.6 16.4 7.5 8.9 6.1 14.1 6.5 12.4 7.0 13.7 14.0 11.6 5.7 16.3 6.7 6.9 17.7 13.4 15.1 20.6 13.2 5.4 12.7 13.0 1.0 6.5 5.6 6.4 9.5 0.0 6.1 2.3 5.3 5.6 4.1 6.1 3.4 3.6 5.9 4.7 3.2 2.5 0.9 4.7 2.8 6.5 3.6 3.6 7.7 8.6 33.2 10.9 6.9 7.1 8.4 7.6 6.9 5.9 3.0 9.8 8.8 3.2 0.0 9.8 7.1 10.2 2.7 4.5 14.0 3.9 5.1 3.3 7.3 1.5 5.2 6.4 0.0 6.0 3.9 7.2 4.7 0.0 10.0 7.3 6.4 7.0 8.6 16.4 2.2 4.6 4.7 0.0 4.6 9.1 6.0 7.5 3.5 4.9 5.6 4.5 0.0 4.7 7.4 6.7 0.0 2.6 5.0 8.1 3.2 FAAP20 "C1orf86, FLJ31031" ENSG00000162585 "Fanconi anemia core complex associated protein 20" Q6NZ36 1 2184461-2212720 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA038829 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA Nucleoplasm "Nuclear bodies, Cell Junctions" "HPA038829: AB_10673476" "unprognostic (1.36e-2)" "unprognostic (2.86e-2)" "unprognostic (2.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.64e-1)" "unprognostic (6.11e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (2.81e-1)" "unprognostic (1.36e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.88e-4)" "unprognostic (1.59e-1)" "unprognostic (1.96e-3)" "unprognostic (1.36e-1)" "unprognostic (1.67e-1)" "unprognostic (4.93e-2)" "unprognostic (8.55e-2)" 33.1 18.8 15.4 14.3 12.1 15.2 20.5 15.4 16.4 17.8 19.1 13.8 19.1 14.6 17.8 17.7 20.3 12.6 14.2 17.0 15.4 14.8 27.7 20.9 15.0 22.5 14.9 10.3 16.9 17.2 8.0 26.4 11.7 13.3 21.8 7.3 20.9 21.4 23.9 27.3 28.1 14.9 15.0 14.3 24.4 30.5 20.2 11.5 35.1 30.5 11.4 16.5 17.1 19.3 13.2 22.0 31.0 8.7 5.1 12.6 5.6 10.4 1.6 2.3 2.8 1.4 1.9 13.8 11.8 4.4 3.9 5.1 2.5 6.9 12.2 17.5 1.8 3.5 5.1 1.6 1.7 1.9 26.0 24.0 10.1 2.7 5.3 5.4 7.0 9.8 3.3 3.9 2.3 2.5 2.4 4.7 9.7 13.9 2.9 2.6 4.3 10.2 21.9 8.2 2.0 21.9 13.7 7.2 11.4 1.8 1.6 18.9 25.3 7.7 3.3 20.2 2.2 3.3 2.9 9.9 6.0 14.3 7.4 6.7 27.5 14.6 17.8 11.2 4.4 2.5 3.6 8.7 31.0 10.1 8.1 10.0 13.2 9.2 10.9 8.8 13.1 12.6 10.4 11.2 5.1 7.5 22.0 7.8 5.6 15.4 12.1 15.4 14.1 15.4 14.8 14.9 10.3 13.3 11.5 6.0 11.0 59.7 76.1 0.0 25.1 17.1 50.9 14.7 12.5 92.5 3.9 105.4 144.2 110.3 81.6 33.1 20.8 23.3 96.1 118.9 7.2 104.6 7.0 78.0 115.2 14.3 42.1 73.1 106.0 249.7 79.7 47.3 0.0 185.8 72.9 43.5 131.8 46.3 77.8 221.5 25.4 64.7 14.6 118.4 32.4 0.0 75.1 55.3 55.7 99.4 FAAP24 "C19orf40, FLJ46828, MGC32020" ENSG00000131944 "Fanconi anemia core complex associated protein 24" Q9BTP7 19 32972209-32978222 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041168 Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA041168: AB_10960496" "unprognostic (1.18e-2)" "unprognostic (1.22e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (6.52e-2)" "unprognostic (2.73e-1)" "unprognostic (2.58e-3)" "unprognostic (3.76e-2)" "unprognostic (1.88e-2)" "unprognostic (3.98e-2)" "unprognostic (2.82e-3)" "unprognostic (3.54e-2)" "prognostic unfavorable (4.00e-7)" "unprognostic (4.37e-3)" "unprognostic (5.30e-1)" "unprognostic (2.31e-3)" "unprognostic (2.15e-1)" 3.7 3.5 1.8 4.1 2.1 5.3 3.9 2.3 2.9 3.0 2.9 2.4 3.3 2.8 3.3 4.6 4.8 2.6 6.7 1.9 1.5 1.7 4.3 2.5 2.3 4.6 3.8 0.9 4.2 2.4 0.2 2.0 6.1 3.1 9.6 4.0 3.3 3.2 1.9 1.0 4.6 5.1 2.2 2.6 6.1 2.8 16.9 2.0 8.7 3.0 3.1 8.6 3.6 2.7 7.2 7.7 16.0 8.0 7.7 6.2 3.7 5.1 12.7 5.3 8.2 2.7 5.6 4.3 6.5 6.9 12.6 16.6 8.9 8.4 6.0 9.7 2.7 9.7 3.6 10.0 4.9 10.1 16.2 5.2 13.0 5.8 6.7 1.6 4.5 6.7 3.1 3.1 7.9 4.8 2.2 5.1 9.8 6.8 6.1 9.2 5.8 9.5 6.0 2.4 7.3 5.7 8.6 4.7 3.3 2.5 3.2 5.5 4.3 7.4 8.6 5.3 5.7 5.9 11.4 3.0 12.6 6.1 5.3 6.0 4.9 10.0 8.2 9.0 9.9 8.1 10.8 6.4 8.7 3.9 7.3 4.4 6.6 4.7 5.6 4.0 7.2 4.3 6.2 16.0 7.7 8.0 7.7 6.0 3.7 1.8 2.1 2.3 2.9 1.5 1.7 3.8 0.9 3.1 2.0 3.0 0.6 6.5 3.2 0.0 1.1 0.4 2.5 0.0 2.3 3.5 2.0 8.6 1.7 1.2 5.9 1.2 2.0 0.0 6.8 13.0 2.2 2.7 1.1 0.4 7.1 4.8 1.2 1.8 4.3 8.0 3.1 3.7 0.0 10.0 2.6 0.2 3.2 3.2 3.2 0.7 1.0 0.0 2.2 26.7 8.0 0.0 4.2 4.4 2.1 2.2 FABP1 L-FABP ENSG00000163586 "Fatty acid binding protein 1" P07148 2 88122982-88128116 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 453.2;liver: 370.7" "Group enriched" "Detected in many" 5 "Enterocytes: 8164.5;Hepatocytes: 5503.1;Paneth cells: 3221.0" "Group enriched" "Detected in many" 14 "colorectal cancer: 175.1;liver cancer: 437.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 23 "neutrophil: 2.3" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.3" "Group enriched" "Detected in some" 7 "CACO-2: 26.2;Hep G2: 83.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002305, HPA028275" Enhanced Approved Nucleoplasm,Cytosol NA NA 32000000 "Nucleoplasm, Cytosol" "CAB002305: AB_563728, HPA028275: AB_10600909" "unprognostic (1.91e-1)" "unprognostic (7.91e-3)" "unprognostic (5.47e-2)" "unprognostic (1.96e-1)" "unprognostic (2.03e-2)" "unprognostic (2.35e-1)" "unprognostic (7.99e-2)" "unprognostic (8.92e-2)" "unprognostic (2.29e-1)" 0.4 0.1 0.4 33.9 0.4 0.0 0.4 0.4 0.5 0.4 153.5 0.4 0.4 137.9 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.2 57.6 370.7 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 97.7 0.4 0.5 0.4 0.4 0.1 453.2 6.7 0.4 0.4 0.2 0.5 0.4 0.4 0.5 0.5 0.4 0.4 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 26.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 83.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.2 0.1 0.0 0.0 0.0 1.4 7.7 0.0 0.1 0.8 5.7 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.7 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.5 0.4 0.2 0.4 0.4 0.4 0.4 0.0 0.0 173.3 0.0 0.0 0.0 0.4 119.8 0.0 0.0 57.6 0.0 0.1 132.6 0.0 0.0 0.0 8164.5 140.2 0.0 0.1 0.0 0.3 133.2 5503.1 1.4 0.0 251.5 124.0 159.5 0.0 0.0 0.0 0.0 0.0 830.4 0.0 0.1 3221.0 0.0 668.9 0.0 0.0 0.0 0.0 0.1 0.0 1.1 51.0 1046.9 0.0 FABP3 "FABP11, H-FABP, MDGI, O-FABP" ENSG00000121769 "Fatty acid binding protein 3" P05413 1 31365625-31376850 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "heart muscle: 420.9;skeletal muscle: 129.4" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 2447.6" "Cancer enhanced" "Detected in all" "renal cancer: 92.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "ASC TERT1: 120.7" "Low region specificity" "Detected in all" "CAB017830, HPA055754" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Focal adhesion sites" NA NA 1640000 4400000 "Focal adhesion sites" "Golgi apparatus, Plasma membrane" "CAB017830: , HPA055754: AB_2682909" "unprognostic (2.07e-2)" "unprognostic (2.50e-2)" "unprognostic (1.32e-3)" "unprognostic (1.73e-2)" "unprognostic (2.05e-1)" "unprognostic (1.62e-1)" "unprognostic (6.07e-3)" "unprognostic (1.04e-1)" "unprognostic (6.86e-2)" "unprognostic (1.18e-1)" "unprognostic (2.85e-1)" "unprognostic (1.67e-1)" "prognostic favorable (1.54e-7)" "unprognostic (5.80e-3)" "unprognostic (3.45e-1)" "unprognostic (7.38e-3)" "unprognostic (9.76e-3)" 2.3 5.2 8.1 0.7 6.0 0.5 22.7 1.4 14.6 3.9 1.3 0.8 3.4 0.7 6.8 5.3 3.1 2.8 1.1 420.9 11.0 5.3 21.3 1.9 4.3 1.3 9.8 6.0 2.2 0.4 0.3 0.7 1.1 13.7 5.0 1.5 3.0 4.4 14.0 129.4 0.9 0.6 13.0 3.4 3.9 3.6 2.0 1.3 0.1 1.7 31.6 2.2 2.5 2.5 1.4 0.5 0.0 0.9 0.2 0.9 0.6 0.1 0.0 3.3 0.2 23.1 120.7 1.1 0.9 8.9 0.1 3.2 0.2 0.9 0.2 12.8 2.5 0.0 0.3 0.9 0.0 0.1 0.1 0.5 0.4 1.1 2.4 1.5 0.2 0.0 10.7 0.0 2.4 0.0 0.3 0.0 0.1 0.2 0.0 1.1 0.0 0.0 0.2 6.1 0.0 0.4 0.1 1.2 0.0 2.9 0.0 0.3 0.0 0.5 0.0 13.9 7.1 0.1 1.4 0.3 0.2 0.1 2.1 0.2 0.1 0.4 0.1 0.5 0.1 0.3 0.0 0.4 0.0 0.9 0.9 0.6 0.2 0.5 0.5 0.5 1.4 0.0 0.9 0.0 0.2 0.1 0.4 0.6 0.6 8.1 6.0 1.4 13.3 11.0 5.3 9.8 6.0 13.7 1.3 0.0 1.7 0.8 1.0 3.2 3.1 2447.6 5.1 2.7 2.3 26.2 2.0 2.1 383.0 0.3 2.1 0.8 0.0 0.0 0.3 1.3 14.9 3.8 1.1 0.0 96.1 7.9 0.0 3.7 20.0 4.2 6.4 17.6 8.5 0.0 0.0 2.7 0.5 3.6 7.4 399.5 8.1 0.0 32.3 0.3 0.1 2.6 1.4 1.0 0.1 5.2 FAM110A "bA371L19.3, C20orf55" ENSG00000125898 "Family with sequence similarity 110 member A" Q9BQ89 20 833715-857463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 83.4" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 131.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 83.4;eosinophil: 24.8;intermediate monocyte: 25.1;non-classical monocyte: 37.7" "Group enriched" "Detected in all" 9 "granulocytes: 83.4;monocytes: 37.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB034110, HPA069240" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol Yes Yes "Nucleoplasm, Vesicles" Cytosol "CAB034110: AB_1562838, HPA069240: AB_2686103" "unprognostic (6.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.57e-2)" "unprognostic (3.43e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "unprognostic (4.90e-3)" "unprognostic (5.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.78e-2)" "unprognostic (2.35e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (4.42e-4)" "unprognostic (9.64e-3)" "unprognostic (1.17e-2)" "unprognostic (6.42e-3)" "unprognostic (4.21e-3)" 5.2 3.6 1.7 17.7 4.2 7.4 7.7 1.9 3.9 6.5 8.8 2.0 7.7 10.0 4.0 6.1 22.1 1.9 6.9 4.8 1.7 2.5 4.8 3.9 15.2 18.7 2.1 1.9 2.6 3.5 9.3 5.1 11.1 3.6 11.1 3.4 3.1 12.7 10.5 3.7 39.9 9.2 1.3 1.6 15.1 5.5 2.8 1.3 22.9 7.7 8.0 18.9 7.8 9.7 1.9 5.8 83.4 37.7 1.0 6.4 3.2 12.7 3.4 1.9 3.6 2.2 0.9 13.4 4.0 2.2 2.6 2.3 7.5 8.0 4.1 1.8 2.5 3.6 20.7 1.6 10.5 2.1 3.3 1.1 8.6 2.2 1.9 1.0 2.3 3.0 0.6 13.1 3.5 3.5 0.8 1.7 3.8 4.6 10.3 2.3 7.6 6.5 6.4 2.5 8.2 5.9 6.5 3.4 5.4 1.9 9.2 3.7 4.4 3.4 40.4 1.8 0.8 16.7 3.5 2.2 6.1 4.5 5.5 4.4 3.8 3.2 1.7 0.9 6.1 4.4 83.4 4.4 24.8 2.2 25.1 2.0 1.1 4.0 4.6 5.8 1.9 4.9 4.7 2.5 1.0 37.7 0.6 6.4 3.2 1.7 4.2 1.9 3.9 1.7 2.5 2.1 1.9 3.6 1.3 0.0 6.5 19.9 14.7 29.0 0.2 2.4 5.1 4.0 0.0 10.4 0.0 36.4 1.7 8.3 6.0 5.8 6.9 46.7 5.2 131.1 4.7 17.7 52.8 0.8 17.4 4.8 10.4 18.4 36.5 13.5 3.1 27.8 6.8 6.4 7.5 0.2 10.7 8.0 1.8 2.1 2.5 6.5 5.2 1.9 5.3 32.1 26.2 26.2 7.8 20.9 FAM122C RP3-473B4.1 ENSG00000156500 "Family with sequence similarity 122C" Q6P4D5 X 134796395-134854835 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 41.5;Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 14.9" HPA059961 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA059961: AB_2684181" "unprognostic (1.32e-2)" "unprognostic (3.50e-2)" "unprognostic (7.63e-2)" "unprognostic (3.38e-3)" "unprognostic (1.08e-1)" "unprognostic (5.25e-2)" "unprognostic (1.85e-1)" "unprognostic (3.76e-3)" "unprognostic (3.50e-2)" "unprognostic (7.20e-3)" "unprognostic (2.28e-1)" "unprognostic (1.03e-2)" "unprognostic (2.41e-2)" "unprognostic (5.93e-2)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" "unprognostic (4.16e-3)" 4.2 3.8 4.1 4.7 6.0 8.7 4.1 2.9 5.0 4.6 3.8 7.9 3.8 1.8 11.5 4.2 3.5 4.7 3.4 3.9 4.0 4.2 3.6 3.2 5.6 7.1 6.3 4.6 22.0 2.1 2.9 5.5 2.9 5.3 4.4 3.2 11.5 6.6 3.2 2.9 3.3 4.0 7.9 6.2 6.4 4.7 12.0 5.2 9.1 3.8 2.1 6.5 5.9 3.5 4.8 7.0 7.3 5.8 4.5 3.8 2.1 1.1 1.4 4.4 4.5 1.2 1.7 2.6 3.7 3.3 3.4 4.7 3.2 4.5 1.5 5.7 1.6 7.4 1.7 3.7 1.3 2.5 3.7 1.4 2.6 14.9 1.4 1.3 3.9 2.3 1.8 0.7 3.3 2.1 2.3 2.8 11.6 10.9 8.7 2.4 6.8 4.0 3.2 2.4 1.2 3.3 6.9 3.0 3.2 1.1 1.0 1.8 3.0 2.3 0.7 3.8 3.3 1.1 1.1 0.9 2.0 1.3 3.1 2.4 3.3 2.9 6.5 2.9 4.4 2.2 2.7 2.8 7.3 2.6 3.1 2.7 4.8 3.0 3.8 1.9 4.1 3.7 3.3 5.3 4.5 5.8 7.0 2.7 2.1 4.1 6.0 2.9 5.0 4.0 4.2 6.3 4.6 5.3 5.2 6.0 5.0 0.0 2.1 1.1 4.2 1.9 0.0 13.4 3.4 1.8 13.7 1.3 1.7 1.0 41.5 5.7 2.3 23.3 1.6 2.2 2.0 1.3 12.7 0.5 1.9 3.2 1.2 4.9 1.9 4.5 3.7 2.7 3.3 3.6 1.7 4.6 2.0 1.1 2.1 1.1 13.0 0.0 2.3 10.7 1.9 1.0 1.6 8.7 1.7 2.2 FAM124B FLJ22746 ENSG00000124019 "Family with sequence similarity 124 member B" Q9H5Z6 2 224378698-224402085 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.8;blood: 18.0" "Group enriched" "Detected in some" 4 "Endothelial cells: 4.4;granulocytes: 4.6;Ito cells: 1.3;Kupffer cells: 1.9" "Cancer enriched" "Detected in many" 10 "testis cancer: 7.3" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 18.0;eosinophil: 11.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "HUVEC TERT2: 49.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA070240 Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA070240: AB_2686238" "unprognostic (2.01e-1)" "unprognostic (1.83e-1)" "unprognostic (6.87e-3)" "unprognostic (2.49e-1)" "unprognostic (7.10e-2)" "unprognostic (1.72e-2)" "unprognostic (1.28e-2)" "unprognostic (5.78e-2)" "unprognostic (3.19e-1)" "unprognostic (1.85e-1)" "unprognostic (1.57e-1)" "unprognostic (3.36e-1)" "unprognostic (7.61e-3)" "unprognostic (1.36e-2)" "unprognostic (4.30e-1)" "unprognostic (2.25e-1)" "unprognostic (5.80e-3)" 28.8 0.6 1.6 1.4 1.9 5.9 16.0 0.6 1.8 4.2 2.1 1.6 0.7 1.3 2.4 2.5 2.6 1.8 1.7 2.4 2.2 2.2 1.4 2.6 5.8 0.8 2.0 0.6 2.5 0.5 9.4 0.8 12.5 1.8 3.9 1.5 4.0 1.7 0.6 4.3 2.6 1.5 3.5 2.1 0.8 1.2 2.3 0.2 1.0 2.9 0.8 1.0 3.4 2.6 0.0 5.6 18.0 2.1 3.8 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 49.2 0.0 2.2 0.1 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 3.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 2.1 11.6 0.1 1.6 0.0 0.0 0.5 0.0 5.6 0.0 0.0 0.0 0.1 3.8 0.5 0.0 1.7 0.7 1.6 1.9 0.6 1.8 2.2 2.2 2.0 0.6 1.8 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 4.4 0.0 0.0 0.0 0.1 0.2 0.0 4.6 0.2 0.4 0.0 0.0 1.3 1.9 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 FAM133A "CT115, FLJ37659, RP1-32F7.2" ENSG00000179083 "Family with sequence similarity 133 member A" Q8N9E0 X 93674013-93712274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.8;pituitary gland: 8.2;testis: 16.1" "Group enriched" "Detected in some" 9 "Bipolar cells: 12.3;Early spermatids: 14.0;Horizontal cells: 19.1;Late spermatids: 18.2;Spermatocytes: 21.3;Spermatogonia: 34.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 7.1;Karpas-707: 22.2;U-2197: 11.6;U-266/70: 17.4;U-266/84: 37.7" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Uncertain Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA066175: AB_2685629, HPA069513: AB_2686143" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-3)" "unprognostic (4.45e-1)" "unprognostic (4.05e-2)" "unprognostic (3.86e-3)" "unprognostic (4.22e-2)" "unprognostic (8.76e-2)" "unprognostic (1.09e-2)" "unprognostic (7.42e-2)" "unprognostic (1.39e-2)" "unprognostic (7.12e-4)" "unprognostic (1.67e-3)" "unprognostic (2.13e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-3)" 0.5 3.0 4.7 0.4 14.8 0.3 0.8 2.3 7.7 1.7 0.5 0.5 0.0 0.4 1.0 0.8 0.4 1.1 0.7 2.2 2.5 4.5 0.4 0.4 0.5 0.4 2.3 4.4 1.4 0.4 0.4 8.2 0.4 3.7 0.4 0.5 0.2 0.4 0.5 0.3 0.6 0.5 0.8 4.5 0.5 0.4 16.1 2.6 0.0 0.9 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 22.2 0.0 0.0 0.0 0.0 0.5 0.0 5.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.4 0.5 11.6 0.5 17.4 37.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 14.8 2.3 7.3 2.5 4.5 2.3 4.4 3.7 2.6 0.0 0.0 0.0 0.0 0.6 12.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 19.1 0.0 1.3 0.0 18.2 1.1 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.7 0.0 1.1 0.0 0.2 21.3 34.9 0.1 0.0 0.0 0.0 0.0 FAM169A "KIAA0888, SLAP75" ENSG00000198780 "Family with sequence similarity 169 member A" Q9Y6X4 5 74777574-74866951 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8;epididymis: 23.6" "Group enriched" "Detected in many" 5 "Bipolar cells: 120.0;Collecting duct cells: 47.1;Cone photoreceptor cells: 133.5;Horizontal cells: 81.0;Muller glia cells: 163.2;Rod photoreceptor cells: 163.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 22.8;Hep G2: 15.5;SuSa: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041574 Enhanced Supported "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA041574: AB_10794382" "unprognostic (3.39e-1)" "unprognostic (2.25e-2)" "unprognostic (1.75e-4)" "unprognostic (5.87e-2)" "unprognostic (2.28e-2)" "unprognostic (1.46e-3)" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (6.48e-2)" "unprognostic (5.11e-2)" "unprognostic (2.72e-2)" "unprognostic (8.02e-2)" "unprognostic (3.51e-3)" "unprognostic (4.57e-1)" "unprognostic (4.72e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" 0.7 4.2 9.9 1.4 13.5 1.5 1.1 11.0 21.8 1.7 1.9 5.2 2.9 0.7 3.8 23.6 0.9 3.8 3.0 2.2 9.4 14.2 6.7 3.1 0.8 2.5 9.6 10.3 3.4 2.0 10.7 8.3 1.2 10.4 6.4 3.0 11.3 1.9 7.0 0.8 0.7 1.0 1.0 11.1 2.5 2.1 15.5 4.6 3.7 9.6 0.0 2.5 4.1 1.1 1.4 0.5 0.0 0.0 0.8 4.0 1.2 5.1 4.6 3.3 4.4 0.0 0.0 22.8 0.7 1.7 3.5 3.5 2.1 3.4 0.0 2.3 0.0 9.4 3.7 6.8 10.3 3.6 3.8 7.8 1.4 0.8 15.5 0.1 0.0 0.0 0.1 10.9 0.8 5.1 0.5 0.0 5.0 0.0 0.0 2.0 1.5 4.9 0.0 8.2 1.4 2.5 7.1 2.1 0.3 3.2 8.2 2.0 2.7 8.6 3.9 0.6 15.6 3.7 1.0 0.0 0.2 3.3 0.0 3.7 12.6 11.7 0.0 0.4 0.0 0.4 0.0 0.0 0.0 2.7 0.0 4.0 0.8 1.6 2.5 0.0 1.4 3.5 3.4 0.0 0.8 0.0 0.5 0.9 1.2 9.9 13.5 11.0 17.1 9.4 14.2 9.6 10.3 10.4 4.6 0.0 0.0 0.9 4.9 0.2 120.0 1.2 0.0 2.7 3.4 47.1 133.5 4.4 3.3 1.6 12.3 0.6 1.3 0.0 0.0 0.4 0.4 6.7 1.1 2.9 0.4 81.0 3.4 0.0 0.6 22.2 4.6 0.0 1.7 1.0 1.2 163.2 2.0 0.0 3.9 2.0 163.5 0.0 0.3 18.9 10.7 0.1 0.2 5.1 0.6 3.4 FAM171A1 "C10orf38, FLJ12884" ENSG00000148468 "Family with sequence similarity 171 member A1" Q5VUB5 10 15211643-15371062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.9" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 104.4;Ito cells: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.6;MAIT T-cell: 6.8;memory CD4 T-cell: 3.8;memory CD8 T-cell: 3.3;naive CD4 T-cell: 7.4;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 23 "T-cells: 7.4" "Cell line enhanced" "Detected in many" "TIME: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051345 Approved Approved "Nucleoplasm,Plasma membrane" NA NA 96000 "Plasma membrane" Nucleoplasm "HPA051345: AB_2681449" "unprognostic (3.60e-2)" "unprognostic (7.15e-2)" "unprognostic (2.21e-1)" "unprognostic (5.28e-2)" "unprognostic (1.57e-1)" "unprognostic (4.11e-2)" "unprognostic (9.84e-2)" "unprognostic (9.19e-2)" "unprognostic (2.28e-1)" "unprognostic (3.97e-2)" "unprognostic (3.09e-2)" "unprognostic (1.87e-1)" "prognostic favorable (2.71e-5)" "unprognostic (3.08e-1)" "unprognostic (1.86e-1)" "prognostic unfavorable (4.90e-6)" "unprognostic (3.28e-2)" 6.9 3.7 22.1 5.5 37.9 0.2 4.6 11.1 31.8 8.8 16.1 25.3 6.5 13.7 9.7 4.8 4.7 11.8 9.3 7.0 24.1 17.5 17.8 6.2 5.3 3.7 25.1 14.3 10.9 13.8 8.9 1.9 2.9 21.5 8.4 12.9 2.5 10.0 9.4 5.1 2.4 8.9 9.0 43.9 8.5 10.3 2.4 21.9 0.6 4.3 1.1 4.6 6.0 6.2 0.0 0.0 0.0 0.0 0.3 7.4 1.3 0.0 6.3 13.0 5.0 5.3 10.1 0.1 7.9 1.5 4.0 3.5 1.1 7.4 0.0 9.6 20.5 9.1 0.6 9.3 0.1 4.5 2.6 14.6 18.4 2.0 18.2 5.8 0.0 14.9 7.9 1.9 10.9 1.6 14.6 20.0 2.7 7.2 0.0 12.7 0.5 3.1 0.0 12.5 3.5 3.5 12.4 6.9 1.9 5.0 0.0 9.0 11.5 4.4 0.1 0.0 14.5 0.0 0.2 42.6 5.5 23.2 19.9 8.3 2.7 0.7 0.0 12.2 0.0 4.2 0.0 0.0 0.0 2.6 0.0 6.8 0.0 3.8 3.3 0.0 0.0 7.4 3.7 0.0 0.3 0.0 0.0 0.7 1.3 22.1 37.9 11.1 23.1 24.1 17.5 25.1 14.3 21.5 21.9 0.0 0.0 0.0 3.3 1.1 3.8 5.1 104.4 2.7 2.3 14.0 0.0 0.1 3.3 17.1 0.6 18.9 12.0 0.0 10.5 0.1 8.9 13.8 1.1 18.3 0.3 6.4 20.2 41.1 4.4 1.0 4.9 0.0 1.7 1.0 25.9 1.5 15.9 8.6 5.3 4.1 1.1 0.0 6.2 2.3 3.5 1.6 0.1 1.3 31.1 2.1 FAM178B LOC51252 ENSG00000168754 "Family with sequence similarity 178 member B" Q8IXR5 2 96875882-96986592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.2;lymphoid tissue: 13.3;testis: 29.5" "Cell type enhanced" "Detected in some" 17 "Extravillous trophoblasts: 6.9;Late spermatids: 5.1;Spermatogonia: 19.4" "Cancer enriched" "Detected in many" 5 "melanoma: 8.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;naive CD4 T-cell: 2.6" "Lineage enhanced" "Detected in single" "T-cells: 2.6" "Cell line enhanced" "Detected in some" "K-562: 17.5;OE19: 4.8;RH-30: 4.8;RPMI-8226: 19.1;WM-115: 19.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042516, HPA062110" Uncertain Uncertain "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA042516: AB_10806241, HPA062110: " "unprognostic (2.47e-2)" "unprognostic (1.76e-1)" "unprognostic (1.08e-2)" "unprognostic (8.04e-4)" "unprognostic (1.39e-1)" "unprognostic (1.28e-2)" "unprognostic (9.02e-4)" "unprognostic (4.70e-2)" "unprognostic (8.55e-2)" "unprognostic (6.49e-3)" "unprognostic (1.49e-1)" "unprognostic (5.13e-2)" "unprognostic (9.82e-11)" "unprognostic (6.93e-2)" "unprognostic (1.57e-1)" "unprognostic (9.63e-3)" "unprognostic (1.08e-1)" 0.8 0.0 2.4 0.6 3.8 18.2 0.6 1.0 1.5 0.6 1.0 0.6 0.6 0.1 0.7 6.8 0.6 1.5 0.6 0.6 3.4 1.9 0.6 0.6 0.6 0.6 5.3 0.6 0.6 0.6 0.0 0.6 1.1 0.6 0.6 0.2 1.0 0.6 1.0 0.6 1.2 0.6 0.6 8.5 13.3 0.0 29.5 0.6 0.6 0.6 0.6 0.6 1.0 0.6 0.0 0.8 0.0 0.0 0.1 2.6 0.6 4.2 0.0 0.0 1.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.4 1.7 0.0 0.0 0.1 4.8 0.0 0.0 4.8 19.1 0.0 0.0 0.6 0.0 0.0 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 19.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 1.7 0.0 0.1 0.0 0.8 0.0 0.6 2.4 3.8 1.0 1.5 3.4 1.9 5.3 0.6 0.6 0.6 0.0 0.0 0.8 0.6 0.7 0.1 0.3 0.0 0.0 0.0 0.0 2.0 2.7 0.0 0.0 2.4 0.0 0.0 0.0 0.0 6.9 1.4 0.2 0.0 0.0 1.1 1.6 0.0 0.6 0.0 5.1 0.9 0.3 3.3 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 1.7 19.4 1.5 2.1 0.0 0.0 0.1 FAM205A C9orf144B ENSG00000205108 "Family with sequence similarity 205 member A" Q6ZU69 9 34723055-34729467 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 243 "testis: 24.3" "Cell type enriched" "Detected in some" 6 "Early spermatids: 99.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;THP-1: 2.3" HPA071267 Enhanced Uncertain "Nucleoli fibrillar center,Plasma membrane" NA NA "Plasma membrane" "Nucleoli fibrillar center" "HPA071267: AB_2686376" "unprognostic (2.25e-1)" "unprognostic (3.66e-3)" "unprognostic (6.29e-3)" "unprognostic (1.90e-1)" "unprognostic (2.73e-3)" "unprognostic (7.82e-2)" "unprognostic (9.61e-2)" "unprognostic (6.41e-2)" "unprognostic (4.78e-1)" "unprognostic (7.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 FAM20B "GXK1, KIAA0475" ENSG00000116199 "FAM20B, glycosaminoglycan xylosylkinase" O75063 1 179025804-179076562 "Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007409 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA 280000 "Golgi apparatus" Nucleoplasm "HPA007409: AB_10601649" "unprognostic (7.58e-2)" "unprognostic (1.12e-1)" "unprognostic (4.97e-2)" "unprognostic (6.23e-3)" "unprognostic (3.29e-1)" "unprognostic (3.07e-1)" "unprognostic (4.76e-2)" "unprognostic (7.70e-3)" "unprognostic (7.85e-2)" "unprognostic (3.93e-2)" "unprognostic (5.36e-2)" "unprognostic (1.58e-1)" "unprognostic (3.76e-1)" "unprognostic (2.03e-1)" "unprognostic (1.76e-1)" "unprognostic (3.67e-2)" "unprognostic (3.74e-1)" 18.2 21.3 17.7 12.8 20.9 8.8 26.0 16.1 26.4 15.8 20.8 10.8 13.3 8.7 18.5 14.7 17.5 14.7 17.3 32.9 17.1 17.2 16.2 14.8 14.6 9.1 16.1 19.9 19.0 10.1 22.5 16.9 15.2 15.2 15.6 13.4 14.5 9.9 18.8 19.0 11.4 10.6 25.9 13.6 10.5 14.4 6.8 9.4 7.3 16.5 7.7 9.4 17.6 28.7 4.9 3.6 2.3 2.3 4.4 4.1 1.5 17.9 16.5 12.8 13.5 22.9 24.2 14.2 15.0 17.2 10.6 9.5 8.2 18.0 9.3 19.8 26.4 8.7 13.2 13.0 11.0 15.6 11.8 8.8 29.7 15.6 10.4 11.4 19.6 18.8 14.0 12.1 14.4 11.2 16.2 13.0 13.1 33.0 13.7 16.9 10.0 8.5 7.1 16.8 20.3 3.5 10.5 13.5 12.4 8.9 20.4 17.1 42.1 15.8 18.0 15.3 19.0 15.5 14.4 13.7 16.9 14.9 23.2 20.2 11.2 20.4 8.2 16.8 9.6 16.7 2.3 2.0 0.6 3.8 1.7 4.1 4.2 2.4 3.5 2.2 4.9 3.5 3.2 1.9 4.4 2.3 3.6 2.7 1.5 17.7 20.9 16.1 26.4 17.1 17.2 16.1 19.9 15.2 9.4 6.0 10.7 11.2 8.9 13.9 12.3 31.9 17.8 8.1 7.9 17.4 23.6 8.0 3.3 8.2 4.2 11.2 4.1 0.0 11.0 5.7 12.4 14.8 16.2 12.2 6.9 36.5 13.8 10.4 8.9 2.5 16.4 6.9 15.1 10.0 7.6 7.8 11.0 0.0 20.1 5.4 20.2 12.9 20.3 12.9 15.8 11.3 6.3 6.9 6.6 23.8 FAM20C "DKFZp547D065, DMP4, G-CK, IMAGE:4942737" ENSG00000177706 "FAM20C, golgi associated secretory pathway kinase" Q8IXL6 7 192969-260745 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" Biomineralization "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 80.6" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 52.4;Hepatocytes: 80.0;Hofbauer cells: 49.0;Peritubular cells: 53.0;Proximal tubular cells: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HSkMC: 50.3;hTERT-RPE1: 39.1;U-87 MG: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019823 Approved "Nucleoplasm,Golgi apparatus" "Secreted in other tissues" NA NA 160000000 "Golgi apparatus" Nucleoplasm "HPA019823: AB_1848389" "unprognostic (1.94e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (3.15e-2)" "unprognostic (1.03e-2)" "unprognostic (3.33e-3)" "unprognostic (2.47e-2)" "unprognostic (7.86e-2)" "unprognostic (2.45e-3)" "unprognostic (3.35e-2)" "prognostic unfavorable (9.40e-6)" "unprognostic (1.97e-3)" "unprognostic (2.49e-1)" "unprognostic (3.08e-3)" "unprognostic (1.94e-2)" "unprognostic (3.92e-2)" "unprognostic (2.16e-2)" "unprognostic (3.83e-3)" 27.5 10.2 10.8 19.3 16.6 3.3 25.6 7.4 14.9 8.3 20.1 13.5 15.1 12.9 9.5 6.9 11.1 9.7 15.0 15.0 8.8 7.2 31.8 31.6 12.7 5.1 16.9 5.6 11.8 14.8 2.6 9.2 7.2 15.8 15.0 4.6 8.8 80.6 11.8 20.4 6.8 16.5 17.0 17.0 6.9 20.0 5.9 14.8 0.4 9.6 8.4 4.4 20.5 17.5 0.0 0.6 0.0 1.6 0.2 0.0 0.0 13.3 6.5 0.2 9.3 11.9 19.7 0.0 11.9 20.2 6.5 5.2 0.7 8.2 0.0 6.6 17.8 8.8 11.6 1.0 0.5 1.6 2.8 0.6 0.0 3.1 3.5 9.0 0.0 0.9 50.3 1.5 0.2 0.7 39.1 4.5 0.0 0.0 0.1 1.7 1.8 0.0 0.7 6.3 0.1 0.4 1.5 0.3 0.0 4.8 0.0 3.1 0.1 12.4 0.0 1.8 1.2 8.8 6.1 12.5 8.1 4.0 6.9 3.6 0.0 0.0 0.0 31.0 0.8 23.1 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.8 16.6 7.4 14.9 8.8 7.2 16.9 5.6 15.8 14.8 6.0 3.2 2.4 1.9 9.0 20.6 8.1 33.1 5.3 0.0 52.4 0.0 0.5 5.0 1.3 0.0 2.4 3.5 0.0 4.1 0.6 13.5 6.8 3.5 80.0 49.0 1.6 11.3 9.8 15.6 1.1 15.0 14.7 1.7 11.8 4.2 16.6 6.5 3.5 53.0 46.8 8.0 12.9 15.3 0.2 0.7 7.0 0.5 0.0 7.3 1.4 FAM212B "C1orf183, FLJ31105, INKA2" ENSG00000284755 "Family with sequence similarity 212 member B" 1 111722064-111755824 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.4" "Group enriched" "Detected in many" 5 "Early spermatids: 52.0;Late spermatids: 39.5;Sertoli cells: 32.3" "Cell type enriched" "Detected in single" 5 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 5 "NK-cells: 3.4" "Cell line enhanced" "Detected in some" "AF22: 2.5;HHSteC: 3.7;HSkMC: 2.9;LHCN-M2: 3.5;SuSa: 3.5;THP-1: 2.5;U-87 MG: 2.5" "HPA027810, HPA027811" Uncertain Uncertain Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Vesicles" Nucleoli "HPA027810: , HPA027811: AB_10600872" 0.1 0.3 0.1 0.4 2.8 0.2 0.1 0.1 1.7 0.1 0.2 1.5 0.1 0.3 1.7 2.0 0.1 0.0 0.3 0.4 0.1 0.7 0.1 0.5 0.2 0.1 0.1 0.1 1.0 0.0 0.1 1.0 1.6 0.8 1.3 0.1 0.1 1.2 0.1 0.0 1.0 2.5 2.6 2.2 0.0 0.7 1.2 2.6 0.8 0.1 0.1 1.9 0.1 0.1 0.2 0.7 0.1 3.4 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 3.7 1.5 0.0 2.9 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 3.5 1.3 0.5 1.9 1.8 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.8 3.5 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 2.5 2.2 0.0 0.7 0.0 0.0 0.2 0.0 0.2 0.1 0.5 0.3 0.0 0.1 0.3 0.3 0.0 3.4 0.1 0.2 0.2 0.0 0.0 0.0 0.5 3.1 6.2 6.2 0.0 0.0 2.7 0.0 0.0 7.9 0.0 0.0 0.0 52.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 6.9 1.3 2.8 39.5 2.0 2.0 6.8 0.0 4.6 1.2 0.0 1.1 5.3 0.0 5.9 32.3 6.1 4.2 2.1 3.4 0.0 0.0 0.9 0.6 FAM213B "C1orf93, MGC26818" ENSG00000157870 "Family with sequence similarity 213 member B" Q8TBF2 1 2586491-2591469 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 26.7;U-2197: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006403 Approved Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA006403: AB_1853870" "unprognostic (1.81e-2)" "unprognostic (2.25e-1)" "unprognostic (2.03e-1)" "unprognostic (2.83e-1)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.20e-1)" "unprognostic (8.76e-2)" "unprognostic (3.09e-2)" "unprognostic (1.24e-3)" "unprognostic (2.76e-1)" "prognostic favorable (1.28e-4)" "unprognostic (5.22e-3)" "unprognostic (2.03e-1)" "unprognostic (7.91e-3)" "unprognostic (2.20e-2)" 6.0 9.1 14.7 5.7 14.9 3.8 4.6 7.4 20.0 7.9 15.4 6.2 5.2 22.0 4.5 6.7 5.7 10.5 23.7 3.2 15.0 15.5 7.4 3.5 6.0 5.8 11.7 11.0 7.1 4.6 4.4 4.3 8.4 10.7 5.7 7.4 9.0 5.3 7.7 1.8 6.1 20.2 4.8 6.5 7.4 11.7 3.3 4.7 5.4 5.2 0.9 5.2 6.3 3.5 2.1 2.2 1.5 2.3 7.5 6.3 3.2 7.7 4.3 4.4 4.8 2.1 2.4 0.6 7.0 2.9 6.6 2.9 3.1 9.1 2.0 7.1 4.5 2.7 6.5 3.9 4.9 2.2 5.8 2.0 4.8 3.3 4.9 5.1 2.7 1.4 3.5 2.5 4.6 1.7 3.1 9.3 3.6 6.5 3.1 6.6 5.6 6.3 1.2 5.3 9.0 16.6 6.9 6.5 5.1 6.9 3.9 5.9 9.8 6.0 26.7 8.0 1.1 4.6 1.0 13.5 5.8 6.7 22.9 2.6 2.9 4.3 1.4 5.4 9.2 1.1 1.5 2.0 1.1 3.8 2.3 6.3 2.1 4.2 4.1 2.2 1.5 3.5 5.4 1.5 7.5 2.0 1.0 5.6 3.2 14.7 14.9 7.4 20.0 15.0 15.5 11.7 11.0 10.7 4.7 3.0 1.7 3.9 4.5 3.7 11.0 4.5 12.7 10.7 6.8 33.2 0.0 0.4 6.6 24.6 0.6 11.6 37.6 0.0 8.8 0.4 4.0 3.7 0.0 2.6 8.0 22.3 15.1 12.3 4.9 1.1 4.9 7.6 6.8 8.2 25.7 6.0 31.4 38.2 3.9 11.8 5.2 19.4 8.1 0.9 11.1 4.5 0.6 6.9 32.8 7.0 FAM227A ENSG00000184949 "Family with sequence similarity 227 member A" F5H4B4 22 38578120-38656629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 26.2;testis: 15.6" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 80.3;Cone photoreceptor cells: 37.3;Early spermatids: 62.3;Late spermatids: 43.0;Rod photoreceptor cells: 33.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HDLM-2: 11.4;Karpas-707: 21.5" HPA003077 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA003077: AB_1079264" "unprognostic (7.52e-2)" "unprognostic (3.06e-2)" "unprognostic (1.63e-1)" "unprognostic (8.14e-2)" "unprognostic (5.85e-2)" "unprognostic (2.91e-3)" "unprognostic (4.79e-5)" "unprognostic (5.91e-2)" "unprognostic (3.04e-2)" "unprognostic (4.04e-2)" "unprognostic (1.85e-2)" "unprognostic (4.62e-2)" "unprognostic (6.46e-6)" "unprognostic (3.74e-1)" "unprognostic (3.47e-2)" "unprognostic (2.65e-3)" "unprognostic (1.35e-2)" 0.5 1.2 4.7 0.9 7.0 1.5 2.8 0.9 3.1 2.6 0.8 5.0 5.5 0.7 2.3 7.8 0.7 9.3 2.2 0.8 4.2 3.4 2.0 0.5 2.4 0.7 1.9 2.5 1.6 1.5 2.3 26.2 0.6 6.7 1.5 1.0 2.7 1.1 1.8 0.5 2.4 0.6 1.5 0.9 0.7 1.3 15.6 3.0 0.8 3.5 0.1 0.6 1.1 0.7 1.4 1.0 2.3 0.7 1.0 1.3 0.3 0.4 1.2 1.8 2.4 0.4 1.2 0.4 0.2 0.2 0.3 0.2 0.0 1.1 0.2 0.5 0.2 0.5 1.1 0.8 0.2 0.4 11.4 1.1 0.1 3.3 0.2 0.2 0.5 0.5 0.6 0.7 1.3 0.4 1.8 0.2 1.6 0.4 21.5 0.1 0.5 0.5 0.5 0.8 0.2 0.7 1.1 0.1 0.6 0.8 0.3 2.3 0.6 1.5 0.1 0.1 0.7 1.4 0.2 0.4 0.6 0.5 0.5 0.1 2.0 1.0 0.1 0.8 0.2 0.3 2.0 0.7 0.7 0.7 0.6 0.5 0.8 0.7 0.6 0.3 1.4 0.9 1.3 2.3 1.0 0.6 1.0 0.7 0.3 4.7 7.0 0.9 3.1 4.2 3.4 1.9 2.5 6.7 3.0 3.0 1.6 0.0 2.3 2.2 5.7 1.6 5.1 80.3 10.3 5.2 37.3 0.2 0.0 2.9 62.3 1.4 0.0 0.0 2.2 0.2 1.9 2.1 0.0 0.0 0.2 4.8 4.6 0.6 0.0 43.0 2.0 1.0 0.0 0.0 0.4 12.4 1.8 0.0 1.1 0.9 33.1 0.0 1.0 15.4 13.8 3.0 0.1 0.0 1.2 1.4 FAM234A "C16orf9, DKFZP761D0211, FLJ32603, ITFG3" ENSG00000167930 "Family with sequence similarity 234 member A" Q9H0X4 16 234546-268971 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria NA NA 3700000 Mitochondria Nucleoplasm "HPA011651: , HPA071871: AB_2732188" "unprognostic (1.00e-1)" "unprognostic (1.85e-2)" "unprognostic (3.49e-1)" "unprognostic (4.80e-2)" "unprognostic (5.51e-2)" "unprognostic (2.03e-1)" "unprognostic (1.54e-2)" "unprognostic (2.55e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.16e-1)" "unprognostic (3.28e-2)" "unprognostic (2.23e-1)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (3.68e-1)" 20.2 19.1 11.3 11.7 24.3 6.4 16.5 12.2 16.2 11.6 20.3 56.0 13.7 36.3 17.4 12.6 26.4 14.0 16.0 31.1 8.3 7.3 18.3 15.6 11.4 10.5 39.8 9.0 13.4 29.6 24.3 19.2 15.4 37.8 16.8 12.4 15.5 14.1 15.4 51.4 14.9 26.8 29.0 42.0 9.7 18.8 13.0 27.2 7.2 16.6 16.2 6.3 19.0 11.7 10.3 17.8 12.5 17.4 14.2 11.5 12.5 9.0 18.7 23.4 54.2 36.4 21.7 12.3 22.0 27.9 13.4 17.3 18.9 26.1 8.2 35.8 27.7 11.9 18.3 7.4 13.2 11.2 11.3 13.1 11.5 11.7 15.2 22.2 6.1 6.9 22.5 20.5 18.9 15.5 37.1 21.6 10.8 12.7 2.1 14.5 37.2 6.9 6.8 29.5 13.2 9.5 20.9 16.5 40.8 23.1 8.8 29.7 24.0 35.6 20.9 18.6 20.5 26.7 10.6 21.5 28.3 8.3 15.1 6.7 5.0 2.0 10.8 19.9 9.8 38.5 11.3 17.4 12.5 10.8 16.9 5.6 8.0 9.6 10.2 17.8 10.3 11.1 11.5 7.6 14.2 16.5 6.3 9.3 12.5 11.3 24.3 12.2 16.2 8.3 7.3 39.8 9.0 37.8 27.2 8.9 13.0 2.2 9.1 0.0 8.6 0.0 10.2 12.0 9.1 29.6 23.6 49.9 6.6 41.4 21.8 13.9 34.2 0.0 23.0 42.1 9.7 12.0 8.1 19.8 22.9 9.5 33.9 20.9 14.5 52.2 15.5 11.9 0.0 57.7 30.3 9.3 17.1 51.6 20.5 15.1 11.9 19.4 0.0 16.4 28.1 0.0 55.4 6.9 42.9 9.8 FAM47E-STBD1 ENSG00000272414 "FAM47E-STBD1 readthrough" 4 76251721-76311129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 38.2;skeletal muscle: 41.3" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 1.7;Ciliated cells: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 17.1;Karpas-707: 23.8" HPA053331 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA053331: AB_2682115" "unprognostic (3.52e-3)" "unprognostic (3.44e-1)" "unprognostic (1.53e-1)" "unprognostic (8.98e-2)" "unprognostic (5.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-1)" "unprognostic (2.51e-2)" "unprognostic (1.91e-1)" "unprognostic (6.92e-6)" "unprognostic (5.59e-2)" "unprognostic (1.52e-1)" "unprognostic (3.77e-1)" 17.4 2.3 7.8 1.6 8.0 4.0 7.6 1.9 13.9 2.5 8.2 8.6 4.1 2.1 3.0 7.3 3.5 5.0 4.2 16.5 9.4 3.9 4.2 38.2 7.5 0.6 5.4 14.6 2.6 4.6 2.8 9.2 9.4 11.4 6.3 9.0 2.5 5.0 5.0 41.3 1.6 10.7 6.5 9.6 1.6 3.7 6.1 5.8 0.0 8.1 1.3 0.9 4.9 2.5 0.2 1.0 2.2 1.5 3.4 1.6 0.4 2.0 2.4 1.0 2.1 17.1 5.8 2.2 3.4 7.1 2.9 3.0 4.0 2.2 0.0 2.1 8.1 7.9 1.1 3.5 1.4 2.7 2.6 0.5 0.8 4.8 5.7 1.8 1.7 2.4 2.5 9.0 2.8 3.6 11.1 0.3 0.0 0.2 23.8 7.0 3.7 0.0 1.8 1.0 13.2 1.6 0.0 0.5 1.5 3.3 6.0 1.0 4.2 1.5 4.7 0.1 2.2 0.9 1.0 0.9 1.5 0.7 3.8 2.9 5.7 2.6 0.0 4.2 1.8 1.3 0.0 0.5 2.2 1.1 1.5 0.6 0.2 1.1 1.2 0.9 0.1 0.9 1.3 1.3 3.4 0.1 1.0 1.6 0.4 7.8 8.0 1.9 13.9 9.4 3.9 5.4 14.6 11.4 5.8 6.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM71F1 "FAM137A, NYD-SP18" ENSG00000135248 "Family with sequence similarity 71 member F1" Q96KD3 7 128709061-128731743 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 146 "testis: 64.8" "Group enriched" "Detected in some" 103 "Early spermatids: 1001.4;Late spermatids: 1429.0" "Cancer enriched" "Detected in single" 23 "testis cancer: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "NTERA-2: 19.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA020636 Uncertain Cytosol No NA Cytosol "HPA020636: AB_1854739" "unprognostic (3.09e-2)" "unprognostic (3.39e-3)" "unprognostic (6.03e-2)" "unprognostic (5.25e-1)" "unprognostic (2.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-2)" "unprognostic (2.17e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-5)" "unprognostic (1.48e-1)" "unprognostic (2.18e-6)" "unprognostic (6.97e-2)" "unprognostic (2.09e-1)" "unprognostic (2.19e-3)" "unprognostic (1.99e-1)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 64.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 1.5 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1001.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1429.0 11.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.3 0.0 1.8 0.0 0.0 11.7 5.5 0.1 1.0 0.0 0.0 0.0 FAM78A "C9orf59, FLJ00024" ENSG00000126882 "Family with sequence similarity 78 member A" Q5JUQ0 9 131258076-131276547 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.7;skeletal muscle: 32.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 57.8;Early spermatids: 73.4;Late spermatids: 101.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 18.5;HEL: 17.4;HL-60: 17.2;NB-4: 27.2;THP-1: 24.3;U-937: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021472, HPA023914" Uncertain Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "HPA021472: AB_1848411, HPA023914: AB_1848412" "unprognostic (5.16e-2)" "prognostic favorable (3.67e-4)" "unprognostic (3.65e-2)" "unprognostic (2.07e-2)" "unprognostic (2.71e-1)" "prognostic favorable (2.00e-4)" "unprognostic (3.24e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-2)" "unprognostic (5.83e-1)" "unprognostic (5.84e-2)" "unprognostic (6.79e-2)" "unprognostic (1.59e-3)" "unprognostic (2.61e-3)" "unprognostic (7.42e-2)" "unprognostic (2.61e-2)" "unprognostic (2.39e-1)" 4.9 1.5 2.9 9.3 4.6 12.4 2.5 1.1 4.3 1.0 1.6 3.4 0.8 1.8 1.2 1.1 1.1 1.1 2.0 19.2 3.8 2.0 2.1 2.5 8.0 18.4 4.3 1.0 1.8 0.8 0.8 1.0 5.8 3.2 1.3 1.1 5.4 2.7 0.7 32.3 0.8 6.1 1.2 3.6 15.9 2.3 20.1 2.4 23.7 1.5 1.8 15.0 3.1 0.8 14.4 5.2 14.5 10.9 2.5 10.5 6.9 0.3 0.1 1.1 2.6 0.8 0.2 18.5 0.2 0.1 0.2 0.1 0.1 0.1 7.7 0.1 0.1 0.3 0.0 7.4 0.1 0.0 1.9 0.6 17.4 0.2 0.1 0.3 17.2 0.8 0.2 0.4 0.0 0.0 0.2 10.3 5.0 6.1 2.2 0.2 2.6 0.7 27.2 1.2 0.1 0.3 1.8 1.1 10.7 0.1 0.0 0.7 0.9 1.0 0.3 1.0 0.4 0.6 24.3 0.3 1.1 1.2 0.6 0.0 1.6 0.8 4.4 0.1 16.3 0.2 0.4 8.6 14.5 8.6 10.9 6.8 12.5 8.3 9.3 5.2 14.4 10.5 8.7 8.8 2.5 8.1 2.4 8.2 6.9 2.9 4.6 1.1 4.3 3.8 2.0 4.3 1.0 3.2 2.4 0.0 1.0 24.3 0.0 0.8 57.8 12.8 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 73.4 3.1 0.0 0.0 0.0 28.2 1.3 0.0 1.1 0.0 22.1 0.0 0.0 3.7 14.3 101.2 4.6 10.1 1.7 5.4 0.0 0.8 0.2 0.0 3.2 0.0 1.7 0.0 0.5 1.2 0.4 0.6 1.1 14.4 0.0 0.1 FAM86B1 MGC16279 ENSG00000186523 "Family with sequence similarity 86 member B1" Q8N7N1 8 12182096-12194133 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.5" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 10.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 5.8" "HPA041610, HPA055718" Uncertain Uncertain Vesicles NA NA Vesicles "HPA041610: AB_2677581, HPA055718: AB_2682895" "unprognostic (1.90e-2)" "unprognostic (8.67e-2)" "unprognostic (2.79e-1)" "unprognostic (3.74e-2)" "unprognostic (3.13e-3)" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (1.74e-1)" "unprognostic (5.68e-2)" "unprognostic (1.91e-2)" "unprognostic (1.32e-1)" "unprognostic (6.69e-2)" "unprognostic (8.00e-3)" "unprognostic (2.66e-2)" "unprognostic (1.58e-1)" "unprognostic (7.02e-2)" "unprognostic (2.58e-2)" 0.9 2.0 3.2 1.0 6.9 1.2 0.7 4.8 7.5 0.8 0.5 2.2 4.0 1.3 1.2 2.8 1.3 1.1 3.3 4.1 1.3 0.1 1.2 0.7 2.8 5.0 0.9 2.0 5.4 0.3 2.6 0.0 2.4 1.0 2.0 3.0 0.7 0.1 2.3 1.4 0.3 0.6 2.6 0.0 0.8 1.1 0.2 0.6 0.9 0.1 0.0 0.8 0.2 0.5 2.9 0.0 5.8 0.0 0.7 2.5 4.7 0.3 1.1 0.7 1.6 1.3 1.0 0.2 0.2 1.1 4.9 1.0 0.8 0.8 0.5 0.8 0.2 0.7 0.8 3.1 2.0 2.2 0.3 0.5 0.5 1.4 1.3 0.2 2.4 1.6 1.6 0.2 2.7 0.0 1.3 1.9 0.6 0.5 1.5 1.0 0.7 0.3 1.3 4.7 1.0 0.9 0.5 0.6 0.4 2.2 0.0 0.0 1.0 0.9 4.0 1.6 0.6 1.4 0.6 0.8 0.1 0.8 0.8 0.1 0.7 0.1 0.0 0.7 0.2 0.8 0.5 0.3 0.0 0.6 0.7 0.9 0.0 0.0 0.6 0.4 0.2 3.0 2.6 0.8 2.5 1.0 2.6 0.4 5.1 10.7 4.5 1.8 2.0 1.3 5.0 3.9 4.4 1.1 0.5 0.0 1.6 1.2 2.9 2.2 1.1 0.8 1.9 1.6 4.1 1.8 1.9 4.0 1.7 1.1 3.3 0.0 1.2 2.3 2.9 0.0 2.5 6.8 1.2 0.0 2.1 0.9 0.7 1.1 0.9 0.0 2.0 1.3 FAM86B2 ENSG00000145002 "Family with sequence similarity 86 member B2" P0C5J1 8 12425614-12436343 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 4.6" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 3.0;Early spermatids: 1.2;Late spermatids: 3.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "hTERT-HME1: 6.3;RPMI-8226: 18.5" "HPA041610, HPA055718" Uncertain Uncertain Vesicles NA NA Vesicles "HPA041610: AB_2677581, HPA055718: AB_2682895" "unprognostic (3.75e-2)" "unprognostic (1.87e-1)" "unprognostic (6.57e-2)" "unprognostic (1.01e-1)" "unprognostic (3.26e-2)" "unprognostic (2.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.48e-1)" "unprognostic (3.82e-1)" "unprognostic (3.24e-1)" "unprognostic (6.04e-4)" "unprognostic (9.37e-2)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.62e-1)" "unprognostic (1.37e-1)" "unprognostic (2.13e-2)" 0.4 0.9 0.2 0.4 0.7 0.0 0.8 0.2 0.3 0.8 0.8 0.4 1.0 0.0 3.9 4.6 0.7 0.1 0.2 0.5 1.1 0.5 0.6 0.1 0.2 1.3 1.1 0.6 2.2 0.1 0.6 0.6 0.5 1.8 0.3 1.2 0.0 0.6 0.0 0.0 0.4 0.1 3.4 0.1 1.0 0.6 0.4 1.3 0.0 0.9 0.6 2.1 0.3 0.2 1.3 0.2 0.0 0.3 1.5 1.5 0.3 0.7 0.5 1.3 0.5 1.3 0.8 0.0 1.5 0.3 0.2 1.1 1.8 0.0 0.0 0.0 0.2 1.8 0.0 1.2 0.0 0.0 0.4 1.5 1.4 6.3 0.1 0.0 0.0 1.3 0.2 0.1 0.4 0.0 0.4 1.2 2.2 0.4 0.2 0.7 18.5 0.0 1.2 1.9 0.0 0.5 1.4 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.5 0.4 0.9 1.1 1.3 0.4 0.4 0.3 0.0 0.6 0.9 0.0 2.1 0.3 3.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FAM9B TEX39B ENSG00000177138 "Family with sequence similarity 9 member B" Q8IZU0 X 9024232-9164639 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.4;liver: 3.7;testis: 11.4" "Group enriched" "Detected in some" 7 "Spermatocytes: 32.2;Spermatogonia: 62.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.4" "Group enriched" "Detected in some" 49 "U-266/70: 21.2;U-266/84: 22.8" HPA035135 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA035135: AB_10669999" "unprognostic (3.95e-1)" "unprognostic (4.49e-1)" "unprognostic (3.76e-2)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.40e-2)" "unprognostic (2.62e-1)" "unprognostic (6.08e-10)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" 0.1 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.2 0.1 2.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.5 0.5 0.1 0.0 1.1 0.2 11.4 0.1 0.0 0.2 0.6 0.8 0.7 3.4 0.7 0.7 0.4 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 21.2 22.8 0.1 0.0 0.1 0.0 1.0 0.7 0.4 0.3 0.3 0.3 0.5 0.4 0.3 0.2 0.8 0.4 0.4 3.4 0.7 0.4 0.7 0.3 0.4 0.0 0.6 0.0 0.2 0.2 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.9 0.2 1.6 0.0 0.6 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 6.5 0.3 32.2 62.0 0.3 0.0 0.0 0.0 0.1 FAN1 "KIAA1018, MTMR15" ENSG00000198690 "FANCD2 and FANCI associated nuclease 1" Q9Y2M0 15 30903852-30943108 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048198 Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA048198: AB_2680311" "unprognostic (7.18e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-1)" "unprognostic (3.30e-2)" "unprognostic (6.99e-2)" "unprognostic (2.86e-1)" "unprognostic (1.97e-1)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (3.53e-2)" "unprognostic (3.53e-2)" "unprognostic (9.67e-2)" "prognostic favorable (1.42e-6)" "unprognostic (3.73e-1)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" "unprognostic (1.29e-1)" 5.9 8.9 11.6 6.9 17.4 6.3 12.7 19.6 18.4 15.0 11.4 17.7 11.9 4.6 11.6 22.9 6.5 8.5 8.5 13.0 12.6 11.0 14.7 14.4 6.9 5.5 18.5 11.8 12.5 18.2 7.2 17.0 10.6 15.4 16.4 9.7 8.6 17.3 8.3 16.8 9.3 6.7 11.5 13.0 7.3 8.5 9.4 15.0 5.1 14.3 6.3 5.8 9.0 9.1 4.0 3.6 0.6 1.7 4.5 5.4 1.6 6.3 10.9 3.6 2.0 12.9 11.5 2.4 4.5 1.9 4.8 5.0 7.5 3.3 1.4 8.0 4.8 10.0 12.9 6.1 9.4 4.7 5.1 2.9 1.1 11.2 1.3 5.6 0.9 6.1 3.4 7.0 2.9 7.6 10.4 2.3 6.6 5.4 10.0 7.8 1.4 9.9 4.4 2.8 10.2 2.5 8.4 11.8 2.7 7.0 5.0 8.3 5.8 9.9 6.8 3.5 13.6 6.1 7.6 8.2 15.0 3.6 4.1 5.7 13.8 9.6 1.7 6.5 4.8 1.3 0.1 0.8 0.6 3.7 1.3 4.7 2.8 3.5 1.7 2.7 4.0 5.4 2.8 0.3 4.5 1.7 3.6 3.2 1.6 11.6 17.4 19.6 18.4 12.6 11.0 18.5 11.8 15.4 15.0 14.9 9.6 0.8 4.9 3.7 20.0 15.7 0.0 16.0 13.6 8.7 19.6 5.5 8.3 3.3 8.7 6.7 3.8 0.0 2.5 1.8 3.5 4.6 8.1 11.0 3.2 25.4 7.5 8.0 4.1 5.8 9.8 4.1 5.0 2.8 9.7 14.7 3.3 2.9 6.3 5.1 24.3 6.5 4.2 19.5 12.9 2.0 3.4 6.9 8.3 3.1 FANCD2 "FA-D2, FACD, FAD, FANCD" ENSG00000144554 "Fanconi anemia complementation group D2" Q9BXW9 3 10026414-10101930 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 24.4;testis: 23.3" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 46.7;Spermatocytes: 55.1;Spermatogonia: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 46.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB016117, HPA063742" Approved Supported "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" No No Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB016117: AB_2278211, HPA063742: AB_2685110" "unprognostic (3.25e-2)" "unprognostic (1.09e-1)" "unprognostic (6.21e-2)" "unprognostic (1.12e-2)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (1.08e-5)" "unprognostic (2.96e-2)" "unprognostic (1.59e-3)" "prognostic unfavorable (5.00e-5)" "unprognostic (1.23e-2)" "unprognostic (9.14e-2)" "unprognostic (4.41e-10)" "unprognostic (9.11e-3)" "unprognostic (3.99e-1)" "unprognostic (7.76e-2)" "unprognostic (2.89e-2)" 2.0 1.3 0.8 10.3 2.6 12.2 2.4 1.6 2.7 1.7 2.9 1.1 1.0 2.2 2.2 1.8 4.7 2.4 2.5 1.1 0.8 0.9 2.3 1.0 2.4 9.5 1.3 1.2 3.5 3.5 0.6 1.1 5.3 1.4 2.2 4.9 1.6 3.3 0.4 3.0 3.3 6.2 1.2 2.0 7.3 2.4 23.3 1.6 24.4 1.6 5.6 14.6 2.2 2.4 6.8 3.7 5.3 2.6 2.1 2.9 1.0 8.7 9.3 17.8 5.0 0.9 1.4 46.0 8.0 3.6 11.5 9.4 6.9 8.7 17.1 3.8 2.6 9.5 7.6 18.3 6.2 11.5 8.1 12.4 23.3 14.3 6.6 0.1 17.3 14.6 0.4 1.0 13.0 7.2 1.6 6.9 14.7 14.2 19.6 8.7 10.0 14.4 6.7 21.4 6.7 6.5 15.8 14.5 12.1 4.0 9.8 4.9 9.8 9.8 7.7 3.1 13.5 11.8 11.0 4.0 9.6 11.0 5.8 11.6 8.3 16.3 28.9 5.5 17.8 16.3 5.3 1.4 3.7 1.5 1.0 1.3 4.9 2.0 1.2 0.9 6.8 2.5 1.9 3.3 2.1 2.6 3.7 2.9 1.0 0.8 2.6 1.6 2.7 0.8 0.9 1.3 1.2 1.4 1.6 0.0 0.3 9.7 2.8 4.0 2.8 1.6 0.0 1.4 1.2 1.8 9.8 6.6 0.0 1.6 4.4 1.5 0.7 46.7 2.9 12.7 1.3 2.2 1.1 1.0 5.0 0.0 1.2 3.7 3.4 5.6 2.0 5.2 3.3 7.2 2.0 0.8 1.4 2.8 1.4 0.5 5.8 19.4 0.8 55.1 32.4 2.4 5.8 3.8 5.0 2.3 FANCG "FAG, XRCC9" ENSG00000221829 "Fanconi anemia complementation group G" O15287 9 35073835-35080016 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 17.3;Spermatogonia: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008105, HPA045335" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" Nucleoli "CAB008105: AB_2231542, HPA045335: AB_2679292" "unprognostic (9.41e-2)" "unprognostic (2.62e-2)" "unprognostic (1.82e-1)" "unprognostic (1.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.83e-3)" "prognostic unfavorable (2.02e-4)" "unprognostic (8.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.27e-3)" "unprognostic (9.01e-2)" "unprognostic (5.62e-2)" "prognostic unfavorable (2.38e-7)" "unprognostic (1.14e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" 5.8 5.0 4.4 7.1 6.5 14.9 7.5 13.9 8.5 6.2 5.9 5.3 8.4 6.7 6.8 3.2 9.2 8.6 4.7 5.9 7.6 4.0 5.2 4.5 5.1 9.9 8.7 4.4 9.2 17.0 6.7 4.8 7.6 6.6 7.0 5.5 3.5 8.7 9.7 2.9 8.9 6.5 6.4 4.2 8.6 5.8 8.9 7.6 25.6 9.3 4.8 9.2 6.8 6.9 6.8 4.8 8.9 2.5 8.8 9.2 3.4 15.7 19.6 14.4 13.3 3.2 5.1 12.1 11.1 8.0 21.8 21.0 9.3 9.9 15.6 7.7 3.5 15.6 9.7 11.9 10.2 8.4 18.3 7.2 11.2 21.0 5.7 0.9 11.3 12.9 4.2 2.0 19.0 8.6 3.8 11.1 19.2 7.3 21.0 11.0 14.0 19.1 15.6 14.9 11.8 15.1 19.9 16.9 11.0 5.1 6.7 7.0 12.7 7.3 10.4 4.1 6.5 13.5 8.2 6.7 10.4 20.7 13.3 14.9 5.7 10.8 9.4 9.2 8.4 14.2 8.9 0.8 7.7 7.4 2.5 6.5 6.8 6.1 5.7 2.2 6.5 4.8 5.0 1.3 8.8 2.3 4.8 9.2 3.4 4.4 6.5 13.9 8.5 7.6 4.0 8.7 4.4 6.6 7.6 3.0 5.8 5.2 3.6 3.9 4.3 1.0 0.0 0.0 2.3 3.5 3.9 8.2 3.3 3.7 0.3 2.8 1.6 0.0 2.0 17.3 3.8 3.5 13.9 1.0 6.5 4.8 1.7 3.7 0.3 0.4 3.1 2.0 3.3 3.6 3.9 3.5 2.3 3.2 3.9 1.7 3.0 0.0 2.7 10.9 23.7 2.3 5.5 5.3 5.0 3.3 FASTK FAST ENSG00000164896 "Fas activated serine/threonine kinase" Q14296 7 151076593-151080866 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031621, CAB032539" Approved Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "CAB032539: AB_2101115, HPA031621: AB_10611966" "unprognostic (7.67e-2)" "unprognostic (6.41e-3)" "prognostic unfavorable (4.73e-4)" "unprognostic (2.60e-1)" "unprognostic (1.75e-3)" "unprognostic (2.03e-3)" "unprognostic (1.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (4.66e-2)" "prognostic favorable (3.99e-4)" "unprognostic (3.49e-2)" "unprognostic (2.79e-2)" "unprognostic (4.12e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (8.17e-2)" 13.8 16.8 18.8 15.7 19.0 6.4 10.2 19.0 26.4 18.0 20.6 13.4 20.3 21.2 12.4 14.6 20.3 16.7 16.8 35.7 17.6 12.9 17.7 25.6 9.5 10.4 12.0 15.0 14.4 20.7 20.2 21.8 18.5 12.0 16.8 10.6 14.0 21.7 17.9 89.5 14.4 25.8 11.3 9.2 14.9 14.8 10.6 10.9 11.2 16.8 28.1 16.9 17.4 11.8 15.4 26.0 19.7 22.3 13.1 19.0 14.5 15.9 18.6 5.9 14.2 22.1 10.0 9.9 12.8 17.4 10.9 13.1 12.8 13.7 3.8 17.5 17.3 20.1 10.3 5.7 15.3 2.9 10.9 10.2 4.6 4.6 10.8 28.1 3.2 10.5 13.0 22.5 12.6 9.3 8.9 12.8 9.5 6.8 8.0 12.6 31.9 7.8 9.2 9.9 19.8 21.8 5.2 7.1 11.8 14.8 10.9 7.1 7.4 16.9 26.2 17.0 5.3 14.1 12.7 10.4 13.9 3.0 13.0 11.3 21.4 13.0 2.4 27.7 7.2 15.9 10.5 22.3 19.7 16.4 21.7 17.1 13.7 17.3 16.9 19.4 15.4 19.0 16.3 4.8 13.1 20.8 26.0 18.7 14.5 18.8 19.0 19.0 26.4 17.6 12.9 12.0 15.0 12.0 10.9 0.0 6.5 32.8 35.2 21.9 39.2 16.5 28.1 2.7 12.5 24.4 23.6 42.5 72.9 43.5 7.1 22.2 63.6 0.0 41.8 23.0 34.8 27.1 39.1 31.6 38.4 35.0 43.1 22.7 26.6 11.6 33.6 25.5 89.4 34.3 42.5 51.0 35.5 39.6 32.2 50.2 48.9 12.9 27.8 47.1 68.2 22.1 50.6 38.4 50.8 26.7 FBP2 ENSG00000130957 "Fructose-bisphosphatase 2" O00757 9 94558720-94593793 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Gluconeogenesis" "Allosteric enzyme, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 33.7;skeletal muscle: 134.7;tongue: 45.6" "Cell type enhanced" "Detected in some" 29 "Exocrine glandular cells: 1.2;Spermatogonia: 3.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 36 "pons and medulla: 33.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.1;CACO-2: 3.6;HMC-1: 4.0;MCF7: 5.3;OE19: 5.0;PC-3: 3.7;SiHa: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA012513, HPA077371" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA012513: AB_1848446, HPA077371: " "unprognostic (3.88e-2)" "unprognostic (3.54e-4)" "unprognostic (2.38e-1)" "unprognostic (6.03e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-2)" "unprognostic (9.40e-4)" "unprognostic (3.95e-3)" "unprognostic (5.11e-2)" "unprognostic (2.39e-2)" "unprognostic (4.69e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.48e-4)" 2.0 0.4 0.1 0.0 0.1 0.0 0.2 0.1 0.9 0.1 0.1 3.8 4.4 1.0 0.1 1.0 1.6 0.1 0.0 0.1 0.7 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 1.2 4.1 0.1 0.0 33.7 0.2 0.0 5.0 1.4 1.8 134.7 0.1 0.1 0.1 0.2 0.1 9.0 0.4 0.0 0.0 0.2 45.6 2.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.3 0.0 2.5 0.0 0.0 7.1 0.0 0.0 0.1 0.0 3.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.9 2.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.0 5.0 3.7 0.0 0.0 0.1 0.0 2.4 0.6 0.1 4.9 1.1 0.0 0.2 0.4 0.1 0.0 0.0 2.3 2.2 0.0 0.0 0.1 1.0 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.9 0.7 0.1 0.1 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.0 0.1 0.0 0.0 0.0 FBXL22 "Fbl22, FLJ39626" ENSG00000197361 "F-box and leucine rich repeat protein 22" Q6P050 15 63597353-63602428 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 65.9;smooth muscle: 68.0" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 10.5;Muller glia cells: 9.8;Peritubular cells: 10.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 8.0;SCLC-21H: 9.1;U-937: 5.7" "HPA047624, HPA054627" Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA047624: AB_2680107, HPA054627: AB_2682548" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (3.03e-2)" "unprognostic (1.29e-2)" "unprognostic (1.15e-1)" "unprognostic (6.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (1.07e-3)" "unprognostic (1.90e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-2)" "unprognostic (1.02e-2)" 1.9 0.4 0.4 5.5 0.4 0.0 1.1 0.6 0.7 31.4 26.0 0.0 20.8 1.4 65.9 7.6 11.9 10.5 31.1 10.3 0.4 0.4 0.6 0.4 0.7 0.2 0.4 0.3 7.1 0.4 0.0 0.4 1.0 0.2 20.1 2.9 1.9 3.3 24.0 2.2 0.7 4.1 68.0 0.4 0.4 6.3 4.2 0.0 0.0 0.6 1.0 0.4 38.2 4.8 1.5 4.3 0.5 0.2 2.0 2.9 0.5 1.2 2.2 0.3 1.3 0.7 0.9 0.1 0.4 0.1 0.5 0.0 1.4 1.6 0.5 1.1 0.2 0.8 1.3 0.7 0.4 0.0 1.3 0.9 0.4 1.5 3.5 0.2 0.5 0.2 0.5 0.3 0.1 0.7 0.1 0.2 3.7 0.0 1.9 0.0 8.0 1.2 1.0 2.5 1.3 0.8 1.1 0.0 3.9 0.3 0.4 9.1 0.3 1.1 1.8 0.3 0.0 3.2 0.9 1.3 0.6 1.8 0.8 0.4 1.2 2.0 1.3 0.9 5.7 1.3 0.4 0.1 0.0 1.2 0.1 1.6 1.5 1.3 1.4 0.0 1.2 2.9 1.0 0.5 2.0 0.2 4.3 0.1 0.5 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.3 0.2 0.0 0.0 0.0 2.2 1.7 0.1 10.5 7.2 5.1 0.0 1.2 7.0 3.9 0.6 8.3 0.9 0.6 0.6 1.3 0.0 1.0 0.7 0.6 1.4 0.0 3.6 0.7 0.0 4.7 5.5 1.5 0.2 0.3 0.4 0.0 0.0 5.6 9.8 0.6 3.5 10.6 2.1 2.5 0.0 1.3 3.9 3.4 0.6 0.5 0.5 3.6 0.5 FBXO28 "CENP-30, Fbx28, FLJ10766, KIAA0483" ENSG00000143756 "F-box protein 28" Q9NVF7 1 224114087-224162047 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003289 Supported "Nucleoplasm,Focal adhesion sites" NA NA Nucleoplasm "Focal adhesion sites" "HPA003289: AB_2666879" "unprognostic (4.91e-2)" "unprognostic (5.57e-2)" "unprognostic (1.78e-2)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.12e-1)" "unprognostic (8.25e-2)" "unprognostic (2.03e-1)" "unprognostic (7.09e-2)" "unprognostic (5.09e-3)" "unprognostic (2.60e-1)" "unprognostic (1.98e-3)" "unprognostic (9.46e-2)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (2.61e-1)" 17.4 13.1 16.4 14.9 19.7 12.1 19.6 22.5 21.6 18.7 15.9 15.0 13.1 13.3 16.2 13.3 22.2 14.1 15.1 15.0 15.3 15.6 21.4 26.6 14.0 14.9 15.9 13.6 18.7 13.4 25.7 16.2 15.8 20.2 16.5 17.1 11.9 16.6 14.9 24.6 32.3 14.4 15.7 15.6 16.1 13.7 11.9 15.5 19.4 15.7 13.1 16.1 17.5 20.0 10.3 10.0 14.7 8.9 10.9 11.0 5.7 14.1 6.3 9.8 10.4 10.3 11.8 16.1 14.3 11.7 9.7 9.3 8.6 11.1 6.8 14.8 13.0 6.2 12.5 14.4 13.9 16.8 9.6 16.1 8.6 7.9 6.2 12.8 16.3 11.4 11.5 16.8 14.0 25.6 11.4 16.1 8.9 14.1 9.8 17.4 4.6 8.4 8.3 23.3 18.8 13.5 9.0 14.0 12.8 18.3 9.4 15.9 17.0 14.9 22.9 15.9 10.7 12.1 16.4 18.4 12.1 9.2 15.1 26.9 10.7 12.6 10.7 15.0 8.0 23.4 8.9 8.7 14.7 7.8 8.1 10.1 10.3 8.2 9.6 10.0 10.2 8.3 9.1 5.3 10.9 8.9 4.7 11.0 5.7 16.4 19.7 22.5 21.6 15.3 15.6 15.9 13.6 20.2 15.5 6.0 8.8 12.3 21.3 30.5 18.7 10.6 7.6 6.7 11.4 10.4 21.6 12.1 8.3 10.9 19.1 14.2 10.6 23.3 9.8 11.5 11.0 18.7 13.9 22.2 12.3 17.5 17.7 9.8 16.3 11.5 12.0 13.9 27.0 10.8 14.0 10.1 13.4 10.5 12.4 17.9 18.4 12.9 11.3 26.0 26.5 34.3 19.2 17.5 11.9 27.2 FCGR1A "CD64, CD64A" ENSG00000150337 "Fc fragment of IgG receptor Ia" P12314 1 149782671-149792518 "CD markers, FDA approved drug targets, Predicted membrane proteins" "Immunity, Innate immunity" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.6;epididymis: 33.2" "Cell type enhanced" "Detected in many" 21 "Hofbauer cells: 235.7;Kupffer cells: 121.8;Late spermatids: 48.6;Macrophages: 101.0" "Cancer enhanced" "Detected in many" "glioma: 10.3" "Group enriched" "Detected in some" 7 "classical monocyte: 35.6;intermediate monocyte: 14.0;myeloid DC: 9.5;neutrophil: 25.5" "Group enriched" "Detected in many" 80 "dendritic cells: 9.5;granulocytes: 25.5;monocytes: 35.6" "Cell line enriched" "Detected in some" 5 "THP-1: 61.0" HPA026910 Uncertain "Golgi apparatus,Vesicles,Plasma membrane" NA NA Vesicles "Golgi apparatus, Plasma membrane" "HPA026910: " "unprognostic (5.27e-2)" "unprognostic (2.89e-2)" "unprognostic (2.34e-2)" "unprognostic (7.97e-2)" "unprognostic (8.44e-3)" "unprognostic (1.73e-1)" "unprognostic (7.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.72e-1)" "unprognostic (1.98e-2)" "unprognostic (6.18e-2)" "prognostic unfavorable (4.83e-8)" "unprognostic (1.28e-1)" "unprognostic (4.51e-2)" "unprognostic (9.99e-2)" "unprognostic (9.03e-2)" 3.9 2.4 6.7 14.1 4.4 5.0 0.7 0.3 3.5 1.1 0.3 0.0 0.1 33.2 0.3 0.7 2.4 0.7 5.3 4.9 1.0 1.1 8.9 3.4 10.1 0.3 1.0 0.5 1.2 10.8 0.4 0.3 0.7 0.2 0.0 0.0 0.1 5.5 14.3 7.0 0.3 0.9 0.3 0.0 3.3 0.0 0.2 9.5 25.5 35.6 0.0 0.2 11.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 61.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.5 35.6 0.4 0.0 14.0 0.2 0.2 0.0 0.1 9.5 0.0 0.0 0.0 25.5 0.0 2.8 0.2 0.1 11.2 0.0 1.9 3.5 0.0 0.1 1.5 1.2 2.5 1.4 2.3 0.0 2.0 2.1 0.0 0.0 28.2 0.1 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 235.7 0.0 0.0 1.3 121.8 48.6 0.3 101.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 6.5 0.0 0.7 0.4 0.0 3.4 0.0 0.0 0.0 FCGR1B CD64b ENSG00000198019 "Fc fragment of IgG receptor Ib" Q92637 1 121087345-121096310 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.8;epididymis: 36.9" "Group enriched" "Detected in some" 5 "Hofbauer cells: 68.7;Kupffer cells: 38.3;Macrophages: 36.3;Sertoli cells: 19.4" "Cancer enhanced" "Detected in single" "glioma: 1.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 19.2;neutrophil: 21.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "NB-4: 10.7;THP-1: 40.9" HPA026910 Uncertain "Golgi apparatus,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA Vesicles "Golgi apparatus, Plasma membrane" "HPA026910: " "unprognostic (3.21e-2)" "unprognostic (4.35e-2)" "unprognostic (1.13e-2)" "unprognostic (2.84e-1)" "unprognostic (1.85e-1)" "unprognostic (9.60e-2)" "unprognostic (1.56e-2)" "unprognostic (6.42e-2)" "unprognostic (3.10e-2)" "unprognostic (8.17e-2)" "unprognostic (1.91e-1)" "unprognostic (3.65e-1)" "unprognostic (3.24e-10)" "unprognostic (8.99e-2)" "unprognostic (2.85e-2)" "unprognostic (7.86e-3)" "unprognostic (8.93e-2)" 4.2 2.3 6.6 13.2 6.2 3.9 1.3 0.8 3.2 0.8 0.5 3.0 0.2 0.5 0.9 36.9 0.5 0.8 1.5 7.4 5.0 4.2 1.0 1.1 4.8 7.9 8.9 0.2 1.1 1.9 0.4 1.5 8.1 6.4 0.6 0.6 0.4 1.3 0.5 0.2 0.0 0.4 4.2 11.3 6.8 0.5 0.5 6.2 0.4 1.8 0.2 0.4 1.5 0.2 0.0 5.2 21.8 19.2 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 40.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 19.2 0.2 0.0 11.3 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 21.8 0.0 6.2 0.1 0.0 5.3 6.6 6.2 0.8 3.0 5.0 4.2 8.9 0.2 6.4 6.2 0.0 1.3 0.8 0.0 0.0 0.8 2.0 0.0 0.0 1.2 0.0 2.0 0.5 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 68.7 3.2 0.0 0.0 38.3 8.2 1.1 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 19.4 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 FDXACB1 "hCG_2033039, LOC91893" ENSG00000255561 "Ferredoxin-fold anticodon binding domain containing 1" Q9BRP7 11 111874056-111881243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 35.1;Late spermatids: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039012, HPA061375" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039012: AB_10670916, HPA061375: " "unprognostic (2.91e-2)" "unprognostic (3.32e-3)" "unprognostic (1.32e-2)" "unprognostic (6.81e-7)" "unprognostic (1.32e-1)" "unprognostic (9.64e-2)" "unprognostic (2.05e-1)" "unprognostic (7.11e-3)" "unprognostic (3.95e-2)" "unprognostic (7.42e-2)" "unprognostic (3.67e-1)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (6.57e-2)" "unprognostic (4.42e-1)" "unprognostic (4.61e-2)" "unprognostic (1.79e-2)" 3.7 6.7 4.4 6.2 5.2 4.0 5.8 2.2 6.1 4.4 3.2 4.7 3.1 4.0 3.9 6.0 3.9 3.7 5.0 2.8 6.6 4.7 3.4 4.3 5.2 8.5 3.6 3.4 4.3 5.1 5.3 3.6 3.0 5.2 3.4 4.2 4.1 6.2 2.2 1.6 6.6 4.3 3.0 5.3 7.6 3.2 11.1 4.0 11.2 3.4 2.6 7.9 4.2 2.7 6.5 4.8 1.8 4.6 5.6 10.4 4.5 1.6 2.1 3.0 6.0 2.3 2.0 1.4 1.2 1.3 1.3 1.6 2.6 3.6 5.9 3.3 1.1 2.2 4.8 2.8 2.7 2.9 7.4 1.3 6.7 1.1 2.1 1.3 6.7 6.0 1.7 1.6 1.9 2.4 1.2 2.3 7.5 4.6 7.9 2.5 2.2 6.4 6.5 1.6 6.6 3.1 4.0 1.9 7.2 3.0 2.9 1.4 2.0 1.8 3.6 1.8 1.9 5.1 4.1 1.8 3.2 3.2 3.6 2.9 4.0 5.8 16.0 1.8 9.9 4.2 0.2 3.2 1.8 6.8 4.6 9.0 6.5 6.1 6.2 4.8 5.2 9.4 10.4 0.9 5.6 3.8 4.6 3.2 4.5 4.4 5.2 2.2 6.1 6.6 4.7 3.6 3.4 5.2 4.0 6.0 1.1 5.4 1.1 0.7 3.2 1.2 0.0 1.4 2.3 0.0 0.0 2.7 5.0 1.7 35.1 1.4 0.7 0.0 2.9 1.8 1.4 1.4 1.1 1.3 3.7 1.6 2.4 1.3 1.0 12.1 2.8 2.7 0.0 2.8 1.1 3.2 1.9 0.0 0.4 2.0 2.1 6.5 0.9 6.5 8.6 1.1 1.8 1.9 1.8 0.9 FFAR4 "GPR120, GPR129, O3FAR1, PGR4" ENSG00000186188 "Free fatty acid receptor 4" Q5NUL3 10 93566665-93604480 "G-protein coupled receptors, Predicted membrane proteins" "Differentiation, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 15.8;lung: 11.7;pituitary gland: 39.2" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 18.7;Intestinal endocrine cells: 20.1;Mucus-secreting cells: 63.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "OE19: 16.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042563 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA042563: AB_10794762" "unprognostic (1.96e-1)" "unprognostic (1.06e-2)" "unprognostic (1.14e-2)" "unprognostic (4.21e-2)" "unprognostic (2.12e-1)" "unprognostic (4.98e-4)" "unprognostic (1.41e-3)" "unprognostic (1.20e-2)" "unprognostic (2.34e-2)" "unprognostic (7.87e-2)" "unprognostic (9.51e-2)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (5.32e-2)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" 5.2 0.6 1.8 2.8 1.7 0.2 1.9 0.1 2.6 0.2 11.3 1.1 0.0 0.7 0.1 0.1 0.4 1.4 2.6 1.2 0.9 1.6 0.3 0.6 11.7 1.3 0.6 1.0 0.3 1.1 0.1 39.2 0.4 0.8 0.2 15.8 0.3 0.9 0.1 0.5 1.3 1.0 0.3 2.6 0.2 0.7 2.0 0.9 0.7 0.2 0.0 0.6 0.3 0.2 0.5 3.4 1.3 3.0 0.7 0.3 0.8 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.4 0.4 0.1 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.1 16.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 3.0 0.2 0.3 0.6 0.2 0.4 0.2 0.2 3.4 0.5 0.2 0.3 1.3 0.7 0.4 0.4 0.1 0.8 1.8 1.7 0.1 2.6 0.9 1.6 0.6 1.0 0.8 0.9 0.0 0.3 0.0 0.4 0.0 0.0 0.3 12.7 0.0 1.2 0.0 0.0 0.1 0.0 0.6 18.7 0.1 6.5 0.0 0.0 0.5 0.2 0.3 0.0 0.0 7.8 0.0 20.1 0.0 3.2 12.2 0.6 3.8 1.7 0.0 63.6 0.0 1.4 9.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.2 FILIP1 "FILIP, KIAA1275" ENSG00000118407 "Filamin A interacting protein 1" Q7Z7B0 6 75291859-75493738 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 37.6;smooth muscle: 44.7" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 542.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 10.7;HUVEC TERT2: 2.7;RPTEC TERT1: 3.0;U-266/70: 10.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA053564 Enhanced Approved "Plasma membrane,Actin filaments" No NA "Plasma membrane, Actin filaments" "HPA053564: AB_2682192" "unprognostic (4.90e-2)" "unprognostic (3.77e-2)" "unprognostic (9.77e-3)" "unprognostic (3.83e-1)" "unprognostic (1.52e-1)" "unprognostic (4.98e-1)" "unprognostic (2.27e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (5.17e-3)" "unprognostic (3.29e-2)" "unprognostic (2.23e-1)" "unprognostic (1.30e-3)" "unprognostic (3.97e-3)" "unprognostic (2.34e-1)" "unprognostic (4.65e-2)" "unprognostic (7.66e-3)" 11.0 1.3 2.0 6.3 3.0 0.2 2.5 0.6 2.5 8.2 10.9 0.0 4.1 1.3 8.8 4.1 10.5 4.5 5.9 37.6 3.7 1.2 2.7 2.4 7.5 1.2 1.1 0.7 4.4 1.4 5.4 5.1 3.7 0.8 14.9 2.6 4.3 1.5 2.8 29.4 0.9 4.1 44.7 1.4 0.6 3.9 2.8 0.0 0.0 2.3 10.8 0.7 30.7 6.0 1.4 0.9 1.8 0.8 0.6 0.9 0.0 0.1 1.9 0.3 0.1 0.1 0.3 0.2 0.3 0.1 0.1 0.0 0.0 0.2 0.2 10.7 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.2 0.2 0.2 0.1 0.0 0.3 0.2 1.4 0.1 0.2 0.1 0.1 2.7 0.4 0.1 0.4 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 3.0 0.6 0.2 0.2 0.0 0.1 0.1 2.5 0.1 0.4 0.0 0.1 0.0 0.1 0.1 10.7 1.0 0.1 0.1 0.5 0.1 1.2 0.6 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.2 1.4 0.9 0.6 1.8 0.6 0.8 0.9 0.3 0.0 2.0 3.0 0.6 1.9 3.7 1.2 1.1 0.7 0.8 0.0 119.1 78.3 0.0 0.6 0.6 3.3 542.5 0.0 83.0 14.8 0.0 0.0 0.7 1.7 0.0 36.1 36.8 0.0 0.0 0.3 0.3 26.7 0.6 1.1 0.6 1.2 0.0 0.0 58.3 1.9 16.2 2.3 2.0 1.7 0.0 0.0 4.5 0.0 0.0 4.2 0.0 3.8 90.5 88.2 4.5 6.4 0.6 0.7 0.0 0.0 0.4 FLT1 "FLT, VEGFR1" ENSG00000102755 "Fms related tyrosine kinase 1" P17948 13 28300344-28495145 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "placenta: 155.3" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 778.4;Ito cells: 284.2;Syncytiotrophoblasts: 942.6" "Cancer enhanced" "Detected in all" "renal cancer: 28.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1" "Group enriched" "Detected in many" 5 "B-cells: 3.7;granulocytes: 2.1" "Cell line enhanced" "Detected in some" "BJ: 17.4;BJ hTERT+: 13.8;HMC-1: 86.4;HUVEC TERT2: 15.6;WM-115: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011740, HPA014290, CAB068189, CAB068190" Enhanced Supported "Plasma membrane,Actin filaments" "Secreted to blood" NA NA 876000 54000 "Plasma membrane" "Actin filaments" "CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738" "unprognostic (3.33e-2)" "unprognostic (3.52e-3)" "unprognostic (1.13e-3)" "unprognostic (5.02e-2)" "unprognostic (3.65e-1)" "unprognostic (5.03e-2)" "unprognostic (8.25e-2)" "unprognostic (2.27e-3)" "unprognostic (9.91e-2)" "unprognostic (6.61e-2)" "unprognostic (2.33e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.19e-4)" "unprognostic (4.20e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (6.32e-2)" 18.9 4.0 9.9 4.0 14.3 1.2 13.5 8.0 15.9 7.1 4.6 3.5 1.7 3.5 7.2 2.2 3.4 4.0 6.9 18.3 11.4 7.3 10.3 7.6 12.3 2.5 10.3 3.2 5.1 5.4 13.4 3.7 155.3 13.8 5.1 3.1 9.1 3.0 5.0 12.5 2.6 3.4 7.3 9.6 7.2 4.6 6.8 10.2 0.0 19.1 3.8 2.8 7.6 9.2 3.7 0.5 2.1 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.0 17.4 13.8 6.3 3.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.6 0.0 11.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 86.4 0.1 0.0 0.0 0.2 0.0 15.6 1.4 0.4 0.0 0.0 0.0 1.0 0.8 9.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 11.4 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.5 0.2 0.0 0.1 0.0 31.0 0.2 0.1 0.1 0.1 0.1 0.0 1.1 0.1 0.1 0.0 3.7 0.4 0.4 2.1 0.2 0.1 0.5 0.2 0.2 9.9 14.3 8.0 15.9 11.4 7.3 10.3 3.2 13.8 10.2 0.0 8.9 2.2 0.5 3.7 5.9 12.6 5.1 2.7 1.2 0.0 3.9 155.4 1.7 0.0 116.6 192.1 0.0 0.0 0.0 778.4 17.5 1.1 1.1 2.1 28.1 1.6 0.0 284.2 16.1 130.7 17.3 5.3 0.0 0.0 0.0 172.0 0.0 0.0 45.6 0.0 7.3 90.5 6.6 12.9 2.8 4.3 942.6 2.9 0.0 0.5 FOCAD "FLJ20375, KIAA1797" ENSG00000188352 Focadhesin Q5VW36 9 20658309-20995955 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 62.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "pons and medulla: 62.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055015 Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA055015: AB_2682673" "unprognostic (3.05e-2)" "unprognostic (1.02e-1)" "prognostic favorable (3.25e-4)" "unprognostic (3.69e-3)" "unprognostic (4.14e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (9.64e-2)" "unprognostic (7.38e-2)" "unprognostic (1.23e-1)" "unprognostic (5.26e-2)" "unprognostic (9.15e-2)" "prognostic favorable (3.09e-8)" "unprognostic (1.90e-1)" "unprognostic (2.33e-1)" "unprognostic (3.99e-2)" "unprognostic (1.41e-2)" 3.6 9.0 4.5 3.6 7.2 1.9 3.9 8.7 9.0 4.9 4.8 15.0 3.6 1.8 3.9 6.3 3.6 7.4 3.6 5.3 7.1 7.3 3.8 3.6 3.7 3.6 4.4 3.6 3.6 5.5 10.4 11.8 4.1 62.1 5.6 5.6 6.8 5.8 3.7 5.1 4.2 3.6 4.7 3.6 3.6 4.2 3.6 3.6 3.6 11.8 3.6 3.6 3.6 3.6 3.4 6.9 8.9 5.7 4.5 7.1 3.1 16.3 11.3 12.3 9.2 11.6 13.3 6.5 9.7 15.5 6.9 8.0 7.5 5.6 6.7 5.2 13.9 5.8 5.7 10.7 19.3 12.1 29.8 7.9 5.2 13.9 9.2 6.0 8.7 6.8 12.2 13.3 6.9 11.4 9.7 26.4 5.7 0.1 9.9 11.5 6.3 6.5 16.4 9.7 8.7 11.4 0.0 5.6 4.5 10.8 7.0 8.2 4.1 6.4 11.0 2.6 17.3 6.9 5.1 16.1 0.0 4.5 7.6 8.8 2.4 13.7 7.6 0.0 12.3 4.1 8.9 2.8 8.0 5.3 5.7 7.1 2.7 4.7 5.1 6.9 3.4 4.2 5.0 2.2 4.5 3.1 2.8 4.3 3.1 4.5 7.2 8.7 9.0 7.1 7.3 4.4 3.6 62.1 3.6 8.9 14.3 3.9 2.7 2.6 5.7 10.0 7.6 13.4 7.9 15.7 3.9 4.1 1.7 7.4 11.0 4.4 4.1 0.0 7.4 5.7 6.2 6.5 4.7 3.4 4.6 11.1 16.8 12.3 5.4 3.7 4.6 4.3 8.5 1.0 10.9 7.3 8.1 0.0 3.5 2.8 3.8 6.5 5.7 14.9 7.8 3.1 2.7 3.5 8.9 2.6 FOSB "AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291" ENSG00000125740 "FosB proto-oncogene, AP-1 transcription factor subunit" P53539 19 45467995-45475179 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "GAMG: 12.0;HMC-1: 14.0;hTCEpi: 8.7;Karpas-707: 7.2;SK-BR-3: 10.3" "Group enriched" "Detected in many" 4 "amygdala: 4.1;basal ganglia: 4.2;cerebral cortex: 5.3;hippocampal formation: 4.5;olfactory region: 8.8" "Low region specificity" "Detected in many" "CAB010267, HPA054663" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB010267: AB_640583, HPA054663: AB_2682562" "unprognostic (7.22e-2)" "unprognostic (9.74e-2)" "unprognostic (2.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (1.30e-3)" "unprognostic (9.43e-2)" "unprognostic (2.04e-2)" "unprognostic (2.99e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "unprognostic (3.51e-2)" "unprognostic (4.99e-3)" "unprognostic (8.72e-2)" "unprognostic (4.45e-2)" "unprognostic (4.04e-2)" 72.7 13.0 2.3 111.4 7.4 39.2 10.0 5.5 7.7 62.9 9.0 14.9 2.2 1.7 32.1 6.1 18.9 135.1 102.6 14.1 2.5 2.9 3.4 8.6 22.9 6.0 2.0 1.2 29.1 12.2 8.1 8.1 129.0 8.5 12.2 7.9 38.6 8.7 59.1 2.2 59.5 10.8 36.3 2.5 2.6 30.5 21.7 1.3 4.0 33.6 114.5 8.2 16.7 4.4 0.2 1.7 9.0 1.6 0.2 0.7 0.2 0.4 0.7 0.2 0.3 1.3 0.3 2.3 2.4 1.1 0.7 0.7 0.5 1.0 2.0 0.4 1.5 12.0 0.9 0.5 1.6 0.5 0.3 0.7 0.6 0.7 0.4 0.8 1.1 14.0 0.5 8.7 1.8 2.0 0.4 1.0 2.4 0.7 7.2 0.2 0.2 0.2 1.2 0.5 1.0 0.4 0.5 0.1 1.4 0.7 1.3 3.3 0.4 1.5 10.3 1.2 2.1 0.5 0.8 0.1 0.5 0.6 1.2 0.7 5.4 0.7 0.5 1.1 0.8 1.3 1.5 1.6 1.7 0.3 0.2 0.7 0.1 0.4 0.3 1.7 0.2 0.0 0.0 9.0 0.2 0.1 0.1 0.1 0.2 2.3 7.4 5.5 7.7 2.5 2.9 2.0 1.2 8.5 1.3 637.2 863.6 170.2 357.4 337.9 23.2 156.7 221.7 108.4 179.7 10.4 127.6 182.1 1.7 82.5 6.6 228.5 437.9 23.3 65.2 252.3 314.2 253.2 799.2 48.7 184.0 7.9 843.2 193.3 203.0 5.1 222.4 274.6 163.6 26.2 718.0 71.6 106.5 426.1 55.9 1.9 178.0 297.5 219.5 1.1 3.1 333.0 331.9 203.1 555.5 158.8 FOXC1 "ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1" ENSG00000054598 "Forkhead box C1" Q12948 6 1609972-1613897 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Angiogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Deafness, Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "retina: 32.7;salivary gland: 86.6" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 40.9;Ito cells: 36.2;Urothelial cells: 55.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 1.4" "Lineage enriched" "Detected in single" 6 "NK-cells: 1.4" "Cell line enhanced" "Detected in many" "AN3-CA: 39.8;HEK 293: 38.8;RPTEC TERT1: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040670 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040670: AB_10673412" "unprognostic (2.65e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (3.53e-4)" "unprognostic (3.22e-2)" "unprognostic (3.22e-2)" "unprognostic (1.24e-1)" "unprognostic (3.30e-2)" "unprognostic (1.54e-2)" "unprognostic (4.04e-3)" "unprognostic (1.58e-1)" "unprognostic (2.33e-3)" "unprognostic (9.55e-2)" "unprognostic (1.11e-2)" "unprognostic (6.48e-2)" "unprognostic (2.04e-1)" "unprognostic (3.83e-3)" "unprognostic (3.74e-1)" 7.7 4.4 2.6 1.3 3.4 1.0 9.4 2.3 3.4 6.6 1.4 2.8 3.2 1.2 2.4 3.8 3.8 3.4 9.8 9.5 3.2 2.1 12.9 1.4 3.8 1.6 4.5 2.3 4.8 2.8 2.2 6.5 3.1 6.5 6.0 1.3 32.7 86.6 4.9 3.6 7.1 1.2 2.1 3.9 0.9 1.1 4.6 2.6 2.8 3.7 4.2 2.9 5.7 4.6 0.0 0.0 0.2 0.1 1.4 0.0 0.0 7.3 0.8 0.2 39.8 1.8 2.1 1.2 3.7 4.4 2.3 1.9 2.8 1.5 0.0 4.3 2.2 1.7 8.4 3.8 2.7 1.9 2.3 38.8 1.5 2.2 1.3 1.2 0.5 2.6 7.0 3.8 3.2 3.6 1.2 3.4 0.2 1.0 0.0 1.0 1.6 0.0 0.8 0.1 3.7 3.2 0.0 1.6 0.2 15.6 5.6 1.5 3.4 4.6 0.0 2.6 2.1 1.1 0.6 0.8 5.1 3.1 2.6 3.9 0.1 0.3 0.0 1.4 1.9 4.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.0 2.6 3.4 2.3 3.4 3.2 2.1 4.5 2.3 6.5 2.6 0.0 1.1 0.0 25.0 15.8 0.0 5.6 0.0 26.8 14.8 10.4 0.0 4.5 1.7 3.4 0.4 40.9 0.0 0.0 15.0 0.4 3.6 7.7 0.0 0.0 1.1 0.0 0.0 36.2 0.3 0.9 15.0 1.4 1.7 0.0 0.2 0.3 11.8 0.0 26.5 4.6 0.0 0.0 27.0 0.2 1.9 5.6 0.7 0.0 0.3 55.7 FOXI1 "FKHL10, FREAC6" ENSG00000168269 "Forkhead box I1" Q12951 5 170105897-170109725 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 37.0;salivary gland: 12.4" "Cell type enriched" "Detected in some" 13 "Distal tubular cells: 23.2" "Group enriched" "Detected in many" 7 "breast cancer: 5.8;renal cancer: 23.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 48 "eosinophil: 4.7" "Lineage enriched" "Detected in single" 48 "granulocytes: 4.7" "Group enriched" "Detected in some" 5 "MCF7: 4.0;SuSa: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA071469 Enhanced Uncertain Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "HPA071469: AB_2686403" "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (2.09e-1)" "unprognostic (2.48e-2)" "unprognostic (8.06e-2)" "unprognostic (7.47e-2)" "unprognostic (2.73e-1)" "unprognostic (1.52e-2)" "unprognostic (9.71e-3)" "unprognostic (4.88e-3)" "unprognostic (6.20e-2)" "unprognostic (1.34e-2)" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 37.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 3.3 0.0 0.0 12.4 3.7 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.9 1.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.8 0.0 0.0 0.0 FOXK2 "ILF, ILF1" ENSG00000141568 "Forkhead box K2" Q01167 17 82519713-82644662 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027523, HPA073491" Approved Supported Nucleoplasm,Vesicles,Mitochondria NA NA Nucleoplasm "Vesicles, Mitochondria" "HPA027523: AB_10601013, HPA073491: " "unprognostic (2.39e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (9.52e-2)" "unprognostic (3.11e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.24e-6)" "unprognostic (3.35e-2)" "unprognostic (2.25e-1)" "unprognostic (5.19e-2)" "unprognostic (2.18e-2)" "unprognostic (2.26e-1)" "unprognostic (3.80e-3)" "unprognostic (2.24e-2)" "unprognostic (4.89e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-2)" 16.8 21.2 17.5 14.3 19.2 8.7 19.1 21.3 30.5 17.7 17.1 17.1 16.9 11.2 22.2 13.7 24.2 14.6 13.4 17.1 14.9 14.9 13.0 13.6 15.2 13.6 13.7 17.2 17.6 19.2 25.4 19.8 18.6 15.6 14.9 11.7 13.8 17.1 16.3 41.5 21.6 12.6 19.9 10.3 13.2 15.5 32.3 15.8 21.8 18.6 12.4 13.9 16.4 16.4 4.0 5.9 4.1 2.9 4.1 4.4 1.6 21.7 23.3 21.8 23.8 12.6 13.9 14.6 12.8 14.8 22.5 22.9 22.6 14.0 18.6 9.3 15.8 24.8 12.7 23.2 14.8 21.3 12.7 22.2 19.2 15.4 22.2 19.9 21.4 12.9 13.1 27.1 23.7 27.1 14.0 22.7 20.2 25.6 19.1 12.3 13.0 36.3 13.6 12.5 18.0 17.8 23.9 18.6 15.4 10.3 18.4 36.2 26.7 12.7 32.4 30.2 24.3 22.8 24.8 17.7 29.7 20.8 19.9 25.8 22.1 19.5 24.1 16.0 17.9 15.6 4.1 2.9 3.3 4.4 2.2 3.5 4.0 3.3 4.2 3.3 2.8 2.6 2.9 0.5 4.1 2.3 5.9 3.4 1.6 17.5 19.2 21.3 30.5 14.9 14.9 13.7 17.2 15.6 15.8 47.6 21.9 9.3 7.3 33.1 18.1 17.3 5.1 13.4 18.2 14.0 11.8 10.2 3.3 8.5 11.5 12.8 10.5 0.0 9.1 7.5 13.1 10.0 2.3 11.4 16.3 44.5 10.5 12.9 14.6 18.8 8.6 9.2 11.8 9.0 13.5 9.1 10.2 11.5 12.4 5.4 16.1 0.0 19.6 13.2 9.5 37.6 8.1 6.9 12.1 8.9 FOXL2 "BPES, BPES1" ENSG00000183770 "Forkhead box L2" P58012 3 138944224-138947140 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 13.9;ovary: 55.5;parathyroid gland: 15.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.6;fHDF/TERT166: 6.5;HEL: 9.2;hTCEpi: 8.5;K-562: 9.4;SiHa: 6.5;THP-1: 6.7" "Not detected" "Not detected" HPA069613 Enhanced Supported "Nucleoplasm,Midbody ring" NA NA Nucleoplasm "Midbody ring" "HPA069613: AB_2686160" "unprognostic (1.46e-1)" "unprognostic (3.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.05e-1)" "unprognostic (5.16e-4)" "unprognostic (3.55e-2)" "unprognostic (2.35e-3)" "unprognostic (5.08e-2)" "unprognostic (3.79e-2)" "unprognostic (2.19e-1)" "unprognostic (9.63e-8)" "unprognostic (2.16e-2)" "unprognostic (4.65e-1)" "unprognostic (2.90e-2)" "unprognostic (1.61e-2)" 0.0 1.5 0.3 0.0 1.2 0.0 0.0 0.3 1.0 13.9 0.0 0.6 0.0 0.0 10.0 0.4 0.1 6.4 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.3 0.4 55.5 0.6 15.3 13.1 1.4 0.8 0.2 0.0 1.7 0.0 0.4 0.0 0.2 0.0 0.9 0.3 0.0 0.0 0.8 0.2 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 2.2 0.3 4.0 0.1 0.0 1.7 0.2 0.0 0.4 0.1 0.0 0.4 0.0 2.7 6.5 0.2 1.3 0.0 0.0 0.1 0.0 0.0 9.2 1.1 0.0 0.0 0.1 0.0 0.0 8.5 0.0 0.0 1.4 0.0 0.0 9.4 0.0 3.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.0 0.0 6.5 0.0 0.0 0.3 0.0 6.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.3 1.0 0.4 0.2 0.3 0.4 0.8 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.0 0.0 FOXM1 "FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident" ENSG00000111206 "Forkhead box M1" Q08050 12 2857681-2877155 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.5;testis: 40.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 16.5;Erythroid cells: 23.3;Extravillous trophoblasts: 15.0;Late spermatids: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB017832 Uncertain Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA Yes "Nucleoplasm, Nucleoli, Nucleoli rim" Cytosol "CAB017832: " "unprognostic (3.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.22e-2)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.95e-6)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (6.09e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.80e-2)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (1.94e-1)" 1.7 1.7 1.0 9.3 0.9 13.8 2.4 0.4 1.2 2.0 6.5 0.4 1.1 6.0 1.2 2.1 13.5 0.4 4.1 1.2 0.8 0.6 1.3 1.6 2.8 6.6 0.8 0.3 0.8 0.6 0.0 0.5 3.9 0.9 0.9 8.2 0.6 2.6 1.1 0.7 3.7 7.1 4.4 1.2 5.0 3.2 40.1 0.4 47.5 0.6 11.4 11.6 2.0 3.7 0.7 0.6 1.0 0.6 0.4 1.9 0.1 28.5 29.0 22.5 20.7 3.4 4.5 28.7 18.7 18.4 37.9 34.4 36.6 25.6 18.5 4.0 26.7 43.1 22.2 33.7 17.1 37.2 34.5 18.0 20.8 27.8 15.6 0.5 16.7 17.1 2.3 1.9 35.2 24.8 9.0 26.7 21.2 11.6 41.5 29.8 26.8 22.7 7.9 49.7 29.7 21.7 16.5 34.2 9.6 8.9 18.3 12.7 20.1 23.9 20.1 10.9 44.4 19.6 18.7 10.7 30.8 46.8 35.9 64.8 5.5 9.1 26.8 14.3 16.1 32.6 0.4 0.6 0.1 0.4 0.2 0.4 0.7 0.5 0.4 0.2 0.7 0.9 0.3 1.0 0.4 0.1 0.6 1.9 0.1 1.0 0.9 0.4 1.2 0.8 0.6 0.8 0.3 0.9 0.4 0.0 2.2 0.8 0.7 2.6 1.6 0.5 2.5 0.0 1.2 1.8 3.9 1.4 1.7 0.2 16.5 0.3 1.7 23.3 0.0 15.0 1.3 0.8 0.0 0.9 7.3 4.8 0.0 3.1 1.9 20.0 0.9 1.7 0.0 1.8 3.7 0.6 0.2 0.0 0.7 0.0 4.4 0.0 0.0 7.6 5.9 1.3 1.6 2.5 3.7 1.3 FOXN2 HTLF ENSG00000170802 "Forkhead box N2" P32314 2 48314637-48379294 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 45.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003485 Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA003485: AB_1078905" "unprognostic (5.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.86e-2)" "unprognostic (2.65e-3)" "prognostic favorable (3.85e-4)" "unprognostic (4.00e-1)" "unprognostic (2.32e-2)" "unprognostic (1.52e-1)" "unprognostic (8.95e-2)" "unprognostic (2.59e-1)" "unprognostic (5.15e-3)" "unprognostic (4.14e-2)" "prognostic unfavorable (2.81e-5)" "unprognostic (2.24e-2)" "unprognostic (1.55e-1)" "unprognostic (2.34e-2)" "unprognostic (1.12e-2)" 17.7 6.2 12.7 13.9 17.4 45.5 13.6 23.6 13.8 8.1 7.4 25.0 3.2 8.2 8.2 4.6 9.1 6.5 9.8 8.3 16.1 9.5 6.8 18.7 10.6 17.4 23.3 12.8 6.2 8.4 9.8 7.0 12.6 19.0 6.2 8.0 2.9 7.1 4.7 8.0 5.9 10.1 9.5 23.6 17.2 7.4 6.1 26.0 17.8 7.9 6.9 15.7 10.9 8.2 7.6 11.3 42.3 11.3 8.3 9.9 5.6 6.9 10.7 12.3 10.9 9.8 7.2 13.6 7.8 8.6 6.6 7.4 9.4 8.8 15.3 10.5 9.2 8.1 8.9 7.4 8.9 9.7 11.8 6.5 29.8 7.6 9.4 17.1 16.3 23.8 6.5 3.8 7.1 12.5 5.4 7.0 6.4 14.1 18.3 10.7 5.3 18.0 10.8 9.3 5.2 5.6 9.0 25.8 12.5 5.8 8.9 6.9 7.1 3.8 7.2 13.8 4.4 3.2 9.7 8.1 9.1 9.1 8.6 8.2 9.9 7.4 22.1 7.9 15.1 12.2 35.1 11.1 42.3 8.7 8.9 9.9 7.5 8.3 7.9 11.3 7.6 6.4 6.4 14.1 8.3 11.3 7.0 9.5 5.6 12.7 17.4 23.6 13.8 16.1 9.5 23.3 12.8 19.0 26.0 0.0 6.1 9.5 17.5 13.9 6.9 9.0 15.3 1.4 6.8 1.8 0.0 5.6 5.0 5.3 3.3 17.0 7.7 0.0 4.7 28.3 9.9 31.0 22.0 17.0 16.1 12.7 2.4 19.0 31.1 3.3 11.2 31.1 11.8 35.1 8.6 7.1 8.8 7.0 10.6 4.0 3.7 6.5 13.0 11.1 7.5 18.4 13.8 17.3 8.3 34.0 FPGT GFPP ENSG00000254685 "Fucose-1-phosphate guanylyltransferase" O14772 1 74198212-74234086 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072331 Uncertain Vesicles NA NA Vesicles "HPA072331: " "unprognostic (1.53e-1)" "unprognostic (1.94e-1)" "unprognostic (8.18e-3)" "unprognostic (4.32e-2)" "unprognostic (5.14e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (2.30e-4)" "unprognostic (1.86e-1)" "unprognostic (5.14e-2)" "unprognostic (2.58e-1)" "unprognostic (7.59e-2)" "unprognostic (1.33e-1)" "unprognostic (3.59e-3)" "unprognostic (1.44e-1)" "unprognostic (7.88e-2)" "unprognostic (3.53e-2)" "unprognostic (1.91e-1)" 14.6 11.6 10.9 9.1 12.6 3.4 13.0 19.0 15.8 15.9 11.7 13.0 7.5 11.5 17.7 11.1 15.7 15.4 13.3 12.8 10.9 7.1 15.9 13.7 10.8 8.0 15.5 10.6 14.1 10.2 14.2 27.7 10.6 14.4 11.1 11.3 10.6 11.7 9.1 15.7 12.0 12.0 11.8 16.3 11.0 12.3 8.7 13.9 6.6 20.0 6.8 9.2 17.9 12.9 4.3 9.2 15.2 14.9 3.8 5.4 7.4 9.3 7.7 5.8 8.5 13.5 12.7 8.7 12.2 8.2 8.5 10.0 4.3 7.0 5.7 15.1 7.2 9.6 7.8 10.4 11.2 13.5 11.5 4.4 12.9 9.4 7.3 11.3 9.8 10.0 10.4 14.5 8.4 4.0 5.8 8.7 8.0 13.3 6.9 13.2 2.5 5.4 2.0 6.3 12.0 7.0 5.8 13.7 8.0 7.4 6.8 6.1 6.1 9.0 13.3 14.0 1.9 16.0 11.2 7.8 3.7 7.1 20.2 9.2 7.5 5.4 7.6 15.0 9.7 12.5 12.0 14.9 15.2 4.3 14.5 5.0 3.6 4.4 3.9 9.2 4.3 4.9 4.4 4.4 3.8 12.5 0.9 5.4 7.4 10.9 12.6 19.0 15.8 10.9 7.1 15.5 10.6 14.4 13.9 6.0 2.7 0.5 3.7 6.1 7.0 8.7 10.2 9.4 2.3 10.4 2.0 11.0 16.6 5.0 6.1 5.2 9.3 0.0 6.3 9.1 5.8 2.7 4.7 7.9 13.3 3.2 5.8 6.7 9.8 5.7 9.5 10.6 5.0 3.6 7.6 8.4 5.6 7.0 5.3 12.4 4.5 25.8 5.2 8.1 10.6 5.6 5.1 1.8 7.2 1.7 FRMD7 "FLJ43346, NYS, NYS1" ENSG00000165694 "FERM domain containing 7" Q6ZUT3 X 132076993-132128020 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Neurogenesis "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "endometrium 1: 7.4;kidney: 6.6;smooth muscle: 5.5" "Cell type enriched" "Detected in single" 30 "Distal tubular cells: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.1;HSkMC: 1.6;SuSa: 3.6;U-87 MG: 5.5" "Region enriched" "Detected in single" 29 "olfactory region: 80.8" "Region enriched" "Detected in single" 103 "olfactory region: 45.5" HPA000886 Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA000886: AB_1079269" "unprognostic (3.08e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-1)" "unprognostic (3.07e-1)" "unprognostic (4.02e-2)" "unprognostic (1.64e-2)" "unprognostic (2.28e-1)" "unprognostic (2.18e-2)" "unprognostic (3.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.00e-1)" 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 7.4 1.1 0.0 1.1 0.0 0.1 0.0 0.1 6.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.5 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRMD8 "FKSG44, FLJ90369" ENSG00000126391 "FERM domain containing 8" Q9BZ67 11 65386599-65413525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 73.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 53.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002861 Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Plasma membrane, Centriolar satellite" "Nucleoplasm, Cytosol" "HPA002861: AB_1078878" "unprognostic (1.54e-1)" "unprognostic (4.07e-1)" "unprognostic (6.28e-2)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (9.94e-5)" "unprognostic (9.12e-3)" "unprognostic (1.51e-2)" "unprognostic (6.36e-3)" "unprognostic (1.90e-2)" "unprognostic (6.41e-3)" "unprognostic (4.19e-3)" "unprognostic (1.47e-2)" "unprognostic (7.36e-3)" "unprognostic (3.34e-1)" "unprognostic (2.91e-2)" 14.6 11.9 7.8 18.5 12.1 13.1 15.2 8.9 10.3 12.5 15.1 11.4 6.9 13.6 10.5 12.2 23.9 14.6 17.4 10.0 8.0 5.4 10.5 12.0 15.1 17.3 17.0 8.5 8.9 20.9 5.7 8.2 12.2 11.7 10.7 8.2 7.8 18.6 10.9 12.0 24.3 16.5 8.1 8.9 29.0 11.7 11.3 14.6 16.6 12.4 16.6 21.8 11.0 18.1 10.9 11.4 19.7 14.9 6.5 14.3 9.0 6.9 8.9 3.6 8.4 9.8 5.1 6.4 7.9 7.4 6.8 5.3 8.5 11.6 8.6 17.1 11.2 4.8 12.3 4.6 6.9 2.9 14.3 4.2 11.9 8.2 4.6 5.3 6.7 18.6 6.4 5.5 6.5 3.5 3.7 10.9 8.9 9.9 9.7 7.5 9.5 10.0 9.8 4.0 5.2 11.7 13.4 6.7 9.8 5.6 8.8 7.8 5.4 6.0 24.8 18.9 3.4 9.0 5.5 9.5 7.7 8.0 10.4 4.8 16.7 8.5 8.1 6.7 4.2 53.0 0.8 9.7 13.4 11.5 11.0 12.7 10.9 8.4 14.3 9.1 9.2 7.8 8.4 19.7 6.5 14.9 11.4 8.9 9.0 7.8 12.1 8.9 10.3 8.0 5.4 17.0 8.5 11.7 14.6 3.0 7.2 17.5 19.3 48.2 5.9 7.5 20.4 8.1 6.8 12.2 0.0 5.8 6.6 18.7 22.7 21.1 26.9 23.3 24.9 13.0 14.4 20.4 13.9 9.6 13.4 4.8 12.5 45.4 16.7 3.9 5.8 17.4 18.6 19.0 17.0 3.2 25.9 13.1 6.7 4.2 4.6 6.5 16.0 4.1 8.6 73.0 9.5 21.7 11.2 33.0 FRS3 "FRS2B, FRS2beta, SNT-2" ENSG00000137218 "Fibroblast growth factor receptor substrate 3" O43559 6 41770176-41786542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 12.7;Spermatocytes: 8.6;Spermatogonia: 10.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030162, HPA030174" Enhanced Uncertain Nucleoplasm NA NA Nucleoplasm "HPA030162: AB_10599976, HPA030174: AB_10602093" "unprognostic (2.52e-2)" "unprognostic (1.31e-1)" "unprognostic (4.30e-2)" "unprognostic (8.91e-2)" "unprognostic (8.13e-2)" "unprognostic (1.67e-2)" "unprognostic (3.79e-2)" "unprognostic (8.47e-3)" "unprognostic (2.96e-1)" "unprognostic (1.83e-1)" "prognostic favorable (3.87e-4)" "unprognostic (4.23e-2)" "unprognostic (3.29e-3)" "unprognostic (2.96e-2)" "unprognostic (8.48e-2)" "unprognostic (5.10e-2)" "unprognostic (3.29e-3)" 6.4 7.0 12.1 4.5 13.6 4.2 3.7 20.4 22.2 4.4 5.1 9.1 2.7 5.4 7.1 3.6 5.4 6.9 5.1 8.2 12.3 15.2 4.0 3.1 5.6 6.0 12.2 12.9 7.5 5.9 4.9 4.9 5.2 13.1 5.5 3.4 5.3 8.1 9.3 13.3 2.5 5.3 5.0 8.0 6.4 5.3 18.5 7.0 3.4 7.4 1.7 3.5 4.7 5.0 1.0 1.7 2.3 1.7 1.4 1.4 0.3 3.1 2.7 4.5 6.3 3.7 4.0 9.5 3.4 4.9 4.0 4.1 3.6 1.9 5.4 3.8 2.9 5.3 2.1 2.9 3.6 3.4 5.5 2.8 3.3 5.0 5.7 4.6 2.7 4.9 3.9 4.3 3.9 3.6 5.3 4.2 13.1 3.6 4.5 3.5 5.1 7.9 6.0 2.3 6.9 2.7 7.5 4.1 3.8 3.5 6.0 6.6 9.9 2.4 3.4 6.9 3.5 4.2 5.4 3.6 7.1 7.5 4.6 3.4 8.0 6.5 8.8 1.9 4.6 2.1 0.0 1.7 2.3 0.9 0.5 0.9 0.3 1.4 0.6 1.1 1.0 0.7 0.3 0.3 1.4 0.4 1.7 0.6 0.3 12.1 13.6 20.4 22.2 12.3 15.2 12.2 12.9 13.1 7.0 0.0 3.0 0.9 1.0 0.9 5.8 2.4 12.7 1.4 1.2 0.0 0.0 1.5 0.0 1.5 0.5 2.8 0.4 0.0 1.2 0.8 1.9 0.9 0.0 0.8 1.7 4.8 1.7 1.3 1.3 0.0 2.3 1.3 3.3 0.0 1.6 2.7 1.0 1.5 4.2 0.5 4.0 0.0 1.2 8.6 10.1 0.5 0.5 0.0 1.4 1.3 FSIP1 FLJ35989 ENSG00000150667 "Fibrous sheath interacting protein 1" Q8NA03 15 39588357-39782830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 17.8;pituitary gland: 11.8;testis: 13.9" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 17.4;Early spermatids: 47.1;Late spermatids: 39.8;Spermatocytes: 27.4" "Cancer enriched" "Detected in some" 8 "breast cancer: 6.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 7.3" "Low region specificity" "Detected in many" HPA041002 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA041002: AB_10796565" "unprognostic (1.55e-2)" "unprognostic (1.49e-1)" "unprognostic (9.12e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-2)" "unprognostic (1.43e-3)" "unprognostic (5.17e-3)" "unprognostic (5.37e-2)" "unprognostic (9.22e-2)" "unprognostic (1.60e-1)" "unprognostic (1.04e-2)" "unprognostic (2.49e-1)" "unprognostic (1.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.81e-2)" "unprognostic (2.01e-1)" "unprognostic (1.81e-1)" 0.8 0.7 2.9 0.7 9.3 1.1 1.9 1.0 5.7 0.8 11.7 1.5 0.8 0.5 1.4 2.5 0.6 2.3 0.7 0.8 3.1 3.0 1.6 0.7 0.9 0.5 1.2 4.1 0.7 0.6 1.7 11.8 0.8 4.5 0.8 17.8 0.6 0.5 0.7 0.9 1.7 0.6 0.9 1.1 0.6 1.1 13.9 1.4 0.5 1.0 0.0 0.5 1.0 0.9 1.0 1.0 1.8 1.3 1.5 3.4 1.4 0.6 2.3 6.2 0.9 1.1 2.1 0.1 7.3 1.5 1.2 2.2 1.7 0.6 0.5 0.6 2.1 3.1 1.5 1.0 1.2 1.9 2.5 0.6 4.5 1.7 0.1 0.6 0.9 5.0 1.4 5.2 2.8 1.2 1.6 1.3 2.5 0.2 0.6 1.9 0.3 0.6 0.4 0.7 0.3 1.2 0.6 1.2 0.1 2.4 2.7 1.6 4.7 1.5 0.2 0.3 0.5 2.1 0.5 1.0 3.0 1.7 1.6 0.8 1.3 2.7 0.3 6.2 1.7 1.4 1.8 1.3 1.5 3.4 0.8 2.7 0.8 1.8 2.1 1.0 1.0 1.1 0.9 1.1 1.5 1.0 0.0 0.4 1.4 2.9 9.3 1.0 5.7 3.1 3.0 1.2 4.1 4.5 1.4 0.0 0.3 0.5 0.3 0.6 1.0 0.6 2.5 17.4 3.4 1.8 11.8 0.7 1.7 0.6 47.1 0.1 4.9 0.0 0.4 0.1 0.9 0.7 15.1 0.0 0.1 0.0 0.0 0.6 0.0 39.8 1.1 0.1 0.0 0.0 2.2 1.5 0.1 0.0 0.7 2.4 4.9 0.0 0.2 27.4 7.8 0.0 4.7 1.0 1.5 0.3 FTO "ALKBH9, KIAA1752, MGC5149" ENSG00000140718 "FTO, alpha-ketoglutarate dependent dioxygenase" Q9C0B1 16 53701692-54158512 "Disease related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase, Transferase" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Ciliated cells: 315.8;Club cells: 92.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017123, HPA041086, HPA068695" Enhanced Supported Vesicles,Cytosol No No 130000 Cytosol Vesicles "CAB017123: , HPA041086: AB_2677293, HPA068695: AB_2732117" "unprognostic (9.74e-2)" "unprognostic (2.49e-1)" "unprognostic (9.30e-2)" "unprognostic (1.24e-2)" "unprognostic (1.81e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (1.41e-1)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.88e-2)" "unprognostic (6.80e-2)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-1)" "unprognostic (4.30e-3)" "unprognostic (6.11e-3)" 17.5 25.4 19.7 8.7 37.4 5.6 27.1 29.7 37.5 20.2 13.5 30.1 11.4 5.8 22.7 16.8 13.2 19.5 16.2 19.5 19.9 25.9 19.0 13.0 27.3 10.1 21.8 19.6 21.2 15.2 42.0 31.6 14.7 28.9 15.8 10.9 18.9 13.4 19.1 19.9 13.6 8.1 22.6 23.8 11.5 10.1 6.2 22.2 10.0 20.7 7.8 10.6 16.1 12.5 12.3 15.3 8.1 14.8 16.3 22.1 14.0 6.7 12.2 16.2 16.6 32.0 24.2 5.3 16.2 14.8 13.7 4.0 7.6 8.9 15.4 17.9 20.9 7.8 10.0 15.0 16.0 20.1 7.1 11.7 6.9 16.5 14.1 22.1 5.5 7.9 26.6 16.9 12.4 15.3 17.2 20.2 11.5 6.7 3.9 22.0 5.2 12.2 8.4 8.4 7.0 8.0 18.8 24.6 14.4 20.7 5.7 20.0 13.9 18.4 10.9 5.0 16.4 14.4 13.2 19.2 17.2 11.4 9.2 9.9 7.4 5.9 15.8 15.9 10.3 13.1 8.1 11.6 6.0 17.7 14.8 22.1 12.3 17.0 17.7 15.3 11.7 16.0 17.2 2.0 16.3 10.0 6.1 16.5 14.0 19.7 37.4 29.7 37.5 19.9 25.9 21.8 19.6 28.9 22.2 74.5 43.6 3.7 8.0 11.0 22.7 19.6 17.8 315.8 92.1 7.0 11.8 7.9 6.6 7.4 35.1 11.7 4.2 0.0 4.9 6.2 13.6 6.4 24.4 12.1 7.9 15.9 6.3 11.1 6.3 45.9 13.3 9.3 10.1 2.8 6.0 17.6 5.5 6.8 14.2 12.4 14.2 12.9 11.9 2.5 3.8 8.0 4.2 5.1 6.0 7.1 FUT2 "SE, Se2, SEC2, sej" ENSG00000176920 "Fucosyltransferase 2" Q10981 19 48695971-48705950 "Blood group antigen proteins, Enzymes, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.3;salivary gland: 58.1" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 43.3;Enterocytes: 109.6;Exocrine glandular cells: 41.1;Mucus-secreting cells: 39.5;Paneth cells: 73.7;Undifferentiated cells: 44.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "cerebellum: 8.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "CAPAN-2: 34.7;OE19: 38.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA014402 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014402: AB_1849194" "unprognostic (2.95e-2)" "unprognostic (6.07e-2)" "unprognostic (2.80e-3)" "unprognostic (4.63e-3)" "unprognostic (2.63e-1)" "prognostic favorable (5.83e-4)" "unprognostic (6.30e-3)" "unprognostic (6.55e-3)" "unprognostic (1.58e-1)" "unprognostic (8.44e-2)" "unprognostic (7.89e-2)" "unprognostic (5.11e-1)" "unprognostic (4.04e-2)" "unprognostic (6.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.12e-1)" "unprognostic (2.87e-1)" 0.4 0.6 0.7 5.3 0.8 0.0 0.8 8.7 1.6 9.3 25.0 0.3 13.9 24.1 1.3 0.1 16.0 1.2 23.3 0.5 0.7 0.7 0.8 0.4 1.1 0.1 0.7 0.1 1.0 7.5 0.0 1.5 0.2 0.7 1.2 10.9 0.1 58.1 14.5 0.5 2.6 41.3 0.4 0.7 0.6 15.8 0.7 0.2 0.5 0.6 16.1 19.3 3.1 5.4 1.7 1.8 3.5 1.0 1.4 2.5 0.6 0.9 0.9 0.2 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 4.1 34.7 0.3 0.2 0.0 0.2 6.1 0.0 0.0 0.0 0.3 0.2 0.3 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.4 0.0 0.4 0.4 0.8 0.2 38.7 0.3 0.3 0.1 1.5 0.0 0.3 1.8 0.2 0.1 0.3 0.0 0.2 5.2 0.0 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.0 0.1 0.2 0.1 3.5 0.8 0.4 2.0 0.7 1.1 1.5 2.3 1.0 0.5 1.7 2.1 0.7 3.4 1.4 1.0 1.8 2.5 0.6 0.7 0.8 8.7 1.6 0.7 0.7 0.7 0.1 0.7 0.2 0.0 1.1 0.0 2.5 0.8 2.7 0.4 43.3 12.0 10.3 19.2 2.0 0.0 1.7 5.5 0.5 0.3 109.6 0.0 41.1 0.0 0.2 2.5 0.0 0.0 0.1 0.0 10.9 0.0 0.3 0.0 0.0 0.0 1.7 0.0 39.5 0.8 25.6 73.7 0.0 0.0 3.8 0.0 0.2 0.2 0.2 1.3 0.1 2.2 44.3 14.7 GABARAPL2 "ATG8, ATG8C, GATE-16, GATE16, GEF2" ENSG00000034713 "GABA type A receptor associated protein like 2" P60520 16 75566351-75577881 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036726 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA036726: AB_10672476" "unprognostic (3.29e-2)" "unprognostic (3.16e-2)" "unprognostic (1.30e-2)" "unprognostic (7.00e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.58e-1)" "unprognostic (6.85e-2)" "unprognostic (2.13e-1)" "unprognostic (4.95e-2)" "unprognostic (9.86e-3)" "unprognostic (1.33e-2)" "prognostic favorable (5.95e-8)" "unprognostic (3.11e-3)" "unprognostic (3.84e-3)" "unprognostic (1.37e-2)" "unprognostic (3.85e-1)" 29.6 47.4 69.0 18.0 70.5 24.7 33.8 52.3 61.4 29.4 23.9 54.2 26.0 18.7 25.7 47.1 21.7 30.9 23.7 76.6 59.6 69.5 42.0 31.4 25.4 23.4 73.4 52.5 28.9 25.8 46.2 33.6 31.8 52.4 33.4 23.6 30.8 27.3 31.0 52.7 24.3 19.4 28.2 72.0 25.7 21.8 20.2 45.4 17.5 35.7 22.4 26.8 22.6 19.3 38.2 47.0 87.8 25.4 18.9 35.1 35.9 23.9 20.4 34.9 16.4 54.2 47.8 17.7 28.2 40.9 38.7 43.6 18.7 31.1 34.6 34.8 32.1 23.4 20.7 25.9 26.4 47.9 14.9 49.4 20.4 18.8 27.7 29.6 19.5 36.9 33.0 37.5 32.5 24.3 35.3 31.4 31.4 29.8 14.2 38.6 33.9 28.8 37.4 20.9 27.0 22.9 32.5 16.8 41.7 40.4 15.7 41.1 43.0 44.1 10.6 40.5 29.1 34.0 30.8 28.6 16.8 25.7 24.4 15.1 40.5 38.3 72.4 40.5 19.0 24.7 47.8 25.3 61.1 23.9 23.4 30.6 38.2 25.6 27.3 30.4 32.1 23.3 21.8 87.8 18.9 25.4 47.0 35.1 35.9 69.0 70.5 52.3 61.4 59.6 69.5 73.4 52.5 52.4 45.4 80.4 128.3 143.1 246.6 244.3 234.3 274.6 119.8 196.7 104.6 165.7 43.2 221.0 581.9 172.6 40.2 247.2 151.5 210.2 153.9 100.3 212.4 297.8 105.3 119.0 199.3 290.8 266.6 200.1 176.9 47.4 225.5 212.5 244.6 505.9 147.5 338.5 185.4 241.8 245.4 443.3 155.9 155.2 146.3 296.3 235.3 239.5 326.2 159.2 111.7 275.4 GABPB1 "E4TF1-47, GABPB, GABPB2" ENSG00000104064 "GA binding protein transcription factor beta subunit 1" Q06547 15 50275392-50355408 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019653, HPA067444" Supported Supported "Nucleoplasm,Cytoplasmic bodies" NA Yes Nucleoplasm "Cytoplasmic bodies" "HPA019653: AB_1849370, HPA067444: AB_2685842" "unprognostic (7.79e-3)" "unprognostic (2.42e-2)" "unprognostic (3.84e-1)" "unprognostic (1.92e-1)" "unprognostic (9.33e-2)" "unprognostic (3.99e-2)" "unprognostic (3.25e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-2)" "unprognostic (8.94e-3)" "unprognostic (1.23e-1)" "unprognostic (4.54e-3)" "prognostic unfavorable (2.53e-4)" "unprognostic (3.18e-2)" "unprognostic (2.37e-1)" "unprognostic (1.13e-1)" "unprognostic (3.93e-3)" 15.4 12.6 8.1 13.8 16.8 31.7 14.3 16.0 14.0 12.7 9.5 8.4 8.6 8.1 14.1 10.8 13.8 12.0 12.6 10.3 8.8 7.2 9.1 16.2 15.2 25.7 9.1 8.7 12.1 10.6 8.7 11.5 15.1 7.3 11.4 11.8 10.7 12.1 8.1 15.2 10.4 12.8 13.9 7.3 17.1 11.2 17.3 9.9 35.7 16.2 12.5 20.8 13.4 11.9 23.1 16.8 26.8 15.0 19.1 21.1 14.3 11.8 13.7 20.1 15.6 5.3 7.5 26.9 15.7 12.4 18.6 16.4 23.3 9.8 15.6 9.6 12.9 14.7 19.7 18.0 13.4 23.7 21.6 10.7 18.5 14.3 15.8 12.8 17.7 14.4 9.9 13.2 17.4 22.7 10.5 32.4 17.2 16.9 19.8 12.3 27.0 26.1 16.0 13.8 13.1 9.3 32.3 14.7 14.9 11.2 15.2 19.0 15.7 13.9 13.2 15.8 20.1 11.5 17.6 15.4 17.0 14.1 29.6 27.9 14.1 19.2 27.5 10.5 16.4 17.0 26.8 12.2 23.6 15.9 15.0 21.1 23.1 15.7 16.9 16.8 21.3 14.6 16.8 12.4 19.1 11.1 13.3 20.4 14.3 8.1 16.8 16.0 14.0 8.8 7.2 9.1 8.7 7.3 9.9 8.9 9.1 53.0 89.7 41.9 40.4 15.3 12.7 8.1 0.0 7.0 33.4 37.1 3.3 11.0 80.1 35.3 15.8 0.0 6.7 41.1 28.6 72.8 47.2 24.6 31.6 35.0 48.5 39.3 56.1 27.9 53.5 11.6 18.6 25.2 23.1 30.3 11.9 21.0 36.0 6.5 40.6 25.8 24.5 27.4 31.1 31.2 46.3 116.7 26.4 90.9 GABRA1 EJM5 ENSG00000022355 "Gamma-aminobutyric acid type A receptor alpha1 subunit" P14867 5 161847063-161899981 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 58.6" "Cell type enriched" "Detected in some" 24 "Bipolar cells: 209.5" "Cancer enriched" "Detected in single" 5 "glioma: 1.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 3.7;SCLC-21H: 1.1;U-2 OS: 1.6;U-87 MG: 2.3;WM-115: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022502, HPA029363, HPA055746" Enhanced Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB022502: , HPA029363: , HPA055746: AB_2682904" "unprognostic (2.58e-2)" "unprognostic (4.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.31e-1)" "unprognostic (2.43e-1)" 1.0 2.6 8.5 1.0 21.9 1.0 1.0 35.2 58.6 1.0 1.0 1.8 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 10.5 8.8 1.0 1.0 1.0 1.0 6.7 22.0 1.0 1.0 1.0 0.1 1.0 7.4 1.2 1.0 0.2 1.0 1.1 1.0 1.0 1.0 1.0 1.3 1.1 1.5 1.1 0.0 0.0 1.0 0.0 1.3 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 2.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 21.9 35.2 49.8 10.5 8.8 6.7 22.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 209.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRA2 ENSG00000151834 "Gamma-aminobutyric acid type A receptor alpha2 subunit" P47869 4 46248427-46475230 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 52.6" "Group enriched" "Detected in some" 4 "Collecting duct cells: 38.4;Enterocytes: 16.9;Intestinal endocrine cells: 30.6" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-2 OS: 9.6;U-87 MG: 4.5;WM-115: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029363, CAB079061" Supported Uncertain "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" Nucleoplasm "CAB079061: , HPA029363: " "unprognostic (2.03e-2)" "unprognostic (2.77e-1)" "unprognostic (2.45e-4)" "unprognostic (6.87e-3)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.09e-1)" "unprognostic (6.90e-3)" "unprognostic (8.83e-2)" "unprognostic (2.22e-5)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.67e-1)" "unprognostic (3.04e-2)" 2.2 1.3 38.5 1.4 34.4 1.2 1.9 10.4 52.6 1.7 4.5 4.9 0.0 2.0 1.4 11.7 1.7 1.0 1.6 1.0 38.9 7.7 8.8 1.4 1.0 1.4 3.7 31.0 1.9 1.0 0.9 0.6 1.5 10.5 1.0 3.5 0.0 1.2 1.9 1.0 1.3 7.7 1.3 6.9 2.3 1.6 1.5 7.1 0.0 1.1 0.0 1.4 1.2 0.8 0.2 0.3 1.0 0.1 0.1 0.1 0.0 0.5 0.5 0.1 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 2.1 0.6 0.2 0.5 0.0 0.1 0.8 0.0 0.0 0.2 0.5 0.5 0.1 0.7 0.3 0.8 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.8 0.2 0.0 0.4 0.0 0.3 0.9 1.8 0.1 0.0 0.6 0.4 0.1 0.6 0.2 0.0 0.1 0.3 0.0 0.6 0.4 0.4 0.1 0.5 9.6 0.5 0.1 0.8 1.2 0.2 4.5 0.4 5.1 1.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.1 0.1 0.3 0.0 0.0 38.5 34.4 10.4 31.4 38.9 7.7 3.7 31.0 10.5 7.1 0.0 0.0 0.0 0.0 0.1 1.5 0.4 0.0 0.0 0.0 38.4 3.9 0.0 3.3 0.0 6.4 0.2 16.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 30.6 0.0 0.0 6.9 0.6 0.0 1.7 0.0 1.9 0.3 0.0 0.9 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.0 GABRA3 ENSG00000011677 "Gamma-aminobutyric acid type A receptor alpha3 subunit" P34903 X 152166234-152451358 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 30.1" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 12.1" "Cancer enriched" "Detected in many" 7 "testis cancer: 16.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 9.1;HMC-1: 7.7;Karpas-707: 13.0;PC-3: 7.6;U-266/70: 7.0;U-266/84: 11.6;U-87 MG: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000839, HPA029363" Approved Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA000839: AB_1078929, HPA029363: " "unprognostic (9.63e-3)" "unprognostic (2.04e-1)" "unprognostic (2.02e-1)" "unprognostic (1.18e-2)" "unprognostic (7.07e-2)" "unprognostic (5.42e-2)" "unprognostic (2.34e-6)" "unprognostic (1.24e-1)" "unprognostic (2.70e-1)" "unprognostic (2.39e-2)" "unprognostic (2.63e-2)" "unprognostic (1.73e-1)" "unprognostic (7.29e-6)" "unprognostic (7.42e-3)" "unprognostic (6.20e-2)" "unprognostic (8.13e-2)" 0.7 0.7 7.7 0.6 15.2 0.7 0.7 1.3 30.1 2.2 0.8 3.3 0.0 0.8 1.2 0.8 1.3 0.7 0.7 0.7 10.9 15.9 0.7 0.7 0.7 0.7 4.7 10.5 0.6 0.7 0.6 0.9 5.2 6.2 0.8 0.8 0.4 0.7 1.8 0.8 1.1 0.9 0.8 2.1 0.7 0.7 1.8 1.1 0.0 0.7 0.0 0.9 1.8 0.4 0.0 0.1 1.5 0.3 0.3 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 13.0 0.0 0.0 0.0 0.0 2.4 5.5 7.6 0.0 0.0 0.0 0.0 0.0 0.2 4.7 0.0 4.8 0.4 0.3 0.1 1.2 0.0 4.9 6.5 0.3 1.4 7.0 11.6 0.0 7.7 0.0 4.9 1.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.1 0.2 0.0 7.7 15.2 1.3 28.4 10.9 15.9 4.7 10.5 6.2 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 0.0 1.6 0.0 0.0 0.3 GABRD ENSG00000187730 "Gamma-aminobutyric acid type A receptor delta subunit" O14764 1 2019298-2030758 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 87.0" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 9.3;Ciliated cells: 8.1;Club cells: 11.4;Horizontal cells: 12.7;Spermatogonia: 13.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 87.0" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "EFO-21: 2.9;HMC-1: 2.5;MCF7: 8.3;NB-4: 5.3;NTERA-2: 2.1;SH-SY5Y: 3.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044371 Enhanced Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA044371: AB_2678916" "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-8)" "unprognostic (6.34e-3)" "unprognostic (2.66e-3)" "unprognostic (1.04e-2)" "unprognostic (3.44e-3)" "unprognostic (2.14e-1)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (4.12e-8)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "unprognostic (5.16e-2)" 1.2 3.4 8.8 0.9 16.8 1.0 1.0 87.0 40.0 1.0 1.2 1.7 0.0 0.9 1.3 1.2 1.3 1.0 1.5 1.7 6.0 1.7 1.1 0.9 1.4 1.3 3.3 11.1 0.9 0.9 1.4 0.7 1.2 17.1 1.0 1.0 0.0 1.1 0.9 1.3 1.4 1.0 1.4 1.4 1.0 1.0 3.3 1.5 0.0 1.6 0.0 1.0 1.2 0.1 0.0 1.2 0.2 0.1 0.0 0.0 0.8 0.0 0.7 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 5.3 2.1 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.1 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.8 8.8 16.8 87.0 40.0 6.0 1.7 3.3 11.1 17.1 1.5 3.0 5.1 0.0 0.0 0.5 9.3 0.8 0.0 8.1 11.4 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.2 0.0 0.1 2.3 0.0 0.1 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.0 3.1 0.1 13.5 0.0 0.2 0.0 0.0 0.0 GAGE10 ENSG00000215274 "G antigen 10" A6NGK3 X 49303669-49319844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ovary: 3.9;pituitary gland: 3.1;testis: 2.9" "Cell type enhanced" "Detected in some" 28 "Leydig cells: 1.1;Peritubular cells: 1.1;Spermatocytes: 1.4;Spermatogonia: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 7.0;BJ hTERT+: 1.5;SuSa: 2.2;WM-115: 2.9" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" "unprognostic (2.81e-2)" "unprognostic (2.26e-1)" "unprognostic (3.97e-1)" 0.0 0.0 0.6 0.0 1.8 0.1 0.8 0.5 0.3 0.0 0.2 0.0 0.5 2.0 0.0 1.7 0.1 0.5 0.5 0.5 0.0 0.0 0.0 0.6 0.4 3.9 0.0 0.0 3.1 0.0 0.4 0.3 0.2 1.1 0.2 0.0 0.0 1.4 0.2 0.3 0.0 2.9 0.8 0.2 0.0 0.1 0.0 0.7 0.0 0.5 0.1 0.5 0.3 0.0 0.0 0.6 7.0 0.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 1.0 0.0 0.0 0.2 0.0 0.2 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.2 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.3 0.0 0.1 0.5 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 4.9 0.1 0.0 0.0 0.0 0.1 GAGE12E ENSG00000216649 "G antigen 12E" A1L429 X 49551333-49558649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 9.6" "Cell type enriched" "Detected in some" 12 "Spermatogonia: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 7.4;HeLa: 4.1;Karpas-707: 2.0;T-47d: 1.7;U-266/84: 4.4;WM-115: 2.0" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.6 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.0 0.0 0.5 0.3 0.0 0.0 0.7 4.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 11.5 0.0 0.0 0.0 0.0 0.0 GAL3ST1 CST ENSG00000128242 "Galactose-3-O-sulfotransferase 1" Q99999 22 30554635-30574587 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 28.7;gallbladder: 13.4;intestine: 25.1;kidney: 13.3;stomach 1: 7.2" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 38.2;Enterocytes: 17.4;Muller glia cells: 29.4;Proximal tubular cells: 18.9" "Cancer enriched" "Detected in many" 6 "renal cancer: 38.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 22.7;CACO-2: 6.3;EFO-21: 12.3;K-562: 5.3;OE19: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001220, HPA077138" Approved Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Vesicles Nucleoplasm "HPA001220: AB_1078933, HPA077138: " "unprognostic (2.69e-2)" "unprognostic (3.12e-4)" "unprognostic (5.93e-2)" "unprognostic (1.08e-2)" "unprognostic (2.32e-1)" "unprognostic (6.50e-3)" "unprognostic (1.53e-2)" "unprognostic (2.23e-1)" "unprognostic (2.89e-1)" "unprognostic (5.18e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (2.33e-1)" "unprognostic (4.23e-2)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" 0.8 0.6 8.4 0.7 9.6 1.2 0.8 1.4 12.3 1.4 11.3 25.8 0.0 24.2 1.3 2.3 0.8 2.2 13.4 0.5 12.1 8.3 13.3 1.6 1.5 0.9 14.0 2.6 1.2 2.9 0.6 0.5 1.3 12.4 1.2 2.8 0.3 1.0 1.9 1.9 2.1 25.1 0.7 28.7 0.7 7.2 2.5 7.8 0.0 0.6 0.0 0.4 1.0 0.7 2.3 2.8 2.3 0.7 0.3 0.8 0.0 0.1 22.7 0.4 0.2 0.0 0.0 1.7 0.0 0.1 0.0 0.0 6.3 3.1 0.3 12.3 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.8 0.3 0.2 4.1 0.5 0.1 0.3 0.2 0.0 0.1 0.1 0.0 0.0 0.3 5.3 0.6 0.0 0.1 0.3 0.9 3.3 8.5 0.3 0.2 0.1 0.6 0.9 0.1 0.3 1.5 0.0 0.4 0.2 0.6 0.1 0.1 0.6 0.2 0.1 0.2 0.0 2.0 1.2 0.3 0.1 0.1 0.2 0.9 0.7 0.1 0.4 0.5 0.7 1.8 0.7 0.8 0.2 2.3 0.5 0.8 2.3 0.3 0.3 2.8 0.1 0.0 8.4 9.6 1.4 10.3 12.1 8.3 14.0 2.6 12.4 7.8 0.0 0.0 0.0 0.1 0.3 0.7 0.6 38.2 0.0 0.0 3.5 0.0 0.0 13.3 5.6 0.9 0.1 17.4 0.0 9.7 0.0 0.0 0.2 0.0 1.3 0.1 0.0 10.5 0.0 0.8 0.6 1.4 0.0 0.0 0.0 7.4 29.4 4.6 7.0 2.1 18.9 1.1 0.0 0.0 3.1 7.5 0.3 0.2 0.0 8.0 0.0 GALNT17 "GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17" ENSG00000185274 "Polypeptide N-acetylgalactosaminyltransferase 17" Q6IS24 7 71132169-71713600 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.9" "Cell type enhanced" "Detected in single" 28 "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.6;NTERA-2: 7.2;RPMI-8226: 8.0;SK-BR-3: 30.5;SuSa: 10.0" "Low region specificity" "Detected in all" "HPA013624, HPA047986" Approved Uncertain "Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "Nucleoli, Nuclear bodies" "HPA013624: AB_1858787, HPA047986: " "unprognostic (2.79e-2)" "unprognostic (6.83e-2)" "unprognostic (5.54e-2)" "unprognostic (3.66e-3)" "unprognostic (1.50e-1)" "unprognostic (2.62e-1)" "unprognostic (6.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.00e-1)" "prognostic favorable (4.60e-4)" "unprognostic (2.00e-1)" "unprognostic (4.73e-1)" "unprognostic (1.96e-2)" "unprognostic (9.63e-3)" "prognostic favorable (3.91e-4)" "unprognostic (1.92e-1)" "unprognostic (7.94e-3)" 1.8 7.8 8.2 2.1 13.9 0.5 1.2 25.7 42.9 2.3 4.9 1.7 1.9 0.8 7.9 4.6 8.9 4.4 2.7 19.4 13.2 4.6 2.3 0.6 3.5 0.5 2.1 12.0 22.3 9.4 0.6 4.1 0.7 4.5 9.1 1.4 1.2 1.7 8.3 1.9 0.8 1.5 12.3 1.2 3.3 1.1 3.8 0.8 0.3 9.4 0.0 1.8 10.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.5 0.0 0.0 30.5 0.0 10.0 0.0 0.0 0.0 0.0 2.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 13.9 25.7 22.5 13.2 4.6 2.1 12.0 4.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAPT "C5orf29, FLJ33641" ENSG00000175857 "GRB2 binding adaptor protein, transmembrane" Q8N292 5 58491435-58497090 "Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 117.8" "Group enriched" "Detected in some" 9 "B-cells: 29.7;granulocytes: 52.1;Hofbauer cells: 15.1;Kupffer cells: 25.6;Macrophages: 34.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "eosinophil: 117.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 117.8" "Cell line enhanced" "Detected in some" "HEL: 27.4;HL-60: 15.8;NB-4: 16.5;THP-1: 13.0;U-937: 45.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011048, HPA011070" Uncertain Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus, Vesicles" "HPA011048: , HPA011070: AB_1848887" "unprognostic (9.79e-2)" "unprognostic (5.67e-3)" "unprognostic (2.39e-2)" "unprognostic (3.26e-2)" "unprognostic (3.36e-2)" "unprognostic (8.09e-4)" "unprognostic (4.32e-1)" "unprognostic (1.23e-3)" "unprognostic (4.14e-2)" "unprognostic (9.47e-3)" "unprognostic (7.28e-2)" "unprognostic (2.93e-1)" "unprognostic (3.52e-3)" "unprognostic (3.74e-2)" "unprognostic (2.42e-2)" "unprognostic (2.33e-2)" "unprognostic (1.40e-2)" 1.4 0.8 1.4 15.5 2.7 8.5 1.0 0.6 1.2 1.8 1.4 1.6 0.4 1.8 1.3 2.2 3.3 1.2 3.1 1.1 1.5 1.7 1.6 1.0 7.2 19.4 4.5 0.9 0.7 1.2 0.0 1.5 0.8 4.4 2.6 2.0 1.4 2.3 0.4 0.5 0.9 8.2 2.4 5.9 25.8 1.7 0.8 3.2 5.2 1.1 0.5 23.5 5.1 1.2 12.0 25.4 117.8 8.2 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 15.8 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 16.5 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.7 0.0 12.3 8.2 117.8 0.0 5.7 0.0 12.0 0.0 0.0 9.4 11.9 0.0 0.0 10.1 0.1 6.6 25.4 0.0 3.4 1.4 2.7 0.6 1.2 1.5 1.7 4.5 0.9 4.4 3.2 3.0 3.4 29.7 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.1 0.0 15.1 0.0 0.0 0.6 25.6 0.0 0.0 34.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 GBP2 ENSG00000162645 "Guanylate binding protein 2" P32456 1 89106132-89150456 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 23.9;HDLM-2: 26.3;RT4: 33.0" "HPA042682, CAB045975" Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB045975: AB_10584474, HPA042682: AB_2678113" "prognostic favorable (7.57e-4)" "unprognostic (2.92e-2)" "unprognostic (3.65e-2)" "unprognostic (3.02e-2)" "unprognostic (1.34e-1)" "unprognostic (4.68e-2)" "unprognostic (2.70e-2)" "unprognostic (1.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.75e-3)" "prognostic unfavorable (5.73e-5)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.14e-10)" "unprognostic (7.75e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-2)" "prognostic favorable (1.10e-5)" 40.1 39.4 4.7 24.4 14.3 8.9 31.9 2.3 11.0 38.2 35.7 3.3 9.5 11.0 29.0 20.6 39.0 17.5 18.5 12.6 4.6 4.1 21.6 17.9 42.8 21.3 14.3 2.9 35.5 4.9 39.8 5.9 17.3 12.2 48.7 13.8 12.4 14.2 15.4 20.1 19.5 39.6 48.1 26.7 27.5 20.2 13.0 6.0 7.7 22.0 18.2 15.3 63.1 40.3 3.1 8.5 78.9 44.2 20.1 61.2 22.2 6.1 0.5 0.0 0.0 17.7 15.4 4.6 1.6 15.9 2.6 6.1 0.1 9.7 0.0 23.9 10.6 12.0 1.2 0.0 0.2 1.4 26.3 0.0 0.1 4.5 1.3 4.7 0.7 1.1 16.1 0.1 3.9 0.0 8.9 18.0 0.0 0.3 1.0 7.3 0.0 0.0 5.8 0.0 5.6 0.4 0.1 6.8 0.0 5.0 33.0 0.0 0.2 7.8 2.2 0.2 0.5 0.2 1.0 12.2 2.0 0.4 2.8 1.7 19.1 0.0 0.0 6.1 0.1 0.3 12.2 20.5 6.6 24.6 31.2 32.6 3.1 26.3 27.1 8.5 2.7 18.0 18.9 78.9 20.1 44.2 0.5 61.2 22.2 4.7 14.3 2.3 11.0 4.6 4.1 14.3 2.9 12.2 6.0 23.8 30.1 5.9 100.6 41.3 0.1 2.8 28.1 24.1 17.0 17.4 0.0 26.1 0.0 75.3 22.8 54.8 48.0 23.3 62.4 50.9 30.1 66.0 44.1 22.2 33.3 0.0 9.8 22.1 68.8 22.5 4.4 82.4 8.5 45.9 9.7 0.6 67.5 28.1 8.1 7.7 0.0 19.4 69.6 0.7 2.1 54.1 48.3 77.8 8.6 78.8 GBP4 Mpa2 ENSG00000162654 "Guanylate binding protein 4" Q96PP9 1 89181148-89198932 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 56.2;Endothelial cells: 79.8;Ito cells: 89.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.0;HDLM-2: 8.0;HEL: 10.7;REH: 9.0;RT4: 15.1;U-266/70: 13.6" "HPA030101, HPA062039" Enhanced Supported "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Plasma membrane" "HPA030101: AB_10601654, HPA062039: " "unprognostic (1.32e-2)" "unprognostic (3.89e-3)" "unprognostic (1.02e-2)" "unprognostic (1.07e-3)" "unprognostic (3.22e-1)" "unprognostic (9.93e-3)" "unprognostic (5.65e-2)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "prognostic favorable (9.29e-5)" "unprognostic (1.91e-3)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.30e-5)" "unprognostic (1.22e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-2)" "unprognostic (2.02e-3)" 25.4 4.4 3.9 18.4 5.9 3.6 9.4 2.1 5.0 7.8 5.8 4.4 2.9 8.0 10.5 7.4 7.9 6.3 5.7 9.2 4.6 4.4 8.5 9.8 34.7 20.5 5.8 4.4 12.8 2.4 9.3 4.8 9.1 6.9 12.7 4.8 17.4 4.8 4.8 12.0 3.2 11.0 5.1 7.4 23.4 7.4 2.6 2.7 8.1 23.3 5.7 15.2 9.3 7.7 3.3 2.0 5.1 12.6 12.2 7.6 4.4 0.7 0.0 0.1 0.3 0.1 0.1 0.6 1.5 6.4 6.8 6.2 0.1 10.0 0.5 0.9 1.9 0.6 0.8 0.0 0.3 0.3 8.0 0.1 10.7 0.3 0.3 0.9 0.2 0.3 0.3 0.0 0.1 0.0 1.0 1.6 0.2 0.3 2.0 0.0 0.1 5.3 0.3 0.4 0.0 0.1 9.0 0.2 0.3 0.1 15.1 0.2 0.5 0.2 0.5 0.3 0.7 0.5 1.1 0.4 0.2 1.4 0.2 0.1 13.6 0.2 0.3 0.3 0.1 1.9 0.4 3.8 0.4 6.6 12.6 5.8 2.3 7.3 7.3 2.0 3.3 5.5 5.1 5.1 12.2 11.5 0.7 7.6 4.4 3.9 5.9 2.1 5.0 4.6 4.4 5.8 4.4 6.9 2.7 29.8 44.9 10.0 7.8 4.0 2.1 2.8 10.2 56.2 37.5 5.2 7.9 0.7 0.0 1.9 1.5 79.8 2.5 23.3 2.9 1.1 5.6 14.8 20.8 6.4 8.7 0.0 0.0 89.0 20.0 0.5 3.4 22.5 5.0 29.7 2.8 16.2 21.4 1.9 1.8 0.7 10.6 0.0 5.7 2.6 4.5 2.6 1.3 21.3 0.5 12.5 GCGR GGR ENSG00000215644 "Glucagon receptor" P47871 17 81804132-81814013 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 68.8" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 60.2" "Cancer enhanced" "Detected in many" "liver cancer: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 3.9;MCF7: 6.1;SK-BR-3: 5.3;U-87 MG: 6.1" "Region enriched" "Detected in single" 5 "cerebellum: 0.9" "Not detected" "Not detected" HPA071228 Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA071228: AB_2686368" "unprognostic (3.28e-4)" "unprognostic (9.30e-2)" "unprognostic (2.20e-1)" "unprognostic (1.53e-4)" "unprognostic (1.11e-1)" "unprognostic (2.30e-3)" "unprognostic (4.38e-2)" "unprognostic (1.79e-3)" "unprognostic (2.18e-1)" "unprognostic (2.77e-1)" "unprognostic (3.09e-1)" "unprognostic (2.61e-1)" "unprognostic (6.42e-2)" "unprognostic (5.99e-3)" "unprognostic (1.71e-1)" "unprognostic (1.17e-3)" "unprognostic (8.36e-3)" 0.2 3.9 0.1 0.6 0.3 0.0 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.0 11.4 68.8 0.1 0.1 0.1 0.1 0.1 0.5 3.9 0.1 0.1 0.5 0.2 0.0 1.4 0.3 0.1 0.1 0.9 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.2 0.6 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.9 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.6 0.0 5.3 0.0 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.8 0.2 0.6 0.0 0.0 0.0 3.5 2.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.2 0.1 0.0 0.0 1.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 GCSAML-AS1 ENSG00000284824 "GCSAML antisense RNA 1" Q8N628 1 247524679-247532613 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.1;hTERT-HME1: 1.0;SK-MEL-30: 1.2" HPA058578 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA058578: AB_2683761" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 GDNF "ATF1, ATF2, HFB1-GDNF" ENSG00000168621 "Glial cell derived neurotrophic factor" P39905 5 37812677-37839686 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes, Disease mutation, Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;skeletal muscle: 12.4" "Cell type enhanced" "Detected in single" 9 "Fibroblasts: 1.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 14.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 25.0;SuSa: 7.8;U-87 MG: 7.6;WM-115: 27.5" "Region enhanced" "Detected in single" "basal ganglia: 2.5" "Low region specificity" "Detected in many" "CAB005210, HPA070283" Supported Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA Vesicles Nucleoplasm "CAB005210: AB_2247684, HPA070283: AB_2686246" "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (3.54e-2)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.08e-1)" "unprognostic (5.33e-2)" "unprognostic (1.92e-1)" "unprognostic (3.71e-2)" "unprognostic (2.01e-2)" "unprognostic (2.41e-1)" "unprognostic (2.10e-1)" "unprognostic (1.16e-4)" "unprognostic (2.04e-1)" "unprognostic (8.86e-2)" "unprognostic (1.05e-1)" "unprognostic (4.42e-2)" 1.9 0.3 0.6 1.9 2.3 0.0 0.4 14.1 1.3 0.8 9.4 0.4 0.4 1.6 1.7 3.4 1.0 0.9 0.9 0.9 0.6 0.4 1.0 0.7 0.4 0.4 0.6 1.2 4.5 0.4 0.0 0.4 6.3 1.4 1.6 3.1 1.1 0.4 6.3 12.4 1.4 2.5 2.5 0.5 0.4 1.9 3.9 2.4 0.4 0.4 1.5 0.4 0.6 1.1 0.8 0.4 1.2 0.3 0.9 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 3.4 2.1 0.6 0.9 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.2 0.3 0.1 0.1 0.0 1.0 0.1 25.0 0.0 0.8 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.2 0.0 0.1 0.1 1.7 7.8 0.0 0.0 0.0 3.4 0.0 0.8 3.9 2.3 0.0 0.0 7.6 0.0 27.5 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.8 0.2 0.4 1.2 0.9 0.2 0.4 0.1 0.0 0.6 2.3 14.1 1.3 0.6 0.4 0.6 1.2 1.4 2.4 0.0 0.0 0.0 0.0 0.8 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.5 0.0 0.0 0.6 0.0 0.8 0.3 0.1 0.0 0.0 0.5 GFI1B ZNF163B ENSG00000165702 "Growth factor independent 1B transcriptional repressor" Q5VTD9 9 132944000-132991687 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 71.0;bone marrow: 29.2" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 70.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "basophil: 31.2;eosinophil: 71.0" "Lineage enriched" "Detected in many" 26 "granulocytes: 71.0" "Group enriched" "Detected in some" 5 "HEL: 55.6;HMC-1: 36.0;K-562: 17.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004420, HPA006291" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "CAB004420: AB_2110132, HPA006291: " "unprognostic (1.79e-2)" "unprognostic (2.90e-4)" "unprognostic (6.54e-2)" "unprognostic (1.76e-1)" "unprognostic (2.33e-1)" "unprognostic (1.54e-2)" "unprognostic (2.53e-3)" "unprognostic (1.05e-1)" "unprognostic (2.47e-1)" "unprognostic (1.54e-1)" "unprognostic (4.61e-2)" "unprognostic (3.71e-2)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (1.53e-2)" "unprognostic (1.41e-1)" 0.2 0.0 0.2 2.2 0.2 29.2 0.1 0.1 0.2 0.9 4.2 0.2 0.0 0.8 0.4 0.7 0.8 0.2 3.5 0.8 0.2 0.1 0.3 0.4 2.5 0.0 0.1 0.0 0.1 0.2 0.0 0.1 1.2 0.0 4.2 0.3 0.2 0.1 0.1 0.3 0.8 6.3 1.0 0.2 3.3 0.3 4.0 0.0 1.0 0.2 0.0 0.5 0.4 0.2 0.0 0.3 71.0 2.7 0.1 0.1 2.4 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.1 7.8 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 55.6 0.1 0.0 0.0 0.0 36.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 31.2 0.0 71.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.8 0.1 2.7 0.1 0.0 2.4 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.8 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 70.0 0.0 0.1 0.0 0.5 13.9 0.0 0.1 0.0 1.2 0.0 0.8 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.2 0.0 0.3 0.1 GFRA2 "GDNFRB, NTNRA, RETL2, TRNR2" ENSG00000168546 "GDNF family receptor alpha 2" O00451 8 21690403-21812357 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;thyroid gland: 17.4" "Group enriched" "Detected in many" 5 "Horizontal cells: 208.2;Late spermatids: 217.5" "Cancer enriched" "Detected in some" 5 "thyroid cancer: 6.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 10.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.1;monocytes: 10.9" "Cell line enhanced" "Detected in some" "HEL: 9.0;HMC-1: 20.6;WM-115: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024704, CAB032791" Uncertain Uncertain Vesicles "Intracellular and membrane" NA NA 3300000 Vesicles "CAB032791: AB_2110428, HPA024704: AB_1849629" "unprognostic (4.24e-2)" "unprognostic (1.11e-2)" "unprognostic (4.02e-1)" "unprognostic (3.46e-2)" "unprognostic (3.93e-2)" "unprognostic (1.08e-2)" "unprognostic (7.48e-4)" "unprognostic (2.87e-1)" "unprognostic (6.11e-2)" "unprognostic (4.40e-3)" "unprognostic (2.11e-3)" "unprognostic (7.82e-2)" "unprognostic (1.50e-4)" "unprognostic (8.45e-4)" "unprognostic (1.74e-1)" "unprognostic (4.68e-2)" "unprognostic (9.63e-3)" 4.2 3.4 2.6 3.4 6.7 1.2 1.4 2.1 19.2 4.9 3.6 0.7 2.6 3.4 1.3 4.0 3.0 4.3 1.2 3.2 6.8 8.9 1.1 1.9 2.2 4.3 4.3 7.1 1.0 0.9 0.2 2.0 11.5 3.2 1.3 2.0 3.7 2.0 4.9 0.4 1.2 3.2 3.5 1.9 12.2 2.2 6.7 0.2 1.0 17.4 0.0 1.5 2.4 2.6 0.1 3.1 0.9 10.9 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 2.4 0.9 0.0 10.9 0.0 0.0 0.0 0.0 3.1 0.1 0.2 0.0 0.5 0.0 1.4 0.0 0.0 0.9 2.6 6.7 2.1 19.2 6.8 8.9 4.3 7.1 3.2 0.2 0.0 2.6 0.0 0.1 1.5 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 39.8 0.0 0.0 0.0 0.0 0.1 1.0 0.1 1.1 0.0 0.5 208.2 0.0 1.3 25.5 217.5 0.6 6.0 0.0 0.0 0.0 1.5 0.0 0.0 1.8 0.0 1.7 6.5 2.1 1.2 1.9 0.6 0.2 0.0 0.0 0.1 GFRA3 GFRa-3 ENSG00000146013 "GDNF family receptor alpha 3" O60609 5 138252379-138274671 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 23 "granulocytes: 27.5;Intestinal endocrine cells: 51.2;Late spermatids: 11.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "cerebellum: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SH-SY5Y: 27.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020731 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA020731: AB_1849635" "unprognostic (1.22e-1)" "unprognostic (6.35e-2)" "unprognostic (1.64e-1)" "unprognostic (1.28e-1)" "unprognostic (2.57e-1)" "unprognostic (4.47e-2)" "unprognostic (1.47e-3)" "unprognostic (2.77e-3)" "unprognostic (1.27e-1)" "unprognostic (7.65e-3)" "unprognostic (1.44e-1)" "unprognostic (1.33e-2)" "unprognostic (1.90e-5)" "unprognostic (2.19e-2)" "unprognostic (3.35e-1)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" 2.4 2.4 0.3 7.1 1.0 0.0 1.8 7.0 0.6 7.9 13.0 0.1 11.0 3.8 3.0 6.1 9.3 1.2 9.4 6.2 0.3 0.3 0.9 0.4 2.9 0.1 0.6 0.1 4.7 7.0 0.0 2.3 0.1 1.3 4.4 5.8 10.0 7.5 10.9 1.3 3.6 4.7 8.6 1.4 0.1 6.9 8.4 0.5 0.4 1.0 2.8 0.8 4.4 8.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 1.5 0.9 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 27.0 0.4 0.0 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 7.0 0.6 0.3 0.3 0.6 0.1 1.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.3 0.0 0.0 0.0 0.2 0.2 0.0 0.1 27.5 0.0 0.1 0.0 51.2 0.0 0.0 11.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 8.1 0.0 0.2 0.0 0.0 0.0 GGA1 ENSG00000100083 "Golgi associated, gamma adaptin ear containing, ARF binding protein 1" Q9UJY5 22 37608475-37633564 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 83.8" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 173.5;Spermatocytes: 198.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048280, HPA051016" Supported Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA048280: AB_2680338, HPA051016: AB_2681312" "unprognostic (1.64e-1)" "unprognostic (1.42e-2)" "unprognostic (4.08e-1)" "unprognostic (9.23e-3)" "unprognostic (2.00e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (2.32e-2)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "prognostic favorable (4.86e-4)" "unprognostic (1.42e-2)" "unprognostic (1.53e-2)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.16e-3)" 10.7 15.8 13.5 12.2 14.0 17.3 10.8 21.8 18.4 11.6 10.6 19.3 14.5 13.1 12.9 14.1 13.3 13.8 11.8 10.2 12.5 10.6 12.0 14.1 10.9 14.0 17.7 13.2 18.1 13.9 20.6 19.4 12.5 13.5 12.0 9.6 17.7 16.7 16.7 17.1 17.1 12.0 9.3 14.2 15.8 12.8 83.8 16.6 12.1 15.4 9.9 14.2 10.6 11.0 6.4 5.0 4.9 7.7 7.6 18.0 7.6 18.4 12.9 16.2 15.7 14.2 11.7 17.8 15.2 12.3 13.5 15.0 11.5 10.5 28.3 10.4 10.9 8.3 17.2 14.3 17.0 12.4 24.2 23.8 11.2 23.2 12.3 13.9 27.5 21.9 14.2 15.2 19.1 12.1 22.1 12.6 14.4 22.6 18.4 13.8 17.6 12.2 29.5 12.7 18.6 13.3 13.6 13.0 12.1 13.9 15.0 14.9 26.5 9.7 20.4 23.6 16.1 21.3 20.0 15.1 18.4 18.0 16.5 12.1 39.7 15.9 29.3 20.6 16.7 16.1 4.9 7.7 4.3 14.0 7.6 17.3 6.4 5.6 18.0 5.0 4.1 4.2 13.0 3.3 7.6 5.5 4.3 5.8 7.6 13.5 14.0 21.8 18.4 12.5 10.6 17.7 13.2 13.5 16.6 23.8 36.3 43.5 27.8 21.5 53.9 15.9 15.3 34.8 22.7 41.8 78.5 30.7 5.0 30.2 118.6 26.2 53.9 0.0 17.7 31.6 17.1 20.5 48.5 18.1 69.1 23.8 31.2 32.5 44.8 173.5 24.5 44.5 15.1 46.9 35.7 41.0 27.7 42.1 21.2 10.3 73.2 25.8 21.2 198.9 40.2 25.0 47.5 91.4 34.6 30.1 GGT1 "CD224, D22S672, D22S732, GGT" ENSG00000100031 "Gamma-glutamyltransferase 1" P19440 22 24583750-24629005 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Protease, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.1;seminal vesicle: 41.7" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 74.5;Alveolar cells type 2: 21.4;Cholangiocytes: 40.8;Ductal cells: 54.8;Enterocytes: 80.7;Hepatocytes: 34.1;Pancreatic endocrine cells: 33.5;Paneth cells: 23.0;Proximal tubular cells: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 35.6;Karpas-707: 52.5;OE19: 37.9;RPMI-8226: 51.6;RPTEC TERT1: 48.0" "HPA045635, HPA047534, HPA065444" Supported Uncertain Vesicles "Intracellular and membrane" NA NA 4600000 Vesicles "HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491" "unprognostic (8.13e-3)" "unprognostic (4.76e-1)" "unprognostic (8.29e-2)" "unprognostic (1.28e-2)" "unprognostic (3.70e-2)" "unprognostic (1.43e-2)" "unprognostic (5.60e-3)" "unprognostic (1.68e-1)" "unprognostic (2.21e-1)" "prognostic favorable (7.44e-4)" "unprognostic (4.55e-2)" "unprognostic (2.55e-2)" "prognostic favorable (4.83e-4)" "unprognostic (1.44e-2)" "unprognostic (5.37e-2)" "unprognostic (1.74e-1)" "unprognostic (6.10e-2)" 1.6 0.5 1.7 1.7 2.2 2.7 8.2 2.3 2.6 7.3 7.9 1.6 23.7 22.3 1.4 19.9 1.2 0.8 12.2 2.0 1.8 1.2 54.1 29.2 14.3 3.2 1.7 1.6 1.3 17.3 0.0 1.6 1.4 2.2 14.7 2.4 1.4 8.7 41.7 0.9 1.1 20.9 1.7 1.9 4.7 6.6 5.0 2.1 2.4 4.8 1.6 5.5 2.1 1.1 3.3 7.5 15.9 14.6 6.6 8.6 6.6 0.2 19.3 0.2 0.0 0.0 0.1 0.5 0.1 0.6 0.2 0.2 2.6 4.2 0.2 4.3 0.0 3.8 2.8 1.4 0.2 0.1 35.6 2.9 0.1 8.6 14.0 1.5 0.3 11.9 0.4 0.2 0.6 0.4 0.3 0.1 5.3 2.0 52.5 0.2 0.4 0.3 14.6 1.4 37.9 0.2 0.2 2.2 51.6 48.0 0.6 0.2 0.3 0.1 9.3 0.2 5.5 9.3 11.1 2.2 3.5 2.3 10.8 0.3 15.8 5.9 0.2 7.4 15.0 0.1 5.2 14.6 0.4 1.4 6.8 5.2 3.3 7.7 3.4 7.5 0.3 1.0 1.9 15.9 6.6 5.5 0.1 8.6 6.6 1.7 2.2 2.3 2.6 1.8 1.2 1.7 1.6 2.2 2.1 74.5 21.4 3.4 0.1 0.7 0.4 0.4 40.8 2.7 7.9 1.8 0.0 0.9 1.7 54.8 1.1 0.1 80.7 0.0 7.2 0.3 1.3 3.0 5.7 34.1 4.7 0.0 1.2 2.5 3.0 4.1 0.0 2.9 1.7 5.4 2.5 2.0 33.5 23.0 0.4 32.7 0.0 0.0 0.2 0.6 0.7 0.4 0.7 3.2 4.2 0.0 GGT2 GGT ENSG00000133475 "Gamma-glutamyltransferase 2" P36268 22 21207973-21227637 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.6;salivary gland: 5.5;thyroid gland: 8.4" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 7.4;Early spermatids: 3.8;Late spermatids: 14.7" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.4;HeLa: 4.6;Karpas-707: 2.0;U-2197: 13.9" "HPA045635, HPA047534, HPA065444" Supported Uncertain Vesicles NA NA Vesicles "HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491" "unprognostic (4.27e-1)" "unprognostic (6.91e-2)" "unprognostic (7.03e-2)" "unprognostic (8.13e-2)" "unprognostic (1.01e-2)" "unprognostic (2.38e-5)" "unprognostic (1.05e-3)" "unprognostic (5.85e-4)" "unprognostic (7.97e-3)" "unprognostic (8.84e-2)" "unprognostic (1.16e-1)" "unprognostic (6.39e-2)" "unprognostic (2.39e-1)" "unprognostic (1.48e-2)" "unprognostic (3.46e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.1 0.2 0.0 1.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.1 2.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 5.5 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.3 1.0 8.4 0.0 0.0 0.0 0.1 0.2 0.4 0.4 0.4 0.5 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.1 0.0 0.0 1.0 0.0 1.5 0.0 0.0 0.1 0.5 0.6 13.9 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.1 0.5 0.0 0.2 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.5 0.3 3.0 7.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 GJC1 "CX45, GJA7" ENSG00000182963 "Gap junction protein gamma 1" P36383 17 44798448-44830816 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 23 "Sertoli cells: 155.2;Smooth muscle cells: 65.3;Spermatogonia: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA071788 Uncertain "Nucleoli,Cell Junctions,Cytosol" NA NA Nucleoli "Cell Junctions, Cytosol" "HPA071788: " "unprognostic (1.84e-2)" "unprognostic (2.04e-1)" "unprognostic (2.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (7.02e-2)" "unprognostic (4.01e-1)" "unprognostic (1.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.02e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.55e-8)" "unprognostic (5.18e-2)" "unprognostic (2.20e-1)" "unprognostic (8.52e-2)" "prognostic unfavorable (7.83e-4)" 7.3 0.8 2.2 4.1 3.4 1.0 4.7 8.2 4.2 14.8 23.0 2.8 7.0 1.6 24.2 3.1 3.2 5.0 5.4 10.0 3.3 1.8 1.5 0.9 6.5 2.3 2.5 4.0 2.2 1.3 2.6 0.7 28.5 3.4 8.2 2.8 3.7 1.7 17.0 5.4 1.9 4.8 27.5 2.2 0.9 7.8 8.0 2.9 1.4 5.3 2.9 1.7 12.6 10.4 1.2 1.0 4.7 1.0 1.9 1.0 0.4 17.4 9.0 22.7 7.8 3.0 4.7 8.9 19.4 15.3 20.9 22.5 5.2 9.7 0.1 1.0 18.1 28.6 4.5 11.8 6.0 29.4 0.1 8.8 0.1 4.8 0.5 1.8 0.1 0.7 3.2 0.6 15.9 5.3 7.8 7.1 3.9 0.8 0.2 12.1 0.1 2.8 1.7 10.2 0.0 7.7 16.5 28.8 0.1 5.0 7.3 4.3 9.9 2.2 0.1 6.5 15.3 4.7 2.7 5.9 18.5 17.9 8.4 16.5 0.1 4.5 12.9 6.4 0.1 17.3 4.7 1.0 1.1 0.9 0.6 0.8 0.9 0.7 0.6 0.3 1.2 0.9 1.0 3.9 1.9 0.7 1.0 0.6 0.4 2.2 3.4 8.2 4.2 3.3 1.8 2.5 4.0 3.4 2.9 0.0 0.0 0.0 1.6 1.8 1.0 18.1 0.0 0.0 0.0 1.8 2.0 0.3 0.0 1.3 1.3 11.7 0.0 0.0 0.0 2.1 5.7 1.2 0.0 0.0 1.2 12.7 0.0 6.2 0.8 0.0 1.4 0.0 3.3 1.0 0.0 0.4 0.6 0.0 2.1 0.3 1.0 155.2 65.3 10.2 32.0 2.6 0.5 0.0 0.0 1.4 GLDC "GCSP, NKH" ENSG00000178445 "Glycine decarboxylase" P23378 9 6532464-6645783 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 22.3;liver: 40.3;placenta: 10.6" "Cell type enhanced" "Detected in many" 17 "Cytotrophoblasts: 59.4;Extravillous trophoblasts: 35.6;Hepatocytes: 126.2;Syncytiotrophoblasts: 38.4" "Cancer enhanced" "Detected in many" "testis cancer: 41.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 66.8;CACO-2: 15.9;HMC-1: 14.5;RPTEC TERT1: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002318, HPA052887" Enhanced Supported Nucleoplasm,Mitochondria NA NA 570000 Mitochondria Nucleoplasm "HPA002318: AB_1849700, HPA052887: AB_2681980" "unprognostic (6.73e-2)" "unprognostic (1.19e-1)" "unprognostic (6.50e-2)" "prognostic unfavorable (5.24e-5)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" "unprognostic (2.40e-1)" "unprognostic (1.74e-1)" "unprognostic (2.47e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.50e-4)" "unprognostic (1.65e-2)" "unprognostic (1.27e-1)" "unprognostic (5.62e-3)" "unprognostic (1.17e-2)" 0.2 0.3 3.9 1.0 3.4 0.4 0.4 3.1 5.6 0.3 0.8 1.6 0.0 0.7 0.4 4.2 1.4 0.6 0.6 0.1 2.9 2.2 22.3 40.3 0.8 1.1 1.9 2.9 0.3 0.1 0.0 1.7 10.6 2.1 0.4 0.3 3.2 0.9 0.8 0.9 1.5 0.6 0.1 1.9 0.8 0.8 1.1 1.8 0.0 2.6 0.0 1.9 0.8 0.0 2.9 0.7 2.3 0.5 0.8 0.6 1.1 0.1 1.3 0.6 7.2 0.0 0.1 66.8 0.0 0.0 0.0 0.0 15.9 0.1 0.1 1.6 0.0 0.2 0.1 0.0 0.1 0.0 0.3 3.8 0.0 0.0 10.6 0.0 0.0 14.5 0.0 0.0 0.5 0.0 0.2 2.7 1.2 0.0 0.1 0.3 0.3 0.2 0.0 7.8 1.2 1.2 0.3 0.0 0.1 27.7 0.3 6.4 3.3 0.0 6.2 0.0 4.1 1.4 0.0 0.9 0.1 0.2 0.8 0.3 0.3 9.2 0.0 0.2 0.7 1.5 1.5 0.5 0.5 0.5 0.3 0.5 2.9 0.6 0.4 0.1 0.9 0.4 0.5 2.3 0.8 0.5 0.7 0.2 1.1 3.9 3.4 3.1 5.6 2.9 2.2 1.9 2.9 2.1 1.8 0.0 0.0 4.3 0.0 0.0 0.3 0.6 7.6 0.0 0.0 29.6 0.0 59.4 5.0 0.0 8.8 0.0 0.0 0.0 0.2 35.6 0.0 0.0 0.0 126.2 6.1 0.0 0.0 3.1 2.1 9.0 0.3 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.0 29.3 0.2 0.0 0.3 4.4 5.0 0.0 38.4 0.5 0.0 0.0 GLIPR2 "C9orf19, GAPR-1" ENSG00000122694 "GLI pathogenesis related 2" Q9H4G4 9 36136536-36163913 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 92.9" "Cell type enhanced" "Detected in many" 8 "Hofbauer cells: 191.0;Macrophages: 162.9;monocytes: 200.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 26.8;HDLM-2: 25.6;TIME: 45.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029478 Approved Uncertain Vesicles,Microtubules NA NA 18000000 Vesicles Microtubules "HPA029478: AB_10670038" "unprognostic (1.57e-2)" "unprognostic (5.70e-3)" "unprognostic (1.54e-1)" "unprognostic (1.28e-1)" "unprognostic (1.46e-2)" "unprognostic (1.33e-2)" "unprognostic (9.90e-2)" "unprognostic (2.50e-1)" "unprognostic (1.84e-2)" "unprognostic (4.26e-2)" "unprognostic (3.21e-1)" "unprognostic (5.87e-2)" "prognostic unfavorable (6.54e-7)" "unprognostic (6.57e-3)" "unprognostic (4.94e-1)" "unprognostic (1.02e-1)" "unprognostic (2.43e-2)" 28.5 10.8 8.1 25.5 12.1 32.5 15.6 5.7 11.2 19.9 32.4 23.3 9.1 7.5 40.3 16.8 16.3 18.7 13.0 11.7 9.4 7.1 4.9 3.5 31.2 26.5 14.7 6.5 13.4 2.8 0.4 2.9 4.7 12.3 20.1 17.1 11.6 7.9 21.3 4.8 6.1 14.9 35.5 21.8 21.1 13.8 5.0 13.2 10.1 10.6 7.4 9.4 19.2 14.2 3.3 28.8 92.9 48.6 15.8 24.8 45.5 1.2 1.0 7.6 8.0 26.8 12.8 0.8 12.2 7.4 2.8 5.2 0.4 0.1 0.0 3.8 10.9 7.2 0.0 2.8 0.4 1.7 25.6 2.4 3.0 2.4 0.1 10.6 1.9 10.5 8.6 0.3 16.4 2.8 5.2 22.5 8.2 0.1 1.8 6.5 2.9 9.6 5.2 7.3 0.1 3.9 6.6 16.1 0.3 0.6 0.6 2.0 4.1 1.6 0.8 1.2 16.2 0.8 8.5 45.4 3.9 9.3 3.5 9.8 2.9 0.7 4.4 4.1 12.4 0.9 30.1 48.6 71.9 24.8 22.3 13.1 3.2 17.2 15.8 28.8 3.3 7.3 11.5 92.9 15.8 16.2 2.5 17.6 45.5 8.1 12.1 5.7 9.8 9.4 7.1 14.7 6.5 12.3 13.2 3.0 29.7 14.3 2.0 11.8 0.2 1.6 5.1 40.2 23.9 5.2 0.0 2.7 0.0 16.4 0.6 7.1 4.5 23.3 1.1 2.9 35.5 17.3 51.9 0.4 191.0 0.0 8.1 17.8 102.3 0.9 16.7 162.9 59.1 200.2 27.5 14.0 6.0 10.5 24.4 0.3 0.5 45.3 35.8 1.1 3.2 8.9 2.9 62.3 48.7 2.0 GLOD5 ENSG00000171433 "Glyoxalase domain containing 5" A6NK44 X 48761750-48773648 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 25.2;kidney: 10.2;liver: 7.8" "Cell type enhanced" "Detected in some" 14 "Distal tubular cells: 11.6;Enterocytes: 17.1;Paneth cells: 10.5;Proximal tubular cells: 31.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;Hep G2: 2.2;K-562: 1.9;MCF7: 6.5;SCLC-21H: 1.3;T-47d: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010667 Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA010667: AB_1078975" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (7.78e-2)" "unprognostic (7.04e-2)" "unprognostic (3.14e-1)" "unprognostic (6.11e-2)" "unprognostic (1.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.76e-1)" "unprognostic (2.21e-1)" "unprognostic (1.05e-8)" "unprognostic (2.08e-2)" "unprognostic (1.73e-1)" "unprognostic (5.07e-2)" "unprognostic (6.79e-4)" 0.2 0.0 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.4 14.7 0.2 0.2 10.3 0.4 5.6 0.3 1.6 3.5 0.2 0.2 0.0 10.2 7.8 1.5 0.2 0.2 0.2 0.4 1.1 0.0 0.6 0.2 0.2 0.4 5.7 1.5 0.6 0.2 0.2 0.1 25.2 0.2 0.2 0.2 1.3 0.7 0.2 0.4 1.9 0.2 0.5 0.2 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 6.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.3 0.4 0.3 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 1.6 0.0 0.4 0.0 0.2 0.0 2.5 4.0 0.0 7.0 0.0 0.0 11.6 0.4 0.1 0.0 17.1 0.0 0.8 0.1 0.0 0.5 0.0 6.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 5.3 0.3 1.2 10.5 0.0 31.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.5 GLYATL1 "FLJ34646, MGC15397" ENSG00000166840 "Glycine-N-acyltransferase like 1" Q969I3 11 58905398-59043527 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 113.8" "Cell type enhanced" "Detected in some" 31 "Distal tubular cells: 91.2;Hepatocytes: 198.3;Proximal tubular cells: 523.1" "Group enriched" "Detected in some" 8 "liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 4 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "CACO-2: 3.9;Daudi: 9.7;RPTEC TERT1: 3.3;U-2197: 2.5" HPA039501 Supported Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA039501: AB_2676545" "unprognostic (9.46e-3)" "unprognostic (5.33e-2)" "unprognostic (3.90e-5)" "unprognostic (3.93e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-1)" "prognostic favorable (3.69e-4)" "unprognostic (3.62e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (2.08e-1)" "unprognostic (2.92e-1)" "prognostic favorable (3.03e-5)" "unprognostic (1.50e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-2)" "unprognostic (4.55e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.1 27.7 113.8 0.1 0.0 0.2 0.0 0.2 0.2 0.9 0.1 0.0 0.5 2.1 0.0 0.5 1.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.3 0.0 0.1 1.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.4 1.3 0.0 0.5 0.2 1.1 0.9 3.9 0.0 9.7 0.0 0.7 0.8 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.6 2.2 0.0 0.2 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.4 3.3 0.0 0.2 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 1.2 0.1 2.5 1.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.5 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.3 17.8 0.0 0.0 14.0 0.0 0.0 91.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 198.3 0.0 0.0 0.0 1.8 6.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 523.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.1 GLYATL1B GLYATL1P3 ENSG00000255151 "Glycine-N-acyltransferase like 1B" 11 59086307-59094786 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 4.9;breast: 12.5;lymphoid tissue: 4.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "prostate cancer: 0.7" "Group enriched" "Detected in some" 17 "memory B-cell: 1.9;naive B-cell: 4.9" "Lineage enriched" "Detected in single" 24 "B-cells: 4.9" "Cell line enhanced" "Detected in some" "Daudi: 4.9;JURKAT: 2.0;Karpas-707: 2.2;T-47d: 3.2;U-2197: 2.5;U-266/70: 5.0" HPA039501 Uncertain Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA039501: AB_2676545" "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (5.20e-2)" "unprognostic (2.62e-1)" "unprognostic (2.11e-1)" "unprognostic (3.21e-4)" "unprognostic (3.45e-1)" 0.0 0.0 1.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.1 2.2 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.5 2.5 0.2 5.0 1.6 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GM2A SAP-3 ENSG00000196743 "GM2 ganglioside activator" P17900 5 151212150-151270440 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease mutation, Gangliosidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 108.7" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 163.9;Hofbauer cells: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "B-cells: 15.9;dendritic cells: 19.0;monocytes: 19.4" "Cell line enhanced" "Detected in many" "BEWO: 44.5;HBEC3-KT: 61.5;hTCEpi: 61.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008063 Enhanced Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 23000000 "Vesicles, Cytosol" "HPA008063: AB_1849842" "unprognostic (4.33e-2)" "unprognostic (8.97e-3)" "unprognostic (2.27e-1)" "unprognostic (3.01e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.77e-5)" "unprognostic (1.22e-1)" "unprognostic (1.72e-2)" "unprognostic (1.31e-2)" "unprognostic (1.50e-2)" "unprognostic (5.33e-3)" "unprognostic (9.81e-2)" "unprognostic (4.24e-2)" "unprognostic (4.42e-2)" "unprognostic (3.02e-2)" "unprognostic (1.65e-1)" 55.8 16.1 17.8 15.5 18.8 9.6 15.2 8.1 15.2 20.5 10.3 31.7 6.4 8.4 9.5 17.3 39.5 8.8 12.6 13.8 18.0 12.6 7.5 13.2 24.8 30.2 22.4 13.0 12.2 9.3 11.7 5.6 108.7 18.9 11.9 14.5 14.1 13.3 10.4 3.9 42.8 11.2 10.9 35.9 28.5 8.2 8.9 15.3 21.9 7.1 25.9 39.7 21.0 32.0 15.9 19.0 4.2 19.4 1.9 3.3 8.0 4.6 3.0 3.2 15.3 21.3 10.6 44.5 7.3 15.8 4.0 5.5 6.3 5.4 15.0 7.7 5.6 11.0 12.7 3.5 61.5 5.8 8.4 2.2 2.4 3.8 7.7 5.2 3.9 25.2 14.2 61.3 5.2 3.5 5.6 5.8 19.1 2.3 6.5 6.3 1.9 8.2 3.7 2.2 2.3 6.9 3.7 1.5 9.4 3.9 9.1 0.8 2.9 6.0 28.4 12.0 11.7 6.5 4.6 5.1 10.0 3.9 8.2 2.2 16.2 19.3 41.1 11.4 6.2 4.1 3.5 19.4 1.1 1.9 6.5 1.4 14.9 2.3 2.0 19.0 15.9 3.3 2.5 4.2 1.9 1.4 13.7 2.4 8.0 17.8 18.8 8.1 13.9 18.0 12.6 22.4 13.0 18.9 15.3 14.9 23.1 14.7 13.3 13.3 4.5 26.2 0.0 13.4 12.5 17.4 2.0 45.1 1.7 5.8 0.4 6.3 4.6 0.0 6.9 163.9 8.0 7.4 66.0 16.3 98.1 6.4 3.5 7.4 38.4 1.1 7.5 34.4 8.5 55.1 5.0 8.0 5.4 3.5 13.1 4.5 3.1 0.0 5.7 1.4 4.9 20.8 43.8 3.8 5.6 32.5 GNAI2 "GIP, GNAI2B" ENSG00000114353 "G protein subunit alpha i2" P04899 3 50226292-50259355 "Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007704 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 53000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA007704: AB_1849230" "prognostic favorable (1.03e-4)" "unprognostic (3.89e-1)" "unprognostic (3.35e-2)" "unprognostic (8.40e-3)" "unprognostic (2.58e-1)" "unprognostic (2.32e-2)" "unprognostic (2.59e-2)" "unprognostic (3.23e-1)" "unprognostic (1.08e-3)" "unprognostic (6.01e-2)" "unprognostic (7.00e-3)" "unprognostic (1.12e-1)" "unprognostic (6.24e-3)" "unprognostic (1.44e-1)" "unprognostic (4.30e-2)" "unprognostic (4.33e-2)" "unprognostic (1.38e-1)" 81.9 37.8 50.8 69.5 47.2 102.5 53.4 17.7 45.3 56.2 47.9 67.2 34.5 22.6 51.4 41.1 44.4 47.1 55.5 57.0 44.6 48.0 34.1 50.9 72.8 78.7 53.3 34.3 54.0 21.4 24.9 42.1 81.3 46.8 44.3 22.5 38.5 25.8 60.0 29.6 29.0 35.7 53.6 81.8 96.7 30.1 28.5 45.9 70.0 37.7 32.4 55.5 60.7 49.8 5.3 14.2 35.8 19.4 6.1 8.4 5.6 15.3 8.3 25.2 25.2 31.0 38.9 4.5 33.5 54.1 48.4 49.8 9.3 21.7 18.3 14.7 75.6 26.2 12.3 17.9 46.8 31.0 39.1 6.3 46.2 22.6 14.5 30.6 42.2 61.6 37.7 20.9 43.7 17.9 40.0 113.3 15.7 3.0 39.9 48.2 19.9 35.6 45.6 13.5 7.5 32.6 22.4 12.1 26.8 31.1 17.4 6.1 10.6 24.5 7.4 15.4 21.6 11.7 43.8 98.5 41.7 24.5 39.3 33.5 25.2 32.2 16.1 47.0 57.6 49.9 2.6 16.5 23.4 8.4 19.4 4.9 5.0 6.3 7.6 14.2 5.3 5.0 5.7 35.8 6.1 15.0 11.7 6.6 5.6 50.8 47.2 17.7 45.3 44.6 48.0 53.3 34.3 46.8 45.9 38.7 40.4 91.6 50.8 50.5 26.8 19.8 53.5 14.7 25.0 41.8 13.7 65.7 5.0 114.9 164.1 226.6 12.0 23.3 53.2 68.9 80.2 40.6 86.7 69.5 291.0 6.4 88.5 179.9 279.9 235.2 84.0 263.9 79.2 299.4 19.5 264.2 106.8 32.8 89.8 22.6 18.1 51.8 75.6 14.0 24.7 55.0 97.4 119.3 13.3 55.9 GOLPH3L GPP34R ENSG00000143457 "Golgi phosphoprotein 3 like" Q9H4A5 1 150646225-150697144 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "U-698: 100.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072016 Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA072016: " "unprognostic (1.21e-1)" "unprognostic (2.61e-1)" "unprognostic (3.76e-3)" "unprognostic (3.24e-1)" "unprognostic (3.24e-2)" "unprognostic (1.82e-1)" "unprognostic (3.18e-2)" "unprognostic (4.72e-2)" "unprognostic (5.00e-2)" "unprognostic (2.64e-1)" "unprognostic (9.88e-3)" "unprognostic (2.71e-1)" "unprognostic (3.36e-2)" "unprognostic (1.67e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.93e-2)" 16.5 19.4 16.0 10.2 14.6 4.9 18.6 20.7 16.7 21.6 26.5 10.5 26.2 15.7 19.3 30.0 36.6 24.6 14.8 11.7 10.6 15.5 21.3 13.0 14.5 10.5 12.2 11.0 22.7 30.4 16.8 30.8 14.1 15.9 19.2 32.6 16.5 25.4 22.4 16.1 17.3 20.2 14.9 11.0 15.0 19.5 14.9 12.1 21.1 30.7 11.7 20.8 21.6 22.2 10.6 11.7 7.1 3.1 16.2 13.1 4.9 7.1 7.0 3.9 2.2 9.9 7.2 6.4 6.6 10.1 7.3 10.4 3.1 12.8 9.0 9.6 4.7 4.7 6.2 6.4 5.6 8.8 6.1 7.1 10.0 3.8 4.1 8.7 8.2 8.0 4.8 9.6 7.6 16.4 8.5 10.6 6.2 8.1 5.8 4.2 7.3 6.9 3.5 7.4 13.3 6.8 4.8 4.5 10.2 8.4 4.8 6.0 5.7 3.4 9.6 4.8 10.0 7.3 9.1 8.4 2.4 3.9 3.1 5.5 7.3 6.4 100.5 7.0 8.5 3.2 7.1 1.5 2.7 9.7 1.3 13.1 10.6 9.8 9.5 8.1 8.8 12.9 9.6 1.3 16.2 3.1 11.7 10.3 4.9 16.0 14.6 20.7 16.7 10.6 15.5 12.2 11.0 15.9 12.1 8.9 6.4 8.2 8.5 11.4 8.0 9.7 22.9 37.5 15.9 12.2 5.9 18.7 21.6 17.4 12.4 12.1 29.9 0.0 32.0 12.8 8.8 22.2 11.5 9.7 10.3 0.0 20.2 16.0 9.1 9.7 15.3 8.2 15.1 19.0 40.8 13.4 21.9 31.9 18.7 20.3 12.7 0.0 8.2 11.2 3.2 15.6 25.7 10.0 31.6 23.8 GOLT1B "CGI-141, GOT1, YMR292W" ENSG00000111711 "Golgi transport 1B" Q9Y3E0 12 21501781-21518408 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055909, HPA066383" Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA055909: AB_2682967, HPA066383: AB_2685667" "unprognostic (1.22e-2)" "unprognostic (3.07e-3)" "unprognostic (1.84e-1)" "unprognostic (3.65e-1)" "unprognostic (3.45e-1)" "unprognostic (5.37e-3)" "prognostic unfavorable (1.99e-8)" "unprognostic (2.24e-2)" "unprognostic (1.60e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.32e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.83e-10)" "unprognostic (3.13e-1)" "unprognostic (2.14e-1)" "unprognostic (6.78e-2)" "unprognostic (1.04e-1)" 21.1 26.0 18.3 18.2 24.4 23.4 20.4 31.9 30.4 22.3 14.7 18.9 13.8 12.0 16.9 18.9 15.3 14.6 16.4 17.0 19.1 22.4 23.2 40.1 19.9 16.0 20.1 16.2 14.1 30.9 11.3 34.9 31.1 23.8 19.0 16.8 16.1 17.4 15.3 15.9 14.5 13.0 19.6 22.2 17.8 15.3 11.6 17.5 13.5 19.1 11.6 15.6 22.5 14.2 17.7 22.2 26.7 22.9 14.8 21.1 19.4 11.4 12.1 10.0 12.9 20.2 31.5 17.0 45.1 17.2 14.3 23.4 15.8 17.0 6.9 11.6 23.4 26.6 11.1 8.3 9.3 25.1 10.1 7.9 10.1 7.9 11.0 22.5 13.0 13.0 15.9 18.2 17.1 31.5 24.6 12.9 8.6 6.3 7.7 21.9 10.7 5.8 21.6 27.6 9.9 8.7 5.0 24.4 14.5 11.8 7.0 2.7 8.4 18.4 7.2 24.6 33.8 10.0 14.7 14.4 16.9 18.4 20.8 24.5 7.5 16.3 18.3 23.1 12.5 22.7 26.7 20.6 14.8 17.9 22.9 21.1 17.7 21.1 19.5 20.2 16.5 19.3 19.2 5.6 14.8 20.9 22.2 20.4 19.4 18.3 24.4 31.9 30.4 19.1 22.4 20.1 16.2 23.8 17.5 8.9 14.1 38.8 20.4 41.4 28.9 15.5 15.3 8.1 25.0 15.7 9.8 25.0 23.2 28.8 2.7 27.1 10.5 0.0 29.2 54.0 45.6 35.7 20.8 21.7 37.8 17.5 12.6 17.8 21.3 3.6 16.1 35.7 50.6 22.6 22.7 17.8 30.7 14.4 18.7 17.4 6.7 12.9 30.7 22.9 31.0 55.8 53.5 33.1 13.2 20.5 GP9 "CD42a, GPIX" ENSG00000169704 "Glycoprotein IX platelet" P14770 3 129060767-129062406 "CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 27.1;bone marrow: 10.0;lymphoid tissue: 24.5" "Group enriched" "Detected in some" 11 "Early spermatids: 14.0;Late spermatids: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 8.8;neutrophil: 7.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.8" "Cell line enriched" "Detected in some" 14 "HEL: 43.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063182 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 68000000 "Plasma membrane, Cytosol" Nucleoplasm "HPA063182: AB_2684956" "unprognostic (1.70e-1)" "unprognostic (3.97e-1)" "unprognostic (1.10e-1)" "unprognostic (3.80e-2)" "unprognostic (2.50e-2)" "unprognostic (3.24e-1)" "unprognostic (2.53e-2)" "unprognostic (8.47e-2)" "unprognostic (8.70e-2)" 0.2 0.1 0.1 0.1 0.1 10.0 0.1 0.0 0.6 0.4 0.5 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.1 5.0 0.8 0.1 0.1 0.4 4.8 0.0 0.8 0.2 0.5 0.1 0.0 0.3 1.5 0.4 0.1 0.4 0.2 0.0 0.6 0.2 0.0 0.1 0.0 0.1 24.5 0.3 2.2 0.0 0.0 0.6 0.6 0.0 0.6 3.0 0.1 1.5 8.8 0.6 0.0 0.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.6 0.1 0.1 0.3 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.0 7.5 0.0 0.0 1.5 0.0 27.1 0.1 0.1 0.0 0.6 0.8 0.1 0.8 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 13.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GPAA1 "GAA1, hGAA1" ENSG00000197858 "Glycosylphosphatidylinositol anchor attachment 1" O43292 8 144082590-144086216 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 70.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077224 Approved Approved "Endoplasmic reticulum,Centrosome,Mitochondria,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Centrosome, Mitochondria" "HPA077224: " "unprognostic (2.53e-3)" "unprognostic (1.39e-1)" "unprognostic (3.06e-2)" "unprognostic (2.57e-2)" "unprognostic (2.49e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-3)" "unprognostic (2.64e-1)" "unprognostic (8.92e-2)" "unprognostic (1.67e-2)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (3.89e-1)" "unprognostic (1.27e-1)" "unprognostic (2.73e-2)" 25.2 35.3 23.0 15.9 25.5 32.1 20.0 19.9 43.7 23.6 24.4 27.1 32.3 28.2 26.3 38.3 23.2 24.0 31.1 35.0 20.3 17.4 29.3 47.2 24.9 31.4 19.9 19.0 23.8 46.6 36.4 17.1 32.9 25.1 23.1 10.7 27.4 46.0 35.4 28.5 23.3 31.0 16.3 22.3 21.9 23.0 24.6 16.1 24.0 29.0 22.2 18.6 19.3 18.6 17.2 41.0 21.7 33.3 24.7 34.5 26.1 16.4 29.1 6.8 21.3 15.8 13.5 23.7 16.9 16.8 14.2 14.8 12.0 27.3 9.0 24.7 18.3 6.7 20.5 4.5 16.8 2.1 15.1 15.3 14.1 13.6 8.8 15.3 6.9 21.3 14.8 15.7 14.5 10.1 11.5 11.7 15.3 10.2 31.9 13.6 57.9 13.3 6.4 6.8 19.4 70.8 9.3 8.6 42.8 12.3 11.6 11.8 16.2 22.1 28.5 12.4 3.9 18.3 19.5 7.7 13.2 23.0 7.5 18.9 17.8 13.7 5.9 23.4 8.5 17.9 11.8 24.8 21.7 34.5 29.9 23.7 15.5 17.4 27.1 23.1 17.2 17.3 24.1 5.8 24.7 33.3 41.0 15.0 26.1 23.0 25.5 19.9 43.7 20.3 17.4 19.9 19.0 25.1 16.1 35.7 40.2 43.2 39.6 25.5 57.0 39.1 40.8 26.8 11.4 41.8 60.9 106.7 21.6 110.5 4.7 29.4 99.5 0.0 78.8 116.9 52.6 52.7 65.6 67.2 78.9 52.4 54.6 43.0 45.7 6.6 37.4 40.2 69.2 59.5 47.2 94.2 69.6 80.7 35.3 71.5 53.5 58.2 37.1 132.9 51.7 19.4 91.4 48.0 73.6 37.1 GPAT3 "AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324" ENSG00000138678 "Glycerol-3-phosphate acyltransferase 3" Q53EU6 4 83535914-83605875 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.2;kidney: 43.7" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 41.3;Early spermatids: 68.5;Proximal tubular cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 42.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 51.6;GAMG: 39.2;HMC-1: 19.0;U-87 MG: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029414, CAB033749" Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB033749: AB_2224941, HPA029414: AB_10601562" "unprognostic (9.51e-2)" "unprognostic (1.43e-2)" "unprognostic (5.67e-2)" "unprognostic (1.70e-1)" "unprognostic (3.50e-3)" "unprognostic (2.61e-2)" "unprognostic (2.05e-1)" "unprognostic (1.25e-1)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (2.92e-1)" "prognostic favorable (2.71e-9)" "unprognostic (3.74e-1)" "unprognostic (3.45e-2)" "unprognostic (2.53e-3)" "prognostic unfavorable (8.21e-4)" 7.9 0.7 0.7 5.2 1.4 5.2 17.5 4.2 2.9 3.7 18.0 1.2 1.3 20.2 3.0 2.1 5.1 2.1 6.0 24.8 1.2 2.2 43.7 9.0 3.2 4.5 1.9 0.8 12.9 1.7 11.8 5.8 1.2 9.5 2.6 5.7 1.3 3.6 1.9 35.9 1.9 47.2 3.7 3.0 4.3 7.4 4.6 1.4 0.9 26.6 14.6 3.4 4.5 7.2 0.0 23.2 42.0 9.7 0.5 1.8 2.9 9.8 9.7 0.0 0.1 0.5 1.2 0.2 0.7 1.4 0.2 0.2 0.7 51.6 0.0 1.1 1.8 39.2 2.2 4.6 0.9 0.1 0.6 2.2 0.0 3.1 9.5 1.4 2.8 19.0 0.6 0.0 0.3 1.1 3.8 4.8 2.7 7.9 7.8 0.2 1.0 0.7 0.7 0.2 14.5 4.2 0.1 2.2 3.7 9.8 0.6 0.2 0.0 1.9 2.0 5.4 0.5 0.4 0.5 0.2 2.3 4.2 2.3 9.3 0.4 0.6 0.0 22.6 5.6 17.2 42.0 9.7 1.0 0.2 7.7 1.8 0.0 1.0 0.6 23.2 0.0 0.7 0.3 26.4 0.5 6.1 0.1 0.6 2.9 0.7 1.4 4.2 2.9 1.2 2.2 1.9 0.8 9.5 1.4 6.0 5.0 0.0 41.3 0.0 0.0 0.0 7.6 2.7 9.1 10.4 0.0 0.2 13.3 1.6 68.5 0.6 21.6 0.0 5.9 1.0 0.1 25.8 7.0 11.9 15.3 4.8 1.2 5.5 16.7 17.2 1.1 28.3 0.0 5.4 4.8 0.0 6.6 8.0 0.7 50.3 0.2 6.5 0.0 8.8 1.7 0.0 0.8 0.0 2.1 25.4 GPATCH1 "ECGP, FLJ10206, FLJ38686, GPATC1" ENSG00000076650 "G-patch domain containing 1" Q9BRR8 19 33080880-33130542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043430, HPA043604" Approved Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA043430: AB_10960493, HPA043604: AB_10960499" "unprognostic (2.38e-2)" "unprognostic (1.71e-2)" "unprognostic (9.95e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (2.41e-1)" "unprognostic (1.28e-2)" "unprognostic (4.60e-3)" "unprognostic (3.54e-2)" "unprognostic (5.17e-2)" "unprognostic (3.56e-2)" "unprognostic (6.53e-2)" "unprognostic (5.37e-3)" "unprognostic (8.10e-2)" "unprognostic (4.57e-2)" "unprognostic (1.25e-1)" "unprognostic (1.45e-2)" "unprognostic (6.88e-3)" 8.8 8.0 11.0 10.0 12.2 6.9 9.8 21.2 15.7 9.7 9.9 13.8 8.3 11.0 13.0 9.6 9.1 8.9 8.2 7.8 11.1 7.9 9.6 7.3 7.1 9.4 10.5 7.1 15.9 8.8 13.5 11.8 12.9 10.3 10.1 9.7 8.6 9.6 10.8 10.3 11.4 10.6 9.7 7.5 9.6 10.2 8.9 11.1 13.6 10.0 5.6 13.1 10.3 11.4 6.5 5.7 17.4 6.4 3.0 9.7 4.4 7.4 15.8 7.5 7.9 5.0 5.7 6.2 6.8 4.8 10.5 8.8 11.2 7.0 10.6 8.8 5.4 4.9 6.6 9.4 5.6 9.1 18.3 5.8 10.0 5.9 8.2 6.5 17.3 6.7 4.9 6.6 7.1 6.5 5.0 5.8 8.4 10.5 6.7 5.1 9.6 9.9 5.7 5.2 9.9 6.7 10.1 9.5 4.7 4.8 4.6 8.3 5.6 10.8 6.8 3.8 6.8 5.6 12.5 6.5 9.1 6.8 5.0 9.7 5.7 9.2 9.2 5.7 8.8 8.3 17.4 6.0 6.5 6.1 6.4 4.2 6.2 5.7 7.6 5.7 6.5 9.7 6.1 4.4 3.0 3.3 5.0 8.4 4.4 11.0 12.2 21.2 15.7 11.1 7.9 10.5 7.1 10.3 11.1 8.9 6.4 5.7 4.7 5.5 9.4 8.5 2.5 5.3 11.4 7.0 13.7 9.0 13.3 6.2 2.0 4.5 8.1 0.0 3.9 4.6 5.2 3.1 16.1 4.5 3.5 3.2 4.1 8.6 8.2 1.5 9.5 4.8 8.5 5.4 6.5 7.4 6.6 5.7 7.8 4.8 11.2 0.0 4.9 14.4 11.6 3.1 4.6 7.4 5.6 2.6 GPHN KIAA1385 ENSG00000171723 Gephyrin Q9NQX3 14 66507407-67181803 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" "Multifunctional enzyme, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 49.1;Hepatocytes: 42.9;Horizontal cells: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003116, CAB004419, HPA024694" Enhanced Uncertain "Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "CAB004419: AB_627670, HPA003116: AB_1078963, HPA024694: AB_1849616" "unprognostic (8.37e-2)" "unprognostic (2.53e-2)" "unprognostic (2.42e-1)" "unprognostic (1.20e-1)" "unprognostic (5.14e-2)" "unprognostic (4.89e-3)" "unprognostic (8.29e-2)" "unprognostic (1.41e-2)" "unprognostic (1.42e-1)" "unprognostic (2.23e-1)" "unprognostic (2.49e-2)" "unprognostic (8.54e-2)" "prognostic favorable (5.25e-12)" "unprognostic (9.81e-2)" "unprognostic (2.27e-1)" "unprognostic (7.50e-2)" "prognostic unfavorable (4.61e-5)" 13.0 12.4 26.1 10.9 31.1 5.2 17.1 40.9 31.2 11.0 18.2 9.3 15.6 11.1 12.3 20.8 8.6 7.5 8.2 11.9 26.4 22.9 34.5 49.0 14.1 7.3 18.3 11.5 7.2 22.9 17.4 24.5 5.8 13.9 11.1 13.2 7.4 10.8 21.3 23.4 10.7 10.8 11.6 16.4 5.6 13.5 7.8 16.2 3.1 12.2 10.0 6.8 7.4 15.1 3.1 3.0 0.5 2.5 2.3 6.2 1.5 22.2 4.4 7.8 8.5 9.2 7.8 5.0 6.3 3.1 6.5 6.5 1.3 10.0 0.0 1.1 3.1 3.3 7.9 7.8 12.3 8.6 6.8 8.4 6.6 6.3 13.6 4.8 3.7 9.8 6.7 7.3 1.8 7.2 2.7 7.5 8.3 4.5 8.4 3.6 11.9 6.5 13.9 3.3 16.8 10.1 0.0 15.0 6.4 10.5 4.4 13.8 5.4 4.3 18.9 6.9 2.2 10.1 6.4 2.8 6.5 14.5 6.4 6.5 11.2 4.8 0.1 5.1 0.5 6.3 0.0 1.3 0.5 3.9 2.5 6.2 2.4 4.9 2.9 1.9 3.1 3.5 3.3 0.0 2.3 1.9 3.0 5.3 1.5 26.1 31.1 40.9 27.0 26.4 22.9 18.3 11.5 13.9 16.2 6.0 9.6 5.4 8.3 4.1 33.5 10.9 7.6 1.4 13.6 1.8 49.1 2.8 11.6 4.1 2.5 9.0 5.1 0.0 4.7 2.1 4.1 6.7 0.0 42.9 3.1 41.3 5.8 19.0 7.6 3.6 10.3 2.7 1.7 0.0 11.9 10.4 2.9 7.0 5.3 14.9 34.2 0.0 6.2 10.9 8.9 5.1 1.7 4.9 8.9 6.0 GPR142 PGR2 ENSG00000257008 "G protein-coupled receptor 142" Q7Z601 17 74367407-74372622 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.3;lymphoid tissue: 1.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "pancreatic cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-937: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA031392 Uncertain Uncertain "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA031392: AB_10601935" "unprognostic (6.81e-2)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "unprognostic (6.54e-5)" "unprognostic (4.16e-2)" "unprognostic (4.85e-7)" "unprognostic (3.95e-2)" "unprognostic (7.72e-4)" "unprognostic (1.93e-1)" "unprognostic (1.68e-3)" 0.2 0.0 0.0 1.3 0.1 0.0 0.1 1.3 0.2 0.3 0.1 0.8 0.6 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.2 0.0 0.1 0.8 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR155 "DEP.7, DEPDC3, FLJ31819, PGR22" ENSG00000163328 "G protein-coupled receptor 155" Q7Z3F1 2 174431571-174487094 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5;stomach 1: 43.2" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 117.8;Melanocytes: 145.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 16.3;WM-115: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036159, HPA057384" Approved Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA036159: AB_10671835, HPA057384: AB_2683424" "unprognostic (3.91e-2)" "unprognostic (7.93e-2)" "unprognostic (3.14e-2)" "unprognostic (4.11e-4)" "unprognostic (5.03e-2)" "unprognostic (2.48e-1)" "unprognostic (8.49e-2)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.48e-2)" "unprognostic (4.82e-2)" "unprognostic (2.59e-2)" "unprognostic (9.90e-2)" "unprognostic (1.82e-2)" "unprognostic (4.54e-2)" 4.5 10.1 9.3 6.6 34.5 2.6 3.0 15.1 17.3 3.2 11.4 6.1 2.2 4.0 2.6 13.1 6.7 2.5 5.9 6.8 15.5 9.4 19.8 7.3 3.3 5.9 7.7 11.5 3.0 16.9 8.0 3.2 4.7 27.4 8.0 4.2 4.9 3.7 8.8 5.1 13.4 5.1 7.8 6.9 5.3 43.2 2.6 9.9 1.6 8.3 0.8 3.8 6.6 3.6 1.5 0.8 9.6 6.8 4.7 7.0 1.9 0.7 0.4 1.0 2.5 5.7 3.2 0.6 4.3 1.5 0.7 2.4 0.3 0.4 2.4 1.4 3.0 1.5 0.4 1.4 1.3 2.4 0.9 1.7 2.6 1.4 0.2 1.1 0.9 1.4 4.6 3.6 2.1 0.7 4.6 1.1 3.4 0.4 6.2 4.8 0.7 1.7 1.2 0.6 2.6 1.7 2.1 6.2 1.2 2.4 1.6 6.7 5.7 1.3 1.0 2.2 3.1 0.4 0.4 3.1 3.1 1.2 4.5 0.6 16.3 2.3 0.4 3.6 0.8 10.8 1.5 2.9 0.1 2.4 5.4 2.2 1.3 4.4 4.0 0.8 1.5 3.5 5.4 9.6 4.7 6.8 0.5 7.0 1.9 9.3 34.5 15.1 16.2 15.5 9.4 7.7 11.5 27.4 9.9 11.9 2.2 11.7 2.9 37.9 30.8 21.8 2.5 0.0 10.3 10.4 117.8 1.2 1.7 2.0 0.3 9.0 0.3 0.0 5.0 1.0 7.7 3.4 1.1 16.1 5.9 47.7 12.2 20.9 36.6 0.9 13.8 21.7 145.1 1.8 0.2 15.6 5.6 0.0 30.1 34.6 22.9 0.0 10.8 3.3 2.6 25.0 0.7 17.9 1.1 1.5 GPR157 FLJ12132 ENSG00000180758 "G protein-coupled receptor 157" Q5UAW9 1 9100305-9129170 "G-protein coupled receptors, Predicted membrane proteins" Differentiation "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.2" "Cell type enriched" "Detected in many" 5 "monocytes: 184.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 17.3;SK-BR-3: 34.0;U-266/70: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028697 Uncertain Uncertain "Nucleoli,Nucleoli rim,Plasma membrane,Cell Junctions" NA NA "Nucleoli, Nucleoli rim" "Plasma membrane, Cell Junctions" "HPA028697: AB_10601810" "unprognostic (2.83e-3)" "unprognostic (1.13e-2)" "unprognostic (5.91e-2)" "unprognostic (5.42e-2)" "unprognostic (2.13e-4)" "unprognostic (7.11e-2)" "unprognostic (7.52e-3)" "unprognostic (3.60e-2)" "unprognostic (9.20e-2)" "unprognostic (1.26e-1)" "unprognostic (9.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.02e-2)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-3)" 3.5 3.1 0.3 3.7 0.6 0.5 3.5 0.5 0.4 6.2 2.8 0.9 3.9 2.2 2.1 2.1 23.4 2.1 6.9 10.7 0.8 0.4 2.9 6.9 5.5 3.1 0.3 0.1 4.5 4.3 9.8 1.2 19.0 1.4 2.9 1.2 5.2 14.7 7.1 32.2 14.2 3.3 4.0 0.4 2.4 2.2 2.1 0.8 3.6 4.8 25.2 16.2 4.4 8.3 2.4 1.1 4.6 1.5 1.2 2.6 0.7 4.7 2.7 0.8 2.2 0.7 0.7 4.4 1.5 1.0 1.2 1.7 2.1 1.8 0.6 1.9 1.5 1.6 10.1 2.4 1.0 1.8 13.1 4.0 0.0 7.8 3.2 2.7 0.0 1.1 0.7 2.1 2.1 1.3 1.2 1.0 2.0 0.7 17.3 0.5 3.4 1.9 1.0 0.9 2.3 3.4 0.3 0.7 2.3 0.8 3.2 1.2 3.3 5.8 34.0 2.8 1.7 4.8 0.6 7.1 4.3 1.1 11.1 0.7 16.7 2.7 0.0 3.2 6.7 1.8 1.9 1.5 0.4 2.6 1.2 2.0 1.5 1.9 2.3 0.8 2.4 1.9 2.2 4.6 1.2 0.6 1.1 0.8 0.7 0.3 0.6 0.5 0.4 0.8 0.4 0.3 0.1 1.4 0.8 6.0 9.9 0.5 6.4 12.0 0.2 12.1 5.1 2.7 6.8 5.2 2.0 25.6 0.0 3.0 0.0 2.9 5.6 0.0 3.3 9.1 3.8 4.4 0.0 12.9 3.8 1.6 0.0 0.0 1.2 0.0 1.7 4.5 6.8 184.0 4.3 1.4 9.2 4.8 4.9 1.4 1.5 0.0 3.9 0.5 2.5 21.2 40.3 2.1 4.3 13.7 GPR174 FKSG79 ENSG00000147138 "G protein-coupled receptor 174" Q9BXC1 X 79144663-79175315 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 73.8" "Group enriched" "Detected in some" 20 "Alveolar cells type 2: 3.7;Club cells: 1.2;Collecting duct cells: 1.8;T-cells: 2.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "JURKAT: 24.1;MOLT-4: 39.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA041025 Enhanced Uncertain Vesicles NA NA Vesicles "HPA041025: AB_10794260" "unprognostic (6.38e-3)" "unprognostic (9.87e-3)" "unprognostic (4.36e-2)" "unprognostic (1.18e-2)" "unprognostic (1.84e-1)" "unprognostic (8.48e-4)" "unprognostic (7.12e-2)" "unprognostic (1.05e-2)" "unprognostic (1.75e-1)" "unprognostic (2.02e-1)" "unprognostic (2.46e-1)" "unprognostic (1.05e-1)" "unprognostic (6.53e-5)" "unprognostic (2.27e-1)" "unprognostic (2.64e-2)" "unprognostic (1.21e-1)" "unprognostic (1.78e-2)" 2.2 0.5 0.4 20.3 0.4 2.6 1.3 0.3 0.4 2.4 5.1 0.0 0.5 2.1 1.6 0.9 2.6 0.9 1.9 1.0 0.4 0.4 1.9 1.7 8.2 16.6 0.5 0.0 1.0 0.7 0.0 1.1 0.3 0.2 1.7 2.0 1.6 3.8 0.1 0.5 0.7 9.1 0.2 1.0 21.0 2.2 0.5 0.0 73.8 2.5 1.6 28.1 5.1 1.8 4.0 1.8 6.0 9.1 6.5 8.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 0.7 0.0 0.0 39.8 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 6.0 0.0 4.7 5.7 3.4 1.7 4.0 7.5 8.6 0.1 3.9 6.1 6.8 0.4 6.5 9.1 1.8 7.6 2.7 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 GPR34 ENSG00000171659 "G protein-coupled receptor 34" Q9UPC5 X 41688973-41697277 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 60.8" "Cell type enhanced" "Detected in some" 23 "granulocytes: 35.9;Hofbauer cells: 198.9;Kupffer cells: 113.1;Macrophages: 46.2" "Cancer enhanced" "Detected in all" "glioma: 26.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "basophil: 60.8;eosinophil: 25.3" "Lineage enriched" "Detected in many" 20 "granulocytes: 60.8" "Cell line enhanced" "Detected in some" "HMC-1: 5.0;JURKAT: 2.6;U-937: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010668, CAB025490" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB025490: , HPA010668: AB_1849294" "unprognostic (1.26e-2)" "unprognostic (1.08e-1)" "unprognostic (1.43e-2)" "unprognostic (1.44e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.83e-3)" "unprognostic (5.13e-2)" "unprognostic (1.59e-2)" "unprognostic (9.81e-3)" "unprognostic (7.19e-2)" "unprognostic (1.74e-1)" "unprognostic (3.96e-1)" "unprognostic (2.72e-3)" "unprognostic (1.14e-1)" "unprognostic (1.88e-3)" "unprognostic (3.18e-2)" 25.1 12.4 15.1 9.7 16.6 0.4 15.0 2.1 11.7 10.5 9.1 13.5 1.0 4.4 4.9 6.6 5.8 5.5 12.2 5.9 16.0 9.5 11.7 5.3 11.4 26.8 22.4 7.5 5.4 4.4 2.8 3.3 29.3 15.4 5.7 9.3 4.9 7.1 6.4 2.1 2.4 11.4 11.5 34.0 22.3 5.1 5.0 21.4 1.9 3.4 1.5 11.1 12.5 3.7 0.3 0.4 60.8 2.8 3.0 0.1 0.5 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 1.0 0.4 0.0 0.2 0.0 0.1 5.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.0 0.2 0.7 0.3 0.0 0.4 0.1 1.1 0.0 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.1 0.8 0.1 0.0 0.0 0.1 0.6 1.3 0.0 60.8 2.2 25.3 0.0 2.8 0.0 0.3 0.1 0.0 0.4 0.1 0.0 0.0 0.2 3.0 1.5 0.0 0.1 0.5 15.1 16.6 2.1 11.7 16.0 9.5 22.4 7.5 15.4 21.4 0.0 3.2 2.7 0.2 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.3 0.0 0.0 0.0 1.3 1.7 0.1 35.9 0.0 198.9 0.0 1.2 3.1 113.1 0.6 0.9 46.2 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 19.4 0.0 0.0 0.1 0.9 2.1 1.7 0.0 0.0 GPR63 "PSP24(beta), PSP24B" ENSG00000112218 "G protein-coupled receptor 63" Q9BZJ6 6 96794126-96837463 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Early spermatids: 21.8;Late spermatids: 26.5;Spermatocytes: 22.8;Spermatogonia: 9.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 7.8;HHSteC: 12.8;Karpas-707: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039103 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA039103: AB_10672841" "unprognostic (8.22e-2)" "unprognostic (2.77e-1)" "unprognostic (1.71e-2)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (1.33e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (3.39e-1)" "unprognostic (2.53e-2)" "unprognostic (7.29e-3)" "unprognostic (3.00e-1)" "unprognostic (2.03e-3)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-2)" 1.8 3.4 3.8 3.1 11.0 0.8 1.6 7.5 10.7 3.3 3.9 1.6 1.0 5.1 1.9 1.5 2.0 2.8 2.7 1.9 3.2 2.2 1.4 0.5 1.4 0.9 2.2 6.4 4.0 5.0 3.9 4.3 2.5 10.1 3.3 6.2 2.5 1.7 2.2 1.0 1.7 3.6 3.6 1.4 1.3 4.1 8.0 5.2 2.5 2.3 0.0 0.9 2.2 4.8 0.8 0.9 2.6 0.6 1.4 1.1 0.1 0.0 0.1 1.5 0.3 2.2 0.8 0.4 0.9 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.1 1.2 1.1 4.9 2.3 0.0 7.8 3.8 4.7 0.4 0.0 12.8 2.9 0.5 2.4 0.4 0.0 3.5 0.3 0.0 7.0 3.4 19.2 0.4 0.4 2.2 0.0 5.0 0.0 0.7 0.0 1.8 3.8 0.3 0.2 2.3 1.4 0.3 3.1 0.5 1.7 1.2 0.6 0.0 1.3 2.0 0.2 1.8 1.5 0.8 0.1 0.8 1.8 1.0 0.8 0.6 0.2 0.6 0.2 0.3 0.7 1.1 0.6 0.1 0.8 1.0 0.9 2.6 1.4 0.2 0.9 0.3 0.1 3.8 11.0 7.5 10.7 3.2 2.2 2.2 6.4 10.1 5.2 0.0 0.0 0.0 0.8 1.6 1.1 0.5 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.4 21.8 0.1 0.0 0.0 0.8 0.6 0.9 1.0 0.0 0.0 0.2 0.0 2.9 1.8 0.0 26.5 3.1 0.0 1.7 0.0 0.4 0.3 0.5 0.0 4.6 0.0 0.2 0.0 1.1 22.8 9.3 0.3 0.1 0.0 0.5 0.3 GPRC5C RAIG-3 ENSG00000170412 "G protein-coupled receptor class C group 5 member C" Q9NQ84 17 74424851-74451653 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 76.2" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 193.6;Hepatocytes: 148.3;Paneth cells: 149.7;Sertoli cells: 142.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 31.1" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 10.2" "Group enriched" "Detected in many" 9 "dendritic cells: 10.2;monocytes: 4.7" "Cell line enhanced" "Detected in many" "Hep G2: 24.0;HMC-1: 42.2;RPTEC TERT1: 56.9;RT4: 26.3;T-47d: 32.0" "Region enriched" "Detected in many" 9 "cerebellum: 47.7" "Low region specificity" "Detected in all" HPA029776 Enhanced Uncertain "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA029776: AB_10602324" "unprognostic (1.48e-1)" "unprognostic (3.35e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-3)" "unprognostic (1.80e-2)" "unprognostic (1.09e-2)" "unprognostic (4.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (9.61e-3)" "unprognostic (1.05e-1)" "prognostic favorable (1.58e-5)" "unprognostic (7.58e-2)" "unprognostic (3.70e-2)" "unprognostic (2.75e-2)" "unprognostic (1.54e-3)" 4.3 4.1 5.2 2.2 5.3 0.0 7.7 31.1 5.7 19.7 15.4 4.4 17.0 10.0 5.8 9.9 5.3 12.5 17.6 7.7 5.3 2.6 43.8 46.1 11.5 2.8 4.8 4.9 12.3 76.2 12.0 3.4 4.5 6.1 15.1 6.2 18.0 16.8 11.7 25.4 9.2 15.2 3.9 4.6 5.1 44.7 4.4 4.1 1.9 42.2 10.2 3.5 12.6 8.0 0.7 10.2 0.1 4.7 0.0 0.1 0.3 4.6 16.7 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 21.4 0.0 13.3 0.1 5.4 14.7 2.2 0.3 0.0 0.0 2.7 0.0 1.2 24.0 4.9 0.0 42.2 0.4 7.6 0.0 0.0 22.7 0.0 0.0 1.2 0.3 0.0 5.2 0.1 4.5 2.7 23.1 19.4 0.0 0.0 1.1 56.9 26.3 8.1 0.7 0.8 1.8 0.0 10.9 32.0 1.2 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 2.1 0.6 0.1 0.0 1.7 0.1 0.0 3.4 0.0 0.7 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 4.7 10.2 0.0 0.3 5.2 5.3 31.1 5.7 5.3 2.6 4.8 4.9 6.1 4.1 3.0 48.9 1.5 39.6 12.0 0.8 193.6 68.8 22.7 18.2 129.1 0.0 0.7 24.9 53.1 0.1 8.7 61.7 0.0 58.9 7.1 19.9 46.9 10.3 148.3 9.6 4.8 43.7 25.8 8.5 0.5 16.7 4.2 3.3 5.4 47.3 18.8 37.9 149.7 20.8 51.6 0.8 142.3 56.7 0.4 3.0 9.8 21.2 1.5 44.1 40.9 GRAMD1B "KIAA1201, LINC01059" ENSG00000023171 "GRAM domain containing 1B" Q3KR37 11 123358428-123627774 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.7;brain: 55.2;intestine: 21.7" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 41.9;Cone photoreceptor cells: 108.0;Horizontal cells: 42.9;Rod photoreceptor cells: 85.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 11.5" "Group enriched" "Detected in many" 4 "A549: 22.2;HDLM-2: 58.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008557, HPA075204" Approved Supported "Endoplasmic reticulum,Vesicles,Plasma membrane" NA NA "Endoplasmic reticulum, Plasma membrane" Vesicles "HPA008557: AB_1079197, HPA075204: " "unprognostic (1.86e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.74e-3)" "unprognostic (8.15e-2)" "unprognostic (4.28e-2)" "unprognostic (2.69e-3)" "unprognostic (4.12e-3)" "unprognostic (1.40e-1)" "unprognostic (2.90e-2)" "unprognostic (9.60e-2)" "unprognostic (8.06e-2)" "prognostic unfavorable (4.30e-7)" "unprognostic (1.39e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (1.69e-1)" 1.4 67.7 15.5 3.1 16.0 11.8 1.1 55.2 25.0 1.2 3.1 5.1 5.9 21.7 1.2 6.6 0.9 2.9 8.1 4.3 13.6 7.5 10.4 1.3 1.9 3.6 6.8 15.1 7.6 2.0 0.6 6.7 5.0 14.4 1.1 1.2 11.9 1.3 2.5 1.8 0.8 15.6 1.3 4.1 2.7 7.8 10.6 5.1 3.4 3.7 0.0 2.7 1.5 0.8 0.1 11.5 0.6 2.0 2.6 2.7 0.7 0.0 22.2 1.2 0.0 0.1 0.2 3.6 7.4 5.3 1.6 0.6 0.9 0.1 1.3 3.9 3.7 2.5 0.0 2.3 0.0 1.7 58.9 2.0 0.0 10.0 0.2 0.0 7.6 0.0 0.4 0.0 2.8 0.0 1.9 0.7 0.6 0.0 0.0 1.4 0.1 1.3 2.6 2.8 9.9 8.4 4.0 3.6 2.4 0.1 0.0 7.4 6.0 1.7 0.1 0.0 3.4 0.2 4.3 4.4 8.9 1.4 1.5 0.3 0.0 0.0 0.0 1.8 8.0 0.4 0.0 2.0 0.6 0.7 1.0 0.4 0.0 2.7 2.1 3.0 0.1 0.3 0.3 0.2 2.6 1.0 11.5 1.1 0.7 15.5 16.0 55.2 25.0 13.6 7.5 6.8 15.1 14.4 5.1 0.0 0.3 0.0 0.0 0.0 41.9 5.5 25.5 0.0 0.0 5.2 108.0 4.5 3.3 0.5 5.2 0.7 0.3 0.0 0.4 3.0 1.1 0.1 0.0 0.0 2.3 42.9 0.0 0.6 3.5 2.3 0.6 2.8 0.0 1.0 0.8 21.5 2.3 0.2 0.7 5.5 85.7 0.0 0.8 1.0 1.5 0.4 2.1 1.0 0.4 0.0 GRAMD1C DKFZp434C0328 ENSG00000178075 "GRAM domain containing 1C" Q8IYS0 3 113828182-113947174 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 74.3;Late spermatids: 57.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 5.1;naive B-cell: 4.1;neutrophil: 4.0" "Group enriched" "Detected in many" 11 "B-cells: 5.1;granulocytes: 4.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.4;HUVEC TERT2: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012316 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA012316: AB_1849949" "unprognostic (2.73e-3)" "unprognostic (6.16e-3)" "unprognostic (3.27e-1)" "unprognostic (1.93e-1)" "unprognostic (5.50e-2)" "unprognostic (9.81e-3)" "unprognostic (1.43e-3)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (5.49e-2)" "prognostic favorable (4.22e-15)" "unprognostic (8.48e-2)" "unprognostic (9.96e-2)" "unprognostic (3.61e-2)" "unprognostic (2.09e-2)" 1.7 2.6 12.6 2.5 13.0 0.5 9.1 5.0 13.4 3.4 8.0 2.6 0.5 7.6 5.2 5.1 6.0 10.3 2.9 1.5 13.6 7.6 23.3 26.5 5.0 2.0 9.4 8.1 1.1 12.5 11.8 24.1 6.2 9.2 2.9 4.2 4.5 10.8 2.8 1.1 12.0 24.5 1.0 8.2 1.7 8.6 14.5 9.3 0.0 6.9 1.6 3.7 3.8 3.8 5.1 0.1 4.0 0.0 0.3 0.4 0.1 1.5 0.0 4.1 3.2 0.8 2.1 5.9 3.7 3.3 0.7 2.2 0.0 14.4 0.4 1.1 1.9 1.3 1.6 0.7 1.6 1.7 1.9 0.6 0.3 0.1 0.0 1.6 0.2 0.1 3.3 1.1 0.6 0.1 7.5 11.2 4.5 0.0 0.2 1.1 0.4 1.6 0.2 0.3 1.5 0.5 0.0 0.8 2.5 4.5 2.0 0.8 1.0 1.0 5.9 3.0 1.6 4.1 0.0 2.3 1.5 2.9 0.0 0.3 2.2 1.3 1.8 2.4 0.1 1.7 0.0 0.0 0.0 0.3 0.0 0.0 5.1 0.3 0.4 0.1 4.1 0.3 0.4 4.0 0.3 0.0 0.1 0.0 0.1 12.6 13.0 5.0 13.4 13.6 7.6 9.4 8.1 9.2 9.3 11.9 10.9 0.0 5.9 0.9 0.0 0.8 20.4 18.7 7.9 14.0 35.3 14.6 26.6 2.1 74.3 2.9 12.0 0.0 2.4 3.7 1.0 2.9 0.0 14.8 1.3 11.1 4.7 3.7 0.0 57.8 2.6 0.0 1.7 0.0 4.7 14.5 2.1 5.9 1.4 11.2 18.3 0.0 0.9 25.7 5.1 4.1 35.5 0.0 3.9 5.7 GRHL1 "LBP-32, MGR, TFCP2L2" ENSG00000134317 "Grainyhead like transcription factor 1" Q9NZI5 2 9951693-10002277 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.3;skin 1: 34.4" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 69.0;Suprabasal keratinocytes: 115.9;Syncytiotrophoblasts: 154.4;Urothelial cells: 97.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 4.8;neutrophil: 1.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.8" "Group enriched" "Detected in some" 4 "BEWO: 66.4;SK-BR-3: 34.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA005798, HPA006420" Enhanced Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA005798: AB_1079026, HPA006420: AB_1079025" "unprognostic (2.26e-3)" "unprognostic (5.80e-2)" "unprognostic (8.35e-2)" "unprognostic (7.33e-3)" "unprognostic (2.70e-1)" "unprognostic (2.76e-2)" "unprognostic (4.43e-3)" "unprognostic (6.73e-2)" "unprognostic (1.68e-1)" "unprognostic (1.00e-1)" "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.14e-4)" "unprognostic (3.66e-1)" "unprognostic (3.40e-1)" "unprognostic (4.04e-2)" "unprognostic (2.14e-1)" 1.7 0.6 1.5 0.2 2.4 2.8 15.9 2.0 1.6 10.2 0.9 0.2 10.8 0.3 0.9 3.8 40.3 0.7 1.0 1.6 1.9 1.2 2.5 4.9 2.3 0.2 0.7 1.4 0.5 1.5 12.9 2.6 31.0 0.8 6.1 0.2 1.8 17.5 9.7 0.9 34.4 0.7 5.1 0.6 0.6 1.3 1.6 0.4 0.4 2.8 22.3 25.3 6.7 16.9 0.1 0.2 4.8 0.2 0.5 0.6 4.5 3.2 0.0 0.4 0.9 0.1 0.1 66.4 0.3 0.4 0.2 0.3 0.2 2.3 0.4 0.1 0.0 0.4 2.0 4.0 0.4 0.9 0.9 1.8 0.1 0.6 1.2 0.0 0.2 0.3 0.1 1.7 1.9 0.0 0.0 0.3 0.7 0.6 1.2 0.0 4.2 0.6 0.5 0.2 1.0 0.7 0.2 0.3 0.5 0.4 12.6 0.7 0.5 0.6 34.9 0.8 5.7 4.2 0.1 0.3 0.2 0.8 1.0 0.4 0.8 0.5 0.4 0.2 0.5 0.5 0.0 0.2 4.8 0.1 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.6 4.5 1.5 2.4 2.0 1.6 1.9 1.2 0.7 1.4 0.8 0.4 3.0 7.2 0.0 18.6 35.5 20.9 1.2 0.0 6.7 29.6 19.2 58.9 48.9 0.0 2.8 6.0 3.1 0.5 0.0 8.0 69.0 6.1 30.1 10.3 5.7 6.7 11.1 3.4 3.1 1.3 2.1 0.0 2.7 20.3 1.0 0.6 1.7 4.8 0.0 0.4 1.7 11.8 0.0 6.1 5.1 5.3 115.9 154.4 1.3 0.4 97.4 GRM7 "GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87" ENSG00000196277 "Glutamate metabotropic receptor 7" Q14831 3 6770001-7741533 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.8;parathyroid gland: 11.3" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 22.5;Early spermatids: 24.2;Late spermatids: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015964 Uncertain Cytosol NA NA Cytosol "HPA015964: " "unprognostic (2.04e-2)" "unprognostic (7.03e-3)" "unprognostic (1.43e-1)" "unprognostic (9.37e-2)" "unprognostic (8.48e-3)" "unprognostic (2.58e-1)" "unprognostic (7.30e-2)" "unprognostic (3.50e-2)" "unprognostic (2.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.46e-2)" "unprognostic (2.54e-1)" "unprognostic (6.84e-6)" "unprognostic (1.45e-1)" "unprognostic (2.82e-2)" "unprognostic (5.43e-2)" "unprognostic (2.59e-2)" 0.9 5.3 8.1 0.6 10.5 0.6 0.9 1.6 15.8 2.9 0.8 2.1 0.0 0.9 3.1 0.5 0.6 1.0 0.7 0.6 11.1 9.3 0.5 0.7 0.8 0.5 2.3 10.1 0.8 0.7 11.3 0.6 0.9 4.3 1.2 0.8 0.8 2.1 1.4 0.5 0.6 0.6 5.9 2.8 0.8 0.6 2.8 4.1 0.0 0.7 0.0 0.7 1.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 10.5 1.6 15.8 11.1 9.3 2.3 10.1 4.3 4.1 0.0 0.0 0.0 0.9 0.1 22.5 1.1 7.6 6.7 1.2 0.0 7.9 0.0 1.7 0.0 24.2 0.1 0.0 0.0 0.0 0.1 0.7 1.1 1.1 0.0 0.1 1.6 0.0 0.0 0.0 29.9 0.3 0.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.2 6.5 0.0 1.7 0.7 0.0 0.0 0.0 0.0 0.6 GSTM5 ENSG00000134201 "Glutathione S-transferase mu 5" P46439 1 109712255-109775428 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "breast: 237.6;ovary: 66.1" "Group enriched" "Detected in many" 6 "Leydig cells: 132.9;Muller glia cells: 217.3;Peritubular cells: 119.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.7" "Group enriched" "Detected in many" 5 "dendritic cells: 5.7;T-cells: 1.9" "Group enriched" "Detected in some" 7 "fHDF/TERT166: 18.0;HHSteC: 7.7;HSkMC: 8.3" "HPA048652, HPA055972, HPA055973" Approved Uncertain "Cytokinetic bridge,Cytosol" NA NA Cytosol "Cytokinetic bridge" "HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993" "unprognostic (1.46e-2)" "unprognostic (8.64e-3)" "unprognostic (5.58e-2)" "unprognostic (1.42e-1)" "unprognostic (5.34e-3)" "unprognostic (8.09e-2)" "unprognostic (9.64e-4)" "unprognostic (1.31e-2)" "unprognostic (1.44e-1)" "unprognostic (9.16e-2)" "unprognostic (3.31e-1)" "unprognostic (1.92e-2)" "unprognostic (1.42e-2)" "unprognostic (3.74e-2)" "unprognostic (4.39e-2)" "unprognostic (3.03e-3)" "unprognostic (1.40e-1)" 5.8 3.5 25.7 2.6 23.4 1.6 237.6 15.8 24.6 27.2 4.2 14.0 4.7 2.1 14.0 12.0 4.8 19.8 9.0 4.8 24.9 6.2 2.9 2.1 5.7 2.6 4.9 17.9 66.1 2.7 1.6 2.7 1.6 8.9 12.8 4.0 23.0 3.9 11.9 2.4 3.7 3.5 9.8 11.0 3.5 3.9 5.1 11.9 0.0 2.6 2.1 3.2 10.5 16.1 0.0 5.7 0.6 0.2 0.7 1.9 0.9 0.0 0.0 0.0 0.0 1.6 1.6 0.3 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.1 8.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.6 0.1 0.1 0.1 0.0 0.0 0.1 1.3 0.0 0.2 0.2 0.0 0.7 0.0 5.7 1.9 0.9 25.7 23.4 15.8 24.6 24.9 6.2 4.9 17.9 8.9 11.9 0.0 0.3 0.0 0.5 6.0 2.0 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 8.2 0.8 0.0 0.0 0.0 0.1 12.3 0.1 0.0 0.0 0.2 0.0 0.0 7.4 1.2 9.9 132.9 0.6 10.1 0.0 0.0 217.3 0.0 0.0 119.5 0.0 5.8 25.8 7.6 1.9 1.1 5.6 0.0 0.0 0.0 0.1 GTF2A1 TFIIA ENSG00000165417 "General transcription factor IIA subunit 1" P52655 14 81175452-81221377 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000869 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000869: AB_1080253" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (7.98e-3)" "unprognostic (1.40e-1)" "unprognostic (1.50e-2)" "unprognostic (1.20e-1)" "unprognostic (6.04e-3)" "unprognostic (1.65e-1)" "unprognostic (1.14e-1)" "unprognostic (1.85e-1)" "unprognostic (7.49e-2)" "unprognostic (2.76e-1)" "unprognostic (3.87e-2)" "unprognostic (4.04e-2)" "unprognostic (2.44e-1)" "unprognostic (2.11e-1)" "unprognostic (5.88e-2)" 16.9 14.9 18.2 15.7 23.3 8.7 17.1 32.6 23.4 15.7 12.9 17.7 12.7 12.2 16.0 20.1 17.9 12.5 13.1 12.7 17.0 17.8 15.3 18.4 11.6 18.9 16.2 17.0 17.6 14.7 21.0 20.6 24.5 19.9 14.8 14.7 14.0 14.5 13.1 20.3 14.7 12.4 16.2 18.5 17.2 13.4 23.9 16.7 36.3 30.4 11.3 18.5 15.9 15.0 1.3 3.2 9.3 3.9 1.5 2.3 0.8 10.7 10.7 22.6 15.1 12.9 10.9 8.2 12.9 13.4 12.0 10.8 15.9 10.9 17.5 10.6 10.8 8.8 8.1 15.5 9.8 21.3 14.8 4.6 16.0 12.4 9.5 12.7 11.2 16.5 10.0 7.6 16.4 21.5 12.5 12.1 14.4 9.7 24.2 15.3 17.9 28.4 6.6 12.2 8.2 10.4 15.3 19.8 10.8 8.0 22.0 21.4 12.6 30.6 12.5 13.7 11.4 18.7 9.5 15.2 12.2 9.3 16.8 13.5 19.5 20.8 18.2 9.7 13.0 19.2 9.3 1.2 2.1 2.3 0.9 2.0 1.3 2.1 1.3 0.7 1.2 1.9 2.1 2.0 1.5 3.9 3.2 1.1 0.8 18.2 23.3 32.6 23.4 17.0 17.8 16.2 17.0 19.9 16.7 17.9 12.8 11.5 8.0 16.0 22.8 23.4 2.5 6.7 14.8 22.7 33.4 12.6 1.7 9.6 55.2 18.0 15.4 0.0 11.2 10.7 13.2 14.4 30.0 23.7 14.5 38.1 17.9 17.8 25.7 4.9 11.8 19.2 10.1 28.9 16.5 23.4 10.4 14.1 12.7 12.6 15.2 25.8 15.6 25.1 26.2 21.3 21.7 16.0 10.9 8.0 GTF3C1 TFIIIC220 ENSG00000077235 "General transcription factor IIIC subunit 1" Q12789 16 27459555-27549913 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "gdT-cell: 20.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051617, HPA075900" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051617: AB_2681553, HPA075900: " "unprognostic (6.46e-2)" "unprognostic (6.86e-3)" "unprognostic (2.16e-1)" "unprognostic (5.59e-2)" "unprognostic (6.65e-2)" "unprognostic (2.90e-2)" "prognostic unfavorable (8.73e-4)" "unprognostic (8.23e-2)" "unprognostic (9.25e-3)" "unprognostic (5.32e-2)" "prognostic favorable (9.56e-4)" "unprognostic (2.10e-1)" "prognostic favorable (1.25e-4)" "unprognostic (2.06e-1)" "unprognostic (5.67e-2)" "unprognostic (5.56e-3)" "unprognostic (8.23e-3)" 13.6 18.4 19.4 12.1 25.9 17.3 10.6 25.3 31.2 17.3 12.8 21.0 18.8 11.0 19.0 12.0 39.3 19.9 16.5 23.7 15.8 16.2 16.9 13.2 14.1 13.5 14.3 19.1 20.7 24.0 33.8 33.2 13.5 15.8 35.4 12.4 22.3 15.3 16.9 29.5 41.5 11.7 19.3 12.8 14.2 15.7 24.4 17.1 25.2 35.8 18.8 21.0 12.3 20.7 1.9 4.2 2.1 2.1 7.8 20.6 3.6 12.9 28.5 21.0 24.5 18.9 15.3 11.9 14.1 15.9 19.6 16.8 21.3 12.2 14.2 20.8 17.2 15.0 14.5 26.6 17.9 16.2 6.4 25.5 11.8 24.1 30.4 10.6 13.4 15.7 18.7 13.7 24.0 10.7 13.2 19.4 16.5 14.5 11.7 15.4 31.8 14.9 16.2 28.2 7.0 13.6 27.9 26.0 14.6 12.3 13.6 26.6 17.8 14.2 12.1 8.7 17.6 21.7 10.2 20.5 19.8 12.0 12.4 14.4 12.5 11.3 14.5 8.2 15.0 14.5 1.0 2.1 2.1 20.6 1.9 15.2 1.9 2.4 10.3 2.7 1.6 2.5 6.7 1.6 7.8 2.0 4.2 2.5 3.6 19.4 25.9 25.3 31.2 15.8 16.2 14.3 19.1 15.8 17.1 17.9 22.9 5.6 6.3 16.4 42.3 23.4 10.2 25.4 15.9 12.2 88.4 6.4 5.0 10.2 2.0 12.8 10.9 0.0 9.9 3.8 13.3 16.1 18.5 12.5 9.2 25.4 28.8 15.4 12.3 4.0 17.8 6.4 3.3 8.2 15.9 13.3 13.1 8.6 14.9 7.9 30.3 12.9 7.2 19.1 14.9 18.1 3.5 27.7 11.1 6.2 GTF3C4 "KAT12, TFIIIC90" ENSG00000125484 "General transcription factor IIIC subunit 4" Q9UKN8 9 132670035-132694955 "Enzymes, Predicted intracellular proteins" Transcription "Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069369 Supported Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA069369: AB_2686130" "unprognostic (7.02e-2)" "unprognostic (9.01e-2)" "unprognostic (1.31e-1)" "unprognostic (4.10e-2)" "unprognostic (8.20e-2)" "unprognostic (2.78e-1)" "unprognostic (3.71e-3)" "unprognostic (1.69e-2)" "unprognostic (1.58e-1)" "unprognostic (1.76e-1)" "unprognostic (4.77e-1)" "unprognostic (1.92e-2)" "prognostic favorable (2.99e-4)" "unprognostic (1.65e-1)" "unprognostic (1.23e-1)" "unprognostic (2.35e-1)" "unprognostic (1.54e-2)" 6.9 8.5 12.3 6.6 11.6 7.8 11.6 23.8 13.9 10.8 8.0 7.0 5.6 5.3 10.2 9.3 11.4 9.5 7.4 7.8 8.7 8.1 8.7 7.4 8.9 10.9 9.4 11.6 15.0 8.4 16.6 10.1 9.7 8.9 8.9 7.7 7.6 11.3 8.4 11.6 14.5 6.6 8.6 5.6 6.3 8.1 16.9 6.4 11.6 13.3 5.3 9.3 8.8 7.9 2.3 2.1 1.5 1.5 2.1 3.1 0.9 8.5 12.2 15.5 13.3 7.7 9.1 11.2 8.2 10.9 11.7 8.6 14.9 6.4 13.3 5.6 10.7 10.9 19.8 23.7 13.5 13.0 8.0 9.8 11.2 17.6 6.3 7.6 16.5 7.1 7.0 10.3 12.0 15.7 7.1 10.0 8.9 18.2 6.8 8.4 14.0 10.1 7.7 19.7 13.0 11.9 10.0 18.9 11.7 8.6 7.2 21.6 14.6 14.8 15.0 9.1 10.1 20.9 6.8 10.4 19.4 10.9 8.8 12.3 2.8 6.4 14.8 8.2 10.4 11.9 0.1 1.5 1.2 2.5 1.3 2.0 2.3 2.2 3.1 1.2 2.2 2.3 2.4 1.5 2.1 1.2 2.1 2.0 0.9 12.3 11.6 23.8 13.9 8.7 8.1 9.4 11.6 8.9 6.4 17.9 8.6 7.8 6.7 27.2 15.0 11.2 2.5 18.7 6.8 3.5 13.7 6.2 6.6 7.2 4.8 9.0 3.5 0.0 5.4 6.0 11.5 9.1 1.1 7.8 5.4 19.1 12.6 7.4 7.3 2.1 17.5 4.6 3.3 2.8 7.4 11.3 5.8 7.0 18.0 5.6 16.9 0.0 7.6 15.1 12.6 35.0 5.4 6.1 8.0 4.6 GTPBP4 "CRFG, FLJ10686, FLJ10690, NGB, NOG1" ENSG00000107937 "GTP binding protein 4" Q9BZE4 10 988019-1019936 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039618, HPA056468" Uncertain Supported "Nuclear membrane,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" "Nuclear membrane" "HPA039618: AB_10795292, HPA056468: AB_2683141" "unprognostic (2.11e-3)" "unprognostic (3.10e-3)" "unprognostic (7.77e-3)" "prognostic unfavorable (4.57e-4)" "unprognostic (3.72e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (8.85e-12)" "unprognostic (9.06e-2)" "unprognostic (1.72e-1)" "unprognostic (8.45e-2)" "unprognostic (1.11e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (2.38e-5)" "unprognostic (7.90e-2)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (3.67e-2)" 19.0 24.6 11.3 13.9 14.9 24.8 14.2 11.6 15.0 11.0 10.5 12.2 10.3 9.6 14.8 10.1 12.2 15.8 8.9 11.9 14.1 11.8 11.8 14.0 9.5 13.8 14.0 10.1 16.3 22.8 12.7 18.3 13.8 15.3 11.1 12.2 8.9 10.3 9.9 24.8 11.4 11.0 14.4 18.1 13.5 12.7 22.9 12.2 14.2 11.9 16.3 16.3 11.6 10.4 10.5 11.3 10.7 14.2 15.8 14.2 7.7 21.0 17.2 14.5 12.7 10.3 12.3 10.4 19.8 6.9 24.3 20.7 25.4 16.4 30.6 6.0 15.7 8.4 16.7 28.6 18.1 28.4 15.1 17.9 33.5 12.4 15.5 16.3 14.5 18.1 15.9 15.4 26.7 18.6 9.9 13.2 23.8 34.3 12.7 22.2 19.4 22.2 13.7 21.1 28.0 11.9 22.1 12.7 21.1 14.4 13.4 7.3 22.0 13.0 16.7 22.9 14.9 23.9 14.5 11.4 11.6 6.4 27.8 24.0 16.5 31.5 38.5 13.0 15.4 9.5 10.7 8.4 3.0 11.6 14.2 13.6 10.5 11.0 11.7 11.3 9.9 12.2 11.8 1.4 15.8 10.8 7.4 14.2 7.7 11.3 14.9 11.6 15.0 14.1 11.8 14.0 10.1 15.3 12.2 53.6 69.5 32.8 58.3 55.6 25.5 29.7 22.9 66.9 108.1 27.9 17.7 41.8 28.2 54.3 49.0 30.8 10.0 23.3 37.9 45.9 31.1 41.3 62.7 24.3 30.8 22.3 21.2 20.9 25.9 13.8 23.0 29.0 21.9 38.7 24.5 27.3 52.1 17.5 27.6 24.0 31.8 19.4 25.8 86.5 85.2 58.7 79.8 24.5 28.6 76.5 GTSF1L "C20orf65, dJ1028D15.4, FAM112A" ENSG00000124196 "Gametocyte specific factor 1 like" Q9H1H1 20 43726164-43726998 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 104.1" "Group enriched" "Detected in some" 119 "Early spermatids: 2558.4;Late spermatids: 2369.0" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 7.5" "Lineage enriched" "Detected in many" 5 "T-cells: 7.5" "Cell line enhanced" "Detected in some" "Daudi: 1.3;EFO-21: 1.3;REH: 4.0;U-698: 4.4" "Low region specificity" "Detected in some" HPA054694 Enhanced Uncertain Nucleoli NA NA Nucleoli "HPA054694: AB_2682576" "unprognostic (2.61e-2)" "unprognostic (4.24e-6)" "unprognostic (9.96e-3)" "unprognostic (1.30e-4)" "unprognostic (3.50e-2)" "unprognostic (6.70e-2)" "unprognostic (2.15e-2)" "unprognostic (3.06e-2)" "unprognostic (2.45e-7)" "unprognostic (1.19e-1)" "unprognostic (9.54e-2)" "unprognostic (6.07e-3)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 104.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.9 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 1.0 0.0 1.4 0.6 0.8 0.0 0.0 0.0 0.0 7.5 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2558.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2369.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 6.5 0.0 20.6 8.0 0.0 0.0 0.0 0.0 0.0 GUCY2C "GUC2C, STAR" ENSG00000070019 "Guanylate cyclase 2C" P25092 12 14612632-14696585 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters" "cGMP biosynthesis" "Lyase, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "intestine: 85.1" "Cell type enhanced" "Detected in some" 21 "Enterocytes: 37.2;Intestinal endocrine cells: 169.6;Mucus-secreting cells: 61.9;Paneth cells: 99.3;Undifferentiated cells: 41.2" "Group enriched" "Detected in many" 5 "colorectal cancer: 23.9;stomach cancer: 9.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 3.7;BEWO: 2.2;CACO-2: 3.2;CAPAN-2: 4.6;SiHa: 4.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA037655, HPA073759" Uncertain Uncertain Vesicles NA NA Vesicles "HPA037655: AB_10672388, HPA073759: " "unprognostic (1.08e-1)" "unprognostic (2.12e-1)" "unprognostic (3.58e-2)" "unprognostic (2.11e-2)" "unprognostic (1.60e-2)" "unprognostic (5.67e-3)" "prognostic unfavorable (1.37e-5)" "unprognostic (9.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.95e-1)" "unprognostic (1.58e-1)" "unprognostic (5.40e-2)" "unprognostic (2.35e-4)" "unprognostic (8.02e-2)" "unprognostic (1.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.98e-1)" 0.2 0.1 0.2 3.4 0.2 0.0 0.2 0.2 0.2 0.2 38.8 0.2 0.2 28.0 0.3 0.2 0.4 0.2 0.3 0.4 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.2 17.5 0.2 0.5 0.2 0.2 1.0 85.1 0.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 4.3 0.7 2.7 1.7 0.0 0.0 0.6 1.1 0.1 0.0 3.7 0.0 0.0 2.2 0.2 0.0 0.0 0.0 3.2 4.6 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.6 4.2 0.3 0.0 1.1 0.4 0.1 0.0 0.0 0.0 0.9 0.1 1.3 0.8 1.3 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.5 0.0 4.3 0.0 0.0 0.7 2.3 0.0 0.0 2.7 0.0 0.0 0.7 0.0 0.6 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 1.5 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 169.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.3 99.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 41.2 0.0 GUK1 ENSG00000143774 "Guanylate kinase 1" Q16774 1 228139962-228148984 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028118, HPA048587, HPA068324" Approved Uncertain Nucleoplasm,Cytosol NA NA 240000 Nucleoplasm Cytosol "HPA028118: AB_2756308, HPA048587: AB_2680453, HPA068324: " "unprognostic (9.15e-2)" "unprognostic (2.63e-2)" "unprognostic (3.60e-3)" "unprognostic (7.91e-2)" "unprognostic (8.54e-3)" "unprognostic (1.24e-1)" "unprognostic (3.55e-3)" "unprognostic (2.05e-1)" "unprognostic (3.47e-1)" "unprognostic (7.32e-2)" "unprognostic (3.38e-2)" "unprognostic (5.28e-2)" "prognostic unfavorable (8.85e-5)" "unprognostic (2.91e-1)" "unprognostic (5.41e-1)" "unprognostic (2.39e-2)" "unprognostic (6.12e-2)" 44.6 38.2 106.4 32.5 76.0 76.7 43.0 25.2 74.4 31.5 33.3 30.1 27.3 41.5 26.3 34.1 77.0 28.0 42.5 61.6 93.1 43.9 31.9 43.5 34.6 39.0 60.0 52.9 24.7 62.2 12.8 26.0 29.2 40.1 25.5 12.1 37.4 66.5 29.4 35.8 59.6 42.1 34.8 49.6 36.1 44.3 22.2 34.9 27.5 31.6 29.3 24.1 45.9 44.5 43.9 97.7 110.1 62.9 55.8 83.7 84.5 57.5 20.3 9.0 27.7 27.1 32.6 45.0 38.4 19.7 22.4 17.6 11.6 40.1 21.7 45.6 25.0 18.8 38.3 7.7 42.1 2.4 33.0 59.7 12.9 50.1 25.2 49.3 14.6 22.7 45.2 25.7 15.6 12.6 16.1 30.2 47.0 34.7 34.7 18.3 48.0 65.8 31.5 28.1 28.2 88.0 25.2 16.9 57.6 21.1 27.1 29.6 53.1 24.7 42.4 49.6 2.4 31.3 31.5 52.7 40.9 27.0 59.9 63.1 32.0 34.6 24.0 51.5 23.8 41.2 55.5 57.1 110.1 77.3 59.8 75.2 43.9 64.8 83.7 48.9 36.6 48.7 61.1 74.9 55.8 62.9 97.7 64.6 84.5 106.4 76.0 25.2 74.4 93.1 43.9 60.0 52.9 40.1 34.9 56.6 78.2 181.8 216.6 586.3 182.4 113.0 193.6 93.7 91.0 225.1 675.4 207.7 588.6 495.6 100.8 397.7 599.7 607.3 597.7 329.8 327.6 443.3 180.0 320.2 368.6 103.3 258.9 305.7 236.3 483.4 216.3 309.1 492.6 406.6 288.0 169.2 724.2 491.0 229.1 543.7 445.9 245.8 394.4 82.0 73.0 629.1 219.5 279.1 243.7 436.5 H1F0 "H10, H1FV" ENSG00000189060 "H1 histone family member 0" P07305 22 37805093-37807436 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 158.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 85.2;U-2 OS: 110.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000843 Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments" Yes No "Nucleoplasm, Nuclear bodies" "Golgi apparatus, Actin filaments" "HPA000843: AB_1079062" "unprognostic (1.29e-2)" "unprognostic (1.68e-1)" "unprognostic (1.69e-2)" "unprognostic (1.27e-1)" "unprognostic (3.31e-3)" "unprognostic (1.19e-1)" "unprognostic (2.18e-1)" "unprognostic (3.85e-1)" "unprognostic (7.68e-2)" "unprognostic (1.86e-1)" "unprognostic (5.95e-3)" "unprognostic (4.86e-3)" "prognostic favorable (7.68e-7)" "unprognostic (3.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.37e-3)" "unprognostic (1.73e-1)" 21.7 13.6 27.5 14.7 24.9 158.1 32.3 35.7 41.7 48.2 37.9 20.4 11.3 35.8 42.7 18.5 66.0 31.7 38.5 30.3 23.5 17.6 33.2 90.6 22.8 15.0 16.0 23.8 48.5 43.5 20.2 25.6 33.6 23.5 43.7 34.0 28.3 43.2 12.4 53.5 53.2 59.2 28.0 18.6 16.3 34.6 15.2 18.8 56.3 36.1 33.4 32.0 24.9 45.2 0.1 6.3 12.5 9.0 0.1 2.4 4.7 20.2 8.8 27.4 12.1 7.2 6.6 38.9 16.5 34.6 48.5 69.2 35.9 32.5 0.0 4.1 13.7 11.3 39.8 0.0 11.4 34.6 0.1 2.0 34.3 3.2 23.8 25.4 0.0 0.1 6.2 20.3 24.3 27.4 0.5 12.8 7.9 0.0 0.0 3.7 33.6 5.7 3.3 10.6 85.2 43.5 9.5 16.3 7.0 7.6 5.5 6.3 35.4 45.7 31.2 60.2 12.8 24.3 21.5 8.5 3.7 110.7 16.3 3.3 0.0 2.3 0.1 4.5 12.4 10.5 12.5 7.6 11.3 0.1 9.0 0.1 0.0 0.8 0.2 6.3 0.1 2.4 0.3 4.2 0.1 7.7 5.7 0.2 4.7 27.5 24.9 35.7 41.7 23.5 17.6 16.0 23.8 23.5 18.8 26.8 114.5 10.0 163.5 62.0 29.8 40.3 107.0 97.7 135.4 97.7 3.9 33.1 106.1 132.1 1.8 71.9 117.5 280.4 159.3 112.5 82.5 175.2 22.0 68.2 59.5 42.9 119.1 63.3 67.8 3.7 85.4 44.3 81.0 92.8 180.5 46.0 119.5 160.1 57.0 42.8 5.6 109.9 96.7 55.8 24.9 78.3 183.8 7.0 103.1 138.2 H6PD GDH ENSG00000049239 "Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase" O95479 1 9234775-9271337 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Hydrolase, Multifunctional enzyme, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 116.9" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 29.2;ASC TERT1: 33.5;HSkMC: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004824, HPA005440" Approved Uncertain Cytosol "Intracellular and membrane" NA NA 91000000 Cytosol "HPA004824: AB_1079037, HPA005440: AB_1079036" "unprognostic (4.83e-3)" "unprognostic (3.91e-2)" "unprognostic (1.18e-1)" "unprognostic (3.49e-1)" "unprognostic (5.53e-3)" "unprognostic (2.86e-2)" "unprognostic (8.35e-2)" "unprognostic (5.18e-2)" "unprognostic (9.73e-2)" "unprognostic (1.26e-3)" "unprognostic (2.16e-2)" "unprognostic (7.35e-3)" "unprognostic (8.20e-2)" "unprognostic (3.61e-1)" "unprognostic (1.30e-1)" "unprognostic (8.65e-2)" "unprognostic (1.95e-1)" 18.3 16.1 4.1 10.7 5.5 4.8 12.2 4.1 6.3 16.6 11.9 10.5 8.2 6.3 22.0 18.0 11.1 15.6 11.9 11.9 3.7 3.0 7.0 116.9 12.2 11.1 6.8 2.6 38.3 10.6 8.0 8.7 14.9 6.0 11.6 5.3 11.8 29.8 8.1 24.7 20.7 10.4 10.2 6.6 10.7 9.9 12.4 5.5 16.2 12.6 12.9 14.1 12.2 10.1 4.5 3.7 4.1 6.3 3.1 4.7 3.0 3.9 3.2 2.8 10.5 29.2 33.5 2.7 3.9 9.8 2.9 4.6 0.6 8.1 4.3 4.6 6.1 3.7 4.1 0.7 1.9 4.3 12.9 0.9 0.0 1.0 2.6 16.3 1.4 1.7 32.9 3.8 7.0 4.6 6.5 13.4 2.4 1.1 7.5 5.7 2.3 1.5 3.2 1.5 2.9 1.9 0.5 0.3 3.6 3.8 1.6 0.9 5.0 5.2 4.1 4.9 2.0 3.1 7.0 13.3 10.1 1.7 2.5 1.1 10.0 2.9 1.0 16.9 6.3 6.4 3.5 6.2 0.9 4.7 6.3 3.7 3.5 3.5 4.1 2.8 4.5 3.4 3.2 4.1 3.1 5.8 3.7 2.8 3.0 4.1 5.5 4.1 6.3 3.7 3.0 6.8 2.6 6.0 5.5 23.8 29.3 11.2 11.1 12.7 18.1 13.0 58.6 10.7 12.5 19.2 25.5 9.0 0.0 15.8 0.8 14.7 15.1 0.0 18.5 6.5 24.0 16.2 3.5 132.8 11.5 15.9 7.5 17.8 18.0 1.5 44.5 10.3 11.8 64.9 15.2 11.2 20.1 17.5 34.6 8.2 11.5 0.0 9.2 4.7 4.6 11.2 4.9 13.8 24.1 11.4 HACE1 KIAA1320 ENSG00000085382 "HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1" Q8IYU2 6 104728093-104859919 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 41.9" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046071 Supported "Nuclear bodies,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nuclear bodies" "HPA046071: AB_2679524" "unprognostic (6.32e-2)" "unprognostic (3.77e-2)" "unprognostic (2.93e-2)" "unprognostic (1.12e-2)" "unprognostic (3.75e-2)" "unprognostic (3.75e-3)" "unprognostic (1.22e-3)" "unprognostic (4.63e-2)" "unprognostic (7.41e-2)" "unprognostic (1.24e-1)" "unprognostic (1.56e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.12e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (1.75e-1)" 6.4 5.4 12.7 3.7 16.1 4.3 6.1 15.5 13.1 6.6 4.8 6.8 2.5 3.6 8.5 2.9 8.1 5.4 5.0 5.2 7.5 8.6 9.4 2.9 5.7 3.5 8.8 9.6 6.4 3.8 12.0 7.4 41.9 10.2 6.1 3.3 7.7 6.2 6.9 4.4 4.8 3.6 6.5 9.5 4.1 3.9 14.1 8.9 5.4 7.1 2.7 3.9 6.4 5.8 2.9 2.4 2.2 2.9 2.2 3.9 1.6 3.6 2.5 10.9 13.6 6.5 8.7 12.9 7.3 11.3 4.6 7.0 2.3 2.1 2.1 3.3 5.5 7.9 2.5 2.7 5.0 9.8 8.4 6.9 7.2 2.3 3.1 6.5 6.2 2.4 5.8 4.6 6.0 5.1 6.1 7.6 8.7 6.9 2.3 9.1 2.6 4.6 3.7 4.7 2.7 2.5 7.3 12.4 0.8 3.7 6.2 5.8 8.8 3.9 4.1 2.1 7.3 2.6 8.5 8.0 3.7 3.1 10.0 6.9 3.3 3.7 7.0 3.9 5.9 6.8 0.0 1.9 2.2 3.7 2.9 3.9 2.9 3.7 3.6 1.9 2.7 3.9 3.0 0.4 2.2 1.5 2.4 1.2 1.6 12.7 16.1 15.5 13.1 7.5 8.6 8.8 9.6 10.2 8.9 3.0 0.6 0.0 1.6 4.1 11.4 6.3 2.5 0.0 4.5 5.2 43.2 7.5 1.7 1.7 3.1 6.7 1.3 0.0 1.3 4.6 4.8 2.2 1.1 2.5 4.6 15.9 1.7 4.3 2.2 3.3 5.8 2.4 1.7 4.6 1.4 5.8 1.1 2.9 3.5 4.1 30.6 6.5 6.6 12.5 2.7 4.1 5.3 2.2 2.1 1.8 HACL1 "2-HPCL, HPCL, PHYH2" ENSG00000131373 "2-hydroxyacyl-CoA lyase 1" Q9UJ83 3 15560704-15601852 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 34.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035496, HPA035497, HPA073760" Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA035496: AB_10601328, HPA035497: AB_2674653, HPA073760: AB_2686633" "unprognostic (6.64e-3)" "unprognostic (2.82e-2)" "unprognostic (2.24e-3)" "unprognostic (3.82e-1)" "unprognostic (4.08e-2)" "unprognostic (1.77e-1)" "unprognostic (2.96e-2)" "unprognostic (6.31e-2)" "unprognostic (8.27e-3)" "unprognostic (5.23e-2)" "unprognostic (3.30e-2)" "unprognostic (1.44e-1)" "prognostic favorable (2.63e-5)" "unprognostic (6.62e-2)" "unprognostic (2.66e-1)" "unprognostic (3.23e-2)" "unprognostic (9.07e-2)" 12.9 12.1 9.1 7.3 12.5 7.6 11.6 20.7 14.1 9.0 22.4 13.5 5.8 39.6 13.1 13.2 6.7 7.9 6.6 7.9 6.7 6.0 18.8 38.1 7.5 9.0 9.1 8.3 7.9 14.3 12.9 16.8 6.4 10.1 8.2 9.0 10.9 8.5 6.9 15.7 9.9 31.6 7.2 8.2 11.0 11.5 18.4 10.3 16.6 15.1 6.1 10.7 8.2 6.5 8.5 6.5 34.1 9.1 9.1 9.3 5.0 6.0 12.5 4.0 13.9 7.0 5.6 39.4 5.9 9.6 12.7 12.5 12.9 6.0 6.2 4.3 8.0 5.0 4.5 9.2 11.4 11.3 5.2 17.5 12.2 9.5 12.5 10.5 13.3 10.7 6.4 8.4 18.0 7.5 3.8 15.9 8.3 10.0 10.4 10.8 13.3 6.4 6.3 9.1 9.6 14.6 6.0 9.8 8.2 13.6 9.5 4.2 5.5 8.8 9.7 11.6 6.6 3.1 12.5 9.7 6.9 6.8 8.5 10.8 12.8 21.6 12.2 12.9 12.1 7.8 34.1 6.5 7.0 6.0 8.2 9.3 6.4 6.5 7.5 6.5 8.5 6.4 7.1 1.4 9.1 9.1 4.0 7.8 5.0 9.1 12.5 20.7 14.1 6.7 6.0 9.1 8.3 10.1 10.3 8.9 15.9 11.9 9.6 9.2 18.3 4.9 12.7 37.5 15.9 10.4 27.5 24.4 11.6 10.9 53.9 11.1 8.8 0.0 22.1 15.1 8.6 8.1 12.7 26.4 11.8 12.7 8.7 8.6 9.1 43.3 21.6 8.7 11.8 24.4 5.8 22.5 12.7 10.5 14.5 27.1 32.9 6.5 9.0 49.7 22.6 6.1 15.8 18.7 8.6 5.8 HAND1 "bHLHa27, eHand, Hxt, Thing1" ENSG00000113196 "Heart and neural crest derivatives expressed 1" O96004 5 154474972-154478264 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 25.9;intestine: 35.1;smooth muscle: 14.2" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 13.6" "Group enriched" "Detected in some" 5 "colorectal cancer: 0.6;testis cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SH-SY5Y: 36.0;SuSa: 67.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA040925 Uncertain Uncertain "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA040925: AB_10796563" "unprognostic (2.37e-2)" "unprognostic (8.29e-2)" "unprognostic (2.46e-3)" "unprognostic (7.23e-2)" "unprognostic (5.21e-2)" "unprognostic (6.38e-3)" 0.2 6.0 0.1 9.7 0.1 0.0 0.1 0.1 0.1 0.1 35.1 0.0 0.0 4.4 0.1 0.0 0.1 0.1 5.3 25.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 3.6 0.0 5.4 2.6 0.1 0.1 0.0 0.1 0.1 20.8 14.2 0.1 0.1 0.1 0.2 0.0 0.7 0.1 0.0 0.0 9.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 36.0 0.0 0.0 0.0 67.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 HAP1 "HAP2, hHLP1, HIP5, HLP" ENSG00000173805 "Huntingtin associated protein 1" P54257 17 41717742-41734644 "Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;stomach 1: 23.3" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 5.8;Syncytiotrophoblasts: 13.2" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "REH: 45.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023394, HPA076992" Enhanced Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA023394: AB_1850492, HPA076992: AB_2686822" "unprognostic (2.84e-3)" "unprognostic (3.74e-3)" "unprognostic (2.42e-2)" "unprognostic (2.30e-1)" "unprognostic (7.53e-2)" "unprognostic (4.90e-2)" "unprognostic (1.64e-1)" "unprognostic (1.32e-1)" "unprognostic (6.11e-2)" "unprognostic (8.76e-2)" "prognostic favorable (4.26e-4)" "unprognostic (1.38e-1)" "unprognostic (2.46e-2)" "unprognostic (1.70e-1)" "unprognostic (3.17e-1)" "unprognostic (1.99e-2)" "unprognostic (9.29e-2)" 0.7 3.2 11.7 1.1 16.2 0.8 2.0 5.6 13.1 4.8 1.3 3.8 2.2 5.2 4.6 3.5 0.9 2.8 3.1 0.6 10.1 30.5 1.1 1.2 1.4 0.9 6.6 6.6 1.0 2.2 0.5 6.8 3.1 15.5 1.6 1.4 0.4 3.4 3.0 1.0 1.6 2.5 1.7 8.3 3.3 23.3 3.4 2.2 0.0 7.2 0.0 1.0 0.9 1.2 1.2 0.8 2.6 0.6 1.5 1.0 0.1 0.1 1.5 0.7 1.5 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.9 0.1 0.1 0.5 0.1 0.2 6.3 3.3 0.2 0.0 0.0 1.6 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.8 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.8 9.0 0.4 45.8 0.0 1.7 0.3 0.5 0.2 0.0 0.3 0.2 0.0 0.8 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.6 0.6 0.5 0.6 0.3 0.4 0.5 0.5 0.6 0.2 1.2 0.8 1.0 2.6 1.5 0.6 0.8 0.8 0.1 11.7 16.2 5.6 9.3 10.1 30.5 6.6 6.6 15.5 2.2 0.0 1.7 0.0 5.8 2.7 1.4 2.0 0.0 2.7 2.3 0.0 2.0 1.2 0.0 0.3 0.2 2.5 0.2 0.0 0.8 0.6 2.3 3.9 0.0 0.8 0.4 0.0 0.0 0.6 0.8 0.0 0.3 1.9 0.0 0.0 0.2 0.8 0.8 0.0 0.7 0.0 1.2 0.0 1.0 0.0 4.5 2.8 13.2 0.7 1.0 3.1 HAUS7 "UCHL5IP, UIP1" ENSG00000213397 "HAUS augmin like complex subunit 7" Q99871 X 153447666-153495516 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003614 Approved "Nucleoli,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" Nucleoli "HPA003614: AB_1080368" "unprognostic (2.06e-1)" "prognostic favorable (6.12e-4)" "unprognostic (3.81e-2)" "unprognostic (3.21e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-2)" "unprognostic (1.75e-2)" "unprognostic (7.50e-2)" "unprognostic (1.56e-1)" "unprognostic (3.39e-1)" "unprognostic (4.65e-3)" "unprognostic (6.28e-2)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.98e-1)" "unprognostic (1.15e-1)" "unprognostic (4.25e-2)" "unprognostic (1.09e-2)" 13.1 9.4 16.1 10.3 16.4 9.4 7.9 9.1 19.3 12.7 9.3 8.9 20.3 7.9 10.8 17.1 7.0 9.9 15.1 11.9 20.3 9.1 13.3 11.9 9.4 12.1 12.0 16.5 9.3 4.3 3.1 6.4 12.6 11.1 11.8 6.2 7.8 8.5 17.4 7.2 46.9 7.4 12.1 8.9 16.4 8.8 6.1 18.4 14.2 10.8 8.8 9.8 7.5 11.8 20.2 22.3 10.1 31.1 16.7 18.5 15.8 13.9 22.4 10.0 19.3 3.5 4.8 13.8 9.7 5.5 11.2 19.9 16.3 7.8 13.3 31.1 6.5 15.5 11.9 14.2 9.7 8.7 16.0 23.5 9.7 20.9 12.2 3.2 16.0 14.0 7.4 2.5 9.9 6.3 4.9 7.9 12.2 12.2 6.8 6.6 26.9 15.0 19.3 6.2 22.3 22.4 14.1 16.4 20.1 3.5 8.8 11.1 8.4 5.2 11.5 3.9 5.0 4.5 7.7 5.1 9.7 19.2 22.5 17.7 10.1 26.5 52.2 5.1 28.8 13.2 4.7 26.2 10.1 17.0 31.1 17.8 20.2 18.5 17.1 22.3 16.6 18.4 16.7 3.4 16.7 27.1 12.6 15.5 15.8 16.1 16.4 9.1 19.3 20.3 9.1 12.0 16.5 11.1 18.4 6.0 7.2 4.5 1.3 6.4 1.9 2.0 2.5 5.3 2.3 0.0 3.9 10.4 5.0 7.9 0.0 5.0 5.8 0.0 7.1 20.6 6.2 1.0 19.6 3.9 10.6 3.2 2.4 11.1 11.1 0.0 5.5 8.1 3.3 14.4 11.6 1.9 6.1 10.5 7.1 11.8 1.3 6.5 6.6 1.6 6.3 4.1 7.8 7.4 13.3 1.1 HDAC8 "HDACL1, MRXS6, RPD3, WTS" ENSG00000147099 "Histone deacetylase 8" Q9BY41 X 72329516-72573103 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Disease mutation, FDA approved drug targets, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048560 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA048560: AB_2680442" "unprognostic (1.42e-1)" "unprognostic (6.62e-3)" "unprognostic (3.20e-2)" "unprognostic (9.24e-3)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (4.64e-2)" "unprognostic (6.03e-2)" "unprognostic (1.58e-1)" "unprognostic (2.81e-2)" "unprognostic (3.17e-2)" "unprognostic (9.68e-2)" "unprognostic (8.42e-2)" "unprognostic (2.33e-3)" "unprognostic (9.10e-2)" "unprognostic (7.15e-3)" "unprognostic (2.12e-3)" 9.6 22.5 14.7 9.9 16.2 10.2 12.4 31.4 20.6 12.6 10.4 13.9 11.5 8.6 12.3 28.2 11.0 9.4 9.4 12.6 15.0 15.2 16.8 18.6 10.2 9.6 14.9 9.4 12.8 15.9 13.6 22.0 11.2 19.3 13.3 12.8 14.3 12.2 10.3 10.4 9.3 8.4 13.1 12.2 9.5 10.7 3.6 14.0 8.0 15.0 8.2 11.9 10.4 10.1 9.4 12.8 19.7 13.2 7.7 11.4 7.7 12.5 17.1 12.6 17.4 17.3 12.9 8.7 7.3 14.1 11.2 12.7 12.4 12.9 8.7 23.0 10.0 17.5 9.2 23.5 14.2 14.9 14.3 16.7 11.5 22.0 14.4 9.5 19.1 20.4 13.5 10.4 13.7 10.3 15.9 17.2 11.7 12.8 24.4 14.9 15.8 8.9 25.1 17.5 19.3 24.8 12.2 16.2 15.6 19.5 13.2 9.0 19.7 17.1 13.7 17.5 16.4 6.9 16.3 12.9 9.2 13.3 13.2 8.1 9.4 15.0 11.1 12.5 21.1 11.9 7.2 13.2 19.7 8.8 11.8 6.9 9.4 9.5 7.3 12.8 9.1 7.6 7.1 0.7 7.7 10.5 4.8 11.4 7.7 14.7 16.2 31.4 20.6 15.0 15.2 14.9 9.4 19.3 14.0 3.0 18.8 8.1 10.0 5.5 16.0 10.8 12.7 13.4 10.3 7.0 41.2 14.3 8.3 11.9 0.5 10.5 8.1 0.0 10.7 11.6 8.6 13.3 11.5 9.7 13.8 22.3 8.7 11.6 7.8 1.3 10.9 10.6 6.8 6.4 9.1 10.8 10.1 2.9 9.9 17.8 16.8 25.8 9.5 5.1 0.7 5.5 11.3 11.4 9.7 10.9 HEBP1 "HBP, HEBP" ENSG00000013583 "Heme binding protein 1" Q9NRV9 12 12974864-13000273 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056417, HPA075277" Approved Approved Nucleoplasm,Vesicles NA NA 130000 Vesicles Nucleoplasm "HPA056417: AB_2683122, HPA075277: AB_2686741" "unprognostic (1.65e-1)" "unprognostic (2.31e-2)" "unprognostic (9.28e-2)" "unprognostic (5.67e-3)" "unprognostic (4.45e-3)" "unprognostic (5.42e-3)" "unprognostic (2.70e-1)" "unprognostic (2.44e-1)" "unprognostic (6.04e-2)" "unprognostic (3.50e-2)" "unprognostic (1.94e-3)" "unprognostic (6.19e-2)" "unprognostic (2.28e-3)" "unprognostic (5.71e-2)" "unprognostic (1.64e-1)" "unprognostic (4.02e-2)" "unprognostic (4.43e-2)" 23.4 36.0 12.3 7.6 21.1 16.0 24.5 7.7 14.0 17.7 46.8 18.0 20.0 79.8 14.2 13.9 13.9 13.6 25.4 18.3 11.8 11.7 20.4 48.5 16.2 11.2 16.7 8.0 27.8 27.6 13.3 9.0 13.9 17.2 17.8 7.6 20.0 18.2 16.4 12.8 19.1 79.1 22.9 22.2 19.3 13.4 11.2 15.1 5.5 52.8 13.9 8.7 18.2 23.9 5.3 21.4 9.0 27.4 7.1 9.4 9.9 17.0 10.3 7.2 12.6 54.4 42.4 4.9 15.5 22.1 14.9 19.9 6.5 6.2 5.0 6.2 30.3 12.7 15.5 8.9 12.3 17.3 0.7 7.3 2.8 12.3 16.5 39.1 4.9 2.7 32.6 11.7 19.7 24.5 46.1 30.4 6.0 3.1 4.3 25.2 10.6 4.0 8.1 10.0 16.6 7.3 9.3 20.5 5.1 12.0 16.4 4.0 3.6 20.6 9.6 19.2 21.8 5.0 7.4 33.2 11.0 13.3 17.3 8.0 4.0 3.2 1.8 17.5 9.0 4.4 4.6 27.4 6.8 4.3 19.8 6.0 4.9 7.3 4.7 21.4 5.3 9.4 5.4 9.0 7.1 26.5 10.7 4.1 9.9 12.3 21.1 7.7 14.0 11.8 11.7 16.7 8.0 17.2 15.1 50.6 17.6 17.9 45.0 33.3 5.0 24.6 79.0 4.0 6.8 54.1 3.9 30.7 84.6 74.8 15.7 52.4 88.1 46.7 88.6 23.2 57.2 40.0 1.1 121.3 73.3 6.4 19.5 141.2 67.3 5.6 82.6 41.0 59.1 62.3 33.8 30.7 71.9 44.1 88.4 72.5 5.8 51.8 41.2 13.8 7.4 31.6 22.0 21.8 48.4 46.5 HERC6 FLJ20637 ENSG00000138642 "HECT and RLD domain containing E3 ubiquitin protein ligase family member 6" Q8IVU3 4 88378739-88443111 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "BJ hTERT+ SV40 Large T+: 47.0;BJ hTERT+ SV40 Large T+ RasG12V: 35.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035846 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035846: AB_10673487" "unprognostic (1.95e-2)" "unprognostic (2.71e-1)" "unprognostic (2.23e-2)" "unprognostic (2.67e-2)" "unprognostic (8.61e-2)" "unprognostic (2.98e-2)" "unprognostic (2.78e-2)" "unprognostic (3.27e-1)" "unprognostic (1.49e-1)" "unprognostic (5.95e-2)" "unprognostic (1.52e-2)" "unprognostic (6.22e-2)" "prognostic favorable (7.14e-5)" "unprognostic (1.80e-1)" "unprognostic (2.59e-1)" "unprognostic (8.43e-3)" "unprognostic (3.77e-2)" 8.0 7.5 7.8 7.2 10.2 7.3 6.3 2.1 14.6 13.6 6.3 5.9 3.4 5.4 13.2 9.6 23.9 10.4 11.2 9.8 7.7 8.4 10.4 5.0 8.3 4.6 7.3 15.8 9.8 6.3 5.2 8.4 7.1 8.5 9.1 6.5 7.2 28.4 5.7 2.9 4.3 7.1 8.5 5.6 8.0 7.3 3.9 5.3 9.0 5.9 7.6 7.8 7.2 13.8 3.6 2.7 4.5 6.4 5.6 13.4 4.2 2.6 1.7 0.1 0.3 0.1 1.6 0.5 0.3 8.8 47.0 35.0 0.1 3.3 0.0 0.6 0.8 7.6 1.0 4.3 2.2 3.1 5.3 0.9 2.4 1.5 0.2 1.5 4.3 1.7 2.1 0.5 3.6 0.1 2.8 1.3 2.0 0.0 0.6 1.0 1.5 2.0 1.3 0.6 2.3 0.9 1.3 0.0 0.1 3.2 3.2 0.1 1.1 3.2 1.1 5.2 2.4 1.9 0.8 0.4 0.6 0.9 0.1 0.8 0.1 0.0 0.0 2.1 1.0 2.1 4.4 3.1 4.5 6.7 3.1 13.4 3.6 9.4 6.5 2.7 2.7 7.5 5.1 1.9 5.6 6.4 0.3 11.8 4.2 7.8 10.2 2.1 14.6 7.7 8.4 7.3 15.8 8.5 5.3 11.9 8.8 2.4 4.4 2.5 11.4 10.6 5.1 16.0 10.3 5.2 15.7 4.9 0.0 6.6 0.9 8.4 5.2 0.0 15.0 1.3 3.7 8.2 5.7 2.1 4.3 1.6 1.7 4.3 3.7 1.3 4.0 2.2 5.0 4.6 2.9 4.3 9.1 3.1 5.3 3.6 1.0 6.5 2.0 0.5 1.1 1.0 2.1 7.7 1.7 6.2 HERPUD1 "HERP, KIAA0025, Mif1, SUP" ENSG00000051108 "Homocysteine inducible ER protein with ubiquitin like domain 1" Q15011 16 56932048-56944863 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Melanocytes: 899.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 78.5;U-266/70: 89.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037041, CAB037104, HPA040754, HPA041219" Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB037041: AB_1840910, CAB037104: AB_1840912, HPA040754: AB_10794068, HPA041219: AB_10794268" "unprognostic (1.92e-1)" "unprognostic (3.47e-1)" "unprognostic (8.64e-2)" "unprognostic (3.93e-3)" "unprognostic (3.39e-1)" "unprognostic (5.00e-3)" "unprognostic (1.17e-1)" "unprognostic (9.69e-3)" "unprognostic (3.33e-1)" "unprognostic (2.56e-1)" "unprognostic (2.84e-1)" "unprognostic (3.50e-1)" "prognostic favorable (1.41e-9)" "unprognostic (1.06e-1)" "unprognostic (3.93e-2)" "unprognostic (2.19e-2)" "unprognostic (2.27e-3)" 22.7 38.8 16.2 35.6 20.7 21.6 39.4 17.7 20.0 30.1 32.1 20.0 48.8 21.4 21.6 51.6 15.0 20.2 32.5 28.8 15.8 15.5 42.9 57.7 30.4 40.0 25.6 12.5 44.8 148.6 37.6 26.7 26.2 25.6 49.5 32.3 35.3 108.6 76.1 34.6 18.3 24.7 17.6 24.2 38.3 37.2 10.6 20.8 9.6 64.2 20.4 53.8 24.4 25.9 50.8 121.9 29.0 39.5 22.4 33.4 46.5 4.5 5.0 4.9 10.2 11.4 15.0 17.6 10.8 17.2 14.0 11.0 6.9 10.4 18.5 13.9 10.5 14.3 7.9 8.3 3.8 13.9 10.7 5.0 1.6 8.3 25.0 62.5 3.3 8.3 18.1 36.5 6.3 20.2 16.9 10.6 20.7 2.5 26.5 39.0 3.8 6.2 6.8 3.1 26.5 11.4 4.3 12.5 78.5 30.0 5.1 5.4 6.3 9.4 46.4 47.9 7.3 5.2 12.5 6.5 5.8 5.8 5.1 4.3 89.5 29.1 28.9 8.3 4.6 7.6 23.9 39.5 18.0 16.1 31.0 17.4 50.8 17.5 21.1 30.6 37.8 11.4 17.4 29.0 22.4 21.5 121.9 33.4 46.5 16.2 20.7 17.7 20.0 15.8 15.5 25.6 12.5 25.6 20.8 65.5 113.2 400.7 628.3 323.4 125.0 136.3 71.4 44.2 47.8 68.0 265.1 118.1 144.2 165.3 52.0 119.9 168.3 70.0 173.1 150.4 186.1 478.3 152.0 140.9 178.2 44.5 416.3 118.4 182.3 185.2 96.4 276.3 899.3 227.2 208.8 76.2 141.3 182.4 89.8 157.6 103.7 97.0 210.0 43.1 8.9 223.2 580.2 183.3 123.2 295.1 HEXA ENSG00000213614 "Hexosaminidase subunit alpha" P06865 15 72340919-72376476 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation, Gangliosidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 207.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA018082, HPA054583" Supported Supported Vesicles,Cytosol "Intracellular and membrane" NA NA 20000000 Vesicles Cytosol "HPA018082: , HPA054583: AB_2682531" "unprognostic (1.51e-2)" "unprognostic (1.73e-2)" "unprognostic (3.41e-1)" "prognostic favorable (5.63e-8)" "unprognostic (6.58e-2)" "unprognostic (1.32e-2)" "unprognostic (1.34e-2)" "unprognostic (2.82e-2)" "unprognostic (3.75e-1)" "unprognostic (1.09e-1)" "unprognostic (1.59e-2)" "unprognostic (9.98e-2)" "unprognostic (3.98e-1)" "unprognostic (7.05e-3)" "unprognostic (3.02e-2)" "unprognostic (4.73e-2)" "unprognostic (8.69e-2)" 30.1 37.4 23.1 18.0 22.9 35.5 37.8 23.3 28.1 30.6 20.5 19.4 30.1 18.5 25.9 65.7 11.7 21.8 29.2 33.8 23.4 12.8 34.6 29.5 43.9 31.4 24.9 21.1 20.9 22.2 18.1 22.9 37.9 18.8 18.1 26.0 26.9 24.8 22.0 17.7 17.9 24.6 23.4 21.4 31.5 22.6 18.0 22.9 12.1 31.2 11.1 16.4 26.7 17.1 16.1 37.9 22.4 32.7 17.8 18.1 21.3 7.5 12.8 5.5 10.6 45.5 51.9 7.9 10.6 53.8 23.0 36.8 6.7 55.4 6.3 10.2 21.3 12.0 15.1 14.6 6.7 14.6 5.1 5.8 7.9 12.7 11.6 35.2 18.9 22.7 44.1 20.2 10.0 17.9 42.2 21.0 9.4 12.2 39.2 30.6 6.5 4.1 9.5 3.1 24.7 0.1 4.2 12.0 14.2 25.7 11.9 4.8 5.3 26.5 25.1 59.9 11.7 4.6 23.9 10.6 34.5 14.4 31.7 11.2 20.9 28.2 6.5 12.5 25.3 16.7 8.9 32.7 22.4 18.1 13.7 15.8 16.1 12.0 15.8 37.9 15.6 9.5 14.0 3.1 17.8 4.8 14.4 10.7 21.3 23.1 22.9 23.3 28.1 23.4 12.8 24.9 21.1 18.8 22.9 59.6 55.5 41.1 30.3 19.7 40.2 22.6 35.7 17.4 28.4 62.8 100.1 116.3 51.4 65.3 16.3 43.0 46.2 0.0 33.3 55.3 62.5 30.5 29.9 37.8 207.1 25.4 45.3 44.2 76.0 10.5 68.7 108.5 89.4 50.5 39.4 48.4 43.8 84.5 42.1 55.5 56.1 45.3 20.6 20.4 28.2 13.7 131.8 47.5 44.4 25.0 HHIPL2 "FLJ13840, KIAA1822L" ENSG00000143512 "HHIP like 2" Q6UWX4 1 222522258-222548103 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 9.4;testis: 10.4;thyroid gland: 4.6" "Group enriched" "Detected in some" 9 "Early spermatids: 14.1;Late spermatids: 21.2;Spermatocytes: 8.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 16.2;Hep G2: 4.9;RH-30: 18.4;SuSa: 7.1;U-87 MG: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA059673 Enhanced Uncertain Mitochondria,Cytosol "Secreted in other tissues" No NA Mitochondria Cytosol "HPA059673: AB_2684100" "unprognostic (1.35e-2)" "unprognostic (4.62e-3)" "unprognostic (2.91e-1)" "unprognostic (9.21e-2)" "unprognostic (3.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.74e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.07e-2)" "unprognostic (3.64e-1)" "unprognostic (2.29e-2)" "unprognostic (2.14e-2)" "unprognostic (0.00e+0)" "unprognostic (6.52e-2)" "unprognostic (4.21e-4)" "unprognostic (2.30e-3)" "unprognostic (8.38e-2)" 0.3 0.7 0.0 0.1 0.6 0.1 0.2 0.1 1.4 0.7 0.0 0.6 0.0 0.0 0.1 0.5 0.5 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.9 9.4 0.2 0.3 1.9 3.9 0.0 0.1 0.1 0.0 0.0 0.1 0.1 10.4 0.0 0.0 4.6 0.0 0.3 0.2 0.7 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.1 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 16.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 4.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.3 0.0 18.4 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 7.1 0.0 0.0 0.0 0.8 0.2 0.0 0.2 0.0 0.1 0.0 9.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.1 1.4 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 1.7 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.4 0.5 0.0 0.0 0.0 0.0 0.0 HIF3A "bHLHe17, IPAS, MOP7, PASD7" ENSG00000124440 "Hypoxia inducible factor 3 alpha subunit" Q9Y2N7 19 46297046-46343433 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Apoptosis, Stress response, Transcription, Transcription regulation" "Developmental protein, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 39.5;Leydig cells: 126.2;Muller glia cells: 84.5;Peritubular cells: 97.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.3;HHSteC: 16.9;HSkMC: 14.9;TIME: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041141 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041141: AB_10803997" "unprognostic (9.20e-2)" "unprognostic (2.99e-1)" "unprognostic (5.48e-2)" "prognostic unfavorable (6.90e-9)" "unprognostic (4.12e-2)" "unprognostic (2.35e-2)" "unprognostic (3.57e-3)" "unprognostic (1.30e-1)" "unprognostic (3.32e-2)" "unprognostic (1.38e-2)" "unprognostic (3.76e-2)" "unprognostic (7.07e-2)" "unprognostic (3.41e-4)" "unprognostic (1.55e-2)" "unprognostic (1.61e-1)" "unprognostic (4.45e-4)" "unprognostic (5.98e-2)" 15.8 7.7 17.9 4.9 9.8 2.5 8.7 10.6 11.1 15.8 16.1 4.7 6.7 3.1 8.1 10.3 11.6 9.8 9.2 31.2 21.4 6.8 4.5 2.1 13.5 5.2 10.8 8.3 17.7 5.1 2.1 12.1 42.4 9.8 9.7 4.5 10.0 4.3 13.1 12.3 3.6 7.0 26.9 11.2 21.7 14.1 3.3 11.4 0.0 3.2 5.6 2.0 18.8 14.6 1.0 1.3 3.3 1.1 0.5 0.7 0.1 0.0 0.0 1.3 0.3 3.8 8.3 0.4 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 16.9 0.1 0.6 14.9 0.0 0.0 0.0 0.1 2.9 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.1 0.0 2.1 0.0 0.2 13.6 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.7 0.2 0.1 3.3 0.4 0.8 0.4 0.4 0.4 0.5 0.4 0.4 0.2 1.0 0.6 0.7 3.1 0.5 1.1 1.3 0.2 0.1 17.9 9.8 10.6 11.1 21.4 6.8 10.8 8.3 9.8 11.4 3.0 2.6 0.0 2.1 1.0 1.4 39.5 10.2 0.0 1.2 0.0 0.0 0.2 1.7 0.0 1.4 36.8 0.0 0.0 0.0 0.2 7.5 1.3 0.0 0.5 0.5 0.0 1.2 28.8 1.0 2.6 126.2 0.2 3.3 0.0 1.1 84.5 0.1 1.5 97.2 0.0 2.1 6.5 4.2 1.2 3.1 1.9 0.5 0.0 1.4 0.5 HIGD1B "CLST11240, CLST11240-15" ENSG00000131097 "HIG1 hypoxia inducible domain family member 1B" Q9P298 17 44846353-44850480 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 61.8" "Group enriched" "Detected in some" 32 "Sertoli cells: 750.3;Smooth muscle cells: 198.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079501 Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA079501: " "unprognostic (6.85e-2)" "unprognostic (9.41e-2)" "unprognostic (3.80e-3)" "unprognostic (2.07e-1)" "unprognostic (8.46e-2)" "unprognostic (2.37e-2)" "unprognostic (4.98e-3)" "unprognostic (3.61e-1)" "unprognostic (1.18e-2)" "unprognostic (3.98e-1)" "unprognostic (6.19e-2)" "unprognostic (3.56e-1)" "unprognostic (1.61e-3)" "unprognostic (5.23e-3)" "unprognostic (8.72e-2)" "unprognostic (1.79e-2)" "unprognostic (1.52e-2)" 6.4 0.7 12.4 0.7 18.2 0.6 3.2 4.5 9.7 5.7 1.9 3.6 0.4 1.5 6.4 7.6 2.5 3.1 7.1 11.0 12.4 10.1 2.6 0.6 21.6 1.7 15.8 6.8 2.0 2.0 2.5 0.3 61.8 8.7 3.6 1.0 0.7 1.3 4.4 7.9 1.3 1.3 7.3 6.2 0.4 1.5 1.2 8.9 0.1 3.4 1.8 1.1 3.0 1.6 1.1 3.3 4.6 2.9 1.9 3.5 1.1 0.5 1.8 0.0 2.0 0.0 0.0 1.8 1.7 0.0 0.0 0.0 1.0 0.6 1.7 0.5 0.0 0.1 0.7 0.0 0.0 0.0 1.4 2.0 0.4 2.1 1.3 0.0 2.6 3.7 0.0 0.0 0.0 0.0 0.6 0.0 2.6 2.1 1.5 0.0 0.7 1.9 2.0 1.3 0.7 1.0 2.2 1.2 2.5 0.0 1.3 2.2 1.0 0.6 0.0 0.3 0.1 0.9 1.1 0.0 1.8 0.6 1.2 1.4 1.3 3.9 2.0 1.6 3.1 2.2 4.6 1.9 0.7 3.5 2.9 1.3 0.7 2.3 2.6 3.3 1.1 2.5 2.3 0.0 1.9 0.3 0.9 2.0 1.1 12.4 18.2 4.5 9.7 12.4 10.1 15.8 6.8 8.7 8.9 0.0 0.3 0.0 0.5 3.1 0.4 3.9 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.1 14.7 0.0 0.0 0.0 0.2 2.0 0.3 0.0 0.0 0.6 1.6 0.0 1.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.5 750.3 198.1 0.0 0.2 2.0 0.2 0.0 0.0 0.7 HILPDA "C7orf68, FLJ21076, HIG-2, HIG2" ENSG00000135245 "Hypoxia inducible lipid droplet associated" Q9Y5L2 7 128455849-128458418 "Predicted membrane proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.4;esophagus: 71.4" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 142.7;Syncytiotrophoblasts: 201.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 31.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010515 Approved Supported "Nucleoplasm,Lipid droplets" "Intracellular and membrane" NA NA "Lipid droplets" Nucleoplasm "HPA010515: AB_1850710" "unprognostic (1.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.88e-2)" "unprognostic (2.27e-1)" "unprognostic (2.10e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.30e-11)" "unprognostic (9.20e-3)" "unprognostic (4.07e-3)" "unprognostic (2.49e-1)" "unprognostic (4.06e-3)" "unprognostic (2.15e-2)" "prognostic unfavorable (2.05e-7)" "unprognostic (2.23e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-2)" "unprognostic (1.27e-1)" 24.5 5.2 25.3 5.5 34.2 14.1 16.2 8.6 53.9 15.7 14.4 6.4 2.8 4.7 9.1 6.3 71.4 7.9 7.2 16.7 25.1 8.5 10.4 10.3 13.2 4.9 22.4 3.1 22.9 5.0 3.0 4.2 25.7 46.5 7.0 6.2 2.8 7.7 6.1 5.2 14.4 4.4 6.9 66.4 3.0 6.4 10.1 21.1 1.7 5.6 6.9 6.0 60.5 18.6 9.2 5.9 31.7 3.6 6.9 3.3 2.0 11.2 23.8 13.0 14.2 17.8 6.6 24.4 4.1 5.2 8.7 9.7 5.9 10.3 7.7 3.3 6.2 8.9 7.2 7.3 8.8 11.1 4.2 6.7 4.7 5.0 5.3 4.0 7.4 6.5 10.9 7.6 6.8 4.6 8.9 7.1 12.2 6.8 3.2 8.6 13.9 22.2 13.5 16.1 8.3 10.5 16.8 6.1 11.9 4.8 16.8 12.5 11.5 6.4 45.2 8.0 12.2 36.8 7.2 5.2 11.2 5.5 8.4 5.1 3.1 2.3 9.8 21.1 11.5 9.6 9.2 3.5 31.7 2.3 3.6 3.3 7.8 2.9 2.8 3.4 9.2 3.0 2.9 1.4 6.9 2.7 5.9 1.9 2.0 25.3 34.2 8.6 53.9 25.1 8.5 22.4 3.1 46.5 21.1 8.9 5.6 5.8 11.4 57.1 6.2 3.1 5.1 33.5 47.8 1.8 17.7 95.4 0.0 16.4 0.3 26.9 2.9 0.0 7.6 142.7 49.5 20.7 17.4 3.2 23.2 25.4 12.6 7.4 4.3 1.7 28.1 20.8 35.4 20.8 7.7 14.1 55.4 5.5 23.0 8.4 22.5 6.5 49.5 5.9 16.3 45.5 201.6 5.1 15.3 8.0 HIPK1 "KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2" ENSG00000163349 "Homeodomain interacting protein kinase 1" Q86Z02 1 113929192-113977869 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 90.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 62.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016664 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA016664: AB_1850725" "unprognostic (2.98e-1)" "unprognostic (3.94e-2)" "unprognostic (4.89e-3)" "unprognostic (2.52e-2)" "unprognostic (6.47e-2)" "unprognostic (9.84e-3)" "unprognostic (4.64e-3)" "unprognostic (7.22e-2)" "unprognostic (7.52e-2)" "unprognostic (1.45e-2)" "unprognostic (1.26e-1)" "unprognostic (1.15e-1)" "unprognostic (8.63e-2)" "unprognostic (1.84e-1)" "unprognostic (2.64e-1)" "unprognostic (1.94e-2)" "unprognostic (1.99e-2)" 15.1 16.8 21.2 14.7 23.0 90.1 13.6 38.1 20.4 20.4 14.4 20.7 14.5 10.2 15.5 14.2 18.7 27.3 17.5 27.9 22.9 17.2 14.8 13.8 19.3 14.7 15.0 16.4 18.7 16.8 20.7 23.8 13.8 21.3 14.4 15.2 20.7 13.0 14.9 19.7 18.5 13.4 15.1 18.3 15.9 14.8 33.5 21.3 47.2 23.3 13.1 15.5 17.3 26.7 2.3 6.2 9.8 4.2 4.3 6.0 2.3 8.2 6.7 9.3 7.1 10.9 5.7 6.3 5.7 6.9 8.1 7.8 7.7 3.2 11.1 7.8 9.0 3.0 5.6 12.0 6.6 11.8 8.0 6.0 16.1 8.4 8.1 9.1 12.8 20.0 6.2 9.7 10.4 10.6 7.7 12.0 19.7 11.0 12.0 11.6 62.4 16.8 7.3 9.5 6.2 6.0 10.2 27.3 3.9 7.3 7.1 4.1 5.5 10.4 11.2 7.3 10.8 6.5 18.5 11.6 8.0 10.8 13.0 8.6 7.5 5.8 9.6 9.0 10.4 18.2 3.4 4.2 8.2 5.5 3.7 5.2 1.7 4.9 4.9 3.1 2.3 5.0 6.0 9.8 4.3 2.6 6.2 3.6 2.3 21.2 23.0 38.1 20.4 22.9 17.2 15.0 16.4 21.3 21.3 50.6 37.0 12.9 14.8 54.6 47.6 27.1 22.9 64.3 20.5 26.2 66.8 9.7 5.0 12.5 82.7 29.3 18.8 70.0 18.3 7.9 25.0 26.7 45.1 33.6 19.9 69.9 35.7 23.9 54.6 73.8 20.4 35.5 20.3 15.4 24.2 28.9 17.0 17.3 35.0 13.4 60.3 25.8 37.0 35.4 26.0 70.4 11.9 47.3 22.4 23.0 HIVEP1 "CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A" ENSG00000095951 "Human immunodeficiency virus type I enhancer binding protein 1" P15822 6 12008762-12164999 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050724, HPA067457" Approved Supported "Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Mitochondria, Cytosol" "HPA050724: AB_2616457, HPA067457: " "unprognostic (2.55e-1)" "unprognostic (5.85e-2)" "unprognostic (1.15e-1)" "unprognostic (6.03e-2)" "unprognostic (1.75e-2)" "unprognostic (5.65e-3)" "unprognostic (4.83e-2)" "unprognostic (1.38e-1)" "unprognostic (2.20e-1)" "unprognostic (1.85e-1)" "unprognostic (5.69e-2)" "unprognostic (1.98e-1)" "unprognostic (4.40e-2)" "unprognostic (3.01e-2)" "unprognostic (2.21e-1)" "unprognostic (4.49e-2)" "unprognostic (2.38e-1)" 22.3 5.5 6.4 20.1 5.6 20.5 13.1 8.0 10.0 11.5 12.6 5.4 13.9 7.0 10.0 10.6 12.9 9.2 10.6 8.8 5.6 7.1 7.3 17.1 13.3 12.4 5.3 6.7 11.6 11.7 23.3 12.2 8.7 7.8 10.5 9.5 7.7 10.9 17.6 8.2 14.1 11.8 12.9 5.9 15.2 7.2 7.3 5.0 23.8 7.7 14.2 16.2 17.3 23.1 5.6 9.6 12.9 4.9 3.6 4.6 0.7 5.2 3.9 5.1 2.8 4.0 5.2 4.9 4.3 3.7 3.6 3.9 2.5 2.8 4.4 9.4 5.2 8.5 5.1 5.0 6.1 4.9 9.5 2.9 2.0 3.7 2.4 3.3 2.3 1.7 3.6 6.2 7.2 11.2 7.5 10.4 3.0 21.1 5.1 7.7 3.9 3.8 2.1 4.3 1.8 2.0 2.1 6.6 6.9 2.1 5.8 4.8 3.5 10.6 8.7 3.0 11.9 5.1 3.1 16.8 9.0 4.0 8.3 4.9 20.5 17.1 7.9 2.7 3.1 3.7 2.4 2.2 2.2 1.4 2.2 1.0 3.4 2.3 0.9 1.3 5.6 4.0 2.3 12.9 3.6 4.9 9.6 4.6 0.7 6.4 5.6 8.0 10.0 5.6 7.1 5.3 6.7 7.8 5.0 26.8 19.2 6.5 21.7 28.6 19.2 7.4 10.2 22.7 26.1 7.0 11.8 2.9 3.3 4.8 2.1 15.5 11.3 0.0 6.3 1.8 12.7 18.9 7.0 11.4 4.9 20.6 10.4 7.4 8.5 1.5 3.4 19.0 18.6 45.9 12.5 13.2 8.5 9.7 4.2 2.7 9.1 0.0 13.4 3.6 3.1 29.2 4.3 7.5 7.1 23.3 HJURP "DKFZp762E1312, FAKTS, hFLEG1, URLC9" ENSG00000123485 "Holliday junction recognition protein" Q8NCD3 2 233833416-233854566 "Predicted intracellular proteins" "Cell cycle" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 12.4;Erythroid cells: 46.7;Extravillous trophoblasts: 13.7;Spermatocytes: 18.4;Spermatogonia: 12.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.2" "Group enriched" "Detected in many" 4 "granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA008436, HPA027261" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria" Yes Yes "Nucleoplasm, Nucleoli, Nucleoli rim" Mitochondria "HPA008436: AB_1850757, HPA027261: AB_2672184" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.87e-1)" "unprognostic (1.44e-3)" "unprognostic (3.62e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.37e-5)" "prognostic unfavorable (2.46e-4)" "prognostic unfavorable (6.49e-4)" "unprognostic (9.48e-2)" "prognostic unfavorable (7.72e-5)" "unprognostic (7.60e-2)" "unprognostic (0.00e+0)" "unprognostic (7.42e-2)" "unprognostic (5.58e-2)" "unprognostic (1.89e-2)" "unprognostic (5.74e-2)" 1.4 0.9 0.1 12.2 0.4 27.4 2.2 0.1 0.7 1.1 3.7 0.3 0.1 2.6 0.6 1.8 8.0 0.3 0.7 1.1 0.1 0.2 1.0 1.2 2.0 8.1 0.2 0.1 0.6 0.4 0.0 0.2 3.1 0.2 0.7 3.6 0.3 1.5 1.0 0.2 2.6 4.8 1.1 0.4 5.8 2.4 20.9 0.1 51.1 0.4 3.0 11.6 1.0 2.8 0.5 0.3 1.2 1.3 0.5 4.2 1.7 17.0 23.1 22.6 10.6 0.8 1.8 14.1 25.6 12.3 18.3 20.0 16.2 18.7 5.3 2.9 10.1 32.6 20.0 18.0 13.3 24.4 12.5 6.8 20.6 18.6 15.7 0.1 16.9 14.2 0.6 0.5 14.9 10.3 5.2 11.4 16.5 17.4 13.3 33.6 17.2 23.7 18.7 19.3 13.4 16.0 18.4 33.9 9.5 9.4 10.3 13.0 8.1 14.8 11.2 10.5 10.8 8.4 13.1 8.3 19.8 21.6 14.5 27.7 12.7 10.0 21.4 11.9 12.5 49.3 0.6 0.2 0.2 0.3 0.2 0.2 0.4 0.7 0.6 0.3 0.5 0.3 0.5 1.2 0.5 1.3 0.2 4.2 1.7 0.1 0.4 0.1 0.7 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.3 0.8 0.4 1.1 0.0 0.8 0.0 0.0 3.4 0.0 0.0 1.1 0.0 0.0 12.4 0.1 0.9 46.7 0.0 13.7 0.3 0.4 0.0 0.0 5.7 0.0 0.0 2.5 2.4 7.4 0.6 2.1 0.0 0.0 0.7 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.3 18.4 12.9 0.6 1.3 1.3 1.2 0.6 HK2 ENSG00000159399 "Hexokinase 2" P52789 2 74833981-74893359 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 87.9;Enterocytes: 116.3;Paneth cells: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 26.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 54.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA028587, HPA061711" Enhanced Supported Vesicles,Centrosome,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "Vesicles, Centrosome" "HPA028587: AB_10602605, HPA061711: " "unprognostic (1.28e-1)" "unprognostic (1.52e-3)" "unprognostic (3.02e-1)" "unprognostic (3.63e-2)" "unprognostic (1.69e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (3.65e-4)" "unprognostic (2.85e-2)" "unprognostic (2.57e-1)" "unprognostic (2.17e-1)" "unprognostic (4.43e-3)" "unprognostic (2.24e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.20e-1)" "unprognostic (1.17e-1)" "unprognostic (1.42e-1)" "unprognostic (7.67e-2)" 27.0 2.2 4.4 9.5 5.0 20.4 10.8 0.7 4.5 5.3 23.2 7.3 5.7 1.3 2.6 40.1 13.6 4.8 9.1 8.3 2.8 2.3 2.1 1.4 16.5 5.0 8.5 1.1 14.9 3.5 1.1 1.7 13.2 5.4 4.0 19.2 9.6 10.3 0.5 29.3 9.7 8.9 1.7 10.9 7.4 8.7 24.8 7.4 4.3 7.1 22.3 9.2 29.0 8.3 0.8 6.2 26.2 7.1 0.0 0.8 2.0 16.5 0.1 3.8 14.0 32.9 3.4 14.3 6.4 9.4 7.3 10.5 13.2 3.0 12.0 6.2 3.0 9.4 5.7 17.5 13.6 21.2 3.4 3.7 16.3 3.8 18.2 10.4 23.8 26.9 5.8 14.8 13.8 24.3 8.2 3.4 6.9 14.2 0.0 2.1 11.8 5.7 24.4 13.9 15.7 11.5 9.3 8.1 9.3 4.4 23.4 2.8 13.7 4.1 20.9 8.2 5.8 1.1 3.8 2.8 23.3 4.1 9.6 11.7 8.3 2.3 6.0 54.3 17.5 6.0 6.6 7.1 26.2 0.1 5.7 0.3 0.6 0.4 0.1 6.2 0.8 0.7 0.7 5.9 0.0 3.7 0.1 0.8 2.0 4.4 5.0 0.7 4.5 2.8 2.3 8.5 1.1 5.4 7.4 14.9 37.6 2.9 5.5 45.8 6.2 6.0 7.6 0.0 6.8 5.2 78.5 0.7 0.0 4.4 87.9 3.6 116.3 0.0 3.8 12.3 8.5 17.2 21.9 0.0 15.7 20.6 37.5 1.3 14.6 32.5 13.6 18.9 21.9 1.0 32.2 4.3 18.4 86.0 7.4 0.0 43.3 12.9 2.3 3.1 4.5 49.8 6.9 2.2 19.9 69.9 HMGN4 "HMG17L3, NHC" ENSG00000182952 "High mobility group nucleosomal binding domain 4" O00479 6 26538405-26546254 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077364 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA077364: AB_2686835" "unprognostic (1.91e-1)" "unprognostic (2.48e-2)" "unprognostic (5.88e-2)" "unprognostic (8.81e-2)" "unprognostic (4.10e-2)" "unprognostic (6.02e-2)" "unprognostic (4.00e-3)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (3.22e-1)" "unprognostic (7.81e-3)" "unprognostic (2.09e-1)" "unprognostic (3.06e-2)" "unprognostic (1.64e-1)" "unprognostic (8.02e-3)" "unprognostic (9.01e-2)" "unprognostic (6.07e-3)" 26.3 26.8 16.8 28.9 20.8 16.6 32.0 21.8 26.5 29.0 34.0 16.2 27.5 21.1 42.0 31.7 28.1 32.0 28.6 29.4 14.3 18.2 31.0 10.7 25.5 50.3 15.5 18.3 33.0 24.1 24.4 18.5 23.7 15.9 35.3 31.4 21.1 24.7 36.6 30.8 21.0 32.7 45.3 16.7 33.2 23.1 26.8 15.6 38.2 36.2 24.0 38.1 35.1 34.4 31.8 25.9 57.0 22.1 30.6 39.7 37.7 23.3 9.7 17.2 23.2 23.6 35.9 11.7 20.6 35.1 31.5 42.9 9.2 14.9 28.5 31.4 29.0 29.8 11.1 30.4 25.9 34.6 35.2 28.1 30.0 13.5 16.9 25.9 24.4 30.4 27.0 35.1 24.8 40.7 26.1 29.1 34.8 27.0 46.6 27.9 12.2 40.5 27.7 10.4 18.6 15.9 15.0 20.8 48.6 22.1 16.7 28.9 25.4 17.6 13.4 38.1 21.2 14.7 11.7 22.1 21.4 15.7 19.2 17.5 29.6 79.7 24.5 10.1 56.4 27.3 57.0 19.1 34.9 39.2 18.0 37.5 31.8 39.7 39.6 25.9 27.3 33.6 32.1 28.3 30.6 22.1 20.8 39.4 37.7 16.8 20.8 21.8 26.5 14.3 18.2 15.5 18.3 15.9 15.6 3.0 4.3 10.9 3.3 6.6 0.2 1.2 10.2 1.4 12.5 1.8 0.0 3.0 5.0 1.6 0.3 2.2 2.6 0.0 1.2 8.5 3.7 1.8 8.1 1.0 3.8 0.0 0.0 3.7 3.2 0.0 1.4 9.2 8.5 8.2 1.5 1.9 1.9 1.7 2.5 6.1 0.2 0.0 3.1 0.2 1.1 4.4 6.8 8.5 1.2 1.7 HMGN5 NSBP1 ENSG00000198157 "High mobility group nucleosome binding domain 5" P82970 X 81113701-81201942 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 45.0;Karpas-707: 66.4" "Low region specificity" "Detected in all" "HPA000511, HPA076238" Approved Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA000511: AB_1079505, HPA076238: " "unprognostic (1.49e-2)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (3.98e-2)" "unprognostic (1.08e-1)" "unprognostic (1.96e-1)" "unprognostic (9.63e-3)" "prognostic favorable (6.60e-4)" "unprognostic (2.78e-3)" "unprognostic (1.16e-1)" "unprognostic (2.32e-3)" "unprognostic (3.06e-2)" "unprognostic (1.07e-1)" "unprognostic (6.53e-2)" "unprognostic (1.08e-1)" 5.2 11.4 14.7 3.1 15.6 12.5 6.5 6.0 12.0 8.6 10.6 5.1 12.3 10.2 7.7 30.9 9.8 7.5 4.8 5.4 16.1 14.3 16.2 9.9 3.9 2.0 13.2 10.1 9.5 5.6 11.9 39.8 2.0 10.4 7.0 7.9 3.5 5.6 9.3 3.6 5.2 10.8 7.3 22.1 8.2 5.9 48.6 19.6 10.9 8.1 8.6 2.7 7.8 6.0 6.5 11.0 2.8 3.1 3.4 10.2 3.4 0.2 2.2 5.9 28.8 5.0 1.6 1.2 1.6 2.5 0.4 0.7 0.7 10.9 45.0 5.1 0.7 0.4 1.9 34.8 4.1 1.1 26.3 13.9 18.8 21.2 0.3 0.5 31.2 18.6 1.3 1.1 1.8 1.7 1.6 2.3 29.0 24.8 66.4 2.9 1.0 28.4 11.1 26.2 6.3 7.6 1.1 24.6 21.2 7.1 0.8 0.2 0.7 0.2 0.6 1.9 5.3 3.6 7.4 2.6 0.9 7.7 4.5 6.1 4.6 1.9 7.2 2.8 12.3 1.6 2.0 3.1 1.4 8.5 1.6 7.7 3.6 5.2 4.6 5.3 6.5 10.2 8.7 2.8 3.4 2.5 11.0 1.7 3.4 14.7 15.6 6.0 12.0 16.1 14.3 13.2 10.1 10.4 19.6 8.9 13.1 10.4 21.3 14.2 2.8 11.3 17.8 72.3 14.8 43.6 0.0 0.5 58.0 9.9 14.1 16.1 17.1 70.0 16.2 0.4 10.2 18.1 12.7 74.1 13.2 1.6 16.7 19.0 13.3 43.8 27.3 13.9 8.5 1.0 22.4 20.4 6.7 17.5 38.5 60.3 1.5 45.3 19.4 7.2 8.4 13.0 0.3 7.5 39.1 17.4 HMOX1 "bK286B10, HO-1" ENSG00000100292 "Heme oxygenase 1" P09601 22 35380361-35394214 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 209.8" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 439.8;Kupffer cells: 915.4;monocytes: 247.9;Syncytiotrophoblasts: 419.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 17.7;intermediate monocyte: 40.5;non-classical monocyte: 53.4" "Lineage enriched" "Detected in many" 6 "monocytes: 53.4" "Cell line enhanced" "Detected in many" "BEWO: 108.8;GAMG: 71.3;U-138 MG: 63.5;U-87 MG: 61.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA000635, CAB017444" Enhanced Uncertain "Golgi apparatus,Plasma membrane" NA NA 17000 "Golgi apparatus, Plasma membrane" "CAB017444: AB_10617276, HPA000635: AB_1079089" "unprognostic (3.12e-1)" "unprognostic (1.00e-1)" "unprognostic (9.42e-2)" "unprognostic (6.94e-2)" "unprognostic (5.57e-2)" "unprognostic (2.47e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (7.56e-2)" "unprognostic (1.71e-1)" "unprognostic (4.91e-2)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.95e-3)" "unprognostic (1.91e-1)" "unprognostic (4.82e-2)" "unprognostic (2.26e-1)" "unprognostic (7.54e-2)" 28.4 10.3 4.1 12.5 8.7 16.3 13.8 0.8 20.6 5.7 12.0 6.1 0.6 22.0 2.5 8.5 8.8 9.8 9.8 10.2 4.1 3.1 23.0 63.7 54.0 76.3 12.5 1.3 28.6 8.8 0.5 2.7 21.1 7.5 3.6 4.9 3.3 3.5 0.8 21.9 13.8 22.8 6.9 11.2 209.8 4.6 5.9 7.6 3.6 4.2 7.3 8.3 6.7 10.2 4.8 7.9 8.4 53.4 1.1 0.3 10.1 1.4 22.1 0.2 4.5 18.1 5.3 108.8 10.2 6.0 4.8 5.2 9.8 1.3 0.0 2.3 8.3 71.3 1.2 1.3 0.2 1.5 36.6 1.1 0.5 6.7 20.0 25.2 1.3 6.9 16.6 0.4 31.7 2.1 7.7 14.4 0.0 0.0 10.6 15.3 1.1 0.0 0.5 2.2 13.6 2.5 0.1 1.9 3.4 3.4 11.9 0.3 0.3 26.4 2.3 1.7 9.6 1.0 0.3 5.4 63.5 2.8 10.3 9.9 6.6 8.5 1.0 61.6 0.6 1.0 2.0 17.7 1.2 0.2 40.5 0.0 4.8 0.1 0.3 7.9 0.5 0.0 0.0 8.4 1.1 53.4 0.2 0.2 10.1 4.1 8.7 0.8 4.8 4.1 3.1 12.5 1.3 7.5 7.6 3.0 21.3 13.8 5.9 14.5 0.0 3.1 10.2 1.4 0.0 5.2 0.0 39.4 18.3 10.3 1.6 20.2 43.4 0.0 1.3 204.4 21.6 85.9 11.5 19.5 439.8 0.0 15.3 30.7 915.4 1.3 28.7 175.5 33.7 247.9 5.3 0.2 8.7 10.5 4.9 128.1 0.4 0.0 16.5 0.9 2.7 13.7 419.8 10.0 4.1 91.1 HNMT ENSG00000150540 "Histamine N-methyltransferase" P50135 2 137964020-138016364 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 259.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 19 "classical monocyte: 34.6;intermediate monocyte: 26.7;myeloid DC: 20.9;non-classical monocyte: 14.6" "Group enriched" "Detected in many" 22 "dendritic cells: 20.9;monocytes: 34.6" "Cell line enhanced" "Detected in many" "Hep G2: 60.9;HSkMC: 24.9;RT4: 31.6;SuSa: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035480, HPA035481, HPA073754" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA 64000 "Nucleoplasm, Cytosol" Centrosome "HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: " "unprognostic (1.32e-1)" "unprognostic (3.53e-1)" "unprognostic (5.44e-2)" "unprognostic (2.09e-2)" "unprognostic (2.81e-1)" "unprognostic (2.33e-1)" "unprognostic (2.29e-2)" "unprognostic (6.02e-2)" "unprognostic (5.69e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.41e-4)" "unprognostic (5.24e-2)" "unprognostic (1.34e-2)" "unprognostic (1.76e-2)" "unprognostic (5.34e-2)" "unprognostic (1.21e-1)" "prognostic favorable (4.68e-4)" 41.4 5.8 12.2 12.3 11.1 3.3 28.8 10.7 11.3 27.6 16.3 8.6 13.9 8.7 22.2 21.4 11.6 14.6 21.6 14.7 12.7 7.8 33.4 74.2 21.9 17.0 13.7 9.2 33.1 14.1 24.5 5.5 14.3 11.2 22.3 17.7 8.7 14.1 20.1 4.9 8.1 11.1 13.2 14.8 18.5 11.5 11.7 14.6 1.0 7.3 8.5 6.5 21.3 12.0 0.5 20.9 1.2 34.6 0.1 0.2 9.2 0.2 0.3 1.5 4.1 17.5 18.8 0.1 1.1 1.7 0.1 0.7 7.8 4.4 0.2 13.8 4.5 0.3 0.4 3.2 0.0 0.0 0.2 1.6 0.1 13.0 60.9 7.9 0.0 0.2 24.9 0.0 6.2 0.0 1.4 4.4 0.1 0.2 0.3 13.1 0.9 0.0 0.2 7.8 10.4 1.6 0.1 0.5 0.0 18.8 31.6 0.1 0.4 5.9 7.7 0.0 31.3 0.2 14.3 1.2 1.3 3.4 1.8 4.4 0.1 0.0 0.2 5.9 7.5 0.9 0.8 34.6 0.2 0.2 26.7 0.1 0.5 0.1 0.1 20.9 0.3 0.1 0.2 1.2 0.1 14.6 0.6 0.2 9.2 12.2 11.1 10.7 11.3 12.7 7.8 13.7 9.2 11.2 14.6 26.8 39.0 13.7 77.1 31.6 0.5 1.6 140.1 52.2 86.4 57.6 0.0 45.4 104.5 84.7 1.2 4.9 45.2 0.0 42.0 69.7 45.8 47.7 0.0 146.0 259.0 0.0 15.7 23.4 235.2 1.6 121.7 155.2 54.0 68.5 65.8 22.3 57.9 100.1 99.0 189.5 0.5 77.6 52.5 0.5 0.6 22.6 31.5 5.0 76.2 102.7 HNRNPA1P48 ENSG00000224578 "Heterogeneous nuclear ribonucleoprotein A1 pseudogene 48" 16 51553436-51647132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 74.5;Exocrine glandular cells: 119.5;granulocytes: 106.3;Intestinal endocrine cells: 64.6;monocytes: 100.0;Pancreatic endocrine cells: 81.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 1.0" "HPA001666, HPA005812" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA001666: AB_1850836, HPA005812: AB_2667441" "unprognostic (2.61e-2)" "unprognostic (2.08e-1)" "unprognostic (3.22e-2)" "unprognostic (2.07e-3)" "unprognostic (7.23e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.48e-1)" "unprognostic (2.86e-1)" "unprognostic (6.09e-2)" "unprognostic (1.55e-3)" "unprognostic (7.66e-2)" "unprognostic (5.84e-2)" "unprognostic (2.17e-2)" "unprognostic (1.17e-1)" "unprognostic (1.95e-3)" "unprognostic (2.11e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 26.2 13.4 0.0 0.0 0.0 8.9 0.0 26.8 40.9 1.8 0.0 0.0 10.0 74.5 0.0 0.0 0.0 0.0 119.5 0.0 0.0 0.0 106.3 0.0 0.0 0.0 64.6 0.0 0.0 0.0 0.0 11.0 0.0 100.0 0.0 0.0 81.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HORMAD2 "CT46.2, MGC26710" ENSG00000176635 "HORMA domain containing 2" Q8N7B1 22 30080174-30177075 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 21.3" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 115.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "THP-1: 1.2;U-2197: 3.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA003074, HPA043880" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA003074: AB_1850916, HPA043880: " "unprognostic (1.43e-1)" "unprognostic (6.77e-3)" "unprognostic (2.33e-1)" "unprognostic (1.36e-2)" "unprognostic (8.19e-3)" "unprognostic (1.96e-1)" "unprognostic (2.50e-2)" "unprognostic (2.12e-1)" 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.3 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 115.1 2.7 0.0 0.0 0.0 0.0 0.0 HOXB7 "HOX2, HOX2C" ENSG00000260027 "Homeobox B7" P09629 17 48607227-48633572 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 62.3" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 82.0;Distal tubular cells: 126.0;Enterocytes: 102.1;Mucus-secreting cells: 73.3;Paneth cells: 56.1;Undifferentiated cells: 65.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 30.4;OE19: 26.5;RPTEC TERT1: 24.2;SK-MEL-30: 28.8" "Region enriched" "Detected in single" 45 "pons and medulla: 6.0" "Region enriched" "Detected in single" 14 "pons and medulla: 1.5" HPA049940 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA049940: AB_2616461" "unprognostic (6.76e-2)" "unprognostic (6.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-3)" "unprognostic (1.42e-2)" "unprognostic (1.69e-2)" "unprognostic (8.05e-3)" "unprognostic (9.16e-2)" "unprognostic (9.91e-2)" "unprognostic (7.01e-3)" "unprognostic (7.81e-3)" "unprognostic (1.17e-2)" "unprognostic (1.56e-2)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" "prognostic favorable (2.39e-4)" 8.3 8.3 0.0 7.3 0.3 0.1 17.2 0.1 0.6 10.0 8.1 0.1 24.1 0.5 4.1 62.3 0.8 4.2 0.3 1.1 0.0 0.0 23.7 0.8 1.7 2.4 0.1 0.3 2.3 0.6 0.4 0.5 4.1 4.1 5.2 7.0 0.1 0.1 22.1 2.4 2.2 12.4 3.5 20.1 2.2 4.6 3.0 0.2 0.1 0.5 0.1 0.6 5.8 15.1 2.2 1.8 0.0 0.0 2.0 4.7 0.5 16.9 7.4 0.0 0.1 5.3 8.0 0.0 0.0 0.0 0.1 0.3 11.3 0.3 0.3 30.4 7.1 8.8 2.5 0.0 0.0 0.0 7.8 5.5 2.6 5.8 0.0 4.4 0.0 5.5 5.2 2.3 5.2 0.0 1.3 16.0 5.3 2.8 0.1 16.8 4.4 0.3 0.1 0.0 26.5 0.0 0.0 14.4 1.9 24.2 5.7 0.0 0.0 5.7 0.0 28.8 0.4 1.4 1.6 13.7 0.0 9.3 7.5 13.1 0.9 2.2 0.0 0.1 0.0 21.3 0.0 0.0 0.0 3.8 0.0 1.9 1.9 0.7 2.1 0.0 2.2 0.0 1.4 0.0 2.0 0.0 1.8 4.7 0.5 0.0 0.3 0.1 0.6 0.0 0.0 0.1 0.3 4.1 0.2 0.0 0.0 3.7 0.8 4.8 0.0 0.3 0.0 0.0 0.0 82.0 0.0 6.2 126.0 0.0 0.1 2.2 102.1 0.0 1.1 14.9 8.2 0.7 4.7 0.0 8.8 0.0 35.1 1.3 7.8 0.0 0.6 2.8 23.6 2.8 73.3 0.0 0.5 56.1 0.0 27.8 0.0 0.0 8.0 1.4 23.4 1.8 1.5 1.0 65.0 3.1 HOXC6 "HOX3, HOX3C" ENSG00000197757 "Homeobox C6" P09630 12 53990624-54030823 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 31.2" "Cell type enhanced" "Detected in many" 12 "Distal tubular cells: 14.9;Fibroblasts: 27.4;Leydig cells: 20.8;Peritubular cells: 14.2;Spermatocytes: 39.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 17 "pons and medulla: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 38.1;fHDF/TERT166: 19.0;HDLM-2: 31.8" "Region enriched" "Detected in single" 23 "pons and medulla: 1.5" "Not detected" "Not detected" HPA054981 Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA054981: AB_2682662" "unprognostic (3.54e-2)" "unprognostic (9.20e-2)" "unprognostic (1.68e-6)" "unprognostic (3.92e-2)" "unprognostic (1.10e-3)" "unprognostic (5.01e-4)" "unprognostic (5.52e-3)" "unprognostic (3.32e-3)" "unprognostic (2.81e-1)" "unprognostic (6.26e-2)" "unprognostic (8.82e-2)" "unprognostic (3.70e-3)" "prognostic unfavorable (3.55e-6)" "unprognostic (8.63e-2)" "unprognostic (5.76e-2)" "unprognostic (1.40e-2)" "unprognostic (4.71e-2)" 10.9 11.2 0.4 1.2 0.4 0.0 16.3 0.4 0.4 0.7 1.9 0.6 0.4 0.0 3.9 14.8 3.1 13.5 0.4 2.0 0.4 0.0 11.3 0.4 0.9 3.0 0.4 0.4 31.2 0.4 0.0 0.4 4.0 7.0 0.8 0.0 0.4 0.4 0.4 11.0 7.6 8.8 6.1 8.1 1.0 0.3 3.3 0.4 0.4 0.6 0.8 0.4 0.7 2.5 0.0 0.0 0.1 0.0 0.0 0.5 0.0 2.5 1.8 0.0 38.1 13.9 13.3 0.4 1.9 1.9 3.1 2.9 1.6 2.9 1.1 2.5 19.0 0.9 4.3 1.5 0.2 2.8 31.8 11.0 2.0 4.9 0.0 1.5 0.2 4.8 12.6 2.0 6.2 2.2 0.0 0.1 0.1 1.3 0.0 11.0 0.6 0.0 1.2 0.0 0.3 1.6 0.0 1.4 0.0 9.6 0.1 0.0 4.7 2.9 2.8 7.8 3.4 6.7 0.5 0.0 4.0 8.6 4.3 2.7 0.3 0.3 0.0 1.4 0.3 8.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 7.0 0.4 0.0 0.0 0.0 0.0 5.6 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.3 14.9 0.0 1.1 0.2 0.0 0.0 0.0 2.5 27.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 20.8 0.4 11.8 0.0 0.0 0.2 0.0 0.0 14.2 7.8 1.9 6.5 5.0 39.3 1.1 3.4 0.2 0.0 0.0 0.0 HOXC8 "HOX3, HOX3A" ENSG00000037965 "Homeobox C8" P31273 12 54009106-54012362 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 16.7;ovary: 25.2;skeletal muscle: 12.8" "Cell type enhanced" "Detected in some" 12 "Fibroblasts: 17.3;Melanocytes: 10.1;Peritubular cells: 7.4;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 24.2;ASC TERT1: 15.8;fHDF/TERT166: 28.1;HSkMC: 19.3;LHCN-M2: 21.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028911, CAB037020" Uncertain Supported Nucleoplasm,Microtubules NA NA Nucleoplasm Microtubules "CAB037020: AB_1840935, HPA028911: AB_10602236" "unprognostic (1.03e-1)" "unprognostic (5.90e-2)" "unprognostic (6.26e-6)" "unprognostic (4.89e-2)" "unprognostic (5.20e-4)" "unprognostic (5.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (1.45e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.47e-5)" "unprognostic (2.47e-1)" "unprognostic (1.84e-2)" "unprognostic (4.68e-2)" "unprognostic (1.14e-2)" 5.2 5.4 0.4 0.7 0.2 0.0 7.1 0.2 0.3 0.5 0.5 0.2 0.2 0.0 0.3 16.7 0.4 6.3 0.6 0.6 0.2 0.0 7.0 0.2 0.2 2.2 0.2 0.5 25.2 0.2 0.0 0.2 1.9 0.4 0.3 0.0 0.2 0.2 0.2 12.8 2.6 4.8 7.9 2.5 0.2 0.0 2.6 0.2 0.3 0.7 0.2 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 8.5 24.2 15.8 0.1 1.6 0.0 2.8 1.8 2.5 1.3 0.0 0.2 28.1 0.4 1.0 2.2 0.7 3.2 2.9 3.0 0.4 1.1 0.0 3.0 0.0 3.3 19.3 2.2 9.0 5.3 0.3 0.2 0.5 0.3 0.0 21.1 0.7 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 3.2 0.0 0.0 1.1 2.9 0.5 7.4 2.1 0.8 0.0 0.0 0.5 4.5 3.9 0.9 0.0 0.0 0.0 0.5 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.3 0.2 0.0 0.2 0.5 0.4 0.2 0.0 0.0 0.0 0.1 4.0 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 17.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 10.1 0.0 0.0 0.0 0.0 0.0 7.4 4.4 0.8 6.5 1.7 5.4 2.7 3.8 0.2 0.0 0.0 0.0 HPD "4-HPPD, 4HPPD, GLOD3, PPD" ENSG00000158104 "4-hydroxyphenylpyruvate dioxygenase" P32754 12 121839527-121863596 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Dioxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 267.5" "Group enriched" "Detected in some" 9 "Hepatocytes: 1077.2;Proximal tubular cells: 1892.6" "Cancer enriched" "Detected in many" 100 "liver cancer: 540.9" "Region enriched" "Detected in single" 29 "pons and medulla: 13.7" "Group enriched" "Detected in many" 4 "eosinophil: 9.8;neutrophil: 4.8;plasmacytoid DC: 5.0" "Group enriched" "Detected in many" 5 "dendritic cells: 5.0;granulocytes: 9.8" "Cell line enriched" "Detected in some" 30 "Hep G2: 107.2" "Region enriched" "Detected in single" 8 "amygdala: 0.4" "Not detected" "Not detected" "HPA038321, HPA038322" Enhanced Uncertain "Nuclear speckles" NA NA 23000000 "Nuclear speckles" "HPA038321: AB_2675957, HPA038322: AB_10670778" "unprognostic (3.01e-2)" "unprognostic (2.30e-1)" "unprognostic (4.81e-3)" "unprognostic (1.42e-3)" "unprognostic (1.10e-2)" "unprognostic (9.08e-2)" "unprognostic (1.13e-2)" "unprognostic (8.84e-2)" "unprognostic (5.58e-2)" "unprognostic (6.14e-3)" "unprognostic (9.72e-3)" "unprognostic (8.61e-3)" "unprognostic (7.16e-2)" "unprognostic (1.97e-1)" "unprognostic (4.12e-1)" "unprognostic (3.06e-2)" "unprognostic (2.34e-1)" 0.1 0.5 0.0 0.1 0.1 0.0 0.4 0.1 0.3 0.2 0.1 2.1 0.3 0.0 0.3 0.4 0.1 0.7 0.2 0.3 0.4 0.0 51.3 267.5 0.2 0.4 0.1 0.0 0.7 0.7 0.0 0.1 0.0 13.7 0.5 0.0 3.8 0.0 0.8 0.2 0.0 0.1 0.4 0.2 0.2 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.6 0.2 0.1 5.0 9.8 1.4 0.0 0.3 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 107.2 2.5 0.3 3.5 0.8 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 2.1 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 1.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.8 9.8 0.0 1.0 0.1 0.1 0.1 0.1 1.3 0.1 0.3 0.2 4.8 0.0 1.4 5.0 0.0 0.3 0.0 0.1 0.1 0.3 0.4 0.0 0.1 0.0 13.7 0.1 0.0 0.0 18.3 0.0 0.0 0.0 0.3 48.4 0.0 0.0 87.2 0.0 0.6 164.2 0.3 33.1 0.0 0.0 0.0 14.8 0.2 0.0 0.0 0.0 1077.2 0.3 0.0 0.0 33.2 23.4 97.3 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.9 1892.6 0.0 0.0 0.0 1.7 1.1 0.0 0.9 0.0 0.0 0.0 HPGDS "GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS" ENSG00000163106 "Hematopoietic prostaglandin D synthase" O60760 4 94298535-94342876 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 24.8" "Group enriched" "Detected in many" 10 "granulocytes: 1000.1;Hofbauer cells: 476.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 15.8" "Lineage enriched" "Detected in single" 25 "granulocytes: 15.8" "Group enriched" "Detected in some" 8 "HEL: 32.4;HMC-1: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA024035 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 170000 "Vesicles, Cytosol" Nucleoplasm "HPA024035: AB_1855743" "unprognostic (5.71e-2)" "unprognostic (5.80e-3)" "unprognostic (1.17e-1)" "unprognostic (5.36e-3)" "unprognostic (2.76e-1)" "unprognostic (2.38e-4)" "unprognostic (1.01e-2)" "unprognostic (4.41e-3)" "unprognostic (1.35e-1)" "unprognostic (7.75e-4)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (5.15e-3)" "unprognostic (4.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" 14.3 2.9 8.0 1.6 12.1 1.6 5.8 2.0 7.7 5.4 6.9 4.4 0.2 7.5 4.7 3.3 4.1 2.5 9.3 3.0 8.4 3.6 2.5 1.3 12.7 0.9 9.6 2.4 1.5 1.8 1.7 1.5 24.8 9.0 6.4 7.5 2.9 3.8 2.2 1.4 5.8 8.6 5.8 14.6 1.4 4.4 1.8 12.1 1.5 1.2 2.8 1.5 4.5 3.5 0.0 0.1 15.8 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 2.5 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 8.0 12.1 2.0 7.7 8.4 3.6 9.6 2.4 9.0 12.1 11.9 75.3 0.0 0.8 3.7 0.0 0.0 0.0 2.7 6.8 0.0 0.0 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.5 4.1 4.0 1000.1 0.0 476.4 0.0 6.8 0.0 3.9 0.0 0.3 14.5 3.3 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.1 4.6 4.6 0.0 0.0 0.1 HRASLS5 HRLP5 ENSG00000168004 "HRAS like suppressor family member 5" Q96KN8 11 63461404-63491194 "Predicted intracellular proteins" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.5;testis: 49.4" "Group enriched" "Detected in some" 43 "Early spermatids: 348.1;Late spermatids: 719.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 65 "basophil: 5.1;eosinophil: 14.5" "Lineage enriched" "Detected in single" 104 "granulocytes: 14.5" "Group enriched" "Detected in some" 4 "HAP1: 15.8;NB-4: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042493 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA042493: AB_10797499" "unprognostic (3.16e-1)" "unprognostic (3.45e-2)" "unprognostic (2.83e-3)" "unprognostic (4.24e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (7.11e-3)" "unprognostic (2.14e-1)" "unprognostic (6.66e-2)" "unprognostic (9.46e-2)" "unprognostic (8.89e-3)" "unprognostic (3.15e-2)" "unprognostic (7.33e-2)" "unprognostic (1.04e-5)" "unprognostic (1.52e-1)" "unprognostic (1.21e-2)" "unprognostic (2.57e-3)" "unprognostic (4.50e-4)" 12.4 0.5 2.2 0.4 2.2 0.3 7.6 0.3 2.3 0.4 0.8 2.5 1.7 0.4 0.7 1.0 1.0 1.1 0.9 1.3 1.3 0.9 0.4 0.3 0.8 0.3 1.2 2.1 1.0 11.0 0.2 0.4 0.2 1.7 0.9 0.4 0.6 0.7 2.5 0.3 0.4 0.5 1.3 3.3 0.3 0.6 49.4 0.9 0.0 0.4 0.3 0.3 0.8 0.4 0.0 0.0 14.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 5.1 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 2.2 0.3 2.3 1.3 0.9 1.2 2.1 1.7 0.9 3.0 0.6 0.0 1.8 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 348.1 0.1 0.0 0.0 0.3 0.1 2.0 0.5 1.1 0.0 0.1 0.0 0.0 0.0 0.0 719.6 3.1 0.7 0.0 0.0 0.0 2.4 0.1 0.0 4.2 1.1 0.0 6.5 0.3 12.4 4.7 0.0 0.8 0.0 0.0 1.0 HS6ST2 ENSG00000171004 "Heparan sulfate 6-O-sulfotransferase 2" Q96MM7 X 132626016-132961395 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5;kidney: 17.3;ovary: 18.2" "Cell type enhanced" "Detected in some" 16 "Cytotrophoblasts: 31.0;Leydig cells: 58.1;Peritubular cells: 33.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 29.5" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Lineage enhanced" "Detected in single" "NK-cells: 1.8" "Cell line enhanced" "Detected in some" "HEK 293: 19.6;HeLa: 13.3;RH-30: 28.4;RT4: 14.1;SH-SY5Y: 35.5" "Low region specificity" "Detected in all" "HPA034625, HPA034626" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA034625: AB_10612119, HPA034626: AB_2674252" "unprognostic (7.62e-3)" "unprognostic (4.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.41e-1)" "unprognostic (3.24e-1)" "unprognostic (5.54e-2)" "unprognostic (1.44e-1)" "unprognostic (1.71e-2)" "unprognostic (1.14e-2)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (3.57e-1)" "unprognostic (8.39e-5)" "unprognostic (1.36e-3)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "prognostic favorable (6.03e-4)" 0.4 3.2 6.5 0.9 29.5 0.1 2.6 3.0 6.7 1.0 0.8 0.8 0.6 0.3 4.5 3.2 5.0 2.5 0.5 0.4 4.1 9.1 17.3 0.2 1.0 0.3 3.5 0.9 18.2 6.5 0.1 1.3 9.9 3.3 5.4 1.2 0.0 1.1 1.6 6.7 0.3 0.2 2.0 3.3 0.2 1.1 7.9 0.7 0.7 0.6 1.7 2.7 2.3 0.6 0.0 0.0 0.0 0.0 1.8 0.6 0.0 4.3 0.0 6.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.1 0.0 0.0 6.5 0.0 0.0 0.2 9.2 0.0 0.0 0.0 19.6 0.0 13.3 0.0 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.2 0.1 0.0 5.0 3.0 0.2 0.0 28.4 0.0 5.7 14.1 0.7 35.5 6.2 0.0 0.0 10.7 0.0 0.0 0.0 0.0 1.1 4.1 9.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.5 29.5 3.0 5.8 4.1 9.1 3.5 0.9 3.3 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.7 0.0 13.4 7.9 3.5 0.0 31.0 5.0 0.0 0.4 0.4 0.0 0.0 1.6 1.3 2.2 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.4 58.1 0.0 0.0 0.0 0.0 5.3 1.2 0.0 33.2 0.0 0.0 0.0 0.3 0.2 1.2 0.3 14.5 0.0 0.0 0.2 HSD17B6 "HSE, RODH, SDR9C6" ENSG00000025423 "Hydroxysteroid 17-beta dehydrogenase 6" O14756 12 56752161-56787790 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 241.2" "Cell type enriched" "Detected in many" 10 "Hepatocytes: 1569.2" "Cancer enriched" "Detected in many" 5 "liver cancer: 170.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 11.8;U-266/84: 14.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059141 Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059141: AB_2683922" "unprognostic (7.70e-2)" "unprognostic (8.76e-2)" "unprognostic (5.08e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (3.79e-2)" "prognostic favorable (6.32e-4)" "unprognostic (1.06e-2)" "unprognostic (3.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (2.50e-10)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (1.08e-1)" "unprognostic (1.05e-1)" 1.1 0.5 3.6 1.4 5.2 0.2 0.3 1.2 2.4 9.4 3.3 0.5 2.6 0.6 4.1 0.7 1.6 0.9 2.6 0.4 1.6 1.4 0.5 241.2 8.7 0.3 2.0 2.6 1.1 0.3 0.2 0.0 0.9 0.6 7.9 1.3 1.4 0.2 10.2 0.2 0.2 0.7 11.3 1.0 6.2 0.8 3.2 0.8 0.0 13.3 0.0 0.3 9.9 2.3 2.0 2.0 0.1 1.3 0.1 3.4 0.8 0.3 0.7 1.7 0.3 1.7 1.2 2.0 3.6 3.1 1.7 1.7 0.4 0.4 10.2 1.5 0.4 0.5 0.3 5.3 0.9 1.0 6.5 2.0 3.2 1.0 0.5 1.1 1.6 5.3 0.9 0.3 1.0 0.5 0.5 0.0 9.0 0.9 11.8 0.8 2.1 4.6 1.0 6.6 0.6 0.6 6.3 0.7 2.5 0.2 1.2 9.7 2.0 1.7 3.1 0.8 0.6 0.5 1.3 0.3 0.8 0.8 3.6 0.9 10.3 14.6 6.7 1.2 5.9 0.6 0.0 0.2 0.1 3.0 0.6 3.4 2.0 2.5 2.4 0.6 1.1 3.3 2.2 0.0 0.1 1.3 2.0 2.8 0.8 3.6 5.2 1.2 2.4 1.6 1.4 2.0 2.6 0.6 0.8 160.8 89.7 28.7 2.3 1.1 0.2 0.2 35.7 2.7 17.0 0.0 0.0 1.3 0.0 0.0 2.5 0.4 0.0 23.3 0.0 2.4 4.8 9.9 0.0 1569.2 0.3 0.0 0.0 31.3 41.1 1.5 11.5 0.1 0.0 1.8 0.3 1.0 0.1 0.0 1.4 0.0 0.6 12.9 3.7 13.6 10.6 1.4 0.3 4.4 0.3 0.9 HSD3B1 "HSD3B, HSDB3, SDR11E1" ENSG00000203857 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1" P14060 1 119507198-119515054 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Isomerase, Multifunctional enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "placenta: 231.4" "Group enriched" "Detected in some" 23 "Extravillous trophoblasts: 115.9;Syncytiotrophoblasts: 419.8" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 36.4;SuSa: 16.3" "HPA043261, HPA043264, HPA044028" Supported Approved "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" NA NA "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-1)" "prognostic favorable (4.59e-5)" 0.1 0.6 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 231.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.5 11.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 4.0 0.4 0.5 16.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 115.9 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 419.8 0.0 0.0 0.0 HSD3B2 SDR11E2 ENSG00000203859 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2" P26439 1 119414931-119423035 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis "Isomerase, Multifunctional enzyme, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "adrenal gland: 223.2" "Cell type enhanced" "Detected in some" 17 "Enterocytes: 1.6;Exocrine glandular cells: 1.1;Peritubular cells: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Region enriched" "Detected in single" 198 "basal ganglia: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;SuSa: 1.9;TIME: 1.2;WM-115: 3.2" "HPA043261, HPA043264, HPA044028" Supported Uncertain "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" NA NA "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (3.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.80e-1)" "unprognostic (2.72e-2)" "unprognostic (8.87e-2)" "unprognostic (3.91e-2)" "unprognostic (3.43e-2)" "unprognostic (1.94e-1)" "unprognostic (6.51e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" 0.0 223.2 0.0 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.5 43.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 1.4 0.0 0.0 5.1 1.9 0.0 0.0 1.2 0.2 0.1 0.1 0.7 0.0 0.0 0.0 0.8 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 HSDL1 SDR12C3 ENSG00000103160 "Hydroxysteroid dehydrogenase like 1" Q3SXM5 16 84122146-84145192 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 42.9;Rod photoreceptor cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045745 Supported "Vesicles,Intermediate filaments,Mitochondria" No No Mitochondria "Vesicles, Intermediate filaments" "HPA045745: AB_2679440" "unprognostic (2.16e-1)" "unprognostic (4.32e-2)" "unprognostic (2.09e-1)" "unprognostic (4.80e-3)" "unprognostic (3.66e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (1.25e-2)" "unprognostic (7.43e-2)" "unprognostic (3.39e-2)" "unprognostic (6.42e-2)" "unprognostic (3.66e-1)" "prognostic favorable (4.20e-7)" "unprognostic (2.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (1.14e-2)" 6.0 13.4 16.9 5.6 22.1 3.1 10.2 16.5 18.7 9.7 5.8 9.0 6.7 5.1 11.3 9.4 6.7 11.1 6.0 13.1 14.5 19.5 9.1 4.1 7.6 6.8 11.5 13.2 19.6 4.3 12.6 16.7 7.6 20.8 8.6 6.1 10.5 6.3 10.0 15.2 6.5 4.9 9.4 7.4 7.0 5.3 13.5 8.7 8.6 23.2 5.0 7.5 6.6 6.2 7.4 3.1 14.5 6.6 4.2 6.5 4.4 5.6 6.6 30.5 10.4 11.1 8.0 7.7 7.3 6.9 9.2 4.9 7.3 9.8 11.7 13.1 6.5 10.1 4.0 16.4 6.3 14.6 2.5 10.0 5.6 4.4 16.7 11.6 8.7 10.2 6.1 10.7 12.9 8.3 11.7 10.9 16.0 11.6 14.8 18.1 14.0 18.9 8.7 15.5 3.3 6.9 18.6 10.7 4.3 8.8 6.2 14.4 10.9 18.2 2.9 19.9 16.0 18.2 5.1 9.3 10.4 12.6 7.4 5.8 23.5 18.6 19.1 12.2 6.3 9.4 14.5 5.2 11.7 4.4 3.8 5.6 5.4 4.7 5.2 3.1 7.4 6.1 6.5 6.2 4.2 6.6 0.0 5.6 4.4 16.9 22.1 16.5 18.7 14.5 19.5 11.5 13.2 20.8 8.7 11.9 13.1 5.1 4.6 4.2 18.8 14.1 2.5 10.7 7.9 3.5 13.7 5.9 5.0 6.5 24.6 5.7 2.9 0.0 6.0 4.8 5.4 4.7 1.1 2.9 10.4 42.9 9.1 7.4 6.3 8.8 5.5 5.3 5.0 2.8 3.0 22.6 5.7 2.9 9.6 6.2 38.1 0.0 5.2 27.0 27.0 6.0 7.3 6.7 4.1 3.3 HSPB6 "FLJ32389, Hsp20, PPP1R91" ENSG00000004776 "Heat shock protein family B (small) member 6" O14558 19 35754569-35758079 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 356.8" "Group enriched" "Detected in many" 5 "Leydig cells: 251.7;Peritubular cells: 207.2;Smooth muscle cells: 65.1" "Cancer enhanced" "Detected in all" "stomach cancer: 93.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 189.0;ASC TERT1: 79.8;HHSteC: 64.1;HSkMC: 74.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB001974, HPA044153, HPA054811" Enhanced Supported "Nucleoli,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 86000 Cytosol "Nucleoli, Golgi apparatus" "CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610" "unprognostic (3.19e-2)" "unprognostic (8.07e-2)" "unprognostic (1.41e-2)" "unprognostic (1.01e-1)" "unprognostic (5.21e-3)" "unprognostic (7.02e-2)" "unprognostic (9.67e-2)" "unprognostic (7.57e-2)" "unprognostic (1.18e-1)" "unprognostic (7.23e-2)" "unprognostic (1.20e-1)" "unprognostic (7.02e-2)" "prognostic unfavorable (1.93e-5)" "unprognostic (3.32e-2)" "unprognostic (6.65e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (1.43e-6)" 95.3 39.5 3.9 18.3 8.1 1.1 40.5 1.1 6.1 49.7 48.4 3.8 18.6 5.7 42.6 57.4 24.6 33.3 80.6 132.0 4.4 2.4 6.2 3.5 8.7 7.2 5.4 2.8 53.4 5.8 1.7 1.2 12.7 8.1 42.1 8.7 18.2 8.6 35.8 356.8 2.5 14.3 128.2 10.2 1.9 32.4 22.6 4.9 0.0 11.0 153.5 16.4 121.6 23.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.2 189.0 79.8 0.1 8.4 0.1 0.5 0.9 0.1 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 64.1 0.0 0.1 74.6 0.0 1.9 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 1.8 0.0 0.1 0.2 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 8.1 1.1 6.1 4.4 2.4 5.4 2.8 8.1 4.9 3.0 1.1 0.0 0.2 1.5 7.4 26.8 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 19.2 2.2 0.0 0.0 0.0 2.8 35.4 0.4 0.0 0.0 4.5 0.0 0.0 28.3 0.3 14.1 251.7 2.0 1.7 1.0 0.0 30.6 0.2 0.0 207.2 0.0 2.1 25.8 65.1 2.2 1.2 1.8 4.0 0.0 0.0 0.5 HTD2 ENSG00000255154 "Hydroxyacyl-thioester dehydratase type 2" P86397 3 58306262-58318574 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Club cells: 2.3;granulocytes: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066812, HPA077228" Approved Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA066812: AB_2685727, HPA077228: " "unprognostic (1.95e-1)" "unprognostic (3.20e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "unprognostic (2.28e-2)" "unprognostic (2.01e-1)" "unprognostic (2.56e-1)" "unprognostic (2.05e-1)" "unprognostic (9.19e-3)" "unprognostic (1.11e-1)" "unprognostic (7.41e-2)" "unprognostic (1.04e-1)" "unprognostic (1.99e-1)" "unprognostic (7.50e-2)" "unprognostic (3.86e-2)" "unprognostic (1.24e-1)" "unprognostic (2.33e-2)" 7.9 8.9 9.0 6.6 13.9 6.9 9.4 17.0 11.5 7.4 9.2 6.4 7.1 11.3 8.6 8.5 9.4 7.8 7.1 15.9 7.9 9.3 12.1 16.2 6.9 8.2 8.5 10.7 11.0 12.9 8.8 14.2 6.7 7.8 9.6 10.1 9.7 9.2 9.4 35.2 7.2 9.7 12.6 6.0 9.7 8.6 9.8 6.4 6.8 10.7 19.8 9.2 7.8 8.1 23.9 21.6 23.7 20.4 21.3 26.5 13.5 8.2 6.3 9.6 6.8 8.2 9.2 12.3 11.7 8.9 14.6 12.9 13.7 6.2 16.3 3.5 8.4 11.7 7.2 16.0 10.6 15.0 9.1 11.2 9.8 13.9 11.5 8.9 12.8 9.3 11.3 10.9 15.5 9.4 7.8 12.7 12.1 9.6 15.5 9.1 4.8 8.3 6.5 12.4 8.4 14.2 5.8 6.1 11.7 9.8 12.1 6.0 9.0 7.2 6.8 13.3 10.6 9.1 11.4 7.4 12.4 8.8 11.2 14.3 11.9 21.3 12.7 10.0 9.5 7.5 13.5 17.3 23.7 18.7 20.4 20.1 23.9 18.7 23.5 17.5 23.8 26.5 20.2 18.4 21.3 16.7 21.6 13.4 13.5 9.0 13.9 17.0 11.5 7.9 9.3 8.5 10.7 7.8 6.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IARS "IARS1, ILRS" ENSG00000196305 "Isoleucyl-tRNA synthetase" P41252 9 92210207-92293756 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029806 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029806: AB_10601818" "unprognostic (1.32e-3)" "unprognostic (2.94e-2)" "unprognostic (2.27e-2)" "unprognostic (8.23e-2)" "unprognostic (1.33e-1)" "unprognostic (1.26e-2)" "prognostic unfavorable (4.98e-7)" "unprognostic (2.00e-2)" "unprognostic (3.80e-2)" "unprognostic (1.10e-1)" "unprognostic (4.96e-2)" "unprognostic (3.67e-2)" "unprognostic (1.40e-2)" "unprognostic (2.88e-2)" "unprognostic (4.71e-2)" "unprognostic (2.21e-1)" "unprognostic (7.76e-3)" 20.6 31.0 19.1 21.1 28.5 13.8 24.8 24.5 32.1 22.8 23.7 17.5 25.8 13.6 31.9 24.8 29.7 23.8 15.1 26.0 21.4 18.5 24.5 29.9 24.4 24.1 21.6 20.6 28.4 42.8 57.4 29.0 21.1 31.6 23.6 26.7 17.1 25.2 27.7 47.4 25.4 18.8 32.6 20.0 23.1 29.0 18.7 16.9 25.1 52.3 26.7 28.8 22.1 20.5 14.5 15.3 1.9 7.3 18.6 18.6 9.7 35.0 36.3 20.3 32.0 33.5 37.8 32.2 37.2 35.5 29.5 36.1 12.7 22.6 47.6 14.7 57.4 32.5 43.9 62.6 48.4 37.3 29.9 23.3 29.0 31.3 22.6 70.8 39.5 21.5 36.8 54.4 51.4 85.1 19.4 31.0 57.2 51.1 43.3 41.4 25.5 36.5 15.4 32.9 74.5 33.6 25.6 30.9 22.9 24.3 17.6 26.0 21.6 25.2 27.7 35.0 22.9 22.2 24.8 22.8 21.8 27.3 36.0 30.2 31.7 40.5 25.2 51.0 30.5 40.2 1.9 6.7 0.5 14.7 7.3 18.6 14.5 14.5 14.9 15.3 10.7 14.7 15.3 0.8 18.6 6.2 6.2 12.9 9.7 19.1 28.5 24.5 32.1 21.4 18.5 21.6 20.6 31.6 16.9 17.9 25.5 29.7 27.4 60.8 34.2 44.5 40.8 24.1 27.3 17.4 43.2 23.5 13.3 22.2 8.9 20.8 5.4 0.0 25.9 26.2 31.1 25.2 36.9 26.0 15.7 9.5 11.5 16.0 21.6 4.0 26.4 17.7 13.5 11.8 23.8 15.5 26.0 8.6 27.6 29.1 34.6 6.5 32.5 39.2 38.1 59.2 14.5 18.7 26.3 27.4 ICAM2 CD102 ENSG00000108622 "Intercellular adhesion molecule 2" P13598 17 64002594-64020634 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 74.5;lymphoid tissue: 63.9" "Cell type enhanced" "Detected in many" 13 "B-cells: 46.1;Endothelial cells: 80.1;Ito cells: 147.3;Kupffer cells: 54.5;T-cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 6 "HUVEC TERT2: 167.1;TIME: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA071155 Approved "Plasma membrane,Cytosol" NA NA 1200000000 "Plasma membrane" Cytosol "HPA071155: " "unprognostic (9.43e-3)" "unprognostic (3.31e-2)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (8.97e-2)" "unprognostic (1.64e-3)" "unprognostic (1.34e-1)" "unprognostic (3.74e-1)" "unprognostic (8.28e-2)" "unprognostic (2.15e-1)" "unprognostic (4.18e-2)" "unprognostic (1.55e-2)" "unprognostic (9.07e-2)" "unprognostic (1.48e-1)" "unprognostic (3.93e-2)" "unprognostic (6.04e-2)" "unprognostic (2.29e-1)" 36.0 3.6 8.4 13.0 11.5 8.3 34.1 3.5 7.7 9.4 9.7 5.6 2.8 6.4 9.8 5.2 9.5 7.4 8.8 22.8 9.5 8.9 10.5 8.7 27.9 24.0 12.3 3.1 6.3 7.4 3.1 4.5 36.8 9.1 7.9 8.5 8.1 8.8 4.3 17.1 5.5 10.8 13.9 10.5 63.9 8.0 4.0 7.4 14.3 11.6 9.0 18.0 12.8 23.6 49.0 30.9 56.5 74.5 26.0 65.3 67.5 0.0 0.0 0.0 0.0 1.4 1.5 0.4 0.1 0.1 0.0 0.1 0.3 6.9 11.7 2.1 0.0 0.0 0.0 0.1 0.0 0.2 2.6 0.0 10.5 0.6 1.2 0.2 1.7 0.0 0.0 0.0 0.1 0.0 0.0 167.1 9.9 8.6 6.9 0.0 0.0 13.1 1.5 0.0 0.0 0.0 7.9 0.0 16.3 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 42.2 0.0 0.1 0.8 0.0 6.6 2.2 10.5 0.0 2.2 0.0 56.5 30.0 8.9 45.8 66.5 52.8 36.5 60.1 42.8 30.9 49.0 65.3 40.7 3.6 26.0 74.5 10.0 64.5 67.5 8.4 11.5 3.5 7.7 9.5 8.9 12.3 3.1 9.1 7.4 0.0 12.5 46.1 3.4 6.5 0.0 0.3 0.0 6.7 6.8 7.0 0.0 0.4 0.0 0.8 0.5 80.1 0.3 0.0 1.2 0.3 6.9 1.6 11.5 1.0 18.7 0.0 1.2 147.3 54.5 0.0 0.3 23.4 27.0 6.4 1.4 0.4 5.1 5.8 1.8 0.5 0.3 6.5 4.4 0.2 0.2 4.6 0.8 52.4 1.7 2.6 ICOS "AILIM, CD278" ENSG00000163600 "Inducible T cell costimulator" Q9Y6W8 2 203936748-203961577 "CD markers, Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 18.4;bone marrow: 13.8;lymphoid tissue: 51.8" "Cell type enriched" "Detected in some" 4 "T-cells: 23.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 18.4" "Lineage enriched" "Detected in single" 58 "T-cells: 18.4" "Group enriched" "Detected in some" 7 "HEL: 6.0;MOLT-4: 15.7" "Low region specificity" "Detected in single" "CAB032575, HPA034865" Approved Approved "Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA "Plasma membrane" "Actin filaments" "CAB032575: AB_2122593, HPA034865: " "unprognostic (2.66e-2)" "unprognostic (2.13e-3)" "unprognostic (4.19e-4)" "unprognostic (2.35e-5)" "unprognostic (1.07e-1)" "prognostic favorable (1.80e-4)" "unprognostic (9.38e-2)" "unprognostic (2.89e-2)" "unprognostic (1.49e-2)" "unprognostic (3.51e-4)" "unprognostic (7.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.86e-5)" "unprognostic (7.05e-2)" "unprognostic (2.48e-2)" "unprognostic (1.93e-1)" "unprognostic (8.82e-3)" 1.5 0.3 0.2 15.6 0.2 13.8 0.7 0.2 0.2 0.8 1.2 0.0 0.2 0.5 1.2 0.5 1.1 1.2 1.6 0.5 0.2 0.2 1.0 0.8 4.0 19.4 0.3 0.0 0.6 0.3 0.0 0.4 0.1 0.1 0.7 1.1 0.7 2.9 0.0 0.2 0.6 6.2 0.3 0.4 6.1 1.0 0.6 0.0 51.8 1.4 2.4 28.9 3.0 0.9 0.0 0.0 0.0 0.0 0.3 18.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 2.9 0.0 10.5 4.6 0.0 0.0 11.0 5.0 0.0 0.3 0.0 0.0 18.4 3.0 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.0 0.1 0.0 0.0 2.2 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 5.8 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.6 0.1 23.5 0.0 0.0 IDH1 ENSG00000138413 "Isocitrate dehydrogenase (NADP(+)) 1, cytosolic" O75874 2 208236227-208266074 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glyoxylate bypass, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 277.8;Hepatocytes: 306.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 107.6;RT4: 75.1" "Low region specificity" "Detected in all" "CAB033218, HPA035248, HPA057936, CAB062556" Enhanced Approved "Nuclear bodies,Cytosol" NA NA 16000000 "Nuclear bodies, Cytosol" "CAB033218: AB_2123166, CAB062556: AB_2665593, HPA035248: AB_10600714, HPA057936: AB_2683559" "unprognostic (2.79e-1)" "unprognostic (1.00e-1)" "unprognostic (1.02e-1)" "unprognostic (2.47e-3)" "unprognostic (1.93e-1)" "unprognostic (2.39e-2)" "prognostic unfavorable (6.93e-5)" "unprognostic (3.32e-1)" "unprognostic (2.20e-3)" "unprognostic (8.03e-2)" "unprognostic (5.54e-2)" "unprognostic (4.18e-3)" "prognostic unfavorable (2.45e-5)" "unprognostic (2.09e-1)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (2.69e-2)" 41.3 82.3 6.2 8.8 7.0 1.3 20.9 6.5 8.3 12.6 35.2 8.7 38.0 30.6 8.0 29.9 30.3 8.8 18.7 10.8 6.3 6.2 20.5 91.0 19.8 14.3 8.1 4.7 19.4 21.5 4.8 6.2 24.1 8.7 38.5 23.1 15.4 18.7 39.0 4.7 7.4 54.1 10.1 9.3 21.3 20.4 15.6 8.4 3.5 7.9 11.0 11.9 43.4 12.1 4.9 22.8 6.4 31.6 7.4 6.6 12.0 9.5 16.1 23.0 9.3 41.8 29.9 13.1 4.0 18.3 6.7 16.4 25.4 23.4 1.9 25.4 12.4 28.6 14.8 16.5 19.3 6.5 1.3 6.2 8.2 13.2 107.6 55.7 5.3 8.2 25.7 41.0 15.4 11.2 10.7 18.5 5.6 8.2 6.6 10.3 6.1 3.8 9.2 42.0 68.5 6.6 3.6 8.4 5.4 30.4 75.1 3.9 6.9 15.2 14.7 49.7 25.4 5.6 15.7 12.2 6.9 6.9 9.7 4.3 3.2 5.0 2.5 22.2 32.5 5.5 5.7 31.6 4.8 4.5 14.5 5.1 4.9 4.0 5.3 22.8 4.9 3.3 3.9 6.4 7.4 6.5 8.4 6.6 12.0 6.2 7.0 6.5 8.3 6.3 6.2 8.1 4.7 8.7 8.4 11.9 38.0 25.9 15.5 11.0 19.3 16.8 58.6 14.7 27.3 27.9 23.6 277.8 18.3 23.8 6.9 15.5 112.0 0.0 76.5 152.3 23.7 78.5 13.9 306.5 146.5 11.1 56.1 41.1 109.5 7.7 22.7 46.5 25.3 53.3 85.9 26.7 42.8 52.6 27.6 74.2 45.5 12.9 12.2 7.7 30.8 13.0 80.0 16.0 106.9 38.2 IDH3G ENSG00000067829 "Isocitrate dehydrogenase 3 (NAD(+)) gamma" P51553 X 153785766-153794523 "Citric acid cycle related proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000425, HPA002017" Supported Approved Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" "HPA000425: AB_1079097, HPA002017: AB_1079096" "unprognostic (4.24e-2)" "unprognostic (1.43e-3)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (6.57e-2)" "unprognostic (2.25e-1)" "unprognostic (4.35e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-2)" "unprognostic (1.59e-2)" "unprognostic (2.81e-2)" "unprognostic (1.96e-1)" "prognostic favorable (5.73e-6)" "unprognostic (1.50e-1)" "unprognostic (3.35e-1)" "unprognostic (2.91e-2)" "unprognostic (2.46e-1)" 24.5 34.0 27.7 26.8 47.2 37.1 24.1 37.2 61.5 25.0 28.8 25.7 24.6 34.7 26.6 21.3 31.8 29.4 25.6 50.8 35.0 25.2 40.6 29.5 20.9 25.6 27.3 35.6 31.8 40.5 29.1 24.9 22.5 40.5 21.4 25.2 26.0 34.5 29.8 54.9 36.3 34.9 24.8 20.1 26.9 24.8 16.0 23.3 31.2 24.3 37.1 28.2 24.4 21.1 20.6 45.5 43.7 44.4 23.7 28.8 33.6 29.1 26.9 15.9 22.3 24.9 20.7 19.5 15.2 21.4 27.0 28.7 22.2 22.2 37.1 26.3 24.4 22.1 21.8 24.0 20.7 9.9 12.2 30.7 13.9 36.5 17.8 28.3 19.4 29.4 23.2 15.0 20.8 22.7 17.4 20.6 15.5 7.7 20.4 21.7 40.8 22.0 22.8 7.1 27.1 35.6 19.4 13.6 32.3 30.1 18.2 20.3 13.9 9.5 32.2 15.1 6.8 13.3 16.7 18.2 17.1 10.7 25.1 35.9 28.1 7.0 47.3 28.0 24.0 18.9 42.5 43.9 43.7 21.5 44.4 19.9 19.1 22.0 20.9 45.5 20.6 17.6 19.2 16.3 23.7 43.1 27.9 28.8 33.6 27.7 47.2 37.2 61.5 35.0 25.2 27.3 35.6 40.5 23.3 32.8 32.7 56.5 52.5 71.9 33.9 48.4 43.3 30.8 7.9 48.8 27.5 80.9 175.8 81.7 113.6 44.1 164.4 46.7 79.1 82.6 56.8 36.9 91.2 33.0 116.8 17.5 59.8 43.6 88.9 226.7 49.5 66.0 64.1 101.0 81.8 37.0 65.2 122.8 55.2 192.8 37.1 51.8 69.3 14.0 17.0 67.8 92.7 54.5 93.0 43.8 IDI2 IPPI2 ENSG00000148377 "Isopentenyl-diphosphate delta isomerase 2" Q9BXS1 10 1018907-1025859 "Enzymes, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 125 "skeletal muscle: 141.6" "Cell type enhanced" "Detected in some" 13 "Club cells: 1.2;Horizontal cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 1.4;NB-4: 2.7;NTERA-2: 1.5;SK-MEL-30: 3.4" HPA041254 Uncertain Vesicles NA NA Vesicles "HPA041254: AB_10794270" "unprognostic (6.69e-3)" "unprognostic (4.05e-2)" "unprognostic (1.64e-1)" 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 141.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.7 0.5 0.1 0.0 0.7 0.0 0.8 0.1 0.0 1.0 0.0 0.0 0.4 0.4 0.8 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.5 0.0 0.3 0.9 1.4 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.2 0.3 2.7 1.5 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 3.4 0.2 1.0 0.1 0.0 0.1 0.1 0.4 0.0 0.2 0.4 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 IFI30 "GILT, IFI-30, IP-30, IP30, MGC32056" ENSG00000216490 "IFI30, lysosomal thiol reductase" P13284 19 18173162-18178117 "Predicted intracellular proteins, Predicted membrane proteins" Immunity Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 348.5" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 159.4;Kupffer cells: 201.6;Macrophages: 219.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 348.5" "Group enriched" "Detected in all" 8 "dendritic cells: 145.5;granulocytes: 95.4;monocytes: 348.5" "Cell line enhanced" "Detected in many" "Daudi: 76.0;RPMI-8226: 82.4;SK-BR-3: 55.7;U-266/84: 91.1" "Low region specificity" "Detected in many" HPA026650 Enhanced Supported Vesicles,Cytosol "Intracellular and membrane" NA NA 89000 "Vesicles, Cytosol" "HPA026650: AB_10602237" "unprognostic (4.66e-2)" "unprognostic (1.25e-4)" "unprognostic (2.35e-3)" "unprognostic (7.40e-2)" "unprognostic (1.76e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-3)" "unprognostic (2.40e-1)" "unprognostic (4.01e-2)" "unprognostic (9.19e-3)" "unprognostic (3.04e-1)" "unprognostic (1.19e-1)" "unprognostic (7.29e-11)" "unprognostic (3.50e-1)" "unprognostic (1.62e-2)" "unprognostic (3.39e-2)" "unprognostic (9.59e-3)" 104.2 31.0 5.8 85.5 10.8 28.3 13.9 1.2 5.2 5.3 17.4 6.5 3.2 23.3 5.0 13.7 9.3 15.9 13.1 16.2 5.0 4.0 37.5 60.4 109.7 139.5 12.0 0.8 15.0 14.6 2.0 7.6 123.2 11.0 8.6 18.2 9.2 18.7 4.3 7.2 10.1 28.5 18.9 13.3 140.6 19.4 5.7 7.9 20.6 15.6 9.6 41.2 24.5 8.2 24.3 145.5 95.4 348.5 1.7 1.0 213.4 12.8 6.8 0.0 4.5 1.3 1.8 12.2 1.4 1.9 3.9 10.2 15.3 23.0 76.0 11.7 4.4 20.2 10.1 8.1 3.0 0.4 20.2 5.8 0.9 12.6 21.7 13.0 2.2 5.9 7.9 6.9 6.4 2.3 0.5 0.2 2.3 10.7 47.8 1.9 25.2 1.0 0.2 2.5 44.2 6.8 7.4 0.5 82.4 11.7 0.4 0.6 0.8 23.6 55.7 1.3 0.9 3.8 0.9 0.3 6.8 4.1 13.9 1.4 1.6 91.1 43.3 18.8 15.0 1.0 2.0 228.9 95.4 1.0 348.5 1.0 24.3 0.7 0.8 145.5 16.8 0.5 0.6 52.5 1.7 230.0 4.3 1.0 213.4 5.8 10.8 1.2 5.2 5.0 4.0 12.0 0.8 11.0 7.9 8.9 51.2 68.0 1.9 3.2 0.1 0.6 7.6 13.4 31.8 12.2 0.0 4.4 1.7 1.2 0.2 2.2 3.8 0.0 1.0 12.3 1.9 3.5 12.8 1.5 159.4 0.0 0.0 4.9 201.6 0.0 0.3 219.1 5.0 58.7 4.6 0.6 1.7 2.5 0.0 4.8 0.4 0.0 0.9 0.0 0.7 2.9 10.1 3.8 5.1 1.3 IFI35 IFP35 ENSG00000068079 "Interferon induced protein 35" P80217 17 43006725-43014456 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 132.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 50.9;BJ hTERT+ SV40 Large T+ RasG12V: 75.1;GAMG: 27.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045946, HPA075580" Approved Supported "Nucleoplasm,Intermediate filaments,Cytosol" NA NA 93000 "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA045946: AB_2679509, HPA075580: " "prognostic favorable (1.41e-4)" "unprognostic (1.14e-2)" "unprognostic (1.82e-1)" "unprognostic (2.16e-1)" "unprognostic (1.32e-1)" "unprognostic (3.26e-1)" "unprognostic (3.90e-3)" "unprognostic (1.14e-1)" "unprognostic (6.92e-2)" "unprognostic (9.78e-3)" "unprognostic (6.51e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (4.03e-5)" "unprognostic (3.55e-1)" "unprognostic (3.62e-2)" "unprognostic (1.34e-2)" "unprognostic (1.49e-1)" 24.9 27.9 9.3 18.1 12.4 14.6 15.1 5.0 9.3 10.7 20.5 9.4 12.8 15.9 13.6 17.4 11.3 14.0 15.5 13.2 7.7 7.0 21.8 26.2 17.7 20.2 9.4 8.1 19.2 11.0 8.3 10.1 15.8 9.5 24.2 13.6 19.5 18.7 10.8 6.4 7.3 33.6 14.1 9.2 31.5 14.9 5.7 9.7 19.5 30.3 8.3 17.8 13.2 10.1 13.2 23.3 22.2 43.2 18.6 17.6 24.9 2.9 7.0 0.0 0.3 6.1 7.4 1.5 2.0 20.7 50.9 75.1 2.5 11.2 0.9 4.0 5.9 27.0 1.7 0.3 3.1 4.1 7.9 1.4 2.2 2.5 9.3 15.1 2.4 4.8 10.2 1.2 7.1 0.9 4.6 4.6 1.9 1.2 15.0 2.0 2.9 5.1 1.9 0.0 2.7 3.1 4.3 0.0 5.5 6.3 2.6 1.3 0.0 3.9 1.5 20.4 0.1 6.5 4.7 2.2 3.7 0.0 1.1 3.1 13.3 4.9 0.2 6.7 1.9 3.6 19.1 35.9 20.5 16.6 43.2 15.2 12.9 12.9 15.4 21.7 13.2 10.4 12.8 22.2 18.6 39.3 23.3 17.6 24.9 9.3 12.4 5.0 9.3 7.7 7.0 9.4 8.1 9.5 9.7 14.9 8.9 23.1 25.1 9.3 0.8 4.8 10.2 6.7 10.3 17.4 2.0 20.6 34.9 37.8 8.8 26.3 85.0 0.0 56.2 27.8 22.8 23.2 7.0 27.6 74.5 1.6 30.4 32.5 38.4 27.5 26.7 42.9 23.6 77.5 32.6 8.6 36.2 132.5 22.3 67.8 0.8 6.5 13.0 0.3 0.1 8.2 8.7 29.8 22.2 28.2 IFITM1 "9-27, CD225, IFI17" ENSG00000185885 "Interferon induced transmembrane protein 1" P13164 11 313506-315272 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity, Osteogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Club cells: 187.7;Leydig cells: 278.5;Sertoli cells: 271.7;T-cells: 358.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "eosinophil: 56.6;gdT-cell: 120.0;MAIT T-cell: 80.7;memory CD4 T-cell: 128.1;memory CD8 T-cell: 121.4;naive CD4 T-cell: 123.5;naive CD8 T-cell: 123.4;neutrophil: 106.8;NK-cell: 164.4;T-reg: 70.4" "Group enriched" "Detected in all" 7 "granulocytes: 106.8;NK-cells: 164.4;T-cells: 128.1" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 122.7;BJ hTERT+ SV40 Large T+ RasG12V: 219.9;HMC-1: 67.9" "HPA004810, CAB017615" Enhanced Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "CAB017615: AB_2264496, HPA004810: AB_1851419" "unprognostic (1.03e-3)" "unprognostic (6.79e-2)" "unprognostic (1.03e-1)" "unprognostic (2.98e-1)" "unprognostic (2.57e-1)" "unprognostic (9.06e-2)" "unprognostic (7.58e-2)" "unprognostic (3.03e-1)" "unprognostic (6.21e-2)" "unprognostic (5.53e-2)" "unprognostic (6.64e-3)" "unprognostic (1.48e-2)" "prognostic unfavorable (5.77e-9)" "unprognostic (7.29e-2)" "unprognostic (6.29e-2)" "unprognostic (3.15e-2)" "unprognostic (3.82e-2)" 81.1 14.2 17.4 36.7 24.5 41.2 57.0 11.9 23.1 71.0 28.2 12.9 20.6 17.2 48.3 152.4 44.4 67.2 31.2 62.6 19.8 13.9 59.8 34.5 44.1 159.7 34.8 14.7 100.2 16.3 22.3 23.3 36.3 27.3 38.7 22.1 49.5 27.4 41.6 38.7 23.6 33.0 46.0 37.9 112.9 20.5 29.4 20.1 42.7 48.3 28.0 50.3 39.3 52.8 13.0 4.3 106.8 18.6 164.4 128.1 147.7 6.4 0.1 53.3 4.3 3.9 13.7 0.3 11.3 53.0 122.7 219.9 0.1 44.5 0.1 8.5 11.9 1.2 15.1 1.7 1.1 2.4 13.5 2.8 6.5 4.1 0.4 35.3 9.5 67.9 25.6 0.0 1.3 0.1 1.3 0.2 2.1 23.2 53.9 0.0 0.9 4.7 18.3 15.2 0.0 1.6 1.2 0.1 1.2 32.8 0.0 0.0 0.0 5.9 0.6 10.9 7.6 2.2 0.8 0.3 0.1 0.1 0.0 0.0 3.8 2.0 0.3 0.1 14.3 0.1 15.6 2.3 56.6 120.0 10.9 80.7 13.0 128.1 121.4 4.3 11.3 123.5 123.4 106.8 164.4 18.6 1.2 70.4 147.7 17.4 24.5 11.9 23.1 19.8 13.9 34.8 14.7 27.3 20.1 32.8 96.7 12.5 9.5 24.7 0.0 4.8 0.0 36.1 187.7 31.4 0.0 1.2 5.0 0.9 1.2 146.9 12.4 0.0 1.2 25.0 131.5 1.8 17.4 17.9 9.3 0.0 1.2 130.1 11.0 0.0 278.5 21.9 74.2 0.0 14.4 0.0 0.9 10.1 117.0 0.3 0.0 271.7 95.7 0.3 1.0 12.5 3.3 358.0 24.3 4.4 IFT122 "SPG, WDR10, WDR10p, WDR140" ENSG00000163913 "Intraflagellar transport 122" Q9HBG6 3 129440036-129520507 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 84.7" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 61.8;Late spermatids: 52.6;Spermatocytes: 117.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041815 Uncertain Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA041815: AB_10804118" "unprognostic (7.16e-2)" "unprognostic (3.71e-3)" "unprognostic (3.67e-1)" "unprognostic (7.61e-3)" "unprognostic (5.29e-2)" "unprognostic (5.33e-3)" "unprognostic (4.68e-2)" "unprognostic (1.82e-1)" "unprognostic (7.90e-2)" "unprognostic (3.30e-1)" "unprognostic (1.67e-2)" "unprognostic (3.50e-2)" "unprognostic (1.09e-2)" "unprognostic (7.67e-2)" "unprognostic (5.33e-1)" "unprognostic (9.91e-2)" "unprognostic (4.20e-3)" 7.4 5.7 11.1 4.9 14.0 6.4 9.1 13.3 13.1 10.2 5.6 7.6 6.4 3.5 10.2 9.6 5.4 18.5 5.0 10.0 7.8 6.4 8.8 6.7 6.7 4.5 4.4 9.2 19.0 9.6 13.1 18.9 7.7 7.2 5.7 5.2 10.5 6.3 6.7 3.7 9.9 4.1 7.6 4.2 3.7 6.7 84.7 5.7 7.6 9.6 2.0 4.2 5.3 6.9 4.7 6.0 8.3 5.7 2.8 5.5 3.8 11.0 16.7 14.5 9.5 21.1 15.0 7.7 5.9 8.9 10.3 10.0 8.0 7.3 7.1 7.0 7.6 10.2 7.1 5.6 5.2 9.4 3.8 6.0 5.4 13.6 6.8 5.8 14.9 5.0 17.5 3.9 7.9 6.2 9.0 13.9 15.2 5.5 15.3 8.3 12.2 12.2 7.7 9.7 8.3 4.8 10.9 5.5 5.1 11.1 2.0 18.4 7.5 16.9 5.7 5.1 5.7 15.5 12.0 6.1 7.3 6.2 9.4 7.0 10.5 7.3 6.2 6.6 7.6 5.5 8.3 5.7 6.6 1.9 3.9 3.3 3.8 3.3 4.5 6.0 4.7 3.7 4.5 2.7 2.8 1.7 1.4 5.5 3.8 11.1 14.0 13.3 13.1 7.8 6.4 4.4 9.2 7.2 5.7 8.9 8.0 2.4 4.9 2.4 9.5 5.6 7.6 13.4 4.5 24.4 35.3 5.6 6.6 4.5 61.8 6.0 5.8 0.0 7.8 5.0 8.8 2.8 4.7 3.9 8.4 4.8 2.9 17.8 6.5 52.6 17.3 2.5 3.3 1.8 9.2 10.8 3.4 3.5 13.1 6.0 19.6 0.0 7.1 117.0 35.3 2.5 2.2 3.2 7.0 2.2 IGDCC3 "HsT18880, PUNC" ENSG00000174498 "Immunoglobulin superfamily DCC subclass member 3" Q8IVU1 15 65327127-65378040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;parathyroid gland: 16.6;placenta: 12.2" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 31.4;Cytotrophoblasts: 90.9;Late spermatids: 38.7;Syncytiotrophoblasts: 34.6" "Cancer enhanced" "Detected in many" "testis cancer: 5.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 42.7;CACO-2: 10.7;Hep G2: 33.7;SuSa: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015713 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA015713: " "unprognostic (7.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.24e-2)" "unprognostic (7.25e-3)" "unprognostic (6.67e-2)" "unprognostic (7.35e-3)" "unprognostic (3.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-2)" "unprognostic (4.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.77e-5)" "unprognostic (4.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-2)" 0.2 0.6 3.5 0.4 2.1 0.2 1.7 10.8 4.6 1.0 0.5 3.3 0.0 0.3 1.6 0.4 0.2 1.4 0.4 0.4 3.2 2.6 0.6 0.2 0.3 0.2 2.5 1.7 1.7 0.3 16.6 2.9 12.2 2.6 0.5 0.3 0.6 0.2 0.5 0.5 0.4 0.3 0.6 2.2 0.3 0.4 4.7 2.7 3.7 1.7 0.0 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.7 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.7 0.1 0.0 0.1 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.6 0.0 0.0 0.0 17.7 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 2.1 10.8 4.6 3.2 2.6 2.5 1.7 2.6 2.7 0.0 0.0 0.0 0.2 0.0 4.0 0.5 0.0 0.0 0.0 1.8 31.4 90.9 0.0 0.0 18.8 0.0 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.0 6.1 0.0 0.0 0.0 0.0 38.7 0.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.9 12.6 0.0 34.6 0.0 0.0 0.0 IGFBP5 ENSG00000115461 "Insulin like growth factor binding protein 5" P24593 2 216672105-216695525 "Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 245.3" "Cell type enhanced" "Detected in many" 13 "Leydig cells: 1692.8;Muller glia cells: 665.4;Peritubular cells: 922.8;Sertoli cells: 1254.7;Smooth muscle cells: 840.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 79.7;BJ hTERT+: 211.9;T-47d: 51.5;U-138 MG: 70.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059827, HPA070407" Supported Approved "Nuclear bodies,Golgi apparatus,Vesicles" "Secreted to blood" NA NA 110000000 330000000 "Golgi apparatus, Vesicles" "Nuclear bodies" "HPA059827: AB_2732640, HPA070407: " "unprognostic (7.69e-2)" "unprognostic (2.56e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (4.58e-2)" "unprognostic (3.47e-1)" "unprognostic (2.04e-1)" "unprognostic (1.76e-1)" "unprognostic (1.32e-1)" "unprognostic (9.58e-2)" "unprognostic (1.12e-1)" "unprognostic (2.41e-2)" "unprognostic (4.04e-2)" "unprognostic (9.62e-3)" "unprognostic (1.55e-1)" "unprognostic (3.28e-2)" "unprognostic (1.91e-3)" 47.3 23.4 6.2 19.2 6.3 0.1 41.3 3.6 6.5 191.7 23.1 19.7 15.8 3.9 94.6 91.0 30.0 96.9 21.4 16.9 8.2 2.4 34.8 7.8 9.3 14.5 12.1 7.4 245.3 3.5 6.5 37.7 32.7 7.0 31.4 7.9 188.5 12.0 15.1 47.0 13.5 14.2 71.8 7.4 7.6 36.9 51.7 12.0 1.5 130.1 34.5 17.6 28.8 45.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 20.5 0.0 23.7 0.7 0.0 79.7 211.9 10.6 1.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 2.5 0.0 0.5 0.0 0.7 20.5 0.4 0.0 10.3 0.0 0.1 3.3 0.0 1.4 0.0 2.4 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.1 6.9 23.7 1.4 0.8 1.4 9.8 0.0 1.3 51.5 0.0 7.6 70.3 4.3 10.6 3.8 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 6.2 6.3 3.6 6.5 8.2 2.4 12.1 7.4 7.0 12.0 3.0 4.1 2.4 13.8 91.0 5.3 81.7 0.0 100.4 23.9 106.4 5.9 4.0 5.0 13.3 6.4 89.9 0.0 0.0 0.0 5.9 302.8 15.2 2.3 0.9 7.6 3.2 0.0 62.6 0.8 10.9 1692.8 25.6 96.2 1.0 0.0 665.4 3.2 0.0 922.8 1.1 10.8 1254.7 840.1 1.9 2.1 59.5 4.7 1.0 0.0 13.1 IGFBPL1 bA113O24.1 ENSG00000137142 "Insulin like growth factor binding protein like 1" Q8WX77 9 38408994-38424447 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2" "Group enriched" "Detected in some" 6 "Hofbauer cells: 1.4;Intestinal endocrine cells: 1.7;Spermatogonia: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 67.8;NTERA-2: 18.6;RH-30: 19.5;SCLC-21H: 69.8;SH-SY5Y: 67.7;SuSa: 43.0" "Group enriched" "Detected in some" 4 "basal ganglia: 12.5;olfactory region: 16.2" "Low region specificity" "Detected in many" HPA051354 Uncertain Uncertain Nucleoplasm,Vesicles "Secreted to blood" NA NA "Nucleoplasm, Vesicles" "HPA051354: " "unprognostic (5.63e-2)" "unprognostic (3.33e-1)" "unprognostic (5.22e-2)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.30e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.94e-1)" "unprognostic (3.92e-2)" "unprognostic (1.59e-2)" "unprognostic (6.67e-2)" 1.6 2.6 3.8 1.1 11.0 0.3 0.4 4.7 4.7 0.7 1.0 1.0 0.0 1.9 2.1 0.5 0.7 1.0 1.9 3.7 3.3 2.3 0.7 0.6 1.2 0.4 1.4 1.5 0.5 1.6 0.4 7.4 1.1 1.8 1.6 0.7 0.2 0.5 2.9 0.3 0.3 1.2 2.1 0.6 0.4 2.5 3.3 1.5 2.6 27.2 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 67.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 18.6 0.0 0.1 0.0 19.5 0.1 0.0 0.0 69.8 67.7 1.1 0.0 0.0 43.0 0.3 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 11.0 4.7 4.7 3.3 2.3 1.4 1.5 1.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 IL13RA2 "CD213a2, CT19, IL-13R, IL13BP" ENSG00000123496 "Interleukin 13 receptor subunit alpha 2" Q14627 X 115003975-115019977 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 16.1;testis: 31.5" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 253.7;Ito cells: 63.3;Late spermatids: 36.6;Spermatocytes: 64.6" "Cancer enhanced" "Detected in many" "glioma: 17.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "PC-3: 27.0;U-2197: 86.8;U-251 MG: 58.3;U-87 MG: 34.6" "Region enhanced" "Detected in some" "olfactory region: 8.7" "Low region specificity" "Detected in many" "HPA045831, HPA067363" Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Vesicles" "HPA045831: , HPA067363: " "unprognostic (1.97e-1)" "unprognostic (2.83e-1)" "unprognostic (6.62e-4)" "unprognostic (7.39e-2)" "unprognostic (8.45e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.55e-4)" "unprognostic (3.54e-1)" "unprognostic (2.85e-1)" "unprognostic (1.92e-2)" "unprognostic (2.20e-3)" "unprognostic (2.19e-2)" "unprognostic (1.53e-5)" "unprognostic (1.58e-1)" "unprognostic (1.63e-1)" "unprognostic (9.70e-3)" "unprognostic (1.20e-1)" 0.5 4.8 3.7 3.9 11.3 0.0 0.8 0.3 3.1 1.2 0.4 2.1 5.7 0.3 0.9 4.4 0.5 0.1 0.8 0.6 5.1 11.2 3.5 9.6 1.0 0.1 1.2 2.6 0.1 0.1 0.5 16.1 2.1 3.9 4.3 0.7 1.6 0.8 3.7 0.0 0.1 0.3 0.4 0.6 0.2 0.1 31.5 1.4 0.0 1.3 0.2 0.2 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.7 0.0 5.9 5.7 0.0 0.0 0.0 0.0 0.0 0.1 2.9 9.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.9 5.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 86.8 58.3 0.0 0.0 0.0 34.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 11.3 0.3 3.1 5.1 11.2 1.2 2.6 3.9 1.4 0.0 0.0 0.0 2.6 0.1 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 253.7 1.0 0.0 0.0 0.0 0.0 0.4 2.3 0.0 0.4 0.0 0.0 4.1 63.3 4.8 36.6 2.6 0.0 0.0 1.0 0.0 0.0 5.5 0.0 4.6 0.0 0.0 0.0 0.2 64.6 2.1 0.0 0.0 0.0 0.0 2.5 IL17RB "CRL4, EVI27, IL17BR, IL17RH1" ENSG00000056736 "Interleukin 17 receptor B" Q9NRM6 3 53846580-53865800 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 63.0;liver: 26.6" "Group enriched" "Detected in many" 4 "Intestinal endocrine cells: 28.0;Proximal tubular cells: 57.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 11.1;Hep G2: 32.2;OE19: 25.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002837, HPA005482" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitotic spindle,Centriolar satellite" "Intracellular and membrane" NA NA "Nucleoplasm, Plasma membrane" "Mitotic spindle, Centriolar satellite" "HPA002837: , HPA005482: AB_1234567" "unprognostic (1.85e-3)" "unprognostic (4.22e-3)" "unprognostic (1.60e-3)" "unprognostic (2.86e-2)" "unprognostic (1.42e-2)" "unprognostic (6.20e-3)" "unprognostic (1.62e-2)" "unprognostic (6.09e-3)" "unprognostic (1.30e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" "unprognostic (4.27e-2)" "prognostic favorable (6.61e-4)" "unprognostic (8.10e-2)" "unprognostic (6.97e-2)" "unprognostic (5.29e-1)" "unprognostic (7.15e-3)" 1.1 2.1 13.4 2.2 12.2 0.9 9.2 15.1 14.7 17.1 5.8 6.8 0.0 5.1 5.0 1.3 1.9 3.2 2.4 2.5 17.1 7.4 63.0 26.6 3.5 2.3 11.9 6.4 1.8 5.3 1.4 3.9 1.2 11.2 2.5 6.1 1.9 4.1 1.0 1.4 2.3 5.1 1.2 11.3 1.4 3.4 2.5 15.2 0.0 2.9 0.0 1.0 1.7 1.0 0.9 1.1 4.1 0.6 0.5 3.1 0.5 0.8 1.7 2.5 1.9 0.0 0.0 4.0 1.7 0.0 0.0 0.0 11.1 0.8 2.5 0.6 0.5 0.9 0.4 6.8 0.0 0.0 0.9 1.9 3.3 3.4 32.2 0.0 3.0 1.8 0.0 0.0 0.0 0.0 2.2 0.0 0.9 2.6 1.2 0.0 2.2 0.5 1.2 6.8 25.2 1.4 0.9 1.0 2.9 0.7 2.9 3.6 2.1 5.6 1.3 1.0 1.9 5.2 1.1 1.3 1.7 1.9 1.5 2.1 2.6 2.9 1.6 1.5 1.8 0.9 4.1 0.6 0.2 1.0 0.6 0.6 0.5 2.1 0.6 0.2 0.9 0.8 0.9 0.3 0.5 0.2 1.1 3.1 0.5 13.4 12.2 15.1 14.7 17.1 7.4 11.9 6.4 11.2 15.2 0.0 2.6 0.0 2.0 0.2 0.0 3.4 10.2 0.0 2.3 0.0 0.0 0.3 8.3 3.7 0.8 0.0 1.3 0.0 1.3 0.9 0.2 6.7 2.3 8.9 0.1 0.0 28.0 0.6 0.0 0.0 1.1 0.8 0.0 0.0 4.3 4.5 2.7 2.0 0.4 57.9 0.0 0.0 0.6 0.4 1.3 0.1 0.3 0.0 6.6 0.5 IL18 "IGIF, IL-18, IL-1g, IL1F4" ENSG00000150782 "Interleukin 18" Q14116 11 112143251-112164117 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.9;skin 1: 57.2" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 160.8;Kupffer cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 17.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 26.5;CAPAN-2: 42.1;HaCaT: 38.5;HBEC3-KT: 29.0;hTCEpi: 44.4;PC-3: 25.8;U-2 OS: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003980, CAB007772" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA Yes 196000 "Nucleoplasm, Golgi apparatus" Cytosol "CAB007772: AB_562304, HPA003980: AB_1851670" "unprognostic (2.31e-3)" "unprognostic (3.25e-1)" "prognostic favorable (2.78e-4)" "unprognostic (3.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (8.15e-2)" "unprognostic (3.23e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-3)" "unprognostic (4.13e-1)" "unprognostic (3.58e-2)" "unprognostic (1.51e-1)" "unprognostic (3.19e-2)" "unprognostic (3.15e-2)" "unprognostic (9.01e-2)" 9.4 2.6 5.3 12.5 7.9 10.8 5.2 1.3 5.3 18.5 13.1 6.4 2.5 8.6 2.1 3.7 53.9 3.3 11.9 2.1 5.7 3.1 17.5 3.6 15.2 22.6 7.4 1.4 1.4 7.0 0.3 3.3 2.6 8.2 5.5 11.6 2.2 8.3 1.4 3.8 57.2 9.1 4.0 24.7 26.6 5.1 1.7 7.5 3.9 1.8 21.2 26.5 9.1 35.4 0.5 17.1 10.4 6.9 13.8 0.3 1.6 26.5 9.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 5.1 42.1 0.0 6.1 0.0 0.7 38.5 0.0 29.0 0.0 0.0 0.2 4.0 9.5 2.1 0.9 2.1 7.7 0.0 44.4 0.0 10.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 7.3 25.8 0.0 0.0 0.0 19.0 5.7 0.0 0.0 18.3 12.2 0.1 0.2 7.3 5.8 0.0 0.1 50.0 0.3 8.2 0.1 0.0 0.1 0.0 15.4 0.0 3.5 6.0 10.4 0.1 6.9 0.0 0.4 0.0 0.0 17.1 0.5 0.0 0.3 6.7 13.8 3.7 3.8 0.0 1.6 5.3 7.9 1.3 5.3 5.7 3.1 7.4 1.4 8.2 7.5 160.8 35.5 7.5 33.3 109.2 1.7 0.7 22.9 73.6 43.3 8.7 0.0 2.1 68.0 27.4 1.8 2.4 69.7 0.0 126.1 2.6 5.4 10.6 97.2 2.0 69.6 0.0 13.9 6.2 163.5 0.9 0.0 66.1 3.3 30.7 23.3 1.7 111.9 97.0 4.2 13.2 37.2 6.5 2.2 0.6 0.5 97.2 1.5 27.7 45.4 67.4 IL21R CD360 ENSG00000103522 "Interleukin 21 receptor" Q9HBE5 16 27402162-27452042 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 17.9;lymphoid tissue: 47.8" "Cell type enhanced" "Detected in some" 10 "B-cells: 11.8;Early spermatids: 5.2;Hofbauer cells: 7.0;T-cells: 8.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 10.3;HDLM-2: 43.9;Karpas-707: 20.4;RH-30: 15.4;RPMI-8226: 24.5;U-266/70: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042296 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042296: AB_10806236" "unprognostic (2.91e-2)" "unprognostic (2.65e-3)" "unprognostic (6.64e-4)" "unprognostic (1.58e-3)" "unprognostic (2.14e-1)" "prognostic favorable (7.29e-4)" "unprognostic (8.33e-2)" "unprognostic (2.06e-1)" "unprognostic (8.50e-6)" "unprognostic (2.26e-2)" "unprognostic (1.13e-2)" "unprognostic (8.71e-2)" "unprognostic (2.34e-10)" "unprognostic (8.79e-2)" "unprognostic (4.42e-2)" "unprognostic (1.50e-1)" "unprognostic (9.58e-2)" 0.8 0.6 0.6 33.6 3.7 5.7 0.6 0.5 1.6 0.5 0.9 0.3 0.0 0.5 0.5 1.3 1.0 0.8 1.1 1.8 0.6 2.3 1.6 1.3 5.6 20.9 1.3 0.0 0.5 0.5 0.0 0.9 0.9 1.9 0.9 0.9 1.8 3.7 0.3 0.7 0.7 4.0 0.6 1.7 11.2 1.3 1.0 1.4 47.8 1.3 0.8 31.7 2.7 0.8 11.5 1.6 0.7 17.9 6.3 10.3 4.2 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.3 0.0 0.0 0.9 0.0 0.0 10.3 0.1 0.8 0.5 0.0 0.0 0.0 0.0 43.9 0.0 2.1 0.0 0.3 1.4 0.0 0.6 1.6 0.0 2.8 0.0 0.3 0.0 0.2 0.1 20.4 1.5 0.0 0.0 0.2 0.3 0.0 0.0 0.1 15.4 24.5 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.1 0.0 0.5 1.1 0.8 0.3 0.2 0.0 10.3 3.6 2.3 2.1 0.5 0.0 0.2 0.3 0.0 9.8 5.8 3.6 1.0 6.3 10.3 1.6 11.5 6.9 6.7 0.7 6.3 17.9 0.7 7.6 4.2 0.6 3.7 0.5 1.6 0.6 2.3 1.3 0.0 1.9 1.4 0.0 2.2 11.8 0.1 0.3 1.5 2.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 5.2 0.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 7.0 0.0 0.0 1.3 4.5 4.0 0.0 2.2 1.7 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.1 0.0 0.6 0.1 8.2 0.0 0.0 IL4R CD124 ENSG00000077238 "Interleukin 4 receptor" P24394 16 27313668-27364778 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "granulocytes: 107.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 34.4" "Group enriched" "Detected in all" 6 "B-cells: 34.4;granulocytes: 11.9" "Cell line enhanced" "Detected in many" "Daudi: 36.5;HBEC3-KT: 35.1;U-698: 34.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004451, HPA050124, HPA070380" Enhanced Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" "Secreted to blood" NA NA 49000 "Nucleoplasm, Plasma membrane" "Centriolar satellite" "CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: " "unprognostic (6.80e-2)" "unprognostic (6.35e-2)" "unprognostic (2.84e-1)" "prognostic favorable (6.43e-4)" "unprognostic (1.12e-1)" "unprognostic (1.14e-1)" "unprognostic (2.33e-2)" "unprognostic (1.95e-3)" "unprognostic (1.34e-1)" "unprognostic (1.54e-1)" "unprognostic (2.41e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.49e-2)" "unprognostic (1.73e-1)" "unprognostic (1.36e-1)" "unprognostic (9.58e-2)" 20.7 14.8 8.7 31.6 10.6 36.9 12.0 4.4 7.7 20.8 30.3 5.9 11.5 10.9 18.0 12.8 24.7 13.6 25.1 12.3 6.7 4.4 13.3 39.1 40.9 44.8 10.8 1.7 14.7 11.3 3.8 5.5 16.1 10.1 18.8 15.1 12.3 7.7 11.5 7.2 9.9 18.6 39.6 13.6 31.8 21.1 10.4 9.8 9.1 8.6 13.7 38.4 31.6 15.4 34.4 1.6 11.9 2.6 3.3 4.0 1.8 11.5 3.0 2.0 3.9 1.0 4.6 4.2 7.3 8.5 2.9 2.4 6.2 32.0 36.5 9.1 11.5 5.7 12.3 2.1 35.1 2.5 31.6 1.0 6.8 1.8 9.5 13.2 1.8 19.4 7.0 14.2 13.5 8.0 15.5 15.7 2.1 2.9 3.1 4.7 5.1 0.1 5.5 2.4 10.4 2.7 0.1 15.2 2.9 13.6 13.2 0.6 0.3 1.0 7.0 1.6 5.3 2.7 7.0 23.5 6.7 3.0 5.9 5.1 1.8 0.5 34.0 0.7 6.1 0.0 0.5 2.6 4.7 1.7 1.1 1.3 7.7 2.6 1.7 1.6 34.4 4.0 1.9 11.9 3.3 0.6 1.6 1.8 1.8 8.7 10.6 4.4 7.7 6.7 4.4 10.8 1.7 10.1 9.8 26.8 51.7 49.6 35.5 11.7 0.0 2.2 20.4 17.4 30.7 1.8 0.0 15.0 0.0 31.7 0.1 31.5 27.6 0.0 28.2 3.5 13.9 27.2 107.5 47.4 22.9 0.0 22.4 54.6 31.1 0.2 0.3 21.3 13.5 40.5 32.8 0.0 35.6 22.1 0.0 1.1 0.0 38.8 27.4 0.5 1.9 13.0 20.8 20.3 15.0 38.2 ILK ENSG00000166333 "Integrin linked kinase" Q13418 11 6603708-6610874 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004041, HPA048437" Enhanced Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA 130000000 "Plasma membrane, Focal adhesion sites" Nucleoplasm "CAB004041: AB_2127050, HPA048437: AB_2680391" "unprognostic (1.78e-1)" "unprognostic (2.26e-2)" "unprognostic (5.26e-2)" "unprognostic (2.12e-2)" "unprognostic (7.57e-2)" "unprognostic (1.01e-1)" "unprognostic (6.19e-3)" "unprognostic (5.25e-3)" "unprognostic (1.49e-2)" "unprognostic (9.65e-2)" "unprognostic (2.64e-1)" "unprognostic (8.12e-2)" "prognostic favorable (2.44e-4)" "unprognostic (4.01e-3)" "unprognostic (9.27e-2)" "unprognostic (2.42e-1)" "unprognostic (6.36e-3)" 20.9 17.6 11.0 22.3 11.9 7.5 37.0 9.4 14.6 40.2 75.1 14.7 41.9 13.5 75.4 25.2 35.7 33.2 41.1 35.1 11.1 9.2 21.6 15.1 21.9 18.9 11.5 14.0 24.2 22.3 20.4 10.9 22.2 11.5 39.9 24.6 19.3 19.4 89.9 18.5 12.4 22.2 103.5 10.6 20.2 33.2 14.2 11.0 8.2 17.5 14.1 13.6 60.8 25.9 19.5 45.9 76.5 49.4 45.3 25.8 63.7 23.9 18.5 29.2 10.1 45.2 32.1 13.3 35.3 69.8 41.8 51.0 19.3 28.3 9.0 9.4 57.7 41.0 19.3 16.3 29.9 42.0 15.7 14.8 13.0 17.7 15.0 30.3 10.4 14.9 30.8 14.1 28.2 21.6 42.9 39.8 7.8 11.9 10.7 54.5 18.0 9.2 17.8 18.4 20.4 21.8 9.6 15.3 9.6 30.6 19.2 5.1 11.5 16.7 23.1 19.4 29.8 16.1 11.9 46.0 52.5 23.7 21.7 17.1 7.8 4.8 12.7 38.9 15.7 24.4 48.3 49.4 76.5 25.8 47.9 25.1 19.5 23.3 24.4 45.9 17.1 14.7 18.5 31.7 45.3 44.4 18.5 25.7 63.7 11.0 11.9 9.4 14.6 11.1 9.2 11.5 14.0 11.5 11.0 41.7 17.0 28.3 58.4 44.9 13.9 0.3 66.2 18.7 15.9 54.1 7.9 94.6 49.7 120.2 46.5 56.1 64.4 46.7 108.6 153.9 93.0 39.7 29.0 24.9 111.6 7.9 36.5 84.1 50.9 110.9 66.2 80.3 81.0 196.6 43.0 50.2 101.4 57.5 138.6 74.7 29.6 155.2 137.9 31.1 15.7 37.8 92.0 54.3 41.7 41.9 INPP5E "CORS1, JBTS1, pharbin, PPI5PIV" ENSG00000148384 "Inositol polyphosphate-5-phosphatase E" Q9NRR6 9 136428619-136439823 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Ciliopathy, Disease mutation, Joubert syndrome, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065758 Approved Supported "Nucleoplasm,Golgi apparatus,Focal adhesion sites" NA NA "Golgi apparatus, Focal adhesion sites" Nucleoplasm "HPA065758: AB_2685554" "unprognostic (1.99e-1)" "unprognostic (8.68e-2)" "unprognostic (1.87e-2)" "unprognostic (1.23e-2)" "unprognostic (4.00e-1)" "unprognostic (6.92e-2)" "unprognostic (9.60e-3)" "unprognostic (3.21e-1)" "unprognostic (5.81e-2)" "unprognostic (2.65e-2)" "prognostic favorable (1.82e-4)" "unprognostic (2.03e-1)" "unprognostic (3.04e-2)" "unprognostic (3.76e-1)" "unprognostic (5.48e-2)" "unprognostic (4.64e-1)" "unprognostic (2.66e-2)" 14.3 11.2 14.9 15.3 10.4 8.9 19.2 19.9 19.1 10.5 10.7 11.5 11.1 10.3 13.1 10.1 8.4 17.2 9.4 11.9 12.6 12.0 10.2 9.0 10.1 13.5 8.4 12.3 14.7 11.6 11.4 12.3 9.8 13.2 9.9 5.2 11.0 14.4 12.9 11.6 18.2 10.7 10.7 6.6 19.4 8.6 15.2 10.3 8.5 12.5 6.2 10.7 8.8 19.3 2.6 1.0 1.9 0.5 0.0 2.4 0.6 6.2 7.2 8.5 8.4 4.3 5.6 10.5 7.5 4.4 5.8 3.7 7.4 4.4 7.8 7.7 6.3 8.3 17.5 3.7 5.1 2.2 24.3 14.7 5.2 12.4 4.9 7.3 6.1 8.5 6.0 4.8 6.4 5.7 6.9 5.6 10.0 8.8 7.2 4.9 10.3 7.8 13.4 5.5 3.9 12.0 14.3 6.5 5.8 5.2 6.1 8.9 8.0 7.2 6.8 5.2 6.1 10.9 9.1 8.0 17.9 6.7 7.2 13.0 7.8 6.3 3.3 9.2 5.4 6.5 0.0 0.5 1.9 2.0 0.0 1.3 2.6 2.3 1.5 0.5 1.7 0.8 1.6 0.4 0.0 0.3 1.0 2.4 0.6 14.9 10.4 19.9 19.1 12.6 12.0 8.4 12.3 13.2 10.3 3.0 5.8 2.9 1.5 4.8 7.1 4.1 7.6 6.7 3.4 3.5 2.0 2.0 1.7 4.5 0.3 5.8 2.8 0.0 4.8 2.0 3.9 2.0 9.2 3.0 2.6 14.3 5.8 2.5 3.8 0.7 6.9 3.5 5.0 4.6 2.9 8.5 5.3 0.0 5.3 2.2 11.4 0.0 4.8 9.8 7.8 4.3 0.7 4.3 4.3 1.6 INSIG1 "CL-6, MGC1405" ENSG00000186480 "Insulin induced gene 1" O15503 7 155297776-155310235 "Plasma proteins, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 81.4;liver: 143.2" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 494.0" "Cancer enhanced" "Detected in all" "liver cancer: 142.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "intermediate monocyte: 45.7;non-classical monocyte: 81.4" "Lineage enriched" "Detected in all" 6 "monocytes: 81.4" "Cell line enhanced" "Detected in many" "Karpas-707: 155.1;RPMI-8226: 72.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071524 Uncertain Vesicles NA NA Vesicles "HPA071524: " "unprognostic (8.11e-2)" "unprognostic (3.22e-1)" "unprognostic (2.91e-1)" "unprognostic (1.47e-1)" "unprognostic (9.23e-2)" "unprognostic (3.83e-2)" "unprognostic (2.05e-2)" "unprognostic (3.06e-1)" "unprognostic (1.60e-2)" "unprognostic (1.52e-1)" "unprognostic (4.64e-2)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.85e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (9.62e-4)" "unprognostic (4.97e-2)" 18.4 9.2 8.5 8.3 8.8 9.7 14.1 10.1 14.3 6.0 7.4 21.8 7.5 12.5 5.2 8.3 15.6 4.6 8.0 5.6 10.8 11.6 6.4 143.2 18.5 6.9 8.6 8.3 16.4 27.2 4.6 5.2 17.5 23.9 15.9 6.7 11.9 31.4 3.1 2.4 10.5 14.2 5.1 19.2 4.5 13.4 8.2 8.3 10.7 3.3 6.1 6.9 11.2 5.6 10.0 13.6 10.7 81.4 4.0 12.7 12.5 19.2 3.6 9.6 6.0 25.4 34.0 5.2 1.5 22.0 4.6 30.7 2.2 28.0 12.6 4.5 11.9 35.9 10.4 6.5 11.4 5.5 3.8 19.2 3.4 6.6 0.0 12.5 5.8 57.0 21.1 6.3 35.5 3.3 3.4 6.1 25.1 6.3 155.1 5.9 10.0 28.5 15.4 10.0 3.6 2.2 5.3 0.0 72.7 36.3 9.6 7.2 5.6 5.1 3.7 8.1 3.7 3.6 19.6 6.9 5.1 1.5 9.6 4.0 37.8 6.6 11.2 22.6 22.8 4.7 3.1 4.9 2.1 8.7 45.7 4.4 7.7 6.0 7.4 13.6 10.0 5.9 6.7 10.7 4.0 81.4 7.7 12.7 12.5 8.5 8.8 10.1 14.3 10.8 11.6 8.6 8.3 23.9 8.3 38.7 98.0 59.2 52.4 124.6 12.6 22.7 28.1 48.2 35.2 38.4 9.8 43.4 14.9 38.4 16.5 50.6 41.6 0.0 120.7 153.6 37.0 96.2 61.0 494.0 42.6 36.5 121.5 36.2 57.7 5.6 14.7 90.2 234.5 28.9 44.4 73.4 47.8 10.5 17.3 8.4 17.2 19.4 86.4 38.0 53.2 135.8 109.0 47.3 19.0 105.7 INTS12 "INT12, PHF22, SBBI22" ENSG00000138785 "Integrator complex subunit 12" Q96CB8 4 105682627-105895986 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035772, HPA041814" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies, Plasma membrane" "HPA035772: AB_10671109, HPA041814: AB_2677687" "unprognostic (5.30e-2)" "unprognostic (4.54e-2)" "unprognostic (1.84e-3)" "unprognostic (1.78e-1)" "unprognostic (3.68e-2)" "unprognostic (2.58e-3)" "prognostic unfavorable (2.67e-4)" "unprognostic (3.95e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-3)" "unprognostic (3.00e-2)" "unprognostic (3.48e-2)" "unprognostic (5.93e-3)" "unprognostic (3.62e-1)" "unprognostic (1.37e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-1)" 16.7 13.5 18.7 12.5 20.7 25.3 20.0 17.3 18.1 14.5 17.0 13.4 11.6 17.0 16.1 17.9 13.6 14.4 12.3 19.3 18.3 15.3 18.2 21.4 15.4 12.1 16.5 11.5 15.0 16.0 17.3 20.7 11.2 17.4 18.1 15.4 10.4 14.8 13.7 28.2 14.1 21.0 16.6 19.3 15.9 14.9 12.6 13.8 22.1 31.1 15.9 15.4 13.8 12.6 20.6 27.6 33.3 17.0 27.1 21.9 14.0 12.7 6.8 15.7 16.2 15.5 18.5 11.4 15.2 15.8 19.2 20.0 9.6 14.6 18.5 8.5 17.1 14.9 7.5 17.2 21.9 23.8 19.3 10.4 13.9 11.1 13.5 25.0 24.4 12.7 17.4 28.5 19.0 28.6 12.5 17.6 15.7 20.6 14.5 20.5 13.5 28.6 15.2 6.8 18.7 10.5 14.7 17.1 14.1 17.8 8.7 17.0 13.6 10.7 17.8 16.7 12.9 14.4 14.4 11.4 12.6 13.0 13.6 16.2 22.5 20.8 27.5 14.0 16.7 24.9 33.3 15.9 24.1 17.9 16.8 20.0 20.6 20.6 20.2 18.0 19.3 21.6 20.2 12.1 27.1 17.0 27.6 21.9 14.0 18.7 20.7 17.3 18.1 18.3 15.3 16.5 11.5 17.4 13.8 11.9 7.3 22.4 10.3 9.7 9.6 17.3 17.8 5.3 5.7 3.5 9.8 14.1 36.5 19.4 33.3 13.5 8.0 0.0 17.7 15.1 9.7 14.5 24.3 8.9 15.5 9.5 5.8 12.9 6.7 20.9 11.2 9.1 6.8 19.0 5.5 11.2 16.6 8.2 7.8 12.9 9.0 0.0 10.3 13.0 12.6 9.2 15.3 10.7 8.3 10.0 INTU "KIAA1284, PDZD6, PDZK6" ENSG00000164066 "Inturned planar cell polarity protein" Q9ULD6 4 127623271-127726737 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 112.4;Cone photoreceptor cells: 129.6;Rod photoreceptor cells: 185.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036714, HPA036715, HPA061467" Approved Uncertain Cytosol NA NA Cytosol "HPA036714: AB_10670238, HPA036715: AB_2675267, HPA061467: " "unprognostic (1.09e-1)" "unprognostic (2.89e-1)" "unprognostic (4.11e-2)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.40e-1)" "unprognostic (2.88e-3)" "unprognostic (4.30e-2)" "unprognostic (2.91e-1)" "unprognostic (1.43e-1)" "unprognostic (3.90e-2)" "unprognostic (1.53e-1)" "unprognostic (1.22e-1)" "unprognostic (9.49e-2)" "unprognostic (3.28e-1)" "unprognostic (2.36e-1)" "unprognostic (5.33e-2)" 4.4 4.8 8.3 3.7 23.0 7.3 8.1 5.6 12.6 7.7 4.0 11.9 5.6 5.9 10.2 14.6 4.0 8.1 4.7 3.2 12.0 8.0 5.7 2.4 4.9 3.4 7.2 8.1 9.9 4.1 4.7 25.8 3.3 12.3 5.2 4.8 9.1 5.2 4.2 3.3 10.6 3.1 4.4 9.1 3.8 6.1 6.9 8.0 0.5 7.9 2.8 2.3 4.6 5.0 1.4 1.5 4.7 0.9 1.0 0.9 0.1 3.3 2.3 12.6 4.7 1.8 4.4 1.0 2.0 1.0 1.3 2.6 1.7 3.1 2.8 3.3 2.0 3.9 2.0 10.0 1.9 3.9 1.2 3.0 3.5 4.0 4.2 1.7 3.1 1.8 1.8 2.1 4.2 1.0 3.9 3.8 1.3 4.2 2.9 1.9 1.6 1.1 1.8 5.9 1.2 2.3 1.2 3.1 0.8 2.6 2.6 5.9 4.2 4.3 2.3 1.5 6.7 2.7 1.9 3.2 3.6 2.9 3.5 2.8 1.9 2.8 0.9 3.0 1.6 2.2 2.8 0.8 0.5 0.9 0.6 0.8 0.7 0.7 0.6 0.4 1.4 0.7 0.8 4.7 1.0 0.9 1.5 0.4 0.1 8.3 23.0 5.6 12.6 12.0 8.0 7.2 8.1 12.3 8.0 20.8 12.5 0.5 9.8 5.4 58.4 12.7 7.6 112.4 25.0 3.5 129.6 6.8 6.6 6.2 9.1 5.6 0.9 0.0 4.4 5.1 5.9 7.3 4.7 2.4 2.6 35.0 11.1 7.4 1.5 8.4 13.0 7.4 6.8 0.0 5.5 15.8 2.9 0.0 11.0 6.2 185.9 0.0 7.6 7.7 20.9 5.4 1.6 2.2 6.3 6.2 IQCA1 "DRC11, FLJ22527, IQCA" ENSG00000132321 "IQ motif containing with AAA domain 1" Q86XH1 2 236324147-236507542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 27.8;thyroid gland: 30.0" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 163.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 9.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 4.4" "Group enriched" "Detected in many" 4 "NK-cells: 1.2;T-cells: 4.4" "Cell line enhanced" "Detected in some" "EFO-21: 4.0;HBEC3-KT: 3.7;HeLa: 4.4;hTERT-RPE1: 8.7;SuSa: 5.5;U-2 OS: 15.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA057320 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA057320: " "unprognostic (1.73e-2)" "unprognostic (6.38e-2)" "unprognostic (3.75e-3)" "unprognostic (1.62e-2)" "unprognostic (6.27e-3)" "unprognostic (1.73e-2)" "unprognostic (3.23e-5)" "unprognostic (1.55e-1)" "unprognostic (7.23e-3)" "unprognostic (1.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.62e-1)" "prognostic favorable (2.54e-4)" "unprognostic (1.19e-3)" "unprognostic (1.67e-3)" "unprognostic (1.91e-3)" "unprognostic (5.30e-2)" 1.8 2.7 13.4 1.4 19.2 0.8 3.5 3.8 11.6 2.2 1.0 6.7 0.4 0.9 3.4 9.1 1.6 17.8 3.5 1.1 12.9 10.0 6.6 0.8 5.1 1.3 8.8 9.3 4.7 2.4 0.9 27.8 1.1 13.0 3.1 1.0 2.7 2.6 2.8 0.8 0.9 1.2 1.5 3.2 5.5 1.1 7.4 8.0 1.4 30.0 0.0 1.6 3.0 1.0 0.7 0.0 0.0 0.0 1.2 4.4 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.2 0.0 0.1 0.3 0.1 0.0 0.0 4.0 0.0 1.1 0.0 0.0 3.7 0.0 0.0 0.1 0.0 4.4 0.0 0.1 0.0 0.0 0.3 2.0 0.0 0.0 8.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.1 0.0 15.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.2 0.8 0.0 0.7 1.1 4.4 0.0 1.2 0.0 0.0 0.3 0.1 13.4 19.2 3.8 10.0 12.9 10.0 8.8 9.3 13.0 8.0 14.9 15.9 0.0 6.7 0.5 20.3 0.8 12.7 163.3 30.7 3.5 15.7 0.4 0.0 10.2 19.7 3.8 0.0 0.0 1.4 3.6 0.9 1.1 1.1 0.0 0.3 0.0 0.0 1.3 0.0 11.0 2.0 0.5 0.0 0.0 0.0 0.2 1.7 0.0 5.6 7.9 1.8 0.0 0.3 23.3 27.1 0.3 0.2 0.0 0.0 2.6 IRAK4 NY-REN-64 ENSG00000198001 "Interleukin 1 receptor associated kinase 4" Q9NWZ3 12 43758944-43789543 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016685, CAB022077" Uncertain Approved Nucleoli,Microtubules,Cytosol NA NA Microtubules "Nucleoli, Cytosol" "CAB016685: AB_1618505, CAB022077: " "unprognostic (2.76e-2)" "unprognostic (5.63e-2)" "unprognostic (1.47e-2)" "prognostic favorable (3.46e-5)" "unprognostic (6.15e-2)" "unprognostic (3.50e-3)" "unprognostic (1.44e-2)" "unprognostic (8.49e-2)" "unprognostic (6.44e-3)" "unprognostic (7.50e-2)" "unprognostic (4.00e-3)" "unprognostic (6.29e-2)" "unprognostic (4.52e-2)" "unprognostic (2.95e-1)" "unprognostic (2.31e-1)" "unprognostic (1.84e-1)" "prognostic favorable (4.42e-5)" 18.0 9.4 5.1 15.0 10.4 10.3 11.3 3.7 6.0 10.3 12.2 9.1 12.5 10.2 13.0 14.1 15.0 9.4 10.8 7.6 6.7 5.2 13.3 11.8 12.0 24.0 13.2 3.9 9.3 20.1 9.1 16.1 14.0 9.8 10.5 10.0 11.9 11.9 15.1 4.1 15.2 15.0 11.8 13.0 25.0 12.3 7.1 11.7 30.3 17.0 7.7 18.9 11.1 10.7 5.1 5.8 16.9 6.0 8.8 7.7 4.7 5.3 4.0 2.8 3.7 10.2 17.2 4.0 7.6 5.4 6.0 5.5 3.4 5.2 9.2 7.5 6.3 4.0 4.4 3.1 4.9 8.7 13.2 2.9 8.8 3.1 2.1 5.8 12.1 10.8 9.1 7.8 7.6 4.5 10.6 8.9 9.0 8.1 6.9 16.6 2.9 10.5 6.8 1.0 0.0 4.7 7.0 3.4 4.8 4.7 5.1 2.0 2.0 3.7 4.7 3.6 4.0 5.9 10.8 7.9 7.4 1.4 9.1 5.2 8.4 10.9 8.0 7.7 32.7 4.1 16.9 4.6 9.4 7.4 5.4 7.7 4.0 6.1 6.3 4.5 5.1 5.5 5.9 9.3 8.8 6.0 5.8 7.5 4.7 5.1 10.4 3.7 6.0 6.7 5.2 13.2 3.9 9.8 11.7 17.9 17.0 15.7 9.4 9.6 5.7 4.1 22.9 6.7 10.3 31.4 19.6 12.5 18.3 10.9 12.6 12.4 13.8 0.0 15.4 7.3 9.3 8.1 20.9 7.3 15.2 7.9 3.5 12.9 29.8 16.3 11.5 22.9 10.1 18.0 9.3 9.1 12.5 5.8 10.6 11.3 25.0 6.5 8.6 27.0 12.6 10.3 23.3 41.5 7.8 11.2 IRF4 "LSIRF, MUM1" ENSG00000137265 "Interferon regulatory factor 4" Q15306 6 391739-411447 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 48.7" "Group enriched" "Detected in some" 6 "Melanocytes: 42.2;monocytes: 92.8" "Cancer enriched" "Detected in many" 9 "melanoma: 27.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 9.5;myeloid DC: 9.0;naive B-cell: 9.7;plasmacytoid DC: 10.4;T-reg: 4.8" "Group enriched" "Detected in many" 5 "B-cells: 9.7;dendritic cells: 10.4;T-cells: 4.8" "Cell line enhanced" "Detected in some" "HDLM-2: 50.2;Karpas-707: 46.7;RPMI-8226: 45.1;U-266/70: 42.2;U-266/84: 31.4;WM-115: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002038, HPA002698, CAB013508" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893" "prognostic favorable (6.44e-4)" "unprognostic (1.88e-3)" "unprognostic (1.00e-3)" "unprognostic (1.72e-4)" "unprognostic (2.74e-1)" "prognostic favorable (1.64e-6)" "unprognostic (4.72e-2)" "unprognostic (1.05e-1)" "unprognostic (1.89e-2)" "unprognostic (5.74e-4)" "unprognostic (8.51e-2)" "unprognostic (1.12e-1)" "unprognostic (9.18e-7)" "unprognostic (2.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.90e-1)" "unprognostic (3.65e-2)" 7.1 0.5 0.4 36.6 0.4 18.4 4.0 0.4 0.4 17.4 13.9 0.1 0.4 5.0 2.2 0.7 6.4 1.2 4.1 1.6 0.4 0.5 1.4 5.6 4.2 31.5 0.5 0.0 1.9 0.7 0.0 0.7 0.5 0.1 1.5 4.8 15.8 21.3 1.9 0.7 4.5 11.1 0.3 0.6 33.8 4.6 1.7 0.1 15.2 1.3 2.4 48.7 8.4 4.2 9.7 10.4 0.0 1.6 0.2 4.8 1.3 0.1 0.0 0.0 0.0 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.9 0.0 45.1 0.0 0.0 0.1 0.0 0.0 0.0 7.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.2 31.4 13.7 0.0 0.0 25.6 0.0 1.6 0.0 0.6 1.2 0.0 9.5 0.9 0.9 9.0 9.7 1.6 0.7 0.0 0.2 1.2 10.4 4.8 1.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.0 0.1 0.1 0.0 4.0 12.0 0.1 7.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.0 0.6 0.2 0.0 0.2 0.2 0.0 0.0 1.8 0.0 0.0 3.1 6.9 42.2 92.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 3.8 0.1 6.2 0.0 0.0 IRX4 ENSG00000113430 "Iroquois homeobox 4" P78413 5 1877413-1887236 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 11.2;heart muscle: 11.0;skin 1: 14.2" "Cell type enhanced" "Detected in some" 21 "Basal keratinocytes: 43.0;Glandular cells: 12.7;Suprabasal keratinocytes: 17.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 19 "pons and medulla: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 31.0;HaCaT: 11.5;HBEC3-KT: 6.4;MCF7: 5.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 12 "pons and medulla: 1.9" HPA064094 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA064094: " "unprognostic (1.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (1.35e-2)" "unprognostic (2.77e-1)" "unprognostic (1.53e-1)" "unprognostic (1.35e-1)" "unprognostic (7.52e-2)" "unprognostic (7.54e-2)" "unprognostic (4.26e-1)" "unprognostic (1.70e-2)" 0.2 0.2 0.1 0.1 0.1 0.3 5.1 0.1 0.2 2.4 0.1 0.1 0.1 0.1 0.1 0.1 11.2 0.1 0.1 11.0 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.1 2.7 7.8 0.1 0.1 6.7 0.1 1.2 14.2 0.1 1.0 0.1 0.1 0.1 1.7 0.1 0.1 0.1 2.5 2.1 0.1 7.3 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.5 0.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.7 0.0 0.1 3.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 2.7 0.1 0.0 0.0 0.0 4.2 43.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.6 12.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 17.7 3.1 0.0 0.0 1.3 ITGAV "CD51, MSK8, VNRA, VTNR" ENSG00000138448 "Integrin subunit alpha V" P06756 2 186590065-186680901 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.7" "Group enriched" "Detected in many" 4 "granulocytes: 7.7;monocytes: 2.3" "Cell line enhanced" "Detected in many" "RT4: 71.7;SuSa: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002499, HPA004856" Supported Approved "Focal adhesion sites,Cytosol" NA NA 750000 "Focal adhesion sites, Cytosol" "CAB002499: AB_563594, HPA004856: AB_1846316" "unprognostic (4.03e-2)" "unprognostic (5.17e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (1.33e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (1.48e-2)" "unprognostic (6.95e-2)" "unprognostic (2.89e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (5.84e-2)" "unprognostic (2.67e-2)" "prognostic unfavorable (1.05e-6)" "unprognostic (2.61e-1)" "unprognostic (9.11e-2)" "unprognostic (8.07e-2)" 23.2 22.1 17.9 18.3 21.8 3.1 25.8 16.7 23.1 22.9 13.6 23.4 11.6 8.4 26.0 11.4 14.2 14.5 25.2 40.7 16.8 12.3 51.5 9.5 20.6 7.6 24.2 11.6 35.4 18.7 65.0 11.0 29.6 22.1 16.5 11.9 83.4 17.9 15.9 13.1 21.5 10.1 29.6 33.0 12.1 17.3 11.2 17.0 7.8 33.1 10.9 11.1 17.6 17.9 0.3 0.9 7.7 2.3 0.4 1.1 0.5 9.3 11.1 7.4 23.7 27.3 18.5 28.3 18.3 14.8 6.5 6.5 9.7 32.2 0.0 36.1 20.6 22.7 11.7 3.8 17.2 9.4 1.8 3.4 2.2 14.6 13.3 10.8 1.5 1.4 13.4 8.2 14.4 12.3 39.0 15.4 1.1 2.1 4.7 17.2 3.7 0.9 1.3 5.6 5.6 5.6 0.0 15.2 1.2 16.8 71.7 1.5 4.6 21.1 6.5 7.7 62.1 5.1 4.3 46.8 40.2 12.6 8.2 15.4 1.1 1.9 1.0 16.2 0.6 19.8 7.7 1.1 1.6 1.0 2.3 0.7 0.3 0.5 0.8 0.9 0.1 0.5 0.5 0.5 0.4 1.2 0.4 1.1 0.5 17.9 21.8 16.7 17.3 16.8 12.3 24.2 11.6 22.1 17.0 26.8 18.5 2.4 54.8 114.0 118.2 124.7 73.9 12.0 20.5 73.3 72.6 46.9 1.7 78.4 0.5 50.4 13.2 0.0 89.0 21.8 61.3 83.9 49.5 15.8 26.1 14.3 7.0 34.4 33.9 1.6 17.8 18.2 43.9 20.8 18.9 82.5 120.4 18.2 24.4 16.5 54.8 32.3 47.2 0.7 1.4 90.7 33.2 6.9 11.4 48.6 ITGB3 "CD61, GP3A, GPIIIa" ENSG00000259207 "Integrin subunit beta 3" P05106 17 47253846-47311816 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 36.6" "Cell type enhanced" "Detected in some" 10 "Late spermatids: 4.1;Proximal tubular cells: 3.5;Sertoli cells: 6.5" "Group enriched" "Detected in many" 6 "melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 19 "basophil: 2.8;neutrophil: 2.8" "Lineage enriched" "Detected in single" 19 "granulocytes: 2.8" "Cell line enhanced" "Detected in many" "EFO-21: 46.6;HEL: 41.2;RPTEC TERT1: 26.8;U-87 MG: 21.1;WM-115: 67.2" HPA027852 Approved Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 710000000 "Plasma membrane" Nucleoplasm "HPA027852: AB_10601760" "unprognostic (1.13e-2)" "unprognostic (1.97e-3)" "unprognostic (2.47e-1)" "unprognostic (3.00e-2)" "unprognostic (1.91e-2)" "unprognostic (6.04e-3)" "unprognostic (3.70e-1)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (3.85e-1)" "unprognostic (6.35e-2)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.03e-2)" "unprognostic (2.72e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-3)" 10.0 0.6 1.0 6.2 2.5 2.7 7.0 0.4 1.6 4.6 13.6 0.9 2.4 2.2 9.7 5.7 6.4 6.4 2.8 8.5 0.7 0.6 16.0 3.7 5.2 1.2 2.3 0.1 4.6 0.6 0.7 1.6 23.5 1.6 6.4 4.8 1.8 2.5 11.5 4.9 2.4 5.0 17.0 1.8 9.5 3.6 2.6 0.6 0.2 36.6 1.9 0.9 11.0 7.8 0.1 0.0 2.8 0.1 0.0 0.0 9.5 0.0 0.4 0.1 0.0 2.4 1.0 0.0 1.2 6.1 2.6 2.4 0.0 0.0 0.1 46.6 0.3 3.6 0.0 0.0 0.0 3.4 0.9 0.0 41.2 0.1 0.0 2.0 0.0 0.0 1.0 0.0 15.6 0.4 1.8 11.6 0.6 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.0 26.8 0.0 0.0 0.1 1.5 0.0 8.4 2.4 0.0 0.0 12.6 0.5 0.7 0.3 2.8 0.0 0.0 0.3 21.1 0.0 67.2 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 9.5 1.0 2.5 0.4 1.6 0.7 0.6 2.3 0.1 1.6 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.1 2.7 1.4 0.0 0.0 0.4 0.0 0.8 0.1 0.0 0.8 0.8 0.0 0.0 1.8 0.0 4.1 0.3 0.3 0.0 0.0 0.0 0.0 1.0 0.0 1.1 3.5 0.0 6.5 1.9 0.0 2.3 0.4 1.0 0.0 0.0 0.1 ITGB5 ENSG00000082781 "Integrin subunit beta 5" P18084 3 124761948-124901418 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 71.2;hTERT-RPE1: 81.6;WM-115: 74.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001820, CAB022050" Approved Approved "Plasma membrane,Mitochondria" NA NA 95000 "Plasma membrane, Mitochondria" "CAB022050: , HPA001820: AB_1079142" "unprognostic (2.63e-1)" "unprognostic (1.04e-1)" "unprognostic (3.57e-1)" "unprognostic (4.44e-2)" "unprognostic (1.37e-2)" "unprognostic (6.07e-2)" "unprognostic (3.49e-3)" "unprognostic (3.16e-3)" "unprognostic (1.68e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.16e-1)" "unprognostic (2.16e-3)" "unprognostic (2.49e-3)" "unprognostic (1.12e-1)" "unprognostic (1.01e-1)" "unprognostic (4.38e-3)" 72.5 13.8 9.7 9.7 10.0 0.8 50.1 5.7 8.2 34.2 18.8 14.8 28.0 12.9 31.7 17.2 25.6 13.9 29.1 32.9 9.4 5.1 19.6 22.1 20.4 3.5 12.0 6.2 17.4 12.1 8.9 8.4 36.4 13.0 23.0 10.1 27.1 18.6 23.1 15.9 33.3 16.1 25.1 9.0 18.7 12.4 17.0 8.7 2.8 18.8 16.2 10.9 24.4 27.1 0.1 1.1 0.4 0.6 0.9 2.1 5.8 28.5 71.2 5.1 12.9 48.3 14.1 26.4 30.6 19.0 5.7 9.2 14.2 37.3 0.1 14.9 51.9 28.1 22.9 4.6 15.9 5.0 0.3 3.1 10.1 11.0 14.9 8.4 0.0 18.5 8.4 3.7 14.3 7.5 81.6 19.1 0.0 9.0 15.3 19.5 29.0 0.1 0.1 22.9 16.0 7.9 0.0 8.2 10.7 16.1 6.3 0.1 10.7 22.7 33.8 25.8 9.4 19.1 0.6 49.1 21.5 32.5 18.6 15.8 2.6 2.7 0.1 22.5 0.1 74.2 0.4 0.6 0.2 2.1 0.2 0.0 0.0 0.2 0.0 1.1 0.1 0.3 0.4 0.4 0.9 0.4 0.1 0.0 5.8 9.7 10.0 5.7 8.2 9.4 5.1 12.0 6.2 13.0 8.7 6.0 7.9 2.2 18.8 15.2 6.2 26.4 43.3 5.3 10.3 27.9 3.9 56.6 10.0 34.5 7.5 22.6 19.6 0.0 16.3 4.7 30.7 22.0 0.0 32.1 60.3 33.4 3.4 41.1 27.6 2.3 18.7 16.7 10.1 0.0 13.3 47.4 43.9 27.4 15.6 10.2 15.2 38.8 35.3 1.4 6.4 19.4 46.1 0.0 15.0 12.0 ITGB6 ENSG00000115221 "Integrin subunit beta 6" P18564 2 160099666-160200313 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Amelogenesis imperfecta, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 62.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 142.9;Alveolar cells type 2: 159.2;Pancreatic endocrine cells: 133.9;Spermatocytes: 219.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.5;RPTEC TERT1: 74.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023626, CAB073536" Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" NA NA "Nucleoplasm, Cell Junctions" Centrosome "CAB073536: , HPA023626: AB_2671267" "unprognostic (1.27e-1)" "unprognostic (1.57e-2)" "unprognostic (6.90e-2)" "unprognostic (8.22e-3)" "unprognostic (3.61e-3)" "unprognostic (1.50e-2)" "unprognostic (1.72e-3)" "unprognostic (2.04e-2)" "unprognostic (1.72e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (5.03e-6)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (1.00e-1)" 0.3 0.3 0.3 3.1 0.3 0.0 8.7 0.3 0.3 4.1 8.3 0.1 4.5 3.5 2.1 2.5 18.7 1.2 12.0 0.7 0.3 0.3 62.1 0.3 28.8 0.1 0.3 0.1 1.5 3.8 7.0 2.2 18.7 0.2 7.5 3.0 0.1 3.8 4.8 31.5 1.9 11.7 2.0 0.3 0.3 7.9 0.6 0.1 0.1 4.9 6.8 5.9 12.8 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 37.5 0.0 0.2 0.0 0.0 7.7 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 2.4 0.0 0.0 2.9 0.0 74.9 12.4 0.0 0.0 0.0 11.8 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 142.9 159.2 0.0 106.9 9.3 0.0 37.4 10.2 8.1 77.3 68.0 0.0 6.6 0.0 51.3 71.2 2.2 10.3 0.0 92.6 5.2 3.3 42.3 3.5 0.8 2.0 0.0 0.0 1.8 0.8 24.4 2.6 2.5 1.7 3.6 14.1 0.8 133.9 21.0 1.1 0.2 0.0 0.0 2.7 219.5 2.4 7.4 3.9 0.0 11.2 104.4 ITGB7 ENSG00000139626 "Integrin subunit beta 7" P26010 12 53191318-53207307 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.3;lymphoid tissue: 37.6" "Cell type enhanced" "Detected in many" 10 "B-cells: 35.7;granulocytes: 29.9;T-cells: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 99 "Karpas-707: 295.2;RPMI-8226: 230.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA042277 Approved "Nucleoplasm,Nuclear membrane,Vesicles,Plasma membrane,Cytosol" NA NA 42000 "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear membrane, Vesicles" "HPA042277: AB_10793877" "unprognostic (5.34e-2)" "unprognostic (4.47e-2)" "unprognostic (2.80e-3)" "unprognostic (1.40e-2)" "unprognostic (6.57e-4)" "unprognostic (3.51e-5)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.58e-1)" "unprognostic (2.18e-1)" "unprognostic (9.63e-3)" "unprognostic (3.36e-1)" "unprognostic (1.02e-2)" "unprognostic (2.16e-1)" "unprognostic (6.95e-2)" "unprognostic (9.34e-2)" "unprognostic (2.47e-4)" 1.8 1.4 1.4 29.1 1.8 7.5 1.5 0.6 1.2 1.8 8.7 2.9 0.8 6.7 2.3 2.8 6.6 2.0 5.6 1.4 1.5 1.0 5.4 5.1 4.9 26.4 1.9 1.0 1.1 1.3 0.7 1.7 1.8 2.4 2.7 5.6 2.1 10.7 2.2 1.0 6.4 15.1 1.5 2.0 26.7 4.3 0.9 2.0 7.8 3.6 4.4 37.6 4.6 3.0 10.1 15.4 31.3 1.9 7.5 23.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 295.2 0.0 0.0 0.0 0.4 0.0 2.4 0.0 0.1 0.0 230.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.2 0.2 0.1 0.1 22.6 1.9 31.3 19.3 0.5 14.3 10.1 19.4 23.0 15.4 8.3 16.3 17.1 0.5 7.5 0.1 4.2 22.7 5.2 1.4 1.8 0.6 1.2 1.5 1.0 1.9 1.0 2.4 2.0 3.0 8.5 35.7 0.3 1.9 0.0 0.4 2.5 0.0 0.0 7.0 3.9 0.1 6.6 0.2 0.0 0.1 0.0 0.0 0.5 0.1 1.0 0.1 29.9 1.6 13.8 0.0 0.0 0.6 3.0 0.0 0.0 7.0 6.8 7.2 0.3 6.6 0.6 0.0 0.0 4.4 0.7 0.0 0.4 0.2 1.1 3.1 0.1 27.7 0.9 1.3 ITK "EMT, LYK, PSCTK2" ENSG00000113263 "IL2 inducible T cell kinase" Q08881 5 157142933-157255191 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 28.0;lymphoid tissue: 60.5" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 2: 10.4;granulocytes: 32.2;T-cells: 47.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 28 "gdT-cell: 13.8;MAIT T-cell: 9.1;memory CD4 T-cell: 19.5;memory CD8 T-cell: 18.9;naive CD4 T-cell: 28.0;naive CD8 T-cell: 22.8;NK-cell: 9.2;T-reg: 23.1" "Group enriched" "Detected in many" 29 "NK-cells: 9.2;T-cells: 28.0" "Group enriched" "Detected in some" 9 "JURKAT: 36.5;MOLT-4: 13.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA043670 Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043670: " "unprognostic (2.08e-3)" "unprognostic (6.57e-4)" "unprognostic (5.06e-3)" "unprognostic (4.96e-5)" "unprognostic (1.52e-2)" "unprognostic (1.12e-4)" "unprognostic (8.45e-4)" "unprognostic (1.56e-2)" "unprognostic (1.87e-2)" "unprognostic (5.99e-3)" "unprognostic (1.76e-1)" "unprognostic (2.52e-1)" "unprognostic (4.52e-6)" "unprognostic (3.64e-1)" "unprognostic (4.42e-2)" "unprognostic (1.46e-1)" "unprognostic (3.26e-2)" 2.3 0.7 0.5 12.2 0.6 2.5 1.3 1.9 0.5 1.4 3.3 0.0 0.0 0.5 1.2 1.1 1.8 1.4 4.3 0.9 0.5 0.5 1.4 1.2 6.6 60.5 0.9 0.0 0.7 0.7 0.0 0.9 0.1 0.3 1.1 1.3 1.5 3.5 1.1 0.5 1.0 8.9 0.4 1.2 10.7 2.3 1.4 0.0 60.3 1.6 2.7 24.3 4.1 1.3 0.0 0.0 0.4 0.6 9.2 28.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 36.5 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 13.8 0.0 9.1 0.0 19.5 18.9 0.0 0.0 28.0 22.8 0.4 9.2 0.6 0.0 23.1 13.6 0.5 0.6 1.9 0.5 0.5 0.5 0.9 0.0 0.3 0.0 0.0 10.4 0.0 0.6 2.4 0.0 0.8 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 32.2 0.6 0.0 0.0 0.0 1.8 0.6 5.5 0.0 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.0 3.0 0.1 47.3 0.0 0.4 ITPR2 "CFAP48, IP3R2" ENSG00000123104 "Inositol 1,4,5-trisphosphate receptor type 2" Q14571 12 26336515-26833198 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 137.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059144, HPA062260" Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoplasm "HPA059144: AB_2683925, HPA062260: AB_2684728" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-1)" "unprognostic (2.25e-1)" "unprognostic (2.37e-2)" "unprognostic (3.59e-3)" "unprognostic (8.70e-2)" "unprognostic (1.66e-1)" "unprognostic (8.61e-2)" "unprognostic (2.06e-2)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (2.82e-1)" "unprognostic (9.13e-2)" "unprognostic (3.99e-2)" "unprognostic (3.76e-1)" 8.8 20.6 12.8 14.5 13.8 6.1 18.5 9.3 15.0 7.9 9.9 7.8 3.7 6.0 7.2 7.8 12.0 7.3 8.0 7.1 14.2 6.0 14.4 47.1 6.5 8.1 12.8 4.6 8.0 9.2 17.4 9.9 11.9 13.0 6.6 7.8 4.8 17.6 3.8 4.7 13.3 8.9 5.4 20.3 12.5 5.9 3.4 15.3 35.3 5.3 6.6 10.7 5.5 8.1 4.3 9.0 17.3 5.2 3.6 3.1 0.7 2.7 1.2 1.6 2.6 5.0 5.1 1.8 2.5 3.5 1.8 1.9 0.1 1.4 9.4 1.6 3.4 1.9 3.0 8.7 5.3 2.4 2.2 2.9 7.5 2.5 15.1 4.6 6.7 3.4 4.8 0.7 3.7 7.0 3.5 16.6 3.7 3.3 3.0 2.2 2.3 4.7 9.0 7.2 2.4 0.9 1.5 3.9 5.9 4.1 4.3 0.5 2.6 11.4 2.1 6.3 7.0 4.3 3.3 36.3 3.6 1.4 3.4 3.2 2.8 2.1 17.6 3.3 3.1 2.3 17.3 5.2 7.1 2.4 2.2 2.0 4.2 2.1 1.9 1.0 4.3 2.5 2.2 13.5 3.6 3.0 9.0 3.1 0.7 12.8 13.8 9.3 15.0 14.2 6.0 12.8 4.6 13.0 15.3 44.7 38.7 25.7 17.2 18.5 3.1 19.1 35.7 8.1 13.6 22.7 137.4 16.2 6.6 19.4 2.6 26.3 10.3 23.3 20.5 7.7 11.6 22.1 43.8 96.9 31.6 0.0 75.3 16.5 35.2 4.7 16.7 48.3 32.1 6.4 36.5 12.6 14.9 35.3 16.6 14.6 67.9 0.0 11.7 2.8 4.9 23.3 23.3 16.0 8.4 14.6 ITPR3 IP3R3 ENSG00000096433 "Inositol 1,4,5-trisphosphate receptor type 3" Q14573 6 33620365-33696574 "Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 129.4;Late spermatids: 168.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "basophil: 1.8;gdT-cell: 2.8;MAIT T-cell: 2.1;memory B-cell: 1.5;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.0;naive B-cell: 2.0;naive CD4 T-cell: 1.4;naive CD8 T-cell: 1.7;T-reg: 2.4" "Group enriched" "Detected in many" 10 "B-cells: 2.0;granulocytes: 1.8;T-cells: 2.8" "Cell line enhanced" "Detected in many" "hTERT-HME1: 52.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA003915, HPA064704" Approved Uncertain Vesicles No No Vesicles "HPA003915: AB_1851845, HPA064704: " "unprognostic (2.57e-1)" "unprognostic (2.81e-2)" "unprognostic (1.52e-2)" "unprognostic (2.30e-1)" "unprognostic (5.40e-2)" "unprognostic (1.24e-1)" "unprognostic (2.08e-2)" "unprognostic (6.14e-2)" "unprognostic (3.35e-1)" "unprognostic (3.08e-2)" "unprognostic (4.14e-3)" "unprognostic (1.88e-1)" "unprognostic (6.44e-3)" "unprognostic (5.01e-2)" "unprognostic (1.74e-1)" "unprognostic (8.89e-2)" "unprognostic (2.43e-2)" 7.8 6.0 2.0 17.8 2.4 2.6 9.0 1.7 2.3 6.5 39.6 1.0 35.1 14.8 7.7 15.6 10.0 6.7 28.9 7.2 1.8 1.4 8.6 1.2 21.0 9.7 4.4 1.2 7.3 11.0 1.3 3.9 3.9 4.0 7.2 9.5 5.4 12.7 26.0 2.7 27.9 44.0 6.6 3.5 20.0 21.4 20.1 1.9 10.6 28.4 9.7 18.1 5.2 16.5 2.0 0.2 1.8 0.0 0.1 2.8 0.7 21.8 10.3 1.9 0.1 1.9 6.2 12.8 7.5 19.4 9.5 8.6 14.1 17.1 18.7 8.2 5.4 23.9 21.7 8.8 20.4 4.9 10.9 7.3 0.0 29.3 15.5 4.5 3.3 2.4 4.4 18.5 23.9 52.0 20.9 16.0 7.5 7.3 6.1 10.2 10.4 5.6 1.9 1.9 16.7 15.2 8.6 0.0 11.0 33.8 15.4 17.9 0.6 13.0 19.1 18.7 2.2 6.5 1.8 21.8 12.9 6.4 16.5 16.5 4.2 4.1 8.9 10.3 5.0 7.4 1.8 0.0 0.0 2.8 0.0 2.1 1.5 1.7 2.0 0.2 2.0 1.4 1.7 0.0 0.1 0.0 0.0 2.4 0.7 2.0 2.4 1.7 2.3 1.8 1.4 4.4 1.2 4.0 1.9 44.7 47.5 4.3 10.4 23.6 0.6 1.6 7.6 8.1 18.2 29.6 0.0 0.2 0.0 25.3 129.4 13.2 36.8 0.0 26.2 5.4 5.0 12.7 0.0 0.2 0.5 0.0 23.0 15.4 0.6 168.6 21.6 3.3 11.8 4.6 35.8 0.2 62.5 35.1 13.1 0.0 1.2 6.5 2.0 1.1 3.0 22.2 0.5 10.0 30.7 15.4 ITPRIP "bA127L20.2, DANGER, KIAA1754" ENSG00000148841 "Inositol 1,4,5-trisphosphate receptor interacting protein" Q8IWB1 10 104309698-104338404 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 81.5" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 42.1;Ito cells: 85.3;Suprabasal keratinocytes: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 24.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 24.1" "Cell line enhanced" "Detected in many" "hTCEpi: 38.6" "Low region specificity" "Detected in all" HPA043626 Uncertain Vesicles NA NA Vesicles "HPA043626: AB_10963078" "unprognostic (2.45e-2)" "unprognostic (3.06e-1)" "unprognostic (1.59e-2)" "unprognostic (3.22e-2)" "unprognostic (1.08e-2)" "unprognostic (4.20e-1)" "unprognostic (7.87e-2)" "prognostic unfavorable (3.59e-4)" "unprognostic (9.74e-2)" "unprognostic (1.87e-1)" "unprognostic (2.64e-2)" "unprognostic (4.00e-2)" "unprognostic (5.37e-3)" "unprognostic (1.01e-3)" "unprognostic (2.65e-1)" "unprognostic (2.75e-1)" "unprognostic (2.11e-3)" 23.7 5.8 3.5 7.4 3.8 81.5 20.8 0.5 4.3 13.5 5.5 4.5 6.8 1.6 8.5 6.0 29.5 5.6 9.8 33.8 3.0 1.5 6.9 7.2 20.2 9.8 4.4 1.5 19.9 4.4 4.4 7.3 24.4 4.7 8.6 2.5 21.7 6.7 7.3 7.6 26.4 3.8 8.4 3.4 8.8 5.6 8.4 5.2 12.9 14.0 14.6 14.2 13.6 17.3 2.4 4.4 24.1 5.7 3.2 3.4 9.7 2.3 5.8 7.1 3.2 12.4 12.0 4.1 13.2 27.9 9.6 12.0 0.4 1.0 4.1 3.0 8.1 19.2 7.7 2.3 6.3 10.0 3.6 2.9 2.4 9.3 1.7 24.5 5.5 4.6 11.1 38.6 20.0 16.1 11.2 17.9 4.2 10.3 7.9 11.7 0.9 1.1 6.0 5.3 0.8 6.9 5.1 3.7 2.4 3.9 1.0 4.0 2.7 2.4 2.9 5.7 4.5 0.2 4.2 30.9 19.5 5.1 12.8 12.5 3.0 3.5 2.7 14.3 10.0 9.1 3.5 5.7 9.9 3.4 4.1 3.3 1.9 1.9 1.9 4.4 2.4 2.3 2.0 24.1 3.2 3.7 3.1 1.5 9.7 3.5 3.8 0.5 4.3 3.0 1.5 4.4 1.5 4.7 5.2 3.0 8.8 7.2 17.3 33.7 0.0 5.3 0.0 2.7 5.7 3.5 0.0 5.0 0.0 3.4 4.5 42.1 0.7 23.3 2.1 16.6 10.8 4.5 20.7 1.8 9.8 0.0 0.0 85.3 15.5 0.4 4.6 14.4 8.5 1.0 2.6 2.7 2.5 0.0 5.3 0.6 0.6 12.9 13.0 2.2 1.4 63.6 4.2 13.1 1.6 16.1 ITSN2 "KIAA1256, PRO2015, SH3D1B, SH3P18, SWA, SWAP" ENSG00000198399 "Intersectin 2" Q9NZM3 2 24202864-24360714 "Predicted intracellular proteins" "Differentiation, Endocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036475 Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA036475: AB_10670718" "unprognostic (2.36e-1)" "unprognostic (1.28e-1)" "unprognostic (1.24e-1)" "unprognostic (5.95e-2)" "unprognostic (4.64e-1)" "prognostic favorable (2.98e-4)" "unprognostic (3.32e-2)" "unprognostic (3.83e-2)" "unprognostic (2.77e-1)" "unprognostic (1.66e-1)" "unprognostic (2.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.66e-1)" "unprognostic (2.39e-1)" "unprognostic (2.72e-2)" "unprognostic (2.41e-2)" "unprognostic (2.12e-2)" 16.8 18.8 13.4 30.7 14.8 41.4 16.6 15.2 18.3 17.4 16.8 11.5 17.9 11.3 15.1 11.8 31.4 13.3 12.6 17.3 12.0 10.3 15.3 17.7 23.6 31.7 15.0 11.7 16.4 42.6 16.1 27.2 15.9 14.3 19.1 13.5 9.9 17.2 17.2 23.5 20.5 20.2 18.0 13.3 27.8 16.2 9.6 17.0 27.0 35.1 15.6 31.8 19.8 22.9 27.2 10.6 43.0 20.4 8.9 13.0 6.8 16.3 8.0 2.0 5.9 5.8 7.8 18.0 10.0 9.4 4.6 5.6 7.7 8.7 25.4 8.8 8.2 13.7 7.4 9.0 6.3 7.7 20.1 8.4 34.5 4.9 8.6 9.8 17.6 19.9 6.0 7.4 8.1 14.2 8.9 14.5 9.7 9.8 19.4 7.2 6.7 7.2 8.7 3.7 10.0 7.9 9.1 23.2 7.5 8.2 30.8 1.3 4.1 7.9 8.5 12.0 8.4 5.8 9.5 19.9 9.9 8.7 8.2 9.2 21.2 23.4 26.6 7.9 16.4 8.6 20.6 11.4 19.9 12.4 13.9 13.0 24.1 10.8 10.8 10.6 27.2 11.0 9.9 43.0 8.9 20.4 7.0 11.2 6.8 13.4 14.8 15.2 18.3 12.0 10.3 15.0 11.7 14.3 17.0 89.3 88.9 91.3 70.6 45.9 22.7 60.0 28.1 38.8 61.4 27.9 19.6 21.9 14.9 44.1 3.8 51.3 36.0 23.3 66.3 28.1 26.7 69.2 100.6 25.2 37.6 12.7 23.5 39.3 73.8 3.3 27.9 98.8 23.6 86.6 22.0 17.9 67.9 45.6 17.0 28.3 34.8 12.9 26.8 64.6 43.3 50.7 20.3 66.0 19.3 94.5 JAML "AMICA, AMICA1, Gm638" ENSG00000160593 "Junction adhesion molecule like" Q86YT9 11 118193740-118225094 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 202.6" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 48.3;Kupffer cells: 117.5;Macrophages: 185.0;T-cells: 45.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 202.6" "Group enriched" "Detected in many" 4 "dendritic cells: 60.5;granulocytes: 202.6;monocytes: 59.0" "Cell line enriched" "Detected in some" 5 "HMC-1: 24.9" "Region enriched" "Detected in single" 9 "cerebellum: 7.0" "Region enriched" "Detected in many" 12 "cerebellum: 113.6" "HPA005854, HPA047919" Approved Supported "Nucleoplasm,Plasma membrane" NA NA 1400000 "Plasma membrane" Nucleoplasm "HPA005854: , HPA047919: AB_2680209" "unprognostic (3.91e-3)" "unprognostic (1.55e-3)" "unprognostic (3.00e-2)" "unprognostic (1.28e-3)" "unprognostic (2.87e-3)" "prognostic favorable (3.11e-4)" "unprognostic (2.80e-1)" "prognostic favorable (3.92e-4)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (8.69e-2)" "unprognostic (5.08e-1)" "unprognostic (6.43e-3)" "unprognostic (8.96e-2)" "unprognostic (3.12e-2)" "unprognostic (4.10e-2)" "unprognostic (1.58e-2)" 6.7 2.1 0.9 23.1 1.1 6.6 2.1 5.3 0.8 4.1 8.4 0.7 1.3 6.1 3.8 9.6 4.0 3.1 8.9 3.1 0.9 0.9 3.4 4.3 34.4 43.2 3.7 0.5 2.1 1.8 0.0 2.7 4.2 2.3 3.4 8.3 6.7 6.7 1.1 1.0 2.2 14.0 4.7 1.8 43.4 3.9 1.9 0.6 14.3 2.6 5.9 25.0 9.8 3.0 0.3 60.5 202.6 59.0 1.4 25.2 40.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.1 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.7 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.3 2.3 0.3 2.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.0 5.8 59.0 202.6 3.9 36.6 25.2 0.3 7.0 7.4 60.5 0.1 8.3 6.7 126.6 1.4 17.1 46.6 11.1 40.1 0.9 1.1 5.3 0.8 0.9 0.9 3.7 0.5 2.3 0.6 6.0 48.3 15.4 0.1 0.0 0.0 0.0 0.0 4.0 10.3 1.8 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.3 0.2 0.4 0.1 14.0 2.1 29.9 0.0 0.0 8.0 117.5 0.9 0.0 185.0 0.0 11.8 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.1 1.4 0.0 0.3 45.3 0.0 0.1 JMJD4 FLJ12517 ENSG00000081692 "Jumonji domain containing 4" Q9H9V9 1 227730425-227735411 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 59.1;Late spermatids: 160.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027260, HPA052861" Uncertain Uncertain "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA027260: AB_10602608, HPA052861: AB_2681975" "unprognostic (1.80e-1)" "unprognostic (1.37e-1)" "unprognostic (4.86e-2)" "unprognostic (2.29e-1)" "unprognostic (1.43e-1)" "unprognostic (2.86e-1)" "unprognostic (1.23e-1)" "unprognostic (6.19e-2)" "unprognostic (1.74e-2)" "unprognostic (4.31e-2)" "unprognostic (8.69e-3)" "unprognostic (8.68e-3)" "prognostic unfavorable (3.16e-4)" "unprognostic (4.45e-2)" "unprognostic (2.82e-1)" "unprognostic (2.05e-1)" "unprognostic (4.68e-1)" 10.1 17.5 9.6 8.3 8.3 5.9 13.1 10.1 17.1 10.1 12.0 9.7 13.1 7.9 11.7 12.8 10.0 13.5 11.7 11.7 10.0 9.6 8.7 19.8 7.9 25.0 9.7 10.0 14.9 17.5 9.5 14.4 12.0 6.3 12.2 4.6 11.8 18.2 11.6 14.9 9.8 8.7 8.3 7.2 13.7 8.6 20.1 3.2 21.5 9.7 11.1 14.4 8.5 6.8 8.5 11.6 2.9 6.4 13.2 12.7 7.0 10.7 16.0 5.2 5.7 5.7 3.2 19.2 6.8 7.2 10.6 6.6 13.6 9.3 14.5 10.4 6.5 5.7 11.0 3.6 10.9 1.2 7.7 17.2 8.9 7.9 10.5 10.1 9.3 4.4 5.7 6.9 10.1 7.5 4.2 5.4 10.7 11.5 4.9 5.1 9.2 11.4 4.9 9.0 8.3 25.2 10.6 6.4 13.0 6.2 10.2 10.3 6.9 6.5 23.2 8.7 2.8 18.7 10.1 4.7 5.4 5.5 6.5 12.5 9.0 2.8 5.6 5.4 4.5 14.8 2.9 6.4 2.3 10.2 6.4 11.7 8.3 7.9 7.2 5.8 8.5 12.7 11.0 0.6 13.2 3.4 11.6 8.8 7.0 9.6 8.3 10.1 17.1 10.0 9.6 9.7 10.0 6.3 3.2 6.0 7.4 8.1 5.9 3.7 12.2 3.1 5.1 6.7 4.5 7.0 0.0 10.9 5.0 17.7 59.1 4.2 9.7 46.7 25.0 11.7 6.9 8.8 6.9 13.4 14.4 11.1 8.6 5.5 7.9 160.3 10.6 4.3 11.8 14.4 5.8 11.7 19.1 5.5 3.9 9.2 13.7 6.5 4.2 20.2 7.4 4.1 8.0 8.7 6.4 6.7 JMY "FLJ37870, WHAMM2" ENSG00000152409 "Junction mediating and regulatory protein, p53 cofactor" Q8N9B5 5 79236189-79327215 "Predicted intracellular proteins" "DNA damage, DNA repair" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 17.4;Karpas-707: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037508, HPA043308" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA037508: , HPA043308: AB_10806502" "unprognostic (1.87e-2)" "unprognostic (2.12e-3)" "unprognostic (4.28e-1)" "unprognostic (1.79e-1)" "unprognostic (4.30e-2)" "unprognostic (5.28e-3)" "unprognostic (2.10e-2)" "unprognostic (1.16e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "prognostic favorable (3.03e-5)" "unprognostic (7.21e-2)" "unprognostic (3.22e-1)" "unprognostic (1.85e-1)" "unprognostic (4.15e-1)" 8.6 9.2 13.4 5.8 17.0 14.8 10.3 21.7 15.8 13.6 17.8 10.1 13.0 5.8 20.3 12.9 10.0 9.2 8.4 8.5 11.2 8.9 11.5 9.1 7.1 7.6 13.6 13.4 24.7 15.9 24.8 12.5 5.8 11.7 13.5 7.9 9.2 11.9 11.0 15.4 11.9 8.2 13.0 9.7 8.1 9.5 12.0 14.1 10.4 17.7 5.1 7.2 13.5 10.2 0.9 0.8 0.4 0.4 3.7 1.7 0.1 2.4 2.4 1.8 4.8 5.2 4.7 6.5 2.4 6.1 2.2 3.6 1.1 2.7 1.7 17.4 2.6 2.5 2.7 6.5 3.1 3.5 7.5 6.0 3.4 3.8 2.4 7.9 1.5 2.2 4.4 8.5 1.0 9.6 4.5 2.7 4.7 2.0 29.8 1.8 3.3 3.2 3.2 3.0 0.5 1.6 3.2 5.9 7.2 4.7 2.6 7.4 4.0 3.0 3.3 5.5 3.3 2.7 3.2 2.8 0.9 1.6 0.5 1.5 8.5 7.3 1.7 1.9 1.5 1.6 0.0 0.4 0.1 1.4 0.4 0.9 0.9 1.4 1.4 0.1 0.8 1.7 1.2 0.4 3.7 0.3 0.8 1.2 0.1 13.4 17.0 21.7 15.8 11.2 8.9 13.6 13.4 11.7 14.1 8.9 12.2 7.5 10.3 26.6 32.0 32.7 17.8 20.1 14.8 15.7 41.2 5.1 1.7 6.5 23.3 13.0 4.7 0.0 8.5 4.7 16.9 16.5 8.1 13.9 4.0 38.1 23.0 4.9 5.4 15.4 22.5 9.9 21.9 1.0 8.4 17.3 13.0 10.4 33.6 6.5 38.4 12.9 25.5 22.9 41.1 34.8 16.9 17.0 7.3 9.2 JPH4 "JPHL1, KIAA1831" ENSG00000092051 "Junctophilin 4" Q96JJ6 14 23568035-23578800 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.7;seminal vesicle: 37.8" "Group enriched" "Detected in many" 19 "Bipolar cells: 144.6;Horizontal cells: 387.7" "Cancer enhanced" "Detected in some" "glioma: 6.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 5.4;myeloid DC: 5.9" "Group enriched" "Detected in many" 14 "dendritic cells: 5.9;monocytes: 5.4" "Group enriched" "Detected in some" 6 "SCLC-21H: 10.1;SH-SY5Y: 25.2;U-2 OS: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013492 Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013492: " "unprognostic (3.30e-2)" "unprognostic (1.91e-3)" "unprognostic (5.05e-3)" "unprognostic (7.41e-2)" "unprognostic (2.04e-1)" "unprognostic (1.84e-1)" "unprognostic (3.77e-3)" "unprognostic (5.98e-4)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (3.89e-3)" "unprognostic (1.15e-2)" "unprognostic (3.15e-2)" "unprognostic (2.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.13e-2)" "unprognostic (4.96e-3)" 1.9 12.3 33.6 2.0 43.8 1.3 1.6 45.3 63.7 3.4 1.9 2.1 8.0 1.8 17.1 6.2 1.5 5.1 1.6 1.3 32.3 16.8 2.7 1.3 3.4 2.0 8.3 27.6 6.2 1.5 3.1 23.2 1.6 9.8 11.6 1.7 0.8 1.2 37.8 1.2 1.6 2.2 13.9 4.2 2.9 1.7 2.2 10.9 0.0 1.3 0.0 1.7 1.7 1.8 0.0 5.9 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.5 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.5 10.1 25.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 33.6 43.8 45.3 42.6 32.3 16.8 8.3 27.6 9.8 10.9 0.0 1.1 0.0 0.1 0.0 144.6 1.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 1.6 387.7 1.7 2.5 1.3 0.0 10.0 1.8 0.0 0.0 0.0 1.5 0.0 0.0 13.8 0.0 7.7 12.9 0.3 0.4 2.7 0.0 0.0 0.0 0.0 0.8 KALRN "ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD" ENSG00000160145 "Kalirin RhoGEF kinase" O60229 3 124080023-124726325 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;retina: 31.2" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 71.2;Early spermatids: 45.5;Ito cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.3" "Lineage enriched" "Detected in single" 5 "T-cells: 4.3" "Cell line enhanced" "Detected in many" "CACO-2: 32.4;HEL: 19.8;OE19: 11.2;SH-SY5Y: 9.3" "Low region specificity" "Detected in many" "HPA011913, CAB026456" Approved Approved Nucleoplasm,Cytosol NA NA 110000 "Nucleoplasm, Cytosol" "CAB026456: , HPA011913: AB_1850494" "unprognostic (2.54e-2)" "unprognostic (3.43e-1)" "unprognostic (2.08e-1)" "unprognostic (3.12e-4)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (3.41e-2)" "unprognostic (8.58e-2)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "unprognostic (2.26e-3)" "unprognostic (5.58e-2)" "unprognostic (2.67e-1)" "unprognostic (3.70e-2)" "unprognostic (2.81e-3)" 5.5 4.3 12.7 2.4 14.1 0.6 4.2 1.8 35.2 4.0 3.8 3.7 0.5 2.7 5.6 2.3 9.6 4.2 3.1 12.1 17.6 3.9 2.6 7.3 2.9 1.1 4.1 15.8 2.3 11.9 2.5 14.4 6.8 9.4 3.1 2.1 31.2 2.2 5.4 23.5 1.5 7.2 6.4 3.6 8.0 11.5 2.2 2.4 0.0 5.3 6.7 3.1 2.9 4.1 0.1 0.0 0.9 0.0 0.1 4.3 1.2 0.3 0.6 3.6 0.7 0.5 0.1 4.7 1.4 0.9 1.4 0.6 32.4 2.5 0.1 0.4 3.6 2.2 0.2 0.8 0.0 1.1 0.0 0.3 19.8 0.3 4.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.5 1.6 0.0 4.5 0.1 0.4 2.4 0.0 0.0 2.0 11.2 3.2 1.0 1.6 0.0 0.1 0.3 1.2 9.3 0.4 0.3 0.3 3.6 0.7 0.1 8.2 4.1 1.6 0.6 0.6 0.0 0.3 0.0 0.5 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.8 0.3 0.0 0.0 2.4 0.7 0.9 0.1 0.0 0.0 4.3 1.2 12.7 14.1 1.8 35.2 17.6 3.9 4.1 15.8 9.4 2.4 3.0 3.8 0.0 1.4 1.4 71.2 33.4 17.8 8.1 0.0 15.7 5.9 7.3 1.7 4.7 45.5 26.9 30.6 0.0 7.2 0.7 4.8 2.8 3.5 17.4 0.8 0.0 9.2 50.3 2.6 34.6 3.4 0.7 3.3 0.0 12.2 5.4 3.9 20.4 31.1 2.4 2.7 19.4 14.6 1.9 1.7 1.0 11.9 0.7 10.0 1.4 KANK4 "ANKRD38, KIAA0172" ENSG00000132854 "KN motif and ankyrin repeat domains 4" Q5T7N3 1 62236979-62319414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4" "Cell type enhanced" "Detected in some" 18 "Cytotrophoblasts: 22.8;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 14.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 23.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 23.5;Hep G2: 9.8;SuSa: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA014030 Uncertain Uncertain Microtubules,Cytosol NA NA Cytosol Microtubules "HPA014030: AB_2128155" "unprognostic (1.66e-2)" "unprognostic (1.90e-3)" "unprognostic (2.65e-2)" "unprognostic (1.11e-3)" "unprognostic (2.27e-2)" "unprognostic (1.48e-2)" "unprognostic (6.31e-2)" "unprognostic (1.66e-2)" "unprognostic (3.58e-2)" "unprognostic (1.54e-1)" "unprognostic (3.85e-3)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (9.06e-2)" "unprognostic (1.97e-1)" "unprognostic (3.31e-2)" "unprognostic (7.74e-6)" 10.6 0.7 0.9 1.0 3.1 0.1 3.1 0.5 2.2 0.6 1.2 8.9 1.0 0.4 0.3 1.0 0.4 0.7 0.6 0.6 1.9 2.7 1.7 3.6 2.9 0.1 11.1 0.1 0.4 18.4 20.4 0.4 14.4 23.2 1.8 1.2 2.6 10.4 0.8 0.5 0.8 0.6 0.2 13.4 0.8 2.4 1.0 4.9 0.1 0.7 0.8 0.2 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 23.5 0.1 0.0 0.1 0.0 3.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 9.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.7 0.4 0.0 21.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 3.1 0.5 2.2 1.9 2.7 11.1 0.1 23.2 4.9 0.0 0.0 0.0 2.3 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.1 0.2 0.0 0.0 0.0 7.3 14.9 0.8 0.0 0.0 0.5 2.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.3 0.0 3.5 0.2 0.3 0.0 1.7 0.0 0.1 0.0 4.6 0.0 0.6 0.0 KANSL3 "FLJ10081, KIAA1310, NSL3, Rcd1" ENSG00000114982 "KAT8 regulatory NSL complex subunit 3" Q9P2N6 2 96593170-96642787 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035017, HPA035018" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA035017: AB_2674414, HPA035018: AB_10601763" "unprognostic (2.19e-1)" "unprognostic (6.94e-2)" "unprognostic (5.62e-2)" "unprognostic (8.72e-3)" "unprognostic (3.28e-1)" "unprognostic (4.35e-3)" "prognostic unfavorable (5.34e-4)" "unprognostic (6.34e-2)" "unprognostic (1.41e-1)" "unprognostic (2.02e-1)" "unprognostic (3.01e-2)" "unprognostic (2.99e-2)" "unprognostic (2.04e-3)" "unprognostic (3.28e-1)" "unprognostic (1.92e-1)" "unprognostic (8.30e-3)" "unprognostic (4.99e-3)" 15.3 15.2 8.2 15.4 10.8 15.9 16.9 10.6 13.3 16.6 14.0 13.6 17.8 9.9 21.5 15.3 12.7 17.2 12.1 9.2 7.5 4.8 13.2 9.8 13.7 9.9 10.9 7.3 20.1 17.5 17.0 13.7 12.4 9.6 16.5 9.3 20.2 16.6 19.8 15.7 14.2 15.7 18.0 6.1 15.0 13.4 36.0 8.4 14.8 18.1 10.5 11.0 20.1 14.8 3.6 1.4 4.2 2.6 5.7 5.9 2.8 9.3 5.7 19.1 14.5 8.0 4.3 8.6 7.5 11.9 15.0 16.3 10.6 6.2 13.8 10.9 11.7 11.5 6.1 13.4 7.1 13.0 9.1 10.7 18.9 5.8 11.9 10.7 12.9 7.5 11.0 5.0 10.0 8.5 9.1 8.3 14.8 13.1 9.8 9.3 5.3 23.2 10.3 9.3 4.8 9.7 18.5 13.0 7.5 8.8 9.5 20.4 12.5 8.9 9.8 8.7 11.6 8.5 4.8 12.3 10.4 9.1 7.7 6.7 8.2 5.0 11.6 5.5 14.6 9.6 4.2 2.6 0.8 5.8 2.6 4.3 3.1 3.5 5.9 1.2 3.6 2.6 4.5 0.2 5.7 2.2 1.4 2.5 2.8 8.2 10.8 10.6 13.3 7.5 4.8 10.9 7.3 9.6 8.4 41.7 25.0 4.7 9.1 4.0 14.0 23.7 15.3 12.0 25.0 10.4 41.2 6.6 3.3 8.3 10.9 11.4 10.7 0.0 8.3 3.6 6.6 9.7 17.4 10.6 7.2 14.3 12.6 17.2 8.8 22.8 9.2 8.4 6.8 11.8 16.7 11.4 10.5 5.8 12.0 3.8 29.4 12.9 9.2 23.2 10.5 5.6 9.3 12.5 13.8 9.2 KATNA1 ENSG00000186625 "Katanin catalytic subunit A1" O75449 6 149594873-149648972 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 312.3;Late spermatids: 142.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036207 Approved Supported "Nucleoplasm,Centriolar satellite" NA NA "Centriolar satellite" Nucleoplasm "HPA036207: AB_10672238" "unprognostic (1.57e-1)" "unprognostic (2.41e-2)" "unprognostic (2.95e-2)" "unprognostic (3.57e-2)" "unprognostic (1.21e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.57e-7)" "unprognostic (9.78e-2)" "unprognostic (8.89e-2)" "unprognostic (7.40e-2)" "unprognostic (2.70e-2)" "unprognostic (4.50e-2)" "unprognostic (3.92e-2)" "unprognostic (2.10e-1)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (8.85e-2)" 12.5 7.8 9.3 11.9 9.8 14.2 11.7 13.0 9.5 13.8 12.1 15.0 6.0 7.6 15.3 10.3 12.5 10.9 10.1 11.3 9.1 6.7 13.7 8.4 10.8 11.8 10.4 7.9 18.7 9.6 5.7 12.1 11.0 15.0 12.7 9.5 17.5 10.1 10.5 21.2 12.0 10.8 12.4 8.9 12.2 10.4 36.7 12.0 22.5 13.9 10.3 14.0 15.1 12.7 19.6 19.4 23.5 20.8 12.7 24.2 14.9 11.5 4.1 9.5 20.7 11.5 18.4 14.7 14.5 12.3 15.3 20.3 9.9 6.1 16.1 8.4 14.4 11.1 9.1 18.6 9.5 20.0 14.7 15.7 21.4 8.9 13.7 15.9 29.9 8.1 11.6 11.3 17.5 13.9 14.2 14.0 21.7 22.1 11.8 13.5 16.0 20.5 19.5 9.3 12.9 7.0 14.1 17.3 7.8 10.9 6.5 7.7 10.9 26.4 7.6 10.1 13.9 7.8 29.2 12.0 8.0 12.2 21.0 16.7 11.0 10.1 22.1 10.5 21.3 13.0 23.5 15.2 21.0 19.9 20.8 17.5 19.6 20.2 20.0 19.4 14.2 17.2 17.3 7.0 12.7 18.0 16.7 24.2 14.9 9.3 9.8 13.0 9.5 9.1 6.7 10.4 7.9 15.0 12.0 14.9 9.9 13.7 31.3 26.1 8.6 15.9 10.2 24.1 13.6 14.0 27.5 18.4 14.9 16.5 312.3 15.5 9.7 23.3 10.9 15.9 23.8 16.3 19.7 6.6 15.3 12.7 5.8 10.4 11.8 142.0 19.5 18.0 10.1 22.6 8.4 10.9 12.0 10.5 15.6 16.6 34.9 6.5 18.9 100.5 54.7 25.1 21.4 17.5 8.9 15.2 KATNAL1 MGC2599 ENSG00000102781 "Katanin catalytic subunit A1 like 1" Q9BW62 13 30202630-30307484 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 107.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 30.6" "Low region specificity" "Detected in all" HPA046205 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA046205: AB_10965325" "unprognostic (3.34e-1)" "unprognostic (6.44e-3)" "unprognostic (2.08e-2)" "unprognostic (6.91e-2)" "unprognostic (2.53e-1)" "unprognostic (1.52e-1)" "unprognostic (1.57e-2)" "unprognostic (2.84e-2)" "unprognostic (3.43e-1)" "unprognostic (4.68e-3)" "unprognostic (4.54e-2)" "unprognostic (2.17e-2)" "unprognostic (1.84e-3)" "unprognostic (7.41e-2)" "unprognostic (6.42e-2)" "unprognostic (5.12e-2)" "unprognostic (1.83e-3)" 11.0 5.7 12.2 6.4 12.5 7.6 12.0 11.0 14.4 14.1 11.4 10.4 4.6 2.2 12.7 4.2 8.1 6.6 5.4 22.6 8.5 9.8 5.9 5.4 6.7 8.2 10.3 14.9 6.3 2.9 3.2 11.9 4.2 11.9 6.7 5.9 4.1 3.5 8.5 7.1 3.8 4.2 19.7 10.8 4.5 4.7 25.1 7.8 12.0 4.4 3.3 9.1 7.7 7.9 5.2 6.9 3.4 1.0 9.5 7.1 1.4 5.5 4.6 8.1 4.3 6.2 13.2 0.2 23.0 7.4 12.3 9.7 0.9 5.6 8.9 2.7 30.6 15.5 1.5 5.7 5.9 18.8 7.7 2.1 6.4 5.7 2.1 3.3 3.1 4.3 5.1 3.0 13.8 3.4 11.6 12.9 5.0 3.4 3.9 15.0 1.1 7.0 2.9 3.5 0.1 3.0 7.9 9.6 0.9 4.4 0.4 3.4 7.1 6.1 1.2 4.3 7.1 2.0 1.9 11.7 10.9 16.6 5.9 9.2 2.1 3.8 12.3 4.3 3.1 15.6 1.9 0.9 3.4 5.8 0.5 2.9 2.6 4.6 5.8 2.3 5.2 1.1 2.6 0.3 9.5 1.0 6.9 7.1 1.4 12.2 12.5 11.0 14.4 8.5 9.8 10.3 14.9 11.9 7.8 8.9 2.6 1.9 3.5 5.3 9.0 35.3 2.5 16.0 2.3 5.2 25.5 0.2 3.3 5.4 107.1 6.4 0.0 0.0 1.3 0.7 9.4 1.6 9.3 9.0 2.8 20.6 9.8 6.7 2.1 42.6 8.3 3.4 16.9 35.1 0.5 8.5 4.5 0.0 4.9 5.7 17.6 6.5 11.2 41.6 21.5 5.0 0.2 7.5 0.6 1.3 KCMF1 "DEBT91, DKFZP434L1021, PCMF, ZZZ1" ENSG00000176407 "Potassium channel modulatory factor 1" Q9P0J7 2 84971093-85059472 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030383, HPA030384" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA030383: AB_10599977, HPA030384: AB_10601230" "unprognostic (8.01e-2)" "unprognostic (1.98e-2)" "unprognostic (9.95e-2)" "unprognostic (7.42e-3)" "unprognostic (1.24e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (2.33e-7)" "unprognostic (5.68e-3)" "unprognostic (1.43e-1)" "unprognostic (9.81e-2)" "prognostic unfavorable (6.10e-5)" "unprognostic (4.98e-2)" "prognostic unfavorable (4.18e-6)" "unprognostic (6.11e-2)" "unprognostic (2.66e-1)" "unprognostic (4.42e-1)" "unprognostic (1.01e-1)" 19.2 13.3 17.9 20.2 16.0 23.6 26.1 13.4 18.6 15.0 20.2 10.7 20.3 15.4 16.3 18.8 28.5 12.8 17.9 30.4 16.5 12.0 14.8 20.7 16.4 18.8 13.7 11.1 17.2 48.6 14.7 18.7 20.5 14.4 17.5 21.4 14.0 19.4 15.7 67.2 17.6 20.6 25.7 10.3 16.7 16.8 29.0 11.5 19.7 18.7 21.8 22.5 23.9 34.0 4.0 4.2 8.1 3.4 2.8 8.8 1.5 27.6 21.7 19.4 14.9 20.5 19.9 33.1 29.6 27.5 28.4 19.0 26.5 29.9 30.1 29.8 40.1 28.4 18.4 15.1 28.6 37.6 22.5 10.5 19.2 16.4 27.0 40.2 21.1 18.3 20.5 45.3 27.8 77.2 25.4 21.4 16.3 19.0 24.0 28.4 25.5 20.3 11.7 21.2 35.2 18.3 14.7 27.3 18.8 25.7 24.3 18.7 14.0 17.2 22.0 28.7 23.3 10.2 13.5 18.2 29.1 28.3 27.1 30.7 27.4 33.8 30.5 21.9 15.6 21.7 5.0 2.6 8.1 4.5 2.2 3.6 3.5 3.2 3.4 2.2 4.0 2.8 3.1 7.5 2.8 3.4 4.2 8.8 1.5 17.9 16.0 13.4 18.6 16.5 12.0 13.7 11.1 14.4 11.5 29.8 28.2 27.9 82.6 63.0 31.1 41.6 20.4 10.7 25.0 12.2 13.7 22.2 21.6 33.1 65.6 24.8 41.1 23.3 45.9 22.3 26.3 94.5 17.3 29.8 18.4 68.3 18.5 25.8 25.1 87.4 23.9 22.8 25.3 23.4 27.6 31.3 46.8 35.9 27.3 28.6 27.5 25.8 36.8 31.0 29.4 69.1 34.1 19.1 28.1 106.5 KCNA10 Kv1.8 ENSG00000143105 "Potassium voltage-gated channel subfamily A member 10" Q16322 1 110517217-110519175 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.4;U-87 MG: 1.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 0.2" "HPA015061, CAB022564" Uncertain Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "CAB022564: , HPA015061: AB_1855573" "unprognostic (2.96e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNC4 "C1orf30, HKSHIIIC, Kv3.4" ENSG00000116396 "Potassium voltage-gated channel subfamily C member 4" Q03721 1 110211343-110283100 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 39.3;Ito cells: 63.3;Rod photoreceptor cells: 44.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 16.5;U-87 MG: 14.7;WM-115: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014740 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA014740: AB_1855580" "unprognostic (9.16e-2)" "unprognostic (1.92e-3)" "unprognostic (2.06e-2)" "unprognostic (3.72e-1)" "unprognostic (4.12e-2)" "unprognostic (6.13e-2)" "unprognostic (2.33e-2)" "unprognostic (2.68e-1)" "unprognostic (7.48e-2)" "unprognostic (2.03e-1)" "unprognostic (4.26e-2)" "unprognostic (1.26e-1)" "unprognostic (3.04e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-1)" "unprognostic (1.83e-1)" "unprognostic (1.25e-2)" 2.3 4.7 12.1 1.6 3.2 0.7 3.3 9.2 12.7 1.9 1.4 1.9 1.1 0.8 4.5 3.1 2.1 3.7 4.8 4.5 9.1 14.2 5.1 1.1 3.0 1.9 6.8 2.0 3.4 4.3 11.2 3.8 2.8 14.3 2.4 1.3 4.7 7.1 3.7 4.5 4.0 2.0 2.6 3.6 3.3 2.8 2.2 1.1 7.2 2.3 7.8 2.3 1.2 1.5 0.8 0.7 0.9 0.4 0.3 1.5 0.1 1.9 1.5 0.4 2.9 1.1 0.3 3.5 8.5 1.5 0.6 0.8 4.8 0.9 3.3 3.4 3.1 2.6 3.2 1.4 0.7 0.4 16.5 1.6 0.1 3.3 0.7 0.5 2.7 0.8 0.3 0.3 1.9 0.2 0.5 4.4 1.8 0.6 1.4 0.0 0.4 1.8 0.6 1.7 0.7 3.9 2.7 0.1 0.5 4.1 0.1 0.6 0.8 0.4 8.3 0.8 2.7 1.1 1.4 1.6 1.1 4.0 0.7 0.3 2.1 1.9 0.6 14.7 2.3 9.5 0.8 0.4 0.2 0.5 0.2 1.5 0.6 0.9 0.4 0.0 0.8 1.3 0.5 0.9 0.3 0.3 0.7 0.4 0.1 12.1 3.2 9.2 12.7 9.1 14.2 6.8 2.0 14.3 1.1 0.0 1.4 0.0 12.5 2.9 1.4 6.7 7.6 4.0 2.3 3.5 39.3 0.3 0.0 5.0 0.3 9.8 2.2 0.0 14.8 0.3 2.4 7.4 1.1 0.5 1.2 3.2 12.7 63.3 3.1 0.4 1.4 0.5 1.7 1.8 5.7 3.7 8.7 6.6 3.9 0.5 44.8 25.8 5.1 0.0 5.7 2.6 0.9 1.3 8.3 10.3 KCND1 Kv4.1 ENSG00000102057 "Potassium voltage-gated channel subfamily D member 1" Q9NSA2 X 48961378-48971569 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in some" 8 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Intestinal endocrine cells: 3.4;Leydig cells: 1.7;Peritubular cells: 3.5;Rod photoreceptor cells: 2.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 13.2;NB-4: 10.5;SuSa: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000524, HPA001066" Supported Uncertain Nucleoplasm Yes No Nucleoplasm "HPA000524: AB_2666013, HPA001066: AB_1079662" "unprognostic (6.00e-2)" "unprognostic (2.58e-1)" "unprognostic (1.01e-4)" "unprognostic (2.19e-4)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" "unprognostic (2.79e-1)" "unprognostic (8.13e-3)" "unprognostic (1.13e-2)" "unprognostic (2.41e-3)" "prognostic favorable (2.66e-6)" "unprognostic (2.61e-1)" "unprognostic (4.30e-11)" "unprognostic (3.13e-2)" "unprognostic (3.49e-1)" "unprognostic (7.64e-2)" "unprognostic (2.22e-3)" 4.9 2.4 4.2 3.4 4.7 6.0 2.2 16.8 7.8 5.1 2.2 6.3 1.9 2.0 5.0 3.8 1.4 7.4 6.3 2.9 6.9 2.5 2.5 1.8 3.0 3.1 3.1 3.5 4.6 1.4 1.8 3.0 2.5 10.4 3.3 2.1 2.6 1.2 6.0 0.7 1.6 2.6 6.6 6.5 4.2 2.5 3.0 2.7 1.1 2.3 0.5 3.6 3.0 3.0 0.6 1.3 1.4 0.1 0.0 0.8 0.1 0.4 1.9 0.8 4.7 6.4 5.1 1.6 1.0 4.0 2.8 1.9 1.2 0.6 1.6 3.4 3.1 0.8 0.6 0.8 0.4 2.7 2.6 3.1 1.4 1.9 0.1 2.4 0.4 2.9 13.2 1.8 5.2 0.6 4.7 0.9 2.2 1.1 3.6 2.0 3.5 0.4 10.5 2.5 0.3 0.7 1.3 0.9 1.5 3.1 1.5 0.5 2.1 0.9 0.0 2.1 10.2 2.0 1.5 2.4 0.6 2.6 0.6 0.2 2.9 3.8 3.8 1.7 3.7 2.1 0.0 0.1 0.0 0.5 0.0 0.3 0.6 0.2 0.8 0.0 0.1 0.2 0.0 1.4 0.0 0.0 1.3 0.0 0.1 4.2 4.7 16.8 7.8 6.9 2.5 3.1 3.5 10.4 2.7 0.0 1.4 0.0 0.0 0.7 0.2 0.4 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 3.4 0.6 0.8 0.0 1.7 0.0 0.0 0.0 0.2 0.3 0.1 0.0 3.5 0.0 2.8 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.1 KCNE5 KCNE1L ENSG00000176076 "Potassium voltage-gated channel subfamily E regulatory subunit 5" Q9UJ90 X 109623700-109625172 "Disease related genes, Predicted membrane proteins" "Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5" "Cell type enriched" "Detected in some" 5 "monocytes: 16.2" "Group enriched" "Detected in some" 8 "glioma: 7.9;testis cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 5.6" "Group enriched" "Detected in many" 4 "dendritic cells: 5.6;monocytes: 1.7" "Cell line enhanced" "Detected in some" "HMC-1: 4.2;hTEC/SVTERT24-B: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042316 Uncertain Cytosol NA NA Cytosol "HPA042316: AB_10795397" "unprognostic (5.33e-2)" "unprognostic (2.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (1.59e-2)" "unprognostic (1.01e-1)" "unprognostic (2.14e-3)" "unprognostic (3.27e-2)" "unprognostic (9.46e-2)" "unprognostic (1.05e-1)" "unprognostic (4.62e-3)" "unprognostic (7.83e-2)" "unprognostic (5.64e-6)" "unprognostic (5.10e-2)" "unprognostic (9.06e-2)" "unprognostic (1.36e-1)" "unprognostic (5.37e-3)" 4.8 1.1 6.4 1.3 11.3 6.8 1.2 6.0 6.6 1.0 0.6 8.2 0.0 0.7 0.8 1.3 1.2 0.5 2.4 2.2 8.9 8.1 0.7 0.7 0.8 0.8 14.3 1.6 1.7 0.4 0.4 0.2 2.5 29.5 1.9 0.5 0.1 0.6 2.3 3.2 1.1 0.8 0.9 7.3 1.4 0.6 1.2 0.3 8.5 0.6 2.6 0.8 0.8 0.2 0.0 5.6 0.0 1.7 0.1 0.8 0.3 1.0 0.0 0.2 0.4 0.1 0.1 0.1 1.9 0.5 0.7 0.7 0.1 0.4 0.4 0.0 0.4 0.8 0.8 0.0 2.2 0.9 0.2 0.4 2.7 2.6 1.8 0.1 0.0 4.2 0.6 1.5 5.5 1.3 0.5 0.4 0.4 0.0 0.1 0.5 0.0 0.8 3.4 0.0 0.0 0.1 0.2 0.1 0.1 0.8 0.1 0.2 0.4 1.3 0.0 1.1 1.5 0.0 2.5 1.2 1.8 1.0 1.0 2.4 0.5 0.6 0.3 1.2 1.2 0.5 0.0 0.7 0.0 0.8 1.7 0.0 0.0 0.1 0.1 5.6 0.0 0.0 0.1 0.0 0.1 0.1 1.2 0.0 0.3 6.4 11.3 6.0 6.5 8.9 8.1 14.3 1.6 29.5 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 1.1 0.0 0.6 0.0 0.0 1.3 3.0 0.0 1.1 0.2 0.0 16.2 0.0 2.9 0.2 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 KCNF1 "IK8, KCNF, kH1, Kv5.1" ENSG00000162975 "Potassium voltage-gated channel modifier subfamily F member 1" Q9H3M0 2 10911937-10914225 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 36.9" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 10.2;Syncytiotrophoblasts: 6.4" "Cancer enriched" "Detected in many" 7 "glioma: 27.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 16.9;MCF7: 6.0;T-47d: 7.3" "Group enriched" "Detected in many" 4 "amygdala: 70.7;basal ganglia: 55.9;cerebral cortex: 78.2;hippocampal formation: 69.5;olfactory region: 141.1" "Low region specificity" "Detected in all" "HPA014738, HPA062278" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA014738: AB_1852114, HPA062278: AB_2732679" "unprognostic (2.54e-1)" "unprognostic (6.06e-3)" "unprognostic (1.37e-1)" "unprognostic (3.07e-2)" "unprognostic (4.39e-2)" "unprognostic (7.41e-4)" "unprognostic (1.54e-3)" "unprognostic (4.83e-5)" "unprognostic (1.57e-1)" "unprognostic (6.95e-2)" "unprognostic (1.60e-2)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (3.10e-4)" "unprognostic (2.37e-1)" "unprognostic (4.28e-2)" "unprognostic (4.08e-2)" 0.9 0.9 11.5 1.0 25.5 0.8 1.2 0.8 36.9 0.9 1.2 2.4 0.0 1.2 1.9 0.8 1.6 1.1 1.0 1.1 13.1 4.7 1.1 0.9 1.0 1.0 3.1 10.5 0.9 2.2 0.8 0.2 0.9 3.6 1.0 1.2 0.0 0.8 1.4 0.8 0.8 1.1 1.0 1.0 1.5 1.1 1.0 3.1 0.5 0.8 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 16.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.0 0.0 2.6 0.1 1.8 0.0 0.1 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.2 7.3 0.8 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 11.5 25.5 0.8 28.5 13.1 4.7 3.1 10.5 3.6 3.1 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 KCNJ12 "hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v" ENSG00000184185 "Potassium voltage-gated channel subfamily J member 12" Q14500 17 21376197-21419872 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 39.4;skeletal muscle: 47.8" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 84.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 39.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.6;HeLa: 5.9;PC-3: 6.3;SCLC-21H: 7.3;SiHa: 3.7;SuSa: 8.0;U-2197: 6.3" "Low region specificity" "Detected in all" HPA027021 Approved Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (3.81e-3)" "unprognostic (2.69e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (7.84e-5)" "unprognostic (2.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (4.91e-2)" "unprognostic (8.12e-2)" "unprognostic (1.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-1)" "unprognostic (5.90e-2)" "unprognostic (9.70e-3)" 1.2 1.3 1.9 0.9 2.9 0.7 0.9 39.4 5.8 1.2 0.8 1.1 0.5 0.5 0.8 1.4 1.5 2.1 0.7 5.1 0.9 1.4 1.2 0.5 1.3 0.4 1.3 3.4 0.7 0.5 10.6 0.7 0.7 4.0 0.9 0.6 1.7 0.6 0.9 47.8 6.0 0.6 1.0 0.9 1.3 0.9 1.3 0.9 0.0 1.0 7.5 1.1 0.8 1.5 0.0 0.9 0.0 0.5 0.0 0.1 0.0 0.0 1.1 0.4 2.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 3.6 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 5.9 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.1 0.0 1.5 0.0 6.3 0.0 1.0 1.6 0.0 0.0 7.3 0.4 3.7 0.0 1.5 8.0 0.0 0.0 2.8 0.0 0.5 6.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.0 1.9 2.9 39.4 5.8 0.9 1.4 1.3 3.4 4.0 0.9 0.0 0.0 0.0 0.0 1.3 0.8 12.5 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.4 1.4 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.2 84.2 1.2 5.5 0.0 0.2 6.9 0.0 0.0 0.0 0.4 11.2 0.0 0.0 3.9 0.6 1.4 0.0 0.5 0.5 1.3 1.9 0.1 0.0 0.6 0.0 KCNJ16 "BIR9, Kir5.1" ENSG00000153822 "Potassium voltage-gated channel subfamily J member 16" Q9NPI9 17 70053429-70135608 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 96.5;parathyroid gland: 59.4;thyroid gland: 60.4" "Cell type enhanced" "Detected in some" 27 "Cholangiocytes: 43.3;Collecting duct cells: 232.1;Distal tubular cells: 34.9;Proximal tubular cells: 89.7" "Group enriched" "Detected in many" 10 "renal cancer: 37.2;thyroid cancer: 80.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 5.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.1" "Cell line enriched" "Detected in some" 23 "RPTEC TERT1: 80.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059563 Approved Uncertain Vesicles NA NA Vesicles "HPA059563: AB_2684065" "unprognostic (2.81e-3)" "unprognostic (2.10e-1)" "unprognostic (6.06e-2)" "unprognostic (1.20e-3)" "unprognostic (1.16e-1)" "unprognostic (7.53e-2)" "unprognostic (4.38e-4)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-2)" "unprognostic (3.35e-1)" "unprognostic (1.34e-1)" "prognostic favorable (9.61e-7)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "prognostic favorable (6.58e-4)" "unprognostic (3.88e-1)" 0.4 0.3 4.1 0.3 4.4 0.4 1.5 22.6 6.1 0.3 0.4 1.7 12.6 0.4 0.4 6.4 0.3 2.0 6.5 0.4 6.0 7.2 96.5 0.9 0.5 0.4 8.3 3.4 0.4 15.8 59.4 0.8 0.5 25.5 1.0 0.3 0.0 4.1 14.3 0.4 0.5 1.2 0.2 7.5 1.1 7.4 0.8 5.3 0.0 60.4 0.0 0.2 0.3 0.3 1.1 0.5 5.1 0.2 0.9 1.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.5 0.0 0.0 80.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.6 0.9 0.1 1.2 1.0 1.0 0.5 0.1 1.1 0.7 0.6 5.1 0.9 0.1 0.5 1.1 0.3 4.1 4.4 22.6 6.1 6.0 7.2 8.3 3.4 25.5 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 43.3 17.4 4.5 232.1 0.0 0.0 34.9 6.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 89.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 KCNJ18 "KIR2.6, TTPP2" ENSG00000260458 "Potassium voltage-gated channel subfamily J member 18" B7U540 17 21692523-21704612 "Disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "lymphoid tissue: 3.5;skin 1: 8.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "cervical cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.0;HDLM-2: 2.1;HeLa: 1.7;RPMI-8226: 1.0;U-266/70: 3.3" "Region enhanced" "Detected in many" "cerebellum: 75.1" HPA027021 Uncertain Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (2.41e-1)" "unprognostic (3.90e-5)" "unprognostic (2.56e-1)" "unprognostic (1.95e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 KCNN2 "hSK2, KCa2.2" ENSG00000080709 "Potassium calcium-activated channel subfamily N member 2" Q9H2S1 5 114360945-114496500 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 25.3;brain: 23.1;liver: 33.2" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 10.8;Hepatocytes: 14.7;Melanocytes: 20.3;Rod photoreceptor cells: 7.2" "Group enriched" "Detected in some" 7 "glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 15.0;NTERA-2: 5.7;SK-MEL-30: 10.6;THP-1: 18.7;U-937: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038221 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA038221: AB_10673044" "unprognostic (9.22e-3)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (5.65e-2)" "unprognostic (1.43e-1)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (4.61e-1)" "unprognostic (3.16e-1)" "unprognostic (4.25e-1)" 0.8 25.3 12.6 0.8 7.3 0.6 1.1 21.7 15.0 1.7 1.2 9.5 0.0 0.9 3.9 0.9 0.8 1.0 1.0 7.7 23.1 3.6 4.8 33.2 2.5 0.9 4.5 16.9 1.4 3.8 1.0 16.0 0.6 9.1 11.7 1.3 4.2 1.1 5.4 9.9 2.1 0.9 2.8 8.4 1.1 1.1 3.8 6.5 0.0 0.9 0.0 0.8 2.4 1.1 0.3 0.3 0.8 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 15.0 2.3 0.3 0.1 0.0 0.2 0.0 0.5 0.0 2.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.1 0.0 0.2 0.0 1.2 5.7 0.0 0.0 0.1 0.0 0.7 0.3 0.1 1.8 0.0 0.0 0.2 10.6 0.3 0.2 18.7 0.2 0.0 0.4 1.7 0.0 0.1 0.0 0.1 1.8 6.7 0.5 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.3 0.1 0.3 0.8 0.1 0.3 0.3 0.1 0.0 12.6 7.3 21.7 15.0 23.1 3.6 4.5 16.9 9.1 6.5 0.0 0.6 0.0 0.1 0.2 6.8 10.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.7 5.2 0.0 0.0 0.8 0.0 0.9 4.5 0.0 14.7 0.0 0.0 0.0 6.2 1.0 0.0 0.0 0.0 20.3 0.0 0.5 0.3 1.4 0.0 0.0 0.5 7.2 0.0 0.5 0.5 3.2 0.3 0.0 0.0 0.4 0.1 KCNRG ENSG00000198553 "Potassium channel regulator" Q8N5I3 13 50015254-50020922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 27.7;ovary: 17.1" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 92.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001027 Uncertain Vesicles NA NA Vesicles "HPA001027: " "unprognostic (1.85e-3)" "unprognostic (1.66e-2)" "unprognostic (1.08e-2)" "prognostic favorable (2.61e-5)" "unprognostic (3.15e-1)" "unprognostic (1.47e-1)" "unprognostic (1.27e-1)" "unprognostic (5.39e-3)" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (1.71e-1)" "unprognostic (5.91e-1)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (4.69e-2)" "unprognostic (1.52e-1)" "unprognostic (9.16e-2)" 0.4 0.2 0.3 0.3 0.3 1.1 0.6 0.9 0.3 1.8 0.3 0.5 0.3 0.3 1.0 4.8 0.6 27.7 0.3 1.0 0.3 0.5 0.6 0.3 9.1 0.3 0.3 0.3 17.1 0.3 0.4 0.4 0.3 0.5 0.5 0.8 0.3 0.3 1.7 0.4 0.8 0.4 0.4 0.3 0.4 0.3 1.7 0.3 0.3 0.4 0.3 0.6 0.3 0.3 2.7 1.2 4.4 1.1 1.3 1.4 0.4 0.9 0.9 2.9 0.9 0.9 1.4 0.4 0.1 2.3 1.9 0.1 3.4 0.9 1.8 0.6 2.8 1.2 1.2 2.2 0.8 1.4 1.3 1.4 3.8 1.4 1.6 2.7 3.1 1.1 1.9 2.1 1.4 3.5 1.6 3.7 6.8 1.5 0.4 2.3 1.1 3.4 3.1 2.0 2.3 1.3 2.5 0.0 0.0 1.7 2.4 2.5 5.3 1.0 1.8 1.7 1.5 1.4 1.0 1.2 1.7 0.7 1.1 0.7 0.2 0.4 2.0 0.6 1.3 0.4 3.2 1.1 0.7 0.5 1.1 0.7 1.5 0.7 1.0 0.9 2.7 0.8 0.9 4.4 1.3 0.8 1.2 1.4 0.4 0.3 0.3 0.9 0.3 0.3 0.5 0.3 0.3 0.5 0.3 0.0 2.4 0.0 0.7 0.1 0.6 0.5 0.0 92.3 6.8 0.0 2.0 0.6 0.0 0.5 11.5 0.1 0.5 0.0 1.2 0.4 0.8 0.6 0.0 0.2 0.5 3.2 4.1 0.0 0.0 8.9 0.6 0.0 0.0 1.0 1.1 0.8 0.4 0.0 0.7 1.5 1.0 0.0 0.3 3.4 1.5 0.1 0.6 0.0 0.6 1.0 KCNU1 "KCa5.1, Kcnma3, KCNMC1, Slo3" ENSG00000215262 "Potassium calcium-activated channel subfamily U member 1" A8MYU2 8 36784324-36936128 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 15.8" "Group enriched" "Detected in some" 54 "Early spermatids: 49.4;Late spermatids: 18.0" "Cancer enhanced" "Detected in single" "liver cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HDLM-2: 13.1" "Not detected" "Not detected" HPA063317 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA063317: " "unprognostic (2.42e-3)" "unprognostic (4.26e-2)" "unprognostic (2.07e-1)" "unprognostic (4.76e-3)" "unprognostic (7.57e-2)" "unprognostic (1.12e-1)" "unprognostic (1.11e-1)" "unprognostic (2.71e-1)" "unprognostic (1.98e-1)" "unprognostic (7.73e-2)" "unprognostic (1.24e-2)" 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 13.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 KDM1A "AOF2, BHC110, KDM1, KIAA0601, LSD1" ENSG00000004487 "Lysine demethylase 1A" O60341 1 23019443-23083689 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Oxidoreductase, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005884, HPA053660" Supported Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "CAB005884: AB_443964, HPA053660: AB_2682220" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "prognostic favorable (6.31e-4)" "unprognostic (1.50e-1)" "unprognostic (6.83e-2)" "unprognostic (3.95e-2)" "prognostic unfavorable (4.47e-12)" "unprognostic (1.80e-2)" "unprognostic (1.99e-2)" "unprognostic (9.41e-2)" "unprognostic (3.34e-3)" "unprognostic (2.13e-1)" "unprognostic (2.61e-1)" "unprognostic (1.41e-1)" "unprognostic (3.73e-2)" "unprognostic (7.74e-2)" "unprognostic (1.39e-1)" 15.1 19.0 19.7 16.8 23.2 24.9 19.3 28.0 26.6 20.0 20.6 15.1 21.0 16.2 28.9 30.6 20.9 22.0 15.7 18.6 16.4 18.9 15.9 14.8 15.1 19.5 13.8 25.4 27.4 21.4 24.6 28.7 19.3 20.3 20.9 21.6 16.4 21.3 19.9 24.8 23.3 16.9 19.1 10.7 16.2 17.1 78.4 12.1 48.1 20.9 19.1 22.1 18.7 21.9 9.1 9.7 5.7 6.9 3.8 7.4 1.9 30.3 15.7 44.9 39.6 11.9 15.2 32.0 12.9 16.3 26.4 23.6 14.7 29.5 22.6 18.6 21.2 13.4 34.1 41.6 24.6 33.6 20.5 25.2 31.7 26.2 35.7 15.2 24.4 14.0 14.1 17.7 28.0 19.8 23.3 32.9 42.0 34.7 10.7 18.7 18.0 53.2 18.7 29.2 16.9 22.9 51.1 29.6 15.3 22.1 19.6 56.2 42.5 58.3 15.4 19.2 32.9 15.4 18.3 26.6 11.8 19.9 21.8 17.6 13.9 10.9 26.3 12.3 29.0 16.7 2.8 3.7 5.7 5.9 5.9 5.2 9.1 5.4 5.7 4.4 3.3 7.1 7.4 0.3 3.8 6.9 9.7 5.8 1.9 19.7 23.2 28.0 26.6 16.4 18.9 13.8 25.4 20.3 12.1 17.9 26.1 9.0 22.9 16.6 27.5 21.6 15.3 26.8 17.0 22.7 25.5 25.8 14.9 30.7 32.2 12.8 14.4 0.0 21.5 47.0 17.4 18.6 11.5 13.9 13.3 14.3 21.9 14.1 13.9 16.3 19.8 15.0 11.8 28.9 20.5 19.3 25.4 14.0 21.5 12.6 20.0 0.0 15.9 100.4 63.4 11.2 13.8 8.7 24.7 17.5 KDM2B "CXXC2, Fbl10, FBXL10, JHDM1B, PCCX2" ENSG00000089094 "Lysine demethylase 2B" Q8NHM5 12 121429097-121581015 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071257 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA071257: " "unprognostic (7.67e-2)" "unprognostic (3.72e-3)" "unprognostic (2.15e-1)" "unprognostic (1.69e-1)" "unprognostic (1.37e-1)" "prognostic favorable (6.74e-6)" "unprognostic (1.16e-1)" "unprognostic (5.45e-2)" "unprognostic (1.01e-2)" "unprognostic (1.95e-1)" "prognostic favorable (8.64e-4)" "unprognostic (1.77e-1)" "unprognostic (4.44e-3)" "unprognostic (1.44e-2)" "unprognostic (3.90e-2)" "unprognostic (7.07e-2)" "unprognostic (4.82e-2)" 6.2 6.3 13.9 20.1 15.7 14.9 7.0 31.1 25.1 9.2 7.6 12.3 5.2 8.2 9.9 7.3 14.4 10.8 7.9 5.8 11.8 7.2 6.6 10.2 9.5 21.3 14.3 15.1 14.1 8.2 13.0 8.2 7.2 12.2 6.6 7.7 8.1 9.1 6.8 11.7 18.9 13.1 8.1 13.2 16.3 7.4 9.8 14.5 27.0 8.2 5.5 20.9 11.1 11.6 11.5 5.0 4.2 3.6 2.6 8.3 4.0 6.7 8.6 17.0 5.2 4.7 4.9 17.4 6.7 9.1 9.8 8.3 11.7 3.8 33.1 9.9 6.1 5.2 5.9 18.1 6.6 7.4 13.7 11.7 19.1 7.8 10.4 5.2 22.3 14.8 3.9 4.0 8.8 6.7 9.8 7.0 16.6 14.4 4.7 5.0 10.0 24.2 26.8 27.3 5.4 7.0 27.9 8.6 16.3 5.4 13.1 18.6 11.0 11.5 6.8 6.8 14.8 12.8 24.5 8.8 10.2 7.6 9.7 6.5 11.0 9.7 32.3 9.3 17.5 6.3 4.2 3.6 2.8 8.3 3.2 6.3 11.5 6.6 4.8 5.0 10.6 5.9 7.5 0.5 2.6 1.9 4.8 5.5 4.0 13.9 15.7 31.1 25.1 11.8 7.2 14.3 15.1 12.2 14.5 0.0 11.7 22.7 5.0 15.0 19.7 13.0 15.3 2.7 4.5 10.4 11.8 5.7 10.0 6.6 41.3 7.3 4.7 0.0 5.0 9.1 9.4 5.4 13.9 12.2 21.8 14.3 5.2 8.0 16.4 37.2 7.2 21.0 15.1 64.1 4.7 3.9 5.1 5.9 6.7 3.3 13.8 19.4 9.9 5.1 13.9 13.2 5.5 17.8 6.6 5.4 KDM4A "JHDM3A, JMJD2, JMJD2A, KIAA0677, TDRD14A" ENSG00000066135 "Lysine demethylase 4A" O75164 1 43650158-43705515 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA007610 Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA007610: AB_1852006" "unprognostic (7.01e-2)" "unprognostic (1.50e-1)" "unprognostic (3.22e-2)" "unprognostic (6.18e-2)" "unprognostic (3.54e-2)" "unprognostic (5.40e-3)" "prognostic unfavorable (1.39e-5)" "unprognostic (4.88e-3)" "unprognostic (1.13e-1)" "unprognostic (5.47e-1)" "unprognostic (2.70e-1)" "unprognostic (7.95e-2)" "unprognostic (2.81e-1)" "unprognostic (2.32e-3)" "unprognostic (2.02e-1)" "unprognostic (1.92e-1)" "unprognostic (1.28e-1)" 12.8 29.5 12.7 15.4 19.7 11.2 14.5 23.4 22.3 17.5 18.8 20.7 17.6 29.0 18.2 14.6 19.1 19.7 15.4 10.7 11.9 11.5 13.9 18.5 15.3 14.8 14.8 16.3 22.1 15.1 22.3 22.4 13.8 19.1 15.3 20.0 21.6 17.9 12.9 13.2 23.4 23.3 16.1 13.8 18.6 15.2 6.9 14.1 29.7 18.5 11.3 22.3 17.2 15.5 6.7 5.9 12.8 7.2 6.2 7.7 4.6 10.6 9.9 16.0 28.4 15.8 15.0 11.4 10.1 11.6 15.5 15.4 11.3 9.6 14.0 10.5 10.1 11.8 11.2 19.8 12.0 16.1 9.8 16.3 19.8 14.9 9.1 15.1 14.2 16.0 16.3 19.5 15.2 19.2 11.9 16.1 12.2 9.8 20.1 11.2 8.4 11.1 12.1 26.7 9.2 10.0 14.9 18.8 9.9 11.0 21.4 14.4 13.0 22.1 15.3 27.8 24.9 8.9 48.2 12.3 9.3 15.0 8.3 13.7 9.2 11.0 12.6 9.7 12.0 17.5 11.1 6.8 12.8 6.9 5.6 7.7 6.7 6.7 5.6 5.9 5.1 4.6 4.0 4.5 6.2 7.2 5.3 7.1 4.6 12.7 19.7 23.4 22.3 11.9 11.5 14.8 16.3 19.1 14.1 8.9 21.1 2.2 4.2 8.1 20.8 6.8 7.6 26.8 4.5 1.8 35.3 7.1 5.0 7.9 9.2 7.1 13.8 0.0 5.9 4.7 8.3 4.8 12.7 8.6 7.5 30.2 11.5 9.8 6.4 4.4 11.5 7.7 1.7 10.0 19.3 10.6 8.9 10.5 13.8 5.7 23.4 6.5 6.2 0.7 1.0 4.1 6.8 5.7 14.0 5.0 KDM5B "CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A" ENSG00000117139 "Lysine demethylase 5B" Q9UGL1 1 202724491-202809470 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.0" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 181.0;Spermatocytes: 261.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027179, HPA053723, CAB068193" Enhanced Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241" "unprognostic (1.19e-1)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (4.67e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (3.49e-3)" "unprognostic (3.02e-2)" "unprognostic (3.23e-2)" "unprognostic (6.12e-2)" "unprognostic (1.61e-2)" "unprognostic (4.79e-2)" "unprognostic (8.25e-3)" "unprognostic (2.56e-2)" "unprognostic (1.61e-1)" "unprognostic (5.56e-2)" "unprognostic (4.13e-1)" 7.7 7.1 5.9 8.2 7.8 14.8 12.3 12.7 9.0 12.9 9.6 5.1 9.7 5.0 13.6 9.4 17.6 8.6 8.4 5.7 6.1 4.5 6.0 4.6 9.0 5.4 3.7 7.3 13.3 9.0 9.8 8.6 23.1 5.0 11.3 9.0 16.0 11.1 8.8 4.3 19.5 7.3 10.1 4.9 6.9 8.2 74.0 5.2 25.8 9.1 6.2 10.4 12.2 12.6 4.1 3.0 16.0 5.2 7.3 4.4 2.6 10.6 4.3 28.9 13.9 13.7 12.4 24.4 7.3 11.3 7.7 8.2 3.6 11.3 0.0 5.0 11.4 5.7 16.4 13.6 12.0 9.9 0.1 5.2 5.8 4.1 5.8 11.7 18.0 7.7 12.9 20.0 11.0 14.5 20.8 17.1 7.2 18.0 0.0 7.7 10.8 5.0 21.5 19.6 7.4 7.6 21.2 0.0 0.0 11.1 18.4 8.8 19.5 15.5 9.5 12.9 39.6 19.5 12.9 12.6 6.8 5.1 0.8 4.2 1.1 0.7 4.5 6.0 6.7 2.8 16.0 2.9 6.4 3.7 3.4 3.1 2.8 3.3 2.7 3.0 4.1 4.2 1.8 9.5 7.3 5.2 2.1 4.4 2.6 5.9 7.8 12.7 9.0 6.1 4.5 3.7 7.3 5.0 5.2 83.4 33.4 5.4 32.8 57.2 30.9 7.3 10.2 54.9 40.9 15.7 58.9 35.8 5.0 41.9 155.3 25.3 16.1 0.0 19.5 25.5 34.2 40.2 25.5 9.6 7.0 14.3 41.9 19.0 17.8 181.0 33.6 10.8 25.3 10.0 31.3 68.3 38.0 17.3 30.8 5.9 133.9 32.3 21.7 261.1 71.6 101.6 68.9 12.5 27.0 45.7 KEL "CD238, ECE3" ENSG00000197993 "Kell blood group, metallo-endopeptidase" P23276 7 142941114-142962681 "Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 21.1;testis: 36.4" "Cell type enriched" "Detected in some" 14 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "intermediate monocyte: 1.4" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Group enriched" "Detected in some" 12 "HEL: 15.3;K-562: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA064442 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA064442: " "unprognostic (5.78e-3)" "unprognostic (1.08e-5)" "unprognostic (5.29e-3)" "unprognostic (4.85e-3)" "unprognostic (9.68e-2)" "unprognostic (1.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "unprognostic (5.18e-2)" "unprognostic (1.08e-2)" "unprognostic (3.71e-2)" "unprognostic (3.57e-2)" "unprognostic (2.29e-3)" "unprognostic (9.24e-2)" "unprognostic (7.05e-2)" "unprognostic (3.32e-2)" "unprognostic (3.25e-3)" 0.2 0.0 0.9 2.5 1.1 21.1 0.2 0.2 0.4 0.4 0.2 0.3 0.2 0.0 0.2 0.2 0.6 0.1 0.2 0.2 1.4 0.7 0.4 0.2 1.4 5.0 2.0 0.2 0.2 0.2 0.0 0.2 1.1 0.3 0.2 0.0 0.3 2.5 0.2 0.2 0.0 0.5 0.2 4.4 3.8 0.0 36.4 0.3 0.4 0.2 0.2 3.7 0.2 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.4 0.1 0.0 0.0 0.5 0.3 0.3 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.1 0.2 0.0 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 1.1 0.2 0.4 1.4 0.7 2.0 0.2 0.3 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 2.3 3.5 0.0 0.0 1.7 0.2 1.9 0.0 0.0 46.7 0.0 0.2 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 1.0 KIAA0141 DELE ENSG00000081791 KIAA0141 Q14154 5 141923808-141942047 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036548, HPA061490" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA036548: AB_10673356, HPA061490: " "unprognostic (1.97e-1)" "unprognostic (1.65e-1)" "unprognostic (2.78e-3)" "unprognostic (1.00e-1)" "unprognostic (1.80e-1)" "unprognostic (7.77e-2)" "unprognostic (2.72e-2)" "unprognostic (7.99e-2)" "unprognostic (2.63e-1)" "prognostic unfavorable (6.89e-4)" "unprognostic (1.91e-2)" "unprognostic (1.80e-1)" "unprognostic (2.15e-3)" "unprognostic (7.86e-2)" "unprognostic (1.89e-1)" "unprognostic (4.02e-1)" "unprognostic (2.28e-3)" 26.2 35.7 17.9 28.5 21.0 31.0 27.4 39.6 26.8 24.8 27.2 28.1 33.5 27.3 32.9 29.0 23.5 26.1 29.4 66.5 17.9 16.2 27.0 35.2 28.9 35.6 21.7 25.8 26.2 28.4 25.2 25.2 28.2 22.0 26.2 28.6 23.1 22.1 38.8 40.9 20.1 24.6 27.5 23.2 43.0 26.0 19.0 21.2 19.9 26.9 26.5 24.8 27.6 24.9 10.2 26.2 8.8 28.8 10.9 12.3 10.7 10.0 13.6 20.0 29.3 15.8 21.0 13.3 13.2 21.5 23.1 25.7 19.5 23.7 23.8 15.2 14.3 13.4 15.7 12.0 27.7 12.9 13.6 10.6 14.4 15.8 15.1 20.1 20.4 28.5 25.5 13.9 20.2 16.6 20.8 24.1 5.1 9.1 32.5 11.9 13.1 5.4 11.2 7.7 12.5 21.2 18.6 13.3 26.4 16.7 15.0 11.3 14.3 15.3 24.1 31.2 13.6 31.1 18.4 19.3 17.7 10.8 9.2 11.7 9.1 9.7 14.5 14.4 16.4 19.4 7.7 20.3 6.5 10.4 26.4 9.8 10.2 8.4 10.2 26.2 9.4 7.2 9.2 8.8 10.9 28.8 10.6 12.3 10.7 17.9 21.0 39.6 26.8 17.9 16.2 21.7 25.8 22.0 21.2 11.9 27.4 12.8 15.2 7.2 7.4 0.0 28.1 14.7 10.3 0.0 27.5 22.7 0.0 0.0 0.7 29.7 19.2 0.0 0.0 11.4 12.3 13.8 18.5 25.9 24.6 33.4 20.8 28.3 26.1 1.1 14.7 18.7 15.1 0.0 20.9 4.8 0.0 10.5 8.5 0.0 19.5 12.9 7.2 3.0 5.5 9.4 21.5 15.2 25.0 17.2 KIAA0513 ENSG00000135709 KIAA0513 O60268 16 85027751-85094230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.6" "Cell type enhanced" "Detected in many" 15 "Horizontal cells: 46.1;Late spermatids: 149.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 15.9;monocytes: 13.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012866, HPA014431" Enhanced Uncertain Nucleoplasm,Cytosol NA NA 8400 "Nucleoplasm, Cytosol" "HPA012866: AB_1852321, HPA014431: AB_1852322" "unprognostic (1.98e-2)" "unprognostic (2.47e-2)" "unprognostic (2.35e-1)" "unprognostic (1.69e-2)" "unprognostic (1.49e-2)" "unprognostic (9.37e-3)" "unprognostic (2.90e-2)" "unprognostic (8.56e-2)" "unprognostic (1.38e-1)" "unprognostic (4.85e-2)" "prognostic favorable (1.72e-5)" "unprognostic (7.52e-2)" "unprognostic (1.94e-3)" "unprognostic (7.88e-2)" "unprognostic (4.00e-1)" "unprognostic (2.33e-2)" "unprognostic (2.34e-1)" 5.2 11.0 20.8 8.8 30.8 14.3 2.8 57.6 57.6 6.9 8.1 4.6 1.8 4.7 3.3 3.1 7.6 2.3 4.9 4.5 19.7 14.9 3.0 1.9 6.7 5.2 11.3 27.6 2.9 13.0 4.1 14.8 4.0 17.6 6.2 6.1 2.9 8.3 5.2 5.6 9.9 6.0 5.6 6.9 7.4 10.1 5.7 4.6 0.5 2.8 1.0 6.2 8.3 3.5 0.0 3.6 15.9 13.6 0.7 0.9 3.1 5.7 6.2 4.2 6.1 7.9 5.9 1.0 5.8 9.3 8.4 4.9 2.8 2.7 2.0 2.6 7.0 5.1 5.1 3.9 9.2 5.2 4.3 3.2 3.7 1.9 1.5 3.8 0.4 5.3 10.9 4.9 9.6 1.2 3.6 4.4 4.1 16.2 4.8 7.4 9.0 0.7 1.5 4.1 6.7 5.0 0.7 5.4 1.2 7.8 4.2 12.4 1.9 6.8 11.4 2.8 4.4 9.2 1.2 8.9 5.2 3.9 7.8 2.0 7.6 1.3 4.1 6.8 2.9 5.6 11.0 7.2 10.6 0.9 8.3 0.3 0.0 0.6 0.6 2.6 0.0 0.6 0.6 15.9 0.7 13.6 3.6 0.2 3.1 20.8 30.8 57.6 45.9 19.7 14.9 11.3 27.6 17.6 4.6 6.0 7.2 3.0 6.5 3.5 13.4 5.8 2.5 1.4 2.3 1.8 5.9 0.4 0.0 2.0 38.3 3.2 5.9 0.0 4.1 0.6 3.9 11.1 2.3 2.4 6.7 46.1 10.9 5.5 18.3 149.1 15.0 8.8 3.3 5.4 8.4 2.5 6.6 7.0 25.1 1.3 5.9 0.0 3.1 3.6 4.9 3.9 2.9 4.4 3.5 26.5 KIF16B "C20orf23, dJ971B4.1, FLJ20135, SNX23" ENSG00000089177 "Kinesin family member 16B" Q96L93 20 16272104-16573434 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051198 Approved Uncertain Mitochondria NA NA Mitochondria "HPA051198: AB_2681385" "unprognostic (3.33e-1)" "unprognostic (1.74e-1)" "unprognostic (6.18e-2)" "unprognostic (2.09e-1)" "unprognostic (3.92e-2)" "unprognostic (2.44e-1)" "unprognostic (6.32e-3)" "unprognostic (7.85e-2)" "unprognostic (2.38e-1)" "unprognostic (5.34e-2)" "unprognostic (3.95e-2)" "unprognostic (5.52e-1)" "prognostic favorable (7.61e-6)" "unprognostic (4.04e-2)" "unprognostic (2.78e-1)" "unprognostic (4.74e-2)" "unprognostic (1.61e-2)" 11.3 26.2 10.5 14.8 11.2 4.8 15.1 6.3 11.2 9.4 21.6 10.3 15.7 15.1 10.6 12.8 10.3 6.1 9.4 10.7 10.3 8.4 16.6 10.9 12.9 5.6 12.1 7.0 13.0 8.4 25.7 13.9 5.7 8.4 8.4 17.8 6.6 8.5 28.2 22.8 11.3 23.7 11.7 15.3 9.9 11.6 5.7 11.1 6.5 10.5 8.6 8.2 10.6 15.0 5.2 5.8 0.9 3.7 8.2 5.0 2.6 4.9 12.6 6.0 5.5 4.7 3.4 5.9 4.8 3.0 3.0 3.3 6.1 12.2 6.9 3.2 5.1 8.5 4.5 7.1 7.2 4.5 3.6 4.1 3.1 3.2 11.2 2.9 0.0 7.0 5.4 14.3 3.6 7.2 4.7 1.1 5.3 5.5 0.0 4.9 7.8 0.1 1.2 1.7 16.0 5.7 5.1 4.8 12.1 4.8 7.9 2.7 5.3 5.2 25.3 15.4 7.5 7.5 4.0 2.4 4.7 4.0 7.6 2.2 0.0 3.0 2.0 4.5 2.0 9.4 0.1 3.7 0.9 3.7 3.0 5.0 4.2 4.1 2.8 5.8 5.2 4.5 3.2 0.4 8.2 2.9 2.8 2.7 2.6 10.5 11.2 6.3 11.2 10.3 8.4 12.1 7.0 8.4 11.1 17.9 34.3 9.9 14.0 16.9 8.4 24.2 2.5 14.7 18.2 5.2 17.7 11.8 3.3 5.5 9.6 11.9 40.0 0.0 10.9 4.8 7.6 7.9 9.2 12.8 15.8 35.0 22.4 9.8 9.5 6.6 10.6 15.8 10.1 1.0 36.6 8.0 10.1 28.1 13.8 16.1 10.7 6.5 8.6 8.4 15.9 19.6 31.4 4.1 18.2 19.6 KIF1B "CMT2, CMT2A, HMSNII, KIAA0591, KLP" ENSG00000054523 "Kinesin family member 1B" O60333 1 10210805-10381603 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Motor protein" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 112.9" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 224.2;Cone photoreceptor cells: 545.8;Rod photoreceptor cells: 364.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015177 Approved Approved "Nucleoli fibrillar center,Microtubules" NA NA Microtubules "Nucleoli fibrillar center" "CAB015177: AB_2296564" "unprognostic (1.30e-1)" "unprognostic (6.88e-2)" "unprognostic (4.96e-2)" "unprognostic (9.82e-3)" "unprognostic (7.15e-2)" "unprognostic (1.37e-1)" "unprognostic (1.66e-2)" "unprognostic (1.13e-1)" "unprognostic (2.67e-1)" "unprognostic (8.72e-2)" "unprognostic (3.26e-2)" "unprognostic (1.20e-1)" "prognostic favorable (2.91e-6)" "unprognostic (1.51e-1)" "unprognostic (3.46e-2)" "unprognostic (1.10e-1)" "unprognostic (9.33e-3)" 7.8 11.0 32.9 6.2 30.2 10.3 9.0 37.0 43.2 7.4 7.6 31.0 2.0 7.1 10.0 5.7 12.9 7.4 7.8 19.3 28.3 23.7 10.8 7.4 7.4 3.5 29.2 21.5 11.7 8.9 21.2 5.8 7.5 29.9 8.9 7.2 9.5 8.2 7.5 112.9 9.1 7.7 10.9 25.2 5.3 5.4 13.1 25.6 0.3 8.2 13.0 4.2 6.2 5.4 0.8 1.1 8.0 1.8 0.8 1.2 0.7 10.8 7.8 36.7 14.3 10.2 11.4 3.1 10.6 7.4 11.2 11.4 8.5 5.4 1.5 10.7 17.1 6.0 7.9 26.3 8.3 15.7 15.1 8.7 6.4 11.6 10.0 8.2 2.2 2.0 8.8 8.5 19.1 12.2 8.2 13.8 6.8 7.1 6.4 12.4 3.2 2.5 2.2 8.1 4.7 5.8 10.7 21.3 2.8 4.7 5.3 25.2 12.3 14.9 7.2 14.8 15.9 5.1 3.0 16.0 13.3 8.5 14.9 10.1 3.5 5.9 3.4 11.5 6.9 6.6 2.9 1.4 8.0 1.1 1.4 0.5 0.7 1.1 1.2 1.1 0.8 0.7 0.6 7.5 0.8 1.8 0.8 1.2 0.7 32.9 30.2 37.0 29.5 28.3 23.7 29.2 21.5 29.9 25.6 56.6 16.3 5.6 21.4 45.2 224.2 104.1 12.7 16.0 14.8 21.0 545.8 5.7 0.0 16.6 61.9 34.4 23.8 0.0 15.5 5.0 34.2 27.1 6.9 31.1 19.1 131.9 27.6 19.6 23.7 36.2 17.3 22.4 49.0 8.2 18.0 52.7 19.9 20.1 19.4 13.4 364.1 19.4 44.3 19.6 32.1 51.7 5.6 10.1 17.7 17.0 KIF2B ENSG00000141200 "Kinesin family member 2B" Q8N4N8 17 53822901-53825213 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 261 "testis: 103.6" "Group enriched" "Detected in some" 82 "Early spermatids: 638.1;Late spermatids: 419.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023081, HPA023103, HPA024795" Uncertain Supported "Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Microtubules, Cytokinetic bridge, Mitotic spindle" Nucleoli "HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 638.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 419.7 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 6.5 0.0 4.2 2.0 0.0 0.0 0.0 0.0 0.0 KIF3B "FLA8, KIAA0359, KLP-11" ENSG00000101350 "Kinesin family member 3B" O15066 20 32277664-32335011 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007119 Approved Uncertain "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA007119: AB_1852498" "unprognostic (1.74e-2)" "unprognostic (2.25e-1)" "unprognostic (5.14e-2)" "unprognostic (1.84e-1)" "unprognostic (2.73e-1)" "unprognostic (2.89e-1)" "unprognostic (1.49e-2)" "unprognostic (2.14e-1)" "unprognostic (9.01e-3)" "unprognostic (9.30e-2)" "unprognostic (1.41e-1)" "unprognostic (1.18e-1)" "prognostic favorable (1.44e-12)" "unprognostic (2.41e-2)" "unprognostic (2.68e-1)" "unprognostic (5.11e-2)" "unprognostic (4.42e-2)" 8.4 11.0 22.9 7.7 30.2 5.5 9.1 17.6 24.6 11.6 13.4 13.3 7.7 14.3 8.8 13.5 5.8 15.4 11.0 6.2 19.9 15.1 26.4 17.8 9.3 7.7 15.1 18.7 10.5 16.9 38.5 18.1 6.4 13.2 9.0 14.2 11.8 8.4 8.6 5.3 5.8 17.1 9.0 16.0 6.8 12.7 15.3 13.7 4.3 14.3 4.1 8.4 8.5 6.5 6.5 3.1 3.7 5.9 2.6 6.6 1.8 22.9 15.6 10.9 13.9 14.5 23.1 11.1 11.4 16.0 13.9 10.9 26.5 12.7 12.4 13.8 21.5 19.8 14.9 13.9 16.9 17.7 5.8 6.3 10.7 12.5 13.0 9.2 9.0 8.2 14.1 12.2 23.9 9.5 11.4 11.2 5.0 6.6 4.9 11.1 10.5 4.1 4.1 5.8 12.3 13.7 3.8 17.9 4.5 14.2 17.0 17.9 15.1 29.8 8.0 11.4 9.5 17.6 7.0 13.6 26.1 17.8 15.1 14.1 8.3 11.9 6.4 25.9 15.8 10.5 1.3 3.1 3.7 6.6 4.2 5.5 6.1 5.0 6.1 1.7 6.5 3.1 4.6 3.2 2.6 5.9 3.1 3.9 1.8 22.9 30.2 17.6 24.6 19.9 15.1 15.1 18.7 13.2 13.7 20.8 25.5 9.3 7.3 6.0 31.6 7.0 35.7 53.5 14.8 12.2 100.1 6.5 3.3 29.6 52.5 12.5 61.3 0.0 33.7 5.2 11.0 13.5 8.1 20.4 7.0 30.2 37.8 13.5 7.3 61.7 12.4 5.9 0.0 4.6 25.9 20.6 28.0 33.1 19.1 19.9 58.5 0.0 6.2 30.1 6.9 4.4 5.5 8.6 21.8 7.8 KIF4B ENSG00000226650 "Kinesin family member 4B" Q2VIQ3 5 155013755-155018132 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 9.0" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 2.0;Early spermatids: 4.7;Late spermatids: 3.1;Spermatocytes: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.4" "HPA034745, HPA034746, HPA061583" Uncertain Uncertain Nucleoplasm,Midbody Yes NA "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564" "unprognostic (9.87e-3)" "unprognostic (1.17e-1)" "unprognostic (3.91e-3)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.71e-1)" "unprognostic (4.76e-2)" "unprognostic (1.94e-1)" "unprognostic (1.06e-1)" "unprognostic (4.37e-2)" "unprognostic (6.48e-9)" "unprognostic (7.24e-2)" "unprognostic (5.10e-2)" "unprognostic (1.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.4 0.1 0.0 0.1 0.6 0.0 0.1 0.3 0.0 0.9 0.0 0.5 0.0 0.2 0.5 0.1 0.0 0.1 0.7 0.1 0.4 1.0 0.4 0.0 0.4 0.7 0.0 0.3 0.2 0.0 0.0 1.1 0.6 0.2 2.4 0.4 0.0 0.8 0.5 0.5 0.1 0.5 0.7 1.2 1.0 0.0 0.7 0.5 0.6 1.3 0.2 0.3 0.0 0.5 0.5 0.2 0.8 1.3 0.7 1.2 0.4 0.6 0.5 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 KLC1 "hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A" ENSG00000126214 "Kinesin light chain 1" Q07866 14 103561896-103714249 "Predicted intracellular proteins" "Host-virus interaction" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 117.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB009798, HPA044617, HPA052450" Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009798: AB_2280879, HPA044617: AB_2679024, HPA052450: AB_2681838" "unprognostic (6.93e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (7.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-3)" "unprognostic (2.67e-2)" "unprognostic (9.21e-2)" "unprognostic (5.62e-2)" "prognostic favorable (6.75e-4)" "unprognostic (6.84e-3)" "prognostic unfavorable (7.17e-4)" "unprognostic (6.58e-2)" "unprognostic (8.69e-2)" "unprognostic (4.05e-1)" "unprognostic (1.49e-1)" 19.5 20.4 61.3 15.7 45.6 17.6 16.6 103.0 117.9 15.2 14.8 22.4 11.5 10.5 21.1 18.7 19.7 16.0 15.7 27.1 61.0 65.1 8.6 8.9 20.0 15.9 66.2 47.9 19.8 14.8 25.2 17.0 17.9 50.7 16.3 14.1 14.1 16.9 19.7 28.2 22.4 12.8 23.1 56.0 18.3 13.8 14.3 23.2 7.9 13.8 13.0 18.1 15.7 14.9 7.3 10.4 12.4 8.6 4.1 10.9 3.1 16.4 22.1 42.7 23.3 28.9 31.6 19.7 38.8 31.9 36.5 24.9 18.9 18.0 21.8 20.2 41.8 16.2 27.5 26.0 20.5 34.6 26.3 13.1 12.2 26.1 19.1 32.9 23.9 24.3 22.9 33.3 27.5 33.5 38.9 31.3 15.5 18.2 25.1 31.7 27.7 16.0 21.1 13.7 26.3 40.9 15.4 18.0 10.7 22.7 36.5 50.4 28.2 31.5 16.0 25.6 27.6 14.1 11.8 45.5 27.1 13.4 37.1 21.5 20.1 14.0 24.2 31.0 13.8 29.0 7.6 5.8 12.4 10.3 6.0 9.5 6.4 9.3 10.9 6.8 7.3 7.9 7.2 7.0 4.1 8.6 10.4 8.4 3.1 61.3 45.6 103.0 90.3 61.0 65.1 66.2 47.9 50.7 23.2 41.7 27.5 24.9 39.0 23.1 133.1 34.0 22.9 16.0 14.8 19.2 49.1 19.5 8.3 42.1 4.2 42.8 13.0 0.0 26.7 27.4 32.1 34.5 32.4 15.6 26.3 130.3 43.0 31.9 18.1 11.4 35.6 24.1 37.1 46.9 20.2 42.5 49.1 14.4 45.3 3.4 89.3 25.8 40.6 36.8 78.0 15.4 35.2 28.9 14.7 31.8 KLF15 KKLF ENSG00000163884 "Kruppel like factor 15" Q9UIH9 3 126342635-126357442 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 25.6;Distal tubular cells: 24.9;Erythroid cells: 23.3;Hepatocytes: 54.2;Peritubular cells: 18.7;Proximal tubular cells: 19.2" "Cancer enhanced" "Detected in many" "liver cancer: 30.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 33.4;HHSteC: 20.3;RPMI-8226: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003286, HPA028866" Uncertain Supported "Nucleoplasm,Nuclear speckles,Vesicles" NA NA "Nucleoplasm, Nuclear speckles" Vesicles "HPA003286: , HPA028866: AB_10600819" "unprognostic (3.77e-3)" "unprognostic (1.08e-1)" "unprognostic (1.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.72e-3)" "unprognostic (2.11e-1)" "unprognostic (4.63e-2)" "unprognostic (1.09e-2)" "unprognostic (2.91e-1)" "unprognostic (1.32e-1)" "unprognostic (3.58e-2)" "unprognostic (1.10e-1)" "prognostic favorable (3.27e-7)" "unprognostic (6.75e-2)" "unprognostic (7.65e-2)" "unprognostic (1.91e-2)" "unprognostic (5.58e-3)" 35.0 7.7 11.8 2.3 19.8 1.5 13.8 10.0 14.2 6.1 6.2 11.6 4.4 2.8 7.4 6.0 7.3 10.4 5.1 16.9 15.7 6.0 20.1 32.5 7.1 2.9 24.8 7.0 40.6 46.3 3.2 6.1 3.2 14.6 9.3 2.4 7.0 23.1 7.5 41.0 3.7 3.6 5.8 10.5 4.0 11.1 4.7 22.3 0.0 8.6 4.5 2.3 11.9 22.0 12.2 9.4 18.6 10.4 13.9 12.0 9.1 0.4 0.0 1.2 5.2 33.4 0.6 5.7 0.3 0.8 0.4 0.7 0.6 0.0 1.8 0.5 0.0 1.0 0.0 3.0 0.1 0.1 0.1 1.2 0.1 0.4 4.2 20.3 0.0 0.1 3.1 0.2 0.0 0.7 0.0 0.3 2.5 2.3 4.1 0.1 0.4 0.0 0.7 3.7 0.7 0.1 2.6 0.1 10.9 0.1 0.4 0.4 4.4 0.1 0.2 5.4 1.9 0.3 2.5 0.1 0.1 0.2 0.2 0.1 2.7 0.3 0.4 0.1 0.8 0.7 18.6 7.4 10.2 7.7 10.4 9.3 12.2 8.2 8.1 8.4 11.8 10.7 12.0 17.9 13.9 9.1 9.4 10.7 9.1 11.8 19.8 10.0 14.2 15.7 6.0 24.8 7.0 14.6 22.3 6.0 2.9 1.9 2.3 0.0 1.6 25.6 10.2 1.4 1.2 0.0 0.0 0.1 24.9 0.0 0.1 1.1 0.0 23.3 0.0 0.2 0.9 3.9 0.0 54.2 0.1 0.0 0.0 5.5 2.2 0.6 11.2 0.0 1.7 0.0 0.0 11.0 0.6 0.0 18.7 19.2 3.2 0.0 0.9 0.0 0.1 0.0 0.2 0.0 0.0 1.4 KLF5 "BTEB2, CKLF, IKLF" ENSG00000102554 "Kruppel like factor 5" Q13887 13 73054976-73077542 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.4;intestine: 88.1" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 1017.1;Suprabasal keratinocytes: 599.6;Urothelial cells: 1225.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "basal ganglia: 22.2" "Cell type enriched" "Detected in single" 18 "basophil: 16.3" "Lineage enriched" "Detected in single" 106 "granulocytes: 16.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 27.5;HaCaT: 31.5;HBEC3-KT: 27.5;hTCEpi: 39.3;OE19: 59.4;RT4: 33.2;SiHa: 28.0" "Group enriched" "Detected in many" 4 "amygdala: 5.6;basal ganglia: 9.3;cerebral cortex: 6.9;hippocampal formation: 8.8;hypothalamus: 4.3" "Low region specificity" "Detected in some" HPA040398 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA040398: AB_10673267" "unprognostic (7.90e-3)" "unprognostic (5.11e-2)" "unprognostic (2.03e-2)" "unprognostic (1.56e-1)" "unprognostic (4.69e-2)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (3.97e-2)" "unprognostic (5.82e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (4.43e-2)" "unprognostic (1.42e-3)" "unprognostic (3.56e-3)" "unprognostic (3.98e-1)" "unprognostic (5.09e-2)" "unprognostic (1.54e-2)" 2.3 1.5 4.1 24.3 22.2 12.9 8.1 0.7 1.2 19.6 74.4 0.4 4.3 28.7 4.8 3.7 88.4 8.3 48.4 1.3 1.4 1.2 3.9 1.2 12.8 0.1 0.9 1.1 5.0 3.5 0.0 7.3 22.8 4.3 17.6 32.9 1.8 26.4 5.4 10.0 59.4 88.1 4.1 2.4 0.8 17.9 12.2 1.4 3.0 20.7 64.4 61.8 23.4 34.1 0.0 0.0 16.3 0.0 0.0 0.1 0.0 5.3 7.4 0.0 0.1 0.2 0.4 8.5 3.1 7.3 1.4 1.7 6.9 27.5 0.1 16.7 2.7 0.5 31.5 9.6 27.5 2.2 0.2 2.5 0.1 15.7 0.6 2.0 2.5 0.4 2.0 39.3 0.4 15.4 1.4 0.0 0.9 0.3 0.5 6.3 1.8 0.5 0.1 0.3 59.4 10.6 0.4 7.0 0.6 21.8 33.2 0.7 0.3 28.0 4.5 1.9 3.6 0.6 0.6 0.0 1.9 5.7 0.0 1.3 0.9 0.4 0.9 2.7 0.5 2.3 16.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 4.1 22.2 0.7 1.2 1.4 1.2 0.9 1.1 4.3 1.4 151.8 97.6 0.5 1017.1 460.9 0.4 5.6 79.0 128.5 151.2 34.9 2.0 57.7 18.3 30.8 305.6 1.1 308.2 0.0 40.2 87.3 46.1 522.9 3.5 2.9 5.4 9.5 195.2 0.6 0.0 162.5 6.1 6.1 55.6 5.4 327.8 0.0 63.9 284.0 1.4 2.6 0.0 0.0 28.8 7.2 25.9 599.6 48.5 0.7 397.9 1225.4 KLF6 "BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9" ENSG00000067082 "Kruppel like factor 6" Q99612 10 3775996-3785281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Basal glandular cells: 1442.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013529, HPA069585" Supported Supported Nucleoplasm,Nucleoli,Vesicles,Cytosol No No Nucleoplasm "Nucleoli, Vesicles, Cytosol" "CAB013529: AB_2533431, HPA069585: AB_2686157" "unprognostic (1.23e-1)" "unprognostic (1.53e-2)" "unprognostic (1.47e-3)" "unprognostic (4.53e-2)" "unprognostic (1.47e-1)" "unprognostic (7.55e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-3)" "unprognostic (1.61e-1)" "unprognostic (2.83e-2)" "unprognostic (1.36e-2)" "unprognostic (2.35e-2)" "prognostic favorable (2.28e-4)" "unprognostic (8.07e-3)" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (1.37e-2)" 69.8 10.0 8.4 26.3 10.6 80.6 101.1 7.4 10.1 28.6 31.7 10.3 9.7 11.0 24.9 28.8 38.6 28.0 38.6 18.6 7.8 5.1 32.2 32.5 46.0 35.8 13.8 4.2 20.2 23.8 7.5 4.7 26.1 11.2 20.1 21.0 13.2 26.9 16.5 57.8 60.2 44.8 42.8 17.0 20.3 26.7 14.3 10.0 12.5 41.0 28.8 21.5 44.7 30.7 15.6 29.8 77.8 18.7 13.0 30.8 23.2 13.2 3.6 6.9 2.2 40.3 40.4 4.3 22.8 11.7 24.4 16.6 9.3 17.9 3.8 5.3 24.7 19.0 8.1 4.2 21.1 20.5 18.6 2.5 0.5 4.1 8.7 17.3 2.5 13.1 13.3 40.3 17.4 33.2 8.7 24.9 2.5 4.1 29.7 31.0 0.9 4.6 3.8 2.6 7.1 6.5 3.0 7.1 13.4 24.0 13.2 3.0 2.9 5.6 16.3 34.2 19.6 8.0 2.1 32.4 33.1 4.6 19.5 10.4 5.7 18.5 7.0 8.9 3.3 10.2 50.9 17.0 43.7 27.1 14.2 23.9 15.6 30.8 26.8 13.1 12.5 9.6 14.8 77.8 13.0 18.7 29.8 22.2 23.2 8.4 10.6 7.4 10.1 7.8 5.1 13.8 4.2 11.2 10.0 1158.3 540.6 237.0 1442.7 520.2 42.2 53.1 293.0 254.3 251.4 130.9 31.4 113.5 18.3 616.6 54.4 455.0 961.8 70.0 474.3 369.8 410.0 832.0 597.5 234.2 510.8 35.0 381.0 212.4 420.1 42.4 120.8 593.9 458.9 839.6 556.8 32.1 706.5 466.4 125.9 61.9 78.0 135.8 372.0 6.2 13.6 549.2 163.8 409.2 300.8 382.6 KLF7 UKLF ENSG00000118263 "Kruppel like factor 7" O75840 2 207074137-207167267 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ito cells: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003423, HPA030490" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003423: , HPA030490: AB_10601922" "unprognostic (5.93e-2)" "unprognostic (2.49e-3)" "unprognostic (2.98e-1)" "unprognostic (3.99e-3)" "unprognostic (2.56e-1)" "unprognostic (2.85e-3)" "unprognostic (5.44e-2)" "unprognostic (1.24e-2)" "unprognostic (6.75e-2)" "unprognostic (8.78e-2)" "unprognostic (3.67e-2)" "unprognostic (1.47e-1)" "prognostic favorable (4.26e-4)" "unprognostic (3.27e-3)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (3.47e-2)" 22.2 10.1 10.3 15.1 12.0 40.7 17.3 30.2 12.0 12.2 12.1 14.6 9.3 5.7 19.7 13.4 11.6 10.2 13.8 12.1 10.3 8.0 9.9 8.4 17.1 15.7 12.9 9.1 17.1 6.1 3.0 6.4 7.0 17.4 10.2 6.7 7.0 8.9 9.3 6.2 7.9 11.9 24.2 25.7 11.3 10.7 7.9 14.7 14.4 10.8 8.5 8.3 18.4 18.2 4.5 3.0 24.0 11.7 12.9 9.0 3.5 4.5 3.2 8.7 0.6 3.0 8.0 1.8 5.3 4.2 8.2 3.6 0.0 3.7 0.0 3.4 10.7 14.3 11.3 7.4 24.2 4.4 3.1 0.4 0.1 8.9 1.8 5.3 2.3 3.6 10.6 8.2 5.7 19.0 11.9 9.5 2.4 0.0 4.3 6.3 0.1 2.8 0.8 5.1 0.5 1.6 1.2 2.3 3.2 2.0 3.5 13.5 16.5 4.5 6.4 4.3 7.3 1.0 3.6 18.8 16.4 7.9 6.9 6.2 3.3 2.2 0.0 14.5 2.0 3.2 11.5 5.4 6.8 0.9 6.8 0.4 3.0 5.1 1.0 3.0 4.5 9.0 6.1 24.0 12.9 11.7 1.4 4.1 3.5 10.3 12.0 30.2 12.0 10.3 8.0 12.9 9.1 17.4 14.7 38.7 7.0 15.0 23.7 19.5 5.6 12.5 20.4 8.1 15.9 8.7 11.8 0.4 1.7 20.8 4.5 58.3 0.9 0.0 44.8 0.2 12.4 9.7 11.5 13.5 13.1 11.1 5.8 86.0 44.8 3.3 12.7 20.0 3.3 17.2 0.7 8.2 55.3 0.3 9.6 4.5 8.5 45.3 20.2 0.5 7.5 13.4 0.9 4.9 0.6 7.4 KLF9 BTEB1 ENSG00000119138 "Kruppel like factor 9" Q13886 9 70384597-70414624 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Smooth muscle cells: 214.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 22.7;ASC TERT1: 31.6;HHSteC: 40.6;HSkMC: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029308 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA029308: AB_10601923" "unprognostic (2.12e-2)" "unprognostic (2.56e-1)" "unprognostic (3.12e-1)" "unprognostic (2.69e-2)" "unprognostic (5.86e-2)" "unprognostic (1.37e-1)" "unprognostic (3.64e-3)" "unprognostic (4.34e-1)" "unprognostic (5.55e-1)" "unprognostic (9.47e-2)" "unprognostic (7.86e-2)" "unprognostic (3.44e-1)" "prognostic favorable (6.59e-6)" "unprognostic (1.43e-3)" "unprognostic (1.75e-1)" "unprognostic (3.17e-2)" "unprognostic (1.02e-2)" 35.9 15.3 6.8 8.8 25.8 6.1 25.7 42.6 21.4 10.2 20.0 9.7 16.1 6.0 19.6 13.2 17.0 22.2 17.8 18.2 8.4 4.0 26.2 36.7 22.6 5.1 26.3 8.0 22.1 21.3 13.0 8.6 3.9 14.7 12.4 11.0 20.4 31.4 10.7 38.9 12.6 17.6 25.0 12.0 8.6 16.7 5.5 25.2 1.9 24.0 20.3 5.4 15.4 11.9 2.8 1.7 2.8 0.7 0.7 2.8 0.6 0.1 0.2 0.0 2.8 22.7 31.6 0.3 1.4 9.8 0.5 1.1 0.0 1.3 0.0 1.1 2.6 0.7 0.0 4.3 6.6 1.0 0.0 3.4 1.5 4.8 0.8 40.6 0.7 4.0 27.0 6.8 0.4 9.6 13.7 8.7 0.6 2.9 6.0 3.7 0.4 0.1 2.1 0.2 0.4 1.4 0.0 1.3 3.7 1.8 0.0 0.4 1.9 13.4 7.8 15.4 0.9 2.6 2.3 11.8 2.6 1.9 3.0 0.7 4.3 4.6 0.2 2.3 2.3 13.0 2.8 0.5 0.3 1.6 0.3 2.3 2.8 2.1 1.6 1.2 2.5 2.8 1.6 0.0 0.7 0.7 1.7 2.2 0.6 6.8 25.8 42.6 21.4 8.4 4.0 26.3 8.0 14.7 25.2 38.7 21.0 13.2 56.7 42.7 40.6 62.7 48.4 18.7 28.4 14.0 19.6 0.1 26.6 7.4 17.2 139.1 35.5 0.0 11.6 0.2 78.1 86.9 7.0 140.6 3.5 76.3 13.3 97.6 59.8 11.6 84.0 36.1 37.1 4.6 29.3 151.3 10.9 28.5 79.9 29.8 8.8 77.6 214.2 1.0 3.9 29.9 0.0 24.5 27.3 22.8 KLHL17 ENSG00000187961 "Kelch like family member 17" Q6TDP4 1 960587-965715 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031251 Approved Uncertain "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA031251: AB_10601539" "unprognostic (1.28e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.18e-1)" "unprognostic (8.55e-2)" "unprognostic (1.41e-1)" "unprognostic (1.38e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (3.09e-2)" "unprognostic (1.51e-1)" "unprognostic (8.53e-2)" "unprognostic (1.06e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (2.70e-6)" "unprognostic (1.61e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-1)" "unprognostic (7.73e-2)" 4.7 7.0 9.9 8.7 8.9 8.2 8.8 14.0 10.0 6.2 5.1 4.9 4.1 8.4 6.5 4.8 9.9 4.6 5.8 4.2 8.4 4.2 7.2 6.1 5.6 8.1 6.7 3.4 1.5 9.5 5.4 12.4 5.7 6.3 6.8 2.3 6.0 11.6 5.6 5.2 19.1 6.1 6.6 4.2 9.8 7.7 9.8 8.2 5.6 5.4 4.0 7.6 6.5 6.7 0.4 1.0 0.0 1.2 0.0 1.7 0.4 4.6 5.2 6.5 15.5 2.3 2.4 7.1 9.1 2.5 5.1 5.0 6.8 7.0 1.7 6.4 3.9 4.9 9.9 6.0 3.7 0.8 9.3 14.4 3.0 18.9 9.6 1.5 3.4 9.5 2.0 1.8 5.0 1.4 6.4 3.1 9.7 9.9 3.0 2.2 5.4 5.6 12.0 7.1 1.8 7.7 9.1 2.6 3.2 2.7 1.8 15.8 14.9 2.6 8.2 8.3 2.1 4.5 6.1 5.4 9.8 13.2 8.5 7.5 6.0 2.1 3.9 5.6 7.8 4.5 0.0 1.2 0.0 1.7 0.1 0.4 0.4 0.3 0.4 0.0 0.4 0.7 0.4 0.0 0.0 0.6 1.0 0.0 0.4 9.9 8.9 14.0 10.0 8.4 4.2 6.7 3.4 6.3 8.2 0.0 1.9 2.0 0.9 2.3 4.5 2.5 0.0 0.0 0.0 3.5 2.0 1.1 0.0 0.9 1.1 0.7 0.9 0.0 0.7 1.6 1.1 0.8 0.0 0.6 1.1 6.4 2.9 4.3 1.8 1.5 0.3 1.9 3.3 0.0 1.6 1.0 1.6 0.0 1.4 1.0 6.4 0.0 1.0 3.7 5.5 2.6 0.7 0.9 1.0 1.0 KLHL2 MAV ENSG00000109466 "Kelch like family member 2" O95198 4 165207618-165323156 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.6" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 10.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051637 Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA051637: " "unprognostic (1.14e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (8.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.56e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (4.42e-2)" "unprognostic (2.06e-1)" "unprognostic (4.67e-1)" "unprognostic (4.88e-2)" "prognostic favorable (3.77e-4)" "unprognostic (4.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-2)" "unprognostic (1.81e-1)" 10.5 11.2 25.1 10.4 36.0 16.4 12.1 9.7 41.6 6.1 5.8 19.6 4.0 5.0 7.0 13.4 15.8 8.9 9.5 5.0 37.2 17.7 13.3 23.8 10.6 9.4 25.7 14.7 3.8 6.6 5.3 18.4 6.9 15.1 7.8 6.5 4.0 16.3 9.7 3.2 4.7 5.6 9.6 25.7 11.1 7.4 5.4 25.0 1.6 11.3 3.4 8.4 10.9 7.2 1.3 1.2 10.8 1.9 0.3 1.6 0.6 8.7 8.1 5.6 5.8 8.7 7.8 6.0 11.9 9.4 6.2 6.7 4.8 6.6 9.1 3.0 6.0 11.0 6.1 9.1 6.3 8.0 14.8 3.5 7.6 7.2 7.5 7.6 7.8 11.1 6.5 18.0 5.6 21.2 10.9 14.8 3.4 3.4 19.2 9.5 3.3 0.2 2.5 3.4 5.0 3.6 3.1 4.2 2.8 11.3 8.5 28.8 4.8 7.5 2.7 7.2 10.9 1.8 8.9 20.4 4.9 10.1 5.6 8.0 12.5 8.7 7.3 6.0 5.6 9.6 1.9 1.4 1.9 0.8 1.4 0.5 0.4 0.6 0.5 1.2 1.3 1.4 1.6 10.8 0.3 1.9 0.7 0.7 0.6 25.1 36.0 9.7 24.7 37.2 17.7 25.7 14.7 15.1 25.0 6.0 14.1 5.6 11.1 5.4 8.3 4.0 7.6 5.3 7.9 21.0 13.7 3.5 23.2 6.7 1.1 13.4 4.1 0.0 11.3 8.3 5.4 10.1 9.2 30.8 7.4 30.2 14.9 17.2 40.5 1.3 3.7 20.7 5.0 4.6 4.7 3.2 8.8 4.8 4.2 14.7 6.4 0.0 6.8 2.1 7.1 6.6 3.1 7.0 3.1 16.1 KLHL41 "KBTBD10, Krp1, SARCOSIN" ENSG00000239474 "Kelch like family member 41" O60662 2 169509702-169526262 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "skeletal muscle: 564.4;tongue: 157.3" "Cell type enriched" "Detected in some" 12 "Cardiomyocytes: 97.4" "Group enriched" "Detected in some" 9 "head and neck cancer: 10.8;prostate cancer: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HSkMC: 12.8;LHCN-M2: 20.3;RH-30: 32.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA021165, HPA021753, HPA021760" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091" "unprognostic (2.44e-2)" "unprognostic (6.12e-2)" "unprognostic (9.01e-2)" "unprognostic (2.94e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-3)" "unprognostic (2.05e-1)" "unprognostic (5.46e-3)" "unprognostic (1.88e-1)" "unprognostic (5.38e-2)" "unprognostic (6.65e-4)" "unprognostic (9.64e-2)" "unprognostic (1.50e-1)" "unprognostic (1.69e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-2)" "unprognostic (1.52e-1)" 12.0 0.1 0.2 0.1 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.1 0.1 17.8 9.8 0.2 0.6 10.2 0.2 0.3 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.5 0.1 0.0 3.9 0.1 0.0 6.6 0.1 564.4 0.2 0.1 2.3 0.2 0.1 0.2 0.5 0.0 0.0 2.0 157.3 5.0 2.1 0.1 0.2 0.5 0.0 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.2 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.1 0.0 12.8 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.6 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 2.2 97.4 0.0 4.0 3.4 0.0 7.9 0.0 0.0 0.4 3.7 0.0 0.0 0.0 0.5 0.0 0.3 0.4 0.0 0.0 0.2 0.0 1.2 0.6 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.7 0.7 0.0 1.1 0.2 5.7 0.0 0.6 3.3 0.5 0.0 0.0 0.0 0.0 0.0 KLRB1 "CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A" ENSG00000111796 "Killer cell lectin like receptor B1" Q12918 12 9594551-9607886 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "blood: 178.9" "Cell type enriched" "Detected in many" 21 "T-cells: 765.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "MAIT T-cell: 178.9" "Group enriched" "Detected in many" 133 "NK-cells: 53.0;T-cells: 178.9" "Cell line enhanced" "Detected in some" "HEL: 3.0;Karpas-707: 2.2" "Low region specificity" "Detected in all" HPA039113 Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039113: AB_10674979" "prognostic favorable (3.51e-5)" "unprognostic (1.23e-3)" "unprognostic (7.03e-3)" "prognostic favorable (1.42e-5)" "unprognostic (1.69e-1)" "prognostic favorable (6.99e-5)" "unprognostic (1.54e-3)" "unprognostic (7.15e-3)" "unprognostic (4.12e-1)" "unprognostic (8.23e-3)" "unprognostic (3.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "prognostic favorable (5.61e-4)" "unprognostic (1.17e-2)" 3.8 0.8 0.8 22.8 0.8 18.6 2.1 0.5 0.6 2.9 9.1 0.0 1.3 5.0 1.8 3.7 2.6 1.8 7.3 1.3 0.7 0.8 3.8 4.9 11.8 23.7 1.1 0.2 2.0 1.0 0.0 0.9 2.1 0.8 1.8 3.9 0.9 4.8 1.4 0.9 0.8 20.4 0.6 1.8 25.2 4.4 1.3 0.2 6.2 1.9 2.9 17.7 5.5 2.0 0.1 0.3 0.8 0.2 53.0 178.9 18.5 0.1 0.0 1.5 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.1 0.0 0.9 0.2 1.9 0.0 0.0 0.2 0.0 3.0 0.0 0.4 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.2 2.2 0.0 0.8 0.8 0.6 0.5 0.5 0.0 1.1 0.3 0.9 0.0 0.5 0.4 0.6 0.6 0.7 0.1 1.7 0.3 0.2 0.0 1.6 0.0 0.4 0.7 0.6 0.4 1.5 0.0 1.8 1.0 0.5 0.1 0.0 43.1 0.1 178.9 0.1 25.6 28.1 0.1 0.1 1.5 8.7 0.8 53.0 0.2 0.3 5.7 18.5 0.8 0.8 0.5 0.6 0.7 0.8 1.1 0.2 0.8 0.2 0.0 12.8 14.5 0.6 8.7 0.0 0.8 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 5.1 1.3 0.0 5.5 0.9 0.0 0.0 35.6 22.5 0.0 0.0 3.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.5 0.0 0.0 7.8 0.8 765.3 0.3 1.3 KLRC3 NKG2-E ENSG00000205810 "Killer cell lectin like receptor C3" Q07444 12 10412312-10420595 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 28.5;brain: 9.7;lymphoid tissue: 6.9" "Cell type enhanced" "Detected in some" 19 "Club cells: 1.2;Intestinal endocrine cells: 1.7;T-cells: 1.3" "Cancer enriched" "Detected in single" 9 "glioma: 0.6" "Cell type enriched" "Detected in some" 5 "NK-cell: 28.5" "Lineage enriched" "Detected in many" 5 "NK-cells: 28.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.5;GAMG: 5.1;HEL: 2.2;HeLa: 11.6;HSkMC: 2.2;SuSa: 2.8;U-698: 3.2" "HPA039910, HPA062570" Approved Uncertain Vesicles NA NA Vesicles "HPA039910: , HPA062570: AB_2684795" "unprognostic (8.92e-4)" "unprognostic (4.47e-2)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.07e-3)" "unprognostic (2.48e-1)" "unprognostic (3.22e-1)" "unprognostic (9.12e-2)" "unprognostic (3.52e-3)" "unprognostic (3.09e-1)" "unprognostic (1.08e-1)" "unprognostic (3.15e-1)" 0.1 0.0 4.6 0.2 2.4 2.5 0.0 0.2 9.7 0.0 0.6 1.2 0.7 0.0 0.1 0.3 0.9 0.0 3.7 2.9 0.0 0.6 0.8 2.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.0 2.1 6.9 0.7 0.1 0.1 1.0 0.1 0.0 0.0 0.0 0.3 0.0 28.5 5.6 1.5 0.0 0.0 0.1 0.7 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.1 0.0 1.0 0.0 0.0 0.0 2.2 11.6 0.1 0.0 0.2 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.5 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 4.4 0.3 28.5 0.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 KLRG2 "CLEC15B, FLJ44186" ENSG00000188883 "Killer cell lectin like receptor G2" A4D1S0 7 139452690-139483712 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 9.7;thyroid gland: 22.1" "Group enriched" "Detected in some" 6 "Collecting duct cells: 7.0;Extravillous trophoblasts: 1.8;Syncytiotrophoblasts: 6.4" "Cancer enriched" "Detected in many" 11 "testis cancer: 42.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 11.2;HAP1: 11.8;NTERA-2: 6.2;SCLC-21H: 5.6;SK-BR-3: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018199 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA018199: AB_2133260" "unprognostic (2.50e-2)" "unprognostic (3.05e-2)" "unprognostic (9.82e-2)" "unprognostic (5.38e-8)" "unprognostic (2.41e-1)" "unprognostic (1.97e-2)" "unprognostic (3.13e-2)" "prognostic favorable (8.61e-4)" "unprognostic (2.14e-2)" "unprognostic (2.92e-1)" "unprognostic (5.19e-2)" "unprognostic (8.83e-2)" "unprognostic (1.10e-3)" "unprognostic (5.66e-2)" "unprognostic (1.71e-1)" "unprognostic (1.14e-2)" "unprognostic (2.34e-2)" 0.2 0.1 0.0 0.0 0.3 0.0 2.4 0.0 0.8 1.0 0.0 0.2 0.0 0.0 0.2 0.7 7.3 0.2 0.0 0.0 0.0 0.0 4.5 0.0 6.2 0.0 0.1 0.0 0.0 0.2 6.5 0.9 0.7 0.3 0.2 0.1 0.3 9.7 0.3 0.1 4.7 0.0 1.5 1.4 0.0 0.2 2.3 0.0 0.9 22.1 2.6 2.3 0.8 2.4 0.4 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 3.3 0.0 0.0 1.7 11.8 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.1 0.0 0.2 0.0 5.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.0 1.8 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.4 0.1 5.6 0.3 1.7 23.9 0.0 4.8 5.3 1.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.3 0.0 0.0 0.0 7.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 6.4 0.0 0.0 0.3 KMT5A "PR-Set7, SET07, SET8, SETD8" ENSG00000183955 "Lysine methyltransferase 5A" Q9NQR1 12 123383773-123409358 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064495 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA064495: AB_2685273" "unprognostic (5.62e-2)" "unprognostic (4.45e-2)" "unprognostic (3.90e-1)" "unprognostic (3.04e-1)" "unprognostic (2.20e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (6.21e-7)" "unprognostic (3.88e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-2)" "unprognostic (6.13e-2)" "unprognostic (3.44e-1)" "unprognostic (4.75e-3)" "unprognostic (4.27e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.06e-1)" 7.6 5.4 8.9 14.0 7.5 20.2 7.9 9.8 14.1 13.9 9.1 9.9 21.4 7.3 15.7 9.5 22.3 12.3 8.3 10.9 8.1 5.5 6.7 7.4 8.7 8.4 7.8 10.6 7.2 13.1 6.8 7.4 9.9 12.8 18.6 9.1 7.9 19.3 12.5 13.6 15.6 9.1 11.0 10.3 13.3 9.0 5.2 8.6 42.2 17.2 8.9 19.7 12.3 14.2 3.5 3.8 7.8 3.8 4.1 5.4 0.6 12.4 7.9 9.5 14.6 6.1 10.9 13.0 18.6 8.9 10.8 9.5 9.0 7.3 28.7 10.8 12.3 4.0 11.6 13.6 6.8 11.6 12.1 14.1 24.1 8.3 4.5 9.1 18.7 6.1 4.6 8.6 11.7 10.9 10.4 8.8 12.3 43.6 13.4 8.8 9.0 18.9 27.9 4.4 11.3 9.0 22.5 8.1 7.8 7.5 15.2 13.0 10.2 18.5 9.4 8.5 8.8 13.1 23.9 11.2 12.2 8.9 14.5 13.3 7.5 7.8 26.3 8.4 9.8 10.2 4.1 2.5 7.8 2.8 3.8 5.4 3.5 3.3 4.3 2.0 2.3 1.8 2.3 3.4 4.1 3.6 3.8 2.7 0.6 8.9 7.5 9.8 14.1 8.1 5.5 7.8 10.6 12.8 8.6 11.9 12.6 0.0 14.2 0.0 19.6 0.0 5.1 21.4 12.5 26.2 5.9 10.7 6.6 8.0 7.4 11.3 8.5 0.0 8.1 13.9 8.7 20.1 2.3 13.4 15.1 3.2 4.7 28.8 17.1 2.1 15.0 10.3 0.0 1.0 28.5 22.4 11.3 10.5 40.3 8.3 16.8 6.5 0.0 8.9 11.7 0.0 11.9 8.2 12.4 19.3 KPTN 2E4 ENSG00000118162 "Kaptin, actin binding protein" Q9Y664 19 47475144-47484268 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 18.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041710, HPA041796" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles" "HPA041710: AB_10961904, HPA041796: AB_10962832" "unprognostic (4.80e-3)" "unprognostic (2.22e-1)" "unprognostic (7.24e-2)" "unprognostic (1.53e-1)" "unprognostic (5.54e-2)" "unprognostic (3.47e-2)" "prognostic unfavorable (7.91e-6)" "unprognostic (9.30e-2)" "unprognostic (2.24e-1)" "unprognostic (2.21e-2)" "unprognostic (5.51e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (7.82e-4)" "unprognostic (1.40e-1)" "unprognostic (8.72e-2)" "unprognostic (2.04e-1)" "unprognostic (2.34e-1)" 6.0 5.8 7.1 5.3 15.6 8.9 6.2 17.2 11.0 4.6 5.4 5.7 3.4 6.0 4.5 3.0 7.3 3.6 4.4 6.5 9.5 7.1 5.8 6.8 4.5 5.5 13.0 6.3 2.7 5.5 9.2 8.9 6.3 8.9 6.5 4.2 3.7 17.6 3.9 8.7 5.4 5.1 4.8 8.5 5.0 3.9 3.9 9.6 12.5 4.8 6.2 3.9 5.1 4.7 1.4 18.5 2.6 3.8 0.9 1.3 1.7 6.3 11.1 8.7 5.4 9.0 7.1 6.1 3.5 6.7 19.4 12.2 8.0 7.6 7.6 2.7 6.3 7.0 7.3 7.4 12.8 5.4 7.1 11.5 3.2 7.5 7.1 8.1 6.4 9.3 8.1 8.3 6.4 6.0 4.9 7.4 10.3 6.4 7.4 5.6 4.9 11.4 27.5 7.8 6.9 6.8 8.3 4.4 3.2 6.0 9.5 18.7 14.4 5.9 6.8 4.4 4.5 5.6 9.4 4.2 4.6 5.3 2.5 7.9 1.9 2.9 3.3 4.2 4.2 6.9 0.0 3.0 1.2 1.2 2.5 0.4 1.3 0.8 1.0 3.6 1.4 1.1 0.9 2.6 0.9 3.8 18.5 1.3 1.7 7.1 15.6 17.2 11.0 9.5 7.1 13.0 6.3 8.9 9.6 3.0 2.4 5.6 6.1 2.5 5.6 2.8 7.6 0.0 5.7 5.2 5.9 12.8 8.3 8.7 0.6 2.3 3.5 0.0 3.5 10.6 4.1 5.5 2.3 5.5 7.5 9.5 2.9 3.7 5.1 1.9 1.1 5.3 1.7 1.8 1.5 6.5 5.3 1.9 0.7 5.8 4.1 0.0 2.1 3.2 18.5 2.8 12.8 2.5 2.8 5.8 KRIT1 "CAM, CCM1" ENSG00000001631 "KRIT1, ankyrin repeat containing" O00522 7 92198969-92246166 "Disease related genes, Predicted intracellular proteins" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 177.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049606 Supported Uncertain Vesicles NA NA Vesicles "HPA049606: AB_2680832" "unprognostic (8.12e-2)" "unprognostic (1.11e-2)" "unprognostic (1.83e-2)" "unprognostic (3.75e-2)" "unprognostic (1.94e-1)" "unprognostic (8.93e-2)" "unprognostic (4.10e-3)" "unprognostic (1.06e-2)" "unprognostic (2.30e-3)" "unprognostic (2.18e-1)" "unprognostic (7.24e-2)" "unprognostic (1.04e-1)" "unprognostic (1.19e-1)" "unprognostic (2.82e-1)" "unprognostic (2.61e-1)" "unprognostic (6.18e-2)" "unprognostic (1.04e-1)" 16.7 16.2 18.0 15.6 22.4 7.1 15.8 32.7 32.0 18.7 16.3 11.7 16.8 14.8 19.3 16.1 15.4 16.2 17.1 19.5 14.7 13.5 17.5 14.0 13.5 14.4 22.1 15.9 23.1 16.6 26.2 46.0 16.3 17.2 17.5 13.5 12.8 17.2 19.6 23.0 13.3 14.6 16.7 20.3 14.7 16.2 23.7 19.9 19.1 25.0 12.6 17.2 19.4 19.8 11.8 8.2 11.7 5.8 12.7 11.4 3.6 19.0 13.1 16.4 17.6 14.7 14.5 15.4 17.9 13.1 12.0 11.6 11.1 20.0 17.1 17.8 10.4 16.6 15.9 16.0 10.6 16.6 18.1 19.1 17.4 16.8 7.6 11.5 22.3 21.3 13.6 14.2 11.7 13.5 13.3 12.1 14.4 34.2 24.0 13.8 17.7 24.3 13.2 17.1 14.2 13.6 16.6 24.0 21.6 7.8 17.2 17.9 22.0 21.6 23.0 14.3 21.2 13.7 12.1 17.0 23.3 20.7 32.0 13.1 18.8 21.4 32.1 13.2 18.3 21.9 11.7 5.8 5.9 7.8 4.3 8.1 11.8 8.8 10.5 6.0 10.0 11.4 9.9 2.4 12.7 3.2 8.2 8.2 3.6 18.0 22.4 32.7 32.0 14.7 13.5 22.1 15.9 17.2 19.9 14.9 30.1 23.0 24.1 17.6 42.8 24.6 20.4 44.2 27.3 40.1 31.4 30.9 39.7 19.8 19.6 33.8 18.6 0.0 21.0 25.7 28.6 21.5 34.8 24.5 16.6 27.0 19.5 43.6 20.6 12.2 47.5 20.7 6.8 19.0 19.9 38.9 19.6 28.1 50.9 24.8 49.3 38.8 20.2 177.4 82.6 22.0 23.5 29.4 22.9 16.3 KRT15 "CK15, K15, K1CO" ENSG00000171346 "Keratin 15" P19012 17 41513743-41522529 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 37.4;esophagus: 115.3;skin 1: 119.3;vagina: 38.6" "Cell type enhanced" "Detected in many" 19 "Basal glandular cells: 1816.1;Basal keratinocytes: 1163.5;Urothelial cells: 567.2" "Cancer enhanced" "Detected in many" "cervical cancer: 178.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "HaCaT: 123.1;hTCEpi: 95.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023910, HPA024554" Enhanced Supported "Nucleoplasm,Intermediate filaments" No No 580000000 "Intermediate filaments" Nucleoplasm "HPA023910: AB_1852205, HPA024554: AB_1852207" "prognostic favorable (4.50e-4)" "unprognostic (9.14e-2)" "unprognostic (3.28e-2)" "unprognostic (1.19e-3)" "unprognostic (3.57e-2)" "unprognostic (8.84e-2)" "unprognostic (6.12e-3)" "unprognostic (1.70e-1)" "unprognostic (2.13e-1)" "unprognostic (8.65e-3)" "unprognostic (9.91e-3)" "unprognostic (2.09e-1)" "unprognostic (2.24e-11)" "unprognostic (6.91e-3)" "unprognostic (2.62e-1)" "unprognostic (1.33e-5)" "unprognostic (5.35e-2)" 0.6 0.0 1.4 0.6 1.5 0.0 37.4 0.6 1.1 14.6 1.1 0.6 0.6 0.0 0.6 0.6 115.3 2.7 10.6 0.6 1.3 0.0 1.1 0.6 2.1 0.6 0.6 0.6 0.6 0.6 0.0 0.6 3.0 1.1 16.4 0.0 1.4 15.1 0.6 0.6 119.3 3.5 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 1.9 6.2 0.8 38.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.1 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.6 2.2 0.0 0.2 0.0 1.3 123.1 0.0 4.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.4 0.0 95.2 0.2 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.6 0.0 0.0 10.4 0.3 0.7 0.2 0.0 0.1 1.8 0.1 0.0 2.3 0.0 2.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 1.5 0.6 1.1 1.3 0.0 0.6 0.6 1.1 0.6 11.9 10.1 0.0 1816.1 1163.5 0.6 0.7 7.6 22.7 230.9 1.8 0.0 0.4 1.7 6.9 90.0 0.5 4.7 0.0 6.8 6.5 13.4 221.8 2.3 0.0 0.3 0.0 4.6 0.0 0.0 35.8 1.4 5.1 303.7 0.0 10.4 0.0 8.6 9.7 0.4 0.0 0.6 0.0 22.7 0.6 0.7 169.3 1.0 0.5 6.0 567.2 L1CAM "CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1" ENSG00000198910 "L1 cell adhesion molecule" P32004 X 153861514-153886174 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 29.6;brain: 54.5" "Group enriched" "Detected in some" 6 "Collecting duct cells: 80.3;Horizontal cells: 31.8;Melanocytes: 42.2" "Cancer enhanced" "Detected in many" "melanoma: 34.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 1.0;naive B-cell: 2.2" "Lineage enriched" "Detected in single" 7 "B-cells: 2.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 73.5;BJ hTERT+ SV40 Large T+ RasG12V: 40.4;HeLa: 53.0;RH-30: 32.2;RPTEC TERT1: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010896 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 59000000 "Nucleoplasm, Plasma membrane" "CAB010896: AB_609903" "unprognostic (1.33e-3)" "unprognostic (3.43e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (8.51e-10)" "unprognostic (2.04e-2)" "prognostic unfavorable (3.81e-4)" "unprognostic (9.44e-2)" "prognostic unfavorable (2.36e-6)" "unprognostic (1.13e-1)" "unprognostic (9.12e-2)" "unprognostic (8.52e-3)" "unprognostic (8.02e-2)" "prognostic unfavorable (1.17e-4)" "unprognostic (3.07e-1)" "unprognostic (6.31e-2)" "unprognostic (1.69e-1)" "unprognostic (7.47e-3)" 4.4 29.6 19.9 8.0 21.9 1.2 1.7 54.5 43.6 2.8 16.3 1.5 2.0 4.9 1.7 3.0 5.3 2.6 3.2 5.2 11.2 20.6 12.3 1.3 1.3 3.7 7.3 22.4 1.4 3.0 1.0 6.1 1.4 19.3 3.5 5.7 6.2 5.9 10.8 1.6 9.9 7.6 6.1 3.5 1.7 4.8 1.5 3.4 0.0 1.2 1.3 2.6 2.3 3.9 2.2 0.0 0.0 0.0 0.0 0.3 0.2 17.9 1.4 5.4 0.0 0.0 0.0 2.3 25.5 73.5 24.6 40.4 7.3 0.1 0.0 24.3 0.1 20.6 0.7 0.6 0.4 12.9 0.0 0.1 0.0 53.0 1.1 0.0 0.0 4.0 0.1 0.3 3.7 2.5 0.0 0.0 0.0 0.0 0.0 0.1 24.4 0.0 0.5 1.2 0.0 0.9 0.0 32.2 0.1 43.2 0.3 16.2 10.6 14.3 12.7 10.3 12.7 1.3 0.3 0.0 0.0 10.8 1.1 12.1 0.2 0.3 0.1 0.1 0.2 20.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.9 21.9 54.5 30.2 11.2 20.6 7.3 22.4 19.3 3.4 0.0 0.0 0.8 0.0 1.0 8.5 0.8 0.0 0.0 0.0 80.3 3.9 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 31.8 0.0 1.8 0.0 0.0 0.9 0.0 42.2 0.0 0.0 0.8 0.0 0.0 0.0 0.2 8.6 0.0 0.4 0.0 0.1 1.1 0.1 0.0 0.0 0.1 L3HYPDH "C14orf149, FLJ25436" ENSG00000126790 "Trans-L-3-hydroxyproline dehydratase" Q96EM0 14 59460363-59484430 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 26.8;Proximal tubular cells: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056694 Approved Uncertain Vesicles NA NA 16000 Vesicles "HPA056694: AB_2683210" "unprognostic (3.39e-2)" "unprognostic (5.55e-3)" "unprognostic (3.81e-2)" "unprognostic (5.86e-2)" "unprognostic (1.10e-1)" "unprognostic (5.06e-2)" "unprognostic (8.34e-2)" "unprognostic (1.16e-1)" "unprognostic (7.24e-2)" "unprognostic (9.50e-2)" "unprognostic (1.26e-3)" "unprognostic (6.60e-2)" "prognostic unfavorable (1.72e-9)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (1.05e-1)" "unprognostic (1.14e-1)" 17.9 15.4 13.5 13.5 17.1 4.9 22.8 10.4 16.5 12.6 9.9 18.5 10.9 12.3 17.6 10.3 9.8 16.3 13.2 15.9 13.6 7.2 20.2 17.4 11.5 18.5 22.7 9.6 20.1 12.8 23.1 22.5 11.9 18.2 15.5 12.0 12.9 13.6 15.5 8.7 11.0 13.7 14.0 18.4 14.3 11.0 18.9 17.4 6.6 17.9 9.9 15.0 12.7 18.7 2.3 7.9 0.8 7.0 7.0 5.1 2.5 6.0 16.6 3.6 8.5 7.8 20.7 5.0 16.5 13.2 9.6 9.4 3.3 11.1 2.1 7.0 9.1 17.0 16.6 5.8 8.9 9.5 3.5 7.5 5.7 14.5 12.0 8.8 5.0 4.0 14.9 6.1 9.6 14.9 15.0 11.7 5.9 7.4 9.7 9.9 7.3 1.9 8.3 5.8 2.4 15.0 2.8 5.8 8.4 15.3 3.5 3.7 5.3 15.6 6.5 5.9 3.1 6.8 3.3 16.3 11.2 13.7 8.7 19.3 2.5 1.1 2.0 19.3 4.3 21.9 0.0 5.0 0.8 5.1 7.0 3.4 2.3 2.5 3.0 7.9 2.2 3.9 1.4 0.0 7.0 3.2 4.3 1.1 2.5 13.5 17.1 10.4 16.5 13.6 7.2 22.7 9.6 18.2 17.4 3.0 6.7 3.2 5.1 4.6 3.0 7.5 5.1 26.8 5.7 3.5 2.0 10.8 6.6 6.2 6.8 6.7 2.0 0.0 2.1 9.5 9.7 2.6 13.9 13.1 7.1 1.6 2.9 11.1 3.5 6.8 17.8 3.0 3.3 0.0 3.6 4.0 4.2 0.0 11.3 31.2 2.1 12.9 9.2 13.4 5.1 3.0 4.1 3.9 3.1 0.9 LAMA5 ENSG00000130702 "Laminin subunit alpha 5" O15230 20 62307955-62367312 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 71.5;Cytotrophoblasts: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 30.9;CACO-2: 42.6;EFO-21: 31.8;HaCaT: 29.0;HeLa: 27.8;TIME: 37.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054609, CAB078157" Enhanced Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA 1200000 Vesicles Nucleoplasm "CAB078157: AB_2665809, HPA054609: AB_2682540" "unprognostic (8.01e-2)" "unprognostic (2.47e-1)" "unprognostic (1.92e-2)" "unprognostic (3.42e-3)" "unprognostic (1.17e-1)" "unprognostic (9.90e-3)" "unprognostic (4.01e-3)" "unprognostic (5.45e-2)" "unprognostic (8.99e-2)" "unprognostic (1.34e-2)" "unprognostic (5.98e-3)" "unprognostic (2.98e-3)" "unprognostic (4.04e-2)" "unprognostic (9.86e-3)" "unprognostic (2.07e-1)" "unprognostic (9.76e-2)" "unprognostic (1.33e-2)" 22.6 5.9 5.6 8.1 5.9 2.5 16.8 24.0 6.6 16.7 28.0 3.1 18.6 7.6 23.2 13.8 18.0 14.2 27.4 13.7 4.7 2.9 17.0 7.3 19.7 4.4 3.7 2.3 6.9 13.9 8.3 6.0 33.3 5.5 17.4 2.6 18.6 12.7 25.0 9.4 45.2 9.0 25.0 4.5 8.8 13.3 4.4 3.4 2.0 18.4 11.8 10.4 19.4 24.9 0.9 1.2 0.2 0.0 0.0 0.0 0.0 3.9 30.9 0.6 4.0 0.7 8.8 23.8 1.1 0.6 0.9 0.1 42.6 16.0 0.3 31.8 0.0 0.9 29.0 0.8 12.4 0.0 0.1 1.7 1.0 27.8 12.1 2.8 0.0 4.6 0.4 8.2 2.1 2.2 1.5 4.1 0.0 1.8 0.4 0.0 5.9 0.0 0.1 2.0 5.1 18.0 0.0 0.3 3.3 8.0 18.9 0.3 12.3 17.1 17.1 0.3 3.3 17.0 0.2 37.3 0.4 11.8 0.2 5.0 0.2 0.0 0.1 8.8 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 5.6 5.9 24.0 6.6 4.7 2.9 3.7 2.3 5.5 3.4 71.5 26.6 8.3 15.9 15.1 1.3 15.3 22.9 13.4 35.2 36.6 7.9 73.3 0.0 28.3 4.3 36.5 0.0 0.0 3.8 24.9 7.8 13.3 2.3 9.4 11.6 3.2 2.4 17.8 0.0 1.1 9.2 2.5 1.7 1.8 0.0 8.2 10.9 0.0 18.4 10.2 1.7 25.8 31.9 0.7 1.9 11.0 47.9 1.0 0.2 24.5 LAMP5 "BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46" ENSG00000125869 "Lysosomal associated membrane protein family member 5" Q9UJQ1 20 9514358-9530524 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.1;brain: 105.2" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 57.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "basal ganglia: 105.2" "Cell type enriched" "Detected in some" 15 "plasmacytoid DC: 42.1" "Lineage enriched" "Detected in many" 30 "dendritic cells: 42.1" "Cell line enhanced" "Detected in some" "Karpas-707: 95.0;SH-SY5Y: 17.4;THP-1: 33.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004802, HPA070765" Enhanced Uncertain "Mitotic spindle,Centriolar satellite,Cytosol" NA NA Cytosol "Mitotic spindle, Centriolar satellite" "HPA004802: AB_10603682, HPA070765: AB_2686309" "unprognostic (2.78e-2)" "unprognostic (3.90e-3)" "unprognostic (5.73e-4)" "unprognostic (5.47e-2)" "unprognostic (7.89e-2)" "unprognostic (2.67e-1)" "unprognostic (3.80e-3)" "unprognostic (1.45e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (6.46e-6)" "unprognostic (5.12e-3)" "unprognostic (3.74e-2)" "unprognostic (1.08e-2)" "unprognostic (4.49e-3)" 0.5 4.1 21.6 1.5 105.2 2.0 1.0 2.3 28.6 9.1 1.3 0.6 1.8 1.3 4.6 6.0 0.6 9.7 2.9 0.6 18.7 4.1 0.9 0.5 1.1 4.8 4.5 7.7 21.2 1.3 0.3 2.0 0.4 23.2 2.3 1.4 2.6 1.4 3.6 0.3 0.5 1.4 3.8 6.7 1.4 1.6 1.1 4.8 0.0 1.1 0.0 4.7 1.2 0.6 1.4 42.1 0.9 0.5 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.1 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.9 0.5 0.0 0.0 0.1 0.0 1.4 0.0 0.0 2.8 0.1 0.0 0.0 0.1 0.0 0.0 42.1 0.0 0.7 21.6 105.2 2.3 19.1 18.7 4.1 4.5 7.7 23.2 4.8 0.0 1.4 2.2 0.0 0.1 7.5 0.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.6 5.8 0.1 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 1.1 57.2 0.0 0.0 1.2 5.6 0.6 0.2 3.3 8.2 0.0 4.0 0.2 0.0 0.0 0.0 4.9 0.0 1.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 LANCL1 "GPR69A, p40" ENSG00000115365 "LanC like 1" O43813 2 210431249-210477652 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 73.1" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 104.6;Late spermatids: 88.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034994 Enhanced Uncertain Microtubules NA NA 13000 Microtubules "HPA034994: AB_10601936" "unprognostic (2.34e-1)" "unprognostic (1.78e-1)" "unprognostic (1.24e-1)" "unprognostic (1.50e-2)" "unprognostic (1.98e-1)" "unprognostic (2.67e-2)" "unprognostic (2.02e-2)" "unprognostic (1.20e-1)" "unprognostic (6.10e-2)" "unprognostic (9.76e-2)" "unprognostic (2.82e-2)" "unprognostic (2.08e-1)" "unprognostic (2.13e-3)" "unprognostic (1.23e-1)" "unprognostic (9.27e-2)" "unprognostic (1.29e-1)" "unprognostic (1.06e-1)" 10.7 11.5 26.2 5.7 43.8 6.6 14.0 24.0 48.7 10.3 8.5 66.1 3.5 8.6 12.2 8.4 12.4 10.0 9.4 16.6 36.6 23.0 16.1 9.5 8.5 10.0 43.5 21.5 14.0 9.9 34.9 9.4 8.9 47.3 14.3 9.5 6.6 7.8 14.1 10.4 17.3 8.2 13.9 73.1 8.9 7.3 21.2 37.1 8.7 10.1 5.9 10.9 9.1 7.1 8.6 8.0 6.1 7.4 7.5 13.0 6.0 9.9 11.3 18.2 18.4 20.8 29.5 12.7 15.3 19.8 14.2 18.7 12.6 11.5 8.6 20.1 17.4 23.1 10.4 11.8 24.7 24.0 9.9 12.7 15.1 39.5 22.2 17.3 19.1 5.4 21.2 20.4 18.6 15.2 32.2 20.5 26.7 18.8 14.1 18.3 8.8 25.6 10.6 12.1 12.2 7.9 11.6 25.4 12.7 26.0 9.8 17.4 24.2 17.9 38.5 20.0 28.1 13.1 10.3 20.8 25.0 16.8 13.0 16.0 8.7 16.3 12.0 23.5 14.9 28.8 5.8 2.4 6.1 12.1 5.1 11.8 7.8 10.8 12.1 8.0 8.6 11.5 13.0 0.9 7.5 7.4 7.1 11.1 6.0 26.2 43.8 24.0 48.7 36.6 23.0 43.5 21.5 47.3 37.1 11.9 13.9 9.0 6.7 23.4 26.4 32.3 5.1 13.4 12.5 19.2 17.7 8.7 13.3 8.5 104.6 11.9 5.3 0.0 10.4 4.5 11.0 7.2 5.8 14.3 7.6 47.7 6.4 6.7 8.3 88.3 12.0 4.9 15.1 2.8 7.5 20.4 5.1 3.5 18.0 13.9 22.8 19.4 17.5 30.4 17.7 29.0 4.2 10.7 13.4 5.6 LCA5L "C21orf13, MGC33295" ENSG00000157578 "LCA5L, lebercilin like" O95447 21 39405844-39445805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 57.2" "Cell type enhanced" "Detected in many" 28 "Early spermatids: 967.3;Late spermatids: 347.9;Spermatocytes: 191.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 6.9;T-47d: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019790, HPA032010" Enhanced Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019790: AB_1845690, HPA032010: AB_2674110" "unprognostic (1.02e-1)" "unprognostic (3.81e-1)" "unprognostic (2.43e-1)" "unprognostic (2.54e-3)" "unprognostic (4.69e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-2)" "unprognostic (6.34e-2)" "unprognostic (1.27e-2)" "unprognostic (1.85e-2)" "unprognostic (5.50e-2)" "unprognostic (2.37e-1)" "unprognostic (7.53e-3)" "unprognostic (1.40e-1)" "unprognostic (1.04e-2)" "unprognostic (9.68e-3)" "unprognostic (1.95e-1)" 0.4 1.3 1.4 0.3 3.7 0.3 1.2 1.1 1.6 1.2 0.6 2.3 2.7 0.4 0.9 4.6 0.4 4.4 1.0 0.5 1.9 1.2 1.6 1.3 1.0 0.3 0.7 1.2 0.8 1.1 1.7 9.1 0.3 3.1 0.7 0.4 2.2 0.8 1.8 1.7 0.7 0.4 0.5 0.7 0.4 0.6 57.2 1.1 0.3 2.9 0.4 0.3 0.5 0.5 0.3 0.7 0.2 0.5 0.0 1.1 0.0 1.7 1.8 1.0 3.2 1.6 1.4 0.2 0.5 0.8 1.0 0.1 1.0 1.9 1.2 1.5 1.7 0.4 0.5 0.1 1.0 0.6 0.6 1.5 0.9 1.9 0.2 1.3 2.0 0.0 1.2 4.2 3.0 3.4 2.2 0.6 1.9 3.1 1.2 1.1 6.9 0.6 0.7 6.2 1.3 1.9 0.4 0.4 1.2 3.3 0.6 2.1 0.9 3.8 1.6 2.5 0.6 7.4 0.3 0.1 0.6 0.4 1.8 0.5 3.7 1.9 0.4 2.8 0.7 1.2 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.5 0.6 0.2 0.3 0.0 1.1 0.2 0.0 0.5 0.7 0.0 0.0 1.4 3.7 1.1 1.6 1.9 1.2 0.7 1.2 3.1 1.1 3.0 0.3 0.0 0.8 0.5 2.0 1.7 2.5 84.3 27.3 7.0 5.9 0.8 16.6 2.7 967.3 1.0 0.0 0.0 2.0 0.1 1.5 0.5 0.0 1.5 0.5 1.6 4.1 1.8 0.6 347.9 6.1 1.0 1.7 1.0 1.3 3.1 1.7 0.0 7.4 9.1 15.3 19.4 0.9 191.0 27.7 0.5 0.2 0.0 0.8 0.5 LDB2 "CLIM1, LDB1" ENSG00000169744 "LIM domain binding 2" O43679 4 16501541-16898809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 21 "Endothelial cells: 120.7;Ito cells: 249.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "amygdala: 14.5;basal ganglia: 30.3;cerebral cortex: 45.3;hippocampal formation: 16.6;olfactory region: 21.7" "Cell type enriched" "Detected in single" 13 "NK-cell: 5.1" "Lineage enriched" "Detected in single" 13 "NK-cells: 5.1" "Cell line enhanced" "Detected in some" "AF22: 9.7;ASC TERT1: 9.3;fHDF/TERT166: 9.8;HAP1: 18.0;HUVEC TERT2: 34.0;U-138 MG: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017544, HPA068634" Supported Supported "Nucleoplasm,Nucleoli,Plasma membrane" No NA "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB017544: AB_2137013, HPA068634: AB_2686012" "unprognostic (3.43e-1)" "unprognostic (2.77e-1)" "unprognostic (9.10e-2)" "unprognostic (4.37e-1)" "unprognostic (7.25e-2)" "unprognostic (4.62e-3)" "unprognostic (2.10e-3)" "unprognostic (1.57e-1)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.96e-2)" "unprognostic (2.05e-3)" "unprognostic (1.26e-3)" "unprognostic (1.60e-1)" "unprognostic (9.63e-2)" "unprognostic (7.10e-3)" 27.9 9.5 14.5 4.6 30.3 0.4 26.8 1.1 45.3 27.1 6.8 2.7 8.0 4.0 54.9 14.4 9.5 15.6 18.3 18.5 16.6 4.8 14.9 15.0 31.3 6.9 5.5 21.7 11.9 4.6 15.2 5.6 33.7 3.4 10.4 5.4 15.4 6.1 8.6 7.5 5.4 6.8 32.8 4.2 32.9 6.7 6.4 3.4 0.7 17.8 7.5 3.0 14.7 13.3 0.2 0.0 0.3 0.0 5.1 0.0 0.6 0.0 0.0 9.7 0.0 5.6 9.3 0.0 5.3 4.1 0.6 1.5 0.0 0.0 0.0 0.0 9.8 0.0 0.0 18.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 5.2 0.0 6.7 0.0 1.4 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 2.8 0.0 0.0 8.9 13.7 0.0 0.7 0.0 4.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.6 14.5 30.3 1.1 45.3 16.6 4.8 5.5 21.7 3.4 3.4 0.0 8.5 1.9 0.2 7.7 21.5 9.2 5.1 1.4 0.0 0.0 0.0 0.2 0.0 1.7 1.1 120.7 0.0 0.0 0.2 0.2 22.0 0.3 5.7 1.3 0.3 0.0 0.0 249.8 20.4 1.5 35.4 2.3 8.5 0.0 0.0 9.8 0.3 0.0 47.4 0.0 1.7 6.5 13.4 0.0 0.6 5.9 0.1 5.4 0.0 0.1 LDLRAD1 ENSG00000203985 "Low density lipoprotein receptor class A domain containing 1" Q5T700 1 54007299-54018186 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 64.2;lung: 16.1;ovary: 20.5" "Cell type enriched" "Detected in some" 15 "Ciliated cells: 499.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CAPAN-2: 3.7;Hep G2: 15.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA052489 Enhanced Uncertain "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA052489: AB_2681850" "unprognostic (6.53e-3)" "unprognostic (2.05e-2)" "unprognostic (2.51e-1)" "prognostic favorable (9.21e-4)" "unprognostic (1.59e-2)" "unprognostic (1.67e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-1)" "unprognostic (8.07e-3)" "unprognostic (2.43e-1)" "unprognostic (2.86e-1)" "unprognostic (5.23e-1)" "unprognostic (4.27e-2)" 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.1 0.1 0.0 0.0 0.6 2.1 0.4 64.2 1.1 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 20.5 0.1 0.0 1.5 0.1 0.2 0.5 0.0 0.0 2.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.8 4.8 0.0 0.0 0.7 0.5 2.1 0.4 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 3.7 0.0 1.9 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.1 0.3 0.8 15.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.6 0.3 0.0 0.1 1.0 0.0 0.1 0.8 0.1 0.0 0.3 0.2 0.1 0.1 0.4 0.0 0.1 0.3 0.0 0.2 2.1 0.4 0.3 0.4 0.2 0.3 0.5 0.3 0.4 0.1 0.7 0.4 0.5 2.1 0.4 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.0 7.4 0.0 0.2 0.0 0.0 0.0 0.0 499.2 34.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.6 4.7 0.0 0.1 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 LETMD1 "HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3" ENSG00000050426 "LETM1 domain containing 1" Q6P1Q0 12 51047962-51060424 "Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074361 Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Mitochondria "Nucleoplasm, Nucleoli" "HPA074361: AB_2686682" "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.11e-1)" "unprognostic (2.20e-2)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "unprognostic (5.05e-2)" "unprognostic (7.86e-2)" "unprognostic (6.57e-2)" "prognostic favorable (3.26e-4)" "unprognostic (4.07e-1)" "unprognostic (7.79e-2)" "unprognostic (2.58e-1)" "prognostic favorable (3.16e-4)" 25.7 27.5 23.0 18.1 31.2 17.1 27.1 23.1 37.5 18.6 26.8 18.8 21.5 31.9 22.9 22.4 16.2 30.0 23.5 16.4 21.2 19.0 29.3 35.1 16.6 18.5 20.6 21.3 34.3 38.6 28.5 20.2 12.3 21.6 19.1 26.1 22.6 28.2 24.0 23.8 18.5 28.5 18.7 21.4 17.5 22.6 15.5 14.3 19.9 34.1 10.7 20.1 20.3 14.8 11.3 7.2 2.9 11.6 8.6 17.1 9.3 7.4 6.7 5.0 13.5 22.8 37.4 5.1 7.7 12.8 8.1 9.2 16.2 15.4 19.7 9.6 8.3 5.9 13.9 10.3 10.4 9.4 7.1 12.9 14.1 9.3 12.7 15.1 12.7 10.3 31.5 33.7 9.6 22.8 24.8 8.2 19.1 14.6 14.3 11.1 11.6 8.9 12.3 3.4 9.3 18.3 7.6 6.1 10.7 10.2 11.4 15.0 6.9 5.8 13.1 17.6 5.3 20.7 11.6 6.2 5.1 5.5 8.4 4.4 13.0 20.2 8.4 9.5 8.3 3.6 2.5 7.3 2.9 8.6 7.8 12.5 11.3 14.2 10.6 7.2 8.1 17.1 15.5 2.4 8.6 11.6 6.4 12.6 9.3 23.0 31.2 23.1 37.5 21.2 19.0 20.6 21.3 21.6 14.3 20.8 22.7 30.4 41.1 44.1 20.2 12.5 22.9 25.4 11.4 22.7 9.8 40.0 77.9 12.6 6.3 19.6 22.0 23.3 28.4 18.9 32.4 29.0 25.3 16.3 26.2 17.5 26.7 20.3 41.0 11.9 30.2 21.2 37.1 17.2 34.4 24.4 16.0 28.1 28.7 31.5 16.5 25.8 38.1 20.6 19.4 38.8 23.3 42.4 49.8 24.8 LGALS4 GAL4 ENSG00000171747 "Galectin 4" P56470 19 38801671-38813364 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "gallbladder: 157.1;intestine: 326.8;lymphoid tissue: 83.5" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 3138.6;Mucus-secreting cells: 3717.7;Paneth cells: 2896.2;Undifferentiated cells: 2134.6" "Group enriched" "Detected in many" 21 "colorectal cancer: 450.7;liver cancer: 133.6;pancreatic cancer: 213.7;stomach cancer: 190.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "basophil: 1.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.7" "Cell line enriched" "Detected in single" 239 "OE19: 123.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB025653, HPA031184, HPA031185, HPA031186" Enhanced Uncertain "Plasma membrane" NA NA 92000 "Plasma membrane" "CAB025653: , HPA031184: AB_2673776, HPA031185: AB_2673777, HPA031186: AB_2673778" "unprognostic (1.11e-1)" "unprognostic (1.12e-1)" "unprognostic (2.57e-3)" "unprognostic (7.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.61e-2)" "unprognostic (5.01e-2)" "unprognostic (5.34e-2)" "unprognostic (1.54e-1)" "unprognostic (7.58e-2)" "unprognostic (3.80e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.69e-1)" "unprognostic (3.38e-1)" "unprognostic (9.71e-2)" "prognostic favorable (3.21e-4)" 0.3 0.2 0.2 83.5 0.2 0.0 0.3 0.3 0.2 0.3 190.6 0.3 0.3 65.5 0.3 0.5 0.6 0.5 157.1 0.2 0.2 0.2 0.4 20.3 1.5 0.2 0.2 0.2 0.3 8.3 0.0 0.2 0.2 0.2 0.8 75.8 0.3 0.3 0.4 0.3 0.3 326.8 4.9 0.2 0.6 10.5 0.2 0.2 0.3 0.4 0.3 0.2 2.7 0.3 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 123.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 3.0 6.2 9.0 1.9 1.0 0.8 0.8 820.4 0.0 1.2 0.0 0.0 0.6 0.0 145.0 0.1 0.1 3138.6 0.0 92.9 0.6 0.2 1.5 50.5 28.7 0.1 1.6 624.2 2.5 2.1 0.0 0.0 0.0 0.0 4.6 3717.7 0.9 292.6 2896.2 0.4 1.6 1.8 0.0 0.3 0.0 0.2 2.4 0.5 0.7 2134.6 28.2 LGALS9B ENSG00000170298 "Galectin 9B" Q3B8N2 17 20449395-20467539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 13.4;esophagus: 13.6;stomach 1: 23.2" "Cell type enhanced" "Detected in some" 26 "Enterocytes: 7.8;Mucus-secreting cells: 17.2;Paneth cells: 43.5" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 15 "NK-cell: 13.4" "Lineage enriched" "Detected in single" 15 "NK-cells: 13.4" "Group enriched" "Detected in some" 7 "CAPAN-2: 13.6;U-937: 4.5" "HPA046876, HPA047218" Approved Uncertain Cytosol NA NA Cytosol "HPA046876: AB_2679852, HPA047218: AB_2679988" "unprognostic (4.69e-2)" "unprognostic (1.11e-2)" "unprognostic (2.67e-2)" "unprognostic (4.05e-1)" "unprognostic (8.62e-2)" "unprognostic (1.94e-1)" "unprognostic (3.93e-3)" "unprognostic (2.72e-1)" "unprognostic (2.26e-2)" "unprognostic (6.85e-2)" "unprognostic (1.32e-2)" "unprognostic (3.20e-1)" "unprognostic (3.79e-2)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (5.27e-2)" "unprognostic (1.05e-1)" 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 1.2 5.7 2.3 0.0 0.0 13.6 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.4 1.8 0.0 0.0 0.3 2.6 0.0 0.0 0.4 23.2 0.0 0.0 1.0 0.0 3.4 0.3 0.4 0.2 0.3 13.4 0.9 1.7 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.9 0.2 0.0 0.2 0.2 0.0 0.4 0.3 0.2 0.4 0.2 13.4 0.3 0.2 0.0 1.7 0.0 1.1 0.0 0.1 2.1 0.0 0.0 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.5 43.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 5.1 0.1 LGI2 "FLJ10675, KIAA1916" ENSG00000153012 "Leucine rich repeat LGI family member 2" Q8N0V4 4 24998847-25030879 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "parathyroid gland: 113.9" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 2.6;Collecting duct cells: 5.2;Hofbauer cells: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.3" "Lineage enriched" "Detected in single" 10 "monocytes: 1.3" "Cell line enhanced" "Detected in some" "AF22: 22.7;HAP1: 4.1;RPMI-8226: 10.4;SCLC-21H: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017140 Approved Uncertain Centrosome "Secreted to blood" NA NA Centrosome "HPA017140: AB_1852833" "unprognostic (1.62e-1)" "unprognostic (1.40e-1)" "unprognostic (4.31e-2)" "unprognostic (1.20e-5)" "unprognostic (3.99e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-2)" "unprognostic (8.54e-2)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (3.47e-2)" "unprognostic (1.62e-1)" "unprognostic (9.38e-5)" "unprognostic (5.78e-2)" "unprognostic (1.61e-1)" "unprognostic (2.06e-4)" "unprognostic (5.03e-3)" 2.5 1.6 2.8 6.7 3.3 0.8 2.3 7.9 7.8 3.7 4.0 0.0 1.0 1.1 8.9 4.9 4.1 11.4 4.2 3.7 2.4 3.9 3.0 0.9 1.4 2.0 7.2 0.4 9.1 2.6 113.9 0.5 2.6 18.7 1.0 1.6 6.0 0.9 1.4 0.9 0.9 2.6 7.1 2.9 1.2 2.4 2.0 0.9 0.6 1.8 0.6 4.6 1.8 1.1 0.0 0.1 0.0 1.3 0.0 0.0 0.2 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.6 0.0 0.2 0.0 4.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.7 0.0 0.8 0.0 0.9 10.4 0.4 0.0 14.7 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.2 1.6 0.0 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 3.3 7.9 7.8 2.4 3.9 7.2 0.4 18.7 0.9 0.0 0.0 0.0 0.1 0.1 0.4 2.6 0.0 0.0 0.0 5.2 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.8 1.6 0.0 1.3 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 1.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 LGR5 "FEX, GPR49, GPR67, HG38" ENSG00000139292 "Leucine rich repeat containing G protein-coupled receptor 5" O75473 12 71439770-71586310 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.3;fallopian tube: 19.9;placenta: 21.6;skeletal muscle: 26.6" "Cell type enhanced" "Detected in some" 23 "Cytotrophoblasts: 46.3;Syncytiotrophoblasts: 22.1;Undifferentiated cells: 11.5" "Group enriched" "Detected in many" 7 "colorectal cancer: 16.8;endometrial cancer: 26.8;ovarian cancer: 9.8;stomach cancer: 6.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 10 "B-cells: 1.1" "Group enriched" "Detected in some" 5 "Hep G2: 16.2;SH-SY5Y: 47.7" "Region enriched" "Detected in some" 8 "olfactory region: 41.8" "Low region specificity" "Detected in many" HPA012530 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA012530: AB_1849329" "unprognostic (5.19e-2)" "unprognostic (3.79e-1)" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.49e-3)" "unprognostic (1.52e-1)" "prognostic favorable (5.09e-4)" "unprognostic (1.46e-1)" "unprognostic (2.60e-1)" "unprognostic (3.71e-1)" "unprognostic (8.10e-2)" "unprognostic (2.01e-5)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (2.28e-2)" "unprognostic (6.25e-3)" 2.3 2.2 3.5 0.8 18.1 0.4 2.1 0.9 9.5 2.2 4.2 24.5 0.0 6.1 4.9 1.7 0.6 19.9 0.8 0.8 5.0 3.4 0.9 1.4 1.4 0.4 32.3 5.1 1.5 0.6 1.0 2.0 21.6 10.8 1.8 4.6 0.9 3.1 9.0 26.6 4.0 6.5 0.7 15.0 0.6 2.9 0.7 25.7 0.0 0.9 0.9 2.1 0.7 1.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.4 16.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 5.3 0.7 1.0 0.0 0.0 0.0 6.5 0.1 47.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 18.1 0.9 9.5 5.0 3.4 32.3 5.1 10.8 25.7 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 46.3 0.0 0.0 0.3 0.1 0.4 0.0 0.0 1.7 1.7 0.0 0.0 0.4 5.5 0.0 4.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 22.1 0.0 11.5 0.0 LGR6 FLJ14471 ENSG00000133067 "Leucine rich repeat containing G protein-coupled receptor 6" Q9HBX8 1 202193901-202319781 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 49.6" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 2.8;Cardiomyocytes: 8.3;Late spermatids: 3.2;Spermatocytes: 6.0;Spermatogonia: 3.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 17.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "gdT-cell: 14.3;memory CD8 T-cell: 8.3;naive CD8 T-cell: 4.7" "Lineage enriched" "Detected in single" 41 "T-cells: 14.3" "Cell line enhanced" "Detected in some" "A549: 16.6;CAPAN-2: 14.8;HaCaT: 8.0;HeLa: 4.0" "Region enriched" "Detected in some" 9 "olfactory region: 30.0" HPA008556 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA008556: " "unprognostic (4.72e-3)" "unprognostic (5.29e-2)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (1.08e-1)" "unprognostic (5.13e-2)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (4.01e-2)" "unprognostic (7.89e-2)" "unprognostic (1.00e-2)" "unprognostic (1.17e-3)" "unprognostic (2.08e-1)" "unprognostic (1.70e-1)" "unprognostic (7.83e-2)" 1.1 0.1 0.9 0.8 3.2 1.8 7.9 6.0 2.4 2.6 2.2 1.5 0.5 0.2 1.6 7.3 4.4 13.8 49.6 12.3 0.7 3.3 0.9 1.4 6.9 1.1 6.8 0.2 2.2 0.5 0.1 15.9 0.9 9.3 6.7 1.1 0.8 8.5 2.5 0.3 3.2 1.6 2.6 1.6 5.3 0.7 4.9 3.9 0.2 4.1 2.6 3.4 3.2 2.9 0.0 0.0 0.0 0.0 0.3 14.3 2.5 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 1.7 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.9 0.0 1.7 8.3 0.0 0.0 0.7 4.7 0.0 0.3 0.0 0.0 0.4 2.5 0.9 3.2 6.0 2.4 0.7 3.3 6.8 0.2 9.3 3.9 0.0 0.0 0.0 2.8 1.1 0.0 8.3 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 3.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 6.0 3.3 0.1 0.7 0.5 1.7 0.3 LHX6 LHX6.1 ENSG00000106852 "LIM homeobox 6" Q9UPM6 9 122202577-122229626 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4" "Group enriched" "Detected in some" 9 "Early spermatids: 64.4;Late spermatids: 142.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 11.7;K-562: 8.5;NB-4: 16.1;PC-3: 11.1;U-87 MG: 8.9" "Group enriched" "Detected in many" 5 "amygdala: 11.3;basal ganglia: 16.2;cerebral cortex: 8.5;hippocampal formation: 9.5;hypothalamus: 10.7" "Group enriched" "Detected in many" 7 "amygdala: 13.1;basal ganglia: 12.2;cerebral cortex: 13.3;hippocampal formation: 13.4;hypothalamus: 4.9" "HPA047854, HPA058319" Approved Uncertain "Nucleoli fibrillar center,Plasma membrane" NA NA "Nucleoli fibrillar center" "Plasma membrane" "HPA047854: AB_2680183, HPA058319: " "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (8.06e-2)" "unprognostic (6.18e-2)" "unprognostic (7.72e-2)" "unprognostic (4.49e-2)" "unprognostic (5.83e-2)" "unprognostic (3.47e-1)" "unprognostic (5.94e-3)" "unprognostic (2.15e-1)" "unprognostic (2.98e-2)" "unprognostic (9.14e-2)" "unprognostic (5.64e-6)" "unprognostic (1.77e-3)" "unprognostic (1.96e-1)" "unprognostic (1.08e-1)" "unprognostic (3.51e-2)" 14.4 1.2 7.3 4.2 11.5 0.5 10.6 0.4 17.4 3.6 3.0 0.9 0.9 2.6 3.8 2.5 4.1 2.6 6.1 6.4 12.3 3.5 1.9 0.9 5.2 2.2 2.0 12.4 2.1 1.1 2.3 0.3 6.0 1.1 2.4 3.2 1.4 2.3 2.3 4.3 2.5 3.1 7.4 1.5 0.6 2.3 7.8 2.2 0.0 3.2 4.6 2.5 5.3 7.3 0.0 0.0 0.0 0.1 0.0 0.5 0.1 2.4 0.0 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 11.7 3.0 0.0 2.6 0.0 1.0 0.0 1.3 3.3 0.0 0.0 1.9 0.1 0.8 0.5 0.0 2.2 0.6 0.0 0.8 0.0 0.2 0.0 4.3 0.6 8.5 0.0 0.0 2.4 0.0 16.1 2.6 0.4 11.1 0.0 5.6 0.0 2.0 0.0 1.7 0.4 3.0 0.9 3.0 0.5 2.5 0.0 0.7 0.8 1.2 0.0 0.2 0.3 0.1 0.2 8.9 3.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 7.3 11.5 0.4 17.4 12.3 3.5 2.0 12.4 1.1 2.2 0.0 0.0 0.0 0.1 0.1 0.0 2.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 64.4 11.9 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 142.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 2.3 6.9 0.3 0.0 0.0 0.0 0.1 LIG4 ENSG00000174405 "DNA ligase 4" P49917 13 108207439-108218368 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001334, HPA057325" Approved Supported "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "HPA001334: AB_1078689, HPA057325: AB_2732608" "unprognostic (9.93e-2)" "unprognostic (1.56e-1)" "unprognostic (2.35e-1)" "unprognostic (2.00e-2)" "unprognostic (1.40e-1)" "unprognostic (1.97e-1)" "unprognostic (1.56e-1)" "unprognostic (7.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.87e-1)" "unprognostic (1.96e-2)" "unprognostic (4.21e-3)" "unprognostic (1.94e-2)" "unprognostic (3.04e-1)" "unprognostic (1.82e-1)" "unprognostic (1.50e-2)" "unprognostic (9.03e-3)" 8.8 12.4 11.6 10.4 15.9 4.3 9.1 14.2 20.6 5.4 7.1 10.2 7.8 8.9 5.8 11.4 8.1 5.9 8.7 8.8 15.6 14.4 11.2 16.7 8.7 12.7 15.5 10.6 7.9 8.3 17.0 20.3 8.3 19.6 7.5 8.7 3.8 6.7 7.1 9.5 6.6 8.6 8.4 14.4 12.6 9.7 11.7 13.6 18.6 10.0 5.4 10.2 8.1 5.3 3.3 2.1 6.8 10.7 2.7 2.7 1.5 8.9 3.4 9.2 6.1 7.7 8.3 3.3 8.8 6.7 6.7 8.1 4.0 4.0 15.2 7.2 5.8 8.3 3.7 6.1 5.9 11.8 8.9 5.8 7.1 7.8 2.1 9.2 9.5 7.6 7.5 9.9 6.5 5.9 6.5 8.0 28.1 2.5 2.8 10.4 4.8 15.8 7.0 2.3 7.3 2.1 14.5 3.6 2.4 8.9 5.7 5.8 6.0 1.9 5.4 6.6 7.5 4.6 14.8 11.9 4.0 4.4 4.5 7.9 7.5 4.9 24.7 15.5 5.5 9.1 0.8 2.3 6.8 1.8 3.8 2.5 2.6 2.0 1.9 2.1 3.3 2.0 2.7 3.2 2.7 10.7 1.4 2.7 1.5 11.6 15.9 14.2 20.6 15.6 14.4 15.5 10.6 19.6 13.6 8.9 7.4 2.4 2.3 2.4 9.6 10.1 0.0 26.8 11.4 1.8 7.9 1.9 8.3 4.6 9.5 3.6 4.1 0.0 6.5 1.0 2.3 3.0 3.5 7.8 5.0 17.5 9.2 4.3 7.3 3.6 2.6 5.0 1.7 8.2 4.6 6.9 6.8 5.3 5.6 5.6 12.6 12.9 2.5 16.4 2.7 5.0 1.5 2.5 2.8 2.0 LIMS4 LIMS3L ENSG00000256671 "LIM zinc finger domain containing 4" P0CW20 2 110446640-110473075 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 26 "Exocrine glandular cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.7;HHSteC: 2.5;hTEC/SVTERT24-B: 4.9;HUVEC TERT2: 2.8;U-138 MG: 5.3" HPA058455 Uncertain Uncertain "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "HPA058455: AB_2683723" "unprognostic (2.12e-1)" 4.0 4.1 0.0 0.3 0.0 0.6 1.5 0.0 0.3 0.3 0.6 0.3 4.1 0.3 0.3 3.7 0.3 3.5 0.0 0.0 5.5 2.7 0.8 0.3 0.0 1.9 2.2 0.3 0.8 0.6 0.3 0.3 0.3 0.3 5.6 0.4 0.3 0.3 0.0 0.3 0.3 1.3 1.1 0.3 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 2.7 0.2 0.7 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 4.9 0.0 0.0 2.8 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.3 0.2 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LIPA "CESD, LAL" ENSG00000107798 "Lipase A, lysosomal acid type" P38571 10 89213569-89414557 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 139.0" "Group enriched" "Detected in many" 7 "Hofbauer cells: 503.3;Kupffer cells: 514.1;Macrophages: 167.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 31.8;intermediate monocyte: 68.4;myeloid DC: 23.3;non-classical monocyte: 35.6" "Group enriched" "Detected in all" 5 "dendritic cells: 23.3;monocytes: 68.4" "Cell line enhanced" "Detected in many" "AN3-CA: 61.6;ASC TERT1: 77.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034892, HPA057052" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" "Intracellular and membrane" NA NA 150000 "Vesicles, Cytosol" "Nucleoplasm, Nucleoli fibrillar center" "CAB034892: AB_784329, HPA057052: AB_2683322" "unprognostic (1.27e-1)" "unprognostic (3.23e-1)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" "unprognostic (7.14e-2)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (4.28e-2)" "unprognostic (1.08e-1)" "unprognostic (7.30e-3)" "unprognostic (1.39e-2)" "unprognostic (1.40e-1)" "unprognostic (4.42e-2)" "unprognostic (3.42e-2)" "unprognostic (5.71e-2)" 139.0 16.3 15.8 14.4 22.7 7.8 19.9 8.8 21.4 13.4 28.1 61.3 3.4 37.4 10.2 5.2 9.5 9.0 19.4 8.7 22.5 13.8 10.8 49.3 38.5 45.7 41.6 13.4 10.4 9.5 17.5 6.3 17.8 28.4 7.4 16.7 5.7 11.0 8.8 4.1 6.8 65.8 11.3 55.1 87.3 7.9 3.1 37.2 7.0 8.3 4.7 10.0 15.1 8.6 7.0 23.3 3.2 68.4 5.5 8.3 25.5 55.0 8.5 5.6 61.6 58.1 77.3 1.6 29.2 34.2 12.2 21.9 3.2 29.7 10.2 5.7 45.7 13.1 55.2 2.4 15.8 9.1 14.3 5.7 4.2 3.6 13.1 15.3 8.1 8.4 34.3 11.4 13.0 7.0 14.8 2.4 7.7 0.0 19.0 9.5 4.6 7.0 5.5 3.6 9.8 9.6 4.6 6.6 9.4 11.3 8.7 1.9 3.9 7.1 9.2 21.5 3.9 10.5 10.5 4.4 10.4 2.7 22.2 7.1 9.9 10.5 4.2 12.4 18.0 13.0 0.8 31.8 3.2 8.2 68.4 8.2 6.5 7.3 7.8 23.3 7.0 7.7 8.3 1.4 5.5 35.6 4.7 7.1 25.5 15.8 22.7 8.8 21.4 22.5 13.8 41.6 13.4 28.4 37.2 38.7 42.2 50.6 22.0 15.8 5.2 8.5 45.9 14.7 13.6 31.4 0.0 28.4 18.3 29.7 4.4 53.1 3.9 23.3 31.7 28.0 34.8 15.2 27.7 46.5 503.3 15.9 20.9 52.8 514.1 1.8 10.6 167.0 45.5 27.9 9.4 29.4 17.5 5.9 20.5 14.6 1.3 6.5 21.8 4.8 10.9 10.9 16.7 33.0 8.7 20.1 LMAN1 "ERGIC-53, ERGIC53, F5F8D, FMFD1, gp58, MCFD1, MR60" ENSG00000074695 "Lectin, mannose binding 1" P49257 18 59327823-59359962 "Disease related genes, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 369.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002320, CAB037163" Supported Uncertain Cytosol NA NA 13000000 Cytosol "CAB037163: AB_532237, HPA002320: AB_1079256" "unprognostic (5.64e-2)" "unprognostic (8.96e-3)" "unprognostic (4.20e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-2)" "unprognostic (2.61e-1)" "unprognostic (1.65e-1)" "unprognostic (5.40e-3)" "unprognostic (1.16e-1)" "unprognostic (2.03e-1)" "unprognostic (2.40e-2)" "unprognostic (1.06e-1)" "unprognostic (5.79e-2)" "unprognostic (4.28e-2)" "unprognostic (5.37e-3)" "unprognostic (7.05e-2)" "unprognostic (3.71e-3)" 6.2 7.7 2.6 4.5 3.0 1.6 5.7 4.6 1.8 9.8 3.9 5.7 6.7 7.4 6.6 6.5 3.8 8.0 2.7 3.0 9.1 26.2 7.0 2.7 2.8 8.1 15.3 12.7 9.7 7.1 8.2 5.0 8.4 6.1 6.9 3.4 6.1 4.6 3.5 4.8 7.5 2.1 12.3 3.9 4.7 5.6 6.9 8.2 4.0 3.4 9.0 9.8 3.8 18.7 11.1 11.9 9.9 27.9 48.3 24.1 34.0 48.8 23.0 30.9 11.0 18.2 3.3 24.2 40.3 16.5 23.1 16.9 19.2 42.0 12.7 10.8 10.9 14.9 22.8 33.2 37.8 16.8 32.1 23.2 22.2 45.7 43.4 23.1 11.6 18.3 37.4 22.3 5.0 10.9 7.8 8.2 9.5 13.8 12.4 21.7 36.3 12.8 14.2 8.2 8.9 17.1 16.8 19.2 17.5 12.4 14.8 19.0 37.5 13.1 11.9 19.7 28.6 14.2 16.2 39.3 20.2 30.5 4.0 2.3 0.6 7.2 3.4 9.8 6.9 7.9 7.5 3.1 4.7 7.6 7.5 0.3 9.0 1.9 8.2 8.7 3.8 95.3 75.6 40.2 99.5 62.0 36.5 107.3 68.8 120.5 94.4 76.8 100.1 135.4 18.3 109.7 19.1 71.9 34.5 0.0 73.5 233.6 149.7 186.9 32.4 369.6 72.2 55.6 49.5 84.1 33.9 6.3 102.4 44.4 64.1 62.3 110.0 95.5 79.1 59.6 80.2 62.0 60.8 64.7 72.9 37.1 59.8 49.8 193.4 52.2 80.9 90.2 LMOD2 ENSG00000170807 "Leiomodin 2" Q6P5Q4 7 123655807-123664290 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 44 "heart muscle: 117.3;skeletal muscle: 297.2;tongue: 100.1" "Cell type enriched" "Detected in some" 1164 "Cardiomyocytes: 1233.0" "Group enriched" "Detected in some" 20 "head and neck cancer: 3.5;prostate cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HSkMC: 5.7;SuSa: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046370, HPA051039" Enhanced Uncertain "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA046370: , HPA051039: AB_2681321" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-3)" "unprognostic (1.18e-1)" "unprognostic (5.50e-1)" "unprognostic (5.69e-2)" "unprognostic (6.98e-2)" "unprognostic (2.13e-2)" "unprognostic (1.43e-3)" "unprognostic (3.37e-2)" "unprognostic (1.51e-1)" "unprognostic (1.82e-3)" 3.3 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.2 3.8 0.0 0.0 117.3 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.5 0.0 0.0 2.6 0.0 297.2 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.4 100.1 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.3 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1233.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LMTK3 "KIAA1883, LMR3, PPP1R101, TYKLM3" ENSG00000142235 "Lemur tyrosine kinase 3" Q96Q04 19 48485271-48513189 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.1" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 21.6;Ductal cells: 19.4;Horizontal cells: 17.5;Urothelial cells: 44.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 8.6;SK-BR-3: 10.2;U-266/70: 9.5;U-266/84: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040203, HPA077070" Enhanced Supported Uncertain "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA040203: AB_10671690, HPA077070: AB_2732330" "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (5.37e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-1)" "unprognostic (1.71e-2)" "unprognostic (5.67e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-1)" "unprognostic (2.51e-3)" "unprognostic (5.71e-2)" "unprognostic (1.47e-1)" "prognostic favorable (3.18e-8)" "unprognostic (1.38e-1)" "unprognostic (3.22e-2)" "unprognostic (3.24e-1)" "unprognostic (6.11e-2)" 1.3 4.4 19.8 2.3 28.6 2.0 2.0 20.0 38.1 2.0 1.5 6.0 0.2 6.2 1.4 1.5 2.3 1.6 1.9 1.7 17.2 11.1 2.5 1.3 3.2 2.2 6.5 23.8 1.3 2.1 8.5 6.1 2.1 12.5 3.5 1.2 1.6 5.2 3.1 1.2 2.4 4.0 1.2 6.6 1.8 2.9 1.5 10.3 0.0 2.3 0.0 2.2 1.6 1.2 0.0 0.0 0.0 0.2 0.0 0.4 0.1 4.6 3.1 0.4 0.0 0.0 0.0 4.5 0.0 0.3 0.0 0.1 2.2 3.7 1.7 1.3 0.0 1.2 2.2 0.3 1.6 0.0 0.0 1.2 0.2 0.3 0.7 0.0 0.0 8.6 0.2 0.9 0.0 0.0 2.0 0.1 2.8 1.4 2.9 0.0 3.1 0.6 0.8 1.1 2.4 0.9 3.9 0.0 1.3 1.1 0.8 0.7 2.9 0.1 10.2 0.0 0.6 3.9 0.2 0.1 0.0 0.8 0.1 0.0 9.5 7.7 0.4 0.2 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 19.8 28.6 20.0 38.1 17.2 11.1 6.5 23.8 12.5 10.3 3.0 1.7 0.8 9.2 0.5 16.4 2.2 2.5 4.0 4.5 7.0 0.0 4.3 21.6 19.4 0.1 0.0 0.7 0.0 0.4 2.5 0.9 15.7 0.0 0.0 1.0 17.5 0.0 1.3 0.3 0.0 0.6 0.3 3.3 0.0 1.0 7.3 10.7 0.0 0.0 0.6 1.9 0.0 0.7 2.4 1.3 1.6 5.7 0.0 0.6 44.3 LNPK "KIAA1715, LNP, LNP1, Ul" ENSG00000144320 "Lunapark, ER junction formation factor" Q9C0E8 2 175923892-176002839 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9;Ciliated cells: 16.0;Collecting duct cells: 15.7;Extravillous trophoblasts: 15.2;Hofbauer cells: 20.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 60.1" "Low region specificity" "Detected in all" HPA014205 Approved Supported "Nucleoplasm,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoplasm "HPA014205: AB_2234186" "unprognostic (4.93e-2)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (7.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.85e-2)" "unprognostic (1.08e-2)" "unprognostic (8.73e-2)" "unprognostic (1.27e-1)" "unprognostic (3.15e-1)" "unprognostic (2.72e-2)" "unprognostic (3.13e-1)" "unprognostic (4.17e-3)" "unprognostic (1.63e-1)" "unprognostic (9.27e-2)" "unprognostic (2.35e-3)" "unprognostic (3.43e-2)" 14.2 10.8 13.4 8.4 16.0 29.4 11.3 12.9 26.5 15.0 13.3 13.4 7.1 8.6 11.9 7.7 15.1 8.2 9.1 13.6 13.8 16.1 9.8 16.3 8.1 7.6 19.9 14.2 12.8 6.4 16.8 22.8 9.4 21.1 12.0 11.9 10.1 8.6 10.1 33.5 13.5 8.4 11.3 26.2 6.6 8.9 25.4 14.6 16.4 10.3 14.8 8.7 12.2 15.1 7.1 6.7 11.6 7.3 9.7 11.6 5.2 8.7 4.4 10.6 14.9 22.3 13.9 5.3 25.9 12.5 12.1 17.1 6.1 10.4 8.8 14.8 11.4 15.9 9.7 9.9 6.9 16.9 13.3 10.1 9.9 5.7 5.4 5.3 16.7 12.3 11.4 6.6 11.7 5.8 9.9 2.2 7.0 10.1 11.7 16.5 5.7 11.0 6.7 3.4 9.0 8.6 11.2 10.7 6.4 5.1 8.0 12.2 12.4 11.4 6.5 8.6 10.4 9.7 5.5 3.3 60.1 8.9 20.0 12.1 6.9 12.6 7.3 18.6 5.5 11.2 5.7 6.6 11.6 8.1 7.3 9.5 7.1 7.2 8.9 6.0 5.0 7.2 11.2 5.6 9.7 6.7 6.7 11.6 5.2 13.4 16.0 12.9 23.3 13.8 16.1 19.9 14.2 21.1 14.6 17.9 9.9 0.0 0.0 0.0 0.0 0.0 0.0 16.0 11.4 15.7 0.0 4.3 5.0 14.3 0.0 0.0 0.0 0.0 8.3 15.2 0.0 0.0 10.5 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 3.6 0.0 0.0 11.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 LPAR4 "GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9" ENSG00000147145 "Lysophosphatidic acid receptor 4" Q99677 X 78747709-78757094 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8;ovary: 10.0" "Cell type enriched" "Detected in some" 7 "Leydig cells: 18.7" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "basophil: 7.4" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.4" "Cell line enhanced" "Detected in some" "AF22: 10.3;NTERA-2: 16.7;RH-30: 7.0;SuSa: 4.0;U-937: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046563, HPA054951, HPA055571" Uncertain Supported "Nuclear bodies,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nuclear bodies, Vesicles" "HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853" "unprognostic (1.62e-1)" "unprognostic (3.53e-1)" "unprognostic (1.58e-1)" "unprognostic (5.81e-4)" "unprognostic (3.12e-2)" "unprognostic (4.85e-3)" "unprognostic (2.81e-1)" "unprognostic (2.57e-1)" "unprognostic (6.75e-2)" "unprognostic (6.73e-2)" "unprognostic (8.91e-2)" "unprognostic (4.86e-4)" "unprognostic (2.99e-5)" "unprognostic (9.27e-3)" "unprognostic (1.00e-1)" "unprognostic (3.58e-2)" "unprognostic (6.03e-3)" 1.5 0.2 6.0 1.0 2.1 0.6 2.0 4.9 3.7 1.8 0.9 7.4 0.7 0.2 2.9 0.8 1.8 1.1 2.1 1.9 15.8 1.4 0.3 0.3 0.3 0.2 2.4 4.0 10.0 0.7 0.1 0.7 0.2 3.6 0.6 1.2 0.5 1.0 1.6 0.2 1.6 0.9 1.3 3.8 0.4 1.5 0.8 5.6 0.0 0.6 0.8 1.2 1.4 0.9 0.0 0.5 7.4 0.0 0.0 0.0 0.1 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.6 1.1 1.4 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.7 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.1 2.3 0.0 0.5 1.8 16.7 0.0 0.2 0.9 7.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 2.7 0.0 0.0 0.2 0.0 0.7 1.4 0.0 0.7 0.7 4.0 1.6 7.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 6.0 2.1 4.9 3.5 15.8 1.4 2.4 4.0 3.6 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.7 0.0 1.7 1.0 0.0 0.5 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 LRAT LCA14 ENSG00000121207 "Lecithin retinol acyltransferase" O95237 4 154626945-154753118 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction, Vision" "Acyltransferase, Transferase" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 82.4" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 7.6;Early spermatids: 7.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 4.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "NTERA-2: 16.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA070726 Uncertain "Endoplasmic reticulum,Golgi apparatus" NA NA "Golgi apparatus" "Endoplasmic reticulum" "HPA070726: " "unprognostic (3.64e-3)" "unprognostic (1.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (4.75e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (9.15e-2)" "unprognostic (2.48e-1)" "unprognostic (2.24e-1)" "unprognostic (2.65e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-4)" "unprognostic (4.49e-6)" "unprognostic (6.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.98e-1)" 0.9 0.8 2.2 0.8 3.2 1.8 1.4 0.7 1.1 0.9 4.2 3.0 0.8 3.7 0.5 1.2 0.5 0.9 2.3 0.6 3.1 4.2 0.6 3.3 1.0 0.5 2.9 2.4 1.0 2.9 0.3 1.0 0.3 8.9 1.6 0.4 82.4 0.5 1.6 2.3 1.4 11.1 0.3 7.0 0.7 0.9 2.9 3.1 0.0 4.9 0.2 0.6 0.5 0.7 0.9 3.7 2.0 4.5 0.6 0.3 3.9 0.7 0.5 0.4 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.3 0.0 0.2 0.0 0.0 0.1 0.8 0.6 0.1 0.1 0.2 0.5 0.4 0.3 0.1 0.1 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.3 16.5 0.0 0.0 0.1 0.0 0.1 2.0 0.5 0.1 0.0 0.2 0.1 0.2 0.3 0.1 0.0 0.0 0.4 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.2 0.5 1.0 4.5 0.4 0.3 1.6 0.3 0.5 0.3 0.3 3.7 0.9 0.3 0.3 2.0 0.6 0.5 0.5 0.2 3.9 2.2 3.2 0.7 1.1 3.1 4.2 2.9 2.4 8.9 3.1 0.0 4.1 0.0 4.2 1.0 0.8 0.2 7.6 0.0 1.2 0.0 0.0 0.1 3.3 0.8 7.2 0.2 2.0 0.0 0.7 0.1 0.3 2.4 0.0 2.0 0.1 0.0 0.0 1.8 0.0 1.6 0.0 0.0 5.0 0.0 0.7 3.7 1.4 0.0 0.0 0.3 0.9 0.0 0.1 4.8 4.5 1.0 0.2 0.7 0.3 0.6 LRMP JAW1 ENSG00000118308 "Lymphoid restricted membrane protein" Q12912 12 25004342-25108334 "Predicted intracellular proteins, Predicted membrane proteins" "Fertilization, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.8;lymphoid tissue: 69.5" "Cell type enhanced" "Detected in many" 9 "B-cells: 52.5;granulocytes: 24.4;Kupffer cells: 29.4;T-cells: 40.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 51.8" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Daudi: 96.3;REH: 33.5;U-698: 110.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA002967, HPA018505" Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA002967: AB_1079161, HPA018505: AB_1851988" "unprognostic (3.78e-2)" "unprognostic (2.59e-3)" "unprognostic (7.54e-2)" "unprognostic (7.08e-3)" "unprognostic (2.36e-1)" "unprognostic (1.48e-3)" "unprognostic (7.98e-2)" "unprognostic (4.08e-2)" "unprognostic (7.32e-2)" "unprognostic (1.15e-1)" "unprognostic (3.59e-2)" "unprognostic (7.97e-2)" "unprognostic (7.25e-3)" "unprognostic (7.72e-2)" "unprognostic (9.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.59e-2)" 5.5 1.4 15.1 51.7 2.9 19.2 4.6 0.4 5.6 1.9 3.6 2.1 0.9 3.2 1.4 1.8 3.9 2.3 3.0 1.7 8.1 1.8 5.5 2.3 5.6 57.8 3.5 4.7 2.3 15.1 0.4 2.1 1.7 7.4 2.8 3.5 1.3 4.1 2.1 0.8 2.7 13.2 1.8 5.3 27.6 3.6 0.7 2.8 67.0 3.6 1.7 69.5 10.4 5.7 17.4 5.7 51.8 12.2 12.0 7.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 0.0 5.7 0.0 0.0 0.0 7.4 8.5 0.0 0.0 0.1 0.0 0.0 0.0 4.9 1.1 6.4 0.0 0.0 8.1 13.7 0.0 0.0 0.0 33.5 0.0 9.5 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.2 0.0 0.0 6.3 1.1 110.1 0.0 3.3 0.0 17.0 5.4 51.8 6.5 10.5 5.4 17.4 4.1 6.6 5.7 13.3 7.1 6.9 39.3 12.0 12.2 5.4 0.7 4.7 15.1 2.9 0.4 5.6 8.1 1.8 3.5 4.7 7.4 2.8 0.0 7.4 52.5 2.5 0.8 0.2 0.4 0.0 9.4 15.9 0.0 0.0 0.1 0.0 0.2 1.5 2.1 0.0 0.0 7.5 0.1 0.5 0.2 24.4 1.0 11.5 0.0 8.5 4.9 29.4 0.4 0.9 20.0 5.0 1.8 0.0 0.0 1.6 3.5 4.6 13.0 0.2 0.0 0.2 0.2 0.0 4.8 0.1 40.3 0.2 14.4 LRP4 "CLSS, LRP-4, MEGF7, SOST2" ENSG00000134569 "LDL receptor related protein 4" O75096 11 46856868-46918642 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;skin 1: 33.0" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 17.0;SuSa: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011934, HPA012300" Approved Uncertain Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Nucleoli, Mitochondria" "HPA011934: AB_1853286, HPA012300: AB_1853288" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-1)" "unprognostic (1.33e-2)" "unprognostic (4.39e-2)" "unprognostic (9.73e-3)" "unprognostic (5.29e-4)" "unprognostic (8.61e-2)" "unprognostic (2.29e-2)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (7.59e-2)" "unprognostic (7.95e-2)" "unprognostic (2.76e-2)" "unprognostic (9.90e-3)" "unprognostic (6.79e-2)" 1.2 1.9 16.0 1.3 20.3 0.5 2.1 7.3 23.7 3.0 5.4 11.6 0.6 3.9 2.1 1.3 2.4 2.0 2.5 7.2 20.4 5.8 1.2 0.7 3.4 0.5 9.6 12.6 5.4 2.7 9.3 3.3 3.1 14.5 2.7 4.1 1.3 2.1 3.0 4.4 33.0 5.3 2.0 9.7 4.2 9.6 1.6 19.0 0.0 2.9 1.0 0.8 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.5 17.0 5.2 10.6 2.9 3.9 0.7 1.5 2.3 2.5 2.2 0.0 0.0 1.1 8.7 2.4 3.0 9.5 5.8 1.8 0.0 7.9 0.8 3.0 5.2 2.2 0.1 1.5 3.6 3.4 3.5 0.9 2.0 1.9 2.1 0.7 0.0 1.3 0.6 0.1 0.2 9.2 0.0 0.7 1.2 5.8 0.0 0.2 2.2 0.0 11.2 0.9 0.0 2.8 13.6 0.2 0.4 0.1 4.6 2.9 5.2 1.6 0.0 0.0 0.3 3.4 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 20.3 7.3 17.3 20.4 5.8 9.6 12.6 14.5 19.0 0.0 3.4 0.0 2.5 7.2 0.4 4.8 0.0 0.0 2.3 1.8 39.3 1.8 1.7 0.0 0.4 0.7 6.3 0.0 0.3 0.4 4.3 0.3 4.7 0.0 0.2 0.0 0.0 1.3 0.0 0.0 1.7 0.0 1.7 1.0 2.2 8.7 0.5 2.3 1.1 0.2 2.6 0.0 1.2 0.1 0.7 9.5 1.1 0.0 1.8 0.7 LRRC29 "FBL9, FBXL9" ENSG00000125122 "Leucine rich repeat containing 29" Q8WV35 16 67207139-67227048 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034998 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA034998: AB_10601938" "unprognostic (5.16e-3)" "unprognostic (1.55e-1)" "unprognostic (2.55e-3)" "prognostic favorable (4.33e-4)" "unprognostic (1.80e-1)" "unprognostic (2.49e-1)" "unprognostic (2.10e-1)" "unprognostic (5.29e-2)" "unprognostic (1.92e-1)" "unprognostic (2.45e-1)" "prognostic favorable (5.20e-4)" "unprognostic (1.88e-1)" "unprognostic (4.32e-3)" "unprognostic (3.44e-3)" "unprognostic (4.92e-2)" "unprognostic (1.00e-1)" "unprognostic (1.21e-1)" 2.4 4.9 8.2 1.6 10.3 2.7 3.0 7.4 8.2 2.0 1.7 7.1 3.6 3.1 2.4 2.7 1.5 4.5 3.8 2.4 8.3 4.2 5.6 3.8 3.7 2.7 7.0 6.0 3.1 5.1 4.2 8.1 2.7 5.0 5.4 1.4 3.9 6.6 4.1 4.0 5.0 3.8 3.2 5.0 2.5 2.9 4.3 5.9 2.6 6.3 0.6 1.8 2.1 1.6 1.4 2.3 3.6 2.9 3.9 4.5 2.3 1.0 3.0 0.9 0.4 1.8 1.3 0.2 0.8 1.7 1.6 1.8 0.4 0.6 0.8 2.4 2.2 0.8 0.2 0.4 2.0 0.6 1.0 0.8 0.7 0.2 1.6 2.0 0.1 2.7 1.7 2.1 2.4 1.4 1.2 1.0 0.5 0.6 0.4 3.2 0.1 0.3 1.6 0.4 0.0 1.1 1.4 0.8 2.2 2.0 0.1 1.1 1.4 1.1 1.1 1.8 0.4 3.0 1.3 0.4 3.1 0.9 0.6 0.2 4.4 0.9 1.3 2.2 0.8 0.9 0.0 2.6 3.6 0.9 2.9 1.0 0.8 2.5 3.6 2.3 1.4 4.5 1.9 3.4 3.9 2.7 1.6 0.5 2.3 8.2 10.3 7.4 8.2 8.3 4.2 7.0 6.0 5.0 5.9 0.0 1.3 0.8 2.7 0.5 2.9 1.0 5.1 1.4 0.0 8.7 3.9 3.1 3.3 2.0 4.0 2.4 2.4 0.0 0.8 0.9 3.1 2.8 1.1 0.8 3.4 6.4 2.9 0.0 3.1 6.7 0.9 2.2 3.3 4.6 1.1 1.4 1.2 0.3 1.4 7.7 1.8 0.0 1.9 7.7 2.3 1.3 0.8 0.0 0.7 0.8 LRRC7 "densin-180, KIAA1365" ENSG00000033122 "Leucine rich repeat containing 7" Q96NW7 1 69568398-70151945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 29.1" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 37.9;Early spermatids: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3" "Group enriched" "Detected in many" 14 "granulocytes: 1.4;T-cells: 1.7" "Group enriched" "Detected in some" 6 "HaCaT: 10.5;HEL: 31.3" "Low region specificity" "Detected in many" HPA005625 Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA005625: AB_1853340" "unprognostic (2.81e-2)" "unprognostic (1.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.98e-3)" "unprognostic (2.47e-1)" "unprognostic (1.73e-1)" "unprognostic (1.04e-1)" "unprognostic (3.50e-2)" "unprognostic (4.84e-3)" "unprognostic (2.92e-2)" "unprognostic (1.06e-3)" "unprognostic (1.46e-1)" "unprognostic (5.64e-6)" "unprognostic (1.31e-2)" "unprognostic (1.74e-2)" "unprognostic (5.13e-3)" "unprognostic (2.08e-3)" 1.0 1.3 20.2 1.0 29.1 1.0 0.8 0.5 21.9 1.2 1.9 5.0 0.0 1.0 1.2 1.0 1.3 0.8 3.2 2.8 15.4 5.8 2.8 1.2 0.8 0.9 4.4 17.6 1.0 2.7 0.7 0.4 1.2 2.4 1.5 2.4 0.2 0.9 1.1 2.8 1.1 1.3 1.2 2.5 0.8 0.8 5.8 7.6 0.0 6.7 0.0 0.8 0.9 0.5 0.0 0.1 1.4 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 3.3 0.0 0.0 10.5 0.2 0.0 0.0 0.0 0.5 31.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.7 1.3 0.0 0.0 0.0 0.0 0.0 0.1 20.2 29.1 0.5 19.2 15.4 5.8 4.4 17.6 2.4 7.6 0.0 0.0 5.1 0.5 0.7 37.9 5.8 2.5 0.0 0.0 0.0 2.0 0.4 0.0 0.0 20.2 1.4 0.0 0.0 0.0 0.4 2.1 0.7 0.0 5.5 0.3 6.4 0.0 1.8 1.5 4.6 0.6 0.7 5.0 0.0 0.0 0.5 0.0 0.0 2.8 1.3 7.9 0.0 1.4 7.4 2.7 1.1 0.1 2.5 0.0 0.1 LRRC9 FLJ46156 ENSG00000131951 "Leucine rich repeat containing 9" Q6ZRR7 14 59919713-60063559 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 16.4;pituitary gland: 13.9;testis: 14.3" "Group enriched" "Detected in some" 9 "Early spermatids: 98.5;Late spermatids: 64.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 7.3;pons and medulla: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.3;CACO-2: 2.0;GAMG: 1.1;NTERA-2: 4.2;SCLC-21H: 1.9;SH-SY5Y: 1.3;SuSa: 1.7;U-2 OS: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040965, HPA041381, HPA077675" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Nuclear bodies" "HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: " "unprognostic (1.01e-2)" "unprognostic (2.00e-1)" "unprognostic (4.45e-2)" "unprognostic (2.12e-3)" "unprognostic (2.80e-1)" "unprognostic (2.95e-3)" "unprognostic (1.93e-1)" "unprognostic (3.11e-2)" "unprognostic (1.91e-2)" "unprognostic (4.82e-2)" "unprognostic (3.45e-3)" "unprognostic (6.06e-2)" "unprognostic (2.62e-3)" "unprognostic (8.54e-3)" "unprognostic (8.30e-2)" "unprognostic (1.67e-2)" "unprognostic (2.29e-2)" 0.6 0.4 0.6 0.1 7.3 0.2 0.1 0.2 1.1 0.3 0.1 3.2 0.0 0.1 0.2 1.4 0.1 3.4 0.1 0.1 1.4 1.2 0.2 0.2 0.1 0.1 0.5 1.3 1.0 0.2 4.8 13.9 0.1 16.4 1.3 0.1 0.0 0.1 0.2 0.1 0.1 0.7 0.1 0.9 0.1 0.2 14.3 2.2 0.0 0.1 0.0 0.1 0.2 0.1 0.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 7.3 0.2 1.1 1.4 1.2 0.5 1.3 16.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 98.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 64.1 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 8.8 0.9 0.0 0.1 0.0 0.0 0.0 LRRN4 "C20orf75, dJ1056H1.1, NLRR4" ENSG00000125872 "Leucine rich repeat neuronal 4" Q8WUT4 20 6040778-6054049 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 9.5;kidney: 13.0;lung: 36.4" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 3.8;Ductal cells: 3.6;Proximal tubular cells: 2.2" "Group enriched" "Detected in many" 7 "lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7" "Region enriched" "Detected in single" 5 "basal ganglia: 1.1" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 11 "RPTEC TERT1: 40.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA075974 Uncertain "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 32000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA075974: AB_2686770" "unprognostic (6.16e-2)" "unprognostic (1.69e-3)" "unprognostic (2.40e-3)" "unprognostic (9.04e-3)" "unprognostic (5.95e-2)" "unprognostic (1.32e-2)" "unprognostic (2.59e-1)" "unprognostic (8.94e-2)" "unprognostic (2.73e-1)" "unprognostic (2.44e-2)" "unprognostic (2.79e-2)" "unprognostic (4.83e-3)" "unprognostic (1.15e-3)" "unprognostic (2.33e-2)" "unprognostic (6.88e-2)" "unprognostic (2.31e-1)" "unprognostic (9.84e-3)" 9.5 0.1 0.0 2.4 1.1 0.1 0.1 0.0 0.2 0.7 2.2 0.0 0.0 0.1 0.1 2.8 0.1 1.5 0.1 1.1 0.0 0.2 13.0 0.4 36.4 0.1 0.0 0.0 1.6 2.6 0.1 0.0 3.4 0.0 0.1 0.1 0.0 0.1 0.5 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 40.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.8 0.4 0.2 0.9 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.9 3.8 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 1.8 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LRTOMT "CFAP111, COMT2, DFNB63, LRRC51" ENSG00000184154 "Leucine rich transmembrane and O-methyltransferase domain containing" "Q8WZ04, Q96E66" 11 72080331-72110782 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Catecholamine metabolism, Hearing, Neurotransmitter degradation" "Methyltransferase, Transferase" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 49.8;testis: 47.8" "Group enriched" "Detected in many" 10 "Early spermatids: 522.5;Late spermatids: 1781.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 27.7" HPA039949 Approved Uncertain Microtubules NA NA Microtubules "HPA039949: AB_10960708" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (1.85e-2)" "prognostic favorable (7.70e-4)" "unprognostic (8.09e-2)" "unprognostic (9.07e-2)" "unprognostic (1.42e-1)" "unprognostic (1.90e-1)" "unprognostic (4.22e-2)" "prognostic favorable (5.36e-4)" "unprognostic (6.12e-2)" "unprognostic (8.43e-2)" "unprognostic (2.64e-2)" "unprognostic (1.58e-1)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (1.44e-1)" 3.5 3.7 10.6 2.0 11.1 2.1 7.1 3.7 8.9 7.1 4.2 14.0 6.1 3.2 6.0 13.6 3.5 49.8 5.3 2.6 8.8 7.6 9.0 6.2 6.2 2.6 7.7 8.5 8.5 7.0 7.1 8.9 4.4 10.6 7.5 6.2 7.3 4.3 4.7 5.2 4.5 2.5 4.8 7.7 3.2 3.6 47.8 8.9 3.1 9.3 2.4 3.5 3.5 2.6 4.3 4.2 9.2 2.9 10.1 6.2 2.0 2.6 9.8 6.2 5.0 5.4 4.8 1.5 3.1 2.5 2.8 2.5 4.7 14.3 3.4 4.7 5.3 6.9 5.3 4.4 7.4 3.2 6.4 4.3 2.5 4.5 3.3 0.9 2.0 2.7 2.1 3.8 4.3 3.3 4.6 1.0 7.2 2.7 5.3 4.1 9.3 6.0 4.0 3.1 15.4 2.6 7.3 6.3 5.2 11.0 3.2 5.8 4.5 6.1 14.0 7.5 4.5 27.7 2.4 4.6 3.0 4.2 8.0 2.1 5.7 6.2 3.9 2.9 1.7 3.3 2.3 2.9 5.0 3.1 2.8 3.2 4.2 3.3 2.6 1.7 4.3 3.0 3.0 9.2 10.1 1.8 4.2 6.2 2.0 10.6 11.1 3.7 8.9 8.8 7.6 7.7 8.5 10.6 8.9 0.0 1.0 6.1 6.6 2.1 3.7 1.7 5.1 115.1 9.1 3.5 11.8 11.0 10.0 6.1 522.5 4.5 3.1 0.0 2.1 6.7 4.1 11.4 0.0 5.6 2.7 6.4 1.2 3.1 1.0 1781.2 13.8 2.2 1.7 1.8 8.8 12.6 1.8 2.9 9.6 14.6 12.6 6.5 7.1 69.5 22.8 2.0 11.0 2.6 4.3 4.7 LRWD1 "CENP-33, DKFZp434K1815, ORCA" ENSG00000161036 "Leucine rich repeats and WD repeat domain containing 1" Q9UFC0 7 102464929-102473168 "Predicted intracellular proteins" "DNA replication" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "testis: 129.9" "Group enriched" "Detected in many" 8 "Early spermatids: 733.2;Spermatocytes: 397.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021320 Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Vesicles" "HPA021320: AB_1853372" "unprognostic (1.50e-1)" "unprognostic (1.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.66e-3)" "unprognostic (1.60e-2)" "unprognostic (2.08e-3)" "unprognostic (1.72e-3)" "unprognostic (4.97e-2)" "unprognostic (3.34e-1)" "unprognostic (3.04e-2)" "prognostic favorable (8.71e-5)" "unprognostic (1.00e-1)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.46e-2)" "unprognostic (4.14e-2)" "unprognostic (7.82e-2)" "unprognostic (9.20e-2)" 2.7 4.6 3.6 3.8 5.0 7.6 1.9 7.9 5.8 2.5 2.5 3.4 3.4 2.9 2.8 2.8 2.1 7.1 2.5 2.6 4.3 4.0 4.0 5.1 2.6 4.4 3.4 3.7 3.1 3.4 3.4 4.9 2.0 4.2 2.2 1.6 1.7 3.3 4.0 3.6 2.2 4.3 2.7 2.4 6.6 3.3 129.9 3.8 3.9 2.7 1.6 4.2 2.3 1.8 12.6 9.8 9.2 4.0 9.9 10.4 5.8 7.4 10.3 5.6 15.7 4.3 3.2 8.7 7.9 5.2 13.6 9.4 9.9 4.3 18.4 11.4 6.0 16.0 7.9 8.2 7.1 4.0 6.4 15.9 3.8 4.7 6.1 5.7 7.1 7.4 3.0 4.3 15.7 3.3 4.6 7.1 14.4 17.8 5.7 7.3 22.4 21.3 16.9 11.9 9.4 15.0 11.3 5.2 19.8 4.0 4.7 7.4 21.1 8.7 8.4 7.7 6.8 4.8 5.9 4.1 7.5 16.1 23.2 12.6 20.9 36.0 17.6 8.3 6.6 13.0 9.1 2.5 9.2 10.4 4.0 9.9 11.1 9.1 9.1 2.8 12.6 5.8 7.4 5.9 9.9 3.5 9.8 9.0 5.8 3.6 5.0 7.9 5.8 4.3 4.0 3.4 3.7 4.2 3.8 0.0 0.6 5.2 5.8 9.3 11.7 0.7 2.5 16.0 6.8 12.2 2.0 7.7 6.6 12.2 733.2 5.8 7.9 0.0 9.2 9.8 5.7 3.5 0.0 6.8 7.8 4.8 7.5 5.5 5.7 71.5 17.5 3.9 5.0 10.0 6.3 8.6 9.9 6.0 14.9 11.5 8.1 0.0 5.1 397.6 39.9 8.5 5.1 7.0 6.3 3.3 LSMEM2 "C3orf45, FLJ38608" ENSG00000179564 "Leucine rich single-pass membrane protein 2" Q8N112 3 50279027-50288114 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 26.6;skeletal muscle: 16.3;tongue: 7.2" "Cell type enriched" "Detected in some" 5 "Late spermatids: 197.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HeLa: 3.7;WM-115: 3.5" "Low region specificity" "Detected in many" HPA079523 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA079523: " "unprognostic (2.84e-3)" "unprognostic (6.54e-2)" "unprognostic (2.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" "unprognostic (8.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (2.65e-1)" "unprognostic (3.17e-2)" "unprognostic (2.82e-1)" "unprognostic (1.82e-1)" "unprognostic (2.46e-2)" "unprognostic (2.48e-1)" "unprognostic (6.49e-3)" "unprognostic (1.71e-1)" 0.6 0.3 1.2 0.2 2.1 0.4 0.2 0.7 1.9 1.1 0.3 2.1 0.1 0.4 1.4 0.4 0.7 0.8 0.4 26.6 1.4 0.7 0.3 0.1 0.3 0.1 1.3 0.6 0.9 0.3 0.1 0.1 0.2 1.3 0.4 0.3 1.6 1.4 0.5 16.3 0.1 0.5 0.5 1.6 0.2 0.2 3.0 0.9 0.1 0.2 7.2 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 0.2 0.3 0.0 0.0 0.4 0.4 0.4 0.4 0.2 0.3 0.5 0.1 0.1 0.0 0.5 0.1 0.1 1.1 0.1 0.0 0.5 0.2 3.7 0.2 0.0 0.3 0.2 0.2 0.0 0.1 0.2 0.5 0.0 1.1 0.0 1.0 0.0 0.2 0.1 0.7 0.5 0.4 0.0 0.0 0.3 0.0 0.3 0.3 0.1 0.5 0.0 0.8 1.0 0.4 0.0 0.0 0.0 0.2 1.3 0.4 0.4 0.9 0.6 0.6 0.1 0.9 3.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.1 0.7 1.9 1.4 0.7 1.3 0.6 1.3 0.9 0.0 1.1 0.0 0.1 0.9 0.1 3.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.1 41.7 0.0 0.9 0.0 0.2 0.1 0.3 0.3 4.7 0.0 0.1 0.0 0.0 0.0 0.0 197.4 1.1 0.0 1.7 0.0 0.4 0.5 0.1 0.0 0.7 0.0 0.2 0.0 0.7 1.6 1.0 1.1 0.1 0.0 0.6 0.1 LTA4H ENSG00000111144 "Leukotriene A4 hydrolase" P09960 12 96000828-96043520 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Leukotriene biosynthesis" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 215.6;Kupffer cells: 278.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008399, CAB015221, HPA017017" Supported Approved Nucleoplasm,Cytosol NA NA 85000000 "Nucleoplasm, Cytosol" "CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818" "prognostic favorable (9.79e-4)" "unprognostic (6.62e-2)" "unprognostic (6.04e-2)" "unprognostic (1.87e-1)" "unprognostic (1.38e-2)" "unprognostic (2.59e-2)" "unprognostic (4.25e-3)" "prognostic favorable (8.96e-4)" "unprognostic (1.72e-1)" "unprognostic (1.75e-2)" "unprognostic (3.38e-2)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (1.74e-1)" "unprognostic (1.04e-1)" "unprognostic (3.50e-2)" "unprognostic (1.34e-1)" 27.9 33.2 11.2 21.5 16.7 55.7 19.0 24.1 15.6 27.2 29.1 13.1 16.7 27.6 27.6 14.1 53.4 22.7 14.5 19.2 10.6 12.2 27.2 19.4 68.0 33.4 12.3 11.3 49.9 28.2 21.2 31.8 11.3 13.3 29.6 17.8 20.7 21.1 16.1 20.6 23.6 41.2 21.5 13.3 44.3 22.1 13.7 11.5 29.2 38.8 22.3 43.1 30.1 25.2 20.6 35.3 6.1 84.2 14.2 9.0 54.6 21.0 22.6 31.8 18.9 27.6 30.9 13.9 8.8 26.1 17.4 20.3 16.5 18.2 47.1 11.1 13.1 13.7 27.7 26.0 35.9 23.8 16.1 25.2 17.3 14.5 20.0 16.3 9.1 10.5 29.4 30.3 24.0 29.5 79.5 34.5 27.6 10.5 8.3 25.1 14.4 23.9 28.0 37.0 25.1 30.7 22.4 23.7 27.1 32.0 26.8 16.5 19.5 17.8 20.8 19.1 25.5 25.9 11.2 12.3 7.4 12.5 10.5 9.5 11.2 19.4 21.8 5.2 16.5 5.8 0.4 76.0 2.2 4.5 84.2 8.4 15.1 6.3 5.8 35.3 20.6 9.0 6.7 6.1 14.2 73.2 8.7 6.3 54.6 11.2 16.7 24.1 15.6 10.6 12.2 12.3 11.3 13.3 11.5 35.7 107.1 87.8 57.2 46.0 19.4 23.4 17.8 48.2 91.0 36.6 31.4 27.0 63.0 34.2 44.9 33.1 22.4 0.0 24.3 24.3 27.5 27.6 7.0 18.1 215.6 11.1 20.7 47.3 278.8 8.1 33.9 139.0 20.3 38.7 40.9 32.1 23.4 24.6 38.5 53.1 58.0 6.5 18.5 45.1 12.5 65.5 17.4 34.8 53.6 42.1 LTB4R2 "BLT2, BLTR2, JULF2, NOP9" ENSG00000213906 "Leukotriene B4 receptor 2" Q9NPC1 14 24305734-24312053 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6" "Cell type enhanced" "Detected in some" 7 "Basal glandular cells: 3.0;Horizontal cells: 3.2;Kupffer cells: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 15.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB022689, HPA029680, HPA072921" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" "unprognostic (9.53e-2)" "unprognostic (8.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (1.48e-3)" "unprognostic (7.18e-2)" "unprognostic (7.05e-11)" "unprognostic (1.84e-1)" "unprognostic (1.04e-1)" "unprognostic (4.23e-2)" "unprognostic (1.19e-1)" 1.5 1.2 0.4 1.8 0.5 4.8 1.1 0.4 0.6 7.9 0.4 0.6 0.8 2.4 1.0 4.7 38.9 0.8 0.7 0.4 0.5 0.1 6.1 0.5 1.1 1.8 0.4 0.7 0.7 0.5 0.3 0.7 0.8 0.5 1.8 0.3 0.5 4.7 1.1 0.9 21.4 1.8 0.4 0.4 3.5 1.0 1.4 0.4 3.1 0.9 43.6 26.8 0.6 9.0 0.3 2.2 1.4 2.0 0.9 2.7 1.1 2.5 4.4 1.9 1.8 0.4 0.6 7.7 0.9 0.4 1.3 0.9 3.4 1.5 3.2 1.6 0.6 1.9 15.9 1.3 2.7 1.0 4.0 4.9 2.2 3.5 1.6 0.5 3.6 4.2 0.5 3.6 2.0 2.3 1.2 0.6 5.8 2.8 3.6 0.6 4.8 1.9 3.8 1.0 0.1 5.4 7.9 1.7 1.8 0.4 3.1 3.4 1.6 1.6 2.0 1.3 2.1 3.7 2.7 1.6 2.6 3.2 4.0 1.3 7.9 2.3 5.2 0.5 6.1 2.0 0.0 2.0 1.4 2.7 1.6 1.6 0.1 2.2 2.0 2.2 0.3 1.7 0.9 1.3 0.9 0.8 0.6 0.4 1.1 0.4 0.5 0.4 0.6 0.5 0.1 0.4 0.7 0.5 0.4 0.0 0.0 0.0 3.0 0.2 0.2 0.0 0.0 1.4 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.9 0.3 0.0 1.2 0.1 0.0 0.2 0.0 0.8 0.6 3.2 1.7 1.3 2.2 0.0 0.3 0.2 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.5 0.0 0.0 0.7 0.2 0.1 0.2 0.0 0.6 0.9 LY6K "CT97, FLJ35226, HSJ001348" ENSG00000160886 "Lymphocyte antigen 6 family member K" Q17RY6 8 142700111-142705127 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 39.3" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 132.9;Glandular cells: 88.0;Spermatocytes: 359.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "neutrophil: 5.3" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.3" "Cell line enhanced" "Detected in many" "A-431: 28.8;BJ: 31.3;HeLa: 34.1;SiHa: 49.0;U-2197: 66.2" "HPA017770, CAB075742, CAB075743" Enhanced Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" NA NA "Plasma membrane" Nucleoplasm "CAB075742: AB_2665748, CAB075743: AB_2665749, HPA017770: AB_1853414" "unprognostic (1.25e-1)" "unprognostic (1.95e-2)" "unprognostic (1.48e-1)" "unprognostic (7.23e-3)" "unprognostic (3.47e-2)" "unprognostic (2.39e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (9.17e-5)" "unprognostic (4.18e-2)" "unprognostic (6.89e-2)" "unprognostic (9.75e-2)" "unprognostic (1.40e-1)" "unprognostic (5.27e-5)" "unprognostic (1.71e-1)" "unprognostic (1.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.61e-2)" 6.6 0.4 1.4 0.3 1.8 0.4 7.6 0.9 3.8 1.8 1.6 0.1 9.8 0.5 0.7 0.8 10.9 0.8 1.2 1.2 1.5 1.9 2.0 0.2 0.6 1.9 1.7 0.0 0.7 0.4 0.0 0.3 6.3 1.0 1.1 0.1 0.1 1.4 7.0 6.3 4.3 0.2 0.6 1.1 0.3 0.4 39.3 0.2 0.2 1.1 4.5 6.8 1.0 3.2 0.1 0.1 5.3 0.2 0.4 0.2 0.0 28.8 0.5 0.0 1.5 0.6 1.9 0.3 31.3 3.7 9.7 5.9 0.0 0.2 0.0 2.6 3.5 3.4 2.6 0.0 1.7 8.2 0.3 0.0 0.0 34.1 0.0 0.4 0.0 0.0 2.9 5.1 7.2 9.3 0.0 0.8 0.0 0.0 0.1 18.2 0.2 0.0 0.0 1.0 0.9 0.5 0.0 0.1 0.0 1.6 0.4 0.9 0.1 49.0 0.6 9.5 1.7 0.1 0.0 1.2 0.4 2.8 66.2 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.5 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 5.3 0.4 0.1 0.1 0.0 0.0 1.4 1.8 0.9 1.7 1.5 1.9 1.7 0.0 1.0 0.2 3.0 0.3 0.0 65.7 34.6 0.3 0.1 10.2 1.4 7.9 24.4 0.0 11.3 0.0 0.5 5.0 3.3 0.0 0.0 0.0 132.9 2.9 88.0 0.0 0.0 5.3 0.0 0.0 1.3 0.0 10.1 3.7 2.8 11.8 0.0 0.0 0.5 3.9 0.0 2.8 0.0 0.7 0.0 13.3 359.5 76.0 39.3 21.2 0.0 0.0 76.5 LYPLA2 APT-2 ENSG00000011009 "Lysophospholipase II" O95372 1 23790970-23795539 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063151 Uncertain Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA063151: " "unprognostic (8.84e-2)" "unprognostic (6.87e-2)" "unprognostic (2.65e-1)" "unprognostic (7.81e-3)" "unprognostic (2.12e-2)" "unprognostic (2.22e-2)" "prognostic unfavorable (5.84e-5)" "unprognostic (3.06e-1)" "unprognostic (1.80e-1)" "unprognostic (5.18e-2)" "unprognostic (2.52e-1)" "unprognostic (2.40e-1)" "prognostic favorable (4.99e-4)" "unprognostic (6.10e-2)" "unprognostic (1.47e-1)" "unprognostic (1.71e-3)" "unprognostic (1.24e-1)" 12.4 13.6 14.8 13.3 34.8 20.6 13.5 10.7 17.7 9.9 21.2 12.3 5.6 21.3 10.9 17.2 25.4 19.2 21.6 14.4 9.9 9.5 33.2 34.5 14.3 19.0 7.6 12.8 10.3 18.3 32.0 12.0 31.6 35.4 14.8 12.7 11.3 21.1 11.2 14.2 17.7 24.0 9.5 5.4 22.1 19.1 9.9 6.9 27.7 16.5 9.5 16.5 15.3 13.5 29.5 32.3 50.0 40.6 32.0 48.0 42.4 25.5 15.8 19.3 22.3 9.8 11.9 26.6 15.8 15.1 15.0 12.8 21.8 41.6 13.9 22.3 14.9 10.6 24.3 13.9 41.0 6.4 26.0 19.6 17.5 26.0 35.8 15.2 16.4 23.1 14.7 25.4 22.6 8.6 19.3 35.3 15.9 24.4 14.0 16.4 25.3 22.0 26.7 39.3 21.5 22.3 24.4 11.1 25.6 35.3 19.6 28.0 48.6 17.9 28.7 26.8 14.7 23.3 17.3 30.3 15.1 20.0 18.2 13.1 38.0 32.1 19.4 24.9 37.9 19.0 28.9 40.6 50.0 48.0 39.6 38.7 27.6 40.1 41.6 32.3 29.5 35.2 36.0 48.4 32.0 31.2 24.6 35.6 42.4 14.8 34.8 10.7 17.7 9.9 9.5 7.6 12.8 35.4 6.9 8.9 26.4 19.0 29.7 34.6 31.0 13.7 35.7 37.5 20.5 34.9 17.7 93.7 58.0 104.5 13.5 26.9 80.5 23.3 98.3 88.0 17.6 27.9 36.8 28.8 60.5 22.3 42.6 17.8 16.8 9.9 9.8 20.4 18.6 82.0 39.0 26.1 99.3 53.5 6.0 76.2 20.4 25.8 12.4 6.8 19.0 36.3 96.9 32.4 45.1 36.5 LYZ ENSG00000090382 Lysozyme P61626 12 69348341-69354234 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase" "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 490.0;salivary gland: 1017.8" "Cell type enhanced" "Detected in many" 16 "Kupffer cells: 3040.5;Macrophages: 4386.3;Pancreatic endocrine cells: 1930.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 490.0;myeloid DC: 308.1" "Group enriched" "Detected in all" 18 "dendritic cells: 308.1;monocytes: 490.0" "Cell line enriched" "Detected in some" 13 "OE19: 521.4" "Not detected" "Not detected" "CAB000055, HPA048284, HPA066182" Enhanced Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Secreted to blood" NA NA 1500000000 2600000000 "Golgi apparatus, Actin filaments" Nucleoplasm "CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741" "unprognostic (8.52e-2)" "unprognostic (6.12e-3)" "unprognostic (2.83e-1)" "unprognostic (7.29e-2)" "unprognostic (7.91e-2)" "prognostic favorable (7.45e-4)" "unprognostic (1.21e-1)" "unprognostic (7.40e-2)" "unprognostic (1.41e-1)" "unprognostic (2.08e-2)" "unprognostic (1.44e-1)" "unprognostic (3.13e-1)" "unprognostic (2.50e-1)" "unprognostic (2.37e-1)" "unprognostic (3.65e-2)" "unprognostic (5.78e-2)" "unprognostic (3.62e-2)" 19.1 2.4 1.7 42.1 1.8 187.0 2.9 1.6 1.6 2.9 52.5 2.0 0.1 72.4 2.3 6.9 3.9 3.4 105.0 15.4 1.8 1.8 4.8 4.8 81.0 57.2 2.1 0.0 4.5 5.0 0.0 1.8 8.3 0.9 2.4 5.0 2.7 1017.8 2.8 1.8 2.1 95.0 1.8 2.5 34.2 212.1 1.6 0.5 24.5 2.4 207.7 75.7 6.6 2.4 1.6 308.1 21.9 490.0 2.3 1.1 407.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 39.8 0.0 4.6 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 4.5 0.1 521.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 22.3 0.0 7.5 490.0 5.9 0.7 102.3 1.1 1.6 0.4 0.5 308.1 0.4 0.4 0.4 21.9 2.3 17.6 6.5 0.6 407.9 1.7 1.8 1.6 1.6 1.8 1.8 2.1 0.0 0.9 0.5 80.4 424.7 79.8 2.3 50.8 0.1 0.0 815.3 52.2 87.6 26.2 0.0 4.1 0.0 46.7 1.4 10.8 19.6 0.0 484.8 7.4 19.7 4.1 113.9 7.3 924.7 0.0 12.0 37.4 3040.5 3.7 3.7 4386.3 50.6 757.4 61.5 0.0 1930.3 401.2 2.1 5.0 1.1 38.8 3.9 0.6 2.3 33.4 7.1 13.8 38.3 2.2 LZTS2 "KIAA1813, LAPSER1" ENSG00000107816 "Leucine zipper tumor suppressor 2" Q9BRK4 10 100996618-101007836 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044956 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA044956: AB_10795989" "unprognostic (1.42e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (8.18e-2)" "unprognostic (4.64e-2)" "unprognostic (1.56e-1)" "unprognostic (5.49e-3)" "unprognostic (3.56e-1)" "unprognostic (7.57e-2)" "unprognostic (4.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (3.39e-4)" "unprognostic (7.63e-2)" "unprognostic (1.86e-1)" "unprognostic (5.46e-3)" "unprognostic (1.76e-3)" 34.2 25.8 14.6 12.4 21.4 10.9 24.7 15.4 25.0 29.3 30.2 41.0 16.4 15.2 33.7 18.6 28.0 22.6 21.0 20.0 19.0 13.6 18.2 7.4 18.6 9.5 32.8 14.4 30.1 13.9 22.7 16.1 24.5 20.6 32.9 8.2 22.3 34.6 38.4 28.5 24.7 14.9 32.0 29.9 20.1 19.6 18.7 25.6 9.5 29.7 11.8 13.7 38.8 22.7 5.0 2.8 0.5 1.2 4.4 6.1 2.3 11.1 15.0 12.3 21.1 16.4 13.3 25.3 13.5 25.9 11.4 13.0 17.4 9.3 4.5 12.6 18.2 8.2 19.0 7.6 9.8 2.8 4.3 11.2 4.1 14.8 22.5 23.3 2.1 5.4 24.2 7.2 8.9 10.8 24.2 11.6 5.5 13.0 2.6 10.1 10.7 1.9 5.3 13.7 4.3 12.4 25.5 36.1 4.5 8.6 13.6 3.0 22.5 9.2 4.2 34.6 6.9 21.6 17.8 14.7 13.6 15.6 14.4 7.0 5.0 3.4 1.1 23.1 6.1 6.8 0.0 1.2 0.5 4.5 0.5 6.1 3.7 5.4 4.9 1.8 5.0 5.8 4.9 0.5 4.4 0.1 2.8 4.5 2.3 14.6 21.4 15.4 25.0 19.0 13.6 32.8 14.4 20.6 25.6 14.9 10.9 3.2 7.8 11.8 10.0 3.9 10.2 2.7 4.5 5.2 5.9 14.4 6.6 17.8 4.6 17.7 5.6 0.0 10.7 11.4 17.3 13.7 1.1 2.4 18.1 17.5 16.0 22.7 6.1 2.7 23.9 6.5 15.1 6.4 16.1 17.4 13.0 5.8 27.6 6.8 3.6 25.8 21.5 3.1 11.2 10.7 39.4 4.9 13.5 8.0 MAFF hMafF ENSG00000185022 "MAF bZIP transcription factor F" Q9ULX9 22 38200767-38216511 "Predicted intracellular proteins, Transcription factors" "Stress response, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 114.6" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 289.5;Glandular cells: 257.7;Syncytiotrophoblasts: 400.7;Urothelial cells: 321.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 16.9;neutrophil: 5.9;NK-cell: 14.1" "Group enriched" "Detected in many" 7 "granulocytes: 16.9;NK-cells: 14.1" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 31.3;SK-MEL-30: 37.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB025341, HPA055371" Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "CAB025341: , HPA055371: AB_2682797" "prognostic favorable (4.32e-4)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-2)" "unprognostic (2.13e-3)" "unprognostic (5.06e-3)" "unprognostic (3.42e-3)" "unprognostic (7.83e-3)" "unprognostic (5.36e-3)" "unprognostic (1.23e-3)" "unprognostic (2.44e-1)" "unprognostic (3.24e-2)" "unprognostic (2.84e-1)" "unprognostic (4.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.68e-2)" 45.8 15.4 5.0 10.7 10.7 18.8 32.9 4.1 10.4 16.5 14.7 5.1 6.4 5.1 17.1 4.9 21.5 18.3 27.2 17.2 5.2 5.4 8.6 16.5 31.5 2.9 9.8 1.5 24.5 12.4 3.5 6.2 114.6 12.6 20.1 6.9 5.9 8.8 34.0 60.7 14.3 8.6 15.0 6.5 4.2 13.9 6.9 8.4 0.9 11.3 10.3 8.2 28.6 34.4 0.6 0.9 16.9 2.2 14.1 2.2 1.2 7.5 1.2 1.7 2.6 2.7 8.7 7.9 15.3 21.2 7.8 8.4 2.2 6.2 0.2 1.5 6.5 11.8 5.1 0.4 6.1 13.3 1.4 0.2 0.8 0.8 1.9 7.3 0.5 2.7 3.7 10.2 31.3 17.4 7.0 16.4 0.8 1.5 7.3 6.1 1.7 0.3 2.0 1.2 8.4 6.2 0.5 1.4 1.5 7.9 11.6 0.9 1.4 2.3 6.1 37.2 4.4 1.3 0.6 21.4 9.9 7.3 7.3 5.1 2.7 2.8 0.3 15.0 0.6 6.2 16.9 0.3 0.2 2.2 0.5 2.1 0.6 1.2 1.5 0.9 0.4 1.6 1.2 5.9 14.1 2.2 0.1 0.5 1.2 5.0 10.7 4.1 10.4 5.2 5.4 9.8 1.5 12.6 8.4 50.6 43.7 7.5 289.5 111.8 2.2 13.7 33.1 29.4 33.0 10.4 0.0 30.6 6.6 37.6 0.4 35.0 98.6 0.0 21.5 52.9 80.2 257.7 21.9 5.0 23.2 0.0 100.5 14.7 7.8 0.0 9.2 26.4 55.6 17.2 43.3 16.8 51.3 62.0 3.5 2.4 2.0 19.4 116.4 0.9 1.0 90.2 400.7 27.7 35.7 321.4 MAFIP "FLJ00219, FLJ35473, FLJ39633, MIP, pp5644, TEKT4P4" ENSG00000274847 "MAFF interacting protein (pseudogene)" Unmapped 53594-115055 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 10.5" "Cell type enhanced" "Detected in some" 8 "Cytotrophoblasts: 1.2;Pancreatic endocrine cells: 1.3;Proximal tubular cells: 1.4;Syncytiotrophoblasts: 1.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 15.7" HPA053929 Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA053929: AB_2682314" 2.9 5.1 0.5 0.0 0.2 0.9 0.4 0.3 0.7 1.1 0.1 2.0 1.0 1.2 1.4 1.6 1.2 1.0 2.3 2.4 1.6 0.0 0.5 1.7 0.0 2.5 0.3 1.1 0.0 1.5 1.4 2.0 0.0 0.2 1.3 0.3 1.9 5.4 10.5 2.5 5.6 4.5 4.8 3.5 0.2 3.6 0.0 1.4 0.0 0.0 4.0 3.6 1.8 1.1 1.4 6.5 8.2 0.1 7.4 4.8 5.5 0.9 2.8 3.9 0.7 0.3 3.5 5.8 3.8 6.6 0.3 0.1 9.3 0.6 5.5 3.3 0.0 4.4 3.5 0.0 15.7 8.4 2.4 7.1 5.1 1.1 0.2 4.7 3.0 0.0 4.7 3.7 3.9 1.0 3.1 5.8 0.0 5.3 6.4 2.7 11.7 0.4 9.0 2.3 6.5 3.0 2.9 8.0 6.1 0.0 9.9 0.0 2.3 2.4 4.8 2.5 3.7 5.6 3.1 5.3 3.7 3.5 6.0 5.4 4.6 4.6 0.3 4.5 2.9 10.5 4.8 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.7 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 MAGEB17 ENSG00000182798 "MAGE family member B17" A8MXT2 X 16167481-16171464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 4.4;testis: 5.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 3.3;U-2 OS: 7.2;U-266/70: 17.8" HPA003756 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA003756: AB_2250114" "unprognostic (1.94e-2)" "unprognostic (2.23e-1)" "unprognostic (3.57e-1)" "unprognostic (4.04e-4)" "unprognostic (2.75e-1)" "unprognostic (5.11e-1)" "unprognostic (3.56e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-2)" "unprognostic (1.88e-2)" "unprognostic (2.49e-2)" "unprognostic (1.50e-1)" "unprognostic (7.05e-2)" "unprognostic (2.88e-1)" "unprognostic (5.45e-2)" "unprognostic (6.44e-2)" 0.1 0.0 0.1 0.4 0.0 0.0 0.6 0.1 0.0 0.6 0.4 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.0 1.2 5.4 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 1.8 0.0 0.0 3.3 7.2 0.0 0.2 17.8 0.9 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAK16 "MAK16L, RBM13" ENSG00000198042 "MAK16 homolog" Q9BXY0 8 33484750-33501260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044417, HPA050574" Uncertain Approved Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "HPA044417: AB_2678935, HPA050574: AB_2681181" "unprognostic (2.10e-1)" "unprognostic (1.74e-1)" "unprognostic (8.48e-3)" "unprognostic (2.28e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.00e-4)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.66e-4)" "unprognostic (8.04e-2)" "unprognostic (1.20e-1)" "unprognostic (6.74e-2)" "unprognostic (1.47e-1)" 22.3 11.0 10.6 14.9 15.3 13.5 15.2 11.5 17.6 13.2 11.5 12.5 8.3 9.1 20.8 9.1 15.2 13.6 11.3 13.1 10.5 13.4 17.9 20.0 10.5 17.3 11.4 10.3 24.8 15.7 10.4 19.2 13.1 19.2 14.2 11.3 8.9 10.6 10.3 25.2 12.4 10.8 19.7 13.1 17.3 11.9 9.5 7.1 20.3 14.8 14.3 17.4 16.8 11.3 3.8 4.0 0.9 9.4 5.7 6.2 3.3 6.0 8.5 6.0 13.7 7.1 8.5 9.0 10.9 7.2 11.9 11.3 12.6 5.4 21.3 10.9 9.6 10.3 8.0 20.0 12.1 16.1 4.6 5.5 20.2 6.1 11.1 10.6 8.1 12.3 8.8 11.3 15.5 18.3 4.3 8.7 14.8 25.1 12.4 9.9 7.1 28.9 9.8 31.6 15.1 6.0 10.4 9.0 9.6 10.1 10.3 15.3 12.1 6.7 9.6 13.1 7.7 6.5 8.6 7.7 11.3 8.8 14.5 12.5 6.1 6.8 22.0 7.0 17.4 11.9 0.0 3.2 0.9 4.8 6.8 5.4 3.2 4.7 4.1 3.9 3.8 6.0 6.2 0.7 5.7 9.4 4.0 3.6 3.3 10.6 15.3 11.5 17.6 10.5 13.4 11.4 10.3 19.2 7.1 14.9 8.9 13.8 10.9 13.9 4.7 11.0 10.2 14.7 15.9 8.7 2.0 9.5 6.6 9.5 1.1 7.3 3.5 0.0 6.6 12.6 9.2 6.6 9.2 6.0 8.0 9.5 1.7 4.3 4.3 0.8 8.3 7.9 1.7 5.4 4.2 3.8 9.0 3.7 7.1 7.2 4.2 6.5 9.2 11.9 18.8 13.0 6.3 8.7 6.5 8.4 MAN1B1 "ERManI, MANA-ER, MRT15" ENSG00000177239 "Mannosidase alpha class 1B member 1" Q9UKM7 9 137086927-137109187 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051516 Approved Uncertain Vesicles NA NA 540000 Vesicles "HPA051516: AB_2681518" "unprognostic (1.21e-2)" "unprognostic (4.66e-1)" "unprognostic (1.25e-3)" "unprognostic (4.67e-3)" "unprognostic (2.27e-1)" "unprognostic (3.70e-3)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.59e-1)" "unprognostic (6.67e-2)" "unprognostic (1.79e-2)" "unprognostic (5.93e-3)" "unprognostic (1.75e-1)" "unprognostic (3.55e-2)" "unprognostic (2.28e-1)" "unprognostic (5.85e-2)" "unprognostic (2.37e-1)" "unprognostic (1.44e-3)" 20.4 25.4 19.7 13.5 23.7 9.8 18.6 21.6 36.1 24.3 21.6 24.5 20.6 19.8 22.7 28.1 23.1 28.9 25.9 19.5 20.5 21.5 24.3 32.7 20.4 19.9 18.6 25.2 24.2 32.6 23.6 25.1 30.8 18.0 21.2 12.0 22.0 32.7 23.1 12.2 25.4 17.8 18.5 16.4 22.2 21.8 30.3 18.2 19.9 25.1 12.7 19.3 21.0 16.0 13.0 23.0 16.3 24.4 18.0 21.9 18.5 7.2 17.1 6.0 16.9 22.5 19.4 19.8 12.4 26.2 16.5 14.7 8.4 22.9 6.6 41.5 20.6 23.3 25.1 3.6 12.0 3.0 9.1 6.0 2.9 15.4 9.6 21.3 5.1 11.4 22.9 22.7 9.6 8.1 22.1 10.9 8.9 8.0 10.9 11.7 14.7 5.4 12.1 8.0 21.4 17.3 3.1 10.0 20.9 13.2 3.6 6.9 6.2 18.3 19.4 12.6 3.2 21.6 10.9 15.3 24.5 9.1 18.0 14.4 4.4 3.6 4.4 29.4 6.5 21.0 7.9 20.1 16.3 21.9 21.8 20.5 13.0 17.3 20.6 23.0 11.0 17.0 17.0 5.9 18.0 24.4 16.1 21.5 18.5 19.7 23.7 21.6 36.1 20.5 21.5 18.6 25.2 18.0 18.2 17.9 33.0 15.9 12.9 10.3 17.8 9.3 15.3 16.0 7.9 24.4 15.7 44.1 6.6 27.3 4.5 16.8 31.6 0.0 27.7 61.8 26.8 11.6 20.7 17.9 29.2 28.6 29.2 17.8 16.4 4.3 19.5 16.3 21.9 33.3 26.3 17.7 26.2 24.6 20.5 13.0 18.2 12.9 16.0 15.6 26.2 14.2 38.0 24.5 21.3 6.8 MAN1C1 HMIC ENSG00000117643 "Mannosidase alpha class 1C member 1" Q9NR34 1 25617468-25786207 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 51.1;Ito cells: 82.9" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.3" "Lineage enriched" "Detected in many" 5 "T-cells: 8.3" "Cell line enhanced" "Detected in many" "AF22: 12.7;HSkMC: 47.0;U-266/70: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048352 Uncertain Uncertain Nucleoplasm,Vesicles NA NA 1200000 "Nucleoplasm, Vesicles" "HPA048352: AB_2680368" "unprognostic (2.75e-1)" "unprognostic (5.45e-3)" "unprognostic (5.71e-3)" "unprognostic (2.05e-2)" "unprognostic (1.95e-1)" "unprognostic (8.90e-3)" "unprognostic (4.78e-2)" "prognostic favorable (7.55e-4)" "unprognostic (1.80e-1)" "unprognostic (5.70e-2)" "prognostic favorable (4.79e-4)" "unprognostic (2.51e-1)" "unprognostic (9.09e-3)" "unprognostic (3.18e-2)" "unprognostic (7.23e-2)" "unprognostic (7.44e-2)" "unprognostic (5.18e-2)" 4.6 4.5 4.2 3.0 3.8 0.0 2.2 9.9 8.8 8.6 3.6 1.2 6.6 2.5 2.4 3.9 7.3 3.4 5.2 3.2 10.3 12.1 3.2 4.0 4.2 7.1 0.7 4.4 7.8 8.3 7.2 1.2 1.8 7.5 0.9 2.7 1.9 8.0 6.0 7.0 3.1 1.0 10.7 3.2 4.3 4.0 1.0 0.6 1.1 1.6 0.8 8.3 1.1 0.0 0.1 12.7 2.7 9.5 7.4 3.7 0.1 2.4 0.6 0.2 0.2 0.0 0.1 0.1 0.9 1.7 0.1 1.2 0.1 0.2 4.0 0.5 0.2 0.2 0.0 1.1 2.1 5.3 47.0 0.2 0.2 0.0 0.2 0.0 0.5 0.0 0.5 0.0 0.6 0.0 2.3 3.3 0.0 0.1 0.2 7.8 0.2 0.1 0.2 7.5 0.2 0.3 2.0 0.6 2.4 1.0 1.5 0.0 0.0 0.7 8.6 0.3 14.0 0.0 0.0 1.9 4.5 0.6 0.4 1.6 0.7 0.6 1.0 0.8 0.4 3.6 1.6 0.6 1.0 8.3 4.8 1.1 0.8 1.3 0.4 0.8 1.1 3.0 2.7 1.9 2.9 6.0 19.1 6.4 5.1 2.7 7.9 21.0 51.1 8.3 8.3 0.5 0.3 11.1 0.0 0.0 3.4 1.0 9.9 2.6 2.3 37.6 19.1 20.6 2.9 82.9 16.5 0.9 25.0 3.6 1.7 0.0 0.0 20.6 2.2 0.0 20.8 12.8 4.5 6.5 3.1 0.2 2.0 4.5 35.7 5.3 0.0 1.3 MAN2B1 "LAMAN, MANB" ENSG00000104774 "Mannosidase alpha class 2B member 1" O00754 19 12646511-12666742 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3;Macrophages: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 42.1;intermediate monocyte: 39.4;myeloid DC: 35.2;non-classical monocyte: 28.4;plasmacytoid DC: 41.9" "Group enriched" "Detected in all" 5 "dendritic cells: 41.9;monocytes: 42.1" "Low cell line specificity" "Detected in all" "HPA041530, HPA053404" Supported Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 3400000 "Nucleoplasm, Vesicles" "HPA041530: AB_10795639, HPA053404: " "unprognostic (6.63e-2)" "unprognostic (3.61e-1)" "unprognostic (2.20e-2)" "unprognostic (5.48e-2)" "unprognostic (3.81e-1)" "unprognostic (1.04e-1)" "unprognostic (1.61e-1)" "unprognostic (1.84e-2)" "unprognostic (9.55e-2)" "unprognostic (1.95e-1)" "unprognostic (2.79e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.94e-5)" "unprognostic (4.00e-1)" "unprognostic (4.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.51e-1)" 25.2 15.6 7.9 26.7 11.0 33.4 24.4 4.4 7.0 10.5 15.0 14.0 8.6 14.2 15.3 16.5 12.2 13.4 16.4 19.4 6.4 4.4 13.6 16.3 30.2 68.6 10.0 4.7 12.2 21.7 9.1 7.2 15.8 8.6 13.7 10.6 12.0 22.0 8.1 7.7 18.0 20.0 10.2 11.7 51.3 19.5 6.3 8.2 22.1 11.3 7.8 30.0 18.7 11.2 7.7 41.9 6.5 42.1 2.7 8.4 26.0 16.5 8.5 8.7 10.2 29.0 19.5 24.6 12.3 26.0 11.0 10.8 6.8 7.0 18.2 15.0 9.7 3.1 13.0 4.4 8.2 5.3 9.0 13.5 6.3 4.2 11.0 14.8 41.5 43.3 23.2 16.2 6.1 7.8 11.9 10.4 6.9 8.0 13.8 5.8 12.9 5.6 23.4 7.2 8.3 10.8 13.0 11.9 9.0 13.0 19.2 2.7 8.5 12.2 10.5 20.0 5.5 16.2 25.7 13.6 15.0 6.2 14.5 11.5 18.4 20.2 9.0 10.1 40.9 16.7 2.2 42.1 6.2 7.5 39.4 8.4 7.7 6.9 6.7 35.2 6.5 3.8 3.8 6.5 2.7 28.4 41.9 6.8 26.0 7.9 11.0 4.4 7.0 6.4 4.4 10.0 4.7 8.6 8.2 6.0 6.9 14.4 1.6 3.2 2.6 0.7 2.5 5.3 1.2 1.8 0.0 2.0 1.7 1.6 2.0 1.0 2.5 23.3 2.0 2.3 2.8 2.2 1.1 0.8 7.9 0.0 1.7 2.5 10.2 8.1 3.4 18.6 1.7 5.4 0.9 1.3 1.0 2.9 4.2 1.1 3.0 12.9 1.2 0.5 1.5 2.9 2.3 5.4 1.7 1.6 MAOA ENSG00000189221 "Monoamine oxidase A" P21397 X 43654907-43746824 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" Oxidoreductase "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 358.2;Proximal tubular cells: 497.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.0;MAIT T-cell: 1.3" "Group enriched" "Detected in many" 10 "monocytes: 1.0;T-cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 40.4;HHSteC: 75.9;HSkMC: 19.1;hTCEpi: 21.4;RT4: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009437, HPA054807, HPA059299" Enhanced Enhanced Mitochondria,Cytosol No No Mitochondria Cytosol "CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970" "unprognostic (9.54e-3)" "unprognostic (1.63e-1)" "unprognostic (7.99e-2)" "unprognostic (3.07e-1)" "unprognostic (6.75e-2)" "unprognostic (3.32e-1)" "unprognostic (9.51e-2)" "unprognostic (6.89e-3)" "unprognostic (2.21e-1)" "unprognostic (4.29e-2)" "unprognostic (3.94e-1)" "unprognostic (3.54e-1)" "unprognostic (1.45e-3)" "unprognostic (1.16e-2)" "unprognostic (1.47e-1)" "unprognostic (4.04e-2)" "unprognostic (2.98e-3)" 72.3 11.0 8.2 10.2 7.8 0.3 35.2 3.3 6.1 12.4 85.7 2.8 10.7 53.6 12.5 6.2 36.6 12.0 14.7 37.8 6.7 8.3 77.8 45.9 34.4 5.2 11.1 6.1 14.2 24.4 9.6 1.5 79.8 8.7 26.2 39.9 6.2 49.1 12.9 12.5 11.2 90.1 23.6 3.4 2.1 19.3 5.5 4.7 0.0 68.6 9.7 3.9 35.3 35.1 0.0 0.0 0.1 1.0 0.0 1.3 0.1 0.0 0.8 0.1 2.4 40.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 4.1 1.5 5.4 0.0 0.0 0.6 1.6 0.1 4.3 75.9 0.0 4.1 19.1 21.4 0.0 11.2 0.0 4.8 0.0 0.0 0.1 1.4 0.6 0.0 0.1 0.4 4.9 1.2 0.0 0.0 0.1 5.5 31.3 0.7 1.9 0.0 0.0 0.0 0.1 0.1 0.0 2.1 0.0 2.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.3 0.0 0.1 0.3 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.1 8.2 7.8 3.3 6.1 6.7 8.3 11.1 6.1 8.7 4.7 65.5 115.2 10.9 141.7 9.7 4.4 90.1 91.7 34.8 50.0 57.6 21.6 9.7 102.8 29.5 19.6 35.3 358.2 0.0 12.0 17.7 14.2 55.4 5.7 169.3 6.2 3.2 36.6 36.8 14.9 22.5 5.2 4.0 10.1 29.7 119.4 23.2 31.4 140.8 0.0 497.3 21.7 6.5 15.1 1.1 0.4 12.5 173.1 3.1 215.1 89.9 MAP1LC3B ATG8F ENSG00000140941 "Microtubule associated protein 1 light chain 3 beta" Q9GZQ8 16 87383995-87404779 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037216, HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB037216: AB_796155, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253" "unprognostic (4.70e-3)" "unprognostic (2.89e-1)" "unprognostic (3.21e-1)" "unprognostic (9.70e-3)" "unprognostic (4.28e-1)" "unprognostic (1.79e-2)" "unprognostic (4.98e-3)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (7.26e-2)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "prognostic favorable (2.77e-7)" "prognostic unfavorable (8.97e-4)" "unprognostic (9.66e-2)" "unprognostic (1.14e-1)" "unprognostic (1.60e-1)" 35.8 36.4 37.4 15.3 34.6 89.0 35.9 58.5 46.6 21.2 18.7 25.8 22.9 11.1 22.7 20.0 19.5 17.5 24.5 41.0 35.6 40.5 24.7 22.2 20.6 22.3 49.0 40.2 19.6 15.9 27.9 20.5 31.2 46.7 19.6 20.4 18.6 19.6 22.4 67.4 22.9 13.6 28.3 43.1 18.0 15.8 27.5 28.8 13.6 27.2 23.1 20.9 22.0 31.9 15.5 15.8 50.0 18.6 20.8 21.8 19.9 10.5 6.1 12.0 10.9 36.2 28.1 8.0 20.9 24.0 16.5 11.4 9.9 7.7 6.8 16.1 28.3 18.3 9.6 17.5 13.2 23.5 8.9 15.4 7.1 7.8 16.7 60.1 5.1 8.0 37.3 44.0 25.6 61.3 24.9 19.5 10.6 19.0 14.6 27.8 10.9 9.0 11.4 12.6 4.8 14.9 14.3 8.0 6.7 22.0 5.0 9.8 11.3 32.2 5.4 40.3 16.7 8.9 6.2 24.6 17.9 11.5 16.2 11.7 19.4 23.7 24.9 25.4 12.3 12.8 48.1 18.6 42.0 17.5 16.5 17.8 15.5 16.9 17.7 14.4 12.8 13.1 13.8 50.0 20.8 17.2 15.8 21.8 19.9 37.4 34.6 58.5 46.6 35.6 40.5 49.0 40.2 46.7 28.8 83.4 75.1 94.3 175.2 196.3 67.1 164.8 63.7 120.5 68.2 73.3 49.1 124.6 222.2 290.4 163.3 131.2 195.1 256.9 117.1 101.7 121.4 182.7 127.1 55.7 184.9 82.6 126.6 77.3 139.1 218.9 84.0 179.4 178.8 251.5 103.4 145.6 263.3 235.0 83.8 141.7 98.8 58.2 173.1 309.4 159.5 186.7 528.2 136.3 87.6 216.2 MAP3K14 "FTDCR1B, HS, HSNIK, NIK" ENSG00000006062 "Mitogen-activated protein kinase kinase kinase 14" Q99558 17 45263121-45317040 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "monocytes: 49.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 22.4;HDLM-2: 23.0;U-251 MG: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027269, HPA027270" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" NA NA "Vesicles, Cytosol" "Nucleoplasm, Nucleoli fibrillar center" "HPA027269: AB_2732436, HPA027270: AB_2732437" "unprognostic (1.05e-2)" "prognostic favorable (5.27e-5)" "unprognostic (2.71e-2)" "unprognostic (9.42e-2)" "unprognostic (5.31e-2)" "unprognostic (2.61e-3)" "unprognostic (2.70e-2)" "unprognostic (1.72e-1)" "unprognostic (3.40e-1)" "unprognostic (3.45e-1)" "unprognostic (1.07e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (8.82e-2)" "unprognostic (3.49e-2)" "unprognostic (1.03e-2)" "unprognostic (2.28e-1)" 3.7 3.4 3.0 14.7 4.0 3.4 2.7 4.9 3.6 5.0 7.3 4.5 3.5 6.0 5.5 3.3 6.8 4.2 6.2 4.5 3.0 4.4 5.1 4.9 12.0 3.0 0.6 3.5 5.7 3.5 7.7 1.5 4.6 5.2 3.5 4.3 7.5 4.8 14.5 6.1 9.6 5.2 4.1 8.4 4.0 4.5 4.5 7.1 2.2 6.9 18.0 4.9 2.8 9.5 4.8 7.7 3.6 5.6 5.2 2.3 9.5 22.4 2.3 4.0 1.6 3.8 5.7 2.6 1.8 8.5 5.2 3.4 11.9 4.2 13.6 2.8 8.5 6.8 1.0 3.6 4.4 23.0 1.7 0.9 6.1 1.5 4.1 0.7 4.5 5.9 2.3 4.2 2.2 9.0 1.6 2.0 1.8 18.3 4.3 3.5 4.0 1.5 1.2 5.9 3.1 5.2 6.9 9.6 6.2 1.9 2.4 1.9 4.1 2.7 2.9 3.4 1.7 0.4 3.6 3.9 6.0 3.3 22.5 17.5 6.5 2.2 2.2 2.5 5.2 1.5 3.4 1.6 3.5 3.6 2.0 7.6 2.4 2.5 2.3 9.5 2.6 2.5 7.7 5.6 2.2 4.8 5.2 2.3 3.0 13.8 9.7 13.7 0.0 3.6 2.0 15.3 9.4 4.5 0.0 3.9 0.7 0.0 4.2 3.7 1.6 11.2 0.0 2.3 1.2 1.8 6.5 1.1 8.1 4.4 1.6 12.6 4.9 7.8 4.5 4.4 6.2 0.0 49.5 6.4 2.2 3.3 7.8 1.1 2.5 2.7 0.0 0.6 4.5 2.4 0.0 0.0 5.1 6.7 5.0 MAP3K19 "FLJ23074, RCK, YSK4" ENSG00000176601 "Mitogen-activated protein kinase kinase kinase 19" Q56UN5 2 134964491-135047468 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.3;fallopian tube: 23.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 151.3;Early spermatids: 55.2;Late spermatids: 74.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.8" "Region enhanced" "Detected in many" "pons and medulla: 18.3" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.5" "Group enriched" "Detected in some" 4 "RPMI-8226: 4.1;U-266/70: 2.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "midbrain: 20.2" HPA011388 Uncertain Cytosol NA NA Cytosol "HPA011388: AB_1848822" "unprognostic (7.12e-3)" "unprognostic (6.55e-3)" "unprognostic (6.96e-2)" "unprognostic (3.90e-3)" "unprognostic (3.63e-1)" "unprognostic (2.21e-1)" "unprognostic (1.96e-1)" "unprognostic (9.38e-2)" "unprognostic (1.09e-1)" "unprognostic (4.33e-1)" "unprognostic (2.02e-2)" "unprognostic (1.32e-1)" "unprognostic (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (2.83e-4)" 0.1 0.2 1.7 0.2 6.2 0.1 0.1 0.0 0.5 1.1 0.2 7.3 0.0 0.2 1.0 6.7 0.2 23.9 0.1 0.1 2.9 3.8 0.2 0.2 5.6 0.2 0.5 1.5 7.3 0.1 0.1 1.0 0.1 18.3 0.3 0.2 0.0 0.2 0.2 0.3 0.2 0.2 0.1 0.5 0.2 0.2 7.6 3.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.0 4.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.7 6.2 0.0 0.5 2.9 3.8 0.5 1.5 18.3 3.1 0.0 0.6 0.0 0.0 0.0 0.2 0.4 0.0 151.3 17.0 0.0 9.8 0.0 0.0 0.0 55.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 74.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.1 0.0 0.0 0.0 0.0 0.1 MAP3K7 "MEKK7, TAK1" ENSG00000135341 "Mitogen-activated protein kinase kinase kinase 7" O43318 6 90513573-90587045 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007633, HPA075335" Approved Supported "Nuclear speckles,Plasma membrane,Cytosol" NA NA Cytosol "Nuclear speckles, Plasma membrane" "HPA007633: AB_1079359, HPA075335: " "unprognostic (1.48e-1)" "unprognostic (3.45e-2)" "unprognostic (1.35e-1)" "unprognostic (6.48e-2)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (9.77e-2)" "unprognostic (6.51e-2)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (2.79e-1)" "unprognostic (2.56e-3)" "unprognostic (4.76e-2)" "unprognostic (1.95e-1)" "unprognostic (2.08e-1)" "unprognostic (1.17e-1)" 15.5 17.6 19.6 17.3 26.3 10.3 21.6 27.5 27.3 21.1 16.4 15.7 15.8 12.5 23.1 23.6 15.2 15.5 17.6 22.2 20.5 17.5 15.9 15.5 20.0 22.2 22.9 16.4 25.0 13.5 25.8 25.6 23.6 20.7 21.2 15.3 12.4 17.0 23.3 24.3 18.7 14.7 19.4 23.0 23.3 14.7 13.8 21.7 28.2 20.3 10.8 21.9 17.2 18.9 14.2 15.9 19.4 17.7 18.2 22.1 13.6 7.9 7.0 20.5 17.6 15.0 20.1 14.5 16.0 18.5 14.4 18.2 9.0 7.6 17.7 10.2 17.2 12.8 8.5 12.9 12.4 24.6 9.0 13.7 15.8 9.7 11.9 15.8 17.5 12.2 16.6 15.3 14.0 17.2 16.6 13.5 15.6 31.5 14.5 20.6 9.7 8.1 14.8 16.8 12.4 8.9 14.0 36.9 8.6 12.1 8.9 10.4 14.8 11.1 7.7 12.0 16.8 7.7 31.1 12.9 11.7 7.4 10.7 14.8 12.9 11.5 7.7 18.0 19.2 17.2 15.5 12.7 19.4 15.1 17.4 16.8 14.2 14.5 14.4 15.9 10.5 16.5 16.0 12.5 18.2 17.7 9.8 22.1 13.6 19.6 26.3 27.5 27.3 20.5 17.5 22.9 16.4 20.7 21.7 14.9 24.0 20.7 17.4 32.3 22.8 28.8 12.7 16.0 10.3 15.7 25.5 27.6 6.6 16.6 2.6 20.3 9.3 0.0 18.3 26.6 23.5 24.4 12.8 17.9 21.1 27.0 11.6 30.7 26.3 2.2 24.7 25.3 20.3 27.9 15.6 18.9 15.5 7.0 38.5 13.1 21.1 19.4 19.1 24.6 24.0 32.5 40.5 25.5 15.1 23.0 MAP6 "FLJ41346, KIAA1878, MAP6-N, STOP" ENSG00000171533 "Microtubule associated protein 6" Q96JE9 11 75586918-75669120 "Predicted intracellular proteins" Transport Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.9" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 77.0;Cone photoreceptor cells: 149.2;Horizontal cells: 47.7" "Cancer enhanced" "Detected in many" "glioma: 9.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 2.4" "Lineage enriched" "Detected in single" 24 "B-cells: 2.4" "Group enriched" "Detected in some" 6 "AF22: 19.5;CACO-2: 19.0;HDLM-2: 10.6;SCLC-21H: 32.4;SH-SY5Y: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015442, CAB022600, HPA039061, HPA039062" Enhanced Uncertain "Plasma membrane" NA NA "Plasma membrane" "CAB015442: AB_2140997, CAB022600: , HPA039061: AB_2676325, HPA039062: AB_2676326" "unprognostic (3.04e-2)" "unprognostic (6.18e-2)" "unprognostic (3.15e-2)" "unprognostic (9.07e-2)" "unprognostic (7.54e-2)" "unprognostic (4.49e-2)" "unprognostic (8.29e-2)" "unprognostic (2.51e-2)" "unprognostic (5.99e-2)" "unprognostic (7.99e-2)" "prognostic favorable (3.41e-4)" "prognostic favorable (9.15e-4)" "unprognostic (2.43e-2)" "unprognostic (3.96e-3)" "unprognostic (8.09e-3)" "unprognostic (1.77e-1)" "unprognostic (2.03e-1)" 3.0 16.6 23.7 2.1 26.4 0.6 2.6 14.9 35.9 6.9 6.4 10.0 6.1 1.9 10.0 18.6 4.2 34.6 5.8 5.4 21.3 26.6 7.3 1.3 6.5 1.1 17.0 19.9 7.1 3.4 28.7 24.9 1.8 33.2 12.9 3.6 7.5 2.9 18.7 1.1 2.4 2.0 11.5 13.7 1.7 3.6 12.4 9.9 0.0 6.2 0.0 1.0 2.6 3.1 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 19.5 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.0 19.0 0.0 0.3 0.7 3.1 0.6 0.0 1.7 0.2 0.0 10.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.2 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 32.4 16.4 2.3 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.7 26.4 14.9 29.1 21.3 26.6 17.0 19.9 33.2 9.9 3.0 3.0 0.0 1.3 0.7 77.0 7.6 2.5 28.1 4.5 10.4 149.2 0.1 1.7 0.1 21.3 0.7 0.0 0.0 0.2 0.0 0.8 1.6 0.0 0.4 0.1 47.7 12.6 0.6 0.0 31.1 6.9 0.0 5.0 0.0 0.0 16.8 0.3 0.0 17.3 0.8 8.8 0.0 2.3 20.6 1.9 0.4 0.0 0.0 0.0 0.5 MAPRE2 "EB1, EB2, RP1" ENSG00000166974 "Microtubule associated protein RP/EB family member 2" Q15555 18 34976928-35143470 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.4" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 93.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016738, HPA016739" Enhanced Uncertain Nucleoplasm NA NA 24000000 Nucleoplasm "HPA016738: AB_1853571, HPA016739: AB_1853570" "unprognostic (2.01e-1)" "unprognostic (3.48e-1)" "unprognostic (2.55e-2)" "unprognostic (5.30e-3)" "unprognostic (1.75e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-2)" "unprognostic (8.53e-2)" "unprognostic (1.09e-2)" "unprognostic (2.29e-1)" "unprognostic (2.93e-2)" "unprognostic (5.40e-2)" "unprognostic (2.22e-3)" "unprognostic (5.83e-2)" "unprognostic (1.34e-1)" "unprognostic (3.16e-2)" "unprognostic (3.99e-3)" 12.3 33.8 38.9 15.3 35.5 10.4 9.6 34.6 61.8 11.6 13.4 30.4 3.1 8.3 8.1 11.3 10.1 6.5 22.7 47.9 43.7 29.8 10.6 18.5 15.1 18.4 39.0 43.3 14.8 7.3 7.6 8.6 15.7 32.1 9.4 14.0 8.7 10.5 10.2 24.6 12.8 10.7 14.4 71.4 14.6 16.7 3.8 22.1 31.9 12.3 8.6 17.5 15.7 8.4 27.4 23.1 25.1 22.8 34.0 32.8 32.8 0.2 8.8 9.9 5.2 6.0 5.6 0.7 6.3 15.0 7.5 13.0 0.6 3.3 28.9 7.4 13.8 8.1 11.9 7.7 5.1 13.9 16.9 7.2 29.4 9.6 16.9 4.4 16.1 24.7 6.7 1.4 10.5 3.6 7.1 42.1 20.8 9.1 13.0 9.8 0.5 34.1 5.4 7.7 9.6 1.7 13.7 12.1 6.6 3.9 0.1 12.4 8.2 4.7 0.2 5.2 9.7 1.0 9.5 7.0 8.3 4.7 4.9 4.2 6.8 16.2 17.0 14.4 21.7 12.9 25.1 14.7 22.2 32.8 18.2 25.4 27.4 23.2 29.8 16.0 25.9 26.8 32.6 10.6 34.0 22.8 23.1 23.5 32.8 38.9 35.5 34.6 41.2 43.7 29.8 39.0 43.3 32.1 22.1 20.8 19.4 20.7 4.8 21.1 74.9 93.6 17.8 9.4 6.8 5.2 23.6 0.4 5.0 7.3 8.0 22.0 9.6 0.0 11.4 8.9 21.6 2.9 26.5 22.2 22.9 49.3 28.2 36.2 41.5 5.5 17.8 20.3 28.7 4.6 27.1 43.5 8.6 19.2 19.8 4.6 10.1 77.6 52.6 1.5 11.3 24.1 0.7 35.5 9.9 3.0 MARF1 "KIAA0430, LKAP, LMKB, Marf1, PPP1R34" ENSG00000166783 "Meiosis regulator and mRNA stability factor 1" Q9Y4F3 16 15594386-15643166 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 26.6;Ciliated cells: 32.1;Club cells: 34.2;Collecting duct cells: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.0" "Group enriched" "Detected in many" 4 "B-cells: 6.4;granulocytes: 12.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017992 Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA017992: AB_1852921" "unprognostic (2.33e-1)" "unprognostic (6.44e-3)" "unprognostic (8.84e-2)" "unprognostic (3.78e-2)" "unprognostic (1.28e-1)" "unprognostic (6.13e-3)" "unprognostic (2.35e-1)" "unprognostic (2.10e-2)" "unprognostic (2.47e-2)" "unprognostic (6.93e-2)" "unprognostic (8.44e-3)" "unprognostic (1.35e-1)" "unprognostic (6.94e-3)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (8.74e-2)" "unprognostic (7.94e-2)" 12.2 9.1 22.4 12.3 17.7 16.7 11.2 25.9 40.0 16.9 17.2 12.0 7.6 8.9 15.2 7.1 10.7 15.1 11.0 8.8 20.7 15.4 13.0 9.0 10.8 17.2 15.1 18.4 20.8 12.0 18.8 12.0 9.3 16.5 12.8 12.8 9.1 12.4 12.8 20.4 11.9 13.0 15.5 13.6 14.6 12.0 6.8 14.0 11.8 15.5 4.2 26.1 18.8 13.9 6.4 0.8 12.0 1.9 0.8 2.1 0.8 4.3 8.1 10.3 7.5 9.5 13.6 4.3 4.8 6.6 4.5 7.7 1.3 5.9 19.5 9.7 9.6 3.8 3.0 6.1 6.7 8.1 6.6 4.2 8.2 7.3 6.2 7.9 9.2 10.9 8.1 7.4 9.7 11.7 10.2 11.3 11.1 7.1 7.4 8.8 4.0 7.5 4.2 2.8 3.7 4.1 10.4 13.5 4.9 3.9 8.3 5.9 7.6 7.1 4.6 8.8 5.6 4.9 8.1 11.7 6.7 4.3 11.4 3.9 8.5 7.9 11.9 9.0 6.0 8.6 2.4 1.6 4.3 1.4 1.4 0.8 4.2 2.1 1.4 0.7 6.4 1.9 2.0 12.0 0.8 1.9 0.8 1.9 0.8 22.4 17.7 25.9 40.0 20.7 15.4 15.1 18.4 16.5 14.0 20.8 26.6 0.0 0.0 0.0 0.0 0.0 0.0 32.1 34.2 22.7 0.0 4.6 13.3 8.1 0.0 0.0 0.0 0.0 12.1 4.4 0.0 0.0 10.5 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 12.6 0.0 0.0 12.1 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 MBD3L2 ENSG00000230522 "Methyl-CpG binding domain protein 3 like 2" Q8NHZ7 19 7049321-7051735 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-2 OS: 2.9" HPA060924 Uncertain Mitochondria NA NA Mitochondria "HPA060924: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L2B ENSG00000196589 "Methyl-CpG binding domain protein 3 like 2B" A0A1B0GVZ6 19 7018969-7021450 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 18 "testis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "U-2 OS: 2.7" HPA060924 Uncertain Mitochondria NA NA Mitochondria "HPA060924: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCC ENSG00000171444 "Mutated in colorectal cancers" P23508 5 113022099-113488830 "Predicted intracellular proteins" "Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 49.4" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 97.8;Cone photoreceptor cells: 53.0;Hepatocytes: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 6.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.2;hTCEpi: 19.0;RT4: 17.6" "Low region specificity" "Detected in all" "HPA037390, HPA037391" Approved Approved Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytosol" "Cytoplasmic bodies" "HPA037390: AB_2675451, HPA037391: AB_10671248" "unprognostic (6.60e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.23e-1)" "unprognostic (8.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.20e-1)" "unprognostic (5.21e-2)" "unprognostic (9.59e-2)" "unprognostic (8.02e-3)" "unprognostic (1.56e-1)" "unprognostic (1.74e-1)" "prognostic favorable (6.19e-4)" "unprognostic (1.70e-3)" "unprognostic (3.34e-1)" "unprognostic (2.47e-2)" "unprognostic (2.90e-1)" 7.1 2.3 6.9 3.2 6.1 0.5 7.8 11.4 8.1 11.8 3.2 3.4 5.9 1.7 12.5 4.7 9.1 7.4 4.4 8.4 9.2 5.0 3.9 12.7 4.6 3.0 7.6 5.1 49.4 4.5 28.9 5.2 7.1 7.8 7.7 2.4 15.1 6.7 9.5 5.0 13.9 2.6 9.1 5.8 3.4 3.6 6.5 5.2 1.3 3.2 6.1 4.3 9.3 11.8 0.2 6.3 1.3 0.2 0.1 1.6 0.1 0.4 0.1 7.2 0.7 6.2 5.8 7.9 1.2 3.2 1.3 1.6 0.2 6.5 0.0 7.6 0.5 3.6 8.7 4.3 28.2 0.6 2.3 2.7 0.0 2.5 1.9 1.8 0.3 0.1 7.7 19.0 3.5 13.4 7.2 8.4 0.9 0.0 10.7 2.9 0.6 0.1 0.1 3.9 0.0 0.5 0.1 6.3 1.9 0.1 17.6 3.1 6.8 5.8 0.0 15.4 2.6 2.3 0.0 10.0 4.9 4.6 7.6 2.2 3.1 0.0 0.0 13.1 0.0 5.1 0.0 0.2 0.1 0.5 0.2 1.6 0.2 0.5 0.6 0.0 0.2 0.4 0.5 1.3 0.1 0.1 6.3 1.5 0.1 6.9 6.1 11.4 8.1 9.2 5.0 7.6 5.1 7.8 5.2 0.0 0.6 0.5 24.4 33.4 97.8 13.9 7.6 0.0 3.4 3.5 53.0 0.7 0.0 2.9 10.6 23.9 0.0 0.0 1.2 1.7 27.7 5.4 0.0 50.6 2.0 35.0 4.6 25.2 4.0 24.2 19.5 0.5 15.1 5.4 0.2 7.4 3.0 0.2 25.5 1.4 8.2 0.0 10.3 8.2 8.5 41.3 1.0 2.9 0.0 14.9 MCOLN1 "ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1" ENSG00000090674 "Mucolipin 1" Q9GZU1 19 7522626-7534009 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Ion channel" "Disease mutation, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Hofbauer cells: 91.8;Kupffer cells: 81.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 30.9;monocytes: 28.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031763, CAB032637, HPA069495" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: " "unprognostic (5.51e-2)" "unprognostic (1.31e-2)" "unprognostic (1.35e-2)" "unprognostic (3.30e-2)" "unprognostic (2.66e-1)" "unprognostic (4.07e-2)" "unprognostic (8.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.79e-2)" "unprognostic (1.47e-1)" "prognostic favorable (5.60e-5)" "unprognostic (1.36e-1)" "prognostic favorable (5.67e-4)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (1.83e-1)" 18.9 27.5 10.1 10.3 11.9 10.0 10.3 8.2 19.7 7.7 9.6 11.2 7.2 9.6 8.8 9.5 11.2 8.4 11.7 11.7 9.0 9.2 11.5 20.6 17.9 20.6 10.6 10.0 7.8 10.5 9.8 26.0 17.9 13.6 8.8 6.9 9.7 9.2 8.0 14.2 13.9 8.0 9.5 10.4 38.3 8.9 6.5 9.4 7.0 6.2 7.6 5.1 12.5 8.7 1.3 6.2 30.9 28.9 2.8 2.7 4.4 6.4 6.6 3.2 11.0 18.9 6.1 9.3 12.0 9.7 14.6 12.6 5.0 5.7 3.6 14.8 8.1 12.9 3.0 5.4 4.1 4.3 7.0 12.0 3.2 6.5 4.0 16.6 3.6 14.2 8.6 9.7 13.9 2.4 4.6 6.1 8.1 5.9 16.1 8.4 2.1 4.9 3.6 7.2 3.4 14.2 6.9 5.4 7.7 5.5 5.6 8.4 10.3 5.1 9.1 15.2 3.7 5.5 6.4 7.6 7.0 4.0 28.1 8.9 12.4 19.0 2.5 11.2 5.1 10.4 30.9 13.7 29.7 2.3 27.5 2.0 1.1 2.0 1.9 5.6 1.3 1.9 2.0 12.2 2.8 28.9 6.2 2.7 4.4 10.1 11.9 8.2 19.7 9.0 9.2 10.6 10.0 13.6 9.4 3.0 1.6 10.4 6.1 11.8 26.9 2.0 17.8 4.0 1.2 29.6 21.6 10.4 1.7 20.9 4.9 11.9 19.5 46.7 19.9 15.2 17.9 4.5 1.1 12.4 91.8 55.6 16.1 11.1 81.2 10.8 15.3 42.0 20.3 5.4 8.6 23.6 17.7 20.1 14.9 9.2 37.0 6.5 9.2 10.2 11.9 15.2 24.7 10.2 8.6 4.1 MCTS1 MCT-1 ENSG00000232119 "MCTS1, re-initiation and release factor" Q9ULC4 X 120594010-120621074 "Predicted intracellular proteins" "Cell cycle, DNA damage, Growth regulation, Protein biosynthesis, Transcription, Transcription regulation" "Initiation factor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001045 Supported "Plasma membrane,Cytosol" NA NA 52000 Cytosol "Plasma membrane" "HPA001045: " "prognostic unfavorable (1.38e-4)" "unprognostic (1.44e-1)" "unprognostic (4.50e-1)" "unprognostic (9.37e-3)" "unprognostic (7.29e-2)" "prognostic unfavorable (3.27e-5)" "unprognostic (2.94e-3)" "unprognostic (9.59e-2)" "unprognostic (8.28e-2)" "unprognostic (4.89e-2)" "unprognostic (7.42e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (4.35e-5)" "unprognostic (1.95e-1)" "unprognostic (7.58e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" 20.2 26.8 23.7 22.5 29.3 16.9 27.4 16.8 33.8 20.7 24.0 14.3 26.6 23.2 17.4 30.7 31.7 16.6 16.8 24.6 25.2 22.4 22.7 37.9 17.2 31.1 22.6 25.0 14.7 42.0 21.1 38.2 20.7 22.3 16.6 29.7 13.4 31.0 27.3 20.9 18.1 21.2 19.2 20.8 24.1 22.9 13.1 19.0 28.5 23.1 32.1 36.1 20.5 19.1 28.2 32.0 13.7 24.4 17.7 24.5 15.5 31.3 22.1 18.0 18.0 23.0 33.5 24.5 23.6 21.7 29.8 28.6 19.2 31.1 33.8 34.0 29.1 53.9 20.9 31.6 30.1 43.2 21.3 21.0 10.9 24.5 15.1 26.2 27.4 21.0 23.0 26.6 25.9 28.3 25.3 35.9 24.3 29.7 22.6 36.6 36.1 26.2 36.6 20.1 58.6 43.8 20.2 16.6 40.9 31.8 15.7 22.8 21.2 16.5 26.9 21.3 23.2 19.8 25.3 24.5 24.2 14.8 26.1 43.3 17.1 23.1 46.0 28.1 40.4 26.3 11.9 20.1 13.7 15.1 24.4 24.5 28.2 19.8 19.3 24.8 20.7 18.3 18.5 9.9 17.7 22.4 32.0 22.9 15.5 23.7 29.3 16.8 33.8 25.2 22.4 22.6 25.0 22.3 19.0 17.9 22.2 67.0 49.4 28.6 12.4 74.2 43.3 28.1 29.6 43.6 7.9 83.5 109.5 76.8 43.6 38.3 78.6 0.0 76.9 150.4 40.7 48.4 51.8 84.7 116.3 14.3 53.5 53.4 77.2 73.5 38.9 64.4 59.1 54.1 77.4 19.3 85.0 71.9 26.2 116.5 16.5 38.8 36.0 9.3 15.1 30.2 94.4 51.1 64.3 66.0 MDGA1 "GPIM, MAMDC3" ENSG00000112139 "MAM domain containing glycosylphosphatidylinositol anchor 1" Q8NFP4 6 37630679-37699306 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 94.7" "Group enriched" "Detected in many" 5 "Bipolar cells: 31.7;Cone photoreceptor cells: 47.1;Horizontal cells: 54.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 17 "cerebellum: 94.7" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 3.1" "Group enriched" "Detected in many" 22 "B-cells: 1.1;T-cells: 3.1" "Cell line enhanced" "Detected in many" "ASC diff: 13.8;HaCaT: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031235, HPA050382" Enhanced Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 490000 "Plasma membrane" "Golgi apparatus" "HPA031235: AB_10603017, HPA050382: AB_2681108" "unprognostic (4.67e-2)" "unprognostic (6.97e-3)" "unprognostic (3.24e-1)" "unprognostic (5.69e-4)" "unprognostic (2.75e-2)" "unprognostic (2.41e-1)" "unprognostic (1.45e-2)" "unprognostic (2.00e-1)" "unprognostic (2.02e-2)" "unprognostic (1.45e-1)" "unprognostic (2.16e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-5)" "unprognostic (9.19e-3)" "unprognostic (5.28e-3)" "unprognostic (3.80e-3)" "unprognostic (4.60e-2)" 1.5 3.7 3.4 3.1 2.4 0.0 1.0 94.7 5.1 3.0 1.3 1.5 1.0 0.0 3.0 1.5 1.8 2.1 3.4 1.2 5.0 2.0 0.8 0.5 3.5 3.4 1.7 2.4 8.4 2.6 6.6 2.6 0.5 5.4 1.5 1.1 3.4 0.7 1.2 0.9 6.7 1.5 2.6 4.1 3.9 1.2 1.4 1.3 0.6 1.1 1.7 2.7 1.1 3.1 1.1 0.0 0.0 0.0 0.0 3.1 0.4 0.1 3.8 6.9 2.6 13.8 5.6 3.0 2.7 2.7 3.4 3.9 0.7 0.0 0.9 0.6 1.7 3.6 8.9 0.5 0.0 1.1 6.9 4.0 0.0 0.5 0.0 0.6 0.0 0.9 1.0 0.1 1.4 0.0 8.0 0.0 0.1 0.1 0.0 1.2 0.1 0.0 0.5 0.0 0.1 0.4 7.3 2.4 0.0 0.8 4.2 6.3 0.0 1.5 0.4 3.3 0.2 3.2 0.6 0.5 3.7 1.2 1.3 5.0 0.0 0.1 0.0 5.8 1.1 2.4 0.0 0.0 0.0 1.4 0.0 0.4 1.1 1.2 0.8 0.0 1.0 3.1 0.8 0.0 0.0 0.0 0.0 1.8 0.4 3.4 2.4 94.7 2.7 5.0 2.0 1.7 2.4 5.4 1.3 8.9 0.3 0.0 1.7 2.1 31.7 5.2 0.0 2.7 1.2 3.5 47.1 0.1 0.0 0.6 1.9 1.0 0.0 0.0 0.0 1.2 2.4 1.5 0.0 0.0 0.1 54.0 1.7 1.8 0.0 0.0 9.5 0.0 1.7 0.0 0.0 2.3 0.6 0.0 4.6 0.1 1.3 0.0 3.4 2.3 1.0 2.6 0.6 0.5 0.0 3.8 MDM1 ENSG00000111554 "Mdm1 nuclear protein" Q8TC05 12 68272443-68332381 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 49.5;Spermatocytes: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA040411, HPA041594" Uncertain Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA040411: AB_10805711, HPA041594: AB_10793968" "unprognostic (7.41e-2)" "prognostic favorable (6.01e-4)" "unprognostic (8.58e-2)" "unprognostic (2.62e-3)" "unprognostic (1.21e-1)" "unprognostic (3.50e-3)" "unprognostic (4.24e-3)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" "unprognostic (2.92e-1)" "unprognostic (2.56e-3)" "unprognostic (3.13e-2)" "unprognostic (4.29e-3)" "unprognostic (1.29e-1)" "unprognostic (2.84e-1)" "unprognostic (4.63e-2)" "unprognostic (5.23e-3)" 7.0 6.7 11.5 11.9 11.4 15.4 10.0 8.2 12.7 11.9 28.7 9.6 12.4 5.1 15.2 12.7 5.4 20.3 6.5 6.7 12.3 10.0 8.8 4.9 6.8 12.8 11.4 10.5 10.9 11.3 8.8 22.8 6.0 14.9 12.3 11.1 9.0 6.8 15.9 3.8 4.2 9.0 18.8 11.4 9.5 9.8 20.7 12.4 14.6 11.0 5.3 13.4 17.0 8.9 7.1 4.0 13.3 17.2 6.0 8.1 5.4 5.0 4.2 8.1 7.8 4.0 5.5 6.2 6.7 3.7 10.7 9.9 5.0 2.3 11.6 4.4 3.0 5.3 5.2 5.5 3.6 12.2 15.1 5.3 25.4 5.4 3.4 6.2 14.0 10.1 2.5 4.7 7.2 7.0 5.8 6.0 13.4 4.8 13.0 6.2 3.6 19.8 9.9 4.3 5.0 5.1 19.5 7.2 3.4 5.1 4.4 7.4 3.9 6.5 3.9 6.6 6.7 9.3 10.1 3.2 8.6 3.8 5.4 6.1 6.8 19.8 7.8 4.5 9.2 5.5 6.0 4.7 13.3 5.0 11.1 8.1 6.8 6.4 5.2 4.0 7.1 7.7 6.2 3.1 6.0 17.2 2.3 5.9 5.4 11.5 11.4 8.2 12.7 12.3 10.0 11.4 10.5 14.9 12.4 3.0 5.8 13.3 3.9 4.2 12.7 8.1 0.0 49.5 7.9 7.0 0.0 3.7 8.3 4.3 22.5 6.3 1.6 23.3 3.1 3.8 5.8 2.3 6.9 4.2 5.4 7.9 2.4 3.7 2.4 9.0 8.3 7.6 15.1 3.6 2.6 24.9 2.7 3.6 12.7 8.4 32.9 6.5 7.2 38.1 17.8 3.6 0.2 13.6 4.1 1.3 MDN1 "KIAA0301, Rea1" ENSG00000112159 "Midasin AAA ATPase 1" Q9NU22 6 89642499-89819723 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 27.1;NTERA-2: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029666, HPA029667, HPA029668, HPA029669" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA "Nucleoli, Cytosol" "Nucleoplasm, Intermediate filaments" "HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429" "unprognostic (2.00e-1)" "unprognostic (4.46e-2)" "unprognostic (7.62e-2)" "unprognostic (2.26e-2)" "unprognostic (6.14e-3)" "unprognostic (3.46e-1)" "unprognostic (6.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-1)" "unprognostic (1.75e-1)" "unprognostic (1.77e-2)" "unprognostic (9.07e-2)" "unprognostic (2.54e-3)" "unprognostic (6.28e-3)" "unprognostic (9.22e-2)" "unprognostic (2.02e-1)" "unprognostic (6.09e-2)" 10.0 8.8 8.6 10.1 18.2 16.1 14.9 19.2 18.7 9.1 7.5 14.8 8.6 5.9 14.1 10.0 9.2 10.2 6.4 8.6 9.4 9.6 9.4 15.1 7.3 10.9 13.1 12.4 22.3 10.7 19.0 10.9 5.9 15.9 8.1 8.6 9.4 9.3 8.3 16.2 19.6 8.8 9.2 12.7 9.0 8.2 14.0 13.7 8.4 12.8 8.2 12.7 7.5 7.8 3.8 8.9 6.7 1.0 3.3 4.2 0.3 4.6 4.6 4.8 4.5 7.9 7.5 4.8 3.2 2.4 3.6 4.5 10.6 1.7 14.0 3.7 3.3 3.9 4.1 12.4 4.3 6.5 5.5 8.2 15.2 5.9 6.9 3.0 19.6 3.8 4.6 3.7 9.7 9.0 2.2 6.4 6.4 27.1 3.4 3.5 5.6 3.0 7.4 26.4 3.9 4.0 6.1 9.1 3.5 3.2 6.6 8.7 3.9 4.5 2.7 2.9 6.6 1.9 8.7 8.2 2.4 4.5 3.2 7.4 3.9 4.3 6.9 3.3 11.2 4.2 6.7 1.0 1.9 2.4 0.8 2.1 3.0 3.3 2.6 0.6 3.8 4.2 3.3 0.2 3.3 1.0 8.9 1.3 0.3 8.6 18.2 19.2 18.7 9.4 9.6 13.1 12.4 15.9 13.7 26.8 15.5 8.5 5.2 26.1 24.4 30.7 7.6 13.4 25.0 14.0 23.6 4.9 0.0 5.9 6.0 13.3 4.6 23.3 6.9 5.7 10.0 7.3 5.8 41.4 5.9 17.5 7.5 9.2 3.3 2.5 6.6 6.6 11.8 2.8 6.9 7.8 5.6 3.5 8.1 1.8 19.5 0.0 9.5 21.7 50.0 26.3 2.9 9.6 9.3 8.7 ME1 ENSG00000065833 "Malic enzyme 1" P48163 6 83210389-83431071 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Kupffer cells: 57.7;Muller glia cells: 93.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "MAIT T-cell: 15.6" "Lineage enriched" "Detected in many" 11 "T-cells: 15.6" "Cell line enhanced" "Detected in many" "CACO-2: 42.9;OE19: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006493 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3800000 "Nucleoplasm, Plasma membrane" Cytosol "HPA006493: AB_1078272" "unprognostic (7.21e-2)" "unprognostic (3.99e-2)" "unprognostic (2.24e-1)" "unprognostic (3.12e-3)" "prognostic unfavorable (7.73e-4)" "unprognostic (7.98e-3)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.24e-1)" "unprognostic (4.44e-3)" "unprognostic (1.41e-3)" "unprognostic (7.10e-3)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.81e-7)" "unprognostic (4.07e-2)" "unprognostic (2.49e-1)" "unprognostic (1.85e-2)" "unprognostic (4.51e-2)" 30.7 35.3 16.3 4.6 17.7 0.8 27.1 5.5 13.1 5.9 6.7 5.4 39.2 18.1 3.8 7.4 24.5 4.2 13.5 21.3 10.5 14.0 3.6 12.4 7.7 6.0 16.8 11.8 10.0 3.3 30.0 11.1 2.9 16.3 7.9 10.1 9.3 7.8 30.2 25.7 10.1 8.7 18.7 17.2 6.3 20.0 13.4 7.2 1.4 6.3 20.9 4.5 13.7 14.9 0.0 0.0 0.0 1.4 0.0 15.6 0.5 8.8 18.3 0.4 0.0 15.6 14.6 0.0 5.7 14.7 6.1 11.9 42.9 7.8 0.0 15.0 13.4 12.2 9.3 13.6 5.1 6.7 0.0 7.6 0.0 11.7 0.0 20.0 4.3 16.1 15.9 10.3 12.3 8.4 10.3 9.5 0.0 6.1 0.0 8.3 9.9 0.0 4.9 0.0 48.5 7.2 0.0 15.4 8.5 18.1 4.2 1.8 4.7 9.7 14.4 0.3 8.3 0.0 10.6 10.0 3.8 4.6 1.2 0.0 3.4 3.9 0.0 0.0 0.0 11.2 0.0 1.4 0.0 0.8 0.3 15.6 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 16.3 17.7 5.5 13.1 10.5 14.0 16.8 11.8 16.3 7.2 17.9 8.9 0.0 4.2 1.6 16.7 35.8 5.1 1.4 6.8 5.2 2.0 0.5 1.7 10.0 4.4 1.9 8.0 0.0 8.4 0.6 7.1 5.6 0.0 12.4 6.8 12.7 0.0 4.9 57.7 4.2 23.9 9.5 0.0 5.4 4.0 93.9 12.7 5.8 35.0 2.6 6.4 0.0 3.3 4.9 1.5 3.0 0.7 0.9 5.5 1.8 MEIOC "C17orf104, FLJ35848" ENSG00000180336 "Meiosis specific with coiled-coil domain" A2RUB1 17 44656404-44690308 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 59.6" "Group enriched" "Detected in some" 5 "Early spermatids: 263.1;Late spermatids: 392.6;Spermatocytes: 236.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 13.4;HMC-1: 20.5;NTERA-2: 7.1;SiHa: 7.5;SuSa: 10.2;THP-1: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA027266 Enhanced Uncertain "Cell Junctions" NA NA "Cell Junctions" "HPA027266: AB_1848900" "unprognostic (5.82e-2)" "unprognostic (6.86e-2)" "unprognostic (2.50e-2)" "unprognostic (1.96e-2)" "unprognostic (9.12e-2)" "unprognostic (2.31e-1)" "unprognostic (2.13e-1)" "unprognostic (3.63e-2)" "unprognostic (8.89e-2)" "unprognostic (7.58e-2)" "unprognostic (6.83e-4)" "unprognostic (1.85e-1)" "unprognostic (6.24e-3)" "unprognostic (1.72e-1)" "unprognostic (1.75e-1)" "unprognostic (9.91e-3)" "unprognostic (8.89e-3)" 0.2 0.2 0.4 0.2 0.8 0.6 0.2 2.5 0.9 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.0 0.2 0.3 0.7 0.6 1.4 0.3 0.2 0.3 0.4 0.2 0.2 0.2 0.0 0.4 0.2 0.3 0.2 0.0 0.2 0.2 0.2 1.5 0.7 0.2 0.2 0.3 0.2 0.1 59.6 0.2 0.2 0.3 0.2 0.3 0.2 0.2 1.8 1.9 2.2 0.8 0.8 1.0 0.1 0.2 6.2 0.9 1.0 0.2 0.0 0.5 0.8 0.0 0.5 1.7 0.4 0.2 0.7 1.5 0.3 0.2 0.2 13.4 0.0 0.2 0.6 5.4 0.5 0.8 0.3 0.0 0.5 20.5 0.0 0.0 0.8 0.0 1.4 0.0 1.3 0.4 0.6 0.1 1.2 0.4 1.2 7.1 0.2 0.6 0.3 0.7 0.4 0.0 0.2 1.5 2.0 7.5 0.2 0.1 10.2 0.9 10.2 0.2 0.4 0.2 1.5 0.7 0.5 0.8 0.3 0.5 0.7 1.2 1.9 0.8 0.7 0.9 0.5 0.5 0.9 0.8 0.5 0.2 1.8 1.0 0.9 2.2 0.8 0.6 1.9 0.5 0.1 0.4 0.8 2.5 0.9 0.7 0.6 0.4 0.2 0.3 0.2 0.0 0.6 0.0 1.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 0.2 3.3 0.2 263.1 0.0 0.0 0.0 0.2 0.4 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 1.0 392.6 4.4 0.5 0.0 0.0 0.0 1.0 0.3 0.0 3.5 1.1 2.2 19.4 0.0 236.7 55.3 0.0 0.2 0.0 0.0 0.5 METAP1D "MAP1D, Metap1l" ENSG00000172878 "Methionyl aminopeptidase type 1D, mitochondrial" Q6UB28 2 171999583-172082430 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Leydig cells: 31.1;Peritubular cells: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030298, HPA030299" Uncertain Uncertain Vesicles NA NA Vesicles "HPA030298: AB_2673419, HPA030299: AB_10602421" "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (1.88e-1)" "unprognostic (5.83e-2)" "unprognostic (2.54e-2)" "unprognostic (7.90e-3)" "unprognostic (1.92e-3)" "unprognostic (1.07e-2)" "unprognostic (4.55e-1)" "unprognostic (7.07e-2)" "unprognostic (2.64e-2)" "unprognostic (8.19e-2)" "unprognostic (2.53e-3)" "unprognostic (3.44e-3)" "unprognostic (3.06e-2)" "unprognostic (5.48e-3)" "unprognostic (2.92e-2)" 7.1 7.5 7.2 8.0 8.4 6.3 8.2 6.7 9.2 6.5 6.1 9.6 6.5 5.0 9.0 6.4 5.2 10.3 4.5 6.4 6.0 4.9 5.4 8.3 3.6 8.1 9.3 7.1 18.9 23.8 5.5 13.8 4.1 8.6 8.3 7.1 7.3 9.7 10.3 13.8 7.1 5.9 10.0 7.2 8.6 6.3 5.9 9.5 2.1 5.6 6.3 6.7 5.4 5.7 2.5 0.5 0.2 1.2 1.2 3.6 0.7 3.3 2.7 3.9 13.2 5.8 7.6 8.1 3.9 3.9 6.2 4.0 6.1 4.5 1.7 7.1 4.1 6.4 6.2 8.6 6.8 6.4 6.0 10.3 9.5 7.0 8.1 6.2 5.6 2.5 5.8 10.7 6.2 10.0 5.4 3.5 6.6 13.7 4.9 4.7 4.1 3.2 7.6 7.2 9.6 3.3 7.2 3.4 3.0 4.4 4.7 8.2 3.2 2.7 5.6 9.6 3.6 6.5 7.6 4.1 8.0 6.3 4.8 3.7 6.1 5.5 3.8 5.7 11.2 7.6 0.0 0.2 0.0 1.3 1.2 0.6 1.2 1.9 0.7 0.5 2.5 1.9 3.6 0.2 1.2 0.2 0.0 1.4 0.7 7.2 8.4 6.7 9.2 6.0 4.9 9.3 7.1 8.6 9.5 0.0 5.8 5.8 8.8 4.9 4.9 3.4 5.1 1.4 1.2 3.5 2.0 3.9 6.6 2.1 0.6 3.8 0.4 0.0 2.9 3.9 8.0 4.7 4.6 6.0 3.4 4.8 0.0 6.2 2.8 0.9 31.1 1.3 5.0 0.0 2.6 3.2 1.8 0.0 24.8 3.8 4.9 12.9 5.6 6.9 10.6 5.0 1.6 6.9 5.2 4.1 METTL25 "C12orf26, FLJ22789" ENSG00000127720 "Methyltransferase like 25" Q8N6Q8 12 82358497-82479236 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039534, HPA041207" Uncertain Uncertain "Plasma membrane,Mitochondria,Cytosol" NA NA "Plasma membrane, Mitochondria, Cytosol" "HPA039534: AB_10794749, HPA041207: AB_10794406" "unprognostic (1.60e-2)" "unprognostic (3.36e-3)" "unprognostic (2.06e-2)" "unprognostic (4.15e-2)" "unprognostic (1.56e-1)" "unprognostic (3.15e-1)" "unprognostic (5.73e-3)" "unprognostic (1.21e-2)" "unprognostic (5.20e-2)" "unprognostic (6.66e-2)" "unprognostic (7.00e-3)" "unprognostic (2.15e-2)" "unprognostic (2.59e-3)" "unprognostic (1.48e-1)" "unprognostic (1.11e-2)" "unprognostic (4.05e-2)" "unprognostic (1.44e-2)" 8.3 9.2 8.7 8.5 8.1 5.0 11.1 23.6 8.3 8.2 7.7 8.1 9.0 7.5 8.2 9.1 10.0 8.0 5.8 8.7 9.1 3.1 8.8 6.3 6.5 8.1 7.6 5.7 10.8 6.5 7.8 25.9 6.8 7.6 8.0 9.2 5.8 10.5 6.0 10.7 9.7 8.2 7.5 5.8 8.6 6.7 11.0 13.0 9.9 10.2 8.7 7.4 8.8 8.5 7.9 13.2 14.4 7.6 9.8 7.6 3.8 1.4 3.3 4.5 0.9 5.1 6.0 4.6 7.0 4.0 3.7 2.7 4.3 3.9 8.6 1.5 5.1 0.9 1.5 8.9 1.1 2.4 8.2 7.5 4.1 1.8 4.1 3.1 7.2 5.0 4.4 4.2 1.2 0.0 7.3 7.6 3.1 3.1 3.9 3.8 4.9 3.1 6.3 6.8 3.9 1.0 1.7 2.7 4.4 11.5 5.2 3.4 2.6 2.5 4.2 4.4 3.9 3.7 6.8 2.8 1.7 1.6 2.8 3.9 4.9 3.0 3.2 2.8 4.4 3.9 14.4 7.6 4.4 4.9 6.4 7.3 6.4 5.3 4.0 6.0 7.9 7.6 5.4 13.6 9.8 5.7 13.2 4.5 3.8 8.7 8.1 23.6 8.3 9.1 3.1 7.6 5.7 7.6 13.0 8.9 8.1 3.7 6.4 4.0 6.1 10.1 7.6 16.0 3.4 3.5 5.9 10.0 6.6 4.2 2.8 6.2 4.5 0.0 2.7 4.4 6.1 4.2 3.5 3.9 5.0 3.2 7.0 6.7 3.1 1.1 4.4 5.4 5.0 15.4 4.2 3.5 4.1 5.5 9.9 6.8 9.7 0.0 5.1 11.8 6.4 5.4 6.5 4.9 5.5 3.1 MFAP1 AMP ENSG00000140259 "Microfibril associated protein 1" P55081 15 43804492-43824802 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015583, HPA042370" Uncertain Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA015583: , HPA042370: AB_10796904" "unprognostic (1.05e-1)" "unprognostic (5.94e-2)" "unprognostic (2.56e-2)" "unprognostic (1.23e-2)" "unprognostic (2.06e-1)" "unprognostic (5.28e-2)" "prognostic unfavorable (2.50e-4)" "unprognostic (4.08e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-2)" "unprognostic (3.12e-1)" "unprognostic (7.02e-2)" "prognostic favorable (1.04e-9)" "unprognostic (1.66e-2)" "unprognostic (9.68e-2)" "unprognostic (3.82e-3)" "unprognostic (1.54e-2)" 23.7 32.9 23.8 25.4 25.0 12.5 24.3 35.5 29.2 22.5 19.5 17.7 20.0 15.9 25.2 27.2 28.0 21.2 16.8 21.9 24.6 21.2 28.1 20.0 16.8 26.7 21.5 30.9 29.2 20.0 38.5 33.0 25.2 24.0 26.3 20.7 15.5 21.9 21.8 33.3 24.4 19.3 21.5 26.7 23.9 21.0 21.7 27.3 33.9 28.2 19.2 34.1 24.1 28.2 21.2 20.3 34.3 21.5 29.6 26.0 15.1 15.5 16.2 28.2 18.5 24.0 15.2 17.4 25.1 17.5 20.4 23.9 25.2 10.2 16.7 24.0 15.5 20.8 28.3 25.1 20.5 24.2 28.2 15.0 40.5 29.2 18.8 18.9 24.0 21.7 14.1 22.5 19.5 17.7 19.7 19.9 19.3 36.6 14.4 24.4 11.6 19.5 18.2 19.9 29.1 14.2 28.7 28.3 10.7 21.2 23.3 17.9 17.6 22.1 19.0 10.2 23.5 28.5 15.5 18.8 20.8 14.8 22.8 20.2 17.7 42.6 36.6 17.5 23.0 15.2 21.4 15.8 34.3 23.4 21.5 22.9 21.2 23.4 22.0 20.3 18.6 24.1 23.5 14.4 29.6 17.1 16.7 26.0 15.1 23.8 25.0 35.5 29.2 24.6 21.2 21.5 30.9 24.0 27.3 32.8 24.6 22.3 53.2 27.0 43.5 27.8 22.9 76.3 37.5 48.8 5.9 80.4 48.0 35.7 4.6 33.8 18.8 0.0 25.6 46.4 25.7 30.0 46.1 16.3 30.6 30.2 10.9 19.0 22.6 4.7 25.9 22.6 25.3 32.5 19.6 45.9 21.9 28.1 33.6 32.8 30.7 19.4 23.5 42.6 76.1 24.2 123.1 30.6 18.8 39.7 MFSD8 "CLN7, MGC33302" ENSG00000164073 "Major facilitator superfamily domain containing 8" Q8NHS3 4 127917732-127966034 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044802 Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA044802: AB_10963221" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (8.10e-2)" "unprognostic (1.57e-1)" "unprognostic (4.12e-2)" "unprognostic (1.18e-1)" "unprognostic (8.99e-2)" "unprognostic (2.19e-2)" "unprognostic (8.69e-2)" "unprognostic (4.51e-2)" "unprognostic (3.44e-2)" "unprognostic (3.93e-3)" "unprognostic (1.70e-1)" "unprognostic (5.61e-3)" "unprognostic (3.14e-1)" "prognostic favorable (2.21e-4)" 8.9 9.6 9.1 11.7 15.4 5.3 13.0 19.6 15.4 12.2 12.1 14.6 9.4 17.1 19.0 11.9 10.3 9.8 9.2 7.5 8.9 10.1 12.6 19.1 9.1 9.7 9.3 11.8 13.2 14.5 16.7 21.5 18.0 15.8 10.2 15.6 14.8 10.9 9.7 7.2 11.0 15.0 12.4 11.8 13.5 12.0 9.4 10.2 12.9 13.6 7.1 15.0 9.9 10.5 7.0 5.8 7.1 8.2 5.4 8.3 4.1 8.3 6.9 7.2 4.0 6.4 5.7 6.2 6.2 8.1 8.2 8.2 4.3 11.9 3.9 12.2 11.2 13.2 6.9 8.4 6.3 11.8 9.1 6.7 4.8 7.8 6.6 7.2 5.0 5.9 6.2 2.1 7.7 5.8 4.1 8.7 6.1 8.1 5.3 11.6 7.7 4.3 1.7 1.4 8.6 4.6 4.6 0.5 4.5 5.8 11.9 7.3 2.6 7.8 8.0 3.3 5.7 4.7 3.4 4.5 2.7 2.8 10.1 5.9 11.5 18.9 8.8 8.7 4.3 7.3 4.6 5.6 7.1 7.1 6.2 6.2 7.0 7.9 6.6 4.5 3.6 8.3 8.3 6.3 5.4 8.2 5.8 8.0 4.1 9.1 15.4 19.6 15.4 8.9 10.1 9.3 11.8 15.8 10.2 11.9 13.1 8.1 4.7 2.9 16.3 2.8 2.5 10.7 13.6 15.7 19.6 9.8 1.7 7.4 9.5 5.6 7.0 0.0 6.1 6.5 5.6 4.3 12.7 9.4 6.6 11.1 4.1 8.0 7.5 10.7 8.6 6.0 3.3 6.4 6.8 11.0 6.3 9.7 8.9 5.7 21.2 6.5 3.8 11.4 4.3 5.0 18.4 14.4 6.8 3.5 MICAL2 KIAA0750 ENSG00000133816 "Microtubule associated monooxygenase, calponin and LIM domain containing 2" "O94851, Q6ZW33" 11 12094008-12359144 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Actin-binding, Developmental protein, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 138.4" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 73.9;Late spermatids: 128.9;Peritubular cells: 106.1" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebellum: 138.4;cerebral cortex: 39.8" "Cell type enhanced" "Detected in many" "neutrophil: 12.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-138 MG: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030437, HPA039895, HPA040438" Approved Uncertain "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Plasma membrane" "HPA030437: AB_10601873, HPA039895: AB_2676731, HPA040438: AB_10672896" "unprognostic (2.68e-2)" "unprognostic (1.77e-2)" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (6.88e-4)" "unprognostic (2.20e-2)" "unprognostic (3.60e-2)" "unprognostic (9.32e-2)" "unprognostic (2.86e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (3.63e-5)" "unprognostic (4.61e-2)" "unprognostic (1.97e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 4.1 3.3 15.4 7.3 15.1 6.8 2.9 138.4 39.8 6.6 14.7 2.7 2.9 7.2 14.7 7.7 11.5 5.4 11.1 24.8 22.0 6.9 2.9 3.9 12.8 2.3 5.6 17.9 3.9 4.4 0.7 2.4 5.0 5.5 3.3 15.1 2.8 2.9 8.4 14.6 9.3 10.8 22.7 7.6 2.6 5.9 24.6 0.6 0.0 4.5 1.9 2.2 7.8 3.2 0.2 5.5 12.2 6.7 3.7 3.5 2.1 11.8 6.3 0.3 1.4 1.6 3.0 7.5 18.9 21.4 7.4 11.6 13.2 8.5 0.3 4.1 13.2 21.2 8.4 2.3 30.4 18.4 13.7 1.5 11.2 1.2 0.9 14.2 2.1 1.4 5.3 5.4 32.6 31.9 13.8 16.9 0.8 19.5 0.5 11.9 0.7 0.1 1.0 0.4 8.4 5.9 0.1 7.5 7.9 1.5 14.9 6.1 0.5 6.2 17.3 1.2 4.7 1.7 0.6 30.1 40.3 15.2 6.6 16.4 0.4 0.9 0.4 24.5 3.0 0.8 0.1 6.7 0.5 2.8 1.7 3.5 0.2 1.7 1.7 5.5 0.2 0.2 0.9 12.2 3.7 0.5 1.0 2.1 2.1 15.4 15.1 138.4 39.8 22.0 6.9 5.6 17.9 5.5 0.6 38.7 29.6 4.2 6.7 9.0 2.8 28.1 7.6 5.3 11.4 3.5 0.0 2.1 0.0 9.6 73.9 7.1 31.5 23.3 12.4 9.5 4.5 7.0 1.1 17.8 3.0 0.0 21.7 11.1 11.1 128.9 19.5 8.9 5.0 8.2 10.0 0.2 29.0 14.1 106.1 0.6 1.6 12.9 27.6 0.9 0.9 8.3 1.9 9.2 9.9 9.7 MICAL3 KIAA0819 ENSG00000243156 "Microtubule associated monooxygenase, calponin and LIM domain containing 3" Q7RTP6 22 17787649-18024559 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Exocytosis" "Actin-binding, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Muller glia cells: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 10.0;memory B-cell: 3.3;naive B-cell: 5.2" "Group enriched" "Detected in many" 6 "B-cells: 5.2;granulocytes: 10.0" "Cell line enhanced" "Detected in many" "WM-115: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000639, HPA003421, HPA034882" Approved Supported "Nucleoplasm,Plasma membrane,Midbody ring,Cytosol" Yes No "Nucleoplasm, Midbody ring" "Plasma membrane, Cytosol" "HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: AB_2674371" "unprognostic (1.65e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-2)" "unprognostic (2.00e-2)" "unprognostic (7.68e-2)" "unprognostic (2.06e-1)" "unprognostic (4.71e-2)" "unprognostic (3.07e-3)" "unprognostic (3.41e-1)" "unprognostic (1.01e-1)" "unprognostic (4.58e-1)" "unprognostic (3.82e-1)" "unprognostic (8.86e-3)" "unprognostic (1.36e-2)" "unprognostic (1.23e-1)" "unprognostic (2.03e-2)" "unprognostic (6.64e-2)" 10.1 9.0 15.4 20.7 19.2 10.2 9.6 62.2 25.0 12.8 22.4 30.0 8.8 8.3 30.3 14.0 13.8 28.6 9.5 23.7 15.4 13.8 8.7 16.8 6.1 15.2 21.6 15.6 20.2 10.2 30.4 11.0 11.9 19.4 11.8 16.5 14.2 8.0 14.8 28.0 14.7 13.2 26.1 20.9 12.2 11.1 15.7 22.6 3.0 10.4 7.8 20.8 14.7 15.1 5.2 0.3 10.0 0.1 1.3 1.1 0.2 13.9 15.4 8.2 13.2 6.1 7.9 9.8 12.3 13.4 17.5 13.8 14.6 2.0 15.6 6.3 16.8 20.1 16.2 12.0 14.2 17.0 15.1 11.4 16.2 16.3 6.1 4.1 7.2 8.7 6.3 11.4 18.3 19.5 11.1 10.1 4.5 17.8 10.1 6.4 12.5 6.8 4.5 5.5 10.3 10.0 9.5 12.2 0.7 14.0 9.9 21.5 8.4 17.4 11.0 26.2 13.0 4.4 3.1 17.8 18.0 11.6 12.3 25.6 6.6 11.7 20.9 15.6 3.2 51.4 10.0 0.0 0.1 0.5 0.1 0.8 3.3 0.6 0.5 0.1 5.2 0.3 0.2 0.2 1.3 0.0 0.3 1.1 0.2 15.4 19.2 62.2 25.0 15.4 13.8 21.6 15.6 19.4 22.6 3.0 15.1 14.3 10.9 10.0 13.4 13.4 12.7 20.1 15.9 12.2 49.1 11.8 0.0 19.8 9.4 14.0 21.9 23.3 8.4 29.4 9.6 10.5 18.5 33.0 2.7 1.6 9.8 6.2 2.7 10.5 3.7 3.7 8.5 8.2 18.5 59.7 22.3 20.1 6.0 3.9 11.6 0.0 9.2 19.3 12.6 10.3 9.4 7.7 15.7 6.7 MIEF1 "FLJ20232, MiD51, SMCR7L" ENSG00000100335 "Mitochondrial elongation factor 1" Q9NQG6 22 39499432-39518132 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 232.6;Late spermatids: 280.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061059 Approved "Intermediate filaments,Mitochondria" NA NA "Intermediate filaments, Mitochondria" "HPA061059: " "unprognostic (5.35e-2)" "unprognostic (2.66e-2)" "unprognostic (2.86e-3)" "unprognostic (1.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.49e-1)" "unprognostic (1.95e-3)" "unprognostic (1.85e-2)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (6.65e-2)" "prognostic favorable (3.96e-5)" "unprognostic (1.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (2.30e-1)" 14.9 12.6 14.5 15.1 14.9 16.2 12.3 17.3 21.3 10.0 15.1 12.3 12.9 17.5 12.1 12.9 13.9 10.9 14.2 11.6 13.0 12.9 19.6 26.2 10.8 15.5 13.6 15.9 12.1 14.3 16.6 8.3 12.6 12.1 10.6 14.2 12.5 15.6 14.1 16.7 11.5 16.6 10.3 10.8 18.0 11.7 43.1 10.7 15.9 12.6 11.1 16.6 11.5 13.8 7.1 8.1 5.9 8.3 8.7 9.2 7.6 8.0 8.1 9.0 14.2 8.5 9.3 10.3 7.7 9.2 8.9 8.2 13.3 4.2 22.4 6.5 8.3 5.9 10.3 20.2 10.7 11.1 9.5 18.7 9.2 11.4 13.4 16.4 32.5 12.3 12.2 13.1 7.9 16.9 8.6 9.4 7.6 16.2 12.4 8.8 5.4 10.2 9.0 8.3 16.7 8.9 14.1 12.7 22.8 10.2 9.8 8.2 6.8 8.6 14.9 22.0 9.8 6.6 11.8 9.2 8.4 11.9 7.4 9.4 22.7 23.6 22.8 9.7 14.2 12.9 0.6 7.4 5.9 7.6 8.3 9.2 7.0 7.3 7.2 8.1 7.1 8.1 7.5 0.7 8.7 7.8 4.5 6.3 7.6 14.5 14.9 17.3 21.3 13.0 12.9 13.6 15.9 12.1 10.7 11.9 16.0 5.2 10.4 17.3 18.5 15.7 12.7 8.1 5.7 15.7 23.6 16.0 21.6 10.9 232.6 9.8 16.0 0.0 11.7 16.5 10.1 14.5 9.2 34.2 14.0 6.4 9.4 20.3 15.4 280.8 14.4 13.6 15.1 8.2 10.7 19.8 14.0 3.5 13.1 20.3 13.5 0.0 8.5 17.2 27.1 20.1 10.9 7.7 18.9 14.7 MIF "GIF, GLIF" ENSG00000240972 "Macrophage migration inhibitory factor" P14174 22 23894004-23895227 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Cytokine, Isomerase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 1397.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 129.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003868, CAB005284" Approved Supported Nucleoplasm,Cytosol "Secreted to blood" No No 13800000 14000000 Cytosol Nucleoplasm "CAB005284: AB_648587, HPA003868: AB_1079290" "unprognostic (1.68e-1)" "unprognostic (7.79e-3)" "unprognostic (2.49e-1)" "unprognostic (1.46e-1)" "unprognostic (1.33e-1)" "unprognostic (1.36e-2)" "unprognostic (9.48e-2)" "unprognostic (1.22e-3)" "unprognostic (2.17e-2)" "unprognostic (1.78e-2)" "unprognostic (1.52e-1)" "unprognostic (2.28e-2)" "unprognostic (2.19e-2)" "unprognostic (1.20e-1)" "unprognostic (1.55e-1)" "unprognostic (2.56e-1)" "unprognostic (1.02e-1)" 30.6 49.8 43.9 42.0 39.9 46.0 71.6 19.0 66.1 23.0 42.7 10.4 55.6 39.9 22.5 113.3 51.9 23.3 42.5 60.7 42.8 40.3 71.8 58.8 46.2 113.9 33.5 43.7 24.5 80.2 16.2 41.1 30.5 45.2 54.8 11.6 15.0 57.3 101.2 36.0 63.3 50.6 26.7 78.3 42.5 56.2 24.9 19.2 19.0 28.9 43.7 16.7 21.4 44.6 56.8 42.5 17.6 23.8 38.3 52.7 66.0 49.8 11.0 2.4 11.2 0.9 2.3 18.7 18.8 3.1 6.1 7.8 8.3 8.2 23.7 14.9 1.3 2.8 22.2 2.6 11.4 0.7 19.9 129.4 8.9 10.1 17.2 4.9 34.6 21.1 4.7 6.8 3.6 1.7 4.5 4.8 17.8 13.8 12.1 2.0 25.1 23.5 64.2 14.3 9.8 60.3 30.2 4.1 66.5 4.7 3.4 32.5 37.8 12.0 12.7 31.0 0.6 16.4 10.4 13.7 5.3 35.6 3.2 0.4 52.3 18.4 24.4 21.5 12.9 10.8 16.3 23.8 17.6 37.4 22.3 52.7 56.8 51.8 40.4 31.6 49.1 46.1 38.0 7.1 38.3 14.6 42.5 48.3 66.0 43.9 39.9 19.0 66.1 42.8 40.3 33.5 43.7 45.2 19.2 145.9 147.8 297.7 257.6 597.1 25.5 0.3 433.1 384.1 354.8 657.8 2.0 427.6 1397.6 643.7 166.1 220.2 275.4 0.0 324.9 742.0 370.2 224.8 172.4 900.8 252.9 20.6 335.5 293.4 221.5 97.3 311.3 223.0 733.9 288.6 378.1 30.6 687.0 340.1 284.6 1307.4 25.0 135.8 432.6 7.9 117.5 663.2 573.7 251.6 418.6 198.5 MIF4GD "AD023, MGC45027, MIFD, SLIP1" ENSG00000125457 "MIF4G domain containing" A9UHW6 17 75266228-75271227 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 67.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051222 Approved Supported "Nucleoli,Golgi apparatus,Cytosol" NA NA Nucleoli "Golgi apparatus, Cytosol" "HPA051222: AB_2681393" "unprognostic (1.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.94e-2)" "unprognostic (3.82e-3)" "unprognostic (2.92e-1)" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-1)" "unprognostic (8.15e-2)" "prognostic favorable (2.70e-4)" "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (9.88e-2)" "unprognostic (2.29e-1)" "unprognostic (7.12e-2)" "unprognostic (7.31e-2)" 19.0 13.9 10.4 14.5 11.1 30.5 13.3 7.4 14.6 11.9 12.9 20.8 14.2 10.3 16.8 12.8 18.3 13.9 20.4 20.4 10.2 8.2 16.0 15.1 15.1 30.4 12.0 9.9 12.2 16.2 18.2 7.4 15.9 12.0 12.0 11.7 15.5 15.4 11.5 34.4 18.6 14.1 20.4 15.4 22.0 11.7 12.6 10.9 21.8 15.0 20.7 20.9 16.6 12.2 14.1 67.0 11.3 21.5 14.5 17.5 14.4 12.0 21.3 4.7 11.0 7.7 2.3 6.8 3.1 8.8 6.2 4.2 7.5 13.6 18.8 5.6 4.9 7.3 9.6 5.7 10.8 4.7 9.3 14.6 9.3 9.3 6.6 8.5 8.1 10.8 2.2 16.9 4.3 17.7 8.5 12.8 21.2 12.2 23.0 1.6 23.5 25.8 19.4 2.1 13.9 10.4 16.9 6.0 25.6 12.5 6.5 7.1 10.4 6.3 16.6 15.4 11.4 30.8 19.0 4.9 3.2 7.7 4.0 6.1 33.5 8.7 15.8 5.9 14.4 4.2 5.7 21.5 11.3 15.4 11.0 16.2 14.1 12.5 13.7 25.4 13.0 11.4 12.0 3.8 14.5 13.1 67.0 17.5 14.4 10.4 11.1 7.4 14.6 10.2 8.2 12.0 9.9 12.0 10.9 0.0 11.2 26.7 11.3 10.2 3.8 4.0 25.5 13.4 10.3 12.2 0.0 12.2 18.3 40.4 24.1 17.9 11.2 0.0 38.2 7.9 11.3 11.9 32.2 7.2 42.0 1.6 15.0 11.1 45.6 9.9 8.6 38.5 15.1 48.7 15.0 22.4 20.7 21.6 14.9 22.6 5.3 19.4 24.2 20.0 17.4 16.6 7.8 34.5 16.9 11.4 MIS18BP1 "C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1" ENSG00000129534 "MIS18 binding protein 1" Q6P0N0 14 45203190-45253540 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006504 Approved Approved Nucleoli,Cytosol NA Yes Nucleoli Cytosol "HPA006504: AB_1078317" "unprognostic (2.12e-1)" "unprognostic (1.06e-1)" "unprognostic (2.58e-2)" "unprognostic (1.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (3.83e-4)" "unprognostic (4.18e-1)" "unprognostic (1.36e-2)" "unprognostic (3.33e-1)" "unprognostic (3.32e-2)" "unprognostic (2.32e-3)" "unprognostic (3.31e-2)" "unprognostic (5.49e-2)" "unprognostic (2.30e-1)" "unprognostic (2.97e-1)" "unprognostic (2.21e-1)" 10.3 5.2 5.1 22.5 5.7 26.3 14.1 1.8 5.7 9.0 11.8 2.3 7.6 6.0 9.8 9.5 10.2 8.6 5.7 5.3 5.1 2.8 5.0 4.3 14.3 23.9 4.5 4.1 12.5 7.1 1.8 5.2 9.5 6.7 7.9 7.6 1.9 12.5 10.2 3.0 8.4 10.7 7.3 10.2 22.5 6.9 9.5 3.1 38.4 7.1 8.2 15.5 8.2 7.7 13.1 14.7 23.6 22.6 4.5 4.8 4.0 21.0 7.9 16.5 7.2 5.1 7.3 12.2 14.6 7.7 12.2 15.2 4.2 20.4 29.1 6.4 7.2 5.2 14.8 9.7 7.4 23.0 15.3 6.1 17.4 9.8 5.4 3.4 40.1 16.3 5.2 3.0 7.2 6.8 7.9 14.8 5.6 7.6 6.9 11.8 7.7 16.7 17.7 12.5 10.4 9.9 20.0 6.7 11.2 6.2 8.8 11.6 5.1 5.9 10.0 5.3 10.3 11.9 23.0 8.1 6.5 19.8 7.9 6.4 6.2 8.2 13.6 3.6 16.8 9.1 23.6 14.2 16.2 3.9 13.2 4.1 13.1 3.6 3.2 9.6 12.9 2.4 2.5 8.5 4.5 22.6 14.7 4.8 4.0 5.1 5.7 1.8 5.7 5.1 2.8 4.5 4.1 6.7 3.1 23.8 23.8 43.1 9.7 17.9 7.9 11.8 10.2 20.1 35.2 8.7 15.7 30.2 5.0 11.5 2.9 28.7 11.1 23.3 9.7 38.0 14.2 17.4 41.7 6.7 32.5 0.0 26.5 30.1 69.4 3.6 51.2 58.2 5.0 70.3 23.5 4.8 11.1 34.8 57.0 3.6 8.2 0.0 14.2 67.2 107.7 23.1 16.2 47.3 24.4 11.0 MLLT3 "AF-9, AF9, YEATS3" ENSG00000171843 "MLLT3, super elongation complex subunit" P42568 9 20341665-20622543 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Mucus-secreting cells: 101.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.4" "Group enriched" "Detected in many" 5 "NK-cells: 3.8;T-cells: 14.4" "Cell line enhanced" "Detected in many" "HEL: 73.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001824 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001824: AB_1079394" "unprognostic (3.31e-1)" "unprognostic (2.22e-1)" "unprognostic (1.23e-3)" "unprognostic (1.27e-2)" "unprognostic (1.99e-1)" "unprognostic (7.57e-2)" "unprognostic (3.83e-2)" "unprognostic (1.01e-3)" "unprognostic (2.12e-1)" "unprognostic (3.92e-3)" "unprognostic (1.05e-1)" "unprognostic (2.03e-2)" "prognostic favorable (1.84e-4)" "unprognostic (1.85e-1)" "unprognostic (4.81e-2)" "unprognostic (1.40e-2)" "unprognostic (1.68e-1)" 8.6 17.3 18.0 10.4 25.8 19.7 11.4 34.6 20.3 12.3 20.9 7.2 10.6 7.2 13.6 7.9 10.2 11.5 12.7 8.6 18.0 12.8 10.1 2.1 10.7 9.1 14.8 13.8 10.5 4.6 18.3 24.7 10.3 13.2 11.7 22.8 7.4 21.3 12.1 9.1 7.9 12.3 13.5 12.0 5.9 15.3 3.6 21.4 22.1 22.5 6.1 6.5 12.9 10.4 1.4 0.7 1.6 0.3 3.8 14.4 2.8 2.6 7.2 2.6 2.9 6.0 3.7 1.6 6.8 11.5 3.1 3.5 7.0 2.5 10.0 3.7 3.2 0.9 1.3 2.4 11.8 2.8 20.6 6.3 73.6 22.3 3.3 4.3 1.3 6.2 2.8 4.5 1.1 7.4 10.4 3.0 4.2 0.0 12.9 6.4 2.0 7.2 4.3 1.6 14.4 2.1 0.0 4.7 2.7 14.1 3.9 8.3 2.9 5.5 2.8 3.0 2.6 2.9 1.9 2.0 0.0 1.7 1.7 2.4 5.8 5.3 4.1 0.0 3.2 1.4 1.6 0.3 0.5 3.9 0.2 3.6 0.5 7.0 5.3 0.7 1.4 14.4 8.3 0.1 3.8 0.3 0.4 7.3 2.8 18.0 25.8 34.6 20.3 18.0 12.8 14.8 13.8 13.2 21.4 26.8 23.0 7.3 15.3 7.3 5.5 12.1 7.6 9.4 38.7 21.0 31.4 0.9 11.6 23.0 2.7 8.6 13.6 0.0 7.3 5.3 16.7 15.6 11.5 1.7 2.0 4.8 31.7 6.7 2.6 4.2 12.7 3.2 21.9 1.0 101.9 37.2 18.7 17.3 8.9 7.0 1.0 0.0 16.5 0.1 5.6 7.3 1.4 25.4 28.6 13.2 MNDA PYHIN3 ENSG00000163563 "Myeloid cell nuclear differentiation antigen" P41218 1 158831317-158849506 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 289.8;bone marrow: 83.3" "Group enriched" "Detected in many" 4 "Hofbauer cells: 203.8;Kupffer cells: 493.3;Macrophages: 520.9;Muller glia cells: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 289.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 289.8" "Group enriched" "Detected in some" 15 "NB-4: 36.7;THP-1: 69.4;U-937: 45.4" "Low region specificity" "Detected in all" "HPA034532, HPA073215" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol" NA NA 110000 Nucleoplasm "Nucleoli, Nucleoli rim, Vesicles, Cytosol" "HPA034532: AB_10669677, HPA073215: AB_2686582" "unprognostic (1.53e-2)" "unprognostic (7.84e-3)" "unprognostic (2.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.42e-1)" "unprognostic (1.41e-2)" "unprognostic (2.02e-2)" "unprognostic (7.99e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.65e-1)" "unprognostic (9.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (4.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" 17.6 6.3 5.4 24.4 7.9 83.3 3.0 1.4 5.8 2.1 2.1 3.2 0.2 1.1 1.7 3.4 2.3 4.7 8.4 6.3 4.9 3.2 3.9 4.2 31.3 32.2 10.7 2.6 3.4 2.4 1.1 2.2 9.9 6.8 2.6 2.5 5.0 3.6 1.2 2.0 1.9 3.6 6.2 18.6 57.3 2.6 4.0 6.3 5.5 2.1 1.4 4.2 9.1 4.9 1.6 29.7 289.8 60.9 0.1 0.1 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.4 0.0 7.1 60.9 11.1 0.1 25.4 0.1 1.6 0.0 0.1 29.7 0.6 0.0 0.0 289.8 0.1 12.0 0.4 0.0 40.2 5.4 7.9 1.4 5.8 4.9 3.2 10.7 2.6 6.8 6.3 32.8 82.3 20.5 0.0 2.2 0.6 0.7 10.2 14.7 17.0 0.0 0.0 0.8 0.0 0.0 0.2 2.1 0.0 0.0 0.3 0.9 2.3 0.0 40.7 1.3 203.8 0.0 0.0 6.2 493.3 0.9 1.1 520.9 1.7 25.2 0.0 130.5 0.0 0.0 0.0 1.1 4.7 12.9 9.2 0.3 0.2 1.9 0.8 1.0 0.0 0.0 MOB3A "MOB-LAK, MOB1C, MOBKL2A, moblak" ENSG00000172081 "MOB kinase activator 3A" Q96BX8 19 2071038-2096673 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 69.3" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 40.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (2.05e-2)" "unprognostic (3.58e-2)" "unprognostic (1.39e-1)" "prognostic favorable (1.33e-6)" "unprognostic (3.40e-2)" "unprognostic (3.53e-3)" "unprognostic (3.12e-3)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (2.16e-2)" "unprognostic (7.74e-3)" "unprognostic (3.83e-1)" "prognostic unfavorable (1.93e-4)" "unprognostic (5.90e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.18e-1)" 19.6 9.5 9.8 31.9 10.0 27.4 11.9 11.1 9.2 15.5 19.2 12.7 7.7 7.7 19.9 9.2 14.3 16.7 14.1 10.6 10.0 6.9 10.7 5.7 14.9 39.6 9.4 6.4 15.6 8.2 6.7 7.0 15.9 8.8 15.3 9.2 13.4 11.6 13.1 7.9 12.0 18.2 17.0 7.6 37.3 12.5 8.3 10.0 39.3 11.7 6.7 42.2 17.1 13.1 11.6 14.5 69.3 22.0 13.0 16.5 17.1 14.1 5.8 6.9 6.6 16.5 18.2 5.4 8.9 5.6 6.1 4.9 2.3 5.1 36.3 3.2 15.3 4.9 6.0 3.8 19.7 4.9 12.7 1.9 7.9 4.1 3.1 16.3 12.3 40.9 10.7 13.1 16.6 7.1 7.0 11.3 7.0 4.0 36.5 8.8 5.6 6.4 12.5 2.1 1.7 4.2 3.9 2.0 28.2 7.5 3.5 4.4 5.9 4.5 4.8 4.9 5.4 5.1 20.1 19.2 7.4 4.1 13.7 5.2 7.2 25.6 28.7 19.9 8.3 8.8 18.0 20.6 23.9 16.5 20.8 14.2 11.6 12.3 13.6 14.5 10.7 9.4 11.8 69.3 13.0 22.0 8.3 14.7 17.1 9.8 10.0 11.1 9.2 10.0 6.9 9.4 6.4 8.8 10.0 3.0 5.0 50.6 9.8 13.4 3.1 3.2 2.5 8.1 7.9 10.4 19.6 7.9 3.3 9.5 1.2 10.7 14.2 0.0 8.2 48.6 12.6 10.3 27.6 4.0 28.8 1.6 14.3 14.7 70.3 4.0 17.0 36.1 15.1 49.5 10.5 6.2 9.2 8.6 15.9 6.8 6.6 6.5 12.0 6.6 6.4 13.9 23.0 40.6 7.6 10.1 MOB3B "C9orf35, FLJ13204, MOB1D, MOBKL2B" ENSG00000120162 "MOB kinase activator 3B" Q86TA1 9 27325209-27529781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2;ovary: 29.9" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 47.8;Muller glia cells: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.8;myeloid DC: 4.6;naive B-cell: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.1;HAP1: 10.4;K-562: 29.7;SK-BR-3: 12.5" "Low region specificity" "Detected in many" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (6.96e-3)" "unprognostic (9.60e-2)" "unprognostic (5.10e-3)" "unprognostic (1.41e-1)" "unprognostic (1.38e-1)" "unprognostic (1.02e-1)" "unprognostic (1.87e-1)" "unprognostic (7.05e-2)" "unprognostic (2.42e-1)" "unprognostic (7.57e-3)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "prognostic favorable (2.33e-10)" "unprognostic (1.55e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (7.99e-2)" 6.0 2.3 6.2 4.2 18.0 1.0 7.0 5.0 13.9 7.8 13.2 32.6 2.8 19.0 10.9 6.1 4.3 9.4 5.8 2.0 9.8 6.4 8.6 1.9 7.5 4.2 19.7 6.2 29.9 4.5 0.9 1.8 5.3 17.2 2.8 14.9 5.7 3.9 3.8 8.5 7.1 16.6 7.5 33.2 8.6 6.2 3.7 17.5 0.6 7.0 2.9 6.2 4.0 5.2 5.9 4.6 0.0 1.4 0.0 0.1 0.5 2.0 1.5 4.8 0.0 1.2 0.1 10.1 0.0 0.1 0.1 0.1 1.1 0.0 0.0 2.1 0.0 0.0 6.8 10.4 8.2 0.0 4.6 1.6 3.0 6.3 0.0 0.0 0.0 0.6 2.2 8.7 0.0 1.6 0.0 0.0 0.0 29.7 0.1 0.0 0.0 0.0 0.0 6.1 3.8 0.5 2.0 0.5 0.0 2.9 3.9 0.0 1.5 1.7 12.5 2.9 6.6 0.8 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.9 0.0 0.0 1.4 0.0 4.8 0.0 0.0 4.6 5.9 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.5 6.2 18.0 5.0 12.0 9.8 6.4 19.7 6.2 17.2 17.5 3.0 5.5 18.6 6.8 20.1 1.2 1.2 30.6 1.4 4.5 10.4 0.0 18.9 8.3 13.5 0.7 4.3 47.8 0.0 18.5 45.9 11.2 4.0 1.1 2.6 4.6 1.6 2.4 6.2 11.6 1.7 14.7 22.9 15.1 8.2 27.2 68.7 10.1 17.5 15.2 9.1 1.3 0.0 12.2 1.4 1.7 8.3 9.8 1.0 31.1 6.2 MOB3C "MOB1E, MOBKL2C" ENSG00000142961 "MOB kinase activator 3C" Q70IA8 1 46607715-46616891 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (1.76e-3)" "prognostic favorable (3.16e-5)" "unprognostic (1.32e-2)" "unprognostic (1.45e-2)" "unprognostic (3.36e-2)" "unprognostic (7.22e-2)" "unprognostic (6.26e-3)" "unprognostic (1.56e-1)" "unprognostic (1.76e-1)" "unprognostic (9.97e-2)" "unprognostic (3.85e-2)" "unprognostic (1.20e-1)" "unprognostic (4.81e-2)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (2.35e-2)" "unprognostic (4.61e-3)" 16.9 9.0 8.8 8.0 14.7 4.1 12.1 19.7 7.5 10.7 11.2 9.3 11.8 8.8 8.4 12.9 12.6 9.6 10.8 12.3 10.1 5.6 9.1 8.8 13.3 7.8 13.2 6.8 12.6 29.8 10.4 10.9 12.8 12.5 12.2 9.3 9.5 16.8 12.5 20.2 6.0 12.5 9.8 5.5 14.7 10.9 4.2 9.4 3.1 11.1 19.1 11.4 10.8 16.0 9.3 7.1 15.1 9.0 16.1 21.5 11.4 7.4 3.0 1.5 4.5 14.9 11.7 0.6 4.2 10.7 7.7 7.5 0.9 5.3 0.6 4.6 7.2 11.1 10.8 1.6 5.4 4.1 11.1 0.2 17.5 4.0 1.1 7.8 1.5 6.6 9.5 8.4 7.3 2.0 10.2 5.0 1.9 2.6 4.4 3.2 3.1 0.7 2.3 0.5 4.7 9.0 1.9 5.0 3.2 4.3 13.5 0.6 1.8 6.5 4.6 5.2 1.8 2.8 5.9 3.7 3.9 2.7 6.4 3.7 4.1 0.9 0.5 5.8 2.6 3.2 2.1 8.4 15.1 12.2 9.0 21.5 6.9 12.0 12.3 5.8 9.3 10.7 10.8 6.0 16.1 5.7 7.1 8.1 11.4 8.8 14.7 19.7 7.5 10.1 5.6 13.2 6.8 12.5 9.4 6.0 5.8 3.7 9.1 9.8 2.1 3.9 2.5 5.3 4.5 7.0 0.0 1.6 5.0 2.4 7.1 5.1 6.0 0.0 5.5 0.8 8.0 8.1 5.7 2.6 10.5 4.8 8.1 7.4 8.5 0.4 5.8 10.4 3.3 4.6 7.9 1.5 4.0 2.9 6.3 2.6 0.6 6.5 9.8 0.0 0.2 5.6 1.1 7.9 5.2 13.3 MOCS2 MOCO1 ENSG00000164172 "Molybdenum cofactor synthesis 2" "O96007, O96033" 5 53095679-53110063 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Distal tubular cells: 485.7;Proximal tubular cells: 194.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037679, HPA037680" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear speckles" "HPA037679: AB_2675604, HPA037680: AB_10673635" "unprognostic (3.27e-1)" "unprognostic (3.11e-2)" "unprognostic (2.82e-1)" "unprognostic (8.37e-3)" "unprognostic (2.12e-1)" "unprognostic (3.48e-2)" "unprognostic (1.60e-2)" "unprognostic (1.33e-1)" "unprognostic (6.66e-2)" "unprognostic (7.59e-2)" "unprognostic (2.41e-3)" "unprognostic (1.85e-1)" "prognostic favorable (3.68e-6)" "unprognostic (1.04e-1)" "unprognostic (1.04e-2)" "unprognostic (2.04e-1)" "unprognostic (5.86e-2)" 18.1 34.6 41.5 9.8 38.0 4.0 19.6 21.7 41.8 16.0 17.1 20.7 10.4 17.6 14.8 28.2 17.0 12.9 15.9 39.9 36.7 32.1 49.7 52.0 13.1 11.4 30.0 22.4 21.2 18.4 30.4 23.3 16.2 28.7 18.6 14.9 17.2 21.2 20.8 38.3 8.9 17.6 16.1 27.1 10.7 16.6 11.0 20.0 8.2 31.5 19.4 11.2 16.9 15.4 16.9 12.5 6.3 10.9 17.3 25.8 12.9 20.2 16.6 12.0 28.7 24.6 22.7 15.2 24.9 26.2 22.2 26.4 22.6 15.2 20.7 37.5 19.6 34.4 12.3 24.0 25.5 35.0 5.2 23.4 15.9 16.3 20.4 25.3 17.2 12.0 18.1 12.8 25.2 22.5 22.0 23.8 26.7 15.4 11.3 37.0 30.0 18.5 9.8 10.6 8.7 34.6 9.4 25.8 18.8 38.4 15.4 8.9 10.3 18.1 14.8 18.6 15.9 28.6 4.4 15.2 21.3 22.1 18.9 32.0 13.3 19.7 23.4 30.5 4.9 32.9 5.2 9.2 6.3 16.9 10.9 20.2 16.5 19.0 19.2 12.5 16.9 25.8 22.2 1.7 17.3 9.8 11.4 18.3 12.9 41.5 38.0 21.7 41.8 36.7 32.1 30.0 22.4 28.7 20.0 50.6 20.6 25.2 32.7 11.8 27.0 111.0 66.2 36.1 19.4 66.3 25.5 82.4 485.7 34.6 5.6 32.8 17.8 0.0 38.2 28.9 48.8 44.5 9.3 99.9 36.5 6.4 25.3 19.0 25.0 10.1 46.9 27.4 21.9 7.2 17.9 36.8 23.4 19.3 64.7 194.9 18.1 32.3 50.3 40.7 54.7 13.7 27.0 26.1 22.9 30.2 MORC3 "KIAA0136, NXP2, ZCW5, ZCWCC3" ENSG00000159256 "MORC family CW-type zinc finger 3" Q14149 21 36320189-36386148 "Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018406, HPA034848" Approved Enhanced Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA018406: AB_1858988, HPA034848: AB_2674359" "unprognostic (4.01e-3)" "unprognostic (4.86e-2)" "unprognostic (4.25e-2)" "unprognostic (1.38e-1)" "unprognostic (1.16e-1)" "unprognostic (6.29e-2)" "unprognostic (6.56e-2)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (2.53e-1)" "unprognostic (6.40e-2)" "unprognostic (8.61e-2)" "unprognostic (1.18e-3)" "unprognostic (1.38e-2)" "unprognostic (3.91e-1)" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" 18.0 11.2 15.6 15.4 16.4 28.0 17.5 30.9 16.3 20.3 15.3 10.1 14.1 10.6 22.5 10.6 23.0 17.9 13.5 12.5 14.6 7.9 11.6 13.0 17.0 20.6 17.5 12.1 29.3 11.3 14.8 25.1 20.6 16.6 16.1 12.1 7.3 20.6 14.2 28.1 20.1 14.8 21.4 21.0 19.1 14.0 10.8 18.2 25.5 15.0 17.6 20.0 22.9 23.5 11.2 7.6 21.9 10.7 8.2 11.9 6.6 12.2 4.7 11.4 7.5 11.8 12.8 16.1 11.6 20.3 13.4 11.1 7.6 8.0 5.9 4.5 13.3 13.3 6.2 8.9 11.6 14.1 11.1 7.0 24.4 5.1 5.6 7.7 12.5 21.8 8.0 14.5 12.8 17.7 14.0 10.7 9.3 19.5 15.1 10.8 4.0 8.0 6.8 9.4 15.0 5.7 9.9 5.7 10.6 5.9 12.8 4.7 12.3 13.5 8.8 13.8 9.2 9.9 10.5 14.3 13.0 3.2 8.7 10.0 6.7 5.9 5.7 8.4 19.9 9.3 21.9 7.5 16.1 8.4 9.4 8.3 10.0 9.2 7.9 7.6 11.2 11.9 8.5 11.7 8.2 10.7 4.9 11.3 6.6 15.6 16.4 30.9 16.3 14.6 7.9 17.5 12.1 16.6 18.2 26.8 20.8 20.5 44.0 60.8 20.0 17.6 12.7 32.1 25.0 21.0 7.9 13.4 3.3 14.1 38.2 20.4 10.1 23.3 10.9 15.8 35.2 39.4 46.2 13.6 15.7 15.9 10.9 12.9 25.7 13.5 17.3 33.9 23.6 21.6 14.7 15.5 17.4 14.4 25.1 5.3 11.9 12.9 20.2 24.7 32.9 71.4 21.1 24.5 9.0 52.9 MPHOSPH8 "HSMPP8, mpp8" ENSG00000196199 "M-phase phosphoprotein 8" Q99549 13 19633681-19673459 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039701, HPA040035" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA039701: AB_10805484, HPA040035: AB_10794207" "unprognostic (4.22e-1)" "unprognostic (5.58e-2)" "unprognostic (2.66e-1)" "unprognostic (4.01e-3)" "unprognostic (3.05e-2)" "unprognostic (1.86e-1)" "unprognostic (2.81e-3)" "unprognostic (4.90e-2)" "unprognostic (4.55e-2)" "unprognostic (1.59e-1)" "unprognostic (3.52e-3)" "unprognostic (3.40e-2)" "unprognostic (6.49e-2)" "unprognostic (3.86e-2)" "unprognostic (4.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.02e-1)" 20.6 27.1 37.7 33.4 37.1 19.2 21.4 48.9 45.0 32.0 26.6 13.2 31.7 17.8 29.4 26.7 19.1 22.3 18.8 27.9 31.0 27.2 18.9 16.5 22.9 28.4 28.8 32.8 43.6 22.0 20.9 44.3 20.0 28.4 26.1 20.1 11.9 24.5 38.8 25.7 26.6 23.9 31.3 37.1 30.0 22.5 16.6 33.5 16.5 26.8 11.7 20.4 31.3 37.9 21.7 13.8 39.4 9.9 11.5 17.6 3.6 12.9 8.3 12.5 20.2 16.2 20.6 22.1 19.5 14.2 12.3 10.6 12.7 22.9 20.5 15.6 11.8 19.2 21.7 22.9 13.6 15.9 25.5 11.7 33.0 13.7 15.4 14.4 23.7 26.9 12.1 17.7 9.7 13.7 18.8 16.2 16.7 15.9 13.2 11.4 12.6 18.1 19.9 12.2 24.1 9.3 14.6 28.8 16.2 21.4 10.1 17.1 10.5 18.2 16.8 17.7 21.8 10.2 19.7 19.0 9.6 8.6 18.1 9.8 9.0 9.3 20.4 7.3 22.0 14.8 39.4 9.5 15.4 13.0 6.9 11.5 21.5 14.6 12.5 4.3 21.7 17.6 14.4 27.5 11.5 9.9 13.8 11.3 3.6 37.7 37.1 48.9 45.0 31.0 27.2 28.8 32.8 28.4 33.5 86.4 100.8 102.7 102.3 61.2 189.0 78.6 81.5 60.2 84.2 97.7 78.5 107.7 41.4 45.8 58.1 101.2 89.2 23.3 47.7 70.1 98.0 73.8 137.8 68.9 64.6 198.6 56.6 106.2 53.3 25.9 166.0 79.7 64.1 91.0 71.4 105.7 42.2 94.7 147.8 48.2 208.1 174.6 116.5 181.6 204.0 64.6 49.1 124.6 63.9 55.3 MPHOSPH9 MPP9 ENSG00000051825 "M-phase phosphoprotein 9" Q99550 12 123152320-123244014 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 48.9" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037485 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA037485: AB_10672792" "unprognostic (2.98e-2)" "unprognostic (5.00e-1)" "unprognostic (4.36e-3)" "unprognostic (1.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.81e-1)" "unprognostic (5.81e-3)" "unprognostic (1.64e-1)" "unprognostic (1.58e-2)" "unprognostic (1.88e-1)" "unprognostic (8.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.53e-3)" "unprognostic (1.31e-2)" "unprognostic (2.75e-1)" "unprognostic (5.14e-3)" "unprognostic (1.17e-1)" 5.3 9.8 11.0 10.5 14.6 24.8 5.6 21.6 14.9 5.5 6.7 7.7 4.9 7.9 6.4 12.8 5.9 6.1 4.0 8.8 8.8 6.0 7.1 12.7 6.1 12.0 7.1 8.0 6.9 6.3 9.9 20.4 5.7 9.9 5.8 7.6 7.7 5.9 5.2 7.2 5.4 8.0 5.9 9.1 10.2 5.9 14.4 11.0 48.9 6.2 3.2 10.8 5.5 5.0 6.2 4.9 8.3 3.7 8.5 12.1 3.0 8.5 9.1 14.6 16.4 6.5 6.1 5.5 8.8 4.5 11.1 8.9 8.6 4.2 16.8 6.5 5.8 10.6 6.1 18.8 7.2 15.5 10.7 12.2 17.1 10.1 8.4 5.0 15.9 14.9 6.6 2.7 10.5 10.5 9.8 11.3 25.6 11.8 7.4 10.1 7.2 18.1 25.2 10.0 5.6 9.9 16.2 14.7 10.9 8.6 8.4 18.7 8.8 13.7 5.5 8.6 15.3 10.3 12.0 6.4 9.1 13.1 10.5 12.5 11.6 18.7 14.0 7.3 15.3 18.8 8.3 3.7 5.1 10.9 3.6 7.7 5.6 8.6 9.8 3.5 6.2 12.1 11.8 0.7 8.5 3.1 4.9 7.4 3.0 11.0 14.6 21.6 14.9 8.8 6.0 7.1 8.0 9.9 11.0 8.9 7.4 13.8 3.9 3.9 36.9 12.6 10.2 14.7 9.1 7.0 108.0 8.9 5.0 4.1 46.8 4.5 3.3 0.0 1.6 5.6 8.1 2.8 2.3 27.6 7.3 50.9 13.7 5.5 12.0 48.4 6.6 7.2 3.3 14.4 5.1 17.7 1.6 0.0 10.6 7.1 64.2 0.0 4.1 30.0 19.6 1.9 1.4 22.3 7.5 2.4 MPIG6B "C6orf25, G6b, G6b-B, NG31" ENSG00000204420 "Megakaryocyte and platelet inhibitory receptor G6b" O95866 6 31718594-31726714 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heparin-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.2" "Cell type enriched" "Detected in single" 30 "granulocytes: 9.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "NK-cell: 3.0;plasmacytoid DC: 1.8" "Group enriched" "Detected in many" 4 "dendritic cells: 1.8;NK-cells: 3.0" "Cell line enriched" "Detected in single" 17 "HEL: 11.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA054404, HPA073017" Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 7400000 "Golgi apparatus" "Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA054404: , HPA073017: AB_2686566" "unprognostic (1.45e-1)" "unprognostic (1.25e-1)" "unprognostic (2.93e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (6.53e-2)" "unprognostic (3.53e-2)" "unprognostic (2.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (1.82e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (2.55e-2)" "unprognostic (1.71e-2)" 0.8 0.2 0.0 1.2 0.5 5.3 0.7 0.1 0.4 1.0 0.9 0.0 0.0 0.9 1.0 0.8 2.0 0.7 1.5 7.4 0.2 0.0 0.4 0.5 7.6 2.8 1.0 0.0 2.7 0.2 0.2 0.2 1.4 0.7 0.9 0.2 1.1 1.8 0.3 1.2 10.5 0.8 1.9 0.6 33.2 0.4 2.7 0.1 1.2 1.0 1.4 0.8 1.6 1.6 0.2 1.8 0.5 0.1 3.0 0.1 5.7 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.5 3.0 0.1 1.8 0.0 5.7 0.0 0.5 0.1 0.4 0.2 0.0 1.0 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MPL "CD110, TPOR" ENSG00000117400 "MPL proto-oncogene, thrombopoietin receptor" P40238 1 43337849-43352772 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enriched" "Detected in single" 78 "HEL: 41.7" "Region enhanced" "Detected in single" "cerebral cortex: 1.4" "Low region specificity" "Detected in all" HPA007619 Supported "Nuclear membrane,Plasma membrane" NA NA "Plasma membrane" "Nuclear membrane" "HPA007619: AB_1854080" "unprognostic (2.74e-1)" "unprognostic (6.56e-2)" "unprognostic (2.95e-1)" "unprognostic (8.71e-2)" "unprognostic (1.37e-2)" "unprognostic (1.06e-3)" "unprognostic (1.19e-1)" "unprognostic (1.22e-2)" "unprognostic (5.83e-2)" "unprognostic (1.03e-1)" "unprognostic (5.94e-4)" "unprognostic (1.51e-1)" "unprognostic (1.19e-4)" "unprognostic (2.39e-1)" "unprognostic (3.26e-1)" "unprognostic (1.03e-4)" "unprognostic (1.42e-1)" 1.1 0.3 0.9 0.5 0.8 2.0 0.9 0.5 2.2 0.6 0.6 0.5 0.5 0.3 0.9 1.7 0.9 2.1 0.5 3.9 0.8 0.6 0.5 0.5 2.0 0.5 0.9 0.5 6.6 1.1 0.6 0.6 2.2 0.5 1.5 0.7 0.5 0.5 0.7 0.6 0.4 1.2 2.1 2.5 8.6 0.5 2.1 0.5 0.5 2.2 2.4 0.5 0.9 0.5 0.0 0.0 1.6 0.3 0.0 0.0 4.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 41.7 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.4 0.2 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.0 0.9 0.8 0.5 2.2 0.8 0.6 0.9 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MPLKIP "C7orf11, ORF20, TTDN1" ENSG00000168303 "M-phase specific PLK1 interacting protein" Q8TAP9 7 40126023-40134652 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA058457, HPA065463" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA058457: AB_2683724, HPA065463: AB_2685493" "unprognostic (5.59e-2)" "unprognostic (1.74e-1)" "unprognostic (9.40e-2)" "unprognostic (2.39e-2)" "unprognostic (5.55e-2)" "unprognostic (1.34e-3)" "unprognostic (2.73e-1)" "unprognostic (3.40e-2)" "unprognostic (3.94e-2)" "unprognostic (1.65e-1)" "unprognostic (3.16e-3)" "unprognostic (8.89e-2)" "unprognostic (1.61e-2)" "unprognostic (8.44e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-2)" "unprognostic (6.08e-2)" 13.7 15.2 11.6 9.3 12.7 8.7 14.8 13.9 12.1 12.7 14.5 12.6 9.5 11.9 11.0 13.6 12.9 10.0 9.3 9.3 11.8 11.4 20.5 52.1 8.7 13.3 15.0 8.8 12.0 17.3 10.1 16.1 13.8 10.4 11.5 11.6 11.1 14.4 10.5 10.1 11.3 13.4 9.2 11.9 12.7 10.8 11.0 12.0 25.5 19.2 7.9 12.8 11.3 12.6 53.8 41.9 52.9 38.0 30.7 45.0 40.9 24.1 7.1 13.3 16.7 13.4 15.8 14.7 8.7 10.3 13.9 14.1 9.7 11.8 19.7 12.9 9.0 26.5 29.7 8.0 16.3 17.4 15.1 29.0 15.0 10.5 20.4 16.1 17.8 14.4 14.8 22.6 9.9 12.9 13.9 16.7 21.6 39.3 15.1 14.1 12.4 18.0 60.4 18.4 20.2 24.2 26.4 9.2 25.9 15.4 5.7 19.4 24.1 14.3 13.6 20.9 19.5 17.5 26.7 15.1 7.5 22.7 9.1 13.5 24.6 29.1 33.4 12.8 30.6 22.1 43.4 38.0 52.9 28.0 34.3 31.3 53.8 35.9 32.8 39.4 47.0 40.0 35.1 20.4 30.7 31.5 41.9 45.0 40.9 11.6 12.7 13.9 12.1 11.8 11.4 15.0 8.8 10.4 12.0 47.6 34.6 54.8 74.2 97.8 44.2 15.9 53.5 53.5 39.8 55.8 23.6 94.3 99.5 60.1 107.2 61.3 51.0 0.0 47.7 63.7 58.5 51.4 49.7 109.9 60.4 50.9 46.7 45.4 55.0 29.2 70.2 56.9 55.6 52.3 57.8 42.0 52.6 70.6 51.9 148.0 42.4 51.8 48.1 54.9 49.5 117.2 80.0 48.0 77.3 91.3 MPP5 "FLJ12615, PALS1" ENSG00000072415 "Membrane palmitoylated protein 5" Q8N3R9 14 67241109-67335819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000993, HPA063890" Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA000993: AB_1079407, HPA063890: AB_2732707" "unprognostic (3.65e-1)" "unprognostic (3.82e-3)" "unprognostic (4.56e-2)" "unprognostic (9.20e-2)" "unprognostic (9.86e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.02e-1)" "unprognostic (1.37e-1)" "unprognostic (1.93e-3)" "unprognostic (9.89e-3)" "prognostic favorable (1.71e-12)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (6.90e-2)" "unprognostic (6.87e-2)" 7.1 9.2 14.8 6.8 29.2 7.0 10.1 9.4 18.0 9.0 12.5 15.9 13.7 18.5 6.9 20.8 14.4 7.2 9.0 7.3 16.4 17.0 28.8 17.2 11.5 4.5 30.6 10.2 6.4 8.6 22.9 11.4 27.9 20.5 15.8 11.6 7.6 15.9 18.6 14.6 8.6 18.7 11.9 23.3 6.2 9.7 8.2 25.4 6.8 24.1 6.9 5.8 9.1 9.1 3.6 2.4 3.7 2.8 6.7 4.4 1.2 54.9 8.8 8.9 7.2 5.2 4.7 7.9 16.8 8.8 12.3 8.3 8.7 16.9 4.7 8.0 13.6 4.3 11.5 5.1 9.7 18.9 2.2 3.5 4.3 9.3 6.0 6.0 1.6 3.3 5.0 3.7 7.1 9.1 8.9 6.8 5.4 4.5 2.1 19.6 7.4 5.2 2.0 3.0 8.0 6.0 4.7 14.2 5.6 11.2 13.7 5.0 3.6 10.4 10.2 5.8 8.2 10.5 3.3 10.6 15.7 33.4 5.5 7.3 3.2 2.9 7.2 10.5 3.7 5.4 0.4 2.2 3.7 1.7 2.8 1.4 3.6 2.0 1.9 2.4 1.9 4.4 2.4 0.8 6.7 2.3 2.4 1.1 1.2 14.8 29.2 9.4 18.0 16.4 17.0 30.6 10.2 20.5 25.4 59.6 21.6 6.0 21.7 18.7 9.4 22.4 12.7 9.4 17.0 21.0 41.2 18.5 11.6 19.2 4.4 14.3 41.0 0.0 23.5 8.9 16.6 25.6 4.7 16.8 14.2 3.2 5.2 16.5 9.6 3.9 7.5 7.2 3.3 7.2 18.4 24.1 20.2 31.6 10.6 28.4 34.5 6.5 19.6 8.3 33.8 15.2 14.6 4.4 19.5 31.5 MPP7 FLJ32798 ENSG00000150054 "Membrane palmitoylated protein 7" Q5T2T1 10 28050993-28334486 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.2" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 55.2;Suprabasal keratinocytes: 53.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 11.0;CACO-2: 20.7;CAPAN-2: 12.9;T-47d: 41.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037597, HPA037598" Approved Supported "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA037597: AB_2675569, HPA037598: AB_10696941" "unprognostic (1.12e-1)" "unprognostic (1.24e-1)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "unprognostic (6.64e-2)" "unprognostic (7.78e-2)" "unprognostic (9.31e-3)" "prognostic favorable (5.88e-4)" "unprognostic (2.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.88e-1)" "unprognostic (2.26e-1)" "prognostic favorable (2.79e-14)" "unprognostic (2.46e-1)" "unprognostic (1.88e-1)" "unprognostic (4.66e-2)" "unprognostic (1.03e-2)" 1.9 1.2 1.9 3.2 1.9 2.6 3.7 3.2 3.0 2.3 6.3 1.9 1.9 1.8 1.9 3.7 16.3 4.6 2.0 2.0 1.9 0.6 4.9 1.9 3.7 4.6 1.9 1.9 1.9 11.3 1.8 7.8 4.2 2.2 2.8 3.5 2.6 5.0 1.9 4.7 11.2 3.3 3.0 1.9 2.4 5.9 33.2 1.9 1.9 5.7 1.9 3.0 3.4 5.4 0.7 8.1 9.0 8.2 4.9 9.2 5.3 2.6 0.0 0.2 0.0 0.0 0.0 11.0 0.5 0.4 2.2 3.5 20.7 12.9 0.0 0.1 1.5 1.6 4.8 1.8 3.4 5.2 0.0 3.5 0.0 0.6 1.2 0.0 0.0 0.0 0.1 5.5 0.3 0.2 0.0 0.0 1.0 0.5 0.0 2.9 4.9 1.0 0.0 0.6 4.0 1.0 0.5 6.2 0.0 0.2 8.7 0.5 0.0 1.1 5.3 0.0 1.8 41.8 0.5 0.0 0.8 6.0 0.0 0.4 0.1 0.0 0.0 0.0 4.9 0.0 0.0 8.2 9.0 4.3 2.7 6.3 0.7 4.7 2.9 8.1 0.6 9.2 6.4 3.3 4.9 1.4 0.1 1.1 5.3 1.9 1.9 3.2 3.0 1.9 0.6 1.9 1.9 2.2 1.9 41.7 38.7 0.0 9.3 20.5 1.2 9.0 12.7 16.0 23.9 14.0 15.7 38.9 8.3 3.5 55.2 2.8 10.9 0.0 10.9 2.0 2.1 11.1 1.1 2.6 4.7 3.2 6.4 1.8 5.6 13.5 0.9 2.5 6.8 0.0 8.9 22.1 7.6 7.0 0.4 7.3 7.0 0.0 4.7 2.5 9.3 53.3 38.9 8.7 10.7 12.8 MPPE1 PGAP5 ENSG00000154889 "Metallophosphoesterase 1" Q53F39 18 11882622-11909223 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, GPI-anchor biosynthesis, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 22.1;neutrophil: 66.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 66.2" "Cell line enhanced" "Detected in all" "OE19: 34.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 10 "basal ganglia: 104.4" HPA012639 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA012639: AB_1854088" "unprognostic (9.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-1)" "unprognostic (7.92e-3)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.00e-2)" "unprognostic (4.46e-1)" "unprognostic (1.61e-1)" "prognostic favorable (6.45e-7)" "unprognostic (1.26e-1)" "unprognostic (1.38e-1)" "unprognostic (7.79e-2)" "unprognostic (6.15e-2)" 15.0 13.7 11.8 16.5 16.0 19.9 15.2 11.4 20.9 14.1 16.4 20.1 18.2 13.5 18.7 22.1 13.4 15.8 23.6 17.2 11.5 14.4 23.7 20.8 24.7 29.0 19.8 12.2 11.7 24.6 22.2 16.5 15.2 14.1 13.1 17.2 14.8 16.8 26.6 19.3 22.4 19.7 14.0 15.1 17.5 17.7 6.7 14.8 22.7 37.1 14.6 17.6 14.9 13.9 4.5 8.5 66.2 9.5 6.3 6.0 6.7 3.9 5.7 4.3 10.5 12.5 14.8 4.1 9.4 13.7 5.6 8.9 10.6 11.3 7.8 20.8 9.1 5.6 4.3 3.0 5.3 5.3 8.6 5.2 2.2 11.5 2.4 17.6 10.1 16.3 21.9 7.0 4.9 3.6 8.4 3.3 7.1 2.8 7.6 9.3 9.3 7.4 6.8 3.0 34.0 1.5 3.0 2.7 9.5 9.2 6.0 6.2 3.5 8.8 6.9 8.2 5.0 5.1 13.2 6.8 11.4 4.4 10.9 5.2 11.9 10.5 9.9 8.5 5.3 11.2 4.1 9.5 22.1 6.0 7.7 4.3 4.0 3.7 5.6 8.5 4.5 4.5 5.7 66.2 6.3 5.2 6.7 5.8 6.7 11.8 16.0 11.4 20.9 11.5 14.4 19.8 12.2 14.1 14.8 53.6 33.6 15.2 11.9 16.0 17.3 1.6 20.4 28.1 18.2 21.0 11.8 22.8 18.3 24.9 15.7 14.7 31.5 23.3 36.6 26.4 17.4 11.4 26.6 23.6 22.2 7.9 9.2 9.8 29.2 25.1 11.8 25.8 18.6 10.0 18.0 19.8 30.1 15.9 14.2 23.0 17.9 12.9 13.7 3.4 7.2 17.6 14.0 30.5 13.7 16.6 MRAP "B27, C21orf61, FALP" ENSG00000170262 "Melanocortin 2 receptor accessory protein" Q8TCY5 21 32291813-32314784 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "adipose tissue: 28.3;adrenal gland: 52.7;breast: 68.6" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 41.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "basal ganglia: 2.6" "Cell type enhanced" "Detected in many" "NK-cell: 5.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Hep G2: 4.7;HSkMC: 5.4" "HPA011024, HPA011093" Uncertain Supported "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA011024: AB_10599292, HPA011093: AB_10600889" "unprognostic (1.38e-1)" "unprognostic (1.55e-3)" "unprognostic (1.53e-1)" "unprognostic (1.11e-1)" "unprognostic (9.53e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-1)" "unprognostic (2.27e-1)" "unprognostic (1.18e-1)" "unprognostic (1.80e-2)" "unprognostic (4.12e-1)" "unprognostic (6.30e-6)" "unprognostic (3.32e-2)" "unprognostic (2.37e-1)" "unprognostic (1.18e-1)" "unprognostic (5.76e-2)" 28.3 52.7 0.0 1.6 2.6 0.0 68.6 0.3 0.1 0.0 3.0 0.7 0.0 0.1 0.1 0.2 0.0 0.0 0.4 1.6 0.0 0.0 0.1 0.6 0.2 1.8 0.2 0.1 0.8 0.1 0.0 0.0 1.1 0.3 0.1 0.1 0.2 1.7 0.0 0.9 0.2 1.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.8 0.1 0.6 4.3 1.8 1.5 0.0 0.5 5.5 1.8 0.1 0.0 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.9 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.9 0.5 0.7 1.8 0.7 1.2 0.5 1.4 0.8 1.6 0.0 5.5 0.3 1.5 1.8 0.1 0.0 2.6 0.3 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.3 0.1 41.3 0.0 0.0 0.0 4.6 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 MROH2A HEATR7B1 ENSG00000185038 "Maestro heat like repeat family member 2A" A6NES4 2 233775679-233833423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 1.8;testis: 5.0;thyroid gland: 5.1" "Cell type enhanced" "Detected in single" 13 "Spermatocytes: 1.8" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "RT4: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA052107 Uncertain Uncertain Cytosol NA NA Cytosol "HPA052107: AB_2681729" "unprognostic (7.00e-2)" "unprognostic (3.37e-3)" "unprognostic (4.77e-1)" "unprognostic (1.65e-2)" "unprognostic (4.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.87e-1)" "unprognostic (4.41e-2)" "unprognostic (2.69e-1)" "unprognostic (1.67e-1)" "unprognostic (4.32e-2)" "unprognostic (5.05e-2)" "unprognostic (4.06e-9)" "unprognostic (5.65e-2)" "unprognostic (3.90e-2)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 5.0 5.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 11.6 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.1 0.0 0.0 0.0 0.1 MRPL2 "CGI-22, MRP-L14, RPML14" ENSG00000112651 "Mitochondrial ribosomal protein L2" Q5T653 6 43054029-43059806 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007455, HPA064814" Approved Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA007455: AB_1079410, HPA064814: AB_2685358" "unprognostic (2.31e-1)" "unprognostic (1.49e-2)" "unprognostic (3.06e-1)" "unprognostic (1.48e-2)" "unprognostic (3.34e-1)" "unprognostic (1.62e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-1)" "unprognostic (3.17e-1)" "prognostic favorable (6.01e-4)" "unprognostic (3.07e-1)" "unprognostic (1.79e-1)" "unprognostic (3.24e-2)" "unprognostic (6.42e-2)" "unprognostic (2.33e-2)" "unprognostic (3.13e-1)" "unprognostic (2.78e-1)" 16.9 19.9 17.4 13.1 22.5 16.0 14.2 13.6 21.8 13.0 15.6 13.3 16.4 20.3 14.1 16.9 13.6 16.2 15.5 31.7 16.0 16.8 20.9 55.0 12.9 16.2 18.8 20.3 15.7 17.4 25.8 17.8 11.7 15.3 12.9 15.0 12.6 21.1 19.6 53.2 13.8 15.2 13.4 12.4 11.5 13.4 21.0 13.2 17.5 15.7 25.5 12.3 12.4 11.9 21.0 26.9 14.3 18.5 17.5 16.9 13.6 10.9 12.6 6.3 11.0 7.7 6.2 9.8 4.9 7.0 12.8 11.5 24.1 3.8 15.5 12.3 6.8 9.5 11.6 13.6 13.1 8.0 9.0 28.2 12.5 10.2 29.1 15.2 10.4 6.1 8.1 13.9 14.8 20.1 6.7 9.0 19.8 20.9 10.4 6.8 21.3 13.4 37.0 5.7 42.2 14.9 15.6 6.3 19.8 9.6 6.9 15.2 7.9 4.8 8.5 15.0 5.6 9.6 18.7 8.1 7.5 10.1 9.9 13.6 12.1 11.0 32.0 5.5 16.8 7.3 6.8 18.5 14.3 13.5 17.2 16.9 20.4 15.6 16.0 25.2 21.0 15.9 16.1 5.5 17.5 13.4 26.9 16.6 13.6 17.4 22.5 13.6 21.8 16.0 16.8 18.8 20.3 15.3 13.2 20.8 15.2 33.7 27.7 21.6 18.7 34.1 35.7 29.4 27.3 57.6 25.5 66.2 157.5 45.9 72.1 31.5 50.7 46.7 46.7 41.8 35.6 25.5 27.7 68.6 44.0 4.8 29.4 30.1 23.0 24.4 50.9 27.0 50.6 45.1 37.0 29.6 38.4 49.5 48.4 109.4 17.2 25.8 39.1 33.4 34.3 23.7 53.1 27.7 57.2 21.0 MRPL43 bMRP36a ENSG00000055950 "Mitochondrial ribosomal protein L43" Q8N983 10 100969458-100987515 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073022 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA073022: " "unprognostic (2.65e-1)" "unprognostic (1.10e-2)" "unprognostic (2.01e-2)" "unprognostic (4.11e-3)" "unprognostic (6.07e-2)" "unprognostic (3.74e-1)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.84e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.03e-1)" "unprognostic (6.04e-3)" "unprognostic (3.02e-1)" "unprognostic (3.53e-2)" "unprognostic (7.29e-2)" "unprognostic (2.53e-2)" 34.6 34.5 25.9 20.1 24.2 22.5 25.0 24.0 32.9 26.0 26.1 32.5 25.5 28.5 24.7 29.9 31.8 25.9 30.2 25.0 24.4 20.9 37.2 39.6 20.5 20.3 26.5 19.3 32.7 62.2 16.7 21.4 26.6 22.9 31.9 8.3 30.1 61.4 34.4 100.4 26.8 30.1 25.5 32.1 24.8 32.0 28.6 20.3 23.5 45.2 35.2 25.6 27.6 22.6 36.2 36.6 41.3 32.3 36.4 39.4 33.4 30.1 34.3 7.2 12.7 7.5 9.7 22.4 21.1 19.2 16.4 16.7 19.5 23.7 26.0 28.8 8.8 8.9 18.9 2.6 17.6 2.2 19.6 44.6 20.5 24.9 30.2 16.2 16.1 16.5 15.1 13.8 13.9 6.1 7.8 15.4 16.6 10.1 13.3 4.9 31.9 15.0 36.7 11.6 8.2 32.4 16.2 24.1 17.4 9.1 15.6 8.1 20.9 15.4 7.5 23.6 2.4 40.1 7.8 18.8 15.4 20.6 16.5 22.1 27.9 21.2 13.1 19.7 30.2 11.1 41.3 32.3 35.1 32.3 30.0 33.2 36.2 35.7 32.1 36.6 33.3 34.7 30.9 11.0 36.4 28.8 28.6 39.4 33.4 25.9 24.2 24.0 32.9 24.4 20.9 26.5 19.3 22.9 20.3 41.7 35.1 68.5 70.1 49.5 43.4 32.2 84.1 78.9 51.2 71.5 39.3 112.8 152.5 84.3 53.4 47.0 56.3 70.0 110.7 118.6 57.0 57.6 45.1 59.7 86.2 17.5 58.7 51.5 39.7 31.5 79.1 47.5 60.8 68.5 68.0 64.2 77.6 84.2 69.3 155.7 46.0 51.8 80.4 138.2 73.5 59.8 86.7 61.0 79.0 55.9 MRPL44 "FLJ12701, FLJ13990" ENSG00000135900 "Mitochondrial ribosomal protein L44" Q9H9J2 2 223957404-223967714 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038147, HPA038148" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Mitochondria" NA NA Mitochondria "Nucleoplasm, Nuclear bodies, Plasma membrane" "HPA038147: AB_10671521, HPA038148: AB_2675863" "unprognostic (5.21e-2)" "unprognostic (3.48e-1)" "unprognostic (3.38e-2)" "unprognostic (3.00e-1)" "unprognostic (7.05e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.16e-2)" "unprognostic (3.32e-1)" "unprognostic (7.65e-2)" "unprognostic (8.33e-2)" "unprognostic (6.65e-2)" "prognostic favorable (2.02e-4)" "unprognostic (2.47e-2)" "unprognostic (1.14e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-1)" 16.4 29.2 15.3 16.8 16.4 32.7 26.7 15.1 24.2 11.7 17.9 12.8 9.2 16.0 13.9 12.6 18.3 14.1 14.8 29.0 14.6 16.9 31.0 38.9 13.0 24.1 15.2 17.0 13.5 26.1 11.0 12.7 17.3 13.8 13.3 19.6 11.8 14.1 13.9 35.3 14.7 15.5 12.3 15.6 18.8 14.9 18.4 12.8 23.6 16.2 22.9 21.0 14.1 11.3 31.5 28.2 39.8 30.1 21.2 26.9 23.3 12.1 10.3 15.4 17.7 14.5 17.3 24.4 13.7 15.4 22.3 23.6 36.5 15.3 18.4 14.9 11.7 20.5 16.2 25.0 18.9 20.7 17.3 17.7 20.0 11.9 28.6 21.4 22.1 15.5 20.2 23.7 13.5 18.2 18.9 21.8 18.9 19.1 14.6 17.9 14.1 16.5 28.1 23.0 24.5 10.8 19.5 18.9 11.3 29.7 10.3 21.0 12.1 10.1 22.7 33.0 23.7 19.1 32.0 14.3 14.9 11.6 12.7 11.0 16.1 11.2 26.3 15.1 21.2 16.3 31.5 30.1 22.6 20.5 29.1 25.9 31.5 22.1 24.4 28.2 27.0 26.9 23.5 39.8 21.2 25.6 22.6 22.2 23.3 15.3 16.4 15.1 24.2 14.6 16.9 15.2 17.0 13.8 12.8 6.0 12.5 45.0 23.7 15.9 18.2 9.7 28.1 22.7 12.5 26.2 0.0 79.5 69.6 38.7 3.8 18.8 20.4 23.3 30.7 52.2 18.6 18.3 18.4 47.4 42.1 11.1 12.6 20.3 28.6 5.9 16.7 21.2 32.1 33.3 21.1 13.5 34.8 17.5 17.0 71.1 10.4 19.4 10.3 34.2 56.9 14.4 40.7 18.4 24.3 31.4 MRPL46 "C15orf4, LIECG2, P2ECSL" ENSG00000259494 "Mitochondrial ribosomal protein L46" Q9H2W6 15 88459476-88467419 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050166 Uncertain Supported "Nucleoplasm,Cell Junctions,Mitochondria" NA NA Mitochondria "Nucleoplasm, Cell Junctions" "HPA050166: AB_2681039" "unprognostic (1.42e-1)" "unprognostic (6.94e-3)" "unprognostic (1.02e-1)" "unprognostic (1.21e-2)" "unprognostic (3.28e-2)" "unprognostic (5.16e-2)" "unprognostic (6.22e-2)" "unprognostic (1.84e-1)" "unprognostic (1.79e-1)" "unprognostic (4.64e-3)" "unprognostic (7.78e-2)" "unprognostic (5.65e-2)" "prognostic favorable (2.09e-6)" "unprognostic (7.73e-2)" "unprognostic (9.18e-2)" "unprognostic (6.96e-3)" "unprognostic (1.63e-1)" 11.0 28.3 14.2 11.9 14.7 5.4 13.2 15.8 15.6 7.3 12.4 8.5 10.0 11.1 9.6 11.5 13.3 10.5 8.3 40.8 11.8 11.3 19.3 38.7 7.4 10.4 13.2 13.0 11.4 8.9 8.1 9.2 13.7 13.8 9.0 13.8 7.8 9.3 9.5 57.0 8.2 9.3 11.1 11.4 9.7 12.0 13.7 11.7 12.2 10.0 17.9 11.0 11.1 13.4 31.8 24.6 13.2 24.5 24.3 31.9 25.1 10.0 32.2 10.6 11.3 15.2 11.1 19.6 14.4 13.5 21.8 19.5 39.6 22.2 23.9 14.8 13.0 19.5 24.6 40.7 17.7 17.6 9.7 32.4 19.9 23.2 41.3 9.5 19.4 15.5 12.8 21.6 16.4 11.4 11.0 18.8 23.7 21.8 10.2 15.8 21.5 16.3 24.6 16.4 18.6 19.6 18.8 14.6 18.1 16.9 32.3 16.1 10.5 13.7 21.6 29.5 18.6 24.3 24.2 11.6 17.0 16.1 9.0 20.7 9.5 19.6 19.4 18.7 21.4 12.8 9.9 19.6 13.2 26.8 24.5 30.5 31.8 28.7 26.1 24.6 28.4 31.9 28.4 3.5 24.3 17.6 20.9 26.9 25.1 14.2 14.7 15.8 15.6 11.8 11.3 13.2 13.0 13.8 11.7 0.0 6.4 19.3 18.4 12.2 20.3 64.9 30.6 16.0 10.3 34.9 25.5 77.8 101.2 30.3 48.5 15.4 23.1 0.0 32.9 37.0 13.4 13.1 21.9 82.5 31.2 14.3 27.2 17.2 12.6 6.8 13.3 9.2 6.8 63.1 17.9 17.8 28.5 17.5 17.7 80.1 22.7 25.8 10.5 30.3 24.5 20.5 67.5 22.7 28.6 26.5 MRPL52 ENSG00000172590 "Mitochondrial ribosomal protein L52" Q86TS9 14 22829879-22835037 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012319 Approved Supported Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA012319: AB_1854118" "unprognostic (8.98e-2)" "unprognostic (9.07e-2)" "unprognostic (1.36e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.74e-2)" "unprognostic (4.01e-3)" "unprognostic (1.29e-1)" "unprognostic (6.52e-2)" "unprognostic (8.05e-3)" "unprognostic (8.07e-2)" "unprognostic (2.87e-1)" "unprognostic (7.46e-2)" "unprognostic (2.19e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-1)" "unprognostic (1.41e-1)" 24.3 29.4 31.8 31.8 36.8 27.8 54.5 18.8 34.7 22.7 35.5 13.5 31.4 43.7 21.3 23.5 37.5 20.8 39.2 73.7 28.3 31.0 34.1 41.9 36.9 55.9 35.5 27.8 17.2 58.5 21.6 20.7 20.9 40.1 22.4 22.4 12.7 41.6 43.0 79.5 24.3 35.1 22.9 37.0 27.6 39.9 30.6 24.0 27.8 27.4 38.4 25.2 15.6 31.6 43.9 50.6 25.4 39.0 21.9 30.7 29.7 43.9 34.6 18.9 23.4 11.8 13.9 46.1 30.7 22.2 27.5 26.2 42.4 61.7 33.5 33.9 21.1 28.0 40.1 15.5 42.5 20.7 35.4 25.5 24.9 13.8 96.1 35.9 39.1 35.9 20.8 29.4 35.6 30.4 21.8 43.6 42.7 25.5 33.4 20.1 61.7 31.6 59.5 34.8 54.8 76.5 39.2 23.6 39.5 28.7 26.3 18.9 24.4 23.8 23.3 32.6 14.1 22.4 37.5 33.5 28.8 33.7 36.0 46.5 33.1 39.0 40.8 26.2 26.9 45.9 25.4 36.0 18.0 25.4 39.0 23.2 43.9 27.9 22.9 50.6 37.7 26.4 25.3 6.1 21.9 28.7 41.9 30.7 29.7 31.8 36.8 18.8 34.7 28.3 31.0 35.5 27.8 40.1 24.0 68.5 78.6 124.3 65.2 107.6 20.6 96.4 201.2 95.0 89.9 129.1 17.7 163.2 235.4 222.3 47.9 83.9 246.5 93.5 272.5 246.5 72.7 86.6 121.1 226.4 208.7 19.1 132.6 105.6 152.4 44.5 51.8 104.0 118.1 247.9 188.7 49.5 303.7 207.0 46.3 360.5 27.7 64.7 84.5 124.7 106.0 130.4 105.4 86.1 183.5 87.8 MRPL58 "DS-1, ICT1" ENSG00000167862 "Mitochondrial ribosomal protein L58" Q14197 17 75012670-75021261 "Enzymes, Predicted intracellular proteins, Ribosomal proteins" "Protein biosynthesis" "Hydrolase, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 56.1;Distal tubular cells: 48.0;Exocrine glandular cells: 52.2;Proximal tubular cells: 104.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003634 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA003634: AB_1851388" "unprognostic (2.04e-1)" "unprognostic (1.57e-2)" "unprognostic (1.94e-3)" "unprognostic (7.12e-2)" "unprognostic (3.16e-2)" "unprognostic (4.35e-2)" "unprognostic (1.38e-3)" "unprognostic (1.52e-1)" "unprognostic (2.57e-1)" "unprognostic (3.79e-3)" "unprognostic (4.98e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.66e-2)" "unprognostic (1.71e-1)" 12.4 23.4 13.9 18.4 14.8 13.7 17.6 18.1 15.7 10.6 15.2 9.8 17.5 13.1 12.5 15.1 19.4 12.5 16.3 31.2 12.2 12.0 25.7 41.7 10.2 15.2 14.3 14.0 10.5 24.2 13.5 9.1 13.9 14.0 13.6 16.3 10.1 17.7 22.5 57.3 16.5 13.4 14.8 12.9 14.6 15.1 7.6 14.0 13.2 14.8 31.2 15.7 14.3 11.6 18.3 28.9 11.2 22.0 20.0 33.5 20.9 26.1 36.9 12.3 14.1 13.3 13.2 17.2 15.5 16.9 32.4 27.6 28.3 16.5 18.2 12.8 15.4 20.0 18.7 25.2 26.7 34.3 9.3 29.9 14.3 17.5 23.5 25.1 29.8 9.8 14.2 12.8 21.5 34.5 11.0 24.6 18.9 23.0 13.3 18.3 32.7 25.7 20.5 9.3 40.8 50.0 13.3 21.9 26.5 23.8 19.4 11.5 22.0 13.4 24.5 30.1 16.5 32.8 24.6 10.4 17.5 19.2 18.4 29.2 13.9 11.0 20.1 20.0 33.4 14.4 11.2 22.0 10.5 17.3 20.7 14.9 18.3 21.1 17.2 28.9 14.8 15.7 17.6 2.0 20.0 17.4 19.4 33.5 20.9 13.9 14.8 18.1 15.7 12.2 12.0 14.3 14.0 14.0 14.0 29.8 8.3 0.0 0.0 0.0 0.0 0.0 0.0 38.8 14.8 24.4 0.0 56.1 48.0 41.8 0.0 0.0 0.0 0.0 52.2 30.7 0.0 0.0 1.1 0.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 26.2 0.0 0.0 44.8 0.0 0.0 104.5 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 MRPS14 HSMRPS14 ENSG00000120333 "Mitochondrial ribosomal protein S14" O60783 1 175010789-175023425 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051087 Uncertain Supported "Nuclear membrane,Mitochondria" "Intracellular and membrane" NA NA Mitochondria "Nuclear membrane" "HPA051087: AB_2681339" "unprognostic (9.24e-2)" "unprognostic (6.37e-2)" "unprognostic (1.50e-1)" "unprognostic (3.46e-1)" "unprognostic (3.44e-2)" "unprognostic (5.39e-2)" "unprognostic (1.61e-2)" "unprognostic (3.01e-2)" "unprognostic (7.32e-2)" "unprognostic (4.85e-2)" "unprognostic (7.67e-2)" "unprognostic (3.10e-2)" "unprognostic (1.31e-3)" "unprognostic (1.67e-1)" "unprognostic (8.04e-2)" "unprognostic (2.42e-1)" "unprognostic (3.21e-2)" 17.7 23.6 31.8 11.8 27.6 4.5 23.7 19.6 26.3 19.5 14.9 22.9 18.3 13.8 20.1 25.6 15.4 18.0 15.8 16.6 26.9 26.5 23.4 29.7 14.7 16.0 32.7 14.5 21.8 19.1 28.3 26.1 17.1 22.5 23.6 18.1 15.4 18.4 20.4 13.7 12.7 14.7 17.2 33.5 17.4 15.3 15.8 24.5 22.6 26.5 14.5 16.2 14.3 11.7 14.5 13.6 6.5 12.9 14.3 19.2 11.6 11.0 8.9 21.2 7.5 24.0 17.3 6.8 9.7 11.9 16.6 17.3 11.6 9.8 14.1 11.9 13.0 7.3 9.9 13.1 11.3 17.7 15.5 18.0 11.6 17.5 13.2 10.2 12.8 10.4 18.8 14.0 9.7 6.8 14.7 13.7 12.3 14.0 12.5 11.5 6.1 14.0 9.3 11.6 20.8 4.7 12.2 11.2 16.7 11.4 9.0 17.9 12.6 14.1 13.1 9.3 17.4 15.5 13.7 11.2 5.6 6.3 11.8 8.7 13.8 11.7 17.6 8.1 12.2 11.8 6.5 12.9 6.2 13.4 12.7 18.8 14.5 14.2 14.1 13.6 13.5 19.2 16.2 4.5 14.3 9.7 11.8 15.1 11.6 31.8 27.6 19.6 22.6 26.9 26.5 32.7 14.5 22.5 24.5 26.8 23.2 38.7 45.3 19.6 13.8 73.8 40.8 34.8 34.2 52.4 13.7 85.5 116.0 57.8 11.2 35.8 23.6 46.7 38.9 90.2 43.7 47.0 17.4 59.4 70.3 1.6 30.5 34.4 33.2 8.5 43.1 29.4 47.2 88.4 32.3 32.0 49.2 49.1 40.3 89.3 18.4 38.8 36.4 71.7 37.5 25.6 46.9 31.0 46.9 40.3 MRPS27 KIAA0264 ENSG00000113048 "Mitochondrial ribosomal protein S27" Q92552 5 72219409-72320646 "Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 88.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071751 Approved Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA071751: AB_2686442" "unprognostic (3.05e-1)" "unprognostic (3.09e-1)" "unprognostic (1.14e-3)" "unprognostic (3.60e-2)" "unprognostic (2.23e-2)" "unprognostic (1.63e-1)" "unprognostic (1.79e-2)" "unprognostic (7.20e-3)" "unprognostic (2.12e-1)" "unprognostic (3.22e-3)" "unprognostic (5.07e-2)" "unprognostic (3.26e-2)" "unprognostic (6.58e-3)" "unprognostic (1.33e-1)" "unprognostic (5.27e-2)" "unprognostic (7.73e-2)" "unprognostic (3.95e-2)" 26.9 32.3 19.0 20.9 26.8 13.6 26.1 24.6 31.8 25.1 21.0 20.1 21.8 16.5 28.6 23.7 33.6 26.3 18.0 43.6 18.9 17.5 25.1 30.9 14.9 27.4 18.1 21.7 33.9 25.1 24.5 23.7 17.5 23.5 26.2 26.4 25.5 31.0 26.5 43.7 23.9 17.5 25.0 17.5 22.2 20.9 12.1 12.6 34.2 32.1 26.7 32.4 25.9 21.0 19.6 23.3 6.1 14.1 21.5 21.5 16.1 16.4 22.1 19.7 32.5 25.9 33.5 25.4 15.9 22.8 30.3 24.5 27.5 23.4 42.7 22.3 18.5 33.1 18.4 38.2 56.4 32.9 16.0 23.6 21.9 26.6 30.2 25.9 19.2 17.1 31.3 23.9 31.7 35.6 27.7 32.2 31.5 21.9 12.9 25.0 19.8 28.7 23.3 22.7 12.0 13.9 30.6 32.7 43.8 27.9 17.7 30.5 16.3 26.6 22.0 19.7 19.0 33.7 23.4 18.2 12.4 18.3 17.4 28.5 13.1 19.7 30.1 21.3 31.7 19.5 6.1 12.1 4.1 14.0 14.1 20.6 19.6 17.4 17.0 23.3 16.5 20.3 21.5 1.8 21.5 11.3 8.9 17.8 16.1 19.0 26.8 24.6 31.8 18.9 17.5 18.1 21.7 23.5 12.6 8.9 9.4 25.3 22.2 18.1 10.8 88.0 7.6 10.7 13.6 10.4 15.7 35.7 21.6 16.5 1.7 15.7 8.5 0.0 14.9 37.9 17.7 10.8 7.0 28.9 21.9 9.5 15.5 16.5 33.5 3.0 17.5 13.4 10.1 34.3 21.2 15.6 15.4 17.5 23.7 18.8 12.2 12.9 17.5 8.0 17.4 15.4 24.1 22.3 29.1 12.1 MRPS31 IMOGN38 ENSG00000102738 "Mitochondrial ribosomal protein S31" Q92665 13 40729135-40771173 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Ciliated cells: 350.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039083, HPA046344" Uncertain Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA039083: AB_2676340, HPA046344: AB_2679629" "unprognostic (9.62e-3)" "unprognostic (2.62e-1)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (1.04e-1)" "unprognostic (2.15e-2)" "unprognostic (5.96e-3)" "unprognostic (1.84e-3)" "unprognostic (2.87e-2)" "unprognostic (1.23e-1)" "unprognostic (1.72e-3)" "unprognostic (3.92e-2)" "unprognostic (3.13e-3)" "unprognostic (2.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.86e-2)" "unprognostic (2.54e-2)" 14.2 20.1 19.3 17.9 21.2 13.2 18.2 27.7 22.9 14.4 16.4 16.9 10.7 15.4 18.0 15.4 18.9 16.6 10.9 24.3 18.4 16.9 26.7 29.9 12.1 22.5 17.9 17.1 21.5 15.0 10.7 35.3 13.1 22.1 12.6 17.0 12.4 14.7 12.5 32.5 14.2 16.3 16.3 16.0 16.0 15.3 17.9 23.3 22.9 21.1 17.2 25.1 18.0 15.9 22.2 11.8 17.2 10.4 15.9 25.7 10.9 8.0 7.7 13.1 8.6 9.0 10.6 13.1 10.3 7.2 13.7 9.2 19.8 12.0 47.3 10.1 5.9 18.4 21.3 16.4 12.9 16.3 12.4 12.4 19.6 5.8 12.6 7.5 20.0 9.5 8.5 9.5 11.2 9.5 9.1 10.4 13.6 13.1 5.0 8.7 9.1 15.5 19.6 12.7 27.5 9.2 14.9 10.8 8.8 17.9 9.3 5.7 8.4 7.1 11.9 16.2 16.4 10.4 17.7 6.3 4.3 7.2 9.9 10.7 3.9 7.2 23.8 8.7 14.3 8.1 17.2 9.6 14.4 19.1 9.7 18.6 22.2 21.4 19.2 11.8 18.9 25.7 22.6 7.0 15.9 10.4 11.6 21.4 10.9 19.3 21.2 27.7 22.9 18.4 16.9 17.9 17.1 22.1 23.3 44.7 16.3 16.4 28.7 8.7 32.3 61.3 30.6 350.7 67.1 21.0 17.7 53.8 92.9 37.0 42.6 34.6 21.2 23.3 29.4 40.9 23.6 14.3 22.0 64.5 22.6 39.7 22.4 35.6 18.6 4.9 32.8 19.5 18.6 45.9 31.0 30.1 28.6 21.0 28.7 51.9 47.6 45.3 25.8 51.0 45.1 11.7 56.9 27.4 31.5 26.5 MSH2 "COCA1, HNPCC, HNPCC1" ENSG00000095002 "MutS homolog 2" P43246 2 47402969-47663146 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009572, HPA066845, CAB070867" Approved Supported Nucleoplasm,Vesicles NA Yes Nucleoplasm Vesicles "CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752" "unprognostic (2.35e-1)" "unprognostic (1.54e-2)" "unprognostic (2.89e-3)" "prognostic unfavorable (4.44e-4)" "unprognostic (2.23e-1)" "unprognostic (6.31e-3)" "prognostic unfavorable (1.72e-9)" "unprognostic (1.77e-1)" "unprognostic (7.09e-3)" "unprognostic (8.57e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (5.38e-2)" "unprognostic (3.29e-3)" "unprognostic (1.20e-3)" "unprognostic (5.74e-1)" "unprognostic (8.46e-2)" "unprognostic (1.48e-1)" 7.3 9.8 14.2 12.2 25.5 11.4 14.1 22.6 18.1 9.4 11.6 7.6 5.6 6.5 10.5 13.3 10.8 11.1 4.9 8.4 13.0 14.0 7.3 5.5 7.1 19.7 12.5 17.0 7.9 8.4 15.3 9.1 9.9 18.5 7.9 13.8 12.3 9.4 7.3 6.7 10.3 8.0 7.8 13.8 9.4 6.7 13.4 13.5 37.0 13.9 6.6 21.4 8.5 7.6 7.4 2.9 3.9 4.2 12.2 12.6 6.2 28.3 9.7 26.5 14.3 2.0 5.6 16.1 16.9 8.4 21.0 20.3 18.2 12.3 34.9 22.8 5.9 14.8 12.1 19.8 9.6 31.7 18.0 14.8 25.1 11.2 16.5 2.0 24.5 8.8 3.1 2.8 17.8 4.8 4.7 11.5 0.8 41.8 8.1 16.0 11.3 28.4 18.5 49.9 17.2 11.5 38.1 47.4 20.4 9.1 15.0 22.0 23.9 14.9 11.6 11.9 22.3 11.6 9.6 4.6 13.9 18.3 14.4 18.8 5.2 18.5 48.9 8.5 18.1 8.6 2.8 1.0 3.9 7.9 4.2 8.6 6.3 7.4 9.5 2.3 7.4 12.6 11.9 0.7 12.2 3.2 2.9 10.1 6.2 14.2 25.5 22.6 18.1 13.0 14.0 12.5 17.0 18.5 13.5 8.9 11.5 13.7 5.7 7.3 16.8 13.8 5.1 25.4 13.6 8.7 43.2 14.2 3.3 9.6 13.1 11.7 4.6 23.3 7.3 16.3 8.7 3.4 11.5 1.0 9.6 11.1 3.4 3.7 4.0 17.6 4.9 4.0 8.5 6.4 9.1 20.0 6.0 5.8 6.0 3.5 38.3 0.0 5.5 34.2 59.5 5.6 4.2 8.7 9.8 2.7 MSH6 GTBP ENSG00000116062 "MutS homolog 6" P52701 2 47695530-47810101 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" DNA-binding "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009091, HPA028376, HPA028446, CAB070870" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA Yes Nucleoplasm "Golgi apparatus, Vesicles" "CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182" "unprognostic (5.10e-2)" "unprognostic (5.87e-3)" "unprognostic (3.29e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (1.98e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (1.79e-1)" "unprognostic (2.35e-3)" "unprognostic (1.01e-1)" "unprognostic (1.74e-3)" "unprognostic (8.99e-2)" "prognostic unfavorable (1.06e-7)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (9.68e-2)" "unprognostic (3.48e-2)" 13.0 20.5 9.7 13.1 18.8 13.6 13.0 20.5 13.1 17.9 13.3 17.6 10.7 6.1 28.2 11.0 12.4 18.3 8.4 8.6 11.4 8.8 9.5 14.6 11.0 21.7 23.9 9.6 43.2 27.6 16.2 17.3 14.9 15.0 14.6 10.3 8.7 12.0 13.2 10.4 10.3 10.5 22.1 14.9 11.6 11.1 25.1 22.0 40.4 13.4 10.4 25.8 14.2 16.4 8.4 8.4 7.6 9.8 9.7 15.1 5.7 27.5 20.6 38.3 9.1 11.6 12.2 17.3 15.3 13.5 15.9 16.7 15.1 9.6 45.5 23.0 16.6 21.9 11.6 34.5 19.5 20.8 19.8 17.2 29.1 16.3 15.3 7.1 29.2 10.7 9.9 6.2 16.2 10.8 14.9 9.9 1.1 25.3 16.7 15.5 19.9 31.1 13.8 33.6 18.6 9.5 73.8 50.2 20.5 9.7 17.9 21.5 23.3 21.3 10.2 9.3 35.1 12.2 10.3 6.0 18.5 22.6 14.0 19.8 15.7 21.2 76.2 15.6 18.7 11.3 7.6 5.8 4.9 8.4 9.8 10.4 8.4 9.5 8.3 8.4 8.1 15.1 7.6 3.9 9.7 9.3 4.2 9.5 5.7 9.7 18.8 20.5 13.1 11.4 8.8 23.9 9.6 15.0 22.0 26.8 18.4 9.7 20.1 22.3 26.4 6.9 0.0 28.1 31.8 7.0 33.4 24.9 3.3 12.8 25.7 15.3 2.6 0.0 8.4 16.9 17.4 11.4 17.3 8.5 11.1 14.3 4.6 12.3 5.1 11.5 23.6 12.1 3.3 7.2 7.9 27.0 8.8 3.5 21.2 5.3 29.7 6.5 17.2 40.0 40.2 15.3 8.0 13.3 9.3 10.7 MSRA ENSG00000175806 "Methionine sulfoxide reductase A" Q9UJ68 8 10054268-10428891 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.4" "Cell type enriched" "Detected in many" 6 "Proximal tubular cells: 597.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 78.4" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Group enriched" "Detected in many" 4 "dendritic cells: 2.3;granulocytes: 9.0;monocytes: 3.2" "Cell line enhanced" "Detected in many" "HMC-1: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023804, HPA075766" Approved Supported "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" No No 25000 "Nucleoplasm, Plasma membrane, Cytosol" "Actin filaments" "HPA023804: AB_1853826, HPA075766: " "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" "unprognostic (1.45e-3)" "unprognostic (1.00e-2)" "unprognostic (4.21e-2)" "unprognostic (1.62e-2)" "unprognostic (1.49e-2)" "unprognostic (6.40e-2)" "unprognostic (9.69e-2)" "unprognostic (1.08e-1)" "unprognostic (1.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.07e-3)" "unprognostic (6.43e-3)" "unprognostic (4.02e-1)" "unprognostic (6.36e-3)" "unprognostic (3.07e-1)" 7.0 8.1 8.0 5.2 7.5 36.1 5.9 78.4 13.7 3.6 5.9 4.3 2.2 5.9 4.8 3.7 5.5 4.2 4.4 8.5 8.9 5.5 32.4 22.9 5.7 6.8 6.8 9.5 4.2 10.2 2.9 3.4 4.6 8.1 3.4 4.0 3.9 6.0 5.0 4.7 3.8 12.7 4.9 6.7 7.2 4.9 8.5 5.5 3.5 4.4 2.6 3.8 3.9 2.7 1.1 2.3 9.0 3.2 1.1 0.8 0.3 0.1 1.1 1.8 5.4 1.6 1.8 0.6 3.3 0.7 0.5 2.2 0.7 2.7 0.0 0.8 3.0 7.2 2.9 0.5 0.2 1.7 0.4 0.0 0.5 1.7 2.5 5.3 1.0 15.2 0.5 3.9 0.4 0.0 1.8 0.9 0.3 0.5 0.3 5.9 0.2 0.0 0.3 0.8 3.9 1.0 1.8 1.7 2.3 1.3 1.3 3.1 2.0 5.4 0.2 0.7 0.6 2.8 3.3 3.2 2.2 2.6 0.5 1.6 0.2 0.1 0.9 5.9 1.0 4.1 0.8 3.2 9.0 0.7 2.2 0.6 1.1 0.8 0.5 2.3 0.4 0.6 0.5 3.8 1.1 1.6 0.3 0.5 0.3 8.0 7.5 78.4 13.7 8.9 5.5 6.8 9.5 8.1 5.5 0.0 9.0 10.0 24.1 14.5 10.7 18.1 17.8 5.3 4.5 24.4 29.5 5.8 77.9 27.0 64.1 26.4 29.0 0.0 41.4 4.5 11.3 16.9 81.6 82.9 42.3 15.9 9.2 16.5 31.0 107.2 8.6 33.1 28.7 14.4 19.7 13.4 40.7 28.8 9.2 597.4 5.8 12.9 17.6 27.7 18.8 12.3 7.0 15.3 17.4 28.6 MSS51 "FLJ39565, ZMYND17" ENSG00000166343 "MSS51 mitochondrial translational activator" Q4VC12 10 73423579-73433561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "parathyroid gland: 34.4;skeletal muscle: 66.9" "Cell type enhanced" "Detected in some" 7 "Cardiomyocytes: 3.9;granulocytes: 4.7;Leydig cells: 2.8;Paneth cells: 2.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 6 "cerebellum: 2.7" "Cell type enhanced" "Detected in some" "gdT-cell: 1.7;naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA038564 Uncertain Vesicles,Cytosol NA NA Vesicles Cytosol "HPA038564: AB_10674687" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.40e-3)" "unprognostic (2.06e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-3)" "unprognostic (3.05e-3)" "unprognostic (7.88e-3)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (1.50e-4)" "unprognostic (1.22e-1)" "unprognostic (1.78e-7)" "unprognostic (1.51e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-2)" 2.8 0.3 0.4 0.4 0.4 0.3 0.4 2.7 0.4 0.5 0.5 0.4 0.4 0.2 0.6 0.4 0.9 0.6 0.4 3.9 0.4 0.1 0.4 0.4 0.6 0.4 0.4 0.4 1.1 0.5 34.4 0.7 0.4 0.4 0.8 0.3 0.4 2.3 0.4 66.9 0.8 0.8 0.4 0.4 1.4 0.4 0.4 0.4 0.6 0.4 1.2 0.4 0.5 0.6 0.1 0.0 0.0 0.5 0.0 1.7 0.4 1.2 1.3 3.0 4.7 4.2 6.0 2.6 1.5 1.1 0.6 1.3 0.7 1.5 3.8 0.5 1.5 0.2 2.3 1.9 0.4 1.7 1.8 1.5 3.3 2.0 1.1 1.5 2.2 3.1 4.7 1.5 1.3 3.5 4.3 0.6 1.5 1.1 2.0 2.5 0.5 1.9 3.0 0.9 1.0 1.6 1.1 7.8 0.2 1.8 1.9 0.6 1.2 1.0 2.2 1.7 3.2 1.9 1.8 2.7 2.3 1.4 0.9 3.0 1.2 3.4 2.0 1.0 3.8 0.6 0.0 0.4 0.0 1.7 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.3 1.2 0.0 0.0 0.5 0.0 0.0 0.4 0.4 0.4 2.7 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.0 2.2 2.2 0.0 0.5 1.4 3.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.7 0.4 0.0 0.3 0.1 0.5 0.3 4.7 0.0 0.2 0.0 0.0 1.3 0.6 0.0 2.8 0.1 0.0 0.0 0.6 0.9 0.1 2.9 1.4 0.0 1.2 0.0 0.4 0.5 0.2 0.0 0.1 0.7 0.6 0.1 MT-ND3 "MTND3, NAD3, ND3" ENSG00000198840 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3" P03897 MT 10059-10404 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 357.8" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 33020.6;Erythroid cells: 20674.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 644.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063296 Enhanced Uncertain Cytosol NA NA Cytosol "HPA063296: AB_2684978" "unprognostic (1.71e-2)" "unprognostic (1.05e-1)" "unprognostic (8.10e-2)" "unprognostic (3.07e-1)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "prognostic favorable (4.63e-5)" "unprognostic (2.45e-2)" "unprognostic (7.13e-2)" "unprognostic (8.85e-2)" "unprognostic (1.76e-3)" "unprognostic (1.74e-1)" "unprognostic (7.63e-2)" "unprognostic (2.51e-2)" "unprognostic (1.19e-1)" "unprognostic (2.07e-1)" "unprognostic (5.65e-3)" 102.1 73.9 117.3 17.6 137.2 17.9 59.3 33.7 70.5 31.2 76.3 64.0 25.9 49.2 21.7 24.7 19.7 256.8 110.3 81.7 138.1 145.8 19.7 17.4 92.0 27.5 77.8 14.6 22.2 34.6 39.1 59.1 67.6 50.7 357.8 42.2 48.9 28.4 66.8 19.1 60.6 21.0 25.0 20.3 24.2 15.9 84.8 32.6 159.6 48.5 48.6 75.3 24.4 85.5 139.7 93.3 91.5 644.7 129.2 77.7 72.1 42.4 39.1 44.3 210.2 133.3 89.1 111.9 92.5 70.8 178.3 40.1 157.5 67.3 127.7 192.1 87.6 465.1 346.0 100.6 129.0 132.7 223.4 292.0 65.5 73.9 233.9 60.8 102.4 69.0 104.2 73.7 279.5 67.7 172.2 47.9 245.4 129.3 58.7 91.7 82.0 237.9 236.2 38.5 83.7 34.8 69.8 142.5 254.3 161.5 208.4 103.2 60.5 91.9 105.1 77.0 40.5 53.1 192.1 49.1 78.4 34.2 159.6 48.5 36.6 36.7 36.4 49.8 73.1 42.6 44.8 32.6 84.8 63.1 75.3 100.7 48.6 32.7 32.3 27.6 24.4 652.1 738.1 6543.7 1904.3 1765.5 0.0 33020.6 8848.3 2785.1 1856.3 4782.3 0.0 0.0 986.5 1173.3 880.9 872.1 11850.5 20674.5 2500.6 0.0 790.1 1401.0 1375.6 14769.6 0.0 0.0 2746.0 8921.3 11655.5 4356.4 8457.2 1642.1 1763.0 2463.5 12873.7 0.0 1918.1 9893.1 4573.5 7467.5 0.0 6887.9 1962.1 6063.0 3539.9 1651.0 0.0 4305.8 10869.3 1952.0 MTERF3 "CGI-12, FLJ10939, MTERFD1" ENSG00000156469 "Mitochondrial transcription termination factor 3" Q96E29 8 96239398-96261610 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007355 Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA007355: " "unprognostic (4.08e-2)" "unprognostic (1.46e-1)" "unprognostic (4.68e-2)" "unprognostic (2.31e-2)" "unprognostic (3.86e-2)" "unprognostic (6.66e-2)" "unprognostic (2.75e-3)" "unprognostic (3.11e-3)" "unprognostic (6.43e-2)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (8.56e-2)" "prognostic unfavorable (5.88e-5)" "unprognostic (8.67e-3)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (1.74e-3)" 13.8 16.4 14.2 15.9 20.1 9.9 22.9 17.8 18.0 14.8 13.8 12.3 17.4 11.9 15.4 23.8 12.6 13.2 12.9 21.9 17.3 15.3 15.9 22.2 18.5 18.3 18.1 16.0 13.7 14.8 18.9 14.1 16.1 23.7 15.5 14.5 9.8 12.1 17.9 28.8 16.1 11.6 21.9 13.2 16.9 12.8 10.9 13.5 16.0 15.0 14.1 18.1 13.9 12.3 15.3 18.0 18.6 11.6 16.7 17.8 7.8 18.9 12.2 18.4 14.5 13.1 13.6 8.4 14.6 12.0 21.5 21.7 8.7 14.1 17.1 30.9 8.5 10.9 10.7 19.0 11.4 26.2 16.4 13.9 24.4 9.4 10.5 18.5 8.2 10.0 13.6 17.1 17.4 16.4 11.1 17.5 18.4 20.5 9.0 21.5 12.3 34.9 24.3 9.6 33.5 19.1 21.2 15.1 13.3 15.7 10.1 12.6 9.9 10.9 3.2 15.5 12.4 16.5 11.6 7.8 15.1 10.2 17.4 12.9 10.3 12.9 19.9 16.4 22.1 19.7 18.6 10.3 4.3 12.4 11.6 17.8 15.3 14.1 14.0 14.8 13.2 16.1 16.1 1.8 16.7 11.0 18.0 13.3 7.8 14.2 20.1 17.8 18.0 17.3 15.3 18.1 16.0 23.7 13.5 3.0 5.8 10.9 13.1 0.0 0.0 27.8 10.2 9.4 10.3 5.2 0.0 26.6 11.6 10.9 4.4 8.2 0.8 23.3 8.6 17.4 15.8 7.5 5.8 7.3 14.3 0.0 0.0 6.2 4.9 3.1 12.7 6.3 0.0 21.6 3.8 0.0 7.5 3.5 13.1 8.7 0.0 12.9 10.0 24.4 18.8 0.0 14.5 4.4 6.2 9.1 MTFR2 "DUFD1, FAM54A" ENSG00000146410 "Mitochondrial fission regulator 2" Q6P444 6 136231024-136250335 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.2;lymphoid tissue: 16.8;testis: 13.5" "Cell type enhanced" "Detected in many" 10 "Erythroid cells: 23.3;Extravillous trophoblasts: 18.8;Spermatocytes: 11.8;Spermatogonia: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029792, HPA029794" Approved Uncertain Vesicles NA Yes Vesicles "HPA029792: AB_10600210, HPA029794: AB_10600535" "unprognostic (6.49e-3)" "unprognostic (6.29e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (9.64e-4)" "unprognostic (3.93e-1)" "unprognostic (1.75e-2)" "unprognostic (4.60e-6)" "prognostic unfavorable (8.28e-4)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (6.27e-2)" "unprognostic (6.54e-2)" "unprognostic (1.11e-16)" "unprognostic (8.82e-3)" "unprognostic (1.55e-1)" "unprognostic (4.10e-2)" "unprognostic (3.64e-2)" 1.7 0.9 0.6 5.1 1.5 15.2 0.9 0.9 1.1 0.8 2.9 0.8 0.4 2.8 0.7 0.9 4.5 0.5 1.7 1.0 0.6 0.6 2.5 0.7 1.5 6.4 0.8 0.4 0.9 0.7 0.0 0.7 3.2 1.2 0.7 4.1 0.6 1.3 0.4 1.4 1.9 3.2 0.9 1.1 3.8 1.9 13.5 0.4 16.8 0.4 3.2 5.8 1.1 1.4 1.6 3.0 0.1 2.9 0.0 2.6 1.1 7.2 5.6 4.8 9.0 0.8 1.4 8.6 9.6 6.7 11.4 15.9 9.9 5.9 18.8 5.9 3.8 15.1 11.3 10.9 7.1 17.0 10.5 8.4 14.8 4.1 9.0 0.5 27.1 14.0 1.1 1.5 12.6 8.1 1.3 6.1 16.5 15.9 14.6 8.5 9.6 15.2 22.7 4.8 9.7 6.9 14.0 7.7 9.4 4.9 5.6 3.8 3.8 6.0 10.6 5.5 6.2 4.5 18.7 3.3 5.7 5.9 19.9 14.6 5.6 13.1 12.4 3.3 18.5 8.6 0.0 0.6 0.0 1.2 2.9 0.4 1.6 1.6 2.6 3.0 1.3 0.2 1.3 0.1 0.0 2.3 2.2 2.2 1.1 0.6 1.5 0.9 1.1 0.6 0.6 0.8 0.4 1.2 0.4 0.0 0.6 6.2 0.3 0.9 0.0 0.3 0.0 1.4 1.2 0.0 0.0 4.9 0.0 0.8 6.5 0.3 0.9 23.3 2.2 18.8 0.4 0.8 1.1 0.5 5.6 0.0 0.0 1.3 4.3 4.2 0.3 1.8 0.0 2.8 1.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.3 11.8 9.9 0.3 2.5 1.5 1.4 0.9 MTMR7 ENSG00000003987 "Myotubularin related protein 7" Q9Y216 8 17298030-17413528 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8;parathyroid gland: 17.9" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 9.5;Intestinal endocrine cells: 3.5;Late spermatids: 3.1;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 5.4;SCLC-21H: 14.3;SH-SY5Y: 8.3" "Low region specificity" "Detected in all" HPA075682 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA075682: " "unprognostic (1.01e-1)" "unprognostic (6.10e-2)" "unprognostic (1.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (1.31e-2)" "unprognostic (4.15e-2)" "unprognostic (1.41e-2)" "unprognostic (1.92e-1)" "unprognostic (2.45e-1)" "unprognostic (2.07e-4)" "unprognostic (1.46e-2)" "unprognostic (1.97e-7)" "unprognostic (1.12e-1)" "unprognostic (1.42e-1)" "unprognostic (4.17e-2)" "unprognostic (2.66e-3)" 1.4 4.9 10.9 1.9 16.7 3.4 0.9 16.2 25.8 1.2 1.3 16.0 0.0 2.0 1.8 0.8 1.5 1.5 1.6 1.7 7.5 7.8 2.4 2.2 1.4 1.7 9.2 9.5 3.5 2.6 17.9 10.3 1.8 19.5 1.2 1.3 4.7 1.4 1.1 2.1 2.6 1.9 1.1 11.2 1.4 1.8 2.9 9.4 0.0 6.5 0.0 0.8 1.4 0.7 0.7 0.2 0.8 0.2 0.3 1.4 0.1 0.8 0.7 1.2 1.0 0.0 0.0 0.9 1.8 0.0 0.0 0.0 0.9 0.2 0.9 0.5 0.0 0.8 0.4 4.1 0.1 0.0 0.1 3.0 1.2 1.6 0.5 1.0 0.7 0.9 0.2 0.0 0.1 0.0 0.8 0.2 0.4 0.6 0.7 0.0 0.6 1.3 1.7 5.4 0.7 0.6 0.4 1.8 0.5 0.0 3.4 14.3 8.3 0.6 0.8 0.9 2.0 0.4 0.9 1.5 0.9 0.5 2.0 1.1 0.4 0.4 0.7 2.6 1.3 0.7 0.0 0.1 0.7 0.2 0.2 0.1 0.7 0.1 0.2 0.1 0.0 0.5 0.3 0.8 0.3 0.2 0.2 1.4 0.1 10.9 16.7 16.2 15.2 7.5 7.8 9.2 9.5 19.5 9.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 9.5 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.5 0.5 0.6 1.6 0.1 1.1 0.0 0.0 0.0 MTRR cblE ENSG00000124275 "5-methyltetrahydrofolate-homocysteine methyltransferase reductase" Q9UBK8 5 7851186-7906025 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 57.4;Late spermatids: 61.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038113 Supported Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA038113: AB_10671520" "unprognostic (1.06e-1)" "unprognostic (1.08e-1)" "unprognostic (5.32e-2)" "unprognostic (1.17e-2)" "unprognostic (1.63e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (6.60e-4)" "unprognostic (2.56e-2)" "unprognostic (5.82e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (9.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" 12.2 12.3 11.2 10.5 13.8 5.4 9.7 15.6 14.3 10.8 10.4 24.1 11.5 10.3 17.3 15.9 10.5 11.3 13.3 15.8 14.2 12.9 22.0 23.9 14.9 11.4 18.1 9.6 13.6 13.6 9.4 13.1 11.6 16.6 10.8 11.9 13.6 11.3 7.4 34.6 10.5 11.5 14.2 22.1 9.3 9.2 8.4 12.5 8.1 14.7 9.9 13.5 13.6 8.8 4.6 4.8 4.6 6.8 3.4 11.4 4.2 9.4 8.9 4.7 10.5 18.2 5.9 13.5 14.7 8.7 7.3 8.4 13.4 7.6 15.9 14.1 11.8 14.0 6.1 7.3 7.2 13.9 10.1 8.2 7.6 31.0 7.1 11.1 11.6 3.3 9.5 6.6 12.4 9.1 10.4 4.7 4.1 9.9 12.1 4.3 1.8 7.4 5.9 3.6 14.0 9.9 6.1 5.1 6.7 7.9 7.4 7.4 1.0 25.8 18.8 16.2 9.7 5.8 9.0 7.3 17.1 10.8 13.1 11.5 18.0 5.9 13.1 12.4 25.6 9.1 4.6 5.1 4.1 5.5 6.8 9.5 4.6 9.2 7.9 4.8 4.1 5.4 5.1 0.1 3.4 5.4 2.7 11.4 4.2 11.2 13.8 15.6 14.3 14.2 12.9 18.1 9.6 16.6 12.5 14.9 57.4 8.2 7.5 14.4 0.0 10.1 2.5 9.4 11.4 8.7 0.0 8.3 18.3 8.0 40.0 7.0 8.5 0.0 4.9 7.5 10.2 9.9 10.3 16.6 6.7 0.0 9.2 10.4 12.5 61.7 9.8 8.7 1.7 5.4 9.6 0.0 5.8 7.0 11.0 23.3 0.0 6.5 13.3 16.9 11.9 18.1 9.4 12.9 8.9 7.0 MTTP "ABL, MTP" ENSG00000138823 "Microsomal triglyceride transfer protein" P55157 4 99563761-99623999 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "Lipid transport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 49 "intestine: 211.4;liver: 60.8" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 201.1" "Cancer enriched" "Detected in many" 13 "liver cancer: 28.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Lineage enriched" "Detected in single" 10 "B-cells: 1.0" "Group enriched" "Detected in some" 6 "AF22: 12.8;Hep G2: 14.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA051170, HPA054862" Uncertain Uncertain Cytosol "Intracellular and membrane" NA NA 450000 Cytosol "HPA051170: , HPA054862: AB_2682628" "unprognostic (1.66e-2)" "unprognostic (1.14e-1)" "unprognostic (5.64e-2)" "unprognostic (5.33e-2)" "unprognostic (3.49e-3)" "unprognostic (7.38e-2)" "unprognostic (1.05e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (3.66e-2)" "unprognostic (1.00e-2)" "unprognostic (1.62e-1)" "unprognostic (1.27e-3)" "unprognostic (2.02e-2)" "unprognostic (3.64e-1)" "unprognostic (1.53e-2)" "unprognostic (1.31e-1)" 0.1 0.1 0.3 0.0 0.3 0.0 0.1 0.1 0.2 0.0 53.2 0.2 0.1 53.4 0.0 0.0 0.2 0.2 0.4 0.4 0.3 0.4 2.7 60.8 0.1 0.0 0.4 0.1 1.1 0.1 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 211.4 0.7 0.4 0.1 0.2 1.8 0.2 0.1 0.1 0.1 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.8 0.0 0.0 0.1 1.1 0.1 0.0 0.0 0.3 0.5 0.0 0.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 2.3 0.2 0.3 0.1 14.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.7 0.6 0.0 0.3 0.3 0.2 1.3 0.0 0.0 0.8 1.0 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.3 0.4 0.4 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 7.6 0.0 0.0 1.8 0.0 0.1 0.0 0.0 25.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 201.1 0.1 0.0 0.0 5.5 3.3 7.9 0.9 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.4 18.6 0.0 6.5 0.0 21.9 1.5 0.0 0.0 0.0 0.0 0.0 MTX2 ENSG00000128654 "Metaxin 2" O75431 2 176269395-176338025 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 170.8;Spermatocytes: 167.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031550, HPA031551, HPA031552" Approved Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoli "HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616" "unprognostic (2.61e-1)" "unprognostic (9.86e-2)" "unprognostic (6.54e-2)" "prognostic unfavorable (5.06e-4)" "unprognostic (1.92e-2)" "unprognostic (1.62e-2)" "unprognostic (1.05e-2)" "unprognostic (1.29e-1)" "unprognostic (2.87e-2)" "unprognostic (3.97e-2)" "unprognostic (1.80e-2)" "unprognostic (8.30e-2)" "unprognostic (1.22e-1)" "unprognostic (2.03e-1)" "unprognostic (9.92e-2)" "unprognostic (3.15e-2)" "unprognostic (1.33e-2)" 13.2 26.4 21.3 12.0 22.3 5.5 18.8 15.0 44.9 13.0 20.7 18.5 16.6 15.4 15.5 27.9 22.2 20.0 12.0 33.6 23.6 26.3 31.5 20.2 10.6 8.9 21.5 16.5 13.2 16.4 23.7 25.7 17.3 21.8 18.9 24.6 16.3 24.7 16.5 45.0 12.5 14.8 17.6 25.7 9.4 14.6 40.6 14.0 10.2 14.7 19.8 13.6 14.4 13.6 16.2 12.1 4.7 12.6 15.1 13.4 7.9 17.5 10.4 21.2 13.0 14.3 16.5 20.4 18.9 17.7 17.4 20.3 17.9 19.2 22.5 32.1 16.7 28.1 11.8 23.1 23.3 24.0 22.3 16.6 21.4 13.1 31.5 22.6 33.1 7.2 18.4 29.1 18.2 31.4 21.3 24.7 22.0 28.4 17.5 20.4 16.0 11.6 33.7 20.2 34.4 16.5 0.0 15.4 20.0 49.2 31.9 30.3 26.0 15.8 21.1 39.0 42.7 11.7 21.6 21.7 17.4 15.4 18.2 19.7 19.6 20.4 26.9 21.6 16.7 21.0 4.7 7.7 3.2 8.5 12.6 11.5 16.2 10.9 9.6 12.1 11.4 13.2 13.4 0.0 15.1 10.9 9.8 13.4 7.9 21.3 22.3 15.0 44.9 23.6 26.3 21.5 16.5 21.8 14.0 17.9 16.9 20.4 33.1 27.6 0.0 60.5 28.1 33.5 20.5 54.1 0.0 65.7 170.8 45.6 18.6 25.5 29.0 0.0 34.6 53.9 27.4 37.9 42.7 32.0 41.3 0.0 39.9 12.3 17.8 12.3 32.8 24.8 33.7 34.3 41.6 0.0 41.1 17.5 30.8 83.3 0.0 38.8 36.0 167.0 118.7 36.6 54.3 16.2 51.9 46.0 MUM1 "EXPAND1, MUM-1" ENSG00000160953 "Melanoma associated antigen (mutated) 1" Q2TAK8 19 1354711-1378431 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 192.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048063 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA048063: AB_2680243" "unprognostic (2.50e-2)" "unprognostic (4.67e-1)" "unprognostic (1.72e-1)" "prognostic favorable (4.82e-4)" "unprognostic (1.14e-1)" "unprognostic (4.21e-3)" "unprognostic (4.84e-2)" "unprognostic (2.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.24e-2)" "prognostic favorable (2.25e-6)" "unprognostic (1.60e-1)" "unprognostic (6.05e-3)" "unprognostic (5.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-1)" "unprognostic (7.29e-3)" 6.7 5.3 14.4 3.6 20.9 2.1 5.6 21.9 19.2 7.0 5.8 13.6 4.5 3.7 10.4 5.6 4.3 13.0 5.4 5.3 13.6 9.1 4.9 8.3 6.8 3.6 14.2 11.5 18.4 4.0 7.7 7.5 6.0 11.5 6.7 4.8 5.8 6.7 8.7 5.5 8.1 4.8 11.5 10.5 6.0 4.8 19.9 13.1 1.9 6.0 0.9 4.5 5.6 11.5 4.3 3.9 11.8 2.6 3.8 4.5 1.3 7.2 9.3 13.0 13.8 10.6 14.1 15.9 12.6 7.9 11.6 8.6 6.4 4.8 14.7 5.9 16.2 4.1 8.2 13.1 8.2 8.8 15.8 8.3 7.9 9.5 9.6 10.2 6.1 17.8 9.2 5.1 6.5 4.7 14.9 11.8 9.9 12.2 7.4 11.0 8.1 10.4 6.5 14.7 8.1 5.3 16.8 10.9 6.1 7.7 10.5 9.4 21.5 11.1 13.1 8.4 11.8 6.4 14.0 11.3 10.5 14.6 8.5 11.6 15.0 12.6 6.7 14.0 9.9 14.2 11.8 1.1 6.8 4.5 2.6 3.8 3.9 2.5 3.3 2.1 4.3 3.7 4.0 2.2 3.8 2.2 3.9 1.6 1.3 14.4 20.9 21.9 19.2 13.6 9.1 14.2 11.5 11.5 13.1 32.8 18.3 29.6 30.8 15.0 192.5 23.6 48.4 30.8 14.8 17.4 133.5 16.7 10.0 30.8 84.4 21.8 35.5 0.0 19.1 20.1 33.2 18.7 32.4 72.0 15.3 151.0 36.8 28.8 14.8 101.3 53.8 14.7 28.7 20.8 26.2 51.9 24.8 28.3 53.0 11.0 82.1 116.4 31.5 168.6 74.1 12.9 11.9 20.8 29.5 16.6 MXD1 "bHLHc58, MAD, MAD1" ENSG00000059728 "MAX dimerization protein 1" Q05195 2 69897688-69942945 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.1;bone marrow: 72.8;esophagus: 64.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 212.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 81.1" "Lineage enriched" "Detected in many" 49 "granulocytes: 81.1" "Cell line enhanced" "Detected in many" "hTERT-HME1: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001599 Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA001599: AB_1079434" "unprognostic (1.59e-1)" "unprognostic (5.11e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (8.14e-6)" "unprognostic (1.49e-1)" "unprognostic (1.76e-1)" "unprognostic (4.36e-2)" "unprognostic (8.73e-3)" "unprognostic (3.39e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (8.50e-4)" "unprognostic (8.72e-2)" "unprognostic (3.24e-2)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (1.56e-3)" "unprognostic (1.77e-2)" 6.9 2.2 2.7 18.7 3.8 72.8 3.7 5.7 4.1 15.8 19.6 4.7 0.9 13.6 2.9 2.6 64.8 3.8 4.9 10.8 3.0 2.9 3.0 5.5 17.0 14.3 5.9 2.4 3.3 2.5 3.6 4.0 15.8 3.1 3.3 14.0 5.1 8.8 1.4 3.1 5.9 50.2 4.6 4.3 15.8 8.2 3.6 3.7 9.4 4.0 20.8 34.0 6.3 21.6 0.2 0.8 81.1 1.6 0.4 0.4 0.6 3.5 1.5 2.2 1.6 5.0 2.5 8.4 3.9 2.2 1.9 1.3 4.9 2.8 2.0 2.0 1.5 1.9 12.6 4.2 7.8 2.0 1.1 5.1 4.2 4.5 4.9 16.8 5.0 4.2 2.8 13.3 4.4 20.4 2.4 2.4 2.1 7.3 8.1 1.2 2.8 2.4 10.1 0.6 5.2 2.5 1.1 2.3 5.0 2.5 4.2 7.3 3.1 5.2 7.0 2.7 2.7 1.0 3.0 9.6 2.8 0.8 3.0 3.7 5.5 9.3 0.8 2.9 8.9 1.0 17.0 1.6 16.8 0.3 1.0 0.4 0.1 0.2 0.2 0.8 0.2 0.2 0.3 81.1 0.4 0.8 0.2 0.2 0.6 2.7 3.8 5.7 4.1 3.0 2.9 5.9 2.4 3.1 3.7 35.7 30.8 18.2 23.9 22.9 27.8 4.8 7.6 10.7 11.4 1.8 51.1 7.9 6.6 10.8 12.4 9.0 212.1 0.0 14.8 5.1 13.6 61.3 26.5 6.7 26.9 9.5 93.4 6.2 48.3 15.3 4.4 71.5 15.1 20.8 115.5 40.4 44.4 91.2 2.5 5.1 17.8 0.0 28.7 8.1 2.0 49.3 88.6 20.8 26.6 110.0 MXRA5 DKFZp564I1922 ENSG00000101825 "Matrix remodeling associated 5" Q9NR99 X 3308565-3346641 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 49.4;pancreas: 46.6" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 34.2;Collecting duct cells: 29.6;Exocrine glandular cells: 53.2;Pancreatic endocrine cells: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 12.8;BJ hTERT+: 49.0;fHDF/TERT166: 23.0;HaCaT: 20.3;HSkMC: 9.9" "HPA000508, HPA076518" Uncertain Uncertain Mitochondria "Secreted - unknown location" NA NA 1700000 Mitochondria "HPA000508: AB_2147995, HPA076518: " "unprognostic (7.51e-2)" "unprognostic (6.45e-2)" "unprognostic (8.00e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (7.05e-2)" "unprognostic (7.25e-2)" "unprognostic (1.35e-2)" "unprognostic (1.13e-1)" "unprognostic (2.53e-2)" "unprognostic (6.32e-3)" "unprognostic (1.38e-1)" "unprognostic (1.65e-2)" "unprognostic (1.58e-1)" "unprognostic (1.90e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.94e-4)" 6.5 12.1 0.5 10.4 1.2 0.0 7.5 0.4 0.8 49.4 4.4 0.6 18.8 2.1 11.4 6.0 8.7 4.2 5.8 9.2 0.6 0.5 8.0 4.5 5.9 0.9 0.6 0.7 7.9 46.6 0.5 1.4 7.9 0.8 11.0 5.9 10.2 11.5 29.5 1.1 16.6 7.8 8.8 0.5 7.7 5.1 4.0 0.3 5.7 15.0 11.7 6.2 12.7 9.6 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 12.8 0.0 7.6 49.0 0.0 0.0 0.0 0.2 0.0 0.6 23.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 2.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.4 0.8 0.6 0.5 0.6 0.7 0.8 0.3 0.0 0.0 0.0 3.9 34.2 0.0 1.6 0.0 1.4 5.7 29.6 0.0 0.0 0.0 1.7 0.0 2.2 0.0 0.0 53.2 0.2 19.5 0.1 0.0 0.0 0.3 0.0 0.0 17.2 0.8 0.0 0.0 0.0 16.9 1.0 0.0 0.0 47.4 0.0 1.4 0.0 0.1 0.0 9.2 0.0 0.0 19.1 0.2 0.0 0.0 1.4 MYBBP1A "FLJ37886, P160, PAP2, Pol5" ENSG00000132382 "MYB binding protein 1a" Q9BQG0 17 4538897-4555631 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005466 Supported Supported Nucleoli,Vesicles No No Nucleoli Vesicles "HPA005466: AB_2667327" "unprognostic (8.06e-2)" "unprognostic (2.33e-1)" "unprognostic (1.71e-1)" "unprognostic (9.01e-2)" "unprognostic (7.81e-2)" "unprognostic (1.29e-1)" "unprognostic (1.57e-3)" "unprognostic (2.22e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.84e-1)" "prognostic favorable (1.61e-4)" "unprognostic (3.88e-3)" "prognostic unfavorable (5.95e-4)" "unprognostic (1.78e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (8.12e-4)" "unprognostic (9.70e-2)" 14.1 11.6 13.8 16.5 14.6 13.2 16.2 15.0 21.5 11.3 10.2 14.9 11.1 12.9 15.4 11.7 17.1 15.8 12.4 11.5 11.7 9.2 8.7 21.5 11.6 16.0 15.2 11.1 15.3 23.7 10.5 13.1 7.2 13.0 17.0 7.2 12.7 24.5 15.3 30.8 25.0 12.8 10.9 7.3 15.0 12.9 9.3 12.6 14.6 11.7 18.2 17.6 15.4 13.2 5.3 4.9 0.4 4.9 4.3 5.9 3.8 19.5 31.3 4.1 18.8 5.3 6.2 14.0 13.6 6.0 13.7 10.6 23.0 8.0 26.7 15.8 8.0 6.8 24.7 17.0 20.4 6.4 13.3 45.9 12.8 19.3 20.4 8.6 15.0 11.7 9.0 11.7 20.1 10.0 3.7 9.1 15.4 20.9 12.3 5.8 16.9 17.5 5.9 18.8 6.1 16.4 22.7 6.9 17.7 3.2 15.7 8.7 16.7 13.9 9.7 9.2 2.7 9.3 6.1 11.7 11.9 10.7 11.1 38.8 11.1 7.5 10.9 11.3 17.6 15.3 0.0 2.8 0.4 5.1 2.7 5.9 5.3 4.2 5.5 4.9 3.3 4.5 4.6 0.1 4.3 4.9 3.5 1.8 3.8 13.8 14.6 15.0 21.5 11.7 9.2 15.2 11.1 13.0 12.6 8.9 16.4 12.7 5.2 11.4 7.6 3.6 15.3 10.7 19.4 3.5 11.8 2.6 0.0 8.1 0.4 10.8 5.9 0.0 10.7 4.1 5.9 5.4 4.7 6.6 5.7 9.5 10.9 8.6 3.4 0.4 5.2 5.0 3.3 3.6 8.1 3.5 7.2 3.5 11.3 2.2 5.7 6.5 10.3 2.6 12.0 10.5 0.9 6.9 10.3 5.1 MYCBP2 "FLJ10106, KIAA0916, PAM" ENSG00000005810 "MYC binding protein 2, E3 ubiquitin protein ligase" O75592 13 77044655-77327050 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Guanine-nucleotide releasing factor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 40.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058807 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA058807: AB_2732627" "unprognostic (1.79e-1)" "unprognostic (1.25e-1)" "unprognostic (1.60e-1)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-2)" "unprognostic (8.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-1)" "unprognostic (1.48e-1)" "unprognostic (6.42e-2)" "prognostic favorable (5.01e-5)" "unprognostic (2.63e-1)" "unprognostic (9.84e-2)" "unprognostic (4.04e-2)" "unprognostic (1.00e-1)" 28.0 13.4 31.0 26.1 28.8 24.1 22.4 31.3 32.7 15.5 10.9 8.1 11.5 8.0 16.2 26.7 18.9 11.7 11.1 13.5 24.1 18.6 12.3 13.2 12.4 29.8 15.3 31.1 22.8 12.6 14.5 17.2 9.6 20.0 17.9 11.5 9.6 12.9 12.4 13.7 57.6 13.6 13.2 14.0 24.1 10.3 14.1 16.2 18.6 11.6 12.6 30.7 13.3 34.0 8.3 4.6 3.3 3.7 4.2 7.3 2.5 7.8 4.0 4.9 5.3 24.5 10.9 2.8 5.0 7.4 4.4 5.7 3.5 4.1 22.5 3.2 9.8 4.3 7.3 8.4 9.2 6.0 8.9 8.3 19.1 8.2 7.3 8.3 40.0 6.8 12.2 7.7 4.0 8.0 4.3 9.9 8.3 4.0 7.1 7.8 4.7 10.9 27.0 2.6 10.5 5.1 12.5 5.0 5.4 7.4 7.8 7.7 3.6 6.0 8.7 4.5 5.2 3.2 30.7 13.0 4.2 3.5 2.7 4.8 7.7 5.3 16.1 8.5 33.0 4.2 2.0 3.5 3.2 5.8 3.7 5.1 7.9 6.5 5.0 3.2 8.3 7.3 5.8 3.3 4.2 2.5 4.6 7.3 2.5 31.0 28.8 31.3 32.7 24.1 18.6 15.3 31.1 20.0 16.2 35.7 43.3 79.8 35.8 73.2 212.4 65.7 30.6 17.4 26.1 33.2 98.2 33.8 1.7 22.3 46.1 82.8 12.8 23.3 28.6 26.5 62.0 42.9 47.3 46.5 37.4 206.6 31.4 39.3 93.9 20.0 60.9 48.5 30.4 37.9 18.1 141.3 26.4 17.5 90.5 11.2 95.1 103.5 74.0 61.5 64.3 131.7 36.7 68.3 24.7 36.1 MYCT1 "FLJ21269, MTLC" ENSG00000120279 "MYC target 1" Q8N699 6 152697895-152724567 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endothelial cells: 121.1;Ito cells: 178.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 39 "eosinophil: 20.4" "Lineage enriched" "Detected in single" 190 "granulocytes: 20.4" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 46.9;TIME: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047992 Approved Nucleoplasm,Vesicles NA NA 69000 Nucleoplasm Vesicles "HPA047992: " "unprognostic (2.92e-1)" "unprognostic (1.82e-1)" "unprognostic (5.95e-2)" "unprognostic (2.06e-1)" "unprognostic (6.73e-2)" "unprognostic (6.80e-2)" "unprognostic (4.64e-3)" "unprognostic (6.78e-2)" "unprognostic (9.90e-2)" "unprognostic (2.10e-1)" "unprognostic (2.66e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.26e-3)" "unprognostic (1.08e-1)" "unprognostic (1.25e-1)" "unprognostic (3.36e-2)" 37.3 3.1 4.1 4.4 6.3 1.1 27.5 3.0 7.7 16.2 8.4 1.5 5.2 3.1 14.5 9.4 14.4 6.8 9.1 17.2 5.1 4.2 6.9 11.1 24.1 4.9 5.8 1.9 8.2 2.5 3.4 2.7 17.4 6.6 8.8 5.3 8.3 4.0 3.7 14.2 4.8 5.5 10.8 5.4 39.4 4.6 7.7 5.2 0.6 12.5 11.0 2.8 17.0 12.3 0.1 0.0 20.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.8 0.1 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 38.8 0.2 0.3 0.5 0.0 0.4 0.0 5.8 0.0 0.0 0.0 0.4 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 4.1 6.3 3.0 7.7 5.1 4.2 5.8 1.9 6.6 5.2 0.0 6.9 0.0 0.1 6.4 0.0 2.8 5.1 29.4 1.2 0.0 0.0 0.0 0.0 0.1 6.0 121.1 0.0 0.0 0.2 0.0 2.4 0.4 1.1 1.0 0.1 0.0 0.0 178.6 9.1 2.9 0.3 0.8 13.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.1 4.8 0.0 0.0 0.0 0.2 MYL10 "MGC3479, MYLC2PL, PLRLC" ENSG00000106436 "Myosin light chain 10" Q9BUA6 7 101613325-101629296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 4.5;skeletal muscle: 9.1" "Cell type enhanced" "Detected in some" 26 "Cardiomyocytes: 1.4;Peritubular cells: 2.5" "Cancer enhanced" "Detected in single" "melanoma: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "PC-3: 12.3;RH-30: 7.1;SuSa: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA019763 Uncertain Uncertain Microtubules NA NA Microtubules "HPA019763: AB_1854243" "unprognostic (2.32e-2)" "unprognostic (3.09e-1)" "unprognostic (1.11e-1)" "unprognostic (1.74e-2)" "unprognostic (2.78e-3)" "unprognostic (5.04e-3)" "unprognostic (8.93e-2)" "unprognostic (1.10e-2)" 0.2 0.1 0.2 0.2 0.2 1.5 0.2 0.2 0.3 1.9 0.2 0.2 0.2 0.1 0.9 0.4 0.2 0.4 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 2.7 2.0 0.2 2.9 0.9 0.2 0.3 0.2 9.1 1.1 0.2 0.2 0.2 0.2 0.1 0.9 0.2 0.2 0.2 2.9 0.6 1.0 0.2 1.4 1.0 4.5 0.9 1.4 1.3 0.2 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.9 0.0 0.3 0.1 0.5 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.2 0.1 0.0 0.1 0.2 0.2 0.8 0.1 0.1 0.5 0.2 0.2 0.1 0.1 0.1 0.1 0.5 0.0 0.2 0.3 0.0 12.3 0.0 7.1 0.0 0.1 0.5 0.2 0.0 0.1 0.1 1.2 3.7 0.2 0.1 0.3 0.6 1.3 0.0 0.2 0.4 0.2 1.2 0.1 0.3 0.0 4.5 0.9 0.8 0.4 0.5 0.4 0.9 0.6 0.8 0.3 1.4 0.9 0.7 3.4 1.4 0.5 1.0 1.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYL2 CMH10 ENSG00000111245 "Myosin light chain 2" P10916 12 110910819-110920722 "Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "heart muscle: 656.7;skeletal muscle: 672.9" "Cell type enriched" "Detected in some" 10238 "Cardiomyocytes: 17552.7" "Group enriched" "Detected in some" 46 "head and neck cancer: 31.5;prostate cancer: 25.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 31 "memory B-cell: 3.8;naive B-cell: 2.4" "Lineage enriched" "Detected in single" 38 "B-cells: 3.8" "Cell line enhanced" "Detected in some" "EFO-21: 4.3;HSkMC: 9.4;U-2 OS: 18.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019763, HPA039262" Supported Uncertain Microtubules NA NA 190000 Microtubules "HPA019763: AB_1854243, HPA039262: AB_2676418" "unprognostic (2.07e-2)" "unprognostic (1.37e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.32e-1)" "unprognostic (4.05e-2)" "unprognostic (4.82e-2)" "unprognostic (2.05e-2)" "unprognostic (2.20e-1)" "unprognostic (1.76e-1)" "unprognostic (2.84e-1)" "unprognostic (3.55e-1)" 3.6 0.0 0.1 0.1 0.1 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 6.4 8.9 0.0 0.2 656.7 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 6.1 0.0 0.0 7.7 0.0 672.9 0.1 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.0 2.4 59.4 10.5 0.3 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 4.3 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.4 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.1 0.0 0.0 1.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 17552.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 MYL5 ENSG00000215375 "Myosin light chain 5" Q02045 4 673580-682033 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 61.5" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 71.2;Rod photoreceptor cells: 78.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 34.0;ASC TERT1: 23.4" "Low region specificity" "Detected in many" "HPA037381, HPA039262" Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037381: AB_10672484, HPA039262: AB_2676418" "unprognostic (6.30e-3)" "unprognostic (1.42e-2)" "unprognostic (5.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.53e-2)" "unprognostic (1.33e-1)" "unprognostic (4.77e-3)" "unprognostic (2.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.61e-3)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (2.95e-2)" "unprognostic (3.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.91e-2)" 9.9 11.4 14.5 10.1 12.7 8.5 12.6 13.4 14.6 6.1 10.9 14.7 14.6 18.0 7.1 19.5 10.6 7.1 8.0 4.9 13.9 11.4 9.7 11.3 7.8 19.5 10.8 10.0 7.5 15.4 13.2 7.7 5.3 10.5 9.8 11.8 10.0 61.5 10.7 18.6 16.2 15.4 10.1 9.3 8.8 7.3 15.5 3.9 7.5 7.5 24.2 9.9 6.5 6.9 11.0 12.6 8.2 9.5 15.4 6.5 4.5 2.2 3.7 13.6 7.2 34.0 23.4 6.5 5.5 7.4 5.6 5.2 4.5 9.6 2.6 2.6 8.9 4.0 3.3 2.1 3.7 1.6 4.8 2.7 3.9 5.1 4.1 11.9 5.9 3.6 17.6 3.6 4.4 4.7 8.2 3.4 5.6 4.0 3.5 6.9 4.2 3.1 4.1 2.8 4.7 5.7 2.8 2.9 1.5 9.2 10.6 6.2 3.5 1.8 4.6 3.7 4.6 7.4 5.4 5.6 4.8 0.9 4.1 3.1 13.6 2.6 1.6 5.3 5.3 2.4 8.2 7.4 1.1 3.1 4.7 3.9 7.9 5.1 1.8 6.6 11.0 6.5 6.3 5.0 15.4 9.5 12.6 2.3 4.5 14.5 12.7 13.4 14.6 13.9 11.4 10.8 10.0 10.5 3.9 0.0 11.0 9.5 6.0 10.6 5.7 1.2 7.6 6.7 2.3 7.0 19.6 5.7 10.0 8.8 16.6 4.5 31.5 0.0 4.0 4.3 6.6 7.4 12.8 14.9 18.5 11.1 5.2 9.2 16.2 71.2 6.6 7.5 6.8 20.8 8.8 16.6 6.2 10.5 3.5 30.0 78.4 6.5 5.0 14.4 3.1 11.7 4.6 6.1 13.3 8.9 MYO10 KIAA0799 ENSG00000145555 "Myosin X" Q9HD67 5 16661914-16936276 "Plasma proteins, Predicted intracellular proteins" Transport "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Muller glia cells: 290.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 6.0" "Lineage enriched" "Detected in many" 5 "monocytes: 6.0" "Cell line enhanced" "Detected in many" "HAP1: 39.5;SK-MEL-30: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015224, HPA024223" Enhanced Supported "Nucleoli rim,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli rim" "CAB015224: , HPA024223: AB_1854248" "unprognostic (1.13e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (7.63e-2)" "unprognostic (1.04e-1)" "unprognostic (4.43e-2)" "unprognostic (2.96e-2)" "unprognostic (4.40e-2)" "unprognostic (8.34e-2)" "unprognostic (2.51e-2)" "unprognostic (3.16e-2)" "unprognostic (8.42e-2)" "unprognostic (1.85e-1)" "prognostic favorable (2.75e-4)" "unprognostic (8.93e-2)" "unprognostic (9.86e-2)" "unprognostic (4.56e-2)" "unprognostic (1.84e-1)" 10.5 3.4 28.1 5.1 30.1 3.0 8.0 8.9 39.7 6.3 15.3 17.3 6.6 19.5 5.7 4.3 7.7 3.8 7.7 3.7 26.2 10.9 13.3 7.1 14.5 1.6 14.6 15.3 12.1 22.0 10.4 16.2 22.0 10.6 5.4 15.8 19.7 9.8 7.4 6.6 13.4 14.6 4.3 11.1 10.9 24.2 12.4 18.5 0.5 28.6 3.3 2.3 6.6 7.1 0.9 0.5 1.1 6.0 0.5 0.6 0.3 13.4 21.3 8.9 4.2 6.6 3.6 8.2 24.1 17.0 6.7 5.5 13.5 2.2 0.4 16.5 10.9 9.0 7.1 39.5 15.8 12.5 0.0 3.9 0.0 35.6 3.7 24.0 0.1 0.4 7.3 6.9 16.2 19.4 13.0 22.4 0.0 0.0 1.3 6.5 2.6 0.1 0.1 22.9 14.0 7.7 5.4 2.2 14.2 6.8 10.4 1.2 0.6 5.2 2.7 46.2 14.0 1.7 2.2 27.1 16.3 6.0 0.2 13.2 0.2 0.1 0.1 8.0 2.5 16.2 1.0 0.6 0.5 0.3 1.5 0.4 0.3 0.4 0.3 0.5 0.9 0.6 0.6 1.1 0.5 6.0 0.4 0.3 0.3 28.1 30.1 8.9 20.7 26.2 10.9 14.6 15.3 10.6 18.5 32.8 31.7 1.4 29.1 36.4 7.9 2.8 30.6 21.4 28.4 29.6 17.7 18.9 14.9 93.1 19.9 41.2 28.6 0.0 35.5 49.8 11.5 32.7 26.6 0.8 4.8 77.9 71.0 93.3 9.4 6.5 11.8 4.4 64.1 5.4 48.0 290.6 80.7 37.4 18.0 3.6 6.4 64.7 26.7 1.4 6.4 27.9 123.6 2.5 57.5 32.3 MYO1G HA-2 ENSG00000136286 "Myosin IG" B0I1T2 7 44962662-44979098 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.9;bone marrow: 27.4;lymphoid tissue: 46.8" "Cell type enriched" "Detected in many" 7 "monocytes: 573.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 20.2;HEL: 24.5;HL-60: 14.0;JURKAT: 30.5;MOLT-4: 31.0;NB-4: 13.1;THP-1: 27.5;U-937: 20.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA021252 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 120000 "Plasma membrane" Nucleoplasm "HPA021252: AB_1854254" "unprognostic (2.74e-2)" "prognostic favorable (8.26e-4)" "unprognostic (5.20e-3)" "unprognostic (9.91e-3)" "unprognostic (1.27e-2)" "unprognostic (1.27e-3)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (4.54e-3)" "unprognostic (6.47e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "prognostic unfavorable (8.71e-8)" "unprognostic (3.20e-1)" "unprognostic (2.04e-1)" "unprognostic (1.85e-1)" "unprognostic (7.92e-2)" 2.5 1.2 1.6 11.0 3.0 27.4 1.5 0.4 2.0 1.0 1.9 0.7 0.0 1.8 1.2 2.1 2.4 1.9 3.6 3.2 1.0 0.9 1.9 1.9 13.0 18.6 4.5 0.0 0.9 0.8 0.0 0.9 1.5 2.7 1.5 1.1 1.5 5.8 0.5 0.6 1.2 8.3 1.9 2.6 22.3 2.1 0.9 1.8 46.8 2.1 2.2 26.6 4.7 1.3 9.9 14.0 9.4 37.9 6.7 24.4 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 24.5 0.8 0.0 0.0 14.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 30.5 0.0 0.0 0.0 0.0 31.0 13.1 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 20.2 0.0 9.4 17.0 5.2 19.9 29.6 12.6 9.9 12.7 17.4 14.0 6.6 4.6 9.0 1.7 6.7 37.9 1.2 24.4 19.3 1.6 3.0 0.4 2.0 1.0 0.9 4.5 0.0 2.7 1.8 3.0 11.4 56.6 0.3 2.5 0.0 1.1 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.1 0.3 0.6 0.0 0.0 0.9 0.2 1.7 0.4 30.0 0.9 10.8 3.2 0.0 2.5 71.9 1.2 0.0 51.5 3.3 573.5 0.0 0.2 0.2 0.0 0.4 0.3 0.0 6.5 1.6 0.4 0.2 1.5 0.1 86.3 0.0 0.1 N4BP2L1 CG018 ENSG00000139597 "NEDD4 binding protein 2 like 1" Q5TBK1 13 32400723-32428311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "monocytes: 143.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 13.1;JURKAT: 12.5;NB-4: 33.0" "Low region specificity" "Detected in all" HPA038971 Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038971: AB_10673408" "unprognostic (2.66e-3)" "unprognostic (2.38e-3)" "unprognostic (3.63e-2)" "unprognostic (5.32e-2)" "unprognostic (5.09e-2)" "unprognostic (3.40e-2)" "prognostic favorable (3.11e-4)" "unprognostic (6.91e-3)" "unprognostic (2.30e-1)" "unprognostic (9.37e-2)" "unprognostic (2.30e-2)" "unprognostic (1.20e-3)" "unprognostic (4.56e-2)" "unprognostic (1.04e-1)" "unprognostic (2.30e-1)" "unprognostic (3.29e-2)" "unprognostic (2.57e-3)" 12.1 9.4 19.6 10.5 22.2 29.5 22.1 24.5 21.8 12.3 11.0 9.4 4.2 11.6 14.6 12.8 8.3 14.0 9.6 6.3 15.0 16.6 7.4 57.8 17.3 17.6 12.1 18.8 30.1 11.0 7.3 21.2 10.0 11.0 11.3 11.3 7.3 7.6 9.5 11.0 17.5 13.4 11.3 10.6 19.2 7.2 3.6 15.5 14.2 10.4 5.1 12.9 13.5 16.5 15.9 28.0 24.2 25.5 15.2 13.5 17.4 0.5 0.1 0.7 0.2 2.9 2.3 0.2 0.3 1.2 0.7 1.2 2.1 2.9 5.6 0.8 0.6 2.1 0.0 2.1 0.2 0.9 8.5 1.3 13.1 0.6 6.2 4.6 4.9 0.8 1.6 0.5 0.5 0.6 5.2 0.4 12.5 0.0 10.5 0.5 0.4 10.0 33.0 1.1 0.0 0.3 9.6 0.3 4.7 2.8 1.0 2.0 2.4 2.1 0.0 0.9 1.5 0.3 9.3 0.2 0.2 0.1 0.1 0.1 5.9 3.5 0.3 0.3 1.8 0.4 24.2 25.5 6.6 9.8 23.1 8.5 14.0 9.5 11.9 21.9 15.9 13.1 11.3 6.2 15.2 15.8 28.0 13.5 17.4 19.6 22.2 24.5 21.8 15.0 16.6 12.1 18.8 11.0 15.5 41.7 25.1 28.7 27.2 26.8 7.4 3.4 10.2 5.3 22.7 5.2 0.0 17.0 8.3 8.8 17.8 35.7 4.5 0.0 7.4 0.9 15.9 22.7 8.1 57.2 20.1 0.0 36.5 11.6 41.3 15.5 25.3 44.8 28.7 143.3 11.5 10.0 6.2 10.7 20.8 8.4 1.6 77.6 56.7 0.7 0.2 30.9 8.7 43.1 13.3 12.8 NAA11 "ARD1B, ARD2, hARD2" ENSG00000156269 "N(alpha)-acetyltransferase 11, NatA catalytic subunit" Q9BSU3 4 79225694-79326050 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 166 "placenta: 32.1;testis: 30.5" "Group enriched" "Detected in some" 11 "Cytotrophoblasts: 16.7;Early spermatids: 21.1;Extravillous trophoblasts: 13.6;Late spermatids: 20.7;Spermatocytes: 14.4;Spermatogonia: 15.0;Syncytiotrophoblasts: 11.1" "Cancer enhanced" "Detected in some" "testis cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "GAMG: 14.7;K-562: 8.8;U-266/70: 25.1;U-266/84: 8.0" "Not detected" "Not detected" HPA035922 Approved Supported "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA035922: AB_10673490" "unprognostic (7.37e-2)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 32.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 30.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 25.1 8.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 21.1 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 20.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 14.4 15.0 0.0 11.1 0.0 0.0 0.0 NAA35 "bA379P1.1, FLJ21613, FLJ22643, MAK10" ENSG00000135040 "N(alpha)-acetyltransferase 35, NatC auxiliary subunit" Q5VZE5 9 85941146-86022298 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021547 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA021547: AB_1853505" "unprognostic (5.87e-2)" "unprognostic (2.41e-1)" "unprognostic (4.71e-3)" "unprognostic (9.25e-3)" "unprognostic (2.37e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (1.16e-7)" "unprognostic (1.86e-1)" "unprognostic (5.22e-3)" "unprognostic (1.56e-1)" "unprognostic (8.30e-2)" "unprognostic (1.09e-1)" "unprognostic (2.36e-3)" "unprognostic (1.88e-1)" "unprognostic (4.34e-2)" "unprognostic (9.18e-2)" "unprognostic (1.07e-2)" 11.3 19.5 15.2 16.4 14.6 9.7 17.1 20.1 17.6 13.4 16.5 12.5 22.9 14.9 20.5 21.0 16.8 13.5 14.4 14.2 16.6 14.0 16.0 14.3 10.8 10.2 14.6 16.2 16.2 16.4 19.1 25.5 16.9 14.4 17.4 19.5 13.0 16.3 20.0 28.7 13.4 17.4 16.4 14.1 10.3 13.4 25.7 15.1 10.0 19.8 15.8 12.7 14.4 13.5 12.2 5.8 8.9 4.7 5.9 9.6 4.4 22.9 16.0 16.0 12.5 9.4 11.3 25.1 14.5 14.2 16.3 13.8 11.0 15.9 7.8 8.5 14.7 13.7 32.2 14.6 17.0 17.5 19.5 10.5 17.2 17.4 15.0 17.5 26.3 15.6 11.7 14.8 17.4 25.8 11.4 15.3 16.2 21.0 15.3 15.4 15.8 14.7 15.3 16.1 27.7 16.4 12.6 22.7 12.1 17.8 20.9 14.6 13.0 16.5 14.6 12.8 17.3 11.7 11.1 12.1 10.5 13.2 17.5 13.4 20.5 25.1 5.3 13.4 11.4 10.7 2.0 4.6 8.9 7.0 4.7 9.3 12.2 7.7 6.5 5.8 12.2 9.6 7.7 2.1 5.9 3.2 3.8 6.4 4.4 15.2 14.6 20.1 17.6 16.6 14.0 14.6 16.2 14.4 15.1 3.0 13.1 12.0 17.1 14.4 24.0 19.6 10.2 32.1 21.6 10.4 21.6 18.4 1.7 16.5 5.9 11.9 11.1 0.0 22.5 15.1 13.4 18.4 11.5 8.9 10.6 20.6 20.1 8.6 9.5 3.6 8.6 12.9 13.5 11.8 15.0 22.0 15.4 14.0 11.0 7.1 32.7 12.9 16.5 58.6 33.7 14.4 26.0 12.8 14.6 17.4 NAA40 "FLJ13848, NAT11" ENSG00000110583 "N(alpha)-acetyltransferase 40, NatD catalytic subunit" Q86UY6 11 63938959-63957328 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 96.9;Late spermatids: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037816, HPA056142" Uncertain Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA037816: AB_10672289, HPA056142: " "unprognostic (3.52e-1)" "unprognostic (4.12e-1)" "unprognostic (1.40e-1)" "unprognostic (6.88e-3)" "unprognostic (1.50e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (1.43e-7)" "unprognostic (1.45e-1)" "unprognostic (1.13e-2)" "unprognostic (1.58e-1)" "unprognostic (7.01e-3)" "unprognostic (6.29e-3)" "unprognostic (3.42e-2)" "unprognostic (6.43e-3)" "unprognostic (2.49e-1)" "unprognostic (1.55e-1)" "unprognostic (5.25e-2)" 4.9 12.4 9.8 10.0 11.6 4.1 7.6 16.7 13.5 7.1 7.3 12.2 10.8 9.2 5.0 7.7 9.2 11.2 7.6 13.8 9.8 10.0 10.0 5.1 6.1 10.7 8.3 8.6 4.2 8.9 28.0 22.7 10.5 8.9 6.0 7.9 12.2 9.7 11.3 7.5 4.5 9.8 5.4 7.6 12.5 6.3 19.2 8.9 10.1 10.1 4.1 11.7 8.1 4.9 4.1 5.0 3.5 0.8 6.7 10.1 2.8 10.7 12.6 15.7 8.4 4.4 4.3 10.0 8.0 8.6 19.9 14.0 10.4 13.7 6.6 10.0 7.2 13.9 9.7 13.1 5.8 14.8 8.7 8.1 9.1 8.0 11.7 5.9 14.3 7.8 4.5 5.3 12.3 3.4 7.8 12.8 11.6 15.3 5.0 9.2 8.1 15.2 11.3 14.6 10.0 8.5 15.1 14.2 8.4 13.3 8.3 20.9 11.1 12.5 11.0 6.5 11.9 18.0 6.4 8.2 11.1 13.5 6.4 6.5 6.0 3.8 11.7 6.6 6.2 8.5 3.3 0.8 3.5 10.1 0.6 3.6 4.1 2.7 4.8 3.6 3.9 1.7 4.1 0.3 6.7 0.3 5.0 0.8 2.8 9.8 11.6 16.7 13.5 9.8 10.0 8.3 8.6 8.9 8.9 3.0 3.7 5.1 1.9 2.5 27.2 12.8 7.6 22.7 12.5 17.4 31.4 8.4 0.0 5.2 38.5 7.1 10.5 0.0 4.7 10.2 4.6 1.9 1.1 4.5 7.8 96.9 16.8 10.4 9.4 100.4 4.4 8.4 1.7 3.6 6.5 9.4 4.8 3.5 6.7 3.0 24.2 0.0 3.1 19.1 16.8 2.5 3.4 8.2 6.8 1.0 NAA60 "FLJ14154, NAT15" ENSG00000122390 "N(alpha)-acetyltransferase 60, NatF catalytic subunit" Q9H7X0 16 3443611-3486963 "Enzymes, Predicted intracellular proteins" "Chromosome partition" "Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040916 Approved Uncertain "Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" "HPA040916: AB_10794428" "unprognostic (8.59e-2)" "unprognostic (2.16e-3)" "unprognostic (3.39e-1)" "prognostic favorable (3.14e-4)" "unprognostic (1.81e-1)" "unprognostic (5.90e-2)" "unprognostic (2.88e-2)" "unprognostic (1.53e-2)" "unprognostic (5.23e-2)" "unprognostic (5.12e-2)" "prognostic favorable (4.30e-4)" "unprognostic (9.54e-2)" "unprognostic (1.64e-1)" "unprognostic (1.60e-2)" "unprognostic (8.96e-2)" "unprognostic (3.59e-1)" "unprognostic (6.74e-3)" 18.5 28.7 24.2 17.9 30.8 26.6 16.2 38.1 40.2 17.1 29.4 29.1 34.0 36.8 24.3 18.6 21.3 21.7 23.7 26.2 25.6 21.3 35.8 40.3 23.6 19.4 21.6 17.7 21.2 41.8 46.4 29.0 27.0 24.4 23.7 21.4 29.1 20.7 31.6 38.9 16.9 42.2 19.9 25.7 28.1 34.8 25.3 19.0 22.8 21.8 21.8 24.1 21.7 22.1 8.5 11.2 34.8 13.2 11.6 13.4 10.0 8.2 32.5 23.0 24.2 18.4 12.6 20.6 15.8 16.9 16.4 14.8 22.2 17.8 17.2 16.1 18.0 11.7 19.3 22.7 18.4 16.0 25.8 15.3 20.9 20.5 26.0 19.9 26.7 27.7 15.4 14.3 11.2 21.7 20.2 26.2 15.4 22.0 24.5 11.5 37.8 16.8 19.7 28.0 21.9 9.5 21.1 17.4 26.0 16.9 17.4 12.2 26.4 23.5 26.2 12.5 23.0 23.4 18.9 19.3 21.1 18.1 6.8 14.6 20.5 19.0 16.7 6.7 16.6 16.1 19.8 10.5 34.8 11.8 12.3 12.5 8.0 10.8 11.5 11.2 8.5 9.3 10.8 13.2 11.6 13.2 7.8 13.4 10.0 24.2 30.8 38.1 40.2 25.6 21.3 21.6 17.7 24.4 19.0 8.9 16.5 13.7 11.2 0.1 21.2 12.6 35.7 6.7 10.3 12.2 5.9 22.8 36.5 27.5 41.1 18.6 61.4 0.0 36.4 33.1 15.4 16.7 30.0 42.3 27.8 11.1 25.9 27.6 28.5 44.0 10.6 14.5 0.0 26.2 34.4 20.8 29.9 45.6 14.9 32.7 14.2 25.8 11.2 14.9 20.2 0.3 27.6 21.0 31.9 22.0 NAALADL1 ENSG00000168060 "N-acetylated alpha-linked acidic dipeptidase like 1" Q9UQQ1 11 65044818-65058549 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "blood: 49.5;intestine: 123.4" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 39.3;monocytes: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 49.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.4;fHDF/TERT166: 6.8;HHSteC: 19.0;HSkMC: 12.5;SCLC-21H: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047123 Enhanced Uncertain Cytosol NA NA Cytosol "HPA047123: AB_2679942" "unprognostic (2.98e-2)" "unprognostic (2.06e-1)" "unprognostic (1.58e-1)" "unprognostic (8.76e-2)" "unprognostic (1.70e-1)" "unprognostic (1.28e-3)" "unprognostic (1.36e-1)" "unprognostic (1.40e-1)" "unprognostic (1.89e-2)" "unprognostic (1.38e-1)" "unprognostic (3.03e-1)" "unprognostic (2.18e-1)" "unprognostic (1.75e-4)" "unprognostic (2.10e-3)" "unprognostic (3.22e-2)" "unprognostic (1.45e-1)" "unprognostic (4.80e-2)" 4.1 0.9 1.4 3.3 1.6 7.0 4.1 1.9 1.4 6.0 54.3 1.2 2.6 7.8 7.2 1.8 2.7 4.4 3.4 3.5 1.3 0.6 2.3 1.2 3.4 5.2 1.5 1.5 6.2 1.0 0.9 2.0 1.5 1.6 4.6 2.6 3.1 2.3 4.8 2.0 1.6 123.4 4.3 1.4 5.0 2.8 1.8 1.2 1.8 1.8 2.3 2.9 3.1 5.4 8.8 4.9 49.5 6.3 22.2 12.9 7.0 0.0 0.0 0.1 0.2 0.5 5.4 0.9 2.0 0.0 2.5 1.1 0.0 0.0 0.1 0.0 6.8 0.0 0.0 0.0 0.1 0.0 0.8 0.3 0.0 0.1 3.1 19.0 0.0 0.0 12.5 0.0 2.5 0.0 0.0 3.2 0.1 0.0 0.2 0.0 0.2 0.2 0.6 0.0 0.0 0.1 0.1 0.0 0.8 0.2 0.0 9.8 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.7 0.0 0.1 0.1 49.5 6.3 10.3 9.5 4.3 4.9 8.0 7.6 4.8 4.9 8.8 8.8 4.9 1.1 22.2 2.5 0.2 12.9 7.0 1.4 1.6 1.9 1.4 1.3 0.6 1.5 1.5 1.6 1.2 0.0 0.0 8.2 3.2 3.2 1.1 1.1 2.5 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.6 9.0 39.3 0.0 0.7 0.2 5.7 0.5 19.6 0.0 2.8 9.5 1.2 16.5 7.6 1.7 10.9 6.4 15.1 22.6 0.7 10.8 0.3 14.4 17.0 0.0 0.9 0.0 13.7 1.6 2.6 2.9 0.3 11.7 0.4 0.3 NANOG "FLJ12581, FLJ40451" ENSG00000111704 "Nanog homeobox" Q9H9S0 12 7787794-7799141 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 4.9;testis: 3.8" "Cell type enhanced" "Detected in some" 12 "Cone photoreceptor cells: 7.9;Spermatocytes: 5.7" "Cancer enriched" "Detected in single" 1164 "testis cancer: 58.1" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.9" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "NTERA-2: 52.1" "CAB019380, HPA072117" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB019380: , HPA072117: " "unprognostic (1.76e-1)" "unprognostic (1.86e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (8.59e-3)" "unprognostic (3.50e-1)" "unprognostic (3.46e-2)" "unprognostic (6.35e-2)" "unprognostic (1.10e-1)" "unprognostic (3.87e-1)" "unprognostic (4.51e-7)" "unprognostic (3.46e-2)" "unprognostic (2.09e-1)" "unprognostic (1.51e-1)" "unprognostic (3.85e-2)" 0.4 0.9 0.4 0.4 1.0 1.8 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.4 0.4 0.6 0.4 0.4 0.4 0.1 0.5 0.7 1.7 0.5 0.4 0.4 0.5 0.5 0.0 0.6 0.4 0.4 0.5 0.0 0.4 0.4 0.4 1.1 1.7 0.4 0.4 0.4 1.0 0.7 3.8 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.1 4.9 3.2 0.7 1.1 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 52.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.7 0.5 0.6 0.4 0.4 0.6 0.5 0.4 0.2 1.1 0.7 0.8 2.3 1.1 0.5 4.9 0.3 0.2 0.4 1.0 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.0 0.0 0.5 1.6 1.4 1.9 0.4 0.0 0.0 0.0 0.0 7.9 1.2 0.0 0.3 1.0 0.3 0.0 0.0 0.3 0.2 0.4 0.8 0.0 0.5 0.4 0.0 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.7 0.3 0.0 1.4 0.2 1.2 0.0 0.0 5.7 0.4 0.5 0.6 0.0 0.3 1.4 NANOGP8 ENSG00000255192 "Nanog homeobox retrogene P8" 15 35084193-35085110 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.5;skin 1: 1.7;testis: 2.3" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 415 "testis cancer: 20.7" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 15 "dendritic cells: 1.5" "Group enriched" "Detected in some" 85 "NTERA-2: 32.7;SuSa: 15.4" HPA072117 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA072117: " "unprognostic (1.58e-1)" "unprognostic (9.05e-3)" "unprognostic (1.48e-1)" "unprognostic (2.37e-1)" 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.8 0.0 0.3 0.1 0.0 0.2 0.0 1.7 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NANOS1 "NOS1, ZC2HC12A" ENSG00000188613 "Nanos C2HC-type zinc finger 1" Q8WY41 10 119029716-119033732 "Disease related genes, Predicted intracellular proteins" "Translation regulation" "Repressor, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 40.7" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 10.9;Cone photoreceptor cells: 9.8;Muller glia cells: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "SH-SY5Y: 39.6;SK-BR-3: 22.7;SK-MEL-30: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012219 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB012219: " "prognostic unfavorable (1.52e-4)" "unprognostic (1.17e-1)" "unprognostic (1.50e-3)" "unprognostic (1.59e-3)" "unprognostic (7.07e-3)" "unprognostic (2.01e-1)" "unprognostic (2.19e-2)" "unprognostic (4.76e-3)" "unprognostic (1.97e-1)" "unprognostic (2.70e-1)" "unprognostic (8.22e-3)" "unprognostic (8.79e-2)" "unprognostic (2.64e-4)" "unprognostic (7.89e-2)" "unprognostic (6.99e-2)" "unprognostic (2.78e-2)" "unprognostic (2.52e-3)" 8.5 10.5 8.1 1.0 7.1 1.0 6.4 6.5 4.8 4.9 2.1 4.5 1.3 1.2 2.1 4.4 2.1 1.5 1.0 16.7 5.0 6.7 3.5 1.0 1.3 1.1 3.4 2.4 0.9 3.3 0.9 2.2 8.2 6.0 3.5 1.2 8.8 1.5 2.5 40.7 1.7 1.4 3.4 6.7 0.9 3.1 2.9 3.0 0.1 9.3 0.3 1.0 3.3 9.8 0.6 0.5 3.2 0.3 0.6 0.3 0.1 7.6 0.6 1.1 0.2 3.7 0.5 4.7 0.1 0.2 0.2 0.1 0.9 2.7 4.1 1.0 0.0 0.0 2.8 1.3 1.3 0.3 1.2 3.2 0.1 1.9 0.8 1.7 0.4 0.0 0.7 5.7 0.0 0.8 1.2 0.2 1.4 0.7 0.5 0.2 1.1 1.0 1.3 3.5 1.6 0.6 0.0 1.3 2.7 1.5 0.6 3.0 39.6 2.2 22.7 17.2 6.2 3.6 2.2 0.2 0.0 1.7 0.0 0.3 1.2 3.9 1.4 0.3 1.0 0.0 3.2 0.3 0.4 0.2 0.1 0.1 0.2 0.2 0.2 0.0 0.6 0.3 0.2 1.3 0.6 0.2 0.5 0.1 0.1 8.1 7.1 6.5 4.8 5.0 6.7 3.4 2.4 6.0 3.0 6.0 0.6 0.0 3.5 0.7 3.3 10.9 0.0 0.0 1.2 1.8 9.8 5.3 0.0 0.5 0.1 0.6 0.4 0.0 0.2 0.2 4.1 3.2 0.0 0.0 0.5 1.6 2.9 0.6 0.0 0.0 1.7 0.0 0.0 0.0 1.0 8.5 0.2 0.0 0.7 0.2 1.7 0.0 0.5 0.2 0.7 1.1 0.8 0.0 0.6 0.9 NAP1L1 "MGC23410, MGC8688, NAP1, NAP1L, NRP" ENSG00000187109 "Nucleosome assembly protein 1 like 1" P55209 12 76036587-76085033 "Plasma proteins, Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028861 Approved Uncertain Microtubules NA NA 25000000 Microtubules "HPA028861: AB_10603880" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (9.57e-2)" "unprognostic (1.77e-1)" "unprognostic (3.69e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.29e-9)" "unprognostic (1.67e-1)" "unprognostic (1.76e-1)" "unprognostic (1.66e-1)" "unprognostic (5.24e-3)" "unprognostic (1.32e-1)" "prognostic unfavorable (6.14e-13)" "unprognostic (5.59e-2)" "unprognostic (3.07e-2)" "unprognostic (4.81e-2)" "unprognostic (1.15e-1)" 55.9 73.9 48.7 65.8 54.5 70.1 59.1 33.2 55.4 64.1 49.2 41.0 47.2 18.7 65.9 44.4 56.3 45.4 53.7 59.2 50.1 42.5 36.1 27.3 64.6 99.6 58.1 43.4 154.7 33.5 33.0 51.6 48.3 57.3 60.0 31.2 33.0 45.4 54.8 79.2 34.5 36.1 79.8 78.0 63.7 35.9 33.2 53.1 100.3 50.1 45.3 90.2 92.5 93.7 39.5 34.6 26.7 103.7 22.6 41.9 30.8 70.0 53.5 101.9 64.6 65.9 106.3 57.6 45.2 62.3 69.7 51.7 58.2 26.5 165.8 50.5 56.3 29.6 47.1 59.8 71.7 87.3 52.4 58.9 61.6 39.6 59.5 93.4 97.9 60.6 73.7 78.0 48.2 82.2 173.0 84.7 60.3 90.1 36.4 111.1 33.7 125.0 80.2 115.8 25.8 50.6 98.8 100.9 68.5 61.7 39.6 43.9 63.2 37.7 55.9 105.8 83.0 82.4 71.8 66.4 54.8 62.6 38.8 63.7 45.6 54.3 104.1 33.3 51.5 35.3 0.9 17.2 26.7 15.5 51.4 31.4 39.5 35.7 25.1 34.6 32.7 41.9 33.3 4.4 22.6 103.7 25.4 36.2 30.8 48.7 54.5 33.2 55.4 50.1 42.5 58.1 43.4 57.3 53.1 154.9 208.3 558.4 562.1 407.9 163.1 401.5 142.7 298.4 275.3 129.1 74.6 453.5 202.2 300.7 150.4 320.9 11.8 70.0 241.3 358.5 405.2 301.8 416.7 103.6 395.7 238.4 237.2 221.0 437.3 212.5 656.7 612.5 383.0 725.0 160.2 329.0 376.7 56.1 782.8 194.5 107.1 368.7 416.3 328.8 145.9 295.0 348.8 337.9 182.8 358.8 NAPA ENSG00000105402 "NSF attachment protein alpha" P54920 19 47487637-47515240 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010100, HPA046149, HPA050196" Approved Uncertain Cytosol NA NA 5400000 Cytosol "CAB010100: AB_628263, HPA046149: AB_2679557, HPA050196: AB_2681048" "unprognostic (9.83e-2)" "unprognostic (9.43e-3)" "unprognostic (1.12e-2)" "unprognostic (1.76e-3)" "unprognostic (9.72e-2)" "unprognostic (3.08e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (5.61e-2)" "unprognostic (2.42e-3)" "unprognostic (1.09e-3)" "prognostic favorable (4.26e-9)" "unprognostic (4.04e-2)" "unprognostic (4.17e-2)" "unprognostic (8.55e-2)" "unprognostic (2.90e-2)" 28.1 52.4 35.5 24.5 49.1 43.6 29.3 70.2 86.9 30.9 29.9 34.8 31.0 26.5 37.6 29.0 56.0 29.1 33.4 47.3 41.8 29.6 35.8 73.8 30.3 24.6 28.1 39.4 28.8 41.2 40.4 35.4 30.3 52.6 49.0 21.7 35.5 52.3 45.5 56.9 45.6 27.4 31.8 25.1 24.8 28.8 38.5 20.8 44.8 36.4 39.0 28.4 31.4 29.1 15.7 44.5 68.2 41.1 24.1 23.5 40.6 17.3 22.9 11.2 19.3 23.5 20.2 8.2 19.7 23.8 43.9 55.4 17.2 10.0 13.1 10.3 25.7 29.1 13.0 18.1 22.9 17.5 21.2 19.6 16.9 22.7 21.0 61.8 19.1 30.0 30.1 15.8 18.3 11.4 9.2 21.3 17.3 14.0 34.8 28.9 14.5 26.1 51.2 9.3 25.9 17.6 17.2 10.6 18.4 34.1 33.4 40.6 15.4 25.1 29.5 17.3 11.2 24.2 30.1 22.8 22.5 11.9 19.1 21.1 22.3 32.4 18.7 42.3 20.1 23.2 35.6 35.6 68.2 22.7 41.1 18.8 15.7 19.3 22.0 30.1 15.2 20.5 20.0 39.6 24.1 41.0 44.5 23.5 40.6 35.5 49.1 70.2 86.9 41.8 29.6 28.1 39.4 52.6 20.8 11.9 40.4 29.8 78.5 56.2 53.9 2.8 68.8 9.4 20.5 48.8 25.5 90.7 150.9 96.2 24.5 35.3 77.2 46.7 87.3 57.2 49.8 66.0 64.5 77.8 115.3 33.4 80.2 40.5 54.8 27.9 39.7 56.4 92.8 101.0 48.5 71.6 84.3 49.1 43.5 81.6 37.2 90.5 59.0 82.1 70.7 60.0 191.4 49.8 39.9 62.1 NAPB "SNAP-BETA, SNAPB" ENSG00000125814 "NSF attachment protein beta" Q9H115 20 23374519-23421519 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 110.9" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 176.7;Cone photoreceptor cells: 62.8;Horizontal cells: 63.5;Rod photoreceptor cells: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 24.5;U-937: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037225, CAB037227, HPA046149, HPA050196" Supported Uncertain Cytosol NA NA Cytosol "CAB037225: AB_477555, CAB037227: AB_477554, HPA046149: AB_2679557, HPA050196: AB_2681048" "unprognostic (3.89e-1)" "unprognostic (2.71e-1)" "unprognostic (5.95e-2)" "unprognostic (1.05e-1)" "unprognostic (2.54e-2)" "unprognostic (3.92e-2)" "unprognostic (1.32e-3)" "unprognostic (1.25e-1)" "unprognostic (4.71e-2)" "unprognostic (6.37e-2)" "unprognostic (4.46e-3)" "unprognostic (7.52e-3)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.42e-1)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (4.60e-2)" 3.2 15.5 32.7 3.8 32.7 6.0 4.4 46.0 110.9 4.0 4.0 4.4 2.6 3.8 4.7 6.3 3.7 4.6 3.8 3.7 30.5 32.0 4.4 3.8 3.9 4.0 26.1 40.1 6.4 3.4 6.1 4.6 5.9 50.2 4.0 5.0 6.1 4.0 4.6 3.4 5.0 5.5 4.5 9.7 4.5 4.3 5.3 4.0 0.7 5.1 0.1 3.4 3.6 2.3 2.4 1.9 6.0 2.1 1.5 5.1 2.1 4.3 2.8 4.6 4.8 5.2 4.8 6.5 5.6 3.0 4.5 4.0 3.3 3.8 6.3 6.7 3.3 3.3 5.5 5.9 3.8 5.5 2.0 4.4 6.9 3.7 7.7 6.1 5.1 4.1 4.8 5.0 3.2 4.0 4.1 3.3 6.5 5.8 8.4 7.2 2.9 5.2 4.7 2.0 3.5 5.1 3.5 3.7 4.7 5.9 4.7 24.5 7.8 3.2 3.1 5.2 7.0 3.2 3.2 3.9 4.3 3.2 4.8 3.9 6.2 4.8 2.9 2.2 24.4 4.3 6.0 1.2 0.0 5.1 1.3 1.5 1.7 2.0 2.4 1.9 2.4 2.0 3.3 1.5 1.5 2.1 1.5 2.5 2.1 32.7 32.7 46.0 57.7 30.5 32.0 26.1 40.1 50.2 4.0 11.9 6.2 5.1 4.4 7.7 176.7 4.9 7.6 2.7 6.8 14.0 62.8 5.6 0.0 2.9 39.1 7.7 3.5 0.0 1.2 4.4 8.4 3.3 10.5 4.9 4.4 63.5 9.8 10.4 7.2 45.5 8.3 3.6 10.1 4.6 2.3 15.7 2.7 0.0 8.5 2.2 78.5 6.5 6.2 9.7 9.8 7.3 5.1 5.7 4.5 3.3 NARS2 "DFNB94, FLJ23441, SLM5" ENSG00000137513 "Asparaginyl-tRNA synthetase 2, mitochondrial" Q96I59 11 78435961-78574874 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026793 Supported Approved Nucleoplasm,Mitochondria,Cytosol No No "Nucleoplasm, Mitochondria" Cytosol "HPA026793: AB_1848833" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (5.73e-3)" "unprognostic (1.79e-3)" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (5.62e-2)" "unprognostic (4.62e-3)" "prognostic favorable (1.39e-5)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.22e-6)" "unprognostic (8.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.93e-1)" "unprognostic (1.60e-1)" 10.9 16.0 11.8 9.3 11.2 6.4 13.4 19.4 11.8 11.6 13.0 13.1 13.5 12.0 17.6 13.9 10.8 12.0 9.9 12.7 11.3 12.2 22.3 26.8 9.0 10.2 13.4 8.4 15.9 20.0 14.0 17.3 9.4 13.8 13.3 13.3 23.2 12.7 13.2 24.4 9.1 11.1 10.6 10.8 12.6 11.3 11.8 10.3 17.3 16.0 7.7 14.1 9.7 10.7 14.6 13.5 6.7 9.4 16.2 16.6 8.7 7.3 10.3 10.8 7.1 7.6 6.4 9.0 6.1 6.0 9.5 7.9 17.7 7.9 18.2 15.9 3.9 9.2 9.7 18.2 11.9 13.3 11.9 9.8 12.8 8.0 15.0 6.3 13.7 4.8 4.5 7.7 8.4 15.0 8.6 8.1 15.4 19.3 5.0 10.6 8.6 14.2 22.2 11.8 30.0 12.5 14.9 17.7 24.6 12.7 10.4 12.9 8.1 9.1 11.7 15.7 12.2 11.0 5.5 4.9 13.0 15.3 14.8 10.3 8.4 14.1 40.1 2.5 12.4 8.8 6.7 7.9 3.5 9.8 8.3 12.0 14.6 11.3 10.8 13.5 12.6 16.6 14.8 1.7 16.2 9.4 10.3 8.2 8.7 11.8 11.2 19.4 11.8 11.3 12.2 13.4 8.4 13.8 10.3 17.9 17.1 9.0 12.7 11.9 5.3 8.3 2.5 10.7 7.9 5.2 2.0 17.3 24.9 8.2 11.0 6.3 5.0 0.0 6.5 20.2 10.4 14.0 8.1 16.3 10.6 0.0 11.5 2.5 6.5 3.9 7.2 6.1 16.9 1.0 7.7 5.7 6.1 13.3 4.6 22.1 8.7 6.5 8.3 7.4 18.1 12.0 12.8 5.1 13.7 7.5 NBAS NAG ENSG00000151779 "Neuroblastoma amplified sequence" A2RRP1 2 15166909-15561330 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036817 Approved Approved "Nuclear membrane,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nuclear membrane, Nucleoli" "HPA036817: AB_10670925" "unprognostic (1.72e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-1)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (3.80e-2)" "unprognostic (4.16e-2)" "unprognostic (1.33e-1)" "unprognostic (1.55e-1)" "unprognostic (1.53e-2)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-1)" "prognostic unfavorable (5.84e-5)" 16.8 18.1 23.2 16.3 30.9 21.9 22.5 21.5 28.3 21.9 17.1 20.6 17.4 13.3 27.1 23.4 14.1 18.7 13.5 21.6 20.9 21.5 19.1 16.9 15.4 16.3 19.3 20.8 24.1 28.6 34.1 35.5 16.2 24.9 16.9 17.7 16.8 22.9 19.0 26.5 23.4 20.5 21.0 18.1 18.1 19.0 31.4 16.7 23.8 20.1 14.6 20.0 14.4 15.2 5.3 6.0 3.2 8.7 9.4 9.9 3.6 5.5 7.3 8.1 5.6 21.3 23.4 8.4 10.3 11.3 8.0 8.1 7.3 8.0 7.1 2.3 15.6 8.3 6.7 8.8 12.9 9.6 7.0 5.6 27.1 6.5 20.4 21.9 7.0 13.8 15.4 10.3 10.6 17.8 16.6 16.5 10.1 21.0 8.2 12.2 6.8 5.8 15.8 7.0 9.0 7.0 6.2 14.3 8.4 16.6 7.5 4.8 7.8 8.7 7.2 12.9 10.6 5.1 6.4 14.3 10.2 6.3 7.2 7.4 12.2 10.3 10.1 18.1 8.2 9.1 1.4 5.7 3.2 7.6 3.9 9.5 5.3 5.9 9.9 5.2 5.1 5.9 6.1 1.0 9.4 8.7 6.0 6.9 3.6 23.2 30.9 21.5 28.3 20.9 21.5 19.3 20.8 24.9 16.7 17.9 14.4 12.9 8.3 6.5 15.6 26.3 22.9 25.4 13.6 17.4 27.5 9.8 0.0 9.6 29.5 10.5 11.9 0.0 12.1 11.2 8.0 7.9 37.0 7.8 7.7 12.7 7.0 7.4 9.5 46.9 10.6 8.2 5.0 19.0 13.5 15.2 8.1 9.3 15.6 7.7 22.9 0.0 11.7 30.4 16.6 9.8 8.7 11.8 11.0 5.8 NCAPH2 "384D8-2, CAP-H2, hCAP-H2" ENSG00000025770 "Non-SMC condensin II complex subunit H2" Q6IBW4 22 50508216-50523472 "Predicted intracellular proteins" "DNA condensation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067932, HPA069056" Enhanced Supported "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA067932: AB_2685926, HPA069056: AB_2686076" "unprognostic (2.01e-1)" "prognostic favorable (2.24e-8)" "unprognostic (3.65e-2)" "unprognostic (2.81e-1)" "unprognostic (5.04e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (2.92e-2)" "unprognostic (8.66e-2)" "unprognostic (1.10e-1)" "unprognostic (2.26e-2)" "unprognostic (6.31e-2)" "unprognostic (2.04e-3)" "unprognostic (2.64e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "unprognostic (3.00e-1)" 15.7 12.4 24.5 17.8 18.8 57.4 14.7 33.5 29.4 14.5 14.2 17.4 14.6 15.6 17.5 15.7 18.0 17.2 11.4 18.2 20.0 19.6 14.5 13.8 17.0 22.2 17.8 19.2 22.8 22.6 16.3 22.0 20.0 19.0 15.2 10.8 16.8 22.4 16.6 20.2 23.2 15.7 20.5 15.7 18.4 15.7 26.1 20.4 25.2 16.3 16.8 21.0 12.0 14.5 13.7 10.1 14.5 11.6 11.3 20.9 12.8 19.9 10.8 18.9 19.3 5.6 6.5 24.5 15.8 11.0 28.6 31.2 22.0 13.8 23.1 8.7 11.3 16.0 15.9 17.2 15.1 8.3 13.2 28.5 13.3 27.4 19.7 6.9 29.4 24.0 5.9 9.5 22.6 7.6 4.3 9.2 20.2 16.7 45.0 11.5 27.5 20.1 33.6 13.4 12.0 13.0 33.8 24.6 25.4 8.3 13.1 12.3 16.1 12.4 18.5 14.8 6.3 12.7 29.0 5.9 22.4 27.0 18.3 23.4 23.5 13.1 34.2 16.8 15.1 21.0 10.6 8.4 14.5 17.1 10.4 20.9 13.7 17.7 17.4 7.0 13.2 18.7 15.5 10.2 11.3 11.6 10.1 16.8 12.8 24.5 18.8 33.5 29.4 20.0 19.6 17.8 19.2 19.0 20.4 20.8 26.9 14.1 20.2 16.8 17.5 17.1 15.3 4.0 6.8 8.7 3.9 24.7 13.3 11.3 30.7 11.3 15.5 0.0 20.2 48.4 17.3 13.7 16.2 9.5 16.9 7.9 12.6 11.1 7.2 86.8 16.1 10.9 11.8 19.8 15.5 14.5 14.9 11.5 16.3 7.0 12.9 19.4 21.2 29.6 36.4 16.2 26.3 15.8 15.6 17.6 NCKAP1L HEM1 ENSG00000123338 "NCK associated protein 1 like" P55160 12 54497711-54548238 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 39.1;lymphoid tissue: 56.7" "Group enriched" "Detected in many" 5 "B-cells: 52.5;granulocytes: 53.3;Hofbauer cells: 98.9;Kupffer cells: 144.7;Macrophages: 81.9;monocytes: 90.2;T-cells: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 33.5;HMC-1: 35.4;NB-4: 24.7;REH: 17.7;THP-1: 36.7;U-937: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039490, HPA040772" Approved Uncertain "Plasma membrane,Cytosol" NA NA 52000 Cytosol "Plasma membrane" "HPA039490: AB_2676540, HPA040772: AB_2677129" "unprognostic (4.54e-2)" "unprognostic (5.20e-3)" "unprognostic (1.61e-2)" "unprognostic (1.22e-3)" "unprognostic (9.29e-2)" "unprognostic (1.01e-2)" "unprognostic (3.69e-1)" "unprognostic (2.95e-2)" "unprognostic (6.53e-3)" "unprognostic (4.80e-1)" "unprognostic (1.76e-1)" "unprognostic (2.08e-1)" "unprognostic (1.54e-3)" "unprognostic (2.57e-1)" "unprognostic (2.76e-2)" "unprognostic (3.63e-2)" "unprognostic (4.74e-2)" 18.1 5.0 5.9 22.0 10.5 16.9 7.2 1.2 5.8 3.1 15.0 8.1 0.6 4.0 3.1 4.3 4.8 4.0 5.1 6.5 4.1 3.5 3.9 6.5 19.7 56.7 9.3 2.5 2.2 2.4 4.4 2.3 7.3 6.6 4.8 6.9 3.0 4.3 4.0 1.5 2.8 15.4 7.0 13.9 44.7 4.7 1.7 7.9 47.2 2.8 1.8 30.0 22.2 3.3 11.2 25.4 18.4 39.1 12.3 15.2 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.1 14.4 0.0 0.0 0.0 33.5 35.4 0.0 0.0 0.0 0.0 0.0 0.2 12.4 2.3 13.6 0.0 0.0 14.1 24.7 0.0 0.0 0.0 17.7 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.7 0.8 11.8 0.0 21.5 0.0 8.6 23.3 18.4 11.9 36.4 9.8 11.2 10.7 12.1 25.4 11.0 6.9 10.0 5.9 12.3 39.1 14.4 15.2 19.2 5.9 10.5 1.2 5.8 4.1 3.5 9.3 2.5 6.6 7.9 0.0 15.2 52.5 0.4 1.1 0.9 1.3 7.6 1.4 3.4 0.0 0.0 0.6 0.0 0.0 0.6 2.0 0.0 0.0 0.3 0.7 1.7 0.1 53.3 0.9 98.9 0.0 0.0 9.2 144.7 1.5 1.1 81.9 5.0 90.2 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.0 1.4 0.5 1.0 0.5 1.1 53.6 0.0 0.3 NDC1 "FLJ10407, NET3, TMEM48" ENSG00000058804 "NDC1 transmembrane nucleoporin" Q9BTX1 1 53765460-53838860 "Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069751, HPA070882" Approved Supported "Nuclear membrane,Plasma membrane,Actin filaments" NA NA "Nuclear membrane" "Plasma membrane, Actin filaments" "HPA069751: AB_2686189, HPA070882: AB_2686320" "unprognostic (2.51e-1)" "unprognostic (1.93e-1)" "prognostic favorable (4.48e-5)" "unprognostic (6.96e-3)" "unprognostic (1.31e-1)" "unprognostic (1.36e-3)" "prognostic unfavorable (7.52e-7)" "unprognostic (3.46e-3)" "unprognostic (1.53e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.58e-4)" "unprognostic (9.27e-2)" "unprognostic (6.22e-3)" "unprognostic (3.00e-3)" "unprognostic (4.38e-2)" "unprognostic (9.24e-2)" "unprognostic (6.07e-2)" 8.8 6.7 3.3 8.6 5.7 4.9 12.9 10.9 7.7 4.8 8.4 5.1 1.9 6.2 6.0 5.4 11.0 5.3 2.9 5.5 4.3 2.8 4.9 11.7 4.4 10.6 8.0 1.5 4.6 6.0 7.6 5.5 5.5 6.6 4.0 10.7 5.5 6.4 3.7 7.1 6.8 6.5 5.0 7.5 7.1 5.8 17.4 7.5 9.1 5.8 6.7 13.0 6.4 5.8 5.5 3.8 2.0 7.2 4.0 8.2 3.4 20.0 10.6 14.4 14.7 5.3 5.4 17.0 13.8 10.3 21.6 17.5 15.6 13.5 39.6 9.0 6.1 17.5 24.2 24.3 14.3 30.6 9.8 17.5 19.3 15.5 13.2 5.0 30.9 11.0 3.2 5.7 21.3 12.7 6.3 13.0 14.8 22.0 5.7 11.8 7.2 15.1 12.3 34.3 17.0 16.9 17.1 23.3 21.6 10.1 13.8 8.7 11.1 12.3 24.0 11.8 16.0 18.6 16.4 7.6 11.3 11.3 15.5 24.7 6.3 15.6 28.2 9.4 23.5 14.1 0.0 3.2 2.0 4.5 7.2 6.9 5.5 4.3 4.0 3.8 4.1 8.2 6.3 0.2 4.0 4.5 3.3 4.7 3.4 3.3 5.7 10.9 7.7 4.3 2.8 8.0 1.5 6.6 7.5 6.0 4.6 3.7 6.1 9.0 4.1 7.6 2.5 2.7 2.3 5.2 2.0 8.2 0.0 5.9 1.7 4.8 3.3 0.0 7.7 16.4 5.9 5.0 7.0 5.9 10.3 3.2 0.0 4.3 9.1 1.7 2.6 6.7 6.8 2.8 8.4 4.1 6.1 2.9 3.2 4.5 3.2 6.5 4.7 9.3 13.1 7.4 5.7 4.1 15.1 5.4 NDRG2 "KIAA1248, SYLD" ENSG00000165795 "NDRG family member 2" Q9UN36 14 21016763-21070872 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 310.5;skeletal muscle: 253.0" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 411.1;Leydig cells: 322.7;Muller glia cells: 402.9;Sertoli cells: 588.6" "Cancer enhanced" "Detected in all" "glioma: 78.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 10 "myeloid DC: 54.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 54.5" "Cell line enhanced" "Detected in many" "Hep G2: 27.9;HMC-1: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002896, HPA003590, CAB017491" Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA 150000 "Centriolar satellite" "Nucleoplasm, Cytosol" "CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458" "unprognostic (9.27e-3)" "unprognostic (2.97e-3)" "unprognostic (1.26e-2)" "unprognostic (5.09e-3)" "unprognostic (2.00e-2)" "unprognostic (2.92e-2)" "prognostic favorable (6.71e-4)" "unprognostic (1.85e-3)" "unprognostic (5.57e-2)" "unprognostic (3.46e-2)" "unprognostic (1.69e-1)" "unprognostic (5.10e-2)" "prognostic favorable (1.43e-12)" "unprognostic (1.46e-1)" "unprognostic (5.56e-2)" "unprognostic (6.11e-2)" "unprognostic (4.19e-2)" 19.3 45.3 140.2 4.8 135.1 1.4 50.3 93.5 110.0 35.5 21.0 89.6 23.8 12.2 30.7 44.4 37.3 29.5 21.5 45.2 103.6 86.1 24.3 84.8 13.7 7.7 128.9 73.5 79.7 15.5 35.6 6.0 8.1 95.4 23.7 18.8 8.9 310.5 37.3 253.0 18.9 12.0 22.0 73.0 21.1 11.2 5.2 71.2 0.4 13.6 53.4 16.1 13.9 19.3 1.8 54.5 0.4 1.8 0.7 5.4 4.0 5.3 1.1 3.4 6.4 0.5 0.0 0.5 0.1 2.2 2.0 1.1 7.4 10.0 0.3 2.0 0.1 3.2 8.8 15.3 3.1 2.7 0.0 5.5 6.9 1.2 27.9 0.7 0.6 20.0 6.1 6.7 0.4 0.9 3.2 0.0 6.3 13.9 0.6 0.3 4.5 2.4 1.9 9.1 17.3 0.4 7.1 0.3 1.6 3.8 13.6 0.0 9.9 1.5 1.7 7.0 9.3 13.5 4.0 0.0 0.6 10.9 0.2 0.2 3.1 2.2 0.1 0.9 0.1 2.3 0.0 1.8 0.2 2.4 0.4 3.2 1.8 3.6 3.3 54.5 1.3 5.4 4.0 0.4 0.7 0.0 1.9 2.4 4.0 140.2 135.1 93.5 110.0 103.6 86.1 128.9 73.5 95.4 71.2 0.0 14.8 8.5 70.8 25.4 6.7 160.9 140.1 20.1 13.6 38.4 9.8 8.0 411.1 69.3 4.7 52.6 25.5 0.0 18.9 0.6 20.1 71.2 47.4 183.0 19.8 3.2 32.1 116.6 25.7 5.9 322.7 43.4 305.4 6.4 71.2 402.9 14.6 28.8 156.3 32.0 12.8 588.6 188.5 1.1 3.4 26.6 18.1 10.1 86.6 132.0 NDRG4 "KIAA1180, SMAP-8" ENSG00000103034 "NDRG family member 4" Q9ULP0 16 58462846-58513628 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 59.2;brain: 134.1;heart muscle: 112.6" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 389.7;Horizontal cells: 487.8" "Cancer enriched" "Detected in many" 6 "glioma: 23.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 18.4;GAMG: 16.2;hTERT-RPE1: 15.2;SCLC-21H: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015313, HPA017587" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015313: AB_1854343, HPA017587: AB_1854344" "unprognostic (1.52e-1)" "unprognostic (1.30e-1)" "unprognostic (9.03e-3)" "unprognostic (1.59e-2)" "unprognostic (3.97e-1)" "unprognostic (1.03e-1)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (6.07e-2)" "unprognostic (1.02e-1)" "unprognostic (4.84e-3)" "unprognostic (5.98e-2)" "unprognostic (2.27e-2)" "unprognostic (1.22e-2)" "unprognostic (8.51e-2)" "unprognostic (4.45e-2)" "unprognostic (7.17e-2)" 3.6 59.2 28.7 2.9 49.4 1.6 2.3 65.4 134.1 3.8 3.5 11.0 15.6 3.4 10.2 5.1 10.0 3.9 3.4 112.6 30.5 32.0 2.3 1.9 6.5 3.4 33.7 35.4 2.1 2.6 10.8 11.6 2.6 81.2 2.1 3.2 8.7 2.9 18.2 5.3 3.9 3.2 8.7 11.7 11.7 2.6 19.9 7.4 0.0 2.6 0.3 3.5 2.7 8.0 1.5 0.1 0.2 0.0 0.1 0.9 0.2 0.1 9.3 8.9 1.7 0.2 1.7 0.7 2.9 4.5 1.4 0.9 3.5 2.4 0.2 18.4 2.2 16.2 0.8 0.7 0.5 1.2 0.0 1.8 0.4 1.5 2.5 2.5 0.1 0.1 2.1 0.2 0.9 0.0 15.2 11.7 0.0 0.1 0.1 1.3 2.3 0.9 0.1 0.8 0.3 6.8 0.2 2.5 0.2 0.4 5.8 27.8 10.4 0.3 0.8 0.1 1.1 0.3 0.1 4.2 1.2 3.5 0.3 0.4 0.5 0.2 3.0 6.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.2 28.7 49.4 65.4 63.4 30.5 32.0 33.7 35.4 81.2 7.4 0.0 3.4 0.0 4.0 1.8 38.9 389.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 3.6 4.6 13.5 0.0 0.0 0.2 0.1 1.5 1.4 0.0 0.2 0.0 487.8 1.7 23.9 1.0 6.2 4.0 0.7 6.8 0.0 0.0 74.2 3.2 0.0 2.5 0.0 22.6 6.5 5.7 3.9 3.6 5.1 0.0 0.0 0.0 7.5 NDUFA11 B14.7 ENSG00000174886 "NADH:ubiquinone oxidoreductase subunit A11" Q86Y39 19 5891276-5904006 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA072209 Uncertain Mitochondria NA NA Mitochondria "HPA072209: AB_2686495" "unprognostic (2.24e-1)" "prognostic favorable (4.54e-5)" "unprognostic (8.20e-3)" "prognostic favorable (3.38e-5)" "unprognostic (4.54e-2)" "unprognostic (7.73e-2)" "unprognostic (6.30e-2)" "unprognostic (7.26e-3)" "unprognostic (3.95e-1)" "unprognostic (4.20e-2)" "unprognostic (1.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.12e-2)" "unprognostic (2.91e-1)" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (6.16e-3)" 32.3 70.8 50.2 40.9 41.3 43.4 49.3 29.9 75.2 35.3 45.1 25.8 41.2 41.6 35.9 36.9 53.1 38.4 41.4 149.3 41.9 45.8 44.1 59.8 37.9 51.9 48.3 45.8 38.4 70.9 13.5 33.8 32.5 35.9 35.1 19.6 35.9 76.3 41.1 106.0 32.4 39.5 45.2 40.2 31.5 38.8 21.2 27.0 37.3 37.8 72.1 30.5 38.3 37.2 63.3 90.2 54.3 87.4 44.8 73.7 121.4 49.2 38.1 28.4 46.2 23.3 37.9 31.8 34.1 39.4 62.5 57.8 45.5 26.3 48.7 53.8 32.5 26.8 32.6 19.6 39.7 15.1 42.0 73.5 20.0 36.6 72.7 61.0 29.7 29.8 51.8 36.1 35.4 16.8 24.1 40.7 44.8 42.2 54.3 31.4 37.5 77.1 53.0 43.0 39.3 95.9 53.5 35.5 69.7 38.6 33.0 41.1 43.7 26.5 43.6 60.0 12.7 33.5 63.4 36.4 34.9 33.5 69.3 55.6 82.6 71.6 63.0 58.8 71.4 44.7 54.3 87.4 47.7 53.5 68.0 54.8 63.3 59.6 54.0 74.9 54.6 56.7 49.5 39.2 44.8 57.7 90.2 73.7 121.4 50.2 41.3 29.9 75.2 41.9 45.8 48.3 45.8 35.9 27.0 134.0 182.8 195.8 195.3 182.6 52.9 357.1 252.3 159.3 142.1 277.4 23.6 487.2 712.9 246.9 126.8 162.6 455.6 140.2 261.1 500.5 250.4 204.0 208.9 654.2 369.3 47.7 337.5 259.7 354.1 271.6 180.4 216.7 271.7 380.5 351.7 119.5 275.3 350.7 157.3 766.8 60.4 116.4 219.2 83.0 80.8 212.9 496.2 182.7 391.9 191.2 NDUFA12 "B17.2, DAP13" ENSG00000184752 "NADH:ubiquinone oxidoreductase subunit A12" Q9UI09 12 94897055-95003770 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.0" "Group enriched" "Detected in all" 5 "Cardiomyocytes: 2083.1;Distal tubular cells: 525.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039903 Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA039903: AB_10795516" "unprognostic (2.76e-1)" "unprognostic (5.32e-3)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (2.85e-1)" "unprognostic (4.03e-2)" "unprognostic (3.05e-2)" "unprognostic (6.68e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (3.13e-3)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (6.13e-2)" "unprognostic (3.27e-2)" 24.0 24.8 36.0 17.9 36.8 19.7 19.7 27.2 36.5 17.9 35.5 12.5 20.0 27.4 17.0 21.9 23.3 19.4 14.4 82.8 31.2 32.0 33.2 34.6 18.1 20.1 37.0 29.9 17.0 18.4 22.3 22.4 21.1 31.3 19.1 35.7 13.1 18.7 20.7 129.0 17.4 26.7 24.0 24.2 23.9 20.9 14.2 23.5 21.0 27.9 40.0 28.1 21.9 21.4 60.8 78.4 69.7 67.9 59.1 93.8 100.6 41.6 45.3 37.9 26.9 31.1 29.0 28.2 19.9 29.3 43.5 39.5 55.9 21.5 47.9 11.8 30.4 24.1 31.5 38.9 45.9 49.4 41.3 46.7 40.1 37.8 56.3 32.0 56.8 49.0 31.1 58.0 36.4 44.7 45.5 35.6 41.7 37.4 22.3 42.1 60.4 39.3 87.8 28.7 51.2 78.9 30.1 32.8 54.6 42.6 62.6 36.1 21.9 33.7 49.2 25.8 34.2 48.6 37.4 40.6 23.1 23.5 33.5 33.8 36.4 54.0 73.1 13.9 47.6 35.2 69.7 59.5 29.8 52.1 67.9 48.2 60.8 71.6 62.5 78.4 50.7 93.8 68.6 8.6 59.1 63.3 48.0 74.8 100.6 36.0 36.8 27.2 36.5 31.2 32.0 37.0 29.9 31.3 23.5 68.5 58.6 79.6 121.2 96.5 65.8 2083.1 160.5 77.6 45.5 102.9 60.9 215.5 525.6 141.2 192.8 157.8 177.2 46.7 143.2 214.5 94.4 120.9 56.6 123.1 168.7 35.0 81.9 98.8 95.5 70.6 90.3 125.9 151.8 218.2 146.8 79.4 169.8 188.7 125.5 242.6 113.4 103.5 149.9 130.8 119.2 111.7 175.3 96.5 189.4 182.6 NDUFA4L2 "FLJ26118, NUOMS" ENSG00000185633 "NDUFA4, mitochondrial complex associated like 2" Q9NRX3 12 57234903-57240715 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 82.5;skin 1: 93.4" "Group enriched" "Detected in many" 4 "Muller glia cells: 315.5;Sertoli cells: 1112.4;Smooth muscle cells: 398.4" "Cancer enhanced" "Detected in all" "renal cancer: 356.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.4;T-reg: 2.8" "Group enriched" "Detected in many" 24 "B-cells: 2.4;T-cells: 2.8" "Cell line enriched" "Detected in many" 7 "AN3-CA: 55.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA055323, HPA078265" Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA055323: , HPA078265: " "unprognostic (1.25e-1)" "unprognostic (1.60e-1)" "unprognostic (2.11e-3)" "unprognostic (3.23e-3)" "unprognostic (5.06e-2)" "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (3.53e-1)" "unprognostic (6.67e-2)" "unprognostic (5.79e-2)" "unprognostic (2.13e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (1.37e-5)" "unprognostic (9.10e-3)" "unprognostic (1.31e-1)" "unprognostic (6.41e-2)" "unprognostic (2.74e-2)" 24.5 9.6 8.3 4.9 15.5 1.3 11.5 7.7 10.4 19.1 4.4 8.3 1.1 4.6 4.6 5.4 82.5 3.6 11.0 30.9 9.8 7.3 5.4 4.2 12.7 4.6 10.9 10.7 6.1 6.7 4.6 6.2 42.7 13.2 6.8 2.4 13.7 10.3 7.4 19.0 93.4 4.7 5.6 5.6 29.9 4.3 3.0 8.9 0.7 12.0 14.8 11.9 10.2 31.4 2.4 0.1 0.0 0.0 0.0 2.8 0.3 0.3 0.5 0.1 55.4 2.3 1.3 0.1 0.8 0.6 0.2 0.5 0.0 0.6 2.2 2.3 0.8 0.0 0.4 0.3 0.4 0.0 1.2 0.1 0.2 0.1 0.0 7.9 1.6 0.8 5.1 1.0 0.1 2.0 0.3 0.0 3.1 0.2 2.9 0.1 1.1 0.4 0.0 0.1 0.2 1.0 0.8 0.4 4.2 0.0 0.0 3.0 1.0 0.1 0.1 1.8 0.0 0.6 5.8 0.2 0.5 0.0 0.4 0.2 4.2 1.3 1.0 2.0 3.9 0.3 0.0 0.0 0.0 0.6 0.0 0.0 2.4 0.7 0.0 0.1 0.4 1.1 0.0 0.0 0.0 0.0 0.0 2.8 0.3 8.3 15.5 7.7 10.4 9.8 7.3 10.9 10.7 13.2 8.9 0.0 0.3 0.9 0.7 134.3 28.0 0.8 0.0 0.0 0.0 0.0 17.7 0.8 0.0 1.0 1.0 3.6 0.0 0.0 0.0 0.8 18.6 1.5 9.2 0.0 1.5 11.1 0.0 4.9 0.0 1.3 2.8 1.4 28.7 1.8 0.0 315.5 7.7 0.0 2.1 0.0 17.5 1112.4 398.4 8.1 0.9 141.0 0.9 0.0 0.0 0.9 NDUFA9 "CI-39k, NDUFS2L, SDR22E1" ENSG00000139180 "NADH:ubiquinone oxidoreductase subunit A9" Q16795 12 4649095-4694317 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.6" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 461.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042268, HPA073212" Supported Supported Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA042268: AB_2677922, HPA073212: AB_2686581" "unprognostic (2.26e-1)" "unprognostic (7.85e-3)" "unprognostic (3.67e-2)" "unprognostic (1.84e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (9.64e-3)" "unprognostic (3.02e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (3.45e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.57e-7)" "unprognostic (7.80e-2)" "unprognostic (1.71e-1)" "unprognostic (1.93e-2)" "prognostic favorable (5.75e-4)" 10.7 13.2 11.0 10.1 17.8 21.2 11.7 15.3 20.7 9.2 22.1 12.0 8.6 20.9 10.1 11.0 13.4 8.4 8.5 41.3 11.6 11.0 23.7 22.1 8.5 11.8 12.7 9.9 8.4 10.4 10.4 12.2 9.5 16.2 9.9 22.7 12.1 13.3 10.1 66.6 10.6 18.9 11.7 8.3 11.5 13.6 5.8 9.3 14.4 10.2 30.7 12.8 8.2 8.8 36.8 43.5 14.6 41.5 25.8 35.9 59.6 10.9 19.8 9.8 13.0 7.2 7.2 28.3 8.4 8.5 16.3 12.4 42.9 22.1 12.4 4.5 9.1 18.4 18.5 14.1 12.4 10.6 24.0 24.8 12.1 21.1 32.4 15.8 17.6 13.1 9.2 12.1 11.1 15.1 10.1 12.2 17.8 8.4 23.5 12.0 21.3 17.6 20.3 25.2 20.7 16.5 24.9 14.4 12.9 22.4 25.1 7.1 8.0 10.6 28.5 14.7 22.2 5.9 16.9 8.5 12.4 25.2 11.3 19.4 4.6 5.4 20.5 13.0 11.0 13.6 14.6 35.8 13.3 27.7 41.5 28.0 36.8 29.0 30.2 42.3 26.2 25.3 26.2 3.1 25.8 32.2 43.5 35.9 59.6 11.0 17.8 15.3 20.7 11.6 11.0 12.7 9.9 16.2 9.3 26.8 28.0 46.2 52.9 43.0 46.1 165.0 50.9 41.5 36.4 61.1 55.0 100.9 140.9 108.0 102.8 42.7 83.0 23.3 114.3 98.5 39.0 37.2 56.6 65.2 101.8 31.8 45.5 34.4 33.6 461.4 26.2 46.0 52.3 57.7 92.6 40.4 94.0 94.8 34.6 133.6 48.3 19.4 42.6 28.8 28.1 41.3 83.5 45.7 120.3 64.7 NDUFAF1 "CGI-65, CIA30" ENSG00000137806 "NADH:ubiquinone oxidoreductase complex assembly factor 1" Q9Y375 15 41387349-41402519 "Predicted intracellular proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039933, HPA040064" Supported Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA039933: AB_10795265, HPA040064: AB_10795687" "unprognostic (2.02e-1)" "unprognostic (1.02e-1)" "unprognostic (1.72e-1)" "unprognostic (2.10e-3)" "unprognostic (2.38e-1)" "unprognostic (1.20e-1)" "prognostic favorable (2.88e-5)" "unprognostic (3.01e-1)" "unprognostic (2.34e-1)" "unprognostic (8.92e-2)" "unprognostic (1.34e-1)" "unprognostic (1.46e-1)" "prognostic favorable (3.34e-6)" "unprognostic (1.68e-1)" "unprognostic (3.23e-1)" "unprognostic (3.17e-2)" "unprognostic (2.05e-1)" 11.1 22.0 15.0 6.4 14.0 3.0 9.8 13.3 17.8 7.8 7.7 12.4 5.3 8.4 8.3 10.7 9.6 7.9 7.1 29.7 13.2 13.4 21.9 27.5 7.0 8.5 14.7 14.4 7.0 7.7 11.9 9.7 7.0 13.1 8.5 8.1 8.4 8.5 9.8 38.6 6.2 7.7 10.3 13.5 7.5 8.5 14.1 12.0 6.5 9.6 15.8 9.1 8.8 5.8 14.5 19.1 25.2 16.2 13.9 15.9 8.7 9.2 6.6 8.7 9.0 20.0 20.4 9.6 17.7 14.5 15.6 13.0 12.2 5.1 10.6 24.6 15.5 11.0 15.3 11.8 11.9 14.1 19.9 13.7 15.0 13.9 7.2 17.1 16.0 10.6 22.7 11.4 12.9 13.0 13.6 11.1 19.2 22.8 11.5 22.8 8.5 12.8 13.3 7.0 16.1 11.1 10.0 11.7 21.9 23.8 15.0 10.5 8.3 9.0 20.1 6.7 11.6 16.5 30.9 11.5 12.7 5.9 19.0 14.6 9.4 20.3 16.0 14.2 25.4 12.1 25.2 13.7 16.4 9.6 16.2 9.9 14.5 11.5 12.3 12.1 12.6 13.0 10.3 12.8 13.9 12.4 19.1 15.9 8.7 15.0 14.0 13.3 17.8 13.2 13.4 14.7 14.4 13.1 12.0 11.9 8.5 15.6 13.8 4.1 14.0 56.8 12.7 16.0 5.7 21.0 11.8 32.1 54.7 26.4 36.4 11.3 11.9 0.0 27.1 30.5 15.5 11.6 6.9 25.2 26.1 6.4 6.4 6.7 14.8 5.4 15.3 14.8 10.1 26.2 6.8 19.5 18.8 2.9 15.2 56.4 17.6 25.8 9.9 67.2 17.8 6.8 42.1 10.2 8.1 13.6 NDUFB1 "CI-MNLL, MNLL" ENSG00000183648 "NADH:ubiquinone oxidoreductase subunit B1" O75438 14 92116122-92121917 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 161.6" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 2033.2;Hepatocytes: 1436.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA063737 Supported Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "HPA063737: AB_2685109" "unprognostic (1.12e-2)" "unprognostic (1.31e-3)" "unprognostic (6.70e-2)" "unprognostic (2.67e-2)" "unprognostic (1.28e-1)" "unprognostic (2.54e-2)" "unprognostic (6.91e-2)" "unprognostic (3.74e-3)" "unprognostic (5.35e-3)" "unprognostic (4.55e-3)" "unprognostic (1.18e-2)" "unprognostic (4.15e-2)" "prognostic favorable (1.31e-5)" "unprognostic (7.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.05e-3)" 38.3 48.3 47.8 22.4 43.1 30.2 22.1 30.9 53.6 12.4 39.7 13.4 28.1 36.4 14.8 39.2 23.2 15.9 20.0 142.2 38.4 35.7 51.2 64.6 28.1 24.9 40.6 36.0 16.5 48.5 9.9 30.6 13.2 41.8 19.3 26.9 22.9 54.1 35.9 161.6 12.6 32.9 25.9 31.3 19.3 29.4 10.0 26.4 11.9 21.6 48.9 21.3 17.1 16.3 61.7 98.6 116.1 93.9 45.1 70.1 95.0 27.1 55.1 44.7 28.8 29.3 21.9 20.5 33.5 18.9 19.9 18.4 33.2 46.3 24.5 31.2 18.7 29.1 34.0 25.6 27.2 18.0 38.6 58.5 47.5 86.5 39.5 23.3 37.5 27.2 27.0 16.5 20.8 18.4 47.1 17.7 47.1 25.8 50.5 27.2 102.8 37.0 33.6 22.6 103.1 67.5 33.1 42.5 36.4 49.6 67.3 29.9 21.7 65.6 40.0 42.6 39.3 59.8 58.6 39.5 12.7 24.1 25.3 22.3 40.0 62.3 54.5 38.2 27.8 26.2 58.1 93.9 67.8 43.7 63.5 50.2 61.7 64.7 49.8 82.6 52.0 65.4 60.4 116.1 45.1 58.1 98.6 70.1 95.0 47.8 43.1 30.9 53.6 38.4 35.7 40.6 36.0 41.8 26.4 154.9 246.4 237.3 88.1 114.4 72.8 2033.2 565.6 282.4 178.6 369.9 37.3 225.4 988.2 197.4 98.7 145.0 655.0 280.4 371.9 86.0 164.5 117.3 207.1 1436.2 359.0 52.4 305.2 426.6 707.7 29.0 243.1 282.3 315.5 296.6 433.5 108.9 268.5 512.0 226.7 864.5 130.9 219.9 185.4 133.6 144.5 153.9 172.1 204.2 467.2 90.1 NDUFB2 "AGGG, CI-AGGG" ENSG00000090266 "NADH:ubiquinone oxidoreductase subunit B2" O95178 7 140690777-140722790 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 153.5" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 3102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051377 Approved Uncertain Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA051377: AB_2681460" "unprognostic (1.17e-2)" "unprognostic (4.63e-2)" "unprognostic (2.25e-1)" "unprognostic (4.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.20e-2)" "unprognostic (3.30e-2)" "unprognostic (8.30e-2)" "unprognostic (1.95e-3)" "unprognostic (4.35e-3)" "unprognostic (1.23e-1)" "prognostic favorable (7.60e-7)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" 25.1 31.2 45.1 19.9 52.5 20.2 27.3 29.1 43.3 21.5 39.0 26.0 25.1 28.3 20.1 29.5 27.7 22.0 25.7 105.5 37.0 36.0 46.6 41.2 18.4 23.8 46.0 35.6 14.5 47.0 26.5 23.9 17.7 33.3 20.7 30.8 28.1 37.6 27.4 127.2 17.2 28.1 38.1 37.7 19.7 26.9 14.3 25.2 15.6 57.6 48.1 21.1 25.5 17.5 94.7 116.5 55.2 108.5 75.9 87.8 153.5 41.1 67.0 24.0 52.4 38.6 39.2 34.9 29.9 26.2 31.0 29.6 51.7 41.1 31.3 44.8 36.2 58.7 20.4 21.4 42.1 24.7 52.2 73.6 22.9 57.3 58.1 30.6 35.3 30.9 43.6 36.5 29.4 18.1 26.6 46.1 44.5 38.7 37.9 42.9 122.0 55.3 91.1 55.6 84.7 76.6 31.9 23.4 72.2 62.1 81.8 48.9 48.3 41.0 67.2 35.9 28.6 29.2 40.5 38.4 41.0 24.1 48.4 51.5 36.2 67.2 54.9 62.4 56.8 51.3 55.2 108.5 48.1 83.5 107.8 71.3 94.7 82.1 81.4 116.5 72.9 87.8 87.7 9.0 75.9 97.1 92.8 73.9 153.5 45.1 52.5 29.1 43.3 37.0 36.0 46.0 35.6 33.3 25.2 175.7 232.0 217.4 229.1 201.1 175.8 3102.3 435.7 235.5 197.9 638.6 92.3 489.8 1692.7 343.0 795.3 237.8 727.9 70.0 273.3 377.8 291.6 360.2 272.6 944.1 632.0 131.9 411.8 215.5 261.6 154.7 206.2 385.8 411.7 381.5 493.4 197.7 268.8 531.3 229.1 1640.6 200.8 194.1 278.2 77.7 190.5 245.3 430.7 214.4 506.9 369.0 NDUFV1 CI-51K ENSG00000167792 "NADH:ubiquinone oxidoreductase core subunit V1" P49821 11 67606852-67612535 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 150.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045211, HPA075051" Enhanced Supported Mitochondria,Cytosol No No Mitochondria Cytosol "HPA045211: AB_10962830, HPA075051: AB_2686732" "unprognostic (4.57e-2)" "unprognostic (2.17e-2)" "unprognostic (2.84e-1)" "unprognostic (7.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.54e-3)" "unprognostic (1.19e-1)" "unprognostic (3.31e-2)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (4.02e-2)" "unprognostic (3.03e-2)" "prognostic favorable (7.49e-10)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" 23.3 28.9 27.3 20.7 33.9 20.3 18.9 32.9 48.8 18.5 33.0 23.1 19.2 40.6 19.4 21.5 25.5 22.5 23.4 93.0 26.5 24.1 39.0 41.5 15.9 20.6 31.5 40.5 24.6 38.3 49.2 18.8 15.7 34.8 16.1 25.1 17.6 27.3 27.0 150.8 28.4 30.3 22.7 23.1 21.5 28.2 30.2 24.3 18.3 23.4 67.9 20.3 18.7 18.6 23.8 41.2 13.5 30.7 36.2 28.2 24.3 25.9 27.9 14.2 28.5 17.8 17.9 26.6 16.2 15.6 25.4 17.0 52.8 31.5 48.0 34.2 13.9 20.7 35.0 30.0 25.3 8.0 24.4 23.7 19.6 37.9 26.0 25.2 26.7 22.0 26.5 24.6 20.6 18.5 16.1 22.5 35.2 35.7 39.3 15.4 39.0 31.2 52.9 13.9 59.1 35.2 36.3 27.6 77.9 20.6 19.5 22.7 21.4 20.5 71.8 54.1 9.9 36.4 27.2 17.8 24.7 18.4 35.1 17.0 38.4 21.8 23.9 28.7 28.3 23.7 12.6 26.7 13.5 25.9 30.7 28.2 23.2 21.7 24.5 41.2 23.8 20.2 25.1 4.8 36.2 17.4 26.5 27.8 24.3 27.3 33.9 32.9 48.8 26.5 24.1 31.5 40.5 34.8 24.3 56.6 80.9 64.0 70.8 71.3 67.0 408.9 66.2 72.3 67.1 82.0 47.1 180.6 336.5 96.7 57.0 53.7 205.0 23.3 97.8 127.6 79.5 47.7 59.0 122.2 121.6 60.4 94.7 53.4 67.1 159.3 60.7 67.5 108.0 83.8 141.7 63.1 68.4 126.7 55.5 398.9 60.4 45.3 98.9 77.2 78.1 70.4 158.1 71.2 225.4 78.9 NDUFV2 CI-24k ENSG00000178127 "NADH:ubiquinone oxidoreductase core subunit V2" P19404 18 9102630-9134345 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003404, HPA077896" Supported Supported Nucleoplasm,Mitochondria,Cytosol No No Mitochondria "Nucleoplasm, Cytosol" "HPA003404: AB_1079466, HPA077896: AB_2686866" "unprognostic (1.18e-1)" "unprognostic (3.89e-2)" "unprognostic (2.89e-1)" "unprognostic (8.22e-2)" "unprognostic (1.32e-2)" "unprognostic (6.72e-3)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "unprognostic (6.72e-3)" "unprognostic (1.32e-3)" "unprognostic (2.39e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-1)" "unprognostic (5.51e-2)" "unprognostic (1.31e-1)" "unprognostic (6.56e-2)" "unprognostic (1.95e-3)" 20.0 34.5 25.2 18.0 23.7 31.1 25.6 20.6 37.3 15.6 26.1 13.1 20.3 23.1 14.7 21.5 27.5 13.9 17.6 82.6 22.7 23.8 40.7 89.1 17.2 29.9 26.7 19.4 11.2 36.3 14.9 14.9 21.6 26.2 20.8 27.8 17.8 20.1 20.2 122.6 17.4 24.4 23.5 20.8 19.3 25.2 19.0 12.7 20.5 20.5 59.5 22.7 20.4 14.1 55.6 74.7 49.3 45.1 27.0 53.5 48.1 18.6 19.6 22.7 21.1 16.8 24.0 19.2 23.5 37.4 31.1 29.6 36.6 15.4 28.8 21.6 22.0 28.7 9.5 22.0 24.4 29.8 14.5 19.4 18.4 20.2 49.3 19.4 51.2 22.9 20.1 20.5 19.2 20.8 22.5 33.5 26.0 29.3 91.0 28.5 23.4 35.7 44.9 18.9 103.3 24.4 17.0 16.8 109.2 49.6 30.3 23.8 17.7 23.2 26.5 29.5 16.9 24.8 39.0 20.5 39.7 28.2 28.4 30.5 26.3 39.0 32.2 28.3 22.7 25.6 49.3 39.9 44.1 30.2 45.1 37.6 55.6 45.5 35.7 56.6 43.6 40.0 36.9 18.0 27.0 41.6 74.7 53.5 48.1 25.2 23.7 20.6 37.3 22.7 23.8 26.7 19.4 26.2 12.7 74.5 120.4 122.8 254.8 131.4 96.8 61.3 175.8 207.5 127.4 143.1 82.5 309.8 742.8 337.2 214.8 108.5 232.3 46.7 461.4 265.4 107.6 372.3 115.7 324.6 267.7 89.0 102.4 92.7 98.1 135.7 113.1 187.8 219.4 393.1 177.0 104.6 465.3 175.4 95.8 576.3 143.4 103.5 138.2 182.6 170.4 129.0 242.0 118.9 207.0 348.6 NEO1 "HsT17534, IGDCC2, NGN, NTN1R2" ENSG00000067141 "Neogenin 1" Q92859 15 73051710-73305206 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 57.8;Peritubular cells: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009320, HPA027804, HPA027805, HPA027806" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 280000000 "Nucleoplasm, Plasma membrane" "Golgi apparatus" "CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006" "unprognostic (1.90e-1)" "unprognostic (2.38e-2)" "unprognostic (7.60e-3)" "unprognostic (3.76e-2)" "unprognostic (5.44e-1)" "unprognostic (3.83e-2)" "unprognostic (8.30e-2)" "unprognostic (2.31e-1)" "unprognostic (3.22e-1)" "unprognostic (3.30e-2)" "unprognostic (5.51e-2)" "unprognostic (8.05e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-2)" "unprognostic (3.75e-1)" 7.3 5.8 19.2 6.2 22.4 1.2 11.4 12.7 23.9 13.4 30.0 44.5 14.8 17.9 14.2 7.2 8.0 15.4 13.4 6.8 20.1 14.1 16.2 5.9 10.7 2.7 27.1 15.7 17.5 11.5 44.4 6.9 1.5 19.3 23.1 36.9 16.0 11.5 25.5 17.9 24.6 19.0 16.0 22.3 3.6 15.1 9.0 22.5 2.1 12.5 3.8 4.7 10.1 9.5 0.0 0.3 1.4 0.3 0.8 3.1 0.3 3.7 18.3 21.9 14.4 13.3 3.9 5.5 1.4 1.8 3.6 0.7 2.7 18.5 1.0 2.2 4.0 13.6 0.8 15.3 8.4 1.5 6.6 11.3 12.3 0.2 2.5 3.8 0.3 0.4 9.6 15.6 0.7 7.2 4.2 0.0 9.6 0.0 23.5 0.8 11.2 4.3 0.2 20.9 2.8 1.5 10.0 11.7 2.4 7.0 10.1 10.0 14.1 17.2 7.7 9.1 18.4 8.1 2.2 0.0 16.9 9.0 5.4 3.9 10.1 18.6 2.6 3.6 3.5 4.7 0.0 0.3 0.4 1.8 0.0 3.1 0.0 1.1 1.4 0.0 0.0 0.6 0.5 1.4 0.8 0.0 0.3 0.0 0.3 19.2 22.4 12.7 23.9 20.1 14.1 27.1 15.7 19.3 22.5 8.9 7.2 1.7 6.9 12.6 14.6 4.2 22.9 4.0 6.8 21.0 13.7 0.5 1.7 8.7 3.0 2.9 34.1 0.0 5.5 0.6 7.9 14.5 0.0 5.9 0.7 9.5 57.8 8.0 0.3 4.1 29.4 0.5 10.1 0.0 37.7 10.4 9.4 38.6 59.1 14.3 21.5 6.5 8.6 5.7 18.1 22.2 0.2 4.5 47.7 6.1 NEURL1B "DKFZP761M1511, Neur2, RNF67B" ENSG00000214357 "Neuralized E3 ubiquitin protein ligase 1B" A8MQ27 5 172641266-172691540 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Endothelial cells: 32.6;Enterocytes: 45.0;Ito cells: 36.2;Leydig cells: 50.6;Paneth cells: 33.1;Smooth muscle cells: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "REH: 27.6;T-47d: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037612 Approved Supported "Actin filaments,Cytosol" NA Yes Cytosol "Actin filaments" "HPA037612: AB_10795573" "unprognostic (3.56e-2)" "unprognostic (8.46e-2)" "unprognostic (6.72e-3)" "unprognostic (2.70e-1)" "unprognostic (1.64e-1)" "unprognostic (1.55e-1)" "unprognostic (6.58e-2)" "unprognostic (2.95e-1)" "unprognostic (2.86e-1)" "unprognostic (1.09e-1)" "unprognostic (7.13e-3)" "unprognostic (6.81e-2)" "prognostic unfavorable (3.00e-6)" "unprognostic (1.79e-1)" "unprognostic (1.40e-1)" "unprognostic (4.67e-2)" "unprognostic (3.22e-3)" 26.6 11.8 7.5 10.3 3.2 1.5 23.9 0.6 7.0 21.4 17.5 5.6 31.2 5.7 26.7 24.7 14.0 15.8 23.0 19.2 10.7 4.2 7.6 4.4 10.5 7.8 3.1 3.2 20.9 4.8 4.1 6.0 5.1 2.7 20.7 11.6 6.1 4.9 28.4 12.3 14.7 12.1 29.1 1.5 0.6 5.9 6.6 2.8 3.6 7.2 13.9 5.4 16.0 30.8 0.0 0.6 0.0 0.2 0.0 0.2 0.0 4.5 2.4 1.3 5.8 0.4 0.2 0.1 5.1 2.3 2.7 4.0 8.7 2.1 0.0 1.4 3.3 3.3 1.3 0.5 2.3 1.8 8.3 0.3 6.2 8.3 0.0 0.4 0.0 1.9 0.0 9.9 0.6 2.7 0.8 0.4 0.9 0.0 2.0 5.8 5.0 1.4 0.1 0.8 2.0 0.2 27.6 6.1 0.9 0.1 1.0 1.0 5.9 4.9 7.8 0.2 2.4 13.0 0.9 0.8 2.0 12.2 1.4 3.2 0.8 0.2 0.0 5.9 0.1 1.8 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.5 3.2 0.6 7.0 10.7 4.2 3.1 3.2 2.7 2.8 0.0 3.4 0.0 0.6 4.2 0.1 7.8 0.0 8.1 4.5 0.0 0.0 0.2 0.0 0.3 1.9 32.6 45.0 0.0 0.6 0.2 3.5 1.8 0.0 0.5 0.2 0.0 13.4 36.2 2.4 4.1 50.6 1.8 6.8 1.0 12.5 0.7 3.5 33.1 11.7 0.8 0.3 25.8 30.8 2.1 1.5 4.6 0.1 0.0 15.7 0.9 NEXMIF "KIAA2022, KIDLIA, MRX98, XPN" ENSG00000050030 "Neurite extension and migration factor" Q5QGS0 X 74732856-74925485 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.2;parathyroid gland: 9.0" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 2.2;Ciliated cells: 5.3;Club cells: 4.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HAP1: 6.7;Karpas-707: 10.8;SiHa: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000407 Uncertain Supported "Nucleoplasm,Midbody,Mitotic spindle,Cytosol" Yes NA Nucleoplasm "Midbody, Mitotic spindle, Cytosol" "HPA000407: AB_2665984" "unprognostic (1.04e-3)" "unprognostic (6.07e-5)" "unprognostic (1.81e-2)" "unprognostic (2.07e-5)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (3.71e-1)" "unprognostic (1.79e-2)" "unprognostic (1.64e-3)" "unprognostic (8.25e-2)" "unprognostic (7.58e-3)" "unprognostic (1.37e-2)" "unprognostic (3.80e-2)" "unprognostic (2.79e-4)" "unprognostic (6.94e-4)" 0.6 3.0 5.4 0.7 6.2 0.4 1.3 10.2 9.4 1.7 1.9 0.7 1.0 0.6 1.7 0.9 1.8 1.3 0.5 0.3 5.0 6.2 2.4 0.2 0.9 0.5 1.8 5.0 1.7 4.4 9.0 7.5 0.5 1.9 3.2 1.1 1.1 2.5 2.5 0.4 1.8 1.1 2.6 1.2 0.6 1.6 0.9 1.5 0.0 1.5 0.0 0.5 0.7 2.8 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 10.8 0.0 0.2 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 9.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 6.2 10.2 6.8 5.0 6.2 1.8 5.0 1.9 1.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NFE2L2 NRF2 ENSG00000116044 "Nuclear factor, erythroid 2 like 2" Q16236 2 177227595-177392697 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002990, CAB020317, HPA043438" Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB020317: , HPA002990: AB_1079476, HPA043438: AB_2678482" "unprognostic (2.11e-1)" "unprognostic (3.12e-2)" "unprognostic (5.22e-2)" "unprognostic (1.41e-1)" "unprognostic (5.95e-2)" "unprognostic (3.90e-1)" "unprognostic (5.27e-2)" "unprognostic (9.58e-2)" "unprognostic (3.48e-2)" "unprognostic (9.86e-2)" "unprognostic (4.86e-2)" "unprognostic (1.83e-1)" "prognostic favorable (2.26e-4)" "unprognostic (1.97e-2)" "unprognostic (1.61e-1)" "unprognostic (1.26e-1)" "unprognostic (9.77e-3)" 30.9 24.4 25.4 19.3 34.7 15.0 24.6 36.4 29.7 31.7 28.3 25.8 22.2 28.1 27.7 30.9 82.5 27.0 28.9 32.3 28.0 16.9 44.8 49.3 29.0 19.7 49.0 18.7 53.1 16.3 21.7 52.5 29.4 33.5 39.0 25.4 21.7 34.7 28.1 25.9 48.1 29.2 42.1 42.7 26.8 45.9 21.9 41.6 21.1 49.5 35.8 25.5 43.7 47.1 23.5 41.1 42.4 35.6 25.8 43.2 22.6 10.6 12.3 11.2 12.0 37.8 40.8 12.8 18.2 25.3 16.6 18.8 16.2 20.4 10.5 19.8 20.6 31.6 19.8 13.1 27.7 23.3 8.1 8.0 13.5 21.6 31.6 48.4 8.0 12.8 28.1 65.2 23.6 35.1 39.4 16.4 8.3 14.0 20.6 22.8 10.6 8.1 21.1 12.2 55.2 11.6 6.7 9.8 10.6 25.4 40.1 14.6 9.5 41.2 13.3 43.1 33.7 10.3 21.6 24.7 17.2 11.5 19.1 11.1 14.5 8.7 8.8 17.2 8.9 33.0 42.4 35.6 21.4 23.0 34.1 26.6 23.5 26.9 23.6 41.1 19.9 43.2 28.2 39.9 25.8 31.9 15.5 25.0 22.6 25.4 34.7 36.4 29.7 28.0 16.9 49.0 18.7 33.5 41.6 145.9 85.8 49.5 216.1 262.7 59.6 57.4 96.8 143.2 127.4 146.5 15.7 88.4 333.2 126.2 58.6 116.1 96.6 0.0 147.7 27.7 204.6 118.5 212.0 76.9 78.0 54.0 72.6 97.6 100.1 19.8 266.3 164.9 91.1 213.8 57.7 176.6 122.9 89.2 201.2 56.4 47.1 38.8 169.0 50.5 33.8 275.8 155.7 62.3 90.2 201.5 NFKBID "IkappaBNS, TA-NFKBH" ENSG00000167604 "NFKB inhibitor delta" Q8NI38 19 35887653-35902303 "Predicted intracellular proteins, Transcription factors" "Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.0" "Cell type enhanced" "Detected in many" 9 "granulocytes: 91.9;Macrophages: 54.1;monocytes: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054778 Uncertain "Nuclear bodies,Plasma membrane,Cytosol" NA NA Cytosol "Nuclear bodies, Plasma membrane" "HPA054778: " "prognostic favorable (6.01e-4)" "unprognostic (9.60e-2)" "unprognostic (1.00e-1)" "unprognostic (3.28e-2)" "unprognostic (1.51e-2)" "prognostic favorable (5.43e-4)" "unprognostic (4.21e-2)" "unprognostic (7.68e-2)" "unprognostic (3.83e-1)" "unprognostic (4.10e-2)" "unprognostic (1.47e-3)" "unprognostic (5.64e-2)" "unprognostic (6.83e-2)" "unprognostic (1.04e-1)" "unprognostic (5.21e-2)" "unprognostic (2.71e-2)" "prognostic favorable (8.34e-6)" 4.1 2.8 0.9 13.5 2.5 21.0 7.0 4.5 2.4 1.9 2.1 4.4 0.9 1.9 2.3 2.7 3.0 3.7 6.9 2.1 0.7 1.1 3.4 1.8 11.4 9.1 2.3 0.4 4.3 3.5 1.9 5.5 1.6 2.0 2.6 1.5 2.7 2.3 3.4 0.9 3.6 4.8 5.1 2.4 6.8 2.8 1.5 1.1 14.4 5.1 1.0 14.7 2.8 7.4 9.4 1.9 4.8 1.6 2.0 2.3 0.6 4.7 4.4 0.9 3.0 0.6 0.7 2.1 3.0 3.5 3.2 2.3 1.0 3.9 5.8 2.3 3.1 2.8 2.5 3.1 2.3 1.3 3.3 0.6 3.5 6.2 1.1 0.8 3.0 10.5 1.0 1.6 5.9 1.5 0.8 1.1 2.7 0.7 3.6 0.7 3.7 2.5 3.6 1.3 0.9 0.9 1.3 0.7 1.2 2.8 2.0 1.6 1.2 4.0 3.1 0.3 0.8 1.4 3.0 1.2 5.0 4.5 2.2 2.0 2.5 0.9 6.8 2.7 7.1 0.7 0.0 1.4 2.5 2.3 0.9 1.7 5.4 1.0 1.8 1.4 9.4 1.7 1.0 4.8 2.0 1.6 1.9 2.2 0.6 0.9 2.5 4.5 2.4 0.7 1.1 2.3 0.4 2.0 1.1 0.0 13.7 34.0 7.1 26.4 8.1 0.8 5.1 4.0 2.3 1.8 19.6 1.1 0.0 2.3 0.0 8.7 2.9 0.0 0.9 2.2 15.4 12.3 91.9 0.0 32.9 0.0 2.9 2.5 30.8 0.0 1.1 54.1 18.6 51.3 2.6 1.1 2.7 2.5 1.8 0.9 9.7 0.0 9.5 0.5 0.5 29.2 0.8 15.2 4.8 7.9 NFU1 "CGI-33, HIRIP5, NifU, NIFUC" ENSG00000169599 "NFU1 iron-sulfur cluster scaffold" Q9UMS0 2 69395750-69437628 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035826 Uncertain Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035826: AB_2674803" "unprognostic (4.49e-3)" "unprognostic (5.62e-2)" "unprognostic (5.40e-2)" "unprognostic (1.84e-1)" "unprognostic (2.81e-1)" "unprognostic (2.16e-3)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (6.12e-2)" "unprognostic (1.55e-1)" "unprognostic (1.31e-1)" "unprognostic (2.12e-1)" "unprognostic (2.21e-3)" "unprognostic (2.63e-1)" "unprognostic (1.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.87e-1)" 32.3 26.0 24.9 14.7 23.5 14.9 59.9 19.7 40.4 14.7 20.0 12.1 16.0 15.9 17.1 31.8 13.9 17.6 15.9 83.2 21.4 23.6 32.8 20.0 23.0 20.8 24.1 29.7 18.5 21.7 22.9 23.0 19.1 23.7 17.5 20.8 12.2 19.1 19.8 69.3 9.7 16.3 28.9 24.8 13.9 18.7 16.5 16.8 7.8 21.4 28.3 14.4 19.0 19.4 18.2 17.7 16.0 17.5 12.9 18.2 8.0 20.3 18.8 19.7 19.7 25.1 23.8 21.5 22.0 19.4 19.3 14.5 40.9 17.9 12.3 11.5 18.1 30.6 9.2 20.2 20.6 27.0 25.9 19.8 13.8 16.1 37.2 25.7 25.1 21.0 19.9 12.1 20.8 14.3 22.0 24.6 14.5 23.7 15.1 34.7 4.3 13.2 43.1 18.0 21.8 21.3 14.6 30.9 5.0 29.5 21.5 15.9 12.6 12.0 11.0 34.2 21.8 13.3 17.6 24.2 24.6 17.6 19.1 29.4 19.9 16.8 8.1 18.5 25.5 18.9 13.5 8.5 16.0 12.1 12.4 11.8 15.9 12.3 14.4 8.6 18.2 12.8 14.4 2.8 12.9 17.5 17.7 18.2 8.0 24.9 23.5 19.7 40.4 21.4 23.6 24.1 29.7 23.7 16.8 29.8 16.1 41.2 30.6 14.3 22.2 90.1 35.7 50.9 15.9 36.6 11.8 101.7 160.8 46.6 83.4 32.3 30.2 23.3 53.3 58.8 29.6 33.8 57.7 33.6 71.3 17.5 51.2 28.3 33.0 20.9 32.2 38.6 37.1 88.4 43.8 34.7 48.9 45.6 34.6 134.1 25.7 45.3 49.1 77.4 52.4 13.0 51.3 35.0 49.8 27.4 NGFR "CD271, p75NTR, TNFRSF16" ENSG00000064300 "Nerve growth factor receptor" P08138 17 49495293-49515017 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Apoptosis, Biological rhythms, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 33.8;Leydig cells: 88.9;Muller glia cells: 122.0;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 4.2" "Lineage enriched" "Detected in single" 7 "dendritic cells: 4.2" "Group enriched" "Detected in some" 7 "RH-30: 56.0;WM-115: 62.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 13.1;hypothalamus: 8.2;pons and medulla: 3.7" "CAB000143, CAB001995, HPA004765" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 100000 "Nucleoplasm, Plasma membrane" "CAB000143: , CAB001995: , HPA004765: AB_1079233" "unprognostic (6.25e-3)" "unprognostic (1.06e-3)" "unprognostic (3.39e-3)" "unprognostic (6.67e-2)" "unprognostic (1.46e-2)" "unprognostic (2.26e-1)" "unprognostic (8.22e-2)" "unprognostic (4.94e-2)" "unprognostic (1.08e-2)" "unprognostic (4.10e-3)" "unprognostic (1.85e-2)" "unprognostic (1.25e-1)" "unprognostic (3.37e-2)" "unprognostic (4.01e-2)" "unprognostic (3.06e-2)" "unprognostic (2.77e-3)" "prognostic unfavorable (3.40e-4)" 30.9 24.0 1.2 9.2 7.4 1.0 11.7 6.1 4.5 7.6 9.4 10.4 7.9 3.2 6.8 15.0 11.3 12.6 10.8 22.2 2.4 2.9 4.8 29.1 1.4 11.6 13.8 1.3 7.6 6.2 2.8 6.7 16.7 15.9 17.7 3.4 20.2 17.2 9.7 4.8 8.4 5.0 10.7 22.4 18.9 4.9 12.2 4.4 0.4 25.8 7.4 7.0 13.1 6.8 0.0 4.2 0.0 0.4 0.0 0.5 0.2 0.0 0.0 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 1.3 0.4 1.2 0.0 0.1 0.2 0.1 0.0 1.0 0.1 0.0 0.1 6.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 8.1 0.1 0.0 0.0 1.0 0.0 0.0 1.0 56.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 3.7 2.2 0.1 0.0 0.0 0.0 1.0 0.1 2.7 0.0 0.0 0.0 0.0 0.5 62.2 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 4.2 0.0 0.2 1.2 7.4 6.1 4.0 2.4 2.9 13.8 1.3 15.9 4.4 0.0 0.0 0.5 33.8 3.2 6.1 0.5 0.0 1.4 2.3 0.0 3.9 0.2 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.4 3.3 2.4 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.9 88.9 1.8 15.1 0.0 0.0 122.0 0.0 0.0 26.2 0.0 5.7 32.3 9.5 0.5 0.9 1.5 0.1 1.0 0.0 2.0 NHLRC1 "bA204B7.2, EPM2B" ENSG00000187566 "NHL repeat containing E3 ubiquitin protein ligase 1" Q6VVB1 6 18120440-18122687 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 5 "Exocrine glandular cells: 3.2;Intestinal endocrine cells: 3.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 9.2;K-562: 7.8;SCLC-21H: 8.2" "Low region specificity" "Detected in all" HPA066030 Uncertain Vesicles NA NA Vesicles "HPA066030: " "unprognostic (1.61e-1)" "unprognostic (1.39e-1)" "unprognostic (7.95e-2)" "prognostic unfavorable (9.01e-4)" "unprognostic (6.95e-3)" "unprognostic (2.45e-1)" "unprognostic (1.09e-1)" "unprognostic (3.69e-1)" "unprognostic (2.39e-1)" "unprognostic (7.17e-2)" "unprognostic (5.07e-3)" "unprognostic (1.28e-1)" "unprognostic (2.32e-2)" "unprognostic (3.19e-1)" "unprognostic (2.33e-1)" "unprognostic (2.77e-2)" "prognostic favorable (5.30e-4)" 2.5 3.6 5.0 1.8 6.5 2.1 4.6 2.6 8.5 1.9 3.3 7.1 1.7 3.2 2.0 6.1 2.4 3.5 2.7 3.9 5.0 5.1 1.9 9.0 5.1 4.7 5.4 3.9 3.5 12.2 2.4 2.8 1.0 5.2 3.4 3.0 3.3 5.1 2.8 5.2 8.5 4.3 1.8 5.4 2.4 3.0 2.1 3.8 2.4 3.6 0.9 1.8 2.5 1.8 3.3 7.2 0.6 7.2 2.2 2.5 2.6 3.3 2.0 0.8 0.1 1.8 1.7 0.0 3.5 1.1 1.3 0.7 0.1 2.8 0.1 9.2 2.5 0.2 4.0 0.0 2.2 1.0 0.1 1.2 0.5 1.1 0.2 2.8 0.0 2.2 2.9 3.4 1.3 1.2 0.8 2.8 0.0 7.8 0.1 2.8 3.6 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.1 1.9 3.6 8.2 0.1 6.9 5.8 2.0 0.8 4.2 2.2 0.5 0.2 1.8 2.4 0.0 0.1 0.0 0.1 0.1 0.0 3.5 0.5 6.6 0.6 1.1 7.2 1.2 3.3 1.7 0.8 7.2 2.3 2.5 1.6 0.5 2.2 3.2 0.9 1.8 2.6 5.0 6.5 2.6 8.5 5.0 5.1 5.4 3.9 5.2 3.8 0.0 2.1 0.0 1.0 1.6 0.1 0.4 0.0 0.0 2.3 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.3 0.0 3.2 0.0 0.2 0.1 1.1 1.0 1.1 0.0 3.4 0.0 0.6 0.0 0.6 0.9 1.7 0.0 0.0 0.5 1.7 0.0 0.0 1.1 1.1 0.0 0.4 0.2 0.0 1.6 0.3 0.0 0.4 0.3 NIN ENSG00000100503 Ninein Q8N4C6 14 50719763-50831121 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005939, HPA070691" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Centrosome" NA NA Centrosome "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA005939: AB_2667474, HPA070691: AB_2686296" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (3.54e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (1.43e-2)" "unprognostic (3.41e-2)" "unprognostic (3.31e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-2)" "unprognostic (2.07e-1)" "unprognostic (4.06e-1)" "unprognostic (2.46e-2)" "unprognostic (2.67e-1)" "unprognostic (1.28e-1)" "unprognostic (2.58e-2)" "unprognostic (7.66e-3)" 13.0 6.1 15.1 24.9 10.3 34.8 9.7 12.6 14.0 8.0 9.2 7.6 4.5 5.0 11.8 6.1 11.8 8.2 7.6 16.4 11.7 4.9 6.7 5.2 10.7 30.2 7.6 10.0 11.0 5.4 9.1 12.3 20.2 7.1 6.5 7.7 6.2 8.2 5.1 16.9 10.9 8.3 12.0 7.1 18.2 9.3 4.6 9.0 16.4 7.8 5.1 25.8 11.7 10.3 6.8 6.3 18.4 2.3 1.5 6.0 1.3 12.3 8.7 18.3 15.5 7.0 11.4 7.6 10.6 9.1 8.9 7.5 5.6 6.6 29.1 7.3 14.3 8.5 13.0 14.7 6.7 18.9 14.0 4.5 10.7 5.4 5.3 4.1 18.6 30.9 7.8 5.4 15.7 6.4 5.3 14.2 15.1 2.6 11.9 13.5 13.5 14.1 7.5 2.5 3.9 9.7 16.0 33.8 2.1 8.0 14.0 8.5 9.6 13.3 4.0 11.4 4.2 7.6 16.6 20.7 22.8 31.7 8.7 11.7 9.6 4.8 20.1 5.9 15.2 12.3 12.6 2.3 18.4 3.3 1.7 3.5 6.8 2.2 6.0 1.5 5.5 4.4 3.8 8.3 1.5 1.5 6.3 1.9 1.3 15.1 10.3 12.6 14.0 11.7 4.9 7.6 10.0 7.1 9.0 6.0 7.7 41.0 7.0 16.4 7.5 37.9 12.7 26.8 36.4 10.4 58.9 9.2 3.3 6.9 22.3 24.1 4.1 0.0 3.5 8.9 27.9 13.0 30.1 3.9 20.1 6.4 12.1 27.0 40.6 7.8 7.8 47.2 21.9 12.6 3.9 87.7 4.7 5.8 8.9 5.1 18.0 32.3 20.8 0.0 0.4 18.3 8.1 37.4 4.6 14.5 NINL "KIAA0980, NLP" ENSG00000101004 "Ninein like" Q9Y2I6 20 25452705-25585517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 20.1;Cone photoreceptor cells: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 10 "T-cells: 2.2" "Cell line enhanced" "Detected in many" "AF22: 14.6;Hep G2: 22.9" "Low region specificity" "Detected in many" HPA000686 Uncertain Uncertain "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Microtubules, Cytokinetic bridge, Cytosol" "HPA000686: AB_1079193" "unprognostic (7.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (2.63e-2)" "unprognostic (4.84e-2)" "unprognostic (4.64e-2)" "unprognostic (1.16e-1)" "unprognostic (8.56e-2)" "unprognostic (2.50e-1)" "unprognostic (7.56e-2)" "prognostic favorable (1.47e-4)" "unprognostic (3.39e-1)" "prognostic favorable (1.03e-5)" "unprognostic (3.95e-2)" "unprognostic (2.72e-1)" "unprognostic (1.51e-1)" "unprognostic (6.26e-2)" 3.8 7.5 5.9 7.6 10.7 0.8 4.2 17.2 4.2 10.3 6.7 5.5 3.9 4.1 13.0 9.7 4.7 4.1 7.5 4.0 5.8 6.3 17.1 5.9 5.3 2.7 4.5 4.2 18.5 5.0 14.8 12.1 2.0 7.5 8.8 2.8 13.8 4.7 5.2 5.2 2.7 3.6 9.7 5.5 5.3 6.5 10.5 2.0 17.2 8.2 2.6 3.9 2.8 6.6 0.2 0.0 0.0 0.0 0.0 2.2 0.2 0.6 6.7 14.6 9.6 1.6 4.9 4.5 2.2 1.9 2.0 2.8 1.7 4.7 0.3 3.2 3.5 4.8 0.5 2.1 0.4 1.7 0.3 3.0 1.0 3.0 22.9 3.5 0.3 0.0 6.0 0.4 2.3 0.0 5.6 4.2 11.2 1.1 0.1 2.4 5.9 13.0 0.4 4.1 0.1 0.7 0.3 11.4 0.5 1.0 0.8 14.5 10.3 5.1 1.9 5.5 12.3 3.1 3.9 0.2 0.1 5.6 0.0 0.1 1.5 2.6 0.0 0.1 0.3 1.9 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.2 0.8 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.2 5.9 10.7 17.2 4.2 5.8 6.3 4.5 4.2 7.5 2.0 0.0 10.5 0.0 3.6 1.8 2.4 4.5 15.3 20.1 5.7 7.0 23.6 2.5 0.0 4.7 0.4 1.8 0.3 0.0 1.1 1.1 6.2 3.9 0.0 6.0 1.8 7.9 5.8 6.7 0.8 1.8 12.0 0.7 0.0 0.0 1.6 2.4 2.5 0.8 11.7 6.9 1.9 6.5 2.1 2.4 4.1 0.6 1.3 0.0 1.5 1.6 NISCH "I-1, IRAS, KIAA0975" ENSG00000010322 Nischarin Q9Y2I1 3 52455118-52493071 "FDA approved drug targets, Predicted intracellular proteins" Apoptosis Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Intestinal endocrine cells: 162.6;Peritubular cells: 231.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023189 Approved Approved "Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol" NA NA "Nucleoplasm, Cytosol" "Vesicles, Microtubules, Cytokinetic bridge" "HPA023189: AB_1854495" "unprognostic (6.66e-2)" "unprognostic (1.58e-1)" "unprognostic (1.59e-3)" "unprognostic (4.11e-3)" "unprognostic (1.64e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-2)" "unprognostic (6.56e-3)" "unprognostic (4.96e-2)" "unprognostic (8.33e-3)" "prognostic favorable (1.91e-4)" "unprognostic (1.40e-2)" "unprognostic (5.10e-2)" "unprognostic (1.19e-1)" "unprognostic (2.94e-2)" "unprognostic (1.47e-1)" "unprognostic (7.05e-3)" 16.5 24.9 29.7 14.3 36.1 18.1 16.7 84.5 47.5 24.1 16.4 21.4 22.1 12.9 24.4 19.5 14.1 20.9 16.4 14.1 24.7 18.8 14.9 11.8 17.1 15.9 13.2 35.6 30.7 21.8 23.3 55.3 21.0 20.8 29.8 11.4 27.0 26.5 30.2 12.2 42.5 14.8 20.9 13.3 16.8 14.8 27.3 13.9 16.3 17.1 7.8 12.6 21.9 19.5 5.8 6.6 6.5 8.3 6.1 8.1 6.4 7.4 7.9 24.6 20.0 18.4 20.4 20.2 16.2 10.7 13.0 13.3 11.8 11.3 10.5 4.5 22.4 10.7 10.1 13.0 17.6 7.7 10.6 14.0 18.9 27.5 11.4 16.8 11.1 17.0 32.0 14.2 14.0 12.0 27.5 20.9 21.1 10.0 11.7 12.1 10.7 19.8 24.6 15.0 9.6 13.5 11.8 6.7 12.2 14.8 15.0 10.4 18.2 17.5 4.6 11.2 22.4 14.5 18.7 22.8 18.3 17.6 18.5 11.5 19.5 11.1 13.3 12.6 18.1 11.1 6.3 8.3 6.5 6.4 7.6 6.3 4.7 5.4 8.1 4.5 5.8 6.5 6.5 2.9 6.1 1.1 6.6 5.8 6.4 29.7 36.1 84.5 47.5 24.7 18.8 13.2 35.6 20.8 13.9 23.8 28.8 12.0 14.1 24.5 39.6 18.2 7.6 10.7 18.2 14.0 7.9 26.9 8.3 11.4 7.2 20.2 15.8 0.0 8.2 11.6 19.3 13.0 24.3 12.4 25.4 27.0 162.6 52.2 62.2 16.8 81.7 22.2 18.6 5.4 16.3 10.6 9.2 13.9 231.3 11.0 23.3 25.8 23.1 31.1 15.6 19.4 20.3 13.8 15.0 10.8 NKIRAS1 "kappaB-Ras1, KBRAS1" ENSG00000197885 "NFKB inhibitor interacting Ras like 1" Q9NYS0 3 23891660-23946591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 60.9;Rod photoreceptor cells: 54.6;Spermatocytes: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077387 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA077387: " "unprognostic (1.36e-2)" "unprognostic (1.88e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.31e-4)" "unprognostic (1.08e-2)" "unprognostic (4.25e-2)" "unprognostic (5.30e-2)" "prognostic favorable (3.69e-4)" "unprognostic (3.69e-3)" "unprognostic (8.07e-3)" "unprognostic (1.19e-2)" "unprognostic (3.37e-2)" "prognostic favorable (7.71e-13)" "unprognostic (1.98e-1)" "unprognostic (4.90e-2)" "unprognostic (1.18e-1)" "unprognostic (2.63e-3)" 8.1 12.2 20.2 4.2 20.8 2.3 8.1 21.8 30.3 8.7 5.8 7.4 6.3 3.3 7.8 8.5 7.6 7.2 5.7 13.3 18.3 25.0 14.2 21.6 5.7 4.0 18.1 15.5 10.8 5.1 19.2 16.2 5.7 23.7 8.8 3.9 8.5 5.9 12.3 24.0 4.4 3.5 8.0 11.2 5.3 4.4 18.4 8.2 0.5 9.0 2.5 4.0 7.1 9.2 8.8 5.1 9.4 5.3 4.0 10.7 4.7 6.5 5.5 6.0 6.1 16.6 8.1 5.2 15.6 9.5 11.3 9.7 5.6 1.9 3.4 6.8 8.8 6.8 3.2 10.0 6.8 10.2 12.6 6.9 1.9 5.4 5.4 8.5 3.4 1.8 6.3 9.7 13.9 7.1 11.7 3.2 3.3 3.2 12.9 12.5 3.4 2.3 3.0 7.5 4.1 7.3 3.5 8.7 3.3 8.4 2.8 2.2 10.8 4.8 7.8 10.8 6.6 5.6 4.9 5.9 5.5 6.0 13.6 12.6 28.6 28.0 2.2 7.1 5.1 4.9 9.4 5.3 6.8 9.5 3.8 10.6 6.5 6.9 9.1 5.1 8.8 10.7 8.9 2.7 4.0 4.1 3.6 5.2 4.7 20.2 20.8 21.8 30.3 18.3 25.0 18.1 15.5 23.7 8.2 6.0 8.0 2.2 9.5 10.0 31.6 17.4 0.0 16.0 10.3 5.2 60.9 10.1 13.3 6.4 10.5 5.8 3.6 0.0 4.0 8.6 9.7 6.7 6.9 13.9 6.4 12.7 1.2 6.7 3.1 4.5 6.9 8.8 10.1 6.4 2.0 42.9 4.5 3.1 8.5 19.1 54.6 12.9 12.3 67.0 40.9 8.7 8.7 5.0 2.2 6.7 NKX1-1 "HSPX153, SAX2" ENSG00000235608 "NK1 homeobox 1" Q15270 4 1402932-1406331 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "pituitary gland: 1.0;testis: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "pons and medulla: 0.2" HPA029367 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA029367: AB_2673011" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX2-1 "BCH, NKX2A, TITF1, TTF-1, TTF1" ENSG00000136352 "NK2 homeobox 1" P43699 14 36516392-36521149 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "lung: 51.5;thyroid gland: 122.8" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 128.1;Alveolar cells type 2: 108.1;Club cells: 46.6" "Group enriched" "Detected in some" 39 "lung cancer: 30.9;thyroid cancer: 103.2" "Group enriched" "Detected in some" 6 "basal ganglia: 2.4;hypothalamus: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 48.7" "Group enriched" "Detected in some" 5 "basal ganglia: 3.4;hypothalamus: 12.0" "Group enriched" "Detected in some" 13 "basal ganglia: 6.4;hypothalamus: 16.1" "CAB000078, CAB053633, HPA074316" Enhanced Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "CAB000078: , CAB053633: AB_442138, HPA074316: " "unprognostic (3.79e-1)" "unprognostic (4.25e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" "unprognostic (1.26e-2)" "unprognostic (2.23e-1)" "unprognostic (1.18e-1)" "unprognostic (1.29e-1)" "unprognostic (1.83e-2)" "unprognostic (4.18e-1)" 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.5 0.0 0.0 51.5 0.1 0.0 0.1 0.0 0.0 0.0 4.9 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.4 0.0 122.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 48.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.0 0.1 0.2 2.5 0.0 0.1 0.1 0.4 128.1 108.1 0.0 0.0 0.0 0.0 0.6 0.0 14.7 46.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NKX2-3 "CSX3, NKX2.3, NKX2C, NKX4-3" ENSG00000119919 "NK2 homeobox 3" Q8TAU0 10 99532933-99536524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 12.5;intestine: 21.6;lymphoid tissue: 36.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HAP1: 2.1;NB-4: 4.8;REH: 6.2;THP-1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA047561 Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA047561: AB_2680088" "unprognostic (5.70e-2)" "unprognostic (2.95e-1)" "unprognostic (2.70e-4)" "unprognostic (6.34e-3)" "unprognostic (3.92e-2)" "unprognostic (7.40e-2)" "unprognostic (1.20e-1)" "unprognostic (4.91e-2)" "unprognostic (1.12e-1)" "unprognostic (1.19e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" 0.8 0.0 0.1 17.2 0.1 0.0 0.1 0.1 0.1 0.3 21.6 0.1 0.1 10.4 0.2 0.1 0.5 0.0 12.5 0.1 0.1 0.0 0.1 0.2 0.1 1.1 0.1 0.1 0.1 6.4 0.0 0.1 0.1 0.1 0.1 4.6 0.1 9.0 0.5 0.1 0.0 19.1 3.1 0.1 36.8 1.8 0.1 0.1 0.2 1.0 0.7 3.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 6.2 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.4 0.0 1.6 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NLGN1 KIAA1070 ENSG00000169760 "Neuroligin 1" Q8N2Q7 3 173396284-174286644 "Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 50.9;Leydig cells: 23.9;Muller glia cells: 30.8" "Group enriched" "Detected in some" 9 "glioma: 3.8;melanoma: 2.2;renal cancer: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 16.2;HUVEC TERT2: 15.8;RH-30: 16.9;WM-115: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006572, HPA006680, CAB033261" Enhanced Uncertain "Nuclear bodies,Plasma membrane" NA NA 40000 "Plasma membrane" "Nuclear bodies" "CAB033261: AB_2151659, HPA006572: , HPA006680: AB_1854400" "unprognostic (2.81e-1)" "unprognostic (9.86e-2)" "unprognostic (3.08e-5)" "unprognostic (7.52e-5)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (6.67e-2)" "unprognostic (6.65e-2)" "unprognostic (1.78e-1)" "unprognostic (8.07e-2)" "unprognostic (3.21e-3)" "unprognostic (1.86e-2)" "unprognostic (1.97e-1)" "unprognostic (4.08e-2)" "unprognostic (8.81e-2)" "unprognostic (2.41e-3)" "unprognostic (5.37e-2)" 3.9 2.4 13.4 1.4 9.4 0.6 1.6 20.2 26.9 6.3 3.2 5.6 0.0 1.0 4.3 5.0 4.8 5.9 3.3 5.7 8.8 9.1 5.6 0.6 1.2 1.0 6.3 7.8 2.8 2.0 0.6 6.9 1.4 6.8 4.4 2.2 4.3 0.9 5.9 0.7 1.0 1.6 8.2 4.6 0.7 2.0 11.1 8.9 0.0 2.2 0.4 0.8 5.1 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 7.7 8.3 0.0 3.2 8.1 0.4 0.5 0.0 0.3 0.0 0.1 16.2 3.0 0.0 2.3 0.0 0.8 0.0 3.8 1.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 6.5 15.8 0.0 0.0 1.0 0.1 0.0 0.0 0.0 4.6 0.0 1.1 0.0 16.9 3.9 3.0 0.0 1.6 1.1 0.0 0.0 7.9 0.7 0.4 0.0 1.9 8.8 0.9 6.3 7.2 7.6 0.0 0.0 3.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 9.4 20.2 10.9 8.8 9.1 6.3 7.8 6.8 8.9 0.0 0.3 0.0 0.6 0.7 11.4 2.0 0.0 0.0 0.0 3.5 3.9 0.2 0.0 0.3 50.9 0.3 0.0 0.0 0.0 0.1 2.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.9 23.9 0.0 13.5 0.0 0.0 30.8 0.1 0.0 13.4 7.1 9.7 6.5 1.0 0.4 0.7 0.6 0.1 0.0 0.0 0.1 NLRC3 "CLR16.2, FLJ00348, NOD3" ENSG00000167984 "NLR family CARD domain containing 3" Q7RTR2 16 3539033-3577400 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 27.0" "Cell type enhanced" "Detected in some" 14 "Ito cells: 6.2;T-cells: 15.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 6.3;HL-60: 13.1;HMC-1: 6.6;JURKAT: 6.5;NB-4: 14.0;U-698: 20.2;U-937: 9.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA048062 Supported "Vesicles,Centriolar satellite,Cytosol" NA NA Cytosol "Vesicles, Centriolar satellite" "HPA048062: AB_2680242" "unprognostic (4.93e-3)" "unprognostic (3.84e-4)" "unprognostic (7.61e-4)" "unprognostic (4.94e-7)" "unprognostic (9.56e-2)" "unprognostic (3.76e-5)" "unprognostic (1.86e-3)" "unprognostic (6.70e-3)" "unprognostic (2.66e-2)" "unprognostic (7.02e-2)" "unprognostic (3.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.40e-2)" "unprognostic (5.13e-2)" "unprognostic (7.15e-3)" "unprognostic (4.54e-2)" "unprognostic (2.08e-2)" 0.2 0.4 0.0 20.1 0.1 2.8 0.0 0.0 0.2 0.4 1.3 0.0 0.2 1.2 1.0 0.1 1.0 0.0 1.8 0.8 0.0 0.6 0.5 6.0 11.2 0.2 0.0 0.1 1.5 0.0 0.0 0.6 0.2 0.9 0.7 0.9 2.7 0.2 0.5 0.0 2.4 0.1 0.0 10.5 1.4 0.0 0.0 27.0 0.4 1.1 18.1 1.6 1.0 1.0 0.0 2.6 0.0 4.7 4.1 3.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 5.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 6.3 0.1 0.0 0.0 13.1 6.6 0.0 0.0 0.0 0.0 0.3 0.2 6.5 0.1 0.0 0.0 0.3 5.4 14.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 3.3 0.4 0.2 0.0 0.2 0.1 0.3 0.0 20.2 0.1 9.8 0.0 2.6 0.0 0.0 3.7 0.0 4.1 1.0 2.7 3.8 0.0 0.8 2.1 2.0 0.0 4.7 0.0 0.0 3.1 3.3 3.0 0.0 4.2 0.2 0.0 1.6 3.7 0.0 1.4 1.2 1.8 3.9 0.0 0.0 0.0 2.7 0.6 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.1 0.0 0.0 6.2 0.6 0.7 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.5 0.2 0.0 0.0 15.2 0.0 0.1 NLRP12 "CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2" ENSG00000142405 "NLR family pyrin domain containing 12" P59046 19 53793603-53824394 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 22.8;bone marrow: 11.0;lung: 6.5;lymphoid tissue: 13.5" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 9.0;Club cells: 6.8;granulocytes: 7.0;Kupffer cells: 12.3;Macrophages: 6.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 2.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 22.8;neutrophil: 15.0" "Group enriched" "Detected in many" 4 "granulocytes: 22.8;monocytes: 8.7" "Group enriched" "Detected in some" 4 "HMC-1: 7.7;THP-1: 6.7;U-87 MG: 7.3;U-937: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042099, HPA042981" Approved Uncertain "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA042099: , HPA042981: AB_10795712" "unprognostic (6.92e-2)" "unprognostic (3.11e-1)" "unprognostic (6.66e-3)" "unprognostic (9.82e-2)" "unprognostic (1.81e-4)" "unprognostic (3.90e-2)" "unprognostic (5.79e-2)" "unprognostic (6.26e-2)" "unprognostic (1.29e-1)" "unprognostic (1.60e-5)" "unprognostic (1.63e-1)" "unprognostic (1.68e-1)" "unprognostic (3.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (1.46e-2)" "unprognostic (4.48e-1)" 1.9 0.3 0.2 4.2 0.6 11.0 0.4 0.2 0.2 0.9 0.3 0.1 0.9 0.3 0.7 0.7 0.6 1.0 0.5 3.3 0.2 0.2 0.5 0.5 6.5 13.5 0.6 0.3 1.0 0.3 0.1 0.2 1.1 0.8 0.3 0.1 0.5 1.7 0.0 0.2 0.2 0.3 1.4 0.5 10.2 0.4 1.0 0.6 0.3 0.3 0.4 0.2 1.1 1.4 0.0 3.6 22.8 8.7 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.6 7.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 6.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 7.3 6.1 0.0 22.8 8.7 11.0 0.0 2.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 15.0 0.0 1.5 0.0 0.0 2.1 0.2 0.6 0.2 0.2 0.2 0.2 0.6 0.3 0.8 0.6 6.0 9.0 0.0 0.7 0.3 0.8 0.4 0.0 4.0 6.8 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.4 0.7 7.0 0.0 2.4 0.0 0.0 0.0 12.3 0.0 0.3 6.1 1.7 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.6 NLRP14 "CLR11.2, GC-LRR, Nalp-iota, NALP14, NOD5, PAN8" ENSG00000158077 "NLR family pyrin domain containing 14" Q86W24 11 7020446-7071308 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 2.5;testis: 3.4" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 1.7;Cone photoreceptor cells: 2.0;Distal tubular cells: 1.7;Early spermatids: 1.5;Rod photoreceptor cells: 2.9;Spermatocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HEK 293: 1.7;HL-60: 1.2;HUVEC TERT2: 4.1;U-698: 2.2" "Not detected" "Not detected" HPA039477 Approved Uncertain Cytosol NA NA Cytosol "HPA039477: AB_10794748" "unprognostic (6.46e-3)" "unprognostic (5.76e-3)" "unprognostic (1.44e-4)" "unprognostic (7.20e-4)" "unprognostic (5.57e-2)" "unprognostic (8.02e-3)" "unprognostic (6.57e-2)" "unprognostic (2.65e-1)" "unprognostic (2.68e-1)" "unprognostic (1.44e-1)" "unprognostic (2.68e-1)" "unprognostic (2.65e-2)" "unprognostic (3.17e-3)" "unprognostic (6.69e-2)" "unprognostic (3.22e-1)" "unprognostic (3.85e-2)" "unprognostic (1.25e-1)" 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.1 0.8 0.1 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.3 0.3 1.6 2.5 0.4 0.2 0.4 1.3 0.0 1.7 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.2 0.0 1.2 0.3 0.0 3.4 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.2 0.2 0.9 0.5 0.7 0.0 0.4 1.6 0.0 0.1 0.4 0.0 0.0 0.1 0.7 0.0 1.7 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.1 0.0 0.1 0.0 4.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 2.2 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.3 2.9 0.0 0.0 2.5 0.9 0.0 0.0 0.0 0.0 0.0 NOD2 "BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1" ENSG00000167207 "Nucleotide binding oligomerization domain containing 2" Q9HC29 16 50693588-50734041 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 5.9;Basal keratinocytes: 5.3;Kupffer cells: 9.7;Macrophages: 13.7;Suprabasal keratinocytes: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 15.3;eosinophil: 3.9;intermediate monocyte: 9.1;myeloid DC: 15.5;neutrophil: 6.3;non-classical monocyte: 5.8" "Group enriched" "Detected in many" 6 "dendritic cells: 15.5;granulocytes: 6.3;monocytes: 15.3" "Cell line enhanced" "Detected in some" "HMC-1: 11.9;T-47d: 5.7;THP-1: 6.8;U-266/70: 15.7;U-266/84: 6.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA041985, HPA054494" Enhanced Approved "Golgi apparatus,Cytosol" No NA "Golgi apparatus, Cytosol" "HPA041985: AB_2677780, HPA054494: AB_2682505" "unprognostic (1.01e-1)" "unprognostic (4.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.02e-3)" "unprognostic (9.91e-3)" "unprognostic (5.84e-2)" "unprognostic (5.90e-3)" "unprognostic (1.23e-1)" "unprognostic (4.17e-1)" "unprognostic (3.88e-2)" "unprognostic (6.94e-3)" "unprognostic (1.48e-2)" "unprognostic (2.31e-9)" "unprognostic (4.38e-2)" "unprognostic (1.08e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-1)" 2.6 0.6 0.9 6.2 0.5 13.2 1.7 0.5 1.5 5.7 1.0 0.7 0.9 1.5 1.8 2.6 12.6 1.1 3.7 3.2 1.2 0.5 0.8 1.9 7.6 8.0 1.6 0.0 1.4 0.4 0.0 1.0 2.6 1.4 1.8 1.0 1.2 5.5 0.4 1.4 14.2 1.3 1.9 3.2 4.7 1.4 2.2 0.9 1.0 0.9 12.1 8.3 4.0 10.6 0.0 15.5 6.3 15.3 1.9 1.0 6.8 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 11.9 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.1 0.0 1.4 0.0 0.0 5.7 6.8 0.0 0.0 0.0 0.0 0.0 15.7 6.7 0.0 0.2 0.1 0.0 2.0 15.3 3.9 0.2 9.1 0.5 0.0 1.0 0.9 15.5 0.0 0.1 0.3 6.3 1.9 5.8 0.6 0.6 6.8 0.9 0.5 0.5 1.5 1.2 0.5 1.6 0.0 1.4 0.9 0.0 5.9 0.0 0.3 5.3 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 1.1 0.0 2.4 0.0 1.2 0.0 9.7 0.0 0.0 13.7 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.2 0.7 0.0 0.3 NOL7 "C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1" ENSG00000225921 "Nucleolar protein 7" Q9UMY1 6 13615327-13632739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029185 Supported Supported "Nucleoli,Mitotic chromosome,Mitochondria" Yes Yes "Nucleoli, Mitotic chromosome" Mitochondria "HPA029185: AB_10601274" "unprognostic (8.76e-2)" "unprognostic (8.94e-2)" "unprognostic (8.38e-2)" "unprognostic (1.15e-2)" "unprognostic (3.75e-1)" "unprognostic (5.77e-2)" "unprognostic (2.50e-3)" "unprognostic (1.57e-1)" "unprognostic (4.64e-2)" "prognostic favorable (3.64e-5)" "unprognostic (1.26e-1)" "unprognostic (2.03e-2)" "unprognostic (8.04e-3)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "unprognostic (4.79e-2)" 35.8 40.5 45.2 41.4 42.3 44.9 36.6 26.7 38.7 30.5 36.7 25.9 29.2 37.2 35.2 36.7 38.6 33.0 36.6 53.4 39.9 38.4 56.9 58.6 28.8 36.6 41.6 30.2 42.4 42.6 54.0 40.5 45.6 36.8 39.5 32.4 23.1 42.3 35.6 59.3 30.6 46.4 36.7 47.7 45.2 34.8 32.5 40.4 34.3 49.5 36.9 36.0 43.3 56.0 50.7 45.5 38.3 38.0 28.8 49.6 30.9 29.8 15.5 14.6 21.0 11.4 13.2 29.7 27.4 14.9 25.7 24.4 29.4 12.6 38.5 54.3 16.6 31.4 18.5 22.0 20.7 25.2 21.6 36.0 33.1 15.4 49.4 24.5 49.1 26.1 12.4 21.8 23.5 14.5 13.4 16.7 21.7 51.3 10.5 22.2 19.2 27.9 54.5 19.1 17.5 26.6 30.2 20.8 59.2 25.6 9.9 37.2 23.9 16.0 38.8 35.8 19.0 24.1 17.9 25.3 23.7 22.3 24.3 48.1 24.6 47.7 47.0 13.6 29.1 35.8 16.0 30.2 38.3 31.0 35.3 36.6 50.7 45.5 38.3 35.9 41.4 49.6 37.8 14.0 28.8 38.0 45.5 46.9 30.9 45.2 42.3 26.7 38.7 39.9 38.4 41.6 30.2 36.8 40.4 86.4 58.0 93.0 81.6 80.6 62.4 203.3 63.7 148.5 80.8 54.1 21.6 114.5 104.5 133.3 133.2 97.2 61.4 70.0 226.4 127.6 86.4 80.3 87.8 56.9 100.9 46.1 35.6 46.6 45.5 19.9 76.5 83.5 96.2 155.9 59.8 89.8 148.3 72.9 74.6 135.1 46.0 64.7 96.7 142.1 122.5 79.2 129.9 82.8 73.6 94.7 NOL9 "FLJ23323, Grc3, NET6" ENSG00000162408 "Nucleolar protein 9" Q5SY16 1 6521347-6554535 "Predicted intracellular proteins" "rRNA processing" "Kinase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036347 Supported "Nucleoli,Intermediate filaments" NA NA Nucleoli "Intermediate filaments" "HPA036347: AB_2675076" "unprognostic (3.03e-1)" "unprognostic (4.93e-2)" "unprognostic (4.99e-2)" "unprognostic (3.14e-3)" "unprognostic (2.12e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (2.48e-1)" "unprognostic (1.31e-1)" "unprognostic (8.90e-2)" "unprognostic (1.44e-3)" "unprognostic (2.32e-1)" "unprognostic (3.80e-2)" "unprognostic (3.32e-2)" "unprognostic (3.40e-1)" "unprognostic (3.54e-2)" "unprognostic (4.65e-2)" 12.7 11.3 10.4 10.3 15.1 19.3 11.0 16.4 19.3 14.7 11.2 14.1 6.8 7.7 13.3 11.6 12.1 11.4 8.8 8.3 10.8 9.7 9.6 15.2 9.4 14.4 8.6 9.6 16.8 14.7 15.5 10.5 9.8 12.0 13.0 10.0 9.4 9.1 10.3 17.9 18.0 11.4 12.4 7.2 22.0 11.0 9.4 9.2 20.9 9.4 8.9 14.9 11.0 9.3 6.9 5.8 5.0 4.8 2.8 8.4 1.9 5.1 7.4 4.2 12.6 5.6 3.4 4.5 5.1 3.3 5.3 5.6 10.1 7.0 14.3 6.1 5.7 4.6 6.8 8.4 6.9 9.2 5.8 4.5 9.7 11.4 7.9 5.6 8.2 5.4 4.9 2.1 11.3 9.9 3.1 6.2 6.4 11.4 6.0 5.4 8.9 8.0 7.4 5.7 4.0 7.2 10.2 9.8 6.7 4.2 4.8 8.1 3.7 7.9 10.0 6.2 4.5 6.5 3.8 8.1 8.5 6.9 6.0 8.5 5.1 4.8 26.1 7.9 9.2 4.0 5.0 3.5 2.6 5.7 3.2 5.7 5.1 8.1 5.2 2.3 6.9 8.4 7.0 2.2 2.8 4.8 5.8 5.1 1.9 10.4 15.1 16.4 19.3 10.8 9.7 8.6 9.6 12.0 9.2 17.9 17.9 11.5 5.7 13.7 15.8 12.1 10.2 9.4 7.9 7.0 13.7 13.0 13.3 8.4 4.6 11.3 5.8 0.0 7.4 11.0 11.7 4.8 4.7 11.6 7.8 9.5 6.4 17.2 11.4 13.3 8.9 6.5 1.7 10.0 11.7 7.2 7.8 7.0 12.0 7.8 17.0 0.0 11.1 10.8 19.7 12.9 10.6 15.7 11.8 5.3 NOX3 GP91-3 ENSG00000074771 "NADPH oxidase 3" Q9HBY0 6 155395370-155455903 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "adrenal gland: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "MCF7: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA073837 Uncertain Vesicles NA NA Vesicles "HPA073837: " "unprognostic (3.42e-1)" 0.0 1.8 0.4 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPHP1 "JBTS4, NPH1, SLSN1" ENSG00000144061 "Nephrocystin 1" O15259 2 110122311-110205066 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Ciliopathy, Disease mutation, Joubert syndrome, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 36.7" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 172.6;Early spermatids: 98.9;Rod photoreceptor cells: 72.4;Spermatocytes: 129.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046093, HPA074071" Approved Uncertain Vesicles NA NA Vesicles "HPA046093: AB_2679535, HPA074071: " "unprognostic (2.10e-2)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (5.58e-2)" "unprognostic (4.63e-2)" "unprognostic (1.56e-3)" "unprognostic (4.66e-2)" "unprognostic (1.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.66e-2)" "unprognostic (1.29e-2)" "unprognostic (1.08e-1)" "unprognostic (2.93e-3)" "unprognostic (3.35e-2)" "unprognostic (1.82e-1)" "unprognostic (8.64e-2)" 3.1 4.3 8.5 1.8 13.7 0.8 5.1 2.1 7.2 5.6 4.7 4.9 8.8 1.7 7.2 11.3 2.1 19.3 4.3 4.4 9.0 7.5 8.7 1.5 5.7 1.5 3.8 6.2 5.4 3.5 17.7 28.1 2.1 20.3 4.4 2.6 4.6 2.8 8.9 36.7 1.7 1.8 7.2 5.4 1.9 3.7 25.0 7.2 0.0 8.9 3.2 1.3 4.1 3.7 3.5 1.0 1.0 0.3 3.2 1.8 0.7 8.5 2.7 5.7 4.2 3.2 6.8 1.2 2.2 7.1 7.7 7.6 2.8 6.4 0.5 5.7 5.1 7.3 4.2 2.7 6.9 9.2 1.6 3.4 0.2 1.6 1.9 4.5 1.3 0.0 4.6 4.2 12.0 3.8 11.6 4.8 1.8 0.1 0.8 4.6 1.7 0.8 2.1 2.5 0.2 4.5 0.0 5.9 0.2 13.0 0.7 3.0 3.1 3.2 3.9 7.8 2.9 4.6 1.0 3.1 4.5 3.8 4.9 7.0 2.4 2.5 0.6 13.1 0.2 3.2 0.7 0.1 0.1 1.2 0.3 1.8 2.7 0.9 0.6 1.0 3.5 1.8 1.4 1.0 3.2 0.1 0.1 0.1 0.7 8.5 13.7 2.1 7.2 9.0 7.5 3.8 6.2 20.3 7.2 6.0 6.2 0.9 7.4 4.6 11.8 11.8 7.6 172.6 30.7 8.7 45.2 1.5 16.6 12.1 98.9 6.7 0.0 0.0 4.4 0.4 4.6 3.5 0.0 2.4 1.3 20.6 0.0 7.4 1.0 44.3 6.9 2.3 6.8 0.0 0.5 10.9 6.3 0.2 9.2 21.1 72.4 12.9 3.9 129.6 24.9 3.4 0.2 1.0 1.8 4.7 NR2F6 "EAR-2, ERBAL2" ENSG00000160113 "Nuclear receptor subfamily 2 group F member 6" P10588 19 17231883-17245940 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 123.8;Hepatocytes: 131.0;Horizontal cells: 143.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 59.1;EFO-21: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079917 Supported "Nuclear speckles,Cytosol" NA Yes "Nuclear speckles" Cytosol "CAB079917: AB_2635238" "unprognostic (1.48e-1)" "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (3.07e-1)" "unprognostic (3.67e-1)" "unprognostic (7.20e-2)" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (6.62e-2)" "unprognostic (9.68e-2)" "unprognostic (1.31e-1)" "unprognostic (2.29e-2)" "unprognostic (7.28e-3)" "unprognostic (1.37e-3)" 10.0 8.0 5.4 9.3 5.6 1.1 15.2 6.9 7.4 9.0 23.4 4.7 10.9 26.0 7.9 26.3 16.8 7.7 11.3 14.8 4.6 5.9 17.7 49.3 10.0 2.8 4.8 4.7 9.8 23.5 7.0 8.6 26.5 4.0 10.5 8.2 8.0 13.4 10.3 20.2 9.4 36.2 6.6 2.4 5.0 26.8 9.7 4.5 1.7 13.8 9.3 6.7 10.7 11.5 2.7 1.8 1.6 1.1 7.4 6.5 1.3 19.4 11.7 6.4 11.6 2.5 2.8 59.1 11.0 4.0 4.8 4.1 7.9 17.2 4.6 34.6 4.9 2.8 9.7 4.8 6.3 2.1 6.1 28.0 4.2 7.5 14.2 5.6 2.0 5.9 3.7 7.3 2.2 3.6 5.0 2.9 2.1 9.9 1.1 2.0 10.4 1.7 7.4 17.6 14.6 18.2 3.5 4.0 3.9 6.6 12.7 5.1 14.8 6.1 21.5 12.4 6.5 11.9 6.4 4.8 3.4 8.3 6.5 8.7 6.6 2.3 3.3 4.2 3.0 4.1 0.0 1.1 1.6 2.7 0.0 2.4 0.5 3.9 2.5 1.8 2.7 6.5 2.2 0.2 7.4 0.1 0.8 3.5 1.3 5.4 5.6 6.9 7.4 4.6 5.9 4.8 4.7 4.0 4.5 8.9 18.5 4.7 14.9 9.4 63.1 33.0 33.1 10.7 11.4 24.4 72.6 54.8 24.9 20.6 7.8 12.6 123.8 0.0 41.6 54.2 11.1 17.2 1.1 131.0 13.7 143.0 44.1 17.8 2.9 4.1 16.4 3.3 10.1 1.8 71.7 40.3 40.0 73.0 17.7 29.4 53.0 6.5 15.5 1.0 7.7 9.3 66.7 2.9 56.2 14.1 NR5A1 "AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1" ENSG00000136931 "Nuclear receptor subfamily 5 group A member 1" Q13285 9 124481236-124507430 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 47.7;lymphoid tissue: 50.8" "Group enriched" "Detected in some" 10 "Leydig cells: 10.9;Peritubular cells: 7.1;Sertoli cells: 12.9" "Group enriched" "Detected in some" 5 "head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 13 "dendritic cells: 1.3" "Cell line enhanced" "Detected in some" "HEL: 39.1;Hep G2: 25.3;K-562: 9.3" "Region enriched" "Detected in single" 20 "hypothalamus: 6.1" "Not detected" "Not detected" HPA079181 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA079181: " "unprognostic (1.66e-1)" "unprognostic (3.08e-1)" "unprognostic (6.13e-5)" "unprognostic (2.32e-7)" "unprognostic (3.95e-1)" "unprognostic (1.16e-1)" "unprognostic (1.13e-1)" "unprognostic (1.61e-1)" "unprognostic (1.60e-2)" "unprognostic (9.74e-2)" "unprognostic (4.14e-2)" "unprognostic (4.75e-3)" "unprognostic (1.14e-1)" "unprognostic (1.49e-2)" 0.2 47.7 0.2 0.2 0.5 0.0 0.2 0.2 0.4 0.2 0.2 1.3 0.2 0.0 0.2 0.4 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 13.1 0.2 0.0 5.8 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 50.8 0.0 9.4 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.1 0.0 25.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.5 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 12.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NR5A2 "B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1" ENSG00000116833 "Nuclear receptor subfamily 5 group A member 2" O00482 1 200027602-200177424 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "intestine: 38.7;liver: 36.1;pancreas: 100.4" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 35.9;Exocrine glandular cells: 46.6;Hepatocytes: 34.2;Ito cells: 46.1;Pancreatic endocrine cells: 31.2;Undifferentiated cells: 29.8" "Cancer enhanced" "Detected in many" "liver cancer: 6.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "A549: 19.7;HAP1: 12.0;HMC-1: 5.2;HUVEC TERT2: 16.5" "Region enhanced" "Detected in single" "hypothalamus: 1.5" "HPA005455, HPA017067" Approved Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA005455: AB_1078140, HPA017067: AB_1844767" "unprognostic (7.47e-2)" "unprognostic (1.43e-1)" "unprognostic (5.84e-2)" "unprognostic (1.56e-2)" "unprognostic (1.19e-2)" "unprognostic (6.63e-3)" "unprognostic (4.46e-2)" "unprognostic (3.78e-2)" "unprognostic (3.34e-1)" "unprognostic (8.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.44e-1)" "unprognostic (1.00e-7)" "unprognostic (5.48e-2)" "unprognostic (5.07e-2)" "unprognostic (9.23e-2)" "unprognostic (1.37e-1)" 2.9 0.2 0.2 4.5 0.3 0.0 2.6 0.2 0.2 2.3 23.8 0.2 0.6 8.1 3.5 1.3 0.7 1.3 5.7 0.5 0.2 0.4 0.4 36.1 1.6 0.7 0.3 0.3 1.0 100.4 0.0 0.3 0.3 0.3 1.1 6.3 0.3 0.5 1.3 1.0 0.7 38.7 1.8 0.4 0.3 0.6 0.6 0.2 0.2 0.8 0.3 0.4 0.8 1.1 1.3 1.4 5.5 1.2 1.5 1.1 0.3 0.0 19.7 0.0 0.1 0.0 0.2 0.5 0.0 0.3 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.6 0.5 12.0 0.0 0.0 2.5 0.8 0.0 0.2 2.0 0.4 0.0 5.2 0.1 0.0 0.0 0.1 0.0 16.5 0.1 0.0 0.3 0.0 0.5 0.0 0.3 0.8 0.0 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 1.6 3.8 0.3 0.1 0.8 0.2 0.1 0.1 2.8 1.8 2.0 0.3 0.1 0.1 5.5 1.2 1.1 0.6 0.7 0.7 0.7 1.0 0.8 0.4 1.3 1.1 1.0 4.2 1.5 0.5 1.4 0.9 0.3 0.2 0.3 0.2 0.2 0.2 0.4 0.3 0.3 0.3 0.2 0.0 1.7 0.0 0.1 1.6 0.1 6.2 22.9 1.4 0.0 0.0 0.0 0.0 0.0 25.4 0.2 16.3 35.9 0.0 46.6 0.0 0.6 0.2 12.7 34.2 0.1 0.0 4.7 46.1 6.5 0.0 0.6 0.0 0.0 5.4 9.8 0.0 31.2 24.6 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.3 0.0 0.0 29.8 0.2 NRF1 "ALPHA-PAL, EWG" ENSG00000106459 "Nuclear respiratory factor 1" Q16656 7 129611714-129757082 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029329 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029329: AB_10601240" "unprognostic (2.80e-2)" "unprognostic (2.20e-3)" "unprognostic (4.51e-1)" "unprognostic (4.04e-2)" "unprognostic (2.01e-1)" "unprognostic (4.20e-3)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.09e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-2)" "unprognostic (1.18e-3)" "unprognostic (2.99e-3)" "unprognostic (1.83e-2)" "unprognostic (2.06e-1)" "unprognostic (6.52e-2)" "unprognostic (4.20e-1)" "unprognostic (2.06e-3)" 14.8 7.3 10.9 18.9 13.0 20.3 18.2 22.2 11.1 15.4 10.3 12.6 16.0 9.0 15.7 10.4 10.1 18.7 10.0 12.3 11.5 11.1 10.0 7.8 11.2 18.7 12.1 7.7 24.4 15.2 13.5 10.9 12.5 11.5 11.5 9.9 11.7 13.8 13.9 19.3 12.2 10.7 14.0 9.6 14.2 8.7 17.2 15.2 29.2 13.8 11.4 16.1 12.8 19.2 8.8 7.0 13.1 7.0 5.8 13.3 6.2 11.8 9.7 14.1 12.4 8.5 6.8 11.2 8.3 8.6 12.7 9.9 11.7 7.9 13.6 6.1 9.3 8.0 9.1 15.1 8.4 13.0 13.0 10.8 11.3 8.2 7.9 6.2 13.8 11.3 5.8 7.9 12.5 12.1 7.3 9.3 13.3 13.6 10.5 7.7 10.8 27.0 13.0 13.1 10.9 8.7 17.2 11.4 12.1 7.2 8.7 12.2 13.3 12.5 13.0 8.4 12.0 8.1 13.2 7.2 7.2 10.0 8.4 15.2 11.5 11.4 24.2 7.6 12.8 13.9 6.1 5.5 13.1 11.4 6.9 13.3 7.7 8.7 10.5 7.0 8.8 9.6 8.2 11.4 5.8 7.0 4.7 9.1 6.2 10.9 13.0 22.2 11.1 11.5 11.1 12.1 7.7 11.5 15.2 3.0 6.2 3.7 2.8 6.0 10.2 5.1 5.1 13.4 5.7 3.5 9.8 2.1 0.0 2.1 0.3 6.7 3.2 0.0 3.1 3.5 3.7 4.4 4.7 4.7 2.6 9.5 6.4 8.0 5.6 1.4 4.9 5.8 5.0 2.8 5.0 5.6 2.4 5.8 4.2 2.2 10.4 6.5 3.6 6.7 6.0 6.8 2.9 9.2 3.9 2.6 NRG3 ENSG00000185737 "Neuregulin 3" P56975 10 81875314-82987179 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6" "Group enriched" "Detected in some" 5 "Bipolar cells: 13.7;Cholangiocytes: 5.1;Early spermatids: 17.6;Ito cells: 7.4;Late spermatids: 7.9;Muller glia cells: 5.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.5;HEK 293: 3.4;HUVEC TERT2: 1.7;SK-MEL-30: 7.3;U-2 OS: 6.4" "Low region specificity" "Detected in all" HPA075789 Uncertain Vesicles "Secreted in brain" NA NA Vesicles "HPA075789: " "unprognostic (6.15e-3)" "unprognostic (2.43e-2)" "unprognostic (1.65e-5)" "unprognostic (1.89e-1)" "unprognostic (7.03e-4)" "unprognostic (1.85e-2)" "unprognostic (1.06e-1)" "unprognostic (7.05e-2)" "unprognostic (9.33e-2)" "unprognostic (1.82e-1)" "unprognostic (1.21e-1)" "unprognostic (3.75e-2)" "unprognostic (3.31e-4)" "unprognostic (1.04e-1)" "unprognostic (7.68e-3)" "unprognostic (7.27e-4)" 0.9 1.5 15.6 1.2 8.2 0.6 2.8 1.9 30.6 0.8 0.9 4.8 0.0 0.8 0.7 0.7 0.9 8.0 5.3 0.9 14.5 6.2 1.2 1.5 1.6 0.8 4.9 8.0 0.7 0.9 0.7 1.6 1.2 6.5 0.9 0.9 3.1 5.0 1.1 0.7 0.8 0.9 0.9 5.6 0.8 0.8 3.3 6.0 0.0 0.9 0.0 0.8 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 7.3 0.5 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 8.2 1.9 12.8 14.5 6.2 4.9 8.0 6.5 6.0 0.0 0.0 0.0 0.0 0.0 13.7 0.8 5.1 0.0 0.0 0.0 2.0 0.0 0.0 0.9 17.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 7.9 0.6 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.7 0.0 1.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 NRL "D14S46E, NRL-MAF, RP27" ENSG00000129535 "Neural retina leucine zipper" P54845 14 24080107-24115014 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "retina: 124.5" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 2618.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026066, HPA064599" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB026066: , HPA064599: AB_2685295" "unprognostic (2.71e-2)" "unprognostic (8.17e-4)" "unprognostic (4.60e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (1.99e-2)" "unprognostic (5.29e-2)" "unprognostic (1.88e-5)" "unprognostic (3.59e-2)" "unprognostic (7.84e-3)" "unprognostic (1.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.38e-5)" "unprognostic (2.56e-2)" "unprognostic (1.10e-1)" "unprognostic (1.73e-1)" "unprognostic (1.35e-3)" 1.5 2.7 4.4 2.3 4.1 1.0 1.8 2.1 2.8 1.9 1.3 1.7 1.7 3.2 1.4 7.9 1.3 1.4 1.2 2.7 3.8 3.1 3.5 3.9 1.7 1.9 3.9 1.4 1.8 3.4 5.4 2.8 1.8 2.1 1.8 1.0 124.5 1.6 2.4 4.1 0.9 1.9 1.0 4.4 2.6 1.3 4.3 1.2 3.3 4.3 1.8 1.6 1.5 2.2 3.8 1.4 4.1 1.3 2.0 2.7 1.2 0.8 1.7 0.5 1.8 0.5 0.5 1.6 0.4 0.4 2.2 1.0 1.1 0.8 2.5 0.8 1.0 1.6 1.0 1.0 1.2 0.3 1.8 1.5 0.7 0.5 3.7 1.2 1.9 3.3 0.7 1.0 0.6 1.2 0.4 1.1 3.1 1.6 3.0 0.8 2.6 2.2 1.8 0.6 3.4 1.8 2.2 2.1 0.7 1.2 1.7 2.0 2.0 1.3 1.5 1.6 0.7 1.1 2.6 0.4 1.4 0.8 0.6 1.2 7.6 3.2 2.7 0.2 1.6 1.5 0.0 1.1 4.1 1.1 1.2 0.7 3.8 1.1 1.6 1.3 2.4 2.7 2.3 0.2 2.0 1.3 1.4 1.0 1.2 4.4 4.1 2.1 2.8 3.8 3.1 3.9 1.4 2.1 1.2 0.0 0.3 4.4 1.7 0.7 340.0 1.6 0.0 0.0 1.2 7.0 406.4 1.0 11.6 0.5 1.7 0.6 2.1 23.3 1.0 0.8 0.5 2.4 0.0 2.6 1.7 236.8 1.7 0.0 0.6 2.8 1.1 0.2 1.7 1.0 1.8 381.3 0.4 0.9 1.8 6.8 2618.0 0.0 0.5 8.2 3.4 0.4 2.1 1.5 0.9 1.6 NTNG2 "KIAA1857, Lmnt2, NTNG1" ENSG00000196358 "Netrin G2" Q96CW9 9 132161676-132244534 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.9;brain: 32.0" "Group enriched" "Detected in many" 7 "Bipolar cells: 56.2;Cone photoreceptor cells: 161.0;Rod photoreceptor cells: 109.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "neutrophil: 4.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.0" "Cell line enhanced" "Detected in some" "HL-60: 4.8;HMC-1: 12.2;NB-4: 27.6;U-937: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA065089, HPA071290" Approved Approved "Plasma membrane,Cytokinetic bridge,Midbody ring" "Intracellular and membrane" NA NA "Plasma membrane" "Cytokinetic bridge, Midbody ring" "HPA065089: AB_2732730, HPA071290: AB_2686381" "unprognostic (5.01e-2)" "unprognostic (2.95e-2)" "unprognostic (4.12e-2)" "unprognostic (1.01e-1)" "unprognostic (3.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.73e-2)" "unprognostic (2.87e-1)" "unprognostic (4.86e-2)" "unprognostic (1.47e-1)" "unprognostic (2.62e-2)" "prognostic favorable (6.06e-4)" "unprognostic (9.30e-12)" "unprognostic (1.66e-1)" "unprognostic (3.23e-1)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" 1.2 1.4 11.9 1.6 10.9 38.9 0.6 4.4 32.0 1.0 0.8 11.5 0.2 1.8 0.7 0.9 0.8 0.7 1.4 4.6 11.4 3.1 0.8 0.8 2.0 1.9 4.4 7.4 0.6 1.8 11.9 1.0 1.1 11.7 7.4 0.7 10.7 1.3 1.8 0.9 0.8 1.1 0.8 5.3 2.8 1.2 1.8 2.8 0.0 0.7 0.0 1.0 1.1 0.9 0.1 0.1 4.0 0.2 0.0 0.4 0.0 0.0 0.3 0.2 0.4 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.7 4.8 12.2 0.0 0.0 0.2 0.0 1.0 0.0 1.0 0.0 0.0 0.3 0.1 0.2 27.6 1.0 0.0 0.1 0.3 0.3 0.1 0.0 0.0 3.4 3.1 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.6 2.2 2.6 0.1 0.1 0.0 0.0 1.0 7.2 0.8 0.6 0.2 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.0 0.0 0.1 0.1 0.1 0.0 11.9 10.9 4.4 32.0 11.4 3.1 4.4 7.4 11.7 2.8 0.0 1.1 0.0 0.5 0.2 56.2 2.8 0.0 0.0 1.2 0.0 161.0 0.0 0.0 0.3 1.3 0.1 0.0 0.0 0.0 0.0 1.5 1.4 1.1 0.0 0.6 1.6 0.0 1.3 0.3 1.0 0.6 0.1 1.7 0.0 0.0 15.3 0.2 0.0 1.1 0.0 109.1 6.5 0.6 0.2 0.0 0.3 0.1 0.0 0.0 0.3 NUDCD2 "DKFZp686E10109, NudCL2" ENSG00000170584 "NudC domain containing 2" Q8WVJ2 5 163446526-163460140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037384, HPA037385" Uncertain Supported "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA037384: AB_2675447, HPA037385: AB_10673630" "unprognostic (3.96e-1)" "unprognostic (3.69e-2)" "prognostic favorable (2.80e-4)" "unprognostic (1.46e-1)" "unprognostic (9.12e-2)" "unprognostic (3.75e-3)" "unprognostic (1.84e-1)" "unprognostic (4.74e-1)" "unprognostic (3.47e-2)" "unprognostic (7.63e-3)" "unprognostic (1.81e-1)" "unprognostic (2.45e-1)" "unprognostic (3.91e-2)" "unprognostic (1.34e-2)" "unprognostic (6.86e-2)" "unprognostic (3.40e-2)" "unprognostic (7.85e-2)" 18.3 17.3 19.1 17.4 20.2 14.0 16.6 10.4 21.8 8.5 15.1 23.2 12.7 20.2 12.5 9.7 15.0 14.3 9.9 10.1 19.9 15.1 16.2 20.1 11.8 18.9 27.0 14.5 13.4 24.4 9.6 13.2 14.5 19.3 12.7 9.1 9.3 19.4 10.6 25.7 11.7 18.0 14.1 30.5 16.6 15.9 12.5 20.9 16.9 14.6 11.0 13.4 12.8 11.5 34.3 30.3 14.1 21.6 28.5 36.5 24.4 23.5 12.2 9.3 14.6 5.7 4.2 12.3 9.5 2.8 3.4 5.5 10.9 18.1 13.4 23.0 1.5 15.9 11.9 4.9 5.4 4.1 26.7 13.7 12.4 15.5 9.9 6.2 13.9 14.1 1.5 3.2 3.3 4.8 4.9 3.8 15.3 13.0 16.8 3.5 9.6 20.6 30.7 10.2 7.0 13.5 17.4 15.5 23.8 3.1 5.5 23.7 13.4 15.0 9.7 24.7 5.8 18.6 14.4 8.5 11.8 17.7 13.0 21.8 13.9 23.2 22.6 13.7 24.2 12.3 14.1 18.9 11.8 23.8 21.6 30.3 34.3 34.0 28.4 25.4 24.4 36.5 31.9 2.4 28.5 17.9 30.3 30.0 24.4 19.1 20.2 10.4 18.1 19.9 15.1 27.0 14.5 19.3 20.9 26.8 18.4 48.4 46.7 52.8 29.3 36.7 30.6 41.5 31.8 36.6 21.6 97.0 126.0 54.7 60.9 45.6 19.3 23.3 55.7 43.8 50.3 51.1 30.1 51.3 61.4 9.5 42.1 31.9 41.1 11.4 47.8 38.8 47.2 40.5 42.0 35.3 54.2 28.1 48.1 89.3 36.4 38.8 41.9 69.5 42.8 59.1 47.5 42.4 61.0 48.8 NUDT14 UGPP ENSG00000183828 "Nudix hydrolase 14" O95848 14 105172938-105181323 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046755, HPA058759" Approved Approved Nucleoli,Microtubules NA NA Microtubules Nucleoli "HPA046755: AB_10963433, HPA058759: AB_2683809" "unprognostic (1.05e-2)" "unprognostic (6.01e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.55e-1)" "unprognostic (1.05e-3)" "unprognostic (9.17e-3)" "unprognostic (2.02e-1)" "prognostic favorable (1.66e-4)" "unprognostic (3.16e-3)" "unprognostic (3.13e-1)" "prognostic favorable (1.18e-5)" "unprognostic (1.89e-1)" "unprognostic (1.02e-1)" "unprognostic (7.21e-3)" "unprognostic (2.38e-1)" 18.2 12.6 22.4 5.0 16.0 3.1 14.3 2.5 23.4 6.5 11.0 7.9 5.9 16.7 4.7 11.7 7.1 12.6 9.8 20.9 15.4 13.5 16.7 11.2 12.6 9.4 16.1 14.8 4.0 26.0 4.7 27.6 4.8 11.2 10.5 4.6 14.7 16.7 9.9 28.7 6.2 13.8 3.1 13.2 6.3 12.7 8.9 7.8 3.1 17.9 9.2 5.7 4.9 4.7 5.8 15.1 1.7 27.3 6.1 5.8 8.9 8.2 11.3 1.0 4.4 1.3 1.6 18.1 2.3 3.1 3.8 5.5 8.0 8.8 0.6 11.6 1.2 8.5 10.4 0.5 6.3 0.3 4.3 8.3 1.8 4.9 5.5 9.7 2.2 22.3 2.3 8.0 0.9 0.7 1.6 7.5 4.1 2.8 1.4 1.3 24.0 0.2 0.0 5.9 19.5 15.8 4.3 10.4 4.8 4.1 23.8 15.7 2.3 4.1 0.1 9.6 1.9 8.9 10.7 17.6 6.3 2.8 4.5 2.3 0.7 0.4 1.0 9.3 2.5 2.3 1.7 18.5 0.5 5.8 17.4 3.6 5.8 4.6 3.8 15.1 4.0 4.5 5.2 0.6 6.1 27.3 7.3 2.5 8.9 22.4 16.0 2.5 23.4 15.4 13.5 16.1 14.8 11.2 7.8 11.9 22.0 13.7 80.0 34.6 11.8 47.7 35.7 34.8 5.7 33.2 17.7 39.7 149.2 84.7 2.5 43.4 95.9 0.0 26.5 19.7 19.5 39.7 39.1 21.8 112.1 33.4 35.8 22.7 24.1 8.2 10.6 28.5 43.9 36.9 61.8 28.1 58.1 126.7 3.5 138.7 12.3 0.0 9.5 10.0 28.9 16.7 31.9 15.2 80.1 65.1 NUDT19 RP2 ENSG00000213965 "Nudix hydrolase 19" A8MXV4 19 32691961-32713796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042761 Uncertain Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli, Cytosol" "HPA042761: " "unprognostic (1.20e-1)" "unprognostic (2.90e-1)" "unprognostic (2.35e-3)" "unprognostic (6.61e-3)" "unprognostic (2.62e-2)" "unprognostic (2.44e-1)" "unprognostic (6.18e-3)" "unprognostic (1.97e-1)" "unprognostic (3.14e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (2.64e-2)" "unprognostic (2.81e-1)" "unprognostic (1.23e-1)" "prognostic favorable (1.35e-4)" 9.9 18.7 7.2 11.1 7.0 10.8 10.7 7.4 7.6 5.6 12.8 6.1 8.4 10.2 6.6 8.8 16.9 6.3 7.6 19.3 6.1 6.5 10.5 16.4 15.9 9.2 6.2 5.5 8.5 18.9 9.5 9.3 6.6 6.1 11.2 10.7 9.4 14.7 11.8 29.5 13.2 12.9 6.9 5.6 8.9 11.3 6.8 6.6 6.8 5.9 13.1 13.0 9.9 8.4 8.4 11.9 9.0 23.6 18.7 14.8 6.5 13.7 16.0 1.8 15.9 5.5 7.2 0.3 7.8 2.9 5.8 5.5 9.0 7.6 0.2 9.4 9.0 4.5 9.0 11.0 9.1 7.7 15.8 6.6 17.8 6.4 3.3 7.6 13.3 5.5 5.8 12.1 4.9 12.0 6.8 8.5 2.8 13.7 10.2 10.4 9.1 0.1 12.3 1.9 3.8 7.6 0.1 3.5 7.7 9.6 10.3 7.2 10.3 13.9 11.9 9.8 3.3 6.5 16.3 6.8 8.1 5.2 8.0 13.9 12.0 10.1 4.5 9.7 12.8 7.4 6.6 17.3 9.0 11.9 21.7 12.8 8.4 12.5 14.8 11.9 5.9 10.0 13.8 3.3 18.7 23.6 9.5 13.8 6.5 7.2 7.0 7.4 7.6 6.1 6.5 6.2 5.5 6.1 6.6 11.9 12.6 8.2 6.5 19.5 12.8 18.7 5.1 4.0 4.5 7.0 11.8 9.8 23.2 2.6 7.7 4.5 9.7 0.0 9.9 9.4 9.4 8.5 1.1 9.3 12.6 3.2 11.6 12.3 12.1 3.1 3.7 10.8 11.8 7.2 13.0 5.5 9.5 14.0 8.9 14.8 26.4 0.0 6.6 1.4 1.9 27.6 6.5 13.3 15.8 7.9 NUDT21 "CFIM25, CPSF5" ENSG00000167005 "Nudix hydrolase 21" O43809 16 56429133-56452199 "Predicted intracellular proteins" "Differentiation, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 353.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019863, HPA074228" Uncertain Supported "Nuclear bodies,Centriolar satellite" NA NA "Nuclear bodies" "Centriolar satellite" "HPA019863: AB_2670299, HPA074228: AB_2686675" "unprognostic (4.95e-2)" "unprognostic (4.42e-2)" "unprognostic (4.25e-3)" "unprognostic (1.31e-1)" "unprognostic (5.85e-3)" "unprognostic (1.29e-2)" "unprognostic (8.80e-3)" "unprognostic (6.87e-3)" "unprognostic (4.09e-2)" "unprognostic (3.19e-1)" "unprognostic (3.76e-3)" "unprognostic (4.27e-2)" "unprognostic (1.39e-2)" "unprognostic (2.85e-1)" "unprognostic (1.02e-1)" "unprognostic (1.04e-1)" "unprognostic (3.27e-2)" 26.8 33.0 31.6 33.3 36.0 41.9 31.9 41.7 58.2 32.6 29.4 24.5 21.7 37.7 30.7 22.4 36.6 28.8 22.2 28.9 31.8 39.1 33.6 27.7 23.0 40.8 30.3 38.9 44.9 33.2 34.5 31.2 29.0 34.8 23.8 31.6 24.1 26.1 34.5 27.6 25.6 25.8 27.1 30.2 26.1 25.7 54.0 20.9 46.4 29.3 29.0 47.9 28.9 26.7 17.2 18.9 23.1 19.8 17.5 35.8 15.7 32.7 18.5 34.5 27.7 19.1 27.1 31.4 22.7 26.5 32.6 22.9 38.9 34.5 44.7 23.8 21.1 20.5 30.6 44.8 27.4 49.7 15.3 18.6 29.2 17.9 33.5 15.6 41.7 30.0 16.0 19.9 27.3 19.4 18.8 30.0 34.8 31.1 16.4 26.3 20.2 44.4 29.7 42.6 24.6 31.5 65.7 47.0 38.0 22.6 28.4 38.8 25.7 43.6 21.0 18.0 24.9 25.5 24.9 17.5 26.0 37.1 22.3 24.4 24.7 26.5 84.2 17.2 27.3 23.6 19.4 18.1 23.1 21.8 19.1 21.7 17.2 23.5 20.4 18.9 16.5 22.0 21.6 20.8 17.5 19.8 14.8 35.8 15.7 31.6 36.0 41.7 58.2 31.8 39.1 30.3 38.9 34.8 20.9 26.8 31.5 49.6 44.2 54.1 19.5 31.9 25.5 37.5 34.2 40.1 17.7 55.2 56.3 53.7 353.6 44.3 29.1 70.0 75.7 76.0 42.5 45.0 34.6 32.7 59.5 33.4 29.9 47.3 57.3 152.3 41.4 46.9 35.4 44.1 53.4 21.0 54.8 42.1 38.5 58.0 22.5 38.8 37.6 164.0 80.3 52.4 57.1 40.1 57.5 52.3 NUDT9 MGC3037 ENSG00000170502 "Nudix hydrolase 9" Q9BW91 4 87422582-87459454 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036917, HPA044866, HPA078535" Approved Approved "Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria" "Intracellular and membrane" NA NA 9000 "Nuclear bodies, Mitochondria" "Nuclear membrane, Cell Junctions" "HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885" "unprognostic (7.22e-2)" "unprognostic (2.59e-2)" "unprognostic (1.45e-2)" "prognostic favorable (7.43e-5)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (1.33e-1)" "unprognostic (3.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.09e-2)" "unprognostic (4.23e-1)" "prognostic favorable (8.00e-11)" "unprognostic (1.21e-1)" "unprognostic (1.99e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-3)" 14.2 25.6 19.5 10.0 22.7 4.0 31.1 22.5 22.3 17.9 19.6 11.8 18.0 27.0 17.3 24.5 12.8 16.2 11.4 18.0 21.8 19.4 28.1 30.9 15.8 12.2 22.9 16.5 18.4 64.1 35.4 33.1 17.5 20.0 22.5 18.3 11.3 20.2 18.7 23.8 10.2 30.0 16.0 17.0 9.9 14.1 14.1 22.6 7.6 22.7 16.0 9.7 13.6 35.9 13.9 13.8 3.7 13.9 9.3 18.3 10.6 10.6 11.6 12.9 6.5 25.6 16.2 10.4 20.7 13.5 8.0 8.0 8.1 18.5 15.7 21.2 16.7 14.6 7.4 11.9 14.5 12.8 11.7 9.1 5.1 13.5 14.3 16.1 9.4 8.5 15.5 19.3 9.5 9.0 16.5 15.9 5.1 14.4 10.6 15.0 14.1 13.1 10.2 10.4 25.1 4.7 15.4 11.5 9.2 60.2 9.9 15.7 10.7 13.3 23.6 10.5 17.5 13.5 13.6 16.3 12.9 12.5 9.4 10.1 8.1 6.3 12.8 18.5 8.9 16.3 0.9 11.7 3.7 13.4 13.8 12.4 13.9 13.4 13.2 13.8 12.0 15.9 18.3 1.3 9.3 13.9 13.0 12.3 10.6 19.5 22.7 22.5 22.3 21.8 19.4 22.9 16.5 20.0 22.6 62.5 31.4 15.2 36.7 8.9 13.8 35.3 43.3 45.5 60.3 22.7 25.5 27.4 34.9 42.5 19.0 27.0 24.4 0.0 31.7 28.2 26.6 34.7 19.7 42.0 28.9 6.4 16.1 17.8 11.6 7.6 23.6 17.1 10.1 22.6 15.4 21.8 28.5 25.8 25.1 47.3 15.3 25.8 26.7 29.8 21.7 8.3 31.5 7.2 22.2 26.3 NUF2 "CDCA1, CT106, NUF2R" ENSG00000143228 "NUF2, NDC80 kinetochore complex component" Q9BZD4 1 163266576-163355764 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 38.6;testis: 29.0" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 232.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059692, HPA076604" Supported Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA059692: AB_2684103, HPA076604: " "unprognostic (9.41e-2)" "unprognostic (2.61e-1)" "unprognostic (2.56e-1)" "unprognostic (5.32e-3)" "unprognostic (6.20e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.04e-5)" "prognostic unfavorable (9.16e-4)" "prognostic unfavorable (4.83e-4)" "unprognostic (8.45e-2)" "prognostic unfavorable (9.75e-4)" "unprognostic (3.70e-2)" "unprognostic (0.00e+0)" "unprognostic (9.79e-2)" "unprognostic (7.88e-2)" "unprognostic (2.69e-1)" "unprognostic (5.96e-2)" 1.3 0.9 0.8 9.8 0.9 14.1 0.6 0.5 0.9 1.4 2.5 0.6 0.9 2.3 0.6 2.1 6.1 0.5 0.7 1.5 0.8 0.6 0.7 0.6 1.9 9.9 0.8 0.6 0.7 0.4 0.3 0.4 3.6 0.7 0.6 2.9 0.8 1.3 0.0 0.5 2.2 3.2 1.0 1.4 4.4 1.6 29.0 0.3 38.6 0.5 5.1 9.2 1.5 1.8 1.4 0.6 2.6 0.2 3.0 7.7 1.0 26.3 9.2 24.5 10.2 0.7 2.5 13.3 16.7 11.8 27.2 23.9 7.0 23.3 22.7 14.0 6.7 11.3 15.5 14.9 6.3 34.5 23.7 10.7 8.9 10.6 10.0 0.0 15.3 18.4 0.3 0.6 13.7 9.7 5.1 12.3 22.3 16.7 31.5 25.7 5.1 27.9 20.6 13.3 19.4 14.2 19.0 21.4 20.1 7.7 3.6 18.3 21.1 8.9 9.7 9.2 15.9 14.9 32.1 8.7 20.3 22.8 15.2 33.6 22.6 31.8 43.3 6.7 12.6 22.4 2.6 0.2 2.5 2.4 0.1 1.0 1.2 3.6 2.4 0.5 1.4 2.5 2.1 0.9 3.0 0.2 0.6 7.7 1.0 0.8 0.9 0.5 0.9 0.8 0.6 0.8 0.6 0.7 0.3 0.0 0.3 3.7 1.8 5.3 1.0 0.8 0.0 0.0 4.5 0.0 0.0 2.7 0.0 0.7 15.8 0.1 0.8 46.7 0.2 23.9 1.8 0.4 4.6 0.2 11.3 0.0 0.0 1.8 3.7 10.7 2.3 2.5 0.0 1.0 0.9 2.5 0.2 0.0 2.1 0.0 2.0 6.5 0.5 232.2 40.5 2.0 3.3 3.8 2.2 1.4 NUP107 NUP84 ENSG00000111581 "Nucleoporin 107" P57740 12 68686734-68745809 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031679 Uncertain "Nucleoplasm,Nuclear membrane,Centrosome" NA NA Nucleoplasm "Nuclear membrane, Centrosome" "HPA031679: AB_2673992" "unprognostic (2.89e-1)" "unprognostic (3.32e-1)" "unprognostic (4.10e-1)" "unprognostic (5.43e-2)" "unprognostic (1.60e-1)" "unprognostic (6.32e-2)" "prognostic unfavorable (3.12e-9)" "unprognostic (4.03e-2)" "unprognostic (1.23e-2)" "unprognostic (2.28e-1)" "unprognostic (1.17e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (1.28e-6)" "unprognostic (3.43e-2)" "unprognostic (2.05e-1)" "unprognostic (1.00e-1)" "unprognostic (1.96e-1)" 18.3 12.6 10.2 16.5 13.2 18.7 17.4 20.7 15.2 19.0 12.2 12.1 12.2 9.2 18.6 18.0 14.0 16.6 8.5 12.1 12.2 6.6 12.1 11.1 12.5 21.4 13.2 10.2 19.8 12.5 14.2 16.2 23.5 12.2 12.6 15.3 11.3 13.0 11.8 13.9 14.8 15.8 13.7 12.5 19.7 12.0 20.5 15.9 40.6 12.5 13.1 22.5 17.8 13.1 13.6 7.0 9.5 14.2 20.6 17.0 8.0 17.1 22.1 26.4 19.1 7.8 10.0 28.6 18.8 10.9 28.3 23.7 22.2 14.6 31.5 18.4 9.0 12.6 19.8 29.6 13.9 37.9 29.5 22.0 35.9 15.9 18.7 4.9 31.6 12.2 5.3 6.6 22.6 14.8 9.9 16.9 18.3 42.8 22.7 17.7 20.8 26.0 27.6 29.0 6.6 21.7 26.6 31.8 18.9 12.2 18.3 15.6 16.0 20.8 15.7 11.3 21.5 23.5 15.3 10.3 15.5 15.8 18.0 22.9 9.9 19.8 38.2 11.9 23.1 18.2 6.3 6.5 9.5 13.1 8.5 17.0 13.5 13.0 14.0 7.0 13.6 16.2 14.5 1.7 20.6 14.2 5.5 13.4 8.0 10.2 13.2 20.7 15.2 12.2 6.6 13.2 10.2 12.2 15.9 11.9 15.3 27.4 14.6 15.3 20.5 11.3 12.7 20.1 14.8 8.7 17.7 24.8 10.0 15.4 26.7 16.1 8.4 0.0 15.4 25.3 16.3 13.0 15.1 6.7 15.5 12.7 8.2 17.8 11.1 7.1 35.9 19.8 18.6 27.9 11.3 22.6 17.1 7.0 20.5 5.8 31.5 12.9 14.6 52.6 42.8 15.4 11.8 25.9 13.0 10.0 NUP188 KIAA0169 ENSG00000095319 "Nucleoporin 188" Q5SRE5 9 128947699-129007096 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.3" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2;Spermatocytes: 41.6;Spermatogonia: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061750, HPA063942" Approved Uncertain Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA061750: AB_2684602, HPA063942: AB_2685156" "unprognostic (4.64e-1)" "unprognostic (6.91e-3)" "unprognostic (2.36e-1)" "prognostic favorable (5.20e-5)" "unprognostic (9.50e-2)" "unprognostic (4.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.91e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (7.78e-2)" "unprognostic (4.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.68e-2)" "unprognostic (2.87e-1)" "unprognostic (2.81e-3)" "unprognostic (3.53e-3)" 10.2 11.1 7.6 12.6 9.2 14.3 14.0 13.3 8.7 9.2 9.3 10.1 9.6 5.8 9.8 6.7 16.6 8.3 7.6 9.2 5.6 6.3 8.1 9.6 13.1 16.6 6.5 6.7 10.8 13.3 12.6 13.6 9.1 7.3 9.5 9.3 11.2 9.9 8.3 10.9 16.4 9.0 11.0 7.7 12.2 9.5 60.3 7.3 26.5 9.2 11.3 17.3 8.5 10.5 6.1 7.9 6.3 10.7 6.0 12.0 7.0 10.9 21.0 17.4 23.7 13.2 13.1 15.6 15.4 12.2 28.3 18.9 25.3 8.8 19.2 5.8 16.9 18.3 32.6 39.0 19.1 21.2 15.4 18.8 17.1 39.2 19.9 8.4 29.2 17.3 9.1 9.0 29.7 15.2 8.3 16.2 25.0 37.5 13.7 19.9 27.8 24.9 11.9 23.3 21.1 20.2 22.9 37.7 19.6 8.7 12.4 24.5 11.8 39.9 15.2 5.9 13.4 16.7 10.8 13.1 23.5 16.7 23.6 27.5 11.7 21.6 26.0 13.7 18.7 17.3 6.3 5.3 1.9 9.3 10.7 12.0 6.1 7.9 9.0 7.9 5.9 8.1 8.6 0.8 6.0 5.9 3.3 9.5 7.0 7.6 9.2 13.3 8.7 5.6 6.3 6.5 6.7 7.3 7.3 0.0 13.0 7.5 5.2 5.8 14.9 2.7 7.6 4.0 2.3 5.2 43.2 6.4 1.7 5.5 10.1 6.8 3.2 0.0 5.6 5.9 6.9 7.5 5.8 3.8 7.4 19.1 8.7 12.9 4.9 3.1 8.9 7.2 1.7 4.6 6.7 7.5 7.5 0.0 11.0 1.9 25.0 25.8 4.2 41.6 37.7 9.8 7.2 7.0 6.0 7.2 NUP214 "CAIN, CAN, D9S46E, N214" ENSG00000126883 "Nucleoporin 214" P35658 9 131125561-131234670 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 131.5" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 225.7;Kupffer cells: 255.0;Late spermatids: 282.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 43.7;neutrophil: 131.5" "Group enriched" "Detected in many" 5 "granulocytes: 131.5;monocytes: 43.7" "Cell line enhanced" "Detected in all" "K-562: 73.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048789 Approved "Nucleoplasm,Vesicles,Focal adhesion sites" NA NA 100000 Nucleoplasm "Vesicles, Focal adhesion sites" "HPA048789: AB_2680521" "unprognostic (1.30e-1)" "unprognostic (9.51e-3)" "unprognostic (9.92e-3)" "unprognostic (1.15e-1)" "unprognostic (7.42e-2)" "unprognostic (8.31e-2)" "unprognostic (1.07e-3)" "unprognostic (2.10e-2)" "unprognostic (3.35e-1)" "unprognostic (4.95e-1)" "unprognostic (6.60e-3)" "unprognostic (1.08e-1)" "prognostic favorable (2.39e-5)" "unprognostic (5.49e-2)" "unprognostic (6.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" 16.9 10.3 11.5 13.8 13.9 29.4 12.9 13.0 14.4 10.2 11.4 19.8 10.4 9.0 15.0 13.7 16.1 12.1 10.2 9.7 9.5 8.1 19.0 15.1 11.7 13.3 13.2 8.8 14.2 17.0 16.7 16.9 13.0 11.3 11.1 10.8 15.3 13.0 11.1 15.5 17.5 11.7 11.1 14.3 35.8 12.3 63.7 13.3 27.4 11.8 7.6 16.8 10.7 11.2 1.2 16.8 131.5 43.7 1.2 0.8 17.9 6.8 9.8 8.4 5.0 6.8 6.6 8.8 6.1 6.3 8.0 6.5 8.0 5.0 11.1 4.9 8.4 8.3 15.7 11.3 8.0 7.8 8.0 5.5 6.9 14.0 15.6 6.0 10.8 7.5 7.1 7.4 10.2 8.3 5.1 8.1 7.4 73.0 6.4 8.2 12.8 14.2 16.4 9.1 9.9 8.6 5.0 10.6 11.1 9.2 6.3 7.1 7.4 10.2 9.4 5.3 6.3 12.4 27.0 7.0 14.1 7.9 9.2 9.9 5.6 10.9 10.8 6.9 6.5 8.5 3.5 43.7 17.3 0.7 18.4 0.8 1.2 0.7 0.6 16.8 1.1 0.7 0.7 131.5 1.2 15.0 1.5 0.4 17.9 11.5 13.9 13.0 14.4 9.5 8.1 13.2 8.8 11.3 13.3 17.9 19.9 15.2 9.5 7.7 29.6 24.0 15.3 16.0 15.9 22.7 43.2 10.9 8.3 9.1 225.7 14.6 13.6 0.0 13.1 9.3 11.4 11.4 8.1 11.9 75.5 15.9 19.5 18.4 255.0 282.5 21.6 77.0 10.1 15.4 14.3 14.8 12.0 5.8 19.1 6.7 31.6 6.5 8.1 90.1 44.5 9.5 9.2 11.8 16.3 9.3 NUP43 "bA350J20.1, FLJ13287" ENSG00000120253 "Nucleoporin 43" Q8NFH3 6 149724315-149749665 "Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027126, HPA027291, HPA028500" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287" "prognostic unfavorable (2.08e-4)" "unprognostic (3.02e-1)" "unprognostic (3.86e-2)" "unprognostic (1.45e-3)" "unprognostic (2.29e-1)" "unprognostic (8.19e-3)" "prognostic unfavorable (7.13e-7)" "unprognostic (5.14e-2)" "unprognostic (2.45e-1)" "unprognostic (2.35e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-2)" "unprognostic (6.25e-3)" "unprognostic (2.02e-1)" "unprognostic (2.72e-2)" "unprognostic (3.60e-2)" 16.9 14.2 12.7 15.2 13.8 7.6 19.6 15.6 13.5 20.1 13.1 17.9 18.3 12.4 18.4 11.5 17.4 13.1 9.1 14.7 10.9 10.0 15.7 13.7 12.6 20.3 15.2 9.2 15.7 22.6 14.1 13.2 18.8 12.9 16.6 14.1 17.7 14.2 14.2 20.0 18.7 16.6 16.2 12.1 22.7 14.4 13.8 16.4 28.6 18.9 12.1 24.2 18.4 14.2 10.6 8.1 5.1 8.6 6.1 9.7 3.3 9.0 15.8 13.9 21.8 8.9 11.2 21.8 15.7 9.0 15.4 19.5 22.6 8.5 26.1 16.8 8.6 14.4 14.5 23.8 13.8 26.2 12.2 16.7 29.9 16.8 21.0 6.1 30.6 19.5 6.8 7.3 22.4 14.3 5.8 12.1 15.1 30.5 14.6 12.8 9.7 22.0 12.7 12.2 10.3 9.4 21.6 19.2 8.7 10.1 12.6 5.7 9.6 18.7 11.9 6.1 12.0 12.7 13.0 9.4 12.6 13.7 17.9 23.9 9.0 18.3 28.0 11.2 21.3 17.6 4.4 8.3 5.1 6.3 8.6 6.6 7.3 7.4 6.2 4.2 10.6 7.8 9.7 3.3 6.1 7.2 8.1 7.9 3.3 12.7 13.8 15.6 13.5 10.9 10.0 15.2 9.2 12.9 16.4 3.0 5.6 6.2 4.5 7.0 11.7 12.6 10.2 2.7 4.5 3.5 5.9 9.5 3.3 7.6 27.2 5.3 3.4 0.0 6.7 10.5 4.7 5.3 0.0 3.2 6.7 6.4 9.8 6.2 10.3 58.0 9.5 6.0 8.5 10.0 5.8 11.1 5.5 0.0 9.9 3.8 9.5 12.9 8.2 4.9 10.0 7.4 5.5 6.9 7.6 5.6 NUP98 NUP96 ENSG00000110713 "Nucleoporin 98" P52948 11 3671083-3797792 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 93.4;Late spermatids: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074810 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA074810: AB_2686714" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (7.41e-2)" "unprognostic (2.13e-1)" "unprognostic (7.71e-3)" "unprognostic (3.40e-1)" "unprognostic (4.08e-3)" "unprognostic (6.47e-2)" "unprognostic (1.04e-2)" "unprognostic (1.83e-2)" "unprognostic (7.76e-3)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (5.09e-1)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" 20.2 13.5 8.7 23.5 11.7 40.8 23.5 14.2 13.2 18.0 15.3 14.6 17.8 11.2 19.2 17.5 18.6 17.3 17.1 18.2 7.8 8.0 12.8 20.1 20.7 17.4 11.4 8.7 25.5 19.0 25.7 23.6 20.7 12.7 18.6 15.2 17.8 17.4 25.0 35.2 18.5 15.7 20.8 10.4 18.3 16.0 57.0 10.6 27.5 20.9 15.0 26.6 22.6 19.3 8.9 9.9 24.9 10.0 6.1 13.2 8.7 29.8 23.4 19.3 21.3 21.4 17.6 17.0 21.3 24.9 29.3 26.4 25.7 37.1 29.2 10.1 25.5 29.6 32.2 33.9 21.0 40.0 20.7 24.5 31.3 19.2 17.6 18.0 39.9 26.4 20.0 14.5 16.1 29.4 13.0 22.7 33.4 38.9 23.5 31.1 12.2 40.1 13.0 24.4 32.8 18.0 24.5 23.5 14.0 16.7 23.6 17.8 11.9 30.9 25.1 14.2 21.0 15.4 15.7 16.6 23.5 20.4 25.5 19.4 14.2 24.2 31.0 15.9 17.2 24.7 19.1 7.9 15.5 11.0 10.0 11.0 8.9 10.7 9.7 9.9 7.8 12.2 10.5 24.9 6.1 6.3 2.7 13.2 8.7 8.7 11.7 14.2 13.2 7.8 8.0 11.4 8.7 12.7 10.6 26.8 25.1 21.4 28.7 44.3 14.4 14.3 25.5 13.4 22.7 7.0 15.7 18.8 3.3 11.1 93.4 20.3 12.8 23.3 10.3 14.1 19.3 22.7 17.4 20.2 15.1 14.3 20.6 16.5 15.1 116.3 15.8 20.9 15.1 27.9 14.0 12.4 10.6 12.7 13.4 7.4 14.9 32.3 23.7 48.2 32.6 44.2 38.9 20.2 16.2 23.9 NWD1 ENSG00000188039 "NACHT and WD repeat domain containing 1" Q149M9 19 16719976-16817963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;fallopian tube: 14.1" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 101.7" "Cancer enriched" "Detected in many" 6 "prostate cancer: 9.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 12 "MCF7: 3.4;U-937: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075476 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA075476: " "unprognostic (5.29e-3)" "unprognostic (3.08e-2)" "unprognostic (3.05e-2)" "prognostic favorable (2.55e-4)" "unprognostic (2.49e-1)" "unprognostic (4.20e-4)" "unprognostic (6.54e-2)" "unprognostic (5.15e-2)" "unprognostic (2.95e-1)" "unprognostic (1.60e-1)" "unprognostic (7.94e-2)" "unprognostic (1.76e-1)" "unprognostic (9.20e-2)" "unprognostic (1.31e-1)" "unprognostic (5.09e-2)" "unprognostic (3.53e-2)" "unprognostic (3.25e-1)" 0.6 0.7 6.9 0.6 8.1 0.8 1.0 0.9 5.9 1.7 0.9 11.3 0.5 0.7 1.1 6.5 0.6 14.1 0.8 0.7 10.9 4.2 1.0 0.7 1.8 0.7 3.9 7.8 0.7 4.3 0.6 1.3 0.7 27.8 10.6 0.9 10.3 2.7 3.9 0.8 0.6 0.7 0.8 2.2 0.6 1.0 1.4 4.6 0.0 1.6 0.0 0.6 0.8 0.5 0.5 0.1 1.3 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.5 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 1.3 0.5 0.0 0.1 0.0 0.1 6.9 8.1 0.9 5.9 10.9 4.2 3.9 7.8 27.8 4.6 0.0 1.0 0.0 1.6 0.2 0.1 0.6 0.0 101.7 5.7 0.0 0.0 0.1 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.1 0.0 6.7 0.0 0.0 0.1 0.0 1.2 0.0 0.0 2.7 0.6 0.2 0.0 0.0 0.6 9.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.9 0.0 0.4 1.4 OFD1 "71-7A, CXorf5, JBTS10, RP23" ENSG00000046651 "OFD1, centriole and centriolar satellite protein" O75665 X 13734745-13769353 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 31.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031102, HPA031103, HPA031104" Approved Uncertain Microtubules NA NA Microtubules "HPA031102: AB_10670836, HPA031103: AB_10602188, HPA031104: AB_10669655" "unprognostic (3.10e-3)" "prognostic favorable (9.62e-4)" "unprognostic (2.83e-1)" "unprognostic (2.68e-2)" "unprognostic (1.10e-1)" "unprognostic (7.42e-3)" "unprognostic (2.20e-3)" "unprognostic (3.03e-3)" "unprognostic (1.82e-2)" "unprognostic (1.43e-3)" "unprognostic (2.82e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (3.32e-2)" "unprognostic (3.90e-2)" "unprognostic (1.04e-2)" "prognostic favorable (2.76e-7)" 7.8 8.0 10.1 20.1 12.3 16.6 18.0 18.7 10.9 19.3 15.0 13.3 16.6 12.5 18.9 15.6 13.5 13.0 15.2 8.3 12.5 9.0 14.9 8.7 11.9 21.2 13.6 8.5 16.1 15.1 27.8 27.2 10.3 12.6 14.9 10.3 9.2 18.4 15.8 7.1 14.2 22.0 9.7 14.6 18.4 14.6 11.7 16.1 16.5 17.7 9.3 19.7 15.0 13.6 8.0 31.5 2.9 1.4 6.7 7.4 2.1 10.0 4.6 6.7 12.0 5.6 8.8 5.0 3.2 7.3 3.7 4.8 8.1 11.4 14.7 8.3 3.7 7.0 9.9 4.8 8.8 6.1 7.3 12.3 6.8 13.7 6.8 4.2 9.0 12.6 7.0 6.0 8.5 8.4 7.0 4.1 2.8 10.2 13.3 4.2 7.9 6.2 10.8 7.0 3.7 6.7 15.6 7.8 29.2 5.8 8.6 6.9 11.0 14.9 12.1 7.4 15.7 11.4 8.2 3.7 6.7 3.5 7.9 4.0 9.9 9.3 17.2 5.5 4.0 5.4 2.0 0.8 2.9 6.1 1.0 7.1 6.6 5.4 7.4 1.8 8.0 4.5 6.6 2.4 6.7 1.4 31.5 4.1 2.1 10.1 12.3 18.7 10.9 12.5 9.0 13.6 8.5 12.6 16.1 65.5 57.3 75.4 79.1 19.9 48.4 15.3 33.1 107.1 62.6 29.6 84.4 27.1 6.6 50.6 134.5 31.9 70.6 23.3 51.5 20.6 20.5 76.6 26.5 11.3 20.9 35.0 46.7 20.9 11.0 140.5 48.3 35.4 16.9 39.7 54.7 47.3 50.4 49.2 31.8 13.3 115.6 38.8 15.5 30.3 47.8 23.8 72.8 82.0 44.6 68.6 OIP5 "CT86, hMIS18beta, MIS18B" ENSG00000104147 "Opa interacting protein 5" O43482 15 41309268-41332621 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.7;testis: 41.7" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 19.9;Spermatocytes: 82.8;Spermatogonia: 66.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA052271, HPA059602" Enhanced Supported "Nuclear speckles,Vesicles" NA Yes "Nuclear speckles" Vesicles "HPA052271: AB_2681780, HPA059602: AB_2684079" "unprognostic (5.17e-2)" "unprognostic (7.26e-2)" "unprognostic (3.07e-1)" "unprognostic (1.59e-2)" "unprognostic (6.94e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.79e-4)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.71e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (9.34e-5)" "unprognostic (5.51e-2)" "unprognostic (0.00e+0)" "unprognostic (3.84e-2)" "unprognostic (2.02e-1)" "unprognostic (5.75e-2)" "unprognostic (2.86e-2)" 1.3 2.1 0.5 3.8 0.8 7.5 0.7 1.5 1.1 1.1 3.4 0.7 2.3 3.0 0.6 0.6 4.6 0.6 1.3 1.9 0.9 0.4 1.1 1.1 1.0 4.3 0.6 0.4 1.2 0.6 0.0 0.3 1.6 0.5 0.5 3.1 0.2 1.2 1.3 8.3 2.5 3.1 0.6 0.8 2.7 1.4 41.7 0.7 16.7 0.5 6.3 4.0 0.7 1.5 2.5 7.7 1.1 1.3 1.9 5.9 1.7 13.3 7.1 14.1 10.3 0.7 0.9 13.4 8.3 3.8 9.9 10.7 12.7 6.6 8.0 7.3 3.0 15.6 20.9 14.3 6.4 7.9 17.2 16.5 16.9 20.8 13.1 0.1 18.4 9.5 0.3 1.3 5.6 5.9 2.1 8.4 16.8 23.1 15.4 6.6 6.4 10.8 13.7 12.8 19.9 15.5 13.3 11.8 12.0 4.4 6.2 22.4 7.5 13.7 14.0 3.8 5.9 13.9 10.5 4.1 10.2 15.8 10.2 14.7 7.4 32.4 28.3 3.0 22.5 14.7 0.0 0.8 1.1 0.6 1.3 1.5 2.1 1.8 1.6 1.4 2.5 2.6 1.7 0.0 1.9 0.8 7.7 5.9 1.7 0.5 0.8 1.5 1.1 0.9 0.4 0.6 0.4 0.5 0.7 0.0 0.3 0.0 0.6 3.7 0.0 0.2 0.0 0.0 2.3 0.0 0.0 7.1 0.0 0.5 5.5 0.1 0.9 0.0 0.3 19.9 1.5 0.3 1.1 0.8 6.5 0.0 0.0 0.0 0.6 9.2 0.9 1.6 0.0 1.0 1.7 0.6 0.1 0.0 1.1 0.2 0.2 6.5 0.9 82.8 66.8 2.0 3.2 0.7 3.0 0.1 OLFM3 NOE3 ENSG00000118733 "Olfactomedin 3" Q96PB7 1 101802574-101997030 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 30.0" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 25.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "AF22: 9.5;HAP1: 6.6;HEL: 5.8;SCLC-21H: 3.8;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050297 Uncertain Vesicles "Secreted in brain" NA NA Vesicles "HPA050297: " "unprognostic (4.19e-1)" "unprognostic (4.19e-4)" "unprognostic (1.26e-1)" "unprognostic (4.61e-2)" "unprognostic (2.93e-1)" "unprognostic (1.47e-2)" "unprognostic (3.58e-4)" "unprognostic (2.48e-1)" "unprognostic (5.68e-2)" 0.7 3.2 5.0 1.4 13.7 0.7 0.8 24.2 30.0 0.9 1.8 0.4 0.0 1.0 0.9 1.2 0.7 0.8 0.8 0.7 4.8 7.4 1.5 0.8 0.7 0.7 6.0 11.9 0.8 0.7 0.7 2.4 0.8 16.6 0.7 1.7 0.3 0.8 0.7 0.7 0.7 2.1 1.3 1.5 0.9 1.0 0.9 0.7 0.0 1.2 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 3.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 13.7 24.2 26.7 4.8 7.4 6.0 11.9 16.6 0.7 0.0 0.0 0.0 0.0 0.0 25.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OLFM4 "GC1, GW112, OlfD" ENSG00000102837 "Olfactomedin 4" Q6UX06 13 53028759-53052057 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 280.2;pancreas: 105.8" "Group enriched" "Detected in many" 6 "Exocrine glandular cells: 804.6;Pancreatic endocrine cells: 1519.9;Undifferentiated cells: 937.7;Urothelial cells: 2045.0" "Group enriched" "Detected in many" 14 "colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 4.4;BJ hTERT+: 15.3;HaCaT: 21.4;OE19: 8.3;RPMI-8226: 4.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA077718 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" "Secreted in other tissues" Yes NA "Nucleoplasm, Plasma membrane" "Cytokinetic bridge, Cytosol" "HPA077718: AB_2732358" "prognostic favorable (8.77e-4)" "unprognostic (4.84e-2)" "unprognostic (1.65e-3)" "unprognostic (2.33e-1)" "unprognostic (7.24e-2)" "unprognostic (1.34e-1)" "unprognostic (3.74e-2)" "unprognostic (5.16e-2)" "unprognostic (1.40e-1)" "unprognostic (1.22e-1)" "unprognostic (4.78e-2)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "unprognostic (1.29e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-2)" "unprognostic (4.84e-3)" 0.3 0.0 0.3 18.1 0.3 11.4 2.5 0.3 0.5 50.3 132.5 0.4 0.2 121.4 0.8 3.3 0.5 0.9 6.0 1.1 0.3 0.1 7.5 0.3 1.6 0.4 0.3 0.2 0.7 105.8 0.0 0.2 0.9 0.3 16.2 58.9 0.2 2.9 0.2 0.3 0.1 280.2 5.6 0.2 2.2 2.4 1.4 0.3 1.8 0.3 0.4 0.3 18.4 40.9 0.0 0.0 1.4 0.6 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 4.4 1.9 15.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 21.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 8.3 0.0 0.0 0.7 4.7 0.1 0.0 0.9 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.7 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.0 0.9 0.3 0.3 0.3 0.5 0.3 0.1 0.3 0.2 0.3 0.3 0.0 0.0 0.0 149.7 0.1 0.0 0.4 0.0 0.0 0.0 132.6 0.0 0.0 1.7 216.4 0.2 0.0 104.8 0.0 804.6 0.0 0.0 16.5 0.0 0.0 0.1 0.0 88.9 0.0 0.0 0.0 0.0 0.0 0.0 18.0 135.9 3.2 1519.9 238.2 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 937.7 2045.0 OLIG2 "BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17" ENSG00000205927 "Oligodendrocyte transcription factor 2" Q13516 21 33025845-33029196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 66.2" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 52 "glioma: 46.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 15.4" "Lineage enriched" "Detected in single" 154 "granulocytes: 15.4" "Cell line enhanced" "Detected in some" "HMC-1: 30.0;NB-4: 21.7;THP-1: 18.8;WM-115: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003254, CAB019381" Enhanced Uncertain "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB019381: , HPA003254: AB_1854795" "unprognostic (5.14e-1)" "unprognostic (4.56e-1)" "unprognostic (1.44e-2)" "unprognostic (8.27e-2)" "unprognostic (3.24e-2)" "unprognostic (4.34e-2)" "unprognostic (4.81e-2)" "unprognostic (5.41e-2)" "unprognostic (1.39e-1)" "unprognostic (5.78e-5)" "unprognostic (2.76e-1)" 1.3 1.3 24.1 1.4 19.1 1.4 1.3 4.2 66.2 1.3 1.3 41.4 0.0 1.7 1.3 1.3 1.3 1.3 1.3 1.3 23.6 15.6 1.3 1.3 1.3 1.3 20.9 15.5 1.3 1.3 1.3 0.0 1.3 17.1 1.3 1.3 0.0 1.3 1.3 1.3 1.3 1.5 1.3 16.8 1.3 1.4 1.3 16.6 0.0 1.3 0.0 1.3 1.4 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.0 0.0 0.0 0.6 4.3 0.0 0.0 0.0 0.8 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.7 1.9 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 18.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 6.1 1.8 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 19.1 4.2 27.6 23.6 15.6 20.9 15.5 17.1 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OLR1 "CLEC8A, LOX-1, SCARE1" ENSG00000173391 "Oxidized low density lipoprotein receptor 1" P78380 12 10158301-10172138 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;lung: 46.8;placenta: 53.4" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 386.0;Hofbauer cells: 209.3;Macrophages: 102.1;Syncytiotrophoblasts: 387.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.9" "Group enriched" "Detected in many" 6 "dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5" "Cell line enhanced" "Detected in some" "CACO-2: 32.7;HaCaT: 17.2;HHSteC: 34.6;hTCEpi: 15.9;SiHa: 65.9;SK-BR-3: 26.2" "Low region specificity" "Detected in all" HPA050798 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1060000 "Nucleoplasm, Plasma membrane" Vesicles "HPA050798: AB_2756318" "unprognostic (2.30e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "prognostic unfavorable (8.24e-5)" "unprognostic (6.34e-2)" "unprognostic (6.07e-3)" "unprognostic (5.40e-2)" "unprognostic (2.64e-1)" "unprognostic (1.97e-2)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (4.94e-3)" "unprognostic (3.47e-2)" "unprognostic (1.48e-2)" "unprognostic (1.42e-1)" 2.0 1.9 6.0 14.1 10.3 10.6 2.0 1.3 10.2 1.9 0.5 21.3 0.0 0.8 1.0 0.9 0.5 1.2 3.9 1.1 8.5 6.7 6.9 1.8 46.8 0.5 16.4 4.4 0.4 1.6 2.8 1.9 53.4 12.3 1.4 0.7 0.2 2.0 0.7 0.4 0.5 0.8 1.2 28.5 0.6 1.4 2.8 10.5 0.0 1.5 0.0 0.6 4.3 0.4 0.5 5.9 3.3 1.5 0.3 0.3 1.1 1.8 0.1 0.0 0.1 0.0 0.0 4.5 3.1 0.5 2.0 0.7 32.7 0.0 0.4 0.0 4.2 0.1 17.2 0.0 0.1 1.3 0.0 0.0 0.0 1.6 0.0 34.6 0.0 0.0 0.2 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 65.9 26.2 0.0 4.9 7.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 1.5 2.7 0.2 0.2 0.3 0.3 0.3 0.2 5.9 0.5 0.3 0.3 3.3 0.3 0.4 0.8 0.2 1.1 6.0 10.3 1.3 7.4 8.5 6.7 16.4 4.4 12.3 10.5 26.8 30.9 0.0 0.2 1.3 0.4 0.0 2.5 12.0 7.9 0.0 0.0 386.0 0.0 0.0 9.4 1.2 0.0 0.0 0.0 8.5 1.3 0.0 14.0 0.8 209.3 0.0 0.0 0.0 21.9 7.6 0.3 102.1 0.0 36.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 387.3 0.0 0.0 0.0 OPRK1 "KOR, OPRK" ENSG00000082556 "Opioid receptor kappa 1" P41145 8 53225716-53251697 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.0;prostate: 6.7" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 7.3;Leydig cells: 4.4" "Cancer enhanced" "Detected in some" "prostate cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "U-937: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067549 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA067549: AB_2732770" "unprognostic (1.01e-1)" "unprognostic (1.17e-2)" "unprognostic (8.70e-3)" "unprognostic (3.73e-2)" "unprognostic (6.74e-2)" "unprognostic (2.22e-3)" "unprognostic (8.09e-2)" "unprognostic (9.71e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" "unprognostic (3.35e-2)" "unprognostic (9.54e-4)" "unprognostic (1.61e-1)" 0.7 0.7 15.9 0.3 18.0 0.4 0.3 2.2 8.8 0.4 0.4 0.3 0.0 0.4 0.4 0.6 0.5 0.7 0.4 0.8 4.5 6.2 0.3 0.5 0.8 0.4 1.7 5.8 0.4 0.3 0.4 0.8 2.8 3.1 6.7 0.4 0.0 0.3 0.4 3.8 0.4 0.5 0.5 0.5 0.6 0.3 2.8 1.6 0.2 0.9 0.0 0.3 0.3 0.1 0.2 0.8 1.2 0.2 0.1 0.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 22.1 0.1 1.2 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.8 0.0 0.0 15.9 18.0 2.2 8.8 4.5 6.2 1.7 5.8 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.3 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 OR1N2 ENSG00000171501 "Olfactory receptor family 1 subfamily N member 2" Q8NGR9 9 122553112-122554214 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" 33 "Cardiomyocytes: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "RT4: 1.1" "Not detected" "Not detected" HPA060968 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoli, Plasma membrane" Nucleoplasm "HPA060968: " 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 OR4N4 ENSG00000183706 "Olfactory receptor family 4 subfamily N member 4" Q8N0Y3 15 22094522-22095472 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 22 "testis: 13.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 20.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.7;THP-1: 2.9" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 OR6B2 OR6B2P ENSG00000182083 "Olfactory receptor family 6 subfamily B member 2" Q6IFH4 2 240028965-240030456 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.5" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B3 "OR6B3P, OR6B3Q" ENSG00000178586 "Olfactory receptor family 6 subfamily B member 3" Q8NGW1 2 240045077-240047027 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 6 "brain: 1.6;epididymis: 6.5;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.2" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.1 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OSBPL1A "ORP-1, ORP1, OSBPL1B" ENSG00000141447 "Oxysterol binding protein like 1A" Q9BXW6 18 24162044-24397880 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 18 "basophil: 33.7" "Lineage enriched" "Detected in many" 18 "granulocytes: 33.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040959, HPA043401" Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040959: AB_10964295, HPA043401: AB_10960208" "unprognostic (1.75e-2)" "unprognostic (3.35e-2)" "unprognostic (9.84e-3)" "unprognostic (4.92e-3)" "unprognostic (2.34e-1)" "unprognostic (3.06e-2)" "unprognostic (5.82e-2)" "unprognostic (2.06e-1)" "unprognostic (5.88e-2)" "unprognostic (2.62e-2)" "unprognostic (2.41e-1)" "unprognostic (8.53e-2)" "prognostic favorable (4.98e-13)" "prognostic unfavorable (1.86e-4)" "unprognostic (2.18e-2)" "unprognostic (5.42e-3)" "unprognostic (1.56e-1)" 32.3 14.3 33.3 5.9 28.9 7.0 23.8 6.2 43.1 27.7 13.8 33.9 6.2 10.2 24.4 9.0 15.5 15.2 10.6 24.7 37.6 22.6 21.7 6.6 11.9 5.0 40.6 27.7 14.3 8.3 21.0 8.8 4.2 29.9 12.0 11.5 16.6 23.3 13.9 73.2 8.7 9.8 20.4 49.0 4.8 9.7 6.9 29.0 1.0 14.6 9.9 4.1 12.0 29.7 0.2 1.8 33.7 1.8 0.1 0.4 0.6 15.3 4.6 11.0 20.5 25.8 21.1 10.3 5.7 16.7 5.2 4.3 2.9 16.1 0.0 6.8 10.2 8.3 15.7 4.3 10.0 4.8 0.0 8.1 4.8 3.3 0.0 12.9 12.1 2.5 27.3 14.5 3.9 16.3 22.9 6.5 4.3 0.0 0.1 6.4 6.5 2.7 3.6 9.0 7.9 15.3 0.0 8.8 1.3 1.4 11.3 7.2 7.0 13.4 15.7 18.3 10.8 5.7 8.7 1.4 19.5 4.1 6.2 5.5 0.1 2.1 0.4 9.4 3.5 11.1 33.7 1.8 0.4 0.1 0.9 0.0 0.0 0.4 0.2 1.7 0.2 0.2 0.2 0.7 0.1 0.3 1.8 0.3 0.6 33.3 28.9 6.2 43.1 37.6 22.6 40.6 27.7 29.9 29.0 14.9 16.3 3.2 36.9 17.9 60.0 66.8 28.1 24.1 23.9 19.2 21.6 9.0 54.7 10.3 58.6 58.9 23.8 0.0 6.7 7.0 27.8 29.4 17.3 10.4 24.0 23.8 4.6 33.7 16.4 59.6 39.7 21.9 55.6 1.8 32.2 86.9 8.0 14.8 51.6 55.2 92.0 32.3 45.3 6.7 10.6 8.9 5.4 4.3 8.6 23.1 OSBPL7 "MGC71150, ORP7" ENSG00000006025 "Oxysterol binding protein like 7" Q9BZF2 17 47807372-47821834 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 37.9" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 25.9;Mucus-secreting cells: 23.6;Paneth cells: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036076, HPA053083, HPA073967" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036076: AB_10601042, HPA053083: AB_2682038, HPA073967: " "unprognostic (3.88e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (6.55e-3)" "unprognostic (2.05e-3)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (3.33e-1)" "unprognostic (1.97e-1)" "unprognostic (6.78e-2)" "prognostic unfavorable (8.30e-4)" "unprognostic (2.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.08e-1)" "prognostic favorable (1.19e-5)" 4.1 3.4 9.0 9.6 13.4 7.3 3.9 10.7 11.9 6.8 16.8 12.0 7.5 24.6 6.7 3.7 2.8 6.1 10.5 4.6 9.7 7.3 7.2 1.4 6.3 7.9 13.9 9.8 7.4 11.4 5.3 7.8 3.2 10.3 10.1 10.3 7.7 8.8 10.1 20.2 1.9 32.2 6.2 6.6 12.3 37.9 1.4 16.4 7.9 8.4 2.9 8.1 6.8 5.2 2.6 2.9 1.7 1.4 1.1 5.5 2.1 3.8 4.6 2.0 2.3 2.2 3.2 1.7 1.5 2.1 2.5 2.9 4.6 11.8 3.9 5.8 2.1 0.9 28.9 1.1 3.1 0.8 13.1 1.6 2.9 8.6 3.0 2.0 6.0 0.1 5.0 0.6 1.6 1.1 7.9 5.1 6.9 2.8 5.4 3.9 5.0 6.0 6.4 1.2 15.5 5.8 5.6 3.1 5.4 3.4 3.0 2.0 4.8 2.4 0.8 2.2 2.6 4.2 3.9 5.9 3.9 3.4 0.0 1.2 9.9 3.6 3.8 4.2 5.1 1.4 0.0 1.4 1.7 5.5 1.0 2.3 2.6 2.2 3.1 1.7 1.4 1.6 2.3 0.9 1.1 0.0 2.9 2.7 2.1 9.0 13.4 10.7 11.9 9.7 7.3 13.9 9.8 10.3 16.4 0.0 3.8 4.5 1.0 0.1 5.7 2.8 2.5 1.4 7.9 3.5 5.9 0.2 0.0 2.4 0.0 3.7 25.9 0.0 13.3 0.1 1.5 2.4 2.3 0.4 2.3 11.1 5.8 5.5 2.8 0.0 2.6 0.8 1.7 1.0 23.6 7.7 6.3 26.8 2.5 0.8 7.7 0.0 1.0 0.0 0.2 0.1 0.5 7.2 13.6 0.5 OTUD7B "CEZANNE, ZA20D1" ENSG00000264522 "OTU deubiquitinase 7B" Q6GQQ9 1 149937812-150010676 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 100.1" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 4.7" "Group enriched" "Detected in many" 4 "granulocytes: 4.7;NK-cells: 1.4;T-cells: 2.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027045, HPA076357" Supported Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA027045: AB_1854847, HPA076357: " "unprognostic (2.17e-2)" "unprognostic (2.93e-2)" "unprognostic (1.90e-1)" "prognostic favorable (7.47e-4)" "unprognostic (1.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.23e-3)" "unprognostic (1.46e-2)" "prognostic favorable (5.09e-5)" "unprognostic (4.90e-2)" "unprognostic (7.72e-2)" "unprognostic (8.94e-2)" "unprognostic (3.37e-2)" "unprognostic (1.67e-2)" "unprognostic (1.18e-1)" "unprognostic (4.52e-2)" "unprognostic (1.58e-2)" 8.8 6.2 5.8 2.6 12.3 0.3 6.2 8.5 8.9 8.6 6.3 20.6 4.0 4.6 8.5 4.1 6.1 7.6 4.3 5.3 6.0 4.5 8.6 5.6 0.9 12.7 5.1 9.2 4.5 12.5 4.3 5.3 11.6 5.3 5.6 7.4 5.4 6.3 13.2 4.3 5.1 8.9 8.5 2.3 5.2 9.6 12.5 0.0 8.3 2.3 2.1 6.3 7.1 0.6 0.6 4.7 0.3 1.4 2.3 0.2 11.5 9.3 6.5 10.9 8.6 8.1 6.2 8.2 12.0 9.8 6.8 6.8 9.4 0.1 5.3 14.8 4.4 9.2 9.2 9.0 10.4 11.1 4.7 4.4 12.9 4.6 9.2 5.0 4.9 8.9 7.0 16.6 14.6 7.7 8.0 1.4 12.1 12.6 7.0 11.8 0.9 1.4 8.3 8.7 9.1 1.2 9.0 2.9 3.8 15.9 4.2 8.0 14.4 10.6 12.9 8.9 8.8 2.7 9.5 10.2 9.5 6.8 9.5 13.5 13.0 1.3 9.1 1.5 16.7 4.7 0.3 1.3 2.3 0.2 1.7 0.6 1.0 1.4 0.1 0.6 0.9 1.0 1.2 1.4 0.3 0.6 0.6 0.2 32.8 9.4 2.2 22.0 14.2 25.3 16.2 12.7 12.0 15.9 10.4 100.1 16.8 6.6 11.5 56.6 14.7 19.3 23.3 9.6 7.6 13.6 16.9 0.0 29.3 2.8 22.3 16.7 12.3 0.6 57.7 13.6 2.5 35.4 7.2 12.2 25.5 16.8 21.0 21.5 10.3 66.3 0.0 11.3 10.7 6.4 14.4 17.7 6.7 9.2 21.0 OTULIN "FAM105B, FLJ34884" ENSG00000154124 "OTU deubiquitinase with linear linkage specificity" Q96BN8 5 14664664-14699711 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051074 Uncertain Approved "Plasma membrane,Mitochondria" NA NA Mitochondria "Plasma membrane" "HPA051074: AB_2681334" "unprognostic (4.81e-3)" "unprognostic (1.11e-1)" "unprognostic (4.00e-2)" "unprognostic (1.19e-2)" "unprognostic (7.48e-2)" "unprognostic (1.91e-2)" "unprognostic (7.94e-3)" "unprognostic (1.43e-1)" "unprognostic (2.48e-2)" "unprognostic (9.55e-2)" "unprognostic (1.02e-1)" "unprognostic (7.13e-2)" "prognostic unfavorable (2.59e-7)" "unprognostic (2.92e-2)" "unprognostic (2.28e-2)" "unprognostic (1.60e-1)" "unprognostic (5.02e-2)" 10.0 7.4 5.9 22.6 7.8 32.3 8.4 7.2 6.6 8.2 9.3 8.3 8.9 10.7 9.5 7.7 13.8 6.1 10.8 15.5 6.7 4.9 8.5 19.5 11.1 16.0 9.6 2.8 9.1 12.2 7.5 9.8 11.8 7.0 11.1 7.0 7.7 10.6 10.8 16.5 18.1 11.7 8.1 10.5 12.5 7.1 11.5 7.4 15.0 7.8 9.7 19.3 8.5 15.8 3.4 2.9 3.1 3.0 1.0 4.6 0.9 6.4 7.5 7.5 8.5 7.0 7.3 8.3 6.5 4.6 9.3 7.0 10.1 4.8 11.6 12.8 4.2 13.4 7.4 9.3 8.5 6.4 20.0 7.7 8.3 23.9 5.4 6.0 7.9 14.3 4.1 10.5 7.6 6.5 5.1 7.8 9.8 8.2 18.6 6.6 4.0 7.8 6.9 4.6 6.8 8.0 12.1 6.8 4.6 6.0 6.7 3.4 5.6 23.1 5.2 5.0 9.6 5.7 9.1 7.2 12.1 13.7 9.0 8.5 8.4 12.7 13.2 6.9 15.1 6.2 0.4 2.0 3.1 1.0 2.2 3.0 0.9 2.5 3.4 2.9 3.4 1.8 3.9 2.2 1.0 3.0 2.5 4.6 0.9 5.9 7.8 7.2 6.6 6.7 4.9 9.6 2.8 7.0 7.4 3.0 8.6 13.4 20.2 0.0 10.9 13.4 15.3 9.4 7.9 5.2 13.7 13.2 6.6 4.2 7.3 8.7 13.9 0.0 5.0 8.6 4.9 19.7 10.3 32.7 12.3 7.9 9.1 8.0 11.8 2.5 9.8 10.6 0.0 13.6 11.6 13.0 7.1 8.4 6.0 8.9 32.3 0.0 6.2 23.8 30.4 0.0 11.9 15.0 8.9 19.3 OTX1 ENSG00000115507 "Orthodenticle homeobox 1" P32242 2 63050057-63057836 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 11.3;retina: 18.9;salivary gland: 19.6;skin 1: 14.3" "Cell type enhanced" "Detected in some" 21 "Basal keratinocytes: 1.4;Ciliated cells: 6.7;Club cells: 2.3;Suprabasal keratinocytes: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 113 "neutrophil: 11.3" "Lineage enriched" "Detected in single" 113 "granulocytes: 11.3" "Cell line enriched" "Detected in many" 9 "THP-1: 34.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB012341, HPA052122" Uncertain Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "CAB012341: AB_2157155, HPA052122: AB_2681736" "unprognostic (2.25e-2)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-3)" "unprognostic (2.32e-1)" "unprognostic (1.67e-2)" "unprognostic (6.92e-3)" "unprognostic (3.66e-2)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (2.26e-3)" "unprognostic (1.71e-1)" "unprognostic (0.00e+0)" "unprognostic (4.64e-2)" "unprognostic (2.31e-1)" "unprognostic (3.80e-4)" "unprognostic (3.67e-3)" 0.5 0.4 8.2 0.4 4.3 0.4 1.1 0.2 7.2 0.4 0.4 5.8 0.0 0.6 0.4 0.4 1.4 0.5 0.5 0.4 9.0 1.4 0.4 0.5 0.8 0.4 2.0 3.4 0.6 0.6 0.4 0.1 0.4 0.1 2.3 0.4 18.9 19.6 0.4 0.4 14.3 0.4 0.4 0.1 0.6 1.0 0.9 4.4 0.0 0.4 4.4 5.6 0.6 0.2 0.0 0.0 11.3 0.0 0.0 0.0 0.0 1.5 0.8 2.8 1.7 0.0 0.1 3.9 0.0 0.2 0.2 0.2 2.8 1.5 0.1 0.5 0.0 0.7 2.0 1.8 1.2 0.3 0.7 1.6 1.8 1.4 3.2 0.0 1.2 1.3 0.0 0.5 0.0 0.5 0.5 0.0 1.7 1.5 0.0 0.1 1.3 1.6 2.9 0.0 1.4 1.0 1.5 2.4 0.4 0.7 0.5 0.3 0.4 1.1 0.1 0.9 0.0 0.6 34.7 0.1 0.6 1.1 0.0 0.6 1.0 0.7 2.6 0.2 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 8.2 4.3 0.2 7.2 9.0 1.4 2.0 3.4 0.1 4.4 0.0 0.0 0.0 0.0 1.4 0.0 0.8 0.0 6.7 2.3 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 2.3 0.1 0.0 0.0 0.0 OVGP1 "CHIT5, MUC9" ENSG00000085465 "Oviductal glycoprotein 1" Q12889 1 111414314-111427777 "Plasma proteins, Predicted intracellular proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "fallopian tube: 240.9" "Cell type enhanced" "Detected in many" 11 "Syncytiotrophoblasts: 14.5" "Group enriched" "Detected in many" 13 "endometrial cancer: 58.7;ovarian cancer: 27.9" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 7.2;OE19: 9.2;SK-BR-3: 7.4" "Region enhanced" "Detected in some" "cerebellum: 6.6" "Not detected" "Not detected" "HPA031666, HPA062205" Enhanced Approved Vesicles,Microtubules "Intracellular and membrane" NA NA "Vesicles, Microtubules" "HPA031666: , HPA062205: AB_2684710" "unprognostic (1.52e-1)" "unprognostic (2.06e-2)" "unprognostic (3.35e-2)" "prognostic favorable (1.36e-4)" "unprognostic (8.39e-2)" "unprognostic (3.58e-2)" "unprognostic (2.33e-2)" "unprognostic (3.34e-2)" "unprognostic (5.44e-2)" "unprognostic (3.82e-2)" "unprognostic (7.68e-3)" "unprognostic (2.58e-1)" "unprognostic (5.35e-3)" "unprognostic (2.39e-1)" "unprognostic (1.38e-1)" "unprognostic (3.86e-3)" "prognostic favorable (3.93e-5)" 0.4 0.1 0.4 0.4 0.9 0.2 0.4 1.9 1.0 0.7 0.4 0.4 0.4 0.2 9.7 7.1 0.4 240.9 0.4 0.4 0.5 0.5 0.5 1.0 0.4 0.4 0.4 0.4 32.5 0.4 1.5 0.4 0.4 0.4 0.7 0.3 0.4 0.4 0.4 0.4 1.1 0.6 0.4 0.4 0.5 0.2 1.3 0.4 0.6 0.4 0.4 0.4 0.5 0.4 0.8 0.9 0.0 0.5 0.0 1.6 0.2 0.7 0.5 1.4 0.7 2.8 3.1 2.5 0.3 2.0 0.5 1.1 0.8 0.0 1.2 2.6 0.9 0.0 0.8 0.4 0.4 0.8 2.9 7.2 0.4 1.0 3.4 1.0 1.2 3.3 2.8 4.4 0.1 1.6 2.1 0.6 4.9 0.4 2.3 0.2 0.8 0.9 1.7 0.3 9.2 2.6 0.9 0.3 1.0 2.1 5.3 0.9 0.9 0.2 7.4 1.0 3.8 0.5 1.2 1.2 0.3 0.3 3.7 1.0 2.8 0.8 0.6 0.3 2.3 0.3 0.0 0.5 0.0 0.7 0.0 0.0 0.3 0.5 0.0 0.9 0.8 1.6 1.2 0.0 0.0 0.5 0.0 0.1 0.2 0.4 0.9 1.9 1.0 0.5 0.5 0.4 0.4 0.4 0.4 0.0 1.4 0.0 1.0 2.7 1.7 0.4 0.0 0.0 0.0 0.0 0.0 5.0 1.7 0.3 2.4 1.5 0.7 0.0 0.0 2.1 0.6 1.2 0.0 3.0 0.5 0.0 0.0 1.3 0.3 4.9 1.4 0.3 0.0 0.0 0.9 0.3 0.1 0.0 1.8 1.7 0.7 0.0 0.9 4.1 0.7 2.8 14.5 0.0 1.7 1.4 OXSM "CEM1, FASN2D, FLJ20604, KS" ENSG00000151093 "3-oxoacyl-ACP synthase, mitochondrial" Q9NWU1 3 25782917-25794534 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021293, HPA021300, HPA021337" Enhanced Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776" "unprognostic (2.20e-2)" "unprognostic (3.28e-1)" "prognostic favorable (1.35e-4)" "prognostic favorable (5.51e-4)" "unprognostic (1.01e-1)" "unprognostic (8.17e-2)" "unprognostic (2.15e-3)" "unprognostic (1.41e-1)" "unprognostic (1.76e-1)" "unprognostic (2.83e-2)" "unprognostic (3.06e-2)" "unprognostic (1.20e-1)" "prognostic favorable (4.18e-9)" "unprognostic (1.79e-2)" "unprognostic (2.42e-1)" "unprognostic (3.10e-1)" "unprognostic (1.73e-2)" 6.2 13.7 6.7 9.8 10.5 3.7 10.3 8.3 11.9 6.0 11.8 6.2 13.7 10.1 6.4 16.2 10.3 7.7 7.9 13.5 6.6 6.4 14.9 26.1 10.0 7.7 6.6 6.5 6.4 18.7 8.3 13.0 7.3 7.0 8.0 13.8 10.4 15.5 15.6 19.4 8.3 8.9 5.8 6.7 9.6 8.9 19.9 8.0 8.1 11.7 12.3 11.3 7.9 6.4 8.4 9.0 3.7 6.5 10.3 11.8 6.6 7.7 12.9 2.7 7.6 8.0 8.8 8.0 6.2 9.0 11.7 8.3 9.8 9.3 14.3 8.4 5.7 6.8 8.2 11.4 11.9 11.0 8.6 11.5 15.8 10.9 11.8 9.8 12.7 10.1 8.2 14.8 9.3 9.8 7.6 10.0 13.6 16.2 11.6 9.9 11.5 9.3 9.8 0.5 6.2 14.9 12.4 7.2 23.4 17.1 4.8 3.9 7.2 9.9 17.0 12.6 4.6 18.6 11.9 6.1 7.3 8.8 9.6 8.9 11.1 12.8 4.5 10.3 11.2 7.5 2.1 5.4 3.7 9.4 6.0 10.8 8.4 9.7 11.6 8.6 8.2 11.4 11.8 0.9 10.3 6.5 9.0 6.0 6.6 6.7 10.5 8.3 11.9 6.6 6.4 6.6 6.5 7.0 8.0 0.0 10.3 2.9 5.0 2.7 6.2 9.8 7.6 5.3 4.5 10.4 3.9 17.5 10.0 11.3 38.3 4.9 6.3 0.0 5.9 13.9 6.5 5.4 9.3 13.9 7.7 4.8 2.4 6.7 2.7 11.5 6.6 3.7 5.0 6.4 9.8 8.3 7.4 7.6 3.9 16.1 6.5 0.0 3.1 26.1 12.0 3.9 11.8 5.0 9.6 2.4 P2RY2 P2U ENSG00000175591 "Purinergic receptor P2Y2" P41231 11 73218298-73236352 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.1;skeletal muscle: 29.5" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 14.0;Enterocytes: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 28.1" "Group enriched" "Detected in many" 12 "granulocytes: 28.1;monocytes: 10.4" "Cell line enhanced" "Detected in many" "HaCaT: 16.4;HL-60: 15.5;MCF7: 12.4;NB-4: 12.6;PC-3: 12.9;SK-BR-3: 14.3;THP-1: 36.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB022642 Uncertain Uncertain Cytosol NA NA Cytosol "CAB022642: " "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "unprognostic (6.36e-2)" "unprognostic (7.97e-3)" "unprognostic (6.50e-4)" "unprognostic (2.04e-2)" "unprognostic (4.66e-3)" "unprognostic (8.93e-2)" "unprognostic (2.87e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (9.69e-2)" "unprognostic (4.92e-4)" "unprognostic (1.34e-1)" "unprognostic (2.82e-1)" "unprognostic (1.05e-1)" "unprognostic (8.57e-3)" 0.4 2.3 0.9 1.4 1.2 10.8 1.3 0.3 1.1 5.5 3.1 1.1 0.3 2.2 1.3 2.3 20.0 1.2 2.8 11.7 0.6 0.3 0.9 2.6 2.9 1.5 1.2 0.6 1.7 1.7 6.1 1.1 10.3 1.0 1.7 2.4 3.3 4.0 1.6 29.5 3.4 10.8 0.4 0.4 6.6 0.6 0.7 0.6 0.6 20.2 20.6 12.8 2.1 10.9 0.0 1.6 28.1 10.4 0.0 0.0 1.2 3.6 3.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 8.4 2.8 0.0 5.6 0.2 0.0 16.4 0.4 7.7 0.0 0.0 0.3 1.2 0.2 1.5 0.0 15.5 0.0 0.0 3.6 1.2 0.2 0.0 0.7 0.0 0.7 0.0 0.0 12.4 0.0 12.6 0.2 3.3 12.9 0.0 0.0 0.5 1.2 8.8 0.0 0.0 0.2 14.3 0.0 0.1 6.6 36.3 5.3 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 2.8 0.0 0.2 3.4 28.1 0.0 10.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.0 1.2 0.9 1.2 0.3 1.1 0.6 0.3 1.2 0.6 1.0 0.6 3.0 0.3 0.0 6.8 3.3 0.5 5.3 7.6 0.0 4.5 0.0 0.0 14.0 1.7 5.0 5.3 0.5 12.9 0.0 5.6 0.5 0.4 1.1 0.0 4.5 2.3 0.0 0.0 0.0 2.7 6.7 0.0 0.9 0.0 0.0 2.9 5.2 11.6 10.5 0.0 0.3 0.2 0.0 0.2 0.0 0.0 6.4 9.2 0.0 2.3 11.1 P4HA1 "C-P4Halpha(I), P4HA" ENSG00000122884 "Prolyl 4-hydroxylase subunit alpha 1" P13674 10 73007217-73096974 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 105.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 94.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007599, HPA026593" Enhanced Supported "Endoplasmic reticulum,Vesicles,Mitochondria" "Intracellular and membrane" Yes No "Endoplasmic reticulum" "Vesicles, Mitochondria" "HPA007599: AB_1854891, HPA026593: AB_1854892" "prognostic unfavorable (9.01e-4)" "prognostic unfavorable (3.19e-5)" "unprognostic (2.76e-3)" "unprognostic (3.04e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.19e-5)" "unprognostic (2.30e-1)" "prognostic unfavorable (5.10e-4)" "unprognostic (1.28e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.15e-2)" "prognostic unfavorable (9.40e-9)" "unprognostic (3.14e-1)" "unprognostic (4.22e-2)" "unprognostic (1.02e-2)" "unprognostic (5.75e-2)" 16.8 14.4 16.5 10.4 20.2 7.0 47.6 9.9 18.2 18.5 10.9 11.3 7.4 5.6 14.8 12.2 11.6 22.4 14.1 23.9 17.0 10.9 19.0 39.9 18.1 7.5 33.5 4.9 22.3 13.1 11.1 8.6 33.5 25.4 17.9 9.4 8.6 8.5 10.4 63.5 10.3 7.8 15.1 45.8 9.7 11.1 9.7 30.9 4.1 19.4 7.5 7.3 34.4 105.7 6.9 14.8 10.2 17.3 3.4 7.3 6.1 15.2 3.9 11.4 22.1 35.2 27.1 9.5 44.7 40.5 17.3 41.6 6.5 11.9 5.2 17.1 44.2 10.5 17.3 7.1 16.3 37.9 6.6 2.7 4.4 3.7 7.7 14.7 8.1 3.1 16.4 9.5 14.7 19.5 94.8 8.1 4.4 6.8 2.7 14.9 4.0 3.2 7.8 4.1 7.1 17.3 2.9 7.6 9.3 9.7 6.6 1.0 6.4 9.1 27.0 10.6 26.9 4.1 7.6 7.7 21.2 8.7 5.9 10.4 15.6 5.6 2.5 38.0 11.8 10.3 0.8 13.5 10.2 5.2 16.4 6.7 6.0 6.2 6.0 14.8 6.9 4.6 4.7 7.4 3.4 17.3 11.8 7.3 6.1 16.5 20.2 9.9 18.2 17.0 10.9 33.5 4.9 25.4 30.9 6.0 27.9 18.6 25.1 32.3 12.9 37.9 2.5 56.2 31.8 22.7 25.5 25.0 0.0 26.6 10.0 23.3 10.7 0.0 17.0 76.6 76.1 22.0 39.3 25.1 39.6 11.1 9.9 19.0 44.8 4.7 48.1 41.1 42.2 36.1 7.6 33.4 37.2 18.2 44.2 22.8 17.6 38.8 31.1 35.7 35.8 20.8 27.8 13.8 6.5 17.3 P4HTM "EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4" ENSG00000178467 "Prolyl 4-hydroxylase, transmembrane" Q9NXG6 3 48989886-49007154 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007199 Supported Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA007199: AB_1855272" "unprognostic (1.95e-2)" "unprognostic (3.12e-2)" "unprognostic (9.47e-2)" "prognostic favorable (8.18e-4)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (6.47e-2)" "unprognostic (2.02e-2)" "unprognostic (1.89e-2)" "unprognostic (3.78e-2)" "unprognostic (2.51e-3)" "unprognostic (1.54e-2)" "prognostic favorable (3.28e-5)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (2.60e-2)" "unprognostic (9.65e-3)" 7.4 25.5 22.1 6.4 28.5 4.7 8.9 17.6 32.9 13.5 10.8 15.9 13.8 10.4 9.7 18.9 5.4 34.7 13.0 18.6 23.0 26.5 14.1 5.4 10.6 5.6 18.7 20.3 11.4 29.9 20.8 35.7 9.6 15.7 15.5 6.7 14.1 16.0 16.5 10.0 4.3 7.8 7.0 14.3 6.3 15.7 11.7 16.4 3.4 21.5 3.3 6.7 7.5 6.1 9.8 7.8 6.7 7.6 4.9 14.4 4.8 3.7 10.3 1.9 0.0 5.8 6.9 0.1 6.7 8.9 5.1 5.5 2.3 20.2 3.2 7.1 8.2 4.1 2.0 4.4 2.2 1.5 12.1 7.6 0.0 15.3 0.0 15.3 3.1 0.1 4.0 2.2 5.1 0.4 19.2 5.7 0.0 0.0 14.0 2.4 16.1 0.4 0.4 2.8 18.8 12.1 0.0 0.0 18.8 9.0 5.8 8.0 0.1 7.6 8.1 0.0 0.5 7.1 5.2 4.0 3.0 2.6 7.6 5.3 19.9 11.0 0.0 22.5 0.3 3.1 6.7 7.6 4.8 6.4 2.7 8.7 7.0 11.6 10.3 7.8 9.8 12.0 8.3 0.8 4.9 3.6 1.4 14.4 4.8 22.1 28.5 17.6 32.9 23.0 26.5 18.7 20.3 15.7 16.4 20.8 12.9 13.4 30.2 8.1 71.6 10.6 22.9 76.3 21.6 43.6 82.5 24.6 16.6 32.6 102.4 11.9 34.1 0.0 34.1 8.5 27.3 29.0 23.0 7.6 14.9 111.2 77.7 12.3 8.1 112.9 28.1 11.2 11.8 12.6 33.5 60.4 23.6 40.3 24.4 25.5 55.3 19.4 27.4 37.5 7.9 9.2 21.9 22.4 42.1 30.2 PACSIN3 SDPIII ENSG00000165912 "Protein kinase C and casein kinase substrate in neurons 3" Q9UKS6 11 47177525-47186443 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 40.6;skeletal muscle: 121.6;tongue: 44.6" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 102.9;Muller glia cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039480, HPA043904" Approved Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039480: AB_2676531, HPA043904: AB_2678725" "unprognostic (1.75e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (3.10e-2)" "unprognostic (1.21e-1)" "unprognostic (6.89e-2)" "unprognostic (4.66e-2)" "unprognostic (8.17e-2)" "unprognostic (2.85e-1)" "prognostic favorable (2.09e-4)" "unprognostic (3.86e-3)" "unprognostic (1.26e-1)" "unprognostic (2.75e-2)" "unprognostic (9.72e-2)" "unprognostic (1.92e-1)" "unprognostic (1.29e-1)" "unprognostic (4.76e-2)" 4.1 17.0 3.9 2.2 5.7 0.4 4.3 3.5 4.7 6.5 8.5 8.6 7.1 1.6 6.7 7.6 12.6 4.8 5.8 40.6 4.0 2.4 2.9 10.0 3.9 0.8 7.6 3.6 6.3 14.6 4.8 1.0 8.0 4.4 8.6 1.1 4.6 11.3 6.7 121.6 11.9 1.9 7.4 8.3 1.5 6.0 1.6 6.5 0.3 8.5 44.6 7.1 6.4 5.7 0.0 0.1 0.0 0.9 0.0 0.2 0.9 16.7 8.4 3.9 16.9 3.4 3.4 19.0 5.3 7.6 11.1 6.2 12.5 2.4 0.1 1.6 2.9 7.3 27.7 7.7 12.7 4.4 2.6 13.2 2.6 32.0 28.9 6.7 0.5 2.6 9.5 17.2 5.8 9.3 8.9 4.9 4.5 5.6 0.2 4.5 33.3 0.3 12.4 4.8 13.6 16.9 10.3 14.7 2.7 4.6 16.0 0.1 13.3 8.3 5.9 7.7 8.6 41.9 2.2 2.3 19.3 19.4 2.4 14.4 2.9 1.3 1.5 6.3 5.9 9.9 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.9 5.7 3.5 4.7 4.0 2.4 7.6 3.6 4.4 6.5 0.0 7.2 0.0 23.5 31.9 0.2 102.9 25.5 1.4 7.9 5.2 0.0 27.6 8.3 35.7 0.0 5.9 0.0 0.0 13.1 53.0 16.3 28.4 0.0 29.9 5.0 0.0 0.0 9.2 1.8 0.0 15.0 1.9 16.9 0.0 0.0 62.8 30.4 0.0 11.7 18.2 2.3 32.3 27.0 0.2 10.2 26.1 15.3 0.0 0.2 20.9 PAFAH1B2 ENSG00000168092 "Platelet activating factor acetylhydrolase 1b catalytic subunit 2" P68402 11 117144267-117176894 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051836 Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA 1600000 Cytosol "Nucleoli, Plasma membrane" "HPA051836: AB_2681630" "unprognostic (1.08e-2)" "unprognostic (3.14e-2)" "unprognostic (2.07e-2)" "unprognostic (3.88e-2)" "unprognostic (9.94e-2)" "unprognostic (1.21e-3)" "prognostic unfavorable (9.44e-4)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.01e-1)" "prognostic favorable (4.25e-4)" "prognostic unfavorable (7.79e-5)" "unprognostic (8.18e-2)" "unprognostic (1.11e-2)" "unprognostic (9.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" 21.5 34.1 30.6 19.2 29.7 33.5 32.3 43.5 41.3 21.6 20.2 33.3 12.7 21.1 23.4 22.8 23.3 20.8 19.3 26.2 31.9 36.8 24.6 22.5 20.5 17.7 39.3 31.6 23.6 23.0 23.1 24.2 26.9 39.6 22.2 19.6 17.3 19.3 17.4 14.1 20.8 18.0 19.9 51.6 18.3 21.4 29.9 26.3 15.1 30.9 10.8 20.4 25.9 20.3 26.8 21.6 36.8 35.7 18.9 31.4 26.9 15.0 17.2 19.9 28.7 22.2 15.6 15.5 25.3 22.1 14.1 12.9 31.4 33.2 16.2 36.3 30.3 14.1 24.1 28.9 32.7 18.6 14.5 11.1 41.8 15.7 20.1 19.9 14.4 16.0 17.2 25.9 28.1 35.5 15.4 23.0 9.1 22.1 12.4 21.5 9.6 13.9 21.2 18.2 20.9 13.6 15.6 22.5 17.8 21.5 23.5 22.2 29.4 29.2 22.1 9.6 17.6 24.6 12.4 36.8 25.8 17.1 12.6 17.9 3.9 6.0 21.8 10.4 27.7 21.6 32.1 30.8 26.7 24.2 33.3 28.2 26.8 28.0 25.3 21.6 25.4 29.3 31.4 36.8 18.9 35.7 15.8 19.5 26.9 30.6 29.7 43.5 37.8 31.9 36.8 39.3 31.6 39.6 26.3 26.8 33.3 41.0 38.7 108.6 36.9 31.1 68.8 17.4 26.1 62.8 45.2 36.3 39.7 52.6 7.3 54.4 31.6 0.0 34.5 77.2 42.9 53.9 18.5 39.2 38.5 44.5 79.3 57.7 59.6 8.9 42.0 55.7 47.2 49.5 37.2 33.5 72.8 46.7 32.2 44.8 33.5 12.9 46.4 45.1 75.6 101.4 45.7 38.5 39.1 38.8 PAK6 PAK5 ENSG00000137843 "P21 (RAC1) activated kinase 6" Q9NQU5 15 40238759-40277487 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 22.2" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 38.8;Suprabasal keratinocytes: 16.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 14.8;HaCaT: 23.0;hTCEpi: 14.1;SK-BR-3: 7.8" HPA031124 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.85e-3)" "unprognostic (2.15e-1)" "unprognostic (3.33e-3)" "unprognostic (7.79e-3)" "unprognostic (7.08e-3)" "unprognostic (9.57e-2)" "unprognostic (2.71e-1)" "unprognostic (7.73e-2)" "unprognostic (1.34e-2)" "unprognostic (7.13e-3)" "unprognostic (4.04e-2)" "unprognostic (8.87e-3)" "unprognostic (1.72e-1)" "unprognostic (1.79e-1)" "unprognostic (7.37e-3)" "unprognostic (3.34e-2)" 0.3 5.3 14.7 0.8 18.4 0.8 2.3 11.3 20.1 3.0 1.3 1.6 2.5 1.4 1.0 1.1 15.8 4.3 1.4 7.9 11.6 5.2 3.4 0.4 2.6 1.0 3.0 10.9 0.6 7.4 12.9 6.4 8.1 2.1 3.6 1.2 0.3 3.4 7.5 3.5 22.2 1.4 0.8 1.2 1.0 3.6 12.8 2.2 0.0 7.4 8.5 5.1 3.0 5.1 1.4 0.7 2.9 0.7 2.0 5.5 1.2 2.7 0.0 0.2 0.1 0.0 0.0 4.4 0.0 0.1 0.6 0.4 14.8 2.0 0.1 2.4 0.0 0.9 23.0 3.3 4.9 0.2 0.1 0.7 0.0 1.9 0.1 0.0 0.1 0.3 0.0 14.1 0.2 3.3 0.2 0.0 3.9 1.1 0.2 0.0 3.2 0.0 0.3 0.4 2.7 2.0 0.2 0.1 1.8 1.1 6.0 5.4 1.3 1.9 7.8 0.2 1.3 0.9 7.2 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.0 0.5 0.4 0.1 2.1 0.7 2.9 5.5 0.3 2.1 1.4 0.5 4.2 0.7 0.5 0.3 1.2 1.3 2.0 0.2 0.5 0.1 1.2 14.7 18.4 11.3 20.1 11.6 5.2 3.0 10.9 2.1 2.2 0.0 3.4 0.0 6.8 8.8 3.9 0.0 7.6 4.0 4.5 5.2 0.0 38.8 11.6 4.0 5.9 0.0 0.0 0.0 3.7 1.2 0.6 4.0 0.0 0.0 3.5 0.0 4.7 0.0 0.3 4.5 1.7 0.3 1.7 0.0 0.8 1.4 2.7 0.0 1.8 0.0 0.0 0.0 0.1 1.6 1.5 16.7 7.6 1.3 1.9 6.8 PAM16 "Magmas, Tim16, TIMM16" ENSG00000217930 "Presequence translocase associated motor 16" Q9Y3D7 16 4331549-4355607 "Disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 36.3" HPA062721 Approved Nucleoplasm,Microtubules,Mitochondria NA NA "Nucleoplasm, Mitochondria" Microtubules "HPA062721: AB_2684849" "unprognostic (2.69e-2)" "unprognostic (1.64e-1)" "unprognostic (4.06e-1)" "unprognostic (6.81e-2)" "unprognostic (6.98e-2)" "unprognostic (9.68e-2)" "unprognostic (1.83e-1)" "unprognostic (6.32e-2)" "unprognostic (1.99e-1)" "unprognostic (1.39e-1)" "unprognostic (4.79e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (5.73e-5)" "unprognostic (7.25e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "prognostic favorable (1.33e-4)" 10.9 15.2 12.9 8.4 14.1 17.0 10.0 9.3 15.1 7.0 9.5 5.6 8.2 14.0 7.8 11.8 11.2 7.5 7.5 19.9 11.1 10.7 9.2 33.7 9.8 10.9 9.8 11.3 8.5 26.1 7.1 10.3 8.0 9.2 8.8 8.0 7.8 13.2 11.0 54.5 12.6 10.1 8.2 8.3 9.5 10.1 16.2 7.3 7.3 12.0 17.8 9.6 8.4 9.9 16.0 19.8 11.2 15.3 11.5 14.3 12.3 3.9 7.7 4.2 10.3 2.8 3.9 10.9 9.5 2.3 3.6 2.9 5.4 5.8 11.5 10.6 2.8 3.7 8.1 3.9 4.2 1.7 11.2 25.4 12.0 7.2 3.8 4.6 8.4 9.0 5.8 5.4 4.3 4.7 3.2 2.8 8.1 14.1 5.5 3.0 10.6 7.6 14.7 6.8 2.5 17.2 14.5 3.5 11.1 3.7 3.8 16.0 12.4 8.2 7.0 9.7 3.3 9.2 10.2 3.5 7.2 9.3 36.3 10.4 8.2 8.8 14.3 2.6 8.2 6.8 0.2 15.3 2.3 12.3 9.5 10.5 16.0 11.2 11.3 10.7 15.5 14.3 13.7 11.2 11.5 10.2 19.8 12.7 12.3 12.9 14.1 9.3 15.1 11.1 10.7 9.8 11.3 9.2 7.3 3.0 4.5 2.2 0.9 3.5 0.5 0.4 10.2 6.7 5.7 0.0 0.0 1.9 6.6 3.1 2.6 0.7 2.1 0.0 2.6 2.3 2.7 1.0 1.1 10.9 1.5 1.6 0.0 4.3 7.8 0.8 4.6 1.1 1.7 7.2 2.1 0.3 5.2 3.4 3.5 3.0 0.6 6.5 1.4 8.9 12.9 5.1 1.0 1.7 3.4 1.0 PAOX PAO ENSG00000148832 "Polyamine oxidase" Q6QHF9 10 133379234-133391694 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 36.7" "Group enriched" "Detected in many" 11 "Early spermatids: 115.5;Late spermatids: 346.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 6.4;K-562: 5.0;U-266/70: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047782 Uncertain Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA047782: " "unprognostic (3.67e-3)" "prognostic favorable (6.07e-5)" "unprognostic (2.49e-2)" "unprognostic (1.28e-3)" "unprognostic (1.96e-2)" "prognostic favorable (1.38e-5)" "unprognostic (7.39e-2)" "unprognostic (1.99e-3)" "unprognostic (2.20e-1)" "unprognostic (4.48e-2)" "unprognostic (1.11e-2)" "unprognostic (2.99e-1)" "prognostic favorable (9.49e-4)" "unprognostic (3.56e-2)" "unprognostic (2.86e-1)" "unprognostic (7.61e-2)" "unprognostic (8.29e-3)" 6.7 4.1 4.3 5.8 6.7 1.5 4.7 6.8 8.7 3.7 6.0 10.8 5.6 5.6 3.7 1.8 7.4 3.4 2.4 2.5 5.7 2.7 8.9 9.2 2.8 5.2 10.0 3.4 3.6 3.2 1.9 2.5 2.1 4.2 4.8 1.5 2.8 9.9 5.1 3.5 4.4 8.5 2.8 4.7 8.2 7.5 36.7 7.6 0.7 2.4 2.1 5.4 4.6 4.2 4.3 1.1 1.0 1.0 1.7 0.3 0.4 6.4 0.0 0.2 1.2 0.0 0.7 1.6 2.9 1.2 1.4 0.2 1.1 0.1 0.0 0.9 0.6 0.8 3.5 0.4 0.8 0.6 4.2 0.5 0.6 0.0 0.2 1.7 0.0 1.0 0.1 0.3 0.9 0.4 0.0 0.1 0.0 5.0 0.3 0.0 0.1 0.0 0.1 1.2 0.0 3.0 4.6 0.0 0.0 0.2 0.0 0.3 2.2 0.9 0.1 0.0 0.0 1.4 0.0 2.8 0.3 1.4 1.2 0.0 18.5 3.4 1.7 0.0 0.0 0.1 1.0 0.3 0.0 0.2 1.0 0.0 1.6 0.3 0.2 1.1 4.3 0.0 0.0 0.0 1.7 0.9 0.8 0.0 0.4 4.3 6.7 6.8 6.5 5.7 2.7 10.0 3.4 4.2 7.6 0.0 5.8 20.9 6.2 3.3 1.5 1.5 5.1 1.4 0.0 1.8 0.0 0.7 5.0 4.5 115.5 2.3 6.8 0.0 3.0 1.7 2.3 4.8 5.7 11.3 4.1 4.8 0.0 3.7 10.4 346.0 8.9 3.9 0.0 17.2 3.4 7.7 2.9 2.9 7.4 13.2 2.7 19.4 2.5 9.9 3.0 3.1 0.2 4.6 3.2 8.6 PARM1 "Cipar1, DKFZP564O0823, WSC4" ENSG00000169116 "Prostate androgen-regulated mucin-like protein 1" Q6UWI2 4 74933095-75050115 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 143.3;Mucus-secreting cells: 90.2;Paneth cells: 120.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "memory B-cell: 10.1;myeloid DC: 4.6;naive B-cell: 6.4" "Group enriched" "Detected in many" 15 "B-cells: 10.1;dendritic cells: 4.6" "Cell line enhanced" "Detected in many" "ASC diff: 24.5;Karpas-707: 23.9;U-266/70: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038236 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "HPA038236: AB_10675789" "unprognostic (2.57e-2)" "unprognostic (5.20e-2)" "unprognostic (1.26e-3)" "unprognostic (8.61e-2)" "unprognostic (1.44e-1)" "unprognostic (8.49e-3)" "unprognostic (3.08e-1)" "unprognostic (2.42e-2)" "unprognostic (2.73e-1)" "unprognostic (9.74e-2)" "unprognostic (9.44e-2)" "unprognostic (3.51e-2)" "unprognostic (5.21e-2)" "unprognostic (1.96e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.23e-1)" 23.1 21.5 5.7 25.0 15.2 0.3 16.4 1.3 29.4 18.7 36.0 1.2 28.5 2.8 20.3 18.0 5.8 12.2 11.5 39.8 6.9 13.0 27.5 1.1 15.1 10.2 3.3 10.3 11.9 29.2 23.2 32.1 16.1 4.8 35.0 45.8 70.2 25.6 27.6 7.4 6.2 8.3 29.3 2.4 9.7 5.5 11.2 1.2 6.3 79.8 3.7 8.0 24.9 19.7 10.1 4.6 0.1 0.5 0.0 0.0 0.7 0.5 1.0 0.9 0.0 24.5 0.1 0.1 0.0 0.1 0.0 0.0 2.0 0.2 0.0 0.1 0.0 0.0 0.0 8.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 4.1 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 23.9 0.4 0.2 2.6 0.1 2.3 0.0 1.4 0.0 2.2 6.0 0.1 4.9 1.5 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.0 1.4 1.6 0.1 2.1 26.8 2.5 6.8 2.5 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 10.1 0.0 0.0 4.6 6.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.7 5.7 15.2 1.3 29.4 6.9 13.0 3.3 10.3 4.8 1.2 14.9 63.1 13.4 17.1 2.9 7.9 143.3 30.6 1.4 11.4 0.0 0.0 0.3 3.3 0.1 6.8 3.8 80.6 23.3 43.2 0.6 15.4 43.3 1.1 0.0 1.4 0.0 19.1 3.1 0.0 20.6 33.9 7.2 8.5 1.0 90.2 0.0 26.9 120.2 70.0 27.6 1.0 45.3 52.3 1.7 3.3 1.6 0.7 1.5 46.2 8.4 PATJ "Cipp, INADL" ENSG00000132849 "PATJ, crumbs cell polarity complex component" Q8NI35 1 61742406-62178675 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.4" "Group enriched" "Detected in some" 9 "Alveolar cells type 1: 80.4;Alveolar cells type 2: 49.2;Ciliated cells: 49.5;Club cells: 71.7;Collecting duct cells: 54.1;Ductal cells: 30.3;Exocrine glandular cells: 23.0;Pancreatic endocrine cells: 38.8;Proximal tubular cells: 28.9;Syncytiotrophoblasts: 22.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 66.4" "Cell type enhanced" "Detected in many" "eosinophil: 9.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 19.2;RPTEC TERT1: 16.9;RT4: 18.1" "Low region specificity" "Detected in many" "HPA066352, HPA066960, HPA069079" Approved Supported "Cell Junctions,Centriolar satellite,Cytosol" NA NA "Cell Junctions" "Centriolar satellite, Cytosol" "HPA066352: AB_2685663, HPA066960: AB_2685755, HPA069079: AB_2686079" "unprognostic (1.81e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-2)" "unprognostic (2.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-1)" "unprognostic (7.96e-2)" "unprognostic (7.60e-2)" "unprognostic (1.88e-1)" "unprognostic (9.90e-2)" "unprognostic (3.39e-3)" "unprognostic (2.99e-2)" "prognostic favorable (1.47e-5)" "unprognostic (3.05e-3)" "unprognostic (6.72e-3)" "unprognostic (2.21e-2)" "unprognostic (2.43e-1)" 2.6 4.6 3.4 6.3 4.4 1.9 11.6 66.4 3.2 5.7 9.6 2.0 17.9 5.5 4.4 17.7 11.6 5.3 10.3 27.8 2.3 5.1 19.8 7.7 12.5 6.1 4.6 2.0 4.7 17.9 15.2 21.4 2.8 14.2 8.4 7.0 4.4 24.8 24.3 25.4 13.9 15.7 5.2 15.8 2.2 6.3 2.7 3.0 1.3 17.0 11.1 9.6 7.4 7.5 1.8 0.3 9.9 0.2 3.2 4.1 0.8 19.2 3.9 1.3 1.7 0.7 1.9 16.3 1.1 1.5 1.2 1.6 6.7 7.3 0.1 5.2 2.4 10.5 11.6 2.8 10.2 2.1 1.9 4.8 0.1 5.6 5.9 1.6 0.0 0.1 0.7 10.9 2.0 4.6 3.0 0.6 0.0 0.0 0.0 1.0 6.7 0.0 0.0 6.7 8.7 1.0 0.0 1.4 2.7 16.9 18.1 3.3 1.1 4.9 16.0 4.2 13.8 12.7 0.2 0.1 1.0 2.4 0.1 2.2 0.8 1.4 2.5 0.9 0.0 0.2 0.4 0.1 9.9 1.9 0.1 3.5 1.8 3.1 2.6 0.1 1.5 4.1 2.6 0.9 3.2 0.2 0.3 2.7 0.8 3.4 4.4 66.4 3.2 2.3 5.1 4.6 2.0 14.2 3.0 80.4 49.2 0.0 0.0 0.0 0.0 0.0 0.0 49.5 71.7 54.1 0.0 2.5 5.0 30.3 0.0 0.0 0.0 0.0 23.0 0.6 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.0 PCDH1 pc42 ENSG00000156453 "Protocadherin 1" Q08174 5 141853111-141879246 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 37.9;Exocrine glandular cells: 40.1;Pancreatic endocrine cells: 44.8;Urothelial cells: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.5;HaCaT: 36.8;HUVEC TERT2: 19.3;OE19: 26.1;RT4: 25.2;TIME: 25.1;WM-115: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047720, HPA050538" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA 270000 "Nucleoplasm, Cell Junctions" Nucleoli "HPA047720: AB_2680130, HPA050538: AB_2681162" "unprognostic (4.67e-2)" "unprognostic (1.79e-1)" "unprognostic (5.30e-2)" "unprognostic (4.61e-3)" "unprognostic (5.03e-2)" "unprognostic (4.16e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (1.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.43e-1)" "prognostic favorable (7.55e-5)" "unprognostic (2.05e-1)" "unprognostic (4.16e-2)" "unprognostic (3.13e-2)" "unprognostic (1.91e-1)" 22.4 4.5 14.8 7.4 17.6 1.4 19.0 16.1 25.6 8.3 22.2 7.3 11.4 20.6 7.0 7.0 26.9 9.7 6.8 8.9 11.6 7.4 14.9 13.0 18.9 3.4 8.8 16.9 2.5 11.0 1.3 5.2 32.5 9.2 11.1 14.4 6.0 23.7 12.3 7.4 17.3 15.8 7.5 7.5 1.6 22.8 1.5 9.8 0.0 9.1 3.9 8.8 8.6 11.7 0.0 0.0 0.3 0.0 0.0 2.2 0.5 6.2 0.3 2.6 2.9 0.1 0.0 1.9 0.0 0.0 0.0 0.0 1.5 29.5 0.0 15.2 0.2 0.3 36.8 3.4 2.7 0.0 0.0 0.1 0.0 0.1 0.0 2.4 0.0 0.1 0.0 6.2 0.0 0.4 6.3 19.3 0.0 0.0 3.1 0.0 5.0 0.1 0.0 11.2 26.1 5.0 0.1 0.0 4.2 2.1 25.2 0.3 0.6 0.1 8.1 6.5 7.9 6.5 0.1 25.1 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.2 0.0 17.8 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.5 14.8 17.6 16.1 25.6 11.6 7.4 8.8 16.9 9.2 9.8 0.0 4.0 0.0 10.2 0.9 9.1 2.2 22.9 4.0 2.3 12.2 0.0 0.6 3.3 13.6 0.3 21.8 37.9 0.0 40.1 0.2 1.6 22.4 0.0 26.0 0.2 25.4 7.5 6.2 1.9 0.8 0.6 0.5 0.0 0.0 17.6 4.0 44.8 19.3 0.4 5.1 0.4 12.9 15.1 0.2 0.2 2.3 16.8 0.0 14.7 43.0 PCDH8 "ARCADLIN, PAPC" ENSG00000136099 "Protocadherin 8" O95206 13 52842889-52848641 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 20.6" "Cell type enriched" "Detected in some" 7 "Muller glia cells: 31.8" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AF22: 23.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010509 Uncertain Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA010509: AB_10601384" "unprognostic (3.50e-3)" "unprognostic (6.48e-2)" "unprognostic (1.40e-1)" "unprognostic (9.11e-4)" "unprognostic (2.12e-2)" "unprognostic (1.97e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-1)" "unprognostic (3.59e-1)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (1.32e-1)" 0.8 0.9 11.5 1.1 18.6 0.8 0.8 0.4 20.6 0.9 1.0 1.1 0.0 0.9 1.0 0.8 0.8 0.8 0.8 0.8 18.2 4.8 0.8 0.8 0.9 0.8 3.6 8.4 0.8 0.8 0.8 1.4 0.8 0.8 1.7 0.9 0.8 0.8 0.8 1.4 0.8 1.1 0.9 0.9 0.8 1.2 2.3 2.5 0.0 1.4 0.0 0.8 0.9 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 18.6 0.4 20.6 18.2 4.8 3.6 8.4 0.8 2.5 0.0 0.0 0.0 2.5 0.1 4.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.4 0.0 0.9 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.0 1.3 PCDHB1 PCDH-BETA1 ENSG00000171815 "Protocadherin beta 1" Q9Y5F3 5 141051135-141059344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.9" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 2: 1.4;Basal glandular cells: 1.1;Cardiomyocytes: 2.2;Ciliated cells: 4.0;Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053921 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA053921: AB_2682310" "unprognostic (5.54e-2)" "unprognostic (1.60e-2)" "unprognostic (9.01e-4)" "unprognostic (8.65e-2)" "unprognostic (8.00e-2)" "unprognostic (7.82e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (8.17e-5)" "unprognostic (3.38e-2)" "unprognostic (9.40e-2)" "unprognostic (1.23e-1)" "unprognostic (5.77e-4)" 0.1 0.3 0.3 0.1 0.5 1.0 0.1 0.1 0.2 0.5 0.5 0.4 0.1 0.6 0.1 1.8 0.0 0.1 0.4 0.4 0.7 0.1 0.2 0.4 0.2 0.1 1.1 0.7 1.9 0.0 0.1 0.0 0.5 0.0 4.9 0.8 0.5 0.0 0.3 0.3 0.8 1.8 0.3 0.0 0.1 0.1 1.3 0.7 2.5 0.6 1.0 0.6 0.2 0.8 0.4 0.8 1.1 0.2 0.2 1.1 1.1 0.2 0.1 0.1 1.6 1.4 1.1 1.6 0.3 1.1 1.5 0.0 0.1 0.2 0.9 1.2 1.2 1.9 0.7 0.1 1.4 1.2 0.2 0.3 0.2 0.2 1.7 0.2 1.0 0.8 2.6 0.2 1.4 0.7 0.9 1.2 1.2 0.4 1.2 1.0 0.9 0.1 1.0 2.2 0.8 0.1 1.8 1.3 1.2 0.6 0.5 1.2 1.0 0.7 0.8 0.6 1.5 0.6 1.0 1.1 1.1 1.2 2.3 0.6 0.7 0.5 0.4 0.5 0.7 0.5 0.4 0.2 1.3 0.6 0.5 2.5 1.0 0.4 0.7 0.3 0.2 0.0 1.4 0.0 1.1 0.0 0.2 2.2 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 PCDHB4 PCDH-BETA4 ENSG00000081818 "Protocadherin beta 4" Q9Y5E5 5 141121799-141125623 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 5.1;Horizontal cells: 7.9;Peritubular cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "T-reg: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" "Group enriched" "Detected in some" 5 "SCLC-21H: 13.0;SH-SY5Y: 8.8" HPA014466 Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Intermediate filaments" "HPA014466: AB_1855058" "unprognostic (2.60e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (8.60e-3)" "unprognostic (4.03e-1)" "unprognostic (6.44e-2)" "unprognostic (2.44e-1)" "unprognostic (8.66e-2)" "unprognostic (1.52e-1)" "unprognostic (6.70e-3)" "unprognostic (1.44e-1)" "unprognostic (2.82e-3)" "unprognostic (1.11e-3)" "unprognostic (2.17e-1)" "unprognostic (3.32e-4)" "unprognostic (5.18e-3)" 7.1 5.3 13.0 2.0 12.0 0.6 5.9 11.3 11.4 8.0 3.4 12.9 0.1 1.9 12.3 9.1 4.0 5.8 5.7 4.3 10.9 6.3 4.1 1.3 5.1 1.4 13.1 11.3 9.9 18.2 7.3 5.1 0.9 11.0 6.1 2.7 3.7 5.0 5.1 3.8 3.1 2.6 7.9 21.1 2.0 2.6 1.6 12.3 0.0 2.8 1.5 1.1 5.6 5.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.5 2.1 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 13.0 8.8 0.0 0.0 0.0 0.4 0.4 0.1 0.0 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 13.0 12.0 11.3 11.4 10.9 6.3 13.1 11.3 11.0 12.3 0.0 0.3 0.0 0.4 1.0 5.1 0.6 0.0 4.0 4.5 0.0 0.0 0.0 0.0 0.4 0.0 3.0 0.0 0.0 1.4 0.0 3.8 0.9 0.0 0.0 0.1 7.9 0.0 4.3 0.0 0.0 1.4 0.0 1.7 0.0 0.0 3.5 0.4 0.0 6.0 0.0 0.6 0.0 3.1 1.1 0.2 1.8 0.0 0.0 0.0 0.2 PCDHGA1 PCDH-GAMMA-A1 ENSG00000204956 "Protocadherin gamma subfamily A, 1" Q9Y5H4 5 141330571-141512981 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.0;Bipolar cells: 1.6;Cardiomyocytes: 1.7;Horizontal cells: 3.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 7.0;T-47d: 11.5;WM-115: 5.2" "Low region specificity" "Detected in many" "HPA008755, HPA010580, HPA036547" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA036547: AB_10669798" "unprognostic (9.50e-4)" "unprognostic (2.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.42e-3)" "unprognostic (3.39e-1)" "unprognostic (3.97e-2)" "unprognostic (2.42e-1)" "unprognostic (5.61e-3)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-3)" "unprognostic (4.76e-2)" "unprognostic (1.38e-1)" "unprognostic (2.73e-2)" "unprognostic (1.45e-3)" 1.4 1.3 2.7 0.9 11.7 1.0 1.1 6.8 7.9 1.4 1.2 2.7 0.5 1.0 2.8 3.9 1.3 1.1 0.8 3.9 3.5 2.8 1.2 0.5 1.2 1.0 2.5 2.5 2.9 2.5 2.8 6.1 2.3 5.4 1.5 0.9 2.4 1.1 1.0 1.7 1.5 0.6 1.8 2.4 1.1 0.8 2.7 1.1 0.0 1.3 0.6 0.7 1.2 0.9 1.2 0.9 2.7 0.5 0.8 1.0 0.2 0.1 0.4 0.5 1.9 1.2 2.1 0.3 1.7 1.1 0.5 1.0 0.5 0.2 0.5 2.8 1.1 0.9 0.2 0.2 0.3 1.1 0.3 0.3 0.2 0.4 0.3 0.3 0.1 0.2 1.8 0.5 0.0 0.7 3.4 0.1 0.3 0.2 0.8 7.0 0.1 0.2 0.8 0.3 0.1 0.3 3.1 2.7 0.3 0.3 0.3 1.8 2.1 0.3 0.9 1.7 0.5 11.5 0.4 0.8 3.3 0.7 1.6 0.4 0.3 1.0 0.2 3.9 0.2 5.2 2.7 0.5 0.5 0.7 0.4 0.4 0.7 0.7 0.5 0.2 1.2 1.0 0.8 1.1 0.8 0.5 0.9 0.6 0.2 2.7 11.7 6.8 6.1 3.5 2.8 2.5 2.5 5.4 1.1 3.0 0.0 0.0 0.0 0.0 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PCDHGA10 PCDH-GAMMA-A10 ENSG00000253846 "Protocadherin gamma subfamily A, 10" Q9Y5H3 5 141412987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 33.7" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 27.0;Cone photoreceptor cells: 15.7;Horizontal cells: 22.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 12.2;HSkMC: 13.8;T-47d: 16.3;U-2197: 9.6" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077276" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077276: " "unprognostic (2.92e-1)" "unprognostic (2.17e-4)" "unprognostic (1.63e-1)" "unprognostic (3.33e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-2)" "unprognostic (9.99e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.64e-3)" "unprognostic (2.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.06e-1)" "unprognostic (8.83e-3)" 5.2 4.2 7.9 1.6 11.4 1.2 2.7 2.4 33.7 3.6 2.9 9.8 1.2 2.4 3.0 2.4 4.3 3.6 3.7 2.3 9.1 4.4 2.0 6.5 3.5 1.7 5.1 7.2 3.6 1.9 1.4 2.4 7.4 5.3 3.6 2.6 4.9 4.1 4.6 2.0 4.7 2.9 3.1 6.7 2.5 4.7 2.0 6.5 0.0 4.9 1.5 3.3 2.5 3.5 0.9 1.1 1.5 0.7 0.8 1.0 0.2 0.0 0.0 12.2 6.2 5.4 2.3 5.8 2.1 0.1 3.0 4.8 0.3 0.7 0.7 8.1 3.0 0.2 0.3 2.9 1.9 2.4 0.8 0.0 0.0 0.3 0.0 2.2 1.2 0.2 13.8 0.3 2.0 0.8 0.3 1.1 0.3 0.0 0.1 7.4 0.0 0.1 0.3 1.2 0.0 0.1 0.1 1.0 0.0 2.1 0.1 1.6 0.6 0.3 0.0 0.3 3.0 16.3 1.5 2.7 5.6 0.3 9.6 0.1 0.2 0.9 0.1 2.9 0.0 0.3 1.5 0.3 0.3 1.0 0.4 1.0 0.6 0.4 0.6 0.1 0.9 0.4 0.9 0.9 0.8 0.7 1.1 0.3 0.2 7.9 11.4 2.4 8.5 9.1 4.4 5.1 7.2 5.3 6.5 0.0 1.3 0.0 1.8 0.1 27.0 2.3 2.5 0.0 2.3 1.8 15.7 1.7 0.0 0.9 0.0 2.1 0.4 0.0 1.2 1.1 1.2 3.2 1.1 1.1 0.8 22.3 1.2 3.1 0.0 0.0 3.1 0.3 1.7 0.0 1.1 8.7 2.1 0.0 2.1 0.0 5.2 6.5 1.1 0.3 0.7 0.4 0.3 0.0 0.8 0.9 PCDHGA11 PCDH-GAMMA-A11 ENSG00000253873 "Protocadherin gamma subfamily A, 11" Q9Y5H2 5 141421047-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 1.9;Horizontal cells: 1.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enhanced" "Detected in single" "dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "ASC diff: 12.0;ASC TERT1: 13.0;GAMG: 22.7;hTERT-RPE1: 33.8;WM-115: 20.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.13e-2)" "unprognostic (1.78e-3)" "unprognostic (9.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.68e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.16e-3)" "unprognostic (1.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.97e-1)" "unprognostic (2.22e-1)" "unprognostic (3.03e-2)" "unprognostic (3.74e-2)" "unprognostic (3.54e-1)" "unprognostic (4.34e-3)" "unprognostic (1.89e-1)" 3.4 2.5 7.4 2.8 9.4 0.5 2.1 4.1 8.5 2.4 2.5 8.5 0.0 1.2 2.6 1.7 3.1 2.1 2.1 3.4 11.6 1.9 1.9 1.2 2.3 1.8 4.5 5.2 3.8 2.3 1.3 1.9 8.3 5.0 2.5 1.5 3.3 2.8 3.4 2.8 6.6 1.2 3.3 4.9 1.6 1.8 2.2 7.1 0.1 3.4 0.6 1.7 1.7 2.2 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 1.1 12.0 13.0 0.4 2.6 5.0 2.0 3.2 0.0 0.1 0.3 4.3 2.6 22.7 1.7 0.0 0.3 3.2 0.0 1.1 0.0 0.0 0.0 2.0 0.2 0.0 9.3 0.1 3.5 0.0 33.8 3.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 5.0 0.2 1.5 3.6 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 7.4 9.4 4.1 8.5 11.6 1.9 4.5 5.2 5.0 7.1 0.0 0.6 0.0 0.1 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PCDHGA12 "CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12" ENSG00000253159 "Protocadherin gamma subfamily A, 12" O60330 5 141430589-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 3.5;Cardiomyocytes: 1.8;Ito cells: 1.3" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 7.7;BJ hTERT+: 12.9;fHDF/TERT166: 19.1;HHSteC: 6.3;HSkMC: 14.3;TIME: 6.1" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.17e-3)" "unprognostic (2.71e-2)" "unprognostic (1.04e-2)" "unprognostic (2.67e-1)" "unprognostic (2.74e-1)" "unprognostic (5.06e-2)" "unprognostic (1.99e-1)" "unprognostic (9.01e-3)" "unprognostic (1.19e-1)" "unprognostic (4.65e-4)" "unprognostic (2.98e-1)" "unprognostic (3.02e-1)" "unprognostic (1.28e-4)" "unprognostic (8.30e-3)" "unprognostic (1.57e-1)" "unprognostic (2.42e-1)" "unprognostic (6.85e-3)" 5.1 12.7 14.8 2.8 18.9 0.7 2.4 4.7 13.8 4.9 1.8 8.6 0.6 1.4 5.4 2.3 3.5 2.7 11.3 6.5 15.7 5.6 3.1 2.8 6.5 1.6 4.7 7.3 6.2 3.6 2.0 2.7 6.5 8.4 3.5 1.7 3.4 1.7 4.9 1.9 5.1 1.5 5.3 8.4 3.7 2.2 1.6 12.4 0.4 3.0 0.6 1.7 4.5 3.6 3.7 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.6 1.2 0.1 7.7 12.9 0.0 0.0 0.0 0.0 0.4 0.0 19.1 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 14.3 0.0 3.8 0.0 0.0 4.5 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 6.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 14.8 18.9 4.7 10.4 15.7 5.6 4.7 7.3 8.4 12.4 0.0 0.0 0.0 0.2 0.0 3.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.4 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGA2 PCDH-GAMMA-A2 ENSG00000081853 "Protocadherin gamma subfamily A, 2" Q9Y5H1 5 141338760-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 2.7;Cardiomyocytes: 1.6;Leydig cells: 1.1;Peritubular cells: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.8;BJ: 5.4;fHDF/TERT166: 6.3;HSkMC: 5.0;hTERT-RPE1: 5.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA038625" Approved Approved "Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480" "unprognostic (2.43e-3)" "unprognostic (2.10e-2)" "unprognostic (1.32e-2)" "unprognostic (4.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.14e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (9.01e-2)" "unprognostic (4.32e-2)" "unprognostic (8.45e-3)" "unprognostic (9.68e-3)" "unprognostic (1.04e-2)" "unprognostic (1.18e-2)" "unprognostic (2.23e-4)" 5.1 4.3 6.7 2.1 8.0 0.6 4.2 5.2 12.6 6.6 2.6 4.6 1.0 0.9 6.5 5.7 2.4 5.5 5.5 11.1 6.5 4.6 3.3 2.4 4.6 1.1 6.0 2.3 15.3 8.4 9.2 10.6 2.2 7.8 5.3 1.4 13.8 3.3 5.8 2.6 2.9 1.4 5.2 5.6 1.9 2.1 10.4 3.5 0.0 4.3 1.2 1.1 3.2 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 3.9 9.8 0.1 5.4 2.1 0.5 0.9 0.1 0.1 0.1 0.7 6.3 0.8 0.2 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.0 0.2 0.1 0.3 5.8 2.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.3 0.2 0.8 0.0 0.3 0.7 0.0 3.6 0.1 0.5 0.7 0.0 3.3 0.9 0.5 0.3 0.1 0.0 0.4 0.0 2.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 8.0 5.2 7.2 6.5 4.6 6.0 2.3 7.8 3.5 0.0 0.0 0.0 0.1 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.5 0.3 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PCDHGA3 PCDH-GAMMA-A3 ENSG00000254245 "Protocadherin gamma subfamily A, 3" Q9Y5H0 5 141343829-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 2.4;Cardiomyocytes: 1.1;Horizontal cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 11.2;BJ: 3.7;EFO-21: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.47e-2)" "unprognostic (4.79e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.53e-2)" "unprognostic (1.03e-1)" "unprognostic (2.35e-1)" "unprognostic (1.85e-1)" "unprognostic (7.44e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (3.17e-2)" "unprognostic (2.43e-1)" "unprognostic (2.32e-3)" "unprognostic (7.12e-3)" "unprognostic (3.31e-2)" "unprognostic (2.52e-4)" 4.0 4.5 11.7 1.4 10.5 0.7 2.5 6.9 13.7 4.7 1.3 7.9 0.0 0.7 4.5 3.5 1.5 2.9 3.5 12.2 8.5 5.8 2.5 2.5 2.6 1.0 6.6 7.7 8.6 3.6 1.8 6.3 5.7 8.7 3.0 1.3 4.6 2.9 3.2 1.5 1.9 1.1 3.6 6.0 1.5 1.2 5.2 3.8 0.0 3.3 1.3 1.0 1.7 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.1 0.2 1.5 0.0 3.7 0.3 0.0 0.1 0.0 0.0 0.1 9.2 0.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.4 0.1 0.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 10.5 6.9 13.7 8.5 5.8 6.6 7.7 8.7 3.8 0.0 0.0 0.0 0.1 0.0 2.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 PCDHGA4 PCDH-GAMMA-A4 ENSG00000262576 "Protocadherin gamma subfamily A, 4" Q9Y5G9 5 141355025-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 1.9" "Lineage enriched" "Detected in single" 7 "T-cells: 1.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.3;BJ: 5.7;HSkMC: 6.0;HUVEC TERT2: 5.7;U-87 MG: 8.2" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.27e-2)" "unprognostic (4.55e-3)" "unprognostic (2.00e-2)" "unprognostic (6.54e-4)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-2)" "unprognostic (5.62e-2)" "unprognostic (3.76e-1)" "unprognostic (6.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.94e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.31e-4)" 5.4 4.7 6.5 1.8 8.3 0.5 3.0 8.5 11.2 4.8 2.0 10.4 1.5 1.2 5.0 3.0 1.9 3.4 3.1 4.8 6.3 5.9 2.0 2.7 3.6 0.9 5.6 8.1 5.8 6.7 8.5 3.4 2.8 6.1 4.1 1.4 3.5 4.3 4.2 1.5 1.8 1.2 5.0 5.9 1.3 1.4 2.7 4.0 0.0 2.6 2.7 0.9 2.3 2.5 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 1.0 0.6 4.5 10.3 0.0 5.7 4.6 0.3 1.1 0.0 0.1 1.0 2.0 4.8 1.8 0.1 0.2 0.2 0.6 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.4 6.0 0.2 0.1 0.0 3.5 5.7 0.0 0.2 0.3 2.4 0.8 0.3 0.2 0.2 0.0 0.3 0.3 1.6 0.1 0.3 0.0 0.8 1.7 0.3 0.3 1.1 0.5 2.2 0.0 3.7 2.4 0.7 3.2 0.5 0.2 0.3 0.2 8.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.3 8.5 9.3 6.3 5.9 5.6 8.1 6.1 4.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PCDHGA5 "CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5" ENSG00000253485 "Protocadherin gamma subfamily A, 5" Q9Y5G8 5 141364232-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 10.6;Horizontal cells: 9.5;Sertoli cells: 6.5" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "ASC diff: 18.9;ASC TERT1: 7.5" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.61e-2)" "unprognostic (1.04e-2)" "unprognostic (5.28e-2)" "unprognostic (4.83e-1)" "unprognostic (6.60e-3)" "unprognostic (5.71e-2)" "unprognostic (8.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.07e-1)" "unprognostic (9.40e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" "unprognostic (5.90e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (8.38e-4)" 4.0 2.7 6.1 1.8 9.1 0.9 3.9 19.1 9.6 9.0 2.7 7.7 4.1 1.0 7.6 3.2 3.3 4.7 4.5 4.9 6.9 4.0 1.5 1.2 3.3 1.3 3.2 3.8 6.6 1.7 3.3 3.7 2.7 4.6 5.6 1.6 4.1 2.5 4.0 1.5 3.0 1.5 4.3 6.3 1.4 1.7 1.7 3.7 0.0 1.8 0.9 1.0 2.5 4.2 0.9 0.8 1.6 0.6 1.9 0.7 0.2 0.0 0.5 0.3 0.1 18.9 7.5 0.0 0.8 0.2 0.1 0.4 0.0 0.0 0.9 0.4 0.3 1.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.1 1.8 0.2 0.0 0.0 0.4 0.6 0.0 0.1 0.6 0.8 0.3 0.5 0.7 0.1 0.0 0.3 0.9 0.7 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.3 0.3 1.6 0.0 1.0 0.7 0.2 1.0 0.7 0.1 1.0 0.1 0.3 0.2 0.8 1.5 0.6 0.6 0.7 0.3 0.3 0.6 0.6 0.4 0.1 0.9 0.7 0.7 1.6 1.9 0.2 0.8 0.4 0.2 6.1 9.1 19.1 9.6 6.9 4.0 3.2 3.8 4.6 3.7 0.0 0.6 0.0 0.6 0.1 10.6 1.6 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.4 0.3 1.1 0.0 0.1 9.5 0.0 1.8 0.3 0.0 3.4 0.0 0.0 0.0 0.0 3.3 0.2 0.0 1.8 0.0 1.1 6.5 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 PCDHGA6 PCDH-GAMMA-A6 ENSG00000253731 "Protocadherin gamma subfamily A, 6" Q9Y5G7 5 141373914-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 9.7;Cardiomyocytes: 4.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 5.8;SCLC-21H: 11.2;T-47d: 6.5;WM-115: 14.0" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (4.49e-2)" "unprognostic (8.91e-3)" "unprognostic (5.45e-2)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (3.86e-3)" "unprognostic (2.02e-2)" "unprognostic (5.26e-2)" "unprognostic (7.44e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-3)" 4.1 3.8 6.1 2.3 8.4 0.8 2.9 19.6 10.8 7.9 3.4 8.3 2.9 1.0 6.9 4.7 2.6 4.3 3.6 3.7 5.0 4.3 2.8 1.7 3.3 1.4 2.9 4.7 9.7 2.5 2.5 4.5 6.9 3.3 4.0 1.6 5.8 4.1 5.3 2.1 4.7 1.5 6.1 2.8 2.8 1.7 2.2 2.9 0.2 3.8 1.2 1.5 4.6 3.6 1.3 0.7 2.8 0.6 0.5 0.8 0.2 0.1 0.4 3.2 0.5 1.6 5.4 0.1 2.3 0.8 1.2 1.2 0.0 0.2 2.2 3.1 3.7 1.2 0.5 0.1 0.5 0.8 0.0 0.3 0.0 0.3 0.3 0.9 0.1 0.1 5.8 0.4 0.3 0.1 1.1 1.8 0.1 0.3 1.3 0.4 0.5 0.7 1.8 0.3 0.1 0.1 1.5 0.4 0.0 0.4 0.1 11.2 0.9 0.1 0.3 0.7 0.7 6.5 0.1 5.5 0.9 0.4 0.9 0.8 0.4 1.8 0.4 0.9 0.8 14.0 1.8 0.6 0.3 0.8 0.3 0.3 0.8 0.6 0.2 0.1 1.3 0.3 0.5 2.8 0.5 0.3 0.7 0.5 0.2 6.1 8.4 19.6 10.8 5.0 4.3 2.9 4.7 3.3 2.9 0.0 2.1 0.5 0.5 0.0 9.7 4.5 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.0 0.0 1.3 0.1 0.3 0.4 0.0 0.5 0.1 1.6 0.0 1.8 0.0 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 2.1 0.0 1.0 0.0 0.5 0.1 0.2 0.0 0.2 0.0 0.0 0.1 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 "Protocadherin gamma subfamily A, 7" Q9Y5G6 5 141382739-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 3.5;Cardiomyocytes: 1.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.9;BJ hTERT+: 17.3;hTERT-RPE1: 9.3;SH-SY5Y: 15.5;T-47d: 6.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.00e-2)" "unprognostic (4.73e-3)" "unprognostic (1.42e-1)" "unprognostic (7.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.85e-2)" "unprognostic (2.61e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (5.78e-2)" "unprognostic (3.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.21e-3)" "unprognostic (6.30e-2)" "unprognostic (4.99e-2)" "unprognostic (1.42e-3)" 1.7 2.0 3.1 1.3 9.0 0.6 2.1 5.3 14.9 3.5 3.0 7.1 2.1 1.0 4.2 4.1 2.2 3.3 1.9 3.0 5.1 3.3 3.2 1.9 2.2 1.0 5.1 6.6 4.7 2.5 4.6 3.4 4.8 5.4 3.7 1.5 5.8 2.6 3.3 1.6 3.8 1.2 3.0 6.3 1.3 1.4 2.1 5.1 0.0 6.6 1.5 1.0 2.4 2.5 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 1.9 0.0 5.8 9.9 0.0 2.6 17.3 3.5 5.2 0.0 0.0 0.4 4.3 0.5 0.1 0.1 0.0 0.1 2.9 0.0 0.3 0.0 0.4 0.1 1.0 0.0 0.0 4.3 0.1 0.0 0.6 9.3 1.4 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 15.5 0.0 0.1 0.1 3.3 6.8 0.0 5.2 0.1 0.1 2.5 0.0 0.1 1.5 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.0 5.3 7.7 5.1 3.3 5.1 6.6 5.4 5.1 0.0 0.0 0.0 0.4 0.0 3.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 PCDHGA8 "KIAA0327, PCDH-GAMMA-A8" ENSG00000253767 "Protocadherin gamma subfamily A, 8" Q9Y5G5 5 141390157-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 7.1" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 10.4;Cardiomyocytes: 2.5;Horizontal cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 2.9;neutrophil: 2.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.9" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.28e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (4.10e-2)" "unprognostic (7.68e-2)" "unprognostic (2.30e-2)" "unprognostic (1.83e-2)" "unprognostic (2.23e-1)" "unprognostic (1.24e-1)" "unprognostic (1.35e-2)" "unprognostic (1.49e-3)" "unprognostic (7.59e-2)" "unprognostic (3.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.99e-3)" 0.6 0.7 0.8 0.7 0.6 2.5 0.7 2.3 2.2 1.2 1.2 1.0 7.1 0.4 2.3 1.5 2.1 0.7 0.9 2.0 1.4 0.5 0.5 0.9 1.1 0.7 0.5 0.4 2.6 0.6 0.2 1.9 1.4 3.5 0.9 0.8 0.4 0.8 0.5 2.2 2.5 1.1 0.7 1.6 0.7 0.7 1.0 1.3 1.1 2.4 0.4 0.6 0.6 1.2 0.7 0.4 2.9 0.4 0.5 0.3 0.1 0.3 0.2 1.1 0.6 1.1 2.6 0.6 2.4 1.5 1.7 0.7 0.2 0.4 1.1 1.0 1.8 0.3 0.4 0.0 0.0 1.3 0.3 0.2 0.3 0.5 0.3 0.1 0.4 0.8 1.4 0.1 0.5 0.1 0.5 0.4 0.2 0.2 0.9 0.2 0.2 0.5 0.7 2.6 0.0 0.1 1.0 0.2 0.1 0.1 0.3 0.7 0.6 0.3 0.9 0.4 2.4 1.2 1.7 2.5 2.6 0.9 0.6 0.2 0.3 0.3 0.4 1.3 0.4 1.3 2.9 0.4 0.5 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.2 0.3 2.8 0.5 0.3 0.4 0.2 0.1 0.8 0.6 2.3 2.2 1.4 0.5 0.5 0.4 3.5 1.3 0.0 1.1 0.0 0.8 0.0 10.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 3.2 0.0 0.6 0.8 0.0 2.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.4 0.0 1.7 0.0 0.2 0.6 0.9 0.0 0.0 0.0 0.0 0.4 PCDHGA9 PCDH-GAMMA-A9 ENSG00000261934 "Protocadherin gamma subfamily A, 9" Q9Y5G4 5 141402932-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 3.7;Club cells: 1.2;Horizontal cells: 3.2;Muller glia cells: 1.3" "Cancer enhanced" "Detected in some" "glioma: 3.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 4.1;HSkMC: 4.6;hTERT-RPE1: 19.1;TIME: 5.0;U-87 MG: 5.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.98e-2)" "unprognostic (7.47e-3)" "unprognostic (9.86e-3)" "unprognostic (2.22e-1)" "unprognostic (4.68e-2)" "unprognostic (4.96e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (1.87e-3)" "unprognostic (2.26e-1)" "unprognostic (1.79e-1)" "unprognostic (4.48e-3)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (2.71e-1)" "unprognostic (1.83e-2)" 5.6 5.4 12.0 2.6 12.6 0.9 3.7 11.5 17.3 6.9 2.7 11.2 0.1 2.1 7.6 3.9 4.8 6.3 6.5 3.2 10.3 8.5 3.0 2.8 5.0 2.1 9.6 7.1 9.1 3.0 3.8 3.0 3.6 10.9 5.2 2.7 7.7 3.8 7.3 1.9 5.5 2.0 5.9 13.0 3.6 2.9 2.0 5.9 0.0 4.6 1.4 2.5 4.8 3.7 0.5 0.3 1.0 0.5 0.2 1.0 0.0 0.0 0.2 0.7 1.8 0.1 0.3 0.2 0.8 0.0 0.7 0.7 0.3 0.4 1.4 4.1 2.2 0.3 0.1 0.1 0.2 0.8 0.0 0.3 0.0 0.1 0.0 1.3 0.0 0.3 4.6 0.2 0.4 0.3 19.1 1.1 0.1 0.1 0.2 0.4 0.4 0.2 0.5 0.2 0.1 0.0 0.2 0.5 0.0 0.2 0.2 0.5 1.2 0.4 0.1 0.6 0.5 1.1 0.5 5.0 0.3 0.3 0.1 2.7 0.2 0.1 0.1 5.8 0.1 1.0 1.0 0.5 0.3 1.0 0.3 0.6 0.3 0.4 0.2 0.1 0.5 0.4 0.7 1.0 0.2 0.2 0.3 0.1 0.0 12.0 12.6 11.5 16.2 10.3 8.5 9.6 7.1 10.9 5.9 0.0 0.0 0.0 0.1 0.2 3.7 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 PCDHGB1 PCDH-GAMMA-B1 ENSG00000254221 "Protocadherin gamma subfamily B, 1" Q9Y5G3 5 141350102-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 32.2;pituitary gland: 13.7" "Group enriched" "Detected in some" 17 "Early spermatids: 5.4;Late spermatids: 5.9;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 14.7;ASC TERT1: 7.7;hTERT-RPE1: 8.0;T-47d: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA076182" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody" Yes No "Vesicles, Plasma membrane" "Nucleoplasm, Focal adhesion sites, Midbody" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783" "unprognostic (1.53e-2)" "unprognostic (1.94e-3)" "unprognostic (3.21e-1)" "unprognostic (4.38e-3)" "unprognostic (2.98e-1)" "unprognostic (8.36e-3)" "unprognostic (2.37e-1)" "unprognostic (9.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.78e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-2)" "unprognostic (1.93e-1)" "unprognostic (7.63e-3)" 2.3 2.7 8.2 1.4 7.5 1.0 2.1 4.3 32.2 2.5 1.4 9.4 0.1 1.2 3.7 2.0 1.7 1.9 2.1 2.2 7.6 5.7 2.1 1.3 2.4 1.2 5.5 5.0 4.1 2.8 1.4 13.7 1.6 7.0 2.5 1.4 2.6 1.7 3.1 1.1 1.4 1.3 3.0 6.9 1.4 1.2 1.5 5.6 0.0 2.5 0.0 1.2 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 2.0 1.8 0.0 14.7 7.7 0.1 1.4 3.6 0.5 0.8 0.2 0.5 0.5 4.7 0.5 3.5 0.6 0.4 0.2 0.5 0.0 0.9 0.0 0.2 1.3 0.2 0.0 0.1 1.2 0.0 0.0 0.0 8.0 0.1 0.0 0.2 0.2 3.3 1.8 0.4 0.3 0.2 0.0 0.0 0.0 2.7 0.1 0.0 0.0 1.1 0.8 0.0 0.9 0.1 1.5 9.6 0.0 1.1 0.2 1.6 1.2 0.0 0.0 2.6 0.3 2.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.5 4.3 9.6 7.6 5.7 5.5 5.0 7.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB2 PCDH-GAMMA-B2 ENSG00000253910 "Protocadherin gamma subfamily B, 2" Q9Y5G2 5 141360042-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Cancer enriched" "Detected in many" 5 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 14.4;ASC TERT1: 10.5;LHCN-M2: 8.5;REH: 7.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077526" Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" Nucleoplasm "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077526: AB_2732350" "unprognostic (7.14e-3)" "unprognostic (8.79e-3)" "unprognostic (3.21e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.67e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-4)" "unprognostic (2.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.78e-1)" "unprognostic (1.05e-1)" "unprognostic (8.46e-3)" "unprognostic (4.59e-2)" "unprognostic (2.57e-1)" "unprognostic (3.06e-2)" "unprognostic (1.29e-1)" "unprognostic (3.36e-4)" 4.9 3.6 11.3 2.2 9.7 0.9 3.7 8.7 12.2 7.2 2.4 11.6 0.3 1.2 9.2 3.2 3.2 5.6 6.2 4.6 9.3 7.0 2.7 2.7 5.4 1.4 7.0 8.6 9.0 2.6 7.5 3.0 3.9 7.3 4.4 2.8 3.1 2.4 4.4 1.9 2.9 2.1 5.0 7.0 2.2 2.0 1.8 7.8 0.1 2.6 1.3 1.4 2.8 3.3 0.9 0.9 0.5 0.0 0.0 0.7 0.0 0.1 0.3 2.1 0.2 14.4 10.5 0.1 2.2 3.0 0.6 3.4 0.0 0.3 3.8 1.0 1.7 7.5 0.5 0.5 0.3 1.0 0.0 0.2 0.0 0.3 0.4 0.6 0.2 0.2 2.7 0.5 0.2 0.1 4.9 1.7 0.1 0.2 1.2 8.5 0.4 2.9 0.6 0.1 0.9 0.9 7.8 2.7 0.2 0.2 0.3 1.6 1.7 0.2 0.4 0.4 1.6 3.1 0.2 6.0 3.0 0.7 4.6 3.9 0.2 2.2 0.7 3.3 1.0 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.4 0.0 0.0 0.4 0.0 0.6 0.5 0.0 0.0 0.9 0.0 0.0 11.3 9.7 8.7 10.6 9.3 7.0 7.0 8.6 7.3 7.8 0.0 0.3 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB3 PCDH-GAMMA-B3 ENSG00000262209 "Protocadherin gamma subfamily B, 3" Q9Y5G1 5 141370264-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 13.5;ASC TERT1: 10.9;TIME: 6.8" "HPA008755, HPA010580, HPA035822, HPA035823" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA035822: , HPA035823: AB_2674802" "unprognostic (6.93e-3)" "unprognostic (9.10e-4)" "unprognostic (1.35e-1)" "unprognostic (7.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (7.83e-2)" "unprognostic (1.92e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.81e-2)" "unprognostic (3.11e-1)" "unprognostic (3.62e-2)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" 4.1 1.7 3.3 1.6 6.5 0.5 3.1 3.5 5.6 3.0 3.0 7.2 0.7 0.7 4.9 3.7 3.3 3.3 2.9 4.6 3.3 2.3 2.9 2.0 2.5 3.7 1.9 3.8 5.2 4.2 4.6 5.4 2.3 2.6 2.6 2.2 3.1 6.6 2.6 1.9 3.3 1.4 4.3 2.9 2.4 2.3 1.5 2.8 0.3 3.4 3.2 3.5 2.7 4.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.5 0.3 13.5 10.9 0.2 1.4 2.5 0.9 1.1 0.0 0.0 2.2 0.4 4.3 0.8 0.6 0.0 0.3 0.7 0.0 0.3 0.0 0.3 0.1 0.6 0.1 0.0 2.7 0.6 0.2 0.1 0.2 1.2 0.0 0.3 1.0 0.3 0.4 0.7 1.1 0.1 0.0 0.1 1.9 0.7 0.0 0.2 0.1 3.0 0.6 0.0 0.1 0.3 0.4 0.8 0.0 6.8 0.6 0.1 0.7 0.7 0.3 2.1 0.2 0.6 0.6 1.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 6.5 3.5 5.6 3.3 2.3 1.9 3.8 2.6 2.8 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB4 "CDH20, FIB2, PCDH-GAMMA-B4" ENSG00000253953 "Protocadherin gamma subfamily B, 4" Q9UN71 5 141387698-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 2: 1.1;Horizontal cells: 1.6" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "NK-cell: 1.6" "Lineage enriched" "Detected in single" 7 "NK-cells: 1.6" "Cell line enhanced" "Detected in some" "BJ hTERT+: 28.6;SuSa: 10.9;TIME: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.33e-1)" "unprognostic (1.83e-3)" "unprognostic (2.91e-1)" "unprognostic (1.18e-1)" "unprognostic (1.23e-2)" "unprognostic (9.25e-3)" "unprognostic (2.20e-1)" "unprognostic (1.25e-2)" "unprognostic (1.99e-1)" "unprognostic (1.74e-1)" "unprognostic (1.29e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.70e-2)" "unprognostic (2.62e-1)" "unprognostic (1.13e-1)" "unprognostic (3.27e-2)" 2.4 2.2 2.4 0.7 4.2 0.0 1.2 1.8 2.1 2.6 1.4 0.2 3.2 3.5 1.1 2.1 0.8 2.8 2.3 4.1 2.9 3.3 2.1 0.0 1.8 5.1 1.9 3.0 2.5 6.2 2.6 0.7 3.0 3.1 1.2 3.4 0.3 1.9 2.0 0.6 0.4 0.9 3.6 0.2 1.6 2.0 0.0 0.2 0.0 0.0 1.6 0.2 0.2 0.0 0.7 7.1 0.0 4.6 5.9 0.8 6.8 28.6 2.9 1.9 0.0 0.0 0.2 5.5 0.2 0.1 2.0 0.0 0.0 3.2 0.0 0.0 0.0 0.1 1.6 1.8 0.0 0.0 5.7 0.0 2.7 0.0 0.1 4.4 0.0 0.2 0.0 0.0 0.0 0.6 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 10.9 3.6 2.6 14.3 3.9 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB5 PCDH-GAMMA-B5 ENSG00000276547 "Protocadherin gamma subfamily B, 5" Q9Y5G0 5 141397987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 11.2" "Group enriched" "Detected in some" 4 "Bipolar cells: 1.7;Ciliated cells: 1.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 32.8;ASC TERT1: 24.8;BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (2.71e-3)" "unprognostic (1.95e-2)" "unprognostic (1.09e-1)" "unprognostic (4.14e-2)" "unprognostic (2.35e-1)" "unprognostic (1.20e-1)" "unprognostic (3.64e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.29e-1)" "unprognostic (1.69e-4)" "unprognostic (9.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.25e-4)" 2.1 1.9 0.8 0.3 3.2 0.0 3.6 2.0 4.3 1.4 0.4 2.5 1.9 0.0 2.1 2.5 1.1 2.1 0.8 1.9 0.0 1.6 3.1 6.8 2.6 0.9 1.5 4.9 2.8 11.2 2.1 9.5 1.5 2.2 0.2 3.7 3.2 3.2 1.4 2.6 0.0 1.9 3.0 0.5 0.7 1.0 2.2 0.8 3.5 0.0 0.7 1.9 1.4 0.5 0.2 0.0 0.3 0.0 1.9 0.1 0.0 1.2 0.1 0.0 32.8 24.8 0.6 8.7 0.0 14.2 16.0 1.4 4.7 4.9 11.4 9.6 0.0 6.6 0.0 3.6 8.0 0.0 1.4 0.0 0.0 0.0 3.4 0.0 3.1 8.7 0.7 0.8 4.6 6.1 4.3 0.0 0.1 0.0 0.4 3.7 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.8 2.6 0.0 0.0 0.0 0.0 0.0 1.0 9.2 0.0 4.4 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.3 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.7 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 PCDHGB6 PCDH-GAMMA-B6 ENSG00000253305 "Protocadherin gamma subfamily B, 6" Q9Y5F9 5 141408021-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 6.4;Cone photoreceptor cells: 5.9;Horizontal cells: 9.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 18.6;EFO-21: 6.3;HSkMC: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (2.63e-1)" "unprognostic (7.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-2)" "unprognostic (3.51e-1)" "unprognostic (1.11e-1)" "unprognostic (4.77e-2)" "unprognostic (9.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.27e-1)" "unprognostic (1.21e-2)" "unprognostic (7.71e-4)" 6.7 7.2 8.8 2.6 9.9 1.6 4.4 6.1 26.6 5.8 4.1 10.1 0.3 1.8 7.2 5.7 3.0 5.1 4.4 4.6 8.9 5.7 3.2 9.4 4.4 2.2 6.9 4.4 13.3 5.2 16.1 4.7 6.8 5.9 4.0 2.3 9.0 5.3 5.9 5.7 4.7 2.2 4.8 4.1 4.0 2.5 2.1 6.7 0.3 6.1 1.9 2.1 4.2 5.1 0.8 0.5 3.2 0.4 0.5 0.9 0.2 0.0 0.1 18.6 0.2 0.6 0.7 0.9 1.7 0.0 0.4 1.0 0.2 0.3 1.5 6.3 1.0 0.3 0.3 0.0 0.4 1.2 0.0 0.3 0.0 0.2 0.1 1.5 0.1 0.1 4.3 2.1 0.9 0.1 0.2 0.6 0.4 0.1 0.3 0.1 0.3 0.1 1.2 0.8 0.0 0.0 0.2 0.1 0.1 3.0 0.2 0.2 0.3 0.0 0.1 0.1 0.4 1.5 0.4 3.0 0.1 0.3 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.9 1.1 0.4 0.2 0.9 0.3 0.2 0.6 0.4 0.2 0.1 0.8 0.4 0.3 3.2 0.5 0.3 0.5 0.2 0.2 8.8 9.9 6.1 7.9 8.9 5.7 6.9 4.4 5.9 6.7 3.0 0.3 0.0 1.3 0.0 6.4 2.5 0.0 1.4 2.3 0.0 5.9 0.1 0.0 0.4 0.0 0.9 0.0 0.0 1.1 0.1 0.4 0.6 0.0 0.8 0.2 9.5 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 3.3 1.6 0.0 1.1 0.0 2.4 0.0 1.0 0.2 0.3 0.1 0.1 0.0 0.0 0.6 PCDHGB7 "ME6, PCDH-GAMMA-B7" ENSG00000254122 "Protocadherin gamma subfamily B, 7" Q9Y5F8 5 141417645-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Bipolar cells: 7.4;Horizontal cells: 3.2" "Cancer enhanced" "Detected in many" "glioma: 7.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "AN3-CA: 38.8;HSkMC: 12.3;hTERT-RPE1: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.22e-2)" "unprognostic (2.55e-2)" "unprognostic (7.39e-3)" "unprognostic (2.95e-1)" "unprognostic (1.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (8.40e-2)" "unprognostic (4.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.88e-2)" "unprognostic (3.05e-1)" "unprognostic (2.22e-2)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (5.68e-2)" 10.1 9.8 12.6 3.8 13.5 0.8 8.0 19.1 12.9 10.2 7.0 16.1 1.2 2.3 11.6 5.0 6.8 7.8 9.2 8.5 14.5 7.9 5.4 3.5 11.6 2.6 10.4 7.3 17.3 5.5 9.5 5.3 11.0 9.4 8.3 3.8 15.5 7.1 12.0 5.6 6.8 3.2 10.5 20.1 5.3 4.5 4.2 14.3 0.6 8.4 3.0 2.3 4.6 6.9 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 38.8 0.9 0.1 0.4 2.5 0.3 0.9 1.9 0.0 2.3 0.3 2.1 5.1 0.3 0.6 0.0 0.4 0.9 0.0 0.2 0.0 0.0 0.0 2.9 0.2 0.0 12.3 0.3 0.7 0.4 32.9 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 4.3 0.8 0.0 0.1 0.0 4.2 5.8 0.1 0.0 0.0 0.5 0.4 0.4 5.0 4.7 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 12.6 13.5 19.1 12.9 14.5 7.9 10.4 7.3 9.4 14.3 3.0 2.2 0.0 0.5 0.3 7.4 1.1 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 0.1 1.0 0.0 0.0 0.4 0.1 0.8 0.3 1.1 0.0 0.1 3.2 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.1 0.7 0.0 1.8 0.2 0.4 0.0 1.4 0.0 0.1 0.4 0.0 0.0 0.0 0.1 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 "Protocadherin gamma subfamily C, 4" Q9Y5F7 5 141484997-141512979 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 23.6" "Cell type enhanced" "Detected in single" 32 "Horizontal cells: 3.2" "Cancer enriched" "Detected in single" 10 "glioma: 4.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "REH: 9.3;SCLC-21H: 7.9;SH-SY5Y: 15.2;SuSa: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.05e-2)" "unprognostic (1.26e-3)" "unprognostic (4.78e-2)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (7.84e-2)" "unprognostic (9.48e-2)" "unprognostic (3.27e-1)" "unprognostic (4.55e-1)" "unprognostic (1.17e-1)" "unprognostic (8.72e-3)" "unprognostic (4.73e-3)" "unprognostic (2.20e-4)" "unprognostic (8.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.47e-1)" "unprognostic (2.75e-2)" 0.7 2.9 5.7 0.7 9.5 0.5 0.8 23.6 21.9 1.0 1.1 2.3 0.0 0.6 0.9 1.2 0.8 1.0 1.0 1.3 4.1 10.1 0.6 0.6 1.0 0.9 3.3 4.5 0.8 1.2 0.8 1.3 0.8 8.6 0.8 0.8 1.9 1.0 0.7 1.2 1.5 0.7 0.9 2.3 0.8 0.7 1.5 0.8 0.0 0.7 0.0 1.0 0.6 0.2 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.2 0.2 0.8 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.2 0.9 0.9 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.0 1.5 0.0 0.0 9.3 0.5 0.0 0.0 0.1 7.9 15.2 0.1 0.0 0.2 11.2 0.1 0.3 0.1 0.8 0.1 0.2 0.7 0.2 0.0 0.2 0.6 0.1 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.5 23.6 15.6 4.1 10.1 3.3 4.5 8.6 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 "Protocadherin gamma subfamily C, 5" Q9Y5F6 5 141489121-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 43.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "glioma: 3.1;head and neck cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.0;SuSa: 8.4;U-138 MG: 16.0;U-251 MG: 6.8;U-87 MG: 9.8" "Group enriched" "Detected in many" 5 "amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4" "HPA008755, HPA010580, HPA076140" Supported Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: " "unprognostic (2.86e-3)" "unprognostic (7.63e-4)" "unprognostic (2.00e-1)" "unprognostic (3.52e-3)" "unprognostic (5.42e-2)" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-2)" "unprognostic (3.90e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-9)" "unprognostic (6.87e-3)" "unprognostic (3.89e-2)" "unprognostic (3.13e-1)" "unprognostic (3.77e-3)" 1.0 1.1 7.4 1.1 34.5 0.9 1.1 3.0 43.7 1.1 1.0 2.8 0.0 0.9 1.4 1.3 1.0 1.2 1.2 2.8 11.8 2.8 0.9 0.9 1.1 0.9 2.2 10.0 1.1 1.0 1.0 1.1 1.0 2.3 1.3 1.0 0.0 0.9 1.6 1.6 1.5 0.9 2.0 0.8 1.0 1.0 1.3 1.1 0.0 1.0 0.0 1.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.7 0.2 0.8 0.6 0.5 0.6 0.0 0.0 0.5 1.6 2.4 0.1 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.5 0.0 5.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.9 0.8 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 8.4 0.1 0.2 0.1 16.0 0.2 0.2 6.8 0.0 0.0 0.0 9.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 34.5 3.0 39.2 11.8 2.8 2.2 10.0 2.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCGF5 "MGC16202, RNF159" ENSG00000180628 "Polycomb group ring finger 5" Q86SE9 10 91163012-91284331 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 252.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038349, HPA059071" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA038349: AB_10669523, HPA059071: " "unprognostic (1.34e-2)" "unprognostic (8.22e-2)" "unprognostic (1.25e-2)" "unprognostic (7.41e-2)" "unprognostic (1.15e-1)" "unprognostic (8.35e-2)" "unprognostic (6.53e-2)" "unprognostic (6.43e-2)" "unprognostic (3.89e-1)" "unprognostic (3.24e-2)" "unprognostic (3.75e-2)" "unprognostic (1.49e-1)" "prognostic favorable (4.98e-4)" "unprognostic (2.43e-1)" "unprognostic (2.00e-1)" "unprognostic (2.56e-2)" "prognostic favorable (6.90e-4)" 16.0 30.1 28.0 15.0 25.1 6.3 14.6 19.4 24.5 15.9 21.8 18.6 16.9 21.0 15.4 14.7 16.1 15.4 15.7 32.5 24.0 27.5 29.0 31.1 17.2 25.8 27.9 20.5 19.3 19.3 25.3 16.0 18.9 21.0 17.5 17.5 12.4 19.6 18.4 24.5 13.6 30.9 24.4 29.7 20.9 17.3 14.1 24.1 31.6 29.4 13.5 18.4 20.4 21.2 6.1 3.0 8.0 9.9 7.3 7.4 4.0 16.0 7.1 5.9 2.5 8.6 13.5 4.1 9.1 18.8 8.3 11.7 1.0 9.5 21.2 4.2 11.4 6.8 3.1 6.3 6.2 14.7 24.4 4.7 9.9 4.8 10.8 11.4 7.7 15.9 6.1 11.6 6.1 8.7 17.1 6.9 9.5 5.2 12.0 12.8 2.9 17.4 1.9 0.8 3.7 4.0 8.7 10.9 5.7 15.2 2.5 2.8 4.0 4.4 4.8 7.6 2.2 3.8 3.5 17.7 9.8 6.9 6.0 10.7 20.9 12.8 19.2 13.8 5.6 3.0 8.0 2.2 3.8 4.2 5.6 7.4 6.1 6.2 4.2 3.0 5.8 6.3 6.1 3.1 7.3 9.9 0.8 3.4 4.0 28.0 25.1 19.4 24.5 24.0 27.5 27.9 20.5 21.0 24.1 6.0 20.0 51.8 43.3 30.6 19.5 72.2 22.9 29.4 25.0 27.9 15.7 14.5 41.4 31.0 102.3 34.1 68.0 23.3 55.8 3.0 35.8 48.1 22.0 52.5 45.3 47.7 20.7 36.2 58.8 252.4 18.1 52.4 40.5 61.3 57.3 64.5 45.4 44.6 28.0 48.1 18.3 12.9 47.6 57.4 13.2 27.4 4.7 39.9 44.6 47.4 PDCD11 "ALG-4, KIAA0185, RRP5" ENSG00000148843 "Programmed cell death 11" Q14690 10 103396648-103446292 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017924, CAB026472" Approved Supported "Nucleoli rim,Vesicles" NA NA "Nucleoli rim" Vesicles "CAB026472: , HPA017924: AB_10601045" "unprognostic (1.34e-1)" "unprognostic (6.84e-2)" "unprognostic (1.48e-1)" "unprognostic (2.31e-2)" "unprognostic (1.80e-1)" "unprognostic (8.94e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.11e-1)" "unprognostic (1.89e-1)" "unprognostic (1.16e-1)" "unprognostic (6.49e-2)" "unprognostic (3.25e-2)" "unprognostic (9.29e-2)" "unprognostic (1.01e-2)" "unprognostic (1.77e-1)" "unprognostic (6.28e-2)" "unprognostic (5.59e-2)" 11.3 11.8 11.6 13.9 12.5 9.6 13.8 12.6 12.0 11.0 10.4 10.6 8.9 8.5 17.3 10.6 17.3 14.3 9.9 10.3 10.5 7.0 11.0 14.0 11.3 14.7 9.9 8.6 16.5 17.2 17.7 14.4 10.9 10.5 12.1 12.0 9.2 11.3 13.0 42.8 22.3 11.1 13.6 9.5 14.7 10.8 22.8 12.4 20.7 10.9 13.8 17.0 11.2 16.8 5.6 5.4 1.4 4.4 3.4 9.1 3.5 10.1 15.2 10.6 29.9 9.3 8.4 11.9 11.4 8.0 11.4 9.4 20.7 10.1 28.2 8.1 8.1 7.1 18.4 27.3 14.2 12.9 13.0 18.4 16.4 9.7 16.6 11.1 32.7 11.3 8.7 13.1 17.6 40.2 8.3 12.2 7.5 26.4 12.7 11.0 11.6 16.4 18.7 21.8 8.2 14.7 16.6 15.3 12.8 7.1 10.1 7.1 13.4 7.6 9.0 12.6 10.9 8.8 9.3 13.2 8.5 10.7 11.3 21.1 16.2 22.6 26.9 7.5 31.7 6.2 0.1 4.4 1.4 5.7 4.3 9.1 5.6 5.4 4.6 4.7 4.1 4.8 5.6 0.6 3.4 3.6 5.4 3.8 3.5 11.6 12.5 12.6 12.0 10.5 7.0 9.9 8.6 10.5 12.4 11.9 10.2 8.1 5.7 14.5 15.0 11.4 25.5 26.8 23.9 8.7 27.5 10.1 11.6 23.6 47.9 13.4 4.1 23.3 13.6 13.0 11.0 7.0 17.4 22.1 9.9 6.4 9.1 9.8 10.2 15.0 10.3 8.8 10.1 5.4 9.6 4.0 24.3 0.0 9.6 4.9 11.8 6.5 6.4 25.1 26.0 14.8 6.9 7.1 16.5 5.2 PDCD1LG2 "B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2" ENSG00000197646 "Programmed cell death 1 ligand 2" Q9BQ51 9 5510570-5571254 "Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 15.1;monocytes: 45.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 25.9;BJ hTERT+: 40.8;HDLM-2: 31.1;TIME: 18.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA013411 Approved Uncertain Cytosol "Secreted - unknown location" NA NA 34000000 Cytosol "HPA013411: AB_1855102" "unprognostic (3.93e-2)" "unprognostic (1.90e-1)" "unprognostic (3.51e-3)" "unprognostic (6.68e-3)" "unprognostic (7.66e-2)" "unprognostic (6.77e-2)" "unprognostic (5.72e-2)" "unprognostic (2.91e-1)" "unprognostic (1.68e-1)" "unprognostic (4.37e-3)" "unprognostic (5.79e-2)" "unprognostic (5.29e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (5.00e-2)" "unprognostic (4.66e-2)" "unprognostic (2.01e-1)" "unprognostic (7.51e-3)" 15.2 1.8 1.2 7.7 1.4 0.2 9.5 0.7 1.2 7.0 1.9 2.3 0.0 0.8 2.9 7.2 3.9 3.8 4.0 5.8 1.2 1.3 2.5 6.4 13.3 10.8 1.6 0.5 4.1 1.8 0.5 1.1 12.9 1.9 5.0 2.5 2.4 2.9 1.7 5.5 3.6 2.5 4.6 3.7 19.5 1.9 4.2 1.2 8.1 3.5 3.5 8.1 6.0 5.4 0.5 0.9 4.1 3.6 0.0 3.0 0.7 2.1 0.0 0.0 0.0 1.8 2.1 0.0 25.9 40.8 12.5 15.2 0.0 0.1 0.0 0.1 10.5 1.8 0.2 0.0 3.5 12.5 31.1 0.0 0.0 0.0 0.0 10.1 0.0 0.0 1.9 0.0 5.8 6.9 3.6 8.2 0.0 0.0 3.1 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 18.0 9.0 0.5 4.3 7.1 0.4 0.0 0.0 5.1 0.0 1.1 4.1 0.9 0.0 1.4 3.6 1.9 0.5 2.2 0.9 0.9 0.3 0.0 1.0 2.0 0.0 0.5 0.0 3.0 0.7 1.2 1.4 0.7 1.2 1.2 1.3 1.6 0.5 1.9 1.2 6.0 0.3 0.8 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 1.9 0.0 0.0 0.2 15.1 2.1 0.1 3.5 0.0 2.8 0.0 0.0 6.7 4.3 0.0 5.5 2.2 1.7 45.9 0.0 0.0 2.1 0.0 2.1 0.0 0.0 0.0 1.4 0.0 0.0 0.9 0.7 0.0 0.0 0.0 PDE4A DPDE2 ENSG00000065989 "Phosphodiesterase 4A" P27815 19 10416773-10469631 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.5;testis: 31.8" "Cell type enhanced" "Detected in many" 13 "Late spermatids: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 22.0;NB-4: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017632, HPA043310, HPA076091" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775" "unprognostic (1.29e-2)" "unprognostic (3.98e-2)" "unprognostic (8.91e-2)" "unprognostic (1.82e-1)" "unprognostic (7.00e-2)" "unprognostic (6.84e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (7.91e-2)" "unprognostic (1.52e-2)" "unprognostic (6.90e-2)" "unprognostic (2.41e-1)" "unprognostic (2.27e-2)" "unprognostic (1.64e-2)" "unprognostic (2.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.15e-1)" 6.4 2.5 9.0 4.2 13.9 3.4 6.3 15.0 38.5 8.4 4.3 3.2 0.4 2.0 4.4 1.1 3.1 4.8 5.0 4.1 12.4 6.9 2.8 1.9 7.7 2.0 5.3 19.4 1.7 9.8 17.3 2.3 4.9 34.7 3.7 3.0 3.1 7.1 4.0 26.1 2.2 2.7 4.7 3.6 4.1 6.1 31.8 4.5 0.0 5.4 1.0 1.9 4.6 3.5 0.2 3.3 5.9 4.4 5.3 2.0 1.3 0.0 1.4 0.3 3.9 11.6 6.9 2.2 3.3 6.6 0.4 1.1 3.5 3.2 1.5 9.7 8.5 0.2 0.3 2.3 0.4 0.2 3.8 3.3 13.6 4.7 3.8 7.5 2.2 22.0 5.1 0.4 3.7 0.0 0.4 3.1 1.2 10.7 3.3 2.3 1.0 1.3 25.3 1.8 3.9 2.8 8.9 2.2 11.7 0.6 0.8 2.5 0.9 0.2 0.1 3.6 0.6 0.5 4.5 6.6 5.0 6.5 3.4 2.1 6.5 0.5 7.2 2.1 0.1 4.0 5.9 2.6 5.1 1.5 4.4 0.8 0.2 0.5 2.0 3.3 0.1 0.1 0.7 0.2 5.3 4.4 0.2 1.2 1.3 9.0 13.9 15.0 38.5 12.4 6.9 5.3 19.4 34.7 4.5 3.0 15.2 8.0 2.7 9.0 23.9 5.8 12.7 10.7 7.9 8.7 0.0 0.3 0.0 2.8 44.2 10.9 1.3 0.0 11.1 4.3 13.4 3.1 32.2 0.8 9.8 52.4 0.0 11.6 18.3 164.4 16.1 37.2 13.5 14.4 6.2 1.3 10.6 0.0 17.0 0.0 2.6 6.5 8.1 7.7 7.8 7.0 0.3 16.0 6.8 1.4 PDE6G "PDEG, RP57" ENSG00000185527 "Phosphodiesterase 6G" P18545 17 81650459-81663112 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 260.3" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 2889.5" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basophil: 29.7;NK-cell: 57.8" "Group enriched" "Detected in all" 5 "granulocytes: 29.7;NK-cells: 57.8" "Cell line enhanced" "Detected in some" "Hep G2: 6.3;NB-4: 6.7;NTERA-2: 11.6;REH: 13.5;SuSa: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA045118 Supported Uncertain Vesicles NA NA Vesicles "HPA045118: AB_2732517" "unprognostic (6.16e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.51e-3)" "unprognostic (1.68e-1)" "unprognostic (1.46e-2)" "unprognostic (6.33e-2)" "unprognostic (3.80e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (4.85e-2)" "unprognostic (5.01e-2)" "unprognostic (1.94e-2)" "unprognostic (5.71e-2)" "unprognostic (5.44e-2)" "unprognostic (2.73e-1)" "unprognostic (1.14e-1)" 0.9 1.3 0.4 2.9 0.5 4.7 0.7 0.5 0.6 0.4 0.8 0.5 0.4 0.0 0.4 0.5 0.6 0.3 1.6 0.5 0.5 0.7 3.8 2.6 2.0 13.8 0.6 0.5 0.5 0.4 0.0 0.5 8.6 0.5 0.5 0.5 260.3 0.5 0.4 0.6 0.8 2.8 0.4 0.8 17.9 0.7 2.2 0.5 2.5 0.6 0.4 4.6 2.1 0.4 1.3 8.6 29.7 7.7 57.8 2.4 3.7 0.2 0.3 0.5 0.0 0.3 0.0 0.0 0.3 1.1 1.2 1.3 0.1 0.8 0.6 0.2 0.7 0.6 0.1 0.2 0.2 2.8 0.2 0.0 0.9 0.1 6.3 0.9 0.1 0.2 0.0 0.2 1.2 0.0 2.4 3.3 0.4 0.1 0.3 1.3 0.8 0.1 6.7 11.6 0.0 0.4 13.5 0.1 2.0 0.0 0.0 0.1 0.3 0.0 0.3 0.5 8.6 0.1 0.8 1.3 0.4 0.1 0.2 0.3 0.1 0.6 1.0 1.6 2.7 0.2 29.7 5.1 8.6 1.2 7.7 0.4 0.8 0.3 0.6 8.6 1.3 0.7 2.4 0.7 57.8 4.2 0.8 0.0 3.7 0.4 0.5 0.5 0.6 0.5 0.7 0.6 0.5 0.5 0.5 0.0 1.1 1.4 0.0 0.8 338.0 0.0 0.0 0.0 0.0 5.2 486.9 0.2 1.7 0.4 0.6 0.0 0.0 0.0 0.2 0.3 0.2 0.1 24.1 0.0 18.8 247.9 0.0 3.1 3.8 1.6 0.0 3.2 3.3 19.8 0.0 402.2 0.3 0.0 0.0 0.3 2889.5 0.0 0.0 0.7 0.2 1.3 0.2 2.1 0.0 0.0 PDE6H ENSG00000139053 "Phosphodiesterase 6H" Q13956 12 14973022-14981865 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "retina: 67.4" "Cell type enriched" "Detected in some" 6 "Cone photoreceptor cells: 783.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.2;JURKAT: 1.0;MOLT-4: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA045118 Supported Uncertain Vesicles NA NA Vesicles "HPA045118: AB_2732517" "unprognostic (1.47e-3)" "unprognostic (1.07e-2)" 0.1 1.3 1.2 0.2 1.5 9.4 0.1 0.1 4.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 1.0 2.1 0.1 0.1 0.2 0.2 2.2 0.1 0.1 0.1 0.0 0.1 2.5 0.7 0.1 0.1 67.4 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.8 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.6 0.7 0.0 0.0 1.4 0.2 0.0 0.8 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 1.2 1.5 0.1 4.2 1.0 2.1 2.2 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 47.5 0.0 0.0 0.0 0.0 0.0 783.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 1.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.0 0.0 0.0 0.0 0.0 141.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PDE9A ENSG00000160191 "Phosphodiesterase 9A" O76083 21 42653636-42775509 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 168.7;Paneth cells: 77.2" "Cancer enhanced" "Detected in all" "prostate cancer: 31.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 6.8" "Group enriched" "Detected in many" 4 "NK-cells: 1.7;T-cells: 6.8" "Cell line enhanced" "Detected in many" "AF22: 16.3;EFO-21: 16.5;MCF7: 12.2;NB-4: 18.2;NTERA-2: 22.5;SCLC-21H: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011380, HPA011978" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA011380: AB_1855132, HPA011978: " "unprognostic (5.75e-2)" "unprognostic (9.92e-3)" "unprognostic (3.50e-1)" "unprognostic (1.08e-1)" "unprognostic (1.44e-1)" "unprognostic (1.40e-1)" "unprognostic (5.06e-2)" "unprognostic (3.99e-2)" "unprognostic (6.02e-2)" "unprognostic (1.60e-1)" "unprognostic (1.25e-2)" "unprognostic (5.01e-2)" "unprognostic (1.90e-2)" "unprognostic (4.01e-3)" "unprognostic (1.97e-1)" "unprognostic (6.55e-2)" "unprognostic (1.79e-1)" 6.1 6.6 9.9 6.8 15.2 0.8 9.4 13.7 9.0 3.7 37.1 11.9 14.0 3.0 5.7 18.8 6.1 10.3 7.7 3.5 6.2 7.7 13.2 2.5 4.7 4.6 10.0 4.9 4.1 4.0 4.7 6.0 9.6 6.9 33.2 15.8 9.7 8.8 15.9 2.3 3.8 26.1 22.3 8.0 15.9 8.4 1.5 8.9 4.9 5.2 2.1 4.1 12.6 4.0 0.5 0.9 1.0 0.1 1.7 6.8 0.5 0.0 1.5 16.3 2.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.8 9.8 0.0 16.5 0.0 1.1 0.0 1.4 5.3 0.0 0.0 5.6 0.0 0.0 3.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 12.2 0.8 18.2 22.5 8.0 0.0 0.0 0.0 0.6 11.2 4.5 12.5 7.4 2.8 0.0 0.2 4.0 0.1 10.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.1 0.6 0.2 0.5 6.8 1.7 1.0 1.7 0.1 0.9 2.2 0.5 9.9 15.2 13.7 6.7 6.2 7.7 10.0 4.9 6.9 8.9 3.0 5.3 0.0 8.5 0.9 21.0 1.4 5.1 1.4 0.0 17.4 0.0 0.0 24.9 6.2 0.3 6.7 168.7 0.0 2.1 0.1 3.1 27.6 1.1 0.8 5.6 33.4 12.6 3.7 0.6 1.7 10.9 1.0 27.0 1.8 19.3 9.4 5.1 77.2 5.6 7.6 2.7 12.9 5.9 0.4 0.7 0.5 0.3 2.1 22.2 13.1 PDGFRA "CD140a, GAS9, PDGFR2" ENSG00000134853 "Platelet derived growth factor receptor alpha" P16234 4 54229097-54298247 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Chemotaxis, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 81.5" "Group enriched" "Detected in many" 9 "Fibroblasts: 171.4;Leydig cells: 416.6;Peritubular cells: 384.4" "Cancer enhanced" "Detected in all" "glioma: 30.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 82.8;ASC TERT1: 38.8;BJ hTERT+: 48.0;fHDF/TERT166: 33.4;HHSteC: 28.0;HSkMC: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004947, CAB018143" Supported Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 150000 "Nucleoplasm, Plasma membrane, Cell Junctions" "CAB018143: AB_2162351, HPA004947: AB_2732399" "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "unprognostic (4.59e-3)" "unprognostic (1.60e-1)" "unprognostic (8.92e-2)" "prognostic favorable (9.33e-4)" "unprognostic (1.24e-1)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (2.18e-2)" "unprognostic (2.18e-1)" "unprognostic (7.01e-2)" "prognostic unfavorable (9.79e-6)" "unprognostic (9.58e-3)" "unprognostic (9.87e-2)" "unprognostic (2.16e-2)" "unprognostic (1.72e-3)" 35.0 12.4 12.6 16.1 7.6 0.9 17.2 2.4 20.1 33.2 19.1 9.2 6.4 9.6 27.6 14.6 21.9 22.5 16.2 15.3 8.9 7.4 22.8 8.4 24.1 26.9 9.2 4.0 81.5 6.8 1.6 2.1 25.1 7.2 18.6 15.2 19.2 8.5 8.3 11.9 7.0 17.4 19.7 8.8 51.6 13.6 19.0 9.3 0.5 11.3 12.8 4.3 35.9 24.6 0.9 0.4 2.5 0.4 0.3 0.8 0.3 0.0 0.0 0.2 0.1 82.8 38.8 0.1 4.3 48.0 0.0 0.1 11.5 0.0 0.1 0.1 33.4 0.1 0.1 3.3 0.0 0.0 0.4 0.1 0.1 0.1 0.2 28.0 0.0 0.0 70.4 0.0 5.5 0.0 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 6.7 0.0 0.1 0.0 0.3 0.1 0.0 0.1 15.2 0.5 16.6 0.0 0.0 0.0 0.1 0.4 0.0 0.3 2.5 0.4 0.2 0.5 0.2 0.2 0.6 0.8 0.4 0.0 0.9 0.7 0.4 2.3 0.3 0.3 0.4 0.2 0.3 12.6 7.6 2.4 7.3 8.9 7.4 9.2 4.0 7.2 9.3 0.0 0.3 0.9 0.3 15.1 0.7 4.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 2.9 1.6 3.3 0.0 0.0 5.8 1.2 171.4 0.4 0.0 0.8 2.8 0.0 0.0 38.1 0.6 3.7 416.6 1.6 21.9 8.2 0.0 18.3 12.2 0.0 384.4 0.0 0.4 0.0 13.2 1.1 3.5 13.8 1.1 0.0 0.0 0.8 PDHB PDHE1B ENSG00000168291 "Pyruvate dehydrogenase E1 beta subunit" P11177 3 58427630-58433857 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 245.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033794, HPA036744, HPA036745" Enhanced Supported Nucleoplasm,Mitochondria No No 6500000 Mitochondria Nucleoplasm "CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285" "unprognostic (2.06e-2)" "unprognostic (1.79e-1)" "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (7.22e-2)" "unprognostic (1.42e-1)" "unprognostic (3.20e-2)" "unprognostic (6.13e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (3.98e-1)" "unprognostic (2.35e-1)" "prognostic favorable (2.79e-8)" "unprognostic (2.67e-1)" "unprognostic (8.37e-2)" "unprognostic (1.06e-2)" "unprognostic (9.85e-2)" 21.8 34.3 22.5 19.5 28.4 8.6 17.1 15.1 26.2 18.0 21.6 18.4 19.2 16.2 17.2 18.2 22.8 15.0 16.5 64.2 24.1 20.8 38.7 41.8 13.9 18.2 23.7 23.3 11.0 17.2 26.0 20.0 21.6 26.4 19.5 23.9 16.1 17.6 22.1 92.2 14.3 17.3 24.5 22.8 23.2 21.4 21.8 17.5 20.9 16.1 33.8 20.6 17.9 14.4 37.0 50.1 33.6 39.8 43.4 38.6 38.3 19.0 26.7 27.7 20.8 28.2 34.7 33.3 24.1 30.2 35.7 36.8 48.2 18.5 40.8 13.6 30.5 33.1 11.1 33.7 22.1 27.3 23.6 24.8 36.4 50.5 36.3 28.6 29.5 20.5 30.3 20.5 28.7 16.9 41.9 30.7 34.1 18.7 18.4 38.7 18.2 27.9 31.0 38.2 20.2 30.4 13.3 21.6 39.3 56.3 26.2 19.3 21.2 22.3 32.2 24.0 41.8 47.6 31.7 22.5 19.1 25.5 20.0 27.2 25.8 36.6 28.7 29.3 35.1 18.0 16.4 35.4 33.6 31.5 39.8 33.2 37.0 31.2 30.0 50.1 33.3 35.1 31.4 7.0 43.4 35.9 33.7 38.6 38.3 22.5 28.4 15.1 26.2 24.1 20.8 23.7 23.3 26.4 17.5 56.6 28.0 47.4 32.8 24.7 30.0 245.7 48.4 69.6 48.9 33.2 23.6 144.4 195.6 84.1 43.2 62.9 34.8 23.3 63.6 85.4 31.9 17.8 38.1 61.1 74.4 54.0 55.7 43.6 38.0 10.4 55.8 41.0 54.0 89.2 44.3 51.8 51.0 41.3 48.1 105.9 44.7 64.7 61.8 85.0 80.3 26.1 131.5 46.0 47.8 28.8 PDK2 PDHK2 ENSG00000005882 "Pyruvate dehydrogenase kinase 2" Q15119 17 50094737-50112152 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.0" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 118.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008287 Supported Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA008287: AB_1079589" "unprognostic (2.74e-2)" "prognostic favorable (5.87e-4)" "unprognostic (1.16e-1)" "unprognostic (2.43e-3)" "unprognostic (1.22e-1)" "unprognostic (9.63e-3)" "unprognostic (9.80e-3)" "unprognostic (8.39e-3)" "unprognostic (3.19e-2)" "unprognostic (1.25e-1)" "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "prognostic favorable (9.59e-5)" "unprognostic (3.81e-1)" "unprognostic (2.54e-1)" "unprognostic (5.33e-1)" "unprognostic (1.55e-1)" 20.6 26.1 17.2 5.2 27.5 3.2 10.8 53.7 34.4 10.1 16.1 16.1 10.1 15.5 13.1 69.8 12.5 14.4 11.5 51.7 18.2 13.0 33.7 27.8 9.0 5.7 14.6 20.9 27.7 24.1 16.9 7.5 8.6 14.2 12.7 12.4 19.5 14.0 16.5 101.0 10.6 16.5 15.1 9.9 7.8 13.6 7.2 11.4 6.2 15.6 31.4 7.4 13.8 9.4 11.3 20.1 8.9 12.9 16.5 17.4 12.2 6.4 9.2 11.1 10.0 11.8 8.9 1.2 7.0 10.4 10.5 10.2 0.8 7.0 8.1 11.7 19.5 7.1 3.1 7.4 2.8 10.3 16.3 10.3 7.2 9.1 6.8 6.3 0.0 7.8 18.7 10.8 6.8 0.5 18.5 9.1 10.4 2.9 8.1 5.9 8.2 6.0 0.0 2.4 19.5 9.0 9.1 24.9 10.9 5.7 5.5 7.4 11.2 9.9 3.1 4.7 14.2 18.3 7.2 4.7 12.3 10.1 8.4 5.1 16.0 15.1 4.4 18.0 2.6 7.9 8.9 12.9 6.8 14.0 9.8 11.1 11.1 12.5 14.8 14.2 11.3 14.6 15.0 2.2 16.5 10.5 20.1 17.4 12.2 17.2 27.5 53.7 34.4 18.2 13.0 14.6 20.9 14.2 11.4 8.9 9.3 13.6 13.9 13.5 20.8 5.0 10.2 1.4 11.4 19.2 5.9 15.1 49.7 8.0 7.3 8.3 46.6 0.0 7.9 3.4 19.5 7.6 1.1 39.8 16.7 41.3 13.3 13.5 13.7 15.0 22.5 7.9 23.6 15.4 45.3 33.6 7.9 43.6 49.5 118.5 9.2 19.4 12.1 3.3 4.4 16.4 6.6 15.8 37.1 8.4 PDK3 ENSG00000067992 "Pyruvate dehydrogenase kinase 3" Q15120 X 24465221-24539837 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046583, HPA072492" Approved Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA046583: AB_2679707, HPA072492: AB_2686526" "unprognostic (5.41e-3)" "unprognostic (5.43e-3)" "unprognostic (5.35e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-3)" "unprognostic (5.38e-2)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.51e-1)" "unprognostic (5.57e-2)" "unprognostic (1.35e-1)" "unprognostic (1.39e-2)" "unprognostic (2.02e-1)" "unprognostic (1.72e-1)" "unprognostic (1.02e-1)" "unprognostic (2.92e-1)" "unprognostic (2.28e-2)" "unprognostic (9.43e-3)" 9.6 5.6 5.7 9.8 17.3 16.3 12.8 3.3 23.6 8.0 14.7 5.5 5.6 13.6 7.3 15.7 9.5 13.2 7.0 16.9 12.5 6.8 13.7 11.1 11.2 13.4 6.2 13.7 11.0 7.3 12.8 14.1 7.7 14.9 8.3 10.1 9.9 19.3 5.2 3.9 14.2 15.6 8.6 6.1 17.9 12.7 23.1 4.8 12.5 6.2 4.1 14.9 10.3 9.2 4.5 7.2 36.4 10.9 7.1 11.0 6.7 9.0 4.6 3.9 6.6 0.1 0.0 4.1 2.7 2.4 3.7 6.5 0.4 11.1 9.2 1.9 0.7 10.5 2.1 11.3 6.9 10.0 7.8 5.4 4.9 5.3 2.6 1.3 4.2 4.8 0.7 3.1 0.9 0.9 0.4 5.5 9.6 0.9 14.0 0.5 17.0 7.8 5.4 7.0 9.7 5.4 4.0 7.0 13.5 3.2 17.7 2.5 3.2 14.7 6.0 4.6 6.2 8.3 1.6 0.2 2.6 3.8 4.8 3.2 9.0 6.9 11.0 7.1 6.4 5.4 9.4 8.9 21.3 7.6 10.9 11.0 4.5 6.2 6.2 7.2 4.1 4.9 5.7 36.4 7.1 10.4 2.3 5.1 6.7 5.7 17.3 3.3 23.6 12.5 6.8 6.2 13.7 14.9 4.8 3.0 1.3 2.9 8.6 4.0 3.4 6.3 0.0 1.4 2.3 1.8 0.0 4.0 3.3 3.6 53.4 2.8 4.5 0.0 4.5 26.4 3.2 5.2 5.7 4.2 13.2 7.9 4.1 4.3 18.9 22.4 3.4 9.6 15.1 8.2 2.4 3.2 2.8 0.0 5.3 11.3 3.9 0.0 9.2 6.4 6.3 3.9 14.9 14.9 3.3 7.1 PDPN "aggrus, Gp38, GP40, PA2.26, T1A-2" ENSG00000162493 Podoplanin Q86YL7 1 13583465-13617957 "Predicted membrane proteins" "Cell shape" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.8" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 98.3;Fibroblasts: 108.5;monocytes: 202.8;Muller glia cells: 85.7;Peritubular cells: 59.1" "Cancer enhanced" "Detected in many" "testis cancer: 102.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.1" "Cell line enhanced" "Detected in some" "AF22: 30.3;EFO-21: 72.6;HAP1: 50.4;HHSteC: 44.7;NTERA-2: 23.3;SuSa: 25.2;TIME: 48.3" "HPA007534, HPA007949, CAB008376" Enhanced Supported "Plasma membrane,Cell Junctions,Mitochondria" NA NA "Plasma membrane" "Cell Junctions, Mitochondria" "CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: " "unprognostic (1.75e-1)" "unprognostic (3.19e-2)" "unprognostic (6.03e-2)" "unprognostic (3.61e-2)" "unprognostic (2.73e-2)" "unprognostic (1.05e-2)" "unprognostic (3.85e-2)" "unprognostic (5.23e-2)" "unprognostic (9.21e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-2)" "unprognostic (5.62e-3)" "unprognostic (9.20e-3)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" "unprognostic (2.78e-2)" 27.7 2.0 6.3 29.8 10.9 0.5 30.3 5.0 6.7 21.4 12.8 11.0 4.1 2.5 16.8 15.3 8.9 19.8 23.7 18.6 5.7 6.5 1.9 0.8 17.8 10.4 10.0 2.4 18.4 3.9 0.7 2.3 71.8 13.5 11.3 6.4 26.6 6.0 8.6 21.9 10.0 7.6 18.6 17.5 0.7 15.1 9.7 7.9 3.2 5.7 9.7 9.9 27.3 28.9 0.4 0.2 3.1 0.4 0.3 0.4 0.1 0.0 0.0 30.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 72.6 1.7 0.0 0.1 50.4 9.0 0.0 0.1 9.2 0.0 0.0 0.0 44.7 0.0 0.0 6.1 16.8 3.8 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.1 48.3 8.5 7.3 0.1 0.0 0.0 0.0 0.1 18.1 0.0 0.0 1.0 0.4 0.6 0.2 0.2 0.2 0.4 0.3 0.3 0.2 0.4 0.4 0.3 3.1 0.3 0.2 0.2 0.2 0.1 6.3 10.9 5.0 4.8 5.7 6.5 10.0 2.4 13.5 7.9 98.3 9.1 0.0 29.7 12.9 1.2 6.9 0.0 6.7 29.6 0.0 3.9 1.8 0.0 0.4 0.5 7.4 0.0 0.0 0.0 1.6 108.5 3.5 1.1 0.0 6.5 0.0 0.0 7.4 0.0 0.4 18.7 4.1 6.8 202.8 0.0 85.7 0.5 0.0 59.1 0.0 2.8 0.0 6.2 0.9 8.6 6.0 2.4 0.0 0.0 3.4 PEA15 "HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15" ENSG00000162734 "Proliferation and apoptosis adaptor protein 15" Q15121 1 160205337-160215376 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 199.4" "Cell type enhanced" "Detected in many" 7 "monocytes: 420.2;Muller glia cells: 271.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 30.6" "Group enriched" "Detected in all" 6 "B-cells: 7.6;dendritic cells: 22.1;monocytes: 30.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028356, HPA070820" Enhanced Supported Nucleoplasm,Cytosol NA NA 240000 Cytosol Nucleoplasm "HPA028356: AB_10602814, HPA070820: AB_2732166" "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "unprognostic (1.05e-1)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (1.64e-2)" "unprognostic (1.99e-3)" "unprognostic (6.10e-2)" "unprognostic (4.57e-1)" "unprognostic (1.25e-1)" "unprognostic (6.31e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (6.53e-7)" "unprognostic (2.60e-2)" "unprognostic (1.39e-1)" "unprognostic (2.82e-3)" "unprognostic (1.24e-1)" 45.3 20.4 105.3 28.7 83.6 3.8 25.3 30.5 173.1 25.1 15.5 68.1 5.0 8.0 21.5 21.8 22.6 19.2 22.1 53.9 70.5 81.3 14.8 10.4 23.8 16.6 106.5 67.0 19.7 9.7 14.9 10.2 25.1 74.1 24.4 15.3 18.2 12.3 31.1 10.2 16.9 8.8 47.4 199.4 23.8 10.0 17.5 53.7 1.6 12.6 6.0 22.9 22.4 17.5 7.6 22.1 1.8 30.6 3.1 3.5 5.4 16.9 5.9 24.6 10.6 45.6 25.6 8.2 73.6 64.4 61.3 43.1 13.0 9.2 7.9 26.7 91.9 29.5 18.6 9.1 23.0 48.0 4.2 5.1 6.5 4.1 3.3 56.4 2.1 8.0 21.4 13.0 33.7 43.1 33.9 46.0 5.8 6.7 14.4 81.9 8.4 2.5 5.1 16.3 20.1 17.0 4.2 25.9 5.4 22.2 8.9 4.9 13.0 39.0 26.7 22.4 55.7 16.4 15.3 61.3 40.8 32.0 30.3 31.6 11.4 7.0 15.0 37.6 4.1 57.7 0.3 15.3 1.8 3.5 30.6 2.7 7.6 2.6 2.8 22.1 5.0 1.6 1.8 0.7 3.1 13.9 9.7 2.9 5.4 105.3 83.6 30.5 78.2 70.5 81.3 106.5 67.0 74.1 53.7 14.9 34.6 27.0 105.8 71.2 125.0 203.8 12.7 14.7 27.3 5.2 68.7 17.0 24.9 58.7 49.2 107.8 6.4 0.0 40.4 47.2 66.7 105.1 31.1 4.9 63.6 87.4 11.5 95.2 34.2 51.6 61.9 76.5 70.9 420.2 11.3 271.7 77.0 3.5 103.3 8.1 109.8 45.3 97.6 12.7 2.7 64.1 37.9 14.9 9.7 151.1 PEAK3 "C19orf35, FLJ45778" ENSG00000188305 "PEAK family member 3" Q6ZS72 19 2274622-2282176 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.5;lymphoid tissue: 19.1" "Group enriched" "Detected in some" 11 "Ciliated cells: 1.4;Hofbauer cells: 1.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 24.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 24.5" "Cell line enriched" "Detected in some" 10 "HMC-1: 16.9" "Group enriched" "Detected in many" 5 "basal ganglia: 6.4;cerebellum: 6.0" HPA057806 Uncertain Uncertain Cytosol NA NA Cytosol "HPA057806: AB_2683534" "unprognostic (9.42e-2)" "unprognostic (3.26e-2)" "unprognostic (7.27e-2)" "unprognostic (6.23e-2)" "unprognostic (2.65e-2)" "unprognostic (8.40e-3)" "unprognostic (3.67e-1)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "unprognostic (2.08e-1)" "unprognostic (6.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.19e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-2)" "unprognostic (3.20e-2)" "unprognostic (1.90e-1)" 1.9 1.3 1.4 4.7 3.3 8.2 0.9 0.8 2.0 1.3 1.7 2.1 0.1 1.1 0.7 1.0 0.8 1.6 0.9 2.1 2.0 0.9 3.8 2.0 4.4 14.3 3.3 0.9 1.0 0.8 0.6 1.2 0.8 2.3 1.0 1.1 0.7 0.8 0.6 1.5 1.0 2.5 0.9 4.0 19.1 1.1 0.6 1.7 0.6 0.8 0.0 2.7 0.9 1.9 0.2 1.1 24.5 3.4 2.8 1.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.1 0.2 0.6 0.1 16.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 5.3 2.7 6.6 1.0 3.4 0.1 0.1 0.1 0.1 1.1 0.2 0.0 0.2 24.5 2.8 1.1 0.1 0.0 0.5 1.4 3.3 0.8 2.0 2.0 0.9 3.3 0.9 2.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PEF1 PEF1A ENSG00000162517 "Penta-EF-hand domain containing 1" Q9UBV8 1 31629862-31644896 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061608 Approved Nucleoplasm,Vesicles,Cytosol NA NA 660000 "Nucleoplasm, Cytosol" Vesicles "HPA061608: AB_2684567" "unprognostic (2.92e-2)" "prognostic favorable (3.95e-4)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-1)" "unprognostic (8.40e-2)" "prognostic unfavorable (2.88e-4)" "unprognostic (5.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.79e-2)" "unprognostic (1.60e-2)" "unprognostic (2.12e-1)" "unprognostic (1.35e-1)" "unprognostic (8.85e-3)" "unprognostic (2.38e-1)" "unprognostic (1.60e-1)" "unprognostic (2.89e-3)" 34.0 27.0 26.9 15.3 28.7 17.0 27.1 22.5 40.8 26.6 23.4 25.9 21.1 16.2 27.1 46.5 29.7 29.0 26.1 26.4 24.3 23.8 28.3 38.7 24.9 20.8 25.0 17.3 31.1 20.8 31.6 21.6 44.2 28.6 29.8 24.2 25.7 24.8 33.4 25.5 32.5 20.7 31.9 22.4 23.6 20.5 17.8 16.5 27.4 85.9 20.3 30.7 23.7 21.9 39.1 40.4 60.9 39.5 42.0 49.2 48.7 17.7 20.8 17.4 13.4 20.6 21.6 16.7 16.9 29.1 41.0 36.2 12.2 26.9 19.0 23.7 37.7 21.1 18.7 33.6 43.2 33.3 23.8 36.4 15.7 16.8 24.6 36.3 15.3 14.9 22.2 50.0 40.0 37.6 26.2 39.6 23.5 16.2 19.7 29.3 20.9 23.3 14.9 24.1 22.0 23.7 22.7 16.9 20.7 32.0 19.3 24.9 14.4 19.3 18.2 25.2 28.6 16.2 11.2 20.9 17.8 15.3 30.2 22.3 12.7 12.8 20.4 22.4 22.6 21.3 60.9 39.5 46.2 49.2 35.3 47.5 37.8 42.1 44.6 40.4 39.1 39.9 40.0 40.1 42.0 32.7 37.4 41.9 48.7 26.9 28.7 22.5 40.8 24.3 23.8 25.0 17.3 28.6 16.5 38.7 33.6 34.3 57.8 32.2 37.2 14.6 20.4 20.1 21.6 66.3 11.8 131.6 96.2 58.8 67.1 60.4 35.8 0.0 54.4 80.4 36.6 45.7 71.5 20.5 54.6 50.9 42.5 31.9 17.0 60.2 41.7 26.1 47.2 124.4 29.6 55.3 47.2 34.8 55.2 41.2 20.3 19.4 42.2 34.5 41.5 44.9 152.9 34.6 33.2 48.8 PEMT "PEMPT, PEMT2" ENSG00000133027 "Phosphatidylethanolamine N-methyltransferase" Q9UBM1 17 17505563-17591708 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 95.7;liver: 103.5" "Cell type enhanced" "Detected in many" 12 "Hepatocytes: 168.4;Peritubular cells: 326.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042375, HPA073930" Approved Supported "Endoplasmic reticulum,Vesicles,Mitochondria,Cytosol" NA NA "Endoplasmic reticulum, Mitochondria" "Vesicles, Cytosol" "HPA042375: AB_10796905, HPA073930: " "unprognostic (1.39e-2)" "unprognostic (3.43e-1)" "unprognostic (2.43e-2)" "prognostic favorable (6.77e-6)" "unprognostic (2.85e-1)" "unprognostic (7.14e-2)" "unprognostic (1.31e-1)" "unprognostic (1.28e-1)" "unprognostic (3.89e-1)" "unprognostic (3.41e-2)" "unprognostic (5.47e-3)" "unprognostic (2.67e-1)" "unprognostic (8.63e-3)" "unprognostic (2.08e-1)" "unprognostic (2.10e-1)" "unprognostic (6.66e-2)" "unprognostic (7.60e-2)" 21.8 7.5 5.6 2.8 6.2 4.2 26.5 2.9 8.1 16.1 6.1 6.4 13.2 7.4 8.7 95.7 5.6 10.5 4.7 5.3 5.3 6.1 8.5 103.5 5.5 6.7 6.3 4.8 7.7 11.4 4.4 5.7 7.1 6.2 7.3 2.2 7.3 12.7 12.9 7.4 7.3 5.8 4.0 6.4 2.8 4.6 19.1 3.2 3.8 9.9 6.3 5.4 3.9 5.2 12.8 17.0 1.6 23.4 15.1 14.4 11.6 14.2 27.3 7.2 18.8 15.4 10.8 10.8 9.1 8.2 12.5 9.9 15.9 9.7 12.5 16.6 9.3 9.4 17.0 10.6 5.5 3.2 9.2 37.0 6.2 14.9 22.8 17.0 5.5 9.3 11.0 11.5 8.3 12.7 4.2 6.7 17.6 5.9 5.3 5.5 27.2 9.8 9.9 10.1 27.3 22.4 9.2 11.6 11.4 10.3 5.3 7.2 17.2 6.5 4.4 16.3 14.5 6.7 2.1 5.8 12.3 12.4 20.5 7.9 7.3 4.9 2.2 11.4 7.7 10.1 1.0 23.4 1.1 10.1 20.8 14.4 12.6 13.2 12.7 17.0 12.8 10.6 11.9 1.6 15.1 14.2 15.5 12.0 11.6 5.6 6.2 2.9 8.1 5.3 6.1 6.3 4.8 6.2 3.2 14.9 13.7 17.0 16.7 16.3 4.4 12.5 12.7 16.0 26.1 26.2 0.0 16.2 14.9 26.3 2.2 18.3 14.6 0.0 33.6 18.8 27.5 23.7 12.7 168.4 21.4 4.8 66.0 9.2 11.1 6.8 87.8 10.8 20.3 1.0 24.8 26.7 26.0 10.5 326.0 21.4 4.8 6.5 30.9 11.1 18.5 15.8 12.2 7.0 22.8 16.6 PEX10 RNF69 ENSG00000157911 "Peroxisomal biogenesis factor 10" O60683 1 2403964-2413797 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 144.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049458, HPA049755" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA049458: AB_2680775, HPA049755: AB_2680867" "prognostic favorable (4.50e-6)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (2.50e-1)" "unprognostic (2.16e-1)" "unprognostic (1.81e-2)" "unprognostic (2.91e-1)" "unprognostic (9.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (1.95e-1)" "prognostic favorable (4.16e-6)" "unprognostic (4.78e-2)" "unprognostic (1.21e-1)" "unprognostic (1.19e-1)" "unprognostic (1.42e-1)" 14.6 18.7 20.5 6.2 19.9 5.6 16.3 7.6 24.6 9.8 9.2 23.1 6.6 10.1 7.6 13.6 10.6 11.4 8.3 12.9 17.8 15.5 12.0 12.1 8.3 7.6 19.2 13.5 13.0 19.4 12.5 12.2 10.2 16.0 15.4 7.0 11.4 17.4 12.3 22.1 10.8 9.0 6.6 21.3 8.9 10.1 17.3 12.6 6.0 10.5 11.8 9.0 8.1 6.8 7.4 11.5 2.2 10.7 4.5 6.4 4.8 12.2 10.2 8.0 8.9 5.8 6.7 7.4 6.5 7.5 10.8 7.8 16.3 18.5 6.4 17.2 8.5 7.1 9.5 7.3 12.0 5.0 10.3 14.1 4.8 10.5 32.4 11.2 8.6 2.6 6.6 6.3 7.9 10.9 6.8 9.1 7.7 5.9 8.0 9.5 16.0 8.0 4.1 6.8 6.7 20.5 6.6 8.2 13.3 11.6 4.2 12.5 9.6 7.7 11.6 21.1 4.9 10.1 3.4 8.8 9.9 4.4 15.1 8.6 11.7 4.8 5.8 11.4 6.7 7.8 1.9 6.9 2.2 5.2 10.7 6.0 7.4 4.5 6.4 11.5 6.9 5.2 3.9 1.6 4.5 8.7 9.8 2.5 4.8 20.5 19.9 7.6 24.6 17.8 15.5 19.2 13.5 16.0 12.6 3.0 4.1 5.4 10.8 7.8 15.7 0.7 10.2 8.1 4.5 14.0 0.0 22.0 29.9 19.3 42.4 9.2 9.3 0.0 26.3 21.1 10.8 12.5 0.0 8.2 20.4 12.7 12.7 4.9 10.5 144.2 9.8 10.3 21.9 26.2 9.1 39.6 17.3 3.5 12.7 20.2 9.7 0.0 8.5 24.9 16.2 5.4 23.0 4.4 14.9 9.1 PEX11B ENSG00000131779 "Peroxisomal biogenesis factor 11 beta" O96011 1 145911350-145918837 "Disease related genes, Predicted membrane proteins" "Peroxisome biogenesis" "Peroxisome biogenesis disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA017150, HPA050104" Supported Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA017150: , HPA050104: AB_2681017" "unprognostic (4.59e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (2.29e-1)" "unprognostic (3.62e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.67e-4)" "prognostic favorable (6.85e-4)" "unprognostic (1.19e-1)" "unprognostic (4.08e-2)" "unprognostic (2.10e-1)" "unprognostic (8.48e-2)" "unprognostic (6.96e-2)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (7.62e-3)" "unprognostic (4.28e-1)" 12.0 17.3 25.9 13.3 29.5 8.5 24.4 25.1 39.6 19.9 18.2 17.3 21.3 18.4 16.2 27.2 21.6 20.1 14.7 17.9 25.8 28.1 25.4 19.8 14.9 18.4 24.0 20.3 19.7 23.2 20.4 16.4 17.3 26.9 18.2 21.7 15.7 19.0 20.9 23.7 20.6 17.2 16.1 14.7 18.7 18.4 18.0 14.8 21.4 20.3 17.2 25.3 16.7 13.9 42.5 42.8 32.0 29.6 29.5 37.0 34.1 11.2 10.3 9.2 9.1 21.5 16.9 9.5 11.4 15.2 15.0 11.6 4.7 13.2 10.6 12.4 16.2 7.3 13.8 8.0 17.0 10.5 11.8 6.0 6.5 6.8 12.2 30.4 19.4 12.0 22.2 21.3 10.1 10.0 19.3 19.0 14.9 11.8 17.6 23.6 17.9 14.9 18.5 3.3 24.1 12.8 13.8 13.8 23.1 25.7 8.0 6.4 10.5 8.6 16.6 10.4 9.6 23.0 30.3 16.9 10.1 8.1 13.2 8.3 19.0 21.9 15.0 17.1 11.0 6.9 32.0 29.6 20.6 28.7 26.3 31.2 42.5 32.9 31.0 32.0 37.2 37.0 33.5 14.7 29.5 25.8 42.8 34.8 34.1 25.9 29.5 25.1 39.6 25.8 28.1 24.0 20.3 26.9 14.8 14.9 10.1 11.9 7.5 17.2 7.2 11.8 17.8 12.0 6.8 38.4 0.0 31.7 38.1 11.9 9.5 11.7 16.7 0.0 12.2 11.2 11.8 8.1 3.5 27.2 19.8 4.8 12.2 12.9 18.1 15.7 13.0 11.3 20.3 31.5 18.1 12.6 12.4 14.0 18.7 27.8 4.5 6.5 6.2 34.7 19.1 19.3 16.7 11.8 14.5 8.6 PEX3 ENSG00000034693 "Peroxisomal biogenesis factor 3" P56589 6 143450807-143490010 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042830, HPA058006" Supported Approved Nucleoplasm,Peroxisomes NA NA "Nucleoplasm, Peroxisomes" "HPA042830: AB_10794918, HPA058006: AB_2683576" "unprognostic (3.52e-3)" "unprognostic (6.28e-2)" "unprognostic (1.81e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-1)" "unprognostic (4.16e-1)" "unprognostic (8.45e-2)" "unprognostic (1.19e-1)" "unprognostic (1.09e-1)" "unprognostic (1.56e-2)" "unprognostic (2.50e-2)" "unprognostic (2.16e-1)" "prognostic favorable (3.80e-4)" "unprognostic (1.87e-1)" "unprognostic (7.30e-2)" "unprognostic (3.80e-2)" "unprognostic (2.12e-1)" 10.1 47.5 13.7 14.0 15.5 3.3 14.5 17.3 17.7 13.6 8.5 12.1 14.0 7.0 12.5 16.4 21.1 12.5 9.0 15.8 14.3 11.4 22.7 29.2 9.6 10.3 13.7 15.9 14.4 8.6 16.2 14.8 22.2 17.4 15.0 8.1 10.4 12.8 15.7 12.6 14.6 8.8 12.7 14.6 8.7 11.3 14.4 12.7 10.1 19.3 13.5 11.6 11.9 15.1 18.2 8.7 7.8 9.6 12.0 18.7 8.1 14.6 3.6 7.7 16.1 12.8 12.6 9.6 13.1 10.7 18.2 22.2 23.6 9.5 25.6 15.6 14.0 19.6 12.4 10.6 18.6 22.5 14.8 13.0 18.1 7.4 15.2 11.8 29.1 7.3 15.3 12.7 17.4 13.1 8.6 9.9 13.3 15.4 11.8 17.3 10.2 14.7 11.8 4.9 8.9 13.1 11.3 17.3 11.0 22.3 6.3 11.9 4.3 17.4 15.1 11.6 7.8 7.6 9.7 9.1 13.0 11.1 22.2 15.5 8.5 10.7 25.6 17.0 20.1 10.2 7.8 5.1 4.9 13.2 8.0 15.1 18.2 14.1 13.1 7.9 15.4 18.7 17.9 0.8 12.0 9.6 8.7 16.5 8.1 13.7 15.5 17.3 17.7 14.3 11.4 13.7 15.9 17.4 12.7 14.9 11.8 10.0 10.4 23.7 12.3 11.3 5.1 25.4 14.8 8.7 3.9 32.3 16.6 11.5 3.2 11.7 5.5 0.0 8.3 9.5 12.0 7.4 24.3 18.1 9.9 15.9 5.8 12.9 7.5 3.2 12.7 6.4 8.5 9.0 5.0 14.1 7.5 2.9 10.6 19.9 11.9 6.5 14.1 65.4 17.0 30.5 49.1 8.7 7.0 5.9 PFDN1 PFD1 ENSG00000113068 "Prefoldin subunit 1" O60925 5 140245039-140303121 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006499 Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA 10000 "Plasma membrane, Cytosol" Nucleoli "HPA006499: AB_1079596" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.11e-2)" "unprognostic (5.66e-3)" "prognostic unfavorable (8.81e-5)" "unprognostic (2.12e-2)" "unprognostic (2.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.50e-1)" "unprognostic (2.33e-1)" "unprognostic (4.10e-1)" "unprognostic (8.60e-3)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.00e-1)" 36.1 24.8 39.5 18.8 38.8 26.4 25.8 28.5 48.7 23.1 27.0 29.3 15.8 20.9 28.2 29.6 26.8 22.5 18.6 46.7 38.2 34.7 32.7 20.2 24.2 21.6 38.8 35.3 20.6 18.1 26.5 19.9 26.9 45.6 24.3 23.0 19.8 23.1 24.4 69.5 20.9 22.0 32.1 37.1 23.1 19.2 19.6 24.1 23.7 24.4 28.7 25.5 23.0 19.2 38.9 36.3 45.6 46.4 39.5 45.1 37.2 39.1 18.4 32.8 18.9 21.5 22.1 31.7 53.6 26.7 41.2 45.9 39.1 25.1 26.4 54.2 28.5 43.1 14.6 23.8 52.6 48.6 27.9 24.0 23.4 18.8 25.2 25.3 48.1 18.4 23.5 28.0 35.0 36.9 26.7 45.2 31.1 20.9 17.3 34.6 17.5 32.7 33.0 21.7 16.0 27.6 23.2 46.7 19.4 46.0 18.0 18.6 19.6 40.1 35.3 30.6 32.1 24.1 28.5 58.1 29.1 28.9 17.1 47.9 16.9 43.3 68.4 29.4 31.8 33.7 43.2 31.1 45.6 33.4 46.4 35.3 38.9 38.4 38.4 36.3 35.9 38.5 34.6 5.1 39.5 44.1 33.9 45.1 37.2 39.5 38.8 28.5 48.7 38.2 34.7 38.8 35.3 45.6 24.1 62.5 27.0 57.4 56.0 33.8 39.1 71.1 56.0 54.9 56.9 62.8 43.2 99.5 104.5 108.2 2.6 70.9 60.6 70.0 88.5 69.1 54.6 45.1 52.1 56.2 74.9 23.8 44.7 68.2 54.4 9.4 48.3 63.8 70.9 117.2 33.8 53.2 101.0 51.8 49.1 83.4 38.8 64.7 38.1 20.0 47.7 30.6 71.6 50.7 39.3 59.1 PFKL ENSG00000141959 "Phosphofructokinase, liver type" P17858 21 44300051-44327376 "Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 285.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030047 Approved Uncertain Nucleoli,Mitochondria NA NA 1800000 "Nucleoli, Mitochondria" "HPA030047: AB_10602815" "unprognostic (6.21e-3)" "unprognostic (2.93e-1)" "unprognostic (4.46e-2)" "unprognostic (1.23e-2)" "unprognostic (1.87e-2)" "unprognostic (1.23e-1)" "unprognostic (1.10e-1)" "unprognostic (6.98e-2)" "unprognostic (9.75e-2)" "prognostic unfavorable (4.41e-4)" "unprognostic (5.69e-2)" "unprognostic (5.40e-2)" "unprognostic (1.55e-1)" "unprognostic (4.99e-1)" "unprognostic (2.49e-1)" "unprognostic (8.06e-2)" "unprognostic (3.01e-2)" 32.0 16.7 28.0 26.0 29.5 26.4 23.1 21.3 46.0 28.3 38.7 40.9 30.1 65.5 21.3 33.5 33.5 22.8 37.5 18.4 28.8 23.4 40.3 31.3 21.0 25.2 32.4 33.0 19.5 27.1 12.3 17.1 31.9 29.1 20.2 17.2 36.3 28.8 28.5 8.3 31.1 59.3 20.5 36.1 28.1 42.7 24.0 29.1 16.4 20.4 15.4 26.0 27.2 23.9 20.3 26.9 5.2 38.0 7.7 25.2 22.8 32.6 14.3 10.2 29.4 16.1 12.0 45.0 24.6 16.0 14.3 14.1 19.2 7.2 19.4 29.3 16.4 13.7 17.8 8.1 22.3 3.3 16.3 18.4 39.2 12.5 31.3 12.4 29.5 25.0 15.7 13.6 14.6 7.2 21.7 21.0 14.2 24.1 22.2 9.7 41.5 12.7 23.0 16.0 29.3 16.1 31.5 9.7 52.6 6.5 36.2 18.0 13.5 35.8 30.4 15.7 4.3 24.1 26.1 30.4 21.7 14.0 14.2 9.4 43.2 11.7 7.9 36.1 23.5 17.3 5.1 22.2 5.2 12.9 37.9 10.8 14.4 17.0 11.8 26.9 20.3 10.2 7.9 4.5 7.7 38.0 17.0 25.2 22.8 28.0 29.5 21.3 46.0 28.8 23.4 32.4 33.0 29.1 29.1 20.8 27.5 37.6 33.4 31.7 71.1 12.6 17.8 21.4 28.4 87.2 62.8 106.3 84.6 68.0 1.8 43.0 285.1 0.0 45.0 147.2 44.6 37.8 41.5 60.1 95.6 28.6 44.5 41.1 58.5 5.2 36.2 60.1 65.8 177.7 107.9 59.6 51.1 112.2 52.3 108.3 44.6 25.8 42.9 1.4 8.7 31.6 134.4 31.9 139.6 44.5 PGAM4 "dJ1000K24.1, PGAM-B, PGAM1, PGAM3" ENSG00000226784 "Phosphoglycerate mutase family member 4" Q8N0Y7 X 77968874-77969638 "Enzymes, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 2.1;Melanocytes: 3.3;Suprabasal keratinocytes: 2.0" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 5.4" "HPA042528, HPA060483" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA042528: AB_2678039, HPA060483: AB_2684292" "unprognostic (3.10e-2)" "unprognostic (2.41e-2)" "unprognostic (5.25e-2)" "unprognostic (3.18e-2)" "unprognostic (4.37e-2)" "unprognostic (4.21e-2)" "unprognostic (7.71e-2)" "unprognostic (1.89e-2)" "unprognostic (1.78e-1)" "unprognostic (7.52e-3)" "unprognostic (3.19e-2)" "unprognostic (1.14e-1)" "unprognostic (4.20e-2)" "unprognostic (1.20e-1)" "unprognostic (4.15e-2)" "unprognostic (1.10e-1)" "unprognostic (2.76e-3)" 0.9 2.1 0.9 2.6 1.5 3.0 0.4 0.8 2.1 1.9 0.6 2.4 1.4 0.7 2.9 1.3 0.0 1.3 1.0 1.5 0.9 1.2 0.4 1.2 1.5 1.0 0.1 0.7 0.7 0.7 0.5 0.7 0.6 0.2 1.1 0.8 2.0 1.3 0.4 1.0 1.3 0.5 0.3 0.7 1.6 1.2 0.7 1.9 3.7 2.4 0.8 1.6 3.5 5.4 3.1 0.3 0.9 0.4 0.0 2.7 0.5 0.1 0.6 0.8 0.0 0.5 0.8 1.5 0.3 0.0 2.3 0.2 0.0 0.8 0.6 0.3 0.0 1.1 0.7 0.0 1.6 0.9 0.4 0.2 0.2 0.0 0.1 0.5 0.3 0.0 0.6 0.8 1.0 2.7 3.9 1.1 0.3 0.8 0.8 1.0 2.0 0.0 0.7 0.1 2.7 0.3 0.0 1.3 0.3 1.0 0.6 0.0 1.0 1.8 1.6 3.1 2.8 1.4 0.7 3.7 1.6 0.5 0.6 2.4 3.7 1.4 2.2 1.1 0.7 1.1 1.3 1.9 0.7 0.6 0.9 1.5 0.8 2.1 0.5 1.6 3.5 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.0 0.0 PGM5 PGMRP ENSG00000154330 "Phosphoglucomutase 5" Q15124 9 68328308-68531061 "Predicted intracellular proteins" "Carbohydrate metabolism, Cell adhesion, Glucose metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 123.0" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 88.7;Endothelial cells: 35.0;Ito cells: 31.9;Sertoli cells: 51.8;Smooth muscle cells: 36.4" "Cancer enhanced" "Detected in many" "prostate cancer: 16.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 89 "neutrophil: 8.9" "Lineage enriched" "Detected in single" 89 "granulocytes: 8.9" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 15.9;PC-3: 29.8;RH-30: 20.7;SK-BR-3: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB034397, HPA046329, HPA067102" Enhanced Uncertain Cytosol NA NA 380000 Cytosol "CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: AB_2732758" "unprognostic (3.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.98e-3)" "unprognostic (5.75e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-4)" "unprognostic (1.22e-3)" "unprognostic (2.79e-1)" "unprognostic (5.28e-3)" "unprognostic (4.78e-2)" "unprognostic (2.28e-2)" "prognostic favorable (1.83e-5)" "unprognostic (3.04e-2)" "unprognostic (2.91e-1)" "unprognostic (2.48e-1)" "unprognostic (4.73e-2)" 5.9 13.6 0.8 7.5 1.3 0.0 4.1 2.1 1.5 25.9 52.2 1.8 26.1 2.9 36.9 10.3 22.6 20.9 11.1 31.6 1.0 0.4 2.0 1.5 2.7 5.9 0.9 1.3 9.3 1.9 0.5 1.2 1.7 1.3 37.1 7.6 4.3 2.9 51.1 8.5 2.2 15.4 123.0 1.5 1.7 16.6 4.3 0.9 0.9 2.8 4.5 1.5 57.4 24.5 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 4.2 3.4 2.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.0 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.3 0.0 0.0 29.8 0.0 20.7 0.9 0.9 0.0 0.0 0.1 0.0 25.9 1.4 0.6 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.8 1.3 2.1 1.5 1.0 0.4 0.9 1.3 1.3 0.9 0.0 1.7 0.0 5.1 2.1 22.3 88.7 0.0 1.4 3.4 12.2 3.9 0.0 1.7 0.1 1.2 35.0 0.0 0.0 0.0 0.1 3.3 2.7 0.0 0.0 0.1 0.0 0.0 31.9 3.2 0.0 7.5 1.9 3.3 1.8 0.0 8.4 0.1 0.0 4.6 0.6 1.1 51.8 36.4 0.1 0.2 2.0 0.0 0.0 0.0 1.3 PHACTR1 "dJ257A7.2, KIAA1733, RPEL1" ENSG00000112137 "Phosphatase and actin regulator 1" Q9C0D0 6 12716805-13290484 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.9;brain: 80.3" "Cell type enhanced" "Detected in many" 7 "B-cells: 134.6;Horizontal cells: 170.0;Kupffer cells: 97.1;Macrophages: 102.6" "Cancer enhanced" "Detected in many" "melanoma: 10.2" "Region enhanced" "Detected in all" "basal ganglia: 80.3" "Group enriched" "Detected in many" 13 "memory B-cell: 7.2;myeloid DC: 7.7;naive B-cell: 20.9;neutrophil: 10.1;plasmacytoid DC: 25.9" "Group enriched" "Detected in many" 17 "B-cells: 20.9;dendritic cells: 25.9;granulocytes: 10.1" "Cell line enhanced" "Detected in many" "HMC-1: 16.7;SK-MEL-30: 15.7;U-266/70: 41.2;U-266/84: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029755, HPA029756, HPA029757" Enhanced Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA029755: AB_10600089, HPA029756: AB_10601852, HPA029757: AB_10669870" "unprognostic (7.86e-2)" "unprognostic (7.49e-2)" "unprognostic (2.74e-2)" "unprognostic (2.80e-1)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (7.72e-2)" "unprognostic (4.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-4)" "unprognostic (1.53e-1)" "prognostic unfavorable (5.48e-6)" "unprognostic (1.31e-1)" "unprognostic (1.43e-1)" "unprognostic (5.00e-2)" "unprognostic (1.16e-1)" 3.5 1.6 11.6 7.2 80.3 22.6 1.6 4.9 31.4 1.4 1.4 1.3 0.3 2.0 1.3 2.6 1.5 1.9 4.2 9.2 10.9 4.4 3.9 1.9 9.0 8.7 2.7 16.6 1.8 4.2 0.5 6.0 1.7 2.2 1.4 1.5 0.6 1.4 0.7 1.2 2.6 2.9 1.7 2.6 6.5 2.0 2.2 7.2 0.4 1.3 0.0 13.4 3.4 1.4 20.9 25.9 10.1 1.1 0.4 0.2 1.1 0.0 0.1 1.1 0.2 0.0 0.0 3.2 0.3 1.2 1.2 2.1 0.1 0.0 0.2 0.4 0.1 1.6 0.1 0.0 0.0 1.5 4.2 0.3 8.4 0.1 0.1 0.1 7.9 16.7 0.4 0.0 0.0 0.1 0.1 1.5 0.5 3.9 7.1 1.2 0.0 0.1 6.1 1.1 0.0 0.0 4.0 2.2 0.7 1.0 0.1 5.0 1.5 0.0 3.2 15.7 1.6 9.6 1.9 1.7 0.1 0.3 0.0 0.0 41.2 26.8 7.0 0.6 2.3 6.4 0.1 1.1 0.6 0.1 0.9 0.0 7.2 0.1 0.0 7.7 20.9 0.1 0.2 10.1 0.4 0.3 25.9 0.0 1.1 11.6 80.3 4.9 31.4 10.9 4.4 2.7 16.6 2.2 7.2 62.5 37.4 134.6 1.5 3.3 35.3 9.1 2.5 9.4 14.8 59.3 3.9 1.2 26.6 0.6 54.5 8.3 0.4 0.0 2.5 2.0 6.2 0.8 80.7 0.8 76.1 170.0 1.7 15.4 97.1 44.3 4.4 102.6 45.5 18.0 0.1 21.8 1.0 0.0 6.0 0.6 13.0 0.0 4.0 1.2 2.7 2.8 1.6 2.5 0.4 0.7 PHF2 "CENP-35, JHDM1E, KDM7C, KIAA0662" ENSG00000197724 "PHD finger protein 2" O75151 9 93576407-93679587 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 13 "Early spermatids: 142.5;Late spermatids: 473.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010831 Approved Supported "Nucleoplasm,Nucleoli rim" Yes No "Nucleoli rim" Nucleoplasm "HPA010831: AB_1855294" "unprognostic (9.42e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (9.34e-4)" "unprognostic (1.30e-1)" "unprognostic (2.79e-1)" "unprognostic (1.40e-1)" "unprognostic (2.44e-1)" "unprognostic (8.48e-2)" "unprognostic (1.07e-1)" "unprognostic (5.89e-2)" "unprognostic (7.63e-2)" "unprognostic (1.49e-1)" "prognostic favorable (1.12e-5)" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (2.17e-1)" "unprognostic (4.19e-2)" 16.8 14.6 17.4 17.7 22.2 16.7 23.2 33.1 19.0 19.8 18.1 27.8 18.6 11.3 22.0 15.9 14.5 18.4 16.7 19.1 15.3 14.5 10.8 9.3 17.8 20.7 23.1 15.6 27.1 18.5 22.6 21.7 17.6 16.6 18.6 10.6 16.9 19.0 21.9 27.8 21.4 13.3 24.9 18.5 21.4 15.9 9.6 18.2 19.8 18.8 12.0 12.1 16.4 32.5 2.5 3.8 5.0 2.6 1.0 4.0 2.2 9.3 7.8 16.4 13.4 10.5 8.2 8.5 7.4 9.9 10.7 7.7 3.6 5.5 6.7 5.5 9.5 9.6 18.3 10.3 7.1 5.7 17.9 6.8 5.4 8.9 5.6 9.4 10.6 18.6 8.2 12.3 5.0 8.5 10.5 8.5 10.3 7.8 11.5 7.4 20.6 20.2 11.8 4.3 16.3 6.8 22.8 12.7 2.6 6.8 11.8 21.6 10.7 7.7 12.7 6.7 5.0 8.5 18.7 9.9 10.2 8.8 11.1 10.5 9.3 1.5 5.0 5.6 6.5 11.4 1.1 2.6 2.5 3.3 1.4 3.1 1.8 3.3 2.1 2.7 2.5 3.6 4.0 5.0 1.0 2.0 3.8 1.9 2.2 17.4 22.2 33.1 19.0 15.3 14.5 23.1 15.6 16.6 18.2 14.9 13.6 5.1 5.8 6.8 13.9 13.8 5.1 18.7 20.5 5.2 7.9 6.2 0.0 5.3 142.5 12.0 4.9 23.3 4.9 3.1 8.5 7.5 16.2 6.8 4.9 9.5 15.6 8.0 11.1 473.2 18.4 7.6 3.3 1.8 7.9 9.9 5.2 2.9 19.1 3.0 7.5 19.4 10.3 1.4 2.5 6.9 5.0 7.0 7.0 7.2 PHF20 "C20orf104, dJ1121G12.1, TDRD20A" ENSG00000025293 "PHD finger protein 20" Q9BVI0 20 35771974-35950381 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 349.5;Late spermatids: 510.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029619, HPA029620, HPA029621" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201" "unprognostic (1.21e-3)" "unprognostic (7.30e-2)" "unprognostic (3.20e-2)" "unprognostic (2.35e-3)" "unprognostic (1.36e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (2.76e-1)" "unprognostic (2.17e-1)" "unprognostic (2.64e-2)" "unprognostic (4.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.92e-2)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (7.23e-2)" "unprognostic (1.01e-2)" 19.1 11.6 14.0 16.8 19.0 14.1 17.2 25.1 19.2 15.9 15.9 16.1 8.1 8.1 19.1 11.6 16.5 14.2 14.8 15.2 14.1 13.8 11.2 11.1 16.5 17.3 14.9 13.0 18.9 9.4 17.9 20.0 15.6 15.0 14.7 11.7 14.7 15.3 15.7 46.6 12.9 12.3 17.2 18.9 20.8 12.7 17.4 15.2 19.4 14.2 14.5 20.8 18.7 21.8 12.0 8.2 23.6 11.9 13.0 12.4 6.5 9.7 7.8 13.7 20.3 10.0 11.5 12.8 11.2 10.7 11.3 9.9 22.8 7.4 16.4 10.2 14.9 13.9 6.1 12.6 15.6 13.8 7.4 5.4 30.5 15.0 8.4 10.0 14.6 11.9 9.0 22.0 11.9 18.4 13.4 12.3 11.7 12.5 10.6 12.9 5.8 14.7 8.5 6.8 6.5 9.8 10.8 20.3 9.7 9.0 6.8 12.5 10.2 20.0 23.2 10.2 13.0 18.3 10.9 17.2 25.1 5.7 13.0 11.4 9.8 11.6 12.0 18.5 10.7 12.8 11.9 8.6 23.6 10.6 9.0 11.3 12.0 10.5 11.9 8.2 9.8 12.0 12.4 20.5 13.0 11.9 7.7 5.5 6.5 14.0 19.0 25.1 19.0 14.1 13.8 14.9 13.0 15.0 15.2 35.7 39.9 77.0 65.2 30.9 75.5 47.0 30.6 57.6 40.9 36.6 92.3 85.9 31.5 25.8 349.5 40.9 11.8 0.0 17.4 39.0 36.8 47.3 136.5 15.3 46.9 108.1 34.5 39.3 53.1 510.4 33.1 60.9 37.1 31.5 24.9 44.2 20.8 25.7 50.2 19.5 75.2 19.4 39.6 55.4 46.4 24.7 18.7 82.0 29.0 53.3 PHLDA1 "DT1P1B11, PHRIP, TDAG51" ENSG00000139289 "Pleckstrin homology like domain family A member 1" Q8WV24 12 76025447-76033932 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 142.4" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 1037.1;Smooth muscle cells: 353.3;Urothelial cells: 680.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.4;MAIT T-cell: 3.9;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.5;non-classical monocyte: 2.5;T-reg: 4.1" "Group enriched" "Detected in many" 7 "monocytes: 2.5;T-cells: 4.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 65.6;RPTEC TERT1: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016160, HPA019000, HPA063520" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: AB_2685028" "unprognostic (9.09e-2)" "unprognostic (2.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.51e-3)" "unprognostic (2.33e-1)" "unprognostic (2.60e-3)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (2.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.21e-3)" "unprognostic (5.03e-2)" "unprognostic (1.21e-1)" "unprognostic (3.34e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-1)" "unprognostic (4.55e-3)" 13.2 15.9 9.4 8.4 12.1 9.0 13.5 6.4 15.7 11.5 4.5 11.1 4.8 3.4 7.1 3.1 33.3 5.1 20.0 9.6 8.2 7.9 13.8 33.2 14.2 3.0 8.4 5.6 10.8 8.8 2.6 6.0 7.1 10.0 4.8 5.5 24.9 142.4 6.5 3.3 6.3 7.0 7.6 9.7 14.6 10.8 2.3 10.1 2.5 18.0 13.2 19.9 17.0 17.8 0.3 0.1 0.4 2.5 0.3 4.1 0.6 12.7 15.3 12.0 6.6 5.6 11.7 0.8 10.8 29.2 4.9 6.8 8.4 15.6 0.0 3.2 4.5 16.3 6.5 0.3 18.1 10.6 1.9 0.2 0.3 0.7 14.3 8.2 0.3 3.3 3.6 13.3 20.4 40.6 65.6 11.8 0.0 1.0 0.3 25.1 1.6 0.0 1.6 4.4 7.7 23.6 0.0 3.1 0.3 51.5 28.9 0.8 2.3 1.8 0.1 35.1 15.6 7.7 0.1 10.9 16.8 1.6 19.5 10.6 0.1 0.0 0.0 28.4 0.1 20.9 0.3 0.1 0.2 2.4 0.2 3.9 0.3 2.5 2.5 0.0 0.2 0.5 0.6 0.4 0.3 2.5 0.1 4.1 0.6 9.4 12.1 6.4 7.7 8.2 7.9 8.4 5.6 10.0 10.1 11.9 17.2 2.7 1037.1 173.4 1.5 29.5 10.2 6.7 22.7 29.6 2.0 4.8 71.3 68.6 1.0 95.1 0.7 0.0 35.8 6.3 85.4 57.9 80.5 117.3 97.6 1.6 112.7 23.9 10.8 1.3 8.6 53.3 271.7 41.5 10.3 90.9 162.8 3.5 14.5 32.7 4.0 265.1 353.3 0.5 0.4 66.0 6.2 23.0 8.0 680.5 PHLDA2 "BWR1C, HLDA2, IPL, TSSC3" ENSG00000181649 "Pleckstrin homology like domain family A member 2" Q53GA4 11 2928273-2929455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 163.9" "Cell type enhanced" "Detected in many" 18 "Cytotrophoblasts: 3794.0;Syncytiotrophoblasts: 8329.2;Urothelial cells: 2915.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 8.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 83.8;PC-3: 68.1;SK-MEL-30: 53.5;WM-115: 73.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003994 Uncertain Nucleoli NA NA Nucleoli "HPA003994: AB_1855311" "unprognostic (1.90e-1)" "unprognostic (3.13e-2)" "unprognostic (9.93e-3)" "unprognostic (6.16e-2)" "unprognostic (4.28e-2)" "unprognostic (8.01e-3)" "prognostic unfavorable (4.22e-5)" "unprognostic (1.24e-3)" "unprognostic (3.84e-2)" "unprognostic (8.35e-2)" "unprognostic (1.67e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (2.63e-6)" "unprognostic (2.83e-1)" "unprognostic (6.13e-2)" "unprognostic (2.16e-2)" "unprognostic (1.59e-1)" 3.8 1.1 0.5 3.6 0.7 1.4 7.7 0.3 1.4 5.6 7.9 0.5 1.7 5.9 2.3 5.5 20.3 2.4 15.6 1.5 0.5 1.9 4.8 3.7 3.9 0.8 1.3 0.5 1.8 4.6 1.2 1.2 163.9 1.9 8.0 1.4 0.8 5.3 2.0 0.8 9.6 7.4 1.9 1.0 1.8 11.1 1.0 0.5 0.2 3.5 24.7 15.1 6.1 8.7 1.5 8.2 0.0 4.9 0.0 3.9 1.5 9.4 8.4 0.3 0.1 0.1 1.7 9.1 21.0 5.3 3.0 2.2 3.4 18.7 0.0 10.3 2.3 6.9 11.7 0.0 8.3 0.3 83.8 2.8 0.0 4.5 2.1 6.9 0.0 5.0 2.8 3.8 2.5 2.0 1.7 2.5 0.0 1.8 0.1 1.2 29.8 0.0 1.4 3.4 4.7 68.1 0.0 0.0 5.7 6.1 2.9 0.9 0.0 6.7 4.6 53.5 0.4 1.4 0.8 13.9 6.7 3.6 9.4 7.1 0.1 0.1 0.0 5.5 1.4 73.4 0.0 4.9 0.0 0.7 3.0 0.8 1.5 3.9 0.9 8.2 0.0 1.0 0.2 0.0 0.0 0.6 0.0 1.4 1.5 0.5 0.7 0.3 1.4 0.5 1.9 1.3 0.5 1.9 0.5 17.9 37.7 0.5 1363.4 350.5 0.0 4.8 48.4 16.0 48.9 41.8 0.0 3794.0 8.3 172.2 2.1 8.7 316.4 0.0 128.2 1743.3 110.0 1372.9 82.9 3.4 356.1 0.0 189.0 11.6 9.2 0.4 3.4 47.2 97.8 17.2 122.2 0.0 313.5 273.8 2.8 0.3 0.1 51.8 311.1 0.5 4.5 599.1 8329.2 3.8 109.0 2915.8 PIGB ENSG00000069943 "Phosphatidylinositol glycan anchor biosynthesis class B" Q92521 15 55318960-55355648 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039929 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039929: AB_10673539" "unprognostic (1.91e-2)" "unprognostic (7.45e-2)" "unprognostic (3.00e-1)" "unprognostic (2.03e-2)" "unprognostic (2.96e-2)" "unprognostic (4.65e-2)" "unprognostic (2.04e-1)" "unprognostic (3.37e-3)" "unprognostic (7.52e-2)" "unprognostic (3.52e-2)" "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.30e-1)" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (4.24e-2)" 9.5 11.9 5.7 13.0 11.9 11.2 10.4 3.9 9.3 7.1 8.5 8.2 6.6 9.1 10.5 13.2 11.1 9.5 10.0 6.3 5.9 5.9 12.4 10.3 8.8 20.1 6.9 6.8 8.7 8.1 19.2 12.5 8.7 8.6 9.7 9.4 13.0 9.6 8.4 3.2 8.1 11.6 7.0 8.9 14.2 9.3 17.4 6.0 11.5 16.3 6.2 16.2 10.7 9.3 8.4 8.1 20.1 11.5 5.6 8.9 6.4 7.5 8.7 4.0 3.1 4.4 9.0 5.7 6.3 12.7 7.1 11.4 3.8 7.9 7.3 8.4 8.8 11.0 12.7 2.5 6.6 6.0 7.3 5.7 7.2 10.9 4.7 7.9 20.5 6.3 9.4 8.2 5.6 7.2 9.1 8.8 6.6 8.5 6.2 9.4 6.6 2.5 8.0 2.5 5.8 4.4 3.2 3.9 16.7 11.0 8.3 2.3 4.5 5.8 9.4 11.0 3.8 10.1 14.9 6.7 9.6 3.2 2.5 12.7 6.2 11.1 6.5 8.5 23.1 6.9 10.5 8.9 4.1 8.3 10.4 8.9 8.4 8.3 8.6 8.1 5.4 7.0 7.8 20.1 5.6 11.5 6.3 8.6 6.4 5.7 11.9 3.9 9.3 5.9 5.9 6.9 6.8 8.6 6.0 8.9 7.4 8.6 8.7 4.0 2.7 2.6 2.5 8.1 12.5 0.0 11.8 10.0 1.7 6.2 16.8 4.5 5.2 0.0 9.7 9.3 4.1 4.1 8.1 3.8 7.5 1.6 6.3 7.4 6.5 2.4 1.4 6.3 3.3 8.2 3.7 3.1 5.9 4.2 1.4 8.2 9.1 6.5 4.7 2.6 3.0 3.4 5.5 8.6 3.7 3.3 PIH1D2 ENSG00000150773 "PIH1 domain containing 2" Q8WWB5 11 112064010-112074274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 41.9" "Group enriched" "Detected in many" 10 "Ciliated cells: 123.1;Early spermatids: 307.7;Late spermatids: 93.6;Spermatocytes: 103.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 12.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039496 Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039496: AB_10959385" "unprognostic (8.74e-2)" "unprognostic (6.64e-3)" "unprognostic (1.29e-1)" "unprognostic (3.01e-3)" "unprognostic (4.72e-2)" "unprognostic (1.35e-2)" "unprognostic (3.74e-2)" "unprognostic (1.17e-1)" "unprognostic (2.43e-3)" "unprognostic (5.82e-2)" "unprognostic (9.05e-3)" "unprognostic (1.03e-1)" "unprognostic (2.81e-3)" "unprognostic (1.59e-1)" "unprognostic (6.08e-2)" "unprognostic (3.38e-2)" "unprognostic (1.12e-1)" 0.7 1.0 1.5 0.3 3.3 0.2 1.6 0.9 2.0 1.6 0.8 3.2 2.3 0.4 1.5 8.1 1.0 14.4 1.2 0.9 2.6 2.0 4.9 0.5 2.8 0.3 1.1 1.8 2.5 1.2 4.4 10.5 0.5 9.7 1.4 0.7 2.7 1.1 1.5 0.9 0.9 0.5 0.9 0.8 0.4 0.8 41.9 1.2 0.1 5.8 0.6 0.3 0.9 0.8 1.2 1.0 0.7 1.2 0.3 0.3 0.2 2.9 1.5 4.6 2.0 2.3 2.6 3.2 1.1 3.8 3.8 3.7 5.7 9.4 1.3 4.0 2.2 4.5 3.7 1.0 2.4 3.7 1.4 3.8 2.1 2.5 2.5 2.1 2.2 1.4 1.6 2.8 7.0 4.0 3.4 2.0 2.7 2.7 0.8 2.3 1.1 0.9 2.8 1.3 1.6 2.5 1.8 3.0 3.2 9.8 1.5 5.9 1.5 3.7 1.4 1.9 1.9 12.6 0.6 1.1 2.1 2.4 1.3 1.0 1.1 0.4 1.6 3.1 0.3 1.7 0.0 0.3 0.7 0.0 1.2 0.3 1.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.2 1.5 3.3 0.9 2.0 2.6 2.0 1.1 1.8 9.7 1.2 6.0 0.3 0.0 1.6 0.6 2.0 2.0 7.6 123.1 10.3 3.5 2.0 0.8 13.3 3.1 307.7 0.9 0.2 0.0 2.0 0.6 0.9 0.7 1.1 0.0 0.6 1.6 2.9 0.6 0.3 93.6 2.6 0.8 3.3 1.0 0.3 3.4 1.5 0.0 1.4 6.8 15.4 0.0 1.0 103.7 7.7 0.9 0.2 0.0 0.4 0.8 PIK3CA PI3K ENSG00000121879 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha" P42336 3 179148114-179240093 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Phagocytosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009985, CAB017804" Approved Supported Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB017804: , HPA009985: AB_1079610" "unprognostic (1.81e-1)" "unprognostic (2.77e-1)" "unprognostic (2.18e-1)" "unprognostic (2.69e-3)" "unprognostic (6.49e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-2)" "unprognostic (1.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-3)" "unprognostic (5.21e-2)" "unprognostic (4.50e-2)" "unprognostic (1.16e-2)" "unprognostic (2.48e-1)" "unprognostic (9.74e-2)" "unprognostic (3.82e-2)" 20.1 12.3 13.7 11.5 13.4 25.7 22.4 17.1 24.5 12.9 14.0 5.2 5.7 6.5 15.3 7.9 11.6 11.1 13.2 14.2 18.4 9.7 11.7 10.8 13.2 13.8 9.8 15.7 15.4 9.2 24.7 11.6 16.5 16.3 10.7 8.9 7.2 10.9 10.9 15.2 12.0 10.5 12.8 14.4 16.2 10.6 9.3 9.8 29.6 11.0 7.3 13.9 15.1 15.7 6.2 2.6 7.8 3.8 2.4 5.0 1.1 14.6 5.0 8.0 7.4 19.0 22.2 5.9 9.4 12.7 9.3 14.7 4.3 10.9 13.4 16.1 11.2 13.2 6.0 6.6 8.1 13.5 22.4 5.8 18.4 5.5 3.8 9.1 10.3 10.5 14.0 8.6 10.2 11.7 10.4 13.3 9.7 9.1 15.0 13.3 5.8 7.9 9.3 6.4 7.3 6.8 12.0 8.1 16.1 7.3 9.0 4.5 7.7 10.2 9.1 12.2 7.3 15.2 8.9 14.0 8.7 5.7 13.7 9.3 7.3 10.3 24.1 7.9 7.8 5.1 2.1 3.8 1.6 5.0 2.9 3.9 5.8 4.2 2.8 2.2 6.2 4.6 3.8 7.8 2.4 3.0 2.6 4.1 1.1 13.7 13.4 17.1 24.5 18.4 9.7 9.8 15.7 16.3 9.8 29.8 23.2 13.7 15.2 13.1 26.3 15.4 7.6 18.7 17.0 7.0 29.5 8.1 1.7 9.8 1.7 21.4 4.9 0.0 11.9 5.0 18.3 27.3 30.1 17.4 9.5 36.5 2.4 29.4 21.2 1.6 30.2 16.4 13.5 16.2 9.6 15.6 13.1 12.7 37.1 11.2 26.2 25.8 22.1 9.6 7.6 13.0 7.3 14.0 9.2 27.6 PINX1 "FLJ20565, Gno1, LPTL, LPTS, MGC8850, PinX1, Pxr1" ENSG00000254093 "PIN2/TERF1 interacting telomerase inhibitor 1" Q96BK5 8 10764963-10839884 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023139, HPA023146" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Nucleoli "Nucleoplasm, Mitochondria" "HPA023139: AB_1855384, HPA023146: " "unprognostic (4.01e-1)" "prognostic favorable (2.45e-5)" "unprognostic (7.80e-3)" "unprognostic (3.35e-2)" "unprognostic (4.10e-1)" "unprognostic (4.61e-2)" "unprognostic (1.83e-2)" "unprognostic (3.40e-2)" "unprognostic (9.73e-3)" "unprognostic (2.49e-1)" "unprognostic (1.40e-1)" "unprognostic (4.37e-1)" "unprognostic (2.59e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" 14.3 14.4 9.9 16.0 13.9 14.8 13.8 14.5 16.5 12.6 14.2 12.6 7.1 11.5 15.7 8.9 19.3 10.7 9.3 11.7 10.6 10.1 13.1 19.4 11.2 19.2 13.2 10.9 16.1 17.2 7.6 10.7 13.3 17.6 11.4 12.0 15.6 14.9 8.5 21.2 19.0 11.3 15.9 11.1 14.8 11.7 24.0 9.7 18.7 12.4 17.8 19.6 11.5 14.3 9.8 8.8 4.4 8.4 8.9 16.0 8.4 6.4 8.7 9.4 8.9 8.0 6.5 10.8 9.9 4.5 10.9 7.4 9.1 5.7 17.4 3.5 5.3 13.4 13.1 23.8 18.3 14.1 7.0 7.1 7.3 6.1 9.8 9.0 7.8 4.6 5.4 11.7 8.6 16.1 3.9 15.1 11.9 23.1 10.8 10.7 7.7 25.5 9.8 21.6 28.3 9.7 20.9 11.5 15.9 8.1 8.0 7.8 8.1 6.6 7.9 21.7 12.0 8.4 9.7 9.1 6.6 14.3 8.4 12.7 4.9 12.7 31.7 6.8 14.8 14.9 1.5 6.8 4.4 12.5 8.4 16.0 9.7 10.9 13.1 8.8 9.8 15.0 11.6 0.4 8.9 7.3 6.8 12.3 8.4 9.9 13.9 14.5 16.5 10.6 10.1 13.2 10.9 17.6 9.7 3.0 4.1 9.9 14.8 23.7 5.2 3.3 7.6 10.7 9.1 3.5 11.8 14.9 10.0 0.0 29.6 11.4 4.0 0.0 0.0 9.6 8.0 5.2 13.9 6.6 14.3 3.2 8.1 11.6 4.0 22.3 8.6 9.6 6.8 0.0 3.9 6.2 0.0 4.8 6.0 8.2 21.5 0.0 6.2 24.9 25.1 25.0 40.3 11.7 7.7 8.0 PIP4K2C "FLJ22055, PIP5K2C" ENSG00000166908 "Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma" Q8TBX8 12 57591174-57603418 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 112.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028658 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028658: AB_10601245" "unprognostic (7.84e-3)" "unprognostic (1.51e-1)" "unprognostic (2.42e-1)" "unprognostic (2.77e-2)" "unprognostic (2.49e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (7.98e-4)" "unprognostic (3.17e-2)" "unprognostic (6.00e-2)" "unprognostic (5.51e-2)" "unprognostic (1.75e-1)" "unprognostic (1.88e-1)" "prognostic favorable (2.06e-6)" "unprognostic (1.87e-1)" "unprognostic (2.16e-1)" "unprognostic (3.27e-1)" "unprognostic (3.42e-1)" 9.3 13.3 13.9 9.2 25.9 16.7 15.0 18.9 45.5 12.5 17.5 14.6 15.8 11.6 14.2 62.0 20.0 20.0 12.1 10.8 15.4 10.9 26.9 14.4 14.4 9.2 14.3 21.2 12.3 14.9 29.6 13.7 11.1 18.8 16.7 19.4 17.4 18.6 14.6 9.4 18.4 13.3 11.9 12.7 10.7 27.6 25.6 12.1 5.9 17.9 8.5 13.1 14.6 14.1 6.8 5.4 29.7 8.4 9.4 16.1 6.5 19.1 13.5 5.5 6.6 0.0 0.0 17.8 8.0 15.0 14.5 13.5 17.2 27.7 4.1 17.6 9.3 17.9 17.5 9.0 15.7 11.7 6.2 10.1 7.5 6.5 12.1 12.8 6.9 13.5 5.0 26.7 5.5 10.3 17.8 7.3 4.6 9.6 12.6 7.5 18.9 6.2 6.0 10.5 11.7 11.8 0.1 49.9 6.2 15.2 32.8 9.3 11.5 17.2 11.5 10.9 19.4 31.6 6.4 1.6 7.3 10.1 10.7 8.4 9.7 11.3 9.3 14.4 5.9 12.1 29.7 5.2 15.3 16.1 6.2 10.7 5.9 9.9 12.0 5.4 6.8 9.6 11.5 10.2 9.4 8.4 2.3 12.1 6.5 13.9 25.9 18.9 45.5 15.4 10.9 14.3 21.2 18.8 12.1 8.9 7.5 3.0 5.7 11.0 13.1 112.2 15.3 13.4 9.1 33.2 17.7 9.3 18.3 16.2 23.8 3.5 18.0 0.0 17.1 13.6 4.9 9.9 3.5 11.6 7.9 7.9 21.4 9.8 2.9 35.3 6.4 4.1 11.8 8.2 16.1 6.5 28.1 13.6 4.9 10.1 8.3 19.4 6.4 11.9 7.1 11.2 14.5 8.7 8.6 7.1 PIRT ENSG00000233670 "Phosphoinositide interacting regulator of transient receptor potential channels" P0C851 17 10822475-10838445 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.3;brain: 24.8;intestine: 7.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 40 "glioma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA042337 Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA042337: AB_10794795" "unprognostic (2.95e-1)" "unprognostic (2.19e-2)" "unprognostic (7.57e-2)" "unprognostic (6.58e-3)" "unprognostic (9.42e-2)" "unprognostic (2.05e-1)" "unprognostic (2.85e-3)" 0.4 7.3 9.9 3.2 14.0 0.3 0.3 5.6 5.2 0.4 6.3 10.8 0.0 2.9 0.4 0.4 0.8 0.9 0.7 0.3 13.1 11.6 0.3 0.3 0.4 0.3 12.5 2.3 0.4 0.3 0.3 0.1 0.3 24.8 0.4 7.5 0.0 0.4 0.4 0.4 0.4 5.2 2.5 19.9 0.3 4.9 0.5 12.8 0.0 0.3 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 14.0 5.6 5.2 13.1 11.6 12.5 2.3 24.8 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PKMYT1 "MYT1, PPP1R126" ENSG00000127564 "Protein kinase, membrane associated tyrosine/threonine 1" Q99640 16 2968024-2980539 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4" "Group enriched" "Detected in many" 6 "Extravillous trophoblasts: 39.8;Spermatocytes: 108.0;Spermatogonia: 40.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 4.4" "Lineage enriched" "Detected in single" 5 "T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068860 Supported "Nucleoplasm,Nucleoli,Golgi apparatus" NA Yes "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA068860: AB_2686050" "unprognostic (7.82e-2)" "unprognostic (8.70e-2)" "unprognostic (5.93e-2)" "unprognostic (2.04e-2)" "unprognostic (4.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (8.33e-4)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.52e-2)" "unprognostic (2.15e-1)" "unprognostic (1.61e-2)" "unprognostic (7.95e-3)" "unprognostic (0.00e+0)" "unprognostic (1.09e-3)" "unprognostic (9.13e-2)" "unprognostic (1.96e-1)" "unprognostic (5.91e-2)" 0.9 0.7 0.7 9.4 0.6 19.5 1.3 2.6 0.8 1.3 2.9 0.3 0.5 1.9 0.8 1.5 7.2 0.2 1.5 1.4 0.7 0.7 0.8 1.0 1.3 6.2 0.8 0.2 0.3 1.3 0.0 0.7 4.3 0.4 0.6 0.8 0.3 1.3 0.2 1.6 3.4 3.2 0.6 1.0 4.4 2.7 61.4 0.2 42.8 0.3 9.2 12.7 0.7 2.0 0.8 0.4 0.3 0.5 0.4 4.4 1.0 24.9 17.5 6.8 9.8 0.1 0.3 18.6 19.4 4.6 12.3 11.8 13.6 14.8 15.6 8.7 2.1 7.3 32.1 4.8 6.2 2.2 20.0 15.7 7.9 15.8 11.9 0.0 8.8 22.5 0.2 0.5 7.3 2.0 1.5 2.5 17.3 22.7 27.7 4.0 37.4 24.6 24.5 11.2 11.7 9.3 26.9 15.3 30.2 2.3 5.5 13.0 13.8 9.4 24.5 7.3 3.9 14.0 17.6 2.3 16.6 21.0 24.2 20.3 21.0 15.6 26.8 6.3 11.8 19.2 0.0 0.4 0.3 0.3 0.3 0.0 0.8 0.5 0.5 0.4 0.0 0.0 0.0 0.1 0.4 0.5 0.1 4.4 1.0 0.7 0.6 2.6 0.8 0.7 0.7 0.8 0.2 0.4 0.2 0.0 1.4 0.0 0.8 2.3 0.1 0.4 2.5 0.0 2.3 1.8 5.9 3.0 0.0 1.1 11.2 0.3 0.2 0.0 0.5 39.8 0.4 0.5 0.0 0.2 10.2 0.0 1.7 0.0 1.3 7.5 0.3 1.3 0.0 1.0 1.2 0.3 0.3 0.0 0.4 0.0 6.7 0.0 0.0 108.0 40.5 0.5 6.2 0.7 3.5 0.4 PLAGL1 "LOT1, ZAC" ENSG00000118495 "PLAG1 like zinc finger 1" Q9UM63 6 143940300-144064599 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 95.0" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 117.4;Leydig cells: 128.3;Peritubular cells: 91.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 35.7;ASC TERT1: 29.1;RH-30: 36.3" "Low region specificity" "Detected in all" HPA055706 Supported "Nuclear bodies,Golgi apparatus,Vesicles" No No "Nuclear bodies" "Golgi apparatus, Vesicles" "HPA055706: AB_2682893" "unprognostic (4.74e-3)" "unprognostic (8.35e-3)" "unprognostic (5.43e-2)" "unprognostic (1.74e-3)" "unprognostic (5.09e-2)" "unprognostic (1.95e-1)" "unprognostic (9.32e-2)" "unprognostic (6.17e-2)" "unprognostic (3.49e-2)" "unprognostic (5.02e-2)" "unprognostic (1.78e-3)" "unprognostic (2.07e-1)" "prognostic unfavorable (4.94e-6)" "prognostic unfavorable (6.61e-4)" "unprognostic (4.69e-2)" "unprognostic (5.17e-3)" "unprognostic (4.93e-3)" 14.6 28.5 2.3 14.8 4.3 7.7 12.3 2.0 7.6 12.9 8.9 4.6 10.0 3.9 19.5 16.3 12.4 7.7 13.0 9.0 5.1 1.5 6.8 1.5 12.1 8.2 2.6 2.2 16.0 11.2 5.2 45.6 95.0 3.6 12.6 8.6 19.3 11.7 7.3 4.5 23.1 7.9 16.8 3.8 6.8 10.9 6.8 2.0 3.9 5.6 24.2 12.0 14.2 18.4 4.1 10.3 16.4 8.1 1.7 1.4 2.3 0.0 1.6 35.7 0.0 14.1 29.1 0.1 12.2 7.9 6.1 12.7 0.1 1.9 0.8 6.1 10.6 1.6 0.0 0.2 4.3 12.0 0.9 1.6 15.1 17.8 0.2 4.7 13.5 3.0 21.9 1.6 5.3 4.7 7.9 12.0 5.6 1.5 0.2 7.2 2.1 5.6 6.3 5.9 0.0 1.1 6.8 36.3 0.0 11.4 0.3 3.2 3.5 17.6 0.0 0.0 11.3 0.0 16.8 6.9 0.0 13.0 28.2 13.2 3.1 3.0 0.1 9.4 5.6 0.7 3.4 8.1 16.4 1.0 6.2 1.0 2.7 0.9 1.4 10.3 4.1 0.7 1.2 14.8 1.7 1.9 4.6 1.3 2.3 2.3 4.3 2.0 7.6 5.1 1.5 2.6 2.2 3.6 2.0 47.6 38.2 8.2 12.9 19.3 2.0 6.5 2.5 6.7 18.2 5.2 0.0 4.5 6.6 10.3 1.6 12.8 9.3 0.0 9.8 10.9 117.4 33.9 18.4 0.0 18.0 7.9 16.0 9.2 25.4 1.7 128.3 19.1 8.5 37.9 27.2 1.0 10.6 22.4 91.2 11.6 0.4 12.9 27.6 0.7 0.6 37.9 8.2 5.7 24.3 13.2 PLD3 HU-K4 ENSG00000105223 "Phospholipase D family member 3" Q8IV08 19 40348456-40380439 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 638.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 149.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 149.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012800, CAB020812" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA 490000 "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB020812: , HPA012800: AB_1855330" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.64e-3)" "unprognostic (2.56e-3)" "unprognostic (2.06e-3)" "unprognostic (2.68e-1)" "unprognostic (4.52e-2)" "unprognostic (3.89e-2)" "unprognostic (1.09e-1)" "unprognostic (4.60e-2)" "prognostic favorable (6.44e-4)" "unprognostic (4.34e-2)" "prognostic favorable (2.21e-4)" "unprognostic (3.49e-2)" "unprognostic (2.10e-1)" "unprognostic (1.38e-2)" "unprognostic (6.42e-2)" 45.7 57.5 44.6 23.1 79.0 12.8 21.9 35.5 126.1 31.2 23.5 25.4 17.1 22.6 26.3 35.0 18.3 30.0 30.8 33.0 46.4 73.4 22.1 25.6 49.7 25.2 44.7 53.9 44.8 42.5 32.9 122.1 38.9 62.2 29.6 16.1 31.6 35.3 37.2 27.4 24.2 23.5 25.6 28.6 48.9 23.0 17.0 19.3 11.9 20.6 11.2 12.9 27.3 20.7 3.6 23.0 149.2 24.6 9.7 7.8 16.8 14.1 43.7 28.3 44.5 78.9 37.6 21.6 35.1 35.8 25.5 29.2 8.3 16.0 6.1 36.9 30.5 8.3 6.6 6.8 13.8 11.2 22.9 24.9 6.6 15.0 10.4 53.9 2.7 75.9 71.5 28.9 19.4 13.4 42.8 21.4 10.1 23.3 24.9 18.3 18.5 4.8 13.1 18.5 23.2 9.0 6.1 21.6 25.2 13.1 10.6 20.3 33.8 16.8 10.4 18.8 30.9 14.3 47.6 37.6 21.5 10.3 18.2 7.8 26.0 27.7 6.3 34.6 11.0 13.3 149.2 24.6 35.3 7.8 12.8 6.4 3.6 6.2 6.9 23.0 3.1 6.5 6.5 2.5 9.7 5.7 3.3 6.1 16.8 44.6 79.0 35.5 126.1 46.4 73.4 44.7 53.9 62.2 19.3 29.8 62.9 34.4 70.6 31.5 98.5 18.5 25.5 12.0 28.4 54.1 31.4 137.8 18.3 50.7 5.8 46.8 52.7 0.0 51.3 94.8 142.4 49.1 59.9 35.8 638.2 114.4 69.9 90.9 219.8 8.6 140.4 84.2 87.7 44.1 36.8 99.5 49.7 41.2 135.1 30.0 39.3 19.4 53.1 13.9 57.5 29.2 163.8 35.4 34.5 52.0 PLEK2 ENSG00000100558 "Pleckstrin 2" Q9NYT0 14 67386983-67412200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 132.3;Pancreatic endocrine cells: 114.0;Suprabasal keratinocytes: 79.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 4.0;naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in single" 8 "T-cells: 6.5" "Cell line enhanced" "Detected in many" "A-431: 26.7;CAPAN-2: 28.6;HBEC3-KT: 53.3;PC-3: 19.5;TIME: 20.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA001208 Enhanced Uncertain Vesicles,Cytosol NA NA Vesicles Cytosol "HPA001208: AB_1079631" "unprognostic (4.41e-3)" "unprognostic (3.77e-1)" "unprognostic (1.15e-1)" "unprognostic (6.23e-2)" "unprognostic (6.88e-2)" "unprognostic (3.17e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.97e-1)" "unprognostic (9.21e-3)" "prognostic unfavorable (8.26e-5)" "unprognostic (1.06e-1)" "unprognostic (3.09e-3)" "unprognostic (2.90e-1)" "unprognostic (1.29e-1)" "unprognostic (8.98e-2)" "unprognostic (4.59e-2)" 1.7 28.8 0.5 7.6 1.1 4.1 1.5 0.5 0.8 2.4 14.9 1.4 1.6 12.4 1.1 14.9 9.7 0.4 7.4 0.5 0.5 0.2 6.0 29.1 1.9 0.5 0.5 0.5 1.0 16.5 2.5 0.9 2.6 0.7 5.1 12.7 0.9 6.9 2.3 1.4 12.1 28.1 1.2 0.7 0.6 8.5 2.4 0.5 13.9 28.6 6.5 6.5 4.8 4.4 0.0 0.8 0.0 0.1 0.0 6.5 1.2 26.7 4.0 0.0 0.0 0.0 0.3 2.7 5.4 0.8 1.3 1.6 14.6 28.6 0.0 5.3 0.7 0.0 12.8 0.0 53.3 3.0 0.0 0.2 0.0 6.2 0.1 1.1 0.0 0.0 0.6 3.8 1.4 17.1 0.0 4.4 0.0 0.1 0.1 0.9 8.5 0.0 0.0 0.1 17.3 19.5 0.0 0.0 4.1 9.1 0.7 0.2 0.0 5.1 2.4 1.5 0.2 3.5 0.2 20.7 0.0 16.7 0.1 0.1 0.0 0.0 0.1 3.4 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.7 0.8 0.0 6.5 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.5 1.1 0.5 0.8 0.5 0.2 0.5 0.5 0.7 0.5 0.0 0.6 0.0 20.4 132.3 0.0 0.3 5.1 1.4 3.4 5.2 0.0 0.9 3.3 40.6 0.1 0.7 36.5 0.0 41.0 5.1 9.3 10.8 0.0 9.4 7.0 0.0 8.1 0.0 1.0 0.0 0.3 15.0 20.3 9.0 44.7 0.0 114.0 21.0 0.0 1.6 0.0 0.0 5.1 0.3 0.9 79.3 1.3 0.0 46.5 23.8 PLEKHA2 TAPP2 ENSG00000169499 "Pleckstrin homology domain containing A2" 8 38901235-38973909 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004706 Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA004706: AB_1079633" "unprognostic (2.78e-1)" "unprognostic (8.80e-3)" "unprognostic (4.15e-3)" "unprognostic (3.03e-1)" "unprognostic (8.61e-2)" "unprognostic (9.07e-3)" "unprognostic (6.16e-3)" "unprognostic (1.45e-1)" "unprognostic (1.76e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-2)" "unprognostic (6.59e-2)" "prognostic unfavorable (1.95e-6)" "unprognostic (2.39e-2)" "unprognostic (1.00e-1)" "unprognostic (4.55e-2)" "unprognostic (9.60e-3)" 7.7 9.7 8.8 19.1 6.6 14.2 6.4 3.4 6.9 8.6 8.2 4.8 11.8 3.7 9.0 11.5 6.7 6.9 8.9 17.7 7.0 4.7 7.3 4.0 9.7 29.9 6.6 6.9 10.5 4.5 15.3 6.9 6.9 4.8 9.0 5.0 16.7 5.9 10.3 5.4 5.4 8.8 9.9 8.0 16.3 6.4 5.0 5.7 5.2 7.8 3.2 26.2 12.8 8.6 14.2 5.3 7.5 2.0 3.8 2.7 0.9 9.5 2.2 1.4 3.4 3.6 7.2 1.5 11.6 9.2 8.9 7.6 1.2 6.6 53.5 13.9 10.7 8.0 6.0 3.7 7.4 13.5 13.5 0.3 27.3 19.0 1.3 13.2 8.7 11.2 16.4 5.1 4.6 8.3 21.0 1.5 8.9 2.7 15.5 8.3 1.2 17.8 4.1 1.3 7.7 3.4 4.6 7.4 11.3 10.9 8.3 0.1 2.1 13.6 2.5 9.3 2.2 5.7 4.3 2.1 6.5 5.1 1.1 9.2 4.9 4.5 24.9 10.3 9.5 1.4 5.2 1.5 7.5 2.0 2.0 2.1 8.9 2.3 2.3 1.8 14.2 1.5 2.7 3.4 3.8 2.0 5.3 1.9 0.9 8.8 6.6 3.4 6.9 7.0 4.7 6.6 6.9 4.8 5.7 3.0 22.7 61.4 10.3 7.8 1.4 36.3 12.7 16.0 7.9 38.4 0.0 6.5 1.7 7.0 0.6 10.3 9.7 0.0 4.7 13.6 10.8 9.2 35.8 10.2 42.5 55.6 12.6 26.4 69.1 0.9 21.0 38.7 15.1 13.6 10.4 15.1 16.5 3.5 23.7 11.5 1.4 12.9 14.1 0.5 6.1 5.8 3.8 36.2 12.1 26.6 PLEKHA5 "FLJ10667, KIAA1686, PEPP2" ENSG00000052126 "Pleckstrin homology domain containing A5" Q9HAU0 12 19129752-19376400 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 290.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 14.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 27.2;NTERA-2: 27.8;SuSa: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035923, HPA035924, HPA041455" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035923: AB_10673491, HPA035924: AB_10672994, HPA041455: AB_2677490" "unprognostic (3.16e-1)" "unprognostic (8.35e-3)" "unprognostic (1.30e-1)" "unprognostic (4.85e-3)" "unprognostic (6.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.32e-1)" "unprognostic (2.35e-2)" "unprognostic (3.62e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (5.41e-5)" "unprognostic (3.71e-1)" "prognostic unfavorable (7.42e-5)" "unprognostic (1.27e-1)" "unprognostic (2.43e-1)" "unprognostic (4.03e-2)" "unprognostic (1.07e-2)" 7.7 52.3 13.8 7.8 22.0 2.9 11.9 13.0 22.4 23.5 9.8 7.2 19.4 10.0 23.1 25.7 16.0 16.0 16.7 25.2 11.2 11.5 32.2 12.1 9.9 2.4 10.7 16.3 26.1 11.3 27.2 14.4 10.2 15.0 17.6 10.8 22.2 11.4 22.7 2.0 13.2 10.0 23.1 23.7 2.8 13.7 14.8 13.0 6.1 11.5 5.9 4.3 18.1 18.1 0.4 2.7 14.8 0.4 1.7 6.4 0.4 10.7 5.3 19.4 0.2 6.6 8.9 6.9 4.6 10.0 2.8 4.4 7.9 9.7 0.2 1.5 5.1 5.7 4.6 13.0 8.5 5.9 27.2 4.6 6.4 11.8 3.8 6.2 0.2 0.9 5.2 9.0 8.0 15.3 15.4 3.0 5.5 2.7 0.4 2.9 3.3 4.1 0.8 27.8 8.7 2.8 0.1 9.0 0.1 19.6 12.7 1.8 4.0 4.4 2.6 16.4 27.5 3.2 1.5 4.5 1.8 7.7 0.4 0.2 0.3 0.2 0.2 4.2 0.1 3.5 14.8 0.4 0.3 2.7 0.3 6.4 0.2 2.5 2.3 1.8 0.4 0.4 1.9 1.0 1.7 0.2 2.7 2.1 0.4 13.8 22.0 13.0 22.4 11.2 11.5 10.7 16.3 15.0 13.0 23.8 23.3 2.7 42.8 18.2 89.3 123.9 50.9 72.3 50.0 43.6 129.6 22.7 29.9 26.9 20.2 15.5 24.5 0.0 28.7 34.1 41.5 27.0 3.5 36.2 5.8 119.2 31.2 16.5 8.6 11.8 37.4 12.0 111.3 290.4 12.7 99.2 39.4 30.6 26.5 85.1 145.1 32.3 27.2 41.2 47.8 22.5 22.1 10.7 33.8 41.1 PLEKHM1 KIAA0356 ENSG00000225190 "Pleckstrin homology and RUN domain containing M1" Q9Y4G2 17 45435900-45490749 "Disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 9.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025018, HPA039473" Approved Supported Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA025018: AB_1855465, HPA039473: AB_2676526" "unprognostic (1.52e-1)" "unprognostic (3.13e-2)" "unprognostic (4.29e-2)" "prognostic favorable (1.28e-6)" "unprognostic (8.71e-2)" "unprognostic (3.06e-2)" "prognostic unfavorable (3.25e-4)" "unprognostic (2.20e-2)" "unprognostic (1.88e-1)" "unprognostic (2.93e-2)" "unprognostic (4.02e-1)" "unprognostic (3.93e-2)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.60e-1)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" 8.0 3.6 2.5 3.6 4.5 10.9 5.3 7.6 5.6 6.1 4.1 2.6 0.9 2.2 2.9 2.0 17.2 3.7 3.8 3.9 4.2 1.7 1.7 3.1 4.5 7.3 10.5 2.9 2.5 4.2 3.5 3.6 2.8 4.7 2.6 3.0 3.4 7.6 2.7 6.3 5.8 3.4 2.5 5.3 4.5 3.0 2.4 3.4 6.7 3.8 6.5 10.4 5.2 6.7 2.4 1.3 9.8 1.4 1.3 1.4 0.9 5.2 7.6 1.3 2.5 5.4 2.6 4.7 1.5 3.5 2.7 2.8 2.4 2.8 2.7 4.6 5.0 13.2 1.4 3.1 1.9 0.8 10.6 3.7 0.0 2.8 3.1 5.7 0.0 4.0 10.2 6.0 4.3 7.1 2.3 8.0 2.1 2.6 3.1 4.3 3.3 5.2 1.0 0.8 15.5 5.4 2.3 2.8 2.4 3.9 8.1 2.3 2.1 2.6 2.0 2.9 2.5 4.7 2.3 9.2 6.5 2.5 4.9 2.7 3.2 3.4 1.1 3.7 1.3 2.7 3.8 1.4 1.3 1.4 1.0 0.8 2.4 1.0 1.1 1.3 1.0 0.7 0.6 9.8 1.3 1.3 1.0 1.2 0.9 2.5 4.5 7.6 5.6 4.2 1.7 10.5 2.9 4.7 3.4 11.9 21.5 8.3 16.6 16.0 9.3 7.2 12.7 8.1 12.5 12.2 15.7 3.8 5.0 7.1 4.0 8.7 14.8 23.3 7.0 4.0 7.3 22.8 1.1 6.8 7.8 15.9 13.2 9.2 24.5 1.4 6.6 12.6 6.8 4.6 11.8 6.3 12.8 14.4 7.4 6.3 8.0 0.0 7.1 5.9 3.4 14.3 7.2 13.8 10.1 35.7 PLGRKT "AD025, C9orf46, FLJ14688, MDS030, Plg-RKT" ENSG00000107020 "Plasminogen receptor with a C-terminal lysine" Q9HBL7 9 5357973-5437878 "Predicted intracellular proteins" "Chemotaxis, Inflammatory response, Plasminogen activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 74.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008214, HPA011144" Supported Uncertain Mitochondria NA NA Mitochondria "HPA008214: AB_1078363, HPA011144: AB_1078364" "prognostic favorable (5.56e-4)" "unprognostic (5.31e-2)" "unprognostic (2.96e-2)" "unprognostic (9.67e-2)" "unprognostic (1.05e-1)" "unprognostic (2.12e-2)" "unprognostic (1.72e-1)" "unprognostic (1.89e-2)" "unprognostic (3.85e-2)" "unprognostic (5.45e-3)" "unprognostic (2.19e-2)" "unprognostic (1.84e-1)" "prognostic favorable (5.09e-5)" "unprognostic (1.45e-2)" "unprognostic (1.47e-1)" "unprognostic (1.01e-1)" "unprognostic (2.02e-1)" 11.3 15.6 10.6 12.9 12.1 6.8 15.5 8.7 17.6 11.4 24.0 12.6 11.8 25.6 9.6 17.3 16.4 11.9 9.3 34.5 8.9 7.5 23.1 13.9 13.3 36.5 9.9 9.8 9.2 10.9 7.8 10.1 16.7 14.1 10.6 28.4 13.1 10.7 10.5 30.5 12.1 20.6 15.6 13.3 12.0 11.9 7.4 10.1 18.2 15.2 26.3 14.8 10.7 9.9 14.1 12.9 59.3 7.2 14.1 21.4 13.5 16.3 4.7 9.9 7.1 6.4 9.0 0.0 8.0 9.0 7.0 8.1 0.0 7.4 3.8 4.3 6.0 10.3 3.8 6.8 22.2 14.7 74.5 4.3 29.4 4.0 5.2 14.0 8.8 7.0 9.8 8.1 6.5 13.4 6.0 10.0 12.7 1.6 26.8 16.9 3.6 9.4 10.0 6.4 13.4 2.8 6.0 4.9 11.9 15.8 3.5 7.9 10.3 7.9 12.7 15.1 7.4 10.2 12.5 7.1 8.9 10.9 7.7 15.5 5.1 7.4 7.7 15.4 5.6 5.0 59.3 5.7 10.7 13.6 7.2 16.9 14.1 17.3 17.9 8.1 11.8 16.7 16.5 6.7 14.1 4.8 12.9 21.4 13.5 10.6 12.1 8.7 17.6 8.9 7.5 9.9 9.8 14.1 10.1 11.9 26.7 19.3 18.6 23.5 10.6 52.9 22.9 46.8 23.9 21.0 0.0 76.9 92.9 68.8 0.6 17.9 129.2 23.3 44.8 96.5 28.0 25.8 88.9 24.3 72.3 9.5 25.5 17.2 19.0 1.5 15.3 35.1 32.1 139.7 115.7 18.3 64.0 135.5 18.7 58.8 11.6 0.0 20.9 11.9 8.5 26.5 55.0 34.1 97.8 17.5 PLIN1 PLIN ENSG00000166819 "Perilipin 1" O60240 15 89664365-89679427 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adipose tissue: 187.5;breast: 62.6" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 49.1" "Cancer enhanced" "Detected in many" "breast cancer: 8.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 176 "ASC diff: 70.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA024299, CAB033821, CAB037333" Enhanced Uncertain Peroxisomes NA NA 8900 Peroxisomes "CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467" "unprognostic (4.62e-2)" "unprognostic (2.22e-1)" "unprognostic (2.13e-1)" "unprognostic (1.67e-1)" "unprognostic (1.90e-1)" "unprognostic (3.51e-3)" "unprognostic (9.89e-3)" "unprognostic (3.54e-1)" "unprognostic (7.01e-2)" "unprognostic (2.13e-2)" "unprognostic (8.00e-3)" "unprognostic (2.28e-3)" "unprognostic (2.62e-6)" "unprognostic (5.56e-2)" "unprognostic (1.22e-1)" "unprognostic (1.63e-1)" "unprognostic (4.85e-2)" 187.5 2.6 1.8 7.1 1.3 0.3 62.6 0.8 0.8 0.3 10.6 1.6 0.4 0.4 0.3 1.9 0.5 0.4 7.4 8.3 2.7 0.6 0.6 5.8 0.3 2.8 0.8 1.5 0.4 1.4 0.3 0.1 0.3 1.0 0.4 1.1 0.0 7.6 1.5 7.2 2.2 2.2 0.6 0.4 0.3 0.5 1.6 1.8 0.0 0.7 8.0 0.3 1.5 1.5 0.0 0.0 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 70.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.8 1.3 0.8 0.7 2.7 0.6 0.8 1.5 1.0 1.8 0.0 0.0 0.0 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 49.1 0.0 0.0 0.0 1.8 1.3 4.9 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 5.4 0.2 0.4 0.0 0.0 0.0 0.7 PLOD1 "LH1, LLH, PLOD" ENSG00000083444 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1" Q02809 1 11934205-11975538 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 215.9;Sertoli cells: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049137, HPA055799" Uncertain Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 2700000 Vesicles Nucleoplasm "HPA049137: AB_2680649, HPA055799: AB_2682924" "unprognostic (1.00e-1)" "unprognostic (2.69e-3)" "unprognostic (9.21e-3)" "unprognostic (5.43e-2)" "unprognostic (7.53e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (1.13e-3)" "unprognostic (1.23e-1)" "unprognostic (1.79e-1)" "unprognostic (4.15e-3)" "unprognostic (2.32e-1)" "prognostic unfavorable (1.91e-12)" "unprognostic (2.79e-1)" "unprognostic (7.12e-2)" "unprognostic (5.92e-2)" "prognostic unfavorable (2.43e-4)" 29.0 19.5 14.9 16.8 24.0 7.1 32.1 12.1 17.6 35.8 21.7 17.0 17.7 19.1 34.2 21.1 16.5 24.7 21.3 31.2 17.6 14.8 27.5 51.3 22.2 19.7 24.5 9.9 31.8 30.3 18.2 16.3 41.5 20.8 21.1 12.0 25.1 39.3 22.0 18.3 13.3 20.8 39.0 13.2 21.1 18.6 10.0 22.4 1.7 34.8 11.1 8.2 19.5 69.7 1.6 16.3 17.7 19.4 2.6 9.1 9.3 16.9 14.5 8.0 37.4 54.7 30.6 6.4 50.4 67.0 26.6 45.3 16.5 11.1 9.8 53.4 55.7 19.8 14.3 11.6 17.6 18.3 10.2 12.4 5.3 23.3 20.9 33.9 3.3 25.8 37.1 9.3 32.1 12.9 90.3 47.1 2.2 14.8 4.8 27.7 11.0 0.8 8.9 3.5 17.3 21.6 3.9 16.3 21.3 15.3 3.8 3.0 12.7 22.0 15.1 25.4 13.1 7.6 8.5 46.5 30.4 22.8 38.0 24.7 11.3 18.3 5.8 67.4 11.6 49.6 0.0 19.4 0.9 9.1 17.2 1.6 1.0 1.6 4.4 16.3 1.6 0.6 3.4 17.7 2.6 15.0 2.4 1.0 9.3 14.9 24.0 12.1 17.6 17.6 14.8 24.5 9.9 20.8 22.4 0.0 9.3 3.7 7.6 6.3 4.2 16.2 10.2 4.0 5.7 10.4 2.0 34.8 3.3 30.5 1.1 20.4 18.7 0.0 8.4 215.9 28.4 9.2 0.0 29.9 41.8 6.4 8.1 46.6 21.6 1.7 41.1 15.6 10.1 18.0 9.8 10.1 24.0 12.9 23.0 13.7 2.7 103.5 26.2 0.5 3.6 4.4 28.1 4.4 11.0 3.8 PLOD2 LH2 ENSG00000152952 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2" O00469 3 146069440-146163653 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 73.1" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 109.4;Pancreatic endocrine cells: 83.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.5" "Cell line enhanced" "Detected in many" "HBF TERT88: 82.6;hTERT-RPE1: 93.9;U-87 MG: 73.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB025898, HPA069126" Approved Uncertain Nucleoli,Cytosol "Intracellular and membrane" NA NA "Nucleoli, Cytosol" "CAB025898: , HPA069126: " "unprognostic (8.68e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (2.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.34e-2)" "unprognostic (1.29e-3)" "prognostic unfavorable (7.64e-10)" "prognostic unfavorable (1.42e-4)" "unprognostic (2.97e-2)" "unprognostic (3.36e-2)" "unprognostic (6.27e-3)" "unprognostic (2.24e-1)" "prognostic unfavorable (4.99e-11)" "prognostic unfavorable (2.83e-4)" "unprognostic (6.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.41e-3)" 36.7 14.1 11.2 18.0 12.1 0.7 28.5 7.9 13.5 8.8 25.2 5.1 8.3 21.6 14.8 7.5 12.0 8.0 22.3 16.6 12.5 8.2 16.4 73.1 9.3 3.0 10.7 4.8 17.7 14.4 13.9 7.8 41.0 13.0 11.1 16.1 7.2 7.7 11.3 4.8 3.2 24.7 24.2 19.4 3.2 13.6 6.3 10.9 6.1 47.6 3.5 3.0 21.8 28.7 0.0 0.0 1.5 0.3 0.0 0.0 1.9 16.4 11.8 3.7 1.2 13.5 14.5 9.4 58.5 17.9 31.9 60.2 0.9 1.7 0.0 11.4 9.9 14.6 3.5 4.3 50.3 82.6 0.0 6.8 4.1 11.5 8.2 34.7 0.0 0.0 25.4 7.2 27.6 13.5 93.9 44.0 0.0 5.4 0.2 56.3 6.0 0.0 0.0 2.3 0.0 5.1 0.0 2.4 0.0 13.4 0.8 1.8 0.0 46.6 5.0 4.9 18.1 13.6 0.5 55.2 39.5 12.0 12.5 34.9 17.9 2.5 0.0 73.6 0.0 7.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 11.2 12.1 7.9 13.5 12.5 8.2 10.7 4.8 13.0 10.9 14.9 10.7 0.5 5.9 6.3 14.5 10.6 61.1 12.0 13.6 26.2 33.4 6.8 8.3 62.8 0.4 21.2 46.1 0.0 45.9 109.4 34.5 8.1 0.0 50.8 4.7 0.0 19.0 18.4 1.5 1.3 12.0 2.7 13.5 1.0 18.3 65.1 83.0 31.5 4.6 6.9 22.4 19.4 38.1 8.0 16.3 4.8 15.7 0.7 21.3 5.4 PLPPR2 "LPPR2, PRG-4" ENSG00000105520 "Phospholipid phosphatase related 2" Q96GM1 19 11355386-11365698 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 32.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 32.3" "Cell line enhanced" "Detected in many" "U-2197: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048973 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA048973: AB_2680580" "unprognostic (1.29e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.90e-1)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (7.10e-2)" "unprognostic (1.37e-1)" "unprognostic (9.60e-2)" "unprognostic (1.72e-1)" "prognostic favorable (6.82e-4)" "unprognostic (2.23e-1)" "prognostic unfavorable (7.46e-11)" "unprognostic (1.99e-2)" "unprognostic (1.46e-1)" "unprognostic (4.37e-2)" "unprognostic (1.17e-1)" 12.0 17.1 32.5 10.5 39.9 14.1 6.6 17.7 51.2 14.0 11.1 10.8 5.1 6.0 12.7 8.4 8.4 9.7 13.7 10.4 37.0 22.3 5.5 18.0 10.0 5.4 11.8 17.9 15.2 12.4 11.7 22.7 11.5 12.3 18.5 5.1 11.8 13.1 15.1 23.1 16.2 5.7 16.8 10.5 10.6 9.3 7.6 9.4 0.5 7.7 4.4 3.3 9.8 8.1 0.0 2.9 32.3 7.2 0.0 0.3 2.3 8.8 5.5 3.0 12.6 12.8 12.3 0.8 15.8 14.7 9.8 10.1 1.0 1.6 1.7 9.4 20.1 2.0 1.6 1.7 4.7 5.3 4.6 3.2 0.5 3.8 1.0 6.7 0.5 18.0 11.0 8.6 8.4 1.6 14.2 6.6 2.8 8.5 14.1 8.2 13.1 0.2 2.4 3.3 3.0 30.7 0.2 0.4 4.8 4.6 4.2 3.3 10.9 6.6 5.7 3.3 1.0 8.2 11.3 7.6 22.2 4.7 37.5 8.3 8.8 5.4 0.6 21.6 8.1 8.7 0.8 7.2 3.7 0.3 6.7 0.0 0.0 0.1 0.0 2.9 0.0 0.1 0.0 32.3 0.0 4.4 0.1 0.3 2.3 32.5 39.9 17.7 51.2 37.0 22.3 11.8 17.9 12.3 9.4 6.0 8.8 0.5 5.5 0.0 5.1 0.0 7.6 2.7 2.3 3.5 11.8 0.5 1.7 6.2 11.0 6.9 0.0 0.0 7.6 2.1 2.1 16.2 2.3 6.7 4.0 7.9 16.4 8.0 9.7 8.2 13.3 3.9 0.0 0.0 2.5 15.3 7.5 0.0 15.6 1.3 6.3 6.5 0.0 1.8 4.9 0.0 2.4 0.0 0.8 4.1 PMAIP1 "APR, NOXA" ENSG00000141682 "Phorbol-12-myristate-13-acetate-induced protein 1" Q13794 18 59899948-59904306 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.3;bone marrow: 45.5" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 713.3;Suprabasal keratinocytes: 604.1;Urothelial cells: 478.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "basophil: 42.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 51.8;U-138 MG: 50.1" HPA051063 Uncertain Uncertain Vesicles NA NA Vesicles "HPA051063: AB_2681330" "unprognostic (1.35e-3)" "unprognostic (5.02e-2)" "unprognostic (5.57e-2)" "unprognostic (4.88e-2)" "unprognostic (6.65e-3)" "unprognostic (3.76e-2)" "unprognostic (2.00e-3)" "unprognostic (1.26e-2)" "unprognostic (4.41e-2)" "unprognostic (6.12e-2)" "unprognostic (8.47e-3)" "unprognostic (5.56e-2)" "prognostic unfavorable (3.15e-6)" "unprognostic (2.53e-1)" "unprognostic (7.68e-2)" "unprognostic (8.74e-2)" "unprognostic (1.09e-1)" 1.9 0.4 2.2 9.4 2.4 45.5 3.1 0.9 2.5 6.0 2.8 1.6 0.1 2.2 3.3 1.7 12.4 1.7 4.8 1.3 3.3 2.3 1.3 1.3 10.9 7.8 2.6 0.8 1.6 1.3 5.6 27.3 14.7 3.3 3.0 2.0 0.6 3.9 0.8 1.8 20.2 6.4 1.1 2.3 7.6 1.7 1.7 0.8 12.7 1.3 11.7 18.7 7.3 6.8 10.6 3.7 42.3 9.2 1.9 7.4 4.1 6.2 4.2 1.3 0.4 2.2 17.3 4.8 30.1 20.5 17.6 17.6 0.4 7.8 24.7 4.2 5.6 51.8 9.3 5.0 2.8 17.4 7.9 37.4 4.5 6.3 1.0 22.0 15.5 7.0 7.1 7.6 23.1 12.0 6.4 5.8 11.3 6.1 4.3 5.8 0.6 12.4 4.7 37.0 0.6 7.9 12.7 7.0 9.0 10.2 5.8 9.8 8.0 1.5 0.8 16.7 14.5 1.2 12.9 21.7 50.1 13.3 2.5 33.4 0.7 0.0 21.6 4.1 8.9 11.7 42.3 5.1 30.5 3.5 7.8 3.1 10.6 1.6 2.2 3.7 7.8 1.4 1.9 16.3 1.9 9.2 3.0 7.4 4.1 2.2 2.4 0.9 2.5 3.3 2.3 2.6 0.8 3.3 0.8 29.8 22.6 94.8 231.2 713.3 0.2 2.8 10.2 25.4 37.5 3.5 2.0 82.2 0.0 47.6 0.3 21.1 112.8 0.0 57.4 7.9 58.2 192.2 32.2 0.0 75.3 0.0 127.9 6.7 15.8 1.0 0.9 67.5 70.9 235.4 45.1 0.2 105.0 80.7 1.1 0.2 0.7 0.0 36.8 0.2 3.6 604.1 263.6 50.7 55.5 478.7 PMFBP1 ENSG00000118557 "Polyamine modulated factor 1 binding protein 1" Q8TBY8 16 72112157-72176878 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 13.6;testis: 30.8" "Group enriched" "Detected in some" 5 "Early spermatids: 98.0;Late spermatids: 189.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 21.0;SH-SY5Y: 10.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA056716, HPA075825" Approved Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA056716: AB_2683215, HPA075825: " "unprognostic (1.46e-1)" "unprognostic (3.62e-1)" "unprognostic (5.95e-2)" "unprognostic (1.04e-1)" "unprognostic (2.44e-2)" "unprognostic (7.03e-2)" "unprognostic (1.06e-4)" "unprognostic (1.60e-1)" "unprognostic (3.81e-1)" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (2.68e-5)" "unprognostic (9.85e-2)" "unprognostic (2.66e-1)" "unprognostic (9.85e-2)" "unprognostic (8.67e-2)" 1.1 0.9 1.1 1.1 1.1 3.9 1.1 2.1 1.1 1.1 2.1 1.1 1.1 2.6 1.1 13.6 1.6 0.9 1.1 1.1 1.1 0.7 1.3 1.6 1.1 1.5 1.1 1.1 1.5 4.2 2.9 1.5 1.1 1.1 2.1 3.3 1.1 1.1 1.1 1.1 4.1 2.9 1.1 1.1 2.9 1.1 30.8 1.1 1.1 1.1 1.1 1.1 1.1 1.1 0.5 1.9 0.9 2.0 0.0 0.3 0.2 0.2 0.4 2.8 2.5 0.0 0.6 1.8 0.5 0.2 0.5 2.1 1.0 2.6 1.8 0.4 0.1 0.1 1.8 1.0 0.1 1.3 0.2 4.2 1.8 3.0 2.9 0.0 4.1 3.2 0.0 0.8 0.1 2.1 0.6 0.8 2.1 0.3 1.6 0.1 2.3 1.0 6.0 0.8 0.1 1.2 2.7 0.2 1.4 0.3 0.7 21.0 10.5 0.0 0.0 0.2 2.0 0.5 2.6 1.7 1.3 2.1 0.6 1.3 3.9 1.4 1.2 0.6 2.7 0.7 0.0 1.6 0.9 0.1 0.5 0.0 0.0 0.1 0.2 1.6 0.5 0.1 0.1 0.2 0.0 2.0 1.9 0.3 0.2 1.1 1.1 2.1 1.1 1.1 0.7 1.1 1.1 1.1 1.1 0.0 1.1 0.0 0.1 0.3 0.0 0.7 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 98.0 0.2 0.0 0.0 0.2 0.1 0.2 0.1 3.5 0.0 4.6 28.6 5.2 0.0 1.0 189.3 1.1 2.8 0.0 0.0 0.3 1.3 0.1 0.0 1.4 0.3 0.1 0.0 0.1 1.6 0.8 0.0 0.1 0.0 0.5 0.0 PNMA6A "MGC15827, PNMA6C" ENSG00000235961 "PNMA family member 6A" P0CW24 X 153072482-153075018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3" "Group enriched" "Detected in some" 5 "Bipolar cells: 21.6;Distal tubular cells: 10.0;Horizontal cells: 22.3;Muller glia cells: 18.8;Proximal tubular cells: 20.3;Rod photoreceptor cells: 7.1" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 28 "granulocytes: 5.3" "Cell line enhanced" "Detected in some" "HHSteC: 8.0;HMC-1: 6.9;SK-MEL-30: 6.6;U-2 OS: 15.2;U-698: 8.3" "HPA045007, HPA052115" Uncertain Uncertain Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA045007: AB_2679181, HPA052115: AB_2681734" "unprognostic (2.14e-2)" "unprognostic (2.35e-1)" "unprognostic (2.33e-2)" "unprognostic (4.12e-3)" "unprognostic (4.39e-2)" "unprognostic (3.44e-2)" "unprognostic (9.27e-3)" "unprognostic (2.15e-1)" "unprognostic (1.85e-1)" "unprognostic (2.46e-1)" "unprognostic (7.76e-4)" "unprognostic (5.75e-3)" "prognostic favorable (1.93e-5)" "unprognostic (4.61e-2)" "unprognostic (3.04e-1)" "unprognostic (4.04e-3)" "unprognostic (3.22e-2)" 1.3 2.0 7.2 0.1 6.2 0.2 0.3 7.0 16.3 3.7 0.2 0.5 1.8 7.0 0.1 1.5 0.9 2.1 6.5 11.0 6.2 7.9 0.1 0.2 5.5 3.1 0.7 0.4 3.9 0.1 0.1 0.1 0.9 0.7 0.0 0.3 0.3 0.6 1.6 0.5 0.5 0.8 1.8 0.2 0.1 0.0 0.0 0.0 5.3 0.0 0.0 0.1 0.0 0.0 5.3 0.1 1.6 0.0 0.0 0.0 0.9 0.2 0.3 0.0 0.0 0.5 0.0 1.9 0.4 0.9 0.0 2.9 0.0 0.0 0.0 0.6 0.0 0.3 0.2 8.0 3.2 6.9 1.2 0.0 0.1 0.0 0.2 0.2 5.7 1.3 0.0 0.1 0.4 1.1 0.0 3.4 5.8 0.0 0.0 0.0 0.0 0.3 0.0 3.3 1.9 0.4 0.0 6.6 0.3 0.0 4.1 0.0 0.0 15.2 0.0 0.0 5.8 4.3 8.3 0.0 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 21.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 2.5 3.2 22.3 0.0 0.6 0.0 0.4 2.6 0.0 0.0 0.0 0.0 18.8 0.4 0.0 2.8 20.3 7.1 0.0 0.2 1.0 2.2 0.0 0.0 0.0 0.0 0.1 PNPLA7 "C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2" ENSG00000130653 "Patatin like phospholipase domain containing 7" Q6ZV29 9 137459953-137550534 "Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 16.6" "Cancer enhanced" "Detected in many" "prostate cancer: 9.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.6;T-reg: 3.5" "Group enriched" "Detected in many" 5 "B-cells: 3.6;T-cells: 3.5" "Cell line enriched" "Detected in some" 23 "HMC-1: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009130 Uncertain Uncertain "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA009130: AB_2268411" "unprognostic (1.49e-1)" "unprognostic (1.40e-2)" "unprognostic (3.61e-3)" "unprognostic (2.38e-2)" "unprognostic (3.68e-2)" "unprognostic (6.69e-3)" "unprognostic (2.72e-3)" "unprognostic (5.14e-4)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "prognostic favorable (2.24e-5)" "unprognostic (1.09e-1)" "unprognostic (2.23e-3)" "unprognostic (2.42e-1)" "unprognostic (6.80e-2)" "unprognostic (8.81e-2)" "unprognostic (3.45e-3)" 9.3 5.6 10.6 2.8 11.0 2.8 6.3 17.0 11.4 6.4 4.5 6.7 3.8 3.1 7.6 2.1 2.2 5.8 4.7 4.8 8.4 2.6 2.3 7.4 4.1 5.4 9.7 9.7 9.7 17.7 3.3 7.1 1.1 6.6 14.7 2.1 5.4 18.7 4.8 19.1 15.4 4.8 7.2 6.7 5.4 9.6 1.8 11.6 0.4 7.6 4.2 2.8 7.8 3.7 3.6 0.7 0.0 0.4 0.0 3.5 0.5 0.0 0.5 0.1 0.2 0.4 0.3 0.2 0.4 0.4 0.1 0.1 0.0 0.2 0.3 0.4 0.2 0.2 0.1 0.0 0.0 0.0 0.8 0.4 0.4 0.4 0.1 0.3 0.2 43.9 0.6 0.1 0.1 0.0 0.7 0.0 0.0 0.0 1.2 0.0 0.8 0.1 0.8 0.0 0.6 0.5 1.0 0.7 1.3 0.0 0.2 0.8 0.2 0.0 0.3 0.1 0.1 1.9 0.6 0.3 0.0 0.1 0.2 0.0 0.4 0.1 0.1 0.6 0.4 0.0 0.0 0.4 0.0 0.8 0.3 0.0 0.8 0.5 0.4 0.7 3.6 1.2 0.9 0.0 0.0 0.1 0.4 3.5 0.5 10.6 11.0 17.0 11.4 8.4 2.6 9.7 9.7 6.6 11.6 8.9 5.1 3.7 1.0 1.3 2.5 3.2 2.5 1.4 3.4 1.8 5.9 0.1 0.0 0.4 0.3 0.7 3.5 0.0 0.0 0.2 1.0 3.5 6.9 6.7 2.1 4.8 16.6 2.5 2.5 0.2 4.0 0.9 0.0 1.8 7.4 3.5 0.8 5.8 1.8 0.8 9.1 0.0 0.9 1.6 1.4 2.9 0.0 0.0 1.8 0.7 POLA2 FLJ21662 ENSG00000014138 "DNA polymerase alpha 2, accessory subunit" Q14181 11 65261762-65305589 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037570 Supported Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA037570: AB_10672280" "unprognostic (2.28e-1)" "prognostic favorable (4.61e-4)" "unprognostic (1.67e-2)" "unprognostic (7.44e-2)" "unprognostic (5.20e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.14e-1)" "unprognostic (2.87e-2)" "unprognostic (1.15e-2)" "unprognostic (4.05e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.09e-8)" "unprognostic (1.60e-3)" "unprognostic (8.26e-2)" "unprognostic (8.16e-2)" "unprognostic (6.25e-3)" 7.5 6.6 4.9 11.9 8.8 9.8 7.5 14.1 8.8 12.0 9.6 9.8 6.4 6.7 10.1 5.5 10.4 9.3 5.9 6.1 5.2 4.5 7.9 7.0 7.5 14.7 10.3 5.5 10.3 7.9 8.0 4.8 9.3 6.5 7.1 9.6 6.7 8.9 7.5 6.5 8.0 9.2 10.7 10.2 13.6 8.8 15.0 8.4 35.7 7.9 10.3 19.7 8.6 7.3 6.0 13.3 8.0 10.1 4.9 7.3 7.7 14.4 13.3 22.0 10.2 3.3 3.9 7.5 9.9 15.8 32.0 23.7 5.3 12.7 17.4 11.4 8.6 15.5 9.1 17.9 14.8 27.4 9.4 6.7 13.1 20.2 6.0 1.9 12.1 10.8 2.7 2.1 27.7 5.8 5.8 11.9 8.9 12.6 11.8 21.6 20.0 26.0 5.4 16.4 10.7 8.5 14.1 12.8 16.8 9.6 10.0 14.4 8.6 9.5 10.4 3.3 14.4 13.0 6.2 4.3 11.8 9.5 15.6 7.2 5.5 6.6 17.9 8.5 7.7 15.8 8.0 10.1 3.9 6.5 9.5 7.3 6.0 6.9 7.1 13.3 5.6 5.6 5.1 5.0 4.9 7.6 10.4 7.1 7.7 4.9 8.8 14.1 8.8 5.2 4.5 10.3 5.5 6.5 8.4 0.0 4.3 0.8 3.8 1.4 2.5 2.7 5.1 2.7 3.4 5.2 2.0 8.3 3.3 5.7 2.1 3.5 1.0 0.0 3.0 14.9 4.4 2.2 0.0 1.6 8.4 3.2 2.9 3.7 2.1 2.9 6.9 4.3 0.0 10.8 2.2 2.3 3.6 2.6 7.1 1.4 4.9 6.5 3.6 12.0 14.5 1.3 6.1 5.1 5.3 3.2 POLB ENSG00000070501 "DNA polymerase beta" P06746 8 42338454-42371808 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 73.6" "Group enriched" "Detected in many" 5 "Early spermatids: 173.0;Late spermatids: 102.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 73.6" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 81.2" "Low region specificity" "Detected in all" "CAB011616, HPA049104" Enhanced Uncertain Vesicles NA NA Vesicles "CAB011616: AB_731977, HPA049104: AB_2680632" "unprognostic (1.67e-1)" "unprognostic (2.68e-3)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.46e-4)" "unprognostic (8.49e-2)" "unprognostic (2.64e-2)" "unprognostic (4.24e-2)" "unprognostic (1.02e-1)" "unprognostic (2.31e-2)" "unprognostic (1.99e-1)" "unprognostic (4.57e-2)" "unprognostic (4.77e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (4.22e-2)" "prognostic favorable (5.65e-4)" 5.5 8.6 10.1 9.5 10.7 21.9 13.5 73.6 16.6 7.0 5.5 5.8 6.0 4.9 6.2 11.2 12.4 6.3 11.3 16.3 9.8 9.6 7.2 15.8 9.1 11.8 8.4 10.3 10.3 7.7 10.3 11.6 5.0 10.9 11.4 6.3 6.8 22.1 6.9 36.6 10.8 4.9 6.6 10.0 8.1 6.4 29.5 5.4 9.7 7.7 17.2 10.1 11.5 9.2 4.9 33.8 25.1 9.4 7.9 7.2 4.2 11.0 6.6 11.5 23.0 6.4 6.1 9.7 7.1 8.2 11.7 10.8 9.3 13.0 10.0 9.0 4.5 12.4 5.7 9.6 8.2 14.5 6.5 10.4 7.3 5.5 12.5 9.9 5.1 81.2 5.4 9.8 8.6 10.2 14.9 8.9 21.6 15.8 6.4 11.3 6.6 21.2 14.5 15.5 13.2 7.6 12.1 11.6 8.6 22.0 8.9 6.6 11.9 8.4 5.6 21.3 12.4 14.9 8.8 4.9 5.6 7.8 14.0 6.8 9.3 15.6 14.1 5.6 10.9 14.6 12.5 5.9 17.3 4.9 7.2 5.5 4.9 5.2 5.3 6.1 4.5 5.8 5.4 25.1 7.9 9.4 33.8 7.2 4.2 10.1 10.7 73.6 16.6 9.8 9.6 8.4 10.3 10.9 5.4 3.0 12.8 13.8 19.3 14.9 3.3 19.1 7.6 22.7 28.4 7.0 7.9 6.3 5.0 11.3 173.0 10.3 3.6 0.0 8.4 5.6 5.6 27.3 22.0 11.9 6.5 6.4 5.8 6.2 5.6 102.4 6.6 8.9 6.8 4.6 4.7 6.0 22.7 5.9 3.5 5.6 4.3 0.0 5.8 19.1 12.9 17.6 9.3 10.5 6.1 25.5 POLE POLE1 ENSG00000177084 "DNA polymerase epsilon, catalytic subunit" Q07864 12 132623753-132687365 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 25.8;Spermatocytes: 25.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 34.8" "Cell type enhanced" "Detected in some" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA058210, HPA067385" Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA058210: AB_2683639, HPA067385: AB_2685830" "unprognostic (1.60e-1)" "unprognostic (1.77e-3)" "unprognostic (2.00e-1)" "unprognostic (9.17e-2)" "unprognostic (1.68e-1)" "unprognostic (2.01e-2)" "unprognostic (3.96e-3)" "unprognostic (2.23e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (7.12e-2)" "unprognostic (2.21e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.19e-8)" "unprognostic (8.60e-2)" "unprognostic (3.18e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" 6.1 3.4 6.7 10.2 4.4 29.3 6.2 34.8 14.4 7.0 6.6 2.0 7.6 7.3 6.1 4.4 7.5 6.2 6.5 4.7 5.6 1.6 3.8 8.6 5.4 8.2 3.3 4.3 8.7 6.8 3.6 3.1 6.5 5.1 6.8 7.7 4.3 8.7 7.4 8.9 17.9 8.5 6.8 3.7 16.7 7.8 25.6 4.4 29.8 5.1 6.0 10.3 6.7 8.7 0.5 1.7 0.8 0.8 4.8 0.7 0.5 11.2 15.0 22.3 10.6 4.7 3.7 19.9 11.5 5.2 13.8 10.1 18.2 6.7 12.9 4.9 6.2 5.3 15.7 15.5 7.8 8.4 6.0 19.6 20.4 19.4 8.9 0.9 15.9 11.7 2.8 3.1 14.4 4.7 3.8 4.8 16.6 22.8 7.3 6.8 18.2 26.1 29.2 17.3 5.3 9.0 21.7 12.6 5.8 4.4 18.4 18.6 10.7 13.4 11.0 2.5 11.2 16.2 9.9 4.4 12.6 12.9 9.5 11.6 9.7 6.5 20.3 6.9 22.0 8.9 0.0 0.3 0.8 0.5 0.1 0.7 0.5 0.3 0.4 0.7 0.3 0.5 0.3 0.1 4.8 0.8 1.7 0.6 0.5 6.7 4.4 34.8 14.4 5.6 1.6 3.3 4.3 5.1 4.4 0.0 7.9 4.5 3.5 5.0 8.1 5.6 0.0 2.7 0.0 1.8 0.0 6.2 0.0 2.1 6.5 3.0 4.7 0.0 2.7 9.0 4.7 3.7 2.3 8.9 10.4 0.0 6.9 12.9 7.9 7.0 6.4 3.2 5.0 1.0 6.7 3.7 2.4 5.8 3.2 0.8 5.0 25.8 3.3 25.4 7.9 6.8 3.3 5.7 9.8 2.5 POLQ POLH ENSG00000051341 "DNA polymerase theta" O75417 3 121431427-121546641 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 9.5;lymphoid tissue: 21.4" "Cell type enhanced" "Detected in some" 10 "Club cells: 3.4;Extravillous trophoblasts: 2.8;Spermatocytes: 7.0;Spermatogonia: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 5.2" HPA053359 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes Nucleoplasm "Golgi apparatus, Cytosol" "HPA053359: " "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (2.70e-1)" "unprognostic (6.23e-3)" "unprognostic (3.09e-5)" "unprognostic (8.55e-3)" "unprognostic (1.09e-4)" "unprognostic (2.86e-1)" "unprognostic (5.59e-5)" "unprognostic (2.06e-3)" "unprognostic (0.00e+0)" "prognostic favorable (1.04e-4)" "unprognostic (1.76e-1)" "unprognostic (6.01e-2)" "unprognostic (5.76e-2)" 0.5 0.8 0.2 8.2 0.7 9.5 0.6 0.6 0.4 0.9 3.5 0.2 0.8 2.0 0.9 0.6 6.0 0.3 0.4 0.8 0.3 0.2 0.4 0.6 0.9 4.7 0.3 0.0 0.4 0.4 0.0 0.2 2.8 0.3 0.4 3.7 0.1 1.1 0.8 1.2 2.4 3.9 0.5 0.4 2.6 1.1 5.8 0.6 21.4 0.3 5.6 7.5 0.6 1.7 0.5 1.1 1.6 0.4 0.0 0.4 0.0 13.5 9.2 7.9 5.6 0.7 0.9 7.2 6.4 2.5 7.6 10.2 7.3 5.0 16.1 2.9 3.5 9.2 10.7 9.3 4.1 12.9 4.7 5.1 10.3 5.7 4.5 0.0 11.1 9.5 0.1 0.3 6.9 4.3 1.3 3.7 6.0 6.8 12.3 7.9 5.2 10.0 6.5 7.5 4.1 4.5 8.5 9.5 5.7 2.4 7.8 4.3 3.9 7.4 4.0 2.6 7.2 3.7 11.1 2.9 6.7 8.8 2.6 8.3 6.2 5.0 16.7 3.2 8.3 4.9 1.6 0.2 0.0 0.3 0.2 0.0 0.3 0.4 0.3 0.4 0.5 0.0 0.2 0.0 0.0 0.4 1.1 0.1 0.0 0.2 0.7 0.6 0.4 0.3 0.2 0.3 0.0 0.3 0.6 0.0 0.3 0.0 0.4 0.8 0.3 1.4 0.0 1.4 3.4 0.0 0.0 0.9 0.0 0.1 0.3 0.0 0.4 0.0 0.0 2.8 0.7 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.2 0.3 1.5 0.0 1.0 0.4 0.5 0.3 0.3 0.0 0.1 0.1 0.0 0.5 7.0 3.3 0.1 0.2 0.9 0.9 0.9 POLR1A "DKFZP586M0122, FLJ21915, RPA1, RPO1-4" ENSG00000068654 "RNA polymerase I subunit A" O95602 2 86020216-86106155 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010145, HPA031513, HPA049700" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" No No "Nucleoli fibrillar center" "Nucleoplasm, Intermediate filaments" "CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.55e-1)" "unprognostic (2.46e-2)" "unprognostic (1.32e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (3.70e-9)" "unprognostic (1.06e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.31e-2)" "unprognostic (4.56e-2)" "unprognostic (3.27e-1)" "unprognostic (2.20e-3)" "unprognostic (1.94e-1)" "prognostic unfavorable (8.41e-4)" "unprognostic (7.20e-2)" 14.3 12.9 10.1 12.4 16.5 9.7 10.3 12.2 20.3 11.1 11.0 17.4 8.3 9.4 19.5 7.4 13.5 12.3 11.7 12.7 9.0 9.2 11.5 15.1 9.4 9.6 9.0 9.4 12.6 14.3 18.2 15.9 11.4 13.8 10.7 11.8 13.9 11.2 12.5 22.5 12.3 8.6 16.0 8.0 11.2 10.4 14.9 10.9 14.0 10.3 11.4 14.2 10.9 9.6 2.6 2.6 1.8 2.5 2.0 3.8 1.2 9.4 21.6 9.6 18.5 9.5 7.6 14.0 8.7 5.8 12.6 7.8 27.0 7.5 21.7 9.3 8.9 12.2 11.0 24.7 12.9 11.2 9.0 12.8 18.7 9.2 18.1 6.7 17.7 10.1 5.8 8.1 18.6 14.5 4.8 9.7 10.1 24.7 5.5 8.6 8.4 13.1 7.5 17.5 12.7 14.3 15.8 21.1 10.2 5.6 15.5 15.0 7.8 9.6 12.8 6.9 6.9 7.5 6.2 15.4 15.3 12.1 13.0 17.5 7.8 7.5 19.0 7.9 15.3 13.4 1.8 1.5 0.2 3.0 2.5 3.8 2.0 1.5 2.5 1.8 2.6 1.4 1.8 0.7 2.0 1.9 2.6 0.7 1.2 10.1 16.5 12.2 20.3 9.0 9.2 9.0 9.4 13.8 10.9 3.0 7.8 6.1 2.9 3.8 11.5 7.8 15.3 6.7 3.4 8.7 15.7 5.7 3.3 5.9 2.4 5.7 4.2 0.0 4.0 4.4 3.8 4.3 5.8 7.2 10.2 11.1 9.2 4.9 2.8 1.5 5.8 3.1 5.0 1.8 6.1 2.9 5.0 0.0 4.9 3.0 10.1 0.0 4.7 4.2 7.5 2.4 3.2 4.4 9.0 3.7 POLR1B "FLJ10816, FLJ21921, RPA2, Rpo1-2" ENSG00000125630 "RNA polymerase I subunit B" Q9H9Y6 2 112541915-112577150 "Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 133.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037528 Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA037528: AB_10671627" "unprognostic (1.66e-1)" "unprognostic (3.17e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (2.71e-5)" "unprognostic (2.07e-1)" "unprognostic (1.16e-2)" "unprognostic (1.98e-3)" "unprognostic (1.98e-1)" "unprognostic (2.05e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (6.12e-2)" "unprognostic (1.29e-2)" "unprognostic (1.18e-1)" "unprognostic (2.19e-1)" "unprognostic (1.08e-1)" "unprognostic (3.56e-2)" 8.8 11.0 6.4 10.6 6.8 4.9 15.7 8.0 8.2 7.6 7.0 7.7 8.6 5.8 9.3 7.4 12.8 9.2 9.2 6.1 5.7 6.1 11.3 20.5 8.0 11.3 6.8 3.7 11.3 25.2 20.7 11.5 7.2 5.2 7.7 8.5 7.3 10.0 8.3 14.7 9.2 8.0 7.9 4.8 11.4 8.1 15.7 5.0 9.6 15.7 11.5 14.6 8.9 11.8 9.4 11.0 2.5 6.3 10.2 17.1 7.3 9.5 10.0 6.3 13.1 6.9 6.6 11.9 7.2 5.5 12.2 10.6 22.4 5.7 22.9 10.7 4.7 9.5 13.5 26.7 14.6 14.1 10.3 13.5 13.2 9.9 16.9 7.3 21.1 9.2 6.3 10.6 12.6 19.5 5.1 9.4 4.8 23.9 8.3 6.3 8.4 9.5 13.7 30.9 14.1 19.8 14.3 10.5 24.3 8.4 9.1 16.1 14.9 6.6 16.6 9.0 7.1 7.7 7.5 8.5 7.5 11.0 6.8 10.5 11.2 18.4 19.8 5.7 13.6 6.2 0.2 6.0 2.5 8.3 6.3 17.1 9.4 8.4 8.9 11.0 9.3 10.3 10.4 0.4 10.2 4.8 2.6 11.3 7.3 6.4 6.8 8.0 8.2 5.7 6.1 6.8 3.7 5.2 5.0 14.9 5.1 8.2 2.2 13.4 3.4 5.7 10.2 2.7 7.9 8.7 2.0 2.9 5.0 4.0 133.9 5.6 1.2 0.0 3.9 2.3 2.8 2.2 4.7 8.5 3.3 1.6 3.5 1.8 2.5 29.4 2.8 2.9 1.7 1.8 4.4 3.8 2.9 6.0 2.8 4.1 2.9 0.0 2.8 9.5 7.5 15.1 0.5 6.4 4.5 3.4 POLR2C RPB3 ENSG00000102978 "RNA polymerase II subunit C" P19387 16 57462387-57472010 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040919, HPA041826" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040919: AB_10795483, HPA041826: AB_10793935" "unprognostic (2.10e-2)" "unprognostic (4.42e-2)" "unprognostic (7.52e-3)" "unprognostic (1.82e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.48e-4)" "unprognostic (2.90e-1)" "unprognostic (9.54e-2)" "unprognostic (1.95e-1)" "unprognostic (2.48e-2)" "unprognostic (2.60e-2)" "unprognostic (6.63e-2)" "prognostic favorable (3.03e-6)" "unprognostic (2.29e-1)" "unprognostic (2.31e-2)" "unprognostic (1.20e-1)" "unprognostic (5.43e-3)" 26.2 30.1 24.2 18.4 26.9 23.9 25.8 34.1 37.6 27.2 22.9 28.8 23.1 21.5 26.0 45.0 26.2 30.3 29.9 32.6 24.5 25.9 38.3 44.8 29.9 30.2 25.0 30.1 37.2 39.4 33.7 35.0 29.2 25.5 29.2 26.0 29.6 30.4 31.4 47.5 23.7 27.9 26.1 24.1 22.4 25.2 26.4 21.9 30.5 35.8 27.3 27.1 27.5 22.2 21.8 16.2 41.7 19.8 26.2 28.6 21.9 17.7 29.4 24.6 22.3 22.3 20.1 21.9 23.5 25.6 37.7 24.9 37.6 22.6 20.1 27.6 25.8 22.9 18.7 32.5 24.7 42.0 9.2 24.2 15.4 17.6 42.8 25.3 27.9 29.7 18.0 20.4 28.7 26.6 20.6 22.7 27.5 26.7 11.4 24.6 24.5 30.9 29.6 36.9 21.4 44.8 45.1 29.2 35.6 30.5 17.6 31.3 36.5 38.0 21.3 24.6 24.2 16.2 25.8 17.5 23.8 24.3 18.1 26.7 26.3 22.5 40.9 24.0 24.1 31.4 24.8 17.3 29.0 20.7 16.4 22.6 21.8 23.6 19.1 16.2 20.9 28.6 26.8 41.7 26.2 19.8 13.2 22.5 21.9 24.2 26.9 34.1 37.6 24.5 25.9 25.0 30.1 25.5 21.9 23.8 34.7 45.5 39.7 27.5 84.3 9.7 33.1 28.1 14.8 26.2 53.0 65.7 77.9 47.3 3.0 36.0 36.6 0.0 57.8 72.3 37.6 40.0 61.0 18.5 36.7 49.3 36.7 22.1 18.6 6.6 47.8 21.9 38.8 64.9 27.6 87.9 46.7 36.8 48.8 96.7 87.2 45.3 39.2 40.2 65.5 26.2 77.7 42.4 33.6 35.9 POMT1 LGMD2K ENSG00000130714 "Protein O-mannosyltransferase 1" Q9Y6A1 9 131502902-131523806 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 49.7;Spermatocytes: 57.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065252 Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA065252: AB_2685445" "unprognostic (2.00e-3)" "unprognostic (2.02e-1)" "unprognostic (1.60e-1)" "unprognostic (5.09e-3)" "unprognostic (1.67e-1)" "unprognostic (7.97e-2)" "unprognostic (5.35e-3)" "unprognostic (1.14e-1)" "unprognostic (9.76e-3)" "unprognostic (2.84e-1)" "prognostic favorable (3.90e-5)" "unprognostic (8.36e-2)" "prognostic favorable (4.68e-5)" "unprognostic (2.41e-2)" "unprognostic (1.61e-1)" "unprognostic (4.72e-2)" "unprognostic (2.12e-1)" 9.5 12.3 21.6 10.6 18.8 10.2 10.2 34.2 22.4 10.0 12.1 16.9 14.6 11.2 15.0 14.6 8.8 14.6 13.0 15.2 25.8 17.9 13.8 12.8 10.6 13.2 15.0 16.5 17.2 16.9 17.1 18.0 12.9 15.2 16.0 11.6 13.3 19.5 17.1 28.2 16.6 11.9 12.1 13.4 12.3 10.7 49.9 13.4 8.7 11.6 5.5 11.0 7.8 9.5 2.8 5.1 3.4 3.8 3.8 10.8 4.9 6.7 10.8 9.9 16.6 12.7 10.3 17.8 7.8 9.7 12.5 8.6 11.4 9.5 2.1 9.5 18.0 5.7 15.3 12.1 8.5 6.6 11.1 17.2 3.9 25.5 7.9 15.0 10.0 8.7 7.2 7.7 8.3 2.8 14.8 10.8 13.8 6.8 11.5 12.5 18.0 9.4 22.9 5.7 5.6 13.6 10.9 9.3 16.1 11.0 2.0 11.2 9.9 13.3 15.5 7.8 6.7 22.7 10.1 11.7 9.9 2.1 17.9 6.6 7.2 6.2 3.5 5.9 18.8 8.1 0.0 3.8 3.4 7.4 3.6 10.8 2.8 7.2 7.4 5.1 2.7 6.7 5.5 0.5 3.8 3.3 3.1 7.6 4.9 21.6 18.8 34.2 22.4 25.8 17.9 15.0 16.5 15.2 13.4 8.9 20.2 7.3 4.8 3.9 11.9 8.5 10.2 4.0 6.8 12.2 7.9 18.5 1.7 9.9 49.7 7.1 12.3 0.0 5.8 10.1 7.1 5.3 2.3 9.7 9.1 20.6 7.5 6.7 5.3 24.3 8.1 5.7 5.0 10.0 8.2 14.1 7.3 3.5 9.6 9.0 16.9 6.5 6.0 57.0 7.9 2.6 14.6 6.9 8.0 2.0 POMT2 LGMD2N ENSG00000009830 "Protein O-mannosyltransferase 2" Q9UKY4 14 77274956-77320884 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003663 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA003663: AB_1079655" "unprognostic (2.15e-1)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.40e-4)" "unprognostic (7.10e-3)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-3)" "unprognostic (1.94e-3)" "unprognostic (8.50e-3)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.75e-3)" "unprognostic (3.46e-2)" 6.7 10.8 10.4 6.8 11.4 3.8 7.7 12.5 13.3 6.8 6.3 18.0 9.8 4.6 6.9 17.1 5.7 8.7 6.9 7.7 9.3 7.7 8.1 8.3 6.2 3.0 11.7 6.2 7.6 10.6 14.7 16.1 11.4 9.7 7.3 5.8 8.2 10.1 12.3 17.0 4.3 4.6 7.8 8.4 5.2 5.6 30.9 14.4 2.5 11.5 4.9 3.8 5.7 5.0 1.4 1.9 0.8 1.9 0.0 1.7 0.4 10.4 13.4 13.0 14.7 9.3 7.5 10.4 9.2 7.6 13.8 11.8 6.6 9.4 3.1 7.5 8.6 19.1 11.7 6.1 9.2 9.6 4.6 8.3 1.9 6.6 5.4 11.4 2.1 6.3 7.6 9.8 12.9 12.6 9.6 8.0 3.1 4.9 7.3 9.0 20.6 3.6 10.1 3.7 14.5 11.3 3.5 12.7 2.8 14.3 7.7 11.0 10.8 6.0 10.2 7.7 8.9 10.5 4.4 6.6 10.4 16.4 12.0 8.0 4.8 9.4 1.4 5.3 3.2 9.1 0.0 0.4 0.0 1.7 1.9 0.4 1.4 0.0 0.3 0.9 0.2 0.1 0.0 0.8 0.0 0.8 1.9 0.0 0.4 10.4 11.4 12.5 13.3 9.3 7.7 11.7 6.2 9.7 14.4 6.0 3.2 2.2 2.3 2.7 6.5 4.0 5.1 0.0 0.0 1.8 15.7 5.0 0.0 6.6 8.0 2.8 3.9 0.0 6.4 8.6 6.0 3.5 2.3 4.4 4.8 7.9 17.2 3.1 2.4 12.1 1.7 2.2 1.7 3.6 3.0 8.2 5.8 1.9 3.9 3.0 15.0 0.0 3.9 9.8 8.5 1.6 4.8 0.0 2.6 1.4 POU1F1 "GHF-1, PIT1, POU1F1a" ENSG00000064835 "POU class 1 homeobox 1" P28069 3 87259404-87276587 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 49 "pituitary gland: 138.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.8;SiHa: 1.1;U-87 MG: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA041646, HPA050624" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041646: AB_10794672, HPA050624: AB_2681192" "unprognostic (1.88e-1)" "unprognostic (2.06e-1)" "unprognostic (4.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.60e-1)" "unprognostic (2.93e-1)" "unprognostic (1.87e-2)" "unprognostic (7.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.50e-1)" "unprognostic (4.69e-3)" "unprognostic (1.55e-1)" "unprognostic (1.52e-2)" "unprognostic (1.87e-2)" "unprognostic (1.22e-1)" "unprognostic (1.05e-4)" 0.3 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 138.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.8 0.3 0.1 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.4 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 1.1 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.7 0.2 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 POU6F1 "BRN5, MPOU, TCFB1" ENSG00000184271 "POU class 6 homeobox 1" 12 51186936-51217708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 9.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 8.7" "Low region specificity" "Detected in all" "HPA047021, HPA050411" Enhanced Supported "Nuclear bodies,Actin filaments" NA NA "Nuclear bodies" "Actin filaments" "HPA047021: AB_2679905, HPA050411: AB_2681119" "unprognostic (4.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.48e-3)" "unprognostic (1.45e-2)" "unprognostic (2.72e-1)" "unprognostic (6.58e-2)" "unprognostic (9.70e-2)" "unprognostic (7.11e-3)" "unprognostic (4.45e-1)" "unprognostic (2.05e-1)" "prognostic favorable (6.61e-4)" "unprognostic (2.48e-2)" "unprognostic (9.36e-2)" "unprognostic (2.09e-3)" "unprognostic (1.74e-1)" "unprognostic (2.02e-1)" "unprognostic (2.33e-1)" 8.2 6.9 8.4 5.1 11.6 2.8 5.7 17.6 21.8 8.5 5.6 6.4 2.4 3.7 7.1 2.3 3.9 5.9 5.6 3.5 8.2 4.6 5.2 2.8 5.5 4.1 10.0 8.3 12.4 6.1 3.1 6.2 3.3 8.1 6.9 2.2 5.0 8.4 6.9 13.6 5.6 5.7 6.6 6.6 6.3 3.8 2.4 10.1 0.0 7.5 1.2 3.0 4.7 6.2 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.6 1.3 1.8 2.4 0.6 2.2 1.0 0.8 1.0 1.1 1.3 0.3 0.9 3.2 0.3 0.7 0.5 0.0 2.2 0.1 0.0 4.8 3.1 0.8 1.7 0.0 1.8 0.8 4.4 1.2 0.9 1.8 0.3 2.6 3.6 1.3 1.1 8.7 0.5 0.0 0.4 1.1 3.0 0.0 0.0 1.0 1.0 0.0 0.6 0.0 2.3 4.0 2.0 0.0 4.3 0.9 0.9 2.9 2.7 2.0 1.6 0.6 2.2 5.6 4.4 0.4 1.8 0.8 0.7 0.0 0.0 0.0 1.0 0.0 0.1 0.8 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 11.6 17.6 21.8 8.2 4.6 10.0 8.3 8.1 10.1 6.0 3.2 0.8 1.4 2.7 9.3 2.6 0.0 4.0 2.3 7.0 3.9 0.5 1.7 0.8 3.2 3.3 0.0 0.0 1.7 0.2 2.1 1.6 4.7 1.0 0.3 1.6 0.0 3.1 0.6 2.9 5.5 1.0 1.7 2.8 0.2 3.4 1.8 0.0 6.3 0.3 7.6 0.0 2.8 0.0 0.4 2.5 0.3 0.7 0.6 0.6 PP2D1 "C3orf48, FLJ25449" ENSG00000183977 "Protein phosphatase 2C like domain containing 1" A8MPX8 3 19979961-20012330 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 28.8" "Group enriched" "Detected in some" 83 "Early spermatids: 319.7;Late spermatids: 185.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/84: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036870, HPA066083" Enhanced Uncertain "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA036870: AB_10671246, HPA066083: AB_2685611" "unprognostic (1.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (2.04e-1)" "unprognostic (3.76e-1)" "unprognostic (6.27e-4)" "unprognostic (3.29e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (3.40e-1)" "unprognostic (4.35e-2)" "unprognostic (6.00e-2)" "unprognostic (3.50e-1)" "unprognostic (8.77e-2)" "unprognostic (1.87e-1)" "unprognostic (4.93e-3)" "unprognostic (1.04e-1)" 0.2 0.1 0.1 0.2 0.1 3.0 0.1 0.7 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.3 0.3 0.2 0.1 0.1 0.3 0.2 28.8 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.7 0.5 1.2 0.6 0.0 0.9 0.0 0.3 0.6 0.7 0.9 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.5 0.8 1.5 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.2 0.6 0.6 0.9 0.2 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.5 0.7 0.0 0.2 1.0 0.8 1.0 0.4 0.3 0.9 0.9 1.6 0.0 0.3 0.4 1.9 0.1 2.3 1.4 1.1 0.7 0.8 0.3 0.0 0.3 0.3 0.5 0.6 4.1 1.6 1.8 0.8 0.3 0.0 0.5 0.9 0.8 0.6 0.3 0.2 0.5 0.4 0.1 0.7 0.9 0.8 1.2 0.0 0.4 0.5 0.0 0.0 0.1 0.1 0.7 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 319.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 3.1 1.3 0.0 0.0 0.0 0.0 0.0 PPARGC1B "PERC, PGC1B" ENSG00000155846 "PPARG coactivator 1 beta" Q86YN6 5 149730298-149855022 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Bipolar cells: 105.6;Cone photoreceptor cells: 127.6;Rod photoreceptor cells: 72.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050543 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA050543: AB_2681165" "unprognostic (2.86e-1)" "unprognostic (1.07e-2)" "unprognostic (5.09e-3)" "unprognostic (1.13e-3)" "unprognostic (2.63e-1)" "unprognostic (2.00e-3)" "unprognostic (4.51e-3)" "unprognostic (6.55e-2)" "unprognostic (9.14e-3)" "unprognostic (2.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.21e-1)" "unprognostic (9.01e-6)" "unprognostic (8.45e-2)" "unprognostic (5.09e-2)" "unprognostic (1.51e-1)" "unprognostic (2.77e-3)" 4.5 2.4 3.9 9.5 7.1 4.3 3.5 16.3 8.7 3.9 15.6 1.6 16.3 13.1 5.4 2.6 9.0 5.5 6.2 10.0 3.3 4.1 2.3 3.7 7.4 3.0 3.3 4.8 3.2 3.4 17.7 2.0 3.2 7.2 6.4 11.6 7.6 4.0 19.7 10.3 6.6 16.6 18.6 2.7 4.2 7.9 2.0 1.3 2.2 1.7 8.4 5.8 11.5 5.6 1.9 2.4 2.2 6.2 0.8 0.7 0.5 0.5 1.9 0.8 4.6 1.8 0.6 7.4 0.3 0.0 0.5 0.7 8.3 1.9 9.0 1.3 0.0 2.1 5.6 6.8 3.4 0.6 0.5 5.9 8.4 3.2 1.7 0.5 11.5 3.4 0.9 4.6 1.8 3.1 0.3 1.0 4.0 5.7 3.0 0.4 2.2 4.2 5.4 3.0 2.5 4.9 8.0 5.0 5.0 1.4 11.0 2.5 0.6 1.3 9.8 1.5 1.4 2.6 3.8 1.3 1.1 1.7 3.7 1.8 3.7 2.7 5.3 2.3 7.3 0.9 1.0 2.0 0.7 0.4 3.8 0.7 1.9 0.4 0.3 2.4 0.9 0.6 0.6 2.2 0.8 6.2 0.3 0.3 0.5 3.9 7.1 16.3 8.7 3.3 4.1 3.3 4.8 7.2 1.3 0.0 0.6 1.5 3.2 4.5 105.6 18.8 2.5 0.0 1.2 1.8 127.6 1.5 1.7 0.2 0.2 3.5 17.2 0.0 0.7 1.2 1.8 1.7 1.1 3.4 6.9 7.9 5.2 5.5 9.5 0.0 1.4 8.3 3.3 1.0 8.5 3.6 0.5 3.5 0.4 1.9 72.0 6.5 6.1 0.2 3.2 9.4 4.1 0.0 19.0 3.4 PPEF1 "PPEF, PPP7CA" ENSG00000086717 "Protein phosphatase with EF-hand domain 1" O14829 X 18675909-18827921 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;testis: 20.2" "Group enriched" "Detected in some" 11 "Early spermatids: 51.1;Late spermatids: 94.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 3.6;HAP1: 1.3;HeLa: 5.3;SH-SY5Y: 2.9;SK-MEL-30: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034577 Uncertain "Plasma membrane,Cytokinetic bridge" Yes NA "Plasma membrane" "Cytokinetic bridge" "HPA034577: AB_10602817" "unprognostic (4.13e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-2)" "unprognostic (9.85e-2)" "unprognostic (3.84e-2)" "unprognostic (5.00e-2)" "unprognostic (2.38e-1)" "unprognostic (3.43e-2)" "unprognostic (4.96e-3)" "unprognostic (9.29e-2)" "unprognostic (1.70e-1)" "unprognostic (2.89e-1)" "unprognostic (1.10e-11)" "unprognostic (5.41e-3)" "unprognostic (2.75e-1)" "unprognostic (2.97e-2)" "unprognostic (1.19e-2)" 0.1 0.5 3.1 0.2 6.4 1.4 3.9 0.2 10.6 0.2 0.2 0.1 0.0 0.1 0.3 0.9 0.2 0.2 0.3 0.3 1.9 1.0 0.3 0.1 0.4 0.3 1.7 6.9 0.2 0.2 0.1 0.7 1.0 0.2 0.5 0.1 0.0 0.3 0.6 0.1 0.7 0.1 0.2 10.5 0.3 0.1 20.2 0.0 0.1 0.4 0.0 0.3 0.4 0.1 0.2 1.3 0.0 0.9 0.0 0.0 0.2 0.0 3.6 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.3 1.2 0.0 5.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.3 2.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.1 6.4 0.2 10.6 1.9 1.0 1.7 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 51.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 6.4 0.0 0.0 0.0 94.3 0.6 0.0 3.3 0.0 0.0 0.5 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 PPFIA3 "KIAA0654, LPNA3, MGC126567, MGC126569" ENSG00000177380 "PTPRF interacting protein alpha 3" O75145 19 49119389-49151026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 22.1;pituitary gland: 14.9;skin 1: 25.3" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 35.8;Horizontal cells: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 6 "T-cells: 1.1" "Cell line enhanced" "Detected in many" "OE19: 14.1;PC-3: 22.8;SK-BR-3: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043567, HPA050340" Enhanced Uncertain "Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center, Vesicles" "HPA043567: AB_2678558, HPA050340: AB_2681096" "prognostic unfavorable (3.09e-4)" "unprognostic (4.70e-2)" "unprognostic (5.14e-3)" "prognostic favorable (8.65e-4)" "unprognostic (3.46e-1)" "prognostic favorable (6.46e-7)" "prognostic unfavorable (2.24e-5)" "unprognostic (1.27e-1)" "unprognostic (8.36e-2)" "unprognostic (9.41e-3)" "unprognostic (5.21e-3)" "unprognostic (8.52e-2)" "unprognostic (1.00e-2)" "unprognostic (1.22e-2)" "unprognostic (1.52e-1)" "unprognostic (3.92e-2)" "unprognostic (1.32e-1)" 1.6 3.9 13.9 1.6 9.3 0.9 2.2 22.1 20.8 1.2 4.3 1.6 1.7 5.1 1.6 1.1 4.4 1.3 1.4 1.4 12.8 12.2 1.1 1.6 1.8 1.6 7.4 13.7 1.0 4.9 4.1 14.9 1.1 7.3 3.4 2.0 1.6 2.7 1.6 1.7 25.3 4.6 1.2 2.4 1.3 2.3 2.1 1.8 0.0 1.8 1.2 2.2 1.1 1.9 0.0 0.0 0.0 0.0 0.2 1.1 0.3 1.9 2.0 2.0 5.0 0.0 0.0 3.9 0.2 0.2 1.0 1.4 1.4 0.8 4.5 2.7 0.2 1.5 1.0 3.1 0.4 0.2 4.8 6.8 2.8 1.8 1.0 0.2 1.1 7.2 0.2 1.1 0.6 0.3 0.4 0.0 7.5 5.4 7.1 0.1 8.7 1.4 1.9 0.9 14.1 22.8 4.5 4.0 2.1 0.3 1.0 4.2 5.7 0.8 18.7 1.9 0.0 10.3 2.7 0.4 1.1 3.9 0.7 0.1 13.2 10.8 3.3 1.1 4.4 2.5 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.4 0.0 0.0 1.1 0.2 0.0 0.2 0.0 0.0 0.0 0.3 13.9 9.3 22.1 19.8 12.8 12.2 7.4 13.7 7.3 1.8 0.0 1.1 0.0 6.2 6.4 35.8 3.7 7.6 0.0 1.2 5.2 13.7 0.4 16.6 1.6 0.9 13.5 15.1 23.3 3.7 1.9 3.4 21.2 0.0 7.6 2.1 41.3 25.4 26.4 2.4 1.1 5.2 0.8 15.1 0.0 23.8 14.6 1.9 11.0 3.5 3.6 15.4 0.0 3.3 2.3 5.2 10.3 0.5 0.0 19.0 5.0 PPIG "CARS-Cyp, SCAF10, SRCyp" ENSG00000138398 "Peptidylprolyl isomerase G" Q13427 2 169584340-169641406 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021788, HPA057469" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA021788: AB_1847408, HPA057469: AB_2683445" "unprognostic (2.70e-1)" "unprognostic (2.17e-1)" "unprognostic (2.40e-1)" "unprognostic (2.04e-3)" "unprognostic (4.17e-2)" "unprognostic (3.49e-2)" "unprognostic (1.55e-3)" "unprognostic (3.66e-2)" "unprognostic (2.15e-3)" "unprognostic (3.15e-3)" "unprognostic (2.47e-2)" "unprognostic (2.28e-1)" "prognostic unfavorable (4.56e-4)" "unprognostic (5.23e-2)" "unprognostic (3.29e-1)" "unprognostic (3.41e-2)" "unprognostic (3.39e-2)" 26.2 25.3 28.5 23.8 45.3 39.2 26.7 45.0 40.7 33.1 27.1 14.6 26.0 25.3 27.1 28.1 29.4 24.3 21.2 24.2 30.0 20.3 26.0 41.1 25.5 30.4 27.7 35.9 29.5 22.8 39.4 56.7 26.0 38.0 29.3 23.9 13.8 28.6 28.8 27.8 24.5 30.8 31.9 39.7 29.7 24.1 19.8 33.7 24.1 28.4 22.6 29.9 37.4 27.6 36.4 23.7 41.7 24.7 18.7 29.6 13.3 19.5 9.3 26.3 14.4 14.6 17.9 24.8 22.4 16.8 16.5 17.1 25.4 22.6 33.7 20.6 16.1 20.7 18.8 20.6 18.3 24.5 23.4 16.6 50.7 13.9 30.9 14.1 47.7 22.6 15.0 20.7 22.4 25.2 15.7 18.1 20.6 48.9 28.2 18.8 15.8 35.2 29.3 37.7 15.9 9.5 32.4 26.3 32.9 20.4 29.4 23.0 15.2 24.0 17.9 24.3 21.1 16.7 27.6 20.8 21.6 16.5 14.4 18.3 16.4 23.6 47.1 15.9 25.6 19.7 20.7 20.0 29.9 20.3 20.1 23.2 27.6 27.0 23.8 14.9 36.4 29.6 23.7 41.7 18.7 24.7 23.7 22.9 13.3 28.5 45.3 45.0 40.7 30.0 20.3 27.7 35.9 38.0 33.7 205.4 160.5 152.0 169.4 134.5 178.8 130.1 61.1 132.5 155.8 89.0 51.1 146.0 68.0 90.9 6.8 121.2 97.1 70.0 90.5 147.9 117.4 133.0 172.3 157.2 134.3 208.2 100.6 106.2 118.2 8.4 131.5 135.1 104.6 124.4 115.6 123.1 82.2 108.7 137.9 99.6 103.2 161.7 154.6 225.0 148.0 150.9 171.9 152.4 132.6 136.1 PPP1CB "PP-1B, PP1B, PP1beta" ENSG00000213639 "Protein phosphatase 1 catalytic subunit beta" P62140 2 28751640-28802940 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022558, HPA065425, CAB069426" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 7700000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB022558: , CAB069426: , HPA065425: AB_2685489" "unprognostic (2.90e-1)" "unprognostic (5.03e-2)" "unprognostic (5.49e-2)" "unprognostic (2.00e-1)" "unprognostic (7.08e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (6.52e-6)" "unprognostic (3.47e-2)" "unprognostic (2.44e-1)" "unprognostic (3.15e-2)" "unprognostic (1.54e-3)" "unprognostic (3.95e-1)" "unprognostic (1.68e-1)" "unprognostic (3.66e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-1)" "unprognostic (2.26e-2)" 28.5 22.6 30.0 20.5 37.6 29.5 32.4 19.1 29.8 51.1 39.3 21.1 30.7 24.4 58.0 31.8 86.0 37.0 33.3 67.1 27.8 27.9 32.0 20.0 35.3 22.3 27.4 24.4 39.7 21.9 48.9 28.7 42.3 22.0 46.4 27.7 25.2 36.5 38.6 99.6 25.1 30.0 100.8 27.5 25.2 31.4 25.5 21.4 28.1 27.5 32.9 25.3 82.1 50.5 15.6 25.4 41.5 42.7 23.5 28.3 17.9 37.1 23.4 81.7 25.2 28.0 26.1 47.6 20.0 22.8 19.5 19.3 20.7 22.0 29.7 25.1 20.6 21.6 23.0 23.2 26.7 23.2 47.1 12.0 22.5 28.8 22.4 61.0 25.4 10.6 20.0 38.0 21.0 44.0 20.5 23.5 15.8 20.4 29.5 25.5 18.6 26.9 22.0 26.8 28.6 18.6 26.4 72.4 22.6 63.3 44.9 22.4 27.7 31.0 34.6 27.1 24.4 16.7 14.2 28.1 26.1 28.7 18.6 24.0 21.1 33.1 60.9 27.7 27.4 19.3 22.5 24.8 32.1 16.8 37.8 21.3 15.6 25.5 19.6 25.4 13.4 22.7 25.5 41.5 23.5 42.7 19.6 28.3 17.9 30.0 37.6 19.1 29.8 27.8 27.9 27.4 24.4 22.0 21.4 86.4 80.7 105.5 134.5 437.2 53.8 298.4 104.4 129.8 72.8 294.8 25.5 104.9 207.2 242.7 375.6 106.2 128.9 163.5 183.3 167.5 182.4 291.0 146.3 81.8 104.3 154.1 271.6 108.6 144.9 304.1 182.1 233.4 318.9 92.8 133.9 100.9 238.2 181.4 283.9 113.6 53.2 620.9 265.8 57.5 61.8 400.4 328.6 110.8 99.3 394.6 PPP1R15A GADD34 ENSG00000087074 "Protein phosphatase 1 regulatory subunit 15A" O75807 19 48872392-48876057 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Stress response, Translation regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 156.9" "Cell type enhanced" "Detected in all" 4 "Smooth muscle cells: 862.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 69.8" "Group enriched" "Detected in all" 5 "dendritic cells: 23.8;granulocytes: 69.8" "Cell line enhanced" "Detected in all" "HHSteC: 55.5;hTERT-HME1: 95.7" "Low region specificity" "Detected in all" "CAB018395, HPA020240" Approved Uncertain Vesicles NA NA Vesicles "CAB018395: AB_2237473, HPA020240: AB_1849404" "unprognostic (2.43e-3)" "unprognostic (3.21e-1)" "unprognostic (7.75e-2)" "unprognostic (1.17e-3)" "unprognostic (2.22e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (1.95e-4)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.16e-3)" "unprognostic (5.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.22e-1)" "unprognostic (6.43e-3)" "unprognostic (1.49e-1)" "unprognostic (1.29e-2)" "unprognostic (6.94e-2)" 39.8 29.1 16.2 33.6 12.9 156.9 56.3 12.1 12.8 26.3 19.7 13.6 12.0 12.0 37.8 19.5 28.2 34.0 32.3 42.0 14.6 13.9 18.6 18.6 56.5 10.6 29.5 6.3 24.5 10.9 9.8 16.2 44.7 31.5 28.2 15.6 12.4 9.2 23.6 35.2 40.0 16.0 36.2 17.7 13.3 19.8 14.5 17.8 3.4 18.6 46.7 19.0 41.1 114.7 8.1 23.8 69.8 10.3 2.5 6.1 6.6 10.1 4.4 4.7 3.9 13.9 7.9 7.5 17.8 28.0 20.4 18.6 6.7 5.2 3.5 4.8 12.8 28.1 7.3 1.7 9.3 15.5 1.9 2.7 15.9 2.5 3.3 55.5 3.6 22.9 10.8 25.9 28.1 95.7 9.2 10.6 4.0 21.3 29.6 13.1 1.1 2.0 5.1 1.1 18.5 8.0 2.3 4.4 1.1 4.2 11.9 2.7 4.6 9.2 6.3 40.3 5.2 2.2 6.6 11.3 24.4 6.1 17.0 10.9 15.9 12.6 3.3 8.9 2.5 29.2 27.4 10.3 17.7 4.9 6.3 4.3 8.1 4.8 4.0 7.3 5.5 2.7 2.4 69.8 2.5 7.1 23.8 6.1 6.6 16.2 12.9 12.1 12.8 14.6 13.9 29.5 6.3 31.5 17.8 268.0 205.4 97.6 586.8 428.3 24.0 122.8 56.0 235.5 175.1 12.2 33.4 76.9 3.3 199.0 3.9 212.9 352.3 46.7 84.3 175.7 303.2 750.2 686.4 11.0 180.2 33.4 163.8 100.7 105.3 3.6 54.4 379.2 376.2 163.3 114.7 30.7 160.5 315.6 21.5 6.2 26.9 84.1 862.1 4.9 11.1 376.8 241.2 156.6 127.8 653.4 PPP2R2B "B55beta, PR52B, PR55-BETA, SCA12" ENSG00000156475 "Protein phosphatase 2 regulatory subunit Bbeta" Q00005 5 146581146-147084784 "Disease related genes, Predicted intracellular proteins" Apoptosis "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 73.2" "Cell type enhanced" "Detected in many" 20 "Cone photoreceptor cells: 141.4;Early spermatids: 312.5;Late spermatids: 670.1;Rod photoreceptor cells: 261.9" "Cancer enriched" "Detected in some" 8 "glioma: 7.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 15.1;MAIT T-cell: 13.8;memory CD4 T-cell: 7.1;memory CD8 T-cell: 16.1;naive CD8 T-cell: 12.0;NK-cell: 9.5;T-reg: 8.0" "Group enriched" "Detected in many" 33 "NK-cells: 9.5;T-cells: 16.1" "Cell line enriched" "Detected in some" 4 "HDLM-2: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038118, HPA042122, HPA042770" Approved Uncertain Cytosol NA NA Cytosol "HPA038118: AB_10697238, HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (4.54e-5)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.80e-4)" "unprognostic (2.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.76e-1)" "unprognostic (1.84e-2)" "unprognostic (2.68e-1)" "unprognostic (3.20e-2)" "unprognostic (9.73e-4)" "unprognostic (4.51e-2)" "unprognostic (1.49e-8)" "unprognostic (2.02e-1)" "unprognostic (3.67e-1)" "unprognostic (5.48e-5)" "unprognostic (1.14e-4)" 2.0 9.7 30.8 2.5 35.2 2.9 1.8 10.2 73.2 1.6 2.7 26.0 0.0 3.0 1.7 1.8 2.9 14.5 2.9 2.9 26.4 20.9 4.7 2.4 2.5 4.3 25.5 22.4 1.6 2.9 16.0 6.4 2.6 27.5 2.7 2.8 4.6 2.0 2.9 1.5 4.9 2.3 3.5 18.6 2.9 2.2 15.7 29.3 0.0 4.2 0.0 2.4 6.8 1.1 0.0 0.0 0.3 0.0 9.5 16.1 4.1 0.4 0.4 2.4 1.0 0.1 0.1 0.2 0.5 0.2 1.1 1.6 1.3 4.8 0.2 0.1 0.0 0.0 10.2 0.8 1.0 1.1 47.5 0.2 0.6 2.8 0.5 0.2 0.0 0.2 0.1 0.7 0.0 0.2 0.7 0.1 0.4 0.6 0.5 0.7 0.3 0.0 0.0 6.3 0.0 1.1 0.7 0.1 0.1 4.2 10.9 1.9 0.2 0.3 0.0 0.2 1.7 0.4 0.1 0.3 0.2 0.7 2.5 0.4 0.4 0.2 0.0 1.7 4.3 1.4 0.2 0.0 0.0 15.1 0.0 13.8 0.0 7.1 16.1 0.0 0.0 1.3 12.0 0.3 9.5 0.0 0.0 8.0 4.1 30.8 35.2 10.2 34.1 26.4 20.9 25.5 22.4 27.5 29.3 3.0 2.6 0.0 1.1 1.8 83.2 1.2 12.7 0.0 1.2 8.7 141.4 14.1 18.3 1.3 312.5 2.1 0.0 0.0 0.0 0.2 1.1 0.2 0.0 0.0 0.8 44.5 12.5 0.0 1.2 670.1 3.1 1.7 5.0 0.0 0.0 31.8 0.8 0.0 2.1 4.0 261.9 0.0 8.6 3.7 1.6 1.3 4.5 16.7 0.0 0.7 PPP2R3C "C14orf10, FLJ20644, G4-1, G5PR" ENSG00000092020 "Protein phosphatase 2 regulatory subunit B''gamma" Q969Q6 14 35085467-35122517 "Predicted intracellular proteins" "Cone-rod dystrophy, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 382.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040835, HPA058834" Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No Nucleoplasm "Golgi apparatus, Cytosol" "HPA040835: AB_10794152, HPA058834: AB_2683831" "unprognostic (1.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (7.32e-3)" "unprognostic (5.33e-2)" "unprognostic (9.73e-2)" "unprognostic (1.10e-3)" "unprognostic (3.05e-1)" "unprognostic (7.85e-2)" "unprognostic (9.48e-3)" "unprognostic (1.17e-2)" "unprognostic (1.91e-1)" "unprognostic (2.18e-1)" "unprognostic (3.04e-2)" "unprognostic (3.15e-3)" "unprognostic (8.55e-2)" "unprognostic (8.29e-2)" 14.5 12.5 19.1 15.5 23.8 26.4 12.2 17.9 22.1 12.9 13.8 11.4 9.5 14.1 10.9 11.0 8.9 10.0 12.5 14.8 17.9 11.4 10.1 10.5 12.1 18.9 28.4 17.2 12.6 9.5 11.3 30.8 12.7 20.6 11.8 14.7 6.8 10.2 9.7 20.0 6.5 15.3 14.5 22.8 21.5 13.1 46.8 24.1 18.9 8.7 7.5 16.4 14.7 10.4 12.2 12.7 32.1 19.2 13.9 14.7 11.4 15.6 8.6 14.9 13.3 9.8 19.8 11.2 12.6 10.7 14.9 18.3 6.8 11.3 16.8 5.0 12.0 6.1 6.7 6.7 4.8 22.2 18.4 7.8 9.4 4.6 24.9 14.4 17.4 18.5 15.2 4.5 11.2 6.9 8.0 20.2 9.9 9.9 17.1 21.4 11.3 18.3 16.3 13.5 9.2 10.0 18.2 11.5 13.8 5.2 9.1 16.1 14.0 15.5 11.2 20.3 7.1 7.4 20.8 17.1 16.3 7.0 13.7 14.4 15.3 20.1 34.2 8.3 16.7 18.5 20.0 15.0 32.1 10.7 19.2 11.7 12.2 10.8 13.8 12.7 11.0 9.6 11.7 28.1 13.9 16.4 8.1 14.7 11.4 19.1 23.8 17.9 22.1 17.9 11.4 28.4 17.2 20.6 24.1 14.9 24.8 50.1 18.1 10.2 15.8 23.0 25.5 22.7 12.5 19.2 3.9 16.4 28.2 26.6 382.3 29.2 28.5 23.3 31.4 21.7 23.5 24.4 33.4 19.2 53.2 7.9 30.0 26.4 42.9 134.4 26.2 49.9 27.0 72.1 21.2 18.8 38.8 20.3 28.7 31.1 19.1 32.3 31.1 103.4 61.7 11.8 29.1 39.5 20.2 26.5 PPP2R5C "B56G, B56gamma, PR61G" ENSG00000078304 "Protein phosphatase 2 regulatory subunit B'gamma" Q13362 14 101761798-101927989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "T-cells: 251.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027553 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA027553: AB_10602081" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (3.24e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (1.23e-1)" "unprognostic (1.99e-1)" "unprognostic (1.31e-3)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.09e-1)" "unprognostic (4.49e-1)" "unprognostic (1.72e-1)" 25.5 29.4 52.6 37.7 45.3 48.1 27.4 25.7 38.9 27.8 31.1 25.6 30.1 22.4 24.0 29.2 32.7 22.3 25.4 48.4 49.3 35.6 25.5 38.1 34.5 53.8 44.7 32.4 28.4 25.6 27.6 35.3 19.5 27.5 23.1 33.3 26.6 28.9 27.8 30.5 28.9 31.7 27.7 45.5 36.8 25.4 27.6 29.5 51.4 29.6 28.3 52.1 33.2 21.9 20.1 24.9 35.3 25.3 16.8 60.5 20.9 21.0 14.5 24.6 23.7 22.3 31.5 23.8 19.9 26.4 25.0 24.0 14.5 36.8 57.7 19.3 25.8 17.6 22.2 22.4 21.1 32.6 25.9 10.6 16.7 17.2 14.1 16.5 25.6 35.9 20.7 27.4 17.2 16.0 22.3 22.4 31.5 34.7 24.4 23.8 32.1 25.7 28.3 14.3 42.5 24.2 21.8 27.7 14.2 24.0 24.0 19.3 36.1 27.0 17.9 33.7 18.0 32.8 19.7 22.1 15.8 15.1 60.7 19.7 34.1 51.0 96.2 23.7 19.0 17.5 20.1 19.8 18.2 60.5 24.3 38.9 20.1 39.7 47.5 16.9 17.8 28.6 44.1 35.3 16.8 25.3 24.9 39.7 20.9 52.6 45.3 25.7 38.9 49.3 35.6 44.7 32.4 27.5 29.5 77.4 85.3 74.9 37.2 52.1 31.6 113.5 48.4 68.3 52.4 34.9 55.0 41.1 39.7 33.2 55.5 45.2 45.9 46.7 40.7 39.2 41.8 41.7 66.0 70.6 61.7 25.4 45.5 59.5 108.0 50.8 48.6 71.4 81.0 136.1 71.3 33.5 39.8 66.8 42.8 53.6 38.0 38.8 46.4 23.7 25.4 61.5 43.8 251.6 58.7 59.3 PPP5D1 ENSG00000230510 "PPP5 tetratricopeptide repeat domain containing 1" E7EU14 19 46480796-46601200 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 19.6;Early spermatids: 14.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 6.7" HPA073186 Uncertain Uncertain Cytosol NA NA Cytosol "HPA073186: AB_2732220" "unprognostic (2.84e-2)" "unprognostic (3.26e-1)" "unprognostic (3.50e-2)" "unprognostic (2.26e-1)" "unprognostic (7.10e-2)" "unprognostic (1.89e-1)" "unprognostic (2.41e-1)" "unprognostic (4.86e-2)" "unprognostic (2.22e-2)" "unprognostic (1.62e-2)" "unprognostic (1.00e-4)" "unprognostic (3.90e-1)" "unprognostic (1.96e-1)" "unprognostic (1.27e-1)" "unprognostic (3.62e-1)" "unprognostic (1.41e-1)" "unprognostic (1.96e-1)" 1.9 4.5 8.9 0.9 6.8 1.5 2.2 3.6 7.5 3.5 1.5 5.8 6.6 0.9 3.9 7.4 1.1 6.8 2.6 2.8 6.5 8.7 1.6 1.2 2.2 1.4 6.9 5.9 5.8 2.3 2.8 6.9 2.3 4.1 4.4 0.9 3.7 7.2 4.3 2.4 2.2 0.9 1.9 5.4 1.9 1.8 5.3 4.7 1.0 5.8 0.6 1.4 1.9 2.4 2.0 2.2 6.2 1.4 2.6 1.8 0.5 1.7 1.0 1.4 1.0 0.9 3.0 0.3 1.0 0.9 2.6 0.6 0.1 1.2 1.8 1.7 3.4 2.6 1.0 2.3 0.4 1.4 2.1 5.8 3.0 1.5 1.7 1.4 1.0 2.4 2.3 3.6 0.4 1.2 2.1 0.8 3.1 1.2 1.4 2.3 6.7 1.0 3.0 0.7 0.3 1.4 3.3 0.6 0.5 1.3 1.0 4.4 1.6 1.0 0.6 0.7 0.3 0.8 1.6 1.9 0.2 0.6 0.4 0.8 0.9 0.8 1.5 0.9 3.1 0.7 6.2 1.4 0.7 0.9 1.0 0.5 1.7 0.4 0.7 2.2 2.0 0.8 1.8 2.0 2.6 0.4 0.9 0.4 0.5 8.9 6.8 3.6 7.5 6.5 8.7 6.9 5.9 4.1 4.7 3.0 1.3 2.7 2.4 1.4 8.1 1.6 10.2 1.4 0.0 1.8 19.6 1.7 1.7 1.2 14.6 3.0 1.6 0.0 1.6 1.4 2.8 2.4 0.0 0.8 2.5 9.5 0.0 5.5 2.9 2.7 3.7 2.1 3.3 4.6 0.6 8.6 0.7 0.0 2.8 0.4 9.1 0.0 1.7 4.9 3.6 1.1 1.4 2.9 1.7 1.7 PRAG1 "DKFZp761P0423, NACK, PEAK2, PRAGMIN, SgK223" ENSG00000275342 "PEAK1 related, kinase-activating pseudokinase 1" Q86YV5 8 8317736-8386498 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.4" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 6.2;Cytotrophoblasts: 6.4;Ductal cells: 6.6;Extravillous trophoblasts: 5.5;Hofbauer cells: 14.8;Pancreatic endocrine cells: 5.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 27.5;NTERA-2: 17.8;SuSa: 19.0" "Low region specificity" "Detected in all" "HPA011776, HPA012066" Uncertain Uncertain "Nucleoli,Focal adhesion sites" NA NA Nucleoli "Focal adhesion sites" "HPA011776: , HPA012066: AB_1847706" "unprognostic (7.04e-3)" "unprognostic (7.90e-2)" "unprognostic (2.32e-1)" "unprognostic (2.95e-2)" "unprognostic (1.60e-1)" "unprognostic (2.92e-1)" "unprognostic (1.05e-1)" "unprognostic (4.78e-3)" "unprognostic (2.64e-3)" "unprognostic (5.19e-2)" "unprognostic (4.95e-2)" "unprognostic (1.78e-1)" "prognostic favorable (4.81e-4)" "unprognostic (5.27e-2)" "unprognostic (1.23e-1)" "unprognostic (5.04e-2)" "unprognostic (5.22e-3)" 7.6 0.2 6.4 8.8 4.9 0.1 5.4 30.4 7.0 2.4 5.7 1.8 3.2 9.8 0.8 1.7 2.6 5.0 4.0 1.8 2.1 1.3 0.9 4.3 9.1 0.0 1.4 1.7 1.0 2.2 0.0 5.4 1.2 1.5 3.4 0.0 1.7 5.7 5.6 2.8 9.4 0.9 1.4 5.7 3.9 0.7 1.2 1.8 15.4 4.7 6.2 1.5 0.2 3.1 4.6 2.2 1.6 1.3 3.9 0.4 3.3 27.5 3.1 0.4 0.0 0.2 7.8 7.0 1.5 2.8 1.1 13.6 8.0 5.5 4.8 3.3 7.6 12.0 0.5 8.4 0.6 0.2 0.8 0.0 3.3 7.6 3.0 0.8 8.7 0.7 5.5 0.4 1.2 1.6 5.7 0.8 0.0 0.0 2.1 4.6 0.7 2.6 17.8 10.5 7.1 3.5 3.3 1.3 4.1 9.5 1.5 1.0 2.7 7.7 2.7 19.0 6.0 3.4 7.5 0.2 7.4 0.0 1.7 0.4 0.6 7.5 1.7 1.8 4.1 0.0 0.5 2.2 1.2 0.1 0.9 3.1 1.5 0.4 0.7 2.6 3.9 3.2 0.0 1.3 1.6 4.6 0.2 0.4 8.9 6.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 6.4 0.0 6.6 0.0 0.0 0.0 0.0 2.7 5.5 0.0 0.0 2.3 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.8 0.0 0.0 5.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 PRAMEF12 ENSG00000116726 "PRAME family member 12" O95522 1 12774841-12777906 "Plasma proteins, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.8" "HPA045286, HPA051704" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045286: AB_10794782, HPA051704: AB_2681581" "unprognostic (6.60e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRDM14 ENSG00000147596 "PR/SET domain 14" Q9GZV8 8 70051651-70071693 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 5.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 658 "testis cancer: 34.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 57 "NTERA-2: 33.7;SuSa: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019094, HPA057070" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA019094: AB_1855686, HPA057070: AB_2683327" "unprognostic (5.86e-2)" "unprognostic (9.32e-2)" "unprognostic (6.14e-3)" "unprognostic (1.37e-2)" "unprognostic (8.62e-2)" 0.2 0.2 0.2 0.2 0.2 1.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.4 1.1 0.2 0.3 0.2 1.1 0.2 0.2 0.5 0.2 0.5 0.2 0.2 0.2 0.5 0.2 0.3 0.3 0.2 0.2 0.2 0.1 1.7 0.3 0.2 0.4 1.2 0.2 0.2 0.2 0.6 0.3 5.4 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.6 1.0 1.4 1.6 1.0 2.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 9.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.5 0.6 1.0 0.4 0.8 1.4 1.1 0.7 0.3 1.6 2.5 1.9 1.4 1.0 1.6 1.0 0.4 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 PRDM7 ZNF910 ENSG00000126856 "PR/SET domain 7" Q9NQW5 16 90056566-90092072 "Enzymes, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 4.8" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 1.4;Cardiomyocytes: 5.0;Ciliated cells: 2.7" "Cancer enriched" "Detected in single" 30 "melanoma: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "REH: 9.1;SK-MEL-30: 6.7" HPA059944 Approved Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA059944: AB_2684174" "unprognostic (3.98e-1)" "unprognostic (8.89e-2)" "unprognostic (8.02e-3)" "unprognostic (8.26e-2)" "unprognostic (9.01e-2)" "unprognostic (5.61e-3)" "unprognostic (1.05e-2)" "unprognostic (1.46e-1)" "unprognostic (5.73e-1)" "unprognostic (5.52e-4)" "unprognostic (1.36e-1)" "unprognostic (1.61e-1)" "unprognostic (4.03e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 PRELID1 "CGI-106, PRELI, PX19" ENSG00000169230 "PRELI domain containing 1" Q9Y255 5 177303774-177306959 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005701 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA005701: AB_1079721" "unprognostic (1.27e-1)" "unprognostic (8.99e-2)" "unprognostic (3.18e-2)" "unprognostic (2.09e-3)" "unprognostic (2.19e-1)" "unprognostic (8.07e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (7.63e-3)" "unprognostic (1.49e-1)" "unprognostic (8.90e-3)" "unprognostic (1.71e-1)" "unprognostic (6.97e-2)" "prognostic unfavorable (2.89e-7)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.21e-1)" 18.9 25.0 21.9 33.9 20.3 30.3 21.6 12.0 31.1 16.9 44.6 14.8 15.4 43.5 18.3 15.5 35.6 17.4 20.6 16.8 19.3 18.6 46.1 62.3 18.9 43.0 20.2 14.7 20.3 91.6 12.3 17.7 29.4 21.0 19.8 35.0 18.9 40.1 16.4 11.9 26.2 70.6 19.0 14.8 43.5 24.6 12.9 13.5 25.2 29.3 27.2 33.7 18.0 18.9 27.1 77.4 111.7 94.2 30.4 26.4 49.2 32.3 30.4 18.5 49.4 16.6 18.0 61.7 23.1 16.2 33.8 32.7 68.1 37.1 27.5 27.3 21.7 36.8 18.4 33.0 61.8 23.1 117.7 45.7 23.8 31.5 45.3 17.5 37.3 33.4 16.2 22.3 26.6 22.8 14.0 41.8 19.8 26.1 39.9 32.8 84.0 23.9 54.6 37.7 37.8 50.4 7.7 37.4 49.4 22.0 27.1 29.6 37.2 21.6 43.1 40.1 24.1 27.8 46.0 23.0 31.0 27.1 25.4 55.3 22.4 38.2 40.0 26.7 50.4 32.1 31.5 75.7 111.7 26.4 94.2 25.8 27.1 21.9 26.2 77.4 21.1 19.3 21.1 55.2 30.4 90.3 28.3 23.3 49.2 21.9 20.3 12.0 31.1 19.3 18.6 20.2 14.7 21.0 13.5 20.8 22.6 181.8 227.7 309.4 61.7 0.3 145.2 13.4 28.4 99.5 21.6 650.2 257.0 407.3 4.8 123.4 610.0 116.8 488.9 446.5 187.8 329.7 110.3 191.7 318.8 57.2 151.0 114.8 245.1 15.2 105.6 182.1 243.0 153.3 210.5 81.8 553.8 343.7 102.6 293.8 49.9 45.3 167.5 80.1 183.7 367.9 738.9 173.0 351.5 462.0 PRIM1 ENSG00000198056 "DNA primase subunit 1" P49642 12 56731596-56752373 "Predicted intracellular proteins" "DNA replication, Transcription" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 38.6;Spermatogonia: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040010 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA Yes "Nucleoplasm, Golgi apparatus, Vesicles" "HPA040010: AB_10805599" "unprognostic (3.04e-3)" "unprognostic (1.67e-2)" "unprognostic (2.12e-2)" "unprognostic (1.51e-2)" "unprognostic (4.63e-2)" "unprognostic (3.61e-2)" "prognostic unfavorable (2.40e-8)" "unprognostic (4.68e-2)" "unprognostic (2.73e-3)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (1.82e-1)" "unprognostic (1.98e-3)" "unprognostic (3.94e-1)" "unprognostic (2.16e-1)" "unprognostic (5.35e-2)" "unprognostic (6.53e-2)" 5.7 5.2 6.7 9.8 9.3 26.0 10.1 16.0 10.6 6.0 8.2 6.7 5.5 4.5 6.2 4.9 9.6 6.2 3.1 4.0 7.6 4.6 4.5 8.2 5.4 11.1 9.2 4.6 9.7 10.7 7.9 12.3 5.0 7.9 5.2 11.1 5.3 7.0 4.3 6.3 7.9 8.3 6.1 11.8 10.2 6.3 17.0 10.8 28.3 5.1 6.8 13.2 5.6 6.9 8.6 6.3 3.5 6.2 5.3 12.7 4.6 12.2 10.6 14.7 9.0 1.7 2.6 17.3 10.4 8.5 18.5 17.3 11.4 15.8 24.1 8.7 4.8 7.4 12.4 17.7 11.3 20.4 12.0 11.0 31.8 6.8 10.9 0.5 38.9 13.5 1.1 2.1 16.4 7.1 2.8 6.6 28.1 29.9 38.1 10.7 9.1 22.2 14.8 16.3 8.8 13.3 25.0 25.8 20.8 4.4 9.3 15.0 13.3 12.4 6.0 5.6 11.2 19.4 14.9 3.0 9.6 22.8 10.0 13.1 13.9 27.7 13.6 6.0 16.5 12.7 1.4 1.4 3.5 7.8 3.4 9.0 8.6 10.5 7.5 3.4 8.2 12.7 10.0 0.0 5.3 6.2 6.3 9.1 4.6 6.7 9.3 16.0 10.6 7.6 4.6 9.2 4.6 7.9 10.8 6.0 5.0 11.5 11.9 3.4 4.2 2.4 2.5 8.1 6.8 7.0 5.9 7.0 0.0 4.4 5.0 5.8 1.3 70.0 6.4 22.0 3.3 2.7 3.5 4.3 10.3 19.1 1.2 3.7 7.3 2.5 6.6 7.2 3.3 9.0 2.9 5.6 3.4 0.0 4.6 1.6 11.8 12.9 3.9 38.6 82.6 3.4 3.8 10.5 8.5 2.0 PRKACG PKACg ENSG00000165059 "Protein kinase cAMP-activated catalytic subunit gamma" P22612 9 69012529-69014113 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 27.4" "Group enriched" "Detected in some" 8 "Early spermatids: 55.1;Late spermatids: 73.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.3" "CAB004530, HPA071185" Supported Uncertain "Cytokinetic bridge,Cytosol" NA NA Cytosol "Cytokinetic bridge" "CAB004530: AB_628137, HPA071185: AB_2686356" "unprognostic (2.74e-1)" "unprognostic (3.61e-2)" "unprognostic (7.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 1.5 0.0 0.0 0.0 0.0 0.0 PRKAR2B PRKAR2 ENSG00000005249 "Protein kinase cAMP-dependent type II regulatory subunit beta" P31323 7 107044649-107161811 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "adipose tissue: 80.2;breast: 114.1" "Cell type enhanced" "Detected in many" 7 "Peritubular cells: 49.8;Smooth muscle cells: 35.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 20.1;Daudi: 27.6;K-562: 16.6;U-698: 71.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008421, HPA063879" Enhanced Uncertain Mitochondria NA NA 1600000 Mitochondria "HPA008421: AB_1855421, HPA063879: " "unprognostic (3.18e-1)" "unprognostic (2.48e-2)" "prognostic favorable (6.38e-4)" "unprognostic (1.63e-2)" "unprognostic (3.33e-3)" "unprognostic (2.43e-3)" "unprognostic (2.76e-1)" "unprognostic (8.14e-3)" "unprognostic (1.70e-1)" "unprognostic (5.97e-2)" "prognostic favorable (4.03e-4)" "unprognostic (1.50e-1)" "unprognostic (5.12e-3)" "unprognostic (2.39e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (8.74e-4)" "unprognostic (7.15e-2)" 80.2 21.5 9.4 6.0 17.2 8.4 114.1 4.5 17.0 3.9 9.1 1.9 2.4 3.1 5.1 3.9 8.4 3.4 4.7 9.0 8.8 8.6 4.5 2.4 3.2 3.0 8.4 12.1 19.5 6.5 5.6 8.1 10.7 3.0 6.4 5.5 2.6 6.8 3.9 2.2 1.6 4.7 7.4 3.4 11.1 4.1 14.5 4.6 0.8 1.6 2.8 3.3 8.4 11.8 0.2 3.1 1.3 1.5 0.5 0.1 2.5 0.0 0.4 2.6 20.1 10.8 0.0 0.0 1.0 3.2 0.8 0.8 0.0 0.0 27.6 0.2 0.6 2.5 0.0 2.0 0.0 1.6 0.7 2.2 9.2 0.0 0.0 3.0 0.1 1.3 0.1 0.0 0.0 0.0 0.9 12.1 1.5 16.6 0.8 0.0 2.0 3.7 0.1 4.9 0.0 0.8 1.1 0.0 0.0 0.0 0.0 3.3 4.8 1.5 0.3 1.0 6.9 0.6 1.9 6.8 1.0 2.6 0.0 1.9 0.6 0.0 71.0 0.7 4.8 9.6 1.3 1.5 0.0 0.0 1.4 0.1 0.2 0.0 0.0 3.1 0.0 0.1 0.1 0.7 0.5 0.7 1.1 0.0 2.5 9.4 17.2 4.5 17.0 8.8 8.6 8.4 12.1 3.0 4.6 3.0 1.0 0.8 1.4 2.2 29.0 26.0 10.2 6.7 1.2 7.0 9.8 0.0 0.0 1.7 6.2 15.5 0.0 0.0 0.0 0.4 5.1 5.9 4.6 0.0 1.5 4.8 0.0 14.1 14.0 4.7 27.6 10.4 16.9 13.6 0.5 5.5 0.2 2.6 49.8 0.6 9.1 19.4 35.8 1.6 4.5 2.0 0.0 2.9 1.9 3.9 PRKD3 "EPK2, PRKCN" ENSG00000115825 "Protein kinase D3" O94806 2 37250502-37324808 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 110.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029529 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029529: AB_10602082" "unprognostic (1.39e-1)" "unprognostic (7.34e-2)" "prognostic favorable (4.84e-4)" "unprognostic (1.23e-2)" "unprognostic (5.61e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.10e-1)" "unprognostic (1.16e-1)" "unprognostic (2.52e-2)" "unprognostic (2.93e-1)" "unprognostic (1.81e-1)" "unprognostic (7.62e-3)" "unprognostic (2.49e-2)" "unprognostic (1.18e-1)" "unprognostic (1.36e-1)" "unprognostic (1.35e-1)" 16.1 22.1 9.5 20.7 10.7 5.3 35.1 4.8 9.2 17.2 18.0 7.2 7.2 6.0 19.2 16.0 9.8 11.3 10.0 11.6 12.7 6.1 9.9 8.4 20.4 22.3 11.4 3.7 15.0 7.6 12.9 20.7 11.1 10.3 14.4 8.3 27.8 11.1 13.3 19.1 11.5 12.1 16.5 15.4 22.0 10.5 16.8 10.8 16.2 11.8 9.3 21.2 12.4 17.7 16.4 8.2 5.7 8.3 6.3 11.5 3.4 12.8 5.4 14.5 11.9 11.1 18.6 10.6 8.3 15.5 9.4 9.6 8.7 4.5 18.8 7.0 12.4 14.1 5.1 9.8 10.2 12.7 24.3 14.4 12.4 8.4 5.8 4.5 8.8 7.6 8.8 5.2 14.9 9.8 8.7 16.7 6.3 10.4 23.2 10.9 2.1 3.8 6.9 15.3 0.1 5.3 13.0 22.9 16.1 6.2 14.4 10.9 28.3 8.0 4.6 48.8 7.8 4.9 8.1 16.1 27.0 14.0 10.7 9.3 26.5 49.1 22.0 9.4 3.7 16.2 5.7 8.3 5.5 10.5 6.6 9.1 12.4 8.8 8.4 7.8 16.4 10.4 11.5 1.5 6.3 3.3 8.2 4.1 3.4 9.5 10.7 4.8 9.2 12.7 6.1 11.4 3.7 10.3 10.8 38.7 16.2 38.3 20.7 33.7 29.6 7.1 15.3 5.3 13.6 17.4 64.8 9.1 3.3 10.9 42.2 44.7 5.4 0.0 9.0 28.2 34.8 27.0 77.1 11.3 11.1 41.3 18.1 38.1 28.4 78.9 31.1 24.5 47.2 12.6 6.1 16.0 12.3 3.5 29.0 7.1 110.0 25.8 26.9 56.0 44.5 20.8 8.1 27.4 11.0 32.3 PRM1 CT94.1 ENSG00000175646 "Protamine 1" P04553 16 11280836-11281350 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 125 "testis: 747.3" "Group enriched" "Detected in some" 154 "Early spermatids: 123959.8;Late spermatids: 465852.4" "Cancer enriched" "Detected in single" 161 "testis cancer: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.1;Hep G2: 1.1;NB-4: 6.0;U-2197: 4.5;U-698: 2.0" "HPA055150, HPA059371" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA055150: AB_2682718, HPA059371: " "unprognostic (2.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 747.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123959.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 465852.4 1718.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1588.2 0.0 0.0 1138.3 0.0 1916.0 855.6 0.0 0.0 0.0 0.0 0.0 PRODH "HSPOX2, PIG6, PRODH1, PRODH2, TP53I6" ENSG00000100033 "Proline dehydrogenase 1" O43272 22 18912777-18936553 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 48.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 24.6;Melanocytes: 20.3;Suprabasal keratinocytes: 13.2" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "OE19: 39.9;RPTEC TERT1: 19.8" HPA020361 Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA Mitochondria "Nucleoplasm, Vesicles" "HPA020361: AB_10963116" "unprognostic (2.46e-2)" "prognostic favorable (1.54e-4)" "unprognostic (1.40e-1)" "unprognostic (3.70e-2)" "unprognostic (3.80e-2)" "unprognostic (1.20e-1)" "unprognostic (1.78e-2)" "unprognostic (1.07e-2)" "unprognostic (2.49e-2)" "unprognostic (6.56e-2)" "unprognostic (3.12e-2)" "unprognostic (1.61e-2)" "unprognostic (7.44e-2)" "unprognostic (1.07e-1)" "unprognostic (1.21e-1)" "unprognostic (5.34e-2)" "unprognostic (3.94e-2)" 3.8 2.3 20.8 2.8 19.3 2.0 3.3 9.8 21.3 2.0 3.5 16.2 0.1 13.8 2.3 2.2 8.8 2.4 2.2 4.6 22.2 10.8 9.9 6.6 8.6 2.3 14.9 21.8 2.4 2.2 1.9 1.5 2.4 13.5 2.6 2.6 7.4 2.1 2.4 15.5 13.0 48.9 1.9 12.6 2.2 2.1 3.5 9.8 0.1 4.3 4.1 3.7 2.1 2.3 0.4 0.4 0.0 0.0 1.0 0.3 0.0 0.0 0.4 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 1.4 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.4 39.9 0.0 0.0 0.0 0.2 19.8 0.4 0.0 0.1 0.4 0.6 0.1 2.9 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 20.8 19.3 9.8 21.3 22.2 10.8 14.9 21.8 13.5 9.8 14.9 24.6 0.0 0.2 4.5 0.0 1.6 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.9 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.5 0.0 2.9 0.0 0.0 0.0 0.0 0.7 0.0 0.3 13.2 0.0 0.0 0.4 0.1 PROSER2 "C10orf47, MGC35403" ENSG00000148426 "Proline and serine rich 2" Q86WR7 10 11823339-11872277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 40.8" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 26.1;Urothelial cells: 72.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 32.9;CAPAN-2: 39.5;HBEC3-KT: 25.2" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 32.0" HPA041337 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041337: AB_10794663" "unprognostic (2.36e-3)" "unprognostic (1.39e-1)" "unprognostic (3.55e-2)" "unprognostic (1.19e-1)" "unprognostic (4.60e-2)" "unprognostic (7.60e-3)" "unprognostic (4.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (1.25e-3)" "unprognostic (1.61e-1)" "unprognostic (1.26e-2)" "unprognostic (4.04e-2)" "unprognostic (3.01e-1)" "unprognostic (5.06e-2)" "unprognostic (8.69e-2)" 2.7 1.1 0.7 1.8 1.4 9.5 9.8 1.0 1.3 3.7 2.5 0.4 2.4 1.2 2.5 1.7 6.2 3.0 2.2 1.4 1.5 0.7 8.6 40.8 10.2 0.2 1.4 0.3 1.7 21.7 0.0 1.5 9.2 1.2 7.3 2.0 9.9 4.5 2.7 1.7 3.2 1.1 1.3 1.0 8.2 7.1 7.5 0.5 4.3 12.0 3.6 5.6 6.5 9.9 0.0 1.9 0.0 1.0 0.0 0.7 0.9 32.9 4.7 0.3 0.1 1.0 1.3 1.9 1.5 0.7 1.2 0.6 10.9 39.5 0.0 6.1 0.1 0.5 8.7 3.3 25.2 0.6 0.0 8.1 3.8 2.0 7.0 5.9 0.0 2.4 1.4 5.5 7.1 8.1 0.1 3.6 0.6 5.6 0.0 1.7 4.5 0.0 1.2 2.1 4.4 2.7 5.3 4.3 0.0 2.6 1.6 0.0 0.4 2.4 10.0 4.2 1.7 5.2 2.0 2.5 0.0 8.0 13.2 0.1 0.0 0.0 0.0 0.0 1.3 1.8 0.0 1.0 0.0 0.0 0.3 0.7 0.0 0.1 0.2 0.1 0.0 0.4 0.2 0.0 0.0 0.0 1.9 0.0 0.9 0.7 1.4 1.0 1.3 1.5 0.7 1.4 0.3 1.2 0.5 8.9 5.1 0.0 22.8 5.0 0.0 0.9 20.4 6.7 5.7 5.2 0.0 4.7 5.0 9.6 2.5 2.8 0.8 0.0 3.3 16.0 3.1 21.4 0.0 26.1 0.7 0.0 1.7 1.8 0.8 2.3 1.7 0.3 3.3 0.0 1.3 0.0 13.3 0.0 4.2 0.3 0.0 0.0 1.0 1.7 2.8 4.1 0.6 0.0 3.3 72.6 PRPS1L1 "PRPS3, PRPSL" ENSG00000229937 "Phosphoribosyl pyrophosphate synthetase 1-like 1" P21108 7 18026774-18027863 "Enzymes, Predicted intracellular proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 38.4" "Group enriched" "Detected in some" 8 "Early spermatids: 39.0;Spermatocytes: 72.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 1.3;K-562: 2.1" HPA051269 Uncertain Vesicles NA NA Vesicles "HPA051269: " "unprognostic (2.39e-2)" "unprognostic (3.18e-2)" "unprognostic (1.11e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.7 0.3 0.6 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.4 0.3 0.6 0.8 0.9 0.5 0.1 0.4 1.1 0.7 0.1 0.6 0.1 0.4 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 6.5 0.0 72.2 1.3 0.0 0.0 0.0 0.0 0.0 PRR15 ENSG00000176532 "Proline rich 15" Q8IV56 7 29563811-29567295 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 66.1" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 66.9;Enterocytes: 108.9;Paneth cells: 46.5;Undifferentiated cells: 48.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.6" "Lineage enhanced" "Detected in single" "B-cells: 1.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.5;HaCaT: 17.9;OE19: 38.3;RT4: 13.7;SK-BR-3: 30.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040996, HPA048121" Enhanced Uncertain "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA040996: AB_2677241, HPA048121: AB_2680271" "unprognostic (5.46e-2)" "unprognostic (1.27e-1)" "unprognostic (8.97e-2)" "prognostic favorable (6.37e-4)" "unprognostic (7.49e-2)" "unprognostic (1.96e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (3.69e-3)" "unprognostic (1.25e-1)" "prognostic favorable (1.83e-6)" "unprognostic (1.30e-2)" "unprognostic (5.71e-2)" "unprognostic (2.33e-3)" "unprognostic (1.58e-2)" 3.8 0.5 0.7 14.4 0.4 0.0 3.1 0.4 0.8 22.8 58.9 0.8 2.6 24.8 6.8 13.3 0.7 2.9 12.1 1.0 0.6 0.5 12.7 0.5 3.7 0.6 0.4 0.4 4.0 2.0 0.0 2.7 19.0 0.5 2.7 18.5 0.3 4.6 0.9 0.5 0.3 66.1 1.1 1.1 0.4 16.6 1.4 0.4 0.3 1.0 1.0 1.9 7.0 1.9 1.6 0.0 0.0 0.5 0.0 0.0 0.6 6.5 9.3 0.0 0.0 3.6 4.5 11.9 0.3 0.4 0.1 0.1 8.1 15.5 0.0 1.7 2.2 0.2 17.9 1.9 0.0 0.0 0.0 1.3 0.5 1.7 8.8 1.2 0.0 0.0 0.0 3.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 1.5 0.2 1.2 1.4 38.3 7.4 0.0 0.0 8.2 10.7 13.7 0.2 0.1 0.9 30.2 0.0 5.5 2.2 0.0 7.9 0.2 0.0 0.0 0.3 0.7 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.4 0.4 0.8 0.6 0.5 0.4 0.4 0.5 0.4 0.0 0.3 0.0 1.1 0.1 0.0 0.3 10.2 66.9 6.8 36.6 0.0 12.5 24.9 6.1 0.6 0.3 108.9 0.0 19.6 8.7 0.3 2.1 0.0 0.0 2.5 0.0 8.1 0.0 0.0 0.0 1.4 2.7 0.0 1.0 37.6 0.0 10.9 46.5 2.1 9.2 0.0 0.0 0.4 0.0 0.4 0.0 5.3 0.0 48.1 19.0 PRR23B FLJ46116 ENSG00000184814 "Proline rich 23B" Q6ZRT6 3 139019031-139020926 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "testis: 4.7" "Group enriched" "Detected in some" 13 "Spermatocytes: 6.6;Spermatogonia: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (7.57e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 4.1 0.0 0.0 0.0 0.0 0.1 PRR29 "C17orf72, DKFZp761M2312, FLJ11724" ENSG00000224383 "Proline rich 29" P0C7W0 17 63998351-64004304 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 17.9;fallopian tube: 48.7;testis: 23.5" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 164.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.8;REH: 7.0;TIME: 5.6" HPA051264 Uncertain Nucleoli NA NA Nucleoli "HPA051264: " "unprognostic (2.05e-2)" "unprognostic (6.46e-2)" "unprognostic (2.87e-2)" "unprognostic (2.92e-3)" "unprognostic (4.71e-3)" "unprognostic (3.22e-2)" "unprognostic (3.84e-1)" "unprognostic (3.95e-2)" "unprognostic (1.04e-2)" "unprognostic (1.44e-1)" "unprognostic (2.63e-3)" "unprognostic (5.76e-2)" "unprognostic (1.30e-3)" "unprognostic (6.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (9.98e-3)" 0.9 0.5 3.3 0.8 7.6 0.6 0.9 0.1 2.1 4.0 0.5 8.3 0.4 0.6 1.0 17.9 0.6 48.7 1.0 0.7 5.6 5.5 0.6 0.6 7.3 0.7 1.6 0.8 8.1 0.5 0.9 5.8 0.7 15.2 0.6 0.4 0.2 0.9 0.9 0.6 0.5 0.5 0.6 1.1 2.5 0.5 23.5 1.0 0.0 2.5 0.0 0.7 1.0 0.0 1.0 0.7 3.1 1.8 1.0 3.0 1.6 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.2 0.0 0.0 0.4 0.0 6.8 0.0 0.7 0.0 1.5 0.0 0.1 0.5 0.2 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.8 0.2 1.9 1.0 0.0 0.0 0.0 2.4 0.0 0.2 1.4 0.2 7.0 0.1 2.9 0.5 0.0 0.4 2.1 0.0 0.3 0.4 1.1 1.1 0.0 5.6 0.2 2.4 0.7 0.2 0.7 0.2 0.5 0.9 0.3 0.0 3.1 0.9 0.0 2.0 1.8 0.4 0.7 1.7 1.0 0.7 1.0 3.0 1.7 0.8 1.0 1.7 0.1 1.1 1.6 3.3 7.6 0.1 2.1 5.6 5.5 1.6 0.8 15.2 1.0 0.0 3.2 0.5 0.0 0.0 0.0 0.1 0.0 164.6 18.2 3.5 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 2.5 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 21.8 1.4 0.0 0.2 0.0 0.0 0.0 PRRC2A "BAT2, D6S51E, G2" ENSG00000204469 "Proline rich coiled-coil 2A" P48634 6 31620720-31637771 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 26.4;HEK 293: 48.2;U-266/70: 24.8;U-266/84: 26.3;U-698: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026383, HPA046791, HPA066501" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "CAB026383: , HPA046791: AB_2679809, HPA066501: AB_2732747" "unprognostic (2.07e-1)" "unprognostic (6.84e-2)" "unprognostic (3.82e-1)" "unprognostic (2.25e-3)" "unprognostic (5.04e-2)" "unprognostic (4.63e-1)" "unprognostic (2.42e-3)" "unprognostic (2.09e-1)" "unprognostic (3.07e-1)" "unprognostic (1.14e-1)" "unprognostic (8.29e-3)" "unprognostic (2.38e-1)" "unprognostic (2.75e-1)" "unprognostic (1.01e-1)" "unprognostic (1.57e-1)" "unprognostic (5.40e-2)" "unprognostic (3.10e-1)" 10.9 18.4 20.7 28.9 22.1 5.0 12.2 25.2 29.1 15.0 24.6 18.4 11.9 4.8 19.7 51.5 47.2 32.3 13.8 24.2 18.4 13.2 16.0 10.2 41.7 14.9 14.3 20.4 29.3 12.2 4.8 18.5 8.6 15.9 30.9 7.1 15.0 12.3 15.9 35.1 28.8 23.0 12.8 11.5 43.5 34.6 46.3 16.7 27.1 16.8 10.4 14.4 16.0 13.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.1 0.0 0.0 11.9 11.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 7.5 13.4 0.0 0.0 0.0 26.4 0.0 0.0 48.2 0.1 0.1 0.0 0.0 0.1 0.0 5.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.0 0.0 24.8 26.3 25.1 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 22.1 25.2 29.1 18.4 13.2 14.3 20.4 15.9 16.7 0.0 5.6 32.9 25.1 29.2 36.4 5.9 22.9 4.0 3.4 38.4 56.9 23.5 5.0 21.7 40.5 23.2 27.9 0.0 22.0 18.4 28.7 31.4 10.4 23.6 28.8 35.0 37.4 33.2 22.9 13.8 45.5 23.5 18.6 25.2 37.1 21.4 27.4 37.9 42.1 12.2 34.7 19.4 30.3 66.6 44.4 24.8 15.3 26.2 41.7 23.6 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes No "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853" "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favorable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 16.3 15.3 21.0 13.4 34.9 19.2 15.7 15.5 24.7 16.5 26.2 66.1 9.5 26.6 14.2 15.4 19.0 12.6 17.1 9.9 28.6 18.2 19.7 16.9 16.9 10.8 42.1 20.7 13.5 15.0 21.8 9.2 22.7 31.8 13.6 25.6 15.0 16.8 13.4 13.0 24.7 27.9 14.6 61.9 14.6 16.3 16.8 39.7 15.4 19.7 8.7 15.9 17.2 13.5 9.0 24.4 38.1 34.0 11.7 10.5 17.1 14.4 22.2 20.8 8.3 29.1 20.8 18.9 21.3 24.5 21.9 27.6 27.6 36.2 9.4 14.1 20.2 17.9 38.5 17.5 16.1 23.9 21.5 10.8 10.8 15.1 13.4 26.9 10.8 21.1 21.3 29.4 18.1 22.4 20.0 17.5 10.6 12.0 19.2 20.4 28.7 8.2 14.1 9.0 25.7 16.5 10.5 17.7 12.0 30.4 30.7 11.6 15.5 23.2 21.8 18.9 19.7 27.0 24.3 18.5 22.3 18.4 18.1 10.0 12.6 18.4 9.6 18.7 13.2 13.5 29.2 27.1 27.1 7.2 30.8 7.0 7.2 7.0 5.9 24.4 9.0 6.6 6.4 38.1 11.7 34.0 12.8 10.5 17.1 21.0 34.9 15.5 24.7 28.6 18.2 42.1 20.7 31.8 39.7 26.8 35.7 14.6 21.9 25.3 16.5 10.1 20.4 22.7 26.1 22.7 37.3 22.8 5.0 24.3 8.6 20.3 63.6 0.0 23.2 24.7 22.1 24.7 17.4 18.6 27.3 12.7 15.5 13.5 47.8 10.0 15.3 43.2 15.1 33.3 34.1 13.6 29.5 51.8 14.5 13.3 27.4 25.8 18.4 21.6 13.7 28.9 41.8 20.3 36.6 44.4 PSORS1C1 "C6orf16, SEEK1" ENSG00000204540 "Psoriasis susceptibility 1 candidate 1" Q9UIG5 6 31114750-31140092 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "testis: 52.2" "Group enriched" "Detected in many" 5 "Early spermatids: 289.3;Late spermatids: 996.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.0;hTCEpi: 5.5;JURKAT: 2.4;U-2 OS: 1.7" HPA045049 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045049: " "unprognostic (1.15e-1)" "unprognostic (4.25e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.72e-1)" "unprognostic (9.23e-2)" "unprognostic (4.77e-3)" "unprognostic (8.48e-2)" "unprognostic (3.05e-3)" "unprognostic (1.66e-2)" "unprognostic (4.17e-2)" "unprognostic (9.56e-2)" "unprognostic (5.72e-3)" "unprognostic (4.80e-2)" "unprognostic (1.59e-1)" "unprognostic (6.33e-2)" "unprognostic (1.30e-1)" 0.9 0.7 1.1 0.7 2.8 0.7 0.8 0.5 1.5 3.4 6.9 2.2 2.6 0.7 7.7 6.4 2.1 1.1 7.5 0.7 0.7 0.6 1.0 0.7 3.7 0.7 4.4 0.0 1.9 1.5 0.7 0.4 1.7 3.0 1.7 1.1 0.2 0.9 1.8 0.7 2.0 6.0 6.5 3.4 0.7 1.1 52.2 0.9 0.0 1.8 1.1 0.7 3.6 3.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 5.5 0.6 1.0 0.0 0.0 2.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.8 0.5 1.5 0.7 0.6 4.4 0.0 3.0 0.9 17.9 2.7 0.0 3.6 7.8 0.0 2.0 17.8 0.0 3.4 8.7 0.0 0.1 0.0 13.8 289.3 3.6 20.7 0.0 1.9 0.4 8.0 2.6 0.0 0.0 0.3 0.0 2.9 3.7 0.0 996.1 8.6 0.0 3.3 1.0 4.6 0.5 9.4 8.0 6.3 0.7 0.0 6.5 1.4 117.0 17.9 9.3 0.1 0.0 4.7 2.3 PTAFR ENSG00000169403 "Platelet activating factor receptor" P25105 1 28147166-28193936 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 98.3" "Group enriched" "Detected in many" 7 "granulocytes: 73.9;Hofbauer cells: 62.8;Kupffer cells: 70.6;Macrophages: 55.7;Pancreatic endocrine cells: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 28.2;eosinophil: 98.3;neutrophil: 85.7" "Group enriched" "Detected in many" 5 "granulocytes: 98.3;monocytes: 28.2" "Group enriched" "Detected in some" 4 "HBEC3-KT: 14.7;HMC-1: 53.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027543 Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "HPA027543: AB_10610287" "unprognostic (2.22e-2)" "unprognostic (2.59e-2)" "unprognostic (6.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.75e-1)" "unprognostic (3.74e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.23e-1)" "unprognostic (2.39e-1)" "unprognostic (1.60e-1)" "unprognostic (2.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.59e-2)" "unprognostic (5.48e-2)" "unprognostic (1.38e-2)" 5.6 2.3 2.4 16.2 1.9 20.3 2.4 0.6 2.0 6.9 3.4 1.6 3.5 1.8 2.8 1.4 16.8 2.8 7.5 3.5 2.1 2.3 6.4 1.8 9.2 6.1 4.1 1.0 1.5 2.7 0.9 0.7 3.5 1.8 2.6 3.4 0.6 3.4 2.6 1.1 2.8 5.0 3.8 5.1 15.4 2.3 2.2 1.1 2.3 1.4 22.2 21.7 5.9 3.6 1.5 13.2 98.3 28.2 0.0 0.1 10.1 7.7 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.1 2.2 0.5 0.0 0.0 0.1 5.3 0.2 14.7 0.3 0.1 0.2 2.9 0.0 0.3 0.0 0.7 53.6 0.0 2.4 0.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 7.2 0.2 0.2 0.1 0.1 0.0 0.0 3.6 0.8 0.1 0.0 0.0 7.3 0.0 0.2 0.1 2.0 0.0 0.1 0.3 0.0 0.0 0.5 0.4 2.1 0.0 0.9 0.2 5.9 28.2 98.3 0.0 8.9 0.1 1.5 0.0 0.0 13.2 0.7 0.0 0.0 85.7 0.0 3.5 0.1 0.1 10.1 2.4 1.9 0.6 2.0 2.1 2.3 4.1 1.0 1.8 1.1 6.0 7.9 4.3 1.5 5.8 1.2 2.0 2.5 6.7 2.3 1.8 2.0 0.5 0.0 8.8 0.0 5.9 0.2 0.0 4.6 0.4 2.2 0.4 73.9 0.8 62.8 0.0 0.0 1.8 70.6 0.0 0.6 55.7 0.0 4.6 0.0 0.2 55.1 0.0 0.0 0.0 0.8 0.0 0.9 2.1 0.5 2.5 1.3 1.0 0.0 8.6 PTPN22 "Lyp, Lyp1, Lyp2, PTPN8" ENSG00000134242 "Protein tyrosine phosphatase, non-receptor type 22" Q9Y2R2 1 113813811-113871759 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, Immunity" "Hydrolase, Protein phosphatase" "Diabetes mellitus, Disease mutation, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.6;lymphoid tissue: 46.0" "Cell type enhanced" "Detected in many" 15 "B-cells: 29.6;granulocytes: 26.6;Kupffer cells: 19.2;Macrophages: 20.5;T-cells: 65.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 33.5;HL-60: 13.3;U-266/70: 14.4;U-698: 18.0;U-937: 13.6" "Region enriched" "Detected in single" 10 "cerebellum: 5.9" "Not detected" "Not detected" "HPA004912, CAB012209, HPA013350" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570" "unprognostic (2.25e-2)" "unprognostic (5.31e-3)" "unprognostic (3.48e-1)" "unprognostic (3.33e-4)" "unprognostic (9.14e-2)" "unprognostic (2.47e-3)" "unprognostic (9.60e-2)" "unprognostic (8.14e-2)" "unprognostic (3.71e-1)" "unprognostic (1.82e-1)" "unprognostic (1.62e-1)" "unprognostic (3.02e-1)" "unprognostic (2.75e-6)" "unprognostic (3.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-2)" 4.2 1.4 0.5 17.1 0.8 23.6 1.9 1.0 0.5 2.4 3.3 0.3 1.0 4.1 2.0 2.2 2.0 1.7 3.2 2.5 0.6 0.7 3.4 1.8 9.0 14.9 0.7 0.4 1.5 2.4 0.0 0.9 0.9 1.0 1.7 2.8 1.3 2.7 3.0 0.6 1.0 9.9 0.9 2.1 19.0 3.1 1.1 0.4 46.0 1.5 2.4 12.8 4.8 1.7 7.2 6.2 17.2 3.5 7.5 14.9 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.3 0.0 0.2 33.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 3.1 0.0 4.7 0.0 0.0 0.1 13.3 10.5 3.0 0.0 1.4 0.1 2.7 5.2 8.4 0.0 7.7 5.1 0.1 9.4 7.5 0.0 0.0 0.0 0.5 3.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 2.4 8.0 0.1 0.1 0.2 14.4 3.0 18.0 5.5 13.6 0.0 10.2 3.5 17.2 12.8 0.9 14.9 7.2 6.5 10.1 6.2 4.7 3.9 9.4 1.7 7.5 0.4 3.7 10.0 4.6 0.5 0.8 1.0 0.5 0.6 0.7 0.7 0.4 1.0 0.4 0.0 9.2 29.6 0.2 2.3 0.4 0.5 0.0 4.0 0.0 1.8 2.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.5 0.2 0.9 0.2 26.6 0.6 7.1 0.0 0.0 0.6 19.2 0.6 0.0 20.5 3.3 1.8 1.0 0.0 0.6 0.0 0.0 0.0 0.4 12.9 0.9 0.3 0.2 2.4 0.1 65.4 1.7 0.2 PTPRC "CD45, GP180, LCA, T200" ENSG00000081237 "Protein tyrosine phosphatase, receptor type C" 1 198638457-198757476 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 116.9;lymphoid tissue: 172.5" "Cell type enhanced" "Detected in many" 12 "B-cells: 266.4;granulocytes: 232.9;Kupffer cells: 338.8;Macrophages: 290.3;T-cells: 539.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 47.1;HEL: 26.6;HL-60: 24.0;JURKAT: 61.5;MOLT-4: 35.5;THP-1: 19.7;U-266/70: 22.0;U-266/84: 20.0;U-698: 28.2;U-937: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000052, HPA000440, CAB002800, CAB056154, CAB068221" Enhanced Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377" "unprognostic (1.51e-2)" "unprognostic (1.24e-2)" "unprognostic (5.10e-3)" "unprognostic (2.33e-3)" "unprognostic (1.30e-1)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (3.17e-2)" "unprognostic (1.25e-1)" "unprognostic (3.18e-2)" "unprognostic (8.08e-2)" "unprognostic (3.95e-1)" "prognostic unfavorable (2.42e-4)" "unprognostic (2.31e-1)" "unprognostic (3.43e-2)" "unprognostic (6.41e-2)" "unprognostic (7.06e-2)" 9.8 2.9 3.4 48.0 6.2 36.1 4.3 1.3 3.5 3.1 5.6 2.8 0.5 4.9 2.9 3.9 4.8 5.6 8.8 4.9 3.9 4.5 4.4 5.2 27.5 93.2 7.9 1.3 2.9 2.1 0.3 2.5 4.5 5.3 4.2 5.8 3.3 10.7 1.0 1.7 2.5 22.2 4.5 13.2 89.3 6.5 2.3 5.3 172.5 4.6 3.9 53.2 13.1 3.7 28.5 42.8 94.7 103.8 53.7 76.1 116.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 26.6 0.0 0.0 0.0 24.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 61.5 0.5 0.7 0.0 0.0 35.5 14.5 0.1 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.1 0.0 0.0 19.7 0.3 0.0 0.2 0.1 0.1 22.0 20.0 28.2 0.0 21.5 0.1 20.8 52.0 56.3 76.1 99.7 64.5 28.5 52.9 72.7 42.8 26.8 60.2 60.3 94.7 53.7 103.8 6.4 54.6 116.9 3.4 6.2 1.3 3.5 3.9 4.5 7.9 1.3 5.3 5.3 41.7 86.9 266.4 0.7 14.1 0.0 4.1 7.6 21.4 26.1 1.8 0.0 0.4 0.0 0.0 2.0 11.9 0.1 23.3 0.0 0.5 8.9 0.9 232.9 3.0 90.3 0.0 1.2 14.1 338.8 1.5 1.1 290.3 20.3 120.0 0.2 0.0 0.1 0.0 0.0 1.7 0.2 6.5 4.3 0.2 0.2 13.2 0.7 539.1 0.5 0.9 PTPRK R-PTP-kappa ENSG00000152894 "Protein tyrosine phosphatase, receptor type K" Q15262 6 127968779-128520674 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 2.3;naive B-cell: 4.8;naive CD8 T-cell: 1.6" "Group enriched" "Detected in many" 7 "B-cells: 4.8;T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054056, HPA054822" Uncertain Supported "Vesicles,Plasma membrane,Cell Junctions" NA NA 13000000 "Cell Junctions" "Vesicles, Plasma membrane" "HPA054056: AB_2682359, HPA054822: AB_2682614" "unprognostic (3.15e-2)" "unprognostic (1.07e-2)" "unprognostic (5.79e-3)" "unprognostic (4.95e-3)" "unprognostic (1.89e-2)" "unprognostic (7.26e-2)" "unprognostic (3.27e-1)" "unprognostic (6.06e-2)" "unprognostic (2.04e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (1.46e-1)" "prognostic favorable (9.33e-5)" "unprognostic (2.10e-1)" "unprognostic (1.55e-1)" "unprognostic (2.59e-1)" "unprognostic (9.32e-2)" 12.0 5.2 18.6 10.7 20.3 1.2 20.9 4.7 24.4 12.2 21.9 25.6 11.2 25.7 12.1 10.3 9.1 13.2 29.6 11.4 17.2 12.6 13.3 23.6 17.4 5.7 20.5 19.3 15.6 25.7 11.4 12.2 17.4 14.9 16.3 23.4 3.9 18.3 17.5 9.1 13.5 27.4 14.6 17.1 6.4 24.6 2.7 23.7 15.3 10.1 6.5 7.6 18.4 15.1 4.8 0.0 0.0 0.0 0.4 1.6 0.2 4.5 4.9 2.9 0.2 6.2 8.3 3.0 12.3 23.8 5.1 4.6 8.1 3.8 0.0 3.7 11.3 14.8 12.9 3.1 9.7 7.2 13.6 4.9 0.1 7.5 11.2 7.6 0.0 0.4 6.1 9.0 10.6 14.5 13.3 13.8 4.4 0.0 0.2 12.4 9.1 6.9 0.0 3.1 8.3 6.3 24.8 6.3 0.8 12.6 9.3 15.5 0.0 12.7 14.2 0.7 3.5 3.9 0.3 23.4 8.0 5.6 15.5 11.1 0.1 1.6 0.0 10.2 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.0 4.8 0.4 1.6 0.0 0.4 0.0 0.0 0.1 0.2 18.6 20.3 4.7 24.4 17.2 12.6 20.5 19.3 14.9 23.7 23.8 27.4 9.7 78.6 56.3 3.1 19.3 76.5 18.7 33.0 17.4 3.9 21.8 0.0 51.8 3.4 46.7 63.1 0.0 53.2 4.5 30.5 99.0 1.1 36.5 5.1 9.5 42.2 8.0 1.0 2.1 15.8 1.8 16.9 2.8 41.3 7.0 84.8 57.5 17.0 11.2 0.6 58.2 35.8 3.6 5.8 33.2 22.4 1.0 48.9 100.5 PTPRS ENSG00000105426 "Protein tyrosine phosphatase, receptor type S" Q13332 19 5158495-5340803 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Heparin-binding, Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 54.1;Melanocytes: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 82 "plasmacytoid DC: 13.4" "Lineage enriched" "Detected in single" 82 "dendritic cells: 13.4" "Cell line enhanced" "Detected in many" "AN3-CA: 41.4;HaCaT: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054747 Approved "Plasma membrane,Cytosol" "Secreted - unknown location" NA NA 92000000 "Plasma membrane, Cytosol" "HPA054747: AB_2682591" "unprognostic (8.14e-2)" "unprognostic (4.59e-3)" "unprognostic (2.57e-2)" "unprognostic (9.20e-2)" "unprognostic (2.15e-1)" "unprognostic (6.96e-3)" "unprognostic (6.85e-2)" "unprognostic (2.36e-1)" "unprognostic (3.12e-3)" "unprognostic (1.86e-1)" "prognostic favorable (1.07e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (2.80e-1)" "unprognostic (1.45e-1)" "unprognostic (4.05e-1)" "unprognostic (3.46e-2)" 59.1 17.3 14.4 9.4 14.8 3.1 32.0 27.6 53.3 28.7 11.4 29.6 14.4 4.6 21.4 15.4 13.3 24.0 22.2 18.6 15.9 15.1 10.7 6.9 13.9 8.6 20.5 12.1 29.2 38.4 10.5 16.6 4.3 12.0 23.1 3.6 28.9 21.5 20.1 11.9 23.8 6.5 17.5 13.8 8.3 12.7 10.8 18.7 4.4 21.1 7.2 7.5 19.1 22.7 0.0 13.4 0.0 0.0 0.0 0.1 0.0 3.7 21.3 19.2 41.4 8.8 7.2 2.5 6.4 7.7 7.8 6.4 0.2 2.0 0.0 15.3 10.8 6.2 42.1 5.1 0.0 3.5 0.4 8.2 0.0 8.7 13.2 4.0 0.0 4.8 7.6 1.8 1.6 0.3 10.2 0.2 2.6 5.9 0.0 3.1 15.7 1.6 4.0 10.8 0.1 9.1 0.0 4.2 0.0 1.6 7.5 14.8 20.3 6.1 1.1 11.7 3.9 7.4 1.6 0.9 7.0 12.1 16.0 7.8 2.1 0.0 12.2 3.6 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 14.4 14.8 27.6 17.6 15.9 15.1 20.5 12.1 12.0 18.7 6.0 0.6 3.2 32.4 54.1 33.8 10.9 12.7 1.4 2.3 12.2 2.0 0.5 8.3 1.4 2.3 10.2 0.0 0.0 0.8 23.7 30.9 35.7 0.0 18.3 1.5 11.1 2.9 28.3 0.3 2.9 43.1 1.4 75.9 0.0 0.0 37.3 0.5 0.0 33.9 2.4 7.7 12.9 39.2 7.2 5.3 32.0 0.8 0.0 0.0 21.1 PXDNL "FLJ25471, PMR1" ENSG00000147485 "Peroxidasin like" A1KZ92 8 51319578-51809445 "Enzymes, Predicted intracellular proteins" "Hydrogen peroxide" "Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 59.1" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 29.9;Early spermatids: 34.8;Muller glia cells: 18.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 4 "B-cells: 1.5" "Group enriched" "Detected in some" 7 "AF22: 11.1;Daudi: 8.3;SH-SY5Y: 8.9" HPA007919 Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA007919: AB_1855966" "prognostic unfavorable (3.27e-5)" "unprognostic (4.59e-4)" "unprognostic (5.57e-3)" "unprognostic (2.83e-3)" "unprognostic (2.71e-1)" "unprognostic (5.14e-2)" "unprognostic (1.18e-1)" "unprognostic (7.18e-3)" "unprognostic (1.85e-1)" "unprognostic (1.15e-1)" "unprognostic (7.07e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-4)" "unprognostic (2.28e-2)" "unprognostic (3.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.97e-4)" 1.1 0.1 0.3 0.1 0.2 0.0 0.2 0.1 0.9 0.1 0.1 0.0 0.2 0.0 0.3 7.9 0.4 0.1 0.7 59.1 0.2 0.3 1.0 0.1 0.2 0.3 0.3 0.3 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.0 1.8 1.1 0.3 0.9 0.2 0.2 0.1 0.2 0.3 0.1 5.2 0.0 0.1 0.2 2.5 0.3 0.2 0.1 1.5 0.3 0.3 0.0 0.0 0.1 0.0 0.7 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.5 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.3 0.2 0.1 0.9 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.7 29.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.6 0.1 0.0 0.0 0.0 0.0 PYCR3 "FLJ13852, PYCRL" ENSG00000104524 "Pyrroline-5-carboxylate reductase 3" Q53H96 8 143603913-143609773 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 8.1;Collecting duct cells: 14.0;Ductal cells: 7.1;Exocrine glandular cells: 7.9;Extravillous trophoblasts: 10.5;Proximal tubular cells: 10.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053776, HPA063416, HPA069706" Uncertain Supported "Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA Cytosol "Cytokinetic bridge, Mitotic spindle" "HPA053776: , HPA063416: AB_2685010, HPA069706: AB_2686178" "unprognostic (2.12e-2)" "unprognostic (3.16e-2)" "unprognostic (2.74e-1)" "unprognostic (2.44e-1)" "unprognostic (1.06e-2)" "unprognostic (2.30e-1)" "unprognostic (7.68e-3)" "unprognostic (1.79e-1)" "unprognostic (1.96e-1)" "unprognostic (2.26e-2)" "unprognostic (5.85e-2)" "unprognostic (5.44e-2)" "unprognostic (1.82e-2)" "unprognostic (3.64e-2)" "unprognostic (2.96e-1)" "unprognostic (3.54e-2)" "unprognostic (2.54e-1)" 6.1 8.1 11.5 6.7 9.7 4.8 5.6 5.3 13.4 6.9 5.4 6.1 10.8 4.4 4.7 5.2 6.1 10.1 6.3 4.4 12.2 8.5 7.7 20.5 5.9 6.7 7.6 12.1 6.7 10.6 4.3 9.1 3.5 9.7 7.5 4.0 4.5 13.7 9.1 4.8 4.7 4.9 4.0 4.4 5.9 7.0 8.6 4.5 3.8 9.5 6.3 6.1 3.6 3.1 11.1 5.4 0.4 1.4 3.2 3.2 2.1 5.9 11.1 2.0 4.3 1.9 1.2 4.2 5.3 2.2 4.3 2.4 4.9 5.8 7.8 7.1 3.8 1.6 5.0 1.9 6.2 0.8 5.3 6.8 3.8 4.2 3.2 1.9 1.7 1.2 2.1 1.6 4.9 2.8 1.4 2.4 5.0 5.9 2.4 2.0 18.2 7.4 1.3 1.8 5.5 18.0 5.2 1.9 11.7 3.9 3.8 7.2 2.4 8.5 10.9 2.0 0.8 13.4 2.2 2.1 3.8 8.0 5.9 4.9 4.2 1.0 4.9 4.5 2.4 3.5 0.3 1.4 0.2 3.2 1.1 3.1 5.8 2.1 2.6 2.1 11.1 3.0 3.0 0.4 3.2 1.0 5.4 1.8 2.1 11.5 9.7 5.3 13.4 12.2 8.5 7.6 12.1 9.7 4.5 3.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 1.2 14.0 0.0 4.9 3.3 7.1 0.0 0.0 0.0 0.0 7.9 10.5 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 6.1 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 PYGO2 ENSG00000163348 "Pygopus family PHD finger 2" Q9BRQ0 1 154957026-154963853 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023689, HPA074813" Supported Supported "Nucleoplasm,Plasma membrane" No No Nucleoplasm "Plasma membrane" "HPA023689: AB_1855974, HPA074813: " "unprognostic (1.49e-2)" "unprognostic (1.33e-1)" "unprognostic (6.96e-3)" "unprognostic (2.58e-2)" "unprognostic (5.85e-2)" "unprognostic (4.32e-3)" "prognostic unfavorable (3.88e-6)" "unprognostic (2.45e-1)" "unprognostic (2.07e-1)" "unprognostic (2.00e-2)" "unprognostic (1.51e-1)" "unprognostic (3.74e-1)" "unprognostic (7.40e-3)" "unprognostic (1.63e-2)" "unprognostic (2.81e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.76e-4)" 14.0 28.4 22.2 22.8 23.7 6.6 26.1 28.5 26.8 20.8 20.5 23.4 22.1 21.3 18.7 27.9 21.4 24.1 21.6 15.0 18.7 22.9 19.1 17.4 17.2 26.7 22.2 19.4 32.5 17.5 37.7 31.0 18.4 21.3 24.5 17.9 21.3 25.3 32.6 16.4 25.0 22.5 18.3 22.1 26.4 19.1 15.7 22.1 30.9 35.5 12.9 30.1 20.3 21.8 8.9 4.3 10.5 8.2 6.3 12.8 5.7 12.9 9.2 19.6 17.3 19.8 9.7 18.0 8.1 11.0 12.9 11.1 12.3 16.3 16.3 12.9 9.4 14.0 17.7 17.0 11.3 8.5 16.1 12.1 13.0 15.0 10.9 9.2 11.9 11.6 8.0 16.4 11.6 9.8 14.7 7.9 25.0 17.0 27.8 12.1 19.8 16.4 13.9 20.9 26.1 16.6 18.6 12.5 25.7 13.1 12.3 23.6 35.1 12.8 23.4 16.1 19.9 28.7 21.5 6.6 11.5 17.4 12.4 11.7 27.6 24.4 17.4 9.6 15.2 15.2 2.4 3.9 10.5 9.0 6.8 11.6 7.5 11.5 11.9 4.3 8.9 12.8 9.6 4.0 6.3 8.2 4.2 6.0 5.7 22.2 23.7 28.5 26.8 18.7 22.9 22.2 19.4 21.3 22.1 8.9 8.2 8.4 3.2 4.8 10.2 4.2 5.1 1.4 6.8 12.2 2.0 12.8 16.6 5.0 2.7 6.8 7.0 0.0 5.1 10.1 5.3 4.2 0.0 7.8 5.5 20.6 5.2 6.7 6.9 1.8 8.3 3.9 5.0 4.6 9.7 9.8 8.0 8.6 8.5 7.6 6.1 6.5 6.6 4.1 10.9 4.5 9.7 11.7 9.5 2.8 RAB22A ENSG00000124209 "RAB22A, member RAS oncogene family" Q9UL26 20 58309696-58367507 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 120.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058894, HPA066920" Approved Uncertain Centrosome NA NA Centrosome "HPA058894: , HPA066920: AB_2685749" "unprognostic (4.14e-2)" "unprognostic (1.08e-1)" "unprognostic (2.68e-1)" "unprognostic (8.34e-3)" "unprognostic (6.20e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (7.33e-5)" "unprognostic (1.95e-1)" "unprognostic (1.36e-1)" "unprognostic (3.12e-1)" "unprognostic (2.00e-2)" "unprognostic (3.59e-2)" "unprognostic (1.12e-2)" "unprognostic (2.16e-1)" "unprognostic (2.55e-1)" "unprognostic (7.52e-2)" "unprognostic (7.01e-3)" 12.4 19.3 19.1 9.5 21.5 7.7 12.4 11.9 23.0 12.8 13.2 15.9 5.9 13.0 11.5 15.3 19.3 9.3 10.7 8.6 17.6 17.0 14.2 13.6 11.1 9.9 16.5 10.3 11.3 10.4 27.7 15.1 11.3 18.1 10.4 13.1 6.8 11.3 11.2 7.8 13.8 17.3 11.1 17.1 10.9 12.7 9.9 13.4 11.8 16.0 11.6 12.9 10.7 12.6 4.3 3.6 5.2 5.1 5.8 6.3 2.1 11.1 4.6 5.9 3.8 12.2 11.5 3.5 8.5 9.8 11.7 7.1 7.7 7.7 6.2 10.6 11.8 13.1 9.0 3.0 13.3 13.3 4.1 2.9 4.3 6.6 6.1 9.5 5.4 7.7 7.8 16.3 8.3 8.6 8.3 7.3 4.9 3.8 8.9 12.2 16.0 6.3 5.1 1.4 9.9 11.5 3.3 5.7 5.3 7.3 7.2 4.5 6.1 11.9 22.6 9.8 3.2 8.3 7.4 11.5 19.4 8.0 12.0 10.1 7.7 10.6 4.1 19.9 5.2 6.6 3.1 2.9 2.1 6.3 3.3 5.8 4.3 4.7 5.4 3.6 3.8 4.4 5.3 5.2 5.8 5.1 2.9 3.8 2.1 19.1 21.5 11.9 23.0 17.6 17.0 16.5 10.3 18.1 13.4 20.8 14.4 20.7 58.6 49.7 13.9 16.5 30.6 24.1 18.2 19.2 7.9 14.1 43.1 34.7 4.4 20.2 23.8 23.3 31.5 20.3 31.8 63.8 11.5 22.1 24.4 11.1 18.5 22.7 19.6 6.5 29.1 27.3 23.6 17.2 22.0 25.7 53.3 21.2 19.4 31.6 10.7 12.9 38.1 21.9 33.3 60.2 29.6 31.5 18.8 120.4 RAB24 ENSG00000169228 "RAB24, member RAS oncogene family" Q969Q5 5 177301198-177303744 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034945 Uncertain "Focal adhesion sites" No No "Focal adhesion sites" "HPA034945: " "unprognostic (1.03e-2)" "unprognostic (6.81e-2)" "unprognostic (3.05e-2)" "unprognostic (1.59e-1)" "unprognostic (7.86e-2)" "prognostic favorable (6.22e-4)" "prognostic unfavorable (7.56e-5)" "unprognostic (1.28e-1)" "unprognostic (1.78e-2)" "unprognostic (9.66e-2)" "unprognostic (1.43e-3)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.54e-7)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (2.75e-1)" "unprognostic (1.12e-2)" 13.6 19.7 18.3 19.9 20.9 24.6 16.8 25.0 24.2 12.1 13.7 7.5 25.3 15.3 10.9 23.6 21.0 11.9 12.4 12.7 15.4 18.0 16.6 15.2 14.2 15.5 13.1 22.0 16.9 31.4 16.2 26.0 15.6 19.8 15.3 11.0 14.1 23.2 20.8 27.1 19.5 15.6 14.5 10.6 27.6 12.8 5.7 13.1 5.9 18.8 15.1 19.9 11.0 15.9 7.5 14.5 38.0 42.0 7.9 5.1 10.2 2.9 7.9 5.2 10.4 8.5 7.5 10.9 9.1 11.4 11.3 13.7 9.5 3.9 3.2 11.2 7.2 12.6 2.8 7.0 9.8 6.3 55.2 5.6 11.0 8.0 8.1 17.9 6.9 10.0 12.4 8.0 12.0 8.5 16.7 6.9 8.8 8.2 17.5 7.9 11.2 2.5 19.9 3.3 5.9 8.0 1.5 8.6 12.4 7.6 5.2 6.7 9.1 2.8 5.6 23.5 6.6 10.1 17.4 7.6 4.0 6.5 9.1 7.8 13.4 6.3 4.1 7.5 11.2 8.4 8.7 21.4 38.0 5.1 42.0 4.4 7.5 2.5 4.2 14.5 6.8 2.8 4.4 33.0 7.9 40.7 3.2 2.1 10.2 18.3 20.9 25.0 24.2 15.4 18.0 13.1 22.0 19.8 13.1 3.0 10.3 9.9 1.7 4.7 3.1 2.0 0.0 4.0 10.3 1.8 2.0 6.2 3.3 21.3 0.3 4.2 15.7 0.0 17.6 4.6 4.4 1.9 11.5 1.5 3.9 12.7 17.3 8.0 10.0 0.2 4.6 9.1 3.3 1.0 12.6 1.9 16.4 15.2 1.1 5.4 4.4 0.0 4.1 2.4 3.3 5.3 25.6 4.9 12.8 2.0 RAB25 CATX-8 ENSG00000132698 "RAB25, member RAS oncogene family" P57735 1 156061160-156070514 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 98.3" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 238.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.3;naive CD4 T-cell: 3.4" "Lineage enriched" "Detected in single" 24 "T-cells: 3.4" "Cell line enhanced" "Detected in some" "BEWO: 24.3;CAPAN-2: 23.6;MCF7: 32.8;OE19: 75.9;RT4: 29.8;SK-BR-3: 48.5;T-47d: 45.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010872, CAB033645" Enhanced Uncertain "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "CAB033645: AB_1128883, HPA010872: AB_1079729" "unprognostic (2.43e-1)" "unprognostic (4.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-1)" "unprognostic (4.27e-2)" "unprognostic (4.63e-2)" "unprognostic (2.82e-1)" "unprognostic (2.03e-2)" "unprognostic (1.22e-2)" "unprognostic (1.39e-1)" "prognostic favorable (1.38e-6)" "unprognostic (2.31e-2)" "unprognostic (3.24e-2)" "unprognostic (3.14e-2)" "unprognostic (4.94e-2)" 0.4 0.3 0.3 10.9 0.3 0.0 10.8 0.5 0.4 23.6 28.4 0.3 28.1 14.8 4.0 15.9 98.3 9.7 33.3 0.3 0.3 0.3 18.2 1.0 19.1 0.6 0.3 0.2 2.3 27.4 8.6 9.5 19.1 0.3 13.3 16.2 0.4 44.1 26.8 0.4 48.0 43.0 2.1 0.4 0.3 16.2 1.1 0.2 3.7 36.1 74.6 60.9 13.0 31.8 0.1 0.0 0.0 0.0 0.0 3.4 0.8 17.8 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 17.5 23.6 0.0 0.0 0.0 0.0 21.5 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.0 0.9 75.9 0.0 0.0 0.0 0.0 0.0 29.8 2.6 0.0 0.0 48.5 0.0 4.4 45.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 2.8 0.8 0.0 0.0 3.4 2.9 0.0 0.0 0.0 0.0 0.9 0.8 0.3 0.3 0.5 0.4 0.3 0.3 0.3 0.2 0.3 0.2 26.8 27.6 0.0 90.6 48.9 0.0 0.1 79.0 53.5 27.3 82.0 0.0 84.0 140.9 146.8 0.0 0.1 182.7 0.0 132.5 23.0 3.7 95.3 5.7 0.0 6.1 0.0 82.1 0.0 0.0 0.0 0.3 2.5 20.3 6.4 160.3 0.0 154.4 238.4 0.0 16.8 0.0 0.0 2.1 0.2 0.7 135.3 67.2 1.5 195.0 192.0 RAB26 ENSG00000167964 "RAB26, member RAS oncogene family" Q9ULW5 16 2140803-2154165 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;liver: 21.9;pancreas: 24.6;salivary gland: 17.7" "Group enriched" "Detected in many" 7 "Bipolar cells: 34.1;Intestinal endocrine cells: 95.4;Mucus-secreting cells: 41.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 13.9;HeLa: 15.2;MCF7: 9.1;SCLC-21H: 19.3;SK-BR-3: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075624 Uncertain "Vesicles,Plasma membrane,Centrosome" "Intracellular and membrane" No No "Vesicles, Plasma membrane" Centrosome "HPA075624: " "unprognostic (1.01e-2)" "prognostic favorable (8.20e-5)" "unprognostic (7.25e-2)" "unprognostic (1.52e-1)" "unprognostic (7.34e-2)" "unprognostic (9.41e-3)" "unprognostic (2.81e-2)" "unprognostic (5.10e-2)" "unprognostic (1.82e-2)" "unprognostic (3.55e-2)" "unprognostic (3.75e-2)" "unprognostic (2.14e-1)" "unprognostic (6.48e-2)" "unprognostic (5.68e-2)" "unprognostic (1.23e-1)" "unprognostic (7.16e-2)" "unprognostic (2.92e-3)" 0.6 1.0 13.6 0.4 19.9 0.5 0.9 30.5 13.5 2.0 4.1 0.5 1.5 5.7 0.4 2.3 1.2 0.9 1.1 1.2 18.0 6.2 0.7 21.9 0.6 0.6 5.6 9.1 0.6 24.6 3.1 9.2 0.3 2.5 2.2 5.4 0.7 17.7 1.6 1.1 1.2 6.0 0.4 1.9 0.6 5.3 0.6 3.2 0.0 1.2 0.0 1.1 0.9 0.0 0.8 0.2 0.0 0.1 0.0 1.1 0.7 1.1 13.9 0.0 3.5 0.2 0.1 0.1 0.6 1.1 0.5 0.9 0.4 2.8 0.2 1.0 0.9 0.4 2.2 0.7 0.2 0.0 1.5 1.4 0.5 15.2 1.2 0.6 0.0 0.4 0.5 0.1 0.1 0.2 3.3 0.3 2.2 0.3 0.0 1.6 9.1 0.0 0.6 0.8 4.5 1.3 1.1 1.1 2.3 5.4 0.9 19.3 3.8 0.3 17.5 0.7 0.2 5.7 0.2 0.6 0.0 2.5 0.2 0.2 2.0 0.1 0.2 0.4 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.1 0.0 0.8 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.7 13.6 19.9 30.5 13.5 18.0 6.2 5.6 9.1 2.5 3.2 0.0 0.6 1.4 1.9 1.1 34.1 1.2 2.5 0.0 2.3 0.0 3.9 0.0 0.0 0.2 0.0 0.1 3.9 0.0 0.8 0.0 0.0 1.6 0.0 7.3 0.2 1.6 95.4 0.6 0.3 0.0 0.0 0.0 3.3 0.0 41.2 8.1 0.8 1.9 0.0 0.4 8.4 0.0 0.1 0.0 2.3 0.1 0.1 0.0 2.7 1.4 RAB33A RabS10 ENSG00000134594 "RAB33A, member RAS oncogene family" Q14088 X 130171649-130184870 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.3;brain: 32.4" "Cell type enhanced" "Detected in many" 10 "granulocytes: 23.0;Melanocytes: 11.8;T-cells: 20.3" "Group enriched" "Detected in many" 6 "glioma: 10.7;melanoma: 2.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 32.2;Karpas-707: 36.5;U-266/70: 26.8;U-937: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059737 Uncertain Uncertain Vesicles NA NA Vesicles "HPA059737: AB_2684115" "unprognostic (5.40e-2)" "unprognostic (6.64e-3)" "unprognostic (3.48e-2)" "unprognostic (8.47e-3)" "unprognostic (4.88e-2)" "unprognostic (1.17e-2)" "unprognostic (2.34e-1)" "unprognostic (1.76e-2)" "unprognostic (3.12e-2)" "unprognostic (4.16e-2)" "unprognostic (3.03e-2)" "unprognostic (8.28e-2)" "unprognostic (7.00e-6)" "unprognostic (2.51e-1)" "unprognostic (6.35e-2)" "unprognostic (3.45e-2)" "unprognostic (1.61e-1)" 1.8 2.3 12.5 4.9 11.6 6.8 1.6 15.8 32.4 2.0 1.7 20.8 0.0 1.6 2.1 1.4 1.4 2.2 3.5 10.3 15.9 9.9 1.1 1.5 1.9 11.9 13.0 12.6 2.5 0.8 3.2 1.6 2.3 10.1 1.1 1.9 0.6 1.5 1.0 0.8 1.0 1.9 1.6 21.5 3.3 2.3 1.5 17.3 1.2 1.0 0.0 13.1 3.3 0.6 7.1 3.3 27.3 1.7 5.7 22.9 5.9 0.1 0.0 2.2 0.0 0.9 0.2 0.0 0.2 0.6 0.5 0.9 0.0 0.2 1.6 0.0 0.1 0.1 0.0 2.6 0.0 0.5 8.4 0.0 9.6 0.0 0.0 8.9 7.7 32.2 0.3 0.0 0.1 0.3 0.2 0.2 10.0 0.0 36.5 0.0 0.0 3.5 2.7 0.3 0.0 0.3 0.0 0.0 0.4 0.0 0.0 7.0 5.8 0.0 0.0 0.1 0.1 0.0 4.1 0.0 0.0 0.0 0.1 0.0 26.8 8.0 0.0 1.1 15.2 0.0 9.4 0.4 27.3 11.2 0.2 7.0 7.1 10.1 11.1 3.3 2.6 9.8 13.9 1.3 5.7 1.7 0.3 22.9 5.9 12.5 11.6 15.8 18.5 15.9 9.9 13.0 12.6 10.1 17.3 0.0 0.6 0.5 0.5 1.6 8.4 4.2 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.9 2.1 0.0 0.0 0.2 1.1 5.8 0.3 23.0 0.0 1.9 4.8 0.0 3.1 0.3 0.0 1.7 3.7 11.8 2.8 0.0 1.3 0.6 0.0 0.4 0.0 7.4 0.0 4.1 0.1 1.1 1.0 1.1 20.3 0.0 0.5 RAB38 NY-MEL-1 ENSG00000123892 "RAB38, member RAS oncogene family" P57729 11 88113242-88175467 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 35.5;tongue: 38.1" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 41.2;Cytotrophoblasts: 78.5;Melanocytes: 124.9;Suprabasal keratinocytes: 86.1;Syncytiotrophoblasts: 45.8" "Cancer enhanced" "Detected in all" "melanoma: 73.8" "Region enriched" "Detected in single" 5 "pons and medulla: 3.2" "Group enriched" "Detected in many" 5 "NK-cell: 15.3;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 5 "dendritic cells: 4.2;NK-cells: 15.3" "Cell line enhanced" "Detected in many" "HBEC3-KT: 19.4;hTCEpi: 69.6;hTERT-HME1: 62.0;SK-MEL-30: 37.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071701 Uncertain "Nuclear bodies,Mitochondria" NA NA "Nuclear bodies, Mitochondria" "HPA071701: " "unprognostic (2.85e-1)" "unprognostic (1.30e-1)" "unprognostic (4.40e-2)" "unprognostic (2.66e-2)" "unprognostic (1.36e-2)" "unprognostic (7.95e-2)" "unprognostic (3.96e-4)" "unprognostic (2.36e-1)" "unprognostic (1.44e-1)" "unprognostic (9.34e-2)" "unprognostic (1.00e-2)" "unprognostic (8.23e-2)" "prognostic favorable (8.26e-4)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.61e-1)" "unprognostic (2.65e-2)" 1.8 15.6 0.4 1.2 0.4 0.4 4.6 0.3 0.6 10.8 1.6 1.2 2.8 1.0 7.0 8.7 29.9 2.8 8.2 1.7 0.6 0.5 2.6 0.8 5.3 0.4 0.5 0.2 3.0 2.3 0.9 4.6 7.7 3.2 4.0 0.4 35.5 4.9 5.2 0.5 24.9 2.4 2.7 0.7 1.3 0.9 5.3 0.1 1.6 6.6 38.1 21.0 4.2 13.3 0.0 4.2 0.5 1.3 15.3 1.8 0.6 2.3 0.3 0.0 0.1 0.0 0.5 0.1 1.4 5.8 2.3 4.3 1.0 1.0 0.1 1.4 1.5 0.2 15.9 1.2 19.4 3.2 0.2 1.1 11.7 1.5 0.0 0.2 0.1 0.1 0.5 69.6 0.3 62.0 2.9 2.7 0.2 0.0 0.2 0.0 0.0 0.1 3.9 1.8 0.1 0.0 0.1 0.0 0.1 4.5 8.9 0.4 0.2 0.0 0.0 37.4 1.4 3.5 1.0 1.5 0.0 1.0 0.0 0.2 0.3 1.4 0.0 0.3 0.4 0.2 0.0 0.6 0.1 1.6 0.6 0.9 0.0 0.5 1.8 1.5 0.0 0.1 0.9 0.5 15.3 1.3 4.2 0.9 0.6 0.4 0.4 0.3 0.6 0.6 0.5 0.5 0.2 3.2 0.1 0.0 4.1 0.0 12.1 41.2 0.0 0.1 0.0 4.0 7.9 0.0 0.0 78.5 3.3 1.3 0.0 1.5 1.1 0.0 1.0 6.8 6.7 2.1 16.1 0.0 14.7 0.0 0.0 0.0 1.0 0.0 3.1 4.9 124.9 10.8 0.0 0.5 1.8 1.1 1.1 3.2 5.9 0.0 2.8 0.0 3.2 86.1 45.8 1.5 2.1 22.8 RAB40A "Rar-2, RAR2A" ENSG00000172476 "RAB40A, member RAS oncogene family" Q8WXH6 X 103499130-103519489 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 34.0" "Cell type enriched" "Detected in single" 7 "Peritubular cells: 5.6" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 4.2" "Cell type enriched" "Detected in single" 5 "memory B-cell: 1.2" "Lineage enriched" "Detected in single" 5 "B-cells: 1.2" "Cell line enhanced" "Detected in many" "AF22: 6.5;NTERA-2: 7.2" HPA076172 Uncertain Vesicles NA NA Vesicles "HPA076172: " "unprognostic (3.49e-1)" "unprognostic (6.01e-2)" "unprognostic (4.33e-2)" "unprognostic (4.49e-3)" "unprognostic (8.73e-2)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "unprognostic (4.05e-1)" "unprognostic (3.82e-2)" "unprognostic (4.43e-1)" "unprognostic (7.36e-4)" "unprognostic (7.85e-3)" "unprognostic (9.39e-5)" "unprognostic (1.43e-1)" "unprognostic (1.11e-3)" 2.0 1.4 0.6 0.6 4.2 0.0 0.8 0.6 1.1 2.8 0.8 0.6 11.9 0.5 5.5 34.0 10.6 2.6 2.9 0.6 0.6 0.9 1.3 0.6 2.0 1.7 0.6 0.6 5.4 0.6 0.6 2.4 0.8 0.8 5.5 0.4 0.6 0.6 6.2 0.6 0.7 0.9 1.3 0.6 0.8 0.5 7.8 0.6 0.6 0.6 0.6 0.6 1.5 2.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.4 1.7 6.5 0.2 1.5 1.9 3.2 1.9 0.4 0.3 0.5 1.3 0.9 1.6 2.5 0.3 2.0 0.1 0.4 0.1 0.3 0.0 3.8 0.5 3.0 0.3 0.6 0.1 0.3 1.5 0.3 0.6 0.4 2.5 0.3 0.5 2.3 1.0 0.6 0.4 0.4 0.2 7.2 0.0 1.0 0.0 0.5 0.1 0.1 0.6 2.7 3.4 0.6 0.1 1.4 2.0 0.0 0.2 3.2 2.7 1.5 4.1 1.8 1.2 0.7 1.2 3.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.6 4.2 0.6 0.6 0.6 0.9 0.6 0.6 0.8 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 RAB40AL "RAR2, RLGP" ENSG00000102128 "RAB40A like" P0C0E4 X 102937272-102938300 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 2.9" "Cell type enhanced" "Detected in some" 7 "Cone photoreceptor cells: 2.0;Intestinal endocrine cells: 2.9;Ito cells: 2.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.3;HEK 293: 2.0" HPA076172 Uncertain Vesicles NA NA Vesicles "HPA076172: " "unprognostic (1.99e-1)" "unprognostic (3.05e-1)" "unprognostic (1.31e-1)" "unprognostic (1.11e-2)" "unprognostic (1.24e-1)" "unprognostic (1.04e-1)" "unprognostic (2.91e-1)" "unprognostic (1.39e-1)" "unprognostic (3.49e-1)" "unprognostic (1.83e-1)" "unprognostic (1.15e-1)" "unprognostic (2.18e-2)" "unprognostic (5.90e-10)" "unprognostic (4.74e-1)" "unprognostic (1.32e-1)" "unprognostic (5.02e-3)" "unprognostic (2.64e-2)" 0.3 1.0 0.2 0.2 0.3 0.7 0.4 2.1 0.4 0.3 0.4 1.0 0.8 2.9 0.2 0.3 0.7 0.3 0.3 0.3 0.2 0.5 0.5 0.0 0.2 1.0 0.2 0.0 0.9 0.6 0.8 0.1 0.2 0.5 0.0 0.2 0.1 0.6 0.4 0.2 0.1 0.3 0.8 0.2 0.0 0.5 0.0 1.2 0.0 0.3 0.0 0.7 0.0 0.5 0.6 0.8 0.2 0.0 0.0 2.3 0.0 0.2 0.0 0.5 0.0 0.5 0.0 0.6 0.0 0.8 0.0 1.2 0.0 0.6 0.2 2.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.3 0.3 0.4 0.4 0.3 0.1 0.4 0.0 0.0 1.4 0.6 1.0 0.6 0.0 1.6 0.0 0.3 0.0 0.2 1.0 0.0 0.2 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.3 1.4 0.5 0.5 0.3 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 2.0 0.8 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.1 0.6 0.0 0.8 0.3 1.6 2.9 2.5 1.5 0.7 1.4 0.0 0.0 0.0 0.0 0.9 0.1 0.0 1.4 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.6 0.0 0.5 0.3 RAB5A RAB5 ENSG00000144566 "RAB5A, member RAS oncogene family" P20339 3 19947079-19985175 "Predicted intracellular proteins, RAS pathway related proteins" "Endocytosis, Phagocytosis, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004567, HPA049354" Approved Supported Nucleoplasm,Vesicles NA NA 920000 "Nucleoplasm, Vesicles" "CAB004567: AB_628191, HPA049354: AB_2680725" "unprognostic (2.49e-3)" "unprognostic (1.95e-1)" "unprognostic (2.58e-2)" "unprognostic (4.72e-1)" "unprognostic (3.85e-1)" "unprognostic (5.58e-2)" "unprognostic (1.40e-2)" "unprognostic (6.75e-2)" "unprognostic (7.12e-2)" "unprognostic (5.97e-2)" "unprognostic (1.83e-3)" "unprognostic (4.68e-2)" "unprognostic (2.10e-2)" "unprognostic (1.93e-1)" "unprognostic (1.33e-1)" "unprognostic (2.45e-1)" "unprognostic (8.36e-2)" 25.8 21.2 42.5 19.3 34.7 26.5 25.5 25.2 36.6 24.8 21.9 26.0 18.1 21.6 17.5 33.4 32.4 16.3 24.7 28.3 38.4 38.0 25.5 31.3 22.5 16.3 43.5 33.8 16.2 21.9 39.2 23.8 36.1 35.1 24.0 23.4 16.2 25.4 23.3 35.8 27.2 21.6 21.2 49.1 17.0 23.6 15.7 30.3 22.7 31.4 22.2 20.8 23.7 23.7 5.0 11.2 22.7 14.8 12.5 7.0 6.8 11.6 10.7 15.7 10.8 27.6 24.6 16.0 20.6 24.2 19.7 22.8 12.6 18.6 8.6 12.5 22.6 11.5 7.4 11.7 15.3 23.1 14.8 9.7 12.5 10.4 12.2 34.6 17.4 15.8 22.5 29.1 23.0 33.9 24.8 24.8 11.5 14.3 13.9 23.5 18.0 13.5 12.5 19.7 16.2 17.3 10.1 11.1 12.5 40.2 15.5 4.9 16.3 14.7 18.5 23.7 24.5 14.4 14.2 24.6 14.4 12.5 18.2 17.4 17.2 28.2 11.4 22.9 16.0 23.3 15.1 11.4 18.7 5.3 12.1 7.0 5.0 6.3 6.4 11.2 3.5 5.9 5.4 22.7 12.5 14.8 7.4 6.6 6.8 42.5 34.7 25.2 36.6 38.4 38.0 43.5 33.8 35.1 30.3 56.6 39.7 36.6 109.3 151.1 33.1 53.1 22.9 46.8 40.9 40.1 29.5 67.4 87.9 48.7 14.5 60.9 53.0 23.3 40.0 57.3 76.1 98.0 84.2 36.4 48.3 14.3 59.4 39.3 42.9 12.4 33.9 55.8 79.2 41.5 43.4 64.7 48.5 38.6 33.2 49.4 31.1 51.8 76.2 19.5 25.5 164.4 137.4 44.9 37.0 131.9 RAB6C WTH3 ENSG00000222014 "RAB6C, member RAS oncogene family" Q9H0N0 2 129979664-129982738 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 17.2" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 8.7" "Cancer enhanced" "Detected in some" "prostate cancer: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 4.5;HMC-1: 4.0;REH: 9.3;T-47d: 5.8;U-266/70: 3.9" HPA059131 Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA059131: AB_2683916" "unprognostic (3.84e-2)" "unprognostic (5.77e-2)" "unprognostic (1.02e-1)" "unprognostic (1.07e-1)" "unprognostic (2.54e-1)" "unprognostic (8.62e-2)" "unprognostic (1.83e-1)" "unprognostic (1.98e-1)" "unprognostic (1.38e-2)" "unprognostic (1.50e-2)" "unprognostic (1.28e-1)" "unprognostic (2.44e-1)" "unprognostic (1.33e-1)" "unprognostic (4.48e-2)" "unprognostic (6.04e-2)" "unprognostic (1.24e-1)" "unprognostic (4.78e-1)" 1.7 3.3 5.1 1.4 6.2 1.1 9.9 1.3 10.3 7.6 2.0 4.0 1.3 1.1 3.3 1.4 2.2 1.6 1.5 1.5 7.6 5.3 1.4 3.8 1.2 1.2 5.2 4.9 1.5 4.2 17.2 1.6 2.8 8.6 7.0 1.3 2.1 2.0 2.8 1.7 1.2 4.4 1.3 5.3 2.7 1.3 4.0 1.5 0.8 1.5 0.9 1.3 1.2 1.5 0.2 0.3 0.8 0.5 0.6 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.0 9.3 0.0 0.9 0.0 0.0 0.1 0.8 0.0 0.8 0.2 1.1 5.8 0.0 0.0 0.0 0.7 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.9 0.4 0.3 0.2 0.2 0.4 0.3 0.1 0.1 0.2 0.2 0.6 0.5 0.2 0.4 0.3 5.1 6.2 1.3 10.3 7.6 5.3 5.2 4.9 8.6 1.5 0.0 0.0 0.0 0.2 0.7 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.4 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.8 1.0 0.5 0.0 0.0 0.3 RAB8B ENSG00000166128 "RAB8B, member RAS oncogene family" Q92930 15 63189469-63267782 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 177.9;Late spermatids: 271.9;monocytes: 180.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 44.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074534 Supported Nucleoplasm,Vesicles NA NA 5200000 Vesicles Nucleoplasm "HPA074534: AB_2686700" "unprognostic (7.67e-2)" "unprognostic (3.33e-2)" "unprognostic (2.75e-1)" "unprognostic (1.32e-1)" "unprognostic (5.20e-2)" "unprognostic (4.01e-2)" "unprognostic (1.46e-2)" "unprognostic (5.94e-2)" "unprognostic (3.19e-1)" "unprognostic (2.75e-2)" "unprognostic (1.71e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.97e-2)" "unprognostic (3.14e-2)" "unprognostic (4.19e-2)" "unprognostic (7.47e-2)" 21.8 12.1 15.2 20.9 12.9 50.8 22.6 10.1 12.2 15.8 17.7 11.8 7.6 13.6 14.2 8.6 10.9 12.7 18.4 17.5 19.2 14.4 13.7 11.4 27.7 30.8 15.3 12.9 25.2 5.7 6.6 11.7 22.0 16.9 14.3 9.0 9.8 9.3 11.3 7.5 8.2 21.1 14.3 19.5 33.7 9.8 11.8 11.5 38.8 16.4 4.7 27.8 24.4 23.7 10.7 10.4 30.8 14.5 13.1 19.2 14.3 4.8 4.1 15.7 6.5 30.0 24.8 4.7 4.8 11.0 8.7 17.1 4.4 3.9 13.2 4.4 10.3 10.5 2.4 13.5 6.5 14.7 19.8 2.6 16.6 3.7 2.8 28.0 6.2 10.5 14.9 3.4 16.4 9.6 11.3 22.0 13.8 6.5 12.8 15.9 3.2 10.1 3.4 9.8 4.5 4.0 8.7 21.0 1.9 6.9 22.9 1.3 3.3 7.3 0.9 13.4 10.5 3.5 6.3 24.8 16.3 10.5 8.6 6.4 8.3 8.2 12.5 10.4 17.7 44.1 27.1 14.5 11.9 15.8 13.1 14.4 10.7 12.8 15.0 10.4 10.6 10.0 12.2 30.8 13.1 11.6 1.3 19.2 14.3 15.2 12.9 10.1 12.0 19.2 14.4 15.3 12.9 16.9 11.5 17.9 20.2 18.8 6.9 27.6 1.9 3.1 12.7 8.1 7.9 7.0 11.8 10.5 10.0 19.1 177.9 29.2 2.4 0.0 11.5 84.9 38.5 11.2 38.1 5.5 47.2 19.1 10.3 34.4 65.8 271.9 29.4 57.9 33.7 180.3 4.1 12.8 27.6 0.0 35.7 18.6 12.1 19.4 19.5 43.7 15.9 19.6 31.2 66.1 3.0 20.9 RAB9A RAB9 ENSG00000123595 "RAB9A, member RAS oncogene family" P51151 X 13689125-13710506 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "monocytes: 563.5;Syncytiotrophoblasts: 309.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003094, CAB016411" Supported Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016411: AB_630176, HPA003094: AB_1079736" "unprognostic (3.40e-2)" "unprognostic (1.36e-2)" "unprognostic (3.56e-3)" "unprognostic (3.08e-2)" "unprognostic (1.62e-1)" "unprognostic (2.56e-2)" "unprognostic (1.79e-2)" "unprognostic (1.45e-1)" "unprognostic (8.77e-2)" "unprognostic (8.23e-2)" "unprognostic (1.27e-2)" "unprognostic (4.88e-2)" "prognostic favorable (3.35e-5)" "unprognostic (3.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.46e-1)" "unprognostic (2.68e-2)" 17.1 36.0 17.7 20.3 17.1 30.6 48.4 16.2 24.1 14.8 17.6 20.2 19.7 9.3 18.8 14.3 19.7 11.9 14.5 23.1 16.9 14.3 19.6 15.6 17.3 21.0 24.7 13.8 18.9 23.6 19.1 11.3 17.8 18.1 13.5 16.2 8.0 22.8 17.6 12.0 21.2 12.3 15.3 25.5 15.1 14.2 6.4 23.4 9.8 16.8 13.2 19.3 16.1 19.7 13.1 19.1 17.7 25.7 19.8 27.3 13.9 12.5 6.7 8.6 20.4 29.0 23.2 7.7 7.0 24.7 10.8 15.7 7.2 14.0 11.4 17.4 11.0 25.8 12.9 12.8 14.9 10.6 25.1 19.9 3.6 14.8 8.2 17.4 6.3 9.8 24.9 26.4 13.5 14.6 17.4 9.9 6.4 6.9 16.8 11.5 8.6 5.9 10.3 9.3 8.7 12.7 8.2 9.1 33.9 29.5 11.6 7.1 5.0 14.9 21.2 24.2 22.5 11.7 6.7 7.7 8.2 4.3 29.0 4.2 13.4 23.2 4.5 8.2 5.5 8.0 17.7 25.7 11.1 27.3 16.6 21.1 13.1 15.0 22.4 17.6 10.0 11.3 19.4 15.3 19.8 14.5 19.1 11.7 13.9 17.7 17.1 16.2 24.1 16.9 14.3 24.7 13.8 18.1 23.4 44.7 26.4 18.5 59.6 57.6 9.0 13.8 43.3 33.5 26.1 31.4 0.0 70.1 68.0 112.1 0.4 21.5 28.9 0.0 55.4 48.9 36.8 75.0 44.9 17.8 51.1 14.3 23.5 13.5 35.6 1.1 34.8 34.0 54.0 563.5 26.2 40.0 73.2 70.2 37.8 51.9 8.8 12.9 28.8 5.9 19.0 72.9 309.7 49.6 23.6 72.2 RABEPK "bA65N13.1, RAB9P40" ENSG00000136933 "Rab9 effector protein with kelch motifs" Q7Z6M1 9 125200542-125234158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 59.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023920, HPA067106" Supported Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA023920: AB_1856023, HPA067106: " "unprognostic (8.72e-2)" "unprognostic (1.29e-1)" "unprognostic (1.76e-2)" "unprognostic (1.58e-1)" "unprognostic (3.24e-2)" "unprognostic (2.70e-2)" "unprognostic (3.47e-2)" "unprognostic (3.47e-2)" "unprognostic (9.74e-2)" "unprognostic (4.92e-2)" "unprognostic (1.27e-1)" "unprognostic (1.92e-1)" "unprognostic (1.52e-3)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (8.25e-2)" "unprognostic (2.69e-1)" 11.9 11.7 14.9 11.5 21.6 8.6 13.7 9.3 21.3 11.0 11.4 12.4 9.0 9.9 18.7 15.3 12.9 13.7 10.6 11.6 13.8 15.1 9.8 49.6 8.6 13.9 16.5 17.7 11.5 10.9 7.7 13.6 10.2 15.0 10.1 13.1 9.5 13.0 12.0 17.4 12.4 8.5 14.3 13.0 8.1 9.0 11.1 12.6 11.6 9.2 10.0 11.4 10.2 10.0 15.9 14.6 19.0 13.5 13.8 28.5 16.0 9.3 22.9 8.7 16.0 14.0 17.1 16.6 13.3 13.1 16.0 12.7 28.1 9.7 29.0 11.7 18.0 15.6 25.8 22.2 16.7 15.5 16.2 18.6 12.4 21.4 41.5 12.7 24.0 9.0 12.5 20.4 23.0 24.4 9.5 16.7 18.1 27.9 8.1 15.0 26.6 16.7 16.4 18.0 38.3 21.2 24.4 16.7 31.8 12.6 7.5 21.0 10.3 13.7 9.1 15.4 9.0 19.1 10.5 14.1 10.5 10.8 25.1 22.9 11.0 24.2 19.6 13.9 15.9 16.1 16.5 13.5 14.9 17.2 10.8 15.9 15.9 25.0 16.8 14.6 13.4 28.5 20.6 19.0 13.8 11.1 14.0 25.3 16.0 14.9 21.6 9.3 21.3 13.8 15.1 16.5 17.7 15.0 12.6 0.0 9.9 9.3 12.6 12.9 11.2 8.1 7.6 6.7 4.5 5.2 7.9 28.7 21.6 12.3 59.9 10.5 7.7 0.0 11.5 25.3 19.1 8.8 4.7 48.8 18.9 12.7 2.4 10.4 8.2 12.6 15.0 8.7 8.5 47.7 10.6 9.2 9.0 0.0 17.7 16.8 16.3 0.0 13.9 7.7 13.0 11.3 10.6 8.7 15.6 11.6 RAD1 "HRAD1, REC1" ENSG00000113456 "RAD1 checkpoint DNA exonuclease" O60671 5 34905264-34918989 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006692 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA006692: AB_2667645" "prognostic unfavorable (6.30e-4)" "unprognostic (1.85e-2)" "unprognostic (9.40e-2)" "unprognostic (1.98e-3)" "unprognostic (2.00e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (1.06e-5)" "unprognostic (1.22e-2)" "unprognostic (2.25e-3)" "unprognostic (1.61e-3)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (3.12e-3)" 3.1 6.5 3.4 3.2 4.9 4.8 4.4 5.2 4.7 5.4 3.2 2.9 4.6 3.8 3.7 3.5 3.3 6.6 3.5 4.4 3.7 3.5 5.6 6.1 2.9 4.0 3.3 3.0 3.4 6.0 5.3 3.1 4.3 3.7 7.4 4.5 3.6 3.3 2.6 3.1 3.7 5.8 5.2 4.7 3.8 4.7 9.4 7.6 7.2 3.1 4.8 9.3 2.6 5.8 6.8 7.3 14.0 5.1 6.0 10.4 9.2 9.0 9.7 8.0 6.4 8.0 15.2 3.3 8.2 11.7 5.4 8.0 5.6 10.9 6.8 6.8 8.1 20.7 4.4 8.8 11.1 7.5 5.3 4.8 10.6 7.1 3.6 4.7 6.6 14.4 9.1 8.2 7.3 11.3 7.9 9.5 3.8 10.3 10.4 15.2 5.3 4.7 6.2 7.5 7.9 19.0 13.0 8.5 5.3 8.0 9.3 4.2 12.7 9.7 6.5 9.6 5.0 9.1 13.4 6.6 16.8 8.8 7.2 3.0 6.8 5.9 3.1 7.7 8.7 6.5 8.0 2.9 9.4 9.3 8.0 2.3 4.8 2.9 7.6 5.3 2.6 20.8 39.2 16.0 18.1 26.0 22.1 20.7 15.3 9.4 13.6 19.2 25.5 69.8 16.6 14.1 15.1 14.1 9.5 23.3 19.5 44.4 23.7 18.0 20.8 12.1 20.7 22.3 12.6 9.2 13.2 11.8 23.3 15.3 16.9 10.0 11.0 18.9 14.2 10.5 20.5 13.2 33.2 12.9 19.1 59.4 59.0 25.0 67.4 26.3 11.2 19.7 RAI14 "DKFZp564G013, KIAA1334, NORPEG, RAI13" ENSG00000039560 "Retinoic acid induced 14" Q9P0K7 5 34656237-34832627 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 64.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 166.4;Early spermatids: 198.0;Late spermatids: 250.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 59.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036949, HPA036950" Supported Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA Nucleoplasm "Actin filaments, Cytosol" "HPA036949: AB_10670568, HPA036950: AB_10669721" "unprognostic (7.63e-2)" "unprognostic (9.86e-2)" "unprognostic (4.87e-2)" "unprognostic (1.40e-1)" "unprognostic (3.38e-2)" "unprognostic (4.75e-2)" "unprognostic (5.49e-2)" "unprognostic (6.18e-2)" "unprognostic (6.28e-2)" "unprognostic (2.62e-1)" "unprognostic (8.18e-2)" "unprognostic (4.58e-2)" "prognostic unfavorable (9.75e-4)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.33e-1)" "unprognostic (4.81e-2)" "unprognostic (4.34e-2)" 5.6 4.5 3.9 8.3 5.9 0.5 5.1 4.4 3.2 23.3 9.1 5.5 14.1 2.5 29.2 8.2 8.8 6.8 8.8 3.6 4.4 3.5 7.7 11.2 10.4 5.1 6.9 1.5 9.5 4.8 6.4 2.7 64.4 5.6 10.4 4.0 8.2 8.4 10.8 2.0 7.6 3.6 34.7 17.0 21.2 6.0 26.6 5.7 2.1 6.7 2.7 3.8 22.5 14.9 0.8 0.6 2.5 0.8 2.5 3.3 0.3 2.7 10.8 12.5 8.3 6.7 23.5 16.0 32.7 26.4 18.9 19.0 8.2 3.5 0.6 13.1 16.0 20.7 1.8 14.2 24.1 41.1 0.0 6.8 4.5 10.2 5.0 20.8 0.1 0.4 21.9 7.6 33.9 27.1 31.2 59.9 1.0 6.3 0.2 24.6 2.2 0.4 0.1 9.7 1.6 10.5 3.9 19.1 0.1 22.0 15.6 3.3 1.8 19.3 2.9 8.8 19.1 3.3 0.5 38.5 30.8 16.5 7.5 14.2 0.7 0.0 0.0 26.0 0.0 11.9 2.5 0.8 0.3 3.3 0.3 0.4 0.5 1.0 0.2 0.2 0.8 0.3 0.6 1.6 2.5 0.1 0.6 0.1 0.3 3.9 5.9 4.4 3.2 4.4 3.5 6.9 1.5 5.6 5.7 98.3 166.4 1.7 20.2 10.6 1.9 3.3 5.1 24.1 95.5 33.2 64.8 23.9 6.6 30.0 198.0 51.8 3.2 0.0 24.7 59.3 26.2 11.8 3.5 21.9 6.5 14.3 1.7 16.5 2.4 250.8 66.7 4.2 5.0 1.8 0.8 18.5 39.1 1.9 29.7 18.0 4.7 0.0 17.3 8.1 12.4 13.8 130.6 2.5 2.3 63.1 RALGDS "RalGEF, RGDS, RGF" ENSG00000160271 "Ral guanine nucleotide dissociation stimulator" Q12967 9 133097720-133149334 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 88.7;Urothelial cells: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 16.7;MAIT T-cell: 6.6;memory CD4 T-cell: 7.6;memory CD8 T-cell: 12.0;naive CD8 T-cell: 6.5;NK-cell: 5.7;T-reg: 13.1" "Group enriched" "Detected in many" 9 "NK-cells: 5.7;T-cells: 16.7" "Cell line enhanced" "Detected in all" "HDLM-2: 53.1;SH-SY5Y: 33.7" "HPA025961, CAB032582" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB032582: AB_2238105, HPA025961: AB_2671795" "unprognostic (1.01e-1)" "prognostic favorable (4.19e-4)" "unprognostic (1.35e-2)" "unprognostic (7.92e-3)" "unprognostic (8.20e-2)" "unprognostic (7.95e-2)" "unprognostic (5.09e-2)" "unprognostic (2.20e-1)" "unprognostic (8.91e-2)" "unprognostic (2.88e-1)" "unprognostic (2.69e-3)" "unprognostic (5.03e-2)" "unprognostic (9.54e-3)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" 18.9 19.8 28.2 14.5 43.2 26.3 16.8 33.1 38.1 14.8 11.1 43.6 12.8 13.0 10.3 10.4 28.7 18.8 23.9 18.7 30.4 23.0 6.3 5.7 19.9 18.8 45.6 19.2 26.6 17.4 11.5 31.8 8.2 38.0 11.8 8.0 8.0 21.6 16.7 13.1 24.8 15.3 10.6 44.3 13.4 13.3 3.8 48.0 5.5 12.2 14.5 13.6 17.1 12.7 1.1 0.5 1.3 0.4 5.7 16.7 3.5 2.6 3.8 8.1 10.0 3.1 4.5 6.8 3.1 4.7 3.2 2.1 3.3 5.7 3.9 2.9 5.3 4.9 12.4 8.2 5.7 1.1 53.1 5.8 3.4 7.6 4.7 4.0 5.3 6.2 5.3 8.1 1.7 3.6 8.8 6.6 7.8 6.6 24.8 2.9 8.5 7.6 5.1 5.5 11.7 10.0 7.8 1.9 6.6 3.9 4.5 25.6 33.7 3.7 5.5 4.9 3.3 5.7 5.6 3.5 3.6 3.8 2.7 2.1 1.1 3.0 4.7 3.2 6.1 4.0 1.3 0.4 0.5 16.7 0.2 6.6 1.1 7.6 12.0 0.5 0.3 1.7 6.5 0.2 5.7 0.1 0.5 13.1 3.5 28.2 43.2 33.1 38.1 30.4 23.0 45.6 19.2 38.0 48.0 29.8 13.7 6.9 42.4 49.2 12.3 5.9 12.7 12.0 17.0 8.7 11.8 3.6 3.3 9.9 0.4 26.3 24.7 0.0 5.8 3.4 9.1 38.3 15.1 3.0 11.6 58.8 35.5 37.4 8.3 1.5 12.4 18.0 21.9 1.8 13.4 20.5 10.0 13.5 8.5 2.2 8.5 0.0 11.2 2.3 3.8 88.7 4.9 23.0 15.8 86.8 RALGPS2 "FLJ10244, FLJ25604, KIAA0351" ENSG00000116191 "Ral GEF with PH domain and SH3 binding motif 2" Q86X27 1 178725147-178921841 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Alzheimer disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.7" "Cell type enhanced" "Detected in all" 10 "Cone photoreceptor cells: 194.4;Rod photoreceptor cells: 376.7;Spermatocytes: 162.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "memory B-cell: 17.8;naive B-cell: 14.6" "Lineage enriched" "Detected in many" 12 "B-cells: 17.8" "Cell line enhanced" "Detected in many" "U-266/84: 62.7;U-698: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027143, HPA028328" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA027143: AB_10602071, HPA028328: AB_10601889" "unprognostic (8.13e-2)" "unprognostic (1.46e-2)" "unprognostic (4.06e-3)" "unprognostic (2.71e-1)" "unprognostic (1.23e-1)" "unprognostic (1.50e-1)" "unprognostic (5.72e-2)" "unprognostic (6.63e-3)" "unprognostic (4.07e-2)" "unprognostic (1.33e-1)" "unprognostic (2.82e-2)" "unprognostic (7.77e-2)" "unprognostic (1.55e-1)" "unprognostic (3.45e-1)" "unprognostic (6.35e-2)" "unprognostic (4.37e-2)" "unprognostic (8.97e-2)" 5.5 6.4 5.0 27.9 10.5 6.2 5.4 8.9 5.1 8.0 9.9 1.2 7.2 5.8 8.2 7.3 14.0 8.7 4.7 4.7 6.0 3.2 6.1 16.4 3.7 25.3 2.2 4.1 11.5 5.0 6.2 8.4 4.6 3.8 5.3 6.4 9.9 9.2 7.4 2.1 10.0 19.7 6.1 3.2 26.1 6.8 37.7 2.1 16.0 4.3 4.7 29.4 7.5 8.4 17.8 0.5 1.4 0.1 0.3 0.5 0.8 10.3 3.4 10.5 0.1 11.8 17.3 4.1 9.1 20.1 7.4 6.7 4.1 10.2 22.0 3.0 26.7 3.7 8.6 4.6 2.3 9.7 0.0 2.7 0.0 2.2 3.8 2.0 2.8 0.1 7.6 2.0 9.5 6.7 5.1 6.4 4.1 5.3 0.8 4.8 1.6 4.3 0.9 7.2 4.0 3.6 6.1 10.8 0.2 2.5 6.6 1.6 4.7 5.9 6.6 12.8 7.5 7.9 1.4 4.7 3.4 3.3 12.3 4.3 25.1 62.7 51.4 1.9 1.5 3.8 0.5 0.1 1.4 0.2 0.0 0.2 17.8 0.1 0.1 0.2 14.6 0.5 0.1 0.8 0.3 0.0 0.5 0.0 0.8 5.0 10.5 8.9 5.1 6.0 3.2 2.2 4.1 3.8 2.1 11.9 8.6 135.8 14.0 13.2 83.6 11.7 5.1 26.8 7.9 14.0 194.4 6.4 18.3 12.8 103.8 2.7 23.8 23.3 10.3 8.6 12.0 23.1 8.1 51.8 5.0 12.7 34.4 3.1 7.5 137.4 46.3 3.6 8.5 1.8 18.2 23.8 20.4 24.6 43.9 6.6 376.7 19.4 8.1 162.4 24.7 29.7 2.7 4.8 13.0 54.0 RANBP3L FLJ25422 ENSG00000164188 "RAN binding protein 3 like" Q86VV4 5 36248434-36302114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;kidney: 33.8" "Cell type enhanced" "Detected in some" 23 "Collecting duct cells: 8.7;Distal tubular cells: 39.7;Muller glia cells: 12.8;Sertoli cells: 12.9" "Cancer enhanced" "Detected in some" "prostate cancer: 4.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "ASC diff: 16.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037471, HPA037472, HPA061526" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA037471: AB_10671756, HPA037472: AB_2675489, HPA061526: AB_2684552" "unprognostic (1.19e-1)" "unprognostic (1.02e-1)" "unprognostic (1.27e-1)" "unprognostic (1.41e-3)" "unprognostic (5.52e-3)" "unprognostic (2.85e-1)" "unprognostic (2.35e-3)" "unprognostic (1.08e-2)" "unprognostic (9.56e-2)" "unprognostic (2.66e-1)" "unprognostic (2.81e-1)" "unprognostic (1.28e-1)" "unprognostic (3.76e-4)" "unprognostic (1.68e-2)" "unprognostic (9.13e-2)" "unprognostic (8.87e-3)" "unprognostic (5.71e-2)" 4.6 2.8 25.7 1.0 27.5 0.8 10.7 8.5 24.5 2.4 1.1 5.6 0.6 1.0 1.4 3.1 1.4 2.3 3.0 2.5 30.3 5.6 33.8 12.2 3.2 1.1 8.2 16.5 3.4 1.2 1.1 5.3 7.0 12.2 18.6 1.3 1.0 1.5 4.7 0.9 0.9 1.0 6.6 21.4 1.0 2.7 6.4 18.4 0.0 3.6 0.0 1.5 8.2 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 16.9 0.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.1 0.0 3.5 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 27.5 8.5 21.2 30.3 5.6 8.2 16.5 12.2 18.4 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 8.7 0.0 0.0 39.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.2 0.0 1.3 1.4 0.0 0.0 0.6 0.0 0.0 2.0 0.0 1.7 0.0 0.0 12.8 0.0 0.0 2.1 0.1 0.5 12.9 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 RAPH1 "ALS2CR18, ALS2CR9, KIAA1681" ENSG00000173166 "Ras association (RalGDS/AF-6) and pleckstrin homology domains 1" Q70E73 2 203394345-203535410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 51.1" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 68.3;Ito cells: 89.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.8;non-classical monocyte: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA016744, HPA020027" Approved Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nuclear bodies, Plasma membrane" Cytosol "HPA016744: AB_1844781, HPA020027: AB_1844782" "unprognostic (9.78e-2)" "unprognostic (9.05e-2)" "unprognostic (7.17e-4)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (1.83e-1)" "unprognostic (8.32e-2)" "unprognostic (6.31e-2)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.24e-4)" "unprognostic (1.92e-1)" "unprognostic (1.40e-2)" "unprognostic (5.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.19e-2)" "unprognostic (2.79e-1)" 11.0 6.1 7.3 6.3 7.6 2.7 17.6 8.4 12.7 9.8 7.9 3.7 6.8 6.9 6.8 8.4 9.2 6.3 12.5 8.3 5.2 5.0 8.2 51.1 17.2 6.8 4.2 8.4 3.6 5.8 4.0 9.9 11.1 6.0 7.2 6.7 8.5 11.2 4.4 8.3 10.2 10.2 7.1 4.8 26.7 7.8 7.9 3.1 1.7 25.8 7.9 5.6 9.6 8.7 0.0 1.1 0.0 2.8 1.1 0.6 0.3 5.5 3.8 8.1 4.6 6.4 8.3 7.2 7.7 5.7 8.0 10.2 17.7 5.9 0.0 1.9 11.7 5.9 2.7 4.2 6.6 16.8 1.1 2.4 0.0 9.2 3.1 16.0 0.0 0.1 11.5 5.6 14.7 15.5 8.8 12.5 0.8 0.4 4.3 16.0 3.1 0.0 0.0 4.8 2.8 4.9 0.1 11.5 3.1 5.8 17.9 2.8 3.8 5.3 5.1 6.4 11.2 2.8 0.2 14.8 19.8 6.4 9.4 8.1 2.0 3.4 0.0 16.3 0.1 4.4 0.0 0.8 0.0 0.2 2.8 0.6 0.0 0.5 0.1 1.1 0.0 0.4 0.1 0.0 1.1 2.6 0.1 0.5 0.3 7.3 7.6 8.4 12.7 5.2 5.0 4.2 8.4 6.0 3.1 14.9 6.7 2.2 16.6 43.6 9.3 0.8 15.3 5.3 10.3 14.0 13.7 7.1 6.6 5.8 10.1 18.9 21.2 0.0 8.0 5.9 19.4 17.6 1.1 68.3 15.3 9.5 2.4 89.0 14.9 3.2 4.4 15.9 11.8 2.8 7.2 20.0 14.3 14.0 4.6 2.4 4.6 19.4 16.1 15.7 10.4 35.8 9.2 1.8 11.2 19.1 RASEF "FLJ31614, RAB45" ENSG00000165105 "RAS and EF-hand domain containing" Q8IZ41 9 82979585-83063177 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 71.5;Alveolar cells type 2: 74.7;Ciliated cells: 144.6;Club cells: 84.2;Glandular cells: 74.9;Mucus-secreting cells: 70.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 27.9;RT4: 21.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021431, HPA078596" Approved Uncertain Microtubules NA NA Microtubules "HPA021431: AB_1856087, HPA078596: " "unprognostic (1.22e-1)" "unprognostic (1.20e-1)" "unprognostic (1.73e-2)" "unprognostic (1.26e-1)" "unprognostic (2.59e-1)" "unprognostic (2.40e-2)" "unprognostic (9.91e-3)" "unprognostic (1.61e-1)" "unprognostic (1.20e-1)" "unprognostic (8.60e-2)" "unprognostic (1.66e-3)" "unprognostic (3.67e-1)" "unprognostic (1.41e-3)" "unprognostic (5.07e-2)" "unprognostic (6.05e-3)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" 0.7 0.8 2.1 7.0 0.7 1.6 9.0 0.6 2.2 1.7 8.2 0.6 15.5 2.8 1.8 9.6 7.1 2.9 23.5 0.7 1.3 1.1 4.2 2.0 6.8 0.4 0.7 0.4 1.6 23.9 2.7 13.4 5.1 1.7 10.4 7.6 3.7 22.2 12.0 0.6 2.2 10.4 1.2 0.7 0.6 20.3 2.4 0.2 4.8 20.1 3.7 10.0 8.1 5.5 7.6 5.2 13.9 3.0 5.0 5.4 0.8 7.8 8.6 1.2 1.2 0.2 0.3 3.6 0.9 0.2 0.9 2.1 5.1 9.6 2.4 8.9 0.3 6.1 8.9 0.3 0.2 1.1 1.0 9.3 1.5 6.7 1.3 0.1 1.1 1.1 0.3 3.8 4.1 0.2 1.4 0.0 1.5 1.6 10.6 0.1 15.8 1.5 1.4 6.9 27.9 3.5 1.6 2.7 3.4 9.8 21.2 3.4 4.9 1.8 14.8 0.7 4.5 13.2 1.1 1.6 1.9 9.9 1.4 1.1 7.2 6.4 1.0 3.8 0.7 2.1 7.3 3.0 2.5 5.2 1.9 5.0 4.7 4.9 4.1 1.4 7.6 5.4 4.7 13.9 5.0 2.2 5.2 3.7 0.8 2.1 0.7 0.6 2.2 1.3 1.1 0.7 0.4 1.7 0.2 71.5 74.7 0.0 3.0 0.7 1.3 0.4 38.2 144.6 84.2 8.7 3.9 5.1 6.6 26.1 0.4 0.6 35.4 0.0 32.2 9.3 0.6 74.9 20.9 1.0 0.7 0.0 3.5 0.6 0.0 1.3 0.3 0.6 1.7 2.8 70.8 0.0 40.9 26.9 0.0 5.6 1.2 0.0 2.1 0.1 2.5 0.6 6.3 0.0 17.4 32.7 RB1CC1 "ATG17, Cc1, DRAGOU14, FIP200, KIAA0203, PPP1R131" ENSG00000023287 "RB1 inducible coiled-coil 1" Q8TDY2 8 52622456-52745843 "Predicted intracellular proteins" "Autophagy, Cell cycle, Transcription, Transcription regulation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024391, HPA053049" Approved Supported "Nuclear membrane,Cytosol" NA NA Cytosol "Nuclear membrane" "HPA024391: AB_2671554, HPA053049: AB_2682025" "unprognostic (1.58e-2)" "unprognostic (7.51e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.22e-1)" "unprognostic (4.21e-2)" "unprognostic (7.39e-2)" "unprognostic (1.38e-2)" "unprognostic (9.34e-2)" "unprognostic (1.21e-1)" "unprognostic (8.77e-3)" "unprognostic (2.07e-1)" "unprognostic (9.56e-3)" "unprognostic (7.67e-2)" "unprognostic (4.41e-1)" "unprognostic (8.00e-2)" "unprognostic (2.42e-1)" 16.2 13.7 36.6 9.8 19.8 38.0 15.0 21.8 36.8 14.5 13.3 7.9 11.9 11.0 15.5 11.9 15.0 11.0 12.2 22.7 31.1 17.0 15.2 18.3 13.5 10.5 16.5 22.5 18.4 14.6 21.5 15.2 13.3 17.0 14.2 10.1 7.6 12.9 11.4 35.9 13.2 13.2 13.4 12.2 11.7 12.0 28.2 17.0 21.6 15.7 10.3 10.9 16.4 14.1 7.1 7.6 25.5 9.7 8.5 8.4 6.6 13.3 11.9 14.8 12.9 16.5 18.8 8.4 10.2 20.9 10.8 13.5 8.3 15.2 9.8 17.2 15.0 27.4 17.9 18.2 9.5 20.5 7.4 15.9 16.7 12.4 11.4 20.3 5.9 9.5 17.5 19.7 10.7 29.5 22.7 14.6 15.5 19.8 16.0 13.1 8.7 15.1 8.8 14.6 12.7 6.2 7.7 7.1 9.9 10.0 10.5 14.3 14.9 10.6 12.2 22.6 18.1 13.9 10.9 17.2 10.4 14.6 16.3 8.9 15.9 13.7 9.8 16.4 10.4 11.6 22.3 8.0 14.7 7.8 7.6 7.8 7.1 6.5 7.9 7.6 6.2 8.0 7.4 25.5 8.5 9.7 3.9 8.4 6.6 36.6 19.8 21.8 36.8 31.1 17.0 16.5 22.5 17.0 17.0 181.7 102.5 28.4 53.1 78.5 76.8 142.2 12.7 147.2 72.8 17.4 64.8 22.9 8.3 41.1 35.1 49.4 36.0 140.2 42.8 21.5 70.2 73.7 24.4 38.4 20.5 82.6 42.4 33.2 36.1 39.4 71.7 44.0 40.5 35.1 29.8 34.2 55.5 30.8 68.9 23.0 54.0 45.3 68.0 171.7 121.8 80.4 50.6 41.5 24.7 56.8 RBL2 "p130, Rb2" ENSG00000103479 "RB transcriptional corepressor like 2" Q08999 16 53433977-53491649 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 410.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016547, HPA019703" Supported Supported "Nucleoplasm,Nucleoli rim,Mitotic chromosome,Cytosol" Yes No "Nucleoplasm, Nucleoli rim, Mitotic chromosome" Cytosol "CAB016547: AB_785011, HPA019703: AB_1856106" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (4.00e-2)" "unprognostic (1.26e-1)" "unprognostic (6.88e-2)" "unprognostic (6.43e-2)" "unprognostic (5.03e-2)" "unprognostic (2.46e-2)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (4.70e-1)" "unprognostic (8.12e-2)" "prognostic favorable (3.57e-5)" "unprognostic (9.57e-3)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (7.51e-2)" 27.8 20.6 15.7 22.2 20.0 11.1 25.5 24.1 18.7 26.3 23.7 24.7 25.6 15.4 30.0 20.2 21.5 25.1 19.5 19.9 15.5 11.7 23.8 34.2 24.0 31.6 25.8 13.7 29.3 30.7 55.3 22.6 12.4 15.8 28.2 18.9 20.2 26.2 30.5 28.3 20.8 24.6 26.1 17.9 27.2 24.9 28.6 22.8 54.4 31.0 10.3 31.6 36.5 26.8 9.1 8.0 20.2 9.8 26.2 35.1 24.5 12.6 8.6 11.6 10.7 30.3 29.3 5.4 9.3 13.3 11.7 4.0 5.6 16.0 18.6 14.2 15.8 11.0 16.0 8.7 14.5 18.6 6.6 12.0 8.3 8.8 10.4 13.1 11.6 26.2 18.6 17.8 7.9 11.4 23.5 18.0 20.6 6.8 11.7 13.0 3.7 23.0 15.6 4.7 14.4 7.9 16.8 21.1 21.3 11.4 13.0 9.4 7.9 21.2 9.3 9.1 10.1 12.1 15.2 14.9 14.5 7.7 11.9 6.9 17.9 10.6 21.8 18.0 14.5 9.9 16.4 8.2 20.2 21.2 5.9 23.7 8.7 23.8 24.3 8.0 9.1 35.1 29.6 15.7 26.2 9.8 4.9 17.5 24.5 15.7 20.0 24.1 18.7 15.5 11.7 25.8 13.7 15.8 22.8 38.7 83.1 23.6 26.7 20.5 27.2 10.1 40.8 42.8 43.3 26.2 19.6 4.5 14.9 10.6 410.5 23.6 18.8 0.0 8.9 12.0 22.6 37.9 53.2 40.8 10.1 33.4 19.0 33.2 46.3 128.8 38.9 26.4 10.1 23.4 31.9 37.2 10.2 10.5 40.3 21.4 22.5 38.8 24.7 118.2 42.4 24.1 3.4 79.1 23.7 30.9 RBM39 "CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2" ENSG00000131051 "RNA binding motif protein 39" Q14498 20 35701347-35742312 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001591 Supported Supported "Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite" NA NA "Nucleoplasm, Nuclear speckles" "Microtubules, Centriolar satellite" "HPA001591: AB_1079749" "unprognostic (1.37e-2)" "unprognostic (4.97e-1)" "unprognostic (2.72e-2)" "unprognostic (9.09e-2)" "unprognostic (3.47e-1)" "unprognostic (4.99e-2)" "unprognostic (3.55e-3)" "unprognostic (4.56e-2)" "unprognostic (7.83e-2)" "unprognostic (2.65e-1)" "unprognostic (2.04e-2)" "unprognostic (7.65e-3)" "prognostic unfavorable (2.78e-5)" "unprognostic (1.88e-1)" "unprognostic (2.86e-1)" "unprognostic (2.64e-1)" "unprognostic (2.28e-3)" 41.4 44.1 37.5 41.5 41.4 120.8 38.5 57.5 41.8 43.4 35.0 30.7 46.3 29.5 51.9 34.3 42.8 35.3 40.7 40.2 35.8 29.9 39.2 32.4 40.4 41.8 41.1 31.4 52.3 35.6 40.9 71.5 45.2 37.4 39.2 27.0 28.9 37.1 46.0 44.1 32.1 30.6 40.2 43.0 38.4 33.5 22.9 46.4 52.4 40.7 28.2 40.5 39.9 46.1 27.6 32.5 88.9 25.1 24.2 22.5 16.8 28.9 26.9 27.9 24.7 22.1 25.1 30.6 38.9 19.5 25.4 23.9 38.8 26.8 39.9 30.3 15.0 23.7 27.4 41.5 24.6 29.3 26.8 29.7 53.2 27.2 44.9 25.0 48.9 33.3 10.2 42.7 21.3 24.1 25.2 23.6 19.8 54.8 35.7 21.7 25.1 56.9 35.3 33.8 30.4 32.3 34.8 44.5 30.1 23.0 20.9 27.2 23.7 30.4 38.7 33.9 45.7 26.1 34.5 27.2 33.1 28.3 30.6 34.9 23.0 46.6 58.7 22.7 39.4 24.2 41.2 25.1 38.2 22.5 22.1 22.1 25.3 19.8 20.7 22.4 27.6 18.9 18.0 88.9 24.2 19.4 32.5 22.1 16.8 37.5 41.4 57.5 41.8 35.8 29.9 41.1 31.4 37.4 46.4 217.4 272.9 286.2 469.4 547.4 245.5 170.5 147.7 277.1 246.9 190.1 298.4 332.4 160.8 177.8 36.1 270.2 247.4 93.5 161.5 312.9 353.4 410.0 503.4 165.1 177.4 208.2 283.3 159.0 179.4 26.2 243.1 231.7 256.4 248.9 177.6 221.0 173.7 189.4 201.5 125.5 372.3 161.7 294.1 267.2 236.8 513.0 469.7 366.7 196.0 480.8 RBP7 CRBPIV ENSG00000162444 "Retinol binding protein 7" Q96R05 1 9997206-10016020 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 68.1;breast: 210.2" "Group enriched" "Detected in many" 5 "Endothelial cells: 121.4;Kupffer cells: 402.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 54.1;intermediate monocyte: 23.4;neutrophil: 60.6" "Group enriched" "Detected in many" 30 "granulocytes: 60.6;monocytes: 54.1" "Cell line enhanced" "Detected in some" "EFO-21: 10.5;SK-MEL-30: 7.1;T-47d: 26.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA034749 Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA034749: AB_10602084" "unprognostic (1.93e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (9.59e-2)" "unprognostic (2.31e-1)" "unprognostic (6.28e-2)" "unprognostic (1.39e-2)" "unprognostic (1.85e-1)" "unprognostic (1.05e-3)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (7.90e-2)" "unprognostic (5.07e-2)" "unprognostic (2.38e-2)" "unprognostic (2.93e-1)" "unprognostic (1.15e-1)" "unprognostic (1.61e-2)" 68.1 3.7 3.8 3.0 11.4 7.5 210.2 2.1 5.5 4.3 10.9 8.7 2.7 0.5 6.4 4.5 7.2 2.4 14.7 29.7 5.3 2.8 7.6 2.5 2.5 4.5 7.6 3.0 2.6 3.7 14.7 3.5 4.4 6.2 4.7 1.2 3.5 4.8 2.7 5.9 6.6 2.0 4.4 8.9 21.5 3.0 2.6 5.2 1.2 11.3 1.8 1.4 4.5 17.5 0.0 1.8 60.6 54.1 0.0 0.1 15.0 0.0 0.6 0.2 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.8 1.8 2.4 0.0 10.5 1.0 0.0 0.0 0.0 0.8 3.4 0.0 2.5 0.0 0.1 0.9 1.2 0.0 0.0 0.0 1.6 1.6 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 4.4 0.0 0.0 0.0 0.5 0.0 0.1 0.4 1.9 0.1 7.1 2.9 26.8 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 54.1 0.4 0.0 23.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 60.6 0.0 11.1 0.3 0.1 15.0 3.8 11.4 2.1 5.5 5.3 2.8 7.6 3.0 6.2 5.2 0.0 2.2 11.2 7.8 18.3 0.0 17.6 10.2 1.4 1.2 1.8 0.0 4.5 19.9 1.3 2.6 121.4 0.0 0.0 2.3 2.2 8.2 19.2 3.5 1.3 54.6 0.0 0.0 49.7 402.1 4.7 5.8 23.1 20.3 0.0 0.0 1.3 3.7 0.0 0.7 0.7 1.1 0.0 5.3 1.2 1.5 15.4 5.1 1.3 0.4 4.3 RCN3 RLP49 ENSG00000142552 "Reticulocalbin 3" Q96D15 19 49527618-49546962 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Fibroblasts: 101.3;Ito cells: 43.6;Leydig cells: 35.4;Peritubular cells: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 9.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 30.9;ASC diff: 53.2;ASC TERT1: 36.8;BJ: 58.2;BJ hTERT+ SV40 Large T+ RasG12V: 33.6;fHDF/TERT166: 50.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA043134, HPA050402" Uncertain Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" No No "Endoplasmic reticulum" Vesicles "HPA043134: AB_2678332, HPA050402: AB_2681114" "unprognostic (7.10e-2)" "unprognostic (1.19e-1)" "unprognostic (3.77e-3)" "unprognostic (8.87e-2)" "unprognostic (3.36e-3)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (1.16e-1)" "unprognostic (7.47e-2)" "unprognostic (9.75e-2)" "unprognostic (2.85e-1)" "unprognostic (3.86e-2)" "prognostic unfavorable (5.80e-12)" "unprognostic (5.26e-2)" "unprognostic (3.90e-2)" "unprognostic (1.56e-2)" "unprognostic (4.20e-3)" 19.6 10.9 3.7 18.2 5.3 3.2 15.6 7.2 6.6 36.3 10.7 2.0 9.6 22.2 28.2 33.9 11.4 10.7 26.2 18.2 3.4 3.5 12.6 18.6 12.6 4.4 3.3 2.8 29.5 5.1 2.1 9.0 18.0 6.0 19.4 7.0 10.7 6.2 8.2 10.6 8.2 23.7 16.8 2.9 21.3 7.8 17.3 4.2 1.8 9.9 9.8 7.9 21.5 21.6 0.6 0.5 3.9 0.4 2.3 9.7 1.6 0.5 0.9 0.5 30.9 53.2 36.8 0.3 58.2 15.1 21.9 33.6 0.7 0.2 0.2 3.5 50.8 0.2 0.0 1.4 0.1 10.5 0.0 0.4 3.2 0.2 1.7 18.7 0.0 7.6 20.7 0.0 15.3 0.0 0.6 8.4 0.4 1.4 0.1 17.8 0.6 0.0 0.3 0.2 1.8 4.0 0.1 0.7 0.9 0.2 0.0 0.3 1.9 0.0 0.2 0.0 0.6 0.2 2.1 19.5 0.3 9.8 25.4 0.0 2.8 8.5 0.5 1.4 1.8 2.4 0.0 0.3 2.2 0.9 0.0 1.0 0.6 2.5 0.9 0.5 0.4 9.7 3.2 3.9 2.3 0.4 0.4 1.9 1.6 3.7 5.3 7.2 6.6 3.4 3.5 3.3 2.8 6.0 4.2 0.0 9.6 2.2 0.5 16.6 0.6 1.4 2.5 1.4 0.0 1.8 0.0 2.4 1.7 1.6 1.9 9.0 7.4 0.0 0.4 4.3 101.3 0.6 1.1 2.6 18.2 1.6 1.2 43.6 11.4 2.2 35.4 6.9 10.1 1.0 6.1 0.6 2.4 5.8 42.1 0.3 0.8 12.9 11.3 6.0 6.8 12.2 5.1 0.5 5.5 0.4 RDH5 "HSD17B9, RDH1, SDR9C5" ENSG00000135437 "Retinol dehydrogenase 5" Q92781 12 55720367-55724705 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Sensory transduction, Steroid metabolism, Vision" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 39.4;retina: 127.9" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 68.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 19.0;ASC TERT1: 16.4;hTEC/SVTERT24-B: 9.9;hTERT-RPE1: 16.2;LHCN-M2: 9.9;U-87 MG: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063345 Uncertain Vesicles "Intracellular and membrane" NA NA Vesicles "HPA063345: AB_2684992" "unprognostic (1.04e-2)" "unprognostic (6.45e-2)" "unprognostic (1.80e-1)" "unprognostic (2.67e-1)" "unprognostic (3.66e-2)" "unprognostic (1.48e-2)" "unprognostic (1.88e-2)" "unprognostic (1.54e-1)" "unprognostic (5.35e-2)" "unprognostic (4.04e-2)" "unprognostic (4.05e-1)" "unprognostic (1.26e-3)" "unprognostic (7.63e-2)" "unprognostic (8.79e-2)" "unprognostic (3.46e-2)" "unprognostic (2.12e-3)" "unprognostic (3.27e-2)" 39.4 0.7 0.6 2.8 0.8 0.2 14.9 0.5 0.8 1.0 7.6 1.0 1.5 8.6 1.9 4.5 2.4 2.2 4.8 3.9 1.0 0.5 3.7 27.2 0.7 1.6 0.8 0.8 1.4 1.5 0.0 0.6 0.4 1.5 1.8 1.9 127.9 3.2 1.0 3.1 1.0 9.4 8.8 1.1 0.9 2.7 0.9 1.0 0.3 1.1 2.6 0.7 2.0 2.5 0.4 2.3 2.1 0.9 1.5 2.6 0.4 0.4 0.9 0.5 0.3 19.0 16.4 0.3 2.4 2.7 0.5 0.9 0.3 5.1 0.6 0.4 1.3 0.1 0.2 0.2 0.0 0.4 0.6 0.8 0.1 1.0 1.3 0.5 0.0 0.2 7.0 0.6 9.9 0.0 16.2 0.2 0.3 0.1 0.8 9.9 0.4 0.2 0.1 0.2 2.3 1.4 0.3 0.3 0.3 0.1 0.5 0.1 0.7 0.1 0.3 2.2 0.1 0.4 0.3 0.3 1.0 1.0 0.7 0.6 0.7 0.3 0.1 17.7 0.2 0.2 0.3 0.6 2.1 0.4 0.9 0.2 0.4 1.2 2.6 1.2 0.3 1.0 0.4 0.9 1.5 0.9 2.3 0.2 0.4 0.6 0.8 0.5 0.8 1.0 0.5 0.8 0.8 1.5 1.0 8.9 2.1 6.7 4.2 1.6 22.6 2.1 5.1 5.3 1.2 1.8 58.9 1.6 1.7 1.6 0.6 4.2 28.4 0.0 2.3 1.0 3.3 2.8 0.0 17.9 0.5 15.9 11.1 1.8 2.2 1.8 12.4 4.0 5.0 4.6 8.7 10.9 2.8 17.6 6.3 8.4 68.6 12.9 4.7 3.5 6.3 1.5 1.3 10.0 11.8 2.7 RDX DFNB24 ENSG00000137710 Radixin P35241 11 109864295-110296722 "Disease related genes, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 81.0" "Cell type enhanced" "Detected in all" 4 "Alveolar cells type 1: 449.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000263, HPA000763, CAB037312" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 77000000 "Plasma membrane" Nucleoplasm "CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042" "unprognostic (2.23e-3)" "unprognostic (2.56e-2)" "unprognostic (3.85e-1)" "unprognostic (2.74e-2)" "unprognostic (6.93e-2)" "unprognostic (9.82e-2)" "unprognostic (2.01e-2)" "unprognostic (1.44e-2)" "unprognostic (3.91e-2)" "unprognostic (6.91e-2)" "unprognostic (1.32e-3)" "unprognostic (6.47e-2)" "unprognostic (4.14e-3)" "unprognostic (5.43e-2)" "unprognostic (4.40e-1)" "unprognostic (1.24e-1)" "unprognostic (1.08e-3)" 15.9 81.0 17.9 7.0 29.2 4.2 22.3 9.3 20.2 14.7 10.1 19.5 11.1 2.9 12.7 9.1 11.9 8.8 11.6 16.9 20.8 17.0 21.7 28.6 20.4 8.7 27.5 15.2 23.7 22.0 16.0 16.1 16.4 31.6 11.3 4.9 7.4 9.0 11.9 35.5 5.5 5.3 14.9 50.4 10.6 8.3 13.9 30.6 3.5 19.7 11.8 5.9 13.4 11.9 9.4 9.6 17.1 11.4 13.1 15.8 5.6 17.1 9.1 36.3 14.4 21.4 23.8 20.7 21.8 12.4 14.4 15.9 25.5 30.1 0.0 33.5 27.0 22.6 15.8 20.1 20.9 21.6 10.3 11.1 12.7 30.4 18.9 20.0 4.7 8.8 24.3 11.9 17.9 32.2 23.9 39.1 2.8 18.1 7.7 33.3 30.3 2.7 3.8 11.5 1.0 14.9 7.9 25.5 7.5 18.3 8.6 9.9 10.7 38.4 17.4 13.7 28.5 22.3 7.6 24.1 24.0 17.9 11.5 16.9 2.5 4.1 16.6 9.1 2.8 55.1 17.1 11.4 16.5 9.4 9.4 12.5 9.4 8.4 6.9 9.6 6.1 5.7 4.6 1.3 13.1 7.1 7.8 15.8 5.6 17.9 29.2 9.3 19.0 20.8 17.0 27.5 15.2 31.6 30.6 449.6 96.4 30.6 43.1 49.8 78.4 144.4 71.4 41.5 64.8 71.5 41.2 104.4 92.9 108.4 11.2 193.3 6.7 70.0 374.9 158.2 87.8 55.0 65.8 217.4 75.7 95.3 21.4 279.3 93.7 28.8 254.9 61.2 69.2 186.7 9.3 84.0 127.6 20.1 250.7 141.1 88.4 122.9 79.0 72.1 242.5 35.4 190.1 31.6 16.8 27.6 RELB REL-B ENSG00000104856 "RELB proto-oncogene, NF-kB subunit" Q01201 19 45001430-45038198 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 90.3;Glandular cells: 104.0;monocytes: 170.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 14.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 25.4;HDLM-2: 32.4;U-698: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB007753, HPA040506" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB007753: AB_562340, HPA040506: AB_2677011" "prognostic favorable (1.55e-4)" "unprognostic (1.20e-1)" "unprognostic (7.13e-2)" "unprognostic (5.52e-2)" "unprognostic (1.12e-2)" "unprognostic (3.41e-2)" "unprognostic (1.71e-2)" "unprognostic (4.30e-2)" "unprognostic (5.81e-3)" "unprognostic (1.02e-3)" "unprognostic (6.01e-2)" "unprognostic (6.48e-2)" "prognostic unfavorable (2.99e-6)" "unprognostic (2.68e-2)" "unprognostic (4.69e-2)" "unprognostic (2.09e-1)" "unprognostic (2.20e-2)" 8.0 6.8 2.2 27.6 3.6 27.8 6.8 1.2 3.1 4.9 12.2 2.1 1.6 8.8 8.5 4.7 6.4 5.2 10.9 11.9 1.8 1.6 10.1 7.4 12.8 18.2 3.6 0.9 7.8 12.3 1.9 2.1 4.7 2.8 9.9 3.4 3.6 7.3 4.8 8.1 8.3 13.0 8.4 3.9 17.2 8.3 3.7 1.7 17.7 5.6 7.2 24.8 8.8 6.1 8.2 3.9 14.5 5.0 2.1 2.2 1.7 8.9 5.3 0.5 2.4 1.2 4.0 1.9 1.6 11.6 2.5 4.1 1.8 9.9 25.4 4.7 2.6 8.9 4.1 0.2 3.7 2.2 32.4 0.8 0.9 0.3 1.0 10.4 1.9 15.1 6.5 1.5 5.2 6.1 2.3 1.6 0.7 0.2 16.5 0.9 2.1 0.4 6.0 0.8 2.5 1.0 1.9 1.3 3.0 4.2 13.9 0.0 0.8 1.7 4.8 4.6 0.6 1.7 4.9 5.2 6.1 3.0 2.2 5.9 21.0 12.4 27.3 6.7 0.7 3.4 0.0 5.0 2.1 1.4 3.2 2.1 8.2 2.2 2.0 3.6 7.9 1.8 0.9 14.5 2.1 2.6 3.9 1.1 1.7 2.2 3.6 1.2 3.1 1.8 1.6 3.6 0.9 2.8 1.7 6.0 14.3 26.4 90.3 33.7 0.0 1.7 12.7 1.4 11.4 3.5 0.0 3.5 8.3 30.3 5.1 11.3 45.5 0.0 27.0 5.8 13.4 104.0 51.7 3.4 17.6 3.2 21.9 6.7 13.3 2.4 4.4 25.4 23.6 170.5 12.4 0.6 29.3 80.7 2.5 14.3 0.2 6.5 41.2 0.5 1.2 27.9 8.2 7.5 8.1 75.4 RELL2 "C5orf16, FLJ90583" ENSG00000164620 "RELT like 2" Q8NC24 5 141636950-141641077 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.6;parathyroid gland: 27.6" "Cell type enhanced" "Detected in many" 16 "Horizontal cells: 62.0;Spermatocytes: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 18.3;JURKAT: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077928 Uncertain Vesicles NA NA Vesicles "HPA077928: " "unprognostic (3.27e-2)" "unprognostic (8.46e-2)" "unprognostic (2.12e-1)" "unprognostic (4.95e-3)" "unprognostic (1.91e-3)" "unprognostic (7.12e-2)" "unprognostic (1.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.69e-2)" "unprognostic (2.12e-2)" "unprognostic (6.76e-4)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (7.85e-2)" "unprognostic (8.74e-3)" "unprognostic (4.31e-2)" "unprognostic (6.58e-2)" 2.0 4.5 6.9 2.4 12.3 2.2 2.3 12.5 27.6 1.4 2.3 2.3 0.0 2.5 1.3 1.8 2.7 1.2 2.4 1.6 10.8 14.5 3.3 1.8 2.7 4.7 17.8 8.4 1.1 2.2 27.6 9.4 7.4 24.9 2.2 2.1 1.7 3.7 1.8 1.0 4.2 1.8 2.2 3.8 5.4 2.3 4.6 2.5 4.6 2.8 1.7 5.0 2.9 0.9 2.5 7.8 1.2 3.5 0.1 5.4 1.9 0.8 2.8 2.8 5.2 2.2 0.7 1.3 2.3 4.4 7.7 11.5 10.3 1.0 0.1 1.1 3.5 16.3 4.2 2.5 10.0 2.0 2.5 1.6 6.3 6.0 5.1 3.6 2.0 18.3 1.4 6.3 7.1 5.2 1.6 2.1 20.3 2.2 3.3 1.7 1.3 3.7 0.7 3.2 3.7 1.4 0.2 0.6 4.3 2.4 2.5 4.6 5.0 2.1 10.1 1.7 0.4 3.5 4.7 1.8 5.9 2.6 4.7 4.0 1.9 5.2 14.8 3.2 8.8 3.7 0.0 1.4 0.0 3.0 3.5 1.1 2.5 3.2 3.0 2.3 1.5 2.9 1.6 1.2 0.1 2.5 7.8 5.4 1.9 6.9 12.3 12.5 27.6 10.8 14.5 17.8 8.4 24.9 2.5 0.0 1.1 1.4 1.1 4.0 4.8 0.2 2.5 0.0 0.0 1.8 11.8 0.2 1.7 2.5 1.3 2.2 2.6 0.0 2.3 3.3 1.0 3.0 0.0 0.2 3.7 62.0 1.2 0.6 4.9 2.7 0.6 2.8 6.8 0.0 1.5 6.4 1.9 3.5 1.4 4.7 7.0 0.0 1.4 18.6 6.0 3.8 5.1 5.9 0.6 1.8 RERG MGC15754 ENSG00000134533 "RAS like estrogen regulated growth inhibitor" Q96A58 12 15107783-15348675 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 73.6" "Cell type enhanced" "Detected in many" 10 "Sertoli cells: 90.5;Smooth muscle cells: 84.3" "Cancer enhanced" "Detected in all" "breast cancer: 19.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "myeloid DC: 1.5" "Lineage enriched" "Detected in single" 4 "dendritic cells: 1.5" "Cell line enhanced" "Detected in some" "AN3-CA: 8.2;BEWO: 18.8;T-47d: 36.0;U-2 OS: 12.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041387 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA041387: AB_10796669" "unprognostic (5.33e-2)" "unprognostic (1.05e-1)" "unprognostic (7.72e-2)" "prognostic unfavorable (7.56e-4)" "unprognostic (8.72e-2)" "unprognostic (9.42e-3)" "unprognostic (2.47e-1)" "unprognostic (2.38e-2)" "unprognostic (1.85e-3)" "unprognostic (2.76e-2)" "unprognostic (5.07e-2)" "unprognostic (2.69e-1)" "unprognostic (7.16e-3)" "unprognostic (2.61e-3)" "unprognostic (3.30e-2)" "unprognostic (3.50e-1)" "unprognostic (2.58e-2)" 12.6 21.9 3.5 8.2 23.9 0.2 22.8 0.8 9.3 31.9 14.5 0.8 24.6 2.0 73.6 43.2 7.3 29.0 6.7 6.0 4.2 4.8 19.5 1.3 7.8 2.0 4.3 4.1 23.6 5.1 0.9 0.9 15.4 17.6 12.6 4.6 2.9 6.0 38.9 3.5 4.2 7.4 40.3 2.3 15.2 9.8 11.7 3.5 0.0 2.6 2.8 1.8 15.7 10.6 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.1 8.2 3.4 0.2 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.3 0.0 3.3 0.0 2.6 0.0 1.1 0.4 0.5 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.7 0.3 0.1 0.1 0.9 0.0 0.5 0.0 0.0 0.1 3.2 0.1 0.0 1.2 1.3 1.4 0.0 0.6 36.0 0.0 0.0 0.5 12.1 0.2 0.1 0.1 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 23.9 0.8 9.3 4.2 4.8 4.3 4.1 17.6 3.5 0.0 2.1 0.0 7.7 3.4 1.0 0.7 5.1 0.0 5.7 7.0 0.0 10.8 13.3 6.3 15.0 2.2 0.0 0.0 9.0 11.7 23.8 2.4 0.0 0.0 1.8 3.2 1.7 1.8 0.0 13.1 20.4 2.3 6.8 0.0 0.0 6.0 1.6 0.0 30.1 20.9 0.6 90.5 84.3 7.9 14.5 4.8 11.7 0.0 0.0 4.2 RETSAT FLJ20296 ENSG00000042445 "Retinol saturase" Q6NUM9 2 85342088-85354620 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 86.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 209.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 65.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007961, HPA046513" Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA007961: AB_1079802, HPA046513: AB_2679680" "unprognostic (6.17e-2)" "unprognostic (1.02e-1)" "unprognostic (1.29e-1)" "unprognostic (5.84e-3)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "prognostic favorable (4.23e-4)" "unprognostic (1.89e-1)" "unprognostic (2.16e-1)" "unprognostic (3.59e-2)" "unprognostic (1.77e-2)" "unprognostic (1.59e-1)" "prognostic favorable (1.95e-10)" "unprognostic (2.73e-2)" "unprognostic (5.34e-1)" "unprognostic (8.24e-3)" "unprognostic (9.90e-2)" 65.7 24.8 7.7 9.8 9.1 0.9 35.6 5.6 9.3 7.4 46.5 12.4 12.7 49.0 6.8 12.3 16.7 5.0 17.7 7.3 7.4 5.7 20.6 51.9 7.2 5.1 10.2 7.7 5.5 11.5 13.1 3.5 5.7 8.9 10.1 22.6 10.0 12.5 7.6 24.3 14.3 86.1 7.0 12.7 4.0 18.2 9.2 10.1 3.5 27.2 13.9 9.3 9.9 9.0 3.8 5.6 5.3 10.0 6.5 9.2 4.1 16.2 9.4 5.5 12.7 65.6 12.3 7.1 11.9 14.7 7.2 10.2 6.5 11.4 5.7 9.8 9.4 5.8 13.6 7.3 20.7 7.1 7.0 5.0 2.8 7.8 15.9 15.8 5.4 6.3 16.1 28.4 9.3 12.4 16.8 12.0 5.0 2.9 13.7 13.5 3.4 3.9 2.8 1.7 16.4 11.6 2.5 10.8 7.4 12.8 9.5 2.6 4.4 10.0 19.1 32.3 3.8 9.0 0.9 9.4 8.2 4.5 7.6 6.2 7.4 6.9 2.3 10.0 6.5 5.6 0.0 5.1 2.4 7.0 5.5 9.2 3.8 5.6 8.8 5.6 2.5 3.8 4.0 5.3 6.5 10.0 4.0 5.8 4.1 7.7 9.1 5.6 9.3 7.4 5.7 10.2 7.7 8.9 10.1 26.8 23.5 2.2 8.5 10.1 3.5 18.5 20.4 9.4 10.3 12.2 17.7 9.6 0.0 19.1 27.2 9.2 209.6 0.0 31.4 5.6 6.6 11.3 10.4 39.3 8.7 11.1 10.4 8.0 9.9 41.4 13.6 7.5 28.7 9.0 43.9 8.2 29.0 59.4 11.7 15.6 4.3 0.0 7.8 2.6 3.0 13.0 7.1 8.9 33.1 8.4 RGL3 FLJ32585 ENSG00000205517 "Ral guanine nucleotide dissociation stimulator like 3" Q3MIN7 19 11384341-11419342 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 65.1;thyroid gland: 38.2" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 48.8;Muller glia cells: 28.8;Sertoli cells: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.4" "Cell line enhanced" "Detected in many" "BEWO: 14.8;CACO-2: 8.4;RT4: 17.4;SK-BR-3: 7.7;T-47d: 12.8" "Region enriched" "Detected in single" 6 "cerebellum: 10.1" "HPA042763, HPA043615, HPA064578" Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: " "prognostic favorable (7.35e-4)" "unprognostic (3.12e-2)" "unprognostic (2.92e-1)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (6.60e-2)" "unprognostic (3.82e-2)" "unprognostic (5.31e-2)" "unprognostic (1.24e-2)" "unprognostic (1.48e-2)" "unprognostic (3.19e-3)" "unprognostic (5.99e-2)" "prognostic favorable (6.61e-4)" "unprognostic (4.17e-2)" "unprognostic (3.37e-1)" "unprognostic (3.21e-2)" "unprognostic (7.12e-3)" 4.3 6.2 5.3 1.2 7.9 0.7 4.3 1.9 6.8 7.6 1.9 3.4 23.3 1.8 4.9 14.5 1.1 5.3 6.5 5.2 8.2 1.3 20.7 6.0 7.5 1.2 6.7 3.0 1.6 12.1 65.1 9.1 5.8 7.9 4.1 1.8 7.3 3.5 23.9 5.0 1.1 1.2 1.4 9.5 5.1 6.8 1.1 7.3 0.0 38.2 0.4 0.9 4.5 4.5 0.3 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.9 0.1 14.8 0.9 1.1 0.5 1.6 8.4 6.0 0.0 5.4 1.0 2.1 3.7 0.0 0.0 0.0 0.0 0.0 0.1 3.1 2.6 2.3 0.0 0.0 0.0 0.1 0.1 0.0 3.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.3 1.1 0.0 0.6 1.6 5.1 17.4 0.8 4.4 0.2 7.7 2.6 3.1 12.8 0.0 0.0 2.7 0.0 2.0 0.7 0.0 0.4 0.7 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 5.3 7.9 1.9 6.8 8.2 1.3 6.7 3.0 7.9 7.3 17.9 15.2 0.0 2.0 0.1 0.1 2.5 5.1 2.7 22.7 48.8 0.0 12.2 10.0 8.3 0.0 3.9 0.0 0.0 3.6 9.6 4.6 1.0 1.1 4.3 2.6 0.0 9.9 25.8 4.3 0.0 3.4 0.6 5.0 0.0 7.1 28.8 5.8 5.3 0.4 3.0 0.4 38.8 12.4 0.5 1.2 0.0 10.1 0.0 2.7 1.4 RGPD4 "DKFZp686P0288, RGP4" ENSG00000196862 "RANBP2-like and GRIP domain containing 4" Q7Z3J3 2 107826937-107890841 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 8.6" "Cell type enhanced" "Detected in some" 20 "Cardiomyocytes: 4.8;Early spermatids: 7.2;Late spermatids: 2.1;Spermatocytes: 2.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 5 "T-cells: 1.5" "Cell line enriched" "Detected in single" 12 "U-266/70: 4.4" "HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (4.96e-2)" "unprognostic (3.04e-1)" "unprognostic (4.38e-1)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "unprognostic (3.05e-3)" "unprognostic (7.79e-2)" "unprognostic (1.52e-1)" "unprognostic (4.47e-1)" "unprognostic (6.05e-2)" "unprognostic (2.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.4 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.2 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 0.0 RGPD5 "BS-63, DKFZp686I1842, RGP5" ENSG00000015568 "RANBP2-like and GRIP domain containing 5" Q99666 2 109792758-109857695 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 15.0;Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 16.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 10.7;PC-3: 11.2" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.50e-2)" "unprognostic (1.55e-1)" "unprognostic (3.49e-1)" "unprognostic (2.23e-1)" "unprognostic (4.23e-2)" "unprognostic (3.19e-1)" "unprognostic (3.19e-3)" "unprognostic (3.19e-1)" 4.9 5.0 5.2 2.5 11.7 11.4 9.4 8.2 6.3 6.4 5.2 7.5 6.0 12.3 6.8 6.1 2.6 4.0 3.4 4.4 4.7 4.8 5.3 5.1 5.6 3.0 5.1 4.9 6.0 11.9 3.8 15.1 4.9 5.6 6.4 2.0 8.3 8.5 4.9 7.4 5.2 5.8 6.9 4.9 3.7 8.7 15.7 3.7 1.0 6.8 3.2 2.6 6.3 15.3 6.9 4.3 9.2 3.5 2.8 6.7 0.9 8.5 4.8 1.7 1.9 0.4 0.1 1.6 4.3 1.4 1.7 2.4 9.2 1.0 0.6 5.4 0.7 1.5 3.5 1.4 0.3 0.3 1.9 10.7 3.8 3.7 0.2 0.2 0.6 0.5 0.7 2.3 0.9 0.6 0.5 0.9 1.6 2.3 2.2 0.7 2.3 0.4 1.3 2.4 0.1 11.2 3.7 5.9 0.0 0.5 3.1 5.8 3.2 5.1 0.0 1.4 0.3 0.1 0.9 5.9 1.8 6.5 0.4 2.4 4.1 0.3 0.6 3.3 0.1 0.7 6.8 3.5 4.1 4.1 1.6 6.7 4.0 3.8 4.0 2.3 6.9 4.9 3.7 9.2 2.8 3.0 4.3 2.9 0.9 5.2 11.7 8.2 6.3 4.7 4.8 5.1 4.9 5.6 3.7 3.0 7.3 0.9 3.6 3.1 15.0 12.2 0.0 4.0 5.7 12.2 15.7 2.0 0.0 1.0 2.4 2.7 1.6 0.0 0.9 1.6 3.1 5.2 0.0 0.8 1.6 3.2 5.1 2.5 2.8 0.9 2.3 2.2 1.7 1.0 0.9 1.9 1.4 1.7 1.1 0.3 16.7 0.0 4.7 2.7 2.3 2.9 3.7 5.7 0.6 4.2 RGPD6 RGP6 ENSG00000183054 "RANBP2-like and GRIP domain containing 6" Q99666 2 110513812-110577185 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 11.3;Ciliated cells: 4.0;Club cells: 14.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (1.11e-2)" "unprognostic (6.38e-2)" "unprognostic (1.18e-1)" "unprognostic (3.67e-2)" "unprognostic (1.53e-1)" "unprognostic (3.22e-1)" "unprognostic (2.91e-2)" "unprognostic (4.14e-4)" "unprognostic (2.04e-1)" 5.6 4.1 3.2 2.4 4.9 6.9 5.5 5.6 8.1 4.5 3.8 2.1 4.9 10.1 2.3 3.8 3.4 4.7 3.8 4.4 3.3 4.7 5.1 2.8 3.4 6.4 6.9 8.5 9.5 5.3 6.0 3.5 3.3 4.4 5.2 6.2 4.1 3.5 2.6 3.2 4.0 19.9 7.5 2.4 3.8 3.7 5.7 3.8 8.1 2.6 2.9 4.1 0.3 13.9 3.5 16.7 12.6 5.0 6.2 1.7 10.2 9.3 8.3 5.9 11.3 5.2 0.3 7.5 8.7 10.6 6.2 10.3 5.6 11.0 3.3 5.8 14.7 1.2 7.8 6.3 1.9 1.9 5.5 5.7 10.7 10.9 10.0 5.3 5.1 6.3 3.4 6.9 4.0 4.4 0.4 11.2 2.6 4.4 2.1 8.4 0.1 8.2 7.4 23.7 4.2 5.2 1.1 9.7 13.5 0.6 5.6 7.8 9.1 12.3 2.3 10.9 7.7 0.3 0.3 7.3 0.8 4.0 6.8 2.6 3.2 2.4 1.3 4.1 2.5 3.1 2.7 1.7 5.7 3.1 2.5 8.1 2.9 1.6 3.8 0.9 0.3 8.9 11.3 0.0 0.2 0.8 0.0 0.8 0.0 4.0 14.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.2 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.1 RGPD8 "RanBP2alpha, RANBP2L1" ENSG00000169629 "RANBP2-like and GRIP domain containing 8" O14715 2 112370092-112434488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 14.0" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 8.9;Cardiomyocytes: 6.9;Ciliated cells: 10.7;Early spermatids: 19.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 14.6;hTEC/SVTERT24-B: 12.4" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "unprognostic (3.62e-1)" "unprognostic (7.61e-2)" "unprognostic (2.65e-1)" "unprognostic (7.15e-3)" "unprognostic (3.17e-3)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.57e-1)" "unprognostic (9.18e-3)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.05e-2)" 2.4 0.9 0.5 1.3 0.9 6.2 2.3 2.6 2.7 1.7 1.5 0.4 1.9 2.1 1.1 1.6 1.4 1.7 0.6 0.8 1.3 2.8 2.4 0.9 0.6 2.2 2.3 2.0 2.8 2.0 1.4 1.0 1.3 1.6 1.5 2.4 1.3 1.5 0.8 1.3 1.2 14.0 2.1 1.4 1.9 1.5 2.9 2.1 3.1 2.4 1.4 5.1 1.2 6.2 3.0 4.6 2.8 1.4 3.1 0.1 2.9 2.2 2.3 1.7 5.4 0.4 0.0 1.9 3.4 1.9 2.7 11.0 1.5 2.4 7.7 3.6 14.6 3.8 2.9 1.7 0.1 0.2 0.5 2.1 12.4 3.1 4.7 2.0 2.3 7.4 0.4 3.4 2.3 6.7 0.8 2.8 0.8 3.3 0.0 0.7 0.0 1.0 2.8 2.9 0.6 7.2 0.1 1.6 3.1 0.7 3.2 8.7 1.5 2.2 4.9 4.3 0.1 0.0 0.0 0.4 1.8 0.3 3.1 1.3 1.3 3.5 1.0 5.1 1.7 2.3 2.9 1.4 2.9 3.2 2.2 1.0 1.4 2.4 2.1 1.3 1.2 8.9 2.2 0.0 0.2 0.3 0.7 6.9 0.0 10.7 3.4 0.0 2.0 0.1 0.0 0.4 19.2 0.0 0.0 0.0 1.0 0.1 0.4 0.0 4.7 0.0 0.4 0.0 0.0 0.6 0.6 6.2 0.3 1.1 0.0 3.6 0.0 0.2 1.0 0.0 0.0 0.1 0.6 0.0 0.5 4.3 1.1 0.0 0.3 0.0 0.0 0.1 RGS6 ENSG00000182732 "Regulator of G protein signaling 6" P49758 14 71932439-72566529 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8" "Group enriched" "Detected in some" 9 "Early spermatids: 155.9;Late spermatids: 221.8" "Group enriched" "Detected in some" 7 "glioma: 3.1;thyroid cancer: 1.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.6;T-reg: 1.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HEL: 8.3;Karpas-707: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003067 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA003067: AB_1079807" "unprognostic (7.18e-2)" "unprognostic (7.78e-2)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (5.61e-2)" "unprognostic (3.80e-2)" "unprognostic (1.24e-4)" "unprognostic (7.83e-2)" "unprognostic (2.03e-1)" "unprognostic (8.17e-2)" "unprognostic (1.30e-1)" "unprognostic (2.06e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-2)" "unprognostic (8.06e-3)" "unprognostic (2.10e-1)" "unprognostic (3.68e-2)" 6.9 0.8 8.6 1.1 11.1 2.0 4.9 4.0 18.0 7.9 1.8 2.8 0.3 0.8 2.7 4.2 1.0 3.6 1.9 15.7 3.7 7.5 3.3 0.6 1.7 0.5 15.4 9.3 2.3 0.6 10.9 2.6 4.6 20.8 0.7 1.8 1.3 1.3 2.5 1.7 1.4 1.4 2.2 5.2 1.5 0.8 13.9 2.4 0.0 8.5 0.3 1.0 1.1 1.3 0.5 0.4 1.6 0.2 0.6 1.2 4.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 30.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.6 0.0 0.4 1.2 4.1 8.6 11.1 4.0 18.0 3.7 7.5 15.4 9.3 20.8 2.4 0.0 0.0 0.0 0.0 0.2 1.4 19.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 155.9 0.7 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 221.8 1.7 0.0 0.0 8.2 0.0 0.0 0.0 0.0 7.1 0.1 0.4 12.9 20.2 1.2 1.0 0.1 0.7 0.0 0.0 0.4 RHBDF1 "C16orf8, Dist1, EGFR-RS, FLJ2235, iRhom1" ENSG00000007384 "Rhomboid 5 homolog 1" Q96CC6 16 58059-76355 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077399 Uncertain Vesicles NA NA Vesicles "HPA077399: " "unprognostic (2.62e-1)" "unprognostic (2.86e-2)" "unprognostic (4.76e-2)" "unprognostic (4.04e-2)" "unprognostic (1.51e-2)" "unprognostic (3.69e-2)" "unprognostic (5.60e-3)" "unprognostic (4.54e-3)" "unprognostic (4.51e-2)" "unprognostic (1.02e-1)" "unprognostic (7.81e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (2.49e-5)" "unprognostic (4.81e-2)" "unprognostic (1.87e-1)" "unprognostic (8.36e-2)" "unprognostic (4.22e-2)" 12.7 3.7 6.2 11.5 9.3 0.3 17.7 3.5 6.2 21.8 10.8 6.1 6.7 5.6 13.0 10.4 17.5 10.6 17.2 15.9 7.0 2.8 8.2 3.8 17.8 4.1 6.9 4.9 18.8 9.6 9.8 4.3 26.5 7.3 19.6 5.5 15.9 20.1 13.5 13.4 22.4 7.5 14.6 5.8 6.1 9.2 7.1 3.1 1.2 11.2 15.7 10.1 16.0 19.4 0.0 0.5 0.0 1.7 0.0 0.4 0.0 4.3 7.0 4.0 9.3 15.9 19.7 13.3 11.9 22.5 8.4 8.1 9.5 15.2 0.2 5.0 12.7 4.3 13.8 2.0 8.0 1.4 0.1 2.2 0.1 7.0 2.6 17.8 0.1 7.7 16.4 8.5 21.8 3.6 15.0 12.8 0.0 1.6 0.2 13.3 24.2 0.0 1.4 3.6 9.1 6.0 0.1 4.8 0.3 9.4 4.4 0.1 1.0 3.4 13.2 7.4 5.2 20.4 1.5 13.3 13.4 9.4 10.3 3.2 0.1 0.2 0.1 9.3 0.2 20.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.2 9.3 3.5 6.2 7.0 2.8 6.9 4.9 7.3 3.1 17.9 3.8 0.0 8.9 6.1 0.9 8.1 20.4 1.4 6.8 8.7 62.8 14.0 0.0 19.1 0.5 9.5 5.3 0.0 6.9 14.1 18.2 19.2 0.0 2.6 1.9 0.0 0.0 6.2 0.3 0.9 18.1 0.3 15.1 0.0 8.3 5.7 19.4 7.2 13.1 2.1 4.3 12.9 12.9 0.2 2.5 4.8 25.6 0.5 2.9 9.4 RHCE "CD240CE, RH" ENSG00000188672 "Rh blood group CcEe antigens" P18577 1 25362249-25430192 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 40.5" "Cell type enriched" "Detected in some" 33 "Erythroid cells: 210.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.4" "Cell line enriched" "Detected in some" 5 "HEL: 44.7" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (1.37e-1)" "unprognostic (3.53e-1)" "unprognostic (2.38e-1)" "unprognostic (6.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.91e-2)" "unprognostic (7.01e-2)" "unprognostic (3.12e-2)" "unprognostic (3.81e-2)" "unprognostic (1.35e-1)" "unprognostic (6.08e-2)" "unprognostic (4.61e-2)" "unprognostic (5.77e-5)" "unprognostic (1.38e-1)" "unprognostic (3.94e-2)" "unprognostic (7.15e-3)" "unprognostic (1.63e-1)" 0.6 0.8 2.0 0.6 5.1 40.5 0.9 3.3 4.7 0.8 0.7 3.5 1.0 0.7 0.7 5.2 1.4 1.6 0.8 2.1 2.6 1.5 0.8 2.2 0.7 1.0 2.1 2.5 0.9 9.6 0.5 4.0 1.6 5.9 1.6 0.8 2.2 8.4 0.8 1.9 1.1 0.6 0.5 2.9 2.1 0.8 2.6 1.4 1.2 1.1 1.2 0.8 0.5 0.6 0.1 0.2 2.4 0.2 0.1 0.3 0.9 0.1 0.0 0.1 0.2 0.4 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.7 0.3 0.5 0.5 0.0 0.1 0.0 0.1 0.1 0.2 0.0 44.7 0.0 0.0 0.6 0.0 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.3 8.7 0.2 0.2 0.4 0.0 0.3 0.9 0.3 0.2 0.1 0.1 1.2 0.0 0.0 0.3 0.4 0.1 0.1 0.5 0.4 0.2 0.0 0.0 0.1 0.0 0.4 0.0 2.6 0.6 0.5 1.5 0.4 0.2 2.4 0.2 0.6 0.3 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.2 0.0 1.0 0.1 0.0 0.1 0.3 0.9 2.0 5.1 3.3 4.7 2.6 1.5 2.1 2.5 5.9 1.4 0.0 0.0 0.0 0.5 0.5 3.3 0.4 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.8 0.0 0.0 210.2 0.2 0.4 0.2 0.4 4.6 0.4 0.2 6.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.4 0.0 0.7 0.0 2.5 6.5 0.0 2.8 5.1 1.3 0.7 0.0 0.1 0.7 RHD "CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI" ENSG00000187010 "Rh blood group D antigen" Q02161 1 25272393-25330445 "Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 10.0;bone marrow: 16.5;salivary gland: 7.1" "Cell type enriched" "Detected in some" 20 "Erythroid cells: 23.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.0" "Group enriched" "Detected in some" 6 "HEL: 28.2;K-562: 8.7" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (4.75e-3)" "unprognostic (7.70e-2)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.09e-2)" "unprognostic (4.84e-2)" "unprognostic (1.11e-2)" "unprognostic (5.25e-2)" "unprognostic (1.11e-2)" "unprognostic (1.91e-1)" "unprognostic (1.27e-2)" "unprognostic (1.89e-1)" "unprognostic (4.96e-3)" "unprognostic (1.93e-1)" "unprognostic (8.09e-2)" "unprognostic (5.53e-2)" "unprognostic (4.92e-3)" 0.3 0.3 0.3 0.5 0.5 16.5 0.3 1.5 1.4 0.6 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.4 0.9 0.3 0.2 0.3 0.3 2.5 0.8 0.3 0.3 0.9 0.3 0.1 0.4 0.3 1.1 0.5 0.0 0.3 7.1 0.3 4.1 2.5 0.4 0.3 0.4 1.8 0.3 0.5 0.3 0.3 0.4 2.3 0.3 0.3 0.3 2.0 0.6 10.0 1.4 1.4 1.4 1.2 0.1 0.0 0.2 0.2 0.1 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.1 28.2 0.7 0.2 0.0 0.3 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 8.7 0.7 0.0 0.1 0.2 0.2 3.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.5 0.3 0.1 0.2 0.1 0.1 0.2 0.5 0.4 0.5 0.2 0.4 0.1 0.3 0.1 0.1 0.5 0.2 0.1 4.9 1.4 2.8 1.0 0.6 1.1 1.3 1.3 0.8 0.2 2.0 1.4 1.3 10.0 1.4 0.8 0.6 0.9 1.2 0.3 0.5 1.5 1.4 0.3 0.2 0.3 0.3 1.1 0.3 0.0 0.3 0.0 0.1 0.1 0.2 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 23.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 RHEBL1 "FLJ25797, MGC34869, RHEB2" ENSG00000167550 "RHEB like 1" Q8TAI7 12 49064685-49070025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.6;brain: 9.5" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 9.4;Erythroid cells: 23.3;monocytes: 7.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.1;granulocytes: 10.6;T-cells: 10.1" "Cell line enhanced" "Detected in many" "HDLM-2: 16.7;U-266/84: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA053111, HPA061001" Uncertain Uncertain Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA053111: AB_2682047, HPA061001: AB_2684409" "unprognostic (2.94e-1)" "unprognostic (1.11e-3)" "unprognostic (2.36e-2)" "unprognostic (9.81e-3)" "unprognostic (8.76e-2)" "unprognostic (2.03e-2)" "unprognostic (3.03e-5)" "unprognostic (9.13e-2)" "unprognostic (9.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.98e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-10)" "unprognostic (4.67e-2)" "unprognostic (1.11e-1)" "unprognostic (7.66e-2)" "unprognostic (2.07e-1)" 1.6 0.6 3.6 2.7 2.0 4.0 2.3 4.0 9.5 0.8 1.1 0.4 1.3 1.1 3.3 2.5 0.9 5.5 1.0 1.4 2.2 2.7 0.9 0.7 2.6 6.8 2.0 5.1 1.0 0.6 0.2 0.7 1.4 1.9 0.5 1.8 0.4 1.0 1.3 0.6 5.6 1.8 1.0 1.2 5.2 1.2 3.0 0.9 2.5 0.8 0.0 3.9 1.0 4.1 3.1 0.9 10.6 1.6 1.3 10.1 1.2 0.9 2.0 1.2 2.9 0.7 0.1 1.2 0.9 2.7 5.1 5.8 1.8 1.6 2.8 0.9 0.2 2.9 0.8 0.8 1.1 2.3 16.7 0.1 2.7 1.4 0.9 0.6 1.1 5.8 0.3 0.4 2.6 0.8 0.3 2.0 5.0 3.5 8.1 1.9 0.8 1.2 6.8 1.8 3.5 2.9 2.6 1.8 4.4 0.4 0.1 0.6 1.7 0.7 0.7 4.5 1.8 0.3 1.8 1.0 1.6 2.6 3.1 0.9 9.8 33.3 1.7 1.3 4.1 0.6 10.6 0.3 0.7 7.3 1.6 10.1 1.9 3.1 3.9 0.7 3.1 1.0 3.8 0.6 1.3 1.4 0.9 6.1 1.2 3.6 2.0 4.0 9.5 2.2 2.7 2.0 5.1 1.9 0.9 0.0 0.0 4.3 0.2 1.1 1.5 0.8 2.5 9.4 2.3 0.0 0.0 0.1 0.0 0.4 0.4 1.4 0.0 23.3 0.2 0.4 0.8 0.3 0.0 0.0 1.5 3.2 0.0 1.3 0.0 0.4 0.0 1.8 0.0 7.2 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.9 5.0 1.8 0.1 5.1 0.2 0.0 RHOBTB3 KIAA0878 ENSG00000164292 "Rho related BTB domain containing 3" O94955 5 95713522-95824383 "Predicted intracellular proteins" Transport Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 86.0" "Cell type enhanced" "Detected in many" 6 "Leydig cells: 367.9;Muller glia cells: 260.1;Peritubular cells: 295.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 10.1" "Group enriched" "Detected in many" 4 "granulocytes: 10.1;T-cells: 2.9" "Cell line enhanced" "Detected in many" "EFO-21: 49.0;HaCaT: 62.3;SuSa: 64.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000265 Uncertain Vesicles NA NA Vesicles "HPA000265: " "unprognostic (1.68e-1)" "unprognostic (9.60e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-3)" "unprognostic (1.84e-1)" "unprognostic (3.39e-2)" "unprognostic (7.37e-2)" "unprognostic (4.28e-1)" "unprognostic (6.00e-3)" "unprognostic (9.29e-2)" "unprognostic (9.15e-2)" "unprognostic (3.64e-1)" "unprognostic (1.56e-3)" "unprognostic (7.01e-3)" "unprognostic (1.15e-1)" "unprognostic (3.23e-1)" "unprognostic (8.21e-2)" 38.7 21.4 27.0 6.4 25.8 4.0 12.8 11.8 23.1 16.4 12.0 26.9 11.8 8.2 7.5 15.5 9.8 7.8 11.0 17.6 26.2 12.8 16.4 11.5 9.5 3.6 20.1 21.3 46.6 59.2 24.1 11.0 86.0 13.0 16.4 11.7 21.7 21.0 12.2 15.3 7.4 9.0 11.2 18.2 6.0 12.1 12.4 21.3 1.8 11.1 4.1 1.6 10.9 12.8 0.8 1.2 10.1 1.5 0.5 2.9 0.9 9.8 4.0 9.9 10.5 37.3 21.6 0.1 17.3 16.4 6.7 10.6 19.1 1.8 0.0 49.0 8.8 17.6 62.3 5.3 1.2 11.6 0.4 6.8 3.4 37.9 5.5 29.4 0.8 4.9 35.0 0.9 10.0 0.1 28.8 5.1 3.0 13.5 2.6 26.7 2.8 1.0 2.7 3.7 6.2 6.2 1.4 19.4 1.2 5.6 7.1 17.5 22.7 13.5 5.9 16.0 64.3 4.5 4.9 8.2 9.0 38.9 6.0 6.5 2.6 5.0 0.4 2.8 0.2 14.8 0.1 0.9 10.1 2.9 0.5 1.2 0.8 2.1 2.5 0.2 0.2 2.9 0.6 0.7 0.5 1.5 1.2 1.1 0.9 27.0 25.8 11.8 18.6 26.2 12.8 20.1 21.3 13.0 21.3 163.8 14.1 3.7 50.7 9.6 69.6 74.7 38.2 41.5 47.8 134.3 19.6 42.1 51.4 57.7 7.8 11.7 11.8 0.0 94.5 117.9 62.8 65.1 97.1 69.3 27.2 6.4 88.2 13.5 15.6 6.5 367.9 11.7 40.5 4.6 63.7 260.1 55.3 49.1 295.9 3.4 33.3 32.3 54.7 1.7 1.9 24.0 96.3 10.1 77.7 76.4 RHOXF1 "OTEX, PEPP1" ENSG00000101883 "Rhox homeobox family member 1" Q8NHV9 X 120109053-120115937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 8.1;brain: 9.2;testis: 27.8" "Cell type enriched" "Detected in some" 39 "Spermatogonia: 154.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 9.2" "Cell type enriched" "Detected in some" 6 "T-reg: 8.1" "Lineage enriched" "Detected in single" 30 "T-cells: 8.1" "Cell line enhanced" "Detected in some" "HDLM-2: 3.2;HEK 293: 3.9;NB-4: 2.8" "HPA052560, HPA056506" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA052560: , HPA056506: AB_2683157" "unprognostic (5.03e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (2.31e-2)" "unprognostic (8.65e-2)" "unprognostic (1.07e-3)" "unprognostic (2.46e-1)" "unprognostic (3.15e-1)" "unprognostic (3.89e-1)" "unprognostic (2.15e-1)" "unprognostic (7.50e-4)" "unprognostic (1.97e-1)" "unprognostic (5.85e-4)" "unprognostic (3.00e-1)" "unprognostic (7.96e-2)" "unprognostic (2.26e-1)" "unprognostic (1.73e-3)" 2.8 0.5 0.9 0.5 1.1 0.3 0.9 9.2 1.7 0.5 0.7 0.5 0.5 0.2 0.5 0.5 0.5 1.5 0.5 0.5 0.8 2.4 0.8 0.5 0.5 0.6 0.8 0.5 2.2 0.5 0.8 0.9 1.1 0.5 0.5 0.1 0.5 0.8 0.6 0.5 2.4 0.5 0.5 0.5 0.5 0.2 27.8 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.1 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 3.2 3.9 0.4 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.2 8.1 0.0 0.9 1.1 9.2 1.7 0.8 2.4 0.8 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 2.7 0.0 0.0 3.9 0.1 1.7 0.1 1.0 0.1 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.0 0.1 0.8 0.0 0.0 1.4 0.0 1.3 0.0 0.0 2.9 154.2 0.3 0.0 0.0 0.1 0.0 RIF1 "FLJ10599, FLJ12870" ENSG00000080345 "Replication timing regulatory factor 1" Q5UIP0 2 151409883-151508013 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036887, HPA036888" Supported Uncertain "Nucleoplasm,Nuclear bodies,Plasma membrane" No No "Nucleoplasm, Nuclear bodies, Plasma membrane" "HPA036887: AB_2675361, HPA036888: AB_2675362" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.71e-1)" "unprognostic (4.71e-3)" "unprognostic (5.87e-2)" "unprognostic (1.79e-2)" "unprognostic (3.73e-2)" "unprognostic (1.86e-1)" "unprognostic (2.51e-2)" "unprognostic (2.84e-2)" "unprognostic (1.80e-3)" "unprognostic (4.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (1.57e-2)" "unprognostic (8.41e-2)" 13.7 9.0 12.1 11.7 18.2 31.1 16.6 23.6 17.1 12.7 10.9 12.4 8.7 7.2 15.5 7.3 10.2 11.5 9.8 8.5 11.7 8.5 9.8 11.2 10.9 13.0 15.7 11.6 19.4 12.1 16.3 17.3 13.4 13.6 10.8 10.6 9.6 12.0 9.3 18.3 13.9 10.4 13.5 11.6 10.2 10.1 17.8 15.9 18.4 15.5 9.4 12.9 11.6 11.9 6.2 2.6 7.9 4.7 10.7 7.8 2.3 9.9 8.5 13.3 10.1 5.5 7.0 12.8 12.1 9.0 11.0 13.2 13.9 8.2 19.1 11.0 8.5 9.1 10.4 20.4 8.6 18.7 13.4 9.7 30.4 10.4 9.9 5.8 30.5 10.2 5.3 5.6 19.7 15.0 6.1 10.6 11.8 24.5 16.2 11.2 6.7 18.0 10.6 21.3 5.3 11.6 18.5 21.1 12.5 5.7 12.4 12.1 9.3 15.8 7.3 8.2 9.8 6.4 11.1 13.2 16.7 11.7 10.1 12.8 8.0 13.9 27.9 7.6 12.3 11.0 7.9 3.6 4.3 6.8 2.5 7.8 6.2 5.8 4.9 2.6 5.2 7.7 5.9 4.2 10.7 4.7 2.4 4.0 2.3 12.1 18.2 23.6 17.1 11.7 8.5 15.7 11.6 13.6 15.9 89.3 38.8 22.7 37.6 43.8 43.2 30.5 30.6 22.7 51.2 14.0 29.5 33.1 1.7 31.1 9.9 38.7 14.2 0.0 18.7 32.2 38.4 39.1 32.4 17.1 19.6 44.5 24.0 27.6 27.0 9.9 40.6 34.9 28.7 29.7 28.7 37.8 25.0 23.5 32.2 9.5 42.4 84.1 40.1 87.8 126.0 36.4 34.2 27.4 28.4 37.2 RIMBP3 "KIAA1666, RIMBP3.1, RIMBP3A" ENSG00000275793 "RIMS binding protein 3" Q9UFD9 22 18605815-18611919 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 6.0;THP-1: 6.5" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.55e-2)" "unprognostic (3.95e-3)" "unprognostic (1.62e-1)" "unprognostic (3.95e-2)" "unprognostic (2.29e-2)" "unprognostic (9.81e-3)" "unprognostic (1.83e-3)" "unprognostic (1.84e-1)" "unprognostic (2.71e-1)" "unprognostic (4.72e-3)" "unprognostic (6.06e-3)" "unprognostic (9.58e-2)" "unprognostic (8.49e-3)" "unprognostic (7.23e-2)" "unprognostic (1.03e-1)" "unprognostic (2.69e-3)" "unprognostic (7.95e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 22.0 0.1 0.2 0.0 0.7 1.1 0.9 1.0 1.7 2.5 1.1 0.8 2.8 1.2 0.9 1.6 0.8 0.1 1.0 3.1 1.4 1.5 0.1 0.0 0.7 1.2 0.3 0.8 0.8 0.6 0.0 0.3 2.8 0.9 1.3 0.8 1.2 0.1 4.0 0.1 0.3 0.1 0.6 0.0 0.3 0.0 2.4 0.6 0.7 1.2 1.4 6.0 3.1 1.2 1.2 0.3 2.4 3.5 0.4 0.4 0.2 1.6 0.3 2.5 0.0 0.5 0.2 0.3 6.5 0.2 2.1 1.5 1.1 0.5 0.2 0.8 0.6 1.2 1.4 2.3 0.0 1.0 0.9 1.0 0.6 2.5 0.7 1.4 1.4 1.1 0.6 1.8 0.9 0.3 1.7 0.4 0.1 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 RIMBP3B ENSG00000274600 "RIMS binding protein 3B" A6NNM3 22 21383374-21389478 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 2.8;RH-30: 3.5;THP-1: 4.9" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (3.78e-1)" "unprognostic (3.54e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-1)" "unprognostic (3.28e-1)" "unprognostic (5.35e-2)" "unprognostic (4.37e-1)" "unprognostic (3.61e-4)" "unprognostic (1.69e-2)" "unprognostic (7.11e-2)" 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.2 0.0 0.3 0.4 0.4 0.9 1.0 1.5 0.4 0.1 1.7 0.2 0.4 1.1 0.7 0.3 0.5 1.2 0.5 0.9 0.2 0.3 0.3 1.0 0.2 0.1 0.0 0.7 0.0 0.1 1.7 1.1 0.6 0.3 0.2 0.0 0.6 0.0 0.1 0.0 0.1 0.2 0.0 0.0 1.0 0.6 0.3 0.6 0.2 2.0 2.8 0.4 0.6 0.4 2.0 3.5 0.0 0.1 0.0 0.5 0.0 1.6 0.0 0.5 0.0 0.1 4.9 0.0 0.4 0.5 0.4 0.2 0.1 0.1 0.0 0.9 0.4 1.5 0.0 0.5 0.4 1.1 0.2 1.4 0.1 0.7 1.5 0.4 0.3 1.1 0.7 0.1 1.0 0.9 0.1 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RIMBP3C ENSG00000183246 "RIMS binding protein 3C" A6NJZ7 22 21545357-21551461 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 16.6" "Group enriched" "Detected in some" 18 "Early spermatids: 22.4;Late spermatids: 37.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 3.2;THP-1: 3.6" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.74e-1)" "unprognostic (4.05e-2)" "unprognostic (3.49e-2)" "unprognostic (2.18e-1)" "unprognostic (8.30e-2)" "unprognostic (4.53e-2)" "unprognostic (6.65e-2)" "unprognostic (1.15e-3)" "unprognostic (6.23e-2)" "unprognostic (2.17e-6)" "unprognostic (3.04e-1)" "unprognostic (3.29e-1)" "unprognostic (3.76e-6)" "unprognostic (1.66e-2)" 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 16.6 0.0 0.3 0.1 0.0 0.5 1.3 0.9 0.8 1.4 1.7 1.0 0.2 0.0 0.5 0.1 0.1 0.0 0.2 0.1 0.9 0.7 0.3 0.1 0.3 0.0 1.6 0.6 0.7 0.5 0.7 0.2 0.1 0.7 0.5 0.5 0.0 0.3 0.2 1.6 0.6 0.0 0.2 0.5 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.7 1.8 3.2 0.3 1.6 0.3 1.5 0.9 0.1 0.1 0.1 0.8 0.2 0.5 0.4 0.2 0.2 0.0 3.6 0.0 1.3 0.6 0.7 0.2 0.5 0.4 0.2 1.3 1.1 1.7 0.9 0.8 0.8 0.5 0.5 1.4 0.5 0.9 0.7 1.3 0.4 1.7 0.6 0.8 1.4 0.7 0.1 0.9 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 37.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 RIMKLA "FAM80A, MGC47816, NAAGS-II, RP11-157D18.1" ENSG00000177181 "Ribosomal modification protein rimK like family member A" Q8IXN7 1 42380795-42422578 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.1" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 41.2;Horizontal cells: 33.4;Rod photoreceptor cells: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 7.8;JURKAT: 6.3;Karpas-707: 9.1;SCLC-21H: 11.9;U-266/70: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027826 Uncertain Uncertain "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA027826: AB_10603992" "unprognostic (4.04e-2)" "unprognostic (1.61e-1)" "unprognostic (3.68e-3)" "unprognostic (9.84e-2)" "unprognostic (2.49e-2)" "unprognostic (1.06e-1)" "unprognostic (2.63e-3)" "prognostic favorable (1.43e-4)" "unprognostic (8.89e-2)" "unprognostic (3.76e-1)" "unprognostic (9.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.22e-3)" "unprognostic (3.99e-2)" "unprognostic (7.07e-2)" "unprognostic (1.63e-2)" "unprognostic (3.44e-1)" 0.9 1.2 6.2 1.5 10.4 0.8 1.3 7.8 18.4 1.0 7.9 1.7 0.0 1.4 1.0 0.8 1.0 0.9 1.8 8.5 7.5 5.9 2.5 0.7 5.4 0.8 7.9 8.5 0.7 2.5 6.6 2.0 1.3 20.1 2.2 9.0 3.3 1.1 1.2 1.4 1.1 1.3 2.4 3.6 1.1 2.1 2.3 1.2 0.0 2.2 0.0 0.8 1.1 0.4 0.3 1.6 1.3 0.2 0.4 2.0 0.1 0.0 0.8 0.1 7.8 0.1 0.0 1.5 0.0 0.0 0.2 0.5 0.4 0.2 0.0 1.6 0.0 1.3 0.0 4.6 0.0 0.4 4.1 3.1 0.3 0.1 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 9.1 0.0 0.3 2.1 0.0 4.0 0.6 5.5 0.0 0.3 0.4 0.7 2.1 11.9 5.1 0.4 0.3 0.1 0.9 0.4 2.0 0.0 0.0 0.4 0.0 0.8 8.3 4.7 5.5 0.1 0.0 0.0 1.1 0.2 1.3 0.2 0.2 2.0 0.2 0.1 1.0 0.0 0.3 0.1 0.2 1.0 0.4 0.1 1.6 0.1 0.1 6.2 10.4 7.8 18.4 7.5 5.9 7.9 8.5 20.1 1.2 14.9 4.6 0.0 0.8 0.6 13.2 13.0 0.0 0.0 1.2 1.8 41.2 1.0 1.7 3.2 4.7 0.9 7.8 0.0 4.2 11.6 0.3 2.9 0.0 0.0 0.8 33.4 10.9 1.3 0.0 6.4 0.3 0.8 5.0 0.0 7.5 4.5 6.8 5.9 0.0 2.4 23.9 0.0 0.5 1.0 2.5 0.1 1.4 0.0 5.5 0.7 RLIM "MGC15161, NY-REN-43, RNF12" ENSG00000131263 "Ring finger protein, LIM domain interacting" Q9NVW2 X 74585217-74614617 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018895 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA018895: AB_1856323" "unprognostic (1.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.72e-1)" "unprognostic (1.31e-3)" "unprognostic (1.25e-1)" "unprognostic (1.03e-1)" "unprognostic (8.98e-3)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (4.91e-2)" "unprognostic (2.25e-1)" "unprognostic (3.82e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.04e-4)" "unprognostic (1.20e-1)" 11.8 14.3 17.5 10.6 25.6 37.4 12.4 12.6 20.5 12.2 7.4 8.3 5.6 6.4 10.6 8.0 10.2 9.5 10.7 10.5 17.1 16.6 11.6 9.7 13.8 9.2 12.4 13.7 12.4 9.7 19.5 18.5 10.5 28.6 11.9 7.6 5.2 8.9 8.7 11.2 10.2 7.1 10.1 13.9 9.8 8.4 6.9 12.4 9.7 13.0 6.2 10.1 10.5 9.3 3.5 4.8 16.3 7.4 5.2 4.6 3.0 13.7 14.0 13.6 11.3 13.7 14.5 13.4 13.2 15.4 11.9 14.7 10.9 14.4 7.4 15.5 16.6 16.1 11.9 27.3 15.9 18.2 6.7 14.4 13.0 24.7 6.6 12.2 19.5 23.2 14.0 10.0 16.9 29.1 10.2 13.8 12.4 11.2 13.5 15.6 10.5 14.5 11.1 20.9 8.5 13.5 13.9 28.8 12.5 11.0 16.5 10.0 11.7 24.9 12.1 15.4 13.0 6.8 15.4 18.3 14.4 14.0 14.7 11.5 7.2 13.8 11.9 15.7 19.9 14.0 16.3 5.9 5.6 3.2 7.4 3.3 3.0 4.1 4.0 4.8 3.5 4.5 4.1 11.4 5.2 5.4 2.6 4.6 3.0 17.5 25.6 12.6 20.5 17.1 16.6 12.4 13.7 28.6 12.4 14.9 17.1 2.9 24.0 31.8 12.3 26.3 15.3 24.1 20.5 24.4 13.7 14.1 10.0 12.7 5.5 27.4 7.8 0.0 9.2 17.5 26.4 21.1 36.9 11.9 16.0 20.6 22.2 20.3 20.2 3.3 9.2 23.6 16.9 3.6 9.8 13.7 11.6 8.6 17.7 9.6 13.8 6.5 17.6 7.2 17.2 33.9 22.0 17.0 10.2 31.0 RMC1 "C18orf8, HsT2591, MIC1, WDR98" ENSG00000141452 "Regulator of MON1-CCZ1" Q96DM3 18 23503470-23531807 "Cancer-related genes, Predicted intracellular proteins" Autophagy "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 13.6;monocytes: 15.4;Proximal tubular cells: 14.5;Syncytiotrophoblasts: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043589 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043589: AB_2678568" "unprognostic (6.45e-2)" "unprognostic (6.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.78e-1)" "unprognostic (5.51e-3)" "unprognostic (8.16e-2)" "prognostic unfavorable (3.94e-4)" "unprognostic (4.26e-2)" "unprognostic (3.77e-1)" "unprognostic (1.73e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (3.03e-1)" "unprognostic (3.76e-1)" "unprognostic (1.25e-1)" "unprognostic (3.04e-2)" "unprognostic (4.13e-2)" 16.6 14.3 11.6 13.9 13.2 30.1 25.2 15.8 20.5 13.2 17.1 13.1 11.8 20.3 16.4 12.4 15.0 14.4 13.3 12.7 16.6 10.7 20.9 23.8 19.5 24.1 15.4 12.0 14.1 17.3 14.6 23.5 17.5 13.4 13.2 14.1 16.2 16.3 14.2 17.2 16.3 23.1 13.6 14.0 21.9 18.9 26.2 11.6 19.7 13.3 11.0 22.9 16.3 14.8 20.0 27.1 24.1 25.4 19.7 18.0 10.2 8.4 8.7 6.5 11.3 14.9 10.7 8.7 13.3 14.2 17.9 21.4 7.9 5.2 12.7 11.2 11.4 26.0 16.7 16.9 7.5 15.9 13.1 9.6 6.4 6.2 7.9 19.5 16.8 22.9 9.6 11.8 22.1 12.7 10.3 10.5 11.1 10.0 13.7 11.9 10.9 14.0 7.7 3.5 12.1 13.4 11.3 9.8 12.5 9.4 8.2 8.8 11.9 17.2 8.7 10.9 9.4 6.7 10.5 10.1 15.3 4.1 6.1 11.4 21.9 16.5 14.6 15.8 11.5 11.5 24.1 9.9 21.5 15.5 18.4 16.0 19.9 13.8 14.9 12.1 20.0 9.4 11.4 9.6 19.7 25.4 27.1 18.0 10.2 11.6 13.2 15.8 20.5 16.6 10.7 15.4 12.0 13.4 11.6 8.9 13.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 6.8 7.0 0.0 8.9 5.0 10.1 0.0 0.0 0.0 0.0 10.7 6.5 0.0 0.0 3.5 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 15.4 0.0 0.0 10.2 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 RMI2 "BLAP18, C16orf75, MGC24665" ENSG00000175643 "RecQ mediated genome instability 2" Q96E14 16 11249619-11351762 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.7;testis: 29.6" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 100.7;Peritubular cells: 40.0;Spermatogonia: 42.9;Syncytiotrophoblasts: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 6.5" "Group enriched" "Detected in many" 5 "B-cells: 6.5;T-cells: 3.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA040995 Uncertain Supported "Nuclear speckles,Cytosol" NA Yes "Nuclear speckles" Cytosol "HPA040995: AB_10795531" "unprognostic (2.76e-1)" "prognostic favorable (5.69e-5)" "unprognostic (1.17e-1)" "unprognostic (3.09e-3)" "unprognostic (1.69e-2)" "unprognostic (1.80e-3)" "prognostic unfavorable (2.77e-5)" "unprognostic (3.98e-1)" "unprognostic (1.16e-1)" "unprognostic (1.83e-1)" "unprognostic (3.44e-3)" "unprognostic (3.89e-1)" "unprognostic (2.18e-1)" "unprognostic (5.50e-2)" "unprognostic (3.68e-2)" "unprognostic (3.60e-3)" "unprognostic (1.03e-1)" 1.0 1.8 4.2 18.0 5.1 4.8 2.8 0.7 4.1 2.8 7.3 1.0 0.4 4.3 2.5 3.2 11.8 1.0 2.6 1.9 2.5 1.5 3.1 2.3 2.9 17.9 1.6 5.6 3.6 1.6 0.7 1.1 13.2 1.2 2.6 9.0 0.8 2.9 1.7 1.1 8.7 5.6 1.1 1.4 4.2 4.0 29.6 1.2 31.7 1.4 2.8 20.4 3.6 4.5 6.5 0.6 0.9 0.0 0.3 3.0 0.3 19.2 12.9 25.4 10.8 1.1 5.5 10.6 11.2 8.9 10.6 17.7 4.9 22.9 26.7 9.7 5.2 12.0 11.3 10.8 10.7 17.3 5.2 10.1 14.6 7.6 32.6 0.4 5.6 6.6 1.2 2.1 4.6 4.4 4.2 5.8 11.8 20.1 21.3 5.5 22.2 19.3 26.2 21.3 26.9 5.1 23.5 27.4 28.5 6.3 12.5 14.6 11.6 9.5 15.9 8.3 15.3 27.0 8.4 1.8 8.5 8.0 16.3 1.6 5.8 9.6 31.7 7.9 18.5 15.7 0.0 0.0 0.9 0.6 0.0 0.0 6.5 0.2 0.0 0.4 2.5 1.8 0.7 0.2 0.3 0.0 0.6 3.0 0.3 4.2 5.1 0.7 4.1 2.5 1.5 1.6 5.6 1.2 1.2 0.0 0.3 4.9 6.4 6.1 0.1 0.8 5.1 0.0 2.3 7.0 0.0 100.7 5.0 2.3 2.2 0.7 1.1 23.3 0.4 27.0 2.6 1.6 0.0 0.8 15.8 0.0 2.4 1.3 1.0 4.3 14.7 3.4 3.3 1.8 5.9 0.0 1.1 3.5 40.0 0.0 0.5 32.3 0.9 31.4 42.9 4.6 39.9 0.0 7.0 2.8 RNASEK-C17orf49 ENSG00000161939 "RNASEK-C17orf49 readthrough" 17 7012635-7017520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.3" "Group enriched" "Detected in many" 8 "Alveolar cells type 1: 59.6;Alveolar cells type 2: 63.9;Ciliated cells: 103.1;Club cells: 56.9;granulocytes: 55.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 5.3;THP-1: 6.3;U-87 MG: 6.9" "HPA022961, HPA024457" Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (4.08e-2)" "unprognostic (3.30e-1)" "unprognostic (1.58e-1)" "unprognostic (9.37e-5)" "unprognostic (4.19e-1)" "unprognostic (1.71e-1)" "unprognostic (7.91e-2)" "unprognostic (3.01e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.77e-3)" "unprognostic (8.26e-3)" "unprognostic (8.58e-3)" "unprognostic (3.00e-1)" "unprognostic (2.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.78e-1)" 4.8 4.8 2.8 3.5 3.5 5.3 2.9 3.6 4.0 2.0 2.8 0.4 1.5 1.4 4.9 3.3 2.3 2.7 3.2 6.3 2.5 3.3 6.6 14.5 16.7 20.3 2.9 2.4 2.4 7.9 1.4 4.7 2.5 1.8 1.8 1.4 0.4 1.6 5.0 4.2 1.9 6.3 2.3 1.7 9.1 1.6 6.4 0.7 4.1 2.0 4.6 3.4 2.3 1.6 1.9 4.0 7.5 4.3 0.9 1.7 2.8 1.2 3.6 0.5 0.5 0.0 0.0 1.1 2.3 1.9 2.8 2.2 2.3 1.1 1.9 0.2 0.0 0.3 0.6 0.7 5.3 0.8 0.0 4.4 0.0 2.9 1.0 2.8 0.0 0.6 0.0 0.0 1.6 0.0 0.4 0.7 0.2 0.6 0.0 0.0 1.2 1.9 2.3 2.3 0.5 1.2 1.4 0.0 0.0 0.8 0.7 0.5 1.8 0.0 0.0 0.2 0.3 0.6 6.3 0.0 0.0 0.2 3.5 1.0 0.0 0.8 0.2 6.9 0.5 0.0 3.6 4.3 3.4 1.2 3.0 1.7 1.9 1.5 0.8 3.8 1.8 1.4 1.2 7.5 0.9 3.1 4.0 0.9 2.8 2.8 3.5 3.6 4.0 2.5 3.3 2.9 2.4 1.8 0.7 59.6 63.9 0.0 0.0 0.3 0.0 0.0 0.0 103.1 56.9 0.0 0.0 0.2 3.3 6.7 0.0 0.1 2.9 0.0 7.0 0.1 0.2 0.1 55.8 0.0 0.6 0.0 5.2 0.6 1.2 0.0 0.3 1.0 0.0 8.2 4.7 0.0 6.7 6.8 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.7 0.0 2.7 0.1 RNF125 FLJ20456 ENSG00000101695 "Ring finger protein 125" Q96EQ8 18 32018372-32073213 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 67.5;T-cells: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "HMC-1: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041514 Uncertain Supported "Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" Nucleoli "HPA041514: AB_10795596" "unprognostic (2.13e-2)" "unprognostic (2.05e-2)" "unprognostic (2.88e-1)" "unprognostic (3.93e-1)" "unprognostic (5.03e-1)" "unprognostic (4.50e-2)" "unprognostic (2.30e-3)" "unprognostic (6.15e-2)" "unprognostic (4.21e-2)" "unprognostic (3.24e-1)" "unprognostic (1.68e-1)" "unprognostic (4.35e-2)" "prognostic unfavorable (4.06e-4)" "unprognostic (2.99e-1)" "unprognostic (4.12e-1)" "unprognostic (1.82e-1)" "unprognostic (7.07e-3)" 21.9 2.3 4.1 9.1 5.7 18.2 20.4 1.2 6.6 5.0 8.9 12.2 3.3 12.3 7.2 5.5 3.9 4.3 6.0 5.4 6.1 4.1 2.1 14.1 10.3 13.5 7.7 3.1 2.4 4.2 2.5 1.3 4.4 7.0 3.1 7.8 1.6 5.0 1.9 4.4 6.0 26.0 4.1 12.0 7.4 4.2 3.3 8.3 14.8 3.2 2.9 7.2 4.5 6.2 2.1 3.4 9.0 3.8 11.7 12.5 5.1 0.7 0.1 0.1 0.2 0.3 0.5 0.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 0.0 0.2 0.5 0.9 0.8 0.1 4.0 1.6 0.2 0.2 0.2 0.1 5.2 32.5 1.0 1.5 0.0 1.8 0.2 0.3 1.6 0.1 1.2 0.0 1.2 1.3 4.9 2.6 5.3 0.9 5.5 0.4 0.1 0.3 0.3 0.5 0.2 0.1 0.1 8.0 1.1 0.8 2.5 0.1 0.1 0.5 0.1 0.0 3.8 0.1 0.1 0.4 7.0 4.2 9.0 3.8 3.3 12.5 2.0 8.2 2.0 10.1 10.5 3.4 2.1 8.2 10.6 1.5 11.7 1.9 3.4 10.0 5.1 4.1 5.7 1.2 6.6 6.1 4.1 7.7 3.1 7.0 8.3 3.0 8.0 9.9 2.9 8.8 0.4 1.4 2.5 2.7 5.7 12.2 0.0 0.3 1.7 0.8 67.5 23.2 25.5 0.0 1.6 0.1 1.9 2.4 17.4 15.5 8.9 0.0 1.2 6.7 14.8 11.5 2.6 13.9 1.7 1.0 8.2 1.2 1.3 0.0 0.0 1.1 0.6 0.0 1.9 0.5 0.7 5.9 0.7 66.0 13.6 2.1 RNF144B "bA528A10.3, IBRDC2, P53RFP" ENSG00000137393 "Ring finger protein 144B" Q7Z419 6 18387350-18468874 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Basal keratinocytes: 563.5;Suprabasal keratinocytes: 1312.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 28.8" "Group enriched" "Detected in many" 9 "dendritic cells: 7.9;granulocytes: 15.6;monocytes: 28.8" "Cell line enhanced" "Detected in many" "Daudi: 55.9;EFO-21: 15.4;hTCEpi: 17.8;HUVEC TERT2: 16.5;TIME: 16.5;U-698: 47.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046013, HPA054127, HPA072469" Uncertain Approved Nucleoli,Mitochondria NA NA Nucleoli Mitochondria "CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: " "unprognostic (2.24e-2)" "unprognostic (1.16e-1)" "unprognostic (1.56e-1)" "unprognostic (4.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.48e-3)" "unprognostic (5.89e-2)" "unprognostic (1.18e-2)" "unprognostic (6.55e-2)" "unprognostic (2.87e-3)" "unprognostic (2.44e-2)" "unprognostic (2.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-1)" "unprognostic (3.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" 16.3 2.0 4.6 11.1 6.8 15.7 21.1 5.1 7.5 8.0 4.2 2.8 4.6 1.5 6.8 7.5 9.4 9.0 6.8 8.7 5.3 4.3 13.8 11.4 39.0 11.1 8.3 2.3 4.2 3.7 3.0 2.3 11.1 8.8 12.8 2.3 8.3 16.9 6.2 36.8 19.2 3.7 4.9 9.2 37.1 4.3 3.3 6.9 5.8 32.9 11.4 12.2 7.3 6.6 2.0 7.9 15.6 28.8 0.2 0.7 2.6 1.3 0.2 0.1 0.0 0.0 0.6 2.9 1.5 1.7 3.3 3.6 0.0 0.1 55.9 15.4 0.6 0.2 4.8 0.0 4.7 4.7 0.2 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.8 17.8 1.3 4.0 1.5 16.5 1.2 0.0 0.0 0.8 0.5 0.4 0.0 0.5 0.1 0.3 0.2 0.5 3.3 10.0 3.1 0.5 0.0 0.3 7.1 5.3 0.4 8.4 0.1 16.5 2.6 0.5 0.2 0.3 0.0 0.0 47.0 0.3 0.1 0.2 0.1 9.1 5.1 0.2 16.4 0.7 2.0 0.3 0.3 5.6 1.6 0.7 0.4 15.6 0.2 28.8 7.9 0.2 2.6 4.6 6.8 5.1 7.5 5.3 4.3 8.3 2.3 8.8 6.9 41.7 12.9 4.2 36.0 563.5 0.9 10.4 10.2 21.4 36.4 36.6 2.0 9.7 16.6 8.2 1.6 32.1 1.0 0.0 7.7 2.9 12.4 85.1 3.5 17.4 13.8 0.0 1.2 28.8 98.2 1.6 1.1 68.0 57.3 44.1 1.3 16.0 6.0 2.9 2.8 16.3 1.0 0.0 10.1 1.7 2.6 1312.2 1.3 3.2 2.4 20.3 RNF32 "FKSG33, HSD15, LMBR2" ENSG00000105982 "Ring finger protein 32" Q9H0A6 7 156640281-156677130 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 55.2" "Group enriched" "Detected in many" 4 "Early spermatids: 227.1;Late spermatids: 367.1;Spermatocytes: 116.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 11.3;HDLM-2: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019516, HPA073560" Enhanced Supported "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA019516: , HPA073560: AB_2686616" "unprognostic (9.23e-2)" "unprognostic (3.01e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (7.85e-2)" "unprognostic (3.98e-2)" "unprognostic (2.21e-2)" "unprognostic (5.73e-3)" "unprognostic (1.71e-2)" "unprognostic (8.72e-3)" "unprognostic (6.08e-4)" "unprognostic (4.64e-2)" "unprognostic (2.06e-1)" "unprognostic (8.15e-3)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" "unprognostic (3.81e-3)" "unprognostic (1.44e-1)" 1.1 1.0 2.2 0.8 2.6 0.9 0.8 1.0 2.2 0.6 1.2 4.7 0.8 1.0 0.6 7.7 0.6 2.2 1.6 0.4 2.0 1.9 1.5 0.8 1.0 1.2 1.8 2.2 1.8 2.6 0.8 2.6 0.9 2.0 1.5 1.0 0.7 1.4 0.6 0.6 1.4 0.9 0.1 2.8 0.8 1.9 55.2 1.9 1.1 1.7 0.0 0.9 0.6 0.6 3.7 3.5 10.5 0.6 0.6 2.8 0.9 4.2 2.2 0.4 1.1 1.0 0.6 0.6 0.7 0.1 1.1 0.9 11.3 4.9 6.9 5.4 0.7 1.2 0.1 0.0 0.2 2.2 12.5 2.9 0.6 0.8 0.4 1.0 1.9 4.0 1.7 0.8 0.6 2.3 0.7 0.5 6.1 9.9 1.9 3.4 7.4 2.7 4.8 2.4 7.1 5.5 2.7 0.1 3.1 1.6 1.4 7.1 5.5 4.2 0.4 2.1 1.1 1.2 1.4 1.8 0.0 0.1 0.9 0.5 10.1 4.3 3.9 0.8 4.5 1.7 10.5 0.5 1.8 0.6 0.3 2.2 3.7 2.3 0.6 1.4 2.6 0.6 0.7 0.1 0.6 0.6 3.5 2.8 0.9 2.2 2.6 1.0 2.2 2.0 1.9 1.8 2.2 2.0 1.9 6.0 1.6 0.5 1.9 0.2 2.3 1.2 5.1 54.9 7.9 3.5 0.0 0.0 5.0 1.8 227.1 0.1 2.1 0.0 2.9 0.4 0.6 1.8 5.7 2.1 0.3 1.6 4.1 1.3 0.0 367.1 6.1 1.1 1.7 0.0 2.9 2.7 2.3 0.0 3.9 4.1 2.0 0.0 0.5 116.1 17.9 0.5 0.1 0.0 2.1 0.8 RNF4 "RES4-26, SLX5, SNURF" ENSG00000063978 "Ring finger protein 4" P78317 4 2462220-2625320 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022047, HPA049356" Approved Supported "Nucleoplasm,Nuclear bodies,Microtubule ends" NA NA "Nucleoplasm, Nuclear bodies" "Microtubule ends" "HPA022047: , HPA049356: AB_2680726" "unprognostic (8.38e-3)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-1)" "unprognostic (9.31e-3)" "unprognostic (9.03e-3)" "prognostic unfavorable (6.38e-4)" "unprognostic (1.34e-1)" "unprognostic (6.79e-2)" "unprognostic (2.58e-1)" "unprognostic (5.64e-2)" "unprognostic (1.93e-2)" "unprognostic (6.40e-2)" "unprognostic (4.70e-2)" "unprognostic (8.67e-2)" "unprognostic (1.54e-1)" 28.6 29.1 25.4 32.2 39.4 36.4 28.6 35.9 50.3 28.2 25.1 34.8 28.4 27.0 32.2 28.0 30.3 27.8 27.1 24.6 22.7 22.8 32.3 25.6 27.4 41.9 23.5 23.4 32.1 31.0 31.2 30.0 29.4 36.7 28.5 26.7 29.2 36.1 28.5 26.0 28.5 29.3 31.8 23.1 41.9 28.9 36.8 23.7 50.4 29.3 19.1 51.5 27.7 26.3 36.9 35.3 41.8 39.9 39.7 43.7 45.8 20.1 19.1 20.0 13.9 17.5 18.2 22.4 24.6 27.7 26.2 23.8 21.6 19.0 25.5 14.7 24.8 34.7 13.2 21.2 19.3 25.0 12.0 12.8 30.9 19.7 20.7 26.2 21.7 27.1 21.1 23.4 24.3 20.3 18.4 24.2 21.7 16.3 35.3 26.7 13.8 34.7 30.3 30.8 16.9 24.0 25.4 19.1 13.2 17.8 25.7 18.6 17.6 17.3 13.4 17.2 22.5 21.3 16.4 20.1 22.9 11.2 21.5 37.7 45.7 60.8 28.3 22.3 23.7 23.7 14.6 29.6 41.8 43.7 39.3 43.7 36.9 37.5 43.0 35.3 27.2 36.2 36.3 32.9 39.7 39.9 23.6 39.9 45.8 25.4 39.4 35.9 50.3 22.7 22.8 23.5 23.4 36.7 23.7 20.8 20.3 25.1 14.7 24.5 12.4 15.7 17.8 13.4 21.6 21.0 15.7 18.0 18.3 19.5 11.0 20.2 14.8 0.0 20.4 27.8 17.2 19.5 13.9 17.8 17.4 12.7 11.6 15.4 34.2 17.3 15.8 20.0 6.8 27.9 14.2 9.2 25.2 14.0 19.4 17.7 16.5 25.8 21.7 26.7 47.3 28.1 18.2 33.1 15.6 29.1 RP2 "NM23-H10, NME10, TBCCD2" ENSG00000102218 "RP2, ARL3 GTPase activating protein" O75695 X 46836940-46882358 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000234, HPA000909" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA 77000 "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA000234: AB_1079831, HPA000909: AB_2666140" "unprognostic (2.26e-1)" "unprognostic (6.01e-3)" "unprognostic (2.79e-2)" "unprognostic (2.98e-1)" "unprognostic (1.69e-1)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.97e-4)" "unprognostic (2.58e-2)" "unprognostic (9.76e-3)" "unprognostic (3.10e-2)" "unprognostic (3.79e-3)" "unprognostic (9.75e-2)" "unprognostic (6.15e-3)" "unprognostic (2.96e-2)" "unprognostic (9.66e-2)" "unprognostic (1.61e-1)" "unprognostic (4.28e-3)" 17.2 10.6 5.0 10.7 6.6 31.4 8.2 5.6 4.3 6.3 10.1 5.5 3.5 7.4 8.4 7.1 17.2 5.8 9.3 5.9 5.7 4.8 10.2 17.1 14.0 18.1 8.1 2.8 6.9 4.7 5.6 4.1 28.0 8.5 6.9 7.7 4.9 8.3 6.1 2.9 5.0 18.6 6.3 10.6 24.3 6.4 5.7 6.7 12.1 5.9 8.7 11.7 7.0 8.7 5.0 10.7 23.0 15.9 3.4 3.3 5.3 11.3 5.4 11.0 6.0 8.7 10.8 26.2 14.6 11.5 12.9 13.1 23.4 9.8 13.5 5.9 15.4 11.0 7.5 10.6 10.6 17.6 5.9 6.1 7.2 6.9 5.6 10.0 15.0 25.3 8.4 7.0 10.2 5.5 7.3 16.3 6.1 3.2 7.1 14.5 1.0 9.3 13.8 6.8 7.7 10.5 11.9 15.1 7.2 8.3 11.6 4.1 5.5 12.9 8.1 6.6 20.6 9.0 14.2 14.4 10.0 7.5 15.8 5.1 2.7 3.5 8.0 5.2 10.8 10.4 23.0 10.6 16.6 3.2 14.4 2.6 5.0 2.6 2.7 10.7 4.6 3.3 3.0 20.9 3.4 15.9 3.8 2.8 5.3 5.0 6.6 5.6 4.3 5.7 4.8 8.1 2.8 8.5 6.7 8.9 6.1 9.3 2.7 14.1 1.7 1.2 10.2 13.4 3.4 8.7 2.0 20.8 0.0 4.1 1.0 6.7 17.1 0.0 4.6 5.1 11.3 5.8 11.5 18.8 21.5 0.0 3.5 11.6 61.8 1.9 5.2 29.1 20.3 10.8 8.8 3.2 9.2 11.6 5.3 3.1 4.8 6.5 6.0 6.0 4.6 13.0 31.9 6.5 8.0 11.8 RPIA ENSG00000153574 "Ribose 5-phosphate isomerase A" P49247 2 88691644-88750935 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Cytotrophoblasts: 210.0;Syncytiotrophoblasts: 188.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042620, HPA057954" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA 4100000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA042620: AB_10793980, HPA057954: AB_2683563" "unprognostic (3.35e-2)" "unprognostic (1.35e-2)" "unprognostic (6.96e-2)" "unprognostic (9.24e-2)" "unprognostic (4.31e-1)" "unprognostic (8.24e-2)" "prognostic unfavorable (1.46e-5)" "unprognostic (2.73e-3)" "unprognostic (1.82e-3)" "unprognostic (8.70e-2)" "unprognostic (8.82e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (8.53e-6)" "unprognostic (3.47e-2)" "unprognostic (2.53e-1)" "unprognostic (1.01e-2)" "unprognostic (8.79e-3)" 12.9 8.8 6.6 15.6 7.0 43.0 12.1 11.1 6.4 8.1 12.7 6.1 11.0 12.4 11.1 7.3 18.3 8.5 14.0 10.9 5.0 4.9 6.8 6.2 9.0 16.2 7.2 3.8 11.7 26.5 3.6 11.4 26.1 6.5 8.8 13.4 6.0 12.6 8.5 17.6 9.2 12.7 7.7 5.1 15.4 10.4 8.9 7.6 30.7 9.6 10.5 19.3 8.1 11.8 18.5 14.1 21.4 12.5 13.3 22.4 11.6 8.5 5.0 10.2 8.1 7.2 7.4 22.4 4.8 4.5 7.9 5.4 17.8 11.4 43.7 10.4 5.5 10.9 5.2 12.7 4.0 12.5 20.7 16.5 17.5 3.2 17.6 7.3 32.0 12.9 6.8 3.4 7.0 11.0 3.9 11.1 23.4 18.7 7.6 7.4 13.4 35.1 28.1 9.2 28.4 8.3 18.4 12.1 10.7 6.5 13.8 7.3 8.3 5.7 7.4 11.0 5.8 4.0 13.2 6.3 4.7 12.4 15.4 13.6 5.9 4.8 43.8 4.8 29.1 6.7 5.5 9.7 21.4 11.1 9.8 14.2 18.5 15.5 16.4 14.1 15.4 22.4 18.4 2.3 13.3 12.5 6.8 12.6 11.6 6.6 7.0 11.1 6.4 5.0 4.9 7.2 3.8 6.5 7.6 11.9 10.4 45.3 15.3 33.2 8.7 11.4 15.3 2.7 3.4 19.2 2.0 210.0 8.3 13.5 6.8 26.6 15.2 70.0 30.1 69.7 29.7 21.6 21.8 5.9 38.8 12.7 18.4 17.8 15.5 2.6 18.4 22.5 38.8 25.2 24.7 4.3 21.4 28.1 17.7 12.9 5.1 19.4 18.0 25.3 32.5 35.8 188.7 37.3 56.2 35.5 RPL18 L18 ENSG00000063177 "Ribosomal protein L18" Q07020 19 48615328-48619536 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "NB-4: 559.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046572 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 100000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA046572: AB_2679705" "unprognostic (2.12e-2)" "unprognostic (1.86e-2)" "unprognostic (7.30e-2)" "unprognostic (2.57e-2)" "unprognostic (3.48e-3)" "unprognostic (4.76e-2)" "unprognostic (3.21e-3)" "unprognostic (2.80e-1)" "unprognostic (2.39e-1)" "unprognostic (9.15e-2)" "unprognostic (6.15e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.40e-1)" "unprognostic (3.04e-2)" "unprognostic (6.36e-2)" "unprognostic (1.27e-2)" 56.2 57.3 50.3 79.1 40.8 122.4 84.9 35.2 51.1 89.8 76.6 44.8 60.8 66.1 100.6 56.1 129.6 78.2 99.2 43.4 38.3 33.1 56.4 101.9 62.1 194.1 40.3 27.0 206.5 260.5 19.8 57.1 74.8 26.8 100.5 39.6 54.6 136.7 62.3 78.8 108.6 60.5 69.1 39.7 88.7 64.0 45.8 28.6 114.9 115.8 116.5 122.2 91.2 90.5 137.1 84.5 19.0 57.5 71.1 144.1 148.6 58.3 91.0 33.5 58.2 34.2 67.5 49.0 26.8 44.7 55.7 46.9 82.1 54.3 85.4 28.2 25.6 21.1 48.4 30.4 61.0 21.2 36.4 105.9 30.9 42.6 78.4 69.2 43.0 48.3 79.5 89.5 29.8 40.2 40.8 54.7 62.6 43.6 75.3 34.9 74.1 67.6 559.5 53.4 76.1 45.4 70.8 27.0 77.4 45.0 72.2 47.7 62.1 24.2 85.4 81.0 16.2 48.0 83.8 31.2 41.3 45.9 25.6 61.5 62.6 72.9 50.9 26.0 66.4 48.6 19.0 57.5 12.2 65.7 47.6 115.3 130.3 116.4 88.1 79.2 137.1 144.1 113.9 8.6 71.1 37.3 84.5 89.6 148.6 50.3 40.8 35.2 51.1 38.3 33.1 40.3 27.0 26.8 28.6 550.9 838.5 3591.6 3815.8 3969.4 373.7 225.2 1370.7 546.0 953.2 671.7 135.5 3294.6 1175.5 1414.5 62.6 1818.4 1578.0 724.2 3930.9 4507.0 2016.4 3365.3 983.1 1161.9 1943.0 127.1 1609.4 1403.2 2086.4 135.2 3008.2 2285.6 2161.1 2417.6 2644.1 668.4 2833.8 2163.8 1372.2 1352.6 310.0 1015.4 2447.3 225.6 356.8 4859.7 3460.6 2407.5 3173.8 4275.2 RPL36 "DKFZp566B023, L36" ENSG00000130255 "Ribosomal protein L36" Q9Y3U8 19 5674947-5691876 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047153 Supported Uncertain "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA047153: AB_2679958" "unprognostic (2.81e-2)" "unprognostic (5.70e-3)" "unprognostic (8.16e-2)" "unprognostic (6.28e-3)" "unprognostic (2.25e-2)" "unprognostic (1.20e-1)" "unprognostic (3.82e-2)" "unprognostic (5.48e-2)" "unprognostic (1.29e-1)" "unprognostic (2.39e-2)" "unprognostic (2.27e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.32e-4)" "unprognostic (7.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.23e-2)" "unprognostic (3.51e-2)" 52.2 101.2 56.3 80.9 43.1 120.2 88.4 40.8 71.1 59.7 63.4 21.2 58.0 60.4 72.2 64.9 79.6 63.2 66.2 69.6 39.7 33.9 48.4 59.7 58.6 201.6 38.7 52.9 225.0 196.1 12.9 48.0 38.6 34.9 65.0 36.7 29.4 129.4 70.4 78.7 101.9 61.4 60.8 39.5 75.3 64.7 53.8 32.3 39.9 40.9 106.1 55.5 48.4 103.1 163.2 79.0 29.1 57.6 68.6 180.7 220.0 101.3 50.9 35.7 88.2 42.7 82.5 52.8 55.9 36.5 56.9 47.0 94.3 51.7 69.2 135.4 26.3 26.9 71.5 32.0 66.4 17.3 52.3 225.5 43.5 52.2 77.6 94.6 93.8 61.2 70.2 109.4 35.2 74.1 57.0 48.0 89.6 55.7 225.4 33.1 108.2 116.3 130.1 119.9 60.9 173.0 72.3 41.9 187.7 54.9 67.9 63.5 85.2 32.9 94.5 156.1 17.8 72.9 161.5 51.3 37.6 50.4 54.9 121.9 111.3 101.0 108.4 71.4 150.5 52.3 29.1 57.6 21.4 77.3 48.3 125.2 161.4 157.2 113.1 79.0 163.2 180.7 146.6 8.0 68.6 40.4 74.6 120.6 220.0 56.3 43.1 40.8 71.1 39.7 33.9 38.7 52.9 34.9 32.3 539.0 792.8 4383.3 2587.1 5914.7 210.4 280.4 1931.2 633.0 1136.3 1175.9 76.6 2530.1 2224.9 2450.7 422.3 2391.0 1994.6 934.5 7046.1 4296.7 2490.5 2459.5 1236.6 2515.3 2437.5 92.2 1971.2 2721.6 3281.5 1128.6 3011.7 2570.0 2884.9 4260.7 4637.6 399.1 5342.0 3492.9 1450.3 2290.2 228.2 911.9 2225.2 393.6 813.8 8042.2 2327.4 2040.6 4783.5 2658.3 RPS19BP1 "FLJ21770, MGC52010" ENSG00000187051 "Ribosomal protein S19 binding protein 1" Q86WX3 22 39529093-39532855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042874 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Nucleoli, Cytosol" Nucleoplasm "HPA042874: AB_10793988" "unprognostic (2.44e-1)" "unprognostic (1.67e-1)" "unprognostic (7.79e-2)" "unprognostic (5.07e-3)" "unprognostic (1.65e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.65e-1)" "unprognostic (5.68e-2)" "unprognostic (8.31e-2)" "unprognostic (7.00e-2)" "unprognostic (6.73e-2)" "unprognostic (1.04e-1)" "unprognostic (6.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.34e-1)" "unprognostic (4.32e-2)" 32.8 38.8 38.9 29.5 30.6 36.9 47.5 24.2 34.7 26.4 28.0 19.2 40.6 31.4 18.8 25.2 24.1 18.0 25.0 30.5 38.9 28.4 30.8 40.7 22.5 29.4 40.3 27.0 23.4 45.0 15.4 18.8 21.9 31.9 31.6 14.4 19.2 65.2 35.4 55.0 19.8 30.9 28.5 31.1 27.1 32.6 28.8 24.6 16.3 40.8 28.0 23.7 24.3 54.5 64.2 73.5 67.3 57.7 42.8 60.3 50.5 20.9 25.9 12.5 17.6 14.1 9.2 26.3 24.1 19.6 21.1 16.8 28.7 13.9 26.2 25.2 14.2 17.2 17.0 19.6 24.7 7.3 37.7 62.7 25.2 22.0 25.3 20.6 36.8 32.9 13.8 18.7 18.1 22.2 11.4 14.3 19.9 28.1 19.0 13.3 23.2 17.6 36.7 21.7 46.7 49.7 28.1 16.3 39.4 22.1 20.8 27.9 15.6 19.5 31.1 43.3 8.0 22.4 29.8 16.9 17.6 40.2 19.6 31.4 33.1 30.4 40.7 23.9 25.6 41.1 42.1 57.7 67.3 53.4 52.1 49.2 62.0 54.4 55.2 46.3 64.2 53.2 54.1 63.4 42.8 42.0 73.5 60.3 50.5 38.9 30.6 24.2 34.7 38.9 28.4 40.3 27.0 31.9 24.6 41.7 44.3 107.2 91.0 121.8 95.6 68.3 109.5 34.8 36.4 92.5 49.1 134.1 184.1 166.7 17.8 129.5 196.8 46.7 167.0 202.1 94.9 166.3 69.2 175.1 185.7 33.4 136.9 111.1 105.7 22.2 126.8 125.3 102.9 172.3 137.0 80.8 187.2 164.9 118.5 232.2 81.9 77.6 104.0 59.0 146.0 129.4 110.1 136.4 130.8 112.7 RPS25 S25 ENSG00000118181 "Ribosomal protein S25" P62851 11 119015712-119018691 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031801, HPA078683" Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 54000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA031801: AB_10610419, HPA078683: " "unprognostic (1.60e-2)" "unprognostic (1.79e-1)" "unprognostic (2.12e-1)" "unprognostic (1.40e-1)" "unprognostic (8.32e-2)" "unprognostic (1.78e-2)" "unprognostic (1.55e-2)" "unprognostic (8.47e-2)" "unprognostic (5.23e-2)" "unprognostic (1.54e-2)" "unprognostic (2.36e-2)" "unprognostic (7.75e-3)" "prognostic unfavorable (3.00e-7)" "unprognostic (1.16e-1)" "unprognostic (1.07e-1)" "unprognostic (8.58e-2)" "unprognostic (2.20e-1)" 72.3 68.1 54.9 99.5 60.7 117.7 140.7 38.1 62.2 84.9 69.4 26.8 87.7 53.5 79.6 93.4 92.9 68.0 78.6 87.3 44.4 41.7 58.6 76.5 88.4 256.5 57.1 48.1 190.0 274.5 34.3 67.5 52.5 54.3 77.1 52.2 41.6 113.5 131.7 173.6 82.0 57.7 125.4 68.3 80.7 68.3 35.3 47.3 78.5 83.9 128.8 86.4 112.2 110.6 136.6 83.3 30.0 43.2 64.7 166.9 150.1 39.1 22.5 48.5 48.5 65.3 101.1 39.8 53.0 47.7 31.3 27.3 59.5 68.7 99.1 92.7 36.9 37.1 54.4 42.9 57.0 35.7 48.7 46.8 141.1 19.9 49.9 50.7 100.2 44.1 91.0 101.7 29.9 74.7 98.9 56.9 80.2 73.3 59.8 43.5 80.7 78.3 137.7 50.0 99.7 54.5 68.7 50.9 107.6 57.8 34.5 35.6 67.8 28.2 87.8 54.8 57.4 70.6 109.3 54.0 30.7 35.7 31.1 50.8 50.7 41.3 81.9 21.3 99.7 36.2 30.0 43.2 27.1 75.8 42.5 120.7 136.6 133.4 102.4 69.1 112.6 166.9 128.2 11.7 64.7 37.2 83.3 88.7 150.1 54.9 60.7 38.1 62.2 44.4 41.7 57.1 48.1 54.3 47.3 753.4 1471.8 4134.9 3644.0 3526.8 272.7 156.5 1931.2 1062.7 1885.9 884.5 108.0 3031.7 2773.7 1545.4 1495.6 2111.7 1048.3 1191.4 2746.5 3534.5 2149.5 2685.4 1909.4 2155.6 2228.4 127.1 1279.9 2210.4 2932.5 2021.0 3541.3 3243.7 2073.4 4078.5 2284.3 466.6 2362.4 1995.5 1610.5 3361.8 311.5 1312.9 2458.2 606.9 848.3 4074.2 3057.4 2507.2 2899.2 3437.7 RPUSD4 FLJ14494 ENSG00000165526 "RNA pseudouridylate synthase domain containing 4" Q96CM3 11 126202094-126211692 "Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 72.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039689 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA039689: AB_10673537" "unprognostic (2.02e-2)" "unprognostic (3.65e-1)" "prognostic favorable (6.14e-4)" "unprognostic (3.16e-3)" "unprognostic (2.90e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.32e-1)" "unprognostic (7.64e-3)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.56e-1)" "unprognostic (7.11e-2)" "unprognostic (5.44e-2)" "unprognostic (7.33e-2)" "unprognostic (5.47e-2)" 7.5 6.8 5.1 7.7 7.8 6.0 7.8 8.2 9.6 6.3 6.0 4.8 7.6 6.4 7.0 6.8 7.8 7.2 5.2 13.2 5.1 4.9 6.3 10.2 5.0 7.7 6.5 8.1 10.1 16.1 5.7 5.1 4.5 7.2 6.9 6.9 5.2 9.5 8.2 72.0 8.9 5.9 8.3 4.8 7.6 9.3 7.0 7.1 6.2 7.7 18.2 9.3 6.2 12.0 9.8 11.0 1.0 8.5 8.4 15.2 8.7 6.6 6.7 8.0 9.6 12.6 16.5 5.7 7.5 10.5 8.2 7.3 20.5 13.2 15.7 7.4 6.7 11.4 11.7 18.3 11.5 8.7 13.1 10.1 36.6 7.1 19.2 8.3 19.2 8.4 15.1 17.4 8.9 11.2 12.3 16.4 12.9 22.8 11.6 9.6 6.5 12.0 22.2 8.8 22.7 11.8 14.1 12.2 14.5 12.5 9.7 13.9 9.5 9.6 14.3 7.0 8.7 21.4 10.2 9.9 9.2 6.4 6.9 8.8 4.9 5.2 13.5 4.2 21.9 9.4 1.0 8.5 0.8 10.8 7.7 14.0 9.8 13.3 10.3 11.0 9.5 15.2 12.2 0.7 8.4 8.3 4.7 12.2 8.7 5.1 7.8 8.2 9.6 5.1 4.9 6.5 8.1 7.2 7.1 3.0 6.7 16.7 17.9 24.5 8.9 30.7 12.7 8.1 5.7 7.0 7.9 11.7 8.3 10.7 1.1 11.3 9.7 0.0 16.9 13.7 10.1 10.5 5.7 11.1 11.8 11.1 14.9 8.6 10.2 1.4 8.9 8.5 10.1 21.6 9.3 4.5 13.0 7.0 8.1 11.8 7.6 6.5 10.8 7.7 15.4 21.0 11.1 15.9 15.7 13.3 RREB1 HNT ENSG00000124782 "Ras responsive element binding protein 1" Q92766 6 7107597-7251980 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001756, HPA034843" Approved Supported "Nucleoli fibrillar center,Nuclear speckles" NA NA "Nuclear speckles" "Nucleoli fibrillar center" "HPA001756: AB_1856477, HPA034843: AB_2674357" "unprognostic (1.69e-1)" "unprognostic (3.16e-2)" "unprognostic (2.93e-1)" "unprognostic (5.05e-2)" "unprognostic (7.38e-2)" "unprognostic (1.23e-3)" "unprognostic (2.53e-1)" "unprognostic (1.32e-2)" "unprognostic (2.45e-2)" "unprognostic (6.51e-2)" "unprognostic (3.31e-2)" "unprognostic (1.16e-1)" "prognostic favorable (1.41e-4)" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "unprognostic (9.54e-2)" "unprognostic (2.92e-1)" 17.4 13.3 3.4 17.9 3.6 24.1 15.9 1.4 3.3 15.8 16.8 3.6 13.5 9.7 18.5 16.3 26.6 9.4 19.1 8.5 3.8 2.1 12.7 18.5 14.4 15.9 4.2 1.8 12.5 26.4 14.6 11.2 15.9 4.6 13.7 8.3 15.2 23.6 18.5 30.5 16.5 20.3 14.5 5.2 20.0 9.6 10.6 4.4 12.8 15.9 17.1 24.9 12.5 17.5 3.0 7.8 8.6 3.6 5.2 2.3 2.0 7.0 6.7 5.6 6.5 5.2 3.4 23.1 2.7 3.9 3.1 4.3 10.4 5.5 3.3 5.9 5.2 3.6 5.1 8.1 8.7 3.5 4.7 6.5 13.1 4.7 13.1 7.2 7.2 10.0 5.8 7.1 5.0 7.6 2.2 4.2 7.9 23.0 0.0 3.5 8.4 4.3 20.2 2.6 5.1 5.9 6.8 6.9 5.3 5.3 13.4 1.6 1.4 6.1 8.9 5.8 9.1 6.7 16.9 6.5 6.2 4.0 4.4 3.6 2.3 2.5 5.1 1.8 6.0 5.0 6.0 3.6 8.6 2.2 3.1 1.7 3.0 1.3 1.4 2.4 1.6 2.3 2.1 2.8 5.2 3.2 7.8 0.8 2.0 3.4 3.6 1.4 3.3 3.8 2.1 4.2 1.8 4.6 4.4 23.8 26.6 13.7 15.3 27.9 0.6 21.6 33.1 12.0 20.5 34.9 66.8 22.4 6.6 13.6 33.8 23.2 42.6 0.0 14.2 29.1 17.1 24.7 9.3 56.8 29.4 0.0 30.5 36.2 57.4 3.6 18.4 36.8 21.9 10.8 34.2 11.7 19.0 28.8 18.0 15.8 27.5 51.8 10.2 7.9 14.3 30.4 38.3 16.7 40.3 46.8 RSC1A1 RS1 ENSG00000215695 "Regulator of solute carriers 1" Q92681 1 15659869-15661722 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027813, HPA028676" Approved Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA027813: AB_10600308, HPA028676: AB_10600895" 3.0 0.9 0.3 1.7 0.4 2.8 2.6 0.1 0.6 2.2 0.6 0.0 1.2 0.0 3.5 1.2 1.1 2.9 0.3 0.5 4.0 7.7 2.7 2.0 0.4 4.6 0.2 2.1 1.3 2.3 3.9 1.3 0.1 0.8 0.6 2.1 0.6 3.0 0.8 0.1 0.6 4.7 1.7 3.2 1.1 2.2 1.1 2.8 0.5 3.5 1.7 2.3 1.5 3.3 3.9 4.8 3.2 6.0 4.2 6.4 2.8 4.7 7.9 7.4 6.4 5.5 7.4 2.8 6.3 3.9 2.3 12.5 4.0 9.7 4.9 3.1 6.9 7.7 6.8 1.3 10.1 3.5 3.3 0.0 13.6 7.5 1.8 4.9 5.0 19.0 7.0 5.7 3.3 5.3 0.0 5.2 1.9 2.2 4.5 6.8 3.1 1.8 6.2 3.9 1.6 5.3 2.4 4.6 4.3 3.4 0.9 4.8 4.0 7.4 3.6 2.1 2.1 4.0 12.9 1.6 2.7 2.8 0.0 1.2 0.5 0.4 3.5 1.4 1.1 0.5 2.3 2.8 0.2 0.6 0.5 0.0 1.7 0.1 0.7 2.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RSPH14 RTDR1 ENSG00000100218 "Radial spoke head 14 homolog" Q9UHP6 22 23059415-23145021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.3;testis: 24.8" "Group enriched" "Detected in some" 6 "Ciliated cells: 53.5;Early spermatids: 109.2;Late spermatids: 198.9" "Cancer enhanced" "Detected in some" "renal cancer: 2.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 10.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.8" "Cell line enhanced" "Detected in many" "GAMG: 6.5;RPTEC TERT1: 6.9;U-266/70: 7.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA018420, HPA050425" Approved Uncertain Nucleoli NA NA Nucleoli "HPA018420: AB_1856496, HPA050425: " "unprognostic (8.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.15e-3)" "unprognostic (3.80e-3)" "unprognostic (1.97e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.41e-1)" "unprognostic (1.22e-2)" "unprognostic (8.31e-2)" "unprognostic (7.28e-2)" "prognostic favorable (4.04e-4)" "unprognostic (5.18e-2)" "unprognostic (4.40e-2)" "unprognostic (3.16e-1)" "unprognostic (7.73e-2)" 0.8 3.0 4.8 0.5 6.8 0.4 0.5 1.2 8.8 1.4 0.7 2.6 0.9 0.4 1.3 4.9 0.6 15.3 1.8 0.3 4.7 4.7 9.3 0.3 1.8 0.5 2.9 3.3 5.5 0.6 0.9 3.1 0.4 6.4 1.1 0.5 1.0 1.0 2.4 0.9 1.6 0.4 0.6 1.6 0.4 0.8 24.8 1.6 0.0 2.7 0.0 0.5 0.6 0.3 0.1 0.0 10.8 2.0 0.2 0.3 0.6 0.4 3.9 3.5 3.3 0.0 1.6 0.2 0.0 0.8 0.7 0.6 0.7 1.2 0.8 1.2 0.0 6.5 0.1 0.2 0.0 0.0 0.0 0.2 0.4 0.2 1.5 0.2 0.2 1.7 0.0 0.4 0.6 0.0 2.0 0.0 1.4 0.1 1.7 0.0 0.5 0.8 0.6 0.0 1.0 0.1 0.2 0.1 3.7 6.9 0.0 4.5 2.1 0.1 0.1 0.2 0.2 0.7 0.8 0.0 3.1 0.8 0.2 0.0 7.9 3.0 2.2 2.5 0.4 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.2 10.8 0.2 2.0 0.0 0.1 0.6 4.8 6.8 1.2 8.8 4.7 4.7 2.9 3.3 6.4 1.6 0.0 0.0 0.0 0.6 0.0 0.8 0.0 2.5 53.5 6.8 0.0 3.9 0.0 6.6 0.7 109.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 11.1 0.0 0.6 0.0 198.9 2.0 0.0 0.0 0.0 0.0 3.1 0.3 0.0 1.8 13.9 4.5 0.0 0.0 21.7 7.5 0.0 0.0 0.0 0.0 0.3 RTP3 "LTM1, TMEM7, Z3CXXC3" ENSG00000163825 "Receptor transporter protein 3" Q9BQQ7 3 46497491-46500949 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 91 "liver: 43.3" "Cell type enriched" "Detected in some" 19 "Hepatocytes: 59.6" "Group enriched" "Detected in some" 17 "liver cancer: 22.9;testis cancer: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SiHa: 15.1" HPA075932 Uncertain Mitochondria NA NA Mitochondria "HPA075932: " "unprognostic (2.09e-1)" "unprognostic (1.64e-1)" "prognostic favorable (3.11e-6)" "unprognostic (1.08e-1)" "unprognostic (1.58e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 15.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 59.6 0.0 0.0 0.0 3.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 RUNDC3B "RPIB9, RPIP9" ENSG00000105784 "RUN domain containing 3B" Q96NL0 7 87627548-87832296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 13.2;brain: 16.4" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 13.7;Hepatocytes: 16.6;Spermatocytes: 20.2;Spermatogonia: 21.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1;memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.0;HEK 293: 2.5;SCLC-21H: 6.7;SH-SY5Y: 3.0;U-138 MG: 2.5;U-266/70: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056968, HPA057155, HPA075760" Uncertain Uncertain Vesicles,Cytosol NA NA Cytosol Vesicles "HPA056968: AB_2683292, HPA057155: AB_2683353, HPA075760: " "unprognostic (2.49e-1)" "unprognostic (1.99e-1)" "unprognostic (2.12e-1)" "unprognostic (1.83e-1)" "unprognostic (2.20e-2)" "unprognostic (1.77e-3)" "unprognostic (1.19e-2)" "unprognostic (4.16e-2)" "unprognostic (2.56e-1)" "unprognostic (1.19e-1)" "unprognostic (9.42e-5)" "unprognostic (4.44e-1)" "prognostic favorable (2.62e-6)" "unprognostic (1.97e-2)" "unprognostic (2.41e-1)" "unprognostic (2.32e-1)" "unprognostic (9.55e-2)" 1.1 13.2 3.6 0.8 9.4 0.1 1.4 16.4 7.9 2.7 3.7 1.0 1.0 4.7 3.4 1.2 1.0 2.0 1.7 1.4 2.8 5.1 3.3 9.7 0.8 0.4 2.8 4.8 2.3 0.5 0.5 2.0 0.2 7.9 1.1 2.7 0.7 0.9 0.8 1.1 0.9 5.2 3.8 2.2 0.4 0.6 3.1 1.0 0.0 0.6 0.1 0.5 1.6 1.1 0.1 0.0 0.4 0.0 0.0 2.1 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 3.0 0.4 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 2.5 0.1 1.5 1.0 0.1 1.2 0.4 0.0 0.7 0.0 0.4 0.0 1.2 0.0 1.2 0.0 0.0 1.3 0.0 0.0 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.2 6.7 3.0 0.0 0.2 0.1 0.1 0.1 0.0 0.4 2.5 0.0 0.2 0.0 3.9 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.4 2.1 0.0 0.8 0.1 0.0 1.7 0.0 0.1 0.3 1.2 0.3 0.0 0.0 0.0 0.0 0.1 3.6 9.4 16.4 6.5 2.8 5.1 2.8 4.8 7.9 1.0 0.0 0.0 0.0 0.1 4.2 8.0 2.2 5.1 0.0 0.0 0.0 5.9 0.5 1.7 0.9 2.0 13.7 9.7 0.0 0.2 0.3 0.1 0.1 0.0 16.6 0.1 11.1 0.0 1.8 0.0 1.0 3.7 0.0 3.3 0.0 2.9 0.7 0.8 5.8 1.4 8.7 7.6 0.0 1.2 20.2 21.5 2.6 1.0 0.0 3.8 0.0 RYR2 "ARVC2, ARVD2, VTSIP" ENSG00000198626 "Ryanodine receptor 2" Q92736 1 237042205-237833988 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 106.6" "Cell type enriched" "Detected in many" 30 "Cardiomyocytes: 1960.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.8;HEK 293: 10.7;K-562: 3.3;NB-4: 2.7;NTERA-2: 4.0;U-937: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020028 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA020028: AB_1856528" "unprognostic (5.23e-3)" "unprognostic (2.15e-2)" "unprognostic (5.02e-4)" "unprognostic (6.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (1.45e-3)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (0.00e+0)" "unprognostic (2.36e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" 1.1 0.9 6.2 0.9 18.7 0.5 1.1 14.8 10.5 1.3 1.2 0.0 1.2 0.7 1.1 0.7 1.8 1.0 1.8 106.6 5.7 1.1 0.9 0.9 1.4 0.6 1.0 7.3 2.2 4.2 0.5 2.0 1.1 1.6 2.0 0.8 0.2 0.9 1.4 0.9 1.0 1.0 4.6 1.0 1.0 1.2 1.1 3.0 0.0 2.7 0.0 0.6 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.3 0.0 0.0 0.3 0.6 0.0 0.0 7.8 10.7 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 2.7 4.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 18.7 14.8 10.5 5.7 1.1 1.0 7.3 1.6 3.0 0.0 0.3 0.0 0.0 0.3 65.2 1960.0 0.0 1.4 2.3 1.8 9.8 0.0 0.0 0.0 15.8 1.5 0.0 0.0 2.5 0.0 2.1 0.0 0.0 0.0 0.1 1.6 3.4 1.3 0.0 10.2 1.1 0.0 8.5 0.0 0.0 1.5 0.3 0.0 0.0 0.0 4.7 0.0 18.6 3.2 0.9 0.0 0.0 0.0 0.0 0.0 S100A7 "PSOR1, S100A7c" ENSG00000143556 "S100 calcium binding protein A7" P31151 1 153457744-153460701 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 116.2;lymphoid tissue: 156.7;tongue: 409.9" "Group enriched" "Detected in some" 5 "Suprabasal keratinocytes: 78.3;Syncytiotrophoblasts: 22.1" "Group enriched" "Detected in many" 5 "cervical cancer: 458.9;head and neck cancer: 1201.5;melanoma: 638.4;urothelial cancer: 281.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 7.4;SK-BR-3: 17.3" "CAB001453, HPA006997, CAB033766" Enhanced Uncertain Cytosol "Secreted in other tissues" NA NA 17000000 Cytosol "CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860" "unprognostic (3.28e-1)" "unprognostic (9.85e-2)" "unprognostic (1.32e-2)" "unprognostic (2.16e-2)" "unprognostic (3.17e-1)" "unprognostic (2.94e-2)" "unprognostic (1.03e-2)" "unprognostic (4.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.27e-1)" "unprognostic (2.99e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 2.2 0.1 0.1 45.2 0.1 0.1 0.1 0.0 3.7 3.9 116.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 6.2 0.1 0.1 45.7 0.1 0.2 0.1 0.1 0.0 0.3 0.1 1.2 0.1 409.9 156.7 0.2 85.3 0.0 0.4 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 7.4 0.0 2.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.5 0.0 0.2 0.0 0.2 0.0 0.0 0.7 0.2 0.4 0.0 0.0 0.0 0.8 17.3 0.0 1.1 0.3 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 78.3 22.1 0.0 0.0 0.4 S100A7A "S100A15, S100A7f, S100A7L1" ENSG00000184330 "S100 calcium binding protein A7A" Q86SG5 1 153416524-153423225 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "tongue: 178.1" "Group enriched" "Detected in some" 6 "Early spermatids: 1.1;Late spermatids: 1.6;Suprabasal keratinocytes: 1.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SK-BR-3: 3.4" HPA006997 Supported Uncertain Cytosol NA NA Cytosol "HPA006997: AB_1079860" "unprognostic (2.18e-1)" "unprognostic (1.26e-1)" "unprognostic (3.73e-2)" "unprognostic (4.65e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" "unprognostic (1.17e-1)" "unprognostic (4.40e-3)" 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 11.5 0.0 0.0 0.0 0.0 1.9 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 178.1 12.5 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 S100A9 "60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14" ENSG00000163220 "S100 calcium binding protein A9" P06702 1 153357854-153361027 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" "Antimicrobial, Antioxidant" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6" "Cell type enriched" "Detected in many" 7 "Kupffer cells: 11072.0" "Cancer enhanced" "Detected in all" "cervical cancer: 5468.0;head and neck cancer: 6692.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 381.5;neutrophil: 638.3" "Group enriched" "Detected in many" 6 "granulocytes: 638.3;monocytes: 381.5" "Cell line enriched" "Detected in some" 6 "SK-BR-3: 233.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA004193, CAB009441" Enhanced Supported "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA 10600000 1400000000 "Nucleoplasm, Cell Junctions, Cytosol" "CAB009441: AB_2184420, HPA004193: AB_1856537" "unprognostic (1.72e-1)" "unprognostic (3.33e-2)" "unprognostic (2.40e-1)" "unprognostic (3.94e-3)" "unprognostic (1.36e-2)" "unprognostic (5.45e-3)" "prognostic unfavorable (1.13e-6)" "unprognostic (1.10e-2)" "unprognostic (4.31e-1)" "unprognostic (3.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.59e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.48e-1)" "unprognostic (7.52e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-2)" 19.5 2.1 1.3 41.9 4.2 820.1 4.1 0.9 2.1 143.6 4.4 0.7 0.4 0.7 4.9 4.0 642.6 9.9 4.4 51.2 2.5 0.4 2.8 4.8 29.2 169.0 5.3 0.6 3.4 4.4 0.1 0.9 10.4 5.2 2.2 0.7 2.0 109.6 0.5 3.4 7.5 1.4 13.1 2.1 103.2 3.5 2.9 1.4 3.8 6.7 477.6 228.0 24.3 237.0 0.5 87.5 638.3 381.5 0.3 1.0 323.2 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.8 36.6 0.0 0.0 2.2 0.0 15.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 12.7 0.0 0.8 0.0 0.0 0.0 0.7 0.3 0.0 2.9 0.0 0.3 0.0 0.2 0.0 0.0 0.5 7.7 0.0 9.5 0.1 0.0 0.3 233.1 0.1 0.1 3.6 29.6 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 6.7 0.0 5.3 381.5 46.4 0.5 31.6 1.0 0.4 0.4 0.3 87.5 0.5 0.3 0.3 638.3 0.3 15.0 2.9 0.5 323.2 1.3 4.2 0.9 2.1 2.5 0.4 5.3 0.6 5.2 1.4 214.4 574.2 57.1 52.5 17.7 0.0 2.5 66.2 112.4 185.4 34.9 0.0 111.0 5.0 49.4 1.3 7.0 0.5 23.3 32.9 44.2 7.1 19.6 151.1 16.4 1627.6 0.0 0.0 71.2 11072.0 2.2 5.5 1162.8 0.0 4.6 2.1 0.0 10.3 0.8 0.0 16.3 0.2 0.0 2.5 0.3 1.3 29.1 1033.7 24.9 1.9 291.7 S1PR2 "AGR16, DFNB68, EDG5, Gpcr13, H218" ENSG00000267534 "Sphingosine-1-phosphate receptor 2" O95136 19 10221433-10231331 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 75.1;Early spermatids: 83.7;Late spermatids: 119.0;Syncytiotrophoblasts: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 23.7" "Group enriched" "Detected in many" 7 "granulocytes: 23.7;T-cells: 7.4" "Cell line enhanced" "Detected in many" "BEWO: 14.6;Daudi: 25.8;U-266/70: 19.3;U-698: 27.9;WM-115: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014255, HPA014307" Approved Uncertain "Nuclear speckles,Golgi apparatus" NA NA "Golgi apparatus" "Nuclear speckles" "HPA014255: , HPA014307: AB_1847989" "unprognostic (5.38e-3)" "unprognostic (1.83e-3)" "unprognostic (1.20e-1)" "unprognostic (1.26e-2)" "unprognostic (3.31e-2)" "unprognostic (1.05e-3)" "unprognostic (8.50e-2)" "unprognostic (8.71e-2)" "unprognostic (2.84e-1)" "unprognostic (1.70e-1)" "unprognostic (7.40e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (4.36e-10)" "unprognostic (4.91e-2)" "unprognostic (4.56e-2)" "unprognostic (3.11e-1)" "unprognostic (8.09e-2)" 17.1 2.3 1.4 13.7 1.3 0.9 7.2 0.9 1.5 13.3 4.1 1.7 3.9 1.8 8.3 9.2 6.4 7.9 6.5 6.1 1.3 1.5 2.4 9.5 11.2 10.6 1.3 0.0 12.9 2.6 3.9 2.2 31.3 1.7 9.8 2.5 3.2 9.4 5.7 3.4 4.0 3.9 8.7 1.7 2.2 4.2 21.8 1.0 2.0 3.3 6.3 15.6 8.0 12.0 0.3 1.6 23.7 1.9 2.1 7.4 1.2 1.4 0.2 1.7 3.4 9.4 11.5 14.6 2.1 4.4 1.0 2.0 0.9 0.8 25.8 2.5 4.0 1.1 0.8 0.6 1.0 0.7 2.6 1.3 0.6 0.6 0.6 3.1 0.7 0.6 6.3 0.5 1.9 0.6 2.7 0.1 1.3 0.6 5.6 0.6 1.2 0.3 1.2 1.7 0.4 0.8 1.8 0.7 0.9 0.8 1.2 1.2 2.3 1.2 0.7 1.8 1.4 0.6 0.6 0.2 3.5 1.1 7.9 0.6 19.3 9.1 27.9 1.3 1.3 19.1 23.7 1.9 0.4 4.9 1.5 5.9 0.2 6.2 4.6 1.6 0.3 2.6 2.6 0.5 2.1 0.6 0.2 7.4 1.2 1.4 1.3 0.9 1.3 1.3 1.5 1.3 0.0 1.7 1.0 0.0 1.4 0.0 3.5 0.0 0.6 0.4 0.0 0.0 1.2 1.8 2.0 75.1 0.0 3.1 83.7 1.5 0.0 0.0 2.7 13.9 15.8 4.2 0.0 5.9 12.5 0.0 2.4 4.9 0.6 119.0 20.4 4.8 0.0 4.6 0.1 7.1 2.3 0.0 12.4 0.5 0.4 12.9 2.0 1.2 1.1 0.0 57.2 1.5 0.0 2.6 SARS2 "FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS" ENSG00000104835 "Seryl-tRNA synthetase 2, mitochondrial" Q9NP81 19 38915266-38930896 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 34.4;Late spermatids: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA052730, HPA056957" Approved Uncertain Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA052730: AB_2681929, HPA056957: AB_2683286" "unprognostic (3.20e-3)" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (3.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.88e-3)" "unprognostic (4.38e-3)" "unprognostic (1.22e-1)" "unprognostic (2.57e-2)" "unprognostic (8.62e-3)" "unprognostic (8.36e-2)" "unprognostic (1.67e-1)" "unprognostic (5.62e-3)" "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.24e-2)" "unprognostic (2.69e-2)" 5.8 16.5 9.9 7.2 12.8 11.1 7.4 10.7 20.4 8.0 9.2 11.3 11.4 12.3 9.0 9.4 12.9 11.5 8.2 12.3 8.3 8.6 13.4 20.6 6.3 11.0 10.9 7.8 9.5 14.4 11.2 11.4 10.7 15.0 11.0 8.5 11.8 13.6 9.9 15.5 15.6 9.9 8.1 7.2 11.3 11.1 8.8 11.5 11.4 13.8 9.5 12.6 11.0 8.3 6.3 12.7 0.4 7.2 6.5 8.0 4.3 5.7 17.4 7.0 4.1 2.9 6.0 9.6 4.0 5.5 9.5 7.5 14.2 7.1 6.5 5.8 5.7 3.8 5.4 7.3 11.4 2.4 5.5 9.4 12.9 7.5 12.2 6.9 11.0 12.9 9.1 6.2 6.2 4.3 4.7 6.7 10.5 11.1 6.4 4.8 12.2 8.3 10.0 7.1 9.0 3.5 12.0 6.3 7.1 10.1 13.9 12.0 7.6 5.4 14.5 3.6 2.7 7.4 7.4 4.3 5.9 6.8 4.6 3.9 4.7 2.7 5.1 3.8 7.7 4.9 0.0 4.1 0.4 8.0 7.2 6.4 6.3 5.9 8.0 12.7 5.7 4.3 4.9 0.3 6.5 6.4 5.0 6.6 4.3 9.9 12.8 10.7 20.4 8.3 8.6 10.9 7.8 15.0 11.5 6.0 6.4 9.5 3.4 3.8 7.2 8.1 10.2 4.0 4.5 5.2 7.9 34.4 13.3 13.2 10.2 3.2 5.1 0.0 11.2 19.0 5.1 2.3 5.7 8.1 11.2 4.8 10.9 6.2 6.2 42.6 4.4 3.5 3.3 6.4 7.1 2.9 7.8 3.5 4.6 5.6 13.4 0.0 2.1 1.5 7.2 3.6 24.4 6.9 16.6 2.6 SCARF2 "HUMZD58C02, SREC-II, SREC2" ENSG00000244486 "Scavenger receptor class F member 2" Q96GP6 22 20424815-20437826 "Disease related genes, Predicted membrane proteins" "Cell adhesion" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 28.8;Fibroblasts: 17.0;Leydig cells: 12.4;Peritubular cells: 16.6;Sertoli cells: 12.9;Smooth muscle cells: 14.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 14.2;SH-SY5Y: 15.8;SK-MEL-30: 15.7;U-138 MG: 21.8;U-2 OS: 22.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035079 Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 360000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA035079: AB_10670287" "unprognostic (2.12e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-3)" "unprognostic (2.29e-1)" "unprognostic (2.92e-1)" "unprognostic (7.68e-2)" "unprognostic (7.87e-2)" "unprognostic (8.27e-2)" "unprognostic (2.18e-2)" "unprognostic (1.68e-1)" "unprognostic (2.94e-1)" "prognostic unfavorable (2.78e-5)" "unprognostic (4.38e-3)" "unprognostic (3.18e-2)" "unprognostic (3.00e-3)" "prognostic unfavorable (4.28e-4)" 6.5 2.4 0.0 4.1 0.3 0.1 9.2 0.0 1.2 10.6 3.2 0.4 2.9 1.4 8.1 6.6 1.8 2.6 11.3 3.4 0.6 3.2 1.1 5.9 5.1 0.8 0.4 12.6 1.6 0.0 0.6 5.6 0.9 5.5 0.0 9.2 1.1 6.8 1.8 2.2 1.9 9.9 0.5 5.3 1.4 2.5 0.0 0.0 5.4 3.3 1.4 7.1 10.9 0.1 0.1 0.9 0.0 0.0 1.8 0.0 0.4 0.2 3.2 5.5 1.9 2.7 1.3 14.2 5.9 3.4 1.8 0.0 0.0 0.2 8.3 6.8 0.2 0.1 1.8 0.0 0.4 0.4 11.9 1.1 0.2 2.5 11.8 0.0 0.6 4.6 0.0 1.7 0.8 1.6 1.7 0.0 0.1 0.1 1.2 0.6 0.0 0.2 4.3 0.0 1.8 0.3 9.0 0.0 0.0 0.0 1.4 15.8 0.1 0.0 15.7 0.6 0.5 0.0 2.1 21.8 22.9 0.5 3.2 0.6 0.2 0.2 0.1 0.3 10.8 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 1.7 2.5 3.0 28.8 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.2 3.3 0.0 0.0 0.0 1.2 17.0 2.2 0.0 0.0 0.5 0.0 0.0 2.5 0.6 0.0 12.4 0.6 3.3 0.0 0.0 0.5 0.0 0.0 16.6 0.0 0.4 12.9 14.4 0.5 0.2 2.4 0.3 0.0 0.0 0.5 SCP2 ENSG00000116171 "Sterol carrier protein 2" P22307 1 52927229-53051703 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid transport, Transport" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 168.3" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 1150.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027101, HPA027135, HPA027317" Supported Supported Nucleoplasm,Peroxisomes NA NA 370000 Peroxisomes Nucleoplasm "HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422" "unprognostic (7.51e-2)" "unprognostic (5.23e-2)" "prognostic favorable (7.05e-5)" "unprognostic (9.68e-2)" "unprognostic (1.53e-2)" "unprognostic (5.53e-2)" "unprognostic (1.87e-3)" "unprognostic (1.22e-2)" "unprognostic (1.62e-2)" "unprognostic (1.59e-1)" "unprognostic (4.53e-2)" "unprognostic (6.16e-2)" "prognostic favorable (7.85e-8)" "unprognostic (1.49e-2)" "unprognostic (1.09e-1)" "unprognostic (8.64e-2)" "unprognostic (1.13e-2)" 29.1 26.2 21.8 19.9 21.2 14.0 30.3 12.0 19.7 24.4 51.9 15.9 28.1 49.2 19.0 28.8 32.2 18.1 32.1 29.3 20.0 20.0 54.2 168.3 21.8 14.0 25.6 17.8 22.8 24.6 16.7 24.1 17.1 21.9 25.5 40.5 18.9 21.8 23.3 22.0 18.8 80.1 20.6 27.1 20.9 33.9 16.7 19.4 23.0 28.2 28.6 17.6 22.3 20.5 36.4 57.1 67.8 50.7 40.8 49.2 61.2 25.6 14.1 19.0 34.8 62.4 53.4 20.6 30.6 45.9 20.1 29.2 12.6 27.8 24.4 33.1 44.8 23.5 18.0 13.0 28.6 30.8 35.5 18.9 26.2 20.3 25.9 41.6 37.7 44.2 43.3 39.0 23.8 11.9 44.1 56.9 28.9 23.3 12.7 40.6 14.8 42.0 32.8 20.8 65.1 27.7 22.0 33.5 33.3 55.8 43.6 15.7 19.0 26.7 54.2 25.6 44.1 27.7 43.2 44.0 27.4 14.2 47.7 24.4 21.3 27.0 28.5 35.5 37.5 25.3 55.4 48.7 67.8 49.2 50.7 39.9 36.4 39.2 48.6 57.1 29.8 33.2 47.1 7.5 40.8 46.8 37.1 47.1 61.2 21.8 21.2 12.0 19.7 20.0 20.0 25.6 17.8 21.9 19.4 125.0 163.3 99.5 107.7 133.6 35.0 136.8 201.2 147.2 103.5 176.2 29.5 158.8 401.3 140.3 42.8 125.8 592.0 70.0 143.6 134.4 129.4 170.2 138.2 1150.9 181.7 39.7 225.9 115.4 211.6 39.0 170.6 166.5 182.2 152.3 388.8 98.9 131.8 498.1 161.5 617.2 27.0 77.6 119.7 10.6 19.8 149.3 112.0 172.0 297.8 155.6 SCYL3 "PACE-1, PACE1" ENSG00000000457 "SCY1 like pseudokinase 3" Q8IZE3 1 169849631-169894267 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005624 Approved Uncertain "Nuclear bodies,Microtubules" NA NA Microtubules "Nuclear bodies" "HPA005624: AB_1854916" "unprognostic (2.35e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (8.36e-2)" "unprognostic (7.13e-2)" "unprognostic (2.72e-3)" "unprognostic (1.31e-1)" "unprognostic (2.12e-2)" "unprognostic (2.85e-2)" "unprognostic (7.17e-2)" "unprognostic (8.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.20e-3)" "unprognostic (3.54e-1)" "unprognostic (1.75e-1)" "unprognostic (4.60e-2)" "prognostic favorable (8.85e-4)" 10.8 11.4 8.5 15.4 10.6 5.0 15.8 10.5 11.9 12.1 14.6 11.0 14.6 10.7 12.6 14.0 14.4 10.6 11.0 7.8 7.3 6.5 12.1 18.0 11.8 13.7 9.3 7.8 13.0 12.8 22.7 14.4 15.8 9.5 13.2 13.9 12.3 15.5 13.8 14.6 14.1 14.9 13.0 7.3 12.6 11.3 9.1 8.9 17.2 13.3 9.5 16.0 16.0 12.7 8.3 13.6 12.3 4.3 11.8 10.5 5.9 3.4 4.5 7.0 4.8 9.0 6.5 8.0 5.4 7.1 6.3 6.0 4.1 6.7 7.1 4.0 5.6 3.5 8.1 4.1 4.8 5.7 13.1 3.8 4.9 5.0 2.6 6.4 7.1 6.4 6.3 4.8 4.4 6.1 6.0 6.0 8.0 7.8 9.5 6.0 2.7 5.7 5.5 5.6 23.5 2.2 5.3 3.8 8.5 6.7 6.3 5.2 7.6 4.3 14.3 8.5 10.3 8.0 6.6 4.4 4.6 3.0 5.4 4.3 12.8 11.3 8.5 3.4 5.4 5.0 12.3 3.7 9.7 8.0 3.9 10.5 8.3 10.4 8.7 6.0 7.3 9.2 7.5 8.2 11.8 4.3 13.6 9.5 5.9 8.5 10.6 10.5 11.9 7.3 6.5 9.3 7.8 9.5 8.9 6.0 11.8 5.2 1.7 2.2 9.6 3.4 22.9 2.7 9.1 1.8 9.8 14.5 8.3 5.3 2.9 5.8 10.8 0.0 8.0 4.3 4.3 3.7 5.7 8.6 5.5 9.5 8.7 7.4 10.8 1.5 4.0 5.3 1.7 7.2 12.7 8.9 5.8 10.5 5.3 4.9 17.6 6.5 4.1 7.2 6.4 1.6 9.7 10.2 9.9 2.3 SDCBP2 "SITAC18, ST-2" ENSG00000125775 "Syndecan binding protein 2" Q9H190 20 1309909-1329239 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 104.7" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 454.6;Pancreatic endocrine cells: 472.7;Paneth cells: 448.9;Urothelial cells: 654.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.2;OE19: 33.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005804, HPA064490" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA005804: , HPA064490: AB_2732713" "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (2.37e-1)" "unprognostic (5.85e-2)" "unprognostic (2.54e-1)" "unprognostic (2.27e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (1.01e-1)" "unprognostic (3.78e-3)" "prognostic unfavorable (3.07e-4)" "unprognostic (3.17e-1)" "unprognostic (1.07e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "prognostic favorable (3.37e-4)" 1.7 0.4 5.2 10.6 6.7 0.2 1.5 1.5 4.9 6.6 59.4 1.2 0.9 46.1 1.5 9.1 32.4 0.9 35.1 1.3 3.5 3.6 2.5 3.8 3.7 0.9 2.8 1.0 1.2 4.4 0.2 1.4 1.9 1.4 3.7 19.0 1.0 6.4 1.9 1.1 13.4 104.7 2.5 1.1 1.1 34.0 1.5 1.6 1.0 4.0 12.5 24.3 17.0 9.8 1.2 2.6 4.4 2.0 2.1 5.3 1.8 6.3 0.3 0.9 0.3 3.7 3.3 0.6 1.9 3.9 1.8 1.7 1.3 11.2 0.7 1.3 0.7 1.2 5.0 0.3 9.3 0.9 0.2 0.6 0.5 0.4 0.9 3.7 0.6 0.7 1.1 6.6 1.4 1.4 3.8 6.1 1.2 0.9 0.5 0.7 1.5 1.0 1.8 0.9 33.8 0.4 1.0 0.4 1.2 0.7 8.7 1.5 1.2 1.0 5.7 2.1 0.4 0.3 0.5 4.1 0.9 0.4 1.8 0.7 1.7 1.6 0.6 0.4 2.5 0.5 0.4 2.0 4.4 2.4 0.7 1.8 0.6 3.2 2.5 2.6 1.2 2.7 4.7 2.2 2.1 1.3 1.7 5.3 1.8 5.2 6.7 1.5 4.9 3.5 3.6 2.8 1.0 1.4 1.6 14.9 6.2 5.0 56.0 49.5 0.7 0.7 81.5 4.0 6.8 15.7 0.0 1.3 23.2 94.6 12.4 13.0 454.6 0.0 187.2 0.8 4.4 102.5 9.2 4.9 0.9 1.6 34.4 4.9 1.6 1.1 1.4 2.2 8.5 3.6 127.5 1.0 472.7 448.9 0.0 1.3 1.0 0.0 4.2 1.7 6.6 83.6 1.4 2.5 60.5 654.3 SDE2 "C1orf55, FLJ35382" ENSG00000143751 "SDE2 telomere maintenance homolog" Q6IQ49 1 225982702-225999331 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028467, HPA031255, HPA031256" Approved Supported "Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nuclear speckles" "Golgi apparatus, Plasma membrane, Cytosol" "HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568" "unprognostic (9.69e-2)" "unprognostic (2.69e-2)" "unprognostic (1.10e-1)" "unprognostic (2.36e-2)" "unprognostic (2.12e-1)" "unprognostic (3.10e-1)" "unprognostic (9.59e-2)" "unprognostic (2.68e-1)" "unprognostic (3.63e-2)" "unprognostic (1.84e-2)" "unprognostic (3.34e-2)" "unprognostic (9.01e-2)" "unprognostic (1.41e-3)" "unprognostic (3.90e-2)" "unprognostic (3.51e-1)" "unprognostic (3.98e-2)" "unprognostic (3.84e-2)" 25.6 11.2 10.7 13.3 12.8 33.6 21.6 10.8 11.5 12.3 10.6 17.9 9.0 11.0 15.1 11.5 14.3 12.8 13.4 12.2 10.8 11.0 11.9 17.9 16.2 13.9 14.1 9.8 16.2 14.2 15.6 13.9 14.5 12.5 12.9 11.6 11.1 12.0 11.2 20.9 18.0 12.9 12.7 13.5 14.4 11.5 14.1 14.4 33.9 15.8 11.0 14.1 15.6 16.9 8.2 7.8 17.9 7.2 12.5 11.2 6.3 8.5 6.2 10.1 10.7 7.1 7.9 12.6 9.1 8.7 12.5 9.6 9.0 9.8 12.5 14.3 7.7 4.9 11.0 12.6 7.9 15.3 9.5 10.3 13.8 5.3 8.2 13.0 13.5 16.8 8.7 11.5 13.3 16.9 7.1 8.6 15.1 25.1 15.2 9.2 2.5 18.8 10.8 14.0 13.2 6.6 15.9 13.0 16.2 7.5 6.0 9.1 15.1 10.4 11.4 17.1 8.5 11.2 16.7 8.4 10.7 7.6 13.8 19.9 9.1 6.5 15.5 11.0 8.4 21.1 16.3 6.0 5.5 8.2 6.2 11.2 8.2 8.3 7.9 6.7 7.1 8.6 8.0 17.9 12.5 7.2 7.8 6.4 6.3 10.7 12.8 10.8 11.5 10.8 11.0 14.1 9.8 12.5 14.4 26.8 23.5 17.7 14.0 38.7 5.2 7.3 2.5 13.4 25.0 8.7 0.0 7.6 13.3 5.8 47.5 16.2 11.3 23.3 6.1 8.4 15.4 11.4 34.6 17.9 9.7 14.3 16.7 12.9 16.1 12.7 9.2 13.9 18.6 5.4 10.7 11.4 8.2 10.7 6.0 9.0 7.7 6.5 17.3 15.1 13.9 51.7 11.9 15.0 9.8 16.6 SDHAF2 "C11orf79, FLJ20487, PGL2, SDH5" ENSG00000167985 "Succinate dehydrogenase complex assembly factor 2" Q9NX18 11 61430042-61447529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039464, HPA039732" Supported Approved Nucleoli,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoli "HPA039464: AB_10962146, HPA039732: AB_10962868" "unprognostic (5.31e-2)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (1.30e-2)" "unprognostic (1.40e-1)" "unprognostic (6.71e-2)" "unprognostic (1.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.17e-1)" "unprognostic (2.09e-3)" "unprognostic (4.21e-3)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (1.45e-1)" "unprognostic (4.48e-2)" 23.7 33.0 22.2 22.4 27.2 34.1 24.8 19.9 33.8 20.5 22.1 23.4 21.0 22.3 23.3 33.5 25.3 25.8 21.1 32.5 20.8 26.9 26.8 39.1 19.9 36.7 24.3 25.0 25.7 22.7 23.3 38.4 26.7 25.2 26.1 24.9 32.0 28.1 21.5 31.4 22.9 27.9 26.6 20.8 32.2 24.3 19.2 21.1 36.1 27.0 20.2 30.9 24.0 19.2 31.3 23.2 44.6 25.4 32.7 43.7 26.7 15.4 22.3 13.2 9.2 19.2 15.7 10.3 12.0 17.4 16.3 12.5 20.8 16.7 15.6 22.1 17.4 22.2 16.8 17.2 17.1 17.5 23.1 16.3 13.4 18.3 30.0 20.0 15.8 18.8 19.4 20.9 17.7 17.3 11.6 26.2 16.8 15.4 20.1 19.6 34.2 16.1 35.9 20.4 15.9 32.8 17.4 17.1 28.8 23.2 23.0 14.2 17.7 16.5 19.3 33.4 14.1 30.1 18.9 16.3 16.6 13.5 19.7 14.2 12.4 19.3 19.9 16.1 14.1 17.4 41.9 25.4 44.6 32.4 22.8 38.4 31.3 35.9 34.7 20.3 29.9 39.5 38.4 37.0 32.7 17.9 23.2 43.7 26.7 22.2 27.2 19.9 33.8 20.8 26.9 24.3 25.0 25.2 21.1 32.8 38.1 35.3 31.0 18.3 14.0 20.5 12.7 32.1 21.6 27.9 5.9 61.5 46.4 50.2 11.4 29.8 27.1 23.3 52.7 47.1 28.8 26.8 31.2 37.0 45.9 14.3 32.8 36.8 33.7 13.8 29.1 32.1 42.2 81.2 28.5 36.7 49.4 31.7 29.0 38.3 14.1 32.3 24.7 15.8 23.5 19.6 83.3 44.5 23.9 29.9 SDHB "SDH, SDH1" ENSG00000117118 "Succinate dehydrogenase complex iron sulfur subunit B" P21912 1 17018722-17054170 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 395.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002868, CAB009822, CAB068233, CAB068234, CAB068235" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" "Intracellular and membrane" NA NA Mitochondria "Nucleoplasm, Plasma membrane" "CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889" "unprognostic (1.06e-1)" "unprognostic (2.86e-2)" "unprognostic (2.19e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.79e-3)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (1.19e-1)" "unprognostic (8.45e-2)" "unprognostic (5.51e-2)" "unprognostic (3.93e-2)" "prognostic favorable (2.93e-7)" "unprognostic (1.46e-1)" "unprognostic (2.75e-1)" "unprognostic (7.82e-2)" "unprognostic (3.82e-2)" 17.8 25.6 19.8 16.6 21.7 17.0 26.4 18.0 29.1 13.9 30.8 12.3 15.1 34.0 14.2 15.7 19.8 13.6 15.1 86.9 18.2 16.4 51.0 75.1 16.8 24.6 20.1 18.9 10.5 30.7 20.0 11.3 15.6 16.7 13.0 31.5 11.7 15.9 19.5 96.2 13.2 31.4 21.3 16.5 17.2 21.7 18.7 15.7 14.2 15.5 52.2 18.0 15.4 17.1 22.2 45.9 48.5 48.7 18.9 26.7 25.0 26.0 25.8 14.7 18.8 28.7 28.5 16.8 22.8 29.3 52.3 47.2 36.3 31.3 35.7 28.5 30.7 33.8 30.7 58.7 45.4 59.0 20.9 48.1 32.1 26.9 27.8 35.1 50.2 23.9 29.3 30.0 45.2 76.6 27.8 36.9 31.4 26.8 41.4 36.3 21.5 33.3 28.7 12.2 41.9 51.9 24.0 28.4 44.2 48.1 14.8 27.8 15.2 30.9 38.7 64.9 16.3 22.7 28.4 18.3 20.1 22.7 36.9 30.0 17.3 21.3 36.5 30.8 76.6 22.2 16.6 38.4 37.4 18.3 48.7 18.3 22.2 21.2 19.5 45.9 18.3 19.3 19.5 48.5 18.9 42.2 21.5 26.7 25.0 19.8 21.7 18.0 29.1 18.2 16.4 20.1 18.9 16.7 15.7 59.6 39.6 77.3 79.1 46.2 28.1 395.8 109.5 78.9 40.9 45.4 13.7 93.2 300.1 104.4 146.0 54.0 212.4 116.8 130.5 121.6 58.6 70.1 65.7 198.8 162.9 35.0 46.7 41.7 81.2 13.8 53.5 90.6 60.8 125.4 89.5 52.1 97.2 192.9 63.6 355.3 35.5 38.8 60.4 85.9 68.4 47.7 101.8 52.3 135.8 97.0 SEC14L5 "KIAA0420, PRELID4B" ENSG00000103184 "SEC14 like lipid binding 5" O43304 16 4958317-5019158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 29.4;heart muscle: 7.5;skeletal muscle: 11.0" "Cell type enriched" "Detected in some" 9 "Cone photoreceptor cells: 80.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.2;RPMI-8226: 4.2;SCLC-21H: 6.5;T-47d: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041492, HPA041825" Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA041492: AB_10794519, HPA041825: AB_10794526" "unprognostic (1.90e-3)" "unprognostic (4.08e-2)" "unprognostic (5.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.99e-1)" "unprognostic (5.68e-2)" "unprognostic (7.33e-3)" "unprognostic (8.71e-4)" "unprognostic (6.87e-2)" "unprognostic (1.56e-4)" "unprognostic (1.01e-3)" "unprognostic (7.12e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" 1.1 1.7 7.4 1.3 17.5 1.5 1.2 2.2 22.1 2.8 1.7 29.4 0.0 1.4 0.9 1.2 2.0 2.2 1.1 7.5 13.5 6.1 1.1 0.8 1.0 1.4 25.8 8.8 1.7 1.8 0.8 1.7 1.3 15.2 1.7 2.1 0.3 1.9 1.1 11.0 2.9 1.1 0.9 25.2 1.2 3.7 1.4 15.6 0.0 0.9 0.5 1.7 0.9 0.4 0.1 0.4 1.6 0.0 0.1 0.2 2.9 0.0 0.4 0.6 0.3 0.6 4.2 0.6 0.1 0.0 0.1 0.0 0.5 0.2 0.2 0.3 0.5 0.1 0.6 0.2 0.1 0.0 0.0 0.5 2.0 0.4 1.1 0.3 0.0 0.4 0.6 0.9 0.1 0.1 0.3 0.1 0.2 0.2 0.4 0.1 0.3 0.0 0.2 1.3 1.0 0.3 0.1 0.4 4.2 0.3 0.1 6.5 0.2 0.4 0.3 0.5 0.7 4.3 0.0 0.5 0.2 0.4 0.3 0.0 0.2 0.0 0.2 1.1 0.2 0.2 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 1.6 0.1 0.0 0.4 0.0 2.9 7.4 17.5 2.2 20.0 13.5 6.1 25.8 8.8 15.2 15.6 0.0 0.0 0.0 0.1 0.2 3.7 8.9 0.0 0.0 0.0 0.0 80.5 0.6 0.0 0.1 1.1 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.4 0.0 SEC31B "DKFZP434M183, SEC31B-1, SEC31L2" ENSG00000075826 "SEC31 homolog B, COPII coat complex component" Q9NQW1 10 100486642-100519864 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Bipolar cells: 34.2;Collecting duct cells: 10.4;Cone photoreceptor cells: 37.3;Horizontal cells: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.4;JURKAT: 12.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA035882, HPA040819, HPA060052" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "HPA035882: AB_10795246, HPA040819: AB_10794151, HPA060052: " "unprognostic (1.23e-1)" "unprognostic (3.13e-3)" "unprognostic (3.39e-3)" "unprognostic (1.03e-2)" "unprognostic (4.85e-2)" "unprognostic (1.42e-3)" "unprognostic (1.97e-3)" "unprognostic (6.63e-2)" "unprognostic (2.22e-1)" "unprognostic (2.25e-2)" "unprognostic (1.10e-4)" "unprognostic (8.23e-3)" "prognostic unfavorable (6.41e-7)" "unprognostic (2.31e-2)" "unprognostic (2.54e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-4)" 2.8 2.4 3.3 3.2 5.0 6.4 2.6 12.1 11.8 2.7 2.8 5.4 4.3 1.9 3.0 3.5 1.4 2.9 2.6 5.6 3.1 3.6 2.7 3.4 2.4 4.3 3.3 5.6 3.9 0.8 3.9 5.0 2.4 6.3 2.9 2.7 6.1 2.8 2.5 13.6 2.4 2.9 3.2 3.4 4.9 1.9 16.2 3.4 0.0 2.6 5.2 3.6 2.3 1.9 0.9 0.0 0.1 0.2 0.0 2.1 0.1 0.2 0.2 2.8 0.9 0.9 1.6 0.3 0.5 1.3 0.2 0.9 0.3 0.4 0.6 0.8 0.0 0.1 0.3 1.5 0.4 0.8 3.5 0.8 1.4 1.8 0.3 1.2 1.0 1.2 2.4 1.4 0.2 1.7 12.4 0.5 12.5 0.3 1.7 0.0 0.0 1.8 3.1 0.0 0.2 0.6 2.7 0.1 1.1 0.9 0.0 0.2 0.9 0.3 0.0 0.6 2.1 0.7 0.3 0.0 0.4 0.4 0.3 0.2 1.3 0.6 0.8 0.1 3.4 0.4 0.0 0.1 0.0 0.5 0.2 2.1 0.0 0.0 0.4 0.0 0.9 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 3.3 5.0 12.1 11.8 3.1 3.6 3.3 5.6 6.3 3.4 6.0 5.0 0.0 0.8 1.0 34.2 6.5 5.1 2.7 2.3 10.4 37.3 1.0 0.0 0.4 0.9 2.1 2.1 0.0 0.2 0.3 1.9 1.8 1.1 6.4 1.9 38.1 5.2 3.1 4.3 0.8 3.1 1.8 1.7 3.6 3.9 4.3 0.3 0.0 3.9 0.6 6.7 0.0 1.2 7.5 3.2 1.0 0.7 2.6 4.0 0.9 SELENOK SELK ENSG00000113811 "Selenoprotein K" Q9Y6D0 3 53884410-53891988 "Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 244.0;Pancreatic endocrine cells: 237.2;Proximal tubular cells: 306.1;Syncytiotrophoblasts: 292.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 78.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 78.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008196 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA008196: AB_1856665" "unprognostic (1.29e-2)" "unprognostic (1.18e-2)" "unprognostic (3.85e-1)" "prognostic favorable (7.18e-4)" "unprognostic (9.92e-2)" "unprognostic (1.53e-1)" "unprognostic (3.02e-2)" "prognostic favorable (3.76e-4)" "unprognostic (2.75e-1)" "unprognostic (5.21e-2)" "unprognostic (8.34e-2)" "unprognostic (1.14e-1)" "unprognostic (3.40e-2)" "unprognostic (8.43e-2)" "unprognostic (8.12e-2)" "unprognostic (9.35e-2)" "unprognostic (2.56e-3)" 20.4 33.5 29.2 19.0 30.2 38.8 24.1 19.7 21.7 18.9 20.5 20.9 28.3 17.3 15.8 49.4 15.0 16.3 17.1 43.2 25.3 26.2 27.6 38.5 18.0 15.1 32.8 16.8 24.8 72.6 20.0 33.0 18.4 27.9 19.3 22.1 27.3 34.2 20.6 41.0 11.5 20.4 16.7 30.1 16.9 18.4 16.8 27.4 8.7 37.7 18.6 20.3 20.2 18.7 12.4 13.4 78.6 10.9 9.9 15.2 15.4 8.8 6.0 13.1 9.7 20.3 12.4 15.5 12.7 14.8 15.1 18.6 13.4 13.6 13.3 5.7 8.2 18.8 5.5 14.6 8.5 13.9 23.3 20.8 8.3 27.0 31.7 18.0 10.9 20.0 7.1 15.1 10.9 14.8 10.2 13.6 9.5 8.0 36.1 14.6 10.0 7.0 13.4 13.6 10.8 22.6 4.6 8.2 24.8 18.8 15.4 7.1 20.5 8.1 12.1 12.6 16.0 7.9 18.0 8.6 10.2 11.8 25.4 17.9 24.9 29.2 11.7 15.4 14.3 15.3 78.6 8.9 21.9 15.2 9.4 14.6 12.4 14.1 15.1 7.5 9.9 12.3 14.1 19.6 9.9 10.9 13.4 14.3 15.4 29.2 30.2 19.7 21.6 25.3 26.2 32.8 16.8 27.9 27.4 125.0 114.9 0.0 0.0 0.0 0.0 0.0 0.0 99.0 99.0 141.3 0.0 144.5 160.8 244.0 0.0 0.0 0.0 0.0 174.6 157.8 0.0 0.0 218.6 0.0 145.4 0.0 0.0 0.0 0.0 0.0 0.0 41.2 0.0 130.8 0.0 0.0 237.2 0.0 0.0 306.1 0.0 0.0 0.0 0.0 0.0 0.0 292.8 0.0 0.0 0.0 SELENON "MDRS1, RSMD1, RSS, SELN, SEPN1" ENSG00000162430 "Selenoprotein N" Q9NZV5 1 25800176-25818224 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Desmin-related myopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 19.2;Ductal cells: 16.8;Exocrine glandular cells: 36.9;Hofbauer cells: 25.2;Pancreatic endocrine cells: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA058076 Approved Uncertain Cytosol "Intracellular and membrane" NA NA Cytosol "HPA058076: AB_2683598" "unprognostic (2.65e-1)" "unprognostic (1.75e-1)" "unprognostic (4.11e-1)" "prognostic favorable (2.23e-4)" "unprognostic (1.93e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (3.40e-5)" "unprognostic (1.94e-1)" "unprognostic (4.72e-1)" "unprognostic (3.32e-3)" "unprognostic (6.01e-2)" "unprognostic (3.07e-1)" "unprognostic (1.64e-1)" "unprognostic (1.53e-1)" "unprognostic (1.10e-1)" "unprognostic (5.56e-3)" "unprognostic (5.89e-2)" 41.4 27.2 26.3 26.4 24.8 12.4 53.6 22.0 29.7 32.2 21.9 26.5 26.3 14.3 30.7 20.4 25.4 34.3 27.4 29.3 26.3 16.3 33.0 15.1 35.2 47.8 19.2 18.2 35.3 39.9 23.0 23.7 31.6 22.0 37.5 17.8 30.0 29.1 35.0 30.0 18.0 16.5 45.8 21.0 29.1 24.4 11.6 19.1 10.7 31.4 17.6 16.8 26.1 28.0 1.7 2.1 5.9 3.3 0.7 2.6 1.0 12.2 11.7 39.1 33.4 25.5 44.9 13.2 14.8 22.5 16.5 13.2 3.0 13.0 0.0 9.9 22.4 18.3 11.9 10.2 15.7 12.6 12.9 7.8 12.0 4.5 3.7 18.4 2.5 28.5 47.8 10.6 17.3 8.7 19.6 51.5 4.2 4.2 1.7 15.5 6.2 0.5 3.6 14.7 9.6 8.1 10.5 17.1 1.5 6.8 3.5 8.2 13.9 9.3 8.5 12.4 11.0 8.6 8.4 42.8 16.8 11.5 30.7 8.6 1.4 0.0 0.3 23.3 3.7 20.2 5.9 3.3 3.8 1.8 2.6 1.1 1.7 1.7 1.3 2.1 1.1 2.6 1.6 0.5 0.7 2.5 0.3 1.7 1.0 26.3 24.8 22.0 29.7 26.3 16.3 19.2 18.2 22.0 19.1 8.9 9.3 0.0 0.0 0.0 0.0 0.0 0.0 6.7 6.8 19.2 0.0 12.7 0.0 16.8 0.0 0.0 0.0 0.0 36.9 9.5 0.0 0.0 2.3 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 5.4 0.0 0.0 23.6 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 SELENOP "SELP, SeP, SEPP, SEPP1" ENSG00000250722 "Selenoprotein P" P49908 5 42799880-42887392 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 248.3;liver: 403.8" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 416.9;Alveolar cells type 2: 429.0;Hofbauer cells: 658.5;Proximal tubular cells: 719.9" "Cancer enhanced" "Detected in all" "liver cancer: 116.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Hep G2: 92.9;HSkMC: 81.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036287 Approved Uncertain "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA 2220000000 2300000000 "Nucleoplasm, Golgi apparatus" "HPA036287: AB_10794618" "unprognostic (7.96e-2)" "unprognostic (2.10e-1)" "unprognostic (4.28e-3)" "unprognostic (1.19e-3)" "unprognostic (6.67e-2)" "unprognostic (6.37e-2)" "unprognostic (9.22e-2)" "unprognostic (2.19e-2)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (2.07e-2)" "unprognostic (1.05e-1)" "prognostic favorable (6.97e-6)" "unprognostic (1.35e-2)" "unprognostic (4.19e-2)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" 53.8 31.4 17.5 13.5 54.6 2.2 41.1 11.9 24.0 34.9 56.8 52.8 24.2 40.9 22.3 39.0 20.5 26.2 44.4 26.6 27.6 17.5 57.5 403.8 55.0 30.4 106.2 16.1 49.1 15.3 18.2 21.4 62.7 63.6 30.5 48.5 27.1 19.5 41.2 16.4 18.1 248.3 16.1 137.1 87.1 21.6 19.6 70.3 6.3 24.5 14.7 11.3 30.0 33.0 2.2 3.6 2.2 0.7 2.7 2.4 1.4 0.1 0.3 1.4 0.1 7.7 2.1 1.4 0.6 1.9 0.0 0.0 2.0 11.0 0.3 6.9 0.2 0.2 0.3 0.0 0.0 0.0 0.4 8.9 0.5 0.0 92.9 4.7 0.5 0.0 81.3 0.1 0.0 0.0 0.3 0.0 0.3 1.0 2.2 4.0 0.2 0.1 1.1 5.4 3.1 0.1 0.2 0.3 15.9 2.1 1.3 0.3 0.5 0.5 2.8 0.2 10.6 21.7 0.1 0.1 0.5 0.3 0.9 0.1 1.5 0.2 0.3 0.3 1.0 0.2 0.3 0.6 1.8 2.2 0.6 2.4 1.6 1.6 1.7 1.2 2.2 2.4 2.0 2.2 2.7 0.7 3.6 1.5 1.4 17.5 54.6 11.9 24.0 27.6 17.5 106.2 16.1 63.6 70.3 416.9 429.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 187.7 118.7 0.0 169.8 167.5 38.5 0.0 0.0 0.0 0.0 45.9 18.4 0.0 0.0 24.4 0.0 658.5 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.8 0.0 0.0 47.6 0.0 0.0 719.9 0.0 0.0 0.0 0.0 0.0 0.0 94.4 0.0 0.0 0.0 SELL "CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR" ENSG00000188404 "Selectin L" P14151 1 169690667-169711698 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 227.5;lymphoid tissue: 77.8" "Group enriched" "Detected in many" 6 "B-cells: 178.5;Kupffer cells: 97.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 7.0;EFO-21: 6.8;JURKAT: 18.6;MOLT-4: 12.8;U-266/70: 24.1;U-698: 11.2;U-937: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002144, HPA051972" Enhanced Uncertain Cytosol NA NA 8100000000 Cytosol "CAB002144: AB_563862, HPA051972: AB_2797242" "prognostic favorable (3.76e-4)" "prognostic favorable (2.25e-4)" "unprognostic (1.52e-2)" "unprognostic (2.89e-2)" "unprognostic (7.87e-3)" "prognostic favorable (6.43e-4)" "unprognostic (1.39e-3)" "unprognostic (3.43e-1)" "unprognostic (2.70e-3)" "prognostic favorable (3.14e-4)" "unprognostic (1.42e-1)" "unprognostic (4.21e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (4.76e-2)" "unprognostic (8.71e-3)" "unprognostic (9.57e-2)" "unprognostic (1.01e-1)" 6.9 0.9 2.0 25.1 4.6 30.3 1.5 1.1 2.5 0.9 1.4 1.1 0.0 0.4 1.0 1.1 4.2 3.2 5.4 4.1 2.5 2.2 2.3 2.5 11.4 77.8 5.2 0.2 0.8 1.0 10.7 7.9 3.4 2.7 1.2 1.3 3.8 12.1 0.1 0.9 0.8 8.8 2.9 5.2 67.7 1.7 1.0 2.3 43.8 1.9 1.3 64.0 8.1 6.1 40.4 40.7 227.5 49.7 130.8 69.5 90.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.2 7.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.8 0.8 0.3 0.0 0.0 0.0 0.0 1.2 18.6 0.0 0.9 0.0 0.8 12.8 0.1 0.0 0.2 0.2 4.9 0.1 0.3 3.9 0.2 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 24.1 0.0 11.2 1.3 7.0 0.1 170.8 49.7 88.6 16.5 11.2 4.5 33.8 30.7 17.0 40.7 40.4 69.5 39.6 227.5 130.8 4.5 32.8 52.7 90.1 2.0 4.6 1.1 2.5 2.5 2.2 5.2 0.2 2.7 2.3 8.9 20.2 178.5 0.3 0.3 0.0 0.3 2.5 2.7 3.4 10.4 0.0 9.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.6 0.8 0.0 9.3 0.4 5.6 0.0 0.0 1.8 97.5 0.0 0.6 7.5 1.7 0.0 0.0 2.3 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 23.8 20.3 0.0 0.5 SEMA4G "FLJ20590, KIAA1619" ENSG00000095539 "Semaphorin 4G" Q9NTN9 10 100969518-100985871 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.0;liver: 33.9" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 42.3;Hepatocytes: 52.1;Mucus-secreting cells: 37.8;Paneth cells: 25.9;Undifferentiated cells: 30.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 13.1;CACO-2: 12.5;Hep G2: 45.8;OE19: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038362, HPA077752" Uncertain Uncertain "Vesicles,Lipid droplets" "Intracellular and membrane" NA NA 840000 "Vesicles, Lipid droplets" "HPA038362: AB_10669524, HPA077752: " "unprognostic (3.90e-3)" "unprognostic (9.43e-3)" "unprognostic (2.84e-1)" "unprognostic (1.13e-2)" "unprognostic (5.55e-2)" "unprognostic (8.11e-2)" "unprognostic (3.28e-1)" "unprognostic (3.71e-2)" "unprognostic (3.63e-1)" "unprognostic (1.41e-2)" "unprognostic (3.09e-2)" "unprognostic (3.14e-1)" "unprognostic (3.93e-2)" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" "unprognostic (3.05e-2)" 1.2 5.0 8.2 9.2 5.6 0.2 1.9 17.8 9.0 2.5 34.3 4.9 3.2 25.9 2.1 16.6 1.8 3.1 25.9 1.6 4.9 5.0 9.5 33.9 2.9 1.2 4.2 4.6 9.2 21.3 3.7 4.4 2.2 7.8 8.6 42.3 4.8 4.3 6.1 1.2 7.1 44.0 2.5 2.5 1.8 10.4 2.5 3.7 0.1 9.8 0.5 0.5 2.3 2.4 2.4 1.0 0.4 0.4 0.0 1.3 0.0 0.0 13.1 3.4 1.4 2.1 0.7 2.8 0.5 1.4 0.7 0.7 12.5 2.1 0.2 1.7 0.6 0.2 0.8 3.3 0.6 0.6 0.2 2.0 0.6 1.0 45.8 5.4 0.5 0.4 3.6 0.7 0.6 0.3 9.5 1.8 1.4 1.3 0.1 1.0 0.8 0.2 0.5 0.5 28.1 0.7 1.2 0.3 0.6 3.1 0.4 1.0 5.3 0.4 0.9 1.3 3.9 3.6 0.6 1.2 0.4 1.6 0.4 0.1 0.4 0.2 0.2 0.4 0.4 0.4 0.0 0.4 0.4 0.3 0.0 0.2 2.4 0.4 1.3 1.0 0.6 0.4 0.2 0.0 0.0 0.2 0.3 0.1 0.0 8.2 5.6 17.8 9.0 4.9 5.0 4.2 4.6 7.8 3.7 3.0 1.4 2.9 0.3 0.0 0.7 0.9 17.8 2.7 0.0 0.0 0.0 6.0 0.0 1.8 0.2 0.1 42.3 0.0 2.2 1.2 0.4 2.9 0.0 52.1 0.7 11.1 8.2 2.5 4.6 0.0 2.0 0.0 1.7 0.0 37.8 1.1 2.2 25.9 1.1 5.6 1.2 0.0 0.3 0.1 0.7 0.1 2.4 0.0 30.7 0.4 SEMA6D "FLJ11598, KIAA1479" ENSG00000137872 "Semaphorin 6D" Q8NFY4 15 47184101-47774223 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.8;placenta: 36.7" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 47.6;Cone photoreceptor cells: 108.0;Enterocytes: 37.0;Horizontal cells: 74.7" "Cancer enhanced" "Detected in many" "glioma: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 13.4;SCLC-21H: 11.9;SH-SY5Y: 11.0;SuSa: 13.2;U-266/70: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043109 Approved "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 480000 "Plasma membrane" "Golgi apparatus" "HPA043109: AB_10793941" "unprognostic (2.00e-1)" "unprognostic (4.62e-2)" "unprognostic (3.10e-2)" "unprognostic (3.83e-3)" "unprognostic (1.38e-1)" "unprognostic (3.85e-2)" "unprognostic (1.98e-1)" "unprognostic (2.17e-3)" "unprognostic (1.24e-1)" "unprognostic (5.36e-2)" "unprognostic (7.96e-4)" "unprognostic (1.42e-1)" "prognostic favorable (5.96e-5)" "unprognostic (3.74e-2)" "unprognostic (8.56e-2)" "unprognostic (3.30e-3)" "unprognostic (2.39e-4)" 5.3 1.9 10.3 3.7 16.7 0.8 5.3 5.4 17.1 5.3 14.7 15.3 4.3 18.9 2.1 2.9 2.0 5.2 4.0 8.3 10.3 11.2 14.2 3.0 8.2 2.2 14.0 13.6 25.0 14.8 16.2 6.1 36.7 15.9 4.8 12.0 10.0 4.4 8.5 15.6 3.1 40.8 3.4 12.7 2.5 3.4 2.6 11.0 0.2 6.3 1.5 1.1 3.1 9.6 0.5 0.0 1.9 0.6 0.0 0.8 0.0 0.0 0.0 2.2 0.0 1.3 1.1 0.2 0.5 13.4 0.3 0.0 0.3 0.1 1.8 0.0 3.4 0.0 7.0 2.8 0.9 0.0 0.9 1.6 0.0 4.1 0.0 3.6 0.0 0.1 1.0 7.3 0.0 0.4 0.0 0.9 4.8 0.1 2.9 0.4 0.7 2.2 0.5 4.2 0.0 0.0 1.3 0.0 2.0 1.0 0.9 11.9 11.0 0.1 0.9 3.7 13.2 0.4 0.0 0.0 6.2 0.3 0.2 0.0 8.8 0.0 2.0 1.6 0.2 1.6 0.0 0.6 0.0 0.5 0.0 0.0 0.5 0.3 0.8 0.0 0.0 0.1 0.2 1.9 0.0 0.0 0.0 0.0 0.0 10.3 16.7 5.4 17.1 10.3 11.2 14.0 13.6 15.9 11.0 47.6 1.0 0.0 4.0 1.8 3.3 9.4 0.0 0.0 3.4 10.4 108.0 14.7 5.0 1.0 0.1 6.7 37.0 0.0 0.2 1.2 6.7 0.9 3.5 0.8 2.3 74.7 16.7 4.9 0.0 0.0 21.6 0.0 8.5 0.0 2.6 14.3 0.4 6.0 12.7 0.2 2.0 0.0 12.2 0.7 5.1 1.0 3.9 0.0 9.8 1.4 SEMA7A "CD108, H-Sema-L, SEMAL" ENSG00000138623 "Semaphorin 7A (John Milton Hagen blood group)" O75326 15 74409289-74433958 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins" "Differentiation, Inflammatory response, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;lymphoid tissue: 34.7;placenta: 54.0" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 64.8;Extravillous trophoblasts: 51.6;monocytes: 49.5;Pancreatic endocrine cells: 55.5;Rod photoreceptor cells: 57.4;Syncytiotrophoblasts: 139.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 8.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.9" "Cell line enhanced" "Detected in many" "HMC-1: 101.9;hTEC/SVTERT24-B: 40.0;U-251 MG: 58.8;U-87 MG: 34.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008210, HPA042273" Uncertain Uncertain Vesicles NA NA 29000000 Vesicles "HPA008210: , HPA042273: AB_10806234" "unprognostic (2.00e-1)" "unprognostic (2.72e-1)" "unprognostic (2.02e-2)" "unprognostic (5.81e-2)" "unprognostic (6.49e-2)" "unprognostic (8.61e-2)" "unprognostic (2.54e-2)" "unprognostic (4.18e-3)" "unprognostic (1.33e-1)" "unprognostic (1.39e-1)" "unprognostic (5.18e-3)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.45e-11)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "unprognostic (6.25e-2)" "unprognostic (2.57e-2)" 2.2 1.9 5.4 10.4 13.8 12.8 1.4 22.9 27.3 1.3 1.8 19.9 1.4 2.7 4.3 1.8 3.2 1.2 3.3 1.4 10.8 5.7 1.4 1.5 4.4 19.0 28.5 5.7 5.9 0.9 6.4 1.9 54.0 28.6 1.4 1.8 7.8 1.7 3.5 1.4 4.7 6.0 2.0 36.4 34.7 3.7 23.6 15.4 9.0 1.1 0.4 19.7 4.6 1.7 1.4 1.8 8.9 0.0 0.8 0.2 0.0 5.8 0.0 1.7 0.5 2.2 7.6 14.6 27.1 10.9 5.7 8.8 2.3 9.6 0.0 1.6 12.2 4.6 1.7 0.5 1.7 5.9 0.4 0.3 10.6 0.0 2.9 0.5 0.3 101.9 5.3 0.0 40.0 2.2 14.4 0.0 0.7 6.0 3.7 18.5 0.4 1.4 3.4 1.9 0.1 4.1 0.2 1.2 1.5 2.4 2.5 0.1 0.1 0.2 4.9 2.2 1.6 0.3 2.1 1.0 10.7 7.1 5.1 58.8 0.6 0.4 0.1 34.3 1.2 0.5 3.9 0.0 8.9 0.2 0.0 0.2 1.4 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.8 0.0 1.8 0.0 0.0 5.4 13.8 22.9 27.3 10.8 5.7 28.5 5.7 28.6 15.4 3.0 0.0 2.7 0.5 0.3 10.9 0.8 0.0 0.0 2.3 1.8 64.8 20.3 0.0 17.3 0.5 2.4 0.0 0.0 12.1 51.6 0.8 1.9 8.1 0.8 6.4 1.6 0.0 0.6 0.8 1.5 3.4 1.2 8.5 49.5 0.0 4.2 55.5 0.0 1.8 0.0 57.4 0.0 0.9 0.7 0.4 1.3 139.1 2.5 0.0 25.3 SENP5 MGC27076 ENSG00000119231 "SUMO1/sentrin specific peptidase 5" Q96HI0 3 196867856-196934714 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006575 Approved Nucleoplasm,Nucleoli,Centrosome,Cytosol NA NA "Nucleoplasm, Nucleoli" "Centrosome, Cytosol" "HPA006575: " "unprognostic (4.07e-2)" "unprognostic (4.91e-3)" "unprognostic (7.63e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (4.13e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (2.95e-1)" "unprognostic (2.20e-1)" "unprognostic (2.88e-1)" "unprognostic (2.89e-1)" "unprognostic (9.57e-3)" "prognostic unfavorable (2.14e-5)" "unprognostic (2.02e-1)" "unprognostic (1.62e-1)" "unprognostic (1.62e-2)" "unprognostic (6.71e-2)" 13.8 13.5 20.0 15.3 20.0 25.7 16.1 28.3 23.8 15.0 15.1 16.1 14.5 11.3 14.6 16.2 16.3 12.9 14.4 15.9 18.9 21.7 13.6 19.5 15.2 15.9 19.4 18.4 17.5 15.7 19.8 21.5 17.8 23.5 15.1 14.0 12.0 13.2 15.9 17.8 16.4 13.0 16.8 18.2 17.1 14.0 36.6 16.4 19.3 14.1 9.2 21.1 14.9 20.1 8.9 7.8 15.8 8.7 7.6 8.9 4.2 13.3 6.1 9.8 8.8 8.3 9.9 7.8 8.5 9.1 9.3 15.0 10.6 5.3 12.5 23.8 9.3 15.9 9.2 10.1 4.5 15.1 6.7 6.6 16.9 9.1 7.4 9.6 14.0 8.0 8.5 12.3 9.5 10.1 6.7 9.0 11.2 11.2 19.4 10.8 11.5 13.1 8.2 7.6 7.3 12.0 8.5 7.9 8.5 4.5 7.6 6.1 8.1 9.5 10.8 10.5 10.3 18.1 10.7 10.1 9.1 9.3 12.4 17.4 20.8 36.3 27.0 12.2 11.3 10.3 15.8 7.6 7.1 8.9 8.1 8.1 8.9 8.6 8.8 5.0 8.5 8.0 8.6 14.9 7.6 8.7 7.8 6.9 4.2 20.0 20.0 28.3 23.8 18.9 21.7 19.4 18.4 23.5 16.4 20.8 13.0 17.1 20.7 54.0 26.0 12.5 10.2 9.4 14.8 8.7 15.7 15.8 10.0 14.8 27.7 20.4 12.4 0.0 12.2 12.8 21.0 19.3 25.5 16.6 12.0 27.0 20.7 13.5 16.1 36.8 15.0 18.8 13.5 14.4 13.2 15.4 20.6 17.5 15.6 14.7 27.7 25.8 24.0 36.7 40.5 54.3 19.1 26.7 10.1 28.1 SEPHS1 "SPS, SPS1" ENSG00000086475 "Selenophosphate synthetase 1" P49903 10 13317424-13348298 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037645, HPA062118" Enhanced Uncertain Nucleoplasm NA NA Nucleoplasm "HPA037645: AB_10671631, HPA062118: AB_2732676" "unprognostic (8.18e-3)" "unprognostic (1.79e-1)" "unprognostic (1.06e-3)" "unprognostic (2.07e-1)" "unprognostic (3.50e-2)" "unprognostic (2.99e-2)" "prognostic unfavorable (2.16e-7)" "unprognostic (2.66e-2)" "unprognostic (1.43e-1)" "unprognostic (2.61e-2)" "prognostic favorable (3.12e-4)" "unprognostic (1.09e-1)" "unprognostic (1.38e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (5.11e-2)" 15.1 21.9 19.8 11.4 18.0 11.5 33.2 17.3 16.2 14.4 16.0 14.6 10.4 11.9 17.5 20.2 15.4 19.1 15.1 16.1 18.3 15.4 30.5 39.1 20.0 24.3 16.3 11.2 19.8 37.3 23.2 16.6 14.2 17.3 14.4 17.6 15.1 20.6 14.0 20.5 11.8 13.0 17.7 16.6 17.9 15.1 13.7 16.1 44.7 29.8 22.2 17.2 14.1 17.0 8.1 13.2 8.7 19.6 12.7 10.9 6.6 27.5 20.1 41.2 39.7 13.7 10.5 19.4 12.3 9.5 26.3 22.4 22.8 26.0 26.9 15.3 14.3 12.7 17.7 43.6 20.3 27.6 40.4 18.0 14.7 15.0 28.8 14.2 19.8 9.4 9.1 14.6 15.3 9.0 12.3 21.2 57.1 19.3 22.0 18.6 36.5 48.9 8.4 68.1 26.1 9.1 38.2 20.1 16.0 14.2 11.2 14.6 27.2 37.7 16.7 16.8 37.5 21.1 21.1 14.1 11.7 22.3 15.2 25.6 16.2 29.9 49.8 9.4 14.8 9.3 8.7 9.7 7.1 7.1 14.5 8.6 8.1 7.3 8.0 11.6 6.3 9.4 8.7 1.5 12.7 19.6 13.2 10.9 6.6 19.8 18.0 17.3 16.2 18.3 15.4 16.3 11.2 17.3 16.1 11.9 12.5 6.0 14.0 15.2 15.5 10.8 17.8 10.7 15.9 21.0 0.0 28.1 28.2 26.2 8.6 19.0 12.4 23.3 26.1 37.4 15.8 15.2 15.1 27.1 18.2 20.6 16.0 16.5 7.5 11.1 13.8 14.2 15.1 7.2 10.4 22.9 27.4 14.0 17.3 32.7 11.3 6.5 20.6 18.2 15.4 14.8 21.4 11.4 14.6 12.1 SEPT12 FLJ25410 ENSG00000140623 "Septin 12" Q8IYM1 16 4777669-4788521 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Spermatogenesis" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 69 "testis: 99.8" "Cell type enriched" "Detected in some" 5 "Early spermatids: 274.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Region enriched" "Detected in single" 8 "cerebellum: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 2.6;SCLC-21H: 1.3;SK-BR-3: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA041128 Uncertain Microtubules NA NA Microtubules "HPA041128: AB_10796568" "unprognostic (2.11e-2)" "unprognostic (1.11e-1)" "unprognostic (1.56e-2)" "unprognostic (2.29e-2)" "unprognostic (2.71e-1)" "unprognostic (5.45e-2)" "unprognostic (7.40e-2)" "unprognostic (1.39e-1)" "unprognostic (3.80e-2)" "unprognostic (1.61e-1)" "unprognostic (1.49e-8)" "unprognostic (7.41e-2)" "unprognostic (9.87e-2)" "unprognostic (8.36e-3)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 99.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 2.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 274.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 1.0 0.0 0.0 56.9 1.5 0.0 0.1 0.0 0.0 0.0 SERF1A "4F5, FAM2A, H4F5, SERF1, SMAM1" ENSG00000172058 "Small EDRK-rich factor 1A" O75920 5 70900665-70918530 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 81.1;Cone photoreceptor cells: 23.6;Rod photoreceptor cells: 24.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA075271 Uncertain "Nuclear bodies" NA NA "Nuclear bodies" "HPA075271: AB_2686740" "unprognostic (1.14e-1)" "unprognostic (3.00e-2)" "unprognostic (9.58e-2)" "unprognostic (3.07e-1)" "unprognostic (1.73e-1)" "unprognostic (3.81e-3)" "unprognostic (1.29e-3)" "unprognostic (1.40e-2)" "unprognostic (2.55e-2)" "unprognostic (1.03e-1)" "unprognostic (9.83e-3)" "unprognostic (4.13e-2)" "unprognostic (2.11e-1)" "unprognostic (1.98e-2)" "unprognostic (1.22e-2)" "unprognostic (9.53e-2)" 1.3 1.2 6.4 1.8 5.0 3.0 1.5 5.3 7.2 1.2 1.8 0.2 3.1 7.8 1.8 1.1 3.7 1.6 5.4 5.2 4.1 0.4 1.9 3.3 4.9 2.6 2.6 3.2 2.5 0.8 2.4 3.5 2.1 1.2 1.9 2.8 1.4 3.1 3.5 2.4 2.0 2.8 4.4 0.6 5.8 1.6 7.3 2.6 2.8 1.2 2.1 6.3 0.9 3.7 0.3 3.2 4.6 3.0 4.3 6.4 1.0 0.8 0.9 1.4 1.2 1.5 3.2 6.4 2.6 1.8 1.0 1.8 1.1 2.4 1.5 3.2 3.6 2.1 1.7 1.5 0.7 1.3 2.0 1.4 0.7 1.0 3.6 2.6 0.5 0.5 2.0 2.5 1.7 9.7 11.5 2.3 0.3 1.0 0.5 4.6 5.1 3.3 3.0 9.8 2.9 10.2 0.5 10.1 1.5 6.4 1.3 8.8 3.8 1.2 3.0 1.4 0.8 1.0 3.2 1.9 0.5 8.8 1.0 0.3 2.8 4.2 1.2 5.1 4.9 4.0 6.3 0.5 7.3 4.7 3.9 2.8 2.1 0.8 2.6 3.0 0.9 0.0 3.4 0.8 2.0 1.6 2.6 81.1 0.0 6.7 4.5 3.5 23.6 0.2 3.3 1.2 2.0 2.4 2.4 0.0 0.4 0.3 1.3 1.9 2.3 0.0 0.5 0.0 5.2 1.3 0.0 1.0 2.0 0.8 0.0 1.8 1.2 2.3 0.9 2.9 3.5 0.8 24.0 0.0 1.2 3.1 1.3 1.9 0.1 2.9 1.8 0.9 SERF2 "4F5REL, FAM2C, H4F5rel, HsT17089" ENSG00000140264 "Small EDRK-rich factor 2" P84101 15 43777087-43802589 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056613 Uncertain Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA056613: " "unprognostic (3.29e-1)" "unprognostic (7.29e-2)" "unprognostic (1.13e-3)" "prognostic favorable (5.33e-4)" "unprognostic (1.40e-1)" "unprognostic (3.91e-2)" "unprognostic (6.06e-2)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (2.50e-1)" "unprognostic (3.04e-1)" "unprognostic (1.36e-1)" "unprognostic (3.37e-2)" "unprognostic (2.84e-1)" "unprognostic (3.35e-2)" "unprognostic (2.76e-2)" "unprognostic (9.42e-2)" 78.4 109.1 61.4 103.2 58.1 110.6 115.0 33.0 45.9 71.2 107.6 45.1 99.7 59.2 65.1 121.7 109.6 60.0 128.9 166.4 56.1 48.2 97.5 153.1 79.7 81.4 72.9 42.6 51.8 125.4 23.5 62.5 102.9 89.4 84.7 87.6 63.0 134.3 106.7 98.7 59.9 86.4 68.5 66.7 79.5 79.5 65.5 45.8 77.0 122.5 116.7 82.9 84.8 116.3 146.1 259.3 225.7 218.7 91.4 142.8 413.5 34.8 58.0 43.3 59.0 150.7 111.1 33.4 62.2 78.0 40.5 51.9 74.4 35.1 18.1 51.6 106.7 53.7 46.4 33.8 46.7 20.3 49.5 40.1 43.7 84.4 142.7 73.9 40.7 94.4 104.9 60.6 32.8 35.2 63.3 59.0 51.4 45.0 119.6 79.4 106.8 52.0 96.5 36.9 136.5 67.6 53.4 28.7 83.0 110.5 127.6 32.5 35.0 33.3 140.1 31.8 39.2 117.3 174.4 49.9 69.4 35.4 104.1 45.4 44.2 59.2 125.6 74.8 74.1 71.8 127.3 218.7 225.7 113.6 194.5 103.1 142.2 125.7 116.0 185.9 146.1 116.7 118.3 129.1 91.4 166.0 259.3 142.8 413.5 61.4 58.1 33.0 45.9 56.1 48.2 72.9 42.6 89.4 45.8 470.5 717.5 1171.8 1145.4 1022.8 54.4 1942.2 1490.4 1019.8 757.5 1647.0 51.1 2342.3 3302.5 1581.0 331.8 1228.3 2242.3 817.7 1967.3 2747.0 1831.7 2360.8 754.3 2534.0 3171.2 44.5 1122.7 1502.0 1926.7 193.3 1134.5 1999.7 1724.2 2939.6 2776.8 318.1 1792.5 2080.9 932.7 3520.7 108.9 595.0 1152.9 641.0 342.8 1360.5 2739.6 1068.3 1696.1 2044.0 SERINC5 "C5orf12, TPO1" ENSG00000164300 "Serine incorporator 5" Q86VE9 5 80111651-80256079 "Predicted membrane proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 145.8;Urothelial cells: 161.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037898, HPA037899" Supported Supported "Vesicles,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" "Vesicles, Centrosome" "HPA037898: AB_10673649, HPA037899: AB_2675727" "unprognostic (2.95e-1)" "unprognostic (1.80e-1)" "unprognostic (4.98e-3)" "unprognostic (1.08e-2)" "unprognostic (5.05e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-2)" "unprognostic (8.00e-2)" "unprognostic (2.10e-1)" "unprognostic (2.68e-2)" "unprognostic (7.71e-2)" "unprognostic (1.62e-1)" "unprognostic (1.40e-2)" "unprognostic (4.81e-2)" "unprognostic (8.09e-2)" "unprognostic (4.93e-2)" "unprognostic (9.17e-2)" 6.9 21.1 9.0 7.8 11.2 3.0 6.7 5.3 15.6 10.2 16.3 28.8 11.2 5.1 6.9 12.9 9.7 9.6 8.4 4.1 9.5 7.3 5.3 26.3 8.0 9.3 13.4 7.0 9.8 7.8 4.2 5.3 24.7 12.1 20.3 17.5 3.6 9.8 8.4 3.1 10.9 9.5 4.4 9.7 8.3 9.7 18.9 15.0 7.8 5.2 6.7 12.3 9.3 7.7 0.8 4.0 6.2 6.9 0.4 17.5 4.7 4.9 8.9 3.0 1.9 4.2 4.4 9.1 4.1 2.7 1.8 1.9 18.0 25.9 0.8 4.2 5.2 4.2 14.5 4.1 10.8 2.6 0.7 2.2 0.6 1.1 9.6 1.5 0.6 1.9 5.1 6.0 4.7 12.3 5.1 3.3 24.6 1.6 4.3 4.8 8.6 10.0 2.4 4.2 7.0 3.1 12.0 2.7 1.3 5.3 24.7 0.2 2.9 3.6 8.5 15.9 16.2 3.7 3.1 3.6 5.3 1.5 5.3 5.0 5.6 1.5 13.0 9.9 1.7 21.5 6.2 6.9 4.4 1.6 3.4 1.2 0.5 13.9 4.2 4.0 0.8 17.5 10.5 3.6 0.4 1.0 0.9 4.5 4.7 9.0 11.2 5.3 10.9 9.5 7.3 13.4 7.0 12.1 15.0 56.6 23.8 3.7 42.8 5.7 3.7 7.5 22.9 2.7 23.9 15.7 0.0 14.2 8.3 21.5 1.4 17.5 72.2 0.0 16.8 20.9 20.6 145.8 8.1 74.0 19.5 3.2 57.7 43.0 25.4 4.2 17.0 27.0 5.0 36.1 63.6 60.6 25.3 57.5 37.4 4.6 4.8 32.3 3.8 1.2 7.9 8.5 108.0 16.7 74.3 161.9 SERPINB13 "headpin, HUR7, hurpin, PI13" ENSG00000197641 "Serpin family B member 13" Q9UIV8 18 63586989-63604639 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "cervix, uterine: 37.7;esophagus: 70.8;lymphoid tissue: 54.2;tongue: 107.2;vagina: 34.1" "Group enriched" "Detected in some" 11 "Ciliated cells: 8.1;Club cells: 29.6;Urothelial cells: 8.5" "Cancer enhanced" "Detected in many" "cervical cancer: 45.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 132 "HaCaT: 65.6;hTCEpi: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052630, HPA057129" Enhanced Approved "Nuclear speckles,Cytosol" NA NA 59000 "Nuclear speckles, Cytosol" "HPA052630: AB_2681891, HPA057129: AB_2683347" "unprognostic (3.49e-2)" "unprognostic (3.73e-1)" "unprognostic (1.11e-1)" "unprognostic (7.27e-2)" "unprognostic (2.28e-1)" "unprognostic (4.29e-2)" "unprognostic (2.81e-1)" "unprognostic (6.04e-3)" 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 0.1 37.7 0.1 0.0 0.0 0.1 3.1 0.1 70.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 10.9 0.1 0.2 5.7 0.1 0.1 0.0 0.1 0.1 0.1 0.0 1.0 0.1 107.2 54.2 1.5 34.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.0 0.0 0.0 8.1 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 8.5 SERPINI1 "neuroserpin, PI12" ENSG00000163536 "Serpin family I member 1" Q99574 3 167735243-167825568 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 96.0" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 71.8;Muller glia cells: 71.6;Smooth muscle cells: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 15.9;HeLa: 16.5;Karpas-707: 18.5;U-266/84: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001565, HPA056092" Enhanced Uncertain Cytosol "Secreted in brain" NA NA 200000 Cytosol "HPA001565: AB_1079924, HPA056092: AB_2683036" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (4.09e-3)" "unprognostic (1.35e-1)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.25e-4)" "unprognostic (2.48e-1)" "unprognostic (2.61e-1)" "unprognostic (6.07e-3)" "unprognostic (2.18e-2)" "unprognostic (1.01e-1)" "unprognostic (1.58e-3)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (1.22e-1)" "unprognostic (1.11e-1)" 5.9 8.2 31.9 2.4 27.9 1.3 6.1 3.6 96.0 4.2 2.8 7.1 0.4 1.5 4.3 4.3 3.2 3.9 3.4 6.4 35.9 35.3 14.5 2.5 3.4 2.3 36.9 35.7 4.0 16.3 3.7 10.3 3.5 22.9 5.8 2.5 2.4 9.9 3.6 1.7 2.1 2.5 3.1 51.6 4.1 3.6 7.0 15.9 0.0 5.2 0.3 3.8 3.1 1.6 15.4 4.4 1.0 0.4 6.0 16.0 3.4 0.4 2.0 3.2 0.2 6.0 1.6 0.2 1.2 1.8 0.8 1.3 0.7 3.9 15.9 6.1 0.8 2.7 0.9 2.1 2.2 0.9 5.0 4.5 5.4 16.5 6.7 0.4 0.8 0.6 2.3 0.8 0.4 0.8 1.8 0.2 6.1 10.1 18.5 0.7 1.5 0.4 1.1 2.0 2.5 2.5 1.8 0.1 2.0 6.9 0.5 1.3 8.4 2.3 4.3 5.1 7.8 6.6 2.4 0.5 3.5 0.3 0.3 5.7 13.9 17.1 11.6 2.9 4.1 2.0 1.0 0.2 0.5 6.2 0.4 4.5 12.7 6.5 6.6 0.3 15.4 4.7 5.7 0.6 6.0 0.3 4.4 16.0 3.4 31.9 27.9 3.6 78.9 35.9 35.3 36.9 35.7 22.9 15.9 6.0 1.0 8.0 12.2 3.3 71.8 7.3 0.0 13.4 7.9 5.2 13.7 5.0 6.6 1.5 0.3 9.2 0.0 0.0 15.6 4.7 5.2 9.8 2.3 0.6 2.3 4.8 4.6 3.1 0.8 1.8 3.7 1.9 6.8 1.8 0.1 71.6 4.6 0.0 2.5 31.2 31.4 25.8 68.9 1.8 13.2 1.5 4.2 5.3 0.0 1.6 SETBP1 "KIAA0437, SEB" ENSG00000152217 "SET binding protein 1" Q9Y6X0 18 44680173-45068510 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Leydig cells: 58.1;Peritubular cells: 37.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.9;naive B-cell: 7.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "AF22: 9.5;Karpas-707: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049022, HPA057259" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA049022: AB_2680602, HPA057259: AB_2683384" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.11e-1)" "unprognostic (1.97e-2)" "unprognostic (4.63e-2)" "unprognostic (1.80e-1)" "unprognostic (1.91e-1)" "unprognostic (3.57e-2)" "unprognostic (3.49e-1)" "unprognostic (2.01e-2)" "unprognostic (2.71e-3)" "unprognostic (6.52e-2)" "prognostic favorable (6.34e-8)" "unprognostic (2.18e-2)" "unprognostic (2.29e-1)" "unprognostic (6.06e-2)" "unprognostic (7.81e-5)" 10.6 2.9 3.8 13.2 8.7 2.1 9.8 16.0 12.6 16.9 14.6 4.2 19.9 2.5 14.0 17.5 6.6 11.0 7.9 6.8 3.6 3.5 15.0 7.2 9.8 7.0 2.9 7.4 12.8 8.2 9.1 5.1 10.2 3.2 12.2 5.3 14.0 6.9 21.3 14.5 6.6 6.9 19.9 3.7 5.9 9.1 5.5 1.2 3.4 8.4 8.7 8.8 11.9 13.3 7.5 4.3 0.2 1.6 0.0 0.6 0.2 0.0 1.7 9.5 0.0 2.7 0.7 0.6 0.8 1.7 0.9 0.7 0.1 0.0 0.5 0.3 1.0 0.5 2.8 1.0 3.0 0.6 0.8 0.5 0.0 1.0 0.6 0.0 0.0 0.0 2.3 1.1 0.0 1.8 1.6 0.3 0.0 0.0 37.9 0.2 0.5 0.0 0.0 1.3 0.0 0.6 3.1 0.0 3.3 3.2 2.2 4.8 2.5 0.0 0.0 0.5 4.5 1.3 0.0 0.0 5.6 2.1 0.0 4.4 5.0 0.3 0.0 3.4 0.1 3.2 0.2 0.0 0.0 0.6 1.1 0.0 4.9 0.1 0.5 0.1 7.5 0.0 0.2 0.0 0.0 1.6 4.3 0.0 0.2 3.8 8.7 16.0 12.6 3.6 3.5 2.9 7.4 3.2 1.2 0.0 2.6 26.0 8.5 13.7 11.5 3.6 10.2 2.7 3.4 15.7 17.7 1.3 3.3 4.1 0.9 9.5 0.4 0.0 2.9 1.2 27.4 6.4 0.0 13.5 1.6 3.2 11.5 12.3 1.6 1.8 58.1 2.7 3.3 0.0 2.5 9.1 3.3 8.4 37.4 6.8 19.3 6.5 30.7 0.0 0.1 13.2 0.7 4.9 4.6 1.0 SETD6 FLJ21148 ENSG00000103037 "SET domain containing 6" Q8TBK2 16 58515479-58521181 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041481, HPA053546" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041481: AB_10804004, HPA053546: AB_2682182" "unprognostic (1.32e-1)" "unprognostic (2.98e-3)" "unprognostic (3.35e-1)" "unprognostic (2.81e-1)" "unprognostic (7.90e-3)" "unprognostic (1.95e-1)" "unprognostic (1.93e-3)" "unprognostic (1.65e-1)" "unprognostic (3.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (3.74e-3)" "unprognostic (2.14e-1)" "unprognostic (3.73e-1)" "unprognostic (5.93e-3)" "unprognostic (1.55e-1)" 7.8 11.3 7.7 7.4 8.8 4.3 12.6 18.6 11.8 8.4 7.1 6.6 17.0 7.0 10.2 14.0 11.5 10.3 9.6 8.6 8.8 7.0 11.7 12.1 7.9 7.9 8.9 9.0 9.0 20.0 22.1 17.1 7.0 8.3 12.2 8.2 7.2 15.5 19.7 14.7 14.4 7.8 9.2 7.7 9.2 9.6 10.2 9.7 5.5 13.6 9.5 8.8 7.4 10.3 3.2 3.9 3.8 3.0 8.6 4.9 2.7 1.8 3.8 0.8 7.3 2.8 2.0 13.7 3.1 3.4 4.4 2.6 6.5 3.8 13.6 5.0 3.1 0.6 5.7 5.7 4.1 3.2 1.7 20.6 0.6 6.3 11.6 2.9 9.9 6.2 2.5 8.3 3.7 5.7 3.2 3.2 0.1 10.8 1.7 0.9 6.6 0.2 11.9 15.5 5.9 8.4 0.2 1.7 18.5 4.6 0.2 13.6 9.6 13.6 10.4 5.1 4.1 6.7 1.2 2.7 1.7 4.9 2.1 5.2 9.4 5.7 10.1 3.5 4.8 3.3 3.8 2.4 0.2 4.6 3.0 3.3 3.2 3.9 4.9 3.9 3.1 4.8 4.8 0.1 8.6 2.9 3.8 3.2 2.7 7.7 8.8 18.6 11.8 8.8 7.0 8.9 9.0 8.3 9.7 6.0 5.8 7.9 8.7 12.4 13.5 7.6 10.2 13.4 7.9 8.7 13.7 14.4 1.7 7.0 6.6 6.7 4.9 0.0 10.5 7.4 5.2 8.3 1.1 6.2 3.2 11.1 4.6 3.7 3.5 14.2 8.3 4.5 5.0 7.2 4.0 12.1 5.3 2.9 9.6 8.4 11.9 12.9 6.3 9.8 20.4 10.7 10.5 5.3 6.8 5.4 SFN YWHAS ENSG00000175793 Stratifin P31947 1 26863138-26864457 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 6884.3;Suprabasal keratinocytes: 9365.4;Urothelial cells: 2426.4" "Cancer enhanced" "Detected in all" "head and neck cancer: 2526.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "basophil: 7.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.1" "Cell line enhanced" "Detected in many" "A-431: 70.1;HaCaT: 110.7;HBEC3-KT: 170.4;hTCEpi: 114.4" "Low region specificity" "Detected in some" "CAB006268, HPA011105, CAB040552, HPA061603" Enhanced Supported "Nucleoli rim,Cytosol" "Secreted in other tissues" NA NA 54000000 Cytosol "Nucleoli rim" "CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: " "unprognostic (5.70e-2)" "unprognostic (1.26e-1)" "unprognostic (8.37e-2)" "prognostic favorable (1.92e-4)" "unprognostic (1.26e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (5.68e-5)" "unprognostic (1.71e-2)" "unprognostic (2.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavorable (6.01e-4)" "unprognostic (3.83e-1)" "prognostic unfavorable (7.45e-6)" "unprognostic (7.90e-3)" "unprognostic (3.25e-1)" "unprognostic (8.12e-2)" "unprognostic (2.06e-2)" 0.4 0.0 0.5 3.1 0.5 0.0 3.8 0.4 0.7 37.5 10.7 0.5 0.5 5.9 3.3 0.7 256.2 0.0 6.0 0.3 0.6 0.1 1.2 0.5 8.2 0.3 0.4 0.3 0.3 0.3 0.0 0.3 3.4 0.8 5.9 4.0 0.3 25.5 0.4 0.4 123.8 13.2 0.5 0.7 0.3 6.6 0.4 0.4 3.1 0.4 256.0 107.4 9.1 47.7 0.0 0.0 7.1 0.0 0.0 0.6 0.0 70.1 11.8 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 4.3 37.1 0.6 3.1 0.0 0.0 110.7 0.0 170.4 0.0 16.7 0.5 0.0 11.8 12.5 0.0 0.0 0.1 0.0 114.4 0.0 29.9 0.0 0.0 0.0 0.1 0.4 0.0 15.0 0.0 0.0 0.2 12.2 19.7 0.0 0.0 3.9 26.5 16.2 0.0 0.0 16.9 3.0 0.1 0.2 7.9 0.1 0.0 0.0 32.4 0.0 0.4 0.1 0.5 0.3 0.1 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.5 0.5 0.4 0.7 0.6 0.1 0.4 0.3 0.8 0.4 166.7 216.2 0.5 1339.8 6884.3 0.0 0.3 33.1 30.8 122.8 15.7 0.0 6.7 3.3 52.1 0.0 0.6 409.5 0.0 68.0 45.3 37.0 487.4 31.2 0.0 1.6 0.0 64.7 0.6 0.3 0.0 0.0 15.6 506.2 1.8 78.2 0.0 315.2 136.8 0.0 0.0 0.0 0.0 110.7 0.0 0.2 9365.4 5.0 0.0 146.1 2426.4 SGO1 "NY-BR-85, SGOL1" ENSG00000129810 "Shugoshin 1" Q5FBB7 3 20160593-20186292 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 40.1" "Cell type enhanced" "Detected in some" 27 "Cytotrophoblasts: 5.4;Extravillous trophoblasts: 33.5;Hofbauer cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA035501, HPA069302, HPA069857" Enhanced Enhanced Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214" "unprognostic (6.87e-3)" "unprognostic (5.01e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-3)" "unprognostic (2.51e-2)" "unprognostic (4.10e-2)" "unprognostic (2.55e-6)" "unprognostic (9.49e-3)" "unprognostic (2.45e-2)" "unprognostic (3.69e-2)" "unprognostic (1.65e-4)" "unprognostic (1.52e-2)" "unprognostic (0.00e+0)" "unprognostic (2.29e-2)" "unprognostic (4.95e-2)" "unprognostic (4.14e-1)" "unprognostic (1.64e-1)" 0.6 0.6 0.4 9.1 0.4 8.9 1.0 0.4 1.5 0.9 3.4 0.3 0.6 2.7 0.8 0.5 4.0 0.3 1.7 0.4 0.3 0.4 0.8 1.0 0.9 6.9 0.4 0.1 0.5 0.5 0.0 0.4 3.7 0.2 0.6 3.5 0.1 1.0 0.1 0.3 1.1 3.4 0.8 0.4 4.9 1.5 8.6 0.2 40.1 0.5 2.4 7.4 1.2 1.5 9.0 4.5 8.3 0.2 0.3 2.7 0.6 9.5 10.9 14.9 9.1 0.7 1.3 10.1 10.3 5.3 15.0 16.5 7.7 11.8 14.6 5.2 4.2 10.6 5.6 14.0 5.7 19.0 18.6 9.3 16.6 7.5 6.1 0.1 15.1 14.3 0.1 0.4 16.5 7.0 2.1 8.9 17.4 14.2 26.2 12.4 9.4 23.7 8.5 15.8 10.2 8.3 15.2 19.1 8.5 3.8 7.0 7.4 7.8 11.4 14.1 6.8 11.6 9.1 10.6 2.4 11.4 13.7 10.2 20.5 11.3 26.2 17.0 6.2 15.3 17.1 8.3 0.1 1.5 0.3 0.2 0.1 8.6 0.7 0.8 0.4 9.0 0.2 0.4 1.6 0.3 0.2 4.5 2.7 0.6 0.4 0.4 0.4 1.5 0.3 0.4 0.4 0.1 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 5.4 0.0 1.1 0.0 0.0 0.0 0.0 1.6 33.5 0.0 0.0 1.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 SGTB "FLJ39002, Sgt2" ENSG00000197860 "Small glutamine rich tetratricopeptide repeat containing beta" Q96EQ0 5 65665928-65723035 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.8" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 66.7;Muller glia cells: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044689, HPA063674" Enhanced Uncertain Nucleoplasm NA NA Nucleoplasm "HPA044689: AB_10960838, HPA063674: AB_2685084" "unprognostic (9.94e-2)" "unprognostic (2.28e-1)" "unprognostic (9.58e-2)" "unprognostic (1.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.49e-1)" "unprognostic (5.92e-5)" "unprognostic (4.27e-2)" "unprognostic (2.86e-1)" "unprognostic (2.41e-1)" "unprognostic (1.64e-2)" "unprognostic (5.35e-2)" "unprognostic (2.54e-3)" "unprognostic (6.82e-2)" "unprognostic (1.87e-1)" "unprognostic (6.34e-2)" "unprognostic (3.05e-3)" 5.9 4.0 14.5 9.4 17.1 11.1 4.0 14.0 40.8 4.6 3.2 4.2 0.2 2.4 6.5 3.2 4.3 2.9 4.4 5.6 13.4 13.4 3.8 3.7 5.3 9.3 14.8 11.9 4.4 2.8 3.7 3.9 5.1 16.9 6.8 3.8 3.0 2.4 3.3 3.5 3.1 2.6 7.2 12.2 6.0 2.7 2.8 4.9 3.1 5.8 0.9 6.4 5.1 3.0 1.5 2.4 8.5 6.6 1.0 13.4 3.1 4.7 3.0 5.8 5.9 8.8 11.6 5.7 19.9 6.2 6.7 9.2 4.1 2.0 6.4 10.8 15.4 11.8 4.8 8.3 7.6 10.9 4.8 8.1 2.8 8.4 8.2 22.8 2.1 4.7 8.6 6.7 14.5 19.2 4.7 6.4 5.1 4.8 4.4 10.4 1.7 4.5 3.3 3.9 0.4 1.6 5.4 10.2 6.6 3.0 1.7 9.1 4.9 8.1 1.4 9.3 6.1 2.0 3.2 9.6 8.8 9.5 9.4 4.4 3.5 5.3 8.7 4.5 6.1 3.4 8.5 5.7 1.3 2.9 6.6 2.7 1.5 6.8 3.8 2.4 1.4 7.4 4.2 6.1 1.0 5.5 0.6 13.4 3.1 14.5 17.1 14.0 29.9 13.4 13.4 14.8 11.9 16.9 4.9 14.9 5.6 1.4 2.4 5.7 6.0 3.2 5.1 2.7 6.8 1.8 0.0 1.3 0.0 2.7 1.9 6.8 0.0 0.0 1.7 3.5 7.5 3.6 20.7 3.8 20.5 66.7 1.7 1.8 20.2 1.4 3.7 16.4 11.8 19.0 1.5 59.7 3.6 1.4 3.9 1.8 4.2 12.9 10.8 4.1 4.8 4.0 1.0 10.2 0.6 1.3 SHANK2 "CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3" ENSG00000162105 "SH3 and multiple ankyrin repeat domains 2" Q9UPX8 11 70467856-71252577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 38.7;Horizontal cells: 128.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.1" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.1" "Cell line enhanced" "Detected in many" "Karpas-707: 16.9;MCF7: 9.7;RT4: 15.6;T-47d: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008174, HPA017220" Approved Uncertain "Nucleoplasm,Nuclear speckles,Vesicles" NA NA Nucleoplasm "Nuclear speckles, Vesicles" "HPA008174: AB_1856822, HPA017220: " "unprognostic (3.08e-1)" "unprognostic (1.31e-3)" "unprognostic (1.79e-1)" "unprognostic (1.51e-2)" "unprognostic (1.51e-1)" "unprognostic (7.23e-5)" "unprognostic (1.24e-1)" "unprognostic (6.67e-2)" "unprognostic (1.83e-2)" "unprognostic (8.42e-2)" "unprognostic (4.87e-2)" "unprognostic (4.01e-1)" "prognostic favorable (1.94e-6)" "unprognostic (3.46e-2)" "unprognostic (2.34e-1)" "unprognostic (4.03e-2)" "unprognostic (4.80e-2)" 2.1 1.7 16.8 0.8 22.6 0.0 7.3 6.1 24.1 2.8 3.1 2.3 1.9 2.4 1.8 3.1 5.1 7.9 1.1 0.2 12.2 8.1 7.0 4.7 5.5 0.3 3.6 12.9 0.2 11.3 0.0 7.3 2.7 8.7 4.6 2.8 1.4 12.7 3.3 0.1 1.2 2.0 0.6 1.5 1.5 4.7 1.2 3.7 0.0 8.5 0.0 0.5 2.3 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 7.8 4.3 0.0 0.5 0.7 3.1 0.6 0.3 0.0 0.0 8.2 2.9 5.1 1.5 0.0 0.2 0.8 0.0 2.9 0.0 0.0 0.2 0.0 0.0 8.5 0.0 0.0 1.7 0.2 1.5 0.0 0.0 1.1 0.0 0.1 0.0 16.9 1.6 9.7 0.0 0.0 3.3 7.4 0.3 0.0 7.7 7.6 3.9 15.6 2.5 1.0 0.0 6.2 0.0 3.6 12.0 0.0 0.0 0.1 1.2 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.8 22.6 6.1 24.1 12.2 8.1 3.6 12.9 8.7 3.7 38.7 14.2 0.0 2.7 0.0 16.0 2.4 10.2 20.1 5.7 7.0 0.0 9.5 3.3 7.0 1.4 1.0 0.9 0.0 1.9 2.4 0.6 8.4 2.3 19.0 1.0 128.7 0.0 0.0 0.0 1.6 0.0 0.5 5.0 0.0 8.2 5.0 7.6 3.5 0.7 8.7 0.9 0.0 1.4 0.6 0.7 0.5 12.2 0.0 5.2 3.8 SHD ENSG00000105251 "Src homology 2 domain containing transforming protein D" Q96IW2 19 4278601-4290724 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "blood: 14.8;brain: 23.1;heart muscle: 17.3" "Group enriched" "Detected in some" 5 "Enterocytes: 82.3;Hepatocytes: 45.0;Mucus-secreting cells: 54.3;Paneth cells: 66.4;Undifferentiated cells: 41.3" "Cancer enhanced" "Detected in some" "glioma: 11.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 148 "plasmacytoid DC: 14.8" "Lineage enriched" "Detected in single" 148 "dendritic cells: 14.8" "Group enriched" "Detected in some" 46 "RH-30: 19.2;SH-SY5Y: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017955 Uncertain Uncertain "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA017955: AB_1856828" "unprognostic (2.41e-3)" "unprognostic (7.68e-3)" "unprognostic (4.77e-3)" "unprognostic (3.67e-2)" "unprognostic (3.48e-2)" "unprognostic (3.42e-1)" "unprognostic (6.53e-2)" "unprognostic (1.43e-1)" "unprognostic (5.93e-2)" "unprognostic (3.73e-1)" "unprognostic (2.47e-2)" "unprognostic (3.76e-1)" "unprognostic (3.48e-1)" "unprognostic (1.21e-1)" "unprognostic (5.21e-2)" "unprognostic (9.69e-2)" "unprognostic (8.16e-4)" 0.5 0.7 4.0 1.4 2.5 1.2 0.4 4.1 23.1 0.4 0.9 2.4 0.0 0.7 0.4 0.4 0.4 0.4 0.6 17.3 3.3 4.5 0.4 1.7 0.5 1.2 4.7 2.3 0.4 0.5 0.4 0.2 0.4 6.1 0.5 0.7 0.0 0.5 0.4 0.8 0.4 0.6 0.4 2.5 0.6 0.4 0.5 1.1 0.0 0.4 0.0 0.8 0.5 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.1 62.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 4.0 2.5 4.1 20.4 3.3 4.5 4.7 2.3 6.1 1.1 0.0 0.0 0.0 0.0 0.0 1.3 7.5 0.0 0.0 0.0 0.0 0.0 1.4 1.7 0.0 0.1 0.0 82.3 0.0 0.0 0.4 0.0 0.0 9.2 45.0 0.3 9.5 12.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 54.3 0.4 0.0 66.4 0.0 0.0 0.2 0.0 0.0 0.0 2.7 0.0 3.7 0.0 41.3 0.0 SHISA6 FLJ45455 ENSG00000188803 "Shisa family member 6" Q6ZSJ9 17 11241263-11564063 "Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;cervix, uterine: 22.4" "Group enriched" "Detected in some" 4 "Late spermatids: 9.9;Peritubular cells: 27.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "OE19: 34.1" "Low region specificity" "Detected in many" HPA023440 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA023440: AB_1848945" "unprognostic (1.70e-1)" "unprognostic (2.78e-2)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "prognostic unfavorable (8.41e-4)" "unprognostic (3.11e-2)" "unprognostic (1.71e-1)" "unprognostic (8.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (9.63e-2)" "unprognostic (1.27e-1)" "unprognostic (2.40e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (4.20e-2)" "unprognostic (2.47e-2)" 2.2 0.7 5.8 0.6 5.5 0.2 1.2 9.8 7.5 22.4 0.9 2.5 1.9 0.4 4.2 2.4 0.9 1.7 0.5 1.1 12.1 9.9 2.5 0.2 1.5 0.2 11.8 2.9 0.6 1.4 6.0 0.0 0.3 13.6 5.9 0.8 0.8 0.2 10.1 1.0 0.5 0.4 1.2 9.6 0.2 6.0 2.9 2.1 0.0 0.7 0.0 0.2 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 34.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.5 9.8 4.9 12.1 9.9 11.8 2.9 13.6 2.1 0.0 0.0 0.0 0.0 0.1 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.1 0.0 1.2 0.0 0.0 9.9 4.6 0.0 1.7 0.0 0.0 0.4 0.0 0.0 27.3 0.0 0.1 0.0 0.1 0.5 1.9 0.1 0.0 0.0 0.0 0.1 SHMT1 "CSHMT, MGC15229, MGC24556, SHMT" ENSG00000176974 "Serine hydroxymethyltransferase 1" P34896 17 18327860-18363563 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 57.8;liver: 108.3" "Cell type enhanced" "Detected in many" 14 "Hepatocytes: 213.8;Proximal tubular cells: 332.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023314, HPA078682" Enhanced Supported Nucleoplasm,Cytosol NA NA 240000 Cytosol Nucleoplasm "HPA023314: AB_1856830, HPA078682: " "unprognostic (4.76e-2)" "unprognostic (1.98e-2)" "unprognostic (5.46e-2)" "unprognostic (3.76e-1)" "unprognostic (2.45e-1)" "unprognostic (8.44e-3)" "prognostic favorable (2.52e-4)" "unprognostic (7.55e-3)" "unprognostic (4.50e-1)" "unprognostic (2.42e-1)" "unprognostic (2.14e-1)" "unprognostic (1.70e-1)" "prognostic favorable (8.54e-6)" "unprognostic (1.70e-2)" "unprognostic (2.66e-1)" "unprognostic (2.57e-3)" "unprognostic (4.04e-2)" 10.9 3.2 2.2 4.9 4.1 2.1 10.4 6.5 3.0 4.6 15.2 5.3 7.3 12.3 2.8 7.4 16.3 3.9 4.0 2.0 2.6 1.8 57.8 108.3 4.3 3.8 3.5 1.9 4.1 3.5 30.1 1.6 2.8 3.6 3.4 3.5 7.2 9.8 8.0 5.7 6.2 15.1 2.3 2.9 8.6 3.9 6.3 3.8 11.1 10.9 10.8 8.7 4.3 6.3 8.6 6.7 6.2 10.6 13.0 18.7 7.9 22.6 23.0 7.3 11.4 18.6 11.6 27.0 4.8 5.9 16.1 17.8 22.8 10.1 17.6 14.3 4.1 11.7 22.4 15.2 19.3 9.2 10.5 22.2 7.9 18.0 17.2 4.7 5.2 8.6 9.7 7.6 12.5 5.6 6.5 11.0 22.7 6.6 4.0 5.7 16.7 26.1 7.3 9.1 34.5 7.5 21.4 28.9 14.9 25.6 15.4 10.0 5.3 32.6 6.2 8.2 38.7 25.4 7.5 2.6 3.1 9.3 28.4 15.1 8.2 7.8 7.1 6.1 12.4 7.4 6.0 8.2 6.2 10.1 10.6 17.1 8.6 12.3 12.8 6.7 6.9 12.3 13.0 0.1 13.0 7.5 3.1 18.7 7.9 2.2 4.1 6.5 3.0 2.6 1.8 3.5 1.9 3.6 3.8 11.9 26.5 19.1 16.8 9.2 2.8 2.2 25.5 2.7 9.1 34.9 3.9 17.7 69.6 11.6 4.9 4.3 8.4 0.0 7.0 62.1 4.8 6.6 8.1 213.8 31.1 0.0 1.2 10.4 27.9 4.1 5.5 5.0 11.8 5.4 10.3 31.2 5.1 7.0 2.8 332.8 3.9 19.4 3.8 15.6 21.8 9.3 7.1 10.0 29.5 4.8 SIAH1 hSIAH1 ENSG00000196470 "Siah E3 ubiquitin protein ligase 1" Q8IUQ4 16 48356364-48448402 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 102.6" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 161.7;Syncytiotrophoblasts: 624.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018724 Enhanced Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB018724: AB_2188865" "unprognostic (7.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.88e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-3)" "unprognostic (1.25e-2)" "unprognostic (7.93e-3)" "unprognostic (1.12e-2)" "unprognostic (9.22e-3)" "unprognostic (3.26e-1)" "unprognostic (8.02e-2)" "unprognostic (7.84e-3)" "unprognostic (7.67e-3)" "unprognostic (4.38e-2)" "unprognostic (4.00e-1)" "unprognostic (9.55e-2)" "unprognostic (1.26e-2)" 20.6 11.4 11.9 11.0 13.5 19.2 25.5 15.5 16.6 14.6 13.1 15.0 6.5 12.8 16.8 13.4 12.7 12.9 12.9 11.4 12.6 11.6 12.1 17.5 13.9 10.0 12.8 11.6 16.7 11.4 13.1 9.1 102.6 14.1 14.2 12.2 32.1 13.2 12.1 17.0 16.6 16.0 18.6 12.7 11.3 12.5 17.9 13.0 17.5 14.5 9.3 11.5 15.9 14.8 12.6 8.3 21.9 5.2 5.3 6.1 3.5 8.6 7.8 16.9 15.1 14.6 12.8 17.3 8.1 11.0 12.1 5.9 5.9 11.3 11.2 9.0 10.2 8.4 10.1 11.6 11.8 14.9 4.5 9.4 6.0 6.1 15.4 20.4 5.9 9.3 15.3 21.3 7.0 16.4 13.5 10.1 10.5 9.7 10.7 9.8 5.9 15.9 12.1 20.6 9.6 12.1 18.6 25.4 11.8 11.2 10.9 19.3 17.1 24.0 12.0 20.7 15.2 7.6 13.7 10.7 12.9 11.7 7.0 8.6 14.0 5.8 20.6 9.6 7.4 11.6 6.9 5.2 21.9 2.7 2.2 3.0 12.6 3.0 4.2 8.3 12.1 6.1 4.5 2.9 5.3 1.3 7.9 1.6 3.5 11.9 13.5 15.5 16.6 12.6 11.6 12.8 11.6 14.1 13.0 11.9 11.9 16.4 51.3 76.1 18.3 12.0 10.2 9.4 10.3 15.7 7.9 161.7 26.6 21.4 60.8 27.0 18.8 0.0 19.9 25.3 52.6 43.7 4.6 19.5 29.5 33.4 21.7 28.8 18.3 53.9 21.0 23.2 47.2 38.7 18.3 30.7 19.2 14.4 18.4 21.1 16.5 19.4 37.1 68.6 47.5 66.1 624.0 13.4 16.7 38.7 SIAH3 FLJ39203 ENSG00000215475 "Siah E3 ubiquitin protein ligase family member 3" Q8IW03 13 45777243-45851736 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.2;fallopian tube: 11.8" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 9.0;Ciliated cells: 4.0;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Distal tubular cells: 1.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 0.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 6 "EFO-21: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060576 Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA060576: AB_2684325" "unprognostic (1.07e-3)" "unprognostic (1.26e-1)" "unprognostic (3.00e-2)" "unprognostic (1.14e-1)" "unprognostic (4.96e-2)" "unprognostic (1.00e-2)" "unprognostic (1.05e-1)" "unprognostic (7.53e-2)" "unprognostic (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (4.77e-3)" "unprognostic (3.24e-3)" "unprognostic (9.03e-4)" "unprognostic (2.03e-1)" "unprognostic (2.18e-1)" 0.6 1.3 5.1 0.9 8.3 0.9 0.6 5.6 10.2 4.1 0.6 0.0 0.1 0.8 1.7 2.0 0.6 11.8 0.7 0.6 4.0 2.8 1.7 0.6 0.8 0.8 3.4 6.6 0.7 0.6 0.5 0.4 0.5 8.9 0.6 0.7 2.8 1.7 3.6 0.6 0.8 0.8 0.8 1.3 0.8 0.7 0.8 0.7 0.4 0.6 0.0 0.9 0.7 0.4 0.1 0.1 0.5 0.1 0.2 1.5 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 5.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 1.5 0.7 0.5 0.2 0.0 0.1 0.0 0.0 5.1 8.3 5.6 10.2 4.0 2.8 3.4 6.6 8.9 0.7 0.0 0.0 0.0 0.0 0.0 9.0 0.3 0.0 4.0 0.0 1.8 2.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SIGLEC11 ENSG00000161640 "Sialic acid binding Ig like lectin 11" Q96RL6 19 49948985-49961172 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "lymphoid tissue: 11.3;ovary: 36.6" "Cell type enhanced" "Detected in some" 16 "Distal tubular cells: 16.6;Hofbauer cells: 6.3;Ito cells: 8.6;Kupffer cells: 19.6" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 15 "HEL: 15.4" "HPA052132, HPA060278" Approved Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA052132: , HPA060278: AB_2684240" "unprognostic (1.07e-1)" "unprognostic (2.85e-3)" "unprognostic (1.56e-1)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (3.35e-2)" "unprognostic (9.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" "unprognostic (2.06e-1)" "unprognostic (3.63e-1)" "unprognostic (1.20e-1)" "unprognostic (8.79e-4)" "unprognostic (2.11e-1)" "unprognostic (1.41e-1)" "unprognostic (9.95e-3)" "unprognostic (5.38e-2)" 0.4 3.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.1 36.6 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 11.3 1.8 0.5 0.0 0.0 0.3 0.0 0.6 0.5 2.6 3.3 0.8 0.2 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.2 15.4 0.3 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.7 0.6 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.1 0.1 0.4 0.2 0.1 0.3 0.1 0.1 0.2 0.3 0.1 0.0 0.2 0.2 0.5 1.0 2.6 0.1 3.3 0.1 0.5 0.2 0.1 0.5 0.6 0.1 0.2 1.4 0.8 3.3 0.3 0.0 0.3 0.0 1.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.2 6.3 0.0 0.0 8.6 19.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.5 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.5 0.1 0.1 0.0 0.0 0.0 SIGLEC14 ENSG00000254415 "Sialic acid binding Ig like lectin 14" Q08ET2 19 51642553-51646801 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 48.7;bone marrow: 13.3;lymphoid tissue: 21.6" "Cell type enhanced" "Detected in some" 22 "Hofbauer cells: 16.1;Kupffer cells: 31.5;Macrophages: 9.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 25.8;intermediate monocyte: 29.7;myeloid DC: 15.9;neutrophil: 48.7;non-classical monocyte: 21.3" "Group enriched" "Detected in many" 6 "dendritic cells: 15.9;granulocytes: 48.7;monocytes: 29.7" "Cell line enriched" "Detected in some" 4 "HMC-1: 47.5" "HPA014377, HPA014428" Uncertain Uncertain "Vesicles,Plasma membrane" NA NA 18000000 Vesicles "Plasma membrane" "HPA014377: AB_2189277, HPA014428: " "unprognostic (3.05e-1)" "unprognostic (1.75e-1)" "unprognostic (6.47e-3)" "unprognostic (1.60e-1)" "unprognostic (3.83e-2)" "unprognostic (1.50e-2)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (9.77e-3)" "unprognostic (9.28e-2)" "unprognostic (6.73e-2)" "unprognostic (1.02e-1)" "unprognostic (4.28e-3)" "unprognostic (8.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.34e-1)" "unprognostic (1.89e-1)" 1.6 1.6 0.6 13.0 0.5 13.3 0.5 0.0 0.3 0.6 0.6 0.0 0.4 0.0 0.2 1.7 1.0 0.8 0.6 0.6 0.4 1.4 5.1 6.2 1.3 0.1 0.3 0.0 0.1 0.9 0.4 0.4 0.7 0.1 0.0 0.0 4.0 0.9 1.9 21.6 0.7 1.3 0.2 7.0 2.2 0.2 4.9 15.9 48.7 29.7 0.1 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.7 47.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 3.6 25.8 0.4 0.0 29.7 0.0 4.9 0.0 0.0 15.9 4.8 0.0 0.0 48.7 0.1 21.3 2.9 0.0 7.6 0.0 1.4 0.9 0.0 0.0 0.0 0.1 2.5 1.4 0.0 0.0 0.0 0.3 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 16.1 0.0 0.0 0.0 31.5 0.0 0.3 9.8 0.0 1.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SIGLEC8 "MGC59785, SAF2, SIGLEC-8, SIGLEC8L" ENSG00000105366 "Sialic acid binding Ig like lectin 8" Q9NYZ4 19 51450847-51458456 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 63.0" "Cell type enriched" "Detected in some" 4 "granulocytes: 42.8" "Cancer enhanced" "Detected in many" "glioma: 7.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 42 "eosinophil: 63.0" "Lineage enriched" "Detected in single" 623 "granulocytes: 63.0" "Cell line enriched" "Detected in some" 45 "HMC-1: 58.8" HPA012556 Uncertain Uncertain Cytosol NA NA Cytosol "HPA012556: AB_1856869" "unprognostic (1.27e-1)" "unprognostic (1.88e-4)" "unprognostic (1.28e-1)" "unprognostic (6.70e-2)" "unprognostic (2.97e-1)" "unprognostic (1.30e-2)" "unprognostic (7.84e-2)" "unprognostic (2.51e-2)" "unprognostic (2.72e-2)" "unprognostic (2.17e-1)" "unprognostic (1.10e-1)" "unprognostic (4.19e-1)" "unprognostic (8.62e-3)" "unprognostic (7.18e-2)" "unprognostic (6.02e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" 0.6 6.7 5.8 2.4 8.4 0.7 2.3 0.7 7.0 1.4 2.9 7.4 0.0 2.9 1.0 1.1 1.1 1.1 2.7 0.3 8.6 4.8 0.4 1.6 4.1 9.6 8.3 3.6 0.3 0.7 0.7 1.2 0.1 7.5 1.0 2.8 0.1 1.1 0.9 0.3 0.8 4.5 1.5 14.8 9.2 2.1 0.5 6.2 0.6 0.7 0.0 4.1 2.0 0.7 0.0 0.0 63.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 58.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.5 0.1 63.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.8 8.4 0.7 5.6 8.6 4.8 8.3 3.6 7.5 6.2 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 42.8 0.0 0.3 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SIPA1L3 KIAA0545 ENSG00000105738 "Signal induced proliferation associated 1 like 3" O60292 19 37907228-38208372 "Disease related genes, Predicted intracellular proteins" "GTPase activation" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A549: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042072, HPA045480, HPA074988" Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA042072: AB_2677832, HPA045480: AB_2679342, HPA074988: " "unprognostic (4.24e-2)" "unprognostic (1.23e-1)" "unprognostic (1.86e-1)" "unprognostic (5.56e-2)" "unprognostic (9.99e-2)" "unprognostic (1.22e-2)" "unprognostic (1.31e-2)" "unprognostic (5.48e-2)" "unprognostic (3.11e-1)" "unprognostic (6.05e-2)" "unprognostic (3.15e-1)" "unprognostic (5.43e-2)" "unprognostic (9.26e-3)" "unprognostic (6.45e-2)" "unprognostic (4.94e-2)" "unprognostic (5.36e-2)" "unprognostic (1.96e-2)" 6.2 6.2 10.8 15.3 11.9 5.4 10.0 18.1 13.2 9.8 18.3 13.0 13.9 31.1 6.7 6.4 9.0 9.3 7.6 11.1 15.8 7.7 12.4 6.9 10.5 11.4 10.5 7.8 6.0 17.1 7.4 7.8 3.4 8.5 9.7 12.8 11.2 14.1 9.1 11.4 19.0 29.7 6.2 8.7 12.2 16.4 8.1 12.4 11.7 18.2 6.7 20.2 10.0 11.8 4.6 0.9 1.1 3.5 0.9 1.4 0.3 16.8 29.9 3.7 4.7 2.2 2.2 2.5 7.3 6.2 4.8 4.6 10.2 9.8 9.6 6.3 6.2 4.1 3.8 3.4 13.7 5.4 3.2 1.6 2.6 2.8 3.2 4.3 1.8 2.8 1.7 7.2 9.0 19.3 7.2 5.5 2.8 1.9 2.1 8.4 5.2 2.4 2.5 3.0 13.4 8.0 5.3 3.0 1.4 10.7 14.5 8.9 4.8 8.0 13.8 1.1 2.1 9.2 1.7 11.6 8.1 2.8 24.8 11.2 2.8 4.7 3.3 10.4 2.4 10.4 0.2 0.4 1.1 0.5 0.7 0.2 3.0 0.4 0.5 0.2 4.6 0.4 1.4 0.3 0.9 3.5 0.9 0.3 0.3 10.8 11.9 18.1 13.2 15.8 7.7 10.5 7.8 8.5 12.4 6.0 8.5 13.9 4.5 10.6 18.9 5.1 22.9 10.7 10.3 22.7 13.7 1.6 3.3 6.9 4.1 4.5 68.3 0.0 13.1 1.1 2.2 6.5 2.3 20.2 2.9 31.8 24.2 6.2 4.9 6.4 2.0 5.3 5.0 5.4 41.5 2.3 12.5 30.2 1.8 17.1 5.9 6.5 2.8 1.4 4.7 14.1 0.7 3.2 27.0 4.6 SIRPB1 "CD172b, SIRP-BETA-1" ENSG00000101307 "Signal regulatory protein beta 1" "O00241, Q5TFQ8" 20 1563521-1620061 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 137.6" "Cell type enhanced" "Detected in some" 19 "Hofbauer cells: 14.8;Kupffer cells: 35.5;Macrophages: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 137.6" "Group enriched" "Detected in many" 6 "granulocytes: 137.6;monocytes: 43.6" "Group enriched" "Detected in some" 4 "HMC-1: 25.3;NB-4: 33.6;THP-1: 26.0" HPA047463 Uncertain Uncertain Vesicles NA NA 33000000 Vesicles "HPA047463: AB_2680057" "unprognostic (1.88e-2)" "unprognostic (6.19e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (5.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.40e-2)" "unprognostic (7.18e-2)" "unprognostic (4.11e-3)" "unprognostic (9.12e-2)" "unprognostic (6.31e-2)" "unprognostic (4.57e-2)" "unprognostic (2.65e-3)" "unprognostic (5.76e-2)" "unprognostic (2.39e-3)" "unprognostic (5.00e-3)" "unprognostic (1.19e-2)" 23.7 1.8 2.3 18.7 5.4 31.9 1.8 2.7 3.2 1.1 1.4 1.9 0.1 1.0 1.0 0.5 0.9 2.5 7.6 7.2 2.3 1.6 1.5 7.5 19.4 19.5 6.6 0.7 1.9 0.9 0.1 1.5 3.8 3.7 1.2 1.2 1.7 1.8 0.6 0.9 0.9 2.6 2.1 7.2 28.7 1.2 1.2 3.9 2.5 0.9 0.4 2.9 4.1 1.9 0.2 15.2 137.6 43.6 0.7 1.0 19.2 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 3.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 25.3 0.0 0.1 0.1 0.0 3.7 0.2 0.5 0.0 0.1 0.2 0.0 0.0 33.6 0.1 0.0 1.5 0.0 0.0 0.0 5.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 26.0 0.7 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.5 6.1 0.1 0.5 43.6 72.5 0.6 36.3 0.9 0.2 0.6 0.5 15.2 0.2 0.8 0.5 137.6 0.7 29.5 14.5 1.0 19.2 2.3 5.4 2.7 3.2 2.3 1.6 6.6 0.7 3.7 3.9 3.0 6.9 0.5 0.0 0.0 0.2 0.4 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.9 0.0 14.8 0.0 0.0 3.1 35.5 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SKIDA1 "C10orf140, FLJ45187" ENSG00000180592 "SKI/DACH domain containing 1" 10 21513478-21526368 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "thyroid gland: 9.6" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 13.7;Early spermatids: 13.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 23.1;AN3-CA: 5.9;BEWO: 10.7;SH-SY5Y: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039208, HPA040439" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA039208: AB_10795034, HPA040439: AB_10796122" "unprognostic (5.36e-2)" "unprognostic (1.84e-1)" "unprognostic (5.32e-3)" "unprognostic (6.45e-4)" "unprognostic (9.97e-2)" "unprognostic (3.23e-3)" "unprognostic (3.61e-2)" "unprognostic (1.12e-2)" "unprognostic (1.59e-2)" "unprognostic (4.23e-1)" "unprognostic (9.35e-3)" "unprognostic (5.93e-2)" "unprognostic (3.38e-6)" "unprognostic (8.13e-2)" "unprognostic (1.50e-1)" "unprognostic (8.20e-2)" "unprognostic (8.52e-3)" 0.9 1.9 1.9 0.4 3.3 1.7 2.2 3.1 5.9 1.3 1.7 0.0 0.0 0.3 1.0 1.0 0.9 1.7 0.6 5.5 2.5 1.8 4.1 4.3 1.0 0.3 1.4 3.4 4.2 1.5 7.3 1.8 2.5 3.0 1.1 0.6 4.1 2.6 2.0 0.5 2.9 0.5 1.0 1.2 0.4 0.6 4.6 0.3 0.9 9.6 0.7 0.3 1.1 1.1 0.6 0.5 1.5 0.6 0.5 0.3 0.1 0.4 1.0 23.1 5.9 0.5 0.2 10.7 0.5 0.3 0.0 0.0 2.1 0.1 0.2 0.9 0.3 0.1 1.4 2.1 0.4 0.0 0.0 2.6 0.1 1.0 0.2 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.7 0.2 0.4 0.1 0.2 0.1 0.9 0.7 0.1 1.4 0.0 0.0 0.3 0.7 0.0 0.4 0.6 2.5 5.3 0.8 4.0 0.1 2.0 0.4 4.6 0.3 0.2 0.7 0.2 0.5 0.1 0.0 0.3 1.4 0.0 0.2 1.5 0.3 0.5 0.2 0.3 0.3 0.3 0.2 0.2 0.3 0.6 0.3 0.3 1.3 0.5 0.6 0.5 0.2 0.1 1.9 3.3 3.1 5.9 2.5 1.8 1.4 3.4 3.0 0.3 0.0 1.0 0.0 0.8 1.3 13.7 5.2 5.1 0.0 2.3 1.8 0.0 4.6 6.6 0.1 13.5 3.5 0.0 0.0 0.6 3.1 1.7 0.6 1.1 8.9 2.4 1.6 0.0 3.1 1.5 6.6 1.4 0.0 0.0 0.0 0.0 6.8 0.5 0.0 2.1 5.1 4.0 6.5 0.6 4.8 3.2 1.6 2.9 0.0 0.0 0.2 SLC12A1 NKCC2 ENSG00000074803 "Solute carrier family 12 member 1" Q13621 15 48178438-48304078 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Bartter syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "kidney: 143.2" "Cell type enriched" "Detected in some" 5 "Distal tubular cells: 177.4" "Cancer enhanced" "Detected in single" "renal cancer: 1.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "basophil: 1.9;neutrophil: 1.5" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.9" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA014967, HPA018107" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA014967: AB_1854503, HPA018107: AB_1854504" "unprognostic (3.52e-2)" "unprognostic (1.30e-2)" "unprognostic (9.65e-2)" "unprognostic (1.74e-2)" "unprognostic (7.77e-2)" "unprognostic (1.04e-1)" "unprognostic (8.72e-2)" "unprognostic (2.06e-1)" "unprognostic (9.85e-3)" "unprognostic (2.81e-4)" "unprognostic (9.75e-2)" "unprognostic (2.61e-1)" "unprognostic (5.47e-2)" "unprognostic (2.03e-1)" "unprognostic (5.20e-4)" "unprognostic (8.52e-2)" 0.0 0.0 0.3 0.0 1.0 0.0 0.0 1.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 143.2 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.0 0.1 0.0 0.0 0.3 1.0 1.4 1.5 0.1 0.3 0.3 0.4 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 36.6 0.0 0.0 177.4 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SLC12A7 "DKFZP434F076, KCC4" ENSG00000113504 "Solute carrier family 12 member 7" Q9Y666 5 1050376-1112035 "Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Horizontal cells: 265.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 25.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041652 Approved Uncertain Cytosol NA NA Cytosol "HPA041652: AB_10793971" "unprognostic (2.22e-2)" "unprognostic (1.56e-1)" "unprognostic (8.92e-2)" "unprognostic (2.86e-1)" "unprognostic (1.69e-2)" "unprognostic (8.72e-2)" "prognostic unfavorable (2.12e-6)" "unprognostic (1.67e-1)" "unprognostic (1.71e-3)" "unprognostic (4.40e-2)" "unprognostic (4.50e-2)" "unprognostic (3.44e-2)" "unprognostic (1.65e-3)" "unprognostic (1.17e-3)" "unprognostic (1.26e-1)" "unprognostic (3.93e-2)" "prognostic favorable (3.16e-5)" 10.1 6.4 5.7 14.1 7.3 4.3 13.0 2.4 8.3 6.5 11.5 5.6 6.6 28.0 7.2 7.6 4.7 8.9 29.4 27.9 6.1 3.8 20.4 31.3 10.0 10.3 5.8 3.2 8.5 12.4 8.2 11.5 3.8 7.9 10.2 7.0 15.5 10.9 8.7 3.2 7.9 20.3 8.2 4.9 17.9 15.2 14.5 7.4 12.2 13.3 5.5 6.9 7.1 34.5 1.4 4.2 0.5 6.9 2.5 2.7 2.2 2.1 6.0 3.3 10.4 0.5 0.5 5.2 0.1 0.7 0.5 0.0 14.3 3.8 0.0 11.8 0.2 4.1 4.4 2.7 3.6 0.0 13.0 3.6 2.8 7.5 4.9 7.6 0.0 6.3 1.1 0.5 0.0 1.1 0.2 3.3 1.3 4.0 0.1 0.0 6.9 8.4 0.0 7.2 8.4 9.6 25.3 14.4 11.8 4.0 8.7 1.8 2.3 3.2 0.0 3.6 2.1 5.8 1.6 2.8 0.0 3.4 0.0 0.0 0.2 0.0 1.4 0.0 0.4 1.7 0.5 3.4 0.0 2.5 5.4 2.6 1.1 2.4 2.7 4.2 1.4 2.5 2.5 0.0 2.5 6.9 1.8 2.4 2.2 5.7 7.3 2.4 8.3 6.1 3.8 5.8 3.2 7.9 7.4 8.9 17.5 5.4 5.2 6.3 17.7 32.1 40.8 10.7 14.8 27.9 2.0 0.2 1.7 23.0 0.3 14.9 28.8 0.0 15.7 0.3 7.3 14.6 8.1 29.2 15.8 265.4 12.7 9.2 20.4 1.3 3.4 12.2 15.1 1.8 16.5 6.6 28.0 17.5 5.3 26.1 2.9 19.4 7.2 0.7 4.5 5.9 0.2 3.3 14.2 13.2 SLC13A5 "INDY, NACT" ENSG00000141485 "Solute carrier family 13 member 5" Q86YT5 17 6684713-6713567 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 65 "liver: 150.4;salivary gland: 153.9" "Cell type enriched" "Detected in some" 16 "Hepatocytes: 374.3" "Cancer enriched" "Detected in some" 15 "liver cancer: 27.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 61 "Hep G2: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044343 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044343: AB_10961771" "unprognostic (8.46e-3)" "unprognostic (3.89e-2)" "unprognostic (3.24e-2)" "unprognostic (1.75e-2)" "unprognostic (7.33e-2)" "unprognostic (1.07e-1)" "unprognostic (6.79e-2)" "unprognostic (8.79e-3)" "unprognostic (1.32e-1)" "unprognostic (3.23e-1)" "unprognostic (1.26e-3)" "unprognostic (1.30e-3)" "unprognostic (3.78e-11)" "unprognostic (2.42e-2)" "unprognostic (2.46e-1)" "unprognostic (2.05e-2)" "unprognostic (2.04e-1)" 0.2 0.8 1.0 0.1 1.9 0.1 0.2 0.6 2.3 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.3 0.9 0.1 0.1 0.9 0.7 0.4 150.4 0.1 0.2 0.8 1.2 0.3 0.2 0.1 0.2 0.1 0.6 0.1 0.1 0.0 153.9 0.1 0.1 0.1 0.1 0.1 0.2 0.9 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 1.9 0.6 2.3 0.9 0.7 0.8 1.2 0.6 0.0 0.0 0.0 7.0 0.6 0.5 0.2 0.6 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 23.3 0.4 0.1 0.0 0.3 0.0 374.3 0.0 0.0 0.0 15.4 21.0 0.0 0.6 0.3 0.0 0.0 0.0 7.4 9.8 0.0 0.0 0.0 1.4 0.0 0.0 0.9 1.5 0.4 0.1 0.0 0.0 0.2 SLC16A7 MCT2 ENSG00000118596 "Solute carrier family 16 member 7" O60669 12 59596067-59789855 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 34.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 116.7;Cholangiocytes: 104.4;Early spermatids: 85.1;Late spermatids: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 64.5" HPA005911 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA005911: AB_1853659" "unprognostic (1.52e-2)" "unprognostic (9.47e-3)" "unprognostic (9.48e-2)" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (5.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (8.39e-2)" "unprognostic (9.79e-2)" "prognostic favorable (8.85e-5)" "unprognostic (2.19e-3)" "unprognostic (3.11e-1)" "unprognostic (9.35e-2)" "unprognostic (2.45e-2)" 20.1 10.0 2.2 9.2 4.3 4.5 9.2 6.4 8.3 5.4 4.8 1.1 1.1 2.2 8.6 2.7 12.3 4.4 8.9 34.7 2.0 1.9 16.4 5.7 9.4 12.1 3.2 3.3 4.7 13.7 2.2 9.5 2.1 5.5 3.8 3.7 2.7 6.2 2.6 4.2 9.4 4.6 10.5 3.7 16.8 12.8 6.2 2.3 12.8 4.0 8.6 9.4 9.7 8.5 5.8 2.8 0.3 9.1 3.0 7.2 2.4 0.1 2.3 0.5 0.3 10.7 16.3 0.1 9.9 6.4 3.4 3.1 0.2 5.9 5.1 2.3 16.7 3.2 0.5 0.6 1.2 5.2 1.4 0.3 9.2 10.4 0.3 5.6 14.9 0.1 8.4 3.2 0.9 9.8 6.1 1.2 6.2 0.1 11.2 5.5 2.1 4.3 2.2 0.6 1.0 3.1 0.3 0.0 2.4 7.6 14.4 2.6 0.6 0.0 0.2 4.7 0.6 0.3 1.8 0.0 8.1 2.7 14.8 0.3 10.8 0.1 8.6 9.3 0.0 1.3 0.3 2.0 0.0 5.4 3.7 7.2 2.4 4.3 4.8 2.1 5.8 4.9 6.9 0.2 3.0 9.1 2.8 4.8 2.4 2.2 4.3 6.4 8.3 2.0 1.9 3.2 3.3 5.5 2.3 26.8 21.3 14.7 5.7 9.0 23.7 116.7 104.4 24.1 15.9 43.6 9.8 0.2 19.9 46.2 85.1 7.1 0.7 0.0 57.0 0.2 12.5 1.9 9.3 10.5 3.0 7.9 0.0 11.1 27.7 90.6 6.4 8.4 3.3 1.8 24.4 1.3 30.7 0.0 9.6 1.0 5.3 6.5 16.0 4.1 3.0 11.0 0.6 20.8 0.9 2.8 SLC18A2 "SVAT, SVMT, VMAT2" ENSG00000165646 "Solute carrier family 18 member A2" Q05940 10 117241073-117279430 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Disease mutation, Dystonia, FDA approved drug targets, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.3;brain: 28.3;cervix, uterine: 31.2" "Cell type enriched" "Detected in some" 22 "granulocytes: 603.6" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 10 "hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5" "Cell type enriched" "Detected in some" 13 "basophil: 26.3" "Lineage enriched" "Detected in many" 13 "granulocytes: 26.3" "Cell line enriched" "Detected in some" 20 "HMC-1: 91.2" "Region enhanced" "Detected in many" "midbrain: 75.4" "Group enriched" "Detected in all" 5 "midbrain: 143.8;pons and medulla: 34.7" HPA073224 Enhanced Approved Vesicles,Centrosome NA NA "Vesicles, Centrosome" "HPA073224: AB_2732222" "unprognostic (1.49e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (9.00e-2)" "unprognostic (2.85e-1)" "unprognostic (5.33e-3)" "unprognostic (2.23e-1)" "unprognostic (1.71e-2)" "unprognostic (1.40e-1)" "unprognostic (4.55e-2)" "unprognostic (2.00e-1)" "unprognostic (6.06e-3)" "unprognostic (7.94e-5)" "unprognostic (2.95e-2)" "unprognostic (2.31e-1)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" 1.7 13.9 1.7 3.1 2.0 2.0 2.0 1.7 1.6 31.2 2.3 0.5 2.2 1.5 11.2 4.9 3.0 1.1 15.9 1.0 1.9 9.0 1.1 3.3 7.6 1.5 28.3 0.2 9.7 3.7 0.5 1.6 2.1 26.5 10.8 3.4 3.1 1.0 4.0 1.1 5.8 2.5 5.4 2.9 0.5 3.5 1.5 0.3 14.1 0.6 3.4 2.9 3.1 5.4 0.0 2.0 26.3 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.6 0.0 0.0 0.0 0.2 91.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.1 0.0 0.1 0.4 0.0 26.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 2.0 0.0 1.1 1.7 2.0 1.7 1.6 1.9 9.0 28.3 0.2 26.5 0.3 8.9 27.6 0.0 0.0 1.6 0.6 0.2 0.0 1.4 4.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.4 603.6 0.0 0.7 0.0 8.5 11.6 1.8 0.0 0.6 0.6 1.7 0.0 0.0 0.3 0.1 0.0 4.6 0.0 0.7 0.0 0.2 0.2 0.1 2.4 0.0 0.0 0.0 0.0 SLC1A6 EAAT4 ENSG00000105143 "Solute carrier family 1 member 6" P48664 19 14950034-15022990 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 52.1;testis: 23.3" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 12.3;Early spermatids: 29.3;Horizontal cells: 22.3;Late spermatids: 27.3;Syncytiotrophoblasts: 33.4" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 5.2" "Region enriched" "Detected in many" 5 "cerebellum: 52.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 6.6;NTERA-2: 5.4;U-698: 24.6" "Region enriched" "Detected in many" 6 "cerebellum: 152.9" "Low region specificity" "Detected in all" "HPA041505, HPA044066" Enhanced Supported Supported "Plasma membrane,Intermediate filaments" NA NA "Plasma membrane" "Intermediate filaments" "HPA041505: AB_2677520, HPA044066: AB_2678796" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.94e-3)" "unprognostic (8.90e-2)" "unprognostic (6.52e-4)" "unprognostic (1.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.11e-2)" "unprognostic (9.92e-2)" "unprognostic (1.35e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (6.88e-6)" 0.4 0.5 3.2 0.5 9.6 1.2 0.8 52.1 12.8 0.4 0.5 0.6 0.0 0.6 0.8 4.2 0.4 0.5 0.5 0.4 4.8 4.0 0.4 0.5 0.5 0.5 1.6 3.4 0.6 0.9 0.6 0.0 4.3 3.0 0.9 0.6 0.1 0.7 0.9 0.5 9.2 0.5 0.5 1.4 0.7 0.5 23.3 0.9 0.0 0.6 0.0 0.6 0.4 0.0 2.0 0.7 2.2 0.7 0.5 0.6 0.1 0.1 0.1 0.3 0.3 0.2 0.2 0.8 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.2 6.6 0.1 0.1 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.6 0.1 0.5 0.0 0.3 5.4 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.2 0.2 2.6 0.0 1.1 0.3 0.1 0.0 0.3 1.0 0.2 0.1 0.4 0.1 24.6 0.1 0.3 0.1 1.6 0.7 0.5 0.6 0.4 0.4 1.0 0.5 0.3 0.3 2.0 0.6 0.6 2.2 0.5 0.4 0.7 0.3 0.1 3.2 9.6 52.1 6.5 4.8 4.0 1.6 3.4 3.0 0.9 0.0 0.0 0.0 0.6 2.9 12.3 1.6 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 29.3 0.0 0.0 0.0 0.3 8.5 1.0 0.2 0.0 0.0 0.4 22.3 0.0 0.0 0.0 27.3 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.7 0.0 0.3 1.7 1.5 5.9 33.4 0.0 0.0 0.1 SLC23A2 "KIAA0238, SLC23A1, SVCT2, YSPL2" ENSG00000089057 "Solute carrier family 23 member 2" Q9UGH3 20 4852356-5010293 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 55.6" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 215.7;Cone photoreceptor cells: 108.0;Horizontal cells: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052825, HPA059314" Approved Uncertain "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA052825: AB_2681965, HPA059314: AB_2683975" "unprognostic (3.83e-1)" "unprognostic (1.08e-2)" "unprognostic (1.95e-3)" "unprognostic (1.64e-3)" "unprognostic (8.05e-2)" "unprognostic (2.09e-1)" "prognostic favorable (3.35e-4)" "unprognostic (6.22e-3)" "unprognostic (2.08e-1)" "unprognostic (6.36e-3)" "prognostic favorable (7.14e-5)" "unprognostic (1.57e-1)" "unprognostic (1.60e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-1)" "prognostic favorable (6.08e-5)" 6.6 55.6 14.7 6.1 17.5 5.4 6.3 15.9 27.2 8.6 4.6 19.3 4.0 5.0 9.5 7.1 4.6 12.4 7.8 5.4 14.4 14.5 6.0 27.7 7.4 7.2 14.9 16.6 29.4 7.5 15.1 12.5 25.1 16.4 9.0 5.0 22.1 4.2 8.4 2.6 8.5 6.3 7.8 17.5 11.7 7.1 8.5 11.4 5.3 18.6 2.2 7.4 18.7 6.4 4.2 6.0 3.1 2.5 0.8 2.8 2.0 10.7 12.7 17.0 6.4 12.0 6.8 21.7 4.6 6.3 5.4 5.1 6.5 12.3 4.9 5.0 6.4 15.5 10.4 4.7 12.6 10.3 3.0 8.5 6.8 2.2 24.4 6.8 9.5 4.0 5.7 7.3 13.7 8.2 11.5 7.9 8.1 4.6 4.2 7.2 4.0 10.3 5.3 6.0 8.6 7.8 9.6 11.2 7.3 3.0 17.6 5.7 6.4 8.8 9.3 32.7 6.3 5.1 5.6 6.8 12.3 5.7 14.7 8.8 5.9 10.9 13.2 4.3 5.7 19.3 0.0 2.5 0.2 2.8 1.8 2.6 4.2 2.2 2.0 3.6 2.9 2.1 2.1 3.1 0.8 2.1 6.0 1.3 2.0 14.7 17.5 15.9 25.3 14.4 14.5 14.9 16.6 16.4 11.4 6.0 7.4 9.5 4.0 6.5 215.7 5.5 20.4 4.0 13.6 14.0 108.0 3.6 0.0 4.0 3.5 7.7 0.5 0.0 4.7 4.8 8.9 5.5 8.1 58.7 9.5 81.0 6.9 22.1 27.3 7.0 18.7 8.3 15.1 7.2 1.5 26.4 2.9 5.1 27.6 1.3 64.3 12.9 5.6 0.5 9.6 5.4 3.3 7.1 3.1 10.1 SLC25A10 DIC ENSG00000183048 "Solute carrier family 25 member 10" Q9UBX3 17 81712236-81721016 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 51.8" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 37.7;Late spermatids: 65.6;Proximal tubular cells: 75.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 50.4;SK-BR-3: 38.8" HPA023048 Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA023048: AB_2301950" "unprognostic (7.17e-2)" "unprognostic (2.38e-2)" "unprognostic (2.36e-2)" "unprognostic (1.36e-1)" "unprognostic (9.50e-2)" "prognostic favorable (2.56e-4)" "unprognostic (5.66e-2)" "unprognostic (2.11e-1)" "unprognostic (1.78e-2)" "prognostic favorable (8.14e-4)" "unprognostic (6.73e-2)" "unprognostic (1.33e-1)" "unprognostic (6.02e-2)" "unprognostic (6.32e-2)" "unprognostic (2.76e-1)" "unprognostic (2.05e-1)" "prognostic favorable (1.31e-4)" 10.2 4.9 2.7 5.9 3.2 5.2 6.3 3.3 5.2 4.2 9.5 3.9 7.5 13.9 1.3 3.8 12.2 5.4 8.2 4.3 2.1 2.5 21.0 51.8 3.3 4.6 3.7 4.6 2.4 17.4 10.7 2.1 2.1 3.5 5.6 4.4 4.7 16.8 6.6 2.0 5.9 11.2 1.8 4.7 1.6 7.4 21.8 2.5 7.8 3.3 7.7 8.7 4.3 3.4 0.9 0.7 0.0 1.2 3.6 1.9 0.7 14.2 26.4 2.5 12.6 0.9 0.7 5.0 6.0 2.0 7.8 5.9 16.0 6.1 6.4 4.7 1.4 3.8 9.2 3.6 6.3 1.4 4.7 20.4 5.2 16.1 50.4 1.1 11.7 6.4 0.5 3.3 5.5 1.1 1.5 4.5 9.1 8.7 8.1 2.6 26.8 17.1 12.4 2.6 6.0 19.9 13.0 5.4 20.2 6.9 12.9 16.7 11.3 5.7 38.8 1.3 0.7 16.6 6.5 1.9 6.0 19.8 8.7 11.0 5.0 2.5 3.7 2.6 12.4 5.2 0.0 0.9 0.0 0.8 1.2 1.5 0.1 0.5 1.9 0.7 0.9 0.5 0.4 0.0 3.6 0.2 0.4 1.0 0.7 2.7 3.2 3.3 5.2 2.1 2.5 3.7 4.6 3.5 2.5 0.0 2.1 0.0 5.5 0.0 2.9 3.3 17.8 13.4 5.7 14.0 0.0 11.3 21.6 15.4 23.8 0.5 9.3 0.0 20.3 4.7 0.9 3.9 0.0 37.7 6.8 0.0 4.7 3.1 0.3 65.6 2.0 0.3 0.0 1.0 15.4 1.5 9.6 24.6 1.8 75.1 3.8 0.0 0.2 8.4 2.3 0.0 3.5 1.5 28.8 4.3 SLC25A12 Aralar ENSG00000115840 "Solute carrier family 25 member 12" O75746 2 171784370-171999859 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 84.7" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035333, HPA035334" Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA035333: AB_10603028, HPA035334: AB_2674577" "unprognostic (3.24e-2)" "unprognostic (2.52e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (2.65e-2)" "unprognostic (7.27e-2)" "unprognostic (4.21e-3)" "unprognostic (5.23e-2)" "unprognostic (1.39e-1)" "unprognostic (4.96e-2)" "unprognostic (7.76e-2)" "unprognostic (1.13e-1)" "prognostic favorable (2.91e-8)" "unprognostic (8.64e-3)" "unprognostic (2.08e-1)" "unprognostic (1.73e-1)" "unprognostic (2.70e-1)" 6.4 6.7 8.8 6.2 18.2 2.9 9.2 17.9 25.0 10.6 12.2 5.7 5.2 4.2 10.4 7.1 11.5 6.9 5.9 42.4 9.9 13.4 10.7 1.9 5.2 6.5 10.4 12.4 10.0 3.5 16.4 14.7 4.7 15.2 10.6 10.0 11.0 21.7 14.8 84.7 7.6 5.7 14.3 7.1 5.6 9.0 4.3 6.2 5.8 10.1 23.8 8.4 10.0 6.7 6.4 3.6 5.1 4.6 6.6 8.1 2.9 7.2 5.3 5.6 13.0 16.7 18.9 0.1 9.2 15.7 12.6 12.1 2.8 6.8 22.9 6.1 10.8 9.8 9.1 11.8 11.6 15.8 14.0 11.1 10.0 7.7 6.7 6.4 20.0 10.0 16.5 11.5 14.6 4.2 6.8 13.0 9.1 6.9 10.5 8.0 4.4 14.1 8.4 4.5 6.1 7.5 14.7 8.1 11.9 13.2 6.3 7.9 2.5 5.8 13.7 7.3 3.8 5.0 5.9 8.9 10.5 4.6 11.6 6.3 14.2 9.1 23.2 14.5 10.6 7.1 5.1 3.0 1.6 6.5 3.9 7.3 6.4 4.5 6.8 3.6 3.9 6.3 8.1 0.2 6.6 4.6 0.6 4.5 2.9 8.8 18.2 17.9 25.0 9.9 13.4 10.4 12.4 15.2 6.2 0.0 6.0 1.5 11.2 6.2 25.4 94.4 0.0 13.4 22.7 17.4 23.6 6.0 16.6 1.5 2.5 7.0 5.6 23.3 2.9 1.2 7.0 4.3 10.4 0.2 4.0 35.0 13.8 8.6 7.3 1.7 11.5 5.4 15.1 6.4 7.0 18.3 1.3 3.5 23.0 10.9 22.1 12.9 11.8 3.2 9.0 6.8 1.0 8.7 7.4 4.6 SLC25A18 ENSG00000182902 "Solute carrier family 25 member 18" Q9H1K4 22 17563439-17590994 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adipose tissue: 13.1;brain: 49.0;liver: 50.0" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 15.9;Ciliated cells: 28.1;Hepatocytes: 67.6" "Group enriched" "Detected in some" 5 "glioma: 10.6;liver cancer: 11.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 5.7;BEWO: 12.9" "Low region specificity" "Detected in all" HPA068110 Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA068110: " "unprognostic (2.15e-1)" "unprognostic (6.07e-2)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "unprognostic (3.79e-1)" "unprognostic (3.98e-2)" "unprognostic (1.00e-1)" "unprognostic (1.89e-1)" "unprognostic (1.45e-2)" "unprognostic (2.72e-2)" "unprognostic (8.70e-4)" "unprognostic (1.44e-1)" "unprognostic (3.92e-2)" "unprognostic (1.67e-2)" "unprognostic (1.29e-1)" "unprognostic (5.24e-2)" "unprognostic (1.62e-1)" 13.1 2.2 33.2 1.5 28.0 1.2 2.7 7.5 49.0 1.4 1.4 13.3 0.0 1.5 1.7 1.4 1.5 1.7 2.1 2.3 33.3 15.7 1.8 50.0 1.5 1.5 25.6 19.1 1.9 1.8 1.7 0.0 1.3 17.8 4.8 1.3 0.0 1.6 1.6 2.5 1.4 1.4 1.8 14.9 1.9 1.5 3.4 21.6 0.0 1.5 0.0 1.3 1.4 0.0 0.4 0.4 2.1 0.6 0.0 0.5 0.1 0.5 0.9 3.4 0.6 5.7 0.0 12.9 0.4 0.0 0.0 0.0 0.3 0.3 0.3 0.4 0.0 3.7 1.1 0.1 0.0 0.0 0.4 1.4 0.5 0.4 0.8 2.3 0.5 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.6 0.4 0.0 0.6 0.1 0.8 2.9 1.3 2.1 4.2 1.2 0.0 0.1 0.6 1.2 0.5 0.4 0.6 1.0 2.6 3.7 1.4 0.2 0.2 0.5 0.3 0.4 1.4 1.7 0.0 2.7 0.3 0.5 0.0 0.4 2.1 0.4 0.6 0.0 0.4 0.5 0.1 0.3 0.2 0.1 0.3 0.5 0.0 0.2 0.4 0.1 0.1 33.2 28.0 7.5 25.7 33.3 15.7 25.6 19.1 17.8 21.6 26.8 15.9 0.0 0.2 0.0 0.5 1.4 0.0 28.1 12.5 0.0 0.0 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.5 4.6 5.8 67.6 0.2 0.0 0.0 2.5 4.6 0.6 0.9 0.7 0.0 0.0 0.0 1.4 0.0 0.0 2.5 0.6 3.2 0.0 0.0 2.7 4.8 0.1 1.5 0.0 0.0 0.1 SLC25A20 "CAC, CACT" ENSG00000178537 "Solute carrier family 25 member 20" O43772 3 48856931-48898993 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 57.8;liver: 58.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 38.0;Hepatocytes: 55.2;monocytes: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 35.4;RPMI-8226: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016862, HPA029863" Approved Approved Mitochondria,Cytosol NA NA 13000 "Mitochondria, Cytosol" "HPA016862: AB_1857028, HPA029863: AB_10602893" "unprognostic (1.02e-1)" "unprognostic (1.84e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (5.18e-2)" "unprognostic (3.97e-2)" "unprognostic (1.03e-1)" "unprognostic (5.96e-3)" "unprognostic (4.06e-1)" "unprognostic (1.73e-1)" "unprognostic (1.36e-2)" "unprognostic (2.51e-1)" "unprognostic (3.71e-3)" "unprognostic (3.34e-1)" "unprognostic (5.12e-1)" "unprognostic (4.22e-2)" "unprognostic (3.49e-2)" 11.9 13.7 6.7 5.6 7.3 3.4 10.2 3.0 5.6 3.3 19.7 4.7 5.2 25.0 4.7 3.1 3.3 5.0 9.9 37.1 7.3 4.6 16.8 58.3 6.6 4.9 8.5 5.1 2.7 16.8 5.9 5.1 3.3 5.8 5.0 9.1 5.4 7.4 3.7 27.4 4.0 32.2 5.7 5.5 8.8 7.5 4.4 6.6 9.1 5.5 5.5 5.9 4.5 9.8 9.4 33.3 57.8 29.0 17.3 28.4 24.7 1.4 4.5 3.6 5.0 11.5 4.4 0.7 8.0 4.3 5.6 5.8 5.6 6.9 6.6 5.7 12.6 6.8 1.4 8.8 3.5 4.2 16.8 4.2 9.2 7.0 7.1 5.2 9.6 17.8 5.6 4.0 7.5 1.2 2.2 7.2 10.1 8.2 35.4 7.3 3.7 10.5 4.8 1.8 8.1 10.2 3.8 2.1 48.7 6.0 3.5 1.4 5.1 7.4 0.0 4.0 5.2 11.3 4.5 5.8 6.4 1.1 9.3 5.8 13.1 9.1 7.7 9.1 6.8 8.4 13.8 29.0 57.8 28.4 21.0 18.1 9.4 16.1 20.8 27.0 7.8 12.7 21.3 13.5 17.3 21.4 33.3 16.1 24.7 6.7 7.3 3.0 5.6 7.3 4.6 8.5 5.1 5.8 6.6 6.0 2.4 7.5 2.3 1.5 1.1 31.1 7.6 5.3 2.3 0.0 5.9 1.7 3.3 3.2 1.1 3.1 38.0 0.0 3.7 1.9 4.1 2.4 1.1 55.2 15.8 0.0 7.0 9.2 13.2 1.0 9.8 7.5 1.7 40.5 10.8 2.8 4.0 13.5 11.7 12.5 1.1 0.0 2.2 7.1 7.0 1.1 1.0 13.8 12.8 2.0 SLC25A22 "EIEE3, FLJ13044, GC1, NET44" ENSG00000177542 "Solute carrier family 25 member 22" Q9H936 11 790475-798333 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.0;pancreas: 43.0" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 147.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 44.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014662 Approved Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA014662: AB_10600808" "unprognostic (1.01e-2)" "unprognostic (2.12e-1)" "unprognostic (7.28e-2)" "unprognostic (4.68e-2)" "unprognostic (2.09e-3)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (8.67e-3)" "unprognostic (4.19e-2)" "unprognostic (3.70e-1)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.97e-3)" "unprognostic (2.61e-2)" "unprognostic (8.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" 4.9 5.2 23.3 8.3 19.0 5.7 2.7 32.2 45.0 3.5 4.1 3.4 2.5 10.3 3.2 2.3 4.4 5.0 3.8 3.2 27.8 13.2 4.1 14.2 4.6 7.5 9.6 22.8 4.8 43.0 4.0 13.4 4.4 13.5 5.2 2.9 4.6 11.4 4.2 1.1 5.8 8.5 3.3 2.8 5.3 6.8 6.6 2.6 3.5 3.1 3.0 5.1 4.5 2.4 2.5 3.1 4.0 5.7 3.6 7.2 2.3 23.4 15.2 8.9 8.0 3.8 6.8 8.4 11.2 9.4 12.5 7.9 15.0 16.1 7.0 8.4 9.3 14.2 20.8 9.8 13.5 2.8 13.2 18.1 6.4 7.5 9.2 16.2 10.4 10.9 6.8 8.2 9.5 10.2 3.9 5.7 8.3 13.1 11.1 5.5 14.2 10.8 9.8 19.3 14.5 23.4 12.8 4.9 16.6 7.4 3.9 44.3 19.9 6.4 15.5 8.0 1.4 7.5 5.3 5.6 14.0 9.4 6.4 10.5 9.7 5.7 9.0 16.8 9.3 8.3 0.0 2.4 4.0 6.6 5.6 4.2 2.5 4.1 7.2 3.1 2.1 2.5 4.2 1.5 3.6 5.7 0.9 2.2 2.3 23.3 19.0 32.2 37.4 27.8 13.2 9.6 22.8 13.5 2.6 6.0 10.4 2.2 6.3 11.2 147.0 1.8 5.1 2.7 4.5 8.7 31.4 5.9 3.3 22.2 11.5 4.9 7.0 0.0 17.0 8.9 7.4 13.6 2.3 15.3 4.0 41.3 12.5 1.8 1.8 5.6 4.4 2.6 3.3 6.4 7.3 13.4 14.1 7.0 4.6 5.6 29.9 0.0 6.1 1.4 6.3 11.7 2.6 5.2 5.0 8.1 SLC26A6 DKFZp586E1422 ENSG00000225697 "Solute carrier family 26 member 6" Q9BXS9 3 48625723-48635493 "Plasma proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 43.3;Mucus-secreting cells: 32.0;Paneth cells: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048363 Approved Uncertain Cytosol NA NA Cytosol "HPA048363: AB_2680371" "unprognostic (1.54e-1)" "unprognostic (4.94e-2)" "unprognostic (3.34e-1)" "unprognostic (3.15e-2)" "unprognostic (2.15e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.92e-4)" "unprognostic (2.39e-1)" "unprognostic (2.35e-1)" "unprognostic (2.04e-1)" "unprognostic (4.09e-1)" "unprognostic (9.66e-3)" "prognostic unfavorable (1.53e-5)" "unprognostic (1.39e-2)" "unprognostic (1.17e-1)" "unprognostic (1.55e-1)" "unprognostic (3.58e-2)" 5.3 5.7 6.4 12.3 9.8 18.8 5.7 6.8 6.9 6.3 24.8 6.0 7.3 9.7 6.8 7.4 6.5 4.7 6.3 6.7 4.9 3.1 13.6 6.2 7.8 7.4 9.4 3.1 6.7 14.9 6.8 5.8 6.5 9.3 10.2 25.4 7.7 9.6 7.4 8.8 6.7 19.5 6.8 4.8 10.6 19.7 7.7 9.9 7.7 5.5 5.4 6.3 5.1 6.6 0.9 8.8 5.2 10.7 0.5 3.3 4.5 4.5 5.1 7.3 8.2 23.1 11.6 6.2 7.5 9.9 14.6 15.7 9.7 4.2 6.5 2.6 6.4 16.2 6.1 6.8 6.9 4.2 4.8 6.8 5.9 14.5 18.7 16.8 2.8 9.2 15.8 24.8 9.9 7.2 12.6 4.5 6.7 4.5 7.4 3.5 5.4 5.4 14.8 10.4 12.5 9.9 2.8 2.7 7.9 10.7 4.5 1.8 3.5 9.8 12.1 14.1 10.6 6.3 10.5 3.6 6.3 5.3 8.5 17.1 8.8 9.2 2.9 5.3 11.1 15.9 5.2 10.7 2.1 3.1 10.0 2.8 0.9 1.9 2.0 8.8 0.2 1.1 1.6 1.5 0.5 8.9 5.0 3.3 4.5 6.4 9.8 6.8 6.9 4.9 3.1 9.4 3.1 9.3 9.9 3.0 5.1 0.8 2.4 2.9 1.5 6.4 2.5 2.7 1.2 1.8 13.7 7.5 0.0 2.5 1.2 2.9 43.3 0.0 5.6 13.1 4.3 1.9 0.0 4.2 6.2 4.8 19.5 5.5 5.2 0.7 3.4 7.0 5.0 4.6 32.0 2.0 5.2 36.6 8.9 5.1 6.4 0.0 5.7 2.5 5.7 3.0 8.8 3.8 23.5 0.8 SLC28A1 CNT1 ENSG00000156222 "Solute carrier family 28 member 1" O00337 15 84884654-84945796 "Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 25 "intestine: 32.7;kidney: 35.6;liver: 43.8" "Group enriched" "Detected in some" 5 "Hepatocytes: 34.1;Hofbauer cells: 40.6;Proximal tubular cells: 88.5" "Group enriched" "Detected in some" 63 "liver cancer: 10.9;renal cancer: 33.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "A-431: 3.5;BEWO: 2.0;Karpas-707: 1.1;RPMI-8226: 1.6;SK-BR-3: 1.8;SuSa: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019551, HPA056247" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nuclear speckles, Cytosol" "HPA019551: AB_2670187, HPA056247: " "unprognostic (3.81e-2)" "unprognostic (1.60e-1)" "unprognostic (2.22e-1)" "unprognostic (7.49e-2)" "unprognostic (5.08e-2)" "unprognostic (7.08e-2)" "unprognostic (8.68e-3)" "unprognostic (1.82e-1)" "unprognostic (1.98e-1)" "unprognostic (2.18e-2)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (1.35e-1)" "unprognostic (7.42e-2)" "unprognostic (7.72e-3)" "unprognostic (6.65e-2)" "unprognostic (1.55e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 5.0 0.1 0.1 17.3 0.1 1.5 0.1 0.1 0.1 0.5 0.1 0.1 35.6 43.8 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 32.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.5 0.3 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.5 0.0 0.9 0.1 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.1 0.4 0.1 1.8 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 7.6 1.4 0.0 7.0 0.0 0.4 10.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 34.1 40.6 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 88.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 SLC29A2 "DER12, ENT2, HNP36" ENSG00000174669 "Solute carrier family 29 member 2" Q14542 11 66362521-66372214 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.9" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 1.6;dendritic cells: 1.6;T-cells: 4.1" "Cell line enhanced" "Detected in many" "BEWO: 16.7;CAPAN-2: 21.4;K-562: 16.1;T-47d: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018168 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA018168: AB_1857077" "unprognostic (3.20e-2)" "unprognostic (4.50e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (3.37e-1)" "unprognostic (5.08e-2)" "unprognostic (5.64e-2)" "unprognostic (1.60e-1)" "unprognostic (1.96e-1)" "unprognostic (2.09e-1)" "unprognostic (1.76e-1)" "unprognostic (5.28e-2)" "prognostic favorable (2.78e-4)" "unprognostic (2.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.13e-1)" "unprognostic (6.38e-3)" 5.4 1.3 2.5 2.8 3.2 1.2 13.2 10.3 5.1 1.9 4.0 3.1 4.8 5.6 1.2 5.2 2.7 3.0 3.2 9.0 2.9 3.3 6.4 1.5 3.4 2.5 3.3 3.5 1.0 7.8 11.3 5.9 3.3 7.0 4.2 2.3 2.2 6.0 6.3 68.9 1.9 4.3 0.9 1.7 2.0 6.6 0.9 2.0 1.6 4.2 18.0 2.5 1.5 2.2 1.6 1.6 0.2 0.1 0.1 4.1 1.2 5.8 4.4 3.5 0.7 0.3 0.0 16.7 0.2 0.0 0.2 0.3 7.0 21.4 2.6 5.5 0.0 1.1 5.9 3.3 4.2 0.0 0.1 9.6 5.7 5.4 0.5 0.7 9.5 0.1 0.3 1.7 0.6 1.9 1.7 0.3 2.0 16.1 0.0 0.0 12.1 0.7 13.4 10.1 7.3 4.6 0.7 0.0 12.1 8.9 4.4 7.1 3.2 0.3 9.2 0.6 0.4 26.0 2.1 0.0 0.1 5.8 0.1 0.0 0.1 0.3 0.2 0.4 0.2 0.2 0.0 0.1 0.0 3.5 0.0 1.1 0.6 2.2 4.1 0.8 1.6 4.1 4.1 0.2 0.1 0.1 1.6 0.4 1.2 2.5 3.2 10.3 5.1 2.9 3.3 3.3 3.5 7.0 2.0 3.0 4.6 1.4 4.4 0.6 2.5 9.7 5.1 5.3 7.9 14.0 11.8 40.5 3.3 4.3 0.0 0.7 2.1 0.0 5.8 12.3 1.0 2.8 4.6 0.5 3.8 4.8 2.4 0.0 0.6 0.0 0.0 0.0 0.0 1.0 8.5 2.3 3.2 3.5 0.4 0.6 3.3 0.0 2.3 0.1 0.2 0.0 11.3 1.3 10.7 2.5 SLC2A10 GLUT10 ENSG00000197496 "Solute carrier family 2 member 10" O95528 20 46709487-46736347 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 51.5" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 33.5;Hepatocytes: 41.2;Mucus-secreting cells: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 44 "basophil: 13.8" "Lineage enriched" "Detected in single" 44 "granulocytes: 13.8" "Cell line enhanced" "Detected in many" "ASC diff: 19.5;HSkMC: 24.2;OE19: 20.0;SK-MEL-30: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041015 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA041015: AB_2677252" "unprognostic (8.94e-3)" "unprognostic (2.62e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (6.17e-3)" "unprognostic (1.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.80e-1)" "unprognostic (1.83e-1)" "unprognostic (8.06e-2)" "unprognostic (4.94e-3)" "unprognostic (1.70e-1)" "unprognostic (3.63e-3)" "unprognostic (1.25e-2)" "unprognostic (1.05e-1)" "unprognostic (3.00e-1)" "unprognostic (5.96e-2)" 4.7 4.6 2.6 4.3 3.3 0.1 8.7 2.1 3.1 11.4 6.7 2.7 6.7 2.6 5.4 6.6 4.8 5.6 10.2 6.7 3.3 1.4 2.6 51.5 4.8 3.4 2.2 2.0 7.1 22.9 15.0 4.2 8.3 3.8 18.0 8.8 9.8 11.5 11.0 2.1 2.4 3.0 9.7 2.3 1.9 12.4 3.4 1.0 0.8 18.1 4.5 4.6 7.1 5.7 0.0 0.0 13.8 0.0 0.3 0.0 0.0 0.0 0.0 4.7 4.8 19.5 16.7 14.3 9.1 12.4 4.2 5.1 0.3 16.0 0.0 6.9 16.5 0.0 0.1 0.0 0.4 2.0 0.0 0.1 1.3 0.0 7.6 13.8 0.0 0.0 24.2 0.4 2.6 0.0 4.9 1.7 0.0 0.1 0.0 7.2 16.6 0.0 0.4 1.7 20.0 1.2 0.0 0.7 0.0 0.0 4.3 0.0 0.7 1.8 3.0 24.8 3.5 2.3 3.7 1.0 9.1 4.0 7.2 1.1 0.1 0.0 0.0 0.0 0.0 1.9 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.6 3.3 2.1 3.1 3.3 1.4 2.2 2.0 3.8 1.0 6.0 4.6 0.0 6.8 0.6 0.0 2.2 10.2 33.5 11.4 1.8 0.0 1.9 0.0 5.2 0.1 4.1 2.2 0.0 4.9 12.8 11.7 28.1 5.8 41.2 0.9 0.0 3.5 9.2 2.8 0.9 24.5 0.3 1.7 0.0 60.1 5.6 5.1 2.9 16.3 0.7 0.5 12.9 3.9 0.4 0.2 0.9 1.7 0.0 6.6 10.2 SLC2A11 "GLUT10, GLUT11" ENSG00000133460 "Solute carrier family 2 member 11" Q9BYW1 22 23856703-23886309 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 280.8;Rod photoreceptor cells: 194.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 12.0" "HPA042960, HPA071184" Uncertain Uncertain "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA042960: AB_2678241, HPA071184: AB_2686355" "unprognostic (1.31e-1)" "unprognostic (1.14e-1)" "unprognostic (3.69e-2)" "unprognostic (6.97e-2)" "unprognostic (7.93e-2)" "unprognostic (1.32e-1)" "unprognostic (4.24e-2)" "unprognostic (1.60e-3)" "unprognostic (3.53e-1)" "unprognostic (4.89e-2)" "prognostic favorable (3.83e-4)" "unprognostic (2.32e-1)" "prognostic favorable (5.77e-7)" "unprognostic (1.25e-1)" "unprognostic (1.70e-1)" "unprognostic (3.85e-1)" "unprognostic (6.29e-2)" 4.3 7.8 8.5 6.1 15.3 3.5 6.2 22.9 17.0 4.1 4.9 6.4 17.2 3.9 7.7 9.0 2.8 5.0 5.2 8.5 11.0 13.4 19.5 4.9 4.5 7.1 9.5 10.9 6.6 28.8 18.6 14.0 21.0 9.7 7.6 6.0 10.4 6.1 11.4 13.6 4.2 4.8 10.4 9.6 5.3 6.1 4.5 6.2 1.6 9.2 2.4 6.4 4.5 5.3 2.2 4.6 1.5 1.1 1.2 1.6 0.3 2.6 1.3 1.7 7.6 1.6 3.4 0.7 1.6 2.0 1.8 1.3 1.8 1.8 3.4 0.9 2.2 1.6 2.2 3.2 0.9 0.9 2.3 2.9 1.7 2.8 2.6 2.5 1.6 1.8 1.3 3.2 2.7 2.3 8.4 0.7 2.7 0.7 7.6 1.0 2.8 0.3 0.7 2.5 1.7 2.1 4.6 0.2 3.8 5.6 0.7 4.1 2.3 0.8 12.0 2.7 2.1 6.2 0.8 0.5 0.7 1.2 0.7 0.8 7.1 1.9 3.3 1.5 1.2 1.8 1.5 0.4 0.9 0.9 1.1 0.7 2.1 0.8 0.8 0.2 2.2 1.6 1.1 1.2 1.2 0.7 4.6 0.2 0.3 8.5 15.3 22.9 17.0 11.0 13.4 9.5 10.9 9.7 6.2 17.9 12.9 16.6 8.2 2.9 57.0 29.0 7.6 8.1 4.5 24.4 280.8 7.0 11.6 4.7 5.9 3.3 3.4 0.0 4.9 7.6 4.5 8.0 2.3 5.8 5.2 35.0 10.4 4.9 3.1 8.5 8.6 4.2 3.3 2.8 4.9 15.4 3.5 2.9 9.2 20.7 194.1 0.0 6.2 3.9 5.1 2.8 16.7 7.5 7.3 5.4 SLC34A1 "NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2" ENSG00000131183 "Solute carrier family 34 member 1" Q06495 5 177379235-177398848 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 79 "kidney: 94.5" "Cell type enriched" "Detected in some" 16 "Proximal tubular cells: 128.7" "Cancer enriched" "Detected in single" 12 "renal cancer: 1.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Group enriched" "Detected in some" 12 "HEL: 6.7;U-937: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051255, HPA077175" Approved Approved "Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol" Yes NA "Nuclear speckles, Plasma membrane" "Nucleoplasm, Mitotic spindle, Cytosol" "HPA051255: AB_2681409, HPA077175: " "unprognostic (1.17e-1)" "unprognostic (3.33e-3)" "unprognostic (1.49e-1)" "unprognostic (3.49e-2)" "unprognostic (1.56e-3)" "unprognostic (2.28e-1)" "unprognostic (4.50e-2)" "unprognostic (4.43e-3)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (5.95e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.2 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 7.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 SLC35E2B ENSG00000189339 "Solute carrier family 35 member E2B" P0CK96 1 1659529-1692728 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045641, HPA062711" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045641: AB_2679402, HPA062711: AB_2684844" "unprognostic (9.00e-2)" "unprognostic (2.13e-1)" "unprognostic (8.74e-3)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "prognostic favorable (7.64e-4)" "unprognostic (1.18e-1)" "unprognostic (4.09e-2)" "unprognostic (5.70e-2)" "unprognostic (5.83e-2)" "unprognostic (2.04e-2)" "unprognostic (2.20e-1)" "unprognostic (2.92e-1)" "unprognostic (2.68e-2)" "unprognostic (6.61e-2)" "unprognostic (2.54e-2)" "prognostic favorable (5.15e-4)" 7.4 9.7 11.3 5.8 9.3 6.4 14.2 15.5 14.5 8.1 15.4 9.7 15.4 12.5 10.2 10.5 6.8 9.0 9.8 5.0 11.7 7.5 7.7 14.2 8.6 18.8 10.0 8.5 15.0 16.6 6.5 14.4 11.0 9.2 9.7 7.3 8.7 12.1 10.2 10.4 10.5 12.1 13.6 7.1 12.8 8.2 3.9 12.6 8.5 9.8 7.2 10.2 7.3 13.0 4.8 8.7 6.8 3.9 4.5 9.5 5.0 6.1 7.7 27.5 19.4 15.4 14.7 6.9 3.4 8.0 4.0 4.1 3.5 8.4 8.3 12.4 16.4 9.9 4.5 10.9 5.9 3.5 11.7 10.3 12.3 13.7 9.9 15.3 11.6 10.0 13.7 13.8 10.7 12.0 21.4 16.8 16.0 14.6 14.9 9.3 3.8 15.2 13.2 9.5 5.1 9.1 12.7 5.8 14.4 9.9 3.4 18.6 23.8 12.7 11.2 20.1 12.5 9.0 15.8 12.4 11.5 6.1 4.9 4.1 12.5 9.6 17.5 9.1 21.1 8.1 1.7 3.9 3.3 8.3 3.5 8.9 4.3 6.8 9.5 2.8 4.8 8.1 6.7 6.8 4.5 2.5 8.7 6.4 5.0 11.3 9.3 15.5 14.5 11.7 7.5 10.0 8.5 9.2 12.6 11.9 27.0 23.5 6.5 6.5 33.6 15.3 35.7 13.4 27.3 3.5 72.6 11.2 0.0 5.0 0.8 18.6 25.2 0.0 5.3 7.3 19.3 8.4 22.0 18.1 8.9 28.6 24.5 30.1 33.0 1.3 28.1 8.0 11.8 6.4 23.6 12.3 4.8 17.5 25.1 2.2 66.3 6.5 9.5 6.1 15.5 8.4 7.3 30.6 26.7 6.7 SLC35F5 FLJ22004 ENSG00000115084 "Solute carrier family 35 member F5" Q8WV83 2 113705011-113756823 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034828, HPA049229" Uncertain Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA034828: AB_2674350, HPA049229: AB_2680682" "unprognostic (1.59e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (8.37e-2)" "unprognostic (3.87e-3)" "unprognostic (5.62e-2)" "unprognostic (4.73e-3)" "unprognostic (3.94e-2)" "unprognostic (5.68e-2)" "unprognostic (1.19e-1)" "unprognostic (1.63e-2)" "unprognostic (1.93e-2)" "unprognostic (1.77e-1)" "prognostic favorable (1.71e-5)" "unprognostic (1.64e-1)" "unprognostic (1.84e-1)" "unprognostic (2.33e-1)" "unprognostic (4.83e-2)" 20.0 46.8 7.9 11.7 9.2 3.6 13.8 10.6 9.0 16.9 18.1 15.0 18.9 14.5 14.2 12.6 20.4 10.7 14.9 20.0 8.2 7.9 44.7 29.5 15.0 12.7 10.4 5.0 19.1 23.6 21.6 20.6 24.6 11.7 16.1 16.5 14.1 23.4 16.9 20.0 15.1 32.4 13.1 9.6 12.6 13.7 12.6 10.3 9.2 33.1 14.6 16.7 14.1 16.7 3.4 6.8 5.8 9.1 6.2 4.3 3.2 9.9 9.4 5.1 2.8 47.8 33.3 15.2 16.5 17.4 10.6 15.8 18.7 18.4 9.3 21.3 21.2 27.1 9.2 9.1 8.6 14.7 3.7 3.7 6.5 6.5 16.5 16.4 9.4 17.7 28.8 11.5 13.5 19.2 16.9 11.2 2.5 8.3 9.1 22.5 6.9 2.8 4.8 5.0 11.7 7.7 3.9 10.3 5.9 37.4 13.5 1.6 3.8 12.2 13.2 9.2 10.2 10.4 5.4 10.0 16.8 8.9 8.7 5.2 6.1 8.1 6.3 13.0 5.3 10.9 5.8 5.4 3.7 2.9 8.0 3.8 3.3 2.6 3.1 6.8 3.4 2.9 2.1 4.3 6.2 9.1 3.0 4.3 3.2 7.9 9.2 10.6 9.0 8.2 7.9 10.4 5.0 11.7 10.3 20.8 16.6 2.4 27.7 22.6 10.8 21.0 22.9 20.1 28.4 69.8 21.6 39.1 10.0 25.8 21.3 12.6 39.7 0.0 25.0 60.1 22.6 31.6 24.2 22.1 24.5 4.8 13.9 10.4 14.3 11.0 11.5 11.2 8.5 19.0 23.1 20.9 21.3 26.6 13.1 35.7 17.6 0.0 12.2 42.6 11.7 29.6 55.5 10.4 21.3 29.8 SLC38A2 "ATA2, KIAA1382, SAT2, SNAT2" ENSG00000134294 "Solute carrier family 38 member 2" Q96QD8 12 46358189-46372867 "Predicted membrane proteins" "Amino-acid transport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Basal keratinocytes: 993.3;Suprabasal keratinocytes: 942.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 135.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035180 Approved Uncertain Vesicles NA NA Vesicles "HPA035180: AB_10669901" "unprognostic (6.61e-3)" "unprognostic (2.87e-2)" "unprognostic (4.88e-2)" "unprognostic (2.51e-2)" "unprognostic (2.96e-1)" "unprognostic (1.00e-2)" "unprognostic (7.78e-2)" "unprognostic (5.50e-3)" "unprognostic (1.20e-1)" "unprognostic (3.79e-1)" "unprognostic (9.24e-3)" "unprognostic (1.75e-1)" "unprognostic (1.47e-1)" "unprognostic (5.08e-2)" "unprognostic (3.80e-1)" "unprognostic (1.83e-1)" "unprognostic (8.68e-2)" 44.7 45.4 19.9 23.3 34.5 27.0 72.0 34.5 40.6 36.2 25.5 23.6 20.0 11.6 45.2 16.2 47.1 36.6 46.8 39.2 24.2 14.0 27.4 102.9 51.9 34.5 54.4 15.2 49.3 27.3 54.3 16.2 76.6 32.6 25.7 17.8 17.7 36.6 20.3 47.8 69.5 25.1 40.4 60.0 28.6 29.2 19.7 43.8 40.7 32.0 35.6 26.2 36.0 49.3 12.1 24.7 17.9 13.5 30.0 15.3 12.7 8.4 20.0 17.4 47.6 40.5 40.9 12.6 40.1 103.1 35.2 29.1 11.9 16.1 0.0 54.0 68.5 23.5 29.2 12.1 37.3 34.5 6.8 6.8 11.0 24.4 36.6 62.3 8.9 11.7 40.9 81.3 22.2 135.9 86.7 29.8 12.4 10.8 17.1 62.4 10.6 10.9 13.1 14.8 0.0 20.9 9.9 12.9 21.0 21.5 19.1 11.5 9.9 27.1 7.6 24.4 19.7 15.4 20.9 49.0 16.9 13.4 7.2 6.3 19.7 18.6 10.4 16.3 32.4 8.3 17.9 13.5 10.5 14.3 7.8 11.1 12.1 12.0 14.2 20.8 11.9 15.2 15.3 10.5 30.0 10.1 24.7 13.9 12.7 19.9 34.5 34.5 40.6 24.2 14.0 54.4 15.2 32.6 43.8 77.4 94.1 77.1 114.9 993.3 38.3 137.9 99.3 25.4 56.9 54.1 66.8 40.9 5.0 36.4 4.2 142.4 78.6 186.9 43.6 41.4 160.4 157.7 78.7 245.9 47.8 50.9 73.5 233.9 166.5 5.0 243.7 110.6 237.8 20.8 107.5 73.3 64.3 63.0 79.9 22.3 73.5 278.1 220.9 7.2 14.7 942.6 32.2 136.8 67.6 105.8 SLC39A5 ENSG00000139540 "Solute carrier family 39 member 5" Q6ZMH5 12 56230049-56237846 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 77.8;liver: 38.2;pancreas: 101.1" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 110.0;Enterocytes: 260.0;Hepatocytes: 140.6;Mucus-secreting cells: 92.0;Paneth cells: 142.5;Proximal tubular cells: 149.4;Undifferentiated cells: 142.6" "Cancer enhanced" "Detected in many" "liver cancer: 36.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 51 "CACO-2: 22.8;Hep G2: 32.9" "Region enhanced" "Detected in single" "basal ganglia: 0.9" "Not detected" "Not detected" HPA018423 Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA018423: AB_1857154" "unprognostic (5.94e-3)" "unprognostic (8.29e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-7)" "unprognostic (1.73e-1)" "unprognostic (7.79e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (7.33e-2)" "unprognostic (2.93e-3)" "prognostic favorable (5.05e-4)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.96e-4)" 0.2 0.1 0.2 4.1 0.2 0.0 0.2 0.2 0.2 0.2 40.5 0.2 0.2 48.6 0.2 2.3 0.2 0.1 5.9 0.2 0.2 0.1 22.5 38.2 0.2 0.2 0.2 0.2 0.2 101.1 0.0 0.2 0.2 0.2 0.2 9.1 0.2 0.2 0.2 0.2 0.1 77.8 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 22.8 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 32.9 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.1 0.1 0.2 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 2.2 0.0 0.6 0.6 0.2 12.7 0.0 0.0 3.5 110.0 0.0 16.6 0.3 0.4 0.1 260.0 0.0 17.7 0.0 0.1 0.1 0.0 140.6 0.1 0.0 24.3 2.5 1.3 0.0 0.0 0.0 0.0 1.0 92.0 0.5 12.1 142.5 0.0 149.4 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 142.6 0.0 SLC39A6 LIV-1 ENSG00000141424 "Solute carrier family 39 member 6" Q13433 18 36108532-36129385 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 212.3" "Cancer enhanced" "Detected in all" "breast cancer: 361.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042377 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA042377: AB_2677968" "unprognostic (7.60e-2)" "unprognostic (2.27e-2)" "unprognostic (5.50e-3)" "unprognostic (2.58e-3)" "unprognostic (1.02e-1)" "unprognostic (4.87e-3)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (1.18e-1)" "unprognostic (3.19e-1)" "unprognostic (4.50e-2)" "unprognostic (7.63e-3)" "unprognostic (2.16e-1)" "unprognostic (4.74e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" 11.1 12.6 14.3 8.6 13.4 4.3 63.5 19.4 14.7 15.7 8.7 16.0 68.7 4.1 24.7 24.5 9.8 27.7 10.3 8.2 14.2 17.5 12.3 7.7 7.9 8.2 18.3 8.7 30.5 15.5 32.1 23.9 52.5 16.0 55.2 5.9 25.1 15.5 51.5 7.7 22.6 5.7 12.7 21.7 11.2 8.1 9.9 13.5 8.0 15.7 10.7 11.3 23.8 20.2 12.6 25.2 22.2 14.6 12.9 15.6 9.7 10.4 13.2 31.7 18.6 33.5 24.8 8.3 28.5 33.8 19.1 22.5 7.3 11.6 11.3 14.4 27.4 13.3 25.5 27.6 26.7 29.1 25.1 10.0 4.9 18.6 10.6 21.3 16.5 12.4 22.6 59.1 29.0 25.3 17.6 2.8 9.4 2.5 22.8 26.8 16.0 16.2 3.7 7.6 5.7 7.5 16.8 18.1 14.8 21.3 35.2 33.4 29.4 35.1 10.3 48.1 13.6 14.0 7.8 4.6 46.7 7.8 8.8 14.3 21.5 20.8 8.6 16.1 11.7 24.5 19.5 9.8 22.2 13.0 14.6 15.6 12.6 11.1 11.5 12.2 12.3 9.8 14.2 7.5 12.9 13.7 25.2 12.2 9.7 14.3 13.4 19.4 12.4 14.2 17.5 18.3 8.7 16.0 13.5 35.7 16.0 13.7 44.4 40.8 40.2 16.6 10.2 42.8 60.3 40.1 31.4 5.4 1.7 46.8 16.8 10.8 2.8 0.0 32.7 50.5 40.3 212.3 23.1 7.9 18.4 22.3 24.5 7.4 15.6 14.6 34.5 25.1 64.1 24.4 6.7 35.8 34.0 0.0 44.9 13.9 25.8 38.8 37.6 43.4 22.9 65.1 19.9 16.0 4.1 55.4 SLC3A1 "ATR1, CSNU1, D2H, NBAT, RBAT" ENSG00000138079 "Solute carrier family 3 member 1" Q07837 2 44275458-44321494 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cystinuria, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 66.0;kidney: 191.5;pancreas: 36.8" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 256.0" "Cancer enriched" "Detected in many" 7 "renal cancer: 61.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 17 "RPTEC TERT1: 49.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038360, HPA071102" Enhanced Approved "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA038360: AB_2675975, HPA071102: AB_2732171" "unprognostic (1.67e-2)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (1.43e-2)" "unprognostic (6.14e-2)" "unprognostic (9.45e-2)" "unprognostic (2.76e-2)" "unprognostic (1.34e-1)" "unprognostic (3.90e-1)" "unprognostic (8.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "prognostic favorable (3.67e-7)" "unprognostic (6.10e-2)" "unprognostic (1.26e-1)" "unprognostic (3.77e-1)" "unprognostic (1.58e-4)" 0.2 0.1 0.2 0.7 0.2 0.0 0.2 0.7 0.2 0.3 28.4 0.1 0.1 18.8 1.3 4.6 0.2 0.2 17.9 0.1 0.2 0.2 191.5 5.3 0.2 0.1 0.2 0.1 0.2 36.8 0.0 0.2 0.5 0.1 0.3 3.7 0.2 0.1 0.1 0.2 0.2 66.0 0.1 0.2 0.2 0.3 0.5 0.1 0.1 0.2 0.1 0.1 0.2 0.2 4.0 1.3 2.0 1.3 1.6 2.7 0.3 0.0 0.9 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.9 0.2 0.0 0.1 0.2 49.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.1 1.3 1.3 1.0 2.6 1.3 1.9 1.9 2.5 1.4 0.4 4.0 2.5 2.7 2.0 1.6 0.6 1.3 0.9 0.3 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.1 0.1 0.1 3.0 1.0 1.5 0.2 0.0 12.5 0.3 63.7 0.0 0.0 40.1 9.8 0.0 53.0 18.3 10.9 0.0 32.7 0.0 12.6 0.0 0.2 1.4 0.0 2.8 0.1 20.6 0.0 0.6 0.0 3.3 1.1 0.0 0.0 2.8 3.8 1.6 3.4 7.2 0.4 256.0 11.9 0.0 0.1 0.7 0.3 0.1 0.1 0.0 8.0 0.5 SLC3A2 "4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE" ENSG00000168003 "Solute carrier family 3 member 2" P08195 11 62856102-62888875 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Syncytiotrophoblasts: 652.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 132.2;SiHa: 134.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010455, HPA017980" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 210000000 "Plasma membrane" Nucleoplasm "CAB010455: AB_638288, HPA017980: AB_2669723" "unprognostic (1.79e-1)" "unprognostic (9.61e-3)" "unprognostic (3.59e-1)" "unprognostic (7.87e-3)" "unprognostic (2.06e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (2.09e-3)" "unprognostic (2.62e-1)" "unprognostic (4.16e-2)" "unprognostic (2.29e-2)" "unprognostic (3.71e-1)" "prognostic favorable (8.22e-4)" "unprognostic (2.92e-2)" "unprognostic (5.52e-3)" "unprognostic (3.49e-3)" "prognostic unfavorable (1.48e-4)" 28.5 30.8 34.6 23.0 36.8 62.4 30.8 18.7 34.8 26.0 26.8 25.3 30.4 34.3 29.2 41.2 31.2 23.8 19.9 14.7 31.3 27.1 71.4 31.8 33.5 17.8 37.8 24.1 29.9 39.2 138.6 19.3 75.5 32.9 28.3 13.9 52.5 39.0 27.5 32.5 32.1 33.8 19.6 38.0 21.9 28.2 33.4 30.8 13.6 33.7 33.4 22.2 20.6 56.6 16.6 73.9 11.6 36.2 20.3 39.8 37.3 16.4 69.3 7.1 22.0 8.6 6.9 65.6 28.6 11.0 15.0 13.3 66.2 31.2 18.1 31.8 16.8 28.7 57.0 12.9 56.2 8.0 32.9 12.2 13.0 50.5 29.2 79.9 15.2 19.0 15.1 132.2 18.3 56.1 5.5 8.7 39.4 25.0 40.1 9.2 79.2 15.6 19.4 11.8 20.5 23.5 16.2 10.7 35.4 10.5 9.2 12.1 5.8 134.7 50.5 97.2 12.0 18.1 19.9 16.0 15.3 22.8 22.4 20.1 49.9 55.3 57.4 15.0 23.9 43.6 8.5 36.2 11.6 30.1 34.8 39.8 14.4 27.7 30.8 22.1 16.6 23.5 25.2 7.5 20.3 27.6 73.9 26.2 37.3 34.6 36.8 18.7 34.7 31.3 27.1 37.8 24.1 32.9 30.8 44.7 40.7 54.9 229.6 193.7 59.3 10.9 20.4 36.1 40.9 47.1 62.8 187.9 28.2 148.4 23.7 94.0 85.3 93.5 129.2 134.7 88.4 145.6 82.0 22.5 178.6 50.9 80.9 70.6 47.5 19.5 28.1 97.7 212.6 153.3 33.1 212.1 128.6 31.6 28.7 161.8 52.2 6.5 137.2 12.6 29.8 131.6 652.9 75.6 40.7 193.5 SLC40A1 "FPN1, HFE4, IREG1, MTP1, SLC11A3" ENSG00000138449 "Solute carrier family 40 member 1" Q9NP59 2 189560579-189583758 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 126.4;lymphoid tissue: 170.2" "Group enriched" "Detected in many" 5 "Kupffer cells: 1044.2;Syncytiotrophoblasts: 2060.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 64.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 93.2;CACO-2: 21.3;HEL: 75.5;HMC-1: 19.9;T-47d: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065634 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA065634: AB_2685524" "unprognostic (1.28e-2)" "unprognostic (1.73e-2)" "unprognostic (9.41e-2)" "unprognostic (1.83e-2)" "unprognostic (8.00e-3)" "unprognostic (1.36e-2)" "unprognostic (1.66e-1)" "unprognostic (6.22e-2)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "unprognostic (6.43e-2)" "unprognostic (6.44e-2)" "prognostic favorable (8.55e-5)" "unprognostic (4.66e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.11e-2)" 18.2 126.4 3.9 10.1 5.5 3.9 47.4 1.8 3.5 20.0 25.7 3.7 13.9 34.4 24.7 24.3 6.3 25.9 25.2 37.1 4.1 4.3 14.4 42.1 45.9 170.2 5.1 1.9 50.9 24.0 4.6 9.8 51.3 6.4 18.4 15.8 11.6 10.2 16.6 12.3 4.9 44.7 13.6 5.8 76.4 11.3 16.2 3.5 17.0 20.8 6.4 8.8 11.1 20.4 0.1 22.7 64.7 20.8 0.8 17.3 20.1 0.0 1.3 0.1 0.0 93.2 0.6 4.5 0.0 1.1 0.3 0.5 21.3 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.3 75.5 0.3 7.8 0.3 0.2 19.9 6.5 0.0 0.2 0.0 2.1 2.2 2.9 7.7 0.2 1.1 0.0 3.1 4.9 0.2 16.0 0.3 0.0 0.8 0.4 0.9 3.1 0.1 0.9 0.1 6.2 0.0 7.4 36.8 1.1 0.0 0.1 2.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.3 20.8 32.9 0.4 4.7 0.6 0.0 11.3 1.0 22.7 0.1 17.3 3.7 64.7 0.8 0.4 3.7 1.0 20.1 3.9 5.5 1.8 3.5 4.1 4.3 5.1 1.9 6.4 3.5 116.1 32.3 28.1 45.3 8.1 3.7 37.5 142.7 53.5 39.8 31.4 3.9 335.3 41.4 23.9 6.9 30.8 119.4 70.0 64.9 10.7 46.3 32.2 9.2 223.5 72.3 6.4 17.9 211.8 1044.2 4.7 112.2 26.2 8.5 1.8 50.3 9.6 51.2 77.2 55.2 100.1 43.2 64.7 18.1 5.0 0.9 7.0 2060.1 8.4 30.8 19.7 SLC43A3 "DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1" ENSG00000134802 "Solute carrier family 43 member 3" Q8NBI5 11 57406954-57427580 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 149.9;thyroid gland: 69.0" "Cell type enhanced" "Detected in many" 5 "granulocytes: 63.7;Hofbauer cells: 71.5;Sertoli cells: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 71.0;HMC-1: 62.7;RPMI-8226: 80.1;WM-115: 76.4" "Region enriched" "Detected in many" 4 "olfactory region: 12.7" "Low region specificity" "Detected in all" "HPA030551, HPA077244" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA030551: AB_10604094, HPA077244: AB_2732335" "unprognostic (2.64e-1)" "unprognostic (7.63e-2)" "unprognostic (9.67e-3)" "unprognostic (7.41e-3)" "unprognostic (6.59e-3)" "unprognostic (5.30e-3)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (1.36e-1)" "unprognostic (2.26e-1)" "unprognostic (5.73e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (3.97e-13)" "unprognostic (8.16e-2)" "unprognostic (1.77e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-1)" 32.3 6.3 2.5 12.4 4.3 18.8 16.8 2.2 3.0 11.9 9.6 3.6 2.4 2.7 10.1 6.5 12.6 8.9 11.4 12.5 3.1 1.5 4.2 149.9 16.5 8.8 4.0 1.8 16.0 7.2 1.2 1.8 5.1 3.4 11.6 4.2 9.4 12.2 3.1 15.4 11.0 6.2 10.3 4.7 11.6 6.9 6.8 2.3 10.4 69.0 11.5 13.8 20.3 15.4 2.7 23.6 6.1 36.8 1.1 7.8 14.0 40.0 0.0 2.3 0.0 7.8 11.5 0.1 3.1 13.3 4.6 7.9 0.0 8.8 23.1 1.4 7.3 2.4 23.1 6.7 4.1 9.3 0.1 0.0 36.0 13.7 0.0 15.9 71.0 62.7 34.5 0.1 44.6 0.5 3.3 12.9 10.7 41.1 22.4 17.8 0.0 14.9 45.6 3.5 0.0 0.7 30.9 0.4 80.1 11.0 0.0 5.5 0.0 8.8 0.2 37.4 0.2 3.4 10.8 6.8 0.2 12.0 30.4 8.7 0.0 0.1 5.8 27.5 25.8 76.4 3.2 28.8 6.1 5.7 34.5 6.5 2.7 4.0 7.8 23.6 2.0 3.1 3.2 2.5 1.1 36.8 23.6 6.9 14.0 2.5 4.3 2.2 3.0 3.1 1.5 4.0 1.8 3.4 2.3 14.9 41.4 4.5 6.7 41.6 0.5 2.8 30.6 5.3 34.2 1.8 0.0 0.5 0.0 47.0 1.0 23.3 0.0 0.0 5.5 2.2 20.2 3.4 63.7 53.8 71.5 0.0 0.0 11.6 17.3 1.4 9.2 55.1 28.7 0.0 0.5 0.9 10.9 0.0 11.7 0.0 0.0 64.7 18.4 1.0 0.2 15.4 0.7 15.0 0.6 2.5 SLC4A11 "BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1" ENSG00000088836 "Solute carrier family 4 member 11" Q8NBS3 20 3227417-3239559 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Symport, Transport" "Corneal dystrophy, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 34.4;thyroid gland: 42.7" "Cell type enriched" "Detected in some" 4 "Collecting duct cells: 106.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 1.4;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 36.0;Hep G2: 21.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA018120, HPA058377" Uncertain Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA018120: AB_1857186, HPA058377: " "unprognostic (2.33e-1)" "prognostic favorable (9.03e-4)" "unprognostic (1.18e-2)" "unprognostic (3.05e-2)" "unprognostic (1.00e-1)" "unprognostic (6.52e-2)" "unprognostic (9.66e-3)" "unprognostic (3.73e-2)" "unprognostic (3.10e-3)" "unprognostic (1.52e-3)" "unprognostic (2.94e-1)" "unprognostic (2.64e-1)" "prognostic favorable (6.21e-6)" "unprognostic (7.37e-2)" "unprognostic (4.30e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-3)" 0.8 3.1 3.3 0.8 4.9 0.3 2.4 2.1 2.8 8.6 0.2 1.3 0.8 0.1 0.9 2.0 7.5 1.1 2.2 0.5 3.0 0.6 11.4 0.1 1.3 0.9 1.4 1.1 0.6 0.1 0.4 2.4 0.3 1.8 2.2 0.3 1.1 34.4 5.8 3.5 5.3 0.3 0.2 1.4 0.3 1.9 3.2 1.2 0.2 42.7 3.3 5.1 2.6 2.1 0.0 0.7 0.0 1.4 0.0 1.1 0.4 5.4 7.8 0.9 4.1 2.7 0.7 11.1 2.7 1.7 1.4 0.8 0.5 7.2 0.0 3.2 0.9 3.4 36.0 4.2 8.5 0.2 0.0 1.7 0.3 3.4 21.0 1.7 1.9 7.0 0.3 3.5 1.7 1.6 1.2 3.6 5.0 0.7 5.0 1.4 3.5 0.2 0.2 6.2 6.7 10.6 1.2 5.3 1.7 8.7 15.3 0.4 2.5 1.4 9.0 0.2 2.9 3.4 3.4 6.1 1.1 3.7 0.2 1.3 0.2 0.3 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.7 0.0 0.3 0.0 0.0 0.0 1.4 0.0 1.1 0.4 3.3 4.9 2.1 2.8 3.0 0.6 1.4 1.1 1.8 1.2 0.0 0.0 0.0 1.7 0.7 0.1 1.2 0.0 5.3 2.3 106.4 0.0 0.0 0.0 0.7 3.5 0.3 0.0 0.0 0.4 0.1 0.3 2.0 0.0 0.0 0.3 0.0 0.0 1.8 0.3 1.5 0.0 0.0 0.0 1.0 0.1 0.0 2.2 0.6 0.4 0.3 0.0 25.8 0.5 0.6 5.2 0.4 0.0 0.0 0.0 2.6 SLC4A1AP "HLC3, kanadaptin" ENSG00000163798 "Solute carrier family 4 member 1 adaptor protein" Q9BWU0 2 27663471-27694976 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 127.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036679 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA036679: AB_2675244" "unprognostic (5.63e-2)" "unprognostic (1.01e-1)" "unprognostic (4.62e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (2.21e-1)" "unprognostic (7.89e-3)" "prognostic unfavorable (3.76e-7)" "unprognostic (1.32e-1)" "unprognostic (7.74e-2)" "unprognostic (1.83e-2)" "unprognostic (1.06e-1)" "unprognostic (9.66e-2)" "unprognostic (9.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.42e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.79e-4)" 12.3 16.1 18.8 14.2 27.0 12.7 13.9 27.4 29.0 11.5 11.3 15.8 8.7 11.6 12.8 12.2 14.2 12.3 9.8 18.6 17.9 19.6 15.3 15.0 12.8 14.6 17.0 20.5 15.2 13.3 23.8 16.0 14.5 29.1 12.6 12.3 9.0 12.4 12.1 26.0 15.1 12.0 12.5 15.4 13.1 12.5 29.9 16.8 16.1 14.6 14.9 15.1 11.1 11.0 16.7 13.3 40.8 17.9 22.5 19.5 14.1 22.0 12.9 13.0 12.1 13.4 12.4 19.1 18.4 12.7 19.4 15.9 18.8 16.2 14.0 17.1 14.7 20.5 15.8 20.8 14.2 17.4 19.4 17.0 16.1 13.5 20.6 16.4 22.9 15.4 11.1 18.1 19.3 18.3 16.3 19.7 13.8 23.2 15.3 17.8 13.4 15.4 22.5 13.1 14.6 12.7 12.8 28.5 16.1 19.9 10.3 14.2 14.0 14.3 19.6 17.6 13.8 11.8 15.1 19.9 18.1 16.4 12.5 21.4 25.3 35.7 44.8 19.6 18.5 14.4 40.8 17.7 24.2 17.6 16.9 17.4 13.5 16.1 15.3 13.3 16.7 19.5 16.5 16.5 22.5 17.9 10.7 17.1 14.1 18.8 27.0 27.4 29.0 17.9 19.6 17.0 20.5 29.1 16.8 29.8 21.6 5.2 11.5 10.5 20.1 26.0 12.7 22.7 29.6 17.4 17.7 21.1 5.0 23.4 23.8 18.3 9.7 0.0 31.5 17.0 12.3 7.8 37.0 14.0 21.3 23.8 15.6 12.9 15.8 3.1 16.1 13.3 16.9 27.1 10.6 21.0 27.1 8.6 18.0 12.6 20.2 32.3 10.0 127.5 65.0 10.5 20.4 15.0 8.5 7.6 SLC5A1 "D22S675, NAGT, SGLT1" ENSG00000100170 "Solute carrier family 5 member 1" P13866 22 32043032-32113029 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "intestine: 274.9" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 111.5;Cholangiocytes: 117.2;Early spermatids: 40.8;Late spermatids: 54.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "OE19: 27.0" "Region enriched" "Detected in single" 26 "cerebellum: 8.6" "Not detected" "Not detected" "CAB015467, HPA051805, HPA055106" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Nuclear membrane, Cytosol" "CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "prognostic favorable (2.59e-4)" "unprognostic (3.85e-2)" "unprognostic (2.75e-2)" "unprognostic (1.60e-2)" "unprognostic (2.15e-1)" "unprognostic (9.22e-2)" "unprognostic (4.83e-2)" "unprognostic (6.21e-2)" "unprognostic (9.53e-2)" "prognostic favorable (6.97e-7)" "unprognostic (4.68e-3)" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.45e-2)" 0.2 0.0 0.2 1.3 0.2 0.0 1.5 0.2 0.2 2.2 181.5 0.2 2.9 95.5 0.3 0.8 1.9 0.0 14.1 24.5 0.2 0.0 1.0 0.9 0.3 0.2 0.2 0.2 0.2 0.4 0.0 1.0 0.2 0.2 0.8 1.6 0.2 5.7 3.5 0.2 4.6 274.9 0.2 0.2 0.7 1.2 0.8 0.2 0.2 0.2 3.5 1.5 0.2 2.0 0.3 0.1 0.6 0.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 27.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.8 0.1 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 1.8 0.6 0.0 111.5 117.2 0.0 4.5 0.0 0.0 0.0 0.0 2.4 40.8 0.0 26.1 0.0 1.2 0.0 0.2 19.7 0.0 0.0 0.0 0.0 24.5 0.0 0.0 54.9 1.1 0.0 0.0 0.0 8.7 0.0 0.6 14.7 1.4 1.9 0.0 0.0 0.0 4.2 0.5 4.8 0.0 0.0 19.6 4.8 SLC5A12 "MGC52019, SMCT2" ENSG00000148942 "Solute carrier family 5 member 12" Q1EHB4 11 26667019-26723427 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 60.8;kidney: 90.3" "Cell type enriched" "Detected in some" 18 "Proximal tubular cells: 145.9" "Cancer enriched" "Detected in single" 26 "renal cancer: 9.0" "Region enriched" "Detected in single" 7 "basal ganglia: 1.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 5.2;NTERA-2: 3.8;SuSa: 7.8;T-47d: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA060904 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA060904: AB_2684385" "unprognostic (3.69e-3)" "unprognostic (6.92e-2)" "unprognostic (1.79e-1)" "unprognostic (2.86e-1)" "unprognostic (2.01e-2)" "unprognostic (9.35e-3)" "unprognostic (4.21e-3)" "unprognostic (4.49e-2)" "unprognostic (2.36e-3)" "unprognostic (1.71e-1)" "unprognostic (2.03e-2)" "unprognostic (3.43e-1)" "unprognostic (2.91e-3)" "unprognostic (1.34e-1)" "unprognostic (8.53e-2)" "unprognostic (1.42e-2)" "unprognostic (9.40e-3)" 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.1 0.0 11.3 0.0 0.2 1.7 0.0 18.5 0.0 0.0 0.0 3.4 0.1 0.1 90.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.8 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.8 1.0 0.7 0.9 0.7 0.1 0.4 0.1 0.2 0.6 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.6 0.2 0.6 0.8 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.7 0.1 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.4 5.2 0.1 0.3 0.2 0.5 3.8 0.7 0.1 0.1 0.0 0.6 0.1 1.1 2.0 0.3 1.7 0.2 0.0 7.8 2.8 0.5 0.6 0.4 0.2 0.4 0.2 2.3 0.7 0.2 0.2 0.0 0.0 1.0 0.5 0.1 0.6 0.7 0.4 1.1 0.4 0.4 0.5 1.5 0.7 0.6 0.4 0.9 0.6 0.8 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 3.5 0.0 0.1 8.3 0.0 0.7 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.3 0.0 145.9 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 SLC6A1 "GABATHG, GABATR, GAT1" ENSG00000157103 "Solute carrier family 6 member 1" P30531 3 10992186-11039249 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 56.2;liver: 75.6" "Cell type enhanced" "Detected in some" 16 "Cholangiocytes: 17.8;Hepatocytes: 24.5;Muller glia cells: 41.9;Sertoli cells: 12.9" "Group enriched" "Detected in some" 16 "glioma: 16.1;liver cancer: 24.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013341, CAB022293" Enhanced Uncertain Mitochondria No NA Mitochondria "CAB022293: , HPA013341: AB_1849509" "unprognostic (1.66e-3)" "unprognostic (1.30e-3)" "unprognostic (4.12e-3)" "unprognostic (1.70e-1)" "unprognostic (2.53e-1)" "unprognostic (2.53e-1)" "prognostic favorable (3.20e-4)" "unprognostic (1.05e-1)" "unprognostic (4.27e-2)" "unprognostic (8.26e-2)" "unprognostic (2.90e-1)" "unprognostic (2.69e-1)" "prognostic unfavorable (5.05e-6)" "unprognostic (7.32e-3)" "unprognostic (2.36e-1)" "unprognostic (1.35e-1)" "unprognostic (5.34e-2)" 1.8 2.1 32.2 1.6 31.0 3.0 1.8 15.1 56.2 2.0 1.7 25.4 0.0 1.7 1.9 3.9 4.3 2.4 2.3 3.3 22.2 16.6 2.1 75.6 2.5 1.7 22.7 25.3 2.4 1.4 9.3 1.0 2.0 17.0 2.1 1.8 1.7 1.6 5.0 3.3 1.7 1.7 1.8 13.7 1.9 1.7 4.4 14.3 0.5 1.9 0.0 1.7 1.9 0.9 1.0 0.8 1.2 0.3 0.2 0.8 0.2 0.8 0.6 1.9 1.3 1.5 0.4 1.1 0.7 0.2 0.8 1.1 1.5 1.0 1.6 0.3 0.4 1.8 1.3 2.3 0.9 0.7 0.2 1.8 1.3 4.6 2.8 0.7 2.2 2.3 1.1 0.2 0.2 1.3 0.5 0.3 1.7 1.1 3.7 0.2 1.1 0.7 1.8 0.8 1.2 1.4 1.2 0.2 0.1 0.6 1.8 0.8 0.3 1.0 0.7 0.2 1.1 1.0 1.0 0.3 0.8 0.5 0.7 0.7 1.1 0.3 1.2 0.9 1.7 0.4 0.3 0.3 1.1 0.5 0.1 0.8 0.9 0.6 0.5 0.3 1.0 0.3 0.5 1.2 0.2 0.3 0.8 0.3 0.2 32.2 31.0 15.1 41.5 22.2 16.6 22.7 25.3 17.0 14.3 0.0 0.3 0.0 0.0 0.2 1.8 1.4 17.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 24.5 0.0 0.0 0.0 0.0 1.0 0.2 5.2 0.0 0.0 0.0 0.0 41.9 0.0 0.0 9.6 0.1 3.3 12.9 2.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC6A11 GAT3 ENSG00000132164 "Solute carrier family 6 member 11" P48066 3 10816200-10940733 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 37.0;esophagus: 10.5;skin 1: 11.5" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 7.9;Extravillous trophoblasts: 6.2;Muller glia cells: 21.8;Peritubular cells: 6.3" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 4.7;HaCaT: 12.7;Hep G2: 14.6;hTCEpi: 11.5;NTERA-2: 6.4;SH-SY5Y: 4.4;T-47d: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037981 Supported Supported Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA037981: AB_10671383" "unprognostic (6.04e-2)" "unprognostic (8.01e-2)" "unprognostic (1.21e-7)" "unprognostic (8.60e-2)" "unprognostic (8.68e-2)" "unprognostic (9.72e-3)" "unprognostic (6.39e-3)" "unprognostic (9.77e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (8.78e-2)" "unprognostic (1.51e-3)" "unprognostic (6.06e-2)" "unprognostic (4.44e-2)" "unprognostic (9.83e-2)" "unprognostic (2.31e-2)" 0.8 0.8 11.5 0.7 14.1 0.8 2.9 3.1 23.0 0.9 0.8 5.0 0.0 0.7 1.7 1.1 10.5 1.8 0.7 0.8 8.4 24.5 0.7 0.9 0.8 0.7 37.0 5.9 0.8 1.0 0.7 0.2 1.6 35.4 2.3 0.8 0.4 1.1 0.7 1.0 11.5 0.8 1.0 10.4 1.5 0.7 3.4 9.2 0.0 0.8 0.2 1.1 1.3 0.7 0.5 0.3 1.2 0.4 0.2 0.3 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 12.7 0.0 2.1 0.0 0.0 0.2 0.2 0.0 14.6 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.8 4.4 3.7 0.1 0.0 0.1 4.8 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.5 0.2 0.2 1.2 0.2 0.4 0.3 0.3 0.0 11.5 14.1 3.1 14.7 8.4 24.5 37.0 5.9 35.4 9.2 0.0 0.0 0.0 0.2 1.1 7.9 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.2 0.2 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.0 21.8 0.3 0.0 6.3 0.0 1.3 0.0 0.0 0.2 1.5 3.1 0.8 0.0 0.0 1.5 SLC6A13 GAT2 ENSG00000010379 "Solute carrier family 6 member 13" Q9NSD5 12 220621-262873 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 77.6;retina: 95.9" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 261.2" "Cancer enriched" "Detected in some" 18 "renal cancer: 32.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 10.0;SuSa: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036449, HPA052726" Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Nucleoli, Cytosol" "HPA036449: AB_2675130, HPA052726: AB_2681927" "unprognostic (8.45e-3)" "unprognostic (4.20e-1)" "unprognostic (5.44e-2)" "unprognostic (1.64e-5)" "unprognostic (1.13e-1)" "unprognostic (8.02e-2)" "unprognostic (1.32e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (7.21e-4)" "unprognostic (2.93e-1)" "unprognostic (1.25e-3)" "unprognostic (3.79e-2)" "unprognostic (2.62e-1)" "unprognostic (6.23e-2)" "unprognostic (1.91e-1)" 0.6 0.5 3.0 0.4 5.8 0.5 0.5 2.1 5.8 0.5 0.5 2.5 0.0 1.8 0.5 0.9 0.4 4.2 0.5 1.0 3.1 2.4 77.6 13.2 0.9 0.5 3.4 4.1 0.5 0.4 0.4 1.0 0.5 4.8 0.5 0.5 95.9 0.5 0.5 0.6 0.6 0.8 0.4 5.7 0.5 0.5 1.1 2.1 0.0 4.9 0.0 0.5 0.5 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.3 0.0 0.0 0.1 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 1.3 0.2 0.1 0.0 0.0 0.3 0.0 0.5 0.4 0.4 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 10.0 0.1 0.1 0.0 0.1 0.0 0.9 3.7 0.0 0.0 0.3 0.2 1.0 0.0 0.4 1.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.3 3.0 5.8 2.1 5.8 3.1 2.4 3.4 4.1 4.8 2.1 0.0 1.1 0.5 0.0 0.0 0.2 1.3 0.0 1.4 0.0 17.4 2.0 0.0 41.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 19.7 0.0 0.0 0.0 0.6 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 261.2 0.8 0.0 0.0 0.5 0.5 0.0 0.2 0.0 0.0 0.0 SLC7A10 asc-1 ENSG00000130876 "Solute carrier family 7 member 10" Q9NS82 19 33208664-33225850 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.9;brain: 13.6;breast: 15.6" "Group enriched" "Detected in some" 5 "Muller glia cells: 1.8;Spermatogonia: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 4.3;HHSteC: 2.6;HSkMC: 3.7;THP-1: 8.4;U-2 OS: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041884, HPA057036" Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041884: AB_10794494, HPA057036: AB_2683317" "unprognostic (1.85e-2)" "unprognostic (1.69e-3)" "unprognostic (2.79e-2)" "unprognostic (1.79e-6)" "unprognostic (1.16e-1)" "unprognostic (2.08e-1)" "unprognostic (1.31e-1)" "unprognostic (4.98e-3)" "unprognostic (4.64e-2)" "unprognostic (1.96e-1)" "unprognostic (3.28e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-2)" "unprognostic (1.34e-3)" "unprognostic (8.91e-2)" "unprognostic (3.47e-1)" "unprognostic (2.18e-2)" 40.9 1.0 9.8 1.9 13.6 1.0 15.6 2.4 12.1 1.0 2.2 0.8 0.0 1.0 1.0 1.0 1.0 1.0 1.0 1.1 4.7 6.2 1.3 1.0 1.0 1.2 7.6 5.0 1.0 1.2 1.0 0.0 1.2 9.0 1.0 1.0 8.4 2.3 1.0 1.0 1.1 1.0 1.1 0.8 1.0 1.0 1.4 1.8 0.0 1.4 0.0 1.4 1.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 8.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 9.8 13.6 2.4 12.1 4.7 6.2 7.6 5.0 9.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.0 0.0 SLC7A14 "KIAA1613, PPP1R142" ENSG00000013293 "Solute carrier family 7 member 14" Q8TBB6 3 170459584-170586074 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.4;pituitary gland: 14.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 31.5;Horizontal cells: 27.0" "Group enriched" "Detected in some" 11 "glioma: 0.8;pancreatic cancer: 0.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "LHCN-M2: 7.2;SCLC-21H: 7.2;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045929 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Cytosol" "Nucleoplasm, Plasma membrane" "HPA045929: AB_2679501" "unprognostic (1.00e-1)" "unprognostic (9.56e-2)" "unprognostic (1.03e-1)" "unprognostic (4.15e-2)" "unprognostic (1.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.16e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-1)" "unprognostic (6.68e-3)" "unprognostic (6.36e-2)" "unprognostic (3.03e-6)" "unprognostic (1.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.71e-2)" "unprognostic (3.24e-3)" 1.1 5.8 12.1 1.9 17.7 1.4 1.1 14.9 33.4 1.0 1.8 8.0 0.0 1.6 1.1 1.2 1.1 1.1 1.3 1.1 11.5 12.1 1.3 1.2 1.1 1.1 6.7 12.8 1.3 2.4 1.1 14.5 1.1 11.8 1.2 1.9 0.1 1.1 1.1 1.2 1.3 1.7 1.3 9.0 1.1 1.5 1.3 6.3 0.0 1.1 0.0 1.1 1.1 0.3 1.0 0.6 2.1 0.5 0.7 0.6 0.1 0.0 0.0 0.4 0.1 1.3 2.0 0.1 0.6 0.2 0.8 0.8 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 1.8 0.0 0.1 1.3 0.8 0.2 0.1 0.0 0.2 7.2 0.0 0.0 0.2 1.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 7.2 2.1 0.0 0.1 0.0 0.3 0.1 0.1 1.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 2.1 0.5 0.5 0.4 0.3 0.3 0.8 0.3 0.3 0.1 1.0 0.6 0.5 1.2 0.7 0.3 0.6 0.3 0.1 12.1 17.7 14.9 16.9 11.5 12.1 6.7 12.8 11.8 6.3 3.0 2.1 0.0 0.3 0.3 31.5 0.8 0.0 5.3 4.5 0.0 2.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.5 0.2 2.3 1.0 0.0 27.0 1.7 0.0 0.0 0.4 2.0 0.9 3.3 0.0 0.0 1.8 0.1 0.0 2.5 0.0 3.9 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.1 SLC9A5 NHE5 ENSG00000135740 "Solute carrier family 9 member A5" Q14940 16 67237683-67272190 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5;lymphoid tissue: 14.5" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 15.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-138 MG: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041004, HPA041329" Uncertain Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA041004: AB_10794433, HPA041329: AB_10794373" "unprognostic (8.90e-2)" "unprognostic (9.70e-2)" "unprognostic (3.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.44e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (5.17e-2)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-3)" "unprognostic (4.84e-2)" "unprognostic (9.85e-11)" "unprognostic (9.21e-2)" "unprognostic (1.95e-1)" "unprognostic (8.12e-3)" "unprognostic (9.07e-2)" 1.7 1.7 2.9 1.1 8.8 0.5 1.1 13.5 8.6 0.9 1.4 0.5 3.6 1.3 1.1 3.2 0.6 0.6 1.9 2.3 2.9 3.6 1.1 0.6 2.9 2.1 2.1 2.3 1.4 1.5 0.5 0.6 1.7 4.3 1.0 1.1 0.5 1.0 2.5 1.7 4.2 0.9 0.6 2.7 14.5 0.8 3.3 1.2 0.0 1.0 0.0 1.3 1.6 0.4 1.5 0.8 1.0 0.5 0.6 0.9 0.1 0.5 4.1 3.7 1.2 6.8 4.7 0.4 1.3 5.8 3.4 3.1 0.2 2.9 0.0 0.8 1.6 1.7 0.2 1.0 0.7 1.3 1.2 1.2 3.2 0.3 0.9 0.8 1.4 6.7 5.3 1.4 1.9 0.4 6.3 0.7 1.2 0.7 1.9 2.2 2.3 0.1 0.3 2.5 0.2 0.4 0.0 0.8 0.9 0.6 0.7 2.1 0.9 3.5 0.2 1.8 0.9 1.4 0.3 1.0 8.8 1.4 1.6 0.6 3.6 0.9 1.8 6.3 0.7 2.2 0.0 0.4 0.0 0.0 0.0 0.6 1.5 0.4 0.9 0.1 0.0 0.4 0.4 1.0 0.6 0.5 0.8 0.0 0.1 2.9 8.8 13.5 8.6 2.9 3.6 2.1 2.3 4.3 1.2 3.0 3.2 0.0 0.1 0.6 1.9 1.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.6 0.7 0.0 0.0 0.2 0.1 0.6 0.4 0.0 0.0 0.1 15.9 1.2 2.5 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.3 0.4 0.0 2.1 0.0 0.6 0.0 0.7 1.7 1.1 0.6 0.0 0.0 0.2 0.1 SLFN11 FLJ34922 ENSG00000172716 "Schlafen family member 11" Q7Z7L1 17 35350305-35373701 "Predicted intracellular proteins" "Antiviral defense, DNA damage, Immunity" "Helicase, Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Fibroblasts: 26.8;Hofbauer cells: 27.4;Kupffer cells: 33.5;Macrophages: 35.9;Smooth muscle cells: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 32.5" "HPA023030, HPA062062" Uncertain Supported Nucleoplasm,Cytosol No NA Nucleoplasm Cytosol "HPA023030: AB_1856613, HPA062062: AB_2684673" "unprognostic (1.93e-2)" "unprognostic (2.56e-1)" "unprognostic (3.04e-2)" "unprognostic (1.03e-2)" "unprognostic (3.48e-3)" "unprognostic (1.01e-1)" "unprognostic (5.19e-2)" "unprognostic (1.31e-1)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (9.93e-10)" "unprognostic (1.65e-1)" "unprognostic (5.71e-3)" "unprognostic (6.33e-2)" "unprognostic (8.81e-3)" 20.9 5.3 5.4 10.3 10.0 6.0 24.1 3.2 5.2 15.5 7.3 4.8 10.3 3.0 12.2 24.6 8.1 15.0 9.9 12.6 6.6 2.8 5.5 3.5 20.4 10.4 6.9 2.2 21.3 4.4 2.1 5.0 5.4 8.9 7.8 6.1 8.9 8.3 9.6 6.0 4.1 10.1 10.3 6.7 17.5 6.1 4.2 7.3 18.3 19.0 4.6 12.9 10.9 17.7 3.1 13.0 1.4 18.3 2.0 6.0 5.2 8.1 7.3 0.0 0.0 7.5 21.7 0.1 10.1 7.3 17.5 30.7 0.0 0.0 0.0 0.1 13.2 5.5 4.0 22.7 0.0 21.3 4.6 27.2 17.7 0.0 0.0 9.9 22.8 0.0 8.8 0.2 19.5 0.0 0.0 28.6 13.5 0.0 0.0 2.9 0.0 32.5 18.5 0.1 0.0 0.0 27.6 21.4 0.0 0.2 3.9 0.0 0.0 0.0 3.8 0.0 0.0 6.0 16.5 14.8 4.8 0.1 18.1 15.1 0.7 0.2 0.0 3.6 19.9 10.3 0.4 11.8 1.4 4.3 18.3 6.0 3.1 2.7 3.9 9.2 1.3 2.1 2.9 1.3 2.0 11.4 13.0 3.9 5.2 5.4 10.0 3.2 5.2 6.6 2.8 6.9 2.2 8.9 7.3 0.0 6.9 9.1 0.7 6.6 0.0 2.5 0.0 16.0 3.4 1.8 0.0 0.7 0.0 0.0 1.2 16.1 0.0 0.0 0.5 0.6 26.8 1.1 3.5 0.0 27.4 0.0 0.0 10.4 33.5 1.1 9.5 35.9 11.8 1.0 0.0 0.1 0.1 0.2 2.8 0.0 0.0 6.5 27.9 0.0 0.0 7.4 0.7 20.3 0.0 0.6 SLITRK4 DKFZp547M2010 ENSG00000179542 "SLIT and NTRK like family member 4" Q8IW52 X 143622790-143635777 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 15.7;brain: 21.8" "Cell type enhanced" "Detected in many" 14 "Leydig cells: 46.1;Melanocytes: 20.3;Peritubular cells: 15.2;Sertoli cells: 25.8" "Cancer enhanced" "Detected in many" "renal cancer: 3.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "basophil: 11.4;classical monocyte: 4.7;intermediate monocyte: 3.0;myeloid DC: 3.7;non-classical monocyte: 3.2" "Group enriched" "Detected in many" 67 "dendritic cells: 3.7;granulocytes: 11.4;monocytes: 4.7" "Cell line enhanced" "Detected in some" "HeLa: 8.2;HHSteC: 4.3;LHCN-M2: 3.1;T-47d: 12.5;U-2 OS: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000431 Enhanced Uncertain Microtubules NA NA 320000 Microtubules "HPA000431: AB_2665991" "unprognostic (1.72e-1)" "unprognostic (2.11e-2)" "unprognostic (2.63e-2)" "unprognostic (1.15e-3)" "unprognostic (4.09e-1)" "unprognostic (1.75e-2)" "unprognostic (3.79e-3)" "unprognostic (1.21e-1)" "unprognostic (1.97e-2)" "unprognostic (1.86e-1)" "unprognostic (3.64e-2)" "unprognostic (9.61e-2)" "unprognostic (6.02e-2)" "unprognostic (1.02e-5)" "unprognostic (1.29e-2)" "unprognostic (7.75e-2)" "unprognostic (9.23e-3)" 5.9 15.7 13.6 0.6 12.1 1.7 3.3 21.3 21.8 8.5 1.0 0.2 0.1 0.3 2.1 4.7 1.1 1.1 0.6 3.0 17.0 1.2 5.1 0.8 1.1 0.6 1.2 16.1 6.1 1.5 0.1 0.8 0.7 5.0 2.6 0.6 0.0 1.7 2.3 6.9 3.3 1.0 1.6 2.7 0.9 1.0 1.8 1.7 0.0 1.3 0.0 0.2 1.1 1.1 0.0 3.7 11.4 4.7 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 4.3 0.6 0.8 2.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 1.4 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 4.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.9 13.6 12.1 21.3 21.8 17.0 1.2 1.2 16.1 5.0 1.7 0.0 0.0 0.0 0.5 10.6 1.8 1.0 0.0 0.0 0.0 3.5 0.0 0.0 1.7 0.0 0.2 0.3 0.0 0.0 1.3 0.0 5.1 1.3 0.0 0.0 3.3 0.0 0.0 0.0 6.5 1.5 46.1 4.9 20.3 0.0 0.0 0.0 1.0 0.0 15.2 0.8 0.3 25.8 8.2 0.3 0.6 10.2 0.0 0.0 0.0 0.5 SLX4 "BTBD12, FANCP, KIAA1784, KIAA1987" ENSG00000188827 "SLX4 structure-specific endonuclease subunit" Q8IY92 16 3581181-3611598 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 19.9;testis: 25.0" "Cell type enhanced" "Detected in many" 8 "Rod photoreceptor cells: 10.9;Spermatocytes: 18.6;Spermatogonia: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049421, HPA066238" Approved Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "HPA049421: AB_2680759, HPA066238: AB_2685642" "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-2)" "unprognostic (4.62e-1)" "unprognostic (6.08e-3)" "unprognostic (8.28e-5)" "unprognostic (6.52e-2)" "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.97e-2)" "unprognostic (1.50e-1)" "unprognostic (4.32e-2)" "unprognostic (8.39e-3)" "unprognostic (1.20e-1)" "unprognostic (1.43e-3)" "unprognostic (5.74e-2)" 2.9 3.1 5.3 6.1 8.5 6.0 2.4 19.9 11.8 2.5 2.9 9.8 2.5 4.9 6.5 3.3 3.4 3.0 2.8 2.2 7.4 4.3 2.9 2.7 3.0 8.6 3.8 8.1 2.7 3.1 3.7 8.6 2.6 7.4 3.3 2.2 5.4 3.0 2.6 5.5 4.2 4.0 3.1 3.3 4.8 3.7 25.0 3.2 5.8 2.6 1.0 6.5 3.1 2.7 0.6 0.2 3.0 1.1 0.6 0.6 0.7 3.0 9.3 6.1 7.5 2.3 2.4 6.3 4.8 2.4 5.6 6.2 4.6 3.7 10.9 4.8 2.4 4.3 6.7 4.1 3.4 3.3 9.1 5.1 7.5 6.7 2.9 2.0 7.2 10.6 1.8 2.5 5.2 2.9 1.4 4.0 6.2 7.1 6.0 4.4 5.1 4.4 6.3 5.0 1.8 3.5 8.9 10.0 3.0 2.2 2.1 5.2 4.6 4.2 3.0 1.5 3.3 7.3 5.7 4.7 6.5 9.0 5.5 5.6 5.4 4.2 12.8 2.1 7.4 6.3 3.0 0.4 0.0 0.6 0.5 0.4 0.3 0.3 0.3 0.2 0.6 0.3 0.5 0.5 0.6 1.1 0.2 0.3 0.7 5.3 8.5 19.9 11.8 7.4 4.3 3.8 8.1 7.4 3.2 0.0 2.9 4.5 0.8 0.7 7.7 1.4 2.5 2.7 4.5 0.0 2.0 1.3 0.0 1.4 3.5 1.1 1.5 0.0 2.1 1.5 1.5 0.4 0.0 0.9 2.3 0.0 0.0 1.8 1.6 1.6 2.0 3.2 0.0 1.0 2.2 1.7 1.6 0.0 1.8 0.4 10.9 0.0 1.8 18.6 10.0 0.5 0.8 3.5 1.7 0.5 SMAD6 "HsT17432, MADH6, MADH7" ENSG00000137834 "SMAD family member 6" O43541 15 66702228-66782848 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.1" "Cell type enriched" "Detected in many" 6 "Ito cells: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 21.2;HaCaT: 12.6;HeLa: 17.4;U-2197: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061917 Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA061917: AB_2684637" "unprognostic (1.20e-1)" "unprognostic (7.43e-3)" "unprognostic (5.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.02e-1)" "unprognostic (3.50e-3)" "unprognostic (9.59e-2)" "unprognostic (4.50e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (1.10e-3)" "unprognostic (1.68e-1)" "unprognostic (1.67e-2)" "unprognostic (1.55e-3)" "unprognostic (4.30e-2)" "unprognostic (1.33e-1)" "prognostic favorable (5.45e-5)" 9.8 1.9 2.5 3.1 4.6 0.6 5.1 0.8 2.8 6.3 4.7 2.6 2.1 3.8 5.2 1.9 3.1 4.4 11.6 21.6 3.0 2.0 6.1 6.2 37.1 1.2 3.6 2.3 5.1 3.1 2.3 2.8 13.8 4.5 9.7 2.5 18.5 1.6 22.1 1.8 1.6 3.8 3.1 2.9 3.2 8.0 1.7 2.0 0.0 16.7 0.6 0.8 6.8 7.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.9 7.0 1.1 2.4 4.3 1.1 6.7 4.9 0.1 0.8 0.0 1.4 3.1 0.5 21.2 4.2 0.6 12.6 1.5 0.0 0.1 1.5 5.8 10.9 17.4 1.1 0.5 0.0 0.8 1.4 0.0 0.0 0.0 2.4 0.9 3.6 0.9 0.7 0.3 1.3 0.1 3.0 2.1 7.1 2.6 0.0 1.3 1.5 2.4 5.5 2.6 1.1 2.7 3.0 0.5 4.3 1.0 2.0 4.2 3.1 4.0 12.3 0.9 0.4 1.2 0.2 2.2 3.9 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.5 4.6 0.8 2.8 3.0 2.0 3.6 2.3 4.5 2.0 11.9 5.9 1.4 1.0 0.7 0.0 4.5 5.1 0.0 4.5 1.8 2.0 0.5 3.3 4.3 2.8 19.4 2.8 0.0 5.0 0.7 4.3 1.5 4.6 2.8 1.7 0.0 0.0 107.4 9.5 1.0 2.6 0.8 0.0 1.0 2.0 11.1 5.6 0.0 7.8 1.5 0.3 0.0 1.0 0.2 0.6 0.1 0.7 0.5 5.3 0.3 SMAGP "hSMAGP, MGC149453, MGC149454" ENSG00000170545 "Small cell adhesion glycoprotein" Q0VAQ4 12 51244558-51270890 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.4" "Group enriched" "Detected in many" 9 "Cytotrophoblasts: 1087.3;Syncytiotrophoblasts: 704.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 39.4;OE19: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039711 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA039711: AB_10674985" "unprognostic (2.55e-3)" "unprognostic (2.63e-1)" "unprognostic (3.96e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (5.36e-4)" "unprognostic (3.01e-1)" "unprognostic (1.63e-3)" "unprognostic (6.26e-2)" "unprognostic (7.48e-2)" "unprognostic (9.11e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.46e-1)" "prognostic favorable (2.24e-4)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.99e-2)" "unprognostic (1.52e-1)" 7.5 6.9 0.9 11.3 1.7 0.9 26.3 1.1 1.3 13.1 22.6 0.9 5.3 6.9 8.0 13.6 53.4 3.2 21.8 6.0 1.0 1.0 10.9 4.3 17.6 14.2 1.5 0.4 5.2 14.9 4.6 1.9 50.0 3.0 4.8 24.3 2.6 10.2 6.9 3.6 12.6 8.5 3.4 4.3 11.5 14.1 4.8 0.7 1.2 4.2 28.7 33.1 7.9 24.6 22.5 2.6 8.6 3.7 12.3 9.5 3.5 23.3 7.2 0.8 0.8 3.2 12.7 39.4 18.0 18.1 9.2 5.7 14.2 24.6 0.2 3.2 11.1 3.4 8.3 5.1 6.9 12.9 1.1 4.1 3.1 0.9 4.7 8.9 0.7 3.0 8.2 5.3 19.9 18.0 21.1 22.1 6.0 2.4 1.3 14.8 20.6 3.8 2.8 3.6 47.5 27.9 0.2 0.3 0.8 13.3 5.4 0.9 1.1 3.9 15.8 2.8 9.9 13.6 1.2 7.7 10.3 9.8 0.5 10.9 0.4 0.6 0.4 15.1 7.7 5.5 1.9 3.7 6.4 9.5 2.4 6.1 22.5 4.2 6.9 2.6 17.6 3.9 7.0 8.6 12.3 2.6 1.5 2.7 3.5 0.9 1.7 1.1 1.3 1.0 1.0 1.5 0.4 3.0 0.7 0.0 18.8 28.2 46.4 19.3 1.2 1.1 53.5 8.1 12.5 15.7 0.0 1087.3 41.4 27.1 6.5 53.4 61.6 0.0 95.9 65.5 13.8 46.6 12.7 5.8 83.3 1.6 19.7 38.1 5.4 2.1 12.0 6.7 13.5 5.4 100.2 2.5 97.3 73.7 9.2 15.3 1.2 25.8 8.1 5.2 28.8 26.0 704.6 15.2 97.4 72.3 SMARCA2 "BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2" ENSG00000080503 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2" P51531 9 1980290-2193624 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Hypotrichosis, Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "HDLM-2: 180.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029981, CAB037276" Enhanced Approved "Nucleoplasm,Vesicles,Intermediate filaments" NA NA "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB037276: AB_477083, HPA029981: AB_10602406" "unprognostic (5.34e-2)" "unprognostic (1.99e-2)" "unprognostic (6.27e-2)" "unprognostic (6.53e-2)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (2.62e-1)" "unprognostic (3.97e-1)" "unprognostic (3.60e-3)" "unprognostic (9.64e-2)" "prognostic favorable (1.26e-6)" "unprognostic (3.09e-1)" "unprognostic (2.81e-1)" "unprognostic (8.32e-3)" "unprognostic (8.50e-2)" 23.6 29.6 38.8 21.3 43.6 40.7 30.1 41.6 44.0 23.8 17.3 20.0 38.4 10.3 26.4 30.1 20.4 29.4 22.8 21.2 30.2 30.8 23.4 28.9 20.2 29.5 25.9 32.4 85.0 18.5 104.1 35.0 23.2 24.7 23.2 15.9 22.8 26.1 44.8 41.3 27.0 18.3 26.6 19.7 23.9 15.8 26.5 23.4 20.6 28.0 24.8 27.1 23.7 22.0 9.9 11.3 20.4 8.3 8.6 12.5 4.2 5.4 4.0 3.0 4.3 6.2 7.3 9.0 6.8 5.5 3.1 2.4 0.0 2.2 9.3 2.8 6.2 1.7 2.3 1.6 5.7 2.2 180.9 2.5 25.2 11.1 1.9 2.4 10.5 14.8 4.8 2.2 3.1 5.9 5.7 5.0 4.4 0.8 32.1 5.3 2.2 2.6 8.8 3.0 3.3 1.5 11.8 3.8 8.4 7.3 4.9 1.9 1.7 4.4 1.0 1.9 4.5 2.0 6.8 6.0 5.1 2.5 3.2 3.3 2.9 3.7 4.2 5.6 4.0 1.4 20.4 4.6 13.1 10.3 6.2 9.9 9.9 9.9 10.5 5.6 8.0 12.5 10.0 13.5 8.6 8.3 11.3 10.4 4.2 38.8 43.6 41.6 44.0 30.2 30.8 25.9 32.4 24.7 23.4 68.5 60.6 20.6 16.9 52.1 54.6 85.9 25.5 107.1 55.7 101.2 35.3 80.6 26.6 21.1 24.7 47.7 25.6 0.0 19.4 19.6 52.6 19.1 45.2 54.3 27.1 33.4 35.7 35.0 45.5 17.2 71.1 37.2 47.2 35.1 32.1 44.7 15.3 7.0 81.7 15.9 34.9 12.9 28.8 18.6 13.6 46.0 74.1 47.1 24.0 12.4 SMARCA5 "hISWI, hSNF2H, ISWI" ENSG00000153147 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5" O60264 4 143513463-143557486 "Predicted intracellular proteins, Transcription factors" "Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 285.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005227, HPA008751, HPA074181" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "CAB005227: AB_2191863, HPA008751: AB_1857268, HPA074181: " "unprognostic (9.21e-3)" "unprognostic (7.99e-2)" "unprognostic (4.99e-3)" "unprognostic (8.03e-2)" "unprognostic (8.96e-2)" "unprognostic (3.47e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.85e-2)" "unprognostic (8.84e-2)" "unprognostic (1.99e-1)" "unprognostic (4.19e-2)" "unprognostic (1.32e-1)" "unprognostic (1.87e-2)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (4.20e-2)" "unprognostic (1.82e-1)" 21.0 39.5 24.7 24.8 32.6 34.5 21.9 26.9 29.2 24.0 23.8 27.7 24.6 17.9 27.3 26.3 19.8 23.0 23.8 29.8 25.0 25.1 21.1 21.0 33.3 29.5 30.2 26.5 29.4 24.6 33.1 33.3 27.7 29.6 23.1 22.5 16.3 22.0 25.7 24.6 14.7 22.6 22.9 34.6 28.6 22.8 37.8 32.8 44.3 28.5 15.1 29.7 25.6 23.7 11.7 13.2 15.4 19.4 15.6 16.3 10.6 11.9 9.4 34.6 21.7 20.3 14.7 20.7 15.2 18.1 22.1 18.8 16.0 16.8 32.4 10.5 12.9 8.9 9.5 31.6 14.2 21.5 21.5 11.2 24.2 13.9 13.1 15.0 29.9 14.3 12.9 10.3 15.7 13.5 13.0 17.1 16.6 21.8 20.5 14.4 10.7 34.8 10.4 28.1 20.0 13.5 38.7 22.2 10.5 17.3 14.6 27.7 23.5 19.8 14.0 17.5 27.1 10.1 14.0 18.2 14.7 11.3 15.3 14.9 22.6 27.0 39.4 11.5 25.1 14.9 5.0 10.7 15.4 13.9 12.7 16.3 11.7 14.2 15.0 13.2 11.5 14.9 14.7 9.7 15.6 19.4 10.1 16.1 10.6 24.7 32.6 26.9 29.2 25.0 25.1 30.2 26.5 29.6 32.8 285.9 217.7 44.0 61.8 41.2 94.8 89.1 28.1 137.9 128.5 41.8 60.9 60.5 33.2 66.8 37.7 52.0 32.2 0.0 53.1 58.4 45.4 47.0 98.4 21.7 39.5 81.0 76.6 36.2 50.0 18.9 55.8 51.0 28.7 101.0 33.6 83.9 56.1 32.8 58.4 29.3 110.5 51.8 54.2 117.2 123.0 35.8 85.4 55.4 37.9 62.6 SMG5 "EST1B, KIAA1089, LPTS-RP1, LPTSRP1, RP11-54H19.7, SMG-5" ENSG00000198952 "SMG5, nonsense mediated mRNA decay factor" Q9UPR3 1 156249224-156282825 "Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072651 Uncertain "Cytoplasmic bodies" No No "Cytoplasmic bodies" "HPA072651: AB_2686544" "unprognostic (2.09e-2)" "unprognostic (3.45e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.39e-4)" "unprognostic (3.20e-1)" "unprognostic (4.06e-2)" "prognostic unfavorable (6.70e-9)" "unprognostic (1.28e-1)" "unprognostic (3.21e-3)" "unprognostic (6.90e-2)" "unprognostic (1.82e-2)" "unprognostic (1.71e-2)" "unprognostic (1.23e-1)" "unprognostic (1.42e-2)" "unprognostic (4.28e-1)" "unprognostic (8.77e-2)" "unprognostic (4.26e-2)" 18.0 28.8 30.3 17.9 38.3 34.8 19.7 30.0 40.3 14.2 20.4 38.4 23.6 23.4 19.1 22.6 23.4 21.9 16.6 43.3 28.7 24.4 27.2 30.5 20.7 20.2 45.1 24.1 19.3 21.1 43.1 26.3 22.8 32.5 22.9 19.6 21.3 20.1 22.3 39.4 31.1 23.7 24.5 30.6 22.0 20.8 25.6 44.1 14.5 20.1 13.2 20.8 20.5 24.3 6.2 4.9 9.4 8.5 5.7 8.1 5.3 19.3 17.0 20.8 15.4 20.3 11.6 30.2 20.1 18.1 30.6 26.1 42.8 25.3 17.6 23.7 24.0 24.4 23.5 36.6 25.5 19.9 19.8 30.4 20.4 15.9 23.4 26.4 21.2 20.8 14.6 25.4 29.3 31.4 15.8 19.6 26.4 27.6 17.8 21.4 19.8 17.3 17.3 42.0 35.6 35.7 28.1 15.9 18.7 20.0 23.5 28.1 23.4 25.6 38.1 22.8 28.8 32.8 45.7 16.4 21.3 23.9 22.4 29.2 27.4 6.3 33.0 18.8 21.3 26.9 3.1 6.3 9.4 8.1 8.5 6.8 6.2 6.2 6.0 4.7 6.2 5.4 5.6 8.5 5.7 8.2 4.9 4.0 5.3 30.3 38.3 30.0 40.3 28.7 24.4 45.1 24.1 32.5 44.1 14.9 11.2 17.4 7.2 13.1 11.0 34.0 25.5 8.1 7.9 19.2 31.4 15.0 6.6 11.0 2.1 9.0 29.2 0.0 12.5 8.5 7.3 11.4 12.7 16.3 11.0 17.5 21.8 11.6 12.9 3.2 7.8 7.1 5.0 12.6 19.1 8.5 15.2 16.4 6.7 13.3 11.4 6.5 9.0 7.4 7.4 10.7 14.3 7.1 16.2 10.7 SMIM18 ENSG00000253457 "Small integral membrane protein 18" P0DKX4 8 30638600-30646064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 18.8;pituitary gland: 10.7" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 9.9;Horizontal cells: 4.8;Rod photoreceptor cells: 2.7" "Cancer enriched" "Detected in single" 8 "glioma: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066648 Supported Uncertain Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA066648: AB_2685697" "unprognostic (2.19e-2)" "unprognostic (9.37e-2)" "unprognostic (3.31e-1)" "unprognostic (4.24e-2)" "unprognostic (1.66e-1)" "unprognostic (2.60e-1)" "unprognostic (7.29e-2)" "unprognostic (4.70e-1)" "unprognostic (8.91e-3)" "unprognostic (1.05e-1)" "unprognostic (2.36e-1)" "unprognostic (6.08e-2)" "unprognostic (4.01e-3)" "unprognostic (1.33e-1)" "unprognostic (3.25e-1)" "unprognostic (4.14e-1)" 0.6 3.2 5.2 0.7 6.6 2.7 0.6 18.8 18.7 0.6 0.7 0.4 0.0 0.6 0.7 0.6 0.7 0.7 0.8 0.9 10.9 10.7 2.9 0.7 0.6 0.6 5.7 7.5 0.7 1.8 0.6 10.7 0.6 11.7 0.7 0.8 0.2 0.6 0.6 0.6 0.7 0.7 0.6 4.6 0.7 0.8 0.7 1.4 0.0 0.7 0.0 0.6 0.6 0.0 2.9 4.1 3.0 2.3 0.2 4.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.4 0.0 0.0 0.0 3.0 1.9 1.9 3.7 1.3 3.6 2.9 2.3 2.1 0.9 2.9 3.0 4.3 2.1 0.2 2.3 4.1 2.9 0.3 5.2 6.6 18.8 9.7 10.9 10.7 5.7 7.5 11.7 1.4 0.0 0.0 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM2 "C13orf44, MGC5590" ENSG00000139656 "Small integral membrane protein 2" Q9BVW6 13 44143543-44161257 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 15.9" "Cell type enriched" "Detected in some" 8 "Early spermatids: 36.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 4.4;OE19: 12.1" "Low region specificity" "Detected in many" "HPA026891, HPA077071" Enhanced Uncertain "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA026891: AB_10602924, HPA077071: " "unprognostic (4.34e-2)" "unprognostic (8.70e-2)" "unprognostic (1.07e-1)" "unprognostic (4.87e-5)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (3.26e-1)" "unprognostic (1.26e-1)" "unprognostic (2.32e-1)" "unprognostic (1.85e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.10e-1)" "unprognostic (4.80e-2)" "unprognostic (2.39e-2)" "unprognostic (1.05e-2)" 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.2 0.8 0.9 0.1 2.9 0.1 0.2 0.3 1.2 0.2 0.2 0.9 0.4 0.1 0.0 0.2 0.1 0.7 0.0 0.3 0.2 0.2 0.0 0.6 0.0 1.0 0.1 2.2 0.2 0.2 0.1 0.4 15.9 0.1 0.0 0.2 0.1 0.5 0.0 0.0 0.2 1.8 0.4 0.0 0.9 0.8 0.9 0.2 0.0 0.0 1.1 0.0 4.4 1.0 0.0 1.5 0.2 1.7 1.1 0.0 1.2 2.7 0.0 1.7 1.2 0.0 1.7 0.0 1.9 0.0 1.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.2 1.1 0.0 0.7 12.1 1.2 1.0 0.0 0.2 0.0 0.5 2.3 1.2 3.4 1.5 2.2 1.9 0.0 0.2 0.4 0.0 0.8 1.2 0.2 0.0 0.0 0.7 1.3 0.4 0.8 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.3 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.0 SMPD4 "FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3" ENSG00000136699 "Sphingomyelin phosphodiesterase 4" Q9NXE4 2 130151392-130182750 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046279, HPA049426" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA046279: AB_2679611, HPA049426: AB_2680762" "unprognostic (5.02e-2)" "unprognostic (9.61e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (7.47e-5)" "unprognostic (1.69e-1)" "unprognostic (8.80e-2)" "prognostic unfavorable (8.37e-6)" "unprognostic (3.27e-2)" "unprognostic (1.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (1.73e-4)" "prognostic unfavorable (8.16e-8)" "unprognostic (1.74e-1)" "unprognostic (2.28e-1)" "unprognostic (1.47e-3)" "unprognostic (2.09e-1)" 13.2 16.1 12.4 17.1 20.7 39.1 14.8 22.1 25.1 19.9 15.8 31.4 15.3 15.5 22.5 14.1 19.3 19.5 12.7 13.4 13.2 16.0 14.3 18.5 14.7 20.5 21.3 12.2 22.2 22.2 24.1 31.2 24.3 19.5 16.3 16.7 17.7 17.1 15.2 17.0 17.5 15.2 18.3 16.0 16.4 14.5 23.6 21.6 27.9 22.8 19.6 27.1 16.9 16.6 10.5 9.8 14.5 11.4 11.7 15.2 9.7 32.0 15.8 20.0 14.8 10.3 7.6 26.1 17.1 12.7 25.2 21.1 45.8 16.5 20.9 15.2 17.1 14.4 18.2 25.5 22.6 17.5 27.7 24.7 23.5 17.0 36.3 8.8 26.2 15.0 8.8 15.2 28.3 11.3 9.3 14.5 20.9 29.2 17.0 14.1 17.3 27.4 13.2 30.7 13.7 21.1 29.1 15.2 22.7 10.7 15.2 27.8 15.6 16.8 20.6 7.5 11.6 14.0 11.5 11.2 21.6 21.0 14.1 20.0 14.8 16.6 28.1 19.5 15.0 15.3 1.8 9.3 14.5 13.9 11.4 15.2 9.5 10.4 12.4 9.8 10.5 10.2 11.4 4.5 11.7 8.0 6.4 9.4 9.7 12.4 20.7 22.1 25.1 13.2 16.0 21.3 12.2 19.5 21.6 3.0 9.9 10.2 9.1 13.4 20.0 3.2 5.1 6.7 6.8 7.0 11.8 19.8 8.3 8.1 17.4 7.4 7.1 0.0 10.5 21.1 10.3 8.6 5.8 13.5 12.1 14.3 12.6 9.8 9.4 32.6 13.6 6.5 15.1 5.4 12.5 7.8 11.0 9.1 17.3 5.6 15.1 0.0 8.0 24.0 22.0 18.1 13.0 12.8 12.1 7.9 SMURF1 KIAA1625 ENSG00000198742 "SMAD specific E3 ubiquitin protein ligase 1" Q9HCE7 7 99027438-99144100 "Enzymes, Predicted intracellular proteins" "Differentiation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019671, HPA055245" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA019671: , HPA055245: AB_2682757" "unprognostic (2.21e-1)" "unprognostic (6.15e-2)" "unprognostic (8.88e-2)" "unprognostic (1.04e-1)" "unprognostic (1.96e-2)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-1)" "unprognostic (2.15e-2)" "unprognostic (3.92e-3)" "unprognostic (2.58e-1)" "unprognostic (1.46e-1)" "unprognostic (7.83e-2)" "unprognostic (1.68e-1)" "unprognostic (3.81e-1)" "unprognostic (4.62e-2)" 15.0 11.1 8.7 10.5 15.0 23.8 12.4 12.1 16.5 11.8 10.9 20.9 6.9 9.5 11.6 5.7 19.3 10.2 12.5 7.9 9.3 8.4 10.3 10.1 16.0 8.1 15.4 9.4 19.6 22.5 9.0 15.1 15.4 14.9 11.7 10.6 14.3 13.4 9.6 10.7 17.3 10.3 9.8 10.6 9.1 19.5 26.0 11.8 6.6 7.8 6.6 12.7 11.5 13.3 1.2 1.2 2.4 1.9 1.0 2.1 0.6 13.7 7.9 6.4 4.5 5.1 5.4 9.6 7.7 7.4 6.3 5.9 3.9 11.4 4.3 8.4 7.2 13.9 7.5 3.5 10.0 6.5 3.2 3.0 2.3 4.6 3.8 4.8 2.6 5.7 4.8 6.9 9.9 11.5 9.6 5.9 4.2 6.9 7.6 5.8 11.2 4.5 5.4 7.5 7.6 8.5 4.3 6.0 2.6 6.9 11.4 2.8 6.4 7.4 9.8 6.8 11.8 3.1 5.0 8.7 10.0 10.3 17.8 15.4 6.8 4.6 4.5 5.0 5.2 15.4 2.0 1.4 2.3 1.3 1.5 1.6 0.9 2.1 1.3 1.1 1.2 1.2 1.0 2.4 1.0 1.9 1.2 2.0 0.6 8.7 15.0 12.1 16.5 9.3 8.4 15.4 9.4 14.9 11.8 17.9 28.0 5.2 20.4 23.0 25.8 3.9 20.4 20.1 20.5 12.2 7.9 6.1 1.7 13.9 3.7 10.8 7.8 0.0 13.9 8.0 10.1 31.9 2.3 6.7 5.7 25.4 10.9 7.4 3.1 5.3 5.8 8.5 8.5 4.6 8.7 3.7 25.0 10.5 13.1 4.4 6.9 6.5 15.5 41.5 1.0 19.3 17.6 2.5 7.8 65.2 SNAP91 "AP180, CALM, KIAA0656" ENSG00000065609 "Synaptosome associated protein 91" O60641 6 83552880-83709691 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 81.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 46.7;Cone photoreceptor cells: 58.9;Early spermatids: 16.0;Horizontal cells: 30.2;Rod photoreceptor cells: 59.2;Spermatocytes: 25.0" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 6.3" "Lineage enriched" "Detected in single" 20 "dendritic cells: 6.3" "Group enriched" "Detected in some" 11 "GAMG: 6.7;SCLC-21H: 21.5;SH-SY5Y: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009745, HPA029632, HPA029633" Enhanced Uncertain Centrosome,Cytosol NA NA "Centrosome, Cytosol" "CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615" "unprognostic (1.07e-2)" "unprognostic (1.74e-1)" "unprognostic (7.55e-3)" "unprognostic (3.68e-2)" "unprognostic (1.03e-1)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.17e-1)" "unprognostic (4.54e-4)" "unprognostic (6.99e-2)" "unprognostic (1.75e-2)" "unprognostic (4.82e-2)" "unprognostic (2.15e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" 1.2 8.0 17.8 1.9 25.5 1.1 1.7 44.2 81.9 2.1 1.7 3.4 0.0 1.4 1.7 1.2 1.3 1.8 2.0 1.3 19.2 19.9 1.2 1.1 1.4 3.3 14.3 20.5 3.1 2.4 1.1 9.3 1.6 34.7 3.9 1.7 4.5 1.6 1.7 1.2 1.3 1.7 1.8 7.0 2.2 1.9 10.8 2.9 0.0 2.0 0.0 2.7 1.3 0.2 0.0 6.3 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 6.7 0.3 0.9 0.0 0.0 0.3 1.3 0.5 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.1 0.2 21.5 13.4 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.1 17.8 25.5 44.2 43.6 19.2 19.9 14.3 20.5 34.7 2.9 0.0 0.0 0.0 0.0 0.0 46.7 0.8 0.0 0.0 0.0 0.0 58.9 1.0 0.0 0.0 16.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 30.2 0.0 0.0 0.0 9.5 0.9 0.0 0.0 0.0 0.0 8.9 0.5 0.0 1.1 0.0 59.2 0.0 0.0 25.0 2.4 0.0 3.7 0.0 0.0 0.0 SNAPIN "BLOC1S7, BORCS3, SNAPAP" ENSG00000143553 "SNAP associated protein" O95295 1 153658654-153661830 "Predicted intracellular proteins, Transporters" "Exocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046974 Approved Approved "Nucleoli,Golgi apparatus" NA NA 15000 "Golgi apparatus" Nucleoli "HPA046974: AB_10962506" "unprognostic (3.65e-1)" "unprognostic (1.67e-1)" "unprognostic (1.47e-1)" "unprognostic (5.66e-2)" "unprognostic (1.75e-1)" "unprognostic (2.06e-1)" "unprognostic (1.64e-3)" "unprognostic (1.54e-1)" "unprognostic (4.86e-2)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (5.42e-4)" "unprognostic (2.31e-1)" "unprognostic (4.73e-1)" "unprognostic (1.31e-3)" "unprognostic (4.89e-2)" 21.8 32.5 20.2 14.5 25.9 8.4 30.2 12.1 26.3 17.5 19.2 18.5 17.2 9.1 19.7 25.0 20.7 20.4 21.4 38.1 17.4 17.7 21.8 22.1 15.7 26.1 21.6 17.8 17.9 22.9 18.0 10.8 14.5 20.5 17.9 14.7 15.6 14.1 22.6 56.9 16.1 13.2 24.9 22.1 19.4 16.0 16.5 20.8 18.1 19.9 29.8 21.7 19.6 13.9 42.4 50.8 44.6 49.9 35.4 42.8 42.8 20.1 24.8 21.1 12.7 27.0 18.1 13.6 17.1 19.0 24.3 18.5 17.6 16.2 14.5 34.6 17.4 11.9 27.0 17.3 22.3 17.0 19.3 23.9 16.0 19.1 8.4 27.9 15.7 10.2 21.7 16.7 18.1 20.7 24.5 22.7 17.0 13.6 11.2 24.3 32.6 17.9 9.2 11.4 31.7 26.7 17.1 18.4 38.3 26.8 19.4 16.1 28.2 19.7 22.9 22.4 20.7 34.8 16.8 20.0 11.3 17.3 22.4 16.0 27.3 29.8 22.1 21.6 9.9 14.7 27.6 49.9 44.6 30.9 49.1 35.0 42.4 31.4 31.0 50.8 36.9 34.8 31.8 10.4 35.4 39.0 38.1 42.8 42.8 20.2 25.9 12.1 26.3 17.4 17.7 21.6 17.8 20.5 20.8 17.9 17.6 24.3 31.9 18.3 13.6 35.0 22.9 36.1 22.7 27.9 7.9 54.7 63.0 60.4 5.7 30.1 18.8 0.0 57.1 40.8 26.9 29.4 30.0 25.5 77.8 20.6 13.3 31.9 48.5 18.5 28.4 40.8 25.3 91.0 20.8 57.6 41.2 25.7 46.7 60.8 17.2 45.3 38.2 29.6 39.2 20.6 61.7 26.6 25.6 33.4 SNCAIP SYPH1 ENSG00000064692 "Synuclein alpha interacting protein" Q9Y6H5 5 122311354-122464219 "Disease related genes, Predicted intracellular proteins" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 22.6;ovary: 32.3" "Cell type enhanced" "Detected in many" 19 "Ciliated cells: 26.8;Early spermatids: 55.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 9.9" "Lineage enriched" "Detected in single" 21 "granulocytes: 9.9" "Cell line enhanced" "Detected in some" "AF22: 7.7;BJ hTERT+: 7.4;HBF TERT88: 4.7;OE19: 5.8;RPMI-8226: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064687 Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Nucleoplasm "HPA064687: AB_2685324" "unprognostic (7.28e-3)" "unprognostic (1.02e-2)" "unprognostic (3.01e-1)" "unprognostic (6.56e-2)" "unprognostic (2.18e-2)" "unprognostic (1.56e-1)" "unprognostic (1.47e-2)" "unprognostic (4.95e-2)" "unprognostic (1.95e-2)" "unprognostic (3.73e-1)" "unprognostic (3.52e-2)" "unprognostic (3.00e-1)" "unprognostic (5.98e-2)" "unprognostic (1.82e-3)" "unprognostic (5.77e-2)" "unprognostic (2.82e-1)" "unprognostic (2.44e-1)" 3.9 1.2 2.2 2.1 5.8 0.7 4.1 15.4 6.4 16.0 1.6 3.7 4.0 1.6 22.6 4.3 0.9 4.5 2.4 1.5 3.4 2.2 1.6 0.4 1.4 4.5 1.6 2.4 32.3 0.7 0.3 1.6 2.1 3.2 2.6 1.1 2.3 0.8 2.7 0.7 1.9 1.1 10.6 1.5 6.1 1.2 11.6 2.1 0.5 1.2 3.3 1.4 4.6 4.1 0.4 0.4 9.9 0.3 0.1 0.4 0.0 0.0 0.1 7.7 0.2 0.0 0.5 0.5 3.4 7.4 1.3 0.4 0.5 0.6 0.1 0.2 3.3 0.7 0.2 3.0 0.5 4.7 2.8 1.0 0.0 0.6 0.4 0.1 0.0 0.4 0.6 0.1 0.6 0.4 0.0 2.2 0.3 0.0 2.0 0.0 0.0 0.2 0.1 3.6 5.8 0.6 0.2 0.0 7.9 0.3 1.0 1.5 0.3 0.0 0.7 0.0 2.4 0.6 0.2 0.8 0.4 1.0 0.5 0.8 0.2 0.2 0.3 0.4 0.0 0.5 9.9 0.3 0.0 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.4 0.2 0.4 1.7 0.1 0.1 0.4 0.1 0.0 2.2 5.8 15.4 4.3 3.4 2.2 1.6 2.4 3.2 2.1 0.0 0.3 0.0 3.7 1.5 0.0 0.8 0.0 26.8 2.3 0.0 0.0 0.0 0.0 6.2 55.3 6.8 0.0 0.0 0.0 0.1 2.5 1.8 1.1 0.0 0.2 0.0 0.0 9.2 0.3 11.7 4.9 0.2 1.7 0.0 0.0 0.3 0.6 0.0 5.3 0.0 0.0 0.0 1.7 1.4 1.6 2.4 0.1 0.0 0.0 1.2 SNIP1 PML1 ENSG00000163877 "Smad nuclear interacting protein 1" Q8TAD8 1 37534449-37554344 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, RNA-mediated gene silencing" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036896 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036896: AB_10670244" "unprognostic (1.37e-1)" "unprognostic (2.83e-1)" "unprognostic (1.65e-3)" "unprognostic (7.24e-2)" "unprognostic (5.83e-2)" "unprognostic (8.30e-3)" "unprognostic (3.26e-2)" "unprognostic (3.66e-2)" "unprognostic (7.74e-2)" "unprognostic (5.01e-2)" "unprognostic (9.30e-2)" "unprognostic (5.34e-3)" "unprognostic (3.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.63e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-1)" 10.6 13.4 10.6 13.3 12.4 15.9 15.0 18.4 14.4 12.8 10.8 10.0 14.2 8.5 14.2 11.9 13.5 11.9 10.0 8.5 11.1 9.0 9.9 20.6 10.2 11.7 10.8 10.5 12.7 15.3 9.8 13.1 13.2 9.9 13.3 9.0 12.3 11.7 11.5 13.5 13.2 12.3 11.6 7.9 14.9 11.8 21.7 11.6 16.9 10.5 11.1 14.0 11.7 17.0 3.7 4.3 4.6 3.5 3.1 5.5 1.8 6.2 3.5 7.0 6.9 8.4 8.0 4.8 8.0 9.1 7.7 6.7 3.4 5.7 8.6 6.3 8.5 5.0 6.6 6.5 7.3 6.4 7.7 9.4 13.2 6.2 6.9 9.6 12.2 7.5 7.7 8.6 7.6 9.7 8.3 7.4 6.7 9.3 8.0 5.4 4.7 7.2 9.5 11.3 5.2 8.1 7.6 11.8 7.2 5.6 6.0 5.6 11.3 8.5 5.5 10.4 7.6 4.9 6.7 12.2 6.1 6.8 7.5 7.9 9.5 11.0 7.1 7.2 8.7 5.4 4.1 3.1 3.9 5.5 2.8 5.4 3.7 3.7 5.3 2.6 3.6 5.1 4.5 4.6 3.1 3.5 4.3 4.2 1.8 10.6 12.4 18.4 14.4 11.1 9.0 10.8 10.5 9.9 11.6 17.9 14.8 3.4 10.6 14.3 10.1 4.8 5.1 10.7 19.4 5.2 7.9 4.7 1.7 6.3 4.6 6.5 7.3 0.0 6.2 4.0 8.4 7.8 11.5 10.0 3.9 9.5 8.1 12.3 8.1 7.9 7.5 5.2 8.5 7.2 8.6 11.3 6.5 6.0 7.4 3.5 15.4 0.0 7.5 10.2 13.2 15.7 8.5 10.2 6.6 11.2 SNN ENSG00000184602 Stannin O75324 16 11668414-11679159 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Cell type enhanced" "Detected in many" 7 "monocytes: 71.3;Muller glia cells: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 31.5;REH: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011055 Approved Uncertain Cytosol NA NA Cytosol "HPA011055: AB_1857326" "unprognostic (1.94e-1)" "unprognostic (7.26e-2)" "unprognostic (2.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (1.85e-6)" "unprognostic (4.51e-2)" "unprognostic (3.45e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-2)" "unprognostic (2.14e-1)" "prognostic favorable (1.83e-5)" "unprognostic (4.91e-2)" "unprognostic (2.09e-1)" "unprognostic (3.58e-1)" "unprognostic (4.72e-2)" 29.2 16.6 34.7 10.0 51.5 11.0 13.7 27.2 52.2 6.9 4.4 11.2 1.8 4.9 6.8 11.5 10.5 5.9 12.0 13.2 33.0 15.5 7.0 5.1 9.2 15.0 29.8 25.2 9.8 4.7 4.5 4.6 4.5 15.6 8.1 3.3 6.9 9.9 12.9 29.1 4.5 4.4 6.6 15.2 17.4 4.6 2.2 11.4 6.1 9.5 4.8 14.2 9.3 6.1 7.0 9.0 24.1 20.3 0.3 3.0 7.4 3.0 2.9 31.5 8.5 20.9 6.0 3.0 1.3 2.8 3.8 3.8 4.7 2.1 3.1 12.9 4.3 6.7 6.0 9.4 3.7 2.9 0.8 2.1 10.4 3.2 6.2 5.6 0.7 6.3 5.2 17.2 2.0 4.2 5.4 7.0 9.3 1.6 5.0 3.5 5.1 8.3 2.3 16.3 3.8 2.1 29.4 4.2 21.7 3.5 9.0 18.8 7.6 7.1 9.4 4.6 12.9 3.8 6.2 6.2 4.4 9.2 25.7 1.3 2.0 1.3 7.4 2.6 8.9 5.5 0.0 9.5 6.9 0.3 16.3 0.3 7.0 1.6 0.7 9.0 6.8 3.0 2.1 24.1 0.3 20.3 3.6 0.9 7.4 34.7 51.5 27.2 39.3 33.0 15.5 29.8 25.2 15.6 11.4 0.0 6.7 34.4 17.9 16.4 6.5 14.3 10.2 4.0 3.4 5.2 0.0 1.0 21.6 15.0 0.6 14.3 0.0 0.0 16.3 19.9 8.2 15.5 13.8 2.4 17.7 6.4 5.1 20.3 27.0 0.0 4.6 26.4 20.3 71.3 0.2 90.5 13.6 0.0 14.5 4.4 5.9 6.5 26.7 0.3 2.1 16.7 1.1 5.7 0.4 9.1 SNPH bA314N13.5 ENSG00000101298 Syntaphilin O15079 20 1266316-1309328 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.2" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 19.5;Horizontal cells: 28.6;Rod photoreceptor cells: 19.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.5;naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 9 "T-cells: 3.5" "Cell line enhanced" "Detected in many" "GAMG: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049393 Approved Uncertain "Cytokinetic bridge,Mitochondria" Yes No Mitochondria "Cytokinetic bridge" "HPA049393: AB_2680744" "unprognostic (1.43e-2)" "unprognostic (2.55e-2)" "unprognostic (2.28e-1)" "unprognostic (8.84e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.56e-2)" "unprognostic (5.33e-2)" "unprognostic (3.08e-2)" "unprognostic (3.15e-2)" "prognostic favorable (6.97e-5)" "unprognostic (1.03e-1)" "unprognostic (6.94e-3)" "unprognostic (2.45e-2)" "unprognostic (1.55e-1)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" 2.9 5.0 26.7 3.0 22.5 1.6 1.8 14.4 36.2 3.5 3.5 3.1 5.9 3.1 4.5 3.9 3.6 4.7 4.8 4.7 26.8 15.3 2.1 0.9 2.6 3.1 12.8 17.5 2.4 6.1 6.2 5.8 1.7 17.1 5.5 2.2 3.1 9.9 19.2 6.1 1.9 3.1 8.1 3.8 2.1 5.1 2.7 4.4 0.1 4.5 0.1 2.0 3.6 1.6 0.1 0.4 0.0 0.0 0.0 3.5 1.2 2.2 6.6 0.1 6.7 8.0 4.4 0.0 4.0 5.3 4.5 2.1 0.2 0.7 0.4 2.4 4.9 11.2 1.2 1.0 5.7 0.8 1.4 1.8 4.2 1.1 0.1 4.2 0.0 6.9 2.8 2.8 4.5 0.9 4.5 5.7 4.5 0.8 0.2 4.1 0.0 0.4 0.2 2.4 0.0 5.6 0.0 1.4 0.1 6.0 3.2 0.4 2.0 3.9 0.2 5.8 0.7 0.3 0.1 9.7 7.3 5.4 6.4 1.1 0.6 1.2 0.0 3.9 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.6 0.1 0.8 0.9 0.1 0.1 3.5 3.2 0.0 0.0 0.0 0.4 0.4 1.2 26.7 22.5 14.4 36.2 26.8 15.3 12.8 17.5 17.1 4.4 0.0 0.0 0.0 0.1 0.1 19.5 4.3 5.1 0.0 0.0 3.5 5.9 0.0 0.0 0.4 8.3 0.6 0.0 0.0 0.5 0.0 0.8 0.9 0.0 0.0 0.2 28.6 8.1 1.8 0.0 3.2 1.4 0.0 0.0 0.0 0.9 2.9 1.7 0.0 3.9 1.3 19.9 6.5 1.0 0.6 0.1 0.1 0.0 0.0 1.3 0.0 SNRNP48 "C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234" ENSG00000168566 "Small nuclear ribonucleoprotein U11/U12 subunit 48" Q6IEG0 6 7590199-7611967 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029234 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029234: AB_10604097" "prognostic unfavorable (8.30e-4)" "unprognostic (3.46e-2)" "unprognostic (2.65e-1)" "unprognostic (9.65e-2)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (9.46e-3)" "unprognostic (2.55e-1)" "unprognostic (9.87e-3)" "unprognostic (1.62e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (4.16e-4)" "unprognostic (1.55e-1)" "unprognostic (8.70e-2)" "unprognostic (1.41e-2)" "unprognostic (1.03e-1)" 9.5 7.1 12.3 11.7 14.9 15.6 12.6 28.9 13.3 10.5 10.3 7.0 13.6 9.9 11.7 8.6 9.4 9.2 7.1 12.2 11.9 7.5 10.7 12.7 8.6 11.7 14.1 8.1 14.4 10.5 7.3 11.0 9.2 11.4 10.5 10.1 5.9 10.1 13.0 15.8 11.0 11.5 10.5 17.8 11.2 9.6 5.3 14.3 15.3 10.4 7.1 10.0 9.9 30.2 3.3 2.7 6.0 2.0 2.7 3.7 1.7 5.7 4.6 9.7 18.0 5.2 7.7 6.5 6.6 6.1 7.2 8.0 9.8 4.7 13.6 7.1 5.4 6.9 7.4 12.0 7.1 11.1 10.4 11.7 9.8 14.7 18.8 5.5 11.6 6.5 5.4 11.0 8.1 6.2 8.6 6.2 12.2 13.6 2.2 10.0 3.2 19.0 16.9 13.1 9.9 5.2 20.5 8.4 18.2 6.5 5.1 15.0 4.1 12.8 3.3 11.3 18.7 6.5 4.1 6.9 9.6 4.3 5.6 11.3 3.5 19.4 8.4 3.2 9.3 17.1 0.4 2.0 1.0 2.0 1.4 3.4 1.7 2.4 2.6 2.4 3.3 2.1 3.7 6.0 2.7 0.8 2.7 1.7 1.7 12.3 14.9 28.9 13.3 11.9 7.5 14.1 8.1 11.4 14.3 17.9 9.3 14.1 18.6 31.7 17.1 25.2 5.1 8.1 21.6 8.7 19.6 13.5 10.0 15.9 2.2 20.2 18.4 0.0 17.5 12.7 12.9 15.7 23.1 19.5 13.7 4.8 10.9 13.5 16.4 2.2 16.4 16.3 8.5 21.6 15.0 15.3 10.9 15.2 15.6 13.5 17.2 6.5 17.9 10.2 17.9 29.6 13.6 17.5 13.8 18.0 SNTB2 "D16S2531E, EST25263, SNT2B2, SNT3, SNTL" ENSG00000168807 "Syntrophin beta 2" Q13425 16 69187129-69309052 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 187.1;Rod photoreceptor cells: 126.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001394 Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA001394: AB_1080170" "unprognostic (4.86e-1)" "unprognostic (3.26e-2)" "unprognostic (2.77e-2)" "unprognostic (8.07e-3)" "unprognostic (6.46e-2)" "unprognostic (9.68e-2)" "unprognostic (1.89e-2)" "unprognostic (5.50e-2)" "unprognostic (1.22e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-2)" "unprognostic (3.64e-2)" "unprognostic (5.77e-3)" "unprognostic (1.71e-2)" "unprognostic (7.43e-2)" "unprognostic (1.73e-2)" "unprognostic (1.88e-1)" 20.7 8.4 5.8 10.2 7.9 3.8 13.4 5.3 9.4 22.9 12.2 4.5 13.3 5.5 17.8 10.9 16.1 13.0 10.4 8.6 4.8 3.2 14.1 5.8 12.7 7.2 4.8 4.8 13.9 6.6 31.9 7.2 7.4 5.3 16.7 7.8 26.0 8.3 8.4 8.8 12.7 9.6 15.7 5.0 8.6 9.3 10.5 4.0 6.4 22.8 6.8 7.5 18.3 20.2 1.0 0.6 3.0 1.0 2.6 3.7 0.9 4.0 6.2 4.3 3.4 16.0 21.6 5.3 8.0 11.2 6.3 7.0 6.1 3.7 5.1 4.9 9.3 3.3 7.4 5.8 3.9 8.2 2.2 3.2 2.2 6.1 5.2 5.3 0.1 3.4 15.4 2.9 10.3 4.2 6.6 18.8 1.4 1.3 8.0 7.6 4.6 1.7 0.7 2.9 2.4 5.0 10.1 3.8 9.5 3.3 6.2 1.6 3.6 24.5 3.5 2.5 3.4 4.1 0.3 14.6 11.9 5.7 8.3 7.4 1.8 2.8 5.8 7.6 0.8 5.4 1.1 1.0 1.0 3.2 1.0 3.3 1.0 1.6 1.8 0.6 0.8 1.0 3.7 3.0 2.6 1.0 0.4 1.6 0.9 5.8 7.9 5.3 9.4 4.8 3.2 4.8 4.8 5.3 4.0 17.9 9.4 7.8 23.9 33.8 22.9 6.5 2.5 5.3 7.9 26.2 39.3 8.1 3.3 9.2 20.9 65.9 17.4 0.0 21.0 7.0 31.2 42.1 1.1 9.7 6.1 4.8 9.9 84.7 22.9 21.8 54.7 10.1 28.7 1.8 17.0 187.1 14.1 24.6 61.2 27.4 126.8 6.5 39.2 22.7 8.3 33.9 3.1 21.0 16.8 25.9 SNTG2 "G2SYN, SYN5" ENSG00000172554 "Syntrophin gamma 2" Q9NY99 2 950868-1367613 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 58.0;Horizontal cells: 85.8;Late spermatids: 26.8;Spermatocytes: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 3.7;HAP1: 4.1;JURKAT: 3.8;MOLT-4: 2.4;NTERA-2: 5.0;SCLC-21H: 4.9" "Low region specificity" "Detected in single" "HPA065258, HPA077904" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA065258: , HPA077904: " "unprognostic (7.52e-3)" "unprognostic (7.52e-4)" "unprognostic (4.15e-1)" "unprognostic (3.50e-2)" "unprognostic (2.52e-2)" "unprognostic (1.39e-3)" "unprognostic (2.46e-3)" "unprognostic (2.05e-1)" "unprognostic (2.23e-1)" "unprognostic (3.26e-2)" "unprognostic (7.87e-3)" "unprognostic (3.58e-3)" "unprognostic (3.64e-1)" "unprognostic (2.52e-1)" "unprognostic (1.77e-2)" "unprognostic (5.05e-2)" 8.8 2.2 0.9 1.2 1.7 0.7 7.5 1.7 1.4 5.6 1.8 0.4 1.0 1.3 10.2 8.1 4.3 2.5 4.9 1.0 2.6 1.4 0.8 0.6 1.3 0.9 1.1 0.3 1.2 6.7 0.9 9.2 0.7 5.1 1.6 1.6 3.5 1.4 0.8 6.4 3.5 1.4 5.2 2.9 7.7 1.4 5.7 0.9 2.2 2.0 3.1 2.0 2.8 2.6 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 3.7 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 2.4 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 1.7 1.4 2.6 1.4 1.1 0.3 5.1 0.9 0.0 0.0 0.0 0.1 0.8 0.7 0.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 58.0 5.2 0.0 0.0 0.2 0.4 0.4 0.3 0.0 0.0 0.1 85.8 0.0 0.0 0.0 26.8 0.3 0.0 1.7 0.0 0.0 0.5 0.0 0.0 3.9 0.2 4.0 0.0 0.4 17.7 3.1 0.1 0.0 0.0 0.0 0.1 SNX15 ENSG00000110025 "Sorting nexin 15" Q9NRS6 11 65027408-65040572 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "granulocytes: 8.1;Intestinal endocrine cells: 7.5;monocytes: 12.6;Undifferentiated cells: 6.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038955 Approved Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoli, Cytosol" "Vesicles, Plasma membrane" "HPA038955: AB_10672834" "unprognostic (2.00e-2)" "unprognostic (4.90e-2)" "unprognostic (3.93e-1)" "unprognostic (9.61e-4)" "unprognostic (2.79e-1)" "unprognostic (4.06e-3)" "unprognostic (4.45e-3)" "unprognostic (4.74e-2)" "unprognostic (1.09e-1)" "unprognostic (9.55e-2)" "unprognostic (8.93e-3)" "unprognostic (1.79e-2)" "unprognostic (8.84e-2)" "unprognostic (7.86e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.68e-4)" 17.9 13.6 17.1 12.7 18.3 11.6 23.5 25.7 21.9 13.2 22.7 16.7 9.5 19.7 14.2 8.9 15.9 11.4 13.9 15.1 16.2 14.3 15.7 9.8 14.1 14.7 16.3 14.5 18.3 17.7 13.7 8.4 9.5 13.4 15.1 11.6 11.2 15.6 15.4 25.2 17.2 20.4 15.0 17.6 11.3 13.5 7.6 15.8 12.4 14.4 10.1 11.5 14.9 12.5 7.7 8.0 10.9 18.3 3.2 7.1 5.7 17.4 12.9 8.4 8.2 10.2 7.5 4.7 1.7 7.9 13.8 12.7 10.2 13.7 17.8 9.9 10.0 17.4 9.8 9.8 8.7 3.8 26.8 8.1 8.9 10.6 17.0 11.0 4.6 14.4 6.3 13.1 14.6 8.5 7.7 8.2 13.1 15.0 11.4 7.2 10.5 16.3 20.7 9.1 6.8 12.8 13.5 5.0 19.2 10.2 3.8 15.2 11.5 14.9 13.5 12.9 4.0 13.7 10.7 16.1 14.0 13.5 14.1 7.4 12.3 21.1 17.0 13.7 7.3 4.8 7.8 11.3 10.9 6.9 13.6 5.6 7.7 7.1 6.1 8.0 6.1 5.2 4.7 1.6 3.2 18.3 5.5 6.7 5.7 17.1 18.3 25.7 21.9 16.2 14.3 16.3 14.5 13.4 15.8 0.0 3.5 0.0 0.0 0.9 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.3 0.0 4.7 0.0 0.4 4.2 0.0 2.7 0.4 0.4 0.0 8.1 0.0 0.9 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.0 12.6 3.1 0.2 3.5 5.1 0.4 0.5 0.4 0.0 0.3 0.0 0.0 0.4 0.3 1.0 6.0 0.0 SNX20 "SLIC-1, SLIC1" ENSG00000167208 "Sorting nexin 20" Q7Z614 16 50666300-50681353 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 58.5;lymphoid tissue: 42.5" "Cell type enhanced" "Detected in some" 7 "B-cells: 16.1;Cardiomyocytes: 14.3;Hofbauer cells: 16.3;Kupffer cells: 17.3;Macrophages: 22.2;monocytes: 17.2;Sertoli cells: 12.9;T-cells: 22.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 13.3;HMC-1: 37.2;NB-4: 21.6;RPMI-8226: 9.2;THP-1: 9.7;U-266/70: 12.1;U-937: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043649 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043649: AB_10965697" "unprognostic (1.53e-2)" "prognostic favorable (9.07e-4)" "unprognostic (5.58e-2)" "unprognostic (5.06e-3)" "unprognostic (9.03e-2)" "prognostic favorable (6.56e-4)" "unprognostic (1.97e-1)" "unprognostic (1.26e-2)" "unprognostic (1.78e-2)" "unprognostic (1.04e-1)" "unprognostic (4.06e-2)" "unprognostic (1.84e-1)" "prognostic unfavorable (6.00e-6)" "unprognostic (3.24e-1)" "unprognostic (3.37e-2)" "unprognostic (1.53e-1)" "unprognostic (1.54e-1)" 2.0 1.4 2.5 12.7 5.7 10.7 1.3 1.2 2.7 1.3 1.7 1.4 0.1 1.8 1.2 2.4 1.7 1.7 3.1 2.7 1.5 1.5 1.9 1.5 5.7 21.1 2.6 0.2 1.1 1.0 0.1 1.1 1.8 3.1 1.8 2.3 1.3 3.0 0.2 0.7 1.4 7.4 1.6 3.0 23.6 2.1 0.6 3.3 42.5 1.5 0.8 22.3 4.7 1.2 5.5 27.9 58.5 30.7 11.1 30.1 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.3 0.0 2.3 0.0 0.0 0.0 3.3 37.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 1.1 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.0 0.0 0.0 12.1 6.3 2.9 0.0 12.9 0.0 58.5 15.1 45.5 10.1 26.6 12.6 5.5 18.0 12.2 27.9 5.2 14.0 9.5 14.1 11.1 30.7 7.7 30.1 15.8 2.5 5.7 1.2 2.7 1.5 1.5 2.6 0.2 3.1 3.3 0.0 0.0 16.1 0.0 0.7 0.0 14.3 2.5 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.4 0.0 4.7 0.0 16.3 1.6 0.0 0.0 17.3 0.0 0.0 22.2 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.5 0.3 22.4 0.0 0.0 SNX32 "FLJ30934, SNX6B" ENSG00000172803 "Sorting nexin 32" Q86XE0 11 65833641-65856896 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 16.6" "Cell type enhanced" "Detected in some" 12 "Early spermatids: 10.4;Late spermatids: 8.2;Spermatocytes: 4.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 1.0;dendritic cells: 1.2;T-cells: 3.0" "Cell line enhanced" "Detected in some" "HHSteC: 6.1;HSkMC: 8.0;REH: 2.6;SH-SY5Y: 3.1;U-266/70: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041775 Uncertain Uncertain "Cell Junctions,Focal adhesion sites" NA NA "Cell Junctions, Focal adhesion sites" "HPA041775: AB_10797268" "unprognostic (6.74e-4)" "unprognostic (1.06e-1)" "unprognostic (1.67e-2)" "unprognostic (4.50e-5)" "unprognostic (1.00e-1)" "unprognostic (9.28e-2)" "unprognostic (7.30e-2)" "unprognostic (9.17e-3)" "unprognostic (2.70e-1)" "unprognostic (2.87e-1)" "unprognostic (5.08e-2)" "unprognostic (1.52e-1)" "unprognostic (3.64e-4)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (9.80e-2)" "unprognostic (5.36e-2)" 0.8 1.0 9.0 1.1 16.6 1.3 1.3 3.5 16.1 1.6 2.2 1.6 0.0 3.4 2.0 1.3 0.9 2.5 2.8 0.9 10.2 5.0 0.9 0.7 0.8 1.0 3.6 10.9 1.3 0.8 0.8 0.3 0.9 3.4 0.8 1.9 0.1 0.7 0.9 0.6 1.1 1.5 2.0 1.8 0.9 0.9 3.5 3.7 0.0 0.7 0.0 1.3 1.0 0.2 1.0 1.2 0.2 0.3 0.1 3.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.1 0.0 0.7 8.0 0.1 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.4 0.0 0.5 0.3 0.1 0.0 0.0 2.6 0.0 2.3 0.1 0.0 0.0 3.1 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 9.3 1.6 0.0 0.7 0.0 0.3 0.0 0.1 0.0 1.2 0.3 3.0 0.3 1.6 1.2 1.2 1.0 1.4 0.6 0.2 0.1 0.0 0.7 1.2 0.4 9.0 16.6 3.5 15.4 10.2 5.0 3.6 10.9 3.4 3.7 0.0 1.1 0.0 0.3 0.3 1.7 0.8 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 10.4 0.5 0.8 0.0 0.0 0.1 0.6 0.1 3.5 0.0 0.3 0.0 0.0 0.6 0.0 8.2 0.3 0.0 1.7 0.0 0.3 0.8 0.1 0.0 1.1 0.2 0.5 0.0 0.3 4.4 1.3 0.4 0.0 0.0 1.2 0.1 SOHLH2 "bHLHe81, FLJ20449, SPATA28, TEB1" ENSG00000120669 "Spermatogenesis and oogenesis specific basic helix-loop-helix 2" Q9NX45 13 36168208-36214615 "Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 23.6" "Group enriched" "Detected in some" 8 "Early spermatids: 52.6;Extravillous trophoblasts: 15.9;Late spermatids: 58.0;Spermatocytes: 19.1;Spermatogonia: 40.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 7.2;HL-60: 9.5;Karpas-707: 10.9;NB-4: 13.9;U-266/84: 13.9" HPA029182 Uncertain Vesicles NA NA Vesicles "HPA029182: AB_10602409" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" "unprognostic (1.99e-1)" "unprognostic (2.99e-2)" "unprognostic (2.54e-2)" "unprognostic (3.01e-2)" "unprognostic (2.95e-1)" "unprognostic (7.88e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-3)" "unprognostic (2.10e-1)" "unprognostic (8.56e-2)" "unprognostic (7.44e-2)" "unprognostic (5.93e-2)" 0.3 0.3 0.9 0.3 2.1 0.5 0.4 0.3 3.5 0.3 1.8 0.3 0.3 0.2 0.3 2.0 0.3 0.2 0.3 0.9 1.2 1.2 0.6 0.3 0.3 0.3 1.2 0.3 0.3 0.3 0.2 0.3 3.5 0.3 1.8 0.0 0.3 0.3 1.2 0.4 0.2 0.3 0.4 0.6 0.3 0.1 23.6 0.3 0.3 0.4 0.3 0.3 1.3 0.3 1.0 0.3 0.5 0.3 0.0 0.5 0.0 7.2 0.2 0.8 0.0 0.6 1.2 4.3 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.2 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.1 9.5 0.0 2.1 0.6 0.0 0.0 0.4 0.9 0.2 0.4 10.9 2.2 0.1 0.0 13.9 0.2 0.0 0.0 0.2 0.2 0.8 1.0 0.7 0.1 1.3 0.0 0.0 0.0 2.7 0.1 0.6 0.0 0.0 0.8 0.5 0.5 1.4 13.9 0.2 0.8 5.1 0.5 0.0 0.3 0.5 0.2 0.0 0.1 0.1 0.1 0.1 0.0 1.0 0.2 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.9 2.1 0.3 3.5 1.2 1.2 1.2 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 52.6 0.0 0.0 0.0 0.0 15.9 0.3 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 58.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 1.1 0.3 0.0 0.0 19.1 40.2 0.1 2.9 0.0 0.0 0.1 SORBS1 "CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12" ENSG00000095637 "Sorbin and SH3 domain containing 1" Q9BX66 10 95311771-95561414 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 126.5" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 479.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 7.6;eosinophil: 2.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.6" "Cell line enhanced" "Detected in many" "CACO-2: 15.2;HMC-1: 26.6;SK-MEL-30: 22.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027559, CAB032850, HPA043084" Enhanced Supported "Plasma membrane,Focal adhesion sites,Centrosome" NA NA "Focal adhesion sites" "Plasma membrane, Centrosome" "CAB032850: AB_2286335, HPA027559: AB_10600812, HPA043084: AB_2678307" "prognostic favorable (2.84e-4)" "unprognostic (3.53e-1)" "unprognostic (1.89e-1)" "unprognostic (7.85e-2)" "unprognostic (3.43e-1)" "unprognostic (1.41e-1)" "unprognostic (2.98e-2)" "unprognostic (5.30e-2)" "unprognostic (1.95e-2)" "unprognostic (1.65e-2)" "unprognostic (3.17e-2)" "unprognostic (1.27e-1)" "unprognostic (3.40e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (2.55e-2)" "unprognostic (5.01e-3)" 95.0 6.4 23.0 16.4 21.6 1.8 23.5 16.8 22.5 14.9 70.2 18.7 22.1 8.1 41.8 12.5 45.0 25.1 28.9 83.7 20.9 8.3 5.9 14.7 8.7 1.4 13.4 14.1 9.8 7.3 17.5 3.5 9.9 19.2 42.0 20.0 6.4 7.2 65.7 46.4 6.3 15.5 126.5 20.6 2.9 40.0 5.5 19.3 0.0 4.0 12.7 1.2 63.9 31.4 0.1 0.0 7.6 1.2 0.6 1.0 0.2 0.7 0.7 6.4 1.6 2.4 0.1 0.9 0.2 0.1 0.2 0.0 15.2 5.7 0.0 1.2 0.1 2.4 0.3 1.2 0.3 0.1 1.8 2.3 3.7 0.2 9.1 0.8 0.0 26.6 0.4 0.2 0.3 0.1 0.1 2.6 0.9 6.0 1.2 0.6 0.4 0.0 0.3 3.0 2.8 1.4 0.5 2.2 0.2 7.2 10.0 2.8 2.0 0.9 0.3 22.8 4.6 1.2 0.2 0.2 0.0 2.3 0.1 1.2 0.8 0.2 0.1 2.8 0.2 6.4 7.6 0.2 2.2 0.7 1.2 1.0 0.1 0.3 0.4 0.0 0.1 0.3 0.1 0.2 0.6 0.2 0.0 0.5 0.2 23.0 21.6 16.8 20.7 20.9 8.3 13.4 14.1 19.2 19.3 20.8 18.1 0.5 5.1 10.3 5.9 479.0 12.7 0.0 2.3 1.8 2.0 17.9 3.3 4.4 61.7 19.0 1.0 0.0 2.6 1.9 15.3 5.3 15.1 42.9 2.7 6.4 5.8 38.6 4.9 26.4 6.9 1.1 13.5 1.0 14.0 18.2 2.8 3.5 72.2 4.3 5.4 0.0 64.3 2.8 4.7 10.9 24.7 0.0 5.2 3.3 SOSTDC1 "DAND7, DKFZp564D206, USAG1" ENSG00000171243 "Sclerostin domain containing 1" Q6X4U4 7 16461481-16530580 "Predicted secreted proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.1;retina: 74.8;stomach 1: 32.3" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 24.9;Horizontal cells: 28.6;Melanocytes: 30.4" "Cancer enhanced" "Detected in many" "renal cancer: 25.9" "Region enriched" "Detected in many" 9 "pons and medulla: 51.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.5;EFO-21: 11.2;HEL: 4.2;NTERA-2: 4.4;RPTEC TERT1: 20.8" "Group enriched" "Detected in many" 5 "basal ganglia: 9.4;hippocampal formation: 20.4;pons and medulla: 15.8;thalamus: 12.8" "Low region specificity" "Detected in many" HPA042856 Uncertain "Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA "Golgi apparatus" "Nucleoli, Nucleoli rim, Vesicles" "HPA042856: " "unprognostic (2.08e-2)" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.17e-3)" "unprognostic (5.59e-3)" "unprognostic (4.13e-2)" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (1.41e-2)" "prognostic favorable (8.69e-4)" "unprognostic (2.59e-1)" "unprognostic (2.62e-1)" "prognostic favorable (3.22e-5)" "unprognostic (7.01e-2)" "unprognostic (1.23e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (8.72e-4)" 0.4 0.4 2.0 1.4 1.9 0.0 9.5 0.5 5.8 2.6 5.9 7.0 0.2 6.1 2.5 2.4 2.7 2.7 0.4 3.7 3.5 1.6 12.8 0.2 22.0 0.1 0.7 5.3 0.6 1.1 0.0 2.9 0.0 51.1 1.1 8.4 74.8 12.5 6.4 0.3 13.7 4.8 0.5 1.0 0.2 32.3 1.9 0.0 0.0 4.7 3.1 4.9 1.0 3.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 11.2 0.0 0.0 0.2 0.4 0.0 0.0 0.1 2.2 4.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.3 0.1 0.0 0.0 0.7 0.8 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.0 1.9 0.5 5.8 3.5 1.6 0.7 5.3 51.1 0.0 0.0 0.0 0.0 4.5 4.9 0.4 1.0 0.0 0.0 3.4 14.0 0.0 0.0 24.9 0.0 14.4 0.2 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 28.6 2.4 0.6 0.0 9.4 6.6 0.0 30.4 0.0 0.0 15.0 0.2 0.0 2.5 14.4 0.4 0.0 0.4 2.7 0.9 6.4 0.0 0.0 2.1 0.3 SOX11 ENSG00000176887 "SRY-box 11" P35716 2 5692667-5701385 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 3.1;brain: 12.3;heart muscle: 5.3;intestine: 3.3;testis: 3.7" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 10.1;Ductal cells: 2.5" "Group enriched" "Detected in many" 6 "breast cancer: 2.0;glioma: 8.5;ovarian cancer: 1.8;testis cancer: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 26.5;NTERA-2: 12.9;REH: 9.4;RH-30: 10.1;SCLC-21H: 16.3;SH-SY5Y: 24.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000448, HPA000536, CAB056152, CAB056153" Approved Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB056152: AB_2665567, CAB056153: AB_2665568, HPA000448: , HPA000536: AB_1080060" "unprognostic (2.17e-2)" "unprognostic (2.02e-2)" "unprognostic (1.44e-2)" "unprognostic (7.35e-6)" "unprognostic (2.79e-1)" "unprognostic (1.19e-1)" "unprognostic (4.04e-8)" "unprognostic (2.79e-2)" "unprognostic (7.27e-2)" "unprognostic (3.17e-1)" "unprognostic (3.35e-3)" "unprognostic (2.42e-1)" "unprognostic (8.45e-8)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (5.50e-3)" "unprognostic (7.47e-2)" 0.5 0.5 4.2 0.5 7.1 0.6 0.6 0.3 12.3 0.4 3.3 5.8 0.0 0.6 0.7 0.6 0.5 0.5 0.6 5.3 4.4 5.1 0.5 0.5 0.6 0.5 3.3 5.0 0.5 0.4 0.5 0.7 0.5 4.5 0.5 0.8 0.0 0.9 0.4 1.0 0.6 0.7 1.3 6.3 1.0 0.6 3.7 3.6 0.0 0.6 0.0 0.6 0.5 0.1 1.1 0.8 3.1 1.5 1.6 1.1 0.5 0.0 0.0 26.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 1.3 0.0 0.0 2.4 0.0 0.0 0.0 12.9 0.0 0.0 9.4 10.1 0.4 0.0 0.0 16.3 24.6 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.8 0.3 0.6 0.0 0.0 6.1 3.1 0.5 1.0 0.5 0.8 1.1 1.1 0.6 0.7 0.6 0.7 0.9 0.9 1.6 1.6 1.5 0.8 0.9 0.5 4.2 7.1 0.3 6.4 4.4 5.1 3.3 5.0 4.5 3.6 0.0 0.0 0.0 0.0 0.0 1.3 10.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 2.5 0.7 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 SOX4 ENSG00000124766 "SRY-box 4" Q06945 6 21592768-21598619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.8" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 757.4;Pancreatic endocrine cells: 1059.7" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.8" "Group enriched" "Detected in all" 4 "dendritic cells: 21.8;granulocytes: 12.8;monocytes: 10.0" "Cell line enhanced" "Detected in many" "AN3-CA: 55.4;MOLT-4: 47.6;SH-SY5Y: 31.2" "Region enriched" "Detected in many" 4 "olfactory region: 66.5" "Low region specificity" "Detected in many" HPA029901 Approved Supported Nucleoplasm,Mitochondria NA Yes Nucleoplasm Mitochondria "HPA029901: AB_10601592" "unprognostic (4.01e-2)" "unprognostic (3.06e-1)" "unprognostic (9.28e-2)" "unprognostic (5.18e-2)" "unprognostic (5.00e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (2.57e-5)" "unprognostic (1.78e-1)" "unprognostic (8.01e-3)" "unprognostic (1.98e-2)" "unprognostic (3.88e-3)" "unprognostic (1.18e-1)" "unprognostic (8.73e-3)" "unprognostic (3.66e-2)" "unprognostic (3.31e-1)" "unprognostic (2.01e-1)" "unprognostic (9.27e-2)" 4.2 0.7 2.0 1.9 0.9 6.0 6.3 3.0 6.3 6.7 2.8 3.0 18.0 4.1 2.3 4.2 5.5 2.0 1.1 1.8 4.3 1.3 5.1 0.8 0.6 18.1 5.3 0.0 1.8 1.0 4.1 3.7 9.6 1.4 0.3 4.1 2.7 4.9 0.3 1.0 4.4 2.5 3.4 1.4 6.2 3.6 3.1 21.8 12.8 10.0 3.3 1.1 2.0 1.8 5.2 13.3 55.4 4.9 1.2 21.7 0.8 1.7 1.0 0.9 3.5 3.5 0.6 22.2 1.3 0.7 5.4 6.9 3.8 0.7 7.6 14.5 0.5 2.4 2.3 0.8 1.8 0.4 2.1 3.9 0.4 1.6 14.2 15.6 30.0 0.1 0.0 1.1 4.3 47.6 4.5 9.9 2.6 5.0 21.0 1.1 0.0 9.6 16.7 17.4 31.2 7.7 9.0 2.9 17.3 4.4 6.5 11.9 1.5 5.2 0.3 3.9 0.3 0.0 15.4 0.5 6.5 6.1 12.8 9.8 0.9 0.2 5.5 0.0 2.8 0.1 0.1 4.1 3.1 1.1 0.8 0.4 3.3 10.0 21.8 0.9 2.0 184.6 59.8 33.5 82.0 99.9 88.8 228.6 341.4 161.9 235.4 146.5 11.8 61.5 56.3 757.4 3.9 238.0 78.0 0.0 523.0 358.6 243.9 126.1 56.8 5.8 33.0 46.1 327.2 70.6 85.2 8.3 11.2 56.1 231.2 80.2 156.9 228.7 1059.7 155.6 10.6 77.4 25.8 6.5 198.6 3.7 175.2 81.3 25.3 23.5 265.6 178.0 SPINT2 "HAI-2, Kop" ENSG00000167642 "Serine peptidase inhibitor, Kunitz type 2" O43291 19 38244035-38292614 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 1193.1;Syncytiotrophoblasts: 1181.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 77.2;CAPAN-2: 114.0;OE19: 138.0;RPTEC TERT1: 85.0;SK-BR-3: 74.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011101, CAB018969" Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" No NA "Plasma membrane, Intermediate filaments, Cytosol" "CAB018969: , HPA011101: AB_1079039" "unprognostic (5.13e-2)" "unprognostic (1.06e-3)" "unprognostic (1.40e-1)" "unprognostic (6.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.91e-2)" "unprognostic (2.23e-1)" "unprognostic (2.03e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.04e-1)" "prognostic favorable (3.41e-4)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.94e-2)" "unprognostic (2.68e-2)" 1.5 7.2 11.9 15.1 14.0 10.7 29.2 14.3 20.8 24.0 46.3 4.7 63.2 38.3 7.1 44.9 60.6 30.4 51.8 3.3 10.4 22.9 47.5 2.8 25.6 10.3 9.3 14.6 15.3 78.7 30.2 82.7 77.3 11.0 29.6 40.3 15.3 143.1 61.6 0.7 41.7 82.3 13.1 5.6 9.4 34.1 87.0 2.8 15.0 95.6 32.0 37.5 27.1 25.0 23.1 73.9 70.7 17.9 2.6 13.2 17.6 77.2 56.1 0.2 0.3 0.0 0.0 36.8 1.5 0.1 0.1 0.2 39.7 114.0 0.6 6.2 0.4 0.1 25.6 4.0 55.0 0.1 0.7 4.6 14.5 1.4 0.0 0.0 0.1 0.0 0.0 63.5 0.0 26.9 6.8 0.1 13.4 0.3 0.0 0.1 59.9 2.2 0.2 5.6 138.0 15.8 7.9 0.0 34.7 85.0 65.9 21.2 0.3 23.0 74.8 0.2 23.2 33.4 9.6 0.0 0.1 0.4 0.3 0.3 5.3 6.7 4.3 0.1 1.0 0.1 57.2 17.9 70.7 0.5 12.5 1.1 20.0 6.5 3.2 41.7 23.1 13.2 11.9 7.8 2.6 8.4 73.9 2.5 17.6 11.9 14.0 14.3 20.8 10.4 22.9 9.3 14.6 11.0 2.8 342.4 185.3 64.0 449.2 334.9 13.5 2.4 313.4 305.1 279.8 530.4 5.9 1193.1 86.2 726.2 49.0 27.7 770.2 23.3 582.2 418.7 47.4 567.4 114.2 0.9 201.0 3.2 346.3 19.6 47.0 43.3 17.5 123.0 84.4 555.5 581.5 122.0 696.1 614.1 15.9 155.0 17.0 51.8 17.6 285.2 308.8 374.4 1181.8 32.3 502.6 795.6 SPIRE1 "KIAA1135, spir-1" ENSG00000134278 "Spire type actin nucleation factor 1" Q08AE8 18 12446512-12658134 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 147.7;Late spermatids: 226.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 41.1;U-2197: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040737, HPA040942" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040737: AB_10960987, HPA040942: AB_10960492" "unprognostic (3.39e-1)" "unprognostic (4.77e-2)" "unprognostic (9.18e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (2.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.09e-1)" "unprognostic (1.60e-1)" "unprognostic (9.49e-2)" "unprognostic (1.04e-1)" "unprognostic (1.46e-2)" "unprognostic (4.60e-1)" "unprognostic (3.66e-3)" "prognostic unfavorable (7.92e-4)" "unprognostic (1.41e-1)" "unprognostic (2.54e-1)" "unprognostic (1.44e-1)" 8.4 20.2 20.6 4.7 16.2 1.7 10.6 20.5 35.3 10.8 6.5 15.0 3.4 2.5 9.2 7.0 8.8 5.6 8.6 22.0 21.6 14.8 12.7 5.5 12.2 3.3 21.3 20.5 9.8 8.5 15.7 8.2 7.5 17.3 10.1 4.3 9.4 10.0 9.9 17.5 7.7 3.5 9.9 17.7 5.3 5.5 34.8 17.5 0.4 15.0 3.6 4.9 8.8 10.7 1.0 1.0 0.0 1.1 0.9 0.6 0.2 7.5 3.3 7.4 8.2 8.3 7.4 0.4 8.2 8.5 8.1 7.8 0.3 1.7 3.6 9.4 10.6 13.6 1.7 9.9 7.3 10.3 5.3 4.9 2.2 7.0 4.3 17.1 1.5 5.7 5.1 14.0 14.0 41.1 9.4 10.8 1.2 5.6 0.1 12.0 10.1 0.4 2.0 3.1 2.7 8.3 0.0 9.1 7.5 9.8 10.3 10.9 4.4 8.9 7.4 18.6 3.4 2.3 4.7 13.2 13.5 4.0 31.5 9.7 2.7 0.3 0.2 10.8 1.0 3.6 0.0 1.1 0.0 0.4 0.8 0.2 0.0 0.2 0.6 1.0 1.0 0.0 0.4 0.0 0.9 1.1 0.0 0.0 0.2 20.6 16.2 20.5 24.3 21.6 14.8 21.3 20.5 17.3 17.5 23.8 39.2 0.0 8.2 3.3 52.8 25.0 7.6 6.7 15.9 12.2 7.9 0.1 18.3 7.4 147.7 7.1 0.0 0.0 4.2 0.7 7.4 18.7 15.1 5.0 11.5 25.4 2.9 6.7 12.7 226.2 5.5 6.0 16.9 2.8 1.0 14.3 8.9 0.0 10.3 1.1 11.8 19.4 9.5 10.5 19.2 1.9 0.5 1.3 0.0 8.9 SPNS1 "HSpin1, LAT, nrs, PP2030, SPIN1, SPINL" ENSG00000169682 "Sphingolipid transporter 1 (putative)" Q9H2V7 16 28974221-28984548 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041995, HPA042988" Enhanced Approved "Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol" NA NA Vesicles "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA041995: AB_10959609, HPA042988: AB_10964587" "unprognostic (3.54e-2)" "unprognostic (4.57e-4)" "unprognostic (2.15e-1)" "unprognostic (2.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.66e-1)" "unprognostic (7.86e-5)" "unprognostic (1.01e-1)" "unprognostic (2.00e-1)" "unprognostic (1.27e-1)" "unprognostic (4.12e-2)" "unprognostic (3.02e-3)" "unprognostic (8.85e-7)" "unprognostic (1.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.26e-3)" "unprognostic (1.12e-2)" 23.4 23.9 14.5 22.0 15.9 38.3 24.2 21.0 22.8 18.2 22.1 24.1 20.1 26.9 25.1 21.3 20.9 17.1 26.8 16.1 14.9 12.1 24.1 28.3 33.4 22.6 15.4 17.0 18.3 20.8 29.5 17.2 40.7 15.4 20.1 12.6 19.8 20.8 22.8 21.3 30.9 22.3 26.3 14.5 27.3 20.7 22.3 17.2 31.0 22.0 24.5 17.2 21.2 19.5 3.1 15.6 7.2 23.5 4.2 7.9 10.1 10.3 24.5 9.3 21.6 17.9 9.9 26.5 11.6 12.0 19.4 17.4 22.3 24.9 6.6 28.6 10.4 16.1 22.0 15.0 12.8 7.0 7.6 25.5 9.6 23.9 27.7 30.4 10.6 20.7 16.5 17.2 20.9 8.9 11.4 17.8 12.4 21.5 12.0 9.7 27.7 11.6 30.4 21.9 8.4 16.2 14.7 11.2 29.6 10.5 10.1 16.7 21.6 8.2 24.7 18.0 8.1 24.6 12.9 15.0 15.8 12.0 22.0 8.9 18.2 14.3 6.2 20.2 16.3 12.7 6.4 18.2 7.2 6.0 23.5 5.0 3.1 6.0 7.9 15.6 2.8 6.2 4.1 3.3 4.2 15.7 6.5 6.8 10.1 14.5 15.9 21.0 22.8 14.9 12.1 15.4 17.0 15.4 17.2 6.0 7.4 9.0 18.6 18.9 27.1 0.4 10.2 12.0 3.4 19.2 27.5 55.8 11.6 51.1 1.5 21.6 16.8 0.0 39.5 59.8 27.5 13.4 20.9 12.1 87.9 25.4 11.7 19.6 37.6 1.9 21.0 27.5 32.1 26.2 18.9 29.6 34.8 14.0 15.6 13.5 33.9 6.5 15.3 17.2 28.3 19.8 73.0 22.5 23.8 17.0 SPPL2B "IMP4, KIAA1532, PSL1" ENSG00000005206 "Signal peptide peptidase like 2B" Q8TCT7 19 2328615-2354806 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 82.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005592, HPA039292" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA "Nucleoplasm, Plasma membrane" Centrosome "CAB005592: AB_325074, HPA039292: AB_2676429" "unprognostic (4.16e-2)" "unprognostic (2.97e-2)" "unprognostic (2.48e-2)" "prognostic favorable (5.00e-5)" "unprognostic (2.34e-1)" "unprognostic (1.54e-3)" "unprognostic (1.74e-1)" "unprognostic (7.93e-3)" "unprognostic (3.00e-1)" "unprognostic (1.72e-1)" "prognostic favorable (1.33e-4)" "unprognostic (3.29e-3)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.26e-2)" "unprognostic (2.45e-1)" "unprognostic (3.02e-1)" "unprognostic (3.40e-2)" 5.4 4.6 5.0 11.7 5.4 11.7 4.0 6.9 6.9 3.4 9.0 7.9 9.6 19.3 4.7 10.0 3.2 5.2 9.8 3.3 5.6 4.2 3.9 3.5 10.3 7.1 4.7 3.4 13.8 6.3 11.0 6.8 7.1 4.7 3.9 6.0 10.5 8.7 7.5 8.7 16.2 5.0 7.0 8.1 13.8 20.1 6.4 9.3 3.0 3.7 5.7 2.3 2.0 14.4 17.4 9.3 7.7 6.2 8.2 5.9 8.3 13.4 5.8 10.2 4.8 4.9 14.8 11.0 3.2 4.0 4.3 9.4 9.6 8.0 10.4 5.1 3.8 11.3 1.9 3.8 1.2 9.3 8.4 5.3 21.0 12.5 9.0 9.3 7.0 7.1 4.3 3.8 2.7 6.3 5.6 16.8 8.6 20.5 2.4 9.3 10.1 11.9 10.8 7.5 5.5 16.9 3.0 22.1 4.4 21.1 10.3 9.8 11.0 6.7 8.4 3.9 11.2 15.7 12.5 7.4 5.3 18.6 8.6 27.1 9.7 8.4 9.2 10.9 12.8 9.3 7.7 7.0 6.6 7.5 4.8 9.0 6.0 6.5 9.4 14.4 7.8 8.2 3.4 6.2 5.1 17.4 5.9 5.9 3.0 15.0 22.0 6.2 0.0 23.4 5.1 28.1 20.1 9.1 24.4 45.2 44.0 1.7 13.7 36.9 9.0 59.3 0.0 10.0 18.3 4.6 7.2 6.9 10.6 10.4 30.2 39.1 14.7 9.5 82.4 13.8 5.3 0.0 5.4 51.1 13.7 10.1 30.8 14.9 6.2 39.6 0.0 8.1 41.9 12.4 0.0 35.8 4.5 38.9 4.3 SPRED2 "FLJ21897, FLJ31917, Spred-2" ENSG00000198369 "Sprouty related EVH1 domain containing 2" Q7Z698 2 65310851-65432637 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "NK-cell: 3.2;plasmacytoid DC: 7.7" "Group enriched" "Detected in many" 4 "dendritic cells: 7.7;NK-cells: 3.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038256, HPA064394" Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038256: , HPA064394: AB_2732712" "unprognostic (1.49e-1)" "unprognostic (5.95e-3)" "unprognostic (3.46e-2)" "unprognostic (4.40e-3)" "unprognostic (8.94e-2)" "unprognostic (1.63e-1)" "unprognostic (2.90e-2)" "unprognostic (9.94e-2)" "unprognostic (9.07e-2)" "unprognostic (4.25e-1)" "unprognostic (5.05e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-2)" "unprognostic (3.82e-2)" "unprognostic (1.58e-1)" "unprognostic (7.21e-3)" "unprognostic (5.43e-2)" 25.1 13.5 21.0 19.3 17.8 6.7 26.2 26.2 28.9 16.9 18.9 9.0 5.8 17.2 20.1 12.3 12.8 13.8 18.3 17.5 19.0 14.3 16.1 28.1 22.0 14.8 15.3 19.0 18.3 20.6 29.5 15.1 18.1 20.5 15.1 18.7 15.1 17.9 13.6 9.6 13.6 20.7 13.7 16.5 11.0 22.6 8.1 12.9 40.3 22.1 10.4 17.1 21.2 30.5 0.1 7.7 1.2 1.2 3.2 1.2 1.5 27.0 14.3 15.6 15.9 20.4 20.4 11.3 8.1 12.0 5.2 7.2 18.8 7.7 20.9 4.3 10.0 15.1 9.1 8.9 18.2 10.7 23.9 6.5 4.3 3.8 20.3 10.3 13.3 8.9 16.3 10.8 18.7 17.9 11.4 3.3 11.7 18.6 8.2 8.4 18.3 10.3 12.4 7.8 21.1 16.8 8.2 14.1 10.8 16.3 22.9 6.7 23.8 8.5 7.3 21.7 10.1 6.9 11.3 5.1 13.3 17.9 11.8 12.9 16.2 6.5 34.1 21.6 12.8 25.6 0.0 0.4 0.0 1.2 1.2 0.1 0.0 0.2 1.0 0.8 0.1 0.2 0.3 1.2 3.2 0.6 7.7 0.0 1.5 21.0 17.8 26.2 26.7 19.0 14.3 15.3 19.0 20.5 12.9 17.9 16.5 2.2 27.6 35.4 14.1 6.5 17.8 6.7 4.5 8.7 5.9 10.2 11.6 10.1 1.3 9.8 16.0 0.0 7.4 7.2 13.1 21.2 1.1 12.7 5.9 23.8 10.9 15.4 6.5 2.5 15.8 7.8 18.6 44.1 19.7 8.9 9.7 15.8 11.7 5.7 10.7 25.8 15.4 2.8 9.8 14.6 2.5 0.7 10.1 22.0 SPRED3 ENSG00000188766 "Sprouty related EVH1 domain containing 3" Q2MJR0 19 38388421-38399587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.7" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 7.3;Intestinal endocrine cells: 10.4" "Cancer enhanced" "Detected in many" "glioma: 3.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.3;TIME: 14.7;U-87 MG: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071521 Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA071521: " "unprognostic (1.09e-1)" "unprognostic (1.88e-3)" "unprognostic (8.71e-3)" "unprognostic (3.35e-3)" "unprognostic (3.70e-2)" "unprognostic (2.00e-3)" "unprognostic (2.09e-3)" "unprognostic (7.77e-3)" "unprognostic (1.49e-1)" "unprognostic (9.22e-3)" "unprognostic (1.69e-2)" "unprognostic (3.09e-2)" "unprognostic (1.40e-11)" "unprognostic (6.21e-4)" "unprognostic (3.67e-1)" "unprognostic (1.04e-3)" "unprognostic (8.45e-3)" 2.0 1.2 4.3 2.7 10.1 0.9 1.2 2.8 10.7 0.9 0.6 1.7 0.0 4.7 1.2 1.2 0.9 0.7 2.0 1.1 5.0 4.7 1.2 0.4 0.9 0.5 2.8 4.6 0.5 2.9 4.5 5.8 0.8 4.7 1.2 0.8 0.9 0.8 1.1 0.9 2.3 3.7 2.3 1.7 0.5 1.3 1.7 0.9 0.0 1.8 0.0 0.6 0.9 0.8 0.8 0.7 2.2 0.6 0.9 0.5 0.3 0.2 1.1 3.8 3.1 0.6 1.8 2.1 7.5 5.0 2.5 2.3 0.4 0.8 0.2 2.7 2.5 2.0 0.1 0.6 0.9 2.3 0.7 1.4 0.0 0.2 0.4 1.3 2.0 0.1 1.3 0.9 5.9 1.7 12.3 7.8 0.6 0.6 1.4 7.6 0.4 0.0 0.1 1.7 0.5 3.8 0.9 1.3 0.1 5.4 0.6 0.2 2.9 0.1 0.2 0.3 1.7 0.6 0.1 14.7 2.8 8.6 2.3 4.1 0.6 0.2 0.5 9.4 0.3 4.7 1.6 0.6 0.4 0.4 0.2 0.3 0.3 0.5 0.3 0.1 0.8 0.4 0.3 2.2 0.9 0.5 0.7 0.2 0.3 4.3 10.1 2.8 9.8 5.0 4.7 2.8 4.6 4.7 0.9 0.0 0.0 0.0 1.1 0.0 7.3 1.0 0.0 0.0 0.0 1.8 2.0 0.4 0.0 0.8 0.3 0.1 0.7 0.0 0.5 0.2 0.0 1.1 0.0 0.0 0.1 1.6 10.4 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.3 2.5 2.2 0.0 0.0 0.0 0.2 0.0 1.0 0.9 0.6 0.1 0.7 0.0 0.6 0.6 SPTAN1 ENSG00000197694 "Spectrin alpha, non-erythrocytic 1" Q13813 9 128552558-128633662 "Disease related genes, Predicted intracellular proteins" "Actin capping, Actin-binding, Calmodulin-binding" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 263.0;Cone photoreceptor cells: 292.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004581, HPA007927" Enhanced Approved Vesicles,Microtubules NA NA 270000 "Vesicles, Microtubules" "CAB004581: AB_671135, HPA007927: AB_1857435" "unprognostic (1.46e-2)" "unprognostic (2.73e-2)" "unprognostic (1.56e-1)" "unprognostic (9.06e-2)" "unprognostic (3.24e-1)" "unprognostic (4.02e-2)" "unprognostic (2.56e-3)" "unprognostic (2.20e-1)" "unprognostic (1.81e-1)" "unprognostic (1.30e-2)" "unprognostic (2.49e-1)" "unprognostic (1.36e-1)" "prognostic favorable (1.84e-12)" "unprognostic (2.94e-2)" "unprognostic (1.60e-1)" "unprognostic (4.18e-3)" "unprognostic (2.19e-3)" 27.8 18.0 46.4 21.3 54.0 14.7 18.0 80.9 74.7 21.1 22.3 33.3 17.0 14.5 27.5 20.5 22.2 33.1 19.4 37.2 42.6 46.2 19.5 13.8 32.1 20.6 41.8 59.8 32.4 14.2 47.2 18.2 33.1 75.1 20.2 22.0 26.9 16.7 29.3 12.7 40.1 17.9 35.1 31.8 24.2 18.2 26.1 29.9 18.0 22.2 11.4 21.7 19.6 27.5 5.5 2.5 3.2 1.2 5.7 12.8 4.2 23.8 26.4 17.4 19.2 25.5 28.9 14.3 20.5 17.2 23.0 17.4 37.5 17.0 20.9 18.3 30.9 16.2 43.9 18.5 20.5 14.3 11.7 10.9 3.5 71.6 21.0 14.4 15.4 11.8 13.8 16.6 38.6 13.1 19.5 30.8 19.9 1.9 24.7 22.5 16.5 29.7 6.5 22.2 28.1 16.5 20.1 20.9 13.2 18.7 20.5 13.5 21.2 67.1 9.3 9.7 22.3 16.1 4.4 52.6 16.0 23.8 23.1 15.8 15.1 17.8 11.8 19.5 7.1 15.0 2.5 1.2 3.2 8.9 1.1 12.2 5.5 11.2 8.2 1.9 5.3 7.0 7.2 1.3 5.7 0.9 2.5 12.8 4.2 46.4 54.0 80.9 74.1 42.6 46.2 41.8 59.8 75.1 29.9 65.5 28.0 29.7 27.3 33.2 263.0 64.5 71.4 26.8 15.9 96.0 292.6 22.3 6.6 59.2 14.0 81.5 108.9 0.0 51.0 14.3 55.4 41.9 11.5 31.0 25.3 117.6 54.6 74.9 26.2 29.1 78.9 22.5 33.7 22.6 49.0 93.5 75.3 73.0 89.1 15.8 152.1 25.8 39.7 29.2 41.3 39.6 15.2 38.9 54.5 43.6 SQLE ENSG00000104549 "Squalene epoxidase" Q14534 8 124998497-125022283 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018038, HPA020762" Enhanced Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA018038: AB_2669753, HPA020762: AB_2670512" "unprognostic (1.37e-2)" "unprognostic (6.26e-3)" "unprognostic (5.12e-2)" "unprognostic (9.51e-3)" "unprognostic (4.63e-1)" "prognostic unfavorable (7.42e-4)" "unprognostic (4.76e-3)" "prognostic unfavorable (4.67e-4)" "unprognostic (3.45e-2)" "unprognostic (7.21e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (7.51e-2)" "prognostic unfavorable (5.70e-4)" "unprognostic (9.71e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-3)" "unprognostic (7.74e-3)" 4.6 15.7 11.1 9.9 13.9 10.4 12.1 8.9 19.9 15.1 11.5 28.8 4.4 15.8 8.9 5.1 40.3 10.0 6.3 4.2 15.4 14.5 7.8 38.1 16.0 8.6 10.8 9.7 17.5 6.3 16.5 9.5 24.7 28.5 13.8 10.1 9.3 10.4 4.7 1.3 23.8 8.7 6.6 36.0 5.6 11.5 29.3 18.7 9.8 5.7 24.2 15.0 5.3 21.6 15.1 12.4 1.2 9.7 9.5 9.0 6.1 25.8 10.0 60.2 17.3 18.7 31.8 6.1 6.8 21.0 9.3 17.1 13.6 37.9 17.8 9.9 8.4 37.4 19.8 25.1 37.7 10.8 14.7 53.0 50.9 6.8 34.7 27.6 5.9 15.0 21.7 40.4 27.7 22.9 6.0 10.1 12.6 29.0 34.7 7.5 42.7 20.6 7.5 24.9 17.8 6.9 9.1 11.0 24.3 65.6 29.8 18.8 9.5 14.0 45.0 14.0 20.2 12.0 15.6 9.9 3.8 13.6 4.5 6.0 6.3 12.8 24.4 6.4 18.2 6.6 1.2 5.1 0.5 9.0 8.5 4.4 13.6 5.4 8.3 12.4 15.1 7.5 7.8 0.1 9.5 9.7 8.8 5.6 6.1 11.1 13.9 8.9 16.4 15.4 14.5 10.8 9.7 28.5 18.7 56.6 84.1 38.7 41.4 20.4 26.3 6.1 28.1 108.4 52.4 50.6 47.1 81.6 6.6 50.5 18.8 11.2 44.6 46.7 73.0 111.6 54.5 79.8 41.4 15.7 48.5 139.8 30.4 12.3 13.0 9.6 22.2 16.0 20.3 154.1 29.4 23.5 64.9 21.0 10.3 2.9 47.5 25.8 29.0 131.6 152.1 77.9 181.6 17.5 20.4 100.4 SRCAP "DOMO1, EAF1, KIAA0309, SWR1" ENSG00000080603 "Snf2 related CREBBP activator protein" Q6ZRS2 16 30698209-30741409 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 21.9;Suprabasal keratinocytes: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA028929 Approved Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA028929: AB_10601265" "unprognostic (1.26e-1)" "unprognostic (1.35e-1)" "unprognostic (5.07e-1)" "unprognostic (6.57e-2)" "unprognostic (1.78e-1)" "unprognostic (6.95e-2)" "unprognostic (8.59e-2)" "unprognostic (2.34e-2)" "unprognostic (3.77e-1)" "unprognostic (6.45e-2)" "unprognostic (4.36e-2)" "unprognostic (8.57e-2)" "unprognostic (1.16e-2)" "unprognostic (2.09e-1)" "unprognostic (4.11e-2)" "unprognostic (7.71e-2)" "unprognostic (1.07e-1)" 13.5 15.5 15.4 17.1 15.6 23.6 13.6 24.8 18.1 14.8 16.3 20.4 14.0 14.1 23.6 12.0 13.0 15.1 16.0 11.9 11.5 9.3 10.5 9.3 11.6 13.9 18.2 10.8 17.2 17.8 31.2 18.2 16.3 13.0 14.1 10.3 17.5 17.2 13.4 23.5 14.8 18.0 13.4 12.6 16.0 15.9 22.4 14.0 20.5 17.4 10.1 15.1 21.4 12.7 3.2 2.3 6.2 3.2 1.7 2.4 1.5 13.8 27.4 16.5 16.8 13.0 9.3 17.8 10.5 9.7 12.1 9.7 13.0 10.2 28.8 14.5 13.3 8.3 13.9 17.1 13.1 10.0 18.6 39.3 18.3 24.0 11.1 5.8 21.2 22.2 9.7 6.5 18.1 14.9 6.2 12.3 9.7 28.1 16.3 8.8 17.1 18.1 8.4 17.2 5.8 12.3 25.3 13.0 16.5 3.8 16.0 16.0 16.6 11.7 15.3 4.5 5.8 17.3 12.0 19.8 17.2 12.6 9.7 14.0 18.6 15.7 21.2 13.8 11.2 13.1 0.7 1.8 6.2 2.4 3.2 1.9 1.8 1.3 2.4 1.3 3.2 1.3 1.1 5.4 1.7 0.8 2.3 2.1 1.5 15.4 15.6 24.8 18.1 11.5 9.3 18.2 10.8 13.0 14.0 3.0 3.0 1.9 1.7 21.9 7.6 1.4 2.5 0.0 2.3 1.8 7.9 2.0 0.0 1.0 0.8 1.7 4.7 0.0 2.7 1.1 1.7 2.4 2.3 2.9 2.0 7.9 10.9 1.8 0.3 0.5 2.6 1.7 10.1 2.8 2.8 2.9 1.5 1.7 1.1 0.5 5.5 0.0 3.9 4.7 5.1 50.8 2.1 4.3 2.7 2.5 SSH1 KIAA1298 ENSG00000084112 "Slingshot protein phosphatase 1" Q8WYL5 12 108778192-108857590 "Enzymes, Predicted intracellular proteins" "Actin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019845 Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA019845: AB_1857497" "unprognostic (1.18e-3)" "unprognostic (3.00e-1)" "unprognostic (2.49e-1)" "unprognostic (2.70e-2)" "unprognostic (9.40e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (5.80e-5)" "unprognostic (3.28e-2)" "unprognostic (3.69e-2)" "unprognostic (1.72e-3)" "unprognostic (7.12e-2)" "unprognostic (3.42e-1)" "unprognostic (1.71e-2)" "unprognostic (1.41e-1)" "unprognostic (8.66e-2)" "unprognostic (9.55e-2)" "unprognostic (6.22e-2)" 7.3 7.8 8.5 7.4 8.1 10.6 9.3 20.3 8.8 7.4 8.5 6.8 13.1 4.4 9.8 7.9 7.6 8.2 8.3 10.1 8.0 6.9 5.8 7.4 10.1 8.7 7.7 5.2 7.9 8.0 9.7 6.8 7.8 8.4 6.5 6.5 15.0 5.9 8.0 21.4 7.1 6.5 10.4 8.1 8.6 7.1 5.2 6.6 2.0 7.0 7.9 6.6 10.0 13.3 1.8 2.0 5.7 4.0 2.1 2.9 1.2 5.1 6.8 4.5 3.5 8.5 7.3 4.0 6.6 14.2 6.1 5.4 3.4 2.5 2.4 4.7 15.5 10.4 5.1 2.7 11.2 5.0 5.0 2.6 5.7 3.1 2.1 4.6 2.9 15.2 10.0 3.8 5.5 12.3 15.1 5.6 3.0 1.3 2.0 15.9 2.9 3.3 4.2 3.1 2.0 5.5 2.4 5.3 3.2 2.4 9.2 3.3 4.5 5.8 1.6 12.8 6.5 2.1 2.6 4.4 10.9 4.7 6.5 3.8 3.9 3.5 3.0 5.7 2.4 34.4 4.2 2.4 4.8 2.9 4.0 2.7 1.6 1.5 2.5 1.6 1.8 1.4 1.6 5.7 2.1 3.2 2.0 1.7 1.2 8.5 8.1 20.3 8.8 8.0 6.9 7.7 5.2 8.4 6.6 8.9 17.3 4.7 15.4 8.4 10.6 21.2 12.7 8.1 14.8 14.0 15.7 4.7 5.0 7.7 1.6 37.5 3.5 0.0 7.0 3.7 10.3 7.2 19.7 13.4 11.2 11.1 5.2 25.8 24.7 2.6 6.1 17.8 11.8 43.3 6.6 8.8 10.1 0.0 12.0 4.9 20.7 6.5 17.6 1.1 6.6 7.9 1.9 15.4 5.7 12.2 STAC STAC1 ENSG00000144681 "SH3 and cysteine rich domain" Q99469 3 36380344-36548007 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 22 "Distal tubular cells: 5.0;Early spermatids: 4.5;granulocytes: 5.8;Muller glia cells: 21.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 21.3" "Group enriched" "Detected in some" 5 "eosinophil: 3.2;NK-cell: 2.8;T-reg: 3.8" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;NK-cells: 2.8;T-cells: 3.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 22.0;HaCaT: 16.2;hTERT-RPE1: 13.5;SH-SY5Y: 23.2;U-251 MG: 14.1;U-87 MG: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035143 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA035143: AB_10603892" "unprognostic (5.29e-2)" "unprognostic (7.61e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-6)" "unprognostic (4.24e-2)" "unprognostic (1.83e-2)" "unprognostic (3.06e-2)" "unprognostic (3.89e-1)" "unprognostic (2.02e-1)" "unprognostic (3.31e-3)" "unprognostic (1.77e-3)" "unprognostic (5.82e-2)" "unprognostic (8.07e-2)" "unprognostic (1.73e-4)" "unprognostic (8.93e-2)" "unprognostic (1.95e-1)" "unprognostic (7.94e-3)" 3.7 6.4 1.4 1.1 5.4 0.6 5.7 21.3 0.8 9.2 4.6 1.2 4.7 0.3 9.0 2.2 3.3 4.0 5.1 0.7 0.9 3.9 3.3 1.8 15.0 0.7 1.6 0.2 3.2 0.6 18.8 1.8 0.6 5.2 17.2 1.1 1.9 1.8 5.7 4.0 1.6 0.6 12.5 1.2 0.9 1.5 2.4 0.2 0.7 1.0 4.4 0.5 8.4 15.5 0.0 0.6 3.2 0.4 2.8 3.8 0.2 3.5 1.5 0.8 0.0 3.2 1.0 0.0 9.0 0.2 1.9 2.3 0.0 0.0 0.0 3.7 22.0 6.3 16.2 1.1 3.9 2.0 0.0 2.8 0.5 4.9 0.1 0.0 9.0 0.1 1.2 0.1 0.0 0.3 13.5 0.0 0.9 0.0 0.2 0.2 0.0 1.8 0.1 6.7 0.0 1.4 0.0 0.0 0.0 5.1 0.0 3.0 23.2 3.6 2.5 0.0 7.0 0.0 0.9 4.0 0.2 9.4 0.3 14.1 0.0 0.0 0.0 23.9 3.6 4.0 0.0 0.1 3.2 0.0 0.4 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 2.8 0.1 0.0 3.8 0.2 1.4 5.4 21.3 0.8 0.9 3.9 1.6 0.2 5.2 0.2 0.0 0.3 0.0 0.0 0.0 0.7 1.1 0.0 0.0 2.3 0.0 0.0 0.0 5.0 0.1 4.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.8 0.0 0.0 0.0 21.3 0.1 0.0 0.0 0.0 0.6 0.0 2.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 STAP1 "BRDG1, STAP-1" ENSG00000035720 "Signal transducing adaptor family member 1" Q9ULZ2 4 67558728-67607337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.8;ductus deferens: 12.3;intestine: 9.3;kidney: 20.0;lymphoid tissue: 30.4" "Cell type enhanced" "Detected in some" 23 "B-cells: 31.9;granulocytes: 75.5;Melanocytes: 15.1" "Cancer enriched" "Detected in many" 7 "renal cancer: 13.0" "Region enriched" "Detected in single" 7 "hippocampal formation: 3.2" "Cell type enhanced" "Detected in many" "memory B-cell: 28.1;naive B-cell: 36.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 63.5;U-698: 28.4" "Region enriched" "Detected in single" 5 "cerebellum: 2.6" "Low region specificity" "Detected in many" HPA038529 Enhanced Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA038529: AB_10673011" "unprognostic (1.14e-4)" "unprognostic (1.49e-3)" "unprognostic (2.30e-2)" "unprognostic (2.17e-1)" "unprognostic (1.63e-3)" "unprognostic (6.30e-4)" "unprognostic (1.95e-3)" "unprognostic (6.95e-3)" "unprognostic (5.18e-2)" "unprognostic (6.38e-3)" "unprognostic (1.47e-1)" "unprognostic (8.43e-3)" "unprognostic (3.11e-2)" "unprognostic (1.49e-2)" "unprognostic (4.69e-2)" "unprognostic (2.71e-2)" "unprognostic (1.40e-1)" 0.7 0.3 0.4 27.8 0.3 2.9 0.6 0.3 0.4 0.7 2.1 0.0 12.3 0.8 0.6 1.2 2.4 0.4 0.7 0.4 3.2 0.3 20.0 0.5 2.7 23.9 0.4 0.0 0.3 0.6 0.0 0.4 0.1 0.2 1.0 1.3 0.3 2.6 5.1 0.4 0.5 9.3 0.1 0.4 26.5 1.1 2.1 0.0 5.9 0.7 0.7 30.4 4.6 0.6 36.8 1.7 7.7 0.0 12.6 2.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 8.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 9.2 0.0 1.2 0.0 7.7 0.3 0.0 0.7 28.1 0.7 0.3 0.4 36.8 2.9 0.1 0.3 12.6 0.0 1.7 0.1 1.7 0.4 0.3 0.3 0.4 3.2 0.3 0.4 0.0 0.2 0.0 0.0 10.1 31.9 0.0 0.2 0.0 0.0 0.0 1.4 1.2 5.2 0.0 0.0 8.3 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.5 0.0 0.6 0.0 0.0 0.0 0.0 5.2 0.3 0.6 15.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 4.9 0.0 0.0 STARD3 "es64, MLN64" ENSG00000131748 "StAR related lipid transfer domain containing 3" Q14849 17 39637065-39663484 "Cancer-related genes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "SK-BR-3: 89.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017021, HPA024307, HPA073948" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB017021: , HPA024307: , HPA073948: " "unprognostic (1.11e-1)" "unprognostic (2.14e-2)" "unprognostic (6.35e-2)" "unprognostic (8.92e-3)" "unprognostic (2.09e-2)" "unprognostic (2.94e-1)" "prognostic unfavorable (3.60e-5)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (6.25e-3)" "unprognostic (5.88e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (1.33e-1)" "unprognostic (5.22e-2)" "unprognostic (8.51e-3)" "unprognostic (3.00e-2)" 22.2 34.8 23.3 27.5 28.0 33.5 22.8 27.7 30.1 17.1 23.7 38.1 21.7 26.6 20.6 20.7 22.4 25.6 27.7 17.8 21.0 16.8 18.2 24.0 27.0 31.5 28.5 25.7 21.5 32.7 21.9 23.7 26.9 25.7 19.0 9.7 17.9 21.4 26.7 20.8 24.5 34.2 15.8 27.8 32.3 25.3 26.7 26.1 33.0 21.1 15.1 24.8 28.8 18.7 15.3 23.2 35.3 21.2 21.4 25.3 17.4 7.9 12.6 5.7 10.1 6.9 8.4 8.5 6.5 8.5 8.5 7.8 7.4 13.1 7.1 14.2 5.9 10.5 15.2 3.4 7.7 1.9 9.6 12.9 4.8 5.5 8.6 9.7 9.7 10.8 9.1 6.3 9.6 4.6 6.5 8.2 9.9 11.1 9.2 7.8 7.0 9.1 9.2 6.3 5.4 6.9 7.2 9.8 10.5 5.8 9.0 7.2 7.7 4.9 89.9 16.1 4.0 10.6 11.6 7.7 12.0 8.3 13.1 12.2 8.8 10.8 5.7 10.7 10.5 12.3 12.5 21.2 29.3 25.3 19.6 18.5 11.9 18.3 19.0 23.2 15.3 18.4 16.9 35.3 21.4 15.6 10.8 20.4 17.4 23.3 28.0 27.7 30.1 21.0 16.8 28.5 25.7 25.7 26.1 3.0 9.8 21.7 11.2 14.7 13.5 3.0 20.4 5.3 3.4 10.4 35.3 24.1 8.3 20.7 2.3 23.3 21.4 0.0 30.9 31.1 16.0 17.5 18.5 10.6 45.2 17.5 26.4 42.4 36.6 4.1 15.8 20.8 5.0 17.2 11.7 17.0 30.5 15.8 12.4 8.7 13.2 12.9 9.5 8.4 13.9 14.8 33.4 34.8 12.4 16.9 STAT2 STAT113 ENSG00000170581 "Signal transducer and activator of transcription 2" P52630 12 56341597-56360155 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003858, HPA018888" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB003858: AB_562227, HPA018888: AB_1857550" "unprognostic (3.03e-1)" "unprognostic (8.59e-2)" "unprognostic (6.92e-3)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "unprognostic (7.27e-2)" "unprognostic (1.93e-1)" "unprognostic (2.60e-1)" "unprognostic (4.12e-3)" "unprognostic (1.56e-1)" "unprognostic (7.45e-3)" "prognostic unfavorable (4.78e-13)" "unprognostic (1.88e-1)" "unprognostic (5.56e-2)" "unprognostic (2.77e-1)" "unprognostic (1.46e-3)" 30.8 14.7 10.4 24.2 20.8 11.9 18.4 21.3 18.6 21.4 13.8 39.8 12.2 15.1 24.0 12.6 13.9 16.7 23.0 11.6 10.9 9.2 12.8 25.7 22.1 19.9 27.3 13.3 22.9 13.1 18.3 28.0 18.7 29.1 15.8 15.1 24.5 18.7 12.4 10.6 15.2 17.3 22.9 29.2 29.4 13.9 7.0 22.1 19.9 20.3 7.6 23.1 24.2 16.7 6.6 8.5 8.2 16.9 3.5 6.8 8.1 4.7 2.5 5.9 4.7 30.5 21.1 9.6 8.5 30.4 33.9 33.6 3.5 6.3 6.2 7.9 13.8 8.5 6.5 6.9 5.0 6.7 5.2 2.1 9.4 4.7 3.5 20.9 2.1 9.1 31.4 4.5 7.7 7.7 28.7 7.9 5.6 5.1 17.3 10.9 2.8 3.2 2.6 1.8 4.4 3.3 3.0 7.0 4.9 6.9 6.9 1.7 3.5 12.2 6.7 12.7 8.3 6.3 5.3 5.2 11.8 4.2 4.0 1.5 13.8 10.0 3.2 10.9 2.7 4.0 8.2 11.2 7.6 5.8 16.9 5.8 3.7 5.7 5.9 8.5 6.6 4.4 3.7 5.7 3.5 12.6 7.6 6.8 8.1 10.4 20.8 21.3 18.6 10.9 9.2 27.3 13.3 29.1 22.1 11.9 48.6 22.1 6.7 12.7 16.2 10.1 22.9 18.7 28.4 17.4 19.6 9.4 1.7 10.6 10.6 22.4 17.5 0.0 9.4 22.2 18.4 10.4 9.3 62.1 24.2 3.2 14.9 25.8 41.9 23.3 18.1 29.9 30.4 10.8 13.8 10.3 11.6 17.5 16.3 7.8 19.8 25.8 14.6 2.3 4.4 12.7 9.3 14.0 11.0 10.1 STEAP4 "FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9" ENSG00000127954 "STEAP4 metalloreductase" Q687X5 7 88270892-88306891 "Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 122.8" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 2: 320.5;Club cells: 178.6;Sertoli cells: 452.7" "Cancer enhanced" "Detected in many" "prostate cancer: 45.9" "Group enriched" "Detected in some" 5 "midbrain: 1.7;pons and medulla: 6.4" "Cell type enriched" "Detected in some" 13 "neutrophil: 48.9" "Lineage enriched" "Detected in many" 13 "granulocytes: 48.9" "Group enriched" "Detected in some" 6 "HSkMC: 39.3;SiHa: 36.9;U-2197: 52.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065201 Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA065201: " "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (8.82e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" "unprognostic (9.96e-2)" "prognostic favorable (2.97e-4)" "unprognostic (7.40e-2)" "unprognostic (3.12e-1)" "unprognostic (4.66e-2)" "unprognostic (4.21e-1)" "unprognostic (2.98e-1)" "unprognostic (7.51e-3)" "prognostic unfavorable (5.77e-4)" "unprognostic (1.72e-1)" "unprognostic (2.00e-1)" "unprognostic (4.53e-2)" 122.8 29.3 0.3 12.7 0.8 2.4 55.6 0.6 0.7 15.9 14.0 1.1 5.3 1.4 10.7 22.3 23.7 17.1 9.3 18.7 0.5 0.3 10.8 71.7 27.5 49.4 1.7 0.2 17.8 13.3 12.0 35.1 45.0 6.4 25.8 3.9 4.9 14.6 4.6 22.1 10.5 5.2 13.9 1.8 5.3 5.7 27.3 0.4 0.4 40.9 8.4 5.2 28.4 26.3 0.0 0.3 48.9 3.8 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 39.3 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 36.9 3.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 52.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 0.7 0.3 0.8 0.6 0.7 0.5 0.3 1.7 0.2 6.4 0.4 50.6 320.5 0.0 6.3 8.4 1.1 4.0 0.0 97.7 178.6 0.0 2.0 0.3 0.0 11.7 12.9 8.9 0.0 0.0 8.2 9.0 11.1 62.8 15.1 0.4 2.1 0.0 0.0 19.0 5.1 1.9 106.4 7.7 5.0 0.0 0.0 2.4 16.5 0.0 8.5 0.0 0.2 452.7 115.4 0.9 0.2 16.4 9.2 0.0 0.0 12.2 STK16 "MPSK, PKL12" ENSG00000115661 "Serine/threonine kinase 16" O75716 2 219245455-219250337 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029450 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA029450: AB_10603118" "unprognostic (1.99e-1)" "unprognostic (2.08e-1)" "unprognostic (5.84e-2)" "prognostic favorable (6.09e-4)" "unprognostic (6.21e-2)" "unprognostic (5.55e-2)" "unprognostic (4.98e-3)" "unprognostic (4.25e-1)" "unprognostic (1.48e-1)" "unprognostic (4.22e-2)" "unprognostic (1.73e-2)" "unprognostic (3.17e-1)" "unprognostic (4.39e-3)" "unprognostic (1.76e-1)" "unprognostic (2.00e-1)" "unprognostic (2.68e-1)" "unprognostic (1.34e-1)" 10.2 19.0 15.7 12.8 20.3 13.3 14.6 8.8 21.0 11.5 16.2 15.2 20.5 17.2 11.4 22.1 16.0 18.3 15.5 13.0 14.5 11.9 19.5 30.1 11.4 24.6 14.2 13.2 13.2 24.5 16.5 15.1 14.0 13.3 14.3 13.7 12.8 19.0 16.3 9.9 12.2 14.2 11.5 12.3 15.9 16.8 18.9 12.7 27.2 19.8 12.8 17.0 12.9 10.3 7.9 7.8 5.8 7.6 14.5 11.2 9.7 7.4 9.8 8.6 7.3 21.5 21.0 9.9 9.6 13.3 8.2 8.2 11.4 16.6 4.3 13.5 16.0 13.1 7.7 10.0 16.0 4.4 10.5 11.5 9.7 8.9 9.8 19.5 9.2 11.4 22.4 25.7 11.3 29.9 16.2 9.9 10.1 12.1 11.8 14.0 13.7 10.0 20.1 8.0 13.5 6.0 9.5 9.7 12.6 17.1 8.6 6.9 8.8 3.4 13.7 19.7 6.5 14.3 19.5 7.6 11.2 7.9 9.1 9.2 14.6 6.2 10.3 12.4 9.8 9.8 2.0 7.6 5.8 6.0 4.2 6.8 7.8 7.5 11.2 7.8 7.9 7.8 10.0 5.2 14.5 3.6 6.7 8.4 9.7 15.7 20.3 8.8 21.0 14.5 11.9 14.2 13.2 13.3 12.7 6.0 6.4 22.9 15.0 8.8 7.4 7.8 28.1 5.3 5.7 7.0 15.7 20.2 58.0 33.5 69.7 11.7 27.6 0.0 51.6 21.3 17.4 15.1 8.1 39.4 25.1 12.7 24.8 11.6 19.1 56.4 14.1 15.7 20.3 43.3 36.3 18.3 30.3 42.9 12.7 72.1 18.4 0.0 12.2 38.1 6.9 9.8 10.8 30.5 35.9 14.0 STK17B DRAK2 ENSG00000081320 "Serine/threonine kinase 17b" O94768 2 196133566-196176503 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2" "Cell type enhanced" "Detected in many" 5 "B-cells: 158.6;granulocytes: 189.5;Kupffer cells: 142.8;Macrophages: 145.8;T-cells: 178.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 36.3;HMC-1: 36.8;Karpas-707: 34.1;U-698: 39.5" "Region enriched" "Detected in many" 6 "cerebellum: 71.1" "Low region specificity" "Detected in all" HPA034858 Enhanced Uncertain "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA034858: AB_10670981" "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (3.68e-2)" "unprognostic (3.61e-2)" "unprognostic (3.63e-2)" "unprognostic (7.43e-3)" "unprognostic (1.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.14e-1)" "unprognostic (9.90e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.72e-8)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.64e-2)" "unprognostic (5.80e-2)" 21.0 4.1 3.2 42.8 3.8 103.4 10.1 3.2 3.3 8.2 18.8 1.1 3.8 8.5 3.4 3.9 8.9 6.3 8.6 5.7 3.3 2.2 7.2 2.9 26.2 53.7 2.3 1.8 3.1 5.0 0.7 3.8 6.5 1.7 6.8 5.7 3.5 16.7 6.1 3.4 10.9 31.8 5.3 2.7 59.3 6.0 4.6 1.4 72.2 7.5 7.0 56.2 11.3 6.0 16.9 13.6 62.0 27.0 10.3 28.4 19.0 3.2 2.2 3.4 1.2 15.0 5.7 3.8 7.7 11.6 8.5 8.9 6.8 1.1 36.3 7.1 4.4 2.2 2.2 1.4 3.3 10.4 6.4 3.8 3.4 2.9 0.6 4.5 13.7 36.8 7.2 3.3 10.5 5.5 12.1 3.5 8.6 2.6 34.1 21.1 1.7 17.8 31.0 1.9 5.9 5.2 2.9 20.7 11.0 5.0 7.6 1.3 1.3 1.9 1.9 1.6 5.5 1.3 7.2 4.2 8.3 4.1 5.9 4.3 14.0 22.6 39.5 6.2 4.7 3.6 35.9 19.7 40.2 12.0 20.7 15.3 13.3 21.5 14.5 13.6 16.9 28.4 23.1 62.0 10.3 27.0 9.7 18.5 19.0 3.2 3.8 3.2 3.3 3.3 2.2 2.3 1.8 1.7 1.4 83.4 80.3 158.6 22.9 53.1 0.3 2.2 10.2 34.8 52.4 10.4 0.0 5.9 3.3 5.2 4.6 11.6 59.1 46.7 2.5 20.9 21.2 28.7 189.5 2.4 23.5 0.0 2.9 7.4 142.8 2.0 5.2 145.8 55.6 40.5 11.0 0.9 7.9 38.6 4.2 1.4 0.2 6.5 20.5 28.6 24.9 55.5 4.2 178.5 10.5 39.9 STK26 "MASK, MST4" ENSG00000134602 "Serine/threonine kinase 26" Q9P289 X 132023265-132075943 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 44.8;Syncytiotrophoblasts: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 41.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059921 Approved Uncertain "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" Yes No Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA059921: AB_2684163" "unprognostic (6.53e-2)" "unprognostic (7.83e-2)" "unprognostic (1.77e-1)" "unprognostic (1.02e-3)" "unprognostic (4.42e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (1.42e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (4.76e-2)" "unprognostic (1.83e-1)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" 5.4 1.4 1.1 13.5 5.1 25.9 3.3 3.8 1.1 18.0 6.4 0.3 34.8 3.7 42.3 29.6 11.7 6.0 5.2 1.9 1.2 2.3 3.5 3.2 6.7 12.8 1.2 0.3 4.7 4.0 10.2 5.8 50.7 1.2 11.5 4.8 2.2 6.3 22.4 1.2 5.1 6.1 19.1 1.5 8.5 4.7 5.2 0.8 44.7 2.3 6.8 10.2 18.0 6.6 8.4 6.2 26.4 11.6 22.0 13.3 10.2 9.1 3.2 0.4 0.0 1.5 1.4 21.0 0.3 1.1 0.1 0.1 8.4 8.3 12.5 5.7 2.0 6.5 10.4 23.4 14.7 0.0 10.8 19.1 18.0 7.9 7.9 1.4 37.6 1.5 2.0 8.8 0.0 9.9 4.4 4.1 17.2 8.0 11.8 3.5 8.1 38.7 35.0 18.8 6.2 1.2 28.0 11.6 16.1 9.5 14.8 7.8 8.6 5.5 5.0 0.2 17.0 6.4 9.9 0.1 3.8 4.0 11.4 13.5 9.1 14.2 13.9 3.4 41.0 1.9 26.4 5.1 16.6 13.3 6.7 13.0 8.4 9.1 11.3 6.2 7.3 11.8 12.2 10.0 22.0 11.6 2.3 4.0 10.2 1.1 5.1 3.8 1.1 1.2 2.3 1.2 0.3 1.2 0.8 20.8 14.1 8.6 27.8 0.0 0.0 1.1 5.1 12.0 14.8 10.4 0.0 44.8 3.3 4.4 0.4 0.4 0.9 0.0 6.3 28.5 4.9 17.5 10.5 3.0 10.7 0.0 1.2 0.6 10.1 0.0 3.1 7.2 0.0 9.0 6.4 0.0 8.6 3.5 2.1 1.2 0.0 6.5 2.9 1.1 2.3 0.0 49.4 17.5 6.3 15.3 STMN4 RB3 ENSG00000015592 "Stathmin 4" Q9H169 8 27235323-27258420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 132.2" "Group enriched" "Detected in some" 6 "Bipolar cells: 43.7;Horizontal cells: 87.4" "Cancer enriched" "Detected in some" 27 "glioma: 14.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 26 "SCLC-21H: 45.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027765 Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA027765: AB_1857607" "unprognostic (1.52e-1)" "unprognostic (3.45e-2)" "unprognostic (2.37e-2)" "unprognostic (3.19e-6)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (8.27e-2)" "unprognostic (1.37e-1)" "unprognostic (3.57e-3)" "unprognostic (2.36e-1)" "unprognostic (2.31e-3)" "unprognostic (9.84e-2)" "unprognostic (1.68e-3)" "unprognostic (1.37e-2)" "unprognostic (5.96e-2)" "unprognostic (4.15e-1)" "unprognostic (7.63e-2)" 1.5 7.9 30.8 1.5 23.4 1.5 1.5 22.2 132.2 1.5 2.3 37.3 0.0 1.8 1.5 2.0 1.5 1.5 1.6 1.4 36.3 27.9 1.5 1.4 1.5 1.5 34.9 37.2 1.4 1.4 1.5 0.0 1.4 21.4 1.5 2.3 0.0 1.5 1.5 1.4 1.5 2.2 1.8 71.8 1.4 1.5 1.6 6.6 0.0 1.4 0.0 1.4 1.5 0.0 1.0 0.9 0.3 0.2 0.1 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.7 0.0 0.1 0.3 0.2 0.4 0.1 1.0 0.7 0.2 0.3 0.1 0.2 0.9 0.4 0.0 30.8 23.4 22.2 34.4 36.3 27.9 34.9 37.2 21.4 6.6 0.0 0.0 0.0 0.1 0.3 43.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 87.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 1.4 0.0 11.1 0.0 0.0 0.5 1.2 0.1 0.0 0.0 0.0 0.0 STON2 "STN2, STNB2" ENSG00000140022 "Stonin 2" Q8WXE9 14 81260656-81436465 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 23.2;Proximal tubular cells: 20.1;Urothelial cells: 26.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;intermediate monocyte: 3.6" "Lineage enriched" "Detected in single" 4 "monocytes: 3.6" "Cell line enhanced" "Detected in many" "HEL: 43.7;HMC-1: 24.8;Karpas-707: 22.5;RT4: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003086 Enhanced Approved Nucleoli,Cytosol NA NA 9800 "Nucleoli, Cytosol" "HPA003086: AB_2302748" "unprognostic (5.28e-2)" "unprognostic (9.83e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.50e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (3.55e-2)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (3.30e-1)" "unprognostic (9.88e-2)" "unprognostic (9.19e-2)" "unprognostic (5.82e-3)" "unprognostic (1.37e-1)" "unprognostic (6.15e-2)" "unprognostic (1.44e-1)" 6.1 1.2 26.8 1.5 23.5 5.6 11.5 2.0 22.4 4.3 5.3 18.1 1.6 4.7 1.8 6.7 11.3 13.6 7.1 4.0 26.1 11.6 17.5 3.7 5.0 1.3 10.3 11.5 3.7 1.3 0.6 7.9 4.3 9.6 2.6 6.1 7.9 4.6 3.8 9.5 9.2 4.9 2.2 4.5 18.7 6.8 4.0 15.9 0.3 13.1 4.9 3.4 6.8 6.6 0.0 0.5 0.8 3.6 0.0 0.1 3.2 1.8 1.3 4.8 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.1 4.3 1.5 0.0 2.2 0.0 1.3 12.0 6.7 15.1 0.0 0.2 2.3 43.7 8.0 1.6 0.0 0.0 24.8 0.6 13.3 0.0 4.6 0.0 0.0 2.5 16.0 22.5 0.4 2.7 2.1 0.0 4.8 4.3 1.1 0.0 7.1 1.4 3.2 18.1 11.8 0.7 5.3 0.2 0.0 4.0 0.6 0.1 0.2 0.9 3.7 4.0 1.0 2.6 4.6 0.0 3.3 0.1 1.1 0.0 2.4 0.0 0.1 3.6 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.8 0.0 1.2 0.0 0.0 3.2 26.8 23.5 2.0 17.5 26.1 11.6 10.3 11.5 9.6 15.9 3.0 0.3 0.0 9.7 12.0 0.4 1.2 2.5 2.7 1.2 17.4 11.8 0.8 6.6 0.6 0.2 2.2 4.1 0.0 0.4 0.3 5.3 4.6 0.0 0.8 2.6 3.2 0.0 4.9 10.2 1.1 9.5 2.5 1.7 0.0 2.5 23.2 2.1 1.5 8.1 20.1 6.7 0.0 1.2 0.9 6.6 7.8 12.9 0.5 3.3 26.4 STPG3 "C9orf173, FLJ40246" ENSG00000197768 "Sperm-tail PG-rich repeat containing 3" Q8N7X2 9 137251261-137253483 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 55.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.3;RPMI-8226: 3.0;SK-BR-3: 3.0;T-47d: 4.6;U-266/70: 2.9" HPA044352 Uncertain Vesicles NA NA Vesicles "HPA044352: AB_10965328" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (4.32e-3)" "unprognostic (4.72e-4)" "unprognostic (2.56e-1)" "unprognostic (1.22e-2)" "unprognostic (1.08e-2)" "unprognostic (2.77e-3)" "unprognostic (1.29e-1)" "unprognostic (3.93e-2)" "unprognostic (8.59e-4)" "unprognostic (2.09e-1)" "unprognostic (7.25e-2)" "unprognostic (2.65e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (7.95e-2)" 0.8 0.4 0.2 0.2 0.2 0.1 0.4 0.2 0.2 0.3 0.2 0.2 0.2 4.4 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.0 1.1 1.7 0.2 0.2 0.2 0.2 0.2 1.4 0.0 1.1 0.2 0.2 0.2 0.0 0.2 1.5 0.2 0.2 0.5 3.2 0.2 0.2 0.2 0.5 55.3 0.2 0.2 1.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.9 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.6 2.0 1.2 0.3 0.0 0.0 1.0 0.0 0.0 0.0 7.3 0.0 0.1 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.5 1.3 1.1 0.0 1.7 0.0 0.2 0.0 0.5 0.4 0.0 0.0 3.0 0.0 0.0 0.9 0.6 0.4 3.0 0.0 0.6 4.6 0.0 0.0 0.8 1.4 0.2 0.0 2.9 1.5 1.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STRADB "ALS2CR2, CALS-21, ILPIP, ILPIPA, PAPK" ENSG00000082146 "STE20-related kinase adaptor beta" Q9C0K7 2 201387858-201480846 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Erythroid cells: 186.9;Proximal tubular cells: 173.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 60.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026549, HPA028520" Approved Uncertain Aggresome,Cytosol NA NA Cytosol Aggresome "HPA026549: AB_1844779, HPA028520: AB_10604100" "unprognostic (6.34e-2)" "unprognostic (2.48e-1)" "unprognostic (2.63e-1)" "unprognostic (3.56e-3)" "unprognostic (4.04e-2)" "unprognostic (7.64e-2)" "unprognostic (1.35e-1)" "unprognostic (1.58e-1)" "unprognostic (2.63e-3)" "unprognostic (2.65e-2)" "unprognostic (6.21e-2)" "unprognostic (2.74e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.08e-1)" "unprognostic (7.83e-2)" "prognostic favorable (4.45e-4)" "unprognostic (4.93e-2)" 13.8 28.6 13.8 7.9 11.7 32.7 9.2 8.8 13.5 6.4 13.7 16.9 4.9 18.8 10.3 9.5 8.9 5.7 7.9 15.2 15.3 11.5 35.2 50.5 7.2 10.1 15.8 11.0 7.8 9.1 3.9 14.1 11.6 12.7 7.1 15.9 10.1 7.1 7.7 48.3 4.4 21.3 7.4 21.0 7.3 4.7 7.8 9.4 8.3 9.7 7.8 7.7 6.2 6.2 24.1 10.4 9.7 8.6 16.3 10.4 9.6 3.9 6.8 11.9 15.2 19.4 24.6 8.4 8.0 14.0 11.2 17.0 9.0 3.8 0.0 5.3 12.7 13.8 4.0 11.5 7.6 20.3 4.6 9.4 4.8 3.2 19.9 14.7 5.6 5.4 20.8 6.9 14.3 12.8 20.9 8.4 9.2 10.2 1.7 60.3 2.1 5.1 9.8 16.0 3.7 7.0 7.0 4.6 2.9 9.5 3.2 2.0 9.8 5.5 4.2 23.6 22.7 2.2 10.8 8.1 6.9 5.3 8.7 6.1 6.7 11.8 1.8 11.6 2.5 6.4 3.4 8.0 9.7 6.0 8.6 5.4 16.7 8.0 8.6 10.4 24.1 10.4 10.3 1.6 16.3 7.5 4.6 9.5 9.6 13.8 11.7 8.8 13.5 15.3 11.5 15.8 11.0 12.7 9.4 8.9 3.4 20.8 6.4 1.9 10.4 29.0 15.3 5.3 3.4 14.0 78.5 41.3 33.2 9.4 3.0 4.9 62.6 186.9 13.6 22.9 10.8 10.0 5.7 77.9 16.8 11.1 16.3 3.1 17.8 5.8 10.0 8.3 15.1 17.2 23.2 13.5 11.0 26.2 3.5 173.8 17.1 6.5 4.1 27.0 44.7 1.3 23.3 9.6 22.7 7.7 STT3A "ITM1, MGC9042, STT3-A, TMC" ENSG00000134910 "STT3A, catalytic subunit of the oligosaccharyltransferase complex" P46977 11 125591712-125625215 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 202.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030735 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA030735: AB_10603342" "unprognostic (8.25e-3)" "unprognostic (5.45e-2)" "unprognostic (3.02e-2)" "prognostic favorable (1.32e-4)" "unprognostic (5.10e-2)" "unprognostic (1.72e-2)" "prognostic unfavorable (3.57e-4)" "unprognostic (8.40e-2)" "unprognostic (4.80e-2)" "unprognostic (1.16e-2)" "unprognostic (8.96e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.60e-2)" "unprognostic (6.38e-2)" "unprognostic (1.28e-1)" "unprognostic (1.82e-2)" 20.6 20.5 8.3 13.1 11.7 8.3 16.9 10.7 13.9 27.8 19.3 17.7 39.6 12.0 30.5 41.4 19.6 20.8 15.1 19.5 8.3 9.1 26.2 67.1 18.7 14.9 9.3 7.7 30.1 59.0 202.3 27.5 35.9 11.6 22.2 17.4 20.8 50.7 41.4 9.5 12.9 19.8 17.1 12.3 21.8 17.7 17.1 6.7 19.2 38.6 13.6 20.8 19.5 18.0 15.0 53.2 27.0 15.5 17.2 27.5 13.4 21.0 19.2 24.5 33.6 46.2 35.8 26.3 38.5 46.0 31.3 39.2 58.2 56.9 27.4 46.7 56.6 44.4 38.9 33.9 33.7 41.7 21.3 18.0 64.5 13.2 40.2 51.1 38.6 30.3 27.6 24.5 43.4 84.8 36.9 34.9 12.3 27.1 41.1 39.5 15.5 15.5 12.3 15.7 42.1 20.9 18.4 20.9 41.2 34.2 32.7 15.2 13.2 27.2 44.5 13.7 30.0 52.2 27.8 31.2 45.2 16.3 19.0 30.2 12.9 15.1 21.1 17.4 39.1 35.8 27.0 15.5 11.6 19.7 14.8 27.5 15.0 19.1 18.2 21.6 11.6 13.8 16.0 5.4 17.2 13.0 53.2 14.1 13.4 8.3 11.7 10.7 13.9 8.3 9.1 9.3 7.7 11.6 6.7 26.8 23.5 18.2 11.3 14.3 10.2 18.6 12.7 14.7 14.8 15.7 19.6 40.7 1.7 26.7 7.6 11.9 13.5 23.3 23.5 56.2 25.7 16.7 16.2 32.7 27.0 1.6 15.0 33.2 22.3 2.6 19.8 13.2 23.6 8.2 32.3 15.2 29.5 14.0 17.7 11.9 13.8 19.4 10.3 29.9 10.9 12.9 38.1 13.3 22.9 12.9 STX17 FLJ20651 ENSG00000136874 "Syntaxin 17" P56962 9 99906633-99970341 "Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001204 Approved Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA001204: AB_1080118" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (8.67e-2)" "unprognostic (2.93e-1)" "unprognostic (6.71e-2)" "unprognostic (1.88e-1)" "unprognostic (2.36e-1)" "unprognostic (1.70e-2)" "unprognostic (9.75e-2)" "unprognostic (1.62e-1)" "unprognostic (1.04e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.62e-5)" "unprognostic (9.48e-2)" "unprognostic (4.32e-2)" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" 15.1 15.8 13.5 16.4 16.3 13.6 16.1 10.8 17.8 19.4 18.5 14.2 29.3 13.4 21.7 25.2 19.9 12.0 14.9 14.5 13.8 13.2 14.3 26.0 13.2 11.9 15.4 14.2 18.2 17.8 25.5 37.1 17.6 14.1 18.2 14.6 16.3 20.6 28.7 28.5 20.6 18.9 20.4 19.1 13.3 15.0 12.0 10.4 17.0 21.8 18.3 15.9 18.8 17.8 7.4 4.9 15.5 8.1 14.3 10.4 4.5 10.7 9.8 10.0 12.0 11.4 11.6 19.9 8.2 12.2 9.3 8.0 12.2 14.4 21.0 8.2 8.7 15.0 12.3 8.3 11.5 7.5 18.3 6.8 13.5 12.9 7.4 13.3 19.8 4.9 11.4 13.4 10.0 15.2 9.8 10.8 18.2 18.7 11.7 7.0 13.1 11.8 5.4 8.8 14.0 7.9 10.1 17.7 9.6 12.3 12.5 5.8 10.3 16.6 12.7 8.1 6.7 12.6 5.5 8.5 6.2 8.8 10.0 6.6 16.6 20.2 4.2 8.7 8.3 6.7 15.5 4.2 7.3 7.4 4.5 10.3 7.4 9.1 8.2 4.9 5.9 10.4 9.8 4.3 14.3 8.1 3.1 4.9 4.5 13.5 16.3 10.8 17.8 13.8 13.2 15.4 14.2 14.1 10.4 14.9 21.7 14.5 18.1 9.4 14.0 16.9 10.2 24.1 22.7 22.7 19.6 20.4 24.9 15.8 40.4 13.7 9.7 0.0 17.1 15.8 11.1 23.3 25.4 23.1 9.2 9.5 24.2 20.9 8.3 24.8 23.9 15.1 8.5 27.1 15.7 20.3 14.1 15.9 17.0 15.7 12.9 38.8 13.9 25.9 16.6 10.7 22.9 16.6 13.1 12.9 SULT1E1 "EST, STE" ENSG00000109193 "Sulfotransferase family 1E member 1" P49888 4 69841212-69860152 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 37.8;liver: 26.2;vagina: 15.8" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 47.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 8 "pons and medulla: 3.3" "Cell type enhanced" "Detected in single" "neutrophil: 1.7" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 16 "HHSteC: 38.0;HSkMC: 17.2;hTCEpi: 14.3;HUVEC TERT2: 10.4" "HPA028213, HPA028728, CAB047344" Enhanced Uncertain "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894" "unprognostic (5.60e-2)" "prognostic favorable (4.06e-4)" "unprognostic (2.48e-1)" "unprognostic (1.07e-3)" "unprognostic (2.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.70e-1)" "unprognostic (1.72e-1)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (3.22e-3)" "unprognostic (8.62e-2)" "unprognostic (6.48e-5)" "unprognostic (2.48e-1)" "unprognostic (4.11e-2)" "unprognostic (5.55e-2)" 0.1 9.8 0.1 0.1 0.3 0.1 1.1 0.1 0.4 13.1 8.9 0.5 0.1 19.8 0.4 3.7 0.4 0.1 1.2 0.1 0.1 0.0 1.5 26.2 2.0 0.1 0.3 0.3 0.2 0.1 0.0 0.4 0.1 3.3 1.0 0.1 0.3 4.7 0.3 0.1 10.9 37.8 0.5 0.3 0.1 1.3 0.4 0.1 0.6 0.2 0.1 1.0 0.4 15.8 0.6 0.2 1.7 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 38.0 0.0 0.0 17.2 14.3 0.0 0.4 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.1 0.1 0.3 0.2 0.2 0.1 0.6 0.2 0.1 1.7 0.3 0.3 0.2 0.0 0.0 0.1 0.3 0.1 0.4 0.1 0.0 0.3 0.3 3.3 0.1 0.0 0.0 0.0 1.0 10.5 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.2 0.1 0.0 0.0 47.0 0.2 0.0 0.0 1.8 1.0 0.0 0.3 0.0 1.7 0.0 0.2 0.0 0.5 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 1.3 0.0 0.0 0.1 SUMF2 DKFZp566I1024 ENSG00000129103 "Sulfatase modifying factor 2" Q8NBJ7 7 56064002-56080670 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024040, CAB025743, HPA074892" Enhanced Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" Yes No 730000 "Vesicles, Plasma membrane" "CAB025743: , HPA024040: AB_1857651, HPA074892: " "unprognostic (2.93e-1)" "prognostic unfavorable (6.58e-6)" "unprognostic (2.42e-2)" "prognostic favorable (3.96e-4)" "unprognostic (3.87e-2)" "unprognostic (9.11e-3)" "unprognostic (1.69e-2)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (7.20e-2)" "unprognostic (1.92e-1)" "unprognostic (7.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.74e-2)" "unprognostic (2.64e-1)" "unprognostic (1.99e-3)" "prognostic unfavorable (7.71e-4)" 26.8 38.3 13.0 17.7 17.0 15.4 26.2 10.9 28.2 35.0 31.9 24.8 35.4 31.1 32.2 32.3 23.8 37.8 51.2 16.8 12.8 11.6 36.0 40.4 30.2 25.9 19.8 18.0 28.6 91.0 34.7 18.3 37.5 20.7 29.5 25.0 25.0 39.7 37.1 14.0 23.6 35.1 27.2 19.6 27.0 32.9 16.2 17.6 29.8 33.3 15.1 25.1 29.1 23.1 21.0 43.1 17.1 28.5 15.7 33.4 28.5 64.4 19.5 8.5 39.3 42.0 29.1 13.2 21.1 29.6 17.8 22.2 10.6 52.4 10.1 18.3 30.2 17.3 32.8 5.1 24.4 11.9 16.5 8.2 6.5 12.8 9.9 27.2 15.9 20.8 23.0 24.0 16.0 27.9 36.2 26.2 18.7 20.6 45.4 28.6 14.2 13.5 18.7 11.6 50.2 9.9 10.9 8.7 65.0 24.3 7.1 10.0 12.2 26.5 56.1 25.9 19.9 56.3 26.5 21.6 16.5 23.6 40.4 18.1 30.9 23.5 15.1 27.1 30.1 52.6 17.1 21.0 7.5 26.2 27.4 33.4 21.0 25.6 26.2 24.8 18.7 28.5 27.7 1.3 15.7 28.5 43.1 26.8 28.5 13.0 17.0 10.9 28.2 12.8 11.6 19.8 18.0 20.7 17.6 53.6 29.1 34.1 31.9 30.0 26.4 8.5 76.5 34.8 25.0 85.5 13.7 39.0 16.6 71.5 2.7 41.8 53.0 23.3 48.6 78.8 43.6 38.3 53.1 70.4 61.1 41.3 57.0 43.0 64.9 5.8 64.5 46.7 50.6 84.8 54.5 25.7 53.3 63.1 44.6 36.9 12.1 51.8 39.4 16.8 23.6 36.6 39.0 50.0 78.0 31.5 SUSD5 KIAA0527 ENSG00000173705 "Sushi domain containing 5" O60279 3 33150042-33219215 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Sertoli cells: 32.3;Smooth muscle cells: 13.0" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.9;neutrophil: 1.5" "Group enriched" "Detected in many" 9 "B-cells: 1.9;granulocytes: 1.5" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 14.8;HUVEC TERT2: 36.7;LHCN-M2: 14.2;TIME: 14.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052788 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA 4300000 "Golgi apparatus, Vesicles" "HPA052788: AB_2681948" "unprognostic (1.81e-1)" "unprognostic (1.52e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-3)" "unprognostic (1.39e-3)" "unprognostic (4.05e-2)" "unprognostic (3.72e-1)" "unprognostic (6.28e-2)" "unprognostic (2.77e-1)" "unprognostic (2.24e-2)" "unprognostic (1.69e-1)" "unprognostic (2.15e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-3)" "unprognostic (6.45e-2)" "unprognostic (8.46e-2)" "unprognostic (1.89e-2)" 7.6 2.5 7.0 1.5 6.1 0.4 2.5 2.0 13.2 11.0 2.6 4.6 2.3 1.5 7.0 6.5 2.3 7.9 13.1 5.7 6.4 8.1 2.6 1.1 3.0 4.4 6.9 6.9 6.4 1.2 1.0 1.3 0.5 6.3 1.9 2.2 3.7 1.3 10.7 2.2 2.8 2.7 7.7 4.6 3.9 3.3 4.7 3.3 0.0 5.3 2.9 8.1 3.0 3.5 1.9 0.1 1.5 0.1 0.1 0.1 0.1 0.0 0.5 0.6 0.3 0.8 0.1 0.0 4.5 1.6 14.8 5.0 0.0 0.0 0.0 4.2 1.1 4.6 0.0 6.4 2.1 6.1 0.1 7.1 0.0 1.0 0.0 0.1 0.0 0.0 0.6 1.1 9.5 1.8 7.2 36.7 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 1.1 0.3 0.8 0.9 14.4 0.0 7.0 0.6 2.1 0.0 0.3 0.0 0.1 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.9 0.1 0.1 1.5 0.1 0.0 0.1 0.0 0.1 7.0 6.1 2.0 13.2 6.4 8.1 6.9 6.9 6.3 3.3 0.0 0.0 0.0 0.0 0.9 1.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 3.2 0.0 0.6 1.3 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 32.3 13.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 SVIL ENSG00000197321 Supervillin O95425 10 29457338-29736781 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 235.1;tongue: 93.5" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 411.9;Peritubular cells: 245.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 15.2" "Group enriched" "Detected in many" 6 "granulocytes: 15.2;monocytes: 4.2" "Cell line enhanced" "Detected in many" "HaCaT: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010878, HPA020095, HPA020138" Approved Supported "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681" "unprognostic (1.11e-1)" "unprognostic (2.94e-1)" "unprognostic (8.06e-2)" "unprognostic (1.15e-2)" "unprognostic (3.47e-3)" "unprognostic (2.26e-2)" "unprognostic (4.12e-1)" "unprognostic (1.49e-1)" "unprognostic (4.28e-1)" "unprognostic (3.42e-3)" "unprognostic (1.55e-1)" "unprognostic (9.20e-2)" "unprognostic (2.38e-3)" "unprognostic (7.11e-3)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (5.70e-5)" 11.9 2.1 0.7 10.5 1.1 3.7 4.5 0.6 0.9 18.7 42.3 0.6 10.7 1.7 34.3 13.3 18.2 8.9 15.5 25.5 0.5 0.6 2.8 2.0 3.8 2.3 0.8 0.7 13.9 2.4 5.1 4.1 2.9 1.7 12.6 5.3 10.0 10.6 15.3 235.1 4.7 9.1 36.4 1.3 1.5 14.2 5.5 0.5 4.6 6.9 93.5 11.6 28.6 9.9 0.1 0.7 15.2 4.2 1.2 1.7 0.6 17.4 7.5 3.4 1.2 10.0 26.8 5.6 2.8 6.8 1.1 1.1 8.9 17.3 0.0 12.4 1.1 10.9 40.4 1.9 6.6 1.1 0.2 3.7 0.0 9.6 5.7 6.0 1.5 0.3 24.6 6.5 12.5 4.5 22.5 20.0 2.5 0.0 0.1 1.7 5.4 1.4 0.8 1.7 7.8 2.7 3.2 10.2 0.1 11.9 5.8 4.2 3.4 2.5 0.3 8.9 11.7 3.1 1.9 12.9 5.7 5.9 28.3 8.4 0.1 0.0 0.0 22.2 3.4 19.7 2.9 1.1 5.2 1.2 1.9 1.5 0.0 1.1 0.6 0.7 0.1 1.7 1.1 15.2 1.2 4.2 0.2 0.1 0.6 0.7 1.1 0.6 0.9 0.5 0.6 0.8 0.7 1.7 0.5 44.7 29.1 9.7 91.1 62.4 7.4 411.9 15.3 60.2 75.1 36.6 23.6 24.9 6.6 80.7 2.3 48.5 22.2 0.0 36.6 17.5 59.3 70.6 9.3 10.2 8.5 4.8 23.0 21.5 9.7 2.7 101.5 25.2 27.0 1.8 26.4 30.4 47.2 34.5 245.1 9.7 16.1 45.3 155.7 6.3 7.7 52.4 20.7 4.4 38.0 78.2 SYCE1 "bA108K14.6, C10orf94, CT76" ENSG00000171772 "Synaptonemal complex central element protein 1" Q8N0S2 10 133553901-133569835 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 75.4" "Group enriched" "Detected in some" 5 "Early spermatids: 103.1;Late spermatids: 85.3;Spermatocytes: 250.9;Spermatogonia: 112.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "K-562: 17.4;U-2 OS: 16.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040208 Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "HPA040208: AB_10796450" "unprognostic (5.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.85e-1)" "unprognostic (9.05e-2)" "unprognostic (1.61e-1)" "unprognostic (3.20e-1)" "unprognostic (5.75e-1)" "unprognostic (5.38e-2)" "unprognostic (3.36e-1)" "unprognostic (2.22e-2)" "unprognostic (7.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (2.42e-1)" 1.8 1.8 4.9 0.7 5.4 0.3 1.3 8.1 8.2 0.4 0.7 0.9 0.0 0.4 0.8 0.5 0.6 1.4 1.6 0.7 4.0 3.3 0.9 3.9 0.5 1.1 1.5 6.7 1.1 1.5 0.2 0.3 8.6 3.5 1.8 0.6 0.2 0.4 0.6 0.9 0.3 0.5 0.7 1.7 0.8 0.5 75.4 0.0 0.1 1.4 0.1 0.7 0.4 0.0 1.3 2.0 0.3 2.6 0.2 3.2 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.7 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17.4 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.1 16.1 0.2 0.3 0.2 0.3 0.4 0.0 0.1 0.0 0.0 1.7 0.3 3.2 1.8 3.0 0.9 2.4 0.8 1.2 1.3 1.4 2.7 0.0 0.2 2.6 2.0 2.2 1.8 4.9 5.4 8.1 8.2 4.0 3.3 1.5 6.7 3.5 0.0 0.0 1.0 0.0 1.5 0.9 1.8 0.2 2.5 2.7 2.3 0.0 0.0 0.3 0.0 0.0 103.1 0.1 0.0 0.0 0.9 0.1 0.8 0.4 0.0 5.1 0.6 9.5 0.0 0.0 0.0 85.3 4.9 0.6 0.0 0.0 0.0 0.3 0.7 0.0 3.5 0.3 1.6 25.8 0.4 250.9 112.4 0.9 0.2 0.0 0.0 0.3 SYCP2 SCP2 ENSG00000196074 "Synaptonemal complex protein 2" Q9BX26 20 59863563-59933655 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 11.1;testis: 41.7" "Cell type enriched" "Detected in many" 6 "Spermatocytes: 330.2" "Group enriched" "Detected in many" 6 "breast cancer: 6.7;cervical cancer: 11.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "JURKAT: 19.1;MOLT-4: 21.1;SiHa: 37.2;T-47d: 33.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062401, HPA065613" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA062401: AB_2684752, HPA065613: AB_2685519" "unprognostic (8.10e-3)" "unprognostic (8.28e-3)" "unprognostic (1.62e-1)" "unprognostic (2.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.19e-3)" "unprognostic (2.50e-2)" "unprognostic (2.18e-1)" "unprognostic (4.11e-2)" "unprognostic (1.44e-1)" "unprognostic (3.74e-1)" "unprognostic (7.02e-3)" "unprognostic (4.84e-3)" "unprognostic (8.48e-2)" "unprognostic (2.46e-1)" "unprognostic (7.87e-3)" "unprognostic (1.21e-1)" 2.2 0.5 1.3 0.9 2.3 1.4 11.1 2.5 5.7 1.3 1.2 1.0 0.8 1.1 1.1 0.9 0.8 0.8 2.0 2.1 1.2 1.2 3.3 0.8 1.6 3.1 1.8 2.7 0.4 4.9 1.3 3.0 2.9 3.9 2.9 0.8 0.6 3.0 0.7 0.8 2.0 1.7 0.6 1.6 2.3 4.5 41.7 0.8 3.0 1.9 0.2 1.5 1.3 1.0 0.9 0.1 2.6 0.3 0.0 2.7 0.5 0.1 0.5 0.1 0.5 0.2 0.3 0.6 1.6 0.4 0.7 0.1 10.2 1.0 0.0 1.6 0.7 0.3 0.2 0.2 0.0 0.4 3.2 0.2 0.1 2.0 0.1 0.0 0.1 7.6 0.1 0.1 0.1 0.0 0.4 0.0 19.1 0.1 0.0 0.3 4.9 21.1 1.1 0.2 0.6 0.1 0.0 0.0 0.1 0.9 2.4 0.1 1.8 37.2 5.4 1.1 0.7 33.6 1.9 0.2 0.0 1.1 4.5 0.0 0.0 0.0 0.0 0.0 0.7 2.1 2.5 0.3 2.3 2.6 0.0 2.7 0.7 1.5 1.7 0.1 0.9 0.9 1.5 2.6 0.0 0.1 0.1 1.0 0.5 1.3 2.3 2.5 5.7 1.2 1.2 1.8 2.7 3.9 0.8 0.0 0.6 0.5 1.0 0.9 1.3 3.6 2.5 14.7 10.3 1.8 2.0 0.5 1.7 0.6 36.7 2.3 0.0 0.0 3.1 0.2 1.2 2.0 2.3 0.0 0.5 0.0 0.0 3.1 0.6 13.5 4.4 1.1 5.0 0.0 0.0 2.2 1.6 0.2 1.8 2.6 1.0 51.8 1.9 330.2 31.3 0.0 0.3 1.3 0.2 1.1 SYNJ1 "INPP5G, PARK20" ENSG00000159082 "Synaptojanin 1" O43426 21 32628759-32728048 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, RNA-binding" "Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011916 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA011916: AB_1857692" "unprognostic (6.84e-2)" "unprognostic (8.64e-2)" "unprognostic (5.76e-2)" "unprognostic (6.44e-2)" "unprognostic (1.27e-1)" "prognostic favorable (4.43e-4)" "unprognostic (1.45e-1)" "unprognostic (3.73e-3)" "unprognostic (1.63e-1)" "unprognostic (6.22e-3)" "unprognostic (1.84e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-1)" "unprognostic (6.36e-2)" "unprognostic (5.97e-2)" "unprognostic (1.79e-1)" "unprognostic (2.92e-1)" 5.5 6.8 13.6 5.0 25.9 20.6 4.2 19.5 39.0 4.8 4.8 6.5 0.8 3.9 4.6 5.3 3.9 4.0 5.2 5.2 18.3 18.2 7.4 5.5 6.5 5.7 16.6 18.4 4.6 4.5 10.6 10.9 9.3 33.5 3.6 5.5 7.0 3.8 4.0 4.4 5.0 4.6 5.0 7.3 6.0 4.2 9.0 5.7 3.2 6.8 1.5 4.8 4.7 3.3 0.4 3.1 11.5 6.0 0.5 3.0 1.1 5.6 2.8 5.2 5.7 9.1 7.3 10.6 11.7 6.7 7.2 6.0 6.4 2.6 2.1 3.9 7.0 9.6 5.3 9.3 6.8 8.6 6.7 8.9 14.1 9.2 3.5 4.9 5.8 12.5 4.1 5.1 12.4 6.3 5.9 11.2 7.5 10.5 12.1 9.2 5.7 5.4 4.8 3.7 6.2 6.5 5.9 11.3 7.4 7.6 4.1 5.9 4.6 14.4 9.2 5.6 7.4 7.9 7.5 12.3 11.1 5.5 8.9 6.4 6.3 7.3 4.4 8.4 11.0 8.8 3.7 3.4 7.9 1.6 6.0 2.7 0.2 2.4 2.6 3.1 0.4 2.9 2.8 11.5 0.5 5.3 1.6 3.0 1.1 13.6 25.9 19.5 28.7 18.3 18.2 16.6 18.4 33.5 5.7 6.0 4.8 2.9 2.0 4.2 21.5 7.3 5.1 4.0 2.3 1.8 43.2 13.3 5.0 1.6 14.8 7.9 4.9 0.0 1.2 7.9 3.7 2.2 3.5 3.6 8.6 9.5 2.9 8.6 19.0 8.6 2.6 7.5 1.7 1.0 2.7 19.5 2.1 3.5 4.2 5.0 40.7 6.5 3.4 16.4 10.9 2.9 31.8 6.9 4.0 4.1 SYT10 ENSG00000110975 "Synaptotagmin 10" Q6XYQ8 12 33374238-33439819 "Predicted membrane proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;fallopian tube: 8.1" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 2.0;Club cells: 4.5;Distal tubular cells: 6.6;Ito cells: 2.5;Spermatogonia: 4.5" "Cancer enriched" "Detected in single" 5 "renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.8;K-562: 2.2;MCF7: 7.7;NTERA-2: 1.9;RPTEC TERT1: 2.0;RT4: 3.0;SCLC-21H: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA055426 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA055426: AB_2682812" "unprognostic (3.60e-1)" "unprognostic (4.93e-2)" "unprognostic (9.34e-4)" "unprognostic (5.53e-2)" "unprognostic (3.67e-1)" "unprognostic (4.74e-3)" "unprognostic (3.19e-1)" "unprognostic (1.97e-6)" "unprognostic (4.00e-1)" "unprognostic (2.39e-1)" "unprognostic (2.41e-1)" "unprognostic (1.91e-1)" 0.3 1.5 0.6 0.7 10.1 0.1 0.3 0.2 4.1 2.9 3.6 0.9 3.0 1.0 0.3 0.8 0.3 8.1 0.4 0.5 0.8 3.1 3.3 1.4 0.2 0.1 0.6 3.4 0.4 0.2 0.1 5.8 0.2 14.6 1.6 1.6 0.1 1.8 3.2 0.2 0.2 1.3 0.6 2.7 0.2 1.6 0.6 0.3 0.0 0.2 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 7.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 3.0 4.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.1 0.2 4.1 0.8 3.1 0.6 3.4 14.6 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.5 0.0 1.4 4.5 0.0 0.0 0.0 6.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 4.5 0.0 0.1 0.0 0.0 0.0 SYTL2 "CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2" ENSG00000137501 "Synaptotagmin like 2" Q9HCH5 11 85694224-85811159 "Plasma proteins, Predicted intracellular proteins, Transporters" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 65.2" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 139.2;granulocytes: 122.9;Mucus-secreting cells: 160.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 10.5;MAIT T-cell: 17.9" "Lineage enriched" "Detected in many" 6 "T-cells: 17.9" "Cell line enhanced" "Detected in many" "MCF7: 25.3;OE19: 41.5;RH-30: 51.1;RPTEC TERT1: 36.5" "Low region specificity" "Detected in many" HPA039651 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Nucleoplasm, Golgi apparatus" "Plasma membrane" "HPA039651: AB_10795153" "unprognostic (8.07e-3)" "unprognostic (6.72e-3)" "prognostic favorable (2.67e-4)" "unprognostic (9.34e-4)" "unprognostic (6.60e-3)" "unprognostic (2.19e-4)" "unprognostic (2.24e-2)" "unprognostic (5.37e-2)" "unprognostic (5.56e-2)" "unprognostic (5.45e-2)" "unprognostic (1.92e-2)" "unprognostic (2.97e-2)" "unprognostic (2.85e-2)" "unprognostic (4.03e-1)" "unprognostic (1.87e-2)" "unprognostic (9.72e-2)" "prognostic favorable (9.07e-4)" 12.8 5.5 27.6 11.8 13.9 1.8 9.7 6.8 32.0 6.5 26.3 6.8 2.1 11.4 7.6 11.8 9.6 6.3 15.0 5.7 13.8 9.0 14.5 3.9 8.1 5.7 8.4 21.5 3.7 2.5 7.2 5.5 9.8 12.4 9.9 39.8 5.7 8.4 5.8 3.7 4.6 17.7 7.8 12.8 5.4 65.2 3.2 5.1 5.8 4.2 5.0 3.8 17.2 11.3 0.1 0.7 0.0 0.0 3.0 17.9 1.7 0.9 2.2 3.5 0.3 0.8 4.6 0.0 8.6 11.3 7.6 17.4 9.7 1.3 0.2 3.2 6.0 11.1 6.3 0.2 0.7 10.1 0.6 0.0 0.0 0.0 0.1 0.5 0.7 0.1 5.8 1.1 16.5 0.2 1.8 0.0 0.2 0.1 0.1 9.6 25.3 0.0 0.2 5.9 41.5 3.9 0.3 51.1 0.0 36.5 13.2 0.1 0.1 1.9 1.5 0.8 3.1 0.1 0.1 0.0 12.0 4.6 7.5 0.4 0.0 0.0 4.5 12.3 0.1 7.3 0.0 0.0 0.0 10.5 0.0 17.9 0.0 2.1 6.3 0.0 0.1 1.7 3.1 0.0 3.0 0.0 0.7 0.8 1.7 27.6 13.9 6.8 32.0 13.8 9.0 8.4 21.5 12.4 5.1 20.8 30.4 1.4 10.2 3.2 8.3 1.6 10.2 139.2 38.7 64.6 7.9 0.7 0.0 8.4 1.1 3.6 40.7 0.0 14.7 0.2 9.3 37.7 122.9 0.4 0.5 1.6 18.5 7.4 4.7 0.4 1.7 3.9 10.1 1.0 160.5 13.4 13.2 34.8 28.3 7.7 8.1 32.3 29.7 3.3 2.1 5.0 0.3 30.0 35.7 46.4 TACC2 AZU-1 ENSG00000138162 "Transforming acidic coiled-coil containing protein 2" O95359 10 121989174-122254545 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 109.4" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 186.1;Syncytiotrophoblasts: 191.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 36.6" "Low region specificity" "Detected in all" "HPA031020, HPA031021, HPA061394" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 110000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA031020: AB_10669988, HPA031021: AB_2673701, HPA061394: AB_2684500" "unprognostic (3.28e-2)" "unprognostic (4.88e-2)" "unprognostic (1.75e-2)" "unprognostic (7.07e-2)" "unprognostic (2.26e-1)" "unprognostic (1.14e-1)" "unprognostic (9.15e-2)" "unprognostic (8.43e-3)" "unprognostic (1.14e-1)" "unprognostic (3.51e-1)" "unprognostic (2.13e-1)" "unprognostic (1.83e-2)" "prognostic favorable (2.50e-10)" "unprognostic (7.02e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (8.45e-4)" "unprognostic (1.61e-1)" 8.2 5.8 9.6 2.4 11.7 0.6 7.8 17.7 16.6 6.9 17.2 2.6 4.0 6.3 8.4 4.3 13.4 9.6 7.7 43.3 8.0 4.8 19.3 3.8 54.1 0.8 3.1 9.0 4.7 6.3 11.9 41.0 45.4 6.8 12.0 8.6 4.8 18.5 6.0 109.4 28.9 8.2 8.9 3.2 1.3 10.2 2.2 3.9 0.1 19.6 4.4 2.5 15.1 8.8 0.1 0.1 0.3 0.0 0.1 0.2 0.0 7.2 22.8 11.2 6.4 3.2 3.2 13.6 3.2 8.6 4.4 3.1 9.3 12.0 0.0 2.9 5.0 5.1 24.3 3.5 8.6 4.6 1.2 1.8 0.0 2.8 17.7 4.9 0.0 0.1 1.4 36.6 2.4 15.6 3.6 9.2 0.0 1.8 0.2 4.3 9.5 0.0 4.0 6.6 11.2 10.4 0.1 6.4 3.4 12.0 11.1 7.5 6.1 5.2 21.8 11.6 3.4 4.3 0.1 8.5 2.0 1.5 4.9 5.9 1.0 4.5 0.1 3.7 0.0 5.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 9.6 11.7 17.7 16.6 8.0 4.8 3.1 9.0 6.8 3.9 77.4 80.3 0.8 44.9 29.9 18.8 186.1 7.6 88.3 50.0 34.9 0.0 36.8 1.7 7.5 1.6 14.3 44.5 0.0 12.6 2.8 12.8 69.9 6.9 14.5 5.4 41.3 28.8 7.4 0.0 2.1 6.4 3.5 6.8 0.0 35.8 1.1 14.9 38.5 7.1 9.8 2.5 12.9 35.4 0.5 4.3 47.2 191.1 2.5 36.7 77.4 TACC3 ERIC1 ENSG00000013810 "Transforming acidic coiled-coil containing protein 3" Q9Y6A5 4 1721490-1745176 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 43.8;Late spermatids: 49.1;Spermatocytes: 69.6;Spermatogonia: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 54.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005781, HPA006050, CAB010111, HPA022039" Enhanced Enhanced "Vesicles,Mitotic spindle,Centriolar satellite,Cytosol" Yes Yes "Mitotic spindle, Centriolar satellite, Cytosol" Vesicles "CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725" "unprognostic (2.95e-1)" "unprognostic (1.18e-1)" "unprognostic (7.71e-2)" "unprognostic (4.35e-2)" "unprognostic (6.58e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (1.10e-3)" "unprognostic (4.61e-2)" "unprognostic (9.12e-2)" "unprognostic (2.91e-2)" "unprognostic (2.26e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.66e-2)" "unprognostic (2.09e-1)" "unprognostic (4.44e-3)" "unprognostic (9.75e-2)" 3.8 2.7 1.1 39.1 1.1 26.0 3.4 2.1 1.4 1.9 4.4 1.1 0.8 4.5 1.8 2.7 8.8 1.6 3.5 2.0 1.4 1.3 2.5 2.4 4.3 20.1 1.3 0.7 1.6 1.0 0.5 1.8 5.7 1.1 1.6 4.9 1.6 3.0 1.2 2.0 2.6 7.7 2.5 1.8 15.6 3.4 58.1 0.9 64.3 1.6 7.3 27.9 3.2 3.0 4.0 10.4 54.8 19.9 3.8 17.9 16.1 25.4 21.2 32.5 18.6 1.7 3.6 18.3 28.9 15.5 33.2 22.0 23.5 30.8 32.5 12.3 15.7 38.6 17.2 34.3 21.0 33.8 14.3 18.6 27.5 17.6 21.6 1.6 37.2 23.4 1.5 1.4 20.9 12.1 7.3 25.2 26.8 24.8 25.7 31.4 20.8 49.0 53.3 35.1 21.8 27.9 34.8 23.0 13.0 18.8 38.6 25.3 15.9 17.4 11.0 8.1 25.5 21.6 21.6 14.7 19.4 23.2 17.5 43.5 18.0 23.9 52.1 11.2 36.0 27.4 24.7 19.9 17.9 5.5 9.0 6.0 4.0 12.3 7.6 10.4 3.8 17.9 9.8 54.8 3.8 5.5 3.1 17.5 16.1 1.1 1.1 2.1 1.4 1.4 1.3 1.3 0.7 1.1 0.9 0.0 7.9 16.0 0.5 1.9 1.0 2.2 0.0 0.0 4.5 8.7 7.9 3.3 0.0 2.1 43.8 2.5 2.0 23.3 0.6 16.5 2.6 1.0 4.7 4.3 35.7 4.8 1.2 4.9 20.5 49.1 2.6 21.9 0.0 12.6 3.1 1.4 1.9 3.5 2.5 1.8 3.2 6.5 1.0 69.6 47.8 1.3 3.3 15.3 5.7 1.3 TAF11 "TAF2I, TAFII28" ENSG00000064995 "TATA-box binding protein associated factor 11" Q15544 6 34877778-34888089 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029326, HPA049127" Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA029326: AB_2672999, HPA049127: AB_2680645" "unprognostic (4.02e-2)" "unprognostic (5.36e-3)" "unprognostic (7.41e-2)" "unprognostic (5.18e-3)" "unprognostic (6.65e-3)" "unprognostic (1.70e-1)" "unprognostic (2.56e-3)" "unprognostic (1.45e-2)" "unprognostic (1.68e-3)" "prognostic favorable (5.87e-4)" "unprognostic (2.91e-1)" "unprognostic (6.77e-3)" "unprognostic (1.89e-2)" "unprognostic (3.24e-1)" "unprognostic (1.87e-2)" "unprognostic (4.92e-1)" "unprognostic (3.32e-1)" 20.6 25.5 22.2 26.8 28.1 43.1 27.2 30.1 29.8 23.0 23.2 17.5 26.7 21.1 23.6 24.2 23.5 22.7 22.0 33.3 21.5 17.9 20.7 28.7 23.2 28.6 24.8 22.1 27.9 25.4 16.7 18.8 30.6 26.7 23.8 25.3 20.4 20.3 31.0 39.3 31.2 24.2 26.8 23.4 31.1 22.6 32.7 29.0 29.4 23.3 24.6 28.7 22.8 22.6 14.9 20.1 26.5 23.6 13.2 16.7 12.8 14.7 6.5 21.3 37.5 13.3 14.2 18.8 11.9 10.0 20.5 19.8 14.9 9.5 20.3 15.9 11.3 9.9 9.4 26.1 11.0 16.7 12.2 21.0 22.7 13.4 25.0 18.8 28.7 16.0 15.9 18.0 13.8 11.3 12.5 24.9 22.7 35.8 15.7 9.8 26.9 18.3 24.0 19.0 31.0 11.1 20.0 18.9 15.9 15.1 9.6 25.7 23.2 14.0 15.4 26.8 19.1 24.9 36.1 14.3 14.2 18.7 8.2 14.4 14.2 35.0 29.1 5.3 34.4 20.5 26.5 23.6 19.3 12.6 21.0 12.1 11.6 13.4 13.5 20.1 14.9 15.7 14.0 14.6 13.2 16.8 17.7 16.7 12.8 22.2 28.1 30.1 29.8 21.5 17.9 24.8 22.1 26.7 29.0 26.8 15.0 26.1 25.7 40.9 27.7 20.1 17.8 9.4 27.3 40.1 11.8 61.7 54.7 36.9 4.5 33.1 30.6 46.7 54.7 56.3 29.1 24.0 21.9 52.1 38.6 30.2 37.9 55.9 51.2 5.7 31.4 34.5 23.6 33.3 34.7 36.0 41.8 49.1 35.0 24.2 31.6 32.3 23.1 88.2 45.3 51.1 64.2 35.9 39.2 25.5 TAOK1 "FLJ14314, KIAA1361, MAP3K16, MARKK, PSK2, TAO1" ENSG00000160551 "TAO kinase 1" Q7L7X3 17 29390464-29551904 "Enzymes, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007669 Approved Uncertain Vesicles NA NA 13000 Vesicles "HPA007669: AB_1080201" "unprognostic (1.46e-1)" "unprognostic (7.15e-3)" "unprognostic (2.70e-2)" "unprognostic (1.52e-1)" "unprognostic (1.81e-2)" "unprognostic (4.85e-2)" "unprognostic (1.28e-2)" "unprognostic (4.31e-2)" "unprognostic (1.15e-1)" "unprognostic (6.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.36e-1)" "unprognostic (2.85e-2)" "unprognostic (5.53e-3)" "unprognostic (3.57e-1)" "unprognostic (1.66e-1)" "unprognostic (2.62e-1)" 17.2 11.5 19.1 11.9 25.0 12.7 13.3 20.1 24.4 15.8 11.9 22.2 7.9 7.1 14.9 10.8 12.7 11.0 11.6 15.3 18.7 15.5 13.6 10.6 13.2 11.1 30.0 17.6 13.5 9.3 31.7 13.7 14.3 21.8 12.0 10.7 10.9 11.1 13.3 15.0 13.8 9.8 17.7 21.0 13.0 10.8 14.3 23.5 11.7 17.7 6.0 11.2 14.5 17.1 2.4 4.8 5.5 2.1 1.4 3.0 0.9 13.7 24.5 19.3 8.2 14.4 18.3 8.1 13.0 13.9 11.9 12.6 13.2 4.8 8.5 12.7 21.1 12.8 10.8 17.6 9.0 21.6 17.8 13.0 13.6 14.1 7.0 10.5 15.0 12.6 12.0 11.6 17.6 18.1 12.6 16.3 8.7 13.9 7.8 15.6 9.2 11.8 5.6 8.2 7.6 6.3 10.9 27.2 5.9 11.3 19.9 10.7 13.1 22.3 20.9 13.4 20.4 15.1 13.9 23.6 18.3 14.9 16.0 18.2 7.2 15.4 9.9 13.4 9.4 16.5 1.7 1.9 1.5 2.0 2.1 1.6 1.6 2.0 2.4 1.7 2.4 3.0 2.2 5.5 1.4 1.9 4.8 1.2 0.9 19.1 25.0 20.1 22.7 18.7 15.5 30.0 17.6 21.8 23.5 44.7 47.4 18.4 23.0 39.5 53.4 78.7 30.6 24.1 38.7 43.6 92.3 15.2 13.3 23.9 10.7 41.3 21.4 0.0 20.9 13.5 47.9 34.5 27.7 23.6 25.9 49.3 36.1 51.5 65.2 12.5 36.8 44.8 38.8 23.4 20.1 35.6 30.2 21.2 50.9 15.9 48.3 25.8 36.8 55.4 33.6 40.1 31.5 19.8 18.0 38.2 TAOK3 "DPK, JIK, MAP3K18" ENSG00000135090 "TAO kinase 3" Q9H2K8 12 118149801-118372945 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Rod photoreceptor cells: 324.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017160 Approved Uncertain Mitochondria NA NA Mitochondria "HPA017160: AB_1851994" "unprognostic (3.21e-1)" "unprognostic (1.31e-1)" "unprognostic (1.65e-1)" "unprognostic (3.74e-2)" "unprognostic (5.18e-2)" "unprognostic (2.09e-1)" "unprognostic (4.80e-1)" "unprognostic (5.86e-2)" "unprognostic (1.00e-1)" "unprognostic (7.38e-2)" "unprognostic (2.76e-2)" "unprognostic (8.23e-2)" "unprognostic (1.08e-2)" "unprognostic (2.08e-2)" "unprognostic (4.14e-3)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" 14.6 16.2 31.9 24.1 31.0 30.8 14.6 44.3 33.5 11.6 21.2 17.2 10.3 23.1 15.2 11.4 16.0 9.8 16.9 15.1 27.8 31.7 14.0 15.3 19.4 26.3 25.7 20.8 17.5 10.9 20.2 23.6 11.9 20.7 25.6 21.3 12.0 13.6 14.6 18.5 17.0 31.6 15.3 23.7 24.2 20.9 8.9 28.6 28.3 18.1 9.9 26.9 18.5 18.3 20.9 22.4 38.2 37.8 36.4 27.8 17.1 8.3 5.8 4.3 3.8 10.7 13.1 4.9 8.8 10.0 5.1 6.7 2.9 13.0 25.6 2.9 11.7 7.4 7.6 3.7 7.8 8.0 9.2 3.2 30.2 2.9 3.8 12.5 30.9 42.6 8.8 9.4 16.1 23.7 10.8 16.3 15.3 17.5 3.0 9.3 5.9 16.3 20.3 1.7 3.9 3.1 9.5 5.9 2.7 4.8 14.5 0.8 4.3 8.1 3.7 11.2 2.0 7.6 23.2 25.3 8.8 1.5 8.2 7.5 2.9 2.8 20.3 12.5 21.4 11.8 38.2 17.0 37.6 27.8 23.3 26.2 20.9 21.2 24.1 22.4 19.3 18.8 24.5 37.7 36.4 37.8 20.9 19.3 17.1 31.9 31.0 44.3 33.5 27.8 31.7 25.7 20.8 20.7 28.6 32.8 78.2 81.8 42.2 31.3 72.1 47.4 63.7 6.7 30.7 43.6 200.3 29.7 59.7 35.4 11.4 29.2 94.6 23.3 52.0 83.1 34.9 47.7 159.8 52.0 71.7 38.1 24.1 26.4 84.7 8.2 35.9 117.0 33.7 141.5 60.6 40.4 64.9 98.2 44.9 27.2 324.3 45.3 40.5 20.5 22.8 27.5 36.6 86.3 58.2 47.4 TAP1 "ABCB2, D6S114E, PSF1, RING4" ENSG00000168394 "Transporter 1, ATP binding cassette subfamily B member" Q03518 6 32845209-32853978 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.3" "Cell type enhanced" "Detected in many" 5 "monocytes: 144.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 16.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009516, HPA072354" Approved Approved "Endoplasmic reticulum,Centriolar satellite" NA NA 110000 "Endoplasmic reticulum, Centriolar satellite" "CAB009516: AB_2303048, HPA072354: AB_2686513" "unprognostic (3.59e-2)" "unprognostic (1.06e-1)" "prognostic favorable (9.01e-4)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (3.22e-2)" "unprognostic (4.92e-2)" "unprognostic (6.16e-3)" "unprognostic (2.56e-2)" "prognostic favorable (4.07e-4)" "unprognostic (3.02e-3)" "unprognostic (2.37e-1)" "prognostic unfavorable (6.58e-5)" "unprognostic (2.07e-2)" "unprognostic (4.69e-2)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" 10.7 7.9 3.8 20.4 5.2 6.1 8.7 3.1 4.9 6.5 12.6 4.5 1.9 9.1 8.2 3.9 10.5 6.4 9.6 6.5 3.5 3.3 6.5 6.4 17.6 26.9 6.4 3.6 5.0 4.4 3.0 3.6 8.7 6.0 9.0 5.4 6.6 9.4 4.4 7.5 15.3 19.5 5.7 5.2 24.2 12.6 5.8 4.9 20.8 13.1 8.9 20.3 6.6 7.6 22.7 8.8 45.3 10.9 14.4 25.3 21.0 2.8 1.8 0.0 1.7 0.9 1.2 16.8 1.5 3.4 7.0 9.5 0.1 3.0 6.0 4.0 1.1 6.5 5.5 1.2 2.5 0.4 10.2 1.6 6.7 1.4 2.3 4.4 0.0 2.4 1.3 2.1 1.9 1.2 0.0 1.7 2.2 0.4 5.7 0.8 1.7 1.1 13.3 0.0 0.6 2.0 5.9 1.2 4.0 9.0 0.5 0.0 0.3 1.6 4.3 5.8 0.3 3.9 12.0 0.9 2.6 1.0 6.4 0.0 7.6 10.6 1.7 1.7 4.0 1.8 27.7 10.6 44.2 15.5 10.9 16.3 22.7 17.5 16.4 8.8 20.9 25.3 19.4 45.3 14.4 10.5 7.2 21.7 21.0 3.8 5.2 3.1 4.9 3.5 3.3 6.4 3.6 6.0 4.9 23.8 29.5 66.8 38.2 66.3 4.1 5.3 35.7 8.1 17.0 5.2 0.0 3.2 5.0 68.6 0.4 41.7 52.4 0.0 65.7 73.1 29.1 47.1 26.5 9.7 45.6 14.3 16.1 26.4 22.4 0.0 12.0 40.0 21.9 144.3 54.7 32.1 71.9 35.1 9.9 5.0 3.0 6.5 44.0 0.9 0.7 66.9 4.0 91.4 30.7 39.7 TAP2 "ABCB3, D6S217E, PSF2, RING11" ENSG00000204267 "Transporter 2, ATP binding cassette subfamily B member" Q03519 6 32821833-32838780 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "monocytes: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.6;U-251 MG: 28.3" HPA001312 Approved Supported "Nuclear speckles,Endoplasmic reticulum" NA NA 14000 "Endoplasmic reticulum" "Nuclear speckles" "HPA001312: AB_1080206" "unprognostic (2.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.28e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.51e-4)" "unprognostic (1.90e-1)" "prognostic unfavorable (5.22e-8)" "unprognostic (5.32e-1)" "unprognostic (4.17e-2)" "unprognostic (2.35e-1)" "unprognostic (4.71e-2)" 12.8 8.4 6.5 22.5 6.9 14.7 9.5 6.3 7.3 8.8 15.0 7.6 3.3 15.3 9.6 5.9 17.4 7.9 11.5 7.7 5.2 6.0 10.8 19.0 18.0 14.0 7.1 6.3 9.7 6.1 2.6 5.8 5.7 7.9 8.2 11.9 7.9 12.1 5.2 5.8 9.6 28.0 7.0 6.1 24.9 7.7 3.3 6.9 25.9 14.7 7.1 20.1 23.6 10.7 0.9 2.8 4.9 5.4 2.9 4.1 1.9 7.9 0.0 0.0 2.3 2.2 3.1 0.0 0.5 1.6 6.2 8.5 2.1 16.3 15.5 3.1 4.0 11.2 8.3 7.1 28.6 2.5 10.5 0.9 1.8 6.1 0.7 1.0 0.0 12.3 0.3 0.4 8.4 13.1 0.0 4.0 0.0 8.6 5.2 0.0 0.6 2.0 1.0 0.3 0.6 4.0 8.4 0.0 5.9 5.2 0.1 0.1 0.0 7.7 16.4 1.6 0.3 0.8 0.0 2.3 8.8 2.0 2.3 28.3 8.1 13.4 14.5 8.1 10.9 1.6 1.7 2.0 1.8 4.1 5.4 2.0 0.9 1.2 2.7 2.0 0.6 1.0 0.6 4.9 2.9 4.1 2.8 1.9 1.9 6.5 6.9 6.3 7.3 5.2 6.0 7.1 6.3 7.9 6.9 0.0 6.9 28.3 12.0 0.0 4.5 2.4 2.5 2.7 6.8 14.0 2.0 1.2 1.7 33.7 0.0 28.7 19.3 0.0 28.6 35.6 4.1 11.3 4.7 5.8 22.4 17.5 3.5 16.0 12.3 0.0 5.2 14.5 0.0 92.8 18.4 18.9 27.4 13.9 5.6 4.7 4.8 0.0 7.5 0.4 1.2 0.0 1.4 24.5 10.3 14.8 TAPT1 FLJ90013 ENSG00000169762 "Transmembrane anterior posterior transformation 1" Q6NXT6 4 16160505-16227410 "Disease related genes, Predicted membrane proteins" "Chondrogenesis, Cilium biogenesis/degradation, Differentiation, Host-virus interaction, Osteogenesis" "Developmental protein, Receptor" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 108.0;Late spermatids: 117.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "REH: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042567, HPA048658" Approved Uncertain Vesicles NA NA Vesicles "HPA042567: AB_2678055, HPA048658: AB_2680482" "unprognostic (2.34e-1)" "unprognostic (5.84e-2)" "unprognostic (1.41e-2)" "prognostic favorable (9.75e-4)" "unprognostic (2.43e-1)" "unprognostic (2.56e-2)" "unprognostic (2.32e-3)" "unprognostic (3.15e-3)" "unprognostic (1.54e-1)" "unprognostic (6.30e-2)" "prognostic favorable (5.34e-4)" "unprognostic (7.07e-2)" "prognostic favorable (8.52e-4)" "unprognostic (9.00e-2)" "unprognostic (8.52e-2)" "unprognostic (7.25e-3)" "prognostic favorable (4.18e-4)" 10.2 19.2 18.6 7.4 18.0 26.2 13.1 15.0 17.3 10.2 10.1 20.2 8.2 8.3 15.1 12.2 8.2 10.7 10.8 14.4 17.5 13.5 15.8 35.9 14.7 11.0 20.1 10.8 10.8 9.8 14.4 14.5 17.2 13.5 10.2 10.7 11.3 9.4 11.0 38.0 9.8 12.8 12.0 18.5 11.2 9.2 13.1 19.1 15.3 17.8 7.8 9.9 10.1 16.8 6.5 1.8 2.6 0.7 0.9 2.4 0.7 3.0 2.2 3.8 4.4 5.7 4.4 1.6 5.0 3.7 4.7 5.2 3.0 5.3 19.4 5.4 3.1 6.9 2.5 3.2 2.5 6.0 1.8 4.0 3.8 3.2 3.2 5.5 7.6 4.0 2.7 4.9 4.6 3.4 5.8 2.3 12.1 5.8 9.1 4.5 2.1 11.2 6.2 2.5 5.7 5.3 27.4 5.3 3.5 7.6 3.1 6.3 5.1 4.6 3.9 5.7 2.7 7.2 7.5 4.4 3.9 2.6 2.6 6.3 8.9 7.3 14.8 8.0 19.0 4.5 2.6 0.7 0.2 0.6 0.6 0.2 2.1 1.8 1.0 1.1 6.5 2.4 1.7 1.6 0.9 0.7 1.8 1.3 0.7 18.6 18.0 15.0 16.2 17.5 13.5 20.1 10.8 13.5 19.1 29.8 50.5 7.1 5.3 8.0 20.4 13.4 12.7 17.4 10.3 7.0 108.0 3.6 3.3 6.4 69.0 8.4 8.4 0.0 7.0 2.3 6.6 5.8 2.3 37.6 3.6 66.7 13.8 6.2 7.5 117.7 9.2 11.5 15.1 2.8 10.1 28.6 7.9 8.6 14.2 7.9 54.9 6.5 7.2 23.1 5.5 6.9 5.8 5.9 7.3 5.6 TBC1D2 "Armus, PARIS1, TBC1D2A" ENSG00000095383 "TBC1 domain family member 2" Q9BYX2 9 98198999-98255721 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 53.6;Hofbauer cells: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 18.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 27.5;HaCaT: 36.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030871, HPA076521" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA Yes "Nucleoplasm, Plasma membrane, Cytosol" "HPA030871: AB_10670046, HPA076521: " "unprognostic (2.32e-2)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (2.77e-4)" "unprognostic (1.86e-1)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (9.21e-3)" "unprognostic (6.40e-3)" "unprognostic (2.30e-1)" "unprognostic (6.07e-2)" "unprognostic (4.32e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.30e-2)" "unprognostic (4.30e-1)" 13.1 4.1 6.6 7.0 15.6 14.5 7.6 7.7 7.6 7.8 12.0 17.8 6.0 15.5 4.4 4.3 25.3 4.4 5.3 2.2 9.5 7.4 4.6 12.6 27.4 4.5 15.2 5.3 4.3 3.0 4.5 3.1 11.9 9.0 8.1 5.9 6.2 10.1 8.8 3.3 18.8 15.2 5.7 14.3 6.7 5.1 3.1 12.2 4.7 7.1 14.7 16.8 14.7 11.6 0.9 7.0 8.1 18.4 0.7 3.9 6.4 27.5 4.0 0.2 0.9 3.1 6.1 9.1 12.2 6.8 8.9 7.4 2.6 12.1 0.4 9.3 7.1 1.9 36.4 0.2 13.6 3.1 0.9 0.5 0.2 14.1 2.0 14.6 0.6 1.1 8.4 22.5 8.9 22.3 15.8 3.1 0.7 0.8 0.3 7.0 3.5 0.1 1.6 0.6 2.7 2.3 0.4 1.8 0.0 13.6 17.2 0.3 0.5 4.1 9.1 1.2 0.6 3.0 0.9 19.0 10.9 3.3 1.8 4.9 0.6 0.5 0.2 11.1 1.0 1.2 1.1 18.4 5.5 1.9 10.8 1.3 0.9 2.8 1.6 7.0 0.6 1.2 1.4 8.1 0.7 8.0 0.9 3.9 6.4 6.6 15.6 7.7 7.6 9.5 7.4 15.2 5.3 9.0 12.2 53.6 12.2 1.9 11.4 7.3 2.4 0.6 7.6 5.3 20.5 3.5 0.0 18.5 3.3 3.7 1.5 3.1 15.0 0.0 2.8 9.4 2.1 3.8 0.0 4.7 31.3 1.6 7.5 0.6 19.8 1.0 1.7 9.3 3.3 3.6 11.1 2.9 8.7 7.0 0.7 2.5 2.2 0.0 2.0 1.6 2.8 9.5 14.5 1.9 4.2 11.1 TBC1D22B "C6orf197, dJ744I24.2, FLJ20337" ENSG00000065491 "TBC1 domain family member 22B" Q9NU19 6 37257772-37332970 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027908, HPA027909, HPA027910" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA027908: AB_10602073, HPA027909: AB_10601857, HPA027910: AB_10602203" "unprognostic (9.83e-2)" "unprognostic (5.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavorable (8.15e-5)" "unprognostic (2.70e-1)" "unprognostic (1.45e-1)" "unprognostic (2.29e-2)" "unprognostic (1.44e-1)" "unprognostic (9.48e-2)" "unprognostic (6.06e-3)" "unprognostic (3.10e-2)" "unprognostic (1.46e-1)" "unprognostic (3.53e-3)" "unprognostic (9.87e-2)" "unprognostic (2.71e-1)" "unprognostic (3.19e-1)" "unprognostic (9.73e-2)" 11.5 17.9 9.6 11.0 12.1 26.0 12.8 15.2 17.1 9.7 13.1 11.2 14.3 13.1 13.9 13.0 19.8 14.1 16.8 11.2 10.5 10.5 13.3 8.7 11.7 9.0 8.9 9.9 15.0 20.9 16.8 11.8 13.3 13.1 12.3 13.3 12.2 21.6 11.8 32.7 20.7 16.1 11.5 8.3 11.1 10.6 19.9 8.2 20.7 13.0 10.5 14.4 10.4 13.3 4.6 7.7 8.0 6.6 5.7 6.2 4.6 7.0 3.0 5.6 6.1 5.2 5.2 8.0 4.0 8.3 7.5 9.2 6.8 4.7 6.6 4.2 5.0 10.1 4.9 7.0 6.3 8.4 10.7 5.7 10.5 5.0 9.2 7.5 5.9 9.0 4.4 9.3 7.3 8.7 7.1 10.4 11.2 11.9 1.7 5.3 6.4 8.7 4.5 7.2 8.1 2.8 5.8 5.1 5.2 7.6 5.2 7.3 4.7 4.3 6.3 7.7 7.8 4.5 10.7 10.1 4.5 7.0 3.0 5.2 6.3 6.5 43.8 3.1 9.0 7.0 2.4 5.0 8.0 4.8 6.6 5.6 3.6 5.3 4.6 7.7 4.6 6.2 5.0 2.2 5.7 2.9 2.2 3.6 4.6 9.6 12.1 15.2 17.1 10.5 10.5 8.9 9.9 13.1 8.2 3.0 6.4 2.7 7.2 7.2 5.1 3.5 2.5 12.0 9.1 1.8 3.9 5.5 3.3 10.8 4.4 4.9 11.1 23.3 13.4 7.1 4.1 7.9 5.7 3.6 4.9 0.0 1.7 4.3 4.3 2.9 2.8 4.3 1.7 7.2 5.1 3.8 13.3 5.8 1.1 7.7 4.6 0.0 2.5 5.5 5.1 13.9 5.6 4.9 4.7 10.1 TBC1D3 "DKFZp434P2235, PRC17, TBC1D3A" ENSG00000274611 "TBC1 domain family member 3" Q8IZP1 17 38181659-38192541 "Predicted membrane proteins" "GTPase activation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 3.4;intestine: 5.5;lymphoid tissue: 3.5;testis: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Cell line enhanced" "Detected in some" "AF22: 9.1;REH: 5.7;U-138 MG: 7.9;U-266/70: 12.4;U-266/84: 4.8;U-698: 6.2" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 3.4 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.9 1.9 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 5.5 0.0 3.5 0.0 0.0 0.0 2.2 0.0 0.0 0.9 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.7 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 7.9 0.0 0.0 0.0 12.4 4.8 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3B "PRC17, TBC1D3I" ENSG00000274808 "TBC1 domain family member 3B" A6NDS4 17 36165681-36176636 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 6.6;testis: 3.5" "Cell type enriched" "Detected in some" 11 "Early spermatids: 11.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.5;HeLa: 9.8;T-47d: 8.0" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (1.05e-1)" "unprognostic (3.63e-1)" "unprognostic (1.94e-2)" "unprognostic (1.49e-1)" "unprognostic (1.67e-1)" "unprognostic (4.13e-2)" "unprognostic (1.11e-1)" "unprognostic (2.83e-1)" "unprognostic (2.51e-1)" "unprognostic (1.17e-1)" "unprognostic (7.15e-2)" "unprognostic (9.96e-3)" "unprognostic (1.05e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-1)" "unprognostic (3.56e-1)" "unprognostic (1.34e-1)" 0.0 0.1 1.0 0.4 0.4 0.1 0.0 0.1 1.2 0.0 0.0 1.0 0.4 0.2 0.0 0.0 0.0 0.2 0.6 0.1 1.3 0.0 0.0 0.2 0.0 0.8 0.8 1.2 6.6 0.5 0.0 2.0 1.9 3.5 0.0 0.1 0.4 0.0 0.0 0.7 0.0 1.0 0.4 0.1 1.5 2.5 1.5 1.8 1.5 1.8 4.9 1.2 0.7 1.3 2.1 0.5 11.5 0.2 1.0 0.7 0.6 5.0 0.7 1.1 0.5 2.0 3.9 0.8 9.8 0.7 0.9 0.3 1.4 1.5 2.3 1.6 0.2 3.3 1.0 1.2 0.7 1.1 0.5 0.1 1.0 4.4 0.5 0.4 0.5 1.5 0.4 0.2 1.6 1.5 1.0 1.3 1.1 0.7 0.9 2.0 8.0 1.0 2.7 0.5 0.4 4.0 0.5 1.6 1.2 0.5 1.5 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TBC1D3C MGC44903 ENSG00000278299 "TBC1 domain family member 3C" Q6IPX1 17 38057693-38068592 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.3;skin 1: 3.5;testis: 3.4" "Cell type enriched" "Detected in single" 8 "Early spermatids: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CAPAN-2: 27.5" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.5 1.2 0.5 0.1 0.0 1.8 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.3 3.5 0.0 0.1 0.0 1.5 3.4 0.0 0.9 0.0 0.0 0.0 0.8 0.3 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 5.3 0.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.2 0.0 1.0 0.0 0.0 2.8 5.6 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3D ENSG00000274419 "TBC1 domain family member 3D" A0A087WVF3 17 38003976-38014902 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 7.9;skin 1: 4.2" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 2.4;Cholangiocytes: 2.5;Club cells: 2.3;Cone photoreceptor cells: 5.9;Pancreatic endocrine cells: 2.5;Syncytiotrophoblasts: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.8;CAPAN-2: 11.6;HaCaT: 8.4;HeLa: 9.4;RPMI-8226: 5.0;RT4: 5.6" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.8 1.5 0.8 0.0 0.0 0.8 4.2 7.9 0.0 0.0 0.0 2.6 0.0 0.5 0.0 0.0 0.0 0.7 0.2 0.0 0.3 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 1.1 8.4 0.0 0.0 0.0 0.0 0.0 2.2 9.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 5.0 0.0 5.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 2.9 1.0 0.0 3.5 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.4 2.5 0.0 2.3 0.0 5.9 0.3 0.0 1.0 0.4 0.0 0.0 0.0 1.6 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 TBC1D3E ENSG00000278599 "TBC1 domain family member 3E" A0A087X179 17 38127951-38138862 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.9;gallbladder: 3.0;pancreas: 4.3;testis: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HHSteC: 9.8" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (1.18e-1)" "unprognostic (3.35e-1)" "unprognostic (3.51e-1)" "unprognostic (4.22e-2)" "unprognostic (6.28e-2)" "unprognostic (1.87e-2)" "unprognostic (5.07e-3)" "unprognostic (1.32e-3)" 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.7 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 9.8 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3F ENSG00000275954 "TBC1 domain family member 3F" 17 36428618-36439566 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 1.3" HPA046969 Uncertain Vesicles NA NA Vesicles "HPA046969: " 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3I ENSG00000274933 "TBC1 domain family member 3I" A0A087WXS9 17 36253456-36264553 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "skin 1: 1.3;testis: 3.0" "Cell type enriched" "Detected in some" 23 "Early spermatids: 30.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 11.1" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.2 0.0 0.9 0.5 0.0 1.3 0.9 0.0 0.3 0.1 3.0 0.0 0.1 0.2 0.1 0.2 0.7 0.2 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.6 0.0 0.1 0.1 0.2 0.1 11.1 0.1 0.6 0.0 0.0 1.7 0.0 0.1 0.0 0.1 0.7 0.7 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.4 0.2 0.1 0.9 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.7 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TBC1D3K ENSG00000273513 "TBC1 domain family member 3K" A0A087X1G2 17 37924415-37935365 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.3;skeletal muscle: 1.1;testis: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SiHa: 2.2;T-47d: 5.4" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3L ENSG00000274512 "TBC1 domain family member 3L" B9A6J9 17 37977972-37989048 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 10.8" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 1.8;Early spermatids: 2.1" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 22.7;hTERT-RPE1: 24.9" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (5.14e-2)" "unprognostic (8.71e-2)" "unprognostic (8.44e-2)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (6.34e-2)" "unprognostic (3.19e-1)" "unprognostic (9.50e-2)" "unprognostic (1.76e-1)" "unprognostic (1.04e-1)" "unprognostic (1.80e-2)" "unprognostic (6.63e-6)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (1.28e-3)" 0.5 2.4 1.8 0.6 1.8 1.3 0.2 1.2 2.4 0.0 2.9 2.4 1.2 0.8 0.0 0.0 0.6 1.0 1.8 0.5 0.3 0.1 0.3 1.4 1.1 3.3 1.3 4.1 10.8 1.0 0.2 2.7 1.8 0.9 0.0 0.3 1.2 0.6 0.3 3.8 0.8 1.0 1.0 0.4 7.0 9.3 3.8 5.7 7.2 6.6 22.7 3.2 2.2 2.9 3.4 5.1 0.1 2.4 0.1 4.1 2.6 11.6 3.4 3.1 1.9 7.0 8.8 0.0 15.1 2.2 5.1 0.9 8.9 5.5 7.6 3.8 2.2 24.9 3.9 4.6 1.8 8.4 4.8 3.8 4.2 21.0 3.6 5.4 2.1 2.8 4.4 0.0 9.2 9.7 5.2 7.2 0.0 3.8 4.2 9.3 5.5 1.5 8.9 0.0 5.1 3.9 4.4 5.9 2.6 0.0 5.9 3.0 3.3 0.0 0.8 0.9 0.3 0.6 0.0 0.1 0.3 0.9 0.1 0.6 0.6 1.0 3.8 1.0 0.8 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.4 0.0 TBCA ENSG00000171530 "Tubulin folding cofactor A" O75347 5 77691166-77868780 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 1097.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036487 Approved Supported Nucleoli,Microtubules NA NA 1000000 Microtubules Nucleoli "HPA036487: AB_10669794" "unprognostic (2.03e-2)" "unprognostic (2.12e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-2)" "unprognostic (2.06e-1)" "unprognostic (1.78e-2)" "unprognostic (4.95e-2)" "unprognostic (9.59e-2)" "unprognostic (1.73e-1)" "unprognostic (5.68e-2)" "unprognostic (4.67e-2)" "unprognostic (1.98e-1)" "unprognostic (2.78e-3)" "unprognostic (7.63e-2)" "unprognostic (2.66e-1)" "unprognostic (1.55e-1)" "unprognostic (7.44e-2)" 40.5 77.3 50.0 32.5 66.7 41.2 108.9 46.8 86.9 33.0 35.7 22.1 34.1 31.8 37.5 78.5 44.4 43.0 27.1 76.7 69.2 56.5 57.7 85.1 59.8 69.6 51.0 50.8 62.3 80.7 24.0 57.9 36.7 77.9 39.1 33.2 30.6 37.3 36.8 43.4 24.6 31.0 62.4 117.9 30.3 38.9 31.2 29.0 26.7 39.8 35.2 40.7 33.3 35.4 53.6 63.1 20.9 39.2 30.9 57.8 34.8 60.2 42.0 77.2 76.1 34.4 49.0 42.2 51.3 44.1 55.9 64.4 57.5 66.6 93.3 94.1 28.8 81.9 37.5 47.7 65.5 55.4 43.4 76.4 44.3 45.2 63.2 50.4 38.3 37.0 49.1 51.7 39.8 61.6 55.3 47.8 77.4 46.1 58.5 50.3 53.5 80.5 92.0 47.4 17.0 38.6 54.5 64.5 99.7 54.1 54.0 74.5 48.5 49.3 34.9 92.2 69.7 49.5 97.1 44.5 28.8 32.0 50.6 80.4 48.4 46.6 81.4 65.6 66.2 57.1 13.9 34.9 18.2 35.9 36.7 40.4 53.6 43.0 42.4 42.4 49.0 41.3 52.0 20.9 30.9 39.2 63.1 57.8 34.8 50.0 66.7 46.8 86.9 69.2 56.5 51.0 50.8 77.9 29.0 142.9 126.0 317.1 216.5 187.4 175.0 82.6 310.8 251.6 117.2 287.9 55.0 354.5 608.5 336.6 34.6 194.4 208.5 233.6 337.0 312.3 228.2 275.0 154.8 1097.6 351.6 139.8 243.5 299.6 467.9 22.5 283.9 268.6 214.2 303.0 234.6 152.1 407.1 224.7 243.3 722.7 101.8 232.8 249.2 165.4 125.2 197.6 471.5 186.9 246.2 247.1 TBCEL "LRRC35, MGC10233" ENSG00000154114 "Tubulin folding cofactor E like" Q5QJ74 11 121024072-121090775 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA038593, HPA038594" Approved Uncertain Cytosol NA NA Cytosol "HPA038593: AB_10669647, HPA038594: AB_2676103" "unprognostic (9.06e-3)" "unprognostic (3.42e-2)" "unprognostic (2.65e-1)" "unprognostic (2.29e-1)" "unprognostic (5.80e-2)" "unprognostic (3.13e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.27e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.14e-1)" "unprognostic (8.55e-2)" "unprognostic (3.07e-3)" "unprognostic (1.86e-1)" "unprognostic (1.66e-2)" "unprognostic (1.02e-1)" 12.4 10.8 9.2 8.3 11.9 6.6 12.2 12.5 13.8 10.8 11.4 15.6 25.8 7.3 18.4 18.3 8.1 11.5 10.8 12.8 9.6 9.1 11.7 19.6 13.7 9.1 12.5 11.1 15.3 10.8 30.8 22.8 14.3 15.8 12.8 8.3 13.2 12.9 17.7 11.0 7.6 9.6 13.1 11.8 14.1 10.2 26.1 12.3 9.5 14.6 6.1 9.6 10.5 10.2 1.1 2.1 0.8 1.4 2.8 2.2 1.0 4.4 4.3 7.4 6.4 13.6 12.9 5.7 8.6 10.6 6.6 9.7 4.4 7.2 5.6 13.3 10.6 6.5 1.2 8.1 2.8 8.9 6.6 6.0 9.6 3.3 4.4 16.9 6.8 6.7 14.1 9.7 6.4 7.0 6.8 10.8 3.2 2.8 10.8 9.2 3.2 2.7 5.6 4.3 0.2 4.2 2.4 10.9 2.5 8.9 2.8 3.9 9.2 8.4 8.9 5.7 6.9 8.5 5.8 14.0 14.7 3.3 5.9 4.7 4.2 3.0 2.9 2.1 0.0 5.5 0.0 1.1 0.5 1.5 1.4 2.1 0.5 2.1 2.1 1.3 1.1 2.2 1.4 0.8 2.8 1.0 2.1 1.0 1.0 9.2 11.9 12.5 13.8 9.6 9.1 12.5 11.1 15.8 12.3 6.0 7.0 4.5 1.7 2.6 8.5 7.0 7.6 6.7 1.2 7.0 13.7 1.3 1.7 3.7 7.6 4.9 2.0 46.7 2.1 1.5 4.2 2.6 1.1 17.9 2.7 7.9 3.5 12.3 6.3 4.2 8.6 2.4 10.1 14.4 2.5 6.0 3.3 0.0 9.2 3.6 8.5 0.0 4.7 12.7 5.5 1.5 1.1 4.4 2.2 1.0 TCEA2 TFIIS ENSG00000171703 "Transcription elongation factor A2" Q15560 20 64049836-64072347 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043836 Approved Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA043836: AB_2678694" "unprognostic (6.51e-2)" "unprognostic (2.02e-1)" "unprognostic (3.91e-2)" "unprognostic (2.16e-2)" "unprognostic (2.80e-1)" "unprognostic (4.91e-3)" "unprognostic (2.38e-1)" "unprognostic (2.91e-1)" "unprognostic (1.65e-3)" "unprognostic (9.03e-3)" "unprognostic (2.49e-2)" "unprognostic (9.67e-2)" "unprognostic (1.17e-1)" "unprognostic (3.81e-3)" "unprognostic (2.70e-1)" "unprognostic (2.28e-1)" "unprognostic (3.79e-1)" 14.8 19.5 31.4 7.9 32.8 6.6 9.3 34.7 40.4 18.3 11.7 17.7 11.0 5.6 18.8 10.9 8.4 24.5 13.5 19.1 27.7 30.0 14.8 27.5 10.9 9.2 27.2 32.8 30.3 16.1 18.6 17.9 14.7 26.5 16.9 3.2 14.5 17.9 22.3 30.7 10.4 7.8 11.7 18.3 16.2 10.5 32.0 18.9 8.7 15.0 6.1 5.2 10.9 15.4 9.7 3.0 4.4 2.6 3.6 5.5 1.6 7.6 8.3 13.2 22.4 11.8 7.4 5.4 8.0 8.9 14.1 6.8 4.9 13.6 8.7 18.0 9.2 8.1 20.5 5.2 6.8 2.8 5.4 10.5 3.3 14.5 12.8 17.6 3.6 4.6 11.5 6.1 3.6 4.7 18.9 9.6 10.9 5.7 16.4 4.3 16.6 14.8 17.7 8.5 9.3 20.0 14.5 10.0 22.5 7.1 5.1 13.1 22.1 8.1 5.5 20.0 4.4 15.2 9.1 13.7 25.5 13.5 14.3 4.9 19.1 12.5 4.6 22.7 4.2 5.0 2.4 1.7 4.4 3.6 1.6 1.6 9.7 3.2 2.6 2.1 5.0 5.5 3.4 0.8 3.6 2.6 3.0 5.4 1.6 31.4 32.8 34.7 37.6 27.7 30.0 27.2 32.8 26.5 18.9 0.0 1.9 12.3 28.6 20.0 50.6 26.9 22.9 6.7 7.9 68.0 25.5 21.6 91.2 30.0 85.6 40.8 1.7 0.0 13.9 11.1 39.4 27.1 2.3 35.5 14.9 62.0 18.3 33.7 14.8 118.7 48.1 23.3 59.1 21.6 2.8 84.3 20.7 2.5 46.3 82.3 30.1 25.8 42.9 95.9 31.9 17.7 17.4 13.8 1.7 17.4 TCEAL3 "MGC15737, WEX8" ENSG00000196507 "Transcription elongation factor A like 3" Q969E4 X 103607451-103629690 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 240.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045564, HPA058982" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045564: AB_2679369, HPA058982: AB_2683870" "unprognostic (2.55e-1)" "unprognostic (2.64e-1)" "unprognostic (2.20e-2)" "unprognostic (1.46e-1)" "unprognostic (1.61e-1)" "unprognostic (1.58e-2)" "unprognostic (2.41e-1)" "prognostic favorable (4.05e-4)" "unprognostic (2.26e-1)" "prognostic favorable (8.33e-4)" "unprognostic (6.35e-3)" "unprognostic (2.30e-1)" "unprognostic (2.22e-3)" "unprognostic (7.19e-3)" "unprognostic (1.79e-1)" "unprognostic (1.53e-1)" "unprognostic (2.64e-1)" 14.8 36.9 36.8 11.0 34.2 9.9 18.3 30.2 47.4 35.0 15.5 24.9 33.7 9.3 42.8 24.9 17.8 27.4 17.9 21.0 33.7 40.7 16.0 5.1 12.5 7.3 43.4 29.1 49.8 22.6 28.3 35.2 13.5 40.3 45.5 7.9 11.9 21.9 55.4 9.7 8.0 8.9 48.3 44.0 18.5 14.5 15.2 23.6 0.8 17.7 4.0 6.4 44.3 23.0 9.6 9.7 4.5 6.9 14.7 12.2 5.3 24.3 2.6 6.6 5.4 23.1 11.8 0.2 36.6 17.3 16.5 22.1 0.0 2.4 0.0 4.5 26.2 29.5 9.6 4.7 14.2 12.1 0.0 1.2 1.8 10.4 0.0 22.2 0.0 8.1 15.2 4.4 11.7 16.7 23.5 11.2 8.5 0.0 7.1 22.4 20.3 1.1 0.1 2.9 0.0 7.0 8.5 4.2 0.1 7.8 4.8 10.2 8.3 1.6 2.1 8.4 3.4 10.0 5.6 14.6 8.7 4.5 17.7 11.2 7.6 3.5 0.0 21.5 0.0 19.0 4.5 6.9 3.8 11.1 3.5 12.2 7.3 9.7 8.8 7.6 9.6 9.7 11.8 1.1 14.7 0.3 9.7 12.2 5.3 36.8 34.2 30.2 31.1 33.7 40.7 43.4 29.1 40.3 23.6 14.9 45.8 12.7 75.4 23.0 50.9 40.8 28.1 71.0 45.5 71.5 17.7 2.8 121.0 35.9 2.5 42.8 1.5 0.0 34.1 1.9 50.3 86.9 94.6 3.4 51.9 17.5 41.8 54.6 26.4 9.3 145.6 40.9 15.1 39.7 22.5 116.7 22.7 8.6 240.8 25.8 28.7 25.8 47.6 2.1 1.5 14.8 2.3 16.0 4.4 34.1 TCEAL6 WEX2 ENSG00000204071 "Transcription elongation factor A like 6" Q6IPX3 X 102140476-102142970 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 14.3;brain: 48.4;pituitary gland: 20.7;testis: 21.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 30.0;Horizontal cells: 14.3" "Cancer enriched" "Detected in single" 9 "glioma: 3.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 1.1;SCLC-21H: 2.0" "HPA045564, HPA058982" Supported Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045564: AB_2679369, HPA058982: AB_2683870" "unprognostic (5.43e-2)" "unprognostic (6.54e-2)" "unprognostic (1.87e-3)" "unprognostic (6.69e-3)" "unprognostic (1.39e-1)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (3.89e-2)" "unprognostic (1.41e-1)" "unprognostic (2.18e-2)" "unprognostic (3.33e-2)" "unprognostic (1.18e-1)" 1.1 14.3 16.6 1.3 15.2 1.0 1.1 31.4 48.4 1.2 1.4 2.5 0.0 1.3 5.3 2.8 1.1 3.2 1.1 1.1 11.3 26.0 1.2 1.0 1.0 1.0 15.2 7.5 6.1 1.3 1.1 20.7 1.0 12.5 1.9 1.3 2.0 3.1 1.9 1.0 1.0 1.3 1.9 7.5 1.0 1.0 21.9 2.8 0.0 1.8 0.0 1.0 1.0 1.7 0.7 0.6 0.1 0.5 1.3 0.7 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.0 0.0 0.7 0.0 0.3 0.1 0.5 0.1 0.5 0.3 0.7 0.4 0.2 0.3 0.5 0.7 0.4 0.6 0.0 1.3 0.0 0.6 0.6 0.6 16.6 15.2 31.4 26.0 11.3 26.0 15.2 7.5 12.5 2.8 0.0 0.0 0.0 0.2 0.1 30.0 4.0 0.0 0.0 0.0 3.5 2.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.1 14.3 0.0 0.0 0.0 2.6 2.3 0.0 1.7 0.0 0.0 2.0 0.7 0.0 0.7 0.0 4.3 0.0 1.9 1.1 0.8 0.3 0.0 0.0 0.0 0.0 TCF7L2 "TCF-4, TCF4" ENSG00000148737 "Transcription factor 7 like 2" Q9NQB0 10 112950250-113167678 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 184.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 12.1;non-classical monocyte: 33.1" "Lineage enriched" "Detected in many" 13 "monocytes: 33.1" "Low cell line specificity" "Detected in many" "Group enriched" "Detected in many" 8 "midbrain: 84.5;thalamus: 98.3" "Group enriched" "Detected in all" 5 "midbrain: 190.1;pons and medulla: 104.8;thalamus: 169.1" "CAB013535, HPA038800" Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "CAB013535: AB_2533167, HPA038800: " "unprognostic (1.79e-2)" "unprognostic (3.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (4.59e-3)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-2)" "unprognostic (5.09e-1)" "unprognostic (7.10e-2)" "unprognostic (6.10e-3)" "unprognostic (3.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (3.64e-1)" "unprognostic (7.36e-3)" 27.4 10.3 8.7 18.7 10.0 7.3 46.4 5.4 10.3 27.4 34.2 15.4 28.1 21.0 26.6 14.9 12.6 18.2 15.3 13.5 8.1 17.9 10.2 22.9 26.9 13.9 8.5 9.0 25.6 13.9 16.5 17.9 24.0 10.2 14.4 23.7 13.9 14.9 52.8 13.7 17.6 40.4 18.0 13.9 27.3 24.0 10.6 10.1 6.6 14.3 9.3 7.0 21.5 16.3 0.0 1.7 2.5 33.1 0.0 0.6 1.1 7.1 18.6 20.4 19.7 10.7 7.1 24.4 5.1 9.9 3.5 4.3 12.3 21.6 0.0 5.7 9.5 4.8 5.1 6.9 8.8 4.5 0.8 6.4 5.0 12.4 11.3 11.4 1.9 1.8 12.6 3.2 5.5 9.4 15.1 5.9 4.2 5.2 0.3 4.1 13.9 3.2 1.2 14.6 8.0 10.7 9.0 15.0 3.2 7.7 9.9 0.4 6.3 7.7 7.6 8.1 16.5 4.9 1.1 13.7 3.3 9.6 8.5 10.4 1.3 0.1 0.1 3.3 4.2 7.4 0.1 1.8 0.1 0.6 12.1 0.4 0.0 0.1 0.5 1.7 0.0 0.1 0.3 2.5 0.0 33.1 0.0 0.0 1.1 8.7 10.0 5.4 10.3 8.1 17.9 8.5 9.0 10.2 10.1 20.8 21.6 4.7 23.8 37.8 2.4 10.6 35.7 20.1 34.2 38.4 5.9 36.9 10.0 28.5 5.5 37.0 121.0 0.0 38.6 184.2 40.4 33.1 0.0 57.7 15.1 4.8 19.0 55.3 68.7 2.7 54.7 21.0 30.4 1.0 68.2 36.6 41.7 91.2 45.6 13.4 5.7 90.5 44.3 3.0 23.4 34.8 23.8 4.3 42.7 42.0 TCTE1 "D6S46, DRC5, FAP155, MGC33600" ENSG00000146221 "T-complex-associated-testis-expressed 1" Q5JU00 6 44278743-44297688 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "fallopian tube: 17.3;testis: 48.6" "Group enriched" "Detected in some" 11 "Early spermatids: 137.7;Late spermatids: 222.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 2.6;Karpas-707: 3.8;SCLC-21H: 3.2;U-266/70: 1.8;U-266/84: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA031739 Uncertain Vesicles NA NA Vesicles "HPA031739: AB_10601269" "unprognostic (3.27e-2)" "unprognostic (1.86e-1)" "unprognostic (2.04e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (7.06e-2)" "unprognostic (1.42e-2)" "unprognostic (3.46e-1)" "unprognostic (3.49e-2)" "unprognostic (1.17e-2)" "unprognostic (7.05e-2)" "unprognostic (2.23e-5)" "unprognostic (7.68e-2)" "unprognostic (3.13e-2)" "unprognostic (1.37e-3)" "unprognostic (2.68e-1)" 0.2 0.2 2.2 0.2 2.2 1.1 0.2 5.8 1.8 0.7 0.2 1.1 0.0 0.2 0.6 3.0 0.2 17.3 0.3 0.2 2.8 2.0 0.2 0.2 2.1 0.2 0.8 1.0 2.2 0.3 0.2 0.2 0.2 3.2 0.4 0.2 0.0 0.4 0.4 0.2 0.6 0.3 0.3 0.6 0.3 0.2 48.6 0.3 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.9 0.0 0.1 0.0 0.2 0.1 0.3 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.4 0.3 0.1 0.2 0.1 0.6 0.3 0.0 0.0 2.6 0.3 0.0 0.4 0.1 3.8 0.0 0.3 0.2 0.5 0.2 0.2 0.0 0.9 0.4 0.0 0.0 0.1 3.2 1.1 0.0 0.2 1.2 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.0 1.8 3.2 0.3 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.1 0.2 0.0 2.2 2.2 5.8 1.8 2.8 2.0 0.8 1.0 3.2 0.3 0.0 0.0 0.0 0.1 0.1 0.6 0.3 0.0 16.0 2.3 0.0 0.0 0.0 0.0 0.0 137.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 222.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 10.7 1.9 0.0 0.1 0.0 0.0 0.0 TDG ENSG00000139372 "Thymine DNA glycosylase" Q13569 12 103965804-103988874 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052263 Supported Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA052263: AB_2681777" "unprognostic (3.15e-1)" "unprognostic (1.36e-1)" "unprognostic (9.89e-3)" "unprognostic (6.93e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.27e-5)" "unprognostic (1.56e-2)" "prognostic unfavorable (6.90e-5)" "unprognostic (5.37e-2)" "unprognostic (1.82e-1)" "unprognostic (8.48e-2)" "prognostic unfavorable (1.90e-10)" "unprognostic (3.68e-1)" "unprognostic (2.90e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" 12.3 16.6 7.0 17.9 11.1 15.9 12.8 10.7 13.4 17.7 14.7 10.0 11.3 11.0 15.8 17.8 23.8 12.4 12.8 12.0 7.7 6.9 13.4 17.4 13.7 19.7 8.7 7.9 14.4 13.2 11.0 21.0 27.9 10.8 13.0 16.8 10.9 13.2 11.3 11.1 16.3 18.7 17.8 8.8 19.8 13.1 5.8 8.1 33.4 12.4 15.3 19.6 13.3 14.7 18.9 41.4 18.8 24.3 14.2 13.6 7.2 13.3 6.8 21.5 12.5 5.3 4.8 21.7 10.1 4.2 14.2 8.0 11.6 6.1 31.6 6.2 8.4 2.3 9.0 25.6 11.9 11.2 12.9 20.7 24.8 10.3 5.2 5.0 30.7 18.8 5.6 15.9 10.5 8.5 8.7 13.9 18.7 27.7 5.3 6.8 14.0 34.3 17.3 26.0 9.9 10.9 35.4 11.1 11.2 15.5 19.8 28.3 19.6 12.3 14.5 9.0 13.2 23.2 16.6 8.4 4.4 7.3 4.7 12.0 11.6 15.3 27.1 4.9 16.6 8.5 18.5 24.3 18.8 13.6 16.3 10.3 17.7 13.0 11.2 14.9 18.9 13.5 12.1 16.0 14.2 15.9 41.4 12.6 7.2 7.0 11.1 10.7 13.4 7.7 6.9 8.7 7.9 10.8 8.1 35.7 18.4 41.0 33.6 70.2 45.5 23.0 35.7 40.2 40.9 31.4 25.5 58.2 31.5 66.4 3.9 43.9 26.9 23.3 46.9 70.7 38.1 38.3 38.3 30.1 39.3 33.4 78.4 36.2 38.6 2.1 25.3 39.1 15.1 39.7 39.8 23.0 64.5 34.5 28.3 18.0 37.1 45.3 30.7 9.9 25.0 89.8 131.0 39.9 38.9 48.0 TDGF1 "CR, CRIPTO, Cripto-1" ENSG00000241186 "Teratocarcinoma-derived growth factor 1" P13385 3 46574534-46582463 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7" "Cell type enriched" "Detected in some" 18 "Distal tubular cells: 102.8" "Group enriched" "Detected in many" 9 "colorectal cancer: 6.4;testis cancer: 27.1" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 9.5;NTERA-2: 43.2;SuSa: 27.0" "Group enriched" "Detected in many" 5 "cerebellum: 12.5;pons and medulla: 9.1" "Low region specificity" "Detected in single" HPA051928 Uncertain Vesicles,Cytosol "Secreted in other tissues" NA NA Vesicles Cytosol "HPA051928: " "unprognostic (7.84e-3)" "unprognostic (2.00e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (2.80e-2)" "unprognostic (1.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (3.61e-1)" "unprognostic (1.72e-2)" "unprognostic (6.77e-2)" "unprognostic (1.74e-1)" "unprognostic (8.76e-3)" "unprognostic (2.01e-1)" "unprognostic (2.10e-2)" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" 0.6 3.9 0.6 0.6 0.8 0.0 0.6 0.6 0.6 0.6 2.1 0.6 0.6 0.2 0.7 1.3 0.6 0.0 0.6 0.6 1.0 0.6 9.9 0.8 0.6 0.6 0.9 0.6 9.7 0.6 0.0 0.6 0.6 0.6 0.6 4.3 1.1 0.6 0.6 1.0 0.0 0.6 0.8 1.0 16.7 2.4 0.6 0.6 5.2 2.1 0.6 0.6 0.6 0.6 1.0 0.7 3.7 0.6 1.5 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 9.5 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 43.2 1.7 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.6 0.5 0.5 0.3 0.3 0.6 0.4 0.3 0.1 1.0 0.6 0.4 3.7 1.5 0.4 0.7 0.2 0.1 0.6 0.8 0.6 0.6 1.0 0.6 0.9 0.6 0.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 5.2 0.0 0.0 102.8 0.1 4.3 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 2.4 0.0 0.0 0.7 0.3 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.7 0.0 TDO2 "TDO, TPH2" ENSG00000151790 "Tryptophan 2,3-dioxygenase" P48775 4 155854738-155920406 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "liver: 187.9" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 1048.1" "Cancer enriched" "Detected in many" 18 "liver cancer: 35.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.6;HDLM-2: 16.7;U-87 MG: 9.8" "Group enriched" "Detected in some" 9 "cerebellum: 7.0;hippocampal formation: 5.9" "Not detected" "Not detected" HPA039611 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039611: " "unprognostic (1.10e-1)" "unprognostic (3.00e-3)" "unprognostic (3.84e-2)" "unprognostic (1.95e-1)" "unprognostic (7.06e-2)" "unprognostic (3.50e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (4.68e-8)" "unprognostic (7.99e-2)" "unprognostic (9.29e-3)" "unprognostic (1.28e-1)" "unprognostic (1.95e-2)" 0.2 0.5 0.2 2.5 0.5 0.0 0.1 0.1 2.0 0.1 0.2 0.0 0.1 0.6 0.1 0.2 0.2 0.1 0.3 0.1 1.5 0.2 0.2 187.9 0.8 2.9 0.2 0.7 0.1 0.1 0.0 5.8 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 1.1 0.4 0.2 1.5 0.3 0.1 0.0 0.0 0.1 0.0 0.4 1.2 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 8.6 0.0 0.2 0.0 0.1 0.0 0.0 16.7 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.1 2.9 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 1.3 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.1 0.4 0.4 0.0 2.7 0.0 0.0 9.8 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 2.0 1.5 0.2 0.2 0.7 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.4 132.5 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.0 23.3 0.0 0.0 0.1 0.3 0.0 1048.1 0.9 0.0 0.0 25.2 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.8 0.2 0.2 0.0 0.2 0.0 0.0 0.0 TEKT2 TEKTB1 ENSG00000092850 "Tektin 2" Q9UIF3 1 36084075-36088275 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "fallopian tube: 41.4;testis: 33.3" "Group enriched" "Detected in some" 7 "Early spermatids: 414.8;Late spermatids: 228.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 45 "neutrophil: 4.4" "Lineage enriched" "Detected in single" 45 "granulocytes: 4.4" "Cell line enriched" "Detected in some" 7 "NB-4: 28.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA027248, HPA027461" Approved Uncertain Microtubules NA NA Microtubules "HPA027248: AB_1857884, HPA027461: AB_10600912" "unprognostic (1.02e-3)" "unprognostic (1.21e-2)" "unprognostic (2.96e-2)" "unprognostic (2.12e-3)" "unprognostic (2.64e-1)" "unprognostic (1.78e-2)" "unprognostic (1.98e-2)" "unprognostic (3.42e-2)" "unprognostic (1.35e-1)" "unprognostic (1.13e-3)" "unprognostic (5.28e-4)" "unprognostic (6.11e-2)" "prognostic favorable (1.98e-4)" "unprognostic (9.78e-2)" "unprognostic (8.35e-2)" "unprognostic (5.29e-2)" "unprognostic (7.68e-2)" 0.2 0.5 1.9 0.2 3.8 0.9 0.8 0.8 1.1 2.3 0.2 3.1 0.5 0.2 1.1 6.1 0.2 41.4 0.2 0.2 2.3 2.5 1.0 0.1 4.0 0.2 0.5 0.8 3.3 1.1 1.2 2.0 0.2 6.4 0.3 0.1 0.1 0.4 1.1 0.1 0.1 0.1 0.4 0.7 0.1 0.3 33.3 1.2 0.3 1.9 0.3 0.2 0.2 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 28.6 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 1.9 3.8 0.8 1.1 2.3 2.5 0.5 0.8 6.4 1.2 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 44.2 4.5 1.8 0.0 0.1 0.0 0.5 414.8 0.1 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.1 0.0 1.7 0.0 0.0 228.6 4.6 0.0 0.0 0.0 0.0 0.9 0.1 0.0 3.5 1.6 0.0 0.0 0.0 6.2 3.8 0.0 0.0 0.0 0.0 0.1 TEKT4 MGC27019 ENSG00000163060 "Tektin 4" Q8WW24 2 94871433-94876829 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 7.6;testis: 21.1" "Group enriched" "Detected in many" 14 "Ciliated cells: 66.9;Early spermatids: 109.5;Late spermatids: 99.2" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 2.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 1.0;fHDF/TERT166: 1.8;HEK 293: 1.0;HEL: 1.3;HMC-1: 1.0;MCF7: 1.5" "HPA048600, HPA053929, HPA069872" Enhanced Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA048600: AB_2680460, HPA053929: AB_2682314, HPA069872: " "unprognostic (1.49e-2)" "unprognostic (4.00e-1)" "prognostic favorable (1.29e-4)" "unprognostic (9.95e-2)" "unprognostic (1.25e-1)" "unprognostic (2.35e-3)" "unprognostic (2.82e-3)" "unprognostic (2.15e-1)" "unprognostic (5.25e-2)" "unprognostic (5.00e-2)" "unprognostic (9.01e-2)" "unprognostic (5.25e-3)" "unprognostic (5.45e-3)" "unprognostic (2.33e-1)" "unprognostic (3.27e-2)" "unprognostic (7.56e-3)" 0.1 0.1 0.7 0.2 1.5 0.1 0.1 0.2 0.2 0.6 0.1 1.4 0.7 0.1 0.5 5.5 0.1 7.6 0.1 0.1 0.9 0.9 0.1 0.1 3.7 0.1 0.1 0.2 1.7 0.2 0.1 0.0 0.1 2.9 0.1 0.1 0.0 0.7 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 21.1 0.3 0.0 1.0 0.0 0.1 0.1 0.0 1.1 1.8 0.7 0.6 0.1 0.8 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.3 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.7 0.6 0.4 0.3 1.1 0.6 0.7 0.8 0.6 0.8 0.5 0.0 0.1 0.6 1.8 0.6 0.3 0.7 1.5 0.2 0.2 0.9 0.9 0.1 0.2 2.9 0.3 0.0 1.0 0.0 0.2 1.3 0.0 0.3 2.5 66.9 5.7 1.8 0.0 0.5 1.7 1.2 109.5 0.9 0.0 0.0 0.3 0.2 1.4 0.4 1.1 0.9 0.2 0.0 0.0 1.8 0.3 99.2 2.6 0.9 0.0 4.6 0.0 0.0 1.2 0.0 1.1 6.3 0.0 6.5 0.9 1.1 0.6 1.1 0.5 0.0 0.1 0.3 TERB2 "C15orf43, MGC33951" ENSG00000167014 "Telomere repeat binding bouquet formation protein 2" Q8NHR7 15 44956702-44979229 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 51.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041780 Uncertain Nucleoplasm,Nucleoli No NA Nucleoli Nucleoplasm "HPA041780: AB_10796460" "unprognostic (1.42e-3)" "unprognostic (4.19e-2)" "unprognostic (1.29e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX10 "bA208F1.2, FLJ20287, Ipi1" ENSG00000136891 "Testis expressed 10" Q9NXF1 9 100302077-100352939 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045434 Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA045434: AB_10965650" "unprognostic (2.88e-2)" "unprognostic (1.73e-2)" "unprognostic (2.80e-1)" "unprognostic (1.21e-1)" "unprognostic (8.28e-2)" "unprognostic (5.26e-2)" "prognostic unfavorable (4.46e-5)" "unprognostic (2.43e-2)" "unprognostic (3.74e-2)" "unprognostic (7.73e-2)" "unprognostic (1.43e-2)" "unprognostic (3.25e-2)" "unprognostic (2.07e-1)" "unprognostic (7.39e-2)" "unprognostic (3.27e-1)" "unprognostic (2.66e-3)" "unprognostic (9.63e-3)" 11.1 8.5 7.6 14.0 10.1 12.2 11.3 12.6 11.1 12.2 9.5 7.7 7.5 6.1 14.2 9.9 12.5 12.1 10.3 10.4 7.7 7.1 7.5 7.9 9.7 15.1 7.3 5.9 14.9 10.3 9.8 13.5 25.4 9.4 10.2 8.1 6.3 10.2 9.1 25.4 16.2 8.7 11.8 9.9 14.4 9.2 24.5 7.2 32.9 10.0 10.2 15.0 11.2 11.9 13.0 9.3 12.4 9.0 9.9 12.6 7.2 11.7 12.9 17.0 19.0 6.2 11.1 26.3 14.8 15.4 19.4 18.1 13.2 13.9 33.4 8.0 9.6 17.9 16.0 24.2 19.1 22.8 13.4 10.7 18.1 8.4 11.5 13.4 26.2 13.6 9.6 10.8 19.7 20.9 9.6 10.5 11.9 20.2 11.0 25.0 18.4 19.1 16.8 34.7 22.9 15.6 18.7 29.0 10.1 14.3 7.7 15.1 12.8 8.1 13.5 13.1 10.9 5.6 7.7 10.7 13.0 11.5 17.3 13.8 7.8 13.2 13.4 13.2 11.8 13.4 12.4 7.6 2.5 9.8 9.0 10.7 12.7 10.0 9.8 9.3 13.0 10.7 12.6 1.9 9.9 6.7 5.4 11.4 7.2 7.6 10.1 12.6 11.1 7.7 7.1 7.3 5.9 9.4 7.2 3.0 9.4 10.0 8.3 19.7 6.7 10.6 0.0 6.7 17.0 8.7 11.8 44.5 3.3 5.8 9.9 8.3 2.1 0.0 7.5 12.7 13.0 6.1 16.2 6.8 8.4 7.9 5.1 6.7 3.8 10.0 8.1 7.5 16.9 7.2 5.2 3.4 6.3 5.3 7.4 3.0 5.9 0.0 12.8 28.4 34.5 19.7 38.6 6.5 6.0 7.1 TEX38 "ATPAF1-AS1, C1orf223, LOC374973, THEG4" ENSG00000186118 "Testis expressed 38" Q6PEX7 1 46668855-46673594 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "testis: 109.8" "Group enriched" "Detected in some" 114 "Early spermatids: 1833.7;Late spermatids: 4115.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.0;SK-BR-3: 2.2;TIME: 2.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA073711 Uncertain Vesicles NA NA Vesicles "HPA073711: " "unprognostic (8.46e-2)" "unprognostic (1.99e-1)" "unprognostic (3.14e-2)" "unprognostic (8.86e-2)" "unprognostic (6.81e-3)" "unprognostic (3.50e-1)" "unprognostic (1.99e-1)" "unprognostic (9.21e-2)" "unprognostic (5.39e-2)" "unprognostic (4.15e-3)" "unprognostic (4.93e-4)" "unprognostic (2.64e-1)" "unprognostic (5.28e-2)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (7.84e-2)" "unprognostic (3.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 2.5 0.3 0.1 1.6 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.0 1.3 0.6 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.8 0.3 0.0 0.5 0.4 0.0 0.6 0.6 0.5 0.1 0.0 0.4 0.1 0.9 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.9 0.0 0.6 0.6 2.0 1.4 1.0 2.2 0.0 1.8 0.8 0.0 2.5 0.3 0.0 1.0 0.2 0.9 0.3 0.6 0.2 0.0 0.2 0.0 0.3 2.5 1.2 0.2 1.6 0.9 0.1 0.9 0.4 0.4 0.9 0.2 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1833.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4115.3 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.4 6.5 0.0 24.7 13.3 0.0 0.0 0.0 0.0 0.0 TEX47 "C7orf62, MGC26647" ENSG00000164645 "Testis expressed 47" Q8TBZ9 7 88794106-88795721 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 158 "testis: 26.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA023817, HPA024163" Uncertain Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA023817: AB_1853868, HPA024163: AB_1853869" "unprognostic (1.43e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TFAP2D TFAP2BL1 ENSG00000008197 "Transcription factor AP-2 delta" Q7Z6R9 6 50713828-50772988 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 4.4" "Cell type enhanced" "Detected in single" 24 "Horizontal cells: 1.6" "Cancer enriched" "Detected in single" 10 "lung cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HAP1: 5.2;U-2197: 1.6" "Region enriched" "Detected in many" 4 "midbrain: 14.1" "Region enriched" "Detected in many" 7 "midbrain: 16.3" HPA048962 Uncertain "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA048962: AB_2680573" 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TFCP2 "CP2, LBP-1C, LSF, TFCP2C" ENSG00000135457 "Transcription factor CP2" Q12800 12 51093663-51173134 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070247 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA070247: AB_2686239" "unprognostic (6.27e-2)" "unprognostic (6.77e-2)" "unprognostic (6.90e-2)" "unprognostic (1.42e-1)" "unprognostic (4.68e-2)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (9.69e-2)" "unprognostic (4.91e-3)" "unprognostic (1.01e-1)" "unprognostic (3.20e-1)" "unprognostic (5.58e-2)" "unprognostic (5.31e-2)" 17.4 16.7 21.1 29.3 21.6 9.6 17.7 22.7 21.6 20.2 19.0 20.5 20.8 15.7 19.3 18.9 16.7 21.1 20.7 17.7 20.0 18.7 17.2 12.5 14.1 20.4 19.4 24.9 20.8 14.6 29.2 23.2 22.4 15.4 20.3 21.7 16.4 17.8 19.0 26.6 15.4 15.9 23.8 21.3 18.4 16.1 11.2 18.6 32.1 17.9 12.9 25.9 19.0 18.1 4.5 8.2 9.1 9.4 9.4 6.1 5.0 7.5 13.0 19.5 17.5 11.2 14.1 28.6 14.7 8.0 12.9 7.7 24.8 16.3 0.7 12.9 12.8 10.3 14.5 24.9 15.8 12.9 16.2 14.4 22.9 12.5 10.3 9.4 25.9 22.2 9.6 14.3 13.3 21.2 15.3 12.0 7.5 23.1 0.0 13.6 0.0 23.3 17.2 28.2 17.8 23.6 18.0 10.8 0.1 16.8 18.2 18.6 16.2 18.2 14.9 11.9 19.0 5.6 21.6 12.1 11.9 12.9 12.3 12.7 14.1 23.8 0.0 11.3 16.1 8.5 9.1 9.2 9.0 3.9 7.7 6.1 4.5 4.1 4.2 8.2 3.4 4.9 4.0 3.5 9.4 9.4 3.5 5.4 5.0 21.1 21.6 22.7 19.4 20.0 18.7 19.4 24.9 15.4 18.6 8.9 16.0 9.8 6.7 6.0 19.0 21.8 7.6 2.7 5.7 12.2 19.6 10.4 5.0 8.7 0.4 9.2 9.2 0.0 6.7 8.9 8.4 9.3 10.4 8.9 11.7 9.5 10.4 9.8 24.1 0.4 11.2 12.1 10.1 16.2 11.9 8.7 9.6 8.6 10.3 7.2 25.6 0.0 7.5 6.1 11.1 4.5 14.0 8.7 14.0 5.4 TFCP2L1 "CRTR1, LBP-9" ENSG00000115112 "Transcription factor CP2 like 1" Q9NZI6 2 121216587-121285207 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 52.2;salivary gland: 93.5;thyroid gland: 37.3" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 45.7;Collecting duct cells: 75.0;Enterocytes: 75.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "pons and medulla: 7.0" "Cell type enriched" "Detected in single" 7 "gdT-cell: 2.9" "Lineage enriched" "Detected in single" 7 "T-cells: 2.9" "Cell line enhanced" "Detected in some" "BEWO: 11.4;HEL: 9.4;hTCEpi: 10.8;RPTEC TERT1: 26.7;RT4: 19.3;SCLC-21H: 8.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA029708 Uncertain Approved "Nucleoli fibrillar center,Mitochondria" Yes NA "Nucleoli fibrillar center" Mitochondria "HPA029708: AB_10602479" "unprognostic (8.85e-3)" "unprognostic (4.19e-1)" "unprognostic (1.06e-1)" "unprognostic (1.02e-2)" "unprognostic (1.48e-1)" "unprognostic (3.91e-2)" "unprognostic (1.32e-2)" "unprognostic (3.16e-1)" "unprognostic (3.25e-2)" "unprognostic (2.72e-3)" "unprognostic (1.20e-3)" "unprognostic (5.76e-2)" "prognostic favorable (7.72e-6)" "unprognostic (1.05e-1)" "unprognostic (2.39e-1)" "unprognostic (6.67e-3)" "unprognostic (2.01e-1)" 1.0 0.2 0.6 4.0 1.1 0.0 12.9 0.6 0.9 8.7 8.5 1.2 6.3 0.2 0.8 8.2 6.0 1.5 8.7 0.1 0.6 0.1 52.2 0.1 12.3 1.5 0.4 0.0 0.6 2.8 0.4 1.5 4.7 7.0 6.1 10.5 0.8 93.5 2.9 2.4 13.1 1.3 0.4 0.4 0.9 6.2 0.8 0.3 0.4 37.3 7.2 6.3 1.4 4.1 0.0 0.1 0.1 0.1 0.4 2.9 0.0 0.0 1.0 0.0 0.1 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.4 0.0 0.4 0.2 2.7 2.7 0.0 0.0 1.9 9.4 0.0 0.0 0.0 0.0 0.3 0.0 10.8 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.0 0.3 1.2 26.7 19.3 8.3 0.0 1.0 0.0 0.0 4.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 1.1 0.6 0.9 0.6 0.1 0.4 0.0 7.0 0.3 6.0 20.8 0.0 45.7 1.4 0.0 2.2 25.5 0.0 12.5 75.0 0.0 23.2 26.6 2.2 0.1 0.1 75.7 0.0 1.3 1.2 0.6 33.2 0.0 0.2 4.3 0.0 9.8 0.0 5.4 0.0 0.3 2.1 6.8 0.0 37.4 0.4 4.7 34.0 0.0 23.2 0.0 0.0 0.1 0.0 0.2 2.9 16.9 0.0 34.7 33.5 TFE3 "bHLHe33, TFEA" ENSG00000068323 "Transcription factor binding to IGHM enhancer 3" P19532 X 49028726-49043486 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023881 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023881: AB_1857931" "unprognostic (2.68e-2)" "unprognostic (2.89e-3)" "unprognostic (2.40e-2)" "unprognostic (5.36e-2)" "unprognostic (2.71e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (6.03e-5)" "unprognostic (2.40e-1)" "unprognostic (1.26e-1)" "unprognostic (4.32e-2)" "unprognostic (5.41e-2)" "unprognostic (1.16e-1)" "prognostic unfavorable (2.19e-8)" "unprognostic (1.93e-1)" "unprognostic (8.77e-2)" "unprognostic (4.19e-2)" "unprognostic (6.25e-1)" 31.3 20.9 12.6 18.2 14.4 22.6 53.1 16.5 18.1 22.6 17.7 16.6 30.0 9.9 22.8 21.9 20.5 18.8 16.4 15.1 11.3 11.8 21.6 14.1 22.8 10.3 13.2 9.4 24.4 15.9 16.5 16.3 22.0 15.9 21.2 10.4 15.7 12.6 30.6 13.6 14.1 13.5 21.2 14.8 23.0 14.7 10.4 15.2 4.2 21.7 10.8 10.5 28.6 20.5 1.2 1.9 10.5 4.4 0.4 1.4 1.6 11.8 15.3 5.1 14.7 16.6 15.1 5.1 15.7 18.2 16.0 13.7 9.3 9.5 4.5 6.7 23.0 17.7 9.8 9.6 14.1 13.0 9.8 5.2 4.1 11.3 8.7 22.4 4.3 10.2 13.0 9.1 26.3 18.8 14.9 7.7 3.1 7.9 19.6 13.6 7.0 2.8 4.0 13.9 3.5 13.8 4.3 8.8 10.1 10.2 5.5 4.9 4.8 16.7 7.2 5.5 18.0 10.2 3.9 16.2 17.6 18.8 17.5 8.6 12.1 11.3 3.7 21.0 5.3 12.0 0.0 3.5 1.6 0.5 4.3 0.9 0.6 0.9 0.5 1.9 1.2 0.6 0.4 10.5 0.4 4.4 0.4 1.4 1.6 12.6 14.4 16.5 14.9 11.3 11.8 13.2 9.4 15.9 15.2 14.9 9.1 5.2 18.6 17.5 6.5 6.2 17.8 4.0 11.4 19.2 3.9 13.6 8.3 16.6 0.6 14.6 11.8 0.0 13.7 7.4 16.4 16.4 5.7 13.9 19.2 17.5 12.0 9.8 23.8 1.3 25.3 13.0 8.5 10.0 8.5 9.6 17.6 14.0 23.0 8.6 5.3 12.9 13.3 2.6 0.9 19.3 31.0 8.6 6.5 15.8 TGFB1 "CED, DPD1, TGFB, TGFbeta" ENSG00000105329 "Transforming growth factor beta 1" P01137 19 41301587-41353911 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Mitogen" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 377.2;Hofbauer cells: 124.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 7.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000361, HPA073356" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 1290000 38000000 "Golgi apparatus" Cytosol "CAB000361: AB_2201910, HPA073356: " "unprognostic (1.49e-2)" "unprognostic (5.43e-3)" "unprognostic (3.29e-2)" "unprognostic (4.90e-2)" "unprognostic (3.75e-3)" "prognostic unfavorable (3.38e-4)" "unprognostic (8.51e-3)" "unprognostic (5.63e-3)" "unprognostic (2.47e-2)" "unprognostic (5.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (1.19e-8)" "unprognostic (1.65e-3)" "unprognostic (2.79e-2)" "unprognostic (6.39e-2)" "unprognostic (4.86e-3)" 24.3 14.4 7.7 29.8 11.9 53.1 19.0 2.2 8.2 27.8 15.3 14.3 11.5 11.4 24.1 12.8 24.5 13.0 15.6 17.6 8.8 6.5 19.2 10.4 32.4 33.3 12.0 4.1 15.3 8.2 6.9 9.7 54.7 11.7 17.2 5.8 10.3 10.9 15.9 8.7 14.0 17.6 14.6 12.8 55.8 12.8 9.5 12.3 30.6 10.3 9.1 30.6 28.7 24.6 0.7 1.4 7.5 2.2 0.5 1.7 1.3 14.5 22.9 1.2 0.2 10.6 9.4 2.9 21.1 19.0 6.8 4.6 9.7 9.1 14.4 22.8 28.6 6.7 7.9 4.2 13.5 2.4 19.2 4.5 48.6 5.5 12.3 13.8 13.4 33.2 12.2 4.3 13.2 8.4 33.9 34.2 6.0 26.0 36.4 6.3 10.7 11.4 19.5 2.5 2.9 13.7 12.3 3.2 21.7 12.1 6.3 0.2 1.6 5.8 0.3 4.1 7.4 0.5 12.0 43.2 26.8 20.9 5.6 23.0 20.1 7.8 9.5 26.2 26.8 4.7 1.5 1.9 7.5 1.7 2.2 1.3 0.4 0.9 0.9 1.4 0.7 0.7 0.9 4.7 0.5 2.0 1.4 0.5 1.3 7.7 11.9 2.2 7.6 8.8 6.5 12.0 4.1 11.7 12.3 0.0 0.0 38.4 25.0 39.4 0.1 1.6 5.1 2.7 0.0 15.7 0.0 2.6 0.0 11.9 0.4 42.2 0.0 0.0 14.4 377.2 50.3 9.8 66.6 2.1 124.5 0.0 0.0 65.1 113.9 1.1 11.2 100.1 21.9 10.8 0.3 0.3 34.0 11.6 17.0 7.9 0.5 38.8 45.3 1.7 7.8 16.6 46.6 119.6 0.1 27.1 THAP3 ENSG00000041988 "THAP domain containing 3" Q8WTV1 1 6624866-6635586 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067114 Approved Approved Nucleoplasm,Nucleoli,Mitochondria No No Nucleoplasm "Nucleoli, Mitochondria" "HPA067114: AB_2685782" "unprognostic (1.82e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.89e-2)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (2.14e-3)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (4.63e-2)" "unprognostic (3.50e-3)" "unprognostic (4.30e-2)" "unprognostic (1.11e-2)" "unprognostic (4.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.67e-1)" "unprognostic (2.26e-3)" 14.2 17.2 16.4 11.4 16.8 12.9 31.4 21.5 20.3 16.5 16.6 13.8 11.8 12.0 15.2 13.6 11.8 16.3 11.9 19.0 16.0 14.5 17.2 17.3 10.8 15.5 18.1 14.1 23.7 28.8 12.1 14.2 11.4 17.6 17.0 7.2 11.5 24.8 16.7 20.9 14.2 11.4 12.7 13.0 15.3 12.0 11.9 16.3 11.6 22.6 9.0 12.9 17.2 21.6 22.2 18.0 10.6 14.7 17.0 22.0 15.0 9.9 9.4 8.6 12.4 14.3 12.9 8.3 9.0 11.8 24.0 15.0 12.6 6.3 8.8 12.2 9.9 8.9 7.9 13.6 8.0 8.4 15.1 22.3 10.1 12.6 11.2 17.9 7.1 10.5 12.0 10.3 15.1 13.3 14.7 10.3 15.5 10.2 11.4 8.8 6.9 12.4 16.2 7.4 11.7 16.0 11.9 10.5 12.7 10.7 2.4 11.4 12.9 11.0 15.2 20.8 7.5 9.7 12.9 9.3 12.8 7.7 8.7 14.0 12.9 13.7 11.6 10.8 15.4 7.2 10.2 14.7 10.6 20.1 11.7 20.2 17.1 19.7 20.8 18.0 22.2 22.0 18.5 9.0 17.0 9.1 16.4 19.3 15.0 16.4 16.8 21.5 20.3 16.0 14.5 18.1 14.1 17.6 16.3 0.0 6.9 9.8 10.6 12.5 10.9 5.6 7.6 14.7 3.4 8.7 5.9 12.9 16.6 9.6 5.3 14.0 11.6 23.3 9.0 15.6 14.6 13.0 5.7 10.0 13.4 4.8 7.5 10.4 13.2 2.3 17.3 8.3 10.1 22.6 7.7 9.8 9.8 8.4 21.9 15.1 6.9 12.9 20.6 8.1 16.0 12.9 13.7 9.2 11.5 13.7 THAP7 MGC10963 ENSG00000184436 "THAP domain containing 7" Q9BT49 22 20999104-21002196 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 123.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003083 Approved Supported "Nucleoplasm,Nuclear membrane,Vesicles" NA NA Nucleoplasm "Nuclear membrane, Vesicles" "HPA003083: AB_1080264" "unprognostic (6.48e-2)" "unprognostic (2.13e-3)" "unprognostic (3.28e-1)" "unprognostic (4.89e-3)" "unprognostic (1.92e-2)" "unprognostic (1.82e-3)" "unprognostic (5.56e-2)" "unprognostic (1.40e-2)" "unprognostic (2.82e-1)" "unprognostic (2.74e-3)" "unprognostic (1.27e-3)" "unprognostic (2.23e-2)" "unprognostic (9.15e-2)" "unprognostic (2.29e-2)" "unprognostic (1.83e-1)" "unprognostic (3.72e-2)" "unprognostic (3.51e-3)" 11.2 17.1 12.0 10.5 11.5 9.7 11.5 14.8 24.1 16.6 15.0 14.0 19.8 15.6 14.3 11.7 11.6 13.6 16.6 12.5 11.3 11.4 13.1 22.5 11.1 14.8 12.0 11.5 20.2 20.5 11.7 26.8 12.4 11.4 18.8 5.8 18.7 30.2 19.8 44.5 15.0 14.4 12.2 8.9 16.2 15.3 28.6 11.7 12.3 22.1 14.6 14.2 13.0 12.0 23.9 15.7 4.3 11.6 11.0 24.7 12.4 10.6 12.0 3.2 5.5 2.9 3.6 7.2 6.1 5.4 7.4 7.0 6.1 6.2 9.0 5.8 3.4 4.0 7.3 2.8 5.6 1.1 8.4 17.7 10.5 9.1 7.1 8.9 10.0 6.6 3.4 7.0 6.5 6.0 3.3 3.9 6.0 49.9 9.2 4.0 13.6 10.7 6.7 4.7 7.2 12.1 8.9 6.5 4.8 3.9 5.5 7.3 6.1 7.0 9.0 9.5 1.5 10.4 6.8 2.5 12.2 9.6 7.2 6.1 13.4 7.6 6.8 13.1 6.4 10.4 1.0 11.5 4.3 14.3 11.6 19.0 23.9 17.6 14.8 10.7 18.4 24.7 19.7 1.0 11.0 11.4 15.7 14.5 12.4 12.0 11.5 14.8 24.1 11.3 11.4 12.0 11.5 11.4 11.7 14.9 22.6 29.8 17.2 16.9 31.2 10.0 38.2 18.7 10.3 24.4 13.7 26.0 54.7 21.0 23.7 22.4 23.1 0.0 33.0 27.5 22.8 23.6 20.8 30.8 24.2 12.7 21.4 15.4 10.5 35.5 38.6 16.3 38.8 28.9 19.4 37.0 21.8 17.6 30.4 35.1 21.3 38.8 25.9 123.0 55.1 14.3 24.7 22.4 21.5 10.6 THTPA THTPASE ENSG00000259431 "Thiamine triphosphatase" Q9BU02 14 23555988-23560271 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028876 Approved Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA028876: AB_10600731" "unprognostic (3.50e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (7.11e-2)" "unprognostic (2.25e-1)" "unprognostic (2.12e-1)" "unprognostic (4.13e-1)" "unprognostic (1.58e-3)" "unprognostic (1.98e-1)" "unprognostic (1.57e-1)" "unprognostic (4.47e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.70e-9)" "unprognostic (3.47e-2)" "unprognostic (2.32e-1)" "unprognostic (3.62e-2)" "unprognostic (5.40e-2)" 14.9 19.5 27.7 12.2 23.3 7.6 12.9 16.4 24.3 12.3 14.0 20.7 15.9 15.7 13.3 18.4 10.1 17.7 16.8 16.3 23.3 17.4 16.3 12.1 10.7 10.7 21.9 13.3 15.4 12.7 25.0 12.4 7.6 16.1 18.8 12.3 17.1 18.0 23.5 21.9 7.4 11.7 13.7 19.5 11.3 11.6 18.8 14.3 14.1 15.9 12.3 11.2 9.9 7.9 14.3 17.0 11.1 14.4 6.9 11.6 8.7 2.7 17.1 8.4 9.1 19.3 10.9 4.6 8.0 7.1 7.9 7.9 3.5 11.3 5.2 7.0 9.6 9.0 8.5 8.8 10.0 5.9 10.9 9.6 7.0 12.1 9.3 9.8 6.4 6.4 14.8 7.4 12.1 8.9 16.7 9.5 8.4 5.3 11.4 11.5 8.2 10.1 2.6 3.0 14.6 14.6 6.9 5.7 9.4 13.9 5.4 16.2 7.7 7.9 16.2 4.6 5.2 10.8 3.1 7.4 5.2 5.5 10.7 4.7 13.5 8.2 2.9 5.4 2.9 8.0 11.1 14.4 7.3 9.6 10.6 9.5 9.6 6.9 7.5 13.2 14.3 11.6 9.9 1.5 6.9 13.4 17.0 5.4 8.7 27.7 23.3 16.4 24.3 23.3 17.4 21.9 13.3 16.1 14.3 6.0 6.9 15.9 5.8 0.0 27.6 0.0 10.2 5.3 6.8 7.0 7.9 9.0 46.4 13.0 16.7 2.9 8.4 0.0 10.7 4.4 7.2 8.5 23.1 7.6 15.9 7.9 5.8 8.0 10.0 16.8 10.6 8.2 0.0 11.8 6.4 18.8 8.1 8.6 7.1 24.6 9.4 12.9 0.1 19.6 8.7 0.0 5.6 6.4 8.5 5.4 THUMPD2 "C2orf8, MGC2454" ENSG00000138050 "THUMP domain containing 2" Q9BTF0 2 39736060-39779267 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043042, HPA058025" Approved Uncertain Nucleoplasm Yes No Nucleoplasm "HPA043042: AB_10964424, HPA058025: " "unprognostic (6.30e-2)" "unprognostic (9.12e-3)" "unprognostic (2.48e-2)" "unprognostic (4.62e-3)" "unprognostic (2.16e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.22e-1)" "unprognostic (2.31e-2)" "unprognostic (1.30e-1)" "unprognostic (2.72e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (7.27e-5)" "unprognostic (2.17e-1)" "unprognostic (1.61e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-3)" 6.9 7.1 6.3 8.2 7.4 13.3 9.3 21.1 7.9 8.5 6.0 5.0 4.5 7.7 12.0 6.8 9.2 4.3 5.1 8.7 6.0 6.8 7.9 7.3 5.8 9.4 7.1 5.0 10.8 5.9 5.4 19.7 4.3 6.7 6.9 5.1 6.4 6.0 6.4 14.5 5.8 6.5 6.4 5.5 6.6 6.7 3.8 6.4 13.5 7.8 5.1 9.3 6.0 9.6 6.1 9.9 0.3 4.5 8.6 5.2 3.1 9.2 6.0 2.1 8.9 2.9 4.7 4.7 3.9 4.3 4.3 4.7 7.5 6.9 11.9 4.3 2.8 9.9 3.3 11.5 6.7 5.0 14.6 13.8 8.7 4.2 7.3 6.5 10.2 5.4 4.9 4.3 4.1 1.6 4.6 6.4 2.7 9.4 4.1 8.3 3.1 8.8 8.6 0.2 16.9 4.2 6.7 7.8 7.0 4.6 5.5 9.0 6.6 3.3 8.4 5.9 0.7 3.7 5.7 3.9 7.2 6.2 3.2 8.1 6.6 7.6 12.5 4.2 16.3 5.5 0.0 4.5 0.2 3.3 3.2 3.9 6.1 5.2 3.4 5.5 4.7 4.8 4.2 0.3 8.6 2.1 9.9 4.2 3.1 6.3 7.4 21.1 7.9 6.0 6.8 7.1 5.0 6.7 6.4 23.8 19.4 14.8 22.9 12.7 22.1 20.6 7.6 13.4 25.0 14.0 17.7 10.0 16.6 15.0 1.9 11.7 7.3 0.0 12.0 11.4 8.6 13.8 6.9 7.6 9.5 6.4 9.2 9.8 12.4 2.8 25.9 10.6 5.0 7.2 8.4 11.5 13.2 13.3 24.1 11.5 18.3 6.5 12.2 8.9 16.9 11.8 5.7 10.2 11.8 22.1 TICAM1 "MGC35334, PRVTIRB, TICAM-1, TRIF" ENSG00000127666 "Toll like receptor adaptor molecule 1" Q8IUC6 19 4815932-4831704 "Disease related genes, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Urothelial cells: 129.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042460 Uncertain Uncertain "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA042460: AB_10806240" "unprognostic (2.09e-2)" "unprognostic (1.48e-1)" "unprognostic (1.86e-2)" "prognostic favorable (4.81e-4)" "unprognostic (3.52e-2)" "unprognostic (2.88e-2)" "unprognostic (7.60e-3)" "prognostic unfavorable (3.48e-4)" "unprognostic (9.86e-2)" "unprognostic (1.59e-1)" "unprognostic (6.16e-2)" "unprognostic (2.82e-1)" "unprognostic (4.43e-2)" "unprognostic (2.30e-2)" "unprognostic (5.02e-2)" "unprognostic (3.53e-2)" "unprognostic (6.48e-2)" 10.5 6.9 7.3 9.4 9.5 18.2 9.4 5.9 15.8 10.2 15.4 7.0 3.4 20.3 8.3 5.2 35.6 8.0 11.4 7.7 5.9 5.4 11.0 15.2 14.1 9.0 6.4 6.1 8.0 14.8 4.2 7.8 6.8 7.1 8.2 5.2 6.1 11.8 5.7 15.3 15.8 21.3 5.2 6.5 11.6 15.2 2.8 6.5 4.4 8.5 12.1 21.7 9.3 13.3 5.3 5.0 7.8 9.1 1.5 3.1 5.4 21.3 4.2 0.0 3.7 3.2 4.1 2.0 7.0 7.3 5.7 6.4 4.3 7.7 14.6 4.0 8.1 5.7 14.6 2.0 7.4 2.2 15.6 3.9 3.6 8.5 4.1 9.0 1.3 9.5 6.6 9.3 7.1 5.2 4.4 5.9 5.1 7.8 3.1 3.1 8.0 3.6 0.7 0.6 3.8 16.9 8.1 0.9 9.5 5.1 6.7 2.9 5.5 4.3 13.1 7.2 0.0 5.9 3.0 11.6 7.0 4.8 17.6 10.6 12.7 11.1 10.1 8.1 5.0 5.3 7.8 5.3 2.3 2.6 7.8 2.4 5.3 2.6 3.0 5.0 4.0 1.7 1.0 1.6 1.5 9.1 3.6 3.1 5.4 7.3 9.5 5.9 15.8 5.9 5.4 6.4 6.1 7.1 6.5 6.0 11.1 7.8 63.8 61.6 0.7 2.1 17.8 4.0 9.1 5.2 0.0 5.3 6.6 27.1 0.0 10.5 58.5 0.0 15.3 9.5 9.3 51.3 10.4 12.5 12.1 1.6 28.0 11.1 8.6 0.0 3.4 18.8 13.5 23.4 15.2 0.8 36.4 38.6 4.9 7.0 0.2 6.5 8.9 0.3 1.1 62.2 2.9 7.9 11.0 129.1 TIMM13 "Tim13, TIMM13B" ENSG00000099800 "Translocase of inner mitochondrial membrane 13" Q9Y5L4 19 2425624-2427894 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048985 Uncertain Supported "Nucleoli fibrillar center,Mitochondria" NA NA Mitochondria "Nucleoli fibrillar center" "HPA048985: AB_2680589" "unprognostic (5.47e-2)" "unprognostic (6.63e-2)" "unprognostic (7.15e-2)" "prognostic favorable (4.68e-5)" "unprognostic (8.67e-2)" "unprognostic (4.43e-2)" "unprognostic (1.37e-3)" "unprognostic (1.14e-1)" "unprognostic (3.50e-1)" "unprognostic (1.53e-1)" "prognostic favorable (9.77e-4)" "unprognostic (4.91e-2)" "prognostic favorable (3.88e-5)" "unprognostic (4.00e-2)" "unprognostic (3.35e-2)" "unprognostic (4.33e-1)" "unprognostic (2.47e-2)" 18.5 38.2 21.7 21.3 19.9 25.0 15.7 15.9 28.6 14.6 26.4 18.5 19.8 43.0 14.2 20.4 32.5 17.1 22.9 28.1 20.6 19.1 29.4 49.8 13.6 20.7 23.1 19.3 22.5 57.0 9.7 16.9 21.5 21.1 20.6 14.7 16.7 32.7 26.1 56.6 22.3 34.5 13.7 17.3 21.7 25.6 33.3 17.4 23.6 20.0 44.6 18.5 15.7 17.4 21.1 72.7 10.5 36.1 19.6 21.0 24.5 29.0 30.5 11.1 21.9 6.3 6.3 15.3 17.0 6.0 12.5 9.2 43.9 14.8 17.5 6.1 5.6 9.2 21.5 17.2 23.1 3.5 16.1 60.4 14.6 29.6 33.4 18.0 28.2 16.0 14.8 12.5 13.7 9.4 8.6 15.0 23.2 29.5 26.3 4.9 12.1 33.2 38.8 31.0 23.7 44.8 25.1 8.9 47.1 12.1 25.0 41.3 38.0 7.7 31.4 19.5 5.2 20.9 31.4 14.0 14.8 16.4 27.6 33.8 41.5 21.3 18.3 15.2 38.7 22.4 6.3 36.1 10.5 14.5 33.2 17.8 21.1 16.6 15.2 32.6 19.9 21.0 17.9 2.3 19.6 19.5 72.7 16.3 24.5 21.7 19.9 15.9 28.6 20.6 19.1 23.1 19.3 21.1 17.4 47.6 68.0 116.2 113.2 207.0 40.2 121.0 165.6 61.6 52.4 123.9 3.9 298.1 356.4 234.7 53.8 96.6 287.7 46.7 331.2 342.2 152.2 160.2 61.1 358.4 276.3 25.4 184.3 95.2 160.0 96.5 119.0 123.6 214.2 119.0 243.4 60.1 263.5 192.9 93.0 418.3 36.8 51.8 100.2 95.0 119.4 241.4 237.7 84.3 327.1 151.1 TIMM17A "TIM17, TIM17A" ENSG00000134375 "Translocase of inner mitochondrial membrane 17A" Q99595 1 201955491-201970661 "Cancer-related genes, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010083 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA010083: AB_10602899" "prognostic unfavorable (1.98e-5)" "unprognostic (3.28e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-3)" "unprognostic (7.58e-2)" "unprognostic (4.15e-2)" "unprognostic (7.45e-2)" "unprognostic (1.64e-2)" "unprognostic (8.54e-3)" "unprognostic (2.02e-2)" "unprognostic (2.01e-1)" "unprognostic (6.45e-3)" "unprognostic (1.21e-1)" "unprognostic (1.44e-2)" "unprognostic (2.81e-1)" 16.6 27.6 22.7 18.7 23.2 16.9 16.8 16.3 29.3 16.5 19.3 9.9 19.2 17.2 15.0 24.1 17.9 11.8 10.7 39.0 32.3 19.6 25.1 53.7 13.5 15.3 20.6 27.0 11.2 18.7 21.5 14.8 17.4 25.0 14.5 21.8 11.7 24.8 17.1 42.1 11.5 13.0 19.6 13.4 14.4 16.3 13.7 14.2 11.3 21.6 30.4 18.9 15.9 12.7 17.6 28.9 16.0 24.9 15.9 20.6 17.8 26.4 27.0 24.5 29.3 20.7 21.7 41.4 42.3 30.3 34.8 31.3 31.6 27.6 36.7 15.6 36.2 25.5 21.2 44.9 25.3 37.5 26.9 28.1 20.2 35.9 29.9 21.4 43.1 21.8 25.0 28.2 35.5 29.8 25.1 36.3 23.2 51.0 20.6 40.8 16.9 23.1 23.4 31.1 26.7 14.6 22.9 28.5 46.0 42.7 25.2 37.0 26.2 25.9 66.4 39.1 32.5 36.7 29.3 29.0 23.3 24.7 27.0 43.9 31.3 33.7 30.8 24.8 32.9 25.9 8.9 19.0 16.0 13.6 24.9 17.5 17.6 14.9 17.2 28.9 12.7 14.2 16.7 4.4 15.9 24.7 19.3 20.6 17.8 22.7 23.2 16.3 29.3 32.3 19.6 20.6 27.0 25.0 14.2 35.7 37.0 55.2 74.7 81.9 22.9 117.0 40.8 46.8 42.1 36.6 33.4 102.6 116.0 97.2 44.4 41.4 33.9 0.0 74.9 170.0 67.6 57.0 54.3 165.4 105.8 33.4 32.6 35.6 45.4 26.9 31.1 72.6 50.6 99.2 41.2 32.7 83.8 23.0 36.0 93.3 25.4 25.8 62.2 38.1 50.8 86.4 222.1 56.4 49.3 91.8 TLDC1 KIAA1609 ENSG00000140950 "TBC/LysM-associated domain containing 1" Q6P9B6 16 84476421-84554033 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 115.8;Rod photoreceptor cells: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041020 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA041020: AB_10794184" "unprognostic (8.35e-3)" "unprognostic (4.27e-2)" "unprognostic (1.48e-1)" "unprognostic (5.45e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-3)" "unprognostic (5.97e-4)" "prognostic unfavorable (1.03e-5)" "unprognostic (3.94e-1)" "unprognostic (2.85e-2)" "prognostic unfavorable (7.05e-5)" "unprognostic (2.92e-2)" "unprognostic (6.78e-3)" "unprognostic (9.87e-2)" "unprognostic (1.83e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-2)" 5.5 4.9 7.6 7.1 10.7 1.8 7.3 8.1 11.5 8.1 7.1 6.3 5.2 6.0 14.0 8.8 24.4 6.9 6.5 4.7 6.3 4.5 7.6 5.1 6.4 6.1 5.0 9.4 8.7 5.2 11.3 4.4 15.8 10.7 7.8 7.8 12.9 7.7 6.1 4.5 11.0 9.3 10.7 4.0 5.4 6.8 8.1 3.4 8.3 7.6 6.5 10.0 10.4 12.1 3.3 2.7 13.6 3.5 3.1 8.7 2.6 14.7 10.4 9.1 4.9 4.2 7.4 4.3 10.9 9.8 11.3 3.3 5.9 17.9 2.0 5.9 21.0 8.3 16.5 2.5 29.3 14.9 1.1 2.2 1.6 5.1 5.1 5.2 1.2 5.1 5.1 12.7 10.5 13.9 9.2 4.7 5.9 2.7 2.5 7.6 3.5 1.1 1.2 2.8 7.7 3.6 4.5 2.3 0.7 10.0 8.3 3.0 2.1 9.9 7.1 4.9 10.0 10.2 2.0 11.5 7.9 3.6 4.2 4.5 2.0 3.5 5.4 4.7 0.6 2.7 13.6 3.1 4.4 3.8 2.7 3.7 3.3 6.8 5.5 2.7 2.7 7.6 4.7 3.1 3.1 3.5 0.8 8.7 2.6 7.6 10.7 8.1 11.5 6.3 4.5 5.0 9.4 10.7 3.4 3.0 4.5 2.7 8.9 2.1 14.1 3.3 5.1 8.1 6.8 12.2 115.8 28.9 5.0 15.5 1.4 5.8 13.6 0.0 7.5 8.8 5.1 7.2 4.7 1.5 7.3 4.8 2.9 5.5 4.8 1.2 7.5 2.7 3.3 10.8 4.5 8.1 14.4 7.0 5.3 6.1 65.7 0.0 5.1 4.6 3.9 3.0 39.4 3.2 4.8 20.0 TM4SF5 ENSG00000142484 "Transmembrane 4 L six family member 5" O14894 17 4771884-4783213 "Predicted membrane proteins" "Cell cycle" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "intestine: 80.9;liver: 69.8" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 55.9;Hepatocytes: 125.4;Intestinal endocrine cells: 110.5;Mucus-secreting cells: 76.1;Paneth cells: 190.0" "Cancer enriched" "Detected in many" 9 "liver cancer: 219.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 5 "monocytes: 1.1" "Group enriched" "Detected in some" 13 "CACO-2: 23.4;Hep G2: 40.5;OE19: 25.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA055674 Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA055674: " "unprognostic (1.81e-1)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (4.44e-2)" "unprognostic (9.33e-2)" "unprognostic (3.57e-2)" "unprognostic (1.95e-1)" "unprognostic (5.21e-3)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 45.1 0.1 0.1 50.5 0.1 0.2 0.1 0.1 7.0 0.1 0.1 0.1 3.1 69.8 0.1 0.1 0.1 0.1 0.1 0.9 4.1 0.1 0.6 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.1 80.9 0.1 0.1 0.1 8.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 23.4 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 40.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 25.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 25.5 0.0 0.0 1.8 0.0 0.0 5.0 1.1 1.5 0.0 55.9 0.0 8.1 1.2 0.0 0.0 4.6 125.4 0.1 0.0 110.5 6.2 3.2 1.3 0.0 0.0 0.0 0.0 76.1 0.0 4.9 190.0 0.0 47.6 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.9 34.5 0.0 TMC8 "EVER2, EVIN2" ENSG00000167895 "Transmembrane channel like 8" Q8IU68 17 78130770-78142968 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 33.6;intestine: 23.2;lymphoid tissue: 52.9" "Cell type enhanced" "Detected in many" 7 "B-cells: 29.6;granulocytes: 40.4;Hofbauer cells: 25.4;monocytes: 26.2;T-cells: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 15.7;HL-60: 20.9;HMC-1: 42.3;Karpas-707: 36.0;RPMI-8226: 22.2;U-266/70: 17.4;U-937: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047387, HPA054429" Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA047387: , HPA054429: AB_2682485" "unprognostic (8.54e-3)" "prognostic favorable (8.45e-6)" "unprognostic (1.32e-1)" "unprognostic (2.33e-3)" "unprognostic (3.59e-1)" "prognostic favorable (4.19e-5)" "unprognostic (6.38e-3)" "unprognostic (6.47e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-1)" "unprognostic (6.06e-2)" "unprognostic (4.27e-1)" "prognostic unfavorable (1.96e-7)" "unprognostic (6.24e-2)" "unprognostic (1.01e-2)" "unprognostic (1.25e-1)" "unprognostic (2.89e-2)" 3.6 1.6 2.3 30.1 4.6 33.6 1.9 0.7 2.3 1.7 4.4 3.5 0.1 4.2 2.5 2.1 2.5 2.1 6.2 1.5 2.3 1.7 3.4 3.1 10.7 38.7 4.0 0.8 0.9 1.2 0.1 1.3 1.5 2.8 2.4 1.9 2.6 10.2 1.0 0.6 1.7 23.2 1.0 5.1 52.9 4.1 0.7 3.7 49.7 3.1 1.8 36.6 3.9 2.5 5.0 2.1 5.5 6.6 6.7 13.1 4.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 15.7 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.2 0.0 20.9 42.3 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.3 36.0 0.0 0.4 7.1 0.9 0.0 1.1 0.1 0.4 0.1 22.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 2.3 4.3 0.0 0.0 0.0 0.0 0.0 17.4 0.7 1.5 0.0 17.7 0.0 2.3 1.8 5.5 13.1 3.1 9.4 5.0 10.5 12.9 2.1 5.0 9.4 8.4 3.0 6.7 6.6 1.9 5.7 4.2 2.3 4.6 0.7 2.3 2.3 1.7 4.0 0.8 2.8 3.7 3.0 15.1 29.6 9.3 4.7 0.0 1.6 0.0 1.4 7.9 0.0 0.0 0.3 0.0 0.9 0.3 1.4 2.1 0.0 1.1 1.0 1.5 2.2 40.4 0.4 25.4 0.0 1.2 6.2 22.6 0.0 0.0 15.6 6.8 26.2 0.8 0.2 0.4 3.1 0.4 0.3 0.0 0.0 1.7 0.4 0.5 4.0 0.5 39.2 2.2 11.7 TMEM100 "FLJ10970, FLJ37856" ENSG00000166292 "Transmembrane protein 100" Q9NV29 17 55719627-55732121 "Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 52.8;lung: 99.5" "Cell type enhanced" "Detected in some" 12 "Fibroblasts: 20.4;Leydig cells: 37.7;Peritubular cells: 49.5;Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 18.1;ASC TERT1: 12.3;HHSteC: 28.0;HSkMC: 12.9;U-87 MG: 8.5;WM-115: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055936 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA055936: AB_2682975" "unprognostic (1.35e-1)" "unprognostic (2.75e-1)" "unprognostic (1.57e-1)" "unprognostic (4.02e-2)" "unprognostic (6.78e-3)" "unprognostic (3.07e-1)" "prognostic favorable (2.67e-5)" "unprognostic (5.74e-2)" "unprognostic (1.87e-2)" "unprognostic (4.66e-1)" "unprognostic (1.89e-2)" "unprognostic (8.11e-3)" "prognostic unfavorable (1.32e-4)" "unprognostic (4.91e-3)" "unprognostic (1.12e-1)" "unprognostic (2.07e-2)" "unprognostic (1.26e-3)" 24.7 2.0 3.4 1.5 3.9 0.0 52.8 0.7 5.3 5.1 10.5 0.7 8.8 2.7 1.6 16.7 4.6 3.6 4.8 5.8 1.6 2.8 1.2 5.8 99.5 1.5 3.4 0.6 10.1 1.9 0.0 3.3 23.5 2.6 7.4 5.1 2.6 2.2 11.7 7.0 1.3 6.6 5.2 1.4 2.3 10.7 3.9 0.6 0.5 3.8 3.7 1.3 5.3 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 18.1 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 28.0 0.0 0.0 12.9 0.0 0.9 0.1 0.1 0.0 0.2 0.5 0.1 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 1.2 2.4 0.0 0.5 0.0 0.1 8.5 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.9 0.7 1.7 1.6 2.8 3.4 0.6 2.6 0.6 0.0 5.1 0.0 0.3 2.3 0.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 14.1 0.0 0.0 0.0 0.0 20.4 0.1 1.1 13.9 0.1 0.0 0.0 7.4 0.0 0.0 37.7 0.6 6.8 0.0 0.0 0.0 0.2 0.0 49.5 0.5 0.0 32.3 12.2 0.0 0.0 2.3 0.1 0.0 0.0 0.1 TMEM107 MGC10744 ENSG00000179029 "Transmembrane protein 107" Q6UX40 17 8173237-8176399 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease mutation, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 171.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052555, HPA059653" Approved Approved "Nucleoplasm,Plasma membrane,Midbody ring" Yes No "Nucleoplasm, Plasma membrane" "Midbody ring" "HPA052555: AB_2681870, HPA059653: AB_2684096" "unprognostic (2.87e-2)" "unprognostic (2.67e-1)" "unprognostic (2.85e-2)" "prognostic favorable (9.39e-5)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (5.70e-3)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (6.02e-3)" "unprognostic (1.83e-2)" "unprognostic (1.87e-1)" "unprognostic (2.66e-3)" "unprognostic (1.26e-1)" "unprognostic (4.99e-1)" "unprognostic (2.66e-1)" "unprognostic (1.49e-1)" 8.6 11.8 13.7 7.1 19.6 17.5 13.0 7.3 23.2 11.7 8.3 9.9 10.7 4.2 10.0 30.1 8.8 38.7 9.4 8.8 11.0 13.4 12.1 4.0 12.8 17.7 10.9 17.1 7.5 9.6 17.8 20.8 10.0 15.6 5.9 7.8 12.6 8.7 10.1 1.7 12.7 6.0 10.1 10.5 11.9 7.1 15.9 8.2 7.8 19.1 4.3 9.6 9.5 7.8 33.1 18.7 28.4 29.9 14.5 20.8 12.7 31.6 10.0 15.5 7.1 9.4 14.2 3.1 7.4 7.0 6.5 8.6 1.2 18.2 8.7 9.5 7.4 4.6 22.1 6.3 14.5 10.3 10.7 7.4 4.7 17.4 3.4 3.8 1.8 5.2 6.9 9.2 17.1 8.3 13.7 10.8 10.8 4.0 17.1 15.3 9.4 4.3 5.0 1.6 3.9 4.6 7.9 4.2 12.5 12.0 2.4 4.5 7.1 8.6 1.8 6.3 3.7 5.4 6.4 6.8 3.3 6.3 5.2 3.9 6.7 3.7 3.4 19.0 7.1 5.3 10.5 13.3 28.4 18.8 15.8 16.3 26.7 18.1 20.0 11.8 33.1 20.0 20.8 10.9 14.5 29.9 18.7 14.3 12.7 13.7 19.6 7.3 23.2 11.0 13.4 10.9 17.1 15.6 8.2 8.9 9.8 33.9 18.2 17.1 17.7 6.2 40.8 171.3 25.0 31.4 43.2 15.0 11.6 14.4 7.1 20.4 10.3 0.0 9.6 17.4 16.6 14.7 34.8 17.8 39.4 11.1 8.7 23.9 38.4 6.3 11.8 29.7 32.1 21.6 12.1 32.1 11.5 14.4 14.2 15.3 60.3 0.0 11.3 47.4 49.2 25.0 11.1 34.5 15.3 9.7 TMEM131 "CC28, KIAA0257, PRO1048, RW1, YR-23" ENSG00000075568 "Transmembrane protein 131" Q92545 2 97756333-97995891 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017678, HPA017682" Approved Uncertain "Vesicles,Intermediate filaments" NA NA "Vesicles, Intermediate filaments" "HPA017678: AB_1858086, HPA017682: AB_1858087" "unprognostic (1.16e-2)" "unprognostic (1.39e-1)" "unprognostic (1.04e-1)" "unprognostic (7.42e-2)" "unprognostic (8.58e-2)" "unprognostic (4.18e-2)" "unprognostic (7.59e-3)" "unprognostic (3.26e-1)" "unprognostic (1.53e-1)" "unprognostic (3.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (5.10e-3)" "unprognostic (5.37e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-1)" "unprognostic (1.77e-1)" 16.6 19.4 13.7 33.6 19.2 15.8 15.6 18.5 19.4 21.0 25.5 19.1 14.5 18.6 21.8 15.7 19.9 17.3 20.1 17.3 11.7 12.1 14.6 15.8 15.7 24.0 14.1 14.0 21.2 22.0 31.4 27.8 30.9 15.0 17.7 24.1 14.6 18.6 12.7 31.4 24.2 23.6 21.1 13.2 22.5 26.3 14.4 15.3 23.2 14.7 16.8 27.6 20.5 16.7 4.5 5.2 7.3 3.5 5.4 5.4 2.2 13.6 8.4 15.7 11.4 16.6 20.2 17.2 20.3 19.8 10.4 12.5 10.8 19.8 21.8 11.2 20.9 17.7 9.9 16.5 27.0 15.5 15.3 10.7 15.8 5.9 15.4 18.7 14.6 21.2 19.2 11.1 18.4 19.2 17.7 12.7 10.7 9.3 23.3 31.5 8.2 10.6 9.3 8.6 10.6 18.1 15.5 10.0 9.5 10.7 16.3 17.8 8.6 13.1 9.1 12.4 17.6 7.6 13.6 15.0 27.2 12.5 13.0 7.7 9.9 13.6 11.0 21.3 12.9 18.3 7.3 2.8 7.3 4.0 3.5 4.6 4.5 3.4 4.0 3.7 4.2 4.2 5.4 1.9 5.4 3.2 5.2 2.1 2.2 13.7 19.2 18.5 19.4 11.7 12.1 14.1 14.0 15.0 15.3 14.9 27.5 29.8 15.3 17.5 27.3 31.1 15.3 40.2 23.9 19.2 21.6 12.6 3.3 8.3 10.4 15.3 33.8 0.0 20.6 11.0 15.4 18.0 23.1 19.4 20.0 23.8 28.9 21.5 24.0 13.6 19.2 23.2 11.8 42.3 41.7 13.4 16.0 35.1 18.0 6.2 18.5 12.9 16.4 18.6 26.4 22.3 11.3 14.0 28.1 13.7 TMEM131L "DKFZp586H1322, KIAA0922" ENSG00000121210 "Transmembrane 131 like" A2VDJ0 4 153466346-153636711 "Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 69.4" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 11.1;Ciliated cells: 10.7;Exocrine glandular cells: 8.0;monocytes: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 37.3;MOLT-4: 34.7;U-698: 44.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043472, HPA048443" Uncertain Approved "Nucleoli fibrillar center,Vesicles" NA NA Vesicles "Nucleoli fibrillar center" "HPA043472: AB_2678496, HPA048443: AB_2680395" "unprognostic (1.12e-1)" "prognostic favorable (6.69e-6)" "unprognostic (1.71e-1)" "unprognostic (3.75e-2)" "unprognostic (8.37e-2)" "unprognostic (1.34e-2)" "unprognostic (1.90e-2)" "unprognostic (3.30e-2)" "unprognostic (3.23e-2)" "unprognostic (4.11e-2)" "unprognostic (4.37e-2)" "unprognostic (7.29e-2)" "unprognostic (4.35e-3)" "unprognostic (2.92e-2)" "unprognostic (3.39e-2)" "unprognostic (3.94e-2)" "unprognostic (3.51e-2)" 7.5 1.9 2.1 37.9 6.0 27.3 6.6 0.5 3.0 6.5 5.6 2.3 3.5 1.5 11.9 7.9 6.6 5.0 4.3 5.6 2.5 1.6 3.4 13.0 6.1 27.6 2.2 1.6 4.9 23.0 0.8 6.4 2.5 2.1 5.3 3.1 5.3 10.3 3.2 17.5 5.2 10.0 8.1 3.0 26.5 6.0 3.2 3.9 69.4 4.1 5.5 36.8 7.1 5.8 18.5 13.3 13.6 23.7 14.9 17.9 10.3 2.0 1.3 5.7 6.0 3.4 3.0 0.1 2.9 1.4 2.1 2.6 9.2 1.3 37.3 0.7 3.9 2.3 2.0 4.4 5.1 3.1 3.4 3.2 7.3 2.5 2.3 2.2 8.0 0.4 2.7 3.2 2.7 2.5 2.3 5.2 6.9 6.8 0.1 2.0 3.7 34.7 5.8 5.1 0.0 1.9 12.1 5.6 2.4 1.4 0.8 4.3 3.3 2.3 5.2 3.0 3.1 2.0 5.9 4.1 2.8 5.0 3.3 2.4 4.1 4.1 44.2 0.8 4.8 2.2 6.1 12.4 13.1 8.5 23.7 11.2 18.5 10.7 7.9 13.3 17.3 17.9 12.0 13.6 14.9 18.6 1.3 12.9 10.3 2.1 6.0 0.5 3.0 2.5 1.6 2.2 1.6 2.1 3.9 6.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 10.7 3.4 0.0 0.0 0.5 1.7 1.9 0.0 0.0 0.0 0.0 8.0 0.2 0.0 0.0 4.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.0 0.0 5.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM147 "MGC1936, NIFIE14" ENSG00000105677 "Transmembrane protein 147" Q9BVK8 19 35545595-35547526 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067837 Approved "Golgi apparatus,Actin filaments" NA NA "Golgi apparatus, Actin filaments" "HPA067837: " "unprognostic (6.98e-2)" "unprognostic (1.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.20e-2)" "unprognostic (1.38e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (4.98e-6)" "unprognostic (1.33e-1)" "unprognostic (2.53e-1)" "unprognostic (7.34e-2)" "unprognostic (1.35e-1)" "unprognostic (9.26e-2)" "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (4.00e-2)" "unprognostic (1.85e-1)" "unprognostic (2.70e-1)" 22.7 46.2 22.3 19.3 26.8 15.6 53.2 18.9 42.0 23.1 23.4 16.3 30.0 18.9 23.7 47.2 29.5 24.8 30.2 57.5 20.1 22.0 33.3 29.8 29.9 53.2 26.3 19.0 22.6 88.4 31.7 23.3 20.1 22.8 18.1 24.5 23.1 30.5 33.1 39.1 33.1 17.5 26.8 26.6 18.0 22.9 41.8 19.2 9.8 39.4 31.4 18.9 21.0 25.4 40.9 54.9 22.6 51.8 21.8 35.1 47.2 29.8 65.4 13.1 30.5 58.0 26.6 21.5 19.0 31.3 23.7 22.1 30.9 18.2 17.4 30.6 28.9 25.9 11.8 22.5 27.4 19.6 27.5 30.9 18.8 19.7 36.2 46.3 26.5 20.8 28.9 42.9 22.3 56.0 20.6 21.7 23.9 24.3 61.7 25.1 36.6 15.2 14.7 18.5 90.6 28.5 14.7 12.1 41.2 37.3 30.4 11.6 19.4 17.7 40.7 36.4 13.8 14.7 22.3 14.0 27.0 21.6 15.3 38.4 32.4 32.7 9.6 23.5 36.0 21.7 7.3 51.8 22.6 25.1 47.3 35.1 40.9 34.0 28.9 47.0 34.7 25.7 26.0 3.0 21.8 33.3 54.9 32.9 47.2 22.3 26.8 18.9 42.0 20.1 22.0 26.3 19.0 22.8 19.2 41.7 36.1 61.0 106.8 89.9 51.4 92.9 122.3 33.5 42.1 148.3 17.7 150.6 94.5 199.6 77.8 100.8 76.7 0.0 219.9 199.2 111.4 171.1 50.6 97.2 232.5 42.9 85.5 72.4 122.6 242.1 129.2 109.7 227.7 61.3 96.0 111.2 180.6 63.1 113.8 224.3 45.9 116.4 81.2 327.5 106.5 146.7 115.7 69.2 124.9 160.1 TMEM173 "ERIS, FLJ38577, MITA, MPYS, NET23, STING" ENSG00000184584 "Transmembrane protein 173" Q86WV6 5 139475534-139482935 "Disease related genes, Predicted membrane proteins" "Autophagy, Host-virus interaction, Immunity, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 152.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 25.3;EFO-21: 38.2;HDLM-2: 81.1;Karpas-707: 25.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038116, HPA038534" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA038116: AB_2675841, HPA038534: AB_2676067" "unprognostic (1.45e-1)" "unprognostic (4.10e-3)" "unprognostic (1.29e-1)" "unprognostic (2.23e-2)" "unprognostic (2.70e-2)" "unprognostic (1.71e-2)" "unprognostic (7.66e-2)" "unprognostic (2.77e-2)" "unprognostic (6.30e-2)" "unprognostic (1.01e-1)" "unprognostic (5.69e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (3.59e-8)" "unprognostic (9.18e-3)" "unprognostic (4.14e-2)" "unprognostic (4.45e-2)" "unprognostic (1.34e-1)" 22.9 6.5 6.3 17.4 6.7 18.1 15.9 1.2 4.5 22.5 9.4 6.0 13.3 6.4 16.7 18.1 16.0 24.4 13.5 26.3 3.8 3.1 12.5 8.1 32.0 41.3 7.9 2.3 30.7 3.9 1.9 8.1 13.9 6.8 20.3 8.8 14.7 16.6 14.6 10.3 9.6 10.9 16.2 7.1 35.8 8.0 11.1 6.3 15.8 13.0 16.5 29.7 17.7 17.9 0.3 26.9 5.8 29.1 39.8 28.9 26.1 1.2 0.5 0.0 0.0 1.3 4.1 0.1 6.6 25.3 3.2 10.5 0.0 9.1 0.0 38.2 19.7 0.7 4.8 0.1 9.7 1.2 81.1 0.9 5.5 2.5 0.3 2.2 1.6 0.1 5.8 0.4 2.2 2.6 4.4 11.3 0.6 1.7 25.4 11.8 0.0 0.8 8.5 0.0 0.2 1.9 0.3 2.4 7.5 2.9 2.5 2.5 0.0 2.2 2.4 6.3 0.2 0.3 22.0 8.2 0.9 0.4 2.5 1.9 0.0 7.7 0.0 0.1 23.7 2.9 5.8 29.1 0.0 28.8 19.4 14.2 0.3 28.2 23.2 26.9 0.2 19.4 17.5 2.4 39.8 7.8 9.2 28.9 26.1 6.3 6.7 1.2 4.5 3.8 3.1 7.9 2.3 6.8 6.3 41.7 56.7 6.7 69.0 27.4 0.1 22.6 2.5 152.6 59.1 7.0 0.0 0.7 0.0 26.9 1.0 87.0 0.5 0.0 14.2 0.7 35.0 14.4 48.7 0.0 55.0 0.0 8.1 57.7 62.8 0.4 47.8 46.4 33.7 45.9 13.3 0.0 50.6 5.8 34.3 0.0 0.3 45.3 78.8 0.0 0.3 14.6 1.5 66.0 28.2 26.1 TMEM179 "C14orf90, FLJ42486, TMEM179A" ENSG00000258986 "Transmembrane protein 179" Q6ZVK1 14 104474678-104605647 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 20.2;brain: 30.4;pituitary gland: 23.0" "Group enriched" "Detected in some" 12 "Bipolar cells: 41.7;Horizontal cells: 62.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 6.5;SCLC-21H: 28.3;SH-SY5Y: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002942 Uncertain Mitochondria NA NA Mitochondria "HPA002942: AB_1078113" "unprognostic (8.65e-2)" "unprognostic (8.24e-2)" "unprognostic (3.10e-2)" "unprognostic (1.29e-2)" "unprognostic (1.90e-2)" "unprognostic (1.08e-2)" "unprognostic (3.46e-2)" "unprognostic (2.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (2.82e-3)" "unprognostic (1.09e-1)" "unprognostic (1.89e-4)" "unprognostic (8.68e-3)" "unprognostic (1.56e-1)" "unprognostic (9.71e-6)" "unprognostic (1.70e-2)" 1.1 20.2 11.8 1.5 18.9 0.9 0.9 10.3 30.4 1.0 1.8 3.4 0.0 1.4 1.0 1.6 1.1 1.1 1.1 1.2 12.4 21.7 1.0 1.1 0.9 0.9 13.7 7.2 1.0 4.8 1.0 23.0 2.3 8.3 1.4 1.4 2.2 1.1 1.3 1.0 1.0 1.8 1.4 6.1 0.9 1.8 3.1 4.5 0.0 1.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 28.3 8.9 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 18.9 10.3 16.7 12.4 21.7 13.7 7.2 8.3 4.5 0.0 0.0 0.0 0.0 0.0 41.7 1.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 62.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 4.3 0.0 0.1 0.6 3.2 0.0 0.0 0.0 0.0 0.0 TMEM184A "MGC9712, SDMG1" ENSG00000164855 "Transmembrane protein 184A" Q6ZMB5 7 1542235-1560821 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.2;intestine: 39.3" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 57.2;Mucus-secreting cells: 31.0;Paneth cells: 31.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 15.2;RT4: 17.3;SCLC-21H: 17.8;SK-BR-3: 27.6;T-47d: 24.4" "Low region specificity" "Detected in many" "HPA053790, HPA071312" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA053790: AB_2682263, HPA071312: AB_2686387" "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.38e-1)" "unprognostic (4.41e-3)" "unprognostic (1.07e-1)" "unprognostic (2.36e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-1)" "unprognostic (1.31e-1)" "unprognostic (6.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (5.47e-2)" 0.4 0.1 0.2 3.5 0.2 0.1 1.6 0.2 0.3 8.6 15.6 0.2 8.0 15.1 1.7 2.9 40.2 4.4 9.6 0.2 0.2 0.1 5.3 18.0 1.5 0.2 0.2 0.3 0.9 24.7 3.1 5.4 14.3 0.4 5.1 4.0 0.3 10.3 12.0 2.3 17.9 39.3 1.2 0.2 0.2 7.5 3.8 0.2 0.5 0.3 22.9 31.9 10.0 15.8 0.8 0.8 2.0 0.5 0.4 0.5 0.0 9.7 6.6 0.0 0.0 0.0 0.0 2.2 0.3 0.1 0.4 0.0 8.9 11.7 0.2 3.4 0.1 3.6 7.5 0.0 4.4 0.1 0.1 0.2 0.0 6.0 4.0 0.1 0.0 0.0 0.0 4.3 0.1 3.9 0.2 0.0 2.9 0.1 0.0 0.0 15.2 0.0 0.0 0.3 6.0 8.6 0.2 0.0 4.7 3.3 17.3 17.8 0.0 2.9 27.6 0.0 0.2 24.4 0.0 0.0 0.0 3.7 4.6 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.2 0.5 0.1 0.3 0.2 0.3 0.2 0.1 0.8 0.4 0.3 2.0 0.4 0.2 0.8 0.3 0.0 0.2 0.2 0.2 0.3 0.2 0.1 0.2 0.3 0.4 0.2 3.0 4.1 0.8 5.3 3.5 0.9 2.5 17.8 13.4 10.3 8.7 0.0 6.6 1.7 11.9 0.0 0.7 57.2 0.0 9.6 7.7 1.3 11.9 1.1 12.4 0.7 0.0 6.9 0.0 1.2 0.0 0.0 1.7 0.0 1.0 31.0 0.0 12.3 31.6 0.0 3.8 0.4 0.0 1.0 0.0 0.0 8.2 14.1 0.0 13.3 11.3 TMEM196 MGC42090 ENSG00000173452 "Transmembrane protein 196" Q5HYL7 7 19719310-19773598 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 15.0;pituitary gland: 12.6" "Cell type enriched" "Detected in some" 10 "Bipolar cells: 51.1" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "ASC diff: 8.8;ASC TERT1: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043163 Uncertain Uncertain "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA "Nucleoplasm, Golgi apparatus" "HPA043163: AB_10794772" "unprognostic (6.08e-3)" "unprognostic (1.88e-2)" "unprognostic (2.14e-2)" "unprognostic (9.30e-2)" "unprognostic (5.63e-2)" 0.7 3.7 8.0 0.6 8.6 0.4 0.4 0.3 15.0 1.2 0.6 0.3 0.0 0.4 3.8 1.5 0.5 1.2 0.4 0.4 3.6 10.1 0.6 0.4 0.4 0.4 2.9 7.4 0.4 3.0 0.7 12.6 0.4 5.0 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.4 1.0 1.4 0.4 2.6 0.5 2.8 0.0 0.4 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 8.8 8.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 8.6 0.3 7.3 3.6 10.1 2.9 7.4 5.0 2.8 0.0 0.0 0.0 0.0 0.0 51.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.8 0.4 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM220 ENSG00000187824 "Transmembrane protein 220" Q6QAJ8 17 10699015-10730316 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 58.2" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 146.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 11.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047680 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047680: " "unprognostic (1.71e-2)" "unprognostic (4.60e-2)" "unprognostic (6.31e-3)" "unprognostic (4.04e-3)" "unprognostic (1.05e-3)" "unprognostic (1.84e-4)" "prognostic favorable (2.23e-5)" "unprognostic (4.58e-2)" "unprognostic (4.96e-3)" "unprognostic (2.81e-1)" "prognostic favorable (1.72e-4)" "unprognostic (2.97e-1)" "unprognostic (4.34e-3)" "unprognostic (2.25e-1)" "unprognostic (2.63e-2)" "unprognostic (7.80e-3)" "unprognostic (5.97e-2)" 6.5 7.4 4.5 2.4 4.6 3.3 7.8 1.3 2.8 4.7 6.1 3.8 14.3 8.1 4.9 11.1 3.3 3.9 10.1 6.3 3.8 2.4 6.4 58.2 4.6 3.1 2.9 1.2 4.8 6.0 2.4 2.4 1.7 4.9 12.0 2.8 6.6 3.5 18.5 4.1 3.7 15.4 5.4 2.5 4.7 7.1 17.2 3.5 0.6 9.4 2.6 2.4 4.1 3.4 11.6 2.9 2.3 2.5 4.5 9.0 1.9 0.5 3.5 1.3 8.3 5.2 5.2 1.0 6.9 7.3 4.7 6.8 0.0 0.3 1.2 0.5 4.3 0.4 0.4 3.4 0.6 3.5 0.4 1.5 0.5 0.2 2.9 7.6 0.9 0.8 3.4 0.4 1.5 0.3 1.0 2.2 3.0 0.4 0.3 3.0 0.4 1.1 1.5 5.0 0.4 0.0 4.8 0.2 0.6 11.1 0.2 0.5 6.0 0.3 0.1 0.7 1.9 0.4 1.8 4.8 0.4 1.3 2.6 0.4 0.8 0.3 0.3 4.9 1.4 0.6 1.4 2.5 2.3 0.9 1.8 1.1 4.2 2.2 1.3 2.9 11.6 9.0 6.1 2.1 4.5 0.8 2.3 0.4 1.9 4.5 4.6 1.3 2.8 3.8 2.4 2.9 1.2 4.9 3.5 3.0 8.3 5.6 13.2 8.5 1.5 8.8 56.0 8.1 11.4 17.4 7.9 10.1 18.3 13.7 72.2 7.9 60.8 23.3 20.8 20.6 12.0 37.1 39.3 146.5 20.4 0.0 2.9 10.4 11.8 12.5 16.7 5.4 23.6 6.4 15.2 44.1 14.9 28.8 9.2 20.3 22.1 19.4 9.6 52.0 7.5 6.9 3.8 2.5 10.0 21.1 TMEM255A "FAM70A, FLJ20716" ENSG00000125355 "Transmembrane protein 255A" Q5JRV8 X 120258650-120311556 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.4;ovary: 29.6" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 3.0;Melanocytes: 5.0;monocytes: 5.4" "Group enriched" "Detected in many" 10 "glioma: 21.3;melanoma: 8.0;renal cancer: 7.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 5.9;MAIT T-cell: 3.3;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 10 "T-cells: 5.9" "Cell line enhanced" "Detected in some" "Karpas-707: 17.3;NTERA-2: 6.0;RPMI-8226: 11.1;SK-MEL-30: 18.1;U-2 OS: 7.8;U-87 MG: 19.8" "Low region specificity" "Detected in all" HPA048470 Approved Uncertain "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA048470: AB_2680406" "unprognostic (3.41e-2)" "unprognostic (8.96e-2)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" "unprognostic (8.55e-4)" "unprognostic (7.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (2.02e-1)" "unprognostic (1.32e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.17e-2)" "unprognostic (2.55e-4)" 3.9 5.5 6.8 3.4 14.4 1.5 5.4 6.8 7.8 11.2 3.5 12.4 1.7 1.9 3.2 2.9 4.4 6.3 2.1 2.4 5.3 25.4 2.4 1.5 4.8 5.0 30.4 4.4 29.6 1.1 0.6 6.6 0.8 18.4 3.8 3.9 7.1 1.3 3.3 2.4 4.0 2.8 2.0 13.0 2.8 2.1 0.9 7.8 6.4 0.9 1.8 5.7 1.6 8.0 0.5 0.3 0.0 0.6 0.0 5.9 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.3 0.1 0.0 0.1 0.2 0.0 1.8 0.0 1.1 0.4 0.5 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 17.3 0.3 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 3.5 0.2 0.3 0.0 18.1 0.2 0.0 0.2 0.0 0.0 7.8 0.0 2.8 0.0 3.3 2.4 19.8 0.0 0.0 0.0 0.6 0.0 5.9 0.2 3.3 0.5 0.4 2.2 0.3 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.9 6.8 14.4 6.8 3.9 5.3 25.4 30.4 4.4 18.4 7.8 3.0 0.0 0.0 0.0 0.3 0.6 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.6 1.1 0.6 0.7 5.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 1.1 0.1 0.0 0.0 0.0 TMEM35A "FLJ14084, TMEM35" ENSG00000126950 "Transmembrane protein 35A" Q53FP2 X 101078720-101096364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;seminal vesicle: 46.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.5;HUVEC TERT2: 32.3;SH-SY5Y: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048583 Enhanced Supported Supported "Vesicles,Focal adhesion sites,Cytosol" NA NA Vesicles "Focal adhesion sites, Cytosol" "HPA048583: AB_2680451" "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-2)" "unprognostic (3.02e-2)" "unprognostic (3.89e-3)" "unprognostic (2.77e-2)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (3.34e-3)" "unprognostic (9.20e-2)" "unprognostic (4.72e-2)" "unprognostic (3.49e-4)" "unprognostic (5.91e-2)" "unprognostic (1.85e-1)" "unprognostic (1.48e-2)" "unprognostic (9.37e-3)" 3.6 6.7 12.8 1.7 28.2 0.7 1.3 21.2 28.6 3.3 17.3 2.5 6.8 3.5 7.4 3.9 10.4 4.3 3.6 1.1 14.4 33.8 1.1 0.7 2.6 0.8 12.2 10.0 7.7 0.9 6.1 1.5 0.8 30.0 20.5 9.1 2.9 1.0 46.4 1.3 0.9 4.1 11.8 3.9 1.3 3.4 1.8 2.3 0.0 1.3 0.0 0.9 13.3 2.7 0.2 0.0 0.2 0.1 0.6 0.8 0.4 0.0 0.0 3.4 0.0 2.5 6.5 0.0 0.6 0.4 0.3 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 2.2 0.0 1.1 0.0 4.7 32.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 8.3 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.5 0.2 0.5 0.2 0.0 0.0 0.6 0.4 0.2 0.6 0.1 0.0 0.8 0.4 12.8 28.2 21.2 28.6 14.4 33.8 12.2 10.0 30.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM42 MGC29956 ENSG00000169964 "Transmembrane protein 42" Q69YG0 3 44861869-44865670 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 73.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052569 Uncertain Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA052569: AB_2681871" "prognostic favorable (5.23e-4)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (3.73e-2)" "unprognostic (2.32e-1)" "unprognostic (7.93e-2)" "unprognostic (6.99e-3)" "unprognostic (1.64e-2)" "unprognostic (9.16e-2)" "unprognostic (9.23e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "prognostic favorable (1.10e-5)" "unprognostic (1.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" 11.1 14.6 18.6 5.7 26.1 4.6 13.4 7.8 17.3 12.7 8.5 17.7 8.5 6.1 10.4 25.9 7.2 16.8 8.9 10.2 18.4 19.7 12.9 19.1 9.7 9.3 19.1 14.1 17.1 17.5 12.7 16.5 8.9 16.4 12.7 8.5 8.5 10.9 12.7 16.6 8.6 6.2 9.2 19.8 8.7 9.9 20.0 15.5 11.6 17.1 6.5 9.1 7.5 8.7 13.9 11.8 4.2 10.2 9.1 15.9 9.2 4.1 4.2 1.2 2.4 16.1 12.7 0.1 3.4 4.8 4.2 4.2 0.9 8.2 2.8 6.7 6.6 1.9 2.8 0.3 5.2 4.2 4.4 0.0 1.7 5.4 4.4 17.1 2.0 0.1 13.1 13.4 4.3 9.7 9.0 7.1 7.2 0.1 5.8 6.3 3.2 1.7 3.4 2.3 5.0 1.9 1.5 0.7 0.6 9.1 1.6 1.3 1.7 4.1 1.4 1.6 4.2 3.0 3.5 4.6 3.7 0.4 5.4 3.7 2.0 1.5 0.8 7.4 2.4 1.6 3.7 8.6 4.2 7.8 7.7 8.2 13.9 11.6 7.2 10.6 11.9 15.9 12.6 1.6 9.1 10.2 11.8 9.2 9.2 18.6 26.1 7.8 17.3 18.4 19.7 19.1 14.1 16.4 15.5 20.8 4.8 10.7 14.4 5.5 8.0 10.1 15.3 16.0 4.5 31.4 2.0 17.6 11.6 15.3 56.7 9.3 5.2 0.0 8.9 11.3 14.2 14.8 3.5 15.3 19.8 17.5 11.5 11.6 13.3 73.6 25.3 10.3 6.8 9.0 9.1 20.9 11.7 8.4 18.4 17.0 15.9 6.5 6.9 36.1 19.3 7.9 8.1 13.1 11.8 6.2 TMEM70 FLJ20533 ENSG00000175606 "Transmembrane protein 70" Q9BUB7 8 73972437-73982783 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023187, CAB034226" Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB034226: AB_2205189, HPA023187: AB_2671101" "unprognostic (2.26e-3)" "unprognostic (4.87e-1)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (8.22e-3)" "unprognostic (9.17e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (7.04e-2)" "unprognostic (2.88e-2)" "unprognostic (9.14e-2)" "unprognostic (3.65e-3)" "unprognostic (6.86e-2)" "unprognostic (5.08e-2)" "unprognostic (2.13e-1)" "unprognostic (2.70e-2)" 9.5 12.3 7.6 7.4 8.0 7.0 9.4 7.1 12.8 6.0 7.4 3.6 3.9 4.8 6.1 9.0 6.2 9.1 7.4 13.3 9.3 7.9 9.7 38.8 6.2 9.6 6.8 7.3 7.3 17.0 5.1 6.3 8.1 10.0 6.3 8.0 3.8 7.1 5.3 81.1 4.8 6.9 7.7 6.3 9.9 10.6 10.9 5.1 8.5 6.5 13.4 7.9 6.7 5.9 18.4 12.3 7.5 11.0 6.2 12.7 12.7 11.2 9.0 7.2 7.5 8.5 7.3 7.4 9.6 8.7 10.7 8.7 8.4 6.5 15.2 8.3 6.4 9.1 10.2 13.8 9.2 12.1 9.8 9.4 15.2 5.9 11.2 8.5 8.2 8.1 6.8 8.6 6.8 3.6 4.1 9.0 7.7 11.4 7.5 11.4 8.3 18.8 15.6 6.7 14.4 11.2 13.3 7.1 12.9 11.3 10.6 16.4 7.3 5.9 43.0 12.1 6.0 8.9 7.6 5.7 6.3 7.6 11.4 9.0 11.2 9.6 14.9 9.1 6.4 6.9 6.3 10.8 7.0 9.5 11.0 10.9 18.4 10.9 10.8 10.5 10.8 12.7 11.8 7.5 6.2 8.1 12.3 8.6 12.7 7.6 8.0 7.1 12.8 9.3 7.9 6.8 7.3 10.0 5.1 14.9 36.2 37.2 32.5 59.8 24.1 39.1 15.3 42.8 23.9 21.0 7.9 61.6 56.3 28.4 11.2 35.3 22.8 0.0 55.5 44.6 47.0 32.0 38.2 44.2 119.9 9.5 13.3 28.3 89.0 5.6 27.6 68.1 38.8 36.1 27.6 19.7 38.3 37.1 27.3 55.5 15.9 38.8 44.8 32.9 28.3 52.1 58.8 34.8 29.0 23.3 TMEM82 ENSG00000162460 "Transmembrane protein 82" A0PJX8 1 15742422-15747982 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 35.6;liver: 30.1" "Group enriched" "Detected in some" 9 "Enterocytes: 86.8;Hepatocytes: 38.2;Paneth cells: 57.5;Proximal tubular cells: 47.1" "Cancer enhanced" "Detected in some" "liver cancer: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "CACO-2: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA060282 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060282: AB_2684241" "unprognostic (2.46e-2)" "unprognostic (7.96e-2)" "unprognostic (4.88e-2)" "unprognostic (1.40e-2)" "unprognostic (6.45e-2)" "unprognostic (6.90e-2)" "unprognostic (4.80e-2)" "prognostic favorable (3.80e-7)" "unprognostic (1.41e-1)" "unprognostic (5.80e-2)" "unprognostic (4.75e-2)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 18.9 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 7.5 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.1 6.6 0.0 0.0 0.0 86.8 0.0 0.2 1.9 0.0 0.0 0.0 38.2 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.5 57.5 0.0 47.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 6.3 0.0 TMEM86B MGC30208 ENSG00000180089 "Transmembrane protein 86B" Q8N661 19 55226639-55229264 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 15.1" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 30.6;Hepatocytes: 28.9" "Cancer enriched" "Detected in all" 5 "liver cancer: 10.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA057689 Uncertain Uncertain Midbody,Centrosome Yes No Centrosome Midbody "HPA057689: AB_2683504" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.76e-5)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (6.55e-2)" "prognostic favorable (3.13e-4)" "unprognostic (1.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.10e-1)" "prognostic favorable (9.97e-6)" "unprognostic (1.96e-2)" "unprognostic (6.63e-8)" "unprognostic (2.28e-1)" "unprognostic (1.07e-1)" "unprognostic (3.70e-1)" "unprognostic (3.19e-3)" 2.5 2.4 2.8 3.1 4.0 7.8 1.4 4.7 4.2 1.4 7.5 1.4 1.4 5.6 1.5 1.4 1.4 1.8 7.7 2.9 2.2 1.6 2.0 15.1 2.7 5.2 1.4 1.4 1.4 1.4 1.7 2.8 5.2 1.7 1.5 0.4 1.4 1.4 1.4 2.2 3.0 7.7 1.4 1.4 4.3 3.6 2.8 1.4 1.4 2.3 1.4 3.0 1.4 1.4 0.7 1.0 0.6 0.7 0.0 1.6 0.4 4.1 3.9 2.4 3.9 0.4 0.6 3.6 1.5 0.7 1.3 1.8 6.3 2.2 4.8 1.2 1.1 1.3 1.7 0.9 1.0 0.6 0.9 11.2 8.8 2.5 5.9 1.2 4.0 3.7 0.8 1.7 2.1 1.3 1.8 0.5 9.2 6.0 3.5 0.8 2.4 6.4 10.0 0.9 1.9 2.4 6.0 2.8 12.6 1.1 5.1 2.1 3.9 1.8 0.8 4.9 1.3 2.2 8.4 2.8 5.7 3.2 2.5 3.8 2.9 3.4 10.2 4.7 11.1 2.1 0.0 0.7 0.6 1.6 0.1 0.6 0.0 0.5 0.1 0.1 0.7 0.6 1.4 0.1 0.0 0.1 1.0 0.0 0.4 2.8 4.0 4.7 4.2 2.2 1.6 1.4 1.4 1.7 1.4 6.0 2.4 0.8 0.4 3.0 7.6 0.5 30.6 0.0 1.2 0.0 2.0 0.4 0.0 0.9 2.0 1.7 5.2 0.0 0.2 0.3 1.1 1.1 0.0 28.9 0.9 9.5 10.3 0.0 6.2 3.6 0.9 1.7 3.3 1.8 1.9 1.1 0.8 0.0 0.4 0.8 3.6 0.0 0.5 1.6 1.1 1.9 0.2 4.6 1.9 1.7 TMEM9 TMEM9A ENSG00000116857 "Transmembrane protein 9" Q9P0T7 1 201134772-201171574 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008483 Approved "Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Vesicles "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA008483: " "unprognostic (1.88e-1)" "prognostic unfavorable (6.57e-4)" "unprognostic (2.95e-1)" "unprognostic (3.67e-2)" "unprognostic (3.96e-1)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.05e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-2)" "unprognostic (1.69e-2)" "unprognostic (2.46e-2)" "unprognostic (2.99e-1)" "unprognostic (1.88e-2)" "unprognostic (2.38e-1)" "unprognostic (9.17e-2)" "unprognostic (3.32e-1)" "unprognostic (9.90e-2)" 12.4 33.4 32.3 8.4 33.3 10.1 20.4 19.9 43.5 31.3 13.1 23.0 20.1 10.9 24.4 30.4 12.0 34.5 17.2 18.4 31.2 35.9 25.7 21.8 18.2 13.4 24.2 29.4 32.8 36.0 20.2 19.0 12.3 23.0 25.9 11.3 28.3 26.3 22.0 15.9 11.0 9.5 16.6 17.0 9.4 15.2 22.2 12.2 7.8 30.7 7.0 10.8 17.6 14.9 28.0 29.3 21.2 32.7 15.1 36.8 37.2 15.0 28.5 18.1 41.8 9.8 14.0 32.1 11.9 12.7 19.0 17.2 27.9 24.5 8.0 17.4 17.8 17.6 30.2 18.9 19.5 9.4 5.1 32.5 13.9 46.0 18.2 18.9 6.6 13.0 16.6 21.7 17.7 10.8 23.0 11.7 11.3 24.8 8.8 16.3 19.3 8.0 10.9 27.6 13.8 70.5 14.5 27.0 10.4 21.8 11.7 16.9 34.5 21.2 36.4 21.9 28.2 44.7 11.7 8.7 21.4 17.8 17.0 14.3 36.2 31.1 6.1 16.2 7.2 10.3 19.1 32.7 16.9 25.5 20.9 28.7 28.0 24.8 20.9 26.9 27.0 36.8 24.2 21.2 15.1 18.9 29.3 21.5 37.2 32.3 33.3 19.9 43.5 31.2 35.9 24.2 29.4 23.0 12.2 47.6 38.0 4.5 30.3 11.4 64.1 33.1 48.4 54.9 40.9 34.9 29.5 35.6 14.9 74.6 47.8 25.3 7.4 0.0 65.8 41.2 50.3 37.0 12.7 32.1 24.1 7.9 30.6 29.4 15.0 47.1 65.6 14.5 21.9 11.8 25.4 102.0 41.4 18.2 49.8 48.1 26.0 12.9 32.0 44.2 81.2 12.2 10.9 12.8 28.5 22.0 TMIE DFNB6 ENSG00000181585 "Transmembrane inner ear" Q8NEW7 3 46694528-46710886 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 11.7;brain: 11.4" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 3.5;Distal tubular cells: 1.7;Spermatogonia: 3.1" "Cancer enriched" "Detected in many" 5 "glioma: 6.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.1" "Lineage enriched" "Detected in single" 17 "T-cells: 6.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.3;EFO-21: 3.8;JURKAT: 15.0;SH-SY5Y: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038298 Uncertain Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA038298: AB_10675792" "unprognostic (6.59e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-3)" "unprognostic (2.48e-3)" "unprognostic (1.88e-2)" "unprognostic (5.40e-3)" "unprognostic (3.94e-2)" "unprognostic (8.80e-2)" "unprognostic (3.37e-2)" "unprognostic (6.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.35e-2)" "unprognostic (4.58e-2)" "unprognostic (1.23e-1)" "unprognostic (4.41e-2)" "unprognostic (5.29e-2)" "unprognostic (6.78e-2)" 1.2 11.7 6.7 0.7 2.9 0.0 0.5 2.7 7.0 0.8 0.9 2.3 0.4 0.6 0.8 1.2 2.2 1.0 0.4 1.0 5.9 11.4 1.4 0.9 1.8 1.2 5.8 4.8 2.8 0.4 0.0 8.1 0.7 3.8 0.9 0.6 1.1 0.8 1.8 5.8 1.3 0.6 0.7 5.2 1.2 0.3 1.6 1.0 0.4 0.8 1.7 1.3 0.8 0.4 0.0 0.3 0.0 0.1 0.0 6.1 1.2 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.3 0.0 3.8 0.0 0.7 0.2 0.2 0.3 0.0 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 2.6 0.0 1.7 0.0 0.7 15.0 0.0 0.4 0.0 0.2 0.1 0.0 0.3 1.0 0.2 1.6 0.0 0.3 0.1 0.1 0.4 3.3 0.4 0.5 0.0 0.2 0.1 0.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.2 0.0 1.8 1.0 0.3 0.0 6.1 0.9 0.0 0.0 0.0 0.0 1.0 1.2 6.7 2.9 2.7 7.0 5.9 11.4 5.8 4.8 3.8 1.0 0.0 0.0 0.0 0.1 0.7 3.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.2 0.2 0.0 0.0 0.4 0.1 0.5 0.2 0.0 0.0 0.5 0.0 0.0 0.6 0.0 1.0 0.6 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.4 0.0 0.4 0.0 1.4 1.4 3.1 0.6 0.1 0.0 0.0 0.1 TMPRSS2 PRSS10 ENSG00000184012 "Transmembrane serine protease 2" O15393 21 41464551-41531116 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 75.6;pancreas: 64.5;prostate: 68.2" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 190.3;Glandular cells: 290.4;Paneth cells: 127.7;Urothelial cells: 115.9" "Cancer enriched" "Detected in many" 7 "prostate cancer: 250.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 14.1;MCF7: 6.1;OE19: 20.6;RT4: 33.9;SK-BR-3: 6.9" "Not detected" "Not detected" "HPA034493, HPA035787" Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" Nucleoplasm "HPA034493: , HPA035787: AB_2674782" "unprognostic (4.80e-3)" "unprognostic (3.49e-1)" "unprognostic (2.16e-1)" "prognostic favorable (2.56e-4)" "unprognostic (1.72e-1)" "unprognostic (1.05e-2)" "unprognostic (4.28e-2)" "unprognostic (1.51e-3)" "unprognostic (9.43e-2)" "unprognostic (9.02e-3)" "unprognostic (6.24e-2)" "unprognostic (6.43e-2)" "prognostic favorable (7.86e-6)" "unprognostic (2.00e-2)" "unprognostic (1.68e-1)" "unprognostic (1.41e-1)" "unprognostic (2.15e-2)" 0.2 0.1 0.2 15.5 0.4 0.0 6.1 0.2 0.5 1.3 38.7 0.4 24.4 17.5 0.5 0.9 10.7 2.2 17.3 0.2 0.3 0.1 19.4 18.4 20.7 0.2 0.2 0.2 0.7 64.5 0.0 1.3 1.0 0.4 68.2 18.5 0.3 52.3 35.7 0.2 2.1 75.6 0.9 0.2 0.3 36.7 0.8 0.3 0.5 19.9 3.9 10.2 5.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 14.1 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.1 0.5 1.2 20.6 0.0 0.0 0.0 1.3 0.5 33.9 0.0 0.4 0.0 6.9 0.1 0.2 5.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.4 0.2 0.5 0.3 0.1 0.2 0.2 0.4 0.3 47.6 88.6 0.0 31.0 0.2 0.0 0.6 25.5 14.7 38.7 45.4 0.0 0.5 19.9 30.0 19.4 0.0 190.3 0.0 52.6 0.1 0.6 290.4 6.9 28.7 0.1 0.0 17.3 0.0 0.8 3.5 0.0 1.5 10.1 1.0 79.6 0.0 53.4 127.7 0.0 3.7 0.0 0.0 1.0 0.2 0.0 0.1 0.2 0.0 73.2 115.9 TNFRSF11A "CD265, FEO, LOH18CR1, PDB2, RANK" ENSG00000141655 "TNF receptor superfamily member 11a" Q9Y6Q6 18 62325287-62391292 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Deafness, Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 28.7;intestine: 23.9;salivary gland: 34.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 21.1;monocytes: 34.3;Mucus-secreting cells: 23.6;Paneth cells: 28.1;Undifferentiated cells: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "NK-cell: 8.9" "Lineage enriched" "Detected in many" 8 "NK-cells: 8.9" "Cell line enriched" "Detected in some" 6 "HDLM-2: 52.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB010391, HPA047976" Approved Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" Cytosol "CAB010391: AB_2205352, HPA047976: AB_2680227" "unprognostic (4.08e-1)" "unprognostic (2.71e-1)" "unprognostic (3.23e-3)" "unprognostic (1.73e-1)" "unprognostic (6.03e-2)" "unprognostic (1.35e-1)" "unprognostic (9.96e-4)" "unprognostic (4.24e-3)" "unprognostic (7.79e-4)" "unprognostic (1.52e-1)" "unprognostic (4.05e-2)" "unprognostic (2.88e-1)" "unprognostic (4.69e-5)" "unprognostic (1.56e-1)" "unprognostic (1.78e-1)" "unprognostic (4.02e-2)" "unprognostic (7.07e-2)" 6.5 1.7 1.7 4.8 1.2 0.2 4.3 0.4 2.3 1.5 18.4 0.8 7.6 23.1 0.9 1.9 3.8 1.3 28.7 1.1 1.3 0.7 0.9 0.8 2.3 7.4 1.0 1.0 0.7 2.9 0.1 10.1 2.8 0.7 2.1 13.9 1.3 34.3 12.9 0.6 3.3 23.9 1.3 2.9 1.2 4.3 1.2 0.8 0.7 2.0 1.8 2.3 2.3 2.3 0.0 0.6 0.2 0.0 8.9 1.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.0 1.5 0.1 0.6 0.9 3.5 0.3 0.1 52.5 2.3 0.0 0.5 0.7 0.0 0.2 0.5 0.1 0.1 0.3 1.3 1.8 1.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.5 2.9 8.3 0.1 0.0 0.2 0.6 0.6 8.9 0.3 0.2 1.3 0.0 0.3 0.5 0.1 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 8.9 0.0 0.6 1.0 0.0 1.7 1.2 0.4 2.3 1.3 0.7 1.0 1.0 0.7 0.8 0.0 2.1 0.0 2.9 1.1 0.4 1.1 10.2 0.0 0.0 0.0 0.0 0.1 0.0 7.3 0.2 2.2 21.1 0.0 6.5 0.6 0.3 2.6 0.0 0.0 12.8 3.2 10.4 3.7 15.0 0.0 0.6 2.5 1.7 34.3 23.6 0.0 9.6 28.1 0.0 0.0 0.0 0.0 0.3 0.7 1.4 1.9 0.1 0.0 33.6 3.8 TNFRSF19 "TAJ, TAJ-alpha, TRADE, TROY" ENSG00000127863 "TNF receptor superfamily member 19" Q9NS68 13 23570370-23676104 "Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 60.5;skin 1: 47.9" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 55.3;Ciliated cells: 84.3;Suprabasal keratinocytes: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "naive B-cell: 1.9;T-reg: 4.0" "Group enriched" "Detected in many" 4 "B-cells: 1.9;T-cells: 4.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.5;BJ hTERT+: 26.9;fHDF/TERT166: 20.4;Hep G2: 27.9;SK-MEL-30: 46.5;WM-115: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010135 Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA010135: AB_1079797" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" "unprognostic (1.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.86e-3)" "unprognostic (2.01e-2)" "prognostic favorable (3.87e-4)" "unprognostic (3.74e-1)" "unprognostic (5.47e-2)" "unprognostic (4.41e-2)" "unprognostic (6.56e-2)" "prognostic favorable (9.13e-7)" "unprognostic (3.44e-2)" "unprognostic (6.05e-2)" "unprognostic (3.25e-3)" "unprognostic (5.38e-3)" 1.3 1.3 1.0 0.4 1.4 0.6 4.6 0.8 2.0 3.4 1.5 3.0 17.1 0.7 5.3 7.3 5.1 14.3 2.3 14.7 1.5 1.5 7.1 0.5 7.9 0.6 3.0 1.3 3.4 2.2 0.1 8.0 3.8 2.8 12.7 0.8 11.4 60.5 13.0 1.2 47.9 0.9 4.1 1.9 2.5 2.4 2.7 1.1 0.8 5.7 8.0 3.7 2.7 4.0 1.9 0.7 0.7 0.0 0.6 4.0 0.2 0.0 1.0 1.2 0.0 1.6 16.5 1.2 1.2 26.9 0.6 0.9 7.8 0.0 0.0 0.0 20.4 0.1 0.0 1.1 0.9 1.2 0.0 0.9 0.2 0.8 27.9 0.7 0.0 0.3 7.8 0.2 7.8 0.1 0.5 0.0 0.0 0.0 0.0 4.4 0.3 0.0 0.0 0.7 9.6 1.7 0.0 4.5 0.0 2.8 0.1 10.7 1.8 0.0 0.0 46.5 1.3 0.0 0.1 0.0 3.9 0.2 0.0 1.1 0.0 0.0 0.0 1.5 0.0 28.9 0.0 0.0 0.7 0.0 0.0 0.4 0.7 0.4 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.7 4.0 0.2 1.0 1.4 0.8 2.0 1.5 1.5 3.0 1.3 2.8 1.1 0.0 17.3 0.0 3.6 55.3 0.6 19.1 2.5 84.3 14.8 8.7 7.9 0.2 0.0 9.9 1.1 2.9 0.0 0.0 0.9 0.0 9.8 18.5 1.1 0.6 0.1 0.0 0.0 0.0 0.0 0.8 10.6 0.2 13.5 0.0 0.0 3.0 7.4 0.0 13.1 18.8 2.5 0.0 5.7 0.9 2.1 70.1 0.0 0.5 0.0 0.5 TNNI1 ENSG00000159173 "Troponin I1, slow skeletal type" P19237 1 201403768-201429866 "Predicted intracellular proteins" "Actin-binding, Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 559.6" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 50.9" "Group enriched" "Detected in many" 5 "head and neck cancer: 9.6;prostate cancer: 3.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 9 "RH-30: 106.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA028190 Approved Uncertain Nucleoplasm,Nucleoli NA NA 25000 Nucleoplasm Nucleoli "HPA028190: AB_10600831" "unprognostic (2.82e-2)" "unprognostic (2.27e-1)" "unprognostic (2.91e-1)" "unprognostic (5.39e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (9.27e-4)" "unprognostic (1.93e-2)" "unprognostic (2.37e-1)" "unprognostic (4.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.92e-2)" "unprognostic (1.05e-2)" "unprognostic (2.59e-2)" "unprognostic (3.52e-1)" "unprognostic (2.11e-1)" "unprognostic (1.71e-1)" 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 22.9 9.5 0.0 0.1 6.6 0.1 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 6.8 0.0 559.6 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 2.7 83.8 10.7 0.0 0.1 0.2 0.6 1.7 0.4 0.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 106.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.3 0.3 0.3 0.1 0.2 0.2 0.2 0.6 0.2 0.3 0.5 1.7 0.4 0.3 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 50.9 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 2.7 0.0 0.8 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 TNNT2 "CMD1D, CMH2, CMPD2" ENSG00000118194 "Troponin T2, cardiac type" P45379 1 201359008-201377762 "Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 241 "heart muscle: 679.2" "Cell type enriched" "Detected in many" 289 "Cardiomyocytes: 11884.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "RH-30: 189.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB015371, HPA015774, HPA017888" Enhanced Uncertain "Nucleoplasm,Nucleoli,Focal adhesion sites" No No 50000 "Nucleoplasm, Nucleoli" "Focal adhesion sites" "CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "unprognostic (2.33e-4)" "unprognostic (1.85e-1)" "unprognostic (7.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-2)" "unprognostic (5.50e-3)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (9.98e-2)" 0.1 0.3 0.1 0.1 0.7 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.2 679.2 0.9 0.0 1.9 0.0 0.7 0.3 0.1 1.1 0.1 0.3 0.0 0.2 0.7 0.1 0.7 0.0 0.0 0.2 0.1 2.0 1.3 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.4 0.5 0.0 0.0 189.8 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 10.5 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 2.1 0.9 0.0 0.1 1.1 0.1 0.0 3.0 4.0 0.0 1.1 3.1 1.0 11884.8 0.0 0.0 1.2 1.8 0.0 2.3 0.0 0.5 9.4 0.0 1.6 0.0 0.3 0.9 41.1 0.5 0.0 0.0 2.7 0.0 0.0 0.0 0.0 13.6 0.6 0.0 0.0 4.6 0.5 0.0 0.7 0.8 1.1 0.8 0.5 0.0 0.4 0.0 0.2 6.4 3.5 0.0 2.8 1.4 TNRC6A "CAGH26, GW182, KIAA1460, TNRC6" ENSG00000090905 "Trinucleotide repeat containing 6A" Q8NDV7 16 24610209-24827632 "Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Horizontal cells: 166.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015305, HPA017869" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA015305: AB_1850454, HPA017869: AB_1850456" "unprognostic (2.64e-1)" "unprognostic (2.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.86e-1)" "unprognostic (5.00e-2)" "unprognostic (1.10e-3)" "unprognostic (1.62e-1)" "unprognostic (3.22e-3)" "unprognostic (5.49e-2)" "unprognostic (2.74e-1)" "unprognostic (7.44e-3)" "unprognostic (2.63e-3)" "unprognostic (1.78e-1)" "unprognostic (9.18e-2)" "unprognostic (5.77e-2)" "unprognostic (2.31e-1)" "unprognostic (3.35e-2)" 17.3 23.6 14.7 23.2 15.1 10.2 17.0 25.0 19.3 20.8 17.0 15.6 17.2 10.5 26.6 23.1 12.5 20.2 12.6 13.4 11.3 9.4 13.0 17.0 14.0 16.7 14.5 10.9 26.7 20.1 42.6 25.4 12.6 16.2 16.4 12.8 17.8 16.6 18.6 26.5 16.5 16.0 27.5 19.4 14.2 15.8 11.4 14.7 15.9 19.6 14.9 13.8 16.4 16.4 5.4 5.2 2.3 2.7 3.3 3.9 1.3 11.5 16.2 19.2 10.4 16.6 22.1 10.9 19.8 16.1 14.5 15.9 11.8 9.7 11.7 8.6 19.8 14.9 13.1 23.8 16.7 21.9 11.9 12.3 11.7 17.8 16.2 14.3 11.9 8.3 22.1 8.7 18.9 12.5 17.9 19.8 7.8 17.7 7.5 18.7 13.6 10.0 7.9 27.4 5.6 8.1 19.6 14.9 10.6 11.0 10.8 9.4 13.1 13.9 8.6 7.6 15.2 9.9 7.9 18.1 18.6 12.8 9.1 13.9 16.5 13.0 19.6 17.3 7.5 13.3 2.3 2.7 1.9 3.0 1.6 2.5 5.2 2.9 2.7 1.0 5.4 3.9 2.7 1.5 3.3 1.6 5.2 2.9 1.3 14.7 15.1 25.0 19.3 11.3 9.4 14.5 10.9 16.2 14.7 35.7 51.8 48.1 14.8 31.0 84.5 67.4 58.6 22.7 38.7 43.6 111.9 18.0 14.9 20.3 16.0 35.8 32.0 23.3 21.0 12.6 36.1 20.9 38.1 104.9 18.0 166.8 53.7 65.1 54.2 8.1 63.9 27.5 28.7 23.4 36.7 48.9 23.3 33.4 76.4 12.2 83.3 19.4 26.9 44.2 27.2 25.1 6.9 31.7 32.1 14.0 TOR1B "DQ1, MGC4386" ENSG00000136816 "Torsin family 1 member B" O14657 9 129803153-129811281 "Predicted intracellular proteins" "Chaperone, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013403, HPA013697, CAB022709" Approved Uncertain "Nuclear speckles,Cytosol" "Intracellular and membrane" NA NA "Nuclear speckles" Cytosol "CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196" "unprognostic (2.91e-3)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (8.55e-2)" "unprognostic (3.23e-1)" "unprognostic (3.72e-2)" "unprognostic (1.75e-1)" "unprognostic (5.73e-3)" "unprognostic (1.95e-1)" "unprognostic (7.47e-2)" "unprognostic (1.40e-1)" "unprognostic (2.13e-2)" "unprognostic (2.07e-3)" "unprognostic (4.09e-2)" "unprognostic (1.23e-1)" "unprognostic (5.40e-3)" "unprognostic (1.69e-3)" 14.2 14.4 9.7 13.8 12.2 14.0 18.4 23.6 11.9 11.3 22.5 10.5 11.6 12.3 14.0 8.2 13.5 10.5 15.0 13.3 11.7 11.5 11.8 35.3 13.0 10.8 9.4 9.0 10.8 21.1 13.3 13.6 20.0 10.6 12.9 25.8 10.8 12.8 13.7 13.5 13.0 18.1 14.2 8.9 12.4 14.9 19.5 8.3 16.8 16.4 10.0 11.9 14.9 18.0 4.6 6.2 17.2 14.6 7.3 12.3 8.4 5.3 12.3 5.1 13.7 25.9 19.4 12.0 19.2 12.5 13.2 13.1 10.1 12.2 3.8 12.2 18.8 20.6 21.8 5.6 7.9 13.6 13.9 5.9 3.3 10.4 7.1 11.1 6.3 14.9 11.0 13.9 18.8 9.3 9.8 11.7 10.1 11.5 8.9 12.3 14.9 8.6 9.9 10.8 25.1 9.7 3.5 9.0 11.5 10.1 5.6 7.1 8.3 12.4 14.3 7.6 9.7 20.6 6.2 10.7 25.0 11.9 29.7 16.4 6.5 24.2 3.2 13.7 8.2 16.9 6.3 11.5 17.2 12.2 14.6 12.3 3.9 9.5 10.5 6.2 4.6 7.1 7.1 14.2 7.3 8.5 3.8 9.1 8.4 9.7 12.2 23.6 11.9 11.7 11.5 9.4 9.0 10.6 8.3 8.9 3.7 4.5 5.2 5.8 2.5 5.1 5.1 5.3 1.2 5.2 3.9 9.7 0.0 8.8 9.2 6.7 8.0 0.0 12.2 15.2 8.5 9.2 4.6 13.5 10.8 6.4 18.4 11.6 4.3 10.9 4.0 7.6 3.3 12.6 15.5 4.8 10.0 3.5 5.3 3.0 2.5 19.4 9.5 10.3 7.0 4.6 12.7 10.0 10.7 10.1 TP53TG3C ENSG00000205457 "TP53 target 3C" Q9ULZ0 16 33193659-33196858 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "brain: 3.0;epididymis: 4.3;testis: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.4;REH: 1.1" "HPA047832, HPA060916" Uncertain "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.1 0.1 0.8 0.1 1.3 0.1 0.1 3.0 1.3 0.1 0.1 0.1 0.1 4.3 0.3 0.1 0.1 0.1 0.6 1.3 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.3 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 2.0 0.1 0.1 3.9 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.3 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TPH1 "TPH, TPRH" ENSG00000129167 "Tryptophan hydroxylase 1" P17752 11 18017564-18042426 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Serotonin biosynthesis" "Monooxygenase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 4.2;intestine: 16.2;pituitary gland: 5.4;stomach 1: 13.3" "Cell type enriched" "Detected in many" 164 "Intestinal endocrine cells: 1412.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "cerebral cortex: 4.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 4.5" "Low region specificity" "Detected in some" "CAB010767, HPA022483" Approved Uncertain Cytosol NA NA Cytosol "CAB010767: AB_261587, HPA022483: AB_1858378" "unprognostic (2.14e-4)" "unprognostic (9.97e-2)" "unprognostic (6.92e-2)" "unprognostic (6.78e-2)" "unprognostic (1.55e-1)" "unprognostic (6.26e-5)" "unprognostic (1.73e-1)" "unprognostic (5.33e-2)" "unprognostic (1.60e-1)" "unprognostic (2.12e-2)" "unprognostic (1.19e-4)" "unprognostic (6.72e-2)" "unprognostic (5.40e-8)" "unprognostic (3.76e-2)" "unprognostic (7.42e-2)" "unprognostic (3.10e-1)" "unprognostic (2.46e-5)" 0.7 0.0 0.7 0.7 0.7 0.6 0.9 0.7 4.2 0.7 7.1 0.7 0.7 8.2 0.7 0.7 0.7 1.5 0.7 0.7 0.7 0.3 0.7 0.7 0.7 0.7 0.7 0.7 1.0 0.7 0.0 5.4 0.7 0.7 1.3 16.2 0.7 0.7 0.7 0.7 1.0 9.1 0.7 0.7 1.0 13.3 0.9 0.7 0.7 0.7 0.7 0.7 0.7 0.7 1.4 0.8 1.5 0.5 0.9 1.6 0.2 0.4 0.1 1.7 1.5 0.1 0.0 0.6 0.6 0.5 0.2 1.1 1.8 0.3 1.4 0.3 0.0 0.1 0.6 0.4 1.5 0.7 1.3 3.1 2.2 0.8 3.5 0.0 4.5 1.2 0.0 1.8 0.2 0.6 0.3 0.7 2.7 0.9 0.8 0.1 0.5 1.0 0.7 0.5 0.1 0.3 1.7 0.3 0.0 0.0 1.0 1.3 0.9 0.2 0.4 0.9 0.2 0.3 2.9 0.2 0.4 1.3 0.5 1.7 0.2 0.3 1.1 0.2 1.0 1.4 1.5 0.4 0.4 1.6 0.2 0.8 0.5 0.5 0.4 0.1 1.4 0.6 0.6 1.5 0.9 0.5 0.8 0.6 0.2 0.7 0.7 0.7 4.2 0.7 0.3 0.7 0.7 0.7 0.7 0.0 0.0 0.0 0.4 0.3 4.7 0.4 0.0 1.4 0.0 5.2 2.0 0.2 0.0 0.2 0.7 0.3 1.0 0.0 0.5 0.0 0.7 2.0 0.0 0.0 0.2 1.6 1412.4 0.0 0.0 0.4 0.9 0.9 0.0 0.0 2.8 1.5 0.4 8.6 1.1 0.2 6.0 6.5 1.0 2.7 3.4 1.3 0.0 0.5 1.7 0.0 TRAF5 RNF84 ENSG00000082512 "TNF receptor associated factor 5" O00463 1 211326615-211374946 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "B-cells: 48.9;Early spermatids: 42.9;Late spermatids: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 22.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008052, CAB010277" Enhanced Supported Centrosome,Cytosol NA NA Cytosol Centrosome "CAB010277: AB_2287961, HPA008052: AB_1858230" "unprognostic (6.44e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (1.55e-2)" "unprognostic (1.04e-1)" "unprognostic (3.39e-2)" "unprognostic (6.44e-3)" "unprognostic (7.94e-3)" "unprognostic (1.39e-1)" "unprognostic (1.75e-1)" "unprognostic (5.92e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (2.94e-10)" "unprognostic (3.72e-1)" "unprognostic (1.34e-1)" "unprognostic (1.71e-2)" "prognostic favorable (7.29e-5)" 7.5 3.1 3.9 33.6 6.5 3.1 6.1 1.2 4.6 11.1 11.6 3.3 9.9 4.2 24.3 17.4 6.1 17.1 10.4 4.5 3.4 2.3 5.3 1.9 5.4 22.7 1.9 3.1 8.6 19.4 1.7 3.1 4.4 5.3 8.7 8.1 9.6 13.3 17.8 1.6 2.9 15.5 21.4 1.9 16.5 8.6 5.6 1.7 15.9 3.1 4.1 27.4 12.0 6.5 14.7 0.9 5.3 0.3 13.1 11.9 4.8 3.8 2.9 5.2 4.6 4.6 3.3 1.8 5.5 6.6 8.0 7.2 1.4 7.7 11.8 3.2 8.7 4.1 0.7 9.7 0.9 4.0 22.7 3.5 0.6 4.2 0.0 6.6 1.8 8.7 3.9 1.7 4.3 1.3 12.1 5.6 10.4 4.7 5.6 2.2 3.0 5.1 2.1 6.2 6.1 2.4 7.8 7.2 10.9 6.1 2.7 9.2 9.6 4.1 0.2 11.8 20.0 2.9 0.2 3.4 5.2 4.1 1.7 6.1 1.6 2.3 12.6 1.4 0.0 1.9 5.3 0.2 0.3 6.3 0.2 11.9 14.7 7.9 8.4 0.9 13.0 7.2 7.0 0.4 13.1 0.3 0.7 10.8 4.8 3.9 6.5 1.2 4.6 3.4 2.3 1.9 3.1 5.3 1.7 11.9 11.1 48.9 3.5 3.3 1.0 2.0 0.0 13.4 10.3 10.4 0.0 7.1 0.0 0.7 42.9 7.4 1.6 0.0 8.4 1.7 8.6 2.6 14.0 0.0 8.4 0.0 14.3 6.2 3.7 38.6 13.3 7.5 8.5 23.4 10.9 0.8 7.3 8.6 25.8 0.5 0.4 12.9 10.3 3.0 1.1 3.4 1.1 26.3 10.2 1.6 TRAF6 RNF85 ENSG00000175104 "TNF receptor associated factor 6" Q9Y4K3 11 36487027-36510272 "Enzymes, Predicted intracellular proteins" "DNA damage, Immunity, Osteogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004605, HPA019805, HPA020599" Approved Uncertain Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "CAB004605: AB_628391, HPA019805: AB_1858231, HPA020599: AB_1858232" "unprognostic (2.48e-2)" "unprognostic (1.38e-1)" "unprognostic (2.83e-1)" "unprognostic (8.73e-2)" "unprognostic (1.71e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" "unprognostic (1.16e-2)" "unprognostic (9.22e-2)" "prognostic favorable (1.36e-4)" "unprognostic (2.82e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-2)" "unprognostic (1.07e-1)" 13.0 11.0 12.9 8.5 17.0 31.8 11.9 18.1 15.0 10.6 10.7 13.6 8.2 9.5 12.9 9.8 12.4 11.5 9.4 13.9 9.8 7.1 11.2 12.3 15.2 9.2 14.8 10.6 14.6 11.3 11.0 11.9 10.3 12.7 9.6 10.5 10.5 11.0 9.3 13.9 12.7 12.5 12.1 10.1 13.0 10.3 15.0 12.8 18.5 15.6 6.7 10.8 11.3 13.0 10.6 7.7 27.7 11.4 9.6 13.1 8.5 5.2 6.6 12.9 7.2 12.2 8.9 5.6 7.9 8.6 7.4 9.6 5.8 3.5 6.9 4.9 8.4 8.5 9.9 10.2 8.0 12.2 11.3 11.9 6.6 5.2 5.2 7.8 7.3 8.2 8.2 11.3 3.9 12.1 7.2 10.3 9.3 9.9 7.6 9.2 6.4 11.7 4.0 7.0 6.0 6.1 7.8 17.5 3.9 8.9 10.9 2.1 11.3 7.9 7.7 5.6 9.0 8.9 7.2 8.1 10.5 9.3 9.6 9.6 8.8 7.4 7.5 5.9 5.3 7.8 27.7 8.0 20.9 11.9 11.4 11.7 10.6 10.3 11.6 7.7 8.1 10.0 13.1 11.1 9.6 8.2 4.5 8.0 8.5 12.9 17.0 18.1 15.0 9.8 7.1 14.8 10.6 12.7 12.8 8.9 6.1 5.0 10.6 11.3 2.6 6.9 10.2 1.4 1.2 3.5 5.9 5.6 5.0 7.6 3.2 9.2 7.2 0.0 6.4 5.2 6.0 9.7 18.5 5.6 6.2 7.9 4.1 20.3 8.1 2.7 2.3 6.6 6.8 11.8 5.5 3.9 5.9 5.7 3.9 4.3 2.6 12.9 10.5 9.1 8.3 10.9 5.4 8.5 3.2 10.6 TRAM1L1 MGC26568 ENSG00000174599 "Translocation associated membrane protein 1 like 1" Q8N609 4 117083554-117085576 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 6.9;Horizontal cells: 4.8;Spermatogonia: 5.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 9.6;U-138 MG: 11.8;U-266/70: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044560 Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA044560: AB_10796097" "unprognostic (9.06e-2)" "unprognostic (2.87e-2)" "unprognostic (4.40e-2)" "unprognostic (2.17e-3)" "unprognostic (9.77e-2)" "unprognostic (2.37e-2)" "unprognostic (5.97e-2)" "unprognostic (3.02e-1)" "unprognostic (1.14e-1)" "unprognostic (3.25e-1)" "unprognostic (1.09e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.68e-2)" "unprognostic (1.62e-1)" "unprognostic (4.82e-3)" "unprognostic (1.23e-2)" 2.1 4.3 7.8 1.1 10.0 0.3 7.3 5.6 14.9 4.6 1.8 9.4 0.0 0.9 3.4 10.5 1.6 6.8 3.1 2.2 8.8 8.6 11.9 0.5 2.9 1.0 8.5 5.9 4.1 5.0 0.6 8.5 1.2 10.3 7.5 2.2 4.5 2.5 4.7 0.7 4.1 1.1 3.6 10.3 1.2 3.2 5.9 7.4 0.0 8.4 0.3 0.9 3.2 1.2 0.1 0.2 0.0 0.0 0.1 0.2 0.0 1.4 1.0 4.5 2.2 0.0 0.0 0.0 0.6 0.5 0.9 2.7 0.1 5.2 0.0 0.5 1.2 5.8 0.1 2.1 2.4 3.7 0.0 0.1 1.2 1.2 0.6 1.3 1.3 0.0 4.9 2.1 1.1 0.0 3.8 0.0 0.0 0.0 2.7 7.3 0.3 2.3 0.0 0.3 0.0 1.1 0.0 5.8 0.0 0.8 0.3 2.6 9.6 0.0 3.8 4.4 2.5 6.5 1.4 3.1 11.8 5.2 0.1 1.8 9.6 2.1 0.0 4.5 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 7.8 10.0 5.6 13.9 8.8 8.6 8.5 5.9 10.3 7.4 0.0 1.0 0.0 0.2 0.8 6.9 0.6 0.0 4.0 2.3 1.8 3.9 1.7 1.7 2.1 0.1 1.0 0.0 0.0 0.6 0.2 2.2 0.2 0.0 0.0 0.3 4.8 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 0.1 3.1 0.3 0.0 1.8 1.8 2.9 0.0 0.9 1.7 5.1 1.3 0.2 0.0 0.0 0.0 TREML1 "dJ238O23.3, TLT1" ENSG00000161911 "Triggering receptor expressed on myeloid cells like 1" Q86YW5 6 41149342-41154337 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 37.9;bone marrow: 10.5;heart muscle: 10.0;lymphoid tissue: 26.7" "Cell type enriched" "Detected in some" 11 "monocytes: 44.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "basophil: 19.2" "Lineage enriched" "Detected in single" 31 "granulocytes: 19.2" "Cell line enriched" "Detected in single" 167 "HEL: 38.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016700, HPA017860" Enhanced Approved "Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol" NA NA 94000000 "Nuclear speckles, Cytosol" "Golgi apparatus, Plasma membrane" "HPA016700: AB_1858262, HPA017860: AB_1858261" "unprognostic (6.70e-2)" "unprognostic (3.50e-3)" "unprognostic (1.15e-3)" "unprognostic (1.62e-1)" "unprognostic (3.48e-2)" "unprognostic (4.53e-5)" "unprognostic (1.10e-2)" "unprognostic (2.55e-3)" "unprognostic (4.50e-1)" "unprognostic (2.12e-3)" "unprognostic (2.34e-2)" "unprognostic (7.04e-2)" "unprognostic (1.11e-4)" "unprognostic (1.36e-1)" "unprognostic (8.38e-2)" "unprognostic (7.51e-2)" "unprognostic (3.41e-2)" 1.2 1.2 2.1 3.7 1.2 10.5 0.6 0.5 1.3 0.4 0.3 0.3 0.3 0.0 0.3 0.6 0.3 0.6 1.3 10.0 2.1 1.6 0.3 0.3 2.9 7.7 3.3 0.3 1.9 0.5 0.2 0.6 1.7 1.2 0.3 1.3 0.6 1.3 0.3 0.8 0.3 0.4 0.3 4.3 26.7 0.2 0.8 0.3 1.4 0.6 0.3 7.1 1.1 0.3 0.1 0.3 19.2 0.6 0.0 0.2 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 38.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.6 0.8 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.0 3.9 0.0 0.1 0.3 0.0 37.9 2.1 1.2 0.5 0.7 2.1 1.6 3.3 0.3 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 1.0 0.0 0.0 1.7 0.0 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRIM25 "EFP, RNF147, ZNF147" ENSG00000121060 "Tripartite motif containing 25" Q14258 17 56887909-56914038 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" "Ligase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 20.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 20.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA005909 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 35000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA005909: AB_1078722" "unprognostic (8.73e-3)" "unprognostic (1.57e-2)" "unprognostic (2.06e-2)" "unprognostic (6.06e-2)" "unprognostic (2.69e-1)" "unprognostic (3.78e-2)" "prognostic unfavorable (9.37e-4)" "unprognostic (1.53e-1)" "unprognostic (4.23e-1)" "unprognostic (1.15e-1)" "prognostic favorable (3.36e-4)" "unprognostic (3.23e-1)" "unprognostic (3.11e-2)" "prognostic favorable (9.35e-4)" "unprognostic (5.21e-2)" "unprognostic (5.13e-2)" "unprognostic (7.39e-2)" 20.0 19.7 7.5 23.6 8.9 32.6 19.3 11.6 7.8 15.3 22.5 5.0 8.0 15.3 13.4 12.6 17.7 15.3 18.4 8.3 5.8 6.3 10.1 27.0 20.8 15.9 6.7 5.5 13.3 15.3 13.6 11.5 55.0 7.4 12.2 14.3 12.5 14.5 11.5 11.7 23.1 20.7 10.1 5.2 35.8 14.1 12.8 6.5 26.2 11.8 15.1 18.5 10.6 35.9 1.7 2.4 20.0 2.3 0.8 1.5 0.7 28.5 14.2 3.5 11.8 26.5 22.4 0.0 11.3 22.9 27.1 23.3 13.8 15.7 27.9 23.5 10.8 29.6 17.0 17.0 15.2 15.2 23.8 13.5 18.0 11.0 15.3 22.7 21.5 13.0 10.0 25.6 14.1 30.0 12.9 17.9 19.2 4.4 17.1 13.7 19.1 24.0 15.5 2.2 23.7 27.6 17.2 11.7 17.6 15.8 22.6 6.8 6.4 8.9 14.3 26.2 2.3 19.4 17.5 11.9 12.7 9.1 19.5 11.7 9.7 18.5 4.6 12.3 14.8 4.9 3.0 2.3 0.9 0.9 1.9 1.1 1.7 0.8 0.8 2.4 1.4 0.6 0.8 20.0 0.8 1.4 1.7 1.5 0.7 7.5 8.9 11.6 7.8 5.8 6.3 6.7 5.5 7.4 6.5 32.8 17.5 11.5 7.3 16.5 8.7 7.0 12.7 20.1 20.5 8.7 27.5 4.1 0.0 16.7 2.1 22.4 32.6 0.0 18.7 8.3 7.8 14.6 3.5 28.7 12.5 3.2 17.9 28.3 31.6 1.2 8.9 23.3 13.5 5.4 26.1 5.2 26.1 26.4 8.9 6.3 19.2 6.5 6.4 0.3 0.0 26.7 13.3 8.6 21.8 16.6 TRIM29 "ATDC, FLJ36085" ENSG00000137699 "Tripartite motif containing 29" Q14134 11 120111275-120185529 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 97.6;Basal keratinocytes: 241.7;Suprabasal keratinocytes: 402.6;Urothelial cells: 144.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 93.4" "Region enriched" "Detected in single" 8 "pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 54.2;hTCEpi: 72.1;RT4: 28.5;SiHa: 40.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020053, HPA074841" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA020053: AB_1858280, HPA074841: " "unprognostic (1.10e-1)" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (2.88e-4)" "unprognostic (9.79e-3)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (5.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.46e-4)" "unprognostic (9.37e-2)" "unprognostic (4.29e-3)" "prognostic favorable (4.93e-4)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.15e-2)" 0.3 0.2 0.1 0.0 0.1 0.1 7.3 0.0 0.1 30.4 0.6 0.2 1.6 0.3 3.1 2.9 176.3 3.7 0.8 0.1 0.1 0.1 0.5 0.4 1.4 0.0 0.0 0.0 0.4 0.2 0.0 2.2 24.4 1.1 11.1 0.5 0.0 25.5 4.8 0.9 90.1 0.2 1.6 0.3 0.0 0.2 0.7 0.0 7.5 0.1 113.6 93.6 9.6 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 3.4 0.0 0.8 0.0 0.1 54.2 0.0 12.4 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.1 0.0 72.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 28.5 0.2 0.9 40.5 5.7 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 1.0 0.0 97.6 241.7 0.0 1.1 2.5 33.5 13.6 0.0 0.0 37.9 0.0 1.3 21.4 0.4 2.1 0.0 3.9 5.0 5.4 34.5 1.1 0.0 4.4 0.0 2.4 0.0 0.0 78.0 0.6 1.7 21.9 0.0 2.3 0.0 33.2 0.8 0.0 0.2 0.0 0.0 7.2 0.6 1.4 402.6 20.7 0.0 1.4 144.0 TRIM42 "FLJ40097, PPP1R40, T4A1" ENSG00000155890 "Tripartite motif containing 42" Q8IWZ5 3 140678039-140701150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 85 "testis: 43.2" "Group enriched" "Detected in some" 113 "Early spermatids: 249.5;Late spermatids: 89.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003581, HPA022481" Uncertain Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA003581: AB_1080383, HPA022481: AB_1858301" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 249.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 TRIM6-TRIM34 ENSG00000258588 "TRIM6-TRIM34 readthrough" 11 5596725-5644398 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "kidney: 30.3;salivary gland: 9.5;testis: 8.0" "Cell type enriched" "Detected in single" 9 "Ciliated cells: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "A549: 10.1" HPA077996 Uncertain Nucleoli,Centrosome NA NA Centrosome Nucleoli "HPA077996: AB_2686873" 0.9 0.7 0.4 0.6 0.4 0.1 0.9 0.4 0.4 1.4 0.4 0.0 0.7 0.8 1.5 1.6 1.9 0.7 0.2 1.4 0.4 0.3 30.3 0.4 0.7 0.1 0.3 0.0 1.7 2.7 1.1 0.4 1.4 0.3 1.5 0.2 2.2 9.5 1.9 0.4 0.4 0.6 1.9 0.4 1.1 0.4 8.0 0.0 0.0 1.7 0.0 1.5 1.1 0.5 0.5 1.5 1.3 0.8 0.9 0.2 0.2 0.0 10.1 0.0 0.0 0.2 0.8 1.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 1.1 0.0 0.0 0.7 0.6 0.6 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 0.2 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.2 0.2 0.1 0.4 0.0 0.1 1.5 0.5 0.1 0.1 1.3 0.9 0.4 0.3 0.0 0.2 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM60 "FLJ35882, RNF129, RNF33" ENSG00000176979 "Tripartite motif containing 60" Q495X7 4 165031953-165041744 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "placenta: 5.0;testis: 6.6" "Cell type enhanced" "Detected in some" 11 "Cytotrophoblasts: 4.8;Extravillous trophoblasts: 8.2;Spermatocytes: 3.8;Spermatogonia: 6.4;Syncytiotrophoblasts: 4.7" "Cancer enriched" "Detected in single" 103 "testis cancer: 5.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "BEWO: 18.0" "Not detected" "Not detected" "HPA035809, HPA035810, HPA061496" Uncertain Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540" "unprognostic (1.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 1.1 0.2 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.4 0.1 0.2 1.1 0.2 0.3 0.0 0.5 0.3 0.2 1.1 0.1 0.1 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.5 0.0 1.4 0.0 0.0 0.0 4.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 8.2 0.2 0.2 0.0 0.8 0.4 0.0 0.0 0.0 2.2 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.3 0.0 0.0 3.8 6.4 0.3 4.7 0.5 0.0 0.0 TRIM73 TRIM50B ENSG00000178809 "Tripartite motif containing 73" Q86UV7 7 75395063-75410996 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "stomach 1: 11.5" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 20.3;Cone photoreceptor cells: 17.7;Horizontal cells: 30.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 7.9;Hep G2: 13.3" "HPA047843, HPA051845" Uncertain Uncertain Cytosol NA NA Cytosol "HPA047843: AB_2680176, HPA051845: AB_2681635" "unprognostic (1.01e-2)" "unprognostic (9.85e-5)" "unprognostic (4.72e-3)" "unprognostic (9.44e-3)" "unprognostic (2.49e-1)" "unprognostic (1.48e-2)" "unprognostic (1.25e-3)" "unprognostic (9.17e-3)" "unprognostic (1.41e-1)" "unprognostic (2.80e-1)" "unprognostic (5.46e-3)" "unprognostic (6.79e-2)" "unprognostic (4.18e-2)" "unprognostic (9.67e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-2)" "unprognostic (2.73e-3)" 1.9 1.6 0.3 1.2 0.9 2.4 1.6 4.0 0.6 2.4 0.6 4.2 1.7 0.3 0.3 3.8 1.0 0.9 0.4 0.5 1.7 2.3 1.1 2.3 0.2 2.3 7.2 1.3 1.7 0.1 2.1 0.0 1.9 1.9 2.6 2.4 2.2 0.0 0.5 1.8 11.5 5.4 2.4 0.2 0.7 1.3 1.3 1.4 2.0 0.8 1.7 2.2 1.3 1.3 4.1 1.7 2.5 0.0 0.9 0.6 0.5 0.1 0.1 1.0 0.0 2.0 2.3 0.4 0.2 0.3 1.4 0.3 0.0 0.2 5.1 7.9 1.5 3.1 13.3 0.9 0.8 5.6 2.3 0.0 0.3 0.4 1.2 0.1 3.3 0.7 6.5 0.0 0.9 2.1 2.7 0.2 0.3 1.4 3.6 0.2 1.2 0.4 0.0 2.1 1.6 2.6 0.9 2.1 0.7 0.6 2.4 1.6 1.1 1.9 1.7 1.1 3.1 1.8 2.4 1.7 3.3 1.5 1.1 0.8 0.7 2.2 0.6 1.2 1.1 1.3 0.4 0.4 1.3 2.1 1.6 2.0 1.7 0.2 1.4 2.0 1.3 0.0 0.3 1.9 2.2 0.8 20.3 2.0 2.5 5.3 3.4 5.2 17.7 1.9 5.0 1.6 5.0 2.2 2.0 0.0 4.0 0.6 1.3 2.7 0.0 1.8 2.5 30.2 4.7 3.1 1.0 8.5 6.1 1.7 1.7 1.0 4.0 9.5 3.1 4.0 3.5 2.9 12.6 0.0 1.1 9.4 2.7 1.8 0.9 4.5 3.3 2.4 TRMT10A "MGC27034, RG9MTD2, TRM10" ENSG00000145331 "TRNA methyltransferase 10A" Q8TBZ6 4 99546709-99564032 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 76.6;Spermatogonia: 51.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047601, HPA058241" Uncertain Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" NA NA "Nucleoplasm, Nucleoli, Actin filaments" Cytosol "HPA047601: AB_2680099, HPA058241: AB_2683651" "unprognostic (5.24e-2)" "unprognostic (1.69e-1)" "unprognostic (1.34e-1)" "unprognostic (1.96e-3)" "unprognostic (2.10e-1)" "unprognostic (5.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.59e-2)" "unprognostic (3.65e-2)" "unprognostic (1.57e-1)" "unprognostic (3.51e-1)" "unprognostic (7.49e-3)" "unprognostic (3.32e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (1.68e-2)" 7.0 8.9 6.5 7.5 8.9 3.3 13.1 6.1 8.7 4.6 6.0 9.3 7.5 7.3 5.5 7.2 9.2 10.1 6.1 5.0 7.9 6.7 9.1 16.8 4.9 7.4 9.2 6.1 6.6 12.4 6.7 12.2 10.0 9.7 7.4 6.9 2.5 7.3 4.7 9.3 6.5 10.4 5.1 10.5 7.0 7.6 16.7 10.1 10.7 10.8 5.1 8.0 7.2 10.8 8.8 10.0 9.2 7.6 5.8 7.1 4.0 6.7 4.8 9.3 4.8 5.5 7.8 6.7 8.2 3.2 5.8 4.3 3.9 8.4 9.3 3.2 4.8 5.2 3.9 10.8 5.2 8.9 11.8 4.8 6.4 4.1 6.4 5.3 16.2 6.9 4.9 13.4 5.8 12.7 3.4 5.8 8.5 14.7 8.4 4.9 7.8 13.6 3.3 5.5 12.1 4.6 7.9 8.9 5.9 7.8 5.5 5.8 5.1 4.5 24.9 8.2 8.1 8.1 7.0 4.2 5.9 6.1 4.8 9.3 5.8 9.8 8.5 4.5 9.5 4.1 4.0 7.6 3.7 3.8 7.1 3.1 6.3 6.5 6.4 10.0 8.8 6.7 6.2 9.2 5.8 6.2 5.6 7.1 4.0 6.5 8.9 6.1 8.7 7.9 6.7 9.2 6.1 9.7 10.1 3.0 9.3 6.0 5.1 7.2 4.6 5.9 12.7 20.1 4.5 10.4 3.9 14.6 36.5 11.9 34.0 6.7 10.7 0.0 16.6 14.7 5.4 5.0 8.1 24.2 7.1 4.8 6.9 9.2 7.9 11.7 6.1 4.7 5.0 5.4 9.8 7.8 14.8 11.0 7.1 17.0 5.9 12.9 7.1 76.6 51.2 8.3 14.6 4.8 9.6 5.9 TRMT10C "FLJ20432, MRPP1, RG9MTD1" ENSG00000174173 "TRNA methyltransferase 10C, mitochondrial RNase P subunit" Q7L0Y3 3 101561862-101566446 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036671 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA036671: AB_10602085" "unprognostic (7.42e-2)" "unprognostic (2.68e-1)" "unprognostic (9.08e-3)" "unprognostic (4.47e-3)" "unprognostic (5.01e-2)" "unprognostic (5.55e-2)" "prognostic unfavorable (6.56e-5)" "unprognostic (1.67e-2)" "unprognostic (8.48e-2)" "unprognostic (5.42e-2)" "unprognostic (4.70e-2)" "unprognostic (3.28e-2)" "prognostic favorable (3.32e-5)" "unprognostic (2.77e-2)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" 18.0 21.2 13.1 13.6 14.1 14.4 19.7 16.4 19.1 16.1 15.3 5.5 12.9 11.6 14.6 13.1 20.9 15.0 10.7 20.4 13.0 13.4 26.6 34.6 10.0 19.3 12.5 16.7 18.8 12.1 9.9 19.9 18.2 18.5 16.2 14.2 5.5 14.5 13.0 35.2 15.2 16.5 15.3 14.3 19.6 15.6 14.7 10.6 23.0 16.6 30.5 18.5 15.6 11.3 21.6 15.4 27.4 14.8 12.2 23.1 11.8 21.0 10.3 13.7 13.8 12.6 10.8 12.8 12.6 12.3 16.4 18.4 15.6 14.3 43.8 16.4 7.8 13.3 21.3 26.4 19.2 22.7 15.6 13.0 29.4 8.2 11.3 9.7 25.8 12.5 12.6 20.0 14.3 13.4 8.8 15.9 16.8 24.9 9.8 17.6 14.4 20.6 18.9 25.5 27.4 22.4 15.4 11.2 19.5 21.0 17.9 34.2 19.5 9.8 20.9 27.6 12.6 27.6 28.4 10.5 9.0 17.0 5.9 13.2 11.4 20.8 42.0 15.2 18.6 13.4 27.4 11.2 7.3 13.6 14.4 18.8 21.6 16.8 15.8 13.5 20.4 23.1 21.1 4.9 12.2 14.8 15.4 15.0 11.8 13.1 14.1 16.4 19.1 13.0 13.4 12.5 16.7 18.5 10.6 20.8 20.0 45.2 114.9 83.8 27.3 45.1 15.3 44.2 47.8 27.9 13.7 57.1 44.7 44.7 22.0 33.0 12.7 0.0 29.3 34.7 35.1 33.3 46.1 46.1 28.0 20.6 34.3 28.8 19.4 6.3 34.5 28.4 13.5 36.9 26.7 27.5 31.9 14.0 35.3 55.3 29.1 32.3 41.5 61.4 51.3 91.8 54.8 41.7 40.3 115.3 TRMT61B FLJ20628 ENSG00000171103 "TRNA methyltransferase 61B" Q9BVS5 2 28849821-28870301 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026747, HPA026751" Enhanced Uncertain Cytosol NA NA Cytosol "HPA026747: AB_1848782, HPA026751: AB_1848784" "unprognostic (1.01e-2)" "unprognostic (1.32e-2)" "unprognostic (1.63e-3)" "unprognostic (2.05e-2)" "unprognostic (3.32e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.36e-2)" "unprognostic (2.55e-2)" "unprognostic (2.77e-1)" "unprognostic (2.52e-2)" "unprognostic (2.52e-2)" "prognostic favorable (9.61e-5)" "unprognostic (2.19e-1)" "unprognostic (1.43e-1)" "unprognostic (5.38e-2)" "unprognostic (2.34e-1)" 11.6 19.5 20.4 12.8 22.5 10.9 18.5 33.7 21.0 13.8 11.7 17.4 10.9 19.2 15.6 20.4 12.6 11.8 10.1 16.3 17.2 18.4 19.8 16.9 9.0 13.8 17.0 15.6 13.7 10.0 21.1 25.4 12.2 17.8 15.2 13.2 14.2 12.6 11.8 17.9 11.9 18.6 14.4 14.7 13.2 12.4 14.6 18.7 12.6 12.8 10.4 14.5 14.8 10.8 11.9 6.8 2.7 7.0 13.9 12.4 6.3 17.9 10.8 11.0 19.4 15.0 12.9 13.3 10.7 13.3 13.7 12.8 12.3 9.7 19.0 9.9 9.3 16.4 14.1 15.3 13.0 14.2 14.2 10.3 5.8 8.9 16.1 17.1 12.2 6.6 13.1 14.5 10.8 14.8 10.1 13.0 12.5 11.7 7.3 11.2 7.1 10.8 18.6 20.3 21.4 17.4 8.1 17.7 16.4 11.9 11.7 18.6 19.8 11.5 18.2 17.5 9.6 9.3 4.3 10.2 9.2 15.4 9.0 13.4 9.1 14.9 29.5 12.1 18.4 12.2 0.0 6.6 2.7 9.8 7.0 12.1 11.9 11.1 10.5 6.4 11.6 12.4 8.9 0.9 13.9 5.7 6.8 11.6 6.3 20.4 22.5 33.7 21.0 17.2 18.4 17.0 15.6 17.8 18.7 14.9 5.4 12.0 9.6 16.1 9.9 2.0 10.2 12.0 9.1 8.7 5.9 17.9 13.3 12.4 6.3 6.8 7.1 0.0 8.9 13.0 9.9 6.1 9.2 8.3 8.0 6.4 4.6 1.3 6.9 2.7 8.1 7.1 6.8 10.0 9.5 9.1 9.0 9.9 9.9 23.8 20.7 6.5 9.5 21.8 9.6 13.8 7.3 7.9 13.3 6.5 TRPC7 ENSG00000069018 "Transient receptor potential cation channel subfamily C member 7" Q9HCX4 5 136213320-136365545 "Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.2;brain: 1.6;intestine: 1.3;kidney: 1.5;pituitary gland: 2.2;testis: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.8;SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB022592, HPA031126" Uncertain Uncertain "Actin filaments,Focal adhesion sites" NA NA "Focal adhesion sites" "Actin filaments" "CAB022592: , HPA031126: AB_10603221" "unprognostic (1.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.03e-2)" "unprognostic (2.89e-5)" "unprognostic (3.26e-1)" "unprognostic (2.75e-1)" "unprognostic (9.99e-2)" "unprognostic (1.77e-1)" "unprognostic (6.78e-2)" 0.0 2.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TRPM1 "CSNB1C, LTRPC1, MLSN1" ENSG00000134160 "Transient receptor potential cation channel subfamily M member 1" Q7Z4N2 15 31001061-31161273 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 99.0" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 705.2" "Cancer enriched" "Detected in single" 179 "melanoma: 14.6" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 113 "SK-MEL-30: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014779, HPA071139" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Centriolar satellite" NA NA "Centriolar satellite" "Golgi apparatus, Plasma membrane" "HPA014779: AB_2669090, HPA071139: " "unprognostic (5.28e-2)" "unprognostic (1.35e-1)" "unprognostic (9.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-3)" "unprognostic (2.83e-1)" "unprognostic (2.89e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (2.58e-1)" "unprognostic (7.84e-2)" "unprognostic (6.20e-4)" "unprognostic (1.48e-1)" "unprognostic (2.63e-2)" 0.1 0.0 0.4 0.0 0.6 0.0 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.3 0.1 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 99.0 0.4 0.0 0.2 10.4 0.0 0.1 1.9 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.1 0.3 0.7 0.2 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 3.8 705.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 30.8 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 12.7 0.0 0.0 0.0 2.4 0.0 0.0 150.1 0.0 0.0 10.0 0.0 0.0 0.0 0.6 18.1 0.0 0.0 7.9 3.8 0.9 0.8 0.0 0.0 0.0 TSLP ENSG00000145777 "Thymic stromal lymphopoietin" Q969D9 5 111070062-111078024 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 24.2;Basal keratinocytes: 49.6;Club cells: 45.5;Early spermatids: 30.8;Late spermatids: 20.5;Suprabasal keratinocytes: 22.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.1" "Lineage enhanced" "Detected in single" "T-cells: 2.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.3;HHSteC: 11.7;hTCEpi: 6.9;hTEC/SVTERT24-B: 14.7;hTERT-HME1: 8.4;hTERT-RPE1: 26.0;U-87 MG: 9.5" HPA056350 Uncertain "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 38400 "Golgi apparatus, Vesicles" "HPA056350: " "unprognostic (6.47e-4)" "unprognostic (3.26e-1)" "unprognostic (6.57e-2)" "unprognostic (1.93e-1)" "unprognostic (5.03e-2)" "unprognostic (7.72e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-2)" "unprognostic (5.81e-2)" "unprognostic (1.24e-1)" "unprognostic (6.15e-2)" "unprognostic (4.24e-1)" "unprognostic (1.88e-1)" "unprognostic (5.04e-2)" "unprognostic (1.95e-1)" "unprognostic (2.76e-1)" "unprognostic (1.74e-3)" 5.1 1.7 0.7 2.0 1.1 0.2 19.1 0.5 0.8 5.4 4.6 1.4 6.6 1.5 4.2 0.7 14.1 1.1 14.1 18.7 1.4 0.8 1.6 17.3 4.6 1.8 1.2 1.7 1.1 0.8 0.2 1.5 0.4 2.3 16.4 1.7 1.0 3.5 6.8 2.3 1.7 2.7 12.6 4.6 1.0 2.6 7.9 1.1 0.3 4.1 3.2 2.3 10.0 6.0 0.0 0.0 0.0 0.5 0.0 2.1 0.3 0.0 0.0 0.0 1.2 1.6 10.3 0.0 0.0 1.5 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.3 0.5 0.0 1.6 1.8 0.1 0.0 11.7 0.3 0.0 0.2 6.9 14.7 8.4 26.0 0.0 4.3 0.1 0.0 2.1 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.9 0.0 0.7 0.0 0.0 0.6 0.0 0.0 2.7 0.0 0.0 9.5 0.2 0.4 0.0 0.5 0.0 0.9 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.5 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.7 1.1 0.5 0.8 1.4 0.8 1.2 1.7 2.3 1.1 0.0 1.9 0.0 24.2 49.6 0.0 5.2 0.0 2.7 45.5 0.0 0.0 0.0 0.0 0.1 30.8 4.7 0.0 0.0 0.0 0.0 2.1 4.0 0.0 8.3 0.2 0.0 0.0 4.9 0.0 20.5 0.6 0.2 3.3 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 3.1 0.3 0.4 22.0 0.0 0.0 0.0 2.1 TSPAN15 "NET-7, TM4SF15" ENSG00000099282 "Tetraspanin 15" O95858 10 69451473-69507669 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 106.8;Exocrine glandular cells: 167.5;Mucus-secreting cells: 103.1;Pancreatic endocrine cells: 141.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 17.4" "Lineage enriched" "Detected in many" 6 "T-cells: 17.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.9;EFO-21: 48.7;MCF7: 36.8;OE19: 33.8;PC-3: 60.5;SK-BR-3: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044657, HPA071160" Approved Approved "Nuclear bodies,Vesicles,Plasma membrane,Cytosol" NA NA "Nuclear bodies, Plasma membrane" "Vesicles, Cytosol" "HPA044657: AB_10967927, HPA071160: " "unprognostic (2.03e-1)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (1.48e-2)" "unprognostic (9.44e-3)" "unprognostic (6.81e-3)" "prognostic unfavorable (8.00e-4)" "unprognostic (2.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.76e-1)" "unprognostic (8.22e-3)" "unprognostic (2.36e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (8.49e-2)" "unprognostic (4.66e-2)" "unprognostic (6.34e-2)" "unprognostic (3.78e-3)" 34.2 3.1 11.5 9.7 22.7 0.9 24.9 40.4 17.0 8.9 30.4 49.2 12.5 24.0 15.1 8.4 7.1 16.2 17.1 8.3 18.0 9.2 10.2 3.0 20.4 4.9 33.1 11.2 3.0 10.8 1.4 3.3 17.7 16.8 17.6 24.9 5.4 16.8 17.0 9.9 4.6 21.5 23.0 43.0 13.5 46.4 4.0 28.3 0.8 6.7 2.7 4.8 22.6 6.8 0.0 2.7 0.0 0.0 0.1 17.4 0.5 11.1 23.2 0.4 0.0 0.5 0.0 2.7 0.0 0.4 0.6 1.5 10.0 34.9 0.0 48.7 0.5 2.1 22.8 1.6 2.5 0.7 9.2 4.6 0.6 0.7 2.2 0.2 0.0 0.4 0.5 0.7 0.3 0.3 1.7 8.9 4.6 0.2 0.0 0.2 36.8 0.1 0.2 0.6 33.8 60.5 0.8 0.4 0.4 6.8 20.7 7.9 3.0 0.1 30.7 3.8 4.1 13.4 0.5 7.7 0.0 0.1 0.0 3.8 0.2 1.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 17.4 0.0 2.7 2.5 2.7 0.0 0.9 0.2 0.0 0.1 0.0 0.2 0.9 0.5 11.5 22.7 40.4 17.0 18.0 9.2 33.1 11.2 16.8 28.3 29.8 5.8 2.7 9.7 3.2 3.0 0.8 25.5 14.7 6.8 27.9 5.9 1.5 3.3 106.8 26.3 18.7 73.5 0.0 167.5 9.1 4.7 50.7 1.1 0.0 20.5 1.6 38.6 11.1 5.6 4.9 0.6 10.5 27.0 27.1 103.1 36.7 141.3 88.3 0.0 1.3 1.4 12.9 7.6 0.9 17.7 2.8 2.5 2.5 61.6 27.1 TSPO "BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS" ENSG00000100300 "Translocator protein" "B1AH88, P30536" 22 43151514-43163242 "Cancer-related genes, FDA approved drug targets, Predicted membrane proteins" "Lipid transport, Transport" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 139.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB011232, HPA046260, HPA072304" Uncertain Supported Vesicles,Mitochondria,Cytosol NA NA Mitochondria "Vesicles, Cytosol" "CAB011232: , HPA046260: , HPA072304: " "unprognostic (5.29e-3)" "unprognostic (1.41e-1)" "unprognostic (3.31e-1)" "unprognostic (4.02e-3)" "unprognostic (3.95e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.16e-1)" "unprognostic (1.17e-1)" "unprognostic (3.75e-2)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.34e-3)" 33.9 21.2 9.8 17.8 11.0 117.3 48.7 2.7 8.1 24.9 23.9 12.3 10.3 20.5 12.3 13.6 83.2 14.3 36.8 32.1 8.0 5.4 18.0 22.0 39.8 40.0 15.4 5.2 13.3 13.2 4.0 6.7 15.5 9.7 23.1 9.7 16.4 34.6 9.2 13.2 46.6 23.0 12.7 11.4 27.2 39.0 10.5 10.0 9.4 17.9 44.3 50.0 19.1 41.3 22.9 99.9 91.4 139.5 28.5 43.8 104.8 47.6 23.6 1.6 22.4 9.0 29.9 1.8 35.6 17.4 17.9 19.1 4.6 36.5 0.0 24.7 27.6 8.8 39.5 4.5 27.6 2.3 7.9 18.6 4.8 25.9 1.6 32.7 10.8 24.4 23.2 45.5 10.6 9.5 21.1 42.4 0.0 3.9 9.0 18.3 39.9 0.1 30.2 1.9 24.6 59.0 10.7 0.0 81.4 22.9 28.8 2.3 11.0 16.9 33.8 41.5 0.0 12.7 42.0 43.7 22.3 16.7 22.7 14.9 3.6 0.6 0.4 28.9 35.1 28.5 43.8 139.5 75.3 28.4 86.3 22.2 16.3 39.5 27.8 99.9 22.9 30.4 24.5 91.4 28.5 57.1 17.7 43.8 104.8 9.8 11.0 2.7 8.1 8.0 5.4 15.4 5.2 9.7 10.0 148.9 135.1 105.0 344.2 325.8 2.2 79.7 336.3 127.2 167.2 195.4 2.0 9.0 313.4 570.0 2.1 215.5 499.4 46.7 512.5 126.3 307.4 297.1 261.1 99.0 745.0 3.2 187.3 163.2 688.0 6.1 76.5 573.3 686.7 477.9 485.1 116.9 963.2 644.9 148.2 97.5 17.1 103.5 217.3 1.1 4.9 468.6 16.7 155.6 529.3 666.0 TTBK1 KIAA1855 ENSG00000146216 "Tau tubulin kinase 1" Q5TCY1 6 43243680-43288259 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.9" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 6.7;Horizontal cells: 4.8;Proximal tubular cells: 1.9" "Cancer enhanced" "Detected in some" "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "SCLC-21H: 21.3;SH-SY5Y: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031735, HPA031736" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA031735: AB_2674019, HPA031736: AB_10670294" "unprognostic (1.68e-1)" "unprognostic (7.88e-3)" "unprognostic (7.01e-2)" "unprognostic (1.62e-3)" "unprognostic (2.18e-1)" "unprognostic (2.24e-4)" "unprognostic (2.46e-3)" "unprognostic (3.01e-2)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (3.01e-2)" "unprognostic (2.12e-4)" "unprognostic (7.42e-2)" "unprognostic (3.68e-1)" "unprognostic (1.32e-1)" "unprognostic (2.64e-3)" "unprognostic (3.04e-4)" 1.1 3.9 12.4 1.3 12.9 0.9 1.0 14.9 28.9 1.0 1.4 8.2 0.0 4.6 1.0 1.0 1.0 1.1 1.4 1.3 10.3 7.5 1.7 3.5 1.1 1.2 7.1 12.5 1.0 1.4 1.6 7.7 1.0 9.0 1.3 1.3 0.7 1.0 1.2 1.0 1.0 6.8 1.1 6.2 1.2 1.3 2.3 8.3 0.0 1.0 0.0 1.3 1.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.0 21.3 8.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 12.4 12.9 14.9 21.7 10.3 7.5 7.1 12.5 9.0 8.3 0.0 0.0 0.0 0.0 0.0 6.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 4.8 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.9 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 TTBK2 "KIAA0847, SCA11" ENSG00000128881 "Tau tubulin kinase 2" Q6IQ55 15 42738734-42920809 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.8" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 69.2;Late spermatids: 113.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018113, HPA049866" Approved Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA018113: AB_1858421, HPA049866: AB_2680923" "unprognostic (2.15e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (7.73e-2)" "unprognostic (4.26e-1)" "unprognostic (6.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.43e-2)" "unprognostic (2.78e-2)" "unprognostic (8.62e-2)" "unprognostic (3.46e-2)" "unprognostic (7.29e-2)" "unprognostic (3.63e-2)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" 6.7 7.3 8.7 5.1 14.0 8.0 6.0 17.8 22.0 7.0 7.2 10.9 3.8 3.3 8.5 6.2 4.2 7.8 6.2 10.7 9.4 11.5 6.1 4.3 6.1 5.5 11.1 14.8 11.5 3.3 9.0 13.9 8.8 24.7 8.2 5.6 7.6 4.8 6.5 11.6 6.3 4.6 8.4 10.9 7.1 4.9 41.8 10.8 3.6 6.7 1.9 5.4 6.8 8.7 2.5 1.4 1.3 3.0 2.1 3.1 0.7 6.2 3.4 9.3 4.9 6.4 6.6 1.9 5.1 7.3 4.4 6.6 4.6 1.5 4.0 6.5 4.9 8.9 4.2 8.1 6.0 6.8 13.0 5.7 5.0 7.7 1.9 5.0 7.1 8.6 5.2 6.2 4.0 21.0 9.6 5.5 5.4 7.5 6.5 4.2 0.8 4.7 5.0 2.6 1.5 3.8 7.9 8.8 2.0 5.6 3.8 6.9 7.8 12.5 0.9 2.6 6.7 3.2 8.8 6.7 5.7 5.7 7.1 7.1 7.6 10.1 6.0 4.2 5.5 3.6 0.4 3.0 1.2 1.7 1.4 3.1 1.5 1.6 1.3 0.8 2.5 2.1 1.5 1.3 2.1 1.5 1.4 0.5 0.7 8.7 14.0 17.8 22.0 9.4 11.5 11.1 14.8 24.7 10.8 6.0 10.2 7.4 11.8 9.5 31.0 14.2 15.3 33.5 9.1 8.7 35.3 3.5 0.0 4.9 69.2 12.8 3.6 23.3 3.7 2.6 13.1 11.0 18.5 6.8 6.4 42.9 13.7 12.9 13.9 113.0 15.5 15.4 11.8 9.0 4.9 15.0 6.5 2.9 19.1 4.5 38.8 12.9 18.9 39.4 7.1 8.2 2.6 8.7 5.2 5.5 TTC3 "DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII" ENSG00000182670 "Tetratricopeptide repeat domain 3" P53804 21 37073226-37203112 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016810, HPA023964, HPA036304" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049" "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.37e-2)" "unprognostic (8.52e-2)" "unprognostic (9.29e-2)" "unprognostic (8.71e-2)" "unprognostic (1.61e-1)" "unprognostic (2.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (6.74e-2)" 22.9 22.1 34.0 18.7 36.5 12.0 23.4 39.2 40.0 34.9 20.6 15.9 26.7 13.0 21.6 33.3 15.3 19.5 19.0 21.5 29.1 16.5 21.4 17.0 15.4 14.3 17.7 27.5 34.5 25.8 27.4 50.4 15.2 34.7 28.9 19.9 16.1 24.5 25.4 21.6 16.1 16.8 21.6 21.7 13.6 21.3 19.5 19.9 19.7 35.4 11.1 15.1 23.3 18.9 10.6 12.8 4.8 5.7 9.1 18.6 3.8 21.7 7.8 36.3 6.8 35.0 51.1 12.6 24.0 29.9 10.8 14.7 10.2 11.0 18.8 8.4 40.2 10.1 7.2 10.9 14.8 15.3 19.9 7.8 38.0 11.6 13.4 12.8 21.2 12.3 26.4 9.1 11.0 9.8 21.8 16.0 16.7 22.8 22.1 20.3 16.8 20.6 5.5 10.3 14.5 13.2 27.6 17.4 9.9 12.6 16.9 27.7 21.1 29.8 17.1 15.4 8.7 19.4 8.3 20.9 15.5 6.2 19.0 9.0 22.2 15.9 18.8 25.6 21.2 11.7 2.9 4.4 4.8 9.1 4.8 13.6 9.5 10.6 12.3 7.9 10.6 18.6 11.3 0.7 9.1 5.7 12.8 7.2 3.8 34.0 36.5 39.2 40.0 29.1 16.5 17.7 27.5 34.7 19.9 116.1 118.5 109.7 81.2 58.5 344.6 127.3 56.0 75.0 101.2 71.5 214.0 39.6 140.9 74.9 160.4 67.6 60.1 0.0 65.5 79.7 132.8 164.9 62.4 80.5 56.3 311.4 182.6 102.5 80.0 149.3 194.5 74.4 200.8 61.3 133.8 187.6 72.0 84.2 245.4 81.7 228.9 51.8 103.8 264.1 280.4 54.8 44.1 76.7 118.3 90.4 TTC36 HBP21 ENSG00000172425 "Tetratricopeptide repeat domain 36" A6NLP5 11 118527472-118531197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 53.9" "Group enriched" "Detected in some" 12 "Hepatocytes: 410.0;Proximal tubular cells: 138.6" "Group enriched" "Detected in some" 7 "breast cancer: 5.0;liver cancer: 12.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038731 Enhanced Uncertain Nucleoplasm NA NA 20000 Nucleoplasm "HPA038731: AB_10672651" "unprognostic (1.57e-3)" "unprognostic (2.58e-3)" "unprognostic (1.16e-1)" "unprognostic (6.50e-2)" "unprognostic (1.02e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.81e-5)" "unprognostic (6.32e-2)" "unprognostic (8.80e-2)" "unprognostic (6.14e-2)" "unprognostic (4.77e-3)" "unprognostic (3.38e-2)" "unprognostic (5.77e-7)" "unprognostic (5.60e-2)" "unprognostic (2.24e-1)" "unprognostic (1.59e-1)" "unprognostic (8.95e-3)" 2.9 0.4 0.2 0.4 0.3 0.0 3.7 0.6 0.2 0.1 5.5 0.1 0.1 3.4 0.3 8.3 0.1 0.1 0.6 0.7 0.1 0.2 3.2 53.9 0.2 0.1 0.1 0.1 0.1 0.3 0.0 0.5 0.1 0.1 0.2 0.0 0.1 1.0 0.6 0.4 0.1 2.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.8 2.4 0.0 0.0 0.7 0.5 0.0 0.2 0.2 0.2 0.8 0.0 0.0 2.7 0.4 0.0 0.0 0.0 0.2 0.5 0.3 1.7 0.0 0.0 0.8 0.1 0.0 0.0 1.5 2.0 0.1 0.1 0.5 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.8 0.2 0.0 0.0 0.5 0.0 0.5 0.0 2.7 0.6 0.5 1.3 0.0 0.0 0.7 1.7 0.6 12.4 0.0 0.1 2.2 0.0 0.3 0.0 0.9 0.0 0.2 1.1 1.4 1.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.8 0.2 0.3 0.2 0.1 0.5 0.0 0.0 0.7 0.0 2.4 0.0 0.0 0.2 0.3 0.6 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 4.3 0.6 0.2 0.0 0.3 7.6 0.0 0.0 12.2 0.0 0.8 14.9 0.3 0.0 0.0 1.7 23.3 0.4 0.2 0.0 3.0 0.0 410.0 0.1 0.0 2.4 10.4 11.0 0.0 0.3 0.0 0.0 1.0 2.6 0.5 0.3 0.2 0.0 138.6 0.7 0.0 0.1 0.2 0.0 0.1 1.7 0.0 1.0 1.0 TTLL9 "C20orf125, dJ310O13.1" ENSG00000131044 "Tubulin tyrosine ligase like 9" Q3SXZ7 20 31870702-31944963 "Cancer-related genes, Predicted intracellular proteins" Ligase "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.0;epididymis: 8.9;fallopian tube: 9.2;testis: 11.0" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 30.5;Ciliated cells: 65.6;Early spermatids: 31.2;Late spermatids: 53.4" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.8;REH: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041772, HPA055676" Uncertain Uncertain Nucleoplasm,Microtubules NA NA "Nucleoplasm, Microtubules" "HPA041772: AB_10959904, HPA055676: AB_2682881" "unprognostic (8.77e-2)" "unprognostic (8.19e-3)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (4.63e-1)" "unprognostic (1.53e-3)" "unprognostic (1.80e-1)" "unprognostic (1.44e-1)" "unprognostic (1.06e-1)" "unprognostic (4.59e-1)" "unprognostic (9.05e-3)" "unprognostic (6.17e-2)" "unprognostic (8.35e-3)" "unprognostic (1.84e-1)" "unprognostic (1.70e-1)" "unprognostic (1.25e-3)" "unprognostic (2.23e-2)" 0.4 0.6 3.4 0.5 8.9 0.4 1.3 1.0 2.8 0.6 0.5 10.9 1.8 0.6 1.1 8.9 0.6 9.2 0.8 0.5 4.8 3.7 0.8 0.5 1.7 0.7 5.2 0.6 1.8 0.4 2.8 2.8 0.7 16.0 0.6 0.5 0.0 0.5 1.8 0.4 0.6 0.4 0.6 4.5 0.5 0.6 11.0 4.0 0.0 2.1 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.3 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 1.8 0.0 0.9 0.0 0.8 0.0 0.4 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.4 0.7 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.3 0.5 0.3 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 8.9 1.0 2.7 4.8 3.7 5.2 0.6 16.0 4.0 11.9 30.5 0.0 0.9 0.1 1.7 0.8 0.0 65.6 13.6 0.0 3.9 0.1 0.0 0.1 31.2 0.4 0.0 0.0 0.0 0.0 0.0 0.4 7.0 0.0 0.0 4.8 0.0 0.6 0.0 53.4 1.4 0.8 0.0 1.0 0.0 0.3 0.2 0.0 1.1 0.0 0.5 0.0 0.0 9.7 1.1 0.1 0.0 0.0 0.0 0.3 TWF1 "A6, PTK9" ENSG00000151239 "Twinfilin actin binding protein 1" Q12792 12 43793723-43806375 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018116 Approved Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA018116: AB_1855899" "unprognostic (3.06e-1)" "unprognostic (1.95e-2)" "prognostic favorable (8.29e-4)" "unprognostic (7.39e-3)" "unprognostic (2.35e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (5.19e-2)" "unprognostic (1.13e-2)" "unprognostic (7.30e-2)" "unprognostic (3.11e-3)" "unprognostic (2.51e-1)" "unprognostic (8.48e-2)" "unprognostic (1.03e-1)" "unprognostic (2.19e-1)" "unprognostic (2.95e-1)" "unprognostic (2.62e-1)" 14.2 15.8 15.1 11.0 15.8 11.8 20.4 7.8 13.5 17.9 19.7 8.5 33.1 20.5 13.3 15.4 39.5 13.8 14.8 6.7 14.9 11.9 17.6 31.3 12.6 13.7 16.1 9.6 15.7 21.0 8.8 23.5 14.0 14.6 14.6 20.5 4.6 14.8 32.1 3.5 10.7 24.1 16.0 15.7 10.0 16.9 9.7 12.7 7.1 25.0 19.1 9.6 18.3 19.4 7.8 5.4 10.1 5.2 14.7 8.7 4.1 26.4 19.8 10.3 12.5 27.0 31.3 25.2 37.4 30.7 30.3 23.0 31.7 37.3 7.2 34.8 35.6 17.7 18.1 14.1 26.5 43.2 2.4 16.5 6.6 16.8 15.0 22.1 7.6 8.6 21.3 21.7 31.4 35.2 38.6 26.4 3.6 7.2 8.1 47.0 14.1 3.6 5.2 6.2 0.0 32.6 3.1 11.6 8.1 40.1 33.3 7.7 11.5 31.0 28.3 26.8 15.1 26.4 7.6 25.3 37.5 24.9 29.9 30.9 7.1 7.0 9.8 34.4 19.7 14.1 10.1 3.3 6.7 6.7 4.9 7.6 7.8 8.1 8.3 5.4 3.9 8.1 8.7 5.4 14.7 5.2 3.4 8.0 4.1 15.1 15.8 7.8 13.5 14.9 11.9 16.1 9.6 14.6 12.7 11.9 26.0 17.9 26.8 37.1 20.9 5.7 38.2 29.4 34.2 33.2 19.6 35.6 34.9 42.9 10.5 29.2 58.0 0.0 69.1 48.1 27.0 50.2 4.7 27.9 23.2 19.1 43.1 22.1 27.4 8.5 24.7 18.4 33.7 17.2 45.0 29.0 57.9 63.2 30.1 49.4 29.6 25.8 45.3 10.2 22.2 44.7 71.1 15.4 50.2 53.7 TWF2 "A6r, A6RP, PTK9L" ENSG00000247596 "Twinfilin actin binding protein 2" Q6IBS0 3 52228610-52239260 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.7" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 187.1;monocytes: 272.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053874 Uncertain Uncertain "Plasma membrane" NA NA 14000000 "Plasma membrane" "HPA053874: AB_2682287" "unprognostic (4.24e-2)" "unprognostic (8.61e-2)" "unprognostic (2.18e-1)" "unprognostic (2.62e-2)" "unprognostic (2.70e-2)" "unprognostic (3.51e-2)" "unprognostic (5.46e-3)" "unprognostic (2.76e-1)" "unprognostic (6.56e-2)" "unprognostic (1.97e-1)" "unprognostic (2.58e-2)" "unprognostic (5.07e-2)" "unprognostic (4.31e-3)" "unprognostic (4.40e-1)" "unprognostic (1.03e-1)" "unprognostic (1.09e-1)" "unprognostic (7.07e-2)" 25.0 13.0 10.4 21.0 10.9 17.0 22.3 17.5 21.1 13.8 15.2 7.7 10.4 12.1 14.3 13.1 17.2 11.4 18.7 38.8 13.2 9.4 13.9 11.7 16.5 39.4 9.2 13.2 14.4 10.9 5.4 7.5 11.0 9.1 13.4 7.1 10.4 18.2 13.5 81.7 11.9 13.5 13.5 8.4 23.3 13.4 7.9 7.3 34.5 9.4 15.4 19.5 18.7 14.3 32.3 46.8 72.5 50.1 26.9 40.9 38.7 6.6 17.1 6.0 10.4 19.6 24.0 10.7 15.7 25.4 18.8 16.9 8.9 18.3 23.9 10.4 18.4 17.2 11.8 7.5 22.0 4.2 15.1 9.9 24.6 12.8 21.5 16.9 14.8 41.3 22.2 10.6 22.3 7.6 12.8 28.6 15.2 5.7 12.5 14.0 5.8 20.4 34.0 9.3 8.7 48.6 7.9 6.2 25.0 14.8 10.8 4.7 17.9 5.6 23.7 31.1 3.8 5.4 16.1 29.4 18.5 20.1 14.3 13.5 11.2 9.9 11.6 36.4 42.0 22.2 26.8 50.1 39.6 33.7 48.9 30.6 32.3 35.9 35.8 46.8 25.4 28.9 35.6 72.5 26.9 49.5 42.3 40.9 38.7 10.4 10.9 17.5 21.1 13.2 9.4 9.2 13.2 9.1 7.3 6.0 8.5 43.9 25.9 15.2 12.0 25.8 30.6 5.3 4.5 12.2 0.0 35.9 31.5 70.3 2.8 31.5 60.1 0.0 89.7 67.2 36.1 19.7 40.3 8.9 187.1 6.4 21.2 23.4 112.2 2.4 32.5 86.2 32.1 272.3 18.1 14.9 81.2 38.6 31.8 14.6 4.5 51.8 24.5 0.9 23.6 13.4 18.9 73.4 21.1 23.7 TXNRD2 "TR, TR3, TRXR2" ENSG00000184470 "Thioredoxin reductase 2" Q9NNW7 22 19875517-19941992 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2 OS: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002007, HPA003323" Supported Approved Vesicles,Mitochondria,Cytosol NA NA 410000 "Vesicles, Mitochondria, Cytosol" "CAB002007: , HPA003323: AB_1080396" "unprognostic (3.17e-2)" "unprognostic (8.72e-2)" "unprognostic (4.30e-1)" "unprognostic (9.71e-3)" "unprognostic (7.25e-2)" "unprognostic (6.35e-2)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "unprognostic (2.83e-1)" "unprognostic (4.94e-3)" "unprognostic (2.49e-1)" "prognostic favorable (1.10e-7)" "unprognostic (2.47e-1)" "unprognostic (5.99e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" 9.8 30.2 8.5 8.3 10.1 11.6 7.4 19.0 15.0 8.3 10.3 9.0 7.6 9.2 11.9 12.3 8.8 8.4 13.0 22.6 8.3 7.5 13.9 40.9 10.8 8.4 7.8 9.7 11.9 13.0 9.9 9.9 14.0 7.1 17.9 4.5 10.0 15.2 8.8 16.5 6.0 10.2 5.4 5.6 11.2 14.6 10.5 6.8 4.9 12.6 9.2 10.5 7.5 7.9 4.8 9.1 5.8 12.1 4.8 4.9 4.9 6.4 13.3 1.2 5.2 2.4 3.4 3.0 6.2 7.3 11.2 8.3 12.4 6.7 3.6 15.1 6.5 11.6 11.4 6.2 8.5 4.3 6.8 15.3 6.0 10.6 7.3 4.6 6.7 2.9 3.3 6.5 5.7 4.9 4.6 31.8 0.7 33.2 6.1 8.7 15.6 2.3 10.0 6.1 15.9 9.5 3.4 29.6 3.3 6.8 7.0 6.6 5.8 10.7 13.9 7.1 2.1 11.4 9.1 17.7 8.2 49.4 6.8 13.0 6.1 4.4 2.2 7.9 5.1 10.3 3.2 12.1 5.8 4.3 9.2 3.3 4.8 3.8 3.9 9.1 3.6 4.9 4.0 1.3 4.8 8.7 3.4 2.4 4.9 8.5 10.1 19.0 15.0 8.3 7.5 7.8 9.7 7.1 6.8 14.9 27.1 5.2 19.2 3.8 20.0 13.6 17.8 13.4 10.3 19.2 9.8 51.6 49.7 18.7 21.0 11.3 13.5 0.0 27.8 19.6 12.5 19.5 1.1 47.4 23.3 9.5 1.2 10.4 20.5 14.1 14.4 12.1 5.0 25.2 12.1 19.0 19.9 14.0 8.5 44.0 9.5 6.5 9.1 8.6 12.8 4.5 35.1 11.7 14.7 12.7 TYSND1 "MGC34695, NET41" ENSG00000156521 "Trypsin domain containing 1" Q2T9J0 10 70137981-70146676 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.7" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 90.7;Late spermatids: 154.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 18.0;PC-3: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030304 Approved Uncertain Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA030304: AB_10670560" "unprognostic (4.75e-3)" "unprognostic (4.30e-2)" "unprognostic (2.44e-2)" "unprognostic (7.69e-2)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.02e-2)" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.10e-1)" "unprognostic (1.59e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-1)" "unprognostic (9.26e-3)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" 15.2 8.2 4.7 7.0 6.8 3.0 8.0 6.7 7.3 6.0 6.7 5.9 6.9 10.1 5.3 8.4 13.9 5.4 5.2 3.5 3.7 2.8 7.4 7.4 3.5 7.2 3.7 3.6 5.6 9.0 3.3 4.5 4.7 3.5 6.9 2.7 6.9 8.0 5.7 5.3 12.5 8.5 4.8 4.7 9.0 8.2 40.7 3.4 6.2 8.5 6.6 10.1 6.5 7.6 6.1 1.4 1.2 1.6 2.9 6.3 2.3 9.5 6.9 0.5 4.1 0.8 0.6 2.5 1.2 0.9 1.4 1.3 4.3 6.1 8.6 4.0 0.3 0.3 18.0 0.7 2.7 0.3 5.4 6.2 0.5 1.9 2.1 1.7 0.7 0.0 1.3 5.2 1.2 2.2 0.8 1.0 3.1 0.0 2.6 0.6 4.2 3.2 3.5 2.2 2.3 27.7 5.7 1.6 3.8 0.6 1.6 5.0 2.6 4.2 9.4 3.6 0.2 6.1 0.7 1.7 1.6 1.1 3.0 5.4 9.8 5.9 4.2 1.9 3.6 1.2 0.0 1.3 1.2 6.3 1.6 4.1 5.1 3.7 4.9 1.4 6.1 5.3 4.4 0.4 2.9 1.1 1.0 4.0 2.3 4.7 6.8 6.7 7.3 3.7 2.8 3.7 3.6 3.5 3.4 8.9 4.0 13.7 13.8 12.7 6.8 4.3 25.5 1.4 5.7 10.4 0.0 30.0 14.9 6.8 90.7 6.7 14.8 0.0 8.3 6.8 6.3 10.9 13.8 14.3 10.7 0.0 13.7 6.7 9.5 154.7 8.6 8.0 11.8 2.8 10.6 6.2 5.1 10.5 7.4 12.4 4.5 6.5 4.7 41.1 11.1 16.2 14.0 11.8 20.3 5.2 U2AF1L5 ENSG00000275895 "U2 small nuclear RNA auxiliary factor 1 like 5" P0DN76 21 6484623-6499261 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 74.4" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 20.7;Ciliated cells: 18.7;Club cells: 26.1;granulocytes: 27.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044833, HPA052083" Supported Uncertain Nucleoplasm NA NA Nucleoplasm "HPA044833: AB_10960990, HPA052083: AB_2681720" "unprognostic (6.54e-2)" "unprognostic (2.42e-1)" "unprognostic (2.75e-2)" "unprognostic (8.31e-3)" "unprognostic (2.80e-1)" "unprognostic (5.99e-2)" "unprognostic (2.02e-1)" "unprognostic (4.54e-2)" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (1.70e-1)" "unprognostic (3.42e-2)" "unprognostic (5.39e-3)" "unprognostic (3.14e-1)" "unprognostic (2.79e-2)" "unprognostic (5.98e-2)" "unprognostic (8.20e-2)" 4.7 5.3 0.5 5.3 6.4 7.0 6.2 6.2 21.0 4.7 6.0 7.3 6.8 3.7 9.5 8.6 8.9 4.5 8.5 8.2 3.0 7.4 5.8 6.6 6.0 0.5 12.0 11.9 8.5 3.9 0.5 14.9 6.4 4.0 6.5 8.1 12.8 5.3 4.3 4.2 3.5 11.0 4.6 5.0 3.2 11.2 0.8 10.6 14.2 0.5 11.4 4.2 7.7 40.6 63.8 74.4 41.8 33.3 47.6 47.0 25.6 10.6 55.2 24.0 15.4 14.1 24.6 15.3 18.2 29.6 20.5 39.0 17.3 57.8 13.2 21.2 32.7 17.9 44.6 22.0 42.8 11.4 4.2 74.1 24.9 48.4 25.4 80.5 25.8 10.7 13.7 19.8 21.3 15.0 27.1 27.3 58.3 33.7 30.1 24.7 56.1 51.0 57.5 41.5 3.4 88.1 30.3 33.2 33.6 39.1 29.0 19.3 27.0 27.3 27.3 13.9 19.2 45.1 24.0 21.5 28.9 11.4 33.8 41.1 34.6 67.0 19.4 49.1 29.3 35.8 41.8 36.9 29.9 34.6 36.4 37.9 38.7 35.2 43.5 40.6 43.8 37.0 74.4 33.3 26.1 63.8 47.6 47.0 11.9 20.7 0.5 1.5 0.0 0.1 0.0 2.5 18.7 26.1 0.0 0.0 1.3 1.7 4.2 0.6 0.0 0.2 0.0 6.1 1.5 0.8 2.9 27.9 0.8 0.9 0.0 2.4 1.8 0.6 0.0 0.3 1.3 0.0 4.6 1.9 0.4 5.4 2.3 1.1 1.3 0.4 0.0 0.0 1.7 1.9 0.0 1.7 0.0 1.7 1.1 UBA5 "FLJ23251, UBE1DC1" ENSG00000081307 "Ubiquitin like modifier activating enzyme 5" Q9GZZ9 3 132654446-132678097 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 126.0;Late spermatids: 301.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017235 Uncertain Enhanced Vesicles,Cytosol NA NA Cytosol Vesicles "HPA017235: AB_1858507" "unprognostic (4.34e-3)" "unprognostic (6.44e-2)" "unprognostic (7.70e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.06e-1)" "unprognostic (3.28e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-2)" "unprognostic (1.84e-2)" "unprognostic (3.56e-1)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (1.02e-2)" "unprognostic (2.40e-2)" 14.8 30.3 17.8 12.3 19.8 13.2 17.4 17.9 26.2 14.5 15.0 10.5 27.8 16.2 13.4 24.2 15.1 13.3 12.7 21.2 15.3 16.3 22.7 29.8 13.7 14.8 16.0 25.0 15.1 41.4 29.3 32.7 18.1 21.2 18.8 16.7 11.7 37.8 33.5 32.5 15.7 17.9 14.6 13.6 18.9 18.5 15.3 12.7 17.9 23.5 17.5 17.4 15.1 12.5 11.1 14.1 5.0 6.6 18.9 15.0 7.9 27.3 10.2 18.0 14.8 12.7 14.6 18.9 23.7 24.4 14.9 17.3 18.5 10.2 21.8 17.4 17.1 9.8 16.7 17.8 18.7 22.2 20.7 7.6 26.5 16.5 20.7 12.7 32.5 15.6 12.7 11.0 14.1 21.3 13.9 16.7 11.9 16.5 32.4 16.6 24.3 17.9 12.2 16.4 23.5 9.8 15.7 15.7 41.3 13.7 21.2 17.4 15.7 13.9 14.0 20.0 17.2 16.8 16.5 14.9 15.8 15.5 7.6 12.4 30.6 20.5 40.4 18.0 11.9 14.0 4.1 5.1 5.0 9.6 5.8 11.6 11.1 10.8 15.0 11.8 6.9 12.9 12.8 1.1 18.9 6.6 14.1 10.7 7.9 17.8 19.8 17.9 26.2 15.3 16.3 16.0 25.0 21.2 12.7 32.8 23.4 11.1 16.1 15.2 19.2 32.5 15.3 17.4 19.4 7.0 13.7 52.9 58.0 21.3 126.0 17.0 14.5 0.0 39.4 38.1 22.6 19.5 23.1 20.2 20.4 20.6 20.7 15.4 6.4 301.4 15.5 11.7 16.9 27.9 20.1 24.6 21.2 15.9 25.5 29.4 19.8 32.3 25.0 27.9 14.9 16.2 83.4 17.5 15.6 14.8 UBAP1L ENSG00000246922 "Ubiquitin associated protein 1 like" F5GYI3 15 65092770-65115197 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "retina: 91.1" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 227.8;Rod photoreceptor cells: 149.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SK-MEL-30: 6.9;U-266/70: 3.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 10 "cerebellum: 49.0;pons and medulla: 8.6" HPA065334 Uncertain "Nuclear bodies" NA NA "Nuclear bodies" "HPA065334: AB_2685472" "unprognostic (6.89e-3)" "unprognostic (2.62e-1)" "unprognostic (2.66e-3)" "unprognostic (2.73e-2)" "unprognostic (1.64e-1)" "unprognostic (2.98e-3)" "unprognostic (6.59e-2)" "unprognostic (7.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.56e-1)" "unprognostic (5.62e-5)" "unprognostic (6.40e-3)" "unprognostic (3.11e-6)" "unprognostic (5.03e-2)" "unprognostic (1.39e-1)" "unprognostic (3.70e-1)" "unprognostic (6.11e-3)" 1.4 1.5 2.4 0.9 2.4 1.1 1.3 11.5 3.6 1.5 0.9 0.9 0.9 0.4 2.7 1.1 1.2 1.5 0.9 0.9 2.8 3.2 0.9 1.1 1.0 1.1 2.6 0.9 3.2 1.0 0.5 0.9 0.9 3.6 1.1 0.2 91.1 2.0 1.8 6.2 1.5 1.1 1.2 3.1 2.0 0.9 1.5 0.9 0.9 1.2 0.9 2.2 0.9 0.9 0.1 1.3 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.8 2.0 0.6 0.2 1.8 1.3 0.1 0.6 0.6 1.2 0.3 0.9 1.6 0.2 0.3 1.4 1.1 0.1 0.0 1.7 1.1 0.1 1.1 0.2 0.8 1.0 0.9 0.6 0.9 0.3 0.4 1.7 0.2 0.8 0.5 0.8 0.2 0.2 0.3 1.3 0.7 0.2 0.7 1.5 0.5 1.1 0.0 0.4 1.1 0.7 0.6 0.2 6.9 1.0 0.4 1.0 0.0 0.6 0.3 0.7 0.6 3.6 0.6 0.4 0.4 0.7 0.5 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.4 0.0 1.3 0.0 0.0 2.4 2.4 11.5 3.1 2.8 3.2 2.6 0.9 3.6 0.9 0.0 1.4 0.0 1.1 0.6 26.4 5.2 0.0 0.0 1.2 3.5 227.8 0.6 1.7 0.5 0.4 1.4 0.4 0.0 0.7 0.2 0.9 1.1 0.0 2.1 0.3 3.2 1.2 1.8 0.6 0.9 3.1 0.4 1.7 0.0 1.2 16.6 0.9 0.0 3.2 2.2 149.2 6.5 1.4 1.8 3.6 0.6 0.6 3.2 0.7 0.6 UBE2D1 "E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A" ENSG00000072401 "Ubiquitin conjugating enzyme E2 D1" P51668 10 58334975-58370753 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 74.9" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 172.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 41.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (1.12e-1)" "unprognostic (2.08e-1)" "unprognostic (4.23e-3)" "unprognostic (1.76e-1)" "unprognostic (1.52e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.03e-1)" "unprognostic (2.24e-2)" "unprognostic (4.37e-3)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.04e-6)" "unprognostic (9.71e-3)" "unprognostic (4.14e-1)" "unprognostic (1.95e-1)" "unprognostic (5.66e-2)" 8.2 10.6 8.1 10.0 7.9 17.1 7.5 7.7 9.0 6.3 7.3 5.5 4.8 4.7 8.5 5.5 8.2 5.5 6.4 25.6 7.6 7.2 5.5 5.4 7.0 13.7 8.1 6.7 5.9 4.8 5.3 7.4 6.8 7.4 6.5 7.9 3.5 6.4 5.0 74.9 4.6 5.8 8.8 8.4 11.0 5.6 3.2 8.4 5.5 6.0 25.1 7.1 9.5 10.0 3.7 7.2 41.0 13.7 2.8 3.5 7.1 10.7 5.8 10.9 14.0 22.4 18.1 7.1 7.1 12.1 8.1 12.0 11.8 9.3 0.0 11.2 10.6 6.0 9.8 21.1 10.3 11.5 11.1 12.4 2.8 2.1 6.7 14.7 8.5 6.9 20.9 11.6 8.5 15.8 11.0 16.2 7.5 5.5 4.5 11.0 3.4 9.1 9.5 13.4 6.5 9.2 7.7 9.9 5.9 12.2 6.3 8.3 11.1 13.9 23.5 11.3 17.5 8.6 5.7 13.1 3.1 10.9 10.6 7.8 11.6 9.0 9.5 9.9 17.7 3.5 2.8 13.7 6.2 2.4 9.5 2.8 3.3 2.9 3.0 7.2 3.7 3.0 2.3 41.0 2.8 7.9 3.0 3.5 7.1 8.1 7.9 7.7 9.0 7.6 7.2 8.1 6.7 7.4 8.4 11.9 9.1 36.6 70.2 172.6 16.8 82.7 20.4 12.0 15.9 26.2 17.7 26.7 64.6 55.7 3.4 26.3 20.4 0.0 37.1 42.2 48.3 73.3 23.0 12.3 68.9 15.9 39.9 20.3 88.9 2.2 30.8 81.6 50.6 49.5 35.6 15.8 57.2 16.4 30.4 41.3 13.7 6.5 58.7 28.6 16.0 166.2 124.6 28.7 24.7 105.6 UBE2D3 UbcH5C ENSG00000109332 "Ubiquitin conjugating enzyme E2 D3" P61077 4 102794383-102868896 "Enzymes, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (7.43e-2)" "unprognostic (3.19e-1)" "unprognostic (1.27e-2)" "unprognostic (5.78e-2)" "unprognostic (6.44e-2)" "unprognostic (4.96e-2)" "unprognostic (1.17e-1)" "unprognostic (8.44e-3)" "unprognostic (1.14e-1)" "unprognostic (1.95e-1)" "unprognostic (5.75e-2)" "unprognostic (3.31e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.08e-2)" "unprognostic (2.79e-1)" "unprognostic (4.54e-2)" "unprognostic (1.34e-2)" 67.2 70.6 39.1 52.7 44.6 132.7 70.4 36.9 50.9 45.5 51.8 37.5 38.4 49.3 46.3 39.1 63.2 45.7 47.5 72.5 37.3 39.5 63.0 91.9 67.5 68.1 43.4 36.9 60.6 53.4 42.8 49.1 66.5 45.2 49.6 48.5 38.4 46.7 43.3 91.1 53.2 58.9 48.4 44.4 68.2 49.5 40.0 42.2 88.8 66.3 55.4 61.4 74.6 81.4 24.7 31.2 118.0 36.2 29.7 33.2 50.9 53.5 30.7 51.2 41.3 54.7 79.0 44.0 54.5 72.7 48.7 46.0 46.0 76.5 57.4 35.7 55.3 63.2 30.7 54.6 73.2 67.1 53.2 27.5 52.2 31.6 37.5 57.4 73.4 45.0 59.9 46.4 53.7 75.3 63.0 63.1 47.3 65.6 58.7 64.8 43.2 107.7 41.8 37.1 61.3 30.7 56.8 50.3 41.4 49.1 51.2 51.8 43.6 33.5 86.1 61.5 63.1 35.7 43.4 57.9 51.0 43.6 33.3 49.5 52.0 67.0 87.8 54.3 40.9 54.7 71.1 35.9 54.6 25.1 36.1 33.2 24.7 31.8 29.6 31.2 20.1 32.6 29.7 118.0 29.7 36.2 21.5 32.6 50.9 39.1 44.6 36.9 50.9 37.3 39.5 43.4 36.9 45.2 42.2 154.9 181.2 227.9 605.7 749.7 127.0 210.7 150.3 190.1 129.7 132.6 117.8 279.1 464.2 286.3 668.3 228.0 265.9 93.5 333.2 474.9 260.0 477.5 219.4 203.4 354.6 116.0 231.0 159.0 357.1 423.2 152.5 359.3 339.1 356.1 198.5 111.8 351.4 245.4 140.0 328.0 157.1 103.5 376.3 128.5 151.0 711.0 533.9 297.5 192.3 680.6 UBE2L5 UBE2L5P ENSG00000236444 "Ubiquitin conjugating enzyme E2 L5" 13 30422488-30428616 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 31.5" "Cell type enriched" "Detected in single" 4 "Ciliated cells: 1.4" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA045609, HPA062415" Approved Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045609: AB_10961322, HPA062415: AB_2684756" "unprognostic (2.09e-1)" "unprognostic (1.18e-2)" "unprognostic (8.01e-3)" "unprognostic (6.41e-4)" "unprognostic (1.78e-1)" "unprognostic (7.13e-2)" "unprognostic (2.20e-1)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (6.49e-3)" "unprognostic (1.78e-1)" "unprognostic (8.00e-2)" "unprognostic (3.50e-2)" "unprognostic (9.37e-2)" "unprognostic (2.60e-1)" "unprognostic (2.44e-2)" "unprognostic (8.75e-2)" 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.3 0.3 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.7 0.3 0.2 0.2 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 31.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.2 1.9 2.7 3.6 1.9 2.0 2.8 0.7 0.3 1.3 1.6 0.6 0.7 0.7 1.2 0.6 0.4 0.2 0.0 3.1 1.4 0.6 1.3 1.3 0.6 0.8 0.4 1.1 2.5 0.6 0.4 0.8 0.2 0.2 0.7 1.5 0.2 0.3 0.6 0.2 1.4 0.9 0.9 0.8 1.3 0.3 0.0 1.6 2.6 1.4 0.2 0.2 0.4 0.6 0.4 0.9 1.5 1.2 0.3 0.4 0.1 1.8 0.9 0.6 2.4 0.0 0.7 0.5 0.7 1.1 1.5 0.3 1.6 1.0 0.9 0.4 1.8 1.1 1.9 1.4 3.6 1.2 3.2 1.5 1.6 1.5 1.7 1.4 2.0 2.7 1.9 1.6 1.9 2.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBE2QL1 FLJ25076 ENSG00000215218 "Ubiquitin conjugating enzyme E2 Q family like 1" A1L167 5 6448623-6494909 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 28.1;heart muscle: 11.3;retina: 8.2;seminal vesicle: 8.6;skeletal muscle: 21.3" "Group enriched" "Detected in some" 4 "Bipolar cells: 23.6;Cardiomyocytes: 25.0;Horizontal cells: 42.9;Rod photoreceptor cells: 49.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "eosinophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "Karpas-707: 18.2;PC-3: 15.2;SCLC-21H: 14.2;U-266/70: 34.1;U-266/84: 30.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057414 Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA057414: " "unprognostic (1.45e-2)" "unprognostic (1.58e-2)" "unprognostic (1.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-2)" "unprognostic (7.43e-2)" "unprognostic (1.15e-2)" "unprognostic (1.36e-1)" "unprognostic (3.10e-1)" "unprognostic (7.16e-2)" "unprognostic (2.15e-3)" "unprognostic (8.41e-2)" "prognostic favorable (6.81e-8)" "unprognostic (3.18e-3)" "unprognostic (2.81e-1)" "unprognostic (1.27e-2)" "unprognostic (1.41e-2)" 0.6 2.3 8.6 0.8 4.2 0.3 0.9 20.7 28.1 1.0 1.8 1.0 0.5 0.7 1.4 1.8 1.0 0.5 0.8 11.3 12.6 8.2 2.6 1.1 0.4 0.7 5.2 4.6 3.6 0.8 0.3 1.3 0.3 8.7 3.1 0.8 8.2 1.0 8.6 21.3 2.4 1.0 1.3 1.4 0.4 2.2 0.9 0.0 0.0 1.9 2.0 0.5 0.5 0.9 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.2 0.0 3.1 0.0 0.0 0.2 0.0 15.2 0.1 0.0 6.7 0.0 0.0 14.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 34.1 30.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 4.2 20.7 19.4 12.6 8.2 5.2 4.6 8.7 0.0 0.0 0.0 0.0 0.6 1.1 23.6 25.0 0.0 0.0 0.0 0.0 5.9 0.0 5.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.5 0.7 0.0 0.8 0.1 42.9 5.2 0.0 0.3 0.0 3.7 0.0 0.0 0.0 0.0 8.4 0.2 0.0 6.3 0.0 49.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 UBE2R2 "CDC34B, FLJ20419, MGC10481, UBC3B" ENSG00000107341 "Ubiquitin conjugating enzyme E2 R2" Q712K3 9 33817567-33920404 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 295.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 21.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061000, HPA074334" Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA061000: AB_2684408, HPA074334: " "unprognostic (1.51e-1)" "unprognostic (1.50e-1)" "unprognostic (7.08e-2)" "unprognostic (1.53e-1)" "unprognostic (6.55e-2)" "unprognostic (5.15e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (1.82e-3)" "unprognostic (4.61e-3)" "unprognostic (3.05e-3)" "unprognostic (2.22e-2)" "unprognostic (4.19e-1)" "unprognostic (2.01e-2)" "unprognostic (4.18e-2)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (1.43e-1)" 26.1 19.7 29.4 19.7 26.8 13.9 39.3 23.7 32.3 25.6 24.1 27.9 16.3 28.0 26.1 18.4 25.3 22.3 21.8 29.2 25.5 20.3 22.1 34.5 23.0 27.1 30.5 23.2 29.8 44.5 15.7 13.9 24.6 21.6 21.0 21.4 19.3 18.7 20.8 56.1 28.1 25.7 28.5 24.2 21.6 20.8 34.5 29.6 36.7 19.5 22.5 25.7 35.8 30.5 3.3 4.2 21.9 11.6 5.0 2.1 2.4 16.5 18.1 35.0 15.2 19.3 31.5 10.8 14.7 20.5 17.3 17.3 14.5 12.4 14.1 6.0 20.5 12.6 7.4 18.3 16.8 19.0 23.2 9.7 12.2 20.0 18.4 27.5 14.4 13.3 26.7 25.0 14.1 26.8 27.7 29.0 17.0 11.4 15.2 17.1 9.6 27.1 38.0 19.9 14.2 15.1 25.3 10.6 7.3 18.3 12.5 16.4 19.7 17.2 15.4 11.0 23.2 13.5 17.6 21.7 16.7 15.2 11.5 13.6 9.7 9.1 19.8 15.9 8.4 35.9 12.4 7.5 4.1 2.0 7.5 1.3 3.1 1.9 1.6 4.2 3.3 1.9 1.7 21.9 5.0 11.6 2.6 2.1 2.4 29.4 26.8 23.7 32.3 25.5 20.3 30.5 23.2 21.6 29.6 20.8 30.7 29.5 39.6 93.8 61.0 106.8 56.0 22.7 25.0 21.0 13.7 52.6 13.3 43.8 295.7 77.1 60.6 23.3 59.7 65.2 54.0 68.4 12.7 72.1 68.5 57.2 69.2 77.3 105.2 195.4 62.2 81.9 33.7 49.5 57.3 87.1 69.4 38.6 71.5 49.6 30.1 58.2 41.9 90.2 66.2 105.3 69.2 30.5 49.0 79.7 UBXN1 "2B28, LOC51035, SAKS1, UBXD10" ENSG00000162191 "UBX domain protein 1" Q04323 11 62676498-62679117 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012669, HPA076932" Approved Supported Nucleoplasm,Cytosol NA NA 12000 Cytosol Nucleoplasm "HPA012669: AB_1853149, HPA076932: " "unprognostic (1.76e-3)" "unprognostic (8.72e-3)" "unprognostic (3.67e-3)" "unprognostic (2.94e-2)" "unprognostic (9.39e-2)" "unprognostic (8.72e-2)" "unprognostic (2.96e-2)" "unprognostic (1.15e-1)" "unprognostic (1.15e-1)" "unprognostic (4.36e-2)" "unprognostic (1.73e-1)" "unprognostic (1.07e-1)" "unprognostic (3.81e-2)" "unprognostic (3.52e-2)" "unprognostic (1.43e-1)" "unprognostic (3.34e-3)" "unprognostic (2.42e-1)" 40.4 37.8 33.1 33.8 35.1 27.6 44.1 27.7 37.8 36.0 36.6 36.3 32.3 36.1 38.0 33.7 36.7 37.8 42.3 38.2 30.8 27.2 30.4 26.1 27.3 46.9 33.7 28.5 62.3 41.7 31.4 25.0 29.3 27.2 37.6 19.5 26.6 29.5 32.1 115.3 42.8 31.2 51.5 36.6 37.9 35.0 35.8 29.0 58.9 56.6 40.9 41.2 43.5 67.2 84.1 54.9 27.8 64.2 44.6 85.4 77.8 19.6 31.7 23.8 33.2 33.2 35.7 21.8 17.3 31.9 33.1 22.6 22.6 25.4 31.4 31.9 23.0 29.2 28.1 19.0 29.5 15.4 28.1 24.4 21.9 28.2 30.4 65.1 34.5 24.3 46.1 45.9 29.1 45.0 35.5 30.7 39.7 33.7 20.2 20.6 44.0 26.0 63.7 1.2 15.2 22.0 19.7 26.0 30.6 26.6 19.9 23.7 41.1 16.5 25.3 74.9 10.7 35.3 42.8 30.2 26.9 20.3 27.3 19.5 26.0 19.7 28.1 31.1 14.8 24.4 21.0 51.1 24.4 46.3 53.1 58.9 83.4 70.6 54.2 54.9 84.1 85.4 62.3 27.8 44.6 64.2 43.7 84.9 77.8 33.1 35.1 27.7 37.8 30.8 27.2 33.7 28.5 27.2 29.0 86.4 85.3 236.7 136.4 234.5 60.3 74.7 104.4 105.7 99.0 71.5 43.2 143.5 132.6 157.2 130.0 200.5 201.1 93.5 159.6 151.0 161.2 139.3 157.2 69.5 190.4 28.6 121.1 125.2 291.0 195.1 193.3 259.6 173.7 301.2 133.8 117.2 161.2 178.9 134.7 178.9 48.1 194.1 250.4 238.0 204.7 264.7 271.5 236.6 131.7 176.3 UBXN8 "D8S2298E, REP8, UBXD6" ENSG00000104691 "UBX domain protein 8" O00124 8 30732247-30767006 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 30.6" "Group enriched" "Detected in many" 4 "Early spermatids: 162.1;Hepatocytes: 56.2;Late spermatids: 132.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017725, HPA077538" Enhanced Supported "Nucleoplasm,Nucleoli,Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "Nucleoplasm, Nucleoli" "HPA017725: AB_1847462, HPA077538: AB_2686844" "unprognostic (3.00e-2)" "unprognostic (2.30e-1)" "prognostic favorable (6.13e-4)" "unprognostic (7.71e-2)" "unprognostic (2.24e-1)" "unprognostic (1.03e-1)" "unprognostic (2.41e-1)" "unprognostic (1.84e-2)" "unprognostic (1.90e-1)" "unprognostic (5.13e-2)" "unprognostic (1.58e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.25e-5)" "unprognostic (2.49e-1)" "unprognostic (1.96e-1)" "unprognostic (1.51e-1)" "unprognostic (6.88e-2)" 5.0 5.3 3.9 1.4 4.8 1.4 4.3 1.5 9.2 3.0 3.5 4.0 6.7 3.1 3.8 14.3 4.1 3.6 3.8 2.8 5.7 8.2 21.5 2.1 3.9 7.6 4.0 30.6 10.3 6.2 3.5 6.2 6.2 4.8 4.7 1.6 1.8 6.1 1.7 4.1 2.9 2.9 7.1 5.7 3.3 11.5 6.1 0.9 9.1 2.8 2.3 2.9 3.7 6.0 8.2 1.0 6.1 3.3 8.4 3.4 7.6 7.7 5.6 5.8 9.1 12.2 6.3 13.7 8.0 7.5 9.2 12.2 2.8 12.2 11.3 11.1 12.4 6.8 1.1 7.6 11.6 6.4 12.5 34.3 6.3 14.9 13.7 7.8 19.4 9.6 7.9 12.0 5.9 6.4 6.5 5.6 33.5 9.2 16.5 7.2 7.9 6.0 10.8 22.8 5.8 9.5 5.4 8.5 12.8 10.0 3.2 8.1 3.8 11.3 24.7 7.0 8.4 13.6 8.3 8.5 3.7 3.8 12.7 4.0 12.5 9.2 7.6 12.6 12.1 0.0 6.0 0.7 8.4 6.1 7.3 6.0 4.5 8.0 6.7 2.9 4.4 7.4 1.0 3.3 3.0 8.2 4.3 3.4 3.0 8.0 3.0 4.1 0.0 1.9 3.2 15.3 1.4 5.7 14.0 19.6 20.6 6.6 7.1 162.1 6.2 6.3 0.0 4.5 16.0 9.4 4.1 13.9 56.2 19.0 11.1 8.2 27.0 14.2 132.0 13.3 6.9 0.0 10.0 6.4 6.6 3.9 3.5 9.2 22.0 1.8 6.5 3.9 14.1 20.4 0.0 12.7 7.2 10.0 2.4 UGGT1 "HUGT1, UGCGL1" ENSG00000136731 "UDP-glucose glycoprotein glucosyltransferase 1" Q9NYU2 2 128091200-128195677 "Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012761, HPA015127" Enhanced Uncertain Cytosol NA NA 3800000 Cytosol "HPA012761: AB_1858597, HPA015127: AB_1858596" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (6.14e-2)" "unprognostic (1.87e-1)" "unprognostic (4.63e-2)" "unprognostic (6.45e-2)" "unprognostic (7.03e-3)" "unprognostic (3.13e-2)" "unprognostic (3.02e-2)" "unprognostic (1.05e-1)" "unprognostic (4.09e-3)" "unprognostic (7.05e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (3.86e-1)" "unprognostic (1.50e-1)" "unprognostic (2.23e-2)" "unprognostic (8.38e-3)" 13.7 14.7 7.6 16.4 10.2 23.8 11.3 10.7 10.8 12.7 15.2 10.0 21.1 11.4 12.3 26.3 13.1 10.6 11.3 13.0 7.7 7.9 13.7 33.4 13.9 14.6 11.0 5.7 10.4 44.1 13.4 11.2 22.1 9.1 11.7 13.5 9.7 15.5 20.5 19.3 11.1 17.4 8.9 9.0 16.1 13.0 9.9 9.5 24.3 13.8 6.4 15.7 11.4 11.0 6.3 7.4 8.8 6.2 4.7 5.9 2.8 16.5 5.8 11.1 23.8 14.6 11.7 16.9 19.1 8.4 6.4 5.8 12.8 12.3 23.5 7.7 14.0 5.8 12.3 8.4 8.3 13.1 14.9 4.0 20.6 7.6 39.1 14.5 27.5 13.0 8.5 6.6 12.9 11.8 12.8 14.9 9.8 13.2 12.8 13.5 11.6 11.1 15.8 19.6 11.7 6.0 9.1 10.6 10.0 11.8 12.3 5.8 8.8 13.2 18.1 11.2 11.9 7.1 19.5 20.5 17.7 12.1 10.1 13.6 13.4 18.6 10.8 15.0 15.1 16.3 7.1 6.2 5.4 5.9 6.0 5.8 4.0 4.8 5.3 4.5 6.3 4.1 5.9 8.8 4.7 5.7 7.4 3.8 2.8 7.6 10.2 10.7 10.8 7.7 7.9 11.0 5.7 9.1 9.5 32.8 24.8 6.7 4.9 7.2 20.0 14.1 17.8 6.7 25.0 3.5 21.6 9.5 1.7 12.2 7.0 11.3 19.4 0.0 16.8 15.8 10.8 11.7 10.5 33.0 14.7 19.1 21.9 19.6 23.0 1.8 13.8 15.5 13.5 12.6 20.8 9.7 18.4 10.5 12.7 8.7 18.9 6.5 11.1 8.9 8.1 9.4 9.0 13.8 17.5 9.8 UHMK1 "KIS, Kist" ENSG00000152332 "U2AF homology motif kinase 1" Q8TAS1 1 162497251-162529629 "Enzymes, Predicted intracellular proteins" "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071190 Approved "Nucleoplasm,Golgi apparatus,Midbody" Yes No "Nucleoplasm, Golgi apparatus" Midbody "HPA071190: AB_2686358" "unprognostic (6.69e-2)" "unprognostic (1.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-1)" "unprognostic (2.08e-2)" "unprognostic (8.16e-2)" "unprognostic (9.63e-2)" "unprognostic (1.82e-1)" "unprognostic (7.81e-3)" "unprognostic (9.10e-2)" "unprognostic (3.11e-1)" "unprognostic (3.44e-2)" "unprognostic (9.08e-2)" "unprognostic (8.77e-2)" "unprognostic (4.66e-2)" 21.6 22.0 23.5 18.9 26.2 30.1 23.5 10.8 30.5 14.3 16.3 17.2 30.8 16.3 11.5 12.9 16.0 12.9 12.1 11.4 27.0 31.8 27.9 32.4 16.9 24.3 30.6 20.3 12.1 11.8 25.0 12.5 16.5 33.4 14.7 17.4 14.1 15.9 22.9 30.6 11.5 21.8 9.6 20.5 21.3 16.8 10.4 14.1 23.0 17.1 11.7 24.1 16.1 12.8 5.7 4.3 4.5 9.2 5.9 8.5 4.0 21.1 9.9 5.2 12.7 14.9 11.8 11.7 28.0 15.3 23.0 16.6 6.4 13.3 17.3 24.5 20.9 11.2 12.3 9.9 15.5 37.1 23.7 7.2 17.1 12.3 5.8 11.5 24.9 20.0 12.1 16.4 22.6 21.7 16.1 13.2 12.0 14.9 24.1 39.4 8.9 13.2 6.6 6.9 15.9 13.4 8.5 23.3 14.4 15.3 21.9 9.5 8.8 24.7 23.0 18.0 7.5 19.9 28.0 20.5 26.3 14.9 18.1 39.0 25.0 34.7 20.5 21.9 12.2 23.8 4.5 3.3 3.7 8.2 8.6 8.5 5.4 6.2 6.8 3.6 5.7 6.3 7.1 2.0 5.9 9.2 4.3 4.9 4.0 23.5 26.2 10.8 30.5 27.0 31.8 30.6 20.3 33.4 14.1 17.9 32.1 50.1 25.7 26.2 21.7 29.4 56.0 41.5 50.0 50.6 11.8 22.6 48.0 23.2 35.7 30.8 40.7 0.0 20.2 32.6 19.3 44.8 45.0 71.0 27.6 22.3 32.1 35.0 64.6 34.6 19.8 51.7 27.0 44.1 35.0 13.6 28.8 34.8 18.4 49.4 21.6 0.0 27.3 23.4 22.0 21.5 18.8 52.2 31.1 52.1 UHRF1BP1L KIAA0701 ENSG00000111647 "UHRF1 binding protein 1 like" A0JNW5 12 100028455-100142848 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039671, HPA075150" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA039671: AB_10794201, HPA075150: " "unprognostic (4.80e-2)" "unprognostic (3.17e-1)" "unprognostic (2.34e-2)" "unprognostic (1.14e-1)" "unprognostic (8.96e-2)" "unprognostic (7.36e-2)" "unprognostic (8.10e-2)" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (5.43e-2)" "unprognostic (1.88e-2)" "unprognostic (2.53e-1)" "unprognostic (2.94e-3)" "unprognostic (6.84e-2)" "unprognostic (1.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.28e-2)" 14.9 13.9 15.9 11.4 19.9 31.9 10.8 16.9 26.0 9.5 10.0 8.7 5.3 9.9 9.3 8.8 10.2 8.0 10.6 10.4 18.0 13.7 14.7 28.0 10.6 9.7 14.8 12.0 11.1 4.7 21.5 15.3 13.7 22.6 11.1 9.6 6.9 8.7 11.2 26.2 8.4 11.1 11.2 13.7 11.8 9.0 15.2 9.8 10.0 13.0 8.1 8.1 16.7 8.4 3.8 8.4 22.9 8.4 3.7 3.7 3.4 11.3 12.4 6.9 7.1 10.7 15.3 13.8 17.8 17.9 14.4 10.6 9.2 3.9 9.9 4.7 18.1 8.4 4.4 12.9 6.0 14.0 26.2 6.4 6.6 9.9 10.6 9.9 12.4 10.8 8.6 5.1 17.3 12.0 13.4 10.0 6.9 5.2 10.3 14.0 6.3 7.9 10.7 11.9 3.9 11.3 9.0 12.3 9.7 7.4 20.1 11.8 7.4 13.5 15.6 5.3 6.2 13.9 14.2 7.9 16.0 8.5 13.7 12.4 12.2 20.8 13.9 8.0 9.4 9.6 12.5 7.6 4.9 2.6 8.4 3.7 3.8 2.9 2.9 8.4 3.4 2.5 3.0 22.9 3.7 6.8 5.1 3.2 3.4 15.9 19.9 16.9 26.0 18.0 13.7 14.8 12.0 22.6 9.8 26.8 8.3 9.8 13.2 11.3 10.8 11.5 2.5 30.8 19.4 8.7 3.9 3.9 5.0 4.8 17.2 6.8 8.0 0.0 5.0 7.4 14.6 16.5 23.1 17.4 9.8 14.3 5.2 6.2 17.7 2.1 6.6 20.6 10.1 8.2 2.8 5.8 4.2 7.0 7.4 12.2 11.3 0.0 9.7 19.8 21.5 10.2 9.2 12.5 4.7 10.2 ULBP3 RAET1N ENSG00000131019 "UL16 binding protein 3" Q9BZM4 6 150063150-150069095 "Predicted intracellular proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 2.7" "Lineage enriched" "Detected in single" 7 "T-cells: 2.7" "Low cell line specificity" "Detected in many" "HPA056541, HPA063007" Approved Uncertain "Vesicles,Centriolar satellite" "Intracellular and membrane" NA NA Vesicles "Centriolar satellite" "HPA056541: , HPA063007: AB_2684920" "unprognostic (4.87e-2)" "unprognostic (4.49e-2)" "unprognostic (3.14e-3)" "unprognostic (1.50e-2)" "unprognostic (1.86e-2)" "unprognostic (2.99e-2)" "unprognostic (8.47e-2)" "unprognostic (1.96e-1)" "unprognostic (5.87e-2)" "unprognostic (8.71e-2)" "unprognostic (1.66e-2)" "unprognostic (3.54e-2)" "unprognostic (6.26e-2)" "unprognostic (3.43e-1)" "unprognostic (2.12e-1)" "unprognostic (5.45e-2)" "unprognostic (5.16e-2)" 8.0 3.6 1.0 0.4 1.2 0.2 8.2 0.3 2.0 1.9 2.8 0.4 1.1 1.4 1.1 2.1 3.6 3.6 4.4 1.2 1.3 2.3 5.5 2.6 3.1 0.3 0.7 0.6 2.0 1.1 1.9 0.7 1.4 0.8 1.3 1.1 1.7 1.2 0.4 0.7 1.0 1.0 0.8 0.5 0.5 2.9 24.3 0.3 0.3 8.2 5.3 2.1 1.8 3.1 0.3 0.0 0.0 0.0 0.0 2.7 0.5 3.9 1.6 4.6 5.1 1.5 8.8 1.4 4.2 1.9 5.4 6.0 8.4 3.7 0.0 9.4 6.9 8.4 6.5 13.8 15.2 5.4 3.4 7.0 0.1 2.4 0.4 2.1 0.0 0.6 7.8 2.9 11.5 6.0 5.0 7.0 0.0 0.2 0.0 4.8 5.7 0.0 0.0 2.1 1.7 12.4 4.4 4.7 0.2 10.7 9.0 0.8 0.1 9.8 6.1 2.1 2.2 1.8 1.0 3.8 0.9 7.1 14.0 9.8 0.0 0.0 2.8 7.5 2.0 3.8 0.0 0.0 0.0 1.5 0.0 2.0 0.3 2.0 1.1 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.0 2.7 0.5 1.0 1.2 0.3 2.0 1.3 2.3 0.7 0.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UNC13B "hmunc13, UNC13, Unc13h2" ENSG00000198722 "Unc-13 homolog B" O14795 9 35161992-35405338 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 53.6;Alveolar cells type 2: 55.9;Cone photoreceptor cells: 90.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.9" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024493, HPA062300" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments" Yes No Vesicles "Nucleoplasm, Golgi apparatus, Intermediate filaments" "HPA024493: AB_1858618, HPA062300: AB_2684742" "unprognostic (9.73e-3)" "unprognostic (2.33e-1)" "prognostic favorable (4.96e-4)" "unprognostic (6.56e-2)" "unprognostic (9.93e-2)" "prognostic favorable (8.51e-5)" "unprognostic (7.64e-2)" "prognostic favorable (6.59e-5)" "unprognostic (3.80e-1)" "unprognostic (1.64e-1)" "prognostic favorable (3.71e-4)" "unprognostic (1.74e-1)" "prognostic favorable (4.34e-11)" "unprognostic (2.40e-1)" "unprognostic (1.89e-1)" "unprognostic (1.48e-1)" "unprognostic (2.80e-2)" 11.9 12.1 9.3 9.0 18.3 1.4 10.4 16.6 18.8 12.2 21.4 10.1 35.0 11.5 10.6 8.4 14.9 11.1 14.6 11.1 9.2 7.1 22.1 21.5 37.6 2.2 9.5 9.5 7.9 28.7 21.7 13.7 6.3 10.1 20.5 25.1 27.2 20.7 33.6 21.1 14.6 13.0 12.2 9.4 5.0 15.8 16.2 9.1 0.8 12.5 11.6 5.8 8.6 10.4 0.9 1.9 0.0 0.4 0.0 0.3 0.4 5.4 7.2 8.1 13.0 15.6 8.7 6.8 8.9 4.0 6.6 9.0 6.0 2.5 0.0 4.1 11.6 11.7 2.6 20.3 10.3 8.5 0.0 6.5 3.3 20.6 7.7 7.5 1.2 3.7 6.9 8.1 10.4 10.8 10.6 21.3 9.0 7.4 4.6 7.7 4.1 1.1 0.1 7.3 16.9 7.6 0.0 5.0 1.9 9.1 7.1 8.7 9.1 6.2 3.9 6.5 14.0 6.6 4.2 19.5 4.6 4.3 7.1 6.8 7.4 8.8 0.0 5.0 10.3 4.6 0.0 0.4 0.0 0.0 0.3 0.0 0.9 0.3 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 9.3 18.3 16.6 18.8 9.2 7.1 9.5 9.5 10.1 9.1 53.6 55.9 0.8 1.2 2.7 37.4 11.0 17.8 10.7 25.0 8.7 90.3 3.2 3.3 6.0 5.6 6.7 14.8 0.0 10.6 1.9 3.1 10.8 2.3 11.1 4.1 6.4 23.6 4.9 2.2 8.5 2.0 3.1 6.8 0.0 28.6 6.7 8.2 14.1 2.8 6.8 42.9 6.5 4.7 7.5 8.3 6.5 2.4 0.0 16.7 2.6 UPK3A UPK3 ENSG00000100373 "Uroplakin 3A" O75631 22 45284982-45295874 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.7;skeletal muscle: 24.5;urinary bladder: 45.5" "Cell type enhanced" "Detected in some" 20 "Basal glandular cells: 20.5;Glandular cells: 61.9;monocytes: 13.6;Urothelial cells: 21.4" "Group enriched" "Detected in many" 6 "prostate cancer: 35.3;urothelial cancer: 78.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "classical monocyte: 8.5;intermediate monocyte: 9.6;myeloid DC: 33.7;non-classical monocyte: 11.3;plasmacytoid DC: 13.0" "Group enriched" "Detected in many" 16 "dendritic cells: 33.7;monocytes: 11.3" "Group enriched" "Detected in some" 5 "Hep G2: 18.7;RT4: 31.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018407, HPA018415" Enhanced Uncertain "Nuclear membrane,Nuclear bodies" NA NA "Nuclear membrane" "Nuclear bodies" "HPA018407: AB_1858641, HPA018415: AB_1858640" "unprognostic (1.27e-2)" "unprognostic (3.20e-3)" "unprognostic (1.80e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (3.98e-5)" "unprognostic (1.69e-2)" "unprognostic (4.82e-4)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-5)" "unprognostic (2.01e-2)" "unprognostic (5.45e-2)" "unprognostic (1.83e-1)" "unprognostic (6.05e-3)" 0.2 0.1 0.3 1.6 0.4 0.9 0.3 0.2 0.5 0.4 0.7 0.0 0.0 0.0 0.2 2.3 0.2 0.2 0.6 0.2 0.3 0.3 0.2 0.2 0.2 1.0 0.4 0.1 0.2 0.2 6.4 0.5 0.0 0.7 17.9 0.5 0.6 12.9 1.8 24.5 0.2 1.8 13.0 0.3 0.7 0.2 0.2 0.0 1.3 4.6 1.7 0.6 45.5 2.7 0.3 33.7 1.4 11.3 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.2 0.0 2.9 0.0 0.0 0.0 0.1 0.0 31.3 0.1 0.0 0.1 0.5 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 9.6 0.0 0.3 0.0 0.0 33.7 0.2 0.0 0.0 1.4 0.1 11.3 13.0 0.0 2.8 0.3 0.4 0.2 0.5 0.3 0.3 0.4 0.1 0.7 0.0 0.0 0.0 0.5 20.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.0 61.9 0.0 0.0 1.6 0.0 0.0 0.0 6.4 0.9 0.3 6.3 0.0 13.6 3.1 0.7 0.0 7.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.4 0.1 0.0 2.8 21.4 UQCC3 "C11orf83, UNQ655" ENSG00000204922 "Ubiquinol-cytochrome c reductase complex assembly factor 3" Q6UW78 11 62670273-62673687 "Disease related genes, Predicted membrane proteins" "ATP synthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046851 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA046851: AB_2679839" "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "unprognostic (3.42e-2)" "unprognostic (3.91e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (2.18e-1)" "unprognostic (1.67e-1)" "unprognostic (8.70e-3)" "unprognostic (7.84e-2)" "unprognostic (8.96e-2)" "unprognostic (7.07e-2)" "unprognostic (7.21e-3)" "unprognostic (1.48e-1)" "unprognostic (3.20e-1)" "unprognostic (1.36e-1)" 10.0 13.4 8.9 11.4 8.5 10.6 14.7 8.7 9.9 7.3 15.4 4.7 19.7 16.5 7.3 8.5 14.5 6.5 12.4 13.2 8.0 8.7 10.7 13.4 5.6 8.3 8.5 8.7 9.5 15.4 5.3 7.6 6.2 7.7 12.3 4.9 7.1 22.9 14.1 27.8 8.6 14.8 6.0 6.2 9.6 12.2 5.7 5.4 6.4 13.5 12.3 9.1 8.0 18.1 23.7 21.2 15.2 20.8 14.0 19.4 15.5 12.0 24.5 3.6 5.6 2.2 2.2 3.0 4.8 1.6 3.6 3.6 14.3 10.5 7.8 10.0 1.6 4.9 12.0 3.4 5.6 1.1 3.9 12.7 4.4 12.8 9.1 3.0 7.1 3.6 2.1 4.8 3.2 3.6 2.3 2.8 3.8 9.4 5.7 2.0 36.8 6.9 17.5 4.0 4.8 13.9 8.1 5.5 13.9 2.7 6.0 7.3 7.4 5.3 19.4 7.1 1.1 18.4 6.7 3.6 7.9 9.3 8.2 10.6 8.8 4.8 8.1 6.5 6.2 5.7 9.1 20.8 15.2 18.1 14.4 17.1 23.5 18.0 15.9 15.8 23.7 16.6 13.3 8.9 14.0 12.7 21.2 19.4 15.5 8.9 8.5 8.7 9.9 8.0 8.7 8.5 8.7 7.7 5.4 41.7 23.5 61.4 42.6 0.0 20.8 31.7 66.2 22.7 29.6 61.1 15.7 44.7 119.3 51.7 1.4 26.8 115.3 46.7 67.1 41.2 21.0 70.4 4.7 99.1 47.7 17.5 33.9 39.9 38.4 2.3 44.8 22.9 0.0 43.3 98.1 39.6 57.0 91.2 33.9 137.3 26.2 38.8 31.1 2.7 33.7 0.0 24.3 25.9 101.8 45.4 USF3 KIAA2018 ENSG00000176542 "Upstream transcription factor family member 3" Q68DE3 3 113648385-113696646 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029243, HPA029245" Uncertain Uncertain Nucleoplasm,Nucleoli,Centrosome NA NA "Nucleoplasm, Nucleoli" Centrosome "HPA029243: AB_10611114, HPA029245: AB_10600443" "unprognostic (2.80e-2)" "unprognostic (2.80e-1)" "unprognostic (4.21e-2)" "unprognostic (7.80e-2)" "unprognostic (2.25e-2)" "unprognostic (1.96e-2)" "unprognostic (3.53e-1)" "unprognostic (2.62e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (8.74e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.74e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (3.28e-1)" "unprognostic (5.55e-2)" 9.0 5.1 8.8 11.0 7.3 13.8 11.4 13.9 7.5 7.2 12.2 5.3 5.4 4.8 5.8 13.3 7.0 6.3 5.3 8.1 7.6 5.5 12.7 24.0 6.1 9.2 6.3 5.6 6.9 10.8 14.4 8.9 4.9 6.5 6.2 6.7 6.4 8.3 5.4 28.7 11.4 14.7 8.3 11.2 12.0 7.3 4.8 6.9 13.3 7.1 11.5 8.9 6.1 6.0 5.9 5.1 6.9 3.7 2.6 3.1 1.4 5.2 4.0 5.0 4.7 12.1 4.7 3.4 2.1 3.4 2.1 2.0 3.7 2.2 9.3 3.9 5.4 3.4 3.3 5.3 4.2 4.0 2.8 2.2 6.6 2.5 6.1 3.6 12.1 7.4 6.7 7.7 3.9 4.4 3.2 5.0 7.1 3.1 5.0 4.4 7.4 6.7 6.7 3.6 7.1 4.1 2.9 3.9 3.7 7.5 7.4 2.4 3.6 5.1 2.9 6.1 3.6 3.9 9.0 6.8 3.3 7.2 1.8 3.0 5.8 3.2 11.1 3.8 5.1 2.4 4.1 2.4 3.5 3.1 2.8 2.3 2.2 2.2 2.3 1.7 5.9 2.7 2.8 6.9 2.6 3.7 5.1 1.1 1.4 8.8 7.3 13.9 7.5 7.6 5.5 6.3 5.6 6.5 6.9 20.8 10.8 4.8 9.6 0.0 20.4 0.0 10.2 22.7 11.4 24.4 13.7 6.7 21.6 7.4 4.6 10.8 9.7 0.0 10.3 3.1 5.4 14.9 4.7 36.5 6.7 12.7 5.8 20.3 16.4 9.1 12.0 10.4 0.0 3.6 13.2 11.3 10.2 16.5 13.1 18.7 17.2 6.5 0.0 9.5 3.9 0.0 12.1 13.4 13.3 17.8 USP15 "KIAA0529, UNPH4" ENSG00000135655 "Ubiquitin specific peptidase 15" Q9Y4E8 12 62260338-62417431 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 88.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 68.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 68.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006237, HPA006428, HPA071014" Approved Supported "Plasma membrane,Cytosol" NA NA 280000 Cytosol "Plasma membrane" "HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333" "unprognostic (8.18e-2)" "unprognostic (3.22e-1)" "unprognostic (9.63e-2)" "unprognostic (2.09e-1)" "unprognostic (1.10e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (6.59e-2)" "unprognostic (7.70e-3)" "unprognostic (2.19e-1)" "unprognostic (2.47e-1)" "unprognostic (4.51e-2)" "prognostic unfavorable (1.58e-5)" "unprognostic (9.28e-2)" "unprognostic (5.81e-3)" "unprognostic (1.11e-2)" "unprognostic (1.26e-1)" 23.1 16.8 11.5 22.5 11.9 88.9 17.8 21.1 15.7 14.5 14.5 5.2 11.9 11.4 12.7 12.4 16.1 14.1 11.2 15.2 9.6 6.2 13.8 20.4 23.8 26.2 11.6 9.4 22.5 15.8 18.9 22.5 31.0 14.9 12.4 13.8 7.6 16.2 10.7 28.5 23.0 19.7 16.3 16.2 35.6 14.3 20.0 11.0 33.1 14.1 15.4 18.9 18.4 17.9 5.7 6.0 68.5 14.2 3.3 12.1 4.8 9.4 8.9 8.9 7.8 14.1 16.5 16.0 15.4 13.7 13.6 12.2 8.9 9.5 10.1 8.8 13.2 5.8 10.4 11.9 13.4 16.0 11.2 7.3 13.9 7.6 6.8 13.6 22.0 33.8 12.0 14.0 16.1 14.3 12.8 16.2 10.3 45.0 19.6 12.6 10.5 13.1 11.1 13.0 8.6 13.2 8.4 9.4 16.3 12.7 10.9 11.3 5.4 17.8 11.3 8.7 9.7 15.0 13.2 19.3 10.6 10.6 16.5 9.5 9.3 10.4 11.6 12.2 17.9 12.0 27.2 14.2 13.8 3.4 7.3 3.5 5.7 4.6 3.2 4.9 4.7 5.9 3.5 68.5 3.3 5.8 6.0 12.1 4.8 11.5 11.9 21.1 15.7 9.6 6.2 11.6 9.4 14.9 11.0 35.7 31.3 91.0 32.3 52.2 54.5 62.7 17.8 42.8 59.1 22.7 104.1 25.1 10.0 31.3 139.8 44.6 32.3 93.5 36.2 36.1 49.5 31.6 85.6 42.0 41.1 39.7 40.4 22.1 108.1 130.5 57.2 94.6 50.6 36.1 22.9 24.4 41.2 45.6 27.6 19.4 146.4 38.8 56.5 62.9 41.8 67.2 55.0 65.0 23.3 54.9 USP21 "USP16, USP23" ENSG00000143258 "Ubiquitin specific peptidase 21" Q9UK80 1 161159450-161165723 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028397 Uncertain Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028397: AB_10603227" "unprognostic (9.17e-2)" "unprognostic (1.44e-1)" "unprognostic (3.95e-2)" "prognostic unfavorable (7.05e-4)" "unprognostic (1.22e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (5.35e-2)" "unprognostic (6.73e-2)" "unprognostic (2.76e-2)" "unprognostic (3.87e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (9.50e-6)" "unprognostic (2.45e-1)" "unprognostic (3.28e-1)" "unprognostic (2.13e-2)" "prognostic favorable (3.35e-5)" 11.8 16.4 22.1 12.8 21.2 15.3 19.1 23.6 24.8 18.1 16.1 25.5 14.0 15.5 19.7 14.6 18.3 33.3 14.1 13.7 20.9 12.1 15.4 10.6 14.0 16.7 26.4 14.1 28.3 19.0 24.4 17.2 15.2 20.5 18.1 13.1 17.1 19.0 25.3 19.4 23.5 15.4 15.1 17.0 18.7 16.0 17.0 22.9 16.0 24.5 9.6 15.6 17.9 19.2 14.1 12.0 18.3 11.1 13.4 17.2 10.7 7.4 12.9 16.9 16.3 13.5 11.3 10.4 5.5 9.0 15.2 11.9 11.8 14.7 9.8 9.5 6.8 9.5 12.9 10.9 10.7 8.4 18.6 18.4 11.6 18.6 9.2 9.8 10.3 8.7 9.5 14.4 10.4 15.1 17.2 10.7 21.7 17.2 13.6 9.7 13.7 18.2 16.2 15.8 14.6 16.4 17.3 5.6 16.4 8.9 8.9 15.4 19.9 10.3 10.9 8.3 13.2 23.9 16.7 6.3 10.9 9.8 7.6 9.4 27.6 21.3 14.5 10.0 8.9 9.8 13.0 11.1 18.3 14.9 7.1 17.2 12.8 13.8 15.4 12.0 14.1 16.0 14.6 9.6 13.4 7.7 12.0 13.3 10.7 22.1 21.2 23.6 24.8 20.9 12.1 26.4 14.1 20.5 22.9 0.0 3.0 1.7 1.5 1.3 3.9 2.2 10.2 10.7 3.4 1.8 5.9 3.6 1.7 1.4 0.6 2.8 2.0 0.0 2.0 2.1 2.4 2.0 2.3 1.7 1.9 0.0 5.2 6.2 7.6 0.4 4.6 1.7 1.7 0.0 4.1 3.0 1.7 2.9 3.9 1.8 4.4 6.5 1.9 3.6 2.7 1.3 2.6 2.5 3.7 1.4 USP4 "UNP, Unph" ENSG00000114316 "Ubiquitin specific peptidase 4" Q13107 3 49277831-49340712 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 100.2;Late spermatids: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018499 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA018499: AB_1858689" "unprognostic (2.34e-3)" "unprognostic (1.52e-1)" "unprognostic (2.22e-3)" "unprognostic (6.12e-2)" "unprognostic (3.51e-1)" "unprognostic (4.33e-2)" "unprognostic (9.42e-2)" "prognostic favorable (4.46e-5)" "unprognostic (3.54e-1)" "unprognostic (9.07e-3)" "unprognostic (2.78e-2)" "unprognostic (1.70e-3)" "prognostic favorable (4.29e-5)" "unprognostic (7.30e-2)" "unprognostic (1.00e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-2)" 22.1 18.4 21.4 22.4 29.3 41.4 23.1 30.3 32.5 20.7 20.1 26.8 16.9 16.1 23.6 20.9 23.5 19.3 17.5 22.8 22.2 18.0 20.2 18.5 25.7 25.5 20.2 17.5 23.6 17.1 23.6 19.7 22.1 24.3 20.9 21.9 23.6 19.1 21.3 25.7 27.6 19.4 25.9 20.4 30.6 17.7 25.0 19.7 36.8 21.2 14.1 42.4 22.1 22.0 17.0 24.1 59.4 27.3 21.5 18.6 22.2 6.4 7.4 10.2 13.6 19.0 20.4 6.9 17.5 15.6 22.7 20.5 7.8 16.2 12.4 7.0 25.5 13.1 8.7 13.6 24.8 21.2 19.1 4.0 27.5 14.7 8.7 27.9 14.5 15.9 20.9 10.9 24.9 20.5 16.5 26.2 14.1 9.6 19.7 21.0 10.9 17.1 24.6 8.7 8.0 12.9 7.1 6.4 10.8 17.8 13.3 8.5 11.4 12.7 9.0 6.5 10.7 6.2 23.3 23.2 15.3 8.3 19.1 10.2 15.8 7.6 18.1 13.7 23.0 17.5 18.0 27.3 30.0 16.9 22.1 18.6 17.0 17.6 16.9 24.1 14.1 17.1 15.0 59.4 21.5 24.4 9.6 18.6 22.2 21.4 29.3 30.3 32.5 22.2 18.0 20.2 17.5 24.3 19.7 38.7 21.4 18.1 15.0 16.7 16.6 15.3 15.3 33.5 25.0 19.2 19.6 18.9 18.3 14.2 100.2 17.9 11.6 0.0 11.9 12.1 12.3 13.1 32.4 12.1 21.7 11.1 10.3 16.0 38.8 90.2 14.4 25.3 15.1 30.7 11.4 12.0 14.6 5.8 18.0 10.5 21.5 12.9 14.7 18.5 13.6 16.2 20.3 24.9 11.9 11.8 USP40 FLJ10785 ENSG00000085982 "Ubiquitin specific peptidase 40" Q9NVE5 2 233475520-233566782 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005821 Uncertain Approved "Vesicles,Focal adhesion sites" NA NA Vesicles "Focal adhesion sites" "HPA005821: AB_1080526" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-1)" "unprognostic (3.70e-1)" "unprognostic (2.15e-1)" "unprognostic (5.30e-2)" "unprognostic (2.25e-1)" "unprognostic (1.80e-2)" "unprognostic (1.18e-1)" "unprognostic (1.96e-1)" "unprognostic (1.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.45e-1)" "unprognostic (4.09e-2)" "unprognostic (1.90e-2)" "unprognostic (2.53e-2)" 12.5 20.5 11.0 8.2 17.7 3.5 16.1 8.2 13.5 12.4 12.1 26.1 22.5 11.6 16.2 28.1 13.9 13.4 13.2 10.8 11.3 8.5 16.9 15.7 13.9 7.6 22.1 10.1 19.6 17.2 22.8 24.3 16.3 16.5 16.1 11.2 16.4 13.9 19.7 13.6 21.7 15.2 17.1 20.1 11.4 16.3 23.3 18.9 9.8 21.2 9.4 12.0 18.0 11.8 1.9 5.0 0.4 2.8 1.4 2.2 1.4 9.5 11.1 10.2 6.9 15.0 14.1 9.0 9.4 7.3 8.8 9.6 7.9 11.4 0.2 2.8 15.1 22.6 17.0 7.8 16.7 12.6 0.0 5.1 7.5 9.2 13.3 13.1 3.1 5.1 13.4 12.1 12.9 18.2 15.4 10.1 4.6 12.1 1.8 12.3 7.7 3.4 4.7 4.5 9.9 9.0 0.0 21.2 4.4 10.4 15.4 5.6 6.1 7.5 7.8 9.7 8.0 8.8 7.1 9.9 12.2 7.6 5.1 11.4 3.4 2.6 0.4 15.9 5.7 10.6 0.0 2.7 0.0 1.3 2.8 0.6 1.3 1.5 1.3 4.0 1.9 1.9 2.2 0.4 1.4 2.3 5.0 2.0 1.4 11.0 17.7 8.2 13.5 11.3 8.5 22.1 10.1 16.5 18.9 29.8 31.5 3.7 9.6 6.5 18.6 8.9 10.2 24.1 23.9 15.7 23.6 17.1 6.6 7.9 6.7 7.1 10.9 0.0 10.6 8.8 7.4 11.3 9.2 20.9 7.0 22.3 14.5 12.3 10.4 7.8 6.4 6.7 3.3 5.4 9.1 13.0 9.7 8.6 7.8 11.6 20.8 12.9 8.2 31.2 14.9 9.3 13.2 4.4 11.2 7.1 USP6 "HRP1, Tre-2, TRE17, Tre2, TRESMCR" ENSG00000129204 "Ubiquitin specific peptidase 6" P35125 17 5116438-5175034 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Calmodulin-binding, Hydrolase, Protease, Thiol protease" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "skeletal muscle: 18.2;testis: 29.0" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 19.3;Erythroid cells: 23.3;Spermatocytes: 19.2" "Cancer enriched" "Detected in single" 14 "testis cancer: 2.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046969 Uncertain Vesicles NA NA Vesicles "HPA046969: " "unprognostic (3.89e-2)" "unprognostic (3.79e-3)" "unprognostic (2.50e-1)" "unprognostic (1.85e-1)" "unprognostic (9.32e-2)" "unprognostic (3.50e-3)" "unprognostic (1.29e-1)" "unprognostic (1.67e-2)" "unprognostic (3.45e-2)" "unprognostic (2.46e-2)" "unprognostic (7.91e-4)" "unprognostic (6.28e-3)" "unprognostic (3.24e-4)" "unprognostic (3.75e-2)" "unprognostic (3.13e-1)" "unprognostic (2.71e-1)" "unprognostic (7.09e-4)" 0.3 0.3 0.3 0.3 0.6 0.2 0.4 0.5 0.5 0.3 0.5 0.3 1.2 0.0 0.6 0.6 0.3 0.5 0.4 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.3 0.3 2.6 0.3 0.0 0.4 0.4 0.3 0.4 0.1 0.3 0.3 0.3 18.2 0.6 0.7 0.9 0.3 0.3 0.0 29.0 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.9 1.2 1.9 1.0 0.2 0.4 0.1 2.2 0.9 2.2 1.6 0.4 0.2 2.3 1.9 0.1 0.6 0.4 0.8 1.0 2.2 1.6 1.2 1.9 1.0 0.7 0.8 0.5 1.5 1.3 1.7 1.3 0.9 1.2 0.5 2.8 1.1 0.5 0.1 0.2 2.5 0.3 1.8 0.5 0.3 0.5 2.5 1.8 0.7 1.5 0.7 0.1 1.4 1.9 0.2 0.5 0.7 0.9 2.1 1.0 0.1 3.3 3.7 2.1 2.2 1.2 0.9 3.2 2.0 1.4 2.0 1.6 1.5 0.0 0.1 2.6 0.1 0.4 0.9 0.4 0.3 0.2 0.6 0.3 0.3 0.3 0.9 0.3 0.4 1.9 0.2 1.0 1.2 0.1 0.1 0.3 0.6 0.5 0.3 0.3 0.1 0.3 0.3 0.3 0.3 6.0 9.6 0.5 0.9 9.6 7.9 1.6 7.6 5.3 5.7 3.5 11.8 0.5 3.3 0.0 19.3 2.9 0.0 23.3 0.0 0.8 1.5 2.4 0.0 2.6 2.3 1.6 0.0 4.9 4.9 9.4 1.7 5.7 3.3 0.0 0.0 4.7 0.1 0.0 2.5 2.8 9.8 6.5 0.6 19.2 5.5 9.2 0.6 0.7 0.0 0.9 USP9X "DFFRX, FAF, MRX99" ENSG00000124486 "Ubiquitin specific peptidase 9, X-linked" Q93008 X 41085635-41236579 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Cell division, Chromosome partition, Mitosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011618, HPA047417, CAB070164" Approved Uncertain Vesicles NA NA Vesicles "CAB011618: AB_470860, CAB070164: AB_10011071, HPA047417: " "unprognostic (5.42e-3)" "unprognostic (6.42e-2)" "unprognostic (3.19e-3)" "unprognostic (2.94e-2)" "unprognostic (5.99e-2)" "unprognostic (4.76e-1)" "unprognostic (1.82e-2)" "unprognostic (4.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.72e-1)" "unprognostic (7.07e-2)" "unprognostic (1.09e-1)" "unprognostic (5.82e-2)" "unprognostic (1.59e-1)" "unprognostic (4.19e-2)" "unprognostic (2.78e-1)" "unprognostic (1.33e-1)" 18.0 21.8 17.7 14.0 15.9 15.5 16.8 16.6 16.7 18.4 20.6 11.4 25.4 13.2 19.6 19.0 17.3 17.0 17.1 20.9 14.2 14.2 18.5 34.2 16.7 23.1 15.2 15.4 15.7 16.5 45.8 17.0 41.1 12.9 13.4 14.4 13.9 14.2 25.2 42.8 14.8 22.0 17.3 14.0 16.7 16.9 16.9 14.0 21.1 20.3 17.6 16.5 20.3 19.9 6.4 5.5 13.0 5.0 4.9 7.8 3.1 18.2 21.6 19.2 19.6 16.1 16.9 4.4 10.5 14.1 12.0 13.9 9.9 8.5 12.3 5.9 23.9 35.9 12.4 32.9 19.1 20.1 15.4 23.6 14.2 20.9 8.9 13.6 12.3 10.4 14.6 8.6 28.7 27.2 17.2 18.5 8.3 17.2 10.0 18.5 13.3 8.8 4.9 20.3 6.5 11.9 9.7 26.2 7.9 11.4 15.1 10.9 10.2 44.2 12.2 12.0 36.0 11.8 6.9 19.7 18.3 14.2 17.3 11.3 9.2 10.7 15.7 13.1 5.5 9.1 3.3 4.7 6.0 5.6 4.2 7.8 6.4 6.6 6.2 5.5 4.7 6.7 6.0 13.0 4.9 5.0 4.2 5.6 3.1 17.7 15.9 16.6 16.7 14.2 14.2 15.2 15.4 12.9 14.0 38.7 32.0 23.8 26.8 42.8 35.0 73.6 43.3 30.8 36.4 26.2 35.3 31.0 6.6 26.8 13.0 39.8 39.2 70.0 22.8 21.8 35.1 30.2 24.4 55.5 29.3 35.0 25.8 52.8 43.4 13.1 30.8 38.0 32.1 33.3 42.5 32.0 27.0 35.7 46.3 20.3 29.3 32.3 39.6 31.4 69.2 48.3 39.0 26.1 36.7 34.3 USP9Y DFFRY ENSG00000114374 "Ubiquitin specific peptidase 9, Y-linked" O00507 Y 12701231-12860839 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 60.9" "Cancer enhanced" "Detected in many" "prostate cancer: 5.7" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.4;dendritic cells: 2.0;T-cells: 2.7" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 16.2;RT4: 8.7" "Not detected" "Not detected" HPA057687 Uncertain Vesicles NA NA Vesicles "HPA057687: " "unprognostic (2.63e-1)" "unprognostic (8.97e-2)" "unprognostic (1.10e-5)" "unprognostic (8.46e-3)" "unprognostic (4.93e-2)" "unprognostic (2.53e-2)" "unprognostic (2.77e-1)" "unprognostic (3.17e-2)" "unprognostic (1.71e-1)" "unprognostic (4.05e-2)" "unprognostic (1.41e-4)" "unprognostic (2.28e-1)" "unprognostic (1.19e-2)" "unprognostic (1.42e-1)" 1.2 2.2 1.4 0.9 3.1 1.7 1.1 9.6 4.0 0.0 1.6 1.4 0.0 8.6 4.4 0.0 3.8 2.4 1.8 3.4 2.9 2.2 2.2 1.4 2.1 0.0 2.7 0.0 4.8 1.7 9.3 4.8 2.3 7.6 2.8 2.0 1.8 0.0 1.5 2.2 1.5 2.9 2.8 4.5 3.2 0.0 2.4 2.0 0.1 0.2 0.5 2.7 0.2 0.0 2.3 0.0 0.0 0.0 0.0 2.5 7.2 7.2 3.6 3.9 0.0 0.0 4.1 0.0 6.0 0.0 0.0 0.0 0.0 3.3 2.3 0.0 2.6 0.0 7.1 4.0 0.0 0.0 6.0 5.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.5 0.0 4.0 0.0 1.5 0.0 0.0 0.0 2.0 0.9 16.2 8.7 2.8 0.0 0.0 0.0 2.1 5.4 0.0 0.0 5.5 4.4 0.0 0.0 3.2 0.0 3.8 7.1 0.1 0.0 0.0 0.0 0.1 0.0 1.9 0.2 2.7 1.2 2.2 1.5 0.3 2.4 2.2 1.3 0.1 0.5 0.0 2.0 1.6 0.2 23.8 19.7 0.8 7.4 10.4 22.1 24.6 2.5 21.4 15.9 19.2 60.9 4.3 1.7 4.1 0.4 5.8 0.0 0.0 0.0 1.1 9.3 11.2 2.3 0.2 2.5 25.4 0.0 5.5 6.9 0.0 11.5 7.3 3.3 2.8 0.3 8.1 3.7 0.0 14.5 5.4 24.9 0.0 7.6 3.2 1.7 10.2 2.9 10.0 0.0 9.9 UTP14A "NY-CO-16, SDCCAG16, Utp14" ENSG00000156697 "UTP14A, small subunit processome component" Q9BVJ6 X 129906121-129929761 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047217, HPA054023" Uncertain Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA047217: AB_2679987, HPA054023: AB_2682346" "unprognostic (6.75e-2)" "unprognostic (2.20e-1)" "unprognostic (1.10e-1)" "unprognostic (7.84e-3)" "unprognostic (2.95e-1)" "prognostic unfavorable (7.67e-4)" "unprognostic (3.00e-3)" "unprognostic (8.24e-2)" "unprognostic (4.09e-3)" "unprognostic (2.81e-1)" "unprognostic (2.28e-2)" "unprognostic (6.99e-3)" "prognostic unfavorable (8.12e-8)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (5.06e-2)" "unprognostic (9.99e-2)" 15.1 11.4 8.2 13.3 11.2 10.2 15.8 12.7 13.8 13.3 13.4 8.4 8.5 8.5 17.6 13.9 16.9 13.9 9.0 10.0 7.1 7.2 13.2 14.9 10.7 14.8 7.6 9.8 17.4 22.7 13.1 13.8 12.5 10.6 13.5 14.7 8.6 13.2 10.6 19.6 11.8 11.0 15.3 7.7 16.1 13.3 4.3 7.7 20.7 12.4 16.3 19.5 16.0 13.5 11.1 11.8 16.2 14.3 15.5 14.6 7.7 14.3 16.0 8.6 22.6 14.5 14.8 14.5 15.9 12.2 16.0 12.8 16.3 14.2 34.0 32.1 11.5 17.5 18.4 34.4 17.3 19.7 11.3 17.1 19.4 13.7 12.3 16.4 27.4 14.9 18.1 15.3 21.7 23.0 10.4 12.6 12.7 19.3 10.7 13.8 23.6 19.7 20.9 17.9 27.4 18.0 15.5 13.0 23.3 11.1 11.0 9.0 23.8 9.0 16.7 18.8 11.9 9.0 16.0 10.9 7.1 9.2 19.7 30.5 13.4 15.5 30.3 10.7 34.1 15.9 16.2 8.0 4.0 12.7 14.3 14.6 11.1 10.7 11.8 11.8 10.9 13.5 12.4 1.0 15.5 12.0 9.4 14.4 7.7 8.2 11.2 12.7 13.8 7.1 7.2 7.6 9.8 10.6 7.7 11.9 10.4 11.5 13.1 7.4 5.4 8.1 15.3 12.0 29.6 0.0 3.9 19.7 11.6 16.5 0.3 7.4 2.9 0.0 10.9 16.6 8.7 7.6 13.9 4.0 12.0 1.6 7.5 6.2 7.8 0.2 5.8 9.4 5.0 17.2 7.3 6.0 12.1 10.2 6.7 6.7 4.4 12.9 10.8 1.4 2.4 6.9 34.0 10.2 10.1 9.5 UTP14C "2700066J21Rik, KIAA0266" ENSG00000253797 "UTP14C, small subunit processome component" Q5TAP6 13 52024691-52033600 "Predicted intracellular proteins" "Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047217, HPA054023" Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA047217: AB_2679987, HPA054023: AB_2682346" "unprognostic (7.89e-2)" "unprognostic (5.98e-2)" "unprognostic (4.47e-1)" "unprognostic (1.25e-1)" "unprognostic (2.33e-3)" "unprognostic (2.51e-1)" "unprognostic (2.02e-1)" "unprognostic (3.30e-1)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (7.35e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.46e-5)" "unprognostic (2.44e-2)" "unprognostic (3.43e-1)" "unprognostic (1.74e-1)" "unprognostic (3.04e-2)" 4.8 4.8 5.3 3.4 5.9 0.5 6.2 6.6 5.9 6.8 5.3 4.6 6.7 4.6 3.6 5.2 3.9 5.5 5.1 5.2 8.0 7.9 4.5 3.5 5.5 6.1 5.8 8.9 4.8 6.6 7.1 5.9 5.7 5.5 5.3 2.9 4.5 5.3 6.2 4.4 5.7 2.3 9.1 3.8 4.6 4.2 4.1 5.8 6.7 4.8 3.5 6.8 3.1 4.2 6.8 14.1 11.1 14.5 10.5 10.9 12.3 9.6 8.3 7.7 6.7 9.0 10.5 3.3 11.6 10.5 10.0 12.4 6.8 11.0 10.7 8.8 20.2 4.8 6.5 9.9 17.9 14.0 9.2 13.0 6.4 12.4 10.9 6.8 12.5 11.6 5.3 12.4 3.1 10.9 10.0 12.8 19.5 4.9 10.7 9.9 4.5 14.1 6.9 4.6 9.5 7.3 11.0 8.4 13.5 9.8 14.2 10.3 7.7 8.0 8.6 8.4 5.4 7.8 12.7 4.1 6.7 14.4 6.7 3.7 5.4 4.6 4.8 3.9 3.0 4.9 3.7 4.4 4.1 6.8 6.7 2.4 3.5 3.9 5.8 5.2 3.1 6.0 17.4 11.2 5.0 5.3 13.0 18.5 20.4 12.0 13.6 15.7 3.9 8.5 0.0 6.0 0.3 10.6 10.8 0.0 6.6 8.1 10.8 11.1 11.5 28.1 7.9 23.8 17.9 12.3 14.8 0.0 9.8 6.7 8.5 2.8 15.1 13.6 6.8 14.0 13.4 5.0 10.6 6.5 7.6 6.6 12.2 7.3 5.8 6.9 12.7 5.4 UTP15 "FLJ12787, FLJ23637, NET21" ENSG00000164338 "UTP15, small subunit processome component" Q8TED0 5 73565443-73583377 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044697 Approved "Nucleoli,Endoplasmic reticulum" No No "Nucleoli, Endoplasmic reticulum" "HPA044697: AB_2679050" "unprognostic (8.96e-2)" "unprognostic (1.19e-1)" "unprognostic (1.87e-3)" "unprognostic (8.36e-2)" "unprognostic (1.78e-1)" "unprognostic (5.80e-2)" "unprognostic (1.39e-2)" "unprognostic (5.74e-2)" "unprognostic (2.12e-1)" "unprognostic (4.16e-3)" "unprognostic (1.02e-1)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (9.66e-2)" "unprognostic (7.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.22e-1)" 17.1 11.8 6.5 9.4 11.7 38.6 13.2 8.7 12.5 7.5 8.6 10.4 9.3 7.0 11.3 8.7 13.6 10.4 6.7 8.8 12.9 5.6 9.3 12.9 10.2 12.1 11.0 8.0 11.0 9.7 11.8 16.4 8.8 12.5 10.1 10.9 7.5 10.9 6.6 14.5 18.3 10.7 9.9 10.3 11.4 11.9 10.1 10.0 11.4 10.3 13.2 12.8 9.5 9.4 8.3 9.0 4.6 8.0 8.8 10.8 5.4 10.7 11.6 7.9 23.7 6.9 8.2 15.0 12.8 7.4 14.5 16.1 13.0 14.4 24.2 13.0 8.6 16.8 9.0 13.5 23.8 22.5 11.8 9.8 11.1 12.3 10.6 8.5 10.1 9.1 8.3 10.8 16.4 18.5 4.3 10.0 10.5 17.0 13.4 12.3 13.5 15.3 7.2 10.7 3.8 6.7 12.3 12.1 23.4 8.7 14.7 8.1 8.7 11.5 9.5 13.4 7.0 12.1 7.5 8.1 8.6 11.9 10.1 24.9 9.8 13.0 31.2 13.6 17.4 12.5 2.5 7.0 4.6 9.7 8.0 9.7 8.3 9.8 10.6 9.0 7.2 10.5 10.8 3.8 8.8 7.3 6.5 7.9 5.4 6.5 11.7 8.7 12.5 12.9 5.6 11.0 8.0 12.5 10.0 0.0 5.3 2.9 10.8 13.1 3.9 6.4 2.5 0.0 4.5 5.2 5.9 6.8 3.3 8.1 3.5 4.9 2.3 0.0 6.8 7.3 4.9 5.6 6.9 6.7 6.0 1.6 2.4 3.1 7.3 2.2 2.8 4.3 6.8 1.8 3.6 3.5 5.7 3.5 4.9 4.9 4.4 6.5 8.5 6.3 13.6 14.9 5.5 4.4 6.0 9.0 UTP18 "CGI-48, WDR50" ENSG00000011260 "UTP18, small subunit processome component" Q9Y5J1 17 51260528-51297936 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 146.3;Late spermatids: 145.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052378 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear membrane" "HPA052378: AB_2681805" "unprognostic (1.36e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.33e-4)" "unprognostic (2.62e-2)" "unprognostic (2.55e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.47e-2)" "unprognostic (8.37e-3)" "unprognostic (1.10e-2)" "unprognostic (8.82e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-3)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.72e-3)" "unprognostic (1.93e-2)" 15.6 16.1 14.4 18.0 20.5 26.9 20.2 23.3 20.9 15.0 13.6 14.5 12.4 13.6 13.0 13.4 17.7 14.0 11.1 8.9 14.2 13.9 17.1 16.9 14.0 22.9 17.0 20.5 19.4 18.1 17.3 19.4 28.3 16.1 13.1 15.0 12.8 14.9 11.9 19.1 25.7 13.0 10.2 14.4 22.0 13.5 42.5 16.9 21.6 19.1 15.6 25.3 15.2 17.9 26.1 26.4 12.4 22.9 17.4 28.1 24.9 26.5 26.4 16.8 15.4 11.1 16.7 43.9 14.7 12.2 25.8 24.9 16.5 14.9 33.7 21.1 10.9 27.6 14.5 27.3 15.7 38.5 22.0 35.6 35.4 16.0 28.7 15.2 37.4 17.4 10.6 12.2 21.9 17.8 13.1 15.4 16.8 28.7 15.5 19.4 16.4 33.5 25.5 24.1 37.9 28.0 30.5 38.3 26.4 18.8 17.7 18.8 23.8 17.1 20.4 33.4 21.9 25.1 19.1 13.4 26.6 22.3 21.9 30.5 30.1 55.4 39.0 16.5 26.1 19.0 6.8 22.9 12.4 20.5 21.6 24.9 26.1 25.8 24.7 26.4 24.4 28.1 26.2 4.0 17.4 21.1 16.6 25.7 24.9 14.4 20.5 23.3 20.9 14.2 13.9 17.0 20.5 16.1 16.9 14.9 25.5 32.0 48.3 53.3 16.3 3.9 17.8 48.2 22.7 14.0 13.7 61.4 33.2 24.4 146.3 25.4 10.5 0.0 40.8 58.4 26.5 24.1 31.1 16.6 54.8 9.5 15.4 8.6 38.6 145.5 24.7 35.4 21.9 38.7 19.4 20.6 29.1 17.8 20.8 29.8 10.3 12.9 16.5 115.2 106.7 46.0 66.6 27.7 22.5 46.3 UTRN "DMDL, DRP, DRP1" ENSG00000152818 Utrophin P46939 6 144285701-144853034 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 381.2;Early spermatids: 418.2;Late spermatids: 250.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 58.4;HUVEC TERT2: 41.7;TIME: 53.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016348, HPA018894" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 6000000 "Nucleoplasm, Plasma membrane" "CAB016348: AB_628424, HPA018894: AB_10600839" "unprognostic (3.47e-2)" "unprognostic (2.82e-1)" "unprognostic (2.32e-1)" "unprognostic (6.87e-3)" "unprognostic (1.75e-1)" "unprognostic (3.30e-2)" "unprognostic (3.99e-3)" "unprognostic (2.44e-1)" "unprognostic (9.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.10e-2)" "prognostic favorable (7.61e-5)" "unprognostic (6.32e-2)" "unprognostic (2.20e-1)" "unprognostic (1.66e-1)" "unprognostic (1.49e-2)" 34.5 14.1 11.6 34.5 23.5 22.9 25.4 3.1 11.3 32.6 15.3 6.8 21.9 7.7 28.8 21.5 17.7 21.4 15.8 13.8 9.2 12.8 15.5 11.8 35.2 30.9 12.7 8.8 22.7 23.8 53.1 13.0 21.1 16.0 23.4 15.2 17.3 18.4 24.8 11.7 16.7 14.8 19.8 16.6 45.8 13.3 45.0 8.5 27.4 32.4 20.0 25.7 20.7 23.4 11.7 15.0 10.6 48.0 10.3 12.6 3.7 6.9 5.9 10.5 13.6 18.3 16.8 6.3 10.3 10.1 8.4 12.3 22.5 2.6 2.2 9.1 23.1 9.9 4.1 58.4 8.7 12.1 23.3 6.7 8.3 6.4 13.3 7.2 9.2 0.1 9.7 1.8 12.4 6.5 7.9 41.7 6.6 0.5 6.1 11.8 4.6 7.3 4.0 4.2 4.3 6.3 6.6 19.0 0.2 9.7 0.2 13.4 0.2 16.1 2.2 6.4 16.8 8.9 12.5 53.6 8.1 10.1 4.1 9.8 4.7 6.3 0.3 4.9 5.6 13.2 9.8 12.3 6.6 12.6 36.3 9.0 7.4 8.0 10.2 5.1 11.7 7.0 7.3 10.6 10.3 48.0 15.0 6.4 3.7 11.6 23.5 3.1 11.3 9.2 12.8 12.7 8.8 16.0 8.5 381.2 100.6 59.6 24.2 26.2 6.0 51.2 35.7 125.8 185.4 29.6 0.0 73.5 0.0 20.7 418.2 142.7 5.3 0.0 27.6 3.8 38.2 40.0 27.8 12.1 19.7 57.2 30.0 68.2 90.1 250.3 22.2 56.1 37.1 8.2 14.2 29.3 24.9 10.5 31.5 4.9 3.4 142.3 109.3 5.7 4.6 39.6 108.1 64.0 20.4 18.4 VAMP8 EDB ENSG00000118640 "Vesicle associated membrane protein 8" Q9BV40 2 85561562-85582031 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 172.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 82.0;NB-4: 128.2;THP-1: 63.7;U-937: 85.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006882, HPA007215, CAB037132, CAB037147" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 210000 "Golgi apparatus, Plasma membrane" Nucleoplasm "CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: " "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "unprognostic (7.46e-3)" "unprognostic (1.13e-1)" "unprognostic (7.33e-2)" "unprognostic (1.31e-1)" "unprognostic (1.76e-2)" "unprognostic (3.79e-3)" "unprognostic (3.83e-2)" "unprognostic (4.15e-1)" "unprognostic (2.74e-2)" "unprognostic (8.62e-2)" "unprognostic (1.57e-3)" "unprognostic (1.92e-2)" "unprognostic (2.16e-1)" "prognostic favorable (8.07e-9)" "prognostic favorable (1.59e-6)" 16.5 8.2 7.1 20.7 11.2 27.6 24.2 1.9 6.2 16.3 49.4 5.7 43.5 24.1 6.0 25.5 65.4 17.1 28.8 13.0 4.7 3.8 67.7 46.5 53.1 48.0 10.5 3.2 7.1 58.0 15.4 8.3 108.1 11.9 22.1 31.9 7.7 90.7 40.4 9.0 43.3 87.1 6.8 10.4 53.5 28.7 5.5 8.4 24.5 47.5 35.4 34.9 20.6 30.4 39.2 172.5 37.7 69.7 41.4 51.3 100.9 23.9 3.1 0.2 0.2 0.2 0.1 23.9 0.0 0.0 0.0 0.0 17.8 22.0 5.3 17.4 0.1 1.8 17.0 0.2 42.9 0.0 21.8 16.6 27.6 10.6 20.2 0.3 82.0 28.6 0.2 30.5 0.0 7.1 0.1 5.5 0.1 19.7 1.1 9.8 33.6 0.0 128.2 0.3 30.0 2.5 0.5 0.9 36.0 49.7 36.0 0.8 0.3 11.7 62.1 1.9 13.0 22.8 63.7 11.0 0.0 1.5 0.3 0.2 0.3 13.5 31.4 0.3 85.1 0.1 37.7 69.7 25.2 40.4 57.7 38.8 39.2 46.8 39.5 63.5 37.8 37.3 39.1 4.5 41.4 34.3 172.5 51.3 100.9 7.1 11.2 1.9 6.2 4.7 3.8 10.5 3.2 11.9 8.4 345.4 256.8 171.2 244.0 230.2 1.1 5.5 331.2 341.3 271.8 347.2 0.0 869.6 648.2 536.4 20.3 29.2 900.3 0.0 637.4 386.9 34.1 294.8 263.2 244.8 1050.6 0.0 124.1 155.3 836.3 34.0 8.6 660.7 334.0 762.0 322.8 2.4 674.2 501.5 7.1 797.0 1.6 45.3 25.8 28.4 6.4 288.3 734.1 248.2 230.6 528.7 VDAC1 "MGC111064, PORIN" ENSG00000213585 "Voltage dependent anion channel 1" P21796 5 133971915-134005133 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 189.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005885, HPA030780, CAB072343" Supported Uncertain Vesicles NA NA 4800000 Vesicles "CAB005885: AB_2214787, CAB072343: , HPA030780: AB_2673608" "prognostic unfavorable (5.30e-4)" "unprognostic (7.63e-3)" "unprognostic (3.07e-3)" "unprognostic (2.01e-1)" "unprognostic (5.11e-3)" "prognostic unfavorable (4.90e-4)" "prognostic unfavorable (8.49e-4)" "prognostic unfavorable (2.87e-5)" "unprognostic (1.81e-1)" "unprognostic (1.86e-1)" "unprognostic (1.20e-2)" "unprognostic (2.64e-1)" "unprognostic (3.19e-2)" "unprognostic (8.98e-2)" "unprognostic (1.78e-1)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" 22.4 27.0 32.2 18.9 36.6 9.8 22.6 24.4 46.4 13.8 31.3 15.6 20.4 54.0 12.1 42.8 35.2 13.3 25.8 79.0 31.0 32.3 44.9 52.5 16.3 17.3 30.6 29.5 14.6 27.5 31.6 14.1 22.8 41.8 17.9 35.3 23.3 26.6 17.9 189.4 21.9 39.9 18.9 20.7 18.3 32.5 8.3 14.7 16.3 17.3 66.6 25.5 18.9 21.3 18.9 44.7 9.2 36.5 26.5 23.3 20.0 55.6 49.5 45.4 47.0 45.6 63.9 64.1 62.7 46.4 62.4 64.3 101.2 44.8 77.0 47.2 65.3 83.3 43.9 64.0 110.4 78.3 45.4 52.7 44.3 53.0 80.9 46.6 40.6 44.1 58.1 59.3 48.4 54.1 62.5 60.4 39.2 39.4 31.6 81.4 62.1 49.4 40.5 31.7 86.1 42.0 45.6 45.4 73.1 96.9 70.5 50.8 28.7 39.9 48.8 62.5 65.2 23.4 39.9 48.9 58.8 39.2 53.8 81.9 42.4 41.8 48.3 87.3 54.6 66.7 6.4 26.2 9.2 18.5 36.5 20.4 18.9 19.1 19.3 44.7 13.4 13.7 15.1 2.2 26.5 31.2 13.1 23.3 20.0 32.2 36.6 24.4 46.4 31.0 32.3 30.6 29.5 41.8 14.7 98.3 53.8 114.9 202.6 182.0 420.0 257.9 188.5 124.5 83.0 120.4 76.6 339.7 618.4 271.3 51.9 101.8 313.3 0.0 265.3 390.2 136.0 191.2 120.0 170.9 298.9 491.0 99.9 56.4 90.4 40.4 88.6 191.3 236.2 427.4 159.8 195.2 250.0 193.2 105.4 471.4 182.7 84.1 306.0 8.8 29.6 203.5 272.3 89.7 280.1 214.3 VDR "NR1I1, PPP1R163" ENSG00000111424 "Vitamin D receptor" P11473 12 47841537-47943048 "Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 57.1;parathyroid gland: 45.8" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 101.9;Paneth cells: 43.0;Undifferentiated cells: 54.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "classical monocyte: 3.7;eosinophil: 2.1;intermediate monocyte: 7.0;myeloid DC: 5.7;neutrophil: 7.5;non-classical monocyte: 6.9" "Group enriched" "Detected in many" 8 "dendritic cells: 5.7;granulocytes: 7.5;monocytes: 7.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 23.0;HDLM-2: 32.4;U-937: 31.8" "Region enhanced" "Detected in single" "olfactory region: 2.5" "Not detected" "Not detected" "CAB004617, HPA047740, HPA072102" Supported "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Nucleoplasm "Intermediate filaments, Cytosol" "CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: " "unprognostic (1.11e-2)" "unprognostic (5.49e-2)" "unprognostic (1.01e-1)" "unprognostic (7.59e-3)" "unprognostic (3.33e-3)" "unprognostic (2.74e-2)" "unprognostic (4.78e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (6.72e-2)" "prognostic favorable (4.89e-6)" "unprognostic (1.46e-1)" "unprognostic (8.76e-2)" "unprognostic (3.28e-1)" "unprognostic (3.82e-2)" 3.0 9.2 0.2 10.0 0.3 2.5 7.8 0.3 0.6 3.5 40.9 0.4 4.1 21.2 1.2 7.7 10.2 1.1 10.7 1.5 0.5 0.3 13.0 0.6 8.3 3.8 0.5 0.1 1.3 6.5 45.8 11.7 4.4 0.6 2.1 12.6 0.4 4.9 2.8 5.3 15.2 57.1 1.2 1.5 3.1 2.6 1.5 0.2 2.0 1.9 9.4 8.2 4.0 5.2 0.7 5.7 7.5 7.0 0.2 0.8 1.2 5.5 0.9 0.0 0.0 4.8 7.0 0.1 6.8 3.5 5.8 5.0 4.0 4.7 1.4 7.4 4.6 4.1 10.4 0.2 23.0 2.7 32.4 1.7 2.4 1.3 0.3 3.5 4.9 7.8 9.4 10.8 6.4 10.5 9.2 0.4 0.5 0.7 1.5 2.6 3.7 0.1 2.4 0.0 13.8 7.5 0.1 0.0 3.5 5.2 5.5 2.6 0.1 5.8 16.7 2.1 0.0 18.8 2.7 0.4 11.1 2.9 3.2 3.8 0.9 0.0 1.2 3.4 31.8 2.8 0.2 3.7 2.1 0.0 7.0 0.1 0.7 0.3 0.0 5.7 0.1 0.1 0.0 7.5 0.2 6.9 0.6 0.8 1.2 0.2 0.3 0.3 0.6 0.5 0.3 0.5 0.1 0.6 0.2 11.9 15.3 1.9 8.2 32.1 0.4 1.2 0.0 9.4 11.4 7.0 0.0 0.1 6.6 3.7 0.1 0.8 101.9 0.0 9.4 0.1 7.8 3.9 6.9 0.4 3.6 0.0 20.8 0.0 6.6 0.0 0.0 18.7 8.5 6.4 30.0 0.2 14.7 43.0 0.4 17.5 0.2 0.0 2.8 0.7 0.3 35.5 0.2 3.2 54.4 8.4 VENTX "HPX42B, VENTX2" ENSG00000151650 "VENT homeobox" O95231 10 133237404-133241929 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 2: 1.4;Collecting duct cells: 1.8;Kupffer cells: 6.5;Macrophages: 5.6" "Cancer enriched" "Detected in some" 15 "testis cancer: 30.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 2.4;classical monocyte: 4.6;intermediate monocyte: 5.1;myeloid DC: 3.1;neutrophil: 1.8;non-classical monocyte: 3.9" "Group enriched" "Detected in many" 5 "dendritic cells: 3.1;granulocytes: 2.4;monocytes: 5.1" "Group enriched" "Detected in some" 10 "NB-4: 18.0;NTERA-2: 10.3" HPA050955 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" Cytosol "HPA050955: AB_2681288" "unprognostic (9.41e-2)" "unprognostic (8.89e-2)" "unprognostic (2.34e-1)" "unprognostic (4.26e-1)" "unprognostic (3.22e-2)" "unprognostic (2.01e-1)" "unprognostic (2.54e-1)" "unprognostic (9.62e-3)" "unprognostic (2.22e-1)" "unprognostic (3.00e-3)" "unprognostic (3.70e-4)" "unprognostic (4.22e-1)" "unprognostic (2.51e-3)" "unprognostic (3.43e-2)" "unprognostic (3.48e-1)" "unprognostic (7.54e-2)" "unprognostic (3.14e-1)" 5.6 2.4 1.2 6.6 1.2 4.4 2.0 1.2 1.2 1.7 1.7 1.2 1.2 0.4 1.7 1.2 1.2 2.0 2.5 1.2 1.2 1.5 1.9 1.2 4.4 1.2 1.2 1.2 1.7 2.1 1.0 1.5 1.2 1.2 1.2 0.4 1.2 1.5 1.2 1.2 2.0 1.2 2.1 2.2 7.3 0.9 6.3 1.2 2.9 1.2 1.2 1.2 1.5 1.2 0.5 3.1 2.4 5.1 0.6 0.3 1.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 18.0 10.3 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 2.4 4.6 0.6 0.3 5.1 0.1 0.5 0.2 0.2 3.1 0.5 0.2 0.3 1.8 0.6 3.9 0.2 0.1 1.0 1.2 1.2 1.2 1.2 1.2 1.5 1.2 1.2 1.2 1.2 0.0 1.4 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.5 0.0 0.0 5.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VLDLR "CARMQ1, CHRMQ1, VLDLRCH" ENSG00000147852 "Very low density lipoprotein receptor" P98155 9 2621834-2660053 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Receptor "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 50.5" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 72.2;Cone photoreceptor cells: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "eosinophil: 14.1" "Lineage enriched" "Detected in many" 12 "granulocytes: 14.1" "Cell line enhanced" "Detected in many" "BEWO: 27.2;JURKAT: 21.2;THP-1: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032462, HPA051312" Uncertain Uncertain "Vesicles,Cytokinetic bridge,Centriolar satellite" NA NA 180000 Vesicles "Cytokinetic bridge, Centriolar satellite" "CAB032462: AB_2216805, HPA051312: " "unprognostic (5.31e-2)" "unprognostic (2.65e-1)" "unprognostic (6.92e-2)" "prognostic favorable (5.95e-4)" "unprognostic (1.15e-1)" "unprognostic (2.67e-2)" "unprognostic (2.48e-3)" "unprognostic (1.76e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-2)" "unprognostic (3.79e-2)" "unprognostic (2.33e-1)" "unprognostic (6.75e-2)" "unprognostic (1.48e-2)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (4.34e-2)" 11.3 13.7 7.2 3.7 9.6 1.3 11.2 8.7 7.3 6.9 3.9 12.8 6.5 1.2 12.1 4.3 11.6 15.1 5.5 38.0 7.6 4.5 8.8 2.5 6.9 0.9 13.2 5.3 50.5 20.8 43.6 5.9 9.4 7.7 5.7 2.9 12.3 7.5 4.4 21.2 3.4 1.6 15.7 10.1 5.5 5.8 5.6 10.3 0.0 8.8 12.5 3.9 11.9 6.1 0.1 0.8 14.1 0.1 0.1 1.1 0.0 0.0 2.9 18.8 0.8 2.8 0.2 27.2 8.5 2.8 2.2 6.5 4.7 0.3 0.0 9.2 5.2 1.4 0.2 5.2 5.7 7.3 9.9 1.9 0.1 2.5 2.2 3.0 11.8 2.1 1.2 4.2 0.8 0.4 9.7 1.1 21.2 0.0 16.7 1.3 0.8 2.1 1.6 9.5 1.5 1.1 0.2 0.6 0.0 10.9 1.1 4.2 3.0 0.6 0.9 11.8 14.2 0.4 28.0 0.3 3.1 5.8 0.0 5.6 12.7 5.1 3.0 20.2 9.9 1.1 0.1 0.1 14.1 0.2 0.0 1.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 2.0 0.1 0.0 0.8 0.0 0.0 7.2 9.6 8.7 7.3 7.6 4.5 13.2 5.3 7.7 10.3 14.9 9.1 0.0 1.0 2.4 17.9 72.2 2.5 8.1 2.3 5.2 98.2 11.4 1.7 10.1 4.5 2.7 0.9 0.0 8.9 18.7 14.0 5.0 0.0 1.3 2.1 11.1 10.5 1.3 0.3 1.9 7.2 0.6 10.1 1.8 0.3 2.7 11.2 2.6 10.3 4.4 30.4 0.0 10.3 1.5 7.0 1.8 2.9 1.8 0.6 3.0 VN1R1 "V1RL1, VNR19I1, ZVNH1, ZVNR1" ENSG00000178201 "Vomeronasal 1 receptor 1" Q9GZP7 19 57454790-57457142 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 4.8;Cone photoreceptor cells: 2.0;Horizontal cells: 6.4;Rod photoreceptor cells: 3.3" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 6.2;U-266/70: 5.6;U-266/84: 6.7" HPA062209 Uncertain Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA062209: " "unprognostic (7.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (1.51e-2)" "unprognostic (5.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.21e-2)" "unprognostic (5.41e-2)" "unprognostic (5.68e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-2)" "unprognostic (4.59e-5)" 0.1 1.4 2.0 0.3 2.9 0.3 1.5 9.2 3.5 0.2 0.7 0.0 0.5 5.3 0.9 0.8 0.6 1.9 1.9 2.0 0.8 0.9 0.9 0.7 1.5 1.6 0.4 3.6 3.5 1.1 2.0 0.4 0.8 1.3 3.6 4.0 0.5 0.5 1.5 1.1 0.9 1.4 2.7 0.4 0.5 0.3 2.3 0.3 0.5 0.3 0.6 0.4 0.1 0.5 0.1 1.8 1.9 0.1 0.5 0.9 0.5 0.7 0.4 1.9 0.0 0.2 0.2 0.9 0.2 0.3 0.0 0.4 0.2 0.7 0.0 6.2 0.9 0.0 0.6 0.3 0.4 1.2 0.7 0.7 0.1 0.4 1.0 0.2 0.6 0.3 0.9 0.9 0.3 0.4 2.1 0.5 0.1 0.6 0.4 1.2 0.9 0.6 1.1 3.4 1.4 0.0 0.5 0.1 1.0 0.9 0.6 0.1 1.5 0.2 0.4 0.6 5.6 6.7 0.5 0.5 0.1 1.1 0.5 0.3 0.3 0.4 0.0 0.2 1.3 0.3 0.3 0.2 2.3 0.4 0.3 0.5 0.6 0.2 0.3 0.0 0.1 0.0 0.6 0.5 0.0 0.0 4.8 0.2 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.7 0.0 3.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 VPS4B "SKD1, SKD1B, VPS4-2" ENSG00000119541 "Vacuolar protein sorting 4 homolog B" O75351 18 63389190-63422483 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040393, CAB046445, HPA057649" Approved Approved "Vesicles,Intermediate filaments" No No 34000 Vesicles "Intermediate filaments" "CAB046445: AB_10603252, HPA040393: , HPA057649: AB_2683489" "unprognostic (8.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (1.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.10e-2)" "unprognostic (1.94e-3)" "unprognostic (1.67e-1)" "prognostic favorable (1.23e-4)" "unprognostic (4.59e-1)" "unprognostic (1.40e-1)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" 16.8 13.0 14.3 14.3 17.2 28.0 17.2 15.4 19.1 19.8 24.0 21.8 15.5 20.0 16.7 12.1 55.0 13.1 15.1 9.9 13.7 16.0 15.6 20.5 14.3 21.6 17.0 14.7 11.9 14.0 17.5 17.4 27.4 23.4 14.3 22.2 9.3 21.8 15.0 9.9 22.1 28.7 15.2 20.2 17.3 18.7 9.0 14.6 27.8 17.0 17.6 31.8 18.6 24.7 20.7 13.6 56.4 20.6 19.1 18.9 15.4 18.7 6.9 7.7 8.4 12.0 17.0 13.5 16.5 15.6 12.6 13.8 5.1 13.4 18.1 10.8 12.0 10.7 40.8 9.2 18.0 16.8 13.1 7.5 9.0 9.7 7.9 17.2 31.1 19.8 15.4 28.1 11.1 19.8 12.8 11.7 10.5 4.5 17.0 17.9 6.5 19.4 9.8 8.0 7.6 10.9 16.3 16.4 17.4 15.9 22.0 13.2 11.7 12.4 12.2 18.4 10.3 11.7 17.0 18.0 19.5 9.5 7.3 10.8 57.1 27.4 23.3 11.2 14.7 14.5 39.4 16.8 36.0 16.5 16.6 15.4 18.9 17.4 17.0 13.6 20.7 15.8 16.6 56.4 19.1 20.6 13.6 18.9 15.4 14.3 17.2 15.4 19.1 13.7 16.0 17.0 14.7 23.4 14.6 107.2 43.6 46.5 38.8 61.1 39.4 35.8 45.9 89.7 64.8 31.4 21.6 56.4 38.1 41.7 73.2 41.4 81.3 23.3 36.8 46.3 33.4 30.3 55.7 52.3 40.7 41.3 43.7 33.7 56.7 9.1 45.5 48.9 30.4 30.7 72.2 37.9 63.8 86.0 34.3 37.8 28.4 58.2 32.9 26.0 26.6 72.9 117.4 69.2 60.0 67.1 VPS50 "CCDC132, DKFZp313I2429, FLJ20097, KIAA1861, VPS54L" ENSG00000004766 "VPS50, EARP/GARPII complex subunit" Q96JG6 7 93232340-93361121 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026679 Approved Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA026679: AB_1846135" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (3.12e-2)" "unprognostic (7.43e-2)" "unprognostic (4.97e-2)" "prognostic unfavorable (7.21e-5)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" "unprognostic (1.37e-1)" "unprognostic (3.69e-1)" "unprognostic (5.17e-2)" "prognostic favorable (1.35e-6)" "unprognostic (2.08e-1)" "unprognostic (3.46e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" 15.9 16.3 16.4 15.3 24.2 6.9 21.6 26.1 28.3 13.0 16.0 9.9 13.3 11.5 17.7 17.5 15.7 11.9 10.4 12.6 19.8 16.0 20.0 12.1 13.2 15.3 16.4 22.2 15.4 13.5 23.9 30.8 12.8 26.7 14.3 18.5 7.5 15.0 14.2 18.7 16.8 12.8 14.8 15.9 15.5 14.1 13.8 19.2 15.8 15.8 14.0 15.3 14.2 12.9 5.5 10.4 4.2 8.1 5.2 11.2 4.3 11.1 6.7 8.7 13.4 16.2 11.6 8.7 10.5 9.0 10.9 12.0 9.4 13.0 9.9 11.9 9.1 20.1 9.6 12.9 10.0 15.2 11.5 9.0 18.4 13.0 5.9 9.9 9.4 10.1 9.8 11.6 13.2 13.3 10.7 14.1 9.7 14.5 12.8 14.5 11.1 8.8 8.4 6.0 15.2 9.5 7.0 11.5 13.4 10.2 8.9 6.3 13.4 12.2 26.8 10.8 13.7 9.2 7.1 12.7 15.9 9.4 29.0 10.7 7.0 15.5 11.9 11.7 9.3 12.6 4.2 7.0 3.4 6.2 8.1 11.2 5.5 6.9 7.6 10.4 5.5 5.5 7.4 1.7 5.2 4.8 5.1 8.1 4.3 16.4 24.2 26.1 28.3 19.8 16.0 16.4 22.2 26.7 19.2 11.9 9.9 3.4 3.8 0.0 11.8 0.0 2.5 10.7 9.1 5.2 15.7 5.9 3.3 6.3 12.3 5.3 1.1 23.3 4.7 9.2 1.9 2.7 7.0 6.4 9.4 9.5 2.4 9.8 10.4 11.0 8.3 6.4 0.0 6.4 9.9 8.5 6.3 7.0 6.7 6.9 13.7 6.5 0.0 17.2 12.5 0.0 7.9 6.9 5.9 2.0 VPS51 "ANG2, ANG3, C11orf2, C11orf3, FFR" ENSG00000149823 "VPS51, GARP complex subunit" Q9UID3 11 65089324-65111860 "Predicted intracellular proteins" "Lipid transport, Protein transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039650, HPA061447" Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoli "HPA039650: AB_10673147, HPA061447: AB_2684521" "unprognostic (2.36e-2)" "unprognostic (7.58e-2)" "unprognostic (8.35e-2)" "unprognostic (1.56e-1)" "unprognostic (2.11e-2)" "unprognostic (1.64e-1)" "unprognostic (9.72e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (2.03e-3)" "unprognostic (1.56e-1)" "prognostic favorable (2.41e-9)" "unprognostic (7.77e-3)" "unprognostic (4.63e-2)" "unprognostic (2.85e-1)" "unprognostic (2.18e-1)" 22.1 19.5 17.5 19.4 24.3 30.3 21.7 29.8 33.8 23.4 30.9 16.9 22.4 31.2 27.7 15.5 22.9 20.9 25.0 27.7 15.9 13.0 18.5 24.7 16.6 35.0 14.5 19.2 53.2 77.6 22.9 14.5 21.7 15.9 22.0 15.7 17.2 54.2 18.4 39.4 32.0 27.7 24.4 13.2 20.5 30.3 17.5 12.6 36.5 34.7 24.4 21.9 24.6 22.4 15.6 14.8 9.9 10.5 21.8 19.8 10.5 21.8 24.2 11.9 14.5 5.3 13.2 22.2 8.6 17.7 17.6 13.1 17.5 29.0 38.2 24.8 16.7 9.1 18.8 12.5 19.4 6.4 22.2 18.9 22.8 24.6 16.8 17.4 24.6 20.9 22.7 13.3 13.0 10.8 14.0 19.3 17.9 23.1 27.5 7.1 29.8 32.9 24.6 19.2 9.9 18.5 20.6 5.7 46.1 12.0 24.6 19.8 27.2 6.4 36.8 21.5 7.4 30.0 12.3 15.6 11.9 10.5 14.8 12.3 35.1 27.2 21.4 13.3 8.9 8.5 7.0 10.0 9.9 13.3 10.5 15.5 15.3 18.5 19.8 14.8 15.6 16.9 14.7 6.3 21.8 10.3 13.4 11.9 10.5 17.5 24.3 29.8 33.8 15.9 13.0 14.5 19.2 15.9 12.6 17.9 45.0 65.3 52.1 43.6 62.1 5.6 35.7 5.3 12.5 29.6 27.5 63.6 53.0 43.3 65.8 40.2 144.6 0.0 103.8 66.7 40.9 44.2 38.0 45.2 39.6 63.5 91.9 45.4 49.7 145.2 49.5 26.5 47.2 65.9 97.4 47.8 56.6 144.0 51.2 58.6 41.1 25.8 45.3 35.7 31.3 47.9 96.5 55.8 135.4 40.9 VSIG4 Z39IG ENSG00000155659 "V-set and immunoglobulin domain containing 4" Q9Y279 X 66021738-66040125 "Plasma proteins, Predicted membrane proteins" "Complement alternate pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 31 "Hofbauer cells: 772.9;Kupffer cells: 436.3;Macrophages: 389.0" "Cancer enhanced" "Detected in all" "glioma: 88.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 26 "classical monocyte: 13.9;intermediate monocyte: 8.1;myeloid DC: 13.1" "Group enriched" "Detected in many" 30 "dendritic cells: 13.1;monocytes: 13.9" "Cell line enhanced" "Detected in some" "BEWO: 1.2;HMC-1: 1.1;NB-4: 3.1;SH-SY5Y: 1.1;U-937: 2.7" "Low region specificity" "Detected in many" "HPA003903, CAB026000" Enhanced Uncertain "Nucleoli,Plasma membrane,Cytosol" NA NA 41000000 "Plasma membrane, Cytosol" Nucleoli "CAB026000: , HPA003903: AB_1858776" "unprognostic (6.87e-3)" "unprognostic (4.79e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (3.19e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (9.37e-3)" "unprognostic (1.24e-1)" "unprognostic (3.10e-1)" "unprognostic (1.37e-3)" "unprognostic (1.06e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (1.95e-6)" "unprognostic (3.70e-2)" "unprognostic (5.45e-2)" "unprognostic (3.37e-2)" "unprognostic (3.47e-2)" 67.1 28.1 15.9 17.6 16.6 2.6 19.0 1.8 10.4 6.3 18.0 5.6 1.0 9.2 6.1 14.2 9.3 28.7 15.5 15.9 11.5 3.5 18.5 22.9 61.4 37.0 17.9 3.4 8.2 8.2 3.7 7.9 52.4 12.0 10.9 12.6 8.1 11.3 4.0 10.5 4.0 14.6 39.9 16.7 28.5 9.4 13.5 17.8 0.0 10.7 1.7 1.8 14.4 9.0 0.1 13.1 0.4 13.9 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.0 0.0 0.1 3.1 0.2 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.8 2.7 0.0 0.0 13.9 0.0 0.0 8.1 0.0 0.0 0.0 0.2 13.1 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 3.3 15.9 16.6 1.8 10.1 11.5 3.5 17.9 3.4 12.0 17.8 3.0 17.3 3.0 0.1 2.1 0.0 0.8 7.6 8.1 5.7 0.0 0.0 4.4 0.0 0.0 5.8 1.9 0.0 0.0 0.0 3.7 3.8 0.2 3.5 2.4 772.9 0.0 0.0 5.5 436.3 13.2 1.4 389.0 3.3 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 6.5 0.2 0.2 0.9 1.5 10.3 0.0 0.0 0.2 VSTM5 "C11orf90, LOC387804" ENSG00000214376 "V-set and transmembrane domain containing 5" A8MXK1 11 93818232-93850531 "Predicted membrane proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 9.9;placenta: 10.7" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 16.9;Syncytiotrophoblasts: 4.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.3;OE19: 6.8;PC-3: 10.0;SH-SY5Y: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029525, HPA063591" Uncertain Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029525: AB_10600789, HPA063591: AB_2732704" "unprognostic (1.26e-1)" "unprognostic (4.48e-3)" "unprognostic (2.78e-1)" "unprognostic (1.54e-4)" "unprognostic (2.45e-2)" "unprognostic (9.91e-2)" "unprognostic (8.56e-2)" "unprognostic (1.37e-2)" "unprognostic (1.68e-2)" "unprognostic (1.04e-1)" "unprognostic (2.52e-2)" "unprognostic (2.13e-1)" "unprognostic (1.31e-1)" "unprognostic (3.53e-2)" "unprognostic (2.37e-1)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" 0.5 0.6 3.1 0.4 2.9 0.1 1.1 2.2 8.2 2.8 3.0 0.4 0.6 0.5 0.9 3.2 0.5 0.5 1.5 0.8 3.2 9.9 2.1 0.1 0.3 0.2 4.7 3.5 0.3 1.3 0.1 1.2 10.7 4.9 1.6 4.4 0.3 1.4 1.3 0.2 0.3 1.3 1.9 1.3 0.1 4.9 0.4 0.0 0.0 0.4 0.0 0.3 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.9 0.2 1.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 10.0 0.0 0.0 0.3 0.0 0.3 0.2 4.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.9 2.2 8.2 3.2 9.9 4.7 3.5 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.3 0.0 0.0 0.5 0.0 2.7 0.3 0.2 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.8 2.5 0.4 1.0 0.3 0.0 0.0 0.0 0.0 0.1 4.9 0.0 1.6 0.0 WAPL "FOE, KIAA0261, WAPAL" ENSG00000062650 "WAPL cohesin release factor" Q7Z5K2 10 86435256-86521815 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037874, HPA037875, HPA066141" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Mitotic spindle,Centrosome,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytokinetic bridge, Mitotic spindle, Centrosome, Cytosol" "HPA037874: AB_10697086, HPA037875: AB_10672396, HPA066141: " "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "unprognostic (3.03e-2)" "unprognostic (2.91e-2)" "unprognostic (6.63e-2)" "unprognostic (3.51e-1)" "unprognostic (3.94e-2)" "unprognostic (1.37e-1)" "unprognostic (2.25e-1)" "unprognostic (5.78e-2)" "unprognostic (5.56e-2)" "unprognostic (7.61e-2)" "unprognostic (1.14e-1)" "unprognostic (1.88e-1)" "unprognostic (4.56e-1)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" 15.3 15.4 16.0 15.5 16.9 19.8 15.6 23.6 15.0 13.4 14.0 12.1 6.8 12.5 16.0 8.7 20.4 12.6 11.2 13.3 15.3 8.2 14.5 23.1 17.5 19.3 14.8 11.5 14.8 13.6 18.1 18.2 19.0 13.4 13.9 13.1 9.4 14.9 10.6 34.4 20.4 16.0 16.0 16.4 18.2 13.5 28.1 16.4 39.2 15.9 9.4 22.4 15.1 15.9 5.2 6.2 14.3 8.7 3.9 7.7 3.1 20.2 9.5 16.7 22.0 13.3 14.2 14.7 17.8 22.0 15.2 16.6 20.6 17.9 30.8 12.1 15.9 13.4 19.1 18.9 15.3 23.4 20.0 12.4 18.6 15.2 22.6 15.2 37.6 21.5 11.1 17.9 19.4 32.7 17.3 16.9 18.0 19.5 18.6 17.3 17.3 23.4 14.1 14.8 12.7 9.6 16.7 13.5 12.2 13.1 18.0 6.5 12.6 15.7 10.6 19.3 17.3 23.2 20.1 16.2 14.6 17.4 12.8 23.3 18.3 25.4 32.6 13.4 26.9 10.3 14.3 4.7 9.4 4.7 5.3 7.0 5.2 6.3 6.5 6.2 4.8 7.2 5.7 7.3 3.9 8.7 4.7 7.7 3.1 16.0 16.9 23.6 15.0 15.3 8.2 14.8 11.5 13.4 16.4 77.4 51.5 21.9 40.4 0.0 47.2 0.0 12.7 25.4 38.7 15.7 19.6 36.2 18.3 52.5 61.6 29.2 15.6 70.0 46.0 25.0 22.4 50.1 23.3 41.2 35.6 52.4 17.5 28.8 48.6 27.3 29.7 49.5 0.0 56.9 31.7 45.3 46.8 37.1 30.4 26.7 127.3 64.7 0.0 125.1 82.8 0.0 63.6 38.9 32.2 54.7 WASHC2A "bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824" ENSG00000099290 "WASH complex subunit 2A" Q641Q2 10 50067888-50133506 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 35.7;Ciliated cells: 76.3;Club cells: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (2.46e-1)" "unprognostic (1.11e-3)" "unprognostic (8.82e-2)" "unprognostic (3.28e-1)" "unprognostic (2.75e-1)" "unprognostic (6.51e-3)" "prognostic unfavorable (6.75e-5)" "unprognostic (4.60e-2)" "unprognostic (2.85e-2)" "unprognostic (2.37e-2)" "unprognostic (9.04e-2)" "unprognostic (2.73e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-1)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (4.40e-2)" 24.0 21.0 15.8 31.4 19.3 24.7 27.1 22.5 18.3 19.1 21.2 16.2 12.6 19.4 22.8 15.3 15.7 15.5 14.4 42.9 17.6 13.9 26.1 12.1 20.7 20.2 15.3 15.8 22.5 14.0 21.2 27.0 17.7 22.0 16.7 23.0 13.1 17.5 16.5 15.5 19.2 21.3 16.8 14.6 27.4 16.2 9.4 14.8 27.0 21.4 9.8 20.2 18.4 27.4 6.6 9.0 11.7 13.9 9.0 12.5 8.8 11.1 5.4 9.2 10.8 37.6 21.0 7.5 13.1 27.8 19.5 20.8 12.5 16.7 9.8 8.2 19.5 18.3 12.2 13.3 11.0 19.3 9.4 9.7 7.0 10.8 12.5 26.2 11.9 12.2 21.6 13.9 21.3 13.5 20.5 14.7 8.4 11.3 9.9 23.4 7.9 6.5 19.5 7.5 7.1 25.5 10.0 13.4 5.8 13.4 12.8 3.2 9.9 12.2 11.3 17.4 14.2 14.0 8.2 21.5 10.0 8.4 28.1 10.7 10.3 20.3 8.4 21.9 21.9 4.0 1.2 10.7 11.7 12.0 13.9 12.5 6.6 10.2 11.0 9.0 6.5 10.2 7.4 5.1 9.0 8.2 5.3 10.4 8.8 15.8 19.3 22.5 18.3 17.6 13.9 15.3 15.8 22.0 14.8 35.7 22.0 0.0 0.0 0.0 0.0 0.0 0.0 76.3 42.1 14.0 0.0 6.6 0.0 14.2 0.0 0.0 0.0 0.0 13.5 5.7 0.0 0.0 14.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 10.0 0.0 0.0 12.2 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 WASHC2C "Em:AC012044.3, FAM21C, KIAA0592" ENSG00000172661 "WASH complex subunit 2C" Q9Y4E1 10 45727200-45792961 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 26.2;Ciliated cells: 45.5;Collecting duct cells: 22.7;granulocytes: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (7.50e-2)" "unprognostic (2.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-2)" "unprognostic (5.98e-3)" "prognostic unfavorable (1.35e-5)" "prognostic favorable (4.69e-4)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.00e-3)" "unprognostic (1.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-2)" 17.2 15.8 10.0 33.6 15.7 30.1 27.2 24.9 17.1 16.7 15.8 10.7 15.9 12.2 18.3 17.0 12.3 13.2 13.6 23.2 14.2 10.2 20.6 12.8 17.3 14.8 16.0 8.4 20.2 10.1 22.7 16.5 13.4 16.2 13.4 18.5 13.0 15.3 24.0 17.1 14.8 17.0 15.8 14.0 15.5 12.5 10.1 15.3 19.4 14.9 13.2 14.6 19.3 14.8 10.7 11.4 17.2 20.3 12.2 13.4 11.6 11.2 12.2 9.9 11.3 25.9 23.0 6.0 13.3 21.9 15.7 15.2 7.4 11.1 9.3 9.1 19.6 15.0 10.3 11.1 6.1 15.9 8.7 9.2 9.6 15.2 5.7 27.5 9.6 12.0 21.7 14.8 17.0 12.8 15.5 16.2 7.9 15.3 7.4 19.3 5.9 6.4 16.7 7.2 6.8 1.9 8.1 14.6 4.8 11.7 17.8 4.8 10.9 15.4 7.8 18.6 10.6 10.5 9.7 27.2 8.2 8.8 21.7 8.9 10.5 16.2 9.3 11.6 23.2 4.3 12.5 16.9 11.0 13.0 18.2 12.5 10.7 10.8 13.4 11.4 9.6 10.8 9.7 17.2 12.2 20.3 8.4 10.1 11.6 10.0 15.7 24.9 17.1 14.2 10.2 16.0 8.4 16.2 15.3 32.8 26.2 0.0 0.0 0.0 0.0 0.0 0.0 45.5 21.6 22.7 0.0 6.2 3.3 10.9 0.0 0.0 0.0 0.0 12.1 5.4 0.0 0.0 27.9 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 18.0 0.0 0.0 10.6 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 WBP4 "FBP21, MGC117310" ENSG00000120688 "WW domain binding protein 4" O75554 13 41061274-41084006 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038965, HPA058738" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA038965: AB_10672836, HPA058738: AB_2683803" "unprognostic (2.56e-1)" "unprognostic (3.69e-3)" "unprognostic (1.75e-1)" "unprognostic (1.99e-2)" "unprognostic (9.30e-2)" "unprognostic (1.76e-3)" "unprognostic (1.54e-2)" "unprognostic (2.13e-2)" "unprognostic (1.34e-2)" "unprognostic (2.05e-2)" "unprognostic (3.71e-3)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "unprognostic (8.52e-2)" "unprognostic (7.65e-3)" "prognostic favorable (2.89e-4)" "unprognostic (2.52e-1)" 14.0 14.2 17.2 7.9 22.1 11.4 11.5 15.8 17.2 12.0 10.7 8.6 8.9 9.6 16.6 14.1 10.9 10.1 8.0 18.8 14.7 15.8 10.5 13.4 8.7 9.0 14.7 19.0 11.8 7.5 8.8 11.3 15.9 15.9 12.5 8.0 4.8 7.2 13.2 76.2 9.4 9.6 14.7 15.0 7.9 8.1 10.0 12.8 12.7 9.6 12.6 9.3 13.3 11.1 10.9 15.2 22.7 16.2 9.7 12.9 5.0 8.9 5.9 16.5 10.6 10.9 16.6 10.1 20.3 14.3 16.0 12.3 9.3 9.6 12.8 8.2 14.2 19.6 12.6 6.2 10.1 20.6 13.2 8.8 18.0 5.8 9.4 16.7 11.2 11.8 13.6 15.5 11.6 16.5 13.3 13.4 12.4 9.6 5.7 16.7 7.5 16.0 12.3 10.0 13.9 4.9 15.1 10.2 5.0 14.5 8.8 3.8 9.2 6.4 7.0 9.5 14.0 5.7 17.6 11.8 10.1 9.2 13.8 11.6 3.8 4.1 8.9 12.4 8.2 13.6 13.0 11.0 9.7 9.3 9.6 8.5 10.9 11.8 9.9 8.9 10.6 12.9 12.6 22.7 9.7 16.2 15.2 11.3 5.0 17.2 22.1 15.8 17.2 14.7 15.8 14.7 19.0 15.9 12.8 47.6 24.8 31.2 52.4 48.3 47.0 92.8 28.1 20.1 28.4 24.4 31.4 49.2 64.6 45.6 4.7 45.0 27.6 116.8 36.7 51.6 45.6 38.5 45.0 61.4 36.2 42.9 36.4 33.7 22.5 5.0 44.3 37.8 30.4 80.2 20.9 62.1 40.8 34.5 49.5 46.9 43.4 25.8 50.5 63.7 97.3 39.3 41.8 21.3 24.9 37.1 WDFY3 "ALFY, KIAA0993, ZFYVE25" ENSG00000163625 "WD repeat and FYVE domain containing 3" Q8IZQ1 4 84669610-84966391 "Disease related genes, Predicted intracellular proteins" Autophagy "Developmental protein" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.3" "Group enriched" "Detected in many" 23 "dendritic cells: 1.1;granulocytes: 4.3;monocytes: 1.5" "Cell line enhanced" "Detected in many" "TIME: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042734, HPA048572" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoli, Plasma membrane" "HPA042734: AB_2678135, HPA048572: AB_2680447" "unprognostic (7.14e-2)" "unprognostic (6.02e-2)" "unprognostic (7.68e-2)" "unprognostic (1.60e-1)" "unprognostic (1.84e-2)" "unprognostic (2.48e-1)" "unprognostic (2.86e-2)" "unprognostic (3.36e-1)" "unprognostic (1.01e-1)" "unprognostic (4.33e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "prognostic favorable (3.64e-5)" "prognostic unfavorable (9.35e-4)" "unprognostic (2.79e-1)" "unprognostic (4.41e-2)" "unprognostic (4.95e-2)" 10.1 15.2 17.2 7.5 18.7 13.1 9.0 17.9 18.6 9.6 8.3 17.6 4.8 3.6 11.5 6.9 9.4 9.3 9.0 7.3 17.3 6.5 21.3 5.8 7.9 2.4 22.8 9.5 14.7 9.0 24.0 14.6 11.8 17.0 9.2 5.9 8.6 9.8 8.1 13.7 10.9 5.6 8.7 14.8 7.5 7.8 8.0 21.4 0.4 12.1 3.2 2.6 14.2 6.6 0.0 1.1 4.3 1.5 0.0 0.0 0.3 6.5 4.5 8.1 4.5 14.5 11.4 5.1 6.3 6.7 6.6 6.0 5.0 5.4 0.0 6.5 10.4 7.0 3.3 8.7 6.9 8.4 4.5 2.7 4.1 4.9 3.0 5.5 3.2 7.8 8.3 6.3 8.6 8.7 8.0 20.9 3.4 4.1 20.0 12.0 4.7 3.1 0.7 4.2 6.3 2.2 4.6 6.5 0.9 11.4 8.6 9.6 4.5 7.7 8.6 4.3 8.1 4.4 8.0 31.7 8.7 8.7 4.8 7.9 0.0 0.0 0.0 5.9 2.8 9.5 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.3 0.0 0.5 0.0 0.0 0.3 17.2 18.7 17.9 18.6 17.3 6.5 22.8 9.5 17.0 21.4 17.9 11.7 1.5 8.3 13.1 41.7 15.5 15.3 10.7 12.5 15.7 33.4 9.5 1.7 8.5 6.7 16.9 4.6 0.0 6.2 5.5 12.3 13.0 0.0 7.6 17.1 27.0 8.7 22.1 39.6 7.7 17.0 17.4 6.8 5.4 7.0 26.8 8.9 5.8 23.0 14.9 41.9 25.8 15.6 7.4 7.8 14.1 12.1 0.5 6.6 10.0 WDR45 "JM5, NBIA5, WDRX1, WIPI4" ENSG00000196998 "WD repeat domain 45" Q9Y484 X 49071470-49101170 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 124.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027562 Uncertain Uncertain "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA027562: AB_10610565" "unprognostic (1.39e-1)" "prognostic favorable (1.21e-4)" "unprognostic (1.82e-2)" "unprognostic (1.33e-1)" "unprognostic (2.32e-1)" "prognostic favorable (1.61e-4)" "unprognostic (4.30e-2)" "unprognostic (6.66e-3)" "unprognostic (7.12e-2)" "unprognostic (3.57e-1)" "unprognostic (3.22e-2)" "unprognostic (1.77e-1)" "unprognostic (5.06e-3)" "unprognostic (2.85e-1)" "unprognostic (5.27e-1)" "unprognostic (3.60e-2)" "unprognostic (1.11e-3)" 21.2 30.3 16.7 13.5 22.6 21.4 20.3 16.1 29.8 19.4 20.7 16.6 30.6 16.2 21.1 124.8 16.5 18.1 21.9 28.6 16.4 15.1 24.6 34.4 17.1 18.4 19.1 12.7 20.7 23.7 26.3 17.6 28.4 17.0 18.6 12.3 20.0 28.2 26.6 40.7 17.9 16.8 15.1 12.2 18.2 21.5 7.6 13.6 18.8 32.4 24.5 17.1 20.5 16.4 19.8 27.1 44.0 36.0 32.4 25.5 26.4 12.6 14.8 8.5 8.6 18.7 24.2 16.5 13.9 28.9 11.0 15.5 7.7 18.6 8.8 8.0 27.7 14.1 11.1 12.9 11.3 8.0 9.9 21.8 5.4 27.1 11.7 42.8 4.2 12.7 21.4 20.0 18.1 19.4 17.7 11.0 8.5 11.4 16.0 14.4 14.1 8.8 10.7 8.6 5.6 12.9 7.2 12.5 29.3 19.5 11.6 11.3 16.7 17.9 13.7 42.2 11.7 8.7 15.6 15.1 12.0 10.9 23.9 5.8 24.5 16.5 6.3 22.3 6.9 8.7 44.0 36.0 31.5 23.1 32.1 22.8 19.8 17.6 21.8 26.7 18.6 14.0 15.9 36.5 32.4 35.4 27.1 25.5 26.4 16.7 22.6 16.1 29.8 16.4 15.1 19.1 12.7 17.0 13.6 29.8 38.3 23.8 41.6 41.3 15.9 30.3 35.7 13.4 34.2 33.2 11.8 27.4 48.0 57.6 0.8 29.2 33.3 23.3 86.2 44.8 53.1 51.2 26.5 44.8 37.4 25.4 27.6 31.3 37.3 1.5 37.4 39.7 33.7 92.0 30.1 29.0 88.8 30.2 30.4 90.2 20.8 19.4 45.3 1.8 2.5 41.4 51.9 42.6 24.2 58.5 WDR66 "CaM-IP4, MGC33630" ENSG00000158023 "WD repeat domain 66" Q8TBY9 12 121917862-122003927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.6;pituitary gland: 28.4;testis: 35.0" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 228.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 4.9" "Lineage enriched" "Detected in single" 10 "dendritic cells: 4.9" "Cell line enhanced" "Detected in some" "HBEC3-KT: 21.9;hTCEpi: 20.7;hTERT-HME1: 14.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039902, HPA040005" Supported Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039902: AB_10795236, HPA040005: AB_10795160" "unprognostic (4.92e-3)" "unprognostic (9.05e-2)" "unprognostic (7.99e-3)" "prognostic favorable (3.11e-4)" "unprognostic (5.58e-3)" "unprognostic (6.89e-3)" "unprognostic (1.44e-2)" "unprognostic (2.45e-1)" "unprognostic (2.89e-1)" "unprognostic (2.34e-1)" "unprognostic (7.72e-2)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "unprognostic (4.29e-2)" "unprognostic (1.37e-1)" "unprognostic (1.79e-2)" "unprognostic (1.35e-1)" 1.3 1.2 6.3 1.0 13.2 0.4 1.7 0.4 4.0 4.4 0.5 4.5 1.5 0.4 2.5 11.3 0.5 24.6 2.0 1.5 6.4 3.7 3.2 1.8 6.4 0.9 0.7 3.2 3.9 2.1 4.7 28.4 1.3 18.0 0.8 0.4 1.3 1.3 2.2 0.5 1.8 0.5 1.0 0.9 2.0 0.8 35.0 2.4 0.0 6.7 0.0 1.2 0.8 1.7 0.2 4.9 0.4 0.0 0.1 0.3 0.0 1.8 0.2 0.3 0.1 0.3 0.3 0.3 0.2 1.7 0.8 2.1 0.2 0.9 0.1 2.5 0.1 0.5 0.6 0.2 21.9 3.1 0.1 0.3 0.1 0.4 0.2 2.6 0.0 6.0 1.2 20.7 1.7 14.0 0.4 0.9 0.3 5.0 0.0 1.3 0.6 0.2 0.4 0.3 0.3 0.1 0.3 0.5 0.0 3.8 0.3 1.7 0.1 0.2 0.0 0.1 0.6 0.5 0.1 0.7 1.8 2.7 0.3 0.3 0.3 0.1 2.6 2.0 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.4 0.1 0.0 4.9 0.3 0.0 6.3 13.2 0.4 4.0 6.4 3.7 0.7 3.2 18.0 2.4 6.0 10.0 1.5 5.9 5.5 5.0 2.2 5.1 228.8 36.4 10.4 29.5 0.2 3.3 3.1 38.6 1.3 0.0 0.0 0.4 0.1 1.9 1.9 8.1 0.8 0.5 7.9 1.7 28.3 2.2 49.3 6.9 1.8 1.7 1.0 0.0 1.8 0.7 0.0 7.1 1.1 16.8 6.5 1.0 34.9 14.4 3.1 0.5 0.8 0.0 2.2 WDR93 ENSG00000140527 "WD repeat domain 93" Q6P2C0 15 89690797-89743638 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 12.0;testis: 28.6" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 58.9;Cone photoreceptor cells: 19.6;Early spermatids: 41.0;Late spermatids: 27.2;Spermatocytes: 24.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA046196, HPA048112" Uncertain Uncertain "Actin filaments" NA NA "Actin filaments" "HPA046196: AB_2679582, HPA048112: AB_2680267" "unprognostic (2.56e-3)" "unprognostic (3.21e-3)" "unprognostic (7.31e-2)" "unprognostic (1.54e-2)" "unprognostic (1.90e-2)" "unprognostic (3.01e-1)" "unprognostic (1.15e-2)" "unprognostic (2.08e-2)" "unprognostic (1.22e-2)" "unprognostic (7.40e-2)" "unprognostic (3.03e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (2.40e-2)" "unprognostic (4.73e-2)" "unprognostic (9.84e-2)" "unprognostic (4.44e-2)" 0.5 0.3 1.2 0.7 2.3 0.8 1.1 1.1 1.4 1.2 0.2 3.7 0.0 0.0 0.6 8.0 0.1 12.0 0.3 1.6 1.6 1.6 2.5 0.2 1.3 0.3 0.3 0.4 1.7 0.8 0.4 3.0 0.2 6.2 0.9 0.2 2.5 1.1 1.9 0.3 0.4 0.2 0.0 0.5 0.3 0.2 28.6 1.2 0.1 3.3 0.0 0.2 0.2 0.1 0.5 1.1 2.2 0.3 1.3 0.6 0.2 1.1 1.0 0.1 0.5 1.3 1.0 1.5 1.0 0.5 1.2 0.7 0.5 2.8 0.6 1.1 0.7 0.4 0.7 0.1 0.8 1.9 1.3 0.8 0.8 1.3 0.6 1.8 1.1 0.2 1.6 2.0 0.4 0.1 0.5 0.3 1.1 0.1 0.9 0.9 1.0 1.0 0.5 1.5 0.4 0.6 0.4 0.4 0.4 2.7 0.6 3.4 0.8 2.8 0.8 3.7 0.9 0.5 1.8 0.0 1.0 0.8 1.6 0.6 0.5 0.9 0.9 1.2 0.4 0.7 1.2 0.3 0.4 0.5 0.3 0.2 0.2 0.3 0.2 0.3 0.5 0.3 0.6 2.2 1.3 0.2 1.1 0.2 0.2 1.2 2.3 1.1 1.4 1.6 1.6 0.3 0.4 6.2 1.2 3.0 0.3 0.0 0.5 0.2 3.0 0.3 0.0 58.9 5.7 8.7 19.6 0.3 3.3 0.7 41.0 0.0 0.0 0.0 0.2 0.2 0.2 0.7 0.0 0.0 0.2 3.2 0.0 0.6 0.8 27.2 1.4 0.7 1.7 1.0 0.0 0.6 0.2 0.0 0.7 1.3 14.9 0.0 0.1 24.5 5.9 0.1 0.2 0.7 0.0 0.2 WEE2 FLJ16107 ENSG00000214102 "WEE1 homolog 2" P0C1S8 7 141708353-141731271 "Enzymes, Predicted intracellular proteins" Meiosis "Kinase, Transferase, Tyrosine-protein kinase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 21 "Distal tubular cells: 1.7;Proximal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CACO-2: 8.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA027418, HPA054280" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027418: AB_10603144, HPA054280: " "unprognostic (6.35e-2)" "unprognostic (1.47e-1)" "unprognostic (1.89e-1)" "unprognostic (3.18e-1)" "unprognostic (2.33e-1)" "unprognostic (4.00e-2)" "unprognostic (2.90e-1)" "unprognostic (1.97e-2)" "unprognostic (3.23e-2)" "unprognostic (3.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.76e-2)" "unprognostic (1.73e-1)" "unprognostic (3.25e-2)" "unprognostic (2.66e-1)" "unprognostic (6.07e-2)" "unprognostic (2.88e-3)" 0.6 0.1 0.5 0.3 1.0 0.0 0.4 0.8 0.6 0.6 0.1 0.0 0.7 0.0 1.3 0.7 1.6 1.3 0.5 0.6 1.3 0.1 0.3 1.6 0.6 1.2 1.1 0.0 1.0 0.0 0.3 0.0 0.9 0.0 0.7 2.8 0.4 0.0 0.8 0.4 0.8 1.3 2.0 0.0 0.5 0.3 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.2 0.4 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.4 0.1 0.1 0.0 0.3 1.0 0.3 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.3 0.5 1.6 1.2 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.0 0.2 0.1 1.7 1.1 0.5 0.0 0.4 0.7 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.4 0.6 0.0 0.1 0.1 0.6 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WIPF3 "CR16, FLJ36931" ENSG00000122574 "WAS/WASL interacting protein family member 3" A6NGB9 7 29806486-29917066 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6;ovary: 44.7" "Group enriched" "Detected in many" 8 "Leydig cells: 46.9;Peritubular cells: 94.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 18.5;HEK 293: 4.1;K-562: 6.3;NTERA-2: 5.2;RPMI-8226: 11.1;SK-MEL-30: 4.5" "Region enhanced" "Detected in many" "hippocampal formation: 234.6" "HPA041145, HPA041211" Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA041145: AB_10795001, HPA041211: AB_10795003" "prognostic favorable (7.93e-4)" "unprognostic (1.35e-1)" "unprognostic (1.37e-3)" "unprognostic (2.12e-3)" "unprognostic (3.65e-3)" "unprognostic (1.53e-1)" "unprognostic (8.95e-3)" "unprognostic (4.53e-2)" "unprognostic (3.49e-1)" "unprognostic (1.19e-2)" "unprognostic (1.08e-2)" "unprognostic (7.49e-2)" "unprognostic (1.61e-2)" "unprognostic (1.35e-1)" "unprognostic (2.27e-2)" "unprognostic (3.33e-2)" "unprognostic (1.41e-1)" 1.8 6.6 13.4 1.6 40.6 1.1 1.9 5.5 15.1 1.2 1.4 3.8 1.0 3.6 4.2 21.8 2.1 9.9 3.5 4.6 30.0 5.1 3.3 1.3 1.3 1.4 4.0 12.1 44.7 2.4 1.6 5.6 1.0 1.5 5.5 1.3 0.8 4.5 5.9 23.0 1.7 3.5 5.2 1.7 1.7 6.3 27.6 7.8 0.0 2.8 2.9 2.3 3.2 0.8 0.8 2.1 2.6 1.2 0.9 1.3 0.2 0.3 1.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.2 0.0 18.5 0.0 0.0 0.0 4.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 6.3 0.1 0.0 0.1 0.0 0.1 5.2 0.0 3.6 0.0 0.0 11.1 0.0 0.0 1.8 1.6 0.1 0.1 4.5 2.6 0.4 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.6 0.5 0.9 0.3 0.7 0.6 0.7 0.9 0.3 0.3 0.8 1.3 0.8 1.2 0.9 1.2 2.1 0.5 0.2 13.4 40.6 5.5 15.1 30.0 5.1 4.0 12.1 1.5 7.8 0.0 0.0 0.0 1.3 1.9 4.9 8.9 0.0 8.1 2.3 3.5 2.0 0.0 3.3 3.7 1.3 1.1 1.3 0.0 3.1 0.1 0.9 1.1 0.0 0.4 4.7 4.8 1.7 0.6 0.0 3.0 46.9 0.0 5.0 0.0 0.5 5.4 2.3 0.8 94.4 3.5 2.7 6.5 2.1 0.5 3.0 0.4 0.0 0.0 1.9 0.3 WSCD2 KIAA0789 ENSG00000075035 "WSC domain containing 2" Q2TBF2 12 108129471-108250537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;seminal vesicle: 18.2;thyroid gland: 21.8" "Group enriched" "Detected in some" 10 "Bipolar cells: 35.7;Horizontal cells: 20.6" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.6" "Region enhanced" "Detected in all" "cerebellum: 44.0" "Cell type enhanced" "Detected in single" "T-reg: 2.5" "Lineage enhanced" "Detected in single" "T-cells: 2.5" "Cell line enriched" "Detected in some" 21 "RT4: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013346, HPA048133" Approved Uncertain Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA013346: AB_1858865, HPA048133: AB_2797236" "unprognostic (1.50e-1)" "unprognostic (1.64e-3)" "unprognostic (1.50e-2)" "unprognostic (4.27e-3)" "unprognostic (1.68e-1)" "unprognostic (3.43e-1)" "unprognostic (1.80e-2)" "unprognostic (3.43e-3)" "unprognostic (3.03e-2)" "unprognostic (3.05e-1)" "unprognostic (3.15e-1)" "unprognostic (7.43e-2)" "unprognostic (5.99e-2)" "unprognostic (3.73e-2)" "unprognostic (2.11e-1)" "unprognostic (2.32e-3)" "unprognostic (7.62e-3)" 1.4 1.2 6.5 0.5 12.5 0.4 1.0 44.0 15.2 5.4 1.7 1.6 0.0 0.7 6.9 3.0 3.8 2.0 0.5 0.5 10.0 3.0 1.3 0.4 0.8 0.5 1.3 6.0 0.6 2.1 0.4 0.9 0.6 1.9 6.0 0.7 9.9 0.5 18.2 0.5 0.6 0.9 9.2 1.5 0.5 2.0 0.6 2.0 0.0 21.8 0.2 0.5 3.0 0.9 0.8 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 6.5 12.5 44.0 15.2 10.0 3.0 1.3 6.0 1.9 2.0 0.0 0.0 0.5 0.0 0.1 35.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.6 0.0 1.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 XDH "XO, XOR" ENSG00000158125 "Xanthine dehydrogenase" P47989 2 31334321-31414715 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 78.6;liver: 32.5" "Group enriched" "Detected in many" 5 "Enterocytes: 95.3;Hepatocytes: 35.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 6.2;HBEC3-KT: 15.3;hTERT-HME1: 24.5;U-251 MG: 6.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA062641, HPA069323" Supported Uncertain Nucleoplasm,Nucleoli "Intracellular and membrane" No No Nucleoplasm Nucleoli "HPA062641: AB_2684816, HPA069323: AB_2686121" "unprognostic (8.58e-2)" "unprognostic (4.07e-2)" "unprognostic (1.34e-2)" "unprognostic (1.79e-1)" "unprognostic (2.08e-2)" "unprognostic (7.06e-2)" "unprognostic (4.38e-3)" "unprognostic (7.48e-3)" "unprognostic (3.55e-1)" "unprognostic (3.60e-2)" "unprognostic (3.95e-3)" "unprognostic (3.51e-2)" "unprognostic (1.24e-6)" "unprognostic (2.25e-1)" "unprognostic (5.25e-2)" "unprognostic (2.54e-1)" "prognostic favorable (8.73e-6)" 0.2 0.2 0.2 2.4 0.2 0.0 17.8 0.2 0.2 2.6 17.9 0.1 0.0 20.1 0.3 6.3 9.3 0.2 1.8 0.2 0.1 0.2 0.4 32.5 0.2 0.0 0.2 0.0 0.2 0.4 0.0 1.5 3.7 0.1 1.2 4.2 0.1 20.9 0.0 0.7 1.0 78.6 0.1 0.2 0.2 1.3 0.2 0.0 0.2 0.3 2.4 6.1 1.8 1.1 0.7 0.3 1.0 0.6 0.7 0.5 0.0 1.5 0.3 0.0 0.0 0.0 0.1 0.1 6.2 3.6 0.7 1.1 0.2 1.7 0.0 1.2 0.2 0.6 3.2 0.0 15.3 0.8 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.4 0.9 24.5 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.3 0.9 0.1 0.0 1.1 3.3 4.5 3.9 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 3.0 1.9 0.1 6.7 2.0 0.1 0.0 0.2 0.0 0.0 0.5 0.6 0.2 0.2 0.2 0.4 0.1 0.3 0.3 0.0 0.7 0.2 0.5 1.0 0.7 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.0 0.1 0.0 0.0 3.7 0.0 2.6 0.5 0.3 0.3 2.5 0.0 2.3 0.0 0.0 0.1 0.0 2.4 0.2 0.0 95.3 0.0 7.2 0.5 0.0 0.5 0.0 35.8 0.0 0.0 11.3 1.8 1.6 0.0 0.0 0.0 0.0 0.0 5.2 0.1 8.8 7.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.1 0.3 0.0 12.8 14.2 XIRP2 CMYA3 ENSG00000163092 "Xin actin binding repeat containing 2" A4UGR9 2 166888487-167259753 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 292.8" "Cell type enriched" "Detected in some" 66 "Cardiomyocytes: 1858.5" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;HEL: 1.5;HUVEC TERT2: 8.7;U-2197: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034813, HPA074599" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA034813: AB_10602588, HPA074599: " "unprognostic (5.27e-4)" "unprognostic (5.96e-3)" "unprognostic (7.42e-2)" "unprognostic (2.42e-1)" "unprognostic (1.74e-1)" "unprognostic (2.56e-1)" 7.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.3 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 4.3 0.0 292.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 2.3 51.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.2 0.2 0.0 0.0 0.9 0.0 0.2 0.7 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1858.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 YARS2 "CGI-04, FLJ13995, mt-TyrRS" ENSG00000139131 "Tyrosyl-tRNA synthetase 2" Q9Y2Z4 12 32727490-32755902 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038721, HPA057610, HPA074097" Uncertain Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA038721: AB_10674837, HPA057610: AB_2683483, HPA074097: AB_2686660" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (2.30e-3)" "unprognostic (1.02e-2)" "unprognostic (2.12e-1)" "unprognostic (5.99e-3)" "prognostic unfavorable (3.19e-5)" "unprognostic (1.41e-2)" "unprognostic (4.98e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-2)" "unprognostic (8.39e-2)" "unprognostic (7.45e-2)" "unprognostic (1.99e-1)" "unprognostic (4.71e-1)" "unprognostic (4.07e-1)" "unprognostic (2.09e-1)" 12.6 15.8 11.0 12.6 15.3 13.9 13.8 11.6 14.9 13.1 11.8 11.5 18.4 9.8 13.3 12.9 17.5 11.3 9.1 12.1 11.9 9.7 12.4 16.3 9.2 15.5 10.8 11.7 13.3 21.0 11.0 16.6 15.9 13.5 12.9 13.7 11.3 17.4 10.0 15.9 12.0 10.8 11.1 12.6 13.3 12.3 12.5 12.6 17.5 12.3 16.0 16.4 13.3 11.8 11.8 9.5 9.4 9.9 12.9 12.7 5.2 9.4 11.4 6.7 7.9 7.3 8.6 21.0 7.2 7.4 9.0 8.8 28.5 12.1 17.1 11.9 7.3 13.0 12.3 13.2 19.1 10.2 7.4 20.7 11.3 8.6 15.8 10.6 12.0 6.6 8.0 12.2 8.5 15.5 11.6 14.2 9.1 15.9 7.9 9.4 7.7 8.9 14.5 36.6 6.3 14.0 10.1 14.2 10.1 11.4 13.6 10.3 5.0 11.1 9.7 7.1 27.1 18.1 10.9 9.5 8.5 9.0 13.8 12.2 4.7 5.0 17.8 7.9 9.0 7.0 9.4 7.0 4.1 10.1 8.9 10.6 8.8 10.7 10.4 9.5 11.8 11.2 12.7 1.4 12.9 9.9 9.3 9.3 5.2 11.0 15.3 11.6 14.9 11.9 9.7 10.8 11.7 13.5 12.6 6.0 4.1 13.7 17.3 9.0 16.5 6.9 2.5 5.3 7.9 10.4 19.6 29.4 6.6 17.0 4.4 5.7 5.2 23.3 14.2 29.0 10.7 7.9 6.9 4.5 17.9 14.3 6.9 5.5 7.0 2.8 9.8 5.5 5.0 19.0 6.6 11.6 12.2 10.4 8.1 9.3 18.8 12.9 6.2 4.9 14.7 7.3 15.0 12.1 11.5 11.4 YIPF1 "DJ167A19.1, FinGER1" ENSG00000058799 "Yip1 domain family member 1" Q9Y548 1 53851719-53889834 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014716, HPA073931" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA014716: AB_1847686, HPA073931: " "unprognostic (4.94e-2)" "unprognostic (4.50e-1)" "unprognostic (6.37e-2)" "unprognostic (2.06e-2)" "unprognostic (3.93e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.34e-4)" "unprognostic (1.96e-1)" "unprognostic (6.64e-2)" "unprognostic (2.34e-1)" "unprognostic (1.49e-1)" "unprognostic (2.76e-1)" "unprognostic (1.24e-2)" "unprognostic (7.75e-3)" "unprognostic (2.38e-1)" "unprognostic (5.39e-3)" "unprognostic (6.35e-1)" 10.1 15.6 12.8 9.1 13.9 8.0 18.2 6.9 12.8 11.2 12.1 8.8 11.5 11.0 6.6 12.2 14.0 10.2 10.8 13.4 10.6 12.1 16.1 31.8 11.9 14.1 12.4 9.1 11.8 13.7 7.2 15.5 15.4 14.4 17.8 14.4 10.2 17.1 14.3 18.7 13.9 10.6 9.4 10.6 13.3 13.0 10.8 11.1 10.3 33.5 9.8 15.7 12.9 16.2 8.1 11.4 26.7 14.5 6.9 16.0 10.2 6.9 4.2 6.7 4.7 7.9 8.9 6.0 5.0 7.9 9.3 12.2 4.8 2.1 2.3 8.5 6.0 14.3 8.3 8.8 11.1 9.6 17.6 7.0 5.8 4.7 7.2 10.9 6.4 5.5 8.9 10.5 7.4 9.0 7.9 10.0 8.7 6.0 6.7 9.0 5.9 6.5 9.3 4.9 8.2 7.0 4.1 6.3 9.9 7.9 3.6 3.0 3.8 4.7 9.0 23.0 22.1 13.9 7.2 4.5 3.8 3.9 6.7 4.3 13.5 15.4 4.3 5.8 5.3 3.3 12.5 12.5 13.2 8.5 11.3 8.0 8.1 7.3 8.5 11.4 7.7 7.1 6.7 26.7 6.9 14.5 7.8 16.0 10.2 12.8 13.9 6.9 12.8 10.6 12.1 12.4 9.1 14.4 11.1 6.0 13.0 10.7 15.1 7.6 6.5 8.5 28.1 14.7 15.9 8.7 0.0 65.7 10.0 23.6 22.9 8.7 11.7 0.0 28.3 23.0 8.3 37.4 9.2 17.4 34.5 9.5 9.2 13.5 19.9 41.4 5.5 15.8 10.1 16.2 23.0 16.2 25.6 12.9 8.9 13.5 5.4 0.0 6.2 12.7 18.3 9.5 108.4 13.8 9.5 22.0 YME1L1 ENSG00000136758 "YME1 like 1 ATPase" Q96TA2 10 27110112-27155266 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066953 Approved Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA066953: AB_2685753" "unprognostic (2.28e-3)" "unprognostic (3.00e-2)" "unprognostic (1.34e-1)" "unprognostic (7.19e-2)" "unprognostic (8.12e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (8.25e-6)" "unprognostic (7.08e-2)" "unprognostic (2.91e-1)" "unprognostic (9.24e-2)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (1.44e-2)" "unprognostic (7.09e-2)" 27.8 37.3 22.7 25.0 26.2 41.4 39.2 27.8 27.5 27.6 24.3 15.7 29.8 22.3 29.9 35.9 34.5 25.3 24.4 34.1 23.4 21.5 26.8 45.4 26.9 38.7 19.3 25.5 32.5 33.8 27.8 28.6 33.4 22.0 25.9 26.3 23.3 28.1 31.3 79.0 26.8 25.3 34.6 20.2 26.5 24.7 24.7 20.9 41.7 30.9 32.0 28.9 36.4 28.9 55.6 79.2 73.9 53.0 45.5 56.0 45.9 40.9 30.8 36.8 18.2 36.2 38.9 30.1 40.5 23.7 41.5 47.7 41.5 50.4 43.6 26.9 44.6 29.8 39.6 44.2 35.7 45.9 39.6 26.5 41.5 27.4 29.1 39.7 28.3 34.1 31.9 42.3 36.2 36.7 36.7 43.4 39.9 48.1 44.5 45.8 27.7 52.3 16.4 29.2 34.2 14.4 45.3 59.1 40.4 33.9 19.5 28.4 36.4 40.4 31.4 40.5 31.8 30.1 35.5 42.5 25.2 35.2 42.2 36.2 22.4 32.8 55.8 35.8 52.6 19.2 53.0 53.0 55.2 55.3 44.8 56.0 51.4 53.8 51.2 42.6 55.6 49.7 51.9 73.9 45.5 47.3 79.2 52.6 45.9 22.7 26.2 27.8 27.5 23.4 21.5 19.3 25.5 22.0 20.9 62.5 66.8 93.1 70.6 62.3 52.1 93.2 25.5 80.3 70.5 27.9 78.5 53.8 13.3 45.6 37.7 61.8 166.4 0.0 41.6 60.0 62.5 67.3 107.5 64.8 64.5 47.7 48.2 55.3 92.4 21.3 53.5 112.2 54.0 43.3 68.3 59.1 53.7 84.2 40.7 38.2 67.9 71.1 75.6 83.7 30.3 56.8 79.3 84.7 70.3 58.6 YWHAB YWHAA ENSG00000166913 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta" P31946 20 44885676-44908532 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003759, HPA007925, HPA011212, HPA061603" Enhanced Supported "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 210000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB003759: AB_289588, HPA007925: AB_1844340, HPA011212: AB_1844334, HPA061603: " "prognostic unfavorable (9.18e-4)" "unprognostic (1.48e-1)" "unprognostic (9.06e-2)" "prognostic unfavorable (5.46e-4)" "unprognostic (3.80e-1)" "prognostic unfavorable (6.14e-4)" "prognostic unfavorable (1.91e-6)" "prognostic unfavorable (6.01e-4)" "unprognostic (8.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.53e-2)" "unprognostic (2.35e-1)" "prognostic favorable (2.52e-5)" "unprognostic (6.72e-2)" "unprognostic (2.40e-1)" "unprognostic (6.60e-3)" "unprognostic (8.59e-2)" 39.3 38.6 65.5 39.4 79.2 28.6 33.0 60.1 87.9 34.0 47.5 27.7 28.7 37.9 35.2 26.4 48.1 30.2 29.6 40.3 68.7 63.4 47.3 36.5 37.4 46.8 49.8 76.2 25.8 18.9 41.1 18.4 36.7 50.1 31.4 53.4 22.9 30.7 43.2 28.3 38.4 39.3 43.3 38.4 53.7 36.7 16.8 33.6 48.2 36.1 31.8 60.2 41.2 34.9 30.9 41.9 37.3 58.4 26.8 43.5 26.6 52.4 39.8 32.1 30.7 53.4 47.3 43.5 47.8 46.6 58.9 51.7 82.8 59.4 56.0 50.1 63.1 64.1 55.9 45.2 88.8 70.5 21.4 27.6 41.7 35.0 49.1 35.4 67.5 40.4 36.9 66.5 46.1 59.6 40.4 58.9 34.5 44.9 27.1 60.4 62.0 52.7 55.6 30.3 60.2 61.9 41.4 46.5 43.5 63.1 58.7 34.3 36.6 81.0 86.6 55.7 39.1 63.0 65.0 66.8 91.6 47.0 51.6 48.6 18.1 33.0 51.4 66.9 45.2 46.5 34.8 40.1 34.4 29.7 52.2 30.2 30.9 37.7 36.3 41.9 28.6 30.8 36.6 37.3 26.8 58.4 26.5 43.5 26.6 65.5 79.2 60.1 87.9 68.7 63.4 49.8 76.2 50.1 33.6 235.2 267.7 257.8 195.0 245.8 236.2 168.2 214.0 242.2 213.9 235.5 47.1 316.7 195.6 394.2 12.6 314.4 343.6 0.0 427.4 513.3 214.8 235.2 219.7 140.9 363.9 276.5 286.2 292.8 365.8 16.1 174.9 402.5 210.9 466.1 277.5 222.2 471.9 382.0 197.7 259.3 98.3 226.4 208.3 50.5 174.0 284.4 444.3 286.3 279.8 359.2 YWHAQ "14-3-3, HS1" ENSG00000134308 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta" P27348 2 9583972-9631014 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007925, CAB010286, HPA061603" Approved Supported "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 120000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB010286: AB_2218221, HPA007925: AB_1844340, HPA061603: " "unprognostic (2.65e-2)" "unprognostic (3.99e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (1.53e-1)" "unprognostic (5.78e-3)" "prognostic unfavorable (9.83e-6)" "unprognostic (4.90e-3)" "unprognostic (2.98e-2)" "unprognostic (5.51e-2)" "unprognostic (6.18e-2)" "unprognostic (1.45e-1)" "unprognostic (2.95e-2)" "unprognostic (6.74e-2)" "unprognostic (9.75e-2)" "unprognostic (1.63e-1)" "unprognostic (4.39e-3)" 40.5 47.3 77.8 32.1 60.8 48.0 50.8 88.5 82.5 52.2 44.0 82.5 25.0 37.9 60.5 48.2 57.6 45.3 40.0 68.5 73.7 76.2 45.9 37.2 35.0 38.2 74.3 54.8 55.9 64.4 39.2 39.0 39.3 69.8 54.2 44.1 31.2 38.9 48.8 17.6 33.3 36.5 57.9 72.2 29.8 36.9 44.3 63.5 58.8 45.4 56.7 43.3 47.7 46.3 31.5 30.9 24.8 28.9 51.4 58.4 60.9 43.6 65.8 59.7 57.5 47.0 65.1 56.1 59.9 59.1 63.0 52.9 49.4 38.4 56.5 31.3 85.8 65.8 41.1 66.2 65.3 81.4 139.0 53.8 52.8 42.9 52.8 35.9 50.8 32.0 43.9 38.5 68.7 44.9 57.7 70.6 40.7 51.8 34.1 77.3 30.3 89.9 51.9 101.2 49.2 75.8 65.8 77.4 69.1 69.4 39.1 56.8 96.2 54.5 56.6 43.3 52.3 35.2 26.2 64.3 79.2 56.1 68.5 91.3 34.9 47.7 74.5 67.7 53.1 65.6 17.1 22.2 24.8 47.8 28.9 58.4 31.5 45.1 50.8 30.9 28.8 24.7 39.9 6.8 51.4 27.2 15.7 43.1 60.9 77.8 60.8 88.5 69.0 73.7 76.2 74.3 54.8 69.8 63.5 47.6 54.2 118.7 293.0 281.3 203.3 78.7 73.9 77.6 76.2 129.1 25.5 223.0 353.1 336.2 171.2 152.5 136.5 93.5 248.0 498.0 248.0 243.9 124.5 87.6 192.8 540.3 179.5 67.5 94.8 285.3 161.1 114.1 280.0 283.1 112.7 196.5 233.6 132.5 235.5 197.6 82.9 194.1 334.9 246.8 203.3 310.7 199.5 181.1 168.3 364.8 YWHAZ "14-3-3-zeta, KCIP-1, YWHAD" ENSG00000164924 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta" P63104 8 100916525-100953388 "Plasma proteins, Predicted intracellular proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 1590.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005065, HPA061603" Approved Approved "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 760000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB005065: AB_2218378, HPA061603: " "unprognostic (4.70e-3)" "unprognostic (7.38e-3)" "unprognostic (8.09e-2)" "prognostic unfavorable (3.91e-4)" "unprognostic (1.83e-3)" "unprognostic (2.00e-2)" "prognostic unfavorable (2.28e-5)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.65e-1)" "unprognostic (3.72e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.03e-6)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" 54.6 40.9 89.9 51.8 104.6 70.8 39.6 55.8 117.7 52.4 69.6 38.7 25.3 47.4 43.5 37.6 141.8 38.3 51.9 29.1 81.7 67.0 44.1 32.9 40.7 60.0 50.1 66.7 46.4 27.5 37.8 25.2 69.0 78.2 42.5 70.3 31.7 55.2 47.2 19.7 63.0 71.4 53.5 43.8 56.3 51.5 34.1 31.5 89.4 46.0 74.9 83.2 53.6 70.2 58.6 57.2 129.4 77.9 57.0 78.4 104.9 135.5 66.0 125.8 36.1 31.3 39.8 62.4 63.7 82.9 86.3 84.1 45.9 89.0 60.9 69.1 101.2 71.9 59.0 79.1 90.8 131.5 53.9 31.2 57.5 49.9 29.7 41.2 24.0 66.0 36.9 123.8 71.3 113.7 73.1 77.5 43.6 65.4 59.8 73.7 49.2 99.1 42.6 42.5 171.2 69.1 42.2 36.6 41.9 83.0 76.6 70.5 50.3 48.4 48.1 100.9 93.7 69.7 28.4 63.0 43.8 64.3 52.7 57.1 38.1 45.2 74.8 72.4 45.4 179.2 129.4 45.0 81.2 69.1 66.5 70.3 58.6 59.0 66.5 57.2 48.0 44.8 56.4 74.6 57.0 77.9 35.4 78.4 104.9 89.9 104.6 55.8 117.7 81.7 67.0 50.1 66.7 78.2 31.5 232.3 218.0 255.7 330.0 894.5 96.7 77.9 206.4 306.5 335.5 249.5 84.4 219.2 102.8 385.1 1094.8 171.9 335.2 46.7 365.6 441.5 215.1 349.2 432.9 89.1 253.4 127.1 254.5 172.5 286.2 1590.1 116.2 345.3 371.2 266.9 443.9 100.4 544.8 334.6 138.3 122.2 86.4 129.4 256.3 148.6 68.6 1035.6 342.0 343.9 282.9 758.7 ZBED1 "ALTE, DREF, hDREF, KIAA0785, TRAMP" ENSG00000214717 "Zinc finger BED-type containing 1" O96006 X 2486414-2500967 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 63.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 43.3" "Low region specificity" "Detected in all" HPA077591 Approved Approved "Nucleoplasm,Nuclear membrane,Centrosome" NA NA "Nucleoplasm, Centrosome" "Nuclear membrane" "HPA077591: AB_2686847" "unprognostic (7.66e-3)" "unprognostic (3.79e-2)" "unprognostic (2.39e-2)" "unprognostic (4.92e-3)" "unprognostic (4.86e-2)" "unprognostic (1.50e-2)" "unprognostic (1.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (3.95e-2)" "unprognostic (3.27e-1)" 8.5 10.5 24.8 6.0 30.7 3.1 63.7 24.8 29.0 36.8 8.1 1.7 1.7 10.6 28.9 2.8 6.1 6.4 7.1 43.4 27.3 7.2 39.6 13.6 5.9 6.0 25.1 19.6 28.7 10.4 6.8 27.8 37.5 32.5 6.8 6.4 1.7 7.7 6.3 29.5 9.5 11.2 5.1 30.4 7.9 6.6 3.4 27.1 1.7 5.4 1.7 4.8 5.8 31.4 12.7 13.7 13.0 12.4 5.4 11.5 10.2 5.2 13.1 9.6 10.5 6.1 6.5 43.3 7.4 8.2 4.4 5.1 16.7 4.6 10.4 8.6 9.9 12.1 2.5 9.1 7.7 3.3 12.2 12.2 7.7 11.2 14.2 8.0 4.7 16.2 9.6 6.1 4.6 3.5 6.6 10.4 7.1 9.8 3.4 8.5 3.7 7.9 3.8 23.5 3.4 7.8 6.4 9.4 4.9 7.4 10.2 11.4 11.2 6.3 17.1 11.8 11.2 4.7 10.2 14.2 9.5 5.0 5.2 8.1 4.2 0.0 17.2 3.8 6.8 5.3 1.8 11.6 9.7 11.5 12.4 10.3 9.4 6.8 6.5 13.7 12.7 6.6 5.4 13.0 5.4 9.3 10.1 6.6 10.2 24.8 30.7 24.8 29.0 27.3 7.2 25.1 19.6 32.5 27.1 11.9 9.4 11.5 14.3 13.5 56.5 22.9 48.4 14.7 7.9 24.4 13.7 13.2 10.0 21.0 0.2 17.9 19.8 0.0 20.2 15.4 16.9 18.3 14.9 33.1 15.5 9.5 14.9 13.5 11.8 0.8 18.4 17.7 8.5 19.0 19.5 19.9 20.8 17.3 21.5 15.8 22.4 6.5 14.4 0.0 3.2 9.8 31.8 12.5 21.9 11.5 ZBTB4 "KAISO-L1, KIAA1538, ZNF903" ENSG00000174282 "Zinc finger and BTB domain containing 4" Q9P1Z0 17 7459366-7484263 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008980, HPA064763" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB008980: , HPA064763: AB_2685347" "unprognostic (2.23e-1)" "unprognostic (3.95e-1)" "unprognostic (7.17e-2)" "unprognostic (2.92e-2)" "unprognostic (5.32e-2)" "unprognostic (7.62e-3)" "unprognostic (2.43e-1)" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (1.63e-3)" "prognostic favorable (2.53e-4)" "unprognostic (1.73e-1)" "prognostic favorable (1.65e-9)" "unprognostic (1.10e-1)" "unprognostic (4.86e-2)" "unprognostic (1.88e-1)" "unprognostic (6.04e-3)" 20.1 23.5 20.1 10.9 22.7 4.7 20.6 27.9 38.3 26.3 21.8 19.8 13.7 9.2 22.8 22.7 16.6 22.5 15.1 22.3 19.6 18.3 15.6 6.3 21.4 10.7 21.0 19.4 35.1 16.3 70.1 15.4 14.6 25.8 22.3 9.9 26.2 19.9 30.0 21.4 14.8 11.3 22.3 20.2 18.7 14.2 10.6 14.7 8.2 23.9 9.5 12.7 23.4 24.7 1.8 1.3 1.4 4.6 2.0 3.5 1.5 6.3 8.7 2.2 4.2 23.5 12.2 4.0 8.9 12.9 8.1 8.1 2.9 3.1 0.6 7.1 16.9 5.9 10.1 2.2 12.5 5.9 10.1 3.8 3.2 7.1 2.0 6.6 0.6 7.6 8.5 13.1 7.8 10.0 19.1 7.0 2.4 1.0 2.1 8.9 4.2 2.2 1.3 0.9 2.6 4.2 4.0 3.8 0.9 9.9 5.4 1.3 3.3 3.9 2.8 4.1 4.1 5.2 1.4 9.7 9.1 3.6 8.6 7.3 3.8 2.6 0.4 9.8 2.0 4.7 1.1 0.9 1.4 3.2 1.4 3.5 1.6 2.6 2.6 0.7 1.8 3.4 3.1 0.6 2.0 4.6 1.3 1.3 1.5 20.1 22.7 27.9 38.3 19.6 18.3 21.0 19.4 25.8 14.7 47.6 49.8 8.2 16.6 27.2 75.9 76.7 22.9 17.4 19.4 19.2 64.8 8.5 3.3 13.6 34.6 26.1 5.4 0.0 12.4 1.9 17.3 18.9 12.8 7.8 11.9 69.9 16.7 22.1 26.3 41.2 48.1 17.7 16.9 5.4 10.3 24.7 16.4 7.0 65.7 8.9 38.5 32.3 30.9 5.4 4.1 20.6 4.3 20.1 7.6 11.1 ZBTB48 "HKR3, TZAP, ZNF855" ENSG00000204859 "Zinc finger and BTB domain containing 48" P10074 1 6580001-6589280 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030417 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030417: AB_10603145" "unprognostic (6.66e-2)" "prognostic favorable (1.04e-4)" "unprognostic (7.15e-3)" "unprognostic (9.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (8.15e-3)" "unprognostic (6.43e-2)" "unprognostic (1.70e-1)" "prognostic favorable (5.19e-6)" "unprognostic (7.73e-2)" "unprognostic (1.82e-2)" "unprognostic (1.23e-1)" "unprognostic (2.77e-2)" "unprognostic (2.84e-1)" "unprognostic (1.91e-3)" 10.8 12.0 9.6 15.1 12.6 13.3 12.3 11.1 16.3 13.5 12.2 12.7 21.4 11.7 13.2 15.1 12.7 14.2 17.6 9.6 8.9 7.5 12.9 21.6 14.3 17.1 7.0 11.3 19.9 15.8 17.1 14.0 10.7 11.4 17.2 13.2 16.9 12.6 11.7 10.9 14.4 17.2 11.3 8.8 17.1 12.9 28.2 10.3 19.9 18.4 7.4 15.9 13.0 14.4 7.5 7.8 26.7 6.8 6.6 6.4 5.3 3.9 4.8 7.6 11.1 8.5 6.6 3.9 4.0 4.8 7.7 8.4 4.9 9.1 13.1 7.2 3.5 5.3 7.4 11.5 8.0 6.2 13.3 10.9 10.6 13.9 4.8 10.1 17.0 28.8 6.6 6.2 7.5 12.1 10.4 5.6 10.0 10.4 8.6 5.7 7.6 8.3 12.2 5.7 7.7 8.3 9.5 7.1 14.4 6.9 3.7 14.9 6.9 6.0 13.8 9.2 8.3 7.9 13.7 6.3 5.3 3.5 5.7 5.0 9.4 8.1 20.3 4.9 13.7 3.0 10.9 6.8 26.7 6.0 4.2 6.0 6.5 4.7 5.7 7.8 7.5 6.4 5.5 10.0 6.6 6.6 5.0 3.8 5.3 9.6 12.6 11.1 16.3 8.9 7.5 7.0 11.3 11.4 10.3 3.0 10.5 6.7 8.5 4.1 7.1 4.5 12.7 13.4 7.9 10.4 5.9 5.1 10.0 4.1 36.3 4.7 15.8 0.0 3.2 4.1 5.8 5.2 26.5 11.6 9.6 9.5 14.9 4.3 6.2 14.2 8.1 9.8 5.0 10.0 12.7 10.4 2.7 14.0 5.3 10.5 7.4 19.4 5.2 17.7 10.4 4.8 4.2 10.1 9.5 5.8 ZC3H14 "FLJ11806, NY-REN-37, UKp68" ENSG00000100722 "Zinc finger CCCH-type containing 14" Q6PJT7 14 88562909-88627596 "Disease related genes, Predicted intracellular proteins" RNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.1" "Group enriched" "Detected in many" 5 "Early spermatids: 961.1;Late spermatids: 410.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049798, HPA053510" Enhanced Enhanced "Nucleoli,Nucleoli rim,Nuclear speckles" NA NA "Nuclear speckles" "Nucleoli, Nucleoli rim" "HPA049798: AB_2680888, HPA053510: AB_2682174" "unprognostic (5.80e-3)" "unprognostic (2.25e-1)" "unprognostic (1.35e-2)" "unprognostic (7.39e-2)" "unprognostic (2.06e-1)" "unprognostic (1.91e-1)" "unprognostic (6.47e-3)" "unprognostic (9.57e-2)" "unprognostic (7.21e-3)" "unprognostic (2.77e-3)" "unprognostic (4.83e-2)" "unprognostic (1.50e-2)" "prognostic favorable (7.08e-4)" "unprognostic (2.09e-1)" "unprognostic (8.23e-2)" "unprognostic (3.71e-1)" "unprognostic (4.25e-2)" 13.5 12.6 16.2 10.8 16.4 9.7 13.3 23.4 19.6 14.0 15.3 14.3 17.5 10.6 17.2 15.5 12.4 15.8 10.4 12.3 14.8 8.4 15.2 24.9 13.9 9.1 16.1 16.3 17.1 19.4 19.3 24.1 14.8 16.0 14.9 16.6 11.3 18.0 16.3 15.4 13.6 15.2 14.8 11.2 9.4 12.7 73.1 14.1 9.3 19.4 8.2 11.4 16.2 12.8 13.3 17.4 21.7 21.1 18.5 17.7 13.3 16.4 31.8 29.2 23.1 23.2 22.5 29.6 25.3 23.0 36.0 31.8 22.6 26.0 23.0 18.3 25.7 19.8 20.3 20.6 23.6 49.1 19.4 15.5 11.2 22.7 18.4 23.3 24.6 14.7 18.0 27.8 28.1 28.2 24.6 23.4 21.1 21.9 10.6 32.5 35.1 22.2 13.6 18.6 25.9 28.1 19.4 37.3 10.0 24.3 29.7 21.9 19.6 31.6 36.2 17.7 25.2 33.0 16.1 17.2 43.8 26.8 18.4 25.1 13.6 11.8 25.7 21.5 12.0 20.0 12.9 16.0 21.7 15.9 20.0 17.7 13.3 15.5 17.5 17.4 12.0 14.7 14.7 2.9 18.5 21.1 9.5 13.2 13.3 16.2 16.4 23.4 19.6 14.8 8.4 16.1 16.3 16.0 14.1 113.2 41.2 16.2 22.0 20.1 59.3 19.0 25.5 75.0 46.6 19.2 72.6 40.8 29.9 22.1 961.1 18.2 22.3 0.0 19.9 23.4 21.3 22.4 43.9 29.7 17.6 62.0 30.5 23.4 10.4 410.4 36.5 14.0 5.0 13.6 27.9 35.0 19.9 14.0 44.6 24.5 76.1 12.9 27.6 125.8 76.6 17.2 34.0 17.5 29.2 13.6 ZC3H7B "DKFZp434K0920, FLJ13787, KIAA1031, RoXaN" ENSG00000100403 "Zinc finger CCCH-type containing 7B" Q9UGR2 22 41301522-41360147 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001784, HPA076092" Uncertain Uncertain Cytosol NA NA Cytosol "HPA001784: AB_1080637, HPA076092: " "unprognostic (1.71e-1)" "unprognostic (1.68e-1)" "unprognostic (3.49e-2)" "unprognostic (3.53e-2)" "unprognostic (3.35e-2)" "unprognostic (5.66e-2)" "unprognostic (3.73e-2)" "unprognostic (7.92e-2)" "unprognostic (7.12e-2)" "unprognostic (7.73e-2)" "unprognostic (1.39e-2)" "unprognostic (3.19e-1)" "prognostic favorable (5.43e-7)" "unprognostic (1.43e-2)" "unprognostic (2.92e-2)" "unprognostic (4.81e-2)" "unprognostic (2.89e-1)" 21.7 31.9 31.0 14.7 24.9 10.9 13.4 30.0 45.6 17.8 13.3 24.2 13.7 18.8 19.0 11.3 15.1 21.3 14.4 17.1 30.5 20.2 21.3 29.0 18.4 14.9 24.5 27.8 34.3 23.9 41.7 21.9 14.4 29.4 18.8 10.7 20.4 32.8 22.7 17.2 15.4 19.6 16.6 21.7 19.4 16.1 9.8 28.0 13.1 37.2 9.2 11.7 14.4 11.8 1.9 1.5 0.5 0.6 1.4 1.4 0.3 22.2 12.5 16.6 10.0 15.3 13.9 19.5 25.6 27.4 21.4 16.9 13.5 9.3 12.6 31.6 35.5 12.0 15.2 14.0 24.0 11.0 28.8 23.1 11.3 15.4 17.2 20.5 21.6 9.9 17.4 13.8 18.4 22.6 18.3 23.1 10.0 22.6 7.0 18.0 22.5 16.9 11.2 11.9 16.9 9.5 26.1 10.5 14.4 18.2 16.0 10.8 8.1 23.5 14.4 12.1 12.1 9.5 14.6 46.1 21.0 22.0 6.4 15.6 12.3 6.8 12.7 17.6 10.7 18.1 0.0 0.6 0.5 1.0 0.4 1.0 1.9 1.2 1.1 0.5 1.8 1.4 0.9 0.0 1.4 0.2 1.5 0.9 0.3 31.0 24.9 30.0 45.6 30.5 20.2 24.5 27.8 29.4 28.0 11.9 20.3 13.7 10.3 6.4 20.6 8.3 22.9 12.0 18.2 21.0 17.7 7.7 6.6 13.0 0.7 16.5 13.8 0.0 11.2 7.7 10.8 15.7 8.1 35.4 10.0 39.7 32.2 20.3 10.8 2.4 30.8 7.4 11.8 16.2 13.6 7.8 16.5 5.8 27.3 16.7 22.5 19.4 12.5 1.9 5.1 5.1 5.1 8.3 16.9 13.7 ZCCHC14 "BDG29, MGC14139" ENSG00000140948 "Zinc finger CCHC-type containing 14" Q8WYQ9 16 87406246-87492045 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 48.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014122 Uncertain "Nuclear membrane" NA NA "Nuclear membrane" "HPA014122: " "unprognostic (2.04e-2)" "unprognostic (2.84e-1)" "unprognostic (4.62e-2)" "unprognostic (2.67e-1)" "unprognostic (3.99e-1)" "unprognostic (6.74e-2)" "unprognostic (7.44e-2)" "unprognostic (1.69e-1)" "unprognostic (1.46e-1)" "unprognostic (6.41e-2)" "unprognostic (1.20e-1)" "unprognostic (2.88e-2)" "prognostic favorable (1.47e-14)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (7.13e-2)" "unprognostic (2.83e-2)" 4.9 5.3 3.3 2.2 3.7 0.6 3.9 9.3 4.5 5.2 3.6 6.3 5.0 2.9 3.5 4.0 4.6 4.2 3.1 2.5 4.6 9.0 4.0 1.6 2.1 7.8 5.7 8.5 4.2 3.1 2.6 3.5 3.3 3.3 3.4 5.4 6.3 3.4 1.8 1.8 3.6 16.8 5.3 1.3 4.2 3.7 0.3 0.3 0.8 1.8 1.0 2.6 0.3 6.9 5.2 8.6 11.3 11.5 7.8 5.2 3.5 5.0 4.2 2.1 11.3 6.0 3.8 4.7 6.7 10.6 11.3 8.1 2.7 5.4 1.1 10.5 3.7 7.6 11.0 5.0 0.9 1.9 6.8 5.6 8.0 5.0 6.3 5.8 2.2 8.7 1.1 3.7 7.6 0.1 4.6 6.4 4.2 4.8 9.8 4.7 1.6 7.6 3.9 19.5 24.7 25.7 3.5 14.2 5.6 8.4 8.1 4.7 10.4 7.8 9.4 5.8 2.4 1.3 11.4 4.6 6.0 6.7 0.0 0.4 0.3 1.1 0.1 2.6 0.3 1.1 1.7 0.3 0.3 2.0 1.0 0.8 1.0 1.8 0.2 1.8 0.3 11.9 9.8 1.9 2.2 16.3 20.0 8.1 15.3 12.0 18.2 5.2 5.9 2.8 3.3 6.4 19.8 11.2 16.3 0.0 7.0 1.6 8.8 2.9 1.1 26.4 4.7 22.3 20.2 14.1 8.1 31.5 10.3 5.6 6.8 0.0 15.8 7.5 7.3 5.8 9.6 8.4 14.8 19.4 26.4 48.6 19.0 15.3 3.1 4.3 14.2 2.0 ZDHHC12 "FLJ14524, ZNF400" ENSG00000160446 "Zinc finger DHHC-type containing 12" Q96GR4 9 128720869-128724127 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 77.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 54.8" "Low region specificity" "Detected in all" HPA059339 Uncertain Approved "Nucleoplasm,Intermediate filaments" No No Nucleoplasm "Intermediate filaments" "HPA059339: AB_2683985" "unprognostic (2.05e-1)" "unprognostic (5.81e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-3)" "unprognostic (5.34e-3)" "unprognostic (3.11e-2)" "unprognostic (1.50e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-1)" "unprognostic (6.42e-2)" "unprognostic (9.97e-2)" "unprognostic (9.41e-2)" "unprognostic (1.09e-2)" "unprognostic (8.82e-3)" "unprognostic (2.18e-1)" "unprognostic (1.95e-2)" "unprognostic (3.23e-1)" 7.3 10.9 3.9 15.3 4.5 21.8 11.2 2.5 6.5 7.5 21.2 6.8 19.3 16.2 5.9 8.3 27.2 6.9 21.5 9.2 3.5 3.1 20.6 23.6 14.2 28.0 3.8 3.8 5.0 40.5 4.3 5.0 24.7 4.8 11.1 8.4 7.7 26.3 13.3 7.5 16.8 33.0 5.4 5.8 14.9 18.7 9.2 2.7 23.6 10.3 16.4 24.4 10.1 11.7 22.2 50.6 77.4 28.7 17.4 26.1 18.8 14.2 39.0 1.6 8.4 5.1 3.5 16.4 9.2 8.2 10.1 6.8 31.9 16.5 9.9 8.6 6.9 17.6 37.7 3.5 18.2 1.0 18.2 9.4 5.2 29.7 14.0 10.4 8.7 24.2 5.6 12.6 8.2 3.1 4.8 7.4 18.8 5.2 25.3 1.9 54.8 11.9 17.5 7.2 31.7 32.3 5.4 5.9 28.5 7.7 13.4 11.6 8.4 12.5 17.3 4.9 2.7 26.7 9.3 7.4 0.0 10.5 7.1 12.3 16.4 28.9 4.4 16.8 10.1 11.1 39.2 26.5 77.4 23.5 24.7 20.3 20.3 21.8 22.5 21.0 22.2 22.7 20.6 56.8 17.4 28.7 50.6 26.1 18.8 3.9 4.5 2.5 6.5 3.5 3.1 3.8 3.8 4.8 2.7 14.9 8.1 54.1 42.0 14.3 0.9 9.6 79.0 4.0 11.4 43.6 0.0 147.4 11.6 94.7 58.6 14.7 157.1 70.0 176.4 191.0 11.1 49.6 18.4 48.9 121.4 0.0 49.2 28.3 52.9 22.4 8.9 39.8 40.5 159.7 93.7 14.5 109.4 171.9 6.7 32.7 1.7 6.5 9.5 23.1 17.5 24.6 112.1 48.4 94.2 52.6 ZEB2 "KIAA0569, SIP-1, SIP1, ZFHX1B" ENSG00000169554 "Zinc finger E-box binding homeobox 2" O60315 2 144364364-144524583 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.6" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 626.1;Kupffer cells: 357.2;Macrophages: 271.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 39.1;THP-1: 46.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003456 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA003456: AB_10603840" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.42e-1)" "unprognostic (4.12e-1)" "unprognostic (4.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.77e-2)" "unprognostic (5.83e-2)" "unprognostic (7.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.04e-5)" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (7.45e-2)" "unprognostic (1.32e-2)" 30.2 23.7 48.0 27.8 42.4 55.5 16.6 6.7 36.6 29.4 12.3 72.9 3.4 11.3 15.6 11.1 14.4 11.1 22.6 22.5 52.5 28.8 9.9 11.6 20.7 19.6 54.4 26.4 37.5 3.6 5.0 3.1 31.5 37.6 10.9 16.3 15.7 5.7 12.5 9.6 7.7 12.8 17.2 76.6 32.6 9.3 8.2 38.7 1.9 8.3 7.5 12.4 21.5 14.8 5.0 12.7 9.7 21.6 3.6 10.7 7.4 0.4 0.5 22.5 0.0 26.9 13.7 0.0 9.2 9.4 10.4 10.1 0.0 0.2 1.7 0.0 10.0 2.8 0.1 3.8 0.0 13.0 9.6 2.6 39.1 1.6 0.0 6.1 6.7 31.1 11.2 0.2 12.9 6.2 8.8 7.8 0.0 10.9 1.1 12.2 0.0 0.0 20.5 3.2 0.0 0.5 11.5 15.5 0.0 0.1 0.2 0.2 5.9 1.1 0.0 24.3 7.5 0.0 46.5 12.1 12.0 0.2 23.3 2.9 12.7 0.0 1.9 17.9 20.2 32.2 9.7 21.6 5.7 10.7 20.8 1.0 4.4 1.4 5.3 12.7 5.0 1.1 4.0 7.5 3.6 19.5 10.2 0.3 7.4 48.0 42.4 6.7 35.6 52.5 28.8 54.4 26.4 37.6 38.7 6.0 25.8 45.8 1.2 22.0 178.1 50.1 2.5 6.7 18.2 5.2 3.9 1.3 1.7 0.6 2.0 23.8 0.0 23.3 0.7 1.6 146.0 1.5 150.5 2.1 126.8 626.1 0.0 81.0 357.2 4.0 111.7 271.2 97.8 46.9 0.0 84.2 0.2 0.0 62.6 7.3 8.6 181.1 167.0 2.3 7.0 17.1 3.9 99.2 0.0 2.0 ZHX1-C8orf76 ENSG00000259305 "ZHX1-C8orf76 readthrough" Q96EF9 8 123226189-123274284 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 9.5;Urothelial cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 24.3" HPA023708 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023708: AB_1845785" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (1.37e-2)" "unprognostic (1.83e-3)" "unprognostic (1.13e-1)" "unprognostic (1.16e-1)" "unprognostic (2.49e-3)" "unprognostic (7.10e-2)" "unprognostic (1.91e-2)" "unprognostic (9.34e-3)" "unprognostic (2.29e-1)" "unprognostic (3.09e-2)" "unprognostic (5.64e-11)" "unprognostic (1.79e-1)" "unprognostic (2.09e-1)" "unprognostic (1.98e-1)" "unprognostic (1.06e-2)" 8.6 7.4 11.4 5.0 11.0 25.9 8.7 10.3 10.7 8.5 6.2 5.9 8.9 8.1 7.3 8.1 10.4 5.9 5.4 8.7 11.2 5.0 7.1 9.7 9.7 8.7 9.6 7.4 8.7 6.8 7.1 12.7 7.1 8.8 8.7 9.9 4.5 9.0 8.7 11.9 9.9 9.3 7.7 11.4 10.5 6.6 5.1 11.7 5.8 10.5 4.6 10.2 7.5 11.6 5.5 4.6 8.0 8.3 4.8 8.5 3.3 3.0 3.9 2.9 2.0 1.8 2.0 2.1 1.3 1.4 3.4 2.6 3.2 2.4 1.8 1.2 2.3 2.0 2.1 3.3 1.8 5.1 2.9 6.7 5.3 2.7 3.8 1.9 1.1 3.0 2.7 2.7 2.8 1.7 1.5 3.9 5.6 4.4 2.6 3.0 9.5 4.4 3.5 0.7 6.2 4.4 3.5 1.9 2.5 2.4 3.1 4.5 3.3 2.8 24.3 1.4 1.7 3.6 1.0 0.3 1.5 2.7 2.3 3.2 3.7 4.5 3.9 2.0 2.9 1.0 3.1 5.7 8.0 4.1 8.3 3.7 5.5 5.3 3.5 4.6 4.6 4.4 3.6 1.8 4.8 5.9 4.0 8.5 3.3 11.4 11.0 10.3 10.7 11.2 5.0 9.6 7.4 8.8 11.7 0.0 1.4 0.5 3.5 0.0 0.4 0.8 2.5 2.7 1.2 3.5 0.0 1.6 1.7 1.6 0.7 1.5 1.1 0.0 1.6 2.0 0.1 2.4 0.0 0.9 2.5 9.5 2.9 1.3 0.6 0.9 0.9 1.2 0.0 1.8 1.3 0.8 1.7 0.0 1.1 1.2 1.1 0.0 0.9 2.5 2.2 0.0 0.8 0.7 1.0 6.0 ZIC5 ENSG00000139800 "Zic family member 5" Q96T25 13 99962964-99971909 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 48.9" "Cell type enhanced" "Detected in some" 29 "Muller glia cells: 1.7;Rod photoreceptor cells: 1.3;Spermatocytes: 5.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 24 "cerebellum: 48.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.2;HEK 293: 6.4;NTERA-2: 7.6;SCLC-21H: 43.8" "Group enriched" "Detected in many" 5 "basal ganglia: 19.3;cerebellum: 20.7;thalamus: 5.7" "Region enriched" "Detected in all" 6 "cerebellum: 53.2" HPA074045 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA074045: " "unprognostic (2.78e-5)" "unprognostic (1.71e-2)" "unprognostic (2.44e-2)" "unprognostic (2.29e-3)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (4.38e-4)" "unprognostic (2.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.06e-2)" "unprognostic (3.87e-2)" "unprognostic (1.13e-1)" "unprognostic (3.12e-2)" "unprognostic (4.94e-2)" 0.1 0.0 1.2 0.0 0.5 0.0 0.1 48.9 4.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.5 0.1 0.1 0.1 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 11.2 0.9 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.5 1.0 0.0 1.6 0.0 0.5 0.0 2.2 0.0 0.0 1.9 6.4 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.4 1.5 0.0 0.0 0.8 0.0 0.8 7.6 0.0 0.1 0.9 0.4 0.0 0.0 0.0 43.8 0.0 1.2 1.0 0.0 0.8 0.0 1.4 0.0 0.6 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.5 48.9 1.3 1.5 0.5 0.4 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.7 0.4 0.0 0.0 0.0 0.0 0.0 ZMIZ2 "DKFZp761I2123, hZIMP7, KIAA1886, NET27, ZIMP7" ENSG00000122515 "Zinc finger MIZ-type containing 2" Q8NF64 7 44748581-44769881 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040716 Supported Supported Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA040716: AB_10805826" "unprognostic (2.28e-2)" "unprognostic (1.89e-1)" "unprognostic (1.44e-2)" "unprognostic (2.21e-2)" "unprognostic (9.46e-3)" "unprognostic (1.01e-3)" "prognostic unfavorable (6.82e-5)" "unprognostic (2.47e-1)" "unprognostic (2.36e-1)" "unprognostic (2.73e-1)" "unprognostic (5.89e-2)" "unprognostic (4.58e-2)" "unprognostic (1.05e-1)" "unprognostic (1.80e-1)" "unprognostic (1.66e-1)" "unprognostic (1.15e-1)" "unprognostic (3.15e-3)" 14.3 16.0 31.7 24.5 31.5 19.8 13.3 24.0 43.2 12.7 15.2 22.9 17.5 23.8 16.4 16.8 16.8 17.3 17.3 15.9 28.2 15.4 19.0 10.1 18.3 24.0 17.0 27.2 17.9 32.3 19.8 23.0 11.0 17.0 16.4 12.5 16.5 32.5 23.0 18.7 31.1 22.2 17.9 16.5 28.8 21.3 20.8 17.5 16.7 25.1 14.0 19.1 15.5 13.2 4.9 4.1 1.0 2.4 3.4 2.5 0.9 14.4 16.6 7.8 15.0 5.3 3.5 8.2 7.4 7.1 6.4 7.7 9.4 22.7 9.9 11.7 7.7 15.9 19.8 4.8 8.4 3.8 23.5 9.2 4.0 15.6 7.4 10.9 5.7 8.9 5.4 5.2 10.0 6.6 5.7 11.8 10.8 11.7 22.6 9.3 13.8 12.7 15.9 14.7 11.0 16.2 15.9 4.3 12.9 7.5 11.1 27.7 18.3 10.0 19.6 4.5 7.7 18.6 8.9 17.5 6.1 13.4 16.4 17.0 33.3 10.5 7.7 11.8 10.2 24.9 1.0 1.6 0.7 2.5 2.4 1.6 2.7 1.2 1.8 1.6 4.9 0.8 0.9 0.7 3.4 1.2 4.1 1.1 0.9 31.7 31.5 24.0 43.2 28.2 15.4 17.0 27.2 17.0 17.5 11.9 19.2 10.7 3.8 9.0 10.7 14.5 2.5 8.1 11.4 22.7 13.7 6.7 1.7 15.0 24.7 12.3 15.8 0.0 13.5 2.1 9.7 8.2 13.9 14.5 9.7 11.1 19.1 15.4 17.9 62.4 12.4 14.8 13.5 32.5 17.7 4.9 20.5 14.0 17.0 6.9 6.9 6.5 9.8 4.5 5.3 16.2 6.1 9.6 20.0 8.4 ZMYND15 DKFZp434N127 ENSG00000141497 "Zinc finger MYND-type containing 15" Q9H091 17 4740015-4746119 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.6" "Group enriched" "Detected in many" 6 "Early spermatids: 141.0;monocytes: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.1;non-classical monocyte: 1.5" "Group enriched" "Detected in many" 11 "granulocytes: 1.1;monocytes: 1.5" "Cell line enhanced" "Detected in some" "A-431: 5.1;CAPAN-2: 4.8;HaCaT: 3.9;T-47d: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA023286 Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA023286: AB_1859076" "unprognostic (2.30e-3)" "unprognostic (1.63e-2)" "unprognostic (1.61e-2)" "unprognostic (7.49e-3)" "unprognostic (3.62e-2)" "unprognostic (7.86e-2)" "unprognostic (4.97e-2)" "unprognostic (1.59e-2)" "unprognostic (1.33e-2)" "unprognostic (3.49e-1)" "unprognostic (6.72e-3)" "unprognostic (4.02e-1)" "unprognostic (5.47e-2)" "unprognostic (4.62e-2)" "unprognostic (9.24e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" 3.6 1.6 2.3 2.9 2.0 0.9 2.0 0.7 2.7 1.3 1.0 5.1 1.4 5.2 1.8 4.5 1.2 1.5 3.8 3.8 3.6 1.8 2.4 3.5 6.1 4.9 3.7 1.7 0.9 4.7 12.5 1.8 1.5 3.4 1.9 1.0 4.2 3.8 2.7 0.4 1.8 3.9 1.2 4.8 6.2 2.4 25.6 2.9 0.7 1.4 0.7 0.8 1.6 0.9 0.0 0.1 1.1 1.5 0.0 0.0 0.2 5.1 0.9 0.0 2.5 0.1 0.2 0.4 0.1 1.4 1.3 3.1 2.3 4.8 0.0 0.2 0.0 0.6 3.9 0.9 0.4 0.1 0.5 1.7 0.0 0.5 1.3 0.8 0.1 1.4 0.2 0.6 0.2 0.2 0.7 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.7 0.6 0.6 0.0 0.1 1.4 1.6 2.3 0.0 3.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 1.5 0.0 0.0 0.2 2.3 2.0 0.7 2.7 3.6 1.8 3.7 1.7 3.4 2.9 0.0 1.3 0.0 5.2 0.8 0.1 0.6 0.0 0.0 1.2 1.8 0.0 0.0 0.0 1.4 141.0 0.3 4.0 0.0 3.5 0.0 0.3 5.3 0.0 0.2 5.0 0.0 1.2 3.7 7.6 15.1 0.6 10.7 1.7 36.9 2.6 1.4 2.6 0.6 2.1 0.7 0.2 0.0 0.5 0.7 1.2 0.6 0.0 0.0 0.6 7.4 ZNF143 "pHZ-1, SBF, STAF" ENSG00000166478 "Zinc finger protein 143" P52747 11 9460319-9528524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003263, HPA003264, HPA074818" Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus, Vesicles" "HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715" "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (5.51e-2)" "unprognostic (9.72e-2)" "unprognostic (5.09e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.76e-5)" "unprognostic (4.87e-3)" "unprognostic (2.57e-3)" "unprognostic (9.56e-2)" "unprognostic (1.26e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.20e-3)" "unprognostic (1.92e-2)" "unprognostic (1.06e-2)" "unprognostic (7.55e-2)" 22.7 9.8 11.6 13.6 11.7 20.9 16.4 25.4 11.8 16.8 14.7 11.0 12.8 11.8 20.8 19.5 14.7 13.4 10.7 13.2 11.9 10.8 11.9 12.1 14.0 18.0 12.6 8.7 18.8 10.7 10.3 24.0 15.7 11.4 17.4 12.9 11.7 14.9 13.0 27.0 12.8 13.5 16.1 15.2 18.7 11.6 20.4 13.8 27.4 18.8 10.4 17.3 25.0 21.8 13.0 12.0 31.2 15.6 10.2 17.0 10.5 15.2 14.9 18.8 12.2 15.3 14.3 16.9 16.9 13.8 13.1 14.4 20.8 19.1 15.1 7.9 13.7 11.2 17.5 18.1 13.5 19.8 15.1 21.9 14.3 21.9 14.4 12.6 19.8 14.4 12.5 16.2 17.8 15.7 17.1 13.0 14.0 15.4 18.6 14.3 13.2 18.1 8.1 20.9 17.7 15.7 16.5 17.0 9.3 11.6 18.8 12.9 12.6 18.8 12.8 11.1 17.3 11.8 11.1 12.5 17.4 12.4 12.1 15.0 9.2 15.7 25.9 11.1 11.3 9.9 20.6 14.2 31.2 17.0 13.9 15.3 13.0 15.2 13.8 12.0 11.2 14.2 12.2 25.7 10.2 15.6 5.8 16.6 10.5 11.6 11.7 25.4 11.8 11.9 10.8 12.6 8.7 11.4 13.8 6.0 15.5 5.7 33.1 23.7 6.6 14.0 5.1 13.4 7.9 5.2 7.9 8.5 3.3 11.2 13.0 11.3 5.1 0.0 10.1 13.6 10.5 16.9 13.9 8.5 8.8 4.8 6.3 4.9 7.1 7.8 10.9 14.1 10.1 9.0 6.0 14.3 11.6 7.4 6.3 5.3 13.5 58.2 16.0 42.3 21.7 20.6 15.3 15.7 6.6 28.8 ZNF148 "BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148" ENSG00000163848 "Zinc finger protein 148" Q9UQR1 3 125225561-125375354 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001656, CAB017486" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "CAB017486: AB_794260, HPA001656: AB_1079995" "unprognostic (2.40e-1)" "unprognostic (1.12e-2)" "unprognostic (5.03e-2)" "unprognostic (3.94e-2)" "unprognostic (5.94e-3)" "unprognostic (5.66e-2)" "unprognostic (1.24e-2)" "unprognostic (2.36e-1)" "unprognostic (1.69e-2)" "unprognostic (1.33e-2)" "prognostic unfavorable (2.88e-4)" "unprognostic (6.36e-2)" "unprognostic (7.97e-3)" "unprognostic (1.71e-1)" "unprognostic (2.84e-1)" "unprognostic (3.63e-2)" "unprognostic (2.72e-1)" 10.5 9.2 12.5 13.4 17.4 5.3 9.4 18.4 17.7 10.7 8.9 4.1 3.3 5.7 11.2 8.3 8.9 10.2 8.6 11.7 11.2 7.2 10.6 9.0 8.8 8.8 11.9 11.8 14.5 7.7 15.7 18.2 7.6 10.5 9.1 9.2 6.7 10.3 12.2 12.2 7.6 8.0 11.0 7.6 8.6 7.4 9.5 10.9 25.4 24.4 3.2 10.8 10.7 9.8 13.9 7.3 29.7 12.1 18.8 17.3 10.2 18.4 12.2 13.3 11.8 11.9 12.9 10.1 16.8 19.7 18.9 18.1 11.5 10.3 14.9 11.8 24.8 15.3 15.1 14.5 12.7 27.0 6.6 5.5 18.3 14.7 5.9 8.8 12.5 18.5 10.4 13.3 17.7 18.8 12.5 12.9 10.9 8.9 12.7 13.9 14.4 15.5 4.6 8.5 12.5 10.5 11.2 14.6 8.3 10.8 20.6 11.5 9.7 22.4 11.4 18.7 7.7 14.2 12.6 16.6 14.4 15.5 18.0 10.7 11.1 12.6 22.6 10.8 8.0 13.2 2.5 8.7 17.4 13.4 8.4 13.8 13.8 11.8 12.5 7.3 13.9 17.3 13.5 29.7 18.8 12.1 6.5 10.8 10.2 12.5 17.4 18.4 17.7 11.2 7.2 11.9 11.8 10.5 10.9 86.4 32.9 27.3 25.1 31.6 67.0 66.1 28.1 24.1 43.3 31.4 37.3 23.6 21.6 32.2 73.6 43.1 22.7 46.7 32.7 20.8 30.5 30.4 48.6 37.5 26.6 71.5 46.0 36.8 37.3 83.4 44.5 32.2 16.9 28.9 37.1 41.2 29.0 17.5 55.5 36.0 37.8 32.3 38.1 18.2 18.1 33.5 26.4 45.9 33.3 32.5 ZNF232 ZSCAN11 ENSG00000167840 "Zinc finger protein 232" Q9UNY5 17 5105541-5123116 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027309, HPA028611" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA027309: AB_10603464, HPA028611: AB_2672700" "unprognostic (4.20e-2)" "unprognostic (2.06e-3)" "unprognostic (3.69e-1)" "unprognostic (5.59e-3)" "unprognostic (5.21e-2)" "unprognostic (5.90e-3)" "prognostic unfavorable (4.66e-4)" "unprognostic (3.12e-2)" "unprognostic (5.46e-3)" "unprognostic (2.49e-2)" "prognostic favorable (6.55e-4)" "unprognostic (3.28e-2)" "unprognostic (3.49e-3)" "unprognostic (2.22e-2)" "unprognostic (2.28e-1)" "unprognostic (1.11e-1)" "unprognostic (8.61e-3)" 6.7 5.2 6.5 6.7 9.5 2.0 7.4 14.3 11.1 6.6 8.2 11.1 7.8 4.5 8.9 10.1 5.5 9.9 5.5 5.9 7.3 5.4 6.6 6.3 6.3 7.0 9.8 5.7 14.3 10.0 3.8 8.7 6.2 8.7 7.6 5.9 6.5 8.8 6.4 7.7 5.5 6.3 8.5 6.2 6.9 7.2 7.5 10.7 6.4 8.0 5.4 6.1 6.3 6.2 11.8 7.4 1.9 2.1 5.4 7.8 3.9 5.4 4.1 6.8 6.9 2.4 1.0 3.7 2.7 1.4 2.7 3.7 6.4 1.3 11.0 3.3 0.9 3.9 3.8 4.7 2.7 1.6 4.3 7.2 1.9 9.5 5.7 3.5 0.0 3.4 2.0 3.0 2.8 2.5 1.9 1.9 13.3 9.2 4.1 3.2 2.6 9.3 3.8 13.3 4.7 4.5 8.0 4.3 7.4 2.2 0.8 7.1 4.6 5.3 2.1 4.3 5.4 1.1 2.7 3.1 2.7 4.6 2.1 5.2 5.5 8.6 2.8 6.9 0.3 4.4 1.4 2.1 1.9 4.7 1.9 5.5 11.8 5.2 6.2 4.0 11.0 7.8 7.2 0.1 5.4 1.2 7.4 4.2 3.9 6.5 9.5 14.3 11.1 7.3 5.4 9.8 5.7 8.7 10.7 0.0 1.6 2.2 3.1 3.8 5.0 5.0 0.0 5.3 4.5 5.2 0.0 3.2 3.3 5.3 6.0 4.0 2.1 0.0 3.5 4.0 2.4 2.0 0.0 3.2 5.1 0.0 1.2 3.1 2.7 4.8 3.4 1.8 0.0 1.0 2.7 3.8 3.5 5.8 4.9 2.6 2.8 0.0 4.1 12.1 10.9 4.1 1.7 1.5 3.3 1.6 ZNF260 "ozrf1, Zfp260" ENSG00000254004 "Zinc finger protein 260" Q3ZCT1 19 36510695-36528660 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028806 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028806: AB_10795285" "unprognostic (1.34e-1)" "unprognostic (6.31e-2)" "unprognostic (8.35e-3)" "unprognostic (1.11e-3)" "unprognostic (3.55e-2)" "unprognostic (1.29e-3)" "unprognostic (7.83e-3)" "unprognostic (3.91e-1)" "unprognostic (1.13e-2)" "unprognostic (8.36e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-2)" "prognostic favorable (1.44e-4)" "unprognostic (7.73e-2)" "unprognostic (2.17e-1)" "unprognostic (1.06e-1)" "unprognostic (7.89e-3)" 8.4 9.4 10.3 7.6 16.8 2.3 12.0 18.4 14.1 10.8 7.0 6.2 9.4 6.2 11.2 7.9 8.0 8.4 8.2 7.5 11.2 9.5 11.6 8.5 7.3 12.4 17.1 9.1 13.4 6.6 20.4 19.5 10.9 11.9 10.3 7.1 5.9 8.8 7.6 4.8 10.0 7.7 8.1 20.6 8.3 8.1 4.5 15.4 17.3 14.7 5.5 9.7 10.7 8.4 5.9 3.2 6.8 3.5 4.1 7.2 3.0 7.9 8.1 18.8 14.1 5.8 8.9 8.2 7.0 7.5 6.5 8.3 3.6 4.5 5.2 11.5 5.6 4.9 3.0 9.4 4.3 10.0 6.9 4.1 7.8 6.2 4.1 8.1 3.9 6.5 8.0 7.2 6.7 10.3 9.3 8.6 7.9 6.1 5.8 12.8 4.3 14.4 2.5 11.9 4.9 3.5 9.6 11.6 3.9 7.2 14.3 13.6 14.9 15.5 8.3 5.7 12.1 7.0 7.4 7.4 11.3 11.8 6.6 6.2 7.5 14.3 12.3 0.3 4.1 15.2 6.8 2.8 3.0 4.0 2.5 4.2 5.1 5.3 3.2 3.2 5.9 7.2 5.5 1.6 4.1 3.5 2.2 4.6 3.0 10.3 16.8 18.4 14.1 11.2 9.5 17.1 9.1 11.9 15.4 8.9 3.8 4.4 7.3 9.2 7.6 7.5 0.0 5.3 12.5 0.0 7.9 5.5 5.0 7.1 7.4 6.7 2.5 0.0 3.9 5.7 6.1 7.0 8.1 3.0 4.1 20.6 11.5 9.8 3.3 3.1 5.5 4.9 1.7 7.2 6.6 7.5 5.2 2.9 7.8 6.7 7.4 6.5 4.8 5.6 3.7 11.4 3.4 6.9 5.0 10.8 ZNF318 "HRIHFB2436, ZFP318" ENSG00000171467 "Zinc finger protein 318" Q5VUA4 6 43307134-43369478 "Predicted intracellular proteins" "Meiosis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 78.2;Spermatogonia: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "naive B-cell: 6.3" "Lineage enriched" "Detected in many" 4 "B-cells: 6.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027022, HPA027031" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027022: AB_1859189, HPA027031: AB_1859190" "unprognostic (1.64e-1)" "unprognostic (3.80e-1)" "unprognostic (1.13e-1)" "unprognostic (4.11e-3)" "unprognostic (1.97e-2)" "unprognostic (3.02e-2)" "unprognostic (2.53e-3)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (3.37e-2)" "unprognostic (8.24e-2)" "unprognostic (3.47e-1)" "unprognostic (4.61e-3)" "unprognostic (3.61e-1)" "unprognostic (3.00e-1)" "unprognostic (2.82e-1)" "unprognostic (1.54e-2)" 8.3 7.1 14.2 15.3 13.7 9.9 12.2 24.7 17.7 12.5 8.9 10.4 9.2 7.1 12.7 11.1 7.0 9.0 7.1 7.6 12.8 6.3 7.3 8.3 9.2 23.6 15.4 9.4 13.2 8.6 14.6 8.0 7.9 11.4 10.2 8.2 7.9 7.9 8.6 8.6 11.7 10.0 9.2 9.0 14.6 6.8 39.2 16.8 10.0 13.7 4.7 23.6 9.8 10.9 6.3 0.9 0.4 0.7 0.7 1.4 0.5 15.4 3.9 11.3 18.8 10.0 9.0 5.6 6.7 8.9 8.2 7.1 4.1 2.0 24.6 3.8 8.9 9.6 7.0 12.6 5.9 10.7 6.4 6.4 6.8 5.0 6.5 5.0 12.1 5.5 5.7 6.3 6.9 6.1 6.9 6.3 7.0 9.1 12.3 8.6 5.5 3.6 7.7 5.1 26.2 3.7 4.5 11.0 3.9 4.5 3.7 10.4 6.4 5.2 4.6 5.5 9.2 5.7 16.9 6.3 11.5 5.7 7.7 6.6 7.3 5.9 17.6 3.6 9.3 6.4 0.0 0.7 0.0 1.4 0.5 0.4 1.4 1.2 0.9 0.9 6.3 0.9 1.0 0.4 0.7 0.4 0.7 1.2 0.5 14.2 13.7 24.7 17.7 12.8 6.3 15.4 9.4 11.4 16.8 8.9 12.6 7.3 4.2 8.7 15.4 7.7 12.7 6.7 7.9 8.7 7.9 4.9 3.3 4.1 21.1 4.7 5.7 0.0 4.0 3.8 6.4 3.2 5.8 16.8 5.5 23.8 5.2 14.1 10.8 12.9 5.8 6.6 3.3 4.6 4.9 10.2 4.2 9.1 9.2 3.4 12.1 25.8 3.9 78.2 41.7 4.4 1.5 5.0 8.5 1.3 ZNF320 "DKFZp686G16228, ZFPL" ENSG00000182986 "Zinc finger protein 320" A2RRD8 19 52863790-52897693 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 24.5;U-266/84: 20.2" "HPA043696, HPA062474" Uncertain Uncertain "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "HPA043696: AB_10793951, HPA062474: AB_2732685" "unprognostic (3.33e-2)" "unprognostic (4.43e-2)" "unprognostic (2.55e-2)" "unprognostic (2.25e-1)" "unprognostic (2.92e-2)" "unprognostic (7.12e-2)" "unprognostic (1.47e-4)" "unprognostic (8.90e-2)" "unprognostic (3.71e-3)" "unprognostic (2.75e-3)" "unprognostic (2.50e-1)" "unprognostic (2.01e-3)" "unprognostic (6.41e-3)" "unprognostic (1.32e-1)" "unprognostic (2.76e-1)" "unprognostic (7.65e-2)" "unprognostic (2.61e-3)" 6.3 8.6 10.5 8.7 11.7 8.3 9.9 15.5 12.2 10.8 9.9 9.4 27.7 7.1 13.8 12.7 7.0 11.3 9.5 9.8 9.0 7.0 11.8 2.5 7.1 6.8 9.1 10.1 15.5 10.3 17.7 15.7 15.7 10.9 12.1 10.9 9.7 9.7 23.8 7.4 13.1 7.8 8.6 11.4 9.8 8.7 6.3 12.6 8.9 13.0 5.3 6.8 19.4 11.0 5.0 3.7 5.9 3.4 10.1 5.1 2.6 3.5 0.3 4.7 10.8 0.7 1.7 8.1 1.8 1.7 3.0 3.9 1.4 1.3 3.2 3.2 2.1 1.5 1.8 0.0 0.6 1.4 0.0 1.2 4.0 4.9 0.0 2.1 0.4 4.2 2.6 1.7 3.8 0.4 1.2 2.0 2.1 3.5 0.5 2.4 0.0 3.6 3.6 5.5 0.1 3.3 4.2 6.0 4.3 1.7 24.5 4.1 8.5 0.1 2.8 1.7 4.8 3.0 0.0 2.2 1.6 3.5 0.8 3.5 6.3 20.2 2.8 0.2 0.1 2.3 3.1 3.3 2.6 3.9 3.4 3.5 3.2 2.6 2.9 2.6 5.0 4.7 5.1 5.9 10.1 2.6 3.7 2.5 2.6 10.5 11.7 15.5 12.2 9.0 7.0 9.1 10.1 10.9 12.6 3.0 1.7 2.2 5.4 1.6 7.2 10.0 17.8 1.4 4.5 1.8 9.8 8.1 0.0 0.2 3.8 5.0 5.1 0.0 0.0 5.5 4.3 6.8 1.1 0.8 3.6 15.9 10.3 5.5 1.9 2.1 4.0 1.5 3.3 0.0 9.4 5.6 0.1 3.5 2.5 0.2 12.6 0.0 2.7 3.4 5.3 3.8 6.4 0.7 4.3 6.7 ZNF341 dJ553F4.3 ENSG00000131061 "Zinc finger protein 341" Q9BYN7 20 33731657-33792269 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Club cells: 6.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023240, HPA024607, HPA067108" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA023240: AB_1859207, HPA024607: AB_1859208, HPA067108: AB_2685780" "unprognostic (1.74e-1)" "unprognostic (2.18e-1)" "unprognostic (3.73e-1)" "unprognostic (2.10e-1)" "unprognostic (9.31e-2)" "prognostic favorable (3.93e-4)" "prognostic unfavorable (1.87e-4)" "unprognostic (2.44e-1)" "unprognostic (1.70e-1)" "unprognostic (1.80e-1)" "unprognostic (7.38e-2)" "unprognostic (9.31e-2)" "unprognostic (8.17e-5)" "unprognostic (4.84e-2)" "unprognostic (2.90e-1)" "unprognostic (8.67e-3)" "unprognostic (3.68e-2)" 4.5 4.3 7.3 6.9 10.4 7.7 5.1 10.4 9.1 6.5 4.9 7.2 2.1 5.8 6.5 3.5 6.7 5.4 5.2 4.5 6.8 3.1 3.1 3.6 4.7 5.5 8.8 6.3 5.5 5.4 4.0 5.2 5.4 4.9 4.9 4.9 3.7 5.7 6.9 7.2 8.2 5.0 4.9 4.2 5.8 4.5 7.4 6.9 4.9 4.9 2.9 4.7 6.5 5.5 2.6 1.5 5.9 2.4 2.2 2.4 1.4 1.8 8.3 3.0 4.0 3.0 2.1 11.2 2.8 1.7 2.7 1.3 6.2 5.3 3.8 3.8 2.0 3.0 3.6 2.8 4.9 0.9 3.7 2.8 4.3 3.4 2.9 1.1 2.4 4.7 2.1 3.0 2.1 1.2 2.3 2.7 4.5 2.2 1.6 2.4 3.8 2.2 1.0 2.6 3.5 4.2 2.6 1.3 1.8 1.5 6.4 2.1 1.9 8.2 5.5 1.0 2.4 6.3 2.2 2.1 3.5 1.2 0.9 2.2 1.2 1.6 2.9 4.3 1.6 2.7 3.5 1.9 5.9 1.9 2.4 1.6 2.6 1.2 1.3 1.5 2.5 1.1 2.4 3.8 2.2 1.5 1.1 1.0 1.4 7.3 10.4 10.4 9.1 6.8 3.1 8.8 6.3 4.9 6.9 3.0 6.1 4.7 1.0 0.3 2.3 2.0 2.5 5.3 6.8 1.8 2.0 2.2 0.0 1.5 0.5 0.7 4.2 0.0 1.2 2.6 1.3 1.9 2.3 0.8 1.2 1.6 1.2 1.3 2.2 0.0 0.6 2.5 0.0 0.0 2.1 0.2 1.6 0.8 0.4 0.3 2.1 0.0 0.6 1.1 2.2 0.9 1.7 0.0 1.3 1.8 ZNF354A "EZNF, HKL1, KID-1, KID1, TCF17" ENSG00000169131 "Zinc finger protein 354A" O60765 5 178694605-178730702 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052043 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA052043: AB_2681706" "unprognostic (2.79e-1)" "unprognostic (3.44e-2)" "unprognostic (7.06e-3)" "unprognostic (1.78e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (3.25e-2)" "unprognostic (1.41e-1)" "unprognostic (7.66e-3)" "prognostic favorable (8.28e-4)" "unprognostic (4.06e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (8.71e-2)" "unprognostic (4.13e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" 14.0 7.0 13.0 12.1 13.6 14.2 14.2 13.3 14.4 12.6 15.0 6.7 11.4 7.1 13.7 13.3 10.4 11.7 9.8 14.5 13.2 9.3 18.0 6.2 10.8 12.7 16.7 16.1 10.9 15.0 11.7 14.1 14.0 13.4 13.3 10.0 7.1 8.8 15.1 11.9 12.3 10.6 13.6 12.9 17.1 10.4 14.0 14.4 13.1 15.1 8.6 14.2 17.0 25.1 5.7 5.3 15.0 5.8 6.0 6.4 3.6 4.3 3.4 7.1 18.8 12.4 10.1 29.4 5.0 6.7 7.0 7.5 5.0 7.3 5.8 6.6 4.5 12.9 8.6 2.6 21.3 10.8 7.7 8.1 1.7 4.2 0.6 9.4 0.0 4.9 7.9 13.7 6.1 12.5 9.0 6.6 7.9 1.4 0.0 10.1 8.7 8.7 5.8 6.2 4.0 8.8 6.5 1.2 3.6 6.5 4.4 7.8 8.5 6.3 7.2 9.7 9.8 5.9 8.5 5.1 7.9 5.2 4.5 4.2 1.9 4.0 3.6 0.2 1.3 9.9 4.4 5.8 14.5 5.1 3.8 6.4 5.7 4.6 5.7 5.3 3.6 5.3 3.8 15.0 6.0 3.9 1.9 4.1 3.6 13.0 13.6 13.3 14.4 13.2 9.3 16.7 16.1 13.4 14.4 11.9 6.1 3.2 10.0 4.4 8.9 5.5 0.0 12.0 10.3 7.0 13.7 10.6 11.6 9.8 9.2 8.0 2.1 0.0 6.6 10.6 6.1 5.3 5.8 0.8 8.0 6.4 4.6 6.2 8.2 3.2 6.4 7.8 10.1 3.6 2.2 7.4 6.7 0.0 9.9 13.5 9.7 6.5 9.2 22.3 9.8 4.8 10.2 10.9 4.3 6.9 ZNF417 MGC34079 ENSG00000173480 "Zinc finger protein 417" Q8TAU3 19 57900296-57916610 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Club cells: 7.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 34.1" "HPA042125, HPA043288, HPA056213" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (1.28e-1)" "unprognostic (3.74e-2)" "unprognostic (8.93e-2)" "unprognostic (1.63e-2)" "unprognostic (1.85e-1)" "unprognostic (5.76e-2)" "unprognostic (2.59e-3)" "unprognostic (2.34e-1)" "unprognostic (7.65e-3)" "unprognostic (5.33e-2)" "unprognostic (7.63e-2)" "unprognostic (1.01e-1)" "unprognostic (1.93e-2)" "unprognostic (8.75e-2)" "prognostic favorable (3.48e-4)" 7.4 8.8 12.3 11.8 11.8 10.2 16.6 18.5 12.8 15.1 10.1 11.8 16.8 7.0 10.7 38.9 7.9 10.3 11.4 9.5 11.7 10.4 9.4 11.0 9.1 12.8 13.3 12.3 12.7 9.4 14.2 23.8 10.8 10.2 12.7 10.5 12.3 14.2 13.9 6.2 21.5 13.1 10.3 10.1 12.7 10.7 8.0 13.4 14.9 16.1 5.6 16.3 9.1 9.8 6.8 5.8 9.7 3.8 3.6 7.6 2.7 4.1 6.2 10.2 7.0 10.3 9.9 8.7 5.1 7.5 4.8 4.0 6.7 2.4 8.6 2.8 7.5 3.7 2.8 6.4 6.9 13.5 1.6 34.1 9.2 14.2 6.3 7.0 8.5 10.0 7.2 7.2 4.7 6.3 9.1 6.1 7.1 2.8 0.5 9.9 3.9 9.2 4.1 5.9 2.8 6.4 7.2 12.3 6.2 4.8 18.7 9.5 6.2 6.8 4.6 1.6 11.1 4.9 7.1 4.1 12.2 5.3 2.7 5.1 9.6 15.2 7.3 5.1 3.4 5.7 9.7 3.6 7.9 5.0 3.8 5.9 5.1 5.7 4.9 2.8 6.8 7.6 5.5 6.3 3.6 2.8 5.8 4.4 2.7 12.3 11.8 18.5 12.8 11.7 10.4 13.3 12.3 10.2 13.4 6.0 0.6 0.5 1.0 0.7 4.2 2.4 2.5 2.7 7.9 0.0 0.0 0.8 0.0 0.9 0.4 2.2 0.9 0.0 1.2 0.7 0.8 1.4 4.6 1.7 0.9 1.6 5.8 3.1 1.6 0.0 2.3 1.5 0.0 0.0 1.6 1.1 0.4 0.0 1.4 1.1 3.6 6.5 0.9 1.2 2.1 1.1 0.7 0.0 1.7 1.3 ZNF418 "FLJ31551, KIAA1956" ENSG00000196724 "Zinc finger protein 418" Q8TF45 19 57921884-57935393 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 7.7;Ciliated cells: 8.1;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 13.2;SuSa: 9.5;T-47d: 8.2" "HPA043800, HPA053762, HPA072145" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "unprognostic (4.41e-2)" "unprognostic (3.20e-1)" "unprognostic (1.91e-1)" "unprognostic (4.27e-1)" "unprognostic (2.21e-2)" "unprognostic (1.44e-2)" "unprognostic (1.62e-1)" "unprognostic (2.20e-1)" "unprognostic (2.96e-3)" "unprognostic (1.14e-1)" "unprognostic (6.92e-3)" "prognostic unfavorable (1.72e-4)" "unprognostic (1.63e-2)" "unprognostic (4.77e-2)" "unprognostic (1.66e-1)" "unprognostic (1.29e-1)" "unprognostic (1.36e-3)" 3.0 4.5 9.4 4.2 13.4 2.7 9.3 25.8 11.8 4.4 6.0 16.0 9.4 1.6 6.4 8.6 3.1 7.5 5.5 13.2 9.8 6.3 5.7 3.2 5.4 7.5 14.5 10.2 10.3 6.9 14.8 10.0 8.7 9.9 7.7 2.5 5.8 5.0 9.2 4.6 13.7 3.6 6.5 9.7 7.4 5.3 8.2 11.9 3.5 9.9 1.0 6.8 5.8 4.3 8.5 2.9 1.9 2.1 5.9 3.0 1.1 0.4 2.0 13.2 4.2 2.1 4.5 1.5 3.7 1.3 3.0 0.2 0.3 1.4 0.5 2.7 2.3 4.0 1.2 0.0 3.3 3.6 0.3 1.1 0.2 0.9 0.2 1.2 0.4 2.7 3.7 1.0 3.7 0.0 0.0 0.6 1.1 1.0 0.9 2.5 0.5 0.7 0.5 6.8 0.1 0.5 0.5 1.0 4.4 2.6 1.6 0.2 0.6 0.1 2.4 0.1 9.5 8.2 1.4 0.0 0.8 0.6 0.5 0.7 2.2 5.2 3.3 0.4 1.5 2.6 1.9 0.8 0.7 0.3 2.1 0.8 5.0 1.8 1.2 1.7 8.5 3.0 0.8 1.1 5.9 0.7 2.9 0.0 1.1 9.4 13.4 25.8 11.8 9.8 6.3 14.5 10.2 9.9 11.9 0.0 1.1 0.5 0.8 0.3 3.9 7.7 2.5 8.1 1.2 0.0 3.9 1.0 1.7 1.1 0.1 1.6 0.0 0.0 0.5 0.5 0.9 1.1 5.7 0.5 0.7 3.2 0.0 1.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 4.0 0.2 0.0 1.4 0.7 5.4 12.9 0.9 1.0 6.4 0.4 0.7 0.5 0.0 0.7 ZNF439 DKFZp571K0837 ENSG00000171291 "Zinc finger protein 439" Q8NDP4 19 11848726-11883750 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 49.1;Rod photoreceptor cells: 47.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 15.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 12.9;U-138 MG: 13.8" HPA047845 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.56e-1)" "unprognostic (2.56e-3)" "unprognostic (4.83e-2)" "unprognostic (3.55e-3)" "unprognostic (2.93e-2)" "unprognostic (1.19e-3)" "unprognostic (8.26e-3)" "unprognostic (7.54e-2)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "unprognostic (9.66e-4)" "unprognostic (1.00e-1)" "unprognostic (8.68e-2)" "unprognostic (2.40e-1)" "unprognostic (8.19e-2)" "unprognostic (4.94e-2)" "unprognostic (1.29e-2)" 3.4 4.7 11.0 8.6 13.2 6.2 9.9 19.7 10.7 6.2 6.0 9.2 6.6 2.3 7.4 9.0 4.3 5.2 4.4 5.5 8.8 5.3 8.0 1.9 6.7 11.2 15.7 10.5 11.4 6.1 27.3 16.8 8.8 11.8 8.2 6.8 5.8 7.0 8.1 1.8 13.1 10.0 4.9 9.7 12.4 5.1 8.5 12.8 13.7 10.0 2.3 12.4 9.0 8.1 8.6 2.5 15.9 2.8 1.9 5.3 1.9 0.1 0.0 3.6 10.6 0.3 0.3 0.0 4.5 1.6 5.4 3.7 2.5 0.2 3.8 1.9 2.4 1.6 0.1 0.0 0.3 6.4 0.0 0.1 3.7 0.0 1.5 1.1 0.0 3.7 1.1 0.3 1.1 0.0 2.4 0.0 3.6 0.7 0.0 0.3 0.3 5.1 12.9 4.5 0.0 1.0 6.1 1.0 0.0 4.0 2.2 6.6 7.1 0.0 0.1 4.6 4.0 2.8 8.4 0.0 13.8 1.3 1.2 2.6 5.3 8.2 8.6 0.2 0.0 3.7 15.9 0.5 4.8 1.7 1.4 2.1 8.6 2.8 1.7 2.5 7.6 5.3 2.9 1.5 1.9 2.8 2.4 1.1 1.9 11.0 13.2 19.7 10.7 8.8 5.3 15.7 10.5 11.8 12.8 3.0 7.2 15.7 1.8 0.5 27.0 3.1 12.7 6.7 10.3 0.0 49.1 24.1 3.3 6.9 3.6 4.7 4.1 0.0 1.6 17.8 3.1 2.5 28.9 0.0 3.5 15.9 5.8 7.4 1.6 2.8 4.0 3.1 5.0 1.0 2.4 12.5 2.5 3.2 7.4 1.9 47.8 12.9 3.8 15.6 6.6 1.6 11.3 8.5 2.1 1.4 ZNF468 ENSG00000204604 "Zinc finger protein 468" "A2RRD8, Q5VIY5" 19 52838008-52890375 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 46.9" "HPA043696, HPA062474" Uncertain Uncertain "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "HPA043696: AB_10793951, HPA062474: AB_2732685" "prognostic unfavorable (6.87e-4)" "unprognostic (2.16e-1)" "unprognostic (1.00e-2)" "unprognostic (1.31e-1)" "unprognostic (1.46e-2)" "unprognostic (2.24e-1)" "unprognostic (1.42e-2)" "unprognostic (9.93e-2)" "unprognostic (1.38e-2)" "unprognostic (2.55e-1)" "unprognostic (2.09e-1)" "unprognostic (1.25e-2)" "prognostic favorable (3.94e-7)" "unprognostic (1.04e-1)" "unprognostic (2.95e-2)" "unprognostic (1.41e-1)" "unprognostic (5.59e-2)" 6.6 7.6 6.6 3.5 5.1 5.2 6.9 8.4 5.1 6.2 6.2 4.3 11.0 3.2 4.7 6.4 6.3 6.3 8.0 4.6 4.2 2.9 8.2 3.4 4.9 9.8 4.2 2.8 4.8 10.0 8.8 5.5 65.5 5.2 7.9 7.2 3.1 7.0 5.8 3.7 4.6 10.8 6.2 3.9 5.1 7.1 3.4 3.3 12.0 10.4 1.9 5.5 8.0 5.4 8.8 7.0 11.5 10.3 19.1 12.5 8.6 6.2 0.8 5.7 10.0 6.1 4.5 16.7 5.0 6.3 6.5 9.7 6.2 3.9 9.6 5.1 5.3 7.7 3.3 3.9 5.1 8.6 0.0 5.8 7.3 6.4 2.6 12.4 0.4 9.4 7.2 6.1 8.0 6.6 3.6 5.4 5.3 7.2 0.4 5.7 1.4 9.1 5.9 7.0 4.5 6.1 5.5 8.2 6.4 8.8 46.9 5.9 8.7 6.3 5.7 1.5 12.6 7.5 5.7 4.4 2.2 5.7 3.0 7.3 3.9 13.9 8.6 0.5 0.8 8.0 8.3 6.1 11.5 12.3 10.3 12.5 8.1 8.0 9.8 7.0 8.8 10.0 9.2 6.3 19.1 8.0 5.3 9.3 8.6 6.6 5.1 8.4 5.1 4.2 2.9 4.2 2.8 5.2 3.3 3.0 3.7 4.5 4.7 3.0 1.0 3.3 7.6 0.0 5.7 8.7 0.0 6.4 14.9 6.1 2.4 3.1 5.3 0.0 8.3 10.7 2.5 8.9 17.3 2.6 5.4 0.0 8.2 3.1 10.0 0.4 0.9 3.5 1.7 3.6 12.2 0.8 7.5 7.0 2.5 5.4 0.2 0.0 2.7 0.5 4.0 4.6 20.1 6.9 6.9 9.7 ZNF480 MGC32104 ENSG00000198464 "Zinc finger protein 480" Q8WV37 19 52297177-52325922 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042218 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042218: AB_10794791" "unprognostic (1.50e-2)" "unprognostic (1.43e-1)" "unprognostic (1.56e-1)" "unprognostic (1.35e-1)" "unprognostic (3.01e-2)" "unprognostic (5.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.65e-4)" "unprognostic (4.22e-2)" "unprognostic (7.81e-3)" "unprognostic (4.97e-2)" "prognostic favorable (2.03e-4)" "unprognostic (3.05e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-1)" "unprognostic (1.82e-3)" 9.8 8.4 8.2 7.9 15.4 7.0 7.1 13.6 12.5 6.5 8.3 4.8 3.4 7.9 6.2 2.4 8.5 4.5 4.7 17.9 8.7 3.2 10.9 7.5 8.4 9.8 13.1 4.1 6.0 3.8 5.6 10.7 6.2 12.5 5.9 8.6 4.9 8.4 5.5 12.9 8.0 9.3 5.1 8.7 15.0 8.0 3.3 12.6 10.8 8.4 7.9 12.3 8.7 8.2 16.6 17.0 9.4 9.1 14.6 15.0 5.9 3.2 13.4 8.8 10.2 10.4 9.8 7.0 8.6 12.7 6.2 7.3 6.0 4.8 16.7 5.4 7.1 11.4 7.2 9.4 8.7 9.0 0.1 15.8 17.0 6.7 5.7 10.0 24.0 13.9 8.9 11.2 8.5 10.1 13.0 8.9 14.6 12.2 6.0 13.8 5.4 21.9 4.9 6.8 10.9 11.0 11.3 9.3 13.8 8.9 23.9 8.6 7.2 12.5 9.1 3.5 18.9 7.5 17.7 15.2 6.2 7.8 3.5 13.3 13.7 25.3 34.6 2.7 13.2 10.9 7.7 8.5 9.4 12.0 8.2 13.7 16.6 12.0 13.9 10.4 16.5 11.5 15.0 3.6 14.6 9.1 17.0 13.4 5.9 8.2 15.4 13.6 12.5 8.7 3.2 13.1 4.1 12.5 12.6 32.8 10.2 16.1 11.4 4.8 4.0 37.0 10.2 20.1 14.8 3.5 2.0 7.5 14.9 15.0 1.5 18.5 10.3 23.3 24.0 12.9 7.1 10.7 11.6 13.5 15.1 6.4 12.1 14.7 14.0 2.1 8.3 16.7 6.8 19.8 17.3 4.1 29.6 8.6 7.8 20.7 6.6 0.0 9.2 1.8 5.6 7.3 12.4 23.5 16.1 18.3 ZNF496 "MGC15548, ZKSCAN17, ZSCAN49" ENSG00000162714 "Zinc finger protein 496" Q96IT1 1 247297412-247331846 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055834 Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA055834: " "unprognostic (1.88e-3)" "unprognostic (3.31e-2)" "unprognostic (2.48e-2)" "unprognostic (1.23e-1)" "unprognostic (5.87e-2)" "unprognostic (6.88e-2)" "unprognostic (3.72e-3)" "unprognostic (3.31e-1)" "unprognostic (1.89e-2)" "unprognostic (6.10e-2)" "unprognostic (6.41e-2)" "unprognostic (4.19e-1)" "unprognostic (1.89e-3)" "unprognostic (8.24e-2)" "unprognostic (1.86e-1)" "unprognostic (2.25e-2)" "unprognostic (2.55e-1)" 10.1 6.2 6.9 6.4 8.2 6.3 8.7 11.4 13.5 17.8 10.8 15.1 4.7 4.1 16.1 11.4 7.2 16.8 8.7 9.6 6.3 5.8 8.1 4.7 8.7 6.8 6.3 6.2 21.7 20.4 12.7 7.0 10.6 7.3 10.1 6.3 14.5 8.1 12.3 16.6 5.9 6.7 13.0 7.1 9.6 9.2 21.1 7.8 22.4 14.1 7.0 7.5 12.8 8.5 1.5 2.7 0.3 1.0 2.7 5.5 1.8 12.0 11.1 11.7 14.3 4.7 12.0 14.8 5.7 14.1 12.7 11.5 6.0 11.3 3.4 9.8 9.2 4.8 10.4 12.0 10.9 12.8 9.3 2.9 11.2 7.8 6.8 12.7 13.6 5.8 12.7 11.5 9.9 23.9 14.2 15.0 16.4 19.8 8.8 7.8 7.7 13.4 9.4 23.6 5.3 16.6 12.8 12.9 4.6 7.8 14.6 10.1 22.2 7.6 8.6 11.3 11.2 9.0 16.9 10.3 9.3 13.2 4.1 17.6 9.8 7.8 9.9 3.9 0.9 10.0 0.0 1.0 0.3 2.1 0.7 3.4 0.8 0.9 2.3 2.7 1.5 1.9 5.5 0.3 2.7 1.0 1.6 0.3 1.8 6.9 8.2 11.4 13.5 6.3 5.8 6.3 6.2 7.3 7.8 0.0 2.7 1.5 3.6 3.3 6.8 7.6 2.5 4.0 5.7 1.8 2.0 4.1 1.7 3.8 8.3 5.7 1.0 0.0 5.0 5.0 6.6 4.8 3.5 1.8 5.0 3.2 4.7 7.4 4.7 28.7 5.2 2.0 3.3 3.6 2.0 1.5 4.4 2.9 6.7 2.4 6.9 6.5 6.6 14.0 8.3 3.0 3.5 1.7 3.4 3.9 ZNF511-PRAP1 ENSG00000283496 "ZNF511-PRAP1 readthrough" 10 133309410-133352529 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 31.6;liver: 23.8" "Cell type enriched" "Detected in single" 12 "Club cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 16.1;OE19: 11.5" "HPA035360, HPA038713, HPA052451" Supported Uncertain "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA035360: AB_10601931, HPA038713: AB_10673117, HPA052451: AB_2681839" 2.1 1.6 1.1 5.0 1.7 1.2 6.2 3.0 2.7 3.1 11.9 1.9 4.9 31.6 3.9 3.5 3.5 1.3 3.0 4.8 1.8 13.7 23.8 2.1 4.7 2.2 1.9 4.9 9.7 0.9 2.1 1.5 1.7 5.1 7.6 2.9 5.0 3.0 5.8 1.3 28.1 4.4 0.8 3.0 3.4 6.5 2.7 3.2 4.6 7.1 3.0 2.0 4.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.2 3.1 5.0 0.0 0.0 6.7 0.0 1.4 0.0 0.0 6.7 2.1 0.0 3.2 1.7 0.2 0.1 0.8 0.0 2.1 0.3 0.0 0.9 0.0 16.1 0.0 1.2 1.8 0.0 0.0 1.5 4.8 0.0 0.0 0.6 0.3 6.1 0.0 0.0 3.2 5.2 0.3 11.5 0.0 0.9 1.2 2.9 0.2 0.3 0.5 5.4 0.3 2.7 2.3 3.3 0.0 0.5 0.0 0.0 3.0 2.5 0.1 1.5 0.0 0.8 0.3 1.1 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF552 FLJ21603 ENSG00000178935 "Zinc finger protein 552" Q9H707 19 57803841-57814913 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "breast cancer: 23.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 20.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 20.5" "Cell line enhanced" "Detected in many" "RT4: 23.0;T-47d: 37.1" "HPA043800, HPA053762, HPA072145" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "prognostic favorable (4.57e-4)" "unprognostic (2.09e-1)" "prognostic favorable (2.66e-4)" "unprognostic (9.03e-2)" "unprognostic (9.89e-2)" "prognostic favorable (9.96e-4)" "unprognostic (3.03e-2)" "unprognostic (1.29e-3)" "unprognostic (3.36e-3)" "unprognostic (6.72e-2)" "unprognostic (1.93e-1)" "unprognostic (1.18e-1)" "unprognostic (2.24e-3)" "unprognostic (2.41e-2)" "unprognostic (9.01e-2)" "unprognostic (3.09e-1)" "unprognostic (2.04e-3)" 2.9 3.3 3.4 14.7 2.8 5.9 22.2 5.4 3.8 8.4 10.1 4.6 6.5 5.6 8.4 6.0 7.1 4.5 7.8 4.0 2.8 2.2 12.3 5.5 5.7 8.0 3.8 1.2 4.8 5.9 3.8 5.7 11.9 4.7 12.9 10.0 5.2 22.4 14.7 7.2 7.7 10.2 4.3 3.0 6.5 14.2 3.5 2.7 6.7 3.9 2.6 6.3 28.7 11.1 3.4 1.8 20.5 2.7 1.9 3.7 1.8 3.0 1.9 2.2 3.8 1.7 1.0 16.3 1.1 1.5 2.6 1.6 5.1 4.9 4.3 2.1 2.2 0.6 2.9 4.5 3.3 3.5 1.8 8.6 1.5 4.2 3.8 4.1 4.7 2.2 2.0 6.0 1.8 2.0 1.5 3.3 4.6 3.0 1.4 1.6 2.7 2.0 1.3 3.4 3.7 4.1 4.0 2.7 4.4 7.4 23.0 2.7 2.1 5.5 12.3 2.6 6.3 37.1 2.0 2.5 2.3 2.4 1.4 2.0 6.2 4.1 3.5 1.8 3.5 1.3 1.2 2.7 5.5 2.2 2.5 2.1 2.8 2.9 3.5 1.3 3.4 3.7 3.2 20.5 1.9 1.0 1.8 2.2 1.8 3.4 2.8 5.4 3.8 2.8 2.2 3.8 1.2 4.7 2.7 11.9 1.9 5.9 15.6 2.3 5.1 1.3 17.8 22.7 10.3 19.2 2.0 16.8 21.6 5.6 3.3 2.3 9.7 0.0 1.6 5.8 2.7 9.4 8.1 3.4 4.3 3.2 8.1 5.5 2.2 0.9 2.6 3.2 1.7 1.0 9.3 2.0 2.6 9.1 2.1 3.6 13.3 6.5 2.1 2.7 4.1 2.4 17.8 5.7 7.8 11.2 ZNF587 "FLJ14710, FLJ20813, UBF-fl, ZF6" ENSG00000198466 "Zinc finger protein 587" Q96SQ5 19 57849857-57865112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 29.4" "HPA042125, HPA043288, HPA056213" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069" "unprognostic (1.61e-2)" "unprognostic (5.39e-2)" "unprognostic (3.92e-2)" "unprognostic (1.91e-1)" "unprognostic (2.42e-1)" "unprognostic (2.12e-2)" "unprognostic (6.81e-2)" "unprognostic (3.53e-1)" "unprognostic (6.60e-3)" "unprognostic (1.43e-1)" "unprognostic (2.29e-1)" "unprognostic (6.84e-3)" "prognostic unfavorable (7.98e-4)" "unprognostic (1.59e-1)" "unprognostic (2.11e-1)" "unprognostic (7.30e-2)" "unprognostic (3.68e-3)" 7.4 6.3 11.8 17.8 11.2 9.4 13.5 11.0 10.5 7.7 20.0 10.1 16.7 11.6 9.4 13.0 7.8 7.7 13.4 7.5 7.6 6.6 9.0 7.5 7.7 7.5 11.2 9.5 10.0 11.2 8.9 14.7 10.7 7.8 12.4 18.8 7.5 15.0 9.3 7.7 8.2 25.1 7.6 6.8 8.1 13.2 5.1 9.5 17.0 10.5 2.6 13.1 9.2 9.0 3.6 2.0 6.0 2.0 1.7 2.4 1.0 5.5 6.7 5.9 5.0 5.7 7.9 7.6 5.6 6.7 7.9 6.6 8.7 4.1 6.0 2.9 5.2 3.3 4.2 9.9 8.5 15.1 3.7 20.9 9.0 17.4 5.4 3.7 9.0 7.4 7.7 3.7 8.4 7.7 7.2 8.4 5.9 9.2 5.1 5.6 2.6 5.4 2.8 2.5 2.1 6.0 5.3 5.9 3.2 5.0 29.4 8.2 4.2 7.6 5.7 2.3 7.9 5.8 4.9 4.4 7.6 4.6 2.4 7.0 10.2 7.4 5.7 3.7 4.1 4.3 6.0 1.8 1.9 1.8 1.6 2.1 1.9 1.9 1.6 1.3 3.6 2.1 2.4 5.1 1.7 2.0 2.0 1.7 1.0 11.8 11.2 11.0 10.5 7.6 6.6 11.2 9.5 7.8 9.5 3.0 5.0 6.0 10.8 8.1 19.4 6.9 25.5 13.4 6.8 7.0 29.5 9.3 10.0 7.9 7.4 6.0 12.0 0.0 3.1 9.3 8.4 12.6 12.7 6.6 5.6 19.1 22.4 11.6 5.1 1.0 4.4 5.5 0.0 3.6 19.3 8.4 6.0 14.4 8.5 6.1 23.9 0.0 5.1 3.7 7.6 5.8 8.5 6.9 14.1 13.3 ZNF587B ENSG00000269343 "Zinc finger protein 587B" E7ETH6 19 57819741-57846238 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 29.1" "HPA043800, HPA053762, HPA072145" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "unprognostic (4.13e-3)" "unprognostic (1.43e-1)" "unprognostic (1.36e-1)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (5.69e-2)" "unprognostic (3.22e-3)" "unprognostic (3.80e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (5.47e-2)" "unprognostic (2.47e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (1.16e-1)" "unprognostic (3.57e-2)" "unprognostic (2.94e-1)" "unprognostic (7.48e-2)" "unprognostic (8.70e-2)" 7.6 7.1 5.0 15.0 7.9 19.4 14.1 8.9 6.5 7.8 10.4 6.6 12.4 12.6 13.6 10.7 9.4 9.1 10.7 6.4 5.4 3.3 8.9 14.6 9.3 10.9 6.2 5.5 10.9 17.2 13.3 14.5 8.2 5.7 10.1 11.5 7.6 19.5 16.7 12.7 14.5 12.6 10.2 3.7 15.5 10.3 11.8 7.4 8.0 10.2 7.1 13.1 10.8 7.0 4.5 3.7 5.0 5.3 3.2 6.3 4.5 4.8 13.0 5.8 12.0 1.4 1.5 6.2 3.6 3.1 4.4 2.6 7.8 7.3 9.9 2.1 5.4 2.0 3.8 5.0 13.2 10.0 1.6 11.6 7.0 10.6 8.4 5.1 12.3 7.1 5.0 2.7 5.8 6.2 1.1 3.4 6.9 8.1 4.8 2.5 5.3 5.7 2.1 14.7 4.9 6.0 4.8 5.1 4.5 5.3 29.1 3.4 5.5 4.0 5.9 3.4 9.5 7.8 5.2 4.6 5.1 5.8 1.0 5.5 6.4 5.1 7.8 4.2 3.8 5.6 5.0 5.3 2.5 3.9 5.3 4.8 4.5 4.4 4.9 3.2 4.4 6.3 5.3 2.4 3.2 2.9 3.7 3.0 4.5 5.0 7.9 8.9 6.5 5.4 3.3 6.2 5.5 5.7 7.4 6.0 1.0 4.2 2.9 2.9 3.6 2.8 5.1 2.7 7.9 0.0 0.0 2.9 1.7 3.2 3.6 2.8 1.1 0.0 1.7 2.7 1.0 2.6 0.0 2.4 1.2 3.2 4.1 5.5 2.1 1.0 0.6 3.2 1.7 0.0 3.3 0.8 1.7 0.0 0.7 2.5 3.2 6.5 0.5 3.8 4.7 3.3 2.1 1.5 2.8 2.6 ZNF644 "BM-005, KIAA1221, MGC60165, MGC70410" ENSG00000122482 "Zinc finger protein 644" Q9H582 1 90915298-91022272 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057795 Uncertain Uncertain Vesicles NA NA Vesicles "HPA057795: AB_2683529" "unprognostic (8.20e-2)" "unprognostic (5.86e-3)" "prognostic favorable (4.27e-4)" "prognostic unfavorable (8.39e-4)" "unprognostic (3.19e-3)" "unprognostic (4.62e-3)" "unprognostic (8.04e-2)" "unprognostic (7.01e-2)" "unprognostic (2.44e-2)" "unprognostic (6.32e-2)" "unprognostic (1.70e-1)" "unprognostic (1.16e-1)" "unprognostic (2.61e-2)" "unprognostic (3.03e-1)" "unprognostic (5.09e-2)" "unprognostic (1.03e-1)" "unprognostic (3.07e-1)" 22.2 14.1 20.7 19.0 20.0 19.4 23.9 34.9 25.1 24.7 17.6 17.8 17.1 11.2 23.8 16.7 17.6 14.4 14.2 14.9 21.7 16.6 15.2 26.2 15.1 19.5 23.7 18.9 21.3 14.4 22.4 24.2 18.2 23.3 18.3 18.7 12.0 20.6 15.3 20.3 14.4 19.1 19.2 25.3 21.6 14.6 17.1 26.5 35.3 26.1 14.9 19.7 19.9 18.3 8.1 7.0 5.0 4.8 12.5 8.6 3.2 13.0 6.3 18.4 10.1 8.6 10.1 10.6 11.4 12.1 13.1 14.0 8.3 4.8 16.0 12.7 8.7 17.2 10.4 18.3 13.3 19.4 11.4 10.3 20.7 12.4 11.9 12.3 18.7 6.9 9.5 15.7 12.9 17.6 12.1 13.6 12.0 14.4 18.5 13.6 4.7 15.3 16.7 16.7 6.9 11.8 15.1 30.1 9.0 13.5 12.1 15.1 11.8 14.1 11.0 29.2 13.1 7.2 19.0 10.7 14.4 11.9 11.7 17.5 13.2 8.9 21.4 5.8 14.4 7.4 5.0 4.5 5.0 6.2 4.8 7.0 8.1 7.0 7.0 5.8 7.2 8.6 7.5 1.3 12.5 4.7 7.0 5.5 3.2 20.7 20.0 34.9 25.1 21.7 16.6 23.7 18.9 23.3 26.5 65.5 23.0 38.4 82.6 48.1 32.9 41.2 22.9 36.1 45.5 10.4 23.6 21.1 26.6 28.4 7.0 36.5 26.5 0.0 19.7 15.1 32.9 51.0 43.7 23.2 19.0 52.4 52.8 20.3 24.0 11.7 43.1 27.4 33.7 20.8 24.3 37.9 25.0 28.1 32.5 22.1 34.8 51.8 64.6 45.3 49.0 41.5 10.1 34.6 31.0 62.6 ZNF660 FLJ36870 ENSG00000144792 "Zinc finger protein 660" Q6AZW8 3 44578223-44599694 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 23.8;Muller glia cells: 30.4;Rod photoreceptor cells: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "myeloid DC: 1.1;naive B-cell: 1.3;NK-cell: 1.6;plasmacytoid DC: 3.7" "Group enriched" "Detected in many" 5 "B-cells: 1.3;dendritic cells: 3.7;NK-cells: 1.6" "Cell line enhanced" "Detected in some" "AF22: 5.6;HEL: 5.5;NTERA-2: 8.6;RH-30: 5.7;SuSa: 4.9" "Low region specificity" "Detected in all" HPA029705 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" "HPA029705: AB_10602592" "unprognostic (5.43e-2)" "unprognostic (3.58e-2)" "unprognostic (1.07e-1)" "unprognostic (9.52e-3)" "unprognostic (1.25e-1)" "unprognostic (6.34e-2)" "unprognostic (1.22e-1)" "unprognostic (3.73e-2)" "unprognostic (2.46e-2)" "unprognostic (1.36e-2)" "unprognostic (2.91e-3)" "unprognostic (8.56e-2)" "unprognostic (2.79e-3)" "unprognostic (4.87e-3)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "unprognostic (1.94e-2)" 3.1 3.1 3.5 3.0 5.9 3.5 3.0 10.3 7.2 7.6 3.8 3.8 4.4 1.3 7.9 5.2 2.2 5.2 3.6 2.9 4.4 3.8 2.5 1.3 2.9 4.2 5.7 6.2 11.3 2.6 6.3 11.5 3.7 6.0 5.7 2.2 5.5 2.1 4.7 2.3 2.1 2.7 5.9 6.4 3.4 2.7 4.4 4.7 1.8 4.7 0.8 3.1 4.1 4.1 1.3 3.7 0.4 0.4 1.6 0.3 0.2 0.0 0.0 5.6 1.3 0.1 0.0 0.8 0.6 1.4 0.8 0.8 0.0 0.0 0.1 1.2 0.5 0.0 0.0 1.8 0.0 1.0 0.0 0.0 5.5 0.4 0.8 1.3 0.1 0.0 2.3 0.1 2.0 0.0 0.1 1.3 0.0 0.0 0.3 2.9 0.0 0.0 3.2 8.6 0.0 0.0 0.1 5.7 0.0 0.1 0.3 1.4 3.8 0.0 0.0 0.1 4.9 0.1 2.1 0.4 1.6 1.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.2 0.1 0.1 0.2 0.2 0.3 1.1 1.3 0.2 0.2 0.2 1.6 0.0 3.7 0.0 0.2 3.5 5.9 10.3 7.2 4.4 3.8 5.7 6.2 6.0 4.7 0.0 5.9 0.0 0.8 0.1 23.8 1.9 5.1 1.4 5.7 0.0 5.9 0.0 0.0 0.9 8.0 3.6 0.0 0.0 0.5 0.0 2.4 0.6 5.8 0.0 1.6 11.1 4.1 1.8 0.6 1.3 4.6 1.1 0.0 3.6 0.1 30.4 0.8 0.0 3.2 0.1 22.7 0.0 2.5 3.9 3.1 0.0 0.0 0.8 0.2 0.3 ZNF682 BC39498_3 ENSG00000197124 "Zinc finger protein 682" O95780 19 19997058-20039506 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 13.7" "Cancer enhanced" "Detected in many" "testis cancer: 7.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 12.0;AN3-CA: 18.0" HPA055998 Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA055998: AB_2683002" "unprognostic (8.96e-2)" "unprognostic (3.93e-2)" "unprognostic (4.78e-2)" "unprognostic (1.10e-1)" "unprognostic (6.16e-2)" "unprognostic (6.95e-3)" "unprognostic (1.69e-2)" "unprognostic (1.71e-2)" "unprognostic (6.44e-2)" "unprognostic (1.24e-3)" "unprognostic (7.70e-4)" "unprognostic (1.77e-3)" "unprognostic (4.06e-7)" "unprognostic (2.07e-1)" "unprognostic (2.10e-1)" "unprognostic (1.19e-1)" "prognostic favorable (3.51e-4)" 4.1 4.9 11.0 5.2 14.1 4.1 7.6 13.6 12.9 5.9 5.3 10.3 8.5 3.5 5.2 8.1 5.3 6.9 5.3 7.1 10.5 7.6 6.3 6.9 8.1 7.9 12.5 6.5 4.6 4.9 4.6 12.0 6.7 9.4 11.0 5.8 4.3 3.3 16.2 6.7 13.9 4.6 5.6 9.7 6.7 5.4 5.6 12.4 6.5 17.4 4.6 9.6 6.2 4.8 5.7 2.2 7.6 1.0 2.2 6.4 2.1 0.0 0.0 12.0 18.0 0.9 1.3 0.5 2.5 1.2 4.3 6.9 2.0 2.5 0.1 4.4 3.6 1.2 2.2 4.9 0.4 4.8 0.0 5.1 0.0 0.1 1.3 1.7 0.0 4.3 1.8 1.4 2.4 0.0 0.6 0.0 4.7 0.0 0.1 3.2 3.7 6.8 1.0 6.6 0.0 1.6 4.3 6.2 0.1 2.2 7.8 6.6 7.1 0.0 2.3 0.0 6.8 4.5 2.4 0.0 6.3 1.0 10.6 4.3 0.0 7.0 1.1 0.0 0.0 2.0 7.6 0.7 1.4 4.0 0.8 3.0 5.7 5.8 3.1 2.2 4.3 6.3 6.4 2.4 2.2 1.0 1.9 6.2 2.1 11.0 14.1 13.6 12.3 10.5 7.6 12.5 6.5 9.4 12.4 8.9 13.7 4.2 2.2 3.1 5.5 9.5 5.1 1.4 6.8 3.5 0.0 6.4 5.0 3.4 1.1 3.3 1.0 0.0 6.4 5.4 2.4 2.4 2.3 2.6 2.3 3.2 1.2 4.9 4.1 0.5 1.7 2.5 1.7 0.0 3.5 3.8 3.6 0.0 4.2 3.0 2.0 0.0 2.0 4.4 4.1 3.0 2.1 7.5 2.6 1.6 ZNF69 Cos5 ENSG00000198429 "Zinc finger protein 69" Q9UC07 19 11887784-11914329 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 15.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 11.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 13.1" HPA047845 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.08e-1)" "unprognostic (4.58e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.55e-4)" "unprognostic (2.45e-2)" "unprognostic (1.21e-2)" "unprognostic (3.47e-2)" "unprognostic (1.37e-2)" "unprognostic (3.08e-3)" "unprognostic (3.97e-2)" "unprognostic (2.09e-1)" "unprognostic (4.83e-3)" "unprognostic (4.12e-2)" "unprognostic (2.54e-1)" "unprognostic (1.26e-1)" "unprognostic (7.97e-2)" "unprognostic (1.93e-2)" 3.8 7.7 4.3 10.6 4.9 3.5 14.3 6.7 5.4 7.9 10.9 3.5 5.4 3.4 6.3 4.6 2.9 8.3 7.8 7.1 6.1 3.6 14.0 11.8 7.1 7.1 4.5 1.6 11.1 11.0 22.7 4.9 4.5 7.1 7.4 11.6 5.7 5.9 4.1 2.5 2.1 5.2 12.1 6.3 4.2 12.7 11.1 4.8 9.4 6.3 1.9 3.0 7.8 13.8 1.0 2.4 11.0 2.3 3.3 4.8 2.0 5.0 0.2 13.1 7.3 1.4 0.1 4.5 7.6 5.3 4.2 5.2 3.4 2.0 3.2 4.5 4.4 3.2 0.1 0.0 2.9 4.3 0.0 0.1 1.5 0.1 7.5 1.1 0.0 3.1 2.1 0.0 1.5 0.1 2.1 0.1 4.6 0.0 0.2 8.7 0.0 3.9 0.6 8.1 0.4 0.0 0.1 3.0 0.1 9.6 3.4 1.2 3.6 0.0 0.2 1.9 6.7 6.7 2.0 0.3 3.4 2.2 3.4 4.2 3.5 3.2 0.0 0.1 0.0 10.6 11.0 2.1 1.5 2.6 2.3 2.5 1.0 1.8 1.1 2.4 0.7 4.7 4.8 0.8 3.3 1.2 1.7 1.2 2.0 4.3 4.9 6.7 5.4 6.1 3.6 4.5 1.6 7.1 4.8 3.0 7.5 0.0 1.3 0.2 0.7 2.4 15.3 5.3 6.8 5.2 0.0 3.1 3.3 4.5 6.8 1.8 2.0 0.0 3.1 2.8 1.3 1.0 7.0 9.6 2.5 0.0 0.0 3.7 2.7 12.7 2.3 3.6 5.0 0.0 5.6 0.5 8.4 3.5 1.8 8.6 0.2 12.9 1.0 2.7 1.5 0.1 1.6 2.9 5.9 2.6 ZNF700 DKFZp434I1610 ENSG00000196757 "Zinc finger protein 700" Q9H0M5 19 11925068-11950773 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA047845 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.92e-1)" "unprognostic (1.20e-2)" "unprognostic (3.99e-1)" "unprognostic (1.97e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.27e-4)" "unprognostic (8.63e-2)" "unprognostic (8.68e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (9.02e-2)" "unprognostic (7.44e-2)" "prognostic unfavorable (1.75e-4)" "prognostic unfavorable (2.01e-5)" "unprognostic (8.38e-2)" "unprognostic (2.24e-1)" "unprognostic (1.30e-1)" "prognostic favorable (2.53e-5)" 10.2 10.3 7.7 22.2 9.6 19.7 21.6 10.2 8.9 8.3 11.3 5.7 13.6 8.4 9.5 12.7 11.8 8.6 13.9 6.8 7.2 3.8 13.6 16.7 13.5 14.6 8.6 5.4 13.1 23.7 13.4 12.4 6.9 7.4 12.0 15.2 7.2 15.8 11.5 5.1 21.8 15.3 14.4 7.1 20.7 11.3 17.3 8.5 10.3 11.2 6.7 14.7 10.8 13.4 6.9 6.4 9.5 8.1 7.2 8.3 3.8 6.5 0.3 7.1 7.3 4.5 5.0 7.2 7.0 6.1 6.3 8.4 5.5 3.3 8.7 6.2 4.5 4.3 5.2 5.8 5.1 8.8 4.9 3.1 8.9 6.5 4.9 3.8 12.6 13.3 4.1 6.1 5.4 6.1 4.3 3.9 5.8 10.0 19.6 9.1 5.4 6.9 11.7 7.3 3.9 6.5 5.9 9.4 6.7 9.0 7.6 4.2 5.1 6.4 4.3 8.2 6.8 7.3 14.5 5.6 16.3 4.2 11.1 8.0 13.6 7.2 9.2 4.3 10.4 5.3 9.5 4.6 9.0 6.9 5.2 7.8 6.9 5.7 8.3 6.4 4.4 5.5 6.9 7.3 7.2 8.1 4.1 6.4 3.8 7.7 9.6 10.2 8.9 7.2 3.8 8.6 5.4 7.4 8.5 8.9 10.2 6.7 1.7 2.7 2.3 3.6 10.2 4.0 10.3 1.8 2.0 4.3 1.7 4.6 0.4 3.6 5.2 0.0 4.0 3.9 1.7 1.7 15.1 7.2 3.8 0.0 2.9 6.2 7.5 0.9 4.0 4.6 5.0 1.0 6.8 2.0 4.9 8.6 1.8 1.3 4.1 0.0 5.1 10.6 6.4 1.5 3.1 5.1 8.1 1.1 ZNF727 ZNF727P ENSG00000214652 "Zinc finger protein 727" A8MUV8 7 64045443-64078549 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 13.7" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 1.9;Distal tubular cells: 3.3;Early spermatids: 1.8;Horizontal cells: 1.6;Late spermatids: 1.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "T-47d: 13.1" "HPA051027, HPA061215" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA051027: , HPA061215: AB_2684452" "unprognostic (5.87e-2)" "unprognostic (3.05e-1)" "unprognostic (1.28e-1)" "unprognostic (2.75e-3)" "unprognostic (1.36e-2)" "unprognostic (1.80e-1)" "unprognostic (3.86e-2)" "unprognostic (1.56e-1)" "unprognostic (1.16e-2)" "unprognostic (2.59e-1)" "unprognostic (1.69e-1)" "unprognostic (2.54e-1)" "unprognostic (4.04e-2)" "unprognostic (5.73e-4)" "unprognostic (8.70e-2)" "unprognostic (6.36e-2)" "unprognostic (8.61e-2)" 2.6 1.6 2.7 0.9 10.6 0.3 5.4 3.9 7.4 5.2 1.7 5.8 0.0 0.6 5.9 3.1 2.0 4.7 1.6 2.2 4.7 3.1 0.5 1.9 1.2 5.3 2.5 9.1 2.0 1.1 13.7 0.3 7.2 4.9 2.0 3.1 2.2 3.3 1.2 2.0 1.0 3.7 4.2 1.6 2.0 5.5 6.1 0.0 8.7 0.0 0.9 2.6 3.9 1.1 0.4 0.0 0.4 0.4 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.0 13.1 0.0 0.0 0.0 1.6 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.4 1.1 1.0 0.7 0.0 0.4 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.4 0.1 0.2 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 ZNF736 ENSG00000234444 "Zinc finger protein 736" B4DX44 7 64307459-64354860 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 36.3;Late spermatids: 47.2;Rod photoreceptor cells: 44.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA051027, HPA061215" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA051027: , HPA061215: AB_2684452" "unprognostic (2.41e-1)" "unprognostic (2.71e-2)" "unprognostic (1.17e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (4.14e-1)" "unprognostic (1.24e-1)" "unprognostic (1.20e-3)" "unprognostic (4.89e-2)" "unprognostic (2.51e-2)" "unprognostic (2.11e-2)" "unprognostic (2.01e-2)" "prognostic unfavorable (5.01e-4)" "unprognostic (2.26e-1)" "unprognostic (9.63e-2)" "unprognostic (5.28e-2)" "unprognostic (2.22e-3)" "prognostic favorable (8.65e-4)" 7.1 5.4 8.5 8.2 17.4 17.0 12.9 8.3 19.8 7.7 5.5 7.8 4.7 3.9 8.4 9.8 5.4 7.7 6.3 5.3 7.5 6.0 8.2 3.7 7.4 14.0 5.5 8.2 13.1 7.5 6.2 7.6 5.4 13.8 8.6 6.1 11.5 7.7 5.7 4.2 13.1 8.5 6.3 5.8 10.1 6.2 16.8 7.0 17.1 10.6 2.0 11.4 6.1 7.4 4.7 3.5 2.8 2.1 0.3 2.4 1.0 0.5 0.2 4.6 15.9 1.7 3.1 4.7 2.5 0.1 3.3 5.4 1.2 2.6 11.9 3.8 2.1 4.5 2.0 3.5 1.0 5.3 0.2 3.3 4.8 1.4 0.1 1.7 2.1 6.9 2.5 1.0 3.8 0.1 1.6 0.4 7.0 5.7 2.6 4.6 3.0 7.2 11.3 8.9 0.1 0.9 6.2 7.2 5.8 4.1 7.0 5.0 7.3 5.7 4.1 1.5 9.1 11.3 8.8 0.3 5.2 3.7 1.3 3.0 3.1 4.3 14.5 0.1 2.6 0.1 0.0 1.9 2.8 1.5 1.8 1.1 4.7 2.3 1.3 2.1 4.5 2.4 1.9 0.4 0.3 2.1 3.5 1.0 1.0 8.5 17.4 8.3 19.8 7.5 6.0 5.5 8.2 13.8 7.0 6.0 4.8 7.7 2.1 3.4 14.4 2.8 10.2 1.4 4.5 5.2 11.8 3.0 5.0 3.3 36.3 4.3 1.3 0.0 1.9 2.6 3.1 2.5 0.0 2.9 3.1 7.9 1.2 6.2 5.3 47.2 2.3 6.4 3.3 1.8 4.7 6.8 1.9 2.9 2.8 3.4 44.8 0.0 2.0 6.3 6.5 3.4 2.3 4.4 2.8 1.7 ZNF763 ZNF440L ENSG00000197054 "Zinc finger protein 763" Q0D2J5 19 11965037-11980381 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 9.7" HPA047845 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (4.09e-3)" "unprognostic (6.15e-4)" "unprognostic (1.28e-1)" "unprognostic (1.54e-2)" "unprognostic (6.15e-2)" "unprognostic (1.43e-4)" "unprognostic (1.43e-1)" "unprognostic (8.26e-3)" "unprognostic (9.36e-3)" "unprognostic (1.93e-2)" "unprognostic (1.17e-3)" "unprognostic (1.43e-1)" "unprognostic (6.07e-6)" "unprognostic (1.47e-1)" "unprognostic (3.08e-1)" "unprognostic (1.11e-1)" "unprognostic (8.89e-3)" 7.0 5.2 3.6 4.1 6.6 3.0 9.1 5.5 5.4 7.3 9.0 5.6 6.8 4.8 8.3 5.4 5.1 6.0 4.5 9.7 4.0 3.3 11.1 3.6 7.1 6.3 5.5 3.5 12.6 7.6 12.4 7.5 8.6 5.6 9.5 5.7 9.2 6.5 10.3 4.9 4.7 7.1 6.2 4.6 9.4 5.5 7.1 7.1 8.0 14.3 3.9 6.5 7.3 7.6 8.0 3.2 11.1 4.8 4.9 4.2 2.1 0.4 0.0 2.9 3.1 1.8 0.8 9.7 2.6 2.4 2.2 2.2 1.0 0.6 3.0 2.5 2.0 0.7 0.8 0.0 1.5 1.0 0.4 0.1 1.2 0.1 0.1 0.4 1.6 3.3 4.2 2.0 0.5 0.3 0.7 0.4 4.6 0.4 1.3 2.2 0.3 3.4 0.8 1.3 0.3 0.3 0.2 0.1 1.0 4.4 2.7 0.5 1.2 0.2 0.1 0.6 5.6 5.6 1.8 0.4 3.0 0.1 2.5 0.7 4.5 5.7 0.9 0.7 0.6 0.4 11.1 1.9 5.7 3.1 2.5 2.3 3.4 2.8 4.2 3.2 8.0 3.5 3.8 10.5 4.9 4.8 2.5 1.5 2.1 3.6 6.6 5.5 5.4 4.0 3.3 5.5 3.5 5.6 7.1 3.0 4.5 0.0 0.4 0.1 2.8 0.6 0.0 2.7 4.5 0.0 9.8 4.3 1.7 0.6 3.7 0.0 0.8 0.0 0.3 1.6 0.5 0.5 1.1 0.8 1.1 0.0 1.2 0.0 1.0 0.0 1.4 0.0 0.0 1.0 2.2 2.9 0.3 0.0 1.8 1.3 6.1 0.0 0.3 2.8 1.4 0.0 1.5 0.0 0.9 0.1 ZNF814 ENSG00000204514 "Zinc finger protein 814" B7Z6K7 19 57848731-57889074 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 21.5;U-266/84: 19.8" "HPA043800, HPA053762, HPA072145" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "unprognostic (3.74e-2)" "unprognostic (1.24e-1)" "unprognostic (4.53e-2)" "unprognostic (3.29e-2)" "unprognostic (6.01e-2)" "unprognostic (2.12e-2)" "unprognostic (1.03e-1)" "unprognostic (4.69e-2)" "unprognostic (6.78e-4)" "unprognostic (5.05e-3)" "unprognostic (2.41e-4)" "unprognostic (1.56e-2)" "unprognostic (4.99e-4)" "unprognostic (3.94e-1)" "unprognostic (2.33e-1)" "unprognostic (1.08e-1)" "unprognostic (1.54e-5)" 5.6 13.3 11.6 9.0 11.0 12.6 12.2 19.2 10.8 6.4 10.0 4.4 15.7 9.7 5.6 10.5 5.2 12.5 9.8 9.5 11.5 10.3 15.0 11.7 5.9 11.1 9.1 8.4 7.8 6.7 10.9 16.2 9.7 7.7 11.4 7.3 16.1 9.0 18.4 18.6 13.3 12.7 9.0 7.3 13.8 5.5 14.0 5.6 18.7 23.0 4.0 11.5 6.6 5.0 21.2 15.3 5.0 5.0 12.8 13.6 4.5 0.9 2.4 7.3 10.8 0.8 0.7 1.8 2.7 1.8 3.0 0.4 1.3 1.0 5.5 1.8 2.5 2.9 0.8 0.5 5.9 3.8 0.8 4.9 4.1 3.3 1.3 3.3 4.7 5.1 4.9 5.2 1.2 1.1 4.8 0.9 1.9 1.0 2.0 4.6 0.9 15.4 2.1 21.5 0.5 3.1 1.7 0.8 9.7 2.4 3.9 2.8 7.8 0.9 1.8 3.7 16.4 5.3 1.4 1.3 6.8 2.3 1.5 1.2 6.4 19.8 13.9 1.4 2.5 8.1 2.2 4.5 5.0 3.2 5.0 8.2 19.4 8.4 6.9 6.6 21.2 13.6 11.0 2.7 12.8 2.9 15.3 2.1 4.5 11.6 11.0 19.2 10.8 11.5 10.3 9.1 8.4 7.7 5.6 0.0 1.0 19.5 6.3 6.1 21.1 12.0 15.3 10.7 10.3 12.2 45.2 11.4 14.9 6.7 32.9 7.0 5.4 0.0 1.2 16.8 7.2 7.8 16.1 12.3 10.7 19.1 4.7 15.4 3.4 16.6 3.7 9.3 10.1 6.4 3.8 7.5 1.1 21.5 6.7 37.9 32.5 19.4 4.2 8.4 11.7 11.4 9.7 8.7 13.9 10.7 ZNF816-ZNF321P ZNF816-ZNF321 ENSG00000221874 "ZNF816-ZNF321P readthrough" 19 52928475-52962823 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 8.1;Syncytiotrophoblasts: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "RT4: 14.2" HPA051271 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA051271: AB_2681415" "unprognostic (4.18e-2)" 2.4 1.7 1.7 3.4 3.6 2.1 4.3 1.7 2.6 4.6 4.7 1.5 5.8 0.7 2.8 4.5 3.6 4.7 4.4 2.2 1.8 1.2 4.2 1.5 3.2 1.7 4.7 0.9 4.2 2.7 2.1 5.4 4.5 2.4 8.5 7.5 1.5 3.0 4.4 1.2 2.4 3.0 3.4 4.0 5.0 4.9 2.0 3.9 9.3 4.6 2.2 2.7 6.3 4.2 0.9 0.0 0.0 0.1 1.6 0.7 0.0 0.5 0.0 1.3 0.4 0.7 0.2 0.7 0.0 0.4 0.8 1.0 0.0 0.4 1.3 0.4 0.5 1.3 0.1 1.2 0.2 0.0 0.8 1.5 0.5 0.2 1.6 1.1 0.0 0.3 0.8 0.0 1.4 0.0 0.4 0.7 0.0 1.3 0.0 0.3 0.2 0.0 0.0 0.2 0.0 1.1 0.4 0.1 0.1 0.5 14.2 0.7 0.2 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.5 0.8 2.2 0.0 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.7 0.3 0.0 1.6 0.0 0.0 0.0 0.0 1.7 3.6 1.7 2.6 1.8 1.2 4.7 0.9 2.4 3.9 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 8.1 3.3 3.2 1.6 0.4 3.1 0.0 3.1 5.3 0.6 2.3 4.6 0.4 3.3 0.0 0.0 1.3 1.8 0.9 0.3 0.0 0.0 3.6 3.0 0.0 2.8 3.4 0.7 0.6 0.0 0.0 0.3 0.4 1.8 0.0 9.4 1.0 3.3 4.7 ZNRF2 RNF202 ENSG00000180233 "Zinc and ring finger 2" Q8NHG8 7 30284307-30367692 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072244 Approved Uncertain "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoplasm, Vesicles" "Nucleoli fibrillar center" "HPA072244: AB_2732197" "unprognostic (9.44e-2)" "unprognostic (2.38e-2)" "unprognostic (8.64e-2)" "prognostic unfavorable (7.68e-4)" "unprognostic (4.46e-2)" "unprognostic (1.24e-1)" "unprognostic (3.06e-1)" "unprognostic (6.10e-2)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" "unprognostic (5.93e-2)" "prognostic favorable (2.29e-4)" "unprognostic (1.51e-1)" "unprognostic (2.71e-1)" "prognostic favorable (8.71e-4)" "unprognostic (8.67e-2)" 7.8 8.0 10.0 9.3 10.6 9.7 16.2 12.8 10.0 5.8 16.1 10.5 7.6 11.3 7.7 9.7 14.2 5.2 8.7 8.4 9.6 6.1 19.3 24.0 7.9 12.0 10.0 7.4 5.8 14.0 8.0 9.9 9.6 11.0 7.0 14.3 5.8 10.5 13.7 17.5 11.5 12.7 8.3 10.5 9.2 12.4 20.6 9.1 7.9 13.3 9.8 10.9 9.4 11.8 1.3 5.8 1.4 1.1 0.7 2.4 0.5 6.7 2.5 2.0 1.8 2.3 1.6 10.7 2.6 2.7 2.9 3.9 1.2 11.3 7.1 6.8 2.1 7.5 6.6 6.7 4.4 3.1 6.9 6.1 4.4 5.2 3.3 1.2 3.4 8.4 2.5 7.5 2.0 4.9 3.0 2.4 5.5 5.4 14.2 3.1 2.6 6.9 9.0 4.7 6.7 3.1 6.0 4.4 12.1 8.7 14.6 7.0 6.6 5.2 22.0 4.3 12.4 5.9 13.8 2.7 2.8 4.8 2.7 5.4 24.3 20.8 9.3 3.1 7.4 4.1 0.5 0.9 1.1 1.0 0.9 1.5 1.3 1.2 1.4 0.8 0.8 0.7 1.1 1.4 0.7 1.1 5.8 2.4 0.5 10.0 10.6 12.8 10.0 9.6 6.1 10.0 7.4 11.0 9.1 8.9 6.7 5.2 5.8 14.2 11.0 3.2 17.8 2.7 4.5 15.7 39.3 7.5 6.6 4.9 4.3 4.5 42.5 0.0 8.9 8.0 4.4 5.5 3.5 33.4 9.4 1.6 30.1 9.2 18.9 7.6 2.6 11.2 11.8 9.0 14.5 4.3 6.7 14.4 2.1 26.0 5.7 6.5 7.2 20.9 7.9 16.6 9.6 8.7 19.6 10.8 ZNRF3 "BK747E2.3, FLJ22057, KIAA1133, RNF203" ENSG00000183579 "Zinc and ring finger 3" Q9ULT6 22 28883592-29057487 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036702, HPA036703" Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA036702: , HPA036703: AB_10672227" "unprognostic (1.07e-1)" "unprognostic (2.13e-3)" "unprognostic (7.48e-3)" "unprognostic (5.72e-2)" "unprognostic (6.81e-2)" "unprognostic (1.36e-1)" "unprognostic (2.22e-2)" "unprognostic (1.75e-2)" "unprognostic (1.37e-1)" "unprognostic (3.68e-2)" "unprognostic (5.18e-2)" "unprognostic (3.94e-1)" "unprognostic (9.55e-5)" "unprognostic (6.49e-2)" "unprognostic (1.02e-1)" "unprognostic (3.70e-2)" "unprognostic (2.55e-2)" 4.6 11.8 16.8 2.5 14.7 1.0 4.5 12.2 18.1 7.8 5.7 7.7 21.8 5.1 8.3 22.2 5.9 8.1 3.8 4.3 22.0 5.0 13.6 7.5 8.7 1.2 6.1 17.7 10.0 5.4 16.3 4.2 8.0 8.1 12.0 5.9 4.9 12.1 13.4 5.6 7.6 4.7 7.8 8.9 2.2 6.4 6.7 10.5 0.0 6.9 1.9 1.5 5.7 4.9 0.2 0.4 1.5 1.0 2.0 0.5 0.1 3.7 8.9 8.3 2.3 1.5 1.8 15.8 2.3 1.1 1.8 1.7 13.4 2.1 0.0 3.6 1.2 3.3 6.4 5.7 3.5 2.2 4.9 5.8 1.5 1.6 29.2 1.4 4.3 1.5 1.8 3.3 2.9 2.9 1.5 1.6 2.7 3.1 2.1 2.5 3.5 0.1 2.2 3.0 4.7 3.6 4.4 5.4 3.4 7.7 5.5 13.8 5.1 4.0 4.0 2.3 2.7 2.7 2.0 1.5 6.9 6.0 5.4 3.7 2.8 3.9 5.2 3.0 2.5 3.6 1.0 0.2 1.3 0.2 1.0 0.4 0.1 0.2 0.1 0.4 0.2 0.1 0.5 1.5 2.0 0.2 0.3 0.1 0.1 16.8 14.7 12.2 18.1 22.0 5.0 6.1 17.7 8.1 10.5 11.9 17.6 0.0 4.4 11.2 3.7 6.2 5.1 6.7 6.8 12.2 0.0 23.0 1.7 4.7 12.1 5.2 1.3 23.3 2.1 1.5 4.7 6.0 0.0 16.1 2.9 1.6 8.1 1.8 1.0 11.0 10.0 0.2 0.0 0.0 8.3 6.6 4.0 0.0 12.0 9.8 4.1 0.0 4.4 3.4 2.9 6.6 6.4 0.7 14.1 2.0 ZSCAN10 ZNF206 ENSG00000130182 "Zinc finger and SCAN domain containing 10" Q96SZ4 16 3088890-3099317 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 2.8;testis: 3.9" "Cell type enhanced" "Detected in single" 25 "Cytotrophoblasts: 1.5" "Cancer enriched" "Detected in single" 207 "testis cancer: 19.5" "Region enriched" "Detected in single" 7 "cerebellum: 2.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 9 "NTERA-2: 36.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA076826 Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA076826: " "unprognostic (4.37e-2)" "unprognostic (5.13e-2)" "unprognostic (9.15e-2)" "unprognostic (6.65e-3)" "unprognostic (6.24e-2)" "unprognostic (7.60e-2)" "unprognostic (3.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.72e-1)" "unprognostic (1.85e-11)" "unprognostic (5.98e-2)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" 0.2 0.2 0.3 0.2 0.2 1.3 0.2 2.7 1.4 0.2 0.2 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.5 0.2 1.3 0.9 0.3 0.2 0.2 0.1 0.2 0.2 0.2 1.1 2.8 0.3 0.2 0.2 0.6 1.2 3.9 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.8 0.7 2.4 0.8 0.6 1.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 36.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 2.4 0.8 0.8 0.4 0.6 1.1 0.8 0.2 1.0 0.4 0.8 0.5 0.6 1.3 0.6 0.7 0.7 0.1 0.2 0.3 0.2 2.7 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 ZSCAN22 "HKR2, ZNF50" ENSG00000182318 "Zinc finger and SCAN domain containing 22" P10073 19 58327019-58342332 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 5.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 18.2" "Low region specificity" "Detected in all" HPA006471 Uncertain Uncertain "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA006471: AB_2221026" "unprognostic (5.55e-3)" "unprognostic (2.24e-1)" "unprognostic (6.56e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-1)" "unprognostic (3.82e-2)" "unprognostic (2.47e-3)" "unprognostic (1.52e-1)" "unprognostic (2.91e-1)" "unprognostic (1.15e-1)" "unprognostic (2.15e-3)" "unprognostic (5.00e-2)" "unprognostic (7.59e-2)" "unprognostic (2.59e-2)" "unprognostic (1.74e-1)" "unprognostic (5.22e-3)" "unprognostic (1.07e-1)" 4.8 5.6 4.1 8.5 6.1 3.0 10.8 9.3 6.2 6.7 4.8 4.7 9.3 5.1 5.7 4.2 6.1 4.6 3.5 4.9 4.3 4.1 4.2 7.7 4.8 4.8 9.7 3.7 7.8 7.3 9.4 9.1 5.3 6.8 5.1 4.3 2.7 7.0 9.2 6.1 8.1 5.2 5.6 3.9 5.2 5.5 5.7 6.2 8.0 6.5 4.3 6.4 4.6 5.3 3.2 3.0 2.7 2.3 3.2 5.6 2.3 2.8 5.3 2.9 4.4 3.4 2.1 3.1 2.4 1.2 1.5 1.4 2.8 2.0 2.4 1.6 2.1 1.9 2.3 4.1 2.8 1.6 3.6 18.2 4.9 4.9 2.6 2.7 3.9 5.1 2.4 2.8 3.4 3.6 2.8 2.2 2.4 4.9 4.5 2.6 2.4 1.9 1.8 2.5 3.6 5.9 2.7 4.5 3.9 1.6 3.8 4.6 3.3 3.6 5.0 2.2 2.5 2.4 2.6 2.1 8.3 2.4 2.1 4.2 4.5 6.1 1.8 3.3 2.7 2.9 0.3 2.1 2.7 5.6 1.8 3.9 2.6 3.3 4.6 3.0 3.2 2.9 2.9 0.7 3.2 2.3 1.4 2.6 2.3 4.1 6.1 9.3 6.2 4.3 4.1 9.7 3.7 6.8 6.2 0.0 5.5 0.0 0.4 1.5 0.7 0.4 2.5 1.4 2.3 1.8 0.0 0.7 1.7 0.8 0.1 0.9 0.5 0.0 0.6 0.7 0.9 0.9 0.0 0.8 0.4 1.6 0.0 0.0 0.8 0.0 2.0 1.1 1.7 1.8 0.7 0.3 1.2 0.9 0.4 0.5 0.7 0.0 0.8 2.2 1.3 3.1 0.6 1.3 0.9 0.4 ZSCAN5A "MGC4161, ZNF495, ZSCAN5" ENSG00000131848 "Zinc finger and SCAN domain containing 5A" Q9BUG6 19 56219670-56368383 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 29.9" "Group enriched" "Detected in many" 6 "Early spermatids: 101.0;Late spermatids: 64.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041263, HPA043123, HPA046836, HPA060667" Uncertain Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: " "unprognostic (1.72e-1)" "unprognostic (3.19e-3)" "unprognostic (8.22e-4)" "unprognostic (1.65e-2)" "unprognostic (2.05e-3)" "unprognostic (6.99e-2)" "unprognostic (1.39e-3)" "unprognostic (3.10e-3)" "unprognostic (1.17e-1)" "unprognostic (2.42e-1)" "unprognostic (8.67e-4)" "unprognostic (1.14e-1)" "unprognostic (5.04e-2)" "unprognostic (2.10e-2)" "unprognostic (4.70e-2)" "unprognostic (6.15e-3)" "unprognostic (3.99e-3)" 4.0 4.9 5.2 5.4 9.9 3.8 4.3 5.9 8.0 6.0 6.0 6.5 4.9 6.1 6.6 5.0 4.7 11.3 4.3 8.1 5.2 4.8 5.6 5.8 5.0 4.3 4.9 3.9 6.3 5.9 6.4 14.3 4.9 6.9 4.6 7.4 9.9 5.7 7.8 5.9 6.1 5.6 6.3 3.4 4.6 4.1 29.9 5.5 7.6 5.4 5.9 5.3 4.6 4.7 4.2 10.8 4.7 8.9 1.4 8.0 4.1 4.8 4.2 6.1 7.4 5.0 3.2 8.9 2.9 6.2 8.8 5.3 8.4 2.9 8.7 2.3 5.0 5.3 6.0 7.8 6.2 8.0 2.5 16.5 10.7 2.8 8.3 4.0 11.8 12.1 2.5 9.4 8.7 4.0 1.7 6.3 6.9 4.2 4.0 2.7 5.9 2.8 6.7 10.9 4.3 11.1 4.5 9.2 5.1 3.6 9.1 5.9 6.0 7.6 5.9 3.1 3.6 2.6 10.9 3.4 7.7 7.7 4.1 9.4 6.6 16.7 6.1 10.0 11.8 2.9 4.4 7.7 4.7 5.3 8.9 8.0 4.2 5.5 4.0 8.7 2.5 7.2 3.8 0.6 1.4 5.0 10.8 1.4 4.1 5.2 9.9 5.9 8.0 5.2 4.8 4.9 3.9 6.9 5.5 0.0 3.4 5.4 4.3 4.2 3.9 14.8 0.0 12.0 4.5 0.0 7.9 2.7 10.0 4.2 101.0 4.6 3.2 0.0 4.5 3.0 3.1 4.0 2.3 5.9 5.9 3.2 7.5 4.9 6.3 64.2 2.3 4.3 0.0 1.0 3.6 4.8 4.0 0.0 2.5 4.5 9.6 0.0 3.9 11.9 13.8 3.1 5.8 2.5 4.9 2.7 ZSCAN5B "ZNF371, ZNF495B" ENSG00000197213 "Zinc finger and SCAN domain containing 5B" A6NJL1 19 56189570-56197920 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.5;testis: 6.1" "Cell type enriched" "Detected in single" 11 "Spermatogonia: 5.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 1.5;plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 1.7;hTCEpi: 1.3" "HPA043123, HPA046836, HPA059494, HPA060667" Uncertain Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA043123: AB_2678328, HPA046836: AB_2679832, HPA059494: AB_2684038, HPA060667: " "unprognostic (4.73e-2)" "unprognostic (9.73e-2)" "unprognostic (3.43e-1)" "unprognostic (1.18e-1)" "unprognostic (1.06e-2)" "unprognostic (5.79e-2)" "unprognostic (2.88e-2)" "unprognostic (2.44e-1)" "unprognostic (5.15e-1)" "unprognostic (1.98e-1)" "unprognostic (7.01e-2)" "unprognostic (2.90e-1)" "unprognostic (2.55e-1)" "unprognostic (3.52e-2)" "unprognostic (2.24e-2)" "unprognostic (1.02e-1)" "unprognostic (2.83e-2)" 0.0 0.0 0.7 0.0 1.2 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.4 0.0 0.2 0.1 0.0 0.0 0.8 0.3 0.4 0.3 0.2 0.5 0.5 0.0 0.6 0.0 0.0 1.0 0.1 0.9 0.1 0.1 0.2 0.0 0.0 0.0 1.7 0.9 0.0 0.3 0.0 0.6 0.3 0.4 1.3 0.0 0.0 0.1 0.2 0.5 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.9 0.0 0.3 0.0 0.4 0.0 1.0 0.0 0.4 0.0 0.3 0.0 0.6 0.8 0.3 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 5.7 0.0 0.0 0.0 0.0 0.0 ZSCAN5C "ZNF495C, ZSCAN5CP" ENSG00000204532 "Zinc finger and SCAN domain containing 5C" A6NGD5 19 56202301-56209452 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.7" "HPA041263, HPA043123, HPA046836, HPA060667" Uncertain Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: " "unprognostic (3.74e-1)" "unprognostic (1.54e-1)" "unprognostic (3.29e-2)" "unprognostic (2.56e-2)" "unprognostic (9.17e-3)" "unprognostic (1.53e-1)" "unprognostic (1.47e-1)" "unprognostic (3.68e-2)" "unprognostic (4.01e-2)" "unprognostic (2.13e-2)" "unprognostic (7.45e-2)" "unprognostic (1.35e-1)" "unprognostic (8.51e-2)" "unprognostic (1.55e-1)" "unprognostic (7.89e-2)" "unprognostic (2.53e-1)" "unprognostic (9.53e-3)" 0.4 0.0 0.1 0.4 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 1.0 0.3 0.0 0.7 0.0 0.9 0.3 0.0 0.3 0.0 0.7 0.2 0.2 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.9 0.0 0.4 0.7 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.4 0.0 0.4 0.9 0.2 1.7 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.8 0.0 0.0 0.2 0.4 0.7 0.7 0.3 0.0 0.3 0.4 0.4 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.6 0.3 0.7 0.7 0.7 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZSWIM7 SWS1 ENSG00000214941 "Zinc finger SWIM-type containing 7" Q19AV6 17 15976560-15999717 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054681 Uncertain Uncertain Cytosol NA NA Cytosol "HPA054681: AB_2682572" "unprognostic (3.07e-2)" "unprognostic (5.51e-2)" "unprognostic (1.58e-1)" "prognostic favorable (3.54e-5)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (1.75e-2)" "unprognostic (8.28e-2)" "unprognostic (4.61e-2)" "unprognostic (3.82e-2)" "prognostic favorable (1.77e-4)" "unprognostic (4.23e-2)" "unprognostic (1.84e-2)" "unprognostic (8.56e-2)" "unprognostic (2.45e-3)" "unprognostic (8.80e-3)" "unprognostic (1.70e-1)" 10.0 16.2 14.3 11.5 21.7 7.0 21.5 9.8 28.7 9.4 10.3 9.8 13.8 13.2 11.5 14.2 11.6 11.2 8.8 18.7 17.4 13.8 15.2 14.4 13.6 13.8 16.9 12.2 14.3 13.9 8.6 15.5 10.2 16.5 9.6 9.1 9.9 14.0 13.1 49.2 13.8 9.3 11.2 22.1 12.2 10.5 10.8 12.1 6.2 12.1 8.4 7.3 11.4 11.2 17.2 26.0 15.2 17.2 10.0 12.6 12.2 10.1 14.9 8.1 18.6 3.3 3.1 9.4 6.9 2.6 7.3 5.4 2.8 3.0 4.9 6.1 7.5 2.2 3.3 2.5 5.5 3.5 5.0 9.1 5.5 6.9 5.7 7.7 4.4 9.3 7.5 9.9 4.0 6.9 1.1 9.3 12.8 3.5 2.7 3.7 13.8 15.2 10.5 4.9 14.9 8.9 9.7 19.8 7.6 6.6 5.6 2.7 11.8 10.6 10.7 6.9 21.8 7.7 1.1 13.1 11.9 4.1 3.1 5.9 1.3 3.6 5.6 10.2 5.6 10.1 15.2 17.2 7.0 8.9 16.1 9.3 17.2 10.4 8.5 26.0 14.3 12.6 12.0 1.0 10.0 11.3 16.1 7.5 12.2 14.3 21.7 9.8 28.7 17.4 13.8 16.9 12.2 16.5 12.1 32.8 55.7 24.4 28.2 22.8 38.5 59.6 68.8 41.5 26.1 38.4 58.9 74.3 72.9 53.3 8.3 29.2 35.8 0.0 45.1 51.4 24.4 30.3 54.3 39.8 44.0 17.5 48.8 32.5 52.9 9.8 42.0 43.4 52.3 18.0 36.4 46.9 43.1 35.1 37.4 102.1 54.4 25.8 26.9 89.2 59.4 24.1 60.9 27.9 31.8 20.3